Citrus Sinensis ID: 044366
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
ID ![]() | Alignment graph ![]() | Length ![]() |
Definition ![]() |
RBH(Q2H) ![]() |
RBH(H2Q) ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 918 | 2.2.26 [Sep-21-2011] | |||||||
| Q8VZG8 | 1045 | Probable LRR receptor-lik | yes | no | 0.984 | 0.865 | 0.475 | 0.0 | |
| Q9LP24 | 1120 | Probable leucine-rich rep | no | no | 0.981 | 0.804 | 0.440 | 0.0 | |
| Q9SHI2 | 1101 | Leucine-rich repeat recep | no | no | 0.980 | 0.817 | 0.374 | 1e-159 | |
| Q9LVP0 | 1102 | Probable leucine-rich rep | no | no | 0.991 | 0.825 | 0.370 | 1e-159 | |
| O49318 | 1124 | Probable leucine-rich rep | no | no | 0.994 | 0.812 | 0.370 | 1e-156 | |
| C0LGQ5 | 1249 | LRR receptor-like serine/ | no | no | 0.984 | 0.723 | 0.360 | 1e-150 | |
| Q9FIZ3 | 1252 | LRR receptor-like serine/ | no | no | 0.988 | 0.724 | 0.358 | 1e-146 | |
| C0LGV1 | 1135 | LRR receptor-like serine/ | no | no | 0.959 | 0.776 | 0.360 | 1e-143 | |
| Q9LHP4 | 1141 | Receptor-like protein kin | no | no | 0.953 | 0.766 | 0.363 | 1e-143 | |
| Q9FZ59 | 1088 | Leucine-rich repeat recep | no | no | 0.980 | 0.827 | 0.339 | 1e-136 |
| >sp|Q8VZG8|Y4885_ARATH Probable LRR receptor-like serine/threonine-protein kinase At4g08850 OS=Arabidopsis thaliana GN=At4g08850 PE=1 SV=3 | Back alignment and function desciption |
|---|
Score = 804 bits (2077), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 437/919 (47%), Positives = 600/919 (65%), Gaps = 15/919 (1%)
Query: 2 LNLGFNLLFGNIPPQIGNLSKLQYLDLGNNQLSGVIPPEIGKLNQLRRLYLDVNQLHGTI 61
++L N G I P G SKL+Y DL NQL G IPPE+G L+ L L+L N+L+G+I
Sbjct: 123 VDLSMNRFSGTISPLWGRFSKLEYFDLSINQLVGEIPPELGDLSNLDTLHLVENKLNGSI 182
Query: 62 PPVIGQLSLINELVFCHNNVSGRIPSSLGNLSNLALLYLNDNSLFGSIPIVMGNLKSLST 121
P IG+L+ + E+ N ++G IPSS GNL+ L LYL NSL GSIP +GNL +L
Sbjct: 183 PSEIGRLTKVTEIAIYDNLLTGPIPSSFGNLTKLVNLYLFINSLSGSIPSEIGNLPNLRE 242
Query: 122 LDLSQNQLNGSIPCSLDNLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSENRLSGLI 181
L L +N L G IP S NL N+ L +++N LSG IP IGN+ +L L L N+L+G I
Sbjct: 243 LCLDRNNLTGKIPSSFGNLKNVTLLNMFENQLSGEIPPEIGNMTALDTLSLHTNKLTGPI 302
Query: 182 PLSLSNLSSLTVMSLFNNSLSGSIPPILGNLKSLSTLGLHINQLNGVIPPSIGNLSSLRN 241
P +L N+ +L V+ L+ N L+GSIPP LG ++S+ L + N+L G +P S G L++L
Sbjct: 303 PSTLGNIKTLAVLHLYLNQLNGSIPPELGEMESMIDLEISENKLTGPVPDSFGKLTALEW 362
Query: 242 LSLFNNRLYGFVPKEIGYLKSLSKLEFCANHLSGVIPHSVGNLTGLVLLNMCENHLFGPI 301
L L +N+L G +P I L+ L+ N+ +G +P ++ L L + +NH GP+
Sbjct: 363 LFLRDNQLSGPIPPGIANSTELTVLQLDTNNFTGFLPDTICRGGKLENLTLDDNHFEGPV 422
Query: 302 PKSLRNLTSLERVRFNQNNLYGKVYEAFGDHPNLTFLDLSQNNFYCEISFNWRNFSKLGT 361
PKSLR+ SL RVRF N+ G + EAFG +P L F+DLS NNF+ ++S NW KL
Sbjct: 423 PKSLRDCKSLIRVRFKGNSFSGDISEAFGVYPTLNFIDLSNNNFHGQLSANWEQSQKLVA 482
Query: 362 FNASMNNIYGSIPPEIGDSSKLQVLDLSSNHIFGKIPVQLVKLFSLNKLILSLNQLFGGV 421
F S N+I G+IPPEI + ++L LDLSSN I G++P + + ++KL L+ N+L G +
Sbjct: 483 FILSNNSITGAIPPEIWNMTQLSQLDLSSNRITGELPESISNINRISKLQLNGNRLSGKI 542
Query: 422 PLEFGTLTELQYLDLSANKLSSSIPMSIGNLLKLHYLNLSNNQFSHKIPTEFEKLIHLSE 481
P LT L+YLDLS+N+ SS IP ++ NL +L+Y+NLS N IP KL L
Sbjct: 543 PSGIRLLTNLEYLDLSSNRFSSEIPPTLNNLPRLYYMNLSRNDLDQTIPEGLTKLSQLQM 602
Query: 482 LDLSHNILQEEIPPQICKMESLEKLNLSHNNLSDFIPRCFEEMRSLSWIDISYNELQGPI 541
LDLS+N L EI Q +++LE+L+LSHNNLS IP F++M +L+ +D+S+N LQGPI
Sbjct: 603 LDLSYNQLDGEISSQFRSLQNLERLDLSHNNLSGQIPPSFKDMLALTHVDVSHNNLQGPI 662
Query: 542 PNSTAFKNG---LMEGNKGLCGNF---KALPSCDAFTSHKQTFRKKWVVIAL--PILGMV 593
P++ AF+N EGNK LCG+ + L C + TS K++ + + ++I + PI+G +
Sbjct: 663 PDNAAFRNAPPDAFEGNKDLCGSVNTTQGLKPC-SITSSKKSHKDRNLIIYILVPIIGAI 721
Query: 594 VLLIGLIGFFFLFRRRKRDPQEKRSSSANPFGFFSVLNFNGKVLYEEITKATGNFGEKYC 653
++L G F FR+R + +E S + S+ +F+GKV Y+EI KATG F KY
Sbjct: 722 IILSVCAGIFICFRKRTKQIEEHTDSESGG-ETLSIFSFDGKVRYQEIIKATGEFDPKYL 780
Query: 654 IGKGGQRSVYKAELPSGNIFAVKKFKAELFSDETANPS---EFLNEVLALTEIRHRNIIK 710
IG GG VYKA+LP+ I AVKK E +NPS EFLNE+ ALTEIRHRN++K
Sbjct: 781 IGTGGHGKVYKAKLPNA-IMAVKKLN-ETTDSSISNPSTKQEFLNEIRALTEIRHRNVVK 838
Query: 711 FHGFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCI 770
GFCS+ +++F+V EY+ RGSL +L +D AK+ W +R+NV+KGVA+ALSY+HHD
Sbjct: 839 LFGFCSHRRNTFLVYEYMERGSLRKVLENDDEAKKLDWGKRINVVKGVAHALSYMHHDRS 898
Query: 771 PPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGTVGYAAPELAYTMRAT 830
P IVHRDISS N+LL +YEA +SDFG AK L+P SSNW+ AGT GY APELAY M+ T
Sbjct: 899 PAIVHRDISSGNILLGEDYEAKISDFGTAKLLKPDSSNWSAVAGTYGYVAPELAYAMKVT 958
Query: 831 EKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRDVTDKLRS 890
EK DVYSFGVL LEVIKG HPGD VST+ SS + + + I DHRLP P+ ++ +++
Sbjct: 959 EKCDVYSFGVLTLEVIKGEHPGDLVSTLSSSPPDATLSLKSISDHRLPEPTPEIKEEVLE 1018
Query: 891 IMEVAILCLVENPEARPTM 909
I++VA+LCL +P+ARPTM
Sbjct: 1019 ILKVALLCLHSDPQARPTM 1037
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9LP24|Y1571_ARATH Probable leucine-rich repeat receptor-like protein kinase At1g35710 OS=Arabidopsis thaliana GN=At1g35710 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 766 bits (1978), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 446/1013 (44%), Positives = 602/1013 (59%), Gaps = 112/1013 (11%)
Query: 2 LNLGFNLLFGNIPPQIGNLSKLQYLDLGNNQLSGVIPPEIGKLNQLRRLYLDVNQLHGTI 61
++L NLL G IPPQ GNLSKL Y DL N L+G I P +G L L LYL N L I
Sbjct: 107 VDLSMNLLSGTIPPQFGNLSKLIYFDLSTNHLTGEISPSLGNLKNLTVLYLHQNYLTSVI 166
Query: 62 PPVIGQLSLINELVFCHNNVSGRIPSSLGNLSNLALLYLNDNSLFGSIPIVMGNLKSLST 121
P +G + + +L N ++G IPSSLGNL NL +LYL +N L G IP +GN++S++
Sbjct: 167 PSELGNMESMTDLALSQNKLTGSIPSSLGNLKNLMVLYLYENYLTGVIPPELGNMESMTD 226
Query: 122 LDLSQNQLNGSIPCSLDNLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSENRLSGLI 181
L LSQN+L GSIP +L NL NL L+LY+N L+G IP IGN++S+ L LS+N+L+G I
Sbjct: 227 LALSQNKLTGSIPSTLGNLKNLMVLYLYENYLTGVIPPEIGNMESMTNLALSQNKLTGSI 286
Query: 182 PLSLSNLSSLTVMSLF------------------------NNSLSGSIPPILGNLKSLST 217
P SL NL +LT++SLF NN L+GSIP LGNLK+L+
Sbjct: 287 PSSLGNLKNLTLLSLFQNYLTGGIPPKLGNIESMIDLELSNNKLTGSIPSSLGNLKNLTI 346
Query: 218 LGLHINQLNGVIPPSIGNLSSLRNLSLFNNRL------------------------YGFV 253
L L+ N L GVIPP +GN+ S+ +L L NN+L G +
Sbjct: 347 LYLYENYLTGVIPPELGNMESMIDLQLNNNKLTGSIPSSFGNLKNLTYLYLYLNYLTGVI 406
Query: 254 PKEIGYLKSLSKLEFCANHLSGVIPHSVGNLTGLVLL----------------------- 290
P+E+G ++S+ L+ N L+G +P S GN T L L
Sbjct: 407 PQELGNMESMINLDLSQNKLTGSVPDSFGNFTKLESLYLRVNHLSGAIPPGVANSSHLTT 466
Query: 291 --------------NMCE-----------NHLFGPIPKSLRNLTSLERVRFNQNNLYGKV 325
+C+ NHL GPIPKSLR+ SL R RF N G +
Sbjct: 467 LILDTNNFTGFFPETVCKGRKLQNISLDYNHLEGPIPKSLRDCKSLIRARFLGNKFTGDI 526
Query: 326 YEAFGDHPNLTFLDLSQNNFYCEISFNWRNFSKLGTFNASMNNIYGSIPPEIGDSSKLQV 385
+EAFG +P+L F+D S N F+ EIS NW KLG S NNI G+IP EI + ++L
Sbjct: 527 FEAFGIYPDLNFIDFSHNKFHGEISSNWEKSPKLGALIMSNNNITGAIPTEIWNMTQLVE 586
Query: 386 LDLSSNHIFGKIPVQLVKLFSLNKLILSLNQLFGGVPLEFGTLTELQYLDLSANKLSSSI 445
LDLS+N++FG++P + L +L++L L+ NQL G VP LT L+ LDLS+N SS I
Sbjct: 587 LDLSTNNLFGELPEAIGNLTNLSRLRLNGNQLSGRVPAGLSFLTNLESLDLSSNNFSSEI 646
Query: 446 PMSIGNLLKLHYLNLSNNQFSHKIPTEFEKLIHLSELDLSHNILQEEIPPQICKMESLEK 505
P + + LKLH +NLS N+F IP KL L++LDLSHN L EIP Q+ ++SL+K
Sbjct: 647 PQTFDSFLKLHDMNLSRNKFDGSIP-RLSKLTQLTQLDLSHNQLDGEIPSQLSSLQSLDK 705
Query: 506 LNLSHNNLSDFIPRCFEEMRSLSWIDISYNELQGPIPNSTAFKNGL---MEGNKGLCGNF 562
L+LSHNNLS IP FE M +L+ +DIS N+L+GP+P++ F+ +E N GLC N
Sbjct: 706 LDLSHNNLSGLIPTTFEGMIALTNVDISNNKLEGPLPDTPTFRKATADALEENIGLCSNI 765
Query: 563 --KALPSCDAFTSHKQTFR-KKWVVIALPILGMVVLLIGLIGFFFLFRRRKRDPQEKRSS 619
+ L C K+ W+++ PILG++V+L + F + RKR Q R++
Sbjct: 766 PKQRLKPCRELKKPKKNGNLVVWILV--PILGVLVIL-SICANTFTYCIRKRKLQNGRNT 822
Query: 620 SANPFGFFSVLNFNGKVLYEEITKATGNFGEKYCIGKGGQRSVYKAELPSGNIFAVKKFK 679
S+ + +GK Y++I ++T F + IG GG VY+A L I AVK+
Sbjct: 823 DPETGENMSIFSVDGKFKYQDIIESTNEFDPTHLIGTGGYSKVYRANL-QDTIIAVKRLH 881
Query: 680 AELFSDETANP---SEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFIVCEYLARGSLTTI 736
+ +E + P EFLNEV ALTEIRHRN++K GFCS+ +H+F++ EY+ +GSL +
Sbjct: 882 -DTIDEEISKPVVKQEFLNEVKALTEIRHRNVVKLFGFCSHRRHTFLIYEYMEKGSLNKL 940
Query: 737 LRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDF 796
L +D AK +W +R+NV+KGVA+ALSY+HHD I PIVHRDISS N+LLD++Y A +SDF
Sbjct: 941 LANDEEAKRLTWTKRINVVKGVAHALSYMHHDRITPIVHRDISSGNILLDNDYTAKISDF 1000
Query: 797 GFAKFLEPHSSNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVS 856
G AK L+ SSNW+ AGT GY APE AYTM+ TEK DVYSFGVL LE+I G HPGD VS
Sbjct: 1001 GTAKLLKTDSSNWSAVAGTYGYVAPEFAYTMKVTEKCDVYSFGVLILELIIGKHPGDLVS 1060
Query: 857 TIFSSISNMIIEVNQILDHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTM 909
++ SS + + I D R+ P +KL ++E+A+LCL NPE+RPTM
Sbjct: 1061 SLSSSPGEA-LSLRSISDERVLEPRGQNREKLLKMVEMALLCLQANPESRPTM 1112
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SHI2|Y1723_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase At1g17230 OS=Arabidopsis thaliana GN=At1g17230 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 563 bits (1452), Expect = e-159, Method: Compositional matrix adjust.
Identities = 351/938 (37%), Positives = 501/938 (53%), Gaps = 38/938 (4%)
Query: 7 NLLFGNIPPQIGNLSKLQYLDLGNNQLSGVIPPEIGKLNQLRRLYLDVNQLHGTIPPVIG 66
N LFG+IP QIGNLS LQ L + +N L+GVIPP + KL QLR + N G IP I
Sbjct: 149 NYLFGSIPRQIGNLSSLQELVIYSNNLTGVIPPSMAKLRQLRIIRAGRNGFSGVIPSEIS 208
Query: 67 QLSLINELVFCHNNVSGRIPSSLGNLSNLALLYLNDNSLFGSIPIVMGNLKSLSTLDLSQ 126
+ L N + G +P L L NL L L N L G IP +GN+ L L L +
Sbjct: 209 GCESLKVLGLAENLLEGSLPKQLEKLQNLTDLILWQNRLSGEIPPSVGNISRLEVLALHE 268
Query: 127 NQLNGSIPCSLDNLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSENRLSGLIPLSLS 186
N GSIP + L+ + L+LY N L+G IP IGNL ++D SEN+L+G IP
Sbjct: 269 NYFTGSIPREIGKLTKMKRLYLYTNQLTGEIPREIGNLIDAAEIDFSENQLTGFIPKEFG 328
Query: 187 NLSSLTVMSLFNNSLSGSIPPILGNLKSLSTLGLHINQLNGVIPPSIGNLSSLRNLSLFN 246
++ +L ++ LF N L G IP LG L L L L IN+LNG IP + L L +L LF+
Sbjct: 329 HILNLKLLHLFENILLGPIPRELGELTLLEKLDLSINRLNGTIPQELQFLPYLVDLQLFD 388
Query: 247 NRLYGFVPKEIGYLKSLSKLEFCANHLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLR 306
N+L G +P IG+ + S L+ AN LSG IP L+LL++ N L G IP+ L+
Sbjct: 389 NQLEGKIPPLIGFYSNFSVLDMSANSLSGPIPAHFCRFQTLILLSLGSNKLSGNIPRDLK 448
Query: 307 NLTSLERVRFNQNNLYGKVYEAFGDHPNLTFLDLSQNNFYCEISFNWRNFSKLGTFNASM 366
SL ++ N L G + + NLT L+L QN IS + L +
Sbjct: 449 TCKSLTKLMLGDNQLTGSLPIELFNLQNLTALELHQNWLSGNISADLGKLKNLERLRLAN 508
Query: 367 NNIYGSIPPEIGDSSKLQVLDLSSNHIFGKIPVQLVKLFSLNKLILSLNQLFGGVPLEFG 426
NN G IPPEIG+ +K+ ++SSN + G IP +L ++ +L LS N+ G + E G
Sbjct: 509 NNFTGEIPPEIGNLTKIVGFNISSNQLTGHIPKELGSCVTIQRLDLSGNKFSGYIAQELG 568
Query: 427 TLTELQYLDLSANKLSSSIPMSIGNLLKLHYLNLSNNQFSHKIPTEFEKLIHLS-ELDLS 485
L L+ L LS N+L+ IP S G+L +L L L N S IP E KL L L++S
Sbjct: 569 QLVYLEILRLSDNRLTGEIPHSFGDLTRLMELQLGGNLLSENIPVELGKLTSLQISLNIS 628
Query: 486 HNILQEEIPPQICKMESLEKLNLSHNNLSDFIPRCFEEMRSLSWIDISYNELQGPIPNST 545
HN L IP + ++ LE L L+ N LS IP + SL +IS N L G +P++
Sbjct: 629 HNNLSGTIPDSLGNLQMLEILYLNDNKLSGEIPASIGNLMSLLICNISNNNLVGTVPDTA 688
Query: 546 AFK---NGLMEGNKGLCGNFKALPSCDAFTSHKQTF---------RKKWVVIALPILGMV 593
F+ + GN GLC + ++ C H + R+K + I ++G
Sbjct: 689 VFQRMDSSNFAGNHGLCNSQRS--HCQPLVPHSDSKLNWLINGSQRQKILTITCIVIG-S 745
Query: 594 VLLIGLIGFFFLFRRRKRDP-----QEKRSSSANPFGFFSVLNFNGKVLYEEITKATGNF 648
V LI +G + +R R+P +++ +F F Y+ + AT NF
Sbjct: 746 VFLITFLGLCWTIKR--REPAFVALEDQTKPDVMDSYYFPKKGFT----YQGLVDATRNF 799
Query: 649 GEKYCIGKGGQRSVYKAELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNI 708
E +G+G +VYKAE+ G + AVKK + + ++ + F E+ L +IRHRNI
Sbjct: 800 SEDVVLGRGACGTVYKAEMSGGEVIAVKKLNSR--GEGASSDNSFRAEISTLGKIRHRNI 857
Query: 709 IKFHGFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHD 768
+K +GFC + + ++ EY+++GSL L+ WN R + G A L YLHHD
Sbjct: 858 VKLYGFCYHQNSNLLLYEYMSKGSLGEQLQRGEKNCLLDWNARYRIALGAAEGLCYLHHD 917
Query: 769 CIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLE-PHSSNWTEFAGTVGYAAPELAYTM 827
C P IVHRDI S N+LLD ++AHV DFG AK ++ +S + + AG+ GY APE AYTM
Sbjct: 918 CRPQIVHRDIKSNNILLDERFQAHVGDFGLAKLIDLSYSKSMSAVAGSYGYIAPEYAYTM 977
Query: 828 RATEKYDVYSFGVLALEVIKGYHP-------GDFVSTIFSSISNMIIEVNQILDHRLPTP 880
+ TEK D+YSFGV+ LE+I G P GD V+ + SI NMI + ++ D RL T
Sbjct: 978 KVTEKCDIYSFGVVLLELITGKPPVQPLEQGGDLVNWVRRSIRNMIPTI-EMFDARLDTN 1036
Query: 881 SRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLLCK 918
+ ++ ++++A+ C +P +RPTM+EV ++ +
Sbjct: 1037 DKRTVHEMSLVLKIALFCTSNSPASRPTMREVVAMITE 1074
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LVP0|Y5639_ARATH Probable leucine-rich repeat receptor-like protein kinase At5g63930 OS=Arabidopsis thaliana GN=At5g63930 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 562 bits (1449), Expect = e-159, Method: Compositional matrix adjust.
Identities = 365/986 (37%), Positives = 524/986 (53%), Gaps = 76/986 (7%)
Query: 2 LNLGFNLLFGNIPPQIGNLSKLQYLDLGNNQLSGVIPPEIGKLNQLRRLYLDVNQLHGTI 61
L+L +N L G IP +IGN S L+ L L NNQ G IP EIGKL L L + N++ G++
Sbjct: 102 LDLSYNGLSGKIPKEIGNCSSLEILKLNNNQFDGEIPVEIGKLVSLENLIIYNNRISGSL 161
Query: 62 PPVIGQLSLINELVFCHNNVSGRIPSSLGNLSNLALLYLNDNSLFGSIPIVMGNLKSLST 121
P IG L +++LV NN+SG++P S+GNL L N + GS+P +G +SL
Sbjct: 162 PVEIGNLLSLSQLVTYSNNISGQLPRSIGNLKRLTSFRAGQNMISGSLPSEIGGCESLVM 221
Query: 122 LDLSQNQLNGS------------------------IPCSLDNLSNLDTLFLYKNSLSGPI 157
L L+QNQL+G IP + N ++L+TL LYKN L GPI
Sbjct: 222 LGLAQNQLSGELPKEIGMLKKLSQVILWENEFSGFIPREISNCTSLETLALYKNQLVGPI 281
Query: 158 PSVIGNLKSL------------------------LQLDLSENRLSGLIPLSLSNLSSLTV 193
P +G+L+SL +++D SEN L+G IPL L N+ L +
Sbjct: 282 PKELGDLQSLEFLYLYRNGLNGTIPREIGNLSYAIEIDFSENALTGEIPLELGNIEGLEL 341
Query: 194 MSLFNNSLSGSIPPILGNLKSLSTLGLHINQLNGVIPPSIGNLSSLRNLSLFNNRLYGFV 253
+ LF N L+G+IP L LK+LS L L IN L G IP L L L LF N L G +
Sbjct: 342 LYLFENQLTGTIPVELSTLKNLSKLDLSINALTGPIPLGFQYLRGLFMLQLFQNSLSGTI 401
Query: 254 PKEIGYLKSLSKLEFCANHLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLRNLTSLER 313
P ++G+ L L+ NHLSG IP + + +++LN+ N+L G IP + +L +
Sbjct: 402 PPKLGWYSDLWVLDMSDNHLSGRIPSYLCLHSNMIILNLGTNNLSGNIPTGITTCKTLVQ 461
Query: 314 VRFNQNNLYGKVYEAFGDHPNLTFLDLSQNNFYCEISFNWRNFSKLGTFNASMNNIYGSI 373
+R +NNL G+ N+T ++L QN F I N S L + N G +
Sbjct: 462 LRLARNNLVGRFPSNLCKQVNVTAIELGQNRFRGSIPREVGNCSALQRLQLADNGFTGEL 521
Query: 374 PPEIGDSSKLQVLDLSSNHIFGKIPVQLVKLFSLNKLILSLNQLFGGVPLEFGTLTELQY 433
P EIG S+L L++SSN + G++P ++ L +L + N G +P E G+L +L+
Sbjct: 522 PREIGMLSQLGTLNISSNKLTGEVPSEIFNCKMLQRLDMCCNNFSGTLPSEVGSLYQLEL 581
Query: 434 LDLSANKLSSSIPMSIGNLLKLHYLNLSNNQFSHKIPTEFEKLIHLS-ELDLSHNILQEE 492
L LS N LS +IP+++GNL +L L + N F+ IP E L L L+LS+N L E
Sbjct: 582 LKLSNNNLSGTIPVALGNLSRLTELQMGGNLFNGSIPRELGSLTGLQIALNLSYNKLTGE 641
Query: 493 IPPQICKMESLEKLNLSHNNLSDFIPRCFEEMRSLSWIDISYNELQGPIPNSTAFKNGLM 552
IPP++ + LE L L++NNLS IP F + SL + SYN L GPIP
Sbjct: 642 IPPELSNLVMLEFLLLNNNNLSGEIPSSFANLSSLLGYNFSYNSLTGPIPLLRNISMSSF 701
Query: 553 EGNKGLCGNFKALPSC---DAFTSHKQTFR------KKWVVIALPILGMVVLLIGLIGFF 603
GN+GLCG L C F + T + K + I ++G V L+ LI
Sbjct: 702 IGNEGLCG--PPLNQCIQTQPFAPSQSTGKPGGMRSSKIIAITAAVIGGVSLM--LIALI 757
Query: 604 FLFRRRKRDPQEKRSSSANPFGFFSVLNFNGK--VLYEEITKATGNFGEKYCIGKGGQRS 661
RR + P + F K ++++ AT NF E + +G+G +
Sbjct: 758 VYLMRRPVRTVASSAQDGQPSEMSLDIYFPPKEGFTFQDLVAATDNFDESFVVGRGACGT 817
Query: 662 VYKAELPSGNIFAVKKFKAELFSDETAN-PSEFLNEVLALTEIRHRNIIKFHGFCSNAQH 720
VYKA LP+G AVKK + N + F E+L L IRHRNI+K HGFC++
Sbjct: 818 VYKAVLPAGYTLAVKKLASNHEGGNNNNVDNSFRAEILTLGNIRHRNIVKLHGFCNHQGS 877
Query: 721 SFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISS 780
+ ++ EY+ +GSL IL D + W++R + G A L+YLHHDC P I HRDI S
Sbjct: 878 NLLLYEYMPKGSLGEILHDPSC--NLDWSKRFKIALGAAQGLAYLHHDCKPRIFHRDIKS 935
Query: 781 KNVLLDSEYEAHVSDFGFAKFLE-PHSSNWTEFAGTVGYAAPELAYTMRATEKYDVYSFG 839
N+LLD ++EAHV DFG AK ++ PHS + + AG+ GY APE AYTM+ TEK D+YS+G
Sbjct: 936 NNILLDDKFEAHVGDFGLAKVIDMPHSKSMSAIAGSYGYIAPEYAYTMKVTEKSDIYSYG 995
Query: 840 VLALEVIKGYHP-------GDFVSTIFSSISNMIIEVNQILDHRLPTPSRDVTDKLRSIM 892
V+ LE++ G P GD V+ + S I + + +LD RL + + +++
Sbjct: 996 VVLLELLTGKAPVQPIDQGGDVVNWVRSYIRRDALS-SGVLDARLTLEDERIVSHMLTVL 1054
Query: 893 EVAILCLVENPEARPTMKEVCNLLCK 918
++A+LC +P ARP+M++V +L +
Sbjct: 1055 KIALLCTSVSPVARPSMRQVVLMLIE 1080
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O49318|Y2317_ARATH Probable leucine-rich repeat receptor-like protein kinase At2g33170 OS=Arabidopsis thaliana GN=At2g33170 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 551 bits (1421), Expect = e-156, Method: Compositional matrix adjust.
Identities = 368/992 (37%), Positives = 529/992 (53%), Gaps = 79/992 (7%)
Query: 2 LNLGFNLLFGNIPPQIGNLSKLQYLDLGNNQLSGVIPPEIGKLNQLRRLYLDVNQLHGTI 61
LNL +N L G+IP +IGN SKL+ + L NNQ G IP EI KL+QLR + N+L G +
Sbjct: 114 LNLAYNALTGDIPREIGNCSKLEVMFLNNNQFGGSIPVEINKLSQLRSFNICNNKLSGPL 173
Query: 62 PPVIGQLSLINELVFCHNNVSGRIPSSLGNLS------------------------NLAL 97
P IG L + ELV NN++G +P SLGNL+ NL L
Sbjct: 174 PEEIGDLYNLEELVAYTNNLTGPLPRSLGNLNKLTTFRAGQNDFSGNIPTEIGKCLNLKL 233
Query: 98 LYLNDNSLFGSIPIVMGNLKSLSTLDLSQNQLNGSIPCSLDNLSNLDTLFLYKNSLSGPI 157
L L N + G +P +G L L + L QN+ +G IP + NL++L+TL LY NSL GPI
Sbjct: 234 LGLAQNFISGELPKEIGMLVKLQEVILWQNKFSGFIPKDIGNLTSLETLALYGNSLVGPI 293
Query: 158 PSVIGNLKSL------------------------LQLDLSENRLSGLIPLSLSNLSSLTV 193
PS IGN+KSL +++D SEN LSG IP+ LS +S L +
Sbjct: 294 PSEIGNMKSLKKLYLYQNQLNGTIPKELGKLSKVMEIDFSENLLSGEIPVELSKISELRL 353
Query: 194 MSLFNNSLSGSIPPILGNLKSLSTLGLHINQLNGVIPPSIGNLSSLRNLSLFNNRLYGFV 253
+ LF N L+G IP L L++L+ L L IN L G IPP NL+S+R L LF+N L G +
Sbjct: 354 LYLFQNKLTGIIPNELSKLRNLAKLDLSINSLTGPIPPGFQNLTSMRQLQLFHNSLSGVI 413
Query: 254 PKEIGYLKSLSKLEFCANHLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLRNLTSLER 313
P+ +G L ++F N LSG IP + + L+LLN+ N +FG IP + SL +
Sbjct: 414 PQGLGLYSPLWVVDFSENQLSGKIPPFICQQSNLILLNLGSNRIFGNIPPGVLRCKSLLQ 473
Query: 314 VRFNQNNLYGKVYEAFGDHPNLTFLDLSQNNFYCEISFNWRNFSKLGTFNASMNNIYGSI 373
+R N L G+ NL+ ++L QN F + KL + + N ++
Sbjct: 474 LRVVGNRLTGQFPTELCKLVNLSAIELDQNRFSGPLPPEIGTCQKLQRLHLAANQFSSNL 533
Query: 374 PPEIGDSSKLQVLDLSSNHIFGKIPVQLVKLFSLNKLILSLNQLFGGVPLEFGTLTELQY 433
P EI S L ++SSN + G IP ++ L +L LS N G +P E G+L +L+
Sbjct: 534 PNEISKLSNLVTFNVSSNSLTGPIPSEIANCKMLQRLDLSRNSFIGSLPPELGSLHQLEI 593
Query: 434 LDLSANKLSSSIPMSIGNLLKLHYLNLSNNQFSHKIPTEFEKLIHLS-ELDLSHNILQEE 492
L LS N+ S +IP +IGNL L L + N FS IP + L L ++LS+N E
Sbjct: 594 LRLSENRFSGNIPFTIGNLTHLTELQMGGNLFSGSIPPQLGLLSSLQIAMNLSYNDFSGE 653
Query: 493 IPPQICKMESLEKLNLSHNNLSDFIPRCFEEMRSLSWIDISYNELQGPIPNSTAFKNGLM 552
IPP+I + L L+L++N+LS IP FE + SL + SYN L G +P++ F+N +
Sbjct: 654 IPPEIGNLHLLMYLSLNNNHLSGEIPTTFENLSSLLGCNFSYNNLTGQLPHTQIFQNMTL 713
Query: 553 E---GNKGLCGNFKALPSCDA-------FTSHKQTFRKKWVVIALPILGMVVLLIGLIGF 602
GNKGLCG L SCD +S K ++ +I + + + + LI
Sbjct: 714 TSFLGNKGLCGGH--LRSCDPSHSSWPHISSLKAGSARRGRIIIIVSSVIGGISLLLIAI 771
Query: 603 FFLFRRRKRDPQEKRSSSANPFGFFSVLNFNGKVLY--EEITKATGNFGEKYCIGKGGQR 660
F R +P PF S + F K + ++I +AT F + Y +G+G
Sbjct: 772 VVHFLRNPVEPTAPYVHDKEPFFQESDIYFVPKERFTVKDILEATKGFHDSYIVGRGACG 831
Query: 661 SVYKAELPSGNIFAVKKFK---AELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFC-- 715
+VYKA +PSG AVKK + ++ + F E+L L +IRHRNI++ + FC
Sbjct: 832 TVYKAVMPSGKTIAVKKLESNREGNNNNSNNTDNSFRAEILTLGKIRHRNIVRLYSFCYH 891
Query: 716 SNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVH 775
+ + ++ EY++RGSL +L + W R + G A L+YLHHDC P I+H
Sbjct: 892 QGSNSNLLLYEYMSRGSLGELLH-GGKSHSMDWPTRFAIALGAAEGLAYLHHDCKPRIIH 950
Query: 776 RDISSKNVLLDSEYEAHVSDFGFAKFLE-PHSSNWTEFAGTVGYAAPELAYTMRATEKYD 834
RDI S N+L+D +EAHV DFG AK ++ P S + + AG+ GY APE AYTM+ TEK D
Sbjct: 951 RDIKSNNILIDENFEAHVGDFGLAKVIDMPLSKSVSAVAGSYGYIAPEYAYTMKVTEKCD 1010
Query: 835 VYSFGVLALEVIKGYHP-------GDFVSTIFSSISNMIIEVNQILDHRLPTPSRDVT-D 886
+YSFGV+ LE++ G P GD + + I + + ++ILD L DV +
Sbjct: 1011 IYSFGVVLLELLTGKAPVQPLEQGGDLATWTRNHIRDHSL-TSEILDPYLTKVEDDVILN 1069
Query: 887 KLRSIMEVAILCLVENPEARPTMKEVCNLLCK 918
+ ++ ++A+LC +P RPTM+EV +L +
Sbjct: 1070 HMITVTKIAVLCTKSSPSDRPTMREVVLMLIE 1101
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGQ5|GSO1_ARATH LRR receptor-like serine/threonine-protein kinase GSO1 OS=Arabidopsis thaliana GN=GSO1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 531 bits (1369), Expect = e-150, Method: Compositional matrix adjust.
Identities = 362/1005 (36%), Positives = 514/1005 (51%), Gaps = 101/1005 (10%)
Query: 1 MLNLGFNLLFGNIPPQIGNLSKLQYLDLGNNQLSGVIPPEIGKLNQLRRLYLDVNQLHGT 60
+LNL N L G IP Q+G +S+LQYL L NQL G+IP + L L+ L L N L G
Sbjct: 243 ILNLANNSLTGEIPSQLGEMSQLQYLSLMANQLQGLIPKSLADLGNLQTLDLSANNLTGE 302
Query: 61 IPPVIGQLSLINELVFCHNNVSGRIPSSL-GNLSNLALLYLNDNSLFGSIPIVMGNLKSL 119
IP +S + +LV +N++SG +P S+ N +NL L L+ L G IP+ + +SL
Sbjct: 303 IPEEFWNMSQLLDLVLANNHLSGSLPKSICSNNTNLEQLVLSGTQLSGEIPVELSKCQSL 362
Query: 120 STLDLSQNQLNGSIPCSLDNLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSENRLSG 179
LDLS N L GSIP +L L L L+L+ N+L G + I NL +L L L N L G
Sbjct: 363 KQLDLSNNSLAGSIPEALFELVELTDLYLHNNTLEGTLSPSISNLTNLQWLVLYHNNLEG 422
Query: 180 LIPLSLSNLSSLTVMSLFNNSLSGSIPPILGNLKSLSTLGLHINQLNGVIPPSIGNLSSL 239
+P +S L L V+ L+ N SG IP +GN SL + + N G IPPSIG L L
Sbjct: 423 KLPKEISALRKLEVLFLYENRFSGEIPQEIGNCTSLKMIDMFGNHFEGEIPPSIGRLKEL 482
Query: 240 RNLSLFNNRLYGFVPKEIGYLKSLSKLEFCANHLSGVIPHSVGNLTGLVLLNMCENHLFG 299
L L N L G +P +G L+ L+ N LSG IP S G L GL L + N L G
Sbjct: 483 NLLHLRQNELVGGLPASLGNCHQLNILDLADNQLSGSIPSSFGFLKGLEQLMLYNNSLQG 542
Query: 300 PIPKSLRNLTSLERVRFNQNNLYGKVYEAFGDHPNLTFLDLSQNNFYCEISFNWRNFSKL 359
+P SL +L +L R+ + N L G ++ G L+F D++ N F EI N L
Sbjct: 543 NLPDSLISLRNLTRINLSHNRLNGTIHPLCGSSSYLSF-DVTNNGFEDEIPLELGNSQNL 601
Query: 360 GTFNASMNNIYGSIPPEIGDSSKLQVLDLSSNHIFGKIPVQLV----------------- 402
N + G IP +G +L +LD+SSN + G IP+QLV
Sbjct: 602 DRLRLGKNQLTGKIPWTLGKIRELSLLDMSSNALTGTIPLQLVLCKKLTHIDLNNNFLSG 661
Query: 403 -------KLFSLNKLILSLNQLFGGVPLEFGTLTELQYLDLSANKLSSSIPMSIGNLLKL 455
KL L +L LS NQ +P E T+L L L N L+ SIP IGNL L
Sbjct: 662 PIPPWLGKLSQLGELKLSSNQFVESLPTELFNCTKLLVLSLDGNSLNGSIPQEIGNLGAL 721
Query: 456 HYLNLSNNQFSHKIPTEFEKLIHLSELDLSHNILQEEIPPQICKMESLEK-LNLSHNNLS 514
+ LNL NQFS +P KL L EL LS N L EIP +I +++ L+ L+LS+NN +
Sbjct: 722 NVLNLDKNQFSGSLPQAMGKLSKLYELRLSRNSLTGEIPVEIGQLQDLQSALDLSYNNFT 781
Query: 515 DFIPRCFEEMRSLSWIDISYNELQGPIPNS-----------TAFKN--GLME-------- 553
IP + L +D+S+N+L G +P S +F N G ++
Sbjct: 782 GDIPSTIGTLSKLETLDLSHNQLTGEVPGSVGDMKSLGYLNVSFNNLGGKLKKQFSRWPA 841
Query: 554 ----GNKGLCGNFKALPSCDAFTSH--KQTFRKKWVVI--ALPILGMVVLLIGLIGFFFL 605
GN GLCG+ L C+ S+ +Q + VVI A+ L + L+I +I FF
Sbjct: 842 DSFLGNTGLCGS--PLSRCNRVRSNNKQQGLSARSVVIISAISALTAIGLMILVIALFF- 898
Query: 606 FRRRKRDPQEKRSSSANPFG------------FFSVLNFNGKVLYEEITKATGNFGEKYC 653
+++ D +K + + F + +E+I +AT N E++
Sbjct: 899 --KQRHDFFKKVGHGSTAYTSSSSSSQATHKPLFRNGASKSDIRWEDIMEATHNLSEEFM 956
Query: 654 IGKGGQRSVYKAELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHG 713
IG GG VYKAEL +G AVKK L+ D+ + F EV L IRHR+++K G
Sbjct: 957 IGSGGSGKVYKAELENGETVAVKKI---LWKDDLMSNKSFSREVKTLGRIRHRHLVKLMG 1013
Query: 714 FCSNAQH--SFIVCEYLARGSLTTILRDDAAAKE-----FSWNQRMNVIKGVANALSYLH 766
+CS+ + ++ EY+ GS+ L +D E W R+ + G+A + YLH
Sbjct: 1014 YCSSKSEGLNLLIYEYMKNGSIWDWLHEDKPVLEKKKKLLDWEARLRIAVGLAQGVEYLH 1073
Query: 767 HDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFL----EPHSSNWTEFAGTVGYAAPE 822
HDC+PPIVHRDI S NVLLDS EAH+ DFG AK L + ++ + T FA + GY APE
Sbjct: 1074 HDCVPPIVHRDIKSSNVLLDSNMEAHLGDFGLAKVLTENCDTNTDSNTWFACSYGYIAPE 1133
Query: 823 LAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSR 882
AY+++ATEK DVYS G++ +E++ G P D ++F + +M+ V L+ +
Sbjct: 1134 YAYSLKATEKSDVYSMGIVLMEIVTGKMPTD---SVFGAEMDMVRWVETHLEVAGSARDK 1190
Query: 883 DVTDKLR-----------SIMEVAILCLVENPEARPTMKEVCNLL 916
+ KL+ ++E+A+ C +P+ RP+ ++ C+ L
Sbjct: 1191 LIDPKLKPLLPFEEDAACQVLEIALQCTKTSPQERPSSRQACDSL 1235
|
Together with GSO2, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FIZ3|GSO2_ARATH LRR receptor-like serine/threonine-protein kinase GSO2 OS=Arabidopsis thaliana GN=GSO2 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 521 bits (1342), Expect = e-146, Method: Compositional matrix adjust.
Identities = 357/996 (35%), Positives = 522/996 (52%), Gaps = 89/996 (8%)
Query: 2 LNLGFNLLFGNIPPQIGNLSKLQYLDLGNNQLSGVIPPEIGKLNQLRRLYLDVNQLHGTI 61
LNLG N G IP Q+G+L +QYL+L NQL G+IP + +L L+ L L N L G I
Sbjct: 245 LNLGDNSFSGEIPSQLGDLVSIQYLNLIGNQLQGLIPKRLTELANLQTLDLSSNNLTGVI 304
Query: 62 PPVIGQLSLINELVFCHNNVSGRIPSSL-GNLSNLALLYLNDNSLFGSIPIVMGNLKSLS 120
+++ + LV N +SG +P ++ N ++L L+L++ L G IP + N +SL
Sbjct: 305 HEEFWRMNQLEFLVLAKNRLSGSLPKTICSNNTSLKQLFLSETQLSGEIPAEISNCQSLK 364
Query: 121 TLDLSQNQLNGSIPCSLDNLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSENRLSGL 180
LDLS N L G IP SL L L L+L NSL G + S I NL +L + L N L G
Sbjct: 365 LLDLSNNTLTGQIPDSLFQLVELTNLYLNNNSLEGTLSSSISNLTNLQEFTLYHNNLEGK 424
Query: 181 IPLSLSNLSSLTVMSLFNNSLSGSIPPILGNLKSLSTLGLHINQLNGVIPPSIGNLSSLR 240
+P + L L +M L+ N SG +P +GN L + + N+L+G IP SIG L L
Sbjct: 425 VPKEIGFLGKLEIMYLYENRFSGEMPVEIGNCTRLQEIDWYGNRLSGEIPSSIGRLKDLT 484
Query: 241 NLSLFNNRLYGFVPKEIGYLKSLSKLEFCANHLSGVIPHSVGNLTGLVLLNMCENHLFGP 300
L L N L G +P +G ++ ++ N LSG IP S G LT L L + N L G
Sbjct: 485 RLHLRENELVGNIPASLGNCHQMTVIDLADNQLSGSIPSSFGFLTALELFMIYNNSLQGN 544
Query: 301 IPKSLRNLTSLERVRFNQNNLYGKV--------YEAF--------GDHP-------NLTF 337
+P SL NL +L R+ F+ N G + Y +F GD P NL
Sbjct: 545 LPDSLINLKNLTRINFSSNKFNGSISPLCGSSSYLSFDVTENGFEGDIPLELGKSTNLDR 604
Query: 338 LDLSQNNFYCEISFNWRNFSKLGTFNASMNNIYGSIPPEIGDSSKLQVLDLSSNHIFGKI 397
L L +N F I + S+L + S N++ G IP E+G KL +DL++N++ G I
Sbjct: 605 LRLGKNQFTGRIPRTFGKISELSLLDISRNSLSGIIPVELGLCKKLTHIDLNNNYLSGVI 664
Query: 398 PVQLVKLFSLNKLILSLNQLFGGVPLEFGTLTELQYLDLSANKLSSSIPMSIGNLLKLHY 457
P L KL L +L LS N+ G +P E +LT + L L N L+ SIP IGNL L+
Sbjct: 665 PTWLGKLPLLGELKLSSNKFVGSLPTEIFSLTNILTLFLDGNSLNGSIPQEIGNLQALNA 724
Query: 458 LNLSNNQFSHKIPTEFEKLIHLSELDLSHNILQEEIPPQICKMES--------------- 502
LNL NQ S +P+ KL L EL LS N L EIP +I +++
Sbjct: 725 LNLEENQLSGPLPSTIGKLSKLFELRLSRNALTGEIPVEIGQLQDLQSALDLSYNNFTGR 784
Query: 503 ----------LEKLNLSHNNLSDFIPRCFEEMRSLSWIDISYNELQGPIPNS-TAFKNGL 551
LE L+LSHN L +P +M+SL ++++SYN L+G + + ++
Sbjct: 785 IPSTISTLPKLESLDLSHNQLVGEVPGQIGDMKSLGYLNLSYNNLEGKLKKQFSRWQADA 844
Query: 552 MEGNKGLCGNFKALPSCD-AFTSHKQTFRKKWVVI--ALPILGMVVLLIGLIGFFF---- 604
GN GLCG+ L C+ A + ++++ K VVI A+ L + L++ +I FF
Sbjct: 845 FVGNAGLCGS--PLSHCNRAGSKNQRSLSPKTVVIISAISSLAAIALMVLVIILFFKQNH 902
Query: 605 -LFRR-RKRDPQEKRSSSANPFGFFSVLNFNGKVLYEEITKATGNFGEKYCIGKGGQRSV 662
LF++ R + +SS++ FS + +++I +AT E++ IG GG V
Sbjct: 903 DLFKKVRGGNSAFSSNSSSSQAPLFSNGGAKSDIKWDDIMEATHYLNEEFMIGSGGSGKV 962
Query: 663 YKAELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQH-- 720
YKAEL +G AVKK L+ D+ + F EV L IRHR+++K G+CS+
Sbjct: 963 YKAELKNGETIAVKKI---LWKDDLMSNKSFNREVKTLGTIRHRHLVKLMGYCSSKADGL 1019
Query: 721 SFIVCEYLARGSLTTILRDDAAAKE---FSWNQRMNVIKGVANALSYLHHDCIPPIVHRD 777
+ ++ EY+A GS+ L + K+ W R+ + G+A + YLH+DC+PPIVHRD
Sbjct: 1020 NLLIYEYMANGSVWDWLHANENTKKKEVLGWETRLKIALGLAQGVEYLHYDCVPPIVHRD 1079
Query: 778 ISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTE----FAGTVGYAAPELAYTMRATEKY 833
I S NVLLDS EAH+ DFG AK L + TE FAG+ GY APE AY+++ATEK
Sbjct: 1080 IKSSNVLLDSNIEAHLGDFGLAKILTGNYDTNTESNTMFAGSYGYIAPEYAYSLKATEKS 1139
Query: 834 DVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRD--VTDKLRS- 890
DVYS G++ +E++ G P +F ++M+ V +LD + +R+ + +L+S
Sbjct: 1140 DVYSMGIVLMEIVTGKMP---TEAMFDEETDMVRWVETVLDTPPGSEAREKLIDSELKSL 1196
Query: 891 ----------IMEVAILCLVENPEARPTMKEVCNLL 916
++E+A+ C P+ RP+ ++ L
Sbjct: 1197 LPCEEEAAYQVLEIALQCTKSYPQERPSSRQASEYL 1232
|
Together with GSO1, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons. Involved in the nuclear division phase of megagametogenesis. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGV1|RCH1_ARATH LRR receptor-like serine/threonine-protein kinase RCH1 OS=Arabidopsis thaliana GN=RCH1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 509 bits (1311), Expect = e-143, Method: Compositional matrix adjust.
Identities = 340/943 (36%), Positives = 492/943 (52%), Gaps = 62/943 (6%)
Query: 2 LNLGFNLLFGNIPPQIGNLSKLQYLDLGNNQLSGVIPPEIGKLNQLRRLYLDVN-QLHGT 60
L L N L G IPP++G+ L+ L++ +N LS +P E+GK++ L + N +L G
Sbjct: 159 LCLNSNGLTGKIPPELGDCVSLKNLEIFDNYLSENLPLELGKISTLESIRAGGNSELSGK 218
Query: 61 IPPVIGQLSLINELVFCHNNVSGRIPSSLGNLSNLALLYLNDNSLFGSIPIVMGNLKSLS 120
IP IG + L +SG +P SLG LS L L + L G IP +GN L
Sbjct: 219 IPEEIGNCRNLKVLGLAATKISGSLPVSLGQLSKLQSLSVYSTMLSGEIPKELGNCSELI 278
Query: 121 TLDLSQNQLNGSIPCSLDNLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSENRLSGL 180
L L N L+G++P L L NL+ + L++N+L GPIP IG +KSL +DLS N SG
Sbjct: 279 NLFLYDNDLSGTLPKELGKLQNLEKMLLWQNNLHGPIPEEIGFMKSLNAIDLSMNYFSGT 338
Query: 181 IPLSLSNLSSLTVMSLFNNSLSGSIPPILGNLKSLSTLGLHINQLNGVIPPSIGNLSSLR 240
IP S NLS+L + L +N+++GSIP IL N L + NQ++G+IPP IG L L
Sbjct: 339 IPKSFGNLSNLQELMLSSNNITGSIPSILSNCTKLVQFQIDANQISGLIPPEIGLLKELN 398
Query: 241 NLSLFNNRLYGFVPKEIGYLKSLSKLEFCANHLSGVIPHSVGNLTGLVLLNMCENHLFGP 300
+ N+L G +P E+ ++L L+ N+L+G +P + L L L + N + G
Sbjct: 399 IFLGWQNKLEGNIPDELAGCQNLQALDLSQNYLTGSLPAGLFQLRNLTKLLLISNAISGV 458
Query: 301 IPKSLRNLTSLERVRFNQNNLYGKVYEAFGDHPNLTFLDLSQNNFYCEISFNWRNFSKLG 360
IP + N TSL R+R N + G++ + G NL+FLDLS+NN + N +L
Sbjct: 459 IPLEIGNCTSLVRLRLVNNRITGEIPKGIGFLQNLSFLDLSENNLSGPVPLEISNCRQLQ 518
Query: 361 TFNASMNNIYGSIPPEIGDSSKLQVLDLSSNHIFGKIPVQLVKLFSLNKLILSLNQLFGG 420
N S N + G +P + +KLQVLD+SSN + GKIP L L SLN+LILS N G
Sbjct: 519 MLNLSNNTLQGYLPLSLSSLTKLQVLDVSSNDLTGKIPDSLGHLISLNRLILSKNSFNGE 578
Query: 421 VPLEFGTLTELQYLDLSANKLSSSIPMSIGNLLKLHY-LNLSNNQFSHKIPTEFEKLIHL 479
+P G T LQ LDLS+N +S +IP + ++ L LNLS N IP L L
Sbjct: 579 IPSSLGHCTNLQLLDLSSNNISGTIPEELFDIQDLDIALNLSWNSLDGFIPERISALNRL 638
Query: 480 SELDLSHNILQEEIPPQICKMESLEKLNLSHNNLSDFIPRCFEEMRSLSWIDISYNELQG 539
S LD+SHN+L ++ + +E+L LN+SHN S G
Sbjct: 639 SVLDISHNMLSGDL-SALSGLENLVSLNISHNRFS------------------------G 673
Query: 540 PIPNSTAFKN---GLMEGNKGLCGNFKALPSCDAFTSHKQTFRK----KWVVIALPILGM 592
+P+S F+ MEGN GLC K SC S + T ++ + IA+ +L
Sbjct: 674 YLPDSKVFRQLIGAEMEGNNGLCS--KGFRSCFVSNSSQLTTQRGVHSHRLRIAIGLLIS 731
Query: 593 VVLLIGLIGFFFLFRRRK--RDPQEKRSSS---ANPFGFFSVLNFNGKVLYEEITKATGN 647
V ++ ++G + R ++ RD + + F F LNF E + K
Sbjct: 732 VTAVLAVLGVLAVIRAKQMIRDDNDSETGENLWTWQFTPFQKLNFT----VEHVLKC--- 784
Query: 648 FGEKYCIGKGGQRSVYKAELPSGNIFAVKKFKAELF------SDETANPSEFLNEVLALT 701
E IGKG VYKAE+P+ + AVKK + + F EV L
Sbjct: 785 LVEGNVIGKGCSGIVYKAEMPNREVIAVKKLWPVTVPNLNEKTKSSGVRDSFSAEVKTLG 844
Query: 702 EIRHRNIIKFHGFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANA 761
IRH+NI++F G C N ++ +Y++ GSL ++L + + W R +I G A
Sbjct: 845 SIRHKNIVRFLGCCWNKNTRLLMYDYMSNGSLGSLLHERSGVCSLGWEVRYKIILGAAQG 904
Query: 762 LSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLE----PHSSNWTEFAGTVG 817
L+YLHHDC+PPIVHRDI + N+L+ ++E ++ DFG AK ++ SSN AG+ G
Sbjct: 905 LAYLHHDCVPPIVHRDIKANNILIGPDFEPYIGDFGLAKLVDDGDFARSSN--TIAGSYG 962
Query: 818 YAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVN--QILDH 875
Y APE Y+M+ TEK DVYS+GV+ LEV+ G P D I + + ++ Q++D
Sbjct: 963 YIAPEYGYSMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGLHIVDWVKKIRDIQVIDQ 1022
Query: 876 RLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLLCK 918
L +++ + VA+LC+ PE RPTMK+V +L +
Sbjct: 1023 GLQARPESEVEEMMQTLGVALLCINPIPEDRPTMKDVAAMLSE 1065
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LHP4|RCH2_ARATH Receptor-like protein kinase 2 OS=Arabidopsis thaliana GN=RCH2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 509 bits (1311), Expect = e-143, Method: Compositional matrix adjust.
Identities = 353/972 (36%), Positives = 524/972 (53%), Gaps = 97/972 (9%)
Query: 1 MLNLGFNLLFGNIPPQIGNLSKLQYLDLGNNQLSGVIPPEIGKLNQLRRLYLDVNQLHGT 60
+L+L N L G+IP + L L+ L L +NQL+G IPP+I K ++L+ L L N L G+
Sbjct: 133 VLDLSSNGLVGDIPWSLSKLRNLETLILNSNQLTGKIPPDISKCSKLKSLILFDNLLTGS 192
Query: 61 IPPVIGQLSLINELVFCHNN-VSGRIPSSLGNLSNLALLYLNDNSLFGSIPIVMGNLKSL 119
IP +G+LS + + N +SG+IPS +G+ SNL +L L + S+ G++P +G LK L
Sbjct: 193 IPTELGKLSGLEVIRIGGNKEISGQIPSEIGDCSNLTVLGLAETSVSGNLPSSLGKLKKL 252
Query: 120 STLDLSQNQLNGSIPCSLDNLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSENRLSG 179
TL + ++G IP L N S L LFLY+NSLSG IP IG L L QL L +N L G
Sbjct: 253 ETLSIYTTMISGEIPSDLGNCSELVDLFLYENSLSGSIPREIGQLTKLEQLFLWQNSLVG 312
Query: 180 LIPLSLSNLSSLTVMSLFNNSLSGSIPPILGNLKSLSTLGLHINQLNGVIPPSIGNLSSL 239
IP + N S+L ++ L N LSGSIP +G L L + N+ +G IP +I N SSL
Sbjct: 313 GIPEEIGNCSNLKMIDLSLNLLSGSIPSSIGRLSFLEEFMISDNKFSGSIPTTISNCSSL 372
Query: 240 RNLSLFNNRLYGFVPKEIGYLKSLSKLEFCANHLSGVIPHSVGNLTGLVLLNMCENHLFG 299
L L N++ G +P E+G L L+ +N L G IP + + T L L++ N L G
Sbjct: 373 VQLQLDKNQISGLIPSELGTLTKLTLFFAWSNQLEGSIPPGLADCTDLQALDLSRNSLTG 432
Query: 300 PIPKS---LRNLT---------------------SLERVRFNQNNLYGKVYEAFGDHPNL 335
IP LRNLT SL R+R N + G++ G +
Sbjct: 433 TIPSGLFMLRNLTKLLLISNSLSGFIPQEIGNCSSLVRLRLGFNRITGEIPSGIGSLKKI 492
Query: 336 TFLDLSQNNFYCEISFNWRNFSKLGTFNASMNNIYGSIPPEIGDSSKLQVLDLSSNHIFG 395
FLD S N + ++ + S+L + S N++ GS+P + S LQVLD+S+N G
Sbjct: 493 NFLDFSSNRLHGKVPDEIGSCSELQMIDLSNNSLEGSLPNPVSSLSGLQVLDVSANQFSG 552
Query: 396 KIPVQLVKLFSLNKLILSLNQLFGGVPLEFGTLTELQYLDLSANKLSSSIPMSIGNLLKL 455
KIP L +L SLNKLILS N G +P G + LQ LDL +N+LS IP +G++ L
Sbjct: 553 KIPASLGRLVSLNKLILSKNLFSGSIPTSLGMCSGLQLLDLGSNELSGEIPSELGDIENL 612
Query: 456 HY-LNLSNNQFSHKIPTEFEKLIHLSELDLSHNILQEEIPPQICKMESLEKLNLSHNNLS 514
LNLS+N+ + KIP++ L LS LDLSHN+L+ ++ P + +E+L LN+S+N+ S
Sbjct: 613 EIALNLSSNRLTGKIPSKIASLNKLSILDLSHNMLEGDLAP-LANIENLVSLNISYNSFS 671
Query: 515 DFIPRCFEEMRSLSWIDISYNELQGPIPNSTAFKNGLMEGNKGLCGNFKALPSCDAFTSH 574
++P + R LS D +EGNK LC + + SC F ++
Sbjct: 672 GYLPD-NKLFRQLSPQD--------------------LEGNKKLCSSTQ--DSC--FLTY 706
Query: 575 KQ-----------TFRKKWVVIALPILGMVVLLIGLIGFFFLFRRRKRDPQEKRSSSANP 623
++ RK + +AL I VVL+I +G + R R+ E+ S
Sbjct: 707 RKGNGLGDDGDASRTRKLRLTLALLITLTVVLMI--LGAVAVIRARRNIDNERDSELGET 764
Query: 624 FGF----FSVLNFNGKVLYEEITKATGNFGEKYCIGKGGQRSVYKAELPSGNIFAVKKFK 679
+ + F LNF+ ++I + E IGKG VY+A++ +G + AVKK
Sbjct: 765 YKWQFTPFQKLNFS----VDQIIRC---LVEPNVIGKGCSGVVYRADVDNGEVIAVKKLW 817
Query: 680 AELF----SDETANPSE-FLNEVLALTEIRHRNIIKFHGFCSNAQHSFIVCEYLARGSLT 734
+ ++T N + F EV L IRH+NI++F G C N ++ +Y+ GSL
Sbjct: 818 PAMVNGGHDEKTKNVRDSFSAEVKTLGTIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLG 877
Query: 735 TILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVS 794
++L + + W+ R ++ G A L+YLHHDC+PPIVHRDI + N+L+ ++E +++
Sbjct: 878 SLLHERRGSS-LDWDLRYRILLGAAQGLAYLHHDCLPPIVHRDIKANNILIGLDFEPYIA 936
Query: 795 DFGFAKFLEP----HSSNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYH 850
DFG AK ++ SN AG+ GY APE Y+M+ TEK DVYS+GV+ LEV+ G
Sbjct: 937 DFGLAKLVDEGDIGRCSN--TVAGSYGYIAPEYGYSMKITEKSDVYSYGVVVLEVLTGKQ 994
Query: 851 PGDFVSTIFSSISNMIIEVNQ------ILDHRLPTPSRDVTDKLRSIMEVAILCLVENPE 904
P D T+ I +++ V Q +LD L + + D++ ++ A+LC+ +P+
Sbjct: 995 PID--PTVPEGI-HLVDWVRQNRGSLEVLDSTLRSRTEAEADEMMQVLGTALLCVNSSPD 1051
Query: 905 ARPTMKEVCNLL 916
RPTMK+V +L
Sbjct: 1052 ERPTMKDVAAML 1063
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FZ59|PEPR2_ARATH Leucine-rich repeat receptor-like protein kinase PEPR2 OS=Arabidopsis thaliana GN=PEPR2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 484 bits (1247), Expect = e-136, Method: Compositional matrix adjust.
Identities = 331/976 (33%), Positives = 490/976 (50%), Gaps = 76/976 (7%)
Query: 2 LNLGFNLLFGNIPPQIGNLSKLQYLDLGNNQLSGVIPPEIGKLNQLRRLYLDVNQLHGTI 61
L+L N G +P +GN + L+YLDL NN SG +P G L L LYLD N L G I
Sbjct: 105 LDLSLNSFSGLLPSTLGNCTSLEYLDLSNNDFSGEVPDIFGSLQNLTFLYLDRNNLSGLI 164
Query: 62 PPVIGQLSLINELVFCHNNVSGRIPSSLGNLSNLALLYLNDNSLFGSIPIVM-------- 113
P +G L + +L +NN+SG IP LGN S L L LN+N L GS+P +
Sbjct: 165 PASVGGLIELVDLRMSYNNLSGTIPELLGNCSKLEYLALNNNKLNGSLPASLYLLENLGE 224
Query: 114 ----------------GNLKSLSTLDLSQNQLNGSIPCSLDNLSNLDTLFLYKNSLSGPI 157
N K L +LDLS N G +P + N S+L +L + K +L+G I
Sbjct: 225 LFVSNNSLGGRLHFGSSNCKKLVSLDLSFNDFQGGVPPEIGNCSSLHSLVMVKCNLTGTI 284
Query: 158 PSVIGNLKSLLQLDLSENRLSGLIPLSLSNLSSLTVMSLFNNSLSGSIPPILGNLKSLST 217
PS +G L+ + +DLS+NRLSG IP L N SSL + L +N L G IPP L LK L +
Sbjct: 285 PSSMGMLRKVSVIDLSDNRLSGNIPQELGNCSSLETLKLNDNQLQGEIPPALSKLKKLQS 344
Query: 218 LGLHINQLNGVIPPSIGNLSSLRNLSLFNNRLYGFVPKEIGYLKSLSKLEFCANHLSGVI 277
L L N+L+G IP I + SL + ++NN L G +P E+ LK L KL N G I
Sbjct: 345 LELFFNKLSGEIPIGIWKIQSLTQMLVYNNTLTGELPVEVTQLKHLKKLTLFNNGFYGDI 404
Query: 278 PHSVG-------------NLTGLVLLNMCE-----------NHLFGPIPKSLRNLTSLER 313
P S+G TG + ++C N L G IP S+R +LER
Sbjct: 405 PMSLGLNRSLEEVDLLGNRFTGEIPPHLCHGQKLRLFILGSNQLHGKIPASIRQCKTLER 464
Query: 314 VRFNQNNLYGKVYEAFGDHPNLTFLDLSQNNFYCEISFNWRNFSKLGTFNASMNNIYGSI 373
VR N L G V F + +L++++L N+F I + + L T + S N + G I
Sbjct: 465 VRLEDNKLSG-VLPEFPESLSLSYVNLGSNSFEGSIPRSLGSCKNLLTIDLSQNKLTGLI 523
Query: 374 PPEIGDSSKLQVLDLSSNHIFGKIPVQLVKLFSLNKLILSLNQLFGGVPLEFGTLTELQY 433
PPE+G+ L +L+LS N++ G +P QL L + N L G +P F + L
Sbjct: 524 PPELGNLQSLGLLNLSHNYLEGPLPSQLSGCARLLYFDVGSNSLNGSIPSSFRSWKSLST 583
Query: 434 LDLSANKLSSSIPMSIGNLLKLHYLNLSNNQFSHKIPTEFEKLIHLS-ELDLSHNILQEE 492
L LS N +IP + L +L L ++ N F KIP+ L L LDLS N+ E
Sbjct: 584 LVLSDNNFLGAIPQFLAELDRLSDLRIARNAFGGKIPSSVGLLKSLRYGLDLSANVFTGE 643
Query: 493 IPPQICKMESLEKLNLSHNNLSDFIPRCFEEMRSLSWIDISYNELQGPIPNSTAFKNGLM 552
IP + + +LE+LN+S+N L+ + + ++SL+ +D+SYN+ GPIP + +
Sbjct: 644 IPTTLGALINLERLNISNNKLTGPL-SVLQSLKSLNQVDVSYNQFTGPIPVNLLSNSSKF 702
Query: 553 EGNKGLCGNFKALPSCDAFTSHKQTFRKKWVVIALPILGMVVLLIGLIGFFFLFRRRKRD 612
GN LC +A S A + K V ++ + ++ L LF
Sbjct: 703 SGNPDLC--IQASYSVSAIIRKEFKSCKGQVKLSTWKIALIAAGSSLSVLALLFALFLVL 760
Query: 613 PQEKRSSSANPFGFFSVLNFNGKVLYEEITKATGNFGEKYCIGKGGQRSVYKAELPSGNI 672
+ KR + + + +L ++ AT N +KY IG+G VY+A L SG
Sbjct: 761 CRCKRGTKTEDANILAEEGLS--LLLNKVLAATDNLDDKYIIGRGAHGVVYRASLGSGEE 818
Query: 673 FAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFIVCEYLARGS 732
+AVKK +F++ E+ + +RHRN+I+ F + ++ +Y+ GS
Sbjct: 819 YAVKKL---IFAEHIRANQNMKREIETIGLVRHRNLIRLERFWMRKEDGLMLYQYMPNGS 875
Query: 733 LTTIL-RDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEA 791
L +L R + W+ R N+ G+++ L+YLHHDC PPI+HRDI +N+L+DS+ E
Sbjct: 876 LHDVLHRGNQGEAVLDWSARFNIALGISHGLAYLHHDCHPPIIHRDIKPENILMDSDMEP 935
Query: 792 HVSDFGFAKFLEPHSSNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHP 851
H+ DFG A+ L+ + + GT GY APE AY +++ DVYS+GV+ LE++ G
Sbjct: 936 HIGDFGLARILDDSTVSTATVTGTTGYIAPENAYKTVRSKESDVYSYGVVLLELVTGKRA 995
Query: 852 GD-----------FVSTIFSSISNMIIEVNQILDHRLPTPSRDVTDKLR----SIMEVAI 896
D +V ++ SS + I+D +L D KLR + ++A+
Sbjct: 996 LDRSFPEDINIVSWVRSVLSSYEDEDDTAGPIVDPKLVDELLDT--KLREQAIQVTDLAL 1053
Query: 897 LCLVENPEARPTMKEV 912
C + PE RP+M++V
Sbjct: 1054 RCTDKRPENRPSMRDV 1069
|
Acts as a receptor for PEP defense peptides. Unlike typical immune receptors, senses an endogenous elicitor that potentiates PAMP-inducible plant responses. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST 
Original result of BLAST against Nonredundant Database
GI ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 918 | ||||||
| 225456159 | 1038 | PREDICTED: probable LRR receptor-like se | 0.993 | 0.878 | 0.535 | 0.0 | |
| 147772402 | 996 | hypothetical protein VITISV_022117 [Viti | 0.989 | 0.911 | 0.534 | 0.0 | |
| 225456161 | 1037 | PREDICTED: probable LRR receptor-like se | 0.991 | 0.877 | 0.537 | 0.0 | |
| 147767326 | 1032 | hypothetical protein VITISV_008862 [Viti | 0.993 | 0.883 | 0.528 | 0.0 | |
| 359491509 | 1032 | PREDICTED: probable LRR receptor-like se | 0.993 | 0.883 | 0.526 | 0.0 | |
| 359491512 | 1078 | PREDICTED: probable LRR receptor-like se | 0.969 | 0.825 | 0.528 | 0.0 | |
| 255545702 | 1008 | receptor protein kinase, putative [Ricin | 0.969 | 0.882 | 0.516 | 0.0 | |
| 186511602 | 1045 | Leucine-rich repeat-containing protein [ | 0.984 | 0.865 | 0.475 | 0.0 | |
| 7267528 | 1027 | receptor protein kinase-like protein [Ar | 0.984 | 0.880 | 0.475 | 0.0 | |
| 297813345 | 1019 | hypothetical protein ARALYDRAFT_489780 [ | 0.984 | 0.887 | 0.474 | 0.0 |
| >gi|225456159|ref|XP_002278561.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At4g08850-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 908 bits (2346), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 495/924 (53%), Positives = 625/924 (67%), Gaps = 12/924 (1%)
Query: 2 LNLGFNLLFGNIPPQIGNLSKLQYLDLGNNQLSGVIPPEIGKLNQLRRLYLDVNQLHGTI 61
+++ N L G IPPQIG L +L+YLDL NQ SG IP EIG L L L+L NQL+G+I
Sbjct: 118 VDISMNNLSGPIPPQIGLLFELKYLDLSINQFSGGIPSEIGLLTNLEVLHLVQNQLNGSI 177
Query: 62 PPVIGQLSLINELVFCHNNVSGRIPSSLGNLSNLALLYLNDNSLFGSIPIVMGNLKSLST 121
P IGQL+ + EL N + G IP+SLGNLSNLA LYL +N L GSIP MGNL +L
Sbjct: 178 PHEIGQLASLYELALYTNQLEGSIPASLGNLSNLASLYLYENQLSGSIPPEMGNLTNLVE 237
Query: 122 LDLSQNQLNGSIPCSLDNLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSENRLSGLI 181
+ + N L G IP + NL L L+L+ NSLSGPIP IGNLKSL +L L EN LSG I
Sbjct: 238 IYSNNNNLTGPIPSTFGNLKRLTVLYLFNNSLSGPIPPEIGNLKSLQELSLYENNLSGPI 297
Query: 182 PLSLSNLSSLTVMSLFNNSLSGSIPPILGNLKSLSTLGLHINQLNGVIPPSIGNLSSLRN 241
P+SL +LS LT++ L+ N LSG IP +GNLKSL L L NQLNG IP S+GNL++L
Sbjct: 298 PVSLCDLSGLTLLHLYANQLSGPIPQEIGNLKSLVDLELSENQLNGSIPTSLGNLTNLEI 357
Query: 242 LSLFNNRLYGFVPKEIGYLKSLSKLEFCANHLSGVIPHSVGNLTGLVLLNMCENHLFGPI 301
L L +N+L G++P+EIG L L LE N L G +P + LV + +NHL GPI
Sbjct: 358 LFLRDNQLSGYIPQEIGKLHKLVVLEIDTNQLFGSLPEGICQAGSLVRFAVSDNHLSGPI 417
Query: 302 PKSLRNLTSLERVRFNQNNLYGKVYEAFGDHPNLTFLDLSQNNFYCEISFNWRNFSKLGT 361
PKSL+N +L R F N L G + E GD PNL F+DLS N F+ E+S NW +L
Sbjct: 418 PKSLKNCRNLTRALFQGNRLTGNISEVVGDCPNLEFIDLSYNRFHGELSHNWGRCPQLQR 477
Query: 362 FNASMNNIYGSIPPEIGDSSKLQVLDLSSNHIFGKIPVQLVKLFSLNKLILSLNQLFGGV 421
+ NNI GSIP + G S+ L +LDLSSNH+ G+IP ++ L SL LIL+ NQL G +
Sbjct: 478 LEIAGNNITGSIPEDFGISTNLTLLDLSSNHLVGEIPKKMGSLTSLLGLILNDNQLSGSI 537
Query: 422 PLEFGTLTELQYLDLSANKLSSSIPMSIGNLLKLHYLNLSNNQFSHKIPTEFEKLIHLSE 481
P E G+L+ L+YLDLSAN+L+ SIP +G+ L LHYLNLSNN+ SH IP + KL HLS+
Sbjct: 538 PPELGSLSHLEYLDLSANRLNGSIPEHLGDCLDLHYLNLSNNKLSHGIPVQMGKLSHLSQ 597
Query: 482 LDLSHNILQEEIPPQICKMESLEKLNLSHNNLSDFIPRCFEEMRSLSWIDISYNELQGPI 541
LDLSHN+L IPPQI ++SLE L+LSHNNL FIP+ FE+M +LS++DISYN+LQGPI
Sbjct: 598 LDLSHNLLAGGIPPQIQGLQSLEMLDLSHNNLCGFIPKAFEDMPALSYVDISYNQLQGPI 657
Query: 542 PNSTAFKNGLME---GNKGLCGNFKALPSCD-AFTSHKQTFRKKWVV---IALPILGMVV 594
P+S AF+N +E GNK LCGN K L C F +Q +K V I P+LG +V
Sbjct: 658 PHSNAFRNATIEVLKGNKDLCGNVKGLQPCKYGFGVDQQPVKKSHKVVFIIIFPLLGALV 717
Query: 595 LLIGLIGFFFLFRRRKRDPQEKRSSSANPFGFFSVLNFNGKVLYEEITKATGNFGEKYCI 654
LL IG F + RR+R P+ + N FS+ NF+G+ +YEEI KAT +F YCI
Sbjct: 718 LLFAFIGIFLIAERRERTPEIEEGDVQN--DLFSISNFDGRTMYEEIIKATKDFDPMYCI 775
Query: 655 GKGGQRSVYKAELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGF 714
GKGG SVYKAELPS NI AVKK E AN +FLNE+ ALTEI+HRNI+K GF
Sbjct: 776 GKGGHGSVYKAELPSSNIVAVKKLHPS--DTEMANQKDFLNEIRALTEIKHRNIVKLLGF 833
Query: 715 CSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIV 774
CS+ +H F+V EYL RGSL TIL + AK+ W R+N+IKGVA+AL+Y+HHDC PPIV
Sbjct: 834 CSHPRHKFLVYEYLERGSLATILSRE-EAKKLGWATRVNIIKGVAHALAYMHHDCSPPIV 892
Query: 775 HRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGTVGYAAPELAYTMRATEKYD 834
HRD+SS N+LLDS+YEAH+SDFG AK L+ SSN + AGT GY APELAYTM+ TEK D
Sbjct: 893 HRDVSSNNILLDSQYEAHISDFGTAKLLKLDSSNQSILAGTFGYLAPELAYTMKVTEKTD 952
Query: 835 VYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRDVTDKLRSIMEV 894
V+SFGV+ALEVIKG HPGD + ++ S I + +LD RLP + ++ +I++
Sbjct: 953 VFSFGVIALEVIKGRHPGDQILSLSVSPEKDNIALEDMLDPRLPPLTPQDEGEVIAILKQ 1012
Query: 895 AILCLVENPEARPTMKEVCNLLCK 918
AI CL NP++RPTM+ V +L +
Sbjct: 1013 AIECLKANPQSRPTMQTVSQMLSQ 1036
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147772402|emb|CAN73988.1| hypothetical protein VITISV_022117 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 899 bits (2323), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 492/920 (53%), Positives = 617/920 (67%), Gaps = 12/920 (1%)
Query: 6 FNLLFGNIPPQIGNLSKLQYLDLGNNQLSGVIPPEIGKLNQLRRLYLDVNQLHGTIPPVI 65
N L G IPPQIG LS+L+YLDL NQ SG IP EIG L L L+L NQL+G+IP I
Sbjct: 80 MNNLSGPIPPQIGLLSELKYLDLSINQFSGGIPSEIGLLTNLEVLHLVQNQLNGSIPHEI 139
Query: 66 GQLSLINELVFCHNNVSGRIPSSLGNLSNLALLYLNDNSLFGSIPIVMGNLKSLSTLDLS 125
GQL+ + EL N + G IP+SLGNLSNLA LYL +N L SIP MGNL +L +
Sbjct: 140 GQLASLYELALYTNQLEGSIPASLGNLSNLAYLYLYENQLSDSIPPEMGNLTNLVEIYSD 199
Query: 126 QNQLNGSIPCSLDNLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSENRLSGLIPLSL 185
N L G IP + NL L L+L+ N LSG IP IGNLKSL L L EN LSG IP SL
Sbjct: 200 TNNLIGPIPSTFGNLKRLTVLYLFNNRLSGHIPPEIGNLKSLQGLSLYENNLSGPIPASL 259
Query: 186 SNLSSLTVMSLFNNSLSGSIPPILGNLKSLSTLGLHINQLNGVIPPSIGNLSSLRNLSLF 245
+LS LT++ L+ N LSG IP +GNLKSL L L NQLNG IP S+GNL++L L L
Sbjct: 260 GDLSGLTLLHLYANQLSGPIPQEIGNLKSLVDLELSENQLNGSIPTSLGNLTNLETLFLR 319
Query: 246 NNRLYGFVPKEIGYLKSLSKLEFCANHLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSL 305
+N+L G++P+EIG L L LE N L G +P + L + +NHL GPIPKSL
Sbjct: 320 DNQLSGYIPQEIGKLHKLVVLEIDTNQLFGSLPEGICQGGSLERFTVSDNHLSGPIPKSL 379
Query: 306 RNLTSLERVRFNQNNLYGKVYEAFGDHPNLTFLDLSQNNFYCEISFNWRNFSKLGTFNAS 365
+N +L R F N L G + E GD PNL ++++S N+F+ E+S NW + +L +
Sbjct: 380 KNCKNLTRALFGGNQLTGNISEVVGDCPNLEYINVSYNSFHGELSHNWGRYPRLQRLEMA 439
Query: 366 MNNIYGSIPPEIGDSSKLQVLDLSSNHIFGKIPVQLVKLFSLNKLILSLNQLFGGVPLEF 425
NNI GSIP + G S+ L +LDLSSNH+FG+IP ++ + SL KLIL+ NQL G +P E
Sbjct: 440 WNNITGSIPEDFGISTDLTLLDLSSNHLFGEIPKKMGSVTSLWKLILNDNQLSGNIPPEL 499
Query: 426 GTLTELQYLDLSANKLSSSIPMSIGNLLKLHYLNLSNNQFSHKIPTEFEKLIHLSELDLS 485
G+L +L YLDLSAN+L+ SIP +G+ L L+YLNLSNN+ SH IP + KL HLS+LDLS
Sbjct: 500 GSLADLGYLDLSANRLNGSIPEHLGDCLGLNYLNLSNNKLSHGIPVQMGKLGHLSQLDLS 559
Query: 486 HNILQEEIPPQICKMESLEKLNLSHNNLSDFIPRCFEEMRSLSWIDISYNELQGPIPNST 545
HN+L +IPPQI ++SLE LNLSHNNLS FIP+ FEEM LS +DISYN+LQGPIPNS
Sbjct: 560 HNLLTGDIPPQIEGLQSLENLNLSHNNLSGFIPKAFEEMLGLSDVDISYNQLQGPIPNSK 619
Query: 546 AFKNGLME---GNKGLCGNFKALPSCDAFTSHKQTFRKK----WVVIALPILGMVVLLIG 598
AF++ +E GNKGLCGN K L C + Q KK +I P+LG +VLL
Sbjct: 620 AFRDATIEALKGNKGLCGNVKRLRPCKYGSGVDQQPVKKSHKVVFIIIFPLLGALVLLFA 679
Query: 599 LIGFFFLFRRRKRDPQEKRSSSANPFGFFSVLNFNGKVLYEEITKATGNFGEKYCIGKGG 658
IG F + RR+R P+ K N FS+ F+G+ +YEEI KAT +F YCIGKGG
Sbjct: 680 FIGIFLIAARRERTPEIKEGEVQN--DLFSISTFDGRTMYEEIIKATKDFDPMYCIGKGG 737
Query: 659 QRSVYKAELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNA 718
SVYKAELPS NI AVKK E AN +FLNE+ ALTEI+HRNI+K GFCS+
Sbjct: 738 HGSVYKAELPSSNIVAVKKLHPS--DTEMANQKDFLNEIRALTEIKHRNIVKLLGFCSHP 795
Query: 719 QHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDI 778
+H F+V EYL RGSL TIL + AK+ W R+N+IKGVA+AL+Y+HHDC PPIVHRDI
Sbjct: 796 RHKFLVYEYLERGSLATILSRE-EAKKLGWATRVNIIKGVAHALAYMHHDCSPPIVHRDI 854
Query: 779 SSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGTVGYAAPELAYTMRATEKYDVYSF 838
SS N+LLDS+YEAH+SDFG AK L+ SSN + AGT GY APELAYTM+ TEK DV+SF
Sbjct: 855 SSNNILLDSQYEAHISDFGTAKLLKLDSSNQSILAGTFGYLAPELAYTMKVTEKTDVFSF 914
Query: 839 GVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRDVTDKLRSIMEVAILC 898
GV+ALEVIKG HPGD + ++ S I + +LD RLP + ++ +I++ A C
Sbjct: 915 GVIALEVIKGRHPGDQILSLSVSPEKDNIALEDMLDPRLPPLTPQDEGEVIAIIKQATEC 974
Query: 899 LVENPEARPTMKEVCNLLCK 918
L NP++RPTM+ V +L +
Sbjct: 975 LKANPQSRPTMQTVSQMLSQ 994
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225456161|ref|XP_002278590.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At4g08850-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 897 bits (2317), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 497/925 (53%), Positives = 623/925 (67%), Gaps = 15/925 (1%)
Query: 2 LNLGFNLLFGNIPPQIGNLSKLQYLDLGNNQLSGVIPPEIGKLNQLRRLYLDVNQLHGTI 61
+++ N L G IPPQIG LSKL+YLDL NQ SG IPPEIG L L L+L NQL+G+I
Sbjct: 118 VDISMNNLSGPIPPQIGLLSKLKYLDLSINQFSGGIPPEIGLLTNLEVLHLVQNQLNGSI 177
Query: 62 PPVIGQLSLINELVFCHNNVSGRIPSSLGNLSNLALLYLNDNSLFGSIPIVMGNLKSLST 121
P IGQL+ + EL N + G IP+SLGNLSNLA LYL +N L GSIP MGNL +L
Sbjct: 178 PHEIGQLTSLYELALYTNQLEGSIPASLGNLSNLASLYLYENQLSGSIPPEMGNLTNLVQ 237
Query: 122 LDLSQNQLNGSIPCSLDNLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSENRLSGLI 181
L N L G IP + NL +L L+L+ NSLSGPIP IGNLKSL L L N LSG I
Sbjct: 238 LYSDTNNLTGPIPSTFGNLKHLTVLYLFNNSLSGPIPPEIGNLKSLQGLSLYGNNLSGPI 297
Query: 182 PLSLSNLSSLTVMSLFNNSLSGSIPPILGNLKSLSTLGLHINQLNGVIPPSIGNLSSLRN 241
P+SL +LS LT++ L+ N LSG IP +GNLKSL L L NQLNG IP S+GNL++L
Sbjct: 298 PVSLCDLSGLTLLHLYANQLSGPIPQEIGNLKSLVDLELSENQLNGSIPTSLGNLTNLEI 357
Query: 242 LSLFNNRLYGFVPKEIGYLKSLSKLEFCANHLSGVIPHSVGNLTGLVLLNMCENHLFGPI 301
L L +NRL G+ P+EIG L L LE N L G +P + L + +NHL GPI
Sbjct: 358 LFLRDNRLSGYFPQEIGKLHKLVVLEIDTNQLFGSLPEGICQGGSLERFTVSDNHLSGPI 417
Query: 302 PKSLRNLTSLERVRFNQNNLYGKVYEAFGDHPNLTFLDLSQNNFYCEISFNWRNFSKLGT 361
PKSL+N +L R F N L G V E GD PNL F+DLS N F+ E+S NW +L
Sbjct: 418 PKSLKNCRNLTRALFQGNRLTGNVSEVVGDCPNLEFIDLSYNRFHGELSHNWGRCPQLQR 477
Query: 362 FNASMNNIYGSIPPEIGDSSKLQVLDLSSNHIFGKIPVQLVKLFSLNKLILSLNQLFGGV 421
+ NNI GSIP + G S+ L +LDLSSNH+ G+IP ++ L SL LIL+ NQL G +
Sbjct: 478 LEIAGNNITGSIPEDFGISTNLILLDLSSNHLVGEIPKKMGSLTSLLGLILNDNQLSGSI 537
Query: 422 PLEFGTLTELQYLDLSANKLSSSIPMSIGNLLKLHYLNLSNNQFSHKIPTEFEKLIHLSE 481
P E G+L+ L+YLDLSAN+L+ SIP +G+ L LHYLNLSNN+ SH IP + KL HLS+
Sbjct: 538 PPELGSLSHLEYLDLSANRLNGSIPEHLGDCLDLHYLNLSNNKLSHGIPVQMGKLSHLSQ 597
Query: 482 LDLSHNILQEEIPPQICKMESLEKLNLSHNNLSDFIPRCFEEMRSLSWIDISYNELQGPI 541
LDLSHN+L IP QI +ESLE L+LSHNNL FIP+ FE+M +LS++DISYN+LQGPI
Sbjct: 598 LDLSHNLLTGGIPAQIQGLESLEMLDLSHNNLCGFIPKAFEDMPALSYVDISYNQLQGPI 657
Query: 542 PNSTAFKNGLME---GNKGLCGNFKALPSCD-AFTSHKQTFRKKWVV---IALPILGMVV 594
P+S AF+N +E GNK LCGN K L C F +Q +K V I P+LG +V
Sbjct: 658 PHSNAFRNATIEVLKGNKDLCGNVKGLQPCKYGFGVDQQPVKKSHKVVFIIIFPLLGALV 717
Query: 595 LLIGLIGFFFLFRRRKRDPQEKRSSSANPFGFFSVLNFNGKVLYEEITKATGNFGEKYCI 654
LL IG F + RR+R P+ + N S+ F+G+ +YEEI KAT +F YCI
Sbjct: 718 LLSAFIGIFLIAERRERTPEIEEGDVQN--NLLSISTFDGRAMYEEIIKATKDFDPMYCI 775
Query: 655 GKGGQRSVYKAELPSGNIFAVKKFKAELFSD-ETANPSEFLNEVLALTEIRHRNIIKFHG 713
GKGG SVYKAELPSGNI AVKK SD + AN +FLN+V A+TEI+HRNI++ G
Sbjct: 776 GKGGHGSVYKAELPSGNIVAVKKLHP---SDMDMANQKDFLNKVRAMTEIKHRNIVRLLG 832
Query: 714 FCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPI 773
FCS +HSF+V EYL RGSL TIL + AK+ W R+ +IKGVA+ALSY+HHDC PPI
Sbjct: 833 FCSYPRHSFLVYEYLERGSLATILSRE-EAKKLGWATRVKIIKGVAHALSYMHHDCSPPI 891
Query: 774 VHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGTVGYAAPELAYTMRATEKY 833
VHRDISS N+LLDS+YEAH+S+ G AK L+ SSN ++ AGTVGY APE AYTM+ TEK
Sbjct: 892 VHRDISSNNILLDSQYEAHISNLGTAKLLKVDSSNQSKLAGTVGYVAPEHAYTMKVTEKT 951
Query: 834 DVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRDVTDKLRSIME 893
DVYSFGV+ALEVIKG HPGD + +I S I+ + +LD RLP + ++ +I++
Sbjct: 952 DVYSFGVIALEVIKGRHPGDQILSISVSPEKNIV-LKDMLDPRLPPLTPQDEGEVVAIIK 1010
Query: 894 VAILCLVENPEARPTMKEVCNLLCK 918
+A CL NP++RPTM+ + +L +
Sbjct: 1011 LATACLNANPQSRPTMEIISQMLSQ 1035
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147767326|emb|CAN68996.1| hypothetical protein VITISV_008862 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 878 bits (2268), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 486/919 (52%), Positives = 625/919 (68%), Gaps = 7/919 (0%)
Query: 3 NLGFNLLFGNIPPQIGNLSKLQYLDLGNNQLSGVIPPEIGKLNQLRRLYLDVNQLHGTIP 62
++ N L G IPPQIG LSKL+YLDL NQ SG IP EIG L L L+L NQL+G+IP
Sbjct: 116 DINMNKLSGPIPPQIGFLSKLKYLDLSTNQFSGRIPSEIGLLTNLEVLHLVENQLNGSIP 175
Query: 63 PVIGQLSLINELVFCHNNVSGRIPSSLGNLSNLALLYLNDNSLFGSIPIVMGNLKSLSTL 122
IGQL + +L N + G IP+SLGNLSNL LYL++N L G IP MGNL L L
Sbjct: 176 HEIGQLKSLCDLSLYTNKLEGSIPASLGNLSNLTNLYLDENKLSGLIPPEMGNLTKLVEL 235
Query: 123 DLSQNQLNGSIPCSLDNLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSENRLSGLIP 182
L+ N L G IP +L NL +L L LY N LSGPIP+ IGNLK L L LS N LSG IP
Sbjct: 236 CLNANNLTGPIPSTLGNLKSLTLLRLYNNQLSGPIPTEIGNLKHLRNLSLSSNYLSGPIP 295
Query: 183 LSLSNLSSLTVMSLFNNSLSGSIPPILGNLKSLSTLGLHINQLNGVIPPSIGNLSSLRNL 242
+SL +LS L + LF+N LSG IP +GNL+SL L + NQLNG IP S+GNL +L L
Sbjct: 296 MSLGDLSGLKSLQLFDNQLSGPIPQEMGNLRSLVDLEISQNQLNGSIPTSLGNLINLEIL 355
Query: 243 SLFNNRLYGFVPKEIGYLKSLSKLEFCANHLSGVIPHSVGNLTGLVLLNMCENHLFGPIP 302
L +N+L +P EIG L L +LE N LSG +P + L + +N L GPIP
Sbjct: 356 YLRDNKLSSSIPPEIGKLHKLVELEIDTNQLSGFLPEGICQGGSLENFTVFDNFLIGPIP 415
Query: 303 KSLRNLTSLERVRFNQNNLYGKVYEAFGDHPNLTFLDLSQNNFYCEISFNWRNFSKLGTF 362
+SL+N SL R R +N L G + EAFG PNL ++LS N FY E+S NW KL
Sbjct: 416 ESLKNCPSLARARLQRNQLTGNISEAFGVCPNLYHINLSNNKFYGELSQNWGRCHKLQWL 475
Query: 363 NASMNNIYGSIPPEIGDSSKLQVLDLSSNHIFGKIPVQLVKLFSLNKLILSLNQLFGGVP 422
+ + NNI GSIP + G S++L VL+LSSNH+ G+IP +L + SL KLIL+ N+L G +P
Sbjct: 476 DIAGNNITGSIPADFGISTQLTVLNLSSNHLVGEIPKKLGSVSSLWKLILNDNRLSGNIP 535
Query: 423 LEFGTLTELQYLDLSANKLSSSIPMSIGNLLKLHYLNLSNNQFSHKIPTEFEKLIHLSEL 482
E G+L +L YLDLS N+L+ SIP +GN L L+YLNLSNN+ SH IP + KL HLS L
Sbjct: 536 PELGSLADLGYLDLSGNRLNGSIPEHLGNCLDLNYLNLSNNKLSHGIPVQMGKLSHLSLL 595
Query: 483 DLSHNILQEEIPPQICKMESLEKLNLSHNNLSDFIPRCFEEMRSLSWIDISYNELQGPIP 542
DLSHN+L EIP QI ++SLEKLNLSHNNLS IP+ FE+M L +DISYN+LQG IP
Sbjct: 596 DLSHNLLTGEIPSQIQGLQSLEKLNLSHNNLSGIIPKAFEDMHGLWQVDISYNDLQGSIP 655
Query: 543 NSTAFKN---GLMEGNKGLCGNFKALPSCDAFTSHKQTFRKKWVVIALPILGMVVLLIGL 599
NS AF+N +++GNKGLCG+ K L C+ ++ K T + +++I +LG +++L
Sbjct: 656 NSEAFQNVTIEVLQGNKGLCGSVKGLQPCENRSATKGTHKAVFIII-FSLLGALLILSAF 714
Query: 600 IGFFFLFRRRKRDPQEKRSSSANPFGFFSVLNFNGKVLYEEITKATGNFGEKYCIGKGGQ 659
IG + + R R+ + +++ FS+ F+G+ YE I +AT +F YCIG+GG
Sbjct: 715 IGISLISQGR-RNAKMEKAGDVQTENLFSISTFDGRTTYEAIIEATKDFDPMYCIGEGGH 773
Query: 660 RSVYKAELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQ 719
SVYKAELPSGNI AVKK F + A+ +F+NE+ ALTEI+HRNI+K GFCS+++
Sbjct: 774 GSVYKAELPSGNIVAVKKLHR--FDIDMAHQKDFMNEIRALTEIKHRNIVKLLGFCSHSR 831
Query: 720 HSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDIS 779
HSF+V EYL RGSL TIL + AKE W R+N+IKGVA+ALSYLHHDC+PPIVHRDIS
Sbjct: 832 HSFLVYEYLERGSLGTILSKELQAKEVGWGTRVNIIKGVAHALSYLHHDCVPPIVHRDIS 891
Query: 780 SKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGTVGYAAPELAYTMRATEKYDVYSFG 839
S NVLLDS+YEAHVSDFG AKFL+ SSNW+ AGT GY APELAYTM+ TEK DVYSFG
Sbjct: 892 SNNVLLDSKYEAHVSDFGTAKFLKLDSSNWSTLAGTYGYVAPELAYTMKVTEKCDVYSFG 951
Query: 840 VLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRDVTDKLRSIMEVAILCL 899
VLALEV++G HPGD +S++ +S + + +LD RLP P+ ++ S++++A CL
Sbjct: 952 VLALEVMRGRHPGDLISSLSASPGKDNVVLKDVLDPRLPPPTLRDEAEVMSVIQLATACL 1011
Query: 900 VENPEARPTMKEVCNLLCK 918
+P++RPTM+ V +L +
Sbjct: 1012 NGSPQSRPTMQMVSQMLSQ 1030
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359491509|ref|XP_002278522.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At4g08850-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 871 bits (2251), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 484/919 (52%), Positives = 622/919 (67%), Gaps = 7/919 (0%)
Query: 3 NLGFNLLFGNIPPQIGNLSKLQYLDLGNNQLSGVIPPEIGKLNQLRRLYLDVNQLHGTIP 62
++ N L G IPPQIG LSKL+YLDL NQ SG IP EIG L L L+L NQL+G+IP
Sbjct: 116 DINMNKLSGPIPPQIGFLSKLKYLDLSTNQFSGRIPSEIGLLTNLEVLHLVENQLNGSIP 175
Query: 63 PVIGQLSLINELVFCHNNVSGRIPSSLGNLSNLALLYLNDNSLFGSIPIVMGNLKSLSTL 122
IGQL + +L N + G IP+SLGNLSNL LYL++N L G IP MGNL L L
Sbjct: 176 HEIGQLKSLCDLSLYTNKLEGTIPASLGNLSNLTNLYLDENKLSGLIPPEMGNLTKLVEL 235
Query: 123 DLSQNQLNGSIPCSLDNLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSENRLSGLIP 182
L+ N L G IP +L NL +L L LY N LSGPIP+ IGNLK L L LS N LSG IP
Sbjct: 236 CLNANNLTGPIPSTLGNLKSLTLLRLYNNQLSGPIPTEIGNLKHLRNLSLSSNYLSGPIP 295
Query: 183 LSLSNLSSLTVMSLFNNSLSGSIPPILGNLKSLSTLGLHINQLNGVIPPSIGNLSSLRNL 242
+SL +LS L + LF+N LSG IP +GNL+SL L + NQLNG IP +GNL +L L
Sbjct: 296 MSLGDLSGLKSLQLFDNQLSGPIPQEMGNLRSLVDLEISQNQLNGSIPTLLGNLINLEIL 355
Query: 243 SLFNNRLYGFVPKEIGYLKSLSKLEFCANHLSGVIPHSVGNLTGLVLLNMCENHLFGPIP 302
L +N+L +P EIG L L +LE N LSG +P + L + +N L GPIP
Sbjct: 356 YLRDNKLSSSIPPEIGKLHKLVELEIDTNQLSGFLPEGICQGGSLENFTVFDNFLIGPIP 415
Query: 303 KSLRNLTSLERVRFNQNNLYGKVYEAFGDHPNLTFLDLSQNNFYCEISFNWRNFSKLGTF 362
+SL+N SL R R N L G + EAFG PNL ++LS N FY E+S NW KL
Sbjct: 416 ESLKNCPSLARARLQGNQLTGNISEAFGVCPNLYHINLSNNKFYGELSQNWGRCHKLQWL 475
Query: 363 NASMNNIYGSIPPEIGDSSKLQVLDLSSNHIFGKIPVQLVKLFSLNKLILSLNQLFGGVP 422
+ + NNI GSIP + G S++L VL+LSSNH+ G+IP +L + SL KLIL+ N+L G +P
Sbjct: 476 DIAGNNITGSIPADFGISTQLTVLNLSSNHLVGEIPKKLGSVSSLWKLILNDNRLSGNIP 535
Query: 423 LEFGTLTELQYLDLSANKLSSSIPMSIGNLLKLHYLNLSNNQFSHKIPTEFEKLIHLSEL 482
E G+L +L YLDLS N+L+ SIP +GN L L+YLNLSNN+ SH IP + KL HLS L
Sbjct: 536 PELGSLADLGYLDLSGNRLNGSIPEHLGNCLDLNYLNLSNNKLSHGIPVQMGKLSHLSLL 595
Query: 483 DLSHNILQEEIPPQICKMESLEKLNLSHNNLSDFIPRCFEEMRSLSWIDISYNELQGPIP 542
DLSHN+L EIP QI ++SLEKLNLSHNNLS IP+ FE+M L +DISYN+LQG IP
Sbjct: 596 DLSHNLLTGEIPSQIQGLQSLEKLNLSHNNLSGIIPKAFEDMHGLWQVDISYNDLQGSIP 655
Query: 543 NSTAFKN---GLMEGNKGLCGNFKALPSCDAFTSHKQTFRKKWVVIALPILGMVVLLIGL 599
NS AF+N +++GNKGLCG+ K L C+ ++ K T + +++I +LG +++L
Sbjct: 656 NSEAFQNVTIEVLQGNKGLCGSVKGLQPCENRSATKGTHKAVFIII-FSLLGALLILSAF 714
Query: 600 IGFFFLFRRRKRDPQEKRSSSANPFGFFSVLNFNGKVLYEEITKATGNFGEKYCIGKGGQ 659
IG + + R R+ + +++ FS+ F+G+ YE I +AT +F YCIG+GG
Sbjct: 715 IGISLISQGR-RNAKMEKAGDVQTENLFSISTFDGRTTYEAIIEATKDFDPMYCIGEGGH 773
Query: 660 RSVYKAELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQ 719
SVYKAELPSGNI AVKK F + A+ +F+NE+ ALTEI+HRNI+K GFCS+++
Sbjct: 774 GSVYKAELPSGNIVAVKKLHR--FDIDMAHQKDFVNEIRALTEIKHRNIVKLLGFCSHSR 831
Query: 720 HSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDIS 779
HSF+V EYL RGSL TIL + AKE W R+N+IKGV++ALSYLHHDC+PPIVHRDIS
Sbjct: 832 HSFLVYEYLERGSLGTILSKELQAKEVGWGTRVNIIKGVSHALSYLHHDCVPPIVHRDIS 891
Query: 780 SKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGTVGYAAPELAYTMRATEKYDVYSFG 839
S NVLLDS+YEAHVSDFG AKFL+ SSNW+ AGT GY APELAYTM+ TEK DVYSFG
Sbjct: 892 SNNVLLDSKYEAHVSDFGTAKFLKLDSSNWSTLAGTYGYVAPELAYTMKVTEKCDVYSFG 951
Query: 840 VLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRDVTDKLRSIMEVAILCL 899
VLALEV++G HPGD +S++ S + + +LD RLP P+ ++ S++++A CL
Sbjct: 952 VLALEVMRGRHPGDLISSLSDSPGKDNVVLKDVLDPRLPPPTFRDEAEVTSVIQLATACL 1011
Query: 900 VENPEARPTMKEVCNLLCK 918
+P++RPTM+ V +L +
Sbjct: 1012 NGSPQSRPTMQMVSQMLSQ 1030
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359491512|ref|XP_002278614.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At4g08850-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 860 bits (2223), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 479/907 (52%), Positives = 598/907 (65%), Gaps = 17/907 (1%)
Query: 23 LQYLDLGNNQLSGVIPPEIGKLNQLRRLYLDVNQLHGTIPPVIG---QLSLINELVFCHN 79
L Y+D+ N LSG IPP+IG L++L+ L L NQ G IPP IG L +++ L N
Sbjct: 143 LAYVDVCINNLSGPIPPQIGLLSKLKYLDLSTNQFSGGIPPEIGLLTNLEVLHLLALYTN 202
Query: 80 NVSGRIPSSLGNLSNLALLYLNDNSLFGSIPIVMGNLKSLSTLDLSQNQLNGSIPCSLDN 139
+ G IP+SLGNLSNLA LYL +N L GSIP MGNL +L + N L G IP + N
Sbjct: 203 QLEGSIPASLGNLSNLASLYLYENQLSGSIPPEMGNLANLVEIYSDTNNLTGLIPSTFGN 262
Query: 140 LSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSENRLSGLIPLSLSNLSSLTVMSLFNN 199
L L TL+L+ N LSG IP IGNL SL + L N LSG IP SL +LS LT++ L+ N
Sbjct: 263 LKRLTTLYLFNNQLSGHIPPEIGNLTSLQGISLYANNLSGPIPASLGDLSGLTLLHLYAN 322
Query: 200 SLSGSIPPILGNLKSLSTLGLHINQLNGVIPPSIGNLSSLRNLSLFNNRLYGFVPKEIGY 259
LSG IPP +GNLKSL L L NQLNG IP S+GNL++L L L +N L G+ PKEIG
Sbjct: 323 QLSGPIPPEIGNLKSLVDLELSENQLNGSIPTSLGNLTNLEILFLRDNHLSGYFPKEIGK 382
Query: 260 LKSLSKLEFCANHLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLRNLTSLERVRFNQN 319
L L LE N LSG +P + LV + +N L GPIPKS++N +L R F N
Sbjct: 383 LHKLVVLEIDTNRLSGSLPEGICQGGSLVRFTVSDNLLSGPIPKSMKNCRNLTRALFGGN 442
Query: 320 NLYGKVYEAFGDHPNLTFLDLSQNNFYCEISFNWRNFSKLGTFNASMNNIYGSIPPEIGD 379
L G + E GD PNL ++DLS N F+ E+S NW +L + N+I GSIP + G
Sbjct: 443 QLTGNISEVVGDCPNLEYIDLSYNRFHGELSHNWGRCPQLQRLEMAGNDITGSIPEDFGI 502
Query: 380 SSKLQVLDLSSNHIFGKIPVQLVKLFSLNKLILSLNQLFGGVPLEFGTLTELQYLDLSAN 439
S+ L +LDLSSNH+ G+IP ++ L SL +L L+ NQL G +P E G+L L +LDLSAN
Sbjct: 503 STNLTLLDLSSNHLVGEIPKKMGSLTSLLELKLNDNQLSGSIPPELGSLFSLAHLDLSAN 562
Query: 440 KLSSSIPMSIGNLLKLHYLNLSNNQFSHKIPTEFEKLIHLSELDLSHNILQEEIPPQICK 499
+L+ SI ++G L LHYLNLSNN+ S++IP + KL HLS+LDLSHN+L EIPPQI
Sbjct: 563 RLNGSITENLGACLNLHYLNLSNNKLSNRIPAQMGKLSHLSQLDLSHNLLSGEIPPQIEG 622
Query: 500 MESLEKLNLSHNNLSDFIPRCFEEMRSLSWIDISYNELQGPIPNSTAFKNG---LMEGNK 556
+ESLE LNLSHNNLS FIP+ FEEMR LS IDISYN+LQGPIPNS AF++ L++GNK
Sbjct: 623 LESLENLNLSHNNLSGFIPKAFEEMRGLSDIDISYNQLQGPIPNSKAFRDATIELLKGNK 682
Query: 557 GLCGNFKALPSCDAFTSHKQTFRKKW----VVIALPILGMVVLLIGLIGFFFLFRRRKRD 612
LCGN K L C + Q KK +I P+LG +VLL IG F + R KR
Sbjct: 683 DLCGNVKGLQPCKNDSGAGQQPVKKGHKIVFIIVFPLLGALVLLFAFIGIFLIAERTKRT 742
Query: 613 PQEKRSSSANPFGFFSVLNFNGKVLYEEITKATGNFGEKYCIGKGGQRSVYKAELPSGNI 672
P+ + N FS+ F+G+ +YEEI KAT +F YCIGKGG SVYKAEL SGNI
Sbjct: 743 PEIEEGDVQN--DLFSISTFDGRAMYEEIIKATKDFDPMYCIGKGGHGSVYKAELSSGNI 800
Query: 673 FAVKKFKAELFSD-ETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFIVCEYLARG 731
AVKK A SD + AN +F NEV ALTEI+HRNI+K GFCS+ +HSF+V EYL RG
Sbjct: 801 VAVKKLYA---SDIDMANQRDFFNEVRALTEIKHRNIVKLLGFCSHPRHSFLVYEYLERG 857
Query: 732 SLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEA 791
SL +L + AK+ W R+N+IKGVA+ALSY+HHDC PPIVHRDISS N+LLDS+YE
Sbjct: 858 SLAAMLSRE-EAKKLGWATRINIIKGVAHALSYMHHDCSPPIVHRDISSNNILLDSQYEP 916
Query: 792 HVSDFGFAKFLEPHSSNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHP 851
H+SDFG AK L+ SSN + AGT GY APE AYTM+ TEK DVYSFGV+ LEVIKG HP
Sbjct: 917 HISDFGTAKLLKLDSSNQSALAGTFGYVAPEHAYTMKVTEKTDVYSFGVITLEVIKGRHP 976
Query: 852 GDFVSTIFSSISNMIIEVNQILDHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKE 911
GD + ++ S I + +LD RLP + ++ SI+ +A CL NPE+RPTMK
Sbjct: 977 GDQILSLSVSPEKENIVLEDMLDPRLPPLTAQDEGEVISIINLATACLSVNPESRPTMKI 1036
Query: 912 VCNLLCK 918
+ +L +
Sbjct: 1037 ISQMLSQ 1043
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255545702|ref|XP_002513911.1| receptor protein kinase, putative [Ricinus communis] gi|223546997|gb|EEF48494.1| receptor protein kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 810 bits (2091), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 466/903 (51%), Positives = 607/903 (67%), Gaps = 13/903 (1%)
Query: 23 LQYLDLGNNQLSGVIPPEIGKLNQLRRLYLDVNQLHGTIPPVIGQLSLINELVFCHNNVS 82
L++LDL N LS IP EI +L +L L L NQL G IPP IG L+ +N L N +
Sbjct: 110 LEFLDLSCNSLSSTIPLEITQLPKLIFLDLSSNQLSGVIPPDIGLLTNLNTLRLSANRLD 169
Query: 83 GRIPSSLGNLSNLALLYLNDNSLFGSIPIVMGNLKSLSTLDLSQNQLNGSIPCSLDNLSN 142
G IPSS+GNL+ LA L+L DN GSIP MGNLK+L L + N L GSIP + +L+
Sbjct: 170 GSIPSSVGNLTELAWLHLYDNRFSGSIPSEMGNLKNLVELFMDTNLLTGSIPSTFGSLTK 229
Query: 143 LDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSENRLSGLIPLSLSNLSSLTVMSLFNNSLS 202
L LFLY N LSG IP +G+LKSL L L N LSG IP SL L+SLT++ L+ N LS
Sbjct: 230 LVQLFLYNNQLSGHIPQELGDLKSLTSLSLFGNNLSGPIPASLGGLTSLTILHLYQNQLS 289
Query: 203 GSIPPILGNLKSLSTLGLHINQLNGVIPPSIGNLSSLRNLSLFNNRLYGFVPKEIGYLKS 262
G+IP LGNL SLS L L N+L G IP S+GNLS L L L NN+L G +P++I L
Sbjct: 290 GTIPKELGNLNSLSNLELSENKLTGSIPASLGNLSRLELLFLKNNQLSGPIPEQIANLSK 349
Query: 263 LSKLEFCANHLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLRNLTSLERVRFNQNNLY 322
LS L+ +N L+G +P ++ L ++ +N L GPIPKS+R+ SL R+ N
Sbjct: 350 LSLLQLQSNQLTGYLPQNICQSKVLQNFSVNDNRLEGPIPKSMRDCKSLVRLHLEGNQFI 409
Query: 323 GKVYEAFGDHPNLTFLDLSQNNFYCEISFNWRNFSKLGTFNASMNNIYGSIPPEIGDSSK 382
G + E FG +P L F+D+ N F+ EIS W LGT S NNI G IPPEIG++++
Sbjct: 410 GNISEDFGVYPYLQFVDIRYNKFHGEISSKWGMCPHLGTLLISGNNISGIIPPEIGNAAR 469
Query: 383 LQVLDLSSNHIFGKIPVQLVKLFSLNKLILSLNQLFGGVPLEFGTLTELQYLDLSANKLS 442
LQ LD SSN + G+IP +L KL SL ++ L NQL GVP EFG+LT+L+ LDLSAN+ +
Sbjct: 470 LQGLDFSSNQLVGRIPKELGKLTSLVRVNLEDNQLSDGVPSEFGSLTDLESLDLSANRFN 529
Query: 443 SSIPMSIGNLLKLHYLNLSNNQFSHKIPTEFEKLIHLSELDLSHNILQEEIPPQICKMES 502
SIP +IGNL+KL+YLNLSNNQFS +IP + KL+HLS+LDLS N L EIP ++ M+S
Sbjct: 530 QSIPGNIGNLVKLNYLNLSNNQFSQEIPIQLGKLVHLSKLDLSQNFLIGEIPSELSGMQS 589
Query: 503 LEKLNLSHNNLSDFIPRCFEEMRSLSWIDISYNELQGPIPNSTAFKNGLME---GNKGLC 559
LE LNLS NNLS FIP +EM LS IDISYN+L+GP+P++ AF+N +E GNKGLC
Sbjct: 590 LEVLNLSRNNLSGFIPGDLKEMHGLSSIDISYNKLEGPVPDNKAFQNSSIEAFQGNKGLC 649
Query: 560 GNFKALPSCDAFTSHKQT---FRKK-WVVIALPILGMVVLLIGLIGFFFLFRRRKRDPQE 615
G+ + L C ++ + + F K+ ++VI+LP+ G L++ +G F +R ++ E
Sbjct: 650 GHVQGLQPCKPSSTEQGSSIKFHKRLFLVISLPLFG-AFLILSFLGVLFFQSKRSKEALE 708
Query: 616 KRSSSANPFGFFSVLNFNGKVLYEEITKATGNFGEKYCIGKGGQRSVYKAELPSGNIFAV 675
SS + +F+GK +++EI +AT +F + YCIGKGG SVYKA+L SG+ AV
Sbjct: 709 AEKSSQESEEILLITSFDGKSMHDEIIEATDSFNDIYCIGKGGCGSVYKAKLSSGSTVAV 768
Query: 676 KKFKAELFSDETANP--SEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFIVCEYLARGSL 733
KK S + P EF +E+ ALTEI+HRNI+KF+GFCS + +SF+V E + +GSL
Sbjct: 769 KKLHQ---SHDAWKPYQKEFWSEIRALTEIKHRNIVKFYGFCSYSAYSFLVYECIEKGSL 825
Query: 734 TTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHV 793
TILRD+ AAKE W +R N+IKGVANALSY+HHDC PPIVHRDISSKN+LLDSE EA V
Sbjct: 826 ATILRDNEAAKELEWFKRANIIKGVANALSYMHHDCSPPIVHRDISSKNILLDSENEARV 885
Query: 794 SDFGFAKFLEPHSSNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGD 853
SDFG A+ L SS+ T AGT GY APELAY++ TEK DVYSFGVLALEVI G HPG+
Sbjct: 886 SDFGIARILNLDSSHRTALAGTFGYMAPELAYSIVVTEKCDVYSFGVLALEVINGKHPGE 945
Query: 854 FVSTIFSSISNMIIEVNQILDHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVC 913
+S+I SS S + + I+D RLP PS +V +L +I+ +A CL NP+ RPTM+ +C
Sbjct: 946 IISSISSSSSTRKMLLENIVDLRLPFPSPEVQVELVNILNLAFTCLNSNPQVRPTMEMIC 1005
Query: 914 NLL 916
++L
Sbjct: 1006 HML 1008
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|186511602|ref|NP_849538.2| Leucine-rich repeat-containing protein [Arabidopsis thaliana] gi|281185491|sp|Q8VZG8.3|Y4885_ARATH RecName: Full=Probable LRR receptor-like serine/threonine-protein kinase At4g08850; Flags: Precursor gi|18086327|gb|AAL57627.1| AT4g08850/T32A17_160 [Arabidopsis thaliana] gi|224589610|gb|ACN59338.1| leucine-rich repeat receptor-like protein kinase [Arabidopsis thaliana] gi|332657282|gb|AEE82682.1| Leucine-rich repeat-containing protein [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 804 bits (2077), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 437/919 (47%), Positives = 600/919 (65%), Gaps = 15/919 (1%)
Query: 2 LNLGFNLLFGNIPPQIGNLSKLQYLDLGNNQLSGVIPPEIGKLNQLRRLYLDVNQLHGTI 61
++L N G I P G SKL+Y DL NQL G IPPE+G L+ L L+L N+L+G+I
Sbjct: 123 VDLSMNRFSGTISPLWGRFSKLEYFDLSINQLVGEIPPELGDLSNLDTLHLVENKLNGSI 182
Query: 62 PPVIGQLSLINELVFCHNNVSGRIPSSLGNLSNLALLYLNDNSLFGSIPIVMGNLKSLST 121
P IG+L+ + E+ N ++G IPSS GNL+ L LYL NSL GSIP +GNL +L
Sbjct: 183 PSEIGRLTKVTEIAIYDNLLTGPIPSSFGNLTKLVNLYLFINSLSGSIPSEIGNLPNLRE 242
Query: 122 LDLSQNQLNGSIPCSLDNLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSENRLSGLI 181
L L +N L G IP S NL N+ L +++N LSG IP IGN+ +L L L N+L+G I
Sbjct: 243 LCLDRNNLTGKIPSSFGNLKNVTLLNMFENQLSGEIPPEIGNMTALDTLSLHTNKLTGPI 302
Query: 182 PLSLSNLSSLTVMSLFNNSLSGSIPPILGNLKSLSTLGLHINQLNGVIPPSIGNLSSLRN 241
P +L N+ +L V+ L+ N L+GSIPP LG ++S+ L + N+L G +P S G L++L
Sbjct: 303 PSTLGNIKTLAVLHLYLNQLNGSIPPELGEMESMIDLEISENKLTGPVPDSFGKLTALEW 362
Query: 242 LSLFNNRLYGFVPKEIGYLKSLSKLEFCANHLSGVIPHSVGNLTGLVLLNMCENHLFGPI 301
L L +N+L G +P I L+ L+ N+ +G +P ++ L L + +NH GP+
Sbjct: 363 LFLRDNQLSGPIPPGIANSTELTVLQLDTNNFTGFLPDTICRGGKLENLTLDDNHFEGPV 422
Query: 302 PKSLRNLTSLERVRFNQNNLYGKVYEAFGDHPNLTFLDLSQNNFYCEISFNWRNFSKLGT 361
PKSLR+ SL RVRF N+ G + EAFG +P L F+DLS NNF+ ++S NW KL
Sbjct: 423 PKSLRDCKSLIRVRFKGNSFSGDISEAFGVYPTLNFIDLSNNNFHGQLSANWEQSQKLVA 482
Query: 362 FNASMNNIYGSIPPEIGDSSKLQVLDLSSNHIFGKIPVQLVKLFSLNKLILSLNQLFGGV 421
F S N+I G+IPPEI + ++L LDLSSN I G++P + + ++KL L+ N+L G +
Sbjct: 483 FILSNNSITGAIPPEIWNMTQLSQLDLSSNRITGELPESISNINRISKLQLNGNRLSGKI 542
Query: 422 PLEFGTLTELQYLDLSANKLSSSIPMSIGNLLKLHYLNLSNNQFSHKIPTEFEKLIHLSE 481
P LT L+YLDLS+N+ SS IP ++ NL +L+Y+NLS N IP KL L
Sbjct: 543 PSGIRLLTNLEYLDLSSNRFSSEIPPTLNNLPRLYYMNLSRNDLDQTIPEGLTKLSQLQM 602
Query: 482 LDLSHNILQEEIPPQICKMESLEKLNLSHNNLSDFIPRCFEEMRSLSWIDISYNELQGPI 541
LDLS+N L EI Q +++LE+L+LSHNNLS IP F++M +L+ +D+S+N LQGPI
Sbjct: 603 LDLSYNQLDGEISSQFRSLQNLERLDLSHNNLSGQIPPSFKDMLALTHVDVSHNNLQGPI 662
Query: 542 PNSTAFKNG---LMEGNKGLCGNF---KALPSCDAFTSHKQTFRKKWVVIAL--PILGMV 593
P++ AF+N EGNK LCG+ + L C + TS K++ + + ++I + PI+G +
Sbjct: 663 PDNAAFRNAPPDAFEGNKDLCGSVNTTQGLKPC-SITSSKKSHKDRNLIIYILVPIIGAI 721
Query: 594 VLLIGLIGFFFLFRRRKRDPQEKRSSSANPFGFFSVLNFNGKVLYEEITKATGNFGEKYC 653
++L G F FR+R + +E S + S+ +F+GKV Y+EI KATG F KY
Sbjct: 722 IILSVCAGIFICFRKRTKQIEEHTDSESGG-ETLSIFSFDGKVRYQEIIKATGEFDPKYL 780
Query: 654 IGKGGQRSVYKAELPSGNIFAVKKFKAELFSDETANPS---EFLNEVLALTEIRHRNIIK 710
IG GG VYKA+LP+ I AVKK E +NPS EFLNE+ ALTEIRHRN++K
Sbjct: 781 IGTGGHGKVYKAKLPNA-IMAVKKLN-ETTDSSISNPSTKQEFLNEIRALTEIRHRNVVK 838
Query: 711 FHGFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCI 770
GFCS+ +++F+V EY+ RGSL +L +D AK+ W +R+NV+KGVA+ALSY+HHD
Sbjct: 839 LFGFCSHRRNTFLVYEYMERGSLRKVLENDDEAKKLDWGKRINVVKGVAHALSYMHHDRS 898
Query: 771 PPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGTVGYAAPELAYTMRAT 830
P IVHRDISS N+LL +YEA +SDFG AK L+P SSNW+ AGT GY APELAY M+ T
Sbjct: 899 PAIVHRDISSGNILLGEDYEAKISDFGTAKLLKPDSSNWSAVAGTYGYVAPELAYAMKVT 958
Query: 831 EKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRDVTDKLRS 890
EK DVYSFGVL LEVIKG HPGD VST+ SS + + + I DHRLP P+ ++ +++
Sbjct: 959 EKCDVYSFGVLTLEVIKGEHPGDLVSTLSSSPPDATLSLKSISDHRLPEPTPEIKEEVLE 1018
Query: 891 IMEVAILCLVENPEARPTM 909
I++VA+LCL +P+ARPTM
Sbjct: 1019 ILKVALLCLHSDPQARPTM 1037
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|7267528|emb|CAB78010.1| receptor protein kinase-like protein [Arabidopsis thaliana] gi|7321074|emb|CAB82121.1| receptor protein kinase-like protein [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 804 bits (2077), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 437/919 (47%), Positives = 600/919 (65%), Gaps = 15/919 (1%)
Query: 2 LNLGFNLLFGNIPPQIGNLSKLQYLDLGNNQLSGVIPPEIGKLNQLRRLYLDVNQLHGTI 61
++L N G I P G SKL+Y DL NQL G IPPE+G L+ L L+L N+L+G+I
Sbjct: 105 VDLSMNRFSGTISPLWGRFSKLEYFDLSINQLVGEIPPELGDLSNLDTLHLVENKLNGSI 164
Query: 62 PPVIGQLSLINELVFCHNNVSGRIPSSLGNLSNLALLYLNDNSLFGSIPIVMGNLKSLST 121
P IG+L+ + E+ N ++G IPSS GNL+ L LYL NSL GSIP +GNL +L
Sbjct: 165 PSEIGRLTKVTEIAIYDNLLTGPIPSSFGNLTKLVNLYLFINSLSGSIPSEIGNLPNLRE 224
Query: 122 LDLSQNQLNGSIPCSLDNLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSENRLSGLI 181
L L +N L G IP S NL N+ L +++N LSG IP IGN+ +L L L N+L+G I
Sbjct: 225 LCLDRNNLTGKIPSSFGNLKNVTLLNMFENQLSGEIPPEIGNMTALDTLSLHTNKLTGPI 284
Query: 182 PLSLSNLSSLTVMSLFNNSLSGSIPPILGNLKSLSTLGLHINQLNGVIPPSIGNLSSLRN 241
P +L N+ +L V+ L+ N L+GSIPP LG ++S+ L + N+L G +P S G L++L
Sbjct: 285 PSTLGNIKTLAVLHLYLNQLNGSIPPELGEMESMIDLEISENKLTGPVPDSFGKLTALEW 344
Query: 242 LSLFNNRLYGFVPKEIGYLKSLSKLEFCANHLSGVIPHSVGNLTGLVLLNMCENHLFGPI 301
L L +N+L G +P I L+ L+ N+ +G +P ++ L L + +NH GP+
Sbjct: 345 LFLRDNQLSGPIPPGIANSTELTVLQVDTNNFTGFLPDTICRGGKLENLTLDDNHFEGPV 404
Query: 302 PKSLRNLTSLERVRFNQNNLYGKVYEAFGDHPNLTFLDLSQNNFYCEISFNWRNFSKLGT 361
PKSLR+ SL RVRF N+ G + EAFG +P L F+DLS NNF+ ++S NW KL
Sbjct: 405 PKSLRDCKSLIRVRFKGNSFSGDISEAFGVYPTLNFIDLSNNNFHGQLSANWEQSQKLVA 464
Query: 362 FNASMNNIYGSIPPEIGDSSKLQVLDLSSNHIFGKIPVQLVKLFSLNKLILSLNQLFGGV 421
F S N+I G+IPPEI + ++L LDLSSN I G++P + + ++KL L+ N+L G +
Sbjct: 465 FILSNNSITGAIPPEIWNMTQLSQLDLSSNRITGELPESISNINRISKLQLNGNRLSGKI 524
Query: 422 PLEFGTLTELQYLDLSANKLSSSIPMSIGNLLKLHYLNLSNNQFSHKIPTEFEKLIHLSE 481
P LT L+YLDLS+N+ SS IP ++ NL +L+Y+NLS N IP KL L
Sbjct: 525 PSGIRLLTNLEYLDLSSNRFSSEIPPTLNNLPRLYYMNLSRNDLDQTIPEGLTKLSQLQM 584
Query: 482 LDLSHNILQEEIPPQICKMESLEKLNLSHNNLSDFIPRCFEEMRSLSWIDISYNELQGPI 541
LDLS+N L EI Q +++LE+L+LSHNNLS IP F++M +L+ +D+S+N LQGPI
Sbjct: 585 LDLSYNQLDGEISSQFRSLQNLERLDLSHNNLSGQIPPSFKDMLALTHVDVSHNNLQGPI 644
Query: 542 PNSTAFKNG---LMEGNKGLCGNF---KALPSCDAFTSHKQTFRKKWVVIAL--PILGMV 593
P++ AF+N EGNK LCG+ + L C + TS K++ + + ++I + PI+G +
Sbjct: 645 PDNAAFRNAPPDAFEGNKDLCGSVNTTQGLKPC-SITSSKKSHKDRNLIIYILVPIIGAI 703
Query: 594 VLLIGLIGFFFLFRRRKRDPQEKRSSSANPFGFFSVLNFNGKVLYEEITKATGNFGEKYC 653
++L G F FR+R + +E S + S+ +F+GKV Y+EI KATG F KY
Sbjct: 704 IILSVCAGIFICFRKRTKQIEEHTDSESGG-ETLSIFSFDGKVRYQEIIKATGEFDPKYL 762
Query: 654 IGKGGQRSVYKAELPSGNIFAVKKFKAELFSDETANPS---EFLNEVLALTEIRHRNIIK 710
IG GG VYKA+LP+ I AVKK E +NPS EFLNE+ ALTEIRHRN++K
Sbjct: 763 IGTGGHGKVYKAKLPNA-IMAVKKLN-ETTDSSISNPSTKQEFLNEIRALTEIRHRNVVK 820
Query: 711 FHGFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCI 770
GFCS+ +++F+V EY+ RGSL +L +D AK+ W +R+NV+KGVA+ALSY+HHD
Sbjct: 821 LFGFCSHRRNTFLVYEYMERGSLRKVLENDDEAKKLDWGKRINVVKGVAHALSYMHHDRS 880
Query: 771 PPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGTVGYAAPELAYTMRAT 830
P IVHRDISS N+LL +YEA +SDFG AK L+P SSNW+ AGT GY APELAY M+ T
Sbjct: 881 PAIVHRDISSGNILLGEDYEAKISDFGTAKLLKPDSSNWSAVAGTYGYVAPELAYAMKVT 940
Query: 831 EKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRDVTDKLRS 890
EK DVYSFGVL LEVIKG HPGD VST+ SS + + + I DHRLP P+ ++ +++
Sbjct: 941 EKCDVYSFGVLTLEVIKGEHPGDLVSTLSSSPPDATLSLKSISDHRLPEPTPEIKEEVLE 1000
Query: 891 IMEVAILCLVENPEARPTM 909
I++VA+LCL +P+ARPTM
Sbjct: 1001 ILKVALLCLHSDPQARPTM 1019
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297813345|ref|XP_002874556.1| hypothetical protein ARALYDRAFT_489780 [Arabidopsis lyrata subsp. lyrata] gi|297320393|gb|EFH50815.1| hypothetical protein ARALYDRAFT_489780 [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 804 bits (2076), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 435/916 (47%), Positives = 597/916 (65%), Gaps = 12/916 (1%)
Query: 2 LNLGFNLLFGNIPPQIGNLSKLQYLDLGNNQLSGVIPPEIGKLNQLRRLYLDVNQLHGTI 61
++L N G I P G SKL Y DL NQL G IPPE+G L+ L L+L N+L+G+I
Sbjct: 100 VDLSMNRFSGTISPLWGRFSKLVYFDLSINQLVGEIPPELGDLSNLDTLHLVENKLNGSI 159
Query: 62 PPVIGQLSLINELVFCHNNVSGRIPSSLGNLSNLALLYLNDNSLFGSIPIVMGNLKSLST 121
P IG+L+ + E+ N ++G IPSS GNL+ L LYL NSL G IP +GNL +L
Sbjct: 160 PSEIGRLTKVTEIAIYDNLLTGPIPSSFGNLTRLVNLYLFINSLSGPIPSEIGNLPNLRE 219
Query: 122 LDLSQNQLNGSIPCSLDNLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSENRLSGLI 181
L L +N L G IP S NL N+ L +++N LSG IP IGN+ +L L L N+L+G I
Sbjct: 220 LCLDRNNLTGKIPSSFGNLKNVSLLNMFENQLSGEIPPEIGNMTALDTLSLHTNKLTGPI 279
Query: 182 PLSLSNLSSLTVMSLFNNSLSGSIPPILGNLKSLSTLGLHINQLNGVIPPSIGNLSSLRN 241
P +L N+ +L ++ L+ N LSGSIPP LG+++++ L + N+L G +P S G L+ L
Sbjct: 280 PSTLGNIKTLAILHLYLNQLSGSIPPELGDMEAMIDLEISENKLTGPVPDSFGKLTVLEW 339
Query: 242 LSLFNNRLYGFVPKEIGYLKSLSKLEFCANHLSGVIPHSVGNLTGLVLLNMCENHLFGPI 301
L L +N+L G +P I L+ L+ N+ +G +P ++ L L + +NH GP+
Sbjct: 340 LFLRDNQLSGPIPPGIANSTELTVLQLDTNNFTGFLPDTICRSGKLENLTLDDNHFEGPV 399
Query: 302 PKSLRNLTSLERVRFNQNNLYGKVYEAFGDHPNLTFLDLSQNNFYCEISFNWRNFSKLGT 361
PKSLRN SL RVRF N+ G + +AFG +P L F+DLS NNF+ ++S NW +KL
Sbjct: 400 PKSLRNCKSLVRVRFKGNHFSGDISDAFGVYPTLNFIDLSNNNFHGQLSANWEQSTKLVA 459
Query: 362 FNASMNNIYGSIPPEIGDSSKLQVLDLSSNHIFGKIPVQLVKLFSLNKLILSLNQLFGGV 421
F S N+I G+IPPEI + ++L LDLS N I G++P + + ++KL L+ NQL G +
Sbjct: 460 FILSNNSISGAIPPEIWNMTQLNQLDLSFNRITGELPESISNINRISKLQLNGNQLSGKI 519
Query: 422 PLEFGTLTELQYLDLSANKLSSSIPMSIGNLLKLHYLNLSNNQFSHKIPTEFEKLIHLSE 481
P LT L+YLDLS+N+ IP ++ NL +L+Y+NLS N IP KL L
Sbjct: 520 PSGIRLLTNLEYLDLSSNQFGFEIPATLNNLPRLYYMNLSRNDLDQTIPEGLTKLSQLQM 579
Query: 482 LDLSHNILQEEIPPQICKMESLEKLNLSHNNLSDFIPRCFEEMRSLSWIDISYNELQGPI 541
LDLS+N L EI Q +++LE+L+LSHNNLS IP F++M +L+ ID+S+N LQGPI
Sbjct: 580 LDLSYNQLDGEISSQFGSLQNLERLDLSHNNLSGQIPTSFKDMLALTHIDVSHNNLQGPI 639
Query: 542 PNSTAFKNG---LMEGNKGLCGNFKALPSCDAFTSHKQTFRKKWVVIAL--PILGMVVLL 596
P++ AF+N +EGN LCG+ KAL C + TS K++ + + ++I + PI+G +++L
Sbjct: 640 PDNAAFRNASPNALEGNNDLCGDNKALKPC-SITSSKKSHKDRNLIIYILVPIIGAIIIL 698
Query: 597 IGLIGFFFLFRRRKRDPQEKRSSSANPFGFFSVLNFNGKVLYEEITKATGNFGEKYCIGK 656
G F FR+R + +E S S + S+ +F+GKV Y+EI KATG F KY IG
Sbjct: 699 SVCAGIFICFRKRTKQIEEN-SDSESGGETLSIFSFDGKVRYQEIIKATGEFDSKYLIGT 757
Query: 657 GGQRSVYKAELPSGNIFAVKKFKAELFSDETANPS---EFLNEVLALTEIRHRNIIKFHG 713
GG VYKA+LP+ I AVKK E NPS EFLNE+ ALTEIRHRN++K G
Sbjct: 758 GGHGKVYKAKLPNA-IMAVKKLN-ETTDSSITNPSTKQEFLNEIRALTEIRHRNVVKLFG 815
Query: 714 FCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPI 773
FCS+ +++F+V EY+ RGSL +L +D AK+ W +R+NV+KGVA+ALSY+HHD P I
Sbjct: 816 FCSHRRNTFLVYEYMERGSLRKVLENDDEAKKLDWGKRINVVKGVADALSYMHHDRSPAI 875
Query: 774 VHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGTVGYAAPELAYTMRATEKY 833
VHRDISS N+LL +YEA +SDFG AK L+P SSNW+ AGT GY APELAY M+ TEK
Sbjct: 876 VHRDISSGNILLGEDYEAKISDFGTAKLLKPDSSNWSAVAGTYGYVAPELAYAMKVTEKC 935
Query: 834 DVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRDVTDKLRSIME 893
DVYSFGVL LEVIKG HPGD VST+ SS + + + I DHRLP P+ ++ +++ I++
Sbjct: 936 DVYSFGVLTLEVIKGEHPGDLVSTLSSSPPDTSLSLKTISDHRLPEPTPEIKEEVLEILK 995
Query: 894 VAILCLVENPEARPTM 909
VA++CL +P+ARPTM
Sbjct: 996 VALMCLHSDPQARPTM 1011
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST 
Original result of BLAST against Gene Ontology (AMIGO)
ID ![]() |
Alignment graph ![]() |
Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 918 | ||||||
| TAIR|locus:2138268 | 1045 | AT4G08850 [Arabidopsis thalian | 0.977 | 0.858 | 0.438 | 2e-191 | |
| TAIR|locus:2011339 | 1120 | AT1G35710 [Arabidopsis thalian | 0.972 | 0.797 | 0.416 | 5.5e-180 | |
| TAIR|locus:2160791 | 1102 | AT5G63930 [Arabidopsis thalian | 0.981 | 0.817 | 0.345 | 5.4e-134 | |
| TAIR|locus:2020417 | 1101 | AT1G17230 [Arabidopsis thalian | 0.618 | 0.515 | 0.346 | 5.9e-134 | |
| TAIR|locus:2046525 | 1124 | AT2G33170 [Arabidopsis thalian | 0.980 | 0.800 | 0.337 | 2.6e-127 | |
| TAIR|locus:2085949 | 1141 | AT3G24240 [Arabidopsis thalian | 0.956 | 0.769 | 0.338 | 2.8e-121 | |
| TAIR|locus:2154344 | 1135 | AT5G48940 [Arabidopsis thalian | 0.948 | 0.767 | 0.332 | 5.2e-120 | |
| TAIR|locus:2120362 | 1249 | GSO1 "GASSHO1" [Arabidopsis th | 0.863 | 0.634 | 0.329 | 2e-102 | |
| TAIR|locus:2156349 | 1252 | GSO2 "GASSHO 2" [Arabidopsis t | 0.974 | 0.714 | 0.317 | 1.1e-117 | |
| UNIPROTKB|P93194 | 1109 | INRPK1 "Receptor-like protein | 0.598 | 0.495 | 0.338 | 3.2e-115 |
| TAIR|locus:2138268 AT4G08850 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1855 (658.1 bits), Expect = 2.0e-191, P = 2.0e-191
Identities = 399/910 (43%), Positives = 545/910 (59%)
Query: 13 IPPQIGNLSKLQYLDLGNNQLSGVIPPEIGKLNQLRRLYLDVNQLHGTIPPVIGQLSLIN 72
I P G SKL+Y DL NQL G IPPE+G L+ L L+L N+L+G+IP IG+L+ +
Sbjct: 134 ISPLWGRFSKLEYFDLSINQLVGEIPPELGDLSNLDTLHLVENKLNGSIPSEIGRLTKVT 193
Query: 73 ELVFCHNNVSGRIPXXXXXXXXXXXXXXXXXXXFGSIPIVMGNLKSLSTLDLSQNQLNGS 132
E+ N ++G IP GSIP +GNL +L L L +N L G
Sbjct: 194 EIAIYDNLLTGPIPSSFGNLTKLVNLYLFINSLSGSIPSEIGNLPNLRELCLDRNNLTGK 253
Query: 133 IPCSLDNLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSENRXXXXXXXXXXXXXXXX 192
IP S NL N+ L +++N LSG IP IGN+ +L L L N+
Sbjct: 254 IPSSFGNLKNVTLLNMFENQLSGEIPPEIGNMTALDTLSLHTNKLTGPIPSTLGNIKTLA 313
Query: 193 XXXXFNNSLSGSIPPILGNLKSLSTLGLHINQLNGVIPPSIGXXXXXXXXXXXXXXXYGF 252
+ N L+GSIPP LG ++S+ L + N+L G +P S G G
Sbjct: 314 VLHLYLNQLNGSIPPELGEMESMIDLEISENKLTGPVPDSFGKLTALEWLFLRDNQLSGP 373
Query: 253 VPKEIGYLKSLSKLEFCANHLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLRNLTSLE 312
+P I L+ L+ N+ +G +P ++ L L + +NH GP+PKSLR+ SL
Sbjct: 374 IPPGIANSTELTVLQLDTNNFTGFLPDTICRGGKLENLTLDDNHFEGPVPKSLRDCKSLI 433
Query: 313 RVRFNQNNLYGKVYEAFGDHPNLTFLDLSQNNFYCEISFNWRNFSKLGTFNASMNNIYGS 372
RVRF N+ G + EAFG +P L F+DLS NNF+ ++S NW KL F S N+I G+
Sbjct: 434 RVRFKGNSFSGDISEAFGVYPTLNFIDLSNNNFHGQLSANWEQSQKLVAFILSNNSITGA 493
Query: 373 IPPEIGDSSKLQVLDLSSNHIFGKIPVQLVKLFSLNKLILSLNQLFGGVPLEFGTLTELQ 432
IPPEI + ++L LDLSSN I G++P + + ++KL L+ N+L G +P LT L+
Sbjct: 494 IPPEIWNMTQLSQLDLSSNRITGELPESISNINRISKLQLNGNRLSGKIPSGIRLLTNLE 553
Query: 433 YLDLSANKLSSSIPMSIGNLLKLHYLNLSNNQFSHKIPTEFEKLIHLSELDLSHNILQEE 492
YLDLS+N+ SS IP ++ NL +L+Y+NLS N IP KL L LDLS+N L E
Sbjct: 554 YLDLSSNRFSSEIPPTLNNLPRLYYMNLSRNDLDQTIPEGLTKLSQLQMLDLSYNQLDGE 613
Query: 493 IPPQICKMESLEKLNLSHNNLSDFIPRCFEEMRSLSWIDISYNELQGPIPNSTAFKNG-- 550
I Q +++LE+L+LSHNNLS IP F++M +L+ +D+S+N LQGPIP++ AF+N
Sbjct: 614 ISSQFRSLQNLERLDLSHNNLSGQIPPSFKDMLALTHVDVSHNNLQGPIPDNAAFRNAPP 673
Query: 551 -LMEGNKGLCGNF---KALPSCDAFTSHKQTFRKKWVVIAXXXXXXXXXXXXXXXXXXXX 606
EGNK LCG+ + L C + TS K++ + + ++I
Sbjct: 674 DAFEGNKDLCGSVNTTQGLKPC-SITSSKKSHKDRNLIIYILVPIIGAIIILSVCAGIFI 732
Query: 607 XXXXXDPQ-EKRSSSANPFGFFSVLNFNGKVLYEEITKATGNFGEKYCIGKGGQRSVYKA 665
Q E+ + S + S+ +F+GKV Y+EI KATG F KY IG GG VYKA
Sbjct: 733 CFRKRTKQIEEHTDSESGGETLSIFSFDGKVRYQEIIKATGEFDPKYLIGTGGHGKVYKA 792
Query: 666 ELPSGNIFAVKKFKAELFSDETANPS---EFLNEVLALTEIRHRNIIKFHGFCSNAQHSF 722
+LP+ I AVKK E +NPS EFLNE+ ALTEIRHRN++K GFCS+ +++F
Sbjct: 793 KLPNA-IMAVKKLN-ETTDSSISNPSTKQEFLNEIRALTEIRHRNVVKLFGFCSHRRNTF 850
Query: 723 IVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKN 782
+V EY+ RGSL +L +D AK+ W +R+NV+KGVA+ALSY+HHD P IVHRDISS N
Sbjct: 851 LVYEYMERGSLRKVLENDDEAKKLDWGKRINVVKGVAHALSYMHHDRSPAIVHRDISSGN 910
Query: 783 VLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLA 842
+LL +YEA +SDFG AK L+P SSNW+ AGT GY APELAY M+ TEK DVYSFGVL
Sbjct: 911 ILLGEDYEAKISDFGTAKLLKPDSSNWSAVAGTYGYVAPELAYAMKVTEKCDVYSFGVLT 970
Query: 843 LEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRDVTDKLRSIMEVAILCLVEN 902
LEVIKG HPGD VST+ SS + + + I DHRLP P+ ++ +++ I++VA+LCL +
Sbjct: 971 LEVIKGEHPGDLVSTLSSSPPDATLSLKSISDHRLPEPTPEIKEEVLEILKVALLCLHSD 1030
Query: 903 PEARPTMKEV 912
P+ARPTM +
Sbjct: 1031 PQARPTMLSI 1040
|
|
| TAIR|locus:2011339 AT1G35710 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1747 (620.0 bits), Expect = 5.5e-180, P = 5.5e-180
Identities = 379/909 (41%), Positives = 522/909 (57%)
Query: 13 IPPQIGNLSKLQYLDLGNNQLSGVIPPEIGKLNQLRRLYLDVNQLHGTIPPVIGQLSLIN 72
IPP++GN+ + L L N+L+G IP +G L L LYL N L G IPP IG + +
Sbjct: 214 IPPELGNMESMTDLALSQNKLTGSIPSTLGNLKNLMVLYLYENYLTGVIPPEIGNMESMT 273
Query: 73 ELVFCHNNVSGRIPXXXXXXXXXXXXXXXXXXXFGSIPIVMGNLKSLSTLDLSQNQLNGS 132
L N ++G IP G IP +GN++S+ L+LS N+L GS
Sbjct: 274 NLALSQNKLTGSIPSSLGNLKNLTLLSLFQNYLTGGIPPKLGNIESMIDLELSNNKLTGS 333
Query: 133 IPCSLDNLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSENRXXXXXXXXXXXXXXXX 192
IP SL NL NL L+LY+N L+G IP +GN++S++ L L+ N+
Sbjct: 334 IPSSLGNLKNLTILYLYENYLTGVIPPELGNMESMIDLQLNNNKLTGSIPSSFGNLKNLT 393
Query: 193 XXXXFNNSLSGSIPPILGNLKSLSTLGLHINQLNGVIPPSIGXXXXXXXXXXXXXXXYGF 252
+ N L+G IP LGN++S+ L L N+L G +P S G G
Sbjct: 394 YLYLYLNYLTGVIPQELGNMESMINLDLSQNKLTGSVPDSFGNFTKLESLYLRVNHLSGA 453
Query: 253 VPKEIGYLKSLSKLEFCANHLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLRNLTSLE 312
+P + L+ L N+ +G P +V L +++ NHL GPIPKSLR+ SL
Sbjct: 454 IPPGVANSSHLTTLILDTNNFTGFFPETVCKGRKLQNISLDYNHLEGPIPKSLRDCKSLI 513
Query: 313 RVRFNQNNLYGKVYEAFGDHPNLTFLDLSQNNFYCEISFNWRNFSKLGTFNASMNNIYGS 372
R RF N G ++EAFG +P+L F+D S N F+ EIS NW KLG S NNI G+
Sbjct: 514 RARFLGNKFTGDIFEAFGIYPDLNFIDFSHNKFHGEISSNWEKSPKLGALIMSNNNITGA 573
Query: 373 IPPEIGDSSKLQVLDLSSNHIFGKIPVQLVKLFSLNKLILSLNQLFGGVPLEFGTLTELQ 432
IP EI + ++L LDLS+N++FG++P + L +L++L L+ NQL G VP LT L+
Sbjct: 574 IPTEIWNMTQLVELDLSTNNLFGELPEAIGNLTNLSRLRLNGNQLSGRVPAGLSFLTNLE 633
Query: 433 YLDLSANKLSSSIPMSIGNLLKLHYLNLSNNQFSHKIPTEFEKLIHLSELDLSHNILQEE 492
LDLS+N SS IP + + LKLH +NLS N+F IP KL L++LDLSHN L E
Sbjct: 634 SLDLSSNNFSSEIPQTFDSFLKLHDMNLSRNKFDGSIP-RLSKLTQLTQLDLSHNQLDGE 692
Query: 493 IPPQICKMESLEKLNLSHNNLSDFIPRCFEEMRSLSWIDISYNELQGPIPNSTAFKNGL- 551
IP Q+ ++SL+KL+LSHNNLS IP FE M +L+ +DIS N+L+GP+P++ F+
Sbjct: 693 IPSQLSSLQSLDKLDLSHNNLSGLIPTTFEGMIALTNVDISNNKLEGPLPDTPTFRKATA 752
Query: 552 --MEGNKGLCGNF--KALPSCDAFTSHKQTFRKK-WVVIAXXXXXXXXXXXXXXXXXXXX 606
+E N GLC N + L C K+ W+++
Sbjct: 753 DALEENIGLCSNIPKQRLKPCRELKKPKKNGNLVVWILVPILGVLVILSICANTFTYCIR 812
Query: 607 XXXXXDPQEKRSSSANPFGFFSVLNFNGKVLYEEITKATGNFGEKYCIGKGGQRSVYKAE 666
+ + + FSV +GK Y++I ++T F + IG GG VY+A
Sbjct: 813 KRKLQNGRNTDPETGENMSIFSV---DGKFKYQDIIESTNEFDPTHLIGTGGYSKVYRAN 869
Query: 667 LPSGNIFAVKKFKAELFSDETANP---SEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFI 723
L I AVK+ + +E + P EFLNEV ALTEIRHRN++K GFCS+ +H+F+
Sbjct: 870 LQD-TIIAVKRLH-DTIDEEISKPVVKQEFLNEVKALTEIRHRNVVKLFGFCSHRRHTFL 927
Query: 724 VCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNV 783
+ EY+ +GSL +L +D AK +W +R+NV+KGVA+ALSY+HHD I PIVHRDISS N+
Sbjct: 928 IYEYMEKGSLNKLLANDEEAKRLTWTKRINVVKGVAHALSYMHHDRITPIVHRDISSGNI 987
Query: 784 LLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLAL 843
LLD++Y A +SDFG AK L+ SSNW+ AGT GY APE AYTM+ TEK DVYSFGVL L
Sbjct: 988 LLDNDYTAKISDFGTAKLLKTDSSNWSAVAGTYGYVAPEFAYTMKVTEKCDVYSFGVLIL 1047
Query: 844 EVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRDVTDKLRSIMEVAILCLVENP 903
E+I G HPGD VS++ SS + + I D R+ P +KL ++E+A+LCL NP
Sbjct: 1048 ELIIGKHPGDLVSSLSSSPGEAL-SLRSISDERVLEPRGQNREKLLKMVEMALLCLQANP 1106
Query: 904 EARPTMKEV 912
E+RPTM +
Sbjct: 1107 ESRPTMLSI 1115
|
|
| TAIR|locus:2160791 AT5G63930 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1313 (467.3 bits), Expect = 5.4e-134, P = 5.4e-134
Identities = 318/921 (34%), Positives = 463/921 (50%)
Query: 13 IPPQIGNLSKLQYLDLGNNQLSGVIPPEIGKLNQLRRLYLDVNQLHGTIPPVIGQLSLIN 72
+P +IGNL L L +N +SG +P IG L +L N + G++P IG +
Sbjct: 161 LPVEIGNLLSLSQLVTYSNNISGQLPRSIGNLKRLTSFRAGQNMISGSLPSEIGGCESLV 220
Query: 73 ELVFCHNNVSGRIPXXXXXXXXXXXXXXXXXXXFGSIPIVMGNLKSLSTLDLSQNQLNGS 132
L N +SG +P G IP + N SL TL L +NQL G
Sbjct: 221 MLGLAQNQLSGELPKEIGMLKKLSQVILWENEFSGFIPREISNCTSLETLALYKNQLVGP 280
Query: 133 IPCSLDNLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSENRXXXXXXXXXXXXXXXX 192
IP L +L +L+ L+LY+N L+G IP IGNL +++D SEN
Sbjct: 281 IPKELGDLQSLEFLYLYRNGLNGTIPREIGNLSYAIEIDFSENALTGEIPLELGNIEGLE 340
Query: 193 XXXXFNNSLSGSIPPILGNLKSLSTLGLHINQLNGVIPPSIGXXXXXXXXXXXXXXXYGF 252
F N L+G+IP L LK+LS L L IN L G IP G
Sbjct: 341 LLYLFENQLTGTIPVELSTLKNLSKLDLSINALTGPIPLGFQYLRGLFMLQLFQNSLSGT 400
Query: 253 VPKEIGYLKSLSKLEFCANHLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLRNLTSLE 312
+P ++G+ L L+ NHLSG IP + + +++LN+ N+L G IP + +L
Sbjct: 401 IPPKLGWYSDLWVLDMSDNHLSGRIPSYLCLHSNMIILNLGTNNLSGNIPTGITTCKTLV 460
Query: 313 RVRFNQNNLYGKVYEAFGDHPNLTFLDLSQNNFYCEISFNWRNFSKLGTFNASMNNIYGS 372
++R +NNL G+ N+T ++L QN F I N S L + N G
Sbjct: 461 QLRLARNNLVGRFPSNLCKQVNVTAIELGQNRFRGSIPREVGNCSALQRLQLADNGFTGE 520
Query: 373 IPPEIGDSSKLQVLDLSSNHIFGKIPVQLVKLFSLNKLILSLNQLFGGVPLEFGTLTELQ 432
+P EIG S+L L++SSN + G++P ++ L +L + N G +P E G+L +L+
Sbjct: 521 LPREIGMLSQLGTLNISSNKLTGEVPSEIFNCKMLQRLDMCCNNFSGTLPSEVGSLYQLE 580
Query: 433 YLDLSANKLSSSIPMSIGNLLKLHYLNLSNNQFSHKIPTEFEKLIHLS-ELDLSHNILQE 491
L LS N LS +IP+++GNL +L L + N F+ IP E L L L+LS+N L
Sbjct: 581 LLKLSNNNLSGTIPVALGNLSRLTELQMGGNLFNGSIPRELGSLTGLQIALNLSYNKLTG 640
Query: 492 EIPPQICKMESLEKLNLSHNNLSDFIPRCFEEMRSLSWIDISYNELQGPIPNSTAFKNGL 551
EIPP++ + LE L L++NNLS IP F + SL + SYN L GPIP
Sbjct: 641 EIPPELSNLVMLEFLLLNNNNLSGEIPSSFANLSSLLGYNFSYNSLTGPIPLLRNISMSS 700
Query: 552 MEGNKGLCG---N--FKALPSCDAFTSHKQTFRKKWVVIAXXXXXXXXXXXXXXXXXXXX 606
GN+GLCG N + P + ++ K + +IA
Sbjct: 701 FIGNEGLCGPPLNQCIQTQPFAPSQSTGKPGGMRSSKIIAITAAVIGGVSLMLIALIVYL 760
Query: 607 XXXXXDPQEKRSSSANPFGFFSVLNFNGK--VLYEEITKATGNFGEKYCIGKGGQRSVYK 664
+ P + F K ++++ AT NF E + +G+G +VYK
Sbjct: 761 MRRPVRTVASSAQDGQPSEMSLDIYFPPKEGFTFQDLVAATDNFDESFVVGRGACGTVYK 820
Query: 665 AELPSGNIFAVKKFKAELFSDETAN-PSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFI 723
A LP+G AVKK + N + F E+L L IRHRNI+K HGFC++ + +
Sbjct: 821 AVLPAGYTLAVKKLASNHEGGNNNNVDNSFRAEILTLGNIRHRNIVKLHGFCNHQGSNLL 880
Query: 724 VCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNV 783
+ EY+ +GSL IL D + W++R + G A L+YLHHDC P I HRDI S N+
Sbjct: 881 LYEYMPKGSLGEILHDPSC--NLDWSKRFKIALGAAQGLAYLHHDCKPRIFHRDIKSNNI 938
Query: 784 LLDSEYEAHVSDFGFAKFLE-PHSSNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLA 842
LLD ++EAHV DFG AK ++ PHS + + AG+ GY APE AYTM+ TEK D+YS+GV+
Sbjct: 939 LLDDKFEAHVGDFGLAKVIDMPHSKSMSAIAGSYGYIAPEYAYTMKVTEKSDIYSYGVVL 998
Query: 843 LEVIKGYHP-------GDFVSTIFSSISNMIIEVNQILDHRLPTPSRDVTDKLRSIMEVA 895
LE++ G P GD V+ + S I + + +LD RL + + +++++A
Sbjct: 999 LELLTGKAPVQPIDQGGDVVNWVRSYIRRDALS-SGVLDARLTLEDERIVSHMLTVLKIA 1057
Query: 896 ILCLVENPEARPTMKEVCNLL 916
+LC +P ARP+M++V +L
Sbjct: 1058 LLCTSVSPVARPSMRQVVLML 1078
|
|
| TAIR|locus:2020417 AT1G17230 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 764 (274.0 bits), Expect = 5.9e-134, Sum P(2) = 5.9e-134
Identities = 200/577 (34%), Positives = 274/577 (47%)
Query: 13 IPPQIGNLSKLQYLDLGNNQLSGVIPPEIGKLNQLRRLYLDVNQLHGTIPPVIGQLSLIN 72
IP QIGNLS LQ L + +N L+GVIPP + KL QLR + N G IP I +
Sbjct: 155 IPRQIGNLSSLQELVIYSNNLTGVIPPSMAKLRQLRIIRAGRNGFSGVIPSEISGCESLK 214
Query: 73 ELVFCHNNVSGRIPXXXXXXXXXXXXXXXXXXXFGSIPIVMGNLKSLSTLDLSQNQLNGS 132
L N + G +P G IP +GN+ L L L +N GS
Sbjct: 215 VLGLAENLLEGSLPKQLEKLQNLTDLILWQNRLSGEIPPSVGNISRLEVLALHENYFTGS 274
Query: 133 IPCSLDNLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSENRXXXXXXXXXXXXXXXX 192
IP + L+ + L+LY N L+G IP IGNL ++D SEN+
Sbjct: 275 IPREIGKLTKMKRLYLYTNQLTGEIPREIGNLIDAAEIDFSENQLTGFIPKEFGHILNLK 334
Query: 193 XXXXFNNSLSGSIPPILGNLKSLSTLGLHINQLNGVIPPSIGXXXXXXXXXXXXXXXYGF 252
F N L G IP LG L L L L IN+LNG IP + G
Sbjct: 335 LLHLFENILLGPIPRELGELTLLEKLDLSINRLNGTIPQELQFLPYLVDLQLFDNQLEGK 394
Query: 253 VPKEIGYLKSLSKLEFCANHLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLRNLTSLE 312
+P IG+ + S L+ AN LSG IP L+LL++ N L G IP+ L+ SL
Sbjct: 395 IPPLIGFYSNFSVLDMSANSLSGPIPAHFCRFQTLILLSLGSNKLSGNIPRDLKTCKSLT 454
Query: 313 RVRFNQNNLYGKV-YEAFGDHPNLTFLDLSQNNFYCEISFNWRNFSKLGTFNASMNNIYG 371
++ N L G + E F + NLT L+L QN IS + L + NN G
Sbjct: 455 KLMLGDNQLTGSLPIELF-NLQNLTALELHQNWLSGNISADLGKLKNLERLRLANNNFTG 513
Query: 372 SIPPEIGDSSKLQVLDLSSNHIFGKIPVQLVKLFSLNKLILSLNQLFGGVPLEFGTLTEL 431
IPPEIG+ +K+ ++SSN + G IP +L ++ +L LS N+ G + E G L L
Sbjct: 514 EIPPEIGNLTKIVGFNISSNQLTGHIPKELGSCVTIQRLDLSGNKFSGYIAQELGQLVYL 573
Query: 432 QYLDLSANKLSSSIPMSIGNLLKLHYLNLSNNQFSHKIPTEFEKLIHLS-ELDLSHNILQ 490
+ L LS N+L+ IP S G+L +L L L N S IP E KL L L++SHN L
Sbjct: 574 EILRLSDNRLTGEIPHSFGDLTRLMELQLGGNLLSENIPVELGKLTSLQISLNISHNNLS 633
Query: 491 EEIPPQICKMESLEKLNLSHNNLSDFIPRCFEEMRSLSWIDISYNELQGPIPNSTAFK-- 548
IP + ++ LE L L+ N LS IP + SL +IS N L G +P++ F+
Sbjct: 634 GTIPDSLGNLQMLEILYLNDNKLSGEIPASIGNLMSLLICNISNNNLVGTVPDTAVFQRM 693
Query: 549 -NGLMEGNKGLCGNFKALPSCDAFTSHKQTFRKKWVV 584
+ GN GLC + ++ C H + + W++
Sbjct: 694 DSSNFAGNHGLCNSQRS--HCQPLVPHSDS-KLNWLI 727
|
|
| TAIR|locus:2046525 AT2G33170 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1250 (445.1 bits), Expect = 2.6e-127, P = 2.6e-127
Identities = 314/931 (33%), Positives = 463/931 (49%)
Query: 13 IPPQIGNLSKLQYLDLGNNQLSGVIPPEIGKLNQLRRLYLDVNQLHGTIPPVIGQLSLIN 72
+P +IG+L L+ L N L+G +P +G LN+L N G IP IG+ +
Sbjct: 173 LPEEIGDLYNLEELVAYTNNLTGPLPRSLGNLNKLTTFRAGQNDFSGNIPTEIGKCLNLK 232
Query: 73 ELVFCHNNVSGRIPXXXXXXXXXXXXXXXXXXXFGSIPIVMGNLKSLSTLDLSQNQLNGS 132
L N +SG +P G IP +GNL SL TL L N L G
Sbjct: 233 LLGLAQNFISGELPKEIGMLVKLQEVILWQNKFSGFIPKDIGNLTSLETLALYGNSLVGP 292
Query: 133 IPCSLDNLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSENRXXXXXXXXXXXXXXXX 192
IP + N+ +L L+LY+N L+G IP +G L ++++D SEN
Sbjct: 293 IPSEIGNMKSLKKLYLYQNQLNGTIPKELGKLSKVMEIDFSENLLSGEIPVELSKISELR 352
Query: 193 XXXXFNNSLSGSIPPILGNLKSLSTLGLHINQLNGVIPPSIGXXXXXXXXXXXXXXXYGF 252
F N L+G IP L L++L+ L L IN L G IPP G
Sbjct: 353 LLYLFQNKLTGIIPNELSKLRNLAKLDLSINSLTGPIPPGFQNLTSMRQLQLFHNSLSGV 412
Query: 253 VPKEIGYLKSLSKLEFCANHLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLRNLTSLE 312
+P+ +G L ++F N LSG IP + + L+LLN+ N +FG IP + SL
Sbjct: 413 IPQGLGLYSPLWVVDFSENQLSGKIPPFICQQSNLILLNLGSNRIFGNIPPGVLRCKSLL 472
Query: 313 RVRFNQNNLYGKVYEAFGDHPNLTFLDLSQNNFYCEISFNWRNFSKLGTFNASMNNIYGS 372
++R N L G+ NL+ ++L QN F + KL + + N +
Sbjct: 473 QLRVVGNRLTGQFPTELCKLVNLSAIELDQNRFSGPLPPEIGTCQKLQRLHLAANQFSSN 532
Query: 373 IPPEIGDSSKLQVLDLSSNHIFGKIPVQLVKLFSLNKLILSLNQLFGGVPLEFGTLTELQ 432
+P EI S L ++SSN + G IP ++ L +L LS N G +P E G+L +L+
Sbjct: 533 LPNEISKLSNLVTFNVSSNSLTGPIPSEIANCKMLQRLDLSRNSFIGSLPPELGSLHQLE 592
Query: 433 YLDLSANKLSSSIPMSIGNLLKLHYLNLSNNQFSHKIPTEFEKLIHLS-ELDLSHNILQE 491
L LS N+ S +IP +IGNL L L + N FS IP + L L ++LS+N
Sbjct: 593 ILRLSENRFSGNIPFTIGNLTHLTELQMGGNLFSGSIPPQLGLLSSLQIAMNLSYNDFSG 652
Query: 492 EIPPQICKMESLEKLNLSHNNLSDFIPRCFEEMRSLSWIDISYNELQGPIPNSTAFKNGL 551
EIPP+I + L L+L++N+LS IP FE + SL + SYN L G +P++ F+N
Sbjct: 653 EIPPEIGNLHLLMYLSLNNNHLSGEIPTTFENLSSLLGCNFSYNNLTGQLPHTQIFQNMT 712
Query: 552 ME---GNKGLCGNFKALPSCDAFTS---HKQTFR----KKWVVIAXXXXXXXXXXXXXXX 601
+ GNKGLCG L SCD S H + + ++ +I
Sbjct: 713 LTSFLGNKGLCGGH--LRSCDPSHSSWPHISSLKAGSARRGRIIIIVSSVIGGISLLLIA 770
Query: 602 XXXXXXXXXXDPQEKRSSSANPFGFFSVLNFNGKVLY--EEITKATGNFGEKYCIGKGGQ 659
+P PF S + F K + ++I +AT F + Y +G+G
Sbjct: 771 IVVHFLRNPVEPTAPYVHDKEPFFQESDIYFVPKERFTVKDILEATKGFHDSYIVGRGAC 830
Query: 660 RSVYKAELPSGNIFAVKKFKAELF-SDETANPSE--FLNEVLALTEIRHRNIIKFHGFC- 715
+VYKA +PSG AVKK ++ ++ +N ++ F E+L L +IRHRNI++ + FC
Sbjct: 831 GTVYKAVMPSGKTIAVKKLESNREGNNNNSNNTDNSFRAEILTLGKIRHRNIVRLYSFCY 890
Query: 716 -SNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIV 774
+ + ++ EY++RGSL +L + W R + G A L+YLHHDC P I+
Sbjct: 891 HQGSNSNLLLYEYMSRGSLGELLHG-GKSHSMDWPTRFAIALGAAEGLAYLHHDCKPRII 949
Query: 775 HRDISSKNVLLDSEYEAHVSDFGFAKFLE-PHSSNWTEFAGTVGYAAPELAYTMRATEKY 833
HRDI S N+L+D +EAHV DFG AK ++ P S + + AG+ GY APE AYTM+ TEK
Sbjct: 950 HRDIKSNNILIDENFEAHVGDFGLAKVIDMPLSKSVSAVAGSYGYIAPEYAYTMKVTEKC 1009
Query: 834 DVYSFGVLALEVIKGYHP-------GDFVSTIFSSISNMIIEVNQILDHRLPTPSRDVT- 885
D+YSFGV+ LE++ G P GD + + I + + ++ILD L DV
Sbjct: 1010 DIYSFGVVLLELLTGKAPVQPLEQGGDLATWTRNHIRDHSL-TSEILDPYLTKVEDDVIL 1068
Query: 886 DKLRSIMEVAILCLVENPEARPTMKEVCNLL 916
+ + ++ ++A+LC +P RPTM+EV +L
Sbjct: 1069 NHMITVTKIAVLCTKSSPSDRPTMREVVLML 1099
|
|
| TAIR|locus:2085949 AT3G24240 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1193 (425.0 bits), Expect = 2.8e-121, P = 2.8e-121
Identities = 312/921 (33%), Positives = 462/921 (50%)
Query: 13 IPPQIGNLSKLQYLDLGNNQLSGVIPPEIGKLNQLRRLYLDVN-QLHGTIPPVIGQLSLI 71
IPP I SKL+ L L +N L+G IP E+GKL+ L + + N ++ G IP IG S +
Sbjct: 169 IPPDISKCSKLKSLILFDNLLTGSIPTELGKLSGLEVIRIGGNKEISGQIPSEIGDCSNL 228
Query: 72 NELVFCHNNVSGRIPXXXXXXXXXXXXXXXXXXXFGSIPIVMGNLKSLSTLDLSQNQLNG 131
L +VSG +P G IP +GN L L L +N L+G
Sbjct: 229 TVLGLAETSVSGNLPSSLGKLKKLETLSIYTTMISGEIPSDLGNCSELVDLFLYENSLSG 288
Query: 132 SIPCSLDNLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSENRXXXXXXXXXXXXXXX 191
SIP + L+ L+ LFL++NSL G IP IGN +L +DLS N
Sbjct: 289 SIPREIGQLTKLEQLFLWQNSLVGGIPEEIGNCSNLKMIDLSLNLLSGSIPSSIGRLSFL 348
Query: 192 XXXXXFNNSLSGSIPPILGNLKSLSTLGLHINQLNGVIPPSIGXXXXXXXXXXXXXXXYG 251
+N SGSIP + N SL L L NQ++G+IP +G G
Sbjct: 349 EEFMISDNKFSGSIPTTISNCSSLVQLQLDKNQISGLIPSELGTLTKLTLFFAWSNQLEG 408
Query: 252 FVPKEIGYLKSLSKLEFCANHLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLRNLTSL 311
+P + L L+ N L+G IP + L L L + N L G IP+ + N +SL
Sbjct: 409 SIPPGLADCTDLQALDLSRNSLTGTIPSGLFMLRNLTKLLLISNSLSGFIPQEIGNCSSL 468
Query: 312 ERVRFNQNNLYGKVYEAFGDHPNLTFLDLSQNNFYCEISFNWRNFSKLGTFNASMNNIYG 371
R+R N + G++ G + FLD S N + ++ + S+L + S N++ G
Sbjct: 469 VRLRLGFNRITGEIPSGIGSLKKINFLDFSSNRLHGKVPDEIGSCSELQMIDLSNNSLEG 528
Query: 372 SIPPEIGDSSKLQVLDLSSNHIFGKIPVQLVKLFSLNKLILSLNQLFGGVPLEFGTLTEL 431
S+P + S LQVLD+S+N GKIP L +L SLNKLILS N G +P G + L
Sbjct: 529 SLPNPVSSLSGLQVLDVSANQFSGKIPASLGRLVSLNKLILSKNLFSGSIPTSLGMCSGL 588
Query: 432 QYLDLSANKLSSSIPMSIGNLLKLHY-LNLSNNQFSHKIPTEFEKLIHLSELDLSHNILQ 490
Q LDL +N+LS IP +G++ L LNLS+N+ + KIP++ L LS LDLSHN+L+
Sbjct: 589 QLLDLGSNELSGEIPSELGDIENLEIALNLSSNRLTGKIPSKIASLNKLSILDLSHNMLE 648
Query: 491 EEIPPQICKMESLEKLNLSHNNLSDFIPRCFEEMRSLSWIDISYNELQGPIPNSTAFKNG 550
++ P + +E+L LN+S+N+ S ++P + R LS D+ N+ + F
Sbjct: 649 GDLAP-LANIENLVSLNISYNSFSGYLPDN-KLFRQLSPQDLEGNKKLCSSTQDSCFLT- 705
Query: 551 LMEGNKGLCGNFKALPSCDAFTSHKQTFRKKWVVIAXXXXXXXXXXXXXXXXXXXXXXXX 610
+GN GL G+ D S + R ++
Sbjct: 706 YRKGN-GL-GD-------DGDASRTRKLRLTLALLITLTVVLMILGAVAVIRARRNIDNE 756
Query: 611 XDPQEKRSSSANPFGFFSVLNFNGKVLYEEITKATGNFGEKYCIGKGGQRSVYKAELPSG 670
D E + F F LNF+ ++I + E IGKG VY+A++ +G
Sbjct: 757 RD-SELGETYKWQFTPFQKLNFS----VDQIIRC---LVEPNVIGKGCSGVVYRADVDNG 808
Query: 671 NIFAVKKFKAELFS---DE-TANPSE-FLNEVLALTEIRHRNIIKFHGFCSNAQHSFIVC 725
+ AVKK + + DE T N + F EV L IRH+NI++F G C N ++
Sbjct: 809 EVIAVKKLWPAMVNGGHDEKTKNVRDSFSAEVKTLGTIRHKNIVRFLGCCWNRNTRLLMY 868
Query: 726 EYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLL 785
+Y+ GSL ++L + + W+ R ++ G A L+YLHHDC+PPIVHRDI + N+L+
Sbjct: 869 DYMPNGSLGSLLHERRGSS-LDWDLRYRILLGAAQGLAYLHHDCLPPIVHRDIKANNILI 927
Query: 786 DSEYEAHVSDFGFAKFLEP----HSSNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVL 841
++E +++DFG AK ++ SN AG+ GY APE Y+M+ TEK DVYS+GV+
Sbjct: 928 GLDFEPYIADFGLAKLVDEGDIGRCSNTV--AGSYGYIAPEYGYSMKITEKSDVYSYGVV 985
Query: 842 ALEVIKGYHPGDFVSTIFSSISNMIIEVNQ------ILDHRLPTPSRDVTDKLRSIMEVA 895
LEV+ G P D T+ I +++ V Q +LD L + + D++ ++ A
Sbjct: 986 VLEVLTGKQPID--PTVPEGI-HLVDWVRQNRGSLEVLDSTLRSRTEAEADEMMQVLGTA 1042
Query: 896 ILCLVENPEARPTMKEVCNLL 916
+LC+ +P+ RPTMK+V +L
Sbjct: 1043 LLCVNSSPDERPTMKDVAAML 1063
|
|
| TAIR|locus:2154344 AT5G48940 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1181 (420.8 bits), Expect = 5.2e-120, P = 5.2e-120
Identities = 308/927 (33%), Positives = 449/927 (48%)
Query: 13 IPPQIGNLSKLQYLDLGNNQLSGVIPPEIGKLNQLRRLYLDVN-QLHGTIPPVIGQLSLI 71
IPP++G+ L+ L++ +N LS +P E+GK++ L + N +L G IP IG +
Sbjct: 170 IPPELGDCVSLKNLEIFDNYLSENLPLELGKISTLESIRAGGNSELSGKIPEEIGNCRNL 229
Query: 72 NELVFCHNNVSGRIPXXXXXXXXXXXXXXXXXXXFGSIPIVMGNLKSLSTLDLSQNQLNG 131
L +SG +P G IP +GN L L L N L+G
Sbjct: 230 KVLGLAATKISGSLPVSLGQLSKLQSLSVYSTMLSGEIPKELGNCSELINLFLYDNDLSG 289
Query: 132 SIPCSLDNLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSENRXXXXXXXXXXXXXXX 191
++P L L NL+ + L++N+L GPIP IG +KSL +DLS N
Sbjct: 290 TLPKELGKLQNLEKMLLWQNNLHGPIPEEIGFMKSLNAIDLSMNYFSGTIPKSFGNLSNL 349
Query: 192 XXXXXFNNSLSGSIPPILGNLKSLSTLGLHINQLNGVIPPSIGXXXXXXXXXXXXXXXYG 251
+N+++GSIP IL N L + NQ++G+IPP IG G
Sbjct: 350 QELMLSSNNITGSIPSILSNCTKLVQFQIDANQISGLIPPEIGLLKELNIFLGWQNKLEG 409
Query: 252 FVPKEIGYLKSLSKLEFCANHLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLRNLTSL 311
+P E+ ++L L+ N+L+G +P + L L L + N + G IP + N TSL
Sbjct: 410 NIPDELAGCQNLQALDLSQNYLTGSLPAGLFQLRNLTKLLLISNAISGVIPLEIGNCTSL 469
Query: 312 ERVRFNQNNLYGKVYEAFGDHPNLTFLDLSQNNFYCEISFNWRNFSKLGTFNASMNNIYG 371
R+R N + G++ + G NL+FLDLS+NN + N +L N S N + G
Sbjct: 470 VRLRLVNNRITGEIPKGIGFLQNLSFLDLSENNLSGPVPLEISNCRQLQMLNLSNNTLQG 529
Query: 372 SIPPEIGDSSKLQVLDLSSNHIFGKIPVQLVKLFSLNKLILSLNQLFGGVPLEFGTLTEL 431
+P + +KLQVLD+SSN + GKIP L L SLN+LILS N G +P G T L
Sbjct: 530 YLPLSLSSLTKLQVLDVSSNDLTGKIPDSLGHLISLNRLILSKNSFNGEIPSSLGHCTNL 589
Query: 432 QYLDLSANKLSSSIPMSIGNLLKLHY-LNLSNNQFSHKIPTEFEKLIHLSELDLSHNILQ 490
Q LDLS+N +S +IP + ++ L LNLS N IP L LS LD+SHN+L
Sbjct: 590 QLLDLSSNNISGTIPEELFDIQDLDIALNLSWNSLDGFIPERISALNRLSVLDISHNMLS 649
Query: 491 EEIPPQICKMESLEKLNLSHNNLSDFIPRCFEEMRSLSWIDISYNELQGPIPNSTAFKNG 550
++ + +E+L LN+SHN S ++P S + + +L G
Sbjct: 650 GDLSA-LSGLENLVSLNISHNRFSGYLPD--------SKV---FRQLIG----------A 687
Query: 551 LMEGNKGLCGNFKALPSCDAFTSHKQTFRKKW------VVIAXXXXXXXXXXXXXXXXXX 604
MEGN GLC K SC S + T ++ + I
Sbjct: 688 EMEGNNGLCS--KGFRSCFVSNSSQLTTQRGVHSHRLRIAIGLLISVTAVLAVLGVLAVI 745
Query: 605 XXXXXXXDPQEKRSSS---ANPFGFFSVLNFNGKVLYEEITKATGNFGEKYCIGKGGQRS 661
D + + F F LNF E + K E IGKG
Sbjct: 746 RAKQMIRDDNDSETGENLWTWQFTPFQKLNFT----VEHVLKC---LVEGNVIGKGCSGI 798
Query: 662 VYKAELPSGNIFAVKKF---KAELFSDETANPS---EFLNEVLALTEIRHRNIIKFHGFC 715
VYKAE+P+ + AVKK +++T + F EV L IRH+NI++F G C
Sbjct: 799 VYKAEMPNREVIAVKKLWPVTVPNLNEKTKSSGVRDSFSAEVKTLGSIRHKNIVRFLGCC 858
Query: 716 SNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVH 775
N ++ +Y++ GSL ++L + + W R +I G A L+YLHHDC+PPIVH
Sbjct: 859 WNKNTRLLMYDYMSNGSLGSLLHERSGVCSLGWEVRYKIILGAAQGLAYLHHDCVPPIVH 918
Query: 776 RDISSKNVLLDSEYEAHVSDFGFAKFLEP----HSSNWTEFAGTVGYAAPELAYTMRATE 831
RDI + N+L+ ++E ++ DFG AK ++ SSN AG+ GY APE Y+M+ TE
Sbjct: 919 RDIKANNILIGPDFEPYIGDFGLAKLVDDGDFARSSN--TIAGSYGYIAPEYGYSMKITE 976
Query: 832 KYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVN--QILDHRLPTPSRDVTDKLR 889
K DVYS+GV+ LEV+ G P D I + + ++ Q++D L +++
Sbjct: 977 KSDVYSYGVVVLEVLTGKQPIDPTIPDGLHIVDWVKKIRDIQVIDQGLQARPESEVEEMM 1036
Query: 890 SIMEVAILCLVENPEARPTMKEVCNLL 916
+ VA+LC+ PE RPTMK+V +L
Sbjct: 1037 QTLGVALLCINPIPEDRPTMKDVAAML 1063
|
|
| TAIR|locus:2120362 GSO1 "GASSHO1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1015 (362.4 bits), Expect = 2.0e-102, P = 2.0e-102
Identities = 271/822 (32%), Positives = 386/822 (46%)
Query: 13 IPPQIGNLSKLQYLDLGNNQLSGVIPPEIGKLN-QLRRLYLDVNQLHGTIPPVIGQLSLI 71
IP + N+S+L L L NN LSG +P I N L +L L QL G IP + + +
Sbjct: 303 IPEEFWNMSQLLDLVLANNHLSGSLPKSICSNNTNLEQLVLSGTQLSGEIPVELSKCQSL 362
Query: 72 NELVFCHNNVSGRIPXXXXXXXXXXXXXXXXXXXFGSIPIVMGNLKSLSTLDLSQNQLNG 131
+L +N+++G IP G++ + NL +L L L N L G
Sbjct: 363 KQLDLSNNSLAGSIPEALFELVELTDLYLHNNTLEGTLSPSISNLTNLQWLVLYHNNLEG 422
Query: 132 SIPCSLDNLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSENRXXXXXXXXXXXXXXX 191
+P + L L+ LFLY+N SG IP IGN SL +D+ N
Sbjct: 423 KLPKEISALRKLEVLFLYENRFSGEIPQEIGNCTSLKMIDMFGNHFEGEIPPSIGRLKEL 482
Query: 192 XXXXXFNNSLSGSIPPILGNLKSLSTLGLHINQLNGVIPPSIGXXXXXXXXXXXXXXXYG 251
N L G +P LGN L+ L L NQL+G IP S G G
Sbjct: 483 NLLHLRQNELVGGLPASLGNCHQLNILDLADNQLSGSIPSSFGFLKGLEQLMLYNNSLQG 542
Query: 252 FVPKEIGYLKSLSKLEFCANHLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLRNLTSL 311
+P + L++L+++ N L+G I H + + + ++ N IP L N +L
Sbjct: 543 NLPDSLISLRNLTRINLSHNRLNGTI-HPLCGSSSYLSFDVTNNGFEDEIPLELGNSQNL 601
Query: 312 ERVRFNQNNLYGKVYEAFGDHPNLTFLDLSQNNFYCEISFNWRNFSKLGTFNASMNNIYG 371
+R+R +N L GK+ G L+ LD+S N I KL + + N + G
Sbjct: 602 DRLRLGKNQLTGKIPWTLGKIRELSLLDMSSNALTGTIPLQLVLCKKLTHIDLNNNFLSG 661
Query: 372 SIPPEIGDSSKLQVLDLSSNHIFGKIPVQLVKLFSLNKLILSLNQLFGGVPLEFGTLTEL 431
IPP +G S+L L LSSN +P +L L L L N L G +P E G L L
Sbjct: 662 PIPPWLGKLSQLGELKLSSNQFVESLPTELFNCTKLLVLSLDGNSLNGSIPQEIGNLGAL 721
Query: 432 QYLDLSANKLSSSIPMSIGNLLKLHYLNLSNNQFSHKIPTEFEKLIHL-SELDLSHNILQ 490
L+L N+ S S+P ++G L KL+ L LS N + +IP E +L L S LDLS+N
Sbjct: 722 NVLNLDKNQFSGSLPQAMGKLSKLYELRLSRNSLTGEIPVEIGQLQDLQSALDLSYNNFT 781
Query: 491 EEIPPQICKMESLEKLNLSHNNLSDFIPRCFEEMRSLSWIDISYNELQGPIPNS-TAFKN 549
+IP I + LE L+LSHN L+ +P +M+SL ++++S+N L G + + +
Sbjct: 782 GDIPSTIGTLSKLETLDLSHNQLTGEVPGSVGDMKSLGYLNVSFNNLGGKLKKQFSRWPA 841
Query: 550 GLMEGNKGLCGNFKALPSCDAFTSH-KQTFRKKWVVIAXXXXXXXXXXXXXXXXXXXXXX 608
GN GLCG+ L C+ S+ KQ V+
Sbjct: 842 DSFLGNTGLCGS--PLSRCNRVRSNNKQQGLSARSVVIISAISALTAIGLMILVIALFFK 899
Query: 609 XXXDPQEK--------RSSSANPFGFFSVLNFNGK----VLYEEITKATGNFGEKYCIGK 656
D +K SSS++ L NG + +E+I +AT N E++ IG
Sbjct: 900 QRHDFFKKVGHGSTAYTSSSSSSQATHKPLFRNGASKSDIRWEDIMEATHNLSEEFMIGS 959
Query: 657 GGQRSVYKAELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCS 716
GG VYKAEL +G AVKK L+ D+ + F EV L IRHR+++K G+CS
Sbjct: 960 GGSGKVYKAELENGETVAVKKI---LWKDDLMSNKSFSREVKTLGRIRHRHLVKLMGYCS 1016
Query: 717 NAQH--SFIVCEYLARGSLTTILRDDAAAKE-----FSWNQRMNVIKGVANALSYLHHDC 769
+ + ++ EY+ GS+ L +D E W R+ + G+A + YLHHDC
Sbjct: 1017 SKSEGLNLLIYEYMKNGSIWDWLHEDKPVLEKKKKLLDWEARLRIAVGLAQGVEYLHHDC 1076
Query: 770 IPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTE 811
+PPIVHRDI S NVLLDS EAH+ DFG AK L + T+
Sbjct: 1077 VPPIVHRDIKSSNVLLDSNMEAHLGDFGLAKVLTENCDTNTD 1118
|
|
| TAIR|locus:2156349 GSO2 "GASSHO 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1159 (413.0 bits), Expect = 1.1e-117, P = 1.1e-117
Identities = 298/938 (31%), Positives = 462/938 (49%)
Query: 13 IPPQIGNLSKLQYLDLGNNQLSGVIPPEIGKLN-QLRRLYLDVNQLHGTIPPVIGQLSLI 71
I + +++L++L L N+LSG +P I N L++L+L QL G IP I +
Sbjct: 304 IHEEFWRMNQLEFLVLAKNRLSGSLPKTICSNNTSLKQLFLSETQLSGEIPAEISNCQSL 363
Query: 72 NELVFCHNNVSGRIPXXXXXXXXXXXXXXXXXXXFGSIPIVMGNLKSLSTLDLSQNQLNG 131
L +N ++G+IP G++ + NL +L L N L G
Sbjct: 364 KLLDLSNNTLTGQIPDSLFQLVELTNLYLNNNSLEGTLSSSISNLTNLQEFTLYHNNLEG 423
Query: 132 SIPCSLDNLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSENRXXXXXXXXXXXXXXX 191
+P + L L+ ++LY+N SG +P IGN L ++D NR
Sbjct: 424 KVPKEIGFLGKLEIMYLYENRFSGEMPVEIGNCTRLQEIDWYGNRLSGEIPSSIGRLKDL 483
Query: 192 XXXXXFNNSLSGSIPPILGNLKSLSTLGLHINQLNGVIPPSIGXXXXXXXXXXXXXXXYG 251
N L G+IP LGN ++ + L NQL+G IP S G G
Sbjct: 484 TRLHLRENELVGNIPASLGNCHQMTVIDLADNQLSGSIPSSFGFLTALELFMIYNNSLQG 543
Query: 252 FVPKEIGYLKSLSKLEFCANHLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLRNLTSL 311
+P + LK+L+++ F +N +G I G+ + + ++ EN G IP L T+L
Sbjct: 544 NLPDSLINLKNLTRINFSSNKFNGSISPLCGS-SSYLSFDVTENGFEGDIPLELGKSTNL 602
Query: 312 ERVRFNQNNLYGKVYEAFGDHPNLTFLDLSQNNFYCEISFNWRNFSKLGTFNASMNNIYG 371
+R+R +N G++ FG L+ LD+S+N+ I KL + + N + G
Sbjct: 603 DRLRLGKNQFTGRIPRTFGKISELSLLDISRNSLSGIIPVELGLCKKLTHIDLNNNYLSG 662
Query: 372 SIPPEIGDSSKLQVLDLSSNHIFGKIPVQLVKLFSLNKLILSLNQLFGGVPLEFGTLTEL 431
IP +G L L LSSN G +P ++ L ++ L L N L G +P E G L L
Sbjct: 663 VIPTWLGKLPLLGELKLSSNKFVGSLPTEIFSLTNILTLFLDGNSLNGSIPQEIGNLQAL 722
Query: 432 QYLDLSANKLSSSIPMSIGNLLKLHYLNLSNNQFSHKIPTEFEKLIHL-SELDLSHNILQ 490
L+L N+LS +P +IG L KL L LS N + +IP E +L L S LDLS+N
Sbjct: 723 NALNLEENQLSGPLPSTIGKLSKLFELRLSRNALTGEIPVEIGQLQDLQSALDLSYNNFT 782
Query: 491 EEIPPQICKMESLEKLNLSHNNLSDFIPRCFEEMRSLSWIDISYNELQGPIPNS-TAFKN 549
IP I + LE L+LSHN L +P +M+SL ++++SYN L+G + + ++
Sbjct: 783 GRIPSTISTLPKLESLDLSHNQLVGEVPGQIGDMKSLGYLNLSYNNLEGKLKKQFSRWQA 842
Query: 550 GLMEGNKGLCGNFKALPSCD-AFTSHKQTFRKKWVVIAXXXXXXXXXXXXXXXXXXXXXX 608
GN GLCG+ L C+ A + ++++ K VVI
Sbjct: 843 DAFVGNAGLCGS--PLSHCNRAGSKNQRSLSPKTVVIISAISSLAAIALMVLVIILFFKQ 900
Query: 609 XXXDPQEKR--------SSSANPFGFFSVLNFNGKVLYEEITKATGNFGEKYCIGKGGQR 660
++ R +SS++ FS + +++I +AT E++ IG GG
Sbjct: 901 NHDLFKKVRGGNSAFSSNSSSSQAPLFSNGGAKSDIKWDDIMEATHYLNEEFMIGSGGSG 960
Query: 661 SVYKAELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQH 720
VYKAEL +G AVKK L+ D+ + F EV L IRHR+++K G+CS+
Sbjct: 961 KVYKAELKNGETIAVKKI---LWKDDLMSNKSFNREVKTLGTIRHRHLVKLMGYCSSKAD 1017
Query: 721 --SFIVCEYLARGSLTTILR--DDAAAKE-FSWNQRMNVIKGVANALSYLHHDCIPPIVH 775
+ ++ EY+A GS+ L ++ KE W R+ + G+A + YLH+DC+PPIVH
Sbjct: 1018 GLNLLIYEYMANGSVWDWLHANENTKKKEVLGWETRLKIALGLAQGVEYLHYDCVPPIVH 1077
Query: 776 RDISSKNVLLDSEYEAHVSDFGFAKFL----EPHSSNWTEFAGTVGYAAPELAYTMRATE 831
RDI S NVLLDS EAH+ DFG AK L + ++ + T FAG+ GY APE AY+++ATE
Sbjct: 1078 RDIKSSNVLLDSNIEAHLGDFGLAKILTGNYDTNTESNTMFAGSYGYIAPEYAYSLKATE 1137
Query: 832 KYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRD--VTDKLR 889
K DVYS G++ +E++ G P + +F ++M+ V +LD + +R+ + +L+
Sbjct: 1138 KSDVYSMGIVLMEIVTGKMPTE---AMFDEETDMVRWVETVLDTPPGSEAREKLIDSELK 1194
Query: 890 S-----------IMEVAILCLVENPEARPTMKEVCNLL 916
S ++E+A+ C P+ RP+ ++ L
Sbjct: 1195 SLLPCEEEAAYQVLEIALQCTKSYPQERPSSRQASEYL 1232
|
|
| UNIPROTKB|P93194 INRPK1 "Receptor-like protein kinase" [Ipomoea nil (taxid:35883)] | Back alignment and assigned GO terms |
|---|
Score = 714 (256.4 bits), Expect = 3.2e-115, Sum P(2) = 3.2e-115
Identities = 188/556 (33%), Positives = 274/556 (49%)
Query: 13 IPPQIGNLSKLQYLDLGNNQLSGVIPPEIGKLNQLRRLYLDVNQLHGTIPPVIGQLSLIN 72
IP IGN+S+L L L +NQ SG +P +G + L+ LYL+ N L GT+P + L +
Sbjct: 180 IPSNIGNMSELTTLWLDDNQFSGPVPSSLGNITTLQELYLNDNNLVGTLPVTLNNLENLV 239
Query: 73 ELVFCHNNVSGRIPXXXXXXXXXXXXXXXXXXXFGSIPIVMGNLKSLSTLDLSQNQLNGS 132
L +N++ G IP G +P +GN SL L+G
Sbjct: 240 YLDVRNNSLVGAIPLDFVSCKQIDTISLSNNQFTGGLPPGLGNCTSLREFGAFSCALSGP 299
Query: 133 IPCSLDNLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSENRXXXXXXXXXXXXXXXX 192
IP L+ LDTL+L N SG IP +G KS++ L L +N+
Sbjct: 300 IPSCFGQLTKLDTLYLAGNHFSGRIPPELGKCKSMIDLQLQQNQLEGEIPGELGMLSQLQ 359
Query: 193 XXXXFNNSLSGSIPPILGNLKSLSTLGLHINQLNGVIPPSIGXXXXXXXXXXXXXXXYGF 252
+ N+LSG +P + ++SL +L L+ N L+G +P + G
Sbjct: 360 YLHLYTNNLSGEVPLSIWKIQSLQSLQLYQNNLSGELPVDMTELKQLVSLALYENHFTGV 419
Query: 253 VPKEIGYLKSLSKLEFCANHLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLRNLTSLE 312
+P+++G SL L+ N +G IP ++ + L L + N+L G +P L ++LE
Sbjct: 420 IPQDLGANSSLEVLDLTRNMFTGHIPPNLCSQKKLKRLLLGYNYLEGSVPSDLGGCSTLE 479
Query: 313 RVRFNQNNLYGKVYEAFGDHPNLTFLDLSQNNFYCEISFNWRNFSKLGTFNASMNNIYGS 372
R+ +NNL G + + F + NL F DLS NNF I + N + S N + GS
Sbjct: 480 RLILEENNLRGGLPD-FVEKQNLLFFDLSGNNFTGPIPPSLGNLKNVTAIYLSSNQLSGS 538
Query: 373 IPPEIGDSSKLQVLDLSSNHIFGKIPVQLVKLFSLNKLILSLNQLFGGVPLEFGTLTELQ 432
IPPE+G KL+ L+LS N + G +P +L L++L S N L G +P G+LTEL
Sbjct: 539 IPPELGSLVKLEHLNLSHNILKGILPSELSNCHKLSELDASHNLLNGSIPSTLGSLTELT 598
Query: 433 YLDLSANKLSSSIPMSIGNLLKLHYLNLSNNQFSHKIPTEFEKLIHLSELDLSHNILQEE 492
L L N S IP S+ KL L L N + IP L L L+LS N L +
Sbjct: 599 KLSLGENSFSGGIPTSLFQSNKLLNLQLGGNLLAGDIPP-VGALQALRSLNLSSNKLNGQ 657
Query: 493 IPPQICKMESLEKLNLSHNNLSDFIPRCFEEMRSLSWIDISYNELQGPIPNS-TAFKNGL 551
+P + K++ LE+L++SHNNLS + R ++SL++I+IS+N GP+P S T F N
Sbjct: 658 LPIDLGKLKMLEELDVSHNNLSGTL-RVLSTIQSLTFINISHNLFSGPVPPSLTKFLNSS 716
Query: 552 ---MEGNKGLCGNFKA 564
GN LC N A
Sbjct: 717 PTSFSGNSDLCINCPA 732
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries 
Original result of BLAST against SWISS-PROT
ID ![]() | Name ![]() | Annotated EC number ![]() | Identity ![]() | Query coverage ![]() | Hit coverage ![]() | RBH(Q2H) ![]() | RBH(H2Q) ![]() |
| Q8VZG8 | Y4885_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.4755 | 0.9847 | 0.8650 | yes | no |
EC Number Prediction by Ezypred Server 
Original result from Ezypred Server
Fail to connect to Ezypred Server
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING 
Original result from the STRING server
| Your Input: | |||||||||||
| fgenesh2_kg.6__2914__AT4G08850.1 | annotation not avaliable (1019 aa) | ||||||||||
(Arabidopsis lyrata) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against CDD database part I
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 918 | |||
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-132 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 8e-66 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 3e-45 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-43 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 1e-42 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 8e-41 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 2e-38 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 2e-38 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 2e-38 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 7e-37 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 8e-37 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 1e-34 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 1e-29 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 9e-28 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 1e-27 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 4e-27 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 6e-26 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 1e-25 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 2e-25 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 4e-25 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 1e-24 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 4e-24 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 5e-24 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 7e-24 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 7e-24 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 1e-23 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 2e-23 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 6e-23 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 7e-23 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 3e-22 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 9e-22 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 1e-21 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 1e-20 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 2e-20 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 3e-20 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 4e-20 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 4e-20 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 4e-20 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 4e-20 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 5e-20 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 1e-19 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 1e-19 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 2e-19 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 3e-19 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 3e-19 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 6e-19 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 6e-19 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 7e-19 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 7e-19 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 1e-18 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 1e-18 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 2e-18 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 2e-18 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 2e-18 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 3e-18 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 5e-18 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 9e-18 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 2e-17 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 2e-17 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 2e-17 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 3e-17 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 4e-17 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 4e-17 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 6e-17 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 9e-17 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 9e-17 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 1e-16 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 1e-16 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 1e-16 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 2e-16 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 2e-16 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 2e-16 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 4e-16 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 7e-16 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 7e-16 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 8e-16 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 8e-16 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 9e-16 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 1e-15 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 1e-15 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 1e-15 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 2e-15 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 2e-15 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 2e-15 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 2e-15 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 2e-15 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 2e-15 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 3e-15 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 3e-15 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 5e-15 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 5e-15 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 6e-15 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 6e-15 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 7e-15 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 7e-15 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 8e-15 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 8e-15 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 8e-15 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 8e-15 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 9e-15 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 9e-15 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 1e-14 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 1e-14 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 1e-14 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 1e-14 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 1e-14 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 2e-14 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 2e-14 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 2e-14 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 2e-14 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 4e-14 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 5e-14 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 5e-14 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 6e-14 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 6e-14 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 6e-14 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 7e-14 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 7e-14 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 8e-14 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 8e-14 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 9e-14 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-13 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 1e-13 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 1e-13 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 2e-13 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 3e-13 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 3e-13 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 4e-13 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 5e-13 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 6e-13 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 6e-13 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 6e-13 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 6e-13 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 7e-13 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 7e-13 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 7e-13 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 7e-13 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 7e-13 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 7e-13 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 8e-13 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 9e-13 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 9e-13 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-12 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 1e-12 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 1e-12 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 1e-12 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 1e-12 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 1e-12 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-12 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-12 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 2e-12 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 2e-12 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 2e-12 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 3e-12 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 3e-12 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 3e-12 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 4e-12 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 5e-12 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 6e-12 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 6e-12 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 6e-12 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 9e-12 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 9e-12 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 1e-11 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 3e-11 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 5e-11 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 6e-11 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 6e-11 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 7e-11 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 8e-11 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-10 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 1e-10 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 1e-10 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 1e-10 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 2e-10 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 2e-10 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 2e-10 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 3e-10 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 3e-10 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 4e-10 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 4e-10 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 5e-10 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 6e-10 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 7e-10 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 8e-10 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 9e-10 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 1e-09 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 1e-09 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 1e-09 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 2e-09 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 2e-09 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 2e-09 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 2e-09 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 2e-09 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 2e-09 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 2e-09 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 3e-09 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 3e-09 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 3e-09 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 3e-09 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 4e-09 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 4e-09 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 5e-09 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 6e-09 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 7e-09 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 7e-09 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 7e-09 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 7e-09 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 8e-09 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 8e-09 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 1e-08 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 1e-08 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 1e-08 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 1e-08 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 1e-08 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 2e-08 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 2e-08 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 2e-08 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 2e-08 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 2e-08 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 2e-08 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 2e-08 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 3e-08 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 3e-08 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 3e-08 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 3e-08 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 3e-08 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 3e-08 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 4e-08 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 4e-08 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 4e-08 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 5e-08 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 5e-08 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 5e-08 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 6e-08 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 6e-08 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 7e-08 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 8e-08 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 8e-08 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 9e-08 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-07 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 1e-07 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 1e-07 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 1e-07 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 1e-07 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 1e-07 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 1e-07 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 1e-07 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 1e-07 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 2e-07 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 2e-07 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 2e-07 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 2e-07 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 2e-07 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 2e-07 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 3e-07 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 3e-07 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 4e-07 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 4e-07 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 5e-07 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 5e-07 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 5e-07 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 6e-07 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 7e-07 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 7e-07 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 8e-07 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 9e-07 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 1e-06 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 1e-06 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 1e-06 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 1e-06 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 1e-06 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 1e-06 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 1e-06 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 1e-06 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-06 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 2e-06 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 2e-06 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 2e-06 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 3e-06 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 3e-06 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 3e-06 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 4e-06 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 4e-06 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 4e-06 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 4e-06 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 1e-05 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 1e-05 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 1e-05 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 1e-05 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 1e-05 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 1e-05 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 1e-05 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 1e-05 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 2e-05 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 2e-05 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 2e-05 | |
| cd00116 | 319 | cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo | 2e-05 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 3e-05 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 3e-05 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 3e-05 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 4e-05 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 5e-05 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 7e-05 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 7e-05 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 9e-05 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 9e-05 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 1e-04 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 1e-04 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 1e-04 | |
| cd00116 | 319 | cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo | 2e-04 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 2e-04 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 2e-04 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 2e-04 | |
| cd00116 | 319 | cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo | 3e-04 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 3e-04 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 3e-04 | |
| cd00116 | 319 | cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo | 4e-04 | |
| PRK15370 | 754 | PRK15370, PRK15370, E3 ubiquitin-protein ligase Sl | 4e-04 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 4e-04 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 5e-04 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 6e-04 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 7e-04 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 0.001 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 0.001 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 0.001 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 0.001 | |
| cd00116 | 319 | cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo | 0.002 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 0.002 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 0.003 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 0.003 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 0.003 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 0.004 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 420 bits (1080), Expect = e-132
Identities = 304/936 (32%), Positives = 447/936 (47%), Gaps = 131/936 (13%)
Query: 2 LNLGFNLLFGNIPPQIGNLSKLQYLDLGNNQLSGVIPPEIGKLNQLRRLYLDVNQLHGTI 61
LNL N G+IP G++ L+ LDL NN LSG IP +IG + L+ L L N L G I
Sbjct: 123 LNLSNNNFTGSIPR--GSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKI 180
Query: 62 PPVIGQLSLINELVFCHNNVSGRIPSSLGNLSNLALLYLNDNSLFGSIPIVMGNLKSLST 121
P + L+ + L N + G+IP LG + +L +YL N+L G IP +G L SL+
Sbjct: 181 PNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNH 240
Query: 122 LDLSQNQLNGSIPCSLDNLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSENRLSGLI 181
LDL N L G IP SL NL NL LFLY+N LSGPIP I +L+ L+ LDLS+
Sbjct: 241 LDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSD------- 293
Query: 182 PLSLSNLSSLTVMSLFNNSLSGSIPPILGNLKSLSTLGLHINQLNGVIPPSIGNLSSLRN 241
NSLSG IP ++ L++L L L N G IP ++ +L L+
Sbjct: 294 -----------------NSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQV 336
Query: 242 LSLFNNRLYGFVPKEIGYLKSLSKLEFCANHLSGVIPHSV---GNLTGLVLLNMCENHLF 298
L L++N+ G +PK +G +L+ L+ N+L+G IP + GNL L+L + N L
Sbjct: 337 LQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFS---NSLE 393
Query: 299 GPIPKSLRNLTSLERVRFNQNNLYGKVYEAFGDHPNLTFLDLSQNNFYCEISFNWRNFSK 358
G IPKSL SL RVR N+ G++ F P + FLD+S NN
Sbjct: 394 GEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNL------------- 440
Query: 359 LGTFNASMNNIYGSIPPEIGDSSKLQVLDLSSNHIFGKIPVQLVKLFSLNKLILSLNQLF 418
G I D LQ+L L+ N FG +P L L LS NQ
Sbjct: 441 -----------QGRINSRKWDMPSLQMLSLARNKFFGGLP-DSFGSKRLENLDLSRNQFS 488
Query: 419 GGVPLEFGTLTELQYLDLSANKLSSSIPMSIGNLLKLHYLNLSNNQFSHKIPTEFEKLIH 478
G VP + G+L+EL L LS NKLS IP + + KL L+LS+NQ S +IP F ++
Sbjct: 489 GAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPV 548
Query: 479 LSELDLSHNILQEEIPPQICKMESLEKLNLSHNNLSDFIPRCFEEMRSLSWIDISYNELQ 538
LS+LDLS N L EIP + +ESL ++N+SHN+ L
Sbjct: 549 LSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNH------------------------LH 584
Query: 539 GPIPNSTAF---KNGLMEGNKGLCGNFKA--LPSCDAFTSHKQTFRKKWVVIALPILGMV 593
G +P++ AF + GN LCG LP C W I + +
Sbjct: 585 GSLPSTGAFLAINASAVAGNIDLCGGDTTSGLPPCKRVRKTPS----WWFYITCTLGAFL 640
Query: 594 VLLIGLIGFFFLFRRRKRDPQEKRSSSANPFGFFSVLNFNGKVLYE-EITKATGNFGEKY 652
VL L+ F F+F R + + + KR + + G + + F+ KV I + E+
Sbjct: 641 VLA--LVAFGFVFIRGRNNLELKRVENED--GTWELQFFDSKVSKSITINDILSSLKEEN 696
Query: 653 CIGKGGQRSVYKAELPSGNI-FAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKF 711
I +G + + YK + + F VK+ D + PS + + + +++H NI+K
Sbjct: 697 VISRGKKGASYKGKSIKNGMQFVVKEIN-----DVNSIPSSEIAD---MGKLQHPNIVKL 748
Query: 712 HGFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIP 771
G C + + ++++ EY+ +L+ +LR+ SW +R + G+A AL +LH C P
Sbjct: 749 IGLCRSEKGAYLIHEYIEGKNLSEVLRN------LSWERRRKIAIGIAKALRFLHCRCSP 802
Query: 772 PIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGTV--GYAAPELAYTMRA 829
+V ++S + +++D + E H+ L T+ + Y APE T
Sbjct: 803 AVVVGNLSPEKIIIDGKDEPHLR-------LSLPGLLCTDTKCFISSAYVAPETRETKDI 855
Query: 830 TEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMI------IEVNQILDHRLPTPSRD 883
TEK D+Y FG++ +E++ G P D + SI ++ +D P+ D
Sbjct: 856 TEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWID---PSIRGD 912
Query: 884 VTDKLRSIMEV---AILCLVENPEARPTMKEVCNLL 916
V+ I+EV A+ C +P ARP +V L
Sbjct: 913 VSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTL 948
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 238 bits (609), Expect = 8e-66
Identities = 160/456 (35%), Positives = 223/456 (48%), Gaps = 24/456 (5%)
Query: 111 IVMGNLKSLSTLDLSQNQLNGSIPCSLDNLSNLDTLFLYKNSLSGPIPSVIGNL-KSLLQ 169
I N + ++DLS ++G I ++ L + T+ L N LSGPIP I SL
Sbjct: 63 ITCNNSSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRY 122
Query: 170 LDLSENRLSGLIP---------LSLSN-------------LSSLTVMSLFNNSLSGSIPP 207
L+LS N +G IP L LSN SSL V+ L N L G IP
Sbjct: 123 LNLSNNNFTGSIPRGSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPN 182
Query: 208 ILGNLKSLSTLGLHINQLNGVIPPSIGNLSSLRNLSLFNNRLYGFVPKEIGYLKSLSKLE 267
L NL SL L L NQL G IP +G + SL+ + L N L G +P EIG L SL+ L+
Sbjct: 183 SLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLD 242
Query: 268 FCANHLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLRNLTSLERVRFNQNNLYGKVYE 327
N+L+G IP S+GNL L L + +N L GPIP S+ +L L + + N+L G++ E
Sbjct: 243 LVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPE 302
Query: 328 AFGDHPNLTFLDLSQNNFYCEISFNWRNFSKLGTFNASMNNIYGSIPPEIGDSSKLQVLD 387
NL L L NNF +I + +L N G IP +G + L VLD
Sbjct: 303 LVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLD 362
Query: 388 LSSNHIFGKIPVQLVKLFSLNKLILSLNQLFGGVPLEFGTLTELQYLDLSANKLSSSIPM 447
LS+N++ G+IP L +L KLIL N L G +P G L+ + L N S +P
Sbjct: 363 LSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPS 422
Query: 448 SIGNLLKLHYLNLSNNQFSHKIPTEFEKLIHLSELDLSHNILQEEIPPQICKMESLEKLN 507
L +++L++SNN +I + + L L L+ N + P + LE L+
Sbjct: 423 EFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGL-PDSFGSKRLENLD 481
Query: 508 LSHNNLSDFIPRCFEEMRSLSWIDISYNELQGPIPN 543
LS N S +PR + L + +S N+L G IP+
Sbjct: 482 LSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPD 517
|
Length = 968 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 163 bits (414), Expect = 3e-45
Identities = 80/268 (29%), Positives = 116/268 (43%), Gaps = 23/268 (8%)
Query: 653 CIGKGGQRSVYKA-ELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKF 711
+G G +VYKA +G I AVK K + E+ L + H NI++
Sbjct: 6 KLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSK--KDQTARREIRILRRLSHPNIVRL 63
Query: 712 HGFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIP 771
+ H ++V EY G L L S ++ + + L YLH +
Sbjct: 64 IDAFEDKDHLYLVMEYCEGGDLFDYLSRG---GPLSEDEAKKIALQILRGLEYLHSN--- 117
Query: 772 PIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGTVGYAAPE-LAYTMRAT 830
I+HRD+ +N+LLD ++DFG AK L SS+ T F GT Y APE L
Sbjct: 118 GIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNGYG 177
Query: 831 EKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRDVTDKLRS 890
K DV+S GV+ E++ G P FS + I++ Q++ L P K S
Sbjct: 178 PKVDVWSLGVILYELLTGKPP-------FSGEN--ILDQLQLIRRILGPPLEFDEPKWSS 228
Query: 891 IMEVAIL----CLVENPEARPTMKEVCN 914
E A CL ++P RPT +E+
Sbjct: 229 GSEEAKDLIKKCLNKDPSKRPTAEEILQ 256
|
Length = 260 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 158 bits (403), Expect = 1e-43
Identities = 69/264 (26%), Positives = 123/264 (46%), Gaps = 23/264 (8%)
Query: 654 IGKGGQRSVYKA-ELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFH 712
+G+G VY A + +G + A+K K + + L E+ L +++H NI++ +
Sbjct: 7 LGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKD---RERILREIKILKKLKHPNIVRLY 63
Query: 713 GFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPP 772
+ ++V EY G L +L+ S ++ ++ + +AL YLH I
Sbjct: 64 DVFEDEDKLYLVMEYCEGGDLFDLLKKR---GRLSEDEARFYLRQILSALEYLHSKGI-- 118
Query: 773 IVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGTVGYAAPELAYTMRATEK 832
VHRD+ +N+LLD + ++DFG A+ L+P T F GT Y APE+ +
Sbjct: 119 -VHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTT-FVGTPEYMAPEVLLGKGYGKA 176
Query: 833 YDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSR--DVTDKLRS 890
D++S GV+ E++ G P F ++ +I + P P D++ + +
Sbjct: 177 VDIWSLGVILYELLTGKPP-------FPGDDQLLELFKKIGKPKPPFPPPEWDISPEAKD 229
Query: 891 IMEVAILCLVENPEARPTMKEVCN 914
++ LV++PE R T +E
Sbjct: 230 LIR---KLLVKDPEKRLTAEEALQ 250
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 154 bits (391), Expect = 1e-42
Identities = 71/266 (26%), Positives = 119/266 (44%), Gaps = 54/266 (20%)
Query: 654 IGKGGQRSVYKAE-LPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFH 712
+G+GG +VY A +G A+K K D ++ E L E+ L ++ H NI+K +
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIK---KEDSSSLLEELLREIEILKKLNHPNIVKLY 57
Query: 713 GFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPP 772
G + H ++V EY GSL +L+++ + S ++ + ++ + L YLH +
Sbjct: 58 GVFEDENHLYLVMEYCEGGSLKDLLKEN--EGKLSEDEILRILLQILEGLEYLHSN---G 112
Query: 773 IVHRDISSKNVLLDS-EYEAHVSDFGFAKFLEPHSSNWTEFAGTVGYAAPE-LAYTMRAT 830
I+HRD+ +N+LLDS + ++DFG +K L S GT Y APE L +
Sbjct: 113 IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYS 172
Query: 831 EKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRDVTDKLRS 890
EK D++S GV+ E+ +L+
Sbjct: 173 EKSDIWSLGVILYEL----------------------------------------PELKD 192
Query: 891 IMEVAILCLVENPEARPTMKEVCNLL 916
++ L ++PE RP+ KE+ L
Sbjct: 193 LIR---KMLQKDPEKRPSAKEILEHL 215
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 162 bits (411), Expect = 8e-41
Identities = 106/278 (38%), Positives = 147/278 (52%), Gaps = 1/278 (0%)
Query: 1 MLNLGFNLLFGNIPPQIGNLSKLQYLDLGNNQLSGVIPPEIGKLNQLRRLYLDVNQLHGT 60
+L+L N G IP + +L +LQ L L +N+ SG IP +GK N L L L N L G
Sbjct: 312 ILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGE 371
Query: 61 IPPVIGQLSLINELVFCHNNVSGRIPSSLGNLSNLALLYLNDNSLFGSIPIVMGNLKSLS 120
IP + + +L+ N++ G IP SLG +L + L DNS G +P L +
Sbjct: 372 IPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVY 431
Query: 121 TLDLSQNQLNGSIPCSLDNLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSENRLSGL 180
LD+S N L G I ++ +L L L +N G +P G+ K L LDLS N+ SG
Sbjct: 432 FLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGS-KRLENLDLSRNQFSGA 490
Query: 181 IPLSLSNLSSLTVMSLFNNSLSGSIPPILGNLKSLSTLGLHINQLNGVIPPSIGNLSSLR 240
+P L +LS L + L N LSG IP L + K L +L L NQL+G IP S + L
Sbjct: 491 VPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLS 550
Query: 241 NLSLFNNRLYGFVPKEIGYLKSLSKLEFCANHLSGVIP 278
L L N+L G +PK +G ++SL ++ NHL G +P
Sbjct: 551 QLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLP 588
|
Length = 968 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 143 bits (364), Expect = 2e-38
Identities = 78/287 (27%), Positives = 118/287 (41%), Gaps = 54/287 (18%)
Query: 646 GNFGEKYCIGKGGQRSVYKAELPSGNI-FAVKKFKAELFSDETANPSEFLNEVLALTEIR 704
G FGE Y KG K + AVK K +E EFL E + ++
Sbjct: 10 GAFGEVY---KG----TLKGDGEGTETKVAVKTLKEGASEEERE---EFLEEASIMKKLS 59
Query: 705 HRNIIKFHGFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSY 764
H NI++ G C+ + +IV EY+ G L LR + + + +A + Y
Sbjct: 60 HPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEK--LTLKDLLQMALQIAKGMEY 117
Query: 765 LH-HDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSS-----------NWTEF 812
L + + HRD++++N L+ +SDFG ++ + W
Sbjct: 118 LESKNFV----HRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWM-- 171
Query: 813 AGTVGYAAPELAYTMRATEKYDVYSFGVLALEVI-KGYHPGDFVSTIFSSISNMIIEV-N 870
APE + T K DV+SFGVL E+ G P + +SN EV
Sbjct: 172 -------APESLKDGKFTSKSDVWSFGVLLWEIFTLGEQP-------YPGMSNE--EVLE 215
Query: 871 QILD-HRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLL 916
+ D +RLP P + D+L +M + C +PE RPT E+ L
Sbjct: 216 LLEDGYRLPRP-ENCPDELYELM---LQCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 143 bits (363), Expect = 2e-38
Identities = 82/290 (28%), Positives = 117/290 (40%), Gaps = 58/290 (20%)
Query: 645 TGNFGEKYCIGKGGQRSVYKAEL--PSGNIF---AVKKFKAELFSDETANPSEFLNEVLA 699
G FGE VYK L AVK K + + EFL E
Sbjct: 9 EGAFGE-----------VYKGTLKGKGDGKEVEVAVKTLKEDASEQQIE---EFLREARI 54
Query: 700 LTEIRHRNIIKFHGFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVA 759
+ ++ H NI+K G C+ + IV EY+ G L LR KE S + ++ +A
Sbjct: 55 MRKLDHPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLR-KNRPKELSLSDLLSFALQIA 113
Query: 760 NALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSN----------W 809
+ YL +HRD++++N L+ +SDFG ++ L W
Sbjct: 114 RGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRW 170
Query: 810 TEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVI-KGYHPGDFVSTIFSSISNMIIE 868
APE + T K DV+SFGVL E+ G P + +SN E
Sbjct: 171 M---------APESLKEGKFTSKSDVWSFGVLLWEIFTLGEEP-------YPGMSN--AE 212
Query: 869 VNQILD--HRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLL 916
V + L +RLP P +L +M C E+PE RPT E+ +L
Sbjct: 213 VLEYLKKGYRLPKPPNC-PPELYKLML---QCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 143 bits (363), Expect = 2e-38
Identities = 79/290 (27%), Positives = 119/290 (41%), Gaps = 59/290 (20%)
Query: 645 TGNFGEKYCIGKGGQRSVYKAELPSGNIF-----AVKKFKAELFSDETANPSEFLNEVLA 699
G FGE VYK +L AVK K + + EFL E
Sbjct: 9 EGAFGE-----------VYKGKLKGKGGKKKVEVAVKTLKEDASEQQIE---EFLREARI 54
Query: 700 LTEIRHRNIIKFHGFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVA 759
+ ++ H N++K G C+ + +IV EY+ G L + LR + S + ++ +A
Sbjct: 55 MRKLDHPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRK--NRPKLSLSDLLSFALQIA 112
Query: 760 NALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSN----------W 809
+ YL +HRD++++N L+ +SDFG ++ L W
Sbjct: 113 RGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRW 169
Query: 810 TEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVI-KGYHPGDFVSTIFSSISNMIIE 868
APE + T K DV+SFGVL E+ G P + +SN E
Sbjct: 170 M---------APESLKEGKFTSKSDVWSFGVLLWEIFTLGEQP-------YPGMSN--EE 211
Query: 869 VNQILD--HRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLL 916
V + L +RLP P +L +M C E+PE RPT E+ +L
Sbjct: 212 VLEYLKNGYRLPQPPNC-PPELYDLML---QCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 139 bits (352), Expect = 7e-37
Identities = 77/273 (28%), Positives = 122/273 (44%), Gaps = 42/273 (15%)
Query: 651 KYCIGKGGQRSVYKAE-LPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNII 709
IGKGG VYKA +G A+K K E + +NE+ L + +H NI+
Sbjct: 5 LEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKI----INEIQILKKCKHPNIV 60
Query: 710 KFHGFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMN------VIKGVANALS 763
K++G +IV E+ + GSL +L+ S NQ + V K + L
Sbjct: 61 KYYGSYLKKDELWIVMEFCSGGSLKDLLK--------STNQTLTESQIAYVCKELLKGLE 112
Query: 764 YLH--HDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGTVGYAAP 821
YLH I+HRDI + N+LL S+ E + DFG + L + GT + AP
Sbjct: 113 YLHSNG-----IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKAR-NTMVGTPYWMAP 166
Query: 822 ELAYTMRATEKYDVYSFGVLALEVIKG---YHPGDFVSTIFSSISNMIIEVNQILDHRLP 878
E+ K D++S G+ A+E+ +G Y + +F ++ L
Sbjct: 167 EVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALF--------KIATNGPPGLR 218
Query: 879 TPSRDVTDKLRSIMEVAILCLVENPEARPTMKE 911
P + +D+ + ++ CL +NPE RPT ++
Sbjct: 219 NPEK-WSDEFKDFLK---KCLQKNPEKRPTAEQ 247
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 139 bits (352), Expect = 8e-37
Identities = 75/294 (25%), Positives = 114/294 (38%), Gaps = 61/294 (20%)
Query: 646 GNFGEKYCIGKGGQRSVYKAELPSGNIF----AVKKFKAELFSDETANPSEFLNEVLALT 701
G FGE VYK +L + AVK K +FL E +
Sbjct: 6 GAFGE-----------VYKGKLKGKDGKTTEVAVKTLKE---DASEEERKDFLKEARVMK 51
Query: 702 EIRHRNIIKFHGFCSNAQHSFIVCEYLARGSLTTILR------DDAAAKEFSWNQRMNVI 755
++ H N+++ G C+ + ++V EY+ G L LR S ++
Sbjct: 52 KLGHPNVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFA 111
Query: 756 KGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSN------- 808
+A + YL VHRD++++N L+ + +SDFG ++ +
Sbjct: 112 IQIAKGMEYLAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGK 168
Query: 809 ----WTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISN 864
W APE T K DV+SFGVL E+ +T + +SN
Sbjct: 169 LPIRWM---------APESLKDGIFTSKSDVWSFGVLLWEIF------TLGATPYPGLSN 213
Query: 865 MIIEVNQIL--DHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLL 916
EV + L +RLP P D+L +M C +PE RPT E+ L
Sbjct: 214 --EEVLEYLRKGYRLPKPE-YCPDELYELML---SCWQLDPEDRPTFSELVERL 261
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 133 bits (336), Expect = 1e-34
Identities = 70/272 (25%), Positives = 121/272 (44%), Gaps = 44/272 (16%)
Query: 653 CIGKGGQRSVYKAELP-SGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKF 711
+G+G SVY A +G + AVK + S+E E+ L+ ++H NI+++
Sbjct: 7 LLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEEL--EALEREIRILSSLQHPNIVRY 64
Query: 712 HGFCSNAQHSF--IVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVAN----ALSYL 765
+G + + + I EY++ GSL+++L+ E VI+ L+YL
Sbjct: 65 YGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPE-------PVIRKYTRQILEGLAYL 117
Query: 766 H-HDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEF----AGTVGYAA 820
H + IVHRDI N+L+DS+ ++DFG AK L E GT + A
Sbjct: 118 HSNG----IVHRDIKGANILVDSDGVVKLADFGCAKRL--GDIETGEGTGSVRGTPYWMA 171
Query: 821 PELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILD----HR 876
PE+ D++S G +E+ G P +S + N + + +I
Sbjct: 172 PEVIRGEEYGRAADIWSLGCTVIEMATGKPP-------WSELGNPMAALYKIGSSGEPPE 224
Query: 877 LPTPSRDVTDKLRSIMEVAILCLVENPEARPT 908
+P ++++ + + CL +P+ RPT
Sbjct: 225 IPE---HLSEEAKDFLR---KCLRRDPKKRPT 250
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 1e-29
Identities = 73/265 (27%), Positives = 118/265 (44%), Gaps = 26/265 (9%)
Query: 653 CIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKF 711
+G+G VYK P+G I+A+KK + + L E+ L ++K
Sbjct: 8 VLGQGSSGVVYKVRHKPTGKIYALKKIH---VDGDEEFRKQLLRELKTLRSCESPYVVKC 64
Query: 712 HG-FCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCI 770
+G F + S IV EY+ GSL +L+ E + + + L YLH
Sbjct: 65 YGAFYKEGEIS-IVLEYMDGGSLADLLKKVGKIPE---PVLAYIARQILKGLDYLHTK-- 118
Query: 771 PPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGTVGYAAPEL----AYT 826
I+HRDI N+L++S+ E ++DFG +K LE F GTV Y +PE +Y+
Sbjct: 119 RHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQGESYS 178
Query: 827 MRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRDVTD 886
A D++S G+ LE G P F+ S ++ + L P+ + +
Sbjct: 179 YAA----DIWSLGLTLLECALGKFP--FLPPGQPSFFELMQAICDGPPPSL--PAEEFSP 230
Query: 887 KLRSIMEVAILCLVENPEARPTMKE 911
+ R + CL ++P+ RP+ E
Sbjct: 231 EFRDFIS---ACLQKDPKKRPSAAE 252
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 9e-28
Identities = 81/279 (29%), Positives = 132/279 (47%), Gaps = 35/279 (12%)
Query: 646 GNFGEKYCIGKGGQRSVYKAELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRH 705
G FGE G + K E+ A+K KA +FL E + + H
Sbjct: 15 GEFGEVCR---GRLKLPGKKEID----VAIKTLKA---GSSDKQRLDFLTEASIMGQFDH 64
Query: 706 RNIIKFHGFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYL 765
NII+ G + ++ I+ EY+ GSL LR++ +F+ Q + +++G+A+ + YL
Sbjct: 65 PNIIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDG--KFTVGQLVGMLRGIASGMKYL 122
Query: 766 HHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAG--TVGYAAPEL 823
VHRD++++N+L++S VSDFG ++ LE + +T G + + APE
Sbjct: 123 SEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPE- 178
Query: 824 AYTMRA-TEKYDVYSFGVLALEVIK-GYHPGDFVSTIFSSISN--MIIEVNQILDHRLPT 879
A R T DV+SFG++ EV+ G P + +SN +I V +RLP
Sbjct: 179 AIAYRKFTSASDVWSFGIVMWEVMSYGERP-------YWDMSNQDVIKAVED--GYRLPP 229
Query: 880 PSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLLCK 918
P D L +M + C ++ RPT ++ + L K
Sbjct: 230 P-MDCPSALYQLM---LDCWQKDRNERPTFSQIVSTLDK 264
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 1e-27
Identities = 70/267 (26%), Positives = 114/267 (42%), Gaps = 24/267 (8%)
Query: 654 IGKGGQRSVYKAE-LPSGNIFAVKKFK-AELFSDETANPSEFLNEVLALTEIRHRNIIKF 711
IGKG VY G ++ +K+ + + E + LNEV L ++ H NIIK+
Sbjct: 8 IGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDA---LNEVKILKKLNHPNIIKY 64
Query: 712 HGFCSNAQHSFIVCEYLARGSLTTILRDDAAAKE-FSWNQRMNVIKGVANALSYLH--HD 768
+ IV EY G L+ ++ + F Q ++ + AL YLH
Sbjct: 65 YESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK- 123
Query: 769 CIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGTVGYAAPELAYTMR 828
I+HRDI +N+ L S + DFG +K L GT Y +PEL
Sbjct: 124 ----ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPELCQNKP 179
Query: 829 ATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRDVTDKL 888
K D++S G + E+ HP F ++ I++ P PS+ + +L
Sbjct: 180 YNYKSDIWSLGCVLYELCTLKHP--FEGENLLELALKILKG-----QYPPIPSQ-YSSEL 231
Query: 889 RSIMEVAILCLVENPEARPTMKEVCNL 915
R+++ L ++PE RP++ ++
Sbjct: 232 RNLVS---SLLQKDPEERPSIAQILQS 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (278), Expect = 4e-27
Identities = 76/270 (28%), Positives = 120/270 (44%), Gaps = 30/270 (11%)
Query: 654 IGKGGQRSVYKAELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHG 713
IGKG VYK L AVK ++ L D +FL E L + H NI+K G
Sbjct: 3 IGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKR---KFLQEAEILKQYDHPNIVKLIG 59
Query: 714 FCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLH-HDCIPP 772
C Q +IV E + GSL T LR + + + + A + YL +CI
Sbjct: 60 VCVQKQPIYIVMELVPGGSLLTFLRKKKN--RLTVKKLLQMSLDAAAGMEYLESKNCI-- 115
Query: 773 IVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGT----VGYAAPELAYTMR 828
HRD++++N L+ +SDFG ++ E +T G + + APE R
Sbjct: 116 --HRDLAARNCLVGENNVLKISDFGMSR--EEEGGIYTVSDGLKQIPIKWTAPEALNYGR 171
Query: 829 ATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILD--HRLPTPSRDVTD 886
T + DV+S+G+L E T + +SN + + ++ +R+P P + +
Sbjct: 172 YTSESDVWSYGILLWETFS------LGDTPYPGMSNQ--QTRERIESGYRMPAP-QLCPE 222
Query: 887 KLRSIMEVAILCLVENPEARPTMKEVCNLL 916
++ +M C +PE RP+ E+ N L
Sbjct: 223 EIYRLML---QCWAYDPENRPSFSEIYNEL 249
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 6e-26
Identities = 77/277 (27%), Positives = 123/277 (44%), Gaps = 44/277 (15%)
Query: 650 EKYC----IGKGGQRSVYKA-ELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIR 704
E Y IG+G VYKA + +G A+KK + + E +NE+L + + +
Sbjct: 19 ELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELI-----INEILIMKDCK 73
Query: 705 HRNIIKFHGFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQ-RMN------VIKG 757
H NI+ ++ ++V EY+ GSLT I+ N RMN V +
Sbjct: 74 HPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIIT---------QNFVRMNEPQIAYVCRE 124
Query: 758 VANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGTVG 817
V L YLH ++HRDI S N+LL + ++DFGFA L S GT
Sbjct: 125 VLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVVGTPY 181
Query: 818 YAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPG-DF--VSTIFSSISNMIIEVNQILD 874
+ APE+ K D++S G++ +E+ +G P + +F + I
Sbjct: 182 WMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGI-------- 233
Query: 875 HRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKE 911
L P + + + + + CLV++PE RP+ +E
Sbjct: 234 PPLKNPEK-WSPEFKDFLN---KCLVKDPEKRPSAEE 266
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 1e-25
Identities = 80/280 (28%), Positives = 139/280 (49%), Gaps = 36/280 (12%)
Query: 646 GNFGEKYCIGKGGQRSVYKAELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRH 705
G FGE + +G + + E+ A+K K ++++ +FL+E + + H
Sbjct: 16 GEFGEVF---RGILKMPGRKEVA----VAIKTLKPG-YTEKQRQ--DFLSEASIMGQFSH 65
Query: 706 RNIIKFHGFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYL 765
NII+ G + + + I+ EY+ G+L LRD EFS Q + +++G+A + YL
Sbjct: 66 HNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDG--EFSSYQLVGMLRGIAAGMKYL 123
Query: 766 HHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLE--PHSSNWTEFAGTVG--YAAP 821
VHRD++++N+L++S E VSDFG ++ LE P + +T G + + AP
Sbjct: 124 SD---MNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGT-YTTSGGKIPIRWTAP 179
Query: 822 ELAYTMRATEKYDVYSFGVLALEVIK-GYHPGDFVSTIFSSISNMIIEVNQILD--HRLP 878
E + T DV+SFG++ EV+ G P + +SN EV + ++ RLP
Sbjct: 180 EAIAYRKFTSASDVWSFGIVMWEVMSFGERP-------YWDMSNH--EVMKAINDGFRLP 230
Query: 879 TPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLLCK 918
P D ++ ++ + C ++ RP ++ NLL K
Sbjct: 231 AP----MDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDK 266
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 2e-25
Identities = 68/266 (25%), Positives = 118/266 (44%), Gaps = 26/266 (9%)
Query: 653 CIGKGGQRSVYKAE-LPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKF 711
IG+G VYK L +G+ A+K+ E +E + E+ L ++H NI+K+
Sbjct: 7 LIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEE--ALKSIMQEIDLLKNLKHPNIVKY 64
Query: 712 HGFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIP 771
G + +I+ EY GSL I++ F + + V L+YLH
Sbjct: 65 IGSIETSDSLYIILEYAENGSLRQIIK---KFGPFPESLVAVYVYQVLQGLAYLHEQ--- 118
Query: 772 PIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGTVGYAAPELAYTMRATE 831
++HRDI + N+L + ++DFG A L S + GT + APE+ A+
Sbjct: 119 GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMSGAST 178
Query: 832 KYDVYSFGVLALEVIKG---YHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRDVTDKL 888
D++S G +E++ G Y+ + ++ +F I D P P ++ +L
Sbjct: 179 ASDIWSLGCTVIELLTGNPPYYDLNPMAALF-RIVQ---------DDHPPLPE-GISPEL 227
Query: 889 RSIMEVAILCLVENPEARPTMKEVCN 914
+ + C ++P RPT K++
Sbjct: 228 KDFLM---QCFQKDPNLRPTAKQLLK 250
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 4e-25
Identities = 58/203 (28%), Positives = 102/203 (50%), Gaps = 15/203 (7%)
Query: 654 IGKGGQRSVYKA-ELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRH---RNII 709
IG+G +VY+ +P+G + A+K + D+ S+ EV L+++R NI
Sbjct: 9 IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDV---SDIQREVALLSQLRQSQPPNIT 65
Query: 710 KFHGFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDC 769
K++G +I+ EY GS+ T+++ A+++ +I+ V AL Y+H
Sbjct: 66 KYYGSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYI----SVIIREVLVALKYIHKV- 120
Query: 770 IPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGTVGYAAPELAYTMRA 829
++HRDI + N+L+ + + DFG A L +SS + F GT + APE+ +
Sbjct: 121 --GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEGKY 178
Query: 830 TE-KYDVYSFGVLALEVIKGYHP 851
+ K D++S G+ E+ G P
Sbjct: 179 YDTKADIWSLGITIYEMATGNPP 201
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 103 bits (260), Expect = 1e-24
Identities = 72/266 (27%), Positives = 116/266 (43%), Gaps = 22/266 (8%)
Query: 654 IGKGGQRSVYKAE-LPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFH 712
IG G VY A LP+ A+K+ E + E EV A+++ H N++K++
Sbjct: 9 IGVGATAVVYAAICLPNNEKVAIKRIDLEKCQ---TSVDELRKEVQAMSQCNHPNVVKYY 65
Query: 713 GFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPP 772
++V YL+ GSL I++ V+K V L YLH +
Sbjct: 66 TSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSN---G 122
Query: 773 IVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNW----TEFAGTVGYAAPELAYTMR 828
+HRDI + N+LL + ++DFG + L F GT + APE+ +
Sbjct: 123 QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVH 182
Query: 829 A-TEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRDVTDK 887
K D++SFG+ A+E+ G P +S M + + L + P+ K
Sbjct: 183 GYDFKADIWSFGITAIELATGAAP-------YSKYPPMKVLML-TLQNDPPSLETGADYK 234
Query: 888 L--RSIMEVAILCLVENPEARPTMKE 911
+S ++ LCL ++P RPT +E
Sbjct: 235 KYSKSFRKMISLCLQKDPSKRPTAEE 260
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 4e-24
Identities = 70/242 (28%), Positives = 124/242 (51%), Gaps = 25/242 (10%)
Query: 674 AVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFIVCEYLARGSL 733
A+K K S++ EF+ E + ++ H +++ +G C+ + +IV EY++ G L
Sbjct: 32 AIKMIKEGSMSED-----EFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCL 86
Query: 734 TTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHV 793
LR+ K F +Q + + K V ++YL +HRD++++N L+D + V
Sbjct: 87 LNYLRE--HGKRFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKV 141
Query: 794 SDFGFAKFL---EPHSSNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYH 850
SDFG ++++ E SS ++F V ++ PE+ + + K DV++FGVL EV Y
Sbjct: 142 SDFGLSRYVLDDEYTSSVGSKFP--VRWSPPEVLLYSKFSSKSDVWAFGVLMWEV---YS 196
Query: 851 PGDFVSTIFSSISNMIIEVNQILDHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMK 910
G F++ S + +V+Q RL P ++K+ +IM C E E RPT +
Sbjct: 197 LGKMPYERFNN-SETVEKVSQ--GLRLYRPHL-ASEKVYAIMYS---CWHEKAEERPTFQ 249
Query: 911 EV 912
++
Sbjct: 250 QL 251
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 5e-24
Identities = 68/270 (25%), Positives = 118/270 (43%), Gaps = 18/270 (6%)
Query: 654 IGKGGQRSVYKAELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRH-RNIIKFH 712
+G+G VY A + A+K +L S FL E+ L + H NI+K +
Sbjct: 8 LGEGSFGEVYLARDRK--LVALKVLAKKLESKSKEVER-FLREIQILASLNHPPNIVKLY 64
Query: 713 GFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPP 772
F + ++V EY+ GSL +L+ S ++ + ++ + +AL YLH
Sbjct: 65 DFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG--- 121
Query: 773 IVHRDISSKNVLLDSEY-EAHVSDFGFAKFLEPHSSN------WTEFAGTVGYAAPELAY 825
I+HRDI +N+LLD + + DFG AK L S + GT GY APE+
Sbjct: 122 IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLL 181
Query: 826 TM---RATEKYDVYSFGVLALEVIKGYHPGD-FVSTIFSSISNMIIEVNQILDHRLPTPS 881
+ A+ D++S G+ E++ G P + ++ +S + II P
Sbjct: 182 GLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASPLSP 241
Query: 882 RDVTDKLRSIMEVAILCLVENPEARPTMKE 911
+ ++ ++ L ++P+ R +
Sbjct: 242 SNPELISKAASDLLKKLLAKDPKNRLSSSS 271
|
Length = 384 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 7e-24
Identities = 82/290 (28%), Positives = 145/290 (50%), Gaps = 41/290 (14%)
Query: 639 EEITKATGNFGEKYCIGK---GGQRSVYKAELPSGNIFAVKKFKAELFSDETANPSEFLN 695
EE+ A G FGE C G+ G+R ++ A+K K+ ++++ +FL+
Sbjct: 9 EEVIGA-GEFGE-VCRGRLKLPGKREIF---------VAIKTLKSG-YTEKQRR--DFLS 54
Query: 696 EVLALTEIRHRNIIKFHGFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVI 755
E + + H NII G + ++ I+ E++ G+L + LR + +F+ Q + ++
Sbjct: 55 EASIMGQFDHPNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDG--QFTVIQLVGML 112
Query: 756 KGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGT 815
+G+A + YL VHRD++++N+L++S VSDFG ++FLE +S+ T +
Sbjct: 113 RGIAAGMKYLSE---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSL 169
Query: 816 VG-----YAAPELAYTMRATEKYDVYSFGVLALEVIK-GYHPGDFVSTIFSSISNMIIEV 869
G + APE + T DV+S+G++ EV+ G P + +SN + +
Sbjct: 170 GGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERP-------YWDMSNQDV-I 221
Query: 870 NQI-LDHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLLCK 918
N I D+RLP P D L +M + C ++ ARP ++ + L K
Sbjct: 222 NAIEQDYRLPPPM-DCPTALHQLM---LDCWQKDRNARPKFGQIVSTLDK 267
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 7e-24
Identities = 71/277 (25%), Positives = 121/277 (43%), Gaps = 53/277 (19%)
Query: 646 GNFGEKYCIGKGGQRSVYKAELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRH 705
G FGE + ++K + A+K K SD+ +F EV AL +RH
Sbjct: 17 GYFGEVW-------EGLWKNRVR----VAIKILK----SDDLLKQQDFQKEVQALKRLRH 61
Query: 706 RNIIKFHGFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYL 765
+++I CS + +I+ E + +GSL LR + +++ VA ++YL
Sbjct: 62 KHLISLFAVCSVGEPVYIITELMEKGSLLAFLR-SPEGQVLPVASLIDMACQVAEGMAYL 120
Query: 766 HHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLE-----PHSSN----WTEFAGTV 816
+HRD++++N+L+ + V+DFG A+ ++ WT
Sbjct: 121 EEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWT------ 171
Query: 817 GYAAPELAYTMRATEKYDVYSFGVLALEVI-KGYHPGDFVSTIFSSISNMIIEVNQILD- 874
APE A + K DV+SFG+L E+ G P + ++N EV +
Sbjct: 172 ---APEAASHGTFSTKSDVWSFGILLYEMFTYGQVP-------YPGMNNH--EVYDQITA 219
Query: 875 -HRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMK 910
+R+P P++ ++ IM + C PE RP+ K
Sbjct: 220 GYRMPCPAK-CPQEIYKIM---LECWAAEPEDRPSFK 252
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 1e-23
Identities = 69/252 (27%), Positives = 119/252 (47%), Gaps = 37/252 (14%)
Query: 674 AVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFIVCEYLARGSL 733
A+K + S++ +F+ E + ++ H N+++ +G C+ + FIV EY+A G L
Sbjct: 32 AIKMIREGAMSED-----DFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGCL 86
Query: 734 TTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHV 793
LR + +++ V A+ YL + +HRD++++N L+ + V
Sbjct: 87 LNYLR--ERKGKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKV 141
Query: 794 SDFGFAKFL---EPHSSNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVI-KGY 849
SDFG A+++ + SS T+F V +A PE+ R + K DV+SFGVL EV +G
Sbjct: 142 SDFGLARYVLDDQYTSSQGTKFP--VKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGK 199
Query: 850 HPGDFVSTIFSSISNMIIEVNQILDH-----RLPTPSRDVTDKLRSIMEVAILCLVENPE 904
P + SN +++++ RL P T + + C E PE
Sbjct: 200 MP-------YERFSN-----SEVVESVSAGYRLYRPKLAPT----EVYTIMYSCWHEKPE 243
Query: 905 ARPTMKEVCNLL 916
RP K++ + L
Sbjct: 244 DRPAFKKLLSQL 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 2e-23
Identities = 62/195 (31%), Positives = 93/195 (47%), Gaps = 17/195 (8%)
Query: 653 CIGKGGQRSVYKAELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFH 712
IGKG V + G AVK K D++ FL E +T +RH N+++
Sbjct: 13 TIGKGEFGDVMLGDY-RGQKVAVKCLK-----DDSTAAQAFLAEASVMTTLRHPNLVQLL 66
Query: 713 GFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPP 772
G +IV EY+A+GSL LR A + Q++ V + YL
Sbjct: 67 GVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAV-ITLAQQLGFALDVCEGMEYLEEK---N 122
Query: 773 IVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGT--VGYAAPELAYTMRAT 830
VHRD++++NVL+ + A VSDFG AK ++ + +G V + APE + +
Sbjct: 123 FVHRDLAARNVLVSEDLVAKVSDFGLAK-----EASQGQDSGKLPVKWTAPEALREKKFS 177
Query: 831 EKYDVYSFGVLALEV 845
K DV+SFG+L E+
Sbjct: 178 TKSDVWSFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 98.9 bits (247), Expect = 6e-23
Identities = 73/269 (27%), Positives = 128/269 (47%), Gaps = 41/269 (15%)
Query: 646 GNFGEKYCIGKGGQRSVYKAELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRH 705
G FGE V+ AVK K T +P FL E + ++RH
Sbjct: 17 GQFGE-----------VWMGTWNGTTKVAVKTLK-----PGTMSPEAFLQEAQIMKKLRH 60
Query: 706 RNIIKFHGFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYL 765
+++ + CS + +IV EY+++GSL L+ K+ Q +++ +A ++YL
Sbjct: 61 DKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSG-EGKKLRLPQLVDMAAQIAEGMAYL 119
Query: 766 HHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGT---VGYAAPE 822
+HRD++++N+L+ ++DFG A+ +E +T G + + APE
Sbjct: 120 ESR---NYIHRDLAARNILVGENLVCKIADFGLARLIE--DDEYTAREGAKFPIKWTAPE 174
Query: 823 LAYTMRATEKYDVYSFGVLALEVI-KGYHPGDFVSTIFSSISNMIIEVNQILD--HRLPT 879
A R T K DV+SFG+L E++ G P + ++N EV + ++ +R+P
Sbjct: 175 AANYGRFTIKSDVWSFGILLTEIVTYGRVP-------YPGMTNR--EVLEQVERGYRMPR 225
Query: 880 PSRDVTDKLRSIMEVAILCLVENPEARPT 908
P + ++L +M + C ++PE RPT
Sbjct: 226 PP-NCPEELYDLM---LQCWDKDPEERPT 250
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 98.7 bits (246), Expect = 7e-23
Identities = 77/268 (28%), Positives = 126/268 (47%), Gaps = 39/268 (14%)
Query: 646 GNFGEKYCIGKGGQRSVYKAELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRH 705
G FGE + ++ P AVK K T +P +FL E + ++RH
Sbjct: 17 GQFGEVW-------EGLWNNTTP----VAVKTLKPG-----TMDPKDFLAEAQIMKKLRH 60
Query: 706 RNIIKFHGFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYL 765
+I+ + C+ + +IV E + GSL L+ A + Q +++ VA+ ++YL
Sbjct: 61 PKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGG-AGRALKLPQLIDMAAQVASGMAYL 119
Query: 766 H-HDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAG-TVGYAAPEL 823
+ I HRD++++NVL+ V+DFG A+ ++ E A + + APE
Sbjct: 120 EAQNYI----HRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEA 175
Query: 824 AYTMRATEKYDVYSFGVLALEVIK-GYHPGDFVSTIFSSISNMIIEVNQILDH--RLPTP 880
A R + K DV+SFG+L E++ G P + ++N EV Q +D R+P P
Sbjct: 176 ALYNRFSIKSDVWSFGILLTEIVTYGRMP-------YPGMTNA--EVLQQVDQGYRMPCP 226
Query: 881 SRDVTDKLRSIMEVAILCLVENPEARPT 908
+L IM + C E+P+ RPT
Sbjct: 227 P-GCPKELYDIM---LDCWKEDPDDRPT 250
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 96.8 bits (241), Expect = 3e-22
Identities = 66/210 (31%), Positives = 106/210 (50%), Gaps = 18/210 (8%)
Query: 654 IGKGGQRSVYKA-ELPSGNIFAVKKFKAELFSDETANPSEFLNEVLA-----LTEIRHRN 707
IG G SVY SG + AVK+ + S + + + + LA L E++H N
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 708 IIKFHGFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHH 767
I+++ G +A H I EY+ GS+ +L + A +E N ++ + L+YLH+
Sbjct: 68 IVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEE---TLVRNFVRQILKGLNYLHN 124
Query: 768 DCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWT------EFAGTVGYAAP 821
I+HRDI N+L+D++ +SDFG +K LE +S + G+V + AP
Sbjct: 125 R---GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAP 181
Query: 822 ELAYTMRATEKYDVYSFGVLALEVIKGYHP 851
E+ T K D++S G L +E++ G HP
Sbjct: 182 EVVKQTSYTRKADIWSLGCLVVEMLTGKHP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 96.5 bits (240), Expect = 9e-22
Identities = 64/219 (29%), Positives = 107/219 (48%), Gaps = 28/219 (12%)
Query: 644 ATGNFGEKYC----IGKGGQRSVYKA-ELPSGNIFAVKKF------KAELFSDETANPSE 692
+ G+ +KY IG+G +VY A ++ +G A+K+ K EL
Sbjct: 13 SVGDPKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELI--------- 63
Query: 693 FLNEVLALTEIRHRNIIKFHGFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRM 752
+NE+L + E +H NI+ + ++V EYLA GSLT ++ + + Q
Sbjct: 64 -INEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDE----GQIA 118
Query: 753 NVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEF 812
V + AL +LH + ++HRDI S N+LL + ++DFGF + P S +
Sbjct: 119 AVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM 175
Query: 813 AGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHP 851
GT + APE+ K D++S G++A+E+++G P
Sbjct: 176 VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 94.9 bits (236), Expect = 1e-21
Identities = 68/245 (27%), Positives = 114/245 (46%), Gaps = 31/245 (12%)
Query: 674 AVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFIVCEYLARGSL 733
A+K S+E +F+ E + ++ H +++ +G C+ + +IV E++ G L
Sbjct: 32 AIKAINEGAMSEE-----DFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENGCL 86
Query: 734 TTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHV 793
LR + S + +++ + V + YL + +HRD++++N L+ S V
Sbjct: 87 LNYLRQRQG--KLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKV 141
Query: 794 SDFGFAKFL---EPHSSNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVI-KGY 849
SDFG +++ E SS+ +F V ++ PE+ + + K DV+SFGVL EV +G
Sbjct: 142 SDFGMTRYVLDDEYTSSSGAKFP--VKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGK 199
Query: 850 HPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRDVTDKL--RSIMEVAILCLVENPEARP 907
P F SN + RL P KL ++ EV C E PE RP
Sbjct: 200 MP-------FEKKSNYEVVEMISRGFRLYRP------KLASMTVYEVMYSCWHEKPEGRP 246
Query: 908 TMKEV 912
T E+
Sbjct: 247 TFAEL 251
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 93.3 bits (231), Expect = 1e-20
Identities = 59/199 (29%), Positives = 101/199 (50%), Gaps = 12/199 (6%)
Query: 654 IGKGGQRSVYKA-ELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFH 712
IG+G +V+ A ++ +G A+K+ + + +NE+L + E+++ NI+ F
Sbjct: 27 IGQGASGTVFTAIDVATGQEVAIKQINLQ----KQPKKELIINEILVMKELKNPNIVNFL 82
Query: 713 GFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPP 772
F+V EYLA GSLT ++ + + Q V + AL +LH +
Sbjct: 83 DSFLVGDELFVVMEYLAGGSLTDVVTETCMDEA----QIAAVCRECLQALEFLHAN---Q 135
Query: 773 IVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGTVGYAAPELAYTMRATEK 832
++HRDI S NVLL + ++DFGF + P S + GT + APE+ K
Sbjct: 136 VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPK 195
Query: 833 YDVYSFGVLALEVIKGYHP 851
D++S G++A+E+++G P
Sbjct: 196 VDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 92.5 bits (229), Expect = 2e-20
Identities = 57/199 (28%), Positives = 100/199 (50%), Gaps = 12/199 (6%)
Query: 654 IGKGGQRSVYKA-ELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFH 712
IG+G +VY A ++ +G A+++ + + +NE+L + E ++ NI+ +
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQ----QQPKKELIINEILVMRENKNPNIVNYL 83
Query: 713 GFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPP 772
++V EYLA GSLT ++ + + Q V + AL +LH +
Sbjct: 84 DSYLVGDELWVVMEYLAGGSLTDVVTETCMDE----GQIAAVCRECLQALEFLHSN---Q 136
Query: 773 IVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGTVGYAAPELAYTMRATEK 832
++HRDI S N+LL + ++DFGF + P S + GT + APE+ K
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPK 196
Query: 833 YDVYSFGVLALEVIKGYHP 851
D++S G++A+E+I+G P
Sbjct: 197 VDIWSLGIMAIEMIEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 91.0 bits (226), Expect = 3e-20
Identities = 68/265 (25%), Positives = 115/265 (43%), Gaps = 24/265 (9%)
Query: 647 NFGEKYCIGKGGQRSVYKAELPS-GNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRH 705
+F IGKG V+K + ++A+K+ +L E ++E L ++
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQI--DLSKMNRREREEAIDEARVLAKLDS 58
Query: 706 RNIIKFHGFCSNAQHSFIVCEYLARGSLTTIL---RDDAAAKEFSWNQRMNVIKGVANAL 762
II+++ + IV EY G L +L R ++ W + ++ G L
Sbjct: 59 SYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLG----L 114
Query: 763 SYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGTVGYAAPE 822
++LH I+HRDI S N+ LD+ + D G AK L +++ GT Y +PE
Sbjct: 115 AHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPE 171
Query: 823 LAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSR 882
L EK DV++ GV+ E G HP D +N + +I+ P S+
Sbjct: 172 LCEDKPYNEKSDVWALGVVLYECCTGKHPFD--------ANNQGALILKIIRGVFPPVSQ 223
Query: 883 DVTDKLRSIMEVAILCLVENPEARP 907
+ +L +++ CL ++ RP
Sbjct: 224 MYSQQLAQLID---QCLTKDYRQRP 245
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.1 bits (227), Expect = 4e-20
Identities = 72/261 (27%), Positives = 116/261 (44%), Gaps = 23/261 (8%)
Query: 653 CIGKGGQRSVYKA-ELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKF 711
CIGKG VYKA + + + A+K E DE + E+ L++ R I K+
Sbjct: 8 CIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIE---DIQQEIQFLSQCRSPYITKY 64
Query: 712 HGFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIP 771
+G +I+ EY GS +L+ + +++ V L YLH +
Sbjct: 65 YGSFLKGSKLWIIMEYCGGGSCLDLLK----PGKLDETYIAFILREVLLGLEYLHEE--- 117
Query: 772 PIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGTVGYAAPELAYTMRATE 831
+HRDI + N+LL E + ++DFG + L S F GT + APE+ E
Sbjct: 118 GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIKQSGYDE 177
Query: 832 KYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPT-PSRDVTDKLRS 890
K D++S G+ A+E+ KG P S + M + I + P+ + +
Sbjct: 178 KADIWSLGITAIELAKGEPP-------LSDLHPMRVLFL-IPKNNPPSLEGNKFSKPFKD 229
Query: 891 IMEVAILCLVENPEARPTMKE 911
+ LCL ++P+ RP+ KE
Sbjct: 230 FVS---LCLNKDPKERPSAKE 247
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.2 bits (227), Expect = 4e-20
Identities = 71/290 (24%), Positives = 118/290 (40%), Gaps = 49/290 (16%)
Query: 654 IGKGGQRSVYKA-ELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFH 712
+G+G V K +G I A+KKFK ++ + L EV L ++RH NI+
Sbjct: 9 VGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTA--LREVKVLRQLRHENIVNLK 66
Query: 713 GFCSNAQHSFIVCEYLARGSLTTILR-----DDAAAKEFSWNQRMNVIKGVANALSYLH- 766
++V EY+ R L + A + + W + A++Y H
Sbjct: 67 EAFRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQ--------LLQAIAYCHS 118
Query: 767 HDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFL-EPHSSNWTEFAGTVGYAAPELAY 825
H+ I+HRDI +N+L+ + DFGFA+ L +S T++ T Y APEL
Sbjct: 119 HN----IIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPEL-- 172
Query: 826 TMRATEKY----DVYSFGVLALEVIKG--YHPG----DFVSTIFSSISNMIIEVNQILDH 875
+ Y DV++ G + E++ G PG D + I + + ++
Sbjct: 173 -LVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSS 231
Query: 876 -------RLPTPSRDVTDKLR-------SIMEVAILCLVENPEARPTMKE 911
P PS+ + + R ++ CL +P+ R T E
Sbjct: 232 NPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDE 281
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 90.7 bits (225), Expect = 4e-20
Identities = 79/283 (27%), Positives = 139/283 (49%), Gaps = 42/283 (14%)
Query: 646 GNFGEKYCIGK---GGQRSVYKAELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTE 702
G FGE C G+ G+R + A+K KA ++++ +FL+E + +
Sbjct: 15 GEFGE-VCSGRLKLPGKREIP---------VAIKTLKAG-YTEKQRR--DFLSEASIMGQ 61
Query: 703 IRHRNIIKFHGFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANAL 762
H NII G + ++ IV EY+ GSL LR +F+ Q + +++G+A+ +
Sbjct: 62 FDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDG--QFTVIQLVGMLRGIASGM 119
Query: 763 SYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLE--PHSSNWTEFAGT--VGY 818
YL VHRD++++N+L++S VSDFG ++ LE P ++ +T G + +
Sbjct: 120 KYLSD---MGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAA-YTTRGGKIPIRW 175
Query: 819 AAPELAYTMRATEKYDVYSFGVLALEVIK-GYHPGDFVSTIFSSISN--MIIEVNQILDH 875
APE + T DV+S+G++ EV+ G P + +SN +I + + +
Sbjct: 176 TAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERP-------YWEMSNQDVIKAIEE--GY 226
Query: 876 RLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLLCK 918
RLP P D L +M + C ++ RP +++ ++L K
Sbjct: 227 RLPAP-MDCPAALHQLM---LDCWQKDRNERPKFEQIVSILDK 265
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 90.9 bits (225), Expect = 4e-20
Identities = 71/262 (27%), Positives = 114/262 (43%), Gaps = 26/262 (9%)
Query: 654 IGKGGQRSVYKA-ELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFH 712
IGKG V+K + + + A+K E DE + + E+ L++ + K++
Sbjct: 12 IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQ---EITVLSQCDSPYVTKYY 68
Query: 713 GFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPP 772
G +I+ EYL GS +LR A F Q ++K + L YLH +
Sbjct: 69 GSYLKGTKLWIIMEYLGGGSALDLLR----AGPFDEFQIATMLKEILKGLDYLHSE---K 121
Query: 773 IVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGTVGYAAPELAYTMRATEK 832
+HRDI + NVLL + + ++DFG A L F GT + APE+ K
Sbjct: 122 KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSK 181
Query: 833 YDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDH--RLPTPSRDVTDKLRS 890
D++S G+ A+E+ KG P N + ++L + P+ + +
Sbjct: 182 ADIWSLGITAIELAKGEPP------------NSDMHPMRVLFLIPKNNPPTL-TGEFSKP 228
Query: 891 IMEVAILCLVENPEARPTMKEV 912
E CL ++P RPT KE+
Sbjct: 229 FKEFIDACLNKDPSFRPTAKEL 250
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 90.5 bits (225), Expect = 5e-20
Identities = 72/268 (26%), Positives = 117/268 (43%), Gaps = 27/268 (10%)
Query: 654 IGKGGQRSVYKAE-LPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFH 712
+G G V K P+G I AVK + E +E + L E+ L + I+ F+
Sbjct: 9 LGAGNSGVVSKVLHRPTGKIMAVKTIRLE--INEAIQ-KQILRELDILHKCNSPYIVGFY 65
Query: 713 GFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPP 772
G N I EY+ GSL IL++ + V L+YLH
Sbjct: 66 GAFYNNGDISICMEYMDGGSLDKILKE--VQGRIPERILGKIAVAVLKGLTYLHEKH--K 121
Query: 773 IVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGTVGYAAPE----LAYTMR 828
I+HRD+ N+L++S + + DFG + L +S F GT Y APE Y+++
Sbjct: 122 IIHRDVKPSNILVNSRGQIKLCDFGVSGQLV--NSLAKTFVGTSSYMAPERIQGNDYSVK 179
Query: 829 ATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEV-NQILDHRLPT-PSRDVTD 886
+ D++S G+ +E+ G P + + I E+ I++ P PS +
Sbjct: 180 S----DIWSLGLSLIELATGRFPYPPE----NDPPDGIFELLQYIVNEPPPRLPSGKFSP 231
Query: 887 KLRSIMEVAILCLVENPEARPTMKEVCN 914
+ + LCL+++P RP+ KE+
Sbjct: 232 DFQDFVN---LCLIKDPRERPSYKELLE 256
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 90.2 bits (223), Expect = 1e-19
Identities = 57/199 (28%), Positives = 100/199 (50%), Gaps = 12/199 (6%)
Query: 654 IGKGGQRSVYKA-ELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFH 712
IG+G +VY A ++ +G A+K+ + + +NE+L + E ++ NI+ +
Sbjct: 27 IGQGASGTVYTAIDIATGQEVAIKQMNLQ----QQPKKELIINEILVMRENKNPNIVNYL 82
Query: 713 GFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPP 772
++V EYLA GSLT ++ + + Q V + AL +LH +
Sbjct: 83 DSYLVGDELWVVMEYLAGGSLTDVVTETCMDE----GQIAAVCRECLQALDFLHSN---Q 135
Query: 773 IVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGTVGYAAPELAYTMRATEK 832
++HRDI S N+LL + ++DFGF + P S + GT + APE+ K
Sbjct: 136 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPK 195
Query: 833 YDVYSFGVLALEVIKGYHP 851
D++S G++A+E+++G P
Sbjct: 196 VDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 89.2 bits (222), Expect = 1e-19
Identities = 68/272 (25%), Positives = 115/272 (42%), Gaps = 27/272 (9%)
Query: 650 EKYCIGKGGQRSVYKA-ELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNI 708
IGKG +V K G I K+ + + ++EV L E++H NI
Sbjct: 4 VLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMT--EKEKQQLVSEVNILRELKHPNI 61
Query: 709 IKFHGFCSNAQHS--FIVCEYLARGSLTTILR-----DDAAAKEFSWNQRMNVIKGVANA 761
++++ + + +IV EY G L +++ +EF W ++ + A
Sbjct: 62 VRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWR----ILTQLLLA 117
Query: 762 LSYLHH--DCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGTVGYA 819
L H+ D ++HRD+ N+ LD+ + DFG AK L SS + GT Y
Sbjct: 118 LYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYVGTPYYM 177
Query: 820 APELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPT 879
+PE M EK D++S G L E+ P F + +++ I E
Sbjct: 178 SPEQLNHMSYDEKSDIWSLGCLIYELCALSPP--FTARNQLQLASKIKE-----GKFRRI 230
Query: 880 PSRDVTDKLRSIMEVAILCLVENPEARPTMKE 911
P R + +L +++ L +P+ RP+ +E
Sbjct: 231 PYR-YSSELNEVIK---SMLNVDPDKRPSTEE 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.9 bits (221), Expect = 2e-19
Identities = 62/244 (25%), Positives = 109/244 (44%), Gaps = 25/244 (10%)
Query: 654 IGKGGQRSVYKA-ELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFH 712
IG+G VYKA + +G I A+KK K L + P L E+ L E+ H NIIK
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIK--LRFESEGIPKTALREIKLLKELNHPNIIKLL 64
Query: 713 GFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLH-HDCIP 771
+ ++V E++ L +++D + + + + + L++ H H +
Sbjct: 65 DVFRHKGDLYLVFEFM-DTDLYKLIKD--RQRGLPESLIKSYLYQLLQGLAFCHSHGIL- 120
Query: 772 PIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGTVGYAAPELAYTMRA-T 830
HRD+ +N+L+++E ++DFG A+ +T + T Y APEL + +
Sbjct: 121 ---HRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDKGYS 177
Query: 831 EKYDVYSFGVLALEVIKG--YHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRDVTDKL 888
D++S G + E++ PG + I ++ +I L TP +V K
Sbjct: 178 TPVDIWSVGCIFAELLSRRPLFPGK----------SEIDQLFKIFR-TLGTPDPEVWPKF 226
Query: 889 RSIM 892
S+
Sbjct: 227 TSLA 230
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 88.1 bits (219), Expect = 3e-19
Identities = 70/270 (25%), Positives = 120/270 (44%), Gaps = 31/270 (11%)
Query: 651 KYCIGKGGQRSVYKA-ELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNII 709
+G+G SVYKA +G + A+K + D E + E+ L + I+
Sbjct: 8 LEKLGEGSYGSVYKAIHKETGQVVAIKVV--PVEEDL----QEIIKEISILKQCDSPYIV 61
Query: 710 KFHGFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDC 769
K++G +IV EY GS++ I++ K + + ++ L YLH +
Sbjct: 62 KYYGSYFKNTDLWIVMEYCGAGSVSDIMK--ITNKTLTEEEIAAILYQTLKGLEYLHSN- 118
Query: 770 IPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGTVGYAAPELAYTMRA 829
+HRDI + N+LL+ E +A ++DFG + L + GT + APE+ +
Sbjct: 119 --KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQEIGY 176
Query: 830 TEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNM--IIEVNQILDHRLPTP---SRDV 884
K D++S G+ A+E+ +G P +S I M I + L P S +
Sbjct: 177 NNKADIWSLGITAIEMAEGKPP-------YSDIHPMRAIFMIPNKPPPTLSDPEKWSPEF 229
Query: 885 TDKLRSIMEVAILCLVENPEARPTMKEVCN 914
D ++ CLV++PE RP+ ++
Sbjct: 230 NDFVKK-------CLVKDPEERPSAIQLLQ 252
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 88.6 bits (220), Expect = 3e-19
Identities = 69/281 (24%), Positives = 117/281 (41%), Gaps = 36/281 (12%)
Query: 654 IGKGGQRSVYKA--ELPSGNIF---AVKKFKAELFSDETANPSEFLNEVLALTEIRHRNI 708
+G+G V + N AVK S E + S+F E+ L + H NI
Sbjct: 12 LGEGHFGKVELCRYDPLGDNTGEQVAVKSLNH---SGEEQHRSDFEREIEILRTLDHENI 68
Query: 709 IKFHGFCSNAQHSFIVC---EYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYL 765
+K+ G + EYL GSL L+ + + + + + + YL
Sbjct: 69 VKYKG-VCEKPGGRSLRLIMEYLPSGSLRDYLQRHRD--QINLKRLLLFSSQICKGMDYL 125
Query: 766 HHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWT-----EFAGTVGYAA 820
+HRD++++N+L++SE +SDFG AK L + E + + A
Sbjct: 126 GSQ---RYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESP--IFWYA 180
Query: 821 PELAYTMRATEKYDVYSFGVLALEVI----KGYHP-GDFVSTIFSSISNMIIE--VNQIL 873
PE T + + DV+SFGV E+ P +F+ I + MI+ + +
Sbjct: 181 PECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLK 240
Query: 874 DH-RLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVC 913
+ RLP P D++ +M+ LC P+ RP+ ++
Sbjct: 241 EGERLPRPPS-CPDEVYDLMK---LCWEAEPQDRPSFADLI 277
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 6e-19
Identities = 64/234 (27%), Positives = 115/234 (49%), Gaps = 22/234 (9%)
Query: 687 TANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEF 746
T +P FL E + ++RH +++ + S + +IV EY+++GSL L+D +
Sbjct: 42 TMSPESFLEEAQIMKKLRHDKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKD-GEGRAL 99
Query: 747 SWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHS 806
+++ VA ++Y+ +HRD+ S N+L+ ++DFG A+ +E
Sbjct: 100 KLPNLVDMAAQVAAGMAYIER---MNYIHRDLRSANILVGDGLVCKIADFGLARLIE--D 154
Query: 807 SNWTEFAGT---VGYAAPELAYTMRATEKYDVYSFGVLALEVI-KGYHPGDFVSTIFSSI 862
+ +T G + + APE A R T K DV+SFG+L E++ KG P + +
Sbjct: 155 NEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVP-------YPGM 207
Query: 863 SNMIIEVNQILDHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLL 916
+N + +R+P P D S+ E+ + C ++PE RPT + + + L
Sbjct: 208 NNREVLEQVERGYRMPCPQ----DCPISLHELMLQCWKKDPEERPTFEYLQSFL 257
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 87.3 bits (217), Expect = 6e-19
Identities = 77/266 (28%), Positives = 113/266 (42%), Gaps = 41/266 (15%)
Query: 654 IGKGGQRSVYKAEL-PSGNIFAVKKF-KAELFSDETANPSEFLNEVLALTEIRHRNIIKF 711
+G GG V ++ FA+K K + ET +E L E H I+K
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIV--ETGQQEHIFSEKEILEECNHPFIVKL 58
Query: 712 HGFCSNAQHSFIVCEYLARGSLTTILRD----DAAAKEFSWNQRMNVIKGVANALSYLHH 767
+ + ++ +++ EY G L TILRD D F I V A YLH+
Sbjct: 59 YRTFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFY-------IACVVLAFEYLHN 111
Query: 768 DCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGTVGYAAPEL---- 823
I++RD+ +N+LLDS + DFGFAK L+ WT F GT Y APE+
Sbjct: 112 R---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWT-FCGTPEYVAPEIILNK 167
Query: 824 AYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEV-NQILDH--RLPTP 880
Y D +S G+L E++ G P F +E+ N IL +L P
Sbjct: 168 GYDFSV----DYWSLGILLYELLTGRPP-------FGEDDEDPMEIYNDILKGNGKLEFP 216
Query: 881 SRDVTDKLRSIMEVAILCLVENPEAR 906
+ + + +++ L NPE R
Sbjct: 217 NY-IDKAAKDLIKQ--LLR-RNPEER 238
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 87.2 bits (216), Expect = 7e-19
Identities = 67/268 (25%), Positives = 117/268 (43%), Gaps = 23/268 (8%)
Query: 654 IGKGGQRSVYKA-ELPSGNIFAVK--KFKAELFSDETANPSEFLNEVLALTEIRHRNIIK 710
+G G S Y+A ++ +G + AVK + S++ E+ + + H +II+
Sbjct: 8 LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67
Query: 711 FHGFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCI 770
G H + E++A GS++ +L A F +N + + LSYLH +
Sbjct: 68 MLGATCEDSHFNLFVEWMAGGSVSHLLSKYGA---FKEAVIINYTEQLLRGLSYLHEN-- 122
Query: 771 PPIVHRDISSKNVLLDSE-YEAHVSDFGFAKFLEPHSSNWTEFA----GTVGYAAPELAY 825
I+HRD+ N+L+DS ++DFG A L + EF GT+ + APE+
Sbjct: 123 -QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLR 181
Query: 826 TMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRDVT 885
+ DV+S G + +E+ P + SN + + +I +
Sbjct: 182 GEQYGRSCDVWSVGCVIIEMATAKPPWN-----AEKHSNHLALIFKIASATTAPS---IP 233
Query: 886 DKLR-SIMEVAILCLVENPEARPTMKEV 912
+ L + +V + CL PE RP +E+
Sbjct: 234 EHLSPGLRDVTLRCLELQPEDRPPSREL 261
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 7e-19
Identities = 64/233 (27%), Positives = 113/233 (48%), Gaps = 32/233 (13%)
Query: 687 TANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEF 746
T +P FL E + ++RH +++ + S + +IV EY+++GSL L+ + K
Sbjct: 42 TMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGEMG-KYL 99
Query: 747 SWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHS 806
Q +++ +A+ ++Y+ VHRD+ + N+L+ V+DFG A+ +E
Sbjct: 100 RLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIE--D 154
Query: 807 SNWTEFAGT---VGYAAPELAYTMRATEKYDVYSFGVLALEV-IKGYHPGDFVSTIFSSI 862
+ +T G + + APE A R T K DV+SFG+L E+ KG P + +
Sbjct: 155 NEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP-------YPGM 207
Query: 863 SNMIIEVNQILD-----HRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMK 910
N ++LD +R+P P + S+ ++ C + PE RPT +
Sbjct: 208 VN-----REVLDQVERGYRMPCPP----ECPESLHDLMCQCWRKEPEERPTFE 251
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 86.6 bits (215), Expect = 1e-18
Identities = 80/281 (28%), Positives = 118/281 (41%), Gaps = 52/281 (18%)
Query: 646 GNFGEKYCIGKGGQRSVYKAELPSGNIF--AVKKFKAELFSDETANPSEFLNEVLALTEI 703
GNFG + KG VY + SG AVK K E A EFL E + ++
Sbjct: 6 GNFGS---VVKG----VYL--MKSGKEVEVAVKTLKQE---HIAAGKKEFLREASVMAQL 53
Query: 704 RHRNIIKFHGFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIK------G 757
H I++ G C + +V E G L L+ + + V
Sbjct: 54 DHPCIVRLIGVCK-GEPLMLVMELAPLGPLLKYLKK---------RREIPVSDLKELAHQ 103
Query: 758 VANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWT-EFAGT- 815
VA ++YL VHRD++++NVLL + ++A +SDFG ++ L S + AG
Sbjct: 104 VAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRW 160
Query: 816 -VGYAAPELAYTMRATEKYDVYSFGVLALEVIK-GYHPGDFVSTIFSSISNMIIEVNQIL 873
+ + APE + + K DV+S+GV E G P + + EV +L
Sbjct: 161 PLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKP-------YGEMKG--AEVIAML 211
Query: 874 D--HRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEV 912
+ RLP P ++ SIM C PE RPT E+
Sbjct: 212 ESGERLPRPEE-CPQEIYSIML---SCWKYRPEDRPTFSEL 248
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 86.6 bits (215), Expect = 1e-18
Identities = 73/272 (26%), Positives = 121/272 (44%), Gaps = 36/272 (13%)
Query: 654 IGKGGQRSVYKA-ELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFH 712
IG G VY A L +G + AVK+ + + ++ E +E+ L ++H N++K++
Sbjct: 8 IGGGTFGKVYTAVNLDTGELMAVKEIRIQ--DNDPKTIKEIADEMKVLELLKHPNLVKYY 65
Query: 713 GFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVAN----ALSYLHHD 768
G + + +I EY + G+L +L E +VI+ L+YLH
Sbjct: 66 GVEVHREKVYIFMEYCSGGTLEELL-------EHGRILDEHVIRVYTLQLLEGLAYLHSH 118
Query: 769 CIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTE----FAGTVGYAAPELA 824
IVHRDI N+ LD + DFG A L+ +++ E AGT Y APE+
Sbjct: 119 ---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEV- 174
Query: 825 YTMRATEKY----DVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTP 880
T + + D++S G + LE+ G P + F I + H+ P P
Sbjct: 175 ITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQ------IMFHVGAGHKPPIP 228
Query: 881 SRD-VTDKLRSIMEVAILCLVENPEARPTMKE 911
++ + + ++ CL +P+ RPT E
Sbjct: 229 DSLQLSPEGKDFLD---RCLESDPKKRPTASE 257
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 85.9 bits (212), Expect = 2e-18
Identities = 63/236 (26%), Positives = 118/236 (50%), Gaps = 26/236 (11%)
Query: 687 TANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEF 746
T P FL E + ++RH ++ + S + +IV E++ +GSL L++ K
Sbjct: 42 TMMPEAFLQEAQIMKKLRHDKLVPLYAVVSE-EPIYIVTEFMGKGSLLDFLKE-GDGKYL 99
Query: 747 SWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHS 806
Q +++ +A+ ++Y+ +HRD+ + N+L+ ++DFG A+ +E
Sbjct: 100 KLPQLVDMAAQIADGMAYIER---MNYIHRDLRAANILVGDNLVCKIADFGLARLIE--D 154
Query: 807 SNWTEFAGT---VGYAAPELAYTMRATEKYDVYSFGVLALEVI-KGYHPGDFVSTIFSSI 862
+ +T G + + APE A R T K DV+SFG+L E++ KG P + +
Sbjct: 155 NEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVP-------YPGM 207
Query: 863 SNMIIEVNQILD--HRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLL 916
N EV + ++ +R+P P + + L +M+ LC ++P+ RPT + + + L
Sbjct: 208 VNR--EVLEQVERGYRMPCP-QGCPESLHELMK---LCWKKDPDERPTFEYIQSFL 257
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 2e-18
Identities = 70/261 (26%), Positives = 121/261 (46%), Gaps = 31/261 (11%)
Query: 654 IGKGGQRSVYKAELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHG 713
IG G V+ A+K + S+E +F+ E + ++ H +++ +G
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEE-----DFIEEAQVMMKLSHPKLVQLYG 66
Query: 714 FCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPI 773
C+ +V E++ G L+ LR A +FS + + V ++YL +
Sbjct: 67 VCTERSPICLVFEFMEHGCLSDYLR--AQRGKFSQETLLGMCLDVCEGMAYLESSNV--- 121
Query: 774 VHRDISSKNVLLDSEYEAHVSDFGFAKFL---EPHSSNWTEFAGTVGYAAPELAYTMRAT 830
+HRD++++N L+ VSDFG +F+ + SS T+F V +++PE+ + +
Sbjct: 122 IHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFP--VKWSSPEVFSFSKYS 179
Query: 831 EKYDVYSFGVLALEVI-KGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRDVTDKL- 888
K DV+SFGVL EV +G P + S S ++ +N RL P +L
Sbjct: 180 SKSDVWSFGVLMWEVFSEGKTPYENRSN-----SEVVETINA--GFRLYKP------RLA 226
Query: 889 -RSIMEVAILCLVENPEARPT 908
+S+ E+ C E PE RP+
Sbjct: 227 SQSVYELMQHCWKERPEDRPS 247
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 85.7 bits (212), Expect = 2e-18
Identities = 71/274 (25%), Positives = 125/274 (45%), Gaps = 41/274 (14%)
Query: 651 KYCIGKGGQRSVYKAELPS-GNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNII 709
K+ +G G VY+ AVK K ++T EFL E + EI+H N++
Sbjct: 11 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-----EDTMEVEEFLKEAAVMKEIKHPNLV 65
Query: 710 KFHGFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDC 769
+ G C+ +I+ E++ G+L LR + +E + + + +++A+ YL
Sbjct: 66 QLLGVCTREPPFYIITEFMTYGNLLDYLR-ECNRQEVNAVVLLYMATQISSAMEYLEKK- 123
Query: 770 IPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGT---VGYAAPE-LAY 825
+HRD++++N L+ + V+DFG ++ + +T AG + + APE LAY
Sbjct: 124 --NFIHRDLAARNCLVGENHLVKVADFGLSRLMT--GDTYTAHAGAKFPIKWTAPESLAY 179
Query: 826 TMRATEKYDVYSFGVLALEVIKGY----HPGDFVSTIFSSISNMIIEVNQILDHRLPTPS 881
+ K DV++FGVL E I Y +PG +S ++ + +R+ P
Sbjct: 180 NKFSI-KSDVWAFGVLLWE-IATYGMSPYPGIDLSQVYELLEK---------GYRMERPE 228
Query: 882 ---RDVTDKLRSIMEVAILCLVENPEARPTMKEV 912
V + +R+ C NP RP+ E+
Sbjct: 229 GCPPKVYELMRA-------CWQWNPSDRPSFAEI 255
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 3e-18
Identities = 71/290 (24%), Positives = 123/290 (42%), Gaps = 51/290 (17%)
Query: 654 IGKGGQRSVYKAELPSG------NIFAVKKFKAELFSDETANPS---EFLNEVLALTEIR 704
+G+G V+ E + AVK K ETA+ +F E LT +
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLK------ETASNDARKDFEREAELLTNFQ 66
Query: 705 HRNIIKFHGFCSNAQHSFIVCEYLARGSLTTILR-----------DDAAAKEFSWNQRMN 753
H NI+KF+G C+ +V EY+ G L LR D+ E + +Q +
Sbjct: 67 HENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQ 126
Query: 754 VIKGVANALSYL--HHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTE 811
+ +A+ + YL H VHRD++++N L+ + + DFG ++ + +++++
Sbjct: 127 IAVQIASGMVYLASQH-----FVHRDLATRNCLVGYDLVVKIGDFGMSR--DVYTTDYYR 179
Query: 812 FAGT----VGYAAPELAYTMRATEKYDVYSFGVLALEVIK-GYHPGDFVSTIFSSISNMI 866
G + + PE + T + DV+SFGV+ E+ G P + + +
Sbjct: 180 VGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQP------WYGLSNEEV 233
Query: 867 IEVNQILDHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLL 916
IE I RL R ++ IM C +P+ R +K++ L
Sbjct: 234 IEC--ITQGRLLQRPRTCPSEVYDIMLG---CWKRDPQQRINIKDIHERL 278
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 5e-18
Identities = 77/293 (26%), Positives = 126/293 (43%), Gaps = 45/293 (15%)
Query: 634 GKVLYEEITKATGNFGEKYCIGKGGQRSVYKAELPSGNI-FAVKKFKAELFSDETANPSE 692
KVL +G FG Y KG V+ E I A+K + E + AN E
Sbjct: 12 IKVL------GSGAFGTVY---KG----VWIPEGEKVKIPVAIKVLREE--TSPKAN-KE 55
Query: 693 FLNEVLALTEIRHRNIIKFHGFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRM 752
L+E + + H ++++ G C ++Q I + + G L +R+ +
Sbjct: 56 ILDEAYVMASVDHPHVVRLLGICLSSQVQLIT-QLMPLGCLLDYVRNHKD--NIGSQYLL 112
Query: 753 NVIKGVANALSYL--HHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWT 810
N +A +SYL +VHRD++++NVL+ + ++DFG AK L+ +
Sbjct: 113 NWCVQIAKGMSYLEEKR-----LVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYH 167
Query: 811 EFAGTV--GYAAPELAYTMRATEKYDVYSFGVLALEVIK-GYHPGDFVSTIFSSISNMII 867
G V + A E T K DV+S+GV E++ G P + + +
Sbjct: 168 AEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPA---------V 218
Query: 868 EVNQILDH--RLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLLCK 918
E+ +L+ RLP P D + V + C + + E+RPT KE+ N K
Sbjct: 219 EIPDLLEKGERLPQPPICTID----VYMVLVKCWMIDAESRPTFKELINEFSK 267
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 9e-18
Identities = 67/267 (25%), Positives = 119/267 (44%), Gaps = 26/267 (9%)
Query: 654 IGKGGQRSVYKAELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHG 713
+G G V+ + AVK K S + FL E + ++H +++ +
Sbjct: 14 LGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQA-----FLEEANLMKTLQHDKLVRLYA 68
Query: 714 FCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPI 773
+ + +I+ EY+A+GSL L+ D K + ++ +A ++Y+
Sbjct: 69 VVTKEEPIYIITEYMAKGSLLDFLKSDEGGK-VLLPKLIDFSAQIAEGMAYIERK---NY 124
Query: 774 VHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAG-TVGYAAPELAYTMRATEK 832
+HRD+ + NVL+ ++DFG A+ +E + E A + + APE T K
Sbjct: 125 IHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIK 184
Query: 833 YDVYSFGVLALEVI---KGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRDVTDKLR 889
DV+SFG+L E++ K +PG S + S++ +R+P + D+L
Sbjct: 185 SDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQR---------GYRMPRM-ENCPDELY 234
Query: 890 SIMEVAILCLVENPEARPTMKEVCNLL 916
IM+ C E E RPT + ++L
Sbjct: 235 DIMK---TCWKEKAEERPTFDYLQSVL 258
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.0 bits (206), Expect = 2e-17
Identities = 70/272 (25%), Positives = 111/272 (40%), Gaps = 56/272 (20%)
Query: 654 IGKGGQRSVYKA-ELPSGNIFAVKKF-KAELFS-DETANPSEFLNEVLALTEIRHRNIIK 710
+GKG V + +G ++A+K K ++ E + L E L+ I H I+K
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHT---LTERNILSRINHPFIVK 57
Query: 711 FHGFCS--NAQHSFIVCEYLARGSLTTILR-----DDAAAK----EFSWNQRMNVIKGVA 759
H + + ++V EY G L + L + A+ E +
Sbjct: 58 LH--YAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAE------------IV 103
Query: 760 NALSYLH-HDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGTVGY 818
AL YLH I++RD+ +N+LLD++ ++DFG AK L S F GT Y
Sbjct: 104 LALEYLHSLG----IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEY 159
Query: 819 AAPEL----AYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILD 874
APE+ Y D +S GVL E++ G P F + I +IL
Sbjct: 160 LAPEVLLGKGYGKAV----DWWSLGVLLYEMLTGKPP-------FYAEDRKEI-YEKILK 207
Query: 875 HRLPTPSRDVTDKLRSIMEVAILCLVENPEAR 906
L P ++ + R ++ L ++P R
Sbjct: 208 DPLRFPE-FLSPEARDLISG---LLQKDPTKR 235
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 2e-17
Identities = 71/267 (26%), Positives = 113/267 (42%), Gaps = 32/267 (11%)
Query: 654 IGKGGQRSVYKA-ELPSGNIFAVKKFKAELFSDETANPSEFLN-EVLALTEIRHRNIIKF 711
+G G SVY+ L G+ FAVK+ + L E+ L++++H NI+++
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 712 HGFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIP 771
G + +I E + GSL +L+ + E + + L YLH
Sbjct: 68 LGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPE---PVIRLYTRQILLGLEYLHDR--- 121
Query: 772 PIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGTVGYAAPELAYTMRATE 831
VHRDI N+L+D+ ++DFG AK + S F G+ + APE+ +
Sbjct: 122 NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFA-KSFKGSPYWMAPEV---IAQQG 177
Query: 832 KY----DVYSFGVLALEVIKG---YHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRDV 884
Y D++S G LE+ G + + V+ +F I E+ I DH S +
Sbjct: 178 GYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVF-KIGRS-KELPPIPDHL----SDEA 231
Query: 885 TDKLRSIMEVAILCLVENPEARPTMKE 911
D + CL +P RPT E
Sbjct: 232 KDFIL-------KCLQRDPSLRPTAAE 251
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 82.7 bits (204), Expect = 2e-17
Identities = 64/193 (33%), Positives = 93/193 (48%), Gaps = 15/193 (7%)
Query: 654 IGKGGQRSVYKAELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHG 713
IGKG V + GN AVK K +D TA FL E +T++RH N+++ G
Sbjct: 14 IGKGEFGDVMLGDY-RGNKVAVKCIK----NDATAQA--FLAEASVMTQLRHSNLVQLLG 66
Query: 714 FCSNAQHS-FIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPP 772
+ +IV EY+A+GSL LR + + + V A+ YL +
Sbjct: 67 VIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV-LGGDCLLKFSLDVCEAMEYLEAN---N 122
Query: 773 IVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGTVGYAAPELAYTMRATEK 832
VHRD++++NVL+ + A VSDFG K SS V + APE + + K
Sbjct: 123 FVHRDLAARNVLVSEDNVAKVSDFGLTK---EASSTQDTGKLPVKWTAPEALREKKFSTK 179
Query: 833 YDVYSFGVLALEV 845
DV+SFG+L E+
Sbjct: 180 SDVWSFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 3e-17
Identities = 63/247 (25%), Positives = 120/247 (48%), Gaps = 27/247 (10%)
Query: 674 AVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFIVCEYLARGSL 733
A+K K + +P FL E + +++H +++ + + + +I+ EY+ GSL
Sbjct: 34 AIKSLK-----QGSMSPEAFLAEANLMKQLQHPRLVRLYAVVTQ-EPIYIITEYMENGSL 87
Query: 734 TTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHV 793
L+ K + N+ +++ +A ++++ +HRD+ + N+L+ +
Sbjct: 88 VDFLKTPEGIK-LTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKI 143
Query: 794 SDFGFAKFLEPHSSNWTEFAG-TVGYAAPELAYTMRATEKYDVYSFGVLALEVIK-GYHP 851
+DFG A+ +E + E A + + APE T K DV+SFG+L E++ G P
Sbjct: 144 ADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIP 203
Query: 852 GDFVSTIFSSISNMIIEVNQILD--HRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTM 909
+ ++N EV Q L+ +R+P P + ++L +M LC E PE RPT
Sbjct: 204 -------YPGMTNP--EVIQNLERGYRMPRPD-NCPEELYELM---RLCWKEKPEERPTF 250
Query: 910 KEVCNLL 916
+ + ++L
Sbjct: 251 EYLRSVL 257
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 81.9 bits (203), Expect = 4e-17
Identities = 72/277 (25%), Positives = 118/277 (42%), Gaps = 44/277 (15%)
Query: 654 IGKGGQRSVYKAELPS-GNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFH 712
I KG V+ A+ S G+I+A+K K + + L E L++ + ++K
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQV-DQVLTERDILSQAQSPYVVKL- 58
Query: 713 GFCS--NAQHSFIVCEYLARGSLTTILR-----DDAAAKEFSWNQRMNVIKGVANALSYL 765
+ S ++ ++V EYL G L ++L D+ A+ I + AL YL
Sbjct: 59 -YYSFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVAR--------IYIAEIVLALEYL 109
Query: 766 HHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKF--------LEPHSSNWTEFAGTVG 817
H + I+HRD+ N+L+DS ++DFG +K L GT
Sbjct: 110 HSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPD 166
Query: 818 YAAPELAYTMRATEKYDVYSFGVLALEVIKGYHP--GDFVSTIFSSISNMIIEVNQILDH 875
Y APE+ ++ D +S G + E + G P G+ IF +I N IE + ++
Sbjct: 167 YIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPEDVE- 225
Query: 876 RLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEV 912
+ + D+ KL LV +PE R K +
Sbjct: 226 -VSDEAIDLISKL----------LVPDPEKRLGAKSI 251
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 4e-17
Identities = 73/270 (27%), Positives = 118/270 (43%), Gaps = 37/270 (13%)
Query: 654 IGKGGQRSVYKA-ELPSGNIFAVKKF------KAELFSDETANPSEFLNEVLALTEIRHR 706
IG+G V A + +G AVKK + EL NEV+ + + +H
Sbjct: 27 IGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELL----------FNEVVIMRDYQHP 76
Query: 707 NIIKFHGFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLH 766
NI++ + ++V E+L G+LT I+ +E Q V V ALS+LH
Sbjct: 77 NIVEMYSSYLVGDELWVVMEFLEGGALTDIVTHTRMNEE----QIATVCLAVLKALSFLH 132
Query: 767 HDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGTVGYAAPELAYT 826
++HRDI S ++LL S+ +SDFGF + GT + APE+
Sbjct: 133 AQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVISR 189
Query: 827 MRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPT--PSRDV 884
+ + D++S G++ +E++ G P F ++ I D+ P V
Sbjct: 190 LPYGTEVDIWSLGIMVIEMVDG-EPPYFNEPPLQAMKR-------IRDNLPPKLKNLHKV 241
Query: 885 TDKLRSIMEVAILCLVENPEARPTMKEVCN 914
+ +LRS ++ LV +P R T E+ N
Sbjct: 242 SPRLRSFLD---RMLVRDPAQRATAAELLN 268
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 81.3 bits (201), Expect = 6e-17
Identities = 65/265 (24%), Positives = 112/265 (42%), Gaps = 28/265 (10%)
Query: 654 IGKGGQRSVYKAE-LPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFH 712
+GKG SVYK + L +A+K+ S + +NE+ L + H NII +
Sbjct: 8 LGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQ--KEREDAVNEIRILASVNHPNIISYK 65
Query: 713 GFCSNAQHSFIVCEYLARGSLTTILRDDAAAK-----EFSWNQRMNVIKGVANALSYLHH 767
+ IV EY G L+ + + + W + +++G L LH
Sbjct: 66 EAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRG----LQALHE 121
Query: 768 DCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGTVGYAAPELAYTM 827
I+HRD+ S N+LL + + D G +K L+ + + T+ GT Y APE+
Sbjct: 122 Q---KILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAK-TQI-GTPHYMAPEVWKGR 176
Query: 828 RATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRDVTDK 887
+ K D++S G L E+ P F + + + P S+D+ +
Sbjct: 177 PYSYKSDIWSLGCLLYEMATFAPP--FEARSMQDLRYKVQRGK--YPPIPPIYSQDLQNF 232
Query: 888 LRSIMEVAILCLVENPEARPTMKEV 912
+RS+++V P+ RP ++
Sbjct: 233 IRSMLQV-------KPKLRPNCDKI 250
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.8 bits (200), Expect = 9e-17
Identities = 69/269 (25%), Positives = 114/269 (42%), Gaps = 34/269 (12%)
Query: 654 IGKGGQRSVYKA-ELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFH 712
IG G VYKA ++ +G + A+K K E + E+ L E RH NI+ +
Sbjct: 11 IGSGTYGDVYKARDIATGELVAIKVIKLE----PGDDFEIIQQEISMLKECRHPNIVAYF 66
Query: 713 GFCSNAQHSFIVCEYLARGSLTTI---LRDDAAAKEFSWNQRMNVIKGVANALSYLHHDC 769
G +IV EY GSL I R + + ++ R +KG L+YLH
Sbjct: 67 GSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCR-ETLKG----LAYLHET- 120
Query: 770 IPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGTVGYAAPELA---YT 826
+HRDI N+LL + + ++DFG + L + F GT + APE+A
Sbjct: 121 --GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVAAVERK 178
Query: 827 MRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNM----IIEVNQILDHRLPTPSR 882
K D+++ G+ A+E+ + P + M +I + +L +
Sbjct: 179 GGYDGKCDIWALGITAIELAELQPP-------MFDLHPMRALFLISKSNFPPPKLKDKEK 231
Query: 883 DVTDKLRSIMEVAILCLVENPEARPTMKE 911
+ ++ CL ++P+ RPT +
Sbjct: 232 -WSPVFHDFIKK---CLTKDPKKRPTATK 256
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 9e-17
Identities = 71/260 (27%), Positives = 115/260 (44%), Gaps = 22/260 (8%)
Query: 654 IGKGGQRSVYKA-ELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFH 712
IGKG VYK + + + A+K E DE + + E+ L++ I +++
Sbjct: 12 IGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQ---EITVLSQCDSPYITRYY 68
Query: 713 GFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPP 772
G +I+ EYL GS +L+ + + ++KG L YLH +
Sbjct: 69 GSYLKGTKLWIIMEYLGGGSALDLLKPGPLEETYIATILREILKG----LDYLHSE---R 121
Query: 773 IVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGTVGYAAPELAYTMRATEK 832
+HRDI + NVLL + + ++DFG A L F GT + APE+ K
Sbjct: 122 KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFK 181
Query: 833 YDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRDVTDKLRSIM 892
D++S G+ A+E+ KG P S + M + + I + PT + + +
Sbjct: 182 ADIWSLGITAIELAKGEPP-------NSDLHPMRV-LFLIPKNSPPTLEGQYSKPFKEFV 233
Query: 893 EVAILCLVENPEARPTMKEV 912
E CL ++P RPT KE+
Sbjct: 234 EA---CLNKDPRFRPTAKEL 250
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 80.8 bits (200), Expect = 1e-16
Identities = 68/260 (26%), Positives = 109/260 (41%), Gaps = 26/260 (10%)
Query: 652 YCIGKGGQRSVYKAEL-PSGNIFAVKKFKAE--LFSDETANPSEFLNEVLALTEIRHRNI 708
IGKG V + + +FA+K + + N LNE L E+ H +
Sbjct: 6 RVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRN---VLNERRILQELNHPFL 62
Query: 709 IKFH-GFCSNAQHSFIVCEYLARGSLT-TILRDDAAAKEFSWNQRMNVIKGVANALSYLH 766
+ F ++ ++V + L G L + + +FS Q I + AL YLH
Sbjct: 63 VNLWYSFQDE-ENMYLVVDLLLGGDLRYHLSQ----KVKFSEEQVKFWICEIVLALEYLH 117
Query: 767 HDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGTVGYAAPELAYT 826
I+HRDI N+LLD + H++DF A + P + T +GT GY APE+
Sbjct: 118 SK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTP-DTLTTSTSGTPGYMAPEVLCR 173
Query: 827 MRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRDVTD 886
+ D +S GV A E ++G P S +I + I + + P+ T+
Sbjct: 174 QGYSVAVDWWSLGVTAYECLRGKRPYRGHS---RTIRDQI--RAKQETADVLYPATWSTE 228
Query: 887 KLRSIMEVAILCLVENPEAR 906
+ +I L +P+ R
Sbjct: 229 AIDAIN----KLLERDPQKR 244
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.9 bits (200), Expect = 1e-16
Identities = 66/271 (24%), Positives = 125/271 (46%), Gaps = 36/271 (13%)
Query: 654 IGKGGQRSVYKAELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHG 713
+G G VYKA+ +FA K ++ S+E +F+ E+ L+E +H NI+ +
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAK-IIQIESEE--ELEDFMVEIDILSECKHPNIVGLYE 69
Query: 714 FCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPI 773
+I+ E+ G+L +I+ + + Q V + + AL++LH +
Sbjct: 70 AYFYENKLWILIEFCDGGALDSIM--LELERGLTEPQIRYVCRQMLEALNFLHSH---KV 124
Query: 774 VHRDISSKNVLLDSEYEAHVSDFGF----AKFLEPHSSNWTEFAGTVGYAAPELAY--TM 827
+HRD+ + N+LL + + ++DFG L+ + F GT + APE+ T
Sbjct: 125 IHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDT----FIGTPYWMAPEVVACETF 180
Query: 828 RATE---KYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTP---S 881
+ K D++S G+ +E+ + P ++ + +++++ + L P S
Sbjct: 181 KDNPYDYKADIWSLGITLIELAQMEPPHHELNPM-----RVLLKILKSEPPTLDQPSKWS 235
Query: 882 RDVTDKLRSIMEVAILCLVENPEARPTMKEV 912
D L+S CLV++P+ RPT E+
Sbjct: 236 SSFNDFLKS-------CLVKDPDDRPTAAEL 259
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 80.1 bits (198), Expect = 1e-16
Identities = 73/274 (26%), Positives = 112/274 (40%), Gaps = 40/274 (14%)
Query: 654 IGKGGQRSVYKAEL--PSGNIF--AVKKFKAELFSDETANPSEFLNEVLALTEIRHRNII 709
+G G V + E G + AVK K++ SD +FL E + + H N+I
Sbjct: 3 LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSD---IMDDFLKEAAIMHSLDHENLI 59
Query: 710 KFHGFCSNAQHSF-IVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHD 768
+ +G H +V E GSL LR DA F + + +AN + YL
Sbjct: 60 RLYGVV--LTHPLMMVTELAPLGSLLDRLRKDALG-HFLISTLCDYAVQIANGMRYLESK 116
Query: 769 CIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWT-EFAGTVGYA--APELAY 825
+HRD++++N+LL S+ + + DFG + L + ++ E V +A APE
Sbjct: 117 ---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLR 173
Query: 826 TMRATEKYDVYSFGVLALEVIK-GYHPGDFVSTIFSSISNMIIEVNQILD------HRLP 878
T + DV+ FGV E+ G P +S QIL RL
Sbjct: 174 TRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGS------------QILKKIDKEGERLE 221
Query: 879 TPSRDVTDKLRSIMEVAILCLVENPEARPTMKEV 912
P + ++M + C NP RPT +
Sbjct: 222 RP-EACPQDIYNVM---LQCWAHNPADRPTFAAL 251
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 2e-16
Identities = 73/299 (24%), Positives = 122/299 (40%), Gaps = 41/299 (13%)
Query: 632 FNGKVLYEEITKATGNFGEKYCIGKGGQRSVYKAELPSGNIFAVKKFKAELFSDETANPS 691
F L E T G FGE + + K E VK + + + S
Sbjct: 2 FPRSNLQEITTLGRGEFGEVF-LAKAKGIEEEGGETL----VLVKALQK---TKDENLQS 53
Query: 692 EFLNEVLALTEIRHRNIIKFHGFCSNAQHSFIVCEYLARGSLTTILRDDAAAKE------ 745
EF E+ ++ H+N+++ G C A+ +++ EY G L LR + E
Sbjct: 54 EFRRELDMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPP 113
Query: 746 FSWNQRMNVIKGVANALSYL--HHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLE 803
S Q++ + +A + +L VHRD++++N L+ S+ E VS +K +
Sbjct: 114 LSTKQKVALCTQIALGMDHLSNAR-----FVHRDLAARNCLVSSQREVKVSLLSLSK--D 166
Query: 804 PHSSNWTEFAGT---VGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTI-- 858
++S + + + + APE + K DV+SFGVL EV F
Sbjct: 167 VYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEV--------FTQGELP 218
Query: 859 FSSISN-MIIEVNQILDHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLL 916
F +S+ ++ Q LP P +L +M C NP+ RP+ E+ + L
Sbjct: 219 FYGLSDEEVLNRLQAGKLELPVPE-GCPSRLYKLMTR---CWAVNPKDRPSFSELVSAL 273
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 2e-16
Identities = 71/260 (27%), Positives = 114/260 (43%), Gaps = 22/260 (8%)
Query: 654 IGKGGQRSVYKA-ELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFH 712
IGKG V+K + + + A+K E DE + + E+ L++ + K++
Sbjct: 12 IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQ---EITVLSQCDSPYVTKYY 68
Query: 713 GFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPP 772
G +I+ EYL GS +L + Q +++ + L YLH +
Sbjct: 69 GSYLKDTKLWIIMEYLGGGSALDLLEPGPLDE----TQIATILREILKGLDYLHSE---K 121
Query: 773 IVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGTVGYAAPELAYTMRATEK 832
+HRDI + NVLL E ++DFG A L F GT + APE+ K
Sbjct: 122 KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSK 181
Query: 833 YDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRDVTDKLRSIM 892
D++S G+ A+E+ KG P S + M + + I + PT + + L+ +
Sbjct: 182 ADIWSLGITAIELAKGEPP-------HSELHPMKV-LFLIPKNNPPTLEGNYSKPLKEFV 233
Query: 893 EVAILCLVENPEARPTMKEV 912
E CL + P RPT KE+
Sbjct: 234 EA---CLNKEPSFRPTAKEL 250
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 79.6 bits (196), Expect = 2e-16
Identities = 60/192 (31%), Positives = 97/192 (50%), Gaps = 15/192 (7%)
Query: 654 IGKGGQRSVYKAELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHG 713
IG+G +V + E +G AVK K D TA FL E +T++ H+N+++ G
Sbjct: 14 IGEGEFGAVLQGEY-TGQKVAVKNIKC----DVTAQA--FLEETAVMTKLHHKNLVRLLG 66
Query: 714 FCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPI 773
+ +IV E +++G+L LR A S Q + VA + YL +
Sbjct: 67 VILH-NGLYIVMELMSKGNLVNFLRTRGRAL-VSVIQLLQFSLDVAEGMEYLESK---KL 121
Query: 774 VHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGTVGYAAPELAYTMRATEKY 833
VHRD++++N+L+ + A VSDFG A+ + + ++ V + APE + + K
Sbjct: 122 VHRDLAARNILVSEDGVAKVSDFGLAR-VGSMGVDNSKLP--VKWTAPEALKHKKFSSKS 178
Query: 834 DVYSFGVLALEV 845
DV+S+GVL EV
Sbjct: 179 DVWSYGVLLWEV 190
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.2 bits (196), Expect = 4e-16
Identities = 73/290 (25%), Positives = 113/290 (38%), Gaps = 67/290 (23%)
Query: 654 IGKGGQRSVYKA-ELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEI-RHRNIIKF 711
IG+G VYKA +G + A+K +E E E L + H NI F
Sbjct: 14 IGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEE-----EIKEEYNILRKYSNHPNIATF 68
Query: 712 HGFCSNAQHS------FIVCEYLARGSLTTILRDDAAAKEFSWNQRMN------VIKGVA 759
+G ++V E GS+T D +R+ +++
Sbjct: 69 YGAFIKKNPPGNDDQLWLVMELCGGGSVT-----DLVKGLRKKGKRLKEEWIAYILRETL 123
Query: 760 NALSYLH-HDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGTVGY 818
L+YLH + I HRDI +N+LL E + DFG + L+ F GT +
Sbjct: 124 RGLAYLHENKVI----HRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFIGTPYW 179
Query: 819 AAPEL---------AYTMRATEKYDVYSFGVLALEVIKG------YHPGDFVSTIFSSIS 863
APE+ +Y R+ DV+S G+ A+E+ G HP + +F
Sbjct: 180 MAPEVIACDEQPDASYDARS----DVWSLGITAIELADGKPPLCDMHP---MRALF---- 228
Query: 864 NMIIEVNQILDHRLPT--PSRDVTDKLRSIMEVAILCLVENPEARPTMKE 911
+I + PT + + K + CL++N E RP M+E
Sbjct: 229 -------KIPRNPPPTLKSPENWSKKFNDFISE---CLIKNYEQRPFMEE 268
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 7e-16
Identities = 71/267 (26%), Positives = 117/267 (43%), Gaps = 31/267 (11%)
Query: 654 IGKGGQRSVYKAELPSGN-IFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFH 712
IG+G V+ L + N AVK + L D A +FL E L + H NI++
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKA---KFLQEARILKQYSHPNIVRLI 59
Query: 713 GFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPP 772
G C+ Q +IV E + G T LR + + + +++ A + YL
Sbjct: 60 GVCTQKQPIYIVMELVQGGDFLTFLRTEGP--RLKVKELIQMVENAAAGMEYLESKH--- 114
Query: 773 IVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGT----VGYAAPELAYTMR 828
+HRD++++N L+ + +SDFG ++ E + G V + APE R
Sbjct: 115 CIHRDLAARNCLVTEKNVLKISDFGMSR--EEEDGVYASTGGMKQIPVKWTAPEALNYGR 172
Query: 829 ATEKYDVYSFGVLALEVIK-GYHPGDFVSTIFSSISNMIIEVNQILDH--RLPTPSRDVT 885
+ + DV+SFG+L E G P ++++SN + + ++ RLP P
Sbjct: 173 YSSESDVWSFGILLWEAFSLGAVP-------YANLSNQ--QTREAIEQGVRLPCPE-LCP 222
Query: 886 DKLRSIMEVAILCLVENPEARPTMKEV 912
D + +ME C +P RP+ V
Sbjct: 223 DAVYRLME---RCWEYDPGQRPSFSTV 246
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 7e-16
Identities = 76/266 (28%), Positives = 128/266 (48%), Gaps = 33/266 (12%)
Query: 654 IGKGGQRSVYKA-ELPSGNIFAVKKFKAELFSDETANP--SEFLNEVLALTEIRHRNIIK 710
IG G +VY A ++ + + A+KK +S + +N + + EV L ++RH N I+
Sbjct: 23 IGHGSFGAVYFARDVRTNEVVAIKKM---SYSGKQSNEKWQDIIKEVRFLQQLRHPNTIE 79
Query: 711 FHGFCSNAQHS-FIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDC 769
+ G C +H+ ++V EY GS + IL + K + + G L+YLH
Sbjct: 80 YKG-CYLREHTAWLVMEYCL-GSASDIL--EVHKKPLQEVEIAAICHGALQGLAYLHSHE 135
Query: 770 IPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGTVGYAAPELAYTM-- 827
+HRDI + N+LL ++DFG A + P +S F GT + APE+ M
Sbjct: 136 R---IHRDIKAGNILLTEPGTVKLADFGSASLVSPANS----FVGTPYWMAPEVILAMDE 188
Query: 828 -RATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPT-PSRDVT 885
+ K DV+S G+ +E+ + P +F+ N + + I + PT S D +
Sbjct: 189 GQYDGKVDVWSLGITCIELAERKPP------LFN--MNAMSALYHIAQNDSPTLSSNDWS 240
Query: 886 DKLRSIMEVAILCLVENPEARPTMKE 911
D R+ ++ CL + P+ RP+ +E
Sbjct: 241 DYFRNFVD---SCLQKIPQDRPSSEE 263
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 8e-16
Identities = 42/103 (40%), Positives = 59/103 (57%), Gaps = 3/103 (2%)
Query: 135 CSLDNLSN---LDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSENRLSGLIPLSLSNLSSL 191
C D+ +D L L L G IP+ I L+ L ++LS N + G IP SL +++SL
Sbjct: 409 CQFDSTKGKWFIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSL 468
Query: 192 TVMSLFNNSLSGSIPPILGNLKSLSTLGLHINQLNGVIPPSIG 234
V+ L NS +GSIP LG L SL L L+ N L+G +P ++G
Sbjct: 469 EVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 8e-16
Identities = 53/222 (23%), Positives = 100/222 (45%), Gaps = 20/222 (9%)
Query: 693 FLNEVLALTEIRHRNIIKFHGFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRM 752
NEV+ + + +H+N+++ + + +++ E+L G+LT I+ +E Q
Sbjct: 65 LFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQTRLNEE----QIA 120
Query: 753 NVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEF 812
V + V AL YLH ++HRDI S ++LL + +SDFGF +
Sbjct: 121 TVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSL 177
Query: 813 AGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQI 872
GT + APE+ + D++S G++ +E++ G P F + ++ +
Sbjct: 178 VGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDG-EPPYFSDSPVQAMKRLRDSPPPK 236
Query: 873 LD--HRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEV 912
L H++ RD +++ L P+ R T +E+
Sbjct: 237 LKNAHKISPVLRDFLERM----------LTREPQERATAQEL 268
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 9e-16
Identities = 76/267 (28%), Positives = 124/267 (46%), Gaps = 33/267 (12%)
Query: 654 IGKGGQRSVYKAELPSGN-IFAVKKFKAELFSDETANP--SEFLNEVLALTEIRHRNIIK 710
IG G +VY A N + AVKK +S + N + + EV L +++H N I+
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMS---YSGKQTNEKWQDIIKEVKFLQQLKHPNTIE 85
Query: 711 FHGFCSNAQHS-FIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDC 769
+ G C +H+ ++V EY GS + +L + K + + G L+YLH
Sbjct: 86 YKG-CYLKEHTAWLVMEY-CLGSASDLL--EVHKKPLQEVEIAAITHGALQGLAYLHSHN 141
Query: 770 IPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGTVGYAAPELAYTMRA 829
+ +HRDI + N+LL + ++DFG A P +S F GT + APE+ M
Sbjct: 142 M---IHRDIKAGNILLTEPGQVKLADFGSASKSSPANS----FVGTPYWMAPEVILAMDE 194
Query: 830 TE---KYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPT-PSRDVT 885
+ K DV+S G+ +E+ + P +F+ N + + I + PT S + T
Sbjct: 195 GQYDGKVDVWSLGITCIELAERKPP------LFN--MNAMSALYHIAQNDSPTLQSNEWT 246
Query: 886 DKLRSIMEVAILCLVENPEARPTMKEV 912
D R ++ CL + P+ RP E+
Sbjct: 247 DSFRGFVD---YCLQKIPQERPASAEL 270
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 1e-15
Identities = 69/264 (26%), Positives = 112/264 (42%), Gaps = 27/264 (10%)
Query: 654 IGKGGQRSVYKAELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHG 713
+GKG V+K L AVK K +L + +FL+E L + H NI+K G
Sbjct: 3 LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKI---KFLSEARILKQYDHPNIVKLIG 59
Query: 714 FCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLH-HDCIPP 772
C+ Q +IV E + G + LR E Q + A ++YL +CI
Sbjct: 60 VCTQRQPIYIVMELVPGGDFLSFLRKK--KDELKTKQLVKFALDAAAGMAYLESKNCI-- 115
Query: 773 IVHRDISSKNVLLDSEYEAHVSDFGFAKFLEP---HSSNWTEFAGTVGYAAPELAYTMRA 829
HRD++++N L+ +SDFG ++ + SS + + + APE R
Sbjct: 116 --HRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIP--IKWTAPEALNYGRY 171
Query: 830 TEKYDVYSFGVLALEVIK-GYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRDVTDKL 888
+ + DV+S+G+L E G P + ++N +R+ P + D +
Sbjct: 172 SSESDVWSYGILLWETFSLGVCP-------YPGMTNQQAREQVEKGYRMSCPQK-CPDDV 223
Query: 889 RSIMEVAILCLVENPEARPTMKEV 912
+M+ C PE RP E+
Sbjct: 224 YKVMQ---RCWDYKPENRPKFSEL 244
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 1e-15
Identities = 81/308 (26%), Positives = 134/308 (43%), Gaps = 59/308 (19%)
Query: 640 EITKATGNFGEKYCIGKGGQRSVYKAEL--PSGN----IFAVKKFKAELFSDETANP--- 690
EI + F E+ +G+G VYK EL P+ A+K K E A P
Sbjct: 1 EIPLSAVRFLEE--LGEGAFGKVYKGELTGPNERLSATSVAIKTLK------ENAEPKVQ 52
Query: 691 SEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFIVCEYLARGSLTTIL------------- 737
EF E +++++H NI+ G C+ Q + ++ EYLA G L L
Sbjct: 53 QEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAES 112
Query: 738 RDDAAAKEFSWNQRMNVIKGVANALSYL--HHDCIPPIVHRDISSKNVLLDSEYEAHVSD 795
D+ + +++ +A + YL HH VHRD++++N L+ +SD
Sbjct: 113 GDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH-----FVHRDLAARNCLVGEGLTVKISD 167
Query: 796 FGFAKFLEPHSSNWTEFAGT----VGYAAPELAYTMRATEKYDVYSFGVLALEVIK-GYH 850
FG ++ + +S+++ V + PE + T + D++SFGV+ E+ G
Sbjct: 168 FGLSR--DIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQ 225
Query: 851 PGDFVSTIFSSISNMIIEVNQILDHR--LPTPSRDVTDKLRSIMEVAILCLVENPEARPT 908
P + SN EV +++ R LP P D ++ ++M I C E P RP
Sbjct: 226 P-------YYGFSNQ--EVIEMIRSRQLLPCPE-DCPARVYALM---IECWNEIPARRPR 272
Query: 909 MKEVCNLL 916
K++ L
Sbjct: 273 FKDIHTRL 280
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 79.6 bits (196), Expect = 1e-15
Identities = 87/248 (35%), Positives = 123/248 (49%), Gaps = 13/248 (5%)
Query: 1 MLNLGFNLLFGNIPPQIGNLSKLQYLDLGNNQLSGVIPPEIGKLN-QLRRLYLDVNQLHG 59
L+L N L NI + L+ L LDL NN ++ IPP IG L L+ L L N++
Sbjct: 97 SLDLNLNRLRSNISE-LLELTNLTSLDLDNNNITD-IPPLIGLLKSNLKELDLSDNKI-E 153
Query: 60 TIPPVIGQLSLINELVFCHNNVSGRIPSSLGNLSNLALLYLNDNSLFGSIPIVMGNLKSL 119
++P + L + L N++S +P L NLSNL L L+ N +P + L +L
Sbjct: 154 SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGN-KISDLPPEIELLSAL 211
Query: 120 STLDLSQNQLNGSIPCSLDNLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSENRLSG 179
LDLS N + + SL NL NL L L N L +P IGNL +L LDLS N++S
Sbjct: 212 EELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLE-DLPESIGNLSNLETLDLSNNQIS- 268
Query: 180 LIPLSLSNLSSLTVMSLFNNSLSGSIPPILGNLKSLSTLGLHINQLNGVIPPSIGNLSSL 239
SL +L++L + L NSLS ++P I L L L + L + S L
Sbjct: 269 -SISSLGSLTNLRELDLSGNSLSNALPLIALLLLLLELLLNLLLTL---KALELKLNSIL 324
Query: 240 RNLSLFNN 247
N ++ +N
Sbjct: 325 LNNNILSN 332
|
Length = 394 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 2e-15
Identities = 75/275 (27%), Positives = 123/275 (44%), Gaps = 38/275 (13%)
Query: 654 IGKGGQRSVYKAE-LPSGNIFAVKKFKAELFSDETANPS---EFLNEVLALTEIRHRNII 709
+G G SV K + +P+G + A K A S + L E+ + E R I+
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMAKKVVHIG------AKSSVRKQILRELQIMHECRSPYIV 66
Query: 710 KFHGFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANA----LSYL 765
F+G N + + E++ GSL I + + ++ +A A L+YL
Sbjct: 67 SFYGAFLNENNICMCMEFMDCGSLDRIYKKGGPI-------PVEILGKIAVAVVEGLTYL 119
Query: 766 ---HHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGTVGYAAPE 822
H I+HRDI N+L++S + + DFG + E +S F GT Y +PE
Sbjct: 120 YNVHR-----IMHRDIKPSNILVNSRGQIKLCDFGVSG--ELINSIADTFVGTSTYMSPE 172
Query: 823 LAYTMRATEKYDVYSFGVLALEVIKGYHPGDF--VSTIFSSISNMIIE-VNQILDHRLPT 879
+ T K DV+S G+ +E+ G P F + I++ + QI+ P
Sbjct: 173 RIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPR 232
Query: 880 -PSRDVTDKLRSIMEVAILCLVENPEARPTMKEVC 913
PS D + LR ++ CL+++P RPT +++C
Sbjct: 233 LPSSDFPEDLRDFVD---ACLLKDPTERPTPQQLC 264
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 2e-15
Identities = 71/263 (26%), Positives = 115/263 (43%), Gaps = 27/263 (10%)
Query: 654 IGKGGQRSVYKA-ELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFH 712
IG+G V A E +G AVKK + NEV+ + + H N++ +
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKMDLR----KQQRRELLFNEVVIMRDYHHENVVDMY 85
Query: 713 GFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPP 772
++V E+L G+LT I+ +E Q V V ALSYLH+
Sbjct: 86 NSYLVGDELWVVMEFLEGGALTDIVTHTRMNEE----QIATVCLSVLRALSYLHNQ---G 138
Query: 773 IVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGTVGYAAPELAYTMRATEK 832
++HRDI S ++LL S+ +SDFGF + GT + APE+ + +
Sbjct: 139 VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLPYGTE 198
Query: 833 YDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRD---VTDKLR 889
D++S G++ +E+I G P + ++ + + LP +D V+ LR
Sbjct: 199 VDIWSLGIMVIEMIDGEPP---------YFNEPPLQAMRRIRDNLPPRVKDSHKVSSVLR 249
Query: 890 SIMEVAILCLVENPEARPTMKEV 912
++ L LV P R T +E+
Sbjct: 250 GFLD---LMLVREPSQRATAQEL 269
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 2e-15
Identities = 58/228 (25%), Positives = 101/228 (44%), Gaps = 24/228 (10%)
Query: 692 EFLNEVLALTEIRHRNIIKFHGFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQR 751
E + +LA+ + H I++ G C A +V + GSL +R + +
Sbjct: 55 EITDHMLAMGSLDHAYIVRLLGICPGASLQ-LVTQLSPLGSLLDHVRQHRDS--LDPQRL 111
Query: 752 MNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSN--W 809
+N +A + YL + VHR+++++N+LL S+ ++DFG A L P +
Sbjct: 112 LNWCVQIAKGMYYLEEHRM---VHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFY 168
Query: 810 TEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIK-GYHPGDFVSTIFSSISNMIIE 868
+E + + A E R T + DV+S+GV E++ G P ++ + E
Sbjct: 169 SEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEP-------YAGMR--PHE 219
Query: 869 VNQILD--HRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914
V +L+ RL P D + V + C + + RPT KE+ N
Sbjct: 220 VPDLLEKGERLAQPQICTID----VYMVMVKCWMIDENVRPTFKELAN 263
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 2e-15
Identities = 53/170 (31%), Positives = 82/170 (48%), Gaps = 11/170 (6%)
Query: 695 NEVLALTEIRHRNIIKFHGFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNV 754
NE L E+ H II+ + + +++ EY+ G L + LR + FS + +
Sbjct: 50 NEKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLR---NSGRFSNSTGLFY 106
Query: 755 IKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAG 814
+ AL YLH IV+RD+ +N+LLD E ++DFGFAK + WT G
Sbjct: 107 ASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAK--KLRDRTWT-LCG 160
Query: 815 TVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHP--GDFVSTIFSSI 862
T Y APE+ + + D ++ G+L E++ GY P D I+ I
Sbjct: 161 TPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKI 210
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 2e-15
Identities = 74/278 (26%), Positives = 126/278 (45%), Gaps = 33/278 (11%)
Query: 654 IGKGGQRSVYKAEL--PSGNIFAVKKFK------AELFSDETANPSEFLNEVLALTE-IR 704
+G G VYK N+ A+K+ + + + + ++EV + E +R
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67
Query: 705 HRNIIKFHGFCSNAQHSFIVCEYLARGSLTTILRDDAAAKE-FSWNQRMNVIKGVANALS 763
H NI++++ +IV + + L K+ F+ + N+ + AL
Sbjct: 68 HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALR 127
Query: 764 YLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGTVGYAAPEL 823
YLH + IVHRD++ N++L + + ++DFG AK +P S T GT+ Y+ PE+
Sbjct: 128 YLHKE--KRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESK-LTSVVGTILYSCPEI 184
Query: 824 AYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRL-PTP-- 880
EK DV++FG + ++ P F ST NM+ +I++ P P
Sbjct: 185 VKNEPYGEKADVWAFGCILYQMCTLQPP--FYST------NMLSLATKIVEAVYEPLPEG 236
Query: 881 --SRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLL 916
S DVTD + S CL + EARP + +V ++
Sbjct: 237 MYSEDVTDVITS-------CLTPDAEARPDIIQVSAMI 267
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 2e-15
Identities = 71/266 (26%), Positives = 120/266 (45%), Gaps = 34/266 (12%)
Query: 669 SGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNA--QHSFIVCE 726
+G + AVK K E N S + E+ L + H NI+K+ G CS + ++ E
Sbjct: 32 TGEMVAVKTLKRE---CGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIME 88
Query: 727 YLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLD 786
Y+ GSL RD + + Q + + + ++YLH +HRD++++NVLLD
Sbjct: 89 YVPLGSL----RDYLPKHKLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLD 141
Query: 787 SEYEAHVSDFGFAKFL-EPHSSNWTEFAGT--VGYAAPELAYTMRATEKYDVYSFGVLAL 843
++ + DFG AK + E H G V + A E + + DV+SFGV
Sbjct: 142 NDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLY 201
Query: 844 EVI-----KGYHPGDFVSTIFSSISNM-IIEVNQILD--HRLPTPSRDVTDKLRSIMEVA 895
E++ K P F I M ++ + ++L+ RLP P ++ ++ +M+
Sbjct: 202 ELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERGMRLPCP-KNCPQEVYILMKN- 259
Query: 896 ILCLVENPEARPT-------MKEVCN 914
C + RPT +KE+ +
Sbjct: 260 --CWETEAKFRPTFRSLIPILKEMHH 283
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 3e-15
Identities = 76/280 (27%), Positives = 116/280 (41%), Gaps = 54/280 (19%)
Query: 654 IGKGGQRSVYKAELP-SGNIFAVKKFKAELFSDETANPS---EFLNEVLALTEIRHRNII 709
+G+G SV K L +G IFA+K NP + L E+ + I+
Sbjct: 9 LGEGAGGSVTKCRLKNTGMIFALKTITT------DPNPDLQKQILRELEINKSCKSPYIV 62
Query: 710 KFHGFCSNAQHS--FIVCEYLARGSLTTILRDDAAAKEFSWNQRMN------VIKGVANA 761
K++G + S I EY GSL +I + K R+ + + V
Sbjct: 63 KYYGAFLDESSSSIGIAMEYCEGGSLDSIYK-----KVKKRGGRIGEKVLGKIAESVLKG 117
Query: 762 LSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGTVGYAAP 821
LSYLH I+HRDI N+LL + + + DFG + E +S F GT Y AP
Sbjct: 118 LSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSG--ELVNSLAGTFTGTSFYMAP 172
Query: 822 E----LAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVST---------IFSSISNMIIE 868
E Y++ + DV+S G+ LEV + P F + S I NM
Sbjct: 173 ERIQGKPYSITS----DVWSLGLTLLEVAQNRFP--FPPEGEPPLGPIELLSYIVNM--P 224
Query: 869 VNQILDHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPT 908
++ D P +++ + ++ CL ++P RPT
Sbjct: 225 NPELKDE--PGNGIKWSEEFKDFIKQ---CLEKDPTRRPT 259
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 76.8 bits (190), Expect = 3e-15
Identities = 52/162 (32%), Positives = 79/162 (48%), Gaps = 17/162 (10%)
Query: 694 LNEVLALTEIRHRNIIKFHGFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMN 753
LNE L IRH ++ +G + + ++V EY+ G L + LR + F
Sbjct: 49 LNEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLR---KSGRFPEPVARF 105
Query: 754 VIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFA 813
V AL YLH IV+RD+ +N+LLDS+ ++DFGFAK ++ + +T
Sbjct: 106 YAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRT--YT-LC 159
Query: 814 GTVGYAAPEL----AYTMRATEKYDVYSFGVLALEVIKGYHP 851
GT Y APE+ Y D ++ G+L E++ GY P
Sbjct: 160 GTPEYLAPEIILSKGYGKAV----DWWALGILIYEMLAGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 5e-15
Identities = 41/89 (46%), Positives = 52/89 (58%)
Query: 170 LDLSENRLSGLIPLSLSNLSSLTVMSLFNNSLSGSIPPILGNLKSLSTLGLHINQLNGVI 229
L L L G IP +S L L ++L NS+ G+IPP LG++ SL L L N NG I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 230 PPSIGNLSSLRNLSLFNNRLYGFVPKEIG 258
P S+G L+SLR L+L N L G VP +G
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 5e-15
Identities = 67/289 (23%), Positives = 117/289 (40%), Gaps = 67/289 (23%)
Query: 667 LPSGNIFAVKKFKAELFSDETANPSEF---LNEVLALTEIRHRNIIKFHGFCSNAQHSFI 723
AVK K E A+ SE L+E L ++ H ++IK +G CS +
Sbjct: 27 RAGYTTVAVKMLK------ENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80
Query: 724 VCEYLARGSLTTILR--------------------DDAAAKE---------FSWNQRMNV 754
+ EY GSL + LR D + F+W
Sbjct: 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQ----- 135
Query: 755 IKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAG 814
++ + YL +VHRD++++NVL+ + +SDFG ++ + S G
Sbjct: 136 ---ISRGMQYLAE---MKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKG 189
Query: 815 --TVGYAAPELAYTMRATEKYDVYSFGVLALEVIK---GYHPGDFVSTIFSSISNMIIEV 869
V + A E + T + DV+SFGVL E++ +PG +F+ +
Sbjct: 190 RIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERLFNLLKT----- 244
Query: 870 NQILDHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLLCK 918
+R+ P + ++++ ++M + C + P+ RPT ++ L K
Sbjct: 245 ----GYRMERPE-NCSEEMYNLM---LTCWKQEPDKRPTFADISKELEK 285
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.0 bits (188), Expect = 6e-15
Identities = 51/176 (28%), Positives = 83/176 (47%), Gaps = 17/176 (9%)
Query: 653 CIGKGGQRSVYKA-ELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKF 711
+G+G VYKA + +G I A+KK + + ++E PS L E+ L E++H NI+K
Sbjct: 6 KLGEGTYGVVYKARDKKTGEIVALKKIRLD--NEEEGIPSTALREISLLKELKHPNIVKL 63
Query: 712 HGFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVA----NALSYLHH 767
+ ++V EY L L D S N+IK + L+Y H
Sbjct: 64 LDVIHTERKLYLVFEYCDM-DLKKYL--DKRPGPLS----PNLIKSIMYQLLRGLAYCHS 116
Query: 768 DCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGTVGYAAPEL 823
I +HRD+ +N+L++ + ++DFG A+ +T T+ Y APE+
Sbjct: 117 HRI---LHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVVTLWYRAPEI 169
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 6e-15
Identities = 76/281 (27%), Positives = 128/281 (45%), Gaps = 41/281 (14%)
Query: 654 IGKGGQRSVYKA-ELPSGNIFAVK-----KFKAELFSDETANPSEFLN-EVLALTEIRHR 706
IGKG VY A + +G + AVK A + + L E+ L ++ H
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68
Query: 707 NIIKFHGFCSNAQHSFIVCEYLARGSLTTILRDDAAAKE----FSWNQRMNVIKGVANAL 762
NI+++ GF + ++ I EY+ GS+ + LR +E F Q V++G L
Sbjct: 69 NIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQ---VLEG----L 121
Query: 763 SYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNW--TEFAGTVGYAA 820
+YLH I+HRD+ + N+L+D++ +SDFG +K + N G+V + A
Sbjct: 122 AYLHSK---GILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMA 178
Query: 821 PELAYTMRA--TEKYDVYSFGVLALEVIKGYHP---GDFVSTIFSSISNMIIEVNQILDH 875
PE+ ++ + K D++S G + LE+ G P + ++ +F +
Sbjct: 179 PEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGN---------KRS 229
Query: 876 RLPTPSRDVTDKLRSIMEVAIL--CLVENPEARPTMKEVCN 914
P P DV+ L + + L C NP+ RPT +E+
Sbjct: 230 APPIPP-DVSMNLSPV-ALDFLNACFTINPDNRPTARELLQ 268
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 7e-15
Identities = 61/221 (27%), Positives = 97/221 (43%), Gaps = 31/221 (14%)
Query: 646 GNFGEKYCIGKGGQRSVYKAELPSGNIFAVK---KFKAELFSDETANPSEFLNEVLALTE 702
G FGE VY+ + AV+ K S + S+FL E L +++
Sbjct: 17 GAFGE-----------VYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSK 65
Query: 703 IRHRNIIKFHGFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRM----NVIKGV 758
H+NI++ G FI+ E +A G L + LR++ E + M + V
Sbjct: 66 FNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDV 125
Query: 759 ANALSYLHHDCIPPIVHRDISSKNVLLDSEYE---AHVSDFGFAKFLEPHSSNWTEFAGT 815
A YL + +HRDI+++N LL + A ++DFG A+ + + +++ G
Sbjct: 126 AKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMAR--DIYRASYYRKGGR 180
Query: 816 ----VGYAAPELAYTMRATEKYDVYSFGVLALEVIK-GYHP 851
+ + PE T K DV+SFGVL E+ GY P
Sbjct: 181 AMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMP 221
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 7e-15
Identities = 68/270 (25%), Positives = 117/270 (43%), Gaps = 27/270 (10%)
Query: 653 CIGKGGQRSVYKA-ELPSGNIFAVKKFKAELFSDETANPSEFL-NEVLALTEIRHRNIIK 710
+G+G VY ++ +G AVK+ + S ET L E+ L ++H I++
Sbjct: 9 LLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQ 68
Query: 711 FHGFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCI 770
++G + + I EY+ GS+ L+ A E + + + YLH +
Sbjct: 69 YYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTE---TVTRKYTRQILEGVEYLHSN-- 123
Query: 771 PPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEP---HSSNWTEFAGTVGYAAPELAYTM 827
IVHRDI N+L DS + DFG +K L+ + GT + +PE+
Sbjct: 124 -MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGE 182
Query: 828 RATEKYDVYSFGVLALEVIKGYHP-GDF--VSTIFSSISNMIIEVNQILDHRLPTPSRDV 884
K DV+S G +E++ P +F ++ IF + Q + +LP+ V
Sbjct: 183 GYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIAT-------QPTNPQLPS---HV 232
Query: 885 TDKLRSIMEVAILCLVENPEARPTMKEVCN 914
+ R+ + VEN + RP+ +E+
Sbjct: 233 SPDARNFLR---RTFVENAKKRPSAEELLR 259
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 8e-15
Identities = 39/92 (42%), Positives = 54/92 (58%)
Query: 119 LSTLDLSQNQLNGSIPCSLDNLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSENRLS 178
+ L L L G IP + L +L ++ L NS+ G IP +G++ SL LDLS N +
Sbjct: 420 IDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFN 479
Query: 179 GLIPLSLSNLSSLTVMSLFNNSLSGSIPPILG 210
G IP SL L+SL +++L NSLSG +P LG
Sbjct: 480 GSIPESLGQLTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 75.3 bits (185), Expect = 8e-15
Identities = 75/279 (26%), Positives = 125/279 (44%), Gaps = 34/279 (12%)
Query: 645 TGNFGEKYCIGKGGQRSVYKAELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIR 704
TG FGE + +G + K ELP A+ +A FL E L L +
Sbjct: 15 TGRFGE---LCRGCLKLPSKRELP----VAIHTLRA---GCSDKQRRGFLAEALTLGQFD 64
Query: 705 HRNIIKFHGFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSY 764
H NI++ G + IV EY++ G+L + LR + Q M ++ G+A+ + Y
Sbjct: 65 HSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEG--QLVAGQLMGMLPGLASGMKY 122
Query: 765 LHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSN-WTEFAG--TVGYAAP 821
L VH+ +++ VL++S+ +S GF + E S +T +G V +AAP
Sbjct: 123 LSE---MGYVHKGLAAHKVLVNSDLVCKIS--GFRRLQEDKSEAIYTTMSGKSPVLWAAP 177
Query: 822 ELAYTMRATEKYDVYSFGVLALEVIK-GYHPGDFVSTIFSSISNMIIEVNQILD-HRLPT 879
E + DV+SFG++ EV+ G P + +S + + + D RLP
Sbjct: 178 EAIQYHHFSSASDVWSFGIVMWEVMSYGERP-------YWDMSGQDV-IKAVEDGFRLPA 229
Query: 880 PSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLLCK 918
P R+ + L +M + C + RP ++ ++L K
Sbjct: 230 P-RNCPNLLHQLM---LDCWQKERGERPRFSQIHSILSK 264
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 8e-15
Identities = 66/278 (23%), Positives = 127/278 (45%), Gaps = 23/278 (8%)
Query: 640 EITKATGNFGEKYCIGKGGQRSVYKAELPSGNIFAVKKFKAELFSDETANPSEFLNEVLA 699
EI + + +K G+ G+ V+ A AVK K S E FL E
Sbjct: 2 EIPRESLKLEKKLGAGQFGE--VWMATYNKHTKVAVKTMKPGSMSVEA-----FLAEANV 54
Query: 700 LTEIRHRNIIKFHGFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVA 759
+ ++H ++K H + + +I+ E++A+GSL L+ D +K+ + ++ +A
Sbjct: 55 MKTLQHDKLVKLHAVVTK-EPIYIITEFMAKGSLLDFLKSDEGSKQ-PLPKLIDFSAQIA 112
Query: 760 NALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAG-TVGY 818
++++ +HRD+ + N+L+ + ++DFG A+ +E + E A + +
Sbjct: 113 EGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKW 169
Query: 819 AAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLP 878
APE T K DV+SFG+L +E++ + + +SN EV + L+
Sbjct: 170 TAPEAINFGSFTIKSDVWSFGILLMEIVT------YGRIPYPGMSNP--EVIRALERGYR 221
Query: 879 TPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLL 916
P + + + + + C PE RPT + + ++L
Sbjct: 222 MPRPENCPE--ELYNIMMRCWKNRPEERPTFEYIQSVL 257
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 75.5 bits (186), Expect = 8e-15
Identities = 66/282 (23%), Positives = 119/282 (42%), Gaps = 39/282 (13%)
Query: 654 IGKGGQRSVYK---AELPSGNIF---AVKK-FKAELFSDETANPSEFLNEVLALTEIRHR 706
+G+G VY+ + G A+K + + EFLNE + E
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERI----EFLNEASVMKEFNCH 69
Query: 707 NIIKFHGFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEF-------SWNQRMNVIKGVA 759
++++ G S Q + +V E +A+G L + LR E + + + + +A
Sbjct: 70 HVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIA 129
Query: 760 NALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGT---- 815
+ ++YL VHRD++++N ++ + + DFG + + + +++ G
Sbjct: 130 DGMAYLAAK---KFVHRDLAARNCMVAEDLTVKIGDFGMTRDI--YETDYYRKGGKGLLP 184
Query: 816 VGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEV-NQILD 874
V + APE T K DV+SFGV+ E+ + +SN EV ++D
Sbjct: 185 VRWMAPESLKDGVFTTKSDVWSFGVVLWEMAT------LAEQPYQGLSNE--EVLKFVID 236
Query: 875 HRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLL 916
+ DKL +M +C NP+ RPT E+ + L
Sbjct: 237 GGHLDLPENCPDKLLELMR---MCWQYNPKMRPTFLEIVSSL 275
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 9e-15
Identities = 41/99 (41%), Positives = 58/99 (58%), Gaps = 6/99 (6%)
Query: 64 VIGQLSLINELVFCHNNVSGRIPSSLGNLSNLALLYLNDNSLFGSIPIVMGNLKSLSTLD 123
I L L N+ + G IP+ + L +L + L+ NS+ G+IP +G++ SL LD
Sbjct: 419 FIDGLGLDNQ------GLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLD 472
Query: 124 LSQNQLNGSIPCSLDNLSNLDTLFLYKNSLSGPIPSVIG 162
LS N NGSIP SL L++L L L NSLSG +P+ +G
Sbjct: 473 LSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 9e-15
Identities = 37/89 (41%), Positives = 53/89 (59%)
Query: 26 LDLGNNQLSGVIPPEIGKLNQLRRLYLDVNQLHGTIPPVIGQLSLINELVFCHNNVSGRI 85
L L N L G IP +I KL L+ + L N + G IPP +G ++ + L +N+ +G I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 86 PSSLGNLSNLALLYLNDNSLFGSIPIVMG 114
P SLG L++L +L LN NSL G +P +G
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 1e-14
Identities = 56/199 (28%), Positives = 91/199 (45%), Gaps = 12/199 (6%)
Query: 654 IGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFH 712
IG+G V A + SG + AVKK + NEV+ + + +H N+++ +
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMDLR----KQQRRELLFNEVVIMRDYQHENVVEMY 83
Query: 713 GFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPP 772
++V E+L G+LT I+ +E Q V V ALS LH
Sbjct: 84 NSYLVGDELWVVMEFLEGGALTDIVTHTRMNEE----QIAAVCLAVLKALSVLHAQ---G 136
Query: 773 IVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGTVGYAAPELAYTMRATEK 832
++HRDI S ++LL + +SDFGF + GT + APEL + +
Sbjct: 137 VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPE 196
Query: 833 YDVYSFGVLALEVIKGYHP 851
D++S G++ +E++ G P
Sbjct: 197 VDIWSLGIMVIEMVDGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 75.9 bits (186), Expect = 1e-14
Identities = 73/266 (27%), Positives = 126/266 (47%), Gaps = 31/266 (11%)
Query: 654 IGKGGQRSVYKA-ELPSGNIFAVKKFKAELFSDETANP--SEFLNEVLALTEIRHRNIIK 710
IG G +VY A ++ + + A+KK +S + +N + + EV L I+H N I+
Sbjct: 33 IGHGSFGAVYFARDVRTNEVVAIKKMS---YSGKQSNEKWQDIIKEVKFLQRIKHPNSIE 89
Query: 711 FHGFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCI 770
+ G +++V EY GS + +L + K + + G L+YLH
Sbjct: 90 YKGCYLREHTAWLVMEY-CLGSASDLL--EVHKKPLQEVEIAAITHGALQGLAYLHSH-- 144
Query: 771 PPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGTVGYAAPELAYTMRAT 830
++HRDI + N+LL + ++DFG A P +S F GT + APE+ M
Sbjct: 145 -NMIHRDIKAGNILLTEPGQVKLADFGSASIASPANS----FVGTPYWMAPEVILAMDEG 199
Query: 831 E---KYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPT-PSRDVTD 886
+ K DV+S G+ +E+ + P +F+ N + + I + PT S + +D
Sbjct: 200 QYDGKVDVWSLGITCIELAERKPP------LFN--MNAMSALYHIAQNESPTLQSNEWSD 251
Query: 887 KLRSIMEVAILCLVENPEARPTMKEV 912
R+ ++ CL + P+ RPT +E+
Sbjct: 252 YFRNFVDS---CLQKIPQDRPTSEEL 274
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 1e-14
Identities = 71/275 (25%), Positives = 116/275 (42%), Gaps = 20/275 (7%)
Query: 645 TGNFGEKYCIGKGGQRSVYKAE-LPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEI 703
GNF + IGKG VYKA L G + A+KK + D A + L E+ L ++
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKAR-QDCLKEIDLLKQL 59
Query: 704 RHRNIIKFH-GFCSNAQHSFIVCEYLARGSLTTILRDDAAAKE-FSWNQRMNVIKGVANA 761
H N+IK+ F N + + IV E G L+ +++ K + +A
Sbjct: 60 DHPNVIKYLASFIENNELN-IVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSA 118
Query: 762 LSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGTVGYAAP 821
L ++H I+HRDI NV + + + D G +F ++ GT Y +P
Sbjct: 119 LEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSP 175
Query: 822 ELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQI--LDHRLPT 879
E + K D++S G L E+ S + N+ +I D+ P
Sbjct: 176 ERIHENGYNFKSDIWSLGCLLYEM------AALQSPFYGDKMNLYSLCKKIEKCDYP-PL 228
Query: 880 PSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914
P+ +++LR ++ C+ +PE RP + V
Sbjct: 229 PADHYSEELRDLVSR---CINPDPEKRPDISYVLQ 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 74.9 bits (184), Expect = 1e-14
Identities = 70/278 (25%), Positives = 118/278 (42%), Gaps = 42/278 (15%)
Query: 654 IGKGGQRSVYKA-ELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHR----NI 708
+GKG SVYK P+G A+K+ + EL DE+ N+++ +I H+ I
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEIRLEL--DESK-----FNQIIMELDILHKAVSPYI 61
Query: 709 IKFHGFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHD 768
+ F+G ++ EY+ GSL + A + + + V L +L +
Sbjct: 62 VDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEE 121
Query: 769 CIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGTVGYAAPE------ 822
I+HRD+ NVL++ + + DFG + L + G Y APE
Sbjct: 122 --HNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTN--IGCQSYMAPERIKSGG 177
Query: 823 ----LAYTMRATEKYDVYSFGVLALEVIKGY--HPGDFVSTIFSSISNMIIEVNQILDHR 876
YT+++ DV+S G+ LE+ G +P + + IF+ +S I+D
Sbjct: 178 PNQNPTYTVQS----DVWSLGLSILEMALGRYPYPPETYANIFAQLS-------AIVDGD 226
Query: 877 LPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914
PT +D + + CL + P RPT ++
Sbjct: 227 PPTLPSGYSDDAQDFVA---KCLNKIPNRRPTYAQLLE 261
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 1e-14
Identities = 73/282 (25%), Positives = 120/282 (42%), Gaps = 30/282 (10%)
Query: 640 EITKATGNFGEKYCIGKGGQRSVYKAELPSGNIFAVKKFKAELFSDETANPSEFLNEVLA 699
E GE+ +GKG VY A S + K E S + L+E +A
Sbjct: 2 EYEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRY----VQPLHEEIA 57
Query: 700 L-TEIRHRNIIKFHGFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGV 758
L + ++HRNI+++ G S I E + GSL+ +LR + + + K +
Sbjct: 58 LHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQI 117
Query: 759 ANALSYLHHDCIPPIVHRDISSKNVLLDSEYEA--HVSDFGFAKFLEPHSSNWTEFAGTV 816
L YLH + IVHRDI NVL+++ Y +SDFG +K L + F GT+
Sbjct: 118 LEGLKYLHDN---QIVHRDIKGDNVLVNT-YSGVVKISDFGTSKRLAGINPCTETFTGTL 173
Query: 817 GYAAPEL------AYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVN 870
Y APE+ Y A D++S G +E+ G P F+ + +V
Sbjct: 174 QYMAPEVIDKGPRGYGAPA----DIWSLGCTIVEMATGKPP--FIE--LGEPQAAMFKVG 225
Query: 871 QILDHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEV 912
H P ++ + ++ + + C +P+ R + ++
Sbjct: 226 MFKIH--PEIPESLSAEAKNFI---LRCFEPDPDKRASAHDL 262
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 2e-14
Identities = 57/220 (25%), Positives = 106/220 (48%), Gaps = 37/220 (16%)
Query: 651 KYCIGKGGQRSVYKAE----LPSGN--IFAVKKFKAELFSDETANPSEFLNEVLALTEIR 704
K+ +G+G V+ AE LP + + AVK K + E+A +F E LT ++
Sbjct: 10 KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKE---ASESAR-QDFQREAELLTVLQ 65
Query: 705 HRNIIKFHGFCSNAQHSFIVCEYLARGSLTTILR------------DDAAAKEFSWNQRM 752
H++I++F+G C+ + +V EY+ G L LR +D A + + Q +
Sbjct: 66 HQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQML 125
Query: 753 NVIKGVANALSY---LHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNW 809
+ +A+ + Y LH VHRD++++N L+ + DFG ++ + +S+++
Sbjct: 126 AIASQIASGMVYLASLH------FVHRDLATRNCLVGQGLVVKIGDFGMSR--DIYSTDY 177
Query: 810 TEFAG----TVGYAAPELAYTMRATEKYDVYSFGVLALEV 845
G + + PE + T + D++SFGV+ E+
Sbjct: 178 YRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEI 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 2e-14
Identities = 65/257 (25%), Positives = 114/257 (44%), Gaps = 25/257 (9%)
Query: 669 SGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFI--VCE 726
+G AVK K E + A+ E+ L + H NI+K+ G C+ + I + E
Sbjct: 32 TGEQVAVKSLKPESGGNHIAD---LKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIME 88
Query: 727 YLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLD 786
+L GSL L + + + Q++ + + YL VHRD++++NVL++
Sbjct: 89 FLPSGSLKEYLPRNKN--KINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVE 143
Query: 787 SEYEAHVSDFGFAKFLEPHSSNWT---EFAGTVGYAAPELAYTMRATEKYDVYSFGVLAL 843
SE++ + DFG K +E +T + V + APE + DV+SFGV
Sbjct: 144 SEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLY 203
Query: 844 EVI----KGYHP-GDFVSTIFSSISNMII-EVNQILDH--RLPTPSRDVTDKLRSIMEVA 895
E++ P F+ I + M + + ++L+ RLP P + +++ +M
Sbjct: 204 ELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEGKRLPRPP-NCPEEVYQLMRK- 261
Query: 896 ILCLVENPEARPTMKEV 912
C P R T + +
Sbjct: 262 --CWEFQPSKRTTFQNL 276
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 2e-14
Identities = 67/262 (25%), Positives = 115/262 (43%), Gaps = 43/262 (16%)
Query: 674 AVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFIVCEYLARGSL 733
AVK + E EFL E ++ H NI+K G C + +I+ E + G L
Sbjct: 30 AVKTLRKGATDQEKK---EFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELMEGGDL 86
Query: 734 TTILRDDAAAKE----FSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLL---- 785
+ LRD + + + +++ VA YL +HRD++++N L+
Sbjct: 87 LSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQ---MHFIHRDLAARNCLVSEKG 143
Query: 786 -DSEYEAHVSDFGFAKFLEPHSSNWTEFAG----TVGYAAPELAYTMRATEKYDVYSFGV 840
D++ + DFG A+ + + S++ G V + APE + T + DV+SFGV
Sbjct: 144 YDADRVVKIGDFGLARDI--YKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGV 201
Query: 841 LALEVIK-GYHPGDFVSTIFSSISNMIIEVNQILDH-----RLPTPSRDVTDKLRSIMEV 894
L E++ G P + +++N ++L H RL P + DK+ +M
Sbjct: 202 LMWEILTLGQQP-------YPALNNQ-----EVLQHVTAGGRLQKP-ENCPDKIYQLMT- 247
Query: 895 AILCLVENPEARPTMKEVCNLL 916
C ++P RPT + +L
Sbjct: 248 --NCWAQDPSERPTFDRIQEIL 267
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 74.3 bits (183), Expect = 2e-14
Identities = 72/290 (24%), Positives = 126/290 (43%), Gaps = 38/290 (13%)
Query: 646 GNFGEKY-CIGKGGQRSVYKAELPSGN-----IFAVKKFKAELFSDETANPSEFLNEVLA 699
G FGE + C G Q KA + N + AVK + + SD +FL EV
Sbjct: 16 GQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDA-SDNARE--DFLKEVKI 72
Query: 700 LTEIRHRNIIKFHGFCSNAQHSFIVCEYLARGSLTTILR--------DDAAAKEFSWNQR 751
L+ + NI + G C+ ++ EY+ G L L+ +K S++
Sbjct: 73 LSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTL 132
Query: 752 MNVIKGVANALSYL-HHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWT 810
+ + +A+ + YL + VHRD++++N L+ Y ++DFG ++ L +SS++
Sbjct: 133 LYMATQIASGMRYLESLN----FVHRDLATRNCLVGKNYTIKIADFGMSRNL--YSSDYY 186
Query: 811 EFAGT----VGYAAPELAYTMRATEKYDVYSFGVLALEVIK--GYHPGDFVSTIFSSISN 864
G + + A E + T K DV++FGV E++ P + ++ I N
Sbjct: 187 RVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTD-QQVIEN 245
Query: 865 MIIEVNQILDHR--LPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEV 912
+ + LP P + + I E+ + C + E RPT +E+
Sbjct: 246 A-GHFFRDDGRQIYLPRP----PNCPKDIYELMLECWRRDEEDRPTFREI 290
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.3 bits (181), Expect = 4e-14
Identities = 57/200 (28%), Positives = 101/200 (50%), Gaps = 13/200 (6%)
Query: 654 IGKGGQRSVYKAE-LPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFH 712
IG+G VYKA +G + A+KK + + +++ P + E+ L ++RH NI++
Sbjct: 7 IGEGTYGQVYKARNKKTGELVALKKIR--MENEKEGFPITAIREIKLLQKLRHPNIVRLK 64
Query: 713 GFC-SNAQHS-FIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCI 770
S + S ++V EY+ LT +L +F+ +Q +K + L YLH +
Sbjct: 65 EIVTSKGKGSIYMVFEYMDH-DLTGLLDS--PEVKFTESQIKCYMKQLLEGLQYLHSN-- 119
Query: 771 PPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSS-NWTEFAGTVGYAAPELAY-TMR 828
I+HRDI N+L++++ ++DFG A+ +S ++T T+ Y PEL R
Sbjct: 120 -GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELLLGATR 178
Query: 829 ATEKYDVYSFGVLALEVIKG 848
+ D++S G + E+ G
Sbjct: 179 YGPEVDMWSVGCILAELFLG 198
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 73.8 bits (181), Expect = 5e-14
Identities = 62/234 (26%), Positives = 104/234 (44%), Gaps = 40/234 (17%)
Query: 704 RHRNIIKFHGFCSNAQHSFIVCEYLARGSLTTILR-------DDA------AAKEFSWNQ 750
+H+NII G C+ +++ EY A+G+L LR D ++ S+
Sbjct: 76 KHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKD 135
Query: 751 RMNVIKGVANALSYLH-HDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNW 809
++ VA + YL CI HRD++++NVL+ + ++DFG A+ + H ++
Sbjct: 136 LVSCAYQVARGMEYLESRRCI----HRDLAARNVLVTEDNVMKIADFGLARGV--HDIDY 189
Query: 810 TEFAGT----VGYAAPELAYTMRATEKYDVYSFGVLALEVIK---GYHPGDFVSTIFSSI 862
+ V + APE + T + DV+SFG+L E+ +PG V +F +
Sbjct: 190 YKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFKLL 249
Query: 863 SNMIIEVNQILDHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLL 916
HR+ PS + T +L +M C P RPT K++ L
Sbjct: 250 RE---------GHRMDKPS-NCTHELYMLMRE---CWHAVPTQRPTFKQLVEAL 290
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 73.2 bits (180), Expect = 5e-14
Identities = 75/287 (26%), Positives = 123/287 (42%), Gaps = 50/287 (17%)
Query: 654 IGKGGQRSVYKAEL------PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEI-RHR 706
+G+G V KAE + AVK K + + S+ ++E+ + I +H+
Sbjct: 20 LGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDL---SDLVSEMEMMKMIGKHK 76
Query: 707 NIIKFHGFCSNAQHSFIVCEYLARGSLTTILRDDAAAKE-FSWNQRMNVIKG-------- 757
NII G C+ ++V EY A G+L LR E S + +
Sbjct: 77 NIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVS 136
Query: 758 ----VANALSYL-HHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNW--- 809
VA + +L CI HRD++++NVL+ ++ ++DFG A+ + H ++
Sbjct: 137 FAYQVARGMEFLASKKCI----HRDLAARNVLVTEDHVMKIADFGLAR--DIHHIDYYRK 190
Query: 810 -TEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIK---GYHPGDFVSTIFSSISNM 865
T V + APE + T + DV+SFGVL E+ +PG V +F +
Sbjct: 191 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKE- 249
Query: 866 IIEVNQILDHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEV 912
+R+ P + T +L +M C E P RPT K++
Sbjct: 250 --------GYRMEKPQ-NCTQELYHLM---RDCWHEVPSQRPTFKQL 284
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 72.6 bits (178), Expect = 6e-14
Identities = 74/287 (25%), Positives = 117/287 (40%), Gaps = 46/287 (16%)
Query: 654 IGKGGQRSVYKAELPSGNIFA---VKKFKAELFSDETANPSE---FLNEVLALTEIRHRN 707
IG G V E G A VK+ +A +A P E FL EV E+ H N
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRA------SATPDEQLLFLQEVQPYRELNHPN 56
Query: 708 IIKFHGFCSNAQHSFIVCEYLARGSLTTILRDD----AAAKEFSWNQRM--NVIKGVANA 761
+++ G C + +V E+ G L LR + A + QRM V G+
Sbjct: 57 VLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLL-W 115
Query: 762 LSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFA--KFLEPHSSNWTEFAGTVGYA 819
L +H D++ +N L ++ + D+G A ++ E + A + +
Sbjct: 116 LHQAD------FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWL 169
Query: 820 APELA-------YTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQI 872
APEL T+K +++S GV E+ + +S+ + + Q+
Sbjct: 170 APELVEIRGQDLLPKDQTKKSNIWSLGVTMWELF------TAADQPYPDLSDEQV-LKQV 222
Query: 873 L---DHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLL 916
+ D +LP P D+ R EV C ++ PE RPT +EV LL
Sbjct: 223 VREQDIKLPKPQLDLKYSDR-WYEVMQFCWLD-PETRPTAEEVHELL 267
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 6e-14
Identities = 68/273 (24%), Positives = 114/273 (41%), Gaps = 51/273 (18%)
Query: 654 IGKGGQRSVYKA-ELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFH 712
IG G +VYK P+G ++A+K + E + E+ L ++ H N++K H
Sbjct: 82 IGSGAGGTVYKVIHRPTGRLYALKVIYG---NHEDTVRRQICREIEILRDVNHPNVVKCH 138
Query: 713 GFCSNAQHSFIVCEYLARGSL--TTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCI 770
+ ++ E++ GSL T I + A +V + + + ++YLH
Sbjct: 139 DMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLA---------DVARQILSGIAYLHRR-- 187
Query: 771 PPIVHRDISSKNVLLDSEYEAHVSDFGFAKFL----EPHSSNWTEFAGTVGYAAPELAYT 826
IVHRDI N+L++S ++DFG ++ L +P +S+ GT+ Y +PE T
Sbjct: 188 -HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSS----VGTIAYMSPERINT 242
Query: 827 MRATEKY-----DVYSFGVLALEVIKGYHP------GDFVSTIFSSISNMIIEVNQILDH 875
Y D++S GV LE G P GD+ S + + I
Sbjct: 243 DLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCA-----------ICMS 291
Query: 876 RLPTPSRDVTDKLRSIMEVAILCLVENPEARPT 908
+ P + + R + CL P R +
Sbjct: 292 QPPEAPATASREFRHFIS---CCLQREPAKRWS 321
|
Length = 353 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 6e-14
Identities = 72/287 (25%), Positives = 126/287 (43%), Gaps = 44/287 (15%)
Query: 654 IGKGGQRSVYKAEL----PSGN--IFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRN 707
+G+G V+ AE P+ + + AVK K + +F E LT ++H +
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAAR----KDFQREAELLTNLQHEH 68
Query: 708 IIKFHGFCSNAQHSFIVCEYLARGSLTTILR---DDA----------AAKEFSWNQRMNV 754
I+KF+G C + +V EY+ G L LR DA A E +Q +++
Sbjct: 69 IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 128
Query: 755 IKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAG 814
+A+ + YL VHRD++++N L+ + + DFG ++ + +S+++ G
Sbjct: 129 ASQIASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMSR--DVYSTDYYRVGG 183
Query: 815 ----TVGYAAPELAYTMRATEKYDVYSFGVLALEVIK-GYHPGDFVSTIFSSISNMIIEV 869
+ + PE + T + DV+SFGV+ E+ G P F + +IE
Sbjct: 184 HTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPW------FQLSNTEVIEC 237
Query: 870 NQILDHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLL 916
I R+ R ++ IM + C P+ R +KE+ +L
Sbjct: 238 --ITQGRVLERPRVCPKEVYDIM---LGCWQREPQQRLNIKEIYKIL 279
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 73.2 bits (179), Expect = 7e-14
Identities = 70/270 (25%), Positives = 122/270 (45%), Gaps = 34/270 (12%)
Query: 654 IGKGGQRSVYKA-ELPSGNIFAVKKFKAELFSDETANPS---EFLNEVLALTEIRHRNII 709
+G G +VYK +P G VK A +ET P EF++E L + + H +++
Sbjct: 15 LGSGAFGTVYKGIWVPEGE--TVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLV 72
Query: 710 KFHGFCSNAQHSFIVCEYLARGSLTTILRD--DAAAKEFSWNQRMNVIKGVANALSYLHH 767
+ G C + +V + + G L + + D + N + + KG + YL
Sbjct: 73 RLLGVCLSPTIQ-LVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKG----MMYLEE 127
Query: 768 DCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGT--VGYAAPELAY 825
+VHRD++++NVL+ S ++DFG A+ LE + G + + A E +
Sbjct: 128 R---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIH 184
Query: 826 TMRATEKYDVYSFGVLALEVIK-GYHPGDFVSTIFSSISNMIIEVNQILD--HRLPTPSR 882
+ T + DV+S+GV E++ G P D + T E+ +L+ RLP P
Sbjct: 185 YRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPT---------REIPDLLEKGERLPQPPI 235
Query: 883 DVTDKLRSIMEVAILCLVENPEARPTMKEV 912
D + V + C + + ++RP KE+
Sbjct: 236 CTID----VYMVMVKCWMIDADSRPKFKEL 261
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 72.8 bits (179), Expect = 7e-14
Identities = 71/300 (23%), Positives = 130/300 (43%), Gaps = 49/300 (16%)
Query: 638 YEEITKATGNFGEKYCIGKGGQRSVYKA-ELPSGNIFAVKKFKAELFSDETANPSEF-LN 695
YE+++K IG+G V+K +G I A+KKF + S++ + L
Sbjct: 3 YEKLSK----------IGEGSYGVVFKCRNRETGQIVAIKKF---VESEDDPVIKKIALR 49
Query: 696 EVLALTEIRHRNIIKFHGFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVI 755
E+ L +++H N++ + +V EY L + + + + +I
Sbjct: 50 EIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYCDHTVLNEL---EKNPRGVPEHLIKKII 106
Query: 756 KGVANALSYLH-HDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAG 814
A+++ H H+CI HRD+ +N+L+ + + + DFGFA+ L ++T++
Sbjct: 107 WQTLQAVNFCHKHNCI----HRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVA 162
Query: 815 TVGYAAPELAYTMRATEKY----DVYSFGVLALEVIKG--YHPG----DFVSTIFSSISN 864
T Y APEL + +Y DV++ G + E++ G PG D + I ++ +
Sbjct: 163 TRWYRAPEL---LVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGD 219
Query: 865 MIIEVNQILDH-------RLPTPSR--DVTDKLRSIMEVAI----LCLVENPEARPTMKE 911
+I QI +P P + K +I A+ CL +P R + +E
Sbjct: 220 LIPRHQQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEE 279
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 8e-14
Identities = 71/260 (27%), Positives = 116/260 (44%), Gaps = 42/260 (16%)
Query: 674 AVKKFKAELFSDET-ANPSEFLNEVLALTEI-RHRNIIKFHGFCSNAQHSFIVCEYLARG 731
AVK K SD T + S+ ++E+ + I +H+NII G C+ +++ EY ++G
Sbjct: 54 AVKMLK----SDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKG 109
Query: 732 SLTTILR-DDAAAKEFSWNQRMNVIKG------------VANALSYL-HHDCIPPIVHRD 777
+L LR E+ +N + VA + YL CI HRD
Sbjct: 110 NLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCI----HRD 165
Query: 778 ISSKNVLLDSEYEAHVSDFGFAKFLE--PHSSNWTEFAGTVGYAAPELAYTMRATEKYDV 835
++++NVL+ + ++DFG A+ + + T V + APE + T + DV
Sbjct: 166 LAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDV 225
Query: 836 YSFGVLALEVIK---GYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRDVTDKLRSIM 892
+SFGVL E+ +PG V +F + HR+ PS + T++L +M
Sbjct: 226 WSFGVLLWEIFTLGGSPYPGVPVEELFKLLKE---------GHRMDKPS-NCTNELYMMM 275
Query: 893 EVAILCLVENPEARPTMKEV 912
C P RPT K++
Sbjct: 276 RD---CWHAVPSQRPTFKQL 292
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 73.2 bits (179), Expect = 8e-14
Identities = 69/274 (25%), Positives = 125/274 (45%), Gaps = 33/274 (12%)
Query: 654 IGKGGQRSVYKA-ELPSGNIFAVKKFKAELFSDETANP--SEFLNEVLALTEIRHRNIIK 710
IG G +VY A ++ + + A+KK +S + +N + + EV L ++RH N I+
Sbjct: 23 IGHGSFGAVYFARDVRNSEVVAIKKMS---YSGKQSNEKWQDIIKEVRFLQKLRHPNTIQ 79
Query: 711 FHGFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLH-HDC 769
+ G +++V EY GS + +L + K + V G L+YLH H+
Sbjct: 80 YRGCYLREHTAWLVMEY-CLGSASDLL--EVHKKPLQEVEIAAVTHGALQGLAYLHSHN- 135
Query: 770 IPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGTVGYAAPELAYTMRA 829
++HRD+ + N+LL + DFG A + P + F GT + APE+ M
Sbjct: 136 ---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANX----FVGTPYWMAPEVILAMDE 188
Query: 830 TE---KYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRDVTD 886
+ K DV+S G+ +E+ + P F S++ ++ + L S ++
Sbjct: 189 GQYDGKVDVWSLGITCIELAE-RKPPLFNMNAMSALYHIAQNESPALQ------SGHWSE 241
Query: 887 KLRSIMEVAILCLVENPEARPTMKEVCN--LLCK 918
R+ ++ CL + P+ RPT + + + +
Sbjct: 242 YFRNFVDS---CLQKIPQDRPTSEVLLKHRFVLR 272
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 9e-14
Identities = 72/275 (26%), Positives = 116/275 (42%), Gaps = 39/275 (14%)
Query: 654 IGKGGQRSVYKAELPSGNIFAVKKFKAELFSDETANPSEFLN---EVLALTEIRHRNIIK 710
+GKG +VY G + AVK+ + + S+ A E+ EV L ++H NI++
Sbjct: 8 LGKGAYGTVYCGLTNQGQLIAVKQVELDT-SNVLAAEKEYEKLQEEVDLLKSLKHVNIVQ 66
Query: 711 FHGFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCI 770
+ G C + I E++ GS+++IL E + + K + + ++YLH++C
Sbjct: 67 YLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCK---YTKQILDGVAYLHNNC- 122
Query: 771 PPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLE------PHSSNWTEFAGTVGYAAPELA 824
+VHRDI NV+L + DFG A+ L HS+ GT + APE+
Sbjct: 123 --VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVI 180
Query: 825 YTMRATEKYDVYSFGVLALEVIKGYHP---GDFVSTIFSSISNMIIEVNQILDHRLPTPS 881
K D++S G E+ G P D ++ +F I HR P
Sbjct: 181 NESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFY-----------IGAHRGLMPR 229
Query: 882 RDVTDKLRSIMEVAI----LCLVENPEARPTMKEV 912
S AI CL + RP+ ++
Sbjct: 230 LP-----DSFSAAAIDFVTSCLTRDQHERPSALQL 259
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 1e-13
Identities = 36/92 (39%), Positives = 51/92 (55%)
Query: 242 LSLFNNRLYGFVPKEIGYLKSLSKLEFCANHLSGVIPHSVGNLTGLVLLNMCENHLFGPI 301
L L N L GF+P +I L+ L + N + G IP S+G++T L +L++ N G I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 302 PKSLRNLTSLERVRFNQNNLYGKVYEAFGDHP 333
P+SL LTSL + N N+L G+V A G
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALGGRL 514
|
Length = 623 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 1e-13
Identities = 69/274 (25%), Positives = 119/274 (43%), Gaps = 24/274 (8%)
Query: 646 GNFGEKYCIGKGGQRSVYKAE-LPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIR 704
NF + IG+G VY+A L G A+KK + D A ++ + E+ L ++
Sbjct: 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKAR-ADCIKEIDLLKQLN 60
Query: 705 HRNIIKFHGFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRM----NVIKGVAN 760
H N+IK++ IV E G L+ +++ F +R+ V K
Sbjct: 61 HPNVIKYYASFIEDNELNIVLELADAGDLSRMIK------HFKKQKRLIPEKTVWKYFVQ 114
Query: 761 ALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGTVGYAA 820
S L H ++HRDI NV + + + D G +F ++ GT Y +
Sbjct: 115 LCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMS 174
Query: 821 PELAYTMRATEKYDVYSFGVLALEVIKGYHP--GDFVSTIFSSISNMIIEVNQILDHRLP 878
PE + K D++S G L E+ P GD + ++ ++ ++ Q D+ P
Sbjct: 175 PERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM-----NLYSLCKKIEQC-DYP-P 227
Query: 879 TPSRDVTDKLRSIMEVAILCLVENPEARPTMKEV 912
PS +++LR ++ +C+ +PE RP + V
Sbjct: 228 LPSDHYSEELRQLVN---MCINPDPEKRPDITYV 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.8 bits (177), Expect = 1e-13
Identities = 71/295 (24%), Positives = 124/295 (42%), Gaps = 54/295 (18%)
Query: 653 CIGKGGQRSVYKA-ELPSGNIFAVKKFKAELFS-DETANPSEFLNEVLALTEI-RHRNII 709
+G G SVY A +G + A+KK K + +S +E N L EV +L ++ H NI+
Sbjct: 6 QLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMN----LREVKSLRKLNEHPNIV 61
Query: 710 KFHGFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDC 769
K + V EY+ G+L +++D K FS + ++I + L+++H
Sbjct: 62 KLKEVFRENDELYFVFEYM-EGNLYQLMKDRKG-KPFSESVIRSIIYQILQGLAHIHKH- 118
Query: 770 IPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSN-WTEFAGTVGYAAPELAYTMR 828
HRD+ +N+L+ ++DFG A+ E S +T++ T Y APE+ +R
Sbjct: 119 --GFFHRDLKPENLLVSGPEVVKIADFGLAR--EIRSRPPYTDYVSTRWYRAPEI--LLR 172
Query: 829 ATEKY----DVYSFGVLALEVI--KGYHPG----DFVSTIFS------------------ 860
+T Y D+++ G + E+ + PG D + I S
Sbjct: 173 ST-SYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLAS 231
Query: 861 SISNMIIEVNQI-LDHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914
+ + L +P S + D ++ L +P+ RPT +
Sbjct: 232 KLGFRFPQFAPTSLHQLIPNASPEAIDLIKD-------MLRWDPKKRPTASQALQ 279
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 2e-13
Identities = 66/215 (30%), Positives = 96/215 (44%), Gaps = 15/215 (6%)
Query: 654 IGKGGQRSVYKAELP-SGNIFAVKKFKAEL-FSDETANPSEFLNEVLALTEIRHRNIIKF 711
+GKG V AEL G FAVK K ++ D+ + VLAL N
Sbjct: 3 LGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALA---WENPFLT 59
Query: 712 HGFCS--NAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDC 769
H +C+ +H F V E+L G L ++D F + + L +LH
Sbjct: 60 HLYCTFQTKEHLFFVMEFLNGGDLMFHIQDKG---RFDLYRATFYAAEIVCGLQFLHSK- 115
Query: 770 IPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGTVGYAAPELAYTMRA 829
I++RD+ NV+LD + ++DFG K + + F GT Y APE+ ++
Sbjct: 116 --GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQGLKY 173
Query: 830 TEKYDVYSFGVLALEVIKGYHP--GDFVSTIFSSI 862
T D +SFGVL E++ G P GD +F SI
Sbjct: 174 TFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESI 208
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 3e-13
Identities = 79/244 (32%), Positives = 113/244 (46%), Gaps = 11/244 (4%)
Query: 304 SLRNLTSLERVRFNQNNLYGKVYEAFGDHPNLTFLDLSQNNFYCEISFNWRNFSKLGTFN 363
SL L SL+ + + + E + L LDL+ N I + L + +
Sbjct: 65 SLSRLLSLDLLSPSGISSLDGS-ENLLNLLPLPSLDLNLNRLRSNI-SELLELTNLTSLD 122
Query: 364 ASMNNIYGSIPPEIGDS-SKLQVLDLSSNHIFGKIPVQLVKLFSLNKLILSLNQLFGGVP 422
NN IPP IG S L+ LDLS N I +P L L +L L LS N L
Sbjct: 123 -LDNNNITDIPPLIGLLKSNLKELDLSDNKI-ESLPSPLRNLPNLKNLDLSFNDLSDLPK 180
Query: 423 LEFGTLTELQYLDLSANKLSSSIPMSIGNLLKLHYLNLSNNQFSHKIPTEFEKLIHLSEL 482
L L+ L LDLS NK+S +P I L L L+LSNN ++ + L +LS L
Sbjct: 181 LLSN-LSNLNNLDLSGNKISD-LPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGL 237
Query: 483 DLSHNILQEEIPPQICKMESLEKLNLSHNNLSDFIPRCFEEMRSLSWIDISYNELQGPIP 542
+LS+N E++P I + +LE L+LS+N +S + +L +D+S N L +P
Sbjct: 238 ELSNN-KLEDLPESIGNLSNLETLDLSNNQISSI--SSLGSLTNLRELDLSGNSLSNALP 294
Query: 543 NSTA 546
Sbjct: 295 LIAL 298
|
Length = 394 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 3e-13
Identities = 69/273 (25%), Positives = 112/273 (41%), Gaps = 53/273 (19%)
Query: 669 SGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNA--QHSFIVCE 726
+G + AVKK L + +F E+ L ++H NI+K+ G C +A ++ +V E
Sbjct: 32 TGEVVAVKK----LQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVME 87
Query: 727 YLARGSLTTILR------DDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISS 780
YL GSL L+ D ++ + KG + YL VHRD+++
Sbjct: 88 YLPYGSLRDYLQKHRERLDHRKLLLYASQ----ICKG----MEYLG---SKRYVHRDLAT 136
Query: 781 KNVLLDSEYEAHVSDFGFAKFL----------EPHSSNWTEFAGTVGYAAPELAYTMRAT 830
+N+L++SE + DFG K L EP S + + APE + +
Sbjct: 137 RNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGES-------PIFWYAPESLTESKFS 189
Query: 831 EKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDH---------RLPTPS 881
DV+SFGV+ E+ F + + I+ H RLP P
Sbjct: 190 VASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLKNNGRLPAPP 249
Query: 882 RDVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914
++ +IM+ C +P RP+ E+
Sbjct: 250 -GCPAEIYAIMK---ECWNNDPSQRPSFSELAL 278
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 4e-13
Identities = 54/212 (25%), Positives = 99/212 (46%), Gaps = 13/212 (6%)
Query: 647 NFGEKYCIGKGGQRSVYKAE-LPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRH 705
NF + IG+G VYKA +G + A+KK + L ++ PS + E+ L E+ H
Sbjct: 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR--LDTETEGVPSTAIREISLLKELNH 58
Query: 706 RNIIKFHGFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYL 765
NI+K ++V E+L + L + D + + + + L++
Sbjct: 59 PNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFM-DASPLSGIPLPLIKSYLFQLLQGLAFC 116
Query: 766 H-HDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGTVGYAAPELA 824
H H ++HRD+ +N+L+++E ++DFG A+ +T T+ Y APE+
Sbjct: 117 HSHR----VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEIL 172
Query: 825 YTMR-ATEKYDVYSFGVLALEVI--KGYHPGD 853
+ + D++S G + E++ + PGD
Sbjct: 173 LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 5e-13
Identities = 61/217 (28%), Positives = 88/217 (40%), Gaps = 12/217 (5%)
Query: 654 IGKGGQRSVYKAEL-PSGNIFAVKKFKAE--LFSDETANPSEFLNEVLALTEIRHRNIIK 710
+G+G V AE +G ++A+K K + DE + RH ++
Sbjct: 7 LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVN 66
Query: 711 FHGFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCI 770
H V EY A G L + D FS + + V L YLH +
Sbjct: 67 LFACFQTEDHVCFVMEYAAGGDLMMHIHTDV----FSEPRAVFYAACVVLGLQYLHEN-- 120
Query: 771 PPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGTVGYAAPELAYTMRAT 830
IV+RD+ N+LLD+E ++DFG K + F GT + APE+ T
Sbjct: 121 -KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEVLTETSYT 179
Query: 831 EKYDVYSFGVLALEVIKGYHP--GDFVSTIFSSISNM 865
D + GVL E++ G P GD +F SI N
Sbjct: 180 RAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVND 216
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 6e-13
Identities = 72/241 (29%), Positives = 113/241 (46%), Gaps = 35/241 (14%)
Query: 2 LNLGFNLLFGNIPPQIGNLSKLQYLDLGNNQLSGVIPPEIGKLNQLRRLYLDVNQLHGTI 61
L+L N + ++P + NL L+ LDL N LS +P + L+ L L L N++
Sbjct: 145 LDLSDNKI-ESLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS--- 199
Query: 62 PPVIGQLSLINELVFCHNNVSGRIPSSLGNLSNLALLYLNDNSLFGSIPIVMGNLKSLST 121
+P + LS L L L++NS+ + + NLK+LS
Sbjct: 200 ----------------------DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSG 236
Query: 122 LDLSQNQLNGSIPCSLDNLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSENRLSGLI 181
L+LS N+L +P S+ NLSNL+TL L N +S S +G+L +L +LDLS N LS +
Sbjct: 237 LELSNNKLE-DLPESIGNLSNLETLDLSNNQIS--SISSLGSLTNLRELDLSGNSLSNAL 293
Query: 182 PLSLSNLSSLTVMSLFNNSLSGSIPPILGNLKSLSTLGLHINQLNGVIPPSIGNLSSLRN 241
PL L ++ +L ++ + L S+ ++ P ++ L SL N
Sbjct: 294 PLIA----LLLLLLELLLNLLLTLKALELKLNSILLNNNILSNGETSSPEALSILESLNN 349
Query: 242 L 242
L
Sbjct: 350 L 350
|
Length = 394 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 6e-13
Identities = 66/217 (30%), Positives = 95/217 (43%), Gaps = 15/217 (6%)
Query: 654 IGKGGQRSVYKAELPSGN-IFAVKKFKAE-LFSDETANPSEFLNEVLALTEIRHRNIIKF 711
+GKG V AEL N FA+K K + + D+ + VLAL +
Sbjct: 3 LGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAW---EHPFLT 59
Query: 712 HGFCS--NAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDC 769
H FC+ +H F V EYL G L ++ + F + + L +LH
Sbjct: 60 HLFCTFQTKEHLFFVMEYLNGGDLMFHIQS---SGRFDEARARFYAAEIICGLQFLHKK- 115
Query: 770 IPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGTVGYAAPELAYTMRA 829
I++RD+ NVLLD + ++DFG K + F GT Y APE+ +
Sbjct: 116 --GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQKY 173
Query: 830 TEKYDVYSFGVLALEVIKGYHP--GDFVSTIFSSISN 864
E D +SFGVL E++ G P G+ +F SI N
Sbjct: 174 NESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILN 210
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 6e-13
Identities = 61/242 (25%), Positives = 108/242 (44%), Gaps = 37/242 (15%)
Query: 691 SEFLNEVLALTEI-RHRNIIKFHGFCSNAQHSFIVCEYLARGSLTTILR----------- 738
S+ ++E+ + I +H+NII G C+ +++ EY ++G+L LR
Sbjct: 65 SDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSY 124
Query: 739 --DDAAAKEFSWNQRMNVIKGVANALSYL-HHDCIPPIVHRDISSKNVLLDSEYEAHVSD 795
++ ++ ++ VA + YL CI HRD++++NVL+ ++D
Sbjct: 125 DIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCI----HRDLAARNVLVTENNVMKIAD 180
Query: 796 FGFAKFLE--PHSSNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIK---GYH 850
FG A+ + + T V + APE + T + DV+SFGVL E+ +
Sbjct: 181 FGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY 240
Query: 851 PGDFVSTIFSSISNMIIEVNQILDHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMK 910
PG V +F + HR+ P+ + T++L +M C P RPT K
Sbjct: 241 PGIPVEELFKLLKE---------GHRMDKPA-NCTNELYMMMRD---CWHAIPSHRPTFK 287
Query: 911 EV 912
++
Sbjct: 288 QL 289
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 70.3 bits (173), Expect = 6e-13
Identities = 71/292 (24%), Positives = 113/292 (38%), Gaps = 55/292 (18%)
Query: 654 IGKGGQRSVYKAE-LPSGNIFAVKKFKAELFS--DETANPSEFLNEVLALTEIRHRNIIK 710
+G+G VYKA +G I A+KK K + N + L E+ L E++H NII
Sbjct: 8 LGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTA-LREIKLLQELKHPNIIG 66
Query: 711 FHGFCSNAQHSFIVCEYLARGSLTTILRDD----AAAKEFSWNQRMNVIKGVANALSYLH 766
+ + +V E++ L +++D A S+ L YLH
Sbjct: 67 LLDVFGHKSNINLVFEFME-TDLEKVIKDKSIVLTPADIKSYMLMT------LRGLEYLH 119
Query: 767 HDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGTVGYAAPELAYT 826
+ I +HRD+ N+L+ S+ ++DFG A+ + T T Y APEL +
Sbjct: 120 SNWI---LHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVVTRWYRAPELLF- 175
Query: 827 MRATEKY----DVYSFGVLALEVIKG--YHPG----DFVSTIFSSIS------------- 863
Y D++S G + E++ + PG D + IF ++
Sbjct: 176 --GARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSL 233
Query: 864 NMIIEVNQI----LDHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKE 911
+E L P S D D L+ L NP R T ++
Sbjct: 234 PDYVEFKPFPPTPLKQIFPAASDDALDLLQR-------LLTLNPNKRITARQ 278
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 7e-13
Identities = 34/89 (38%), Positives = 50/89 (56%)
Query: 194 MSLFNNSLSGSIPPILGNLKSLSTLGLHINQLNGVIPPSIGNLSSLRNLSLFNNRLYGFV 253
+ L N L G IP + L+ L ++ L N + G IPPS+G+++SL L L N G +
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 254 PKEIGYLKSLSKLEFCANHLSGVIPHSVG 282
P+ +G L SL L N LSG +P ++G
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 7e-13
Identities = 36/88 (40%), Positives = 56/88 (63%)
Query: 98 LYLNDNSLFGSIPIVMGNLKSLSTLDLSQNQLNGSIPCSLDNLSNLDTLFLYKNSLSGPI 157
L L++ L G IP + L+ L +++LS N + G+IP SL ++++L+ L L NS +G I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 158 PSVIGNLKSLLQLDLSENRLSGLIPLSL 185
P +G L SL L+L+ N LSG +P +L
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAAL 510
|
Length = 623 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 7e-13
Identities = 73/265 (27%), Positives = 107/265 (40%), Gaps = 41/265 (15%)
Query: 654 IGKGGQRSVYKAELPSGN-IFAVKKFKAELF--SDETANPSEFLNE--VLALTEIRHRNI 708
+GKG V AEL + ++AVK K ++ D+ + E VLAL +H +
Sbjct: 3 LGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECT---MTEKRVLALAG-KHPFL 58
Query: 709 IKFHGFCSNAQHSFIVCEYLARGSLT-TILRDDAAAKEFSWNQRMNVIKGVANALSYLH- 766
+ H F V EY+ G L I R F + + L +LH
Sbjct: 59 TQLHSCFQTKDRLFFVMEYVNGGDLMFHIQRS----GRFDEPRARFYAAEIVLGLQFLHE 114
Query: 767 HDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGTVGYAAPELAYT 826
I++RD+ NVLLDSE ++DFG K + F GT Y APE+
Sbjct: 115 RG----IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILSY 170
Query: 827 MRATEKYDVYSFGVLALEVIKGYHP--GDFVSTIFSSISNMIIEVNQILDHRLPTP---S 881
D ++ GVL E++ G P GD +F S IL+ + P S
Sbjct: 171 QPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQS----------ILEDEVRYPRWLS 220
Query: 882 RDVTDKLRSIMEVAILCLVENPEAR 906
++ L+S + +NPE R
Sbjct: 221 KEAKSILKSFL-------TKNPEKR 238
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 7e-13
Identities = 70/268 (26%), Positives = 117/268 (43%), Gaps = 25/268 (9%)
Query: 652 YC----IGKG--GQRSVYKAELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRH 705
YC +GKG G+ S+ + G + +KK S +E E L++++H
Sbjct: 2 YCFVRVVGKGSYGEVSLVRHR-TDGKQYVIKKLNLRNASRRERKAAE--QEAQLLSQLKH 58
Query: 706 RNIIKF-HGFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSY 764
NI+ + + +IV + G L L++ K NQ + +A AL Y
Sbjct: 59 PNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKG-KLLPENQVVEWFVQIAMALQY 117
Query: 765 LHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGTVGYAAPELA 824
LH I+HRD+ ++NV L V D G A+ LE + GT Y +PEL
Sbjct: 118 LHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPELF 174
Query: 825 YTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRDV 884
K DV++ G E+ H F + +S+ V +I++ +LP +D
Sbjct: 175 SNKPYNYKSDVWALGCCVYEMATLKHA--FNAKDMNSL------VYRIIEGKLPPMPKDY 226
Query: 885 TDKLRSIMEVAILCLVENPEARPTMKEV 912
+ +L ++ +L + PE RP++K +
Sbjct: 227 SPELGELIA-TMLS--KRPEKRPSVKSI 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 69.6 bits (171), Expect = 7e-13
Identities = 60/204 (29%), Positives = 99/204 (48%), Gaps = 23/204 (11%)
Query: 654 IGKGGQRSVYKA-ELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFH 712
IG+G V+KA + +G A+KK L E P++ L E+ AL +H ++K
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKK--VALRRLEGGIPNQALREIKALQACQHPYVVKLL 65
Query: 713 GFCSNAQHSFIVCEYLARGSLTTILRD------DAAAKEFSWNQRMNVIKGVANALSYLH 766
+ +V EY+ L+ +LRD +A K + RM ++KGVA Y+H
Sbjct: 66 DVFPHGSGFVLVMEYMPS-DLSEVLRDEERPLPEAQVKSYM---RM-LLKGVA----YMH 116
Query: 767 HDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAK-FLEPHSSNWTEFAGTVGYAAPELAY 825
+ I+HRD+ N+L+ ++ ++DFG A+ F E ++ T Y APEL Y
Sbjct: 117 AN---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLY 173
Query: 826 TMRA-TEKYDVYSFGVLALEVIKG 848
R D+++ G + E++ G
Sbjct: 174 GARKYDPGVDLWAVGCIFAELLNG 197
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 7e-13
Identities = 64/244 (26%), Positives = 112/244 (45%), Gaps = 41/244 (16%)
Query: 691 SEFLNEVLALTEI-RHRNIIKFHGFCSNAQHSFIVCEYLARGSLTTILRD---------- 739
S+ ++E+ + I +H+NII G C+ +++ EY ++G+L LR
Sbjct: 62 SDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSF 121
Query: 740 DAAA---KEFSWNQRMNVIKGVANALSYL-HHDCIPPIVHRDISSKNVLLDSEYEAHVSD 795
D ++ ++ ++ VA + YL CI HRD++++NVL+ + ++D
Sbjct: 122 DTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCI----HRDLAARNVLVTEDNVMKIAD 177
Query: 796 FGFAKFLEPHSSNW----TEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIK---G 848
FG A+ + H+ ++ T V + APE + T + DV+SFGVL E+
Sbjct: 178 FGLAR--DVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGS 235
Query: 849 YHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPT 908
+PG V +F + HR+ P+ + T +L IM C P RPT
Sbjct: 236 PYPGIPVEELFKLLKE---------GHRMDKPA-NCTHELYMIMRE---CWHAVPSQRPT 282
Query: 909 MKEV 912
K++
Sbjct: 283 FKQL 286
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.0 bits (172), Expect = 8e-13
Identities = 50/190 (26%), Positives = 84/190 (44%), Gaps = 19/190 (10%)
Query: 648 FGEKYCIGKGGQRSVYKA---ELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIR 704
+ + CIG+G VYKA G +A+KKFK + + S E+ L E++
Sbjct: 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSA-CREIALLRELK 60
Query: 705 HRNIIKFHG-FCSNAQHS-FIVCEYLARGSLTTILRDDAAAKEFSWNQRM--NVIKGVAN 760
H N++ F +A S +++ +Y A L I++ AK S M +++ + N
Sbjct: 61 HENVVSLVEVFLEHADKSVYLLFDY-AEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILN 119
Query: 761 ALSYLHHDCIPPIVHRDISSKNVLLDSEYEAH----VSDFGFAKFLEPHSSNWTEFAG-- 814
+ YLH + ++HRD+ N+L+ E + D G A+ +
Sbjct: 120 GVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVV 176
Query: 815 -TVGYAAPEL 823
T+ Y APEL
Sbjct: 177 VTIWYRAPEL 186
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 9e-13
Identities = 82/283 (28%), Positives = 128/283 (45%), Gaps = 10/283 (3%)
Query: 221 HINQLNGVIPPSIGNLSSLRNLSLFNNRLYGFVPKEIGYLKSLSKLEFCANHLSGVIPHS 280
+ ++P S+ L SL LS + + L L L+ N L I
Sbjct: 54 LSSNTLLLLPSSLSRLLSLDLLSPSGISSLD-GSENLLNLLPLPSLDLNLNRLRSNISEL 112
Query: 281 VGNLTGLVLLNMCENHLFGPIPKSLRNLTSLERVRFNQNNLYGKVYEAFGDHPNLTFLDL 340
+ LT L L++ N++ IP + L S + +N + + PNL LDL
Sbjct: 113 L-ELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIESLPSPLRNLPNLKNLDL 170
Query: 341 SQNNFYCEISFNWRNFSKLGTFNASMNNIYGSIPPEIGDSSKLQVLDLSSNHIFGKIPVQ 400
S N+ ++ N S L + S N I +PPEI S L+ LDLS+N I ++
Sbjct: 171 SFND-LSDLPKLLSNLSNLNNLDLSGNKI-SDLPPEIELLSALEELDLSNNSII-ELLSS 227
Query: 401 LVKLFSLNKLILSLNQLFGGVPLEFGTLTELQYLDLSANKLSSSIPMSIGNLLKLHYLNL 460
L L +L+ L LS N+L +P G L+ L+ LDLS N++SS S+G+L L L+L
Sbjct: 228 LSNLKNLSGLELSNNKLE-DLPESIGNLSNLETLDLSNNQISS--ISSLGSLTNLRELDL 284
Query: 461 SNNQFSHKIPTEFEKLIHLSELDLSHNILQEEIPPQICKMESL 503
S N S+ L+ L EL L+ + + + ++ +
Sbjct: 285 SGNSLSN-ALPLIALLLLLLELLLNLLLTLKALELKLNSILLN 326
|
Length = 394 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 69.7 bits (171), Expect = 9e-13
Identities = 58/203 (28%), Positives = 91/203 (44%), Gaps = 20/203 (9%)
Query: 654 IGKGGQRSVYKA-ELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFH 712
IG+G VY+A + SG I A+KK + + D P L E+ L +RH NI++
Sbjct: 15 IGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGI--PISSLREITLLLNLRHPNIVELK 72
Query: 713 GFC--SNAQHSFIVCEY----LARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLH 766
+ F+V EY LA L D+ FS +Q ++ + L YLH
Sbjct: 73 EVVVGKHLDSIFLVMEYCEQDLAS------LLDNMPTP-FSESQVKCLMLQLLRGLQYLH 125
Query: 767 HDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGTVGYAAPELAYT 826
+ I +HRD+ N+LL + ++DFG A+ + T T+ Y APEL
Sbjct: 126 ENFI---IHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVVTLWYRAPELLLG 182
Query: 827 MRA-TEKYDVYSFGVLALEVIKG 848
T D+++ G + E++
Sbjct: 183 CTTYTTAIDMWAVGCILAELLAH 205
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 1e-12
Identities = 37/103 (35%), Positives = 56/103 (54%), Gaps = 1/103 (0%)
Query: 386 LDLSSNHIFGKIPVQLVKLFSLNKLILSLNQLFGGVPLEFGTLTELQYLDLSANKLSSSI 445
L L + + G IP + KL L + LS N + G +P G++T L+ LDLS N + SI
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 446 PMSIGNLLKLHYLNLSNNQFSHKIPTEF-EKLIHLSELDLSHN 487
P S+G L L LNL+ N S ++P +L+H + + + N
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDN 525
|
Length = 623 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 1e-12
Identities = 75/284 (26%), Positives = 109/284 (38%), Gaps = 51/284 (17%)
Query: 651 KYCIGKGGQRSVYKA-----ELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRH 705
CIG+G VY+ E + AVK K FL E + + H
Sbjct: 11 GRCIGEGQFGDVYQGVYMSPENEKIAV-AVKTCKNCTSPSVREK---FLQEAYIMRQFDH 66
Query: 706 RNIIKFHGFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIK---GVANAL 762
+I+K G + +IV E G L + L+ ++I ++ AL
Sbjct: 67 PHIVKLIGVITE-NPVWIVMELAPLGELRSYLQ-----VNKYSLDLASLILYSYQLSTAL 120
Query: 763 SYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGTVG----- 817
+YL VHRDI+++NVL+ S + DFG +++LE S + + G
Sbjct: 121 AYLESK---RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESY----YKASKGKLPIK 173
Query: 818 YAAPELAYTMRATEKYDVYSFGVLALEVIK-GYHPGDFVSTIFSSISN----MIIEVNQI 872
+ APE R T DV+ FGV E++ G P F + N IE +
Sbjct: 174 WMAPESINFRRFTSASDVWMFGVCMWEILMLGVKP-------FQGVKNNDVIGRIENGE- 225
Query: 873 LDHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKE-VCNL 915
RLP P L S+M C +P RP E L
Sbjct: 226 ---RLPMPPNCPP-TLYSLMT---KCWAYDPSKRPRFTELKAQL 262
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 1e-12
Identities = 64/251 (25%), Positives = 109/251 (43%), Gaps = 29/251 (11%)
Query: 674 AVKKFKAELFSDETANPSEFLNEVLALTEI-RHRNIIKFHGFCSNAQHSFIVCEYLARGS 732
AVK K S E ++E+ ++ + H NI+ G C+ ++ EY G
Sbjct: 69 AVKMLKPTAHSSER---EALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGD 125
Query: 733 LTTILRDDAAAKEFSWNQRMNVIKGVANALSYL-HHDCIPPIVHRDISSKNVLLDSEYEA 791
L LR + ++ VA +++L +CI HRD++++NVLL
Sbjct: 126 LLNFLRRKRE-SFLTLEDLLSFSYQVAKGMAFLASKNCI----HRDLAARNVLLTHGKIV 180
Query: 792 HVSDFGFAKFLEPHSSNWTEFAGT---VGYAAPELAYTMRATEKYDVYSFGVLALEVIK- 847
+ DFG A+ + + SN+ V + APE + T + DV+S+G+L E+
Sbjct: 181 KICDFGLARDIM-NDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSL 239
Query: 848 --GYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRDVTDKLRSIMEVAILCLVENPEA 905
+PG V + F +I E +R+ P ++ IM+ C +P
Sbjct: 240 GSNPYPGMPVDSKF---YKLIKE-----GYRMAQPEH-APAEIYDIMKT---CWDADPLK 287
Query: 906 RPTMKEVCNLL 916
RPT K++ L+
Sbjct: 288 RPTFKQIVQLI 298
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 1e-12
Identities = 59/221 (26%), Positives = 103/221 (46%), Gaps = 19/221 (8%)
Query: 694 LNEVLALTEIRHRNIIKFHGFCSNAQHSFIVCEYLARGSL-TTILRDDAAAKEFSWNQRM 752
LNE++ L+ ++H NII ++ + I EY G+L I+R + F +
Sbjct: 47 LNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKG--QLFEEEMVL 104
Query: 753 NVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEF 812
+ + +A+SY+H I+HRDI + N+ L + DFG +K L S
Sbjct: 105 WYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETV 161
Query: 813 AGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQI 872
GT Y +PEL ++ K D+++ G + E++ + F + +N + V +I
Sbjct: 162 VGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLT-------LKRTFDA-TNPLNLVVKI 213
Query: 873 LD-HRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEV 912
+ + P S + +L S++ L ++PE RPT EV
Sbjct: 214 VQGNYTPVVSV-YSSELISLVHS---LLQQDPEKRPTADEV 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 1e-12
Identities = 61/217 (28%), Positives = 96/217 (44%), Gaps = 33/217 (15%)
Query: 646 GNFGE--KYCIGKGGQRSVYKAELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEI 703
GNFG+ + I K G + + I +K+F +E + +F E+ L ++
Sbjct: 13 GNFGQVIRAMIKKDGLKM-------NAAIKMLKEFASE------NDHRDFAGELEVLCKL 59
Query: 704 -RHRNIIKFHGFCSNAQHSFIVCEYLARGSLTTILR-------DDAAAKE------FSWN 749
H NII G C N + +I EY G+L LR D A AKE +
Sbjct: 60 GHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQ 119
Query: 750 QRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNW 809
Q + VA + YL +HRD++++NVL+ + ++DFG ++ E +
Sbjct: 120 QLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVKKT 176
Query: 810 TEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVI 846
A L Y++ T K DV+SFGVL E++
Sbjct: 177 MGRLPVRWMAIESLNYSVYTT-KSDVWSFGVLLWEIV 212
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 1e-12
Identities = 72/285 (25%), Positives = 126/285 (44%), Gaps = 43/285 (15%)
Query: 654 IGKGGQRSVYKAEL----PSGN--IFAVKKFKAELFSDETANP-SEFLNEVLALTEIRHR 706
+G+G V+ AE P + + AVK K D + N +F E LT ++H
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLK-----DASDNARKDFHREAELLTNLQHE 67
Query: 707 NIIKFHGFCSNAQHSFIVCEYLARGSLTTILR---DDAA-------AKEFSWNQRMNVIK 756
+I+KF+G C +V EY+ G L LR DA E + +Q +++ +
Sbjct: 68 HIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQ 127
Query: 757 GVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAG-- 814
+A + YL VHRD++++N L+ + DFG ++ + +S+++ G
Sbjct: 128 QIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKIGDFGMSR--DVYSTDYYRVGGHT 182
Query: 815 --TVGYAAPELAYTMRATEKYDVYSFGVLALEVIK-GYHPGDFVSTIFSSISNMIIEVNQ 871
+ + PE + T + DV+S GV+ E+ G P +S +N +IE
Sbjct: 183 MLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLS------NNEVIEC-- 234
Query: 872 ILDHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLL 916
I R+ R + + ++ + C P R +KE+ +LL
Sbjct: 235 ITQGRVLQRPRTCP---KEVYDLMLGCWQREPHMRLNIKEIHSLL 276
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 2e-12
Identities = 38/103 (36%), Positives = 54/103 (52%), Gaps = 1/103 (0%)
Query: 215 LSTLGLHINQLNGVIPPSIGNLSSLRNLSLFNNRLYGFVPKEIGYLKSLSKLEFCANHLS 274
+ LGL L G IP I L L++++L N + G +P +G + SL L+ N +
Sbjct: 420 IDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFN 479
Query: 275 GVIPHSVGNLTGLVLLNMCENHLFGPIPKSLRNLTSLERVRFN 317
G IP S+G LT L +LN+ N L G +P +L L R FN
Sbjct: 480 GSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRL-LHRASFN 521
|
Length = 623 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 2e-12
Identities = 35/89 (39%), Positives = 50/89 (56%)
Query: 2 LNLGFNLLFGNIPPQIGNLSKLQYLDLGNNQLSGVIPPEIGKLNQLRRLYLDVNQLHGTI 61
L L L G IP I L LQ ++L N + G IPP +G + L L L N +G+I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 62 PPVIGQLSLINELVFCHNNVSGRIPSSLG 90
P +GQL+ + L N++SGR+P++LG
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 2e-12
Identities = 74/273 (27%), Positives = 111/273 (40%), Gaps = 41/273 (15%)
Query: 654 IGKGGQRSVYKA-ELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFH 712
+G G VYKA L +G + AVK K E D S E+ + E +H NI+ +
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDF----SLIQQEIFMVKECKHCNIVAYF 72
Query: 713 GFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPP 772
G + + +I EY GSL I E Q V + L+YLH
Sbjct: 73 GSYLSREKLWICMEYCGGGSLQDIYHVTGPLSEL---QIAYVCRETLQGLAYLHSKGK-- 127
Query: 773 IVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGTVGYAAPELAYTMRATEK 832
+HRDI N+LL + ++DFG A + + F GT + APE+A A EK
Sbjct: 128 -MHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVA----AVEK 182
Query: 833 Y-------DVYSFGVLALEVIK------GYHPGDFVSTIFSSISNMIIEVNQILDHRLPT 879
D+++ G+ A+E+ + HP + S SN P
Sbjct: 183 NGGYNQLCDIWAVGITAIELAELQPPMFDLHP--MRALFLMSKSNF-----------QPP 229
Query: 880 PSRDVTDKLRSIMEVAILCLVENPEARPTMKEV 912
+D T + + L +NP+ RPT + +
Sbjct: 230 KLKDKTKWSSTFHNFVKISLTKNPKKRPTAERL 262
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 2e-12
Identities = 76/275 (27%), Positives = 115/275 (41%), Gaps = 41/275 (14%)
Query: 654 IGKGGQRSVYKAEL--PSGNIF--AVKKFKAELFSDETANPSEFLNEVLALTEIRHRNII 709
IGKG VY L G AVK + +FL E + + + H N++
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNR---ITDLEEVEQFLKEGIIMKDFSHPNVL 59
Query: 710 KFHGFCSNAQHS-FIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKG----VANALSY 764
G C ++ S +V Y+ G L +R + + N + + G VA + Y
Sbjct: 60 SLLGICLPSEGSPLVVLPYMKHGDLRNFIRSE------THNPTVKDLIGFGLQVAKGMEY 113
Query: 765 LHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAK------FLEPHSSNWTEFAGTVGY 818
L VHRD++++N +LD + V+DFG A+ + H N T V +
Sbjct: 114 LASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVH--NHTGAKLPVKW 168
Query: 819 AAPELAYTMRATEKYDVYSFGVLALEVI-KGYHPGDFVSTIFSSISNMIIEVNQILDHRL 877
A E T + T K DV+SFGVL E++ +G P + + + I V + RL
Sbjct: 169 MALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP-------YPDVDSFDITVYLLQGRRL 221
Query: 878 PTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEV 912
P D L +M + C PE RPT E+
Sbjct: 222 LQPEY-CPDPLYEVM---LSCWHPKPEMRPTFSEL 252
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 2e-12
Identities = 64/256 (25%), Positives = 115/256 (44%), Gaps = 19/256 (7%)
Query: 654 IGKGG-QRSVYKAELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFH 712
+G+G R++ + S +A+K+ + S + + E + L +++H NI+ F
Sbjct: 8 VGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRK---EAVLLAKMKHPNIVAFK 64
Query: 713 GFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPP 772
H +IV EY G L ++ K F + + + + ++H
Sbjct: 65 ESFEADGHLYIVMEYCDGGDLMQKIKLQRG-KLFPEDTILQWFVQMCLGVQHIHEK---R 120
Query: 773 IVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGTVGYAAPELAYTMRATEK 832
++HRDI SKN+ L + + DFG A+ L + + GT Y PE+ M K
Sbjct: 121 VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIWENMPYNNK 180
Query: 833 YDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRDVTDKLRSIM 892
D++S G + E+ HP F + +S N+I++V Q LP+ + +LRS++
Sbjct: 181 SDIWSLGCILYELCTLKHP--FQA---NSWKNLILKVCQGSYKPLPS---HYSYELRSLI 232
Query: 893 EVAILCLVENPEARPT 908
+ NP +RP+
Sbjct: 233 KQM---FKRNPRSRPS 245
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 3e-12
Identities = 74/237 (31%), Positives = 116/237 (48%), Gaps = 10/237 (4%)
Query: 111 IVMGNLKSLSTLDLSQNQLNGS--IPCSLDNLSNLDTLFLYKNSLSGPIPSVIGNLKSLL 168
++ +L L +LDL S +L NL L +L L N L I + L +L
Sbjct: 61 LLPSSLSRLLSLDLLSPSGISSLDGSENLLNLLPLPSLDLNLNRLRSNISE-LLELTNLT 119
Query: 169 QLDLSENRLSGLIPLSLSNLSSLTVMSLFNNSLSGSIPPILGNLKSLSTLGLHINQLNGV 228
LDL N ++ + PL S+L + L +N + S+P L NL +L L L N L+
Sbjct: 120 SLDLDNNNITDIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS-D 177
Query: 229 IPPSIGNLSSLRNLSLFNNRLYGFVPKEIGYLKSLSKLEFCANHLSGVIPHSVGNLTGLV 288
+P + NLS+L NL L N++ +P EI L +L +L+ N + ++ S+ NL L
Sbjct: 178 LPKLLSNLSNLNNLDLSGNKI-SDLPPEIELLSALEELDLSNNSIIELLS-SLSNLKNLS 235
Query: 289 LLNMCENHLFGPIPKSLRNLTSLERVRFNQNNLYGKVYEAFGDHPNLTFLDLSQNNF 345
L N+ +P+S+ NL++LE + + N + + G NL LDLS N+
Sbjct: 236 GLE-LSNNKLEDLPESIGNLSNLETLDLSNNQI--SSISSLGSLTNLRELDLSGNSL 289
|
Length = 394 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 67.8 bits (165), Expect = 3e-12
Identities = 54/235 (22%), Positives = 104/235 (44%), Gaps = 28/235 (11%)
Query: 692 EFLNEVLALTEIRHRNIIKFHGFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQR 751
EFLNE + E ++++ G S Q + ++ E + RG L + LR E + Q
Sbjct: 55 EFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQA 114
Query: 752 MNVIKG-------VANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEP 804
+K +A+ ++YL+ + VHRD++++N ++ ++ + DFG + +
Sbjct: 115 PPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR--DI 169
Query: 805 HSSNWTEFAGT----VGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFS 860
+ +++ G V + +PE T DV+SFGV+ E+ +
Sbjct: 170 YETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI------ATLAEQPYQ 223
Query: 861 SISNMIIEVNQILDHRLPTPSRDVTDKLRSIM-EVAILCLVENPEARPTMKEVCN 914
+SN Q+L + D D ++ E+ +C NP+ RP+ E+ +
Sbjct: 224 GMSN-----EQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIIS 273
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 3e-12
Identities = 72/289 (24%), Positives = 125/289 (43%), Gaps = 43/289 (14%)
Query: 650 EKY----CIGKGGQRSVYKAE-LPSGNIFAVKKFKAELFSDETANPSEF-LNEVLALTEI 703
EKY +G+G V K + +G I A+KKF L S++ + + E+ L ++
Sbjct: 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKF---LESEDDKMVKKIAMREIRMLKQL 57
Query: 704 RHRNIIKFHGFCSNAQHSFIVCEYLARGSLTTILRD-DAAAKEFSWNQRMNVIKGVANAL 762
RH N++ + ++V E++ T+L D + ++ + + +
Sbjct: 58 RHENLVNLIEVFRRKKRLYLVFEFVDH----TVLDDLEKYPNGLDESRVRKYLFQILRGI 113
Query: 763 SYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGTVGYAAPE 822
+ H I+HRDI +N+L+ + DFGFA+ L +T++ T Y APE
Sbjct: 114 EFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPE 170
Query: 823 LAYTMRATEKY----DVYSFGVLALEVIKG--YHPG----DFVSTIFSSISNMIIEVNQI 872
L + KY D+++ G L E++ G PG D + I + N+I +I
Sbjct: 171 L---LVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEI 227
Query: 873 LDH-------RLPT-----PSRDVTDKLRSIM-EVAILCLVENPEARPT 908
RLP P KL ++ ++A CL +P+ RP+
Sbjct: 228 FQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPS 276
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 4e-12
Identities = 69/274 (25%), Positives = 119/274 (43%), Gaps = 36/274 (13%)
Query: 654 IGKGGQRSVYKAE-LPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFH 712
+G G VYK + +G + A+K ++ DE + +N + + HRNI ++
Sbjct: 14 VGNGTYGQVYKGRHVKTGQLAAIKVM--DVTGDEEEEIKQEINMLKKYSH--HRNIATYY 69
Query: 713 G-FCSNA-----QHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLH 766
G F ++V E+ GS+T ++++ + + + LS+LH
Sbjct: 70 GAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKN-TKGNTLKEEWIAYICREILRGLSHLH 128
Query: 767 HDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGTVGYAAPELAYT 826
++HRDI +NVLL E + DFG + L+ F GT + APE+
Sbjct: 129 QH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIAC 185
Query: 827 MRATE-----KYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTP- 880
+ K D++S G+ A+E+ +G P + +M L R P P
Sbjct: 186 DENPDATYDFKSDLWSLGITAIEMAEGAPP----------LCDMHPMRALFLIPRNPAPR 235
Query: 881 --SRDVTDKLRSIMEVAILCLVENPEARPTMKEV 912
S+ + K +S +E CLV+N RPT +++
Sbjct: 236 LKSKKWSKKFQSFIES---CLVKNHSQRPTTEQL 266
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 67.2 bits (165), Expect = 5e-12
Identities = 70/290 (24%), Positives = 113/290 (38%), Gaps = 47/290 (16%)
Query: 648 FGEKYCIGKGGQRSVYKA-ELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEI-RH 705
FG+ IG+G +V A E + +A+K E E LT + H
Sbjct: 5 FGKI--IGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKY-VKIEKEVLTRLNGH 61
Query: 706 RNIIKFHGFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYL 765
IIK + + ++ + V EY G L +R + AL YL
Sbjct: 62 PGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRK---YGSLDEKCTRFYAAEILLALEYL 118
Query: 766 HHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTE-------------- 811
H I+HRD+ +N+LLD + ++DFG AK L+P+SS +
Sbjct: 119 HSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKN 175
Query: 812 ------FAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVST--IFSSIS 863
F GT Y +PEL A + D+++ G + +++ G P + F I
Sbjct: 176 RRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKIL 235
Query: 864 NMIIEVNQILDHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVC 913
+E + P ++D+ +KL LV +P+ R + E
Sbjct: 236 K--LEYSF--PPNFPPDAKDLIEKL----------LVLDPQDRLGVNEGY 271
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 6e-12
Identities = 59/211 (27%), Positives = 101/211 (47%), Gaps = 24/211 (11%)
Query: 654 IGKGGQRSVYKAELPSGN-IFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFH 712
IG+G VYKA N A+KK + E ++ PS + E+ L E++H NI++
Sbjct: 10 IGEGTYGVVYKARDRVTNETIALKKIRLE--QEDEGVPSTAIREISLLKEMQHGNIVRLQ 67
Query: 713 GFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRM------NVIKGVANALSYLH 766
+ + ++V EYL L D++ +F+ N R+ +++G+A Y H
Sbjct: 68 DVVHSEKRLYLVFEYL---DLDLKKHMDSSP-DFAKNPRLIKTYLYQILRGIA----YCH 119
Query: 767 HDCIPPIVHRDISSKNVLLDSEYEA-HVSDFGFAKFLEPHSSNWTEFAGTVGYAAPELAY 825
++HRD+ +N+L+D A ++DFG A+ +T T+ Y APE+
Sbjct: 120 SH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILL 176
Query: 826 TMRA-TEKYDVYSFGVLALEVI--KGYHPGD 853
R + D++S G + E++ K PGD
Sbjct: 177 GSRHYSTPVDIWSVGCIFAEMVNQKPLFPGD 207
|
Length = 294 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 6e-12
Identities = 69/272 (25%), Positives = 119/272 (43%), Gaps = 32/272 (11%)
Query: 645 TGNFGEKYCIGKGGQRSVYKAELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIR 704
+GNFG ++ +YK S AVK K + +++ A E L E + ++
Sbjct: 5 SGNFGTV-------KKGMYKM-KKSEKTVAVKILKND--NNDPALKDELLREANVMQQLD 54
Query: 705 HRNIIKFHGFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSY 764
+ I++ G C A+ +V E G L L+ + E + + ++ V+ + Y
Sbjct: 55 NPYIVRMIGICE-AESWMLVMELAELGPLNKFLQKNKHVTEKNITE---LVHQVSMGMKY 110
Query: 765 LHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGT----VGYAA 820
L VHRD++++NVLL +++ A +SDFG +K L N+ + V + A
Sbjct: 111 LEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGA-DENYYKAKTHGKWPVKWYA 166
Query: 821 PELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTP 880
PE + + K DV+SFGVL E Y + + ++ M IE + R+ P
Sbjct: 167 PECMNYYKFSSKSDVWSFGVLMWEAFS-YGQKPYKGMKGNEVTQM-IESGE----RMECP 220
Query: 881 SRDVTDKLRSIMEVAILCLVENPEARPTMKEV 912
++ +M+ LC + RP V
Sbjct: 221 Q-RCPPEMYDLMK---LCWTYGVDERPGFAVV 248
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 6e-12
Identities = 65/276 (23%), Positives = 115/276 (41%), Gaps = 34/276 (12%)
Query: 654 IGKGGQRSVYKAELPSGNI---FAVKKFKAELFSDETANPSEFLNEVLALTEI-RHRNII 709
IG+G V KA + + A+K+ K D+ +F E+ L ++ H NII
Sbjct: 15 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDH---RDFAGELEVLCKLGHHPNII 71
Query: 710 KFHGFCSNAQHSFIVCEYLARGSLTTILRD-------------DAAAKEFSWNQRMNVIK 756
G C + + ++ EY G+L LR ++ A S Q ++
Sbjct: 72 NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 131
Query: 757 GVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGTV 816
VA + YL +HRD++++N+L+ Y A ++DFG ++ E +
Sbjct: 132 DVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVR 188
Query: 817 GYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHR 876
A L Y++ T DV+S+GVL E++ T + ++ + +R
Sbjct: 189 WMAIESLNYSVYTTNS-DVWSYGVLLWEIVS------LGGTPYCGMTCAELYEKLPQGYR 241
Query: 877 LPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEV 912
L P + D++ +M C E P RP+ ++
Sbjct: 242 LEKP-LNCDDEVYDLMR---QCWREKPYERPSFAQI 273
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 9e-12
Identities = 59/238 (24%), Positives = 101/238 (42%), Gaps = 34/238 (14%)
Query: 692 EFLNEVLALTEI-RHRNIIKFHGFCSNAQHSFIVCEYLARGSLTTILR-------DDAAA 743
+F E+ L ++ H NII G C + + ++ EY G+L LR D A A
Sbjct: 41 DFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFA 100
Query: 744 KE------FSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFG 797
S Q ++ VA + YL +HRD++++N+L+ Y A ++DFG
Sbjct: 101 IANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFG 157
Query: 798 FAKFLEPHSSNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIK-GYHP--GDF 854
++ E + A L Y++ T DV+S+GVL E++ G P G
Sbjct: 158 LSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTT-NSDVWSYGVLLWEIVSLGGTPYCGMT 216
Query: 855 VSTIFSSISNMIIEVNQILDHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEV 912
+ ++ + +RL P + D++ +M C E P RP+ ++
Sbjct: 217 CAELYEKLPQ---------GYRLEKP-LNCDDEVYDLMR---QCWREKPYERPSFAQI 261
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 9e-12
Identities = 50/154 (32%), Positives = 75/154 (48%), Gaps = 10/154 (6%)
Query: 700 LTEIRHRNIIKFHGFCSNAQHSFIVCEYLARGSLTTILRDDAAAKE--FSWNQRMNVIKG 757
L E+ H I+K H +++ ++L G L T L +KE F+ +
Sbjct: 52 LAEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRL-----SKEVMFTEEDVKFYLAE 106
Query: 758 VANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGTVG 817
+A AL +LH I++RD+ +N+LLD E ++DFG +K H F GTV
Sbjct: 107 LALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVE 163
Query: 818 YAAPELAYTMRATEKYDVYSFGVLALEVIKGYHP 851
Y APE+ T+ D +SFGVL E++ G P
Sbjct: 164 YMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLP 197
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 1e-11
Identities = 61/215 (28%), Positives = 96/215 (44%), Gaps = 15/215 (6%)
Query: 654 IGKGGQRSVYKAELP-SGNIFAVKKFKAEL-FSDETANPSEFLNEVLALTEIRHRNIIKF 711
+GKG V+ AEL + FA+K K ++ D+ + VL+L H +
Sbjct: 3 LGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLA-WEHPFLT-- 59
Query: 712 HGFCS--NAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDC 769
H +C+ ++ F V EYL G L ++ + +F + + L +LH
Sbjct: 60 HLYCTFQTKENLFFVMEYLNGGDLMFHIQ---SCHKFDLPRATFYAAEIICGLQFLHSK- 115
Query: 770 IPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGTVGYAAPELAYTMRA 829
IV+RD+ N+LLD++ ++DFG K + F GT Y APE+ +
Sbjct: 116 --GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQKY 173
Query: 830 TEKYDVYSFGVLALEVIKGYHP--GDFVSTIFSSI 862
D +SFGVL E++ G P G +F SI
Sbjct: 174 NTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSI 208
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 3e-11
Identities = 56/205 (27%), Positives = 98/205 (47%), Gaps = 24/205 (11%)
Query: 645 TGNFGEKYCIGKGGQRSVYKAELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIR 704
+GNFG C+ KG VYK ++ A+K K E +E + E + E + ++
Sbjct: 5 SGNFG---CVKKG----VYKMRKKQIDV-AIKVLKNE---NEKSVRDEMMREAEIMHQLD 53
Query: 705 HRNIIKFHGFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSY 764
+ I++ G C A+ +V E + G L L E + + + ++ V+ + Y
Sbjct: 54 NPYIVRMIGVCE-AEALMLVMEMASGGPLNKFL--SGKKDEITVSNVVELMHQVSMGMKY 110
Query: 765 LHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGTVG-----YA 819
L VHRD++++NVLL +++ A +SDFG +K L S + A + G +
Sbjct: 111 LEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYK--ARSAGKWPLKWY 165
Query: 820 APELAYTMRATEKYDVYSFGVLALE 844
APE + + + DV+S+G+ E
Sbjct: 166 APECINFRKFSSRSDVWSYGITMWE 190
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 5e-11
Identities = 38/95 (40%), Positives = 51/95 (53%), Gaps = 3/95 (3%)
Query: 371 GSIPPEIGDSSKLQVLDLSSNHIFGKIPVQLVKLFSLNKLILSLNQLFGGVPLEFGTLTE 430
G IP +I LQ ++LS N I G IP L + SL L LS N G +P G LT
Sbjct: 432 GFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTS 491
Query: 431 LQYLDLSANKLSSSIPMSIGNLLKLH--YLNLSNN 463
L+ L+L+ N LS +P ++G L LH N ++N
Sbjct: 492 LRILNLNGNSLSGRVPAALGGRL-LHRASFNFTDN 525
|
Length = 623 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 6e-11
Identities = 65/282 (23%), Positives = 120/282 (42%), Gaps = 46/282 (16%)
Query: 654 IGKGGQRSVYKAEL--PSGNI--FAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNII 709
+G+G SV + +L G+ AVK K ++ + + EFL+E + + H N++
Sbjct: 7 LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHT--YSEIEEFLSEAACMKDFDHPNVM 64
Query: 710 KFHGFC--SNAQHSF----IVCEYLARGSLTTIL---RDDAAAKEFSWNQRMNVIKGVAN 760
K G C +++ ++ ++ G L + L R ++ + + +A
Sbjct: 65 KLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIAL 124
Query: 761 ALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAK-------FLEPHSSNWTEFA 813
+ YL + +HRD++++N +L + V+DFG +K + + +
Sbjct: 125 GMEYLSNR---NFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKM---- 177
Query: 814 GTVGYAAPELAYTMRATEKYDVYSFGVLALEVI-KGYHPGDFVSTIFSSISNMIIEVNQI 872
V + A E T K DV++FGV E+ +G P + + N E+
Sbjct: 178 -PVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTP-------YPGVENH--EIYDY 227
Query: 873 LDH--RLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEV 912
L H RL P D D+L +M C +P+ RPT ++
Sbjct: 228 LRHGNRLKQPE-DCLDELYDLM---YSCWRADPKDRPTFTKL 265
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 6e-11
Identities = 61/215 (28%), Positives = 96/215 (44%), Gaps = 15/215 (6%)
Query: 654 IGKGGQRSVYKAELP-SGNIFAVKKFKAE-LFSDETANPSEFLNEVLALTEIRHRNIIKF 711
+GKG V AEL + ++A+K K + + D+ + + +LAL +H +
Sbjct: 3 LGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAA-KHPFLTAL 61
Query: 712 HGFCSNAQHSFIVCEYLARGSLT-TILRDDAAAKEFSWNQRMNVIKGVANALSYLH-HDC 769
H F V EY+ G L I R +++F + V AL +LH H
Sbjct: 62 HCCFQTKDRLFFVMEYVNGGDLMFQIQR----SRKFDEPRSRFYAAEVTLALMFLHRHG- 116
Query: 770 IPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGTVGYAAPELAYTMRA 829
+++RD+ N+LLD+E ++DFG K + T F GT Y APE+ +
Sbjct: 117 ---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELEY 173
Query: 830 TEKYDVYSFGVLALEVIKGYHP--GDFVSTIFSSI 862
D ++ GVL E++ G P D +F SI
Sbjct: 174 GPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESI 208
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 7e-11
Identities = 66/263 (25%), Positives = 107/263 (40%), Gaps = 21/263 (7%)
Query: 654 IGKGGQRSVYKAE-LPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFH 712
IG G VYKA + +G + A+K K E D E++ + + +H NI+ +
Sbjct: 17 IGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAV----VQQEIIMMKDCKHSNIVAYF 72
Query: 713 GFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPP 772
G +I E+ GSL I S +Q V + L YLH
Sbjct: 73 GSYLRRDKLWICMEFCGGGSLQDIYH---VTGPLSESQIAYVSRETLQGLYYLHSK---G 126
Query: 773 IVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGTVGYAAPELAYTMRA--- 829
+HRDI N+LL ++DFG + + + F GT + APE+A R
Sbjct: 127 KMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGY 186
Query: 830 TEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRDVTDKLR 889
+ D+++ G+ A+E+ + P F ++ M Q P +D
Sbjct: 187 NQLCDIWAVGITAIELAE-LQPPMFDLHPMRALFLMTKSNFQ------PPKLKDKMKWSN 239
Query: 890 SIMEVAILCLVENPEARPTMKEV 912
S + L +NP+ RPT +++
Sbjct: 240 SFHHFVKMALTKNPKKRPTAEKL 262
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 8e-11
Identities = 55/240 (22%), Positives = 105/240 (43%), Gaps = 34/240 (14%)
Query: 692 EFLNEVLALTEIRHRNIIKFHGFCSNAQHSFIVCEYLARGSLTTILR-------DDAAAK 744
EFLNE + ++++ G S Q + +V E +A G L + LR ++
Sbjct: 55 EFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRP 114
Query: 745 EFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEP 804
+ + + + +A+ ++YL+ VHRD++++N ++ ++ + DFG + +
Sbjct: 115 PPTLQEMIQMAAEIADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTR--DI 169
Query: 805 HSSNWTEFAGT----VGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFS 860
+ +++ G V + APE T D++SFGV+ E+ +
Sbjct: 170 YETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEI------TSLAEQPYQ 223
Query: 861 SISNMIIEVNQILDHRLPTPSRDVTD----KLRSIMEVAILCLVENPEARPTMKEVCNLL 916
+SN Q+L + D D ++ +M +C NP+ RPT E+ NLL
Sbjct: 224 GLSN-----EQVLKFVMDGGYLDQPDNCPERVTDLMR---MCWQFNPKMRPTFLEIVNLL 275
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 1e-10
Identities = 46/160 (28%), Positives = 73/160 (45%), Gaps = 17/160 (10%)
Query: 458 LNLSNNQFSHKIPTEFEKLIHLSELDLSHNILQEEIPPQICKMESLEKLNLSHNNLSDFI 517
L L N IP + KL HL ++LS N ++ IPP + + SLE L+LS+N+ + I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 518 PRCFEEMRSLSWIDISYNELQGPIPNSTAFKNGLMEG-------NKGLCGNFKALPSCDA 570
P ++ SL ++++ N L G +P + + L+ N GLCG L +C
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALGGR--LLHRASFNFTDNAGLCG-IPGLRACG- 538
Query: 571 FTSHKQTFRKKWVVIALPILGMVVLLIGLIGFFFLFRRRK 610
H K I + V L +I ++RR+
Sbjct: 539 --PHLSVGAK----IGIAFGVSVAFLFLVICAMCWWKRRQ 572
|
Length = 623 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 1e-10
Identities = 67/273 (24%), Positives = 113/273 (41%), Gaps = 24/273 (8%)
Query: 647 NFGEKYCIGKGGQRSVYKAE-LPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRH 705
NF + IG+G VY+A L A+KK + D A + + E+ L ++ H
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKAR-QDCVKEIDLLKQLNH 61
Query: 706 RNIIKF-HGFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRM----NVIKGVAN 760
N+IK+ F + + + IV E G L+ ++ K F +R+ V K
Sbjct: 62 PNVIKYLDSFIEDNELN-IVLELADAGDLSQMI------KYFKKQKRLIPERTVWKYFVQ 114
Query: 761 ALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGTVGYAA 820
S + H ++HRDI NV + + + D G +F ++ GT Y +
Sbjct: 115 LCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMS 174
Query: 821 PELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPT- 879
PE + K D++S G L E+ P + N+ +I P
Sbjct: 175 PERIHENGYNFKSDIWSLGCLLYEMAALQSP------FYGDKMNLFSLCQKIEQCDYPPL 228
Query: 880 PSRDVTDKLRSIMEVAILCLVENPEARPTMKEV 912
P+ ++KLR E+ +C+ +P+ RP + V
Sbjct: 229 PTEHYSEKLR---ELVSMCIYPDPDQRPDIGYV 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 1e-10
Identities = 62/244 (25%), Positives = 103/244 (42%), Gaps = 25/244 (10%)
Query: 654 IGKGGQRSVYKAE-LPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHR-----N 707
I KG SVY A+ +G+ FA+K K SD A + V A I
Sbjct: 4 ISKGAFGSVYLAKKRSTGDYFAIKVLKK---SDMIAKNQ--VTNVKAERAIMMIQGESPY 58
Query: 708 IIKFHGFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHH 767
+ K + + + ++V EYL G ++++ E W + I V + LH
Sbjct: 59 VAKLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPE-DWAK--QYIAEVVLGVEDLHQ 115
Query: 768 DCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKF-LEPHSSNWTEFAGTVGYAAPELAYT 826
I+HRDI +N+L+D ++DFG ++ LE +F GT Y APE
Sbjct: 116 R---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLEN-----KKFVGTPDYLAPETILG 167
Query: 827 MRATEKYDVYSFGVLALEVIKGYHP--GDFVSTIFSSISNMIIEVNQILDHRLPTPSRDV 884
+ + D +S G + E + GY P + +F +I + I + + + D+
Sbjct: 168 VGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDL 227
Query: 885 TDKL 888
++L
Sbjct: 228 INRL 231
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 1e-10
Identities = 72/287 (25%), Positives = 128/287 (44%), Gaps = 43/287 (14%)
Query: 641 ITKATGNFGEKYCIGKGGQRSVYKA-ELPSG-NI---FAVKKFKAELFSDETANP---SE 692
I K T F + +G G +VYK +P G + A+K+ + E +P E
Sbjct: 3 ILKET-EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR------EATSPKANKE 55
Query: 693 FLNEVLALTEIRHRNIIKFHGFC--SNAQHSFIVCEYLARGSLTTILRD--DAAAKEFSW 748
L+E + + + ++ + G C S Q ++ + + G L +R+ D ++
Sbjct: 56 ILDEAYVMASVDNPHVCRLLGICLTSTVQ---LITQLMPFGCLLDYVREHKDNIGSQYLL 112
Query: 749 NQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSN 808
N + + KG+ N L +VHRD++++NVL+ + ++DFG AK L
Sbjct: 113 NWCVQIAKGM-NYLEERR------LVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKE 165
Query: 809 WTEFAGTV--GYAAPELAYTMRATEKYDVYSFGVLALEVIK-GYHPGDFVSTIFSSISNM 865
+ G V + A E T + DV+S+GV E++ G P D + S IS+
Sbjct: 166 YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA--SEISS- 222
Query: 866 IIEVNQILDHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEV 912
I+E + RLP P D + + + C + + ++RP +E+
Sbjct: 223 ILEKGE----RLPQPPICTID----VYMIMVKCWMIDADSRPKFREL 261
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 2e-10
Identities = 62/243 (25%), Positives = 102/243 (41%), Gaps = 28/243 (11%)
Query: 669 SGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHG-FCSNAQHSFIVCEY 727
+G A+KK + FS E+ L +RH NII F S + + V E
Sbjct: 34 TGQNVAIKKI-MKPFS-TPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTEL 91
Query: 728 LARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDS 787
L L +L K+F +++G L Y+H +VHRD+ N+L++
Sbjct: 92 LGT-DLHRLLTSRPLEKQFIQYFLYQILRG----LKYVHS---AGVVHRDLKPSNILINE 143
Query: 788 EYEAHVSDFGFAKFLEPHSSNWTEFAGTVGYAAPELAYT-MRATEKYDVYSFGVLALEVI 846
+ + DFG A+ +P T + T Y APE+ T + + D++S G + E++
Sbjct: 144 NCDLKICDFGLARIQDPQ---MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEML 200
Query: 847 KG--YHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRDVTDKLRSIMEVAILCLVENPE 904
+G PG FS I+++ L TP DV + + S + + + E
Sbjct: 201 EGKPLFPGKDHVNQFSIITDL-----------LGTPPDDVINTICSENTLRFVQSLPKRE 249
Query: 905 ARP 907
P
Sbjct: 250 PVP 252
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 2e-10
Identities = 69/276 (25%), Positives = 120/276 (43%), Gaps = 40/276 (14%)
Query: 654 IGKGGQRSVYKAE-LPSGNIFAVKKFKAELFSDETANPSEFLN-EVLALTEI-RHRNIIK 710
+G G VYK + +G + A+K D T + E + E+ L + HRNI
Sbjct: 24 VGNGTYGQVYKGRHVKTGQLAAIKVM------DVTEDEEEEIKLEINMLKKYSHHRNIAT 77
Query: 711 FHGF------CSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSY 764
++G + ++V E+ GS+T ++++ + + + + L++
Sbjct: 78 YYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKN-TKGNALKEDWIAYICREILRGLAH 136
Query: 765 LHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGTVGYAAPELA 824
LH ++HRDI +NVLL E + DFG + L+ F GT + APE+
Sbjct: 137 LH---AHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVI 193
Query: 825 YTMR---ATEKY--DVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPT 879
AT Y D++S G+ A+E+ +G P + +M L R P
Sbjct: 194 ACDENPDATYDYRSDIWSLGITAIEMAEGAPP----------LCDMHPMRALFLIPRNPP 243
Query: 880 P---SRDVTDKLRSIMEVAILCLVENPEARPTMKEV 912
P S+ + K +E CLV+N +RP+ +++
Sbjct: 244 PKLKSKKWSKKFIDFIEG---CLVKNYLSRPSTEQL 276
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 2e-10
Identities = 66/266 (24%), Positives = 116/266 (43%), Gaps = 29/266 (10%)
Query: 654 IGKGGQRSVYKAELPSGNIFAV-KKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFH 712
IG+G +Y A+ S + V K+ + S+ EV+ L +++H NI+ F
Sbjct: 8 IGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASK--KEVILLAKMKHPNIVTFF 65
Query: 713 GFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPP 772
FIV EY G L + FS +Q ++ ++ L ++H
Sbjct: 66 ASFQENGRLFIVMEYCDGGDLMKRINRQRGVL-FSEDQILSWFVQISLGLKHIHDR---K 121
Query: 773 IVHRDISSKNVLLDSE-YEAHVSDFGFAKFLEPHSSNWTEFA----GTVGYAAPELAYTM 827
I+HRDI S+N+ L A + DFG A+ L ++ E A GT Y +PE+
Sbjct: 122 ILHRDIKSQNIFLSKNGMVAKLGDFGIARQL----NDSMELAYTCVGTPYYLSPEICQNR 177
Query: 828 RATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRL-PTPSRDVTD 886
K D++S G + E+ HP F +++ +++++ Q + P SRD+
Sbjct: 178 PYNNKTDIWSLGCVLYELCTLKHP--FEG---NNLHQLVLKICQGYFAPISPNFSRDLRS 232
Query: 887 KLRSIMEVAILCLVENPEARPTMKEV 912
+ + +V+ P RP++ +
Sbjct: 233 LISQLFKVS-------PRDRPSITSI 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 3e-10
Identities = 32/75 (42%), Positives = 41/75 (54%)
Query: 352 NWRNFSKLGTFNASMNNIYGSIPPEIGDSSKLQVLDLSSNHIFGKIPVQLVKLFSLNKLI 411
+ L + N S N+I G+IPP +G + L+VLDLS N G IP L +L SL L
Sbjct: 437 DISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILN 496
Query: 412 LSLNQLFGGVPLEFG 426
L+ N L G VP G
Sbjct: 497 LNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 3e-10
Identities = 57/206 (27%), Positives = 95/206 (46%), Gaps = 15/206 (7%)
Query: 654 IGKGGQRSVYKA-ELPSGNIFAVKKFKAELFSDETANPSEFLN-EVLALTEIRHRNIIKF 711
+G+G VY ++ +G A K+ + + S ET+ L E+ L ++H I+++
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQY 69
Query: 712 HGFC--SNAQHSF-IVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHD 768
+G C A+ + I EY+ GS+ L+ A E + + + +SYLH +
Sbjct: 70 YG-CLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTE---SVTRKYTRQILEGMSYLHSN 125
Query: 769 CIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWT---EFAGTVGYAAPELAY 825
I VHRDI N+L DS + DFG +K L+ + T GT + +PE+
Sbjct: 126 MI---VHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVIS 182
Query: 826 TMRATEKYDVYSFGVLALEVIKGYHP 851
K DV+S G +E++ P
Sbjct: 183 GEGYGRKADVWSLGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 4e-10
Identities = 54/205 (26%), Positives = 90/205 (43%), Gaps = 13/205 (6%)
Query: 654 IGKGGQRSVYKA-ELPSGNIFAVKKFKAELFSDETANPSEFLN-EVLALTEIRHRNIIKF 711
+G+G VY + +G AVK+ + + S ET+ L E+ L + H I+++
Sbjct: 10 LGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQY 69
Query: 712 HGFCSNAQHSF--IVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDC 769
+G + I E++ GS+ L+ A E N + + +SYLH +
Sbjct: 70 YGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTE---NVTRKYTRQILEGVSYLHSNM 126
Query: 770 IPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEP---HSSNWTEFAGTVGYAAPELAYT 826
I VHRDI N+L DS + DFG +K L+ + GT + +PE+
Sbjct: 127 I---VHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISG 183
Query: 827 MRATEKYDVYSFGVLALEVIKGYHP 851
K D++S G +E++ P
Sbjct: 184 EGYGRKADIWSVGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 4e-10
Identities = 80/288 (27%), Positives = 127/288 (44%), Gaps = 35/288 (12%)
Query: 649 GEKYCI----GKGGQRSVYKAELPS-GNIFAVKKFKAELFSDETANPSEFLNEVLALTEI 703
+KY I G G +V A+ S G FAVK E S+ N ++ EV L
Sbjct: 31 AKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQ--AEVCCLLNC 88
Query: 704 RHRNIIKFH-GFC-------SNAQHSFIVCEYLARGSLTTILRDDA-AAKEFSWNQRMNV 754
+I+K H F N +V +Y G L ++ A + F ++ +
Sbjct: 89 DFFSIVKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLL 148
Query: 755 IKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSN--WTEF 812
V A+ ++H ++HRDI S N+LL S + DFGF+K S+ F
Sbjct: 149 FIQVLLAVHHVHSK---HMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTF 205
Query: 813 AGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQI 872
GT Y APE+ ++K D++S GVL E++ P D NM +++
Sbjct: 206 CGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGE--------NMEEVMHKT 257
Query: 873 LDHRL-PTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNL-LCK 918
L R P P ++ +++ I V L L +P+ RP+ ++ N+ +CK
Sbjct: 258 LAGRYDPLPP-SISPEMQEI--VTAL-LSSDPKRRPSSSKLLNMPICK 301
|
Length = 496 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.1 bits (149), Expect = 5e-10
Identities = 47/178 (26%), Positives = 81/178 (45%), Gaps = 17/178 (9%)
Query: 654 IGKGGQRSVYKA-ELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIR---HRNII 709
IG+G +VYKA +L +G A+KK + L E P L E+ L ++ H NI+
Sbjct: 7 IGEGAYGTVYKARDLNTGRFVALKKVRVPL--SEEGIPLSTLREIALLKQLESFEHPNIV 64
Query: 710 KFHGFCSNAQHS-----FIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSY 764
+ C + +V E++ + L T L ++++ + + +
Sbjct: 65 RLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYL-SKCPKPGLPPETIKDLMRQLLRGVDF 122
Query: 765 LHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGTVGYAAPE 822
LH I VHRD+ +N+L+ S+ + ++DFG A+ + T T+ Y APE
Sbjct: 123 LHSHRI---VHRDLKPQNILVTSDGQVKIADFGLARIYSFEMA-LTSVVVTLWYRAPE 176
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 6e-10
Identities = 54/202 (26%), Positives = 97/202 (48%), Gaps = 27/202 (13%)
Query: 654 IGKGGQRSVYKA-ELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFH 712
IG+G VYKA + +G + A+KK + + +++ P + E+ L ++ HRNI+
Sbjct: 15 IGEGTYGQVYKARDKDTGELVALKKVRLD--NEKEGFPITAIREIKILRQLNHRNIVNLK 72
Query: 713 GFCSNAQHS----------FIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANAL 762
++ Q + ++V EY+ L +L ++ FS + + +K + L
Sbjct: 73 EIVTDKQDALDFKKDKGAFYLVFEYMDH-DLMGLL--ESGLVHFSEDHIKSFMKQLLEGL 129
Query: 763 SYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSN-WTEFAGTVGYAAP 821
+Y H +HRDI N+LL+++ + ++DFG A+ S +T T+ Y P
Sbjct: 130 NYCHKK---NFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVITLWYRPP 186
Query: 822 ELAYTMRATEKY----DVYSFG 839
EL + E+Y DV+S G
Sbjct: 187 EL---LLGEERYGPAIDVWSCG 205
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 7e-10
Identities = 60/205 (29%), Positives = 96/205 (46%), Gaps = 14/205 (6%)
Query: 650 EKYC-IGKGGQRSVYKAE-LPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRN 707
E+ +G G V K + PSG I A K E+ + A ++ + E+ L E
Sbjct: 8 ERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI---KPAIRNQIIRELQVLHECNSPY 64
Query: 708 IIKFHG-FCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLH 766
I+ F+G F S+ + S I E++ GSL +L++ AK V V L+YL
Sbjct: 65 IVGFYGAFYSDGEIS-ICMEHMDGGSLDQVLKE---AKRIPEEILGKVSIAVLRGLAYLR 120
Query: 767 HDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGTVGYAAPELAYT 826
I+HRD+ N+L++S E + DFG + L +N F GT Y +PE
Sbjct: 121 EK--HQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN--SFVGTRSYMSPERLQG 176
Query: 827 MRATEKYDVYSFGVLALEVIKGYHP 851
+ + D++S G+ +E+ G +P
Sbjct: 177 THYSVQSDIWSMGLSLVELAIGRYP 201
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 8e-10
Identities = 58/220 (26%), Positives = 95/220 (43%), Gaps = 11/220 (5%)
Query: 647 NFGEKYCIGKGGQRSVYKAELP-SGNIFAVKKFKAEL-FSDETANPSEFLNEVLALTEIR 704
+F +GKG V AE + ++A+K K ++ D+ + VLAL + +
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQD-K 59
Query: 705 HRNIIKFHGFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSY 764
+ + H + V EY+ G L ++ KE Q + ++ L +
Sbjct: 60 PPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKE---PQAVFYAAEISVGLFF 116
Query: 765 LHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGTVGYAAPELA 824
LH I++RD+ NV+LDSE ++DFG K F GT Y APE+
Sbjct: 117 LHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEII 173
Query: 825 YTMRATEKYDVYSFGVLALEVIKGYHP--GDFVSTIFSSI 862
+ D +++GVL E++ G P G+ +F SI
Sbjct: 174 AYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSI 213
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 9e-10
Identities = 55/191 (28%), Positives = 86/191 (45%), Gaps = 25/191 (13%)
Query: 723 IVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKN 782
++ +Y+ G L T L + F+ ++ I + AL +LH I++RDI +N
Sbjct: 82 LILDYVNGGELFTHL---YQREHFTESEVRVYIAEIVLALDHLHQ---LGIIYRDIKLEN 135
Query: 783 VLLDSEYEAHVSDFGFAK-FLEPHSSNWTEFAGTVGYAAPELAYTMRA--TEKYDVYSFG 839
+LLDSE ++DFG +K FL F GT+ Y APE+ + D +S G
Sbjct: 136 ILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLG 195
Query: 840 VLALEVIKGYHP----GDFVSTIFSSISNMIIEVNQILDHRLPTPSRDVTDKLRSIMEVA 895
VL E++ G P G+ S S IS I++ + +RD KL
Sbjct: 196 VLTFELLTGASPFTVDGEQNSQ--SEISRRILKSKPPFPKTMSAEARDFIQKL------- 246
Query: 896 ILCLVENPEAR 906
L ++P+ R
Sbjct: 247 ---LEKDPKKR 254
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 1e-09
Identities = 65/254 (25%), Positives = 106/254 (41%), Gaps = 29/254 (11%)
Query: 646 GNFGEKYCIGKGGQRSVYKAELPSGNIFAVKKFKAELFSDETANPSEFLN-EVLALTEIR 704
G FGE Y Y A+ +G AVK+ + S ET+ L E+ L +R
Sbjct: 13 GAFGEVYL--------CYDAD--TGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR 62
Query: 705 HRNIIKFHGFCSNAQHS--FIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANAL 762
H I++++G + + I EY+ GS+ L+ A E N + + +
Sbjct: 63 HDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTE---NVTRRYTRQILQGV 119
Query: 763 SYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWT---EFAGTVGYA 819
SYLH + I VHRDI N+L DS + DFG +K ++ + T GT +
Sbjct: 120 SYLHSNMI---VHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWM 176
Query: 820 APELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPT 879
+PE+ K DV+S +E++ P + +++ + Q LP
Sbjct: 177 SPEVISGEGYGRKADVWSVACTVVEMLTEKPPW----AEYEAMAAIFKIATQPTKPMLPD 232
Query: 880 PSRDVTDKLRSIME 893
V+D R ++
Sbjct: 233 ---GVSDACRDFLK 243
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 1e-09
Identities = 70/273 (25%), Positives = 120/273 (43%), Gaps = 40/273 (14%)
Query: 654 IGKGGQRSVYKA-ELPSG-NI---FAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNI 708
+G G +VYK +P G N+ A+K + + AN E L+E + + +
Sbjct: 15 LGSGAFGTVYKGIWIPDGENVKIPVAIKVLREN--TSPKAN-KEILDEAYVMAGVGSPYV 71
Query: 709 IKFHGFC--SNAQHSFIVCEYLARGSLTTILRD--DAAAKEFSWNQRMNVIKGVANALSY 764
+ G C S Q +V + + G L +R+ D + N + + KG +SY
Sbjct: 72 CRLLGICLTSTVQ---LVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKG----MSY 124
Query: 765 LHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGTV--GYAAPE 822
L +VHRD++++NVL+ S ++DFG A+ L+ + + G V + A E
Sbjct: 125 LEE---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALE 181
Query: 823 LAYTMRATEKYDVYSFGVLALEVIK-GYHPGDFVSTIFSSISNMIIEVNQILD--HRLPT 879
R T + DV+S+GV E++ G P D + E+ +L+ RLP
Sbjct: 182 SILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPA---------REIPDLLEKGERLPQ 232
Query: 880 PSRDVTDKLRSIMEVAILCLVENPEARPTMKEV 912
P D + + + C + + E RP +E+
Sbjct: 233 PPICTID----VYMIMVKCWMIDSECRPRFREL 261
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 1e-09
Identities = 68/268 (25%), Positives = 119/268 (44%), Gaps = 38/268 (14%)
Query: 654 IGKGGQRSVYKAELPSGNIFAVKKFKAELFSDETANPSE---FLNEVLALTEIRHRNIIK 710
+G G VYKA+ A K ET + E ++ E+ L H I+K
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVI------ETKSEEELEDYMVEIEILATCNHPYIVK 73
Query: 711 FHGFCSNAQHSFIVCEYLARGSLTTILRD-DAAAKEFSWNQRMNVIKGVANALSYLHHDC 769
G +I+ E+ G++ I+ + D E Q + + + AL YLH
Sbjct: 74 LLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTE---PQIQVICRQMLEALQYLHSM- 129
Query: 770 IPPIVHRDISSKNVLLDSEYEAHVSDFGFA----KFLEPHSSNWTEFAGTVGYAAPELAY 825
I+HRD+ + NVLL + + ++DFG + K L+ S F GT + APE+
Sbjct: 130 --KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDS----FIGTPYWMAPEVVM 183
Query: 826 --TMRATE---KYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTP 880
TM+ T K D++S G+ +E+ + P ++ + +++++ + L P
Sbjct: 184 CETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM-----RVLLKIAKSEPPTLSQP 238
Query: 881 SRDVTDKLRSIMEVAILCLVENPEARPT 908
S+ + R ++ A L ++PE RP+
Sbjct: 239 SKWSME-FRDFLKTA---LDKHPETRPS 262
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 2e-09
Identities = 60/207 (28%), Positives = 91/207 (43%), Gaps = 11/207 (5%)
Query: 654 IGKGGQRSVYKAELP-SGNIFAVKKFKAELFSD-ETANPSEFLNEVLALTEIRHRNIIKF 711
IG+G V L + I+A+K K EL +D E + + V H ++
Sbjct: 3 IGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQAS-NHPFLVGL 61
Query: 712 HGFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIP 771
H F V EY+ G L ++ E + R + ++ AL+YLH
Sbjct: 62 HSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPE--EHARFYSAE-ISLALNYLHER--- 115
Query: 772 PIVHRDISSKNVLLDSEYEAHVSDFGFAK-FLEPHSSNWTEFAGTVGYAAPELAYTMRAT 830
I++RD+ NVLLDSE ++D+G K L P + + F GT Y APE+
Sbjct: 116 GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT-STFCGTPNYIAPEILRGEDYG 174
Query: 831 EKYDVYSFGVLALEVIKGYHPGDFVST 857
D ++ GVL E++ G P D V +
Sbjct: 175 FSVDWWALGVLMFEMMAGRSPFDIVGS 201
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 2e-09
Identities = 72/274 (26%), Positives = 110/274 (40%), Gaps = 37/274 (13%)
Query: 646 GNFGEKYCI----GKGGQRSVYKAELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALT 701
G+FG Y + +R E+P G EL +ET ++ E L+
Sbjct: 11 GSFGTVYLVKDKKAVAEERLKVLKEIPVG----------ELNPNETVQANQ---EAQLLS 57
Query: 702 EIRHRNIIKFHGFCSNAQHSFIVCEYLARGSLTTILRD-DAAAKEFSWNQRMNVIKGVAN 760
++ H I+KFH I+ EY L L + K S NQ +
Sbjct: 58 KLDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLL 117
Query: 761 ALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGTVGYAA 820
+ Y+H I+HRD+ +KN+ L + + DFG ++ L T F GT Y +
Sbjct: 118 GVHYMH---QRRILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCDLATTFTGTPYYMS 173
Query: 821 PELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTP 880
PE K D++S G + E+ H F F S+ I+E PTP
Sbjct: 174 PEALKHQGYDSKSDIWSLGCILYEMCCLAHA--FEGQNFLSVVLRIVEG--------PTP 223
Query: 881 S--RDVTDKLRSIMEVAILCLVENPEARPTMKEV 912
S + +L SIM+ L ++P RP+ E+
Sbjct: 224 SLPETYSRQLNSIMQSM---LNKDPSLRPSAAEI 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 60.3 bits (146), Expect = 2e-09
Identities = 41/168 (24%), Positives = 77/168 (45%), Gaps = 17/168 (10%)
Query: 694 LNEVLALTEIRHRNIIKFHGFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMN 753
L E + L + H ++I+ + + +V + L T L + + +Q +
Sbjct: 105 LIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHY-SSDLYTYLTKRS--RPLPIDQALI 161
Query: 754 VIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKF--LEPHSSNWTE 811
+ K + L YLH I+HRD+ ++N+ ++ + + D G A+F + P +
Sbjct: 162 IEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP---AFLG 215
Query: 812 FAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIF 859
AGTV APE+ + K D++S G++ E++ + STIF
Sbjct: 216 LAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLA------YPSTIF 257
|
Length = 357 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 2e-09
Identities = 61/201 (30%), Positives = 92/201 (45%), Gaps = 19/201 (9%)
Query: 655 GKGGQRSVYKA-ELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHG 713
G GG V K PSG I A K E+ + A ++ + E+ L E I+ F+G
Sbjct: 12 GNGG--VVTKVLHRPSGLIMARKLIHLEI---KPAIRNQIIRELKVLHECNSPYIVGFYG 66
Query: 714 -FCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLH--HDCI 770
F S+ + S I E++ GSL +L+ A N + V L+YL H
Sbjct: 67 AFYSDGEIS-ICMEHMDGGSLDQVLKK---AGRIPENILGKISIAVLRGLTYLREKHK-- 120
Query: 771 PPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGTVGYAAPELAYTMRAT 830
I+HRD+ N+L++S E + DFG + L S F GT Y +PE T
Sbjct: 121 --IMHRDVKPSNILVNSRGEIKLCDFGVSGQL--IDSMANSFVGTRSYMSPERLQGTHYT 176
Query: 831 EKYDVYSFGVLALEVIKGYHP 851
+ D++S G+ +E+ G +P
Sbjct: 177 VQSDIWSLGLSLVEMAIGRYP 197
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 2e-09
Identities = 73/273 (26%), Positives = 121/273 (44%), Gaps = 36/273 (13%)
Query: 654 IGKGGQRSVYKAELP----SGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNII 709
+GKG SV +A+L S AVK KA++FS +++ EFL E + E H N+I
Sbjct: 7 LGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFS--SSDIEEFLREAACMKEFDHPNVI 64
Query: 710 KFHGFC--SNAQHSF----IVCEYLARGSLTTILRDDAAAKE-FSWNQRMNV--IKGVAN 760
K G S A+ ++ ++ G L T L +E F+ + V + +A+
Sbjct: 65 KLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIAS 124
Query: 761 ALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGTVGYAA 820
+ YL +HRD++++N +L+ V+DFG +K + +S ++
Sbjct: 125 GMEYLSSK---NFIHRDLAARNCMLNENMTVCVADFGLSKKI--YSGDYYRQGCASKLPV 179
Query: 821 PELAYTMRATEKY----DVYSFGVLALEVI-KGYHPGDFVSTIFSSISNMIIEVNQILDH 875
LA A Y DV++FGV E++ +G P ++ + N I I +
Sbjct: 180 KWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTP-------YAGVENSEIYNYLIKGN 232
Query: 876 RLPTPSRDVTDKLRSIMEVAILCLVENPEARPT 908
RL P D L + E+ C P+ RP+
Sbjct: 233 RLKQP----PDCLEDVYELMCQCWSPEPKCRPS 261
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 2e-09
Identities = 60/201 (29%), Positives = 97/201 (48%), Gaps = 15/201 (7%)
Query: 654 IGKGGQRSVYK-AELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFH 712
+G G V+K + PSG I A K E+ + A ++ + E+ L E I+ F+
Sbjct: 13 LGAGNGGVVFKVSHKPSGLIMARKLIHLEI---KPAIRNQIIRELQVLHECNSPYIVGFY 69
Query: 713 G-FCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQ-RMNVIKGVANALSYLHHDCI 770
G F S+ + S I E++ GSL +L+ E + + VIKG L+YL
Sbjct: 70 GAFYSDGEIS-ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKG----LTYLREK-- 122
Query: 771 PPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGTVGYAAPELAYTMRAT 830
I+HRD+ N+L++S E + DFG + L +N F GT Y +PE +
Sbjct: 123 HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN--SFVGTRSYMSPERLQGTHYS 180
Query: 831 EKYDVYSFGVLALEVIKGYHP 851
+ D++S G+ +E+ G +P
Sbjct: 181 VQSDIWSMGLSLVEMAIGRYP 201
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 2e-09
Identities = 57/224 (25%), Positives = 99/224 (44%), Gaps = 23/224 (10%)
Query: 654 IGKGGQRSVYKA-ELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIR---HRNII 709
IG G +VYKA + SG+ A+K + + ++E P + EV L + H NI+
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQ--TNEDGLPLSTVREVALLKRLEAFDHPNIV 65
Query: 710 KFHGFCSNAQHS-----FIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSY 764
+ C+ ++ +V E++ + L T L D ++++ L +
Sbjct: 66 RLMDVCATSRTDRETKVTLVFEHVDQ-DLRTYL-DKVPPPGLPAETIKDLMRQFLRGLDF 123
Query: 765 LHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGTVGYAAPELA 824
LH +CI VHRD+ +N+L+ S + ++DFG A+ + T T+ Y APE+
Sbjct: 124 LHANCI---VHRDLKPENILVTSGGQVKLADFGLARIYSCQMA-LTPVVVTLWYRAPEVL 179
Query: 825 YTMRATEKYDVYSFGVLALEVIK------GYHPGDFVSTIFSSI 862
D++S G + E+ + G D + IF I
Sbjct: 180 LQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLI 223
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 59.3 bits (144), Expect = 3e-09
Identities = 65/313 (20%), Positives = 113/313 (36%), Gaps = 78/313 (24%)
Query: 653 CIGKGGQRSVYKAELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFH 712
C + K + P+ + AVKK + S E E++ +++H NI+ +
Sbjct: 9 CFEDLMIVHLAKHK-PTNTLVAVKKINLDSCSKEDL--KLLQQEIITSRQLQHPNILPYV 65
Query: 713 GFCSNAQHSFIVCEYLARGSLTTILR--------DDAAAKEFSWNQRMNVIKGVANALSY 764
++V +A GS +L+ + A A ++K V NAL Y
Sbjct: 66 TSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIA---------FILKDVLNALDY 116
Query: 765 LHHDCIPPIVHRDISSKNVLLDSEYEAHVSDF---------GFAK---FLEPHSS----N 808
+H +HR + + ++LL + + +S G + P SS
Sbjct: 117 IHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLP 173
Query: 809 WTEFAGTVGYAAPELAY-TMRA-TEKYDVYSFGVLALEVIKGYHP-GDFVSTIF------ 859
W +PE+ ++ EK D+YS G+ A E+ G+ P D +T
Sbjct: 174 WL---------SPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVR 224
Query: 860 ------------------SSISNMIIEVNQILDHRLPTPSRDVTDKLRSIMEVAILCLVE 901
S S E D +R ++ +E LCL
Sbjct: 225 GTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVE---LCLQR 281
Query: 902 NPEARPTMKEVCN 914
+PE+RP+ ++ N
Sbjct: 282 DPESRPSASQLLN 294
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 3e-09
Identities = 59/246 (23%), Positives = 101/246 (41%), Gaps = 26/246 (10%)
Query: 669 SGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRN-IIKFHGFCSNAQHSFIVCEY 727
SG ++A+K K + E L IR ++ H ++ +Y
Sbjct: 27 SGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLHLILDY 86
Query: 728 LARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDS 787
+ G L T L + + F + + AL +LH I++RDI +N+LLDS
Sbjct: 87 INGGELFTHL---SQRERFKEQEVQIYSGEIVLALEHLHK---LGIIYRDIKLENILLDS 140
Query: 788 EYEAHVSDFGFAK-FLEPHSSNWTEFAGTVGYAAPELAYTMRA--TEKYDVYSFGVLALE 844
++DFG +K F E F GT+ Y AP++ + D +S GVL E
Sbjct: 141 NGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYE 200
Query: 845 VIKGYHP----GDFVSTIFSSISNMIIEVNQILDHRLPTPSRDVTDKLRSIMEVAILCLV 900
++ G P G+ S + IS I++ + ++D+ +L L+
Sbjct: 201 LLTGASPFTVDGEKNSQ--AEISRRILKSEPPYPQEMSALAKDIIQRL----------LM 248
Query: 901 ENPEAR 906
++P+ R
Sbjct: 249 KDPKKR 254
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 3e-09
Identities = 46/188 (24%), Positives = 88/188 (46%), Gaps = 21/188 (11%)
Query: 671 NIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFIVCEYLAR 730
+ AVK +A++ +TA ++FL E+ ++ +++ NII+ G C + ++ EY+
Sbjct: 45 VLVAVKMLRADV--TKTAR-NDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMEN 101
Query: 731 GSLTTILRDDAAAKEF---------SWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSK 781
G L L F S + + +A+ + YL VHRD++++
Sbjct: 102 GDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLAS---LNFVHRDLATR 158
Query: 782 NVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAG----TVGYAAPELAYTMRATEKYDVYS 837
N L+ + Y ++DFG ++ L +S ++ G + + A E + T DV++
Sbjct: 159 NCLVGNHYTIKIADFGMSRNL--YSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWA 216
Query: 838 FGVLALEV 845
FGV E+
Sbjct: 217 FGVTLWEM 224
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 3e-09
Identities = 65/251 (25%), Positives = 118/251 (47%), Gaps = 35/251 (13%)
Query: 654 IGKGGQRSVYKA-ELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKF- 711
IGKG V A + +G A+KK ++F + ++ + L E+ L +RH +I++
Sbjct: 8 IGKGSYGVVCSAIDTHTGEKVAIKKIN-DVF-EHVSDATRILREIKLLRLLRHPDIVEIK 65
Query: 712 HGFCSNAQHSF---IVCEYLARGSLTTILR--DDAAAKEFSWNQRMNVIKGVANALSYLH 766
H ++ F V L L +++ DD + + + + AL Y+H
Sbjct: 66 HIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHHQF-----FLYQLLRALKYIH 120
Query: 767 HDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAK--FLE-PHSSNWTEFAGTVGYAAPEL 823
+ HRD+ KN+L +++ + + DFG A+ F + P + WT++ T Y APEL
Sbjct: 121 ---TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPEL 177
Query: 824 --AYTMRATEKYDVYSFGVLALEVIKG--YHPGDFVSTIFSSISNMIIEVNQILDHRLPT 879
++ + T D++S G + EV+ G PG N++ +++ I D L T
Sbjct: 178 CGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPG----------KNVVHQLDLITD-LLGT 226
Query: 880 PSRDVTDKLRS 890
PS + ++R+
Sbjct: 227 PSPETISRVRN 237
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 4e-09
Identities = 77/309 (24%), Positives = 124/309 (40%), Gaps = 53/309 (17%)
Query: 626 FFSVLNFNGKVL-YEEITKATGNFGEKYCIGKGGQRSVYK-AELPSGNIFAVKKFKAELF 683
+ + +N +L E + T + IGKG VYK G++ AVK
Sbjct: 1 LYGLFPYNSSMLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISD 60
Query: 684 SDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHS-----FIVCEYLARGSLTTILR 738
DE + + L H N++KF+G A ++V E GS+T +++
Sbjct: 61 VDEEIEAEYNILQSLP----NHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVK 116
Query: 739 DDAAAKEFSWNQRMN------VIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAH 792
QR++ ++ G L +LH++ I+HRD+ N+LL +E
Sbjct: 117 G-----LLICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVK 168
Query: 793 VSDFGFAKFLEPHSSNWTEFAGTVGYAAPEL-----AYTMRATEKYDVYSFGVLALEVIK 847
+ DFG + L GT + APE+ Y + DV+S G+ A+E+
Sbjct: 169 LVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGD 228
Query: 848 G------YHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRDVTDK-LRSIMEVAILCLV 900
G HP V T+F N P P+ +K RS CL+
Sbjct: 229 GDPPLFDMHP---VKTLFKIPRN-------------PPPTLLHPEKWCRSFNHFISQCLI 272
Query: 901 ENPEARPTM 909
++ EARP++
Sbjct: 273 KDFEARPSV 281
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 4e-09
Identities = 46/152 (30%), Positives = 72/152 (47%), Gaps = 21/152 (13%)
Query: 761 ALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAK-FLEPHSSNWTEFAGTVGYA 819
AL +LH IV+RDI +N+LLDSE ++DFG +K FL F GT+ Y
Sbjct: 117 ALEHLHK---LGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYM 173
Query: 820 APELAYTMRATEK-YDVYSFGVLALEVIKGYHP----GDFVSTIFSSISNMIIEVNQILD 874
APE+ K D +S G+L E++ G P G+ + S +S I++ +
Sbjct: 174 APEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQ--SEVSRRILKCDPPFP 231
Query: 875 HRLPTPSRDVTDKLRSIMEVAILCLVENPEAR 906
+ ++D+ KL L ++P+ R
Sbjct: 232 SFIGPEAQDLLHKL----------LRKDPKKR 253
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 5e-09
Identities = 45/152 (29%), Positives = 69/152 (45%), Gaps = 9/152 (5%)
Query: 700 LTEIRHRNIIKFHGFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVA 759
L E+ H I+ + + + E++ G L T LR A F + +
Sbjct: 72 LMELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLR---KAGRFPNDVAKFYHAELV 128
Query: 760 NALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGTVGYA 819
A YLH I++RD+ +N+LLD++ V+DFGFAK + + GT Y
Sbjct: 129 LAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTFT---LCGTPEYL 182
Query: 820 APELAYTMRATEKYDVYSFGVLALEVIKGYHP 851
APE+ + + D ++ GVL E I GY P
Sbjct: 183 APEVIQSKGHGKAVDWWTMGVLLYEFIAGYPP 214
|
Length = 329 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 6e-09
Identities = 53/221 (23%), Positives = 99/221 (44%), Gaps = 37/221 (16%)
Query: 654 IGKGGQRSVYKAELPS------GNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRN 707
IG+G V++A P + AVK K E S + +F E + E H N
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQA--DFQREAALMAEFDHPN 69
Query: 708 IIKFHGFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQ----------------- 750
I+K G C+ + ++ EY+A G L LR + + S +
Sbjct: 70 IVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSC 129
Query: 751 --RMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSN 808
++ + K VA ++YL VHRD++++N L+ ++DFG ++ + +S++
Sbjct: 130 TEQLCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNI--YSAD 184
Query: 809 WTEFAGT----VGYAAPELAYTMRATEKYDVYSFGVLALEV 845
+ + + + + PE + R T + DV+++GV+ E+
Sbjct: 185 YYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEI 225
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 7e-09
Identities = 63/282 (22%), Positives = 113/282 (40%), Gaps = 48/282 (17%)
Query: 655 GKGGQRSVYKAELPSGNIFAVKKFKAELFSDETANP---SEFLNEVLALTEIRHRNIIKF 711
GK + +Y + + A+K K + NP EF E + E+ H NI+
Sbjct: 19 GKIYKGHLYLPGMDHAQLVAIKTLK------DINNPQQWGEFQQEASLMAELHHPNIVCL 72
Query: 712 HGFCSNAQHSFIVCEYLARGSLTTIL--------------RDDAAAKEFSWNQRMNVIKG 757
G + Q ++ EYL +G L L D +++
Sbjct: 73 LGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQ 132
Query: 758 VANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGT-- 815
+A + YL VH+D++++N+L+ + +SD G ++ E +S+++
Sbjct: 133 IAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSR--EIYSADYYRVQPKSL 187
Query: 816 --VGYAAPELAYTMRATEKYDVYSFGVLALEVIK-GYHPGDFVSTIFSSISNMIIEVNQI 872
+ + PE + + D++SFGV+ E+ G P + SN EV ++
Sbjct: 188 LPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQP-------YYGFSNQ--EVIEM 238
Query: 873 LDHR--LPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEV 912
+ R LP D ++ S+M C E P RP K++
Sbjct: 239 VRKRQLLPCS-EDCPPRMYSLMTE---CWQEGPSRRPRFKDI 276
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 7e-09
Identities = 54/200 (27%), Positives = 90/200 (45%), Gaps = 9/200 (4%)
Query: 654 IGKGGQRSVYKAELPS-GNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFH 712
IGKG V A+ S G+ +AVK + + + + L ++H ++ H
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLH 62
Query: 713 GFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPP 772
A+ + V +Y+ G L L+ + + F + VA+A+ YLH
Sbjct: 63 YSFQTAEKLYFVLDYVNGGELFFHLQRE---RCFLEPRARFYAAEVASAIGYLHS---LN 116
Query: 773 IVHRDISSKNVLLDSEYEAHVSDFGFAK-FLEPHSSNWTEFAGTVGYAAPELAYTMRATE 831
I++RD+ +N+LLDS+ ++DFG K +EP + T F GT Y APE+
Sbjct: 117 IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTST-FCGTPEYLAPEVLRKEPYDR 175
Query: 832 KYDVYSFGVLALEVIKGYHP 851
D + G + E++ G P
Sbjct: 176 TVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 7e-09
Identities = 51/197 (25%), Positives = 88/197 (44%), Gaps = 10/197 (5%)
Query: 654 IGKGGQRSVYKAELPSGN-IFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFH 712
+G+G V K I A+KKFK ++E + L E+ L ++ NI++
Sbjct: 9 VGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETT--LRELKMLRTLKQENIVELK 66
Query: 713 GFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPP 772
++V EY+ + L + + + I + A+ + H +
Sbjct: 67 EAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPP---EKVRSYIYQLIKAIHWCHKN---D 120
Query: 773 IVHRDISSKNVLLDSEYEAHVSDFGFAKFL-EPHSSNWTEFAGTVGYAAPELAYTMRATE 831
IVHRDI +N+L+ + DFGFA+ L E ++N+TE+ T Y +PEL +
Sbjct: 121 IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAPYGK 180
Query: 832 KYDVYSFGVLALEVIKG 848
D++S G + E+ G
Sbjct: 181 AVDMWSVGCILGELSDG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 7e-09
Identities = 56/205 (27%), Positives = 92/205 (44%), Gaps = 19/205 (9%)
Query: 654 IGKGGQRSVYKAELP-SGNIFAVKKFKAE-LFSDETANPSEFLNEVLALTEIRHRNIIKF 711
+GKG V A L SG ++AVK K + + D+ + +L+L H + +
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLAR-NHPFLTQL 61
Query: 712 HGFCSNAQHSFIVCEYLARGSLTTILR-----DDAAAKEFSWNQRMNVIKGVANALSYLH 766
+ F V E++ G L ++ D+A A+ ++ + +AL +LH
Sbjct: 62 YCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAE--------ITSALMFLH 113
Query: 767 HDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGTVGYAAPELAYT 826
I++RD+ NVLLD E ++DFG K + + F GT Y APE+
Sbjct: 114 DK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQE 170
Query: 827 MRATEKYDVYSFGVLALEVIKGYHP 851
M D ++ GVL E++ G+ P
Sbjct: 171 MLYGPSVDWWAMGVLLYEMLCGHAP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 8e-09
Identities = 31/85 (36%), Positives = 40/85 (47%)
Query: 434 LDLSANKLSSSIPMSIGNLLKLHYLNLSNNQFSHKIPTEFEKLIHLSELDLSHNILQEEI 493
L L L IP I L L +NLS N IP + L LDLS+N I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 494 PPQICKMESLEKLNLSHNNLSDFIP 518
P + ++ SL LNL+ N+LS +P
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVP 507
|
Length = 623 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.3 bits (139), Expect = 8e-09
Identities = 59/218 (27%), Positives = 103/218 (47%), Gaps = 33/218 (15%)
Query: 650 EKYCIGKGGQRSVYKA-ELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNI 708
EK IG+G VYKA + +G I A+KK + E +++ PS + E+ L E+ H NI
Sbjct: 5 EK--IGEGTYGVVYKARDKLTGEIVALKKIRLE--TEDEGVPSTAIREISLLKELNHPNI 60
Query: 709 IKFHGFCSNAQHSFIVCEYLARG------SLTTILRDDAAAKEFSWNQRMNVIKGVANAL 762
++ + ++V E+L S D K + + +++G+A
Sbjct: 61 VRLLDVVHSENKLYLVFEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQ----LLQGIA--- 113
Query: 763 SYLH-HDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGTVGYAAP 821
Y H H ++HRD+ +N+L+D E ++DFG A+ +T T+ Y AP
Sbjct: 114 -YCHSHR----VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVVTLWYRAP 168
Query: 822 ELAYTMRATEKY----DVYSFGVLALEVI--KGYHPGD 853
E+ + + +Y D++S G + E++ + PGD
Sbjct: 169 EI---LLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGD 203
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 1e-08
Identities = 70/305 (22%), Positives = 130/305 (42%), Gaps = 53/305 (17%)
Query: 640 EITKATGNFGEKYCIGKGGQRSVYKAEL------PSGNIFAVKKFKAELFSDETANPSEF 693
EI +T F E+ +G+ VYK L A+K K + E EF
Sbjct: 1 EINLSTVRFMEE--LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA---EGPLREEF 55
Query: 694 LNEVLALTEIRHRNIIKFHGFCSNAQHSFIVCEYLARGSLTTIL------------RDDA 741
+E + + ++H NI+ G + Q ++ Y + L L DD
Sbjct: 56 KHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDK 115
Query: 742 AAKE-FSWNQRMNVIKGVANALSYL--HHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGF 798
K ++++ +A + +L HH +VH+D++++NVL+ + +SD G
Sbjct: 116 TVKSTLEPADFVHIVTQIAAGMEFLSSHH-----VVHKDLATRNVLVFDKLNVKISDLGL 170
Query: 799 AKFLEPHSSNWTEFAGT----VGYAAPELAYTMRATEKYDVYSFGVLALEVIK-GYHPGD 853
F E +++++ + G + + +PE + + D++S+GV+ EV G P
Sbjct: 171 --FREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP-- 226
Query: 854 FVSTIFSSISNMIIEVNQILDHR--LPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKE 911
+ SN +V +++ +R LP P D + ++M + C E P RP K+
Sbjct: 227 -----YCGYSNQ--DVIEMIRNRQVLPCPD-DCPAWVYTLM---LECWNEFPSRRPRFKD 275
Query: 912 VCNLL 916
+ + L
Sbjct: 276 IHSRL 280
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 57.3 bits (139), Expect = 1e-08
Identities = 66/262 (25%), Positives = 111/262 (42%), Gaps = 42/262 (16%)
Query: 648 FGEKY----CIGKGGQRSVYKA-ELPSGNIFAVKKF-KAELFSDETANPSEFLNEVLALT 701
G +Y IG G V A + SG A+KK A D L E+ L
Sbjct: 3 VGSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHA---FDVPTLAKRTLRELKILR 59
Query: 702 EIRHRNIIK----FHGFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRM-NVIK 756
+H NII ++ + ++V + L L I+ D E + +++
Sbjct: 60 HFKHDNIIAIRDILRPPGADFKDVYVVMD-LMESDLHHIIHSDQPLTEEHIRYFLYQLLR 118
Query: 757 GVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFL----EPHSSNWTEF 812
G L Y+H + +HRD+ N+L++ + E + DFG A+ L H TE+
Sbjct: 119 G----LKYIHSANV---IHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEY 171
Query: 813 AGTVGYAAPELAYTM-RATEKYDVYSFGVLALEVI--KGYHPG-DFVSTIFSSISNMIIE 868
T Y APEL ++ T D++S G + E++ + PG ++V + +I+
Sbjct: 172 VATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQL-----KLILS 226
Query: 869 VNQILDHRLPTPSRDVTDKLRS 890
V L +PS +V +++ S
Sbjct: 227 V-------LGSPSEEVLNRIGS 241
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 1e-08
Identities = 58/208 (27%), Positives = 91/208 (43%), Gaps = 26/208 (12%)
Query: 654 IGKGG-QRSVYKAELPSGNIFAVKKFKAELF--SDETANPSEFLNEVLALTEIRHRNIIK 710
+GKG + + E SG +A+K K E+ DE A+ L E L RH
Sbjct: 3 LGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHT---LTESRVLKNTRHP---- 55
Query: 711 FHGFCSNAQHSF-------IVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALS 763
F ++ ++SF V EY+ G L L + + FS ++ + +AL
Sbjct: 56 ---FLTSLKYSFQTKDRLCFVMEYVNGGELFFHLSRE---RVFSEDRTRFYGAEIVSALD 109
Query: 764 YLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGTVGYAAPEL 823
YLH IV+RD+ +N++LD + ++DFG K ++ F GT Y APE+
Sbjct: 110 YLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEV 166
Query: 824 AYTMRATEKYDVYSFGVLALEVIKGYHP 851
D + GV+ E++ G P
Sbjct: 167 LEDNDYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 1e-08
Identities = 61/267 (22%), Positives = 116/267 (43%), Gaps = 28/267 (10%)
Query: 654 IGKGGQRSVYKAELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHG 713
+G G VYKA+ + A K +E +++ E+ L H NI+K
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEEL---EDYMVEIDILASCDHPNIVKLLD 69
Query: 714 FCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPI 773
+ +I+ E+ A G++ ++ + + + Q V K AL+YLH + I
Sbjct: 70 AFYYENNLWILIEFCAGGAVDAVMLE--LERPLTEPQIRVVCKQTLEALNYLHEN---KI 124
Query: 774 VHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGTVGYAAPELAYTMRATE-- 831
+HRD+ + N+L + + ++DFG + F GT + APE+ + +
Sbjct: 125 IHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRP 184
Query: 832 ---KYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSR---DVT 885
K DV+S G+ +E+ + P ++ + +++++ + L PSR +
Sbjct: 185 YDYKADVWSLGITLIEMAQIEPPHHELNPM-----RVLLKIAKSEPPTLAQPSRWSSEFK 239
Query: 886 DKLRSIMEVAILCLVENPEARPTMKEV 912
D L+ CL +N +AR T ++
Sbjct: 240 DFLKK-------CLEKNVDARWTTTQL 259
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 1e-08
Identities = 62/277 (22%), Positives = 115/277 (41%), Gaps = 60/277 (21%)
Query: 639 EEITKATGNFGEKY----CIGKGGQRSV-YKAELPSGNIFAVKK----FKAELFSDETAN 689
+E+ K ++Y +G G +V + +G A+KK F++ELF+
Sbjct: 4 QEVNKTIWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRA-- 61
Query: 690 PSEFLNEVLALTEIRHRNII-------------KFHGFCSNAQHSFIVCEYLARGSLTTI 736
E+ L ++H N+I +FH F YL + T
Sbjct: 62 ----YRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDF------------YLVMPFMGTD 105
Query: 737 LRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDF 796
L ++ S ++ ++ + L Y+H I+HRD+ N+ ++ + E + DF
Sbjct: 106 LGKLMKHEKLSEDRIQFLVYQMLKGLKYIHA---AGIIHRDLKPGNLAVNEDCELKILDF 162
Query: 797 GFAKFLEPHSSNWTEFAGTVGYAAPELAYT-MRATEKYDVYSFGVLALEVIKGYHPGDFV 855
G A+ + S T + T Y APE+ M T+ D++S G + E++ G
Sbjct: 163 GLARQTD---SEMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTG------- 212
Query: 856 STIF--SSISNMIIEVNQILDHRLPTPSRDVTDKLRS 890
+F + ++E+ ++ TPS++ KL+S
Sbjct: 213 KPLFKGHDHLDQLMEIMKVTG----TPSKEFVQKLQS 245
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 56.8 bits (138), Expect = 2e-08
Identities = 48/183 (26%), Positives = 92/183 (50%), Gaps = 14/183 (7%)
Query: 662 VYKA-ELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHG--FCSNA 718
VY+A + +G I A+KK K E ++ P L E+ L +++H NI+ SN
Sbjct: 21 VYRARDKKTGEIVALKKLKME--KEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNL 78
Query: 719 QHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDI 778
++V EY+ L +++ + + F ++ ++ + + +++LH + I +HRD+
Sbjct: 79 DKIYMVMEYVEH-DLKSLM--ETMKQPFLQSEVKCLMLQLLSGVAHLHDNWI---LHRDL 132
Query: 779 SSKNVLLDSEYEAHVSDFGFA-KFLEPHSSNWTEFAGTVGYAAPELAY-TMRATEKYDVY 836
+ N+LL++ + DFG A ++ P +T+ T+ Y APEL + D++
Sbjct: 133 KTSNLLLNNRGILKICDFGLAREYGSP-LKPYTQLVVTLWYRAPELLLGAKEYSTAIDMW 191
Query: 837 SFG 839
S G
Sbjct: 192 SVG 194
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 2e-08
Identities = 56/221 (25%), Positives = 97/221 (43%), Gaps = 23/221 (10%)
Query: 696 EVLALTEIRHRNIIKFHGFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVI 755
EV L+ ++H NI+++ + +IV +Y G L + F +Q ++
Sbjct: 49 EVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVL-FPEDQILDWF 107
Query: 756 KGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFA-- 813
+ AL ++H I+HRDI S+N+ L + + DFG A+ L ++ E A
Sbjct: 108 VQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVL----NSTVELART 160
Query: 814 --GTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQ 871
GT Y +PE+ K D+++ G + E+ H F + NM V +
Sbjct: 161 CIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHA-------FEA-GNMKNLVLK 212
Query: 872 ILDHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEV 912
I+ P S + LR++ V+ L NP RP++ +
Sbjct: 213 IIRGSYPPVSSHYSYDLRNL--VSQL-FKRNPRDRPSVNSI 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 2e-08
Identities = 33/91 (36%), Positives = 44/91 (48%), Gaps = 4/91 (4%)
Query: 761 ALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGTVGYAA 820
L LH + IV+RD+ +N+LLD +SD G A + P GTVGY A
Sbjct: 114 GLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHV-PEGQTIKGRVGTVGYMA 169
Query: 821 PELAYTMRATEKYDVYSFGVLALEVIKGYHP 851
PE+ R T D ++ G L E+I G P
Sbjct: 170 PEVVKNERYTFSPDWWALGCLLYEMIAGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 2e-08
Identities = 59/265 (22%), Positives = 106/265 (40%), Gaps = 26/265 (9%)
Query: 654 IGKGGQRSVYKAELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHG 713
I + Q S+YK + ++ FK + NE+ L I NI+K +G
Sbjct: 28 IKENDQNSIYKGIF-NNKEVIIRTFK-KFHKGHKVLIDITENEIKNLRRIDSNNILKIYG 85
Query: 714 F----CSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDC 769
F + ++ EY RG L +L + K+ S+ ++++ L L+
Sbjct: 86 FIIDIVDDLPRLSLILEYCTRGYLREVLDKE---KDLSFKTKLDMAIDCCKGLYNLYKYT 142
Query: 770 IPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGTVGYAAPELAYTM-- 827
P +++++S + L+ Y+ + G K L F + Y + ++ +
Sbjct: 143 NKP--YKNLTSVSFLVTENYKLKIICHGLEKILSSPPFKNVNF---MVYFSYKMLNDIFS 197
Query: 828 RATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRDVTDK 887
T K D+YS GV+ E+ G P + ++T I ++II N L L P
Sbjct: 198 EYTIKDDIYSLGVVLWEIFTGKIPFENLTT--KEIYDLIINKNNSLKLPLDCP------- 248
Query: 888 LRSIMEVAILCLVENPEARPTMKEV 912
I + C + RP +KE+
Sbjct: 249 -LEIKCIVEACTSHDSIKRPNIKEI 272
|
Length = 283 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 2e-08
Identities = 53/215 (24%), Positives = 93/215 (43%), Gaps = 38/215 (17%)
Query: 695 NEVLALTEIRHRNIIKFHGFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWN----- 749
NE+LAL + H NI+K + +++++ + L + + D+A F W
Sbjct: 212 NEILALGRLNHENILKIEEILRSEANTYMITQKY-DFDLYSFMYDEA----FDWKDRPLL 266
Query: 750 -QRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFG----FAKFLEP 804
Q ++K + A+ Y+H ++HRDI +N+ L+ + + + DFG F K E
Sbjct: 267 KQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREA 323
Query: 805 HSSNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIK---------GYHPGDFV 855
W GTV +PE+ E D++S G++ L+++ G PG +
Sbjct: 324 FDYGWV---GTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQL 380
Query: 856 STIFSSISNMIIEVNQILDHRLPTPSRDVTDKLRS 890
I S+S + D P P + D + S
Sbjct: 381 LKIIDSLS--------VCDEEFPDPPCKLFDYIDS 407
|
Length = 501 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 2e-08
Identities = 32/120 (26%), Positives = 49/120 (40%), Gaps = 7/120 (5%)
Query: 773 IVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGTVGYAAPELAYTMRATEK 832
IV+RD+ +NVLLD +SD G A L AGT GY APE+
Sbjct: 116 IVYRDLKPENVLLDDHGNVRISDLGLAVEL-KGGKKIKGRAGTPGYMAPEVLQGEVYDFS 174
Query: 833 YDVYSFGVLALEVIKGYHP----GDFVSTIFSSISNMIIEVNQILDHRLPTPSRDVTDKL 888
D ++ G E+I G P + V + +E+ + ++D+ + L
Sbjct: 175 VDWFALGCTLYEMIAGRSPFRQRKEKVEK--EELKRRTLEMAVEYPDKFSPEAKDLCEAL 232
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 2e-08
Identities = 51/199 (25%), Positives = 85/199 (42%), Gaps = 7/199 (3%)
Query: 654 IGKGGQRSVYKAELP-SGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFH 712
IGKG V A+ G +AVK + ++ + + L ++H ++ H
Sbjct: 3 IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 713 GFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPP 772
+ + V +++ G L L+ + + F + +A+AL YLH
Sbjct: 63 YSFQTTEKLYFVLDFVNGGELFFHLQRE---RSFPEPRARFYAAEIASALGYLHS---IN 116
Query: 773 IVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGTVGYAAPELAYTMRATEK 832
IV+RD+ +N+LLDS+ ++DFG K S T F GT Y APE+
Sbjct: 117 IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQPYDNT 176
Query: 833 YDVYSFGVLALEVIKGYHP 851
D + G + E++ G P
Sbjct: 177 VDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 56.2 bits (136), Expect = 3e-08
Identities = 45/166 (27%), Positives = 68/166 (40%), Gaps = 31/166 (18%)
Query: 758 VANALSYL--HHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGT 815
+ AL YL H ++HRD+ N+LLD+ + DFG + L + T AG
Sbjct: 123 IVKALHYLKEKHG----VIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAK-TRSAGC 177
Query: 816 VGYAAPEL--------AYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMII 867
Y APE Y +RA DV+S G+ +E+ G P T F ++
Sbjct: 178 AAYMAPERIDPPDPNPKYDIRA----DVWSLGISLVELATGQFPYKNCKTEFEVLT---- 229
Query: 868 EVNQILDHRLPTPSRDVTDKLRSIM--EVAILCLVENPEARPTMKE 911
+IL P+ ++ S LCL ++ RP +E
Sbjct: 230 ---KILQEEPPSLP---PNEGFSPDFCSFVDLCLTKDHRKRPKYRE 269
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 3e-08
Identities = 63/223 (28%), Positives = 93/223 (41%), Gaps = 47/223 (21%)
Query: 654 IGKGGQRSVYKAELPSGN-IFAVKKFKAELFSD--------------ETANPSEFLNEVL 698
IG+G V EL I+A+K K EL +D ETA+ FL
Sbjct: 3 IGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFL---- 58
Query: 699 ALTEIRHRNIIKFHGFCSNAQHSFIVCEYLARGSLT-TILRDDAAAKEFSWNQRMNVIKG 757
+ H F V E+++ G L + R +E + +
Sbjct: 59 ----------VGLHSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISL- 107
Query: 758 VANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAK-FLEPHSSNWTEFAGTV 816
AL++LH I++RD+ NVLLD+E ++D+G K + P + T F GT
Sbjct: 108 ---ALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTST-FCGTP 160
Query: 817 GYAAPELAYTMRATEKY----DVYSFGVLALEVIKGYHPGDFV 855
Y APE+ +R E Y D ++ GVL E++ G P D V
Sbjct: 161 NYIAPEI---LRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIV 199
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 3e-08
Identities = 43/153 (28%), Positives = 69/153 (45%), Gaps = 6/153 (3%)
Query: 694 LNEVLALTEIRHRNIIKFHGFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMN 753
NE L + H NII+++ + IV EY G+L ++ + S
Sbjct: 47 QNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQK----RCNSLLDEDT 102
Query: 754 VIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYE-AHVSDFGFAKFLEPHSSNWTEF 812
++ L LHH I+HRD+ ++N+LLD + DFG +K L S +T
Sbjct: 103 ILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYT-V 161
Query: 813 AGTVGYAAPELAYTMRATEKYDVYSFGVLALEV 845
GT Y +PEL +K D+++ G + E+
Sbjct: 162 VGTPCYISPELCEGKPYNQKSDIWALGCVLYEL 194
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 56.0 bits (136), Expect = 3e-08
Identities = 68/273 (24%), Positives = 107/273 (39%), Gaps = 80/273 (29%)
Query: 654 IGKGGQRSVYKAE-LPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFH 712
IG G V A +G A+KK + +F D + L E+ L +RH NII
Sbjct: 8 IGSGAYGVVCSAVDKRTGRKVAIKKI-SNVFDDLI-DAKRILREIKLLRHLRHENIIGLL 65
Query: 713 G-FCSNAQHSF----IVCEYL---------ARGSLTT---------ILRDDAAAKEFSWN 749
+ F IV E + + LT ILR
Sbjct: 66 DILRPPSPEDFNDVYIVTELMETDLHKVIKSPQPLTDDHIQYFLYQILR----------- 114
Query: 750 QRMNVIKGVANALSYLH--HDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSS 807
L YLH + ++HRD+ N+L++S + + DFG A+ ++P
Sbjct: 115 -----------GLKYLHSAN-----VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDED 158
Query: 808 ---NWTEFAGTVGYAAPELAYTMRATEKY----DVYSFGVLALEVIKGYH--PG-DFVST 857
TE+ T Y APEL + ++ +Y D++S G + E++ PG D++
Sbjct: 159 EKGFLTEYVVTRWYRAPEL---LLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQ 215
Query: 858 IFSSISNMIIEVNQILDHRLPTPSRDVTDKLRS 890
+ N+I+EV L TPS + + S
Sbjct: 216 L-----NLIVEV-------LGTPSEEDLKFITS 236
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 3e-08
Identities = 67/277 (24%), Positives = 116/277 (41%), Gaps = 45/277 (16%)
Query: 654 IGKGGQRSVYKAE-LPSGNIFAVKKFKAELFSDETANPSEFLNEV-LALTEIRHRNIIKF 711
+G+G V K +P+G I AVK+ +A + S E L ++ +++ + + F
Sbjct: 9 LGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQ---KRLLMDLDISMRSVDCPYTVTF 65
Query: 712 HGFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRM--NVIK----GVANALSYL 765
+G +I C + SL D K + + +++ + AL YL
Sbjct: 66 YGALFREGDVWI-CMEVMDTSL-----DKFYKKVYDKGLTIPEDILGKIAVSIVKALEYL 119
Query: 766 HHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGTVGYAAPEL-- 823
H ++HRD+ NVL++ + + DFG + +L S T AG Y APE
Sbjct: 120 HSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYL-VDSVAKTIDAGCKPYMAPERIN 176
Query: 824 ------AYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRL 877
Y +++ DV+S G+ +E+ G P D T F + ++ E + +L
Sbjct: 177 PELNQKGYDVKS----DVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSP----QL 228
Query: 878 P--TPSRDVTDKLRSIMEVAILCLVENPEARPTMKEV 912
P S + D + CL +N + RP E+
Sbjct: 229 PAEKFSPEFQDFVNK-------CLKKNYKERPNYPEL 258
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 3e-08
Identities = 58/213 (27%), Positives = 92/213 (43%), Gaps = 11/213 (5%)
Query: 654 IGKGGQRSVYKAELPSGN-IFAVKKFKAEL-FSDETANPSEFLNEVLALTEIRHRNIIKF 711
+GKG V AE + ++A+K K ++ D+ + VLAL+ + + +
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSG-KPPFLTQL 66
Query: 712 HGFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIP 771
H + V EY+ G L ++ KE + +A L +LH
Sbjct: 67 HSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKE---PHAVFYAAEIAIGLFFLHSK--- 120
Query: 772 PIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGTVGYAAPELAYTMRATE 831
I++RD+ NV+LDSE ++DFG K F GT Y APE+ +
Sbjct: 121 GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAYQPYGK 180
Query: 832 KYDVYSFGVLALEVIKGYHP--GDFVSTIFSSI 862
D ++FGVL E++ G P G+ +F SI
Sbjct: 181 SVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSI 213
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 4e-08
Identities = 34/117 (29%), Positives = 58/117 (49%), Gaps = 6/117 (5%)
Query: 689 NPSE-FLNEVLALTEIRHRNIIKFHGFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFS 747
N SE F ++++ H++++ +G C S +V EY+ GSL T L+ + S
Sbjct: 41 NYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINIS 100
Query: 748 WNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEP 804
W ++ V K +A AL +L + H ++ +KNVLL E + + F K +P
Sbjct: 101 W--KLEVAKQLAWALHFLEDKGLT---HGNVCAKNVLLIREEDRKTGNPPFIKLSDP 152
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 50.2 bits (121), Expect = 4e-08
Identities = 25/61 (40%), Positives = 35/61 (57%), Gaps = 2/61 (3%)
Query: 478 HLSELDLSHNILQEEIPPQICK-MESLEKLNLSHNNLSDFIPRCFEEMRSLSWIDISYNE 536
+L LDLS+N L IP K + +L+ L+LS NNL+ P F + SL +D+S N
Sbjct: 1 NLKSLDLSNNRLTV-IPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNN 59
Query: 537 L 537
L
Sbjct: 60 L 60
|
Length = 60 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 4e-08
Identities = 53/210 (25%), Positives = 99/210 (47%), Gaps = 33/210 (15%)
Query: 654 IGKGGQRSVYKAE-LPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFH 712
+G+G +VYK +G I A+K+ L ++E PS + E+ + E++H NI++ H
Sbjct: 8 LGEGTYATVYKGRNRTTGEIVALKEIH--LDAEEGT-PSTAIREISLMKELKHENIVRLH 64
Query: 713 GFCSNAQHSFIVCEYL------------ARGSLTTILRDDAAAKEFSWNQRMNVIKGVAN 760
+V EY+ RG+L D K F++ ++KG+A
Sbjct: 65 DVIHTENKLMLVFEYMDKDLKKYMDTHGVRGAL-----DPNTVKSFTYQ----LLKGIA- 114
Query: 761 ALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGTVGYAA 820
+ H + ++HRD+ +N+L++ E ++DFG A+ + ++ T+ Y A
Sbjct: 115 ---FCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVVTLWYRA 168
Query: 821 PELAYTMRA-TEKYDVYSFGVLALEVIKGY 849
P++ R + D++S G + E+I G
Sbjct: 169 PDVLLGSRTYSTSIDIWSVGCIMAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 55.1 bits (133), Expect = 5e-08
Identities = 50/198 (25%), Positives = 94/198 (47%), Gaps = 14/198 (7%)
Query: 654 IGKGGQRSVYKAE-LPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFH 712
IG+G VYK +G I A+KK + E S+E PS + E+ L E++H NI+
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKIRLE--SEEEGVPSTAIREISLLKELQHPNIVCLQ 65
Query: 713 GFCSNAQHSFIVCEYLA---RGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDC 769
+++ E+L+ + L ++ + E + +++G+ + H
Sbjct: 66 DVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGIL----FCHSR- 120
Query: 770 IPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGTVGYAAPE-LAYTMR 828
++HRD+ +N+L+D++ ++DFG A+ +T T+ Y APE L + R
Sbjct: 121 --RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVVTLWYRAPEVLLGSPR 178
Query: 829 ATEKYDVYSFGVLALEVI 846
+ D++S G + E+
Sbjct: 179 YSTPVDIWSIGTIFAEMA 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 55.1 bits (133), Expect = 5e-08
Identities = 69/268 (25%), Positives = 112/268 (41%), Gaps = 26/268 (9%)
Query: 654 IGKGGQRSVYKA-ELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRN---II 709
IG+G +V K PSG I AVK+ ++ DE L ++ + +R + I+
Sbjct: 12 IGRGAFGTVNKMLHKPSGTIMAVKRIRST--VDEKEQ-KRLLMDLDVV--MRSSDCPYIV 66
Query: 710 KFHGFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRM--NVIKGVANALSYLHH 767
KF+G +I C L SL + + + + + AL+YL
Sbjct: 67 KFYGALFREGDCWI-CMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKE 125
Query: 768 DCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGTVGYAAPELAYTM 827
+ I+HRD+ N+LLD + DFG + L S T AG Y APE
Sbjct: 126 EL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQLV-DSIAKTRDAGCRPYMAPERIDPS 182
Query: 828 RATEKYD----VYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRD 883
+ YD V+S G+ EV G P +++F ++ ++ IL + R+
Sbjct: 183 AR-DGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILS---NSEERE 238
Query: 884 VTDKLRSIMEVAILCLVENPEARPTMKE 911
+ + + LCL+++ RP KE
Sbjct: 239 FSPSFVNFIN---LCLIKDESKRPKYKE 263
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 5e-08
Identities = 54/230 (23%), Positives = 97/230 (42%), Gaps = 42/230 (18%)
Query: 639 EEITKATGNFGEKYC----IGKGGQRSVYKA-ELPSGNIFAVKK----FKAELFSDETAN 689
EE+ K E+Y +G G SV A + +G A+KK F++E+F+
Sbjct: 4 EEVNKTVWELPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRA-- 61
Query: 690 PSEFLNEVLALTEIRHRNIIK----------FHGFCSNAQHSFIVCEYLARGSLTTILRD 739
E+ L ++H N+I F Q ++V Y+ + L I+
Sbjct: 62 ----YRELTLLKHMQHENVIGLLDVFTSAVSGDEF----QDFYLVMPYM-QTDLQKIM-- 110
Query: 740 DAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFA 799
S ++ ++ + L Y+H I+HRD+ N+ ++ + E + DFG A
Sbjct: 111 ---GHPLSEDKVQYLVYQMLCGLKYIHS---AGIIHRDLKPGNLAVNEDCELKILDFGLA 164
Query: 800 KFLEPHSSNWTEFAGTVGYAAPELAYT-MRATEKYDVYSFGVLALEVIKG 848
+ + + T + T Y APE+ M + D++S G + E++ G
Sbjct: 165 RHAD---AEMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTG 211
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 6e-08
Identities = 52/199 (26%), Positives = 85/199 (42%), Gaps = 7/199 (3%)
Query: 654 IGKGGQRSVYKAELPSGNIF-AVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFH 712
IGKG V A + F AVK + + + + L ++H ++ H
Sbjct: 3 IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 62
Query: 713 GFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPP 772
A + V +Y+ G L L+ + + F + +A+AL YLH
Sbjct: 63 FSFQTADKLYFVLDYINGGELFYHLQRE---RCFLEPRARFYAAEIASALGYLHS---LN 116
Query: 773 IVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGTVGYAAPELAYTMRATEK 832
IV+RD+ +N+LLDS+ ++DFG K H+ + F GT Y APE+ +
Sbjct: 117 IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQPYDRT 176
Query: 833 YDVYSFGVLALEVIKGYHP 851
D + G + E++ G P
Sbjct: 177 VDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.1 bits (133), Expect = 6e-08
Identities = 50/217 (23%), Positives = 92/217 (42%), Gaps = 19/217 (8%)
Query: 654 IGKGGQRSVYKAELP-SGNIFAVKKFKAELF--SDETANPSEFLNEVLALTEIRHRNIIK 710
+G+GG V+ A+ +G I A+K+ K L +E L E LT + ++K
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEV---RHVLTERDILTTTKSEWLVK 65
Query: 711 FHGFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCI 770
+ ++ ++ EY+ G T+L + E R + + A+ LH
Sbjct: 66 LLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDH--ARFYMAEMFE-AVDALHE--- 119
Query: 771 PPIVHRDISSKNVLLDSEYEAHVSDFGFAK-FLEPHSSNWTEFAGTVGYAAPELAYTMRA 829
+HRD+ +N L+D+ ++DFG +K + +S G+ Y APE+
Sbjct: 120 LGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVTYANS----VVGSPDYMAPEVLRGKGY 175
Query: 830 TEKYDVYSFGVLALEVIKGYHP--GDFVSTIFSSISN 864
D +S G + E + G+ P G + + ++
Sbjct: 176 DFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKY 212
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 7e-08
Identities = 57/215 (26%), Positives = 93/215 (43%), Gaps = 15/215 (6%)
Query: 654 IGKGGQRSVYKAELP-SGNIFAVKKFKAE-LFSDETANPSEFLNEVLALTEIRHRNIIKF 711
+GKG V AE + ++A+K K + + D+ + VLAL + + +
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPG-KPPFLTQL 66
Query: 712 HGFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIP 771
H + V EY+ G L ++ KE + +A L +LH
Sbjct: 67 HSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKE---PHAVFYAAEIAIGLFFLHSK--- 120
Query: 772 PIVHRDISSKNVLLDSEYEAHVSDFGFAK--FLEPHSSNWTEFAGTVGYAAPELAYTMRA 829
I++RD+ NV+LD+E ++DFG K ++ F GT Y APE+
Sbjct: 121 GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTR--TFCGTPDYIAPEIIAYQPY 178
Query: 830 TEKYDVYSFGVLALEVIKGYHP--GDFVSTIFSSI 862
+ D ++FGVL E++ G P G+ +F SI
Sbjct: 179 GKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSI 213
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 8e-08
Identities = 60/245 (24%), Positives = 105/245 (42%), Gaps = 24/245 (9%)
Query: 654 IGKGGQRSVYKAEL----PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNII 709
+GKGG V++ +G IFA+K K + + E L ++H I+
Sbjct: 4 LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIV 63
Query: 710 KFHGFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDC 769
+++ EYL+ G L L + F + + ++ AL +LH
Sbjct: 64 DLIYAFQTGGKLYLILEYLSGGELFMHLEREGI---FMEDTACFYLSEISLALEHLHQQ- 119
Query: 770 IPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGTVGYAAPELAYTMRA 829
I++RD+ +N+LLD++ ++DFG K + F GT+ Y APE+
Sbjct: 120 --GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEILMRSGH 177
Query: 830 TEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTP------SRD 883
+ D +S G L +++ G P F++ N +++IL +L P +RD
Sbjct: 178 GKAVDWWSLGALMYDMLTGAPP-------FTA-ENRKKTIDKILKGKLNLPPYLTPEARD 229
Query: 884 VTDKL 888
+ KL
Sbjct: 230 LLKKL 234
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 8e-08
Identities = 56/227 (24%), Positives = 96/227 (42%), Gaps = 45/227 (19%)
Query: 654 IGKGGQRSVYKAE-LPSGNIFAVKKFKAELFSDETANPSEF----------LNEVLALTE 702
+G+G V KA +G I A+KK K S++ + L E+ + E
Sbjct: 17 LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76
Query: 703 IRHRNIIKFHG-FCSNAQHSFI--VCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVA 759
I+H NI+ + + FI V + +A L ++ + +Q ++ +
Sbjct: 77 IKHENIMGLVDVYV---EGDFINLVMDIMA-SDLKKVVDRKI---RLTESQVKCILLQIL 129
Query: 760 NALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFA-KFLEPHSS----------- 807
N L+ LH +HRD+S N+ ++S+ ++DFG A ++ P S
Sbjct: 130 NGLNVLHKWYF---MHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQR 186
Query: 808 --NWTEFAGTVGYAAPELAYTMRATEKY----DVYSFGVLALEVIKG 848
T T+ Y APEL + EKY D++S G + E++ G
Sbjct: 187 REEMTSKVVTLWYRAPEL---LMGAEKYHFAVDMWSVGCIFAELLTG 230
|
Length = 335 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 54.9 bits (133), Expect = 9e-08
Identities = 83/307 (27%), Positives = 125/307 (40%), Gaps = 79/307 (25%)
Query: 654 IGKGGQRSVYKA-ELPSGNIFAVKK-FKAELFSDETANPSEFLNEVLALTEIR-HRNIIK 710
+GKG V+KA + + + A+KK F A F + T F E++ L E+ H NI+K
Sbjct: 15 LGKGAYGIVWKAIDRRTKEVVALKKIFDA--FRNATDAQRTF-REIMFLQELGDHPNIVK 71
Query: 711 FHGF--CSNAQHSFIVCEYLARGSLTT---------ILRDDAAAKEFSWNQRMNVIKGVA 759
N + ++V EY+ T IL D + ++ +
Sbjct: 72 LLNVIKAENDKDIYLVFEYM-----ETDLHAVIRANILEDV---------HKRYIMYQLL 117
Query: 760 NALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNW-----TEFAG 814
AL Y+H ++HRD+ N+LL+S+ ++DFG A+ L N T++
Sbjct: 118 KALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVA 174
Query: 815 TVGYAAPE--LAYTMRATEKYDVYSFGVLALEVIKG--YHPGDFVST------IFSSI-- 862
T Y APE L T R T+ D++S G + E++ G PG ST I I
Sbjct: 175 TRWYRAPEILLGST-RYTKGVDMWSVGCILGEMLLGKPLFPGT--STLNQLEKIIEVIGP 231
Query: 863 --------------SNMIIEVNQI----LDHRLPTPSRDVTDKLRSIMEVAILCLVENPE 904
+ M+ + LD LP S D D L+ LV NP
Sbjct: 232 PSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKK-------LLVFNPN 284
Query: 905 ARPTMKE 911
R T +E
Sbjct: 285 KRLTAEE 291
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 1e-07
Identities = 30/81 (37%), Positives = 45/81 (55%), Gaps = 1/81 (1%)
Query: 415 NQ-LFGGVPLEFGTLTELQYLDLSANKLSSSIPMSIGNLLKLHYLNLSNNQFSHKIPTEF 473
NQ L G +P + L LQ ++LS N + +IP S+G++ L L+LS N F+ IP
Sbjct: 427 NQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESL 486
Query: 474 EKLIHLSELDLSHNILQEEIP 494
+L L L+L+ N L +P
Sbjct: 487 GQLTSLRILNLNGNSLSGRVP 507
|
Length = 623 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 1e-07
Identities = 54/175 (30%), Positives = 86/175 (49%), Gaps = 6/175 (3%)
Query: 379 DSSKLQVLDLSSNHIFGKIPVQLVKLFSLNKLILSLNQLFGGVPLEFGTLTELQYLDLSA 438
+ L+LSSN + +P L +L SL+ L S G L L LDL+
Sbjct: 45 VAVNRLALNLSSNTLL-LLPSSLSRLLSLDLLSPSGISSLDGSEN-LLNLLPLPSLDLNL 102
Query: 439 NKLSSSIPMSIGNLLKLHYLNLSNNQFSHKIPTEFEKLIHLSELDLSHNILQEEIPPQIC 498
N+L S+I + L L L+L NN + P +L ELDLS N + E +P +
Sbjct: 103 NRLRSNIS-ELLELTNLTSLDLDNNNITDIPPLIGLLKSNLKELDLSDNKI-ESLPSPLR 160
Query: 499 KMESLEKLNLSHNNLSDFIPRCFEEMRSLSWIDISYNELQGPIPNSTAFKNGLME 553
+ +L+ L+LS N+LSD +P+ + +L+ +D+S N++ +P + L E
Sbjct: 161 NLPNLKNLDLSFNDLSD-LPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEE 213
|
Length = 394 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 1e-07
Identities = 62/244 (25%), Positives = 112/244 (45%), Gaps = 32/244 (13%)
Query: 654 IGKGGQRSVYKA-ELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKF- 711
IG G Q V A + G AVKK + F ++T + E++ L + H+NII
Sbjct: 29 IGSGAQGIVCAAFDTVLGINVAVKKL-SRPFQNQTHAKRAY-RELVLLKCVNHKNIISLL 86
Query: 712 -----HGFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLH 766
Q ++V E L +L ++ + + S+ ++ + + +LH
Sbjct: 87 NVFTPQKSLEEFQDVYLVME-LMDANLCQVIHMELDHERMSY-----LLYQMLCGIKHLH 140
Query: 767 HDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNW--TEFAGTVGYAAPELA 824
I+HRD+ N+++ S+ + DFG A+ +N+ T + T Y APE+
Sbjct: 141 S---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TACTNFMMTPYVVTRYYRAPEVI 194
Query: 825 YTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRDV 884
M E D++S G + E++KG S IF ++ I + N++++ +L TPS +
Sbjct: 195 LGMGYKENVDIWSVGCIMGELVKG-------SVIFQG-TDHIDQWNKVIE-QLGTPSAEF 245
Query: 885 TDKL 888
++L
Sbjct: 246 MNRL 249
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 1e-07
Identities = 62/253 (24%), Positives = 105/253 (41%), Gaps = 30/253 (11%)
Query: 679 KAELFSDETANPSEFLNEVLALTEI--RHRNIIKFHGFCSNAQHSFIVCEYLARGSLTTI 736
KAE F + E I + I GF S +++ ++ S +
Sbjct: 136 KAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSS 195
Query: 737 LRDDAAAKEFSWNQRMNVI----KGVANALSYL-HHDCIPPIVHRDISSKNVLLDSEYEA 791
D E SW ++ + VA + +L +CI HRD++++NVLL A
Sbjct: 196 DSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCI----HRDVAARNVLLTDGRVA 251
Query: 792 HVSDFGFAKFLEPHSSNWTEFAGT---VGYAAPELAYTMRATEKYDVYSFGVLALEVI-- 846
+ DFG A+ + + SN+ V + APE + T + DV+S+G+L E+
Sbjct: 252 KICDFGLARDIM-NDSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSL 310
Query: 847 -KGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRDVTDKLRSIMEVAILCLVENPEA 905
K +PG V++ F M+ Q+ P ++ SIM+ +C P
Sbjct: 311 GKSPYPGILVNSKF---YKMVKRGYQMSRPDFAPP------EIYSIMK---MCWNLEPTE 358
Query: 906 RPTMKEVCNLLCK 918
RPT ++ L+ +
Sbjct: 359 RPTFSQISQLIQR 371
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 1e-07
Identities = 56/207 (27%), Positives = 92/207 (44%), Gaps = 13/207 (6%)
Query: 654 IGKGGQRSVYKAELPSGN-IFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRN--IIK 710
IG+G V L + I+A+K K EL D+ +++ + E N ++
Sbjct: 3 IGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDD--EDIDWVQTEKHVFEQASSNPFLVG 60
Query: 711 FHGFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCI 770
H F+V EY+ G L ++ E + R + + AL++LH
Sbjct: 61 LHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPE--EHARFYAAE-ICIALNFLHER-- 115
Query: 771 PPIVHRDISSKNVLLDSEYEAHVSDFGFAK-FLEPHSSNWTEFAGTVGYAAPELAYTMRA 829
I++RD+ NVLLD++ ++D+G K L P + T F GT Y APE+
Sbjct: 116 -GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTST-FCGTPNYIAPEILRGEEY 173
Query: 830 TEKYDVYSFGVLALEVIKGYHPGDFVS 856
D ++ GVL E++ G P D ++
Sbjct: 174 GFSVDWWALGVLMFEMMAGRSPFDIIT 200
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 1e-07
Identities = 52/199 (26%), Positives = 86/199 (43%), Gaps = 7/199 (3%)
Query: 654 IGKGGQRSVYKAELPS-GNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFH 712
IGKG V A+ + G +AVK + + + + L ++H ++ H
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 713 GFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPP 772
A + V +Y+ G L L+ + + F + +A+AL YLH
Sbjct: 63 YSFQTADKLYFVLDYVNGGELFFHLQRE---RSFPEPRARFYAAEIASALGYLHS---LN 116
Query: 773 IVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGTVGYAAPELAYTMRATEK 832
I++RD+ +N+LLDS+ ++DFG K HS + F GT Y APE+
Sbjct: 117 IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQPYDRT 176
Query: 833 YDVYSFGVLALEVIKGYHP 851
D + G + E++ G P
Sbjct: 177 VDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 1e-07
Identities = 55/208 (26%), Positives = 91/208 (43%), Gaps = 17/208 (8%)
Query: 646 GNFGEKYCIGKGGQRSVYKAELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRH 705
G FG+ Y + K R +Y ++ S KK A + L+E + ++
Sbjct: 4 GTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLK- 62
Query: 706 RNIIKFHGFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYL 765
F ++V +Y++ G L L+ + FS ++ I + AL +L
Sbjct: 63 ---FSFQ----TDSDLYLVTDYMSGGELFWHLQKEG---RFSEDRAKFYIAELVLALEHL 112
Query: 766 H-HDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGTVGYAAPELA 824
H +D IV+RD+ +N+LLD+ + DFG +K + F GT Y APE+
Sbjct: 113 HKYD----IVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVL 168
Query: 825 YTMRA-TEKYDVYSFGVLALEVIKGYHP 851
+ T+ D +S GVL E+ G+ P
Sbjct: 169 LDEKGYTKHVDFWSLGVLVFEMCCGWSP 196
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 1e-07
Identities = 32/91 (35%), Positives = 44/91 (48%), Gaps = 4/91 (4%)
Query: 761 ALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGTVGYAA 820
L LH + V+RD+ +N+LLD +SD G A + P + GTVGY A
Sbjct: 114 GLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKI-PEGESIRGRVGTVGYMA 169
Query: 821 PELAYTMRATEKYDVYSFGVLALEVIKGYHP 851
PE+ R T D + G L E+I+G P
Sbjct: 170 PEVLNNQRYTLSPDYWGLGCLIYEMIEGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 1e-07
Identities = 53/212 (25%), Positives = 84/212 (39%), Gaps = 25/212 (11%)
Query: 693 FLNEVLALTEIRHRNIIKF--HGFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQ 750
F E + H NI+ G F V EY+ +L +L D A +
Sbjct: 25 FRRETALCARLYHPNIVALLDSGEAPPGL-LFAVFEYVPGRTLREVLAADGA---LPAGE 80
Query: 751 RMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLL---DSEYEAHVSDFGFAKFL----- 802
++ V +AL+ H+ IVHRD+ +N+++ A V DFG L
Sbjct: 81 TGRLMLQVLDALACAHNQ---GIVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRD 137
Query: 803 --EPHSSNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHP---GDFVST 857
+ TE GT Y APE T D+Y++G++ LE + G G V+
Sbjct: 138 ADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLECLTG-QRVVQGASVAE 196
Query: 858 I-FSSISNMIIEVNQILD-HRLPTPSRDVTDK 887
I + +S + + + + H L R +K
Sbjct: 197 ILYQQLSPVDVSLPPWIAGHPLGQVLRKALNK 228
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 2e-07
Identities = 56/208 (26%), Positives = 90/208 (43%), Gaps = 25/208 (12%)
Query: 654 IGKGG-QRSVYKAELPSGNIFAVKKFKAELF--SDETANPSEFLNEVLALTEIRHRNIIK 710
+GKG + + E +G +A+K K E+ DE A+ LTE R +
Sbjct: 3 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAH---------TLTENRVLQNSR 53
Query: 711 FHGFCSNAQHSF-------IVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALS 763
H F + ++SF V EY G L L + + FS ++ + +AL
Sbjct: 54 -HPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRE---RVFSEDRARFYGAEIVSALD 109
Query: 764 YLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGTVGYAAPEL 823
YLH + +V+RD+ +N++LD + ++DFG K + F GT Y APE+
Sbjct: 110 YLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEV 167
Query: 824 AYTMRATEKYDVYSFGVLALEVIKGYHP 851
D + GV+ E++ G P
Sbjct: 168 LEDNDYGRAVDWWGLGVVMYEMMCGRLP 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 2e-07
Identities = 47/194 (24%), Positives = 87/194 (44%), Gaps = 27/194 (13%)
Query: 731 GSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYL-HHDCIPPIVHRDISSKNVLLDSEY 789
+ +L DD + + + ++ VA + +L +C VHRD++++NVLL
Sbjct: 220 SEVKNLLSDDGS-EGLTTLDLLSFTYQVARGMEFLASKNC----VHRDLAARNVLLAQGK 274
Query: 790 EAHVSDFGFAKFLEPHSSNWTEFAGT---VGYAAPELAYTMRATEKYDVYSFGVLALEVI 846
+ DFG A+ + H SN+ T V + APE + T DV+S+G+L E+
Sbjct: 275 IVKICDFGLARDIM-HDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIF 333
Query: 847 K---GYHPGDFV-STIFSSISNMIIEVNQILDHRLPTPSRDVTDKLRSIMEVAILCLVEN 902
+PG V ST ++ I + +R+ P + + ++ + C
Sbjct: 334 SLGGTPYPGMIVDSTFYNKIKS---------GYRMAKPDHATQE----VYDIMVKCWNSE 380
Query: 903 PEARPTMKEVCNLL 916
PE RP+ + +++
Sbjct: 381 PEKRPSFLHLSDIV 394
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 2e-07
Identities = 54/228 (23%), Positives = 96/228 (42%), Gaps = 29/228 (12%)
Query: 631 NFNGKVLYEEI----TKATGNFGEKYCIGKGGQRSVYKAELPSGNI--FAVKKF-KAELF 683
K+ YE+ T TG+FG V A + + A+K+F K+++
Sbjct: 22 KRKNKMKYEDFNFIRTLGTGSFGR-----------VILATYKNEDFPPVAIKRFEKSKII 70
Query: 684 SDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFIVCEYLARGSLTTILRDDAAA 743
+ + +E L I H + +G + + ++V E++ G T LR +
Sbjct: 71 KQKQVD--HVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRN--- 125
Query: 744 KEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLE 803
K F + + YL IV+RD+ +N+LLD + ++DFGFAK ++
Sbjct: 126 KRFPNDVGCFYAAQIVLIFEYLQS---LNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVD 182
Query: 804 PHSSNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHP 851
+ GT Y APE+ + + D ++ G+ E++ G P
Sbjct: 183 TRTYT---LCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPP 227
|
Length = 340 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 2e-07
Identities = 48/197 (24%), Positives = 92/197 (46%), Gaps = 11/197 (5%)
Query: 654 IGKGGQRSVYKAELP-SGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFH 712
+G+G +VYK + N+ A+K+ + E E P + EV L +++H NI+ H
Sbjct: 14 LGEGTYATVYKGRSKLTDNLVALKEIRLE---HEEGAPCTAIREVSLLKDLKHANIVTLH 70
Query: 713 GFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPP 772
+ +V EYL + L L DD N ++ + + + L+Y H
Sbjct: 71 DIIHTEKSLTLVFEYLDK-DLKQYL-DDCGNSINMHNVKLFLFQ-LLRGLNYCHRR---K 124
Query: 773 IVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGTVGYAAPE-LAYTMRATE 831
++HRD+ +N+L++ E ++DFG A+ + ++ T+ Y P+ L + +
Sbjct: 125 VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGSTDYST 184
Query: 832 KYDVYSFGVLALEVIKG 848
+ D++ G + E+ G
Sbjct: 185 QIDMWGVGCIFYEMSTG 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 2e-07
Identities = 54/215 (25%), Positives = 92/215 (42%), Gaps = 31/215 (14%)
Query: 654 IGKGGQRSVYKAELPS-GNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFH 712
IGKGG VY A P A+KK + +L S+ FL E ++ H I+ +
Sbjct: 10 IGKGGMGEVYLAYDPVCSRRVALKKIREDL-SENPLLKKRFLREAKIAADLIHPGIVPVY 68
Query: 713 GFCSNAQHSFIVCEYLARGSLTTILRD----DAAAKEF----SWNQRMNVIKGVANALSY 764
CS+ + Y+ +L ++L+ ++ +KE S +++ + + Y
Sbjct: 69 SICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEY 128
Query: 765 LHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPH---------------SSNW 809
+H ++HRD+ N+LL E + D+G A F + S+
Sbjct: 129 VHSK---GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSM 185
Query: 810 T---EFAGTVGYAAPELAYTMRATEKYDVYSFGVL 841
T + GT Y APE + A+E D+Y+ GV+
Sbjct: 186 TIPGKIVGTPDYMAPERLLGVPASESTDIYALGVI 220
|
Length = 932 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.5 bits (129), Expect = 2e-07
Identities = 57/213 (26%), Positives = 91/213 (42%), Gaps = 37/213 (17%)
Query: 654 IGKGGQRSVYKA-ELPSGNIFAVKK---FKAELFSDETANPSEFLNEVLALTEIRHRNII 709
IG+G V A P+G A+KK F+ + F T L E+ L +H NII
Sbjct: 13 IGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRT------LREIKILRRFKHENII 66
Query: 710 KFH------GFCSNAQHSFIVCEY----LARGSLTTILRDDAAAKEFSWNQRMNVIKGVA 759
F S +IV E L + T L +D + F + +
Sbjct: 67 GILDIIRPPSFES-FNDVYIVQELMETDLYKLIKTQHLSNDHI-QYF--------LYQIL 116
Query: 760 NALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEP---HSSNWTEFAGTV 816
L Y+H ++HRD+ N+LL++ + + DFG A+ +P H+ TE+ T
Sbjct: 117 RGLKYIHS---ANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATR 173
Query: 817 GYAAPELAYTMRA-TEKYDVYSFGVLALEVIKG 848
Y APE+ + T+ D++S G + E++
Sbjct: 174 WYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSN 206
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 3e-07
Identities = 31/90 (34%), Positives = 45/90 (50%), Gaps = 3/90 (3%)
Query: 762 LSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGTVGYAAP 821
L +LH I++RD+ +NVLLD++ +SD G A L+ S +AGT G+ AP
Sbjct: 110 LEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAP 166
Query: 822 ELAYTMRATEKYDVYSFGVLALEVIKGYHP 851
EL D ++ GV E+I P
Sbjct: 167 ELLQGEEYDFSVDYFALGVTLYEMIAARGP 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 53.1 bits (128), Expect = 3e-07
Identities = 56/245 (22%), Positives = 104/245 (42%), Gaps = 30/245 (12%)
Query: 654 IGKGGQRSVYKAELP-SGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIK-- 710
+G G V A +G A+KK S A + E+ L + H N+I
Sbjct: 23 VGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRT--YRELRLLKHMDHENVIGLL 80
Query: 711 --FHGFCS--NAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLH 766
F S + Q ++V + L I++ ++ S + ++ + L Y+H
Sbjct: 81 DVFTPASSLEDFQDVYLVTHLMGA-DLNNIVK----CQKLSDDHIQFLVYQILRGLKYIH 135
Query: 767 HDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGTVGYAAPELAYT 826
I+HRD+ N+ ++ + E + DFG A+ + T + T Y APE+
Sbjct: 136 S---AGIIHRDLKPSNIAVNEDCELKILDFGLARHTD---DEMTGYVATRWYRAPEIMLN 189
Query: 827 -MRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRDVT 885
M + D++S G + E++ G T+F S+ I ++ +I++ + TP ++
Sbjct: 190 WMHYNQTVDIWSVGCIMAELLTG-------KTLFPG-SDHIDQLKRIMN-LVGTPDEELL 240
Query: 886 DKLRS 890
K+ S
Sbjct: 241 QKISS 245
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 4e-07
Identities = 49/171 (28%), Positives = 75/171 (43%), Gaps = 33/171 (19%)
Query: 761 ALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAK------FLEPHSSNWTEFAG 814
AL +H + +HRD+ S N+ L + DFGF+K L+ SS F G
Sbjct: 181 ALDEVHSRKM---MHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASS----FCG 233
Query: 815 TVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILD 874
T Y APEL R ++K D++S GV+ E++ + P F S I +
Sbjct: 234 TPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRP-------FKGPSQREIMQQVLYG 286
Query: 875 HRLPTPSRDVTDKLRSIMEVAILCLVENPEARPT---------MKEVCNLL 916
P P V+ ++++++ L +NP RPT +K V NL
Sbjct: 287 KYDPFPC-PVSSGMKALLDP---LLSKNPALRPTTQQLLHTEFLKYVANLF 333
|
Length = 478 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 4e-07
Identities = 46/197 (23%), Positives = 92/197 (46%), Gaps = 11/197 (5%)
Query: 654 IGKGGQRSVYKAELP-SGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFH 712
+G+G +V+K + N+ A+K+ + E E P + EV L +++H NI+ H
Sbjct: 14 LGEGTYATVFKGRSKLTENLVALKEIRLE---HEEGAPCTAIREVSLLKDLKHANIVTLH 70
Query: 713 GFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPP 772
+ +V EYL + L + DD N ++ + + + L+Y H
Sbjct: 71 DIVHTDKSLTLVFEYLDK-DLKQYM-DDCGNIMSMHNVKIFLYQ-ILRGLAYCHRR---K 124
Query: 773 IVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGTVGYAAPE-LAYTMRATE 831
++HRD+ +N+L++ E ++DFG A+ + ++ T+ Y P+ L + +
Sbjct: 125 VLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSSEYST 184
Query: 832 KYDVYSFGVLALEVIKG 848
+ D++ G + E+ G
Sbjct: 185 QIDMWGVGCIFFEMASG 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 51.8 bits (125), Expect = 5e-07
Identities = 54/199 (27%), Positives = 95/199 (47%), Gaps = 22/199 (11%)
Query: 655 GKGGQRSVYKAELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGF 714
GK G+ SV K + P+ +F K KA+ F N E + V L + + N IK +
Sbjct: 27 GKFGKVSVLKHK-PTQKLFVQKIIKAKNF-----NAIEPM--VHQLMK-DNPNFIKLYYS 77
Query: 715 CSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLH-HDCIPPI 773
+ + ++ +Y+ G L +L+ + + S + +I+ + AL+ LH H+ I
Sbjct: 78 VTTLKGHVLIMDYIKDGDLFDLLKKE---GKLSEAEVKKIIRQLVEALNDLHKHN----I 130
Query: 774 VHRDISSKNVLLD-SEYEAHVSDFGFAKFLEPHSSNWTEFAGTVGYAAPELAYTMRATEK 832
+H DI +NVL D ++ ++ D+G K + + GT+ Y +PE
Sbjct: 131 IHNDIKLENVLYDRAKDRIYLCDYGLCK----IIGTPSCYDGTLDYFSPEKIKGHNYDVS 186
Query: 833 YDVYSFGVLALEVIKGYHP 851
+D ++ GVL E++ G HP
Sbjct: 187 FDWWAVGVLTYELLTGKHP 205
|
Length = 267 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 5e-07
Identities = 29/79 (36%), Positives = 40/79 (50%), Gaps = 1/79 (1%)
Query: 773 IVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGTVGYAAPELAYTMRATEK 832
IV+RD+ +N+LLD +SD G A + P GTVGY APE+ + T
Sbjct: 123 IVYRDLKPENILLDDRGHIRISDLGLAVQI-PEGETVRGRVGTVGYMAPEVINNEKYTFS 181
Query: 833 YDVYSFGVLALEVIKGYHP 851
D + G L E+I+G P
Sbjct: 182 PDWWGLGCLIYEMIQGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 5e-07
Identities = 33/90 (36%), Positives = 44/90 (48%), Gaps = 4/90 (4%)
Query: 762 LSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGTVGYAAP 821
L LH + IV+RD+ +N+LLD +SD G A + P GTVGY AP
Sbjct: 115 LEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEI-PEGETIRGRVGTVGYMAP 170
Query: 822 ELAYTMRATEKYDVYSFGVLALEVIKGYHP 851
E+ R T D + G L E+I+G P
Sbjct: 171 EVVKNERYTFSPDWWGLGCLIYEMIEGKSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 52.0 bits (125), Expect = 6e-07
Identities = 54/204 (26%), Positives = 91/204 (44%), Gaps = 41/204 (20%)
Query: 638 YEEITK-ATGNFGEKYCIGKGGQRSVYKA-ELPSGNIFAVKKFKAELFSDETANPSEFLN 695
YE++ K G FGE V+KA + I A+KK E +++ P L
Sbjct: 14 YEKLAKIGQGTFGE-----------VFKARHKKTKQIVALKKVLME--NEKEGFPITALR 60
Query: 696 EVLALTEIRHRNIIKFHGFC-------SNAQHSFIV----CEY-LARGSLTTILRDDAAA 743
E+ L ++H N++ C + + SF + CE+ LA L +
Sbjct: 61 EIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAG------LLSNKNV 114
Query: 744 KEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAK-FL 802
K F+ ++ V+K + N L Y+H + I+HRD+ + N+L+ + ++DFG A+ F
Sbjct: 115 K-FTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADFGLARAFS 170
Query: 803 EPHSSNWTEFAG---TVGYAAPEL 823
+S + T+ Y PEL
Sbjct: 171 LSKNSKPNRYTNRVVTLWYRPPEL 194
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 7e-07
Identities = 68/275 (24%), Positives = 114/275 (41%), Gaps = 49/275 (17%)
Query: 654 IGKGGQRSVYKA-ELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHR----NI 708
+G G +VYKA L + I AVK ++ E ++++ EI ++ I
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPLDI-------TVELQKQIMSELEILYKCDSPYI 61
Query: 709 IKFHGFCSNAQHSFIVCEYLARGSLTT-------ILRDDAAAKEFSWNQRMNVIKGVANA 761
I F+G I E++ GSL +L A A V+KG
Sbjct: 62 IGFYGAFFVENRISICTEFMDGGSLDVYRKIPEHVLGRIAVA----------VVKG---- 107
Query: 762 LSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGTVGYAAP 821
L+YL I+HRD+ N+L+++ + + DFG + L +S + GT Y AP
Sbjct: 108 LTYLWS---LKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLV--NSIAKTYVGTNAYMAP 162
Query: 822 ELAYTMRATEKY----DVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRL 877
E + E+Y DV+S G+ +E+ G P + + S M +++ Q +
Sbjct: 163 ERI----SGEQYGIHSDVWSLGISFMELALGRFP--YPQIQKNQGSLMPLQLLQCIVDED 216
Query: 878 PTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEV 912
P P V + C+ + P+ RP + +
Sbjct: 217 P-PVLPVGQFSEKFVHFITQCMRKQPKERPAPENL 250
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 7e-07
Identities = 70/285 (24%), Positives = 121/285 (42%), Gaps = 42/285 (14%)
Query: 654 IGKGGQRSVYKAELPSGNIFA---VKKFKAELFSDETANPSE---FLNEVLALTEIRHRN 707
IG G V E+ SG A VK+ + +A+ E FL E ++H N
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRV------SASVQEQMKFLEEAQPYRSLQHSN 56
Query: 708 IIKFHGFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWN----QRMNVIKGVANALS 763
+++ G C+ +V E+ G L LR A+ + + QRM +A L
Sbjct: 57 LLQCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMAC--EIALGLL 114
Query: 764 YLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFA--KFLEPHSSNWTEFAGTVGYAAP 821
+LH + +H D++ +N LL ++ + D+G + K+ E + + + + AP
Sbjct: 115 HLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAP 171
Query: 822 ELAYTMRA-------TEKYDVYSFGVLALEVIK-GYHPGDFVSTIFSSISNMIIEVNQIL 873
EL + T++ +V+S GV E+ + G P +S + + Q+
Sbjct: 172 ELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSD--EQVLTYTVREQQL- 228
Query: 874 DHRLPTPSRDVT--DKLRSIMEVAILCLVENPEARPTMKEVCNLL 916
+LP P + D+ +M+ L PE RP+ +EV LL
Sbjct: 229 --KLPKPRLKLPLSDRWYEVMQFCWL----QPEQRPSAEEVHLLL 267
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 8e-07
Identities = 55/232 (23%), Positives = 101/232 (43%), Gaps = 24/232 (10%)
Query: 692 EFLNEVLALTEIRHRNIIKFHGFCSNAQHS------FIVCEYLARGSLTTILRDDAAAKE 745
+FL+E + + E H N+++ G C S ++ ++ G L + L
Sbjct: 46 DFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDC 105
Query: 746 FSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPH 805
+ ++K + + S + + +HRD++++N +L+ V+DFG +K + +
Sbjct: 106 PQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKI--Y 163
Query: 806 SSNWTEFAGT----VGYAAPELAYTMRATEKYDVYSFGVLALEV-IKGYHPGDFVSTIFS 860
+ ++ V + A E T K DV+SFGV E+ +G P V S
Sbjct: 164 NGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVEN--S 221
Query: 861 SISNMIIEVNQILDHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEV 912
I + + + N RL P D D L S+M C + NP+ RP+ + +
Sbjct: 222 EIYDYLRQGN-----RLKQPP-DCLDGLYSLMSS---CWLLNPKDRPSFETL 264
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 9e-07
Identities = 48/197 (24%), Positives = 87/197 (44%), Gaps = 11/197 (5%)
Query: 654 IGKGGQRSVYKAELP-SGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFH 712
+G+G +V+K + N+ A+K+ + E E P + EV L ++H NI+ H
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEIRLE---HEEGAPCTAIREVSLLKNLKHANIVTLH 69
Query: 713 GFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPP 772
+ +V EYL L L D S + + + LSY H
Sbjct: 70 DIIHTERCLTLVFEYL-DSDLKQYL--DNCGNLMSMHNVKIFMFQLLRGLSYCHKR---K 123
Query: 773 IVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGTVGYAAPE-LAYTMRATE 831
I+HRD+ +N+L++ + E ++DFG A+ + ++ T+ Y P+ L + +
Sbjct: 124 ILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSTEYST 183
Query: 832 KYDVYSFGVLALEVIKG 848
D++ G + E+ G
Sbjct: 184 PIDMWGVGCILYEMATG 200
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 45.6 bits (109), Expect = 1e-06
Identities = 22/57 (38%), Positives = 28/57 (49%)
Query: 431 LQYLDLSANKLSSSIPMSIGNLLKLHYLNLSNNQFSHKIPTEFEKLIHLSELDLSHN 487
L+ LDLS N+L+ + L L L+LS N + P F L L LDLS N
Sbjct: 2 LKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGN 58
|
Length = 60 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 1e-06
Identities = 47/196 (23%), Positives = 86/196 (43%), Gaps = 30/196 (15%)
Query: 672 IFAVKKFKAELFSDETANP-SEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFIVCEYLAR 730
+ AVK + D N ++FL EV L+ ++ NII+ G C + ++ EY+
Sbjct: 48 LVAVKILRP----DANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMEN 103
Query: 731 GSLTTILR----DDAAAKE------------FSWNQRMNVIKGVANALSYLHHDCIPPIV 774
G L L DD S++ ++V +A+ + YL V
Sbjct: 104 GDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSS---LNFV 160
Query: 775 HRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAG----TVGYAAPELAYTMRAT 830
HRD++++N L+ ++DFG ++ L ++ ++ G + + A E + T
Sbjct: 161 HRDLATRNCLVGENLTIKIADFGMSRNL--YAGDYYRIQGRAVLPIRWMAWECILMGKFT 218
Query: 831 EKYDVYSFGVLALEVI 846
DV++FGV E++
Sbjct: 219 TASDVWAFGVTLWEIL 234
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 1e-06
Identities = 47/167 (28%), Positives = 70/167 (41%), Gaps = 22/167 (13%)
Query: 762 LSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSS-NWTEFAGTVGYAA 820
L YLH I+HRDI N+L++S + DFG A+ EP S + T+ T Y A
Sbjct: 116 LKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRA 172
Query: 821 PELAYTMRA-TEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPT 879
PE+ R T D++S G + E++ I + I +++ I D L T
Sbjct: 173 PEILMGSRHYTSAVDIWSVGCIFAELLGR--------RILFQAQSPIQQLDLITDL-LGT 223
Query: 880 PSRDVTDKLRSIMEVAILCLVENPEARPTM--------KEVCNLLCK 918
PS + IL P + P + E +LLC+
Sbjct: 224 PSLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCR 270
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 1e-06
Identities = 32/93 (34%), Positives = 46/93 (49%), Gaps = 7/93 (7%)
Query: 761 ALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVS--DFGFAKFLEPHSSNWTEFAGTVGY 818
AL LH +++RD+ +N+LLD Y+ H++ DFG K F GT Y
Sbjct: 105 ALENLHK---FNVIYRDLKPENILLD--YQGHIALCDFGLCKLNMKDDDKTNTFCGTPEY 159
Query: 819 AAPELAYTMRATEKYDVYSFGVLALEVIKGYHP 851
APEL T+ D ++ GVL E++ G P
Sbjct: 160 LAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPP 192
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 1e-06
Identities = 42/156 (26%), Positives = 75/156 (48%), Gaps = 10/156 (6%)
Query: 696 EVLALTEIRHRNIIKFHG-FCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNV 754
E L I H +II+ G F N I+ Y + L L AA + + + +
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLILPRY--KTDLYCYL---AAKRNIAICDILAI 187
Query: 755 IKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKF-LEPHSSNWTEFA 813
+ V A+ YLH + I+HRDI ++N+ ++ + + DFG A F ++ +++ + +A
Sbjct: 188 ERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWA 244
Query: 814 GTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGY 849
GT+ APEL D++S G++ E+ +
Sbjct: 245 GTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280
|
Length = 391 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 1e-06
Identities = 50/219 (22%), Positives = 98/219 (44%), Gaps = 26/219 (11%)
Query: 646 GNFGEKYCIGKGGQRSVYKAEL---PSGN---IFAVKKFKAELFSDETANPSEFLNEVLA 699
G FGE + G + SGN + AVK + + +++ A ++FL E+
Sbjct: 16 GQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLRED--ANKNAR-NDFLKEIKI 72
Query: 700 LTEIRHRNIIKFHGFCSNAQHSFIVCEYLARGSLTTILR--------DDAAAKEFSWNQR 751
++ ++ NII+ C + ++ EY+ G L L + A S++
Sbjct: 73 MSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTL 132
Query: 752 MNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTE 811
+ + +A+ + YL VHRD++++N L+ Y ++DFG ++ L +S ++
Sbjct: 133 IFMATQIASGMKYLSS---LNFVHRDLATRNCLVGKNYTIKIADFGMSRNL--YSGDYYR 187
Query: 812 FAG----TVGYAAPELAYTMRATEKYDVYSFGVLALEVI 846
G + + + E + T DV++FGV E++
Sbjct: 188 IQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEIL 226
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 1e-06
Identities = 65/238 (27%), Positives = 110/238 (46%), Gaps = 36/238 (15%)
Query: 647 NFGEKYCIGKG--GQRSVYKAELPSGNIFAVKKF-KAELFSDETANPSEFLNEVLALTEI 703
+F K +G+G G+ V + E +G+I+A+K K+ L + ET + E ++L++
Sbjct: 2 DFDVKSLVGRGHFGEVQVVR-EKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSI--- 57
Query: 704 RHRN---IIKFHGFCSNAQHSFIVCEYLARGSLTTILR--DDAAAKEFSWNQRMNVIKGV 758
N I + + + ++V EY G L ++L +D +F + + +
Sbjct: 58 --SNSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYED----QFDEDMAQFYLAEL 111
Query: 759 ANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFA----G 814
A+ +H VHRDI +NVL+D ++DFG A L ++N + G
Sbjct: 112 VLAIHSVHQ---MGYVHRDIKPENVLIDRTGHIKLADFGSAARL---TANKMVNSKLPVG 165
Query: 815 TVGYAAPELAYTMRATEK--YDV----YSFGVLALEVIKGYHP--GDFVSTIFSSISN 864
T Y APE+ TM K Y V +S GV+A E+I G P + +++I N
Sbjct: 166 TPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMN 223
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 1e-06
Identities = 51/207 (24%), Positives = 95/207 (45%), Gaps = 24/207 (11%)
Query: 654 IGKGGQRSVYKA-ELPSGNIF-AVKKFKAELFSDETANPSEFLNEVLALTEIR---HRNI 708
IG+G V+KA +L +G F A+K+ + + + E P + EV L + H N+
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQ--TGEEGMPLSTIREVAVLRHLETFEHPNV 66
Query: 709 IKFHGFCSNAQHS-----FIVCEYLARGSLTTILR---DDAAAKEFSWNQRMNVIKGVAN 760
++ C+ ++ +V E++ + LTT L + E + +++G
Sbjct: 67 VRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRG--- 122
Query: 761 ALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGTVGYAA 820
L +LH +VHRD+ +N+L+ S + ++DFG A+ + T T+ Y A
Sbjct: 123 -LDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL-TSVVVTLWYRA 177
Query: 821 PELAYTMRATEKYDVYSFGVLALEVIK 847
PE+ D++S G + E+ +
Sbjct: 178 PEVLLQSSYATPVDLWSVGCIFAEMFR 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 2e-06
Identities = 27/81 (33%), Positives = 41/81 (50%), Gaps = 4/81 (4%)
Query: 479 LSELDLSHNILQEEIPPQICKMESLEKLNLSHNNLSDFIPRCFEEMRSLSWIDISYNELQ 538
+ L L + L+ IP I K+ L+ +NLS N++ IP + SL +D+SYN
Sbjct: 420 IDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFN 479
Query: 539 GPIPNS----TAFKNGLMEGN 555
G IP S T+ + + GN
Sbjct: 480 GSIPESLGQLTSLRILNLNGN 500
|
Length = 623 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 2e-06
Identities = 41/158 (25%), Positives = 75/158 (47%), Gaps = 29/158 (18%)
Query: 654 IGKGGQRSVYKA-ELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFH 712
IG+G +V+KA + I A+K+ + + D+ PS L E+ L E++H+NI++ +
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRVRLD--DDDEGVPSSALREICLLKELKHKNIVRLY 65
Query: 713 GFCSNAQHSFIVCEYL----------ARGSLTTILRDDAAAKEFSWNQRMNVIKGVANAL 762
+ + +V EY G + D K F ++KG+A
Sbjct: 66 DVLHSDKKLTLVFEYCDQDLKKYFDSCNGDI-----DPEIVKSFM----FQLLKGLAFCH 116
Query: 763 SYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAK 800
S H+ ++HRD+ +N+L++ E ++DFG A+
Sbjct: 117 S--HN-----VLHRDLKPQNLLINKNGELKLADFGLAR 147
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 2e-06
Identities = 68/285 (23%), Positives = 120/285 (42%), Gaps = 43/285 (15%)
Query: 654 IGKGGQRSVYKAEL---PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIK 710
IG G V +E+ VK+ KA S E +EFL + ++H NI++
Sbjct: 3 IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQ---NEFLQQGDPYRILQHPNILQ 59
Query: 711 FHGFCSNAQHSFIVCEYLARGSLTTILRD------DAAAKEFSWNQRMNVIKGVANALSY 764
G C A +V EY G L + L ++ QRM +A +++
Sbjct: 60 CLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLL---QRMAC--EIAAGVTH 114
Query: 765 LH-HDCIPPIVHRDISSKNVLLDSEYEAHVSDF--GFAKFLEPHSSNWTEFAGTVGYAAP 821
+H H+ +H D++ +N L S+ V D+ G +++ E + + + + AP
Sbjct: 115 MHKHN----FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAP 170
Query: 822 ELA-------YTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQIL- 873
EL T T+ +V++ GV E+ + + +S +S+ + +N ++
Sbjct: 171 ELVGEFHGGLITAEQTKPSNVWALGVTLWELF------ENAAQPYSHLSDREV-LNHVIK 223
Query: 874 --DHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLL 916
+L P ++ R EV C + +PE R T +EV LL
Sbjct: 224 DQQVKLFKPQLELPYSER-WYEVLQFCWL-SPEKRATAEEVHRLL 266
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 50.5 bits (120), Expect = 2e-06
Identities = 46/197 (23%), Positives = 90/197 (45%), Gaps = 11/197 (5%)
Query: 654 IGKGGQRSVYKAELP-SGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFH 712
+G+G +VYK + +G + A+K + + +E P + E L ++H NI+ H
Sbjct: 13 LGEGSYATVYKGKSKVNGKLVALKVIRLQ---EEEGTPFTAIREASLLKGLKHANIVLLH 69
Query: 713 GFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPP 772
+ +V EY+ + D N ++ + + + LSY+H I
Sbjct: 70 DIIHTKETLTLVFEYVHTDLCQYM--DKHPGGLHPENVKLFLFQ-LLRGLSYIHQRYI-- 124
Query: 773 IVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGTVGYAAPE-LAYTMRATE 831
+HRD+ +N+L+ E ++DFG A+ S ++ T+ Y P+ L + +
Sbjct: 125 -LHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLGSTEYST 183
Query: 832 KYDVYSFGVLALEVIKG 848
D++ G + +E+I+G
Sbjct: 184 CLDMWGVGCIFVEMIQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 3e-06
Identities = 61/250 (24%), Positives = 106/250 (42%), Gaps = 37/250 (14%)
Query: 666 ELPSGNIFAVKKFKAELF--SDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSF- 722
E +G +A+K K E+ DE A+ LTE R + H F + ++SF
Sbjct: 16 EKATGKYYAMKILKKEVIIAKDEVAH---------TLTESRVLQNTR-HPFLTALKYSFQ 65
Query: 723 ------IVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHR 776
V EY G L L + + FS ++ + +AL YLH +V+R
Sbjct: 66 THDRLCFVMEYANGGELFFHLSRE---RVFSEDRARFYGAEIVSALGYLHSC---DVVYR 119
Query: 777 DISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGTVGYAAPELAYTMRATEKYDVY 836
D+ +N++LD + ++DFG K + F GT Y APE+ D +
Sbjct: 120 DLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWW 179
Query: 837 SFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRDVTDKLRSIMEVAI 896
GV+ E++ G P ++ + E+ + + R P R ++ + +S++
Sbjct: 180 GLGVVMYEMMCGRLP------FYNQDHEKLFELILMEEIRFP---RTLSPEAKSLLAG-- 228
Query: 897 LCLVENPEAR 906
L ++P+ R
Sbjct: 229 -LLKKDPKQR 237
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 3e-06
Identities = 56/228 (24%), Positives = 93/228 (40%), Gaps = 43/228 (18%)
Query: 700 LTEIRHRNIIKFHGFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVA 759
++++ H ++ HG C + +V E++ G L LR + +W ++ V + +A
Sbjct: 70 MSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAW--KITVAQQLA 127
Query: 760 NALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSS----NWTEFAGT 815
+ALSYL +VH ++ +KN+LL A + F K +P S + E
Sbjct: 128 SALSYLEDK---NLVHGNVCAKNILLARLGLAEGTS-PFIKLSDPGVSFTALSREERVER 183
Query: 816 VGYAAPELAYTMRA-TEKYDVYSFGVLALEV-------IKGYHPGDFVSTIFSSISNMII 867
+ + APE + + D +SFG LE+ +K P +
Sbjct: 184 IPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE-------------K 230
Query: 868 EVNQILDHRLPTPSRDVTDKLRSIMEVAIL---CLVENPEARPTMKEV 912
E HRLP P S E+A L CL P RP+ + +
Sbjct: 231 ERFYEKKHRLPEP---------SCKELATLISQCLTYEPTQRPSFRTI 269
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 3e-06
Identities = 59/223 (26%), Positives = 96/223 (43%), Gaps = 39/223 (17%)
Query: 654 IGKGGQRSVYKA-ELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRN-IIKF 711
IG+G VYKA + +G + A+KK + E DE P L E+ L + I++
Sbjct: 9 IGEGTYGKVYKARDKNTGKLVALKKTRLE--MDEEGIPPTALREISLLQMLSESIYIVRL 66
Query: 712 ----HGFCSNAQHS-FIVCEYL-----------ARGSLTTILRDDAAAKEFSWNQRMNVI 755
H N + S ++V EYL RG + K F + ++
Sbjct: 67 LDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPL--PAKTIKSFMYQ----LL 120
Query: 756 KGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEA-HVSDFGFAKFLEPHSSNWTEFAG 814
KGVA + H ++HRD+ +N+L+D + ++D G + ++T
Sbjct: 121 KGVA----HCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIV 173
Query: 815 TVGYAAPE--LAYTMRATEKYDVYSFGVLALEVIKG--YHPGD 853
T+ Y APE L T +T D++S G + E+ + PGD
Sbjct: 174 TLWYRAPEVLLGSTHYST-PVDIWSVGCIFAEMSRKQPLFPGD 215
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 4e-06
Identities = 47/167 (28%), Positives = 74/167 (44%), Gaps = 26/167 (15%)
Query: 758 VANALSYL-HHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAK--FLEPHSSNWTEFAG 814
VA + +L CI HRD++++N+LL + DFG A+ + +P +
Sbjct: 182 VARGMEFLASRKCI----HRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL 237
Query: 815 TVGYAAPELAYTMRATEKYDVYSFGVLALEVIK---GYHPGDFVSTIFSSISNMIIEVNQ 871
+ + APE + T + DV+SFGVL E+ +PG + E +
Sbjct: 238 PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPG----------VQIDEEFCR 287
Query: 872 ILDH--RLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLL 916
L R+ P T ++ SIM + C NPE RPT E+ +L
Sbjct: 288 RLKEGTRMRAPEY-ATPEIYSIM---LDCWHNNPEDRPTFSELVEIL 330
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 4e-06
Identities = 52/202 (25%), Positives = 89/202 (44%), Gaps = 14/202 (6%)
Query: 654 IGKGG-QRSVYKAELPSGNIFAVKKFKAELF--SDETANPSEFLNEVLALTEIRHRNIIK 710
+GKG + + E +G +A+K + E+ DE A+ + E L RH +
Sbjct: 3 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHT---VTESRVLQNTRHPFLTA 59
Query: 711 F-HGFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDC 769
+ F ++ + F++ EY G L L + + F+ + + +AL YLH
Sbjct: 60 LKYAFQTHDRLCFVM-EYANGGELFFHLSRE---RVFTEERARFYGAEIVSALEYLHSR- 114
Query: 770 IPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGTVGYAAPELAYTMRA 829
+V+RDI +N++LD + ++DFG K + F GT Y APE+
Sbjct: 115 --DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDY 172
Query: 830 TEKYDVYSFGVLALEVIKGYHP 851
D + GV+ E++ G P
Sbjct: 173 GRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 4e-06
Identities = 43/170 (25%), Positives = 74/170 (43%), Gaps = 32/170 (18%)
Query: 758 VANALSYL-HHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAK--FLEPHSSNWTEFAG 814
VA + +L CI HRD++++N+LL + DFG A+ + +P
Sbjct: 183 VARGMEFLASRKCI----HRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARL 238
Query: 815 TVGYAAPELAYTMRATEKYDVYSFGVLALEVIK---GYHPGDFVSTIFSSISNMIIEVNQ 871
+ + APE + T + DV+SFGVL E+ +PG +++N+
Sbjct: 239 PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPG--------------VQINE 284
Query: 872 ILDHRLPTPSR-----DVTDKLRSIMEVAILCLVENPEARPTMKEVCNLL 916
RL +R + T ++ IM + C +P+ RPT + +L
Sbjct: 285 EFCQRLKDGTRMRAPENATPEIYRIM---LACWQGDPKERPTFSALVEIL 331
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 4e-06
Identities = 35/125 (28%), Positives = 54/125 (43%), Gaps = 18/125 (14%)
Query: 773 IVHRDISSKNVLLDSEYEAHVSDFGFA---KFLEPHSSNWTEFAGTVGYAAPEL-----A 824
+V+RD+ N+LLD +SD G A +PH+S GT GY APE+ A
Sbjct: 118 VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS-----VGTHGYMAPEVLQKGVA 172
Query: 825 YTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFS-SISNMIIEVNQILDHRLPTPSRD 883
Y A D +S G + ++++G+ P T I M + + L R
Sbjct: 173 YDSSA----DWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRS 228
Query: 884 VTDKL 888
+ + L
Sbjct: 229 LLEGL 233
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 43.3 bits (103), Expect = 1e-05
Identities = 22/60 (36%), Positives = 30/60 (50%)
Query: 142 NLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSENRLSGLIPLSLSNLSSLTVMSLFNNSL 201
NL +L L N L+ L +L LDLS N L+ + P + S L SL + L N+L
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 1e-05
Identities = 61/212 (28%), Positives = 93/212 (43%), Gaps = 23/212 (10%)
Query: 654 IGKGGQRSVYKA-ELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFH 712
IGKG V+K +G+ AVK DE +E+ N + AL++ H N++KF+
Sbjct: 26 IGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIE-AEY-NILKALSD--HPNVVKFY 81
Query: 713 GF-----CSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMN--VIKGVAN-ALSY 764
G N ++V E GS+T D +RM +I + + AL
Sbjct: 82 GMYYKKDVKNGDQLWLVLELCNGGSVT-----DLVKGFLKRGERMEEPIIAYILHEALMG 136
Query: 765 LHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGTVGYAAPE-L 823
L H + +HRD+ N+LL +E + DFG + L GT + APE +
Sbjct: 137 LQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVI 196
Query: 824 AYTMRATEKY----DVYSFGVLALEVIKGYHP 851
A + Y DV+S G+ A+E+ G P
Sbjct: 197 ACEQQLDSTYDARCDVWSLGITAIELGDGDPP 228
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 47.7 bits (114), Expect = 1e-05
Identities = 59/244 (24%), Positives = 105/244 (43%), Gaps = 31/244 (12%)
Query: 654 IGKGGQRSVYKA-ELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIR-HRNIIKF 711
IG+G V KA +G +A+K K S E N L E+ AL + H NI++
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNN---LREIQALRRLSPHPNILRL 63
Query: 712 HGFCSNAQHS--FIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDC 769
+ + +V E L +L +++ + + + + + +L ++H +
Sbjct: 64 IEVLFDRKTGRLALVFE-LMDMNLYELIKG--RKRPLPEKRVKSYMYQLLKSLDHMHRN- 119
Query: 770 IPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGTVGYAAPELAYTM-R 828
I HRDI +N+L+ + ++DFG + + +TE+ T Y APE T
Sbjct: 120 --GIFHRDIKPENILIKDD-ILKLADFGSCRGIYSKPP-YTEYISTRWYRAPECLLTDGY 175
Query: 829 ATEKYDVYSFGVLALEVI--KGYHPGDFVSTIFSSISNMIIEVNQILDHR-LPTPSRDVT 885
K D+++ G + E++ PG +N + ++ +I H L TP +V
Sbjct: 176 YGPKMDIWAVGCVFFEILSLFPLFPG----------TNELDQIAKI--HDVLGTPDAEVL 223
Query: 886 DKLR 889
K R
Sbjct: 224 KKFR 227
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 1e-05
Identities = 28/79 (35%), Positives = 40/79 (50%), Gaps = 1/79 (1%)
Query: 773 IVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGTVGYAAPELAYTMRATEK 832
IV+RD+ +NVLLD + +SD G A L T+ AGT GY APE+ +
Sbjct: 116 IVYRDMKPENVLLDDQGNCRLSDLGLAVEL-KDGKTITQRAGTNGYMAPEILKEEPYSYP 174
Query: 833 YDVYSFGVLALEVIKGYHP 851
D ++ G E++ G P
Sbjct: 175 VDWFAMGCSIYEMVAGRTP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 1e-05
Identities = 58/196 (29%), Positives = 87/196 (44%), Gaps = 30/196 (15%)
Query: 714 FCS--NAQHSFIVCEYLARGSLTTILRDDAAAK-EFSWNQRMNVIKGVANALSYLHHDCI 770
FCS +H +V EY+ G T+L++ A + + RM + V AL YLH+
Sbjct: 67 FCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMA---RMYFAETVL-ALEYLHN--- 119
Query: 771 PPIVHRDISSKNVLLDSEYEAHVSDFGFAK---------FLEPHSSNWT-EF-----AGT 815
IVHRD+ N+L+ S ++DFG +K E H T EF GT
Sbjct: 120 YGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGT 179
Query: 816 VGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHP--GDFVSTIFSS-ISNMIIEVNQI 872
Y APE+ + D ++ G++ E + G P GD +F IS+ I
Sbjct: 180 PEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEG- 238
Query: 873 LDHRLPTPSRDVTDKL 888
D LP ++D+ +L
Sbjct: 239 -DEALPADAQDLISRL 253
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 1e-05
Identities = 48/223 (21%), Positives = 99/223 (44%), Gaps = 22/223 (9%)
Query: 654 IGKGGQRSVYKA-ELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFH 712
+G+G +VYK +G + A+K + E P + E L ++H NI+ H
Sbjct: 13 LGEGSYATVYKGISRINGQLVALKVISMK---TEEGVPFTAIREASLLKGLKHANIVLLH 69
Query: 713 GFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPP 772
+ V EY+ +++ +N R+ + + + L+Y+H
Sbjct: 70 DIIHTKETLTFVFEYMHTDLAQYMIQHPGGLH--PYNVRLFMFQ-LLRGLAYIHGQ---H 123
Query: 773 IVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGTVGYAAPELAYTMRATE- 831
I+HRD+ +N+L+ E ++DFG A+ S ++ T+ Y P++ + AT+
Sbjct: 124 ILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDV--LLGATDY 181
Query: 832 --KYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQI 872
D++ G + +E+++G F +S++ ++ +I
Sbjct: 182 SSALDIWGAGCIFIEMLQG-------QPAFPGVSDVFEQLEKI 217
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 1e-05
Identities = 27/83 (32%), Positives = 43/83 (51%), Gaps = 9/83 (10%)
Query: 773 IVHRDISSKNVLLDSEYEAHVSDFGFA---KFLEPHSSNWTEFAGTVGYAAPELAYTMRA 829
+V+RD+ N+LLD +SD G A +PH+S GT GY APE+ A
Sbjct: 118 VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS-----VGTHGYMAPEVLQKGTA 172
Query: 830 TEKY-DVYSFGVLALEVIKGYHP 851
+ D +S G + ++++G+ P
Sbjct: 173 YDSSADWFSLGCMLFKLLRGHSP 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.1 bits (115), Expect = 1e-05
Identities = 64/251 (25%), Positives = 102/251 (40%), Gaps = 66/251 (26%)
Query: 654 IGKGG---QRSVYKAELPSGNIFAVKKF-KAELFSDETANPSEFLNEVLALTEIRHRNII 709
IG+G R V K + +G+I+A+KK K+E+ E ++LA E + ++
Sbjct: 9 IGRGAFGEVRLVQKKD--TGHIYAMKKLRKSEMLEKEQVAHVRAERDILA--EADNPWVV 64
Query: 710 KFHGFCS--NAQHSFIVCEYLARGSLTTIL-RDDAAAKEFSWNQRMNVIKGVANALSYLH 766
K + S + + +++ EYL G + T+L + D F+ + I A+ +H
Sbjct: 65 KL--YYSFQDENYLYLIMEYLPGGDMMTLLMKKDT----FTEEETRFYIAETILAIDSIH 118
Query: 767 -HDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFA------------ 813
I HRDI N+LLD++ +SDFG L S+ TEF
Sbjct: 119 KLGYI----HRDIKPDNLLLDAKGHIKLSDFGLCTGL--KKSHRTEFYRILSHALPSNFL 172
Query: 814 ----------------------------GTVGYAAPELAYTMRATEKYDVYSFGVLALEV 845
GT Y APE+ ++ D +S GV+ E+
Sbjct: 173 DFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEM 232
Query: 846 IKGYHPGDFVS 856
+ GY P F S
Sbjct: 233 LVGYPP--FCS 241
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 2e-05
Identities = 44/161 (27%), Positives = 71/161 (44%), Gaps = 27/161 (16%)
Query: 696 EVLALTEIRHRNIIKFHGFCSNAQHSF----IVCEYLA--RGSLTTILRDDAAAKEFSWN 749
E+ L I HR II N H++ VC + + L T + +
Sbjct: 136 EIDILKTISHRAII-------NLIHAYRWKSTVCMVMPKYKCDLFTYVD---RSGPLPLE 185
Query: 750 QRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLE-----P 804
Q + + + + AL+YLH I+HRD+ ++N+ LD A + DFG A L+ P
Sbjct: 186 QAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTP 242
Query: 805 HSSNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEV 845
W +GT+ +PEL K D++S G++ E+
Sbjct: 243 QCYGW---SGTLETNSPELLALDPYCAKTDIWSAGLVLFEM 280
|
Length = 392 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 2e-05
Identities = 25/96 (26%), Positives = 46/96 (47%), Gaps = 5/96 (5%)
Query: 693 FLNEVLALTEIRHRNIIKFHGFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRM 752
F + ++ H++I+ +G C + +V E++ G L + + W +
Sbjct: 51 FFETASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPW--KF 108
Query: 753 NVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSE 788
V K +A+ALSYL +VH ++ +KN+LL E
Sbjct: 109 KVAKQLASALSYLEDK---DLVHGNVCTKNILLARE 141
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 2e-05
Identities = 57/253 (22%), Positives = 112/253 (44%), Gaps = 31/253 (12%)
Query: 654 IGKGGQRSVYKAELPSGN-IFAVKKF-KAELFSDETANPSEFLNEVLALTEIRHRNIIKF 711
IG+G V +L + + +FA+K K E+ + A + F E L ++ I
Sbjct: 9 IGRGAFGEVAVVKLKNADKVFAMKILNKWEML--KRAETACFREERDVLVNGDNQWITTL 66
Query: 712 HGFCSNAQHSFIVCEYLARGSLTTILR--DDAAAKEFSWNQRMNVIKGVANALSYLHHDC 769
H + + ++V +Y G L T+L +D ++ + ++ + +++ LH+
Sbjct: 67 HYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAI-DSVHQLHY-- 123
Query: 770 IPPIVHRDISSKNVLLDSEYEAHVSDFGFA-KFLEPHSSNWTEFAGTVGYAAPELAYTM- 827
VHRDI N+L+D ++DFG K +E + + GT Y +PE+ M
Sbjct: 124 ----VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAME 179
Query: 828 ----RATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHR----LPT 879
+ + D +S GV E++ G P F + +++ +I++H+ P
Sbjct: 180 DGKGKYGPECDWWSLGVCMYEMLYGETP--FYA------ESLVETYGKIMNHKERFQFPA 231
Query: 880 PSRDVTDKLRSIM 892
DV++ + ++
Sbjct: 232 QVTDVSEDAKDLI 244
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Score = 47.0 bits (112), Expect = 2e-05
Identities = 56/270 (20%), Positives = 99/270 (36%), Gaps = 55/270 (20%)
Query: 301 IPKSLRNLTSLERVRFNQNNLYGKVY------EAFGDHPNLTFLDLSQNNFYCEISFNWR 354
+ +LR SL+ + + N + L LDLS N +
Sbjct: 43 LASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGCGLQELDLSDNALGPDGCGVLE 102
Query: 355 NFSKLGTFNASMNNIYGSIPPEIGDSSKLQVLDLSSNHIFGKIPVQLV------KLFSLN 408
+ + SS LQ L L++N + G ++L+ +L
Sbjct: 103 SLLR---------------------SSSLQELKLNNNGL-GDRGLRLLAKGLKDLPPALE 140
Query: 409 KLILSLNQLFGG----VPLEFGTLTELQYLDLSANKLSSSIPMSIGNLLK----LHYLNL 460
KL+L N+L G + +L+ L+L+ N + + ++ LK L L+L
Sbjct: 141 KLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDL 200
Query: 461 SNNQFSHK----IPTEFEKLIHLSELDLSHNILQEEIPPQICK-----MESLEKLNLSHN 511
+NN + + + L L L+L N L + + SL L+LS N
Sbjct: 201 NNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCN 260
Query: 512 NLSDF----IPRCFEEMRSLSWIDISYNEL 537
+++D + E SL +D+ N+
Sbjct: 261 DITDDGAKDLAEVLAEKESLLELDLRGNKF 290
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 42.1 bits (100), Expect = 3e-05
Identities = 25/61 (40%), Positives = 33/61 (54%), Gaps = 2/61 (3%)
Query: 454 KLHYLNLSNNQFSHKIPTEFEKLIHLSELDLSHNILQEEIPPQ-ICKMESLEKLNLSHNN 512
L L+LSNN+ + F+ L +L LDLS N L I P+ + SL L+LS NN
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLT-SISPEAFSGLPSLRSLDLSGNN 59
Query: 513 L 513
L
Sbjct: 60 L 60
|
Length = 60 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 3e-05
Identities = 36/135 (26%), Positives = 56/135 (41%), Gaps = 34/135 (25%)
Query: 762 LSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGTVGYAAP 821
L Y+H I+HRD+ NV ++ + E + DFG A+ + T + T Y AP
Sbjct: 131 LKYIHS---AGIIHRDLKPSNVAVNEDCELRILDFGLARQAD---DEMTGYVATRWYRAP 184
Query: 822 ELAYT-MRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTP 880
E+ M + D++S G + E++KG +F P
Sbjct: 185 EIMLNWMHYNQTVDIWSVGCIMAELLKG-------KALF--------------------P 217
Query: 881 SRDVTDKLRSIMEVA 895
D D+L+ IMEV
Sbjct: 218 GNDYIDQLKRIMEVV 232
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.9 bits (112), Expect = 3e-05
Identities = 63/300 (21%), Positives = 114/300 (38%), Gaps = 80/300 (26%)
Query: 654 IGKGGQRSVYKA-ELPSGNIFAVKKFKAE--LFSDETANPSEFLNEVLALTEIRHRNIIK 710
IG+G V+ + +G ++A+K + + ++ A+ E L + I+K
Sbjct: 9 IGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAH---VRAERDILADADSPWIVK 65
Query: 711 FHGFCSNAQHSFIVCEYLARGSLTT------ILRDDAAAKEFSWNQRMNVIKGVANALSY 764
+ + +H ++V EY+ G L + ++ A R + + V AL
Sbjct: 66 LYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETA--------RFYIAELVL-ALDS 116
Query: 765 LH---HDCIPPIVHRDISSKNVLLDSEYEAHV--SDFGFAK------------------- 800
+H +HRDI N+L+D+ + H+ +DFG K
Sbjct: 117 VHKLGF------IHRDIKPDNILIDA--DGHIKLADFGLCKKMNKAKDREYYLNDSHNLL 168
Query: 801 FLEPHSSNWTEF----------AGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYH 850
F + + GT Y APE+ + D +S GV+ E++ G+
Sbjct: 169 FRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFP 228
Query: 851 PGDFVSTIFSSISNMIIEVNQILDH----RLPTPSRDVTDKLRSIMEVAILCLVENPEAR 906
P F S + N+I++ R P P V+ + + I L+ +PE R
Sbjct: 229 P-------FYSDTLQET-YNKIINWKESLRFP-PDPPVSPEAIDL----ICRLLCDPEDR 275
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 4e-05
Identities = 28/113 (24%), Positives = 54/113 (47%), Gaps = 7/113 (6%)
Query: 692 EFLNEVLALTEIRHRNIIKFHGFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQR 751
F ++++ H++++K +G C + +V EY+ G L L + W +
Sbjct: 47 AFFETASLMSQLSHKHLVKLYGVCV-RDENIMVEEYVKFGPLDVFLHREKNNVSLHW--K 103
Query: 752 MNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEP 804
++V K +A+AL YL +VH ++ KN+L+ + Y + F K +P
Sbjct: 104 LDVAKQLASALHYLEDK---KLVHGNVCGKNILV-ARYGLNEGYVPFIKLSDP 152
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 5e-05
Identities = 31/112 (27%), Positives = 50/112 (44%), Gaps = 24/112 (21%)
Query: 290 LNMCENHLFGPIPKSLRNLTSLERVRFNQNNLYGKVYEAFGDHPNLTFLDLSQNNFYCEI 349
L + L G IP + L L+ + + N++ G + + G +L LDLS N
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYN------ 476
Query: 350 SFNWRNFSKLGTFNASMNNIYGSIPPEIGDSSKLQVLDLSSNHIFGKIPVQL 401
SFN GSIP +G + L++L+L+ N + G++P L
Sbjct: 477 SFN------------------GSIPESLGQLTSLRILNLNGNSLSGRVPAAL 510
|
Length = 623 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 45.5 bits (108), Expect = 7e-05
Identities = 57/234 (24%), Positives = 99/234 (42%), Gaps = 25/234 (10%)
Query: 693 FLNEVLALTEIRHRNIIKFHGFCSNAQHSFIVCE-YLARGSLTTIL---RDDAAAKEFSW 748
L E L + H+NI+ C V Y+ G+L L R A +
Sbjct: 55 LLQESCLLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQAL 114
Query: 749 NQRMNVIKG--VANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEP-- 804
+ + V +A +SYLH ++H+DI+++N ++D E + ++D ++ L P
Sbjct: 115 STQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITDNALSRDLFPMD 171
Query: 805 -HSSNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIK-GYHPGDFVSTIFSSI 862
H E V + A E + DV+SFGVL E++ G P +V +
Sbjct: 172 YHCLGDNENR-PVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTP--YVEIDPFEM 228
Query: 863 SNMIIEVNQILDHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLL 916
+ + + +RL P + D+L ++M C +PE RP+ ++ L
Sbjct: 229 AAYLKD-----GYRLAQPI-NCPDELFAVMAC---CWALDPEERPSFSQLVQCL 273
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 7e-05
Identities = 54/206 (26%), Positives = 93/206 (45%), Gaps = 44/206 (21%)
Query: 727 YLARGSLTTILRDDAAAKE------FSWNQRMNVIKGVANALSYL-HHDCIPPIVHRDIS 779
Y+ + + IL +D A + FS+ VA +S+L +CI HRD++
Sbjct: 194 YIDQDVTSEILEEDELALDTEDLLSFSYQ--------VAKGMSFLASKNCI----HRDLA 241
Query: 780 SKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGT---VGYAAPELAYTMRATEKYDVY 836
++N+LL + DFG A+ + + SN+ V + APE + T + DV+
Sbjct: 242 ARNILLTHGRITKICDFGLARDIR-NDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVW 300
Query: 837 SFGVLALEVI---KGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPS---RDVTDKLRS 890
S+G+L E+ +PG V + F MI E +R+ +P ++ D ++S
Sbjct: 301 SYGILLWEIFSLGSSPYPGMPVDSKF---YKMIKE-----GYRMLSPECAPSEMYDIMKS 352
Query: 891 IMEVAILCLVENPEARPTMKEVCNLL 916
C +P RPT K++ L+
Sbjct: 353 -------CWDADPLKRPTFKQIVQLI 371
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 9e-05
Identities = 56/177 (31%), Positives = 81/177 (45%), Gaps = 9/177 (5%)
Query: 2 LNLGFNLLFGNIPPQIGNLSKLQYLDLGNNQLSGVIPPEIGKLNQLRRLYLDVNQLHGTI 61
L+L N + ++PP+I LS L+ LDL NN + + + L L L L N+L +
Sbjct: 191 LDLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKL-EDL 247
Query: 62 PPVIGQLSLINELVFCHNNVSGRIPSSLGNLSNLALLYLNDNSLFGSIPIVMGNLKSLST 121
P IG LS + L +N +S SSLG+L+NL L L+ NSL ++P++ L L
Sbjct: 248 PESIGNLSNLETLDLSNNQIS--SISSLGSLTNLRELDLSGNSLSNALPLI--ALLLLLL 303
Query: 122 LDLSQNQLNGSIPCSLDNLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSENRLS 178
L L N L+ L S P + L+SL L +N L
Sbjct: 304 ELLLNLLLTLKALELKLNSILLNNNILSNGETS--SPEALSILESLNNLWTLDNALD 358
|
Length = 394 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 9e-05
Identities = 57/211 (27%), Positives = 94/211 (44%), Gaps = 25/211 (11%)
Query: 654 IGKG--GQRSVYKAELPSGNIFAVKKF-KAELFSDETANPSEFLNEVLALTEIRHRNIIK 710
IG+G G+ +V K + +G ++A+K K E+ + A + F E L R I
Sbjct: 9 IGRGAFGEVAVVKMK-NTGQVYAMKILNKWEML--KRAETACFREERDVLVNGDRRWITN 65
Query: 711 FHGFCSNAQHSFIVCEYLARGSLTTILR--DDAAAKEFSWNQRMNVIKGV--ANALSYLH 766
H + + ++V +Y G L T+L +D ++ + R + + V +++ L
Sbjct: 66 LHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMA---RFYLAEMVLAIDSVHQLG 122
Query: 767 HDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFA-GTVGYAAPELAY 825
+ VHRDI NVLLD ++DFG L + + A GT Y +PE+
Sbjct: 123 Y------VHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQ 176
Query: 826 TMR-ATEKY----DVYSFGVLALEVIKGYHP 851
M +Y D +S GV E++ G P
Sbjct: 177 AMEDGKGRYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 1e-04
Identities = 30/93 (32%), Positives = 49/93 (52%), Gaps = 5/93 (5%)
Query: 754 VIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEF- 812
V + + +A+ Y+H + I+HRDI ++NVL++ + + DFG A F S +
Sbjct: 265 VARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYG 321
Query: 813 -AGTVGYAAPELAYTMRATEKYDVYSFGVLALE 844
AGTV APE+ T D++S G++ E
Sbjct: 322 IAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 45.1 bits (107), Expect = 1e-04
Identities = 38/136 (27%), Positives = 67/136 (49%), Gaps = 17/136 (12%)
Query: 761 ALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAK-FLEPHSSN---WTEFAGTV 816
L Y+H ++HRD+ N+L++++ E + DFG A+ F E N TE+ T
Sbjct: 117 GLKYIHS---ANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATR 173
Query: 817 GYAAPELAYTMRA-TEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDH 875
Y APE+ + ++ T+ DV+S G + E++ +F + + ++NQIL
Sbjct: 174 WYRAPEIMLSFQSYTKAIDVWSVGCILAELLGR-------KPVFKG-KDYVDQLNQIL-Q 224
Query: 876 RLPTPSRDVTDKLRSI 891
L TP + ++ S
Sbjct: 225 VLGTPDEETLSRIGSP 240
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 1e-04
Identities = 30/92 (32%), Positives = 48/92 (52%), Gaps = 9/92 (9%)
Query: 758 VANALSYL-HHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGT- 815
VAN + +L +C VHRD++++NVL+ + DFG A+ + SN+ T
Sbjct: 248 VANGMEFLASKNC----VHRDLAARNVLICEGKLVKICDFGLARDIM-RDSNYISKGSTF 302
Query: 816 --VGYAAPELAYTMRATEKYDVYSFGVLALEV 845
+ + APE + T DV+SFG+L E+
Sbjct: 303 LPLKWMAPESIFNNLYTTLSDVWSFGILLWEI 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Score = 44.3 bits (105), Expect = 2e-04
Identities = 30/129 (23%), Positives = 49/129 (37%), Gaps = 18/129 (13%)
Query: 430 ELQYLDLSANKLSS------SIPMSIGNLLKLHYLNLSNNQFSHKIPTEFEKLIH---LS 480
L+ L LS N+ S+ + L L+LS+N E L+ L
Sbjct: 52 SLKELCLSLNETGRIPRGLQSLLQGLTKGCGLQELDLSDNALGPDGCGVLESLLRSSSLQ 111
Query: 481 ELDLSHNILQEEIPPQICK-----MESLEKLNLSHNNLSDF----IPRCFEEMRSLSWID 531
EL L++N L + + K +LEKL L N L + + R L ++
Sbjct: 112 ELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKALRANRDLKELN 171
Query: 532 ISYNELQGP 540
++ N +
Sbjct: 172 LANNGIGDA 180
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 2e-04
Identities = 63/265 (23%), Positives = 114/265 (43%), Gaps = 36/265 (13%)
Query: 639 EEITKATGNFGEKY----CIGKGGQRSVYKA-ELPSGNIFAVKKFKAELFSDETANPSEF 693
+E+ K E+Y +G G SV A + +G AVKK S A +
Sbjct: 6 QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT-- 63
Query: 694 LNEVLALTEIRHRNIIKFHGFCSNAQ-----HSFIVCEYLARGSLTTILRDDAAAKEFSW 748
E+ L ++H N+I + A+ + + +L L I++ ++ +
Sbjct: 64 YRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK----CQKLTD 119
Query: 749 NQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSN 808
+ +I + L Y+H I+HRD+ N+ ++ + E + DFG A+ H+ +
Sbjct: 120 DHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDD 172
Query: 809 -WTEFAGTVGYAAPELAYT-MRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMI 866
T + T Y APE+ M + D++S G + E++ G T+F ++ I
Sbjct: 173 EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG-------RTLFPG-TDHI 224
Query: 867 IEVNQILDHRLP-TPSRDVTDKLRS 890
++ IL RL TP ++ K+ S
Sbjct: 225 DQLKLIL--RLVGTPGAELLKKISS 247
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 2e-04
Identities = 28/91 (30%), Positives = 46/91 (50%), Gaps = 7/91 (7%)
Query: 758 VANALSYL-HHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAK--FLEPHSSNWTEFAG 814
VA + +L CI HRD++++N+LL + DFG A+ + +P +
Sbjct: 188 VAKGMEFLASRKCI----HRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL 243
Query: 815 TVGYAAPELAYTMRATEKYDVYSFGVLALEV 845
+ + APE + T + DV+SFGVL E+
Sbjct: 244 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEI 274
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 43.9 bits (104), Expect = 2e-04
Identities = 34/116 (29%), Positives = 60/116 (51%), Gaps = 10/116 (8%)
Query: 773 IVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGTVGYAAPELAYTMRATEK 832
I+HRD+ N+++ S+ + DFG A+ S T + T Y APE+ M E
Sbjct: 139 IIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTSFMMTPYVVTRYYRAPEVILGMGYKEN 197
Query: 833 YDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRDVTDKL 888
D++S G + E+I+G + +F ++ I + N+I++ +L TPS + +L
Sbjct: 198 VDIWSVGCIMGEMIRG-------TVLFPG-TDHIDQWNKIIE-QLGTPSDEFMSRL 244
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Score = 43.5 bits (103), Expect = 3e-04
Identities = 62/292 (21%), Positives = 101/292 (34%), Gaps = 48/292 (16%)
Query: 252 FVPKEIGYLKSLSKLEFCANHLS------GVIPHSVGNLTGLVLLNMCENHLFG---PIP 302
+ + SL +L N + + GL L++ +N L +
Sbjct: 42 ALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGCGLQELDLSDNALGPDGCGVL 101
Query: 303 KSLRNLTSLERVRFNQNNLYG----KVYEAFGDH-PNLTFLDLSQNNFYCEISFNW---- 353
+SL +SL+ ++ N N L + + D P L L L +N
Sbjct: 102 ESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKAL 161
Query: 354 RNFSKLGTFNASMNNIYG----SIPPEIGDSSKLQVLDLSSNHIFGKIPVQLVKLFSLNK 409
R L N + N I ++ + + L+VLDL++N + + L + + K
Sbjct: 162 RANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLK 221
Query: 410 LILSLNQLFGGVPLEFGTLTELQYLDLSANKLSSSIPMSIGNLLKLHYLNLSNNQFSHK- 468
+ LN G L D A L+S++ +LL L+LS N +
Sbjct: 222 SLEVLN--LGDNNLT----------DAGAAALASALLSPNISLLT---LSLSCNDITDDG 266
Query: 469 ----IPTEFEKLIHLSELDLSHNILQEEIPPQIC-----KMESLEKLNLSHN 511
EK L ELDL N EE + LE L + +
Sbjct: 267 AKDLAEVLAEKESLL-ELDLRGNKFGEEGAQLLAESLLEPGNELESLWVKDD 317
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 42.4 bits (100), Expect = 3e-04
Identities = 42/192 (21%), Positives = 59/192 (30%), Gaps = 38/192 (19%)
Query: 731 GSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYE 790
SL IL + + + V AL LH R S N+LL ++
Sbjct: 1 VSLADILE--VRGRPLNEEEIWAVCLQCLGALRELH---------RQAKSGNILLT--WD 47
Query: 791 AHVSDFGFAKFLEPHSSNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYH 850
+ G F P S + APE+ TEK D+YS G+ E + Y
Sbjct: 48 GLLKLDGSVAFKTPEQSRPDPYFM-----APEVIQGQSYTEKADIYSLGITLYEALD-YE 101
Query: 851 PGDFVSTIFSSISNMIIEVNQILDHRLPTPSRDVTDK---------LRSIMEVAILCLVE 901
N E++ IL+ L D RS + LC
Sbjct: 102 LPY----------NEERELSAILEILLNGMPADDPRDRSNLEGVSAARSFEDFMRLCASR 151
Query: 902 NPEARPTMKEVC 913
P+ R
Sbjct: 152 LPQRREAANHYL 163
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 3e-04
Identities = 59/241 (24%), Positives = 101/241 (41%), Gaps = 57/241 (23%)
Query: 654 IGKGG---QRSVYKAELPSGNIFAVKKF-KAELFSDETANPSEFLNEVLALTEIRHRNII 709
IG+G R V K + +G+I+A+K KA++ E + E L E ++
Sbjct: 9 IGRGAFGEVRLVQKKD--TGHIYAMKILRKADMLEKEQV--AHIRAERDILVEADGAWVV 64
Query: 710 K-FHGFCSNAQHSFIVCEYLARGSLTTIL-RDDAAAKEFSWNQRMNVIKGVANALSYLHH 767
K F+ F + ++ +++ E+L G + T+L + D ++E I A+ +H
Sbjct: 65 KMFYSF-QDKRNLYLIMEFLPGGDMMTLLMKKDTLSEE----ATQFYIAETVLAIDAIHQ 119
Query: 768 DCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGTVGYAAP------ 821
+HRDI N+LLD++ +SDFG L+ ++ TEF + + P
Sbjct: 120 ---LGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLK--KAHRTEFYRNLTHNPPSDFSFQ 174
Query: 822 ----------------ELAYTMRATEKY---------------DVYSFGVLALEVIKGYH 850
+LAY+ T Y D +S GV+ E++ GY
Sbjct: 175 NMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234
Query: 851 P 851
P
Sbjct: 235 P 235
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Score = 43.1 bits (102), Expect = 4e-04
Identities = 48/192 (25%), Positives = 74/192 (38%), Gaps = 25/192 (13%)
Query: 83 GRIPSSLGNLSNLALLYLNDNSLFGSIPIVMGNLKSLSTL---DLSQNQLNGS----IPC 135
+ L L L L+DN+L V+ +L S+L L+ N L +
Sbjct: 71 QSLLQGLTKGCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAK 130
Query: 136 SL-DNLSNLDTLFLYKNSLSG----PIPSVIGNLKSLLQLDLSENRLSG----LIPLSLS 186
L D L+ L L +N L G + + + L +L+L+ N + + L
Sbjct: 131 GLKDLPPALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLK 190
Query: 187 NLSSLTVMSLFNNSL----SGSIPPILGNLKSLSTLGLHINQLNGVI-----PPSIGNLS 237
+L V+ L NN L + ++ L +LKSL L L N L +
Sbjct: 191 ANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGAAALASALLSPNI 250
Query: 238 SLRNLSLFNNRL 249
SL LSL N +
Sbjct: 251 SLLTLSLSCNDI 262
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319 |
| >gnl|CDD|185268 PRK15370, PRK15370, E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 4e-04
Identities = 58/209 (27%), Positives = 98/209 (46%), Gaps = 32/209 (15%)
Query: 45 NQLRRLYLDVNQLHGTIPPVIGQLSLINELVFCHNNVSGRIPSSLGNLSNLALLYLNDNS 104
N L L + L TIP I + I L+ +N + +P +L N+ LY N N
Sbjct: 178 NNKTELRLKILGL-TTIPACIPEQ--ITTLILDNNELKS-LPENLQ--GNIKTLYANSNQ 231
Query: 105 LFGSIPIVMGNLKSLSTLDLSQNQLNGSIPCSLDNLSNLDTLFLYKNSLSGPIPSVIGNL 164
L SIP + + ++ ++LS N++ +P L S L +L L+ N +S +P NL
Sbjct: 232 L-TSIPATLPD--TIQEMELSINRIT-ELPERLP--SALQSLDLFHNKISC-LPE---NL 281
Query: 165 KSLLQ-LDLSENRLSGLIPLSLSNLSSLTVMSLFNNSLS---GSIPPILGNLKSLSTLGL 220
L+ L + +N + L P L S +T +++ +NSL+ ++PP LK+L
Sbjct: 282 PEELRYLSVYDNSIRTL-PAHLP--SGITHLNVQSNSLTALPETLPP---GLKTLEAGEN 335
Query: 221 HINQLNGVIPPSIGNLSSLRNLSLFNNRL 249
+ L +PP L+ L + N++
Sbjct: 336 ALTSLPASLPP------ELQVLDVSKNQI 358
|
Length = 754 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 4e-04
Identities = 48/201 (23%), Positives = 90/201 (44%), Gaps = 27/201 (13%)
Query: 708 IIKFHGFCSNAQHSFIVCEYLARGSLTTILR--DDAAAKEFSWNQRMNVIKGVANALSYL 765
I H + + ++V +Y G L T+L +D ++ + ++ + +++ L
Sbjct: 63 ITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAI-HSIHQL 121
Query: 766 HHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFA-KFLEPHSSNWTEFAGTVGYAAPELA 824
H+ VHRDI NVLLD ++DFG K + + + GT Y +PE+
Sbjct: 122 HY------VHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEIL 175
Query: 825 YTMR-ATEKY----DVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDH---- 875
M KY D +S GV E++ G P F + S ++ +I++H
Sbjct: 176 QAMEDGMGKYGPECDWWSLGVCMYEMLYGETP-------FYAES-LVETYGKIMNHEERF 227
Query: 876 RLPTPSRDVTDKLRSIMEVAI 896
+ P+ DV+++ + +++ I
Sbjct: 228 QFPSHITDVSEEAKDLIQRLI 248
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 5e-04
Identities = 35/119 (29%), Positives = 59/119 (49%), Gaps = 14/119 (11%)
Query: 773 IVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGTVGYAAPELAYTMRATEK 832
I+HRD+ N+++ S+ + DFG A+ S T + T Y APE+ M E
Sbjct: 147 IIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTSFMMTPYVVTRYYRAPEVILGMGYKEN 205
Query: 833 YDVYSFGVLALEVIKG--YHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRDVTDKLR 889
D++S G + E+IKG PG ++ I + N++++ +L TP + KL+
Sbjct: 206 VDIWSVGCIMGEMIKGGVLFPG----------TDHIDQWNKVIE-QLGTPCPEFMKKLQ 253
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 38.3 bits (90), Expect = 6e-04
Identities = 21/60 (35%), Positives = 28/60 (46%)
Query: 94 NLALLYLNDNSLFGSIPIVMGNLKSLSTLDLSQNQLNGSIPCSLDNLSNLDTLFLYKNSL 153
NL L L++N L L +L LDLS N L P + L +L +L L N+L
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 42.8 bits (100), Expect = 7e-04
Identities = 55/249 (22%), Positives = 100/249 (40%), Gaps = 50/249 (20%)
Query: 654 IGKGGQRSV---YKAELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIK 710
IG G Q V Y A L A+KK + F ++T + E++ + + H+NII
Sbjct: 25 IGSGAQGIVCAAYDAVLDRN--VAIKKL-SRPFQNQTHAKRAY-RELVLMKCVNHKNIIS 80
Query: 711 F------HGFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSY 764
Q ++V E L +L +++ + + S+ ++ + + +
Sbjct: 81 LLNVFTPQKSLEEFQDVYLVME-LMDANLCQVIQMELDHERMSY-----LLYQMLCGIKH 134
Query: 765 LHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGTVGYAAPELA 824
LH I+HRD+ N+++ S+ + DFG A+ S T + T Y APE+
Sbjct: 135 LHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTSFMMTPYVVTRYYRAPEVI 190
Query: 825 YTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRDV 884
M E D++S G + E+++ H++ P RD
Sbjct: 191 LGMGYKENVDIWSVGCIMGEMVR---------------------------HKILFPGRDY 223
Query: 885 TDKLRSIME 893
D+ ++E
Sbjct: 224 IDQWNKVIE 232
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 0.001
Identities = 37/138 (26%), Positives = 68/138 (49%), Gaps = 19/138 (13%)
Query: 669 SGNIFAVKKF-KAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFIVCEY 727
+ ++AVK KA++ + + + + LAL+ + I+ + +A + ++V EY
Sbjct: 28 NSKLYAVKVVKKADMINKNMVHQVQAERDALALS--KSPFIVHLYYSLQSANNVYLVMEY 85
Query: 728 LARGSLTTILR-----DDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKN 782
L G + ++L D+ A ++ I VA AL YLH I+HRD+ N
Sbjct: 86 LIGGDVKSLLHIYGYFDEEMAVKY--------ISEVALALDYLHRH---GIIHRDLKPDN 134
Query: 783 VLLDSEYEAHVSDFGFAK 800
+L+ +E ++DFG +K
Sbjct: 135 MLISNEGHIKLTDFGLSK 152
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 0.001
Identities = 58/241 (24%), Positives = 98/241 (40%), Gaps = 57/241 (23%)
Query: 654 IGKGG---QRSVYKAELPSGNIFAVKKF-KAELFSDETANPSEFLNEVLALTEIRHRNII 709
IG+G R V K + +G+++A+K KA++ E ++L E ++
Sbjct: 9 IGRGAFGEVRLVQKKD--TGHVYAMKILRKADMLEKEQVGHIRAERDIL--VEADSLWVV 64
Query: 710 K-FHGFCSNAQHSFIVCEYLARGSLTTIL-RDDAAAKEFSWNQRMNVIKGVANALSYLHH 767
K F+ F + + +++ E+L G + T+L + D +E + I A+ +H
Sbjct: 65 KMFYSF-QDKLNLYLIMEFLPGGDMMTLLMKKDTLTEE----ETQFYIAETVLAIDSIHQ 119
Query: 768 DCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEF--------------- 812
+HRDI N+LLDS+ +SDFG L+ ++ TEF
Sbjct: 120 ---LGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLK--KAHRTEFYRNLNHSLPSDFTFQ 174
Query: 813 ----------------------AGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYH 850
GT Y APE+ + D +S GV+ E++ GY
Sbjct: 175 NMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234
Query: 851 P 851
P
Sbjct: 235 P 235
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 42.8 bits (100), Expect = 0.001
Identities = 44/187 (23%), Positives = 86/187 (45%), Gaps = 27/187 (14%)
Query: 691 SEFLNEVLALTEIRHRNIIKF-HGFCSNA-QHSFIVCEYLARGSLT-TILRDDAAAKEFS 747
S+ + EV + E++H+NI+++ F + A Q +I+ E+ G L+ I + +
Sbjct: 57 SQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIE 116
Query: 748 WNQRMNVIKGVANALSYLHHDCIPP----IVHRDISSKNVLLDSEYE------------- 790
+ +++ + + +AL+Y H+ P ++HRD+ +N+ L +
Sbjct: 117 EHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLN 176
Query: 791 ----AHVSDFGFAKFLEPHSSNWTEFAGTVGYAAPELAY--TMRATEKYDVYSFGVLALE 844
A + DFG +K + S + GT Y +PEL T +K D+++ G + E
Sbjct: 177 GRPIAKIGDFGLSKNIGIESMAHS-CVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYE 235
Query: 845 VIKGYHP 851
+ G P
Sbjct: 236 LCSGKTP 242
|
Length = 1021 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 0.001
Identities = 59/245 (24%), Positives = 100/245 (40%), Gaps = 49/245 (20%)
Query: 646 GNFGEKYCIGKGGQRSVYKAELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRH 705
G FGE + + VY +L S KF+ SD S F E
Sbjct: 54 GAFGEVQLVRHKSSQKVYAMKLLS-------KFEMIKRSD-----SAFFWE--------E 93
Query: 706 RNIIKFHG-------FCS--NAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIK 756
R+I+ F FC+ + ++ ++V EY+ G L ++ + ++++ V+
Sbjct: 94 RDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVL 153
Query: 757 GVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFA-KFLEPHSSNWTEFAGT 815
AL +H ++HRD+ N+LLD ++DFG K E GT
Sbjct: 154 ----ALDAIHS---MGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGT 206
Query: 816 VGYAAPELAYTMRATEKY----DVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQ 871
Y +PE+ + Y D +S GV E++ G P F + S ++ ++
Sbjct: 207 PDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTP-------FYADS-LVGTYSK 258
Query: 872 ILDHR 876
I+DH+
Sbjct: 259 IMDHK 263
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Score = 40.8 bits (96), Expect = 0.002
Identities = 52/257 (20%), Positives = 82/257 (31%), Gaps = 57/257 (22%)
Query: 157 IPSVIGNLKSLLQLDLSENRLS------GLIPLSLSNLSSLTVMSLFNNSLSGSIPPILG 210
+ S + SL +L LS N + L+ L + L +N+L +L
Sbjct: 43 LASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGCGLQELDLSDNALGPDGCGVLE 102
Query: 211 NLKSLSTLGLHINQLNGVIPPSIGNLSSLRNLSLFNNRLYGFVPKEIGYLKSLSKLEFCA 270
+L S+L + L L NN L L+
Sbjct: 103 SLLRSSSL---------------------QELKLNNNGL------GDRGLR--------- 126
Query: 271 NHLSGVIPHSVGNLTGLVL-LNMCENHLFGPIPKSLRNLTSLERVRFNQNNLYG----KV 325
L+ + L LVL N E + K+LR L+ + N + +
Sbjct: 127 -LLAKGLKDLPPALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRAL 185
Query: 326 YEAFGDHPNLTFLDLSQNNFYCE----ISFNWRNFSKLGTFNASMNNIYGSIPPEIGD-- 379
E + NL LDL+ N E ++ + L N NN+ + +
Sbjct: 186 AEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGAAALASAL 245
Query: 380 ---SSKLQVLDLSSNHI 393
+ L L LS N I
Sbjct: 246 LSPNISLLTLSLSCNDI 262
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.002
Identities = 38/145 (26%), Positives = 61/145 (42%), Gaps = 15/145 (10%)
Query: 707 NIIKFHGFCSNAQHSFIVCEYLARGSLTTILRDDAAAKE---FSWNQRMNVIKGVANALS 763
N++ H + + F+V ++ G L + + E W M V AL
Sbjct: 46 NMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVV------ALD 99
Query: 764 YLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGTVGYAAPEL 823
LH + IV RD++ N+LLD H+ F+++ E S E + Y APE+
Sbjct: 100 ALHRE---GIVCRDLNPNNILLDDR--GHIQLTYFSRWSEVEDSCDGEAVENM-YCAPEV 153
Query: 824 AYTMRATEKYDVYSFGVLALEVIKG 848
TE D +S G + E++ G
Sbjct: 154 GGISEETEACDWWSLGAILFELLTG 178
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 36.8 bits (86), Expect = 0.003
Identities = 21/58 (36%), Positives = 25/58 (43%), Gaps = 2/58 (3%)
Query: 1 MLNLGFNLLFGNIPPQI-GNLSKLQYLDLGNNQLSGVIPPEIGKLNQLRRLYLDVNQL 57
L+L N L IP L L+ LDL N L+ + P L LR L L N L
Sbjct: 4 SLDLSNNRL-TVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 36.8 bits (86), Expect = 0.003
Identities = 24/61 (39%), Positives = 31/61 (50%), Gaps = 2/61 (3%)
Query: 406 SLNKLILSLNQLFGGVPLE-FGTLTELQYLDLSANKLSSSIPMSIGNLLKLHYLNLSNNQ 464
+L L LS N+L +P F L L+ LDLS N L+S P + L L L+LS N
Sbjct: 1 NLKSLDLSNNRL-TVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNN 59
Query: 465 F 465
Sbjct: 60 L 60
|
Length = 60 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 40.4 bits (95), Expect = 0.003
Identities = 37/155 (23%), Positives = 61/155 (39%), Gaps = 43/155 (27%)
Query: 762 LSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGTVGYAAP 821
L Y+H ++HRD+ N+LL++ + + DFG A+ TE+ T Y AP
Sbjct: 121 LKYIHS---ANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVVTRWYRAP 177
Query: 822 ELAYTMRATEKY----DVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRL 877
EL + +Y DV+S G + E++ +F
Sbjct: 178 EL---LLNCSEYTTAIDVWSVGCIFAELLGR-------KPLF------------------ 209
Query: 878 PTPSRDVTDKLRSIMEV------AILCLVENPEAR 906
P +D +L+ I E+ L + N +AR
Sbjct: 210 --PGKDYVHQLKLITELLGSPSEEDLGFIRNEKAR 242
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 40.1 bits (94), Expect = 0.004
Identities = 37/167 (22%), Positives = 70/167 (41%), Gaps = 20/167 (11%)
Query: 708 IIKFHGFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHH 767
I++ H + ++ ++V EY+ G L ++ + ++++ V+ AL +H
Sbjct: 105 IVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNYDIPEKWARFYTAEVVL----ALDAIHS 160
Query: 768 DCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEP----HSSNWTEFAGTVGYAAPEL 823
+HRD+ N+LLD ++DFG ++ GT Y +PE+
Sbjct: 161 ---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDT---AVGTPDYISPEV 214
Query: 824 AYTMRATEKY----DVYSFGVLALEVIKGYHP--GDFVSTIFSSISN 864
+ Y D +S GV E++ G P D + +S I +
Sbjct: 215 LKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMD 261
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
Conserved Domains Detected by HHsearch 
Original result of HHsearch against CDD database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 918 | |||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 100.0 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.98 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.98 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.98 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.98 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.98 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.97 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.97 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.97 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.97 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.97 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.97 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.97 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.97 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.97 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.96 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.96 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.96 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.96 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.96 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.96 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.96 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.96 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.95 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.95 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.95 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.95 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.94 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.94 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.94 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.93 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.92 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.91 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.91 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.91 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.91 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.89 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.89 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.88 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.87 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.87 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.85 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.84 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.84 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.84 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.84 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.82 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.82 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.81 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.81 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.81 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.79 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.79 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.78 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.75 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.74 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.74 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.74 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.73 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.73 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.73 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.71 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.7 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.68 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.67 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.67 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.65 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.64 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.59 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.56 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.55 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.54 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.53 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.52 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.45 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.45 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.43 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.43 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.43 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.41 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.29 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.28 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.28 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.28 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.23 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.22 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.22 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.22 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 99.21 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 99.2 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.17 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.16 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.16 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 99.13 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 99.12 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 99.06 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 99.05 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.05 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.05 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 99.01 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.0 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.99 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.94 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.94 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.92 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 98.92 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.91 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.83 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.75 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.71 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.65 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.62 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.61 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.54 | |
| KOG2982 | 418 | consensus Uncharacterized conserved protein [Funct | 98.53 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.51 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.47 | |
| KOG2982 | 418 | consensus Uncharacterized conserved protein [Funct | 98.45 |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-107 Score=1014.75 Aligned_cols=868 Identities=32% Similarity=0.509 Sum_probs=702.6
Q ss_pred CCCCCEEeCCCCcccccCCccccCCCCCCEEEcccccccccCCCCcC-CCCCCCEEEcccccccccCCccccCCCCCCEE
Q 044366 20 LSKLQYLDLGNNQLSGVIPPEIGKLNQLRRLYLDVNQLHGTIPPVIG-QLSLINELVFCHNNVSGRIPSSLGNLSNLALL 98 (918)
Q Consensus 20 l~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~-~l~~L~~L~l~~n~~~~~~p~~l~~l~~L~~L 98 (918)
...++.|||++|++++.+|.+|..+++|++|+|++|++++.+|..+. .+++|++|++++|++++.+|. +.+++|++|
T Consensus 68 ~~~v~~L~L~~~~i~~~~~~~~~~l~~L~~L~Ls~n~~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~--~~l~~L~~L 145 (968)
T PLN00113 68 SSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPR--GSIPNLETL 145 (968)
T ss_pred CCcEEEEEecCCCccccCChHHhCCCCCCEEECCCCccCCcCChHHhccCCCCCEEECcCCccccccCc--cccCCCCEE
Confidence 34688888888888888888888888889999888888877887765 888888888888888877775 457888899
Q ss_pred EccCCcccccCccccCCCCCCCEEECcCCcCCCcCCcCCCCCCCCceeeccccccccCCCcccccccccCeeeccccccC
Q 044366 99 YLNDNSLFGSIPIVMGNLKSLSTLDLSQNQLNGSIPCSLDNLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSENRLS 178 (918)
Q Consensus 99 ~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~ 178 (918)
+|++|.+.+..|..++++++|++|+|++|.+++.+|..++++++|++|+|++|.+.+..|..|+.+++|++|+|++|.+.
T Consensus 146 ~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~ 225 (968)
T PLN00113 146 DLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLS 225 (968)
T ss_pred ECcCCcccccCChHHhcCCCCCEEECccCcccccCChhhhhCcCCCeeeccCCCCcCcCChHHcCcCCccEEECcCCccC
Confidence 99998888888888888888999999988888888888888888999999888888888888888889999999988888
Q ss_pred CcCCccCCCCCCCcEeeccCcccccCCCccccCCCCcceeecccccccCCCCCCCcCCCcCCeEEcccCcCcCCCCcccc
Q 044366 179 GLIPLSLSNLSSLTVMSLFNNSLSGSIPPILGNLKSLSTLGLHINQLNGVIPPSIGNLSSLRNLSLFNNRLYGFVPKEIG 258 (918)
Q Consensus 179 ~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~ 258 (918)
+..|..+.++++|++|++++|.+++..|..|.++++|++|++++|.+++..|..+.++++|++|++++|.+.+..|..+.
T Consensus 226 ~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~ 305 (968)
T PLN00113 226 GEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVI 305 (968)
T ss_pred CcCChhHhcCCCCCEEECcCceeccccChhHhCCCCCCEEECcCCeeeccCchhHhhccCcCEEECcCCeeccCCChhHc
Confidence 88888888888899999998888888888888888999999998888888888888888899999999888888888888
Q ss_pred ccCCCCeEecCCCccCCcCCCcCCCCCCCcEEEccCCcCcCCCCccccCCCCCCeEEeecccccCccccccCCCCCccEE
Q 044366 259 YLKSLSKLEFCANHLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLRNLTSLERVRFNQNNLYGKVYEAFGDHPNLTFL 338 (918)
Q Consensus 259 ~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L 338 (918)
.+++|+.|++++|.+.+..|..+..+++|+.|++++|.+.+.+|..+..+++|+.|++++|.+....+..+..+++|+.|
T Consensus 306 ~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~~~~L~~L~Ls~n~l~~~~p~~~~~~~~L~~L 385 (968)
T PLN00113 306 QLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKL 385 (968)
T ss_pred CCCCCcEEECCCCccCCcCChhHhcCCCCCEEECcCCCCcCcCChHHhCCCCCcEEECCCCeeEeeCChhHhCcCCCCEE
Confidence 88889999999998888888888888899999999998888888888888899999999998887777888888889999
Q ss_pred eCCCCccccccCcccccccccceeeccccccccCCCcCcCCCCCCcEEEccCceeccccccchhhccccCceeccccccc
Q 044366 339 DLSQNNFYCEISFNWRNFSKLGTFNASMNNIYGSIPPEIGDSSKLQVLDLSSNHIFGKIPVQLVKLFSLNKLILSLNQLF 418 (918)
Q Consensus 339 ~Ls~N~l~~~~~~~~~~~~~L~~l~l~~n~i~~~~~~~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 418 (918)
++++|++.......+..+++|+.|++++|++.+..|..|..++.|+.|++++|.+.+.++..+..+++|+.|+|++|++.
T Consensus 386 ~l~~n~l~~~~p~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~~~ 465 (968)
T PLN00113 386 ILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFF 465 (968)
T ss_pred ECcCCEecccCCHHHhCCCCCCEEECcCCEeeeECChhHhcCCCCCEEECcCCcccCccChhhccCCCCcEEECcCceee
Confidence 99999888777777888889999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCcccEEeccCccccccCccccccccccceecccCcccCCCCchhhccccccceEeccCCcCCCCCchhcc
Q 044366 419 GGVPLEFGTLTELQYLDLSANKLSSSIPMSIGNLLKLHYLNLSNNQFSHKIPTEFEKLIHLSELDLSHNILQEEIPPQIC 498 (918)
Q Consensus 419 ~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~ 498 (918)
+..|..+ ..++|+.|+|++|++++..|..|..+++|+.|+|++|++++.+|..|..+++|++|+|++|.+++.+|..|.
T Consensus 466 ~~~p~~~-~~~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~ 544 (968)
T PLN00113 466 GGLPDSF-GSKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFS 544 (968)
T ss_pred eecCccc-ccccceEEECcCCccCCccChhhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHh
Confidence 8888765 458999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccCCcceEecCCCcccccCcccccCCCCccEEEccCCcCCCCCCCCcc---cccccccCCCCccCCCC--CCCCCCccCC
Q 044366 499 KMESLEKLNLSHNNLSDFIPRCFEEMRSLSWIDISYNELQGPIPNSTA---FKNGLMEGNKGLCGNFK--ALPSCDAFTS 573 (918)
Q Consensus 499 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~p~~~~---~~~~~~~~n~~~c~~~~--~~~~c~~~~~ 573 (918)
.+++|+.|+|++|++++.+|..+..+++|+.|++++|++.|.+|.... +....+.||+.+||... ..++|....
T Consensus 545 ~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~~~~~~~~~c~~~~- 623 (968)
T PLN00113 545 EMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGLPPCKRVR- 623 (968)
T ss_pred CcccCCEEECCCCcccccCChhHhcCcccCEEeccCCcceeeCCCcchhcccChhhhcCCccccCCccccCCCCCcccc-
Confidence 999999999999999999999999999999999999999999998755 34556899999998653 356774211
Q ss_pred CCCcccceEEEEehhHHHHHHHHHHHHHhhhhhhcccCCcccccCCCCCCCCceeee--ccCCccCHHHHHHHhcCCCCc
Q 044366 574 HKQTFRKKWVVIALPILGMVVLLIGLIGFFFLFRRRKRDPQEKRSSSANPFGFFSVL--NFNGKVLYEEITKATGNFGEK 651 (918)
Q Consensus 574 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 651 (918)
.+..+.+++++++++++++++++++++ ++|++++.+.++.......-..... .....+.++ .....|...
T Consensus 624 ----~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~ 695 (968)
T PLN00113 624 ----KTPSWWFYITCTLGAFLVLALVAFGFV-FIRGRNNLELKRVENEDGTWELQFFDSKVSKSITIN---DILSSLKEE 695 (968)
T ss_pred ----ccceeeeehhHHHHHHHHHHHHHHHHH-HHHhhhcccccccccccccccccccccccchhhhHH---HHHhhCCcc
Confidence 122333333333333333333333333 3333222111111111100000000 001122333 334567888
Q ss_pred eeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEEEEEeccC
Q 044366 652 YCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFIVCEYLAR 730 (918)
Q Consensus 652 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 730 (918)
+.||+|+||.||+|.. .+|+.||||+++... . ....|++.+++++|||||+++|+|.+++..++||||+++
T Consensus 696 ~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~----~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~ 767 (968)
T PLN00113 696 NVISRGKKGASYKGKSIKNGMQFVVKEINDVN----S----IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEG 767 (968)
T ss_pred cEEccCCCeeEEEEEECCCCcEEEEEEccCCc----c----ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCC
Confidence 8999999999999965 589999999886421 1 113568889999999999999999999999999999999
Q ss_pred CChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccCCCCCCce
Q 044366 731 GSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWT 810 (918)
Q Consensus 731 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~~~~~~~~ 810 (918)
|+|.++++. ++|.++.+|+.|+|+|++|||+.+.++|+|||+||+||+++.++.+++. ||.+...... .
T Consensus 768 g~L~~~l~~------l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~----~ 836 (968)
T PLN00113 768 KNLSEVLRN------LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD----T 836 (968)
T ss_pred CcHHHHHhc------CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC----C
Confidence 999999963 7999999999999999999997666699999999999999999888875 6655443221 2
Q ss_pred ecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhH------hhhhhhcccCCCCCCcch
Q 044366 811 EFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMI------IEVNQILDHRLPTPSRDV 884 (918)
Q Consensus 811 ~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~ 884 (918)
...+++.|+|||++.+..++.++|||||||++|||+||+.|++............. .......++.........
T Consensus 837 ~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (968)
T PLN00113 837 KCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVN 916 (968)
T ss_pred CccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCCCcc
Confidence 23678999999999999999999999999999999999999754322111111100 011222333332222233
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhC
Q 044366 885 TDKLRSIMEVAILCLVENPEARPTMKEVCNLLCK 918 (918)
Q Consensus 885 ~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~ 918 (918)
.++..++.+++.+||+.||++||||+||++.|++
T Consensus 917 ~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~ 950 (968)
T PLN00113 917 QNEIVEVMNLALHCTATDPTARPCANDVLKTLES 950 (968)
T ss_pred HHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHH
Confidence 4556778999999999999999999999999864
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-61 Score=599.20 Aligned_cols=535 Identities=37% Similarity=0.541 Sum_probs=506.4
Q ss_pred cccCCCCCCccCCccCCCCCCCCEEeCCCCcccccCCcccc-CCCCCCEEEcccccccccCCCCcCCCCCCCEEEccccc
Q 044366 2 LNLGFNLLFGNIPPQIGNLSKLQYLDLGNNQLSGVIPPEIG-KLNQLRRLYLDVNQLHGTIPPVIGQLSLINELVFCHNN 80 (918)
Q Consensus 2 l~~~~~~~~~~~p~~~~~l~~L~~L~L~~n~i~~~~p~~l~-~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~ 80 (918)
|+|++|++++.+|+.+..+++|++|+|++|++.+.+|..+. .+++|++|+|++|++++.+|. +.+++|++|++++|.
T Consensus 74 L~L~~~~i~~~~~~~~~~l~~L~~L~Ls~n~~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~--~~l~~L~~L~Ls~n~ 151 (968)
T PLN00113 74 IDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPR--GSIPNLETLDLSNNM 151 (968)
T ss_pred EEecCCCccccCChHHhCCCCCCEEECCCCccCCcCChHHhccCCCCCEEECcCCccccccCc--cccCCCCEEECcCCc
Confidence 78999999999999999999999999999999988888776 999999999999999988886 568999999999999
Q ss_pred ccccCCccccCCCCCCEEEccCCcccccCccccCCCCCCCEEECcCCcCCCcCCcCCCCCCCCceeeccccccccCCCcc
Q 044366 81 VSGRIPSSLGNLSNLALLYLNDNSLFGSIPIVMGNLKSLSTLDLSQNQLNGSIPCSLDNLSNLDTLFLYKNSLSGPIPSV 160 (918)
Q Consensus 81 ~~~~~p~~l~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~ 160 (918)
+.+.+|..++.+++|++|+|++|.+.+..|..+.++++|++|+|++|++++.+|..++++++|++|+|++|.+.+..|..
T Consensus 152 ~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~ 231 (968)
T PLN00113 152 LSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYE 231 (968)
T ss_pred ccccCChHHhcCCCCCEEECccCcccccCChhhhhCcCCCeeeccCCCCcCcCChHHcCcCCccEEECcCCccCCcCChh
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cccccccCeeeccccccCCcCCccCCCCCCCcEeeccCcccccCCCccccCCCCcceeecccccccCCCCCCCcCCCcCC
Q 044366 161 IGNLKSLLQLDLSENRLSGLIPLSLSNLSSLTVMSLFNNSLSGSIPPILGNLKSLSTLGLHINQLNGVIPPSIGNLSSLR 240 (918)
Q Consensus 161 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~ 240 (918)
|+++++|++|++++|.+.+..|..|.++++|+.|++++|.+++..|..+.++++|+.|++++|.+++..|..+.++++|+
T Consensus 232 l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~ 311 (968)
T PLN00113 232 IGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLE 311 (968)
T ss_pred HhcCCCCCEEECcCceeccccChhHhCCCCCCEEECcCCeeeccCchhHhhccCcCEEECcCCeeccCCChhHcCCCCCc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred eEEcccCcCcCCCCccccccCCCCeEecCCCccCCcCCCcCCCCCCCcEEEccCCcCcCCCCccccCCCCCCeEEeeccc
Q 044366 241 NLSLFNNRLYGFVPKEIGYLKSLSKLEFCANHLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLRNLTSLERVRFNQNN 320 (918)
Q Consensus 241 ~L~Ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~ 320 (918)
.|++++|.+.+..|..+..+++|+.|++++|.+.+..|..+..+++|+.|++++|++.+.+|..+..+++|+.|++++|.
T Consensus 312 ~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~~~~L~~L~Ls~n~l~~~~p~~~~~~~~L~~L~l~~n~ 391 (968)
T PLN00113 312 ILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNS 391 (968)
T ss_pred EEECCCCccCCcCChhHhcCCCCCEEECcCCCCcCcCChHHhCCCCCcEEECCCCeeEeeCChhHhCcCCCCEEECcCCE
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccCccccccCCCCCccEEeCCCCccccccCcccccccccceeeccccccccCCCcCcCCCCCCcEEEccCceeccccccc
Q 044366 321 LYGKVYEAFGDHPNLTFLDLSQNNFYCEISFNWRNFSKLGTFNASMNNIYGSIPPEIGDSSKLQVLDLSSNHIFGKIPVQ 400 (918)
Q Consensus 321 l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~n~i~~~~~~~~~~~~~L~~L~L~~N~l~~~~~~~ 400 (918)
+....+..+..+++|+.|++++|+++......+..++.|+.+++++|.+.+.++..+..+++|+.|+|++|++.+..|..
T Consensus 392 l~~~~p~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~ 471 (968)
T PLN00113 392 LEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDS 471 (968)
T ss_pred ecccCCHHHhCCCCCCEEECcCCEeeeECChhHhcCCCCCEEECcCCcccCccChhhccCCCCcEEECcCceeeeecCcc
Confidence 99888899999999999999999999887888999999999999999999999999999999999999999999888876
Q ss_pred hhhccccCceecccccccCCCCCCCCCCCcccEEeccCccccccCccccccccccceecccCcccCCCCchhhccccccc
Q 044366 401 LVKLFSLNKLILSLNQLFGGVPLEFGTLTELQYLDLSANKLSSSIPMSIGNLLKLHYLNLSNNQFSHKIPTEFEKLIHLS 480 (918)
Q Consensus 401 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~ 480 (918)
+ ...+|+.|++++|++++..|..|..+++|++|+|++|.+++.+|..+..+++|++|+|++|++++.+|..|.++++|+
T Consensus 472 ~-~~~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 550 (968)
T PLN00113 472 F-GSKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLS 550 (968)
T ss_pred c-ccccceEEECcCCccCCccChhhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCC
Confidence 5 458999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred eEeccCCcCCCCCchhccccCCcceEecCCCcccccCcccccCCCCccEEEccCCcCCCC
Q 044366 481 ELDLSHNILQEEIPPQICKMESLEKLNLSHNNLSDFIPRCFEEMRSLSWIDISYNELQGP 540 (918)
Q Consensus 481 ~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~ 540 (918)
.|||++|++++.+|..+..+++|+.|++++|++++.+|.. ..+..+....+.+|+.-|.
T Consensus 551 ~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~p~~-~~~~~~~~~~~~~n~~lc~ 609 (968)
T PLN00113 551 QLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPST-GAFLAINASAVAGNIDLCG 609 (968)
T ss_pred EEECCCCcccccCChhHhcCcccCEEeccCCcceeeCCCc-chhcccChhhhcCCccccC
Confidence 9999999999999999999999999999999999988854 3344555566788885553
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-49 Score=425.37 Aligned_cols=280 Identities=39% Similarity=0.660 Sum_probs=234.6
Q ss_pred CCccCHHHHHHHhcCCCCceeeccccceEEEEEEeCCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEe
Q 044366 633 NGKVLYEEITKATGNFGEKYCIGKGGQRSVYKAELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFH 712 (918)
Q Consensus 633 ~~~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~ 712 (918)
...++++++..||++|...+.||+|+||.||+|..++|+.||||++..... .. .++|..|++++.+++|||+|+++
T Consensus 62 ~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~---~~-~~eF~~Ei~~ls~l~H~Nlv~Ll 137 (361)
T KOG1187|consen 62 LRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSG---QG-EREFLNEVEILSRLRHPNLVKLL 137 (361)
T ss_pred cceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCC---cc-hhHHHHHHHHHhcCCCcCcccEE
Confidence 456889999999999999999999999999999999999999998765321 11 46699999999999999999999
Q ss_pred cccccCC-ceEEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcE
Q 044366 713 GFCSNAQ-HSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEA 791 (918)
Q Consensus 713 ~~~~~~~-~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~ 791 (918)
|||.+++ +.++|||||++|+|.++++..... .++|.+|++||.++|+||+|||+.+.|+||||||||+|||+|+++++
T Consensus 138 GyC~e~~~~~~LVYEym~nGsL~d~L~~~~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~a 216 (361)
T KOG1187|consen 138 GYCLEGGEHRLLVYEYMPNGSLEDHLHGKKGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNA 216 (361)
T ss_pred EEEecCCceEEEEEEccCCCCHHHHhCCCCCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCE
Confidence 9999988 599999999999999999886543 78999999999999999999999998899999999999999999999
Q ss_pred EEeccccccccCCCCCCceec-ccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcch-----hhhhhhhhh
Q 044366 792 HVSDFGFAKFLEPHSSNWTEF-AGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVS-----TIFSSISNM 865 (918)
Q Consensus 792 kl~DfG~~~~~~~~~~~~~~~-~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~-----~~~~~~~~~ 865 (918)
||+|||+|+............ .||.+|+|||++..+..+.|+|||||||++.|++||+.|.+... ....+....
T Consensus 217 KlsDFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~ 296 (361)
T KOG1187|consen 217 KLSDFGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPL 296 (361)
T ss_pred EccCccCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHH
Confidence 999999996554312222222 79999999999999999999999999999999999998866432 112222111
Q ss_pred H--hhhhhhcccCCCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 044366 866 I--IEVNQILDHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLLC 917 (918)
Q Consensus 866 ~--~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 917 (918)
. ....+++|+++..........+..+..++.+|++.+|.+||+|.||+++|+
T Consensus 297 ~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~ 350 (361)
T KOG1187|consen 297 LEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELE 350 (361)
T ss_pred HHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHH
Confidence 1 246677777765321111267788999999999999999999999999884
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-46 Score=380.02 Aligned_cols=252 Identities=26% Similarity=0.387 Sum_probs=211.7
Q ss_pred CCCCceeeccccceEEEEEEeC-CCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCC-ceEEE
Q 044366 647 NFGEKYCIGKGGQRSVYKAELP-SGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQ-HSFIV 724 (918)
Q Consensus 647 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-~~~lv 724 (918)
+++....||+|..|+|||++++ +++.+|+|.+... .+.+..+++.+|++++++.+||+||.+||+|...+ ...++
T Consensus 80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~---~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~ 156 (364)
T KOG0581|consen 80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLN---IDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISIC 156 (364)
T ss_pred HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeeccc---CCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEee
Confidence 4445667999999999999664 7899999999543 24455788999999999999999999999998888 59999
Q ss_pred EEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccC
Q 044366 725 CEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHH-DCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLE 803 (918)
Q Consensus 725 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~ 803 (918)
||||++|+|++++... +++++...-+|+.+|++||.|||+ + +||||||||+|||++..|++||||||.++.+.
T Consensus 157 mEYMDgGSLd~~~k~~---g~i~E~~L~~ia~~VL~GL~YLh~~~---~IIHRDIKPsNlLvNskGeVKicDFGVS~~lv 230 (364)
T KOG0581|consen 157 MEYMDGGSLDDILKRV---GRIPEPVLGKIARAVLRGLSYLHEER---KIIHRDIKPSNLLVNSKGEVKICDFGVSGILV 230 (364)
T ss_pred hhhcCCCCHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhhcc---CeeeccCCHHHeeeccCCCEEeccccccHHhh
Confidence 9999999999999865 459999999999999999999996 5 99999999999999999999999999999876
Q ss_pred CCCCCceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCCCCCcc
Q 044366 804 PHSSNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRD 883 (918)
Q Consensus 804 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 883 (918)
.. .....+||..|||||.+.+..|+.++||||||+.++|+++|+.|+....+.+ ......+..+.+..+|..+..
T Consensus 231 nS--~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~---~~~~~Ll~~Iv~~ppP~lP~~ 305 (364)
T KOG0581|consen 231 NS--IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPY---LDIFELLCAIVDEPPPRLPEG 305 (364)
T ss_pred hh--hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCC---CCHHHHHHHHhcCCCCCCCcc
Confidence 54 4466899999999999999999999999999999999999999976542211 122233445555555544443
Q ss_pred hHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 884 VTDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 884 ~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
....++.+++..|+++||.+||++.|+++
T Consensus 306 --~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~ 334 (364)
T KOG0581|consen 306 --EFSPEFRSFVSCCLRKDPSERPSAKQLLQ 334 (364)
T ss_pred --cCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 23456788888999999999999999875
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-45 Score=394.08 Aligned_cols=252 Identities=29% Similarity=0.491 Sum_probs=208.3
Q ss_pred CceeeccccceEEEEEEeCCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCC-ceEEEEEec
Q 044366 650 EKYCIGKGGQRSVYKAELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQ-HSFIVCEYL 728 (918)
Q Consensus 650 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-~~~lv~e~~ 728 (918)
..+.+|+|+||+||+|.+.....||||++......... .++|.+|+.++++++|||||+++|+|.+.. ..++|||||
T Consensus 45 ~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~--~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~ 122 (362)
T KOG0192|consen 45 IEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDES--RKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYM 122 (362)
T ss_pred hhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHH--HHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeC
Confidence 34459999999999999965555999999875433322 679999999999999999999999999887 799999999
Q ss_pred cCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCC-eEEcCCCCCCeeeCCCC-cEEEeccccccccCCCC
Q 044366 729 ARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPP-IVHRDISSKNVLLDSEY-EAHVSDFGFAKFLEPHS 806 (918)
Q Consensus 729 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~-ivH~dlk~~Nill~~~~-~~kl~DfG~~~~~~~~~ 806 (918)
++|+|.++++.. ....+++..+++|+.|||+||.|||++ + ||||||||+|||++.++ ++||+|||+++......
T Consensus 123 ~~GsL~~~l~~~-~~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~ 198 (362)
T KOG0192|consen 123 PGGSLSVLLHKK-RKRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK 198 (362)
T ss_pred CCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEECCCccceeecccc
Confidence 999999999874 345699999999999999999999999 7 99999999999999998 99999999998876543
Q ss_pred CCceecccccccccccccc--cCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCCCCCcch
Q 044366 807 SNWTEFAGTVGYAAPELAY--TMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRDV 884 (918)
Q Consensus 807 ~~~~~~~g~~~y~aPE~~~--~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 884 (918)
...+...||+.|||||++. ...|+.|+||||||+++|||+||+.||...... .... ........+..+..
T Consensus 199 ~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~-~~~~------~v~~~~~Rp~~p~~- 270 (362)
T KOG0192|consen 199 TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPV-QVAS------AVVVGGLRPPIPKE- 270 (362)
T ss_pred ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHH-HHHH------HHHhcCCCCCCCcc-
Confidence 4445578999999999999 668999999999999999999999998765541 1111 11112222222222
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 044366 885 TDKLRSIMEVAILCLVENPEARPTMKEVCNLLC 917 (918)
Q Consensus 885 ~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 917 (918)
....+..++.+||+.||++||++.+++..|+
T Consensus 271 --~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~ 301 (362)
T KOG0192|consen 271 --CPPHLSSLMERCWLVDPSRRPSFLEIVSRLE 301 (362)
T ss_pred --CCHHHHHHHHHhCCCCCCcCCCHHHHHHHHH
Confidence 3356788888999999999999999999885
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-44 Score=386.20 Aligned_cols=250 Identities=26% Similarity=0.439 Sum_probs=215.8
Q ss_pred cCCCCceeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEEE
Q 044366 646 GNFGEKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFIV 724 (918)
Q Consensus 646 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 724 (918)
.+|...+.||+|||+.||.++. .+|+.||+|++.+...... ...+...+|+++.++++|||||+++++|++.+..|+|
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~-~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYiv 96 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKP-KQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIV 96 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCc-chHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEE
Confidence 6789999999999999999955 8999999999987555443 3467889999999999999999999999999999999
Q ss_pred EEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccCC
Q 044366 725 CEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEP 804 (918)
Q Consensus 725 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~~ 804 (918)
.|+|++++|.++++++ .++++.+++.+.+||+.|+.|||+. +|+|||||..|++++++.++||+|||+|..+..
T Consensus 97 LELC~~~sL~el~Krr---k~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~ 170 (592)
T KOG0575|consen 97 LELCHRGSLMELLKRR---KPLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKIGDFGLATQLEY 170 (592)
T ss_pred EEecCCccHHHHHHhc---CCCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEecccceeeeecC
Confidence 9999999999999854 4599999999999999999999999 999999999999999999999999999999998
Q ss_pred CCCCceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCCCCCcch
Q 044366 805 HSSNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRDV 884 (918)
Q Consensus 805 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 884 (918)
+.......+|||-|.|||++....++..+||||+||++|-|+.|++||+... +......+. ......+.
T Consensus 171 ~~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~-----vkety~~Ik---~~~Y~~P~--- 239 (592)
T KOG0575|consen 171 DGERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKT-----VKETYNKIK---LNEYSMPS--- 239 (592)
T ss_pred cccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccch-----HHHHHHHHH---hcCccccc---
Confidence 8777788999999999999999999999999999999999999999998542 122221111 11111111
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 885 TDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 885 ~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
.......++|.++++.||.+|||+++|++
T Consensus 240 -~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~ 268 (592)
T KOG0575|consen 240 -HLSAEAKDLIRKLLRPNPSERPSLDEVLD 268 (592)
T ss_pred -ccCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 22345678899999999999999999985
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-45 Score=370.44 Aligned_cols=257 Identities=26% Similarity=0.369 Sum_probs=214.3
Q ss_pred HhcCCCCceeeccccceEEEEE-EeCCCCEEEEEEcccccccCCC---CChHHHHHHHHHHhhccCCceeeEecccccCC
Q 044366 644 ATGNFGEKYCIGKGGQRSVYKA-ELPSGNIFAVKKFKAELFSDET---ANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQ 719 (918)
Q Consensus 644 ~~~~~~~~~~lg~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~ 719 (918)
..+.|...+.+|+|+||.|-+| +..+|+.||||++......... .......+|+++|++++|||||+++++++.++
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 4456778889999999999999 6678999999999775443322 12234579999999999999999999999999
Q ss_pred ceEEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCC---CcEEEecc
Q 044366 720 HSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSE---YEAHVSDF 796 (918)
Q Consensus 720 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~---~~~kl~Df 796 (918)
..|||||||+||+|.+++-+.+. +.++....+++|++.|+.|||++ ||+||||||+|||+..+ ..+||+||
T Consensus 250 s~YmVlE~v~GGeLfd~vv~nk~---l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~~e~~llKItDF 323 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVANKY---LREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSNDAEDCLLKITDF 323 (475)
T ss_pred ceEEEEEEecCccHHHHHHhccc---cccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccCCcceEEEeccc
Confidence 99999999999999999977653 67788899999999999999999 99999999999999776 67999999
Q ss_pred ccccccCCCCCCceecccccccccccccccCCC---CcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhc
Q 044366 797 GFAKFLEPHSSNWTEFAGTVGYAAPELAYTMRA---TEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQIL 873 (918)
Q Consensus 797 G~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~---~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 873 (918)
|+|+..+ ..+.+...+||+.|.|||++.+..+ ..++|+||+|||||-+++|.+||........ ....+.
T Consensus 324 GlAK~~g-~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~s-------l~eQI~ 395 (475)
T KOG0615|consen 324 GLAKVSG-EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPS-------LKEQIL 395 (475)
T ss_pred chhhccc-cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCcc-------HHHHHh
Confidence 9999887 5666778899999999999986653 3478999999999999999999875443211 122344
Q ss_pred ccCCCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 874 DHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 874 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
..++...+..+.....+..++|.+|+..||++|||++|+++
T Consensus 396 ~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~ 436 (475)
T KOG0615|consen 396 KGRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALN 436 (475)
T ss_pred cCcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence 55555555556666778899999999999999999999875
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-44 Score=382.67 Aligned_cols=250 Identities=27% Similarity=0.470 Sum_probs=205.8
Q ss_pred CCCceeeccccceEEEEEEeCCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEEEEEe
Q 044366 648 FGEKYCIGKGGQRSVYKAELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFIVCEY 727 (918)
Q Consensus 648 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 727 (918)
+...+.||+|.||.||.|.+.....||+|.++.. ....++|.+|+++|++++|++||+++|+|..++..+|||||
T Consensus 208 l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~-----~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~ 282 (468)
T KOG0197|consen 208 LKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEG-----SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEY 282 (468)
T ss_pred HHHHHHhcCCccceEEEEEEcCCCcccceEEecc-----ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEe
Confidence 3445679999999999999987779999998763 34468899999999999999999999999999999999999
Q ss_pred ccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccCCCCC
Q 044366 728 LARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSS 807 (918)
Q Consensus 728 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~~~~~ 807 (918)
|+.|+|.+|++.. .+..+...+.+.++.|||+||+||+++ ++|||||.++||||+++..+||+|||+|+.+.++.+
T Consensus 283 m~~GsLl~yLr~~-~~~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y 358 (468)
T KOG0197|consen 283 MPKGSLLDYLRTR-EGGLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEY 358 (468)
T ss_pred cccCcHHHHhhhc-CCCccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEcccccccccCCCce
Confidence 9999999999973 345688999999999999999999999 999999999999999999999999999996655444
Q ss_pred Cce-ecccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhhhhhhhhhHhhhhhhcccCCCCCCcchH
Q 044366 808 NWT-EFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIK-GYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRDVT 885 (918)
Q Consensus 808 ~~~-~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 885 (918)
... ...-+..|+|||++..++++.|||||||||+||||+| |+.|+...... .....+. ...+++.+. .+
T Consensus 359 ~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~-----ev~~~le--~GyRlp~P~-~C- 429 (468)
T KOG0197|consen 359 TASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNE-----EVLELLE--RGYRLPRPE-GC- 429 (468)
T ss_pred eecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHH-----HHHHHHh--ccCcCCCCC-CC-
Confidence 322 2233678999999999999999999999999999999 78886544321 1111111 123334332 22
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 044366 886 DKLRSIMEVAILCLVENPEARPTMKEVCNLLC 917 (918)
Q Consensus 886 ~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 917 (918)
+..+.+++..||+.+|++|||++.+...++
T Consensus 430 --P~~vY~lM~~CW~~~P~~RPtF~~L~~~l~ 459 (468)
T KOG0197|consen 430 --PDEVYELMKSCWHEDPEDRPTFETLREVLE 459 (468)
T ss_pred --CHHHHHHHHHHhhCCcccCCCHHHHHHHHH
Confidence 345788999999999999999999888765
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-45 Score=355.72 Aligned_cols=257 Identities=22% Similarity=0.310 Sum_probs=210.0
Q ss_pred cCCCCceeeccccceEEEEE-EeCCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecc-cccCC-ceE
Q 044366 646 GNFGEKYCIGKGGQRSVYKA-ELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGF-CSNAQ-HSF 722 (918)
Q Consensus 646 ~~~~~~~~lg~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~-~~~~~-~~~ 722 (918)
.+|.+.++||+|.||+||++ ...+|..||.|.+.... -+.....+...|+.++++++|||||+++++ +.++. ..+
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~--md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evln 96 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGM--MDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLN 96 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhh--ccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhH
Confidence 45677788999999999999 67799999999987432 233446789999999999999999999994 44444 489
Q ss_pred EEEEeccCCChhHHhhccc-ccCCCCHHHHHHHHHHHHHHHHHHHhCCCC-CeEEcCCCCCCeeeCCCCcEEEecccccc
Q 044366 723 IVCEYLARGSLTTILRDDA-AAKEFSWNQRMNVIKGVANALSYLHHDCIP-PIVHRDISSKNVLLDSEYEAHVSDFGFAK 800 (918)
Q Consensus 723 lv~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~-~ivH~dlk~~Nill~~~~~~kl~DfG~~~ 800 (918)
+||||++.|+|..+++..+ ..+.++++.+|+++.|+++||.++|+..+. -|+||||||.||+++.+|.+||+|||+++
T Consensus 97 ivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r 176 (375)
T KOG0591|consen 97 IVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGR 176 (375)
T ss_pred HHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHh
Confidence 9999999999999997654 345689999999999999999999994322 28899999999999999999999999999
Q ss_pred ccCCCCCCceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCCCC
Q 044366 801 FLEPHSSNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTP 880 (918)
Q Consensus 801 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 880 (918)
++..........+|||.||+||.+.+.+|+.||||||+||++|||+.-++||.... +.. ...++.....++.
T Consensus 177 ~l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n--~~~------L~~KI~qgd~~~~ 248 (375)
T KOG0591|consen 177 FLSSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDN--LLS------LCKKIEQGDYPPL 248 (375)
T ss_pred HhcchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCccccc--HHH------HHHHHHcCCCCCC
Confidence 99887777788999999999999999999999999999999999999999987541 111 1122333333322
Q ss_pred CcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 881 SRDVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 881 ~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
+ ...+..++..+|..|+..||+.||+...++.
T Consensus 249 p--~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~ 280 (375)
T KOG0591|consen 249 P--DEHYSTDLRELINMCIAVDPEQRPDTVPYVQ 280 (375)
T ss_pred c--HHHhhhHHHHHHHHHccCCcccCCCcchHHH
Confidence 2 1345667888899999999999998544443
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-49 Score=393.78 Aligned_cols=482 Identities=30% Similarity=0.407 Sum_probs=316.0
Q ss_pred cccCCCCCCccCCccCCCCCCCCEEeCCCCcccccCCccccCCCCCCEEEcccccccccCCCCcCCCCCCCEEEcccccc
Q 044366 2 LNLGFNLLFGNIPPQIGNLSKLQYLDLGNNQLSGVIPPEIGKLNQLRRLYLDVNQLHGTIPPVIGQLSLINELVFCHNNV 81 (918)
Q Consensus 2 l~~~~~~~~~~~p~~~~~l~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~~ 81 (918)
|.|++|.++ .+-+.+.++..|++|++.+|++. .+|.+++.+.+++.|+.++|++. .+|+.++.+..|..|++++|++
T Consensus 50 lils~N~l~-~l~~dl~nL~~l~vl~~~~n~l~-~lp~aig~l~~l~~l~vs~n~ls-~lp~~i~s~~~l~~l~~s~n~~ 126 (565)
T KOG0472|consen 50 LILSHNDLE-VLREDLKNLACLTVLNVHDNKLS-QLPAAIGELEALKSLNVSHNKLS-ELPEQIGSLISLVKLDCSSNEL 126 (565)
T ss_pred hhhccCchh-hccHhhhcccceeEEEeccchhh-hCCHHHHHHHHHHHhhcccchHh-hccHHHhhhhhhhhhhccccce
Confidence 456666666 55555666666677777666666 66666677666777777776666 6666666666666666666666
Q ss_pred cccCCccccCCCCCCEEEccCCcccccCccccCCCCCCCEEECcCCcCCCcCCcCCCCCCCCceeeccccccccCCCccc
Q 044366 82 SGRIPSSLGNLSNLALLYLNDNSLFGSIPIVMGNLKSLSTLDLSQNQLNGSIPCSLDNLSNLDTLFLYKNSLSGPIPSVI 161 (918)
Q Consensus 82 ~~~~p~~l~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~ 161 (918)
. ..|++++.+..|..|+..+|+|. ..|+.+.++.+|..|++.+|+++...|+.+. ++.|++|+..+|.++ .+|..+
T Consensus 127 ~-el~~~i~~~~~l~dl~~~~N~i~-slp~~~~~~~~l~~l~~~~n~l~~l~~~~i~-m~~L~~ld~~~N~L~-tlP~~l 202 (565)
T KOG0472|consen 127 K-ELPDSIGRLLDLEDLDATNNQIS-SLPEDMVNLSKLSKLDLEGNKLKALPENHIA-MKRLKHLDCNSNLLE-TLPPEL 202 (565)
T ss_pred e-ecCchHHHHhhhhhhhccccccc-cCchHHHHHHHHHHhhccccchhhCCHHHHH-HHHHHhcccchhhhh-cCChhh
Confidence 6 56666666666666666666665 5566666666666666666666643333333 666666666666666 455566
Q ss_pred ccccccCeeeccccccCCcCCccCCCCCCCcEeeccCcccccCCCccccCCCCcceeecccccccCCCCCCCcCCCcCCe
Q 044366 162 GNLKSLLQLDLSENRLSGLIPLSLSNLSSLTVMSLFNNSLSGSIPPILGNLKSLSTLGLHINQLNGVIPPSIGNLSSLRN 241 (918)
Q Consensus 162 ~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~ 241 (918)
+++.+|..|+|..|+|..+ | .|.+|+.|++|+++.|+|.-...+...++++|..|+|..|+++ ..|+.++-+.+|++
T Consensus 203 g~l~~L~~LyL~~Nki~~l-P-ef~gcs~L~Elh~g~N~i~~lpae~~~~L~~l~vLDLRdNklk-e~Pde~clLrsL~r 279 (565)
T KOG0472|consen 203 GGLESLELLYLRRNKIRFL-P-EFPGCSLLKELHVGENQIEMLPAEHLKHLNSLLVLDLRDNKLK-EVPDEICLLRSLER 279 (565)
T ss_pred cchhhhHHHHhhhcccccC-C-CCCccHHHHHHHhcccHHHhhHHHHhcccccceeeeccccccc-cCchHHHHhhhhhh
Confidence 6666666666666666644 3 5666666666666666666333333446666666666666666 34566666666666
Q ss_pred EEcccCcCcCCCCccccccCCCCeEecCCCccCCcCCCcCCCCC--CCcEEEccCCcCcCCCCccccCCCCCCeEEeecc
Q 044366 242 LSLFNNRLYGFVPKEIGYLKSLSKLEFCANHLSGVIPHSVGNLT--GLVLLNMCENHLFGPIPKSLRNLTSLERVRFNQN 319 (918)
Q Consensus 242 L~Ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~--~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n 319 (918)
||+|+|.|++ .|..++++ +|+.|-+.+|++..+-...+..-+ -|++|.= .+. .+.+..- .+.
T Consensus 280 LDlSNN~is~-Lp~sLgnl-hL~~L~leGNPlrTiRr~ii~~gT~~vLKyLrs---~~~---~dglS~s--------e~~ 343 (565)
T KOG0472|consen 280 LDLSNNDISS-LPYSLGNL-HLKFLALEGNPLRTIRREIISKGTQEVLKYLRS---KIK---DDGLSQS--------EGG 343 (565)
T ss_pred hcccCCcccc-CCcccccc-eeeehhhcCCchHHHHHHHHcccHHHHHHHHHH---hhc---cCCCCCC--------ccc
Confidence 6666666663 44556666 666666666666533222221111 0111110 000 0000000 000
Q ss_pred ccc--Ccccccc---CCCCCccEEeCCCCccccccCcccccccccceeeccccccccCCCcCcCCCCC---CcEEEccCc
Q 044366 320 NLY--GKVYEAF---GDHPNLTFLDLSQNNFYCEISFNWRNFSKLGTFNASMNNIYGSIPPEIGDSSK---LQVLDLSSN 391 (918)
Q Consensus 320 ~l~--~~~~~~~---~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~n~i~~~~~~~~~~~~~---L~~L~L~~N 391 (918)
.-+ +.+...| ...-+.+.|++++-++ + .+|++++...+ ....+++.|
T Consensus 344 ~e~~~t~~~~~~~~~~~~i~tkiL~~s~~ql------------------------t-~VPdEVfea~~~~~Vt~VnfskN 398 (565)
T KOG0472|consen 344 TETAMTLPSESFPDIYAIITTKILDVSDKQL------------------------T-LVPDEVFEAAKSEIVTSVNFSKN 398 (565)
T ss_pred ccccCCCCCCcccchhhhhhhhhhccccccc------------------------c-cCCHHHHHHhhhcceEEEecccc
Confidence 000 0001111 1122344444444433 3 45555444433 778888899
Q ss_pred eeccccccchhhccccCceecccccccCCCCCCCCCCCcccEEeccCccccccCccccccccccceecccCcccCCCCch
Q 044366 392 HIFGKIPVQLVKLFSLNKLILSLNQLFGGVPLEFGTLTELQYLDLSANKLSSSIPMSIGNLLKLHYLNLSNNQFSHKIPT 471 (918)
Q Consensus 392 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~ 471 (918)
++. ..|..+..+..+.+.-...|+..+.+|..++.+++|..|+|++|-+. .+|..++.+..|+.||+|+|+|. ..|.
T Consensus 399 qL~-elPk~L~~lkelvT~l~lsnn~isfv~~~l~~l~kLt~L~L~NN~Ln-~LP~e~~~lv~Lq~LnlS~NrFr-~lP~ 475 (565)
T KOG0472|consen 399 QLC-ELPKRLVELKELVTDLVLSNNKISFVPLELSQLQKLTFLDLSNNLLN-DLPEEMGSLVRLQTLNLSFNRFR-MLPE 475 (565)
T ss_pred hHh-hhhhhhHHHHHHHHHHHhhcCccccchHHHHhhhcceeeecccchhh-hcchhhhhhhhhheecccccccc-cchH
Confidence 887 78888888887666544444445789999999999999999999998 68899999999999999999996 7899
Q ss_pred hhccccccceEeccCCcCCCCCchhccccCCcceEecCCCcccccCcccccCCCCccEEEccCCcCC
Q 044366 472 EFEKLIHLSELDLSHNILQEEIPPQICKMESLEKLNLSHNNLSDFIPRCFEEMRSLSWIDISYNELQ 538 (918)
Q Consensus 472 ~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~ 538 (918)
....+..|+.+-.++|++....|..+.+|.+|..|||.+|.|.. +|..++++++|++|+++||+|+
T Consensus 476 ~~y~lq~lEtllas~nqi~~vd~~~l~nm~nL~tLDL~nNdlq~-IPp~LgnmtnL~hLeL~gNpfr 541 (565)
T KOG0472|consen 476 CLYELQTLETLLASNNQIGSVDPSGLKNMRNLTTLDLQNNDLQQ-IPPILGNMTNLRHLELDGNPFR 541 (565)
T ss_pred HHhhHHHHHHHHhccccccccChHHhhhhhhcceeccCCCchhh-CChhhccccceeEEEecCCccC
Confidence 98888888888888899987777779999999999999999976 7778999999999999999998
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-43 Score=361.29 Aligned_cols=203 Identities=28% Similarity=0.490 Sum_probs=180.6
Q ss_pred HhcCCCCceeeccccceEEEEEEeC-CCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceE
Q 044366 644 ATGNFGEKYCIGKGGQRSVYKAELP-SGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSF 722 (918)
Q Consensus 644 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 722 (918)
..++|...+.||+|+||+||+|++. ++..||||.+.+... .....+-...|+++++.++|||||++++++..++..|
T Consensus 8 ~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l--~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~ 85 (429)
T KOG0595|consen 8 VVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKL--NKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIY 85 (429)
T ss_pred ccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhcc--CHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEE
Confidence 4567888888999999999999664 689999999976432 2233566889999999999999999999999999999
Q ss_pred EEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCC------CcEEEecc
Q 044366 723 IVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSE------YEAHVSDF 796 (918)
Q Consensus 723 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~------~~~kl~Df 796 (918)
+|||||+||+|.+|++..+ .+++..++.+..|+|.||++||+. +||||||||+|||++.. -.+||+||
T Consensus 86 lVMEyC~gGDLs~yi~~~~---~l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~~~~~LKIADF 159 (429)
T KOG0595|consen 86 LVMEYCNGGDLSDYIRRRG---RLPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARNDTSPVLKIADF 159 (429)
T ss_pred EEEEeCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCCCCceEEeccc
Confidence 9999999999999999864 489999999999999999999999 99999999999999875 35799999
Q ss_pred ccccccCCCCCCceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcc
Q 044366 797 GFAKFLEPHSSNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFV 855 (918)
Q Consensus 797 G~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~ 855 (918)
|+|+...+ .......+|++.|||||++...+|+.|+|+||.|+++|||++|+.||+..
T Consensus 160 GfAR~L~~-~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~ 217 (429)
T KOG0595|consen 160 GFARFLQP-GSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAE 217 (429)
T ss_pred chhhhCCc-hhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCcccc
Confidence 99999874 33345678999999999999999999999999999999999999998743
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-44 Score=396.70 Aligned_cols=259 Identities=25% Similarity=0.398 Sum_probs=209.2
Q ss_pred HHHhcCCCCceeeccccceEEEEEEeC------CCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEeccc
Q 044366 642 TKATGNFGEKYCIGKGGQRSVYKAELP------SGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFC 715 (918)
Q Consensus 642 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~ 715 (918)
+....+....+.||+|+||.||+|+.. +...||||.++.. .+.+...+|.+|+++++.++|||||+++|+|
T Consensus 482 ~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~---a~~~~~~dF~REaeLla~l~H~nIVrLlGVC 558 (774)
T KOG1026|consen 482 EIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDK---AENQARQDFRREAELLAELQHPNIVRLLGVC 558 (774)
T ss_pred EechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhccc---ccHHHHHHHHHHHHHHHhccCCCeEEEEEEE
Confidence 334455566678999999999999653 3457999999874 2333578999999999999999999999999
Q ss_pred ccCCceEEEEEeccCCChhHHhhcccc-----------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCee
Q 044366 716 SNAQHSFIVCEYLARGSLTTILRDDAA-----------AKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVL 784 (918)
Q Consensus 716 ~~~~~~~lv~e~~~~gsL~~~l~~~~~-----------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil 784 (918)
.+++.++||+|||..|||.+||+...+ ..+++..+.+.||.|||.||+||-++ .+|||||..+|+|
T Consensus 559 ~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNCL 635 (774)
T KOG1026|consen 559 REGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNCL 635 (774)
T ss_pred ccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhce
Confidence 999999999999999999999986431 22388999999999999999999999 9999999999999
Q ss_pred eCCCCcEEEeccccccccCCCCCCc-e-ecccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhhhhh
Q 044366 785 LDSEYEAHVSDFGFAKFLEPHSSNW-T-EFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIK-GYHPGDFVSTIFSS 861 (918)
Q Consensus 785 l~~~~~~kl~DfG~~~~~~~~~~~~-~-~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~p~~~~~~~~~~ 861 (918)
|.++..|||+|||+++.+-..++.. . ...-+.+|||||.+..+++|.+||||||||||||+++ |+.|+......
T Consensus 636 Vge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~--- 712 (774)
T KOG1026|consen 636 VGENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQ--- 712 (774)
T ss_pred eccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchH---
Confidence 9999999999999999765444322 1 2334789999999999999999999999999999998 88886533211
Q ss_pred hhhhHhhhhhhcccCCCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 044366 862 ISNMIIEVNQILDHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLLC 917 (918)
Q Consensus 862 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 917 (918)
.-+..+...+.-+-++ ..+.++++++..||+..|++||+++||-..|+
T Consensus 713 -----EVIe~i~~g~lL~~Pe---~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~ 760 (774)
T KOG1026|consen 713 -----EVIECIRAGQLLSCPE---NCPTEVYSLMLECWNENPKRRPSFKEIHSRLQ 760 (774)
T ss_pred -----HHHHHHHcCCcccCCC---CCCHHHHHHHHHHhhcCcccCCCHHHHHHHHH
Confidence 0111222222222222 33456899999999999999999999998885
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-45 Score=386.63 Aligned_cols=397 Identities=25% Similarity=0.260 Sum_probs=247.3
Q ss_pred CCEEECcCCcCCCcCCcCCCCC--CCCceeeccccccccCCCcccccccccCeeeccccccCCcCCccCCCCCCCcEeec
Q 044366 119 LSTLDLSQNQLNGSIPCSLDNL--SNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSENRLSGLIPLSLSNLSSLTVMSL 196 (918)
Q Consensus 119 L~~L~Ls~n~i~~~~~~~l~~l--~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 196 (918)
-..||++++.+.......+.+. +.-+.|++++|++..+.+..|.++++|+++++.+|.++.+ |.......+|+.|+|
T Consensus 54 ~~lldcs~~~lea~~~~~l~g~lp~~t~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt~I-P~f~~~sghl~~L~L 132 (873)
T KOG4194|consen 54 TRLLDCSDRELEAIDKSRLKGFLPSQTQTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELTRI-PRFGHESGHLEKLDL 132 (873)
T ss_pred ceeeecCccccccccccccCCcCccceeeeeccccccccCcHHHHhcCCcceeeeeccchhhhc-ccccccccceeEEee
Confidence 4668888888775433333332 2345588888888877777777888888888888887743 544444455777888
Q ss_pred cCcccccCCCccccCCCCcceeecccccccCCCCCCCcCCCcCCeEEcccCcCcCCCCccccccCCCCeEecCCCccCCc
Q 044366 197 FNNSLSGSIPPILGNLKSLSTLGLHINQLNGVIPPSIGNLSSLRNLSLFNNRLYGFVPKEIGYLKSLSKLEFCANHLSGV 276 (918)
Q Consensus 197 ~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~ 276 (918)
.+|.|+.+..+.+..++.|+.|||+.|.|+.+....|..-.++++|+|++|+|+.+..+.|..+.+|..|.|+.|+++.+
T Consensus 133 ~~N~I~sv~se~L~~l~alrslDLSrN~is~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tlkLsrNrittL 212 (873)
T KOG4194|consen 133 RHNLISSVTSEELSALPALRSLDLSRNLISEIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTLKLSRNRITTL 212 (873)
T ss_pred eccccccccHHHHHhHhhhhhhhhhhchhhcccCCCCCCCCCceEEeeccccccccccccccccchheeeecccCccccc
Confidence 88877776667777777777777777777776666776666777777777777777777777777777777777777766
Q ss_pred CCCcCCCCCCCcEEEccCCcCcCCCCccccCCCCCCeEEeecccccCccccccCCCCCccEEeCCCCccccccCcccccc
Q 044366 277 IPHSVGNLTGLVLLNMCENHLFGPIPKSLRNLTSLERVRFNQNNLYGKVYEAFGDHPNLTFLDLSQNNFYCEISFNWRNF 356 (918)
Q Consensus 277 ~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~ 356 (918)
++..|.++++|+.|+|..|+|...---.|.++++|+.|.|..|.|..+..++|..+.++++|+|+.|++.......
T Consensus 213 p~r~Fk~L~~L~~LdLnrN~irive~ltFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~vn~g~---- 288 (873)
T KOG4194|consen 213 PQRSFKRLPKLESLDLNRNRIRIVEGLTFQGLPSLQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQAVNEGW---- 288 (873)
T ss_pred CHHHhhhcchhhhhhccccceeeehhhhhcCchhhhhhhhhhcCcccccCcceeeecccceeecccchhhhhhccc----
Confidence 6666777777777777777765444556666666666666666666666666666666666666666665444444
Q ss_pred cccceeeccccccccCCCcCcCCCCCCcEEEccCceeccccccchhhccccCceecccccccCCCCCCCCCCCcccEEec
Q 044366 357 SKLGTFNASMNNIYGSIPPEIGDSSKLQVLDLSSNHIFGKIPVQLVKLFSLNKLILSLNQLFGGVPLEFGTLTELQYLDL 436 (918)
Q Consensus 357 ~~L~~l~l~~n~i~~~~~~~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 436 (918)
+.+++.|+.|+||.|.|..+.++.+.-.++|++|+|++|+|+...+..|..+++|+.|+|
T Consensus 289 --------------------lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnL 348 (873)
T KOG4194|consen 289 --------------------LFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNL 348 (873)
T ss_pred --------------------ccccchhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHHHHHHHhhhhcc
Confidence 444455555555555555444444444555555555555555555555555555555555
Q ss_pred cCccccccCccccccccccceecccCcccCCCC---chhhccccccceEeccCCcCCCCCchhccccCCcceEecCCCcc
Q 044366 437 SANKLSSSIPMSIGNLLKLHYLNLSNNQFSHKI---PTEFEKLIHLSELDLSHNILQEEIPPQICKMESLEKLNLSHNNL 513 (918)
Q Consensus 437 s~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~---~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l 513 (918)
++|.|+.+....|..+.+|+.|||++|.|+..+ ...|.+|++|+.|+|.+|+|..+.-.+|.++++|++|||.+|.|
T Consensus 349 s~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk~I~krAfsgl~~LE~LdL~~Nai 428 (873)
T KOG4194|consen 349 SHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKLRLTGNQLKSIPKRAFSGLEALEHLDLGDNAI 428 (873)
T ss_pred cccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhheeecCceeeecchhhhccCcccceecCCCCcc
Confidence 555555444445555555555555555554332 22355555555555555555544444555555555555555555
Q ss_pred cccCcccccCCCCccEEEccCCcCCCCC
Q 044366 514 SDFIPRCFEEMRSLSWIDISYNELQGPI 541 (918)
Q Consensus 514 ~~~~~~~~~~l~~L~~l~l~~N~l~~~~ 541 (918)
.++.|.+|..+ .|+.|-++.-.+-|.+
T Consensus 429 aSIq~nAFe~m-~Lk~Lv~nSssflCDC 455 (873)
T KOG4194|consen 429 ASIQPNAFEPM-ELKELVMNSSSFLCDC 455 (873)
T ss_pred eeecccccccc-hhhhhhhcccceEEec
Confidence 55555555555 5555555554444443
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=380.05 Aligned_cols=389 Identities=27% Similarity=0.255 Sum_probs=314.6
Q ss_pred CCEEEccCCcccccCccccCCC--CCCCEEECcCCcCCCcCCcCCCCCCCCceeeccccccccCCCcccccccccCeeec
Q 044366 95 LALLYLNDNSLFGSIPIVMGNL--KSLSTLDLSQNQLNGSIPCSLDNLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDL 172 (918)
Q Consensus 95 L~~L~L~~n~i~~~~~~~~~~l--~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 172 (918)
-+.|+++++.+..+....+.+. +.-+.||+++|++....+..|.++++|+++++.+|.++ .+|.......+|+.|+|
T Consensus 54 ~~lldcs~~~lea~~~~~l~g~lp~~t~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt-~IP~f~~~sghl~~L~L 132 (873)
T KOG4194|consen 54 TRLLDCSDRELEAIDKSRLKGFLPSQTQTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELT-RIPRFGHESGHLEKLDL 132 (873)
T ss_pred ceeeecCccccccccccccCCcCccceeeeeccccccccCcHHHHhcCCcceeeeeccchhh-hcccccccccceeEEee
Confidence 4567999998865433333332 34677999999999998999999999999999999999 45666666677999999
Q ss_pred cccccCCcCCccCCCCCCCcEeeccCcccccCCCccccCCCCcceeecccccccCCCCCCCcCCCcCCeEEcccCcCcCC
Q 044366 173 SENRLSGLIPLSLSNLSSLTVMSLFNNSLSGSIPPILGNLKSLSTLGLHINQLNGVIPPSIGNLSSLRNLSLFNNRLYGF 252 (918)
Q Consensus 173 s~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~ 252 (918)
.+|.|+++....++-++.|+.|||+.|.|+.+.-..|..-.++++|+|++|.|+.+....|.++.+|..|.|++|+|+..
T Consensus 133 ~~N~I~sv~se~L~~l~alrslDLSrN~is~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tlkLsrNrittL 212 (873)
T KOG4194|consen 133 RHNLISSVTSEELSALPALRSLDLSRNLISEIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTLKLSRNRITTL 212 (873)
T ss_pred eccccccccHHHHHhHhhhhhhhhhhchhhcccCCCCCCCCCceEEeeccccccccccccccccchheeeecccCccccc
Confidence 99999999889999999999999999999988778899989999999999999999999999999999999999999999
Q ss_pred CCccccccCCCCeEecCCCccCCcCCCcCCCCCCCcEEEccCCcCcCCCCccccCCCCCCeEEeecccccCccccccCCC
Q 044366 253 VPKEIGYLKSLSKLEFCANHLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLRNLTSLERVRFNQNNLYGKVYEAFGDH 332 (918)
Q Consensus 253 ~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l 332 (918)
++..|..+++|+.|+|..|+|.-+..-.|.++++|+.|.|..|.|.....+.|.++.++++|+|+.|+++.+..+.+-++
T Consensus 213 p~r~Fk~L~~L~~LdLnrN~irive~ltFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~vn~g~lfgL 292 (873)
T KOG4194|consen 213 PQRSFKRLPKLESLDLNRNRIRIVEGLTFQGLPSLQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQAVNEGWLFGL 292 (873)
T ss_pred CHHHhhhcchhhhhhccccceeeehhhhhcCchhhhhhhhhhcCcccccCcceeeecccceeecccchhhhhhccccccc
Confidence 99999999999999999999997767889999999999999999999999999999999999999999999999999999
Q ss_pred CCccEEeCCCCccccccCcccccccccceeeccccccccCCCcCcCCCCCCcEEEccCceeccccccchhhccccCceec
Q 044366 333 PNLTFLDLSQNNFYCEISFNWRNFSKLGTFNASMNNIYGSIPPEIGDSSKLQVLDLSSNHIFGKIPVQLVKLFSLNKLIL 412 (918)
Q Consensus 333 ~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~n~i~~~~~~~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 412 (918)
..|+.|+||+|.|..+....|.-..+|+.|+|++|+|+...+..|..++.|++|.|++|+|..+....|.++.+|++|||
T Consensus 293 t~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~LdL 372 (873)
T KOG4194|consen 293 TSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSSLHKLDL 372 (873)
T ss_pred chhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHHHHHHHhhhhcccccchHHHHhhHHHHhhhhhhhcC
Confidence 99999999999998888777777777777777777666666666666666666666666666666666666666666666
Q ss_pred ccccccCCCC---CCCCCCCcccEEeccCccccccCccccccccccceecccCcccCCCCchhhccccccceEecc
Q 044366 413 SLNQLFGGVP---LEFGTLTELQYLDLSANKLSSSIPMSIGNLLKLHYLNLSNNQFSHKIPTEFEKLIHLSELDLS 485 (918)
Q Consensus 413 ~~N~l~~~~~---~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls 485 (918)
++|.++..+. ..|.++++|+.|+|.+|+|..+...+|.++++|++|||.+|.|..+.|++|..+ +|++|.++
T Consensus 373 r~N~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk~I~krAfsgl~~LE~LdL~~NaiaSIq~nAFe~m-~Lk~Lv~n 447 (873)
T KOG4194|consen 373 RSNELSWCIEDAAVAFNGLPSLRKLRLTGNQLKSIPKRAFSGLEALEHLDLGDNAIASIQPNAFEPM-ELKELVMN 447 (873)
T ss_pred cCCeEEEEEecchhhhccchhhhheeecCceeeecchhhhccCcccceecCCCCcceeecccccccc-hhhhhhhc
Confidence 6666654332 245556666666666666665555566666666666666666655566666665 55555543
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-44 Score=387.38 Aligned_cols=267 Identities=28% Similarity=0.492 Sum_probs=217.6
Q ss_pred cCCccCHHHHHHHhcC---------CCCceeeccccceEEEEEEeC----CCCEEEEEEcccccccCCCCChHHHHHHHH
Q 044366 632 FNGKVLYEEITKATGN---------FGEKYCIGKGGQRSVYKAELP----SGNIFAVKKFKAELFSDETANPSEFLNEVL 698 (918)
Q Consensus 632 ~~~~~~~~~~~~~~~~---------~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~e~~ 698 (918)
+....+|++.-.|... ..+.++||.|.||.||+|+++ ....||||.++... .+....+|+.|+.
T Consensus 606 YiDP~TYEDPnqAvreFakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gy---tekqrrdFL~EAs 682 (996)
T KOG0196|consen 606 YIDPHTYEDPNQAVREFAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGY---TEKQRRDFLSEAS 682 (996)
T ss_pred ecCCccccCccHHHHHhhhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCc---cHHHHhhhhhhhh
Confidence 3345666655554443 356689999999999999764 23479999998743 3334679999999
Q ss_pred HHhhccCCceeeEecccccCCceEEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCC
Q 044366 699 ALTEIRHRNIIKFHGFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDI 778 (918)
Q Consensus 699 ~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl 778 (918)
+|.++.||||+++-|+.+..+..++|+|||++|+|+.||+... ++|++-+...|.++||.||.||.+. ++|||||
T Consensus 683 IMGQFdHPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~~D--GqftviQLVgMLrGIAsGMkYLsdm---~YVHRDL 757 (996)
T KOG0196|consen 683 IMGQFDHPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQND--GQFTVIQLVGMLRGIASGMKYLSDM---NYVHRDL 757 (996)
T ss_pred hcccCCCCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhhcC--CceEeehHHHHHHHHHHHhHHHhhc---Cchhhhh
Confidence 9999999999999999999999999999999999999999764 5699999999999999999999999 9999999
Q ss_pred CCCCeeeCCCCcEEEeccccccccCCCCCC-ceeccc--ccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCc
Q 044366 779 SSKNVLLDSEYEAHVSDFGFAKFLEPHSSN-WTEFAG--TVGYAAPELAYTMRATEKYDVYSFGVLALEVIK-GYHPGDF 854 (918)
Q Consensus 779 k~~Nill~~~~~~kl~DfG~~~~~~~~~~~-~~~~~g--~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~p~~~ 854 (918)
.++|||++.+..+|++|||+++.+.++... .+...| +.+|.|||.+...+++.+|||||||+|+||.++ |..|+..
T Consensus 758 AARNILVNsnLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWd 837 (996)
T KOG0196|consen 758 AARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWD 837 (996)
T ss_pred hhhheeeccceEEEeccccceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccc
Confidence 999999999999999999999988655422 222222 579999999999999999999999999999886 8999765
Q ss_pred chhhhhhhhhhHhhhhhhc-ccCCCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhC
Q 044366 855 VSTIFSSISNMIIEVNQIL-DHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLLCK 918 (918)
Q Consensus 855 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~ 918 (918)
+... . . +..+. +-++|++ . +++..+.+++..||++|-.+||+++|++..|.|
T Consensus 838 mSNQ--d---V---IkaIe~gyRLPpP-m---DCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDk 890 (996)
T KOG0196|consen 838 MSNQ--D---V---IKAIEQGYRLPPP-M---DCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDK 890 (996)
T ss_pred cchH--H---H---HHHHHhccCCCCC-C---CCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHH
Confidence 5421 1 1 11121 2234433 2 344578999999999999999999999999865
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=338.27 Aligned_cols=261 Identities=23% Similarity=0.383 Sum_probs=209.9
Q ss_pred cCCCCceeeccccceEEEEEEeC-CCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEEE
Q 044366 646 GNFGEKYCIGKGGQRSVYKAELP-SGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFIV 724 (918)
Q Consensus 646 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 724 (918)
+.|+...++|+|+||+|||++.+ +|+.||||++... .+++...+-..+|++++++++|||+|.++++|.....+++|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Es--edd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLV 79 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVES--EDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLV 79 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccC--CccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEE
Confidence 45777888999999999999665 6999999998652 34455567789999999999999999999999999999999
Q ss_pred EEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccCC
Q 044366 725 CEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEP 804 (918)
Q Consensus 725 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~~ 804 (918)
+||++. ++.+-+.+.. ..++...+.+++.|++.|+.|+|++ ++|||||||+||+++.+|.+||||||+|+.+..
T Consensus 80 FE~~dh-TvL~eLe~~p--~G~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~ 153 (396)
T KOG0593|consen 80 FEYCDH-TVLHELERYP--NGVPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLCDFGFARTLSA 153 (396)
T ss_pred eeecch-HHHHHHHhcc--CCCCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEeccchhhHhhcC
Confidence 999998 5555555442 3378899999999999999999999 999999999999999999999999999999987
Q ss_pred CCCCceeccccccccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhh------hhhhHhhhhhhccc--
Q 044366 805 HSSNWTEFAGTVGYAAPELAYT-MRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSS------ISNMIIEVNQILDH-- 875 (918)
Q Consensus 805 ~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~------~~~~~~~~~~~~~~-- 875 (918)
+...++..+.|..|.|||.+.+ .+|...+||||.||++.||++|.+-|....++..- ..+..-+-..++..
T Consensus 154 pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~ 233 (396)
T KOG0593|consen 154 PGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNP 233 (396)
T ss_pred CcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCC
Confidence 7777888999999999999987 78999999999999999999999876554432211 11111111122111
Q ss_pred -----CCCCC------CcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 876 -----RLPTP------SRDVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 876 -----~~~~~------~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
++|.+ ....+....-+++++..|++.||++|++.+|++.
T Consensus 234 ~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 234 FFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred ceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 12222 1223334456899999999999999999999874
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-42 Score=345.20 Aligned_cols=246 Identities=26% Similarity=0.378 Sum_probs=207.8
Q ss_pred HhcCCCCceeeccccceEEEEEE-eCCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceE
Q 044366 644 ATGNFGEKYCIGKGGQRSVYKAE-LPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSF 722 (918)
Q Consensus 644 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 722 (918)
..++|+..++||+|+||.||.++ .++++.||+|++++...... ...+....|..++.+++||.||+++-.|++++.+|
T Consensus 23 ~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~-~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLy 101 (357)
T KOG0598|consen 23 GPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEK-KEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLY 101 (357)
T ss_pred ChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhh-hhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEE
Confidence 35789999999999999999994 45799999999987544433 34678899999999999999999999999999999
Q ss_pred EEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEecccccccc
Q 044366 723 IVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFL 802 (918)
Q Consensus 723 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~ 802 (918)
+|+||+.||.|...+.+.+ .+++..+.-++..|+.||.|||+. +|||||+||+|||+|.+|.++|+|||+++..
T Consensus 102 lVld~~~GGeLf~hL~~eg---~F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~GHi~LtDFgL~k~~ 175 (357)
T KOG0598|consen 102 LVLDYLNGGELFYHLQREG---RFSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQGHIKLTDFGLCKED 175 (357)
T ss_pred EEEeccCCccHHHHHHhcC---CcchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCCcEEEeccccchhc
Confidence 9999999999999998653 489999999999999999999999 9999999999999999999999999999976
Q ss_pred CCCCCCceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCCCCCc
Q 044366 803 EPHSSNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSR 882 (918)
Q Consensus 803 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 882 (918)
...+......+||+.|||||++.+..|+.++|.||+|+++|||++|.+||..... ......+...+.+.++.
T Consensus 176 ~~~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~--------~~~~~~I~~~k~~~~p~ 247 (357)
T KOG0598|consen 176 LKDGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDV--------KKMYDKILKGKLPLPPG 247 (357)
T ss_pred ccCCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccH--------HHHHHHHhcCcCCCCCc
Confidence 6555555668999999999999999999999999999999999999999875432 11222333333233322
Q ss_pred chHHHHHHHHHHHHHcccCCCCCCC
Q 044366 883 DVTDKLRSIMEVAILCLVENPEARP 907 (918)
Q Consensus 883 ~~~~~~~~l~~li~~cl~~dp~~RP 907 (918)
... ....+++.+.+..||++|.
T Consensus 248 ~ls---~~ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 248 YLS---EEARDLLKKLLKRDPRQRL 269 (357)
T ss_pred cCC---HHHHHHHHHHhccCHHHhc
Confidence 222 3467788899999999995
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-46 Score=377.86 Aligned_cols=463 Identities=31% Similarity=0.406 Sum_probs=371.5
Q ss_pred CcccCCCCCCccCCccCCCCCCCCEEeCCCCcccccCCccccCCCCCCEEEcccccccccCCCCcCCCCCCCEEEccccc
Q 044366 1 MLNLGFNLLFGNIPPQIGNLSKLQYLDLGNNQLSGVIPPEIGKLNQLRRLYLDVNQLHGTIPPVIGQLSLINELVFCHNN 80 (918)
Q Consensus 1 ~l~~~~~~~~~~~p~~~~~l~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~ 80 (918)
||++.+|.+. ++|++++.+.++..|+.++|++. .+|++++.+.+|+.|++++|.+. .+|++++.+..|+.|+..+|+
T Consensus 72 vl~~~~n~l~-~lp~aig~l~~l~~l~vs~n~ls-~lp~~i~s~~~l~~l~~s~n~~~-el~~~i~~~~~l~dl~~~~N~ 148 (565)
T KOG0472|consen 72 VLNVHDNKLS-QLPAAIGELEALKSLNVSHNKLS-ELPEQIGSLISLVKLDCSSNELK-ELPDSIGRLLDLEDLDATNNQ 148 (565)
T ss_pred EEEeccchhh-hCCHHHHHHHHHHHhhcccchHh-hccHHHhhhhhhhhhhcccccee-ecCchHHHHhhhhhhhccccc
Confidence 6889999998 99999999999999999999998 99999999999999999999998 899999999999999999999
Q ss_pred ccccCCccccCCCCCCEEEccCCcccccCccccCCCCCCCEEECcCCcCCCcCCcCCCCCCCCceeeccccccccCCCcc
Q 044366 81 VSGRIPSSLGNLSNLALLYLNDNSLFGSIPIVMGNLKSLSTLDLSQNQLNGSIPCSLDNLSNLDTLFLYKNSLSGPIPSV 160 (918)
Q Consensus 81 ~~~~~p~~l~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~ 160 (918)
++ ..|+++..+.+|..|++.+|++....|..+. |+.|++||...|-++ .+|..+++|.+|+.|+|.+|+|.. .| .
T Consensus 149 i~-slp~~~~~~~~l~~l~~~~n~l~~l~~~~i~-m~~L~~ld~~~N~L~-tlP~~lg~l~~L~~LyL~~Nki~~-lP-e 223 (565)
T KOG0472|consen 149 IS-SLPEDMVNLSKLSKLDLEGNKLKALPENHIA-MKRLKHLDCNSNLLE-TLPPELGGLESLELLYLRRNKIRF-LP-E 223 (565)
T ss_pred cc-cCchHHHHHHHHHHhhccccchhhCCHHHHH-HHHHHhcccchhhhh-cCChhhcchhhhHHHHhhhccccc-CC-C
Confidence 99 8999999999999999999999866665555 999999999999998 788899999999999999999994 45 8
Q ss_pred cccccccCeeeccccccCCcCCccCCCCCCCcEeeccCcccccCCCccccCCCCcceeecccccccCCCCCCCcCCCcCC
Q 044366 161 IGNLKSLLQLDLSENRLSGLIPLSLSNLSSLTVMSLFNNSLSGSIPPILGNLKSLSTLGLHINQLNGVIPPSIGNLSSLR 240 (918)
Q Consensus 161 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~ 240 (918)
|.++..|++|+++.|.|+.++.....+++++.+|||..|+++ ..|+.+.-+++|.+|++++|.|++ .|..++++ +|+
T Consensus 224 f~gcs~L~Elh~g~N~i~~lpae~~~~L~~l~vLDLRdNklk-e~Pde~clLrsL~rLDlSNN~is~-Lp~sLgnl-hL~ 300 (565)
T KOG0472|consen 224 FPGCSLLKELHVGENQIEMLPAEHLKHLNSLLVLDLRDNKLK-EVPDEICLLRSLERLDLSNNDISS-LPYSLGNL-HLK 300 (565)
T ss_pred CCccHHHHHHHhcccHHHhhHHHHhcccccceeeeccccccc-cCchHHHHhhhhhhhcccCCcccc-CCcccccc-eee
Confidence 999999999999999999776666779999999999999999 679999999999999999999995 57889999 999
Q ss_pred eEEcccCcCcCCCCccccccCC--CCeEe--cCCCccCCcCCCcCCCCCCCcEEEccCCcCcCCCCccccCCCCCCeEEe
Q 044366 241 NLSLFNNRLYGFVPKEIGYLKS--LSKLE--FCANHLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLRNLTSLERVRF 316 (918)
Q Consensus 241 ~L~Ls~n~l~~~~~~~~~~l~~--L~~L~--l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l 316 (918)
.|-+.+|.+.++-.+.+..-+. |++|. +..-.++......-..+ ... .........+.+.++|++
T Consensus 301 ~L~leGNPlrTiRr~ii~~gT~~vLKyLrs~~~~dglS~se~~~e~~~----------t~~-~~~~~~~~~~i~tkiL~~ 369 (565)
T KOG0472|consen 301 FLALEGNPLRTIRREIISKGTQEVLKYLRSKIKDDGLSQSEGGTETAM----------TLP-SESFPDIYAIITTKILDV 369 (565)
T ss_pred ehhhcCCchHHHHHHHHcccHHHHHHHHHHhhccCCCCCCcccccccC----------CCC-CCcccchhhhhhhhhhcc
Confidence 9999999997554433322111 22221 11111111000000000 000 112233456677889999
Q ss_pred ecccccCccccccCCCC--CccEEeCCCCccccccCcccccccccceeeccccccccCCCcCcCCCCCC-cEEEccCcee
Q 044366 317 NQNNLYGKVYEAFGDHP--NLTFLDLSQNNFYCEISFNWRNFSKLGTFNASMNNIYGSIPPEIGDSSKL-QVLDLSSNHI 393 (918)
Q Consensus 317 ~~n~l~~~~~~~~~~l~--~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~n~i~~~~~~~~~~~~~L-~~L~L~~N~l 393 (918)
++-+++.++.+.|..-. -.+..+++.|++. .+|..+..+..+ +.+++++|.+
T Consensus 370 s~~qlt~VPdEVfea~~~~~Vt~VnfskNqL~-------------------------elPk~L~~lkelvT~l~lsnn~i 424 (565)
T KOG0472|consen 370 SDKQLTLVPDEVFEAAKSEIVTSVNFSKNQLC-------------------------ELPKRLVELKELVTDLVLSNNKI 424 (565)
T ss_pred cccccccCCHHHHHHhhhcceEEEecccchHh-------------------------hhhhhhHHHHHHHHHHHhhcCcc
Confidence 99999999999986543 3777888888875 333333333322 2344444444
Q ss_pred ccccccchhhccccCceecccccccCCCCCCCCCCCcccEEeccCccccccCccccccccccceecccCcccCCCCchhh
Q 044366 394 FGKIPVQLVKLFSLNKLILSLNQLFGGVPLEFGTLTELQYLDLSANKLSSSIPMSIGNLLKLHYLNLSNNQFSHKIPTEF 473 (918)
Q Consensus 394 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~ 473 (918)
. .+|..+..+++|..|+|++|-+- .+|..++.+..|+.||+|.|++. ..|..+..+..|+.+-.++|++..+.|..+
T Consensus 425 s-fv~~~l~~l~kLt~L~L~NN~Ln-~LP~e~~~lv~Lq~LnlS~NrFr-~lP~~~y~lq~lEtllas~nqi~~vd~~~l 501 (565)
T KOG0472|consen 425 S-FVPLELSQLQKLTFLDLSNNLLN-DLPEEMGSLVRLQTLNLSFNRFR-MLPECLYELQTLETLLASNNQIGSVDPSGL 501 (565)
T ss_pred c-cchHHHHhhhcceeeecccchhh-hcchhhhhhhhhheecccccccc-cchHHHhhHHHHHHHHhccccccccChHHh
Confidence 3 66666677777777777776664 56677777888999999999888 788888888888888888899987777779
Q ss_pred ccccccceEeccCCcCCCCCchhccccCCcceEecCCCccc
Q 044366 474 EKLIHLSELDLSHNILQEEIPPQICKMESLEKLNLSHNNLS 514 (918)
Q Consensus 474 ~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 514 (918)
.+|.+|.+|||.+|.|. .+|+.+++|.+|++|.|++|+++
T Consensus 502 ~nm~nL~tLDL~nNdlq-~IPp~LgnmtnL~hLeL~gNpfr 541 (565)
T KOG0472|consen 502 KNMRNLTTLDLQNNDLQ-QIPPILGNMTNLRHLELDGNPFR 541 (565)
T ss_pred hhhhhcceeccCCCchh-hCChhhccccceeEEEecCCccC
Confidence 99999999999999997 78999999999999999999998
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=345.35 Aligned_cols=256 Identities=27% Similarity=0.429 Sum_probs=211.8
Q ss_pred HhcCCCCceeeccccceEEEEE-EeCCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceE
Q 044366 644 ATGNFGEKYCIGKGGQRSVYKA-ELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSF 722 (918)
Q Consensus 644 ~~~~~~~~~~lg~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 722 (918)
..+.|+....||.|..++||+| ..+.++.||||++..+.+.. +.+.+.+|++.++.++||||++++..|..+...|
T Consensus 24 n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~---~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LW 100 (516)
T KOG0582|consen 24 NAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNN---DLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELW 100 (516)
T ss_pred CccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhh---hHHHHHHHHHHhhhcCCCCcceEEEEEEecceeE
Confidence 4467899999999999999999 56788999999998765443 3688999999999999999999999999999999
Q ss_pred EEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEecccccccc
Q 044366 723 IVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFL 802 (918)
Q Consensus 723 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~ 802 (918)
+||+||.+|++.+.++...+.+ +++..+..|.+++++||.|||.+ |.||||||+.|||++.+|.|||+|||.+..+
T Consensus 101 vVmpfMa~GS~ldIik~~~~~G-l~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLadFgvsa~l 176 (516)
T KOG0582|consen 101 VVMPFMAGGSLLDIIKTYYPDG-LEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLADFGVSASL 176 (516)
T ss_pred EeehhhcCCcHHHHHHHHcccc-ccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEcCceeeeee
Confidence 9999999999999998875444 89999999999999999999999 9999999999999999999999999999877
Q ss_pred CCCCCCc----eeccccccccccccccc--CCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccC
Q 044366 803 EPHSSNW----TEFAGTVGYAAPELAYT--MRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHR 876 (918)
Q Consensus 803 ~~~~~~~----~~~~g~~~y~aPE~~~~--~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 876 (918)
...+... ...+||+.|||||++.. ..|+.|+||||||++..|+.+|+.||....+.. ..+ .-+...
T Consensus 177 ~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmk-------vLl-~tLqn~ 248 (516)
T KOG0582|consen 177 FDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMK-------VLL-LTLQND 248 (516)
T ss_pred cccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHH-------HHH-HHhcCC
Confidence 6554433 34489999999999653 468999999999999999999999987544321 111 112222
Q ss_pred CCC------CCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 877 LPT------PSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 877 ~~~------~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
+|. ...........+.+++..|+++||.+|||++++++
T Consensus 249 pp~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 249 PPTLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK 292 (516)
T ss_pred CCCcccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 221 11112233457888999999999999999999875
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-41 Score=322.32 Aligned_cols=259 Identities=24% Similarity=0.318 Sum_probs=210.9
Q ss_pred cCCCCceeeccccceEEEEE-EeCCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEEE
Q 044366 646 GNFGEKYCIGKGGQRSVYKA-ELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFIV 724 (918)
Q Consensus 646 ~~~~~~~~lg~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 724 (918)
.+|...+++|+|+||.||+| +..+|+.||||+++.....+.. .....+|++.++.++|+||+.+++++...+...+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi--~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lV 79 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGI--NRTALREIKLLQELKHPNIIELIDVFPHKSNLSLV 79 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCc--cHHHHHHHHHHHHccCcchhhhhhhccCCCceEEE
Confidence 46777889999999999999 6678999999999876443322 35789999999999999999999999999999999
Q ss_pred EEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccCC
Q 044366 725 CEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEP 804 (918)
Q Consensus 725 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~~ 804 (918)
+|||+. +|+..+++. ...++..++..++.++.+|++|||++ .|+|||+||.|++++.+|.+||+|||+|+.+.+
T Consensus 80 fEfm~t-dLe~vIkd~--~i~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~ 153 (318)
T KOG0659|consen 80 FEFMPT-DLEVVIKDK--NIILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLKIADFGLARFFGS 153 (318)
T ss_pred EEeccc-cHHHHhccc--ccccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEEeecccchhccCC
Confidence 999986 999999876 35689999999999999999999999 999999999999999999999999999999988
Q ss_pred CCCCceecccccccccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhh---------------
Q 044366 805 HSSNWTEFAGTVGYAAPELAYTM-RATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIE--------------- 868 (918)
Q Consensus 805 ~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~--------------- 868 (918)
........+-|..|.|||.++|. .|+..+||||.||++.||+-|.+-+....++. ........
T Consensus 154 p~~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDid-QL~~If~~LGTP~~~~WP~~~~l 232 (318)
T KOG0659|consen 154 PNRIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDID-QLSKIFRALGTPTPDQWPEMTSL 232 (318)
T ss_pred CCcccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHH-HHHHHHHHcCCCCcccCcccccc
Confidence 87777777889999999999875 58999999999999999999887654433221 11110000
Q ss_pred --hhhhcccCCCCCC--cchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 044366 869 --VNQILDHRLPTPS--RDVTDKLRSIMEVAILCLVENPEARPTMKEVCNL 915 (918)
Q Consensus 869 --~~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 915 (918)
..++. ..|.+. .-.+....+..+++.+|+..||.+|+|+.|+++.
T Consensus 233 pdY~~~~--~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 233 PDYVKIQ--QFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred ccHHHHh--cCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 00110 111111 1234445677999999999999999999999863
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-41 Score=356.94 Aligned_cols=249 Identities=25% Similarity=0.434 Sum_probs=211.9
Q ss_pred cCCCCceeeccccceEEEEE-EeCCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEEE
Q 044366 646 GNFGEKYCIGKGGQRSVYKA-ELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFIV 724 (918)
Q Consensus 646 ~~~~~~~~lg~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 724 (918)
..|....+||+|+.|.||.| +..+++.||||++... .....+-...|+.+|+..+|+|||.+++.+-.++..|+|
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~----~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVV 348 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLR----KQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVV 348 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEec----cCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEE
Confidence 35677778999999999999 5668999999998763 233356789999999999999999999999888999999
Q ss_pred EEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccCC
Q 044366 725 CEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEP 804 (918)
Q Consensus 725 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~~ 804 (918)
||||++|+|.+.+.... +++.++..|+.++++||+|||.+ ||+|||||..||+++.+|.+||+|||++..+..
T Consensus 349 MEym~ggsLTDvVt~~~----~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~ 421 (550)
T KOG0578|consen 349 MEYMEGGSLTDVVTKTR----MTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKLTDFGFCAQISE 421 (550)
T ss_pred EeecCCCchhhhhhccc----ccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEEeeeeeeecccc
Confidence 99999999999997653 89999999999999999999999 999999999999999999999999999999988
Q ss_pred CCCCceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCCCCCcch
Q 044366 805 HSSNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRDV 884 (918)
Q Consensus 805 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 884 (918)
........+||+.|||||+.....|.+|+||||||++++||+.|.+||-..... ..+..+.....+. ....
T Consensus 422 ~~~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~Pl--------rAlyLIa~ng~P~-lk~~ 492 (550)
T KOG0578|consen 422 EQSKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPL--------RALYLIATNGTPK-LKNP 492 (550)
T ss_pred ccCccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChH--------HHHHHHhhcCCCC-cCCc
Confidence 887888899999999999999999999999999999999999999997543332 1112222222111 1222
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 885 TDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 885 ~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
......+.+++.+|+..||++||+|.|+++
T Consensus 493 ~klS~~~kdFL~~cL~~dv~~RasA~eLL~ 522 (550)
T KOG0578|consen 493 EKLSPELKDFLDRCLVVDVEQRASAKELLE 522 (550)
T ss_pred cccCHHHHHHHHHHhhcchhcCCCHHHHhc
Confidence 234467888999999999999999999986
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=349.33 Aligned_cols=253 Identities=25% Similarity=0.399 Sum_probs=210.7
Q ss_pred HHhcCCCCceeeccccceEEEEE-EeCCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhc-cCCceeeEecccccCCc
Q 044366 643 KATGNFGEKYCIGKGGQRSVYKA-ELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEI-RHRNIIKFHGFCSNAQH 720 (918)
Q Consensus 643 ~~~~~~~~~~~lg~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~ 720 (918)
....+|.+.+.||+|+|++||+| +..+++.||||++.+.....+ ...+....|-++|..| .||.|++++-.|.++..
T Consensus 70 k~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike-~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s 148 (604)
T KOG0592|consen 70 KTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKE-KKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES 148 (604)
T ss_pred CChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhh-cccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence 44567889999999999999999 456899999999876544332 2356778899999999 89999999999999999
Q ss_pred eEEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEecccccc
Q 044366 721 SFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAK 800 (918)
Q Consensus 721 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~ 800 (918)
+|.|+||+++|+|.+++++.+ .|++...+.++.+|+.|++|||+. |||||||||+|||+|+||+++|+|||.|.
T Consensus 149 LYFvLe~A~nGdll~~i~K~G---sfde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~dmhikITDFGsAK 222 (604)
T KOG0592|consen 149 LYFVLEYAPNGDLLDLIKKYG---SFDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKDGHIKITDFGSAK 222 (604)
T ss_pred eEEEEEecCCCcHHHHHHHhC---cchHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCCCcEEEeeccccc
Confidence 999999999999999999864 489999999999999999999999 99999999999999999999999999999
Q ss_pred ccCCCCCC-------------ceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHh
Q 044366 801 FLEPHSSN-------------WTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMII 867 (918)
Q Consensus 801 ~~~~~~~~-------------~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~ 867 (918)
.+.+.... ....+||..|.+||++.....+..+|+|+|||++|+|+.|.+||....+. .
T Consensus 223 ~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ney--------l 294 (604)
T KOG0592|consen 223 ILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEY--------L 294 (604)
T ss_pred cCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHH--------H
Confidence 87543221 14578999999999999999999999999999999999999998765542 1
Q ss_pred hhhhhcccCCCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 868 EVNQILDHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 868 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
..+++++-....+ +..+ +.+.+|+.+.+..||.+|+|+.|+.+
T Consensus 295 iFqkI~~l~y~fp-~~fp---~~a~dLv~KLLv~dp~~Rlt~~qIk~ 337 (604)
T KOG0592|consen 295 IFQKIQALDYEFP-EGFP---EDARDLIKKLLVRDPSDRLTSQQIKA 337 (604)
T ss_pred HHHHHHHhcccCC-CCCC---HHHHHHHHHHHccCccccccHHHHhh
Confidence 1222222222221 1222 45678888999999999999998865
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-41 Score=349.47 Aligned_cols=262 Identities=25% Similarity=0.385 Sum_probs=207.5
Q ss_pred HhcCCCCceeeccccceEEEEE-EeCCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccC--Cc
Q 044366 644 ATGNFGEKYCIGKGGQRSVYKA-ELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNA--QH 720 (918)
Q Consensus 644 ~~~~~~~~~~lg~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~ 720 (918)
..+.|+..++||+|+||.||+| +..+|+.||+|+++.+.. ......-..+||.+++++.||||+++.+...+. ..
T Consensus 115 ~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~--~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~s 192 (560)
T KOG0600|consen 115 RADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNE--KEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGS 192 (560)
T ss_pred chHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccC--CCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCce
Confidence 3455777788999999999999 667899999999987532 334467789999999999999999999988766 68
Q ss_pred eEEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEecccccc
Q 044366 721 SFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAK 800 (918)
Q Consensus 721 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~ 800 (918)
.|||+|||+. +|.-++... .-.|++.++..+.+|+++||+|||++ ||+|||||.+|||+|.+|.+||+|||+|+
T Consensus 193 iYlVFeYMdh-DL~GLl~~p--~vkft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~G~LKiaDFGLAr 266 (560)
T KOG0600|consen 193 IYLVFEYMDH-DLSGLLSSP--GVKFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNNGVLKIADFGLAR 266 (560)
T ss_pred EEEEEecccc-hhhhhhcCC--CcccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCCCCEEecccccee
Confidence 9999999998 888888653 44699999999999999999999999 99999999999999999999999999999
Q ss_pred ccCCCCCC-ceecccccccccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhccc---
Q 044366 801 FLEPHSSN-WTEFAGTVGYAAPELAYTM-RATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDH--- 875 (918)
Q Consensus 801 ~~~~~~~~-~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~--- 875 (918)
++.+.... .+..+.|..|.|||.+.|. .|+.++|+||.|||+.||++|++.++...+.. .+....+..-..-+.
T Consensus 267 ~y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEve-Ql~kIfklcGSP~e~~W~ 345 (560)
T KOG0600|consen 267 FYTPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVE-QLHKIFKLCGSPTEDYWP 345 (560)
T ss_pred eccCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHH-HHHHHHHHhCCCChhccc
Confidence 98776544 6788899999999998864 69999999999999999999999976543321 111111000000000
Q ss_pred --CCC---------CCCcchHH----HHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 876 --RLP---------TPSRDVTD----KLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 876 --~~~---------~~~~~~~~----~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
++| .......+ .....++++..+|..||.+|.||+++++
T Consensus 346 ~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 346 VSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred cccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 011 00111111 1246788999999999999999999875
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=343.95 Aligned_cols=253 Identities=27% Similarity=0.429 Sum_probs=199.3
Q ss_pred hcCCCCceeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCC--ce
Q 044366 645 TGNFGEKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQ--HS 721 (918)
Q Consensus 645 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~--~~ 721 (918)
..+|...+.||+|+||+||.+.. ++|+..|||.+... +... .+.+.+|+.++++++|||||+++|...... .+
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~---~~~~-~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~ 91 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELE---DSPT-SESLEREIRILSRLNHPNIVQYYGSSSSRENDEY 91 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeecc---cchh-HHHHHHHHHHHHhCCCCCEEeeCCccccccCeee
Confidence 34566778899999999999955 45999999998664 1111 567899999999999999999999855444 68
Q ss_pred EEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCC-CCcEEEecccccc
Q 044366 722 FIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDS-EYEAHVSDFGFAK 800 (918)
Q Consensus 722 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~-~~~~kl~DfG~~~ 800 (918)
++.|||+++|+|.+++.+.+. .+++..+..++.||++||+|||++ ||||+||||+|||++. ++.+||+|||++.
T Consensus 92 ~i~mEy~~~GsL~~~~~~~g~--~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~ 166 (313)
T KOG0198|consen 92 NIFMEYAPGGSLSDLIKRYGG--KLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDVKLADFGLAK 166 (313)
T ss_pred EeeeeccCCCcHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeEEeccCcccc
Confidence 999999999999999988753 699999999999999999999999 9999999999999999 7999999999998
Q ss_pred ccCCC---CCCceecccccccccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccC
Q 044366 801 FLEPH---SSNWTEFAGTVGYAAPELAYTM-RATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHR 876 (918)
Q Consensus 801 ~~~~~---~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 876 (918)
..... ........||+.|||||++..+ ....++||||+||++.||+||++||..... ......... ....
T Consensus 167 ~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~---~~~~~~~ig---~~~~ 240 (313)
T KOG0198|consen 167 KLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFE---EAEALLLIG---REDS 240 (313)
T ss_pred ccccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcc---hHHHHHHHh---ccCC
Confidence 77631 1223457899999999999853 334599999999999999999999875311 111111111 1111
Q ss_pred CCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 044366 877 LPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNL 915 (918)
Q Consensus 877 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 915 (918)
.|..+.. ...+..+++.+|+..||++||||+++++.
T Consensus 241 ~P~ip~~---ls~~a~~Fl~~C~~~~p~~Rpta~eLL~h 276 (313)
T KOG0198|consen 241 LPEIPDS---LSDEAKDFLRKCFKRDPEKRPTAEELLEH 276 (313)
T ss_pred CCCCCcc---cCHHHHHHHHHHhhcCcccCcCHHHHhhC
Confidence 2222222 23456778889999999999999999863
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-41 Score=346.89 Aligned_cols=261 Identities=23% Similarity=0.346 Sum_probs=208.7
Q ss_pred HhcCCCCceeeccccceEEEEE-EeCCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhcc-CCceeeEecccccCC-c
Q 044366 644 ATGNFGEKYCIGKGGQRSVYKA-ELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIR-HRNIIKFHGFCSNAQ-H 720 (918)
Q Consensus 644 ~~~~~~~~~~lg~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~-~ 720 (918)
..++|...++||.|+||.||+| ...+|+.||||+++...... ..-.=.+|+..++++. ||||+++.+++.+.+ .
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~---ee~~nLREvksL~kln~hpniikL~Evi~d~~~~ 84 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSW---EECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRI 84 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccH---HHHHHHHHHHHHHhcCCCCcchhhHHHhhccCce
Confidence 4567888899999999999999 45679999999998754332 1233578999999998 999999999998877 9
Q ss_pred eEEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEecccccc
Q 044366 721 SFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAK 800 (918)
Q Consensus 721 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~ 800 (918)
.++|||||+. +|.+.++++ .+.|++.+++.|+.||++||+|+|.+ |+.|||+||+|||+.....+||+|||+||
T Consensus 85 L~fVfE~Md~-NLYqLmK~R--~r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iKiaDFGLAR 158 (538)
T KOG0661|consen 85 LYFVFEFMDC-NLYQLMKDR--NRLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIKIADFGLAR 158 (538)
T ss_pred EeeeHHhhhh-hHHHHHhhc--CCcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeEeccccccc
Confidence 9999999986 999999887 56799999999999999999999999 99999999999999998999999999999
Q ss_pred ccCCCCCCceecccccccccccccc-cCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhH-------------
Q 044366 801 FLEPHSSNWTEFAGTVGYAAPELAY-TMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMI------------- 866 (918)
Q Consensus 801 ~~~~~~~~~~~~~g~~~y~aPE~~~-~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~------------- 866 (918)
.+.+. ..++..+.|..|+|||++. .+-|+.+.|+||+|||++|+.+-++-|....+... +..+.
T Consensus 159 ev~Sk-pPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dq-i~KIc~VLGtP~~~~~~e 236 (538)
T KOG0661|consen 159 EVRSK-PPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQ-IYKICEVLGTPDKDSWPE 236 (538)
T ss_pred ccccC-CCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHH-HHHHHHHhCCCccccchh
Confidence 88754 3456788999999999874 56789999999999999999998877655443211 11111
Q ss_pred -hhhhhhcccCCCCCCc-----chHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 044366 867 -IEVNQILDHRLPTPSR-----DVTDKLRSIMEVAILCLVENPEARPTMKEVCNL 915 (918)
Q Consensus 867 -~~~~~~~~~~~~~~~~-----~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 915 (918)
..+...+.-++|.... -.+....+.++++.+|+++||++||||+|+++.
T Consensus 237 g~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 237 GYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred HHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 1111222222222111 122244678999999999999999999999863
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-40 Score=337.42 Aligned_cols=259 Identities=28% Similarity=0.424 Sum_probs=197.1
Q ss_pred cCCCCceeeccccceEEEEEEeCCCCEEEEEEcccccccCCCCChHHHHHHHHHHhh--ccCCceeeEecccccCC----
Q 044366 646 GNFGEKYCIGKGGQRSVYKAELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTE--IRHRNIIKFHGFCSNAQ---- 719 (918)
Q Consensus 646 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~~~~~~~~~~---- 719 (918)
......+.||+|.||.||||.+ +++.||||++... ..+.|..|-++.+. ++|+||++|+++-....
T Consensus 210 ~pl~l~eli~~Grfg~V~KaqL-~~~~VAVKifp~~-------~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~ 281 (534)
T KOG3653|consen 210 DPLQLLELIGRGRFGCVWKAQL-DNRLVAVKIFPEQ-------EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRM 281 (534)
T ss_pred CchhhHHHhhcCccceeehhhc-cCceeEEEecCHH-------HHHHHHhHHHHHhccCccchhHHHhhchhccCCcccc
Confidence 3344556799999999999998 4599999998652 35678888777655 58999999999876554
Q ss_pred ceEEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCC------CCCeEEcCCCCCCeeeCCCCcEEE
Q 044366 720 HSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDC------IPPIVHRDISSKNVLLDSEYEAHV 793 (918)
Q Consensus 720 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~------~~~ivH~dlk~~Nill~~~~~~kl 793 (918)
.++||+||.+.|+|.+||..+. ++|.+..+|+..+++||+|||+.. .|+|+|||||++|||+..|+++.|
T Consensus 282 eywLVt~fh~kGsL~dyL~~nt----isw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccI 357 (534)
T KOG3653|consen 282 EYWLVTEFHPKGSLCDYLKANT----ISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCI 357 (534)
T ss_pred ceeEEeeeccCCcHHHHHHhcc----ccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEe
Confidence 8999999999999999998764 899999999999999999999864 378999999999999999999999
Q ss_pred eccccccccCCCCCC--ceecccccccccccccccCCC------CcccchhhHHHHHHHHHhCCCCC------------C
Q 044366 794 SDFGFAKFLEPHSSN--WTEFAGTVGYAAPELAYTMRA------TEKYDVYSFGVLALEVIKGYHPG------------D 853 (918)
Q Consensus 794 ~DfG~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~------~~~~Dv~slG~vl~el~tg~~p~------------~ 853 (918)
+|||+|..+.+.... ....+||.+|||||++.+.-- -.+.||||+|.|+|||+++.... +
T Consensus 358 aDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe 437 (534)
T KOG3653|consen 358 ADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFE 437 (534)
T ss_pred eccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchh
Confidence 999999988765432 234789999999999976421 23689999999999999875432 1
Q ss_pred cchhhhhhhhhhHhhh-hhhcccCCCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 044366 854 FVSTIFSSISNMIIEV-NQILDHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLLC 917 (918)
Q Consensus 854 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 917 (918)
..-...+.+..+...+ ++-..+.++...... .....+.+.+..||..||+.|.|+.-|-+.++
T Consensus 438 ~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h-~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~ 501 (534)
T KOG3653|consen 438 AEVGNHPTLEEMQELVVRKKQRPKIPDAWRKH-AGMAVLCETIEECWDHDAEARLTAGCVEERMA 501 (534)
T ss_pred HHhcCCCCHHHHHHHHHhhccCCCChhhhhcC-ccHHHHHHHHHHHcCCchhhhhhhHHHHHHHH
Confidence 1111112222222111 111122222221112 44567889999999999999999988877664
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=352.74 Aligned_cols=262 Identities=25% Similarity=0.368 Sum_probs=208.2
Q ss_pred HHHHHHhcCCCCceeeccccceEEEEEEeCCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccC
Q 044366 639 EEITKATGNFGEKYCIGKGGQRSVYKAELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNA 718 (918)
Q Consensus 639 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~ 718 (918)
++.++..+.+...+.||+|.||+||+|+|- -.||||++......+ +..++|+.|+..+++-+|.||+=+.|||..+
T Consensus 385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~--~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p 460 (678)
T KOG0193|consen 385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTP--EQLQAFKNEVAVLKKTRHENILLFMGACMNP 460 (678)
T ss_pred cccccCHHHhhccceeccccccceeecccc--cceEEEEEecCCCCH--HHHHHHHHHHHHHhhcchhhheeeehhhcCC
Confidence 344444455667788999999999999873 358999998754333 3578999999999999999999999999998
Q ss_pred CceEEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEecccc
Q 044366 719 QHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGF 798 (918)
Q Consensus 719 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~ 798 (918)
.. .+|+.||+|.+|+.+++..+ ..|+..+.+.||+|||+||.|||++ +|||||+|..||++.++++|||+|||+
T Consensus 461 ~~-AIiTqwCeGsSLY~hlHv~e--tkfdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl~~~~kVkIgDFGL 534 (678)
T KOG0193|consen 461 PL-AIITQWCEGSSLYTHLHVQE--TKFDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIFLHEDLKVKIGDFGL 534 (678)
T ss_pred ce-eeeehhccCchhhhhccchh--hhhhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceEEccCCcEEEecccc
Confidence 87 99999999999999998764 4589999999999999999999999 999999999999999999999999999
Q ss_pred ccccCC--CCCCceeccccccccccccccc---CCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhc
Q 044366 799 AKFLEP--HSSNWTEFAGTVGYAAPELAYT---MRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQIL 873 (918)
Q Consensus 799 ~~~~~~--~~~~~~~~~g~~~y~aPE~~~~---~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 873 (918)
+..-.. .........|..-|||||++.. .+|++.+||||||+|+|||+||..||.. ...+.+..++.+...
T Consensus 535 atvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi--~~~dqIifmVGrG~l-- 610 (678)
T KOG0193|consen 535 ATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSI--QNRDQIIFMVGRGYL-- 610 (678)
T ss_pred eeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCC--CChhheEEEeccccc--
Confidence 964322 1222344567889999999864 4689999999999999999999999762 222222222222111
Q ss_pred ccCCCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 044366 874 DHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLLC 917 (918)
Q Consensus 874 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 917 (918)
.+.......+...++.+|+..||..++++||.+.+++..|+
T Consensus 611 ---~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~ 651 (678)
T KOG0193|consen 611 ---MPDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLE 651 (678)
T ss_pred ---CccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHH
Confidence 11122223344567888999999999999999999999664
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=350.10 Aligned_cols=255 Identities=25% Similarity=0.366 Sum_probs=209.8
Q ss_pred HHhcCCCCceeeccccceEEEEEE-eCCCCEEEEEEcccccccCCC-CChHHHHHHHHHHhhcc-CCceeeEecccccCC
Q 044366 643 KATGNFGEKYCIGKGGQRSVYKAE-LPSGNIFAVKKFKAELFSDET-ANPSEFLNEVLALTEIR-HRNIIKFHGFCSNAQ 719 (918)
Q Consensus 643 ~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~-~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~ 719 (918)
...++|...+.||+|+||.|+.|. ..+|+.||+|.+......... ...+...+|+.+++.++ ||||+++++++....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 456789999999999999999994 457899999977664222111 23456678999999998 999999999999999
Q ss_pred ceEEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCC-CcEEEecccc
Q 044366 720 HSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSE-YEAHVSDFGF 798 (918)
Q Consensus 720 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~-~~~kl~DfG~ 798 (918)
..++||||+.+|+|.+++... +++.+.+...+++|++.|++|||+. ||+||||||+||+++.+ +.+||+|||+
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~~---g~l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~~~~~~Kl~DFG~ 167 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVNK---GRLKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDGNEGNLKLSDFGL 167 (370)
T ss_pred eEEEEEEecCCccHHHHHHHc---CCCChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecCCCCCEEEecccc
Confidence 999999999999999999873 3588899999999999999999999 99999999999999999 9999999999
Q ss_pred ccccCCCCCCceecccccccccccccccCC-CC-cccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccC
Q 044366 799 AKFLEPHSSNWTEFAGTVGYAAPELAYTMR-AT-EKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHR 876 (918)
Q Consensus 799 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~-~~-~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 876 (918)
+.............+|++.|+|||++.+.. |+ .++||||+||+||-|++|+.||+.... ..+ ...+....
T Consensus 168 s~~~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~-----~~l---~~ki~~~~ 239 (370)
T KOG0583|consen 168 SAISPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNV-----PNL---YRKIRKGE 239 (370)
T ss_pred ccccCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccH-----HHH---HHHHhcCC
Confidence 998743344556789999999999999877 75 789999999999999999999986322 111 11222233
Q ss_pred CCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 877 LPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 877 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
...+.. .. ..++.+++.+|+..||.+|+|+.++++
T Consensus 240 ~~~p~~-~~--S~~~~~Li~~mL~~~P~~R~t~~~i~~ 274 (370)
T KOG0583|consen 240 FKIPSY-LL--SPEARSLIEKMLVPDPSTRITLLEILE 274 (370)
T ss_pred ccCCCC-cC--CHHHHHHHHHHcCCCcccCCCHHHHhh
Confidence 222221 11 456888999999999999999999973
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-39 Score=328.22 Aligned_cols=262 Identities=25% Similarity=0.348 Sum_probs=205.4
Q ss_pred HhcCCCCceeeccccceEEEEEEeCCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhc--cCCceeeEecccccC---
Q 044366 644 ATGNFGEKYCIGKGGQRSVYKAELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEI--RHRNIIKFHGFCSNA--- 718 (918)
Q Consensus 644 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l--~h~niv~~~~~~~~~--- 718 (918)
...+....+.||+|.||.||+|++ .|+.||||++.. .+++.+.+|.+++... +|+||+.|++.-..+
T Consensus 209 iarqI~L~e~IGkGRyGEVwrG~w-rGe~VAVKiF~s-------rdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs 280 (513)
T KOG2052|consen 209 IARQIVLQEIIGKGRFGEVWRGRW-RGEDVAVKIFSS-------RDERSWFRETEIYQTVMLRHENILGFIAADNKDNGS 280 (513)
T ss_pred hhheeEEEEEecCccccceeeccc-cCCceEEEEecc-------cchhhhhhHHHHHHHHHhccchhhhhhhccccCCCc
Confidence 345677788999999999999999 689999999853 2356788999888764 999999999875433
Q ss_pred -CceEEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhC-----CCCCeEEcCCCCCCeeeCCCCcEE
Q 044366 719 -QHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHD-----CIPPIVHRDISSKNVLLDSEYEAH 792 (918)
Q Consensus 719 -~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-----~~~~ivH~dlk~~Nill~~~~~~k 792 (918)
..+|||++|.+.|||.|||.+. .++....++++..+|.||++||.+ ..|.|+|||||+.||+|..++.+.
T Consensus 281 ~TQLwLvTdYHe~GSL~DyL~r~----tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~ 356 (513)
T KOG2052|consen 281 WTQLWLVTDYHEHGSLYDYLNRN----TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCC 356 (513)
T ss_pred eEEEEEeeecccCCcHHHHHhhc----cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEE
Confidence 3679999999999999999874 388999999999999999999985 357899999999999999999999
Q ss_pred EeccccccccCCCCC----CceecccccccccccccccCC----C--CcccchhhHHHHHHHHHhC----------CCCC
Q 044366 793 VSDFGFAKFLEPHSS----NWTEFAGTVGYAAPELAYTMR----A--TEKYDVYSFGVLALEVIKG----------YHPG 852 (918)
Q Consensus 793 l~DfG~~~~~~~~~~----~~~~~~g~~~y~aPE~~~~~~----~--~~~~Dv~slG~vl~el~tg----------~~p~ 852 (918)
|+|+|+|.....+.. .....+||.+|||||++...- + -..+||||||.|+||++.+ +.||
T Consensus 357 IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Py 436 (513)
T KOG2052|consen 357 IADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPY 436 (513)
T ss_pred EeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCc
Confidence 999999987765532 235678999999999986532 1 2368999999999999853 4565
Q ss_pred CcchhhhhhhhhhHhhhhhhcccCCCCC-CcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhC
Q 044366 853 DFVSTIFSSISNMIIEVNQILDHRLPTP-SRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLLCK 918 (918)
Q Consensus 853 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~ 918 (918)
....+..++.+++.+-+ .+...++..+ .+...+....+.++++.||..+|..|.|+-.+.+.|.|
T Consensus 437 yd~Vp~DPs~eeMrkVV-Cv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~ 502 (513)
T KOG2052|consen 437 YDVVPSDPSFEEMRKVV-CVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAK 502 (513)
T ss_pred ccCCCCCCCHHHHhcce-eecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHH
Confidence 55544444444443221 1111222222 23345677889999999999999999999999988864
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-40 Score=343.63 Aligned_cols=248 Identities=25% Similarity=0.354 Sum_probs=209.4
Q ss_pred cCCCCceeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEEE
Q 044366 646 GNFGEKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFIV 724 (918)
Q Consensus 646 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 724 (918)
++|.+.+.||+|.||.||||+. .+.+.||+|.+.+.. ....+.+...+|+++++.++||||+.++++|+...+.|+|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~g--r~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vV 79 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSG--RNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVV 79 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcC--CchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEE
Confidence 4677778899999999999955 478999999987642 2333467799999999999999999999999999999999
Q ss_pred EEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccCC
Q 044366 725 CEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEP 804 (918)
Q Consensus 725 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~~ 804 (918)
+||+.| +|..++... +.++++.+..++.+++.||.|||+. +|.|||+||+||+++..+.+|++|||+|+.+..
T Consensus 80 te~a~g-~L~~il~~d---~~lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~ 152 (808)
T KOG0597|consen 80 TEYAVG-DLFTILEQD---GKLPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKLCDFGLARAMST 152 (808)
T ss_pred ehhhhh-hHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceeechhhhhhhccc
Confidence 999987 999999875 4499999999999999999999999 999999999999999999999999999998887
Q ss_pred CCCCceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCCCCCcch
Q 044366 805 HSSNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRDV 884 (918)
Q Consensus 805 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 884 (918)
.....+...||+.|||||...+..|+..+|.||+||++|||++|++||-... +....+.+......++.
T Consensus 153 ~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~s---------i~~Lv~~I~~d~v~~p~-- 221 (808)
T KOG0597|consen 153 NTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARS---------ITQLVKSILKDPVKPPS-- 221 (808)
T ss_pred CceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHH---------HHHHHHHHhcCCCCCcc--
Confidence 7667788899999999999999999999999999999999999999974221 11222222222222222
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 885 TDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 885 ~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
.....+..++...+.+||.+|.|-.+++.
T Consensus 222 -~~S~~f~nfl~gLL~kdP~~RltW~~Ll~ 250 (808)
T KOG0597|consen 222 -TASSSFVNFLQGLLIKDPAQRLTWTDLLG 250 (808)
T ss_pred -cccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence 44566788888999999999999887753
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=341.73 Aligned_cols=248 Identities=27% Similarity=0.400 Sum_probs=210.0
Q ss_pred cCCCCceeeccccceEEEEE-EeCCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEEE
Q 044366 646 GNFGEKYCIGKGGQRSVYKA-ELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFIV 724 (918)
Q Consensus 646 ~~~~~~~~lg~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 724 (918)
..|...+.||+|.||.||+| +..+++.||+|++..+... ...++..+|+.++.+++++||.++||.+-.+..+|++
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~---deIediqqei~~Ls~~~~~~it~yygsyl~g~~Lwii 89 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAE---DEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWII 89 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcc---hhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHH
Confidence 45667788999999999999 5668999999999875433 3357889999999999999999999999999999999
Q ss_pred EEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccCC
Q 044366 725 CEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEP 804 (918)
Q Consensus 725 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~~ 804 (918)
||||.+|++.+.++... .+++..+.-|.+++..|+.|+|++ +.+|||||+.||++..+|.+|++|||.+.....
T Consensus 90 Mey~~gGsv~~lL~~~~---~~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~ 163 (467)
T KOG0201|consen 90 MEYCGGGSVLDLLKSGN---ILDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLADFGVAGQLTN 163 (467)
T ss_pred HHHhcCcchhhhhccCC---CCccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEEecceeeeeec
Confidence 99999999999998653 247778888999999999999999 999999999999999999999999999999887
Q ss_pred CCCCceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhccc-CCCCCCcc
Q 044366 805 HSSNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDH-RLPTPSRD 883 (918)
Q Consensus 805 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 883 (918)
........+||+.|||||++.+..|+.|+||||||++.+||++|.+|+....+. ++.-.+.. .+|....
T Consensus 164 ~~~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPm---------rvlflIpk~~PP~L~~- 233 (467)
T KOG0201|consen 164 TVKRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPM---------RVLFLIPKSAPPRLDG- 233 (467)
T ss_pred hhhccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcc---------eEEEeccCCCCCcccc-
Confidence 777667889999999999999989999999999999999999999997654431 11111111 2222222
Q ss_pred hHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 884 VTDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 884 ~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
...+.+.+++..|+.+||+.||+|.++++
T Consensus 234 --~~S~~~kEFV~~CL~k~P~~RpsA~~LLK 262 (467)
T KOG0201|consen 234 --DFSPPFKEFVEACLDKNPEFRPSAKELLK 262 (467)
T ss_pred --ccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence 44456888888999999999999999986
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=374.21 Aligned_cols=255 Identities=27% Similarity=0.437 Sum_probs=207.3
Q ss_pred cCCCCceeeccccceEEEEEEeC--CCC----EEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCC
Q 044366 646 GNFGEKYCIGKGGQRSVYKAELP--SGN----IFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQ 719 (918)
Q Consensus 646 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~----~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~ 719 (918)
......+.||+|+||.||.|... .|. .||||.++.. .+.+...+|.+|..+|++++|||||+++|+|-+..
T Consensus 692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~---~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~ 768 (1025)
T KOG1095|consen 692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRL---SSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSG 768 (1025)
T ss_pred hheEeeeeeccccccceEEEEEecCCCCccceEEEEEecccc---CCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCC
Confidence 44556678999999999999654 344 4999998763 24455789999999999999999999999999999
Q ss_pred ceEEEEEeccCCChhHHhhcccc----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEec
Q 044366 720 HSFIVCEYLARGSLTTILRDDAA----AKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSD 795 (918)
Q Consensus 720 ~~~lv~e~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~D 795 (918)
..++++|||++|+|..|+++.+. ...++..+.+.++.|||+|+.||++. ++|||||.++|+|++....+||+|
T Consensus 769 ~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~r~VKIaD 845 (1025)
T KOG1095|consen 769 PPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDERRVVKIAD 845 (1025)
T ss_pred CcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeecccCcEEEcc
Confidence 99999999999999999987632 34589999999999999999999999 999999999999999999999999
Q ss_pred cccccccCCCCCC-ceec-ccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhhhhhhhhhHhhhhhh
Q 044366 796 FGFAKFLEPHSSN-WTEF-AGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIK-GYHPGDFVSTIFSSISNMIIEVNQI 872 (918)
Q Consensus 796 fG~~~~~~~~~~~-~~~~-~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~ 872 (918)
||+|+.+-..++. .... .-+.+|||||.+..+.++.|+|||||||++||++| |..||..... ......-.
T Consensus 846 FGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n-------~~v~~~~~ 918 (1025)
T KOG1095|consen 846 FGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSN-------FEVLLDVL 918 (1025)
T ss_pred cchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcch-------HHHHHHHH
Confidence 9999955433332 2222 33579999999999999999999999999999999 7888664432 12222122
Q ss_pred cccCCCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 044366 873 LDHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLLC 917 (918)
Q Consensus 873 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 917 (918)
.+.+++.+. .+ +..++++|..||+.+|++||++..+++++.
T Consensus 919 ~ggRL~~P~-~C---P~~ly~lM~~CW~~~pe~RP~F~~i~~q~~ 959 (1025)
T KOG1095|consen 919 EGGRLDPPS-YC---PEKLYQLMLQCWKHDPEDRPSFRTIVEQDP 959 (1025)
T ss_pred hCCccCCCC-CC---ChHHHHHHHHHccCChhhCccHHHHHhhhh
Confidence 233444432 22 345789999999999999999999998764
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=341.06 Aligned_cols=263 Identities=21% Similarity=0.330 Sum_probs=208.9
Q ss_pred HHhcCCCCceeeccccceEEEEEEeCCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceE
Q 044366 643 KATGNFGEKYCIGKGGQRSVYKAELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSF 722 (918)
Q Consensus 643 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 722 (918)
.......+.++||+|-||.|..+....+..||||.++.... .....+|.+|+++|.+++||||++++|+|..++..+
T Consensus 535 fPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~---~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePic 611 (807)
T KOG1094|consen 535 FPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDAT---KNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLC 611 (807)
T ss_pred cchhheehhhhhcCcccceeEEEEecCceEEEEeecCcccc---hhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchH
Confidence 34456677789999999999999987889999999987532 223589999999999999999999999999999999
Q ss_pred EEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEecccccccc
Q 044366 723 IVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFL 802 (918)
Q Consensus 723 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~ 802 (918)
+|+|||++|+|.+|+.++.... +......+|+.|||.||+||.+- .+||||+.++|++++.++++||+|||+++.+
T Consensus 612 mI~EYmEnGDLnqFl~aheapt-~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadfgmsR~l 687 (807)
T KOG1094|consen 612 MITEYMENGDLNQFLSAHELPT-AETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADFGMSRNL 687 (807)
T ss_pred HHHHHHhcCcHHHHHHhccCcc-cccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCccccccc
Confidence 9999999999999998874322 45567788999999999999999 9999999999999999999999999999965
Q ss_pred CCCCCC--ceecccccccccccccccCCCCcccchhhHHHHHHHHHh--CCCCCCcchhhhhhhhhhHhhhhhhcccCCC
Q 044366 803 EPHSSN--WTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIK--GYHPGDFVSTIFSSISNMIIEVNQILDHRLP 878 (918)
Q Consensus 803 ~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 878 (918)
-+.++. ....+-+.+|||||.+.-++++.++|||+||+++||+++ ...||+...+. +......++.+...+
T Consensus 688 ysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e-----~vven~~~~~~~~~~ 762 (807)
T KOG1094|consen 688 YSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDE-----QVVENAGEFFRDQGR 762 (807)
T ss_pred ccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHH-----HHHHhhhhhcCCCCc
Confidence 443332 234556889999999999999999999999999999864 67786644321 111111222222111
Q ss_pred C-CCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 044366 879 T-PSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLLC 917 (918)
Q Consensus 879 ~-~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 917 (918)
. ......-+...+.+++..||..|.++||+++++...|.
T Consensus 763 ~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq 802 (807)
T KOG1094|consen 763 QVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQ 802 (807)
T ss_pred ceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHH
Confidence 0 00111122346789999999999999999999998775
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-40 Score=343.83 Aligned_cols=236 Identities=31% Similarity=0.498 Sum_probs=194.9
Q ss_pred eeeccccceEEEEEEeCCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEEEEEeccCC
Q 044366 652 YCIGKGGQRSVYKAELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFIVCEYLARG 731 (918)
Q Consensus 652 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 731 (918)
+-+|.|+.|.||.|++ .++.||||+++.- =..+|+-+++++||||+.|.|+|.....+|||||||..|
T Consensus 130 eWlGSGaQGAVF~Grl-~netVAVKKV~el-----------kETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~G 197 (904)
T KOG4721|consen 130 EWLGSGAQGAVFLGRL-HNETVAVKKVREL-----------KETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQG 197 (904)
T ss_pred hhhccCcccceeeeec-cCceehhHHHhhh-----------hhhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccc
Confidence 4499999999999998 5788999987642 135788899999999999999999999999999999999
Q ss_pred ChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccCCCCCCcee
Q 044366 732 SLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTE 811 (918)
Q Consensus 732 sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~ 811 (918)
-|...|+..+ .++....+.|..+||.||.|||.+ .|||||||.-|||++.+..|||+|||-++..... +..-.
T Consensus 198 qL~~VLka~~---~itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~-STkMS 270 (904)
T KOG4721|consen 198 QLYEVLKAGR---PITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISDFGTSKELSDK-STKMS 270 (904)
T ss_pred cHHHHHhccC---ccCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEeccccchHhhhhh-hhhhh
Confidence 9999998754 488889999999999999999999 9999999999999999999999999999887655 44455
Q ss_pred cccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCCCCCcchHHHHHHH
Q 044366 812 FAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRDVTDKLRSI 891 (918)
Q Consensus 812 ~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 891 (918)
++||..|||||++...+.++|+||||||||||||+||..||....... +.+.+ ....+ .++-+ ..++ .-+
T Consensus 271 FaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssA--IIwGV--GsNsL--~LpvP-stcP---~Gf 340 (904)
T KOG4721|consen 271 FAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSA--IIWGV--GSNSL--HLPVP-STCP---DGF 340 (904)
T ss_pred hhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhe--eEEec--cCCcc--cccCc-ccCc---hHH
Confidence 789999999999999999999999999999999999999976543311 10000 00111 11211 2233 345
Q ss_pred HHHHHHcccCCCCCCCCHHHHHHHh
Q 044366 892 MEVAILCLVENPEARPTMKEVCNLL 916 (918)
Q Consensus 892 ~~li~~cl~~dp~~RPt~~evl~~L 916 (918)
.-+++.||+..|..||++.+++.-|
T Consensus 341 klL~Kqcw~sKpRNRPSFrqil~Hl 365 (904)
T KOG4721|consen 341 KLLLKQCWNSKPRNRPSFRQILLHL 365 (904)
T ss_pred HHHHHHHHhcCCCCCccHHHHHHHH
Confidence 5677889999999999999998765
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-39 Score=352.28 Aligned_cols=259 Identities=22% Similarity=0.362 Sum_probs=201.8
Q ss_pred HhcCCCCceeeccccceEEEEEEe------CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhc-cCCceeeEecccc
Q 044366 644 ATGNFGEKYCIGKGGQRSVYKAEL------PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEI-RHRNIIKFHGFCS 716 (918)
Q Consensus 644 ~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~ 716 (918)
..++|.+.+.||+|+||.||+|.. .+++.||||+++... .....+.+.+|+.+++.+ +||||+++++++.
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~ 81 (338)
T cd05102 5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA---TASEHKALMSELKILIHIGNHLNVVNLLGACT 81 (338)
T ss_pred chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc---chHHHHHHHHHHHHHHHhccCcceeeEEeEec
Confidence 456799999999999999999953 245789999986431 222346789999999999 8999999999886
Q ss_pred cC-CceEEEEEeccCCChhHHhhcccc-----------------------------------------------------
Q 044366 717 NA-QHSFIVCEYLARGSLTTILRDDAA----------------------------------------------------- 742 (918)
Q Consensus 717 ~~-~~~~lv~e~~~~gsL~~~l~~~~~----------------------------------------------------- 742 (918)
.. +..++||||+++|+|.++++....
T Consensus 82 ~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (338)
T cd05102 82 KPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQ 161 (338)
T ss_pred CCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccch
Confidence 54 468899999999999999975321
Q ss_pred ------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccCCCCCC--ceeccc
Q 044366 743 ------AKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSN--WTEFAG 814 (918)
Q Consensus 743 ------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~~~~~~--~~~~~g 814 (918)
..++++.++..++.||++||+|||+. +|+||||||+||+++.++.+||+|||+++........ .....+
T Consensus 162 ~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~ 238 (338)
T cd05102 162 ETDDLWKSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARL 238 (338)
T ss_pred hccccccCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCC
Confidence 13478899999999999999999999 9999999999999999999999999999865432221 122345
Q ss_pred ccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhhhhhhhhhHhhhhhhcccCCCCCCcchHHHHHHHHH
Q 044366 815 TVGYAAPELAYTMRATEKYDVYSFGVLALEVIK-GYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRDVTDKLRSIME 893 (918)
Q Consensus 815 ~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 893 (918)
+..|+|||++.+..++.++|||||||++|||++ |..||........ . ... ........... .....+.+
T Consensus 239 ~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~-~---~~~---~~~~~~~~~~~---~~~~~l~~ 308 (338)
T cd05102 239 PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEE-F---CQR---LKDGTRMRAPE---NATPEIYR 308 (338)
T ss_pred CccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHH-H---HHH---HhcCCCCCCCC---CCCHHHHH
Confidence 678999999999899999999999999999997 9999865332110 0 011 11111111111 12346889
Q ss_pred HHHHcccCCCCCCCCHHHHHHHhhC
Q 044366 894 VAILCLVENPEARPTMKEVCNLLCK 918 (918)
Q Consensus 894 li~~cl~~dp~~RPt~~evl~~L~~ 918 (918)
++.+||+.||++|||+.|+++.|++
T Consensus 309 li~~cl~~dp~~RPs~~el~~~l~~ 333 (338)
T cd05102 309 IMLACWQGDPKERPTFSALVEILGD 333 (338)
T ss_pred HHHHHccCChhhCcCHHHHHHHHHH
Confidence 9999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-39 Score=347.80 Aligned_cols=256 Identities=25% Similarity=0.367 Sum_probs=201.6
Q ss_pred cCCCCceeeccccceEEEEEEeCC--C---CEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCc
Q 044366 646 GNFGEKYCIGKGGQRSVYKAELPS--G---NIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQH 720 (918)
Q Consensus 646 ~~~~~~~~lg~G~~g~Vy~~~~~~--~---~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 720 (918)
++....++||+|+||.||+|++.. + ..||||..+... ........+|.+|+++|++++|||||++||++.....
T Consensus 157 ~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~-~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~P 235 (474)
T KOG0194|consen 157 SDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSS-ELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEP 235 (474)
T ss_pred cCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccc-cccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCc
Confidence 344455789999999999996643 3 238999987521 1223446899999999999999999999999999999
Q ss_pred eEEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEecccccc
Q 044366 721 SFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAK 800 (918)
Q Consensus 721 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~ 800 (918)
.++|||+|+||+|.++++..+. .++..++..++.+.|+||+|||+. +++||||.++|+|++.++.+||+|||+++
T Consensus 236 l~ivmEl~~gGsL~~~L~k~~~--~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~~~~~vKISDFGLs~ 310 (474)
T KOG0194|consen 236 LMLVMELCNGGSLDDYLKKNKK--SLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCLYSKKGVVKISDFGLSR 310 (474)
T ss_pred cEEEEEecCCCcHHHHHHhCCC--CCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHheecCCCeEEeCcccccc
Confidence 9999999999999999997643 589999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCCceecccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhhhhhhhhhHhhhhhhcccCCCC
Q 044366 801 FLEPHSSNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIK-GYHPGDFVSTIFSSISNMIIEVNQILDHRLPT 879 (918)
Q Consensus 801 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 879 (918)
.............-+.+|+|||.+..+.+++++|||||||++||+++ |..|+...... .+ ...+ ..-..+.+.
T Consensus 311 ~~~~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~--~v---~~kI-~~~~~r~~~ 384 (474)
T KOG0194|consen 311 AGSQYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY--EV---KAKI-VKNGYRMPI 384 (474)
T ss_pred CCcceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHH--HH---HHHH-HhcCccCCC
Confidence 65311111112235789999999999999999999999999999998 88887654431 00 0111 001112222
Q ss_pred CCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 044366 880 PSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLLC 917 (918)
Q Consensus 880 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 917 (918)
+ . ..+..+..++.+||..||+.||+|.++.+.++
T Consensus 385 ~-~---~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~ 418 (474)
T KOG0194|consen 385 P-S---KTPKELAKVMKQCWKKDPEDRPTMSTIKKKLE 418 (474)
T ss_pred C-C---CCHHHHHHHHHHhccCChhhccCHHHHHHHHH
Confidence 2 2 22345677778999999999999999999875
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-40 Score=309.60 Aligned_cols=253 Identities=25% Similarity=0.363 Sum_probs=210.1
Q ss_pred hcCCCCceeeccccceEEEEE-EeCCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEE
Q 044366 645 TGNFGEKYCIGKGGQRSVYKA-ELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFI 723 (918)
Q Consensus 645 ~~~~~~~~~lg~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 723 (918)
++.|+..+.||+|.|+.||++ ..++|+.+|+|.+....+... ..+++.+|+.+.+.++||||+++.+.+......++
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~--~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~yl 87 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR--DFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL 87 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccc--cHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEE
Confidence 456777788999999999998 667899999999876554433 57889999999999999999999999999999999
Q ss_pred EEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCC---CcEEEecccccc
Q 044366 724 VCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSE---YEAHVSDFGFAK 800 (918)
Q Consensus 724 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~---~~~kl~DfG~~~ 800 (918)
|+|+|+|++|..-+-.+ ..+++..+-++++||++||+|+|.+ +|||||+||+|+++... --+|++|||+|.
T Consensus 88 vFe~m~G~dl~~eIV~R---~~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi 161 (355)
T KOG0033|consen 88 VFDLVTGGELFEDIVAR---EFYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKGAAVKLADFGLAI 161 (355)
T ss_pred EEecccchHHHHHHHHH---HHHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCCCceeecccceEE
Confidence 99999999997655433 2368888899999999999999999 99999999999999653 358999999999
Q ss_pred ccCCCCCCceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCCCC
Q 044366 801 FLEPHSSNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTP 880 (918)
Q Consensus 801 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 880 (918)
.+. +...+...+|||+|||||+++..+|+..+|||+.||+||-++.|+.||...... ...+.+.......+
T Consensus 162 ~l~-~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~--------rlye~I~~g~yd~~ 232 (355)
T KOG0033|consen 162 EVN-DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH--------RLYEQIKAGAYDYP 232 (355)
T ss_pred EeC-CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHH--------HHHHHHhccccCCC
Confidence 888 566677889999999999999999999999999999999999999998653221 11122333333333
Q ss_pred CcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 881 SRDVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 881 ~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
++.+....++..+++++|+..||++|-|+.|.+.
T Consensus 233 ~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~ 266 (355)
T KOG0033|consen 233 SPEWDTVTPEAKSLIRRMLTVNPKKRITADEALK 266 (355)
T ss_pred CcccCcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence 3444455567788999999999999999999874
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=308.35 Aligned_cols=240 Identities=26% Similarity=0.354 Sum_probs=201.0
Q ss_pred hcCCCCceeeccccceEEEEEEeC-CCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEE
Q 044366 645 TGNFGEKYCIGKGGQRSVYKAELP-SGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFI 723 (918)
Q Consensus 645 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 723 (918)
-.+|+..+.||.|+||.|..++.+ +|..+|+|++.....-.. ...+....|..+++.+.||.++++++.+.+.+..+|
T Consensus 43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVkl-KQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lym 121 (355)
T KOG0616|consen 43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKL-KQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYM 121 (355)
T ss_pred hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHH-HHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEE
Confidence 357888999999999999999665 689999999976533322 224567889999999999999999999999999999
Q ss_pred EEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccC
Q 044366 724 VCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLE 803 (918)
Q Consensus 724 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~ 803 (918)
||||++||.|..++++.+ +++++.++-+|.||+.|++|||+. +|++||+||+|||+|++|.+||+|||+|..+.
T Consensus 122 vmeyv~GGElFS~Lrk~~---rF~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~ 195 (355)
T KOG0616|consen 122 VMEYVPGGELFSYLRKSG---RFSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHIKITDFGFAKRVS 195 (355)
T ss_pred EEeccCCccHHHHHHhcC---CCCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcEEEEeccceEEec
Confidence 999999999999998754 599999999999999999999999 99999999999999999999999999999876
Q ss_pred CCCCCceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCCCCCcc
Q 044366 804 PHSSNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRD 883 (918)
Q Consensus 804 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 883 (918)
.. .-..+||+.|+|||.+....+..++|.|||||++|||+.|++||...... ...++++..+...++-
T Consensus 196 ~r---T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~--------~iY~KI~~~~v~fP~~- 263 (355)
T KOG0616|consen 196 GR---TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPI--------QIYEKILEGKVKFPSY- 263 (355)
T ss_pred Cc---EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChH--------HHHHHHHhCcccCCcc-
Confidence 43 34578999999999999999999999999999999999999998755431 2223444444433321
Q ss_pred hHHHHHHHHHHHHHcccCCCCCC
Q 044366 884 VTDKLRSIMEVAILCLVENPEAR 906 (918)
Q Consensus 884 ~~~~~~~l~~li~~cl~~dp~~R 906 (918)
. ..++.+++.+.++.|-.+|
T Consensus 264 f---s~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 264 F---SSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred c---CHHHHHHHHHHHhhhhHhh
Confidence 1 1346677778888888887
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-39 Score=338.15 Aligned_cols=254 Identities=22% Similarity=0.336 Sum_probs=216.5
Q ss_pred hcCCCCceeeccccceEEEEEEeC-CCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCc-eE
Q 044366 645 TGNFGEKYCIGKGGQRSVYKAELP-SGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQH-SF 722 (918)
Q Consensus 645 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-~~ 722 (918)
.++|...+++|+|+||.++.++.+ ++..|++|.+....... ...+...+|+.++++++|||||.+.+.|..++. .+
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~--~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~ 80 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTE--PERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLC 80 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCc--hhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEE
Confidence 357888999999999999999554 67899999998754333 234578999999999999999999999988888 99
Q ss_pred EEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEecccccccc
Q 044366 723 IVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFL 802 (918)
Q Consensus 723 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~ 802 (918)
|||+|++||++.+.+.+.+ +..++++.+..|+.|++.|+.|||+. +|+|||||++||+++.++.|||+|||+|+.+
T Consensus 81 Ivm~Y~eGg~l~~~i~~~k-~~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l 156 (426)
T KOG0589|consen 81 IVMEYCEGGDLAQLIKEQK-GVLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKLGDFGLAKIL 156 (426)
T ss_pred EEEeecCCCCHHHHHHHHh-hccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceeecchhhhhhc
Confidence 9999999999999998766 56689999999999999999999998 9999999999999999999999999999999
Q ss_pred CCCCCCceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCCCCCc
Q 044366 803 EPHSSNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSR 882 (918)
Q Consensus 803 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 882 (918)
.++.......+||+.||.||.+.+.+|..|+||||+||++|||++-+++|..... . ..+.++......+.+.
T Consensus 157 ~~~~~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m-----~---~Li~ki~~~~~~Plp~ 228 (426)
T KOG0589|consen 157 NPEDSLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNM-----S---ELILKINRGLYSPLPS 228 (426)
T ss_pred CCchhhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccch-----H---HHHHHHhhccCCCCCc
Confidence 9887677788999999999999999999999999999999999999999875432 1 1122223333222222
Q ss_pred chHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 044366 883 DVTDKLRSIMEVAILCLVENPEARPTMKEVCNL 915 (918)
Q Consensus 883 ~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 915 (918)
.+..++..++..|++.+|..||++.+++..
T Consensus 229 ---~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 229 ---MYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred ---cccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 344568888999999999999999999864
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=302.08 Aligned_cols=261 Identities=23% Similarity=0.339 Sum_probs=206.7
Q ss_pred HhcCCCCceeeccccceEEEEEE-eCCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccC----
Q 044366 644 ATGNFGEKYCIGKGGQRSVYKAE-LPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNA---- 718 (918)
Q Consensus 644 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~---- 718 (918)
-.++|.+.+.+|+|||+-||.++ ..+++.||+|++... ...+.+...+|++..++++||||+++++++..+
T Consensus 19 n~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~----~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~ 94 (302)
T KOG2345|consen 19 NNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCH----SQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDG 94 (302)
T ss_pred cCceEEEeeeecCCCceeeeeecccCcccchhhheeecc----chHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccC
Confidence 45789999999999999999995 678999999999774 234577899999999999999999999987443
Q ss_pred -CceEEEEEeccCCChhHHhhccccc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEecc
Q 044366 719 -QHSFIVCEYLARGSLTTILRDDAAA-KEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDF 796 (918)
Q Consensus 719 -~~~~lv~e~~~~gsL~~~l~~~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Df 796 (918)
...|++++|...|+|.+.++..+.. ..+++.++++|+.+|++||.+||+. .|+++||||||.||++.+++.+++.||
T Consensus 95 ~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~ 173 (302)
T KOG2345|consen 95 KHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDL 173 (302)
T ss_pred ceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEec
Confidence 3489999999999999999876543 3689999999999999999999997 346999999999999999999999999
Q ss_pred ccccccCCCCC---------Cceecccccccccccccc---cCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhh
Q 044366 797 GFAKFLEPHSS---------NWTEFAGTVGYAAPELAY---TMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISN 864 (918)
Q Consensus 797 G~~~~~~~~~~---------~~~~~~g~~~y~aPE~~~---~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~ 864 (918)
|.++...-.-. .+.....|..|+|||.+. +...++++|||||||++|+|+.|..||+...+.-.++.-
T Consensus 174 GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaL 253 (302)
T KOG2345|consen 174 GSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLAL 253 (302)
T ss_pred cCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEE
Confidence 99976532111 122345789999999875 344688999999999999999999998754332112111
Q ss_pred hHhhhhhhcccCCCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 044366 865 MIIEVNQILDHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLLC 917 (918)
Q Consensus 865 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 917 (918)
.+.. ....+|... ...+.+.+++.+|++.||.+||++.+++..+.
T Consensus 254 Av~n----~q~s~P~~~----~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d 298 (302)
T KOG2345|consen 254 AVQN----AQISIPNSS----RYSEALHQLIKSMLQVDPNQRPTIPELLSKLD 298 (302)
T ss_pred eeec----cccccCCCC----CccHHHHHHHHHHhcCCcccCCCHHHHHHHHH
Confidence 1100 011122211 15567899999999999999999999998764
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=319.00 Aligned_cols=250 Identities=23% Similarity=0.385 Sum_probs=210.8
Q ss_pred HhcCCCCceeeccccceEEEEE-EeCCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceE
Q 044366 644 ATGNFGEKYCIGKGGQRSVYKA-ELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSF 722 (918)
Q Consensus 644 ~~~~~~~~~~lg~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 722 (918)
...+|++.+.||+|+||.|-+| ....|+.||||.+++.... +.++.-.+.+|+++|+.++||||+.+|.+|+..+...
T Consensus 51 lkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIk-deqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIv 129 (668)
T KOG0611|consen 51 LKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIK-DEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIV 129 (668)
T ss_pred hhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcc-cHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEE
Confidence 4467888889999999999999 5578999999999886554 3455678999999999999999999999999999999
Q ss_pred EEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEecccccccc
Q 044366 723 IVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFL 802 (918)
Q Consensus 723 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~ 802 (918)
+||||..+|.|++|+.+++ .+++.+.++++.||+.|+.|+|.+ ++||||+|.+||++|+++++||+|||++-.+
T Consensus 130 ivMEYaS~GeLYDYiSer~---~LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiKIADFGLSNly 203 (668)
T KOG0611|consen 130 IVMEYASGGELYDYISERG---SLSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIKIADFGLSNLY 203 (668)
T ss_pred EEEEecCCccHHHHHHHhc---cccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCeeeeccchhhhh
Confidence 9999999999999998764 499999999999999999999999 9999999999999999999999999999887
Q ss_pred CCCCCCceecccccccccccccccCCC-CcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCCCCC
Q 044366 803 EPHSSNWTEFAGTVGYAAPELAYTMRA-TEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPS 881 (918)
Q Consensus 803 ~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 881 (918)
.. .......+|++-|.+||.+.+..| .+.+|-||+||+||-++.|..||+..+. ..++..+. .....++.
T Consensus 204 ~~-~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dh-----k~lvrQIs---~GaYrEP~ 274 (668)
T KOG0611|consen 204 AD-KKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDH-----KRLVRQIS---RGAYREPE 274 (668)
T ss_pred cc-ccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchH-----HHHHHHhh---cccccCCC
Confidence 64 334456789999999999999888 5789999999999999999999885432 12222222 22222211
Q ss_pred cchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 882 RDVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 882 ~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
.+.....+|++|+..+|++|-|+.+|..
T Consensus 275 -----~PSdA~gLIRwmLmVNP~RRATieDiAs 302 (668)
T KOG0611|consen 275 -----TPSDASGLIRWMLMVNPERRATIEDIAS 302 (668)
T ss_pred -----CCchHHHHHHHHHhcCcccchhHHHHhh
Confidence 1123567889999999999999999875
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=310.45 Aligned_cols=261 Identities=22% Similarity=0.299 Sum_probs=204.7
Q ss_pred hcCCCCceeeccccceEEEEEE-eCCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccc--cCCce
Q 044366 645 TGNFGEKYCIGKGGQRSVYKAE-LPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCS--NAQHS 721 (918)
Q Consensus 645 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~--~~~~~ 721 (918)
.+.|+..+.|++|+||.||+|+ .++++.||+|+++.+. ....-.-...+||.++.+.+|||||.+-.+.. +-+..
T Consensus 75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmek--ek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~i 152 (419)
T KOG0663|consen 75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEK--EKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKI 152 (419)
T ss_pred HHHHHHHhhcccCcceeEEEeccCCcceeEEeeeccccc--ccCCCcchhHHHHHHHHhcCCCCeeeeEEEEecccccee
Confidence 3457777889999999999994 4579999999998753 22223456799999999999999999988764 44679
Q ss_pred EEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccc
Q 044366 722 FIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKF 801 (918)
Q Consensus 722 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~ 801 (918)
|+|||||+. +|...+...+ ++|...++..+..|+++|++|||+. .|+|||+|++|++++..|.+||+|||+|+.
T Consensus 153 y~VMe~~Eh-DLksl~d~m~--q~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ 226 (419)
T KOG0663|consen 153 YIVMEYVEH-DLKSLMETMK--QPFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGILKIADFGLARE 226 (419)
T ss_pred eeeHHHHHh-hHHHHHHhcc--CCCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCcEEecccchhhh
Confidence 999999997 9999998754 6799999999999999999999999 999999999999999999999999999999
Q ss_pred cCCCCCCceecccccccccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCCC-
Q 044366 802 LEPHSSNWTEFAGTVGYAAPELAYTM-RATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPT- 879 (918)
Q Consensus 802 ~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 879 (918)
+.++...++..+-|..|.|||.+.+. .|+++.|+||+|||+.||+++++-|...... +.+......+--.-+..+|.
T Consensus 227 ygsp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~-dQl~~If~llGtPte~iwpg~ 305 (419)
T KOG0663|consen 227 YGSPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEI-DQLDKIFKLLGTPSEAIWPGY 305 (419)
T ss_pred hcCCcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchH-HHHHHHHHHhCCCccccCCCc
Confidence 99887888888999999999988765 5899999999999999999998876544332 11111111000000000100
Q ss_pred ------------------CCcchHH--HHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 880 ------------------PSRDVTD--KLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 880 ------------------~~~~~~~--~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
....+.. -...-.+++...+..||++|-||+|.++
T Consensus 306 ~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~ 360 (419)
T KOG0663|consen 306 SELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLK 360 (419)
T ss_pred cccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhc
Confidence 0001111 1145678889999999999999999875
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-39 Score=301.99 Aligned_cols=254 Identities=28% Similarity=0.408 Sum_probs=213.1
Q ss_pred HHHhcCCCCceeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCc
Q 044366 642 TKATGNFGEKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQH 720 (918)
Q Consensus 642 ~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 720 (918)
.++.++|++.+.||+|-||.||.|+. +++-.||+|++.+.... ......++.+|+++-+.++||||.++|+|+.+...
T Consensus 18 ~~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~-~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~r 96 (281)
T KOG0580|consen 18 TWTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQIL-KTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKR 96 (281)
T ss_pred ccchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHH-HhcchhhhhheeEeecccCCccHHhhhhheeccce
Confidence 45678899999999999999999965 46889999998765433 23346789999999999999999999999999999
Q ss_pred eEEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEecccccc
Q 044366 721 SFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAK 800 (918)
Q Consensus 721 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~ 800 (918)
.|+++||..+|++...+++.+ ..++++...+.++.|+|.|+.|+|.. +|+||||||+|+|++.++..|++|||.+.
T Consensus 97 iyLilEya~~gel~k~L~~~~-~~~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~~~lkiAdfGwsV 172 (281)
T KOG0580|consen 97 IYLILEYAPRGELYKDLQEGR-MKRFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSAGELKIADFGWSV 172 (281)
T ss_pred eEEEEEecCCchHHHHHHhcc-cccccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCCCCeeccCCCcee
Confidence 999999999999999998654 45588999999999999999999999 99999999999999999999999999997
Q ss_pred ccCCCCCCceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCCCC
Q 044366 801 FLEPHSSNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTP 880 (918)
Q Consensus 801 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 880 (918)
... .......+||..|.|||+..+..++..+|+|++|++.||++.|.+||+.... .....++.+ .+...+
T Consensus 173 ~~p--~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~-----~etYkrI~k---~~~~~p 242 (281)
T KOG0580|consen 173 HAP--SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSH-----SETYKRIRK---VDLKFP 242 (281)
T ss_pred ecC--CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhh-----HHHHHHHHH---ccccCC
Confidence 543 4455667899999999999999999999999999999999999999875431 122222222 222111
Q ss_pred CcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 881 SRDVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 881 ~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
. .......++|.+|+.++|.+|.+..|+++
T Consensus 243 -~---~is~~a~dlI~~ll~~~p~~r~~l~~v~~ 272 (281)
T KOG0580|consen 243 -S---TISGGAADLISRLLVKNPIERLALTEVMD 272 (281)
T ss_pred -c---ccChhHHHHHHHHhccCccccccHHHHhh
Confidence 1 22245778899999999999999999875
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=330.56 Aligned_cols=254 Identities=22% Similarity=0.298 Sum_probs=202.2
Q ss_pred HhcCCCCceeeccccceEEEEEE-eCCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceE
Q 044366 644 ATGNFGEKYCIGKGGQRSVYKAE-LPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSF 722 (918)
Q Consensus 644 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 722 (918)
..++|+....||+|+||.||.|+ ..+|+.+|+|++++..... ....+....|-.+|....+|.||+++-.|++.+.+|
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~-~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LY 217 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLK-KNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLY 217 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHh-hhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeE
Confidence 45789999999999999999994 4579999999998854433 233677888999999999999999999999999999
Q ss_pred EEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEecccccccc
Q 044366 723 IVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFL 802 (918)
Q Consensus 723 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~ 802 (918)
|||||++||++..+|...+ .+++..+..++.+.+-|++.+|.. |+|||||||+|+|+|..|++||+|||++..+
T Consensus 218 LiMEylPGGD~mTLL~~~~---~L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl 291 (550)
T KOG0605|consen 218 LIMEYLPGGDMMTLLMRKD---TLTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHIKLSDFGLSTGL 291 (550)
T ss_pred EEEEecCCccHHHHHHhcC---cCchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCEeeccccccchh
Confidence 9999999999999997653 489999999999999999999999 9999999999999999999999999999543
Q ss_pred CC-----------------------CCC-----C-------------------ceecccccccccccccccCCCCcccch
Q 044366 803 EP-----------------------HSS-----N-------------------WTEFAGTVGYAAPELAYTMRATEKYDV 835 (918)
Q Consensus 803 ~~-----------------------~~~-----~-------------------~~~~~g~~~y~aPE~~~~~~~~~~~Dv 835 (918)
.. +.. . ....+|||.|||||++.+..|+..+|.
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDw 371 (550)
T KOG0605|consen 292 DKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDW 371 (550)
T ss_pred hhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccH
Confidence 21 000 0 013479999999999999999999999
Q ss_pred hhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCCCCCcchHHHHHHHHHHHHHcccCCCCCCCC---HHHH
Q 044366 836 YSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPT---MKEV 912 (918)
Q Consensus 836 ~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt---~~ev 912 (918)
||+|||+|||+.|.+||...... ........+..... .|.. . +...+..++|.+|+. ||++|.- +.||
T Consensus 372 WSLG~ImyEmLvGyPPF~s~tp~-~T~rkI~nwr~~l~---fP~~-~---~~s~eA~DLI~rll~-d~~~RLG~~G~~EI 442 (550)
T KOG0605|consen 372 WSLGCIMYEMLVGYPPFCSETPQ-ETYRKIVNWRETLK---FPEE-V---DLSDEAKDLITRLLC-DPENRLGSKGAEEI 442 (550)
T ss_pred HHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhhhcc---CCCc-C---cccHHHHHHHHHHhc-CHHHhcCcccHHHH
Confidence 99999999999999998755432 22222211111111 1111 1 112457788888998 9999975 5555
Q ss_pred H
Q 044366 913 C 913 (918)
Q Consensus 913 l 913 (918)
.
T Consensus 443 K 443 (550)
T KOG0605|consen 443 K 443 (550)
T ss_pred h
Confidence 4
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-38 Score=334.92 Aligned_cols=253 Identities=22% Similarity=0.291 Sum_probs=200.4
Q ss_pred CCCceeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEEEEE
Q 044366 648 FGEKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFIVCE 726 (918)
Q Consensus 648 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 726 (918)
|...+.||+|+||.||+|.. .+|+.||+|.+....... ......+.+|+++++.++|++|+++++++.+++..++|||
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~-~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKK-RKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhh-hhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 67788999999999999954 589999999987543222 2224568899999999999999999999999999999999
Q ss_pred eccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccCCCC
Q 044366 727 YLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHS 806 (918)
Q Consensus 727 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~~~~ 806 (918)
|+++|+|.+++.... ...+++..++.++.|++.|++|||+. +|+||||||+||++++++.++|+|||++.......
T Consensus 81 ~~~~g~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05631 81 IMNGGDLKFHIYNMG-NPGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE 156 (285)
T ss_pred ecCCCcHHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC
Confidence 999999998886533 23589999999999999999999999 99999999999999999999999999998754322
Q ss_pred CCceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCCCCCcchHH
Q 044366 807 SNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRDVTD 886 (918)
Q Consensus 807 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 886 (918)
......|+..|+|||++.+..++.++|||||||++|||++|+.||........ ...... ...... ..... .
T Consensus 157 -~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~-~~~~~~---~~~~~~-~~~~~---~ 227 (285)
T cd05631 157 -TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVK-REEVDR---RVKEDQ-EEYSE---K 227 (285)
T ss_pred -eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchh-HHHHHH---Hhhccc-ccCCc---c
Confidence 22345789999999999999999999999999999999999999875432100 000000 011111 11111 1
Q ss_pred HHHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 044366 887 KLRSIMEVAILCLVENPEARPT-----MKEVCN 914 (918)
Q Consensus 887 ~~~~l~~li~~cl~~dp~~RPt-----~~evl~ 914 (918)
....+.+++.+||+.||++||+ ++++++
T Consensus 228 ~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 260 (285)
T cd05631 228 FSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ 260 (285)
T ss_pred CCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence 2346788999999999999997 788765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-38 Score=334.88 Aligned_cols=250 Identities=24% Similarity=0.374 Sum_probs=208.2
Q ss_pred hcCCCCceeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEE
Q 044366 645 TGNFGEKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFI 723 (918)
Q Consensus 645 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 723 (918)
.+-|...+.||+|+.|.|-.|++ .+|+.+|||++.... .-.......+.+|+-+|+-+.||||+++|++|++..++|+
T Consensus 11 iGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~-~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lyl 89 (786)
T KOG0588|consen 11 IGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRS-ELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYL 89 (786)
T ss_pred ccceeccccccCCCCceehhhhcccccceeEEEeecccc-ccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEE
Confidence 35677888999999999999954 689999999997742 2223335678899999999999999999999999999999
Q ss_pred EEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccC
Q 044366 724 VCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLE 803 (918)
Q Consensus 724 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~ 803 (918)
|.||+++|-|.+++.+.+ ++++.+..+++.||+.|+.|+|+. +|+|||+||+|+++|..+++||+|||+|..-.
T Consensus 90 vlEyv~gGELFdylv~kG---~l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIKIADFGMAsLe~ 163 (786)
T KOG0588|consen 90 VLEYVPGGELFDYLVRKG---PLPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIKIADFGMASLEV 163 (786)
T ss_pred EEEecCCchhHHHHHhhC---CCCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEeeeccceeeccc
Confidence 999999999999998754 489999999999999999999999 99999999999999999999999999998654
Q ss_pred CCCCCceecccccccccccccccCCC-CcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCCCCCc
Q 044366 804 PHSSNWTEFAGTVGYAAPELAYTMRA-TEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSR 882 (918)
Q Consensus 804 ~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 882 (918)
+ +.-....+|++.|.|||++.|.+| ..++||||+|||||.++||+.||++.. +.... .++..+.+..+ .
T Consensus 164 ~-gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdN-----ir~LL---lKV~~G~f~MP-s 233 (786)
T KOG0588|consen 164 P-GKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDN-----IRVLL---LKVQRGVFEMP-S 233 (786)
T ss_pred C-CccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCcc-----HHHHH---HHHHcCcccCC-C
Confidence 3 444556789999999999999998 478999999999999999999998432 12222 22222222222 1
Q ss_pred chHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 883 DVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 883 ~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
....+..+++.+|+..||++|-|++||.+
T Consensus 234 ---~Is~eaQdLLr~ml~VDp~~RiT~~eI~k 262 (786)
T KOG0588|consen 234 ---NISSEAQDLLRRMLDVDPSTRITTEEILK 262 (786)
T ss_pred ---cCCHHHHHHHHHHhccCccccccHHHHhh
Confidence 22346788899999999999999999986
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=331.61 Aligned_cols=248 Identities=23% Similarity=0.318 Sum_probs=196.8
Q ss_pred ceeeccccceEEEEEEeCCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEeccccc----CCceEEEEE
Q 044366 651 KYCIGKGGQRSVYKAELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSN----AQHSFIVCE 726 (918)
Q Consensus 651 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~----~~~~~lv~e 726 (918)
...||+|++|.||+|.. +|+.||||+++.... ......+.|.+|+.++++++||||++++|++.+ ....++|||
T Consensus 25 ~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~E 102 (283)
T PHA02988 25 SVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHK-GHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILE 102 (283)
T ss_pred CeEEeeCCceEEEEEEE-CCEEEEEEecccccc-ccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEE
Confidence 35799999999999987 789999999876421 111124678899999999999999999999866 346789999
Q ss_pred eccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccCCCC
Q 044366 727 YLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHS 806 (918)
Q Consensus 727 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~~~~ 806 (918)
|+++|+|.++++... .+++...++++.+++.|++|||+.. +++||||||+||++++++.+||+|||+++......
T Consensus 103 y~~~g~L~~~l~~~~---~~~~~~~~~i~~~i~~~l~~lH~~~--~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~ 177 (283)
T PHA02988 103 YCTRGYLREVLDKEK---DLSFKTKLDMAIDCCKGLYNLYKYT--NKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP 177 (283)
T ss_pred eCCCCcHHHHHhhCC---CCChhHHHHHHHHHHHHHHHHHhcC--CCCCCcCChhhEEECCCCcEEEcccchHhhhcccc
Confidence 999999999997643 4899999999999999999999732 78899999999999999999999999998654322
Q ss_pred CCceeccccccccccccccc--CCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCCCCCcch
Q 044366 807 SNWTEFAGTVGYAAPELAYT--MRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRDV 884 (918)
Q Consensus 807 ~~~~~~~g~~~y~aPE~~~~--~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 884 (918)
....|+..|+|||++.+ ..++.++|||||||++|||++|+.||...... ....... . ...+++.+ .
T Consensus 178 ---~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~--~~~~~i~--~--~~~~~~~~-~-- 245 (283)
T PHA02988 178 ---FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTK--EIYDLII--N--KNNSLKLP-L-- 245 (283)
T ss_pred ---ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHH--HHHHHHH--h--cCCCCCCC-C--
Confidence 23467899999999976 67899999999999999999999998754321 1111100 0 01111111 1
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhC
Q 044366 885 TDKLRSIMEVAILCLVENPEARPTMKEVCNLLCK 918 (918)
Q Consensus 885 ~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~ 918 (918)
.....+.+++.+||+.||++|||++|+++.|++
T Consensus 246 -~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~ 278 (283)
T PHA02988 246 -DCPLEIKCIVEACTSHDSIKRPNIKEILYNLSL 278 (283)
T ss_pred -cCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHH
Confidence 123468889999999999999999999998863
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=344.53 Aligned_cols=258 Identities=22% Similarity=0.335 Sum_probs=202.5
Q ss_pred hcCCCCceeeccccceEEEEEEe------CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhc-cCCceeeEeccccc
Q 044366 645 TGNFGEKYCIGKGGQRSVYKAEL------PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEI-RHRNIIKFHGFCSN 717 (918)
Q Consensus 645 ~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~ 717 (918)
.++|...+.||+|+||.||+|.. .++..||||+++... .....+.+.+|+.+++.+ +||||++++++|.+
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~ 110 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSA---HLTEREALMSELKVLSYLGNHINIVNLLGACTV 110 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCc---CcHHHHHHHHHHHHHHHhcCCcceeeeeeeecc
Confidence 45788899999999999999953 246689999986532 222346789999999999 89999999999999
Q ss_pred CCceEEEEEeccCCChhHHhhcccc-------------------------------------------------------
Q 044366 718 AQHSFIVCEYLARGSLTTILRDDAA------------------------------------------------------- 742 (918)
Q Consensus 718 ~~~~~lv~e~~~~gsL~~~l~~~~~------------------------------------------------------- 742 (918)
++..++||||+++|+|.++++....
T Consensus 111 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (375)
T cd05104 111 GGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVR 190 (375)
T ss_pred CCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccc
Confidence 9999999999999999999864321
Q ss_pred -----------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccCCC
Q 044366 743 -----------------AKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPH 805 (918)
Q Consensus 743 -----------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~~~ 805 (918)
...+++.++++++.||++||+|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~ 267 (375)
T cd05104 191 SGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIRND 267 (375)
T ss_pred cceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecCccceeccCc
Confidence 12478999999999999999999999 9999999999999999999999999999876543
Q ss_pred CCC--ceecccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhhhhhhhhhHhhhhhhcccCCCCCCc
Q 044366 806 SSN--WTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIK-GYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSR 882 (918)
Q Consensus 806 ~~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 882 (918)
... .....++..|+|||++.+..++.++|||||||++|||++ |..||........... .... ...+..+.
T Consensus 268 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~----~~~~---~~~~~~~~ 340 (375)
T cd05104 268 SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYK----MIKE---GYRMLSPE 340 (375)
T ss_pred ccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHH----HHHh---CccCCCCC
Confidence 221 112334668999999999999999999999999999998 8888764322111111 1111 10111111
Q ss_pred chHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhC
Q 044366 883 DVTDKLRSIMEVAILCLVENPEARPTMKEVCNLLCK 918 (918)
Q Consensus 883 ~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~ 918 (918)
. ...++.+++.+||+.||++||++.||++.|++
T Consensus 341 ~---~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~ 373 (375)
T cd05104 341 C---APSEMYDIMKSCWDADPLKRPTFKQIVQLIEQ 373 (375)
T ss_pred C---CCHHHHHHHHHHccCChhHCcCHHHHHHHHHh
Confidence 1 12468899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=335.71 Aligned_cols=264 Identities=21% Similarity=0.327 Sum_probs=200.7
Q ss_pred hcCCCCceeeccccceEEEEEEeCC-----------------CCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCc
Q 044366 645 TGNFGEKYCIGKGGQRSVYKAELPS-----------------GNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRN 707 (918)
Q Consensus 645 ~~~~~~~~~lg~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~n 707 (918)
.++|...+.||+|+||.||+|...+ +..||+|.++... ......+|.+|++++++++|||
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~h~n 80 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA---NKNARNDFLKEVKILSRLKDPN 80 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC---CHHHHHHHHHHHHHHhhcCCCC
Confidence 3578888999999999999996432 3469999986532 1223467999999999999999
Q ss_pred eeeEecccccCCceEEEEEeccCCChhHHhhccc----------------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCC
Q 044366 708 IIKFHGFCSNAQHSFIVCEYLARGSLTTILRDDA----------------AAKEFSWNQRMNVIKGVANALSYLHHDCIP 771 (918)
Q Consensus 708 iv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~----------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ 771 (918)
|+++++++.+.+..++||||+++|+|.+++.... ....+++.++++++.||+.||+|||+.
T Consensus 81 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~--- 157 (304)
T cd05096 81 IIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL--- 157 (304)
T ss_pred eeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC---
Confidence 9999999999999999999999999999986532 112478899999999999999999999
Q ss_pred CeEEcCCCCCCeeeCCCCcEEEeccccccccCCCCCC--ceecccccccccccccccCCCCcccchhhHHHHHHHHHh--
Q 044366 772 PIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSN--WTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIK-- 847 (918)
Q Consensus 772 ~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-- 847 (918)
+|+||||||+||+++.++.+||+|||+++........ .....++..|+|||++.+..++.++||||||+++|||++
T Consensus 158 ~ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~ 237 (304)
T cd05096 158 NFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLC 237 (304)
T ss_pred CccccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHcc
Confidence 9999999999999999999999999999866443221 122345788999999988889999999999999999987
Q ss_pred CCCCCCcchhhhhhhhhhHhhhhhhcccCCCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhC
Q 044366 848 GYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLLCK 918 (918)
Q Consensus 848 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~ 918 (918)
|..|+...... ....................... .....+.+++.+||+.||++|||+.||.+.|++
T Consensus 238 ~~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~ 304 (304)
T cd05096 238 KEQPYGELTDE-QVIENAGEFFRDQGRQVYLFRPP---PCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE 304 (304)
T ss_pred CCCCCCcCCHH-HHHHHHHHHhhhccccccccCCC---CCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence 45666533211 11111111001000000000011 123468899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=321.62 Aligned_cols=255 Identities=23% Similarity=0.324 Sum_probs=199.9
Q ss_pred HHhcCCCCceeeccccceEEEEEE-eCCCCEEEEEEccccccc----------CCCCChHHHHHHHHHHhhccCCceeeE
Q 044366 643 KATGNFGEKYCIGKGGQRSVYKAE-LPSGNIFAVKKFKAELFS----------DETANPSEFLNEVLALTEIRHRNIIKF 711 (918)
Q Consensus 643 ~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~----------~~~~~~~~~~~e~~~l~~l~h~niv~~ 711 (918)
...++|+..+.||+|.||.|-+|+ ..+++.||||++.+.... ......+...+|+.++++++|||||++
T Consensus 94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L 173 (576)
T KOG0585|consen 94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL 173 (576)
T ss_pred eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence 445789999999999999999994 458999999998553221 111223578999999999999999999
Q ss_pred ecccccC--CceEEEEEeccCCChhHHhhcccccCC-CCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCC
Q 044366 712 HGFCSNA--QHSFIVCEYLARGSLTTILRDDAAAKE-FSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSE 788 (918)
Q Consensus 712 ~~~~~~~--~~~~lv~e~~~~gsL~~~l~~~~~~~~-l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~ 788 (918)
+++..+. +..|||+|||..|.+.+. ..+.+ ++..+.++++.+++.||+|||.+ |||||||||+|+|++++
T Consensus 174 iEvLDDP~s~~~YlVley~s~G~v~w~----p~d~~els~~~Ar~ylrDvv~GLEYLH~Q---giiHRDIKPsNLLl~~~ 246 (576)
T KOG0585|consen 174 IEVLDDPESDKLYLVLEYCSKGEVKWC----PPDKPELSEQQARKYLRDVVLGLEYLHYQ---GIIHRDIKPSNLLLSSD 246 (576)
T ss_pred EEeecCcccCceEEEEEeccCCccccC----CCCcccccHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEEcCC
Confidence 9998765 578999999998876543 22334 89999999999999999999999 99999999999999999
Q ss_pred CcEEEeccccccccCCC-----CCCceecccccccccccccccCC----CCcccchhhHHHHHHHHHhCCCCCCcchhhh
Q 044366 789 YEAHVSDFGFAKFLEPH-----SSNWTEFAGTVGYAAPELAYTMR----ATEKYDVYSFGVLALEVIKGYHPGDFVSTIF 859 (918)
Q Consensus 789 ~~~kl~DfG~~~~~~~~-----~~~~~~~~g~~~y~aPE~~~~~~----~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~ 859 (918)
|++||+|||.+...... +......+||+.|+|||...++. .+.+.||||+||+||.|+.|+.||-....
T Consensus 247 g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~-- 324 (576)
T KOG0585|consen 247 GTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFE-- 324 (576)
T ss_pred CcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchH--
Confidence 99999999999876322 22234578999999999887633 25678999999999999999999753321
Q ss_pred hhhhhhHhhhhhhcccCCCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 860 SSISNMIIEVNQILDHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 860 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
.....+++...+..+ ...+..+.+.++|.+++.+||++|.+..+|..
T Consensus 325 ------~~l~~KIvn~pL~fP--~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~ 371 (576)
T KOG0585|consen 325 ------LELFDKIVNDPLEFP--ENPEINEDLKDLIKRLLEKDPEQRITLPDIKL 371 (576)
T ss_pred ------HHHHHHHhcCcccCC--CcccccHHHHHHHHHHhhcChhheeehhhhee
Confidence 111223333332222 12244567889999999999999999999864
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=343.07 Aligned_cols=244 Identities=24% Similarity=0.303 Sum_probs=197.7
Q ss_pred eeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEEEEEeccC
Q 044366 652 YCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFIVCEYLAR 730 (918)
Q Consensus 652 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 730 (918)
+.||+|+||.||+|.. .+|+.||+|+++...... ......+.+|+++++.++||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~ 79 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIA-KDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANG 79 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhh-hHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCC
Confidence 3699999999999954 579999999987643221 22345788999999999999999999999999999999999999
Q ss_pred CChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccCCCCCCce
Q 044366 731 GSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWT 810 (918)
Q Consensus 731 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~~~~~~~~ 810 (918)
|+|.+++... ..+++.++..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++..........
T Consensus 80 ~~L~~~l~~~---~~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~ 153 (323)
T cd05571 80 GELFFHLSRE---RVFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMK 153 (323)
T ss_pred CcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCccc
Confidence 9999998764 3489999999999999999999999 999999999999999999999999999986543333344
Q ss_pred ecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCCCCCcchHHHHHH
Q 044366 811 EFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRDVTDKLRS 890 (918)
Q Consensus 811 ~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 890 (918)
...|++.|+|||++.+..++.++||||+||++|||++|+.||...... .. ...+.......+ .. ....
T Consensus 154 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~--~~------~~~~~~~~~~~p-~~---~~~~ 221 (323)
T cd05571 154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE--KL------FELILMEEIRFP-RT---LSPE 221 (323)
T ss_pred ceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHH--HH------HHHHHcCCCCCC-CC---CCHH
Confidence 567999999999999989999999999999999999999998643221 00 011111111111 11 2345
Q ss_pred HHHHHHHcccCCCCCCC-----CHHHHHH
Q 044366 891 IMEVAILCLVENPEARP-----TMKEVCN 914 (918)
Q Consensus 891 l~~li~~cl~~dp~~RP-----t~~evl~ 914 (918)
+.+++.+||+.||++|| ++.++++
T Consensus 222 ~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 222 AKSLLAGLLKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred HHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence 78899999999999999 7988874
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-41 Score=369.59 Aligned_cols=507 Identities=31% Similarity=0.334 Sum_probs=376.5
Q ss_pred cccCCCCCCccCCccCCCCCCCCEEeCCCCcccccCCccccCCCCCCEEEcccccccccCCCCcCCCCCCCEEEcccccc
Q 044366 2 LNLGFNLLFGNIPPQIGNLSKLQYLDLGNNQLSGVIPPEIGKLNQLRRLYLDVNQLHGTIPPVIGQLSLINELVFCHNNV 81 (918)
Q Consensus 2 l~~~~~~~~~~~p~~~~~l~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~~ 81 (918)
+|++.+.++ -||..+..-..++.|+++.|-+-...-+.+.+..+|++|||+.|++. ..|..+..+.+|+.|.++.|.+
T Consensus 3 vd~s~~~l~-~ip~~i~~~~~~~~ln~~~N~~l~~pl~~~~~~v~L~~l~lsnn~~~-~fp~~it~l~~L~~ln~s~n~i 80 (1081)
T KOG0618|consen 3 VDASDEQLE-LIPEQILNNEALQILNLRRNSLLSRPLEFVEKRVKLKSLDLSNNQIS-SFPIQITLLSHLRQLNLSRNYI 80 (1081)
T ss_pred cccccccCc-ccchhhccHHHHHhhhccccccccCchHHhhheeeeEEeeccccccc-cCCchhhhHHHHhhcccchhhH
Confidence 566777777 78887777666888888888776333344555666888888888887 7888888888888888888888
Q ss_pred cccCCccccCCCCCCEEEccCCcccccCccccCCCCCCCEEECcCCcCCCcCCcCCCCCCCCceeeccccccccCCCccc
Q 044366 82 SGRIPSSLGNLSNLALLYLNDNSLFGSIPIVMGNLKSLSTLDLSQNQLNGSIPCSLDNLSNLDTLFLYKNSLSGPIPSVI 161 (918)
Q Consensus 82 ~~~~p~~l~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~ 161 (918)
. ..|.+..++.+|++|.|.+|.+. ..|..+..+++|++||+|.|++. ..|..+..++.++++..++|... ..+
T Consensus 81 ~-~vp~s~~~~~~l~~lnL~~n~l~-~lP~~~~~lknl~~LdlS~N~f~-~~Pl~i~~lt~~~~~~~s~N~~~----~~l 153 (1081)
T KOG0618|consen 81 R-SVPSSCSNMRNLQYLNLKNNRLQ-SLPASISELKNLQYLDLSFNHFG-PIPLVIEVLTAEEELAASNNEKI----QRL 153 (1081)
T ss_pred h-hCchhhhhhhcchhheeccchhh-cCchhHHhhhcccccccchhccC-CCchhHHhhhHHHHHhhhcchhh----hhh
Confidence 7 77888888888888888888876 77888888888888888888887 67777888888888888888221 122
Q ss_pred ccccccCeeeccccccCCcCCccCCCCCCCcEeeccCcccccCCCccccCCCCcceeecccccccCCCCCCCcCCCcCCe
Q 044366 162 GNLKSLLQLDLSENRLSGLIPLSLSNLSSLTVMSLFNNSLSGSIPPILGNLKSLSTLGLHINQLNGVIPPSIGNLSSLRN 241 (918)
Q Consensus 162 ~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~ 241 (918)
+... ++.+++..|.+.+.++..+..+.. .|+|.+|.+. .-.+..+.+|+.|....|++.... + .-++|+.
T Consensus 154 g~~~-ik~~~l~~n~l~~~~~~~i~~l~~--~ldLr~N~~~---~~dls~~~~l~~l~c~rn~ls~l~---~-~g~~l~~ 223 (1081)
T KOG0618|consen 154 GQTS-IKKLDLRLNVLGGSFLIDIYNLTH--QLDLRYNEME---VLDLSNLANLEVLHCERNQLSELE---I-SGPSLTA 223 (1081)
T ss_pred cccc-chhhhhhhhhcccchhcchhhhhe--eeecccchhh---hhhhhhccchhhhhhhhcccceEE---e-cCcchhe
Confidence 3322 777777777777766666655554 5888888776 234667777888888888776431 1 2357788
Q ss_pred EEcccCcCcCCCCccccccCCCCeEecCCCccCCcCCCcCCCCCCCcEEEccCCcCcCCCCccccCCCCCCeEEeecccc
Q 044366 242 LSLFNNRLYGFVPKEIGYLKSLSKLEFCANHLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLRNLTSLERVRFNQNNL 321 (918)
Q Consensus 242 L~Ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l 321 (918)
|+.++|.++...+ -....+|++++++.|+++... .+...+.+|+.++...|+++ .+|..+..+++|+.+....|.+
T Consensus 224 L~a~~n~l~~~~~--~p~p~nl~~~dis~n~l~~lp-~wi~~~~nle~l~~n~N~l~-~lp~ri~~~~~L~~l~~~~nel 299 (1081)
T KOG0618|consen 224 LYADHNPLTTLDV--HPVPLNLQYLDISHNNLSNLP-EWIGACANLEALNANHNRLV-ALPLRISRITSLVSLSAAYNEL 299 (1081)
T ss_pred eeeccCcceeecc--ccccccceeeecchhhhhcch-HHHHhcccceEecccchhHH-hhHHHHhhhhhHHHHHhhhhhh
Confidence 8888887773322 223456788888888887544 77777888888888888874 6677777777888888888877
Q ss_pred cCccccccCCCCCccEEeCCCCccccccCcccccccc-cceeeccccccccCCCcCcCCCCCCcEEEccCceeccccccc
Q 044366 322 YGKVYEAFGDHPNLTFLDLSQNNFYCEISFNWRNFSK-LGTFNASMNNIYGSIPPEIGDSSKLQVLDLSSNHIFGKIPVQ 400 (918)
Q Consensus 322 ~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~-L~~l~l~~n~i~~~~~~~~~~~~~L~~L~L~~N~l~~~~~~~ 400 (918)
..+++ ...++..|++|+|..|+|...+...+..... +..++.+-|.+....--.=..++.|+.|.+.+|.++...-..
T Consensus 300 ~yip~-~le~~~sL~tLdL~~N~L~~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~ 378 (1081)
T KOG0618|consen 300 EYIPP-FLEGLKSLRTLDLQSNNLPSLPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELYLANNHLTDSCFPV 378 (1081)
T ss_pred hhCCC-cccccceeeeeeehhccccccchHHHhhhhHHHHHHhhhhccccccccccchhhHHHHHHHHhcCcccccchhh
Confidence 66654 3445677888888888877666655554433 666666666665433222233467888888888888777777
Q ss_pred hhhccccCceecccccccCCCCCCCCCCCcccEEeccCccccccCccccccccccceecccCcccCCCCchhhccccccc
Q 044366 401 LVKLFSLNKLILSLNQLFGGVPLEFGTLTELQYLDLSANKLSSSIPMSIGNLLKLHYLNLSNNQFSHKIPTEFEKLIHLS 480 (918)
Q Consensus 401 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~ 480 (918)
+.+..+|+.|+|++|++...+...+.++..|++|+||+|+++ .+|..+..+..|++|...+|++. ..| .+..++.|+
T Consensus 379 l~~~~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~-~fP-e~~~l~qL~ 455 (1081)
T KOG0618|consen 379 LVNFKHLKVLHLSYNRLNSFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLL-SFP-ELAQLPQLK 455 (1081)
T ss_pred hccccceeeeeecccccccCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCcee-ech-hhhhcCcce
Confidence 888888999999999887777778889999999999999999 57788999999999999999996 567 889999999
Q ss_pred eEeccCCcCCCCCchhccccCCcceEecCCCcccccCcccccCCCCccEEEccCC
Q 044366 481 ELDLSHNILQEEIPPQICKMESLEKLNLSHNNLSDFIPRCFEEMRSLSWIDISYN 535 (918)
Q Consensus 481 ~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~l~l~~N 535 (918)
.+|+|.|+|+...-.....-++|++|||++|.-.......|..+.++...+++-|
T Consensus 456 ~lDlS~N~L~~~~l~~~~p~p~LkyLdlSGN~~l~~d~~~l~~l~~l~~~~i~~~ 510 (1081)
T KOG0618|consen 456 VLDLSCNNLSEVTLPEALPSPNLKYLDLSGNTRLVFDHKTLKVLKSLSQMDITLN 510 (1081)
T ss_pred EEecccchhhhhhhhhhCCCcccceeeccCCcccccchhhhHHhhhhhheecccC
Confidence 9999999998653333233389999999999876666777888888888888877
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=334.21 Aligned_cols=247 Identities=26% Similarity=0.353 Sum_probs=200.7
Q ss_pred cCCCCceeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEEE
Q 044366 646 GNFGEKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFIV 724 (918)
Q Consensus 646 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 724 (918)
++|...+.||+|+||.||+|.. .+|+.||+|++...... .....+.+.+|+++++.++||||+++++++.+++..++|
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 79 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVI-RLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYML 79 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHh-hhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEE
Confidence 3688899999999999999965 47899999998653221 112346788999999999999999999999999999999
Q ss_pred EEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccCC
Q 044366 725 CEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEP 804 (918)
Q Consensus 725 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~~ 804 (918)
|||+++|+|.++++..+ .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.....
T Consensus 80 ~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~ 153 (291)
T cd05612 80 MEYVPGGELFSYLRNSG---RFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRD 153 (291)
T ss_pred EeCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEEecCcchhccC
Confidence 99999999999997643 489999999999999999999999 999999999999999999999999999987643
Q ss_pred CCCCceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCCCCCcch
Q 044366 805 HSSNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRDV 884 (918)
Q Consensus 805 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 884 (918)
.. ....|++.|+|||++.+..++.++|||||||++|||++|+.||...... .. ...+.......+ ...
T Consensus 154 ~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~-~~-------~~~i~~~~~~~~-~~~ 221 (291)
T cd05612 154 RT---WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPF-GI-------YEKILAGKLEFP-RHL 221 (291)
T ss_pred Cc---ccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HH-------HHHHHhCCcCCC-ccC
Confidence 22 2346899999999999888999999999999999999999998654321 00 111111111111 111
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 044366 885 TDKLRSIMEVAILCLVENPEARPT-----MKEVCN 914 (918)
Q Consensus 885 ~~~~~~l~~li~~cl~~dp~~RPt-----~~evl~ 914 (918)
...+.+++.+|++.||.+||+ ++|+++
T Consensus 222 ---~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 253 (291)
T cd05612 222 ---DLYAKDLIKKLLVVDRTRRLGNMKNGADDVKN 253 (291)
T ss_pred ---CHHHHHHHHHHcCCCHHHccCCccCCHHHHhc
Confidence 245788999999999999995 888764
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=333.49 Aligned_cols=261 Identities=19% Similarity=0.324 Sum_probs=200.8
Q ss_pred hcCCCCceeeccccceEEEEEEeC-CCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEE
Q 044366 645 TGNFGEKYCIGKGGQRSVYKAELP-SGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFI 723 (918)
Q Consensus 645 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 723 (918)
.++|.+.+.||+|+||.||+|+.. +|+.||||+++... .......+.+|+.+++.++||||+++++++.+++..++
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 80 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQE---EEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTL 80 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEecccc---ccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEE
Confidence 467999999999999999999654 78999999986532 22234567899999999999999999999999999999
Q ss_pred EEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccC
Q 044366 724 VCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLE 803 (918)
Q Consensus 724 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~ 803 (918)
||||++ ++|.+++... ...+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++....
T Consensus 81 v~e~~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 154 (303)
T cd07869 81 VFEYVH-TDLCQYMDKH--PGGLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGLARAKS 154 (303)
T ss_pred EEECCC-cCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECCCCcceecc
Confidence 999996 5888887654 23478899999999999999999999 99999999999999999999999999997654
Q ss_pred CCCCCceeccccccccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcc--------
Q 044366 804 PHSSNWTEFAGTVGYAAPELAYT-MRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILD-------- 874 (918)
Q Consensus 804 ~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~-------- 874 (918)
..........+++.|+|||++.+ ..++.++||||+||++|||++|+.||......................
T Consensus 155 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (303)
T cd07869 155 VPSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHS 234 (303)
T ss_pred CCCccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhh
Confidence 33333345668999999998865 457889999999999999999999987654332222211110000000
Q ss_pred ------cCCCC-CCcchHH------HHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 875 ------HRLPT-PSRDVTD------KLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 875 ------~~~~~-~~~~~~~------~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
..... ....... ....+.+++.+|++.||++|||+.|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 235 LPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred ccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 00000 0000000 1245778999999999999999999975
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-38 Score=339.10 Aligned_cols=241 Identities=24% Similarity=0.325 Sum_probs=194.3
Q ss_pred eccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEEEEEeccCCC
Q 044366 654 IGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFIVCEYLARGS 732 (918)
Q Consensus 654 lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gs 732 (918)
||+|+||.||+|.. .+++.||+|+++..... .......+.+|++++++++||||+++++++.+++..++||||+++|+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~ 79 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIV-SRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGE 79 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCc
Confidence 69999999999965 46889999998753221 22335678899999999999999999999999999999999999999
Q ss_pred hhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccCCCCCCceec
Q 044366 733 LTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEF 812 (918)
Q Consensus 733 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~ 812 (918)
|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++|+|||+++............
T Consensus 80 L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 153 (312)
T cd05585 80 LFHHLQRE---GRFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTF 153 (312)
T ss_pred HHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECcccccCccCCCccccc
Confidence 99999764 3489999999999999999999999 99999999999999999999999999998654433334456
Q ss_pred ccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCCCCCcchHHHHHHHH
Q 044366 813 AGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRDVTDKLRSIM 892 (918)
Q Consensus 813 ~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 892 (918)
.||+.|+|||++.+..++.++||||+||++|||++|+.||...... .. ........... +. .....+.
T Consensus 154 ~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~-----~~---~~~~~~~~~~~-~~---~~~~~~~ 221 (312)
T cd05585 154 CGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVN-----EM---YRKILQEPLRF-PD---GFDRDAK 221 (312)
T ss_pred cCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHH-----HH---HHHHHcCCCCC-CC---cCCHHHH
Confidence 7899999999999989999999999999999999999998643221 11 11111111111 11 1224578
Q ss_pred HHHHHcccCCCCCCCC---HHHHH
Q 044366 893 EVAILCLVENPEARPT---MKEVC 913 (918)
Q Consensus 893 ~li~~cl~~dp~~RPt---~~evl 913 (918)
+++.+||+.||++||+ +.|++
T Consensus 222 ~li~~~L~~dp~~R~~~~~~~e~l 245 (312)
T cd05585 222 DLLIGLLSRDPTRRLGYNGAQEIK 245 (312)
T ss_pred HHHHHHcCCCHHHcCCCCCHHHHH
Confidence 8899999999999985 55654
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=325.78 Aligned_cols=255 Identities=23% Similarity=0.348 Sum_probs=202.4
Q ss_pred hcCCCCceeeccccceEEEEEEeC----CCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCc
Q 044366 645 TGNFGEKYCIGKGGQRSVYKAELP----SGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQH 720 (918)
Q Consensus 645 ~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 720 (918)
..+|.+.+.||+|+||.||+|.+. .+..||+|.++... .....+.|.+|+..++.++||||++++|++..++.
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 80 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC---SDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNT 80 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCC---CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCC
Confidence 356888899999999999999642 45689999987532 12224678999999999999999999999999999
Q ss_pred eEEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEecccccc
Q 044366 721 SFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAK 800 (918)
Q Consensus 721 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~ 800 (918)
.++||||+++|+|.+++.... ..+++.+++.++.|++.|++|||+. +++||||||+||+++.++.++++|||.+.
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~--~~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~~l~dfg~~~ 155 (266)
T cd05064 81 MMIVTEYMSNGALDSFLRKHE--GQLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCKISGFRRLQ 155 (266)
T ss_pred cEEEEEeCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcEEECCCcccc
Confidence 999999999999999997642 3589999999999999999999999 99999999999999999999999999876
Q ss_pred ccCCCCCC-ceecccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhhhhhhhhhHhhhhhhcccCCC
Q 044366 801 FLEPHSSN-WTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIK-GYHPGDFVSTIFSSISNMIIEVNQILDHRLP 878 (918)
Q Consensus 801 ~~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 878 (918)
........ .....++..|+|||.+.+..++.++|||||||++||+++ |+.||...... ...... .+....
T Consensus 156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~-----~~~~~~---~~~~~~ 227 (266)
T cd05064 156 EDKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQ-----DVIKAV---EDGFRL 227 (266)
T ss_pred cccccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHH-----HHHHHH---HCCCCC
Confidence 54322111 112234678999999999999999999999999999775 99998654321 011111 111111
Q ss_pred CCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhC
Q 044366 879 TPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLLCK 918 (918)
Q Consensus 879 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~ 918 (918)
+.+. .....+.+++.+||+.+|.+||+++|+.+.|++
T Consensus 228 ~~~~---~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~ 264 (266)
T cd05064 228 PAPR---NCPNLLHQLMLDCWQKERGERPRFSQIHSILSK 264 (266)
T ss_pred CCCC---CCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHh
Confidence 1111 233468889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=342.65 Aligned_cols=260 Identities=24% Similarity=0.374 Sum_probs=202.3
Q ss_pred HHhcCCCCceeeccccceEEEEEEe------CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhc-cCCceeeEeccc
Q 044366 643 KATGNFGEKYCIGKGGQRSVYKAEL------PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEI-RHRNIIKFHGFC 715 (918)
Q Consensus 643 ~~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~ 715 (918)
...++|...+.||+|+||.||+|.. .++..||+|+++.... ......+.+|+++++.+ +||||++++++|
T Consensus 35 ~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~E~~il~~l~~h~nIv~~~~~~ 111 (374)
T cd05106 35 FPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAH---TDEREALMSELKILSHLGQHKNIVNLLGAC 111 (374)
T ss_pred ccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCC---HHHHHHHHHHHHHHHhhccCCceeeEeeEe
Confidence 3445788999999999999999853 2345799999875321 12245788999999999 899999999999
Q ss_pred ccCCceEEEEEeccCCChhHHhhccc------------------------------------------------------
Q 044366 716 SNAQHSFIVCEYLARGSLTTILRDDA------------------------------------------------------ 741 (918)
Q Consensus 716 ~~~~~~~lv~e~~~~gsL~~~l~~~~------------------------------------------------------ 741 (918)
...+..++||||+++|+|.++++...
T Consensus 112 ~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (374)
T cd05106 112 THGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSS 191 (374)
T ss_pred cCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccc
Confidence 99999999999999999999986421
Q ss_pred -------------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccCCCCCC
Q 044366 742 -------------AAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSN 808 (918)
Q Consensus 742 -------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~~~~~~ 808 (918)
...++++.++++++.||+.||+|||+. +|+||||||+||++++++.+||+|||+++........
T Consensus 192 ~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~ 268 (374)
T cd05106 192 SQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNY 268 (374)
T ss_pred cccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeeceeeeeccCCcce
Confidence 112478899999999999999999999 9999999999999999999999999999866433221
Q ss_pred --ceecccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhhhhhhhhhHhhhhhhcccCCCCCCcchH
Q 044366 809 --WTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIK-GYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRDVT 885 (918)
Q Consensus 809 --~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 885 (918)
.....++..|+|||++.+..++.++|||||||++|||++ |+.||........ .. .............
T Consensus 269 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~-~~-------~~~~~~~~~~~~~-- 338 (374)
T cd05106 269 VVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSK-FY-------KMVKRGYQMSRPD-- 338 (374)
T ss_pred eeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHH-HH-------HHHHcccCccCCC--
Confidence 112234568999999998899999999999999999997 9999864322110 00 1111111110000
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhC
Q 044366 886 DKLRSIMEVAILCLVENPEARPTMKEVCNLLCK 918 (918)
Q Consensus 886 ~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~ 918 (918)
....++.+++.+||+.||++|||+.++++.|++
T Consensus 339 ~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~ 371 (374)
T cd05106 339 FAPPEIYSIMKMCWNLEPTERPTFSQISQLIQR 371 (374)
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 112568889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=310.85 Aligned_cols=264 Identities=22% Similarity=0.326 Sum_probs=205.3
Q ss_pred hcCCCCceeeccccceEEEEEE-eCCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCc-eeeEecccccCC---
Q 044366 645 TGNFGEKYCIGKGGQRSVYKAE-LPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRN-IIKFHGFCSNAQ--- 719 (918)
Q Consensus 645 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~~~~~~~~~~--- 719 (918)
...|...++||+|+||+||+|+ ..+|+.||+|+++.+... +.......+|+.+++.++|+| ||++++++...+
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~--EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~ 87 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEE--EGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHR 87 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccc--cCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccc
Confidence 3456666779999999999995 458999999999875322 234567799999999999999 999999997766
Q ss_pred ---ceEEEEEeccCCChhHHhhccccc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEec
Q 044366 720 ---HSFIVCEYLARGSLTTILRDDAAA-KEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSD 795 (918)
Q Consensus 720 ---~~~lv~e~~~~gsL~~~l~~~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~D 795 (918)
..++|+||++. +|.+++...... ..++...+..+..||++|++|||++ +|+||||||+||+++++|.+||+|
T Consensus 88 ~~~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~lKlaD 163 (323)
T KOG0594|consen 88 GIGKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSGVLKLAD 163 (323)
T ss_pred ccceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCCcEeeec
Confidence 78899999986 999999876532 3467788999999999999999999 999999999999999999999999
Q ss_pred cccccccCCCCCCceecccccccccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhh------
Q 044366 796 FGFAKFLEPHSSNWTEFAGTVGYAAPELAYTM-RATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIE------ 868 (918)
Q Consensus 796 fG~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~------ 868 (918)
||+|+...-+....+..++|..|.|||++.+. .|+...||||+||+++||++++.-|....+. +........
T Consensus 164 FGlAra~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~-~ql~~If~~lGtP~e 242 (323)
T KOG0594|consen 164 FGLARAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEI-DQLFRIFRLLGTPNE 242 (323)
T ss_pred cchHHHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHH-HHHHHHHHHcCCCCc
Confidence 99999877555556778899999999999887 6899999999999999999988876654431 111111000
Q ss_pred -----hhhhcccC--CCCC--CcchHHH----HHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 044366 869 -----VNQILDHR--LPTP--SRDVTDK----LRSIMEVAILCLVENPEARPTMKEVCNL 915 (918)
Q Consensus 869 -----~~~~~~~~--~~~~--~~~~~~~----~~~l~~li~~cl~~dp~~RPt~~evl~~ 915 (918)
.....+.+ ++.. ....... .....+++.+|++++|++|.|++.++..
T Consensus 243 ~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 243 KDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred cCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 00000111 0000 1111111 1367899999999999999999998863
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=329.58 Aligned_cols=259 Identities=19% Similarity=0.283 Sum_probs=199.2
Q ss_pred cCCCCceeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEEE
Q 044366 646 GNFGEKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFIV 724 (918)
Q Consensus 646 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 724 (918)
++|...+.||+|+||.||+|.. .+++.||+|+++... .......+.+|+++++.++||||+++++++..++..++|
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 81 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEH---EEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLV 81 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccc---cCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEE
Confidence 5688899999999999999955 478999999986532 222345678999999999999999999999999999999
Q ss_pred EEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccCC
Q 044366 725 CEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEP 804 (918)
Q Consensus 725 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~~ 804 (918)
|||+++ +|.+++.... ..+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 82 ~e~~~~-~l~~~l~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~ 155 (288)
T cd07871 82 FEYLDS-DLKQYLDNCG--NLMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLARAKSV 155 (288)
T ss_pred EeCCCc-CHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEECcCcceeeccC
Confidence 999985 9999886542 3478899999999999999999999 999999999999999999999999999986544
Q ss_pred CCCCceeccccccccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhh--------------
Q 044366 805 HSSNWTEFAGTVGYAAPELAYT-MRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEV-------------- 869 (918)
Q Consensus 805 ~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~-------------- 869 (918)
.........+++.|+|||++.+ ..++.++||||+||++|||++|+.||...... ..........
T Consensus 156 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 234 (288)
T cd07871 156 PTKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVK-EELHLIFRLLGTPTEETWPGITSN 234 (288)
T ss_pred CCccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhCCCChHHhhccccc
Confidence 3333344568999999998865 56889999999999999999999998643221 1111000000
Q ss_pred ---hhhcccCCCCCC--cchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 870 ---NQILDHRLPTPS--RDVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 870 ---~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
.....+...... ........+..+++.+|++.||.+|||++|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 235 EEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred hhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 000000000000 000011246789999999999999999999975
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=339.37 Aligned_cols=255 Identities=20% Similarity=0.283 Sum_probs=204.1
Q ss_pred cCCCCceeeccccceEEEEEEeC-CCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEEE
Q 044366 646 GNFGEKYCIGKGGQRSVYKAELP-SGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFIV 724 (918)
Q Consensus 646 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 724 (918)
++|.+.+.||+|+||.||+|... +|+.||+|+++..... .......+..|+++++.++||||+++++++.+++..++|
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv 79 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLF-KLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLA 79 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHh-hhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEE
Confidence 46888999999999999999654 6899999998764322 122356788999999999999999999999999999999
Q ss_pred EEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccCC
Q 044366 725 CEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEP 804 (918)
Q Consensus 725 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~~ 804 (918)
|||+++|+|.+++.... .+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.....
T Consensus 80 ~e~~~g~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~ 153 (333)
T cd05600 80 MEYVPGGDFRTLLNNLG---VLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT 153 (333)
T ss_pred EeCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEEEeCcCCccccc
Confidence 99999999999997543 488999999999999999999999 999999999999999999999999999986543
Q ss_pred CCCCceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCCCCCcch
Q 044366 805 HSSNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRDV 884 (918)
Q Consensus 805 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 884 (918)
......|++.|+|||++.+..++.++|||||||++|||++|+.||...... ..... ......... .+......
T Consensus 154 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~-~~~~~-i~~~~~~~~--~~~~~~~~ 226 (333)
T cd05600 154 ---YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPN-ETWEN-LKYWKETLQ--RPVYDDPR 226 (333)
T ss_pred ---ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHH-HHHHH-HHhcccccc--CCCCCccc
Confidence 223457899999999999989999999999999999999999998654321 11111 111111111 11111001
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 885 TDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 885 ~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
.....++.+++.+|+..+|.+||++.|+++
T Consensus 227 ~~~s~~~~~li~~~l~~~~~rr~s~~~ll~ 256 (333)
T cd05600 227 FNLSDEAWDLITKLINDPSRRFGSLEDIKN 256 (333)
T ss_pred cccCHHHHHHHHHHhhChhhhcCCHHHHHh
Confidence 123356788999999999999999999985
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=334.54 Aligned_cols=245 Identities=26% Similarity=0.352 Sum_probs=202.5
Q ss_pred HHhcCCCCceeeccccceEEEEEEeC-CCCEEEEEEcccccccCCCCChHHHHHHHHHHhhc-cCCceeeEecccccCCc
Q 044366 643 KATGNFGEKYCIGKGGQRSVYKAELP-SGNIFAVKKFKAELFSDETANPSEFLNEVLALTEI-RHRNIIKFHGFCSNAQH 720 (918)
Q Consensus 643 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~ 720 (918)
...++|...++||+|.||.|+.|..+ +++.+|||++++...-.. .+.+..+.|..++... +||.++.++++++..++
T Consensus 365 ~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~-d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~ 443 (694)
T KOG0694|consen 365 LTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQR-DEVESLMCEKRIFELANRHPFLVNLFSCFQTKEH 443 (694)
T ss_pred ccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceecc-ccHHHHHHHHHHHHHhccCCeEeecccccccCCe
Confidence 34578999999999999999999765 688999999988655433 3367788888887777 69999999999999999
Q ss_pred eEEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEecccccc
Q 044366 721 SFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAK 800 (918)
Q Consensus 721 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~ 800 (918)
.|.||||+.||++..+.+. +.+++..+.-+|..|+.||+|||++ +||+||||.+|||+|.+|.+||+|||+++
T Consensus 444 l~fvmey~~Ggdm~~~~~~----~~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh~kiADFGlcK 516 (694)
T KOG0694|consen 444 LFFVMEYVAGGDLMHHIHT----DVFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGHVKIADFGLCK 516 (694)
T ss_pred EEEEEEecCCCcEEEEEec----ccccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCcEEeccccccc
Confidence 9999999999995555443 4599999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCCceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchh--hhhhhhhhHhhhhhhcccCCC
Q 044366 801 FLEPHSSNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVST--IFSSISNMIIEVNQILDHRLP 878 (918)
Q Consensus 801 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 878 (918)
...-.+...+..+||+.|||||++.+..|+.++|.|||||++|||+.|..||..... .++++. ...+.
T Consensus 517 e~m~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~----------~d~~~ 586 (694)
T KOG0694|consen 517 EGMGQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIV----------NDEVR 586 (694)
T ss_pred ccCCCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHh----------cCCCC
Confidence 765445566778999999999999999999999999999999999999999864432 222221 11111
Q ss_pred CCCcchHHHHHHHHHHHHHcccCCCCCCCCH
Q 044366 879 TPSRDVTDKLRSIMEVAILCLVENPEARPTM 909 (918)
Q Consensus 879 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~ 909 (918)
.+ .. ...+.+.++.+++..+|++|.-+
T Consensus 587 yP-~~---ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 587 YP-RF---LSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred CC-Cc---ccHHHHHHHHHHhccCcccccCC
Confidence 11 11 23457788889999999999865
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=337.62 Aligned_cols=248 Identities=25% Similarity=0.332 Sum_probs=201.9
Q ss_pred hcCCCCceeeccccceEEEEEEeC-CCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEE
Q 044366 645 TGNFGEKYCIGKGGQRSVYKAELP-SGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFI 723 (918)
Q Consensus 645 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 723 (918)
.++|.+.+.||+|+||.||+|+.. +|+.||+|+++..... .....+.+.+|+++++.++||||+++++++.+++..++
T Consensus 17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 95 (329)
T PTZ00263 17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREIL-KMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYF 95 (329)
T ss_pred chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHh-hhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEE
Confidence 367888999999999999999654 6899999998754222 22335678999999999999999999999999999999
Q ss_pred EEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccC
Q 044366 724 VCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLE 803 (918)
Q Consensus 724 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~ 803 (918)
||||+++|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++....
T Consensus 96 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~ 169 (329)
T PTZ00263 96 LLEFVVGGELFTHLRKAG---RFPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVP 169 (329)
T ss_pred EEcCCCCChHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEEEeeccCceEcC
Confidence 999999999999997643 478999999999999999999999 99999999999999999999999999998764
Q ss_pred CCCCCceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCCCCCcc
Q 044366 804 PHSSNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRD 883 (918)
Q Consensus 804 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 883 (918)
... ....|++.|+|||++.+..++.++|||||||++|||++|+.||...... . ....+.......+ ..
T Consensus 170 ~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~-~-------~~~~i~~~~~~~p-~~ 237 (329)
T PTZ00263 170 DRT---FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPF-R-------IYEKILAGRLKFP-NW 237 (329)
T ss_pred CCc---ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHH-H-------HHHHHhcCCcCCC-CC
Confidence 322 2356899999999999988999999999999999999999998643321 0 0111112222211 11
Q ss_pred hHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 044366 884 VTDKLRSIMEVAILCLVENPEARPT-----MKEVCN 914 (918)
Q Consensus 884 ~~~~~~~l~~li~~cl~~dp~~RPt-----~~evl~ 914 (918)
. ...+.+++.+||+.||.+||+ +++++.
T Consensus 238 ~---~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 270 (329)
T PTZ00263 238 F---DGRARDLVKGLLQTDHTKRLGTLKGGVADVKN 270 (329)
T ss_pred C---CHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 1 235778999999999999997 677663
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=298.71 Aligned_cols=256 Identities=25% Similarity=0.410 Sum_probs=215.2
Q ss_pred HhcCCCCceeeccccceEEEEE-EeCCCCEEEEEEcccccccCCCCCh----HHHHHHHHHHhhc-cCCceeeEeccccc
Q 044366 644 ATGNFGEKYCIGKGGQRSVYKA-ELPSGNIFAVKKFKAELFSDETANP----SEFLNEVLALTEI-RHRNIIKFHGFCSN 717 (918)
Q Consensus 644 ~~~~~~~~~~lg~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~----~~~~~e~~~l~~l-~h~niv~~~~~~~~ 717 (918)
.-..|...+.+|.|..++|.++ ..++|..+|+|++.........+.. ++-.+|+.+++++ .||+|+.+.++++.
T Consensus 15 fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes 94 (411)
T KOG0599|consen 15 FYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYES 94 (411)
T ss_pred HHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccC
Confidence 3456788889999999999988 4568999999998765443333332 3456789999998 79999999999999
Q ss_pred CCceEEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccc
Q 044366 718 AQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFG 797 (918)
Q Consensus 718 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG 797 (918)
+...++|+|.|+.|.|.+++.... .+++++.++|..|+.+|++|||.. .|||||+||+||+++++.++||+|||
T Consensus 95 ~sF~FlVFdl~prGELFDyLts~V---tlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILlddn~~i~isDFG 168 (411)
T KOG0599|consen 95 DAFVFLVFDLMPRGELFDYLTSKV---TLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILLDDNMNIKISDFG 168 (411)
T ss_pred cchhhhhhhhcccchHHHHhhhhe---eecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheeeccccceEEeccc
Confidence 999999999999999999998754 389999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCCceeccccccccccccccc------CCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhh
Q 044366 798 FAKFLEPHSSNWTEFAGTVGYAAPELAYT------MRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQ 871 (918)
Q Consensus 798 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~------~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 871 (918)
+|+.+.+ +......+|||+|+|||.+.. ..|+..+|+|++||++|.++.|.+||....+ ...+.-
T Consensus 169 Fa~~l~~-GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQ--------mlMLR~ 239 (411)
T KOG0599|consen 169 FACQLEP-GEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQ--------MLMLRM 239 (411)
T ss_pred eeeccCC-chhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHH--------HHHHHH
Confidence 9998875 444567899999999998864 3578899999999999999999999753322 223334
Q ss_pred hcccCCCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 872 ILDHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 872 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
+..+.....++.+.+......++|.+|++.||.+|-|++|+++
T Consensus 240 ImeGkyqF~speWadis~~~KdLIsrlLqVdp~~Ritake~La 282 (411)
T KOG0599|consen 240 IMEGKYQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALA 282 (411)
T ss_pred HHhcccccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence 4555555566677788888999999999999999999999875
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=338.22 Aligned_cols=244 Identities=23% Similarity=0.289 Sum_probs=196.9
Q ss_pred eeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEEEEEeccC
Q 044366 652 YCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFIVCEYLAR 730 (918)
Q Consensus 652 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 730 (918)
+.||+|+||.||+|+. .+|+.||+|+++..... .......+.+|+++++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~ 79 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVII-AKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANG 79 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhh-hhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCC
Confidence 3699999999999954 57999999998764322 222356778899999999999999999999999999999999999
Q ss_pred CChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccCCCCCCce
Q 044366 731 GSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWT 810 (918)
Q Consensus 731 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~~~~~~~~ 810 (918)
|+|.+++.... .+++..++.++.||+.||+|||+. +|+||||||+||+++.++.+||+|||++...........
T Consensus 80 ~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~ 153 (323)
T cd05595 80 GELFFHLSRER---VFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMK 153 (323)
T ss_pred CcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccHHhccccCCCCccc
Confidence 99999887543 489999999999999999999999 999999999999999999999999999876543333334
Q ss_pred ecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCCCCCcchHHHHHH
Q 044366 811 EFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRDVTDKLRS 890 (918)
Q Consensus 811 ~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 890 (918)
...|++.|+|||++.+..++.++|||||||++|||++|+.||...... .. ........... +.. ....
T Consensus 154 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~-----~~---~~~~~~~~~~~-p~~---~~~~ 221 (323)
T cd05595 154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-----RL---FELILMEEIRF-PRT---LSPE 221 (323)
T ss_pred cccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHH-----HH---HHHHhcCCCCC-CCC---CCHH
Confidence 567899999999999989999999999999999999999998643221 00 01111111111 111 2245
Q ss_pred HHHHHHHcccCCCCCCC-----CHHHHHH
Q 044366 891 IMEVAILCLVENPEARP-----TMKEVCN 914 (918)
Q Consensus 891 l~~li~~cl~~dp~~RP-----t~~evl~ 914 (918)
+.+++.+||+.||++|| ++.++++
T Consensus 222 ~~~li~~~L~~dP~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 222 AKSLLAGLLKKDPKQRLGGGPSDAKEVME 250 (323)
T ss_pred HHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence 77899999999999998 8888764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=337.66 Aligned_cols=244 Identities=25% Similarity=0.312 Sum_probs=197.4
Q ss_pred eeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEEEEEeccC
Q 044366 652 YCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFIVCEYLAR 730 (918)
Q Consensus 652 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 730 (918)
+.||+|+||.||+|+. .+|+.||+|++...... .......+.+|+++++.++||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~ 79 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVII-AKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNG 79 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCC
Confidence 3699999999999954 57999999998764322 223356788999999999999999999999999999999999999
Q ss_pred CChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccCCCCCCce
Q 044366 731 GSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWT 810 (918)
Q Consensus 731 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~~~~~~~~ 810 (918)
|+|.+++... ..+++.++..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++..........
T Consensus 80 g~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~ 153 (328)
T cd05593 80 GELFFHLSRE---RVFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMK 153 (328)
T ss_pred CCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCcCCccCCCcccccc
Confidence 9999988654 3489999999999999999999999 999999999999999999999999999976543333334
Q ss_pred ecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCCCCCcchHHHHHH
Q 044366 811 EFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRDVTDKLRS 890 (918)
Q Consensus 811 ~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 890 (918)
...|++.|+|||++.+..++.++|||||||++|||++|+.||...... .. ...+....... +.. ....
T Consensus 154 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~-----~~---~~~~~~~~~~~-p~~---~~~~ 221 (328)
T cd05593 154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-----KL---FELILMEDIKF-PRT---LSAD 221 (328)
T ss_pred cccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHH-----HH---HHHhccCCccC-CCC---CCHH
Confidence 567899999999999889999999999999999999999998643221 00 01111111111 111 2245
Q ss_pred HHHHHHHcccCCCCCCC-----CHHHHHH
Q 044366 891 IMEVAILCLVENPEARP-----TMKEVCN 914 (918)
Q Consensus 891 l~~li~~cl~~dp~~RP-----t~~evl~ 914 (918)
+.+++.+|++.||++|| ++.|+++
T Consensus 222 ~~~li~~~L~~dP~~R~~~~~~~~~~il~ 250 (328)
T cd05593 222 AKSLLSGLLIKDPNKRLGGGPDDAKEIMR 250 (328)
T ss_pred HHHHHHHHcCCCHHHcCCCCCCCHHHHhc
Confidence 78889999999999997 8998875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=346.35 Aligned_cols=254 Identities=21% Similarity=0.337 Sum_probs=206.5
Q ss_pred HhcCCCCceeeccccceEEEEEEeCCC-CEEEEEEcccccccCCCCChHHHHHHHHHHhhcc-CCceeeEecc-cc---c
Q 044366 644 ATGNFGEKYCIGKGGQRSVYKAELPSG-NIFAVKKFKAELFSDETANPSEFLNEVLALTEIR-HRNIIKFHGF-CS---N 717 (918)
Q Consensus 644 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~-~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~-~~---~ 717 (918)
...++++.++|.+|||+.||.|+...+ ..||+|++-.. ++.......+|+++|+.++ |||||.+++. .. .
T Consensus 35 g~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~----de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~ 110 (738)
T KOG1989|consen 35 GSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN----DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSS 110 (738)
T ss_pred CCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC----CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccC
Confidence 445677889999999999999966554 99999997542 4555788999999999996 9999999993 21 1
Q ss_pred ---CCceEEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEe
Q 044366 718 ---AQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVS 794 (918)
Q Consensus 718 ---~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~ 794 (918)
.-+++|.||||.+|.|-+++..+.. .+|++.++++|+.++++|+++||.. .|+|||||||.+|||++.++..|||
T Consensus 111 ~~~~~EvllLmEyC~gg~Lvd~mn~Rlq-~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLC 188 (738)
T KOG1989|consen 111 NNGVWEVLLLMEYCKGGSLVDFMNTRLQ-TRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLC 188 (738)
T ss_pred CCceeEEEeehhhccCCcHHHHHHHHHh-ccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeC
Confidence 1357899999999999999987653 3399999999999999999999986 6689999999999999999999999
Q ss_pred ccccccccCCCCCCc---------eeccccccccccccc---ccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhh
Q 044366 795 DFGFAKFLEPHSSNW---------TEFAGTVGYAAPELA---YTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSI 862 (918)
Q Consensus 795 DfG~~~~~~~~~~~~---------~~~~g~~~y~aPE~~---~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~ 862 (918)
|||.|.-........ -...-|+.|+|||++ .+...++|+|||++||+||-++....||+..+..
T Consensus 189 DFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~l---- 264 (738)
T KOG1989|consen 189 DFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKL---- 264 (738)
T ss_pred cccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcce----
Confidence 999997543222111 012458999999987 4667899999999999999999999999865432
Q ss_pred hhhHhhhhhhcccCCCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 044366 863 SNMIIEVNQILDHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLLC 917 (918)
Q Consensus 863 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 917 (918)
.++...+..+. .+.+...+.+||+.||+.||.+||++-||+..+.
T Consensus 265 --------aIlng~Y~~P~--~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~ 309 (738)
T KOG1989|consen 265 --------AILNGNYSFPP--FPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIF 309 (738)
T ss_pred --------eEEeccccCCC--CccHHHHHHHHHHHHhccCcccCCCHHHHHHHHH
Confidence 34444443332 2456678999999999999999999999998874
|
|
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=320.72 Aligned_cols=251 Identities=24% Similarity=0.383 Sum_probs=202.7
Q ss_pred cCCCCceeeccccceEEEEEEeCCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEEEE
Q 044366 646 GNFGEKYCIGKGGQRSVYKAELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFIVC 725 (918)
Q Consensus 646 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 725 (918)
.+|+..+.||+|+||.||+|+..++..+|+|.+... ....++|.+|+++++.++||||+++++++.+++..++||
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~-----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~ 78 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEG-----AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVT 78 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccC-----CccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEE
Confidence 457788899999999999998888889999987542 233568999999999999999999999999999999999
Q ss_pred EeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccCCC
Q 044366 726 EYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPH 805 (918)
Q Consensus 726 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~~~ 805 (918)
||+++|+|.++++... ..+++..++.++.|++.||+|||+. +++||||||+||++++++.+|++|||.++.....
T Consensus 79 e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~ 153 (256)
T cd05114 79 EFMENGCLLNYLRQRQ--GKLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDD 153 (256)
T ss_pred EcCCCCcHHHHHHhCc--cCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEECCCCCccccCCC
Confidence 9999999999987543 3489999999999999999999999 9999999999999999999999999999865432
Q ss_pred CCC-ceecccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhhhhhhhhhHhhhhhhcccCCCCCCcc
Q 044366 806 SSN-WTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIK-GYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRD 883 (918)
Q Consensus 806 ~~~-~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 883 (918)
... .....++..|+|||++.+..++.++||||||+++|||++ |+.||...... .. .. .+.....+..+..
T Consensus 154 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~-~~----~~---~i~~~~~~~~~~~ 225 (256)
T cd05114 154 EYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNY-EV----VE---MISRGFRLYRPKL 225 (256)
T ss_pred ceeccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHH-HH----HH---HHHCCCCCCCCCC
Confidence 221 122335678999999988889999999999999999999 89997644321 01 11 1111111111111
Q ss_pred hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 044366 884 VTDKLRSIMEVAILCLVENPEARPTMKEVCNLLC 917 (918)
Q Consensus 884 ~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 917 (918)
....+.+++.+||+.+|++||+++++++.|+
T Consensus 226 ---~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~ 256 (256)
T cd05114 226 ---ASMTVYEVMYSCWHEKPEGRPTFAELLRAIT 256 (256)
T ss_pred ---CCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 1246789999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=333.68 Aligned_cols=259 Identities=25% Similarity=0.331 Sum_probs=202.8
Q ss_pred hcCCCCceeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEE
Q 044366 645 TGNFGEKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFI 723 (918)
Q Consensus 645 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 723 (918)
.++|+..+.||+|+||.||+|+. .+|..||+|.+.... .....+.+.+|++++++++||||+++++++..++..++
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI---KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI 80 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc---CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 46789999999999999999965 478899999987532 12234679999999999999999999999999999999
Q ss_pred EEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccC
Q 044366 724 VCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLE 803 (918)
Q Consensus 724 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~ 803 (918)
||||+++|+|.+++.... .+++..+..++.|++.|++|||+.. +|+||||||+||+++.++.+||+|||++....
T Consensus 81 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 155 (331)
T cd06649 81 CMEHMDGGSLDQVLKEAK---RIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 155 (331)
T ss_pred EeecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCccccccc
Confidence 999999999999997643 4889999999999999999999852 69999999999999999999999999998664
Q ss_pred CCCCCceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhh--hhhhhhhHh--------------
Q 044366 804 PHSSNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTI--FSSISNMII-------------- 867 (918)
Q Consensus 804 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~--~~~~~~~~~-------------- 867 (918)
.. ......|+..|+|||++.+..++.++|||||||++|||++|+.||...... .........
T Consensus 156 ~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (331)
T cd06649 156 DS--MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRP 233 (331)
T ss_pred cc--ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCccc
Confidence 32 223456899999999999989999999999999999999999998643211 000000000
Q ss_pred ----------------------hhhhhcccCCCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 044366 868 ----------------------EVNQILDHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNL 915 (918)
Q Consensus 868 ----------------------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 915 (918)
....+.....+... ......++.+++.+||+.||++|||++|+++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h 301 (331)
T cd06649 234 RPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLP--NGVFTPDFQEFVNKCLIKNPAERADLKMLMNH 301 (331)
T ss_pred ccccccccccccccccchhHHHHHHHHHhCCCcCCC--CccccHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 00000000000000 01133568899999999999999999999863
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=337.13 Aligned_cols=245 Identities=24% Similarity=0.363 Sum_probs=198.1
Q ss_pred eeeccccceEEEEEEe----CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEEEEEe
Q 044366 652 YCIGKGGQRSVYKAEL----PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFIVCEY 727 (918)
Q Consensus 652 ~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 727 (918)
+.||+|+||.||+++. .+++.||+|+++.............+..|+++++.++||||+++++++..++..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 5799999999999964 367899999987643333333456788999999999999999999999999999999999
Q ss_pred ccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccCCCCC
Q 044366 728 LARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSS 807 (918)
Q Consensus 728 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~~~~~ 807 (918)
+++|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.......
T Consensus 82 ~~~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 155 (323)
T cd05584 82 LSGGELFMHLEREG---IFMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT 155 (323)
T ss_pred CCCchHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC
Confidence 99999999997643 478889999999999999999999 999999999999999999999999999976544333
Q ss_pred CceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCCCCCcchHHH
Q 044366 808 NWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRDVTDK 887 (918)
Q Consensus 808 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 887 (918)
......|++.|+|||++.+..++.++|||||||++|||++|+.||...... .....+.......+ .. .
T Consensus 156 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~--------~~~~~~~~~~~~~~-~~---~ 223 (323)
T cd05584 156 VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRK--------KTIDKILKGKLNLP-PY---L 223 (323)
T ss_pred cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHH--------HHHHHHHcCCCCCC-CC---C
Confidence 334457899999999999888999999999999999999999998654321 01111222222111 11 1
Q ss_pred HHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 044366 888 LRSIMEVAILCLVENPEARP-----TMKEVCN 914 (918)
Q Consensus 888 ~~~l~~li~~cl~~dp~~RP-----t~~evl~ 914 (918)
...+.+++.+|++.||++|| ++.++++
T Consensus 224 ~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 224 TPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred CHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence 24578899999999999999 7888765
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=310.11 Aligned_cols=262 Identities=22% Similarity=0.351 Sum_probs=202.9
Q ss_pred HhcCCCCceeeccccceEEEEE-EeCCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEeccccc-----
Q 044366 644 ATGNFGEKYCIGKGGQRSVYKA-ELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSN----- 717 (918)
Q Consensus 644 ~~~~~~~~~~lg~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~----- 717 (918)
....|...+.||+|+||.|+.| ...+|+.||||++.... ......++..+|+.+++.++|+||+.+.+++..
T Consensus 20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F--~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~ 97 (359)
T KOG0660|consen 20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPF--ENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDK 97 (359)
T ss_pred ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhh--hchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccc
Confidence 3455666788999999999999 55689999999987532 233446788999999999999999999998754
Q ss_pred CCceEEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccc
Q 044366 718 AQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFG 797 (918)
Q Consensus 718 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG 797 (918)
-+..|+|+|+|+ .+|.+.++... .++.+.+.-+.+|+++||.|+|+. +|+|||+||+|++++.+...||+|||
T Consensus 98 f~DvYiV~elMe-tDL~~iik~~~---~L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~c~lKI~DFG 170 (359)
T KOG0660|consen 98 FNDVYLVFELME-TDLHQIIKSQQ---DLTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNADCDLKICDFG 170 (359)
T ss_pred cceeEEehhHHh-hHHHHHHHcCc---cccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccCCCEEecccc
Confidence 357899999995 49999998753 389999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCC--CCCceecccccccccccccc-cCCCCcccchhhHHHHHHHHHhCCCCCCcchhhh--hhhhh--------
Q 044366 798 FAKFLEPH--SSNWTEFAGTVGYAAPELAY-TMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIF--SSISN-------- 864 (918)
Q Consensus 798 ~~~~~~~~--~~~~~~~~g~~~y~aPE~~~-~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~--~~~~~-------- 864 (918)
+|+...+. ...++..+.|..|.|||.+. ...|+.+.||||.||++.||++|++-|....... ..+..
T Consensus 171 LAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e 250 (359)
T KOG0660|consen 171 LARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEE 250 (359)
T ss_pred ceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHH
Confidence 99988642 34457778899999999764 5679999999999999999999998765433210 00000
Q ss_pred ----hH-hhhhhhcccCCCCCCcc----hHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 865 ----MI-IEVNQILDHRLPTPSRD----VTDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 865 ----~~-~~~~~~~~~~~~~~~~~----~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
.. ......+...+..+... .+...+..++++.+|+..||.+|+|++|.++
T Consensus 251 ~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~ 309 (359)
T KOG0660|consen 251 DLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALA 309 (359)
T ss_pred HHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhc
Confidence 00 00111111111111111 2223356889999999999999999999875
|
|
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-39 Score=310.74 Aligned_cols=248 Identities=26% Similarity=0.421 Sum_probs=212.8
Q ss_pred CCCCceeeccccceEEEEEE-eCCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEEEE
Q 044366 647 NFGEKYCIGKGGQRSVYKAE-LPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFIVC 725 (918)
Q Consensus 647 ~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 725 (918)
-|.+..++|+|+||+||+|. ..+|+.+|||++..+ .+..++..|+.++.+.+.|+||++||.+.....+|+||
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~------sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVM 107 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD------TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVM 107 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc------chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeeh
Confidence 46677789999999999994 457999999998653 34788999999999999999999999999999999999
Q ss_pred EeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccCCC
Q 044366 726 EYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPH 805 (918)
Q Consensus 726 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~~~ 805 (918)
|||..|+..+.++.+ ..+++++++..+.+.-+.||+|||.. .=+|||||+-||+++-+|.+|++|||.|..+.+.
T Consensus 108 EYCGAGSiSDI~R~R--~K~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDT 182 (502)
T KOG0574|consen 108 EYCGAGSISDIMRAR--RKPLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDT 182 (502)
T ss_pred hhcCCCcHHHHHHHh--cCCccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccccchhhhh
Confidence 999999999999865 35699999999999999999999998 8899999999999999999999999999988877
Q ss_pred CCCceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCCCCCcchH
Q 044366 806 SSNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRDVT 885 (918)
Q Consensus 806 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 885 (918)
........||+.|||||++..-.|..++||||+|++..||..|++|+....+... --++...+|+.-....
T Consensus 183 MAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRA---------IFMIPT~PPPTF~KPE 253 (502)
T KOG0574|consen 183 MAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRA---------IFMIPTKPPPTFKKPE 253 (502)
T ss_pred HHhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccce---------eEeccCCCCCCCCChH
Confidence 7777778999999999999999999999999999999999999999764432100 0112223333333444
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 886 DKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 886 ~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
....++.++++.|+.+.|++|-|+.++++
T Consensus 254 ~WS~~F~DFi~~CLiK~PE~R~TA~~L~~ 282 (502)
T KOG0574|consen 254 EWSSEFNDFIRSCLIKKPEERKTALRLCE 282 (502)
T ss_pred hhhhHHHHHHHHHhcCCHHHHHHHHHHhh
Confidence 56678999999999999999999999875
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-38 Score=315.08 Aligned_cols=256 Identities=23% Similarity=0.284 Sum_probs=194.0
Q ss_pred cCCCCceeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccC---C--
Q 044366 646 GNFGEKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNA---Q-- 719 (918)
Q Consensus 646 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~---~-- 719 (918)
-.|...+++|.|+||.||+|.. .+++.||||++..+.. .-.+|+++|+.+.|||||++.-++... +
T Consensus 24 i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r--------~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~ 95 (364)
T KOG0658|consen 24 ISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR--------YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEV 95 (364)
T ss_pred EEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC--------cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchh
Confidence 4567788999999999999955 4579999999765321 225899999999999999999877322 2
Q ss_pred ceEEEEEeccCCChhHHhhcc-cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCC-CcEEEeccc
Q 044366 720 HSFIVCEYLARGSLTTILRDD-AAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSE-YEAHVSDFG 797 (918)
Q Consensus 720 ~~~lv~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~-~~~kl~DfG 797 (918)
...+|||||+. +|.++++.. ...++++.-.+.-+..||.+|++|||+. +|+||||||+|+|+|.+ |.+||||||
T Consensus 96 ~lnlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicDFG 171 (364)
T KOG0658|consen 96 YLNLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICDFG 171 (364)
T ss_pred HHHHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEeccCC
Confidence 44689999987 999999853 1234577788889999999999999998 99999999999999987 899999999
Q ss_pred cccccCCCCCCceecccccccccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhh--hhhH-----hhh
Q 044366 798 FAKFLEPHSSNWTEFAGTVGYAAPELAYTM-RATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSI--SNMI-----IEV 869 (918)
Q Consensus 798 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~--~~~~-----~~~ 869 (918)
.|+.+.+.... .....|..|+|||.+.+. .|+.+.||||.|||+.||+-|++-|.......... .... .++
T Consensus 172 SAK~L~~~epn-iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I 250 (364)
T KOG0658|consen 172 SAKVLVKGEPN-ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDI 250 (364)
T ss_pred cceeeccCCCc-eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 99998776655 445679999999998864 68999999999999999999998876543221111 1100 001
Q ss_pred h-------hhcccCCCCCCc---chHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 870 N-------QILDHRLPTPSR---DVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 870 ~-------~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
. +...+....... .......+.++++.++++++|.+|.++.|++.
T Consensus 251 ~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~ 305 (364)
T KOG0658|consen 251 KSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA 305 (364)
T ss_pred hhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence 0 000111111110 11223467899999999999999999999874
|
|
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=322.93 Aligned_cols=261 Identities=20% Similarity=0.295 Sum_probs=208.1
Q ss_pred cCCCCceeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEEE
Q 044366 646 GNFGEKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFIV 724 (918)
Q Consensus 646 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 724 (918)
++|++.+.||+|+||.||+|.. .+++.||||.++..... .......+.+|+++++.++||||+++++++.+.+..++|
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 80 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMM-DAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIV 80 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccC-CHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEE
Confidence 5788899999999999999965 47899999987653221 222346789999999999999999999999999999999
Q ss_pred EEeccCCChhHHhhccc-ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccC
Q 044366 725 CEYLARGSLTTILRDDA-AAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLE 803 (918)
Q Consensus 725 ~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~ 803 (918)
+||+++|+|.+++.... ....+++.+++.++.|++.||+|||+. +++|+||||+||+++.++.++++|||.+....
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~ 157 (267)
T cd08228 81 LELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFS 157 (267)
T ss_pred EEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEEECccccceecc
Confidence 99999999999886432 234478999999999999999999999 99999999999999999999999999998775
Q ss_pred CCCCCceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCCCCCcc
Q 044366 804 PHSSNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRD 883 (918)
Q Consensus 804 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 883 (918)
..........++..|+|||.+.+..++.++||||||+++|||++|+.|+.......... ..... ....++. .
T Consensus 158 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~---~~~~~---~~~~~~~--~ 229 (267)
T cd08228 158 SKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSL---CQKIE---QCDYPPL--P 229 (267)
T ss_pred chhHHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHH---HHHHh---cCCCCCC--C
Confidence 44333334568889999999988889999999999999999999999975432211111 11111 1111111 1
Q ss_pred hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhC
Q 044366 884 VTDKLRSIMEVAILCLVENPEARPTMKEVCNLLCK 918 (918)
Q Consensus 884 ~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~ 918 (918)
.......+.+++.+||+.+|++||++.+|++.+++
T Consensus 230 ~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~ 264 (267)
T cd08228 230 TEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQ 264 (267)
T ss_pred hhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHH
Confidence 12234568899999999999999999999998863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-37 Score=334.23 Aligned_cols=247 Identities=26% Similarity=0.346 Sum_probs=192.5
Q ss_pred eeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhc-cCCceeeEecccccCCceEEEEEecc
Q 044366 652 YCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEI-RHRNIIKFHGFCSNAQHSFIVCEYLA 729 (918)
Q Consensus 652 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~ 729 (918)
+.||+|+||.||+|.. .+++.||+|+++...... ....+.+..|+.++.++ +||||+++++++..++..++||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~ 79 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVND-DEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVN 79 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcc-hhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCC
Confidence 3699999999999965 468899999997643322 23345678888888776 89999999999999999999999999
Q ss_pred CCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccCCCCCCc
Q 044366 730 RGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNW 809 (918)
Q Consensus 730 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~~~~~~~ 809 (918)
+|+|..++... ..+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.........
T Consensus 80 ~~~L~~~~~~~---~~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~~ 153 (329)
T cd05618 80 GGDLMFHMQRQ---RKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT 153 (329)
T ss_pred CCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCcc
Confidence 99999888654 3489999999999999999999999 99999999999999999999999999997654333333
Q ss_pred eecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhh-hhhhcccCCCCCCcchHHHH
Q 044366 810 TEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIE-VNQILDHRLPTPSRDVTDKL 888 (918)
Q Consensus 810 ~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 888 (918)
....||+.|+|||++.+..++.++|||||||++|||++|+.||................ ...+.......+ .. ..
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p-~~---~~ 229 (329)
T cd05618 154 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIP-RS---LS 229 (329)
T ss_pred ccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCCCC-CC---CC
Confidence 45678999999999999999999999999999999999999986322111000000000 111111111111 11 22
Q ss_pred HHHHHHHHHcccCCCCCCCCH
Q 044366 889 RSIMEVAILCLVENPEARPTM 909 (918)
Q Consensus 889 ~~l~~li~~cl~~dp~~RPt~ 909 (918)
..+.+++.+||+.||++||++
T Consensus 230 ~~~~~ll~~~L~~dP~~R~~~ 250 (329)
T cd05618 230 VKAASVLKSFLNKDPKERLGC 250 (329)
T ss_pred HHHHHHHHHHhcCCHHHcCCC
Confidence 457789999999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-37 Score=334.25 Aligned_cols=252 Identities=24% Similarity=0.338 Sum_probs=196.3
Q ss_pred eeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhc-cCCceeeEecccccCCceEEEEEecc
Q 044366 652 YCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEI-RHRNIIKFHGFCSNAQHSFIVCEYLA 729 (918)
Q Consensus 652 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~ 729 (918)
+.||+|+||.||+|+. .+++.||+|+++..... .....+.+..|..++..+ +||||+++++++.+.+..++||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~-~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~ 79 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVN-DDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVS 79 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCC
Confidence 3699999999999965 47899999999764322 223346688899999888 79999999999999999999999999
Q ss_pred CCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccCCCCCCc
Q 044366 730 RGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNW 809 (918)
Q Consensus 730 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~~~~~~~ 809 (918)
+|+|.+++... ..+++..++.++.|++.||+|||+. +++||||||+||+++.++.+||+|||++..........
T Consensus 80 ~g~L~~~~~~~---~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~ 153 (329)
T cd05588 80 GGDLMFHMQRQ---RKLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTT 153 (329)
T ss_pred CCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCccccccccCCCcc
Confidence 99999988654 3489999999999999999999999 99999999999999999999999999997543333333
Q ss_pred eecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHh-hhhhhcccCCCCCCcchHHHH
Q 044366 810 TEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMII-EVNQILDHRLPTPSRDVTDKL 888 (918)
Q Consensus 810 ~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 888 (918)
....||+.|+|||++.+..++.++|||||||++|||++|+.||+.............. ....+.......+ .. ..
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~p-~~---~~ 229 (329)
T cd05588 154 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIP-RS---LS 229 (329)
T ss_pred ccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCCCC-CC---CC
Confidence 4567899999999999989999999999999999999999998643211100000000 0111111111111 11 12
Q ss_pred HHHHHHHHHcccCCCCCCCC------HHHHHH
Q 044366 889 RSIMEVAILCLVENPEARPT------MKEVCN 914 (918)
Q Consensus 889 ~~l~~li~~cl~~dp~~RPt------~~evl~ 914 (918)
..+.+++.+|++.||.+||+ ++++++
T Consensus 230 ~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05588 230 VKASSVLKGFLNKDPKERLGCHPQTGFRDIKS 261 (329)
T ss_pred HHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence 45788999999999999997 567653
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=327.34 Aligned_cols=261 Identities=23% Similarity=0.311 Sum_probs=201.0
Q ss_pred cCCCCceeeccccceEEEEEEeC-CCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEEE
Q 044366 646 GNFGEKYCIGKGGQRSVYKAELP-SGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFIV 724 (918)
Q Consensus 646 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 724 (918)
++|.+.+.||+|+||.||+|+.. +++.||+|+++.... .....+.+.+|+++++.++||||+++++++..++..++|
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 78 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEE--NEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLV 78 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccc--cccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEE
Confidence 36889999999999999999664 688999999875322 223356788999999999999999999999999999999
Q ss_pred EEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccCC
Q 044366 725 CEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEP 804 (918)
Q Consensus 725 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~~ 804 (918)
|||++++.+..+.+. ...+++..++.++.|++.||+|||+. +++||||||+||+++.++.+||+|||++.....
T Consensus 79 ~e~~~~~~l~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 152 (287)
T cd07848 79 FEYVEKNMLELLEEM---PNGVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSE 152 (287)
T ss_pred EecCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccCcccccc
Confidence 999998777655433 23489999999999999999999999 999999999999999999999999999987643
Q ss_pred CCC-CceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhh--hhhH----hhhhhh-----
Q 044366 805 HSS-NWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSI--SNMI----IEVNQI----- 872 (918)
Q Consensus 805 ~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~--~~~~----~~~~~~----- 872 (918)
... ......|++.|+|||++.+..++.++||||+||++|||++|+.||.......... .... ......
T Consensus 153 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (287)
T cd07848 153 GSNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNP 232 (287)
T ss_pred cccccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccc
Confidence 322 2234568999999999998889999999999999999999999986543211100 0000 000000
Q ss_pred --cccCCCCCC--cc-----hHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 873 --LDHRLPTPS--RD-----VTDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 873 --~~~~~~~~~--~~-----~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
.....+... .. .......+.+++.+|++.||++|||++|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 233 RFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred hhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 000011000 00 0012346899999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-37 Score=326.08 Aligned_cols=249 Identities=22% Similarity=0.279 Sum_probs=196.7
Q ss_pred eccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEEEEEeccCCC
Q 044366 654 IGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFIVCEYLARGS 732 (918)
Q Consensus 654 lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gs 732 (918)
||+|+||.||+|.. .+|+.||+|.+....... ....+.+..|+++++.++||||+++.+++..+...++||||+++|+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~-~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~ 79 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKK-RKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGD 79 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhh-hHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCC
Confidence 69999999999954 578999999986542221 2224567889999999999999999999999999999999999999
Q ss_pred hhHHhhccc-ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccCCCCCCcee
Q 044366 733 LTTILRDDA-AAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTE 811 (918)
Q Consensus 733 L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~ 811 (918)
|.+++.... ....+++..+..++.||+.||+|||+. +|+||||||+||+++.++.++|+|||++..+.........
T Consensus 80 L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~ 156 (280)
T cd05608 80 LRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKG 156 (280)
T ss_pred HHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCccceecCCCCccccc
Confidence 998875432 234589999999999999999999999 9999999999999999999999999999876554443344
Q ss_pred cccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCCCCCcchHHHHHHH
Q 044366 812 FAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRDVTDKLRSI 891 (918)
Q Consensus 812 ~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 891 (918)
..|++.|+|||++.+..++.++||||||+++|||++|+.||......... . ............ ........+
T Consensus 157 ~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~-~---~~~~~~~~~~~~----~~~~~~~~~ 228 (280)
T cd05608 157 YAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVEN-K---ELKQRILNDSVT----YPDKFSPAS 228 (280)
T ss_pred cCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhH-H---HHHHhhcccCCC----CcccCCHHH
Confidence 57899999999999999999999999999999999999998643321100 0 001111111111 111233567
Q ss_pred HHHHHHcccCCCCCCC-----CHHHHHH
Q 044366 892 MEVAILCLVENPEARP-----TMKEVCN 914 (918)
Q Consensus 892 ~~li~~cl~~dp~~RP-----t~~evl~ 914 (918)
.+++.+|++.||++|| +++++++
T Consensus 229 ~~li~~~l~~~P~~R~~~~~~~~~~~l~ 256 (280)
T cd05608 229 KSFCEALLAKDPEKRLGFRDGNCDGLRT 256 (280)
T ss_pred HHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence 8899999999999999 7777764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-37 Score=334.62 Aligned_cols=248 Identities=21% Similarity=0.283 Sum_probs=200.9
Q ss_pred hcCCCCceeeccccceEEEEEEeC-C-CCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceE
Q 044366 645 TGNFGEKYCIGKGGQRSVYKAELP-S-GNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSF 722 (918)
Q Consensus 645 ~~~~~~~~~lg~G~~g~Vy~~~~~-~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 722 (918)
.++|...+.||+|+||.||+|... + +..||+|++...... .....+.+.+|+++++.++||||+++++++.+++..+
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~ 107 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKII-KQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLY 107 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhh-hhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEE
Confidence 356888999999999999999643 3 368999998654322 2233567889999999999999999999999999999
Q ss_pred EEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEecccccccc
Q 044366 723 IVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFL 802 (918)
Q Consensus 723 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~ 802 (918)
+||||+++|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++...
T Consensus 108 lv~Ey~~~g~L~~~i~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~ 181 (340)
T PTZ00426 108 LVLEFVIGGEFFTFLRRNK---RFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDFGFAKVV 181 (340)
T ss_pred EEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEecCCCCeec
Confidence 9999999999999997643 489999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCCCceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCCCCCc
Q 044366 803 EPHSSNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSR 882 (918)
Q Consensus 803 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 882 (918)
... .....||+.|+|||++.+..++.++|||||||++|||++|+.||....... ....+....... +.
T Consensus 182 ~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~--------~~~~i~~~~~~~-p~ 249 (340)
T PTZ00426 182 DTR---TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLL--------IYQKILEGIIYF-PK 249 (340)
T ss_pred CCC---cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHH--------HHHHHhcCCCCC-CC
Confidence 432 234578999999999998889999999999999999999999986543210 011111111111 11
Q ss_pred chHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 044366 883 DVTDKLRSIMEVAILCLVENPEARP-----TMKEVCN 914 (918)
Q Consensus 883 ~~~~~~~~l~~li~~cl~~dp~~RP-----t~~evl~ 914 (918)
.. ...+.+++.+|++.||++|+ +++++++
T Consensus 250 ~~---~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~ 283 (340)
T PTZ00426 250 FL---DNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKE 283 (340)
T ss_pred CC---CHHHHHHHHHHcccCHHHcCCCCCCCHHHHHc
Confidence 11 23467889999999999995 8888865
|
|
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=324.44 Aligned_cols=249 Identities=33% Similarity=0.496 Sum_probs=191.0
Q ss_pred CceeeccccceEEEEEEeC-----CCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEEE
Q 044366 650 EKYCIGKGGQRSVYKAELP-----SGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFIV 724 (918)
Q Consensus 650 ~~~~lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 724 (918)
..+.||.|.||.||+|.+. .+..|+||.++.. ......+.|.+|++.+++++||||++++|++...+..++|
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~---~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv 79 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPS---SSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLV 79 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTT---SSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEE
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccc---cccccceeeeeccccccccccccccccccccccccccccc
Confidence 3568999999999999765 3568999998542 1222367899999999999999999999999988889999
Q ss_pred EEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccCC
Q 044366 725 CEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEP 804 (918)
Q Consensus 725 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~~ 804 (918)
|||+++|+|.++++... ...+++.++++|+.|||+||+|||+. +++|+||+++||++++++.+||+|||++.....
T Consensus 80 ~e~~~~g~L~~~L~~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~ 155 (259)
T PF07714_consen 80 MEYCPGGSLDDYLKSKN-KEPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSDFGLSRPISE 155 (259)
T ss_dssp EE--TTEBHHHHHHHTC-TTTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEESTTTGEETTT
T ss_pred ccccccccccccccccc-cccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccc
Confidence 99999999999998762 34589999999999999999999999 999999999999999999999999999987732
Q ss_pred CCCC--ceecccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhhhhhhhhhHhhhhhhcccCCCCCC
Q 044366 805 HSSN--WTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIK-GYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPS 881 (918)
Q Consensus 805 ~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 881 (918)
.... .........|+|||.+.+..++.++||||||+++|||++ |+.|+..... ..... .+.+.......
T Consensus 156 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~-~~~~~-------~~~~~~~~~~~ 227 (259)
T PF07714_consen 156 KSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDN-EEIIE-------KLKQGQRLPIP 227 (259)
T ss_dssp SSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCH-HHHHH-------HHHTTEETTSB
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccc-ccccc-------cccccccceec
Confidence 2221 122346789999999999889999999999999999999 6788654422 11111 11111111111
Q ss_pred cchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 044366 882 RDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLL 916 (918)
Q Consensus 882 ~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L 916 (918)
.. ....+.+++..||+.||++|||+.++++.|
T Consensus 228 ~~---~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 228 DN---CPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp TT---SBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred cc---hhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 11 224578899999999999999999999986
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=336.84 Aligned_cols=248 Identities=24% Similarity=0.379 Sum_probs=193.0
Q ss_pred cCCCCceeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEEE
Q 044366 646 GNFGEKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFIV 724 (918)
Q Consensus 646 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 724 (918)
.+|+..+.||+|+||.||+|.. .+|+.||||++... ......+.+.+|+++++.++|+||+++++++...+..++|
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 150 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGN---HEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVL 150 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecC---CcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEE
Confidence 3455667899999999999965 47899999998542 1222346789999999999999999999999999999999
Q ss_pred EEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccCC
Q 044366 725 CEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEP 804 (918)
Q Consensus 725 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~~ 804 (918)
|||+++|+|.+.. ..++..+..++.||+.||+|||+. +|+||||||+||++++++.+||+|||+++.+..
T Consensus 151 ~e~~~~~~L~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~ 220 (353)
T PLN00034 151 LEFMDGGSLEGTH-------IADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQ 220 (353)
T ss_pred EecCCCCcccccc-------cCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEcccccceeccc
Confidence 9999999986532 246778889999999999999999 999999999999999999999999999987654
Q ss_pred CCCCceeccccccccccccccc-----CCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCCC
Q 044366 805 HSSNWTEFAGTVGYAAPELAYT-----MRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPT 879 (918)
Q Consensus 805 ~~~~~~~~~g~~~y~aPE~~~~-----~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 879 (918)
.........|+..|+|||++.. ...+.++|||||||++|||++|+.||...... ...... ........+.
T Consensus 221 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~--~~~~~~---~~~~~~~~~~ 295 (353)
T PLN00034 221 TMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQG--DWASLM---CAICMSQPPE 295 (353)
T ss_pred ccccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCc--cHHHHH---HHHhccCCCC
Confidence 4333345678999999998743 23356899999999999999999998632210 111110 1111111111
Q ss_pred CCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 880 PSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 880 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
.. .....++.+++.+||+.||++|||+.|+++
T Consensus 296 ~~---~~~~~~l~~li~~~l~~~P~~Rpt~~ell~ 327 (353)
T PLN00034 296 AP---ATASREFRHFISCCLQREPAKRWSAMQLLQ 327 (353)
T ss_pred CC---CccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 11 122356889999999999999999999986
|
|
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-37 Score=333.96 Aligned_cols=247 Identities=26% Similarity=0.346 Sum_probs=195.4
Q ss_pred CCCceeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHH---hhccCCceeeEecccccCCceEE
Q 044366 648 FGEKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLAL---TEIRHRNIIKFHGFCSNAQHSFI 723 (918)
Q Consensus 648 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l---~~l~h~niv~~~~~~~~~~~~~l 723 (918)
|.+.+.||+|+||.||+|.. .+|+.||||+++...... ....+.+.+|+.++ +.++||||+++++++.+++..++
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~l 79 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIA-RDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCF 79 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhh-hhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEE
Confidence 56788999999999999955 478999999987643222 22245566666554 56789999999999999999999
Q ss_pred EEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccC
Q 044366 724 VCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLE 803 (918)
Q Consensus 724 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~ 803 (918)
||||+++|+|..+++. ..+++.+++.++.|++.||+|||+. +++||||||+||+++.++.+||+|||++....
T Consensus 80 v~E~~~~~~L~~~~~~----~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~ 152 (324)
T cd05589 80 VMEYAAGGDLMMHIHT----DVFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGM 152 (324)
T ss_pred EEcCCCCCcHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcEEeCcccCCccCC
Confidence 9999999999988864 2489999999999999999999999 99999999999999999999999999987654
Q ss_pred CCCCCceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCCCCCcc
Q 044366 804 PHSSNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRD 883 (918)
Q Consensus 804 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 883 (918)
..........|++.|+|||.+.+..++.++|||||||++|||++|+.||...... . .. ..+.......+ ..
T Consensus 153 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~--~---~~---~~i~~~~~~~p-~~ 223 (324)
T cd05589 153 GFGDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEE--E---VF---DSIVNDEVRYP-RF 223 (324)
T ss_pred CCCCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHH--H---HH---HHHHhCCCCCC-CC
Confidence 4333344567899999999999989999999999999999999999998644321 0 00 11111111111 11
Q ss_pred hHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 044366 884 VTDKLRSIMEVAILCLVENPEARP-----TMKEVCN 914 (918)
Q Consensus 884 ~~~~~~~l~~li~~cl~~dp~~RP-----t~~evl~ 914 (918)
....+.+++.+||+.||.+|| ++.++++
T Consensus 224 ---~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~ 256 (324)
T cd05589 224 ---LSREAISIMRRLLRRNPERRLGSGEKDAEDVKK 256 (324)
T ss_pred ---CCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence 224577899999999999999 5666654
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-37 Score=339.21 Aligned_cols=252 Identities=22% Similarity=0.314 Sum_probs=203.9
Q ss_pred cCCCCceeeccccceEEEEEEeC-CCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEEE
Q 044366 646 GNFGEKYCIGKGGQRSVYKAELP-SGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFIV 724 (918)
Q Consensus 646 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 724 (918)
++|.+.+.||+|+||.||+|... +|+.||||+++...... ......+.+|+++++.++||||+++++++.+++..++|
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv 79 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIK-RNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLV 79 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhh-ccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEE
Confidence 46888999999999999999654 79999999987643222 23356789999999999999999999999999999999
Q ss_pred EEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccCC
Q 044366 725 CEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEP 804 (918)
Q Consensus 725 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~~ 804 (918)
|||+++|+|.+++... ..+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.....
T Consensus 80 ~e~~~~~~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~ 153 (350)
T cd05573 80 MEYMPGGDLMNLLIRK---DVFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHIKLADFGLCKKMNK 153 (350)
T ss_pred EcCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEeecCCCCccCcc
Confidence 9999999999999765 3589999999999999999999998 999999999999999999999999999987654
Q ss_pred CC-----------------------------CCceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcc
Q 044366 805 HS-----------------------------SNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFV 855 (918)
Q Consensus 805 ~~-----------------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~ 855 (918)
.. .......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~ 233 (350)
T cd05573 154 AKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSD 233 (350)
T ss_pred cCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCC
Confidence 33 1223456899999999999999999999999999999999999998654
Q ss_pred hhhhhhhhhhHhhhhhhcc-cCCCCCCcchHHHHHHHHHHHHHcccCCCCCCCC-HHHHHH
Q 044366 856 STIFSSISNMIIEVNQILD-HRLPTPSRDVTDKLRSIMEVAILCLVENPEARPT-MKEVCN 914 (918)
Q Consensus 856 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt-~~evl~ 914 (918)
.... .. ..+..... ...+... . ....+.+++.+|+. ||.+||+ ++|+++
T Consensus 234 ~~~~-~~----~~i~~~~~~~~~p~~~-~---~~~~~~~li~~ll~-dp~~R~~s~~~ll~ 284 (350)
T cd05573 234 TLQE-TY----NKIINWKESLRFPPDP-P---VSPEAIDLICRLLC-DPEDRLGSFEEIKS 284 (350)
T ss_pred CHHH-HH----HHHhccCCcccCCCCC-C---CCHHHHHHHHHHcc-ChhhcCCCHHHHhc
Confidence 3211 10 11111000 1111111 1 23567888899997 9999999 999986
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=316.87 Aligned_cols=251 Identities=23% Similarity=0.389 Sum_probs=202.5
Q ss_pred cCCCCceeeccccceEEEEEEeCCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEEEE
Q 044366 646 GNFGEKYCIGKGGQRSVYKAELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFIVC 725 (918)
Q Consensus 646 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 725 (918)
++|...+.||+|+||.||.|+..++..||+|.++.. ....++|.+|+.+++.++||||+++++++...+..++||
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~-----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 78 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG-----SMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVT 78 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCC-----cccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEE
Confidence 457778899999999999998877778999987643 223567999999999999999999999999888999999
Q ss_pred EeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccCCC
Q 044366 726 EYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPH 805 (918)
Q Consensus 726 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~~~ 805 (918)
||+++|+|.+++.... ..+++.+++.++.||+.|++|||+. +++|+||||+||+++.++.+||+|||.++.....
T Consensus 79 e~~~~~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~ 153 (256)
T cd05113 79 EYMSNGCLLNYLREHG--KRFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDD 153 (256)
T ss_pred EcCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECCCccceecCCC
Confidence 9999999999997643 2589999999999999999999999 9999999999999999999999999999866443
Q ss_pred CCC-ceecccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhhhhhhhhhHhhhhhhcccCCCCCCcc
Q 044366 806 SSN-WTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIK-GYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRD 883 (918)
Q Consensus 806 ~~~-~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 883 (918)
... .....++..|+|||+..+..++.++||||||+++|||++ |+.||....... ... .............
T Consensus 154 ~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~-----~~~---~~~~~~~~~~~~~ 225 (256)
T cd05113 154 EYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSE-----TVE---KVSQGLRLYRPHL 225 (256)
T ss_pred ceeecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH-----HHH---HHhcCCCCCCCCC
Confidence 221 112235678999999988889999999999999999998 999976433210 001 1111111111111
Q ss_pred hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 044366 884 VTDKLRSIMEVAILCLVENPEARPTMKEVCNLLC 917 (918)
Q Consensus 884 ~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 917 (918)
....+.+++.+||+.||.+||++.++++.++
T Consensus 226 ---~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 226 ---ASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred ---CCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 2356889999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=318.27 Aligned_cols=254 Identities=23% Similarity=0.381 Sum_probs=205.5
Q ss_pred hcCCCCceeeccccceEEEEEEeCCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEEE
Q 044366 645 TGNFGEKYCIGKGGQRSVYKAELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFIV 724 (918)
Q Consensus 645 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 724 (918)
.++|+..++||+|+||.||+|...+++.||+|.+... ....+.+.+|+.+++.++|+||+++++++.+++..++|
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~-----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 79 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPG-----TMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYII 79 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCC-----chhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEE
Confidence 3578888999999999999998878889999987642 22357899999999999999999999999999999999
Q ss_pred EEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccCC
Q 044366 725 CEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEP 804 (918)
Q Consensus 725 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~~ 804 (918)
|||+++|+|.++++... ...+++.+++.++.|++.|++|||+. +++||||||+||++++++.++++|||++.....
T Consensus 80 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 155 (261)
T cd05072 80 TEYMAKGSLLDFLKSDE-GGKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLARVIED 155 (261)
T ss_pred EecCCCCcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEECCCccceecCC
Confidence 99999999999997643 34578999999999999999999999 999999999999999999999999999987653
Q ss_pred CCCC-ceecccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhhhhhhhhhHhhhhhhcccCCCCCCc
Q 044366 805 HSSN-WTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIK-GYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSR 882 (918)
Q Consensus 805 ~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 882 (918)
.... .....++..|+|||+..+..++.++||||||+++|+|++ |+.||....... ........ ...+.. .
T Consensus 156 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~-----~~~~~~~~--~~~~~~-~ 227 (261)
T cd05072 156 NEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSD-----VMSALQRG--YRMPRM-E 227 (261)
T ss_pred CceeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHH-----HHHHHHcC--CCCCCC-C
Confidence 2211 122345678999999988889999999999999999998 999975432210 01111111 111111 1
Q ss_pred chHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhC
Q 044366 883 DVTDKLRSIMEVAILCLVENPEARPTMKEVCNLLCK 918 (918)
Q Consensus 883 ~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~ 918 (918)
....++.+++.+|++.+|++||+++++.+.|++
T Consensus 228 ---~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 228 ---NCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred ---CCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 123467889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=335.71 Aligned_cols=259 Identities=21% Similarity=0.338 Sum_probs=203.0
Q ss_pred HhcCCCCceeeccccceEEEEEEeC------CCCEEEEEEcccccccCCCCChHHHHHHHHHHhhcc-CCceeeEecccc
Q 044366 644 ATGNFGEKYCIGKGGQRSVYKAELP------SGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIR-HRNIIKFHGFCS 716 (918)
Q Consensus 644 ~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~ 716 (918)
..++|.+.+.||+|+||.||+|... .+..||||+++... .....+.|.+|+++++++. ||||+++++++.
T Consensus 35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~ 111 (400)
T cd05105 35 PRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA---RSSEKQALMSELKIMTHLGPHLNIVNLLGACT 111 (400)
T ss_pred cccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC---ChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEc
Confidence 4568889999999999999999642 23469999986532 2223467999999999996 999999999999
Q ss_pred cCCceEEEEEeccCCChhHHhhcccc------------------------------------------------------
Q 044366 717 NAQHSFIVCEYLARGSLTTILRDDAA------------------------------------------------------ 742 (918)
Q Consensus 717 ~~~~~~lv~e~~~~gsL~~~l~~~~~------------------------------------------------------ 742 (918)
+.+..++||||+++|+|.+++.....
T Consensus 112 ~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (400)
T cd05105 112 KSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPM 191 (400)
T ss_pred cCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchh
Confidence 99999999999999999998864310
Q ss_pred ---------------------------------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCe
Q 044366 743 ---------------------------------------AKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNV 783 (918)
Q Consensus 743 ---------------------------------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Ni 783 (918)
...+++.+++.++.|+++|++|||+. +++||||||+||
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dikp~Ni 268 (400)
T cd05105 192 LEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAARNV 268 (400)
T ss_pred hhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHhE
Confidence 12478889999999999999999999 999999999999
Q ss_pred eeCCCCcEEEeccccccccCCCCC--CceecccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhhhh
Q 044366 784 LLDSEYEAHVSDFGFAKFLEPHSS--NWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIK-GYHPGDFVSTIFS 860 (918)
Q Consensus 784 ll~~~~~~kl~DfG~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~p~~~~~~~~~ 860 (918)
++++++.+||+|||+++....... ......++..|+|||.+.+..++.++|||||||++|||++ |..||........
T Consensus 269 ll~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~ 348 (400)
T cd05105 269 LLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDST 348 (400)
T ss_pred EEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHH
Confidence 999999999999999987643322 1123346788999999998889999999999999999997 8898764321110
Q ss_pred hhhhhHhhhhhhcccCCCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhC
Q 044366 861 SISNMIIEVNQILDHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLLCK 918 (918)
Q Consensus 861 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~ 918 (918)
.. ..... ..+.+. . ......+.+++.+||+.||++||++.+|.++|++
T Consensus 349 ~~----~~~~~--~~~~~~-~---~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~ 396 (400)
T cd05105 349 FY----NKIKS--GYRMAK-P---DHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVES 396 (400)
T ss_pred HH----HHHhc--CCCCCC-C---ccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHH
Confidence 00 00111 011111 1 1223568899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=325.25 Aligned_cols=258 Identities=24% Similarity=0.392 Sum_probs=208.7
Q ss_pred HHHHHHhcCCCCceeeccccceEEEEEEeC-CCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEeccccc
Q 044366 639 EEITKATGNFGEKYCIGKGGQRSVYKAELP-SGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSN 717 (918)
Q Consensus 639 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~ 717 (918)
++++-...+....++||.|.||.||.|.|+ ..-.||||.++. +....++|..|+.+|+.++|||+|+++|+|..
T Consensus 260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKE-----DtMeveEFLkEAAvMKeikHpNLVqLLGVCT~ 334 (1157)
T KOG4278|consen 260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-----DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTH 334 (1157)
T ss_pred chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhh-----cchhHHHHHHHHHHHHhhcCccHHHHhhhhcc
Confidence 444455556677789999999999999775 466899999875 44557999999999999999999999999999
Q ss_pred CCceEEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccc
Q 044366 718 AQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFG 797 (918)
Q Consensus 718 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG 797 (918)
+..+|||+|||.+|+|.+|+++... ..++.-..+.||.||+.||+||... .+|||||.++|+|+.++..+|++|||
T Consensus 335 EpPFYIiTEfM~yGNLLdYLRecnr-~ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKvADFG 410 (1157)
T KOG4278|consen 335 EPPFYIITEFMCYGNLLDYLRECNR-SEVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKVADFG 410 (1157)
T ss_pred CCCeEEEEecccCccHHHHHHHhch-hhcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEeeccc
Confidence 9999999999999999999998753 4467778899999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCCcee-cccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhhhhhhhhhHhhhhhhccc
Q 044366 798 FAKFLEPHSSNWTE-FAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIK-GYHPGDFVSTIFSSISNMIIEVNQILDH 875 (918)
Q Consensus 798 ~~~~~~~~~~~~~~-~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 875 (918)
+++.+..+.+.... ..-++.|.|||.+....++.|+|||+|||+|||+.| |-.|+..... .+ +..++..
T Consensus 411 LsRlMtgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidl-----Sq----VY~LLEk 481 (1157)
T KOG4278|consen 411 LSRLMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-----SQ----VYGLLEK 481 (1157)
T ss_pred hhhhhcCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccH-----HH----HHHHHhc
Confidence 99998766543221 122678999999999999999999999999999998 6666443221 11 1111111
Q ss_pred CCC-CCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 044366 876 RLP-TPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLLC 917 (918)
Q Consensus 876 ~~~-~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 917 (918)
.+. ..++. ++++++++++.||+++|.+||+++|+-+.++
T Consensus 482 gyRM~~PeG---CPpkVYeLMraCW~WsPsDRPsFaeiHqafE 521 (1157)
T KOG4278|consen 482 GYRMDGPEG---CPPKVYELMRACWNWSPSDRPSFAEIHQAFE 521 (1157)
T ss_pred cccccCCCC---CCHHHHHHHHHHhcCCcccCccHHHHHHHHH
Confidence 111 11122 3356889999999999999999999988765
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=325.99 Aligned_cols=255 Identities=27% Similarity=0.399 Sum_probs=205.2
Q ss_pred HHhcCCCCceeeccccceEEEEEEeC---CCC--EEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEeccccc
Q 044366 643 KATGNFGEKYCIGKGGQRSVYKAELP---SGN--IFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSN 717 (918)
Q Consensus 643 ~~~~~~~~~~~lg~G~~g~Vy~~~~~---~~~--~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~ 717 (918)
...+.....++||.|.||.||+|.+- .|+ .||||.-+.+ ......+.|.+|..+|++++||||++++|+|.+
T Consensus 386 l~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d---~t~d~tekflqEa~iMrnfdHphIikLIGv~~e 462 (974)
T KOG4257|consen 386 LRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTD---CTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE 462 (974)
T ss_pred eehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccC---CChhhHHHHHHHHHHHHhCCCcchhheeeeeec
Confidence 33444555668999999999999542 333 5888887654 344457889999999999999999999999975
Q ss_pred CCceEEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccc
Q 044366 718 AQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFG 797 (918)
Q Consensus 718 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG 797 (918)
...|+|||.++.|.|..|+...+ ..++......+++||+.||+|||+. .+|||||.++||++....-+|++|||
T Consensus 463 -~P~WivmEL~~~GELr~yLq~nk--~sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVKLaDFG 536 (974)
T KOG4257|consen 463 -QPMWIVMELAPLGELREYLQQNK--DSLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVKLADFG 536 (974)
T ss_pred -cceeEEEecccchhHHHHHHhcc--ccchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceeeecccc
Confidence 56899999999999999998764 4588889999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCCc-eecccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhhhhhhhhhHhhhhhhccc
Q 044366 798 FAKFLEPHSSNW-TEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIK-GYHPGDFVSTIFSSISNMIIEVNQILDH 875 (918)
Q Consensus 798 ~~~~~~~~~~~~-~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 875 (918)
+++.+.++.... +...-+..|||||.+.-.+++.+||||.|||++||++. |..||...... ..-..---..
T Consensus 537 LSR~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNs-------DVI~~iEnGe 609 (974)
T KOG4257|consen 537 LSRYLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNS-------DVIGHIENGE 609 (974)
T ss_pred hhhhccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCcccccccc-------ceEEEecCCC
Confidence 999987765443 22334678999999999999999999999999999876 99998754321 0101111123
Q ss_pred CCCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 044366 876 RLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLLC 917 (918)
Q Consensus 876 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 917 (918)
++|.++ .+++.+..++.+||++||.+||++.|+...|+
T Consensus 610 RlP~P~----nCPp~LYslmskcWayeP~kRPrftei~~~ls 647 (974)
T KOG4257|consen 610 RLPCPP----NCPPALYSLMSKCWAYEPSKRPRFTEIKAILS 647 (974)
T ss_pred CCCCCC----CCChHHHHHHHHHhccCcccCCcHHHHHHHHH
Confidence 344333 23456889999999999999999999998875
|
|
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=336.04 Aligned_cols=244 Identities=24% Similarity=0.293 Sum_probs=196.5
Q ss_pred eeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEEEEEeccC
Q 044366 652 YCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFIVCEYLAR 730 (918)
Q Consensus 652 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 730 (918)
+.||+|+||.||+|.. .+|+.||+|+++...... ......+..|+++++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~-~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 79 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVA-KDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANG 79 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhh-hhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 3699999999999954 579999999997643222 22346778899999999999999999999999999999999999
Q ss_pred CChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccCCCCCCc
Q 044366 731 GSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHH-DCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNW 809 (918)
Q Consensus 731 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~~~~~~~ 809 (918)
|+|.+++... ..+++.+++.++.||+.||+|||+ . +|+||||||+||+++.++.+||+|||++..........
T Consensus 80 ~~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~lH~~~---~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~ 153 (325)
T cd05594 80 GELFFHLSRE---RVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATM 153 (325)
T ss_pred CcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhcC---CEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCccc
Confidence 9999988654 348999999999999999999997 6 99999999999999999999999999997654333333
Q ss_pred eecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCCCCCcchHHHHH
Q 044366 810 TEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRDVTDKLR 889 (918)
Q Consensus 810 ~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 889 (918)
....|++.|+|||++.+..++.++|||||||++|||++|+.||...... .. ...+....... +.. ...
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~--~~------~~~i~~~~~~~-p~~---~~~ 221 (325)
T cd05594 154 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE--KL------FELILMEEIRF-PRT---LSP 221 (325)
T ss_pred ccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHH--HH------HHHHhcCCCCC-CCC---CCH
Confidence 4557899999999999989999999999999999999999998643221 00 01111111111 111 124
Q ss_pred HHHHHHHHcccCCCCCCC-----CHHHHHH
Q 044366 890 SIMEVAILCLVENPEARP-----TMKEVCN 914 (918)
Q Consensus 890 ~l~~li~~cl~~dp~~RP-----t~~evl~ 914 (918)
.+.+++.+|++.||++|+ ++.++++
T Consensus 222 ~~~~li~~~L~~dP~~R~~~~~~~~~~il~ 251 (325)
T cd05594 222 EAKSLLSGLLKKDPKQRLGGGPDDAKEIMQ 251 (325)
T ss_pred HHHHHHHHHhhcCHHHhCCCCCCCHHHHhc
Confidence 578889999999999996 8998874
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=320.71 Aligned_cols=255 Identities=25% Similarity=0.432 Sum_probs=208.4
Q ss_pred HhcCCCCceeeccccceEEEEEEeCCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEE
Q 044366 644 ATGNFGEKYCIGKGGQRSVYKAELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFI 723 (918)
Q Consensus 644 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 723 (918)
...+|...+.||.|+||.||+|...+++.+|+|.+... ......++..|+++++.++||||+++++++.+.+..++
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~----~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 79 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSD----DLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYI 79 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEecccc----chhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEE
Confidence 45668888999999999999998877999999998653 22235678999999999999999999999999999999
Q ss_pred EEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccC
Q 044366 724 VCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLE 803 (918)
Q Consensus 724 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~ 803 (918)
||||+++|+|.++++... ...+++.+++.++.|++.|++|||+. +++||||+|+||++++++.+||+|||.+....
T Consensus 80 v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~ 155 (261)
T cd05148 80 ITELMEKGSLLAFLRSPE-GQVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIK 155 (261)
T ss_pred EEeecccCCHHHHHhcCC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceEEEccccchhhcC
Confidence 999999999999998653 34589999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCCceecccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhhhhhhhhhHhhhhhhcccCCCCCCc
Q 044366 804 PHSSNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIK-GYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSR 882 (918)
Q Consensus 804 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 882 (918)
..........++..|+|||...+..++.++||||||+++|+|++ |+.||...... ... ..... ..+.+.+ .
T Consensus 156 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~-~~~----~~~~~--~~~~~~~-~ 227 (261)
T cd05148 156 EDVYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNH-EVY----DQITA--GYRMPCP-A 227 (261)
T ss_pred CccccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHH-HHH----HHHHh--CCcCCCC-C
Confidence 44333333445778999999988889999999999999999998 89997643311 011 11111 1111111 1
Q ss_pred chHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 044366 883 DVTDKLRSIMEVAILCLVENPEARPTMKEVCNLLC 917 (918)
Q Consensus 883 ~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 917 (918)
.....+.+++.+||+.||.+|||++++.+.|+
T Consensus 228 ---~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~ 259 (261)
T cd05148 228 ---KCPQEIYKIMLECWAAEPEDRPSFKALREELD 259 (261)
T ss_pred ---CCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 22346789999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-37 Score=332.73 Aligned_cols=239 Identities=25% Similarity=0.344 Sum_probs=192.8
Q ss_pred eeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhc-cCCceeeEecccccCCceEEEEEecc
Q 044366 652 YCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEI-RHRNIIKFHGFCSNAQHSFIVCEYLA 729 (918)
Q Consensus 652 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~ 729 (918)
+.||+|+||.||+|+. .+++.||||+++...... ....+.+..|..++... +||||+++++++...+..++||||++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~ 79 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQ-DDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVN 79 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhh-ccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCC
Confidence 3699999999999965 468999999987643222 23356778888888776 69999999999999999999999999
Q ss_pred CCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccCCCCCCc
Q 044366 730 RGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNW 809 (918)
Q Consensus 730 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~~~~~~~ 809 (918)
+|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++..........
T Consensus 80 ~g~L~~~i~~~~---~l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~~ 153 (320)
T cd05590 80 GGDLMFHIQKSR---RFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTT 153 (320)
T ss_pred CchHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCcc
Confidence 999999987643 489999999999999999999999 99999999999999999999999999987654333334
Q ss_pred eecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCCCCCcchHHHHH
Q 044366 810 TEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRDVTDKLR 889 (918)
Q Consensus 810 ~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 889 (918)
....|++.|+|||++.+..++.++||||+||++|||++|+.||...... . . ...+.......+ .. ...
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~--~---~---~~~i~~~~~~~~-~~---~~~ 221 (320)
T cd05590 154 STFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENED--D---L---FEAILNDEVVYP-TW---LSQ 221 (320)
T ss_pred cccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH--H---H---HHHHhcCCCCCC-CC---CCH
Confidence 4567899999999999888999999999999999999999998654321 0 0 111111111111 11 224
Q ss_pred HHHHHHHHcccCCCCCCCCH
Q 044366 890 SIMEVAILCLVENPEARPTM 909 (918)
Q Consensus 890 ~l~~li~~cl~~dp~~RPt~ 909 (918)
.+.+++.+|++.||++||++
T Consensus 222 ~~~~li~~~L~~dP~~R~~~ 241 (320)
T cd05590 222 DAVDILKAFMTKNPTMRLGS 241 (320)
T ss_pred HHHHHHHHHcccCHHHCCCC
Confidence 57889999999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=322.99 Aligned_cols=256 Identities=25% Similarity=0.411 Sum_probs=203.3
Q ss_pred cCCCCceeeccccceEEEEEEeCC-C-----CEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCC
Q 044366 646 GNFGEKYCIGKGGQRSVYKAELPS-G-----NIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQ 719 (918)
Q Consensus 646 ~~~~~~~~lg~G~~g~Vy~~~~~~-~-----~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~ 719 (918)
++|...+.||+|+||.||+|.... + ..||+|.++... ......+|.+|++.++.++||||+++++++.+.+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~---~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~ 81 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA---EPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQ 81 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC---CHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCC
Confidence 467888999999999999996532 2 579999886431 2223467899999999999999999999999989
Q ss_pred ceEEEEEeccCCChhHHhhcccc-------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeC
Q 044366 720 HSFIVCEYLARGSLTTILRDDAA-------------AKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLD 786 (918)
Q Consensus 720 ~~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~ 786 (918)
..+++|||+++|+|.+++..... ...+++.+++.++.|++.|++|||+. +++||||||+||+++
T Consensus 82 ~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nil~~ 158 (283)
T cd05048 82 PTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVG 158 (283)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccccceEEEc
Confidence 99999999999999999975421 14578999999999999999999999 999999999999999
Q ss_pred CCCcEEEeccccccccCCCCC--CceecccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhhhhhhh
Q 044366 787 SEYEAHVSDFGFAKFLEPHSS--NWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIK-GYHPGDFVSTIFSSIS 863 (918)
Q Consensus 787 ~~~~~kl~DfG~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~p~~~~~~~~~~~~ 863 (918)
+++.++|+|||++........ ......+++.|+|||.+.+..++.++|||||||++|||++ |..||...... ..
T Consensus 159 ~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~--~~- 235 (283)
T cd05048 159 EGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQ--EV- 235 (283)
T ss_pred CCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHH--HH-
Confidence 999999999999986543321 1233456788999999988889999999999999999998 99997643221 11
Q ss_pred hhHhhhhhhcccCCCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhC
Q 044366 864 NMIIEVNQILDHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLLCK 918 (918)
Q Consensus 864 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~ 918 (918)
. ..+.....+.... .....+.+++.+||+.||++||++.||++.|++
T Consensus 236 --~---~~i~~~~~~~~~~---~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 236 --I---EMIRSRQLLPCPE---DCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred --H---HHHHcCCcCCCcc---cCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 1 1111111111111 233568899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=324.31 Aligned_cols=254 Identities=23% Similarity=0.294 Sum_probs=201.6
Q ss_pred CCCCceeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEEEE
Q 044366 647 NFGEKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFIVC 725 (918)
Q Consensus 647 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 725 (918)
.|+..+.||+|+||.||+|.. .+++.||+|++....... ......+.+|+.+++.++||||+++++++.+++..++||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 79 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKK-RKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVL 79 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhh-hhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEE
Confidence 477889999999999999964 578999999986533221 222456788999999999999999999999999999999
Q ss_pred EeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccCCC
Q 044366 726 EYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPH 805 (918)
Q Consensus 726 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~~~ 805 (918)
||+++|+|.+++.... ...+++..+..++.|++.|++|||+. +++||||||+||++++++.++|+|||++......
T Consensus 80 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 155 (285)
T cd05605 80 TLMNGGDLKFHIYNMG-NPGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEG 155 (285)
T ss_pred eccCCCcHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEEeeCCCceecCCC
Confidence 9999999999886543 34589999999999999999999999 9999999999999999999999999999876432
Q ss_pred CCCceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCCCCCcchH
Q 044366 806 SSNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRDVT 885 (918)
Q Consensus 806 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 885 (918)
. ......|+..|+|||++.+..++.++||||+||++|||++|+.||....... .... ....+.........
T Consensus 156 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~-~~~~----~~~~~~~~~~~~~~--- 226 (285)
T cd05605 156 E-TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKV-KREE----VERRVKEDQEEYSE--- 226 (285)
T ss_pred C-ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhh-HHHH----HHHHhhhcccccCc---
Confidence 2 2234568999999999998889999999999999999999999987533211 0011 11111111111111
Q ss_pred HHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 044366 886 DKLRSIMEVAILCLVENPEARP-----TMKEVCN 914 (918)
Q Consensus 886 ~~~~~l~~li~~cl~~dp~~RP-----t~~evl~ 914 (918)
.....+.+++.+||+.||++|| +++++++
T Consensus 227 ~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05605 227 KFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKA 260 (285)
T ss_pred ccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhc
Confidence 2334678899999999999999 8888864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=333.96 Aligned_cols=259 Identities=22% Similarity=0.361 Sum_probs=194.9
Q ss_pred CCCCceeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccC-----Cc
Q 044366 647 NFGEKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNA-----QH 720 (918)
Q Consensus 647 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~~ 720 (918)
+|...+.||+|+||.||+|.. .+|+.||||++..... .......+.+|+++++.++||||+++++++... ..
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 78 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFE--HVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 78 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhc--cchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCce
Confidence 478889999999999999954 5789999999864321 222345788999999999999999999987432 34
Q ss_pred eEEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEecccccc
Q 044366 721 SFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAK 800 (918)
Q Consensus 721 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~ 800 (918)
.++||||++ ++|.+++... ..+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++
T Consensus 79 ~~lv~e~~~-~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kL~Dfg~~~ 151 (338)
T cd07859 79 IYVVFELME-SDLHQVIKAN---DDLTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLAR 151 (338)
T ss_pred EEEEEecCC-CCHHHHHHhc---ccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEccCcccc
Confidence 799999996 6899988754 3489999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCC---Cceeccccccccccccccc--CCCCcccchhhHHHHHHHHHhCCCCCCcchhhhh--hhhh---------
Q 044366 801 FLEPHSS---NWTEFAGTVGYAAPELAYT--MRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFS--SISN--------- 864 (918)
Q Consensus 801 ~~~~~~~---~~~~~~g~~~y~aPE~~~~--~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~--~~~~--------- 864 (918)
....... ......|++.|+|||++.+ ..++.++|||||||++|||++|+.||........ .+..
T Consensus 152 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 231 (338)
T cd07859 152 VAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPET 231 (338)
T ss_pred ccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHH
Confidence 6533221 1234578999999999865 6788999999999999999999999864332100 0000
Q ss_pred ---h----Hhh-hhhhcccCCCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 865 ---M----IIE-VNQILDHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 865 ---~----~~~-~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
. ... ...+............+.....+.+++.+||+.||++|||++|+++
T Consensus 232 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~ 289 (338)
T cd07859 232 ISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALA 289 (338)
T ss_pred HHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 0 000 0000000000000111112346789999999999999999999985
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=338.06 Aligned_cols=253 Identities=19% Similarity=0.249 Sum_probs=195.4
Q ss_pred CCCCceeeccccceEEEEEE-eCCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEEEE
Q 044366 647 NFGEKYCIGKGGQRSVYKAE-LPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFIVC 725 (918)
Q Consensus 647 ~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 725 (918)
.|...+.||+|+||.||+|. ..+++.||+|++....... ....+.+.+|+++++.++||||+++++++.+++..++||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~-~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~ 80 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLN-RNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhh-hHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEE
Confidence 57888999999999999995 4578999999987643222 223467899999999999999999999999999999999
Q ss_pred EeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccCCC
Q 044366 726 EYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPH 805 (918)
Q Consensus 726 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~~~ 805 (918)
||+++|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++..+...
T Consensus 81 E~~~gg~L~~~l~~~~---~~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~ 154 (381)
T cd05626 81 DYIPGGDMMSLLIRME---VFPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWT 154 (381)
T ss_pred ecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEEeeCcCCcccccc
Confidence 9999999999997643 488999999999999999999999 9999999999999999999999999997643210
Q ss_pred CC-----------------------------------------------CceecccccccccccccccCCCCcccchhhH
Q 044366 806 SS-----------------------------------------------NWTEFAGTVGYAAPELAYTMRATEKYDVYSF 838 (918)
Q Consensus 806 ~~-----------------------------------------------~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~sl 838 (918)
.. .....+||+.|+|||++.+..++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl 234 (381)
T cd05626 155 HNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSV 234 (381)
T ss_pred cccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeeh
Confidence 00 0112468999999999998889999999999
Q ss_pred HHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCCCCCcchHHHHHHHHHHHHH--cccCCCCCCCCHHHHHH
Q 044366 839 GVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRDVTDKLRSIMEVAIL--CLVENPEARPTMKEVCN 914 (918)
Q Consensus 839 G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~--cl~~dp~~RPt~~evl~ 914 (918)
||++|||++|+.||......... ... .... .....+.. . ....++.+++.+ |+..+|..||+++|+++
T Consensus 235 G~il~elltG~~Pf~~~~~~~~~-~~i-~~~~--~~~~~~~~-~---~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~ 304 (381)
T cd05626 235 GVILFEMLVGQPPFLAPTPTETQ-LKV-INWE--NTLHIPPQ-V---KLSPEAVDLITKLCCSAEERLGRNGADDIKA 304 (381)
T ss_pred hhHHHHHHhCCCCCcCCCHHHHH-HHH-Hccc--cccCCCCC-C---CCCHHHHHHHHHHccCcccccCCCCHHHHhc
Confidence 99999999999998654321100 000 0000 00111111 1 122346667766 55667777999999975
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=322.50 Aligned_cols=257 Identities=25% Similarity=0.415 Sum_probs=205.1
Q ss_pred hcCCCCceeeccccceEEEEEEeC------CCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccC
Q 044366 645 TGNFGEKYCIGKGGQRSVYKAELP------SGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNA 718 (918)
Q Consensus 645 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~ 718 (918)
.++|.+.+.||+|+||.||+|... +++.||||.++... .....+.|.+|+++++.++||||+++++++..+
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 80 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETA---SNDARKDFEREAELLTNFQHENIVKFYGVCTEG 80 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccC---CHHHHHHHHHHHHHHHhcCCCCchheeeEEecC
Confidence 356778889999999999999653 35789999986531 122356899999999999999999999999999
Q ss_pred CceEEEEEeccCCChhHHhhcccc-----------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCC
Q 044366 719 QHSFIVCEYLARGSLTTILRDDAA-----------AKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDS 787 (918)
Q Consensus 719 ~~~~lv~e~~~~gsL~~~l~~~~~-----------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~ 787 (918)
...++||||+++|+|.++++.... ...+++.++..++.|++.|++|+|+. +++||||||+||+++.
T Consensus 81 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~nili~~ 157 (280)
T cd05049 81 DPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLVGY 157 (280)
T ss_pred CCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceEEEcC
Confidence 999999999999999999975421 24478999999999999999999999 9999999999999999
Q ss_pred CCcEEEeccccccccCCCCC--CceecccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhhhhhhhh
Q 044366 788 EYEAHVSDFGFAKFLEPHSS--NWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIK-GYHPGDFVSTIFSSISN 864 (918)
Q Consensus 788 ~~~~kl~DfG~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~p~~~~~~~~~~~~~ 864 (918)
++.++|+|||++........ ......+++.|+|||++.+..++.++||||||+++|||++ |+.||...... .
T Consensus 158 ~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~-----~ 232 (280)
T cd05049 158 DLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNE-----E 232 (280)
T ss_pred CCeEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHH-----H
Confidence 99999999999976543221 1123345788999999999999999999999999999998 99997543221 0
Q ss_pred hHhhhhhhcccCCCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhC
Q 044366 865 MIIEVNQILDHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLLCK 918 (918)
Q Consensus 865 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~ 918 (918)
.. ..+.......... .....+.+++.+||+.||++||++.||++.|++
T Consensus 233 ~~---~~~~~~~~~~~~~---~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~ 280 (280)
T cd05049 233 VI---ECITQGRLLQRPR---TCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280 (280)
T ss_pred HH---HHHHcCCcCCCCC---CCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence 11 1111122222111 123567889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=331.97 Aligned_cols=254 Identities=23% Similarity=0.303 Sum_probs=199.2
Q ss_pred CCCCceeeccccceEEEEEEe----CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhc-cCCceeeEecccccCCce
Q 044366 647 NFGEKYCIGKGGQRSVYKAEL----PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEI-RHRNIIKFHGFCSNAQHS 721 (918)
Q Consensus 647 ~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~ 721 (918)
+|++.+.||+|+||.||+|+. .+|+.||+|++............+.+..|+++++.+ +||+|+++++++..++..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 478889999999999999854 368899999987643333333456788999999999 599999999999999999
Q ss_pred EEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccc
Q 044366 722 FIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKF 801 (918)
Q Consensus 722 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~ 801 (918)
++||||+++|+|.+++.... .+++.++..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++.
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~~~kl~DfG~~~~ 154 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRD---NFSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEGHVVLTDFGLSKE 154 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCCCEEEeeCcCCcc
Confidence 99999999999999987543 489999999999999999999999 999999999999999999999999999986
Q ss_pred cCCCCC-CceecccccccccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCCC
Q 044366 802 LEPHSS-NWTEFAGTVGYAAPELAYTM-RATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPT 879 (918)
Q Consensus 802 ~~~~~~-~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 879 (918)
+..... ......||..|+|||++.+. .++.++|||||||++|||++|+.||....... ...... ..+.....+
T Consensus 155 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~-~~~~~~---~~~~~~~~~- 229 (332)
T cd05614 155 FLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERN-TQSEVS---RRILKCDPP- 229 (332)
T ss_pred ccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCC-CHHHHH---HHHhcCCCC-
Confidence 543322 22345789999999998865 47889999999999999999999986432110 000011 111111111
Q ss_pred CCcchHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 044366 880 PSRDVTDKLRSIMEVAILCLVENPEARP-----TMKEVCN 914 (918)
Q Consensus 880 ~~~~~~~~~~~l~~li~~cl~~dp~~RP-----t~~evl~ 914 (918)
.... ....+.+++.+|++.||++|| +++++++
T Consensus 230 ~~~~---~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 266 (332)
T cd05614 230 FPSF---IGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE 266 (332)
T ss_pred CCCC---CCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence 1111 224577889999999999999 7777764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=320.39 Aligned_cols=261 Identities=21% Similarity=0.310 Sum_probs=208.2
Q ss_pred cCCCCceeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEEE
Q 044366 646 GNFGEKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFIV 724 (918)
Q Consensus 646 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 724 (918)
++|...+.||+|++|.||+|.. .+++.||||.+...... ......++.+|+.+++.++||||+++++++..++..++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v 80 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLM-DAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV 80 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhh-hHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEE
Confidence 4677888999999999999964 58999999987653211 222346789999999999999999999999999999999
Q ss_pred EEeccCCChhHHhhccc-ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccC
Q 044366 725 CEYLARGSLTTILRDDA-AAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLE 803 (918)
Q Consensus 725 ~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~ 803 (918)
|||+++++|.+++.... ....+++.+++.++.|++.|++|||+. +++|+||||+||+++.++.++++|||++....
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~ 157 (267)
T cd08229 81 LELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFS 157 (267)
T ss_pred EEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEECcchhhhccc
Confidence 99999999999987432 234589999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCCceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCCCCCcc
Q 044366 804 PHSSNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRD 883 (918)
Q Consensus 804 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 883 (918)
..........++..|+|||++.+..++.++||||||+++|+|++|..||....... ........ ....+....
T Consensus 158 ~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~---~~~~~~~~---~~~~~~~~~- 230 (267)
T cd08229 158 SKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL---YSLCKKIE---QCDYPPLPS- 230 (267)
T ss_pred cCCcccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchH---HHHhhhhh---cCCCCCCCc-
Confidence 44333344568899999999998889999999999999999999999975332111 11111111 111111111
Q ss_pred hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhC
Q 044366 884 VTDKLRSIMEVAILCLVENPEARPTMKEVCNLLCK 918 (918)
Q Consensus 884 ~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~ 918 (918)
......+.+++.+||+.||.+|||+.+|++++++
T Consensus 231 -~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~ 264 (267)
T cd08229 231 -DHYSEELRQLVNMCINPDPEKRPDITYVYDVAKR 264 (267)
T ss_pred -ccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhh
Confidence 1234568899999999999999999999998864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=332.45 Aligned_cols=244 Identities=24% Similarity=0.337 Sum_probs=196.0
Q ss_pred eeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhc-cCCceeeEecccccCCceEEEEEecc
Q 044366 652 YCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEI-RHRNIIKFHGFCSNAQHSFIVCEYLA 729 (918)
Q Consensus 652 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~ 729 (918)
+.||+|+||.||+|+. .+++.||+|+++..... .....+.+..|.++++.+ +||||+++++++.+++..++||||++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~ 79 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVIL-QDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVN 79 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhh-hhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCC
Confidence 3599999999999965 46889999998764322 223346678888888866 79999999999999999999999999
Q ss_pred CCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccCCCCCCc
Q 044366 730 RGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNW 809 (918)
Q Consensus 730 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~~~~~~~ 809 (918)
+|+|..++.... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++..........
T Consensus 80 ~~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~ 153 (321)
T cd05591 80 GGDLMFQIQRSR---KFDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTT 153 (321)
T ss_pred CCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeecccceecccCCccc
Confidence 999999987543 489999999999999999999999 99999999999999999999999999998654444334
Q ss_pred eecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCCCCCcchHHHHH
Q 044366 810 TEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRDVTDKLR 889 (918)
Q Consensus 810 ~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 889 (918)
....|++.|+|||++.+..++.++||||+||++|||++|+.||...... .. ...+.......+. . ...
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~-~~-------~~~i~~~~~~~p~-~---~~~ 221 (321)
T cd05591 154 TTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNED-DL-------FESILHDDVLYPV-W---LSK 221 (321)
T ss_pred cccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHH-HH-------HHHHHcCCCCCCC-C---CCH
Confidence 4567899999999999889999999999999999999999998754321 00 1111111111111 1 124
Q ss_pred HHHHHHHHcccCCCCCCC-------CHHHHHH
Q 044366 890 SIMEVAILCLVENPEARP-------TMKEVCN 914 (918)
Q Consensus 890 ~l~~li~~cl~~dp~~RP-------t~~evl~ 914 (918)
++.+++.+|++.||++|| ++.++++
T Consensus 222 ~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~ 253 (321)
T cd05591 222 EAVSILKAFMTKNPNKRLGCVASQGGEDAIKQ 253 (321)
T ss_pred HHHHHHHHHhccCHHHcCCCCCCCCCHHHHhc
Confidence 678899999999999999 7777764
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=336.47 Aligned_cols=255 Identities=20% Similarity=0.283 Sum_probs=201.2
Q ss_pred HhcCCCCceeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceE
Q 044366 644 ATGNFGEKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSF 722 (918)
Q Consensus 644 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 722 (918)
..++|...+.||+|+||.||+|+. .+++.||+|++...... .....+.+.+|+.+++.++||||+++++++.+++..+
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~ 119 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMI-KRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLY 119 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhh-hhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence 456789999999999999999965 47899999998653221 2223456789999999999999999999999999999
Q ss_pred EEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEecccccccc
Q 044366 723 IVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFL 802 (918)
Q Consensus 723 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~ 802 (918)
+||||+++|+|.+++... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++...
T Consensus 120 lv~Ey~~gg~L~~~l~~~----~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~ 192 (370)
T cd05596 120 MVMEYMPGGDLVNLMSNY----DIPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKM 192 (370)
T ss_pred EEEcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCCEEEEeccceeec
Confidence 999999999999998753 378888999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCC-CceecccccccccccccccC----CCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCC
Q 044366 803 EPHSS-NWTEFAGTVGYAAPELAYTM----RATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRL 877 (918)
Q Consensus 803 ~~~~~-~~~~~~g~~~y~aPE~~~~~----~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 877 (918)
..... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||...... . ....+.....
T Consensus 193 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~-~-------~~~~i~~~~~ 264 (370)
T cd05596 193 DANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV-G-------TYSKIMDHKN 264 (370)
T ss_pred cCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHH-H-------HHHHHHcCCC
Confidence 54322 22345689999999998653 3788999999999999999999998654321 0 1111111110
Q ss_pred CCCCcchHHHHHHHHHHHHHcccCCCCC--CCCHHHHHH
Q 044366 878 PTPSRDVTDKLRSIMEVAILCLVENPEA--RPTMKEVCN 914 (918)
Q Consensus 878 ~~~~~~~~~~~~~l~~li~~cl~~dp~~--RPt~~evl~ 914 (918)
.............+.+++.+|++.+|++ ||+++|+++
T Consensus 265 ~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~ 303 (370)
T cd05596 265 SLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKS 303 (370)
T ss_pred cCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhc
Confidence 0000111123356788999999999988 999999975
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=327.86 Aligned_cols=243 Identities=25% Similarity=0.340 Sum_probs=192.1
Q ss_pred eeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhc-cCCceeeEecccccCCceEEEEEecc
Q 044366 652 YCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEI-RHRNIIKFHGFCSNAQHSFIVCEYLA 729 (918)
Q Consensus 652 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~ 729 (918)
+.||+|+||.||+|.. .+++.||+|+++...... ....+.+..|..++... +||||+++++++..++..++||||++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~ 79 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLE-DDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLN 79 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhh-hhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCC
Confidence 3699999999999965 468899999987643222 22345566677776654 89999999999999999999999999
Q ss_pred CCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccCCCCCCc
Q 044366 730 RGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNW 809 (918)
Q Consensus 730 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~~~~~~~ 809 (918)
+|+|.+++.... .+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++..........
T Consensus 80 gg~L~~~~~~~~---~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~ 153 (316)
T cd05592 80 GGDLMFHIQSSG---RFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKA 153 (316)
T ss_pred CCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCcc
Confidence 999999987543 489999999999999999999999 99999999999999999999999999998654433444
Q ss_pred eecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCCCCCcchHHHHH
Q 044366 810 TEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRDVTDKLR 889 (918)
Q Consensus 810 ~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 889 (918)
....||+.|+|||++.+..++.++|||||||++|||++|+.||...... .... .+..... ..+.. ...
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~-----~~~~---~i~~~~~-~~~~~---~~~ 221 (316)
T cd05592 154 STFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDED-----ELFD---SILNDRP-HFPRW---ISK 221 (316)
T ss_pred ccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHH-----HHHH---HHHcCCC-CCCCC---CCH
Confidence 4567899999999999988999999999999999999999998654321 0111 1111111 11111 224
Q ss_pred HHHHHHHHcccCCCCCCCCHH-HHH
Q 044366 890 SIMEVAILCLVENPEARPTMK-EVC 913 (918)
Q Consensus 890 ~l~~li~~cl~~dp~~RPt~~-evl 913 (918)
.+.+++.+||+.||.+||++. +++
T Consensus 222 ~~~~ll~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05592 222 EAKDCLSKLFERDPTKRLGVDGDIR 246 (316)
T ss_pred HHHHHHHHHccCCHHHcCCChHHHH
Confidence 567889999999999999876 443
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=334.43 Aligned_cols=253 Identities=18% Similarity=0.260 Sum_probs=195.6
Q ss_pred hcCCCCceeeccccceEEEEEE-eCCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEE
Q 044366 645 TGNFGEKYCIGKGGQRSVYKAE-LPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFI 723 (918)
Q Consensus 645 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 723 (918)
.++|.+.+.||+|+||.||+|. ..+++.||+|.... ..+.+|++++++++||||+++++++......++
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~----------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~l 160 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR----------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCL 160 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh----------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEE
Confidence 3679999999999999999994 46789999996432 346899999999999999999999999999999
Q ss_pred EEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccC
Q 044366 724 VCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLE 803 (918)
Q Consensus 724 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~ 803 (918)
|+|++. ++|.+++... ..+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 161 v~e~~~-~~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~ 233 (391)
T PHA03212 161 ILPRYK-TDLYCYLAAK---RNIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPV 233 (391)
T ss_pred EEecCC-CCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEeCCcccccc
Confidence 999996 6898888654 3489999999999999999999999 99999999999999999999999999997543
Q ss_pred CCC-CCceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhh------hhhhhhHh---------
Q 044366 804 PHS-SNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIF------SSISNMII--------- 867 (918)
Q Consensus 804 ~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~------~~~~~~~~--------- 867 (918)
... .......||+.|+|||++.+..++.++||||+||++|||++|+.|+-...... ........
T Consensus 234 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~ 313 (391)
T PHA03212 234 DINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEF 313 (391)
T ss_pred cccccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhc
Confidence 222 22334579999999999998899999999999999999999998743211100 00000000
Q ss_pred ------hhh----hhcc--cCCCCCC---cchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 868 ------EVN----QILD--HRLPTPS---RDVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 868 ------~~~----~~~~--~~~~~~~---~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
... .... ...+... ........++.+++.+|++.||++|||++|+++
T Consensus 314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~ 375 (391)
T PHA03212 314 PIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD 375 (391)
T ss_pred CcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence 000 0000 0000000 111223457889999999999999999999985
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=333.96 Aligned_cols=250 Identities=26% Similarity=0.470 Sum_probs=203.4
Q ss_pred CCCceeeccccceEEEEEE-eCCCC----EEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceE
Q 044366 648 FGEKYCIGKGGQRSVYKAE-LPSGN----IFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSF 722 (918)
Q Consensus 648 ~~~~~~lg~G~~g~Vy~~~-~~~~~----~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 722 (918)
....++||+|+||+||+|. .+.|+ +||+|++... .......++.+|+..|.+++|||+++++|+|.... ..
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~---t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~q 773 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEF---TSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQ 773 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeecc---CCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HH
Confidence 3455789999999999994 45554 6888887653 23334678999999999999999999999997766 88
Q ss_pred EEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEecccccccc
Q 044366 723 IVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFL 802 (918)
Q Consensus 723 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~ 802 (918)
||++||+.|+|.+|++.++ ..+-.+..+.|..|||+||.|||++ ++|||||.++||||..-..+|+.|||+++..
T Consensus 774 lvtq~mP~G~LlDyvr~hr--~~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdfgla~ll 848 (1177)
T KOG1025|consen 774 LVTQLMPLGCLLDYVREHR--DNIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDFGLAKLL 848 (1177)
T ss_pred HHHHhcccchHHHHHHHhh--ccccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEecchhhcc
Confidence 9999999999999998864 4577889999999999999999999 9999999999999999999999999999998
Q ss_pred CCCCCCceecc--cccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhhhhhhhhhHhhhhhhcccCCCC
Q 044366 803 EPHSSNWTEFA--GTVGYAAPELAYTMRATEKYDVYSFGVLALEVIK-GYHPGDFVSTIFSSISNMIIEVNQILDHRLPT 879 (918)
Q Consensus 803 ~~~~~~~~~~~--g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 879 (918)
.++........ -.+.|||-|.+....|+.++|||||||++||++| |..|++.... +.+.+.... ..+++.
T Consensus 849 ~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~--~eI~dlle~-----geRLsq 921 (1177)
T KOG1025|consen 849 APDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPA--EEIPDLLEK-----GERLSQ 921 (1177)
T ss_pred CcccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCH--HHhhHHHhc-----cccCCC
Confidence 87766544333 3678999999999999999999999999999998 8999765432 222222111 122333
Q ss_pred CCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 044366 880 PSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLLC 917 (918)
Q Consensus 880 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 917 (918)
++ -...++..++.+||..|++.||+++++...++
T Consensus 922 Pp----iCtiDVy~~mvkCwmid~~~rp~fkel~~~fs 955 (1177)
T KOG1025|consen 922 PP----ICTIDVYMVMVKCWMIDADSRPTFKELAEEFS 955 (1177)
T ss_pred CC----CccHHHHHHHHHHhccCcccCccHHHHHHHHH
Confidence 22 23356788899999999999999999998775
|
|
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=320.57 Aligned_cols=258 Identities=21% Similarity=0.357 Sum_probs=202.7
Q ss_pred HhcCCCCceeeccccceEEEEEEeC------CCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEeccccc
Q 044366 644 ATGNFGEKYCIGKGGQRSVYKAELP------SGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSN 717 (918)
Q Consensus 644 ~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~ 717 (918)
+.++|+..+.||+|+||.||+|... +++.||+|++.... ......+|.+|+.+++.++||||+++++++..
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~---~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~ 80 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA---SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ 80 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccC---CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC
Confidence 4677999999999999999998642 35679999875421 11234578999999999999999999999999
Q ss_pred CCceEEEEEeccCCChhHHhhcccc-------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCc
Q 044366 718 AQHSFIVCEYLARGSLTTILRDDAA-------AKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYE 790 (918)
Q Consensus 718 ~~~~~lv~e~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~ 790 (918)
+...++||||+++|+|.++++.... ...+++..+..++.|++.|++|||+. +++||||||+||++++++.
T Consensus 81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~~~~~ 157 (277)
T cd05062 81 GQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFT 157 (277)
T ss_pred CCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEcCCCC
Confidence 9999999999999999999975321 22367889999999999999999998 9999999999999999999
Q ss_pred EEEeccccccccCCCCCCc--eecccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhhhhhhhhhHh
Q 044366 791 AHVSDFGFAKFLEPHSSNW--TEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIK-GYHPGDFVSTIFSSISNMII 867 (918)
Q Consensus 791 ~kl~DfG~~~~~~~~~~~~--~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~p~~~~~~~~~~~~~~~~ 867 (918)
++++|||++.......... ....++..|+|||++.+..++.++|||||||++|||++ |..||...... ...
T Consensus 158 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~-----~~~- 231 (277)
T cd05062 158 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNE-----QVL- 231 (277)
T ss_pred EEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH-----HHH-
Confidence 9999999997654332211 12345778999999998889999999999999999999 68887543221 000
Q ss_pred hhhhhcccCCCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhC
Q 044366 868 EVNQILDHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLLCK 918 (918)
Q Consensus 868 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~ 918 (918)
........+..... ....+.+++.+|++.||++|||+.|+++.|++
T Consensus 232 --~~~~~~~~~~~~~~---~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 232 --RFVMEGGLLDKPDN---CPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred --HHHHcCCcCCCCCC---CCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 01111111111111 22468889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=324.35 Aligned_cols=255 Identities=24% Similarity=0.327 Sum_probs=217.0
Q ss_pred HHhcCCCCceeeccccceEEEEEEeC-CCCEEEEEEcccccccCCCCChHHHHHHHHHHhhcc-CCceeeEecccccCCc
Q 044366 643 KATGNFGEKYCIGKGGQRSVYKAELP-SGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIR-HRNIIKFHGFCSNAQH 720 (918)
Q Consensus 643 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~ 720 (918)
.....|...+.||+|.||.||++..+ +|+.+|+|.+.+...... ...+...+|+.+|+++. |||||.+++++++...
T Consensus 32 ~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~-~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~ 110 (382)
T KOG0032|consen 32 DIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGK-EDREDVRREVAILQQLSGHPNIVQLKDAFEDPDS 110 (382)
T ss_pred cccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhcccc-ccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCe
Confidence 34456788889999999999999655 599999999977544332 24578999999999998 9999999999999999
Q ss_pred eEEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCC----CcEEEecc
Q 044366 721 SFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSE----YEAHVSDF 796 (918)
Q Consensus 721 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~----~~~kl~Df 796 (918)
.++|||+++||.|.+.+... .+++.++..++.|++.|++|||+. ||+|||+||+|+++... +.+|++||
T Consensus 111 ~~lvmEL~~GGeLfd~i~~~----~~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~~~~~~ik~~DF 183 (382)
T KOG0032|consen 111 VYLVMELCEGGELFDRIVKK----HYSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKDEGSGRIKLIDF 183 (382)
T ss_pred EEEEEEecCCchHHHHHHHc----cCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeeccccCCCCcEEEeeC
Confidence 99999999999999999765 289999999999999999999998 99999999999999643 47999999
Q ss_pred ccccccCCCCCCceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccC
Q 044366 797 GFAKFLEPHSSNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHR 876 (918)
Q Consensus 797 G~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 876 (918)
|++....+ .......+||+.|+|||++....|+.++||||.||++|.|++|..||........ ...+....
T Consensus 184 Gla~~~~~-~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~--------~~~i~~~~ 254 (382)
T KOG0032|consen 184 GLAKFIKP-GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEI--------FLAILRGD 254 (382)
T ss_pred CCceEccC-CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHH--------HHHHHcCC
Confidence 99999887 6667788999999999999999999999999999999999999999876543211 11333444
Q ss_pred CCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 877 LPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 877 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
+......+......+.+++..|+..||.+|+|+.++++
T Consensus 255 ~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~ 292 (382)
T KOG0032|consen 255 FDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQ 292 (382)
T ss_pred CCCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhc
Confidence 44444445556677889999999999999999999986
|
|
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-36 Score=316.55 Aligned_cols=255 Identities=26% Similarity=0.428 Sum_probs=205.7
Q ss_pred HhcCCCCceeeccccceEEEEEEeCCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEE
Q 044366 644 ATGNFGEKYCIGKGGQRSVYKAELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFI 723 (918)
Q Consensus 644 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 723 (918)
..++|...+.||+|++|.||+|...+++.||+|.++.. ....++|.+|++++++++||||+++++++...+..++
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~-----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 78 (261)
T cd05068 4 DRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPG-----TMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYI 78 (261)
T ss_pred chhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCC-----cccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeee
Confidence 34668889999999999999998777889999998652 2235779999999999999999999999999999999
Q ss_pred EEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccC
Q 044366 724 VCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLE 803 (918)
Q Consensus 724 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~ 803 (918)
||||+++++|.+++.... ...+++.++..++.|++.|++|||+. +++||||||+||++++++.++|+|||++....
T Consensus 79 v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~ 154 (261)
T cd05068 79 VTELMKYGSLLEYLQGGA-GRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVADFGLARVIK 154 (261)
T ss_pred eeecccCCcHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEECCcceEEEcc
Confidence 999999999999997654 34589999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCC-ceecccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhhhhhhhhhHhhhhhhcccCCCCCC
Q 044366 804 PHSSN-WTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIK-GYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPS 881 (918)
Q Consensus 804 ~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 881 (918)
..... ......+..|+|||+..+..++.++||||||+++|||++ |+.||....... ........ ...+. .
T Consensus 155 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~-----~~~~~~~~--~~~~~-~ 226 (261)
T cd05068 155 EDIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAE-----VLQQVDQG--YRMPC-P 226 (261)
T ss_pred CCcccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHH-----HHHHHHcC--CCCCC-C
Confidence 33221 111223458999999998899999999999999999999 999976432210 00111111 01111 1
Q ss_pred cchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhC
Q 044366 882 RDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLLCK 918 (918)
Q Consensus 882 ~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~ 918 (918)
. .....+.+++.+|++.+|.+||++.++++.|+.
T Consensus 227 ~---~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 227 P---GCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred C---cCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 1 223568889999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=331.05 Aligned_cols=244 Identities=23% Similarity=0.328 Sum_probs=195.6
Q ss_pred CCCCceeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccC-CceeeEecccccCCceEEE
Q 044366 647 NFGEKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRH-RNIIKFHGFCSNAQHSFIV 724 (918)
Q Consensus 647 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~~~~~~~~~~~~~lv 724 (918)
+|.+.+.||+|+||.||+|.. .+++.||+|+++..... .....+.+..|.++++.++| ++|+++++++.+.+..++|
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv 79 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVII-QDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFV 79 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEE
Confidence 478889999999999999955 46789999998764322 22335678899999999976 5688899999989999999
Q ss_pred EEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccCC
Q 044366 725 CEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEP 804 (918)
Q Consensus 725 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~~ 804 (918)
|||+++|+|.+++... ..+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.....
T Consensus 80 ~E~~~~g~L~~~~~~~---~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~ 153 (324)
T cd05587 80 MEYVNGGDLMYHIQQV---GKFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIF 153 (324)
T ss_pred EcCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEEEeecCcceecCC
Confidence 9999999999998754 3488999999999999999999999 999999999999999999999999999875433
Q ss_pred CCCCceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCCCCCcch
Q 044366 805 HSSNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRDV 884 (918)
Q Consensus 805 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 884 (918)
.........|++.|+|||++.+..++.++||||+||++|||++|+.||...... ... ..+....... +..
T Consensus 154 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~-----~~~---~~i~~~~~~~-~~~- 223 (324)
T cd05587 154 GGKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED-----ELF---QSIMEHNVSY-PKS- 223 (324)
T ss_pred CCCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH-----HHH---HHHHcCCCCC-CCC-
Confidence 333344567899999999999989999999999999999999999998644321 011 1111111111 111
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCH
Q 044366 885 TDKLRSIMEVAILCLVENPEARPTM 909 (918)
Q Consensus 885 ~~~~~~l~~li~~cl~~dp~~RPt~ 909 (918)
....+.+++.+|++.||.+|+++
T Consensus 224 --~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 224 --LSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred --CCHHHHHHHHHHhhcCHHHcCCC
Confidence 22457889999999999999976
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=337.99 Aligned_cols=253 Identities=22% Similarity=0.302 Sum_probs=198.5
Q ss_pred cCCCCceeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEEE
Q 044366 646 GNFGEKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFIV 724 (918)
Q Consensus 646 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 724 (918)
++|+..+.||+|+||.||+|+. .+|+.||||++....... ......+.+|+++++.++||||+++++++.+++..++|
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv 79 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLE-KEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLI 79 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhh-hhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEE
Confidence 3688899999999999999965 478999999987542221 22345688999999999999999999999999999999
Q ss_pred EEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccCC
Q 044366 725 CEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEP 804 (918)
Q Consensus 725 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~~ 804 (918)
|||+++|+|.+++.... .+++.++..++.|++.||+|||+. +|+||||||+||+++.++.++|+|||++..+..
T Consensus 80 ~E~~~~g~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 153 (364)
T cd05599 80 MEYLPGGDMMTLLMKKD---TFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKK 153 (364)
T ss_pred ECCCCCcHHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEeecccceeccc
Confidence 99999999999997643 489999999999999999999999 999999999999999999999999999876532
Q ss_pred CCC--------------------------------------CceecccccccccccccccCCCCcccchhhHHHHHHHHH
Q 044366 805 HSS--------------------------------------NWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVI 846 (918)
Q Consensus 805 ~~~--------------------------------------~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~ 846 (918)
... .....+||+.|+|||++.+..++.++|||||||++|||+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~ 233 (364)
T cd05599 154 SHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEML 233 (364)
T ss_pred cccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhh
Confidence 110 001235899999999999989999999999999999999
Q ss_pred hCCCCCCcchhhhhhhhhhHhhhhhhcccCCCCCCcchHHHHHHHHHHHHHcccCCCCCCCC---HHHHHH
Q 044366 847 KGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPT---MKEVCN 914 (918)
Q Consensus 847 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt---~~evl~ 914 (918)
+|+.||...... .... ..... ......+.. ......+.+++.+|+. +|.+|++ ++|+++
T Consensus 234 ~G~~Pf~~~~~~-~~~~----~i~~~-~~~~~~~~~--~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~ 295 (364)
T cd05599 234 VGYPPFCSDNPQ-ETYR----KIINW-KETLQFPDE--VPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS 295 (364)
T ss_pred cCCCCCCCCCHH-HHHH----HHHcC-CCccCCCCC--CCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence 999998654321 1111 11000 011111111 0122456778888886 9999998 888865
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=323.02 Aligned_cols=260 Identities=22% Similarity=0.323 Sum_probs=195.1
Q ss_pred cCCCCceeeccccceEEEEEEe-C-CCCEEEEEEcccccccCCCCChHHHHHHHHHHhhc---cCCceeeEecccc----
Q 044366 646 GNFGEKYCIGKGGQRSVYKAEL-P-SGNIFAVKKFKAELFSDETANPSEFLNEVLALTEI---RHRNIIKFHGFCS---- 716 (918)
Q Consensus 646 ~~~~~~~~lg~G~~g~Vy~~~~-~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l---~h~niv~~~~~~~---- 716 (918)
.+|.+.+.||+|+||.||+|+. . +|+.||+|+++..... ......+.+|+.+++.+ +||||+++++++.
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~ 78 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGE--EGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 78 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCC--CCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccC
Confidence 3688899999999999999965 3 4688999998754322 22234567787777665 6999999999874
Q ss_pred -cCCceEEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEec
Q 044366 717 -NAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSD 795 (918)
Q Consensus 717 -~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~D 795 (918)
.....++||||++ ++|.+++.... ...+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|
T Consensus 79 ~~~~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~~~~kl~D 153 (290)
T cd07862 79 DRETKLTLVFEHVD-QDLTTYLDKVP-EPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLAD 153 (290)
T ss_pred CCCCcEEEEEccCC-CCHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCCCCEEEcc
Confidence 3456899999997 59999987543 33489999999999999999999999 999999999999999999999999
Q ss_pred cccccccCCCCCCceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhh-----
Q 044366 796 FGFAKFLEPHSSNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVN----- 870 (918)
Q Consensus 796 fG~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~----- 870 (918)
||+++..... .......|++.|+|||++.+..++.++|||||||++|||++|++||...... ...........
T Consensus 154 fg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~-~~~~~i~~~~~~~~~~ 231 (290)
T cd07862 154 FGLARIYSFQ-MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV-DQLGKILDVIGLPGEE 231 (290)
T ss_pred ccceEeccCC-cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHH-HHHHHHHHHhCCCChh
Confidence 9999876533 2233456899999999998888999999999999999999999998754321 11111110000
Q ss_pred ----------hhcccCCCCCCc-chHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 871 ----------QILDHRLPTPSR-DVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 871 ----------~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
.......+.+.. ..++....+.+++.+|++.||++|||+.|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 232 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred hchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 000000000000 00112345789999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=315.43 Aligned_cols=261 Identities=23% Similarity=0.316 Sum_probs=209.5
Q ss_pred cCCCCceeeccccceEEEEEEeC-CCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEEE
Q 044366 646 GNFGEKYCIGKGGQRSVYKAELP-SGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFIV 724 (918)
Q Consensus 646 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 724 (918)
++|...+.||+|+||.||+|... +|+.||+|.++..... .....+.+.+|++++++++|++++++++++..++..++|
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv 80 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMM-DAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIV 80 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeeccccc-chhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence 57889999999999999999665 8999999998653222 222356899999999999999999999999999999999
Q ss_pred EEeccCCChhHHhhccc-ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccC
Q 044366 725 CEYLARGSLTTILRDDA-AAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLE 803 (918)
Q Consensus 725 ~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~ 803 (918)
|||+++|+|.+++.... ....+++.+++.++.+++.|++|||+. +++||||+|+||+++.++.++++|||++....
T Consensus 81 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~ 157 (267)
T cd08224 81 LELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFS 157 (267)
T ss_pred EecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEEEeccceeeecc
Confidence 99999999999986532 234589999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCCceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCCCCCcc
Q 044366 804 PHSSNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRD 883 (918)
Q Consensus 804 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 883 (918)
..........++..|+|||.+.+..++.++||||||+++|+|++|+.|+......... ... .......++.+
T Consensus 158 ~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~---~~~---~~~~~~~~~~~-- 229 (267)
T cd08224 158 SKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYS---LCK---KIEKCDYPPLP-- 229 (267)
T ss_pred CCCcccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHH---HHh---hhhcCCCCCCC--
Confidence 4433334456888999999999888999999999999999999999997543211100 111 11111111111
Q ss_pred hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhC
Q 044366 884 VTDKLRSIMEVAILCLVENPEARPTMKEVCNLLCK 918 (918)
Q Consensus 884 ~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~ 918 (918)
.......+.+++.+||..+|++|||+.+|++.|++
T Consensus 230 ~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~ 264 (267)
T cd08224 230 ADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKE 264 (267)
T ss_pred hhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHH
Confidence 11233568889999999999999999999998863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-36 Score=316.49 Aligned_cols=254 Identities=27% Similarity=0.446 Sum_probs=203.3
Q ss_pred cCCCCceeeccccceEEEEEEeC----CCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCce
Q 044366 646 GNFGEKYCIGKGGQRSVYKAELP----SGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHS 721 (918)
Q Consensus 646 ~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 721 (918)
++|+..+.||+|+||.||+|.+. +...||||.++... ......+|.+|+..++.++||||+++++++...+..
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 80 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS---SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPV 80 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC---ChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCce
Confidence 56888999999999999999764 24579999886532 222356789999999999999999999999999999
Q ss_pred EEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccc
Q 044366 722 FIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKF 801 (918)
Q Consensus 722 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~ 801 (918)
++||||+++++|.+++.... ..+++.++++++.|++.|++|||+. +|+||||||+||++++++.++++|||++..
T Consensus 81 ~iv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~ 155 (266)
T cd05033 81 MIITEYMENGSLDKFLREND--GKFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRR 155 (266)
T ss_pred EEEEEcCCCCCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCCEEECccchhhc
Confidence 99999999999999997643 3589999999999999999999999 999999999999999999999999999988
Q ss_pred cCCCCCCc--eecccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhhhhhhhhhHhhhhhhcccCCC
Q 044366 802 LEPHSSNW--TEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIK-GYHPGDFVSTIFSSISNMIIEVNQILDHRLP 878 (918)
Q Consensus 802 ~~~~~~~~--~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 878 (918)
........ ....++..|+|||.+.+..++.++||||||+++|||++ |..||...... .... .+......
T Consensus 156 ~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~-----~~~~---~~~~~~~~ 227 (266)
T cd05033 156 LEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQ-----DVIK---AVEDGYRL 227 (266)
T ss_pred ccccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHH-----HHHH---HHHcCCCC
Confidence 75222221 12234678999999998889999999999999999998 99997543211 0111 11111111
Q ss_pred CCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhC
Q 044366 879 TPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLLCK 918 (918)
Q Consensus 879 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~ 918 (918)
+... .....+.+++.+||+.+|++||++.|+++.|++
T Consensus 228 ~~~~---~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~ 264 (266)
T cd05033 228 PPPM---DCPSALYQLMLDCWQKDRNERPTFSQIVSTLDK 264 (266)
T ss_pred CCCC---CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence 1111 223467899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=359.02 Aligned_cols=485 Identities=31% Similarity=0.322 Sum_probs=415.5
Q ss_pred cccCCCCCCccCCc-cCCCCCCCCEEeCCCCcccccCCccccCCCCCCEEEcccccccccCCCCcCCCCCCCEEEccccc
Q 044366 2 LNLGFNLLFGNIPP-QIGNLSKLQYLDLGNNQLSGVIPPEIGKLNQLRRLYLDVNQLHGTIPPVIGQLSLINELVFCHNN 80 (918)
Q Consensus 2 l~~~~~~~~~~~p~-~~~~l~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~ 80 (918)
||+..|-+- ..|- .+.+.-+|+.||+++|++. ..|..+..+.+|+.|++++|-|. ..|.+..++.+|++|.|.+|.
T Consensus 26 ln~~~N~~l-~~pl~~~~~~v~L~~l~lsnn~~~-~fp~~it~l~~L~~ln~s~n~i~-~vp~s~~~~~~l~~lnL~~n~ 102 (1081)
T KOG0618|consen 26 LNLRRNSLL-SRPLEFVEKRVKLKSLDLSNNQIS-SFPIQITLLSHLRQLNLSRNYIR-SVPSSCSNMRNLQYLNLKNNR 102 (1081)
T ss_pred hhccccccc-cCchHHhhheeeeEEeeccccccc-cCCchhhhHHHHhhcccchhhHh-hCchhhhhhhcchhheeccch
Confidence 677777555 4443 3455555999999999998 89999999999999999999998 899999999999999999999
Q ss_pred ccccCCccccCCCCCCEEEccCCcccccCccccCCCCCCCEEECcCCcCCCcCCcCCCCCCCCceeeccccccccCCCcc
Q 044366 81 VSGRIPSSLGNLSNLALLYLNDNSLFGSIPIVMGNLKSLSTLDLSQNQLNGSIPCSLDNLSNLDTLFLYKNSLSGPIPSV 160 (918)
Q Consensus 81 ~~~~~p~~l~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~ 160 (918)
+. ..|.++..+++|++|+++.|++. ..|..+..+..+..++.++|.-.. .++... .+.+++..|.+.+.++..
T Consensus 103 l~-~lP~~~~~lknl~~LdlS~N~f~-~~Pl~i~~lt~~~~~~~s~N~~~~----~lg~~~-ik~~~l~~n~l~~~~~~~ 175 (1081)
T KOG0618|consen 103 LQ-SLPASISELKNLQYLDLSFNHFG-PIPLVIEVLTAEEELAASNNEKIQ----RLGQTS-IKKLDLRLNVLGGSFLID 175 (1081)
T ss_pred hh-cCchhHHhhhcccccccchhccC-CCchhHHhhhHHHHHhhhcchhhh----hhcccc-chhhhhhhhhcccchhcc
Confidence 88 89999999999999999999986 788899999999999999993221 233333 889999999999888888
Q ss_pred cccccccCeeeccccccCCcCCccCCCCCCCcEeeccCcccccCCCccccCCCCcceeecccccccCCCCCCCcCCCcCC
Q 044366 161 IGNLKSLLQLDLSENRLSGLIPLSLSNLSSLTVMSLFNNSLSGSIPPILGNLKSLSTLGLHINQLNGVIPPSIGNLSSLR 240 (918)
Q Consensus 161 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~ 240 (918)
+..+.. .|+|++|.+... .+..+++|+.|....|+++.. --..++|+.|+.++|.++...+. + --.+|+
T Consensus 176 i~~l~~--~ldLr~N~~~~~---dls~~~~l~~l~c~rn~ls~l----~~~g~~l~~L~a~~n~l~~~~~~-p-~p~nl~ 244 (1081)
T KOG0618|consen 176 IYNLTH--QLDLRYNEMEVL---DLSNLANLEVLHCERNQLSEL----EISGPSLTALYADHNPLTTLDVH-P-VPLNLQ 244 (1081)
T ss_pred hhhhhe--eeecccchhhhh---hhhhccchhhhhhhhcccceE----EecCcchheeeeccCcceeeccc-c-ccccce
Confidence 877777 799999999833 678889999999999998743 22447899999999999843322 2 235899
Q ss_pred eEEcccCcCcCCCCccccccCCCCeEecCCCccCCcCCCcCCCCCCCcEEEccCCcCcCCCCccccCCCCCCeEEeeccc
Q 044366 241 NLSLFNNRLYGFVPKEIGYLKSLSKLEFCANHLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLRNLTSLERVRFNQNN 320 (918)
Q Consensus 241 ~L~Ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~ 320 (918)
++++|+|+++.. |+++..+.+|+.++...|+++ ..|..+...++|+.|.+..|.+. -+|....++..|+.|+|..|+
T Consensus 245 ~~dis~n~l~~l-p~wi~~~~nle~l~~n~N~l~-~lp~ri~~~~~L~~l~~~~nel~-yip~~le~~~sL~tLdL~~N~ 321 (1081)
T KOG0618|consen 245 YLDISHNNLSNL-PEWIGACANLEALNANHNRLV-ALPLRISRITSLVSLSAAYNELE-YIPPFLEGLKSLRTLDLQSNN 321 (1081)
T ss_pred eeecchhhhhcc-hHHHHhcccceEecccchhHH-hhHHHHhhhhhHHHHHhhhhhhh-hCCCcccccceeeeeeehhcc
Confidence 999999999965 599999999999999999996 66778888999999999999997 567788889999999999999
Q ss_pred ccCccccccCCCCC-ccEEeCCCCccccccCcccccccccceeeccccccccCCCcCcCCCCCCcEEEccCceecccccc
Q 044366 321 LYGKVYEAFGDHPN-LTFLDLSQNNFYCEISFNWRNFSKLGTFNASMNNIYGSIPPEIGDSSKLQVLDLSSNHIFGKIPV 399 (918)
Q Consensus 321 l~~~~~~~~~~l~~-L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~n~i~~~~~~~~~~~~~L~~L~L~~N~l~~~~~~ 399 (918)
|...+...|..... |+.|+.+.|++...+...-...+.|+.|.+.+|.++...-+.+-+..+|++|+|++|+|......
T Consensus 322 L~~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~~fpas 401 (1081)
T KOG0618|consen 322 LPSLPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLNSFPAS 401 (1081)
T ss_pred ccccchHHHhhhhHHHHHHhhhhccccccccccchhhHHHHHHHHhcCcccccchhhhccccceeeeeecccccccCCHH
Confidence 99999988877766 99999999999988877777888999999999999999888999999999999999999977777
Q ss_pred chhhccccCceecccccccCCCCCCCCCCCcccEEeccCccccccCccccccccccceecccCcccCCCCchhhcccccc
Q 044366 400 QLVKLFSLNKLILSLNQLFGGVPLEFGTLTELQYLDLSANKLSSSIPMSIGNLLKLHYLNLSNNQFSHKIPTEFEKLIHL 479 (918)
Q Consensus 400 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L 479 (918)
.+.++..|++|+||+|+++ .+|..+..+..|++|...+|.|. ..| .+..+++|+.+|+|.|+++...-..-...++|
T Consensus 402 ~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~-~fP-e~~~l~qL~~lDlS~N~L~~~~l~~~~p~p~L 478 (1081)
T KOG0618|consen 402 KLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLL-SFP-ELAQLPQLKVLDLSCNNLSEVTLPEALPSPNL 478 (1081)
T ss_pred HHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCcee-ech-hhhhcCcceEEecccchhhhhhhhhhCCCccc
Confidence 8899999999999999997 55688999999999999999999 677 89999999999999999976543333333899
Q ss_pred ceEeccCCcCCCCCchhccccCCcceEecCCCcc
Q 044366 480 SELDLSHNILQEEIPPQICKMESLEKLNLSHNNL 513 (918)
Q Consensus 480 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l 513 (918)
++|||++|.=.......|..+..+...+++-|+.
T Consensus 479 kyLdlSGN~~l~~d~~~l~~l~~l~~~~i~~~~~ 512 (1081)
T KOG0618|consen 479 KYLDLSGNTRLVFDHKTLKVLKSLSQMDITLNNT 512 (1081)
T ss_pred ceeeccCCcccccchhhhHHhhhhhheecccCCC
Confidence 9999999974446667788888888888877743
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=328.05 Aligned_cols=201 Identities=26% Similarity=0.355 Sum_probs=174.3
Q ss_pred hcCCCCceeeccccceEEEEEEeC-CCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEE
Q 044366 645 TGNFGEKYCIGKGGQRSVYKAELP-SGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFI 723 (918)
Q Consensus 645 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 723 (918)
.++|+..+.||+|+||.||+|... +|+.+|+|.+.... .......+.+|+++++.++||||+++++++.+++..++
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI---KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI 80 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc---CHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEE
Confidence 468999999999999999999654 78899999876532 12234678999999999999999999999999999999
Q ss_pred EEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccC
Q 044366 724 VCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLE 803 (918)
Q Consensus 724 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~ 803 (918)
||||+++|+|.++++... .+++..+..++.|++.|++|||+.. +++||||||+||+++.++.+||+|||++..+.
T Consensus 81 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~ 155 (333)
T cd06650 81 CMEHMDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 155 (333)
T ss_pred EEecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhh
Confidence 999999999999997643 4788999999999999999999742 79999999999999999999999999997654
Q ss_pred CCCCCceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcc
Q 044366 804 PHSSNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFV 855 (918)
Q Consensus 804 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~ 855 (918)
... .....|+..|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 156 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~ 205 (333)
T cd06650 156 DSM--ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPP 205 (333)
T ss_pred hhc--cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence 322 23346889999999999888999999999999999999999998643
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=351.88 Aligned_cols=258 Identities=23% Similarity=0.321 Sum_probs=200.1
Q ss_pred cCCCCceeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEEE
Q 044366 646 GNFGEKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFIV 724 (918)
Q Consensus 646 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 724 (918)
++|++.+.||+|+||.||+|.. .+|+.||+|+++.... ......++|.+|+++++.++||||+++++++.+++..++|
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~-~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLV 80 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLS-ENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYT 80 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccc-cCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEE
Confidence 5789999999999999999955 4689999999875322 1222346799999999999999999999999999999999
Q ss_pred EEeccCCChhHHhhccc--------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEecc
Q 044366 725 CEYLARGSLTTILRDDA--------AAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDF 796 (918)
Q Consensus 725 ~e~~~~gsL~~~l~~~~--------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Df 796 (918)
|||+++|+|.+++.... .....++.++++++.||++||+|||+. +|+||||||+||+++.++.++|+||
T Consensus 81 MEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~dg~vKLiDF 157 (932)
T PRK13184 81 MPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDW 157 (932)
T ss_pred EEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCCCCEEEEec
Confidence 99999999999986421 123457788899999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCC------------------CCceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhh
Q 044366 797 GFAKFLEPHS------------------SNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTI 858 (918)
Q Consensus 797 G~~~~~~~~~------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~ 858 (918)
|++....... ......+||+.|+|||++.+..++.++|||||||++|||+||+.||......
T Consensus 158 GLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ 237 (932)
T PRK13184 158 GAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGR 237 (932)
T ss_pred CcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchh
Confidence 9998762111 0112346899999999999999999999999999999999999998643221
Q ss_pred hhhhhhhHhhhhhhcccCCCCCCcchHHHHHHHHHHHHHcccCCCCCCCC-HHHHHHHh
Q 044366 859 FSSISNMIIEVNQILDHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPT-MKEVCNLL 916 (918)
Q Consensus 859 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt-~~evl~~L 916 (918)
... .. .....+... ....+....+.+++.+|++.||++||+ ++++.+.|
T Consensus 238 ki~-----~~-~~i~~P~~~---~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~L 287 (932)
T PRK13184 238 KIS-----YR-DVILSPIEV---APYREIPPFLSQIAMKALAVDPAERYSSVQELKQDL 287 (932)
T ss_pred hhh-----hh-hhccChhhc---cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 000 00 011111000 011123356788999999999999965 55555554
|
|
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-36 Score=314.69 Aligned_cols=252 Identities=25% Similarity=0.354 Sum_probs=206.7
Q ss_pred CCCCceeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEEEE
Q 044366 647 NFGEKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFIVC 725 (918)
Q Consensus 647 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 725 (918)
+|...+.||+|++|.||+|.. .+++.||+|.+..... .....+++.+|+++++.++||||+++++++.+++..++||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 78 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKM--NRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVM 78 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhC--CHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEE
Confidence 477788999999999999965 4789999999865322 2234578999999999999999999999999999999999
Q ss_pred EeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccCCC
Q 044366 726 EYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPH 805 (918)
Q Consensus 726 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~~~ 805 (918)
||+++++|.++++... ...+++.+++.++.|++.|++|||+. +++|+||+|+||+++.++.++++|||++..+...
T Consensus 79 e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~ 154 (256)
T cd08529 79 EYAENGDLHKLLKMQR-GRPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDN 154 (256)
T ss_pred EeCCCCcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEEcccccceeccCc
Confidence 9999999999998642 34689999999999999999999999 9999999999999999999999999999877654
Q ss_pred CCCceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCCCCCcchH
Q 044366 806 SSNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRDVT 885 (918)
Q Consensus 806 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 885 (918)
........|++.|+|||+..+..++.++||||||+++|||++|+.||...... . ..........+....
T Consensus 155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~------~~~~~~~~~~~~~~~--- 223 (256)
T cd08529 155 TNFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQG--A------LILKIIRGVFPPVSQ--- 223 (256)
T ss_pred cchhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH--H------HHHHHHcCCCCCCcc---
Confidence 44344456889999999999888999999999999999999999998654321 0 011111122222111
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 044366 886 DKLRSIMEVAILCLVENPEARPTMKEVCNL 915 (918)
Q Consensus 886 ~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 915 (918)
.....+.+++.+||+.+|++||++.++++.
T Consensus 224 ~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 224 MYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred ccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 233568899999999999999999999863
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=332.80 Aligned_cols=240 Identities=26% Similarity=0.345 Sum_probs=189.7
Q ss_pred eeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHH-HHhhccCCceeeEecccccCCceEEEEEecc
Q 044366 652 YCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVL-ALTEIRHRNIIKFHGFCSNAQHSFIVCEYLA 729 (918)
Q Consensus 652 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~-~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 729 (918)
+.||+|+||.||+|.. .+|+.||+|++........ .....+..|.. +++.++||||+++++++.+.+..++||||++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~ 79 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKK-KEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVN 79 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhh-hHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCC
Confidence 3699999999999965 4799999999875432221 22344555554 4678899999999999999999999999999
Q ss_pred CCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccCCCCCCc
Q 044366 730 RGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNW 809 (918)
Q Consensus 730 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~~~~~~~ 809 (918)
+|+|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||++..........
T Consensus 80 ~g~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 153 (323)
T cd05575 80 GGELFFHLQRE---RSFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTT 153 (323)
T ss_pred CCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCcc
Confidence 99999998764 3488999999999999999999999 99999999999999999999999999997644333334
Q ss_pred eecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCCCCCcchHHHHH
Q 044366 810 TEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRDVTDKLR 889 (918)
Q Consensus 810 ~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 889 (918)
....|++.|+|||++.+..++.++|||||||++|||++|+.||...... ... ..+....... ... ...
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~-----~~~---~~i~~~~~~~-~~~---~~~ 221 (323)
T cd05575 154 STFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTA-----EMY---DNILNKPLRL-KPN---ISV 221 (323)
T ss_pred ccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHH-----HHH---HHHHcCCCCC-CCC---CCH
Confidence 4567899999999999989999999999999999999999998643211 111 1111111111 111 134
Q ss_pred HHHHHHHHcccCCCCCCCCHH
Q 044366 890 SIMEVAILCLVENPEARPTMK 910 (918)
Q Consensus 890 ~l~~li~~cl~~dp~~RPt~~ 910 (918)
.+.+++.+|++.||++||++.
T Consensus 222 ~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 222 SARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred HHHHHHHHHhhcCHHhCCCCC
Confidence 678899999999999999984
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=343.17 Aligned_cols=250 Identities=21% Similarity=0.247 Sum_probs=200.7
Q ss_pred CCCCceeeccccceEEEEEEe-CC-CCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEEE
Q 044366 647 NFGEKYCIGKGGQRSVYKAEL-PS-GNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFIV 724 (918)
Q Consensus 647 ~~~~~~~lg~G~~g~Vy~~~~-~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 724 (918)
.|...+.||+|++|.||+|.. .+ ++.||+|.+... .......+.+|+.+++.++||||+++++++..++..++|
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~----~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv 143 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN----DERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLI 143 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccC----CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEE
Confidence 488889999999999999944 34 678888876432 223345678899999999999999999999999999999
Q ss_pred EEeccCCChhHHhhcc-cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccC
Q 044366 725 CEYLARGSLTTILRDD-AAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLE 803 (918)
Q Consensus 725 ~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~ 803 (918)
|||+++|+|.++++.. ....++++.++..++.|++.||+|+|+. +|+||||||+||+++.++.+||+|||+++.+.
T Consensus 144 ~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~ 220 (478)
T PTZ00267 144 MEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYS 220 (478)
T ss_pred EECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEEEeCcCceecC
Confidence 9999999999988653 2234589999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCC--CceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCCCCC
Q 044366 804 PHSS--NWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPS 881 (918)
Q Consensus 804 ~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 881 (918)
.... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ..............+
T Consensus 221 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~--------~~~~~~~~~~~~~~~ 292 (478)
T PTZ00267 221 DSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQR--------EIMQQVLYGKYDPFP 292 (478)
T ss_pred CccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH--------HHHHHHHhCCCCCCC
Confidence 4322 123456899999999999989999999999999999999999998643221 011111111111111
Q ss_pred cchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 882 RDVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 882 ~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
.. ....+.+++.+||+.||++||++++++.
T Consensus 293 ~~---~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 293 CP---VSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred cc---CCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 11 2246888999999999999999999875
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=334.20 Aligned_cols=256 Identities=18% Similarity=0.262 Sum_probs=199.0
Q ss_pred HHhcCCCCceeeccccceEEEEEEeC-CCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCce
Q 044366 643 KATGNFGEKYCIGKGGQRSVYKAELP-SGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHS 721 (918)
Q Consensus 643 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 721 (918)
...++|+..+.||+|+||.||+|+.. +++.||+|.+...... .....+.+.+|+.+++.++||||+++++++.+++..
T Consensus 40 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~ 118 (370)
T cd05621 40 MKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMI-KRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYL 118 (370)
T ss_pred CCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhh-hhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEE
Confidence 34578999999999999999999654 6889999998653221 122345688999999999999999999999999999
Q ss_pred EEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccc
Q 044366 722 FIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKF 801 (918)
Q Consensus 722 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~ 801 (918)
++||||+++|+|.+++... .+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||++..
T Consensus 119 ~lv~Ey~~gg~L~~~l~~~----~~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~~~kL~DFG~a~~ 191 (370)
T cd05621 119 YMVMEYMPGGDLVNLMSNY----DVPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLADFGTCMK 191 (370)
T ss_pred EEEEcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEEeccccee
Confidence 9999999999999999653 378899999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCC-CceecccccccccccccccCC----CCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccC
Q 044366 802 LEPHSS-NWTEFAGTVGYAAPELAYTMR----ATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHR 876 (918)
Q Consensus 802 ~~~~~~-~~~~~~g~~~y~aPE~~~~~~----~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 876 (918)
...... ......||+.|+|||++.+.. ++.++||||+||++|||++|+.||...... .. ...+....
T Consensus 192 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~-~~-------~~~i~~~~ 263 (370)
T cd05621 192 MDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLV-GT-------YSKIMDHK 263 (370)
T ss_pred cccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHH-HH-------HHHHHhCC
Confidence 654322 223457899999999987543 778999999999999999999998644321 11 11111111
Q ss_pred CCCCCcchHHHHHHHHHHHHHcccCCCCC--CCCHHHHHH
Q 044366 877 LPTPSRDVTDKLRSIMEVAILCLVENPEA--RPTMKEVCN 914 (918)
Q Consensus 877 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~--RPt~~evl~ 914 (918)
.....+........+.+++..|+..++.+ ||++.|+++
T Consensus 264 ~~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~ 303 (370)
T cd05621 264 NSLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQ 303 (370)
T ss_pred cccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhc
Confidence 10000111122345677888888765544 899999875
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=329.94 Aligned_cols=244 Identities=23% Similarity=0.339 Sum_probs=195.8
Q ss_pred CCCCceeeccccceEEEEEEeC-CCCEEEEEEcccccccCCCCChHHHHHHHHHHhhc-cCCceeeEecccccCCceEEE
Q 044366 647 NFGEKYCIGKGGQRSVYKAELP-SGNIFAVKKFKAELFSDETANPSEFLNEVLALTEI-RHRNIIKFHGFCSNAQHSFIV 724 (918)
Q Consensus 647 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv 724 (918)
+|...+.||+|+||.||+|... +++.||+|+++..... .....+.+..|..++... +|++|+++++++...+..++|
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv 79 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVI-QDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFV 79 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEE
Confidence 4778899999999999999554 6789999998764322 122345677788888777 589999999999999999999
Q ss_pred EEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccCC
Q 044366 725 CEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEP 804 (918)
Q Consensus 725 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~~ 804 (918)
|||+++|+|.+++.... .+++.++..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++....
T Consensus 80 ~E~~~~g~L~~~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~ 153 (323)
T cd05616 80 MEYVNGGDLMYQIQQVG---RFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMW 153 (323)
T ss_pred EcCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEEEccCCCceecCC
Confidence 99999999999987543 489999999999999999999999 999999999999999999999999999986543
Q ss_pred CCCCceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCCCCCcch
Q 044366 805 HSSNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRDV 884 (918)
Q Consensus 805 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 884 (918)
.........||+.|+|||++.+..++.++|||||||++|||++|+.||...... . . ...+.......+ ..
T Consensus 154 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~--~---~---~~~i~~~~~~~p-~~- 223 (323)
T cd05616 154 DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED--E---L---FQSIMEHNVAYP-KS- 223 (323)
T ss_pred CCCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHH--H---H---HHHHHhCCCCCC-Cc-
Confidence 333344567899999999999999999999999999999999999998754321 0 0 111111111111 11
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCH
Q 044366 885 TDKLRSIMEVAILCLVENPEARPTM 909 (918)
Q Consensus 885 ~~~~~~l~~li~~cl~~dp~~RPt~ 909 (918)
...++.+++.+|++.||.+|+++
T Consensus 224 --~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 224 --MSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred --CCHHHHHHHHHHcccCHHhcCCC
Confidence 23467889999999999999984
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-36 Score=314.58 Aligned_cols=251 Identities=26% Similarity=0.429 Sum_probs=201.3
Q ss_pred cCCCCceeeccccceEEEEEEeCCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEEEE
Q 044366 646 GNFGEKYCIGKGGQRSVYKAELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFIVC 725 (918)
Q Consensus 646 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 725 (918)
.+|++.+.||+|+||.||+|...+++.+|+|.+... ......|.+|+++++.++||||+++++++...+..++||
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~-----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 78 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREG-----AMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVT 78 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecCCccEEEEEeccC-----CCCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEE
Confidence 347788899999999999998877788999987542 223467899999999999999999999999999999999
Q ss_pred EeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccCCC
Q 044366 726 EYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPH 805 (918)
Q Consensus 726 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~~~ 805 (918)
||+++++|.+++.... ..+++..++.++.|++.|++|||+. +++||||||+||+++.++.+|++|||.++.....
T Consensus 79 e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~ 153 (256)
T cd05059 79 EYMANGCLLNYLRERK--GKLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDD 153 (256)
T ss_pred ecCCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECCcccceecccc
Confidence 9999999999997643 2589999999999999999999999 9999999999999999999999999999866432
Q ss_pred CCCc-eecccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhhhhhhhhhHhhhhhhcccCCCCCCcc
Q 044366 806 SSNW-TEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIK-GYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRD 883 (918)
Q Consensus 806 ~~~~-~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 883 (918)
.... ....++..|+|||.+.+..++.++||||||+++|||++ |+.||+..... . ......... +...+ .
T Consensus 154 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-~----~~~~~~~~~--~~~~~-~- 224 (256)
T cd05059 154 QYTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNS-E----VVESVSAGY--RLYRP-K- 224 (256)
T ss_pred cccccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHH-H----HHHHHHcCC--cCCCC-C-
Confidence 2111 11223457999999998899999999999999999999 78887643221 1 111111111 11111 1
Q ss_pred hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 044366 884 VTDKLRSIMEVAILCLVENPEARPTMKEVCNLLC 917 (918)
Q Consensus 884 ~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 917 (918)
.....+.+++.+||..+|++|||+.|+++.|.
T Consensus 225 --~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l~ 256 (256)
T cd05059 225 --LAPTEVYTIMYSCWHEKPEDRPAFKKLLSQLT 256 (256)
T ss_pred --CCCHHHHHHHHHHhcCChhhCcCHHHHHHHhC
Confidence 12346889999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=332.29 Aligned_cols=203 Identities=24% Similarity=0.335 Sum_probs=175.0
Q ss_pred cCCCCceeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEEE
Q 044366 646 GNFGEKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFIV 724 (918)
Q Consensus 646 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 724 (918)
++|+..+.||+|+||.||+|.. .+++.||+|+++..... .......+.+|+.+++.++||||+++++++.+....++|
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv 79 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADML-EKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLI 79 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHH-HhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEE
Confidence 4688899999999999999954 57899999998753221 122345788899999999999999999999999999999
Q ss_pred EEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccCC
Q 044366 725 CEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEP 804 (918)
Q Consensus 725 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~~ 804 (918)
|||+++|+|.+++... ..+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.+..
T Consensus 80 ~E~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vkL~DFGla~~~~~ 153 (363)
T cd05628 80 MEFLPGGDMMTLLMKK---DTLTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKK 153 (363)
T ss_pred EcCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEEEeeccCcccccc
Confidence 9999999999999764 3489999999999999999999999 999999999999999999999999999976532
Q ss_pred CCC-----------------------------------CceecccccccccccccccCCCCcccchhhHHHHHHHHHhCC
Q 044366 805 HSS-----------------------------------NWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGY 849 (918)
Q Consensus 805 ~~~-----------------------------------~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~ 849 (918)
... .....+||+.|+|||++.+..++.++|||||||++|||++|+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~ 233 (363)
T cd05628 154 AHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY 233 (363)
T ss_pred cccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCC
Confidence 110 012346899999999999989999999999999999999999
Q ss_pred CCCCcc
Q 044366 850 HPGDFV 855 (918)
Q Consensus 850 ~p~~~~ 855 (918)
.||...
T Consensus 234 ~Pf~~~ 239 (363)
T cd05628 234 PPFCSE 239 (363)
T ss_pred CCCCCC
Confidence 998654
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=315.08 Aligned_cols=252 Identities=24% Similarity=0.386 Sum_probs=202.1
Q ss_pred cCCCCceeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEEE
Q 044366 646 GNFGEKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFIV 724 (918)
Q Consensus 646 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 724 (918)
.+|...+.||+|+||.||+|.. .+++.||+|.+... ....+++.+|++.++.++||||+++++++..++..++|
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-----TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 80 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-----chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEE
Confidence 4577888999999999999954 46889999987642 23356799999999999999999999999999999999
Q ss_pred EEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccCC
Q 044366 725 CEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEP 804 (918)
Q Consensus 725 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~~ 804 (918)
|||+++++|.+++.... ...+++..++.++.|+++|++|||+. +++||||||+||++++++.+||+|||.+.....
T Consensus 81 ~e~~~~~~L~~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~ 156 (263)
T cd05052 81 TEFMTYGNLLDYLRECN-RQEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTG 156 (263)
T ss_pred EEeCCCCcHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeCCCcccccccc
Confidence 99999999999997643 34589999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCCc-eecccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhhhhhhhhhHhhhhhhcccCCCCCCc
Q 044366 805 HSSNW-TEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIK-GYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSR 882 (918)
Q Consensus 805 ~~~~~-~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 882 (918)
..... ....++..|+|||.+.+..++.++||||||+++|||++ |..|+...... .. ........ . +....
T Consensus 157 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~-~~----~~~~~~~~--~-~~~~~ 228 (263)
T cd05052 157 DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS-QV----YELLEKGY--R-MERPE 228 (263)
T ss_pred ceeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH-HH----HHHHHCCC--C-CCCCC
Confidence 32211 12233568999999998899999999999999999998 88887543211 11 01111100 1 11111
Q ss_pred chHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 044366 883 DVTDKLRSIMEVAILCLVENPEARPTMKEVCNLLC 917 (918)
Q Consensus 883 ~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 917 (918)
. ....+.+++.+||+.||++||++.++++.|+
T Consensus 229 ~---~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~ 260 (263)
T cd05052 229 G---CPPKVYELMRACWQWNPSDRPSFAEIHQAFE 260 (263)
T ss_pred C---CCHHHHHHHHHHccCCcccCCCHHHHHHHHH
Confidence 1 2356888999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-36 Score=317.71 Aligned_cols=249 Identities=22% Similarity=0.292 Sum_probs=195.0
Q ss_pred eccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEEEEEeccCCC
Q 044366 654 IGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFIVCEYLARGS 732 (918)
Q Consensus 654 lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gs 732 (918)
||+|+||.||+++. .+|+.||+|.+....... ......+..|+++++.++||||+++++++.++...++||||+++|+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~-~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~ 79 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKK-KSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGD 79 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhc-chhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCC
Confidence 69999999999965 469999999986532221 1223456779999999999999999999999999999999999999
Q ss_pred hhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccCCCCCCceec
Q 044366 733 LTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEF 812 (918)
Q Consensus 733 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~ 812 (918)
|.+++.... ...+++..+..++.|++.|++|||+. +++||||||+||+++.++.++|+|||++....... .....
T Consensus 80 L~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~-~~~~~ 154 (277)
T cd05607 80 LKYHIYNVG-ERGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK-TITQR 154 (277)
T ss_pred HHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc-eeecc
Confidence 998886543 33478999999999999999999999 99999999999999999999999999998765332 22345
Q ss_pred ccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCCCCCcchHHHHHHHH
Q 044366 813 AGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRDVTDKLRSIM 892 (918)
Q Consensus 813 ~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 892 (918)
.|+..|+|||++.+..++.++||||+||++|||++|+.||......... . ................ ....++.
T Consensus 155 ~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~-~---~~~~~~~~~~~~~~~~---~~~~~~~ 227 (277)
T cd05607 155 AGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAK-E---ELKRRTLEDEVKFEHQ---NFTEESK 227 (277)
T ss_pred CCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhH-H---HHHHHhhccccccccc---cCCHHHH
Confidence 6899999999999888999999999999999999999998643221110 0 0011111111111111 2234678
Q ss_pred HHHHHcccCCCCCCCCHHHHHHH
Q 044366 893 EVAILCLVENPEARPTMKEVCNL 915 (918)
Q Consensus 893 ~li~~cl~~dp~~RPt~~evl~~ 915 (918)
+++.+||+.||++||++.|+++.
T Consensus 228 ~li~~~L~~~P~~R~~~~~~~~~ 250 (277)
T cd05607 228 DICRLFLAKKPEDRLGSREKNDD 250 (277)
T ss_pred HHHHHHhccCHhhCCCCccchhh
Confidence 89999999999999999776543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=328.73 Aligned_cols=258 Identities=23% Similarity=0.372 Sum_probs=199.9
Q ss_pred hcCCCCceeeccccceEEEEEEe------CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhc-cCCceeeEeccccc
Q 044366 645 TGNFGEKYCIGKGGQRSVYKAEL------PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEI-RHRNIIKFHGFCSN 717 (918)
Q Consensus 645 ~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~ 717 (918)
.++|.+.+.||+|+||.||+|.. .+++.||+|+++... .....+.+.+|++++.++ +|+||++++++|..
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~ 82 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA---TASEYKALMTELKILIHIGHHLNVVNLLGACTK 82 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCC---CHHHHHHHHHHHHHHHhhccCcchhheeeeEec
Confidence 35788999999999999999943 235789999986532 112245678899999999 89999999998754
Q ss_pred -CCceEEEEEeccCCChhHHhhcccc------------------------------------------------------
Q 044366 718 -AQHSFIVCEYLARGSLTTILRDDAA------------------------------------------------------ 742 (918)
Q Consensus 718 -~~~~~lv~e~~~~gsL~~~l~~~~~------------------------------------------------------ 742 (918)
+...+++|||+++|+|.+++.....
T Consensus 83 ~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (337)
T cd05054 83 PGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEG 162 (337)
T ss_pred CCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhh
Confidence 4578899999999999999864321
Q ss_pred ----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccCCCCCC--ceeccccc
Q 044366 743 ----AKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSN--WTEFAGTV 816 (918)
Q Consensus 743 ----~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~~~~~~--~~~~~g~~ 816 (918)
..++++..+..++.||+.||+|||+. +|+||||||+||++++++.++|+|||+++.+...... .....++.
T Consensus 163 ~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~ 239 (337)
T cd05054 163 DELYKEPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPL 239 (337)
T ss_pred hHHhhcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCc
Confidence 13589999999999999999999999 9999999999999999999999999999876433221 12334567
Q ss_pred ccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhhhhhhhhhHhhhhhhcccCCCCCCcchHHHHHHHHHHH
Q 044366 817 GYAAPELAYTMRATEKYDVYSFGVLALEVIK-GYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRDVTDKLRSIMEVA 895 (918)
Q Consensus 817 ~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 895 (918)
.|+|||++.+..++.++|||||||++|||++ |..||...... +.... .... ........ ....++.+++
T Consensus 240 ~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~-~~~~~---~~~~---~~~~~~~~---~~~~~~~~l~ 309 (337)
T cd05054 240 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQID-EEFCR---RLKE---GTRMRAPE---YATPEIYSIM 309 (337)
T ss_pred cccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCcc-HHHHH---HHhc---cCCCCCCc---cCCHHHHHHH
Confidence 8999999999999999999999999999998 99997643211 01111 0111 00111111 1234688999
Q ss_pred HHcccCCCCCCCCHHHHHHHhhC
Q 044366 896 ILCLVENPEARPTMKEVCNLLCK 918 (918)
Q Consensus 896 ~~cl~~dp~~RPt~~evl~~L~~ 918 (918)
.+||+.+|++||++.|+++.|++
T Consensus 310 ~~cl~~~p~~RPs~~ell~~l~~ 332 (337)
T cd05054 310 LDCWHNNPEDRPTFSELVEILGD 332 (337)
T ss_pred HHHccCChhhCcCHHHHHHHHHH
Confidence 99999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=333.12 Aligned_cols=243 Identities=25% Similarity=0.314 Sum_probs=190.1
Q ss_pred eeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHH-HHhhccCCceeeEecccccCCceEEEEEecc
Q 044366 652 YCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVL-ALTEIRHRNIIKFHGFCSNAQHSFIVCEYLA 729 (918)
Q Consensus 652 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~-~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 729 (918)
+.||+|+||.||+|+. .+++.||+|++........ .....+..|.. +++.++||||+++++++..++..++||||++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~-~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~ 79 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKK-KEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYIN 79 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhh-hHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCC
Confidence 3699999999999965 4678999999875432221 22334444444 4678899999999999999999999999999
Q ss_pred CCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccCCCCCCc
Q 044366 730 RGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNW 809 (918)
Q Consensus 730 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~~~~~~~ 809 (918)
+|+|.+++... ..+++..+..++.||++||+|||+. ||+||||||+||+++.++.+||+|||+++.........
T Consensus 80 ~~~L~~~~~~~---~~~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~~ 153 (325)
T cd05602 80 GGELFYHLQRE---RCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTT 153 (325)
T ss_pred CCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCCCCcccccCCCCc
Confidence 99999999764 3478888999999999999999999 99999999999999999999999999997654333334
Q ss_pred eecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCCCCCcchHHHHH
Q 044366 810 TEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRDVTDKLR 889 (918)
Q Consensus 810 ~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 889 (918)
....|++.|+|||++.+..++.++||||+||++|||++|+.||...... .... .+...... ... ....
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-~~~~-------~i~~~~~~-~~~---~~~~ 221 (325)
T cd05602 154 STFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA-EMYD-------NILNKPLQ-LKP---NITN 221 (325)
T ss_pred ccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHH-HHHH-------HHHhCCcC-CCC---CCCH
Confidence 4567999999999999999999999999999999999999998643321 1111 11111111 111 1234
Q ss_pred HHHHHHHHcccCCCCCCCCHHHHH
Q 044366 890 SIMEVAILCLVENPEARPTMKEVC 913 (918)
Q Consensus 890 ~l~~li~~cl~~dp~~RPt~~evl 913 (918)
.+.+++.+|++.||.+||++.+.+
T Consensus 222 ~~~~li~~~l~~~p~~R~~~~~~~ 245 (325)
T cd05602 222 SARHLLEGLLQKDRTKRLGAKDDF 245 (325)
T ss_pred HHHHHHHHHcccCHHHCCCCCCCH
Confidence 578889999999999999987543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=329.03 Aligned_cols=244 Identities=25% Similarity=0.340 Sum_probs=195.8
Q ss_pred eeeccccceEEEEEEeC-CCCEEEEEEcccccccCCCCChHHHHHHHHHHhhc-cCCceeeEecccccCCceEEEEEecc
Q 044366 652 YCIGKGGQRSVYKAELP-SGNIFAVKKFKAELFSDETANPSEFLNEVLALTEI-RHRNIIKFHGFCSNAQHSFIVCEYLA 729 (918)
Q Consensus 652 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~ 729 (918)
+.||+|+||.||+|... +++.||||+++...... ......+..|.++++.+ +||||+++++++...+..++||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~ 79 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQ-DDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVN 79 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhh-hhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCC
Confidence 36999999999999654 68899999987643222 23356678888888887 79999999999999999999999999
Q ss_pred CCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccCCCCCCc
Q 044366 730 RGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNW 809 (918)
Q Consensus 730 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~~~~~~~ 809 (918)
+|+|..++... ..+++.++..++.|++.||+|||+. +++||||||+||++++++.+||+|||+++.........
T Consensus 80 ~~~L~~~~~~~---~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 153 (318)
T cd05570 80 GGDLMFHIQRS---GRFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTT 153 (318)
T ss_pred CCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccCCCeecCcCCCcc
Confidence 99999988764 3489999999999999999999999 99999999999999999999999999997643333333
Q ss_pred eecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCCCCCcchHHHHH
Q 044366 810 TEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRDVTDKLR 889 (918)
Q Consensus 810 ~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 889 (918)
....|++.|+|||++.+..++.++|||||||++|+|++|+.||...... .. . ..+....... +.. ...
T Consensus 154 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~--~~---~---~~i~~~~~~~-~~~---~~~ 221 (318)
T cd05570 154 STFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDED--EL---F---QSILEDEVRY-PRW---LSK 221 (318)
T ss_pred cceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHH--HH---H---HHHHcCCCCC-CCc---CCH
Confidence 4456899999999999999999999999999999999999998644321 00 0 1111111111 111 224
Q ss_pred HHHHHHHHcccCCCCCCCCH-----HHHHH
Q 044366 890 SIMEVAILCLVENPEARPTM-----KEVCN 914 (918)
Q Consensus 890 ~l~~li~~cl~~dp~~RPt~-----~evl~ 914 (918)
.+.+++.+||+.||++||++ .++++
T Consensus 222 ~~~~li~~~l~~dP~~R~s~~~~~~~~ll~ 251 (318)
T cd05570 222 EAKSILKSFLTKNPEKRLGCLPTGEQDIKG 251 (318)
T ss_pred HHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence 67889999999999999999 77764
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=325.15 Aligned_cols=243 Identities=25% Similarity=0.360 Sum_probs=192.6
Q ss_pred eeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhc-cCCceeeEecccccCCceEEEEEecc
Q 044366 652 YCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEI-RHRNIIKFHGFCSNAQHSFIVCEYLA 729 (918)
Q Consensus 652 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~ 729 (918)
+.||+|+||.||+|+. .+++.||||+++...... ....+.+..|..+++.. +||||+++++++.+.+..++||||++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~ 79 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLM-DDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLN 79 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhh-cchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCC
Confidence 3699999999999965 468899999987643221 12245667788887764 89999999999999999999999999
Q ss_pred CCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccCCCCCCc
Q 044366 730 RGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNW 809 (918)
Q Consensus 730 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~~~~~~~ 809 (918)
+|+|.+++... ..+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++..........
T Consensus 80 ~g~L~~~l~~~---~~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 153 (316)
T cd05619 80 GGDLMFHIQSC---HKFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKT 153 (316)
T ss_pred CCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCce
Confidence 99999999754 3488999999999999999999999 99999999999999999999999999997643333333
Q ss_pred eecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCCCCCcchHHHHH
Q 044366 810 TEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRDVTDKLR 889 (918)
Q Consensus 810 ~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 889 (918)
....||+.|+|||++.+..++.++||||+||++|||++|+.||...... ...... .......+ .. ...
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~-----~~~~~i-~~~~~~~~---~~---~~~ 221 (316)
T cd05619 154 CTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEE-----ELFQSI-RMDNPCYP---RW---LTR 221 (316)
T ss_pred eeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHH-----HHHHHH-HhCCCCCC---cc---CCH
Confidence 4567899999999999988999999999999999999999998643321 011111 11111111 11 224
Q ss_pred HHHHHHHHcccCCCCCCCCHH-HHH
Q 044366 890 SIMEVAILCLVENPEARPTMK-EVC 913 (918)
Q Consensus 890 ~l~~li~~cl~~dp~~RPt~~-evl 913 (918)
.+.+++.+|++.||++||++. ++.
T Consensus 222 ~~~~li~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05619 222 EAKDILVKLFVREPERRLGVKGDIR 246 (316)
T ss_pred HHHHHHHHHhccCHhhcCCChHHHH
Confidence 577889999999999999997 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=332.80 Aligned_cols=254 Identities=23% Similarity=0.296 Sum_probs=200.7
Q ss_pred cCCCCceeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEEE
Q 044366 646 GNFGEKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFIV 724 (918)
Q Consensus 646 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 724 (918)
++|...+.||+|+||.||+|.. .+|+.||+|+++..... .....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv 79 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLL-AQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLV 79 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEE
Confidence 3688899999999999999954 57899999999764321 223356788999999999999999999999999999999
Q ss_pred EEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccCC
Q 044366 725 CEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEP 804 (918)
Q Consensus 725 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~~ 804 (918)
|||+++|+|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++..+..
T Consensus 80 ~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~ 154 (330)
T cd05601 80 MEYQPGGDLLSLLNRY--EDQFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIKLADFGSAARLTA 154 (330)
T ss_pred ECCCCCCCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEEeccCCCCeECCC
Confidence 9999999999999765 23589999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCC-ceecccccccccccccc------cCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCC
Q 044366 805 HSSN-WTEFAGTVGYAAPELAY------TMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRL 877 (918)
Q Consensus 805 ~~~~-~~~~~g~~~y~aPE~~~------~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 877 (918)
.... .....||+.|+|||++. ...++.++|||||||++|||++|+.||....... ...... .... ....
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~-~~~~i~-~~~~--~~~~ 230 (330)
T cd05601 155 NKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAK-TYNNIM-NFQR--FLKF 230 (330)
T ss_pred CCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHH-HHHHHH-cCCC--ccCC
Confidence 3322 23346899999999986 4567889999999999999999999986543211 111100 0000 0011
Q ss_pred CCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 878 PTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 878 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
+.. ......+.+++.+|++ +|++|||+++++.
T Consensus 231 ~~~----~~~~~~~~~li~~ll~-~p~~R~t~~~l~~ 262 (330)
T cd05601 231 PED----PKVSSDFLDLIQSLLC-GQKERLGYEGLCC 262 (330)
T ss_pred CCC----CCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence 111 1123457788889997 9999999999874
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=336.70 Aligned_cols=253 Identities=22% Similarity=0.272 Sum_probs=195.7
Q ss_pred cCCCCceeeccccceEEEEEE-eCCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEEE
Q 044366 646 GNFGEKYCIGKGGQRSVYKAE-LPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFIV 724 (918)
Q Consensus 646 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 724 (918)
++|.+.+.||+|+||.||+|. ..+|+.||||++...... .....+.+.+|+++++.++||||+++++++.+++..++|
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv 79 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMF-KKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLI 79 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHH-HhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEE
Confidence 368889999999999999995 457999999998653221 122346788999999999999999999999999999999
Q ss_pred EEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccCC
Q 044366 725 CEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEP 804 (918)
Q Consensus 725 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~~ 804 (918)
|||+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.+..
T Consensus 80 ~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~kl~DfGla~~~~~ 153 (377)
T cd05629 80 MEFLPGGDLMTMLIKY---DTFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHK 153 (377)
T ss_pred EeCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEEeeccccccccc
Confidence 9999999999999754 3488999999999999999999999 999999999999999999999999999964321
Q ss_pred CCC-------------C----------------------------------ceecccccccccccccccCCCCcccchhh
Q 044366 805 HSS-------------N----------------------------------WTEFAGTVGYAAPELAYTMRATEKYDVYS 837 (918)
Q Consensus 805 ~~~-------------~----------------------------------~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s 837 (918)
... . ....+||+.|+|||++.+..++.++||||
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS 233 (377)
T cd05629 154 QHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWS 233 (377)
T ss_pred ccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEe
Confidence 100 0 00246899999999999989999999999
Q ss_pred HHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCCCCCcchHHHHHHHHHHHHHcccCCCCCC---CCHHHHHH
Q 044366 838 FGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRDVTDKLRSIMEVAILCLVENPEAR---PTMKEVCN 914 (918)
Q Consensus 838 lG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~R---Pt~~evl~ 914 (918)
|||++|||++|+.||...... ..... .... ......+ ........+.+++.+|+. +|.+| +++.|++.
T Consensus 234 lGvil~elltG~~Pf~~~~~~-~~~~~----i~~~-~~~~~~p--~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~ 304 (377)
T cd05629 234 LGAIMFECLIGWPPFCSENSH-ETYRK----IINW-RETLYFP--DDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKS 304 (377)
T ss_pred cchhhhhhhcCCCCCCCCCHH-HHHHH----HHcc-CCccCCC--CCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhc
Confidence 999999999999998654321 11111 0000 0011111 111122457788888997 66665 59999875
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-36 Score=317.36 Aligned_cols=254 Identities=26% Similarity=0.363 Sum_probs=202.0
Q ss_pred hcCCCCceeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEE
Q 044366 645 TGNFGEKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFI 723 (918)
Q Consensus 645 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 723 (918)
.++|++.+.||+|+||.||+|.. .+|+.||+|++... .....+.+.+|+.+++.++||||+++++++..++..++
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~----~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~i 83 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLE----PGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWI 83 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecC----ccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEE
Confidence 35789999999999999999964 57899999998643 22234578899999999999999999999999999999
Q ss_pred EEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccC
Q 044366 724 VCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLE 803 (918)
Q Consensus 724 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~ 803 (918)
||||+++++|.++++.. ..+++.++..++.|++.|++|||+. +|+|||++|+||+++.++.++|+|||++....
T Consensus 84 v~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~ 157 (267)
T cd06646 84 CMEYCGGGSLQDIYHVT---GPLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLADFGVAAKIT 157 (267)
T ss_pred EEeCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEECcCccceeec
Confidence 99999999999998754 3479999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCCceecccccccccccccc---cCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCCCC
Q 044366 804 PHSSNWTEFAGTVGYAAPELAY---TMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTP 880 (918)
Q Consensus 804 ~~~~~~~~~~g~~~y~aPE~~~---~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 880 (918)
..........++..|+|||.+. ...++.++|||||||++|||++|+.|+........ ...........+
T Consensus 158 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~--------~~~~~~~~~~~~ 229 (267)
T cd06646 158 ATIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA--------LFLMSKSNFQPP 229 (267)
T ss_pred ccccccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhh--------heeeecCCCCCC
Confidence 4433334456889999999874 34577899999999999999999999753321100 001111111111
Q ss_pred -CcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 044366 881 -SRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLL 916 (918)
Q Consensus 881 -~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L 916 (918)
..........+.+++.+||+.+|++|||++++++.+
T Consensus 230 ~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 230 KLKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred CCccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 111112335788999999999999999999998754
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=337.66 Aligned_cols=253 Identities=20% Similarity=0.242 Sum_probs=195.5
Q ss_pred cCCCCceeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEEE
Q 044366 646 GNFGEKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFIV 724 (918)
Q Consensus 646 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 724 (918)
.+|++.+.||+|+||.||+|+. .+++.||||++....... ......+.+|+++++.++||||+++++++.+++..++|
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~-~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv 79 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLM-RNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFV 79 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHh-hhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEE
Confidence 3688999999999999999954 578999999986532211 22356788999999999999999999999999999999
Q ss_pred EEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccCC
Q 044366 725 CEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEP 804 (918)
Q Consensus 725 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~~ 804 (918)
|||+++|+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||++..+..
T Consensus 80 ~E~~~~g~L~~~i~~~~---~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~ 153 (376)
T cd05598 80 MDYIPGGDMMSLLIRLG---IFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRW 153 (376)
T ss_pred EeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEEEeCCCCccccc
Confidence 99999999999997643 478899999999999999999999 999999999999999999999999999753310
Q ss_pred CC-------------------------------------------CCceecccccccccccccccCCCCcccchhhHHHH
Q 044366 805 HS-------------------------------------------SNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVL 841 (918)
Q Consensus 805 ~~-------------------------------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~v 841 (918)
.. .......||+.|+|||++.+..++.++|||||||+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvi 233 (376)
T cd05598 154 THDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVI 233 (376)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccce
Confidence 00 00112468999999999999999999999999999
Q ss_pred HHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCCCCCcchHHHHHHHHHHHHHcccCCCCCCC---CHHHHHH
Q 044366 842 ALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRDVTDKLRSIMEVAILCLVENPEARP---TMKEVCN 914 (918)
Q Consensus 842 l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RP---t~~evl~ 914 (918)
+|||++|+.||....... .... ... .......+. .......+.+++.+|+ .+|.+|+ ++.|+++
T Consensus 234 lyell~G~~Pf~~~~~~~-~~~~----i~~-~~~~~~~~~--~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~ 300 (376)
T cd05598 234 LYEMLVGQPPFLADTPAE-TQLK----VIN-WETTLHIPS--QAKLSREASDLILRLC-CGAEDRLGKNGADEIKA 300 (376)
T ss_pred eeehhhCCCCCCCCCHHH-HHHH----Hhc-cCccccCCC--CCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhC
Confidence 999999999987543211 1000 000 000111110 0112234566677765 5999999 8898874
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=312.31 Aligned_cols=252 Identities=23% Similarity=0.413 Sum_probs=203.5
Q ss_pred hcCCCCceeeccccceEEEEEEeCCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEEE
Q 044366 645 TGNFGEKYCIGKGGQRSVYKAELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFIV 724 (918)
Q Consensus 645 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 724 (918)
.++|...++||+|+||.||+|...+++.||+|.+... ....++|.+|+.+++.++|+||+++++++. .+..++|
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~-----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v 78 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQG-----SMSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYII 78 (260)
T ss_pred hHHceeeeeeccCccceEEeeecCCCceEEEEEecCC-----CCcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEE
Confidence 4578888999999999999998888999999988642 233578999999999999999999999874 4568999
Q ss_pred EEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccCC
Q 044366 725 CEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEP 804 (918)
Q Consensus 725 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~~ 804 (918)
|||+++|+|.+++.... ...+++.+++.++.|++.|++|||+. +++||||||+||++++++.++++|||++.....
T Consensus 79 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 154 (260)
T cd05067 79 TEYMENGSLVDFLKTPE-GIKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIADFGLARLIED 154 (260)
T ss_pred EEcCCCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCEEEccCcceeecCC
Confidence 99999999999987643 34589999999999999999999998 999999999999999999999999999987653
Q ss_pred CCC-CceecccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhhhhhhhhhHhhhhhhcccCCCCCCc
Q 044366 805 HSS-NWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIK-GYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSR 882 (918)
Q Consensus 805 ~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 882 (918)
... ......++..|+|||++.+..++.++||||||+++|||++ |+.||...... . ........ ...+ ...
T Consensus 155 ~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--~---~~~~~~~~--~~~~-~~~ 226 (260)
T cd05067 155 NEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNP--E---VIQNLERG--YRMP-RPD 226 (260)
T ss_pred CCcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChH--H---HHHHHHcC--CCCC-CCC
Confidence 222 1223345678999999988889999999999999999999 99998643321 1 11111111 1111 111
Q ss_pred chHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 044366 883 DVTDKLRSIMEVAILCLVENPEARPTMKEVCNLLC 917 (918)
Q Consensus 883 ~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 917 (918)
....++.+++.+|+..+|++||+++++.+.|+
T Consensus 227 ---~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 258 (260)
T cd05067 227 ---NCPEELYELMRLCWKEKPEERPTFEYLRSVLE 258 (260)
T ss_pred ---CCCHHHHHHHHHHccCChhhCCCHHHHHHHhh
Confidence 12346889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-37 Score=332.94 Aligned_cols=240 Identities=26% Similarity=0.352 Sum_probs=194.0
Q ss_pred eeeccccceEEEEEEe----CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEEEEEe
Q 044366 652 YCIGKGGQRSVYKAEL----PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFIVCEY 727 (918)
Q Consensus 652 ~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 727 (918)
+.||+|+||.||+++. .+|+.||+|+++..... ......+..|++++++++||||+++++++.+++..++||||
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 79 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLK--VRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDF 79 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhh--hhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcC
Confidence 5799999999999853 36899999998764321 22345678899999999999999999999999999999999
Q ss_pred ccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccCCCCC
Q 044366 728 LARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSS 807 (918)
Q Consensus 728 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~~~~~ 807 (918)
+++|+|.+++... ..+++.+++.++.||+.||+|||+. +|+||||||+||+++.++.+||+|||++........
T Consensus 80 ~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~ 153 (318)
T cd05582 80 LRGGDLFTRLSKE---VMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK 153 (318)
T ss_pred CCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC
Confidence 9999999998654 3489999999999999999999999 999999999999999999999999999987654433
Q ss_pred CceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCCCCCcchHHH
Q 044366 808 NWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRDVTDK 887 (918)
Q Consensus 808 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 887 (918)
......|++.|+|||.+.+..++.++|||||||++|||++|+.||...... .. ...+.......+ .. .
T Consensus 154 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~-~~-------~~~i~~~~~~~p-~~---~ 221 (318)
T cd05582 154 KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRK-ET-------MTMILKAKLGMP-QF---L 221 (318)
T ss_pred ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHH-HH-------HHHHHcCCCCCC-CC---C
Confidence 344567899999999999888999999999999999999999998654321 00 011111111111 11 1
Q ss_pred HHHHHHHHHHcccCCCCCCCCHHH
Q 044366 888 LRSIMEVAILCLVENPEARPTMKE 911 (918)
Q Consensus 888 ~~~l~~li~~cl~~dp~~RPt~~e 911 (918)
...+.+++.+||+.||++||++.+
T Consensus 222 ~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 222 SPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred CHHHHHHHHHHhhcCHhHcCCCCC
Confidence 245778899999999999999544
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-36 Score=324.56 Aligned_cols=243 Identities=25% Similarity=0.315 Sum_probs=192.7
Q ss_pred eeeccccceEEEEEEeC-CCCEEEEEEcccccccCCCCChHHHHHHHHHHhhc-cCCceeeEecccccCCceEEEEEecc
Q 044366 652 YCIGKGGQRSVYKAELP-SGNIFAVKKFKAELFSDETANPSEFLNEVLALTEI-RHRNIIKFHGFCSNAQHSFIVCEYLA 729 (918)
Q Consensus 652 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~ 729 (918)
+.||+|+||.||+|+.. +|+.||+|.++...... ......+..|..++... +||||+++++++.+.+..++||||++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~-~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~ 79 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLI-DDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLN 79 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhh-cchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCC
Confidence 36999999999999654 78999999987643221 22345667788877654 89999999999999999999999999
Q ss_pred CCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccCCCCCCc
Q 044366 730 RGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNW 809 (918)
Q Consensus 730 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~~~~~~~ 809 (918)
+|+|.+++... ..+++.++..++.|++.||+|||+. +|+||||||+||+++.++.++|+|||+++.........
T Consensus 80 ~g~L~~~i~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 153 (316)
T cd05620 80 GGDLMFHIQDK---GRFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRA 153 (316)
T ss_pred CCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccCCCeecccCCCce
Confidence 99999998764 3488999999999999999999999 99999999999999999999999999987543333334
Q ss_pred eecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCCCCCcchHHHHH
Q 044366 810 TEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRDVTDKLR 889 (918)
Q Consensus 810 ~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 889 (918)
....|++.|+|||++.+..++.++||||+||++|||++|+.||...... .... .+.... +..+.. ...
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~-----~~~~---~~~~~~-~~~~~~---~~~ 221 (316)
T cd05620 154 STFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDED-----ELFE---SIRVDT-PHYPRW---ITK 221 (316)
T ss_pred eccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH-----HHHH---HHHhCC-CCCCCC---CCH
Confidence 4567899999999999999999999999999999999999998644321 1111 111111 111111 224
Q ss_pred HHHHHHHHcccCCCCCCCCHH-HHH
Q 044366 890 SIMEVAILCLVENPEARPTMK-EVC 913 (918)
Q Consensus 890 ~l~~li~~cl~~dp~~RPt~~-evl 913 (918)
++.+++.+|++.||++||++. ++.
T Consensus 222 ~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 222 ESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred HHHHHHHHHccCCHHHcCCChHHHH
Confidence 577899999999999999985 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=336.13 Aligned_cols=252 Identities=20% Similarity=0.259 Sum_probs=193.4
Q ss_pred CCCCceeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEEEE
Q 044366 647 NFGEKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFIVC 725 (918)
Q Consensus 647 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 725 (918)
.|...+.||+|+||.||+|+. .+++.||+|++...... .......+.+|+++++.++||||+++++++.+++..++||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~-~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVL-LRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM 80 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhh-hHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEE
Confidence 588899999999999999954 57899999998653211 1222467889999999999999999999999999999999
Q ss_pred EeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccCCC
Q 044366 726 EYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPH 805 (918)
Q Consensus 726 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~~~ 805 (918)
||+++|+|.+++.+. ..+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||++..+...
T Consensus 81 E~~~gg~L~~~l~~~---~~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~ 154 (382)
T cd05625 81 DYIPGGDMMSLLIRM---GIFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 154 (382)
T ss_pred eCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEeECCCCcccccc
Confidence 999999999999764 3478899999999999999999999 9999999999999999999999999997533110
Q ss_pred C-----------------------------------------------CCceecccccccccccccccCCCCcccchhhH
Q 044366 806 S-----------------------------------------------SNWTEFAGTVGYAAPELAYTMRATEKYDVYSF 838 (918)
Q Consensus 806 ~-----------------------------------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~sl 838 (918)
. ......+||+.|+|||++.+..++.++||||+
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl 234 (382)
T cd05625 155 HDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSV 234 (382)
T ss_pred ccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEec
Confidence 0 00112468999999999999899999999999
Q ss_pred HHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCCCCCcchHHHHHHHHHHHHHcccCCCCCCCC---HHHHHH
Q 044366 839 GVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPT---MKEVCN 914 (918)
Q Consensus 839 G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt---~~evl~ 914 (918)
||++|||++|+.||....... .. ..... .......+.. .....+..+++.+|+ .+|++|++ ++|+++
T Consensus 235 Gvil~elltG~~Pf~~~~~~~-~~----~~i~~-~~~~~~~p~~--~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~ 304 (382)
T cd05625 235 GVILYEMLVGQPPFLAQTPLE-TQ----MKVIN-WQTSLHIPPQ--AKLSPEASDLIIKLC-RGPEDRLGKNGADEIKA 304 (382)
T ss_pred hHHHHHHHhCCCCCCCCCHHH-HH----HHHHc-cCCCcCCCCc--ccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhc
Confidence 999999999999987543211 00 00000 0111111110 112234566666665 59999997 887764
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=319.72 Aligned_cols=249 Identities=25% Similarity=0.397 Sum_probs=202.9
Q ss_pred cCCCCceeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEEE
Q 044366 646 GNFGEKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFIV 724 (918)
Q Consensus 646 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 724 (918)
.+|...+.||+|+||.||+|.. .+++.||+|.+... .....+.+.+|+.+++.++||||+++++++..+...++|
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~----~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv 95 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQ----QQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV 95 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecC----CcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEe
Confidence 5788889999999999999954 57899999988653 222356789999999999999999999999999999999
Q ss_pred EEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccCC
Q 044366 725 CEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEP 804 (918)
Q Consensus 725 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~~ 804 (918)
|||+++++|.+++... .+++.++..++.|++.|++|||+. +++||||||+||+++.++.++|+|||++.....
T Consensus 96 ~e~~~~~~L~~~~~~~----~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~ 168 (296)
T cd06654 96 MEYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP 168 (296)
T ss_pred ecccCCCCHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEECccccchhccc
Confidence 9999999999998643 378999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCCceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCCCCCcch
Q 044366 805 HSSNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRDV 884 (918)
Q Consensus 805 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 884 (918)
.........+++.|+|||.+.+..++.++|||||||++|+|++|+.||.......... . ........ ....
T Consensus 169 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~----~---~~~~~~~~--~~~~ 239 (296)
T cd06654 169 EQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY----L---IATNGTPE--LQNP 239 (296)
T ss_pred cccccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHH----H---HhcCCCCC--CCCc
Confidence 4433344568899999999988888999999999999999999999986543211110 0 00011111 0111
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 885 TDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 885 ~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
......+.+++.+||..||++||++.++++
T Consensus 240 ~~~~~~l~~li~~~l~~~p~~Rpt~~eil~ 269 (296)
T cd06654 240 EKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (296)
T ss_pred cccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence 123356788999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=317.68 Aligned_cols=256 Identities=21% Similarity=0.352 Sum_probs=201.1
Q ss_pred cCCCCceeeccccceEEEEEEe-----CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCc
Q 044366 646 GNFGEKYCIGKGGQRSVYKAEL-----PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQH 720 (918)
Q Consensus 646 ~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 720 (918)
.+|+..+.||+|+||.||+|.. .+++.||+|.+.... ......+|.+|+++++.++||||+++++++..++.
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 81 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN---NPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQP 81 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCC---CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCc
Confidence 4577788999999999999963 356789999986421 22234678999999999999999999999999999
Q ss_pred eEEEEEeccCCChhHHhhcccc--------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeC
Q 044366 721 SFIVCEYLARGSLTTILRDDAA--------------AKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLD 786 (918)
Q Consensus 721 ~~lv~e~~~~gsL~~~l~~~~~--------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~ 786 (918)
.++||||+++|+|.+++..... ...+++.+++.++.|++.||+|||+. +++||||||+||+++
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~nili~ 158 (283)
T cd05090 82 VCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNILIG 158 (283)
T ss_pred eEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---CeehhccccceEEEc
Confidence 9999999999999999853321 23478999999999999999999999 999999999999999
Q ss_pred CCCcEEEeccccccccCCCCC--CceecccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhhhhhhh
Q 044366 787 SEYEAHVSDFGFAKFLEPHSS--NWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIK-GYHPGDFVSTIFSSIS 863 (918)
Q Consensus 787 ~~~~~kl~DfG~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~p~~~~~~~~~~~~ 863 (918)
+++.+|++|||++........ ......++..|+|||++.+..++.++||||||+++|||++ |..||...... .+.
T Consensus 159 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~--~~~ 236 (283)
T cd05090 159 EQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQ--EVI 236 (283)
T ss_pred CCCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH--HHH
Confidence 999999999999987643321 1223345678999999988889999999999999999998 88887543210 111
Q ss_pred hhHhhhhhhcccCCCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhC
Q 044366 864 NMIIEVNQILDHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLLCK 918 (918)
Q Consensus 864 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~ 918 (918)
.. ............ ....+.+++.+||+.||++||++.++.+.|.+
T Consensus 237 ~~------~~~~~~~~~~~~---~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 237 EM------VRKRQLLPCSED---CPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred HH------HHcCCcCCCCCC---CCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 11 111111111111 22467888999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=324.12 Aligned_cols=252 Identities=22% Similarity=0.422 Sum_probs=198.8
Q ss_pred cCCCCceeeccccceEEEEEEeC-CCC----EEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCc
Q 044366 646 GNFGEKYCIGKGGQRSVYKAELP-SGN----IFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQH 720 (918)
Q Consensus 646 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 720 (918)
.+|+..+.||+|+||.||+|.+. +|+ .||+|+++.. ......++|.+|+.+++.++||||++++|+|..+ .
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~ 82 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA---TSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-T 82 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEecccc---CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-C
Confidence 56889999999999999999653 444 3899998642 1223356789999999999999999999998764 5
Q ss_pred eEEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEecccccc
Q 044366 721 SFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAK 800 (918)
Q Consensus 721 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~ 800 (918)
.++|+||+++|+|.+++.... ..+++..++.++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++
T Consensus 83 ~~~v~e~~~~g~l~~~l~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~~kl~DfG~a~ 157 (316)
T cd05108 83 VQLITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAK 157 (316)
T ss_pred ceeeeecCCCCCHHHHHHhcc--ccCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCCcEEEccccccc
Confidence 789999999999999998643 3478999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCCc--eecccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhhhhhhhhhHhhhhhhcccCC
Q 044366 801 FLEPHSSNW--TEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIK-GYHPGDFVSTIFSSISNMIIEVNQILDHRL 877 (918)
Q Consensus 801 ~~~~~~~~~--~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 877 (918)
......... ....++..|+|||++.+..++.++||||||+++|||++ |+.||+..... ..... .. ....+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~--~~~~~---~~--~~~~~ 230 (316)
T cd05108 158 LLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS--EISSI---LE--KGERL 230 (316)
T ss_pred cccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH--HHHHH---Hh--CCCCC
Confidence 775433322 12234678999999999899999999999999999997 99997643221 11110 00 11112
Q ss_pred CCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 044366 878 PTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLLC 917 (918)
Q Consensus 878 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 917 (918)
+.+.. ....+.+++.+||+.||.+||++.+++..+.
T Consensus 231 ~~~~~----~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~ 266 (316)
T cd05108 231 PQPPI----CTIDVYMIMVKCWMIDADSRPKFRELIIEFS 266 (316)
T ss_pred CCCCC----CCHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 21111 2245788999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-36 Score=341.27 Aligned_cols=257 Identities=25% Similarity=0.328 Sum_probs=203.6
Q ss_pred HHHhcCCCCceeeccccceEEEEEE-eCCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCC-
Q 044366 642 TKATGNFGEKYCIGKGGQRSVYKAE-LPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQ- 719 (918)
Q Consensus 642 ~~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~- 719 (918)
....++|.+.+.||+|+||.||+|+ ..+|+.||||++..... .......+.+|+..+..++|+||+++++.+...+
T Consensus 28 ~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~--~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~ 105 (496)
T PTZ00283 28 KEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGM--SEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDP 105 (496)
T ss_pred cccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccC--CHHHHHHHHHHHHHHhcCCCCcEEEeecceecccc
Confidence 3455799999999999999999995 45799999999865422 1223467889999999999999999988764322
Q ss_pred -------ceEEEEEeccCCChhHHhhccc-ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcE
Q 044366 720 -------HSFIVCEYLARGSLTTILRDDA-AAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEA 791 (918)
Q Consensus 720 -------~~~lv~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~ 791 (918)
..++||||+++|+|.++++... ....+++..++.++.|++.||+|+|+. +|+||||||+||+++.++.+
T Consensus 106 ~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~~~~~v 182 (496)
T PTZ00283 106 RNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLCSNGLV 182 (496)
T ss_pred cCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEeCCCCE
Confidence 3689999999999999997542 345689999999999999999999999 99999999999999999999
Q ss_pred EEeccccccccCCCCC--CceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhh
Q 044366 792 HVSDFGFAKFLEPHSS--NWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEV 869 (918)
Q Consensus 792 kl~DfG~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~ 869 (918)
||+|||+++.+..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...... . ..
T Consensus 183 kL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~-~-------~~ 254 (496)
T PTZ00283 183 KLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENME-E-------VM 254 (496)
T ss_pred EEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH-H-------HH
Confidence 9999999987653321 223456899999999999989999999999999999999999998643211 0 11
Q ss_pred hhhcccCCCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 870 NQILDHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 870 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
...........+.. ....+.+++.+||+.||++||++.++++
T Consensus 255 ~~~~~~~~~~~~~~---~~~~l~~li~~~L~~dP~~RPs~~ell~ 296 (496)
T PTZ00283 255 HKTLAGRYDPLPPS---ISPEMQEIVTALLSSDPKRRPSSSKLLN 296 (496)
T ss_pred HHHhcCCCCCCCCC---CCHHHHHHHHHHcccChhhCcCHHHHHh
Confidence 11111112111111 2346888999999999999999999875
|
|
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=312.37 Aligned_cols=247 Identities=26% Similarity=0.388 Sum_probs=195.5
Q ss_pred eeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEEEEEeccCC
Q 044366 653 CIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFIVCEYLARG 731 (918)
Q Consensus 653 ~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 731 (918)
.||+|+||.||+|.. .+++.||+|.+.... .......|.+|+++++.++||||+++++++...+..++||||++++
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 78 (252)
T cd05084 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETL---PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGG 78 (252)
T ss_pred ccCcccCccEEEEEEecCCceEEEEecCccC---CHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCC
Confidence 589999999999965 478999999876431 1223467999999999999999999999999999999999999999
Q ss_pred ChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccCCCCCCc--
Q 044366 732 SLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNW-- 809 (918)
Q Consensus 732 sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~~~~~~~-- 809 (918)
+|.++++... ..+++.+++.++.|++.||+|||+. +++||||||+||+++.++.+|++|||++..........
T Consensus 79 ~L~~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 153 (252)
T cd05084 79 DFLTFLRTEG--PRLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTG 153 (252)
T ss_pred cHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccccCcccccccccccC
Confidence 9999997542 3578999999999999999999999 99999999999999999999999999997654321111
Q ss_pred eecccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhhhhhhhhhHhhhhhhcccCCCCCCcchHHHH
Q 044366 810 TEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIK-GYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRDVTDKL 888 (918)
Q Consensus 810 ~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 888 (918)
....++..|+|||.+.+..++.++||||||+++|||++ |..|++...... ........ ...+ ... ...
T Consensus 154 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~-----~~~~~~~~--~~~~-~~~---~~~ 222 (252)
T cd05084 154 GMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQ-----TREAIEQG--VRLP-CPE---LCP 222 (252)
T ss_pred CCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHH-----HHHHHHcC--CCCC-Ccc---cCC
Confidence 11123467999999998889999999999999999998 888875432210 00001110 0111 111 223
Q ss_pred HHHHHHHHHcccCCCCCCCCHHHHHHHhhC
Q 044366 889 RSIMEVAILCLVENPEARPTMKEVCNLLCK 918 (918)
Q Consensus 889 ~~l~~li~~cl~~dp~~RPt~~evl~~L~~ 918 (918)
..+.+++.+|++.+|++|||+.++.+.|++
T Consensus 223 ~~~~~li~~~l~~~p~~Rps~~~~~~~l~~ 252 (252)
T cd05084 223 DAVYRLMERCWEYDPGQRPSFSTVHQELQS 252 (252)
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHHHHhC
Confidence 568889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=312.06 Aligned_cols=252 Identities=25% Similarity=0.420 Sum_probs=202.0
Q ss_pred cCCCCceeeccccceEEEEEEeCCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEEEE
Q 044366 646 GNFGEKYCIGKGGQRSVYKAELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFIVC 725 (918)
Q Consensus 646 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 725 (918)
++|.+.+.||+|+||.||+|...++..||+|.++.. ....+.|.+|+.++++++|++++++++++. ....++||
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~-----~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~ 79 (260)
T cd05070 6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPG-----TMSPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVT 79 (260)
T ss_pred HHhhhhheeccccCceEEEEEecCCceeEEEEecCC-----CCCHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEE
Confidence 468888999999999999998888889999998653 123567999999999999999999999875 45688999
Q ss_pred EeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccCCC
Q 044366 726 EYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPH 805 (918)
Q Consensus 726 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~~~ 805 (918)
||+++++|.+++.... ...+++.+++.++.|++.|++|||+. +++||||||+||++++++.++|+|||.+......
T Consensus 80 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~ 155 (260)
T cd05070 80 EYMSKGSLLDFLKDGE-GRALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIADFGLARLIEDN 155 (260)
T ss_pred EecCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeCCceeeeeccCc
Confidence 9999999999997643 34589999999999999999999999 9999999999999999999999999999876543
Q ss_pred CCC-ceecccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhhhhhhhhhHhhhhhhcccCCCCCCcc
Q 044366 806 SSN-WTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIK-GYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRD 883 (918)
Q Consensus 806 ~~~-~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 883 (918)
... .....++..|+|||+..+..++.++||||||+++|||++ |..||...... ..... +......+...
T Consensus 156 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~-----~~~~~---~~~~~~~~~~~- 226 (260)
T cd05070 156 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNR-----EVLEQ---VERGYRMPCPQ- 226 (260)
T ss_pred ccccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHH-----HHHHH---HHcCCCCCCCC-
Confidence 221 122335678999999988889999999999999999999 88887543211 01111 11111111111
Q ss_pred hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhC
Q 044366 884 VTDKLRSIMEVAILCLVENPEARPTMKEVCNLLCK 918 (918)
Q Consensus 884 ~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~ 918 (918)
.....+.+++.+|+..+|.+|||++++.+.|++
T Consensus 227 --~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 227 --DCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred --cCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 223568899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=318.36 Aligned_cols=255 Identities=25% Similarity=0.409 Sum_probs=202.0
Q ss_pred hcCCCCceeeccccceEEEEEEe------CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccC
Q 044366 645 TGNFGEKYCIGKGGQRSVYKAEL------PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNA 718 (918)
Q Consensus 645 ~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~ 718 (918)
..+|.+.+.||+|+||.||++.. .++..||+|.+... .....+.+.+|++++++++||||+++++++...
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 79 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA----SDNARKDFHREAELLTNLQHEHIVKFYGVCVEG 79 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCc----CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecC
Confidence 35678889999999999999963 23456999987642 222356799999999999999999999999999
Q ss_pred CceEEEEEeccCCChhHHhhcccc----------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCC
Q 044366 719 QHSFIVCEYLARGSLTTILRDDAA----------AKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSE 788 (918)
Q Consensus 719 ~~~~lv~e~~~~gsL~~~l~~~~~----------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~ 788 (918)
+..++||||+++++|.+++..... ...+++.+++.++.|++.||+|||+. +++||||||+||+++++
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili~~~ 156 (288)
T cd05093 80 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGEN 156 (288)
T ss_pred CccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccC
Confidence 999999999999999999975421 23489999999999999999999999 99999999999999999
Q ss_pred CcEEEeccccccccCCCCCC--ceecccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhhhhhhhhh
Q 044366 789 YEAHVSDFGFAKFLEPHSSN--WTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIK-GYHPGDFVSTIFSSISNM 865 (918)
Q Consensus 789 ~~~kl~DfG~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~p~~~~~~~~~~~~~~ 865 (918)
+.++|+|||++......... .....++..|+|||++.+..++.++|||||||++|||++ |..||....... .
T Consensus 157 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~-----~ 231 (288)
T cd05093 157 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE-----V 231 (288)
T ss_pred CcEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-----H
Confidence 99999999999866433211 122335678999999998889999999999999999998 898875433210 0
Q ss_pred HhhhhhhcccCCCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 044366 866 IIEVNQILDHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLLC 917 (918)
Q Consensus 866 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 917 (918)
...+........... ....+.+++.+||+.||.+|||+.|+.+.|+
T Consensus 232 ---~~~i~~~~~~~~~~~---~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~ 277 (288)
T cd05093 232 ---IECITQGRVLQRPRT---CPKEVYDLMLGCWQREPHMRLNIKEIHSLLQ 277 (288)
T ss_pred ---HHHHHcCCcCCCCCC---CCHHHHHHHHHHccCChhhCCCHHHHHHHHH
Confidence 011111111111111 2246889999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=318.46 Aligned_cols=261 Identities=21% Similarity=0.299 Sum_probs=200.3
Q ss_pred CCCCceeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEEEE
Q 044366 647 NFGEKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFIVC 725 (918)
Q Consensus 647 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 725 (918)
+|...+.||+|++|.||+|.. .+|+.||+|+++... ......+.+.+|+.+++.++||||+++++++.+++..++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLES--EEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIF 78 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEecccc--ccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEE
Confidence 477888999999999999965 478999999986532 22233467889999999999999999999999999999999
Q ss_pred EeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccCCC
Q 044366 726 EYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPH 805 (918)
Q Consensus 726 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~~~ 805 (918)
||++ ++|.+++........+++.+++.++.|++.||+|||+. +++||||+|+||+++.++.++|+|||++......
T Consensus 79 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 154 (285)
T cd07861 79 EFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIP 154 (285)
T ss_pred ecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEECcccceeecCCC
Confidence 9997 68999887655446689999999999999999999999 9999999999999999999999999999866544
Q ss_pred CCCceecccccccccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhh------------
Q 044366 806 SSNWTEFAGTVGYAAPELAYTM-RATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQI------------ 872 (918)
Q Consensus 806 ~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~------------ 872 (918)
........+++.|+|||++.+. .++.++||||||+++|+|++|+.||............ .......
T Consensus 155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 233 (285)
T cd07861 155 VRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRI-FRILGTPTEDVWPGVTSLP 233 (285)
T ss_pred cccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHH-HHHhCCCChhhhhcchhhH
Confidence 3333444678899999988654 4688999999999999999999998644322111100 0000000
Q ss_pred -cccCCCCCCc-----chHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 873 -LDHRLPTPSR-----DVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 873 -~~~~~~~~~~-----~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
.....+.... .......++.+++.+||+.||++|||+.++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 234 DYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred HHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 0000000000 00112346778999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=312.13 Aligned_cols=252 Identities=25% Similarity=0.400 Sum_probs=201.8
Q ss_pred hcCCCCceeeccccceEEEEEEeCCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEEE
Q 044366 645 TGNFGEKYCIGKGGQRSVYKAELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFIV 724 (918)
Q Consensus 645 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 724 (918)
.++|.+.++||+|+||.||+|...++..||+|+++.. ....+.|.+|+++++.++||||+++++++.+ ...++|
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~-----~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv 78 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-----TMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIV 78 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccC-----ccCHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEE
Confidence 3568899999999999999998777778999998652 2235679999999999999999999998754 557999
Q ss_pred EEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccCC
Q 044366 725 CEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEP 804 (918)
Q Consensus 725 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~~ 804 (918)
|||+++|+|.+++.... ...+++..++.++.|++.||+|+|+. +++||||||+||++++++.++|+|||.++.+..
T Consensus 79 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~ 154 (262)
T cd05071 79 TEYMSKGSLLDFLKGEM-GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIED 154 (262)
T ss_pred EEcCCCCcHHHHHhhcc-ccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEeccCCceeeccc
Confidence 99999999999997643 33579999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCCc-eecccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhhhhhhhhhHhhhhhhcccCCCCCCc
Q 044366 805 HSSNW-TEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIK-GYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSR 882 (918)
Q Consensus 805 ~~~~~-~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 882 (918)
..... ....++..|+|||+..+..++.++||||||+++|||++ |+.||...... ... ...........
T Consensus 155 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~--~~~------~~~~~~~~~~~-- 224 (262)
T cd05071 155 NEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR--EVL------DQVERGYRMPC-- 224 (262)
T ss_pred cccccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChH--HHH------HHHhcCCCCCC--
Confidence 33221 22345678999999988889999999999999999999 78887643221 000 01111111111
Q ss_pred chHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 044366 883 DVTDKLRSIMEVAILCLVENPEARPTMKEVCNLLC 917 (918)
Q Consensus 883 ~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 917 (918)
..+....+.+++.+|++.||++||++.++++.|+
T Consensus 225 -~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~ 258 (262)
T cd05071 225 -PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLE 258 (262)
T ss_pred -ccccCHHHHHHHHHHccCCcccCCCHHHHHHHHH
Confidence 1223456889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=329.84 Aligned_cols=240 Identities=25% Similarity=0.345 Sum_probs=188.9
Q ss_pred eeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHH-HHhhccCCceeeEecccccCCceEEEEEecc
Q 044366 652 YCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVL-ALTEIRHRNIIKFHGFCSNAQHSFIVCEYLA 729 (918)
Q Consensus 652 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~-~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 729 (918)
+.||+|+||.||+|+. .+|+.||+|++........ .....+..|.. +++.++||||+++++++.+.+..++||||++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~-~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~ 79 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKK-KEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVN 79 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHh-hHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCC
Confidence 3699999999999965 4689999999875432221 22344555554 5788899999999999999999999999999
Q ss_pred CCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccCCCCCCc
Q 044366 730 RGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNW 809 (918)
Q Consensus 730 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~~~~~~~ 809 (918)
+|+|..++... ..+++.++..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||++..........
T Consensus 80 ~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 153 (321)
T cd05603 80 GGELFFHLQRE---RCFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETT 153 (321)
T ss_pred CCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCcc
Confidence 99999888653 3478899999999999999999999 99999999999999999999999999987643333333
Q ss_pred eecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCCCCCcchHHHHH
Q 044366 810 TEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRDVTDKLR 889 (918)
Q Consensus 810 ~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 889 (918)
....|++.|+|||++.+..++.++|||||||++|||++|+.||...... ... ..+.......+ . ....
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-----~~~---~~i~~~~~~~~-~---~~~~ 221 (321)
T cd05603 154 STFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVS-----QMY---DNILHKPLQLP-G---GKTV 221 (321)
T ss_pred ccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHH-----HHH---HHHhcCCCCCC-C---CCCH
Confidence 4557899999999999888999999999999999999999998643211 111 11111111111 1 1224
Q ss_pred HHHHHHHHcccCCCCCCCCHH
Q 044366 890 SIMEVAILCLVENPEARPTMK 910 (918)
Q Consensus 890 ~l~~li~~cl~~dp~~RPt~~ 910 (918)
.+.+++.+|++.||.+||++.
T Consensus 222 ~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 222 AACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred HHHHHHHHHccCCHhhcCCCC
Confidence 578899999999999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=331.63 Aligned_cols=241 Identities=25% Similarity=0.337 Sum_probs=190.0
Q ss_pred eeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHH-HHhhccCCceeeEecccccCCceEEEEEecc
Q 044366 652 YCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVL-ALTEIRHRNIIKFHGFCSNAQHSFIVCEYLA 729 (918)
Q Consensus 652 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~-~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 729 (918)
+.||+|+||.||+|+. .+|+.||+|++....... ......+..|.. +++.++||||+++++++..++..++||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~ 79 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLN-RKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVN 79 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhh-hhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCC
Confidence 3699999999999954 579999999987543222 222345556655 4677899999999999999999999999999
Q ss_pred CCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccCCCCCCc
Q 044366 730 RGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNW 809 (918)
Q Consensus 730 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~~~~~~~ 809 (918)
+|+|..++... ..+++.++..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||++..........
T Consensus 80 ~~~L~~~l~~~---~~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~ 153 (325)
T cd05604 80 GGELFFHLQRE---RSFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTT 153 (325)
T ss_pred CCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCCc
Confidence 99999888754 3489999999999999999999999 99999999999999999999999999997644333334
Q ss_pred eecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCCCCCcchHHHHH
Q 044366 810 TEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRDVTDKLR 889 (918)
Q Consensus 810 ~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 889 (918)
....|++.|+|||++.+..++.++|||||||++|||++|+.||...... . .. ........... . ....
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~-~----~~---~~~~~~~~~~~-~---~~~~ 221 (325)
T cd05604 154 TTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVA-E----MY---DNILHKPLVLR-P---GASL 221 (325)
T ss_pred ccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHH-H----HH---HHHHcCCccCC-C---CCCH
Confidence 4567899999999999999999999999999999999999998643221 1 11 11111111111 1 1224
Q ss_pred HHHHHHHHcccCCCCCCCCHHH
Q 044366 890 SIMEVAILCLVENPEARPTMKE 911 (918)
Q Consensus 890 ~l~~li~~cl~~dp~~RPt~~e 911 (918)
.+.+++.+|++.||.+||++.+
T Consensus 222 ~~~~ll~~ll~~~p~~R~~~~~ 243 (325)
T cd05604 222 TAWSILEELLEKDRQRRLGAKE 243 (325)
T ss_pred HHHHHHHHHhccCHHhcCCCCC
Confidence 5778899999999999998753
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=312.09 Aligned_cols=251 Identities=22% Similarity=0.339 Sum_probs=204.0
Q ss_pred CCCCceeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEEEE
Q 044366 647 NFGEKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFIVC 725 (918)
Q Consensus 647 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 725 (918)
+|+..+.||+|+||.||++.. .+++.||+|.++... .....+.+.+|+.+++.++||||+++++++.+++..++||
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 77 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPK---SSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVM 77 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCc---chHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEE
Confidence 477889999999999999955 478999999986532 2223567889999999999999999999999999999999
Q ss_pred EeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccCCC
Q 044366 726 EYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPH 805 (918)
Q Consensus 726 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~~~ 805 (918)
||+++|+|.+++.... ...+++..++.++.|++.|++|||+. +++|+||||+||++++++.++++|||.+......
T Consensus 78 e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 153 (255)
T cd08219 78 EYCDGGDLMQKIKLQR-GKLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSP 153 (255)
T ss_pred eeCCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEcccCcceeeccc
Confidence 9999999999887543 34578999999999999999999999 9999999999999999999999999999876544
Q ss_pred CCCceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCCCCCcchH
Q 044366 806 SSNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRDVT 885 (918)
Q Consensus 806 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 885 (918)
........|+..|+|||++.+..++.++||||||+++|+|++|..||...... .... .............
T Consensus 154 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~-----~~~~---~~~~~~~~~~~~~-- 223 (255)
T cd08219 154 GAYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWK-----NLIL---KVCQGSYKPLPSH-- 223 (255)
T ss_pred ccccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHH-----HHHH---HHhcCCCCCCCcc--
Confidence 43334567889999999999888999999999999999999999998643211 1111 1111111111111
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 044366 886 DKLRSIMEVAILCLVENPEARPTMKEVCNL 915 (918)
Q Consensus 886 ~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 915 (918)
....+.+++.+||+.||++||++.+++..
T Consensus 224 -~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 224 -YSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred -cCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 22457889999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=316.60 Aligned_cols=253 Identities=25% Similarity=0.383 Sum_probs=200.2
Q ss_pred HHhcCCCCceeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhc-cCCceeeEecccccC--
Q 044366 643 KATGNFGEKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEI-RHRNIIKFHGFCSNA-- 718 (918)
Q Consensus 643 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~-- 718 (918)
.+++.|+..+.||+|+||.||+|.. .+++.||+|.+... ......+.+|+.+++.+ +||||+++++++...
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~-----~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~ 77 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-----GDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNP 77 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcC-----CccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCC
Confidence 4667888899999999999999965 46889999998642 23356789999999998 799999999998642
Q ss_pred ----CceEEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEe
Q 044366 719 ----QHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVS 794 (918)
Q Consensus 719 ----~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~ 794 (918)
...++||||+++|+|.+++.... ...+++..+..++.|++.|++|||+. +++|||++|+||++++++.++|+
T Consensus 78 ~~~~~~~~iv~e~~~~~~L~~~l~~~~-~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~~~~~l~ 153 (272)
T cd06637 78 PGMDDQLWLVMEFCGAGSVTDLIKNTK-GNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLV 153 (272)
T ss_pred CCCCcEEEEEEEcCCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCCCCEEEc
Confidence 45789999999999999997643 34589999999999999999999999 99999999999999999999999
Q ss_pred ccccccccCCCCCCceecccccccccccccc-----cCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhh
Q 044366 795 DFGFAKFLEPHSSNWTEFAGTVGYAAPELAY-----TMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEV 869 (918)
Q Consensus 795 DfG~~~~~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~ 869 (918)
|||++..............|+..|+|||++. +..++.++|||||||++|||++|+.|+.......... ..
T Consensus 154 Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~-----~~ 228 (272)
T cd06637 154 DFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALF-----LI 228 (272)
T ss_pred cCCCceecccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHH-----HH
Confidence 9999987654433444567899999999986 3357889999999999999999999986433211110 00
Q ss_pred hhhcccCCCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 870 NQILDHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 870 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
.. ......... .....+.+++.+||..||.+|||+.|+++
T Consensus 229 ~~--~~~~~~~~~---~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 229 PR--NPAPRLKSK---KWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred hc--CCCCCCCCC---CcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 01 011111111 12346788999999999999999999975
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=323.91 Aligned_cols=246 Identities=23% Similarity=0.314 Sum_probs=192.4
Q ss_pred eeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhc-cCCceeeEecccccCCceEEEEEecc
Q 044366 652 YCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEI-RHRNIIKFHGFCSNAQHSFIVCEYLA 729 (918)
Q Consensus 652 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~ 729 (918)
+.||+|+||.||+|.. .+++.||+|+++...... ....+.+.+|+.++.++ +||+|+++++++.+.+..++||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 79 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHD-DEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVN 79 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhh-hhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCC
Confidence 3699999999999955 468899999997643322 22346688999998888 69999999999999999999999999
Q ss_pred CCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccCCCCCCc
Q 044366 730 RGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNW 809 (918)
Q Consensus 730 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~~~~~~~ 809 (918)
+|+|.+++... ..+++..++.++.|++.|++|||+. +|+||||||+||+++.++.+||+|||++..........
T Consensus 80 ~~~L~~~~~~~---~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 153 (327)
T cd05617 80 GGDLMFHMQRQ---RKLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTT 153 (327)
T ss_pred CCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEeccccceeccCCCCce
Confidence 99999988654 3489999999999999999999999 99999999999999999999999999997643333333
Q ss_pred eecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCCCCCcchHHHHH
Q 044366 810 TEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRDVTDKLR 889 (918)
Q Consensus 810 ~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 889 (918)
....|++.|+|||++.+..++.++|||||||++|||++|+.||+....... ..........+...... .+.. ...
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~-~p~~---~~~ 228 (327)
T cd05617 154 STFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPD-MNTEDYLFQVILEKPIR-IPRF---LSV 228 (327)
T ss_pred ecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcc-cccHHHHHHHHHhCCCC-CCCC---CCH
Confidence 456789999999999999999999999999999999999999864221100 00000001111111111 1111 124
Q ss_pred HHHHHHHHcccCCCCCCCCH
Q 044366 890 SIMEVAILCLVENPEARPTM 909 (918)
Q Consensus 890 ~l~~li~~cl~~dp~~RPt~ 909 (918)
.+.+++.+|++.||++||++
T Consensus 229 ~~~~li~~~L~~dP~~R~~~ 248 (327)
T cd05617 229 KASHVLKGFLNKDPKERLGC 248 (327)
T ss_pred HHHHHHHHHhccCHHHcCCC
Confidence 57789999999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=318.45 Aligned_cols=254 Identities=26% Similarity=0.422 Sum_probs=202.2
Q ss_pred cCCCCceeeccccceEEEEEEe------CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCC
Q 044366 646 GNFGEKYCIGKGGQRSVYKAEL------PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQ 719 (918)
Q Consensus 646 ~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~ 719 (918)
++|...+.||+|+||.||+|.. .++..+|+|.++.. .....+.+.+|++.++.++||||+++++++..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 80 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDP----TLAARKDFQREAELLTNLQHEHIVKFYGVCGDGD 80 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCc----cHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCC
Confidence 4577788999999999999953 23556899987542 2222467899999999999999999999999999
Q ss_pred ceEEEEEeccCCChhHHhhccc-------------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeC
Q 044366 720 HSFIVCEYLARGSLTTILRDDA-------------AAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLD 786 (918)
Q Consensus 720 ~~~lv~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~ 786 (918)
..++||||+++++|.+++.... ....+++..++.++.|++.|++|||+. +++||||||+||+++
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil~~ 157 (291)
T cd05094 81 PLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVG 157 (291)
T ss_pred ceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEc
Confidence 9999999999999999997542 123489999999999999999999999 999999999999999
Q ss_pred CCCcEEEeccccccccCCCCC--CceecccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhhhhhhh
Q 044366 787 SEYEAHVSDFGFAKFLEPHSS--NWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIK-GYHPGDFVSTIFSSIS 863 (918)
Q Consensus 787 ~~~~~kl~DfG~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~p~~~~~~~~~~~~ 863 (918)
.++.++|+|||++........ ......++..|+|||++.+..++.++||||||+++|||++ |+.||....... .
T Consensus 158 ~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~-~-- 234 (291)
T cd05094 158 ANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE-V-- 234 (291)
T ss_pred cCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-H--
Confidence 999999999999976543321 1223446788999999999899999999999999999999 999975433210 0
Q ss_pred hhHhhhhhhcccCCCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 044366 864 NMIIEVNQILDHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLLC 917 (918)
Q Consensus 864 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 917 (918)
.........+.... .....+.+++.+||+.||++||++.+|+++|+
T Consensus 235 -----~~~~~~~~~~~~~~---~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~ 280 (291)
T cd05094 235 -----IECITQGRVLERPR---VCPKEVYDIMLGCWQREPQQRLNIKEIYKILH 280 (291)
T ss_pred -----HHHHhCCCCCCCCc---cCCHHHHHHHHHHcccChhhCcCHHHHHHHHH
Confidence 01111112211111 12346889999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=321.46 Aligned_cols=259 Identities=19% Similarity=0.301 Sum_probs=198.9
Q ss_pred cCCCCceeeccccceEEEEEEeC-CCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEEE
Q 044366 646 GNFGEKYCIGKGGQRSVYKAELP-SGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFIV 724 (918)
Q Consensus 646 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 724 (918)
++|...+.||+|+||.||+|... +++.||+|+++... .......+.+|+++++.++||||+++++++..++..++|
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 82 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEH---EEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLV 82 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccc---cCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEE
Confidence 56888899999999999999654 68899999987542 222345678999999999999999999999999999999
Q ss_pred EEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccCC
Q 044366 725 CEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEP 804 (918)
Q Consensus 725 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~~ 804 (918)
|||+++ +|.+++.... ..+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.....
T Consensus 83 ~e~~~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 156 (309)
T cd07872 83 FEYLDK-DLKQYMDDCG--NIMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSV 156 (309)
T ss_pred EeCCCC-CHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECccccceecCC
Confidence 999985 8888886542 3478999999999999999999999 999999999999999999999999999986544
Q ss_pred CCCCceeccccccccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhh--------h------
Q 044366 805 HSSNWTEFAGTVGYAAPELAYT-MRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIE--------V------ 869 (918)
Q Consensus 805 ~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~--------~------ 869 (918)
.........+++.|+|||.+.+ ..++.++||||+||++|||++|+.||....... ........ .
T Consensus 157 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 235 (309)
T cd07872 157 PTKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVED-ELHLIFRLLGTPTEETWPGISSN 235 (309)
T ss_pred CccccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCCCCHHHHhhhcch
Confidence 4333344567899999998865 457899999999999999999999986543211 00000000 0
Q ss_pred hhhcccCCCCCC-----cchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 870 NQILDHRLPTPS-----RDVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 870 ~~~~~~~~~~~~-----~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
....+...+... ........++.+++.+|++.||.+|||++|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 236 DEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred hhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 000000001000 000112346789999999999999999999975
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-36 Score=330.63 Aligned_cols=261 Identities=18% Similarity=0.252 Sum_probs=200.8
Q ss_pred HHHHHHhcCCCCceeeccccceEEEEEEeC-CCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEeccccc
Q 044366 639 EEITKATGNFGEKYCIGKGGQRSVYKAELP-SGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSN 717 (918)
Q Consensus 639 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~ 717 (918)
.+.....++|.+.+.||+|+||.||+|+.. +++.||+|++...... .....+.+.+|+.+++.++||||+++++++.+
T Consensus 36 ~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~-~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~ 114 (371)
T cd05622 36 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMI-KRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 114 (371)
T ss_pred hhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhh-hhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence 344556689999999999999999999654 7889999998653211 12224567899999999999999999999999
Q ss_pred CCceEEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccc
Q 044366 718 AQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFG 797 (918)
Q Consensus 718 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG 797 (918)
++..++||||+++|+|.+++... .+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 115 ~~~~~lv~Ey~~gg~L~~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~~~~~ikL~DfG 187 (371)
T cd05622 115 DRYLYMVMEYMPGGDLVNLMSNY----DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFG 187 (371)
T ss_pred CCEEEEEEcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEECCCCCEEEEeCC
Confidence 99999999999999999998753 378889999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCC-CceecccccccccccccccCC----CCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhh
Q 044366 798 FAKFLEPHSS-NWTEFAGTVGYAAPELAYTMR----ATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQI 872 (918)
Q Consensus 798 ~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~----~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 872 (918)
++........ ......||+.|+|||++.+.. ++.++|||||||++|||++|+.||...... . . ...+
T Consensus 188 ~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~-~----~---~~~i 259 (371)
T cd05622 188 TCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV-G----T---YSKI 259 (371)
T ss_pred ceeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHH-H----H---HHHH
Confidence 9987654322 223457899999999987543 788999999999999999999998754321 0 1 1111
Q ss_pred cccCCCCCCcchHHHHHHHHHHHHHcccCCCCC--CCCHHHHHHH
Q 044366 873 LDHRLPTPSRDVTDKLRSIMEVAILCLVENPEA--RPTMKEVCNL 915 (918)
Q Consensus 873 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~--RPt~~evl~~ 915 (918)
..................+.+++.+|+..++.+ ||+++|+++.
T Consensus 260 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h 304 (371)
T cd05622 260 MNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 304 (371)
T ss_pred HcCCCcccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcC
Confidence 111100000111123345778888899844433 7899998763
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-36 Score=325.53 Aligned_cols=244 Identities=23% Similarity=0.341 Sum_probs=194.9
Q ss_pred CCCCceeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhcc-CCceeeEecccccCCceEEE
Q 044366 647 NFGEKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIR-HRNIIKFHGFCSNAQHSFIV 724 (918)
Q Consensus 647 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv 724 (918)
+|...+.||+|+||.||+|.. .+|+.||+|+++...... ....+.+..|..+++.+. |++|+++++++.+.+..++|
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv 79 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQ-DDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFV 79 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhh-hhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEE
Confidence 467788999999999999954 578999999987643222 223466788888888885 57788899999999999999
Q ss_pred EEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccCC
Q 044366 725 CEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEP 804 (918)
Q Consensus 725 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~~ 804 (918)
|||+++|+|.+++... ..+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 80 ~Ey~~~g~L~~~i~~~---~~l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~ 153 (323)
T cd05615 80 MEYVNGGDLMYHIQQV---GKFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMV 153 (323)
T ss_pred EcCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeccccccccCC
Confidence 9999999999998754 3489999999999999999999999 999999999999999999999999999986543
Q ss_pred CCCCceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCCCCCcch
Q 044366 805 HSSNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRDV 884 (918)
Q Consensus 805 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 884 (918)
.........||+.|+|||++.+..++.++||||+||++|||++|+.||...... ... ..+.......+ ..
T Consensus 154 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~-----~~~---~~i~~~~~~~p-~~- 223 (323)
T cd05615 154 DGVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDED-----ELF---QSIMEHNVSYP-KS- 223 (323)
T ss_pred CCccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHH-----HHH---HHHHhCCCCCC-cc-
Confidence 333334456899999999999888999999999999999999999998654321 011 11111111111 11
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCH
Q 044366 885 TDKLRSIMEVAILCLVENPEARPTM 909 (918)
Q Consensus 885 ~~~~~~l~~li~~cl~~dp~~RPt~ 909 (918)
....+.+++.+|++.+|.+|+++
T Consensus 224 --~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 224 --LSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred --CCHHHHHHHHHHcccCHhhCCCC
Confidence 22457889999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=310.90 Aligned_cols=253 Identities=23% Similarity=0.311 Sum_probs=202.0
Q ss_pred cCCCCceeeccccceEEEEEEe-CCCCEEEEEEcccccccC-CCCChHHHHHHHHHHhhccCCceeeEecccccCCceEE
Q 044366 646 GNFGEKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSD-ETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFI 723 (918)
Q Consensus 646 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 723 (918)
++|...+.||+|++|.||+|.. .+++.||+|.+....... .....+.+.+|++++++++||||+++++++.+++..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 4688899999999999999954 578999999986532221 11224578999999999999999999999999999999
Q ss_pred EEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccC
Q 044366 724 VCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLE 803 (918)
Q Consensus 724 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~ 803 (918)
|+||+++++|.+++.... .+++..+..++.|++.|++|||+. +++||||+|+||++++++.++|+|||.++...
T Consensus 82 v~e~~~~~~l~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~ 155 (263)
T cd06625 82 FMEYMPGGSVKDQLKAYG---ALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQ 155 (263)
T ss_pred EEEECCCCcHHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecc
Confidence 999999999999987643 478899999999999999999999 99999999999999999999999999998664
Q ss_pred CCCCCc---eecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhccc-CCCC
Q 044366 804 PHSSNW---TEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDH-RLPT 879 (918)
Q Consensus 804 ~~~~~~---~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~ 879 (918)
...... ....++..|+|||++.+..++.++||||+|+++|||++|+.||......... ...... ..+.
T Consensus 156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~--------~~~~~~~~~~~ 227 (263)
T cd06625 156 TICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAI--------FKIATQPTNPQ 227 (263)
T ss_pred ccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHH--------HHHhccCCCCC
Confidence 322211 2345778999999999988999999999999999999999997643221110 001111 1111
Q ss_pred CCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 044366 880 PSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNL 915 (918)
Q Consensus 880 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 915 (918)
... .....+.+++.+||..+|.+|||+.|+++.
T Consensus 228 ~~~---~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 228 LPS---HVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred CCc---cCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 111 123467889999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=309.04 Aligned_cols=252 Identities=25% Similarity=0.433 Sum_probs=201.2
Q ss_pred cCCCCceeeccccceEEEEEEeCCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEEEE
Q 044366 646 GNFGEKYCIGKGGQRSVYKAELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFIVC 725 (918)
Q Consensus 646 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 725 (918)
++|...+.||+|++|.||+|....+..||+|.+... ....+.|.+|+++++.++|||++++++++. .+..++||
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~-----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~ 79 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPG-----TMMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVT 79 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccC-----CccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEE
Confidence 568888999999999999998777778999987642 223467899999999999999999999875 45689999
Q ss_pred EeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccCCC
Q 044366 726 EYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPH 805 (918)
Q Consensus 726 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~~~ 805 (918)
||+++|+|.++++... ...+++..+..++.|++.|++|||+. +++|+||||+||++++++.++|+|||.+......
T Consensus 80 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~ 155 (260)
T cd05069 80 EFMGKGSLLDFLKEGD-GKYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADFGLARLIEDN 155 (260)
T ss_pred EcCCCCCHHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEECCCccceEccCC
Confidence 9999999999997643 34479999999999999999999999 9999999999999999999999999999876433
Q ss_pred CCC-ceecccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhhhhhhhhhHhhhhhhcccCCCCCCcc
Q 044366 806 SSN-WTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIK-GYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRD 883 (918)
Q Consensus 806 ~~~-~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 883 (918)
... .....++..|+|||...+..++.++||||||+++|||++ |+.||....... .. ..... ....+ ...
T Consensus 156 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~-~~----~~~~~--~~~~~-~~~- 226 (260)
T cd05069 156 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNRE-VL----EQVER--GYRMP-CPQ- 226 (260)
T ss_pred cccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH-HH----HHHHc--CCCCC-CCc-
Confidence 221 122345678999999988889999999999999999999 888976433210 00 11111 01111 111
Q ss_pred hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhC
Q 044366 884 VTDKLRSIMEVAILCLVENPEARPTMKEVCNLLCK 918 (918)
Q Consensus 884 ~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~ 918 (918)
.....+.+++.+||+.||++||++++|++.|++
T Consensus 227 --~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 227 --GCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred --ccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 233568889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=316.01 Aligned_cols=263 Identities=22% Similarity=0.337 Sum_probs=201.1
Q ss_pred hcCCCCceeeccccceEEEEEEeC-----------------CCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCc
Q 044366 645 TGNFGEKYCIGKGGQRSVYKAELP-----------------SGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRN 707 (918)
Q Consensus 645 ~~~~~~~~~lg~G~~g~Vy~~~~~-----------------~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~n 707 (918)
.++|++.+.||+|+||.||+|+.. ++..||+|+++... ......+|.+|+++++.++|+|
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~---~~~~~~~~~~E~~~l~~l~~~~ 80 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA---NKNARNDFLKEIKIMSRLKDPN 80 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC---CHHHHHHHHHHHHHHHhCCCCC
Confidence 356889999999999999998432 23468999986531 2223467999999999999999
Q ss_pred eeeEecccccCCceEEEEEeccCCChhHHhhcccc--------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCC
Q 044366 708 IIKFHGFCSNAQHSFIVCEYLARGSLTTILRDDAA--------AKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDIS 779 (918)
Q Consensus 708 iv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~--------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk 779 (918)
|+++++++..++..++||||+++|+|.+++..... ...+++.+++.++.|++.|++|||+. +++|||||
T Consensus 81 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dlk 157 (296)
T cd05095 81 IIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLA 157 (296)
T ss_pred cceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CeecccCC
Confidence 99999999999999999999999999999976421 13478889999999999999999999 99999999
Q ss_pred CCCeeeCCCCcEEEeccccccccCCCCCC--ceecccccccccccccccCCCCcccchhhHHHHHHHHHh--CCCCCCcc
Q 044366 780 SKNVLLDSEYEAHVSDFGFAKFLEPHSSN--WTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIK--GYHPGDFV 855 (918)
Q Consensus 780 ~~Nill~~~~~~kl~DfG~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t--g~~p~~~~ 855 (918)
|+||+++.++.++++|||+++.+...... .....++..|+|||+..++.++.++|||||||++|||++ |..||...
T Consensus 158 p~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~ 237 (296)
T cd05095 158 TRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQL 237 (296)
T ss_pred hheEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCcccc
Confidence 99999999999999999999866433211 122334678999999888889999999999999999998 66776533
Q ss_pred hhhhhhhhhhHhhhhhhcc-cCCCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhC
Q 044366 856 STIFSSISNMIIEVNQILD-HRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLLCK 918 (918)
Q Consensus 856 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~ 918 (918)
... ..+............ ...+.+ . .....+.+++.+||+.||.+||++.||++.|++
T Consensus 238 ~~~-~~~~~~~~~~~~~~~~~~~~~~-~---~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 238 SDE-QVIENTGEFFRDQGRQVYLPKP-A---LCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred ChH-HHHHHHHHHHhhccccccCCCC-C---CCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 221 111111000000000 011111 1 122568899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=314.02 Aligned_cols=252 Identities=24% Similarity=0.417 Sum_probs=195.5
Q ss_pred cCCCCceeeccccceEEEEEEe-CCCC----EEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCc
Q 044366 646 GNFGEKYCIGKGGQRSVYKAEL-PSGN----IFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQH 720 (918)
Q Consensus 646 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~----~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 720 (918)
++|+..+.||+|+||.||+|.+ .+|+ .||+|.+... .......++..|+..+++++||||+++++++.. ..
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~ 82 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDR---SGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-AS 82 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccc---cchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-Cc
Confidence 5678888999999999999965 3555 4677776432 112234577888889999999999999998754 45
Q ss_pred eEEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEecccccc
Q 044366 721 SFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAK 800 (918)
Q Consensus 721 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~ 800 (918)
.++++||+++|+|.+++.... ..+++..++.++.||+.|++|||+. +++||||||+||++++++.+||+|||.++
T Consensus 83 ~~~i~e~~~~gsL~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~kl~Dfg~~~ 157 (279)
T cd05111 83 LQLVTQLSPLGSLLDHVRQHR--DSLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVAD 157 (279)
T ss_pred cEEEEEeCCCCcHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEEcCCccce
Confidence 788999999999999997542 3589999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCC--ceecccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhhhhhhhhhHhhhhhhcccCC
Q 044366 801 FLEPHSSN--WTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIK-GYHPGDFVSTIFSSISNMIIEVNQILDHRL 877 (918)
Q Consensus 801 ~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 877 (918)
...+.... .....++..|+|||.+.+..++.++||||||+++|||++ |+.||...... ..... ... ....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~--~~~~~---~~~--~~~~ 230 (279)
T cd05111 158 LLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPH--EVPDL---LEK--GERL 230 (279)
T ss_pred eccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHH--HHHHH---HHC--CCcC
Confidence 76443221 223456778999999998899999999999999999998 99997654321 01111 000 0111
Q ss_pred CCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 044366 878 PTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLLC 917 (918)
Q Consensus 878 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 917 (918)
+.+ .. ....+.+++.+||..||++|||+.|+++.|.
T Consensus 231 ~~~-~~---~~~~~~~li~~c~~~~p~~Rps~~el~~~l~ 266 (279)
T cd05111 231 AQP-QI---CTIDVYMVMVKCWMIDENVRPTFKELANEFT 266 (279)
T ss_pred CCC-CC---CCHHHHHHHHHHcCCCcccCcCHHHHHHHHH
Confidence 111 11 1235678899999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=319.74 Aligned_cols=246 Identities=27% Similarity=0.417 Sum_probs=198.6
Q ss_pred CCCceeeccccceEEEEE-EeCCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEEEEE
Q 044366 648 FGEKYCIGKGGQRSVYKA-ELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFIVCE 726 (918)
Q Consensus 648 ~~~~~~lg~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 726 (918)
|...+-||.|+||.||.| +..+.+.||||++..... ...+...++..|+..+++++|||++.+.|||-.+...|+|||
T Consensus 28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGK-Qs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME 106 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGK-QSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME 106 (948)
T ss_pred HHHHHHhcCCccceeEEeeccCccceeeeeecccccc-ccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence 455566999999999999 456789999999865322 223335689999999999999999999999999999999999
Q ss_pred eccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccCCCC
Q 044366 727 YLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHS 806 (918)
Q Consensus 727 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~~~~ 806 (918)
||- |+-.+.+.-.+ .++-+.++..|+.+.++||+|||+. +.||||||+-||++++.|.||++|||.|....|.
T Consensus 107 YCl-GSAsDlleVhk--KplqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA- 179 (948)
T KOG0577|consen 107 YCL-GSASDLLEVHK--KPLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKLADFGSASIMAPA- 179 (948)
T ss_pred HHh-ccHHHHHHHHh--ccchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeeeccccchhhcCch-
Confidence 996 48888876553 4578899999999999999999999 9999999999999999999999999999987764
Q ss_pred CCceecccccccccccccc---cCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCCCCCcc
Q 044366 807 SNWTEFAGTVGYAAPELAY---TMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRD 883 (918)
Q Consensus 807 ~~~~~~~g~~~y~aPE~~~---~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 883 (918)
..++|||.|||||++. .+.|+-|+||||+|++..|+...++|.-.+... ..+..+.....|...
T Consensus 180 ---nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAM--------SALYHIAQNesPtLq-- 246 (948)
T KOG0577|consen 180 ---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM--------SALYHIAQNESPTLQ-- 246 (948)
T ss_pred ---hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHH--------HHHHHHHhcCCCCCC--
Confidence 4468999999999874 578999999999999999999999994333221 112222222222222
Q ss_pred hHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 884 VTDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 884 ~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
..++...+..++..|+++-|.+|||.+++++
T Consensus 247 s~eWS~~F~~Fvd~CLqKipqeRptse~ll~ 277 (948)
T KOG0577|consen 247 SNEWSDYFRNFVDSCLQKIPQERPTSEELLK 277 (948)
T ss_pred CchhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence 1233445677777899999999999999875
|
|
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=314.27 Aligned_cols=257 Identities=23% Similarity=0.348 Sum_probs=203.7
Q ss_pred hcCCCCceeeccccceEEEEEEeC------CCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccC
Q 044366 645 TGNFGEKYCIGKGGQRSVYKAELP------SGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNA 718 (918)
Q Consensus 645 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~ 718 (918)
.++|.+.+.||+|+||.||+|... ++..||+|.+.... .......+.+|+.+++.++||||+++++++..+
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~---~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~ 81 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA---SMRERIEFLNEASVMKEFNCHHVVRLLGVVSTG 81 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc---CHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCC
Confidence 457888899999999999999653 34689999975431 122245788999999999999999999999999
Q ss_pred CceEEEEEeccCCChhHHhhcccc-------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcE
Q 044366 719 QHSFIVCEYLARGSLTTILRDDAA-------AKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEA 791 (918)
Q Consensus 719 ~~~~lv~e~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~ 791 (918)
...++||||+++|+|.+++..... ...+++..++.++.|++.|++|||+. +++||||||+||+++.++.+
T Consensus 82 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nill~~~~~~ 158 (277)
T cd05032 82 QPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDLTV 158 (277)
T ss_pred CCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEEEcCCCCE
Confidence 999999999999999999975432 22478999999999999999999999 99999999999999999999
Q ss_pred EEeccccccccCCCCC--CceecccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhhhhhhhhhHhh
Q 044366 792 HVSDFGFAKFLEPHSS--NWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIK-GYHPGDFVSTIFSSISNMIIE 868 (918)
Q Consensus 792 kl~DfG~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~p~~~~~~~~~~~~~~~~~ 868 (918)
||+|||+++.+..... ......++..|+|||.+.+..++.++|||||||++||+++ |..||...... . ....
T Consensus 159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~--~---~~~~ 233 (277)
T cd05032 159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNE--E---VLKF 233 (277)
T ss_pred EECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHH--H---HHHH
Confidence 9999999986644322 1223346789999999988889999999999999999998 88887543221 0 1111
Q ss_pred hhhhcccCCCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhC
Q 044366 869 VNQILDHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLLCK 918 (918)
Q Consensus 869 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~ 918 (918)
. ........+... ...+.+++.+||+.+|++|||+.++++.|++
T Consensus 234 ~---~~~~~~~~~~~~---~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 277 (277)
T cd05032 234 V---IDGGHLDLPENC---PDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277 (277)
T ss_pred H---hcCCCCCCCCCC---CHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence 1 111111111122 3568899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=318.17 Aligned_cols=264 Identities=23% Similarity=0.352 Sum_probs=203.3
Q ss_pred hcCCCCceeeccccceEEEEEEeCC-----------------CCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCc
Q 044366 645 TGNFGEKYCIGKGGQRSVYKAELPS-----------------GNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRN 707 (918)
Q Consensus 645 ~~~~~~~~~lg~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~n 707 (918)
.++|+..+.||+|+||.||+|.... +..||+|.+..... ....+.|.+|++++++++|||
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~---~~~~~~~~~e~~~l~~l~~~~ 80 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDAS---DNAREDFLKEVKILSRLSDPN 80 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccC---HHHHHHHHHHHHHHHhcCCCC
Confidence 4678899999999999999986532 24689998865321 123567899999999999999
Q ss_pred eeeEecccccCCceEEEEEeccCCChhHHhhcccc--------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCC
Q 044366 708 IIKFHGFCSNAQHSFIVCEYLARGSLTTILRDDAA--------AKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDIS 779 (918)
Q Consensus 708 iv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~--------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk 779 (918)
|+++++++..++..++||||+++++|.+++..... ...+++..++.++.|++.||+|||+. +++|||||
T Consensus 81 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i~H~dlk 157 (296)
T cd05051 81 IARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLA 157 (296)
T ss_pred EeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---Cccccccc
Confidence 99999999999999999999999999999976431 22589999999999999999999999 99999999
Q ss_pred CCCeeeCCCCcEEEeccccccccCCCCC--CceecccccccccccccccCCCCcccchhhHHHHHHHHHh--CCCCCCcc
Q 044366 780 SKNVLLDSEYEAHVSDFGFAKFLEPHSS--NWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIK--GYHPGDFV 855 (918)
Q Consensus 780 ~~Nill~~~~~~kl~DfG~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t--g~~p~~~~ 855 (918)
|+||+++.++.++++|||+++....... ......++..|+|||++.+..++.++||||||+++|||++ |..|+...
T Consensus 158 p~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~ 237 (296)
T cd05051 158 TRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHL 237 (296)
T ss_pred hhceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCc
Confidence 9999999999999999999986543321 1223445778999999988889999999999999999998 66776543
Q ss_pred hhhhhhhhhhHhhhhhhcccCCCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhC
Q 044366 856 STIFSSISNMIIEVNQILDHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLLCK 918 (918)
Q Consensus 856 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~ 918 (918)
... ..+.... ............ ........++.+++.+|++.||.+|||+.|+++.|++
T Consensus 238 ~~~-~~~~~~~-~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~ 296 (296)
T cd05051 238 TDQ-QVIENAG-HFFRDDGRQIYL--PRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR 296 (296)
T ss_pred ChH-HHHHHHH-hccccccccccC--CCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence 221 1111111 000000000000 0111123568999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=309.92 Aligned_cols=249 Identities=26% Similarity=0.412 Sum_probs=204.5
Q ss_pred cCCCCceeeccccceEEEEEEeC-CCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEEE
Q 044366 646 GNFGEKYCIGKGGQRSVYKAELP-SGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFIV 724 (918)
Q Consensus 646 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 724 (918)
++|+..+.||+|+||.||+|... +++.||+|.+.... ..+++.+|+++++.++||||+++++++.++...+++
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~------~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~ 76 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE------DLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIV 76 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHH------HHHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEE
Confidence 57888899999999999999765 48999999986531 157899999999999999999999999999999999
Q ss_pred EEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccCC
Q 044366 725 CEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEP 804 (918)
Q Consensus 725 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~~ 804 (918)
+||+++++|.+++.... ..+++..++.++.|++.|++|||+. +++||||+|+||+++.++.++|+|||++.....
T Consensus 77 ~e~~~~~~L~~~l~~~~--~~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~ 151 (256)
T cd06612 77 MEYCGAGSVSDIMKITN--KTLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTD 151 (256)
T ss_pred EecCCCCcHHHHHHhCc--cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEcccccchhccc
Confidence 99999999999997542 4589999999999999999999999 999999999999999999999999999987765
Q ss_pred CCCCceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCCCCCcch
Q 044366 805 HSSNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRDV 884 (918)
Q Consensus 805 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 884 (918)
.........++..|+|||++.+..++.++||||||+++|+|++|+.|+.......... . ............
T Consensus 152 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~--------~-~~~~~~~~~~~~ 222 (256)
T cd06612 152 TMAKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIF--------M-IPNKPPPTLSDP 222 (256)
T ss_pred CccccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhh--------h-hccCCCCCCCch
Confidence 4433344567899999999998899999999999999999999999976433211100 0 001111111111
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 885 TDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 885 ~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
......+.+++.+||+.||++|||+.|+++
T Consensus 223 ~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 223 EKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred hhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 223356888999999999999999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=315.98 Aligned_cols=258 Identities=24% Similarity=0.378 Sum_probs=197.9
Q ss_pred CCCceeeccccceEEEEEEe-----CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEeccccc--CCc
Q 044366 648 FGEKYCIGKGGQRSVYKAEL-----PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSN--AQH 720 (918)
Q Consensus 648 ~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~ 720 (918)
|...+.||+|+||.||.+.. .+++.||+|.++... .....+.|.+|+++++.++||||+++++++.. ...
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC---GQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKG 82 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEecccc---ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCce
Confidence 37888999999999987642 367899999986532 22235678999999999999999999998755 346
Q ss_pred eEEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEecccccc
Q 044366 721 SFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAK 800 (918)
Q Consensus 721 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~ 800 (918)
.++||||+++|+|.+++... .+++.+++.++.|++.|++|||+. +++||||||+||++++++.++|+|||++.
T Consensus 83 ~~lv~e~~~~~~l~~~~~~~----~l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~ 155 (283)
T cd05080 83 LQLIMEYVPLGSLRDYLPKH----KLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAK 155 (283)
T ss_pred EEEEecCCCCCCHHHHHHHc----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcEEEeeccccc
Confidence 78999999999999999753 389999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCC---ceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhh------Hhhhhh
Q 044366 801 FLEPHSSN---WTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNM------IIEVNQ 871 (918)
Q Consensus 801 ~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~------~~~~~~ 871 (918)
........ .....++..|+|||.+.+..++.++||||||+++|||++|+.|+............. ......
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (283)
T cd05080 156 AVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIE 235 (283)
T ss_pred ccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhh
Confidence 76543221 112235667999999988889999999999999999999999976433211111000 001111
Q ss_pred hcccCCCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 044366 872 ILDHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLLC 917 (918)
Q Consensus 872 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 917 (918)
..+.....+ ........+.+++.+||+.||++|||++++++.|+
T Consensus 236 ~~~~~~~~~--~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~ 279 (283)
T cd05080 236 LLERGMRLP--CPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILK 279 (283)
T ss_pred hhhcCCCCC--CCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHH
Confidence 111111100 01112356888999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=316.94 Aligned_cols=249 Identities=27% Similarity=0.425 Sum_probs=202.9
Q ss_pred cCCCCceeeccccceEEEEEE-eCCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEEE
Q 044366 646 GNFGEKYCIGKGGQRSVYKAE-LPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFIV 724 (918)
Q Consensus 646 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 724 (918)
.+|...+.||.|++|.||+|. ..+|+.||+|.+... .....+.+.+|+..++.++||||+++++++..++..++|
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 94 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQ----KQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVV 94 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecc----cCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEE
Confidence 458888999999999999995 467999999988642 223356789999999999999999999999999999999
Q ss_pred EEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccCC
Q 044366 725 CEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEP 804 (918)
Q Consensus 725 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~~ 804 (918)
+||+++++|.+++... .+++.++..++.|++.|++|||+. +++||||+|+||+++.++.++|+|||++....+
T Consensus 95 ~e~~~~~~L~~~~~~~----~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~ 167 (296)
T cd06655 95 MEYLAGGSLTDVVTET----CMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITP 167 (296)
T ss_pred EEecCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccchhccc
Confidence 9999999999998643 379999999999999999999999 999999999999999999999999999987655
Q ss_pred CCCCceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCCCCCcch
Q 044366 805 HSSNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRDV 884 (918)
Q Consensus 805 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 884 (918)
.........++..|+|||.+.+..++.++|||||||++|+|++|+.||......... . .... ...+ .....
T Consensus 168 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~-~----~~~~---~~~~-~~~~~ 238 (296)
T cd06655 168 EQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL-Y----LIAT---NGTP-ELQNP 238 (296)
T ss_pred ccccCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH-H----HHHh---cCCc-ccCCc
Confidence 444334456889999999999888999999999999999999999998654332111 0 0000 0000 00111
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 885 TDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 885 ~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
......+.+++.+||..||.+||++.++++
T Consensus 239 ~~~~~~~~~li~~~l~~dp~~Rpt~~~il~ 268 (296)
T cd06655 239 EKLSPIFRDFLNRCLEMDVEKRGSAKELLQ 268 (296)
T ss_pred ccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 122345778899999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=309.09 Aligned_cols=246 Identities=25% Similarity=0.367 Sum_probs=194.1
Q ss_pred eeccccceEEEEEEe---CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEEEEEecc
Q 044366 653 CIGKGGQRSVYKAEL---PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFIVCEYLA 729 (918)
Q Consensus 653 ~lg~G~~g~Vy~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 729 (918)
.||+|+||.||+|.+ .+++.||+|+++... ......+++.+|+.+++.++||||+++++++. ++..++||||++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~ 78 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDN--NDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAE 78 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCC--CcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCC
Confidence 489999999999954 367899999986532 12223567899999999999999999999885 456789999999
Q ss_pred CCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccCCCCCCc
Q 044366 730 RGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNW 809 (918)
Q Consensus 730 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~~~~~~~ 809 (918)
+|+|.+++.... .+++..+..++.|++.|++|+|+. +++||||||+||+++.++.+||+|||++..........
T Consensus 79 ~~~L~~~l~~~~---~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~ 152 (257)
T cd05116 79 LGPLNKFLQKNK---HVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYY 152 (257)
T ss_pred CCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCccccccCCCCCee
Confidence 999999997543 489999999999999999999999 99999999999999999999999999998765433221
Q ss_pred ---eecccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhhhhhhhhhHhhhhhhcccCCCCCCcchH
Q 044366 810 ---TEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIK-GYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRDVT 885 (918)
Q Consensus 810 ---~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 885 (918)
....++..|+|||.+....++.++||||||+++|||++ |+.||...... .... .... ...+..+..
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--~~~~---~i~~---~~~~~~~~~-- 222 (257)
T cd05116 153 KAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGN--EVTQ---MIES---GERMECPQR-- 222 (257)
T ss_pred eecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH--HHHH---HHHC---CCCCCCCCC--
Confidence 12233578999999988888999999999999999998 99998654321 1111 1111 111111111
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhC
Q 044366 886 DKLRSIMEVAILCLVENPEARPTMKEVCNLLCK 918 (918)
Q Consensus 886 ~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~ 918 (918)
...++.+++.+||+.||++||++++|.+.|++
T Consensus 223 -~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~ 254 (257)
T cd05116 223 -CPPEMYDLMKLCWTYGVDERPGFAVVELRLRN 254 (257)
T ss_pred -CCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence 23567889999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-35 Score=308.99 Aligned_cols=255 Identities=26% Similarity=0.480 Sum_probs=206.2
Q ss_pred HhcCCCCceeeccccceEEEEEEeCCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEE
Q 044366 644 ATGNFGEKYCIGKGGQRSVYKAELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFI 723 (918)
Q Consensus 644 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 723 (918)
..++|.+.+.||+|+||.||+|...+++.||||.+... ....+++.+|+.++++++|+||+++++++......++
T Consensus 4 ~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~-----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 78 (261)
T cd05034 4 PRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPG-----TMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYI 78 (261)
T ss_pred chhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCC-----ccCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEE
Confidence 45678899999999999999998878889999988642 2345789999999999999999999999998889999
Q ss_pred EEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccC
Q 044366 724 VCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLE 803 (918)
Q Consensus 724 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~ 803 (918)
||||+++++|.+++.... ...+++.++..++.|++.|++|||+. +++|+||+|+||++++++.++++|||.+....
T Consensus 79 v~e~~~~~~L~~~i~~~~-~~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~ 154 (261)
T cd05034 79 VTEYMSKGSLLDFLKSGE-GKKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIADFGLARLIE 154 (261)
T ss_pred EEeccCCCCHHHHHhccc-cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEECccccceecc
Confidence 999999999999997643 34589999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCC-ceecccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhhhhhhhhhHhhhhhhcccCCCCCC
Q 044366 804 PHSSN-WTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIK-GYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPS 881 (918)
Q Consensus 804 ~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 881 (918)
..... .....++..|+|||.+.+..++.++||||+|+++|+|++ |+.||...... . ........ ...+.+
T Consensus 155 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~-~----~~~~~~~~--~~~~~~- 226 (261)
T cd05034 155 DDEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNR-E----VLEQVERG--YRMPRP- 226 (261)
T ss_pred chhhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH-H----HHHHHHcC--CCCCCC-
Confidence 32211 112234568999999998889999999999999999998 99997543221 1 11111110 011111
Q ss_pred cchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhC
Q 044366 882 RDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLLCK 918 (918)
Q Consensus 882 ~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~ 918 (918)
... ...+.+++.+|++.+|++||+++++.+.|+.
T Consensus 227 ~~~---~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 227 PNC---PEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred CCC---CHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 111 3468889999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=317.75 Aligned_cols=258 Identities=25% Similarity=0.391 Sum_probs=203.1
Q ss_pred HHhcCCCCceeeccccceEEEEEEeC------CCCEEEEEEcccccccCCCCChHHHHHHHHHHhhc-cCCceeeEeccc
Q 044366 643 KATGNFGEKYCIGKGGQRSVYKAELP------SGNIFAVKKFKAELFSDETANPSEFLNEVLALTEI-RHRNIIKFHGFC 715 (918)
Q Consensus 643 ~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~ 715 (918)
...++|+..+.||+|+||.||+|... ....||+|.+.... ......++.+|+++++.+ +||||+++++++
T Consensus 9 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~---~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~ 85 (293)
T cd05053 9 LPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA---TEKDLSDLVSEMEMMKMIGKHKNIINLLGVC 85 (293)
T ss_pred cCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCC---CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 44567888899999999999999653 23679999886531 122345688999999999 899999999999
Q ss_pred ccCCceEEEEEeccCCChhHHhhcc-------------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCC
Q 044366 716 SNAQHSFIVCEYLARGSLTTILRDD-------------AAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKN 782 (918)
Q Consensus 716 ~~~~~~~lv~e~~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~N 782 (918)
..++..++||||+++|+|.++++.. .....+++..+++++.|++.|++|||+. +|+||||||+|
T Consensus 86 ~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~N 162 (293)
T cd05053 86 TQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAARN 162 (293)
T ss_pred cCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---Cccccccceee
Confidence 9999999999999999999999653 2245689999999999999999999999 99999999999
Q ss_pred eeeCCCCcEEEeccccccccCCCCCC--ceecccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhhh
Q 044366 783 VLLDSEYEAHVSDFGFAKFLEPHSSN--WTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIK-GYHPGDFVSTIF 859 (918)
Q Consensus 783 ill~~~~~~kl~DfG~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~p~~~~~~~~ 859 (918)
|++++++.+|++|||.++.+...... .....++..|+|||++.+..++.++|||||||++|||++ |..|+......
T Consensus 163 il~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~- 241 (293)
T cd05053 163 VLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE- 241 (293)
T ss_pred EEEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHH-
Confidence 99999999999999999876543221 122234578999999988889999999999999999997 88887543211
Q ss_pred hhhhhhHhhhhhhcccCCCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 044366 860 SSISNMIIEVNQILDHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLLC 917 (918)
Q Consensus 860 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 917 (918)
. ....... ...... +. .....+.+++.+||..||++|||+.|+++.|+
T Consensus 242 -~---~~~~~~~--~~~~~~-~~---~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~ 289 (293)
T cd05053 242 -E---LFKLLKE--GYRMEK-PQ---NCTQELYHLMRDCWHEVPSQRPTFKQLVEDLD 289 (293)
T ss_pred -H---HHHHHHc--CCcCCC-CC---CCCHHHHHHHHHHcccCcccCcCHHHHHHHHH
Confidence 0 0111111 111111 11 12346888999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-35 Score=307.55 Aligned_cols=245 Identities=22% Similarity=0.335 Sum_probs=192.5
Q ss_pred eccccceEEEEEEeC---CCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEEEEEeccC
Q 044366 654 IGKGGQRSVYKAELP---SGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFIVCEYLAR 730 (918)
Q Consensus 654 lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 730 (918)
||+|+||.||+|.+. .+..||+|++.... .....+.|.+|+.++++++||||+++++++.. +..++||||+++
T Consensus 3 ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~---~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~ 78 (257)
T cd05115 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN---EKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASG 78 (257)
T ss_pred cCCCCcccEEEEEEecCCCceeEEEEEccccc---ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCC
Confidence 899999999999653 35579999986531 22334679999999999999999999998854 568999999999
Q ss_pred CChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccCCCCCCce
Q 044366 731 GSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWT 810 (918)
Q Consensus 731 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~~~~~~~~ 810 (918)
|+|.+++.... ..+++.++++++.|++.|++|||+. +++||||||+||+++.++.+||+|||++...........
T Consensus 79 ~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 153 (257)
T cd05115 79 GPLNKFLSGKK--DEITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYK 153 (257)
T ss_pred CCHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCCccccccCCcccee
Confidence 99999997532 3589999999999999999999999 999999999999999999999999999986654332211
Q ss_pred ---ecccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhhhhhhhhhHhhhhhhcccCCCCCCcchHH
Q 044366 811 ---EFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIK-GYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRDVTD 886 (918)
Q Consensus 811 ---~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 886 (918)
...++..|+|||++.+..++.++||||||+++||+++ |..||...... .... .+.....+..+. .
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--~~~~------~~~~~~~~~~~~---~ 222 (257)
T cd05115 154 ARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGP--EVMS------FIEQGKRLDCPA---E 222 (257)
T ss_pred ccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHH--HHHH------HHHCCCCCCCCC---C
Confidence 1223578999999988889999999999999999996 99998654321 0110 011111111111 1
Q ss_pred HHHHHHHHHHHcccCCCCCCCCHHHHHHHhhC
Q 044366 887 KLRSIMEVAILCLVENPEARPTMKEVCNLLCK 918 (918)
Q Consensus 887 ~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~ 918 (918)
...++.+++.+||..||++||++.+|.+.|++
T Consensus 223 ~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~ 254 (257)
T cd05115 223 CPPEMYALMKDCWIYKWEDRPNFAKVEERMRT 254 (257)
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHHHHhh
Confidence 23567889999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=325.19 Aligned_cols=259 Identities=22% Similarity=0.286 Sum_probs=196.6
Q ss_pred HhcCCCCceeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCC---
Q 044366 644 ATGNFGEKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQ--- 719 (918)
Q Consensus 644 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~--- 719 (918)
..++|...+.||+|+||.||+|.. .+|+.||+|++..... .......+.+|+.+++.++||||+++++++...+
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 96 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQ--NQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLE 96 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEeccccc--chhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcc
Confidence 457899999999999999999954 5789999999875422 2233567889999999999999999999885443
Q ss_pred ---ceEEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEecc
Q 044366 720 ---HSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDF 796 (918)
Q Consensus 720 ---~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Df 796 (918)
..++||||+++ ++.+.+.. .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+||
T Consensus 97 ~~~~~~lv~e~~~~-~l~~~~~~-----~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~~~~kl~Df 167 (359)
T cd07876 97 EFQDVYLVMELMDA-NLCQVIHM-----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDF 167 (359)
T ss_pred ccceeEEEEeCCCc-CHHHHHhc-----cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEecC
Confidence 47999999975 66666643 278889999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCCCceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhh-------------
Q 044366 797 GFAKFLEPHSSNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSIS------------- 863 (918)
Q Consensus 797 G~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~------------- 863 (918)
|+++..... .......||+.|+|||++.+..++.++||||+||++|+|++|+.||...........
T Consensus 168 g~a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 246 (359)
T cd07876 168 GLARTACTN-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFM 246 (359)
T ss_pred CCccccccC-ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHH
Confidence 999765432 222345689999999999999999999999999999999999999875432111000
Q ss_pred -hhHhhhhhhcccCCCCC----------------CcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 864 -NMIIEVNQILDHRLPTP----------------SRDVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 864 -~~~~~~~~~~~~~~~~~----------------~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
................. ..........+.+++.+|++.||++|||++|+++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 314 (359)
T cd07876 247 NRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALR 314 (359)
T ss_pred HHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhc
Confidence 00000000000000000 0000011246789999999999999999999986
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=316.10 Aligned_cols=254 Identities=20% Similarity=0.312 Sum_probs=199.2
Q ss_pred CCCCceeeccccceEEEEEEeC------CCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCc
Q 044366 647 NFGEKYCIGKGGQRSVYKAELP------SGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQH 720 (918)
Q Consensus 647 ~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 720 (918)
+|...+.||+|+||.||+|... .++.||+|+++... .....+.|.+|+.+++.++||||+++++++...+.
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~ 82 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA---EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQP 82 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC---CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCc
Confidence 4666778999999999999653 35789999987531 11224678899999999999999999999999999
Q ss_pred eEEEEEeccCCChhHHhhccc-------------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCC
Q 044366 721 SFIVCEYLARGSLTTILRDDA-------------AAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDS 787 (918)
Q Consensus 721 ~~lv~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~ 787 (918)
.++++||+++++|.+++.... ....+++..++.++.|++.||+|+|+. +++||||||+||++++
T Consensus 83 ~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Nil~~~ 159 (283)
T cd05091 83 LSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFD 159 (283)
T ss_pred eEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---CccccccchhheEecC
Confidence 999999999999999985321 123478899999999999999999999 9999999999999999
Q ss_pred CCcEEEeccccccccCCCCCC--ceecccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhhhhhhhh
Q 044366 788 EYEAHVSDFGFAKFLEPHSSN--WTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIK-GYHPGDFVSTIFSSISN 864 (918)
Q Consensus 788 ~~~~kl~DfG~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~p~~~~~~~~~~~~~ 864 (918)
++.+||+|||+++........ .....+++.|+|||.+.+..++.++||||||+++|||++ |..||...... ..
T Consensus 160 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~--~~-- 235 (283)
T cd05091 160 KLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ--DV-- 235 (283)
T ss_pred CCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHH--HH--
Confidence 999999999998866433221 123345789999999988889999999999999999998 78886543211 01
Q ss_pred hHhhhhhhcccCCCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 044366 865 MIIEVNQILDHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLLC 917 (918)
Q Consensus 865 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 917 (918)
...+........... ....+.+++.+||+.+|++||++++|+..|+
T Consensus 236 ----~~~i~~~~~~~~~~~---~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~ 281 (283)
T cd05091 236 ----IEMIRNRQVLPCPDD---CPAWVYTLMLECWNEFPSRRPRFKDIHSRLR 281 (283)
T ss_pred ----HHHHHcCCcCCCCCC---CCHHHHHHHHHHhCCCcccCCCHHHHHHHhh
Confidence 111111111111122 2345788999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=311.77 Aligned_cols=258 Identities=24% Similarity=0.318 Sum_probs=201.1
Q ss_pred HHHHhcCCCCceeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCC
Q 044366 641 ITKATGNFGEKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQ 719 (918)
Q Consensus 641 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~ 719 (918)
++.++..+.....||+|+||.||+|.. .+++.||+|.+... .....+.+.+|+++++.++|+||+++++++..++
T Consensus 3 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 78 (268)
T cd06624 3 YEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPER----DSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENG 78 (268)
T ss_pred cccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCC----CHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCC
Confidence 455677777788999999999999964 46789999987653 2223567899999999999999999999999999
Q ss_pred ceEEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCC-CCcEEEecccc
Q 044366 720 HSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDS-EYEAHVSDFGF 798 (918)
Q Consensus 720 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~-~~~~kl~DfG~ 798 (918)
..++|+||+++++|.++++........++..+..++.|++.|++|||+. +|+||||||+||+++. ++.++|+|||.
T Consensus 79 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~~~~l~dfg~ 155 (268)
T cd06624 79 FFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGT 155 (268)
T ss_pred EEEEEEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCeEEEecchh
Confidence 9999999999999999997642221227888999999999999999999 9999999999999986 67899999999
Q ss_pred ccccCCCCCCceecccccccccccccccCC--CCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccC
Q 044366 799 AKFLEPHSSNWTEFAGTVGYAAPELAYTMR--ATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHR 876 (918)
Q Consensus 799 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~--~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 876 (918)
+..............++..|+|||++.+.. ++.++||||||+++|+|++|+.|+........... .......
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~------~~~~~~~ 229 (268)
T cd06624 156 SKRLAGINPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMF------KVGMFKI 229 (268)
T ss_pred heecccCCCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHh------hhhhhcc
Confidence 987654333333456789999999986543 78899999999999999999999754322111000 0000011
Q ss_pred CCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 877 LPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 877 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
.+..+. .....+.+++.+||+.+|.+|||+.|+++
T Consensus 230 ~~~~~~---~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 230 HPEIPE---SLSAEAKNFILRCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred CCCCCc---ccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence 111111 12346788899999999999999999985
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=313.96 Aligned_cols=255 Identities=23% Similarity=0.398 Sum_probs=201.4
Q ss_pred cCCCCceeeccccceEEEEEEe------CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCC
Q 044366 646 GNFGEKYCIGKGGQRSVYKAEL------PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQ 719 (918)
Q Consensus 646 ~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~ 719 (918)
.+|...+.||+|+||.||+|.. .++..+|+|.+... .......|.+|++.++.++|+||+++++++.+.+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 80 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA----SESARQDFQREAELLTVLQHQHIVRFYGVCTEGR 80 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC----CHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCC
Confidence 4577788999999999999953 24568999987642 2223567999999999999999999999999999
Q ss_pred ceEEEEEeccCCChhHHhhcccc------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCC
Q 044366 720 HSFIVCEYLARGSLTTILRDDAA------------AKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDS 787 (918)
Q Consensus 720 ~~~lv~e~~~~gsL~~~l~~~~~------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~ 787 (918)
..++||||+++|+|.++++.... ...+++.+++.++.|++.|++|||+. +++||||||+||++++
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~nil~~~ 157 (280)
T cd05092 81 PLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCLVGQ 157 (280)
T ss_pred ceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhEEEcC
Confidence 99999999999999999976432 13478999999999999999999999 9999999999999999
Q ss_pred CCcEEEeccccccccCCCCCC--ceecccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhhhhhhhh
Q 044366 788 EYEAHVSDFGFAKFLEPHSSN--WTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIK-GYHPGDFVSTIFSSISN 864 (918)
Q Consensus 788 ~~~~kl~DfG~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~p~~~~~~~~~~~~~ 864 (918)
++.++|+|||++......... .....+++.|+|||++.+..++.++|||||||++|||++ |..||...... ..
T Consensus 158 ~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~-~~--- 233 (280)
T cd05092 158 GLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNT-EA--- 233 (280)
T ss_pred CCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHH-HH---
Confidence 999999999999765432211 122334678999999998899999999999999999998 89997543321 00
Q ss_pred hHhhhhhhcccCCCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhC
Q 044366 865 MIIEVNQILDHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLLCK 918 (918)
Q Consensus 865 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~ 918 (918)
.............. .....+.+++.+||+.||.+||++.||.+.|++
T Consensus 234 ----~~~~~~~~~~~~~~---~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~ 280 (280)
T cd05092 234 ----IECITQGRELERPR---TCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA 280 (280)
T ss_pred ----HHHHHcCccCCCCC---CCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence 11111111111111 123457889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=314.61 Aligned_cols=253 Identities=22% Similarity=0.299 Sum_probs=198.8
Q ss_pred CCCceeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEEEEE
Q 044366 648 FGEKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFIVCE 726 (918)
Q Consensus 648 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 726 (918)
|+..+.||+|+||.||+|.. .+++.||+|.+....... ......+.+|+++++.++|++|+++.+++..++..++|||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKK-RKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT 80 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhh-hhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence 66778899999999999955 578999999986542221 1223567889999999999999999999999999999999
Q ss_pred eccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccCCCC
Q 044366 727 YLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHS 806 (918)
Q Consensus 727 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~~~~ 806 (918)
|+++++|.+++.... ...+++..+..++.|++.||.|||+. +|+||||||+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05632 81 IMNGGDLKFHIYNMG-NPGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE 156 (285)
T ss_pred eccCccHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEEecCCcceecCCCC
Confidence 999999999886543 23589999999999999999999999 99999999999999999999999999997654322
Q ss_pred CCceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCCCCCcchHH
Q 044366 807 SNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRDVTD 886 (918)
Q Consensus 807 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 886 (918)
......|+..|+|||++.+..++.++||||+|+++|||++|+.||........ ...... ...... ..... .
T Consensus 157 -~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~-~~~~~~---~~~~~~-~~~~~---~ 227 (285)
T cd05632 157 -SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVK-REEVDR---RVLETE-EVYSA---K 227 (285)
T ss_pred -cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHH---hhhccc-cccCc---c
Confidence 22345689999999999988899999999999999999999999875432110 011111 111111 01111 1
Q ss_pred HHHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 044366 887 KLRSIMEVAILCLVENPEARPT-----MKEVCN 914 (918)
Q Consensus 887 ~~~~l~~li~~cl~~dp~~RPt-----~~evl~ 914 (918)
....+.+++.+|++.||++||+ +++++.
T Consensus 228 ~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05632 228 FSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR 260 (285)
T ss_pred CCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence 2245778899999999999999 666654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=314.82 Aligned_cols=257 Identities=24% Similarity=0.413 Sum_probs=203.0
Q ss_pred hcCCCCceeeccccceEEEEEEeC------CCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccC
Q 044366 645 TGNFGEKYCIGKGGQRSVYKAELP------SGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNA 718 (918)
Q Consensus 645 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~ 718 (918)
.++|+..+.||+|+||.||+|... ++..||+|.++... ......+|.+|+++++.++||||+++++++.++
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~ 80 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA---SADMQADFQREAALMAEFDHPNIVKLLGVCAVG 80 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc---CHHHHHHHHHHHHHHHhcCCCchheEEEEEcCC
Confidence 467888999999999999999653 46789999986532 122246789999999999999999999999999
Q ss_pred CceEEEEEeccCCChhHHhhccc-------------------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCC
Q 044366 719 QHSFIVCEYLARGSLTTILRDDA-------------------AAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDIS 779 (918)
Q Consensus 719 ~~~~lv~e~~~~gsL~~~l~~~~-------------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk 779 (918)
+..++||||+++|+|.+++.... ....+++.+++.++.|++.||+|||+. +++|||||
T Consensus 81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i~H~dl~ 157 (288)
T cd05050 81 KPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLA 157 (288)
T ss_pred CccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---Ceeccccc
Confidence 99999999999999999997432 123478899999999999999999999 99999999
Q ss_pred CCCeeeCCCCcEEEeccccccccCCCCCC--ceecccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcch
Q 044366 780 SKNVLLDSEYEAHVSDFGFAKFLEPHSSN--WTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIK-GYHPGDFVS 856 (918)
Q Consensus 780 ~~Nill~~~~~~kl~DfG~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~p~~~~~ 856 (918)
|+||++++++.++++|||.+..+...... ......+..|+|||.+.+..++.++|||||||++|||++ |..||....
T Consensus 158 p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~ 237 (288)
T cd05050 158 TRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMA 237 (288)
T ss_pred HhheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 99999999999999999999865433211 122234678999999988899999999999999999997 888864332
Q ss_pred hhhhhhhhhHhhhhhhcccCCCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhC
Q 044366 857 TIFSSISNMIIEVNQILDHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLLCK 918 (918)
Q Consensus 857 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~ 918 (918)
.. .. ...+.+........ .....+.+++.+|++.||++|||+.|+++.|++
T Consensus 238 ~~-~~-------~~~~~~~~~~~~~~---~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 238 HE-EV-------IYYVRDGNVLSCPD---NCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred HH-HH-------HHHHhcCCCCCCCC---CCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 11 00 11111111111111 123568889999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=320.58 Aligned_cols=247 Identities=25% Similarity=0.386 Sum_probs=199.6
Q ss_pred CceeeccccceEEEEEEeC--CCC--EEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEEEE
Q 044366 650 EKYCIGKGGQRSVYKAELP--SGN--IFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFIVC 725 (918)
Q Consensus 650 ~~~~lg~G~~g~Vy~~~~~--~~~--~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 725 (918)
..+.||+|.||+|++|.|. +|+ .||||.++.... .....+|.+|+.+|.+++|||++++||+.-+ ....|||
T Consensus 114 l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l---~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ 189 (1039)
T KOG0199|consen 114 LYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSL---NAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVF 189 (1039)
T ss_pred HHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCcc---chhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHh
Confidence 3457999999999999663 454 599999977432 2256899999999999999999999999887 7789999
Q ss_pred EeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccCCC
Q 044366 726 EYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPH 805 (918)
Q Consensus 726 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~~~ 805 (918)
|.++.|+|.+.|++. ....|-....-.++.|||.||.||.++ ++||||+.++|+++.....+||+|||+.+-+...
T Consensus 190 ELaplGSLldrLrka-~~~~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllasprtVKI~DFGLmRaLg~n 265 (1039)
T KOG0199|consen 190 ELAPLGSLLDRLRKA-KKAILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASPRTVKICDFGLMRALGEN 265 (1039)
T ss_pred hhcccchHHHHHhhc-cccceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheecccceeeeecccceeccCCC
Confidence 999999999999983 345577888889999999999999999 9999999999999999999999999999988765
Q ss_pred CCCcee---cccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhhhhhhhhhHhhhhhhcccCCCCCC
Q 044366 806 SSNWTE---FAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIK-GYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPS 881 (918)
Q Consensus 806 ~~~~~~---~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 881 (918)
...+.+ ..-...|+|||.+....++.++|||+|||++|||+| |..||-...... ....+. ...+++.+
T Consensus 266 ed~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~q-----IL~~iD--~~erLpRP- 337 (1039)
T KOG0199|consen 266 EDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQ-----ILKNID--AGERLPRP- 337 (1039)
T ss_pred CcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHH-----HHHhcc--ccccCCCC-
Confidence 444322 234678999999999999999999999999999998 678876543310 111111 12223222
Q ss_pred cchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 044366 882 RDVTDKLRSIMEVAILCLVENPEARPTMKEVCNL 915 (918)
Q Consensus 882 ~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 915 (918)
+ .+.+++++++..||..+|++|||+..+.+.
T Consensus 338 k---~csedIY~imk~cWah~paDRptFsair~~ 368 (1039)
T KOG0199|consen 338 K---YCSEDIYQIMKNCWAHNPADRPTFSAIRED 368 (1039)
T ss_pred C---CChHHHHHHHHHhccCCccccccHHHHHHh
Confidence 2 344679999999999999999999999743
|
|
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=316.06 Aligned_cols=250 Identities=26% Similarity=0.408 Sum_probs=203.2
Q ss_pred hcCCCCceeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEE
Q 044366 645 TGNFGEKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFI 723 (918)
Q Consensus 645 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 723 (918)
..+|...+.||+|+||.||+|.. .+++.||+|.+... .....+.+.+|+.+++.++||||+++++++..++..++
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l 93 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQ----QQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWV 93 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecC----ccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEE
Confidence 36788999999999999999964 57999999998642 22335678899999999999999999999999999999
Q ss_pred EEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccC
Q 044366 724 VCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLE 803 (918)
Q Consensus 724 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~ 803 (918)
||||+++++|.+++.+. .+++.++..++.|++.|+.|||+. +++||||||+||+++.++.++|+|||.+....
T Consensus 94 v~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~ 166 (297)
T cd06656 94 VMEYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT 166 (297)
T ss_pred eecccCCCCHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEECcCccceEcc
Confidence 99999999999998643 378899999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCCceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCCCCCcc
Q 044366 804 PHSSNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRD 883 (918)
Q Consensus 804 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 883 (918)
+.........+++.|+|||.+.+..++.++|||||||++|+|++|+.||......... ........+. ...
T Consensus 167 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~--------~~~~~~~~~~-~~~ 237 (297)
T cd06656 167 PEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL--------YLIATNGTPE-LQN 237 (297)
T ss_pred CCccCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchhe--------eeeccCCCCC-CCC
Confidence 5444334456889999999999888999999999999999999999998643221100 0000000000 011
Q ss_pred hHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 884 VTDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 884 ~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
.......+.+++.+||+.+|++||+++++++
T Consensus 238 ~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 238 PERLSAVFRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred ccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1122345788999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=315.58 Aligned_cols=264 Identities=21% Similarity=0.324 Sum_probs=200.1
Q ss_pred hcCCCCceeeccccceEEEEEEeCC---------------CCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCcee
Q 044366 645 TGNFGEKYCIGKGGQRSVYKAELPS---------------GNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNII 709 (918)
Q Consensus 645 ~~~~~~~~~lg~G~~g~Vy~~~~~~---------------~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv 709 (918)
.++|.+.+.||+|+||.||+|.... ...||+|.++... .......|.+|++++++++|||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~ei~~l~~l~h~~i~ 80 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV---TKTARNDFLKEIKIMSRLKNPNII 80 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC---CHHHHHHHHHHHHHHHhCCCCCcC
Confidence 3578889999999999999985432 2358999986532 112245789999999999999999
Q ss_pred eEecccccCCceEEEEEeccCCChhHHhhcccc---------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCC
Q 044366 710 KFHGFCSNAQHSFIVCEYLARGSLTTILRDDAA---------AKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISS 780 (918)
Q Consensus 710 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~---------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~ 780 (918)
++++++..++..++||||+++++|.+++..... ...+++..++.++.|++.|++|||+. +++||||||
T Consensus 81 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp 157 (295)
T cd05097 81 RLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDLAT 157 (295)
T ss_pred eEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---CeeccccCh
Confidence 999999999999999999999999999865321 12368899999999999999999999 999999999
Q ss_pred CCeeeCCCCcEEEeccccccccCCCCCC--ceecccccccccccccccCCCCcccchhhHHHHHHHHHh--CCCCCCcch
Q 044366 781 KNVLLDSEYEAHVSDFGFAKFLEPHSSN--WTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIK--GYHPGDFVS 856 (918)
Q Consensus 781 ~Nill~~~~~~kl~DfG~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t--g~~p~~~~~ 856 (918)
+||++++++.+||+|||++......... .....++..|+|||+..+..++.++||||||+++|||++ |..||....
T Consensus 158 ~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~ 237 (295)
T cd05097 158 RNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLS 237 (295)
T ss_pred hhEEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccC
Confidence 9999999999999999999865433211 122345678999999988889999999999999999998 556665432
Q ss_pred hhhhhhhhhHhhhhhhcccCCCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhC
Q 044366 857 TIFSSISNMIIEVNQILDHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLLCK 918 (918)
Q Consensus 857 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~ 918 (918)
.. ....................... .....+.+++.+||+.||++||++++|++.|++
T Consensus 238 ~~-~~~~~~~~~~~~~~~~~~~~~~~---~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~ 295 (295)
T cd05097 238 DE-QVIENTGEFFRNQGRQIYLSQTP---LCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE 295 (295)
T ss_pred hH-HHHHHHHHhhhhccccccCCCCC---CCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence 11 11111100000000000011111 123468899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=313.41 Aligned_cols=252 Identities=25% Similarity=0.354 Sum_probs=199.6
Q ss_pred cCCCCceeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEEE
Q 044366 646 GNFGEKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFIV 724 (918)
Q Consensus 646 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 724 (918)
++|...+.||+|+||.||+|.. .+++.||+|.++.. .......+.+|+.+++.++||||+++++++..++..++|
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~----~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv 84 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLE----PGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWIC 84 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecC----chhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEE
Confidence 4677788899999999999954 57899999998653 222345688999999999999999999999999999999
Q ss_pred EEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccCC
Q 044366 725 CEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEP 804 (918)
Q Consensus 725 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~~ 804 (918)
|||+++++|.+++...+ .+++.+++.++.|++.|++|||+. +++|+||||+||+++.++.++|+|||++.....
T Consensus 85 ~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd06645 85 MEFCGGGSLQDIYHVTG---PLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLADFGVSAQITA 158 (267)
T ss_pred EeccCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECcceeeeEccC
Confidence 99999999999987543 489999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCCceecccccccccccccc---cCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCCCCC
Q 044366 805 HSSNWTEFAGTVGYAAPELAY---TMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPS 881 (918)
Q Consensus 805 ~~~~~~~~~g~~~y~aPE~~~---~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 881 (918)
.........|+..|+|||++. ...++.++||||+||++|+|++|..|+......... .. .... ... +...
T Consensus 159 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~-~~---~~~~--~~~-~~~~ 231 (267)
T cd06645 159 TIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRAL-FL---MTKS--NFQ-PPKL 231 (267)
T ss_pred cccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhH-Hh---hhcc--CCC-CCcc
Confidence 433334557899999999874 455788999999999999999999997533221100 00 0000 000 1111
Q ss_pred cchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 882 RDVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 882 ~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
.........+.+++.+|++.+|++||+++++++
T Consensus 232 ~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 232 KDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred cccCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence 111122345788999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=314.45 Aligned_cols=258 Identities=22% Similarity=0.358 Sum_probs=201.5
Q ss_pred HhcCCCCceeeccccceEEEEEEeC------CCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEeccccc
Q 044366 644 ATGNFGEKYCIGKGGQRSVYKAELP------SGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSN 717 (918)
Q Consensus 644 ~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~ 717 (918)
..++|.+.+.||+|+||.||+|... .+..||+|.+.... .......+.+|+..++.++||||+++++++.+
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 80 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA---SLRERIEFLNEASVMKGFTCHHVVRLLGVVSK 80 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcC---CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC
Confidence 4578999999999999999998542 24589999876431 12224568899999999999999999999999
Q ss_pred CCceEEEEEeccCCChhHHhhcccc-------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCc
Q 044366 718 AQHSFIVCEYLARGSLTTILRDDAA-------AKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYE 790 (918)
Q Consensus 718 ~~~~~lv~e~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~ 790 (918)
.+..++||||+++|+|.++++.... ....++..+..++.|++.|++|||+. +++||||||+||++++++.
T Consensus 81 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili~~~~~ 157 (288)
T cd05061 81 GQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFT 157 (288)
T ss_pred CCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEEcCCCc
Confidence 9999999999999999999975321 23457788999999999999999999 9999999999999999999
Q ss_pred EEEeccccccccCCCCCCc--eecccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhhhhhhhhhHh
Q 044366 791 AHVSDFGFAKFLEPHSSNW--TEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIK-GYHPGDFVSTIFSSISNMII 867 (918)
Q Consensus 791 ~kl~DfG~~~~~~~~~~~~--~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~p~~~~~~~~~~~~~~~~ 867 (918)
++++|||+++......... ....++..|+|||.+.+..++.++|||||||++|||++ |..||...... ...
T Consensus 158 ~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~-----~~~- 231 (288)
T cd05061 158 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNE-----QVL- 231 (288)
T ss_pred EEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHH-----HHH-
Confidence 9999999998654332211 22344678999999998889999999999999999998 78887543211 111
Q ss_pred hhhhhcccCCCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhC
Q 044366 868 EVNQILDHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLLCK 918 (918)
Q Consensus 868 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~ 918 (918)
....+......... ....+.+++.+|++.||++|||+.++++.|++
T Consensus 232 --~~~~~~~~~~~~~~---~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~ 277 (288)
T cd05061 232 --KFVMDGGYLDQPDN---CPERVTDLMRMCWQFNPKMRPTFLEIVNLLKD 277 (288)
T ss_pred --HHHHcCCCCCCCCC---CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence 11111111111111 12568899999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=329.10 Aligned_cols=253 Identities=22% Similarity=0.292 Sum_probs=195.2
Q ss_pred cCCCCceeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEEE
Q 044366 646 GNFGEKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFIV 724 (918)
Q Consensus 646 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 724 (918)
++|+..+.||+|+||.||+|.. .+++.||+|+++..... .......+.+|+.++..++||+|+++++++.+++..++|
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv 79 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADML-EKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLI 79 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHh-hhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEE
Confidence 3688899999999999999955 47899999998753222 223356788999999999999999999999999999999
Q ss_pred EEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccCC
Q 044366 725 CEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEP 804 (918)
Q Consensus 725 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~~ 804 (918)
|||+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++|+|||++.....
T Consensus 80 ~E~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~ 153 (360)
T cd05627 80 MEFLPGGDMMTLLMKK---DTLSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKK 153 (360)
T ss_pred EeCCCCccHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEeeccCCccccc
Confidence 9999999999999764 3489999999999999999999999 999999999999999999999999999875532
Q ss_pred CCC-----------------------------------CceecccccccccccccccCCCCcccchhhHHHHHHHHHhCC
Q 044366 805 HSS-----------------------------------NWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGY 849 (918)
Q Consensus 805 ~~~-----------------------------------~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~ 849 (918)
... .....+||+.|+|||++.+..++.++|||||||++|||++|+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~ 233 (360)
T cd05627 154 AHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY 233 (360)
T ss_pred ccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCC
Confidence 110 011346899999999999999999999999999999999999
Q ss_pred CCCCcchhhhhhhhhhHhhhhhhcccCCCCCCcchHHHHHHHHHHHHHcccCCCCCCCC---HHHHHH
Q 044366 850 HPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPT---MKEVCN 914 (918)
Q Consensus 850 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt---~~evl~ 914 (918)
.||....... ... ..... ......+... ....++.+++.+|+ .||.+|++ ++|+++
T Consensus 234 ~Pf~~~~~~~-~~~----~i~~~-~~~~~~p~~~--~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~ 292 (360)
T cd05627 234 PPFCSETPQE-TYR----KVMNW-KETLVFPPEV--PISEKAKDLILRFC-TDSENRIGSNGVEEIKS 292 (360)
T ss_pred CCCCCCCHHH-HHH----HHHcC-CCceecCCCC--CCCHHHHHHHHHhc-cChhhcCCCCCHHHHhc
Confidence 9986543211 111 11000 0111111110 11234666777766 49999985 566653
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-35 Score=307.71 Aligned_cols=253 Identities=22% Similarity=0.309 Sum_probs=206.7
Q ss_pred CCCCceeeccccceEEEEEE-eCCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEEEE
Q 044366 647 NFGEKYCIGKGGQRSVYKAE-LPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFIVC 725 (918)
Q Consensus 647 ~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 725 (918)
+|+..+.||+|+||.||.++ ..+++.+++|.+..... .......+.+|++++++++|+||+++++++.+.+..++||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 78 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRL--SEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEM 78 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeeccc--chhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEE
Confidence 47888999999999999994 45789999999865322 2233567899999999999999999999999999999999
Q ss_pred EeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccCCC
Q 044366 726 EYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPH 805 (918)
Q Consensus 726 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~~~ 805 (918)
||+++|+|.+++.... ...+++.++..++.|++.|++|||+. +++|+||+|+||++++++.+||+|||.+......
T Consensus 79 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~ 154 (256)
T cd08221 79 EYANGGTLYDKIVRQK-GQLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSE 154 (256)
T ss_pred EecCCCcHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEECcCcceEEcccc
Confidence 9999999999997653 34589999999999999999999999 9999999999999999999999999999877554
Q ss_pred CCCceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCCCCCcchH
Q 044366 806 SSNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRDVT 885 (918)
Q Consensus 806 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 885 (918)
........+++.|+|||...+..++.++||||||+++|||++|..||+..... .....+....++... .
T Consensus 155 ~~~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~--------~~~~~~~~~~~~~~~---~ 223 (256)
T cd08221 155 YSMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPL--------NLVVKIVQGNYTPVV---S 223 (256)
T ss_pred cccccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHH--------HHHHHHHcCCCCCCc---c
Confidence 43344567899999999998888899999999999999999999997643221 111111122222211 2
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 044366 886 DKLRSIMEVAILCLVENPEARPTMKEVCNLL 916 (918)
Q Consensus 886 ~~~~~l~~li~~cl~~dp~~RPt~~evl~~L 916 (918)
.....+.+++.+||+.+|.+||++.++++..
T Consensus 224 ~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 224 VYSSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred ccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 2235688899999999999999999998753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-35 Score=312.29 Aligned_cols=253 Identities=23% Similarity=0.321 Sum_probs=199.3
Q ss_pred CCCceeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEEEEE
Q 044366 648 FGEKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFIVCE 726 (918)
Q Consensus 648 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 726 (918)
|+..+.||+|+||.||+|.. .+++.||+|.+....... ....+.+.+|+.+++.++|++|+++++++.+++..++|||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~-~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKK-RKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccc-hHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 67778999999999999954 578999999986532221 2223567889999999999999999999999999999999
Q ss_pred eccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccCCCC
Q 044366 727 YLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHS 806 (918)
Q Consensus 727 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~~~~ 806 (918)
|+++|+|.+++.... ...+++.+++.++.|++.|++|||+. +|+||||||+||++++++.++|+|||++.......
T Consensus 81 ~~~g~~L~~~l~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05630 81 LMNGGDLKFHIYHMG-EAGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ 156 (285)
T ss_pred ecCCCcHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeccceeecCCCc
Confidence 999999999986543 24589999999999999999999998 99999999999999999999999999997654322
Q ss_pred CCceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCCCCCcchHH
Q 044366 807 SNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRDVTD 886 (918)
Q Consensus 807 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 886 (918)
......|+..|+|||++.+..++.++||||+|+++|+|++|+.||......... .. .............. .
T Consensus 157 -~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~--~~---~~~~~~~~~~~~~~---~ 227 (285)
T cd05630 157 -TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKR--EE---VERLVKEVQEEYSE---K 227 (285)
T ss_pred -cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchH--HH---HHhhhhhhhhhcCc---c
Confidence 223457899999999999989999999999999999999999998753221100 00 00111100001111 1
Q ss_pred HHHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 044366 887 KLRSIMEVAILCLVENPEARPT-----MKEVCN 914 (918)
Q Consensus 887 ~~~~l~~li~~cl~~dp~~RPt-----~~evl~ 914 (918)
....+.+++.+||+.||++||| ++|+++
T Consensus 228 ~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 228 FSPDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred CCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 2245788999999999999999 888875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-35 Score=311.66 Aligned_cols=258 Identities=25% Similarity=0.383 Sum_probs=201.1
Q ss_pred HhcCCCCceeeccccceEEEEEEeC------CCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEeccccc
Q 044366 644 ATGNFGEKYCIGKGGQRSVYKAELP------SGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSN 717 (918)
Q Consensus 644 ~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~ 717 (918)
..++|...+.||+|++|.||+|... .+..||+|.+.... .......|.+|+.+++.++|+||+++++++.+
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 80 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC---SEQDESDFLMEALIMSKFNHQNIVRLIGVSFE 80 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC---CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEcc
Confidence 3467888999999999999999654 35689999875421 12224579999999999999999999999988
Q ss_pred CCceEEEEEeccCCChhHHhhcccc----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCC---c
Q 044366 718 AQHSFIVCEYLARGSLTTILRDDAA----AKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEY---E 790 (918)
Q Consensus 718 ~~~~~lv~e~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~---~ 790 (918)
.+..++||||+++++|.+++..... ...+++.++++++.||+.|++|||+. +++||||||+||+++.++ .
T Consensus 81 ~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~~~~~~ 157 (277)
T cd05036 81 RLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRV 157 (277)
T ss_pred CCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEeccCCCcc
Confidence 8899999999999999999976532 23589999999999999999999999 999999999999998764 5
Q ss_pred EEEeccccccccCCCCCC--ceecccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhhhhhhhhhHh
Q 044366 791 AHVSDFGFAKFLEPHSSN--WTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIK-GYHPGDFVSTIFSSISNMII 867 (918)
Q Consensus 791 ~kl~DfG~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~p~~~~~~~~~~~~~~~~ 867 (918)
+|++|||+++........ ......+..|+|||++.+..++.++|||||||++|||++ |+.||+..... .....
T Consensus 158 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~--~~~~~-- 233 (277)
T cd05036 158 AKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQ--EVMEF-- 233 (277)
T ss_pred eEeccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH--HHHHH--
Confidence 899999999876332211 112233568999999998889999999999999999997 99998643321 11111
Q ss_pred hhhhhcccCCCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhC
Q 044366 868 EVNQILDHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLLCK 918 (918)
Q Consensus 868 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~ 918 (918)
... ..+... +. .....+.+++.+|++.+|++||++.+|++.|.+
T Consensus 234 -~~~--~~~~~~-~~---~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~~ 277 (277)
T cd05036 234 -VTG--GGRLDP-PK---GCPGPVYRIMTDCWQHTPEDRPNFATILERIQY 277 (277)
T ss_pred -HHc--CCcCCC-CC---CCCHHHHHHHHHHcCCCcccCcCHHHHHHHhhC
Confidence 101 011111 11 123467889999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=314.86 Aligned_cols=255 Identities=25% Similarity=0.390 Sum_probs=199.1
Q ss_pred CCCCceeeccccceEEEEEEeC------CCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCc
Q 044366 647 NFGEKYCIGKGGQRSVYKAELP------SGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQH 720 (918)
Q Consensus 647 ~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 720 (918)
+|...+.||+|+||.||+|... ....+|+|.+.... ......++.+|+.+++.++||||+++++++..++.
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 77 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENA---SSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGP 77 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCC---CHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCC
Confidence 4677889999999999999542 23578999876532 11224678999999999999999999999999999
Q ss_pred eEEEEEeccCCChhHHhhccc---------------------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCC
Q 044366 721 SFIVCEYLARGSLTTILRDDA---------------------AAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDIS 779 (918)
Q Consensus 721 ~~lv~e~~~~gsL~~~l~~~~---------------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk 779 (918)
.++|+||+++|+|.+++.... ....+++.+++.++.|++.|++|||+. +++|||||
T Consensus 78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~dik 154 (290)
T cd05045 78 LLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRDLA 154 (290)
T ss_pred cEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---Ceehhhhh
Confidence 999999999999999986431 123578999999999999999999999 99999999
Q ss_pred CCCeeeCCCCcEEEeccccccccCCCCCC--ceecccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcch
Q 044366 780 SKNVLLDSEYEAHVSDFGFAKFLEPHSSN--WTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIK-GYHPGDFVS 856 (918)
Q Consensus 780 ~~Nill~~~~~~kl~DfG~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~p~~~~~ 856 (918)
|+||++++++.+||+|||+++........ .....++..|+|||++.+..++.++||||||+++|||++ |..||....
T Consensus 155 p~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~ 234 (290)
T cd05045 155 ARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIA 234 (290)
T ss_pred hheEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCC
Confidence 99999999999999999999865433221 122345678999999988889999999999999999998 999875432
Q ss_pred hhhhhhhhhHhhhhhhcccCCCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhC
Q 044366 857 TIFSSISNMIIEVNQILDHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLLCK 918 (918)
Q Consensus 857 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~ 918 (918)
.. .+.. ...+.. ..+. .. .....+.+++.+||+.+|++||+++|+++.|++
T Consensus 235 ~~--~~~~---~~~~~~--~~~~-~~---~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~ 285 (290)
T cd05045 235 PE--RLFN---LLKTGY--RMER-PE---NCSEEMYNLMLTCWKQEPDKRPTFADISKELEK 285 (290)
T ss_pred HH--HHHH---HHhCCC--CCCC-CC---CCCHHHHHHHHHHccCCcccCCCHHHHHHHHHH
Confidence 11 1111 111111 1111 11 122467889999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-35 Score=315.63 Aligned_cols=258 Identities=22% Similarity=0.366 Sum_probs=202.6
Q ss_pred HhcCCCCceeeccccceEEEEEEe------CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhc-cCCceeeEecccc
Q 044366 644 ATGNFGEKYCIGKGGQRSVYKAEL------PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEI-RHRNIIKFHGFCS 716 (918)
Q Consensus 644 ~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~ 716 (918)
..++|...+.||+|+||.||+|.. .++..||||+++... .....+.+.+|+++++++ +||||+++++++.
T Consensus 33 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 109 (302)
T cd05055 33 PRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA---HSSEREALMSELKIMSHLGNHENIVNLLGACT 109 (302)
T ss_pred cHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccC---ChHHHHHHHHHHHHHHhccCCCCcceEEEEEe
Confidence 335688899999999999999953 234579999886532 122246789999999999 7999999999999
Q ss_pred cCCceEEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEecc
Q 044366 717 NAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDF 796 (918)
Q Consensus 717 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Df 796 (918)
..+..++||||+++|+|.++++... ...+++.++..++.|++.|++|||+. +++|+||||+||+++.++.++++||
T Consensus 110 ~~~~~~lv~e~~~~~~L~~~i~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~df 185 (302)
T cd05055 110 IGGPILVITEYCCYGDLLNFLRRKR-ESFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVKICDF 185 (302)
T ss_pred cCCceEEEEEcCCCCcHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCCCeEEECCC
Confidence 9999999999999999999997543 23379999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCCC--ceecccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhhhhhhhhhHhhhhhhc
Q 044366 797 GFAKFLEPHSSN--WTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIK-GYHPGDFVSTIFSSISNMIIEVNQIL 873 (918)
Q Consensus 797 G~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~ 873 (918)
|++......... .....++..|+|||.+.+..++.++||||+||++|||++ |..||........ .. +..
T Consensus 186 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~-~~-------~~~ 257 (302)
T cd05055 186 GLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSK-FY-------KLI 257 (302)
T ss_pred cccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHH-HH-------HHH
Confidence 999866433221 122345678999999998889999999999999999998 9999754332110 00 111
Q ss_pred ccCCCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhC
Q 044366 874 DHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLLCK 918 (918)
Q Consensus 874 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~ 918 (918)
.......... .....+.+++.+|++.+|++|||+.|+++.|++
T Consensus 258 ~~~~~~~~~~--~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~ 300 (302)
T cd05055 258 KEGYRMAQPE--HAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGK 300 (302)
T ss_pred HcCCcCCCCC--CCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHh
Confidence 1111111000 122468889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=299.17 Aligned_cols=254 Identities=24% Similarity=0.294 Sum_probs=204.4
Q ss_pred cCCCCceeeccccceEEEEEEeC-CCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEEE
Q 044366 646 GNFGEKYCIGKGGQRSVYKAELP-SGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFIV 724 (918)
Q Consensus 646 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 724 (918)
..|+..+.||+|.-|+||.++.. ++..+|+|++.+..... .....+...|-++++.+.||.++.+|+.++.+...|+|
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~-rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~ 155 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLAS-RKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLV 155 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhh-hhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEE
Confidence 34566778999999999999775 45899999998765443 22356778899999999999999999999999999999
Q ss_pred EEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccCC
Q 044366 725 CEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEP 804 (918)
Q Consensus 725 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~~ 804 (918)
||||+||+|....+++. ...+++..++-++..|+-||+|||-. |||.|||||+|||+.++|.+.|+||.++.....
T Consensus 156 meyCpGGdL~~LrqkQp-~~~fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvredGHIMLsDFDLS~~~~~ 231 (459)
T KOG0610|consen 156 MEYCPGGDLHSLRQKQP-GKRFSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVREDGHIMLSDFDLSLRCPV 231 (459)
T ss_pred EecCCCccHHHHHhhCC-CCccchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecCCcEEeeeccccccCCC
Confidence 99999999999887754 56799999999999999999999999 999999999999999999999999998754310
Q ss_pred -------C-------------------------C-C-----------------------CceecccccccccccccccCC
Q 044366 805 -------H-------------------------S-S-----------------------NWTEFAGTVGYAAPELAYTMR 828 (918)
Q Consensus 805 -------~-------------------------~-~-----------------------~~~~~~g~~~y~aPE~~~~~~ 828 (918)
. . . .....+||-.|+|||++.|..
T Consensus 232 ~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~G 311 (459)
T KOG0610|consen 232 SPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEG 311 (459)
T ss_pred CCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCC
Confidence 0 0 0 011346899999999999999
Q ss_pred CCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCCCCCcchHHHHHHHHHHHHHcccCCCCCCCC
Q 044366 829 ATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPT 908 (918)
Q Consensus 829 ~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt 908 (918)
.+.++|.|+|||++|||+.|..||...... .....++...+..+.. +.....+.++|++.+.+||.+|.-
T Consensus 312 HgsAVDWWtfGIflYEmLyG~TPFKG~~~~--------~Tl~NIv~~~l~Fp~~--~~vs~~akDLIr~LLvKdP~kRlg 381 (459)
T KOG0610|consen 312 HGSAVDWWTFGIFLYEMLYGTTPFKGSNNK--------ETLRNIVGQPLKFPEE--PEVSSAAKDLIRKLLVKDPSKRLG 381 (459)
T ss_pred CCchhhHHHHHHHHHHHHhCCCCcCCCCch--------hhHHHHhcCCCcCCCC--CcchhHHHHHHHHHhccChhhhhc
Confidence 999999999999999999999998654321 1122233332222211 134457889999999999999997
Q ss_pred ----HHHHHH
Q 044366 909 ----MKEVCN 914 (918)
Q Consensus 909 ----~~evl~ 914 (918)
|+||.+
T Consensus 382 ~~rGA~eIK~ 391 (459)
T KOG0610|consen 382 SKRGAAEIKR 391 (459)
T ss_pred cccchHHhhc
Confidence 777754
|
|
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=308.48 Aligned_cols=252 Identities=23% Similarity=0.339 Sum_probs=189.4
Q ss_pred eeccccceEEEEEEeC---CCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEEEEEecc
Q 044366 653 CIGKGGQRSVYKAELP---SGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFIVCEYLA 729 (918)
Q Consensus 653 ~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 729 (918)
.||+|+||.||+|... ++..+|+|.++... .......|.+|+.+++.++||||+++++++.+....++||||++
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 78 (269)
T cd05087 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSA---SVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCP 78 (269)
T ss_pred cccccCCceEEEEEEcCCCCceEEEEEecCCCC---ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCC
Confidence 5899999999999654 34579999886532 12234578999999999999999999999999999999999999
Q ss_pred CCChhHHhhcccc--cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccCCCCC
Q 044366 730 RGSLTTILRDDAA--AKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSS 807 (918)
Q Consensus 730 ~gsL~~~l~~~~~--~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~~~~~ 807 (918)
+|+|.++++.... ....++..+..++.|++.|++|||+. +++||||||+||+++.++.++++|||.+........
T Consensus 79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~ 155 (269)
T cd05087 79 LGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDY 155 (269)
T ss_pred CCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCccccccccCcce
Confidence 9999999975432 23457788889999999999999999 999999999999999999999999999975433221
Q ss_pred C--ceecccccccccccccccC-------CCCcccchhhHHHHHHHHHh-CCCCCCcchhhhhhhhhhHhhhhhhcccCC
Q 044366 808 N--WTEFAGTVGYAAPELAYTM-------RATEKYDVYSFGVLALEVIK-GYHPGDFVSTIFSSISNMIIEVNQILDHRL 877 (918)
Q Consensus 808 ~--~~~~~g~~~y~aPE~~~~~-------~~~~~~Dv~slG~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 877 (918)
. .....++..|+|||++.+. .++.++||||||+++|||++ |+.||......... .. .... .....
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~-~~---~~~~-~~~~~ 230 (269)
T cd05087 156 YVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVL-TY---TVRE-QQLKL 230 (269)
T ss_pred eecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHH-HH---Hhhc-ccCCC
Confidence 1 1234567889999988642 35789999999999999996 99998654321110 00 0000 01111
Q ss_pred CCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 044366 878 PTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLLC 917 (918)
Q Consensus 878 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 917 (918)
+.+.. .......+.+++..|| .+|++|||++||++.|+
T Consensus 231 ~~~~~-~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 231 PKPRL-KLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCCcc-CCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 11110 0112234677888898 68999999999999875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-35 Score=311.02 Aligned_cols=252 Identities=23% Similarity=0.326 Sum_probs=197.6
Q ss_pred cCCCCceeeccccceEEEEEE-eCCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEEE
Q 044366 646 GNFGEKYCIGKGGQRSVYKAE-LPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFIV 724 (918)
Q Consensus 646 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 724 (918)
++|...+.||+|+||.||+|. ..+++.||+|.+.... ......+|.+|++++++++||||+++++++..++..++|
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 77 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI---TVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISIC 77 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC---ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEE
Confidence 357788899999999999995 4578999999986531 122346789999999999999999999999999999999
Q ss_pred EEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccCC
Q 044366 725 CEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEP 804 (918)
Q Consensus 725 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~~ 804 (918)
|||+++++|..+. .+++..+..++.|++.|++|||+. +|+|+||||+||+++.++.++|+|||++.....
T Consensus 78 ~e~~~~~~l~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~ 147 (279)
T cd06619 78 TEFMDGGSLDVYR-------KIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVN 147 (279)
T ss_pred EecCCCCChHHhh-------cCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEeeCCcceeccc
Confidence 9999999997652 267888999999999999999999 999999999999999999999999999986643
Q ss_pred CCCCceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCCCCCcch
Q 044366 805 HSSNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRDV 884 (918)
Q Consensus 805 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 884 (918)
.. .....|+..|+|||++.+..++.++||||||+++|+|++|+.||............ ............+... .
T Consensus 148 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~-~~~~~~~~~~~~~~~~--~ 222 (279)
T cd06619 148 SI--AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMP-LQLLQCIVDEDPPVLP--V 222 (279)
T ss_pred cc--ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccch-HHHHHHHhccCCCCCC--C
Confidence 22 23357899999999999888999999999999999999999997643211111000 0001111111111111 1
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 044366 885 TDKLRSIMEVAILCLVENPEARPTMKEVCNL 915 (918)
Q Consensus 885 ~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 915 (918)
.....++.+++.+|++.+|++||+++|+++.
T Consensus 223 ~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 223 GQFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred CcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 1123467899999999999999999999763
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=324.88 Aligned_cols=260 Identities=24% Similarity=0.364 Sum_probs=202.4
Q ss_pred HHhcCCCCceeeccccceEEEEEEeC------CCCEEEEEEcccccccCCCCChHHHHHHHHHHhhcc-CCceeeEeccc
Q 044366 643 KATGNFGEKYCIGKGGQRSVYKAELP------SGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIR-HRNIIKFHGFC 715 (918)
Q Consensus 643 ~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~ 715 (918)
...++|...+.||+|+||.||+|++. .++.||+|+++... .....+.+.+|++++.++. ||||+++++++
T Consensus 34 ~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~ 110 (401)
T cd05107 34 MPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTA---RSSEKQALMSELKIMSHLGPHLNIVNLLGAC 110 (401)
T ss_pred ecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCC---ChhHHHHHHHHHHHHHhcCCCCCeEEEEEEE
Confidence 34456788899999999999999753 34689999997532 1222457899999999997 99999999999
Q ss_pred ccCCceEEEEEeccCCChhHHhhcccc-----------------------------------------------------
Q 044366 716 SNAQHSFIVCEYLARGSLTTILRDDAA----------------------------------------------------- 742 (918)
Q Consensus 716 ~~~~~~~lv~e~~~~gsL~~~l~~~~~----------------------------------------------------- 742 (918)
...+..++||||+++|+|.++++..+.
T Consensus 111 ~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (401)
T cd05107 111 TKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYV 190 (401)
T ss_pred ccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCcc
Confidence 999999999999999999999965321
Q ss_pred ------------------------------------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCC
Q 044366 743 ------------------------------------------AKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISS 780 (918)
Q Consensus 743 ------------------------------------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~ 780 (918)
...+++..++.++.|++.||+|||+. +++||||||
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrdlkp 267 (401)
T cd05107 191 PMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAA 267 (401)
T ss_pred chhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCcccCCc
Confidence 12367888999999999999999998 999999999
Q ss_pred CCeeeCCCCcEEEeccccccccCCCCC--CceecccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchh
Q 044366 781 KNVLLDSEYEAHVSDFGFAKFLEPHSS--NWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIK-GYHPGDFVST 857 (918)
Q Consensus 781 ~Nill~~~~~~kl~DfG~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~p~~~~~~ 857 (918)
+||++++++.+|++|||+++.+..... ......++..|+|||.+.+..++.++||||||+++|||++ |..||.....
T Consensus 268 ~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~ 347 (401)
T cd05107 268 RNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPM 347 (401)
T ss_pred ceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCc
Confidence 999999999999999999986543221 1122356788999999988889999999999999999998 8888754321
Q ss_pred hhhhhhhhHhhhhhhcccCCCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhC
Q 044366 858 IFSSISNMIIEVNQILDHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLLCK 918 (918)
Q Consensus 858 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~ 918 (918)
.. ..... ... ..+.+.+ .. ....+.+++.+||..+|.+||+++|+++.|++
T Consensus 348 ~~-~~~~~---~~~--~~~~~~p-~~---~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~ 398 (401)
T cd05107 348 NE-QFYNA---IKR--GYRMAKP-AH---ASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGD 398 (401)
T ss_pred hH-HHHHH---HHc--CCCCCCC-CC---CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 11 00000 000 1111111 11 23568889999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-35 Score=310.13 Aligned_cols=255 Identities=22% Similarity=0.354 Sum_probs=195.2
Q ss_pred CCCceeeccccceEEEEEEeCC-CC--EEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccC------
Q 044366 648 FGEKYCIGKGGQRSVYKAELPS-GN--IFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNA------ 718 (918)
Q Consensus 648 ~~~~~~lg~G~~g~Vy~~~~~~-~~--~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------ 718 (918)
|.+.+.||+|+||.||+|.... ++ .||+|.++.... .....+.|.+|++.++.++||||+++++++...
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 78 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAIC--TRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGY 78 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCC
Confidence 3456789999999999997643 33 689998865321 222356789999999999999999999987432
Q ss_pred CceEEEEEeccCCChhHHhhccc---ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEec
Q 044366 719 QHSFIVCEYLARGSLTTILRDDA---AAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSD 795 (918)
Q Consensus 719 ~~~~lv~e~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~D 795 (918)
...++||||+++|+|.+++.... ....+++..+..++.|++.|++|||+. +|+||||||+||++++++.+||+|
T Consensus 79 ~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~D 155 (272)
T cd05075 79 PSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVAD 155 (272)
T ss_pred CCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCCCCEEECC
Confidence 25689999999999999874321 234479999999999999999999998 999999999999999999999999
Q ss_pred cccccccCCCCCCc--eecccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhhhhhhhhhHhhhhhh
Q 044366 796 FGFAKFLEPHSSNW--TEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIK-GYHPGDFVSTIFSSISNMIIEVNQI 872 (918)
Q Consensus 796 fG~~~~~~~~~~~~--~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~ 872 (918)
||++..+....... ....+++.|+|||+..+..++.++||||||+++|||++ |+.||...... . .....
T Consensus 156 fg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~-~----~~~~~--- 227 (272)
T cd05075 156 FGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENS-E----IYDYL--- 227 (272)
T ss_pred CCcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHH-H----HHHHH---
Confidence 99998765432211 22245678999999998889999999999999999999 78887643221 1 01111
Q ss_pred cccCCCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhC
Q 044366 873 LDHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLLCK 918 (918)
Q Consensus 873 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~ 918 (918)
........... ....+.+++.+||+.||++|||+.++++.|++
T Consensus 228 ~~~~~~~~~~~---~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~ 270 (272)
T cd05075 228 RQGNRLKQPPD---CLDGLYSLMSSCWLLNPKDRPSFETLRCELEK 270 (272)
T ss_pred HcCCCCCCCCC---CCHHHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence 11111111111 23457899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-35 Score=313.02 Aligned_cols=261 Identities=23% Similarity=0.386 Sum_probs=198.4
Q ss_pred cCCCCceeeccccceEEEEEEe-----CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEeccccc--C
Q 044366 646 GNFGEKYCIGKGGQRSVYKAEL-----PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSN--A 718 (918)
Q Consensus 646 ~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~ 718 (918)
.+|.+.+.||+|+||.||+|.. .+++.||+|++... .....+.|.+|+++++.++||||+++++++.. .
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 79 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS----TAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGR 79 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccC----CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCC
Confidence 4678889999999999999964 35789999997653 22234678999999999999999999997643 4
Q ss_pred CceEEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEecccc
Q 044366 719 QHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGF 798 (918)
Q Consensus 719 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~ 798 (918)
...++||||+++|+|.+++.... ..+++..++.++.|++.||+|||+. +++||||||+||++++++.++|+|||+
T Consensus 80 ~~~~lv~e~~~~~~L~~~l~~~~--~~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~~~l~dfg~ 154 (284)
T cd05081 80 RNLRLVMEYLPYGSLRDYLQKHR--ERLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVKIGDFGL 154 (284)
T ss_pred CceEEEEEecCCCCHHHHHHhcC--cCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCeEEECCCcc
Confidence 56899999999999999997542 3489999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCCc---eecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhh-hhh------hHhh
Q 044366 799 AKFLEPHSSNW---TEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSS-ISN------MIIE 868 (918)
Q Consensus 799 ~~~~~~~~~~~---~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~-~~~------~~~~ 868 (918)
+.......... ....++..|+|||++.+..++.++||||||+++|||++|..|+......... ... ....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
T cd05081 155 TKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYH 234 (284)
T ss_pred cccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHH
Confidence 98765432211 1122345699999998888999999999999999999987764332211100 000 0000
Q ss_pred hhhhcccCC-CCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhC
Q 044366 869 VNQILDHRL-PTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLLCK 918 (918)
Q Consensus 869 ~~~~~~~~~-~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~ 918 (918)
..+...... .+... .....+.+++.+||+.+|++|||+.|+++.|++
T Consensus 235 ~~~~~~~~~~~~~~~---~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~ 282 (284)
T cd05081 235 LIELLKNNGRLPAPP---GCPAEIYAIMKECWNNDPSQRPSFSELALQVEA 282 (284)
T ss_pred HHHHHhcCCcCCCCC---CCCHHHHHHHHHHccCChhhCCCHHHHHHHHHh
Confidence 111111111 11111 123468899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=309.45 Aligned_cols=255 Identities=22% Similarity=0.368 Sum_probs=198.5
Q ss_pred CCCceeeccccceEEEEEEeC-C---CCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCc---
Q 044366 648 FGEKYCIGKGGQRSVYKAELP-S---GNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQH--- 720 (918)
Q Consensus 648 ~~~~~~lg~G~~g~Vy~~~~~-~---~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~--- 720 (918)
|...+.||+|+||.||+|... + +..||+|+++.... .......+.+|++.++.++||||+++++++...+.
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 78 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIH--TYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQK 78 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcC--CHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCcccc
Confidence 456788999999999999653 2 36799999875321 12234678999999999999999999998865543
Q ss_pred ---eEEEEEeccCCChhHHhhccc---ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEe
Q 044366 721 ---SFIVCEYLARGSLTTILRDDA---AAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVS 794 (918)
Q Consensus 721 ---~~lv~e~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~ 794 (918)
.++|+||+++|+|.+++.... ....+++..++.++.|++.||+|||+. +++||||||+||++++++.+||+
T Consensus 79 ~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~ 155 (273)
T cd05035 79 IPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVA 155 (273)
T ss_pred CcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCCCeEEEC
Confidence 799999999999999985532 234589999999999999999999999 99999999999999999999999
Q ss_pred ccccccccCCCCCCc--eecccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhhhhhhhhhHhhhhh
Q 044366 795 DFGFAKFLEPHSSNW--TEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIK-GYHPGDFVSTIFSSISNMIIEVNQ 871 (918)
Q Consensus 795 DfG~~~~~~~~~~~~--~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~ 871 (918)
|||+++.+....... ....++..|+|||.+.+..++.++||||||+++|||++ |..||...... . .. ..
T Consensus 156 dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~-~----~~---~~ 227 (273)
T cd05035 156 DFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENH-E----IY---DY 227 (273)
T ss_pred CccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHH-H----HH---HH
Confidence 999998765433211 12234678999999988889999999999999999999 88887643321 0 11 11
Q ss_pred hcccCCCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhC
Q 044366 872 ILDHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLLCK 918 (918)
Q Consensus 872 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~ 918 (918)
........... .....+.+++.+||+.||.+|||+.|+++.|++
T Consensus 228 ~~~~~~~~~~~---~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~ 271 (273)
T cd05035 228 LRHGNRLKQPE---DCLDELYDLMYSCWRADPKDRPTFTKLREVLEN 271 (273)
T ss_pred HHcCCCCCCCc---CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence 11111111111 223568899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=314.80 Aligned_cols=263 Identities=23% Similarity=0.311 Sum_probs=204.2
Q ss_pred cCHHHHHHHhcCCCCceeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhc-cCCceeeEec
Q 044366 636 VLYEEITKATGNFGEKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEI-RHRNIIKFHG 713 (918)
Q Consensus 636 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~ 713 (918)
+.++.+..+.++|++.+.||+|+||.||+|.. .+++.||+|.+... .....++..|+.+++.+ +||||+++++
T Consensus 8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~-----~~~~~~~~~e~~~l~~l~~h~~i~~~~~ 82 (286)
T cd06638 8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPI-----HDIDEEIEAEYNILKALSDHPNVVKFYG 82 (286)
T ss_pred EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccc-----cchHHHHHHHHHHHHHHhcCCCeeeeee
Confidence 33456667889999999999999999999954 56899999987542 12235688899999999 6999999999
Q ss_pred ccc-----cCCceEEEEEeccCCChhHHhhcc-cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCC
Q 044366 714 FCS-----NAQHSFIVCEYLARGSLTTILRDD-AAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDS 787 (918)
Q Consensus 714 ~~~-----~~~~~~lv~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~ 787 (918)
++. .++..++||||+++++|.++++.. .....+++..+..++.|+++|+.|||+. +++||||||+||++++
T Consensus 83 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~ 159 (286)
T cd06638 83 MYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTT 159 (286)
T ss_pred eeeecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEECC
Confidence 873 445789999999999999988643 2234588999999999999999999999 9999999999999999
Q ss_pred CCcEEEeccccccccCCCCCCceeccccccccccccccc-----CCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhh
Q 044366 788 EYEAHVSDFGFAKFLEPHSSNWTEFAGTVGYAAPELAYT-----MRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSI 862 (918)
Q Consensus 788 ~~~~kl~DfG~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-----~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~ 862 (918)
++.++++|||++..............|+..|+|||++.. ..++.++||||+||++|||++|+.|+.........
T Consensus 160 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~- 238 (286)
T cd06638 160 EGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRAL- 238 (286)
T ss_pred CCCEEEccCCceeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHH-
Confidence 999999999999876544333344568999999998753 44788999999999999999999997644321100
Q ss_pred hhhHhhhhhhcccCCCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 044366 863 SNMIIEVNQILDHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNL 915 (918)
Q Consensus 863 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 915 (918)
........+.. .........+.+++.+||+.||++|||+.|+++.
T Consensus 239 -------~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 283 (286)
T cd06638 239 -------FKIPRNPPPTL-HQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH 283 (286)
T ss_pred -------hhccccCCCcc-cCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence 01101110000 0001122468889999999999999999999874
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=317.01 Aligned_cols=254 Identities=28% Similarity=0.441 Sum_probs=199.0
Q ss_pred CCCceeeccccceEEEEEEeC-CCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEEEEE
Q 044366 648 FGEKYCIGKGGQRSVYKAELP-SGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFIVCE 726 (918)
Q Consensus 648 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 726 (918)
|+..+.||+|+||.||+|+.. +++.||+|.+....... .......+|+.++++++||||+++++++.+....++|||
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~--~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~ 78 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEE--EEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVME 78 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHH--HHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccc--cccchhhhhhhcccccccccccccccccccccccccccc
Confidence 556789999999999999655 56789999987642211 112234559999999999999999999999999999999
Q ss_pred eccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccCCCC
Q 044366 727 YLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHS 806 (918)
Q Consensus 727 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~~~~ 806 (918)
|+++++|.+++.. ...+++.+++.++.|+++||+|||+. +++|+||||+||+++.++.++|+|||.+.......
T Consensus 79 ~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~ 152 (260)
T PF00069_consen 79 YCPGGSLQDYLQK---NKPLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDFGSSVKLSENN 152 (260)
T ss_dssp EETTEBHHHHHHH---HSSBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSGTTTEESTSTT
T ss_pred ccccccccccccc---cccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccc
Confidence 9999999999983 34489999999999999999999999 99999999999999999999999999998653334
Q ss_pred CCceecccccccccccccc-cCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCCCCCcchH
Q 044366 807 SNWTEFAGTVGYAAPELAY-TMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRDVT 885 (918)
Q Consensus 807 ~~~~~~~g~~~y~aPE~~~-~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 885 (918)
.......++..|+|||++. +..++.++||||+|+++|+|++|..|+...... ................... ...
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~----~~~ 227 (260)
T PF00069_consen 153 ENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSD-DQLEIIEKILKRPLPSSSQ----QSR 227 (260)
T ss_dssp SEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHH-HHHHHHHHHHHTHHHHHTT----SHT
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccch-hhhhhhhhccccccccccc----ccc
Confidence 4445567899999999998 888999999999999999999999998765111 0001011111000000000 000
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 886 DKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 886 ~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
.....+.+++.+|++.||++||++.++++
T Consensus 228 ~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 228 EKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp TSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred hhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11267899999999999999999999975
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=306.58 Aligned_cols=250 Identities=28% Similarity=0.430 Sum_probs=203.3
Q ss_pred hcCCCCceeeccccceEEEEEEeCCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEEE
Q 044366 645 TGNFGEKYCIGKGGQRSVYKAELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFIV 724 (918)
Q Consensus 645 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 724 (918)
.++|...+.||+|+||.||+|.. .|+.||+|.++... ...+++.+|+.+++.++|+||+++++++.+....++|
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~-~~~~v~iK~~~~~~-----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v 78 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDY-RGQKVAVKCLKDDS-----TAAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIV 78 (256)
T ss_pred hhhccceeeeecCCCceEEEEEe-cCcEEEEEEeccch-----hHHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEE
Confidence 35788889999999999999976 48999999987542 1467899999999999999999999999989999999
Q ss_pred EEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccCC
Q 044366 725 CEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEP 804 (918)
Q Consensus 725 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~~ 804 (918)
|||+++++|.++++... ...+++..+..++.|++.|++|||+. +++||||||+||+++.++.++|+|||.+.....
T Consensus 79 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~ 154 (256)
T cd05039 79 TEYMAKGSLVDYLRSRG-RAVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQ 154 (256)
T ss_pred EEecCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEEccccccccccc
Confidence 99999999999997653 23589999999999999999999999 999999999999999999999999999987632
Q ss_pred CCCCceecccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhhhhhhhhhHhhhhhhcccCCCCCCcc
Q 044366 805 HSSNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIK-GYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRD 883 (918)
Q Consensus 805 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 883 (918)
... ....+..|+|||++.+..++.++||||||+++|||++ |+.||...... ... ..... +... ....
T Consensus 155 ~~~---~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--~~~---~~~~~--~~~~-~~~~- 222 (256)
T cd05039 155 GQD---SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK--DVV---PHVEK--GYRM-EAPE- 222 (256)
T ss_pred ccc---cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHH--HHH---HHHhc--CCCC-CCcc-
Confidence 211 2334678999999988889999999999999999997 99997543211 111 11111 0011 1111
Q ss_pred hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhC
Q 044366 884 VTDKLRSIMEVAILCLVENPEARPTMKEVCNLLCK 918 (918)
Q Consensus 884 ~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~ 918 (918)
.....+.+++.+|+..+|++||+++|++++|++
T Consensus 223 --~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 223 --GCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred --CCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 123568889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-35 Score=313.25 Aligned_cols=259 Identities=22% Similarity=0.281 Sum_probs=193.7
Q ss_pred CCCCceeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhc---cCCceeeEeccccc-----
Q 044366 647 NFGEKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEI---RHRNIIKFHGFCSN----- 717 (918)
Q Consensus 647 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l---~h~niv~~~~~~~~----- 717 (918)
+|++.+.||+|+||.||+|.. .+|+.||+|.++..... ......+.+|+++++.+ +||||+++++++..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~ 78 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNE--DGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDR 78 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCC--CCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCC
Confidence 478889999999999999955 47899999998753222 12234566777777665 69999999998754
Q ss_pred CCceEEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccc
Q 044366 718 AQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFG 797 (918)
Q Consensus 718 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG 797 (918)
....++||||+++ +|.+++.... ...+++.+++.++.|++.||+|||+. +++||||||+||+++.++.+||+|||
T Consensus 79 ~~~~~lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~kl~dfg 153 (288)
T cd07863 79 ETKVTLVFEHVDQ-DLRTYLDKVP-PPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFG 153 (288)
T ss_pred CceEEEEEccccc-CHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccC
Confidence 3457999999985 8988887643 24489999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCCceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhh----hhc
Q 044366 798 FAKFLEPHSSNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVN----QIL 873 (918)
Q Consensus 798 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~----~~~ 873 (918)
++....... ......++..|+|||++.+..++.++||||+||++|||++|++||....... .......... ...
T Consensus 154 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~-~~~~~~~~~~~~~~~~~ 231 (288)
T cd07863 154 LARIYSCQM-ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEAD-QLGKIFDLIGLPPEDDW 231 (288)
T ss_pred ccccccCcc-cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHH-HHHHHHHHhCCCChhhC
Confidence 998765322 2233567899999999998889999999999999999999999986443211 1111100000 000
Q ss_pred -------ccCCCCCC-----cchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 874 -------DHRLPTPS-----RDVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 874 -------~~~~~~~~-----~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
........ .........+.+++.+|++.||++|||+.|++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 232 PRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred cccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 00000000 001122346789999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=304.84 Aligned_cols=246 Identities=26% Similarity=0.389 Sum_probs=196.9
Q ss_pred eeccccceEEEEEEeCCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEEEEEeccCCC
Q 044366 653 CIGKGGQRSVYKAELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFIVCEYLARGS 732 (918)
Q Consensus 653 ~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gs 732 (918)
+||+|+||.||+|...+++.||+|.++... .......|.+|+++++.++||||+++++++...+..++||||+++++
T Consensus 2 ~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 78 (250)
T cd05085 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDL---PQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGD 78 (250)
T ss_pred ccCCCCCceEEEEEecCCcEEEEEecCCcC---CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCc
Confidence 689999999999988889999999986532 11223568899999999999999999999999999999999999999
Q ss_pred hhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccCCCCCCc-ee
Q 044366 733 LTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNW-TE 811 (918)
Q Consensus 733 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~~~~~~~-~~ 811 (918)
|.+++.... ..+++..++.++.|++.|+.|+|+. +++||||+|+||+++.++.+|++|||++.......... ..
T Consensus 79 L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~ 153 (250)
T cd05085 79 FLSFLRKKK--DELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGL 153 (250)
T ss_pred HHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCccceeccccccccCCC
Confidence 999987543 3478999999999999999999999 99999999999999999999999999997654322111 12
Q ss_pred cccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhhhhhhhhhHhhhhhhcccCCCCCCcchHHHHHH
Q 044366 812 FAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIK-GYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRDVTDKLRS 890 (918)
Q Consensus 812 ~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 890 (918)
..++..|+|||+..+..++.++||||||+++|++++ |..||....... ......... +... .. .....
T Consensus 154 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~-----~~~~~~~~~--~~~~-~~---~~~~~ 222 (250)
T cd05085 154 KQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQ-----AREQVEKGY--RMSC-PQ---KCPDD 222 (250)
T ss_pred CCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHH-----HHHHHHcCC--CCCC-CC---CCCHH
Confidence 234567999999998889999999999999999998 999976443211 111111110 1111 11 12356
Q ss_pred HHHHHHHcccCCCCCCCCHHHHHHHhh
Q 044366 891 IMEVAILCLVENPEARPTMKEVCNLLC 917 (918)
Q Consensus 891 l~~li~~cl~~dp~~RPt~~evl~~L~ 917 (918)
+.+++.+|++.+|++||++.|++++|.
T Consensus 223 ~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 223 VYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred HHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 888999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=313.58 Aligned_cols=257 Identities=22% Similarity=0.353 Sum_probs=203.5
Q ss_pred HhcCCCCceeeccccceEEEEEEeCC-----CCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEeccccc-
Q 044366 644 ATGNFGEKYCIGKGGQRSVYKAELPS-----GNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSN- 717 (918)
Q Consensus 644 ~~~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~- 717 (918)
..++|...+.||+|+||.||+|.... +..||+|++... ......+.+.+|+.+++.++||||+++++++..
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~---~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~ 80 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDH---ASEIQVTLLLQESCLLYGLSHQNILPILHVCIED 80 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCC---CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC
Confidence 45678888999999999999997654 688999987642 122335678999999999999999999998765
Q ss_pred CCceEEEEEeccCCChhHHhhccccc-----CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEE
Q 044366 718 AQHSFIVCEYLARGSLTTILRDDAAA-----KEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAH 792 (918)
Q Consensus 718 ~~~~~lv~e~~~~gsL~~~l~~~~~~-----~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~k 792 (918)
+...++++||+++|+|.+++...... ..+++.+++.++.|++.||+|||+. +++||||||+||++++++.+|
T Consensus 81 ~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~~~~k 157 (280)
T cd05043 81 GEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVK 157 (280)
T ss_pred CCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCCCcEE
Confidence 56789999999999999999765322 4689999999999999999999999 999999999999999999999
Q ss_pred EeccccccccCCCCCCc--eecccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhhhhhhhhhHhhh
Q 044366 793 VSDFGFAKFLEPHSSNW--TEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIK-GYHPGDFVSTIFSSISNMIIEV 869 (918)
Q Consensus 793 l~DfG~~~~~~~~~~~~--~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~ 869 (918)
++|||+++.+.+..... ....++..|+|||++.+..++.++||||||+++||+++ |+.||...... . . ....
T Consensus 158 l~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~-~-~---~~~~ 232 (280)
T cd05043 158 ITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPF-E-M---AAYL 232 (280)
T ss_pred ECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHH-H-H---HHHH
Confidence 99999998664432211 12345678999999988889999999999999999999 99998654321 1 1 1111
Q ss_pred hhhcccCCCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 044366 870 NQILDHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLLC 917 (918)
Q Consensus 870 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 917 (918)
.. ...++.. . .....+.+++.+||+.||++|||+.++++.|+
T Consensus 233 ~~--~~~~~~~-~---~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 274 (280)
T cd05043 233 KD--GYRLAQP-I---NCPDELFAVMACCWALDPEERPSFSQLVQCLT 274 (280)
T ss_pred Hc--CCCCCCC-C---cCCHHHHHHHHHHcCCChhhCCCHHHHHHHHH
Confidence 11 0111111 1 12346789999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=325.52 Aligned_cols=258 Identities=21% Similarity=0.278 Sum_probs=196.5
Q ss_pred CCCCceeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCC-----c
Q 044366 647 NFGEKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQ-----H 720 (918)
Q Consensus 647 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-----~ 720 (918)
+|+..+.||+|+||.||+|.. .+|+.||||++.... ......+.+.+|+++++.++||||+++++++...+ .
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 78 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVF--QNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEE 78 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccc--cchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccce
Confidence 477889999999999999964 579999999986431 12223467899999999999999999999997766 7
Q ss_pred eEEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEecccccc
Q 044366 721 SFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAK 800 (918)
Q Consensus 721 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~ 800 (918)
.++|+||+. ++|.+++... ..+++..+..++.||+.||+|||+. +++||||||+||+++.++.+||+|||+++
T Consensus 79 ~~lv~e~~~-~~l~~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~a~ 151 (372)
T cd07853 79 IYVVTELMQ-SDLHKIIVSP---QPLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLAR 151 (372)
T ss_pred EEEEeeccc-cCHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCEEecccccee
Confidence 899999997 5888877643 3589999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCC-CceecccccccccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhH------------
Q 044366 801 FLEPHSS-NWTEFAGTVGYAAPELAYTM-RATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMI------------ 866 (918)
Q Consensus 801 ~~~~~~~-~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~------------ 866 (918)
....... ......++..|+|||++.+. .++.++||||+||++|||++|+.||....... ......
T Consensus 152 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~i~~~~g~~~~~~~~ 230 (372)
T cd07853 152 VEEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQ-QLDLITDLLGTPSLEAMR 230 (372)
T ss_pred ecccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHH-HHHHHHHHcCCCCHHHHH
Confidence 7643322 22344678999999998774 47899999999999999999999986543211 000000
Q ss_pred ---hhhhhhcccCCCCCCc------chHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 867 ---IEVNQILDHRLPTPSR------DVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 867 ---~~~~~~~~~~~~~~~~------~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
......+......+.. ........+.+++.+|++.||++|||+.|+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 287 (372)
T cd07853 231 SACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALA 287 (372)
T ss_pred HhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhc
Confidence 0000000000000000 00112356789999999999999999999985
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-35 Score=313.24 Aligned_cols=251 Identities=22% Similarity=0.323 Sum_probs=199.7
Q ss_pred cCCCCceeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEEE
Q 044366 646 GNFGEKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFIV 724 (918)
Q Consensus 646 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 724 (918)
+.|++.+.||+|+||.||+|+. .+++.||+|.+... .....+.+.+|+++++.++||||+++++++..++..++|
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 87 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK----SEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIM 87 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC----CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEE
Confidence 5688889999999999999965 46899999998652 223356788999999999999999999999999999999
Q ss_pred EEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccCC
Q 044366 725 CEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEP 804 (918)
Q Consensus 725 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~~ 804 (918)
|||+++++|..++.+.. ..+++..++.++.|++.|++|||+. +++||||||+||+++.++.++|+|||.+.....
T Consensus 88 ~e~~~~~~l~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~ 162 (292)
T cd06644 88 IEFCPGGAVDAIMLELD--RGLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVK 162 (292)
T ss_pred EecCCCCcHHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEccCccceeccc
Confidence 99999999998876532 3489999999999999999999999 999999999999999999999999999876544
Q ss_pred CCCCceecccccccccccccc-----cCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCCC
Q 044366 805 HSSNWTEFAGTVGYAAPELAY-----TMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPT 879 (918)
Q Consensus 805 ~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 879 (918)
.........++..|+|||++. ...++.++|||||||++|||++|..||....... .. ........+.
T Consensus 163 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~-----~~---~~~~~~~~~~ 234 (292)
T cd06644 163 TLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR-----VL---LKIAKSEPPT 234 (292)
T ss_pred cccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHH-----HH---HHHhcCCCcc
Confidence 333334556889999999884 3446789999999999999999999975432210 01 1111111111
Q ss_pred CCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 880 PSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 880 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
. ........++.+++.+||+.||++||+++|+++
T Consensus 235 ~-~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 235 L-SQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred C-CCCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 0 111122346788999999999999999999975
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-35 Score=314.11 Aligned_cols=254 Identities=26% Similarity=0.356 Sum_probs=197.0
Q ss_pred cCCCCceeeccccceEEEEEEeC-CCC--EEEEEEcccccccCCCCChHHHHHHHHHHhhc-cCCceeeEecccccCCce
Q 044366 646 GNFGEKYCIGKGGQRSVYKAELP-SGN--IFAVKKFKAELFSDETANPSEFLNEVLALTEI-RHRNIIKFHGFCSNAQHS 721 (918)
Q Consensus 646 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~--~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~ 721 (918)
++|.+.+.||+|+||.||+|... ++. .+|+|.++... .....+.|.+|+++++++ +||||+++++++...+..
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~ 78 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFA---SENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYL 78 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccC---CHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcc
Confidence 46888899999999999999654 343 47888876421 112246789999999999 799999999999998999
Q ss_pred EEEEEeccCCChhHHhhccc-------------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCC
Q 044366 722 FIVCEYLARGSLTTILRDDA-------------AAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSE 788 (918)
Q Consensus 722 ~lv~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~ 788 (918)
++|+||+++|+|.+++.... ....+++..++.++.|++.|++|||+. +++||||||+||+++++
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~ 155 (297)
T cd05089 79 YIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVGEN 155 (297)
T ss_pred eEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcceEEECCC
Confidence 99999999999999996532 123588999999999999999999999 99999999999999999
Q ss_pred CcEEEeccccccccCCCCCCceecccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhhhhhhhhhHh
Q 044366 789 YEAHVSDFGFAKFLEPHSSNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIK-GYHPGDFVSTIFSSISNMII 867 (918)
Q Consensus 789 ~~~kl~DfG~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~p~~~~~~~~~~~~~~~~ 867 (918)
+.+||+|||++........ ......+..|+|||+..+..++.++|||||||++|||++ |..||...... . ...
T Consensus 156 ~~~kl~dfg~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~-~----~~~ 229 (297)
T cd05089 156 LASKIADFGLSRGEEVYVK-KTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCA-E----LYE 229 (297)
T ss_pred CeEEECCcCCCccccceec-cCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH-H----HHH
Confidence 9999999999874322111 111223567999999988889999999999999999997 99998643321 0 011
Q ss_pred hhhhhcccCCCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 044366 868 EVNQILDHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLLC 917 (918)
Q Consensus 868 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 917 (918)
............. ....+.+++.+||+.+|.+||+++++++.|+
T Consensus 230 ---~~~~~~~~~~~~~---~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 273 (297)
T cd05089 230 ---KLPQGYRMEKPRN---CDDEVYELMRQCWRDRPYERPPFAQISVQLS 273 (297)
T ss_pred ---HHhcCCCCCCCCC---CCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 1111111111111 2246788999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=313.21 Aligned_cols=249 Identities=23% Similarity=0.333 Sum_probs=196.8
Q ss_pred CCCceeeccccceEEEEEEeC-CCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEEEEE
Q 044366 648 FGEKYCIGKGGQRSVYKAELP-SGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFIVCE 726 (918)
Q Consensus 648 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 726 (918)
|++.+.||+|+||.||+|... ++..+|+|.+... .....+.+.+|+++++.++||||+++++++..++..++|+|
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~----~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e 82 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTK----SEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIE 82 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCC----CHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEE
Confidence 566778999999999999654 6788999987542 12235678999999999999999999999999999999999
Q ss_pred eccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccCCCC
Q 044366 727 YLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHS 806 (918)
Q Consensus 727 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~~~~ 806 (918)
|+++++|..++... ...+++..+..++.|+++||+|||+. +++||||||+||+++.++.++++|||++.......
T Consensus 83 ~~~~~~l~~~~~~~--~~~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~ 157 (282)
T cd06643 83 FCAGGAVDAVMLEL--ERPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI 157 (282)
T ss_pred ecCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEccccccccccccc
Confidence 99999999988653 23589999999999999999999999 99999999999999999999999999997665433
Q ss_pred CCceecccccccccccccc-----cCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCCCCC
Q 044366 807 SNWTEFAGTVGYAAPELAY-----TMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPS 881 (918)
Q Consensus 807 ~~~~~~~g~~~y~aPE~~~-----~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 881 (918)
.......++..|+|||++. +..++.++|||||||++|||++|+.||....... . ... ......+..
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~-~----~~~---~~~~~~~~~- 228 (282)
T cd06643 158 QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMR-V----LLK---IAKSEPPTL- 228 (282)
T ss_pred cccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHH-H----HHH---HhhcCCCCC-
Confidence 3334456889999999874 3456789999999999999999999976433211 0 001 111111110
Q ss_pred cchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 882 RDVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 882 ~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
.........+.+++.+||+.||.+||+++++++
T Consensus 229 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 261 (282)
T cd06643 229 AQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQ 261 (282)
T ss_pred CCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 001112356889999999999999999999875
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-35 Score=311.09 Aligned_cols=249 Identities=28% Similarity=0.426 Sum_probs=203.7
Q ss_pred cCCCCceeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEEE
Q 044366 646 GNFGEKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFIV 724 (918)
Q Consensus 646 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 724 (918)
++|...+.||.|++|.||+|.. .+++.||+|.+.... .......+.+|+++++.++|+||+++++++.++...++|
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 77 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE---AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWII 77 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc---cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEE
Confidence 3677888999999999999965 478999999986532 223356789999999999999999999999999999999
Q ss_pred EEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccCC
Q 044366 725 CEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEP 804 (918)
Q Consensus 725 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~~ 804 (918)
+||+++++|.+++... ++++..++.++.|++.|++|||+. +++||||+|+||++++++.++++|||+++....
T Consensus 78 ~e~~~~~~L~~~~~~~----~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~ 150 (274)
T cd06609 78 MEYCGGGSCLDLLKPG----KLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTS 150 (274)
T ss_pred EEeeCCCcHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEcccccceeecc
Confidence 9999999999999754 589999999999999999999999 999999999999999999999999999988765
Q ss_pred CCCCceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCCCCCcch
Q 044366 805 HSSNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRDV 884 (918)
Q Consensus 805 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 884 (918)
.........++..|+|||++.+..++.++||||||+++|+|++|+.||...... .. .. .+.....+.....
T Consensus 151 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~-~~----~~---~~~~~~~~~~~~~- 221 (274)
T cd06609 151 TMSKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPM-RV----LF---LIPKNNPPSLEGN- 221 (274)
T ss_pred cccccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchH-HH----HH---HhhhcCCCCCccc-
Confidence 444444557888999999999888999999999999999999999998643321 00 00 1111111111111
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 885 TDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 885 ~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
.....+.+++.+||..||++|||++++++
T Consensus 222 -~~~~~~~~~l~~~l~~~p~~Rpt~~~il~ 250 (274)
T cd06609 222 -KFSKPFKDFVSLCLNKDPKERPSAKELLK 250 (274)
T ss_pred -ccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 13346888999999999999999999975
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=306.53 Aligned_cols=249 Identities=26% Similarity=0.412 Sum_probs=201.3
Q ss_pred eeeccccceEEEEEEeCC----CCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEEEEEe
Q 044366 652 YCIGKGGQRSVYKAELPS----GNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFIVCEY 727 (918)
Q Consensus 652 ~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 727 (918)
+.||+|+||.||+|.... +..||+|.++..... ...+.+.+|++.++.++|+||+++++++..+...++||||
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 77 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASE---EERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEY 77 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccch---hHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEe
Confidence 369999999999996543 789999998764221 1367899999999999999999999999999999999999
Q ss_pred ccCCChhHHhhcccc------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccc
Q 044366 728 LARGSLTTILRDDAA------AKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKF 801 (918)
Q Consensus 728 ~~~gsL~~~l~~~~~------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~ 801 (918)
+++++|.+++..... ...+++.+++.++.|++.|++|||+. +++||||+|+||++++++.++|+|||.+..
T Consensus 78 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~ 154 (262)
T cd00192 78 MEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRD 154 (262)
T ss_pred ccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCCCcEEEcccccccc
Confidence 999999999987521 25689999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCC--CCceecccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhhhhhhhhhHhhhhhhcccCCC
Q 044366 802 LEPHS--SNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIK-GYHPGDFVSTIFSSISNMIIEVNQILDHRLP 878 (918)
Q Consensus 802 ~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 878 (918)
..... .......++..|+|||.+.+..++.++||||+|+++|||++ |..||...... ........ ....
T Consensus 155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-----~~~~~~~~---~~~~ 226 (262)
T cd00192 155 VYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNE-----EVLEYLRK---GYRL 226 (262)
T ss_pred cccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHH-----HHHHHHHc---CCCC
Confidence 76543 12233456889999999988889999999999999999999 69998654221 11111111 1111
Q ss_pred CCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 044366 879 TPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLLC 917 (918)
Q Consensus 879 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 917 (918)
.... ....++.+++.+||..+|.+||++.|+++.|+
T Consensus 227 ~~~~---~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 227 PKPE---YCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred CCCc---cCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 1111 12356889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-35 Score=330.08 Aligned_cols=257 Identities=22% Similarity=0.299 Sum_probs=190.8
Q ss_pred HhcCCCCceeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEeccccc-----
Q 044366 644 ATGNFGEKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSN----- 717 (918)
Q Consensus 644 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~----- 717 (918)
..++|...+.||+|+||.||+|.. .+++.||||++... .....+|+.+++.++||||+++++++..
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~--------~~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~ 135 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQD--------PQYKNRELLIMKNLNHINIIFLKDYYYTECFKK 135 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecC--------cchHHHHHHHHHhcCCCCCcceeeeEeeccccc
Confidence 346799999999999999999955 57899999987532 1234579999999999999999887532
Q ss_pred ---CCceEEEEEeccCCChhHHhhcc-cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCC-cEE
Q 044366 718 ---AQHSFIVCEYLARGSLTTILRDD-AAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEY-EAH 792 (918)
Q Consensus 718 ---~~~~~lv~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~-~~k 792 (918)
....++||||+++ ++.+++... .....+++..++.++.||+.||+|||+. +|+||||||+||+++.++ .+|
T Consensus 136 ~~~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~~vk 211 (440)
T PTZ00036 136 NEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTHTLK 211 (440)
T ss_pred CCCceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCCcee
Confidence 1246789999985 787776542 2245689999999999999999999999 999999999999999765 699
Q ss_pred EeccccccccCCCCCCceecccccccccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhh---
Q 044366 793 VSDFGFAKFLEPHSSNWTEFAGTVGYAAPELAYTM-RATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIE--- 868 (918)
Q Consensus 793 l~DfG~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~--- 868 (918)
|+|||+|+.+..... .....|++.|+|||++.+. .++.++||||+||++|||++|++||....... ........
T Consensus 212 L~DFGla~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~-~~~~i~~~~~~ 289 (440)
T PTZ00036 212 LCDFGSAKNLLAGQR-SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVD-QLVRIIQVLGT 289 (440)
T ss_pred eeccccchhccCCCC-cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCC
Confidence 999999987654322 2345689999999988654 68999999999999999999999986543211 11111000
Q ss_pred -----hhh----hcccCCCCCC-cchH-----HHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 869 -----VNQ----ILDHRLPTPS-RDVT-----DKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 869 -----~~~----~~~~~~~~~~-~~~~-----~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
... ..+..++... .... ....++.+++.+||+.||.+|||+.|+++
T Consensus 290 p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~ 350 (440)
T PTZ00036 290 PTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALA 350 (440)
T ss_pred CCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhC
Confidence 000 0000111100 0011 12246889999999999999999999874
|
|
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=304.26 Aligned_cols=251 Identities=25% Similarity=0.419 Sum_probs=201.8
Q ss_pred cCCCCceeeccccceEEEEEEeCCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEEEE
Q 044366 646 GNFGEKYCIGKGGQRSVYKAELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFIVC 725 (918)
Q Consensus 646 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 725 (918)
.+|+..+.||+|+||.||+|...+++.+|+|.++.. .....+|.+|+++++.++||+++++++++......++||
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~-----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~ 78 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREG-----AMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVF 78 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCC-----CCCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEE
Confidence 467788899999999999997777889999987642 223567999999999999999999999999999999999
Q ss_pred EeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccCCC
Q 044366 726 EYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPH 805 (918)
Q Consensus 726 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~~~ 805 (918)
||+++++|.+++.... ..++++.++.++.|++.|++|||+. +++||||||+||+++.++.++|+|||.+......
T Consensus 79 e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~ 153 (256)
T cd05112 79 EFMEHGCLSDYLRAQR--GKFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDD 153 (256)
T ss_pred EcCCCCcHHHHHHhCc--cCCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECCCcceeecccC
Confidence 9999999999987542 3478999999999999999999999 9999999999999999999999999999865432
Q ss_pred CCC-ceecccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhhhhhhhhhHhhhhhhcccCCCCCCcc
Q 044366 806 SSN-WTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIK-GYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRD 883 (918)
Q Consensus 806 ~~~-~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 883 (918)
... .....++.+|+|||++.+..++.++||||||+++|||++ |+.||...... .......+. .+... +..
T Consensus 154 ~~~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~-----~~~~~~~~~--~~~~~-~~~ 225 (256)
T cd05112 154 QYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNS-----EVVETINAG--FRLYK-PRL 225 (256)
T ss_pred cccccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHH-----HHHHHHhCC--CCCCC-CCC
Confidence 211 112234678999999998889999999999999999998 89997643211 111111111 01111 111
Q ss_pred hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 044366 884 VTDKLRSIMEVAILCLVENPEARPTMKEVCNLLC 917 (918)
Q Consensus 884 ~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 917 (918)
....+.+++.+||+.+|++|||+.|+++.|+
T Consensus 226 ---~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 226 ---ASQSVYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred ---CCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 1246888999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=308.36 Aligned_cols=254 Identities=28% Similarity=0.455 Sum_probs=201.2
Q ss_pred cCCCCceeeccccceEEEEEEeC-C---CCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCce
Q 044366 646 GNFGEKYCIGKGGQRSVYKAELP-S---GNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHS 721 (918)
Q Consensus 646 ~~~~~~~~lg~G~~g~Vy~~~~~-~---~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 721 (918)
++|.+.+.||+|+||.||+|... + +..||+|.++... .....+.|..|+.+++.++||||+++++++..++..
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 80 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY---TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPV 80 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCC---CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCcc
Confidence 56788899999999999999653 2 3379999886532 112246889999999999999999999999999999
Q ss_pred EEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccc
Q 044366 722 FIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKF 801 (918)
Q Consensus 722 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~ 801 (918)
++||||+++++|.+++.... ..+++.+++.++.|++.|++|||+. +++||||||+||+++.++.++++|||++..
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~~l~dfg~~~~ 155 (267)
T cd05066 81 MIVTEYMENGSLDAFLRKHD--GQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSDFGLSRV 155 (267)
T ss_pred EEEEEcCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCeEEeCCCCcccc
Confidence 99999999999999997643 3589999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCCc---eecccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhhhhhhhhhHhhhhhhcccCC
Q 044366 802 LEPHSSNW---TEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIK-GYHPGDFVSTIFSSISNMIIEVNQILDHRL 877 (918)
Q Consensus 802 ~~~~~~~~---~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 877 (918)
+....... ....++..|+|||++.+..++.++||||||+++||+++ |..||...... . ......+. .+.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~-~----~~~~~~~~--~~~ 228 (267)
T cd05066 156 LEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQ-D----VIKAIEEG--YRL 228 (267)
T ss_pred cccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHH-H----HHHHHhCC--CcC
Confidence 65432211 11223568999999998889999999999999999886 99997643221 0 11111111 111
Q ss_pred CCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhC
Q 044366 878 PTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLLCK 918 (918)
Q Consensus 878 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~ 918 (918)
+.. . .....+.+++.+|++.+|.+||++.++++.|++
T Consensus 229 ~~~-~---~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 265 (267)
T cd05066 229 PAP-M---DCPAALHQLMLDCWQKDRNERPKFEQIVSILDK 265 (267)
T ss_pred CCC-C---CCCHHHHHHHHHHcccCchhCCCHHHHHHHHHh
Confidence 111 1 123467889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=319.03 Aligned_cols=249 Identities=24% Similarity=0.350 Sum_probs=203.0
Q ss_pred CCCceeeccccceEEEEEEeC-CCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEEEEE
Q 044366 648 FGEKYCIGKGGQRSVYKAELP-SGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFIVCE 726 (918)
Q Consensus 648 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 726 (918)
|.++.-||.|+||.||+|..+ ++-..|.|++.. ......++|.-|+++++...||+||++++.|..++.+|+..|
T Consensus 34 WeIiGELGDGAFGKVyKA~nket~~lAAaKvIet----kseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliE 109 (1187)
T KOG0579|consen 34 WEIIGELGDGAFGKVYKAVNKETKLLAAAKVIET----KSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIE 109 (1187)
T ss_pred HHHHhhhcCccchhhhhhhcccchhhhhhhhhcc----cchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEe
Confidence 445556999999999999654 455566777654 244557899999999999999999999999999999999999
Q ss_pred eccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccCCCC
Q 044366 727 YLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHS 806 (918)
Q Consensus 727 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~~~~ 806 (918)
||.||..+..+-.- +..+++.++.-+++|++.||.|||+. .|||||+|+.||+++-+|.++|+|||.+.......
T Consensus 110 FC~GGAVDaimlEL--~r~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~ 184 (1187)
T KOG0579|consen 110 FCGGGAVDAIMLEL--GRVLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTR 184 (1187)
T ss_pred ecCCchHhHHHHHh--ccccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeecccccccchhHH
Confidence 99999999887654 34689999999999999999999999 99999999999999999999999999998766555
Q ss_pred CCceecccccccccccccc-----cCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCCCCC
Q 044366 807 SNWTEFAGTVGYAAPELAY-----TMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPS 881 (918)
Q Consensus 807 ~~~~~~~g~~~y~aPE~~~-----~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 881 (918)
.......|||+|||||+.. ..+|+.++||||||++|.||..+.+|-...... .. +-++....+|. .
T Consensus 185 qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpM-------RV-llKiaKSePPT-L 255 (1187)
T KOG0579|consen 185 QKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPM-------RV-LLKIAKSEPPT-L 255 (1187)
T ss_pred hhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchH-------HH-HHHHhhcCCCc-c
Confidence 5667789999999999874 467899999999999999999999995433221 11 11222222221 1
Q ss_pred cchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 882 RDVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 882 ~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
-....+...+.+++.+|+.+||..||+++++++
T Consensus 256 lqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~ 288 (1187)
T KOG0579|consen 256 LQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLK 288 (1187)
T ss_pred cCcchhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence 223445667889999999999999999999975
|
|
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-35 Score=311.34 Aligned_cols=253 Identities=23% Similarity=0.435 Sum_probs=198.4
Q ss_pred hcCCCCceeeccccceEEEEEEe-CCCC----EEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCC
Q 044366 645 TGNFGEKYCIGKGGQRSVYKAEL-PSGN----IFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQ 719 (918)
Q Consensus 645 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~----~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~ 719 (918)
..+|...+.||+|+||.||+|.+ .+|+ .||+|+++... .....+++.+|+.+++.++||||+++++++...
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~- 81 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT---SPKANKEILDEAYVMAGVGSPYVCRLLGICLTS- 81 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC---CHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-
Confidence 35688889999999999999964 4555 48999886532 222356788999999999999999999998754
Q ss_pred ceEEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccc
Q 044366 720 HSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFA 799 (918)
Q Consensus 720 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~ 799 (918)
..++++||+++|+|.++++... ..+++.+++.++.|+++||+|||+. +++||||||+||++++++.+||+|||++
T Consensus 82 ~~~l~~~~~~~g~l~~~l~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~~~kL~dfG~~ 156 (279)
T cd05109 82 TVQLVTQLMPYGCLLDYVRENK--DRIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNHVKITDFGLA 156 (279)
T ss_pred CcEEEEEcCCCCCHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcEEECCCCce
Confidence 5789999999999999997642 3589999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCCc--eecccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhhhhhhhhhHhhhhhhcccC
Q 044366 800 KFLEPHSSNW--TEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIK-GYHPGDFVSTIFSSISNMIIEVNQILDHR 876 (918)
Q Consensus 800 ~~~~~~~~~~--~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 876 (918)
+......... ....++..|+|||...+..++.++|||||||++|||++ |..||+..... .... .... ...
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--~~~~---~~~~--~~~ 229 (279)
T cd05109 157 RLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAR--EIPD---LLEK--GER 229 (279)
T ss_pred eecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH--HHHH---HHHC--CCc
Confidence 8765332221 12234678999999998899999999999999999998 88997643221 1111 1111 011
Q ss_pred CCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 044366 877 LPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLLC 917 (918)
Q Consensus 877 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 917 (918)
.+.+ . .....+.+++.+||+.||++||++.++++.|+
T Consensus 230 ~~~~-~---~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~ 266 (279)
T cd05109 230 LPQP-P---ICTIDVYMIMVKCWMIDSECRPRFRELVDEFS 266 (279)
T ss_pred CCCC-c---cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 1111 1 12346788999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=309.78 Aligned_cols=253 Identities=25% Similarity=0.378 Sum_probs=203.2
Q ss_pred hcCCCCceeeccccceEEEEEEeCCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhc-cCCceeeEecccccCCceEE
Q 044366 645 TGNFGEKYCIGKGGQRSVYKAELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEI-RHRNIIKFHGFCSNAQHSFI 723 (918)
Q Consensus 645 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~l 723 (918)
...|++.++||+||.+.||++...+.+.||+|++.... .+.+....|..|+..+.++ .|.+|+++++|-..++..||
T Consensus 360 g~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~--~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYm 437 (677)
T KOG0596|consen 360 GREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLE--ADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYM 437 (677)
T ss_pred cchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhh--cCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEE
Confidence 45688889999999999999998888999999886532 3445578899999999999 59999999999999999999
Q ss_pred EEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccC
Q 044366 724 VCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLE 803 (918)
Q Consensus 724 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~ 803 (918)
||||-+ .+|.++|+...... ..| .++.+..|++.|+.++|.+ ||||.||||.|+++-. |.+||+|||+|..+.
T Consensus 438 vmE~Gd-~DL~kiL~k~~~~~-~~~-~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLlVk-G~LKLIDFGIA~aI~ 510 (677)
T KOG0596|consen 438 VMECGD-IDLNKILKKKKSID-PDW-FLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLLVK-GRLKLIDFGIANAIQ 510 (677)
T ss_pred Eeeccc-ccHHHHHHhccCCC-chH-HHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEEEe-eeEEeeeechhcccC
Confidence 999865 49999998764322 234 7888999999999999999 9999999999999854 689999999999887
Q ss_pred CCCCC--ceecccccccccccccccCC-----------CCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhh
Q 044366 804 PHSSN--WTEFAGTVGYAAPELAYTMR-----------ATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVN 870 (918)
Q Consensus 804 ~~~~~--~~~~~g~~~y~aPE~~~~~~-----------~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~ 870 (918)
++... ....+||+-|||||.+.... .+.++||||+||+||+|+.|+.||.. +.+....+.
T Consensus 511 ~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~-------~~n~~aKl~ 583 (677)
T KOG0596|consen 511 PDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQ-------IINQIAKLH 583 (677)
T ss_pred ccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHH-------HHHHHHHHH
Confidence 76553 34578999999999885432 45789999999999999999999653 333444555
Q ss_pred hhcccCCCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 871 QILDHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 871 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
.+.++...-.-++.++. .++++++..|++.||++||++.++++
T Consensus 584 aI~~P~~~Iefp~~~~~-~~li~~mK~CL~rdPkkR~si~eLLq 626 (677)
T KOG0596|consen 584 AITDPNHEIEFPDIPEN-DELIDVMKCCLARDPKKRWSIPELLQ 626 (677)
T ss_pred hhcCCCccccccCCCCc-hHHHHHHHHHHhcCcccCCCcHHHhc
Confidence 55555321111111111 12889999999999999999999985
|
|
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=306.96 Aligned_cols=252 Identities=27% Similarity=0.382 Sum_probs=204.6
Q ss_pred cCCCCceeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEEE
Q 044366 646 GNFGEKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFIV 724 (918)
Q Consensus 646 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 724 (918)
++|...+.||+|+||.||+|.. .+++.+|+|.+.... ....+.+.+|+++++.++||||+++++++.+++..+++
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~----~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~ 78 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEP----GDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIV 78 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCc----hhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEE
Confidence 5788899999999999999965 468899999987532 22467899999999999999999999999999999999
Q ss_pred EEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccCC
Q 044366 725 CEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEP 804 (918)
Q Consensus 725 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~~ 804 (918)
|||+++++|.+++.... ..+++.+++.++.|++.|++|||+. +++|+||+|+||+++.++.++|+|||.+.....
T Consensus 79 ~e~~~~~~l~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~ 153 (262)
T cd06613 79 MEYCGGGSLQDIYQVTR--GPLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTA 153 (262)
T ss_pred EeCCCCCcHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEECccccchhhhh
Confidence 99999999999987642 3489999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCCceecccccccccccccccC---CCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCC-CC
Q 044366 805 HSSNWTEFAGTVGYAAPELAYTM---RATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLP-TP 880 (918)
Q Consensus 805 ~~~~~~~~~g~~~y~aPE~~~~~---~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~ 880 (918)
.........++..|+|||.+.+. .++.++||||||+++|||++|+.|+........ .. . ....... ..
T Consensus 154 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~-~~----~---~~~~~~~~~~ 225 (262)
T cd06613 154 TIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRA-LF----L---ISKSNFPPPK 225 (262)
T ss_pred hhhccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH-HH----H---HHhccCCCcc
Confidence 43333445678899999998776 788999999999999999999999764332111 00 0 0001001 11
Q ss_pred CcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 881 SRDVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 881 ~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
..........+.+++.+||..+|.+|||+.+++.
T Consensus 226 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 226 LKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred ccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 1122334567889999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-35 Score=315.99 Aligned_cols=259 Identities=24% Similarity=0.390 Sum_probs=202.7
Q ss_pred HHhcCCCCceeeccccceEEEEEEe--------CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhc-cCCceeeEec
Q 044366 643 KATGNFGEKYCIGKGGQRSVYKAEL--------PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEI-RHRNIIKFHG 713 (918)
Q Consensus 643 ~~~~~~~~~~~lg~G~~g~Vy~~~~--------~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~ 713 (918)
...++|.+.+.||+|+||.||+|+. .++..||+|.+.... .....+.+.+|+.+++.+ +||||+++++
T Consensus 12 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~~E~~~l~~l~~h~~i~~~~~ 88 (304)
T cd05101 12 FSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA---TEKDLSDLVSEMEMMKMIGKHKNIINLLG 88 (304)
T ss_pred ccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccccc---chHHHHHHHHHHHHHHhhccCCCchheeE
Confidence 3456788889999999999999953 134579999886431 223356789999999999 8999999999
Q ss_pred ccccCCceEEEEEeccCCChhHHhhcccc-------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCC
Q 044366 714 FCSNAQHSFIVCEYLARGSLTTILRDDAA-------------AKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISS 780 (918)
Q Consensus 714 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~ 780 (918)
++......++||||+++|+|.+++..... ...+++.+++.++.||++|++|||+. +++||||||
T Consensus 89 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~dlkp 165 (304)
T cd05101 89 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAA 165 (304)
T ss_pred EEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---Ceeeccccc
Confidence 99999999999999999999999976421 23578899999999999999999999 999999999
Q ss_pred CCeeeCCCCcEEEeccccccccCCCCCC--ceecccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchh
Q 044366 781 KNVLLDSEYEAHVSDFGFAKFLEPHSSN--WTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIK-GYHPGDFVST 857 (918)
Q Consensus 781 ~Nill~~~~~~kl~DfG~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~p~~~~~~ 857 (918)
+||++++++.+||+|||.++........ .....++..|+|||++.+..++.++||||||+++|||++ |..|+.....
T Consensus 166 ~Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~ 245 (304)
T cd05101 166 RNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV 245 (304)
T ss_pred ceEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH
Confidence 9999999999999999999876543222 122345678999999998889999999999999999998 7777653321
Q ss_pred hhhhhhhhHhhhhhhcccCCCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhC
Q 044366 858 IFSSISNMIIEVNQILDHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLLCK 918 (918)
Q Consensus 858 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~ 918 (918)
... ...... ...... .. .....+.+++.+||+.+|.+||++.|+++.|++
T Consensus 246 --~~~---~~~~~~--~~~~~~-~~---~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~ 295 (304)
T cd05101 246 --EEL---FKLLKE--GHRMDK-PA---NCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDR 295 (304)
T ss_pred --HHH---HHHHHc--CCcCCC-CC---CCCHHHHHHHHHHcccChhhCCCHHHHHHHHHH
Confidence 111 111111 011111 11 233568889999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=305.12 Aligned_cols=246 Identities=26% Similarity=0.382 Sum_probs=194.1
Q ss_pred eeeccccceEEEEEEeC-C---CCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEEEEEe
Q 044366 652 YCIGKGGQRSVYKAELP-S---GNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFIVCEY 727 (918)
Q Consensus 652 ~~lg~G~~g~Vy~~~~~-~---~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 727 (918)
+.||+|+||.||+|.+. . +..||+|.+...... ...+++.+|+++++.+.||||+++++++. .+..++||||
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~ 76 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA---AGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMEL 76 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch---HHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEe
Confidence 36999999999999542 2 268999998754221 23568999999999999999999999876 4568999999
Q ss_pred ccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccCCCCC
Q 044366 728 LARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSS 807 (918)
Q Consensus 728 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~~~~~ 807 (918)
+++|+|.+++.... .+++..++.++.|++.|++|||+. +++||||||+||+++.++.+||+|||.++.......
T Consensus 77 ~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~ 150 (257)
T cd05060 77 APLGPLLKYLKKRR---EIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSD 150 (257)
T ss_pred CCCCcHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEeccccccceeecCCc
Confidence 99999999997653 589999999999999999999999 999999999999999999999999999987654333
Q ss_pred Cce---ecccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhhhhhhhhhHhhhhhhcccCCCCCCcc
Q 044366 808 NWT---EFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIK-GYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRD 883 (918)
Q Consensus 808 ~~~---~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 883 (918)
... ...++..|+|||...+..++.++||||||+++|+|++ |+.||...... ... ..... ........
T Consensus 151 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~--~~~---~~~~~---~~~~~~~~- 221 (257)
T cd05060 151 YYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGA--EVI---AMLES---GERLPRPE- 221 (257)
T ss_pred ccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHH--HHH---HHHHc---CCcCCCCC-
Confidence 221 1123467999999998889999999999999999998 99998654321 011 11111 11111111
Q ss_pred hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhC
Q 044366 884 VTDKLRSIMEVAILCLVENPEARPTMKEVCNLLCK 918 (918)
Q Consensus 884 ~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~ 918 (918)
.....+.+++.+||..+|++||++.++++.|++
T Consensus 222 --~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~ 254 (257)
T cd05060 222 --ECPQEIYSIMLSCWKYRPEDRPTFSELESTFRR 254 (257)
T ss_pred --CCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence 123467899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-35 Score=320.89 Aligned_cols=257 Identities=23% Similarity=0.353 Sum_probs=198.2
Q ss_pred hcCCCCceeeccccceEEEEEEe------CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhc-cCCceeeEeccccc
Q 044366 645 TGNFGEKYCIGKGGQRSVYKAEL------PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEI-RHRNIIKFHGFCSN 717 (918)
Q Consensus 645 ~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~ 717 (918)
.++|...+.||+|+||.||+|.. .+++.||||+++... .......+.+|+.++.++ +||||+++++++..
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~ 82 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA---THSEHRALMSELKILIHIGHHLNVVNLLGACTK 82 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCC---ChHHHHHHHHHHHHHHhccCCccHhhhcceeec
Confidence 45789999999999999999953 357899999986532 122245788999999999 68999999998865
Q ss_pred -CCceEEEEEeccCCChhHHhhcccc------------------------------------------------------
Q 044366 718 -AQHSFIVCEYLARGSLTTILRDDAA------------------------------------------------------ 742 (918)
Q Consensus 718 -~~~~~lv~e~~~~gsL~~~l~~~~~------------------------------------------------------ 742 (918)
+...++||||+++|+|.++++....
T Consensus 83 ~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (343)
T cd05103 83 PGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVE 162 (343)
T ss_pred CCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccch
Confidence 4567899999999999999864310
Q ss_pred ----------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccCCCCCC--ce
Q 044366 743 ----------AKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSN--WT 810 (918)
Q Consensus 743 ----------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~~~~~~--~~ 810 (918)
...+++.++..++.|+++|++|||+. +|+||||||+||++++++.+|++|||++......... ..
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 239 (343)
T cd05103 163 EEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKG 239 (343)
T ss_pred hhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcC
Confidence 12368889999999999999999999 9999999999999999999999999999875433221 12
Q ss_pred ecccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhhhhhhhhhHhhhhhhcccCCCCCCcchHHHHH
Q 044366 811 EFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIK-GYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRDVTDKLR 889 (918)
Q Consensus 811 ~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 889 (918)
...++..|+|||.+.+..++.++||||||+++|||++ |..||......... ....... ...+.+ .. ...
T Consensus 240 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~----~~~~~~~--~~~~~~-~~---~~~ 309 (343)
T cd05103 240 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF----CRRLKEG--TRMRAP-DY---TTP 309 (343)
T ss_pred CCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHH----HHHHhcc--CCCCCC-CC---CCH
Confidence 2335678999999988889999999999999999997 88887543221110 0111110 111111 11 124
Q ss_pred HHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 044366 890 SIMEVAILCLVENPEARPTMKEVCNLLC 917 (918)
Q Consensus 890 ~l~~li~~cl~~dp~~RPt~~evl~~L~ 917 (918)
.+.+++..||+.||++|||+.|+++.|+
T Consensus 310 ~~~~~~~~cl~~~p~~Rps~~eil~~l~ 337 (343)
T cd05103 310 EMYQTMLDCWHGEPSQRPTFSELVEHLG 337 (343)
T ss_pred HHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 5789999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-35 Score=317.06 Aligned_cols=194 Identities=20% Similarity=0.363 Sum_probs=159.7
Q ss_pred ceeeccccceEEEEEEeC---CCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEeccccc--CCceEEEE
Q 044366 651 KYCIGKGGQRSVYKAELP---SGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSN--AQHSFIVC 725 (918)
Q Consensus 651 ~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~lv~ 725 (918)
.++||+|+||.||+|+.. +++.||+|.+... .....+.+|++++++++||||+++++++.. +...++||
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~ 79 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGT------GISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLF 79 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCC------CCcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEE
Confidence 357999999999999653 5678999988642 123467899999999999999999998743 45689999
Q ss_pred EeccCCChhHHhhccc------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeee----CCCCcEEEec
Q 044366 726 EYLARGSLTTILRDDA------AAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLL----DSEYEAHVSD 795 (918)
Q Consensus 726 e~~~~gsL~~~l~~~~------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill----~~~~~~kl~D 795 (918)
||+++ +|.+++.... ....+++..+..++.|++.||+|||+. +|+||||||+||++ +.++.+||+|
T Consensus 80 e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl~D 155 (317)
T cd07868 80 DYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIAD 155 (317)
T ss_pred eccCC-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEEee
Confidence 99965 8888875321 123589999999999999999999999 99999999999999 4567899999
Q ss_pred cccccccCCCCC---CceecccccccccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCc
Q 044366 796 FGFAKFLEPHSS---NWTEFAGTVGYAAPELAYTM-RATEKYDVYSFGVLALEVIKGYHPGDF 854 (918)
Q Consensus 796 fG~~~~~~~~~~---~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~vl~el~tg~~p~~~ 854 (918)
||+++.+..... ......||+.|+|||++.+. .++.++||||+||++|||++|++||..
T Consensus 156 fG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~ 218 (317)
T cd07868 156 MGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 218 (317)
T ss_pred cCceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccC
Confidence 999987654322 22345789999999998764 578999999999999999999999853
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-35 Score=307.00 Aligned_cols=249 Identities=27% Similarity=0.436 Sum_probs=198.5
Q ss_pred eeeccccceEEEEEEeC--CCC--EEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEEEEEe
Q 044366 652 YCIGKGGQRSVYKAELP--SGN--IFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFIVCEY 727 (918)
Q Consensus 652 ~~lg~G~~g~Vy~~~~~--~~~--~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 727 (918)
+.||+|++|.||+|.+. .++ .||+|.+...... ...+.|.+|++.+++++||||+++++++.+ ...++||||
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~ 76 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS---DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTEL 76 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH---HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEe
Confidence 35899999999999653 233 6999998764322 345789999999999999999999999888 889999999
Q ss_pred ccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccCCCCC
Q 044366 728 LARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSS 807 (918)
Q Consensus 728 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~~~~~ 807 (918)
+++|+|.+++..... ..+++..++.++.|++.||+|||+. +++||||+|+||+++.++.+||+|||++..+.....
T Consensus 77 ~~~~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~ 152 (257)
T cd05040 77 APLGSLLDRLRKDAL-GHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNED 152 (257)
T ss_pred cCCCcHHHHHHhccc-ccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEecccccccccccccc
Confidence 999999999987542 4589999999999999999999999 999999999999999999999999999987754322
Q ss_pred Cc---eecccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhhhhhhhhhHhhhhhhcccCCCCCCcc
Q 044366 808 NW---TEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIK-GYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRD 883 (918)
Q Consensus 808 ~~---~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 883 (918)
.. ....++..|+|||++.+..++.++||||||+++|||++ |+.||....... ....... .....+.+
T Consensus 153 ~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~-----~~~~~~~-~~~~~~~~--- 223 (257)
T cd05040 153 HYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQ-----ILKKIDK-EGERLERP--- 223 (257)
T ss_pred ceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH-----HHHHHHh-cCCcCCCC---
Confidence 11 12346789999999998899999999999999999998 999976433211 1111111 01111111
Q ss_pred hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhC
Q 044366 884 VTDKLRSIMEVAILCLVENPEARPTMKEVCNLLCK 918 (918)
Q Consensus 884 ~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~ 918 (918)
......+.+++.+|++.+|++||++.++++.|++
T Consensus 224 -~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~ 257 (257)
T cd05040 224 -EACPQDIYNVMLQCWAHNPADRPTFAALREFLPE 257 (257)
T ss_pred -ccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhcC
Confidence 1223568889999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=314.54 Aligned_cols=258 Identities=25% Similarity=0.323 Sum_probs=199.8
Q ss_pred cCCCCceeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEEE
Q 044366 646 GNFGEKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFIV 724 (918)
Q Consensus 646 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 724 (918)
++|++.+.||+|+||.||+|.. .++..||+|.+.... ......++.+|++++++++||||+++++++.+++..++|
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 77 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI---KPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISIC 77 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc---CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEE
Confidence 3688899999999999999954 478899999876531 122245688999999999999999999999999999999
Q ss_pred EEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccCC
Q 044366 725 CEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEP 804 (918)
Q Consensus 725 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~~ 804 (918)
|||+++++|.++++.. ..+++..+..++.|+++||+|||+.. +++||||||+||+++.++.++|+|||++.....
T Consensus 78 ~ey~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 152 (308)
T cd06615 78 MEHMDGGSLDQVLKKA---GRIPENILGKISIAVLRGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 152 (308)
T ss_pred eeccCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhhC--CEEECCCChHHEEEecCCcEEEccCCCcccccc
Confidence 9999999999999764 34889999999999999999999732 899999999999999999999999999876543
Q ss_pred CCCCceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhh--hhhhhhHh---------------
Q 044366 805 HSSNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIF--SSISNMII--------------- 867 (918)
Q Consensus 805 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~--~~~~~~~~--------------- 867 (918)
.. .....++..|+|||++.+..++.++||||||+++|+|++|+.|+....... ........
T Consensus 153 ~~--~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (308)
T cd06615 153 SM--ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHP 230 (308)
T ss_pred cc--cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCC
Confidence 22 233568899999999988889999999999999999999999975332110 00000000
Q ss_pred -----------hhhhhcccCCCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 044366 868 -----------EVNQILDHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNL 915 (918)
Q Consensus 868 -----------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 915 (918)
..........+..+. ......+.+++.+||+.||++|||+.|+++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 287 (308)
T cd06615 231 PDSPRPMAIFELLDYIVNEPPPKLPS--GAFSDEFQDFVDKCLKKNPKERADLKELTKH 287 (308)
T ss_pred CCccchhhHHHHHHHHhcCCCccCcC--cccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000000000000000 0123468899999999999999999999864
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=307.59 Aligned_cols=255 Identities=27% Similarity=0.415 Sum_probs=205.2
Q ss_pred cCCCCceeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEEE
Q 044366 646 GNFGEKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFIV 724 (918)
Q Consensus 646 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 724 (918)
++|+..+.||.|+||.||+|.. .++..+|+|++..... ....+.+.+|++.++.++|+||+++++.+..++..++|
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv 77 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKC---QTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLV 77 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCc---chHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEE
Confidence 4688899999999999999964 4788999999865321 22467899999999999999999999999999999999
Q ss_pred EEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccCC
Q 044366 725 CEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEP 804 (918)
Q Consensus 725 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~~ 804 (918)
+||+++++|.++++.......+++..++.++.|++.|++|||+. +++||||+|+||++++++.++|+|||++..+..
T Consensus 78 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~ 154 (267)
T cd06610 78 MPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVSASLAD 154 (267)
T ss_pred EeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccchHHHhcc
Confidence 99999999999998654445689999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCC----ceecccccccccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCCC
Q 044366 805 HSSN----WTEFAGTVGYAAPELAYTM-RATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPT 879 (918)
Q Consensus 805 ~~~~----~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 879 (918)
.... .....|+..|+|||++... .++.++||||||+++|||++|+.||....... ...+......+.
T Consensus 155 ~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~--------~~~~~~~~~~~~ 226 (267)
T cd06610 155 GGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK--------VLMLTLQNDPPS 226 (267)
T ss_pred CccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhh--------hHHHHhcCCCCC
Confidence 4322 1334688999999998776 78899999999999999999999986443211 011111111111
Q ss_pred CCcc--hHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 880 PSRD--VTDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 880 ~~~~--~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
.... .......+.+++.+|++.||++||++.++++
T Consensus 227 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 227 LETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred cCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 1111 1233466889999999999999999999985
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=308.92 Aligned_cols=252 Identities=27% Similarity=0.360 Sum_probs=187.5
Q ss_pred eeccccceEEEEEEeCC---CCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEEEEEecc
Q 044366 653 CIGKGGQRSVYKAELPS---GNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFIVCEYLA 729 (918)
Q Consensus 653 ~lg~G~~g~Vy~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 729 (918)
.||+|+||.||+|...+ ...+|+|.+... ........|.+|++.++.++||||+++++++......++||||++
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~ 78 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRAS---ATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCP 78 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCcc---CChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCC
Confidence 58999999999996433 346888876542 122234578899999999999999999999999999999999999
Q ss_pred CCChhHHhhcccc--cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccCCCCC
Q 044366 730 RGSLTTILRDDAA--AKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSS 807 (918)
Q Consensus 730 ~gsL~~~l~~~~~--~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~~~~~ 807 (918)
+|+|.+++..... ....++...+.++.|++.|++|||+. +|+||||||+||++++++.+||+|||++........
T Consensus 79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~ 155 (269)
T cd05042 79 LGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDY 155 (269)
T ss_pred CCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEeccccccccccchh
Confidence 9999999976532 23356788899999999999999999 999999999999999999999999999875433221
Q ss_pred C--ceeccccccccccccccc-------CCCCcccchhhHHHHHHHHHh-CCCCCCcchhhhhhhhhhHhhhhhhcccCC
Q 044366 808 N--WTEFAGTVGYAAPELAYT-------MRATEKYDVYSFGVLALEVIK-GYHPGDFVSTIFSSISNMIIEVNQILDHRL 877 (918)
Q Consensus 808 ~--~~~~~g~~~y~aPE~~~~-------~~~~~~~Dv~slG~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 877 (918)
. .....++..|+|||+... ..++.++|||||||++|||++ |..||....... ... .........+
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~-~~~----~~~~~~~~~~ 230 (269)
T cd05042 156 YITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQ-VLK----QVVREQDIKL 230 (269)
T ss_pred eeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHH-HHH----HHhhccCccC
Confidence 1 122345678999998643 356789999999999999999 778875443211 001 0001111111
Q ss_pred CCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 044366 878 PTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLLC 917 (918)
Q Consensus 878 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 917 (918)
+.+. ........+.+++..|| .||++|||++||++.|+
T Consensus 231 ~~~~-~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 231 PKPQ-LDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred CCCc-ccccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 1111 11122345666777888 59999999999999875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-35 Score=323.58 Aligned_cols=259 Identities=21% Similarity=0.287 Sum_probs=197.1
Q ss_pred HHhcCCCCceeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccC---
Q 044366 643 KATGNFGEKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNA--- 718 (918)
Q Consensus 643 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--- 718 (918)
...++|...+.||+|+||.||+|.. ..++.||||++..... .......+.+|+.+++.++||||+++++++...
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 91 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ--NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSL 91 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCccc--ChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccc
Confidence 3457899999999999999999954 4789999999865321 222346788999999999999999999987543
Q ss_pred ---CceEEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEec
Q 044366 719 ---QHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSD 795 (918)
Q Consensus 719 ---~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~D 795 (918)
...++||||+++ ++.+.+.. .+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|
T Consensus 92 ~~~~~~~lv~e~~~~-~l~~~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~~~~kl~D 162 (355)
T cd07874 92 EEFQDVYLVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILD 162 (355)
T ss_pred cccceeEEEhhhhcc-cHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCCCCEEEee
Confidence 357999999975 67776643 378899999999999999999999 999999999999999999999999
Q ss_pred cccccccCCCCCCceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHh--------
Q 044366 796 FGFAKFLEPHSSNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMII-------- 867 (918)
Q Consensus 796 fG~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~-------- 867 (918)
||+++...... ......|+..|+|||++.+..++.++|||||||++|||++|+.||........ ......
T Consensus 163 fg~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~ 240 (355)
T cd07874 163 FGLARTAGTSF-MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ-WNKVIEQLGTPCPE 240 (355)
T ss_pred CcccccCCCcc-ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHhCCCCHH
Confidence 99998654322 22345689999999999998999999999999999999999999865432111 000000
Q ss_pred -------hhhhhcccC----------------CCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 868 -------EVNQILDHR----------------LPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 868 -------~~~~~~~~~----------------~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
......... .+............+.+++.+|++.||++|||+.|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~ 310 (355)
T cd07874 241 FMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQ 310 (355)
T ss_pred HHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhc
Confidence 000000000 00000001112346789999999999999999999986
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-36 Score=319.43 Aligned_cols=248 Identities=23% Similarity=0.370 Sum_probs=197.2
Q ss_pred CceeeccccceEEEEE-EeCCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCc--eEEEEE
Q 044366 650 EKYCIGKGGQRSVYKA-ELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQH--SFIVCE 726 (918)
Q Consensus 650 ~~~~lg~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~--~~lv~e 726 (918)
....||+|+|-+||+| +..+|-.||=-.++.......+...+.|..|+.+++.|+||||+++|.+|.+... .-+|+|
T Consensus 44 ~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTE 123 (632)
T KOG0584|consen 44 FDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITE 123 (632)
T ss_pred hhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeee
Confidence 3457999999999999 5557887775444433344455556899999999999999999999999977654 778999
Q ss_pred eccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCC-CcEEEeccccccccCCC
Q 044366 727 YLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSE-YEAHVSDFGFAKFLEPH 805 (918)
Q Consensus 727 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~-~~~kl~DfG~~~~~~~~ 805 (918)
.|..|+|..|.++.+. .+.+.+.+|++||++||.|||++ .|+|+|||||-.||+++.+ |.|||+|+|+|......
T Consensus 124 L~TSGtLr~Y~kk~~~---vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s 199 (632)
T KOG0584|consen 124 LFTSGTLREYRKKHRR---VNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKS 199 (632)
T ss_pred cccCCcHHHHHHHhcc---CCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhcc
Confidence 9999999999988653 78889999999999999999998 6799999999999999876 89999999999987643
Q ss_pred CCCceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCCCCCcchH
Q 044366 806 SSNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRDVT 885 (918)
Q Consensus 806 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 885 (918)
.....+|||.|||||+.. ..|.+.+||||||++++||+|+.+||..-.... .. ..++..+..|..-....
T Consensus 200 --~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~A----QI---YKKV~SGiKP~sl~kV~ 269 (632)
T KOG0584|consen 200 --HAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPA----QI---YKKVTSGIKPAALSKVK 269 (632)
T ss_pred --ccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHH----HH---HHHHHcCCCHHHhhccC
Confidence 334579999999999887 589999999999999999999999975432211 11 12222222222111111
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 886 DKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 886 ~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
-+++.++|.+|+.. ..+|||+.|+++
T Consensus 270 --dPevr~fIekCl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 270 --DPEVREFIEKCLAT-KSERLSAKELLK 295 (632)
T ss_pred --CHHHHHHHHHHhcC-chhccCHHHHhh
Confidence 14678899999999 899999999985
|
|
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=313.36 Aligned_cols=251 Identities=25% Similarity=0.367 Sum_probs=201.1
Q ss_pred cCCCCceeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEEE
Q 044366 646 GNFGEKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFIV 724 (918)
Q Consensus 646 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 724 (918)
++|.+.+.||+|+||.||+|.. .+++.||+|.++.. .....+.|.+|++++++++||||+++++++..+...++|
T Consensus 5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (280)
T cd06611 5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE----SEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWIL 80 (280)
T ss_pred hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC----CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEE
Confidence 5688888999999999999965 46899999998642 222356789999999999999999999999999999999
Q ss_pred EEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccCC
Q 044366 725 CEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEP 804 (918)
Q Consensus 725 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~~ 804 (918)
|||+++++|.+++.... ..+++.+++.++.|++.|++|||+. +++|+||+|+||+++.++.++|+|||.+.....
T Consensus 81 ~e~~~~~~L~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~ 155 (280)
T cd06611 81 IEFCDGGALDSIMLELE--RGLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKS 155 (280)
T ss_pred eeccCCCcHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEccCccchhhcc
Confidence 99999999999987642 3589999999999999999999999 999999999999999999999999999877654
Q ss_pred CCCCceecccccccccccccc-----cCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCCC
Q 044366 805 HSSNWTEFAGTVGYAAPELAY-----TMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPT 879 (918)
Q Consensus 805 ~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 879 (918)
.........++..|+|||++. +..++.++||||||+++|||++|+.||....... .. ........+.
T Consensus 156 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~-~~-------~~~~~~~~~~ 227 (280)
T cd06611 156 TLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMR-VL-------LKILKSEPPT 227 (280)
T ss_pred cccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHH-HH-------HHHhcCCCCC
Confidence 444444567899999999875 3446779999999999999999999986543211 00 1111111111
Q ss_pred CCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 880 PSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 880 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
. .........+.+++.+||+.+|.+||++.++++
T Consensus 228 ~-~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (280)
T cd06611 228 L-DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLK 261 (280)
T ss_pred c-CCcccCCHHHHHHHHHHhccChhhCcCHHHHhc
Confidence 0 001122346788999999999999999999975
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-35 Score=315.19 Aligned_cols=256 Identities=25% Similarity=0.363 Sum_probs=200.4
Q ss_pred hcCCCCceeeccccceEEEEEEeC--------CCCEEEEEEcccccccCCCCChHHHHHHHHHHhhc-cCCceeeEeccc
Q 044366 645 TGNFGEKYCIGKGGQRSVYKAELP--------SGNIFAVKKFKAELFSDETANPSEFLNEVLALTEI-RHRNIIKFHGFC 715 (918)
Q Consensus 645 ~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~ 715 (918)
.++|.+.+.||+|+||.||+|... ++..||+|.++... ......++.+|+++++.+ +||||+++++++
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 93 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA---TEKDLSDLISEMEMMKMIGKHKNIINLLGAC 93 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC---ChHHHHHHHHHHHHHHHhcCCCCEeeEEEEE
Confidence 357889999999999999999642 23579999987531 222346788999999999 799999999999
Q ss_pred ccCCceEEEEEeccCCChhHHhhcccc-------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCC
Q 044366 716 SNAQHSFIVCEYLARGSLTTILRDDAA-------------AKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKN 782 (918)
Q Consensus 716 ~~~~~~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~N 782 (918)
...+..++||||+++|+|.+++..... ...+++.++++++.|++.||+|||+. +++||||||+|
T Consensus 94 ~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~N 170 (307)
T cd05098 94 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAARN 170 (307)
T ss_pred ecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHHh
Confidence 999999999999999999999976432 23488999999999999999999999 99999999999
Q ss_pred eeeCCCCcEEEeccccccccCCCCCCc--eecccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhhh
Q 044366 783 VLLDSEYEAHVSDFGFAKFLEPHSSNW--TEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIK-GYHPGDFVSTIF 859 (918)
Q Consensus 783 ill~~~~~~kl~DfG~~~~~~~~~~~~--~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~p~~~~~~~~ 859 (918)
|++++++.+||+|||.+.......... ....++..|+|||++.+..++.++|||||||++|||++ |..||.....
T Consensus 171 ill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~-- 248 (307)
T cd05098 171 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV-- 248 (307)
T ss_pred eEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCH--
Confidence 999999999999999997664322111 11224568999999998889999999999999999998 8888754321
Q ss_pred hhhhhhHhhhhhhcccCCCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 044366 860 SSISNMIIEVNQILDHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLLC 917 (918)
Q Consensus 860 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 917 (918)
.... ..... ........ .....+.+++.+||+.+|.+||++.++++.|.
T Consensus 249 ~~~~---~~~~~---~~~~~~~~---~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~ 297 (307)
T cd05098 249 EELF---KLLKE---GHRMDKPS---NCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 297 (307)
T ss_pred HHHH---HHHHc---CCCCCCCC---cCCHHHHHHHHHHcccChhhCcCHHHHHHHHH
Confidence 1111 11111 11111111 12346788999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=306.90 Aligned_cols=255 Identities=29% Similarity=0.508 Sum_probs=201.4
Q ss_pred hcCCCCceeeccccceEEEEEEeC-CCC---EEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCc
Q 044366 645 TGNFGEKYCIGKGGQRSVYKAELP-SGN---IFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQH 720 (918)
Q Consensus 645 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~---~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 720 (918)
..+|+..+.||+|+||.||+|... +++ .+|+|.++... .....+.+..|+++++.++|||++++.+++.+.+.
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY---TEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKP 80 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC---CHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCC
Confidence 346788899999999999999654 333 79999886531 12224678999999999999999999999999999
Q ss_pred eEEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEecccccc
Q 044366 721 SFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAK 800 (918)
Q Consensus 721 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~ 800 (918)
.++||||+++++|.+++.... ..+++.+++.++.|++.|++|||+. +++||||||+||++++++.++++|||++.
T Consensus 81 ~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~ 155 (268)
T cd05063 81 AMIITEYMENGALDKYLRDHD--GEFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSDFGLSR 155 (268)
T ss_pred cEEEEEcCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCcEEECCCccce
Confidence 999999999999999997542 4589999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCCce---ecccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhhhhhhhhhHhhhhhhcccC
Q 044366 801 FLEPHSSNWT---EFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIK-GYHPGDFVSTIFSSISNMIIEVNQILDHR 876 (918)
Q Consensus 801 ~~~~~~~~~~---~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 876 (918)
.......... ....+..|+|||++.+..++.++||||||+++|||++ |+.||...... ......... ..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~-----~~~~~i~~~--~~ 228 (268)
T cd05063 156 VLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNH-----EVMKAINDG--FR 228 (268)
T ss_pred ecccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHH-----HHHHHHhcC--CC
Confidence 6643322111 1123457999999988889999999999999999997 99997543221 111111111 11
Q ss_pred CCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhC
Q 044366 877 LPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLLCK 918 (918)
Q Consensus 877 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~ 918 (918)
.+.. . +....+.+++.+||+.+|++||++.+|++.|.+
T Consensus 229 ~~~~-~---~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~ 266 (268)
T cd05063 229 LPAP-M---DCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDK 266 (268)
T ss_pred CCCC-C---CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence 1111 1 223567899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=317.18 Aligned_cols=194 Identities=25% Similarity=0.345 Sum_probs=170.7
Q ss_pred CCCCceeeccccceEEEEE-EeCCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhcc-C-----CceeeEecccccCC
Q 044366 647 NFGEKYCIGKGGQRSVYKA-ELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIR-H-----RNIIKFHGFCSNAQ 719 (918)
Q Consensus 647 ~~~~~~~lg~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h-----~niv~~~~~~~~~~ 719 (918)
+|.+.+.||+|+||.|.+| +..+++.||||+++.. .....+...|+.++..++ | -|+|++++|+...+
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~-----k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~ 261 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK-----KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRN 261 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccC-----hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccccc
Confidence 8899999999999999999 6778999999999763 233566788999999996 4 38999999999999
Q ss_pred ceEEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCC--CcEEEeccc
Q 044366 720 HSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSE--YEAHVSDFG 797 (918)
Q Consensus 720 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~--~~~kl~DfG 797 (918)
+.|||+|.++. +|.++++...- ..++...++.|+.||+.||.+||+. +|||+||||+|||+.+- ..+||+|||
T Consensus 262 HlciVfELL~~-NLYellK~n~f-~Glsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~r~~vKVIDFG 336 (586)
T KOG0667|consen 262 HLCIVFELLST-NLYELLKNNKF-RGLSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPKRSRIKVIDFG 336 (586)
T ss_pred ceeeeehhhhh-hHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCCcCceeEEecc
Confidence 99999999975 99999988753 4489999999999999999999999 99999999999999764 379999999
Q ss_pred cccccCCCCCCceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 044366 798 FAKFLEPHSSNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGD 853 (918)
Q Consensus 798 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~ 853 (918)
.|++...... ..+.+..|.|||++.|.+|+.+.||||||||++||++|.+-|.
T Consensus 337 SSc~~~q~vy---tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfp 389 (586)
T KOG0667|consen 337 SSCFESQRVY---TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFP 389 (586)
T ss_pred cccccCCcce---eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccC
Confidence 9998764433 4567889999999999999999999999999999999976543
|
|
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=316.48 Aligned_cols=244 Identities=25% Similarity=0.366 Sum_probs=198.7
Q ss_pred eeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEEEEEeccCC
Q 044366 653 CIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFIVCEYLARG 731 (918)
Q Consensus 653 ~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 731 (918)
++|+|+||+||.|+. .+...+|||.+... ......-..+|+...+.++|+|||+++|.+.+++..-+.||-++||
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpek----dsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGG 657 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEK----DSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGG 657 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccc----cchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCC
Confidence 799999999999955 45668999998653 2233456789999999999999999999999999999999999999
Q ss_pred ChhHHhhcccccCCC--CHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeC-CCCcEEEeccccccccCCCCCC
Q 044366 732 SLTTILRDDAAAKEF--SWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLD-SEYEAHVSDFGFAKFLEPHSSN 808 (918)
Q Consensus 732 sL~~~l~~~~~~~~l--~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~-~~~~~kl~DfG~~~~~~~~~~~ 808 (918)
+|.+.++.. .+++ .+.++--+.+||++||.|||+. .|||||||-.||+++ -.|.+||+|||-++++..-...
T Consensus 658 SLSsLLrsk--WGPlKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~ 732 (1226)
T KOG4279|consen 658 SLSSLLRSK--WGPLKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPC 732 (1226)
T ss_pred cHHHHHHhc--cCCCccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccchhhccCCcc
Confidence 999999875 3344 6778888999999999999999 999999999999995 5789999999999887665555
Q ss_pred ceecccccccccccccccC--CCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCCCCCcchHH
Q 044366 809 WTEFAGTVGYAAPELAYTM--RATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRDVTD 886 (918)
Q Consensus 809 ~~~~~g~~~y~aPE~~~~~--~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 886 (918)
.....||..|||||++..+ .|..++|||||||++.||.||++||-..+.....+-. .-+....|+.+ .+
T Consensus 733 TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFk------VGmyKvHP~iP---ee 803 (1226)
T KOG4279|consen 733 TETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFK------VGMYKVHPPIP---EE 803 (1226)
T ss_pred ccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhh------hcceecCCCCc---HH
Confidence 5677899999999999765 4788999999999999999999998655443222111 11111222222 23
Q ss_pred HHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 887 KLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 887 ~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
...+...+|.+|..+||.+||+|.+++.
T Consensus 804 lsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 804 LSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred HHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 4456788899999999999999999875
|
|
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=309.68 Aligned_cols=262 Identities=22% Similarity=0.349 Sum_probs=200.4
Q ss_pred cCCCCceeeccccceEEEEEEe-----CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccC--
Q 044366 646 GNFGEKYCIGKGGQRSVYKAEL-----PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNA-- 718 (918)
Q Consensus 646 ~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-- 718 (918)
.-|.+.+.||+|+||.||.|.. .+++.||+|.++... .......+.+|+++++.++||||+++++++...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES---GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGG 80 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc---cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCC
Confidence 3467888999999999999963 357889999986532 223356799999999999999999999988764
Q ss_pred CceEEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEecccc
Q 044366 719 QHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGF 798 (918)
Q Consensus 719 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~ 798 (918)
...++||||+++++|.+++.+.. ..+++.+++.++.|++.||+|+|+. +++||||||+||+++.++.++|+|||+
T Consensus 81 ~~~~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~~l~dfg~ 155 (284)
T cd05079 81 NGIKLIMEFLPSGSLKEYLPRNK--NKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGL 155 (284)
T ss_pred CceEEEEEccCCCCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCCCCEEECCCcc
Confidence 56899999999999999996542 3479999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCC---ceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhh------h-hhHhh
Q 044366 799 AKFLEPHSSN---WTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSI------S-NMIIE 868 (918)
Q Consensus 799 ~~~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~------~-~~~~~ 868 (918)
++.+...... .....++..|+|||++.+..++.++||||||+++|||++++.|+.......... . .....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd05079 156 TKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRL 235 (284)
T ss_pred ccccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHH
Confidence 9876543221 123456778999999988889999999999999999999877643211100000 0 00000
Q ss_pred hhhhcccCCCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhC
Q 044366 869 VNQILDHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLLCK 918 (918)
Q Consensus 869 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~ 918 (918)
..........+... .....+.+++.+||+.||++|||+.++++.+++
T Consensus 236 ~~~~~~~~~~~~~~---~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~ 282 (284)
T cd05079 236 VRVLEEGKRLPRPP---NCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEA 282 (284)
T ss_pred HHHHHcCccCCCCC---CCCHHHHHHHHHHccCCcccCcCHHHHHHHHHh
Confidence 01111111111111 233568899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=305.67 Aligned_cols=251 Identities=22% Similarity=0.334 Sum_probs=204.0
Q ss_pred CCCCceeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEEEE
Q 044366 647 NFGEKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFIVC 725 (918)
Q Consensus 647 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 725 (918)
+|+..+.||+|+||.||++.. .+|+.||+|++...... ....+++.+|+.+++.++||||+++++++.+.+..++||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 78 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMS--PKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVM 78 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCC--hHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEE
Confidence 478889999999999999954 57899999998653221 223468899999999999999999999999999999999
Q ss_pred EeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccCCC
Q 044366 726 EYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPH 805 (918)
Q Consensus 726 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~~~ 805 (918)
||+++++|.+++.... ...+++.+++.++.|++.|++|||+. +++|+||+|+||+++.++.++++|||.+......
T Consensus 79 e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~ 154 (256)
T cd08218 79 DYCEGGDLYKKINAQR-GVLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNST 154 (256)
T ss_pred ecCCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEeeccceeecCcc
Confidence 9999999999987543 23478999999999999999999999 9999999999999999999999999999876544
Q ss_pred CCCceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCCCCCcchH
Q 044366 806 SSNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRDVT 885 (918)
Q Consensus 806 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 885 (918)
........|+..|+|||+..+..++.++||||||+++|+|++|+.|+...... . ..........+....
T Consensus 155 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~-----~---~~~~~~~~~~~~~~~--- 223 (256)
T cd08218 155 VELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMK-----N---LVLKIIRGSYPPVSS--- 223 (256)
T ss_pred hhhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHH-----H---HHHHHhcCCCCCCcc---
Confidence 33333456788999999999888999999999999999999999997643221 0 111111222221111
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 886 DKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 886 ~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
.....+.+++.+||+.+|++||++.+|++
T Consensus 224 ~~~~~~~~li~~~l~~~p~~Rp~~~~vl~ 252 (256)
T cd08218 224 HYSYDLRNLVSQLFKRNPRDRPSVNSILE 252 (256)
T ss_pred cCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 22356888999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-35 Score=315.07 Aligned_cols=254 Identities=26% Similarity=0.385 Sum_probs=196.7
Q ss_pred cCCCCceeeccccceEEEEEEeC-CCC--EEEEEEcccccccCCCCChHHHHHHHHHHhhc-cCCceeeEecccccCCce
Q 044366 646 GNFGEKYCIGKGGQRSVYKAELP-SGN--IFAVKKFKAELFSDETANPSEFLNEVLALTEI-RHRNIIKFHGFCSNAQHS 721 (918)
Q Consensus 646 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~--~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~ 721 (918)
++|++.+.||+|+||.||+|... +|. .+|+|.++.. ........|.+|++++.++ +||||+++++++..++..
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~---~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~ 83 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY---ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYL 83 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEeccc---CCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCc
Confidence 57888899999999999999653 454 4577776532 1222346788999999999 899999999999999999
Q ss_pred EEEEEeccCCChhHHhhcccc-------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCC
Q 044366 722 FIVCEYLARGSLTTILRDDAA-------------AKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSE 788 (918)
Q Consensus 722 ~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~ 788 (918)
++||||+++|+|.++++.... ...+++.+++.++.|++.|++|||+. +++||||||+||+++++
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~Nili~~~ 160 (303)
T cd05088 84 YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGEN 160 (303)
T ss_pred eEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEecCC
Confidence 999999999999999975421 23578999999999999999999999 99999999999999999
Q ss_pred CcEEEeccccccccCCCCCCceecccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhhhhhhhhhHh
Q 044366 789 YEAHVSDFGFAKFLEPHSSNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIK-GYHPGDFVSTIFSSISNMII 867 (918)
Q Consensus 789 ~~~kl~DfG~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~p~~~~~~~~~~~~~~~~ 867 (918)
+.+||+|||++....... ......++..|+|||++.+..++.++|||||||++|||+| |..||...... ....
T Consensus 161 ~~~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~-----~~~~ 234 (303)
T cd05088 161 YVAKIADFGLSRGQEVYV-KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA-----ELYE 234 (303)
T ss_pred CcEEeCccccCcccchhh-hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChH-----HHHH
Confidence 999999999986432111 1112234678999999988889999999999999999998 99997543221 0011
Q ss_pred hhhhhcccCCCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 044366 868 EVNQILDHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLLC 917 (918)
Q Consensus 868 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 917 (918)
.... ...... .. .....+.+++.+||+.+|++||++++++..++
T Consensus 235 ~~~~--~~~~~~-~~---~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~ 278 (303)
T cd05088 235 KLPQ--GYRLEK-PL---NCDDEVYDLMRQCWREKPYERPSFAQILVSLN 278 (303)
T ss_pred HHhc--CCcCCC-CC---CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 1100 001111 11 12345788999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=311.14 Aligned_cols=260 Identities=20% Similarity=0.298 Sum_probs=198.0
Q ss_pred CCCCceeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEEEE
Q 044366 647 NFGEKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFIVC 725 (918)
Q Consensus 647 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 725 (918)
+|+..+.||+|+||.||+|.. .+|+.||+|+++.... .......+.+|+++++.++||||+++++++.+.+..++|+
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~--~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 78 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD--DEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVF 78 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccc--cccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEE
Confidence 477888999999999999965 4799999999875322 2223456788999999999999999999999999999999
Q ss_pred EeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccCCC
Q 044366 726 EYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPH 805 (918)
Q Consensus 726 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~~~ 805 (918)
||++ ++|.+++... ...+++..++.++.||++||+|||+. +++||||||+||+++.++.++|+|||+++.....
T Consensus 79 e~~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 152 (284)
T cd07839 79 EYCD-QDLKKYFDSC--NGDIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIP 152 (284)
T ss_pred ecCC-CCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEECccchhhccCCC
Confidence 9997 4888887653 23489999999999999999999999 9999999999999999999999999999876544
Q ss_pred CCCceecccccccccccccccCC-CCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHh-----------hhhhhc
Q 044366 806 SSNWTEFAGTVGYAAPELAYTMR-ATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMII-----------EVNQIL 873 (918)
Q Consensus 806 ~~~~~~~~g~~~y~aPE~~~~~~-~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~-----------~~~~~~ 873 (918)
........++..|+|||++.+.. ++.++|||||||++|||++|..|+............... ......
T Consensus 153 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (284)
T cd07839 153 VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLP 232 (284)
T ss_pred CCCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcc
Confidence 33334456788999999887644 688999999999999999999885332221111111000 000000
Q ss_pred cc-CCCCCCcc------hHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 874 DH-RLPTPSRD------VTDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 874 ~~-~~~~~~~~------~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
+. ..+..... .......+.+++.+||+.||.+|||++|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 233 DYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred cccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 00 00000000 0112356788999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=345.60 Aligned_cols=261 Identities=20% Similarity=0.294 Sum_probs=200.6
Q ss_pred HHHHHhcCCCCceeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEeccccc-
Q 044366 640 EITKATGNFGEKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSN- 717 (918)
Q Consensus 640 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~- 717 (918)
+.+...++|.+.+.||+|+||.||+|.. .+++.||+|.+..... .......|..|+.+++.++||||+++++++.+
T Consensus 7 ~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l--~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de 84 (1021)
T PTZ00266 7 DGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGL--KEREKSQLVIEVNVMRELKHKNIVRYIDRFLNK 84 (1021)
T ss_pred CCccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEecccc--CHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEec
Confidence 3445667899999999999999999955 4678899999865322 22235678999999999999999999998744
Q ss_pred -CCceEEEEEeccCCChhHHhhccc-ccCCCCHHHHHHHHHHHHHHHHHHHhCCC----CCeEEcCCCCCCeeeCCC---
Q 044366 718 -AQHSFIVCEYLARGSLTTILRDDA-AAKEFSWNQRMNVIKGVANALSYLHHDCI----PPIVHRDISSKNVLLDSE--- 788 (918)
Q Consensus 718 -~~~~~lv~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~----~~ivH~dlk~~Nill~~~--- 788 (918)
....++||||+++|+|.+++.... ....+++..++.|+.||+.||+|||+... .+||||||||+|||++.+
T Consensus 85 ~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~ 164 (1021)
T PTZ00266 85 ANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRH 164 (1021)
T ss_pred CCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccc
Confidence 456899999999999999997542 23458999999999999999999998521 259999999999999642
Q ss_pred --------------CcEEEeccccccccCCCCCCceeccccccccccccccc--CCCCcccchhhHHHHHHHHHhCCCCC
Q 044366 789 --------------YEAHVSDFGFAKFLEPHSSNWTEFAGTVGYAAPELAYT--MRATEKYDVYSFGVLALEVIKGYHPG 852 (918)
Q Consensus 789 --------------~~~kl~DfG~~~~~~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~~Dv~slG~vl~el~tg~~p~ 852 (918)
+.+||+|||++..+.... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||
T Consensus 165 lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s-~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF 243 (1021)
T PTZ00266 165 IGKITAQANNLNGRPIAKIGDFGLSKNIGIES-MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPF 243 (1021)
T ss_pred cccccccccccCCCCceEEccCCccccccccc-cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCC
Confidence 348999999998764322 2234578999999999854 45789999999999999999999998
Q ss_pred CcchhhhhhhhhhHhhhhhhcccCCCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 853 DFVSTIFSSISNMIIEVNQILDHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 853 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
......... ...+ ...+..+.. .....+.++|..||+.+|.+||++.|++.
T Consensus 244 ~~~~~~~ql----i~~l----k~~p~lpi~---~~S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 244 HKANNFSQL----ISEL----KRGPDLPIK---GKSKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred CcCCcHHHH----HHHH----hcCCCCCcC---CCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 644322111 1111 111111111 12356888999999999999999999984
|
|
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=315.20 Aligned_cols=257 Identities=23% Similarity=0.373 Sum_probs=200.3
Q ss_pred HhcCCCCceeeccccceEEEEEEeC--------CCCEEEEEEcccccccCCCCChHHHHHHHHHHhhc-cCCceeeEecc
Q 044366 644 ATGNFGEKYCIGKGGQRSVYKAELP--------SGNIFAVKKFKAELFSDETANPSEFLNEVLALTEI-RHRNIIKFHGF 714 (918)
Q Consensus 644 ~~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~ 714 (918)
..++|.+.+.||+|+||.||+|+.. .+..||+|.++... .......+..|+++++.+ +||||++++++
T Consensus 10 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~ 86 (314)
T cd05099 10 PRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA---TDKDLADLISEMELMKLIGKHKNIINLLGV 86 (314)
T ss_pred cHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC---ChHHHHHHHHHHHHHHhccCCCCeeeEEEE
Confidence 3467888999999999999999531 24579999876431 122346788999999999 69999999999
Q ss_pred cccCCceEEEEEeccCCChhHHhhcccc-------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCC
Q 044366 715 CSNAQHSFIVCEYLARGSLTTILRDDAA-------------AKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSK 781 (918)
Q Consensus 715 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~ 781 (918)
+.+.+..++||||+++|+|.+++..... ...+++.++.+++.|++.||+|||+. |++||||||+
T Consensus 87 ~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~ 163 (314)
T cd05099 87 CTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAAR 163 (314)
T ss_pred EccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---Ceeeccccce
Confidence 9998999999999999999999976421 23589999999999999999999999 9999999999
Q ss_pred CeeeCCCCcEEEeccccccccCCCCCCc--eecccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhh
Q 044366 782 NVLLDSEYEAHVSDFGFAKFLEPHSSNW--TEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIK-GYHPGDFVSTI 858 (918)
Q Consensus 782 Nill~~~~~~kl~DfG~~~~~~~~~~~~--~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~p~~~~~~~ 858 (918)
||++++++.+||+|||.++......... ....++..|+|||++.+..++.++||||||+++|||++ |..||......
T Consensus 164 Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~ 243 (314)
T cd05099 164 NVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVE 243 (314)
T ss_pred eEEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHH
Confidence 9999999999999999998765322211 12234467999999988889999999999999999999 88887543211
Q ss_pred hhhhhhhHhhhhhhcccCCCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 044366 859 FSSISNMIIEVNQILDHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLLC 917 (918)
Q Consensus 859 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 917 (918)
.. ..... ......... ....++.+++.+||+.||++|||+.|+++.|+
T Consensus 244 --~~---~~~~~---~~~~~~~~~---~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~ 291 (314)
T cd05099 244 --EL---FKLLR---EGHRMDKPS---NCTHELYMLMRECWHAVPTQRPTFKQLVEALD 291 (314)
T ss_pred --HH---HHHHH---cCCCCCCCC---CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHH
Confidence 00 11111 111111111 12346778999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=312.81 Aligned_cols=259 Identities=20% Similarity=0.282 Sum_probs=198.6
Q ss_pred cCCCCceeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEEE
Q 044366 646 GNFGEKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFIV 724 (918)
Q Consensus 646 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 724 (918)
++|...+.||+|+||.||+|.. .+++.||+|.++... .......+.+|+++++.++||||+++++++..++..++|
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv 82 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEH---EEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLV 82 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEeccc---ccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEE
Confidence 5688899999999999999965 468999999986532 222345678999999999999999999999999999999
Q ss_pred EEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccCC
Q 044366 725 CEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEP 804 (918)
Q Consensus 725 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~~ 804 (918)
|||++ ++|.+++.... ..+++..++.++.|+++||+|||+. +++||||||+||+++.++.++|+|||++.....
T Consensus 83 ~e~~~-~~l~~~l~~~~--~~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 156 (301)
T cd07873 83 FEYLD-KDLKQYLDDCG--NSINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSI 156 (301)
T ss_pred Eeccc-cCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcEEECcCcchhccCC
Confidence 99997 58999887542 3478999999999999999999999 999999999999999999999999999976544
Q ss_pred CCCCceecccccccccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhh--------hhhh---
Q 044366 805 HSSNWTEFAGTVGYAAPELAYTM-RATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIE--------VNQI--- 872 (918)
Q Consensus 805 ~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~--------~~~~--- 872 (918)
.........+++.|+|||++.+. .++.++|||||||++|||++|+.||...... ......... ....
T Consensus 157 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 235 (301)
T cd07873 157 PTKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVE-EQLHFIFRILGTPTEETWPGILSN 235 (301)
T ss_pred CCCcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHcCCCChhhchhhhcc
Confidence 33333445678999999988653 4788999999999999999999998654321 111000000 0000
Q ss_pred ---cccCCCCCCcch-----HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 873 ---LDHRLPTPSRDV-----TDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 873 ---~~~~~~~~~~~~-----~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
.....+...... ......+.+++.+|++.||.+|||++|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 236 EEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred ccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 000001000000 012345788999999999999999999985
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=311.17 Aligned_cols=260 Identities=22% Similarity=0.365 Sum_probs=201.3
Q ss_pred cCCCCceeeccccceEEEEEEeC-CCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEEE
Q 044366 646 GNFGEKYCIGKGGQRSVYKAELP-SGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFIV 724 (918)
Q Consensus 646 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 724 (918)
++|+..+.||+|++|.||+|... +|+.||+|++.... ......+.+.+|+++++.++|||++++++++..+...++|
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v 78 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESE--DDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLV 78 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecc--cCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEE
Confidence 46888899999999999999665 68999999986532 1222346788999999999999999999999999999999
Q ss_pred EEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccCC
Q 044366 725 CEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEP 804 (918)
Q Consensus 725 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~~ 804 (918)
|||++++++..+.... ..+++.+++.++.|++.||+|||+. +++||||||+||+++.++.++|+|||++.....
T Consensus 79 ~e~~~~~~l~~~~~~~---~~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 152 (286)
T cd07847 79 FEYCDHTVLNELEKNP---RGVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGFARILTG 152 (286)
T ss_pred EeccCccHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEEECccccceecCC
Confidence 9999999888877543 2489999999999999999999998 999999999999999999999999999987765
Q ss_pred CCCCceeccccccccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhh-------hhhccc-
Q 044366 805 HSSNWTEFAGTVGYAAPELAYT-MRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEV-------NQILDH- 875 (918)
Q Consensus 805 ~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~-------~~~~~~- 875 (918)
.........++..|+|||++.+ ..++.++||||||+++|+|++|+.||........ ........ ....+.
T Consensus 153 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 231 (286)
T cd07847 153 PGDDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQ-LYLIRKTLGDLIPRHQQIFSTN 231 (286)
T ss_pred CcccccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHhCCCChHHhhhcccc
Confidence 4433334567889999999876 4578899999999999999999999864432111 10000000 000000
Q ss_pred ------CCCCCC--cc----hHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 876 ------RLPTPS--RD----VTDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 876 ------~~~~~~--~~----~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
..+.+. .. .......+.+++.+||+.||++||++.|++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 232 QFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred cccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 001100 00 1122356889999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=303.52 Aligned_cols=251 Identities=25% Similarity=0.359 Sum_probs=201.5
Q ss_pred CCCCceeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEeccccc-CCceEEE
Q 044366 647 NFGEKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSN-AQHSFIV 724 (918)
Q Consensus 647 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~~~~lv 724 (918)
+|+..+.||+|++|.||+|.. .+++.||+|++..... .....+.+.+|+++++.++|+|++++++.+.. +...++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv 78 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNA--SRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIV 78 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhc--CHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEE
Confidence 478889999999999999954 4688999999865321 22335678999999999999999999998754 4467899
Q ss_pred EEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccCC
Q 044366 725 CEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEP 804 (918)
Q Consensus 725 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~~ 804 (918)
|||+++++|.++++... ...+++.+++.++.+++.|++|+|+. +++||||+|+||+++.++.++|+|||++.....
T Consensus 79 ~e~~~~~~l~~~l~~~~-~~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~ 154 (257)
T cd08223 79 MGFCEGGDLYHKLKEQK-GKLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLEN 154 (257)
T ss_pred ecccCCCcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEEecccceEEecc
Confidence 99999999999997643 34589999999999999999999999 999999999999999999999999999987754
Q ss_pred CCCCceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCCCCCcch
Q 044366 805 HSSNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRDV 884 (918)
Q Consensus 805 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 884 (918)
.........+++.|+|||++.+..++.++||||+|+++|+|++|+.||+..... ... ........+...
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~-----~~~---~~~~~~~~~~~~--- 223 (257)
T cd08223 155 QCDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMN-----SLV---YRIIEGKLPPMP--- 223 (257)
T ss_pred cCCccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHH-----HHH---HHHHhcCCCCCc---
Confidence 443344556889999999999988999999999999999999999997643211 110 111111121111
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 885 TDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 885 ~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
......+.+++.+|++.||++||++.++++
T Consensus 224 ~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 253 (257)
T cd08223 224 KDYSPELGELIATMLSKRPEKRPSVKSILR 253 (257)
T ss_pred cccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 123356889999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-35 Score=308.48 Aligned_cols=253 Identities=23% Similarity=0.344 Sum_probs=200.7
Q ss_pred CCCCceeeccccceEEEEEEeCCCCEEEEEEcccccccC--CCCChHHHHHHHHHHhhccCCceeeEecccccCCceEEE
Q 044366 647 NFGEKYCIGKGGQRSVYKAELPSGNIFAVKKFKAELFSD--ETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFIV 724 (918)
Q Consensus 647 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 724 (918)
+|...+.||+|+||.||+|...+|+.+|+|.++...... .......+.+|++.++.++|+||+++++++.+.+..++|
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 477888999999999999987789999999886532211 111235688999999999999999999999999999999
Q ss_pred EEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccCC
Q 044366 725 CEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEP 804 (918)
Q Consensus 725 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~~ 804 (918)
+||+++++|.+++.+.. .+++..++.++.|++.|++|+|+. +++|+||+|+||++++++.++|+|||.+.....
T Consensus 81 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 154 (265)
T cd06631 81 MEFVPGGSISSILNRFG---PLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAW 154 (265)
T ss_pred EecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeEEeccchhhHhhhh
Confidence 99999999999997643 478999999999999999999999 999999999999999999999999999976532
Q ss_pred CC------CCceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCC
Q 044366 805 HS------SNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLP 878 (918)
Q Consensus 805 ~~------~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 878 (918)
.. .......++..|+|||++.+..++.++||||||+++|+|++|+.||......... . ..... ....+
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~-~----~~~~~-~~~~~ 228 (265)
T cd06631 155 VGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAM-F----YIGAH-RGLMP 228 (265)
T ss_pred ccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHH-H----Hhhhc-cCCCC
Confidence 11 1112345788999999999888999999999999999999999998643321110 0 00000 01111
Q ss_pred CCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 879 TPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 879 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
.... .....+.+++.+||+.+|.+||++.|+++
T Consensus 229 ~~~~---~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 229 RLPD---SFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred CCCC---CCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 1111 12345788999999999999999999975
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=310.79 Aligned_cols=254 Identities=24% Similarity=0.343 Sum_probs=201.2
Q ss_pred cCCCCceeeccccceEEEEEEeC-CCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEEE
Q 044366 646 GNFGEKYCIGKGGQRSVYKAELP-SGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFIV 724 (918)
Q Consensus 646 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 724 (918)
++|+..+.||+|+||.||+|... +|+.||+|.++... .......+.+|++++++++||||+++++++..++..++|
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~---~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv 77 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL---DESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMC 77 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeeccc---CHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEE
Confidence 35778889999999999999664 78999999886531 222246789999999999999999999999999999999
Q ss_pred EEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccCC
Q 044366 725 CEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEP 804 (918)
Q Consensus 725 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~~ 804 (918)
|||+++++|.++++.......+++..+..++.|++.|+.|||+.+ +++||||||+||+++.++.++|+|||.+..+..
T Consensus 78 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 155 (286)
T cd06622 78 MEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEH--NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVA 155 (286)
T ss_pred EeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcC--CEeeCCCCHHHEEECCCCCEEEeecCCcccccC
Confidence 999999999999876533446899999999999999999999742 899999999999999999999999999976543
Q ss_pred CCCCceecccccccccccccccCC------CCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCC
Q 044366 805 HSSNWTEFAGTVGYAAPELAYTMR------ATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLP 878 (918)
Q Consensus 805 ~~~~~~~~~g~~~y~aPE~~~~~~------~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 878 (918)
.. .....++..|+|||.+.+.. ++.++|||||||++|+|++|+.||...... ..............+
T Consensus 156 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-----~~~~~~~~~~~~~~~ 228 (286)
T cd06622 156 SL--AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYA-----NIFAQLSAIVDGDPP 228 (286)
T ss_pred Cc--cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchh-----hHHHHHHHHhhcCCC
Confidence 22 22345788999999986543 478999999999999999999998643211 111111222222222
Q ss_pred CCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 879 TPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 879 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
.... .....+.+++.+||+.+|++||++++++.
T Consensus 229 ~~~~---~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 261 (286)
T cd06622 229 TLPS---GYSDDAQDFVAKCLNKIPNRRPTYAQLLE 261 (286)
T ss_pred CCCc---ccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence 2111 23456788999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=304.88 Aligned_cols=254 Identities=22% Similarity=0.414 Sum_probs=203.2
Q ss_pred HhcCCCCceeeccccceEEEEEEeCCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEE
Q 044366 644 ATGNFGEKYCIGKGGQRSVYKAELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFI 723 (918)
Q Consensus 644 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 723 (918)
..++|...+.||+|+||.||+|...++..+|+|.+... ....+.|.+|+++++.++|+||+++++++.+ ...++
T Consensus 4 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~-----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~ 77 (260)
T cd05073 4 PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG-----SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYI 77 (260)
T ss_pred cccceeEEeEecCccceEEEEEEecCCccEEEEecCCC-----hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEE
Confidence 34678899999999999999998777888999987642 2235679999999999999999999999877 77899
Q ss_pred EEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccC
Q 044366 724 VCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLE 803 (918)
Q Consensus 724 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~ 803 (918)
||||+++|+|.+++.... ...+++.+++.++.|++.|++|||+. +++|+||+|+||+++.++.++|+|||.+....
T Consensus 78 v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~ 153 (260)
T cd05073 78 ITEFMAKGSLLDFLKSDE-GSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIE 153 (260)
T ss_pred EEEeCCCCcHHHHHHhCC-ccccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCCcceeecc
Confidence 999999999999997643 34578999999999999999999998 99999999999999999999999999997664
Q ss_pred CCCCC-ceecccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhhhhhhhhhHhhhhhhcccCCCCCC
Q 044366 804 PHSSN-WTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIK-GYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPS 881 (918)
Q Consensus 804 ~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 881 (918)
..... .....++..|+|||++.+..++.++||||||+++|++++ |+.||...... .. .... ......+.
T Consensus 154 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~--~~---~~~~----~~~~~~~~ 224 (260)
T cd05073 154 DNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP--EV---IRAL----ERGYRMPR 224 (260)
T ss_pred CCCcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHH--HH---HHHH----hCCCCCCC
Confidence 32221 122345678999999988889999999999999999999 89997643221 00 0000 11111110
Q ss_pred cchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhC
Q 044366 882 RDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLLCK 918 (918)
Q Consensus 882 ~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~ 918 (918)
.......+.+++.+|++.+|++||++.++.+.|+.
T Consensus 225 --~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 225 --PENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred --cccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 11223568899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=306.73 Aligned_cols=251 Identities=23% Similarity=0.337 Sum_probs=185.0
Q ss_pred eeccccceEEEEEEeCCCC---EEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEEEEEecc
Q 044366 653 CIGKGGQRSVYKAELPSGN---IFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFIVCEYLA 729 (918)
Q Consensus 653 ~lg~G~~g~Vy~~~~~~~~---~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 729 (918)
.||+|+||.||+|+..++. .+++|.+... ......+.|.+|+..++.++||||+++++++.+....++||||++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 78 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKAN---ASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCE 78 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCC---CChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCC
Confidence 5899999999999654433 4556665432 122335789999999999999999999999999999999999999
Q ss_pred CCChhHHhhcccc-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccCCCC--
Q 044366 730 RGSLTTILRDDAA-AKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHS-- 806 (918)
Q Consensus 730 ~gsL~~~l~~~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~~~~-- 806 (918)
+|+|.++++.... ....++..++.++.||++||+|||+. +++||||||+||+++.++.++|+|||++.......
T Consensus 79 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~ 155 (268)
T cd05086 79 LGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYI 155 (268)
T ss_pred CCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEecccccccccCcchhh
Confidence 9999999976432 23467778889999999999999999 99999999999999999999999999986432211
Q ss_pred CCceeccccccccccccccc-------CCCCcccchhhHHHHHHHHHh-CCCCCCcchhhhhhhhhhHhh-hhhhcccCC
Q 044366 807 SNWTEFAGTVGYAAPELAYT-------MRATEKYDVYSFGVLALEVIK-GYHPGDFVSTIFSSISNMIIE-VNQILDHRL 877 (918)
Q Consensus 807 ~~~~~~~g~~~y~aPE~~~~-------~~~~~~~Dv~slG~vl~el~t-g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~ 877 (918)
.......++..|+|||++.. ..++.++||||||+++|||++ |..||...... ......... .....++..
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~ 234 (268)
T cd05086 156 ETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDR-EVLNHVIKDQQVKLFKPQL 234 (268)
T ss_pred hcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHH-HHHHHHHhhcccccCCCcc
Confidence 11233467889999998753 245779999999999999997 46676533221 111111000 001111111
Q ss_pred CCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 044366 878 PTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLLC 917 (918)
Q Consensus 878 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 917 (918)
... ....+.+++..|| .+|++||+++||++.|.
T Consensus 235 ---~~~---~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 235 ---ELP---YSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred ---CCC---CcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 111 2245677888899 67999999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=309.91 Aligned_cols=259 Identities=23% Similarity=0.366 Sum_probs=203.1
Q ss_pred CHHHHHHHhcCCCCceeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhc-cCCceeeEecc
Q 044366 637 LYEEITKATGNFGEKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEI-RHRNIIKFHGF 714 (918)
Q Consensus 637 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~ 714 (918)
+..+...+.+.|+..+.||+|+||.||+|.. .+++.||+|.+... .....++..|+.+++++ +||||++++++
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~-----~~~~~~~~~e~~~l~~~~~h~~i~~~~~~ 81 (282)
T cd06636 7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-----EDEEEEIKLEINMLKKYSHHRNIATYYGA 81 (282)
T ss_pred hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecC-----hHHHHHHHHHHHHHHHhcCCCcEEEEeee
Confidence 4455556778999999999999999999955 57899999987542 12346788899999998 69999999998
Q ss_pred ccc------CCceEEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCC
Q 044366 715 CSN------AQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSE 788 (918)
Q Consensus 715 ~~~------~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~ 788 (918)
+.. ....++||||+++|+|.+++.... ...+++..++.++.|++.|++|||+. +++|||++|+||+++++
T Consensus 82 ~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nili~~~ 157 (282)
T cd06636 82 FIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTK-GNALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTEN 157 (282)
T ss_pred hhcccccCCCCEEEEEEEeCCCCcHHHHHHHcc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCC
Confidence 843 457899999999999999997643 34478888999999999999999999 99999999999999999
Q ss_pred CcEEEeccccccccCCCCCCceecccccccccccccc-----cCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhh
Q 044366 789 YEAHVSDFGFAKFLEPHSSNWTEFAGTVGYAAPELAY-----TMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSIS 863 (918)
Q Consensus 789 ~~~kl~DfG~~~~~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~ 863 (918)
+.++|+|||++..............|+..|+|||.+. ...++.++|||||||++|||++|+.||.........
T Consensus 158 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~-- 235 (282)
T cd06636 158 AEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRAL-- 235 (282)
T ss_pred CCEEEeeCcchhhhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhh--
Confidence 9999999999886654333334456889999999875 345788999999999999999999998543221100
Q ss_pred hhHhhhhhhcccCCCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 864 NMIIEVNQILDHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 864 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
........+. .........+.+++.+||+.||.+|||+.|+++
T Consensus 236 ------~~~~~~~~~~--~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 236 ------FLIPRNPPPK--LKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred ------hhHhhCCCCC--CcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 0011111111 111123457889999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=303.89 Aligned_cols=248 Identities=27% Similarity=0.405 Sum_probs=198.2
Q ss_pred cCCCCceeeccccceEEEEEEeCCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEeccc-ccCCceEEE
Q 044366 646 GNFGEKYCIGKGGQRSVYKAELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFC-SNAQHSFIV 724 (918)
Q Consensus 646 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~-~~~~~~~lv 724 (918)
.+|...+.||+|+||.||+|.. .|+.||+|.++.. ...+.|.+|+.+++.++|+|++++++++ ..++..++|
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~-~~~~~~~k~~~~~------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv 78 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND------ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIV 78 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEE-cCCcEEEEEeCCC------chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEE
Confidence 4688889999999999999976 4788999987542 2356799999999999999999999975 455678999
Q ss_pred EEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccCC
Q 044366 725 CEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEP 804 (918)
Q Consensus 725 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~~ 804 (918)
|||+++|+|.+++.... ...+++..++.++.|++.|++|||+. +++||||||+||++++++.+|++|||++.....
T Consensus 79 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 154 (256)
T cd05082 79 TEYMAKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 154 (256)
T ss_pred EECCCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEecCCccceeccc
Confidence 99999999999997643 23478999999999999999999999 999999999999999999999999999876543
Q ss_pred CCCCceecccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhhhhhhhhhHhhhhhhcccCCCCCCcc
Q 044366 805 HSSNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIK-GYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRD 883 (918)
Q Consensus 805 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 883 (918)
.. ....++..|+|||++.+..++.++||||||+++|||++ |+.|+..... ......... ...+....
T Consensus 155 ~~---~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~-----~~~~~~~~~---~~~~~~~~- 222 (256)
T cd05082 155 TQ---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL-----KDVVPRVEK---GYKMDAPD- 222 (256)
T ss_pred cC---CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCH-----HHHHHHHhc---CCCCCCCC-
Confidence 22 22234678999999988889999999999999999997 9998753321 111111111 10111111
Q ss_pred hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhC
Q 044366 884 VTDKLRSIMEVAILCLVENPEARPTMKEVCNLLCK 918 (918)
Q Consensus 884 ~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~ 918 (918)
.....+.+++.+|++.+|++|||+.++++.|++
T Consensus 223 --~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 255 (256)
T cd05082 223 --GCPPVVYDVMKQCWHLDAATRPSFLQLREQLEH 255 (256)
T ss_pred --CCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence 223567889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=314.65 Aligned_cols=245 Identities=27% Similarity=0.397 Sum_probs=197.5
Q ss_pred ceeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEEEEEecc
Q 044366 651 KYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFIVCEYLA 729 (918)
Q Consensus 651 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 729 (918)
...||+|+||.||+|.. .+++.||||++... .....+.+.+|+..++.++||||+++++++..++..++||||++
T Consensus 27 ~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~ 102 (292)
T cd06658 27 FIKIGEGSTGIVCIATEKHTGKQVAVKKMDLR----KQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLE 102 (292)
T ss_pred hhcccCCCCeEEEEEEECCCCCEEEEEEEecc----hHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCC
Confidence 35699999999999955 46899999987542 22335678999999999999999999999999999999999999
Q ss_pred CCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccCCCCCCc
Q 044366 730 RGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNW 809 (918)
Q Consensus 730 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~~~~~~~ 809 (918)
+++|.+++... .+++.+++.++.||+.|++|||+. +++||||||+||++++++.++|+|||++..........
T Consensus 103 ~~~L~~~~~~~----~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~~ 175 (292)
T cd06658 103 GGALTDIVTHT----RMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKR 175 (292)
T ss_pred CCcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccCcchhhcccccccC
Confidence 99999988542 478999999999999999999999 99999999999999999999999999997665443333
Q ss_pred eecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCCCCCcchHHHHH
Q 044366 810 TEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRDVTDKLR 889 (918)
Q Consensus 810 ~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 889 (918)
....|+..|+|||...+..++.++||||||+++|||++|+.||....... .. ...........+ .......
T Consensus 176 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~-~~----~~~~~~~~~~~~----~~~~~~~ 246 (292)
T cd06658 176 KSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQ-AM----RRIRDNLPPRVK----DSHKVSS 246 (292)
T ss_pred ceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HH----HHHHhcCCCccc----cccccCH
Confidence 44568899999999988889999999999999999999999976433211 11 111111111111 1112234
Q ss_pred HHHHHHHHcccCCCCCCCCHHHHHHH
Q 044366 890 SIMEVAILCLVENPEARPTMKEVCNL 915 (918)
Q Consensus 890 ~l~~li~~cl~~dp~~RPt~~evl~~ 915 (918)
.+.+++.+|+..||.+|||++|+++.
T Consensus 247 ~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 247 VLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred HHHHHHHHHccCChhHCcCHHHHhhC
Confidence 67788999999999999999999863
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-35 Score=318.65 Aligned_cols=259 Identities=21% Similarity=0.281 Sum_probs=192.4
Q ss_pred Cceeeccc--cceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEEEEE
Q 044366 650 EKYCIGKG--GQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFIVCE 726 (918)
Q Consensus 650 ~~~~lg~G--~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 726 (918)
...+||+| +|++||++.. .+|+.||+|++...... ....+.+.+|+++++.++||||+++++++..++..++|||
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 79 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACT--NEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTS 79 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhcc--HHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEe
Confidence 34679999 6789999954 58999999998754221 1223567789999999999999999999999999999999
Q ss_pred eccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccCCCC
Q 044366 727 YLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHS 806 (918)
Q Consensus 727 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~~~~ 806 (918)
|+++|+|.+++.... ...+++..++.++.|++.||+|||+. +|+||||||+||+++.++.++++|||.+.......
T Consensus 80 ~~~~~~l~~~~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~ 155 (327)
T cd08227 80 FMAYGSAKDLICTHF-MDGMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMINHG 155 (327)
T ss_pred ccCCCcHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEcccchhhcccccc
Confidence 999999999997543 23489999999999999999999999 99999999999999999999999998765432211
Q ss_pred CC-------ceeccccccccccccccc--CCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcc---
Q 044366 807 SN-------WTEFAGTVGYAAPELAYT--MRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILD--- 874 (918)
Q Consensus 807 ~~-------~~~~~g~~~y~aPE~~~~--~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~--- 874 (918)
.. .....++..|+|||++.+ ..++.++|||||||++|||++|+.||.....................+
T Consensus 156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (327)
T cd08227 156 QRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTT 235 (327)
T ss_pred ccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccc
Confidence 10 112346778999999876 458899999999999999999999986543211100000000000000
Q ss_pred ---------------------------cCCCC----CCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 875 ---------------------------HRLPT----PSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 875 ---------------------------~~~~~----~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
..... ...........+.+++.+||+.||++|||++|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~ 306 (327)
T cd08227 236 IPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN 306 (327)
T ss_pred hhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhc
Confidence 00000 00001122356889999999999999999999975
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-35 Score=311.93 Aligned_cols=258 Identities=25% Similarity=0.379 Sum_probs=202.9
Q ss_pred cCCCCceeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEEE
Q 044366 646 GNFGEKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFIV 724 (918)
Q Consensus 646 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 724 (918)
++|++.+.||+|+||.||+|.. ++|+.||+|++... ......+.+.+|+++++.++||||+++++++...+..++|
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~---~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 81 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIG---AKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMC 81 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEec---CcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEE
Confidence 5677788999999999999954 57899999987643 1233357899999999999999999999999999999999
Q ss_pred EEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccCC
Q 044366 725 CEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEP 804 (918)
Q Consensus 725 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~~ 804 (918)
|||+++++|.+++... +.+++..+..++.+++.|+.|||+.. +++||||+|+||++++++.++|+|||++.....
T Consensus 82 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~ 156 (284)
T cd06620 82 MEFMDCGSLDRIYKKG---GPIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGVSGELIN 156 (284)
T ss_pred EecCCCCCHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHHhc--CeeccCCCHHHEEECCCCcEEEccCCcccchhh
Confidence 9999999999998764 34899999999999999999999732 899999999999999999999999999875532
Q ss_pred CCCCceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhh---hhhhhHhhhhhhcccCCCCCC
Q 044366 805 HSSNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFS---SISNMIIEVNQILDHRLPTPS 881 (918)
Q Consensus 805 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~ 881 (918)
.. .....|+..|+|||++.+..++.++|||||||++|+|++|+.||+....... .................+...
T Consensus 157 ~~--~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
T cd06620 157 SI--ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLP 234 (284)
T ss_pred hc--cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCCCCC
Confidence 21 1234689999999999888899999999999999999999999875432100 000011111222221111111
Q ss_pred cchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 044366 882 RDVTDKLRSIMEVAILCLVENPEARPTMKEVCNL 915 (918)
Q Consensus 882 ~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 915 (918)
.......+.+++.+|++.||++|||+.|+++.
T Consensus 235 --~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~ 266 (284)
T cd06620 235 --SSDFPEDLRDFVDACLLKDPTERPTPQQLCAM 266 (284)
T ss_pred --chhcCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 11233568899999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=303.97 Aligned_cols=238 Identities=20% Similarity=0.340 Sum_probs=186.3
Q ss_pred eeccccceEEEEEEeCC-------------CCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCC
Q 044366 653 CIGKGGQRSVYKAELPS-------------GNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQ 719 (918)
Q Consensus 653 ~lg~G~~g~Vy~~~~~~-------------~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~ 719 (918)
.||+|+||.||+|.+.+ ...||+|.+... .......|.+|+.+++.++||||+++++++....
T Consensus 2 ~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~----~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~ 77 (262)
T cd05077 2 HLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPS----HRDISLAFFETASMMRQVSHKHIVLLYGVCVRDV 77 (262)
T ss_pred ccccCCcceEeeeecccCCCccccccchhhceeEEEeecChh----hhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence 58999999999996532 225888886542 2223457889999999999999999999999988
Q ss_pred ceEEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCc-------EE
Q 044366 720 HSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYE-------AH 792 (918)
Q Consensus 720 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~-------~k 792 (918)
..++||||+++|+|..++.... ..+++..+++++.||++|++|||+. +|+||||||+||+++.++. ++
T Consensus 78 ~~~lv~e~~~~~~l~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~~~~~~~~~ 152 (262)
T cd05077 78 ENIMVEEFVEFGPLDLFMHRKS--DVLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIK 152 (262)
T ss_pred CCEEEEecccCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCCccCCCCceeE
Confidence 9999999999999999987542 3489999999999999999999999 9999999999999987654 89
Q ss_pred EeccccccccCCCCCCceecccccccccccccc-cCCCCcccchhhHHHHHHHHH-hCCCCCCcchhhhhhhhhhHhhhh
Q 044366 793 VSDFGFAKFLEPHSSNWTEFAGTVGYAAPELAY-TMRATEKYDVYSFGVLALEVI-KGYHPGDFVSTIFSSISNMIIEVN 870 (918)
Q Consensus 793 l~DfG~~~~~~~~~~~~~~~~g~~~y~aPE~~~-~~~~~~~~Dv~slG~vl~el~-tg~~p~~~~~~~~~~~~~~~~~~~ 870 (918)
++|||++...... ....++..|+|||.+. +..++.++|||||||++|||+ +|..|+...... .. .
T Consensus 153 l~d~g~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~--~~-------~ 219 (262)
T cd05077 153 LSDPGIPITVLSR----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLA--EK-------E 219 (262)
T ss_pred eCCCCCCccccCc----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchh--HH-------H
Confidence 9999998765432 2345788999999886 466889999999999999998 578886533211 00 0
Q ss_pred hhcccCCCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 044366 871 QILDHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLL 916 (918)
Q Consensus 871 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L 916 (918)
........... +....+.+++.+||+.||.+||++.++++.+
T Consensus 220 ~~~~~~~~~~~----~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 220 RFYEGQCMLVT----PSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred HHHhcCccCCC----CChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 01111111111 1124678899999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=311.54 Aligned_cols=261 Identities=25% Similarity=0.347 Sum_probs=203.2
Q ss_pred CHHHHHHHhcCCCCceeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhc-cCCceeeEecc
Q 044366 637 LYEEITKATGNFGEKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEI-RHRNIIKFHGF 714 (918)
Q Consensus 637 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~ 714 (918)
..+++..+.++|.+.+.||+|+||.||+|.. .+++.||+|.+... ......+.+|+.+++++ +|||+++++++
T Consensus 13 ~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~-----~~~~~~~~~e~~~l~~l~~h~ni~~~~~~ 87 (291)
T cd06639 13 GLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPI-----SDVDEEIEAEYNILQSLPNHPNVVKFYGM 87 (291)
T ss_pred hcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccc-----ccHHHHHHHHHHHHHHhcCCCCeEEEEEE
Confidence 3455566788999999999999999999955 57899999987542 12246678899999998 89999999998
Q ss_pred cccC-----CceEEEEEeccCCChhHHhhccc-ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCC
Q 044366 715 CSNA-----QHSFIVCEYLARGSLTTILRDDA-AAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSE 788 (918)
Q Consensus 715 ~~~~-----~~~~lv~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~ 788 (918)
+... +..++||||+++|+|.++++... ....+++..++.++.|++.|++|||+. +++||||||+||+++.+
T Consensus 88 ~~~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili~~~ 164 (291)
T cd06639 88 FYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTE 164 (291)
T ss_pred EEeccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCC
Confidence 8543 35899999999999999886432 234589999999999999999999999 99999999999999999
Q ss_pred CcEEEeccccccccCCCCCCceecccccccccccccccC-----CCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhh
Q 044366 789 YEAHVSDFGFAKFLEPHSSNWTEFAGTVGYAAPELAYTM-----RATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSIS 863 (918)
Q Consensus 789 ~~~kl~DfG~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-----~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~ 863 (918)
+.+||+|||.+..............|+..|+|||++... .++.++|||||||++|||++|+.|+........ .
T Consensus 165 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~-~- 242 (291)
T cd06639 165 GGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKT-L- 242 (291)
T ss_pred CCEEEeecccchhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHH-H-
Confidence 999999999998765443333345688999999987543 367899999999999999999999764432111 0
Q ss_pred hhHhhhhhhcccCCCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 864 NMIIEVNQILDHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 864 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
..... ...+ ...........+.+++.+||+.+|++||++.|+++
T Consensus 243 ---~~~~~---~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 286 (291)
T cd06639 243 ---FKIPR---NPPP-TLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLE 286 (291)
T ss_pred ---HHHhc---CCCC-CCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 01111 1000 00111122346889999999999999999999975
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-35 Score=302.16 Aligned_cols=250 Identities=21% Similarity=0.360 Sum_probs=210.3
Q ss_pred hcCCCCceeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEE
Q 044366 645 TGNFGEKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFI 723 (918)
Q Consensus 645 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 723 (918)
.+-|...+.||+|-|.+|-.|++ -+|+.||||++.+.... ......+.+|+..|+-++|||||++|++.......|+
T Consensus 17 AGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD--~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyL 94 (864)
T KOG4717|consen 17 AGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLD--TLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYL 94 (864)
T ss_pred eeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccc--hhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEE
Confidence 35577778899999999999954 48999999999876443 3445788999999999999999999999999999999
Q ss_pred EEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCC-CCcEEEecccccccc
Q 044366 724 VCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDS-EYEAHVSDFGFAKFL 802 (918)
Q Consensus 724 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~-~~~~kl~DfG~~~~~ 802 (918)
|+|.-++|+|.+|+-++. ..+.++-..+++.||+.|+.|+|.- .+||||+||+||++-+ -|-+|+.|||++-.+
T Consensus 95 iLELGD~GDl~DyImKHe--~Gl~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf 169 (864)
T KOG4717|consen 95 ILELGDGGDLFDYIMKHE--EGLNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVKLTDFGFSNKF 169 (864)
T ss_pred EEEecCCchHHHHHHhhh--ccccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceEeeeccccccC
Confidence 999999999999997664 3478899999999999999999999 9999999999998755 588999999999988
Q ss_pred CCCCCCceecccccccccccccccCCCC-cccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCCCCC
Q 044366 803 EPHSSNWTEFAGTVGYAAPELAYTMRAT-EKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPS 881 (918)
Q Consensus 803 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~-~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 881 (918)
.+.. .....+|+..|-|||.+.+..|+ +++||||+||+||.+++|+.||+...+. ..+..++|-++.-+
T Consensus 170 ~PG~-kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDS--------ETLTmImDCKYtvP- 239 (864)
T KOG4717|consen 170 QPGK-KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDS--------ETLTMIMDCKYTVP- 239 (864)
T ss_pred CCcc-hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccch--------hhhhhhhcccccCc-
Confidence 7643 44567899999999999999886 5789999999999999999999865431 22334445444332
Q ss_pred cchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 882 RDVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 882 ~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
.....++.++|..|+..||++|-+.+||+.
T Consensus 240 ---shvS~eCrdLI~sMLvRdPkkRAslEeI~s 269 (864)
T KOG4717|consen 240 ---SHVSKECRDLIQSMLVRDPKKRASLEEIVS 269 (864)
T ss_pred ---hhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence 234467889999999999999999999874
|
|
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=305.21 Aligned_cols=251 Identities=28% Similarity=0.428 Sum_probs=200.0
Q ss_pred CCCCceeeccccceEEEEEEe-CCCCEEEEEEcccccccCCC-----CChHHHHHHHHHHhhccCCceeeEecccccCCc
Q 044366 647 NFGEKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDET-----ANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQH 720 (918)
Q Consensus 647 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~-----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 720 (918)
+|.....||+|++|.||+|.. .+++.||+|.+......... ...+.+.+|++++++++||||+++++++.+.+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 466778999999999999954 46899999988654222211 112568899999999999999999999999999
Q ss_pred eEEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEecccccc
Q 044366 721 SFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAK 800 (918)
Q Consensus 721 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~ 800 (918)
.++||||+++++|.+++... ..+++..+..++.|++.|++|||+. +++||||+|+||++++++.++|+|||.++
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~~~~~l~dfg~~~ 154 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNY---GAFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGISK 154 (267)
T ss_pred cEEEEEecCCCCHHHHHHhc---cCccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCCCCEEecccCCCc
Confidence 99999999999999999764 3478999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCC------CceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcc
Q 044366 801 FLEPHSS------NWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILD 874 (918)
Q Consensus 801 ~~~~~~~------~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 874 (918)
....... ......|+..|+|||.+.+..++.++||||+|+++|+|++|+.||....... .+ .....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~-------~~~~~ 226 (267)
T cd06628 155 KLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQ-AI-------FKIGE 226 (267)
T ss_pred ccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHH-HH-------HHHhc
Confidence 7753211 1122357889999999998889999999999999999999999987543211 11 11111
Q ss_pred cCCCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 875 HRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 875 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
...+.... .....+.+++.+||+.||.+||++.|+++
T Consensus 227 ~~~~~~~~---~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 227 NASPEIPS---NISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred cCCCcCCc---ccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 11111111 22356788899999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=322.00 Aligned_cols=243 Identities=25% Similarity=0.309 Sum_probs=187.8
Q ss_pred eccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhc---cCCceeeEecccccCCceEEEEEecc
Q 044366 654 IGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEI---RHRNIIKFHGFCSNAQHSFIVCEYLA 729 (918)
Q Consensus 654 lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l---~h~niv~~~~~~~~~~~~~lv~e~~~ 729 (918)
||+|+||.||+|+. .+|+.||||++....... ......+..|..++... +||||+++++++..++..++||||++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~-~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~ 79 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVA-KKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMS 79 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhh-hhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCC
Confidence 69999999999955 478999999986532222 12234456666666555 69999999999999999999999999
Q ss_pred CCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccCCCCCCc
Q 044366 730 RGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNW 809 (918)
Q Consensus 730 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~~~~~~~ 809 (918)
+|+|.+++... ..+++..++.++.||++||+|||+. +|+||||||+||+++.++.++|+|||++..........
T Consensus 80 ~g~L~~~l~~~---~~~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~ 153 (330)
T cd05586 80 GGELFWHLQKE---GRFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTT 153 (330)
T ss_pred CChHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCCc
Confidence 99999998754 3489999999999999999999999 99999999999999999999999999997654333333
Q ss_pred eecccccccccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCCCCCcchHHHH
Q 044366 810 TEFAGTVGYAAPELAYTM-RATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRDVTDKL 888 (918)
Q Consensus 810 ~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 888 (918)
....||..|+|||++.+. .++.++||||+||++|||++|+.||...... ... ..+.......+... ..
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~-----~~~---~~i~~~~~~~~~~~---~~ 222 (330)
T cd05586 154 NTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQ-----QMY---RNIAFGKVRFPKNV---LS 222 (330)
T ss_pred cCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHH-----HHH---HHHHcCCCCCCCcc---CC
Confidence 456789999999998764 4789999999999999999999998643221 011 11111111111111 12
Q ss_pred HHHHHHHHHcccCCCCCCC----CHHHHHH
Q 044366 889 RSIMEVAILCLVENPEARP----TMKEVCN 914 (918)
Q Consensus 889 ~~l~~li~~cl~~dp~~RP----t~~evl~ 914 (918)
..+.+++.+||+.||.+|| ++.++++
T Consensus 223 ~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 223 DEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred HHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 4567889999999999998 5666654
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=308.17 Aligned_cols=249 Identities=27% Similarity=0.399 Sum_probs=202.2
Q ss_pred cCCCCceeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEEE
Q 044366 646 GNFGEKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFIV 724 (918)
Q Consensus 646 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 724 (918)
..|+..+.||+|+||.||+|.. .+++.||+|.+.... .......+.+|+++++.++||||+++++++.++...++|
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE---AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWII 80 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccc---cHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEE
Confidence 3567778899999999999965 468899999886431 122356789999999999999999999999999999999
Q ss_pred EEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccCC
Q 044366 725 CEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEP 804 (918)
Q Consensus 725 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~~ 804 (918)
|||+++|+|.++++.. ++++.++..++.|++.|++|+|+. +++|+||+|+||+++.++.++++|||++.....
T Consensus 81 ~e~~~~~~L~~~i~~~----~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~ 153 (277)
T cd06640 81 MEYLGGGSALDLLRAG----PFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTD 153 (277)
T ss_pred EecCCCCcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEcccccceeccC
Confidence 9999999999998743 478899999999999999999999 999999999999999999999999999987654
Q ss_pred CCCCceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCCCCCcch
Q 044366 805 HSSNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRDV 884 (918)
Q Consensus 805 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 884 (918)
.........++..|+|||++.+..++.++||||||+++|||++|..|+....... . . .......+ ....
T Consensus 154 ~~~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~-~----~----~~~~~~~~--~~~~ 222 (277)
T cd06640 154 TQIKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMR-V----L----FLIPKNNP--PTLT 222 (277)
T ss_pred CccccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHh-H----h----hhhhcCCC--CCCc
Confidence 4333344567889999999988889999999999999999999999976432210 0 0 00111111 1112
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 044366 885 TDKLRSIMEVAILCLVENPEARPTMKEVCNL 915 (918)
Q Consensus 885 ~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 915 (918)
......+.+++.+||+.+|++||++.+++..
T Consensus 223 ~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 223 GEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred hhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 2345678899999999999999999999753
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=323.72 Aligned_cols=255 Identities=21% Similarity=0.240 Sum_probs=193.6
Q ss_pred hcCCCCceeeccccceEEEEEEeC-CCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEE
Q 044366 645 TGNFGEKYCIGKGGQRSVYKAELP-SGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFI 723 (918)
Q Consensus 645 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 723 (918)
...|.+.+.||+|+||.||+|... +++.||||... ...+.+|++++++++|+||+++++++..++..++
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~----------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~l 237 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW----------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCL 237 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc----------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEE
Confidence 346889999999999999999654 68899999632 1245789999999999999999999999999999
Q ss_pred EEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccC
Q 044366 724 VCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLE 803 (918)
Q Consensus 724 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~ 803 (918)
|||++. ++|.+++.... ..+++.+++.|+.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 238 v~e~~~-~~L~~~l~~~~--~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~ 311 (461)
T PHA03211 238 VLPKYR-SDLYTYLGARL--RPLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFAR 311 (461)
T ss_pred EEEccC-CCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEcccCCceecc
Confidence 999995 68988886532 3589999999999999999999999 99999999999999999999999999998764
Q ss_pred CCCCC--ceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCC-Ccchh-----hhhhhhhhHhhhhhhcc-
Q 044366 804 PHSSN--WTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPG-DFVST-----IFSSISNMIIEVNQILD- 874 (918)
Q Consensus 804 ~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~-~~~~~-----~~~~~~~~~~~~~~~~~- 874 (918)
..... .....||..|+|||++.+..++.++|||||||++|||++|..|+ ..... ....+............
T Consensus 312 ~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~ 391 (461)
T PHA03211 312 GSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDE 391 (461)
T ss_pred cccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhcccccc
Confidence 33221 22356899999999999999999999999999999999987653 21110 00011111110000000
Q ss_pred -------------------cCCCC-CCcch---HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 044366 875 -------------------HRLPT-PSRDV---TDKLRSIMEVAILCLVENPEARPTMKEVCNL 915 (918)
Q Consensus 875 -------------------~~~~~-~~~~~---~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 915 (918)
...+. ....+ ......+.+++.+||+.||.+|||+.|+++.
T Consensus 392 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 392 FPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred CCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 00000 00001 1122367889999999999999999999863
|
|
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=307.69 Aligned_cols=254 Identities=29% Similarity=0.505 Sum_probs=200.1
Q ss_pred cCCCCceeeccccceEEEEEEeC-CC---CEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCce
Q 044366 646 GNFGEKYCIGKGGQRSVYKAELP-SG---NIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHS 721 (918)
Q Consensus 646 ~~~~~~~~lg~G~~g~Vy~~~~~-~~---~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 721 (918)
.+|...+.||+|+||.||+|... ++ ..||||.++... ......+|..|+..++.++||||+++++++.+++..
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 80 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY---TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPV 80 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC---CHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCce
Confidence 35778889999999999999654 33 369999986531 222346899999999999999999999999999999
Q ss_pred EEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccc
Q 044366 722 FIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKF 801 (918)
Q Consensus 722 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~ 801 (918)
++||||+++|+|.++++... ..+++.+++.++.|++.|++|||+. +++||||||+||+++.++.++++|||++..
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~kl~dfg~~~~ 155 (269)
T cd05065 81 MIITEFMENGALDSFLRQND--GQFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRF 155 (269)
T ss_pred EEEEecCCCCcHHHHHhhCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcEEECCCccccc
Confidence 99999999999999997642 3589999999999999999999999 999999999999999999999999999976
Q ss_pred cCCCCCCc--e-ecc--cccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhhhhhhhhhHhhhhhhccc
Q 044366 802 LEPHSSNW--T-EFA--GTVGYAAPELAYTMRATEKYDVYSFGVLALEVIK-GYHPGDFVSTIFSSISNMIIEVNQILDH 875 (918)
Q Consensus 802 ~~~~~~~~--~-~~~--g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 875 (918)
........ . ... .+..|+|||++.+..++.++||||||+++|||++ |..||...... ........ ..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~-----~~~~~i~~--~~ 228 (269)
T cd05065 156 LEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ-----DVINAIEQ--DY 228 (269)
T ss_pred cccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHH-----HHHHHHHc--CC
Confidence 64332211 1 111 2457999999998899999999999999999886 99997643321 11111111 11
Q ss_pred CCCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhC
Q 044366 876 RLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLLCK 918 (918)
Q Consensus 876 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~ 918 (918)
..+.+ . +....+.+++.+||+.+|.+||++.+++..|++
T Consensus 229 ~~~~~-~---~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 267 (269)
T cd05065 229 RLPPP-M---DCPTALHQLMLDCWQKDRNARPKFGQIVSTLDK 267 (269)
T ss_pred cCCCc-c---cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence 11111 1 223457889999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=310.75 Aligned_cols=260 Identities=20% Similarity=0.329 Sum_probs=197.5
Q ss_pred cCCCCceeeccccceEEEEEEeC-CCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEEE
Q 044366 646 GNFGEKYCIGKGGQRSVYKAELP-SGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFIV 724 (918)
Q Consensus 646 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 724 (918)
++|...+.||+|++|.||+|... +++.||+|.+..... ......+.+|+++++.++||||+++++++.+++..++|
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 81 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHE---EGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLV 81 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccc---cCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEE
Confidence 57888899999999999999654 789999999875321 12234577899999999999999999999999999999
Q ss_pred EEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccCC
Q 044366 725 CEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEP 804 (918)
Q Consensus 725 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~~ 804 (918)
|||+++ +|.+++.... ..+++..++.++.|++.||.|||+. +++||||||+||+++.++.+||+|||+++....
T Consensus 82 ~e~~~~-~L~~~~~~~~--~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~ 155 (291)
T cd07844 82 FEYLDT-DLKQYMDDCG--GGLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLARAKSV 155 (291)
T ss_pred EecCCC-CHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEEECccccccccCC
Confidence 999985 9999887543 3578999999999999999999999 999999999999999999999999999876543
Q ss_pred CCCCceeccccccccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhh------------
Q 044366 805 HSSNWTEFAGTVGYAAPELAYT-MRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQ------------ 871 (918)
Q Consensus 805 ~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~------------ 871 (918)
.........++..|+|||+..+ ..++.++||||+|+++|+|++|+.||...................
T Consensus 156 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (291)
T cd07844 156 PSKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSN 235 (291)
T ss_pred CCccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhc
Confidence 2222233356889999998875 457889999999999999999999986443211111111000000
Q ss_pred --hcccCCCCCC-cch------HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 872 --ILDHRLPTPS-RDV------TDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 872 --~~~~~~~~~~-~~~------~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
......+... ... ......+.+++.+|++.+|++|||+.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 236 PEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred cccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 0000000000 000 001156778999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=321.04 Aligned_cols=258 Identities=22% Similarity=0.274 Sum_probs=196.9
Q ss_pred HhcCCCCceeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccC----
Q 044366 644 ATGNFGEKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNA---- 718 (918)
Q Consensus 644 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~---- 718 (918)
..++|...+.||+|+||.||+|.. ..++.||||++..... .......+.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~ 99 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQ--NQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLE 99 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCcccc--CchhHHHHHHHHHHHHhcCCCCccccceeeccccccc
Confidence 457899999999999999999954 5789999999875321 223346788999999999999999999987543
Q ss_pred --CceEEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEecc
Q 044366 719 --QHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDF 796 (918)
Q Consensus 719 --~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Df 796 (918)
...++||||+++ ++.+++.. .+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+||
T Consensus 100 ~~~~~~lv~e~~~~-~l~~~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Df 170 (364)
T cd07875 100 EFQDVYIVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDF 170 (364)
T ss_pred ccCeEEEEEeCCCC-CHHHHHHh-----cCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCCcEEEEeC
Confidence 357999999975 77777753 278899999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCCCceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHh---------
Q 044366 797 GFAKFLEPHSSNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMII--------- 867 (918)
Q Consensus 797 G~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~--------- 867 (918)
|+++...... ......++..|+|||++.+..++.++|||||||++|||++|+.||....... .+.....
T Consensus 171 G~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~ 248 (364)
T cd07875 171 GLARTAGTSF-MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHID-QWNKVIEQLGTPCPEF 248 (364)
T ss_pred CCccccCCCC-cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHhcCCCCHHH
Confidence 9998654322 2234568999999999999999999999999999999999999986543211 1110000
Q ss_pred ------hhhhhcccCCC----------------CCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 868 ------EVNQILDHRLP----------------TPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 868 ------~~~~~~~~~~~----------------~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
........+.. ............+.+++.+|++.||.+|||+.|+++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~ 317 (364)
T cd07875 249 MKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ 317 (364)
T ss_pred HHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 00000000000 000000011246789999999999999999999986
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-35 Score=311.39 Aligned_cols=247 Identities=27% Similarity=0.399 Sum_probs=199.1
Q ss_pred CCCCceeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEEEE
Q 044366 647 NFGEKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFIVC 725 (918)
Q Consensus 647 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 725 (918)
.|...+.||+|+||.||+|.. .+++.||+|.+.... .....+.+.+|+++++.++||||+++++++..+...++||
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEE---AEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIM 81 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEecccc---chHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEE
Confidence 355567799999999999954 568899999876431 1223467899999999999999999999999999999999
Q ss_pred EeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccCCC
Q 044366 726 EYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPH 805 (918)
Q Consensus 726 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~~~ 805 (918)
||+++++|.+++.. ..+++..++.++.|+++|++|||+. +++|+||+|+||++++++.++++|||++......
T Consensus 82 e~~~~~~L~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06642 82 EYLGGGSALDLLKP----GPLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDT 154 (277)
T ss_pred EccCCCcHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEccccccccccCc
Confidence 99999999999864 3478999999999999999999999 9999999999999999999999999999876544
Q ss_pred CCCceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCCCCCcchH
Q 044366 806 SSNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRDVT 885 (918)
Q Consensus 806 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 885 (918)
........++..|+|||++.+..++.++||||||+++|||++|+.|+....... .. ........+... .
T Consensus 155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~-----~~---~~~~~~~~~~~~---~ 223 (277)
T cd06642 155 QIKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMR-----VL---FLIPKNSPPTLE---G 223 (277)
T ss_pred chhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhh-----HH---hhhhcCCCCCCC---c
Confidence 333334467889999999998889999999999999999999999975432110 00 001111111111 1
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 886 DKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 886 ~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
.....+.+++.+||+.+|++||++.++++
T Consensus 224 ~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 252 (277)
T cd06642 224 QYSKPFKEFVEACLNKDPRFRPTAKELLK 252 (277)
T ss_pred ccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 23356889999999999999999999987
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=312.96 Aligned_cols=245 Identities=24% Similarity=0.384 Sum_probs=197.5
Q ss_pred CceeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEEEEEec
Q 044366 650 EKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFIVCEYL 728 (918)
Q Consensus 650 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 728 (918)
....||+|+||.||+|.. .+++.||+|.+... .....+.+.+|+..++.++||||+++++++..++..++|+||+
T Consensus 25 ~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~----~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~ 100 (297)
T cd06659 25 NYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLR----KQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFL 100 (297)
T ss_pred hhhhcCCCCceeEEEEEEcCCCCEEEEEEEEec----ccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecC
Confidence 344699999999999955 47899999998542 2223567889999999999999999999999999999999999
Q ss_pred cCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccCCCCCC
Q 044366 729 ARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSN 808 (918)
Q Consensus 729 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~~~~~~ 808 (918)
++++|.+++.. ..+++.+++.++.|++.|++|||+. +++||||+|+||+++.++.++|+|||++.........
T Consensus 101 ~~~~L~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~ 173 (297)
T cd06659 101 QGGALTDIVSQ----TRLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK 173 (297)
T ss_pred CCCCHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeechhHhhccccccc
Confidence 99999998754 2479999999999999999999999 9999999999999999999999999999766544333
Q ss_pred ceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCCCCCcchHHHH
Q 044366 809 WTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRDVTDKL 888 (918)
Q Consensus 809 ~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 888 (918)
.....|+..|+|||++.+..++.++||||||+++|||++|+.||....... .. .... ..............
T Consensus 174 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~-~~----~~~~----~~~~~~~~~~~~~~ 244 (297)
T cd06659 174 RKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQ-AM----KRLR----DSPPPKLKNAHKIS 244 (297)
T ss_pred ccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HH----HHHh----ccCCCCccccCCCC
Confidence 345678999999999998889999999999999999999999976433211 11 1111 11111111111223
Q ss_pred HHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 889 RSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 889 ~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
..+.+++.+|++.+|++||+++++++
T Consensus 245 ~~l~~~i~~~l~~~P~~Rps~~~ll~ 270 (297)
T cd06659 245 PVLRDFLERMLTREPQERATAQELLD 270 (297)
T ss_pred HHHHHHHHHHhcCCcccCcCHHHHhh
Confidence 45788999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=316.88 Aligned_cols=256 Identities=21% Similarity=0.278 Sum_probs=194.4
Q ss_pred cCCCCceeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEEE
Q 044366 646 GNFGEKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFIV 724 (918)
Q Consensus 646 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 724 (918)
++|.+.+.||+|+||.||+|+. .+++.||+|++...... .....+.+.+|+.+++.++|+||+++++++.+++..++|
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv 79 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEML-KRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLV 79 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHh-hhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEE
Confidence 4688899999999999999965 46899999998653211 222356688999999999999999999999999999999
Q ss_pred EEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccCC
Q 044366 725 CEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEP 804 (918)
Q Consensus 725 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~~ 804 (918)
|||+++|+|.+++... ...+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||++.....
T Consensus 80 ~e~~~g~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 154 (331)
T cd05597 80 MDYYVGGDLLTLLSKF--EDRLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLA 154 (331)
T ss_pred EecCCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEEEEECCceeecCC
Confidence 9999999999999753 23488999999999999999999999 999999999999999999999999999976654
Q ss_pred CCCC-ceeccccccccccccccc-----CCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCC
Q 044366 805 HSSN-WTEFAGTVGYAAPELAYT-----MRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLP 878 (918)
Q Consensus 805 ~~~~-~~~~~g~~~y~aPE~~~~-----~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 878 (918)
.... .....||+.|+|||++.. ..++.++||||+||++|||++|+.||...... ...... .........+
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~-~~~~~i---~~~~~~~~~~ 230 (331)
T cd05597 155 DGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV-ETYGKI---MNHKEHFQFP 230 (331)
T ss_pred CCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHH-HHHHHH---HcCCCcccCC
Confidence 3322 223468999999999863 45788999999999999999999998643221 000000 0000001111
Q ss_pred CCCcchHHHHHHHHHHHHHcccC--CCCCCCCHHHHHH
Q 044366 879 TPSRDVTDKLRSIMEVAILCLVE--NPEARPTMKEVCN 914 (918)
Q Consensus 879 ~~~~~~~~~~~~l~~li~~cl~~--dp~~RPt~~evl~ 914 (918)
..... ....+.+++.+|+.. ++..||++.++++
T Consensus 231 ~~~~~---~~~~~~~li~~ll~~~~~r~~r~~~~~~l~ 265 (331)
T cd05597 231 PDVTD---VSEEAKDLIRRLICSPETRLGRNGLQDFKD 265 (331)
T ss_pred CccCC---CCHHHHHHHHHHccCcccccCCCCHHHHhc
Confidence 11111 234566677776654 3344889998875
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=308.14 Aligned_cols=261 Identities=25% Similarity=0.308 Sum_probs=200.7
Q ss_pred cCCCCceeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEeccccc--CCceE
Q 044366 646 GNFGEKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSN--AQHSF 722 (918)
Q Consensus 646 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~ 722 (918)
++|...+.||.|++|.||+|.. .+++.||+|.+.... ......++.+|+++++.++||||+++++++.+ .+..+
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 77 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDP---NPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIG 77 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCC---chHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEE
Confidence 3678889999999999999965 468999999986531 22335779999999999999999999998854 34689
Q ss_pred EEEEeccCCChhHHhhccc-ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccc
Q 044366 723 IVCEYLARGSLTTILRDDA-AAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKF 801 (918)
Q Consensus 723 lv~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~ 801 (918)
+||||+++++|.+++.... ....+++..+..++.|+++||+|||+. +++|+||+|+||+++.++.++|+|||++..
T Consensus 78 lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~ 154 (287)
T cd06621 78 IAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGE 154 (287)
T ss_pred EEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEEEeecccccc
Confidence 9999999999999876432 234578999999999999999999999 999999999999999999999999999876
Q ss_pred cCCCCCCceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCCCCC
Q 044366 802 LEPHSSNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPS 881 (918)
Q Consensus 802 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 881 (918)
...... ....++..|+|||.+.+..++.++||||+|+++|+|++|+.|++........................+...
T Consensus 155 ~~~~~~--~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (287)
T cd06621 155 LVNSLA--GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEP 232 (287)
T ss_pred cccccc--ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhccCC
Confidence 543221 234568899999999988899999999999999999999999875522100111111111110011111111
Q ss_pred cchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 882 RDVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 882 ~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
.........+.+++.+||+.+|.+|||+.|+++
T Consensus 233 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 233 GNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred CCCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 111123456889999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=309.32 Aligned_cols=250 Identities=26% Similarity=0.427 Sum_probs=203.2
Q ss_pred cCCCCceeeccccceEEEEEE-eCCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEEE
Q 044366 646 GNFGEKYCIGKGGQRSVYKAE-LPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFIV 724 (918)
Q Consensus 646 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 724 (918)
++|...+.||+|+||.||+|. ..+++.||+|.+... .....+.+.+|+.+++.++||||+++++++..++..++|
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~----~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv 94 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQ----QQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVV 94 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccc----cchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEE
Confidence 688899999999999999995 457889999997542 223356789999999999999999999999999999999
Q ss_pred EEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccCC
Q 044366 725 CEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEP 804 (918)
Q Consensus 725 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~~ 804 (918)
+||+++++|.+++.+. .+++.++..++.|++.|++|||+. +++||||+|+||+++.++.++|+|||++....+
T Consensus 95 ~e~~~~~~L~~~~~~~----~l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~ 167 (293)
T cd06647 95 MEYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP 167 (293)
T ss_pred EecCCCCcHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEEccCcceecccc
Confidence 9999999999999753 378999999999999999999999 999999999999999999999999999887665
Q ss_pred CCCCceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCCCCCcch
Q 044366 805 HSSNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRDV 884 (918)
Q Consensus 805 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 884 (918)
.........+++.|+|||++.+..++.++||||||+++|++++|+.||........ . ........+.. ...
T Consensus 168 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~-~-------~~~~~~~~~~~-~~~ 238 (293)
T cd06647 168 EQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA-L-------YLIATNGTPEL-QNP 238 (293)
T ss_pred cccccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhh-e-------eehhcCCCCCC-CCc
Confidence 54444445688899999999888899999999999999999999999864432110 0 00000001110 111
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 044366 885 TDKLRSIMEVAILCLVENPEARPTMKEVCNL 915 (918)
Q Consensus 885 ~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 915 (918)
......+.+++.+||..+|.+||++++++..
T Consensus 239 ~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 239 EKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred cccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1223467889999999999999999999863
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=308.84 Aligned_cols=255 Identities=26% Similarity=0.393 Sum_probs=202.3
Q ss_pred HHhcCCCCceeeccccceEEEEEEeC-CCCEEEEEEcccccccCCCCChHHHHHHHHHHhhc-cCCceeeEecccccCC-
Q 044366 643 KATGNFGEKYCIGKGGQRSVYKAELP-SGNIFAVKKFKAELFSDETANPSEFLNEVLALTEI-RHRNIIKFHGFCSNAQ- 719 (918)
Q Consensus 643 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~- 719 (918)
.++++|+..+.||+|++|.||+|... +++.||+|++... ....+.|.+|+++++++ +|+||+++++++.+..
T Consensus 3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~-----~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~ 77 (275)
T cd06608 3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDII-----EDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNP 77 (275)
T ss_pred CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecC-----chhHHHHHHHHHHHHHhcCCCChheEEEEEEecCC
Confidence 45689999999999999999999654 6889999987653 12356799999999999 6999999999986544
Q ss_pred -----ceEEEEEeccCCChhHHhhccc-ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEE
Q 044366 720 -----HSFIVCEYLARGSLTTILRDDA-AAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHV 793 (918)
Q Consensus 720 -----~~~lv~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl 793 (918)
..++||||+++++|.+++.... ....+++..++.++.|++.|++|||+. +++|+||+|+||++++++.++|
T Consensus 78 ~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~~~~~~l 154 (275)
T cd06608 78 PGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKL 154 (275)
T ss_pred CCcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEccCCeEEE
Confidence 4899999999999999987532 235689999999999999999999999 9999999999999999999999
Q ss_pred eccccccccCCCCCCceeccccccccccccccc-----CCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhh
Q 044366 794 SDFGFAKFLEPHSSNWTEFAGTVGYAAPELAYT-----MRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIE 868 (918)
Q Consensus 794 ~DfG~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-----~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~ 868 (918)
+|||.+..............++..|+|||++.. ..++.++||||||+++|+|++|+.||...... ..
T Consensus 155 ~d~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-~~------- 226 (275)
T cd06608 155 VDFGVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPM-RA------- 226 (275)
T ss_pred CCCccceecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchH-HH-------
Confidence 999999876554444445668899999998753 34678999999999999999999998643221 00
Q ss_pred hhhhcccCCCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 869 VNQILDHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 869 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
...+..... ............+.+++.+||..||++|||+.|+++
T Consensus 227 ~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 227 LFKIPRNPP-PTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred HHHhhccCC-CCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 011111111 111111223457889999999999999999999985
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=307.06 Aligned_cols=239 Identities=21% Similarity=0.345 Sum_probs=185.8
Q ss_pred eeccccceEEEEEEeCC-------------------------CCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCc
Q 044366 653 CIGKGGQRSVYKAELPS-------------------------GNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRN 707 (918)
Q Consensus 653 ~lg~G~~g~Vy~~~~~~-------------------------~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~n 707 (918)
.||+|+||.||+|.+.. ...||+|++.... .....+|.+|+++++.++|||
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~----~~~~~~~~~~~~~~~~l~h~n 77 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH----RDIALAFFETASLMSQVSHIH 77 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH----HHHHHHHHHHHHHHhcCCCCC
Confidence 58999999999995421 1358888875431 122457889999999999999
Q ss_pred eeeEecccccCCceEEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCC
Q 044366 708 IIKFHGFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDS 787 (918)
Q Consensus 708 iv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~ 787 (918)
|+++++++.++...++||||+++|+|..+++.. ...+++..++.++.|+++||+|||+. +|+||||||+||+++.
T Consensus 78 iv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~Nill~~ 152 (274)
T cd05076 78 LAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKE--KGRVPVAWKITVAQQLASALSYLEDK---NLVHGNVCAKNILLAR 152 (274)
T ss_pred eeeEEEEEEeCCceEEEEecCCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHcC---CccCCCCCcccEEEec
Confidence 999999999999999999999999999998753 23578999999999999999999999 9999999999999976
Q ss_pred CC-------cEEEeccccccccCCCCCCceeccccccccccccccc-CCCCcccchhhHHHHHHHHH-hCCCCCCcchhh
Q 044366 788 EY-------EAHVSDFGFAKFLEPHSSNWTEFAGTVGYAAPELAYT-MRATEKYDVYSFGVLALEVI-KGYHPGDFVSTI 858 (918)
Q Consensus 788 ~~-------~~kl~DfG~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~vl~el~-tg~~p~~~~~~~ 858 (918)
.+ .++++|||.+...... ....++..|+|||.+.+ ..++.++||||||+++|||+ +|+.|+......
T Consensus 153 ~~~~~~~~~~~kl~d~g~~~~~~~~----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~ 228 (274)
T cd05076 153 LGLAEGTSPFIKLSDPGVSFTALSR----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPS 228 (274)
T ss_pred cCcccCccceeeecCCccccccccc----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChH
Confidence 43 3799999988654322 22356788999998865 56789999999999999995 688887643221
Q ss_pred hhhhhhhHhhhhhhcccCCCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 044366 859 FSSISNMIIEVNQILDHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLLC 917 (918)
Q Consensus 859 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 917 (918)
. ... ........+.. ....+.+++.+||+.+|++|||+.++++.|+
T Consensus 229 ~--~~~-------~~~~~~~~~~~----~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 229 E--KER-------FYEKKHRLPEP----SCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred H--HHH-------HHHhccCCCCC----CChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 1 000 11111111111 1235788999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=308.67 Aligned_cols=260 Identities=22% Similarity=0.318 Sum_probs=198.8
Q ss_pred CCCCceeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEEEE
Q 044366 647 NFGEKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFIVC 725 (918)
Q Consensus 647 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 725 (918)
+|+..+.||+|++|.||+|.. .+|+.||||+++.... .....+.+.+|++++++++||||+++++++.+++..++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE--TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVF 78 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEcccccc--ccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEe
Confidence 478889999999999999965 4789999999865422 2223467899999999999999999999999999999999
Q ss_pred EeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccCCC
Q 044366 726 EYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPH 805 (918)
Q Consensus 726 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~~~ 805 (918)
||+. ++|.+++.... ...+++..++.++.|++.|++|||+. +++||||+|+||+++.++.+|++|||++......
T Consensus 79 e~~~-~~l~~~~~~~~-~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~ 153 (284)
T cd07860 79 EFLH-QDLKKFMDASP-LSGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP 153 (284)
T ss_pred eccc-cCHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEeeccchhhcccC
Confidence 9996 58999887543 34589999999999999999999999 9999999999999999999999999999876544
Q ss_pred CCCceecccccccccccccccCC-CCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhh-----------hhc
Q 044366 806 SSNWTEFAGTVGYAAPELAYTMR-ATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVN-----------QIL 873 (918)
Q Consensus 806 ~~~~~~~~g~~~y~aPE~~~~~~-~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~-----------~~~ 873 (918)
........++..|+|||+..+.. ++.++||||||+++|||+||+.||........ ......... ...
T Consensus 154 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 232 (284)
T cd07860 154 VRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQ-LFRIFRTLGTPDEVVWPGVTSLP 232 (284)
T ss_pred ccccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHH-HHHHHHHhCCCChhhhhhhhHHH
Confidence 33334445688999999887654 58899999999999999999999864432111 110000000 000
Q ss_pred --ccCCCCCC-cc----hHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 874 --DHRLPTPS-RD----VTDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 874 --~~~~~~~~-~~----~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
....+... .. .......+.+++.+|++.||++|||++++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 233 DYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred HHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 00000000 00 0111245778999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=316.18 Aligned_cols=256 Identities=21% Similarity=0.271 Sum_probs=195.2
Q ss_pred cCCCCceeeccccceEEEEEEeC-CCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEEE
Q 044366 646 GNFGEKYCIGKGGQRSVYKAELP-SGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFIV 724 (918)
Q Consensus 646 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 724 (918)
++|...+.||+|+||.||+++.. +++.||+|++...... .......+.+|+.++..++|++|+++++++.+++..++|
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv 79 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEML-KRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLV 79 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHH-HhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEE
Confidence 36888999999999999999654 5789999998653221 122245688899999999999999999999999999999
Q ss_pred EEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccCC
Q 044366 725 CEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEP 804 (918)
Q Consensus 725 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~~ 804 (918)
|||+++|+|.+++++.. ..+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||++.....
T Consensus 80 ~ey~~~g~L~~~l~~~~--~~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~ 154 (332)
T cd05623 80 MDYYVGGDLLTLLSKFE--DRLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLME 154 (332)
T ss_pred EeccCCCcHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEeecchheeccc
Confidence 99999999999997632 3489999999999999999999999 999999999999999999999999999976543
Q ss_pred CCCC-ceecccccccccccccc-----cCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCC
Q 044366 805 HSSN-WTEFAGTVGYAAPELAY-----TMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLP 878 (918)
Q Consensus 805 ~~~~-~~~~~g~~~y~aPE~~~-----~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 878 (918)
.... .....||+.|+|||++. ...++.++|||||||++|||++|+.||...... ....... ........+
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~-~~~~~i~---~~~~~~~~p 230 (332)
T cd05623 155 DGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLV-ETYGKIM---NHKERFQFP 230 (332)
T ss_pred CCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHH-HHHHHHh---CCCccccCC
Confidence 3322 22356899999999986 345788999999999999999999998644321 1111100 000001111
Q ss_pred CCCcchHHHHHHHHHHHHHcccCCCCC--CCCHHHHHH
Q 044366 879 TPSRDVTDKLRSIMEVAILCLVENPEA--RPTMKEVCN 914 (918)
Q Consensus 879 ~~~~~~~~~~~~l~~li~~cl~~dp~~--RPt~~evl~ 914 (918)
.. .......+.+++.+|+..++.+ |++++|+++
T Consensus 231 ~~---~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~ 265 (332)
T cd05623 231 AQ---VTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQ 265 (332)
T ss_pred Cc---cccCCHHHHHHHHHHccChhhhcCCCCHHHHhC
Confidence 11 1122345677788877554444 789998875
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=307.90 Aligned_cols=254 Identities=26% Similarity=0.380 Sum_probs=203.7
Q ss_pred cCCCCceeeccccceEEEEEEeC-CCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEEE
Q 044366 646 GNFGEKYCIGKGGQRSVYKAELP-SGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFIV 724 (918)
Q Consensus 646 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 724 (918)
++|+..+.||+|++|.||+|... +++.||+|.+.... .....+++.+|++.++.++||||+++++++..++..++|
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv 77 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEI---NEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISIC 77 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEeccc---ChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEE
Confidence 35777889999999999999654 68999999986642 123456789999999999999999999999999999999
Q ss_pred EEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccC
Q 044366 725 CEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHH-DCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLE 803 (918)
Q Consensus 725 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~ 803 (918)
+||+++++|.+++.... ..+++..+..++.|++.|++|+|+ . +++|+||+|+||++++++.++|+|||.+....
T Consensus 78 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~ 152 (265)
T cd06605 78 MEYMDGGSLDKILKEVQ--GRIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLV 152 (265)
T ss_pred EEecCCCcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCCCCEEEeecccchhhH
Confidence 99999999999997653 458899999999999999999999 7 99999999999999999999999999987664
Q ss_pred CCCCCceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCCCCCcc
Q 044366 804 PHSSNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRD 883 (918)
Q Consensus 804 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 883 (918)
..... ...++..|+|||.+.+..++.++||||||+++|+|++|+.|+............ ..........+.....
T Consensus 153 ~~~~~--~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~ 227 (265)
T cd06605 153 NSLAK--TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFE---LLQYIVNEPPPRLPSG 227 (265)
T ss_pred HHHhh--cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHH---HHHHHhcCCCCCCChh
Confidence 32221 256788999999999889999999999999999999999998654321111111 1112222222111111
Q ss_pred hHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 884 VTDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 884 ~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
.....+.++|.+||..||++|||+.|+++
T Consensus 228 --~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 256 (265)
T cd06605 228 --KFSPDFQDFVNLCLIKDPRERPSYKELLE 256 (265)
T ss_pred --hcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence 13456889999999999999999999975
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=315.64 Aligned_cols=192 Identities=22% Similarity=0.343 Sum_probs=165.0
Q ss_pred HHhcCCCCceeeccccceEEEEEEeC-CCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCce
Q 044366 643 KATGNFGEKYCIGKGGQRSVYKAELP-SGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHS 721 (918)
Q Consensus 643 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 721 (918)
....+|.+.+.||+|+||.||+|... +++.||+|.... .....|+.++++++||||+++++++..++..
T Consensus 63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~----------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 132 (357)
T PHA03209 63 VASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQK----------GTTLIEAMLLQNVNHPSVIRMKDTLVSGAIT 132 (357)
T ss_pred hhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCc----------cccHHHHHHHHhCCCCCCcChhheEEeCCee
Confidence 44568999999999999999999654 678999997432 1235789999999999999999999999999
Q ss_pred EEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccc
Q 044366 722 FIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKF 801 (918)
Q Consensus 722 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~ 801 (918)
++|+||+. ++|.+++... ...+++.+++.|+.||+.||+|||+. +||||||||+||+++.++.+||+|||.++.
T Consensus 133 ~lv~e~~~-~~l~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~ 206 (357)
T PHA03209 133 CMVLPHYS-SDLYTYLTKR--SRPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQF 206 (357)
T ss_pred EEEEEccC-CcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEecCccccc
Confidence 99999995 5888888653 34589999999999999999999999 999999999999999999999999999975
Q ss_pred cCCCCCCceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCC
Q 044366 802 LEPHSSNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHP 851 (918)
Q Consensus 802 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p 851 (918)
.... .......||..|+|||++.+..++.++|||||||++|||+++..|
T Consensus 207 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~ 255 (357)
T PHA03209 207 PVVA-PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPST 255 (357)
T ss_pred cccC-cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCc
Confidence 4322 222345689999999999999999999999999999999986554
|
|
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=308.57 Aligned_cols=262 Identities=19% Similarity=0.288 Sum_probs=198.6
Q ss_pred HhcCCCCceeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceE
Q 044366 644 ATGNFGEKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSF 722 (918)
Q Consensus 644 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 722 (918)
++++|...+.||+|+||.||+|.. .+|+.||+|++.... .......+.+|+++++.++|+||+++++++..++..+
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 79 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKT---EEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLT 79 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccC---cCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEE
Confidence 357889999999999999999954 578999999986532 1222346789999999999999999999999999999
Q ss_pred EEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEecccccccc
Q 044366 723 IVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFL 802 (918)
Q Consensus 723 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~ 802 (918)
+||||++ +++.+++.... ..+++.++..++.|++.||+|||+. +++|+||||+||+++.++.++|+|||+++..
T Consensus 80 lv~e~~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~ 153 (291)
T cd07870 80 FVFEYMH-TDLAQYMIQHP--GGLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAK 153 (291)
T ss_pred EEEeccc-CCHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEEEecccccccc
Confidence 9999996 67877765432 3478888999999999999999999 9999999999999999999999999999765
Q ss_pred CCCCCCceecccccccccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhh-----------h-
Q 044366 803 EPHSSNWTEFAGTVGYAAPELAYTM-RATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIE-----------V- 869 (918)
Q Consensus 803 ~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~-----------~- 869 (918)
...........++..|+|||++.+. .++.++||||||+++|||++|+.||+............... .
T Consensus 154 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (291)
T cd07870 154 SIPSQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVS 233 (291)
T ss_pred CCCCCCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhh
Confidence 4433333444578899999998754 47889999999999999999999987554322221111000 0
Q ss_pred --hhhcccCCCCC-Ccch------HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 870 --NQILDHRLPTP-SRDV------TDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 870 --~~~~~~~~~~~-~~~~------~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
........+.. .... ......+.+++.+|++.||++|||+.|++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 234 KLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred hcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 00000000000 0000 011246778999999999999999999874
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=304.16 Aligned_cols=248 Identities=27% Similarity=0.413 Sum_probs=189.8
Q ss_pred eeeccccceEEEEEEeC----CCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccc-cCCceEEEEE
Q 044366 652 YCIGKGGQRSVYKAELP----SGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCS-NAQHSFIVCE 726 (918)
Q Consensus 652 ~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~-~~~~~~lv~e 726 (918)
+.||+|+||.||+|... ++..||+|++... ......+.+.+|+.+++.++||||+++++++. .++..++|+|
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~---~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e 77 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRI---TDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLP 77 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCcc---CCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEe
Confidence 35899999999999642 2457999987532 12223567889999999999999999999775 4556889999
Q ss_pred eccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccCCCC
Q 044366 727 YLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHS 806 (918)
Q Consensus 727 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~~~~ 806 (918)
|+.+|+|.++++... ...++..+..++.|++.|++|||+. +++||||||+||++++++.+||+|||+++.+....
T Consensus 78 ~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~ 152 (262)
T cd05058 78 YMKHGDLRNFIRSET--HNPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKE 152 (262)
T ss_pred cCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCccccccccCCc
Confidence 999999999997542 2367888899999999999999999 99999999999999999999999999998654322
Q ss_pred C----CceecccccccccccccccCCCCcccchhhHHHHHHHHHhC-CCCCCcchhhhhhhhhhHhhhhhhcccCCCCCC
Q 044366 807 S----NWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKG-YHPGDFVSTIFSSISNMIIEVNQILDHRLPTPS 881 (918)
Q Consensus 807 ~----~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 881 (918)
. ......++..|+|||...+..++.++||||||+++|||++| .+|+...... .. .........+...
T Consensus 153 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~-~~-------~~~~~~~~~~~~~ 224 (262)
T cd05058 153 YYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSF-DI-------TVYLLQGRRLLQP 224 (262)
T ss_pred ceeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHH-HH-------HHHHhcCCCCCCC
Confidence 1 11123456789999999888899999999999999999995 5555432211 10 1111111111111
Q ss_pred cchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhC
Q 044366 882 RDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLLCK 918 (918)
Q Consensus 882 ~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~ 918 (918)
... ...+.+++.+||+.+|++||++.|+++.|++
T Consensus 225 ~~~---~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~ 258 (262)
T cd05058 225 EYC---PDPLYEVMLSCWHPKPEMRPTFSELVSRIEQ 258 (262)
T ss_pred CcC---CHHHHHHHHHHcCCChhhCCCHHHHHHHHHH
Confidence 111 2467889999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=307.58 Aligned_cols=261 Identities=24% Similarity=0.417 Sum_probs=202.3
Q ss_pred cCCCCceeeccccceEEEEEEeC-----CCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEeccccc--C
Q 044366 646 GNFGEKYCIGKGGQRSVYKAELP-----SGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSN--A 718 (918)
Q Consensus 646 ~~~~~~~~lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~ 718 (918)
+.|...+.||+|+||.||+|.+. +++.||||.+...... ...+.|.+|++.++.++||||+++++++.. +
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~---~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~ 80 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE---QHRSDFEREIEILRTLDHENIVKYKGVCEKPGG 80 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch---HHHHHHHHHHHHHHhCCCCChheEEeeeecCCC
Confidence 45677789999999999999653 4689999998753211 235789999999999999999999999876 5
Q ss_pred CceEEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEecccc
Q 044366 719 QHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGF 798 (918)
Q Consensus 719 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~ 798 (918)
...++||||+++++|.+++.... ..+++.+++.++.|++.||+|||+. +++||||||+||+++.++.++++|||.
T Consensus 81 ~~~~lv~e~~~~~~l~~~l~~~~--~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~ 155 (284)
T cd05038 81 RSLRLIMEYLPSGSLRDYLQRHR--DQINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFGL 155 (284)
T ss_pred CceEEEEecCCCCCHHHHHHhCc--cccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEccccc
Confidence 67899999999999999997653 2489999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCCc---eecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhh------hhHhhh
Q 044366 799 AKFLEPHSSNW---TEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSIS------NMIIEV 869 (918)
Q Consensus 799 ~~~~~~~~~~~---~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~------~~~~~~ 869 (918)
+.......... ....++..|+|||...+..++.++||||||+++|||++|+.|+........... ......
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd05038 156 AKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRL 235 (284)
T ss_pred ccccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHH
Confidence 98776332211 122345679999999888899999999999999999999998654322110000 000111
Q ss_pred hhhccc--CCCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhC
Q 044366 870 NQILDH--RLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLLCK 918 (918)
Q Consensus 870 ~~~~~~--~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~ 918 (918)
.+.... +.+.+ . ....++.+++.+||+.+|++|||+.||+++|++
T Consensus 236 ~~~~~~~~~~~~~-~---~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~ 282 (284)
T cd05038 236 LELLKEGERLPRP-P---SCPDEVYDLMKLCWEAEPQDRPSFADLILIVDR 282 (284)
T ss_pred HHHHHcCCcCCCC-c---cCCHHHHHHHHHHhccChhhCCCHHHHHHHHhh
Confidence 111111 11111 1 122568899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=303.70 Aligned_cols=252 Identities=23% Similarity=0.327 Sum_probs=194.6
Q ss_pred cCCCCceeeccccceEEEEEEe-CCCCEEEEEEcccccccCC-CCChHHHHHHHHHHhhccCCceeeEeccccc--CCce
Q 044366 646 GNFGEKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDE-TANPSEFLNEVLALTEIRHRNIIKFHGFCSN--AQHS 721 (918)
Q Consensus 646 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~ 721 (918)
.+|...+.||+|+||.||+|.. .+++.||+|++........ ....+.+.+|+++++.++||||+++++++.+ +...
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 3688889999999999999954 5689999999865432211 1224568899999999999999999998764 3567
Q ss_pred EEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccc
Q 044366 722 FIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKF 801 (918)
Q Consensus 722 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~ 801 (918)
++++||+++++|.+++.... .+++..++.++.|++.||+|||+. +++||||+|+||+++.++.++|+|||++..
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~~~l~dfg~~~~ 155 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYG---ALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKR 155 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCCCccc
Confidence 89999999999999997643 478999999999999999999998 999999999999999999999999999986
Q ss_pred cCCCC---CCceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCC
Q 044366 802 LEPHS---SNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLP 878 (918)
Q Consensus 802 ~~~~~---~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 878 (918)
..... .......++..|+|||++.+..++.++||||+||++|||++|+.||....... .... .......+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~-~~~~------~~~~~~~~ 228 (266)
T cd06651 156 LQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMA-AIFK------IATQPTNP 228 (266)
T ss_pred cccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHH-HHHH------HhcCCCCC
Confidence 54321 11223457889999999998889999999999999999999999986442211 1100 00011111
Q ss_pred CCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 879 TPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 879 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
..+ ......+.+++ .||..+|++||+++||++
T Consensus 229 ~~~---~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 229 QLP---SHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred CCc---hhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 111 11223455555 688899999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=310.84 Aligned_cols=260 Identities=22% Similarity=0.369 Sum_probs=200.7
Q ss_pred cCCCCceeeccccceEEEEEEeC-CCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEEE
Q 044366 646 GNFGEKYCIGKGGQRSVYKAELP-SGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFIV 724 (918)
Q Consensus 646 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 724 (918)
++|+..+.||+|+||.||+|... +++.||+|++..... .....+.+.+|+++++.++||||+++++++.+++..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 78 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESED--DKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLV 78 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccC--cchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEE
Confidence 36788899999999999999764 689999999865322 122356788999999999999999999999999999999
Q ss_pred EEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccCC
Q 044366 725 CEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEP 804 (918)
Q Consensus 725 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~~ 804 (918)
|||++++++.++.... ..+++.+++.++.|+++|++|||+. +++|||++|+||++++++.++++|||++.....
T Consensus 79 ~e~~~~~~l~~~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~ 152 (286)
T cd07846 79 FEFVDHTVLDDLEKYP---NGLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAA 152 (286)
T ss_pred EecCCccHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEEEEeeeeeeeccC
Confidence 9999999998877643 2389999999999999999999999 999999999999999999999999999987655
Q ss_pred CCCCceeccccccccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhH-------hhhhhhcc--
Q 044366 805 HSSNWTEFAGTVGYAAPELAYT-MRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMI-------IEVNQILD-- 874 (918)
Q Consensus 805 ~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~-------~~~~~~~~-- 874 (918)
.........++..|+|||+..+ ..++.++||||||+++|||++|+.||....... ...... .......+
T Consensus 153 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 231 (286)
T cd07846 153 PGEVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDID-QLYHIIKCLGNLIPRHQEIFQKN 231 (286)
T ss_pred CccccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHH-HHHHHHHHhCCCchhhHHHhccc
Confidence 4444444567899999998875 446789999999999999999999876433211 000000 00000000
Q ss_pred ----c-CCCCCCc------chHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 875 ----H-RLPTPSR------DVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 875 ----~-~~~~~~~------~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
. ..+.... ........+.+++.+||+.+|++||++.++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 232 PLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred hHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 0 0000000 01122356889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=304.65 Aligned_cols=257 Identities=25% Similarity=0.389 Sum_probs=201.8
Q ss_pred cCCCCceeeccccceEEEEEEeC------CCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCC
Q 044366 646 GNFGEKYCIGKGGQRSVYKAELP------SGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQ 719 (918)
Q Consensus 646 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~ 719 (918)
.+|...+.||+|+||.||+|+.. +.+.||+|.+... ......+.|.+|++++++++||||+++++++.+.+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 81 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKT---KDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAE 81 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCc---cchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCC
Confidence 57888899999999999999753 3467999987542 11223567999999999999999999999999999
Q ss_pred ceEEEEEeccCCChhHHhhccccc------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEE
Q 044366 720 HSFIVCEYLARGSLTTILRDDAAA------KEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHV 793 (918)
Q Consensus 720 ~~~lv~e~~~~gsL~~~l~~~~~~------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl 793 (918)
..++||||+++|+|.+++...... ..+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.+++
T Consensus 82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l 158 (275)
T cd05046 82 PHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKV 158 (275)
T ss_pred cceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEeCCCcEEE
Confidence 999999999999999999765422 2589999999999999999999999 9999999999999999999999
Q ss_pred eccccccccCCCC-CCceecccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhhhhhhhhhHhhhhh
Q 044366 794 SDFGFAKFLEPHS-SNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIK-GYHPGDFVSTIFSSISNMIIEVNQ 871 (918)
Q Consensus 794 ~DfG~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~ 871 (918)
+|||++....... .......++..|+|||.+.+..++.++||||||+++|+|++ |..||...... ... ....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~--~~~---~~~~- 232 (275)
T cd05046 159 SLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDE--EVL---NRLQ- 232 (275)
T ss_pred cccccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchH--HHH---HHHH-
Confidence 9999987543222 12233456778999999988888999999999999999999 77887532211 000 0000
Q ss_pred hcccCCCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhC
Q 044366 872 ILDHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLLCK 918 (918)
Q Consensus 872 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~ 918 (918)
.....++.. . .....+.+++.+||+.+|.+||++.|+++.|++
T Consensus 233 ~~~~~~~~~-~---~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~~ 275 (275)
T cd05046 233 AGKLELPVP-E---GCPSRLYKLMTRCWAVNPKDRPSFSELVSALGE 275 (275)
T ss_pred cCCcCCCCC-C---CCCHHHHHHHHHHcCCCcccCCCHHHHHHHhcC
Confidence 000011111 1 122468889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=322.14 Aligned_cols=255 Identities=21% Similarity=0.232 Sum_probs=195.8
Q ss_pred HhcCCCCceeeccccceEEEEEEeC---CCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCc
Q 044366 644 ATGNFGEKYCIGKGGQRSVYKAELP---SGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQH 720 (918)
Q Consensus 644 ~~~~~~~~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 720 (918)
...+|.+.+.||+|+||.||+|... .++.||+|.+... +.+.+|+++++.++||||+++++++.....
T Consensus 90 ~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~---------~~~~~E~~il~~l~h~~iv~~~~~~~~~~~ 160 (392)
T PHA03207 90 VRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG---------KTPGREIDILKTISHRAIINLIHAYRWKST 160 (392)
T ss_pred ccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc---------ccHHHHHHHHHhcCCCCccceeeeEeeCCE
Confidence 3467999999999999999999542 4578999987532 235689999999999999999999999999
Q ss_pred eEEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEecccccc
Q 044366 721 SFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAK 800 (918)
Q Consensus 721 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~ 800 (918)
.++||||+. ++|.+++... ..+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.++|+|||+++
T Consensus 161 ~~lv~e~~~-~~l~~~l~~~---~~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~l~DfG~a~ 233 (392)
T PHA03207 161 VCMVMPKYK-CDLFTYVDRS---GPLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAAC 233 (392)
T ss_pred EEEEehhcC-CCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEccCcccc
Confidence 999999996 5888888433 4589999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCC--ceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhh--hhhhhhhHh---------
Q 044366 801 FLEPHSSN--WTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTI--FSSISNMII--------- 867 (918)
Q Consensus 801 ~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~--~~~~~~~~~--------- 867 (918)
........ .....||+.|+|||++.+..++.++|||||||++|||++|+.||...... ...+.....
T Consensus 234 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~ 313 (392)
T PHA03207 234 KLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEF 313 (392)
T ss_pred ccCcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCcccc
Confidence 66543221 23457899999999999989999999999999999999999997543211 000000000
Q ss_pred ----------hhhhhcc-cCCCCCCcc-h--HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 868 ----------EVNQILD-HRLPTPSRD-V--TDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 868 ----------~~~~~~~-~~~~~~~~~-~--~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
....... .+.+..... . .....++.+++.+|++.||++|||+.|++.
T Consensus 314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~ 374 (392)
T PHA03207 314 PQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILS 374 (392)
T ss_pred CCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhh
Confidence 0000000 000000000 0 012346778999999999999999999985
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=327.73 Aligned_cols=366 Identities=28% Similarity=0.410 Sum_probs=223.8
Q ss_pred EEccCCccc-ccCccccCCCCCCCEEECcCCcCCCcCCcCCCCCCCCceeeccccccccCCCcccccccccCeeeccccc
Q 044366 98 LYLNDNSLF-GSIPIVMGNLKSLSTLDLSQNQLNGSIPCSLDNLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSENR 176 (918)
Q Consensus 98 L~L~~n~i~-~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~ 176 (918)
.|+++|.++ +-.|.....|++++.|.|...++. .+|+.++.+.+|++|.+++|++. .+-+.++.++.|+.+++..|.
T Consensus 12 vDfsgNDFsg~~FP~~v~qMt~~~WLkLnrt~L~-~vPeEL~~lqkLEHLs~~HN~L~-~vhGELs~Lp~LRsv~~R~N~ 89 (1255)
T KOG0444|consen 12 VDFSGNDFSGDRFPHDVEQMTQMTWLKLNRTKLE-QVPEELSRLQKLEHLSMAHNQLI-SVHGELSDLPRLRSVIVRDNN 89 (1255)
T ss_pred ccccCCcCCCCcCchhHHHhhheeEEEechhhhh-hChHHHHHHhhhhhhhhhhhhhH-hhhhhhccchhhHHHhhhccc
Confidence 344444443 233444444444444444444443 34444444444444444444444 223344444444444444444
Q ss_pred cCC-cCCccCCCCCCCcEeeccCcccccCCCccccCCCCcceeecccccccCCCCCCCcCCCcCCeEEcccCcCcCCCCc
Q 044366 177 LSG-LIPLSLSNLSSLTVMSLFNNSLSGSIPPILGNLKSLSTLGLHINQLNGVIPPSIGNLSSLRNLSLFNNRLYGFVPK 255 (918)
Q Consensus 177 l~~-~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~ 255 (918)
+.. -+|..+-.+..|+.||||+|+++ ..|..+..-+++-.|+|++|+|..++...|-++..|-.||||+|++. ..|.
T Consensus 90 LKnsGiP~diF~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~IetIPn~lfinLtDLLfLDLS~NrLe-~LPP 167 (1255)
T KOG0444|consen 90 LKNSGIPTDIFRLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIETIPNSLFINLTDLLFLDLSNNRLE-MLPP 167 (1255)
T ss_pred cccCCCCchhcccccceeeecchhhhh-hcchhhhhhcCcEEEEcccCccccCCchHHHhhHhHhhhccccchhh-hcCH
Confidence 431 12333344444455555555544 33444444445555555555554433333444445555555555554 2233
Q ss_pred cccccCCCCeEecCCCccCCcCCCcCCCCCCCcEEEccCCcCcCCCCccccCCCCCCeEEeecccccCccccccCCCCCc
Q 044366 256 EIGYLKSLSKLEFCANHLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLRNLTSLERVRFNQNNLYGKVYEAFGDHPNL 335 (918)
Q Consensus 256 ~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L 335 (918)
....+..|++|+|++|++....-..+.. +.+|
T Consensus 168 Q~RRL~~LqtL~Ls~NPL~hfQLrQLPs------------------------------------------------mtsL 199 (1255)
T KOG0444|consen 168 QIRRLSMLQTLKLSNNPLNHFQLRQLPS------------------------------------------------MTSL 199 (1255)
T ss_pred HHHHHhhhhhhhcCCChhhHHHHhcCcc------------------------------------------------chhh
Confidence 3444444444444444443221111222 2334
Q ss_pred cEEeCCCCccccccCcccccccccceeeccccccccCCCcCcCCCCCCcEEEccCceeccccccchhhccccCceecccc
Q 044366 336 TFLDLSQNNFYCEISFNWRNFSKLGTFNASMNNIYGSIPPEIGDSSKLQVLDLSSNHIFGKIPVQLVKLFSLNKLILSLN 415 (918)
Q Consensus 336 ~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~n~i~~~~~~~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N 415 (918)
++|.+++.+=+ ...+|..+.++.+|..+|||.|.+. ..|+.+.++.+|+.|+||+|
T Consensus 200 ~vLhms~TqRT-----------------------l~N~Ptsld~l~NL~dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N 255 (1255)
T KOG0444|consen 200 SVLHMSNTQRT-----------------------LDNIPTSLDDLHNLRDVDLSENNLP-IVPECLYKLRNLRRLNLSGN 255 (1255)
T ss_pred hhhhcccccch-----------------------hhcCCCchhhhhhhhhccccccCCC-cchHHHhhhhhhheeccCcC
Confidence 44444443221 1245666777778888888888886 77888888888888888888
Q ss_pred cccCCCCCCCCCCCcccEEeccCccccccCccccccccccceecccCcccCC-CCchhhccccccceEeccCCcCCCCCc
Q 044366 416 QLFGGVPLEFGTLTELQYLDLSANKLSSSIPMSIGNLLKLHYLNLSNNQFSH-KIPTEFEKLIHLSELDLSHNILQEEIP 494 (918)
Q Consensus 416 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-~~~~~~~~l~~L~~L~Ls~N~l~~~~~ 494 (918)
+|+. .....+...+|++|+||.|+++ .+|+++..+++|+.|++.+|+++- -+|..+++|.+|+.+..++|.+. ..|
T Consensus 256 ~ite-L~~~~~~W~~lEtLNlSrNQLt-~LP~avcKL~kL~kLy~n~NkL~FeGiPSGIGKL~~Levf~aanN~LE-lVP 332 (1255)
T KOG0444|consen 256 KITE-LNMTEGEWENLETLNLSRNQLT-VLPDAVCKLTKLTKLYANNNKLTFEGIPSGIGKLIQLEVFHAANNKLE-LVP 332 (1255)
T ss_pred ceee-eeccHHHHhhhhhhccccchhc-cchHHHhhhHHHHHHHhccCcccccCCccchhhhhhhHHHHhhccccc-cCc
Confidence 8864 3334455678999999999999 789999999999999999999753 26888999999999999999996 899
Q ss_pred hhccccCCcceEecCCCcccccCcccccCCCCccEEEccCCcCCCCCCC
Q 044366 495 PQICKMESLEKLNLSHNNLSDFIPRCFEEMRSLSWIDISYNELQGPIPN 543 (918)
Q Consensus 495 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~p~ 543 (918)
+.++.+..|+.|.|++|++-+ .|.++.-++.|++||+..|+=--..|.
T Consensus 333 EglcRC~kL~kL~L~~NrLiT-LPeaIHlL~~l~vLDlreNpnLVMPPK 380 (1255)
T KOG0444|consen 333 EGLCRCVKLQKLKLDHNRLIT-LPEAIHLLPDLKVLDLRENPNLVMPPK 380 (1255)
T ss_pred hhhhhhHHHHHhcccccceee-chhhhhhcCCcceeeccCCcCccCCCC
Confidence 999999999999999999976 788899999999999999975544443
|
|
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=309.77 Aligned_cols=262 Identities=23% Similarity=0.301 Sum_probs=200.5
Q ss_pred CCCCceeeccccceEEEEEEe-CCCCEEEEEEcccccccCC-CCChHHHHHHHHHHhhccCCceeeEecccccCCceEEE
Q 044366 647 NFGEKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDE-TANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFIV 724 (918)
Q Consensus 647 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 724 (918)
+|...+.||+|++|.||+|.. .+|+.||||.++....... ......+..|++.++.++|+||+++++++.+.+..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 477788999999999999965 4789999999876433211 12245678899999999999999999999999999999
Q ss_pred EEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccCC
Q 044366 725 CEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEP 804 (918)
Q Consensus 725 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~~ 804 (918)
|||+ +|+|.+++.... ..+++.+++.++.||++||+|||+. +++||||+|+||+++.++.++|+|||++.....
T Consensus 81 ~e~~-~~~L~~~i~~~~--~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~ 154 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS--IVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFGS 154 (298)
T ss_pred Eccc-CCCHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEEEccceeeeeccC
Confidence 9999 889999997643 3589999999999999999999999 999999999999999999999999999987765
Q ss_pred CCCCceeccccccccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhh-----------hh
Q 044366 805 HSSNWTEFAGTVGYAAPELAYT-MRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVN-----------QI 872 (918)
Q Consensus 805 ~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~-----------~~ 872 (918)
.........++..|+|||.+.+ ..++.++|||||||++|||++|.+||...... ........... ..
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 233 (298)
T cd07841 155 PNRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDI-DQLGKIFEALGTPTEENWPGVTSL 233 (298)
T ss_pred CCccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccH-HHHHHHHHHcCCCchhhhhhcccc
Confidence 4433344456788999998865 45788999999999999999998776543321 11111100000 00
Q ss_pred ccc---CC-CCC--CcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 044366 873 LDH---RL-PTP--SRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNL 915 (918)
Q Consensus 873 ~~~---~~-~~~--~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 915 (918)
... .. +.. ..........+.+++.+||+.||++|||+.|+++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 234 PDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred cccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 000 00 000 00011224578899999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-34 Score=311.30 Aligned_cols=193 Identities=20% Similarity=0.369 Sum_probs=158.8
Q ss_pred eeeccccceEEEEEEeC---CCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccc--cCCceEEEEE
Q 044366 652 YCIGKGGQRSVYKAELP---SGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCS--NAQHSFIVCE 726 (918)
Q Consensus 652 ~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~--~~~~~~lv~e 726 (918)
.+||+|+||.||+|+.. ++..||+|.+... .....+.+|+++++.++||||+++++++. .+...++|||
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e 80 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGT------GISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFD 80 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCC------CCcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEe
Confidence 57999999999999754 4578999987642 12346789999999999999999999874 4567899999
Q ss_pred eccCCChhHHhhcc------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeee----CCCCcEEEecc
Q 044366 727 YLARGSLTTILRDD------AAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLL----DSEYEAHVSDF 796 (918)
Q Consensus 727 ~~~~gsL~~~l~~~------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill----~~~~~~kl~Df 796 (918)
|+++ +|.+++... .....+++..++.++.|++.||+|||+. +|+||||||+||++ +.++.+||+||
T Consensus 81 ~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl~Df 156 (317)
T cd07867 81 YAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADM 156 (317)
T ss_pred eeCC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEEEeec
Confidence 9875 787777532 1223588999999999999999999999 99999999999999 45678999999
Q ss_pred ccccccCCCCC---CceecccccccccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCc
Q 044366 797 GFAKFLEPHSS---NWTEFAGTVGYAAPELAYTM-RATEKYDVYSFGVLALEVIKGYHPGDF 854 (918)
Q Consensus 797 G~~~~~~~~~~---~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~vl~el~tg~~p~~~ 854 (918)
|+++....... ......+|+.|+|||++.+. .++.++|||||||++|||+||+.||..
T Consensus 157 G~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~ 218 (317)
T cd07867 157 GFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 218 (317)
T ss_pred cceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccc
Confidence 99987654322 22345689999999998764 578999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-34 Score=303.22 Aligned_cols=247 Identities=27% Similarity=0.409 Sum_probs=191.1
Q ss_pred eeccccceEEEEEEeC-CCC--EEEEEEcccccccCCCCChHHHHHHHHHHhhc-cCCceeeEecccccCCceEEEEEec
Q 044366 653 CIGKGGQRSVYKAELP-SGN--IFAVKKFKAELFSDETANPSEFLNEVLALTEI-RHRNIIKFHGFCSNAQHSFIVCEYL 728 (918)
Q Consensus 653 ~lg~G~~g~Vy~~~~~-~~~--~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~ 728 (918)
.||+|+||.||+|... +|. .+|+|.++... .......+.+|+++++++ +||||+++++++...+..++||||+
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~ 78 (270)
T cd05047 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA---SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYA 78 (270)
T ss_pred cCCCCCCceEEEEEEcCCCCeeEEEEEEccccC---CHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeC
Confidence 5899999999999664 444 46888876421 122345788999999999 7999999999999999999999999
Q ss_pred cCCChhHHhhccc-------------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEec
Q 044366 729 ARGSLTTILRDDA-------------AAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSD 795 (918)
Q Consensus 729 ~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~D 795 (918)
++|+|.+++.... ....+++.+++.++.|++.|++|||+. +++||||||+||++++++.+|++|
T Consensus 79 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~~~~~kl~d 155 (270)
T cd05047 79 PHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIAD 155 (270)
T ss_pred CCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcCCCeEEECC
Confidence 9999999997532 123478999999999999999999998 999999999999999999999999
Q ss_pred cccccccCCCCCCceecccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhhhhhhhhhHhhhhhhcc
Q 044366 796 FGFAKFLEPHSSNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIK-GYHPGDFVSTIFSSISNMIIEVNQILD 874 (918)
Q Consensus 796 fG~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 874 (918)
||++....... .......+..|+|||++.+..++.++||||||+++|||++ |..||...... ........ .
T Consensus 156 fgl~~~~~~~~-~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~-----~~~~~~~~--~ 227 (270)
T cd05047 156 FGLSRGQEVYV-KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA-----ELYEKLPQ--G 227 (270)
T ss_pred CCCccccchhh-hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHH-----HHHHHHhC--C
Confidence 99986432111 1111233567999999988889999999999999999997 99997543211 00111100 0
Q ss_pred cCCCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 044366 875 HRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLLC 917 (918)
Q Consensus 875 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 917 (918)
.....+ . .....+.+++.+||+.||.+|||+.+++..|.
T Consensus 228 ~~~~~~-~---~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 266 (270)
T cd05047 228 YRLEKP-L---NCDDEVYDLMRQCWREKPYERPSFAQILVSLN 266 (270)
T ss_pred CCCCCC-C---cCCHHHHHHHHHHcccChhhCCCHHHHHHHHH
Confidence 011111 1 12246789999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=316.57 Aligned_cols=257 Identities=21% Similarity=0.325 Sum_probs=195.1
Q ss_pred HHhcCCCCceeeccccceEEEEEE-eCCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccC---
Q 044366 643 KATGNFGEKYCIGKGGQRSVYKAE-LPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNA--- 718 (918)
Q Consensus 643 ~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--- 718 (918)
...++|...+.||+|+||.||+|. ..+++.||||++..... .....+.+.+|+++++.++||||+++++++...
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 89 (343)
T cd07878 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQ--SLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSI 89 (343)
T ss_pred hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhh--hhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccc
Confidence 445789999999999999999995 45788999999865321 122345678999999999999999999987543
Q ss_pred ---CceEEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEec
Q 044366 719 ---QHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSD 795 (918)
Q Consensus 719 ---~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~D 795 (918)
...++++|++ +++|.+++.. ..+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|
T Consensus 90 ~~~~~~~~~~~~~-~~~l~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~~~~kl~D 161 (343)
T cd07878 90 ENFNEVYLVTNLM-GADLNNIVKC----QKLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRILD 161 (343)
T ss_pred cccCcEEEEeecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCCCCEEEcC
Confidence 3568999988 6799888764 2489999999999999999999999 999999999999999999999999
Q ss_pred cccccccCCCCCCceeccccccccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHh-------
Q 044366 796 FGFAKFLEPHSSNWTEFAGTVGYAAPELAYT-MRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMII------- 867 (918)
Q Consensus 796 fG~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~------- 867 (918)
||+++..... .....|+..|+|||++.+ ..++.++||||+||++|+|++|+.||....... .......
T Consensus 162 fg~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~~~~~~~~~~~ 237 (343)
T cd07878 162 FGLARQADDE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYID-QLKRIMEVVGTPSP 237 (343)
T ss_pred CccceecCCC---cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHH-HHHHHHHHhCCCCH
Confidence 9999876432 234568999999999876 568899999999999999999999986432211 0000000
Q ss_pred ----h-----hhhhcccCCCCCCc-ch----HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 868 ----E-----VNQILDHRLPTPSR-DV----TDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 868 ----~-----~~~~~~~~~~~~~~-~~----~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
. ..... ...+.... .. ......+.+++.+|++.||++|||+.|+++
T Consensus 238 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~ 297 (343)
T cd07878 238 EVLKKISSEHARKYI-QSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALA 297 (343)
T ss_pred HHHHhcchhhHHHHh-hccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0 00000 00000000 00 011234789999999999999999999985
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=315.85 Aligned_cols=256 Identities=20% Similarity=0.257 Sum_probs=196.6
Q ss_pred cCCCCceeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEEE
Q 044366 646 GNFGEKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFIV 724 (918)
Q Consensus 646 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 724 (918)
++|.+.+.||+|+||.||+|+. .+++.||+|.+...... .......+.+|..++..++|++|+++++++.+++..++|
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv 79 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEML-KRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLV 79 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHH-hhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEE
Confidence 4688899999999999999965 46889999998653211 122345688899999999999999999999999999999
Q ss_pred EEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccCC
Q 044366 725 CEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEP 804 (918)
Q Consensus 725 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~~ 804 (918)
|||+++|+|.+++.... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++..+..
T Consensus 80 ~Ey~~gg~L~~~l~~~~--~~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 154 (331)
T cd05624 80 MDYYVGGDLLTLLSKFE--DRLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQ 154 (331)
T ss_pred EeCCCCCcHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCEEEEeccceeeccC
Confidence 99999999999997632 3588999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCC-ceeccccccccccccccc-----CCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCC
Q 044366 805 HSSN-WTEFAGTVGYAAPELAYT-----MRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLP 878 (918)
Q Consensus 805 ~~~~-~~~~~g~~~y~aPE~~~~-----~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 878 (918)
.... .....|++.|+|||++.+ +.++.++|||||||++|||++|+.||...... .... ..... ..+.+
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~-~~~~----~i~~~-~~~~~ 228 (331)
T cd05624 155 DGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLV-ETYG----KIMNH-EERFQ 228 (331)
T ss_pred CCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHH-HHHH----HHHcC-CCccc
Confidence 3332 223568999999999875 46788999999999999999999998643321 1111 11000 01111
Q ss_pred CCCcchHHHHHHHHHHHHHcccCCCCC--CCCHHHHHH
Q 044366 879 TPSRDVTDKLRSIMEVAILCLVENPEA--RPTMKEVCN 914 (918)
Q Consensus 879 ~~~~~~~~~~~~l~~li~~cl~~dp~~--RPt~~evl~ 914 (918)
. +....+....+.+++.+|+..++.+ |++++++++
T Consensus 229 ~-p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~ 265 (331)
T cd05624 229 F-PSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKK 265 (331)
T ss_pred C-CCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhc
Confidence 1 1111222356778888888865544 568888764
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=300.37 Aligned_cols=248 Identities=28% Similarity=0.397 Sum_probs=197.2
Q ss_pred eeeccccceEEEEEEeCCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEEEEEeccCC
Q 044366 652 YCIGKGGQRSVYKAELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFIVCEYLARG 731 (918)
Q Consensus 652 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 731 (918)
++||+|+||.||+|...+++.||+|.+...... ...+.|.+|++++++++||||+++++++.+.+..++||||++++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~ 77 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPP---DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGG 77 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCH---HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCC
Confidence 368999999999997766999999988654221 23568999999999999999999999999999999999999999
Q ss_pred ChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccCCCCCCc--
Q 044366 732 SLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNW-- 809 (918)
Q Consensus 732 sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~~~~~~~-- 809 (918)
+|.++++... ..+++..++.++.+++.|++|||+. +++||||+|+||+++.++.++|+|||.+..........
T Consensus 78 ~l~~~l~~~~--~~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~ 152 (251)
T cd05041 78 SLLTFLRKKK--NRLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSD 152 (251)
T ss_pred cHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeeccccccccCCcceecc
Confidence 9999997542 3578999999999999999999999 99999999999999999999999999998654221111
Q ss_pred eecccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhhhhhhhhhHhhhhhhcccCCCCCCcchHHHH
Q 044366 810 TEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIK-GYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRDVTDKL 888 (918)
Q Consensus 810 ~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 888 (918)
....++..|+|||.+.+..++.++||||||+++|||++ |..||....... .. ...... ...+. .. ...
T Consensus 153 ~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~--~~---~~~~~~--~~~~~-~~---~~~ 221 (251)
T cd05041 153 GLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQ--TR---ERIESG--YRMPA-PQ---LCP 221 (251)
T ss_pred ccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHH--HH---HHHhcC--CCCCC-Cc---cCC
Confidence 11223567999999988889999999999999999999 788875433210 00 011110 01111 11 223
Q ss_pred HHHHHHHHHcccCCCCCCCCHHHHHHHhhC
Q 044366 889 RSIMEVAILCLVENPEARPTMKEVCNLLCK 918 (918)
Q Consensus 889 ~~l~~li~~cl~~dp~~RPt~~evl~~L~~ 918 (918)
..+.+++.+|+..+|.+|||+.|+++.|..
T Consensus 222 ~~~~~li~~~l~~~p~~Rp~~~ell~~l~~ 251 (251)
T cd05041 222 EEIYRLMLQCWAYDPENRPSFSEIYNELQI 251 (251)
T ss_pred HHHHHHHHHHhccChhhCcCHHHHHHHhhC
Confidence 468889999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=313.87 Aligned_cols=256 Identities=24% Similarity=0.357 Sum_probs=199.9
Q ss_pred hcCCCCceeeccccceEEEEEEeC--------CCCEEEEEEcccccccCCCCChHHHHHHHHHHhhc-cCCceeeEeccc
Q 044366 645 TGNFGEKYCIGKGGQRSVYKAELP--------SGNIFAVKKFKAELFSDETANPSEFLNEVLALTEI-RHRNIIKFHGFC 715 (918)
Q Consensus 645 ~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~ 715 (918)
..+|.+.+.||+|+||.||+|... .+..||+|.++.. ......+++.+|+++++++ +||||+++++++
T Consensus 11 ~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 87 (334)
T cd05100 11 RTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDD---ATDKDLSDLVSEMEMMKMIGKHKNIINLLGAC 87 (334)
T ss_pred HhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccc---cCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEE
Confidence 346888899999999999999532 1236899987642 1222356899999999999 799999999999
Q ss_pred ccCCceEEEEEeccCCChhHHhhccc-------------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCC
Q 044366 716 SNAQHSFIVCEYLARGSLTTILRDDA-------------AAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKN 782 (918)
Q Consensus 716 ~~~~~~~lv~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~N 782 (918)
..++..++|+||+++|+|.+++.... ....+++.+++.++.|++.||+|||+. +++||||||+|
T Consensus 88 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~N 164 (334)
T cd05100 88 TQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAARN 164 (334)
T ss_pred ccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---Ceeccccccce
Confidence 99999999999999999999997532 123578999999999999999999999 99999999999
Q ss_pred eeeCCCCcEEEeccccccccCCCCCC--ceecccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhhh
Q 044366 783 VLLDSEYEAHVSDFGFAKFLEPHSSN--WTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIK-GYHPGDFVSTIF 859 (918)
Q Consensus 783 ill~~~~~~kl~DfG~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~p~~~~~~~~ 859 (918)
|++++++.+||+|||+++........ .....++..|+|||++.+..++.++||||||+++|||++ |..||......
T Consensus 165 ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~- 243 (334)
T cd05100 165 VLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE- 243 (334)
T ss_pred EEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHH-
Confidence 99999999999999999866433221 112234567999999999889999999999999999998 88887543211
Q ss_pred hhhhhhHhhhhhhcccCCCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 044366 860 SSISNMIIEVNQILDHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLLC 917 (918)
Q Consensus 860 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 917 (918)
... ... .......... .....+.+++.+||+.+|++||++.|+++.|+
T Consensus 244 -~~~---~~~---~~~~~~~~~~---~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~ 291 (334)
T cd05100 244 -ELF---KLL---KEGHRMDKPA---NCTHELYMIMRECWHAVPSQRPTFKQLVEDLD 291 (334)
T ss_pred -HHH---HHH---HcCCCCCCCC---CCCHHHHHHHHHHcccChhhCcCHHHHHHHHH
Confidence 111 111 1111111111 12346889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-34 Score=302.33 Aligned_cols=258 Identities=24% Similarity=0.396 Sum_probs=202.0
Q ss_pred CCCCceeeccccceEEEEEEeCC--CCEEEEEEcccccccC------CCCChHHHHHHHHHHhh-ccCCceeeEeccccc
Q 044366 647 NFGEKYCIGKGGQRSVYKAELPS--GNIFAVKKFKAELFSD------ETANPSEFLNEVLALTE-IRHRNIIKFHGFCSN 717 (918)
Q Consensus 647 ~~~~~~~lg~G~~g~Vy~~~~~~--~~~vavK~~~~~~~~~------~~~~~~~~~~e~~~l~~-l~h~niv~~~~~~~~ 717 (918)
.|++.+.||+|+||.||+|.... ++.+|+|.+....... ......++.+|+.++.+ ++||||+++++++.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47778899999999999997654 7889999886432211 12224567788888765 799999999999999
Q ss_pred CCceEEEEEeccCCChhHHhhcc-cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEecc
Q 044366 718 AQHSFIVCEYLARGSLTTILRDD-AAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDF 796 (918)
Q Consensus 718 ~~~~~lv~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Df 796 (918)
++..++||||+++++|.+++... .....+++..+++++.|++.|+.|||+.. +++|+||+|+||+++.++.++|+||
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--~i~H~dl~~~nil~~~~~~~~l~df 158 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEK--RIVHRDLTPNNIMLGEDDKVTITDF 158 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCC--ceeecCCCHHHEEECCCCcEEEecc
Confidence 99999999999999999988543 22345899999999999999999999631 8999999999999999999999999
Q ss_pred ccccccCCCCCCceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccC
Q 044366 797 GFAKFLEPHSSNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHR 876 (918)
Q Consensus 797 G~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 876 (918)
|.+....... ......|+..|+|||+..+..++.++||||||+++|+|++|+.||....... .. .......
T Consensus 159 g~~~~~~~~~-~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~-----~~---~~~~~~~ 229 (269)
T cd08528 159 GLAKQKQPES-KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLS-----LA---TKIVEAV 229 (269)
T ss_pred cceeeccccc-ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHH-----HH---HHHhhcc
Confidence 9998765433 3344568899999999998889999999999999999999999975432211 00 1111111
Q ss_pred CCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 044366 877 LPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLLC 917 (918)
Q Consensus 877 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 917 (918)
..+... ......+.+++.+||+.||++||++.|+..+++
T Consensus 230 ~~~~~~--~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 230 YEPLPE--GMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred CCcCCc--ccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 111111 012356888999999999999999999999876
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-34 Score=305.81 Aligned_cols=248 Identities=27% Similarity=0.410 Sum_probs=199.1
Q ss_pred CCCCceeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEEEE
Q 044366 647 NFGEKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFIVC 725 (918)
Q Consensus 647 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 725 (918)
.|...+.||+|++|.||+|.. .+++.||+|++... .....+.+.+|+.+++.++||||+++++++..++..++|+
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~----~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~ 95 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLR----KQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVM 95 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEecc----chhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEE
Confidence 355567899999999999964 57899999987542 2223466889999999999999999999999999999999
Q ss_pred EeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccCCC
Q 044366 726 EYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPH 805 (918)
Q Consensus 726 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~~~ 805 (918)
||+++++|.+++.. .++++.++..++.|++.|++|||+. +++||||+|+||+++.++.++++|||.+......
T Consensus 96 e~~~~~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~ 168 (285)
T cd06648 96 EFLEGGALTDIVTH----TRMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKE 168 (285)
T ss_pred eccCCCCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEcccccchhhccC
Confidence 99999999999876 2478999999999999999999999 9999999999999999999999999988765443
Q ss_pred CCCceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCCCCCcchH
Q 044366 806 SSNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRDVT 885 (918)
Q Consensus 806 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 885 (918)
........|+..|+|||.+.+..++.++||||||+++|||++|+.||...... .... ..... .+.......
T Consensus 169 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~-~~~~-------~~~~~-~~~~~~~~~ 239 (285)
T cd06648 169 VPRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPL-QAMK-------RIRDN-LPPKLKNLH 239 (285)
T ss_pred CcccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHH-HHHH-------HHHhc-CCCCCcccc
Confidence 33334456889999999998888999999999999999999999997543221 1111 11111 111111111
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 886 DKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 886 ~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
.....+.+++.+||+.+|++||++.++++
T Consensus 240 ~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 240 KVSPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred cCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 13356889999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=330.24 Aligned_cols=260 Identities=18% Similarity=0.223 Sum_probs=191.5
Q ss_pred HHHHHhcCCCCceeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccC------CceeeEe
Q 044366 640 EITKATGNFGEKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRH------RNIIKFH 712 (918)
Q Consensus 640 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h------~niv~~~ 712 (918)
++....++|.+.+.||+|+||.||+|.. .+++.||||+++.. .....++..|+++++.++| .+++.++
T Consensus 123 ~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~-----~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~ 197 (467)
T PTZ00284 123 DIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNV-----PKYTRDAKIEIQFMEKVRQADPADRFPLMKIQ 197 (467)
T ss_pred ccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecc-----hhhHHHHHHHHHHHHHHhhcCcccCcceeeeE
Confidence 3445678999999999999999999954 56889999998642 1123456677777777655 4588898
Q ss_pred cccccC-CceEEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCC--
Q 044366 713 GFCSNA-QHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEY-- 789 (918)
Q Consensus 713 ~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~-- 789 (918)
+++..+ ++.++|||++ +++|.+++.+. ..+++.++..|+.||+.||+|||+++ +||||||||+||+++.++
T Consensus 198 ~~~~~~~~~~~iv~~~~-g~~l~~~l~~~---~~l~~~~~~~i~~qi~~aL~yLH~~~--gIiHrDlKP~NILl~~~~~~ 271 (467)
T PTZ00284 198 RYFQNETGHMCIVMPKY-GPCLLDWIMKH---GPFSHRHLAQIIFQTGVALDYFHTEL--HLMHTDLKPENILMETSDTV 271 (467)
T ss_pred EEEEcCCceEEEEEecc-CCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhcC--CeecCCCCHHHEEEecCCcc
Confidence 888654 5788999988 66898888754 34899999999999999999999732 999999999999998765
Q ss_pred --------------cEEEeccccccccCCCCCCceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcc
Q 044366 790 --------------EAHVSDFGFAKFLEPHSSNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFV 855 (918)
Q Consensus 790 --------------~~kl~DfG~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~ 855 (918)
.+||+|||.+..... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||+..
T Consensus 272 ~~~~~~~~~~~~~~~vkl~DfG~~~~~~~---~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~ 348 (467)
T PTZ00284 272 VDPVTNRALPPDPCRVRICDLGGCCDERH---SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTH 348 (467)
T ss_pred cccccccccCCCCceEEECCCCccccCcc---ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 499999998864322 223467899999999999999999999999999999999999998754
Q ss_pred hhhhhhhhhhHhh----------------hhhhccc---CCCCCC----------cch--HHHHHHHHHHHHHcccCCCC
Q 044366 856 STIFSSISNMIIE----------------VNQILDH---RLPTPS----------RDV--TDKLRSIMEVAILCLVENPE 904 (918)
Q Consensus 856 ~~~~~~~~~~~~~----------------~~~~~~~---~~~~~~----------~~~--~~~~~~l~~li~~cl~~dp~ 904 (918)
.... ........ ....... ..+... ... .-....+.+++.+||+.||+
T Consensus 349 ~~~~-~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~ 427 (467)
T PTZ00284 349 DNLE-HLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQ 427 (467)
T ss_pred ChHH-HHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChh
Confidence 3210 00000000 0000000 000000 000 00124578999999999999
Q ss_pred CCCCHHHHHH
Q 044366 905 ARPTMKEVCN 914 (918)
Q Consensus 905 ~RPt~~evl~ 914 (918)
+|||++|+++
T Consensus 428 ~R~ta~e~L~ 437 (467)
T PTZ00284 428 KRLNARQMTT 437 (467)
T ss_pred hCCCHHHHhc
Confidence 9999999985
|
|
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-34 Score=304.02 Aligned_cols=248 Identities=27% Similarity=0.427 Sum_probs=200.1
Q ss_pred CCCCceeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhcc---CCceeeEecccccCCceE
Q 044366 647 NFGEKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIR---HRNIIKFHGFCSNAQHSF 722 (918)
Q Consensus 647 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~~~ 722 (918)
.|+..+.||+|+||.||+|.. .+++.||+|.++... .....+++.+|+.+++.++ |||++++++++.++...+
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~ 78 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT---PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLW 78 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCC---CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEE
Confidence 467778899999999999964 578999999986531 2233567889999999996 999999999999999999
Q ss_pred EEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEecccccccc
Q 044366 723 IVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFL 802 (918)
Q Consensus 723 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~ 802 (918)
+||||+++++|.++++.. .+++..++.++.|++.|++|||+. +++|+||+|+||++++++.++++|||.+...
T Consensus 79 lv~e~~~~~~L~~~~~~~----~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~ 151 (277)
T cd06917 79 IIMEYAEGGSVRTLMKAG----PIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALL 151 (277)
T ss_pred EEEecCCCCcHHHHHHcc----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCEEEccCCceeec
Confidence 999999999999998653 489999999999999999999999 9999999999999999999999999999887
Q ss_pred CCCCCCceecccccccccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCCCCC
Q 044366 803 EPHSSNWTEFAGTVGYAAPELAYTM-RATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPS 881 (918)
Q Consensus 803 ~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 881 (918)
...........|+..|+|||.+.++ .++.++||||||+++|+|++|+.||....... ..........+...
T Consensus 152 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~--------~~~~~~~~~~~~~~ 223 (277)
T cd06917 152 NQNSSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFR--------AMMLIPKSKPPRLE 223 (277)
T ss_pred CCCccccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhh--------hhhccccCCCCCCC
Confidence 6554444455788999999988654 46889999999999999999999986432210 00011111111111
Q ss_pred cchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 882 RDVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 882 ~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
.. .....+.+++.+||+.||++||++.|+++
T Consensus 224 ~~--~~~~~~~~~i~~~l~~~p~~R~~~~~il~ 254 (277)
T cd06917 224 DN--GYSKLLREFVAACLDEEPKERLSAEELLK 254 (277)
T ss_pred cc--cCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence 11 13356888999999999999999999975
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-34 Score=301.24 Aligned_cols=252 Identities=26% Similarity=0.406 Sum_probs=206.2
Q ss_pred CCCCceeeccccceEEEEEEeC-CCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEEEE
Q 044366 647 NFGEKYCIGKGGQRSVYKAELP-SGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFIVC 725 (918)
Q Consensus 647 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 725 (918)
+|+..+.||+|++|.||+|... +++.||+|++..... ......+.+|++.+++++|+|++++++++..++..++||
T Consensus 2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 78 (264)
T cd06623 2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGD---EEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVL 78 (264)
T ss_pred cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcc---hHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEE
Confidence 5788899999999999999655 699999999866421 134678999999999999999999999999999999999
Q ss_pred EeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccCC
Q 044366 726 EYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHH-DCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEP 804 (918)
Q Consensus 726 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~~ 804 (918)
||+++++|.+++... ..+++..++.++.|+++|++|+|+ . +++||||+|+||+++.++.++|+|||.+.....
T Consensus 79 e~~~~~~L~~~l~~~---~~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~ 152 (264)
T cd06623 79 EYMDGGSLADLLKKV---GKIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSKGEVKIADFGISKVLEN 152 (264)
T ss_pred EecCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence 999999999999764 348999999999999999999999 8 999999999999999999999999999987765
Q ss_pred CCCCceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCCCCCcch
Q 044366 805 HSSNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRDV 884 (918)
Q Consensus 805 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 884 (918)
.........++..|+|||.+.+..++.++||||||+++|+|++|+.|+..... ....... ..+.....+.....
T Consensus 153 ~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~--~~~~~~~---~~~~~~~~~~~~~~- 226 (264)
T cd06623 153 TLDQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQ--PSFFELM---QAICDGPPPSLPAE- 226 (264)
T ss_pred CCCcccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccc--cCHHHHH---HHHhcCCCCCCCcc-
Confidence 44443455678999999999988899999999999999999999999865532 0011111 11111111111111
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 885 TDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 885 ~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
.....+.+++.+|++.+|++||++.|+++
T Consensus 227 -~~~~~l~~li~~~l~~~p~~R~~~~~ll~ 255 (264)
T cd06623 227 -EFSPEFRDFISACLQKDPKKRPSAAELLQ 255 (264)
T ss_pred -cCCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence 03357888999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-34 Score=300.30 Aligned_cols=247 Identities=27% Similarity=0.416 Sum_probs=197.8
Q ss_pred cCCCCceeeccccceEEEEEEeCCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEEEE
Q 044366 646 GNFGEKYCIGKGGQRSVYKAELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFIVC 725 (918)
Q Consensus 646 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 725 (918)
.+|.+.+.||+|+||.||+|.. +++.||+|.++.. ...+.+.+|+.+++.++|||++++++++..+ ..++||
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~------~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~ 77 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCD------VTAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVM 77 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCc------chHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEE
Confidence 4578889999999999999975 6888999998642 1246789999999999999999999998654 479999
Q ss_pred EeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccCCC
Q 044366 726 EYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPH 805 (918)
Q Consensus 726 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~~~ 805 (918)
||+++|+|.+++.... ...+++..++.++.|++.|++|||+. +++||||||+||+++.++.++|+|||++......
T Consensus 78 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~ 153 (254)
T cd05083 78 ELMSKGNLVNFLRTRG-RALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG 153 (254)
T ss_pred ECCCCCCHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEECCCccceecccc
Confidence 9999999999997643 33578999999999999999999998 9999999999999999999999999999764322
Q ss_pred CCCceecccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhhhhhhhhhHhhhhhhcccCCCCCCcch
Q 044366 806 SSNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIK-GYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRDV 884 (918)
Q Consensus 806 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 884 (918)
. .....+..|+|||++.+..++.++||||||+++|||++ |+.||...... .... .... ........
T Consensus 154 ~---~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~--~~~~---~~~~---~~~~~~~~-- 220 (254)
T cd05083 154 V---DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLK--EVKE---CVEK---GYRMEPPE-- 220 (254)
T ss_pred C---CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHH--HHHH---HHhC---CCCCCCCC--
Confidence 1 12234578999999988889999999999999999998 89997643321 1111 1111 11111111
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhC
Q 044366 885 TDKLRSIMEVAILCLVENPEARPTMKEVCNLLCK 918 (918)
Q Consensus 885 ~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~ 918 (918)
.....+.+++.+||+.+|++||+++++++.|++
T Consensus 221 -~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 221 -GCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred -cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 223567889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=304.13 Aligned_cols=249 Identities=25% Similarity=0.421 Sum_probs=195.6
Q ss_pred eeccccceEEEEEEeCC-------CCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEEEE
Q 044366 653 CIGKGGQRSVYKAELPS-------GNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFIVC 725 (918)
Q Consensus 653 ~lg~G~~g~Vy~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 725 (918)
.||+|+||.||+|...+ ++.||+|.+... ........|.+|++.++.++||||+++++++...+..++||
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~---~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (269)
T cd05044 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKG---ATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIM 78 (269)
T ss_pred ccccccceeEEeeeecccccCcccceeehhhhhhcc---cchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEE
Confidence 58999999999996532 257999987643 12233568999999999999999999999999999999999
Q ss_pred EeccCCChhHHhhccc----ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCC-----cEEEecc
Q 044366 726 EYLARGSLTTILRDDA----AAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEY-----EAHVSDF 796 (918)
Q Consensus 726 e~~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~-----~~kl~Df 796 (918)
||+++++|.++++... ....+++.+++.++.|++.|++|||+. +++|+||+|+||+++.++ .++++||
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~~~~~l~df 155 (269)
T cd05044 79 ELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDF 155 (269)
T ss_pred eccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCCCCCcceEECCc
Confidence 9999999999997542 123478999999999999999999998 999999999999999887 8999999
Q ss_pred ccccccCCCCC--CceecccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhhhhhhhhhHhhhhhhc
Q 044366 797 GFAKFLEPHSS--NWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIK-GYHPGDFVSTIFSSISNMIIEVNQIL 873 (918)
Q Consensus 797 G~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~ 873 (918)
|++........ ......++..|+|||++.+..++.++||||||+++|||++ |+.||...... ... .....
T Consensus 156 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~-~~~----~~~~~-- 228 (269)
T cd05044 156 GLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQ-EVL----QHVTA-- 228 (269)
T ss_pred ccccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHH-HHH----HHHhc--
Confidence 99976543221 1122345678999999999899999999999999999998 99997643321 000 00000
Q ss_pred ccCCCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhC
Q 044366 874 DHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLLCK 918 (918)
Q Consensus 874 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~ 918 (918)
..... ... .....+.+++.+||..+|.+||+++++++.|.+
T Consensus 229 ~~~~~-~~~---~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 229 GGRLQ-KPE---NCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred CCccC-Ccc---cchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 11111 111 223567899999999999999999999999864
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=300.12 Aligned_cols=252 Identities=23% Similarity=0.302 Sum_probs=195.9
Q ss_pred cCCCCceeeccccceEEEEEEe-CCCCEEEEEEcccccccCC-CCChHHHHHHHHHHhhccCCceeeEecccccC--Cce
Q 044366 646 GNFGEKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDE-TANPSEFLNEVLALTEIRHRNIIKFHGFCSNA--QHS 721 (918)
Q Consensus 646 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~ 721 (918)
.+|...+.||+|+||.||+|.. .+|+.||+|.+........ ....+.+.+|+++++.++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 4688889999999999999955 5689999998864321111 12245788899999999999999999988653 467
Q ss_pred EEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccc
Q 044366 722 FIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKF 801 (918)
Q Consensus 722 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~ 801 (918)
++||||+++++|.+++.... .+++..+++++.|++.||+|||+. +++|+||||+||+++.++.++|+|||.+..
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~ 155 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYG---ALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASKR 155 (265)
T ss_pred EEEEEecCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCCEEECcCccccc
Confidence 89999999999999987543 378889999999999999999999 999999999999999999999999999986
Q ss_pred cCCCC---CCceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCC
Q 044366 802 LEPHS---SNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLP 878 (918)
Q Consensus 802 ~~~~~---~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 878 (918)
..... .......++..|+|||++.+..++.++||||||+++|||++|+.||........ . .. .......+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~-~----~~--~~~~~~~~ 228 (265)
T cd06652 156 LQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAA-I----FK--IATQPTNP 228 (265)
T ss_pred cccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHH-H----HH--HhcCCCCC
Confidence 54321 122334578899999999888899999999999999999999999864322111 0 00 01111111
Q ss_pred CCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 879 TPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 879 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
.. .......+.+++.+|+. +|++||+++|+++
T Consensus 229 ~~---~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~ 260 (265)
T cd06652 229 VL---PPHVSDHCRDFLKRIFV-EAKLRPSADELLR 260 (265)
T ss_pred CC---chhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence 11 12233467788888985 8999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-34 Score=300.42 Aligned_cols=238 Identities=24% Similarity=0.398 Sum_probs=187.9
Q ss_pred eeeccccceEEEEEEeCC-C----------CEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCc
Q 044366 652 YCIGKGGQRSVYKAELPS-G----------NIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQH 720 (918)
Q Consensus 652 ~~lg~G~~g~Vy~~~~~~-~----------~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 720 (918)
+.||+|+||.||+|.... + ..|++|.+... ... ...|.+|+.+++.++||||+++++++.. ..
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~----~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~ 74 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSD----HRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DE 74 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccc----hhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CC
Confidence 368999999999996653 3 25777876542 111 5789999999999999999999999887 77
Q ss_pred eEEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCC-------cEEE
Q 044366 721 SFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEY-------EAHV 793 (918)
Q Consensus 721 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~-------~~kl 793 (918)
.++||||+++|+|.+++..... .+++..++.++.|++.||+|||+. +++||||||+||+++.++ .+|+
T Consensus 75 ~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~~~~~~~~kl 149 (259)
T cd05037 75 NIMVEEYVKFGPLDVFLHREKN--NVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKL 149 (259)
T ss_pred cEEEEEcCCCCcHHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecCccccCCceeEEe
Confidence 8999999999999999986532 589999999999999999999999 999999999999999887 7999
Q ss_pred eccccccccCCCCCCceecccccccccccccccC--CCCcccchhhHHHHHHHHHh-CCCCCCcchhhhhhhhhhHhhhh
Q 044366 794 SDFGFAKFLEPHSSNWTEFAGTVGYAAPELAYTM--RATEKYDVYSFGVLALEVIK-GYHPGDFVSTIFSSISNMIIEVN 870 (918)
Q Consensus 794 ~DfG~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~--~~~~~~Dv~slG~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~ 870 (918)
+|||++..... .....++..|+|||++.+. .++.++||||||+++|||++ |..|+...... .. .. . .
T Consensus 150 ~Dfg~a~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~-~~-~~---~-~ 219 (259)
T cd05037 150 SDPGIPITVLS----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSS-EK-ER---F-Y 219 (259)
T ss_pred CCCCccccccc----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCch-hH-HH---H-H
Confidence 99999986543 1234567789999998876 78899999999999999999 46665443210 00 00 0 0
Q ss_pred hhcccCCCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 044366 871 QILDHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLLC 917 (918)
Q Consensus 871 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 917 (918)
. .....+.+. ...+.+++.+||..+|.+|||+.++++.|.
T Consensus 220 ~-~~~~~~~~~------~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 220 Q-DQHRLPMPD------CAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred h-cCCCCCCCC------chHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 0 011111111 157889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=281.77 Aligned_cols=262 Identities=22% Similarity=0.352 Sum_probs=211.4
Q ss_pred HHHHHHHhcCCCCceeeccccceEEEEE-EeCCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhc-cCCceeeEeccc
Q 044366 638 YEEITKATGNFGEKYCIGKGGQRSVYKA-ELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEI-RHRNIIKFHGFC 715 (918)
Q Consensus 638 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~ 715 (918)
+++.-+.++ +.||+|+|+.|--+ ...+|..||||++.+. .........+|++++.+. .|+||+.+++++
T Consensus 75 F~d~YkLt~-----e~LGeGAyasVqtcv~i~t~~EYAVKiidKq----~gHsR~RvfREVe~f~~Cqgh~nilqLiefF 145 (463)
T KOG0607|consen 75 FEDMYKLTS-----ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQ----PGHSRSRVFREVETFYQCQGHKNILQLIEFF 145 (463)
T ss_pred HHHHHHhHH-----HHhcCccceeeeeeeeeccchhhhhhhhhcC----CchHHHHHHHHHHHHHHhcCCccHHHHHHHh
Confidence 455555555 45999999999988 6789999999999763 344567899999999998 599999999999
Q ss_pred ccCCceEEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCC---cEE
Q 044366 716 SNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEY---EAH 792 (918)
Q Consensus 716 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~---~~k 792 (918)
+++...|+|||-|.||+|...+.+++. +++.+..++.++||.||+|||.. ||+|||+||+||+..... -+|
T Consensus 146 Edd~~FYLVfEKm~GGplLshI~~~~~---F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC~~pn~vsPvK 219 (463)
T KOG0607|consen 146 EDDTRFYLVFEKMRGGPLLSHIQKRKH---FNEREASRVVKDIASALDFLHTK---GIAHRDLKPENILCESPNKVSPVK 219 (463)
T ss_pred cccceEEEEEecccCchHHHHHHHhhh---ccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccceeecCCCCcCcee
Confidence 999999999999999999999987643 89999999999999999999999 999999999999987654 479
Q ss_pred EeccccccccCCCC-------CCceecccccccccccccc-----cCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhh
Q 044366 793 VSDFGFAKFLEPHS-------SNWTEFAGTVGYAAPELAY-----TMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFS 860 (918)
Q Consensus 793 l~DfG~~~~~~~~~-------~~~~~~~g~~~y~aPE~~~-----~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~ 860 (918)
|+||.++..+.... ......+|+..|||||+.. ...|+.+.|.||+|||+|-|++|++||...-...=
T Consensus 220 iCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dC 299 (463)
T KOG0607|consen 220 ICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADC 299 (463)
T ss_pred eeccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcC
Confidence 99998886553221 1234567899999999763 33578899999999999999999999764332111
Q ss_pred hhhh-------hHhhhhhhcccCCCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 861 SISN-------MIIEVNQILDHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 861 ~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
.+.. .......+.+.....+..++.....+..+++...+..|+..|.++.+++.
T Consensus 300 GWdrGe~Cr~CQ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 300 GWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred CccCCCccHHHHHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 1111 12334555666676777777777888889999999999999999998864
|
|
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-34 Score=303.51 Aligned_cols=252 Identities=25% Similarity=0.447 Sum_probs=198.9
Q ss_pred cCCCCceeeccccceEEEEEEeC-CCC----EEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCc
Q 044366 646 GNFGEKYCIGKGGQRSVYKAELP-SGN----IFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQH 720 (918)
Q Consensus 646 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 720 (918)
++|...+.||+|+||.||+|... +|+ .||+|...... ......++.+|++.++.++||||+++++++.. ..
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~ 82 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREET---SPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQ 82 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCC---CHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-Cc
Confidence 56788899999999999999653 343 58999876532 12234678999999999999999999999877 78
Q ss_pred eEEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEecccccc
Q 044366 721 SFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAK 800 (918)
Q Consensus 721 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~ 800 (918)
.++||||+++|+|.+++.... ..+++..++.++.|++.|++|||+. +++||||||+||++++++.+||+|||.++
T Consensus 83 ~~~v~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kL~dfg~~~ 157 (279)
T cd05057 83 VQLITQLMPLGCLLDYVRNHK--DNIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAK 157 (279)
T ss_pred eEEEEecCCCCcHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCeEEECCCcccc
Confidence 899999999999999997643 3489999999999999999999998 99999999999999999999999999998
Q ss_pred ccCCCCCCce--ecccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhhhhhhhhhHhhhhhhcccCC
Q 044366 801 FLEPHSSNWT--EFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIK-GYHPGDFVSTIFSSISNMIIEVNQILDHRL 877 (918)
Q Consensus 801 ~~~~~~~~~~--~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 877 (918)
.......... ...++..|+|||.+....++.++||||||+++||+++ |+.||+..... .+.. .... ....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--~~~~---~~~~--~~~~ 230 (279)
T cd05057 158 LLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAV--EIPD---LLEK--GERL 230 (279)
T ss_pred cccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHH--HHHH---HHhC--CCCC
Confidence 7654332221 1223568999999988889999999999999999998 99998654321 1111 1111 1111
Q ss_pred CCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 044366 878 PTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLLC 917 (918)
Q Consensus 878 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 917 (918)
+.+ .. ....+.+++.+||..||.+||++.++++.|+
T Consensus 231 ~~~-~~---~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~ 266 (279)
T cd05057 231 PQP-PI---CTIDVYMVLVKCWMIDAESRPTFKELINEFS 266 (279)
T ss_pred CCC-CC---CCHHHHHHHHHHcCCChhhCCCHHHHHHHHH
Confidence 111 11 1235788899999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=299.34 Aligned_cols=251 Identities=25% Similarity=0.389 Sum_probs=200.6
Q ss_pred CCCCceeeccccceEEEEEEeC-CCCEEEEEEcccccccC-CCCChHHHHHHHHHHhhccCCceeeEecccccCCceEEE
Q 044366 647 NFGEKYCIGKGGQRSVYKAELP-SGNIFAVKKFKAELFSD-ETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFIV 724 (918)
Q Consensus 647 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 724 (918)
+|...+.||+|++|.||+|... +++.||+|.+....... .....+.+.+|+++++.++|+||+++++++.++...++|
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 4677789999999999999665 78999999986532211 122356799999999999999999999999999999999
Q ss_pred EEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccCC
Q 044366 725 CEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEP 804 (918)
Q Consensus 725 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~~ 804 (918)
+||+++++|.+++.... .+++..+..++.|++.|++|||+. +++|+||+|+||+++.++.+||+|||.+.....
T Consensus 81 ~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~ 154 (258)
T cd06632 81 LELVPGGSLAKLLKKYG---SFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVVE 154 (258)
T ss_pred EEecCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence 99999999999997643 478999999999999999999999 999999999999999999999999999987644
Q ss_pred CCCCceecccccccccccccccCC-CCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCCCCCcc
Q 044366 805 HSSNWTEFAGTVGYAAPELAYTMR-ATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRD 883 (918)
Q Consensus 805 ~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 883 (918)
.. ......++..|+|||.+.... ++.++|+||||+++|+|++|+.||....... .. ..... ....+....
T Consensus 155 ~~-~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~-~~----~~~~~--~~~~~~~~~- 225 (258)
T cd06632 155 FS-FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVA-AV----FKIGR--SKELPPIPD- 225 (258)
T ss_pred cc-cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHH-HH----HHHHh--cccCCCcCC-
Confidence 33 223456789999999987766 8899999999999999999999986543211 11 00000 011111111
Q ss_pred hHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 884 VTDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 884 ~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
.....+.+++.+||+.+|.+||++.++++
T Consensus 226 --~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 226 --HLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred --CcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 12356788899999999999999999975
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-34 Score=301.11 Aligned_cols=252 Identities=25% Similarity=0.353 Sum_probs=201.7
Q ss_pred CCCCceeeccccceEEEEEE-eCCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccc--cCCceEE
Q 044366 647 NFGEKYCIGKGGQRSVYKAE-LPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCS--NAQHSFI 723 (918)
Q Consensus 647 ~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~--~~~~~~l 723 (918)
+|...+.||.|+||.||+|. ..+|+.||+|.+..... .....+.+..|+++++.++||||+++++++. .+...++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~ 78 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNM--TEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYI 78 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccC--CHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEE
Confidence 47788899999999999995 45789999998865322 2233467889999999999999999999775 3456799
Q ss_pred EEEeccCCChhHHhhccc-ccCCCCHHHHHHHHHHHHHHHHHHH-----hCCCCCeEEcCCCCCCeeeCCCCcEEEeccc
Q 044366 724 VCEYLARGSLTTILRDDA-AAKEFSWNQRMNVIKGVANALSYLH-----HDCIPPIVHRDISSKNVLLDSEYEAHVSDFG 797 (918)
Q Consensus 724 v~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH-----~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG 797 (918)
+|||+++++|.+++.... ....+++..++.++.|++.|++||| +. +++|+||+|+||+++.++.+|++|||
T Consensus 79 ~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~---~i~h~dl~p~nili~~~~~~kl~d~g 155 (265)
T cd08217 79 VMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGN---TVLHRDLKPANIFLDANNNVKLGDFG 155 (265)
T ss_pred EehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccC---cceecCCCHHHEEEecCCCEEEeccc
Confidence 999999999999997642 2456899999999999999999999 66 99999999999999999999999999
Q ss_pred cccccCCCCCCceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCC
Q 044366 798 FAKFLEPHSSNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRL 877 (918)
Q Consensus 798 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 877 (918)
++..............++..|+|||.+.+..++.++||||||+++|+|++|+.||+.... .. ... .+.....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~--~~---~~~---~~~~~~~ 227 (265)
T cd08217 156 LAKILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQ--LQ---LAS---KIKEGKF 227 (265)
T ss_pred ccccccCCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCH--HH---HHH---HHhcCCC
Confidence 998776544333445789999999999988899999999999999999999999865431 11 111 1111111
Q ss_pred CCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 878 PTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 878 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
+.... .....+.+++.+|++.+|++||++.+|++
T Consensus 228 ~~~~~---~~~~~~~~l~~~~l~~~p~~Rp~~~~il~ 261 (265)
T cd08217 228 RRIPY---RYSSELNEVIKSMLNVDPDKRPSTEELLQ 261 (265)
T ss_pred CCCcc---ccCHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 11111 23356889999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-34 Score=300.98 Aligned_cols=252 Identities=26% Similarity=0.392 Sum_probs=201.3
Q ss_pred CCCCceeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEEEE
Q 044366 647 NFGEKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFIVC 725 (918)
Q Consensus 647 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 725 (918)
+|...+.||+|+||.||+|.. .+++.||+|.++..... ....+.+..|+++++.++|+||+++++++.+.+..++|+
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~ 78 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDND--PKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFM 78 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccc--hHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEE
Confidence 577889999999999999964 47899999998764221 234678999999999999999999999999999999999
Q ss_pred EeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccCCC
Q 044366 726 EYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPH 805 (918)
Q Consensus 726 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~~~ 805 (918)
||+++++|.+++... ..+++..++.++.++++|++|||+. +++|+||+|+||++++++.+||+|||.+......
T Consensus 79 e~~~~~~L~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~ 152 (264)
T cd06626 79 EYCSGGTLEELLEHG---RILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNN 152 (264)
T ss_pred ecCCCCcHHHHHhhc---CCCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEcccccccccCCC
Confidence 999999999999764 2378899999999999999999999 9999999999999999999999999999876543
Q ss_pred CCCc----eecccccccccccccccCC---CCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCC
Q 044366 806 SSNW----TEFAGTVGYAAPELAYTMR---ATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLP 878 (918)
Q Consensus 806 ~~~~----~~~~g~~~y~aPE~~~~~~---~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 878 (918)
.... ....++..|+|||++.+.. ++.++||||||+++|+|++|+.||.......... .. ......+
T Consensus 153 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~----~~---~~~~~~~ 225 (264)
T cd06626 153 TTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIM----FH---VGAGHKP 225 (264)
T ss_pred CCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHH----HH---HhcCCCC
Confidence 3322 1346788999999998766 7889999999999999999999986443211110 00 0111111
Q ss_pred CCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 879 TPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 879 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
.. +........+.+++.+||+.+|.+|||+.|++.
T Consensus 226 ~~-~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 226 PI-PDSLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred CC-CcccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 11 111112356778999999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-34 Score=304.42 Aligned_cols=252 Identities=28% Similarity=0.435 Sum_probs=205.0
Q ss_pred HhcCCCCceeeccccceEEEEEEeC-CCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceE
Q 044366 644 ATGNFGEKYCIGKGGQRSVYKAELP-SGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSF 722 (918)
Q Consensus 644 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 722 (918)
.++.|+..+.||+|++|.||+|... +++.||+|++..... ..+.+.+|++.++.++|+|++++++++..++..+
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 91 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-----NKELIINEILIMKDCKHPNIVDYYDSYLVGDELW 91 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-----hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEE
Confidence 4566888889999999999999665 689999999865321 4678899999999999999999999999999999
Q ss_pred EEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEecccccccc
Q 044366 723 IVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFL 802 (918)
Q Consensus 723 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~ 802 (918)
+|+||+++++|.+++.... ..+++.+++.++.|++.|++|||+. +++|+|++|+||+++.++.++|+|||.+...
T Consensus 92 lv~e~~~~~~L~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~ 166 (286)
T cd06614 92 VVMEYMDGGSLTDIITQNF--VRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQL 166 (286)
T ss_pred EEEeccCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCCCEEECccchhhhh
Confidence 9999999999999998753 3589999999999999999999998 9999999999999999999999999998766
Q ss_pred CCCCCCceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCCCCCc
Q 044366 803 EPHSSNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSR 882 (918)
Q Consensus 803 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 882 (918)
...........++..|+|||.+.+..++.++||||||+++|+|++|+.|+.......... .......+. ..
T Consensus 167 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~--------~~~~~~~~~-~~ 237 (286)
T cd06614 167 TKEKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALF--------LITTKGIPP-LK 237 (286)
T ss_pred ccchhhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHH--------HHHhcCCCC-Cc
Confidence 544333334457889999999988889999999999999999999999976443221100 011111111 11
Q ss_pred chHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 883 DVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 883 ~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
........+.+++.+|++.+|.+||++.++++
T Consensus 238 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 269 (286)
T cd06614 238 NPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ 269 (286)
T ss_pred chhhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 11113356888999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-34 Score=308.49 Aligned_cols=253 Identities=24% Similarity=0.430 Sum_probs=196.4
Q ss_pred hcCCCCceeeccccceEEEEEEe-CCCC----EEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCC
Q 044366 645 TGNFGEKYCIGKGGQRSVYKAEL-PSGN----IFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQ 719 (918)
Q Consensus 645 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~----~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~ 719 (918)
.++|+..+.||+|+||.||+|.. .+|+ .||+|.+.... ......++.+|+.+++.++||||++++|++...
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~- 81 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT---GPKANVEFMDEALIMASMDHPHLVRLLGVCLSP- 81 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccC---CHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-
Confidence 45678888999999999999954 4554 47888875421 122234788999999999999999999998654
Q ss_pred ceEEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccc
Q 044366 720 HSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFA 799 (918)
Q Consensus 720 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~ 799 (918)
..++|+||+++|+|.+++.... ..+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 82 ~~~~v~e~~~~g~l~~~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~~~kL~Dfg~~ 156 (303)
T cd05110 82 TIQLVTQLMPHGCLLDYVHEHK--DNIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLA 156 (303)
T ss_pred CceeeehhcCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCCceEEcccccc
Confidence 4679999999999999987642 3478999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCC--ceecccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhhhhhhhhhHhhhhhhcccC
Q 044366 800 KFLEPHSSN--WTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIK-GYHPGDFVSTIFSSISNMIIEVNQILDHR 876 (918)
Q Consensus 800 ~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 876 (918)
+........ .....++..|+|||++.+..++.++||||||+++|||++ |+.||...... ...... . ....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~--~~~~~~---~--~~~~ 229 (303)
T cd05110 157 RLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTR--EIPDLL---E--KGER 229 (303)
T ss_pred ccccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHH---H--CCCC
Confidence 876533221 122345678999999998889999999999999999997 88887543211 111111 0 0111
Q ss_pred CCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 044366 877 LPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLLC 917 (918)
Q Consensus 877 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 917 (918)
.+.+. .....+.+++.+||..+|++||+++++++.|+
T Consensus 230 ~~~~~----~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~ 266 (303)
T cd05110 230 LPQPP----ICTIDVYMVMVKCWMIDADSRPKFKELAAEFS 266 (303)
T ss_pred CCCCC----CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 11111 12246788999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-34 Score=301.64 Aligned_cols=253 Identities=26% Similarity=0.376 Sum_probs=197.6
Q ss_pred hcCCCCceeeccccceEEEEEEeCC----CCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCc
Q 044366 645 TGNFGEKYCIGKGGQRSVYKAELPS----GNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQH 720 (918)
Q Consensus 645 ~~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 720 (918)
..+|...+.||+|+||.||+|...+ ...||||...... .....+.+.+|+.+++.++||||+++++++.+ +.
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~---~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~ 80 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT---SPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NP 80 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcC---CHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CC
Confidence 3457788899999999999996533 3468999876532 12235679999999999999999999998875 45
Q ss_pred eEEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEecccccc
Q 044366 721 SFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAK 800 (918)
Q Consensus 721 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~ 800 (918)
.++||||+++|+|.+++.... ..+++.+++.++.|++.|++|+|+. +++||||||+||+++.++.++++|||++.
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~ 155 (270)
T cd05056 81 VWIVMELAPLGELRSYLQVNK--YSLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDFGLSR 155 (270)
T ss_pred cEEEEEcCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCCCeEEccCceee
Confidence 789999999999999997643 3489999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCC-ceecccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhhhhhhhhhHhhhhhhcccCCC
Q 044366 801 FLEPHSSN-WTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIK-GYHPGDFVSTIFSSISNMIIEVNQILDHRLP 878 (918)
Q Consensus 801 ~~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 878 (918)
........ .....++..|+|||.+....++.++||||||+++||+++ |+.||....... . ...... ..+.+
T Consensus 156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~-~----~~~~~~--~~~~~ 228 (270)
T cd05056 156 YLEDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNND-V----IGRIEN--GERLP 228 (270)
T ss_pred ecccccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHH-H----HHHHHc--CCcCC
Confidence 66443211 122234568999999988889999999999999999986 999986443210 0 011111 11111
Q ss_pred CCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 044366 879 TPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLLC 917 (918)
Q Consensus 879 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 917 (918)
. ... ....+.+++.+|+..+|.+|||+.++++.|+
T Consensus 229 ~-~~~---~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~ 263 (270)
T cd05056 229 M-PPN---CPPTLYSLMTKCWAYDPSKRPRFTELKAQLS 263 (270)
T ss_pred C-CCC---CCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 1 111 2246888999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-34 Score=304.89 Aligned_cols=253 Identities=23% Similarity=0.348 Sum_probs=194.8
Q ss_pred cCCCCceeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHH-HhhccCCceeeEecccccCCceEE
Q 044366 646 GNFGEKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLA-LTEIRHRNIIKFHGFCSNAQHSFI 723 (918)
Q Consensus 646 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~-l~~l~h~niv~~~~~~~~~~~~~l 723 (918)
++|++.+.||+|+||.||+|.. .+|+.||+|+++.... ......+..|+.. ++..+||||+++++++..++..++
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~l 77 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVN---SQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWI 77 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCC---cHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEE
Confidence 3688889999999999999965 4799999999865321 1223456667665 566789999999999999999999
Q ss_pred EEEeccCCChhHHhhcc-cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEecccccccc
Q 044366 724 VCEYLARGSLTTILRDD-AAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFL 802 (918)
Q Consensus 724 v~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~ 802 (918)
||||++ |+|.+++... .....+++..++.++.|++.|++|||+++ +++||||||+||+++.++.+||+|||.+..+
T Consensus 78 v~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~ 154 (283)
T cd06617 78 CMEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYL 154 (283)
T ss_pred Ehhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeeccccccc
Confidence 999997 6898888653 22356899999999999999999999853 8999999999999999999999999999876
Q ss_pred CCCCCCceeccccccccccccccc----CCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCC
Q 044366 803 EPHSSNWTEFAGTVGYAAPELAYT----MRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLP 878 (918)
Q Consensus 803 ~~~~~~~~~~~g~~~y~aPE~~~~----~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 878 (918)
.... ......++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||........... .......+
T Consensus 155 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~-------~~~~~~~~ 226 (283)
T cd06617 155 VDSV-AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLK-------QVVEEPSP 226 (283)
T ss_pred cccc-ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHH-------HHHhcCCC
Confidence 4322 1233467889999998865 4468899999999999999999999864322211111 11111111
Q ss_pred CCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 879 TPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 879 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
.... ......+.+++.+||..+|++||++.++++
T Consensus 227 ~~~~--~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 227 QLPA--EKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred CCCc--cccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1110 112356889999999999999999999985
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-34 Score=305.34 Aligned_cols=259 Identities=22% Similarity=0.302 Sum_probs=198.3
Q ss_pred CCCceeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEEEEE
Q 044366 648 FGEKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFIVCE 726 (918)
Q Consensus 648 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 726 (918)
|+..+.||.|++|.||+|.. .+|+.||+|++..... .....+.+.+|++.++.++|||++++++++.+++..++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e 78 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETE--DEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFE 78 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccc--cccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEe
Confidence 56778999999999999954 5799999999875421 22234678899999999999999999999999999999999
Q ss_pred eccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccCCCC
Q 044366 727 YLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHS 806 (918)
Q Consensus 727 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~~~~ 806 (918)
|++ ++|.+++.... ...+++..++.++.|+++||+|||+. +++||||+|+||+++.++.++|+|||.+.......
T Consensus 79 ~~~-~~l~~~~~~~~-~~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~ 153 (283)
T cd07835 79 FLD-LDLKKYMDSSP-LTGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPV 153 (283)
T ss_pred ccC-cCHHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEeecccccccCCCc
Confidence 995 69999987643 24589999999999999999999999 99999999999999999999999999998665433
Q ss_pred CCceecccccccccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhh--------------hhh
Q 044366 807 SNWTEFAGTVGYAAPELAYTM-RATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIE--------------VNQ 871 (918)
Q Consensus 807 ~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~--------------~~~ 871 (918)
.......++..|+|||++.+. .++.++||||||+++|+|++|+.||.......... ..... ...
T Consensus 154 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 232 (283)
T cd07835 154 RTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLF-RIFRTLGTPDEDVWPGVTSLPD 232 (283)
T ss_pred cccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH-HHHHHhCCCChHHhhhhhhchh
Confidence 333334568899999988664 46889999999999999999999986543221100 00000 000
Q ss_pred ----hcccCCCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 872 ----ILDHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 872 ----~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
...................+.+++.+|++.||++|||++|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 233 YKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred hhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 0000000000001112256889999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-34 Score=304.78 Aligned_cols=247 Identities=26% Similarity=0.350 Sum_probs=200.7
Q ss_pred cCCCCceeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEEE
Q 044366 646 GNFGEKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFIV 724 (918)
Q Consensus 646 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 724 (918)
++|...+.||+|++|.||+|.. .+++.||+|++...... .....+.+.+|++++++++||||+++++++.+++..++|
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 79 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIV-KLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLV 79 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEE
Confidence 3678889999999999999955 46899999998653221 222356789999999999999999999999999999999
Q ss_pred EEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccCC
Q 044366 725 CEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEP 804 (918)
Q Consensus 725 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~~ 804 (918)
|||+++++|.+++... ..+++..+..++.|++.||+|||+. +++||||+|+||+++.++.+||+|||++.....
T Consensus 80 ~e~~~~~~L~~~~~~~---~~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~ 153 (290)
T cd05580 80 MEYVPGGELFSHLRKS---GRFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKG 153 (290)
T ss_pred EecCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEeeCCCccccCC
Confidence 9999999999999765 3589999999999999999999998 999999999999999999999999999987654
Q ss_pred CCCCceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCCCCCcch
Q 044366 805 HSSNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRDV 884 (918)
Q Consensus 805 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 884 (918)
. .....+++.|+|||.+.+...+.++||||||+++|+|++|+.||...... . ..........+.+ ...
T Consensus 154 ~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-----~---~~~~~~~~~~~~~-~~~ 221 (290)
T cd05580 154 R---TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPI-----Q---IYEKILEGKVRFP-SFF 221 (290)
T ss_pred C---CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH-----H---HHHHHhcCCccCC-ccC
Confidence 3 23346789999999998888899999999999999999999997644311 0 0111111111111 111
Q ss_pred HHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 044366 885 TDKLRSIMEVAILCLVENPEARP-----TMKEVCN 914 (918)
Q Consensus 885 ~~~~~~l~~li~~cl~~dp~~RP-----t~~evl~ 914 (918)
...+.+++.+||+.||.+|| +++|+++
T Consensus 222 ---~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~ 253 (290)
T cd05580 222 ---SPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN 253 (290)
T ss_pred ---CHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence 34678899999999999999 7777763
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-34 Score=308.98 Aligned_cols=254 Identities=24% Similarity=0.294 Sum_probs=202.3
Q ss_pred cCCCCceeeccccceEEEEEEeC-CCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEEE
Q 044366 646 GNFGEKYCIGKGGQRSVYKAELP-SGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFIV 724 (918)
Q Consensus 646 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 724 (918)
++|...+.||+|++|.||+|... +++.||+|.+....... ....+.+..|++.++.++||||+++++++.+++..++|
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 79 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIK-RNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLV 79 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccch-HHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEE
Confidence 36788899999999999999654 68999999987642221 12356789999999999999999999999999999999
Q ss_pred EEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccCC
Q 044366 725 CEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEP 804 (918)
Q Consensus 725 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~~ 804 (918)
|||+++++|.+++.... ...+++..+..++.|++.||+|||+. +++||||||+||+++.++.++|+|||++.....
T Consensus 80 ~e~~~~~~L~~~~~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 155 (316)
T cd05574 80 MDYCPGGELFRLLQRQP-GKCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFDLSKQSDV 155 (316)
T ss_pred EEecCCCCHHHHHHhCC-CCccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCEEEeecchhhcccc
Confidence 99999999999987543 34589999999999999999999999 999999999999999999999999999876532
Q ss_pred CCCC-----------------------------ceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcc
Q 044366 805 HSSN-----------------------------WTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFV 855 (918)
Q Consensus 805 ~~~~-----------------------------~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~ 855 (918)
.... .....|+..|+|||++.+..++.++||||||+++|+|++|+.||...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~ 235 (316)
T cd05574 156 EPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGS 235 (316)
T ss_pred cccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCC
Confidence 2110 11235788999999999888999999999999999999999998644
Q ss_pred hhhhhhhhhhHhhhhhhcccCCCCCCcchHHHHHHHHHHHHHcccCCCCCCCC----HHHHHH
Q 044366 856 STIFSSISNMIIEVNQILDHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPT----MKEVCN 914 (918)
Q Consensus 856 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt----~~evl~ 914 (918)
.... ............+.. ......+.+++.+|++.||++||+ ++|++.
T Consensus 236 ~~~~--------~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 236 NRDE--------TFSNILKKEVTFPGS--PPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred chHH--------HHHHHhcCCccCCCc--cccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 3211 111111211111111 113457889999999999999999 777765
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-34 Score=305.59 Aligned_cols=260 Identities=25% Similarity=0.356 Sum_probs=201.1
Q ss_pred cCCCCceeeccccceEEEEEEeC-CCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEEE
Q 044366 646 GNFGEKYCIGKGGQRSVYKAELP-SGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFIV 724 (918)
Q Consensus 646 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 724 (918)
++|+..+.||+|++|.||+|... +++.||+|+++.... .....+.+.+|+++++.++|+||+++++++..++..++|
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv 78 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESED--DEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLV 78 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcc--cccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEE
Confidence 36888999999999999999654 688999999865322 223357889999999999999999999999999999999
Q ss_pred EEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccCC
Q 044366 725 CEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEP 804 (918)
Q Consensus 725 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~~ 804 (918)
|||++++.+..+.+.. ..+++.+++.++.|++.|++|||+. +++|+|++|+||++++++.+||+|||.+.....
T Consensus 79 ~e~~~~~~l~~~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~ 152 (288)
T cd07833 79 FEYVERTLLELLEASP---GGLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRA 152 (288)
T ss_pred EecCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEEeeecccccCC
Confidence 9999987777665543 3479999999999999999999999 999999999999999999999999999987765
Q ss_pred CCC-CceecccccccccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHh-------hhhhhcc-
Q 044366 805 HSS-NWTEFAGTVGYAAPELAYTM-RATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMII-------EVNQILD- 874 (918)
Q Consensus 805 ~~~-~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~-------~~~~~~~- 874 (918)
... ......++..|+|||++.+. .++.++||||||+++|+|++|+.||....... ....... .......
T Consensus 153 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 231 (288)
T cd07833 153 RPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDID-QLYLIQKCLGPLPPSHQELFSS 231 (288)
T ss_pred CccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCCHHHhhhccc
Confidence 432 33345678899999999887 78999999999999999999999976433211 0000000 0000000
Q ss_pred -----c-CCCCCCcc------hH-HHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 875 -----H-RLPTPSRD------VT-DKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 875 -----~-~~~~~~~~------~~-~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
. ..+..... .. ....++.+++.+||..+|++||+++++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 232 NPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred CccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 0 01010000 00 11467899999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-34 Score=308.02 Aligned_cols=256 Identities=21% Similarity=0.241 Sum_probs=198.0
Q ss_pred cCCCCceeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEEE
Q 044366 646 GNFGEKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFIV 724 (918)
Q Consensus 646 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 724 (918)
++|...+.||+|+||.||+|.. .+++.||+|.+...... .....+.+.+|+++++.++||||+++++++..++..++|
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv 79 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLI-LRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMV 79 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhh-hHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEE
Confidence 3688889999999999999965 46889999988653211 122345788999999999999999999999999999999
Q ss_pred EEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccCC
Q 044366 725 CEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEP 804 (918)
Q Consensus 725 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~~ 804 (918)
|||+++++|.+++.... .+++..+..++.|++.|++|||+. +++||||||+||+++.++.++++|||+++....
T Consensus 80 ~e~~~g~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~ 153 (305)
T cd05609 80 MEYVEGGDCATLLKNIG---ALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLM 153 (305)
T ss_pred EecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEEEeeCCCccccCc
Confidence 99999999999997643 489999999999999999999999 999999999999999999999999999864211
Q ss_pred CCC---------------CceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhh
Q 044366 805 HSS---------------NWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEV 869 (918)
Q Consensus 805 ~~~---------------~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~ 869 (918)
... ......++..|+|||.+.+..++.++||||||+++|||++|..||...... ....
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~-----~~~~-- 226 (305)
T cd05609 154 SLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE-----ELFG-- 226 (305)
T ss_pred CccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-----HHHH--
Confidence 100 011235678999999998888999999999999999999999997533211 0001
Q ss_pred hhhcccCCCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 044366 870 NQILDHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLLC 917 (918)
Q Consensus 870 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 917 (918)
.........+.. .......+.+++.+||+.||++||++.++.+.|+
T Consensus 227 -~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~ 272 (305)
T cd05609 227 -QVISDDIEWPEG-DEALPADAQDLISRLLRQNPLERLGTGGAFEVKQ 272 (305)
T ss_pred -HHHhcccCCCCc-cccCCHHHHHHHHHHhccChhhccCccCHHHHHh
Confidence 111111111110 0122345789999999999999999766655553
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=300.95 Aligned_cols=248 Identities=27% Similarity=0.419 Sum_probs=200.4
Q ss_pred cCCCCceeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEEE
Q 044366 646 GNFGEKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFIV 724 (918)
Q Consensus 646 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 724 (918)
+-|...+.||+|+||.||+|.. .+++.||+|.+... ......+.+.+|+..++.++||||+++++++..++..++|
T Consensus 4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~---~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 80 (277)
T cd06641 4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLE---EAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWII 80 (277)
T ss_pred HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccc---cchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEE
Confidence 3467788899999999999954 57899999987542 1222346788999999999999999999999999999999
Q ss_pred EEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccCC
Q 044366 725 CEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEP 804 (918)
Q Consensus 725 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~~ 804 (918)
|||+++++|.+++... .+++..+..++.|++.|++|||+. +++|+||+|+||+++.++.++++|||++..+..
T Consensus 81 ~e~~~~~~l~~~i~~~----~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~ 153 (277)
T cd06641 81 MEYLGGGSALDLLEPG----PLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTD 153 (277)
T ss_pred EEeCCCCcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEEEeecccceeccc
Confidence 9999999999998643 478999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCCceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCCCCCcch
Q 044366 805 HSSNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRDV 884 (918)
Q Consensus 805 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 884 (918)
.........++..|+|||.+.+..++.++|||||||++|+|++|..|+...... . ... .+.....+....
T Consensus 154 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~-~----~~~---~~~~~~~~~~~~-- 223 (277)
T cd06641 154 TQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPM-K----VLF---LIPKNNPPTLEG-- 223 (277)
T ss_pred chhhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchH-H----HHH---HHhcCCCCCCCc--
Confidence 333333456788999999998888899999999999999999999997643221 0 000 111111111111
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 885 TDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 885 ~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
.....+.+++.+||+.+|.+||++.++++
T Consensus 224 -~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 252 (277)
T cd06641 224 -NYSKPLKEFVEACLNKEPSFRPTAKELLK 252 (277)
T ss_pred -ccCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 22356788899999999999999999987
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-34 Score=304.85 Aligned_cols=260 Identities=20% Similarity=0.343 Sum_probs=200.3
Q ss_pred CCCCceeeccccceEEEEEEeC-CCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEEEE
Q 044366 647 NFGEKYCIGKGGQRSVYKAELP-SGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFIVC 725 (918)
Q Consensus 647 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 725 (918)
+|+..+.||+|++|.||+|... +|+.||||+++... .....+.+.+|+++++.++||||+++++++.+.+..++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 77 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDA---EEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVF 77 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccc---cccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEE
Confidence 4788899999999999999664 68999999987542 2233467788999999999999999999999999999999
Q ss_pred EeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccCCC
Q 044366 726 EYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPH 805 (918)
Q Consensus 726 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~~~ 805 (918)
||+++ +|.+++........+++.++..++.|++.|++|||+. +++||||+|+||++++++.++++|||++......
T Consensus 78 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~ 153 (284)
T cd07836 78 EYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIP 153 (284)
T ss_pred ecCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEEeecchhhhhcCC
Confidence 99985 8999887654445689999999999999999999999 9999999999999999999999999999866543
Q ss_pred CCCceecccccccccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhH-----------hhhhh--
Q 044366 806 SSNWTEFAGTVGYAAPELAYTM-RATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMI-----------IEVNQ-- 871 (918)
Q Consensus 806 ~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~-----------~~~~~-- 871 (918)
........++..|+|||++.+. .++.++||||||+++|+|++|+.||....... ...... .....
T Consensus 154 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 232 (284)
T cd07836 154 VNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNED-QLLKIFRIMGTPTESTWPGISQLP 232 (284)
T ss_pred ccccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHH-HHHHHHHHhCCCChhhHHHHhcCc
Confidence 3333345678899999988664 46889999999999999999999986443211 000000 00000
Q ss_pred hcccCCCCCCcc-----hHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 872 ILDHRLPTPSRD-----VTDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 872 ~~~~~~~~~~~~-----~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
......+..... .......+.+++.+|++.||.+||+++|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 233 EYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred hhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 000011100000 0112356789999999999999999999975
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-34 Score=305.72 Aligned_cols=260 Identities=20% Similarity=0.295 Sum_probs=199.2
Q ss_pred cCCCCceeeccccceEEEEEEeC-CCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccC--CceE
Q 044366 646 GNFGEKYCIGKGGQRSVYKAELP-SGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNA--QHSF 722 (918)
Q Consensus 646 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~ 722 (918)
++|+..+.||+|+||.||+|... +++.||+|.++..... ......+.+|++++++++||||+++++++..+ ...+
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 82 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEK--EGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIY 82 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeecccc--ccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEE
Confidence 46888899999999999999664 6899999998754322 22335678899999999999999999998776 8899
Q ss_pred EEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEecccccccc
Q 044366 723 IVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFL 802 (918)
Q Consensus 723 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~ 802 (918)
+||||+++ +|.+++.... ..+++.+++.++.|++.||+|||+. +++||||||+||+++.++.++|+|||++...
T Consensus 83 lv~e~~~~-~L~~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~l~d~g~~~~~ 156 (293)
T cd07843 83 MVMEYVEH-DLKSLMETMK--QPFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREY 156 (293)
T ss_pred EEehhcCc-CHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEEEeecCceeec
Confidence 99999974 9999887643 2589999999999999999999999 9999999999999999999999999999877
Q ss_pred CCCCCCceecccccccccccccccCC-CCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhh-----------h
Q 044366 803 EPHSSNWTEFAGTVGYAAPELAYTMR-ATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEV-----------N 870 (918)
Q Consensus 803 ~~~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~-----------~ 870 (918)
...........++..|+|||.+.+.. ++.++||||+|+++|+|++|+.||....... ......... .
T Consensus 157 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 235 (293)
T cd07843 157 GSPLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEID-QLNKIFKLLGTPTEKIWPGFS 235 (293)
T ss_pred cCCccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCCCchHHHHHhh
Confidence 65433334456788999999887644 6889999999999999999999986543211 111000000 0
Q ss_pred hh---c-----ccCCCCCCcchHH--HHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 871 QI---L-----DHRLPTPSRDVTD--KLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 871 ~~---~-----~~~~~~~~~~~~~--~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
.. . ...........+. ....+.+++.+||+.||++|||+.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 236 ELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred ccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 00 0 0000000011111 1456788999999999999999999985
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=300.48 Aligned_cols=256 Identities=26% Similarity=0.397 Sum_probs=198.7
Q ss_pred CCCCceeeccccceEEEEEE-eCCCCEEEEEEcccccccCCCC------ChHHHHHHHHHHhhccCCceeeEecccccCC
Q 044366 647 NFGEKYCIGKGGQRSVYKAE-LPSGNIFAVKKFKAELFSDETA------NPSEFLNEVLALTEIRHRNIIKFHGFCSNAQ 719 (918)
Q Consensus 647 ~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~ 719 (918)
+|...+.||+|+||.||+|. ..+|+.||+|.++......... ..+.+.+|+++++.++|||++++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 46677899999999999995 4578999999886432221111 1246888999999999999999999999999
Q ss_pred ceEEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccc
Q 044366 720 HSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFA 799 (918)
Q Consensus 720 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~ 799 (918)
..++||||+++|+|.++++.. ..+++..+..++.|++.|+.|||+. +++||||+|+||+++.++.++++|||.+
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~~~~~~l~d~~~~ 155 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTY---GRFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDADGICKISDFGIS 155 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcCCCeEEEeecccc
Confidence 999999999999999999765 3589999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCC--CceecccccccccccccccCC--CCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhccc
Q 044366 800 KFLEPHSS--NWTEFAGTVGYAAPELAYTMR--ATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDH 875 (918)
Q Consensus 800 ~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~--~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 875 (918)
........ ......++..|+|||.+.... ++.++||||||+++||+++|..|+.......... .... ...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~-----~~~~-~~~ 229 (272)
T cd06629 156 KKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMF-----KLGN-KRS 229 (272)
T ss_pred ccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHH-----Hhhc-ccc
Confidence 76543211 122345788999999987654 7889999999999999999999975433211110 0000 000
Q ss_pred CCCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 876 RLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 876 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
....+..........+.+++.+||+.||.+||++++|++
T Consensus 230 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (272)
T cd06629 230 APPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQ 268 (272)
T ss_pred CCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence 111111111223467888999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=302.11 Aligned_cols=239 Identities=22% Similarity=0.385 Sum_probs=186.4
Q ss_pred eeccccceEEEEEEeC-C-------CCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEEE
Q 044366 653 CIGKGGQRSVYKAELP-S-------GNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFIV 724 (918)
Q Consensus 653 ~lg~G~~g~Vy~~~~~-~-------~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 724 (918)
.||+|+||.||+|... . ...||+|.+... .....+.+.+|+.+++.++||||+++++++..++..++|
T Consensus 2 ~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~----~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv 77 (258)
T cd05078 2 SLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKS----HRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMV 77 (258)
T ss_pred CCCcccchhheeeeecccccccccccchhhHHhhcch----hHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEE
Confidence 5899999999999543 2 234888876532 222346788999999999999999999999998999999
Q ss_pred EEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCc--------EEEecc
Q 044366 725 CEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYE--------AHVSDF 796 (918)
Q Consensus 725 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~--------~kl~Df 796 (918)
|||+++|+|.++++... ..+++..++.++.||+.|++|||+. +|+||||||+||+++.++. ++++||
T Consensus 78 ~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~ 152 (258)
T cd05078 78 QEYVKFGSLDTYLKKNK--NLINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDP 152 (258)
T ss_pred EecCCCCcHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccCCCceEEeccc
Confidence 99999999999997653 2578999999999999999999999 9999999999999988765 699999
Q ss_pred ccccccCCCCCCceecccccccccccccccC-CCCcccchhhHHHHHHHHHhCC-CCCCcchhhhhhhhhhHhhhhhhcc
Q 044366 797 GFAKFLEPHSSNWTEFAGTVGYAAPELAYTM-RATEKYDVYSFGVLALEVIKGY-HPGDFVSTIFSSISNMIIEVNQILD 874 (918)
Q Consensus 797 G~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~vl~el~tg~-~p~~~~~~~~~~~~~~~~~~~~~~~ 874 (918)
|.+....+. ....++..|+|||++.+. .++.++||||||+++|||++|. .|+...... ... .... ..
T Consensus 153 g~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~-~~~-----~~~~-~~ 221 (258)
T cd05078 153 GISITVLPK----EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQ-KKL-----QFYE-DR 221 (258)
T ss_pred ccccccCCc----hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHH-HHH-----HHHH-cc
Confidence 998765432 234578899999998764 5789999999999999999995 554332211 000 0000 01
Q ss_pred cCCCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 044366 875 HRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLLC 917 (918)
Q Consensus 875 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 917 (918)
...+.. ...++.+++.+||+.||++|||++++++.|.
T Consensus 222 ~~~~~~------~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 222 HQLPAP------KWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred ccCCCC------CcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 111111 1246789999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=297.56 Aligned_cols=251 Identities=28% Similarity=0.438 Sum_probs=199.1
Q ss_pred CCCceeeccccceEEEEEEeCC-----CCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceE
Q 044366 648 FGEKYCIGKGGQRSVYKAELPS-----GNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSF 722 (918)
Q Consensus 648 ~~~~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 722 (918)
|.+.+.||.|+||.||+|.... +..||+|+++... .....+.+..|++.++.++|+||+++++++.+.+..+
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 77 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDA---DEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLM 77 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCC---ChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeE
Confidence 3566789999999999996543 3889999986531 1114678999999999999999999999999999999
Q ss_pred EEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEecccccccc
Q 044366 723 IVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFL 802 (918)
Q Consensus 723 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~ 802 (918)
++|||+++++|.+++..... ..+++.+++.++.|++.|++|||+. +++||||+|+||++++++.++++|||++...
T Consensus 78 ~i~e~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~ 153 (258)
T smart00219 78 IVMEYMEGGDLLDYLRKNRP-KELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDL 153 (258)
T ss_pred EEEeccCCCCHHHHHHhhhh-ccCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEEEcccCCceec
Confidence 99999999999999976432 2289999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCCCce-ecccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhhhhhhhhhHhhhhhhcccCCCCC
Q 044366 803 EPHSSNWT-EFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIK-GYHPGDFVSTIFSSISNMIIEVNQILDHRLPTP 880 (918)
Q Consensus 803 ~~~~~~~~-~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 880 (918)
........ ...++..|+|||.+.+..++.++||||+|+++|+|++ |+.|+...... .... ..........
T Consensus 154 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~-----~~~~---~~~~~~~~~~ 225 (258)
T smart00219 154 YDDDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNE-----EVLE---YLKKGYRLPK 225 (258)
T ss_pred ccccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHH-----HHHH---HHhcCCCCCC
Confidence 54422211 2236789999999988889999999999999999998 78887542211 0001 1111111111
Q ss_pred CcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 044366 881 SRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLL 916 (918)
Q Consensus 881 ~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L 916 (918)
... ....+.+++.+|+..||++|||+.|+++.|
T Consensus 226 ~~~---~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 226 PEN---CPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred CCc---CCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 111 335688899999999999999999999865
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=297.26 Aligned_cols=250 Identities=20% Similarity=0.307 Sum_probs=200.9
Q ss_pred CCCCceeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEEEE
Q 044366 647 NFGEKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFIVC 725 (918)
Q Consensus 647 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 725 (918)
+|+..+.||+|+||.||+|.. .+++.+|+|.+..... .......+.+|+++++.++||||+++++.+..++..++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 78 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQM--TKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVM 78 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEecccc--ccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEE
Confidence 478889999999999999954 5789999999875422 2233578999999999999999999999999899999999
Q ss_pred EeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCC-cEEEeccccccccCC
Q 044366 726 EYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEY-EAHVSDFGFAKFLEP 804 (918)
Q Consensus 726 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~-~~kl~DfG~~~~~~~ 804 (918)
||+++++|.+++.... ...+++..++.++.++++|++|+|+. +++|+||+|+||++++++ .++++|||.+.....
T Consensus 79 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~ 154 (256)
T cd08220 79 EYAPGGTLAEYIQKRC-NSLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGISKILSS 154 (256)
T ss_pred ecCCCCCHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccCCCceecCC
Confidence 9999999999997643 34479999999999999999999999 999999999999998654 579999999987654
Q ss_pred CCCCceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCCCCCcch
Q 044366 805 HSSNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRDV 884 (918)
Q Consensus 805 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 884 (918)
... .....++..|+|||.+.+..++.++||||||+++|+|++|+.||+...... . . .............
T Consensus 155 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~-~----~---~~~~~~~~~~~~~-- 223 (256)
T cd08220 155 KSK-AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPA-L----V---LKIMSGTFAPISD-- 223 (256)
T ss_pred Ccc-ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHH-H----H---HHHHhcCCCCCCC--
Confidence 322 233567889999999998888999999999999999999999976543211 0 1 1111111111111
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 885 TDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 885 ~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
.....+.+++.+||+.+|.+|||+.|++.
T Consensus 224 -~~~~~l~~li~~~l~~~p~~Rpt~~~ll~ 252 (256)
T cd08220 224 -RYSPDLRQLILSMLNLDPSKRPQLSQIMA 252 (256)
T ss_pred -CcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 12346788999999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=299.53 Aligned_cols=255 Identities=24% Similarity=0.384 Sum_probs=200.1
Q ss_pred CCCCceeeccccceEEEEEE-eCCCCEEEEEEcccccccCCC--CChHHHHHHHHHHhhccCCceeeEecccccCCceEE
Q 044366 647 NFGEKYCIGKGGQRSVYKAE-LPSGNIFAVKKFKAELFSDET--ANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFI 723 (918)
Q Consensus 647 ~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 723 (918)
+|+..+.||+|++|.||+|. ..+++.||+|.+......... ...+.+.+|++.++.++|+||+++++++.+++..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 47778899999999999995 467899999998653221111 124678999999999999999999999999999999
Q ss_pred EEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCC-cEEEecccccccc
Q 044366 724 VCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEY-EAHVSDFGFAKFL 802 (918)
Q Consensus 724 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~-~~kl~DfG~~~~~ 802 (918)
|+||+++++|.+++.+.. ++++..+..++.|++.|++|||+. +++|+||+|+||+++.++ .++|+|||.+...
T Consensus 81 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~ 154 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYG---AFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARL 154 (268)
T ss_pred EEeccCCCcHHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccccccccc
Confidence 999999999999997643 488999999999999999999999 999999999999998776 5999999999877
Q ss_pred CCCCCC----ceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCC
Q 044366 803 EPHSSN----WTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLP 878 (918)
Q Consensus 803 ~~~~~~----~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 878 (918)
...... .....++..|+|||.+.+..++.++||||+|+++|+|++|+.||...... .......+.......
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~-----~~~~~~~~~~~~~~~ 229 (268)
T cd06630 155 AAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHS-----NHLALIFKIASATTA 229 (268)
T ss_pred ccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCc-----chHHHHHHHhccCCC
Confidence 543211 12346788999999998888999999999999999999999997533211 000111111111111
Q ss_pred CCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 879 TPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 879 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
. .........+.+++.+|++.+|++||++.|+++
T Consensus 230 ~--~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 230 P--SIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred C--CCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 1 111123356888999999999999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=297.61 Aligned_cols=251 Identities=23% Similarity=0.318 Sum_probs=201.9
Q ss_pred CCCCceeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEEEE
Q 044366 647 NFGEKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFIVC 725 (918)
Q Consensus 647 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 725 (918)
+|...+.||+|+||.||+|.. .+|..||+|.+..... .....+.+.+|+++++.++|+||+++++++..++..++|+
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~ 78 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKM--PVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVM 78 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhc--cchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEE
Confidence 477889999999999999955 4689999999866422 1233567889999999999999999999999999999999
Q ss_pred EeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCc-EEEeccccccccCC
Q 044366 726 EYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYE-AHVSDFGFAKFLEP 804 (918)
Q Consensus 726 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~-~kl~DfG~~~~~~~ 804 (918)
||+++++|.+++.... ...+++..+..++.|+++|++|||+. +++|+||+|+||++++++. ++++|||.+.....
T Consensus 79 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~ 154 (257)
T cd08225 79 EYCDGGDLMKRINRQR-GVLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLND 154 (257)
T ss_pred ecCCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEecccccchhccC
Confidence 9999999999997643 23479999999999999999999999 9999999999999998864 69999999987654
Q ss_pred CCCCceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCCCCCcch
Q 044366 805 HSSNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRDV 884 (918)
Q Consensus 805 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 884 (918)
.........|++.|+|||+..+..++.++||||||+++|||++|+.|+...... ... ........+....
T Consensus 155 ~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-~~~-------~~~~~~~~~~~~~-- 224 (257)
T cd08225 155 SMELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLH-QLV-------LKICQGYFAPISP-- 224 (257)
T ss_pred CcccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHH-HHH-------HHHhcccCCCCCC--
Confidence 433333456889999999998888999999999999999999999997643211 111 1111111111111
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 885 TDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 885 ~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
.....+.+++.+|+..+|++|||+.|+++
T Consensus 225 -~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 253 (257)
T cd08225 225 -NFSRDLRSLISQLFKVSPRDRPSITSILK 253 (257)
T ss_pred -CCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 12246888999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=327.76 Aligned_cols=253 Identities=26% Similarity=0.418 Sum_probs=194.3
Q ss_pred HhcCCCCceeeccccceEEEEEEeC-CCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEeccccc-----
Q 044366 644 ATGNFGEKYCIGKGGQRSVYKAELP-SGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSN----- 717 (918)
Q Consensus 644 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~----- 717 (918)
-..+|++...||+||||.||+++.+ ||+.||||++.... .........+|+..+++++|||||+++..|.+
T Consensus 477 Y~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~---s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~ 553 (1351)
T KOG1035|consen 477 YLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA---SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAEL 553 (1351)
T ss_pred HhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch---HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcc
Confidence 4467888899999999999999665 89999999998753 22335678999999999999999999732100
Q ss_pred -------------------------------------------------------------------------C------
Q 044366 718 -------------------------------------------------------------------------A------ 718 (918)
Q Consensus 718 -------------------------------------------------------------------------~------ 718 (918)
+
T Consensus 554 ~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~t 633 (1351)
T KOG1035|consen 554 TVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNT 633 (1351)
T ss_pred ccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccc
Confidence 0
Q ss_pred -----------------------------------CceEEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHH
Q 044366 719 -----------------------------------QHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALS 763 (918)
Q Consensus 719 -----------------------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~ 763 (918)
...||-||||+..++.+++++..... .....|+++++|++||+
T Consensus 634 S~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~--~~d~~wrLFreIlEGLa 711 (1351)
T KOG1035|consen 634 SDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS--QRDEAWRLFREILEGLA 711 (1351)
T ss_pred cccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch--hhHHHHHHHHHHHHHHH
Confidence 11478899999988888887654211 35788999999999999
Q ss_pred HHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccC------------------CCCCCceecccccccccccccc
Q 044366 764 YLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLE------------------PHSSNWTEFAGTVGYAAPELAY 825 (918)
Q Consensus 764 ~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~------------------~~~~~~~~~~g~~~y~aPE~~~ 825 (918)
|+|++ |+|||||||.||++++++.|||+|||+|.... +.....+..+||.-|+|||++.
T Consensus 712 YIH~~---giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~ 788 (1351)
T KOG1035|consen 712 YIHDQ---GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLS 788 (1351)
T ss_pred HHHhC---ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhc
Confidence 99999 99999999999999999999999999998721 1111335678999999999987
Q ss_pred cC---CCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCCCCCcchHHHHHHHHHHHHHcccCC
Q 044366 826 TM---RATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRDVTDKLRSIMEVAILCLVEN 902 (918)
Q Consensus 826 ~~---~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~d 902 (918)
+. .|+.|+|+||+|+|++||+. ||...-.. ...+..+.++.+|.+.....+....=..+|.+|++.|
T Consensus 789 ~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMER-------a~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hd 858 (1351)
T KOG1035|consen 789 DTSSNKYNSKIDMYSLGIVLFEMLY---PFGTSMER-------ASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHD 858 (1351)
T ss_pred ccccccccchhhhHHHHHHHHHHhc---cCCchHHH-------HHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCC
Confidence 54 49999999999999999973 44422111 1122333345555443333444455678899999999
Q ss_pred CCCCCCHHHHHH
Q 044366 903 PEARPTMKEVCN 914 (918)
Q Consensus 903 p~~RPt~~evl~ 914 (918)
|.+||||.|++.
T Consensus 859 P~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 859 PSKRPTATELLN 870 (1351)
T ss_pred CccCCCHHHHhh
Confidence 999999999985
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=281.14 Aligned_cols=265 Identities=20% Similarity=0.287 Sum_probs=198.0
Q ss_pred HhcCCCCceeeccccceEEEEEEeC---C--CCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEeccccc-
Q 044366 644 ATGNFGEKYCIGKGGQRSVYKAELP---S--GNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSN- 717 (918)
Q Consensus 644 ~~~~~~~~~~lg~G~~g~Vy~~~~~---~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~- 717 (918)
....|+....||+|+||.||+|... + ...+|+|+++.+.... .-.....+|+..++.++||||+.+..++-.
T Consensus 22 ~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~t--GiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~ 99 (438)
T KOG0666|consen 22 DLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGT--GISMSACREIALLRELKHPNVISLVKVFLSH 99 (438)
T ss_pred HHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCC--CcCHHHHHHHHHHHHhcCCcchhHHHHHhcc
Confidence 3456888899999999999999332 2 2379999998754322 223567899999999999999999998866
Q ss_pred CCceEEEEEeccCCChhHHhhccc--ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCC----CcE
Q 044366 718 AQHSFIVCEYLARGSLTTILRDDA--AAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSE----YEA 791 (918)
Q Consensus 718 ~~~~~lv~e~~~~gsL~~~l~~~~--~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~----~~~ 791 (918)
+...++++||.+. +|.+.++-++ ....++...+..|..||+.|+.|||+. -|+|||+||+|||+..+ |.|
T Consensus 100 d~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmgdgperG~V 175 (438)
T KOG0666|consen 100 DKKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMGDGPERGRV 175 (438)
T ss_pred CceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEeccCCccCee
Confidence 8899999999998 9999886432 335689999999999999999999999 89999999999999988 899
Q ss_pred EEeccccccccCCCCCC---ceecccccccccccccccCC-CCcccchhhHHHHHHHHHhCCCCCCcchhhhhhh----h
Q 044366 792 HVSDFGFAKFLEPHSSN---WTEFAGTVGYAAPELAYTMR-ATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSI----S 863 (918)
Q Consensus 792 kl~DfG~~~~~~~~~~~---~~~~~g~~~y~aPE~~~~~~-~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~----~ 863 (918)
||+|+|+++.+..+-.. ....+.|..|.|||.+.|.+ ||.+.|||+.||++.||+|-.+-|.......+.. .
T Consensus 176 KIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~ 255 (438)
T KOG0666|consen 176 KIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQH 255 (438)
T ss_pred EeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchH
Confidence 99999999998765332 24567799999999998764 8999999999999999998776553322111111 0
Q ss_pred hhHhhhhhhcc----cCCCCCC------------------c-chHHH-------HHHHHHHHHHcccCCCCCCCCHHHHH
Q 044366 864 NMIIEVNQILD----HRLPTPS------------------R-DVTDK-------LRSIMEVAILCLVENPEARPTMKEVC 913 (918)
Q Consensus 864 ~~~~~~~~~~~----~~~~~~~------------------~-~~~~~-------~~~l~~li~~cl~~dp~~RPt~~evl 913 (918)
+...++.+++. .++|... . ..... .....+++.+++..||.+|-|+++.+
T Consensus 256 dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAl 335 (438)
T KOG0666|consen 256 DQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQAL 335 (438)
T ss_pred HHHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHh
Confidence 11111111111 1111100 0 00000 12367899999999999999999987
Q ss_pred H
Q 044366 914 N 914 (918)
Q Consensus 914 ~ 914 (918)
+
T Consensus 336 e 336 (438)
T KOG0666|consen 336 E 336 (438)
T ss_pred c
Confidence 6
|
|
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=336.80 Aligned_cols=252 Identities=25% Similarity=0.342 Sum_probs=203.6
Q ss_pred hcCCCCceeeccccceEEEEE-EeCCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEE
Q 044366 645 TGNFGEKYCIGKGGQRSVYKA-ELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFI 723 (918)
Q Consensus 645 ~~~~~~~~~lg~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 723 (918)
+-+|.....||.|.||.||-| ...+|+..|+|.++..... ....+...+|+.++..++|||+|+++|+-.+++..+|
T Consensus 1234 ~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~--~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~I 1311 (1509)
T KOG4645|consen 1234 TFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSD--HKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYI 1311 (1509)
T ss_pred eeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccc--cccCcchHHHHHHHHhccCccccccCceeecHHHHHH
Confidence 346667778999999999999 6778999999998764333 4446778999999999999999999999999999999
Q ss_pred EEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccC
Q 044366 724 VCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLE 803 (918)
Q Consensus 724 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~ 803 (918)
.||||++|+|.+.++..+ ..++.....+..|++.|++|||++ |||||||||.||+++.+|.+|++|||.|..+.
T Consensus 1312 FMEyC~~GsLa~ll~~gr---i~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~ 1385 (1509)
T KOG4645|consen 1312 FMEYCEGGSLASLLEHGR---IEDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKYGDFGSAVKIK 1385 (1509)
T ss_pred HHHHhccCcHHHHHHhcc---hhhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEeecccceeEec
Confidence 999999999999997643 255666677899999999999999 99999999999999999999999999999886
Q ss_pred CCCCC----ceecccccccccccccccC---CCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccC
Q 044366 804 PHSSN----WTEFAGTVGYAAPELAYTM---RATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHR 876 (918)
Q Consensus 804 ~~~~~----~~~~~g~~~y~aPE~~~~~---~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 876 (918)
..... .....||+.|||||++.+. ....++||||+|||+.||+||+.||...+..+. -+..+..+.
T Consensus 1386 ~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~a-------IMy~V~~gh 1458 (1509)
T KOG4645|consen 1386 NNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWA-------IMYHVAAGH 1458 (1509)
T ss_pred CchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhH-------HHhHHhccC
Confidence 65322 2356799999999999754 345689999999999999999999765443221 122222223
Q ss_pred CCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 877 LPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 877 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
.|..+.. ...+-.+++..|+..||++|+++.|+++
T Consensus 1459 ~Pq~P~~---ls~~g~dFle~Cl~~dP~~Rw~~~qlle 1493 (1509)
T KOG4645|consen 1459 KPQIPER---LSSEGRDFLEHCLEQDPKMRWTASQLLE 1493 (1509)
T ss_pred CCCCchh---hhHhHHHHHHHHHhcCchhhhHHHHHHH
Confidence 3332222 3345677888999999999999999876
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=286.89 Aligned_cols=262 Identities=19% Similarity=0.292 Sum_probs=207.2
Q ss_pred HHHHHHhcCCCCceeeccccceEEEEEEeC------CCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEe
Q 044366 639 EEITKATGNFGEKYCIGKGGQRSVYKAELP------SGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFH 712 (918)
Q Consensus 639 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~ 712 (918)
.++.....+++....+.+|+||.||.|.+. +.+.|-||.++.. ..+.....|..|...+..+.|||+.++.
T Consensus 277 ~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~---AS~iQv~~~L~es~lly~~sH~nll~V~ 353 (563)
T KOG1024|consen 277 QELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQH---ASQIQVNLLLQESMLLYGASHPNLLSVL 353 (563)
T ss_pred HhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhc---ccHHHHHHHHHHHHHHhcCcCCCcccee
Confidence 355556667777778999999999999553 2345777877653 2233456789999999999999999999
Q ss_pred cccc-cCCceEEEEEeccCCChhHHhh-----cccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeC
Q 044366 713 GFCS-NAQHSFIVCEYLARGSLTTILR-----DDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLD 786 (918)
Q Consensus 713 ~~~~-~~~~~~lv~e~~~~gsL~~~l~-----~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~ 786 (918)
+++. +....+++|+++.-|+|..|+. +....+.++..+...++.|++.|++|||++ +|||.||.++|.++|
T Consensus 354 ~V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRNCvId 430 (563)
T KOG1024|consen 354 GVSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNCVID 430 (563)
T ss_pred EEEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc---Ccccchhhhhcceeh
Confidence 9885 4567899999999999999998 334456678889999999999999999999 999999999999999
Q ss_pred CCCcEEEeccccccccCCCCCCc--eecccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhhhhhhh
Q 044366 787 SEYEAHVSDFGFAKFLEPHSSNW--TEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIK-GYHPGDFVSTIFSSIS 863 (918)
Q Consensus 787 ~~~~~kl~DfG~~~~~~~~~~~~--~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~p~~~~~~~~~~~~ 863 (918)
+..++||+|=.+++..-|.++.. .....+..||+||.+....|+.++|||||||++|||+| |+.|+...++. .+.
T Consensus 431 d~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPf--Em~ 508 (563)
T KOG1024|consen 431 DQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPF--EME 508 (563)
T ss_pred hheeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHH--HHH
Confidence 99999999999999988776543 23345789999999999999999999999999999998 88996543321 111
Q ss_pred hhHhhhhhhcccCCCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 044366 864 NMIIEVNQILDHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLLC 917 (918)
Q Consensus 864 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 917 (918)
...++ +..-..+..+ +.++..++.-||+.+|++||+++|++.-|+
T Consensus 509 ~ylkd------GyRlaQP~NC---PDeLf~vMacCWallpeeRPsf~Qlv~cLs 553 (563)
T KOG1024|consen 509 HYLKD------GYRLAQPFNC---PDELFTVMACCWALLPEERPSFSQLVICLS 553 (563)
T ss_pred HHHhc------cceecCCCCC---cHHHHHHHHHHHhcCcccCCCHHHHHHHHH
Confidence 11111 2111222223 345888899999999999999999998775
|
|
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=298.86 Aligned_cols=250 Identities=26% Similarity=0.338 Sum_probs=202.1
Q ss_pred CCCCceeeccccceEEEEEEeC-CCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEEEE
Q 044366 647 NFGEKYCIGKGGQRSVYKAELP-SGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFIVC 725 (918)
Q Consensus 647 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 725 (918)
+|...+.||+|+||.||+|... +++.||+|.+...... .....+.+.+|++.+++++||||+++++++.++...++|+
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 79 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCV-EKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVV 79 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhc-chhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEE
Confidence 4778899999999999999654 6899999998764322 2234678999999999999999999999999999999999
Q ss_pred EeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccCCC
Q 044366 726 EYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPH 805 (918)
Q Consensus 726 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~~~ 805 (918)
||+++++|.+++... ..+++.++..++.|+++|++|||+. +++|+||+|+||++++++.++|+|||.+......
T Consensus 80 e~~~~~~L~~~l~~~---~~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 153 (258)
T cd05578 80 DLLLGGDLRYHLSQK---VKFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPD 153 (258)
T ss_pred eCCCCCCHHHHHHhc---CCcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEEeecccccccCCC
Confidence 999999999999764 3588999999999999999999999 9999999999999999999999999999876543
Q ss_pred CCCceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCCCCCcchH
Q 044366 806 SSNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRDVT 885 (918)
Q Consensus 806 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 885 (918)
. ......|+..|+|||.+.+..++.++||||+|+++|+|++|..||...... ....... .........+ .
T Consensus 154 ~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--~~~~~~~---~~~~~~~~~~-~--- 223 (258)
T cd05578 154 T-LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRT--IRDQIRA---KQETADVLYP-A--- 223 (258)
T ss_pred c-cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCcc--HHHHHHH---HhccccccCc-c---
Confidence 2 223456788999999998888999999999999999999999998754421 0011111 1110111111 1
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCH--HHHH
Q 044366 886 DKLRSIMEVAILCLVENPEARPTM--KEVC 913 (918)
Q Consensus 886 ~~~~~l~~li~~cl~~dp~~RPt~--~evl 913 (918)
.....+.+++.+||+.||.+||++ +|++
T Consensus 224 ~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 224 TWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred cCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 123568889999999999999999 7765
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=303.46 Aligned_cols=262 Identities=20% Similarity=0.272 Sum_probs=196.9
Q ss_pred cCCCCceeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhcc-CCceeeEecccccCCc---
Q 044366 646 GNFGEKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIR-HRNIIKFHGFCSNAQH--- 720 (918)
Q Consensus 646 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~--- 720 (918)
++|+..+.||+|+||.||+|.. .+|+.||+|+++.... .......+.+|+.+++.++ ||||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~--~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~ 78 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMD--EEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGK 78 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhcc--ccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCC
Confidence 4688889999999999999965 4789999999865421 2223467889999999995 6999999998876655
Q ss_pred --eEEEEEeccCCChhHHhhcccc--cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCC-CCcEEEec
Q 044366 721 --SFIVCEYLARGSLTTILRDDAA--AKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDS-EYEAHVSD 795 (918)
Q Consensus 721 --~~lv~e~~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~-~~~~kl~D 795 (918)
.++||||+++ +|.+++..... ...+++..++.++.||+.||+|||+. +++||||+|+||+++. ++.+||+|
T Consensus 79 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~~~kl~d 154 (295)
T cd07837 79 PSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIAD 154 (295)
T ss_pred ceEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCCeEEEee
Confidence 7999999985 89888865432 34589999999999999999999999 9999999999999998 88999999
Q ss_pred cccccccCCCCCCceeccccccccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcc
Q 044366 796 FGFAKFLEPHSSNWTEFAGTVGYAAPELAYT-MRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILD 874 (918)
Q Consensus 796 fG~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 874 (918)
||++..+...........+++.|+|||++.+ ..++.++||||||+++|+|++|..||......... ............
T Consensus 155 fg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~-~~~~~~~~~~~~ 233 (295)
T cd07837 155 LGLGRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQL-LHIFKLLGTPTE 233 (295)
T ss_pred cccceecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHH-HHHHHHhCCCCh
Confidence 9999876544333334456889999998865 45789999999999999999999998644322111 100000000000
Q ss_pred c------------CCCCC-----CcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 875 H------------RLPTP-----SRDVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 875 ~------------~~~~~-----~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
. ..+.. ..........+.++|.+||+.||.+||+++|++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 234 QVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred hhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 0 00000 0001123356889999999999999999999875
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=302.09 Aligned_cols=259 Identities=22% Similarity=0.354 Sum_probs=200.1
Q ss_pred CCCCceeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEEEE
Q 044366 647 NFGEKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFIVC 725 (918)
Q Consensus 647 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 725 (918)
+|.+.+.||+|++|.||+|.. .+|+.||+|++...... ....+.+.+|+.++++++||||+++++++..+...++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~--~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~ 78 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLE--GGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVM 78 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEccccc--chhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEe
Confidence 477889999999999999965 47899999998764221 233568999999999999999999999999999999999
Q ss_pred EeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccCCC
Q 044366 726 EYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPH 805 (918)
Q Consensus 726 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~~~ 805 (918)
||+ +++|.+++.... ..+++.+++.++.||++||+|||+. +++|+||||+||+++.++.++++|||.+......
T Consensus 79 e~~-~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~ 152 (286)
T cd07832 79 EYM-PSDLSEVLRDEE--RPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLARLFSEE 152 (286)
T ss_pred ccc-CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEEeeeeecccccCC
Confidence 999 999999987543 4589999999999999999999999 9999999999999999999999999999876543
Q ss_pred CC-CceecccccccccccccccCC-CCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhh-----------h-
Q 044366 806 SS-NWTEFAGTVGYAAPELAYTMR-ATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVN-----------Q- 871 (918)
Q Consensus 806 ~~-~~~~~~g~~~y~aPE~~~~~~-~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~-----------~- 871 (918)
.. ......++..|+|||++.+.. ++.++||||+|+++|||++|.+||...... ........... +
T Consensus 153 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 231 (286)
T cd07832 153 EPRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDI-EQLAIVFRTLGTPNEETWPGLTSL 231 (286)
T ss_pred CCCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHH-HHHHHHHHHcCCCChHHHhhccCc
Confidence 32 223456889999999986544 688999999999999999998776543321 11111000000 0
Q ss_pred --hcccCCCCCCc-----chHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 872 --ILDHRLPTPSR-----DVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 872 --~~~~~~~~~~~-----~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
......+.... ...+....+.+++.+|++.||.+||+++++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~ 281 (286)
T cd07832 232 PDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALR 281 (286)
T ss_pred chhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 00000000000 00122367889999999999999999999986
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=302.84 Aligned_cols=243 Identities=26% Similarity=0.404 Sum_probs=195.7
Q ss_pred eeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEEEEEeccC
Q 044366 652 YCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFIVCEYLAR 730 (918)
Q Consensus 652 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 730 (918)
..||+|+||.||+|.. .+|+.||||++... .....+.+.+|+.+++.++|+||+++++++..++..++||||+++
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 101 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLR----KQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEG 101 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEeccc----chhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCC
Confidence 4699999999999965 57899999987532 223356789999999999999999999999999999999999999
Q ss_pred CChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccCCCCCCce
Q 044366 731 GSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWT 810 (918)
Q Consensus 731 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~~~~~~~~ 810 (918)
++|.+++... .+++..+..++.|++.|++|||+. +++||||+|+||+++.++.++++|||.+...........
T Consensus 102 ~~L~~~~~~~----~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~~ 174 (292)
T cd06657 102 GALTDIVTHT----RMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRK 174 (292)
T ss_pred CcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEcccccceeccccccccc
Confidence 9999987543 378999999999999999999999 999999999999999999999999999876654333334
Q ss_pred ecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCCCCCcchHHHHHH
Q 044366 811 EFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRDVTDKLRS 890 (918)
Q Consensus 811 ~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 890 (918)
...|+..|+|||.+.+..++.++||||+|+++|+|++|+.||...... ... ............ ........
T Consensus 175 ~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~-~~~----~~~~~~~~~~~~----~~~~~~~~ 245 (292)
T cd06657 175 SLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL-KAM----KMIRDNLPPKLK----NLHKVSPS 245 (292)
T ss_pred ccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHH----HHHHhhCCcccC----CcccCCHH
Confidence 456889999999998888899999999999999999999997643221 010 011111111111 11122345
Q ss_pred HHHHHHHcccCCCCCCCCHHHHHH
Q 044366 891 IMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 891 l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
+.+++.+||+.||.+||++.++++
T Consensus 246 l~~li~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 246 LKGFLDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred HHHHHHHHHhCCcccCcCHHHHhc
Confidence 788899999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-33 Score=302.26 Aligned_cols=249 Identities=27% Similarity=0.395 Sum_probs=196.1
Q ss_pred cCCCCceeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEEE
Q 044366 646 GNFGEKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFIV 724 (918)
Q Consensus 646 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 724 (918)
..|...+.||+|+||.||+|.. .+|+.||+|++...... .....+++.+|+++++.++||||+++++++.+++..++|
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv 93 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQ-SNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLV 93 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccC-cHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEE
Confidence 4588889999999999999965 47899999988643211 122245788999999999999999999999999999999
Q ss_pred EEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccCC
Q 044366 725 CEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEP 804 (918)
Q Consensus 725 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~~ 804 (918)
|||++ |++.+++.... ..+++..+..++.|++.|+.|||+. +++||||+|+||++++++.++|+|||++....+
T Consensus 94 ~e~~~-g~l~~~~~~~~--~~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~ 167 (307)
T cd06607 94 MEYCL-GSASDILEVHK--KPLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLADFGSASLVSP 167 (307)
T ss_pred HHhhC-CCHHHHHHHcc--cCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCEEEeecCcceecCC
Confidence 99997 57777775432 3489999999999999999999999 999999999999999999999999999976543
Q ss_pred CCCCceecccccccccccccc---cCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCCCCC
Q 044366 805 HSSNWTEFAGTVGYAAPELAY---TMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPS 881 (918)
Q Consensus 805 ~~~~~~~~~g~~~y~aPE~~~---~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 881 (918)
. ....++..|+|||++. ...++.++||||||+++|||++|+.|+........ .........+..
T Consensus 168 ~----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~--------~~~~~~~~~~~~- 234 (307)
T cd06607 168 A----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA--------LYHIAQNDSPTL- 234 (307)
T ss_pred C----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHH--------HHHHhcCCCCCC-
Confidence 3 2345788999999874 35678899999999999999999999764432110 001111111111
Q ss_pred cchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 044366 882 RDVTDKLRSIMEVAILCLVENPEARPTMKEVCNL 915 (918)
Q Consensus 882 ~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 915 (918)
........+.+++.+||+.||++||++.+++..
T Consensus 235 -~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 235 -SSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred -CchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 111234568899999999999999999999863
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=304.30 Aligned_cols=261 Identities=26% Similarity=0.352 Sum_probs=197.6
Q ss_pred hcCCCCceeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccC--Cce
Q 044366 645 TGNFGEKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNA--QHS 721 (918)
Q Consensus 645 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~ 721 (918)
.++|.+.+.||+|+||.||+|.. .+|+.||+|+++..... ......+.+|++++++++|+||+++++++.+. +..
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNER--DGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSI 83 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCC--CCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeE
Confidence 46789999999999999999965 57999999998754221 12234567899999999999999999998654 568
Q ss_pred EEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccc
Q 044366 722 FIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKF 801 (918)
Q Consensus 722 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~ 801 (918)
++||||+++ +|.+++.... ..+++.+++.++.|++.|++|||+. +++||||||+||+++.++.+||+|||.+..
T Consensus 84 ~lv~e~~~~-~l~~~l~~~~--~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~kL~dfg~~~~ 157 (309)
T cd07845 84 FLVMEYCEQ-DLASLLDNMP--TPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIADFGLART 157 (309)
T ss_pred EEEEecCCC-CHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccceeee
Confidence 999999975 8888887542 4589999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCCceeccccccccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhh----hh----
Q 044366 802 LEPHSSNWTEFAGTVGYAAPELAYT-MRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVN----QI---- 872 (918)
Q Consensus 802 ~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~----~~---- 872 (918)
............++..|+|||.+.+ ..++.++||||+|+++|||++|+.||...... ........... ..
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 236 (309)
T cd07845 158 YGLPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEI-EQLDLIIQLLGTPNESIWPGF 236 (309)
T ss_pred cCCccCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHhcCCCChhhchhh
Confidence 7654333344456788999999865 45788999999999999999999998644321 11111100000 00
Q ss_pred ------cccCCCC-CCcch----HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 873 ------LDHRLPT-PSRDV----TDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 873 ------~~~~~~~-~~~~~----~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
.....+. ..... ......+.+++.+|++.||++|||+.|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~ 289 (309)
T cd07845 237 SDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE 289 (309)
T ss_pred hcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 0000000 00000 112456788999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=300.07 Aligned_cols=247 Identities=23% Similarity=0.274 Sum_probs=194.1
Q ss_pred eccccceEEEEEE-eCCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEEEEEeccCCC
Q 044366 654 IGKGGQRSVYKAE-LPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFIVCEYLARGS 732 (918)
Q Consensus 654 lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gs 732 (918)
||+|+||.||+|. ..+|+.||+|.+....... ......+..|+++++.++||||+++++++...+..++||||+++++
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~ 79 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKK-RKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGD 79 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhh-hhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCc
Confidence 6899999999995 4578999999986532221 2234567889999999999999999999999999999999999999
Q ss_pred hhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccCCCCCCceec
Q 044366 733 LTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEF 812 (918)
Q Consensus 733 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~ 812 (918)
|.+++..... ..+++.+++.++.|++.|+.|||+. +++||||+|+||+++.++.++|+|||.+..... .......
T Consensus 80 L~~~l~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~-~~~~~~~ 154 (277)
T cd05577 80 LKYHIYNVGE-PGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKG-GKKIKGR 154 (277)
T ss_pred HHHHHHHcCc-CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcchhhhcc-CCccccc
Confidence 9999976542 4589999999999999999999999 999999999999999999999999999986643 2222345
Q ss_pred ccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCCCCCcchHHHHHHHH
Q 044366 813 AGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRDVTDKLRSIM 892 (918)
Q Consensus 813 ~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 892 (918)
.++..|+|||++.+..++.++||||+|+++|+|++|+.||........ . ................. ....+.
T Consensus 155 ~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---~--~~~~~~~~~~~~~~~~~---~~~~~~ 226 (277)
T cd05577 155 AGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVE---K--EELKRRTLEMAVEYPDK---FSPEAK 226 (277)
T ss_pred cCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCccccc---H--HHHHhccccccccCCcc---CCHHHH
Confidence 678899999999888899999999999999999999999864432100 0 00011111111111111 234678
Q ss_pred HHHHHcccCCCCCCC-----CHHHHHH
Q 044366 893 EVAILCLVENPEARP-----TMKEVCN 914 (918)
Q Consensus 893 ~li~~cl~~dp~~RP-----t~~evl~ 914 (918)
+++.+||+.||.+|| ++.+++.
T Consensus 227 ~li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 227 DLCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred HHHHHHccCChhHccCCCcccHHHHHh
Confidence 899999999999999 6766754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=295.74 Aligned_cols=244 Identities=28% Similarity=0.350 Sum_probs=196.0
Q ss_pred eccccceEEEEEEeC-CCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEEEEEeccCCC
Q 044366 654 IGKGGQRSVYKAELP-SGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFIVCEYLARGS 732 (918)
Q Consensus 654 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gs 732 (918)
||.|++|.||+|... +++.||+|++....... ....+.+.+|+++++.++||||+++++++.++...++|+||+++++
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 79 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVE-TGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGE 79 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchh-hhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCc
Confidence 699999999999654 58999999987543222 2235789999999999999999999999999999999999999999
Q ss_pred hhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccCCCCCCceec
Q 044366 733 LTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEF 812 (918)
Q Consensus 733 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~ 812 (918)
|.+++.+.. .+++..+..++.|++.|++|+|+. +++|+||+|+||+++.++.++|+|||.+....... .....
T Consensus 80 L~~~l~~~~---~l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~-~~~~~ 152 (262)
T cd05572 80 LWTILRDRG---LFDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ-KTWTF 152 (262)
T ss_pred HHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc-ccccc
Confidence 999997643 388999999999999999999998 99999999999999999999999999998765432 22334
Q ss_pred ccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcc-cCCCCCCcchHHHHHHH
Q 044366 813 AGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILD-HRLPTPSRDVTDKLRSI 891 (918)
Q Consensus 813 ~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l 891 (918)
.++..|+|||.+.+..++.++|+||+|+++|+|++|..||....... ......... ......+... ...+
T Consensus 153 ~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~------~~~~~~~~~~~~~~~~~~~~---~~~~ 223 (262)
T cd05572 153 CGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDP------MEIYNDILKGNGKLEFPNYI---DKAA 223 (262)
T ss_pred cCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCH------HHHHHHHhccCCCCCCCccc---CHHH
Confidence 67889999999988889999999999999999999999986543200 011111111 1111111111 3568
Q ss_pred HHHHHHcccCCCCCCCC-----HHHHHH
Q 044366 892 MEVAILCLVENPEARPT-----MKEVCN 914 (918)
Q Consensus 892 ~~li~~cl~~dp~~RPt-----~~evl~ 914 (918)
.+++.+||+.+|++||+ ++|+++
T Consensus 224 ~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 224 KDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred HHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 89999999999999999 788765
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-33 Score=292.93 Aligned_cols=249 Identities=30% Similarity=0.452 Sum_probs=203.0
Q ss_pred CCCCceeeccccceEEEEEEeC-CCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEEEE
Q 044366 647 NFGEKYCIGKGGQRSVYKAELP-SGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFIVC 725 (918)
Q Consensus 647 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 725 (918)
+|+..+.||+|++|.||+|... +++.|++|++..... ...+.+.+|++.++.++|++++++++++..+...++++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~ 76 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK----EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVM 76 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEE
Confidence 4677889999999999999664 789999999876321 34678999999999999999999999999999999999
Q ss_pred EeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccCCC
Q 044366 726 EYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPH 805 (918)
Q Consensus 726 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~~~ 805 (918)
||+++++|.+++.... ..+++.+++.++.|+++|++|||+. +++||||+|+||++++++.++|+|||.+......
T Consensus 77 e~~~~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 151 (253)
T cd05122 77 EFCSGGSLKDLLKSTN--QTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDT 151 (253)
T ss_pred ecCCCCcHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEeecccccccccc
Confidence 9999999999987652 4589999999999999999999998 9999999999999999999999999999877654
Q ss_pred CCCceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCCCCCcchH
Q 044366 806 SSNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRDVT 885 (918)
Q Consensus 806 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 885 (918)
.. .....++..|+|||.+.+..++.++||||||+++|+|++|+.|+...... ..... ... ...+.. ....
T Consensus 152 ~~-~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-~~~~~----~~~---~~~~~~-~~~~ 221 (253)
T cd05122 152 KA-RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPM-KALFK----IAT---NGPPGL-RNPE 221 (253)
T ss_pred cc-ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchH-HHHHH----HHh---cCCCCc-Cccc
Confidence 32 33456889999999998888999999999999999999999997654221 01000 001 101111 1111
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 886 DKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 886 ~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
.....+.+++.+||+.||++|||+.|+++
T Consensus 222 ~~~~~~~~~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 222 KWSDEFKDFLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred ccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 11356888999999999999999999975
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=320.37 Aligned_cols=387 Identities=29% Similarity=0.394 Sum_probs=319.2
Q ss_pred CCCCCCCCEEeCCCCccc-ccCCccccCCCCCCEEEcccccccccCCCCcCCCCCCCEEEcccccccccCCccccCCCCC
Q 044366 17 IGNLSKLQYLDLGNNQLS-GVIPPEIGKLNQLRRLYLDVNQLHGTIPPVIGQLSLINELVFCHNNVSGRIPSSLGNLSNL 95 (918)
Q Consensus 17 ~~~l~~L~~L~L~~n~i~-~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~l~~l~~L 95 (918)
.+-|+..+-.|+++|.++ +..|.++..++++++|.|++.++. .+|+.++.+.+|++|.++||+++ .+...+..|+.|
T Consensus 3 tgVLpFVrGvDfsgNDFsg~~FP~~v~qMt~~~WLkLnrt~L~-~vPeEL~~lqkLEHLs~~HN~L~-~vhGELs~Lp~L 80 (1255)
T KOG0444|consen 3 TGVLPFVRGVDFSGNDFSGDRFPHDVEQMTQMTWLKLNRTKLE-QVPEELSRLQKLEHLSMAHNQLI-SVHGELSDLPRL 80 (1255)
T ss_pred ccccceeecccccCCcCCCCcCchhHHHhhheeEEEechhhhh-hChHHHHHHhhhhhhhhhhhhhH-hhhhhhccchhh
Confidence 455777888999999998 579999999999999999999998 89999999999999999999998 788899999999
Q ss_pred CEEEccCCcccc-cCccccCCCCCCCEEECcCCcCCCcCCcCCCCCCCCceeeccccccccCCCcccccccccCeeeccc
Q 044366 96 ALLYLNDNSLFG-SIPIVMGNLKSLSTLDLSQNQLNGSIPCSLDNLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSE 174 (918)
Q Consensus 96 ~~L~L~~n~i~~-~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~ 174 (918)
+.+.+.+|++.. -+|..+-.|..|..||||+|+++ ..|..+..-+++-.|+|++|+|+.++...|-++..|-.||||+
T Consensus 81 Rsv~~R~N~LKnsGiP~diF~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~IetIPn~lfinLtDLLfLDLS~ 159 (1255)
T KOG0444|consen 81 RSVIVRDNNLKNSGIPTDIFRLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIETIPNSLFINLTDLLFLDLSN 159 (1255)
T ss_pred HHHhhhccccccCCCCchhcccccceeeecchhhhh-hcchhhhhhcCcEEEEcccCccccCCchHHHhhHhHhhhcccc
Confidence 999999998863 46777888999999999999999 7899999999999999999999988777889999999999999
Q ss_pred cccCCcCCccCCCCCCCcEeeccCcccccCCCccccCCCCcceeeccccccc-CCCCCCCcCCCcCCeEEcccCcCcCCC
Q 044366 175 NRLSGLIPLSLSNLSSLTVMSLFNNSLSGSIPPILGNLKSLSTLGLHINQLN-GVIPPSIGNLSSLRNLSLFNNRLYGFV 253 (918)
Q Consensus 175 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~~l~~L~~L~Ls~n~l~~~~ 253 (918)
|++..++ ..+..+..|+.|.|++|.+....-.-+..+++|+.|.+++.+-+ ..+|.++..+.+|..+|+|.|.+. ..
T Consensus 160 NrLe~LP-PQ~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms~TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp-~v 237 (1255)
T KOG0444|consen 160 NRLEMLP-PQIRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMSNTQRTLDNIPTSLDDLHNLRDVDLSENNLP-IV 237 (1255)
T ss_pred chhhhcC-HHHHHHhhhhhhhcCCChhhHHHHhcCccchhhhhhhcccccchhhcCCCchhhhhhhhhccccccCCC-cc
Confidence 9999764 46888999999999999987554556777889999999988653 257888999999999999999998 78
Q ss_pred CccccccCCCCeEecCCCccCCcCCCcCCCCCCCcEEEccCCcCcCCCCccccCCCCCCeEEeecccccCc-cccccCCC
Q 044366 254 PKEIGYLKSLSKLEFCANHLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLRNLTSLERVRFNQNNLYGK-VYEAFGDH 332 (918)
Q Consensus 254 ~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~-~~~~~~~l 332 (918)
|+.+..+++|+.|+|++|+|+.. ........+|++|+++.|+++ ..|.+++.+++|+.|+..+|++.-. .+..++.+
T Consensus 238 Pecly~l~~LrrLNLS~N~iteL-~~~~~~W~~lEtLNlSrNQLt-~LP~avcKL~kL~kLy~n~NkL~FeGiPSGIGKL 315 (1255)
T KOG0444|consen 238 PECLYKLRNLRRLNLSGNKITEL-NMTEGEWENLETLNLSRNQLT-VLPDAVCKLTKLTKLYANNNKLTFEGIPSGIGKL 315 (1255)
T ss_pred hHHHhhhhhhheeccCcCceeee-eccHHHHhhhhhhccccchhc-cchHHHhhhHHHHHHHhccCcccccCCccchhhh
Confidence 99999999999999999999844 445667889999999999997 7889999999999888888887421 12334455
Q ss_pred CCccEEeCCCCccccccCcccccccccceeeccccccccCCCcCcCCCCCCcEEEccCceeccccccchhhccccCceec
Q 044366 333 PNLTFLDLSQNNFYCEISFNWRNFSKLGTFNASMNNIYGSIPPEIGDSSKLQVLDLSSNHIFGKIPVQLVKLFSLNKLIL 412 (918)
Q Consensus 333 ~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~n~i~~~~~~~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 412 (918)
.+|+++..++|.+. .+|+.++.+.+|+.|.|++|++. ..|+.+.-++.|+.|++
T Consensus 316 ~~Levf~aanN~LE-------------------------lVPEglcRC~kL~kL~L~~NrLi-TLPeaIHlL~~l~vLDl 369 (1255)
T KOG0444|consen 316 IQLEVFHAANNKLE-------------------------LVPEGLCRCVKLQKLKLDHNRLI-TLPEAIHLLPDLKVLDL 369 (1255)
T ss_pred hhhHHHHhhccccc-------------------------cCchhhhhhHHHHHhccccccee-echhhhhhcCCcceeec
Confidence 55555555555543 67778888888888888888876 67777877888888888
Q ss_pred ccccccCCCCCCCCCCCcccEEec
Q 044366 413 SLNQLFGGVPLEFGTLTELQYLDL 436 (918)
Q Consensus 413 ~~N~l~~~~~~~~~~l~~L~~L~L 436 (918)
..|.---.+|..-..-+.|+.-++
T Consensus 370 reNpnLVMPPKP~da~~~lefYNI 393 (1255)
T KOG0444|consen 370 RENPNLVMPPKPNDARKKLEFYNI 393 (1255)
T ss_pred cCCcCccCCCCcchhhhcceeeec
Confidence 887644445544333344544333
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=284.26 Aligned_cols=251 Identities=25% Similarity=0.350 Sum_probs=198.4
Q ss_pred CceeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhh-ccCCceeeEecccccCCceEEEEEe
Q 044366 650 EKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTE-IRHRNIIKFHGFCSNAQHSFIVCEY 727 (918)
Q Consensus 650 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~-l~h~niv~~~~~~~~~~~~~lv~e~ 727 (918)
....||.|+||+|+|..+ +.|+..|||+++.... ..+.+++..|.+...+ -+.||||++||++..++..|+.||.
T Consensus 68 dlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~---~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMEL 144 (361)
T KOG1006|consen 68 DLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI---EKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMEL 144 (361)
T ss_pred HHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccc---hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHH
Confidence 344599999999999954 5799999999987532 3345788888887544 4799999999999999999999999
Q ss_pred ccCCChhHHhhcc--cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccCCC
Q 044366 728 LARGSLTTILRDD--AAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPH 805 (918)
Q Consensus 728 ~~~gsL~~~l~~~--~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~~~ 805 (918)
|+- +++.+.... ....++++.-.-+|+...+.||.||-+.. .|+|||+||+||+++..|.+||||||++..+..+
T Consensus 145 Md~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~S 221 (361)
T KOG1006|consen 145 MDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDS 221 (361)
T ss_pred Hhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHHHH
Confidence 974 887765432 12345888888899999999999998875 8999999999999999999999999999876543
Q ss_pred CCCceecccccccccccccc--cCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCCC--CC
Q 044366 806 SSNWTEFAGTVGYAAPELAY--TMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPT--PS 881 (918)
Q Consensus 806 ~~~~~~~~g~~~y~aPE~~~--~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~ 881 (918)
-. .+..+|-..|||||.+. +..|+-+|||||+|++|||+.||..|++.+...++.+. .+....+|. ..
T Consensus 222 iA-kT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~-------~Vv~gdpp~l~~~ 293 (361)
T KOG1006|consen 222 IA-KTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLC-------QVVIGDPPILLFD 293 (361)
T ss_pred HH-hhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHH-------HHHcCCCCeecCc
Confidence 22 24456788999999885 33588999999999999999999999776555443333 333333332 23
Q ss_pred cchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 882 RDVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 882 ~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
....+....+.++|..|+.+|-..||...++++
T Consensus 294 ~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~ 326 (361)
T KOG1006|consen 294 KECVHYSFSMVRFINTCLIKDRSDRPKYDDLKK 326 (361)
T ss_pred ccccccCHHHHHHHHHHhhcccccCcchhhhhc
Confidence 333455678899999999999999999999875
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-34 Score=308.09 Aligned_cols=261 Identities=25% Similarity=0.349 Sum_probs=201.4
Q ss_pred cCCCCceeeccccceEEEEEE-eCCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccC------
Q 044366 646 GNFGEKYCIGKGGQRSVYKAE-LPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNA------ 718 (918)
Q Consensus 646 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------ 718 (918)
..|...+.||+|+||.||+|+ ..+|+.||||.++... .....+...+|++++++++|+|||+++++-++.
T Consensus 13 y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~---~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~ 89 (732)
T KOG4250|consen 13 YLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKES---SLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVT 89 (732)
T ss_pred cceeehhhhcCCccceeeeecccccccchhHHhhhhhc---ccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCccc
Confidence 345556779999999999997 5689999999998753 344567899999999999999999999986543
Q ss_pred CceEEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeC--CCC--cEEEe
Q 044366 719 QHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLD--SEY--EAHVS 794 (918)
Q Consensus 719 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~--~~~--~~kl~ 794 (918)
+...+|||||.+|||+..+++-.....+++.+.+.+..+++.||.|||++ +||||||||.||++- .+| ..||+
T Consensus 90 ~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyKLt 166 (732)
T KOG4250|consen 90 RLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYKLT 166 (732)
T ss_pred ccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEeee
Confidence 36789999999999999999877777899999999999999999999999 999999999999983 334 37999
Q ss_pred ccccccccCCCCCCceecccccccccccccc-cCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhh---hhhhhHh---
Q 044366 795 DFGFAKFLEPHSSNWTEFAGTVGYAAPELAY-TMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFS---SISNMII--- 867 (918)
Q Consensus 795 DfG~~~~~~~~~~~~~~~~g~~~y~aPE~~~-~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~---~~~~~~~--- 867 (918)
|||.|+...+. +.....+||..|.+||+.. .+.|+..+|.|||||++||++||..||........ .......
T Consensus 167 DfG~Arel~d~-s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp 245 (732)
T KOG4250|consen 167 DFGAARELDDN-SLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKP 245 (732)
T ss_pred cccccccCCCC-CeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCC
Confidence 99999988754 4667889999999999998 47889999999999999999999999865443311 0000000
Q ss_pred -hh----hhh------cccCCCCCCcchHHHHHHHHHHHHHcccCCCCCCC--CHHHHH
Q 044366 868 -EV----NQI------LDHRLPTPSRDVTDKLRSIMEVAILCLVENPEARP--TMKEVC 913 (918)
Q Consensus 868 -~~----~~~------~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RP--t~~evl 913 (918)
.. .+. ....+|.+..-.+.....+...+..++..+|.+|. .+.+..
T Consensus 246 ~~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~F 304 (732)
T KOG4250|consen 246 SGVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFF 304 (732)
T ss_pred CceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHH
Confidence 00 000 00112222222334445566666778888999988 444433
|
|
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-33 Score=296.20 Aligned_cols=255 Identities=25% Similarity=0.377 Sum_probs=195.4
Q ss_pred CCCceeeccccceEEEEEEeC----CCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCC----
Q 044366 648 FGEKYCIGKGGQRSVYKAELP----SGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQ---- 719 (918)
Q Consensus 648 ~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~---- 719 (918)
|.+.+.||+|+||.||+|... +++.||||++..... .....+++.+|++.++.++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 78 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIF--SSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGR 78 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccC--ChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCc
Confidence 556788999999999999542 468899999865321 2223567899999999999999999999875432
Q ss_pred --ceEEEEEeccCCChhHHhhccc---ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEe
Q 044366 720 --HSFIVCEYLARGSLTTILRDDA---AAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVS 794 (918)
Q Consensus 720 --~~~lv~e~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~ 794 (918)
..++++||+++|+|.+++.... ....+++..++.++.|++.|++|||+. +|+||||||+||+++.++.+|++
T Consensus 79 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~~~~~kl~ 155 (273)
T cd05074 79 LPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVA 155 (273)
T ss_pred ccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcCCCCEEEC
Confidence 2478999999999998875321 123478999999999999999999999 99999999999999999999999
Q ss_pred ccccccccCCCCC--CceecccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhhhhhhhhhHhhhhh
Q 044366 795 DFGFAKFLEPHSS--NWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIK-GYHPGDFVSTIFSSISNMIIEVNQ 871 (918)
Q Consensus 795 DfG~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~ 871 (918)
|||.++....... ......++..|++||.+.+..++.++||||||+++|||++ |+.|+...... .. ...
T Consensus 156 dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~--~~---~~~--- 227 (273)
T cd05074 156 DFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENS--EI---YNY--- 227 (273)
T ss_pred cccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHH--HH---HHH---
Confidence 9999986643221 1122345678999999988889999999999999999999 88887543221 00 000
Q ss_pred hcccCCCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhC
Q 044366 872 ILDHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLLCK 918 (918)
Q Consensus 872 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~ 918 (918)
........... .....+.+++.+||+.+|++||++.++++.|++
T Consensus 228 ~~~~~~~~~~~---~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~ 271 (273)
T cd05074 228 LIKGNRLKQPP---DCLEDVYELMCQCWSPEPKCRPSFQHLRDQLEL 271 (273)
T ss_pred HHcCCcCCCCC---CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence 11111111111 223568899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-33 Score=300.82 Aligned_cols=261 Identities=21% Similarity=0.284 Sum_probs=197.0
Q ss_pred cCCCCceeeccccceEEEEEEeC-CCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEEE
Q 044366 646 GNFGEKYCIGKGGQRSVYKAELP-SGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFIV 724 (918)
Q Consensus 646 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 724 (918)
++|+..+.||+|++|.||+|... +|+.||+|.++.... .....+.+.+|+++++.++||||+++++++.++...++|
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 79 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQE--DEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLV 79 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccc--cccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEE
Confidence 46888899999999999999654 789999999865321 223346788999999999999999999999999999999
Q ss_pred EEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCC-CCcEEEeccccccccC
Q 044366 725 CEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDS-EYEAHVSDFGFAKFLE 803 (918)
Q Consensus 725 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~-~~~~kl~DfG~~~~~~ 803 (918)
|||++ +++.+++.... ...+++..++.++.||+.||+|||+. +++||||+|+||+++. ++.+|++|||++....
T Consensus 80 ~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~ 154 (294)
T PLN00009 80 FEYLD-LDLKKHMDSSP-DFAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFG 154 (294)
T ss_pred Eeccc-ccHHHHHHhCC-CCCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEEEcccccccccC
Confidence 99996 58888876543 23368888999999999999999999 9999999999999985 5679999999998665
Q ss_pred CCCCCceecccccccccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhh----------
Q 044366 804 PHSSNWTEFAGTVGYAAPELAYTM-RATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQI---------- 872 (918)
Q Consensus 804 ~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~---------- 872 (918)
..........+++.|+|||++.+. .++.++||||+|+++|+|++|+.||...... +............
T Consensus 155 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 233 (294)
T PLN00009 155 IPVRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEI-DELFKIFRILGTPNEETWPGVTS 233 (294)
T ss_pred CCccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhCCCChhhcccccc
Confidence 433333445678899999988664 5788999999999999999999998654321 1111110000000
Q ss_pred ------cccCCCCCC--cchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 873 ------LDHRLPTPS--RDVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 873 ------~~~~~~~~~--~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
.....+... .........+.+++.+|++.+|++||++.++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 234 LPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred chhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000000000 000112345788999999999999999999985
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=274.96 Aligned_cols=249 Identities=21% Similarity=0.332 Sum_probs=196.1
Q ss_pred CCceeeccccceEEEEEEeC-CCCEEEEEEcccccccCCCCChHHHHHHHHHHhhc-cCCceeeEecccccCCceEEEEE
Q 044366 649 GEKYCIGKGGQRSVYKAELP-SGNIFAVKKFKAELFSDETANPSEFLNEVLALTEI-RHRNIIKFHGFCSNAQHSFIVCE 726 (918)
Q Consensus 649 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e 726 (918)
.....||.|+.|.||+++.. +|...|||.++.. ...++.+++...+.++..- .+|+||+.+|||..+...++.||
T Consensus 95 ~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt---~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMe 171 (391)
T KOG0983|consen 95 ENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRT---GNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICME 171 (391)
T ss_pred hhHHhhcCCCccceEEEEEcccceEEEEEeeccc---CCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHH
Confidence 34455999999999999664 6899999999764 3444456777777775544 58999999999999999999999
Q ss_pred eccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccCCCC
Q 044366 727 YLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHS 806 (918)
Q Consensus 727 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~~~~ 806 (918)
.|.. ..+..+++.+ +++++.-+-++...++.||.||.+.. +|+|||+||+||++|+.|.+|+||||++.++.+..
T Consensus 172 lMs~-C~ekLlkrik--~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSk 246 (391)
T KOG0983|consen 172 LMST-CAEKLLKRIK--GPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSK 246 (391)
T ss_pred HHHH-HHHHHHHHhc--CCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeeccc
Confidence 9964 5677776553 45888888899999999999998875 99999999999999999999999999998886544
Q ss_pred CCceeccccccccccccccc---CCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCCCCCcc
Q 044366 807 SNWTEFAGTVGYAAPELAYT---MRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRD 883 (918)
Q Consensus 807 ~~~~~~~g~~~y~aPE~~~~---~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 883 (918)
.. +..+|-+.|||||.+.- ..|+-++||||||+.++|+.||+.||..-...+.... .+++..+|..+ .
T Consensus 247 Ah-trsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~lt-------kvln~ePP~L~-~ 317 (391)
T KOG0983|consen 247 AH-TRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLT-------KVLNEEPPLLP-G 317 (391)
T ss_pred cc-ccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHH-------HHHhcCCCCCC-c
Confidence 33 44578899999998853 4688899999999999999999999876544433322 33332222211 1
Q ss_pred hHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 884 VTDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 884 ~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
.......+.+++..|+++|+.+||...++++
T Consensus 318 ~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~ 348 (391)
T KOG0983|consen 318 HMGFSPDFQSFVKDCLTKDHRKRPKYNKLLE 348 (391)
T ss_pred ccCcCHHHHHHHHHHhhcCcccCcchHHHhc
Confidence 1124567888899999999999999998875
|
|
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=301.48 Aligned_cols=254 Identities=25% Similarity=0.354 Sum_probs=193.9
Q ss_pred CCCCceeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhcc-CCceeeEecccccCCceEEE
Q 044366 647 NFGEKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIR-HRNIIKFHGFCSNAQHSFIV 724 (918)
Q Consensus 647 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv 724 (918)
+|...+.||+|+||.||++.. .+|+.||+|.+..... ......+.+|+..+.++. ||||+++++++..++..+++
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~---~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~ 81 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVD---EKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWIC 81 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccC---hHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEE
Confidence 455567899999999999954 5789999999875322 133567889999999996 99999999999988999999
Q ss_pred EEeccCCChhHHhhcc--cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEecccccccc
Q 044366 725 CEYLARGSLTTILRDD--AAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFL 802 (918)
Q Consensus 725 ~e~~~~gsL~~~l~~~--~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~ 802 (918)
|||++. ++.++.... .....+++..+..++.|++.|++|||+.. +++||||||+||+++.++.++|+|||++...
T Consensus 82 ~e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~ 158 (288)
T cd06616 82 MELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQL 158 (288)
T ss_pred EecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcC--CeeccCCCHHHEEEccCCcEEEeecchhHHh
Confidence 999864 665543211 11345899999999999999999999742 8999999999999999999999999999766
Q ss_pred CCCCCCceecccccccccccccccC---CCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCCC
Q 044366 803 EPHSSNWTEFAGTVGYAAPELAYTM---RATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPT 879 (918)
Q Consensus 803 ~~~~~~~~~~~g~~~y~aPE~~~~~---~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 879 (918)
...... ....|+..|+|||++.+. .++.++||||+|+++|||++|+.||......... ..+......+.
T Consensus 159 ~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~-------~~~~~~~~~~~ 230 (288)
T cd06616 159 VDSIAK-TRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQ-------LTQVVKGDPPI 230 (288)
T ss_pred ccCCcc-ccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHH-------HhhhcCCCCCc
Confidence 433222 234578899999998776 6889999999999999999999997644321111 11111111111
Q ss_pred C-CcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 880 P-SRDVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 880 ~-~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
. ..........+.+++.+||+.||++|||+++|++
T Consensus 231 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~ 266 (288)
T cd06616 231 LSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLE 266 (288)
T ss_pred CCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1 1111224457889999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=326.67 Aligned_cols=259 Identities=25% Similarity=0.382 Sum_probs=204.8
Q ss_pred HHhcCCCCceeeccccceEEEEEEeC----C----CCEEEEEEcccccccCCCCChHHHHHHHHHHhhc-cCCceeeEec
Q 044366 643 KATGNFGEKYCIGKGGQRSVYKAELP----S----GNIFAVKKFKAELFSDETANPSEFLNEVLALTEI-RHRNIIKFHG 713 (918)
Q Consensus 643 ~~~~~~~~~~~lg~G~~g~Vy~~~~~----~----~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~ 713 (918)
...++..+.+.+|+|+||.||+|... . ...||||.++.... ..+.+.+..|+++++.+ +|+||+.++|
T Consensus 293 ~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~---~~~~~~~~~El~~m~~~g~H~niv~llG 369 (609)
T KOG0200|consen 293 IPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENAS---SSEKKDLMSELNVLKELGKHPNIVNLLG 369 (609)
T ss_pred echhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccC---cHHHHHHHHHHHHHHHhcCCcchhhhee
Confidence 33344455568999999999999542 1 45799999886532 24578999999999999 6999999999
Q ss_pred ccccCCceEEEEEeccCCChhHHhhccc-------c----c--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCC
Q 044366 714 FCSNAQHSFIVCEYLARGSLTTILRDDA-------A----A--KEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISS 780 (918)
Q Consensus 714 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~-------~----~--~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~ 780 (918)
+|..++..++|+||++.|+|.++++..+ . . ..++..+.+.++.|||.|++||++. ++||||+.+
T Consensus 370 ~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRDLAa 446 (609)
T KOG0200|consen 370 ACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRDLAA 446 (609)
T ss_pred eeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---Cccchhhhh
Confidence 9999999999999999999999998765 0 1 2388999999999999999999999 999999999
Q ss_pred CCeeeCCCCcEEEeccccccccCCCCCCc-eecc--cccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcch
Q 044366 781 KNVLLDSEYEAHVSDFGFAKFLEPHSSNW-TEFA--GTVGYAAPELAYTMRATEKYDVYSFGVLALEVIK-GYHPGDFVS 856 (918)
Q Consensus 781 ~Nill~~~~~~kl~DfG~~~~~~~~~~~~-~~~~--g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~p~~~~~ 856 (918)
+||+++++..+||+|||+|+......... .... -+..|||||.+....|+.|+|||||||++||++| |..|+....
T Consensus 447 RNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~ 526 (609)
T KOG0200|consen 447 RNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIP 526 (609)
T ss_pred hhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCC
Confidence 99999999999999999999765544332 2222 3567999999999999999999999999999998 788865422
Q ss_pred hhhhhhhhhHhhhhhhcccCCCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 044366 857 TIFSSISNMIIEVNQILDHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLLC 917 (918)
Q Consensus 857 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 917 (918)
...+. ...+.++.....+..+ ..++.+++..||+.+|++||++.|+++.++
T Consensus 527 ~~~~l-------~~~l~~G~r~~~P~~c---~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~ 577 (609)
T KOG0200|consen 527 PTEEL-------LEFLKEGNRMEQPEHC---SDEIYDLMKSCWNADPEDRPTFSECVEFFE 577 (609)
T ss_pred cHHHH-------HHHHhcCCCCCCCCCC---CHHHHHHHHHHhCCCcccCCCHHHHHHHHH
Confidence 11111 1122222222222222 356789999999999999999999999875
|
|
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-34 Score=292.22 Aligned_cols=252 Identities=23% Similarity=0.274 Sum_probs=201.6
Q ss_pred HHhcCCCCceeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCce
Q 044366 643 KATGNFGEKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHS 721 (918)
Q Consensus 643 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 721 (918)
...+.|+.-++||+|+||.||-++. .+|+.||.|++.+.... ..........|-+++.+++.+.||.+--+++..+..
T Consensus 182 vt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiK-kr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~L 260 (591)
T KOG0986|consen 182 VTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIK-KRKGETMALNEKQILEKVSSPFIVSLAYAFETKDAL 260 (591)
T ss_pred ccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHH-HhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCce
Confidence 3446788888999999999999954 57999999998664333 333456788999999999999999999899999999
Q ss_pred EEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccc
Q 044366 722 FIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKF 801 (918)
Q Consensus 722 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~ 801 (918)
++|+..|.||+|.-++...+. ..++++.++-+|.+|+.||++||.. +||.||+||+|||+|+.|+++|+|.|+|..
T Consensus 261 ClVLtlMNGGDLkfHiyn~g~-~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvRISDLGLAve 336 (591)
T KOG0986|consen 261 CLVLTLMNGGDLKFHIYNHGN-PGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVRISDLGLAVE 336 (591)
T ss_pred EEEEEeecCCceeEEeeccCC-CCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeEeeccceEEe
Confidence 999999999999999887664 4589999999999999999999999 999999999999999999999999999998
Q ss_pred cCCCCCCceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCCCCC
Q 044366 802 LEPHSSNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPS 881 (918)
Q Consensus 802 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 881 (918)
+.... .....+||.+|||||++..+.|+...|.||+||++|||+.|+.||.....-... .++.+.+.......+
T Consensus 337 i~~g~-~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~-----eEvdrr~~~~~~ey~ 410 (591)
T KOG0986|consen 337 IPEGK-PIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKR-----EEVDRRTLEDPEEYS 410 (591)
T ss_pred cCCCC-ccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhH-----HHHHHHHhcchhhcc
Confidence 86543 345569999999999999999999999999999999999999997643221110 111111111111222
Q ss_pred cchHHHHHHHHHHHHHcccCCCCCCCC
Q 044366 882 RDVTDKLRSIMEVAILCLVENPEARPT 908 (918)
Q Consensus 882 ~~~~~~~~~l~~li~~cl~~dp~~RPt 908 (918)
....++ ..++....+++||++|.-
T Consensus 411 ~kFS~e---akslc~~LL~Kdp~~RLG 434 (591)
T KOG0986|consen 411 DKFSEE---AKSLCEGLLTKDPEKRLG 434 (591)
T ss_pred cccCHH---HHHHHHHHHccCHHHhcc
Confidence 333344 445555689999999964
|
|
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=296.09 Aligned_cols=246 Identities=22% Similarity=0.284 Sum_probs=187.7
Q ss_pred eeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHH-hhccCCceeeEecccccCCceEEEEEecc
Q 044366 652 YCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLAL-TEIRHRNIIKFHGFCSNAQHSFIVCEYLA 729 (918)
Q Consensus 652 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l-~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 729 (918)
+.||+|+||.||+|.. .+|+.||+|.++....... .....+..|..++ ...+|+|++++++++..++..++|+||++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~-~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAK-NQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLN 80 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHH-HHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccC
Confidence 4689999999999955 5689999999865322111 1123445555443 44589999999999999999999999999
Q ss_pred CCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccCCCCCCc
Q 044366 730 RGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNW 809 (918)
Q Consensus 730 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~~~~~~~ 809 (918)
+++|.+++.... .+++..+..++.|++.||.|+|+. +++||||+|+||++++++.++|+|||++..... .
T Consensus 81 ~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~----~ 150 (260)
T cd05611 81 GGDCASLIKTLG---GLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE----N 150 (260)
T ss_pred CCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeecccceeccc----c
Confidence 999999997643 478999999999999999999999 999999999999999999999999999875432 2
Q ss_pred eecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCCCCCcchHHHHH
Q 044366 810 TEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRDVTDKLR 889 (918)
Q Consensus 810 ~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 889 (918)
....++..|+|||.+.+..++.++||||+|+++|||++|..||...... ... .. ..................
T Consensus 151 ~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-~~~----~~---~~~~~~~~~~~~~~~~~~ 222 (260)
T cd05611 151 KKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPD-AVF----DN---ILSRRINWPEEVKEFCSP 222 (260)
T ss_pred ccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHH-HHH----HH---HHhcccCCCCcccccCCH
Confidence 2345788999999998888899999999999999999999998643221 111 01 111111111111112335
Q ss_pred HHHHHHHHcccCCCCCCCCHHHHHHHh
Q 044366 890 SIMEVAILCLVENPEARPTMKEVCNLL 916 (918)
Q Consensus 890 ~l~~li~~cl~~dp~~RPt~~evl~~L 916 (918)
.+.+++.+||+.+|++||++.++.+.+
T Consensus 223 ~~~~~i~~~l~~~p~~R~~~~~~~~~l 249 (260)
T cd05611 223 EAVDLINRLLCMDPAKRLGANGYQEIK 249 (260)
T ss_pred HHHHHHHHHccCCHHHccCCCcHHHHH
Confidence 688999999999999999776555544
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-34 Score=275.69 Aligned_cols=253 Identities=23% Similarity=0.300 Sum_probs=201.6
Q ss_pred HhcCCCCc-eeeccccceEEEEE-EeCCCCEEEEEEcccccccCCCCChHHHHHHHHHHh-hccCCceeeEeccccc---
Q 044366 644 ATGNFGEK-YCIGKGGQRSVYKA-ELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALT-EIRHRNIIKFHGFCSN--- 717 (918)
Q Consensus 644 ~~~~~~~~-~~lg~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~-~l~h~niv~~~~~~~~--- 717 (918)
.+++|.+. ++||-|-.|.|..+ ...+|+.+|+|++.. .....+|++..- .-.|||||.++++++.
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~D---------s~KARrEVeLHw~~s~h~~iV~IidVyeNs~~ 129 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLD---------SPKARREVELHWMASGHPHIVSIIDVYENSYQ 129 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhc---------CHHHHhHhhhhhhhcCCCceEEeehhhhhhcc
Confidence 34455443 47999999999998 445899999998864 234578888743 3379999999998853
Q ss_pred -CCceEEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCC---CCcEEE
Q 044366 718 -AQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDS---EYEAHV 793 (918)
Q Consensus 718 -~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~---~~~~kl 793 (918)
...+.+|||.|+||.|...+.+++ .+.+++.++..|..||+.|++|||+. .|+||||||+|+|.+. +..+||
T Consensus 130 ~rkcLLiVmE~meGGeLfsriq~~g-~~afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~na~lKL 205 (400)
T KOG0604|consen 130 GRKCLLIVMECMEGGELFSRIQDRG-DQAFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPNAPLKL 205 (400)
T ss_pred CceeeEeeeecccchHHHHHHHHcc-cccchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCCcceEe
Confidence 457789999999999999998765 56799999999999999999999999 9999999999999965 456899
Q ss_pred eccccccccCCCCCCceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhc
Q 044366 794 SDFGFAKFLEPHSSNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQIL 873 (918)
Q Consensus 794 ~DfG~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 873 (918)
+|||+|+.-... ......+-|+.|.|||++-..+|+...|+||+||++|-|++|.+||-..... .+.. .-..++.
T Consensus 206 tDfGFAK~t~~~-~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~--aisp--gMk~rI~ 280 (400)
T KOG0604|consen 206 TDFGFAKETQEP-GDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL--AISP--GMKRRIR 280 (400)
T ss_pred cccccccccCCC-ccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCc--cCCh--hHHhHhh
Confidence 999999875532 2334456799999999999999999999999999999999999998654331 1111 1112333
Q ss_pred ccCCCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 874 DHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 874 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
......+.+.+....+...++|+.++..+|.+|.|+.|+++
T Consensus 281 ~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~ 321 (400)
T KOG0604|consen 281 TGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMD 321 (400)
T ss_pred ccCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence 44445555666677778899999999999999999999875
|
|
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-33 Score=297.54 Aligned_cols=244 Identities=21% Similarity=0.244 Sum_probs=185.8
Q ss_pred eeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhh---ccCCceeeEecccccCCceEEEEEec
Q 044366 653 CIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTE---IRHRNIIKFHGFCSNAQHSFIVCEYL 728 (918)
Q Consensus 653 ~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~---l~h~niv~~~~~~~~~~~~~lv~e~~ 728 (918)
.||+|+||.||+|.. .+++.||+|.+....... ......+.+|..+++. .+||+|+.+++++..++..++||||+
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 79 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKM-KQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLM 79 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEcccccc-chHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecC
Confidence 489999999999955 568999999986543222 1222344555544433 47999999999999889999999999
Q ss_pred cCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccCCCCCC
Q 044366 729 ARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSN 808 (918)
Q Consensus 729 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~~~~~~ 808 (918)
++|+|.+++.... .+++..+..++.|++.|++|||+. +++||||||+||++++++.++++|||++.......
T Consensus 80 ~~~~L~~~i~~~~---~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~-- 151 (279)
T cd05633 80 NGGDLHYHLSQHG---VFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-- 151 (279)
T ss_pred CCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEccCCcceeccccC--
Confidence 9999999987543 489999999999999999999999 99999999999999999999999999997654322
Q ss_pred ceeccccccccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCCCCCcchHHH
Q 044366 809 WTEFAGTVGYAAPELAYT-MRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRDVTDK 887 (918)
Q Consensus 809 ~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 887 (918)
.....|+..|+|||...+ ..++.++||||+||++|+|++|+.||........ .. ............ . ...
T Consensus 152 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~--~~-~~~~~~~~~~~~---~---~~~ 222 (279)
T cd05633 152 PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK--HE-IDRMTLTVNVEL---P---DSF 222 (279)
T ss_pred ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCH--HH-HHHHhhcCCcCC---c---ccc
Confidence 223468999999998864 5578999999999999999999999864322110 00 000000001111 1 112
Q ss_pred HHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 044366 888 LRSIMEVAILCLVENPEARP-----TMKEVCN 914 (918)
Q Consensus 888 ~~~l~~li~~cl~~dp~~RP-----t~~evl~ 914 (918)
...+.+++.+|++.||++|| +++|+++
T Consensus 223 ~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~ 254 (279)
T cd05633 223 SPELKSLLEGLLQRDVSKRLGCLGRGAQEVKE 254 (279)
T ss_pred CHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHh
Confidence 34678889999999999999 5998876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-33 Score=303.92 Aligned_cols=263 Identities=20% Similarity=0.311 Sum_probs=195.8
Q ss_pred CCCCceeeccccceEEEEEEeC---CCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccC--Cce
Q 044366 647 NFGEKYCIGKGGQRSVYKAELP---SGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNA--QHS 721 (918)
Q Consensus 647 ~~~~~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~ 721 (918)
+|...+.||+|++|.||+|... +++.||+|.+..... ......+.+.+|+++++.++||||+++++++.+. +..
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 79 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKE-QYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSV 79 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccc-cccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceE
Confidence 4778889999999999999654 579999999876422 1222346778999999999999999999999887 789
Q ss_pred EEEEEeccCCChhHHhhccc--ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCC----CCcEEEec
Q 044366 722 FIVCEYLARGSLTTILRDDA--AAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDS----EYEAHVSD 795 (918)
Q Consensus 722 ~lv~e~~~~gsL~~~l~~~~--~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~----~~~~kl~D 795 (918)
++||||+++ ++.+++.... ....+++..++.++.|++.|++|||+. +++||||||+||+++. ++.+|++|
T Consensus 80 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~~~~~~~kl~D 155 (316)
T cd07842 80 YLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGD 155 (316)
T ss_pred EEEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCCCccceEEECC
Confidence 999999975 6777665332 223689999999999999999999999 9999999999999999 89999999
Q ss_pred cccccccCCCCC---CceecccccccccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCcchhhhhh----hhhhHh
Q 044366 796 FGFAKFLEPHSS---NWTEFAGTVGYAAPELAYTM-RATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSS----ISNMII 867 (918)
Q Consensus 796 fG~~~~~~~~~~---~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~----~~~~~~ 867 (918)
||++........ ......++..|+|||++.+. .++.++||||||+++|+|++|+.||......... ......
T Consensus 156 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (316)
T cd07842 156 LGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLE 235 (316)
T ss_pred CccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHH
Confidence 999987644322 12334678899999987664 5788999999999999999999998643321100 000000
Q ss_pred hhhhhcc-----------------------cCCCCCCcchH-------HHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 868 EVNQILD-----------------------HRLPTPSRDVT-------DKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 868 ~~~~~~~-----------------------~~~~~~~~~~~-------~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
...+.+. ........... .....+.+++.+|++.||++|||+.|+++
T Consensus 236 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~ 312 (316)
T cd07842 236 RIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE 312 (316)
T ss_pred HHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 0000000 00000000111 12246889999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=304.84 Aligned_cols=258 Identities=22% Similarity=0.317 Sum_probs=196.7
Q ss_pred HhcCCCCceeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccC----
Q 044366 644 ATGNFGEKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNA---- 718 (918)
Q Consensus 644 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~---- 718 (918)
..++|...+.||+|+||.||+|.. .+|+.||+|++..... .......+.+|+.+++.++||||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 91 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQ--NVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLE 91 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCcccc--ChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcc
Confidence 457899999999999999999954 5799999999865321 222345678899999999999999999987543
Q ss_pred --CceEEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEecc
Q 044366 719 --QHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDF 796 (918)
Q Consensus 719 --~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Df 796 (918)
...++||||+++ +|.+.+... +++.++..++.|++.||+|||+. +++||||||+||+++.++.+||+||
T Consensus 92 ~~~~~~lv~e~~~~-~l~~~~~~~-----l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~~~~kL~Df 162 (353)
T cd07850 92 EFQDVYLVMELMDA-NLCQVIQMD-----LDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDF 162 (353)
T ss_pred ccCcEEEEEeccCC-CHHHHHhhc-----CCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccC
Confidence 357999999964 888887542 78899999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCCCceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHh---------
Q 044366 797 GFAKFLEPHSSNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMII--------- 867 (918)
Q Consensus 797 G~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~--------- 867 (918)
|+++....... .....++..|+|||.+.+..++.++|||||||++|+|++|+.||........ ......
T Consensus 163 g~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~ 240 (353)
T cd07850 163 GLARTAGTSFM-MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQ-WNKIIEQLGTPSDEF 240 (353)
T ss_pred ccceeCCCCCC-CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHH-HHHHHHhcCCCCHHH
Confidence 99987654322 2334678899999999998999999999999999999999999865432110 000000
Q ss_pred ------hhhhhcccCC----------------CCCCcc-hHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 868 ------EVNQILDHRL----------------PTPSRD-VTDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 868 ------~~~~~~~~~~----------------~~~~~~-~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
........+. +..... .......+.+++.+|++.||++|||+.|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~ 310 (353)
T cd07850 241 MSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQ 310 (353)
T ss_pred HHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 0000000000 000000 1122446789999999999999999999985
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=290.39 Aligned_cols=250 Identities=26% Similarity=0.371 Sum_probs=204.3
Q ss_pred CCCCceeeccccceEEEEEEeC-CCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccC--CceEE
Q 044366 647 NFGEKYCIGKGGQRSVYKAELP-SGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNA--QHSFI 723 (918)
Q Consensus 647 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~l 723 (918)
+|...+.||+|++|.||+|... +++.|++|++...... ....+.+.+|++.+++++||||+++++++.+. +..++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~l 78 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDS--EEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNI 78 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccc--hHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEE
Confidence 4677889999999999999665 7899999998664221 23467899999999999999999999999887 88999
Q ss_pred EEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccC
Q 044366 724 VCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLE 803 (918)
Q Consensus 724 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~ 803 (918)
|+||+++++|.+++.... .+++.+++.++.|+++|++|||+. +++|+||+|+||+++.++.++|+|||.+....
T Consensus 79 v~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~ 152 (260)
T cd06606 79 FLEYVSGGSLSSLLKKFG---KLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLG 152 (260)
T ss_pred EEEecCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEcccccEEecc
Confidence 999999999999997653 589999999999999999999998 99999999999999999999999999998776
Q ss_pred CCCC--CceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcc-cCCCCC
Q 044366 804 PHSS--NWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILD-HRLPTP 880 (918)
Q Consensus 804 ~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~ 880 (918)
.... ......++..|+|||...+...+.++||||||+++|+|++|..||......... ...... ...+..
T Consensus 153 ~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~-------~~~~~~~~~~~~~ 225 (260)
T cd06606 153 DIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAA-------LYKIGSSGEPPEI 225 (260)
T ss_pred cccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHH-------HHhccccCCCcCC
Confidence 5443 133456889999999998888999999999999999999999998654411111 111111 111111
Q ss_pred CcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 881 SRDVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 881 ~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
+. .....+.+++.+|++.||.+||++.|++.
T Consensus 226 ~~---~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 226 PE---HLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred Cc---ccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 11 12456888999999999999999999985
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=290.17 Aligned_cols=249 Identities=25% Similarity=0.427 Sum_probs=203.6
Q ss_pred CCCCceeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEEEE
Q 044366 647 NFGEKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFIVC 725 (918)
Q Consensus 647 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 725 (918)
+|+..+.||+|++|.||+|.. .+++.||+|.+...... ....+.+.+|++++++++|||++++++++.+++..++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~ 78 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIK--EEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIIL 78 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccC--HHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEE
Confidence 477888999999999999955 46889999998764321 134568999999999999999999999999999999999
Q ss_pred EeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccCCC
Q 044366 726 EYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPH 805 (918)
Q Consensus 726 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~~~ 805 (918)
||+++++|.+++... ..+++..++.++.|++.|+.|||+. +++||||+|+||+++.++.++|+|||.+......
T Consensus 79 e~~~~~~L~~~~~~~---~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 152 (254)
T cd06627 79 EYAENGSLRQIIKKF---GPFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDV 152 (254)
T ss_pred ecCCCCcHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEEeccccceecCCC
Confidence 999999999999764 3589999999999999999999999 9999999999999999999999999999887655
Q ss_pred CCCceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCCCCCcchH
Q 044366 806 SSNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRDVT 885 (918)
Q Consensus 806 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 885 (918)
........++..|+|||...+..++.++|||++|+++|+|++|+.|+....... ... .......+......
T Consensus 153 ~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~-~~~-------~~~~~~~~~~~~~~- 223 (254)
T cd06627 153 SKDDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMA-ALF-------RIVQDDHPPLPEGI- 223 (254)
T ss_pred cccccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHH-HHH-------HHhccCCCCCCCCC-
Confidence 443344567899999999988888999999999999999999999976443211 110 11111111111111
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 886 DKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 886 ~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
...+.+++.+|+..+|++|||+.+++.
T Consensus 224 --~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 224 --SPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred --CHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 346788999999999999999999875
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=281.14 Aligned_cols=245 Identities=24% Similarity=0.303 Sum_probs=201.4
Q ss_pred HhcCCCCceeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceE
Q 044366 644 ATGNFGEKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSF 722 (918)
Q Consensus 644 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 722 (918)
..++|+..+++|+|+||.|..++. .+|+.||+|+++++......+ .+.-..|-.+++..+||.+..+.-.++..+..|
T Consensus 166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdE-VAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlC 244 (516)
T KOG0690|consen 166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDE-VAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLC 244 (516)
T ss_pred ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHH-hhhhhhHHHHHHhccCcHHHHhhhhhccCceEE
Confidence 446788999999999999999955 479999999999876554332 456678889999999999999988899999999
Q ss_pred EEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEecccccccc
Q 044366 723 IVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFL 802 (918)
Q Consensus 723 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~ 802 (918)
.||||..||.|.-++.+.+ .++++..+-+-..|+.||.|||++ +||.||+|.+|.|+|.||.+||+|||+++.-
T Consensus 245 FVMeyanGGeLf~HLsrer---~FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGHIKitDFGLCKE~ 318 (516)
T KOG0690|consen 245 FVMEYANGGELFFHLSRER---VFSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGHIKITDFGLCKEE 318 (516)
T ss_pred EEEEEccCceEeeehhhhh---cccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCceEeeecccchhc
Confidence 9999999999998887643 488888889999999999999999 9999999999999999999999999999876
Q ss_pred CCCCCCceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCCCCCc
Q 044366 803 EPHSSNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSR 882 (918)
Q Consensus 803 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 882 (918)
-.........+|||.|+|||++....|..++|.|.+|||+|||++|+.||...... . ..++--+.+.++|.
T Consensus 319 I~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~-----k-LFeLIl~ed~kFPr--- 389 (516)
T KOG0690|consen 319 IKYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHE-----K-LFELILMEDLKFPR--- 389 (516)
T ss_pred ccccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchh-----H-HHHHHHhhhccCCc---
Confidence 66666677889999999999999999999999999999999999999997644321 0 01111111222222
Q ss_pred chHHHHHHHHHHHHHcccCCCCCCC
Q 044366 883 DVTDKLRSIMEVAILCLVENPEARP 907 (918)
Q Consensus 883 ~~~~~~~~l~~li~~cl~~dp~~RP 907 (918)
... .+...++...+.+||++|.
T Consensus 390 ~ls---~eAktLLsGLL~kdP~kRL 411 (516)
T KOG0690|consen 390 TLS---PEAKTLLSGLLKKDPKKRL 411 (516)
T ss_pred cCC---HHHHHHHHHHhhcChHhhc
Confidence 122 2345567778999999996
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=296.99 Aligned_cols=261 Identities=20% Similarity=0.199 Sum_probs=184.6
Q ss_pred hcCCCCceeeccccceEEEEEEeCC----CCEEEEEEcccccccCCCC-------ChHHHHHHHHHHhhccCCceeeEec
Q 044366 645 TGNFGEKYCIGKGGQRSVYKAELPS----GNIFAVKKFKAELFSDETA-------NPSEFLNEVLALTEIRHRNIIKFHG 713 (918)
Q Consensus 645 ~~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~-------~~~~~~~e~~~l~~l~h~niv~~~~ 713 (918)
.++|.+.+.||+|+||.||+|...+ +..+|+|...........+ .......+...+..+.|++++++++
T Consensus 11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~ 90 (294)
T PHA02882 11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG 90 (294)
T ss_pred CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence 3679999999999999999997543 4556666543211000000 0011223334456678999999999
Q ss_pred ccccCC----ceEEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCC
Q 044366 714 FCSNAQ----HSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEY 789 (918)
Q Consensus 714 ~~~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~ 789 (918)
++.... ..++++|+... ++.+.+... ...++..++.++.|++.|++|||+. +|+||||||+||+++.++
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~Nill~~~~ 163 (294)
T PHA02882 91 CGSFKRCRMYYRFILLEKLVE-NTKEIFKRI---KCKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENIMVDGNN 163 (294)
T ss_pred eeeEecCCceEEEEEEehhcc-CHHHHHHhh---ccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCC
Confidence 765443 34677777643 666666543 2257888999999999999999999 999999999999999999
Q ss_pred cEEEeccccccccCCCCC-------CceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhh
Q 044366 790 EAHVSDFGFAKFLEPHSS-------NWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSI 862 (918)
Q Consensus 790 ~~kl~DfG~~~~~~~~~~-------~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~ 862 (918)
.++|+|||+|+.+..... ......||+.|+|||+..+..++.++|||||||++|||++|+.||.........+
T Consensus 164 ~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~ 243 (294)
T PHA02882 164 RGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLI 243 (294)
T ss_pred cEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHH
Confidence 999999999987643221 1123468999999999999999999999999999999999999987553221111
Q ss_pred hhhHhh-hhhhcccCCCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 044366 863 SNMIIE-VNQILDHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLLC 917 (918)
Q Consensus 863 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 917 (918)
...... ...+....... ......+.+++..|+..+|++||+++++++.+.
T Consensus 244 ~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~ 294 (294)
T PHA02882 244 HAAKCDFIKRLHEGKIKI-----KNANKFIYDFIECVTKLSYEEKPDYDALIKIFD 294 (294)
T ss_pred HHhHHHHHHHhhhhhhcc-----CCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence 111111 11111111111 112356888999999999999999999998763
|
|
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-33 Score=305.23 Aligned_cols=262 Identities=21% Similarity=0.294 Sum_probs=197.4
Q ss_pred hcCCCCceeeccccceEEEEEE-eCCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccC-----
Q 044366 645 TGNFGEKYCIGKGGQRSVYKAE-LPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNA----- 718 (918)
Q Consensus 645 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~----- 718 (918)
..+|.+.+.||+|+||.||+|. ..+|+.||||.++.... .......+.+|+.+++.++||||+++++++...
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~ 81 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFD--NRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAF 81 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEeccccc--ccchhHHHHHHHHHHHhcCCCCccchHHheeccccccc
Confidence 4578899999999999999995 45799999999875321 222345678899999999999999999987543
Q ss_pred CceEEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEecccc
Q 044366 719 QHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGF 798 (918)
Q Consensus 719 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~ 798 (918)
...++|+||+. ++|.+++... ..+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||+
T Consensus 82 ~~~~lv~e~~~-~~L~~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~ 154 (337)
T cd07858 82 NDVYIVYELMD-TDLHQIIRSS---QTLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGL 154 (337)
T ss_pred CcEEEEEeCCC-CCHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcCcc
Confidence 35799999996 6898888654 3489999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCCceeccccccccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCcchhhh--hhhhhh----------
Q 044366 799 AKFLEPHSSNWTEFAGTVGYAAPELAYT-MRATEKYDVYSFGVLALEVIKGYHPGDFVSTIF--SSISNM---------- 865 (918)
Q Consensus 799 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~--~~~~~~---------- 865 (918)
+..............++..|+|||.+.. ..++.++|||||||++|+|++|+.||....... ......
T Consensus 155 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (337)
T cd07858 155 ARTTSEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLG 234 (337)
T ss_pred ccccCCCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhh
Confidence 9876544333344567889999998764 468899999999999999999999986432100 000000
Q ss_pred --H-hhhhhhcccC--C--CCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 044366 866 --I-IEVNQILDHR--L--PTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNL 915 (918)
Q Consensus 866 --~-~~~~~~~~~~--~--~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 915 (918)
. ....+..... . +............+.+++.+||+.||++|||++|+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h 291 (337)
T cd07858 235 FIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAH 291 (337)
T ss_pred hcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence 0 0000000000 0 00000111234568899999999999999999999853
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-33 Score=292.05 Aligned_cols=250 Identities=24% Similarity=0.331 Sum_probs=203.7
Q ss_pred CCCCceeeccccceEEEEEE-eCCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEEEE
Q 044366 647 NFGEKYCIGKGGQRSVYKAE-LPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFIVC 725 (918)
Q Consensus 647 ~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 725 (918)
+|++.+.||+|+||.||+|. ..+++.+|+|.+...... ......+.+|++.++.++|+||+++++++.+....++||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~ 78 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMS--QKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVM 78 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhcc--HHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEe
Confidence 47788899999999999995 457899999998754322 233567889999999999999999999999999999999
Q ss_pred EeccCCChhHHhhccc-ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccCC
Q 044366 726 EYLARGSLTTILRDDA-AAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEP 804 (918)
Q Consensus 726 e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~~ 804 (918)
||+++++|.+++.+.. ....+++.+++.++.|+++|++|||+. +++|+||+|+||++++++.+|++|||++.....
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~ 155 (256)
T cd08530 79 EYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKK 155 (256)
T ss_pred hhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcEEEeeccchhhhcc
Confidence 9999999999987632 234589999999999999999999999 999999999999999999999999999987755
Q ss_pred CCCCceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCCCCCcch
Q 044366 805 HSSNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRDV 884 (918)
Q Consensus 805 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 884 (918)
. ......++..|+|||...+..++.++|+||+|+++|||++|+.||...... ... ........+...
T Consensus 156 ~--~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~-----~~~---~~~~~~~~~~~~--- 222 (256)
T cd08530 156 N--MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQ-----DLR---YKVQRGKYPPIP--- 222 (256)
T ss_pred C--CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-----HHH---HHHhcCCCCCCc---
Confidence 4 222345788999999999888999999999999999999999998654321 000 111112222221
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 885 TDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 885 ~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
.....++.+++.+|++.+|++||++.|+++
T Consensus 223 ~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 252 (256)
T cd08530 223 PIYSQDLQNFIRSMLQVKPKLRPNCDKILA 252 (256)
T ss_pred hhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 134467899999999999999999999975
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=289.35 Aligned_cols=252 Identities=26% Similarity=0.402 Sum_probs=205.1
Q ss_pred CCCCceeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEEEE
Q 044366 647 NFGEKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFIVC 725 (918)
Q Consensus 647 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 725 (918)
+|...+.||+|++|.||+|.. .+++.||+|++..... .....+.+.+|++.++.++|||++++++.+..++..++|+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~ 78 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNM--SEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVM 78 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccC--ChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEE
Confidence 477888999999999999965 4689999999865322 2234567899999999999999999999998889999999
Q ss_pred EeccCCChhHHhhccc-ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccCC
Q 044366 726 EYLARGSLTTILRDDA-AAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEP 804 (918)
Q Consensus 726 e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~~ 804 (918)
||+++++|.++++... ....+++.++..++.+++.|++|||+. +++|+||+|+||++++++.++|+|||.+.....
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~ 155 (258)
T cd08215 79 EYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSS 155 (258)
T ss_pred EecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEECCccceeeccc
Confidence 9999999999997642 135689999999999999999999999 999999999999999999999999999987765
Q ss_pred CCCCceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCCCCCcch
Q 044366 805 HSSNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRDV 884 (918)
Q Consensus 805 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 884 (918)
.........|++.|+|||...+..++.++||||+|+++|+|++|+.|++..... ..... ......+..+..
T Consensus 156 ~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~-----~~~~~---~~~~~~~~~~~~- 226 (258)
T cd08215 156 TVDLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLL-----ELALK---ILKGQYPPIPSQ- 226 (258)
T ss_pred CcceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHH-----HHHHH---HhcCCCCCCCCC-
Confidence 443334456888999999998888999999999999999999999997654311 11111 111112222212
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 885 TDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 885 ~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
....+.+++.+||..+|++|||+.|+++
T Consensus 227 --~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 227 --YSSELRNLVSSLLQKDPEERPSIAQILQ 254 (258)
T ss_pred --CCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 2346788899999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=290.41 Aligned_cols=251 Identities=23% Similarity=0.312 Sum_probs=196.8
Q ss_pred cCCCCceeeccccceEEEEEEe-CCCCEEEEEEccccccc-CCCCChHHHHHHHHHHhhccCCceeeEecccccC--Cce
Q 044366 646 GNFGEKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFS-DETANPSEFLNEVLALTEIRHRNIIKFHGFCSNA--QHS 721 (918)
Q Consensus 646 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~ 721 (918)
.+|...+.||+|+||.||+|.. .+++.||+|.+...... ........+.+|+++++.++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 4688899999999999999954 57999999987542211 1223346789999999999999999999998654 457
Q ss_pred EEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccc
Q 044366 722 FIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKF 801 (918)
Q Consensus 722 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~ 801 (918)
++|+||+++++|.+++.... .+++..+..++.|++.|++|||+. +++|+||||+||+++.++.++|+|||+++.
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~---~l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~ 155 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYG---ALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKR 155 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECccccccc
Confidence 89999999999999987543 378899999999999999999999 999999999999999999999999999986
Q ss_pred cCCCC---CCceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhccc-CC
Q 044366 802 LEPHS---SNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDH-RL 877 (918)
Q Consensus 802 ~~~~~---~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~ 877 (918)
..... .......++..|+|||++.+..++.++|||||||++|+|++|+.||....... ...+.... ..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--------~~~~~~~~~~~ 227 (264)
T cd06653 156 IQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMA--------AIFKIATQPTK 227 (264)
T ss_pred cccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHH--------HHHHHHcCCCC
Confidence 54321 11223467899999999998889999999999999999999999986543211 11111111 11
Q ss_pred CCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 878 PTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 878 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
+..+ ......+.+++.+|++ +|.+||++.+++.
T Consensus 228 ~~~p---~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 228 PMLP---DGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred CCCC---cccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 1111 1233568888999999 5799999998875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-33 Score=305.50 Aligned_cols=259 Identities=22% Similarity=0.352 Sum_probs=194.6
Q ss_pred hcCCCCceeeccccceEEEEEE-eCCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccC-----
Q 044366 645 TGNFGEKYCIGKGGQRSVYKAE-LPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNA----- 718 (918)
Q Consensus 645 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~----- 718 (918)
.++|.+.+.||+|+||.||+|. ..+|+.||+|++... ........+.+|+.+++.++||||+++++++...
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 80 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPF---EHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESF 80 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEeccc---ccchhHHHHHHHHHHHHhCCCCCcCchhheeeccccccc
Confidence 4689999999999999999995 457999999998642 1223356788999999999999999999986543
Q ss_pred CceEEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEecccc
Q 044366 719 QHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGF 798 (918)
Q Consensus 719 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~ 798 (918)
...++|+||+++ ++.+++.. ..+++..++.++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 81 ~~~~lv~e~~~~-~l~~~~~~----~~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~ 152 (336)
T cd07849 81 NDVYIVQELMET-DLYKLIKT----QHLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGL 152 (336)
T ss_pred ceEEEEehhccc-CHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEECcccc
Confidence 357999999975 88887754 3489999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCC---ceeccccccccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhH--------
Q 044366 799 AKFLEPHSSN---WTEFAGTVGYAAPELAYT-MRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMI-------- 866 (918)
Q Consensus 799 ~~~~~~~~~~---~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~-------- 866 (918)
+......... .....|+..|+|||.+.+ ..++.++||||+||++|+|++|+.||...... .......
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~-~~~~~~~~~~~~~~~ 231 (336)
T cd07849 153 ARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYL-HQLNLILGVLGTPSQ 231 (336)
T ss_pred eeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHcCCCCH
Confidence 9866433221 123467899999998754 46788999999999999999999998543211 0000000
Q ss_pred hhhhhhccc-------CCCCC-Cc----chHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 044366 867 IEVNQILDH-------RLPTP-SR----DVTDKLRSIMEVAILCLVENPEARPTMKEVCNL 915 (918)
Q Consensus 867 ~~~~~~~~~-------~~~~~-~~----~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 915 (918)
.....+... ..+.. .. ..+.....+.+++.+||+.||++|||+.|+++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h 292 (336)
T cd07849 232 EDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH 292 (336)
T ss_pred HHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 000000000 00000 00 011223568899999999999999999999863
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=296.64 Aligned_cols=257 Identities=24% Similarity=0.325 Sum_probs=199.5
Q ss_pred CCCCceeeccccceEEEEEEe----CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhc-cCCceeeEecccccCCce
Q 044366 647 NFGEKYCIGKGGQRSVYKAEL----PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEI-RHRNIIKFHGFCSNAQHS 721 (918)
Q Consensus 647 ~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~ 721 (918)
+|...+.||+|++|.||+|.. .+++.||||.++...........+.+.+|++++.++ +||||+++++++..+...
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 367788999999999999853 357899999987543222333456788999999999 599999999999999999
Q ss_pred EEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccc
Q 044366 722 FIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKF 801 (918)
Q Consensus 722 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~ 801 (918)
++||||+++|+|.+++... ..+++..+..++.|+++||+|||+. +++||||+|+||+++.++.++++|||+++.
T Consensus 81 ~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~~~~~l~dfg~~~~ 154 (288)
T cd05583 81 HLILDYVNGGELFTHLYQR---EHFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGHVVLTDFGLSKE 154 (288)
T ss_pred EEEEecCCCCcHHHHHhhc---CCcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEEECccccc
Confidence 9999999999999998753 3488999999999999999999998 999999999999999999999999999987
Q ss_pred cCCCCCC-ceecccccccccccccccCC--CCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCC
Q 044366 802 LEPHSSN-WTEFAGTVGYAAPELAYTMR--ATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLP 878 (918)
Q Consensus 802 ~~~~~~~-~~~~~g~~~y~aPE~~~~~~--~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 878 (918)
....... .....|+..|+|||...+.. .+.++||||||+++|||++|..||....... ...... ........+
T Consensus 155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~-~~~~~~---~~~~~~~~~ 230 (288)
T cd05583 155 FLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQN-SQSEIS---RRILKSKPP 230 (288)
T ss_pred cccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccc-hHHHHH---HHHHccCCC
Confidence 6443322 22345789999999987655 6889999999999999999999975332110 001111 111111111
Q ss_pred CCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 044366 879 TPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLLC 917 (918)
Q Consensus 879 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 917 (918)
. +.. ....+.+++.+||+.||++|||+.++.+.|.
T Consensus 231 ~-~~~---~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~ 265 (288)
T cd05583 231 F-PKT---MSAEARDFIQKLLEKDPKKRLGANGADEIKN 265 (288)
T ss_pred C-Ccc---cCHHHHHHHHHHhcCCHhhccCcchHHHHhc
Confidence 1 111 2245788899999999999999888876653
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-32 Score=297.26 Aligned_cols=247 Identities=26% Similarity=0.390 Sum_probs=194.3
Q ss_pred CCCceeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEEEEE
Q 044366 648 FGEKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFIVCE 726 (918)
Q Consensus 648 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 726 (918)
|...+.||+|+||.||+|.. .+++.||+|++...... .......+.+|+++++.++|||++++++++.+++..++|||
T Consensus 27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 105 (317)
T cd06635 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQ-SNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME 105 (317)
T ss_pred hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCC-chHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence 66778899999999999964 47899999998653221 22234578899999999999999999999999999999999
Q ss_pred eccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccCCCC
Q 044366 727 YLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHS 806 (918)
Q Consensus 727 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~~~~ 806 (918)
|+++ ++.+.+... ...+++.++..++.|++.|+.|||+. +++||||+|+||+++.++.++|+|||++......
T Consensus 106 ~~~g-~l~~~~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~- 178 (317)
T cd06635 106 YCLG-SASDLLEVH--KKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASPA- 178 (317)
T ss_pred CCCC-CHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEEecCCCccccCCc-
Confidence 9974 787777543 23589999999999999999999999 9999999999999999999999999998765432
Q ss_pred CCceecccccccccccccc---cCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCCCCCcc
Q 044366 807 SNWTEFAGTVGYAAPELAY---TMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRD 883 (918)
Q Consensus 807 ~~~~~~~g~~~y~aPE~~~---~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 883 (918)
....++..|+|||++. ++.++.++|||||||++|||++|+.||....... . .........+...
T Consensus 179 ---~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~-~-------~~~~~~~~~~~~~-- 245 (317)
T cd06635 179 ---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-A-------LYHIAQNESPTLQ-- 245 (317)
T ss_pred ---ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHH-H-------HHHHHhccCCCCC--
Confidence 2345788999999874 4568889999999999999999999975432110 0 0111111111111
Q ss_pred hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 044366 884 VTDKLRSIMEVAILCLVENPEARPTMKEVCNL 915 (918)
Q Consensus 884 ~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 915 (918)
.......+.+++.+||+.+|.+||++.++++.
T Consensus 246 ~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 277 (317)
T cd06635 246 SNEWSDYFRNFVDSCLQKIPQDRPTSEELLKH 277 (317)
T ss_pred CccccHHHHHHHHHHccCCcccCcCHHHHHhC
Confidence 11223457889999999999999999999874
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-33 Score=318.84 Aligned_cols=266 Identities=19% Similarity=0.245 Sum_probs=187.6
Q ss_pred HhcCCCCceeeccccceEEEEEEeC--CCCEEEEEEccc-------------ccccCCCCChHHHHHHHHHHhhccCCce
Q 044366 644 ATGNFGEKYCIGKGGQRSVYKAELP--SGNIFAVKKFKA-------------ELFSDETANPSEFLNEVLALTEIRHRNI 708 (918)
Q Consensus 644 ~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~-------------~~~~~~~~~~~~~~~e~~~l~~l~h~ni 708 (918)
..++|.+.+.||+|+||.||++..+ .++.+++|.+.. ............+.+|++++++++||||
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI 225 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI 225 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence 4578999999999999999998543 233333221100 0001112224568899999999999999
Q ss_pred eeEecccccCCceEEEEEeccCCChhHHhhcccc--cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeC
Q 044366 709 IKFHGFCSNAQHSFIVCEYLARGSLTTILRDDAA--AKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLD 786 (918)
Q Consensus 709 v~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~ 786 (918)
+++++++...+..++|+|++. +++.+++..... .......++..++.|++.||+|||+. +||||||||+||+++
T Consensus 226 v~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~---gIiHrDLKP~NILl~ 301 (501)
T PHA03210 226 LKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIFLN 301 (501)
T ss_pred CcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEC
Confidence 999999999999999999986 477777654321 12234667888999999999999999 999999999999999
Q ss_pred CCCcEEEeccccccccCCCCC-CceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCC-CCcch-hhhhhhh
Q 044366 787 SEYEAHVSDFGFAKFLEPHSS-NWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHP-GDFVS-TIFSSIS 863 (918)
Q Consensus 787 ~~~~~kl~DfG~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p-~~~~~-~~~~~~~ 863 (918)
.++.+||+|||+++.+..... ......|+..|+|||++.+..++.++|||||||++|||++|..+ +.... .......
T Consensus 302 ~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~ 381 (501)
T PHA03210 302 CDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLL 381 (501)
T ss_pred CCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHH
Confidence 999999999999987754332 22345789999999999999999999999999999999998754 32211 1111111
Q ss_pred hhHhhhhhhcccCCCC----------------CCcchHH------HHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 864 NMIIEVNQILDHRLPT----------------PSRDVTD------KLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 864 ~~~~~~~~~~~~~~~~----------------~~~~~~~------~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
...... ......++. ....... ....+.+++.+|++.||++|||+.|+++
T Consensus 382 ~~~~~~-~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~ 453 (501)
T PHA03210 382 KIIDSL-SVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLA 453 (501)
T ss_pred HHHHhc-ccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhh
Confidence 110000 000000000 0000111 1134677789999999999999999986
|
|
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-32 Score=296.03 Aligned_cols=263 Identities=24% Similarity=0.340 Sum_probs=198.1
Q ss_pred HHhcCCCCceeeccccceEEEEEEeC-CCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCC--
Q 044366 643 KATGNFGEKYCIGKGGQRSVYKAELP-SGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQ-- 719 (918)
Q Consensus 643 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-- 719 (918)
...++|++.+.||+|+||.||+|... +|+.||+|+++.... .......+.+|+++++.++||||+++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~ 81 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNE--KEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDA 81 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeeccc--ccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchh
Confidence 45678999999999999999999664 689999999875422 2223457789999999999999999999886654
Q ss_pred --------ceEEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcE
Q 044366 720 --------HSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEA 791 (918)
Q Consensus 720 --------~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~ 791 (918)
..++|+||+++ ++.+.+... ...+++.+++.++.|++.||+|||+. +|+||||||+||++++++.+
T Consensus 82 ~~~~~~~~~~~lv~e~~~~-~l~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~ 155 (302)
T cd07864 82 LDFKKDKGAFYLVFEYMDH-DLMGLLESG--LVHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQI 155 (302)
T ss_pred hhccccCCcEEEEEcccCc-cHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCcE
Confidence 78999999986 777777653 23589999999999999999999999 99999999999999999999
Q ss_pred EEeccccccccCCCCC-Cceeccccccccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhh
Q 044366 792 HVSDFGFAKFLEPHSS-NWTEFAGTVGYAAPELAYT-MRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEV 869 (918)
Q Consensus 792 kl~DfG~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~ 869 (918)
||+|||.+........ ......++..|+|||.+.+ ..++.++|||||||++|||++|++||...... ..........
T Consensus 156 kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~-~~~~~~~~~~ 234 (302)
T cd07864 156 KLADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQEL-AQLELISRLC 234 (302)
T ss_pred EeCcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHh
Confidence 9999999987654332 1223346788999998765 35688999999999999999999998754321 1111110000
Q ss_pred hhhcccCCCC-------------------CCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 870 NQILDHRLPT-------------------PSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 870 ~~~~~~~~~~-------------------~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
.......++. ...........+.+++.+||+.||.+||+++++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 235 GSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred CCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 0000000000 00000112356889999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=293.98 Aligned_cols=258 Identities=23% Similarity=0.332 Sum_probs=200.3
Q ss_pred CCCceeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEEEEE
Q 044366 648 FGEKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFIVCE 726 (918)
Q Consensus 648 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 726 (918)
|...+.||+|++|.||+|.. .+|+.+|+|+++..... ......+.+|+++++.++|+||+++++++..++..++|+|
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 78 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFES--EGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFE 78 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEecccccc--chhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEe
Confidence 56678899999999999965 47899999998764322 1335678899999999999999999999999999999999
Q ss_pred eccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccCCCC
Q 044366 727 YLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHS 806 (918)
Q Consensus 727 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~~~~ 806 (918)
|+++ ++.+++.... ..+++.+++.++.|++.|++|||+. +++|+||+|+||+++.++.++|+|||.+.......
T Consensus 79 ~~~~-~l~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~ 152 (283)
T cd05118 79 FMDT-DLYKLIKDRQ--RGLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPV 152 (283)
T ss_pred ccCC-CHHHHHHhhc--ccCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc
Confidence 9975 8888887642 4589999999999999999999999 99999999999999999999999999998776544
Q ss_pred CCceecccccccccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhh--------hhhcc---
Q 044366 807 SNWTEFAGTVGYAAPELAYTM-RATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEV--------NQILD--- 874 (918)
Q Consensus 807 ~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~--------~~~~~--- 874 (918)
.......++..|+|||.+.+. .++.++||||+|+++|+|++|+.||....... ......... .....
T Consensus 153 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (283)
T cd05118 153 RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEID-QLFKIFRTLGTPDPEVWPKFTSLAR 231 (283)
T ss_pred ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHcCCCchHhcccchhhhh
Confidence 233345678899999998776 68899999999999999999999986543211 110000000 00000
Q ss_pred ---cCCC-----CCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 875 ---HRLP-----TPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 875 ---~~~~-----~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
...+ ...........++.+++.+||+.||.+||++.+++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 232 NYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred hhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 0000 000011223467899999999999999999999985
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=294.37 Aligned_cols=258 Identities=24% Similarity=0.380 Sum_probs=197.3
Q ss_pred CCCceeeccccceEEEEEEeC-CCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccC--CceEEE
Q 044366 648 FGEKYCIGKGGQRSVYKAELP-SGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNA--QHSFIV 724 (918)
Q Consensus 648 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~lv 724 (918)
|.+.+.||+|++|.||+|... +|+.||+|+++... ........+.+|+++++.++|||++++++++.+. +..++|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~--~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv 78 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMEN--EKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMV 78 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEeccc--ccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEE
Confidence 567789999999999999654 58999999997643 2223346788999999999999999999999887 889999
Q ss_pred EEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccCC
Q 044366 725 CEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEP 804 (918)
Q Consensus 725 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~~ 804 (918)
+||+++ +|.+++.... ..+++.+++.++.|++.|++|||+. +++|+||+|+||++++++.++++|||.+.....
T Consensus 79 ~e~~~~-~l~~~~~~~~--~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~ 152 (287)
T cd07840 79 FEYMDH-DLTGLLDSPE--VKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTK 152 (287)
T ss_pred eccccc-cHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEccccceeeccC
Confidence 999985 8988886542 3589999999999999999999999 999999999999999999999999999987754
Q ss_pred CCC-Cceeccccccccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCC-----
Q 044366 805 HSS-NWTEFAGTVGYAAPELAYT-MRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRL----- 877 (918)
Q Consensus 805 ~~~-~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~----- 877 (918)
... ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||+..... .................+
T Consensus 153 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 231 (287)
T cd07840 153 RNSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTEL-EQLEKIFELCGSPTDENWPGVSK 231 (287)
T ss_pred CCcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCchhhcccccc
Confidence 432 1233456788999998765 45789999999999999999999998654321 111111000000000000
Q ss_pred ---------CCC-Cc----chHH-HHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 878 ---------PTP-SR----DVTD-KLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 878 ---------~~~-~~----~~~~-~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
... .. .... ....+.+++.+||+.+|.+||++.++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 232 LPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred chhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 000 00 0001 1457889999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=296.87 Aligned_cols=254 Identities=23% Similarity=0.321 Sum_probs=197.0
Q ss_pred CCCCceeeccccceEEEEEEe----CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhc-cCCceeeEecccccCCce
Q 044366 647 NFGEKYCIGKGGQRSVYKAEL----PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEI-RHRNIIKFHGFCSNAQHS 721 (918)
Q Consensus 647 ~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~ 721 (918)
+|+..+.||+|+||.||.|.. .+|+.||+|+++...........+.+.+|+++++.+ +|++|+++++++..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 467788999999999999964 478999999987643333333456788999999999 599999999999988999
Q ss_pred EEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccc
Q 044366 722 FIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKF 801 (918)
Q Consensus 722 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~ 801 (918)
++||||+++++|.+++.... .+++..+..++.|+++||+|||+. +++||||+|+||+++.++.++|+|||++..
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~ 154 (290)
T cd05613 81 HLILDYINGGELFTHLSQRE---RFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKE 154 (290)
T ss_pred EEEEecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCCCCEEEeeCcccee
Confidence 99999999999999997643 478999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCC-CceecccccccccccccccC--CCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCC
Q 044366 802 LEPHSS-NWTEFAGTVGYAAPELAYTM--RATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLP 878 (918)
Q Consensus 802 ~~~~~~-~~~~~~g~~~y~aPE~~~~~--~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 878 (918)
...... ......|+..|+|||.+.+. .++.++||||||+++|+|++|+.|+...... ....... ........
T Consensus 155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~-~~~~~~~---~~~~~~~~- 229 (290)
T cd05613 155 FHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEK-NSQAEIS---RRILKSEP- 229 (290)
T ss_pred cccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcc-ccHHHHH---HHhhccCC-
Confidence 644322 12234678999999998753 4678999999999999999999997643211 0111111 11111111
Q ss_pred CCCcchHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 044366 879 TPSRDVTDKLRSIMEVAILCLVENPEARP-----TMKEVCN 914 (918)
Q Consensus 879 ~~~~~~~~~~~~l~~li~~cl~~dp~~RP-----t~~evl~ 914 (918)
+.+. .....+.+++.+|++.||++|| ++++++.
T Consensus 230 ~~~~---~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 230 PYPQ---EMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred CCCc---cCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence 1111 1234678899999999999997 6677654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=302.96 Aligned_cols=261 Identities=21% Similarity=0.293 Sum_probs=197.5
Q ss_pred hcCCCCceeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEeccccc----CC
Q 044366 645 TGNFGEKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSN----AQ 719 (918)
Q Consensus 645 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~----~~ 719 (918)
.++|+..+.||+|++|.||+|.. .+|+.||+|++..... .......+.+|+.+++.++||||+++++++.. ..
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 81 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFD--VPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFK 81 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccc--cccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCc
Confidence 47889999999999999999954 5799999999875321 22335677889999999999999999998753 35
Q ss_pred ceEEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccc
Q 044366 720 HSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFA 799 (918)
Q Consensus 720 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~ 799 (918)
..++||||+. |+|.+++.... .+++..++.++.|++.||+|||+. +++||||||+||++++++.+||+|||++
T Consensus 82 ~~~lv~e~~~-~~l~~~~~~~~---~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~~ 154 (334)
T cd07855 82 DVYVVMDLME-SDLHHIIHSDQ---PLTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMA 154 (334)
T ss_pred eEEEEEehhh-hhHHHHhccCC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEecccccc
Confidence 6899999996 58999886543 389999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCC----ceeccccccccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCcchhhhh--hhhhh-------
Q 044366 800 KFLEPHSSN----WTEFAGTVGYAAPELAYT-MRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFS--SISNM------- 865 (918)
Q Consensus 800 ~~~~~~~~~----~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~--~~~~~------- 865 (918)
......... .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||........ .+...
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~ 234 (334)
T cd07855 155 RGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEE 234 (334)
T ss_pred eeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhH
Confidence 766433221 123467889999998765 4578999999999999999999999865432110 00000
Q ss_pred ------HhhhhhhcccCCCCCCc----chHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 866 ------IIEVNQILDHRLPTPSR----DVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 866 ------~~~~~~~~~~~~~~~~~----~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
.....+..+........ ........+.+++.+|++.||.+||++++++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 293 (334)
T cd07855 235 VLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQ 293 (334)
T ss_pred hhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 00000000000000000 01123467899999999999999999999886
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=298.92 Aligned_cols=252 Identities=24% Similarity=0.373 Sum_probs=206.4
Q ss_pred HHhcCCCCceeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCce
Q 044366 643 KATGNFGEKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHS 721 (918)
Q Consensus 643 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 721 (918)
...+.|.+...||+|.|+.|..|.. .+|..||+|.+.+... +......+.+|+++|+.++|||||+++.+.......
T Consensus 53 ~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~l--n~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~l 130 (596)
T KOG0586|consen 53 NSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQL--NPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATL 130 (596)
T ss_pred ccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhccc--ChHHHHHHHHHHHHHHhcCCcceeeeeeeeeeccee
Confidence 4457789999999999999999954 5799999999987533 233345589999999999999999999999999999
Q ss_pred EEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccc
Q 044366 722 FIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKF 801 (918)
Q Consensus 722 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~ 801 (918)
|+||||+.+|.+.+++..... ..+.....++.|+.+|++|||++ .|||||||++||+++.++.+||+|||++.+
T Consensus 131 ylV~eya~~ge~~~yl~~~gr---~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mnikIaDfgfS~~ 204 (596)
T KOG0586|consen 131 YLVMEYASGGELFDYLVKHGR---MKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNIKIADFGFSTF 204 (596)
T ss_pred EEEEEeccCchhHHHHHhccc---chhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccccceeeecccccee
Confidence 999999999999999987653 45578889999999999999999 999999999999999999999999999998
Q ss_pred cCCCCCCceecccccccccccccccCCC-CcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCCCC
Q 044366 802 LEPHSSNWTEFAGTVGYAAPELAYTMRA-TEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTP 880 (918)
Q Consensus 802 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 880 (918)
+.. .......+|++.|.|||+..+..| .+++|+||+|+++|.|++|..||+...- .... .+.+..++.-+
T Consensus 205 ~~~-~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~l--k~Lr------~rvl~gk~rIp 275 (596)
T KOG0586|consen 205 FDY-GLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNL--KELR------PRVLRGKYRIP 275 (596)
T ss_pred ecc-cccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccc--cccc------chheeeeeccc
Confidence 874 344456789999999999998877 5789999999999999999999874321 1111 11111111111
Q ss_pred CcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 044366 881 SRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNL 915 (918)
Q Consensus 881 ~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 915 (918)
. -...++.+++.+++..+|.+|++++++.+-
T Consensus 276 ~----~ms~dce~lLrk~lvl~Pskr~~~dqim~~ 306 (596)
T KOG0586|consen 276 F----YMSCDCEDLLRKFLVLNPSKRGPCDQIMKD 306 (596)
T ss_pred c----eeechhHHHHHHhhccCccccCCHHHhhhh
Confidence 0 122456778889999999999999998753
|
|
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=295.12 Aligned_cols=254 Identities=23% Similarity=0.359 Sum_probs=194.6
Q ss_pred hcCCCCceeeccccceEEEEEEeC-CCCEEEEEEcccccccCCCCChHHHHHHHHHHhhc-cCCceeeEecccccCCceE
Q 044366 645 TGNFGEKYCIGKGGQRSVYKAELP-SGNIFAVKKFKAELFSDETANPSEFLNEVLALTEI-RHRNIIKFHGFCSNAQHSF 722 (918)
Q Consensus 645 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~ 722 (918)
.++|++.+.||+|++|.||+|... +++.||||.++... .......+..|+..+... .||||+++++++.++...+
T Consensus 14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~---~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~ 90 (296)
T cd06618 14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTG---NKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVF 90 (296)
T ss_pred cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccC---ChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEE
Confidence 366888899999999999999765 48999999986532 122245667788777666 4999999999999999999
Q ss_pred EEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEecccccccc
Q 044366 723 IVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFL 802 (918)
Q Consensus 723 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~ 802 (918)
+||||+++ ++.++..... ..+++..+..++.|++.|++|||+.. +++||||+|+||++++++.++|+|||++..+
T Consensus 91 ~v~e~~~~-~l~~l~~~~~--~~l~~~~~~~i~~~i~~~l~~lH~~~--~i~H~dl~p~nill~~~~~~kL~dfg~~~~~ 165 (296)
T cd06618 91 ICMELMST-CLDKLLKRIQ--GPIPEDILGKMTVAIVKALHYLKEKH--GVIHRDVKPSNILLDASGNVKLCDFGISGRL 165 (296)
T ss_pred EEeeccCc-CHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhhC--CEecCCCcHHHEEEcCCCCEEECccccchhc
Confidence 99999864 7777765532 36899999999999999999999732 8999999999999999999999999999876
Q ss_pred CCCCCCceecccccccccccccccCC----CCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCC
Q 044366 803 EPHSSNWTEFAGTVGYAAPELAYTMR----ATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLP 878 (918)
Q Consensus 803 ~~~~~~~~~~~g~~~y~aPE~~~~~~----~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 878 (918)
...... ....++..|+|||++.+.. ++.++||||||+++|+|++|+.||........... .......+
T Consensus 166 ~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~-------~~~~~~~~ 237 (296)
T cd06618 166 VDSKAK-TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLT-------KILQEEPP 237 (296)
T ss_pred cCCCcc-cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHH-------HHhcCCCC
Confidence 433222 2345788999999987554 78899999999999999999999865322211111 11111111
Q ss_pred CCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 044366 879 TPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNL 915 (918)
Q Consensus 879 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 915 (918)
.... .......+.+++.+||+.||.+||++.++++.
T Consensus 238 ~~~~-~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 238 SLPP-NEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred CCCC-CCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 1111 01223468889999999999999999999763
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-32 Score=296.98 Aligned_cols=261 Identities=23% Similarity=0.350 Sum_probs=193.2
Q ss_pred HhcCCCCceeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCC---
Q 044366 644 ATGNFGEKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQ--- 719 (918)
Q Consensus 644 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~--- 719 (918)
..++|...+.||+|+||.||+|.. .+++.||||.+..... .......+.+|++++++++||||+++++++...+
T Consensus 10 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 87 (310)
T cd07865 10 EVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENE--KEGFPITALREIKILQLLKHENVVNLIEICRTKATPY 87 (310)
T ss_pred hhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCC--cCCchhHHHHHHHHHHhCCCCCccceEEEEecccccc
Confidence 345789999999999999999955 4799999999865321 1222345678999999999999999999886544
Q ss_pred -----ceEEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEe
Q 044366 720 -----HSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVS 794 (918)
Q Consensus 720 -----~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~ 794 (918)
..++||||+.+ ++.+++.... ..+++.+++.++.|++.||+|||+. +++|+||||+||+++.++.+||+
T Consensus 88 ~~~~~~~~lv~e~~~~-~l~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~ 161 (310)
T cd07865 88 NRYKGSFYLVFEFCEH-DLAGLLSNKN--VKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLA 161 (310)
T ss_pred cCCCceEEEEEcCCCc-CHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCCcEEEC
Confidence 35999999975 8888876542 3589999999999999999999999 99999999999999999999999
Q ss_pred ccccccccCCCCCC----ceecccccccccccccccCC-CCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhh
Q 044366 795 DFGFAKFLEPHSSN----WTEFAGTVGYAAPELAYTMR-ATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEV 869 (918)
Q Consensus 795 DfG~~~~~~~~~~~----~~~~~g~~~y~aPE~~~~~~-~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~ 869 (918)
|||++......... .....++..|+|||.+.+.. ++.++||||||+++|||++|+.||....... .... ....
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~-~~~~-~~~~ 239 (310)
T cd07865 162 DFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQH-QLTL-ISQL 239 (310)
T ss_pred cCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHH-HHHH-HHHH
Confidence 99999876433221 12345678899999886644 6889999999999999999999976443210 0000 0000
Q ss_pred hh--------------hc-ccCCCCCCc-chHH------HHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 870 NQ--------------IL-DHRLPTPSR-DVTD------KLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 870 ~~--------------~~-~~~~~~~~~-~~~~------~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
.. .. ....+.... .... ....+.+++.+||+.||++|||++|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~ 306 (310)
T cd07865 240 CGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN 306 (310)
T ss_pred hCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence 00 00 000000000 0000 1235678999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=293.35 Aligned_cols=255 Identities=21% Similarity=0.307 Sum_probs=191.9
Q ss_pred CCCceeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhcc-CCceeeEecccccC--CceEE
Q 044366 648 FGEKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIR-HRNIIKFHGFCSNA--QHSFI 723 (918)
Q Consensus 648 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~--~~~~l 723 (918)
|...+.||+|+||.||+|.. .+++.||+|+++.... ........+|+..++++. |+|++++++++.++ +..++
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~---~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~l 77 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFK---SLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLAL 77 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccC---CchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEE
Confidence 56678899999999999954 5789999999875321 112234567888888885 99999999999877 88999
Q ss_pred EEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccC
Q 044366 724 VCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLE 803 (918)
Q Consensus 724 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~ 803 (918)
||||++ |++.+++.... ..+++.+++.++.|++.||+|||+. +++||||+|+||+++. +.+||+|||.+....
T Consensus 78 v~e~~~-~~l~~~l~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~ 150 (282)
T cd07831 78 VFELMD-MNLYELIKGRK--RPLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLADFGSCRGIY 150 (282)
T ss_pred EEecCC-ccHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEEecccccccc
Confidence 999997 58888876542 3589999999999999999999999 9999999999999999 999999999998765
Q ss_pred CCCCCceeccccccccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHh-------hhhhh---
Q 044366 804 PHSSNWTEFAGTVGYAAPELAYT-MRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMII-------EVNQI--- 872 (918)
Q Consensus 804 ~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~-------~~~~~--- 872 (918)
.... .....++..|+|||++.+ ..++.++||||+||++|||++|+.||...... +.+..... .....
T Consensus 151 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 228 (282)
T cd07831 151 SKPP-YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNEL-DQIAKIHDVLGTPDAEVLKKFRK 228 (282)
T ss_pred cCCC-cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHH-HHHHHHHHHcCCCCHHHHHhhcc
Confidence 4322 223457889999997654 55788999999999999999999998654321 11111000 00000
Q ss_pred ---cccCCCCCC-cc----hHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 873 ---LDHRLPTPS-RD----VTDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 873 ---~~~~~~~~~-~~----~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
.....+... .. .......+.+++.+||+.+|++||+++++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 229 SRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred cccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 000000000 00 1123467899999999999999999999986
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=292.45 Aligned_cols=246 Identities=24% Similarity=0.379 Sum_probs=195.1
Q ss_pred eccccceEEEEEEeC-CCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEEEEEeccCCC
Q 044366 654 IGKGGQRSVYKAELP-SGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFIVCEYLARGS 732 (918)
Q Consensus 654 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gs 732 (918)
||+|+||.||+|... +|+.||+|.+....... ....+.+.+|++++++++||||+++++.+..++..++||||+++++
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~-~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 79 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIR-KNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGD 79 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhh-hhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCc
Confidence 689999999999765 59999999986542211 2335678999999999999999999999999999999999999999
Q ss_pred hhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccCCCCC-----
Q 044366 733 LTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSS----- 807 (918)
Q Consensus 733 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~~~~~----- 807 (918)
|.+++.+.. .+++..++.++.|+++||+|||+. +++||||+|+||++++++.++|+|||++........
T Consensus 80 L~~~l~~~~---~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 153 (265)
T cd05579 80 LASLLENVG---SLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLND 153 (265)
T ss_pred HHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccc
Confidence 999997643 589999999999999999999999 999999999999999999999999999876543311
Q ss_pred ---CceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCCCCCcch
Q 044366 808 ---NWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRDV 884 (918)
Q Consensus 808 ---~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 884 (918)
......++..|+|||...+...+.++||||||+++|++++|+.||...... ... ..........+..
T Consensus 154 ~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~-----~~~---~~~~~~~~~~~~~-- 223 (265)
T cd05579 154 DEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPE-----EIF---QNILNGKIEWPED-- 223 (265)
T ss_pred ccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH-----HHH---HHHhcCCcCCCcc--
Confidence 223456788999999998888899999999999999999999998644321 001 1111111111111
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 044366 885 TDKLRSIMEVAILCLVENPEARPTMKEVCNLL 916 (918)
Q Consensus 885 ~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L 916 (918)
......+.+++.+||+.+|++|||+.++.+.|
T Consensus 224 ~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l 255 (265)
T cd05579 224 VEVSDEAIDLISKLLVPDPEKRLGAKSIEEIK 255 (265)
T ss_pred ccCCHHHHHHHHHHhcCCHhhcCCCccHHHHh
Confidence 11235678999999999999999995554444
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-32 Score=291.36 Aligned_cols=258 Identities=23% Similarity=0.329 Sum_probs=195.6
Q ss_pred CCCceeeccccceEEEEEEeC-CCCEEEEEEcccccccCCCCChHHHHHHHHHHhhc---cCCceeeEecccccCCc---
Q 044366 648 FGEKYCIGKGGQRSVYKAELP-SGNIFAVKKFKAELFSDETANPSEFLNEVLALTEI---RHRNIIKFHGFCSNAQH--- 720 (918)
Q Consensus 648 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l---~h~niv~~~~~~~~~~~--- 720 (918)
|++.+.||+|+||.||+|... +++.||+|+++.... .......+.+|+.+++++ +|||++++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~ 78 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLS--EEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRE 78 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccc--cchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCC
Confidence 567789999999999999765 589999999875432 122235567788777666 59999999999987766
Q ss_pred --eEEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEecccc
Q 044366 721 --SFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGF 798 (918)
Q Consensus 721 --~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~ 798 (918)
.+++|||+++ +|.+++.... ...+++.+++.++.|+++||+|||+. +++|+||+|+||++++++.++|+|||.
T Consensus 79 ~~~~l~~e~~~~-~l~~~l~~~~-~~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~~~~l~dfg~ 153 (287)
T cd07838 79 LKLTLVFEHVDQ-DLATYLSKCP-KPGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGL 153 (287)
T ss_pred ceeEEEehhccc-CHHHHHHHcc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCCCEEEeccCc
Confidence 8999999975 8999887643 23589999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCCceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhh-------
Q 044366 799 AKFLEPHSSNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQ------- 871 (918)
Q Consensus 799 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~------- 871 (918)
+..+..... .....++..|+|||++.+..++.++||||||+++|||++|+.||+..... +...........
T Consensus 154 ~~~~~~~~~-~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 231 (287)
T cd07838 154 ARIYSFEMA-LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEA-DQLDKIFDVIGLPSEEEWP 231 (287)
T ss_pred ceeccCCcc-cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChH-HHHHHHHHHcCCCChHhcC
Confidence 987644322 23345788999999999888999999999999999999999987643321 111111100000
Q ss_pred --------hcccCCC-CCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 872 --------ILDHRLP-TPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 872 --------~~~~~~~-~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
....... ............+.+++.+||+.||.+||++.|++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 232 RNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred CCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 0000000 001111233466789999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=298.75 Aligned_cols=254 Identities=20% Similarity=0.275 Sum_probs=188.9
Q ss_pred eccccceEEEEEEeCCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEEEEEeccCCCh
Q 044366 654 IGKGGQRSVYKAELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFIVCEYLARGSL 733 (918)
Q Consensus 654 lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL 733 (918)
+|.|+++.||++.. +++.||||++..... .....+.+.+|++.++.++||||+++++++.+.+..+++|||+++|+|
T Consensus 10 ~~~~~~v~~~~~~~-~~~~~avK~~~~~~~--~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l 86 (314)
T cd08216 10 FEDLMIVHLAKHKP-TNTLVAVKKINLDSC--SKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSC 86 (314)
T ss_pred hcCCceEEEEEecC-CCCEEEEEEEecccc--chhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCH
Confidence 44445555555544 799999999876321 233467899999999999999999999999999999999999999999
Q ss_pred hHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccCCCCC------
Q 044366 734 TTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSS------ 807 (918)
Q Consensus 734 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~~~~~------ 807 (918)
.+++.... ...+++..+..++.|+++||+|||+. +|+||||||+||+++.++.++++|||.+........
T Consensus 87 ~~~l~~~~-~~~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~ 162 (314)
T cd08216 87 EDLLKTHF-PEGLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVH 162 (314)
T ss_pred HHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCccceeeccccccccccc
Confidence 99998653 23478999999999999999999999 999999999999999999999999998876543221
Q ss_pred -Cceeccccccccccccccc--CCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcc----------
Q 044366 808 -NWTEFAGTVGYAAPELAYT--MRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILD---------- 874 (918)
Q Consensus 808 -~~~~~~g~~~y~aPE~~~~--~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~---------- 874 (918)
......++..|+|||++.+ ..++.++|||||||++|||++|+.||.....................+
T Consensus 163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (314)
T cd08216 163 DFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDS 242 (314)
T ss_pred cccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcCC
Confidence 1123456778999999876 357889999999999999999999987543321111110000000000
Q ss_pred ----------cCC--CCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 875 ----------HRL--PTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 875 ----------~~~--~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
... ............++.+++.+||+.||++|||++|+++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~ 294 (314)
T cd08216 243 MSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN 294 (314)
T ss_pred cCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhc
Confidence 000 0000011122356888999999999999999999986
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=247.74 Aligned_cols=259 Identities=19% Similarity=0.321 Sum_probs=199.1
Q ss_pred CCCCceeeccccceEEEEEE-eCCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEEEE
Q 044366 647 NFGEKYCIGKGGQRSVYKAE-LPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFIVC 725 (918)
Q Consensus 647 ~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 725 (918)
+|...++||+|+||+||+|+ ..+++.||+|+++... +++.......+|+.+++.++|+|||++++....+...-+|+
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrldd--ddegvpssalreicllkelkhknivrl~dvlhsdkkltlvf 80 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDD--DDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF 80 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccC--CCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeH
Confidence 45666789999999999994 5578999999998753 34445678899999999999999999999999999999999
Q ss_pred EeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccCCC
Q 044366 726 EYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPH 805 (918)
Q Consensus 726 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~~~ 805 (918)
|||+. +|.+|+.... +.++.+.+..+..|+++|+.|+|++ .+.|||+||+|.+++.+|+.|++|||+++.++-+
T Consensus 81 e~cdq-dlkkyfdsln--g~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkladfglarafgip 154 (292)
T KOG0662|consen 81 EFCDQ-DLKKYFDSLN--GDLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLADFGLARAFGIP 154 (292)
T ss_pred HHhhH-HHHHHHHhcC--CcCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEecccchhhhcCCc
Confidence 99976 8999987653 4578899999999999999999999 9999999999999999999999999999988776
Q ss_pred CCCceecccccccccccccccCC-CCcccchhhHHHHHHHHHhCCCC-CCcchhhhhhhhhhHhhhhhhcccCCCC----
Q 044366 806 SSNWTEFAGTVGYAAPELAYTMR-ATEKYDVYSFGVLALEVIKGYHP-GDFVSTIFSSISNMIIEVNQILDHRLPT---- 879 (918)
Q Consensus 806 ~~~~~~~~g~~~y~aPE~~~~~~-~~~~~Dv~slG~vl~el~tg~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~---- 879 (918)
....+..+.|..|.+|.++.+.+ |+...|+||-||++.|+.....| |.. .+..+............-...+|.
T Consensus 155 vrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg-~dvddqlkrif~~lg~p~ed~wps~t~l 233 (292)
T KOG0662|consen 155 VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPG-NDVDDQLKRIFRLLGTPTEDQWPSMTKL 233 (292)
T ss_pred eEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCC-CcHHHHHHHHHHHhCCCccccCCccccC
Confidence 66667778899999999998865 78899999999999999975544 332 122222222111111111111110
Q ss_pred ----------CCcchHHHHH----HHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 880 ----------PSRDVTDKLR----SIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 880 ----------~~~~~~~~~~----~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
....+...++ .-.+++.+.+.-+|..|.++++.++
T Consensus 234 pdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq 282 (292)
T KOG0662|consen 234 PDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ 282 (292)
T ss_pred CCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence 0111122222 2356666677779999999998875
|
|
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-32 Score=287.91 Aligned_cols=248 Identities=23% Similarity=0.317 Sum_probs=190.4
Q ss_pred HHHHHhcCCCCceee--ccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhc-cCCceeeEeccc
Q 044366 640 EITKATGNFGEKYCI--GKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEI-RHRNIIKFHGFC 715 (918)
Q Consensus 640 ~~~~~~~~~~~~~~l--g~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~ 715 (918)
+.....++|.+.+.+ |+|+||.||++.. .+++.+|+|.+....... .|+.....+ +||||+++++++
T Consensus 8 ~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~---------~e~~~~~~~~~h~~iv~~~~~~ 78 (267)
T PHA03390 8 ELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA---------IEPMVHQLMKDNPNFIKLYYSV 78 (267)
T ss_pred HHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch---------hhHHHHHHhhcCCCEEEEEEEE
Confidence 344445677777766 9999999999954 578899999986532110 122222222 699999999999
Q ss_pred ccCCceEEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCC-cEEEe
Q 044366 716 SNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEY-EAHVS 794 (918)
Q Consensus 716 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~-~~kl~ 794 (918)
..++..++||||+++|+|.+++.... .++++++..++.|+++|++|||+. +++||||+|+||+++.++ .++++
T Consensus 79 ~~~~~~~iv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~l~ 152 (267)
T PHA03390 79 TTLKGHVLIMDYIKDGDLFDLLKKEG---KLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLC 152 (267)
T ss_pred ecCCeeEEEEEcCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeCCCCeEEEe
Confidence 99999999999999999999997653 589999999999999999999999 999999999999999998 99999
Q ss_pred ccccccccCCCCCCceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcc
Q 044366 795 DFGFAKFLEPHSSNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILD 874 (918)
Q Consensus 795 DfG~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 874 (918)
|||.+....... ...++..|+|||++.+..++.++||||+|+++|||++|+.||............. .....
T Consensus 153 dfg~~~~~~~~~----~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~----~~~~~ 224 (267)
T PHA03390 153 DYGLCKIIGTPS----CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESL----LKRQQ 224 (267)
T ss_pred cCccceecCCCc----cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHH----HHhhc
Confidence 999998664322 2357899999999998889999999999999999999999986432211011111 11111
Q ss_pred cCCCCCCcchHHHHHHHHHHHHHcccCCCCCCCC-HHHHHH
Q 044366 875 HRLPTPSRDVTDKLRSIMEVAILCLVENPEARPT-MKEVCN 914 (918)
Q Consensus 875 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt-~~evl~ 914 (918)
...+ ........+.+++.+|++.+|.+||+ ++|+++
T Consensus 225 ~~~~----~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 225 KKLP----FIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred ccCC----cccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 1111 11133456888999999999999996 588874
|
|
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=301.63 Aligned_cols=261 Identities=24% Similarity=0.357 Sum_probs=196.3
Q ss_pred HhcCCCCceeeccccceEEEEEEeC-CCCEEEEEEcccccccCCCCChHHHHHHHHHHhhc-cCCceeeEecccccC--C
Q 044366 644 ATGNFGEKYCIGKGGQRSVYKAELP-SGNIFAVKKFKAELFSDETANPSEFLNEVLALTEI-RHRNIIKFHGFCSNA--Q 719 (918)
Q Consensus 644 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~--~ 719 (918)
..++|...+.||+|+||.||+|... +|+.||+|++..... .......+.+|+.+++++ +||||+++++++... .
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~--~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~ 82 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFR--NATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDK 82 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccC--cchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCc
Confidence 4567888899999999999999654 688999998864321 112245677899999999 999999999988543 4
Q ss_pred ceEEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccc
Q 044366 720 HSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFA 799 (918)
Q Consensus 720 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~ 799 (918)
..++||||++ ++|.+++... .+++..++.++.|++.||+|||+. +++||||||+||+++.++.+||+|||++
T Consensus 83 ~~~lv~e~~~-~~L~~~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~~~~kl~d~g~~ 154 (337)
T cd07852 83 DIYLVFEYME-TDLHAVIRAN----ILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLA 154 (337)
T ss_pred eEEEEecccc-cCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccch
Confidence 6899999997 5999888653 478999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCC-----Cceeccccccccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHh------
Q 044366 800 KFLEPHSS-----NWTEFAGTVGYAAPELAYT-MRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMII------ 867 (918)
Q Consensus 800 ~~~~~~~~-----~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~------ 867 (918)
........ ......|+..|+|||.+.+ ..++.++||||||+++|+|++|+.||........ ......
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~-~~~~~~~~~~~~ 233 (337)
T cd07852 155 RSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQ-LEKIIEVIGPPS 233 (337)
T ss_pred hccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHhCCCC
Confidence 87644322 2233467889999998765 4578899999999999999999999864332110 000000
Q ss_pred ---------h-hhhhcc----cCCCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 044366 868 ---------E-VNQILD----HRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNL 915 (918)
Q Consensus 868 ---------~-~~~~~~----~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 915 (918)
. ...... ................+.+++.+||+.||.+|||+.++++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 234 AEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 0 000000 00001111111124568899999999999999999999863
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-32 Score=291.31 Aligned_cols=244 Identities=20% Similarity=0.225 Sum_probs=186.4
Q ss_pred eeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHH---HhhccCCceeeEecccccCCceEEEEEec
Q 044366 653 CIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLA---LTEIRHRNIIKFHGFCSNAQHSFIVCEYL 728 (918)
Q Consensus 653 ~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~---l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 728 (918)
.||+|+||.||+|.. .+|+.||+|.+........ .....+..|... ++...||+|+++++++.+++..++||||+
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 79 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMK-QGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLM 79 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccc-hhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecC
Confidence 389999999999954 5689999999875432211 112234444433 44457999999999999999999999999
Q ss_pred cCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccCCCCCC
Q 044366 729 ARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSN 808 (918)
Q Consensus 729 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~~~~~~ 808 (918)
++|+|.+++... ..+++.++..++.|++.|++|||+. +++||||||+||+++.++.++|+|||++.......
T Consensus 80 ~g~~L~~~l~~~---~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~-- 151 (278)
T cd05606 80 NGGDLHYHLSQH---GVFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-- 151 (278)
T ss_pred CCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccCcCccccCccC--
Confidence 999999988653 3589999999999999999999999 99999999999999999999999999997654322
Q ss_pred ceecccccccccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCCCCCcchHHH
Q 044366 809 WTEFAGTVGYAAPELAYTM-RATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRDVTDK 887 (918)
Q Consensus 809 ~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 887 (918)
.....|+..|+|||++.++ .++.++||||+|+++|||++|+.||........ ... .. ....... ..+.. .
T Consensus 152 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~--~~~-~~--~~~~~~~-~~~~~---~ 222 (278)
T cd05606 152 PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK--HEI-DR--MTLTMAV-ELPDS---F 222 (278)
T ss_pred CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccch--HHH-HH--HhhccCC-CCCCc---C
Confidence 2234689999999998754 588999999999999999999999865422110 000 00 0000111 11111 2
Q ss_pred HHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 044366 888 LRSIMEVAILCLVENPEARP-----TMKEVCN 914 (918)
Q Consensus 888 ~~~l~~li~~cl~~dp~~RP-----t~~evl~ 914 (918)
...+.+++.+|+..+|.+|| ++.++++
T Consensus 223 s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 223 SPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred CHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence 35688889999999999999 9999985
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=289.31 Aligned_cols=253 Identities=23% Similarity=0.298 Sum_probs=197.6
Q ss_pred CCCCceeeccccceEEEEEEeC-CCCEEEEEEcccccccC-CCCChHHHHHHHHHHhhccCCceeeEecccccCCceEEE
Q 044366 647 NFGEKYCIGKGGQRSVYKAELP-SGNIFAVKKFKAELFSD-ETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFIV 724 (918)
Q Consensus 647 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 724 (918)
+|.+.+.||+|+||.||+|... .+..+++|.++...... ......++.+|+.+++.++||||+++++++.+.+..++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 4778899999999999999553 45556666655422221 222344677899999999999999999999999999999
Q ss_pred EEeccCCChhHHhhccc-ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccC
Q 044366 725 CEYLARGSLTTILRDDA-AAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLE 803 (918)
Q Consensus 725 ~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~ 803 (918)
|||+++++|.+++.... ....+++.+++.++.|++.|++|||+. +++|+||+|+||++++ +.++++|||.+....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeec-CCEeecccCceeecC
Confidence 99999999999886532 234689999999999999999999999 9999999999999975 569999999998765
Q ss_pred CCCCCceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCCCCCcc
Q 044366 804 PHSSNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRD 883 (918)
Q Consensus 804 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 883 (918)
..........|+..|+|||...+..++.++||||||+++|+|++|..|+...... ...........+...
T Consensus 157 ~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~-- 226 (260)
T cd08222 157 GSCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFL--------SVVLRIVEGPTPSLP-- 226 (260)
T ss_pred CCcccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHH--------HHHHHHHcCCCCCCc--
Confidence 4443334456788999999998888899999999999999999999997543211 011111111121111
Q ss_pred hHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 884 VTDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 884 ~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
......+.+++.+||+.+|++||++.|+++
T Consensus 227 -~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 227 -ETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred -chhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 233457888999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-32 Score=298.59 Aligned_cols=254 Identities=22% Similarity=0.324 Sum_probs=189.7
Q ss_pred eeccc--cceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEEEEEecc
Q 044366 653 CIGKG--GQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFIVCEYLA 729 (918)
Q Consensus 653 ~lg~G--~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 729 (918)
.||+| +||+||+|.. .+|+.||+|.+...... ....+.+.+|+.+++.++||||+++++++..++..++|+||+.
T Consensus 5 ~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~--~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~ 82 (328)
T cd08226 5 EIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCT--EEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMA 82 (328)
T ss_pred HhCCcccCceeEEEEEEcCCCcEEEEEEeccccCC--HHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEeccc
Confidence 46666 8999999965 58999999998653221 1224678899999999999999999999999999999999999
Q ss_pred CCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccCCCCCCc
Q 044366 730 RGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNW 809 (918)
Q Consensus 730 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~~~~~~~ 809 (918)
+|++.+++..... ..+++..+..++.|++.||+|||+. +++||||||+||+++.++.++++|||.+..........
T Consensus 83 ~~~l~~~l~~~~~-~~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~ 158 (328)
T cd08226 83 YGSANSLLKTYFP-EGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKA 158 (328)
T ss_pred CCCHHHHHHhhcc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccc
Confidence 9999999876532 3479999999999999999999999 99999999999999999999999998654332211110
Q ss_pred -------eecccccccccccccccC--CCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHh-------------
Q 044366 810 -------TEFAGTVGYAAPELAYTM--RATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMII------------- 867 (918)
Q Consensus 810 -------~~~~g~~~y~aPE~~~~~--~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~------------- 867 (918)
....++..|+|||++.+. .++.++|||||||++|||++|+.||...............
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (328)
T cd08226 159 KVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPC 238 (328)
T ss_pred cccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccch
Confidence 112345679999998763 4788999999999999999999998654321111000000
Q ss_pred hhh------------------------hhcccCCCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 868 EVN------------------------QILDHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 868 ~~~------------------------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
... ........ ..........+.+++.+||+.||++|||++|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~ 307 (328)
T cd08226 239 EESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLR--TPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLS 307 (328)
T ss_pred hhhhhccchhhhhcccccchhcccccccccccccc--chhhhhhhHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 000 00000000 0011234467899999999999999999999975
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=292.91 Aligned_cols=250 Identities=25% Similarity=0.379 Sum_probs=201.6
Q ss_pred cCCCCceeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhcc-CCceeeEecccccCCceEE
Q 044366 646 GNFGEKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIR-HRNIIKFHGFCSNAQHSFI 723 (918)
Q Consensus 646 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~l 723 (918)
++|...+.||+|++|.||+|.. .+|+.||+|++...... .....+.+.+|++++++++ ||||+++++++.+++..++
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~l 79 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLI-KEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYF 79 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhcc-chHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEE
Confidence 3678889999999999999965 47999999998653221 1223467889999999998 9999999999999999999
Q ss_pred EEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccC
Q 044366 724 VCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLE 803 (918)
Q Consensus 724 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~ 803 (918)
||||+++++|.+++.+.. .+++.+++.++.|++.|++|||+. +++|+||+|+||+++.++.++++|||++....
T Consensus 80 v~e~~~~~~L~~~l~~~~---~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~ 153 (280)
T cd05581 80 VLEYAPNGELLQYIRKYG---SLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLD 153 (280)
T ss_pred EEcCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEecCCccccccC
Confidence 999999999999997653 589999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCC--------------------CceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhh
Q 044366 804 PHSS--------------------NWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSIS 863 (918)
Q Consensus 804 ~~~~--------------------~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~ 863 (918)
.... ......++..|+|||...+..++.++||||||++++++++|+.|+....... .
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-~-- 230 (280)
T cd05581 154 PNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYL-T-- 230 (280)
T ss_pred CccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHH-H--
Confidence 4321 1123457889999999988889999999999999999999999987543211 1
Q ss_pred hhHhhhhhhcccCCCCCCcchHHHHHHHHHHHHHcccCCCCCCCCH----HHHHH
Q 044366 864 NMIIEVNQILDHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTM----KEVCN 914 (918)
Q Consensus 864 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~----~evl~ 914 (918)
...........+ .. ....+.+++.+||+.+|.+||++ +++++
T Consensus 231 -----~~~~~~~~~~~~-~~---~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 231 -----FQKILKLEYSFP-PN---FPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred -----HHHHHhcCCCCC-Cc---cCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 111111111111 11 13467889999999999999999 77764
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-32 Score=300.13 Aligned_cols=261 Identities=22% Similarity=0.272 Sum_probs=194.4
Q ss_pred cCCCC-ceeeccccceEEEEEEe-CCCCEEEEEEcccccccCCC----------CChHHHHHHHHHHhhccCCceeeEec
Q 044366 646 GNFGE-KYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDET----------ANPSEFLNEVLALTEIRHRNIIKFHG 713 (918)
Q Consensus 646 ~~~~~-~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~----------~~~~~~~~e~~~l~~l~h~niv~~~~ 713 (918)
++|.. .+.||+|+||.||+|.. .+++.||||+++........ .....+.+|+++++.++||||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 45554 46799999999999954 47999999998654222111 01225789999999999999999999
Q ss_pred ccccCCceEEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEE
Q 044366 714 FCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHV 793 (918)
Q Consensus 714 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl 793 (918)
++..++..++||||++ |+|.+++... ..+++..+..++.|++.||+|||+. +++||||+|+||+++.++.+++
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~~~---~~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~nill~~~~~~kl 160 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVDRK---IRLTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFINSKGICKI 160 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHeEECCCCCEEE
Confidence 9999999999999997 5999998653 3489999999999999999999999 9999999999999999999999
Q ss_pred eccccccccCCC--------------CCCceecccccccccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCcchhh
Q 044366 794 SDFGFAKFLEPH--------------SSNWTEFAGTVGYAAPELAYTM-RATEKYDVYSFGVLALEVIKGYHPGDFVSTI 858 (918)
Q Consensus 794 ~DfG~~~~~~~~--------------~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~ 858 (918)
+|||.+...... ........++..|+|||.+.+. .++.++||||+|+++|||++|+.||......
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~ 240 (335)
T PTZ00024 161 ADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEI 240 (335)
T ss_pred CCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 999999766511 1112233467889999998764 4688999999999999999999998654332
Q ss_pred hhhhhhhHhhhhhhcccCCC-------------CCCcc----hHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 859 FSSISNMIIEVNQILDHRLP-------------TPSRD----VTDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 859 ~~~~~~~~~~~~~~~~~~~~-------------~~~~~----~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
. ................++ ..... .......+.+++.+|++.+|++||+++|++.
T Consensus 241 ~-~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 312 (335)
T PTZ00024 241 D-QLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK 312 (335)
T ss_pred H-HHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence 1 111110000000000000 00000 1112356889999999999999999999985
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-32 Score=292.83 Aligned_cols=258 Identities=25% Similarity=0.350 Sum_probs=200.0
Q ss_pred CCCceeeccccceEEEEEEeC-CCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEEEEE
Q 044366 648 FGEKYCIGKGGQRSVYKAELP-SGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFIVCE 726 (918)
Q Consensus 648 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 726 (918)
|+..+.||+|++|.||+|... +++.||+|.+.... ......+.+..|+++++.++|+|++++++++.+.+..++|||
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e 78 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDN--EEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFE 78 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEecccc--ccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEec
Confidence 456678999999999999654 69999999987643 122334678899999999999999999999999999999999
Q ss_pred eccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccCCCC
Q 044366 727 YLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHS 806 (918)
Q Consensus 727 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~~~~ 806 (918)
|++ ++|.+++.... ..+++.+++.++.|++.|++|||+. +++||||+|+||++++++.++|+|||.+.......
T Consensus 79 ~~~-~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~ 152 (282)
T cd07829 79 YCD-MDLKKYLDKRP--GPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPL 152 (282)
T ss_pred CcC-cCHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEecCCcccccCCCc
Confidence 998 59999998652 3589999999999999999999999 99999999999999999999999999998765544
Q ss_pred CCceecccccccccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHh-----------hhhhh--
Q 044366 807 SNWTEFAGTVGYAAPELAYTM-RATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMII-----------EVNQI-- 872 (918)
Q Consensus 807 ~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~-----------~~~~~-- 872 (918)
.......++..|+|||.+.+. .++.++||||||+++|||++|+.||...... ........ .....
T Consensus 153 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (282)
T cd07829 153 RTYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEI-DQLFKIFQILGTPTEESWPGVTKLPD 231 (282)
T ss_pred cccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHH-HHHHHHHHHhCCCcHHHHHhhccccc
Confidence 333444567889999998776 7889999999999999999999997654321 11110000 00000
Q ss_pred cccCCCCCC-----cchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 873 LDHRLPTPS-----RDVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 873 ~~~~~~~~~-----~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
.+...+... ...+.....+.+++.+||..||++||++.+++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 232 YKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred ccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 011111100 001112357899999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=302.82 Aligned_cols=259 Identities=23% Similarity=0.380 Sum_probs=215.7
Q ss_pred HHHHHHHhcCCCCceeeccccceEEEEEE-eCCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhc-cCCceeeEeccc
Q 044366 638 YEEITKATGNFGEKYCIGKGGQRSVYKAE-LPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEI-RHRNIIKFHGFC 715 (918)
Q Consensus 638 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~ 715 (918)
++.....++.|++.+.||+|.+|.||+++ .++|+.+|+|+..... ...++...|..+++.. .|||++.++|++
T Consensus 11 ~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~-----d~deEiE~eynil~~~~~hpnv~~fyg~~ 85 (953)
T KOG0587|consen 11 LSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE-----DEEEEIELEYNMLKKYSHHPNVATFYGAF 85 (953)
T ss_pred hhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc-----cccHHHHHHHHHHHhccCCCCcceEEEEE
Confidence 44445566789999999999999999994 4579999999876532 2245677888888888 699999999988
Q ss_pred c-----cCCceEEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCc
Q 044366 716 S-----NAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYE 790 (918)
Q Consensus 716 ~-----~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~ 790 (918)
. .++.+|+|||||.+||..+.++.-. +.++.|..+..|++.++.|+.+||.. .++|||||-.||+++.++.
T Consensus 86 ~k~~~~~~DqLWLVMEfC~gGSVTDLVKn~~-g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e~~ 161 (953)
T KOG0587|consen 86 IKKDPGNGDQLWLVMEFCGGGSVTDLVKNTK-GNRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTENAE 161 (953)
T ss_pred EEecCCCCCeEEEEeeccCCccHHHHHhhhc-ccchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEeccCc
Confidence 3 4678999999999999999998877 67799999999999999999999999 9999999999999999999
Q ss_pred EEEeccccccccCCCCCCceeccccccccccccccc-----CCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhh
Q 044366 791 AHVSDFGFAKFLEPHSSNWTEFAGTVGYAAPELAYT-----MRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNM 865 (918)
Q Consensus 791 ~kl~DfG~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-----~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~ 865 (918)
+|++|||.+...+.........+||+.|||||++.. ..|+.++|+||+|++..||..|.+|+.++.+....
T Consensus 162 VKLvDFGvSaQldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraL---- 237 (953)
T KOG0587|consen 162 VKLVDFGVSAQLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRAL---- 237 (953)
T ss_pred EEEeeeeeeeeeecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhh----
Confidence 999999999999887777778899999999999864 34678999999999999999999996655432100
Q ss_pred HhhhhhhcccCCCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 866 IIEVNQILDHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 866 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
-.+...+|+..........++.++|..|+.+|.++||++.++++
T Consensus 238 -----F~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 238 -----FLIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred -----ccCCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence 11122233333445677889999999999999999999999875
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-32 Score=289.23 Aligned_cols=257 Identities=23% Similarity=0.381 Sum_probs=195.7
Q ss_pred CCCceeeccccceEEEEEEeC-CCCEEEEEEcccccccCCCCChHHHHHHHHHHhhcc-CCceeeEecccccCCceEEEE
Q 044366 648 FGEKYCIGKGGQRSVYKAELP-SGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIR-HRNIIKFHGFCSNAQHSFIVC 725 (918)
Q Consensus 648 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~ 725 (918)
|.+.+.||+|++|.||+|... +++.||||++..... ........+|+..+++++ |||++++++++.+++..++||
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~---~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~ 77 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFY---SWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVF 77 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhcc---chhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEE
Confidence 567788999999999999764 588999999865322 122334567999999998 999999999999999999999
Q ss_pred EeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccCCC
Q 044366 726 EYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPH 805 (918)
Q Consensus 726 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~~~ 805 (918)
||+ +|+|.+++.... ...+++.++..++.|++.|+.|||+. +++|+||+|+||++++++.++|+|||.+......
T Consensus 78 e~~-~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~ 152 (283)
T cd07830 78 EYM-EGNLYQLMKDRK-GKPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSR 152 (283)
T ss_pred ecC-CCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEeecccceeccCC
Confidence 999 789999887653 24589999999999999999999999 9999999999999999999999999999876543
Q ss_pred CCCceeccccccccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhH--------------hhhh
Q 044366 806 SSNWTEFAGTVGYAAPELAYT-MRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMI--------------IEVN 870 (918)
Q Consensus 806 ~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~--------------~~~~ 870 (918)
.. .....++..|+|||++.+ ..++.++||||||+++|||++|+.||........ ..... ....
T Consensus 153 ~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 230 (283)
T cd07830 153 PP-YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQ-LYKICSVLGTPTKQDWPEGYKLA 230 (283)
T ss_pred CC-cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHH-HHHHHHhcCCCChhhhhhHhhhh
Confidence 22 234567889999998754 4578999999999999999999998754332110 00000 0000
Q ss_pred hhcccCCCCCC-cchH----HHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 871 QILDHRLPTPS-RDVT----DKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 871 ~~~~~~~~~~~-~~~~----~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
...+...+... .... .....+.+++.+||+.||++|||+.|++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 279 (283)
T cd07830 231 SKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ 279 (283)
T ss_pred ccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence 01111111100 0001 11356889999999999999999999975
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-32 Score=295.36 Aligned_cols=248 Identities=25% Similarity=0.383 Sum_probs=193.7
Q ss_pred CCCCceeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEEEE
Q 044366 647 NFGEKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFIVC 725 (918)
Q Consensus 647 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 725 (918)
.|...+.||+|+||.||+|.. .+++.||+|.+...... ......++.+|+++++.++|+|++++++++..+...++||
T Consensus 16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 94 (308)
T cd06634 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQ-SNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (308)
T ss_pred HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEeccccc-ChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence 366677899999999999965 46889999988642111 1222457889999999999999999999999999999999
Q ss_pred EeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccCCC
Q 044366 726 EYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPH 805 (918)
Q Consensus 726 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~~~ 805 (918)
||+. |++.+.+.... ..+++.++..++.|++.|+.|||+. +++||||+|+||+++.++.++++|||++....+.
T Consensus 95 e~~~-~~l~~~~~~~~--~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~ 168 (308)
T cd06634 95 EYCL-GSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA 168 (308)
T ss_pred EccC-CCHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEEECCcccceeecCc
Confidence 9997 58888775432 3478999999999999999999999 9999999999999999999999999999876543
Q ss_pred CCCceecccccccccccccc---cCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCCCCCc
Q 044366 806 SSNWTEFAGTVGYAAPELAY---TMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSR 882 (918)
Q Consensus 806 ~~~~~~~~g~~~y~aPE~~~---~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 882 (918)
....++..|+|||.+. ...++.++|||||||++|+|++|+.|+....... ..........+...
T Consensus 169 ----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~--------~~~~~~~~~~~~~~- 235 (308)
T cd06634 169 ----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS--------ALYHIAQNESPALQ- 235 (308)
T ss_pred ----ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHH--------HHHHHhhcCCCCcC-
Confidence 2345788999999874 3467889999999999999999999975432110 00011111111111
Q ss_pred chHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 044366 883 DVTDKLRSIMEVAILCLVENPEARPTMKEVCNL 915 (918)
Q Consensus 883 ~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 915 (918)
.......+.+++.+||+.+|++||++.++++.
T Consensus 236 -~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~ 267 (308)
T cd06634 236 -SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 267 (308)
T ss_pred -cccccHHHHHHHHHHhhCCcccCCCHHHHhhC
Confidence 11233567889999999999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-32 Score=299.64 Aligned_cols=258 Identities=23% Similarity=0.342 Sum_probs=199.3
Q ss_pred CCCCceeeccccceEEEEEEeC-CCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCC-----c
Q 044366 647 NFGEKYCIGKGGQRSVYKAELP-SGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQ-----H 720 (918)
Q Consensus 647 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-----~ 720 (918)
+|.+.+.||.|++|.||+|... +|+.||+|++.... ......+.+.+|++.++.++||||+++++++...+ .
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~ 78 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVF--DDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFND 78 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeecccc--ccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccc
Confidence 4778899999999999999654 58999999987532 12333567999999999999999999999987765 7
Q ss_pred eEEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEecccccc
Q 044366 721 SFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAK 800 (918)
Q Consensus 721 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~ 800 (918)
.++||||+++ +|.+++.... .+++..++.++.|++.||+|||+. +++||||||+||+++.++.++|+|||.+.
T Consensus 79 ~~lv~e~~~~-~l~~~l~~~~---~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~~L~dfg~~~ 151 (330)
T cd07834 79 VYIVTELMET-DLHKVIKSPQ---PLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLAR 151 (330)
T ss_pred eEEEecchhh-hHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccCceE
Confidence 8999999984 8988887543 589999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCC---CCceecccccccccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhh--------
Q 044366 801 FLEPHS---SNWTEFAGTVGYAAPELAYTM-RATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIE-------- 868 (918)
Q Consensus 801 ~~~~~~---~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~-------- 868 (918)
...... .......++..|+|||.+.+. .++.++||||+|+++|+|++|+.||....... ........
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~ 230 (330)
T cd07834 152 GVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYID-QLNLIVEVLGTPSEED 230 (330)
T ss_pred eecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHH-HHHHHHHhcCCCChhH
Confidence 775543 123345678899999999887 78999999999999999999999986543210 00000000
Q ss_pred --------hhhhcccCCCCCC----cchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 869 --------VNQILDHRLPTPS----RDVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 869 --------~~~~~~~~~~~~~----~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
............. .........+.+++.+||+.+|.+||+++++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~ 288 (330)
T cd07834 231 LKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALA 288 (330)
T ss_pred hhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence 0000000000000 001112356889999999999999999999986
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-32 Score=292.20 Aligned_cols=246 Identities=26% Similarity=0.384 Sum_probs=192.2
Q ss_pred CCCceeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEEEEE
Q 044366 648 FGEKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFIVCE 726 (918)
Q Consensus 648 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 726 (918)
|...+.||+|+||.||+|.. .+|+.||+|++...... .......+.+|+++++.++|||++++++++.++...++|||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 101 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQ-TNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVME 101 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccC-chHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEe
Confidence 55667899999999999965 47899999998653221 12224578899999999999999999999999999999999
Q ss_pred eccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccCCCC
Q 044366 727 YLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHS 806 (918)
Q Consensus 727 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~~~~ 806 (918)
|+. |++.+++... ...+++.+++.++.|++.|++|||+. +++||||+|+||+++.++.++|+|||++.....
T Consensus 102 ~~~-~~l~~~l~~~--~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~-- 173 (313)
T cd06633 102 YCL-GSASDLLEVH--KKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASKSSP-- 173 (313)
T ss_pred cCC-CCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEEeecCCCcccCC--
Confidence 996 5788877643 23589999999999999999999999 999999999999999999999999999865332
Q ss_pred CCceecccccccccccccc---cCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCCCCCcc
Q 044366 807 SNWTEFAGTVGYAAPELAY---TMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRD 883 (918)
Q Consensus 807 ~~~~~~~g~~~y~aPE~~~---~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 883 (918)
.....|+..|+|||++. ...++.++||||||+++|||++|..|+......... . .......+...
T Consensus 174 --~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~-~-------~~~~~~~~~~~-- 241 (313)
T cd06633 174 --ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL-Y-------HIAQNDSPTLQ-- 241 (313)
T ss_pred --CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHH-H-------HHHhcCCCCCC--
Confidence 22346788999999974 456788999999999999999999997544321100 0 11111111111
Q ss_pred hHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 884 VTDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 884 ~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
.......+.+++.+||+.+|.+||++.++++
T Consensus 242 ~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~ 272 (313)
T cd06633 242 SNEWTDSFRGFVDYCLQKIPQERPASAELLR 272 (313)
T ss_pred ccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1112245788999999999999999999985
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-32 Score=296.30 Aligned_cols=260 Identities=23% Similarity=0.347 Sum_probs=196.7
Q ss_pred HHHhcCCCCceeeccccceEEEEEE-eCCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEeccccc-CC
Q 044366 642 TKATGNFGEKYCIGKGGQRSVYKAE-LPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSN-AQ 719 (918)
Q Consensus 642 ~~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~ 719 (918)
...+++|+..+.||+|+||.||+|. ..+|+.||+|++..... .....+.+.+|+++++.++||||+++++++.. ..
T Consensus 6 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 83 (328)
T cd07856 6 FEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFS--TPVLAKRTYRELKLLKHLRHENIISLSDIFISPLE 83 (328)
T ss_pred eccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEeccccc--ccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCC
Confidence 3467889999999999999999995 45899999998865322 22334678899999999999999999998865 56
Q ss_pred ceEEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccc
Q 044366 720 HSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFA 799 (918)
Q Consensus 720 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~ 799 (918)
..++|+||+. ++|.++++.. .+++..+..++.|+++||+|||+. +++||||+|+||++++++.++++|||.+
T Consensus 84 ~~~lv~e~~~-~~L~~~~~~~----~~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~~~~~l~dfg~~ 155 (328)
T cd07856 84 DIYFVTELLG-TDLHRLLTSR----PLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDLKICDFGLA 155 (328)
T ss_pred cEEEEeehhc-cCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCCCCEEeCccccc
Confidence 7899999984 6898888643 378888999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCCceeccccccccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCcchhhhh--hhhhh----Hhhh-h-
Q 044366 800 KFLEPHSSNWTEFAGTVGYAAPELAYT-MRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFS--SISNM----IIEV-N- 870 (918)
Q Consensus 800 ~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~--~~~~~----~~~~-~- 870 (918)
...... .....++..|+|||.+.+ ..++.++||||||+++|+|++|+.||........ .+... ..+. .
T Consensus 156 ~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (328)
T cd07856 156 RIQDPQ---MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINT 232 (328)
T ss_pred cccCCC---cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 765332 223456889999998766 5688999999999999999999999864432110 00000 0000 0
Q ss_pred -------hh---cccCCCCCC-cchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 871 -------QI---LDHRLPTPS-RDVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 871 -------~~---~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
+. .....+.+. .........+.+++.+|++.+|++|||+++++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~ 287 (328)
T cd07856 233 ICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALA 287 (328)
T ss_pred ccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 00 000000000 001112357889999999999999999999975
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-32 Score=295.75 Aligned_cols=261 Identities=21% Similarity=0.288 Sum_probs=193.6
Q ss_pred hcCCCCceeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccC-----
Q 044366 645 TGNFGEKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNA----- 718 (918)
Q Consensus 645 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~----- 718 (918)
.++|...+.||+|+||.||+|.. .+++.||+|++...... ......+.+|+++++.++||||+++++++.+.
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 84 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEK--DGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSK 84 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCC--CCcchhHHHHHHHHHhcCCCCccchhhheeccccccc
Confidence 57899999999999999999965 47899999998654222 12234678999999999999999999987443
Q ss_pred ---CceEEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEec
Q 044366 719 ---QHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSD 795 (918)
Q Consensus 719 ---~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~D 795 (918)
...++|+||+++ ++...+... ...+++.++..++.|+++||+|||+. +++||||||+||++++++.++|+|
T Consensus 85 ~~~~~~~lv~~~~~~-~l~~~~~~~--~~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~~~~~~l~d 158 (311)
T cd07866 85 RKRGSVYMVTPYMDH-DLSGLLENP--SVKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIAD 158 (311)
T ss_pred ccCceEEEEEecCCc-CHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECc
Confidence 346999999975 677776543 23589999999999999999999999 999999999999999999999999
Q ss_pred cccccccCCCCCC-----------ceecccccccccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhh
Q 044366 796 FGFAKFLEPHSSN-----------WTEFAGTVGYAAPELAYTM-RATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSIS 863 (918)
Q Consensus 796 fG~~~~~~~~~~~-----------~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~ 863 (918)
||+++........ .....+++.|+|||.+.+. .++.++||||||+++|||++|+.||....... ...
T Consensus 159 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~-~~~ 237 (311)
T cd07866 159 FGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDID-QLH 237 (311)
T ss_pred CccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHH-HHH
Confidence 9999865432211 1223567889999987654 57889999999999999999999986433211 101
Q ss_pred hhHhhh--------------hh----hcccCCCCC-CcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 864 NMIIEV--------------NQ----ILDHRLPTP-SRDVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 864 ~~~~~~--------------~~----~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
...... .. ......+.. ..........+.+++.+|++.||++|||+.|++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 238 LIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred HHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 000000 00 000000000 0001112256889999999999999999999875
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.2e-32 Score=297.64 Aligned_cols=264 Identities=20% Similarity=0.321 Sum_probs=198.3
Q ss_pred CHHHHHHHhcCCCCceeeccccceEEEEEE-eCCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEeccc
Q 044366 637 LYEEITKATGNFGEKYCIGKGGQRSVYKAE-LPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFC 715 (918)
Q Consensus 637 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~ 715 (918)
...++...+++|...+.||+|+||.||+|. ..+|+.||+|++..... .....+.+.+|++++++++||||+++++++
T Consensus 8 ~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~ 85 (345)
T cd07877 8 LNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ--SIIHAKRTYRELRLLKHMKHENVIGLLDVF 85 (345)
T ss_pred HHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcch--hhHHHHHHHHHHHHHHHcCCCcccceeeee
Confidence 345667788999999999999999999995 45799999999865321 122246688999999999999999999987
Q ss_pred ccC------CceEEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCC
Q 044366 716 SNA------QHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEY 789 (918)
Q Consensus 716 ~~~------~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~ 789 (918)
... ...+++++++ +++|.++++.. .+++..++.++.|+++|++|||+. +++||||||+||++++++
T Consensus 86 ~~~~~~~~~~~~~lv~~~~-~~~L~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~ 157 (345)
T cd07877 86 TPARSLEEFNDVYLVTHLM-GADLNNIVKCQ----KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDC 157 (345)
T ss_pred eecccccccccEEEEehhc-ccCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEcCCC
Confidence 533 3467888887 67998887643 489999999999999999999999 999999999999999999
Q ss_pred cEEEeccccccccCCCCCCceeccccccccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHh-
Q 044366 790 EAHVSDFGFAKFLEPHSSNWTEFAGTVGYAAPELAYT-MRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMII- 867 (918)
Q Consensus 790 ~~kl~DfG~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~- 867 (918)
.+||+|||++...... .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||........ ......
T Consensus 158 ~~kl~dfg~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~-~~~~~~~ 233 (345)
T cd07877 158 ELKILDFGLARHTDDE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ-LKLILRL 233 (345)
T ss_pred CEEEeccccccccccc---ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHH
Confidence 9999999999765322 233467889999998866 4678899999999999999999999854332110 000000
Q ss_pred ------hh---------hhhcc--cCCCCC--CcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 868 ------EV---------NQILD--HRLPTP--SRDVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 868 ------~~---------~~~~~--~~~~~~--~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
.. ..... ...+.. ..........+.+++.+|++.||.+||++.++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 299 (345)
T cd07877 234 VGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 299 (345)
T ss_pred hCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhc
Confidence 00 00000 000000 0000012346789999999999999999999875
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.1e-32 Score=298.09 Aligned_cols=255 Identities=20% Similarity=0.321 Sum_probs=191.7
Q ss_pred hcCCCCceeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccC-----
Q 044366 645 TGNFGEKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNA----- 718 (918)
Q Consensus 645 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~----- 718 (918)
.++|...+.||+|+||.||+|.. .+|+.||||++..... .......+.+|+++++.++||||+++++++...
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 91 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQ--SEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDE 91 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccc--cccchhHHHHHHHHHHhcCCCCccchhheecccccCCC
Confidence 36898999999999999999964 5799999999875322 122345688999999999999999999988644
Q ss_pred -CceEEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccc
Q 044366 719 -QHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFG 797 (918)
Q Consensus 719 -~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG 797 (918)
...++|+||+.. ++.++.. ..+++..+..++.|++.||+|||+. +++||||||+||+++.++.++|+|||
T Consensus 92 ~~~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~~~~~kL~dfg 162 (342)
T cd07879 92 FQDFYLVMPYMQT-DLQKIMG-----HPLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILDFG 162 (342)
T ss_pred CceEEEEeccccc-CHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCC
Confidence 246899999964 7776653 2488999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCCceeccccccccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHh---------
Q 044366 798 FAKFLEPHSSNWTEFAGTVGYAAPELAYT-MRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMII--------- 867 (918)
Q Consensus 798 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~--------- 867 (918)
+++..... .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||....... .......
T Consensus 163 ~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~ 238 (342)
T cd07879 163 LARHADAE---MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD-QLTQILKVTGVPGPEF 238 (342)
T ss_pred CCcCCCCC---CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHhcCCCCHHH
Confidence 99765332 223457889999999876 458889999999999999999999987543211 1110000
Q ss_pred --hh-----hhhcccCCCCCCcc----hHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 868 --EV-----NQILDHRLPTPSRD----VTDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 868 --~~-----~~~~~~~~~~~~~~----~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
.. .............. .+.....+.+++.+||+.||++||+++|++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~ 296 (342)
T cd07879 239 VQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALE 296 (342)
T ss_pred HHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 00 00000000000000 0112346789999999999999999999984
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.9e-32 Score=299.02 Aligned_cols=258 Identities=21% Similarity=0.294 Sum_probs=191.2
Q ss_pred hcCCCCceeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccC-----
Q 044366 645 TGNFGEKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNA----- 718 (918)
Q Consensus 645 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~----- 718 (918)
.++|...+.||.|+||.||+|.. .+|+.||+|++... .....+.+.+|+++++.++||||+++++++...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~----~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 79 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLT----DPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLT 79 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecC----CCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccc
Confidence 36789999999999999999954 57899999998653 223456788999999999999999999876543
Q ss_pred ---------CceEEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCC-C
Q 044366 719 ---------QHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDS-E 788 (918)
Q Consensus 719 ---------~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~-~ 788 (918)
...++||||++ ++|.+++... .+++..++.++.||+.|++|||+. +++||||||+||+++. +
T Consensus 80 ~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~~~~ 151 (342)
T cd07854 80 EDVGSLTELNSVYIVQEYME-TDLANVLEQG----PLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTED 151 (342)
T ss_pred cccccccccceEEEEeeccc-ccHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCC
Confidence 35789999997 5898887642 488999999999999999999999 9999999999999975 5
Q ss_pred CcEEEeccccccccCCCCC---Cceeccccccccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhh
Q 044366 789 YEAHVSDFGFAKFLEPHSS---NWTEFAGTVGYAAPELAYT-MRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISN 864 (918)
Q Consensus 789 ~~~kl~DfG~~~~~~~~~~---~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~ 864 (918)
+.++++|||.+........ ......++..|+|||.+.+ ..++.++|||||||++|||++|+.||............
T Consensus 152 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~ 231 (342)
T cd07854 152 LVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLI 231 (342)
T ss_pred ceEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 5789999999986543221 1123457889999997654 45788999999999999999999998654321110000
Q ss_pred h--------------HhhhhhhcccCCCCCCcc----hHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 865 M--------------IIEVNQILDHRLPTPSRD----VTDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 865 ~--------------~~~~~~~~~~~~~~~~~~----~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
. .................. ......++.+++.+|++.||++|||++|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~ 299 (342)
T cd07854 232 LESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM 299 (342)
T ss_pred HHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence 0 000000000000000000 0112356788999999999999999999974
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=282.26 Aligned_cols=241 Identities=27% Similarity=0.377 Sum_probs=195.3
Q ss_pred eccccceEEEEEEeC-CCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEEEEEeccCCC
Q 044366 654 IGKGGQRSVYKAELP-SGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFIVCEYLARGS 732 (918)
Q Consensus 654 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gs 732 (918)
||+|+||.||++... +++.||+|.+....... ....+.+..|+++++.++||||+++++.+..++..++||||+++++
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~ 79 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIK-RKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGE 79 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcc-hHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCc
Confidence 699999999999654 68999999987643222 2235688999999999999999999999999999999999999999
Q ss_pred hhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccCCCCCCceec
Q 044366 733 LTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEF 812 (918)
Q Consensus 733 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~ 812 (918)
|.+++.... .+++..+..++.|+++|+.|+|+. +++|+||+|+||+++.++.++++|||.+.............
T Consensus 80 L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~ 153 (250)
T cd05123 80 LFSHLSKEG---RFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTF 153 (250)
T ss_pred HHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCcceecccCCCcccCC
Confidence 999997643 489999999999999999999998 99999999999999999999999999998765443333445
Q ss_pred ccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCCCCCcchHHHHHHHH
Q 044366 813 AGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRDVTDKLRSIM 892 (918)
Q Consensus 813 ~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 892 (918)
.++..|+|||...+...+.++|+||||+++|++++|+.||..... ... .........+.+ ... ...+.
T Consensus 154 ~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~-----~~~---~~~~~~~~~~~~-~~~---~~~l~ 221 (250)
T cd05123 154 CGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR-----KEI---YEKILKDPLRFP-EFL---SPEAR 221 (250)
T ss_pred cCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH-----HHH---HHHHhcCCCCCC-CCC---CHHHH
Confidence 678899999999888889999999999999999999999864432 011 111111222111 111 34678
Q ss_pred HHHHHcccCCCCCCCCH---HHHH
Q 044366 893 EVAILCLVENPEARPTM---KEVC 913 (918)
Q Consensus 893 ~li~~cl~~dp~~RPt~---~evl 913 (918)
+++.+||..||++||++ +++.
T Consensus 222 ~~i~~~l~~~p~~R~~~~~~~~l~ 245 (250)
T cd05123 222 DLISGLLQKDPTKRLGSGGAEEIK 245 (250)
T ss_pred HHHHHHhcCCHhhCCCcccHHHHH
Confidence 89999999999999999 5554
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.7e-32 Score=296.64 Aligned_cols=259 Identities=22% Similarity=0.320 Sum_probs=195.0
Q ss_pred HHhcCCCCceeeccccceEEEEEE-eCCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCC--
Q 044366 643 KATGNFGEKYCIGKGGQRSVYKAE-LPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQ-- 719 (918)
Q Consensus 643 ~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-- 719 (918)
...++|.+.+.||+|+||.||+|. ..+|+.||||++.... ........+.+|+++++.++||||+++++++..+.
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 89 (343)
T cd07880 12 EVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPF--QSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSL 89 (343)
T ss_pred ccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccc--cchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccc
Confidence 356789999999999999999995 5579999999986432 12223456889999999999999999999886543
Q ss_pred ----ceEEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEec
Q 044366 720 ----HSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSD 795 (918)
Q Consensus 720 ----~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~D 795 (918)
..++||||+ +++|.+++.. ..+++..++.++.|+++|++|||+. +|+||||||+||+++.++.++++|
T Consensus 90 ~~~~~~~lv~e~~-~~~l~~~~~~----~~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~~~~~kl~d 161 (343)
T cd07880 90 DRFHDFYLVMPFM-GTDLGKLMKH----EKLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKILD 161 (343)
T ss_pred cccceEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEee
Confidence 358999999 6799888864 2489999999999999999999999 999999999999999999999999
Q ss_pred cccccccCCCCCCceeccccccccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhH------hh
Q 044366 796 FGFAKFLEPHSSNWTEFAGTVGYAAPELAYT-MRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMI------IE 868 (918)
Q Consensus 796 fG~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~------~~ 868 (918)
||++...... .....++..|+|||.+.+ ..++.++||||+|+++|++++|+.||.............. ..
T Consensus 162 fg~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 238 (343)
T cd07880 162 FGLARQTDSE---MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKE 238 (343)
T ss_pred cccccccccC---ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHH
Confidence 9999865432 223456889999998876 4578899999999999999999999864432111000000 00
Q ss_pred hhhhcc--------cCCCCCC-cch----HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 869 VNQILD--------HRLPTPS-RDV----TDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 869 ~~~~~~--------~~~~~~~-~~~----~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
....+. ...+... ... ......+.+++.+|++.||++|||+.++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~ 297 (343)
T cd07880 239 FVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA 297 (343)
T ss_pred HHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 000000 0000000 000 112345789999999999999999999884
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.4e-32 Score=296.13 Aligned_cols=257 Identities=20% Similarity=0.336 Sum_probs=195.5
Q ss_pred HhcCCCCceeeccccceEEEEEEeC-CCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCc--
Q 044366 644 ATGNFGEKYCIGKGGQRSVYKAELP-SGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQH-- 720 (918)
Q Consensus 644 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-- 720 (918)
..++|...+.||+|++|.||+|... +++.||+|++..... .....+.+.+|+.+++.++|||++++++++..++.
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQ--SAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLE 90 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccc--hhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccc
Confidence 4578999999999999999999654 688999999865321 12234567889999999999999999998866554
Q ss_pred ----eEEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEecc
Q 044366 721 ----SFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDF 796 (918)
Q Consensus 721 ----~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Df 796 (918)
.++|+||+ +++|.+++.. ..+++.+++.++.|+++|++|||+. +++||||+|+||++++++.++|+||
T Consensus 91 ~~~~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~~~~kL~df 162 (343)
T cd07851 91 DFQDVYLVTHLM-GADLNNIVKC----QKLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDF 162 (343)
T ss_pred ccccEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEccc
Confidence 89999999 5699998875 3489999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCCCceeccccccccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhh-------
Q 044366 797 GFAKFLEPHSSNWTEFAGTVGYAAPELAYT-MRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIE------- 868 (918)
Q Consensus 797 G~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~------- 868 (918)
|++...... .....++..|+|||.+.+ ..++.++||||+|+++|||++|+.||...... .........
T Consensus 163 g~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~-~~~~~i~~~~~~~~~~ 238 (343)
T cd07851 163 GLARHTDDE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHI-DQLKRIMNLVGTPDEE 238 (343)
T ss_pred ccccccccc---ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHhcCCCCHH
Confidence 999866432 233467889999998865 35788999999999999999999998643321 111000000
Q ss_pred ---------hhhhcccCCCCCCcch----HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 869 ---------VNQILDHRLPTPSRDV----TDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 869 ---------~~~~~~~~~~~~~~~~----~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
................ ......+.+++.+|++.||++|||+.|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~ 297 (343)
T cd07851 239 LLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA 297 (343)
T ss_pred HHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence 0000000000000011 112457889999999999999999999875
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-31 Score=290.99 Aligned_cols=258 Identities=19% Similarity=0.256 Sum_probs=190.7
Q ss_pred CCCCceeeccccceEEEEEEeC-C--CCEEEEEEcccccccCCCCChHHHHHHHHHHhhc-cCCceeeEeccccc----C
Q 044366 647 NFGEKYCIGKGGQRSVYKAELP-S--GNIFAVKKFKAELFSDETANPSEFLNEVLALTEI-RHRNIIKFHGFCSN----A 718 (918)
Q Consensus 647 ~~~~~~~lg~G~~g~Vy~~~~~-~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~----~ 718 (918)
+|...+.||+|+||.||+|+.. + +..||+|++.... ......+.+.+|+++++++ +||||+++++++.. .
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~ 78 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVF--SKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNF 78 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEecccc--ccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccC
Confidence 4777889999999999999654 4 7899999986432 1222346788999999999 59999999987532 2
Q ss_pred CceEEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEecccc
Q 044366 719 QHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGF 798 (918)
Q Consensus 719 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~ 798 (918)
...++++||++ ++|.+++... ..+++.+++.++.||+.||+|||+. +++||||||+||+++.++.++|+|||+
T Consensus 79 ~~~~~~~e~~~-~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~~~kl~Dfg~ 151 (332)
T cd07857 79 NELYLYEELME-ADLHQIIRSG---QPLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGL 151 (332)
T ss_pred CcEEEEEeccc-CCHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCCCEEeCcCCC
Confidence 45788999986 5899988653 3489999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCC----Cceeccccccccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhH-------
Q 044366 799 AKFLEPHSS----NWTEFAGTVGYAAPELAYT-MRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMI------- 866 (918)
Q Consensus 799 ~~~~~~~~~----~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~------- 866 (918)
+........ ......|+..|+|||.+.+ ..++.++||||+|+++|+|++|+.||....... ......
T Consensus 152 a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~ 230 (332)
T cd07857 152 ARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVD-QLNQILQVLGTPD 230 (332)
T ss_pred ceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHH-HHHHHHHHhCCCC
Confidence 986643221 1223468899999998765 467899999999999999999999986533210 000000
Q ss_pred ----hh--------hhhhcccCC-CCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 867 ----IE--------VNQILDHRL-PTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 867 ----~~--------~~~~~~~~~-~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
.. ......... .............+.+++.+|++.||++|||+.|+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~ 291 (332)
T cd07857 231 EETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE 291 (332)
T ss_pred HHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 00 000000000 0000000112356889999999999999999999874
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.3e-33 Score=263.02 Aligned_cols=263 Identities=24% Similarity=0.368 Sum_probs=195.0
Q ss_pred HhcCCCCceeeccccceEEEEEEeC-CCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEeccccc-----
Q 044366 644 ATGNFGEKYCIGKGGQRSVYKAELP-SGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSN----- 717 (918)
Q Consensus 644 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~----- 717 (918)
..+.|....+||+|.||.||+|+.+ +|+.||+|++-.+.- ...-.....+|++++..++|+|++.+++.|..
T Consensus 15 ~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmene--KeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~ 92 (376)
T KOG0669|consen 15 EVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENE--KEGFPITALREIKILQLLKHENVVNLIEICRTKATPT 92 (376)
T ss_pred cchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhcc--ccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCc
Confidence 3455666778999999999999654 678899988754321 22234667999999999999999999998843
Q ss_pred ---CCceEEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEe
Q 044366 718 ---AQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVS 794 (918)
Q Consensus 718 ---~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~ 794 (918)
....++||++++. +|.-.+... ..+++..++.++..++..||.|+|+. .|+|||+||+|++++.++.+||+
T Consensus 93 ~r~r~t~ylVf~~ceh-DLaGlLsn~--~vr~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgilklA 166 (376)
T KOG0669|consen 93 NRDRATFYLVFDFCEH-DLAGLLSNR--KVRFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGILKLA 166 (376)
T ss_pred ccccceeeeeHHHhhh-hHHHHhcCc--cccccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceEEee
Confidence 2357999999987 888888754 35689999999999999999999999 99999999999999999999999
Q ss_pred ccccccccCCCC----CCceecccccccccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCcchhh--hhhhhhhHh
Q 044366 795 DFGFAKFLEPHS----SNWTEFAGTVGYAAPELAYTM-RATEKYDVYSFGVLALEVIKGYHPGDFVSTI--FSSISNMII 867 (918)
Q Consensus 795 DfG~~~~~~~~~----~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~--~~~~~~~~~ 867 (918)
|||+++.+.... ..++.++.|..|.+||.+.|. .|+++.|||+-|||+.||++|.+-++..... ...+.....
T Consensus 167 DFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcG 246 (376)
T KOG0669|consen 167 DFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCG 246 (376)
T ss_pred ccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhc
Confidence 999997664322 234567789999999988765 5899999999999999999998876543221 111111000
Q ss_pred -------------hhhhhcccC-CCC-CCcchHHHH------HHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 868 -------------EVNQILDHR-LPT-PSRDVTDKL------RSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 868 -------------~~~~~~~~~-~~~-~~~~~~~~~------~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
.+.+.+... ++. ..+...+.. .+..+++.+++..||.+|+++++++.
T Consensus 247 s~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~aln 314 (376)
T KOG0669|consen 247 SITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALN 314 (376)
T ss_pred cCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhc
Confidence 000101000 000 001111111 25678888999999999999999874
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-31 Score=312.98 Aligned_cols=149 Identities=27% Similarity=0.361 Sum_probs=131.2
Q ss_pred hcCCCCceeeccccceEEEEEEeC-CCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEE
Q 044366 645 TGNFGEKYCIGKGGQRSVYKAELP-SGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFI 723 (918)
Q Consensus 645 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 723 (918)
.++|.+.+.||+|+||.||+|... +++.||||+++..... .......+.+|+.+++.++||||+++++++...+..++
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~-~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 81 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMI-NKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYL 81 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhcc-CHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEE
Confidence 367888999999999999999654 7899999998753221 12224678899999999999999999999999999999
Q ss_pred EEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEecccccc
Q 044366 724 VCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAK 800 (918)
Q Consensus 724 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~ 800 (918)
||||+++++|.+++.... .+++..++.|+.||+.||+|||+. +||||||||+||+++.++.+||+|||+++
T Consensus 82 VmEy~~g~~L~~li~~~~---~l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 82 VMEYLIGGDVKSLLHIYG---YFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EEeCCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 999999999999997643 478899999999999999999999 99999999999999999999999999885
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-32 Score=306.82 Aligned_cols=256 Identities=23% Similarity=0.284 Sum_probs=202.1
Q ss_pred HHHHHhcCCCCceeeccccceEEEEEEeC-CCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccC
Q 044366 640 EITKATGNFGEKYCIGKGGQRSVYKAELP-SGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNA 718 (918)
Q Consensus 640 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~ 718 (918)
++.-..++|.+.++||+|+||.|..++.+ +++.||.|++.+...- ......-|..|-.+|..-..+-|+.++-+|.++
T Consensus 69 ~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMl-Kr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~ 147 (1317)
T KOG0612|consen 69 ELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEML-KRAETACFREERDIMVFGNSEWIVQLHYAFQDE 147 (1317)
T ss_pred HHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHh-hchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCc
Confidence 44445678999999999999999999764 7899999999774332 233456788899999888899999999999999
Q ss_pred CceEEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEecccc
Q 044366 719 QHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGF 798 (918)
Q Consensus 719 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~ 798 (918)
++.|+|||||+||+|-..+.+.. +++++-++-++..|+-||+-+|+. |+|||||||.|||+|..|++||+|||.
T Consensus 148 ~~LYlVMdY~pGGDlltLlSk~~---~~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld~~GHikLADFGs 221 (1317)
T KOG0612|consen 148 RYLYLVMDYMPGGDLLTLLSKFD---RLPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLDKSGHIKLADFGS 221 (1317)
T ss_pred cceEEEEecccCchHHHHHhhcC---CChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEecccCcEeeccchh
Confidence 99999999999999999998764 589999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCC-ceecccccccccccccc----c-CCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhh
Q 044366 799 AKFLEPHSSN-WTEFAGTVGYAAPELAY----T-MRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQI 872 (918)
Q Consensus 799 ~~~~~~~~~~-~~~~~g~~~y~aPE~~~----~-~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 872 (918)
+..+..++.. ....+|||.|.+||++. + +.|+..+|.||+||++|||+.|..||-... ......++
T Consensus 222 Clkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYads--------lveTY~KI 293 (1317)
T KOG0612|consen 222 CLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADS--------LVETYGKI 293 (1317)
T ss_pred HHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHH--------HHHHHHHH
Confidence 9988866554 35578999999999985 2 568899999999999999999999975322 11222233
Q ss_pred ccc--CCCCCCcchHHHHHHHHHHHHHcccCCCCCCCC---HHHHH
Q 044366 873 LDH--RLPTPSRDVTDKLRSIMEVAILCLVENPEARPT---MKEVC 913 (918)
Q Consensus 873 ~~~--~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt---~~evl 913 (918)
+.+ .+..| +..+.+....++|.+.+ -+|+.|.. ++++.
T Consensus 294 m~hk~~l~FP--~~~~VSeeakdLI~~ll-~~~e~RLgrngiedik 336 (1317)
T KOG0612|consen 294 MNHKESLSFP--DETDVSEEAKDLIEALL-CDREVRLGRNGIEDIK 336 (1317)
T ss_pred hchhhhcCCC--cccccCHHHHHHHHHHh-cChhhhcccccHHHHH
Confidence 333 12111 11123334455554443 36777776 66654
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-32 Score=282.01 Aligned_cols=246 Identities=24% Similarity=0.335 Sum_probs=203.2
Q ss_pred ceeeccccceEEEEEE-eCCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEEEEEecc
Q 044366 651 KYCIGKGGQRSVYKAE-LPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFIVCEYLA 729 (918)
Q Consensus 651 ~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 729 (918)
.+++|.|.||+||-|. .++|+.||||++.+..+.... ...+..|+.++.++.||.||.+---|+..+..++|||-+.
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kq--esqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~ 646 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQ--ESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLH 646 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCch--HHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhc
Confidence 4679999999999994 468999999999887665443 4789999999999999999999999999999999999997
Q ss_pred CCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCC---CcEEEeccccccccCCCC
Q 044366 730 RGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSE---YEAHVSDFGFAKFLEPHS 806 (918)
Q Consensus 730 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~---~~~kl~DfG~~~~~~~~~ 806 (918)
| +..+++-... .+++++....-++.||+.||.|||.. +|||.|+||+||++... -++||||||+|+.+.+ .
T Consensus 647 G-DMLEMILSsE-kgRL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgE-k 720 (888)
T KOG4236|consen 647 G-DMLEMILSSE-KGRLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGE-K 720 (888)
T ss_pred c-hHHHHHHHhh-cccchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeeccccceeecch-h
Confidence 6 5555543322 45688888888999999999999999 99999999999999765 3699999999999875 3
Q ss_pred CCceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCCCCCcchHH
Q 044366 807 SNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRDVTD 886 (918)
Q Consensus 807 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 886 (918)
+.....+||+.|+|||++..+.|...-|+||.||++|--++|..||....++.+.+.+. .+..++..+.+
T Consensus 721 sFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQIQNA----------aFMyPp~PW~e 790 (888)
T KOG4236|consen 721 SFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQIQNA----------AFMYPPNPWSE 790 (888)
T ss_pred hhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhHHhhcc----------ccccCCCchhh
Confidence 44567899999999999999999999999999999999999999998766654444332 12222233445
Q ss_pred HHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 887 KLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 887 ~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
.....+++|...++..-.+|-+.+..+.
T Consensus 791 is~~AidlIn~LLqVkm~kRysvdk~ls 818 (888)
T KOG4236|consen 791 ISPEAIDLINNLLQVKMRKRYSVDKSLS 818 (888)
T ss_pred cCHHHHHHHHHHHHHHHHHhcchHhhcc
Confidence 5567888999999999999998887553
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.1e-32 Score=275.66 Aligned_cols=258 Identities=25% Similarity=0.343 Sum_probs=196.7
Q ss_pred hcCCCCceeeccccceEEEEE-EeCCCCEEEEEEccccccc---CCCCChHHHHHHHHHHhhccCCceeeEeccccc-CC
Q 044366 645 TGNFGEKYCIGKGGQRSVYKA-ELPSGNIFAVKKFKAELFS---DETANPSEFLNEVLALTEIRHRNIIKFHGFCSN-AQ 719 (918)
Q Consensus 645 ~~~~~~~~~lg~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~---~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~ 719 (918)
.++|-....||+|||+.||+| ++...+.||||+-.....- ......+...+|..+.+.+.||.||++|+|+.- .+
T Consensus 462 n~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtd 541 (775)
T KOG1151|consen 462 NDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTD 541 (775)
T ss_pred HHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccc
Confidence 345666778999999999999 6767888999975432111 111123567889999999999999999999964 46
Q ss_pred ceEEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCC---CCcEEEecc
Q 044366 720 HSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDS---EYEAHVSDF 796 (918)
Q Consensus 720 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~---~~~~kl~Df 796 (918)
.+|-|+||++|.+|+-|++..+. +++++++.|+.||+.||.||.+. .|+|||.|+||.||++-. -|.+||.||
T Consensus 542 sFCTVLEYceGNDLDFYLKQhkl---mSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITDF 617 (775)
T KOG1151|consen 542 SFCTVLEYCEGNDLDFYLKQHKL---MSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITDF 617 (775)
T ss_pred cceeeeeecCCCchhHHHHhhhh---hhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeeec
Confidence 78899999999999999987653 89999999999999999999987 568999999999999854 478999999
Q ss_pred ccccccCCCCCC-------ceeccccccccccccccc----CCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhh
Q 044366 797 GFAKFLEPHSSN-------WTEFAGTVGYAAPELAYT----MRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNM 865 (918)
Q Consensus 797 G~~~~~~~~~~~-------~~~~~g~~~y~aPE~~~~----~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~ 865 (918)
|++..++.+... .+...||..|++||++.- .+.+.|+||||.||++|+++.|+.||.......+.....
T Consensus 618 GLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeN 697 (775)
T KOG1151|consen 618 GLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQEN 697 (775)
T ss_pred chhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhh
Confidence 999998765443 234679999999997742 346789999999999999999999998665443333321
Q ss_pred H-hhhhhhcccCCCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHH
Q 044366 866 I-IEVNQILDHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVC 913 (918)
Q Consensus 866 ~-~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl 913 (918)
. ....++ .+|.. +.. ..+...+|++|+++.-++|-...++.
T Consensus 698 TIlkAtEV---qFP~K-PvV---sseAkaFIRRCLaYRKeDR~DV~qLA 739 (775)
T KOG1151|consen 698 TILKATEV---QFPPK-PVV---SSEAKAFIRRCLAYRKEDRIDVQQLA 739 (775)
T ss_pred chhcceec---cCCCC-Ccc---CHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence 1 111111 12211 111 23456788899999888888777664
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.4e-32 Score=273.22 Aligned_cols=269 Identities=20% Similarity=0.280 Sum_probs=203.6
Q ss_pred CCccCHHHHHHHhcCCCCceeeccccceEEEEE-EeCCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhcc-C-C---
Q 044366 633 NGKVLYEEITKATGNFGEKYCIGKGGQRSVYKA-ELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIR-H-R--- 706 (918)
Q Consensus 633 ~~~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h-~--- 706 (918)
+|...|......+.+|.+...+|+|+||.|-++ +...+..||||+++... ...++..-|++++.++. + |
T Consensus 76 dGH~v~~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~-----kYreAa~iEi~vLqki~~~DP~g~ 150 (415)
T KOG0671|consen 76 DGHYVYQVGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD-----KYREAALIEIEVLQKINESDPNGK 150 (415)
T ss_pred CceEEEEeccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH-----HHhhHHHHHHHHHHHHHhcCCCCc
Confidence 344445455556889999999999999999999 55568999999987632 23466788999999993 3 2
Q ss_pred -ceeeEecccccCCceEEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeee
Q 044366 707 -NIIKFHGFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLL 785 (918)
Q Consensus 707 -niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill 785 (918)
-+|.+.+|+...++.|+|+|.+ |-|+.+++.... -.+++...++.|+.|++++++|||+. +++|.|+||+||++
T Consensus 151 ~rcv~m~~wFdyrghiCivfell-G~S~~dFlk~N~-y~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILf 225 (415)
T KOG0671|consen 151 FRCVQMRDWFDYRGHICIVFELL-GLSTFDFLKENN-YIPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILF 225 (415)
T ss_pred eEEEeeehhhhccCceEEEEecc-ChhHHHHhccCC-ccccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEE
Confidence 3788999999999999999988 349999998754 35689999999999999999999999 99999999999998
Q ss_pred CC--------------------CCcEEEeccccccccCCCCCCceecccccccccccccccCCCCcccchhhHHHHHHHH
Q 044366 786 DS--------------------EYEAHVSDFGFAKFLEPHSSNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEV 845 (918)
Q Consensus 786 ~~--------------------~~~~kl~DfG~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el 845 (918)
.+ +..++++|||.|++..... ...+.|..|.|||++.+-.+++++||||+||||+|+
T Consensus 226 vss~~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h---s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~El 302 (415)
T KOG0671|consen 226 VSSEYFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH---STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVEL 302 (415)
T ss_pred eccceEEEeccCCccceeccCCCcceEEEecCCcceeccCc---ceeeeccccCCchheeccCcCCccCceeeeeEEEEe
Confidence 42 2358999999998765433 556789999999999999999999999999999999
Q ss_pred HhCCCCCCcchhh--hhhhhh--------hHhhh--hhhccc---CCCC---------------C----CcchHHHHHHH
Q 044366 846 IKGYHPGDFVSTI--FSSISN--------MIIEV--NQILDH---RLPT---------------P----SRDVTDKLRSI 891 (918)
Q Consensus 846 ~tg~~p~~~~~~~--~~~~~~--------~~~~~--~~~~~~---~~~~---------------~----~~~~~~~~~~l 891 (918)
.+|..-|+..... ...++. +.... .+.... .++. + -.....+..++
T Consensus 303 ytG~~LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~L 382 (415)
T KOG0671|consen 303 YTGETLFQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQL 382 (415)
T ss_pred eccceecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHH
Confidence 9998876533210 000000 00000 000000 0000 0 01112344679
Q ss_pred HHHHHHcccCCCCCCCCHHHHHH
Q 044366 892 MEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 892 ~~li~~cl~~dp~~RPt~~evl~ 914 (918)
.+++.+|+..||.+|+|+.|++.
T Consensus 383 fDLl~~mL~fDP~~RiTl~EAL~ 405 (415)
T KOG0671|consen 383 FDLLRRMLEFDPARRITLREALS 405 (415)
T ss_pred HHHHHHHHccCccccccHHHHhc
Confidence 99999999999999999999875
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=271.69 Aligned_cols=219 Identities=21% Similarity=0.210 Sum_probs=174.7
Q ss_pred ccceEEEEEE-eCCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEEEEEeccCCChhH
Q 044366 657 GGQRSVYKAE-LPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFIVCEYLARGSLTT 735 (918)
Q Consensus 657 G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~ 735 (918)
|.+|.||++. ..+++.||+|+++... .+.+|...+....||||+++++++.+.+..++||||+++|+|.+
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~---------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 74 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS---------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWS 74 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh---------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHH
Confidence 8999999995 4578999999986531 23345555555679999999999999999999999999999999
Q ss_pred HhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccCCCCCCceecccc
Q 044366 736 ILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGT 815 (918)
Q Consensus 736 ~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~g~ 815 (918)
++.... .+++..+..++.|+++||+|+|+. +++||||||+||+++.++.++++|||.+....... ....++
T Consensus 75 ~l~~~~---~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~---~~~~~~ 145 (237)
T cd05576 75 HISKFL---NIPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC---DGEAVE 145 (237)
T ss_pred HHHHhc---CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEecccchhcccccc---ccCCcC
Confidence 987643 489999999999999999999999 99999999999999999999999999887654322 223456
Q ss_pred cccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCCCCCcchHHHHHHHHHHH
Q 044366 816 VGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRDVTDKLRSIMEVA 895 (918)
Q Consensus 816 ~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 895 (918)
..|+|||...+..++.++||||+|+++|||++|+.|++...... ........+ . .....+.+++
T Consensus 146 ~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~----------~~~~~~~~~---~---~~~~~~~~li 209 (237)
T cd05576 146 NMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI----------NTHTTLNIP---E---WVSEEARSLL 209 (237)
T ss_pred ccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc----------ccccccCCc---c---cCCHHHHHHH
Confidence 78999999988888999999999999999999998854321110 000000111 1 1224678899
Q ss_pred HHcccCCCCCCCCH
Q 044366 896 ILCLVENPEARPTM 909 (918)
Q Consensus 896 ~~cl~~dp~~RPt~ 909 (918)
.+|++.||++||++
T Consensus 210 ~~~l~~dp~~R~~~ 223 (237)
T cd05576 210 QQLLQFNPTERLGA 223 (237)
T ss_pred HHHccCCHHHhcCC
Confidence 99999999999996
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.8e-31 Score=284.48 Aligned_cols=239 Identities=25% Similarity=0.293 Sum_probs=188.4
Q ss_pred hcCCCCceeeccccceEEEEE-EeCCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhc-cCCceeeEecccccCCceE
Q 044366 645 TGNFGEKYCIGKGGQRSVYKA-ELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEI-RHRNIIKFHGFCSNAQHSF 722 (918)
Q Consensus 645 ~~~~~~~~~lg~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~ 722 (918)
+..|.....+|.|+|+.|-.+ ..++++..+||++.... .+-.+|+.++... +||||+++.+.+.++.+.|
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~--------~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~ 392 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA--------DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIY 392 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheeccccc--------cccccccchhhhhcCCCcceeecceecCCceee
Confidence 456667777999999999888 55678999999987641 1223566555554 7999999999999999999
Q ss_pred EEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeee-CCCCcEEEeccccccc
Q 044366 723 IVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLL-DSEYEAHVSDFGFAKF 801 (918)
Q Consensus 723 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill-~~~~~~kl~DfG~~~~ 801 (918)
+|||++.++-+.+.++..+. +. .++..|+.+|+.|+.|||++ |+||||+||+|||+ ++.++++|+|||.++.
T Consensus 393 ~v~e~l~g~ell~ri~~~~~---~~-~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~ 465 (612)
T KOG0603|consen 393 LVMELLDGGELLRRIRSKPE---FC-SEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSAGHLRLTYFGFWSE 465 (612)
T ss_pred eeehhccccHHHHHHHhcch---hH-HHHHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCCCcEEEEEechhhh
Confidence 99999999988777765432 23 67788999999999999999 99999999999999 5889999999999998
Q ss_pred cCCCCCCceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCCCCC
Q 044366 802 LEPHSSNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPS 881 (918)
Q Consensus 802 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 881 (918)
..+. ....+-|..|.|||++....|++++|+||||++||+|++|+.|+...... ......+..+. ..
T Consensus 466 ~~~~---~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~-------~ei~~~i~~~~---~s 532 (612)
T KOG0603|consen 466 LERS---CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG-------IEIHTRIQMPK---FS 532 (612)
T ss_pred Cchh---hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch-------HHHHHhhcCCc---cc
Confidence 7654 22234478999999999999999999999999999999999997755432 11111111111 11
Q ss_pred cchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 882 RDVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 882 ~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
. .......+++.+|++.||.+||+++++..
T Consensus 533 ~---~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~ 562 (612)
T KOG0603|consen 533 E---CVSDEAKDLLQQLLQVDPALRLGADEIGA 562 (612)
T ss_pred c---ccCHHHHHHHHHhccCChhhCcChhhhcc
Confidence 2 22345678888999999999999999864
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=246.45 Aligned_cols=215 Identities=23% Similarity=0.334 Sum_probs=175.2
Q ss_pred HHhcCCCCceeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHh-hccCCceeeEecccccCCc
Q 044366 643 KATGNFGEKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALT-EIRHRNIIKFHGFCSNAQH 720 (918)
Q Consensus 643 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~-~l~h~niv~~~~~~~~~~~ 720 (918)
...+.......||+|+||.|-+.++ ++|+..|+|+++... ..+..+...+|+.+.. ...+|.+|.++|.....+.
T Consensus 43 V~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tv---n~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regd 119 (282)
T KOG0984|consen 43 VPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATV---NSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGD 119 (282)
T ss_pred cchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhc---ChHHHHHHHHhhhhhccCCCCCeEEEeehhhhcccc
Confidence 3444455556799999999999865 589999999997643 2334567788888754 4579999999999999999
Q ss_pred eEEEEEeccCCChhHHhhcc-cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccc
Q 044366 721 SFIVCEYLARGSLTTILRDD-AAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFA 799 (918)
Q Consensus 721 ~~lv~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~ 799 (918)
.|+.||.|+- +|+.+.+.. ..++.+++.-+-+||..+.+||.|||++. .++|||+||+|||++.+|++|+||||++
T Consensus 120 vwIcME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGIs 196 (282)
T KOG0984|consen 120 VWICMELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGIS 196 (282)
T ss_pred EEEeHHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcccccc
Confidence 9999999975 898887653 33566899999999999999999999986 8999999999999999999999999999
Q ss_pred cccCCCCCCceecccccccccccccc----cCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhh
Q 044366 800 KFLEPHSSNWTEFAGTVGYAAPELAY----TMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISN 864 (918)
Q Consensus 800 ~~~~~~~~~~~~~~g~~~y~aPE~~~----~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~ 864 (918)
..+.++-.. +...|-..|||||.+. ...|+-|+||||+|+.+.||.++++|++.+...+....+
T Consensus 197 G~L~dSiAk-t~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkq 264 (282)
T KOG0984|consen 197 GYLVDSIAK-TMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQ 264 (282)
T ss_pred eeehhhhHH-HHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHH
Confidence 887643222 2245677899999875 346889999999999999999999998877766544443
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-31 Score=268.21 Aligned_cols=245 Identities=24% Similarity=0.331 Sum_probs=195.4
Q ss_pred HhcCCCCceeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhc-cCCceeeEecccccCCce
Q 044366 644 ATGNFGEKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEI-RHRNIIKFHGFCSNAQHS 721 (918)
Q Consensus 644 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~ 721 (918)
...+|....+||+|+||.|..|+. .+.+.||||++++....++.. .+--..|-++++-- +-|.+++++.+++..+.+
T Consensus 347 ~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDD-vectm~EKrvLAL~~kppFL~qlHScFQTmDRL 425 (683)
T KOG0696|consen 347 KATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDD-VECTMVEKRVLALPGKPPFLVQLHSCFQTMDRL 425 (683)
T ss_pred eecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCc-ccceehhhhheecCCCCchHHHHHHHhhhhhhe
Confidence 345788899999999999999954 467889999998866544322 23334566666655 578899999999999999
Q ss_pred EEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccc
Q 044366 722 FIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKF 801 (918)
Q Consensus 722 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~ 801 (918)
|.||||+.||+|--.+...+ .+.++.+.-+|..||-||-+||++ ||+.||+|..|||++.+|.+||+|||++..
T Consensus 426 yFVMEyvnGGDLMyhiQQ~G---kFKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd~eGHiKi~DFGmcKE 499 (683)
T KOG0696|consen 426 YFVMEYVNGGDLMYHIQQVG---KFKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKE 499 (683)
T ss_pred eeEEEEecCchhhhHHHHhc---ccCCchhhhhhHHHHHHhhhhhcC---CeeeeeccccceEeccCCceEeeecccccc
Confidence 99999999999988887653 478888999999999999999999 999999999999999999999999999986
Q ss_pred cCCCCCCceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCCCCC
Q 044366 802 LEPHSSNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPS 881 (918)
Q Consensus 802 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 881 (918)
---+.......+||+.|+|||.+...+|+.++|.|||||+||||+.|++||+..... .....+.++....+
T Consensus 500 ni~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~--------elF~aI~ehnvsyP- 570 (683)
T KOG0696|consen 500 NIFDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED--------ELFQAIMEHNVSYP- 570 (683)
T ss_pred cccCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHH--------HHHHHHHHccCcCc-
Confidence 544455556789999999999999999999999999999999999999999865431 11122333332222
Q ss_pred cchHHHHHHHHHHHHHcccCCCCCCC
Q 044366 882 RDVTDKLRSIMEVAILCLVENPEARP 907 (918)
Q Consensus 882 ~~~~~~~~~l~~li~~cl~~dp~~RP 907 (918)
. ....+...+....+.+.|.+|.
T Consensus 571 K---slSkEAv~ickg~ltK~P~kRL 593 (683)
T KOG0696|consen 571 K---SLSKEAVAICKGLLTKHPGKRL 593 (683)
T ss_pred c---cccHHHHHHHHHHhhcCCcccc
Confidence 1 1224456667778889999985
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-30 Score=253.33 Aligned_cols=252 Identities=24% Similarity=0.328 Sum_probs=198.8
Q ss_pred hcCCCCceeeccccceEEEEEEeC-CCCEEEEEEcccccccCCCCChHHHHHHHHHHhhc-cCCceeeEecccccCCceE
Q 044366 645 TGNFGEKYCIGKGGQRSVYKAELP-SGNIFAVKKFKAELFSDETANPSEFLNEVLALTEI-RHRNIIKFHGFCSNAQHSF 722 (918)
Q Consensus 645 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~ 722 (918)
..+|...++||+|+|..|..+++. +.+.||+|+++++...+++ +.+=...|-.+..+. +||.+|.+..++..+...+
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~ndde-didwvqtek~vfe~asn~pflvglhscfqtesrlf 327 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDE-DIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLF 327 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcc-cchhHHhhHHHHHhccCCCeEEehhhhhcccceEE
Confidence 357889999999999999999764 6889999999987665543 344445555555555 7999999999999999999
Q ss_pred EEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEecccccccc
Q 044366 723 IVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFL 802 (918)
Q Consensus 723 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~ 802 (918)
.|.||++||+|--.+.+. +.++++.++-+...|+-||.|||++ ||+.||+|..||++|..|.+|+.|+|+++.-
T Consensus 328 fvieyv~ggdlmfhmqrq---rklpeeharfys~ei~lal~flh~r---giiyrdlkldnvlldaeghikltdygmcke~ 401 (593)
T KOG0695|consen 328 FVIEYVNGGDLMFHMQRQ---RKLPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEG 401 (593)
T ss_pred EEEEEecCcceeeehhhh---hcCcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccCCceeecccchhhcC
Confidence 999999999998776554 3489999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCCCceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCCCCCc
Q 044366 803 EPHSSNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSR 882 (918)
Q Consensus 803 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 882 (918)
-.+....+..+||+.|.|||.+.+..|...+|.|++||+++||+.|+.||+..+...+.........+.++......+..
T Consensus 402 l~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqiriprs 481 (593)
T KOG0695|consen 402 LGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIRIPRS 481 (593)
T ss_pred CCCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcccccce
Confidence 55566667789999999999999999999999999999999999999999876532222111111112222222222111
Q ss_pred chHHHHHHHHHHHHHcccCCCCCCC
Q 044366 883 DVTDKLRSIMEVAILCLVENPEARP 907 (918)
Q Consensus 883 ~~~~~~~~l~~li~~cl~~dp~~RP 907 (918)
...+...+++.-+.+||++|.
T Consensus 482 ----lsvkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 482 ----LSVKASHVLKGFLNKDPKERL 502 (593)
T ss_pred ----eehhhHHHHHHhhcCCcHHhc
Confidence 122344566677999999985
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-29 Score=264.52 Aligned_cols=239 Identities=27% Similarity=0.425 Sum_probs=191.9
Q ss_pred cceEEEEEEeC-CCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEEEEEeccCCChhHH
Q 044366 658 GQRSVYKAELP-SGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFIVCEYLARGSLTTI 736 (918)
Q Consensus 658 ~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~ 736 (918)
+||.||+|... +|+.+|+|++...... ...+.+.+|++.+++++|+|++++++++..+...++++||+++++|.++
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~---~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~ 77 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIK---KKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDL 77 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccc---cHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHH
Confidence 58999999765 5899999998753221 1157899999999999999999999999998999999999999999999
Q ss_pred hhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccCCCCCCceeccccc
Q 044366 737 LRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGTV 816 (918)
Q Consensus 737 l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~g~~ 816 (918)
+..... +++..++.++.++++|++|||+. +++|+||+|+||++++++.++++|||.+....... ......++.
T Consensus 78 ~~~~~~---~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~ 150 (244)
T smart00220 78 LKKRGR---LSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG-LLTTFVGTP 150 (244)
T ss_pred HHhccC---CCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeecccc-ccccccCCc
Confidence 976432 78999999999999999999999 99999999999999999999999999998775432 233456788
Q ss_pred ccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCCCCCcchHHHHHHHHHHHH
Q 044366 817 GYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRDVTDKLRSIMEVAI 896 (918)
Q Consensus 817 ~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 896 (918)
.|+|||...+..++.++|||++|+++|++++|..||.......... .......... ..........+.+++.
T Consensus 151 ~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~-------~~~~~~~~~~-~~~~~~~~~~~~~~i~ 222 (244)
T smart00220 151 EYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELF-------KKIGKPKPPF-PPPEWKISPEAKDLIR 222 (244)
T ss_pred CCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHH-------HHHhccCCCC-ccccccCCHHHHHHHH
Confidence 9999999988888999999999999999999999976532111111 1111111111 1110003356888999
Q ss_pred HcccCCCCCCCCHHHHHH
Q 044366 897 LCLVENPEARPTMKEVCN 914 (918)
Q Consensus 897 ~cl~~dp~~RPt~~evl~ 914 (918)
+|+..+|++||++.++++
T Consensus 223 ~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 223 KLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHccCCchhccCHHHHhh
Confidence 999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.8e-29 Score=279.96 Aligned_cols=267 Identities=15% Similarity=0.187 Sum_probs=182.3
Q ss_pred HHhcCCCCceeeccccceEEEEEEe-----------------CCCCEEEEEEcccccccC----------CCCChHHHHH
Q 044366 643 KATGNFGEKYCIGKGGQRSVYKAEL-----------------PSGNIFAVKKFKAELFSD----------ETANPSEFLN 695 (918)
Q Consensus 643 ~~~~~~~~~~~lg~G~~g~Vy~~~~-----------------~~~~~vavK~~~~~~~~~----------~~~~~~~~~~ 695 (918)
+..++|.+.++||+|+||.||+|.. ..++.||||++....... .....+.+..
T Consensus 142 ~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~v 221 (507)
T PLN03224 142 WSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMV 221 (507)
T ss_pred ccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHH
Confidence 4577999999999999999999953 245689999986421100 0011233456
Q ss_pred HHHHHhhccCCce-----eeEeccccc--------CCceEEEEEeccCCChhHHhhcccc--------------------
Q 044366 696 EVLALTEIRHRNI-----IKFHGFCSN--------AQHSFIVCEYLARGSLTTILRDDAA-------------------- 742 (918)
Q Consensus 696 e~~~l~~l~h~ni-----v~~~~~~~~--------~~~~~lv~e~~~~gsL~~~l~~~~~-------------------- 742 (918)
|+.++.+++|.++ +++++||.. .+..++||||+++|+|.++++....
T Consensus 222 E~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~ 301 (507)
T PLN03224 222 EAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNM 301 (507)
T ss_pred HHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhc
Confidence 7777888876654 677787743 3568999999999999999874311
Q ss_pred -cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccCCCCCC-ceeccccccccc
Q 044366 743 -AKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSN-WTEFAGTVGYAA 820 (918)
Q Consensus 743 -~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~~~~~~-~~~~~g~~~y~a 820 (918)
...+++..++.++.|++.||+|+|+. +|+||||||+||+++.++.+||+|||++......... .....+++.|+|
T Consensus 302 ~~~~~~~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~a 378 (507)
T PLN03224 302 PQDKRDINVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSP 378 (507)
T ss_pred ccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeC
Confidence 12356788999999999999999999 9999999999999999999999999999765432211 112334789999
Q ss_pred ccccccCCC----------------------CcccchhhHHHHHHHHHhCCC-CCCcchhhhhhh---hhhHhhhhhhcc
Q 044366 821 PELAYTMRA----------------------TEKYDVYSFGVLALEVIKGYH-PGDFVSTIFSSI---SNMIIEVNQILD 874 (918)
Q Consensus 821 PE~~~~~~~----------------------~~~~Dv~slG~vl~el~tg~~-p~~~~~~~~~~~---~~~~~~~~~~~~ 874 (918)
||.+..... ..+.||||+||++|||++|.. |+.......... ............
T Consensus 379 PE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~ 458 (507)
T PLN03224 379 PEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKG 458 (507)
T ss_pred hhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcc
Confidence 998754221 124799999999999999875 554221111111 111111111111
Q ss_pred cCCCCCCcchHHHHHHHHHHHHHcccCCC---CCCCCHHHHHH
Q 044366 875 HRLPTPSRDVTDKLRSIMEVAILCLVENP---EARPTMKEVCN 914 (918)
Q Consensus 875 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp---~~RPt~~evl~ 914 (918)
...... ..........+++.+|+..+| .+|+|++|+++
T Consensus 459 ~~~~~~--~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~ 499 (507)
T PLN03224 459 QKYDFS--LLDRNKEAGWDLACKLITKRDQANRGRLSVGQALS 499 (507)
T ss_pred cCCCcc--cccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence 111111 111223567788889998766 68999999975
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-29 Score=292.20 Aligned_cols=260 Identities=19% Similarity=0.218 Sum_probs=169.0
Q ss_pred HhcCCCCceeeccccceEEEEEEeC-C----CCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecc----
Q 044366 644 ATGNFGEKYCIGKGGQRSVYKAELP-S----GNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGF---- 714 (918)
Q Consensus 644 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~----~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~---- 714 (918)
..++|...+.||+|+||.||+|... + +..||||++... ...+.+..| .++...+.+++.++..
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~------~~~e~~~~e--~l~~~~~~~~~~~~~~~~~~ 201 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEY------GAVEIWMNE--RVRRACPNSCADFVYGFLEP 201 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEeccc------chhHHHHHH--HHHhhchhhHHHHHHhhhcc
Confidence 5678999999999999999999654 5 789999987532 111111111 1122222333322221
Q ss_pred --cccCCceEEEEEeccCCChhHHhhccccc-----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEE
Q 044366 715 --CSNAQHSFIVCEYLARGSLTTILRDDAAA-----------------KEFSWNQRMNVIKGVANALSYLHHDCIPPIVH 775 (918)
Q Consensus 715 --~~~~~~~~lv~e~~~~gsL~~~l~~~~~~-----------------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH 775 (918)
+..+...++||||+++++|.+++...... .......+..++.|++.||+|||+. +|+|
T Consensus 202 ~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiH 278 (566)
T PLN03225 202 VSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVH 278 (566)
T ss_pred cccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEe
Confidence 24567899999999999999998753210 0112345668999999999999999 9999
Q ss_pred cCCCCCCeeeCC-CCcEEEeccccccccCCCC-CCceecccccccccccccccC----------------------CCCc
Q 044366 776 RDISSKNVLLDS-EYEAHVSDFGFAKFLEPHS-SNWTEFAGTVGYAAPELAYTM----------------------RATE 831 (918)
Q Consensus 776 ~dlk~~Nill~~-~~~~kl~DfG~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~----------------------~~~~ 831 (918)
|||||+|||++. ++.+||+|||+|+.+.... .......+++.|+|||.+... .++.
T Consensus 279 RDLKP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~ 358 (566)
T PLN03225 279 RDVKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPD 358 (566)
T ss_pred CcCCHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCC
Confidence 999999999986 5789999999998654322 223456789999999965322 2344
Q ss_pred ccchhhHHHHHHHHHhCCCCCCcchhhhh-hhhh---hHhhhhhhcccCCCCCCcc----hHHHHHHHHHHHHHcccCCC
Q 044366 832 KYDVYSFGVLALEVIKGYHPGDFVSTIFS-SISN---MIIEVNQILDHRLPTPSRD----VTDKLRSIMEVAILCLVENP 903 (918)
Q Consensus 832 ~~Dv~slG~vl~el~tg~~p~~~~~~~~~-~~~~---~~~~~~~~~~~~~~~~~~~----~~~~~~~l~~li~~cl~~dp 903 (918)
++||||+||++|||+++..|++.....+. .+.. ................... .........+++.+|++.||
T Consensus 359 k~DVwSlGviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP 438 (566)
T PLN03225 359 RFDIYSAGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKG 438 (566)
T ss_pred CcccHHHHHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCc
Confidence 67999999999999998777543211110 0000 0001111111111000000 00011234589999999999
Q ss_pred CCCCCHHHHHH
Q 044366 904 EARPTMKEVCN 914 (918)
Q Consensus 904 ~~RPt~~evl~ 914 (918)
++|||++|+++
T Consensus 439 ~kR~ta~e~L~ 449 (566)
T PLN03225 439 RQRISAKAALA 449 (566)
T ss_pred ccCCCHHHHhC
Confidence 99999999985
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-30 Score=270.85 Aligned_cols=244 Identities=26% Similarity=0.403 Sum_probs=198.9
Q ss_pred CCCCceeeccccceEEEEEEeCCCC-EEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEEEE
Q 044366 647 NFGEKYCIGKGGQRSVYKAELPSGN-IFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFIVC 725 (918)
Q Consensus 647 ~~~~~~~lg~G~~g~Vy~~~~~~~~-~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 725 (918)
++..+-.||-|+||.|-.+.....+ .+|+|.+++...-+ ....+....|-.+|...+.|.||++|..+.+....|+.|
T Consensus 421 dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVd-tkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm 499 (732)
T KOG0614|consen 421 DLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVD-TKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM 499 (732)
T ss_pred hhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccc-hhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence 3445567999999999999765433 48999887744333 333577888999999999999999999999999999999
Q ss_pred EeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccCCC
Q 044366 726 EYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPH 805 (918)
Q Consensus 726 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~~~ 805 (918)
|-|-||.++..+++++. |+.....-++..+++|++|||++ +||.||+||+|.+++.+|-+||.|||+|+.+...
T Consensus 500 EaClGGElWTiLrdRg~---Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g 573 (732)
T KOG0614|consen 500 EACLGGELWTILRDRGS---FDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSG 573 (732)
T ss_pred HhhcCchhhhhhhhcCC---cccchhhhhHHHHHHHHHHHHhc---CceeccCChhheeeccCCceEEeehhhHHHhccC
Confidence 99999999999998654 88888999999999999999999 9999999999999999999999999999999876
Q ss_pred CCCceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCCCCCcchH
Q 044366 806 SSNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRDVT 885 (918)
Q Consensus 806 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 885 (918)
...++ .+||+.|.|||.+.....+.++|.||+|+++||+++|.+||....+. .........+..+- +| .
T Consensus 574 ~KTwT-FcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpm-ktYn~ILkGid~i~---~P---r--- 642 (732)
T KOG0614|consen 574 RKTWT-FCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPM-KTYNLILKGIDKIE---FP---R--- 642 (732)
T ss_pred Cceee-ecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchH-HHHHHHHhhhhhhh---cc---c---
Confidence 65554 68999999999999999999999999999999999999999876542 12121222222211 11 1
Q ss_pred HHHHHHHHHHHHcccCCCCCCCC
Q 044366 886 DKLRSIMEVAILCLVENPEARPT 908 (918)
Q Consensus 886 ~~~~~l~~li~~cl~~dp~~RPt 908 (918)
...+...++|++.+..+|.+|.-
T Consensus 643 ~I~k~a~~Lik~LCr~~P~ERLG 665 (732)
T KOG0614|consen 643 RITKTATDLIKKLCRDNPTERLG 665 (732)
T ss_pred ccchhHHHHHHHHHhcCcHhhhc
Confidence 12234667788889999999974
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-30 Score=286.09 Aligned_cols=244 Identities=27% Similarity=0.375 Sum_probs=188.2
Q ss_pred CCCceeeccccceE-EEEEEeCCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhc-cCCceeeEecccccCCceEEEE
Q 044366 648 FGEKYCIGKGGQRS-VYKAELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEI-RHRNIIKFHGFCSNAQHSFIVC 725 (918)
Q Consensus 648 ~~~~~~lg~G~~g~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~ 725 (918)
|...+++|.|+.|+ ||+|.. +|+.||||++-.+ ..+-+.+|++.++.- +|||||++++.-.++...|++.
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~e-------~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIal 582 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVY-EGREVAVKRLLEE-------FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIAL 582 (903)
T ss_pred eccHHHcccCCCCcEEEEEee-CCceehHHHHhhH-------hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEe
Confidence 44556789999876 799988 6899999998553 134568999998877 6999999999999999999999
Q ss_pred EeccCCChhHHhhccccc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCC---C--CcEEEeccccc
Q 044366 726 EYLARGSLTTILRDDAAA-KEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDS---E--YEAHVSDFGFA 799 (918)
Q Consensus 726 e~~~~gsL~~~l~~~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~---~--~~~kl~DfG~~ 799 (918)
|.|.. +|.++++..... .....-..+.+..|++.||++||+- +|||||+||.|||++. + ..++|+|||++
T Consensus 583 ELC~~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~iSDfgls 658 (903)
T KOG1027|consen 583 ELCAC-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKISDFGLS 658 (903)
T ss_pred hHhhh-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEecccccc
Confidence 99975 999999874111 1111134577899999999999998 9999999999999976 3 46899999999
Q ss_pred cccCCCCCC---ceecccccccccccccccCCCCcccchhhHHHHHHHHHhC-CCCCCcchhhhhhhhhhHhhhhhhccc
Q 044366 800 KFLEPHSSN---WTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKG-YHPGDFVSTIFSSISNMIIEVNQILDH 875 (918)
Q Consensus 800 ~~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg-~~p~~~~~~~~~~~~~~~~~~~~~~~~ 875 (918)
+......+. .....||.+|+|||++...+-+.++||||+|||+|..++| .+||+..-.....+.... .....-
T Consensus 659 Kkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NIl~~~---~~L~~L 735 (903)
T KOG1027|consen 659 KKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANILTGN---YTLVHL 735 (903)
T ss_pred cccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhhhhcCc---cceeee
Confidence 988765543 3456799999999999998889999999999999999986 999875433211111111 111100
Q ss_pred CCCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 876 RLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 876 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
.+ ..++ ...++|.+|+++||..||+|.+|+.
T Consensus 736 ---~~---~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~ 766 (903)
T KOG1027|consen 736 ---EP---LPDC--EAKDLISRMLNPDPQLRPSATDVLN 766 (903)
T ss_pred ---cc---CchH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence 00 1111 5778999999999999999999974
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-29 Score=237.11 Aligned_cols=253 Identities=19% Similarity=0.303 Sum_probs=195.1
Q ss_pred hcCCCCceeeccccceEEEEE-EeCCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhcc-CCceeeEecccccC--Cc
Q 044366 645 TGNFGEKYCIGKGGQRSVYKA-ELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIR-HRNIIKFHGFCSNA--QH 720 (918)
Q Consensus 645 ~~~~~~~~~lg~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~--~~ 720 (918)
.++|++.+++|+|.|+.||.| ...+.+.++||+++.. ..+.+.+|+.++..+. ||||+++++...++ ..
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV-------kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Skt 109 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV-------KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKT 109 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH-------HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccC
Confidence 467888899999999999999 5567889999998753 3567899999999996 99999999999765 45
Q ss_pred eEEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCC-CcEEEeccccc
Q 044366 721 SFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSE-YEAHVSDFGFA 799 (918)
Q Consensus 721 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~-~~~kl~DfG~~ 799 (918)
..+|+||+++.+....... ++.-++..+..+++.||+|+|+. ||+|||+||.|||+|.. -..+++|+|+|
T Consensus 110 paLiFE~v~n~Dfk~ly~t------l~d~dIryY~~elLkALdyCHS~---GImHRDVKPhNvmIdh~~rkLrlIDWGLA 180 (338)
T KOG0668|consen 110 PSLIFEYVNNTDFKQLYPT------LTDYDIRYYIYELLKALDYCHSM---GIMHRDVKPHNVMIDHELRKLRLIDWGLA 180 (338)
T ss_pred chhHhhhhccccHHHHhhh------hchhhHHHHHHHHHHHHhHHHhc---CcccccCCcceeeechhhceeeeeecchH
Confidence 7899999999887776543 67778999999999999999999 99999999999999875 46999999999
Q ss_pred cccCCCCCCceeccccccccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHh-----hh----
Q 044366 800 KFLEPHSSNWTEFAGTVGYAAPELAYT-MRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMII-----EV---- 869 (918)
Q Consensus 800 ~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~-----~~---- 869 (918)
.++.+... ...++.+..|--||.+.. ..|+..-|+|||||++..|+..+.||-...+.++....... +.
T Consensus 181 EFYHp~~e-YnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl 259 (338)
T KOG0668|consen 181 EFYHPGKE-YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYL 259 (338)
T ss_pred hhcCCCce-eeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHH
Confidence 99987543 345677889999998865 45788899999999999999999997544433332222110 00
Q ss_pred ---hhhcccCCCC--------C-----CcchHH-HHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 870 ---NQILDHRLPT--------P-----SRDVTD-KLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 870 ---~~~~~~~~~~--------~-----~~~~~~-~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
.-.++++... + ..+... ..++.++++.+.+..|..+||||.|.++
T Consensus 260 ~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~ 321 (338)
T KOG0668|consen 260 NKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA 321 (338)
T ss_pred HHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence 0001111100 0 000011 1257889999999999999999999764
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.9e-31 Score=266.25 Aligned_cols=275 Identities=23% Similarity=0.315 Sum_probs=168.0
Q ss_pred cccccccccCCccccCCCCCCEEEccCCcccccCccccCCCCCCCEEECcCCcCCCcCCcCCCCCCCCceeeccc-cccc
Q 044366 76 FCHNNVSGRIPSSLGNLSNLALLYLNDNSLFGSIPIVMGNLKSLSTLDLSQNQLNGSIPCSLDNLSNLDTLFLYK-NSLS 154 (918)
Q Consensus 76 l~~n~~~~~~p~~l~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~-n~l~ 154 (918)
.++-.++ .+|..+. ..-..++|..|+|+.+.|++|..+++|+.||||+|+|+.+-|++|.++.+|.+|-+.+ |+|+
T Consensus 53 Cr~~GL~-eVP~~LP--~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~ 129 (498)
T KOG4237|consen 53 CRGKGLT-EVPANLP--PETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKIT 129 (498)
T ss_pred ccCCCcc-cCcccCC--CcceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchh
Confidence 3333444 5565554 4556677777777777777777777777777777777777777777777766666655 7777
Q ss_pred cCCCcccccccccCeeeccccccCCcCCccCCCCCCCcEeeccCcccccCCCccccCCCCcceeeccccc----------
Q 044366 155 GPIPSVIGNLKSLLQLDLSENRLSGLIPLSLSNLSSLTVMSLFNNSLSGSIPPILGNLKSLSTLGLHINQ---------- 224 (918)
Q Consensus 155 ~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~---------- 224 (918)
.+..++|++|.+|+.|.+.-|++.-+....|..+++|..|.+-.|.+..+.-..|..+..++.+.+..|.
T Consensus 130 ~l~k~~F~gL~slqrLllNan~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~icdCnL~wl 209 (498)
T KOG4237|consen 130 DLPKGAFGGLSSLQRLLLNANHINCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFICDCNLPWL 209 (498)
T ss_pred hhhhhHhhhHHHHHHHhcChhhhcchhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCccccccccchh
Confidence 6666777777777777777777776666677777777777777777764444467777777777776666
Q ss_pred --ccCCCCCCCcCCCcCCeEEcccCcCcCCCC--------------------------ccccccCCCCeEecCCCccCCc
Q 044366 225 --LNGVIPPSIGNLSSLRNLSLFNNRLYGFVP--------------------------KEIGYLKSLSKLEFCANHLSGV 276 (918)
Q Consensus 225 --l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--------------------------~~~~~l~~L~~L~l~~n~l~~~ 276 (918)
+....|-.+++.....-..+.++++..+.+ ..|..+++|++|+|++|+|+.+
T Consensus 210 a~~~a~~~ietsgarc~~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~i~~i 289 (498)
T KOG4237|consen 210 ADDLAMNPIETSGARCVSPYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNNKITRI 289 (498)
T ss_pred hhHHhhchhhcccceecchHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccceEeccCCCccchh
Confidence 222222233333333333333333332222 2355556666666666666666
Q ss_pred CCCcCCCCCCCcEEEccCCcCcCCCCccccCCCCCCeEEeecccccCccccccCCCCCccEEeCCCCccccccCccc
Q 044366 277 IPHSVGNLTGLVLLNMCENHLFGPIPKSLRNLTSLERVRFNQNNLYGKVYEAFGDHPNLTFLDLSQNNFYCEISFNW 353 (918)
Q Consensus 277 ~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~ 353 (918)
.+.+|.++..++.|.|..|++..+-...|.++..|+.|+|.+|+|+.+.+.+|..+..|..|+|-.|++.|+|...|
T Consensus 290 ~~~aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~~CnC~l~w 366 (498)
T KOG4237|consen 290 EDGAFEGAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNPFNCNCRLAW 366 (498)
T ss_pred hhhhhcchhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehccCcccCccchHH
Confidence 66666666666666666666655555556666666666666666666666666666666666666666666655544
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.9e-30 Score=247.48 Aligned_cols=259 Identities=24% Similarity=0.321 Sum_probs=192.5
Q ss_pred CCCceeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccC-----Cce
Q 044366 648 FGEKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNA-----QHS 721 (918)
Q Consensus 648 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~~~ 721 (918)
.+..+.||-|+||.||.+.. ++|+.||.|++... ...-...+.+.+|++++..++|.|+...+++..-. .+.
T Consensus 55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnv--fq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEi 132 (449)
T KOG0664|consen 55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNV--FQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQEL 132 (449)
T ss_pred CCCCCcccccceeEEEeccCCCCccchhHhhcchH--HHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHH
Confidence 44557799999999999954 58999999998652 22334568899999999999999999998876433 357
Q ss_pred EEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccc
Q 044366 722 FIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKF 801 (918)
Q Consensus 722 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~ 801 (918)
|+++|.|.. +|.+.+-. .+.++.+.+.-+.+||++||.|||+. +|.||||||.|.+++.+...||+|||+++.
T Consensus 133 YV~TELmQS-DLHKIIVS---PQ~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvLKICDFGLARv 205 (449)
T KOG0664|consen 133 YVLTELMQS-DLHKIIVS---PQALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCILKICDFGLART 205 (449)
T ss_pred HHHHHHHHh-hhhheecc---CCCCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceEEecccccccc
Confidence 889999865 88887754 45688899999999999999999999 999999999999999999999999999997
Q ss_pred cCCCCC-CceecccccccccccccccCC-CCcccchhhHHHHHHHHHhCCCCCCcchhhhh--hhh---------hhH--
Q 044366 802 LEPHSS-NWTEFAGTVGYAAPELAYTMR-ATEKYDVYSFGVLALEVIKGYHPGDFVSTIFS--SIS---------NMI-- 866 (918)
Q Consensus 802 ~~~~~~-~~~~~~g~~~y~aPE~~~~~~-~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~--~~~---------~~~-- 866 (918)
.+.+.. .++..+.|..|.|||.++|.+ |+.+.||||.||++.|++-++.-|+....+.. .+. .+.
T Consensus 206 ee~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~A 285 (449)
T KOG0664|consen 206 WDQRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYA 285 (449)
T ss_pred cchhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHH
Confidence 765543 456677899999999999864 89999999999999999987776654433211 111 110
Q ss_pred -hh-hhhhcccCCCCCC-------cchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 044366 867 -IE-VNQILDHRLPTPS-------RDVTDKLRSIMEVAILCLVENPEARPTMKEVCNL 915 (918)
Q Consensus 867 -~~-~~~~~~~~~~~~~-------~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 915 (918)
.. ...++......+. ....+.-.+-..+..+++..||.+|-+.++.+..
T Consensus 286 CEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~ 343 (449)
T KOG0664|consen 286 CEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQH 343 (449)
T ss_pred hhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccc
Confidence 00 0111111111110 0000112345667778999999999998887643
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-29 Score=270.91 Aligned_cols=253 Identities=26% Similarity=0.333 Sum_probs=203.9
Q ss_pred hcCCCCceeeccccceEEEEEE-eCCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEE
Q 044366 645 TGNFGEKYCIGKGGQRSVYKAE-LPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFI 723 (918)
Q Consensus 645 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 723 (918)
.++|+....+|.|+||.||||+ ..+++..|||+++.+... +.+...+|+-+++..+|||||.++|.+-..+..|+
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~d----d~~~iqqei~~~~dc~h~nivay~gsylr~dklwi 89 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGD----DFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWI 89 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCc----cccccccceeeeecCCCcChHHHHhhhhhhcCcEE
Confidence 4678888999999999999995 457999999999875333 34566789999999999999999999999999999
Q ss_pred EEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccC
Q 044366 724 VCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLE 803 (918)
Q Consensus 724 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~ 803 (918)
+|||+.+|+|.+..+.- +++++.++..+++...+|++|+|+. +=+|||||-.||++++.|.+|++|||.+..+.
T Consensus 90 cMEycgggslQdiy~~T---gplselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~gDvklaDfgvsaqit 163 (829)
T KOG0576|consen 90 CMEYCGGGSLQDIYHVT---GPLSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDEGDVKLADFGVSAQIT 163 (829)
T ss_pred EEEecCCCcccceeeec---ccchhHHHHHHHhhhhccchhhhcC---CcccccccccceeecccCceeecccCchhhhh
Confidence 99999999999987754 4589999999999999999999999 88999999999999999999999999999888
Q ss_pred CCCCCceeccccccccccccc---ccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCCCC
Q 044366 804 PHSSNWTEFAGTVGYAAPELA---YTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTP 880 (918)
Q Consensus 804 ~~~~~~~~~~g~~~y~aPE~~---~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 880 (918)
..-.......||+.|||||+. ..+.|.+++|||+.|+...|+-.-++|.-...+.. . ...+.+... .++.
T Consensus 164 ati~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr----~-l~LmTkS~~--qpp~ 236 (829)
T KOG0576|consen 164 ATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMR----A-LFLMTKSGF--QPPT 236 (829)
T ss_pred hhhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHH----H-HHHhhccCC--CCCc
Confidence 776667788999999999976 45678999999999999999988777722111110 0 000111000 1111
Q ss_pred CcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 881 SRDVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 881 ~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
.++.......+.++++.|+.++|++||+++.++.
T Consensus 237 lkDk~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 237 LKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred ccCCccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 2233344566888888999999999999987653
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.2e-28 Score=252.33 Aligned_cols=133 Identities=24% Similarity=0.416 Sum_probs=113.6
Q ss_pred hcCCCCceeeccccceEEEEE-EeCCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhcc-----C---CceeeEeccc
Q 044366 645 TGNFGEKYCIGKGGQRSVYKA-ELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIR-----H---RNIIKFHGFC 715 (918)
Q Consensus 645 ~~~~~~~~~lg~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-----h---~niv~~~~~~ 715 (918)
.++|.+.++||.|-|++||+| +..+.+.||+|+.+.. ....+....||+++++++ | .+||++++.|
T Consensus 77 ~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA-----qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~F 151 (590)
T KOG1290|consen 77 GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA-----QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHF 151 (590)
T ss_pred CceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh-----hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccc
Confidence 478999999999999999999 6778899999998763 233567789999999883 2 3699999998
Q ss_pred c----cCCceEEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeC
Q 044366 716 S----NAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLD 786 (918)
Q Consensus 716 ~----~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~ 786 (918)
. .+.+.|||+|++ |.+|..++..... +.++...+.+|++||+.||.|||+.| ||||.||||+|||+.
T Consensus 152 khsGpNG~HVCMVfEvL-GdnLLklI~~s~Y-rGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~ 222 (590)
T KOG1290|consen 152 KHSGPNGQHVCMVFEVL-GDNLLKLIKYSNY-RGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLC 222 (590)
T ss_pred eecCCCCcEEEEEehhh-hhHHHHHHHHhCC-CCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeee
Confidence 4 456899999999 4589999877653 34799999999999999999999999 999999999999984
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-30 Score=263.69 Aligned_cols=419 Identities=23% Similarity=0.251 Sum_probs=265.5
Q ss_pred EEccCCcccccCccccCCCCCCCEEECcCCcCCCcCCcCCCCCCCCceeeccccccccCCCcccccccccCeeeccc-cc
Q 044366 98 LYLNDNSLFGSIPIVMGNLKSLSTLDLSQNQLNGSIPCSLDNLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSE-NR 176 (918)
Q Consensus 98 L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~-N~ 176 (918)
.+.++-.++ .+|..+. .+-..++|..|+|+.+.|.+|+.+.+|++|+|++|.|+.+-|++|.++++|..|-+-+ |+
T Consensus 51 VdCr~~GL~-eVP~~LP--~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~Nk 127 (498)
T KOG4237|consen 51 VDCRGKGLT-EVPANLP--PETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNK 127 (498)
T ss_pred EEccCCCcc-cCcccCC--CcceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCc
Confidence 345555554 5555443 4677889999999988889999999999999999999999999999999988887766 89
Q ss_pred cCCcCCccCCCCCCCcEeeccCcccccCCCccccCCCCcceeecccccccCCCCCCCcCCCcCCeEEcccCcC-------
Q 044366 177 LSGLIPLSLSNLSSLTVMSLFNNSLSGSIPPILGNLKSLSTLGLHINQLNGVIPPSIGNLSSLRNLSLFNNRL------- 249 (918)
Q Consensus 177 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l------- 249 (918)
|+.+....|.++.+|+.|.+.-|++..+..+.|..+++|..|.+..|.+..+....|.++..++.+.+..|..
T Consensus 128 I~~l~k~~F~gL~slqrLllNan~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~icdCnL~ 207 (498)
T KOG4237|consen 128 ITDLPKGAFGGLSSLQRLLLNANHINCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFICDCNLP 207 (498)
T ss_pred hhhhhhhHhhhHHHHHHHhcChhhhcchhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCccccccccc
Confidence 9998888999999999999999999988888999999999999999999866666889999999999988873
Q ss_pred -----cCCCCccccccCCCCeEecCCCccCCcCCCcCCCC-CCCcEEEccCCcCcCCCC-ccccCCCCCCeEEeeccccc
Q 044366 250 -----YGFVPKEIGYLKSLSKLEFCANHLSGVIPHSVGNL-TGLVLLNMCENHLFGPIP-KSLRNLTSLERVRFNQNNLY 322 (918)
Q Consensus 250 -----~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l-~~L~~L~l~~n~l~~~~~-~~l~~l~~L~~L~l~~n~l~ 322 (918)
....|..+++..-..-..+.++++..+.+..|..- .++..--.+.+....+-| ..|..+++|+.|+|++|+|+
T Consensus 208 wla~~~a~~~ietsgarc~~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~i~ 287 (498)
T KOG4237|consen 208 WLADDLAMNPIETSGARCVSPYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNNKIT 287 (498)
T ss_pred hhhhHHhhchhhcccceecchHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccceEeccCCCccc
Confidence 22333444444444445555555555544444322 111111111222222222 44555666666666666666
Q ss_pred CccccccCCCCCccEEeCCCCccccccCcccccccccceeeccccccccCCCcCcCCCCCCcEEEccCceecccc-ccch
Q 044366 323 GKVYEAFGDHPNLTFLDLSQNNFYCEISFNWRNFSKLGTFNASMNNIYGSIPPEIGDSSKLQVLDLSSNHIFGKI-PVQL 401 (918)
Q Consensus 323 ~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~n~i~~~~~~~~~~~~~L~~L~L~~N~l~~~~-~~~~ 401 (918)
.+...+|.+...++.|.|..|+|..+....|.+++.|..|+|++|+|+...|.+|..+..|.+|+|-.|.+...- -.++
T Consensus 288 ~i~~~aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~~CnC~l~wl 367 (498)
T KOG4237|consen 288 RIEDGAFEGAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNPFNCNCRLAWL 367 (498)
T ss_pred hhhhhhhcchhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehccCcccCccchHHH
Confidence 666666666556666666666655555555555555555555555555555555555555555555555432110 0011
Q ss_pred hhccccCceecccccccCCCCCCCCCCCcccEEeccCcccccc---Cccccc---------cccccceec-ccCcccCCC
Q 044366 402 VKLFSLNKLILSLNQLFGGVPLEFGTLTELQYLDLSANKLSSS---IPMSIG---------NLLKLHYLN-LSNNQFSHK 468 (918)
Q Consensus 402 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~---~~~~~~---------~l~~L~~L~-Ls~N~l~~~ 468 (918)
+. .|..++..+.+| .+.-..++.++++.+.+... .|++.+ ..+-+.+.. -|++.++ .
T Consensus 368 ~~-------Wlr~~~~~~~~~--Cq~p~~~~~~~~~dv~~~~~~c~~~ee~~~~~s~~cP~~c~c~~tVvRcSnk~lk-~ 437 (498)
T KOG4237|consen 368 GE-------WLRKKSVVGNPR--CQSPGFVRQIPISDVAFGDFRCGGPEELGCLTSSPCPPPCTCLDTVVRCSNKLLK-L 437 (498)
T ss_pred HH-------HHhhCCCCCCCC--CCCCchhccccchhccccccccCCccccCCCCCCCCCCCcchhhhhHhhcccchh-h
Confidence 11 111122111111 12223566666666655421 122211 122233322 3334443 4
Q ss_pred CchhhccccccceEeccCCcCCCCCchhccccCCcceEecCCCcccccCcccccCCCCccEEEccCC
Q 044366 469 IPTEFEKLIHLSELDLSHNILQEEIPPQICKMESLEKLNLSHNNLSDFIPRCFEEMRSLSWIDISYN 535 (918)
Q Consensus 469 ~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~l~l~~N 535 (918)
+|..+.. .-.+|++.+|.++ .+|.. .+.+| .+++++|+|+......|.++++|.+|-+|+|
T Consensus 438 lp~~iP~--d~telyl~gn~~~-~vp~~--~~~~l-~~dls~n~i~~Lsn~tf~n~tql~tlilsyn 498 (498)
T KOG4237|consen 438 LPRGIPV--DVTELYLDGNAIT-SVPDE--LLRSL-LLDLSNNRISSLSNYTFSNMTQLSTLILSYN 498 (498)
T ss_pred cCCCCCc--hhHHHhcccchhc-ccCHH--HHhhh-hcccccCceehhhcccccchhhhheeEEecC
Confidence 4433322 4567889999997 56665 55677 8999999999888888999999999999887
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.5e-28 Score=260.76 Aligned_cols=202 Identities=21% Similarity=0.293 Sum_probs=171.8
Q ss_pred cCCCCceeeccccceEEEEE-EeCCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEEE
Q 044366 646 GNFGEKYCIGKGGQRSVYKA-ELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFIV 724 (918)
Q Consensus 646 ~~~~~~~~lg~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 724 (918)
.-|..++.||-|+||.|.++ +.++...||.|.+++...-.. ......+.|-+++.....+-||++|-.|.+.+.+|.|
T Consensus 629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~r-nQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFV 707 (1034)
T KOG0608|consen 629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMR-NQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFV 707 (1034)
T ss_pred cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhh-hhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEE
Confidence 35778889999999999999 555677899999877533322 2356678899999999999999999999999999999
Q ss_pred EEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccC-
Q 044366 725 CEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLE- 803 (918)
Q Consensus 725 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~- 803 (918)
|+|++||++-..|-+. +-|.+.-++-++..+..|+++.|.. |+|||||||.|||+|.+|.+||.|||++.-+.
T Consensus 708 MdYIPGGDmMSLLIrm---gIFeE~LARFYIAEltcAiesVHkm---GFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRW 781 (1034)
T KOG0608|consen 708 MDYIPGGDMMSLLIRM---GIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRW 781 (1034)
T ss_pred EeccCCccHHHHHHHh---ccCHHHHHHHHHHHHHHHHHHHHhc---cceecccCccceEEccCCceeeeecccccccee
Confidence 9999999999988653 3478888888999999999999999 99999999999999999999999999996441
Q ss_pred --------CCCCC---------------------------------ceecccccccccccccccCCCCcccchhhHHHHH
Q 044366 804 --------PHSSN---------------------------------WTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLA 842 (918)
Q Consensus 804 --------~~~~~---------------------------------~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl 842 (918)
..+.. ....+||+-|+|||++....++..+|.||.||||
T Consensus 782 THdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil 861 (1034)
T KOG0608|consen 782 THDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVIL 861 (1034)
T ss_pred ccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHH
Confidence 00000 0123699999999999999999999999999999
Q ss_pred HHHHhCCCCCCc
Q 044366 843 LEVIKGYHPGDF 854 (918)
Q Consensus 843 ~el~tg~~p~~~ 854 (918)
|||+.|+.||-.
T Consensus 862 ~em~~g~~pf~~ 873 (1034)
T KOG0608|consen 862 YEMLVGQPPFLA 873 (1034)
T ss_pred HHHhhCCCCccC
Confidence 999999999754
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.5e-28 Score=240.88 Aligned_cols=256 Identities=21% Similarity=0.278 Sum_probs=194.5
Q ss_pred cCCCCceeeccccceEEEEE-EeCCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccC------
Q 044366 646 GNFGEKYCIGKGGQRSVYKA-ELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNA------ 718 (918)
Q Consensus 646 ~~~~~~~~lg~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------ 718 (918)
.+|...+.+|.|+- .|..| +.-.+++||+|+...+ +.. ....+...+|...+..++|+||++++.++.-.
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~p-f~n-~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~ 93 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRP-FQN-QTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEF 93 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhhccCceehhhhcCc-ccc-CccchhhhhhhhhhhhhcccceeeeeeccCccccHHHH
Confidence 46777778899988 55555 5557999999998776 333 34457789999999999999999999998544
Q ss_pred CceEEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEecccc
Q 044366 719 QHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGF 798 (918)
Q Consensus 719 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~ 798 (918)
...|+|||||+. +|...+... ++-..+..+..|++.|++|+|+. ||+||||||+||++..++.+||.|||+
T Consensus 94 ~e~y~v~e~m~~-nl~~vi~~e-----lDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsnivv~~~~~lKi~dfg~ 164 (369)
T KOG0665|consen 94 QEVYLVMELMDA-NLCQVILME-----LDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSNIVVNSDCTLKILDFGL 164 (369)
T ss_pred HhHHHHHHhhhh-HHHHHHHHh-----cchHHHHHHHHHHHHHHHHHHhc---ceeecccCcccceecchhheeeccchh
Confidence 357999999975 999888732 66778899999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCCceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhh--------------
Q 044366 799 AKFLEPHSSNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISN-------------- 864 (918)
Q Consensus 799 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~-------------- 864 (918)
|+....+ -..+..+.+..|.|||++.+..+.+.+||||.||++.||++|+.-|.....+..+..-
T Consensus 165 ar~e~~~-~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~q 243 (369)
T KOG0665|consen 165 ARTEDTD-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQ 243 (369)
T ss_pred hcccCcc-cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHH
Confidence 9976654 3456678899999999999988999999999999999999998765433222111110
Q ss_pred ---hHhhhhh-------------hcccCCCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 865 ---MIIEVNQ-------------ILDHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 865 ---~~~~~~~-------------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
......+ .-|..++...+...-......+++.+|+..||++|-+++++++
T Consensus 244 L~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~ 309 (369)
T KOG0665|consen 244 LQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALR 309 (369)
T ss_pred hhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhc
Confidence 0000000 0000111111111122345788899999999999999999875
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.1e-27 Score=238.61 Aligned_cols=212 Identities=33% Similarity=0.563 Sum_probs=184.1
Q ss_pred eccccceEEEEEEeC-CCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEEEEEeccCCC
Q 044366 654 IGKGGQRSVYKAELP-SGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFIVCEYLARGS 732 (918)
Q Consensus 654 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gs 732 (918)
||+|++|.||++... +++.+++|++....... ..+.+.+|++.++.++|++++++++++......++++||+++++
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~---~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~ 77 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS---LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGS 77 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh---HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCc
Confidence 689999999999765 48999999987532111 34789999999999999999999999999899999999999999
Q ss_pred hhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCC-CCcEEEeccccccccCCCCCCcee
Q 044366 733 LTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDS-EYEAHVSDFGFAKFLEPHSSNWTE 811 (918)
Q Consensus 733 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~-~~~~kl~DfG~~~~~~~~~~~~~~ 811 (918)
|.+++.... ..+++..++.++.+++++++|||+. +++|+||+|.||+++. ++.++++|||.+............
T Consensus 78 l~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~ 152 (215)
T cd00180 78 LKDLLKENE--GKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKT 152 (215)
T ss_pred HHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhc
Confidence 999997642 3478999999999999999999999 9999999999999999 899999999999877554322334
Q ss_pred cccccccccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCCCCCcchHHHHHH
Q 044366 812 FAGTVGYAAPELAYTM-RATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRDVTDKLRS 890 (918)
Q Consensus 812 ~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 890 (918)
..+...|++||..... .++.++|+|++|+++++| ..
T Consensus 153 ~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-------------------------------------------~~ 189 (215)
T cd00180 153 IVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL-------------------------------------------PE 189 (215)
T ss_pred ccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH-------------------------------------------HH
Confidence 5678899999998877 788999999999999999 35
Q ss_pred HHHHHHHcccCCCCCCCCHHHHHHHh
Q 044366 891 IMEVAILCLVENPEARPTMKEVCNLL 916 (918)
Q Consensus 891 l~~li~~cl~~dp~~RPt~~evl~~L 916 (918)
+.+++.+|++.+|.+||++.++++.+
T Consensus 190 ~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 190 LKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred HHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 78889999999999999999998753
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.3e-28 Score=254.38 Aligned_cols=203 Identities=24% Similarity=0.322 Sum_probs=171.2
Q ss_pred HHHhcCCCCceeeccccceEEEEEEeC-CCCEEEEEEcccccccCCCC----ChHHHHHHHHHHhhcc---CCceeeEec
Q 044366 642 TKATGNFGEKYCIGKGGQRSVYKAELP-SGNIFAVKKFKAELFSDETA----NPSEFLNEVLALTEIR---HRNIIKFHG 713 (918)
Q Consensus 642 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~----~~~~~~~e~~~l~~l~---h~niv~~~~ 713 (918)
.....+|...+.+|.|+||.|+.|.++ +...|+||.+.++..-.+.. ..-..-.|+++|+.++ |+||+++++
T Consensus 557 ~~k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLd 636 (772)
T KOG1152|consen 557 YKKFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLD 636 (772)
T ss_pred ecccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhh
Confidence 344557889999999999999999665 45679999987643321111 1123567999999997 999999999
Q ss_pred ccccCCceEEEEEecc-CCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEE
Q 044366 714 FCSNAQHSFIVCEYLA-RGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAH 792 (918)
Q Consensus 714 ~~~~~~~~~lv~e~~~-~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~k 792 (918)
+|++++.+|++||-.. +.+|.+++.... ++++.+..-|++||+.|+++||++ ||||||||-+||.++.+|-+|
T Consensus 637 fFEddd~yyl~te~hg~gIDLFd~IE~kp---~m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikdenvivd~~g~~k 710 (772)
T KOG1152|consen 637 FFEDDDYYYLETEVHGEGIDLFDFIEFKP---RMDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDENVIVDSNGFVK 710 (772)
T ss_pred eeecCCeeEEEecCCCCCcchhhhhhccC---ccchHHHHHHHHHHHhcccccccc---CceecccccccEEEecCCeEE
Confidence 9999999999999764 459999998654 489999999999999999999999 999999999999999999999
Q ss_pred EeccccccccCCCCCCceecccccccccccccccCCC-CcccchhhHHHHHHHHHhCCCCC
Q 044366 793 VSDFGFAKFLEPHSSNWTEFAGTVGYAAPELAYTMRA-TEKYDVYSFGVLALEVIKGYHPG 852 (918)
Q Consensus 793 l~DfG~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Dv~slG~vl~el~tg~~p~ 852 (918)
|+|||.|..... ......+||..|.|||++.|.+| ...-|||++|++||.++....||
T Consensus 711 lidfgsaa~~ks--gpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpy 769 (772)
T KOG1152|consen 711 LIDFGSAAYTKS--GPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPY 769 (772)
T ss_pred EeeccchhhhcC--CCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCC
Confidence 999999987653 34567889999999999999887 45689999999999999888875
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3e-27 Score=246.06 Aligned_cols=271 Identities=18% Similarity=0.210 Sum_probs=206.8
Q ss_pred CCccCHHHHHHHhcCCCCceeeccccceEEEEEE-eCCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhcc------C
Q 044366 633 NGKVLYEEITKATGNFGEKYCIGKGGQRSVYKAE-LPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIR------H 705 (918)
Q Consensus 633 ~~~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~------h 705 (918)
++.+.+.-.+....+|.+....|+|-|++|..|. ...|+.||||+|+.... ..+.=..|++++++++ .
T Consensus 419 EGYYrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~-----M~KtGl~EleiLkKL~~AD~Edk 493 (752)
T KOG0670|consen 419 EGYYRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEV-----MHKTGLKELEILKKLNDADPEDK 493 (752)
T ss_pred cceEEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchH-----HhhhhhHHHHHHHHhhccCchhh
Confidence 4445555566677899999999999999999994 45688999999986422 2344578999999994 3
Q ss_pred CceeeEecccccCCceEEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeee
Q 044366 706 RNIIKFHGFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLL 785 (918)
Q Consensus 706 ~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill 785 (918)
-|.++++..|...+++|||||-+.. +|.+.++..+....+....+..++.|+.-||..|-.. +|+|.||||.||||
T Consensus 494 ~Hclrl~r~F~hknHLClVFE~Lsl-NLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNiLV 569 (752)
T KOG0670|consen 494 FHCLRLFRHFKHKNHLCLVFEPLSL-NLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNILV 569 (752)
T ss_pred hHHHHHHHHhhhcceeEEEehhhhc-hHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccceEe
Confidence 4789999999999999999998865 9999999887667788999999999999999999987 99999999999999
Q ss_pred CCC-CcEEEeccccccccCCCCCCceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchh--hhhhh
Q 044366 786 DSE-YEAHVSDFGFAKFLEPHSSNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVST--IFSSI 862 (918)
Q Consensus 786 ~~~-~~~kl~DfG~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~--~~~~~ 862 (918)
++. ...||||||.|..+.... .+.+..+..|.|||.+.|..|+...|+||.||+|||+.||+.-|..... .....
T Consensus 570 NE~k~iLKLCDfGSA~~~~ene--itPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~ 647 (752)
T KOG0670|consen 570 NESKNILKLCDFGSASFASENE--ITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLF 647 (752)
T ss_pred ccCcceeeeccCcccccccccc--ccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHH
Confidence 886 467999999998876433 2333456789999999999999999999999999999999865432110 00000
Q ss_pred hh--------h------------------Hhh-----------hhhhccc---------CCCCCCcchHHHHHHHHHHHH
Q 044366 863 SN--------M------------------IIE-----------VNQILDH---------RLPTPSRDVTDKLRSIMEVAI 896 (918)
Q Consensus 863 ~~--------~------------------~~~-----------~~~~~~~---------~~~~~~~~~~~~~~~l~~li~ 896 (918)
.. + ..+ +...+.+ ..+..+.+....+..+.+++.
T Consensus 648 me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLd 727 (752)
T KOG0670|consen 648 MELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLD 727 (752)
T ss_pred HHhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHH
Confidence 00 0 000 0000000 001122334456678999999
Q ss_pred HcccCCCCCCCCHHHHHH
Q 044366 897 LCLVENPEARPTMKEVCN 914 (918)
Q Consensus 897 ~cl~~dp~~RPt~~evl~ 914 (918)
+|+..||++|-|..|.++
T Consensus 728 kml~LdP~KRit~nqAL~ 745 (752)
T KOG0670|consen 728 KMLILDPEKRITVNQALK 745 (752)
T ss_pred HHhccChhhcCCHHHHhc
Confidence 999999999999999875
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.1e-27 Score=227.07 Aligned_cols=251 Identities=19% Similarity=0.295 Sum_probs=187.6
Q ss_pred hcCCCCceeeccccceEEEEEEeC-CCCEEEEEEcccccccCCCCChHHHHHHHHHHhhc-cCCceeeEecc-cccCCce
Q 044366 645 TGNFGEKYCIGKGGQRSVYKAELP-SGNIFAVKKFKAELFSDETANPSEFLNEVLALTEI-RHRNIIKFHGF-CSNAQHS 721 (918)
Q Consensus 645 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~-~~~~~~~ 721 (918)
.+.|.+.+.+|+|.||.+-.++++ +.+.+++|.+..+ ....++|.+|..---.+ .|.||+.-|+. ++..+.+
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p-----~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~Y 97 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP-----QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAY 97 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc-----hhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceE
Confidence 357888899999999999999765 6788999988764 34468999998765555 58999988875 5677788
Q ss_pred EEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeee-CCC-CcEEEeccccc
Q 044366 722 FIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLL-DSE-YEAHVSDFGFA 799 (918)
Q Consensus 722 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill-~~~-~~~kl~DfG~~ 799 (918)
+.++||++.|+|.+-+...+ +-+....+++.|++.|+.|||+. .+||||||.+|||+ +.| ..+|+||||..
T Consensus 98 vF~qE~aP~gdL~snv~~~G----igE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~rvKlcDFG~t 170 (378)
T KOG1345|consen 98 VFVQEFAPRGDLRSNVEAAG----IGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYRVKLCDFGLT 170 (378)
T ss_pred EEeeccCccchhhhhcCccc----ccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccEEEeeecccc
Confidence 89999999999999887643 67788899999999999999999 99999999999998 333 57999999999
Q ss_pred cccCCCCCCceecccccccccccccccC-----CCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcc
Q 044366 800 KFLEPHSSNWTEFAGTVGYAAPELAYTM-----RATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILD 874 (918)
Q Consensus 800 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~-----~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 874 (918)
+..+.... ...-+..|.|||..... ...+.+|||.||+++|.++||+.||+......+. ..+..+...
T Consensus 171 ~k~g~tV~---~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~----Y~~~~~w~~ 243 (378)
T KOG1345|consen 171 RKVGTTVK---YLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKP----YWEWEQWLK 243 (378)
T ss_pred cccCceeh---hhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCch----HHHHHHHhc
Confidence 86554322 22235679999976532 2467899999999999999999999843222111 112222222
Q ss_pred cCCCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 875 HRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 875 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
...+..+..+....+.+.++.++-+..+|++|=...++.+
T Consensus 244 rk~~~~P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk 283 (378)
T KOG1345|consen 244 RKNPALPKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKK 283 (378)
T ss_pred ccCccCchhhcccCHHHHHHHHHhcCCcccccchhHHHHH
Confidence 2222333334444566788888899999999954444443
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.4e-25 Score=229.86 Aligned_cols=199 Identities=31% Similarity=0.463 Sum_probs=171.5
Q ss_pred CCCceeeccccceEEEEEEeC-CCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEEEEE
Q 044366 648 FGEKYCIGKGGQRSVYKAELP-SGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFIVCE 726 (918)
Q Consensus 648 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 726 (918)
|...+.||+|++|.||+|... +++.+|+|.+...... ...+.+.+|++.++.++|+|++++++++......++++|
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~---~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e 77 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE---KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVME 77 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch---HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEe
Confidence 456788999999999999765 4899999998763211 246789999999999999999999999998899999999
Q ss_pred eccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccCCCC
Q 044366 727 YLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHS 806 (918)
Q Consensus 727 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~~~~ 806 (918)
|+++++|.+++..... .+++..++.++.+++.++.|+|+. +++|+|++|+||+++.++.++++|||.+.......
T Consensus 78 ~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~ 152 (225)
T smart00221 78 YCEGGDLFDYLRKKGG--KLSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADFGLARFIHRDL 152 (225)
T ss_pred ccCCCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcc
Confidence 9999999999976432 178999999999999999999999 99999999999999999999999999998775442
Q ss_pred -CCceeccccccccccccc-ccCCCCcccchhhHHHHHHHHHhCCCCCCc
Q 044366 807 -SNWTEFAGTVGYAAPELA-YTMRATEKYDVYSFGVLALEVIKGYHPGDF 854 (918)
Q Consensus 807 -~~~~~~~g~~~y~aPE~~-~~~~~~~~~Dv~slG~vl~el~tg~~p~~~ 854 (918)
.......++..|++||.. ....++.++|||+||++++||++|+.||..
T Consensus 153 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 153 AALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred cccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 122334677889999998 666778899999999999999999999854
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.4e-25 Score=230.59 Aligned_cols=201 Identities=29% Similarity=0.419 Sum_probs=167.7
Q ss_pred HHHHHHHhcCCCCceeeccccceEEEEEEeC----CCCEEEEEEcccccccCCCCChHHHHHHHHHHhhc-cCCceeeEe
Q 044366 638 YEEITKATGNFGEKYCIGKGGQRSVYKAELP----SGNIFAVKKFKAELFSDETANPSEFLNEVLALTEI-RHRNIIKFH 712 (918)
Q Consensus 638 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~ 712 (918)
++.+......|..+++||.|+|++||+|... ..+.||+|.+... ........|++++..+ .+.||+++.
T Consensus 28 ~q~~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~t------s~p~ri~~El~~L~~~gG~~ni~~~~ 101 (418)
T KOG1167|consen 28 RQDIPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRT------SSPSRILNELEMLYRLGGSDNIIKLN 101 (418)
T ss_pred HhhhhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccc------cCchHHHHHHHHHHHhccchhhhcch
Confidence 3445566778999999999999999999432 4678999998654 2345688999999999 599999999
Q ss_pred cccccCCceEEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCC-CcE
Q 044366 713 GFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSE-YEA 791 (918)
Q Consensus 713 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~-~~~ 791 (918)
+++...+...+|+||++..+..++.+. ++..++..+.+.+..||+++|+. |||||||||+|++.+.. +.-
T Consensus 102 ~~~rnnd~v~ivlp~~~H~~f~~l~~~------l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~~t~rg 172 (418)
T KOG1167|consen 102 GCFRNNDQVAIVLPYFEHDRFRDLYRS------LSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNRRTQRG 172 (418)
T ss_pred hhhccCCeeEEEecccCccCHHHHHhc------CCHHHHHHHHHHHHHHhhhhhcc---CccccCCCccccccccccCCc
Confidence 999999999999999999999998875 56788999999999999999999 99999999999999865 678
Q ss_pred EEeccccccccCCC------------------CC--------------------------Cceeccccccccccccccc-
Q 044366 792 HVSDFGFAKFLEPH------------------SS--------------------------NWTEFAGTVGYAAPELAYT- 826 (918)
Q Consensus 792 kl~DfG~~~~~~~~------------------~~--------------------------~~~~~~g~~~y~aPE~~~~- 826 (918)
.|.|||+|...+.. +. .....+||++|.|||++..
T Consensus 173 ~LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~ 252 (418)
T KOG1167|consen 173 VLVDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRC 252 (418)
T ss_pred eEEechhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhc
Confidence 99999999722100 00 0013469999999999865
Q ss_pred CCCCcccchhhHHHHHHHHHhCCCCCC
Q 044366 827 MRATEKYDVYSFGVLALEVIKGYHPGD 853 (918)
Q Consensus 827 ~~~~~~~Dv~slG~vl~el~tg~~p~~ 853 (918)
..-++++||||.||++..++++++||-
T Consensus 253 ~~QttaiDiws~GVI~Lslls~~~PFf 279 (418)
T KOG1167|consen 253 PRQTTAIDIWSAGVILLSLLSRRYPFF 279 (418)
T ss_pred cCcCCccceeeccceeehhhccccccc
Confidence 456889999999999999999999963
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.9e-23 Score=261.69 Aligned_cols=347 Identities=23% Similarity=0.247 Sum_probs=195.2
Q ss_pred CCccccCCCCCCEEEccccc------ccccCCCCcCCCC-CCCEEEcccccccccCCccccCCCCCCEEEccCCcccccC
Q 044366 37 IPPEIGKLNQLRRLYLDVNQ------LHGTIPPVIGQLS-LINELVFCHNNVSGRIPSSLGNLSNLALLYLNDNSLFGSI 109 (918)
Q Consensus 37 ~p~~l~~l~~L~~L~L~~n~------l~~~~p~~~~~l~-~L~~L~l~~n~~~~~~p~~l~~l~~L~~L~L~~n~i~~~~ 109 (918)
.+.+|..+.+|+.|.+..+. +...+|+.+..++ +|+.|.+.++.+. .+|..| ...+|+.|+|++|++. ..
T Consensus 550 ~~~aF~~m~~L~~L~~~~~~~~~~~~~~~~lp~~~~~lp~~Lr~L~~~~~~l~-~lP~~f-~~~~L~~L~L~~s~l~-~L 626 (1153)
T PLN03210 550 HENAFKGMRNLLFLKFYTKKWDQKKEVRWHLPEGFDYLPPKLRLLRWDKYPLR-CMPSNF-RPENLVKLQMQGSKLE-KL 626 (1153)
T ss_pred cHHHHhcCccccEEEEecccccccccceeecCcchhhcCcccEEEEecCCCCC-CCCCcC-CccCCcEEECcCcccc-cc
Confidence 44566777777777775543 2224566565553 4666777666665 566665 3566777777777665 45
Q ss_pred ccccCCCCCCCEEECcCCcCCCcCCcCCCCCCCCceeeccccccccCCCcccccccccCeeeccccccCCcCCccCCCCC
Q 044366 110 PIVMGNLKSLSTLDLSQNQLNGSIPCSLDNLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSENRLSGLIPLSLSNLS 189 (918)
Q Consensus 110 ~~~~~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~ 189 (918)
+..+..+++|+.|+|+++.....+| .++.+++|++|+|++|.....+|..++.+++|+.|++++|..-..+|..+ +++
T Consensus 627 ~~~~~~l~~Lk~L~Ls~~~~l~~ip-~ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i-~l~ 704 (1153)
T PLN03210 627 WDGVHSLTGLRNIDLRGSKNLKEIP-DLSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGI-NLK 704 (1153)
T ss_pred ccccccCCCCCEEECCCCCCcCcCC-ccccCCcccEEEecCCCCccccchhhhccCCCCEEeCCCCCCcCccCCcC-CCC
Confidence 5556667777777776654333444 36666677777776665444566666667777777776653222334333 566
Q ss_pred CCcEeeccCcccccCCCccccCCCCcceeecccccccCCCCCCCcCCCcCCeEEcccCcCcCCCCccccccCCCCeEecC
Q 044366 190 SLTVMSLFNNSLSGSIPPILGNLKSLSTLGLHINQLNGVIPPSIGNLSSLRNLSLFNNRLYGFVPKEIGYLKSLSKLEFC 269 (918)
Q Consensus 190 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~l~ 269 (918)
+|+.|++++|......|.. ..+|++|++++|.++. .|..+ .+++|++|+++++..... ..
T Consensus 705 sL~~L~Lsgc~~L~~~p~~---~~nL~~L~L~~n~i~~-lP~~~-~l~~L~~L~l~~~~~~~l-~~-------------- 764 (1153)
T PLN03210 705 SLYRLNLSGCSRLKSFPDI---STNISWLDLDETAIEE-FPSNL-RLENLDELILCEMKSEKL-WE-------------- 764 (1153)
T ss_pred CCCEEeCCCCCCccccccc---cCCcCeeecCCCcccc-ccccc-cccccccccccccchhhc-cc--------------
Confidence 6677777666543333432 2456666666666653 23332 355566666555332111 00
Q ss_pred CCccCCcCCCcCCCCCCCcEEEccCCcCcCCCCccccCCCCCCeEEeeccc-ccCccccccCCCCCccEEeCCCCccccc
Q 044366 270 ANHLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLRNLTSLERVRFNQNN-LYGKVYEAFGDHPNLTFLDLSQNNFYCE 348 (918)
Q Consensus 270 ~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~-l~~~~~~~~~~l~~L~~L~Ls~N~l~~~ 348 (918)
.+....+..+...++|+.|++++|.....+|..+.++++|+.|++++|. +..++.. . .+++|+.|++++|...
T Consensus 765 --~~~~l~~~~~~~~~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~-~-~L~sL~~L~Ls~c~~L-- 838 (1153)
T PLN03210 765 --RVQPLTPLMTMLSPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTG-I-NLESLESLDLSGCSRL-- 838 (1153)
T ss_pred --cccccchhhhhccccchheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCC-C-CccccCEEECCCCCcc--
Confidence 0011111112223456666666665555566666666666666666653 3333222 1 4566777777665321
Q ss_pred cCcccccccccceeeccccccccCCCcCcCCCCCCcEEEccCceeccccccchhhccccCceecccccccCCCCCCCCCC
Q 044366 349 ISFNWRNFSKLGTFNASMNNIYGSIPPEIGDSSKLQVLDLSSNHIFGKIPVQLVKLFSLNKLILSLNQLFGGVPLEFGTL 428 (918)
Q Consensus 349 ~~~~~~~~~~L~~l~l~~n~i~~~~~~~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l 428 (918)
..+|.. .++|+.|+|++|.|+ .+|..+..+++|+.|+|++|+--..+|..+..+
T Consensus 839 ----------------------~~~p~~---~~nL~~L~Ls~n~i~-~iP~si~~l~~L~~L~L~~C~~L~~l~~~~~~L 892 (1153)
T PLN03210 839 ----------------------RTFPDI---STNISDLNLSRTGIE-EVPWWIEKFSNLSFLDMNGCNNLQRVSLNISKL 892 (1153)
T ss_pred ----------------------cccccc---ccccCEeECCCCCCc-cChHHHhcCCCCCEEECCCCCCcCccCcccccc
Confidence 111211 245667777777765 456666777777777777643323455566777
Q ss_pred CcccEEeccCcc
Q 044366 429 TELQYLDLSANK 440 (918)
Q Consensus 429 ~~L~~L~Ls~N~ 440 (918)
++|+.|++++|.
T Consensus 893 ~~L~~L~l~~C~ 904 (1153)
T PLN03210 893 KHLETVDFSDCG 904 (1153)
T ss_pred cCCCeeecCCCc
Confidence 788888887763
|
syringae 6; Provisional |
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.2e-24 Score=212.10 Aligned_cols=165 Identities=21% Similarity=0.208 Sum_probs=125.8
Q ss_pred CChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccCCCCCCce
Q 044366 731 GSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWT 810 (918)
Q Consensus 731 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~~~~~~~~ 810 (918)
|+|.++++.. ...+++.+++.|+.|++.||+|||+. + ||+||+++.++.+++ ||.+.......
T Consensus 1 GsL~~~l~~~--~~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~~~---- 63 (176)
T smart00750 1 VSLADILEVR--GRPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTPEQ---- 63 (176)
T ss_pred CcHHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeecccc----
Confidence 6899999764 24589999999999999999999998 5 999999999999999 99998765432
Q ss_pred ecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCCCCCcchHHHH--
Q 044366 811 EFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRDVTDKL-- 888 (918)
Q Consensus 811 ~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 888 (918)
..|++.|+|||++.+..++.++|||||||++|||++|+.||................. ....+..........
T Consensus 64 -~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~ 138 (176)
T smart00750 64 -SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGM----PADDPRDRSNLESVSAA 138 (176)
T ss_pred -CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHh----ccCCccccccHHHHHhh
Confidence 2578999999999999999999999999999999999999865433222111111111 111111111111222
Q ss_pred HHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 044366 889 RSIMEVAILCLVENPEARPTMKEVCNLLC 917 (918)
Q Consensus 889 ~~l~~li~~cl~~dp~~RPt~~evl~~L~ 917 (918)
..+.+++.+||..||++||++.|+++.+.
T Consensus 139 ~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~ 167 (176)
T smart00750 139 RSFADFMRVCASRLPQRREAANHYLAHCR 167 (176)
T ss_pred hhHHHHHHHHHhcccccccCHHHHHHHHH
Confidence 25899999999999999999999998753
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.3e-25 Score=266.75 Aligned_cols=194 Identities=18% Similarity=0.226 Sum_probs=139.8
Q ss_pred hccC-CceeeEeccc-------ccCCceEEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCe
Q 044366 702 EIRH-RNIIKFHGFC-------SNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPI 773 (918)
Q Consensus 702 ~l~h-~niv~~~~~~-------~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i 773 (918)
.++| +||+++++++ ...+..+.++||++ ++|.++++.. ...+++.+++.++.||++||+|||+. +|
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~-~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~---gI 101 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECED-VSLRQWLDNP--DRSVDAFECFHVFRQIVEIVNAAHSQ---GI 101 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccCC-ccHHHHHhcc--cccccHHHHHHHHHHHHHHHHHHHhC---Ce
Confidence 4456 6888888877 22346778899884 5999999753 34589999999999999999999999 99
Q ss_pred EEcCCCCCCeeeCC-------------------CCcEEEeccccccccCCCCC----------------Cceeccccccc
Q 044366 774 VHRDISSKNVLLDS-------------------EYEAHVSDFGFAKFLEPHSS----------------NWTEFAGTVGY 818 (918)
Q Consensus 774 vH~dlk~~Nill~~-------------------~~~~kl~DfG~~~~~~~~~~----------------~~~~~~g~~~y 818 (918)
+||||||+|||++. ++.+|++|||+++....... ......||+.|
T Consensus 102 vHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y 181 (793)
T PLN00181 102 VVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWY 181 (793)
T ss_pred eeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcce
Confidence 99999999999964 34566667776654321000 00113578889
Q ss_pred ccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCCCCCcchHHHHHHHHHHHHHc
Q 044366 819 AAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRDVTDKLRSIMEVAILC 898 (918)
Q Consensus 819 ~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 898 (918)
||||++.+..++.++|||||||++|||++|..|+........... ... .++ ..........+++.+|
T Consensus 182 ~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~~~~~~~------~~~----~~~---~~~~~~~~~~~~~~~~ 248 (793)
T PLN00181 182 TSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSRTMSSLR------HRV----LPP---QILLNWPKEASFCLWL 248 (793)
T ss_pred EChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHHHHHHHH------Hhh----cCh---hhhhcCHHHHHHHHHh
Confidence 999999999999999999999999999999888543221111110 011 111 0111223456778899
Q ss_pred ccCCCCCCCCHHHHHH
Q 044366 899 LVENPEARPTMKEVCN 914 (918)
Q Consensus 899 l~~dp~~RPt~~evl~ 914 (918)
|+.+|.+||++.|+++
T Consensus 249 L~~~P~~Rps~~eil~ 264 (793)
T PLN00181 249 LHPEPSCRPSMSELLQ 264 (793)
T ss_pred CCCChhhCcChHHHhh
Confidence 9999999999999975
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.91 E-value=2e-23 Score=261.52 Aligned_cols=345 Identities=22% Similarity=0.242 Sum_probs=197.8
Q ss_pred cCCCCCCCCceeecccccc------ccCCCccccccc-ccCeeeccccccCCcCCccCCCCCCCcEeeccCcccccCCCc
Q 044366 135 CSLDNLSNLDTLFLYKNSL------SGPIPSVIGNLK-SLLQLDLSENRLSGLIPLSLSNLSSLTVMSLFNNSLSGSIPP 207 (918)
Q Consensus 135 ~~l~~l~~L~~L~L~~n~l------~~~~~~~~~~l~-~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~ 207 (918)
.+|.+|.+|+.|.++.+.. ....|+.|..++ +|+.|++.+|.++.+ |..| ...+|+.|+|++|++. .++.
T Consensus 552 ~aF~~m~~L~~L~~~~~~~~~~~~~~~~lp~~~~~lp~~Lr~L~~~~~~l~~l-P~~f-~~~~L~~L~L~~s~l~-~L~~ 628 (1153)
T PLN03210 552 NAFKGMRNLLFLKFYTKKWDQKKEVRWHLPEGFDYLPPKLRLLRWDKYPLRCM-PSNF-RPENLVKLQMQGSKLE-KLWD 628 (1153)
T ss_pred HHHhcCccccEEEEecccccccccceeecCcchhhcCcccEEEEecCCCCCCC-CCcC-CccCCcEEECcCcccc-cccc
Confidence 3445555555555544321 112334444432 356666665555543 3333 3455666666666655 3444
Q ss_pred cccCCCCcceeecccccccCCCCCCCcCCCcCCeEEcccCcCcCCCCccccccCCCCeEecCCCccCCcCCCcCCCCCCC
Q 044366 208 ILGNLKSLSTLGLHINQLNGVIPPSIGNLSSLRNLSLFNNRLYGFVPKEIGYLKSLSKLEFCANHLSGVIPHSVGNLTGL 287 (918)
Q Consensus 208 ~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L 287 (918)
.+..+++|+.|+|+++.....+| .++.+++|+.|+|++|......|..+..+++|+.|++++|...+..|..+ ++++|
T Consensus 629 ~~~~l~~Lk~L~Ls~~~~l~~ip-~ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i-~l~sL 706 (1153)
T PLN03210 629 GVHSLTGLRNIDLRGSKNLKEIP-DLSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGI-NLKSL 706 (1153)
T ss_pred ccccCCCCCEEECCCCCCcCcCC-ccccCCcccEEEecCCCCccccchhhhccCCCCEEeCCCCCCcCccCCcC-CCCCC
Confidence 55556666666665544222333 35555666666666655444555556666666666666654333444333 55666
Q ss_pred cEEEccCCcCcCCCCccccCCCCCCeEEeecccccCccccccCCCCCccEEeCCCCccccccCcccccccccceeecccc
Q 044366 288 VLLNMCENHLFGPIPKSLRNLTSLERVRFNQNNLYGKVYEAFGDHPNLTFLDLSQNNFYCEISFNWRNFSKLGTFNASMN 367 (918)
Q Consensus 288 ~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~n 367 (918)
+.|++++|.....+|.. ..+|++|++++|.+..++... .+++|+.|++.++...... +
T Consensus 707 ~~L~Lsgc~~L~~~p~~---~~nL~~L~L~~n~i~~lP~~~--~l~~L~~L~l~~~~~~~l~-----------------~ 764 (1153)
T PLN03210 707 YRLNLSGCSRLKSFPDI---STNISWLDLDETAIEEFPSNL--RLENLDELILCEMKSEKLW-----------------E 764 (1153)
T ss_pred CEEeCCCCCCccccccc---cCCcCeeecCCCccccccccc--cccccccccccccchhhcc-----------------c
Confidence 66666666544444432 245566666666665544321 3455666665543321100 0
Q ss_pred ccccCCCcCcCCCCCCcEEEccCceeccccccchhhccccCceecccccccCCCCCCCCCCCcccEEeccCccccccCcc
Q 044366 368 NIYGSIPPEIGDSSKLQVLDLSSNHIFGKIPVQLVKLFSLNKLILSLNQLFGGVPLEFGTLTELQYLDLSANKLSSSIPM 447 (918)
Q Consensus 368 ~i~~~~~~~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~ 447 (918)
.+....+..+...++|+.|+|++|.....+|..+.++++|+.|++++|...+.+|..+ .+++|++|+|++|..-..+|.
T Consensus 765 ~~~~l~~~~~~~~~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~-~L~sL~~L~Ls~c~~L~~~p~ 843 (1153)
T PLN03210 765 RVQPLTPLMTMLSPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGI-NLESLESLDLSGCSRLRTFPD 843 (1153)
T ss_pred cccccchhhhhccccchheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCC-CccccCEEECCCCCccccccc
Confidence 1111111222334567777777776666677777777778888887765444555544 677888888888754434443
Q ss_pred ccccccccceecccCcccCCCCchhhccccccceEeccC-CcCCCCCchhccccCCcceEecCCCc
Q 044366 448 SIGNLLKLHYLNLSNNQFSHKIPTEFEKLIHLSELDLSH-NILQEEIPPQICKMESLEKLNLSHNN 512 (918)
Q Consensus 448 ~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~-N~l~~~~~~~~~~l~~L~~L~L~~N~ 512 (918)
. .++|+.|+|++|.|+ .+|..+..+++|+.|+|++ |+++ .+|..+..+++|+.|++++|.
T Consensus 844 ~---~~nL~~L~Ls~n~i~-~iP~si~~l~~L~~L~L~~C~~L~-~l~~~~~~L~~L~~L~l~~C~ 904 (1153)
T PLN03210 844 I---STNISDLNLSRTGIE-EVPWWIEKFSNLSFLDMNGCNNLQ-RVSLNISKLKHLETVDFSDCG 904 (1153)
T ss_pred c---ccccCEeECCCCCCc-cChHHHhcCCCCCEEECCCCCCcC-ccCcccccccCCCeeecCCCc
Confidence 2 357888888888886 5677888888888888888 4565 466677788888888888774
|
syringae 6; Provisional |
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=4.8e-23 Score=238.39 Aligned_cols=263 Identities=27% Similarity=0.388 Sum_probs=150.7
Q ss_pred CCEEeCCCCcccccCCccccCCCCCCEEEcccccccccCCCCcCCCCCCCEEEcccccccccCCccccCCCCCCEEEccC
Q 044366 23 LQYLDLGNNQLSGVIPPEIGKLNQLRRLYLDVNQLHGTIPPVIGQLSLINELVFCHNNVSGRIPSSLGNLSNLALLYLND 102 (918)
Q Consensus 23 L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~l~~l~~L~~L~L~~ 102 (918)
-..|+|++++++ .+|..+. .+|+.|++++|+++ .+|.. +++|++|++++|+++ .+|.. .++|+.|++++
T Consensus 203 ~~~LdLs~~~Lt-sLP~~l~--~~L~~L~L~~N~Lt-~LP~l---p~~Lk~LdLs~N~Lt-sLP~l---p~sL~~L~Ls~ 271 (788)
T PRK15387 203 NAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPAL---PPELRTLEVSGNQLT-SLPVL---PPGLLELSIFS 271 (788)
T ss_pred CcEEEcCCCCCC-cCCcchh--cCCCEEEccCCcCC-CCCCC---CCCCcEEEecCCccC-cccCc---ccccceeeccC
Confidence 445666666665 4555554 25666666666665 44532 355666666666665 34432 24566666666
Q ss_pred CcccccCccccCCCCCCCEEECcCCcCCCcCCcCCCCCCCCceeeccccccccCCCcccccccccCeeeccccccCCcCC
Q 044366 103 NSLFGSIPIVMGNLKSLSTLDLSQNQLNGSIPCSLDNLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSENRLSGLIP 182 (918)
Q Consensus 103 n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~ 182 (918)
|.+. .+|..+ .+|+.|++++|+++ .+|. .+++|+.|+|++|+++++ |.. ..+|+.|++++|.++++ |
T Consensus 272 N~L~-~Lp~lp---~~L~~L~Ls~N~Lt-~LP~---~p~~L~~LdLS~N~L~~L-p~l---p~~L~~L~Ls~N~L~~L-P 338 (788)
T PRK15387 272 NPLT-HLPALP---SGLCKLWIFGNQLT-SLPV---LPPGLQELSVSDNQLASL-PAL---PSELCKLWAYNNQLTSL-P 338 (788)
T ss_pred Cchh-hhhhch---hhcCEEECcCCccc-cccc---cccccceeECCCCccccC-CCC---cccccccccccCccccc-c
Confidence 6665 233322 45666666666666 3333 234566666666666643 221 13456666666666653 2
Q ss_pred ccCCCCCCCcEeeccCcccccCCCccccCCCCcceeecccccccCCCCCCCcCCCcCCeEEcccCcCcCCCCccccccCC
Q 044366 183 LSLSNLSSLTVMSLFNNSLSGSIPPILGNLKSLSTLGLHINQLNGVIPPSIGNLSSLRNLSLFNNRLYGFVPKEIGYLKS 262 (918)
Q Consensus 183 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~ 262 (918)
. + ..+|+.|+|++|+|+. +|.. ..+|+.|++++|+|+. +|.. .++|+.|++++|+++.+ |.. .++
T Consensus 339 ~-l--p~~Lq~LdLS~N~Ls~-LP~l---p~~L~~L~Ls~N~L~~-LP~l---~~~L~~LdLs~N~Lt~L-P~l---~s~ 403 (788)
T PRK15387 339 T-L--PSGLQELSVSDNQLAS-LPTL---PSELYKLWAYNNRLTS-LPAL---PSGLKELIVSGNRLTSL-PVL---PSE 403 (788)
T ss_pred c-c--ccccceEecCCCccCC-CCCC---Ccccceehhhcccccc-Cccc---ccccceEEecCCcccCC-CCc---ccC
Confidence 2 1 1356677777777664 3332 2356666777777664 3322 24577777777777643 222 256
Q ss_pred CCeEecCCCccCCcCCCcCCCCCCCcEEEccCCcCcCCCCccccCCCCCCeEEeecccccCcccccc
Q 044366 263 LSKLEFCANHLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLRNLTSLERVRFNQNNLYGKVYEAF 329 (918)
Q Consensus 263 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~ 329 (918)
|+.|++++|++..+ |.. ..+|+.|++++|+++ .+|..+.++++|+.|++++|++....+..+
T Consensus 404 L~~LdLS~N~LssI-P~l---~~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~N~Ls~~~~~~L 465 (788)
T PRK15387 404 LKELMVSGNRLTSL-PML---PSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQAL 465 (788)
T ss_pred CCEEEccCCcCCCC-Ccc---hhhhhhhhhccCccc-ccChHHhhccCCCeEECCCCCCCchHHHHH
Confidence 77777777777643 332 235667777777776 467777777777778887777766544444
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=4.7e-24 Score=204.92 Aligned_cols=245 Identities=20% Similarity=0.328 Sum_probs=180.8
Q ss_pred ceeeccccceEEEEEEeCCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEEEEEeccC
Q 044366 651 KYCIGKGGQRSVYKAELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFIVCEYLAR 730 (918)
Q Consensus 651 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 730 (918)
..+|.+.-.|..|+|+++ |..+++|++..... .....++|..|.-.++-+.||||.+++|.|..+....++..||+.
T Consensus 195 ~tkl~e~hsgelwrgrwq-gndivakil~vr~~--t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~ 271 (448)
T KOG0195|consen 195 ITKLAESHSGELWRGRWQ-GNDIVAKILNVREV--TARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPF 271 (448)
T ss_pred hhhhccCCCccccccccc-Ccchhhhhhhhhhc--chhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccc
Confidence 345788889999999995 55566777654322 223346899999999999999999999999999999999999999
Q ss_pred CChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeE-EcCCCCCCeeeCCCCcEEEe--ccccccccCCCCC
Q 044366 731 GSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIV-HRDISSKNVLLDSEYEAHVS--DFGFAKFLEPHSS 807 (918)
Q Consensus 731 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iv-H~dlk~~Nill~~~~~~kl~--DfG~~~~~~~~~~ 807 (918)
|+|...+++.. .-..+-.+..+++.++|+|++|||+-. +++ ---+.++.|++|++.+++|+ |--++- . .
T Consensus 272 gslynvlhe~t-~vvvd~sqav~faldiargmaflhsle--p~ipr~~lns~hvmidedltarismad~kfsf--q-e-- 343 (448)
T KOG0195|consen 272 GSLYNVLHEQT-SVVVDHSQAVRFALDIARGMAFLHSLE--PMIPRFYLNSKHVMIDEDLTARISMADTKFSF--Q-E-- 343 (448)
T ss_pred hHHHHHHhcCc-cEEEecchHHHHHHHHHhhHHHHhhcc--hhhhhhhcccceEEecchhhhheecccceeee--e-c--
Confidence 99999998764 334577889999999999999999974 444 34689999999999988874 322211 1 0
Q ss_pred CceecccccccccccccccCCCC---cccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCCCCCcch
Q 044366 808 NWTEFAGTVGYAAPELAYTMRAT---EKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRDV 884 (918)
Q Consensus 808 ~~~~~~g~~~y~aPE~~~~~~~~---~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 884 (918)
....-.+.||+||.+...+.+ .++|+|||++++||+.|...||...... ...+.-.+..-....++..
T Consensus 344 --~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspm-------ecgmkialeglrv~ippgi 414 (448)
T KOG0195|consen 344 --VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPM-------ECGMKIALEGLRVHIPPGI 414 (448)
T ss_pred --cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCch-------hhhhhhhhccccccCCCCc
Confidence 112236889999999766543 5789999999999999999998654431 1111111111111111222
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhC
Q 044366 885 TDKLRSIMEVAILCLVENPEARPTMKEVCNLLCK 918 (918)
Q Consensus 885 ~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~ 918 (918)
. ..+.+++.-|+.+||.+||.++.|+-.|+|
T Consensus 415 s---~hm~klm~icmnedpgkrpkfdmivpilek 445 (448)
T KOG0195|consen 415 S---RHMNKLMNICMNEDPGKRPKFDMIVPILEK 445 (448)
T ss_pred c---HHHHHHHHHHhcCCCCcCCCcceehhhHHH
Confidence 2 345666777999999999999999988875
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=5.4e-22 Score=229.73 Aligned_cols=258 Identities=27% Similarity=0.361 Sum_probs=138.5
Q ss_pred CCCEEEcccccccccCCCCcCCCCCCCEEEcccccccccCCccccCCCCCCEEEccCCcccccCccccCCCCCCCEEECc
Q 044366 46 QLRRLYLDVNQLHGTIPPVIGQLSLINELVFCHNNVSGRIPSSLGNLSNLALLYLNDNSLFGSIPIVMGNLKSLSTLDLS 125 (918)
Q Consensus 46 ~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~l~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls 125 (918)
.-.+|+|+.|+++ .+|+.+. .+|+.|++.+|+++ .+|.. .++|++|+|++|+|+. +|.. .++|+.|+++
T Consensus 202 ~~~~LdLs~~~Lt-sLP~~l~--~~L~~L~L~~N~Lt-~LP~l---p~~Lk~LdLs~N~Lts-LP~l---p~sL~~L~Ls 270 (788)
T PRK15387 202 GNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPAL---PPELRTLEVSGNQLTS-LPVL---PPGLLELSIF 270 (788)
T ss_pred CCcEEEcCCCCCC-cCCcchh--cCCCEEEccCCcCC-CCCCC---CCCCcEEEecCCccCc-ccCc---ccccceeecc
Confidence 3455666666666 5666554 35666666666666 34432 3566666666666653 3322 2456666666
Q ss_pred CCcCCCcCCcCCCCCCCCceeeccccccccCCCcccccccccCeeeccccccCCcCCccCCCCCCCcEeeccCcccccCC
Q 044366 126 QNQLNGSIPCSLDNLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSENRLSGLIPLSLSNLSSLTVMSLFNNSLSGSI 205 (918)
Q Consensus 126 ~n~i~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 205 (918)
+|.++ .+|..+ ++|+.|++++|+++.+ |. .+++|+.|+|++|+++++ |.. ..+|+.|++++|+++. +
T Consensus 271 ~N~L~-~Lp~lp---~~L~~L~Ls~N~Lt~L-P~---~p~~L~~LdLS~N~L~~L-p~l---p~~L~~L~Ls~N~L~~-L 337 (788)
T PRK15387 271 SNPLT-HLPALP---SGLCKLWIFGNQLTSL-PV---LPPGLQELSVSDNQLASL-PAL---PSELCKLWAYNNQLTS-L 337 (788)
T ss_pred CCchh-hhhhch---hhcCEEECcCCccccc-cc---cccccceeECCCCccccC-CCC---cccccccccccCcccc-c
Confidence 66665 233322 3455666666666643 22 135566666666666654 221 1345566666666653 3
Q ss_pred CccccCCCCcceeecccccccCCCCCCCcCCCcCCeEEcccCcCcCCCCccccccCCCCeEecCCCccCCcCCCcCCCCC
Q 044366 206 PPILGNLKSLSTLGLHINQLNGVIPPSIGNLSSLRNLSLFNNRLYGFVPKEIGYLKSLSKLEFCANHLSGVIPHSVGNLT 285 (918)
Q Consensus 206 ~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~ 285 (918)
|.. ..+|+.|+|++|+|+.+ |.. .++|+.|++++|+|+.+ |.. ..+|+.|++++|++.++ |.. .+
T Consensus 338 P~l---p~~Lq~LdLS~N~Ls~L-P~l---p~~L~~L~Ls~N~L~~L-P~l---~~~L~~LdLs~N~Lt~L-P~l---~s 402 (788)
T PRK15387 338 PTL---PSGLQELSVSDNQLASL-PTL---PSELYKLWAYNNRLTSL-PAL---PSGLKELIVSGNRLTSL-PVL---PS 402 (788)
T ss_pred ccc---ccccceEecCCCccCCC-CCC---CcccceehhhccccccC-ccc---ccccceEEecCCcccCC-CCc---cc
Confidence 321 13566666666666643 221 23556666666666643 221 24566666666666642 222 24
Q ss_pred CCcEEEccCCcCcCCCCccccCCCCCCeEEeecccccCccccccCCCCCccEEeCCCCcccc
Q 044366 286 GLVLLNMCENHLFGPIPKSLRNLTSLERVRFNQNNLYGKVYEAFGDHPNLTFLDLSQNNFYC 347 (918)
Q Consensus 286 ~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~ 347 (918)
+|+.|++++|++.. +|... .+|+.|++++|+|+.++ ..+..+++|+.|+|++|+|+.
T Consensus 403 ~L~~LdLS~N~Lss-IP~l~---~~L~~L~Ls~NqLt~LP-~sl~~L~~L~~LdLs~N~Ls~ 459 (788)
T PRK15387 403 ELKELMVSGNRLTS-LPMLP---SGLLSLSVYRNQLTRLP-ESLIHLSSETTVNLEGNPLSE 459 (788)
T ss_pred CCCEEEccCCcCCC-CCcch---hhhhhhhhccCcccccC-hHHhhccCCCeEECCCCCCCc
Confidence 56666666666653 34322 24555666666666543 335556666666666666653
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=3.1e-21 Score=209.20 Aligned_cols=255 Identities=24% Similarity=0.286 Sum_probs=187.4
Q ss_pred CCCCceeeccccceEEEEEEeCC--CCEEEEEEcccccccCCCCChHHHHHHHHHHhhccC----CceeeEeccc-ccCC
Q 044366 647 NFGEKYCIGKGGQRSVYKAELPS--GNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRH----RNIIKFHGFC-SNAQ 719 (918)
Q Consensus 647 ~~~~~~~lg~G~~g~Vy~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h----~niv~~~~~~-~~~~ 719 (918)
+|.+.+.||+|+||.||.|.... ...+|+|......... ...+..|+.++..+.. +++..+++.. ..+.
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~----~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~ 94 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSK----PSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTED 94 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCC----CccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCc
Confidence 79999999999999999996544 3578888866532111 1257888888888863 6889999888 5778
Q ss_pred ceEEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCC-----CcEEEe
Q 044366 720 HSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSE-----YEAHVS 794 (918)
Q Consensus 720 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~-----~~~kl~ 794 (918)
..++||+.. |.+|.+..+... .+.++..++.+|+.|++.+|+++|+. |++||||||.|+++... ..+++.
T Consensus 95 ~~~iVM~l~-G~sL~dl~~~~~-~~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~~~~~~~~ll 169 (322)
T KOG1164|consen 95 FNFIVMSLL-GPSLEDLRKRNP-PGRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSRSEVRTLYLL 169 (322)
T ss_pred eeEEEEecc-CccHHHHHHhCC-CCCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCCcccceEEEE
Confidence 899999977 569999886655 56799999999999999999999999 99999999999999765 358999
Q ss_pred cccccc--ccCCCCC--------CceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhh
Q 044366 795 DFGFAK--FLEPHSS--------NWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISN 864 (918)
Q Consensus 795 DfG~~~--~~~~~~~--------~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~ 864 (918)
|||+++ .+..... ......||.+|++++++.+...+.+.|+||++.++.|+..|..||........ ...
T Consensus 170 DfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~-~~~ 248 (322)
T KOG1164|consen 170 DFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDL-KSK 248 (322)
T ss_pred ecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccch-HHH
Confidence 999999 3322211 11234599999999999999999999999999999999999999865443211 111
Q ss_pred hHhhhhhhcccCCCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 044366 865 MIIEVNQILDHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLLC 917 (918)
Q Consensus 865 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 917 (918)
............ .....+. .+.++...+-..+..++|....+...++
T Consensus 249 ~~~~~~~~~~~~---~~~~~~~---~~~~~~~~~~~~~~~~~Pdy~~~~~~l~ 295 (322)
T KOG1164|consen 249 FEKDPRKLLTDR---FGDLKPE---EFAKILEYIDSLDYEDKPDYEKLAELLK 295 (322)
T ss_pred HHHHhhhhcccc---ccCCChH---HHHHHHHHhhccCCcCCCCHHHHHHHHH
Confidence 111111111110 1111222 3444444455578999999998877653
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=7.1e-22 Score=212.12 Aligned_cols=170 Identities=19% Similarity=0.199 Sum_probs=131.1
Q ss_pred HHHHHhcCCCCceeeccccceEEEEEEeC--CCCEEEEEEccccccc-CCCCChHHHHHHHHHHhhccCCceee-Eeccc
Q 044366 640 EITKATGNFGEKYCIGKGGQRSVYKAELP--SGNIFAVKKFKAELFS-DETANPSEFLNEVLALTEIRHRNIIK-FHGFC 715 (918)
Q Consensus 640 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~-~~~~~ 715 (918)
......++|...+.||+|+||.||+|... +++.||||++...... ......+.|.+|++++++++|+|+++ ++++
T Consensus 12 ~~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~- 90 (365)
T PRK09188 12 QIPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT- 90 (365)
T ss_pred ccccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc-
Confidence 34456688999999999999999999654 5778899986532110 01122467999999999999999985 4442
Q ss_pred ccCCceEEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCC-CCCCeeeCCCCcEEEe
Q 044366 716 SNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDI-SSKNVLLDSEYEAHVS 794 (918)
Q Consensus 716 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl-k~~Nill~~~~~~kl~ 794 (918)
+..++||||+++++|... ... . ...++.++++||+|||+. ||+|||| ||+||+++.++.+||+
T Consensus 91 ---~~~~LVmE~~~G~~L~~~-~~~------~---~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~~~~~ikLi 154 (365)
T PRK09188 91 ---GKDGLVRGWTEGVPLHLA-RPH------G---DPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMGPDGEAAVI 154 (365)
T ss_pred ---CCcEEEEEccCCCCHHHh-Ccc------c---hHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEcCCCCEEEE
Confidence 457999999999999632 110 1 146788999999999999 9999999 9999999999999999
Q ss_pred ccccccccCCCCCC--------ceeccccccccccccccc
Q 044366 795 DFGFAKFLEPHSSN--------WTEFAGTVGYAAPELAYT 826 (918)
Q Consensus 795 DfG~~~~~~~~~~~--------~~~~~g~~~y~aPE~~~~ 826 (918)
|||+|+.+...... .....+++.|+|||.+..
T Consensus 155 DFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 155 DFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred ECccceecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence 99999977554321 124567888999998864
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=3.9e-21 Score=182.24 Aligned_cols=203 Identities=20% Similarity=0.294 Sum_probs=171.1
Q ss_pred HHhcCCCCceeeccccceEEEEE-EeCCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccC-CceeeEecccccCCc
Q 044366 643 KATGNFGEKYCIGKGGQRSVYKA-ELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRH-RNIIKFHGFCSNAQH 720 (918)
Q Consensus 643 ~~~~~~~~~~~lg~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~~~~~~~~~~~ 720 (918)
...+.|..+++||.|+||.+|.| ...+|+.||||.-+.. +...+...|..+.+.+++ ..|..+..|..+..+
T Consensus 12 iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~------a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~y 85 (341)
T KOG1163|consen 12 IVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSK------AKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDY 85 (341)
T ss_pred eeccceEEEEeecCCchhheeeeeeccCCceEEEEeeccc------CCCcchhHHHHHHHHhccCCCCchhhhhcccccc
Confidence 34578999999999999999999 5678999999986542 223467889999999975 778888888899999
Q ss_pred eEEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCC---CcEEEeccc
Q 044366 721 SFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSE---YEAHVSDFG 797 (918)
Q Consensus 721 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~---~~~kl~DfG 797 (918)
-.+||+.. |.+|++.+.-. .+.++.++++-.|-|++.-++|+|.+ +++||||||+|+++.-+ ..+.++|||
T Consensus 86 nvlVMdLL-GPsLEdLfnfC--~R~ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~kl~LIDFG 159 (341)
T KOG1163|consen 86 NVLVMDLL-GPSLEDLFNFC--SRRFTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCNKLYLIDFG 159 (341)
T ss_pred ceeeeecc-CccHHHHHHHH--hhhhhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccceEEEEecc
Confidence 99999988 56999988654 34589999999999999999999999 99999999999998643 468999999
Q ss_pred cccccCCCCCC-------ceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchh
Q 044366 798 FAKFLEPHSSN-------WTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVST 857 (918)
Q Consensus 798 ~~~~~~~~~~~-------~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~ 857 (918)
+|+.+.+.... .....||.+|.+-....+..-+.+.|+-|+|.++...--|..||+....
T Consensus 160 LaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka 226 (341)
T KOG1163|consen 160 LAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKA 226 (341)
T ss_pred chhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccch
Confidence 99987654332 2456799999999988888888899999999999999999999986654
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.84 E-value=9.9e-22 Score=225.40 Aligned_cols=255 Identities=20% Similarity=0.234 Sum_probs=187.0
Q ss_pred CceeeccccceEEEEE-EeCCCCEEEEEEcccc--cccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEEEEE
Q 044366 650 EKYCIGKGGQRSVYKA-ELPSGNIFAVKKFKAE--LFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFIVCE 726 (918)
Q Consensus 650 ~~~~lg~G~~g~Vy~~-~~~~~~~vavK~~~~~--~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 726 (918)
...++|.|++|.|+.+ +.......+.|.++.. ...........+..|+.+-+.++|||++..+..+.+.....-+||
T Consensus 322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE 401 (601)
T KOG0590|consen 322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME 401 (601)
T ss_pred ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence 4567999999988887 4445555666654421 001111111225667777888999999998888877766666699
Q ss_pred eccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccCCCC
Q 044366 727 YLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHS 806 (918)
Q Consensus 727 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~~~~ 806 (918)
|+++ +|..++.+. ..++..++-.+++|+..|++|+|+. |+.|||+|++|++++.+|.+||+|||.+....-+.
T Consensus 402 ~~~~-Dlf~~~~~~---~~~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~ 474 (601)
T KOG0590|consen 402 YCPY-DLFSLVMSN---GKLTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTENGILKIIDFGAASVFRYPW 474 (601)
T ss_pred cccH-HHHHHHhcc---cccchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecCCceEEeecCcceeeccCc
Confidence 9999 999998764 3478889999999999999999999 99999999999999999999999999998765433
Q ss_pred C----CceecccccccccccccccCCCCc-ccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCCCCC
Q 044366 807 S----NWTEFAGTVGYAAPELAYTMRATE-KYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPS 881 (918)
Q Consensus 807 ~----~~~~~~g~~~y~aPE~~~~~~~~~-~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 881 (918)
. .....+|+..|+|||++.+..|++ ..||||.|++++.|.+|+.||................... .....+.
T Consensus 475 e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~---~~~~~~~ 551 (601)
T KOG0590|consen 475 EKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQR---NIFEGPN 551 (601)
T ss_pred chhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhcccccc---ccccChH
Confidence 2 235678999999999999999875 5799999999999999999987554332221000000000 0001111
Q ss_pred cchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 882 RDVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 882 ~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
.-..........++.+|++.||.+|-|+++|++
T Consensus 552 ~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 552 RLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred HHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 122233456778888999999999999999986
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=4.1e-20 Score=183.44 Aligned_cols=201 Identities=18% Similarity=0.264 Sum_probs=171.5
Q ss_pred hcCCCCceeeccccceEEEEE-EeCCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhc-cCCceeeEecccccCCceE
Q 044366 645 TGNFGEKYCIGKGGQRSVYKA-ELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEI-RHRNIIKFHGFCSNAQHSF 722 (918)
Q Consensus 645 ~~~~~~~~~lg~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~ 722 (918)
.-.|.+.++||+|.||+++.| .+-++++||||.-... ....+...|....+.+ ..+.|..++-+...+.+-.
T Consensus 27 G~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrk------S~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~Ni 100 (449)
T KOG1165|consen 27 GPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRK------SEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNI 100 (449)
T ss_pred cccceeccccccCcceeeecccccccCceEEEEecccc------CCcchHHHHHHHHHHHcCCCCCCceeeeccccchhh
Confidence 346899999999999999999 5678999999975432 2235678888888888 5799999998888888889
Q ss_pred EEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCC-----cEEEeccc
Q 044366 723 IVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEY-----EAHVSDFG 797 (918)
Q Consensus 723 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~-----~~kl~DfG 797 (918)
||+|.+ |-+|++.+.=. +++|+.+++..+|.|+..-++|+|++ .+|.|||||+|+|+...+ .+.++|||
T Consensus 101 LVidLL-GPSLEDLFD~C--gR~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFG 174 (449)
T KOG1165|consen 101 LVIDLL-GPSLEDLFDLC--GRRFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANVIHIIDFG 174 (449)
T ss_pred hhhhhh-CcCHHHHHHHh--cCcccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCceEEEEecc
Confidence 999988 56999988755 45699999999999999999999999 999999999999997543 48999999
Q ss_pred cccccCCCCCC-------ceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchh
Q 044366 798 FAKFLEPHSSN-------WTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVST 857 (918)
Q Consensus 798 ~~~~~~~~~~~-------~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~ 857 (918)
+|+.+.++... .....||.+||+-....+..-+.+.|.=|+|-+++..+-|..||+....
T Consensus 175 mAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA 241 (449)
T KOG1165|consen 175 MAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKA 241 (449)
T ss_pred chhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccC
Confidence 99988765432 2456799999999999999999999999999999999999999986543
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=3.5e-21 Score=224.88 Aligned_cols=247 Identities=25% Similarity=0.382 Sum_probs=170.6
Q ss_pred CCCCEEeCCCCcccccCCccccCCCCCCEEEcccccccccCCCCcCCCCCCCEEEcccccccccCCccccCCCCCCEEEc
Q 044366 21 SKLQYLDLGNNQLSGVIPPEIGKLNQLRRLYLDVNQLHGTIPPVIGQLSLINELVFCHNNVSGRIPSSLGNLSNLALLYL 100 (918)
Q Consensus 21 ~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~l~~l~~L~~L~L 100 (918)
.+.+.|++++++++ .+|..+. ++|+.|+|++|+++ .+|..+. .+|++|++++|+++ .+|..+. .+|+.|+|
T Consensus 178 ~~~~~L~L~~~~Lt-sLP~~Ip--~~L~~L~Ls~N~Lt-sLP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~L 248 (754)
T PRK15370 178 NNKTELRLKILGLT-TIPACIP--EQITTLILDNNELK-SLPENLQ--GNIKTLYANSNQLT-SIPATLP--DTIQEMEL 248 (754)
T ss_pred cCceEEEeCCCCcC-cCCcccc--cCCcEEEecCCCCC-cCChhhc--cCCCEEECCCCccc-cCChhhh--ccccEEEC
Confidence 35677888888777 5666554 46788888888877 6676554 47888888888777 5666554 46888888
Q ss_pred cCCcccccCccccCCCCCCCEEECcCCcCCCcCCcCCCCCCCCceeeccccccccCCCcccccccccCeeeccccccCCc
Q 044366 101 NDNSLFGSIPIVMGNLKSLSTLDLSQNQLNGSIPCSLDNLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSENRLSGL 180 (918)
Q Consensus 101 ~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~ 180 (918)
++|++. .+|..+. .+|+.|++++|+++ .+|..+. ++|+.|++++|+++.+ |..+. ++|+.|++++|+++.+
T Consensus 249 s~N~L~-~LP~~l~--s~L~~L~Ls~N~L~-~LP~~l~--~sL~~L~Ls~N~Lt~L-P~~lp--~sL~~L~Ls~N~Lt~L 319 (754)
T PRK15370 249 SINRIT-ELPERLP--SALQSLDLFHNKIS-CLPENLP--EELRYLSVYDNSIRTL-PAHLP--SGITHLNVQSNSLTAL 319 (754)
T ss_pred cCCccC-cCChhHh--CCCCEEECcCCccC-ccccccC--CCCcEEECCCCccccC-cccch--hhHHHHHhcCCccccC
Confidence 888876 4555553 47888888888887 4565554 4788888888888754 33332 4678888888888765
Q ss_pred CCccCCCCCCCcEeeccCcccccCCCccccCCCCcceeecccccccCCCCCCCcCCCcCCeEEcccCcCcCCCCcccccc
Q 044366 181 IPLSLSNLSSLTVMSLFNNSLSGSIPPILGNLKSLSTLGLHINQLNGVIPPSIGNLSSLRNLSLFNNRLYGFVPKEIGYL 260 (918)
Q Consensus 181 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l 260 (918)
|..+ .++|+.|++++|.+++ +|..+. ++|+.|++++|+++. +|..+ .++|+.|+|++|+++.+ |..+.
T Consensus 320 -P~~l--~~sL~~L~Ls~N~Lt~-LP~~l~--~sL~~L~Ls~N~L~~-LP~~l--p~~L~~LdLs~N~Lt~L-P~~l~-- 387 (754)
T PRK15370 320 -PETL--PPGLKTLEAGENALTS-LPASLP--PELQVLDVSKNQITV-LPETL--PPTITTLDVSRNALTNL-PENLP-- 387 (754)
T ss_pred -Cccc--cccceeccccCCcccc-CChhhc--CcccEEECCCCCCCc-CChhh--cCCcCEEECCCCcCCCC-CHhHH--
Confidence 3322 2578888888888875 454443 678888888888874 45444 25788888888888854 33332
Q ss_pred CCCCeEecCCCccCCcCCCc----CCCCCCCcEEEccCCcCc
Q 044366 261 KSLSKLEFCANHLSGVIPHS----VGNLTGLVLLNMCENHLF 298 (918)
Q Consensus 261 ~~L~~L~l~~n~l~~~~~~~----~~~l~~L~~L~l~~n~l~ 298 (918)
..|+.|++++|++..+ |.. +..++.+..|++.+|++.
T Consensus 388 ~sL~~LdLs~N~L~~L-P~sl~~~~~~~~~l~~L~L~~Npls 428 (754)
T PRK15370 388 AALQIMQASRNNLVRL-PESLPHFRGEGPQPTRIIVEYNPFS 428 (754)
T ss_pred HHHHHHhhccCCcccC-chhHHHHhhcCCCccEEEeeCCCcc
Confidence 3688888888888743 433 334577888888888876
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.2e-19 Score=200.48 Aligned_cols=260 Identities=26% Similarity=0.373 Sum_probs=196.4
Q ss_pred CCCceeeccccceEEEEEEeCCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCC-ceeeEecccccCCceEEEEE
Q 044366 648 FGEKYCIGKGGQRSVYKAELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHR-NIIKFHGFCSNAQHSFIVCE 726 (918)
Q Consensus 648 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~-niv~~~~~~~~~~~~~lv~e 726 (918)
|.....||.|+||.||++... ..+|+|.+........ .....|.+|+..++.+.|+ +++++.+++......+++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~-~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 78 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKS-KEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVME 78 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccch-hHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEe
Confidence 567788999999999999765 8899999876533221 2367899999999999988 79999999977777899999
Q ss_pred eccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCC-cEEEeccccccccCCC
Q 044366 727 YLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEY-EAHVSDFGFAKFLEPH 805 (918)
Q Consensus 727 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~-~~kl~DfG~~~~~~~~ 805 (918)
|+.++++.+++........++......++.|++.+++|+|+. +++|||+||+||+++..+ .++++|||.++.....
T Consensus 79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~ 155 (384)
T COG0515 79 YVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDP 155 (384)
T ss_pred cCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEEEeccCcceecCCC
Confidence 999999997776542112578899999999999999999999 999999999999999988 7999999999866544
Q ss_pred CC------Cceeccccccccccccccc---CCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhccc-
Q 044366 806 SS------NWTEFAGTVGYAAPELAYT---MRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDH- 875 (918)
Q Consensus 806 ~~------~~~~~~g~~~y~aPE~~~~---~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~- 875 (918)
.. ......|+..|+|||.+.+ ..+....|+|++|++++++++|..|+...... ................
T Consensus 156 ~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~-~~~~~~~~~~~~~~~~~ 234 (384)
T COG0515 156 GSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNS-SATSQTLKIILELPTPS 234 (384)
T ss_pred CccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCcc-ccHHHHHHHHHhcCCcc
Confidence 32 2356789999999999987 57888999999999999999999996544321 0000111111111111
Q ss_pred CCCCCCcch-HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 876 RLPTPSRDV-TDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 876 ~~~~~~~~~-~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
......... ......+.+++..|+..+|..|.++.+...
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~ 274 (384)
T COG0515 235 LASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLS 274 (384)
T ss_pred cccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhh
Confidence 000000000 122346778888999999999999887654
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=2.2e-20 Score=218.28 Aligned_cols=247 Identities=28% Similarity=0.461 Sum_probs=175.7
Q ss_pred CCCCEEEcccccccccCCCCcCCCCCCCEEEcccccccccCCccccCCCCCCEEEccCCcccccCccccCCCCCCCEEEC
Q 044366 45 NQLRRLYLDVNQLHGTIPPVIGQLSLINELVFCHNNVSGRIPSSLGNLSNLALLYLNDNSLFGSIPIVMGNLKSLSTLDL 124 (918)
Q Consensus 45 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~l~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L 124 (918)
.+...|++++++++ .+|..+. ..|+.|++++|+++ .+|..+. ++|+.|++++|+++ .+|..+. .+|+.|+|
T Consensus 178 ~~~~~L~L~~~~Lt-sLP~~Ip--~~L~~L~Ls~N~Lt-sLP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~L 248 (754)
T PRK15370 178 NNKTELRLKILGLT-TIPACIP--EQITTLILDNNELK-SLPENLQ--GNIKTLYANSNQLT-SIPATLP--DTIQEMEL 248 (754)
T ss_pred cCceEEEeCCCCcC-cCCcccc--cCCcEEEecCCCCC-cCChhhc--cCCCEEECCCCccc-cCChhhh--ccccEEEC
Confidence 35678888888887 6777664 57888888888888 5676654 58888888888887 4555443 47888888
Q ss_pred cCCcCCCcCCcCCCCCCCCceeeccccccccCCCcccccccccCeeeccccccCCcCCccCCCCCCCcEeeccCcccccC
Q 044366 125 SQNQLNGSIPCSLDNLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSENRLSGLIPLSLSNLSSLTVMSLFNNSLSGS 204 (918)
Q Consensus 125 s~n~i~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ 204 (918)
++|+++ .+|..+. ++|+.|++++|+++. +|..+. ++|+.|++++|+++.+ |..+. ++|+.|++++|.++.
T Consensus 249 s~N~L~-~LP~~l~--s~L~~L~Ls~N~L~~-LP~~l~--~sL~~L~Ls~N~Lt~L-P~~lp--~sL~~L~Ls~N~Lt~- 318 (754)
T PRK15370 249 SINRIT-ELPERLP--SALQSLDLFHNKISC-LPENLP--EELRYLSVYDNSIRTL-PAHLP--SGITHLNVQSNSLTA- 318 (754)
T ss_pred cCCccC-cCChhHh--CCCCEEECcCCccCc-cccccC--CCCcEEECCCCccccC-cccch--hhHHHHHhcCCcccc-
Confidence 888888 5666554 478888888888884 455443 4788888888888865 33332 468888888888874
Q ss_pred CCccccCCCCcceeecccccccCCCCCCCcCCCcCCeEEcccCcCcCCCCccccccCCCCeEecCCCccCCcCCCcCCCC
Q 044366 205 IPPILGNLKSLSTLGLHINQLNGVIPPSIGNLSSLRNLSLFNNRLYGFVPKEIGYLKSLSKLEFCANHLSGVIPHSVGNL 284 (918)
Q Consensus 205 ~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l 284 (918)
+|..+. ++|+.|++++|.++. +|..+. ++|+.|++++|+++. .|..+ .++|+.|++++|++..+ |..+.
T Consensus 319 LP~~l~--~sL~~L~Ls~N~Lt~-LP~~l~--~sL~~L~Ls~N~L~~-LP~~l--p~~L~~LdLs~N~Lt~L-P~~l~-- 387 (754)
T PRK15370 319 LPETLP--PGLKTLEAGENALTS-LPASLP--PELQVLDVSKNQITV-LPETL--PPTITTLDVSRNALTNL-PENLP-- 387 (754)
T ss_pred CCcccc--ccceeccccCCcccc-CChhhc--CcccEEECCCCCCCc-CChhh--cCCcCEEECCCCcCCCC-CHhHH--
Confidence 444332 578888888888875 444443 688888888888874 44444 36788888888888854 33332
Q ss_pred CCCcEEEccCCcCcCCCCcc----ccCCCCCCeEEeeccccc
Q 044366 285 TGLVLLNMCENHLFGPIPKS----LRNLTSLERVRFNQNNLY 322 (918)
Q Consensus 285 ~~L~~L~l~~n~l~~~~~~~----l~~l~~L~~L~l~~n~l~ 322 (918)
.+|+.|++++|++.. +|.. +..++.+..+++.+|.+.
T Consensus 388 ~sL~~LdLs~N~L~~-LP~sl~~~~~~~~~l~~L~L~~Npls 428 (754)
T PRK15370 388 AALQIMQASRNNLVR-LPESLPHFRGEGPQPTRIIVEYNPFS 428 (754)
T ss_pred HHHHHHhhccCCccc-CchhHHHHhhcCCCccEEEeeCCCcc
Confidence 368888888888873 4443 344577888888888875
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=2.4e-20 Score=185.42 Aligned_cols=175 Identities=13% Similarity=0.138 Sum_probs=135.0
Q ss_pred HHhcCCCCceeeccccceEEEEEEeCCCCEEEEEEcccccccCCCCChH------HHHHHHHHHhhccCCceeeEecccc
Q 044366 643 KATGNFGEKYCIGKGGQRSVYKAELPSGNIFAVKKFKAELFSDETANPS------EFLNEVLALTEIRHRNIIKFHGFCS 716 (918)
Q Consensus 643 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~------~~~~e~~~l~~l~h~niv~~~~~~~ 716 (918)
...++|...+++|.|+||.||.++. +++.+|||.++...... +.... .|.+|+..+.+++|++|..+.+++.
T Consensus 28 ~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~-~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~ 105 (232)
T PRK10359 28 FLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRT-ERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYL 105 (232)
T ss_pred HhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCch-HHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeee
Confidence 4568999999999999999999866 57789999997643222 11112 2689999999999999999988754
Q ss_pred cC--------CceEEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCC
Q 044366 717 NA--------QHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSE 788 (918)
Q Consensus 717 ~~--------~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~ 788 (918)
.. +..++||||++|.+|.++.. ++. ....+++.++..+|+. |++|||++|+||+++++
T Consensus 106 ~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~-------~~~----~~~~~i~~~l~~lH~~---gi~H~Dikp~Nili~~~ 171 (232)
T PRK10359 106 LAERKTLRYAHTYIMLIEYIEGVELNDMPE-------ISE----DVKAKIKASIESLHQH---GMVSGDPHKGNFIVSKN 171 (232)
T ss_pred ecccccccccCCeEEEEEEECCccHHHhhh-------ccH----HHHHHHHHHHHHHHHc---CCccCCCChHHEEEeCC
Confidence 32 35789999999999988732 232 2456999999999999 99999999999999998
Q ss_pred CcEEEeccccccccCCCCCCceecccccccccccccccCCCCcccchhhHHHHHHHHH
Q 044366 789 YEAHVSDFGFAKFLEPHSSNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVI 846 (918)
Q Consensus 789 ~~~kl~DfG~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~ 846 (918)
+ ++++|||.......+... . .+.....+..++|+|+||+.+....
T Consensus 172 g-i~liDfg~~~~~~e~~a~-d-----------~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 172 G-LRIIDLSGKRCTAQRKAK-D-----------RIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred C-EEEEECCCcccccchhhH-H-----------HHHHHhHhcccccccceeEeehHHH
Confidence 8 999999988755322111 0 1333445667899999999887764
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.81 E-value=9.3e-20 Score=180.25 Aligned_cols=144 Identities=18% Similarity=0.206 Sum_probs=108.7
Q ss_pred ceeeccccceEEEEEEeCCCCEEEEEEcccccccCCCC-----------------C-----hHHHHHHHHHHhhccCCce
Q 044366 651 KYCIGKGGQRSVYKAELPSGNIFAVKKFKAELFSDETA-----------------N-----PSEFLNEVLALTEIRHRNI 708 (918)
Q Consensus 651 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~-----------------~-----~~~~~~e~~~l~~l~h~ni 708 (918)
...||+|++|.||+|..++|+.||||+++......... . ......|++.+.++.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 35799999999999987799999999997643211110 0 0122348999999987776
Q ss_pred eeEecccccCCceEEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHH-HhCCCCCeEEcCCCCCCeeeCC
Q 044366 709 IKFHGFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYL-HHDCIPPIVHRDISSKNVLLDS 787 (918)
Q Consensus 709 v~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~L-H~~~~~~ivH~dlk~~Nill~~ 787 (918)
.....+.. ...++||||++++++...... ...+++.+...++.|++.+|+|+ |+. ||+||||||+||+++
T Consensus 82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~---~~~~~~~~~~~i~~qi~~~L~~l~H~~---giiHrDlkP~NIli~- 152 (190)
T cd05147 82 PCPEPILL--KSHVLVMEFIGDDGWAAPRLK---DAPLSESKARELYLQVIQIMRILYQDC---RLVHADLSEYNLLYH- 152 (190)
T ss_pred CCCcEEEe--cCCEEEEEEeCCCCCcchhhh---cCCCCHHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEE-
Confidence 43332221 224899999998877654322 23488999999999999999999 688 999999999999998
Q ss_pred CCcEEEeccccccccC
Q 044366 788 EYEAHVSDFGFAKFLE 803 (918)
Q Consensus 788 ~~~~kl~DfG~~~~~~ 803 (918)
++.++++|||+|....
T Consensus 153 ~~~v~LiDFG~a~~~~ 168 (190)
T cd05147 153 DGKLYIIDVSQSVEHD 168 (190)
T ss_pred CCcEEEEEccccccCC
Confidence 4789999999997653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=7.4e-20 Score=199.31 Aligned_cols=212 Identities=26% Similarity=0.464 Sum_probs=160.1
Q ss_pred HhhccCCceeeEecccccCCceEEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCe-EEcCC
Q 044366 700 LTEIRHRNIIKFHGFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPI-VHRDI 778 (918)
Q Consensus 700 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i-vH~dl 778 (918)
++.+.|.|+.+++|.+.++...+.|.+|+..|+|.+.+... ...++|.-...++++|+.||+|+|+. +| +|+.+
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~--~~~~d~~F~~s~~rdi~~Gl~ylh~s---~i~~hg~l 75 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNE--DIKLDYFFILSFIRDISKGLAYLHNS---PIGYHGAL 75 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhcc--ccCccHHHHHHHHHHHHHHHHHHhcC---cceeeeee
Confidence 35688999999999999999999999999999999999873 45689999999999999999999998 55 89999
Q ss_pred CCCCeeeCCCCcEEEeccccccccCCC--CCCceecccccccccccccccC-------CCCcccchhhHHHHHHHHHhCC
Q 044366 779 SSKNVLLDSEYEAHVSDFGFAKFLEPH--SSNWTEFAGTVGYAAPELAYTM-------RATEKYDVYSFGVLALEVIKGY 849 (918)
Q Consensus 779 k~~Nill~~~~~~kl~DfG~~~~~~~~--~~~~~~~~g~~~y~aPE~~~~~-------~~~~~~Dv~slG~vl~el~tg~ 849 (918)
+++|+++|..+.+|++|||+....... ........-..-|.|||.+.+. ..++++||||||++++|+++.+
T Consensus 76 ~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~ 155 (484)
T KOG1023|consen 76 KSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRS 155 (484)
T ss_pred ccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhcc
Confidence 999999999999999999999876431 1111122235679999998763 1467899999999999999999
Q ss_pred CCCCcchhhhhhhhhhHhhhhhhcccCCCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 044366 850 HPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLLC 917 (918)
Q Consensus 850 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 917 (918)
.||+........ ......+.......+.+......+....+..++..||.++|.+||++++|-..++
T Consensus 156 ~~~~~~~~~~~~-~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~ 222 (484)
T KOG1023|consen 156 GPFDLRNLVEDP-DEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRSKLL 222 (484)
T ss_pred CccccccccCCh-HHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHhhhh
Confidence 998765433222 1222222220111011111111123346889999999999999999999977653
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.81 E-value=4.9e-20 Score=188.81 Aligned_cols=235 Identities=22% Similarity=0.232 Sum_probs=150.7
Q ss_pred CCCceeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccC----------CceeeEeccc-
Q 044366 648 FGEKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRH----------RNIIKFHGFC- 715 (918)
Q Consensus 648 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h----------~niv~~~~~~- 715 (918)
+.....||.|+++.||.+.. .+|+.+|||++.... .......+++.+|.-....+.+ -.++-.++..
T Consensus 14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~-~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPA-DASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESS-TTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEccccccCCceEEEEEEEccCCceEEEEEEeccc-ccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 44567899999999999955 579999999987654 2233346677777766555322 1122111111
Q ss_pred --------cc---CC-----ceEEEEEeccCCChhHHhhcc---cc-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEE
Q 044366 716 --------SN---AQ-----HSFIVCEYLARGSLTTILRDD---AA-AKEFSWNQRMNVIKGVANALSYLHHDCIPPIVH 775 (918)
Q Consensus 716 --------~~---~~-----~~~lv~e~~~~gsL~~~l~~~---~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH 775 (918)
.. .. ..+++|+-+. ++|.+++..- .. ...+....++.+..|+++.++++|+. |+||
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~---GlVH 168 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY---GLVH 168 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEEE
T ss_pred EcCCCcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc---ceEe
Confidence 10 11 2367888775 5888876531 11 12234556677889999999999999 9999
Q ss_pred cCCCCCCeeeCCCCcEEEeccccccccCCCCCCceecccccccccccccccC--------CCCcccchhhHHHHHHHHHh
Q 044366 776 RDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGTVGYAAPELAYTM--------RATEKYDVYSFGVLALEVIK 847 (918)
Q Consensus 776 ~dlk~~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~--------~~~~~~Dv~slG~vl~el~t 847 (918)
+||+|+|++++++|.++|+||+.....+.... ....+..|.|||..... .++.+.|.|++|+++|.|+|
T Consensus 169 gdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~~---~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC 245 (288)
T PF14531_consen 169 GDIKPENFLLDQDGGVFLGDFSSLVRAGTRYR---CSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWC 245 (288)
T ss_dssp ST-SGGGEEE-TTS-EEE--GGGEEETTEEEE---GGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHH
T ss_pred cccceeeEEEcCCCCEEEcChHHHeecCceee---ccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHH
Confidence 99999999999999999999998876543211 13446789999976442 46889999999999999999
Q ss_pred CCCCCCcchhhhhhhhhhHhhhhhhcccCCCCCCcchHHHHHHHHHHHHHcccCCCCCC
Q 044366 848 GYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRDVTDKLRSIMEVAILCLVENPEAR 906 (918)
Q Consensus 848 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~R 906 (918)
|..||+.......... ....+. +.++.+.++|..+++.+|.+|
T Consensus 246 ~~lPf~~~~~~~~~~~---------------~f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 246 GRLPFGLSSPEADPEW---------------DFSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp SS-STCCCGGGSTSGG---------------GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred ccCCCCCCCccccccc---------------cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence 9999875543211110 111222 555678889999999999988
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.79 E-value=9.8e-19 Score=174.04 Aligned_cols=144 Identities=21% Similarity=0.262 Sum_probs=110.7
Q ss_pred ceeeccccceEEEEEEeCCCCEEEEEEcccccccCCC-----------------CC-----hHHHHHHHHHHhhccCCce
Q 044366 651 KYCIGKGGQRSVYKAELPSGNIFAVKKFKAELFSDET-----------------AN-----PSEFLNEVLALTEIRHRNI 708 (918)
Q Consensus 651 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~-----------------~~-----~~~~~~e~~~l~~l~h~ni 708 (918)
...||+|++|.||+|...+|+.||||+++........ .. ...+..|.+.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 4579999999999997778999999998764211000 00 1123578899999999887
Q ss_pred eeEecccccCCceEEEEEeccCCChhHH-hhcccccCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEEcCCCCCCeeeC
Q 044366 709 IKFHGFCSNAQHSFIVCEYLARGSLTTI-LRDDAAAKEFSWNQRMNVIKGVANALSYLHH-DCIPPIVHRDISSKNVLLD 786 (918)
Q Consensus 709 v~~~~~~~~~~~~~lv~e~~~~gsL~~~-l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~ivH~dlk~~Nill~ 786 (918)
.....+... ..++||||++++++... +.. .+++..+...++.|++.++.++|+ . ||+||||||+||+++
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~----~~~~~~~~~~i~~~l~~~l~~lH~~~---givHrDlkP~NIll~ 152 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLKD----VPLEEEEAEELYEQVVEQMRRLYQEA---GLVHGDLSEYNILYH 152 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhhhh----ccCCHHHHHHHHHHHHHHHHHHHHhC---CEecCCCChhhEEEE
Confidence 444333322 24899999998865443 332 236788999999999999999999 8 999999999999998
Q ss_pred CCCcEEEeccccccccCC
Q 044366 787 SEYEAHVSDFGFAKFLEP 804 (918)
Q Consensus 787 ~~~~~kl~DfG~~~~~~~ 804 (918)
++.++|+|||++.....
T Consensus 153 -~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 153 -DGKPYIIDVSQAVELDH 169 (190)
T ss_pred -CCCEEEEEcccceecCC
Confidence 78999999999987653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.79 E-value=9.3e-19 Score=169.74 Aligned_cols=187 Identities=13% Similarity=0.064 Sum_probs=137.8
Q ss_pred CCCceeeccccceEEEEEEeCCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhcc-CCceeeEecccccCCceEEEEE
Q 044366 648 FGEKYCIGKGGQRSVYKAELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIR-HRNIIKFHGFCSNAQHSFIVCE 726 (918)
Q Consensus 648 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e 726 (918)
+.+...|++|+||+||.+.. .+++++.+.+.....-........|.+|++++++++ |+++++++++ +..+++||
T Consensus 4 ~~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvme 78 (218)
T PRK12274 4 PAVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRS 78 (218)
T ss_pred cccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEe
Confidence 34567899999999998865 678888777654321111111225889999999995 5889999886 34699999
Q ss_pred eccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCC-CCCCeeeCCCCcEEEeccccccccCCC
Q 044366 727 YLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDI-SSKNVLLDSEYEAHVSDFGFAKFLEPH 805 (918)
Q Consensus 727 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl-k~~Nill~~~~~~kl~DfG~~~~~~~~ 805 (918)
|++|.+|.+.... ....++.|++++++++|+. ||+|||| ||+||+++.++.++|+|||+|....+.
T Consensus 79 yI~G~~L~~~~~~----------~~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~ 145 (218)
T PRK12274 79 YLAGAAMYQRPPR----------GDLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPR 145 (218)
T ss_pred eecCccHHhhhhh----------hhHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCCEEEEECCCceecCCc
Confidence 9999998654321 1135778999999999999 9999999 799999999999999999999865543
Q ss_pred CCC-----c--------eecccccccccccccccC-CCC-cccchhhHHHHHHHHHhCCCCC
Q 044366 806 SSN-----W--------TEFAGTVGYAAPELAYTM-RAT-EKYDVYSFGVLALEVIKGYHPG 852 (918)
Q Consensus 806 ~~~-----~--------~~~~g~~~y~aPE~~~~~-~~~-~~~Dv~slG~vl~el~tg~~p~ 852 (918)
... . .....++.|++|+...-- ..+ .+.+.++-|.-+|.++||..+.
T Consensus 146 ~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~ 207 (218)
T PRK12274 146 ARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLH 207 (218)
T ss_pred chHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCc
Confidence 321 0 011246677777744321 223 4678899999999999999884
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.3e-19 Score=205.56 Aligned_cols=247 Identities=19% Similarity=0.219 Sum_probs=179.8
Q ss_pred CCCCceeeccccceEEEEEEeCCCCEEEEEEcccccccCCCCChHHHHHHHHHHh--hccCCceeeEecccccCCceEEE
Q 044366 647 NFGEKYCIGKGGQRSVYKAELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALT--EIRHRNIIKFHGFCSNAQHSFIV 724 (918)
Q Consensus 647 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~--~l~h~niv~~~~~~~~~~~~~lv 724 (918)
++...+.+|.+.|=.|.+|+.+.|. |+||++-+. +.....+.|.++++..+ .++|||.+++.-+-..+...|||
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~---~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylv 99 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQ---DPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLV 99 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEecc---CCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHH
Confidence 5667778999999999999988888 889988553 44455667777666554 44899999999988888899999
Q ss_pred EEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEecccccccc--
Q 044366 725 CEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFL-- 802 (918)
Q Consensus 725 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~-- 802 (918)
-+|..+ +|.|.+..+. -+...+...|+.|++.|+..+|.. ||+|||||.+|||++.=.=+.|+||..-+-.
T Consensus 100 Rqyvkh-nLyDRlSTRP---FL~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYL 172 (1431)
T KOG1240|consen 100 RQYVKH-NLYDRLSTRP---FLVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSWNWLYLTDFASFKPTYL 172 (1431)
T ss_pred HHHHhh-hhhhhhccch---HHHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeeechhhhhcccccCCccC
Confidence 999976 9999987653 267778888999999999999999 9999999999999998777899999765321
Q ss_pred CCC-CCCceec----ccccccccccccccC-----------CCCcccchhhHHHHHHHHHh-CCCCCCcchhhhhhhhhh
Q 044366 803 EPH-SSNWTEF----AGTVGYAAPELAYTM-----------RATEKYDVYSFGVLALEVIK-GYHPGDFVSTIFSSISNM 865 (918)
Q Consensus 803 ~~~-~~~~~~~----~g~~~y~aPE~~~~~-----------~~~~~~Dv~slG~vl~el~t-g~~p~~~~~~~~~~~~~~ 865 (918)
..+ ....+.. ..-..|.|||.+... ..+++-||||.|||++|+++ |++||+...-. ......
T Consensus 173 PeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~-aYr~~~ 251 (1431)
T KOG1240|consen 173 PEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLL-AYRSGN 251 (1431)
T ss_pred CCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHH-hHhccC
Confidence 111 1122222 223469999976431 14567899999999999988 68887643321 110000
Q ss_pred HhhhhhhcccCCCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 044366 866 IIEVNQILDHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNL 915 (918)
Q Consensus 866 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 915 (918)
.......+.. ++. ..+..++..|++.||.+|.+|++.++.
T Consensus 252 ~~~~e~~Le~-Ied---------~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 252 ADDPEQLLEK-IED---------VSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred ccCHHHHHHh-CcC---------ccHHHHHHHHHccCchhccCHHHHHHh
Confidence 0000111110 000 247788899999999999999999875
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.75 E-value=1.8e-20 Score=204.66 Aligned_cols=201 Identities=26% Similarity=0.279 Sum_probs=103.1
Q ss_pred cccCCCCCC-ccCCccCCCCCCCCEEeCCCCcccc----cCCccccCCCCCCEEEcccccccc------cCCCCcCCCCC
Q 044366 2 LNLGFNLLF-GNIPPQIGNLSKLQYLDLGNNQLSG----VIPPEIGKLNQLRRLYLDVNQLHG------TIPPVIGQLSL 70 (918)
Q Consensus 2 l~~~~~~~~-~~~p~~~~~l~~L~~L~L~~n~i~~----~~p~~l~~l~~L~~L~L~~n~l~~------~~p~~~~~l~~ 70 (918)
|+|.++.+. +..+..+..+++|++|+|++|.++. .++..+...++|++|+++.+.+.+ .++..+..+.+
T Consensus 3 l~L~~~~l~~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~~ 82 (319)
T cd00116 3 LSLKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGCG 82 (319)
T ss_pred cccccCcccccchHHHHHHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhcCc
Confidence 667777776 4455556667778888888888742 245566667778888887776651 12334445556
Q ss_pred CCEEEcccccccccCCccccCCCC---CCEEEccCCcccc----cCccccCCC-CCCCEEECcCCcCCCc----CCcCCC
Q 044366 71 INELVFCHNNVSGRIPSSLGNLSN---LALLYLNDNSLFG----SIPIVMGNL-KSLSTLDLSQNQLNGS----IPCSLD 138 (918)
Q Consensus 71 L~~L~l~~n~~~~~~p~~l~~l~~---L~~L~L~~n~i~~----~~~~~~~~l-~~L~~L~Ls~n~i~~~----~~~~l~ 138 (918)
|++|++++|.+.+..+..+..+.+ |++|++++|++.+ .....+..+ ++|+.|++++|.+++. ++..+.
T Consensus 83 L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~ 162 (319)
T cd00116 83 LQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKALR 162 (319)
T ss_pred eeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHHHHHH
Confidence 666666666555444444444433 5666666555542 112223334 5555555555555521 222334
Q ss_pred CCCCCceeeccccccccC----CCcccccccccCeeeccccccCCcC----CccCCCCCCCcEeeccCcccc
Q 044366 139 NLSNLDTLFLYKNSLSGP----IPSVIGNLKSLLQLDLSENRLSGLI----PLSLSNLSSLTVMSLFNNSLS 202 (918)
Q Consensus 139 ~l~~L~~L~L~~n~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~~----~~~~~~l~~L~~L~L~~N~l~ 202 (918)
.+++|++|++++|.+++. .+..+..+++|+.|++++|.+++.. ...+..+++|++|++++|.++
T Consensus 163 ~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~L~~L~ls~n~l~ 234 (319)
T cd00116 163 ANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLT 234 (319)
T ss_pred hCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHHHHhcccCCCCEEecCCCcCc
Confidence 444555555555554421 1112223335555555555444221 122333444444444444443
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.74 E-value=3e-20 Score=166.93 Aligned_cols=169 Identities=33% Similarity=0.525 Sum_probs=148.8
Q ss_pred cCCccCCCCCCCCEEeCCCCcccccCCccccCCCCCCEEEcccccccccCCCCcCCCCCCCEEEcccccccccCCccccC
Q 044366 12 NIPPQIGNLSKLQYLDLGNNQLSGVIPPEIGKLNQLRRLYLDVNQLHGTIPPVIGQLSLINELVFCHNNVSGRIPSSLGN 91 (918)
Q Consensus 12 ~~p~~~~~l~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~l~~ 91 (918)
++| .+.++.+.+.|.|++|+++ ..|..|..+.+|+.|++++|+|+ .+|.+++.+.+|+.|+++-|++. ..|.+|+.
T Consensus 25 ~~~-gLf~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs 100 (264)
T KOG0617|consen 25 ELP-GLFNMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGS 100 (264)
T ss_pred hcc-cccchhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCC
Confidence 443 3667788899999999998 78888999999999999999998 89999999999999999999988 89999999
Q ss_pred CCCCCEEEccCCcccc-cCccccCCCCCCCEEECcCCcCCCcCCcCCCCCCCCceeeccccccccCCCcccccccccCee
Q 044366 92 LSNLALLYLNDNSLFG-SIPIVMGNLKSLSTLDLSQNQLNGSIPCSLDNLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQL 170 (918)
Q Consensus 92 l~~L~~L~L~~n~i~~-~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 170 (918)
++-|+.|||..|++.. ..|+.|..|..|+-|.|+.|.+. .+|..++++++|+.|.+..|.+- ..|..++.+.+|++|
T Consensus 101 ~p~levldltynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrel 178 (264)
T KOG0617|consen 101 FPALEVLDLTYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLREL 178 (264)
T ss_pred CchhhhhhccccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHH
Confidence 9999999999998874 68889999999999999999998 88999999999999999999988 578889999999999
Q ss_pred eccccccCCcCCccCCC
Q 044366 171 DLSENRLSGLIPLSLSN 187 (918)
Q Consensus 171 ~Ls~N~l~~~~~~~~~~ 187 (918)
.+.+|+++.++| .+.+
T Consensus 179 hiqgnrl~vlpp-el~~ 194 (264)
T KOG0617|consen 179 HIQGNRLTVLPP-ELAN 194 (264)
T ss_pred hcccceeeecCh-hhhh
Confidence 999999996544 4443
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.74 E-value=7e-20 Score=200.03 Aligned_cols=277 Identities=21% Similarity=0.208 Sum_probs=151.2
Q ss_pred eEEcccCcCc-CCCCccccccCCCCeEecCCCccCCc----CCCcCCCCCCCcEEEccCCcCcC------CCCccccCCC
Q 044366 241 NLSLFNNRLY-GFVPKEIGYLKSLSKLEFCANHLSGV----IPHSVGNLTGLVLLNMCENHLFG------PIPKSLRNLT 309 (918)
Q Consensus 241 ~L~Ls~n~l~-~~~~~~~~~l~~L~~L~l~~n~l~~~----~~~~~~~l~~L~~L~l~~n~l~~------~~~~~l~~l~ 309 (918)
.|+|+++.++ ......+..+.+|+.|++++|.+... ++..+...+.++.++++++.+.+ .++..+..++
T Consensus 2 ~l~L~~~~l~~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~ 81 (319)
T cd00116 2 QLSLKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGC 81 (319)
T ss_pred ccccccCcccccchHHHHHHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhcC
Confidence 5677777776 33445566777788888888887532 23334555667777777766542 1123344455
Q ss_pred CCCeEEeecccccCccccccCCCCC---ccEEeCCCCccccccCcccccccccceeeccccccccCCCcCcCCC-CCCcE
Q 044366 310 SLERVRFNQNNLYGKVYEAFGDHPN---LTFLDLSQNNFYCEISFNWRNFSKLGTFNASMNNIYGSIPPEIGDS-SKLQV 385 (918)
Q Consensus 310 ~L~~L~l~~n~l~~~~~~~~~~l~~---L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~n~i~~~~~~~~~~~-~~L~~ 385 (918)
+|++|++++|.+.......+..+.. |+.|++++|++..... ..+...+..+ ++|+.
T Consensus 82 ~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~--------------------~~l~~~l~~~~~~L~~ 141 (319)
T cd00116 82 GLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGL--------------------RLLAKGLKDLPPALEK 141 (319)
T ss_pred ceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHH--------------------HHHHHHHHhCCCCceE
Confidence 5555555555554333333322222 5555555554431100 0111223334 56777
Q ss_pred EEccCceeccc----cccchhhccccCceecccccccCC----CCCCCCCCCcccEEeccCcccccc----Ccccccccc
Q 044366 386 LDLSSNHIFGK----IPVQLVKLFSLNKLILSLNQLFGG----VPLEFGTLTELQYLDLSANKLSSS----IPMSIGNLL 453 (918)
Q Consensus 386 L~L~~N~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~----~~~~~~~l~ 453 (918)
|++++|.+++. .+..+..+.+|+.|+|++|.+.+. .+..+..+++|++|+|++|.+++. ++..+..++
T Consensus 142 L~L~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~ 221 (319)
T cd00116 142 LVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLK 221 (319)
T ss_pred EEcCCCcCCchHHHHHHHHHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHHHHhcccC
Confidence 77777776532 222344445666666666666532 122334445777777777766532 223445566
Q ss_pred ccceecccCcccCCCCchhhcc-----ccccceEeccCCcCCCC----CchhccccCCcceEecCCCccccc----Cccc
Q 044366 454 KLHYLNLSNNQFSHKIPTEFEK-----LIHLSELDLSHNILQEE----IPPQICKMESLEKLNLSHNNLSDF----IPRC 520 (918)
Q Consensus 454 ~L~~L~Ls~N~l~~~~~~~~~~-----l~~L~~L~Ls~N~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~----~~~~ 520 (918)
+|++|++++|.+++.....+.. .+.|+.|++++|.+++. +...+..+++|+.+++++|+++.. ....
T Consensus 222 ~L~~L~ls~n~l~~~~~~~l~~~~~~~~~~L~~L~l~~n~i~~~~~~~l~~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~ 301 (319)
T cd00116 222 SLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFGEEGAQLLAES 301 (319)
T ss_pred CCCEEecCCCcCchHHHHHHHHHHhccCCCceEEEccCCCCCcHHHHHHHHHHhcCCCccEEECCCCCCcHHHHHHHHHH
Confidence 6777777777776433333322 25677777777777521 233445556777777777777643 3333
Q ss_pred ccCC-CCccEEEccCCcC
Q 044366 521 FEEM-RSLSWIDISYNEL 537 (918)
Q Consensus 521 ~~~l-~~L~~l~l~~N~l 537 (918)
+... +.|+.+|+.+|+|
T Consensus 302 ~~~~~~~~~~~~~~~~~~ 319 (319)
T cd00116 302 LLEPGNELESLWVKDDSF 319 (319)
T ss_pred HhhcCCchhhcccCCCCC
Confidence 3344 5667777776654
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.74 E-value=7.1e-19 Score=190.84 Aligned_cols=227 Identities=26% Similarity=0.336 Sum_probs=176.0
Q ss_pred eeccccceEEEEEE----eCCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhcc-CCceeeEecccccCCceEEEEEe
Q 044366 653 CIGKGGQRSVYKAE----LPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIR-HRNIIKFHGFCSNAQHSFIVCEY 727 (918)
Q Consensus 653 ~lg~G~~g~Vy~~~----~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~ 727 (918)
++|+|+||.|+.++ .+.|..||.|+.++........ .....|..++...+ ||.+|++.-.++.+...+++++|
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~--~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~ 78 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDR--THTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDF 78 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccc--cccccHHHHHhhccCCCceeeeeeeeccccchhHhhhh
Confidence 37999999999863 2357789999887643332222 24566777788886 99999999999999999999999
Q ss_pred ccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccCCCCC
Q 044366 728 LARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSS 807 (918)
Q Consensus 728 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~~~~~ 807 (918)
..+|.+...+.... .+++.....+...+|-|++++|+. +++|||+|++||+++.+|.+++.|||.++..-....
T Consensus 79 ~rgg~lft~l~~~~---~f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~ 152 (612)
T KOG0603|consen 79 LRGGDLFTRLSKEV---MFDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI 152 (612)
T ss_pred cccchhhhccccCC---chHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCCchhhhHhHhhhh
Confidence 99999988887653 367778888899999999999999 999999999999999999999999999987654332
Q ss_pred CceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCCCCCcchHHH
Q 044366 808 NWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRDVTDK 887 (918)
Q Consensus 808 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 887 (918)
. +||..|||||++. ....++|.||||++.+||+||..||.. .....+....+..+ . ..
T Consensus 153 ~----cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~------------~~~~~Il~~~~~~p-~---~l 210 (612)
T KOG0603|consen 153 A----CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG------------DTMKRILKAELEMP-R---EL 210 (612)
T ss_pred c----ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch------------HHHHHHhhhccCCc-h---hh
Confidence 2 7899999999998 567789999999999999999999764 11122222222222 1 22
Q ss_pred HHHHHHHHHHcccCCCCCCCCH
Q 044366 888 LRSIMEVAILCLVENPEARPTM 909 (918)
Q Consensus 888 ~~~l~~li~~cl~~dp~~RPt~ 909 (918)
.....+++..+...+|..|.-.
T Consensus 211 ~~~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 211 SAEARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred hHHHHHHHHHHHhhCHHHHhcc
Confidence 3345566667788888887644
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.73 E-value=7.1e-18 Score=171.35 Aligned_cols=194 Identities=23% Similarity=0.362 Sum_probs=136.0
Q ss_pred cCCceeeEeccccc---------------------------CCceEEEEEeccCCChhHHhhcccccCCCCHHHHHHHHH
Q 044366 704 RHRNIIKFHGFCSN---------------------------AQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIK 756 (918)
Q Consensus 704 ~h~niv~~~~~~~~---------------------------~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~ 756 (918)
+|||||++.++|.+ +...|+||...+. +|.+++.... .+.....-|+.
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~~----~s~r~~~~~la 348 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTRH----RSYRTGRVILA 348 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcCC----CchHHHHHHHH
Confidence 69999999887643 2346899987765 9999997643 45566777999
Q ss_pred HHHHHHHHHHhCCCCCeEEcCCCCCCeee--CCCC--cEEEeccccccccCCC------CCCceeccccccccccccccc
Q 044366 757 GVANALSYLHHDCIPPIVHRDISSKNVLL--DSEY--EAHVSDFGFAKFLEPH------SSNWTEFAGTVGYAAPELAYT 826 (918)
Q Consensus 757 ~i~~~l~~LH~~~~~~ivH~dlk~~Nill--~~~~--~~kl~DfG~~~~~~~~------~~~~~~~~g~~~y~aPE~~~~ 826 (918)
|+++|+.|||.+ ||.|||+|+.||++ |+|+ ...++|||.+---+.. .+......|...-||||+...
T Consensus 349 QlLEav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta 425 (598)
T KOG4158|consen 349 QLLEAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATA 425 (598)
T ss_pred HHHHHHHHHHHc---cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhc
Confidence 999999999999 99999999999998 4444 3578999987532221 122234567888999998754
Q ss_pred CCC------CcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCCCCCcchHHHHHHHHHHHHHccc
Q 044366 827 MRA------TEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRDVTDKLRSIMEVAILCLV 900 (918)
Q Consensus 827 ~~~------~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 900 (918)
.+- -.|+|.|+.|.+.||++....||-..+.. ..+.....+..+|..++..+ ..+.+++...++
T Consensus 426 ~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem-------~L~~r~Yqe~qLPalp~~vp---p~~rqlV~~lL~ 495 (598)
T KOG4158|consen 426 VPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEM-------LLDTRTYQESQLPALPSRVP---PVARQLVFDLLK 495 (598)
T ss_pred CCCCceeeccchhhhhhhhhhHHHHhccCCcccccchh-------eechhhhhhhhCCCCcccCC---hHHHHHHHHHhc
Confidence 321 24899999999999999999997542221 11111112223333333333 345677778899
Q ss_pred CCCCCCCCHHHHHHH
Q 044366 901 ENPEARPTMKEVCNL 915 (918)
Q Consensus 901 ~dp~~RPt~~evl~~ 915 (918)
.||.+|+++.-....
T Consensus 496 r~pskRvsp~iAANv 510 (598)
T KOG4158|consen 496 RDPSKRVSPNIAANV 510 (598)
T ss_pred CCccccCCccHHHhH
Confidence 999999987654433
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.73 E-value=3e-17 Score=163.51 Aligned_cols=138 Identities=17% Similarity=0.275 Sum_probs=105.6
Q ss_pred CCCceeeccccceEEEEEEeCCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhc-----cCCceeeEecccccCC---
Q 044366 648 FGEKYCIGKGGQRSVYKAELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEI-----RHRNIIKFHGFCSNAQ--- 719 (918)
Q Consensus 648 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-----~h~niv~~~~~~~~~~--- 719 (918)
+...+.||+|+||.||. .+.....+||++... .....+.+.+|+..++.+ .||||++++|++.++.
T Consensus 4 L~~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~----~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g 77 (210)
T PRK10345 4 LSEQSPLGTGRHRKCYA--HPEDAQRCIKIVYHR----GDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTG 77 (210)
T ss_pred cCCcceecCCCceEEEE--CCCCcCeEEEEEecc----ccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCe
Confidence 44567899999999996 443333479987653 122357899999999999 5799999999997763
Q ss_pred c-eEEEEEe--ccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHH-HHHHhCCCCCeEEcCCCCCCeeeCC----CCcE
Q 044366 720 H-SFIVCEY--LARGSLTTILRDDAAAKEFSWNQRMNVIKGVANAL-SYLHHDCIPPIVHRDISSKNVLLDS----EYEA 791 (918)
Q Consensus 720 ~-~~lv~e~--~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l-~~LH~~~~~~ivH~dlk~~Nill~~----~~~~ 791 (918)
. ..+|+|| +++|+|.+++.+. .+++. ..++.+++.++ +|||++ +|+||||||+||+++. ++.+
T Consensus 78 ~v~~~I~e~~G~~~~tL~~~l~~~----~~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~~~~~~~~ 148 (210)
T PRK10345 78 YVYDVIADFDGKPSITLTEFAEQC----RYEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRISESEVIP 148 (210)
T ss_pred EEEEEEecCCCCcchhHHHHHHcc----cccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEeccCCCCCcE
Confidence 3 3378999 5578999999653 25555 35677888777 999999 9999999999999974 3479
Q ss_pred EEec-ccccc
Q 044366 792 HVSD-FGFAK 800 (918)
Q Consensus 792 kl~D-fG~~~ 800 (918)
+|+| ||...
T Consensus 149 ~LiDg~G~~~ 158 (210)
T PRK10345 149 VVCDNIGEST 158 (210)
T ss_pred EEEECCCCcc
Confidence 9999 55443
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.73 E-value=1.6e-17 Score=193.71 Aligned_cols=199 Identities=22% Similarity=0.238 Sum_probs=163.5
Q ss_pred HHHHHhcCCCCceeeccccceEEEEEEeCCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhcc---CCceeeEecccc
Q 044366 640 EITKATGNFGEKYCIGKGGQRSVYKAELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIR---HRNIIKFHGFCS 716 (918)
Q Consensus 640 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~~~~~~~ 716 (918)
+.+.....|.+.+.||+|+||.||+|...+|+.||+|+-+.. ..-+|.--.+++.+++ -+-|..+..++.
T Consensus 692 ~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~-------~~WEfYI~~q~~~RLk~~~~~~~~~~~~a~~ 764 (974)
T KOG1166|consen 692 EFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPP-------NPWEFYICLQVMERLKPQMLPSIMHISSAHV 764 (974)
T ss_pred eeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCC-------CceeeeehHHHHHhhchhhhcchHHHHHHHc
Confidence 444556778888999999999999998778999999986553 2334444555566666 234455555666
Q ss_pred cCCceEEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCC-------CC
Q 044366 717 NAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDS-------EY 789 (918)
Q Consensus 717 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~-------~~ 789 (918)
..+.-++|+||.+.|||.+++... +.++|.-++.++.|+++.+++||.. +||||||||+|.|+.. ..
T Consensus 765 ~~~~S~lv~ey~~~Gtlld~~N~~---~~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~~~~~~~ 838 (974)
T KOG1166|consen 765 FQNASVLVSEYSPYGTLLDLINTN---KVMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREICADSDSK 838 (974)
T ss_pred cCCcceeeeeccccccHHHhhccC---CCCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccCCCCccc
Confidence 678889999999999999999843 4489999999999999999999999 9999999999999953 23
Q ss_pred cEEEecccccccc--CCCCCCceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCC
Q 044366 790 EAHVSDFGFAKFL--EPHSSNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHP 851 (918)
Q Consensus 790 ~~kl~DfG~~~~~--~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p 851 (918)
.++|+|||.+..+ .++.......++|-.+-.+|+..|..++.++|-|.++.+++-|+.|++-
T Consensus 839 ~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~ 902 (974)
T KOG1166|consen 839 GLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM 902 (974)
T ss_pred ceEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH
Confidence 5899999999765 3445566778899999999999999999999999999999999999875
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.71 E-value=2.1e-19 Score=161.60 Aligned_cols=166 Identities=31% Similarity=0.539 Sum_probs=145.1
Q ss_pred cccCCCCCCEEEcccccccccCCCCcCCCCCCCEEEcccccccccCCccccCCCCCCEEEccCCcccccCccccCCCCCC
Q 044366 40 EIGKLNQLRRLYLDVNQLHGTIPPVIGQLSLINELVFCHNNVSGRIPSSLGNLSNLALLYLNDNSLFGSIPIVMGNLKSL 119 (918)
Q Consensus 40 ~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~l~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L 119 (918)
.+..+.+.++|-|++|+++ .+|+.|..+.+|+.|++++|+++ .+|.++..+++|+.|+++-|++. ..|..|+.++.|
T Consensus 28 gLf~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~l 104 (264)
T KOG0617|consen 28 GLFNMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPAL 104 (264)
T ss_pred cccchhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchh
Confidence 4566778888999999998 88999999999999999999998 89999999999999999999986 889999999999
Q ss_pred CEEECcCCcCCC-cCCcCCCCCCCCceeeccccccccCCCcccccccccCeeeccccccCCcCCccCCCCCCCcEeeccC
Q 044366 120 STLDLSQNQLNG-SIPCSLDNLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSENRLSGLIPLSLSNLSSLTVMSLFN 198 (918)
Q Consensus 120 ~~L~Ls~n~i~~-~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~ 198 (918)
+.|||++|++.. .+|+.|-.|+.|+.|+|+.|.++ ++|..++++++|+.|.+..|.+-++ |..+..+..|++|++.+
T Consensus 105 evldltynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndll~l-pkeig~lt~lrelhiqg 182 (264)
T KOG0617|consen 105 EVLDLTYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLLSL-PKEIGDLTRLRELHIQG 182 (264)
T ss_pred hhhhccccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCchhhC-cHHHHHHHHHHHHhccc
Confidence 999999998864 67888989999999999999998 7888899999999999999988854 77889999999999999
Q ss_pred cccccCCCccccC
Q 044366 199 NSLSGSIPPILGN 211 (918)
Q Consensus 199 N~l~~~~~~~~~~ 211 (918)
|+++ .+|..+++
T Consensus 183 nrl~-vlppel~~ 194 (264)
T KOG0617|consen 183 NRLT-VLPPELAN 194 (264)
T ss_pred ceee-ecChhhhh
Confidence 9998 45544544
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.70 E-value=1e-16 Score=164.13 Aligned_cols=146 Identities=19% Similarity=0.211 Sum_probs=112.5
Q ss_pred CCCCceeeccccceEEEEEE--eCCCCEEEEEEcccccccCCC---------------C-----ChHHHHHHHHHHhhcc
Q 044366 647 NFGEKYCIGKGGQRSVYKAE--LPSGNIFAVKKFKAELFSDET---------------A-----NPSEFLNEVLALTEIR 704 (918)
Q Consensus 647 ~~~~~~~lg~G~~g~Vy~~~--~~~~~~vavK~~~~~~~~~~~---------------~-----~~~~~~~e~~~l~~l~ 704 (918)
-|.+.+.||+|++|.||+|. ..+|+.||+|+++........ . ....+..|++.+.++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 37788999999999999997 568999999998754211100 0 0123568999999997
Q ss_pred CC--ceeeEecccccCCceEEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCC-eEEcCCCCC
Q 044366 705 HR--NIIKFHGFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPP-IVHRDISSK 781 (918)
Q Consensus 705 h~--niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~-ivH~dlk~~ 781 (918)
+. .+.+++++ ...++||||++++++..+.... ......+...++.|++.+++++|+. + ++|||+||+
T Consensus 109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~---~~~~~~~~~~i~~qi~~~l~~LH~~---g~iiH~Dikp~ 178 (237)
T smart00090 109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKD---VEPEEEEEFELYDDILEEMRKLYKE---GELVHGDLSEY 178 (237)
T ss_pred hcCCCCCeeeEe----cCceEEEEEecCCccccccccc---CCcchHHHHHHHHHHHHHHHHHHhc---CCEEeCCCChh
Confidence 53 34455543 2358999999998887664322 2355667789999999999999999 9 999999999
Q ss_pred CeeeCCCCcEEEeccccccccC
Q 044366 782 NVLLDSEYEAHVSDFGFAKFLE 803 (918)
Q Consensus 782 Nill~~~~~~kl~DfG~~~~~~ 803 (918)
||+++ ++.++++|||.+....
T Consensus 179 NIli~-~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 179 NILVH-DGKVVIIDVSQSVELD 199 (237)
T ss_pred hEEEE-CCCEEEEEChhhhccC
Confidence 99999 8899999999987654
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.68 E-value=1.5e-17 Score=177.04 Aligned_cols=174 Identities=24% Similarity=0.386 Sum_probs=136.7
Q ss_pred CceEEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEecccc
Q 044366 719 QHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGF 798 (918)
Q Consensus 719 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~ 798 (918)
.+.++.|++++..+|.+|+++.......++.....++.|++.|++| + +.+|+|+||.||+...+..+||+|||+
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q~kIgDFgl 402 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQLKIGDFGL 402 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchhhhhhhhhh
Confidence 3578999999999999999877777778999999999999999999 5 899999999999999999999999999
Q ss_pred ccccCCCC------CCceecccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhhhhhhhhhHhhhhh
Q 044366 799 AKFLEPHS------SNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIK-GYHPGDFVSTIFSSISNMIIEVNQ 871 (918)
Q Consensus 799 ~~~~~~~~------~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~ 871 (918)
........ ...+..+||..||+||.+.+..|+.|+||||+|++++|++. =..+++ ......+
T Consensus 403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~e-----------r~~t~~d 471 (516)
T KOG1033|consen 403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFE-----------RIATLTD 471 (516)
T ss_pred eeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHH-----------HHHhhhh
Confidence 98765443 13456789999999999999999999999999999999986 122211 1222334
Q ss_pred hcccCCCCC-CcchHHHHHHHHHHHHHcccCCCCCCCCHHHHH
Q 044366 872 ILDHRLPTP-SRDVTDKLRSIMEVAILCLVENPEARPTMKEVC 913 (918)
Q Consensus 872 ~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl 913 (918)
+.+..+|+. ..+.+ .=..++.+++...|.+||++.++.
T Consensus 472 ~r~g~ip~~~~~d~p----~e~~ll~~lls~~p~~RP~~~~~~ 510 (516)
T KOG1033|consen 472 IRDGIIPPEFLQDYP----EEYTLLQQLLSPSPEERPSAIEVA 510 (516)
T ss_pred hhcCCCChHHhhcCc----HHHHHHHHhcCCCcccCchHHHHh
Confidence 444555422 12222 234567788999999999666553
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.67 E-value=3.1e-16 Score=159.85 Aligned_cols=138 Identities=17% Similarity=0.328 Sum_probs=114.1
Q ss_pred eeeccccceEEEEEEeCCCCEEEEEEcccccccCCC----CChHHHHHHHHHHhhccCCceeeEecccccCCceEEEEEe
Q 044366 652 YCIGKGGQRSVYKAELPSGNIFAVKKFKAELFSDET----ANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFIVCEY 727 (918)
Q Consensus 652 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 727 (918)
+.||+|++|.||+|.. .|..|++|+.......... .....+.+|++.+..++|+++.....++.+.+..++||||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 4699999999999977 7788999986543221111 1124578899999999999988777777677788999999
Q ss_pred ccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccc
Q 044366 728 LARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKF 801 (918)
Q Consensus 728 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~ 801 (918)
++|++|.+++.... + ++..++.+++.++.++|+. +++|||++|.||+++ ++.++++|||.+..
T Consensus 81 ~~G~~L~~~~~~~~------~-~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSNG------M-EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhcc------H-HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 99999999986432 2 7889999999999999999 999999999999999 78999999999875
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.67 E-value=3.9e-16 Score=156.87 Aligned_cols=147 Identities=20% Similarity=0.174 Sum_probs=112.4
Q ss_pred HHHhcCCCCceeeccccceEEEEEEeCCCCEEEEEEcccccccCC--C----------------CChHHHHHHHHHHhhc
Q 044366 642 TKATGNFGEKYCIGKGGQRSVYKAELPSGNIFAVKKFKAELFSDE--T----------------ANPSEFLNEVLALTEI 703 (918)
Q Consensus 642 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~--~----------------~~~~~~~~e~~~l~~l 703 (918)
......|...+.||+|+||.||+|..++|+.||||+++....... . .....+..|...+..+
T Consensus 11 ~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 90 (198)
T cd05144 11 VKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKAL 90 (198)
T ss_pred HHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHH
Confidence 333334777889999999999999888899999998765321000 0 0112367888888888
Q ss_pred cCC--ceeeEecccccCCceEEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCC
Q 044366 704 RHR--NIIKFHGFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSK 781 (918)
Q Consensus 704 ~h~--niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~ 781 (918)
.|+ .++..++. ...++||||+++++|.+.... .....++.+++.++.++|+. +++||||+|+
T Consensus 91 ~~~~i~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~---------~~~~~~~~~i~~~l~~lh~~---gi~H~Dl~p~ 154 (198)
T cd05144 91 YEEGFPVPKPIDW----NRHAVVMEYIDGVELYRVRVL---------EDPEEVLDEILEEIVKAYKH---GIIHGDLSEF 154 (198)
T ss_pred HHcCCCCCceeec----CCceEEEEEeCCcchhhcccc---------ccHHHHHHHHHHHHHHHHHC---CCCcCCCCcc
Confidence 877 44445442 345899999999998765431 23567889999999999998 9999999999
Q ss_pred CeeeCCCCcEEEeccccccccCC
Q 044366 782 NVLLDSEYEAHVSDFGFAKFLEP 804 (918)
Q Consensus 782 Nill~~~~~~kl~DfG~~~~~~~ 804 (918)
||++++++.++|+|||.+.....
T Consensus 155 Nill~~~~~~~liDfg~~~~~~~ 177 (198)
T cd05144 155 NILVDDDEKIYIIDWPQMVSTDH 177 (198)
T ss_pred cEEEcCCCcEEEEECCccccCCC
Confidence 99999999999999999976543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.65 E-value=5.5e-16 Score=156.34 Aligned_cols=135 Identities=19% Similarity=0.356 Sum_probs=107.6
Q ss_pred eeccccceEEEEEEeCCCCEEEEEEcccccccCCC----CChHHHHHHHHHHhhccCCceeeEecccccCCceEEEEEec
Q 044366 653 CIGKGGQRSVYKAELPSGNIFAVKKFKAELFSDET----ANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFIVCEYL 728 (918)
Q Consensus 653 ~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 728 (918)
.||+|++|.||+|.+ +|..|++|+.......... .....+.+|+++++.++|+++.....++...+..++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 389999999999985 6788999986542211111 11356778999999999887655555555666779999999
Q ss_pred cCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEecccccccc
Q 044366 729 ARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFL 802 (918)
Q Consensus 729 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~ 802 (918)
+|++|.+++..... .++.+++.+++++|+. +++|||++|.||+++ ++.++++|||.+...
T Consensus 80 ~g~~l~~~~~~~~~----------~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~ 139 (199)
T TIGR03724 80 EGKPLKDVIEEGND----------ELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLIDFGLGKYS 139 (199)
T ss_pred CCccHHHHHhhcHH----------HHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence 99999988754310 7899999999999999 999999999999999 789999999998753
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.64 E-value=1.1e-15 Score=177.39 Aligned_cols=143 Identities=21% Similarity=0.293 Sum_probs=113.3
Q ss_pred HhcCCCCceeeccccceEEEEEEeCCCCEEEEEEcccccccC----CCCChHHHHHHHHHHhhccCCceeeEecccccCC
Q 044366 644 ATGNFGEKYCIGKGGQRSVYKAELPSGNIFAVKKFKAELFSD----ETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQ 719 (918)
Q Consensus 644 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~----~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~ 719 (918)
....|...+.||+|+||.||+|.+... .+++|+........ .....+.+.+|+++++.++|++++....++.+..
T Consensus 331 ~~~~~~~~~~iG~G~~g~Vy~~~~~~~-~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~ 409 (535)
T PRK09605 331 VKRRKIPDHLIGKGAEADIKKGEYLGR-DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPE 409 (535)
T ss_pred cccccCccceeccCCcEEEEEEeecCc-cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCC
Confidence 344556778999999999999977544 34444322111111 1112356889999999999999988887777777
Q ss_pred ceEEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccc
Q 044366 720 HSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFA 799 (918)
Q Consensus 720 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~ 799 (918)
..++||||+++++|.+++. ....++.++++++.|||+. +++|||+||+||++ .++.++++|||++
T Consensus 410 ~~~lv~E~~~g~~L~~~l~-----------~~~~~~~~i~~~L~~lH~~---giiHrDlkp~NILl-~~~~~~liDFGla 474 (535)
T PRK09605 410 EKTIVMEYIGGKDLKDVLE-----------GNPELVRKVGEIVAKLHKA---GIVHGDLTTSNFIV-RDDRLYLIDFGLG 474 (535)
T ss_pred CCEEEEEecCCCcHHHHHH-----------HHHHHHHHHHHHHHHHHhC---CCccCCCChHHEEE-ECCcEEEEeCccc
Confidence 8899999999999999885 3467899999999999999 99999999999999 6779999999999
Q ss_pred ccc
Q 044366 800 KFL 802 (918)
Q Consensus 800 ~~~ 802 (918)
+..
T Consensus 475 ~~~ 477 (535)
T PRK09605 475 KYS 477 (535)
T ss_pred ccC
Confidence 864
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.59 E-value=1.4e-15 Score=173.44 Aligned_cols=207 Identities=24% Similarity=0.317 Sum_probs=139.0
Q ss_pred HhcCCCCceeeccccceEEEEEEeC-CCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceE
Q 044366 644 ATGNFGEKYCIGKGGQRSVYKAELP-SGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSF 722 (918)
Q Consensus 644 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 722 (918)
...+|..++.|..|+||.||.++++ +.+++|.|.=+... +.+- ++.....|.+|
T Consensus 81 ~e~df~~IklisngAygavylvrh~~trqrfa~kiNkq~l----------ilRn--ilt~a~npfvv------------- 135 (1205)
T KOG0606|consen 81 SESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQNL----------ILRN--ILTFAGNPFVV------------- 135 (1205)
T ss_pred CccccceeEeeccCCCCceeeeeccccccchhhcccccch----------hhhc--cccccCCccee-------------
Confidence 3467899999999999999999765 46778885422110 0110 22222333333
Q ss_pred EEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEecccccccc
Q 044366 723 IVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFL 802 (918)
Q Consensus 723 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~ 802 (918)
|+=.+.++.. +.++.+ ++.+++|+|+. ||||||+||.|.+++.-|.+|+.|||++...
T Consensus 136 --------gDc~tllk~~---g~lPvd--------mvla~Eylh~y---givhrdlkpdnllIT~mGhiKlTDfgLsk~G 193 (1205)
T KOG0606|consen 136 --------GDCATLLKNI---GPLPVD--------MVLAVEYLHSY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKKG 193 (1205)
T ss_pred --------chhhhhcccC---CCCcch--------hhHHhHhhccC---CeecCCCCCCcceeeecccccccchhhhhhh
Confidence 3333333332 223322 27889999999 9999999999999999999999999998754
Q ss_pred CCCCC---------------CceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchh--hhhhhhhh
Q 044366 803 EPHSS---------------NWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVST--IFSSISNM 865 (918)
Q Consensus 803 ~~~~~---------------~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~--~~~~~~~~ 865 (918)
..... .....+||+.|.|||++....|...+|.|++|+++||.+-|+.||..... .+..+...
T Consensus 194 Lms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd 273 (1205)
T KOG0606|consen 194 LMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISD 273 (1205)
T ss_pred hhhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhh
Confidence 22111 11345799999999999999999999999999999999999999764421 11111111
Q ss_pred HhhhhhhcccCCCCCCcchHHHHHHHHHHHHHcccCCCCCCCC
Q 044366 866 IIEVNQILDHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPT 908 (918)
Q Consensus 866 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt 908 (918)
+..+++..+. ...+..+++.+.++.+|..|--
T Consensus 274 --------~i~wpE~dea---~p~Ea~dli~~LL~qnp~~Rlg 305 (1205)
T KOG0606|consen 274 --------DIEWPEEDEA---LPPEAQDLIEQLLRQNPLCRLG 305 (1205)
T ss_pred --------hccccccCcC---CCHHHHHHHHHHHHhChHhhcc
Confidence 1112222222 2245667777889999999963
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.56 E-value=1.9e-14 Score=143.49 Aligned_cols=141 Identities=20% Similarity=0.214 Sum_probs=98.8
Q ss_pred ceeeccccceEEEEEEeCCCCEEEEEEcccccccCCCCCh--------------------HHHHHHHHHHhhccCCc--e
Q 044366 651 KYCIGKGGQRSVYKAELPSGNIFAVKKFKAELFSDETANP--------------------SEFLNEVLALTEIRHRN--I 708 (918)
Q Consensus 651 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~--------------------~~~~~e~~~l~~l~h~n--i 708 (918)
.+.||+|+||.||+|...+|+.||||+++........... .....|.+.+..+.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 3579999999999998778999999998753221111100 01134555555554332 3
Q ss_pred eeEecccccCCceEEEEEeccCCChhH-HhhcccccCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEEcCCCCCCeeeC
Q 044366 709 IKFHGFCSNAQHSFIVCEYLARGSLTT-ILRDDAAAKEFSWNQRMNVIKGVANALSYLHH-DCIPPIVHRDISSKNVLLD 786 (918)
Q Consensus 709 v~~~~~~~~~~~~~lv~e~~~~gsL~~-~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~ivH~dlk~~Nill~ 786 (918)
.+.+++ ...++||||++++++.. .+.... .. .+...++.+++.++.++|. . +++|||+||+||+++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~----~~-~~~~~~~~~~~~~l~~lh~~~---~ivH~Dl~p~Nili~ 149 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR----LL-EDPEELYDQILELMRKLYREA---GLVHGDLSEYNILVD 149 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhh----hc-ccHHHHHHHHHHHHHHHhhcc---CcCcCCCChhhEEEE
Confidence 444443 24589999999964432 121111 11 5678899999999999999 7 999999999999999
Q ss_pred CCCcEEEeccccccccCC
Q 044366 787 SEYEAHVSDFGFAKFLEP 804 (918)
Q Consensus 787 ~~~~~kl~DfG~~~~~~~ 804 (918)
++.++++|||.+.....
T Consensus 150 -~~~~~liDfg~a~~~~~ 166 (187)
T cd05119 150 -DGKVYIIDVPQAVEIDH 166 (187)
T ss_pred -CCcEEEEECcccccccC
Confidence 88999999999976543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.55 E-value=4e-14 Score=136.07 Aligned_cols=136 Identities=17% Similarity=0.205 Sum_probs=114.1
Q ss_pred CceeeccccceEEEEEEeCCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccC--CceeeEecccccCCceEEEEEe
Q 044366 650 EKYCIGKGGQRSVYKAELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRH--RNIIKFHGFCSNAQHSFIVCEY 727 (918)
Q Consensus 650 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~~~~~~~~~~~~~lv~e~ 727 (918)
+.+.||+|.++.||++...+ ..+++|....... ...+.+|+..++.++| .++++++++...++..+++|||
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~------~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~ 74 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK------GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEW 74 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCc------hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEe
Confidence 45679999999999998744 7899998755311 4678999999999976 5899999988888889999999
Q ss_pred ccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEecccccccc
Q 044366 728 LARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFL 802 (918)
Q Consensus 728 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~ 802 (918)
++++.+..+ +......++.+++++++++|.....+++|+|++|+||++++.+.++++|||.++..
T Consensus 75 ~~g~~~~~~----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~ 139 (155)
T cd05120 75 IEGETLDEV----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYG 139 (155)
T ss_pred cCCeecccC----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccCC
Confidence 998766544 44567788999999999999964447999999999999999899999999988753
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.54 E-value=2.2e-14 Score=167.94 Aligned_cols=114 Identities=32% Similarity=0.543 Sum_probs=54.2
Q ss_pred cceecccCcccCCCCchhhccccccceEeccCCcCCCCCchhccccCCcceEecCCCcccccCcccccCCCCccEEEccC
Q 044366 455 LHYLNLSNNQFSHKIPTEFEKLIHLSELDLSHNILQEEIPPQICKMESLEKLNLSHNNLSDFIPRCFEEMRSLSWIDISY 534 (918)
Q Consensus 455 L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~l~l~~ 534 (918)
++.|+|++|.+++.+|..+..+++|+.|+|++|.|++.+|..+..+++|+.|+|++|++++.+|..+..+++|+.|||++
T Consensus 420 v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~ 499 (623)
T PLN03150 420 IDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNG 499 (623)
T ss_pred EEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcC
Confidence 34444444444444444444444444444444444444444444444444444444444444444444444444444444
Q ss_pred CcCCCCCCCCcc-----cccccccCCCCccCCCCCCCCCC
Q 044366 535 NELQGPIPNSTA-----FKNGLMEGNKGLCGNFKALPSCD 569 (918)
Q Consensus 535 N~l~~~~p~~~~-----~~~~~~~~n~~~c~~~~~~~~c~ 569 (918)
|+++|.+|..-. .....+.+|+.+|+.+ .++.|.
T Consensus 500 N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~p-~l~~C~ 538 (623)
T PLN03150 500 NSLSGRVPAALGGRLLHRASFNFTDNAGLCGIP-GLRACG 538 (623)
T ss_pred CcccccCChHHhhccccCceEEecCCccccCCC-CCCCCc
Confidence 444444443211 0111245566667643 356674
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.53 E-value=5.6e-14 Score=144.34 Aligned_cols=141 Identities=14% Similarity=0.247 Sum_probs=107.7
Q ss_pred ceeec-cccceEEEEEEeCCCCEEEEEEcccccc-----c----CCCCChHHHHHHHHHHhhccCCce--eeEecccccC
Q 044366 651 KYCIG-KGGQRSVYKAELPSGNIFAVKKFKAELF-----S----DETANPSEFLNEVLALTEIRHRNI--IKFHGFCSNA 718 (918)
Q Consensus 651 ~~~lg-~G~~g~Vy~~~~~~~~~vavK~~~~~~~-----~----~~~~~~~~~~~e~~~l~~l~h~ni--v~~~~~~~~~ 718 (918)
.+.|| .|+.|+||.+... +..++||.+..... . ........+.+|++++..++|++| ++.+++....
T Consensus 36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 35687 8999999999774 77899998854211 1 111234678999999999998775 6677664332
Q ss_pred -C---ceEEEEEeccC-CChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEE
Q 044366 719 -Q---HSFIVCEYLAR-GSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHV 793 (918)
Q Consensus 719 -~---~~~lv~e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl 793 (918)
. ..++||||+++ .+|.+++... +++.. .+.+++.++.+||+. ||+||||||.||+++.++.++|
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~~----~l~~~----~~~~i~~~l~~lH~~---GI~HrDlkp~NILv~~~~~v~L 183 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQEA----PLSEE----QWQAIGQLIARFHDA---GVYHADLNAHNILLDPDGKFWL 183 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhcC----CCCHH----HHHHHHHHHHHHHHC---CCCCCCCCchhEEEcCCCCEEE
Confidence 2 23599999997 6999888642 24443 357899999999999 9999999999999999999999
Q ss_pred eccccccccC
Q 044366 794 SDFGFAKFLE 803 (918)
Q Consensus 794 ~DfG~~~~~~ 803 (918)
+|||.+....
T Consensus 184 IDfg~~~~~~ 193 (239)
T PRK01723 184 IDFDRGELRT 193 (239)
T ss_pred EECCCcccCC
Confidence 9999998643
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.52 E-value=1.9e-15 Score=173.93 Aligned_cols=255 Identities=22% Similarity=0.263 Sum_probs=185.2
Q ss_pred hcCCCCceeeccccceEEEEEEeC--CCCEEEEEEcccccccCCCCChHHHHHHHHHHhhcc-CCceeeEecccccCCce
Q 044366 645 TGNFGEKYCIGKGGQRSVYKAELP--SGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIR-HRNIIKFHGFCSNAQHS 721 (918)
Q Consensus 645 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~ 721 (918)
...|...+.||+|+|+.|-.+... ....+|+|.+.... ......+....|..+-..+. |+|++.+++...+.+..
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~--~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~ 96 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPP--KSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSY 96 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCC--CccchhhhcCccccccccccccccccccCCccCCCccc
Confidence 345667777999999999888443 34456777665432 12222344455777777775 99999999999999999
Q ss_pred EEEEEeccCCChhHHh-hcccccCCCCHHHHHHHHHHHHHHHHHHH-hCCCCCeEEcCCCCCCeeeCCCC-cEEEecccc
Q 044366 722 FIVCEYLARGSLTTIL-RDDAAAKEFSWNQRMNVIKGVANALSYLH-HDCIPPIVHRDISSKNVLLDSEY-EAHVSDFGF 798 (918)
Q Consensus 722 ~lv~e~~~~gsL~~~l-~~~~~~~~l~~~~~~~i~~~i~~~l~~LH-~~~~~~ivH~dlk~~Nill~~~~-~~kl~DfG~ 798 (918)
+++.+|.+++++.+.+ .... ...+....-.+..|+..++.|+| .. +++|+|+||+|.+++..+ ..+++|||+
T Consensus 97 ~~~~~~s~g~~~f~~i~~~~~--~~~~~~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~~s~~~l~~~df~~ 171 (601)
T KOG0590|consen 97 LLSLSYSDGGSLFSKISHPDS--TGTSSSSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLLDESGSALKIADFGL 171 (601)
T ss_pred ccccCcccccccccccccCCc--cCCCCcchhhhhhhhccCccccCccc---ccccCCCCCccchhccCCCcccCCCchh
Confidence 9999999999998888 4332 12455667789999999999999 77 999999999999999999 999999999
Q ss_pred ccccCC-CCC--Cceeccc-ccccccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhc
Q 044366 799 AKFLEP-HSS--NWTEFAG-TVGYAAPELAYTM-RATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQIL 873 (918)
Q Consensus 799 ~~~~~~-~~~--~~~~~~g-~~~y~aPE~~~~~-~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 873 (918)
|..+.. .+. ......| ++.|+|||...+. ...+..|+||.|+++..+++|..||+.......... ...
T Consensus 172 At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~-------~~~ 244 (601)
T KOG0590|consen 172 ATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYS-------SWK 244 (601)
T ss_pred hccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccce-------eec
Confidence 987765 322 2345667 9999999998885 446688999999999999999999876543221111 111
Q ss_pred ccCCCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHH
Q 044366 874 DHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVC 913 (918)
Q Consensus 874 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl 913 (918)
..+.......+........++..+++..+|..|.+.+++.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~ 284 (601)
T KOG0590|consen 245 SNKGRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELK 284 (601)
T ss_pred ccccccccCccccCChhhhhcccccccCCchhcccccccc
Confidence 1110000011112223456777788889999999988764
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.45 E-value=4.8e-15 Score=157.84 Aligned_cols=193 Identities=34% Similarity=0.431 Sum_probs=102.9
Q ss_pred EEeecccccCccccccC-CCCCccEEeCCCCccccccCcccccccccceeeccccccccCCCcCcCCCCCCcEEEccCce
Q 044366 314 VRFNQNNLYGKVYEAFG-DHPNLTFLDLSQNNFYCEISFNWRNFSKLGTFNASMNNIYGSIPPEIGDSSKLQVLDLSSNH 392 (918)
Q Consensus 314 L~l~~n~l~~~~~~~~~-~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~n~i~~~~~~~~~~~~~L~~L~L~~N~ 392 (918)
|.|++-.+...+.+++. ++..-...||+.|++..++. .+..+..|..+.|+.|.|. .+|..++.+..|+.|||+.|+
T Consensus 55 l~Ls~rrlk~fpr~a~~~~ltdt~~aDlsrNR~~elp~-~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~Nq 132 (722)
T KOG0532|consen 55 LLLSGRRLKEFPRGAASYDLTDTVFADLSRNRFSELPE-EACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQ 132 (722)
T ss_pred cccccchhhcCCCccccccccchhhhhccccccccCch-HHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccch
Confidence 44555555555555443 34455667777777753322 3344444555555555554 455555555566666666666
Q ss_pred eccccccchhhccccCceecccccccCCCCCCCCCCCcccEEeccCccccccCccccccccccceecccCcccCCCCchh
Q 044366 393 IFGKIPVQLVKLFSLNKLILSLNQLFGGVPLEFGTLTELQYLDLSANKLSSSIPMSIGNLLKLHYLNLSNNQFSHKIPTE 472 (918)
Q Consensus 393 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~ 472 (918)
++ ..|..++.++ |+.|.+++|+++ ..|..++.+..|..||.+.|.|. .+|..++++.+|+.|++..|++.. .|+.
T Consensus 133 lS-~lp~~lC~lp-Lkvli~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~~-lp~E 207 (722)
T KOG0532|consen 133 LS-HLPDGLCDLP-LKVLIVSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLED-LPEE 207 (722)
T ss_pred hh-cCChhhhcCc-ceeEEEecCccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhhh-CCHH
Confidence 54 4444444443 555555555554 34444455555555555555555 344555555555555555555542 3333
Q ss_pred hccccccceEeccCCcCCCCCchhccccCCcceEecCCCcccc
Q 044366 473 FEKLIHLSELDLSHNILQEEIPPQICKMESLEKLNLSHNNLSD 515 (918)
Q Consensus 473 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 515 (918)
+..| .|..||+|.|+++ .+|-.|.+|..|++|-|.+|+|..
T Consensus 208 l~~L-pLi~lDfScNkis-~iPv~fr~m~~Lq~l~LenNPLqS 248 (722)
T KOG0532|consen 208 LCSL-PLIRLDFSCNKIS-YLPVDFRKMRHLQVLQLENNPLQS 248 (722)
T ss_pred HhCC-ceeeeecccCcee-ecchhhhhhhhheeeeeccCCCCC
Confidence 4433 3555555555554 455555555555555555555554
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.45 E-value=3.3e-14 Score=141.70 Aligned_cols=199 Identities=24% Similarity=0.391 Sum_probs=138.6
Q ss_pred HHHHhhccCCceeeEecccccCC-----ceEEEEEeccCCChhHHhhccc-ccCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 044366 697 VLALTEIRHRNIIKFHGFCSNAQ-----HSFIVCEYLARGSLTTILRDDA-AAKEFSWNQRMNVIKGVANALSYLHHDCI 770 (918)
Q Consensus 697 ~~~l~~l~h~niv~~~~~~~~~~-----~~~lv~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~ 770 (918)
...+-++-|.|+|+++.|+.+.. ....+.|||+.|++.++|++-+ ....+......+|+.||..||.|||+ |.
T Consensus 118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs-~~ 196 (458)
T KOG1266|consen 118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHS-CD 196 (458)
T ss_pred HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhc-cC
Confidence 33455567999999999996543 4678999999999999998653 34457777888999999999999998 57
Q ss_pred CCeEEcCCCCCCeeeCCCCcEEEeccccccccCCCCC-----CceecccccccccccccccCCCCcccchhhHHHHHHHH
Q 044366 771 PPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSS-----NWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEV 845 (918)
Q Consensus 771 ~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el 845 (918)
|+|+|+++.-+-|++..+|-+|+. -+.-....+... ......+-++|.|||+-.....+.++|||+||+...||
T Consensus 197 PpiihgnlTc~tifiq~ngLIkig-~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlem 275 (458)
T KOG1266|consen 197 PPIIHGNLTCDTIFIQHNGLIKIG-SVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEM 275 (458)
T ss_pred CccccCCcchhheeecCCceEEec-ccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHH
Confidence 899999999999999999888874 221111111110 11123456899999998887888899999999999999
Q ss_pred HhCCCCC-Ccchh--hhhhhhhhHhhhhhhcccCCCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 846 IKGYHPG-DFVST--IFSSISNMIIEVNQILDHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 846 ~tg~~p~-~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
.-|..-. ..... ....+.+....... + .=...+.+|++..|..||+|.+++.
T Consensus 276 ailEiq~tnseS~~~~ee~ia~~i~~len-------~----------lqr~~i~kcl~~eP~~rp~ar~llf 330 (458)
T KOG1266|consen 276 AILEIQSTNSESKVEVEENIANVIIGLEN-------G----------LQRGSITKCLEGEPNGRPDARLLLF 330 (458)
T ss_pred HHheeccCCCcceeehhhhhhhheeeccC-------c----------cccCcCcccccCCCCCCcchhhhhc
Confidence 8775431 11110 00011111110000 0 0123566799999999999998763
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.43 E-value=2.5e-12 Score=143.89 Aligned_cols=145 Identities=17% Similarity=0.218 Sum_probs=101.2
Q ss_pred eeeccccceEEEEEEeCCCCEEEEEEcccccccCCC----------------------CC--------------hHHHHH
Q 044366 652 YCIGKGGQRSVYKAELPSGNIFAVKKFKAELFSDET----------------------AN--------------PSEFLN 695 (918)
Q Consensus 652 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~----------------------~~--------------~~~~~~ 695 (918)
+.||.|++|.||+|++.+|+.||||+.+........ .. .-+|.+
T Consensus 123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~ 202 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR 202 (437)
T ss_pred cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence 679999999999999999999999998653211000 00 013555
Q ss_pred HHHHHhhcc-----CCceeeEecccccCCceEEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHH-HHHHHHhCC
Q 044366 696 EVLALTEIR-----HRNIIKFHGFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVAN-ALSYLHHDC 769 (918)
Q Consensus 696 e~~~l~~l~-----h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~-~l~~LH~~~ 769 (918)
|+..+.+++ ++++.-..-|.......++||||++|++|.++...... .. ++.+++..+++ .+..+|..
T Consensus 203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~--~~---~~~~ia~~~~~~~l~ql~~~- 276 (437)
T TIGR01982 203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA--GL---DRKALAENLARSFLNQVLRD- 276 (437)
T ss_pred HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc--CC---CHHHHHHHHHHHHHHHHHhC-
Confidence 666555552 33332111122223457999999999999987653211 12 23456677666 47888988
Q ss_pred CCCeEEcCCCCCCeeeCCCCcEEEeccccccccCC
Q 044366 770 IPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEP 804 (918)
Q Consensus 770 ~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~~ 804 (918)
|++|+|++|.||++++++.++++|||++..+.+
T Consensus 277 --g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 277 --GFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred --CceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 999999999999999999999999999987653
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.43 E-value=2.2e-13 Score=153.12 Aligned_cols=199 Identities=41% Similarity=0.580 Sum_probs=112.2
Q ss_pred EEEcccccccccCCccccCCCCCCEEEccCCcccccCccccCCCC-CCCEEECcCCcCCCcCCcCCCCCCCCceeecccc
Q 044366 73 ELVFCHNNVSGRIPSSLGNLSNLALLYLNDNSLFGSIPIVMGNLK-SLSTLDLSQNQLNGSIPCSLDNLSNLDTLFLYKN 151 (918)
Q Consensus 73 ~L~l~~n~~~~~~p~~l~~l~~L~~L~L~~n~i~~~~~~~~~~l~-~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n 151 (918)
.+++..+.+. ..+..+..++.++.|++.+|.++ .++.....+. +|+.|++++|++. .+|..+..+++|+.|++++|
T Consensus 97 ~l~~~~~~~~-~~~~~~~~~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N 173 (394)
T COG4886 97 SLDLNLNRLR-SNISELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFN 173 (394)
T ss_pred eeeccccccc-cCchhhhcccceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCCc
Confidence 4555555543 23333444456666666666665 3343444443 6666666666665 34445566666666666666
Q ss_pred ccccCCCcccccccccCeeeccccccCCcCCccCCCCCCCcEeeccCcccccCCCccccCCCCcceeecccccccCCCCC
Q 044366 152 SLSGPIPSVIGNLKSLLQLDLSENRLSGLIPLSLSNLSSLTVMSLFNNSLSGSIPPILGNLKSLSTLGLHINQLNGVIPP 231 (918)
Q Consensus 152 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~ 231 (918)
+++. .+...+.+++|+.|++++|+++.+ |........|++|.+++|.+. ..+..+.++.++..+.+.+|++.. .+.
T Consensus 174 ~l~~-l~~~~~~~~~L~~L~ls~N~i~~l-~~~~~~~~~L~~l~~~~N~~~-~~~~~~~~~~~l~~l~l~~n~~~~-~~~ 249 (394)
T COG4886 174 DLSD-LPKLLSNLSNLNNLDLSGNKISDL-PPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLED-LPE 249 (394)
T ss_pred hhhh-hhhhhhhhhhhhheeccCCccccC-chhhhhhhhhhhhhhcCCcce-ecchhhhhcccccccccCCceeee-ccc
Confidence 6663 233333556666666666666644 322233444666666666433 234556666666666666666653 245
Q ss_pred CCcCCCcCCeEEcccCcCcCCCCccccccCCCCeEecCCCccCCcCCCc
Q 044366 232 SIGNLSSLRNLSLFNNRLYGFVPKEIGYLKSLSKLEFCANHLSGVIPHS 280 (918)
Q Consensus 232 ~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~ 280 (918)
.++.++++++|++++|.++.+.. ++.+.+++.|++++|.+....+..
T Consensus 250 ~~~~l~~l~~L~~s~n~i~~i~~--~~~~~~l~~L~~s~n~~~~~~~~~ 296 (394)
T COG4886 250 SIGNLSNLETLDLSNNQISSISS--LGSLTNLRELDLSGNSLSNALPLI 296 (394)
T ss_pred hhccccccceecccccccccccc--ccccCccCEEeccCccccccchhh
Confidence 55666666666666666664433 666666666666666666554433
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.43 E-value=1.4e-13 Score=154.63 Aligned_cols=209 Identities=39% Similarity=0.531 Sum_probs=169.6
Q ss_pred CCCCCCCC---EEeCCCCcccccCCccccCCCCCCEEEcccccccccCCCCcCCCC-CCCEEEcccccccccCCccccCC
Q 044366 17 IGNLSKLQ---YLDLGNNQLSGVIPPEIGKLNQLRRLYLDVNQLHGTIPPVIGQLS-LINELVFCHNNVSGRIPSSLGNL 92 (918)
Q Consensus 17 ~~~l~~L~---~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~-~L~~L~l~~n~~~~~~p~~l~~l 92 (918)
...+..+. .|+++.+++. ..+..+..++.++.|++.+|.++ .+|.....+. +|++|++++|.+. .+|..+..+
T Consensus 86 ~~~~~~~~~~~~l~~~~~~~~-~~~~~~~~~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l 162 (394)
T COG4886 86 SENLLNLLPLPSLDLNLNRLR-SNISELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNL 162 (394)
T ss_pred cccccCCCCCceeeccccccc-cCchhhhcccceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhcc
Confidence 33444444 6888888885 45566777888999999999998 8888888885 9999999999998 777788899
Q ss_pred CCCCEEEccCCcccccCccccCCCCCCCEEECcCCcCCCcCCcCCCCCCCCceeeccccccccCCCcccccccccCeeec
Q 044366 93 SNLALLYLNDNSLFGSIPIVMGNLKSLSTLDLSQNQLNGSIPCSLDNLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDL 172 (918)
Q Consensus 93 ~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 172 (918)
++|+.|++++|++. ..|.....+++|+.|++++|+++ .+|.....+..|++|.+++|++. ..+..+..++++..|.+
T Consensus 163 ~~L~~L~l~~N~l~-~l~~~~~~~~~L~~L~ls~N~i~-~l~~~~~~~~~L~~l~~~~N~~~-~~~~~~~~~~~l~~l~l 239 (394)
T COG4886 163 PNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLEL 239 (394)
T ss_pred ccccccccCCchhh-hhhhhhhhhhhhhheeccCCccc-cCchhhhhhhhhhhhhhcCCcce-ecchhhhhccccccccc
Confidence 99999999999997 45555557889999999999998 56666666677999999999644 35677888999999999
Q ss_pred cccccCCcCCccCCCCCCCcEeeccCcccccCCCccccCCCCcceeecccccccCCCCCCCc
Q 044366 173 SENRLSGLIPLSLSNLSSLTVMSLFNNSLSGSIPPILGNLKSLSTLGLHINQLNGVIPPSIG 234 (918)
Q Consensus 173 s~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~ 234 (918)
++|++... +..+..+++++.|++++|+++.+.. +..+.+|+.|++++|.+....+....
T Consensus 240 ~~n~~~~~-~~~~~~l~~l~~L~~s~n~i~~i~~--~~~~~~l~~L~~s~n~~~~~~~~~~~ 298 (394)
T COG4886 240 SNNKLEDL-PESIGNLSNLETLDLSNNQISSISS--LGSLTNLRELDLSGNSLSNALPLIAL 298 (394)
T ss_pred CCceeeec-cchhccccccceecccccccccccc--ccccCccCEEeccCccccccchhhhc
Confidence 99998854 5678888899999999999985543 88999999999999999876655443
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.41 E-value=8.2e-15 Score=156.10 Aligned_cols=198 Identities=29% Similarity=0.417 Sum_probs=142.0
Q ss_pred EEeCCCCcccccCCccc--cCCCCCCEEEcccccccccCCCCcCCCCCCCEEEcccccccccCCccccCCCCCCEEEccC
Q 044366 25 YLDLGNNQLSGVIPPEI--GKLNQLRRLYLDVNQLHGTIPPVIGQLSLINELVFCHNNVSGRIPSSLGNLSNLALLYLND 102 (918)
Q Consensus 25 ~L~L~~n~i~~~~p~~l--~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~l~~l~~L~~L~L~~ 102 (918)
.|.|++-+++ ..|..= ..++--...||+.|++. .+|..+..+..|+.+.+.+|.+. .+|..+++|..|+.|+|+.
T Consensus 54 ~l~Ls~rrlk-~fpr~a~~~~ltdt~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~ 130 (722)
T KOG0532|consen 54 RLLLSGRRLK-EFPRGAASYDLTDTVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSS 130 (722)
T ss_pred ccccccchhh-cCCCccccccccchhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhcc
Confidence 5777777776 444322 24555567788888887 78888888888888888888777 7788888888888888888
Q ss_pred CcccccCccccCCCCCCCEEECcCCcCCCcCCcCCCCCCCCceeeccccccccCCCcccccccccCeeeccccccCCcCC
Q 044366 103 NSLFGSIPIVMGNLKSLSTLDLSQNQLNGSIPCSLDNLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSENRLSGLIP 182 (918)
Q Consensus 103 n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~ 182 (918)
|++. ..|..++.|+ |+.|-+++|+++ .+|..++.+..|..|+.+.|.+. .+|..++++.+|+.|.+..|++..+ |
T Consensus 131 NqlS-~lp~~lC~lp-Lkvli~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~~l-p 205 (722)
T KOG0532|consen 131 NQLS-HLPDGLCDLP-LKVLIVSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLEDL-P 205 (722)
T ss_pred chhh-cCChhhhcCc-ceeEEEecCccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhhhC-C
Confidence 8876 5666676666 788888888887 67777777777788888888777 4566777777777777777777755 3
Q ss_pred ccCCCCCCCcEeeccCcccccCCCccccCCCCcceeecccccccCCCCCCC
Q 044366 183 LSLSNLSSLTVMSLFNNSLSGSIPPILGNLKSLSTLGLHINQLNGVIPPSI 233 (918)
Q Consensus 183 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~ 233 (918)
..+..|+ |..||+++|+++ .+|-.|.+|+.|++|-|.+|.+. .+|..+
T Consensus 206 ~El~~Lp-Li~lDfScNkis-~iPv~fr~m~~Lq~l~LenNPLq-SPPAqI 253 (722)
T KOG0532|consen 206 EELCSLP-LIRLDFSCNKIS-YLPVDFRKMRHLQVLQLENNPLQ-SPPAQI 253 (722)
T ss_pred HHHhCCc-eeeeecccCcee-ecchhhhhhhhheeeeeccCCCC-CChHHH
Confidence 4455443 677777777777 46667777777777777777776 344444
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.29 E-value=3.5e-12 Score=139.51 Aligned_cols=248 Identities=26% Similarity=0.288 Sum_probs=178.4
Q ss_pred cCCCCceeecc--ccceEEEEEEe---CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhc-cCCceeeEecccccCC
Q 044366 646 GNFGEKYCIGK--GGQRSVYKAEL---PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEI-RHRNIIKFHGFCSNAQ 719 (918)
Q Consensus 646 ~~~~~~~~lg~--G~~g~Vy~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~ 719 (918)
..|.....+|. |.+|.||.+.. .++..+|+|+-+.... .......=.+|+...+.+ .|++.++.+..+..++
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s--~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~ 191 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFS--PPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSG 191 (524)
T ss_pred hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCC--CccccccccchhhcccccCccccccccCcccccCC
Confidence 34566677899 99999999954 4788999998544322 111122225666666666 5999999999999999
Q ss_pred ceEEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHH----HHHHHHhCCCCCeEEcCCCCCCeeeCCC-CcEEEe
Q 044366 720 HSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVAN----ALSYLHHDCIPPIVHRDISSKNVLLDSE-YEAHVS 794 (918)
Q Consensus 720 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~----~l~~LH~~~~~~ivH~dlk~~Nill~~~-~~~kl~ 794 (918)
..++-+|++. .++.++.+... .-++....+.+..+..+ |+.++|+. .++|-|+||.||+...+ ...+++
T Consensus 192 ~lfiqtE~~~-~sl~~~~~~~~--~~~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~~~~~~s~~~~ 265 (524)
T KOG0601|consen 192 ILFIQTELCG-ESLQSYCHTPC--NFLPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFTTSDWTSCKLT 265 (524)
T ss_pred cceeeecccc-chhHHhhhccc--ccCCchhhhhHHhhhhhcccccccccCCC---cccccccchhheecccccceeecC
Confidence 9999999986 58888776532 22567778888888888 99999999 99999999999999999 889999
Q ss_pred ccccccccCCCCCCce-----ecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcc-hhhhhhhhhhHhh
Q 044366 795 DFGFAKFLEPHSSNWT-----EFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFV-STIFSSISNMIIE 868 (918)
Q Consensus 795 DfG~~~~~~~~~~~~~-----~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~-~~~~~~~~~~~~~ 868 (918)
|||+...+.+..-... ...|...|++||...+ .++.++|+|++|.+..+..+|....... ...+......
T Consensus 266 df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~--- 341 (524)
T KOG0601|consen 266 DFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQG--- 341 (524)
T ss_pred CcceeEEccCCccccceeeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccc---
Confidence 9999998876542211 2257889999998876 5788999999999999999886652211 0000000000
Q ss_pred hhhhcccCCCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 869 VNQILDHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 869 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
.. +.+.+.....++...+..|++.+|..|+++..+..
T Consensus 342 -------~i--p~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 342 -------YI--PLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred -------cC--chhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 00 11111122234445778899999999999988754
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.28 E-value=3.7e-11 Score=135.53 Aligned_cols=149 Identities=15% Similarity=0.225 Sum_probs=94.6
Q ss_pred hcCCCCceeeccccceEEEEEEeCC-CCEEEEEEccccccc---------------------CC-CCC--------h---
Q 044366 645 TGNFGEKYCIGKGGQRSVYKAELPS-GNIFAVKKFKAELFS---------------------DE-TAN--------P--- 690 (918)
Q Consensus 645 ~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~---------------------~~-~~~--------~--- 690 (918)
...|+. +.||+|++|.||+|++.+ |+.||||+.+..... .. ... .
T Consensus 119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l 197 (537)
T PRK04750 119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL 197 (537)
T ss_pred HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence 345766 789999999999998877 999999998754211 00 000 1
Q ss_pred ---HHHHHHHHHHhhcc----CCceeeEeccc-ccCCceEEEEEeccCCChhHHh--hccc-ccCCCCHHHHHHHHHHHH
Q 044366 691 ---SEFLNEVLALTEIR----HRNIIKFHGFC-SNAQHSFIVCEYLARGSLTTIL--RDDA-AAKEFSWNQRMNVIKGVA 759 (918)
Q Consensus 691 ---~~~~~e~~~l~~l~----h~niv~~~~~~-~~~~~~~lv~e~~~~gsL~~~l--~~~~-~~~~l~~~~~~~i~~~i~ 759 (918)
-+|.+|+..+.+++ +...+.+-.++ ......++||||++|+.+.++- ...+ ....+....+..++.|+
T Consensus 198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi- 276 (537)
T PRK04750 198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV- 276 (537)
T ss_pred HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH-
Confidence 12444554444442 33223222222 1134578999999999998753 2221 01112223333333443
Q ss_pred HHHHHHHhCCCCCeEEcCCCCCCeeeCCCC----cEEEeccccccccCC
Q 044366 760 NALSYLHHDCIPPIVHRDISSKNVLLDSEY----EAHVSDFGFAKFLEP 804 (918)
Q Consensus 760 ~~l~~LH~~~~~~ivH~dlk~~Nill~~~~----~~kl~DfG~~~~~~~ 804 (918)
... |++|+|+||.||+++.++ .+++.|||++..+.+
T Consensus 277 ------f~~---GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 277 ------FRD---GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred ------HhC---CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 345 999999999999999988 999999999987653
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.28 E-value=2.4e-12 Score=123.02 Aligned_cols=126 Identities=29% Similarity=0.290 Sum_probs=44.6
Q ss_pred hhccccCceecccccccCCCCCCCC-CCCcccEEeccCccccccCccccccccccceecccCcccCCCCchhhccccccc
Q 044366 402 VKLFSLNKLILSLNQLFGGVPLEFG-TLTELQYLDLSANKLSSSIPMSIGNLLKLHYLNLSNNQFSHKIPTEFEKLIHLS 480 (918)
Q Consensus 402 ~~l~~L~~L~L~~N~l~~~~~~~~~-~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~ 480 (918)
.+..++++|+|++|+|+.+. .++ .+.+|+.||||+|.|+.+ +.+..++.|++|++++|+|+.+.+.....+++|+
T Consensus 16 ~n~~~~~~L~L~~n~I~~Ie--~L~~~l~~L~~L~Ls~N~I~~l--~~l~~L~~L~~L~L~~N~I~~i~~~l~~~lp~L~ 91 (175)
T PF14580_consen 16 NNPVKLRELNLRGNQISTIE--NLGATLDKLEVLDLSNNQITKL--EGLPGLPRLKTLDLSNNRISSISEGLDKNLPNLQ 91 (175)
T ss_dssp ----------------------S--TT-TT--EEE-TTS--S----TT----TT--EEE--SS---S-CHHHHHH-TT--
T ss_pred cccccccccccccccccccc--chhhhhcCCCEEECCCCCCccc--cCccChhhhhhcccCCCCCCccccchHHhCCcCC
Confidence 33445666666666665432 233 467788888888888754 3577778888888888888754332234578888
Q ss_pred eEeccCCcCCCCC-chhccccCCcceEecCCCcccccC---cccccCCCCccEEE
Q 044366 481 ELDLSHNILQEEI-PPQICKMESLEKLNLSHNNLSDFI---PRCFEEMRSLSWID 531 (918)
Q Consensus 481 ~L~Ls~N~l~~~~-~~~~~~l~~L~~L~L~~N~l~~~~---~~~~~~l~~L~~l~ 531 (918)
+|+|++|+|.+.. -..+..+++|+.|+|.+|+++... ...+..+|+|+.||
T Consensus 92 ~L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~~~~~YR~~vi~~lP~Lk~LD 146 (175)
T PF14580_consen 92 ELYLSNNKISDLNELEPLSSLPKLRVLSLEGNPVCEKKNYRLFVIYKLPSLKVLD 146 (175)
T ss_dssp EEE-TTS---SCCCCGGGGG-TT--EEE-TT-GGGGSTTHHHHHHHH-TT-SEET
T ss_pred EEECcCCcCCChHHhHHHHcCCCcceeeccCCcccchhhHHHHHHHHcChhheeC
Confidence 8888888886532 245667778888888888877531 12345677777764
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.28 E-value=6.5e-11 Score=130.58 Aligned_cols=168 Identities=18% Similarity=0.253 Sum_probs=129.5
Q ss_pred EeCCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEEEEEeccCCChhHHhhcccccCC
Q 044366 666 ELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFIVCEYLARGSLTTILRDDAAAKE 745 (918)
Q Consensus 666 ~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~ 745 (918)
+..++.+|.|..++... . .......+-++.++.++||+|+++++.+..++..|+|+|.+. .|..++.+.
T Consensus 33 ~k~~~~~vsVF~~~~~~---~-~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l----- 101 (690)
T KOG1243|consen 33 RKADGGPVSVFVYKRSN---G-EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKEL----- 101 (690)
T ss_pred eeccCCceEEEEEeCCC---c-hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHh-----
Confidence 55578899999886532 1 224556778888999999999999999999999999999884 677787653
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccCCCCCCceecccccccccccccc
Q 044366 746 FSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGTVGYAAPELAY 825 (918)
Q Consensus 746 l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~g~~~y~aPE~~~ 825 (918)
....+.-.+.||+.||.|||..| +++|++|....|+|+..|..||++|.+++.............--..|..|+.+.
T Consensus 102 -~~~~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~ 178 (690)
T KOG1243|consen 102 -GKEEVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEID 178 (690)
T ss_pred -HHHHHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcccccchhhhcccChhhcC
Confidence 34556667899999999999876 999999999999999999999999998876543322112222233566676543
Q ss_pred cCCCCcccchhhHHHHHHHHHhCC
Q 044366 826 TMRATEKYDVYSFGVLALEVIKGY 849 (918)
Q Consensus 826 ~~~~~~~~Dv~slG~vl~el~tg~ 849 (918)
... -..|.|.||++++|++.|.
T Consensus 179 ~s~--~s~D~~~Lg~li~el~ng~ 200 (690)
T KOG1243|consen 179 PSE--WSIDSWGLGCLIEELFNGS 200 (690)
T ss_pred ccc--cchhhhhHHHHHHHHhCcc
Confidence 322 2469999999999999993
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.23 E-value=3.7e-11 Score=117.71 Aligned_cols=131 Identities=20% Similarity=0.202 Sum_probs=96.2
Q ss_pred ceeeccccceEEEEEEeCCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCce-eeEecccccCCceEEEEEecc
Q 044366 651 KYCIGKGGQRSVYKAELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNI-IKFHGFCSNAQHSFIVCEYLA 729 (918)
Q Consensus 651 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~~~ 729 (918)
.+.++.|.++.||+++.. |+.|++|...... .....+..|+..++.+.+..+ .+++++. ....++||||++
T Consensus 3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~-----~~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~ 74 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGT-----ELLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIE 74 (170)
T ss_pred eeecCCcccCceEEEEEC-CeEEEEEeCCCCc-----ccccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecC
Confidence 356899999999999864 7889999875421 112356789999998865444 3455443 234589999999
Q ss_pred CCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCeEEcCCCCCCeeeCCCCcEEEeccccccc
Q 044366 730 RGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDC--IPPIVHRDISSKNVLLDSEYEAHVSDFGFAKF 801 (918)
Q Consensus 730 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~ 801 (918)
+.++.+. . . ....++.+++++++.||+.. ..+++|+|++|.||+++ ++.++++|||.+..
T Consensus 75 G~~l~~~--~------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 75 GSELLTE--D------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred CCccccc--c------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 9887643 0 0 11345678999999999982 12369999999999999 66899999998863
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.22 E-value=1.4e-11 Score=144.57 Aligned_cols=114 Identities=30% Similarity=0.379 Sum_probs=106.6
Q ss_pred cccEEeccCccccccCccccccccccceecccCcccCCCCchhhccccccceEeccCCcCCCCCchhccccCCcceEecC
Q 044366 430 ELQYLDLSANKLSSSIPMSIGNLLKLHYLNLSNNQFSHKIPTEFEKLIHLSELDLSHNILQEEIPPQICKMESLEKLNLS 509 (918)
Q Consensus 430 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~ 509 (918)
.++.|+|++|.+++.+|..+..+++|+.|+|++|++++.+|..+..+++|+.|||++|++++.+|..+..+++|+.|+|+
T Consensus 419 ~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls 498 (623)
T PLN03150 419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLN 498 (623)
T ss_pred EEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECc
Confidence 48899999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCcccccCcccccCC-CCccEEEccCCcCCCCCCC
Q 044366 510 HNNLSDFIPRCFEEM-RSLSWIDISYNELQGPIPN 543 (918)
Q Consensus 510 ~N~l~~~~~~~~~~l-~~L~~l~l~~N~l~~~~p~ 543 (918)
+|++++.+|..+..+ .++..+++++|+..|..|.
T Consensus 499 ~N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~p~ 533 (623)
T PLN03150 499 GNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIPG 533 (623)
T ss_pred CCcccccCChHHhhccccCceEEecCCccccCCCC
Confidence 999999999988764 5678999999998887664
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.22 E-value=2.3e-12 Score=126.86 Aligned_cols=129 Identities=30% Similarity=0.283 Sum_probs=76.4
Q ss_pred CCCCEEEccCCcccccCccccCCCCCCCEEECcCCcCCCcCCcCCCCCCCCceeeccccccccCCCcccccccccCeeec
Q 044366 93 SNLALLYLNDNSLFGSIPIVMGNLKSLSTLDLSQNQLNGSIPCSLDNLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDL 172 (918)
Q Consensus 93 ~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 172 (918)
+.|++||||+|.|+ .+.+.+.-++.++.|++|+|.|..+ ..++.|++|+.|+|++|.++.+ .++=.++.+.+.|.|
T Consensus 284 q~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~v--~nLa~L~~L~~LDLS~N~Ls~~-~Gwh~KLGNIKtL~L 359 (490)
T KOG1259|consen 284 QELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIRTV--QNLAELPQLQLLDLSGNLLAEC-VGWHLKLGNIKTLKL 359 (490)
T ss_pred hhhhhccccccchh-hhhhhhhhccceeEEeccccceeee--hhhhhcccceEeecccchhHhh-hhhHhhhcCEeeeeh
Confidence 45666666666665 3444555556666666666666633 2366666666666666666632 333345666666666
Q ss_pred cccccCCcCCccCCCCCCCcEeeccCcccccCC-CccccCCCCcceeecccccccC
Q 044366 173 SENRLSGLIPLSLSNLSSLTVMSLFNNSLSGSI-PPILGNLKSLSTLGLHINQLNG 227 (918)
Q Consensus 173 s~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~-~~~~~~l~~L~~L~L~~n~l~~ 227 (918)
+.|.|.++ ..+..+-+|..||+++|+|.... -..++++|-|+.|.|.+|.+..
T Consensus 360 a~N~iE~L--SGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~ 413 (490)
T KOG1259|consen 360 AQNKIETL--SGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAG 413 (490)
T ss_pred hhhhHhhh--hhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCccc
Confidence 66666643 34555556666666666665321 1345666667777777776653
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.22 E-value=1.8e-12 Score=127.63 Aligned_cols=129 Identities=28% Similarity=0.327 Sum_probs=73.1
Q ss_pred CCCCceeeccccccccCCCcccccccccCeeeccccccCCcCCccCCCCCCCcEeeccCcccccCCCccccCCCCcceee
Q 044366 140 LSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSENRLSGLIPLSLSNLSSLTVMSLFNNSLSGSIPPILGNLKSLSTLG 219 (918)
Q Consensus 140 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 219 (918)
...|++|+|++|.|+ .+.+...-+|.++.|++|+|.|..+ +.+..+++|+.|||++|.++. ..++-..+-+.++|.
T Consensus 283 Wq~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~v--~nLa~L~~L~~LDLS~N~Ls~-~~Gwh~KLGNIKtL~ 358 (490)
T KOG1259|consen 283 WQELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIRTV--QNLAELPQLQLLDLSGNLLAE-CVGWHLKLGNIKTLK 358 (490)
T ss_pred Hhhhhhccccccchh-hhhhhhhhccceeEEeccccceeee--hhhhhcccceEeecccchhHh-hhhhHhhhcCEeeee
Confidence 345666666666666 3344555566666666666666644 235666666666666666652 344445555666666
Q ss_pred cccccccCCCCCCCcCCCcCCeEEcccCcCcCCC-CccccccCCCCeEecCCCccC
Q 044366 220 LHINQLNGVIPPSIGNLSSLRNLSLFNNRLYGFV-PKEIGYLKSLSKLEFCANHLS 274 (918)
Q Consensus 220 L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~-~~~~~~l~~L~~L~l~~n~l~ 274 (918)
|+.|.|... ..+..+-+|..||+++|+|.... ...++.+|-|+.+.|.+|++.
T Consensus 359 La~N~iE~L--SGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~ 412 (490)
T KOG1259|consen 359 LAQNKIETL--SGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLA 412 (490)
T ss_pred hhhhhHhhh--hhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCcc
Confidence 666666533 34455556666666666665321 123455555555555555555
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.21 E-value=1.7e-12 Score=145.86 Aligned_cols=224 Identities=30% Similarity=0.309 Sum_probs=108.1
Q ss_pred ccCCCCCCEEEccCCcccccCccccCCCCCCCEEECcCCcCCCcCCcCCCCCCCCceeeccccccccCCCcccccccccC
Q 044366 89 LGNLSNLALLYLNDNSLFGSIPIVMGNLKSLSTLDLSQNQLNGSIPCSLDNLSNLDTLFLYKNSLSGPIPSVIGNLKSLL 168 (918)
Q Consensus 89 l~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~ 168 (918)
+..+++|+.|++.+|+|..+ ...+..+++|++|+|++|+|+.+ ..+..++.|+.|++++|.|+.+ ..+..+++|+
T Consensus 91 l~~~~~l~~l~l~~n~i~~i-~~~l~~~~~L~~L~ls~N~I~~i--~~l~~l~~L~~L~l~~N~i~~~--~~~~~l~~L~ 165 (414)
T KOG0531|consen 91 LSKLKSLEALDLYDNKIEKI-ENLLSSLVNLQVLDLSFNKITKL--EGLSTLTLLKELNLSGNLISDI--SGLESLKSLK 165 (414)
T ss_pred cccccceeeeeccccchhhc-ccchhhhhcchheeccccccccc--cchhhccchhhheeccCcchhc--cCCccchhhh
Confidence 44445555555555555422 21244455555555555555533 2344445555555555555533 3344455555
Q ss_pred eeeccccccCCcCC-ccCCCCCCCcEeeccCcccccCCCccccCCCCcceeecccccccCCCCCCCcCCCc--CCeEEcc
Q 044366 169 QLDLSENRLSGLIP-LSLSNLSSLTVMSLFNNSLSGSIPPILGNLKSLSTLGLHINQLNGVIPPSIGNLSS--LRNLSLF 245 (918)
Q Consensus 169 ~L~Ls~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~--L~~L~Ls 245 (918)
.+++++|++..+.+ . ...+.+++.+.+.+|.+..+ ..+..+..+..+++..|.++... .+..+.. |+.++++
T Consensus 166 ~l~l~~n~i~~ie~~~-~~~~~~l~~l~l~~n~i~~i--~~~~~~~~l~~~~l~~n~i~~~~--~l~~~~~~~L~~l~l~ 240 (414)
T KOG0531|consen 166 LLDLSYNRIVDIENDE-LSELISLEELDLGGNSIREI--EGLDLLKKLVLLSLLDNKISKLE--GLNELVMLHLRELYLS 240 (414)
T ss_pred cccCCcchhhhhhhhh-hhhccchHHHhccCCchhcc--cchHHHHHHHHhhcccccceecc--CcccchhHHHHHHhcc
Confidence 55555555554432 1 34455555555555555422 33344444444455555554331 1222222 5556666
Q ss_pred cCcCcCCCCccccccCCCCeEecCCCccCCcCCCcCCCCCCCcEEEccCCcCcCC---CCcc-ccCCCCCCeEEeecccc
Q 044366 246 NNRLYGFVPKEIGYLKSLSKLEFCANHLSGVIPHSVGNLTGLVLLNMCENHLFGP---IPKS-LRNLTSLERVRFNQNNL 321 (918)
Q Consensus 246 ~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~---~~~~-l~~l~~L~~L~l~~n~l 321 (918)
+|++... +..+..+..+..|++.+|++.... .+...+.+..+....|.+... .... ......++.+.+..|.+
T Consensus 241 ~n~i~~~-~~~~~~~~~l~~l~~~~n~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (414)
T KOG0531|consen 241 GNRISRS-PEGLENLKNLPVLDLSSNRISNLE--GLERLPKLSELWLNDNKLALSEAISQEYITSAAPTLVTLTLELNPI 317 (414)
T ss_pred cCccccc-cccccccccccccchhhccccccc--cccccchHHHhccCcchhcchhhhhccccccccccccccccccCcc
Confidence 6655522 234445555555666655554322 233344455555555554311 1111 34455666666666666
Q ss_pred cCcc
Q 044366 322 YGKV 325 (918)
Q Consensus 322 ~~~~ 325 (918)
....
T Consensus 318 ~~~~ 321 (414)
T KOG0531|consen 318 RKIS 321 (414)
T ss_pred cccc
Confidence 5433
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.20 E-value=2e-12 Score=145.18 Aligned_cols=266 Identities=27% Similarity=0.297 Sum_probs=169.4
Q ss_pred CCCCEEeCCCCcccccCCccc-cCCCCCCEEEcccccccccCCCCcCCCCCCCEEEcccccccccCCccccCCCCCCEEE
Q 044366 21 SKLQYLDLGNNQLSGVIPPEI-GKLNQLRRLYLDVNQLHGTIPPVIGQLSLINELVFCHNNVSGRIPSSLGNLSNLALLY 99 (918)
Q Consensus 21 ~~L~~L~L~~n~i~~~~p~~l-~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~l~~l~~L~~L~ 99 (918)
+.++.++..++.+... ..+ ..+..++.++++.|.+. .+-..+..+++|+.|++..|.+. .+...+..+++|++|+
T Consensus 49 ~~~~~~~~~~~~~~~~--~~~~~~l~~l~~l~l~~n~i~-~~~~~l~~~~~l~~l~l~~n~i~-~i~~~l~~~~~L~~L~ 124 (414)
T KOG0531|consen 49 SDLEEIDLIFNLDGSD--EDLVESLTSLKELNLRQNLIA-KILNHLSKLKSLEALDLYDNKIE-KIENLLSSLVNLQVLD 124 (414)
T ss_pred chhhhhcchhccccch--hhhHHHhHhHHhhccchhhhh-hhhcccccccceeeeeccccchh-hcccchhhhhcchhee
Confidence 3455555555554321 112 45666666777777766 34444666777777777777776 3333366677777888
Q ss_pred ccCCcccccCccccCCCCCCCEEECcCCcCCCcCCcCCCCCCCCceeeccccccccCCC-cccccccccCeeeccccccC
Q 044366 100 LNDNSLFGSIPIVMGNLKSLSTLDLSQNQLNGSIPCSLDNLSNLDTLFLYKNSLSGPIP-SVIGNLKSLLQLDLSENRLS 178 (918)
Q Consensus 100 L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~l~~~~~-~~~~~l~~L~~L~Ls~N~l~ 178 (918)
+++|.|+.+. .+..++.|+.|++++|.|+.. ..+..+++|+.+++++|++..+.+ . ...+.+++.+++++|.+.
T Consensus 125 ls~N~I~~i~--~l~~l~~L~~L~l~~N~i~~~--~~~~~l~~L~~l~l~~n~i~~ie~~~-~~~~~~l~~l~l~~n~i~ 199 (414)
T KOG0531|consen 125 LSFNKITKLE--GLSTLTLLKELNLSGNLISDI--SGLESLKSLKLLDLSYNRIVDIENDE-LSELISLEELDLGGNSIR 199 (414)
T ss_pred cccccccccc--chhhccchhhheeccCcchhc--cCCccchhhhcccCCcchhhhhhhhh-hhhccchHHHhccCCchh
Confidence 8888776543 355666677888888877733 355557777888888888775543 2 567777888888888777
Q ss_pred CcCCccCCCCCCCcEeeccCcccccCCCccccCCC--CcceeecccccccCCCCCCCcCCCcCCeEEcccCcCcCCCCcc
Q 044366 179 GLIPLSLSNLSSLTVMSLFNNSLSGSIPPILGNLK--SLSTLGLHINQLNGVIPPSIGNLSSLRNLSLFNNRLYGFVPKE 256 (918)
Q Consensus 179 ~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~--~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~ 256 (918)
.+ ..+..+..+..+++..|.++.+.+ +..+. +|+.+++++|.+... +..+..+..+..|++++|++... ..
T Consensus 200 ~i--~~~~~~~~l~~~~l~~n~i~~~~~--l~~~~~~~L~~l~l~~n~i~~~-~~~~~~~~~l~~l~~~~n~~~~~--~~ 272 (414)
T KOG0531|consen 200 EI--EGLDLLKKLVLLSLLDNKISKLEG--LNELVMLHLRELYLSGNRISRS-PEGLENLKNLPVLDLSSNRISNL--EG 272 (414)
T ss_pred cc--cchHHHHHHHHhhcccccceeccC--cccchhHHHHHHhcccCccccc-cccccccccccccchhhcccccc--cc
Confidence 44 344555556666777777764422 23333 377888888887632 24566777888888888887643 33
Q ss_pred ccccCCCCeEecCCCccCCc---CCCc-CCCCCCCcEEEccCCcCcCCCC
Q 044366 257 IGYLKSLSKLEFCANHLSGV---IPHS-VGNLTGLVLLNMCENHLFGPIP 302 (918)
Q Consensus 257 ~~~l~~L~~L~l~~n~l~~~---~~~~-~~~l~~L~~L~l~~n~l~~~~~ 302 (918)
+...+.+..+....|++... .... ......+....+..|.+....+
T Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (414)
T KOG0531|consen 273 LERLPKLSELWLNDNKLALSEAISQEYITSAAPTLVTLTLELNPIRKISS 322 (414)
T ss_pred ccccchHHHhccCcchhcchhhhhccccccccccccccccccCccccccc
Confidence 45566677777777776522 1111 4456677788888887765544
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.17 E-value=3.8e-10 Score=110.23 Aligned_cols=140 Identities=19% Similarity=0.220 Sum_probs=99.2
Q ss_pred eeeccccceEEEEEEeCC-------CCEEEEEEccccccc---------CC---------CCChHHHH----HHHHHHhh
Q 044366 652 YCIGKGGQRSVYKAELPS-------GNIFAVKKFKAELFS---------DE---------TANPSEFL----NEVLALTE 702 (918)
Q Consensus 652 ~~lg~G~~g~Vy~~~~~~-------~~~vavK~~~~~~~~---------~~---------~~~~~~~~----~e~~~l~~ 702 (918)
..||.|--+.||.|.-.+ +..+|||+++..... .+ ....+.+. +|...+++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 468999999999996442 579999987542110 00 00122333 78888888
Q ss_pred ccC--CceeeEecccccCCceEEEEEeccCCChhH-HhhcccccCCCCHHHHHHHHHHHHHHHHHH-HhCCCCCeEEcCC
Q 044366 703 IRH--RNIIKFHGFCSNAQHSFIVCEYLARGSLTT-ILRDDAAAKEFSWNQRMNVIKGVANALSYL-HHDCIPPIVHRDI 778 (918)
Q Consensus 703 l~h--~niv~~~~~~~~~~~~~lv~e~~~~gsL~~-~l~~~~~~~~l~~~~~~~i~~~i~~~l~~L-H~~~~~~ivH~dl 778 (918)
+.. -++...+++ ...++||||+.++.+.. .+++ ..++.++...+..+++.++..+ |.. ++||||+
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd----~~~~~~~~~~i~~~i~~~l~~l~H~~---glVHGDL 151 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD----AKLNDEEMKNAYYQVLSMMKQLYKEC---NLVHADL 151 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc----cccCHHHHHHHHHHHHHHHHHHHHhC---CeecCCC
Confidence 843 456666654 45789999997654422 2222 1245556778889999999999 788 9999999
Q ss_pred CCCCeeeCCCCcEEEeccccccccC
Q 044366 779 SSKNVLLDSEYEAHVSDFGFAKFLE 803 (918)
Q Consensus 779 k~~Nill~~~~~~kl~DfG~~~~~~ 803 (918)
+++||+++ ++.++++|||-+....
T Consensus 152 s~~NIL~~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 152 SEYNMLWH-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred CHHHEEEE-CCcEEEEECCCceeCC
Confidence 99999997 4689999999887654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.16 E-value=2e-11 Score=116.73 Aligned_cols=107 Identities=36% Similarity=0.374 Sum_probs=30.0
Q ss_pred CCCCCEEEccCCcccccCccccC-CCCCCCEEECcCCcCCCcCCcCCCCCCCCceeeccccccccCCCcccccccccCee
Q 044366 92 LSNLALLYLNDNSLFGSIPIVMG-NLKSLSTLDLSQNQLNGSIPCSLDNLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQL 170 (918)
Q Consensus 92 l~~L~~L~L~~n~i~~~~~~~~~-~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 170 (918)
..++++|+|.+|.|+.+ +.++ .+.+|+.|||++|.|+.. +.+..+++|++|++++|+|+.+.+.....+++|++|
T Consensus 18 ~~~~~~L~L~~n~I~~I--e~L~~~l~~L~~L~Ls~N~I~~l--~~l~~L~~L~~L~L~~N~I~~i~~~l~~~lp~L~~L 93 (175)
T PF14580_consen 18 PVKLRELNLRGNQISTI--ENLGATLDKLEVLDLSNNQITKL--EGLPGLPRLKTLDLSNNRISSISEGLDKNLPNLQEL 93 (175)
T ss_dssp --------------------S--TT-TT--EEE-TTS--S----TT----TT--EEE--SS---S-CHHHHHH-TT--EE
T ss_pred ccccccccccccccccc--cchhhhhcCCCEEECCCCCCccc--cCccChhhhhhcccCCCCCCccccchHHhCCcCCEE
Confidence 34566666666666533 2333 456666666666666633 245666666666666666664422222346666666
Q ss_pred eccccccCCcCC-ccCCCCCCCcEeeccCcccc
Q 044366 171 DLSENRLSGLIP-LSLSNLSSLTVMSLFNNSLS 202 (918)
Q Consensus 171 ~Ls~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~ 202 (918)
++++|+|..... ..+..+++|+.|+|.+|.++
T Consensus 94 ~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~ 126 (175)
T PF14580_consen 94 YLSNNKISDLNELEPLSSLPKLRVLSLEGNPVC 126 (175)
T ss_dssp E-TTS---SCCCCGGGGG-TT--EEE-TT-GGG
T ss_pred ECcCCcCCChHHhHHHHcCCCcceeeccCCccc
Confidence 666666664322 24455566666666666655
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.16 E-value=2.4e-11 Score=133.10 Aligned_cols=248 Identities=19% Similarity=0.196 Sum_probs=174.9
Q ss_pred HHHhcCCCCceeeccccceEEEEEEe--CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhc-cCCceeeEecccccC
Q 044366 642 TKATGNFGEKYCIGKGGQRSVYKAEL--PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEI-RHRNIIKFHGFCSNA 718 (918)
Q Consensus 642 ~~~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~ 718 (918)
-.-..+|..+..||.|.|+.|++... .++..|++|.......... ....-..|+.+...+ .|.+++++...|...
T Consensus 261 s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~--~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~ 338 (524)
T KOG0601|consen 261 SCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFA--SDIFSLGEVILEAILGSHLPSVGKNSSWSQL 338 (524)
T ss_pred eeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchH--hhhcchhhhhHhhHhhcccccCCCCCCcccc
Confidence 34567899999999999999999843 4688999998866433221 112235566666555 599999998888888
Q ss_pred CceEEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCC-CcEEEeccc
Q 044366 719 QHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSE-YEAHVSDFG 797 (918)
Q Consensus 719 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~-~~~kl~DfG 797 (918)
+..++--||+++++......- ...+++..++++..|++.++.++|+. .++|+|++|+||++..+ +..+++|||
T Consensus 339 r~~~ip~e~~~~~s~~l~~~~---~~~~d~~~~~~~~~q~~~~l~~i~s~---~~~~~d~~psni~i~~~~~~~~~~~~~ 412 (524)
T KOG0601|consen 339 RQGYIPLEFCEGGSSSLRSVT---SQMLDEDPRLRLTAQILTALNVIHSK---LFVHLDVKPSNILISNDGFFSKLGDFG 412 (524)
T ss_pred ccccCchhhhcCcchhhhhHH---HHhcCcchhhhhHHHHHhccccccch---hhhcccccccceeeccchhhhhccccc
Confidence 888899999999988877632 33467788999999999999999998 99999999999999886 778999999
Q ss_pred cccccCCCCCCceeccccccc-ccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccC
Q 044366 798 FAKFLEPHSSNWTEFAGTVGY-AAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHR 876 (918)
Q Consensus 798 ~~~~~~~~~~~~~~~~g~~~y-~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 876 (918)
.+..+.-. .......+..| .+|+......+-.+.|+|+||.-+.+.++|..--+.... ...+....
T Consensus 413 ~~t~~~~~--~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~-----------~~~i~~~~ 479 (524)
T KOG0601|consen 413 CWTRLAFS--SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQ-----------SLTIRSGD 479 (524)
T ss_pred ccccccee--cccccccccccccchhhccccccccccccccccccccccccCcccCccccc-----------ceeeeccc
Confidence 98753211 11112223334 355555666778899999999999999998664221111 11111222
Q ss_pred CCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 877 LPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 877 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
.+..... ...+..+...+...++..||.+.+...
T Consensus 480 ~p~~~~~----~~~~q~~~kv~~~~~~~~~~l~~~l~~ 513 (524)
T KOG0601|consen 480 TPNLPGL----KLQLQVLLKVMINPDRKRRPSAVELSL 513 (524)
T ss_pred ccCCCch----HHhhhhhhhhhcCCccccchhhhhhcc
Confidence 2221111 134555666688999999999887654
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=99.13 E-value=7.3e-12 Score=130.09 Aligned_cols=86 Identities=27% Similarity=0.200 Sum_probs=32.8
Q ss_pred CCCceeeccccccccCCC-cccccccccCeeeccccccCCcCCccCCCCCCCcEeeccCcccccCC-CccccCCCCccee
Q 044366 141 SNLDTLFLYKNSLSGPIP-SVIGNLKSLLQLDLSENRLSGLIPLSLSNLSSLTVMSLFNNSLSGSI-PPILGNLKSLSTL 218 (918)
Q Consensus 141 ~~L~~L~L~~n~l~~~~~-~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~-~~~~~~l~~L~~L 218 (918)
+.|+.|.|+.|.++...- ..+..+|+|+.|+|..|...........-+..|+.|+|++|.+.... -...+.++.|..|
T Consensus 197 ~~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li~~~~~~~~~~l~~L~~L 276 (505)
T KOG3207|consen 197 SHLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLIDFDQGYKVGTLPGLNQL 276 (505)
T ss_pred hhhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCCcccccccccccccccchhhh
Confidence 344444444444442111 12233444444444444322121222223334444444444443211 0223344444444
Q ss_pred eccccccc
Q 044366 219 GLHINQLN 226 (918)
Q Consensus 219 ~L~~n~l~ 226 (918)
+++.|.+.
T Consensus 277 nls~tgi~ 284 (505)
T KOG3207|consen 277 NLSSTGIA 284 (505)
T ss_pred hccccCcc
Confidence 44444443
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=99.12 E-value=7.2e-12 Score=130.15 Aligned_cols=210 Identities=23% Similarity=0.268 Sum_probs=109.3
Q ss_pred CCCCCCCEEeCCCCcccccCC--ccccCCCCCCEEEcccccccc--cCCCCcCCCCCCCEEEcccccccccCCccccCCC
Q 044366 18 GNLSKLQYLDLGNNQLSGVIP--PEIGKLNQLRRLYLDVNQLHG--TIPPVIGQLSLINELVFCHNNVSGRIPSSLGNLS 93 (918)
Q Consensus 18 ~~l~~L~~L~L~~n~i~~~~p--~~l~~l~~L~~L~L~~n~l~~--~~p~~~~~l~~L~~L~l~~n~~~~~~p~~l~~l~ 93 (918)
+++++|++..|.++.+. ..+ .....|++++.|||++|-+.. .+-.-..+|++|+.|+++.|.+.--.....
T Consensus 118 sn~kkL~~IsLdn~~V~-~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~---- 192 (505)
T KOG3207|consen 118 SNLKKLREISLDNYRVE-DAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNT---- 192 (505)
T ss_pred hhHHhhhheeecCcccc-ccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccc----
Confidence 45666777777777765 333 245567777777777776652 122223445555555555554431111100
Q ss_pred CCCEEEccCCcccccCccccCCCCCCCEEECcCCcCCCc-CCcCCCCCCCCceeeccccccccCCCcccccccccCeeec
Q 044366 94 NLALLYLNDNSLFGSIPIVMGNLKSLSTLDLSQNQLNGS-IPCSLDNLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDL 172 (918)
Q Consensus 94 ~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~-~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 172 (918)
-..++.|+.|.|++|.++.. +-..+...++|+.|+|.+|....+......-++.|+.|||
T Consensus 193 -------------------~~~l~~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdL 253 (505)
T KOG3207|consen 193 -------------------TLLLSHLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDL 253 (505)
T ss_pred -------------------hhhhhhhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccc
Confidence 11234555555555555421 1111233455555555555322222333344555666666
Q ss_pred cccccCCcCC-ccCCCCCCCcEeeccCcccccCC-Ccc-----ccCCCCcceeecccccccCCC-CCCCcCCCcCCeEEc
Q 044366 173 SENRLSGLIP-LSLSNLSSLTVMSLFNNSLSGSI-PPI-----LGNLKSLSTLGLHINQLNGVI-PPSIGNLSSLRNLSL 244 (918)
Q Consensus 173 s~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~-~~~-----~~~l~~L~~L~L~~n~l~~~~-~~~~~~l~~L~~L~L 244 (918)
++|.+-+... .....++.|+.|+++.|.++.+- |+. ...+++|++|++..|++.... -..+..+++|+.|.+
T Consensus 254 s~N~li~~~~~~~~~~l~~L~~Lnls~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~~w~sl~~l~~l~nlk~l~~ 333 (505)
T KOG3207|consen 254 SNNNLIDFDQGYKVGTLPGLNQLNLSSTGIASIAEPDVESLDKTHTFPKLEYLNISENNIRDWRSLNHLRTLENLKHLRI 333 (505)
T ss_pred cCCcccccccccccccccchhhhhccccCcchhcCCCccchhhhcccccceeeecccCccccccccchhhccchhhhhhc
Confidence 6655543321 23445556666666666655322 222 345678888888888875431 123445667788888
Q ss_pred ccCcCcC
Q 044366 245 FNNRLYG 251 (918)
Q Consensus 245 s~n~l~~ 251 (918)
..|.+..
T Consensus 334 ~~n~ln~ 340 (505)
T KOG3207|consen 334 TLNYLNK 340 (505)
T ss_pred ccccccc
Confidence 8888864
|
|
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.06 E-value=7.4e-11 Score=140.93 Aligned_cols=128 Identities=30% Similarity=0.384 Sum_probs=64.3
Q ss_pred CCCCEEeCCCCcccccCCccccCCCCCCEEEccccc--ccccCCCCcCCCCCCCEEEcccccccccCCccccCCCCCCEE
Q 044366 21 SKLQYLDLGNNQLSGVIPPEIGKLNQLRRLYLDVNQ--LHGTIPPVIGQLSLINELVFCHNNVSGRIPSSLGNLSNLALL 98 (918)
Q Consensus 21 ~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~n~--l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~l~~l~~L~~L 98 (918)
...+...+-+|++. .++.....- +|+.|-+..|. +....++.|..++.|+.|||++|.-.+.+|.+++.|-+|++|
T Consensus 523 ~~~rr~s~~~~~~~-~~~~~~~~~-~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~LryL 600 (889)
T KOG4658|consen 523 NSVRRMSLMNNKIE-HIAGSSENP-KLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHLRYL 600 (889)
T ss_pred hheeEEEEeccchh-hccCCCCCC-ccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhhhcc
Confidence 44455555555554 333322222 45555555553 331222234455555555555555545555555555555555
Q ss_pred EccCCcccccCccccCCCCCCCEEECcCCcCCCcCCcCCCCCCCCceeecccc
Q 044366 99 YLNDNSLFGSIPIVMGNLKSLSTLDLSQNQLNGSIPCSLDNLSNLDTLFLYKN 151 (918)
Q Consensus 99 ~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n 151 (918)
+|++..|. ..|..+.+|++|.+|++..+.-...+|.....|++|++|.+...
T Consensus 601 ~L~~t~I~-~LP~~l~~Lk~L~~Lnl~~~~~l~~~~~i~~~L~~Lr~L~l~~s 652 (889)
T KOG4658|consen 601 DLSDTGIS-HLPSGLGNLKKLIYLNLEVTGRLESIPGILLELQSLRVLRLPRS 652 (889)
T ss_pred cccCCCcc-ccchHHHHHHhhheeccccccccccccchhhhcccccEEEeecc
Confidence 55555554 45555555555555555555443334444444555555555443
|
|
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.05 E-value=4.6e-12 Score=128.19 Aligned_cols=134 Identities=20% Similarity=0.149 Sum_probs=71.6
Q ss_pred ccccCeeeccccccCCcCC----ccCCCCCCCcEeeccCcccccC----CCccccCCCCcceeecccccccCCC----CC
Q 044366 164 LKSLLQLDLSENRLSGLIP----LSLSNLSSLTVMSLFNNSLSGS----IPPILGNLKSLSTLGLHINQLNGVI----PP 231 (918)
Q Consensus 164 l~~L~~L~Ls~N~l~~~~~----~~~~~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~L~~n~l~~~~----~~ 231 (918)
-+.|+.+..++|++.+-.. ..|...+.|+.+.+..|.|... ....|..+++|+.|+|..|.++... ..
T Consensus 156 ~~~Lrv~i~~rNrlen~ga~~~A~~~~~~~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~Lak 235 (382)
T KOG1909|consen 156 KPKLRVFICGRNRLENGGATALAEAFQSHPTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALAK 235 (382)
T ss_pred CcceEEEEeeccccccccHHHHHHHHHhccccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHHH
Confidence 3566667777776664322 2345556677777777766421 1134566677777777777665322 23
Q ss_pred CCcCCCcCCeEEcccCcCcCCCCcccc-----ccCCCCeEecCCCccCCcC----CCcCCCCCCCcEEEccCCcC
Q 044366 232 SIGNLSSLRNLSLFNNRLYGFVPKEIG-----YLKSLSKLEFCANHLSGVI----PHSVGNLTGLVLLNMCENHL 297 (918)
Q Consensus 232 ~~~~l~~L~~L~Ls~n~l~~~~~~~~~-----~l~~L~~L~l~~n~l~~~~----~~~~~~l~~L~~L~l~~n~l 297 (918)
.++.+++|+.|++++|.+.......|. ..++|+.|.+.+|.|+... ...+...+.|..|++++|.+
T Consensus 236 aL~s~~~L~El~l~dcll~~~Ga~a~~~al~~~~p~L~vl~l~gNeIt~da~~~la~~~~ek~dL~kLnLngN~l 310 (382)
T KOG1909|consen 236 ALSSWPHLRELNLGDCLLENEGAIAFVDALKESAPSLEVLELAGNEITRDAALALAACMAEKPDLEKLNLNGNRL 310 (382)
T ss_pred HhcccchheeecccccccccccHHHHHHHHhccCCCCceeccCcchhHHHHHHHHHHHHhcchhhHHhcCCcccc
Confidence 345566677777777766644333321 3455666666666555211 11222344445555555544
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.05 E-value=1.3e-09 Score=102.00 Aligned_cols=135 Identities=21% Similarity=0.338 Sum_probs=98.2
Q ss_pred eeccccceEEEEEEeCCCCEEEEEEcccccccCC----CCChHHHHHHHHHHhhccCCceeeEecccccCCceEEEEEec
Q 044366 653 CIGKGGQRSVYKAELPSGNIFAVKKFKAELFSDE----TANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFIVCEYL 728 (918)
Q Consensus 653 ~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~----~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 728 (918)
.+++|+-+.+|.+.+. |.++.+|.-........ .-....-.+|+.++++++--.|...+=+..+.+...++|||+
T Consensus 3 ~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I 81 (204)
T COG3642 3 LIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYI 81 (204)
T ss_pred hhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEe
Confidence 5789999999999773 44555554222111111 111245678888888886544444444556677889999999
Q ss_pred cCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEecccccccc
Q 044366 729 ARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFL 802 (918)
Q Consensus 729 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~ 802 (918)
+|..|.+++... ...++..+-.-+.-||.. ||||+|+.++||++..+. +.++|||++.+-
T Consensus 82 ~G~~lkd~l~~~----------~~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~~-i~~IDfGLg~~s 141 (204)
T COG3642 82 EGELLKDALEEA----------RPDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGGR-IYFIDFGLGEFS 141 (204)
T ss_pred CChhHHHHHHhc----------chHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCCc-EEEEECCccccc
Confidence 999998888764 134666777778889999 999999999999998764 999999999853
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.05 E-value=2e-09 Score=110.62 Aligned_cols=143 Identities=20% Similarity=0.264 Sum_probs=109.8
Q ss_pred eeeccccceEEEEEEeCCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccC--CceeeEecccccC---CceEEEEE
Q 044366 652 YCIGKGGQRSVYKAELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRH--RNIIKFHGFCSNA---QHSFIVCE 726 (918)
Q Consensus 652 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~~~~~~~~~---~~~~lv~e 726 (918)
+.++.|.++.||++...+|+.+++|....... .....++..|+++++.+++ ..+.+++.+.... +..++|||
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~---~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e 80 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGAL---LPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVME 80 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCccc---CcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEE
Confidence 56899999999999876778999998755321 1134578999999999975 3456677776553 35689999
Q ss_pred eccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCC-------------------------------------
Q 044366 727 YLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDC------------------------------------- 769 (918)
Q Consensus 727 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~------------------------------------- 769 (918)
|++++++.+.+.. ..++..+...++.++++++++||+..
T Consensus 81 ~i~G~~l~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (223)
T cd05154 81 RVDGRVLRDRLLR----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPA 156 (223)
T ss_pred EeCCEecCCCCCC----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHH
Confidence 9999888776532 23677778888888999998888531
Q ss_pred ----------------CCCeEEcCCCCCCeeeCC--CCcEEEeccccccc
Q 044366 770 ----------------IPPIVHRDISSKNVLLDS--EYEAHVSDFGFAKF 801 (918)
Q Consensus 770 ----------------~~~ivH~dlk~~Nill~~--~~~~kl~DfG~~~~ 801 (918)
...++|+|+++.||+++. ++.+.++||+.+..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 157 MERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 135799999999999998 56689999998864
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.01 E-value=2.6e-11 Score=122.85 Aligned_cols=133 Identities=25% Similarity=0.372 Sum_probs=80.3
Q ss_pred ccCceecccccccCCC----CCCCCCCCcccEEeccCccccc----cCccccccccccceecccCcccCCC----Cchhh
Q 044366 406 SLNKLILSLNQLFGGV----PLEFGTLTELQYLDLSANKLSS----SIPMSIGNLLKLHYLNLSNNQFSHK----IPTEF 473 (918)
Q Consensus 406 ~L~~L~L~~N~l~~~~----~~~~~~l~~L~~L~Ls~N~l~~----~~~~~~~~l~~L~~L~Ls~N~l~~~----~~~~~ 473 (918)
.|+.+..++|++.... ...|...+.|+.+.++.|.|.. .+...|..++.|+.|||.+|-++.. +..++
T Consensus 158 ~Lrv~i~~rNrlen~ga~~~A~~~~~~~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~LakaL 237 (382)
T KOG1909|consen 158 KLRVFICGRNRLENGGATALAEAFQSHPTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALAKAL 237 (382)
T ss_pred ceEEEEeeccccccccHHHHHHHHHhccccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHHHHh
Confidence 4555555555553322 2234455666666666666652 1233456667777777777766532 33445
Q ss_pred ccccccceEeccCCcCCCCCchhcc-----ccCCcceEecCCCcccc----cCcccccCCCCccEEEccCCcCC
Q 044366 474 EKLIHLSELDLSHNILQEEIPPQIC-----KMESLEKLNLSHNNLSD----FIPRCFEEMRSLSWIDISYNELQ 538 (918)
Q Consensus 474 ~~l~~L~~L~Ls~N~l~~~~~~~~~-----~l~~L~~L~L~~N~l~~----~~~~~~~~l~~L~~l~l~~N~l~ 538 (918)
..+++|++|+++++.+...-..+|. ..++|++|.|.+|.|+. .+..+....+.|..|+|++|++.
T Consensus 238 ~s~~~L~El~l~dcll~~~Ga~a~~~al~~~~p~L~vl~l~gNeIt~da~~~la~~~~ek~dL~kLnLngN~l~ 311 (382)
T KOG1909|consen 238 SSWPHLRELNLGDCLLENEGAIAFVDALKESAPSLEVLELAGNEITRDAALALAACMAEKPDLEKLNLNGNRLG 311 (382)
T ss_pred cccchheeecccccccccccHHHHHHHHhccCCCCceeccCcchhHHHHHHHHHHHHhcchhhHHhcCCccccc
Confidence 6666777777777777654333332 35678888888887764 23445556788888888888874
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.00 E-value=2.8e-09 Score=98.85 Aligned_cols=147 Identities=16% Similarity=0.232 Sum_probs=106.5
Q ss_pred CceeeccccceEEEEEEeCCCCEEEEEEc-----ccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEEE
Q 044366 650 EKYCIGKGGQRSVYKAELPSGNIFAVKKF-----KAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFIV 724 (918)
Q Consensus 650 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~-----~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 724 (918)
....+-+|+-+.|+++.+ .|+.+.||.- +.+... ..-..+..++|+..+.+++--.|....=++.+...-.++
T Consensus 11 ~l~likQGAEArv~~~~~-~Ge~~iIK~Rf~K~YRHP~LD-~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ 88 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF-SGEAAIIKERFSKRYRHPALD-QKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIY 88 (229)
T ss_pred cceeeeccceeeEeeecc-CCceeEEeecccccccchHHH-HHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEE
Confidence 556789999999999987 6787777753 221111 112245678899998888644444333345566667899
Q ss_pred EEeccC-CChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCC---cEEEecccccc
Q 044366 725 CEYLAR-GSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEY---EAHVSDFGFAK 800 (918)
Q Consensus 725 ~e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~---~~kl~DfG~~~ 800 (918)
|||+++ .++.+++....... ........++..|-+.+.-||.. +++||||..+||++..++ .+.++|||++.
T Consensus 89 ME~~~g~~~vk~~i~~~~~~~-~~d~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~~~~~lIdfgls~ 164 (229)
T KOG3087|consen 89 MEFIDGASTVKDFILSTMEDE-SEDEGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQITPILIDFGLSS 164 (229)
T ss_pred EEeccchhHHHHHHHHHccCc-ccchhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCcCceEEEeecchh
Confidence 999986 48888887654322 22233378899999999999999 999999999999997665 35899999996
Q ss_pred cc
Q 044366 801 FL 802 (918)
Q Consensus 801 ~~ 802 (918)
.-
T Consensus 165 ~s 166 (229)
T KOG3087|consen 165 VS 166 (229)
T ss_pred cc
Confidence 43
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.99 E-value=2.3e-08 Score=107.01 Aligned_cols=169 Identities=17% Similarity=0.270 Sum_probs=129.5
Q ss_pred ceEEEEEE-eCCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccc----cCCceEEEEEeccC-CC
Q 044366 659 QRSVYKAE-LPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCS----NAQHSFIVCEYLAR-GS 732 (918)
Q Consensus 659 ~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~----~~~~~~lv~e~~~~-gs 732 (918)
..+.|++. -.+|..|+.|+++...... ...-..-+++++++.|.|||++.+++. .+...++||+|.++ ++
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~----~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~T 364 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQS----TNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPT 364 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccC----cccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCch
Confidence 45789994 4589999999995432111 112245688899999999999999875 34578999999886 47
Q ss_pred hhHHhhccc------------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEecccccc
Q 044366 733 LTTILRDDA------------AAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAK 800 (918)
Q Consensus 733 L~~~l~~~~------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~ 800 (918)
|.+...... .....++..+|.++.|+..||.++|+. |+.-+-+.+++|+++.+.+++|+..|+..
T Consensus 365 L~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kIlv~G~~RIriS~C~i~D 441 (655)
T KOG3741|consen 365 LYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKILVTGKMRIRISGCGIMD 441 (655)
T ss_pred HHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHeEeeCcceEEEeccccee
Confidence 777654321 123367899999999999999999999 99999999999999999999999999887
Q ss_pred ccCCCCCCceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCC
Q 044366 801 FLEPHSSNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHP 851 (918)
Q Consensus 801 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p 851 (918)
.+.++.. |-+. --++-|.=.||.+++.+.||..-
T Consensus 442 vl~~d~~--------------~~le---~~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 442 VLQEDPT--------------EPLE---SQQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred eecCCCC--------------cchh---HHhhhhHHHHHHHHHHHhhcccc
Confidence 7665431 1111 12367999999999999999654
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.94 E-value=5e-10 Score=87.98 Aligned_cols=59 Identities=46% Similarity=0.567 Sum_probs=26.5
Q ss_pred cccEEeccCccccccCccccccccccceecccCcccCCCCchhhccccccceEeccCCc
Q 044366 430 ELQYLDLSANKLSSSIPMSIGNLLKLHYLNLSNNQFSHKIPTEFEKLIHLSELDLSHNI 488 (918)
Q Consensus 430 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~ 488 (918)
+|++|++++|+|+.+.+..|.++++|++|++++|+|+.+.|++|.++++|++|++++|+
T Consensus 2 ~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~ 60 (61)
T PF13855_consen 2 NLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNN 60 (61)
T ss_dssp TESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSS
T ss_pred cCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCc
Confidence 34444444444444333444444444444444444444444444444444444444443
|
... |
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.94 E-value=4.9e-10 Score=88.05 Aligned_cols=59 Identities=39% Similarity=0.553 Sum_probs=29.4
Q ss_pred ccceecccCcccCCCCchhhccccccceEeccCCcCCCCCchhccccCCcceEecCCCc
Q 044366 454 KLHYLNLSNNQFSHKIPTEFEKLIHLSELDLSHNILQEEIPPQICKMESLEKLNLSHNN 512 (918)
Q Consensus 454 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~ 512 (918)
+|++|++++|+|+.+.++.|.++++|++|++++|.|+...|..|.++++|+.|++++|+
T Consensus 2 ~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~ 60 (61)
T PF13855_consen 2 NLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNN 60 (61)
T ss_dssp TESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSS
T ss_pred cCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCc
Confidence 44555555555544444455555555555555555544444444555555555555444
|
... |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.92 E-value=4.4e-08 Score=102.05 Aligned_cols=255 Identities=16% Similarity=0.190 Sum_probs=156.0
Q ss_pred CceeeccccceEEEEEEeCCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhc-cCCceeeEecc------cccC-Cce
Q 044366 650 EKYCIGKGGQRSVYKAELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEI-RHRNIIKFHGF------CSNA-QHS 721 (918)
Q Consensus 650 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~------~~~~-~~~ 721 (918)
..+.+|+|+.+.+|-.-.- +..+.|++... ... .-.+.+..+... .||-+-.-+.| ..++ ...
T Consensus 15 ~gr~LgqGgea~ly~l~e~--~d~VAKIYh~P----ppa---~~aqk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~i 85 (637)
T COG4248 15 PGRPLGQGGEADLYTLGEV--RDQVAKIYHAP----PPA---AQAQKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVI 85 (637)
T ss_pred CCccccCCccceeeecchh--hchhheeecCC----Cch---HHHHHHHHhccCCCCcchhhhhcccHHHhhCCCcccee
Confidence 3456999999999976321 12245666543 111 112233334333 56654331211 1122 225
Q ss_pred EEEEEeccCC-ChhHHhhc---ccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccc
Q 044366 722 FIVCEYLARG-SLTTILRD---DAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFG 797 (918)
Q Consensus 722 ~lv~e~~~~g-sL~~~l~~---~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG 797 (918)
.+.|+.+.+- -...+++. +..-....|+-.++++..+|.+.+.||.+ |.+-+|+.++|+|+.+++.+.+.|-.
T Consensus 86 GflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~---Gh~vGDVn~~~~lVsd~~~V~LVdsD 162 (637)
T COG4248 86 GFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH---GHVVGDVNQNSFLVSDDSKVVLVDSD 162 (637)
T ss_pred EEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc---CCcccccCccceeeecCceEEEEccc
Confidence 6778877654 23333322 12223468999999999999999999999 99999999999999999999998754
Q ss_pred cccccCCCCCCceecccccccccccccc-----cCCCCcccchhhHHHHHHHHHhC-CCCCCcchhhhhh-------hhh
Q 044366 798 FAKFLEPHSSNWTEFAGTVGYAAPELAY-----TMRATEKYDVYSFGVLALEVIKG-YHPGDFVSTIFSS-------ISN 864 (918)
Q Consensus 798 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~Dv~slG~vl~el~tg-~~p~~~~~~~~~~-------~~~ 864 (918)
.-.. ...+......+|...|++||.-. +...+...|-|.+||++++++.| ++||.......+. +..
T Consensus 163 sfqi-~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~ 241 (637)
T COG4248 163 SFQI-NANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAH 241 (637)
T ss_pred ceee-ccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhc
Confidence 3322 22334445678899999999754 34456789999999999999886 9997643221111 111
Q ss_pred hH-hhhhhhcccCCCCC-CcchHHHHHHHHHHHHHcccCC--CCCCCCHHHHHHHhh
Q 044366 865 MI-IEVNQILDHRLPTP-SRDVTDKLRSIMEVAILCLVEN--PEARPTMKEVCNLLC 917 (918)
Q Consensus 865 ~~-~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~d--p~~RPt~~evl~~L~ 917 (918)
.. ..-.+...+..+.+ ...+.--...+..+..+|.... +.-|||++..+..|.
T Consensus 242 g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~ 298 (637)
T COG4248 242 GRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALD 298 (637)
T ss_pred ceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHH
Confidence 00 00011111122222 2222333456777778888764 567999998887663
|
|
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.92 E-value=6.1e-10 Score=133.19 Aligned_cols=268 Identities=25% Similarity=0.275 Sum_probs=149.9
Q ss_pred cCCCCCCEEEcccccccccCCCCcCCCCCCCEEEccccc--ccccCCccccCCCCCCEEEccCCcccccCccccCCCCCC
Q 044366 42 GKLNQLRRLYLDVNQLHGTIPPVIGQLSLINELVFCHNN--VSGRIPSSLGNLSNLALLYLNDNSLFGSIPIVMGNLKSL 119 (918)
Q Consensus 42 ~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~--~~~~~p~~l~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L 119 (918)
......|+..+-+|++. .++.....- .|+.|.+..|. +....++.|..++.|+.|||++|.=.+..|..++.|.+|
T Consensus 520 ~~~~~~rr~s~~~~~~~-~~~~~~~~~-~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~L 597 (889)
T KOG4658|consen 520 KSWNSVRRMSLMNNKIE-HIAGSSENP-KLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHL 597 (889)
T ss_pred cchhheeEEEEeccchh-hccCCCCCC-ccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhh
Confidence 33466777777777776 555555433 67777777775 443334457778888888888776656778888888888
Q ss_pred CEEECcCCcCCCcCCcCCCCCCCCceeeccccccccCCCcccccccccCeeeccccccC--CcCCccCCCCCCCcEeecc
Q 044366 120 STLDLSQNQLNGSIPCSLDNLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSENRLS--GLIPLSLSNLSSLTVMSLF 197 (918)
Q Consensus 120 ~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~--~~~~~~~~~l~~L~~L~L~ 197 (918)
++|+|++..|+ .+|..+++|..|.+|++..+.-...+++....|++|++|.+..-... ...-..+..+.+|+.+...
T Consensus 598 ryL~L~~t~I~-~LP~~l~~Lk~L~~Lnl~~~~~l~~~~~i~~~L~~Lr~L~l~~s~~~~~~~~l~el~~Le~L~~ls~~ 676 (889)
T KOG4658|consen 598 RYLDLSDTGIS-HLPSGLGNLKKLIYLNLEVTGRLESIPGILLELQSLRVLRLPRSALSNDKLLLKELENLEHLENLSIT 676 (889)
T ss_pred hcccccCCCcc-ccchHHHHHHhhheeccccccccccccchhhhcccccEEEeeccccccchhhHHhhhcccchhhheee
Confidence 88888888877 67778888888888888777665556677777888888877654321 1112233344444444443
Q ss_pred CcccccCCCccccCCCCcc----eeecccccccCCCCCCCcCCCcCCeEEcccCcCcCCCCccccc------cCCCCeEe
Q 044366 198 NNSLSGSIPPILGNLKSLS----TLGLHINQLNGVIPPSIGNLSSLRNLSLFNNRLYGFVPKEIGY------LKSLSKLE 267 (918)
Q Consensus 198 ~N~l~~~~~~~~~~l~~L~----~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~------l~~L~~L~ 267 (918)
.... .+-..+..+..|. .+.+..+... ..+..+..+.+|+.|.+.++.+.......... ++++..+.
T Consensus 677 ~~s~--~~~e~l~~~~~L~~~~~~l~~~~~~~~-~~~~~~~~l~~L~~L~i~~~~~~e~~~~~~~~~~~~~~f~~l~~~~ 753 (889)
T KOG4658|consen 677 ISSV--LLLEDLLGMTRLRSLLQSLSIEGCSKR-TLISSLGSLGNLEELSILDCGISEIVIEWEESLIVLLCFPNLSKVS 753 (889)
T ss_pred cchh--HhHhhhhhhHHHHHHhHhhhhcccccc-eeecccccccCcceEEEEcCCCchhhcccccccchhhhHHHHHHHH
Confidence 2222 0111223333333 2222222222 33445666777777777777765432222111 22333333
Q ss_pred cCCCccCCcCCCcCCCCCCCcEEEccCCcCcCCCCccccCCCCCCeEEe
Q 044366 268 FCANHLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLRNLTSLERVRF 316 (918)
Q Consensus 268 l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l 316 (918)
..++.... .+....-.++|+.|.+..+...+.+......+..+.++.+
T Consensus 754 ~~~~~~~r-~l~~~~f~~~L~~l~l~~~~~~e~~i~~~k~~~~l~~~i~ 801 (889)
T KOG4658|consen 754 ILNCHMLR-DLTWLLFAPHLTSLSLVSCRLLEDIIPKLKALLELKELIL 801 (889)
T ss_pred hhcccccc-ccchhhccCcccEEEEecccccccCCCHHHHhhhcccEEe
Confidence 33332211 1111123456667777666655555555555555554333
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.91 E-value=5e-10 Score=128.83 Aligned_cols=252 Identities=20% Similarity=0.200 Sum_probs=168.6
Q ss_pred HHhcCCCCceeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCce
Q 044366 643 KATGNFGEKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHS 721 (918)
Q Consensus 643 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 721 (918)
...+.|.+.+-+..|.++.++-+.- ..|...++|.......... .+.+....+-.+.-..+||-+++..--+......
T Consensus 801 sS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~-~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~ 879 (1205)
T KOG0606|consen 801 SSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRT-NDYESIRSKSNILITPRSPAVVRSFPSFPCRSPL 879 (1205)
T ss_pred CCCccceecccccCCCCcccccCCccccccccchhhhccchhhcc-ccccccCCccCccccCCCCceecccCCCCCCCCc
Confidence 4556677777889999999998843 3454445554332111110 1112222333333333557677665555667788
Q ss_pred EEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccc
Q 044366 722 FIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKF 801 (918)
Q Consensus 722 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~ 801 (918)
++|++|..+++|...++.... .+.......+..+.++.+|||+. .++|+|++|.+.+...++..+++|||....
T Consensus 880 ~L~~~~~~~~~~~Skl~~~~~---~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~ 953 (1205)
T KOG0606|consen 880 PLVGHYLNGGDLPSKLHNSGC---LSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLIAYDGHRPLTDFGTLSK 953 (1205)
T ss_pred chhhHHhccCCchhhhhcCCC---cccccccchhHHHHhhhhccccc---hhhcccccccchhhcccCCcccCccccccc
Confidence 999999999999999887642 44455667788899999999998 799999999999999999999999984432
Q ss_pred cCCC---------------------C----------CCceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCC
Q 044366 802 LEPH---------------------S----------SNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYH 850 (918)
Q Consensus 802 ~~~~---------------------~----------~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~ 850 (918)
..-. . .......||+.|.+||...+......+|.|+.|++++|.++|.+
T Consensus 954 vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~p 1033 (1205)
T KOG0606|consen 954 VGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIP 1033 (1205)
T ss_pred cccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCC
Confidence 2100 0 00123468999999999999999999999999999999999999
Q ss_pred CCCcchhhhhhhhhhHhhhhhhcccCCCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHH
Q 044366 851 PGDFVSTIFSSISNMIIEVNQILDHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMK 910 (918)
Q Consensus 851 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ 910 (918)
||........ ...+.....+ .............+++...+..+|.+|-.|.
T Consensus 1034 p~na~tpq~~--------f~ni~~~~~~-~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1034 PFNAETPQQI--------FENILNRDIP-WPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred CCCCcchhhh--------hhccccCCCC-CCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 9875543210 1111111111 1111222334566677778889999987765
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.83 E-value=1.3e-08 Score=99.31 Aligned_cols=130 Identities=26% Similarity=0.303 Sum_probs=83.8
Q ss_pred EEEEEEeCCCCEEEEEEccccccc----------CCC------------CChHHHHHHHHHHhhccCC--ceeeEecccc
Q 044366 661 SVYKAELPSGNIFAVKKFKAELFS----------DET------------ANPSEFLNEVLALTEIRHR--NIIKFHGFCS 716 (918)
Q Consensus 661 ~Vy~~~~~~~~~vavK~~~~~~~~----------~~~------------~~~~~~~~e~~~l~~l~h~--niv~~~~~~~ 716 (918)
.||.|...+|+.+|||..+..... +.. .......+|.+.|.++..- ++.+.+++.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 389998889999999987542110 000 0123577889999998654 456666542
Q ss_pred cCCceEEEEEecc--CCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHH-HHhCCCCCeEEcCCCCCCeeeCCCCcEEE
Q 044366 717 NAQHSFIVCEYLA--RGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSY-LHHDCIPPIVHRDISSKNVLLDSEYEAHV 793 (918)
Q Consensus 717 ~~~~~~lv~e~~~--~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~-LH~~~~~~ivH~dlk~~Nill~~~~~~kl 793 (918)
...+||||++ |..+....... ++.++...++.++++.+.. +|.. |+||||+.+.||+++++ .+.+
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~~~~-----~~~~~~~~~~~~il~~~~~~~~~~---givHGDLs~~NIlv~~~-~~~i 147 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLKDVD-----LSPEEPKELLEEILEEIIKMLHKA---GIVHGDLSEYNILVDDG-KVYI 147 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHHHCG-----GGGSTHHHHHHHHHHHHHHHHHCT---TEEESS-STTSEEEETT-CEEE
T ss_pred ---CCEEEEEecCCCccchhhHHhcc-----ccchhHHHHHHHHHHHHHHHHHhc---CceecCCChhhEEeecc-eEEE
Confidence 4579999998 54554433322 1123456677888886665 4677 99999999999999988 9999
Q ss_pred eccccccccC
Q 044366 794 SDFGFAKFLE 803 (918)
Q Consensus 794 ~DfG~~~~~~ 803 (918)
+|||.+....
T Consensus 148 IDf~qav~~~ 157 (188)
T PF01163_consen 148 IDFGQAVDSS 157 (188)
T ss_dssp --GTTEEETT
T ss_pred EecCcceecC
Confidence 9999887544
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.75 E-value=7.6e-08 Score=99.90 Aligned_cols=144 Identities=22% Similarity=0.196 Sum_probs=100.2
Q ss_pred eeccccceEEEEEEeCCCCEEEEEEccccccc----C---CCCChHHHHHHHHHHhhccCCce--eeEeccccc-----C
Q 044366 653 CIGKGGQRSVYKAELPSGNIFAVKKFKAELFS----D---ETANPSEFLNEVLALTEIRHRNI--IKFHGFCSN-----A 718 (918)
Q Consensus 653 ~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~----~---~~~~~~~~~~e~~~l~~l~h~ni--v~~~~~~~~-----~ 718 (918)
.+-......|+++.+ +|+.|.||+....... . .......+.+|...+..+...+| +..+++... .
T Consensus 29 ~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~ 107 (268)
T PRK15123 29 VFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPAT 107 (268)
T ss_pred EEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCcc
Confidence 344444455777766 6788999976432100 0 00112257899998888843332 334444432 2
Q ss_pred CceEEEEEeccCC-ChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCC-------CCc
Q 044366 719 QHSFIVCEYLARG-SLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDS-------EYE 790 (918)
Q Consensus 719 ~~~~lv~e~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~-------~~~ 790 (918)
...++|+|++++. +|.+++.... ..+.+...+..++.+++..++-||.. ||+|+|++++||+++. ++.
T Consensus 108 ~~s~LVte~l~~~~sL~~~~~~~~-~~~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl~~~~~~~~~~~~ 183 (268)
T PRK15123 108 RTSFIITEDLAPTISLEDYCADWA-TNPPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLLHLPFPGREEDLK 183 (268)
T ss_pred ceeEEEEeeCCCCccHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEEeccccCCCCCce
Confidence 3578999999986 8999986422 12345677889999999999999999 9999999999999975 467
Q ss_pred EEEeccccccc
Q 044366 791 AHVSDFGFAKF 801 (918)
Q Consensus 791 ~kl~DfG~~~~ 801 (918)
+.++||+.+..
T Consensus 184 ~~LIDl~r~~~ 194 (268)
T PRK15123 184 LSVIDLHRAQI 194 (268)
T ss_pred EEEEECCcccc
Confidence 99999998864
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.71 E-value=3.9e-10 Score=123.92 Aligned_cols=179 Identities=27% Similarity=0.270 Sum_probs=126.9
Q ss_pred CccccCCCCCCEEEccCCcccccCccccCCC-CCCCEEECcCCcCCC---cCC---cCCCC---CCCCceeecccccccc
Q 044366 86 PSSLGNLSNLALLYLNDNSLFGSIPIVMGNL-KSLSTLDLSQNQLNG---SIP---CSLDN---LSNLDTLFLYKNSLSG 155 (918)
Q Consensus 86 p~~l~~l~~L~~L~L~~n~i~~~~~~~~~~l-~~L~~L~Ls~n~i~~---~~~---~~l~~---l~~L~~L~L~~n~l~~ 155 (918)
|-.|..+..|++|.|.++.|.. ...+..+ .+|++|...+ .++. ++. +.+++ -..|...+.++|.+.
T Consensus 102 pi~ifpF~sLr~LElrg~~L~~--~~GL~~lr~qLe~LIC~~-Sl~Al~~v~ascggd~~ns~~Wn~L~~a~fsyN~L~- 177 (1096)
T KOG1859|consen 102 PISIFPFRSLRVLELRGCDLST--AKGLQELRHQLEKLICHN-SLDALRHVFASCGGDISNSPVWNKLATASFSYNRLV- 177 (1096)
T ss_pred CceeccccceeeEEecCcchhh--hhhhHHHHHhhhhhhhhc-cHHHHHHHHHHhccccccchhhhhHhhhhcchhhHH-
Confidence 5566778888899888888753 1222222 2455554332 2221 000 11111 125777788899988
Q ss_pred CCCcccccccccCeeeccccccCCcCCccCCCCCCCcEeeccCcccccCCCc-cccCCCCcceeecccccccCCCCCCCc
Q 044366 156 PIPSVIGNLKSLLQLDLSENRLSGLIPLSLSNLSSLTVMSLFNNSLSGSIPP-ILGNLKSLSTLGLHINQLNGVIPPSIG 234 (918)
Q Consensus 156 ~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~~l~~L~~L~L~~n~l~~~~~~~~~ 234 (918)
...+++.-++.|+.|+|++|+++.+ +.+..|+.|++|||++|.+.. +|. .-.++ +|..|.+++|.++.. ..+.
T Consensus 178 ~mD~SLqll~ale~LnLshNk~~~v--~~Lr~l~~LkhLDlsyN~L~~-vp~l~~~gc-~L~~L~lrnN~l~tL--~gie 251 (1096)
T KOG1859|consen 178 LMDESLQLLPALESLNLSHNKFTKV--DNLRRLPKLKHLDLSYNCLRH-VPQLSMVGC-KLQLLNLRNNALTTL--RGIE 251 (1096)
T ss_pred hHHHHHHHHHHhhhhccchhhhhhh--HHHHhcccccccccccchhcc-ccccchhhh-hheeeeecccHHHhh--hhHH
Confidence 6677888899999999999999976 378889999999999999984 443 23333 499999999999855 5688
Q ss_pred CCCcCCeEEcccCcCcCCCC-ccccccCCCCeEecCCCccC
Q 044366 235 NLSSLRNLSLFNNRLYGFVP-KEIGYLKSLSKLEFCANHLS 274 (918)
Q Consensus 235 ~l~~L~~L~Ls~n~l~~~~~-~~~~~l~~L~~L~l~~n~l~ 274 (918)
++.+|+.||+++|-|.+... ..+..+..|+.|+|.+|++.
T Consensus 252 ~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~ 292 (1096)
T KOG1859|consen 252 NLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLC 292 (1096)
T ss_pred hhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccc
Confidence 89999999999998876433 34567788899999999886
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.65 E-value=1.7e-07 Score=93.37 Aligned_cols=139 Identities=22% Similarity=0.174 Sum_probs=96.4
Q ss_pred CCCceeeccccceEEEEEEeCCCCEEEEEEccccccc------------------CCCCChHHHHHHHHHHhhccCC--c
Q 044366 648 FGEKYCIGKGGQRSVYKAELPSGNIFAVKKFKAELFS------------------DETANPSEFLNEVLALTEIRHR--N 707 (918)
Q Consensus 648 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~------------------~~~~~~~~~~~e~~~l~~l~h~--n 707 (918)
..+...||-|--+.||.|..+.|.++|||.-+....+ .-........+|.++|..+.-. .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 3455789999999999999999999999964321110 0011234578889999888644 5
Q ss_pred eeeEecccccCCceEEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCC
Q 044366 708 IIKFHGFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDS 787 (918)
Q Consensus 708 iv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~ 787 (918)
|.+.+++ +...+||||++|--|...- ++....-.++..|++-+.-.-.. ||||+|+++-||++++
T Consensus 173 VP~P~~~----nRHaVvMe~ieG~eL~~~r--------~~~en~~~il~~il~~~~~~~~~---GiVHGDlSefNIlV~~ 237 (304)
T COG0478 173 VPKPIAW----NRHAVVMEYIEGVELYRLR--------LDVENPDEILDKILEEVRKAYRR---GIVHGDLSEFNILVTE 237 (304)
T ss_pred CCCcccc----ccceeeeehcccceeeccc--------CcccCHHHHHHHHHHHHHHHHHc---CccccCCchheEEEec
Confidence 6666653 4568999999985554321 11223334444455544444455 9999999999999999
Q ss_pred CCcEEEeccccccc
Q 044366 788 EYEAHVSDFGFAKF 801 (918)
Q Consensus 788 ~~~~kl~DfG~~~~ 801 (918)
||.+.++||--+..
T Consensus 238 dg~~~vIDwPQ~v~ 251 (304)
T COG0478 238 DGDIVVIDWPQAVP 251 (304)
T ss_pred CCCEEEEeCccccc
Confidence 99999999976653
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.62 E-value=3.2e-10 Score=124.56 Aligned_cols=21 Identities=33% Similarity=0.275 Sum_probs=12.7
Q ss_pred CccccCCCCCCEEEccccccc
Q 044366 38 PPEIGKLNQLRRLYLDVNQLH 58 (918)
Q Consensus 38 p~~l~~l~~L~~L~L~~n~l~ 58 (918)
|-.|..+.+||+|.|+++.+.
T Consensus 102 pi~ifpF~sLr~LElrg~~L~ 122 (1096)
T KOG1859|consen 102 PISIFPFRSLRVLELRGCDLS 122 (1096)
T ss_pred CceeccccceeeEEecCcchh
Confidence 445566666666666666554
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.61 E-value=7.8e-07 Score=87.03 Aligned_cols=142 Identities=20% Similarity=0.230 Sum_probs=104.2
Q ss_pred eccccceEEEEEEeCCCCEEEEEEcccccccC-C-CCChHHHHHHHHHHhhccCC--ceeeEecccc---c--CCceEEE
Q 044366 654 IGKGGQRSVYKAELPSGNIFAVKKFKAELFSD-E-TANPSEFLNEVLALTEIRHR--NIIKFHGFCS---N--AQHSFIV 724 (918)
Q Consensus 654 lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-~-~~~~~~~~~e~~~l~~l~h~--niv~~~~~~~---~--~~~~~lv 724 (918)
-|+||-+.|+..... |+.+-+|+-....... - +.....|.+|...+..+..- .+.+.. ++. . .-..++|
T Consensus 26 ~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV 103 (216)
T PRK09902 26 YRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV 103 (216)
T ss_pred cCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence 467898999998774 4578888764211111 1 33567899999999998532 244444 332 1 1236799
Q ss_pred EEeccC-CChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCc--EEEeccccccc
Q 044366 725 CEYLAR-GSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYE--AHVSDFGFAKF 801 (918)
Q Consensus 725 ~e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~--~kl~DfG~~~~ 801 (918)
+|-+++ .+|.+++.... ..+.+...+..++.+++++++-||+. |+.|+|+.+.||+++.++. ++++||.-++.
T Consensus 104 Te~L~g~~~L~~~l~~~~-~~~~~~~~k~~il~~va~~ia~LH~~---Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 104 TEDMAGFISIADWYAQHA-VSPYSDEVRQAMLKAVALAFKKMHSV---NRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EEeCCCCccHHHHHhcCC-cCCcchHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 998764 48999986543 23467788899999999999999999 9999999999999986666 99999987764
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.54 E-value=2.3e-08 Score=111.24 Aligned_cols=149 Identities=19% Similarity=0.281 Sum_probs=101.1
Q ss_pred HHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccCCCCCC----ce-----ecccccccccccccc
Q 044366 755 IKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSN----WT-----EFAGTVGYAAPELAY 825 (918)
Q Consensus 755 ~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~~~~~~----~~-----~~~g~~~y~aPE~~~ 825 (918)
+.+++.|+.|+|... ++||++|.|++|.++..+.+|++.|+++....+.... ++ -......|.|||++.
T Consensus 105 l~~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~ 182 (700)
T KOG2137|consen 105 LGNVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL 182 (700)
T ss_pred hhcccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence 344569999999884 9999999999999999999999999998766542221 11 123456899999999
Q ss_pred cCCCCcccchhhHHHHHHHHHh-CCCCCCcchh-hhhhhhhhHhhhhhhcccCCCCCCcchHHHHHHHHHHHHHcccCCC
Q 044366 826 TMRATEKYDVYSFGVLALEVIK-GYHPGDFVST-IFSSISNMIIEVNQILDHRLPTPSRDVTDKLRSIMEVAILCLVENP 903 (918)
Q Consensus 826 ~~~~~~~~Dv~slG~vl~el~t-g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp 903 (918)
+...+.++|+||+|+++|.+.. |+.-+..... ........... ........ ..+.++.+=+.+++..++
T Consensus 183 ~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~------~~~~~~s~---~~p~el~~~l~k~l~~~~ 253 (700)
T KOG2137|consen 183 GTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLN------AGAFGYSN---NLPSELRESLKKLLNGDS 253 (700)
T ss_pred cccccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccc------cccccccc---cCcHHHHHHHHHHhcCCc
Confidence 9888999999999999999995 4444332211 11111110000 00001111 222456666777899999
Q ss_pred CCCCCHHHHHH
Q 044366 904 EARPTMKEVCN 914 (918)
Q Consensus 904 ~~RPt~~evl~ 914 (918)
..||++.++..
T Consensus 254 ~~rp~~~~l~~ 264 (700)
T KOG2137|consen 254 AVRPTLDLLLS 264 (700)
T ss_pred ccCcchhhhhc
Confidence 99998877654
|
|
| >KOG2982 consensus Uncharacterized conserved protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.53 E-value=9e-09 Score=101.98 Aligned_cols=213 Identities=24% Similarity=0.253 Sum_probs=105.8
Q ss_pred CCCccCCccCCCCCCCCEEeCCCCccccc-CCcccc-CCCCCCEEEcccccccc--cCCCCcCCCCCCCEEEcccccccc
Q 044366 8 LLFGNIPPQIGNLSKLQYLDLGNNQLSGV-IPPEIG-KLNQLRRLYLDVNQLHG--TIPPVIGQLSLINELVFCHNNVSG 83 (918)
Q Consensus 8 ~~~~~~p~~~~~l~~L~~L~L~~n~i~~~-~p~~l~-~l~~L~~L~L~~n~l~~--~~p~~~~~l~~L~~L~l~~n~~~~ 83 (918)
+..|..|-.++.+..++.|.+.++.|..+ .-..|+ ..++++.|||.+|+|+. ++-.-+.++
T Consensus 32 ~~~g~s~~~v~s~ra~ellvln~~~id~~gd~~~~~~~~~~v~elDL~~N~iSdWseI~~ile~l--------------- 96 (418)
T KOG2982|consen 32 TSAGLSYLGVSSLRALELLVLNGSIIDNEGDVMLFGSSVTDVKELDLTGNLISDWSEIGAILEQL--------------- 96 (418)
T ss_pred cccccceeeeccccchhhheecCCCCCcchhHHHHHHHhhhhhhhhcccchhccHHHHHHHHhcC---------------
Confidence 44555566666666777777777777521 111122 35667777777777762 222233344
Q ss_pred cCCccccCCCCCCEEEccCCcccccCccccCCCCCCCEEECcCCcCCCc-CCcCCCCCCCCceeeccccccc--------
Q 044366 84 RIPSSLGNLSNLALLYLNDNSLFGSIPIVMGNLKSLSTLDLSQNQLNGS-IPCSLDNLSNLDTLFLYKNSLS-------- 154 (918)
Q Consensus 84 ~~p~~l~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~-~~~~l~~l~~L~~L~L~~n~l~-------- 154 (918)
+.|+.|+|+.|++...+...-..+.+|+.|-|.+..+.-. .-..+..++.+++|+++.|.+.
T Consensus 97 ---------P~l~~LNls~N~L~s~I~~lp~p~~nl~~lVLNgT~L~w~~~~s~l~~lP~vtelHmS~N~~rq~n~Dd~c 167 (418)
T KOG2982|consen 97 ---------PALTTLNLSCNSLSSDIKSLPLPLKNLRVLVLNGTGLSWTQSTSSLDDLPKVTELHMSDNSLRQLNLDDNC 167 (418)
T ss_pred ---------ccceEeeccCCcCCCccccCcccccceEEEEEcCCCCChhhhhhhhhcchhhhhhhhccchhhhhcccccc
Confidence 4455555555544321111112344555555554443211 1122344555555555555322
Q ss_pred --cCCCc--ccccccccCeeeccccccCCcCCccCCCCCCCcEeeccCcccccC-CCccccCCCCcceeecccccccCCC
Q 044366 155 --GPIPS--VIGNLKSLLQLDLSENRLSGLIPLSLSNLSSLTVMSLFNNSLSGS-IPPILGNLKSLSTLGLHINQLNGVI 229 (918)
Q Consensus 155 --~~~~~--~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~-~~~~~~~l~~L~~L~L~~n~l~~~~ 229 (918)
...+. .+..++.+..++++-|++..+ .+++..+.+..|.+... ....+..++.+..|+|+.|+|....
T Consensus 168 ~e~~s~~v~tlh~~~c~~~~w~~~~~l~r~-------Fpnv~sv~v~e~PlK~~s~ek~se~~p~~~~LnL~~~~idswa 240 (418)
T KOG2982|consen 168 IEDWSTEVLTLHQLPCLEQLWLNKNKLSRI-------FPNVNSVFVCEGPLKTESSEKGSEPFPSLSCLNLGANNIDSWA 240 (418)
T ss_pred ccccchhhhhhhcCCcHHHHHHHHHhHHhh-------cccchheeeecCcccchhhcccCCCCCcchhhhhcccccccHH
Confidence 11111 122233444444444554433 24555566666655432 1234555666667777777775432
Q ss_pred -CCCCcCCCcCCeEEcccCcCcC
Q 044366 230 -PPSIGNLSSLRNLSLFNNRLYG 251 (918)
Q Consensus 230 -~~~~~~l~~L~~L~Ls~n~l~~ 251 (918)
-+.+.++++|..|.+++|.+.+
T Consensus 241 svD~Ln~f~~l~dlRv~~~Pl~d 263 (418)
T KOG2982|consen 241 SVDALNGFPQLVDLRVSENPLSD 263 (418)
T ss_pred HHHHHcCCchhheeeccCCcccc
Confidence 1345666777777777776653
|
|
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.51 E-value=7e-09 Score=90.95 Aligned_cols=112 Identities=24% Similarity=0.318 Sum_probs=60.0
Q ss_pred CcccEEeccCccccccCccccc-cccccceecccCcccCCCCchhhccccccceEeccCCcCCCCCchhccccCCcceEe
Q 044366 429 TELQYLDLSANKLSSSIPMSIG-NLLKLHYLNLSNNQFSHKIPTEFEKLIHLSELDLSHNILQEEIPPQICKMESLEKLN 507 (918)
Q Consensus 429 ~~L~~L~Ls~N~l~~~~~~~~~-~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 507 (918)
..|+..+|++|.+.. .|..|. ..+.+++|+|++|+|+ .+|..|..++.|+.|+++.|.|. ..|..+..+.+|..|+
T Consensus 53 ~el~~i~ls~N~fk~-fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~lNl~~N~l~-~~p~vi~~L~~l~~Ld 129 (177)
T KOG4579|consen 53 YELTKISLSDNGFKK-FPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRSLNLRFNPLN-AEPRVIAPLIKLDMLD 129 (177)
T ss_pred ceEEEEecccchhhh-CCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhhcccccCccc-cchHHHHHHHhHHHhc
Confidence 445555666666653 333333 2335666666666665 34555666666666666666664 4555555566666666
Q ss_pred cCCCcccccCcccccCCCCccEEEccCCcCCCCCCCC
Q 044366 508 LSHNNLSDFIPRCFEEMRSLSWIDISYNELQGPIPNS 544 (918)
Q Consensus 508 L~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~p~~ 544 (918)
..+|.+..+.-+.|. -......++..++|.+.+|..
T Consensus 130 s~~na~~eid~dl~~-s~~~al~~lgnepl~~~~~~k 165 (177)
T KOG4579|consen 130 SPENARAEIDVDLFY-SSLPALIKLGNEPLGDETKKK 165 (177)
T ss_pred CCCCccccCcHHHhc-cccHHHHHhcCCcccccCccc
Confidence 666665543333221 122223344666666666653
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.47 E-value=9.5e-07 Score=88.90 Aligned_cols=129 Identities=20% Similarity=0.272 Sum_probs=92.4
Q ss_pred CCCEEEEEEcccccccC---CCCChHHHHHHHHHHhhccCC--ceeeEecccccC----CceEEEEEeccCC-ChhHHhh
Q 044366 669 SGNIFAVKKFKAELFSD---ETANPSEFLNEVLALTEIRHR--NIIKFHGFCSNA----QHSFIVCEYLARG-SLTTILR 738 (918)
Q Consensus 669 ~~~~vavK~~~~~~~~~---~~~~~~~~~~e~~~l~~l~h~--niv~~~~~~~~~----~~~~lv~e~~~~g-sL~~~l~ 738 (918)
.++.+-+|........+ .......+.+|...+..+... .+++.+++.... ...++|+|++++. +|.+++.
T Consensus 31 ~~~~y~~k~~~~~~~~~~~~~~~~~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~ 110 (206)
T PF06293_consen 31 VGRRYYRKRLWNKLRRDRLRFPLRRSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQ 110 (206)
T ss_pred cceEEEECCeechhccchhhhcccchHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHH
Confidence 45566666543221111 112345688888888777432 344555555432 2458999999874 8999987
Q ss_pred cccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCC---cEEEeccccccccC
Q 044366 739 DDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEY---EAHVSDFGFAKFLE 803 (918)
Q Consensus 739 ~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~---~~kl~DfG~~~~~~ 803 (918)
.... .+......++.++++.++-||+. ||+|+|+++.|||++.++ .+.++||+-++...
T Consensus 111 ~~~~---~~~~~~~~ll~~l~~~i~~lH~~---gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~~ 172 (206)
T PF06293_consen 111 QWEQ---LDPSQRRELLRALARLIAKLHDA---GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFRP 172 (206)
T ss_pred hhcc---cchhhHHHHHHHHHHHHHHHHHC---cCCCCCCCcccEEEeCCCCceeEEEEcchhceeCC
Confidence 6332 45567889999999999999999 999999999999999887 89999999887543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG2982 consensus Uncharacterized conserved protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.45 E-value=4e-08 Score=97.50 Aligned_cols=188 Identities=21% Similarity=0.183 Sum_probs=91.9
Q ss_pred CCCCCCeEEeecccccCcc--ccccCCCCCccEEeCCCCccccccCcccccccccceeeccccccc-cCCCcCcCCCCCC
Q 044366 307 NLTSLERVRFNQNNLYGKV--YEAFGDHPNLTFLDLSQNNFYCEISFNWRNFSKLGTFNASMNNIY-GSIPPEIGDSSKL 383 (918)
Q Consensus 307 ~l~~L~~L~l~~n~l~~~~--~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~n~i~-~~~~~~~~~~~~L 383 (918)
..+.+++++|.+|.|++=. ......+|.|++|+++.|++............+|+.+-|.+..+. ......+..++.+
T Consensus 69 ~~~~v~elDL~~N~iSdWseI~~ile~lP~l~~LNls~N~L~s~I~~lp~p~~nl~~lVLNgT~L~w~~~~s~l~~lP~v 148 (418)
T KOG2982|consen 69 SVTDVKELDLTGNLISDWSEIGAILEQLPALTTLNLSCNSLSSDIKSLPLPLKNLRVLVLNGTGLSWTQSTSSLDDLPKV 148 (418)
T ss_pred HhhhhhhhhcccchhccHHHHHHHHhcCccceEeeccCCcCCCccccCcccccceEEEEEcCCCCChhhhhhhhhcchhh
Confidence 3455677777777775421 234466778888888888776544333334444444444444332 1111223344444
Q ss_pred cEEEccCceeccccccchhhccccCceecccccccCCCCC--CCCCCCcccEEeccCccccccCccccccccccceeccc
Q 044366 384 QVLDLSSNHIFGKIPVQLVKLFSLNKLILSLNQLFGGVPL--EFGTLTELQYLDLSANKLSSSIPMSIGNLLKLHYLNLS 461 (918)
Q Consensus 384 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~--~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls 461 (918)
++|.+|.|.+. .+++..|.+..+.+. .+...+.+..+.++-|++..+ .+++..+.+.
T Consensus 149 telHmS~N~~r--------------q~n~Dd~c~e~~s~~v~tlh~~~c~~~~w~~~~~l~r~-------Fpnv~sv~v~ 207 (418)
T KOG2982|consen 149 TELHMSDNSLR--------------QLNLDDNCIEDWSTEVLTLHQLPCLEQLWLNKNKLSRI-------FPNVNSVFVC 207 (418)
T ss_pred hhhhhccchhh--------------hhccccccccccchhhhhhhcCCcHHHHHHHHHhHHhh-------cccchheeee
Confidence 44444444322 222222222211110 111122233333333444432 2345556666
Q ss_pred CcccCCCC-chhhccccccceEeccCCcCCCC-CchhccccCCcceEecCCCcccc
Q 044366 462 NNQFSHKI-PTEFEKLIHLSELDLSHNILQEE-IPPQICKMESLEKLNLSHNNLSD 515 (918)
Q Consensus 462 ~N~l~~~~-~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~~l~~L~~L~L~~N~l~~ 515 (918)
.|.|.+.. -..+..++.+.-|+|+.|+|... .-+++.+++.|.-|.+++|+|.+
T Consensus 208 e~PlK~~s~ek~se~~p~~~~LnL~~~~idswasvD~Ln~f~~l~dlRv~~~Pl~d 263 (418)
T KOG2982|consen 208 EGPLKTESSEKGSEPFPSLSCLNLGANNIDSWASVDALNGFPQLVDLRVSENPLSD 263 (418)
T ss_pred cCcccchhhcccCCCCCcchhhhhcccccccHHHHHHHcCCchhheeeccCCcccc
Confidence 66654332 23455556666677777776543 22455666666666676666654
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST 
Original result of BLAST against Protein Data Bank
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() | |
| Query | 918 | ||||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 2e-41 | ||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 2e-29 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 2e-41 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 4e-41 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 2e-29 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 2e-40 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 1e-28 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 3e-28 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 2e-26 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 3e-26 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-24 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-24 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 2e-24 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 7e-23 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 1e-22 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 4e-22 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 7e-22 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-21 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-21 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 1e-21 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 1e-21 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 2e-21 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 2e-21 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 2e-21 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 2e-21 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 2e-21 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 2e-21 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 3e-21 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 3e-21 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 3e-21 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 3e-21 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 3e-21 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 3e-21 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 3e-21 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 4e-21 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 4e-21 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 5e-21 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 5e-21 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 6e-21 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 8e-21 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 1e-20 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-20 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 1e-20 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 1e-20 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 1e-20 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 1e-20 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 2e-20 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 3e-20 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 5e-20 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 2e-19 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 3e-19 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 3e-19 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 3e-19 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 4e-19 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-19 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 8e-19 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 9e-19 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 1e-18 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-18 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 1e-18 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 1e-18 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-18 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 2e-18 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 2e-18 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 2e-18 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 2e-18 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 2e-18 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 2e-18 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 5e-18 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 6e-18 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 6e-18 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 6e-18 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-17 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 1e-17 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-17 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 1e-17 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 1e-17 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 2e-17 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-17 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 3e-17 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 3e-17 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 4e-17 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 4e-17 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 4e-17 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 4e-17 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 4e-17 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 5e-17 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 5e-17 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 6e-17 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 6e-17 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 6e-17 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 6e-17 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 6e-17 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 7e-17 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 7e-17 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 7e-17 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 8e-17 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 8e-17 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 8e-17 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 8e-17 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 8e-17 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 9e-17 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 9e-17 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 9e-17 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 9e-17 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 1e-16 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 1e-16 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 1e-16 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 1e-16 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 1e-16 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 1e-16 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 1e-16 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 1e-16 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 1e-16 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 1e-16 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-16 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 1e-16 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 2e-16 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-16 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 3e-16 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-16 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 3e-16 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 3e-16 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 3e-16 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-16 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 3e-16 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 4e-16 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 4e-16 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 5e-16 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 5e-16 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 5e-16 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 5e-16 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 5e-16 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 6e-16 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 7e-16 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 7e-16 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 7e-16 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 8e-16 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 1e-15 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-15 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 2e-15 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 2e-15 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 3e-15 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 4e-15 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 6e-15 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 8e-15 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 8e-15 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 8e-15 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 9e-15 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 1e-14 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 1e-14 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 1e-14 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 1e-14 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 1e-14 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 1e-14 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 1e-14 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 1e-14 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 1e-14 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 1e-14 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 1e-14 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 1e-14 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 1e-14 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 1e-14 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 1e-14 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 1e-14 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 2e-14 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 2e-14 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 2e-14 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 3e-14 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 3e-14 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 3e-14 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 3e-14 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 3e-14 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 4e-14 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 5e-14 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 5e-14 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 5e-14 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 7e-14 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 9e-14 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 1e-13 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 1e-13 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 1e-13 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 1e-13 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 1e-13 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 2e-13 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 2e-13 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 2e-13 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-13 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 2e-13 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-13 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 2e-13 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 2e-13 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 2e-13 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-13 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 3e-13 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 3e-13 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 3e-13 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 3e-13 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 3e-13 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 3e-13 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 3e-13 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 4e-13 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 4e-13 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 5e-13 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 5e-13 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 5e-13 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 6e-13 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 6e-13 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 6e-13 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 6e-13 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 6e-13 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 7e-13 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 7e-13 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 8e-13 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 8e-13 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 9e-13 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 9e-13 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 9e-13 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 1e-12 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 1e-12 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-12 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 1e-12 | ||
| 2omx_A | 462 | Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX | 1e-12 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 1e-12 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 1e-12 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-12 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 1e-12 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 1e-12 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 1e-12 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 2e-12 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 2e-12 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 2e-12 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 2e-12 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 2e-12 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 2e-12 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 2e-12 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 2e-12 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-12 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 2e-12 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 2e-12 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-12 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 2e-12 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 2e-12 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 2e-12 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 2e-12 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 2e-12 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 2e-12 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-12 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 2e-12 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-12 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 3e-12 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 3e-12 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 3e-12 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 3e-12 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 3e-12 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 3e-12 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 3e-12 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 3e-12 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 4e-12 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 4e-12 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 4e-12 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 4e-12 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 4e-12 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 5e-12 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 5e-12 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 5e-12 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 5e-12 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 5e-12 | ||
| 2omt_A | 462 | Crystal Structure Of Inla G194s+sHEC1 COMPLEX Lengt | 5e-12 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 5e-12 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 5e-12 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 6e-12 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-12 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 6e-12 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 6e-12 | ||
| 2omu_A | 462 | Crystal Structure Of Inla G194s+s Y369s/hec1 Comple | 6e-12 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-12 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 6e-12 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 7e-12 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 7e-12 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 7e-12 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-12 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 7e-12 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 7e-12 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 7e-12 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 7e-12 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 8e-12 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 8e-12 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 8e-12 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-12 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 8e-12 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 8e-12 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 8e-12 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 9e-12 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 9e-12 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 9e-12 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 9e-12 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 1e-11 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-11 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 1e-11 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-11 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 1e-11 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 1e-11 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 1e-11 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 1e-11 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 1e-11 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 1e-11 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 1e-11 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 1e-11 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 1e-11 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 1e-11 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 2e-11 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 2e-11 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-11 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 2e-11 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 2e-11 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 2e-11 | ||
| 2omz_A | 466 | Crystal Structure Of Inla Y369a/hec1 Complex Length | 2e-11 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-11 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 2e-11 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-11 | ||
| 1o6s_A | 466 | Internalin (Listeria Monocytogenes) E-Cadherin (Hum | 2e-11 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 2e-11 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 2e-11 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 2e-11 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 2e-11 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 2e-11 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 2e-11 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 2e-11 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 2e-11 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 3e-11 | ||
| 2omv_A | 461 | Crystal Structure Of Inla S192n Y369s/hec1 Complex | 3e-11 | ||
| 2omy_A | 461 | Crystal Structure Of Inla S192n/hec1 Complex Length | 3e-11 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 3e-11 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 3e-11 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 3e-11 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 3e-11 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 3e-11 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 3e-11 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 3e-11 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 3e-11 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 3e-11 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 3e-11 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-11 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 3e-11 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-11 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 3e-11 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-11 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 3e-11 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-11 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 4e-11 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 4e-11 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 4e-11 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 4e-11 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 4e-11 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 4e-11 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 4e-11 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 4e-11 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 4e-11 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 4e-11 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 4e-11 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 4e-11 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 4e-11 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 4e-11 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 4e-11 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 4e-11 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 4e-11 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 4e-11 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 4e-11 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-11 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 4e-11 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 4e-11 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-11 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 4e-11 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 4e-11 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 4e-11 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-11 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 5e-11 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 5e-11 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-11 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 5e-11 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 5e-11 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 5e-11 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 5e-11 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 5e-11 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 5e-11 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 5e-11 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 5e-11 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 5e-11 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 6e-11 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 6e-11 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-11 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 6e-11 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 6e-11 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 6e-11 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 7e-11 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 7e-11 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 7e-11 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 7e-11 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 7e-11 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 8e-11 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 8e-11 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 8e-11 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 8e-11 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 8e-11 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 8e-11 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 8e-11 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 8e-11 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 9e-11 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 9e-11 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 9e-11 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 9e-11 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 9e-11 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 9e-11 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 1e-10 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 1e-10 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 1e-10 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-10 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 1e-10 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 1e-10 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 1e-10 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-10 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 1e-10 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 1e-10 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 1e-10 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-10 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 1e-10 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 1e-10 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-10 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 1e-10 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-10 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-10 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-10 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 1e-10 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 1e-10 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 1e-10 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 1e-10 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 1e-10 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 1e-10 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 1e-10 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 1e-10 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-10 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 1e-10 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-10 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 1e-10 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 2e-10 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 2e-10 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 2e-10 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 2e-10 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 2e-10 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-10 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 2e-10 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 2e-10 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-10 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 2e-10 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 2e-10 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 2e-10 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 2e-10 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 2e-10 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-10 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 2e-10 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 3e-10 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 3e-10 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 3e-10 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 3e-10 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 3e-10 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 3e-10 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 3e-10 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 3e-10 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 3e-10 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-10 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 3e-10 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 4e-10 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-10 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 4e-10 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-10 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 4e-10 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 4e-10 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 5e-10 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 5e-10 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 5e-10 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 5e-10 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 5e-10 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 5e-10 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 5e-10 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 5e-10 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 6e-10 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 6e-10 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 7e-10 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 7e-10 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 7e-10 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 7e-10 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 7e-10 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 7e-10 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 8e-10 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 8e-10 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 8e-10 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 8e-10 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 8e-10 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 8e-10 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 8e-10 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 9e-10 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 9e-10 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 9e-10 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 9e-10 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 9e-10 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 9e-10 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 9e-10 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 9e-10 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 9e-10 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 9e-10 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 9e-10 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 9e-10 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 9e-10 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 1e-09 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 1e-09 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-09 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 1e-09 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-09 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 1e-09 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 1e-09 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 1e-09 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-09 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 1e-09 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 1e-09 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-09 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 1e-09 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 1e-09 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 1e-09 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 2e-09 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 2e-09 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 2e-09 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-09 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-09 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 2e-09 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 2e-09 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 2e-09 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 2e-09 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-09 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-09 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-09 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-09 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 2e-09 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 2e-09 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 2e-09 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 2e-09 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-09 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-09 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-09 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 3e-09 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 3e-09 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 3e-09 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 3e-09 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 3e-09 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 3e-09 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 3e-09 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 3e-09 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-09 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 3e-09 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-09 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 3e-09 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 3e-09 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 3e-09 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 3e-09 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 3e-09 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 3e-09 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-09 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-09 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 3e-09 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 3e-09 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 4e-09 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 4e-09 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 4e-09 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 4e-09 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 4e-09 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 4e-09 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 4e-09 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 4e-09 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 4e-09 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 4e-09 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 4e-09 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 4e-09 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 4e-09 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-09 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 4e-09 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 4e-09 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 4e-09 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 4e-09 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 4e-09 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 4e-09 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 5e-09 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 5e-09 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 5e-09 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 5e-09 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 5e-09 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 5e-09 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 5e-09 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 5e-09 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 5e-09 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 5e-09 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 5e-09 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 5e-09 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 6e-09 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 6e-09 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 6e-09 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 7e-09 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 7e-09 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 8e-09 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 8e-09 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 8e-09 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 8e-09 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 8e-09 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 8e-09 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 9e-09 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 9e-09 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 1e-08 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 1e-08 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 1e-08 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 1e-08 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 1e-08 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 1e-08 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 1e-08 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 1e-08 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 1e-08 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 1e-08 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 1e-08 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-08 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 1e-08 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 1e-08 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 1e-08 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 1e-08 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 1e-08 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 1e-08 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 2e-08 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 2e-08 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 2e-08 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-08 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 2e-08 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-08 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-08 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 2e-08 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 2e-08 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-08 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 2e-08 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 2e-08 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 2e-08 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 2e-08 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 2e-08 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-08 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 2e-08 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 2e-08 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-08 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 2e-08 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 2e-08 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 2e-08 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 2e-08 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 2e-08 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 2e-08 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 2e-08 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-08 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 2e-08 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-08 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 2e-08 | ||
| 3rfs_A | 272 | Design Of A Binding Scaffold Based On Variable Lymp | 2e-08 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 2e-08 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 3e-08 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-08 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 3e-08 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 3e-08 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 3e-08 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-08 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 3e-08 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 3e-08 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 3e-08 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 3e-08 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-08 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 3e-08 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 3e-08 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 3e-08 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 3e-08 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 3e-08 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 3e-08 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 3e-08 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 3e-08 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-08 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 3e-08 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-08 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 3e-08 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 4e-08 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-08 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-08 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 5e-08 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 5e-08 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 5e-08 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 5e-08 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 5e-08 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 5e-08 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 5e-08 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 6e-08 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 6e-08 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 6e-08 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 7e-08 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 7e-08 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 7e-08 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 7e-08 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 8e-08 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 9e-08 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 9e-08 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 1e-07 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 1e-07 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-07 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 1e-07 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 1e-07 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 1e-07 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 1e-07 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 1e-07 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 1e-07 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 2e-07 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 2e-07 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 2e-07 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 2e-07 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 2e-07 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 2e-07 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-07 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 2e-07 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 2e-07 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 3e-07 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 3e-07 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 3e-07 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 3e-07 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 3e-07 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 3e-07 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 3e-07 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 3e-07 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 3e-07 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 3e-07 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 3e-07 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 3e-07 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 3e-07 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 3e-07 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 3e-07 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 4e-07 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 4e-07 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 4e-07 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 4e-07 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 4e-07 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 4e-07 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 4e-07 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 4e-07 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 4e-07 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 5e-07 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 5e-07 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 5e-07 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 5e-07 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 5e-07 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 5e-07 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 5e-07 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 5e-07 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 5e-07 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 5e-07 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 5e-07 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 5e-07 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 6e-07 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 6e-07 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 6e-07 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 6e-07 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 6e-07 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 6e-07 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 6e-07 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 6e-07 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 7e-07 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 7e-07 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 7e-07 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 7e-07 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 7e-07 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 7e-07 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 7e-07 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 8e-07 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 8e-07 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 8e-07 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 8e-07 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 8e-07 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 9e-07 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 9e-07 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 1e-06 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 1e-06 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-06 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 1e-06 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 1e-06 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-06 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 1e-06 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-06 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 1e-06 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 1e-06 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 1e-06 | ||
| 3zyj_A | 440 | Netring1 In Complex With Ngl1 Length = 440 | 1e-06 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 1e-06 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 1e-06 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 1e-06 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 1e-06 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 1e-06 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 1e-06 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 1e-06 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 1e-06 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 1e-06 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 1e-06 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 1e-06 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 1e-06 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 2e-06 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 2e-06 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 2e-06 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 2e-06 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 2e-06 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 2e-06 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 2e-06 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-06 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-06 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 2e-06 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-06 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 2e-06 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 2e-06 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 2e-06 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 2e-06 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 3e-06 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 3e-06 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 3e-06 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 3e-06 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 3e-06 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 3e-06 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 3e-06 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 3e-06 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 3e-06 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 3e-06 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 4e-06 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 4e-06 | ||
| 4g8a_A | 635 | Crystal Structure Of Human Tlr4 Polymorphic Variant | 4e-06 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 4e-06 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 4e-06 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 4e-06 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 4e-06 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 4e-06 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-06 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 4e-06 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 4e-06 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 4e-06 | ||
| 2o6s_A | 208 | Structural Diversity Of The Hagfish Variable Lympho | 4e-06 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 4e-06 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 4e-06 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 4e-06 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-06 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 4e-06 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 4e-06 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 4e-06 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 4e-06 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 4e-06 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 4e-06 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 4e-06 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 4e-06 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 5e-06 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 5e-06 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 5e-06 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 5e-06 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 5e-06 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 5e-06 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 5e-06 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 5e-06 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 5e-06 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 5e-06 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 5e-06 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 5e-06 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 5e-06 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 5e-06 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 5e-06 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 5e-06 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 5e-06 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 5e-06 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 5e-06 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 5e-06 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 5e-06 | ||
| 3fxi_A | 605 | Crystal Structure Of The Human Tlr4-Human Md-2-E.Co | 5e-06 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 6e-06 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 6e-06 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 6e-06 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 6e-06 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 6e-06 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 6e-06 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 7e-06 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 7e-06 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 7e-06 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 7e-06 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 7e-06 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 7e-06 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 7e-06 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 7e-06 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 7e-06 | ||
| 3e6j_A | 229 | Crystal Structure Of Variable Lymphocyte Receptor ( | 8e-06 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 8e-06 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 8e-06 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 8e-06 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 8e-06 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 8e-06 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 8e-06 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-06 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 8e-06 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 8e-06 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 9e-06 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 9e-06 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 9e-06 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 9e-06 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 9e-06 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-05 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 1e-05 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 1e-05 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 1e-05 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 1e-05 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 1e-05 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-05 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 1e-05 | ||
| 3rfj_A | 279 | Design Of A Binding Scaffold Based On Variable Lymp | 1e-05 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-05 | ||
| 3b2d_A | 603 | Crystal Structure Of Human Rp105MD-1 Complex Length | 1e-05 | ||
| 3b2d_A | 603 | Crystal Structure Of Human Rp105MD-1 Complex Length | 2e-04 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 1e-05 | ||
| 3t6q_A | 606 | Crystal Structure Of Mouse Rp105MD-1 Complex Length | 1e-05 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 1e-05 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 1e-05 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 1e-05 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 1e-05 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 1e-05 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 2e-05 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-05 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 2e-05 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-05 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 2e-05 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 2e-05 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-05 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-05 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 2e-05 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 2e-05 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 2e-05 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 3e-05 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 3e-05 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 3e-05 | ||
| 2o6q_A | 270 | Structural Diversity Of The Hagfish Variable Lympho | 3e-05 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 3e-05 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 3e-05 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 3e-05 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-05 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 3e-05 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 4e-05 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 4e-05 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 4e-05 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 4e-05 | ||
| 1w8a_A | 192 | Third Lrr Domain Of Drosophila Slit Length = 192 | 4e-05 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 4e-05 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 4e-05 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 4e-05 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 4e-05 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 4e-05 | ||
| 1xku_A | 330 | Crystal Structure Of The Dimeric Protein Core Of De | 4e-05 | ||
| 2wfh_A | 193 | The Human Slit 2 Dimerization Domain D4 Length = 19 | 4e-05 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 4e-05 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 5e-05 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 5e-05 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 5e-05 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 5e-05 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 5e-05 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 5e-05 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 5e-05 | ||
| 3m18_A | 251 | Crystal Structure Of Variable Lymphocyte Receptor V | 5e-05 | ||
| 1xcd_A | 329 | Dimeric Bovine Tissue-Extracted Decorin, Crystal Fo | 5e-05 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 5e-05 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 6e-05 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 6e-05 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 6e-05 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 6e-05 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 6e-05 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 6e-05 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 7e-05 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 7e-05 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 7e-05 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 7e-05 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 7e-05 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 8e-05 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 8e-05 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 8e-05 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 8e-05 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 8e-05 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 8e-05 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 8e-05 | ||
| 3zyo_A | 411 | Crystal Structure Of The N-Terminal Leucine Rich Re | 8e-05 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 8e-05 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 8e-05 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 9e-05 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 9e-05 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 9e-05 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 9e-05 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 9e-05 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 9e-05 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 9e-05 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 9e-05 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 9e-05 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 1e-04 |
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|2OMX|A Chain A, Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX Length = 462 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|2OMT|A Chain A, Crystal Structure Of Inla G194s+sHEC1 COMPLEX Length = 462 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|2OMU|A Chain A, Crystal Structure Of Inla G194s+s Y369s/hec1 Complex Length = 462 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2OMZ|A Chain A, Crystal Structure Of Inla Y369a/hec1 Complex Length = 466 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|1O6S|A Chain A, Internalin (Listeria Monocytogenes) E-Cadherin (Human) Recognition Complex Length = 466 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|2OMV|A Chain A, Crystal Structure Of Inla S192n Y369s/hec1 Complex Length = 461 | Back alignment and structure |
|
| >pdb|2OMY|A Chain A, Crystal Structure Of Inla S192n/hec1 Complex Length = 461 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3RFS|A Chain A, Design Of A Binding Scaffold Based On Variable Lymphocyte Receptors Of Jawless Vertebrates By Module Engineering Length = 272 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3ZYJ|A Chain A, Netring1 In Complex With Ngl1 Length = 440 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|4G8A|A Chain A, Crystal Structure Of Human Tlr4 Polymorphic Variant D299g And T399i In Complex With Md-2 And Lps Length = 635 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2O6S|A Chain A, Structural Diversity Of The Hagfish Variable Lymphocyte Receptors B59 Length = 208 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3FXI|A Chain A, Crystal Structure Of The Human Tlr4-Human Md-2-E.Coli Lps Ra Complex Length = 605 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3E6J|A Chain A, Crystal Structure Of Variable Lymphocyte Receptor (Vlr) Rbc36 In Complex With H-Trisaccharide Length = 229 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3RFJ|A Chain A, Design Of A Binding Scaffold Based On Variable Lymphocyte Receptors Of Jawless Vertebrates By Module Engineering Length = 279 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3B2D|A Chain A, Crystal Structure Of Human Rp105MD-1 Complex Length = 603 | Back alignment and structure |
|
| >pdb|3B2D|A Chain A, Crystal Structure Of Human Rp105MD-1 Complex Length = 603 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3T6Q|A Chain A, Crystal Structure Of Mouse Rp105MD-1 Complex Length = 606 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2O6Q|A Chain A, Structural Diversity Of The Hagfish Variable Lymphocyte Receptors A29 Length = 270 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|1W8A|A Chain A, Third Lrr Domain Of Drosophila Slit Length = 192 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|1XKU|A Chain A, Crystal Structure Of The Dimeric Protein Core Of Decorin, The Archetypal Small Leucine-Rich Repeat Proteoglycan Length = 330 | Back alignment and structure |
|
| >pdb|2WFH|A Chain A, The Human Slit 2 Dimerization Domain D4 Length = 193 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3M18|A Chain A, Crystal Structure Of Variable Lymphocyte Receptor Vlra.R2.1 In Complex With Hen Egg Lysozyme Length = 251 | Back alignment and structure |
|
| >pdb|1XCD|A Chain A, Dimeric Bovine Tissue-Extracted Decorin, Crystal Form 1 Length = 329 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3ZYO|A Chain A, Crystal Structure Of The N-Terminal Leucine Rich Repeats And Immunoglobulin Domain Of Netrin-G Ligand-3 Length = 411 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST 
Original result of RPS-BLAST against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 918 | |||
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 1e-174 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 1e-155 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 1e-146 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 1e-119 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 1e-115 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 1e-111 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 1e-110 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 4e-99 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 4e-97 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 1e-87 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 1e-65 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 1e-18 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 1e-108 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 1e-104 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 4e-80 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 7e-77 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 8e-76 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 1e-18 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 1e-98 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 2e-88 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 1e-77 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 8e-57 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 5e-93 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 1e-85 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 6e-63 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 1e-86 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 2e-86 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 5e-86 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 6e-79 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 9e-38 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 7e-27 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 3e-84 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 5e-81 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 9e-76 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 2e-73 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 2e-69 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 7e-67 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 3e-83 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 6e-81 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 7e-81 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 3e-78 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 1e-66 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 7e-68 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 4e-60 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 1e-55 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 3e-38 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 2e-30 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 5e-28 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 1e-24 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 5e-22 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 2e-67 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 7e-66 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 6e-64 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 7e-60 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 8e-58 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 4e-62 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 3e-45 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 3e-35 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 4e-60 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 8e-53 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 1e-39 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 4e-33 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 6e-60 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 2e-58 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 3e-58 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 6e-58 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 7e-57 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 5e-44 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 1e-55 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 7e-55 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 9e-55 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 1e-54 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 1e-37 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 7e-32 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 9e-19 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 2e-53 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 5e-50 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 1e-49 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 4e-45 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 7e-34 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 2e-25 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 7e-14 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 6e-49 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 2e-48 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 1e-47 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 1e-45 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 1e-48 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 6e-48 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 9e-47 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 2e-45 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 6e-43 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 1e-40 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 1e-48 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 3e-48 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 4e-48 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 6e-48 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 2e-46 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 2e-46 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 4e-46 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 5e-46 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 6e-43 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 3e-37 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 6e-37 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 4e-36 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 2e-31 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 1e-14 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 4e-09 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 1e-42 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 3e-42 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 2e-40 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 7e-16 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 4e-42 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 3e-41 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 7e-39 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 2e-37 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 3e-37 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 9e-37 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 3e-14 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 4e-08 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 7e-42 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 3e-37 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 1e-30 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 7e-16 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 1e-41 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 2e-40 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 7e-29 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 4e-25 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 3e-23 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 2e-40 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 2e-37 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 1e-30 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 3e-12 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 3e-40 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 1e-38 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 8e-37 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 1e-16 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 3e-08 | |
| 3jqh_A | 167 | C-type lectin domain family 4 member M; DC-signr, | 3e-40 | |
| 3jqh_A | 167 | C-type lectin domain family 4 member M; DC-signr, | 1e-39 | |
| 3jqh_A | 167 | C-type lectin domain family 4 member M; DC-signr, | 5e-37 | |
| 3jqh_A | 167 | C-type lectin domain family 4 member M; DC-signr, | 3e-34 | |
| 3jqh_A | 167 | C-type lectin domain family 4 member M; DC-signr, | 2e-33 | |
| 3jqh_A | 167 | C-type lectin domain family 4 member M; DC-signr, | 2e-26 | |
| 3jqh_A | 167 | C-type lectin domain family 4 member M; DC-signr, | 2e-18 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 1e-39 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 2e-39 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 7e-36 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 9e-35 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 6e-34 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 8e-25 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 9e-07 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 2e-39 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 2e-35 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 2e-35 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 1e-31 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 2e-30 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 4e-30 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 2e-28 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 2e-27 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 1e-14 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 3e-35 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 3e-35 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 6e-35 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 2e-34 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 2e-34 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 3e-34 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 8e-34 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 8e-34 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 9e-34 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 2e-33 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 2e-33 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 2e-33 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 2e-33 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 2e-33 | |
| 4apc_A | 350 | Serine/threonine-protein kinase NEK1; transferase; | 3e-33 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 4e-33 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 5e-33 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 6e-33 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 2e-29 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 9e-29 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 4e-27 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 9e-24 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 2e-15 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 2e-09 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 6e-33 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 8e-33 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 1e-32 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 2e-32 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 2e-32 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 2e-32 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 7e-31 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 9e-29 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 2e-24 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 1e-17 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 2e-04 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 2e-32 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 2e-32 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 2e-32 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 2e-32 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 4e-32 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 5e-32 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 6e-32 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 7e-32 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 9e-32 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 1e-31 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 1e-31 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 3e-31 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 3e-31 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 1e-30 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 4e-26 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 1e-23 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 9e-21 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 3e-31 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 3e-31 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 5e-31 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 6e-31 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 4e-28 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 1e-25 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 5e-23 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 1e-04 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 8e-31 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 8e-31 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 9e-31 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 1e-30 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 1e-30 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 1e-30 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 2e-30 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 6e-29 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 4e-26 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 2e-30 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 2e-30 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 2e-30 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 3e-30 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 3e-30 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 7e-30 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 1e-29 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 1e-29 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 2e-29 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 4e-28 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 5e-28 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 9e-26 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 1e-25 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 4e-24 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 2e-29 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 2e-29 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 3e-29 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 3e-29 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 5e-29 | |
| 3v5q_A | 297 | NT-3 growth factor receptor; kinase domain, kinase | 7e-29 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 7e-29 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 1e-25 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 2e-25 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 5e-25 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 2e-22 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 2e-22 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 4e-22 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 4e-21 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 3e-20 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 3e-17 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 8e-29 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 9e-29 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 1e-28 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 6e-26 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 6e-26 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 1e-25 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 1e-24 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 4e-21 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 5e-19 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 2e-28 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 2e-28 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 2e-28 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 2e-28 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 2e-28 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 3e-28 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 4e-28 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 4e-28 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 5e-28 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 5e-28 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 6e-28 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 6e-28 | |
| 3zzw_A | 289 | Tyrosine-protein kinase transmembrane receptor RO; | 8e-28 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 9e-28 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 9e-28 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 1e-22 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 5e-22 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 1e-18 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 4e-16 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 5e-15 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 2e-10 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 9e-28 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 3e-27 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 2e-21 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 9e-21 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 2e-20 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 7e-19 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 1e-27 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 1e-27 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 1e-27 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 1e-22 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 2e-21 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 4e-18 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 8e-15 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 1e-27 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 1e-27 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 2e-27 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 2e-27 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 3e-27 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 4e-27 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 4e-27 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 4e-27 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 5e-27 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 5e-27 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 5e-27 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 9e-27 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 2e-21 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 1e-20 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 4e-16 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 4e-16 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 3e-13 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 1e-26 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 1e-26 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 5e-26 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 7e-26 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 8e-26 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 9e-26 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 1e-25 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 1e-25 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 2e-25 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 2e-25 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 3e-25 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 4e-25 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 4e-25 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 4e-25 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 4e-25 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 5e-25 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 6e-25 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 9e-25 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 1e-24 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 2e-24 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 2e-24 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 3e-24 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 3e-24 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 4e-24 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 5e-24 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 8e-20 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 2e-18 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 4e-18 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 5e-18 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 3e-16 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 7e-12 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 8e-24 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 1e-23 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 1e-23 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 2e-23 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 2e-23 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 2e-23 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 4e-23 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 2e-22 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 3e-22 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 2e-21 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 1e-20 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 1e-17 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 6e-16 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 8e-15 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 4e-09 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 1e-05 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 4e-23 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 2e-19 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 6e-18 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 2e-17 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 2e-17 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 4e-15 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 2e-14 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 4e-23 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 4e-23 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 5e-23 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 5e-23 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 5e-23 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 7e-23 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 8e-23 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 9e-23 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 1e-22 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 2e-17 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 5e-17 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 2e-15 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 8e-13 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 2e-22 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 3e-22 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 3e-22 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 4e-22 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 4e-22 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 4e-22 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 2e-21 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 6e-19 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 3e-15 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 2e-14 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 2e-14 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 2e-11 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 3e-21 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 4e-21 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 1e-20 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 9e-20 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 2e-17 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 2e-17 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 3e-16 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 2e-14 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 2e-14 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 1e-13 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 2e-09 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 3e-20 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 5e-20 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 7e-19 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 5e-15 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 2e-14 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 7e-11 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 9e-07 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 2e-19 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 3e-19 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 3e-13 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 3e-13 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 1e-12 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 8e-11 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 3e-09 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 1e-08 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 4e-19 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 5e-19 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 3e-18 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 5e-17 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 3e-14 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 4e-14 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 1e-10 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 8e-09 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 1e-18 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 3e-18 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 6e-17 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 2e-15 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 1e-13 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 1e-12 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 1e-11 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 6e-11 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 1e-07 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 3e-18 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 4e-18 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 6e-17 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 2e-15 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 1e-13 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 5e-13 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 2e-10 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 6e-09 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 7e-18 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 1e-17 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 2e-17 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 2e-16 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 5e-15 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 9e-15 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 3e-14 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 4e-14 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 7e-12 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 5e-09 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 3e-17 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 4e-17 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 1e-16 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 1e-16 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 5e-15 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 1e-14 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 2e-13 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 4e-12 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 7e-12 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 1e-09 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 2e-08 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 2e-16 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 7e-16 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 1e-14 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 3e-13 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 2e-12 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 2e-12 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 3e-10 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 1e-09 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 2e-06 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 7e-16 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 1e-15 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 2e-15 | |
| 1uu3_A | 310 | HPDK1, 3-phosphoinositide dependent protein kinase | 2e-15 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 3e-15 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 3e-15 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 3e-15 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 2e-14 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 8e-12 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 1e-11 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 1e-09 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 1e-08 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 3e-06 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 4e-05 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 2e-14 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 3e-14 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 1e-13 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 2e-12 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 3e-11 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 9e-11 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 2e-09 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 2e-06 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 3e-14 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 5e-14 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 1e-13 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 1e-13 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 3e-13 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 3e-11 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 3e-10 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 2e-09 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 3e-08 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 8e-08 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 7e-04 | |
| 3pvu_A | 695 | Beta-adrenergic receptor kinase 1; transferase, se | 2e-13 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 3e-13 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 9e-13 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 1e-12 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 1e-12 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 2e-12 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 2e-12 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 2e-12 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 5e-11 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 6e-09 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 8e-09 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 3e-08 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 2e-05 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 2e-04 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 4e-12 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 4e-12 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 1e-09 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 6e-09 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 9e-09 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 1e-08 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 7e-08 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 1e-07 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 1e-06 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 2e-06 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 3e-05 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 4e-05 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 6e-05 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 2e-04 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 8e-12 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 8e-12 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 2e-11 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 1e-09 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 3e-09 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 1e-06 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 1e-06 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 3e-11 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 4e-11 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 5e-11 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 5e-11 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 7e-11 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 7e-11 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 7e-11 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 8e-11 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 1e-10 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 2e-10 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 7e-10 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 3e-09 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 2e-10 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 3e-10 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 3e-10 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 3e-10 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 3e-10 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 3e-10 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 4e-10 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 4e-10 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 5e-10 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 7e-10 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 7e-10 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 1e-09 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 2e-07 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 3e-07 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 3e-07 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 5e-07 | |
| 3g51_A | 325 | Ribosomal protein S6 kinase alpha-3; N-terminal ki | 1e-09 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 2e-09 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 2e-09 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 2e-09 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 3e-09 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 2e-08 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 6e-08 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 3e-09 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 3e-09 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 4e-09 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 2e-08 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 4e-08 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 4e-09 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 2e-08 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 4e-08 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 1e-07 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 1e-06 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 1e-04 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 4e-09 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 7e-09 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 7e-09 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 1e-08 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 1e-08 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 6e-07 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 4e-06 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 6e-06 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 4e-05 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 1e-04 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 4e-04 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 1e-08 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 2e-08 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 2e-08 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 2e-08 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 8e-08 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 1e-06 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 2e-08 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 3e-08 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 4e-07 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 2e-06 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 5e-06 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 1e-05 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 4e-05 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 2e-04 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 3e-08 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 3e-08 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 5e-06 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 2e-04 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 3e-04 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 6e-04 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 4e-08 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 8e-08 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 1e-07 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 1e-07 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 6e-07 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 4e-06 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 2e-05 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 3e-04 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 8e-06 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 9e-06 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 1e-05 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 3e-05 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 3e-05 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 6e-05 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 1e-04 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 4e-04 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 2e-04 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 3e-04 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 4e-04 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 4e-04 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 7e-04 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 8e-04 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 9e-04 |
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 523 bits (1350), Expect = e-174
Identities = 176/590 (29%), Positives = 268/590 (45%), Gaps = 21/590 (3%)
Query: 2 LNLGFNLLFGNIPPQIGNLSKLQYLDLGNNQLSGVIPPEIGKLNQLRRLYLDVNQLHGTI 61
L + N + G++ + L++LD+ +N S IP +G + L+ L + N+L G
Sbjct: 183 LAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGIP-FLGDCSALQHLDISGNKLSGDF 239
Query: 62 PPVIGQLSLINELVFCHNNVSGRIPSSLGNLSNLALLYLNDNSLFGSIPI-VMGNLKSLS 120
I + + L N G IP L +L L L +N G IP + G +L+
Sbjct: 240 SRAISTCTELKLLNISSNQFVGPIPPL--PLKSLQYLSLAENKFTGEIPDFLSGACDTLT 297
Query: 121 TLDLSQNQLNGSIPCSLDNLSNLDTLFLYKNSLSGPIP-SVIGNLKSLLQLDLSENRLSG 179
LDLS N G++P + S L++L L N+ SG +P + ++ L LDLS N SG
Sbjct: 298 GLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSG 357
Query: 180 LIPLSLSNLS-SLTVMSLFNNSLSGSIPPILGN--LKSLSTLGLHINQLNGVIPPSIGNL 236
+P SL+NLS SL + L +N+ SG I P L +L L L N G IPP++ N
Sbjct: 358 ELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNC 417
Query: 237 SSLRNLSLFNNRLYGFVPKEIGYLKSLSKLEFCANHLSGVIPHSVGNLTGLVLLNMCENH 296
S L +L L N L G +P +G L L L+ N L G IP + + L L + N
Sbjct: 418 SELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFND 477
Query: 297 LFGPIPKSLRNLTSLERVRFNQNNLYGKVYEAFGDHPNLTFLDLSQNNFYCEISFNWRNF 356
L G IP L N T+L + + N L G++ + G NL L LS N+F I +
Sbjct: 478 LTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDC 537
Query: 357 SKLGTFNASMNNIYGSIPPEIGDSSKLQVLDLSSNHIFGKIPVQLVKLFSLNKLILSLN- 415
L + + N G+IP + S +++N I GK V + + + N
Sbjct: 538 RSLIWLDLNTNLFNGTIPAAMFKQS----GKIAANFIAGKRYVYIKNDGMKKECHGAGNL 593
Query: 416 -QLFGGVPLEFGTLTELQYLDLSANKLSSSIPMSIGNLLKLHYLNLSNNQFSHKIPTEFE 474
+ G + L+ ++++ + N + +L++S N S IP E
Sbjct: 594 LEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIG 653
Query: 475 KLIHLSELDLSHNILQEEIPPQICKMESLEKLNLSHNNLSDFIPRCFEEMRSLSWIDISY 534
+ +L L+L HN + IP ++ + L L+LS N L IP+ + L+ ID+S
Sbjct: 654 SMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSN 713
Query: 535 NELQGPIPNSTAFKN---GLMEGNKGLCGNFKALPSCDAFTSHKQTFRKK 581
N L GPIP F+ N GLCG LP CD + ++
Sbjct: 714 NNLSGPIPEMGQFETFPPAKFLNNPGLCGY--PLPRCDPSNADGYAHHQR 761
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 474 bits (1223), Expect = e-155
Identities = 157/576 (27%), Positives = 247/576 (42%), Gaps = 39/576 (6%)
Query: 2 LNLGFNLLFGNIPPQIGNLSKLQYLDLGNNQLSGVIPP--EIGKLNQLRRLYLDVNQLHG 59
L L + + G++ + L LDL N LSG + +G + L+ L + N L
Sbjct: 82 LFLSNSHINGSVSG-FKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDF 140
Query: 60 TIP-PVIGQLSLINELVFCHNNVSGRIPSSL---GNLSNLALLYLNDNSLFGSIPIVMGN 115
+L+ + L N++SG L L ++ N + G + +
Sbjct: 141 PGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAISGNKISGDVDV--SR 198
Query: 116 LKSLSTLDLSQNQLNGSIPCSLDNLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSEN 175
+L LD+S N + IP L + S L L + N LSG I L L++S N
Sbjct: 199 CVNLEFLDVSSNNFSTGIP-FLGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSN 257
Query: 176 RLSGLIPLSLSNLSSLTVMSLFNNSLSGSIPP-ILGNLKSLSTLGLHINQLNGVIPPSIG 234
+ G IP L SL +SL N +G IP + G +L+ L L N G +PP G
Sbjct: 258 QFVGPIP--PLPLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFG 315
Query: 235 NLSSLRNLSLFNNRLYGFVPKE-IGYLKSLSKLEFCANHLSGVIPHSVGNLTG-LVLLNM 292
+ S L +L+L +N G +P + + ++ L L+ N SG +P S+ NL+ L+ L++
Sbjct: 316 SCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDL 375
Query: 293 CENHLFGPIPKSLRN--LTSLERVRFNQNNLYGKVYEAFGDHPNLTFLDLSQNNFYCEIS 350
N+ GPI +L +L+ + N GK+ + L L LS N I
Sbjct: 376 SSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIP 435
Query: 351 FNWRNFSKLGTFNASMNNIYGSIPPEIGDSSKLQVLDLSSNHIFGKIPVQLVKLFSLNKL 410
+ + SKL +N + G IP E+ L+ L L N + G+IP L +LN +
Sbjct: 436 SSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWI 495
Query: 411 ILSLNQLFGGVPLEFGTLTELQYLDLSANKLSSSIPMSIGNLLKLHYLNLSNNQFSHKIP 470
LS N+L G +P G L L L LS N S +IP +G+ L +L+L+ N F+ IP
Sbjct: 496 SLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIP 555
Query: 471 TEFEKL--------------------IHLSELDLSHNILQE--EIPPQICKMESLEKLNL 508
K E + N+L+ Q+ ++ + N+
Sbjct: 556 AAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNI 615
Query: 509 SHNNLSDFIPRCFEEMRSLSWIDISYNELQGPIPNS 544
+ F+ S+ ++D+SYN L G IP
Sbjct: 616 TSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKE 651
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 451 bits (1163), Expect = e-146
Identities = 165/555 (29%), Positives = 256/555 (46%), Gaps = 23/555 (4%)
Query: 3 NLGFNLLFGNIPPQIGNLSKLQYLDLGNNQLSGVIPPEIGKLNQLRRLYLDVNQLHGTIP 62
+ N+ F + + +L+ L+ L L N+ ++G + L L L N L G +
Sbjct: 59 SKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSV-SGFKCSASLTSLDLSRNSLSGPVT 117
Query: 63 PV--IGQLSLINELVFCHNNVSGRIPSSLG-NLSNLALLYLNDNSLFGSIPI---VMGNL 116
+ +G S + L N + S G L++L +L L+ NS+ G+ + +
Sbjct: 118 TLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGC 177
Query: 117 KSLSTLDLSQNQLNGSIPCSLDNLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSENR 176
L L +S N+++G + + NL+ L + N+ S IP +G+ +L LD+S N+
Sbjct: 178 GELKHLAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGIPF-LGDCSALQHLDISGNK 234
Query: 177 LSGLIPLSLSNLSSLTVMSLFNNSLSGSIPPILGNLKSLSTLGLHINQLNGVIPPSI-GN 235
LSG ++S + L ++++ +N G IPP LKSL L L N+ G IP + G
Sbjct: 235 LSGDFSRAISTCTELKLLNISSNQFVGPIPP--LPLKSLQYLSLAENKFTGEIPDFLSGA 292
Query: 236 LSSLRNLSLFNNRLYGFVPKEIGYLKSLSKLEFCANHLSGVIPHSV-GNLTGLVLLNMCE 294
+L L L N YG VP G L L +N+ SG +P + GL +L++
Sbjct: 293 CDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSF 352
Query: 295 NHLFGPIPKSLRNLT-SLERVRFNQNNLYGKVYEAFGDHP--NLTFLDLSQNNFYCEISF 351
N G +P+SL NL+ SL + + NN G + +P L L L N F +I
Sbjct: 353 NEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPP 412
Query: 352 NWRNFSKLGTFNASMNNIYGSIPPEIGDSSKLQVLDLSSNHIFGKIPVQLVKLFSLNKLI 411
N S+L + + S N + G+IP +G SKL+ L L N + G+IP +L+ + +L LI
Sbjct: 413 TLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLI 472
Query: 412 LSLNQLFGGVPLEFGTLTELQYLDLSANKLSSSIPMSIGNLLKLHYLNLSNNQFSHKIPT 471
L N L G +P T L ++ LS N+L+ IP IG L L L LSNN FS IP
Sbjct: 473 LDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPA 532
Query: 472 EFEKLIHLSELDLSHNILQEEIPPQICKMESLEKLNLSHNNLSDFIPRCFEEMRSLSWID 531
E L LDL+ N+ IP + K ++ N ++ +
Sbjct: 533 ELGDCRSLIWLDLNTNLFNGTIPAAMFKQ----SGKIAANFIAGKRYVYIKNDGMKKECH 588
Query: 532 ISYN--ELQGPIPNS 544
+ N E QG
Sbjct: 589 GAGNLLEFQGIRSEQ 603
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 379 bits (976), Expect = e-119
Identities = 143/468 (30%), Positives = 224/468 (47%), Gaps = 17/468 (3%)
Query: 88 SLGNLSNLALLYLNDNSLFGSIPIVMGNLKSLSTLDLSQNQLNGSIPCSLDNLSNLDTLF 147
++++ L N F ++ + +L L +L LS + +NGS+ ++L +L
Sbjct: 48 RDDKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVS-GFKCSASLTSLD 106
Query: 148 LYKNSLSGPIPSV--IGNLKSLLQLDLSENRLSGLIPLS-LSNLSSLTVMSLFNNSLSGS 204
L +NSLSGP+ ++ +G+ L L++S N L +S L+SL V+ L NS+SG+
Sbjct: 107 LSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGA 166
Query: 205 IPP---ILGNLKSLSTLGLHINQLNGVIPPSIGNLSSLRNLSLFNNRLYGFVPKEIGYLK 261
+ L L + N+++G + + +L L + +N +P +G
Sbjct: 167 NVVGWVLSDGCGELKHLAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGIP-FLGDCS 223
Query: 262 SLSKLEFCANHLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLRNLTSLERVRFNQNNL 321
+L L+ N LSG ++ T L LLN+ N GPIP L SL+ + +N
Sbjct: 224 ALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPL--PLKSLQYLSLAENKF 281
Query: 322 YGKV-YEAFGDHPNLTFLDLSQNNFYCEISFNWRNFSKLGTFNASMNNIYGSIPPE-IGD 379
G++ G LT LDLS N+FY + + + S L + S NN G +P + +
Sbjct: 282 TGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLK 341
Query: 380 SSKLQVLDLSSNHIFGKIPVQLVKL-FSLNKLILSLNQLFGGVPLEFG--TLTELQYLDL 436
L+VLDLS N G++P L L SL L LS N G + LQ L L
Sbjct: 342 MRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYL 401
Query: 437 SANKLSSSIPMSIGNLLKLHYLNLSNNQFSHKIPTEFEKLIHLSELDLSHNILQEEIPPQ 496
N + IP ++ N +L L+LS N S IP+ L L +L L N+L+ EIP +
Sbjct: 402 QNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQE 461
Query: 497 ICKMESLEKLNLSHNNLSDFIPRCFEEMRSLSWIDISYNELQGPIPNS 544
+ +++LE L L N+L+ IP +L+WI +S N L G IP
Sbjct: 462 LMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKW 509
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 370 bits (952), Expect = e-115
Identities = 142/477 (29%), Positives = 194/477 (40%), Gaps = 82/477 (17%)
Query: 1 MLNLGFNLLFGNIPPQ-IGNLSKLQYLDLGNNQLSGVIPPEIGKL-NQLRRLYLDVNQLH 58
L L N G +P + + L+ LDL N+ SG +P + L L L L N
Sbjct: 322 SLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFS 381
Query: 59 GTIPPVIGQLSLIN--ELVFCHNNVSGRIPSSLGNLSNLALLYLNDNSLFGSIPIVMGNL 116
G I P + Q EL +N +G+IP +L N S L L+L+ N L G+IP +G+L
Sbjct: 382 GPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSL 441
Query: 117 KSLSTLDLSQNQLNGSIPCSLDNLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSENR 176
L L L N L G IP L + L+TL L N L+G IPS + N +L + LS NR
Sbjct: 442 SKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNR 501
Query: 177 LSGLIPLSLSNLSSLTVMSLFNNSLSGSIPPILGNLKSLSTLGLHINQLNGVIPPSIGNL 236
L+G IP + L +L ++ L NNS SG+IP LG+ +SL L L+ N NG IP ++
Sbjct: 502 LTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQ 561
Query: 237 SSLRNLSLFNNRLYGFVPKEIGYLKSLSKLEFCAN--HLSGVIPHSVGNLTGLVLLNMCE 294
S + N + G I + N G+ + L+ N+
Sbjct: 562 SGK----IAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITS 617
Query: 295 NHLFGPIPKSLRNLTSLERVRFNQNNLYGKVYEAFGDHPNLTFLDLSQNNFYCEISFNWR 354
G + N ++ FLD+S N
Sbjct: 618 RVYGGHTSPTFDNNG------------------------SMMFLDMSYNML--------- 644
Query: 355 NFSKLGTFNASMNNIYGSIPPEIGDSSKLQVLDLSSNHIFGKIPVQLVKLFSLNKLILSL 414
G IP EIG L +L+L N I G IP
Sbjct: 645 ---------------SGYIPKEIGSMPYLFILNLGHNDISGSIPD--------------- 674
Query: 415 NQLFGGVPLEFGTLTELQYLDLSANKLSSSIPMSIGNLLKLHYLNLSNNQFSHKIPT 471
E G L L LDLS+NKL IP ++ L L ++LSNN S IP
Sbjct: 675 ---------EVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPE 722
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 355 bits (914), Expect = e-111
Identities = 132/586 (22%), Positives = 213/586 (36%), Gaps = 32/586 (5%)
Query: 2 LNLGFNLLFGNIPPQIGNLSKLQYLDLGNNQLSGVIPPEIGKLNQLRRLYLDVNQLHGTI 61
L++GFN + P L L+ L+L +N+LS + L L+L N +
Sbjct: 54 LDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIK 113
Query: 62 PPVIGQLSLINELVFCHNNVSGRIPSSLGNLSNLALLYLNDNSLFGSIPIVMGNLK--SL 119
+ + L HN +S + L NL L L++N + + SL
Sbjct: 114 NNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSL 173
Query: 120 STLDLSQNQLNGSIPCSLDNLSNLDTLFLYKNSLSGPIPSVIG---NLKSLLQLDLSENR 176
L+LS NQ+ P + L LFL L + + S+ L LS ++
Sbjct: 174 KKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQ 233
Query: 177 LSGLIPLSLSNL--SSLTVMSLFNNSLSGSIPPILGNLKSLSTLGLHINQLNGVIPPSIG 234
LS + L ++LT++ L N+L+ L L L N + + S+
Sbjct: 234 LSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLH 293
Query: 235 NLSSLRNLSLFNN---------RLYGFVPKEIGYLKSLSKLEFCANHLSGVIPHSVGNLT 285
L ++R L+L + L +LK L L N + G+ + L
Sbjct: 294 GLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLI 353
Query: 286 GLVLLNMCENHL--FGPIPKSLRNL--TSLERVRFNQNNLYGKVYEAFGDHPNLTFLDLS 341
L L++ + ++ +L + L + +N + +AF +L LDL
Sbjct: 354 NLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLG 413
Query: 342 QNNFYCEISFN-WRNFSKLGTFNASMNNIYGSIPPEIGDSSKLQVLDLSSNHI--FGKIP 398
N E++ WR + S N LQ L L + P
Sbjct: 414 LNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSP 473
Query: 399 VQLVKLFSLNKLILSLNQLFGGVPLEFGTLTELQYLDLSANKLSS--------SIPMSIG 450
L +L L LS N + L +L+ LDL N L+ +
Sbjct: 474 SPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLK 533
Query: 451 NLLKLHYLNLSNNQFSHKIPTEFEKLIHLSELDLSHNILQEEIPPQICKMESLEKLNLSH 510
L LH LNL +N F F+ L L +DL N L SL+ LNL
Sbjct: 534 GLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQK 593
Query: 511 NNLSDFIPRCFEE-MRSLSWIDISYNELQGPIPNSTAFKNGLMEGN 555
N ++ + F R+L+ +D+ +N + F N + E +
Sbjct: 594 NLITSVEKKVFGPAFRNLTELDMRFNPFDCTCESIAWFVNWINETH 639
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 355 bits (912), Expect = e-110
Identities = 136/574 (23%), Positives = 213/574 (37%), Gaps = 34/574 (5%)
Query: 2 LNLGFNLLFGNIPPQIGNLSKLQYLDLGNNQLSGVIPPEIGKLNQLRRLYLDVNQLHGTI 61
+ L +P + + + L+L +NQL + + +QL L + N +
Sbjct: 9 ADCSHLKLT-QVPDDL--PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLE 65
Query: 62 PPVIGQLSLINELVFCHNNVSGRIPSSLGNLSNLALLYLNDNSLFGSIPIVMGNLKSLST 121
P + +L ++ L HN +S + +NL L+L NS+ K+L T
Sbjct: 66 PELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLIT 125
Query: 122 LDLSQNQLNGSIPCSLDNLSNLDTLFLYKNSLSGPIPSVIGNLK--SLLQLDLSENRLSG 179
LDLS N L+ + + L NL L L N + + SL +L+LS N++
Sbjct: 126 LDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKE 185
Query: 180 LIPLSLSNLSSLTVMSLFNNSLSGSIPPILG---NLKSLSTLGLHINQLNGVIPPSIGNL 236
P + L + L N L S+ L S+ L L +QL+ + L
Sbjct: 186 FSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGL 245
Query: 237 --SSLRNLSLFNNRLYGFVPKEIGYLKSLSKLEFCANHLSGVIPHSVGNLTGLVLLNMCE 294
++L L L N L +L L N++ + HS+ L + LN+
Sbjct: 246 KWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKR 305
Query: 295 N---------HLFGPIPKSLRNLTSLERVRFNQNNLYGKVYEAFGDHPNLTFLDLSQNNF 345
+ L S + L LE + N++ G F NL +L LS +
Sbjct: 306 SFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFT 365
Query: 346 Y----CEISFNWRNFSKLGTFNASMNNIYGSIPPEIGDSSKLQVLDLSSNHIFGKIPVQ- 400
+F S L N + N I L+VLDL N I ++ Q
Sbjct: 366 SLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQE 425
Query: 401 LVKLFSLNKLILSLNQLFGGVPLEFGTLTELQYLDLSANKLSS--SIPMSIGNLLKLHYL 458
L ++ ++ LS N+ F + LQ L L L + S P L L L
Sbjct: 426 WRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTIL 485
Query: 459 NLSNNQFSHKIPTEFEKLIHLSELDLSHNILQE--------EIPPQICKMESLEKLNLSH 510
+LSNN ++ E L L LDL HN L + + L LNL
Sbjct: 486 DLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLES 545
Query: 511 NNLSDFIPRCFEEMRSLSWIDISYNELQGPIPNS 544
N + F+++ L ID+ N L +
Sbjct: 546 NGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASV 579
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 323 bits (831), Expect = 4e-99
Identities = 114/539 (21%), Positives = 195/539 (36%), Gaps = 50/539 (9%)
Query: 23 LQYLDLGNNQLSGVIPPEIGKLNQLRRLYLDVNQLHGTIPPVIGQLSLINELVFCHNNVS 82
+ D + +L+ +P ++ + L L NQL
Sbjct: 6 HEVADCSHLKLTQ-VPDDL--PTNITVLNLTHNQLRRLPA-------------------- 42
Query: 83 GRIPSSLGNLSNLALLYLNDNSLFGSIPIVMGNLKSLSTLDLSQNQLNGSIPCSLDNLSN 142
++ S L L + N++ P + L L L+L N+L+ + +N
Sbjct: 43 ----ANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTN 98
Query: 143 LDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSENRLSGLIPLSLSNLSSLTVMSLFNNSLS 202
L L L NS+ + K+L+ LDLS N LS + L +L + L NN +
Sbjct: 99 LTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQ 158
Query: 203 GSIPPILGNLK--SLSTLGLHINQLNGVIPPSIGNLSSLRNLSLFNNRLYGFVPKEIGY- 259
L SL L L NQ+ P + L L L N +L + +++
Sbjct: 159 ALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLE 218
Query: 260 --LKSLSKLEFCANHLSGVIPHSVGNL--TGLVLLNMCENHLFGPIPKSLRNLTSLERVR 315
S+ L + LS + L T L +L++ N+L S L LE
Sbjct: 219 LANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFF 278
Query: 316 FNQNNLYGKVYEAFGDHPNLTFLDLSQNNFYCEISFN---------WRNFSKLGTFNASM 366
NN+ + N+ +L+L ++ IS ++ L N
Sbjct: 279 LEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMED 338
Query: 367 NNIYGSIPPEIGDSSKLQVLDLSSNHIFGKIPVQLV----KLFSLNKLILSLNQLFGGVP 422
N+I G L+ L LS++ + L+ L L+ N++
Sbjct: 339 NDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIES 398
Query: 423 LEFGTLTELQYLDLSANKLSSSIP-MSIGNLLKLHYLNLSNNQFSHKIPTEFEKLIHLSE 481
F L L+ LDL N++ + L + + LS N++ F + L
Sbjct: 399 DAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQR 458
Query: 482 LDLSHNILQ--EEIPPQICKMESLEKLNLSHNNLSDFIPRCFEEMRSLSWIDISYNELQ 538
L L L+ + P + +L L+LS+NN+++ E + L +D+ +N L
Sbjct: 459 LMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLA 517
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 318 bits (817), Expect = 4e-97
Identities = 117/547 (21%), Positives = 192/547 (35%), Gaps = 35/547 (6%)
Query: 2 LNLGFNLLFGNIPPQIGNLSKLQYLDLGNNQLSGVIPPEIGKLNQLRRLYLDVNQLHGTI 61
L+L N + L LDL +N LS +L L+ L L N++
Sbjct: 102 LHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALK 161
Query: 62 PPVIGQLSLIN--ELVFCHNNVSGRIPSSLGNLSNLALLYLNDNSLFGSIPIVMG---NL 116
+ + + +L N + P + L L+LN+ L S+ +
Sbjct: 162 SEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELAN 221
Query: 117 KSLSTLDLSQNQLNGSIPCSLDNL--SNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSE 174
S+ L LS +QL+ + + L +NL L L N+L+ L L L
Sbjct: 222 TSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEY 281
Query: 175 NRLSGLIPLSLSNLSSLTVMSLFNN---------SLSGSIPPILGNLKSLSTLGLHINQL 225
N + L SL L ++ ++L + SL LK L L + N +
Sbjct: 282 NNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDI 341
Query: 226 NGVIPPSIGNLSSLRNLSLFNNRLYGFVPKEIG----YLKSLSKLEFCANHLSGVIPHSV 281
G+ L +L+ LSL N+ L L N +S + +
Sbjct: 342 PGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAF 401
Query: 282 GNLTGLVLLNMCENHLFGPIPKS-LRNLTSLERVRFNQNNLYGKVYEAFGDHPNLTFLDL 340
L L +L++ N + + R L ++ + + N +F P+L L L
Sbjct: 402 SWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLML 461
Query: 341 SQNNFY--CEISFNWRNFSKLGTFNASMNNIYGSIPPEIGDSSKLQVLDLSSNHI----- 393
+ ++ L + S NNI + KL++LDL N++
Sbjct: 462 RRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWK 521
Query: 394 ---FGKIPVQLVKLFSLNKLILSLNQLFGGVPLEFGTLTELQYLDLSANKLSSSIPMSIG 450
G L L L+ L L N F L EL+ +DL N L++
Sbjct: 522 HANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFN 581
Query: 451 NLLKLHYLNLSNNQFSHKIPTEFEK-LIHLSELDLSHNILQEEIPPQICKMESLEKLNLS 509
N + L LNL N + F +L+ELD+ N + +N +
Sbjct: 582 NQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCESI---AWFVNWINET 638
Query: 510 HNNLSDF 516
H N+ +
Sbjct: 639 HTNIPEL 645
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 293 bits (752), Expect = 1e-87
Identities = 110/477 (23%), Positives = 186/477 (38%), Gaps = 24/477 (5%)
Query: 94 NLALLYLNDNSLFGSIPIVMGNLKSLSTLDLSQNQLNGSIPCSLDNLSNLDTLFLYKNSL 153
+ + + L +P +++ L+L+ NQL + S L +L + N++
Sbjct: 5 SHEVADCSHLKLT-QVP--DDLPTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTI 61
Query: 154 SGPIPSVIGNLKSLLQLDLSENRLSGLIPLSLSNLSSLTVMSLFNNSLSGSIPPILGNLK 213
S P + L L L+L N LS L + + ++LT + L +NS+ K
Sbjct: 62 SKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQK 121
Query: 214 SLSTLGLHINQLNGVIPPSIGNLSSLRNLSLFNNRLYGFVPKEIGYLK--SLSKLEFCAN 271
+L TL L N L+ + L +L+ L L NN++ +E+ SL KLE +N
Sbjct: 122 NLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSN 181
Query: 272 HLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLR---NLTSLERVRFNQNNLYGKVYEA 328
+ P + L L + L + + L TS+ + + + L
Sbjct: 182 QIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTT 241
Query: 329 FG--DHPNLTFLDLSQNNFYCEISFNWRNFSKLGTFNASMNNIYGSIPPEIGDSSKLQVL 386
F NLT LDLS NN + ++ +L F NNI + ++ L
Sbjct: 242 FLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYL 301
Query: 387 DLSSN---------HIFGKIPVQLVKLFSLNKLILSLNQLFGGVPLEFGTLTELQYLDLS 437
+L + + L L L + N + G F L L+YL LS
Sbjct: 302 NLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLS 361
Query: 438 ANKLS----SSIPMSIGNLLKLHYLNLSNNQFSHKIPTEFEKLIHLSELDLSHNILQEEI 493
+ S ++ LH LNL+ N+ S F L HL LDL N + +E+
Sbjct: 362 NSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQEL 421
Query: 494 PPQ-ICKMESLEKLNLSHNNLSDFIPRCFEEMRSLSWIDISYNELQGPIPNSTAFKN 549
Q +E++ ++ LS+N F + SL + + L+ + + F+
Sbjct: 422 TGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQP 478
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 232 bits (593), Expect = 1e-65
Identities = 90/424 (21%), Positives = 157/424 (37%), Gaps = 32/424 (7%)
Query: 1 MLNLGFNLLFGNIPPQIGNLSKLQYLDLGNNQLSGVIPPEIGKLNQLRRLYLD------- 53
ML+L +N L L +L+Y L N + + + L +R L L
Sbjct: 252 MLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQS 311
Query: 54 --VNQLHGTIPPVIGQLSLINELVFCHNNVSGRIPSSLGNLSNLALLYLNDN--SLFGSI 109
+ L L + L N++ G + L NL L L+++ SL
Sbjct: 312 ISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLT 371
Query: 110 PIVMGNL--KSLSTLDLSQNQLNGSIPCSLDNLSNLDTLFLYKNSLSGPIP-SVIGNLKS 166
+L L L+L++N+++ + L +L+ L L N + + L++
Sbjct: 372 NETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLEN 431
Query: 167 LLQLDLSENRLSGLIPLSLSNLSSLTVMSLFNNSLSG--SIPPILGNLKSLSTLGLHINQ 224
+ ++ LS N+ L S + + SL + L +L S P L++L+ L L N
Sbjct: 432 IFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNN 491
Query: 225 LNGVIPPSIGNLSSLRNLSLFNNRL--------YGFVPKEIGYLKSLSKLEFCANHLSGV 276
+ + + L L L L +N L G + L L L +N +
Sbjct: 492 IANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEI 551
Query: 277 IPHSVGNLTGLVLLNMCENHLFGPIPKSLRNLTSLERVRFNQNNLYGKVYEAFGDH-PNL 335
+L L ++++ N+L N SL+ + +N + + FG NL
Sbjct: 552 PVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNL 611
Query: 336 TFLDLSQNNFYCEISF-----NWRNFSKLGTFNASMNNIYGSIPPEIGDSSKLQVLDLSS 390
T LD+ N F C NW N + ++ + PP +++ D SS
Sbjct: 612 TELDMRFNPFDCTCESIAWFVNWINETHT-NIPELSSHYLCNTPPHYHGFP-VRLFDTSS 669
Query: 391 NHIF 394
Sbjct: 670 CKDS 673
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 1e-18
Identities = 30/116 (25%), Positives = 50/116 (43%), Gaps = 3/116 (2%)
Query: 429 TELQYLDLSANKLSSSIPMSIGNLLKLHYLNLSNNQFSHKIPTEFEKLIHLSELDLSHNI 488
+ D S KL + +P + + LNL++NQ F + L+ LD+ N
Sbjct: 4 VSHEVADCSHLKL-TQVPDDLPTNIT--VLNLTHNQLRRLPAANFTRYSQLTSLDVGFNT 60
Query: 489 LQEEIPPQICKMESLEKLNLSHNNLSDFIPRCFEEMRSLSWIDISYNELQGPIPNS 544
+ + P K+ L+ LNL HN LS + F +L+ + + N +Q N
Sbjct: 61 ISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNP 116
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 347 bits (891), Expect = e-108
Identities = 93/573 (16%), Positives = 174/573 (30%), Gaps = 60/573 (10%)
Query: 3 NLGFNLLFGNIPPQIGNLSKLQYLDLGNNQLSGVIPPEIGKLNQLRRLYLDVNQLHG--- 59
N ++ + + ++ L L SG +P IG+L +L L L +
Sbjct: 63 NKELDMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNER 122
Query: 60 -TIPPVIGQLSLINELVFCHNNVSGRIPSSLG--NLSNLALLYLNDNSLFGSIPIVMGNL 116
P I + + + S+L +N + SI
Sbjct: 123 LFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRIT 182
Query: 117 KSLSTLDLSQNQLNGSIPCSLDNLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSENR 176
+ + N + + ++ L+ L ++ + + +
Sbjct: 183 LKDTQIGQLSNNI-TFVSKAVMRLTKLRQFYMGNSPFVAENICEAWEN-----ENSEYAQ 236
Query: 177 LSGLIPLSLSNLSSLTVMSLFNNSLSGSIPPILGNLKSLSTLGLHINQL--------NGV 228
L NL LT + ++N +P L L + + + N+ +
Sbjct: 237 QYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQ 296
Query: 229 IPPSIGNLSSLRNLSLFNNRL-YGFVPKEIGYLKSLSKLEFCANHLSGVIPHSVGNLTGL 287
++ + + N L V + +K L LE N L G +P + G+ L
Sbjct: 297 ALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKL 355
Query: 288 VLLNMCENHLFGPIPKSLRNLTSLERVRFNQNNLYG--KVYEAFGDHPNLTFLDLSQNNF 345
LN+ N + +E + F N L +++ ++ +D S N
Sbjct: 356 ASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLKYIPNIFD-AKSVSVMSAIDFSYNE- 413
Query: 346 YCEISFNWRNFSKLGTFNASMNNIYGSIPPEIGDSSKLQVLDLSSNHIFGKIPVQLVKLF 405
+ + + P + ++LS+N I
Sbjct: 414 ----------------IGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGS 457
Query: 406 SLNKLILSLNQL-------FGGVPLEFGTLTELQYLDLSANKLSSSIP-MSIGNLLKLHY 457
L+ + L N L F L +DL NKL+ L L
Sbjct: 458 PLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLTKLSDDFRATTLPYLVG 517
Query: 458 LNLSNNQFSHKIPTEFEKLIHLSELDLSHNI------LQEEIPPQICKMESLEKLNLSHN 511
++LS N FS K PT+ L + + E P I SL +L + N
Sbjct: 518 IDLSYNSFS-KFPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSN 576
Query: 512 NLSDFIPRCFEEMRSLSWIDISYNELQGPIPNS 544
++ + ++S +DI N +
Sbjct: 577 DIRK-VNEKI--TPNISVLDIKDNPNISIDLSY 606
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 336 bits (863), Expect = e-104
Identities = 84/550 (15%), Positives = 174/550 (31%), Gaps = 61/550 (11%)
Query: 2 LNLGFNLLFGN----IPPQIGNLSKLQYLDLGNNQLSGVIPPEIGKLN--QLRRLYLDVN 55
L LG + N P I + + + L + ++ +
Sbjct: 110 LALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSD 169
Query: 56 QLHGTIPPVIGQLSLINELVFCHNNVSGRIPSSLGNLSNLALLYLNDNSLFGSIPIVMGN 115
+I ++ NN++ + ++ L+ L Y+ ++
Sbjct: 170 PQQKSIKKSSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWE 228
Query: 116 LKSLSTLDLSQNQLNGSIPCSLDNLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSEN 175
++ Q + DNL +L + +Y +P+ + L + ++++ N
Sbjct: 229 NENSEY-----AQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACN 283
Query: 176 RLSGL--------IPLSLSNLSSLTVMSLFNNSL-SGSIPPILGNLKSLSTLGLHINQLN 226
R + ++ + N+L + + L +K L L NQL
Sbjct: 284 RGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLE 343
Query: 227 GVIPPSIGNLSSLRNLSLFNNRLYGFVPKEIGYLKSLSKLEFCANHLSGV-IPHSVGNLT 285
G P+ G+ L +L+L N++ G+ + + L F N L + +++
Sbjct: 344 G-KLPAFGSEIKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLKYIPNIFDAKSVS 402
Query: 286 GLVLLNMCENHL-------FGPIPKSLRNLTSLERVRFNQNNLYGKVYEAFGDHPNLTFL 338
+ ++ N + F P+ + ++ + + N + E F L+ +
Sbjct: 403 VMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSI 462
Query: 339 DLSQNNFYCEISFNWRNFSKLGTFNASMNNIYGSIPPEIGDSSKLQVLDLSSNHIFGKIP 398
+L N EI N ++ L +DL N + K+
Sbjct: 463 NLMGNML-TEIP----------------KNSLKDENENFKNTYLLTSIDLRFNKL-TKLS 504
Query: 399 --VQLVKLFSLNKLILSLNQLFGGVPLEFGTLTELQYL------DLSANKLSSSIPMSIG 450
+ L L + LS N P + + L+ D N+ P I
Sbjct: 505 DDFRATTLPYLVGIDLSYNSF-SKFPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGIT 563
Query: 451 NLLKLHYLNLSNNQFSHKIPTEFEKLIHLSELDLSHNILQEEIPPQICKMESLEKLNLSH 510
L L + +N + + ++S LD+ N +C L +
Sbjct: 564 LCPSLTQLQIGSNDIRK-VNEKI--TPNISVLDIKDNPNISIDLSYVCPYIEAGMYMLFY 620
Query: 511 NNLSDFIPRC 520
+ D I C
Sbjct: 621 DKTQD-IRGC 629
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 271 bits (695), Expect = 4e-80
Identities = 67/500 (13%), Positives = 146/500 (29%), Gaps = 112/500 (22%)
Query: 1 MLNLGFNLLFGNIPPQIGNLSKLQYLDLGNNQLSGVIPPEIGKLNQLRRLYLDVNQLHGT 60
N + + + NL L +++ N +P + L +++ + + N+
Sbjct: 229 NENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISG 288
Query: 61 IPPVIGQLSLINELVFCHNNVSGRIPSSLGNLSNLALLYLNDNSLF-GSIPIVMGNLKSL 119
+ + + ++Y+ N+L + + +K L
Sbjct: 289 EQL----------------KDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKL 332
Query: 120 STLDLSQNQLNGSIPCSLDNLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSENRLSG 179
L+ NQL G +P + + L +L L N ++ + G + + L + N+L
Sbjct: 333 GMLECLYNQLEGKLP-AFGSEIKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLKY 391
Query: 180 L-IPLSLSNLSSLTVMSLFNNSLSG-------SIPPILGNLKSLSTLGLHINQLNGVIPP 231
+ ++S ++ + N + + P ++S++ L NQ++
Sbjct: 392 IPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKE 451
Query: 232 SIGNLSSLRNLSLFNNRLYGFVPKEIGYLKSLSKLEFCANHLSGVIPHSVGNLTGLVLLN 291
S L +++L N L +PK + N L ++
Sbjct: 452 LFSTGSPLSSINLMGNMLTE-IPKNSL----------------KDENENFKNTYLLTSID 494
Query: 292 MCENHLFGPIPKSLRNLTSLERVRFNQNNLYGKVYEAFGDHPNLTFLDLSQNNFYCEISF 351
+ N L + P L +DLS N+F
Sbjct: 495 LRFNKLTK-LSDDF----------------------RATTLPYLVGIDLSYNSF------ 525
Query: 352 NWRNFSKLGTFNASMNNIYGSIPPEIGDSSKLQVLDLSSNHIFGKIPVQLVKLFSLNKLI 411
P + +SS L+ + +
Sbjct: 526 -------------------SKFPTQPLNSSTLKGFGIRNQ------------------RD 548
Query: 412 LSLNQLFGGVPLEFGTLTELQYLDLSANKLSSSIPMSIGNLLKLHYLNLSNNQFSHKIPT 471
N+ P L L + +N + + I + L++ +N +
Sbjct: 549 AQGNRTLREWPEGITLCPSLTQLQIGSNDI-RKVNEKI--TPNISVLDIKDNPNISIDLS 605
Query: 472 EFEKLIHLSELDLSHNILQE 491
I L ++ Q+
Sbjct: 606 YVCPYIEAGMYMLFYDKTQD 625
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 262 bits (672), Expect = 7e-77
Identities = 71/459 (15%), Positives = 138/459 (30%), Gaps = 38/459 (8%)
Query: 121 TLDLSQNQLNGSIPCSLDNLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSENRLSG- 179
+ + SL++ + L L SG +P IG L L L L +
Sbjct: 61 NFNKELDMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVN 120
Query: 180 ---LIPLSLSNLSSLTVMSLFNNSLSGSIPPILGNLK--SLSTLGLHINQLNGVIPPSIG 234
P +S S + L ++ + I S
Sbjct: 121 ERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSR 180
Query: 235 NLSSLRNLSLFNNRLYGFVPKEIGYLKSLSKLEFCANHLSGVIPHSVGNLTGLVLLNMCE 294
+ +N + FV K + L L + +
Sbjct: 181 ITLKDTQIGQLSNNI-TFVSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQ--- 236
Query: 295 NHLFGPIPKSLRNLTSLERVRFNQNNLYGKVYEAFGDHPNLTFLDLSQNNF--YCEISFN 352
+ NL L V K+ P + ++++ N ++ +
Sbjct: 237 --QYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDD 294
Query: 353 WRNFSKLG------TFNASMNNI-YGSIPPEIGDSSKLQVLDLSSNHIFGKIPVQLVKLF 405
W+ + NN+ + + KL +L+ N + GK+P
Sbjct: 295 WQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEI 353
Query: 406 SLNKLILSLNQLFGGVPLEFGTLTELQYLDLSANKLSS-SIPMSIGNLLKLHYLNLSNNQ 464
L L L+ NQ+ G +++ L + NKL ++ + ++ S N+
Sbjct: 354 KLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLKYIPNIFDAKSVSVMSAIDFSYNE 413
Query: 465 FSH-------KIPTEFEKLIHLSELDLSHNILQEEIPPQICKMESLEKLNLSHNNLSDF- 516
+ K I++S ++LS+N + + L +NL N L++
Sbjct: 414 IGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIP 473
Query: 517 ------IPRCFEEMRSLSWIDISYNELQGPIPNSTAFKN 549
F+ L+ ID+ +N+L + +
Sbjct: 474 KNSLKDENENFKNTYLLTSIDLRFNKLTK-LSDDFRATT 511
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 259 bits (665), Expect = 8e-76
Identities = 75/472 (15%), Positives = 153/472 (32%), Gaps = 64/472 (13%)
Query: 103 NSLFGSIPIVMGNLKSLSTLDLSQNQLNGSIPCSLDNLSNLDTLFLYKNSLSGP----IP 158
+ + + + ++ L L +G +P ++ L+ L+ L L + P
Sbjct: 67 DMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGP 126
Query: 159 SVIGNLKSLLQLDLSENRLSGLIP--LSLSNLSSLTVMSLFNNSLSGSIPPILGNLKSLS 216
I S Q + S L + ++ SI +
Sbjct: 127 KGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDT 186
Query: 217 TLGLHINQLNGVIPPSIGNLSSLRNLSLFNNRLYGFVPKEIGYLKSLSKLEFCANHLSGV 276
+G N + + ++ L+ LR + N+ E ++
Sbjct: 187 QIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEY-----AQQYKT 240
Query: 277 IPHSVGNLTGLVLLNMCENHLFGPIPKSLRNLTSLERVRFNQNNLYGKVYEAFGDHPNLT 336
NL L + + +P L+ L +
Sbjct: 241 EDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALP------------------------EMQ 276
Query: 337 FLDLSQNNFYCEISFNWRNFSKLGTFNASMNNIYGSIPPEIGDSSKLQVLDLSSNHIF-G 395
++++ N + + K+Q++ + N++
Sbjct: 277 LINVACNRG----------------ISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTF 320
Query: 396 KIPVQLVKLFSLNKLILSLNQLFGGVPLEFGTLTELQYLDLSANKLSSSIPMSIGNLLKL 455
+ L K+ L L NQL G FG+ +L L+L+ N+++ G ++
Sbjct: 321 PVETSLQKMKKLGMLECLYNQL-EGKLPAFGSEIKLASLNLAYNQITEIPANFCGFTEQV 379
Query: 456 HYLNLSNNQFSHKIPTEFE--KLIHLSELDLSHNILQ-------EEIPPQICKMESLEKL 506
L+ ++N+ + IP F+ + +S +D S+N + + + P K ++ +
Sbjct: 380 ENLSFAHNKLKY-IPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSI 438
Query: 507 NLSHNNLSDFIPRCFEEMRSLSWIDISYNELQGPIPNSTAFKNGLMEGNKGL 558
NLS+N +S F F LS I++ N L NS +N + L
Sbjct: 439 NLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLL 490
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 1e-18
Identities = 23/148 (15%), Positives = 47/148 (31%), Gaps = 13/148 (8%)
Query: 2 LNLGFNLLFGNIPPQI--GNLSKLQYLDLGNNQLSGVIPPEIGKLNQLRRLYL------D 53
++L FN L + L L +DL N S P + + L+ +
Sbjct: 493 IDLRFNKL-TKLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQ 550
Query: 54 VNQLHGTIPPVIGQLSLINELVFCHNNVSGRIPSSLGNLSNLALLYLNDNSLFGSIPIVM 113
N+ P I + +L N++ + + N+++L + DN +
Sbjct: 551 GNRTLREWPEGITLCPSLTQLQIGSNDIRK-VNEKI--TPNISVLDIKDNPNISIDLSYV 607
Query: 114 GNLKSLSTLDLSQNQLNGSIPCSLDNLS 141
L ++ C ++
Sbjct: 608 CPYIEAGMYMLFYDKTQDIRGCDALDIK 635
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 320 bits (822), Expect = 1e-98
Identities = 116/531 (21%), Positives = 193/531 (36%), Gaps = 25/531 (4%)
Query: 2 LNLGFNLLFGNIPPQIGNLSKLQYLDLGNNQLSGVIPPEIGKLNQLRRLYLDVNQLHGTI 61
L+L FN L + +LQ LDL ++ + L+ L L L N +
Sbjct: 33 LDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLA 92
Query: 62 PPVIGQLSLINELVFCHNNVSGRIPSSLGNLSNLALLYLNDNSL-FGSIPIVMGNLKSLS 120
LS + +LV N++ +G+L L L + N + +P NL +L
Sbjct: 93 LGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLE 152
Query: 121 TLDLSQNQLNGSIPCSLDNLSNLD----TLFLYKNSLSGPIPSVIGNLKSLLQLDLSENR 176
LDLS N++ L L + +L L N ++ P + L +L L N
Sbjct: 153 HLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEI-RLHKLTLRNNF 211
Query: 177 LSG-LIPLSLSNLSSLTVMSLFNNSLSGS------IPPILGNLKSLSTLGLHINQLN--- 226
S ++ + L+ L V L L L +L+ + L+
Sbjct: 212 DSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYL 271
Query: 227 GVIPPSIGNLSSLRNLSLFNNRLYGFVPKEIGYLKSLSKLEFCANHLSGVIPHSVGNLTG 286
I L+++ + SL + + Y LE + +L
Sbjct: 272 DDIIDLFNCLTNVSSFSLVSVTIERVKD--FSYNFGWQHLELVNCKFGQFPTLKLKSLKR 329
Query: 287 LVLLNMCENHLFGPIPKSLRNLTSLERVRFNQNNLYGKVYEAFGDHPNLTFLDLSQNNFY 346
L + + F + L +L L + N + G ++ +L +LDLS N
Sbjct: 330 LTFTSNKGGNAFSEV--DLPSLEFL-DLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI 386
Query: 347 CEISFNWRNFSKLGTFNASMNNIYGSIPPEI-GDSSKLQVLDLSSNHIFGKIPVQLVKLF 405
+S N+ +L + +N+ + L LD+S H L
Sbjct: 387 -TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLS 445
Query: 406 SLNKLILSLNQLFGGVPLE-FGTLTELQYLDLSANKLSSSIPMSIGNLLKLHYLNLSNNQ 464
SL L ++ N + F L L +LDLS +L P + +L L LN+S+N
Sbjct: 446 SLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNN 505
Query: 465 FSHKIPTEFEKLIHLSELDLSHNILQEEIPPQICKME-SLEKLNLSHNNLS 514
F ++ L L LD S N + ++ SL LNL+ N+ +
Sbjct: 506 FFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFA 556
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 293 bits (751), Expect = 2e-88
Identities = 110/493 (22%), Positives = 179/493 (36%), Gaps = 28/493 (5%)
Query: 71 INELVFCHNNVSGRIPSSLGNLSNLALLYLNDNSLFGSIPIVMGNLKSLSTLDLSQNQLN 130
L N + S + L +L L+ + +L LSTL L+ N +
Sbjct: 30 TKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQ 89
Query: 131 GSIPCSLDNLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSENRLSGL-IPLSLSNLS 189
+ LS+L L + +L+ IG+LK+L +L+++ N + +P SNL+
Sbjct: 90 SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLT 149
Query: 190 SLTVMSLFNNSLSGSIPPILGNLKSLS----TLGLHINQLNGVIPPSIGNLSSLRNLSLF 245
+L + L +N + L L + +L L +N +N I P L L+L
Sbjct: 150 NLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNF-IQPGAFKEIRLHKLTLR 208
Query: 246 NNRLYGFVPKEIGY-LKSLSKLEFCANHLSGVI---PHSVGNLTGLVLLNMCENHL---- 297
NN V K L L L GL L + E L
Sbjct: 209 NNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLD 268
Query: 298 --FGPIPKSLRNLTSLERVRFNQNNLYGKVYEAFGDHPNLTFLDLSQNNFYCEISFNWRN 355
I LT++ + + + F + L+L F + ++
Sbjct: 269 YYLDDIIDLFNCLTNVSSFSLVSVTI--ERVKDFSYNFGWQHLELVNCKFGQFPTLKLKS 326
Query: 356 FSKLGTFNASMNNIYGSIPPEIGDSSKLQVLDLSSNHI--FGKIPVQLVKLFSLNKLILS 413
+L + + G D L+ LDLS N + G SL L LS
Sbjct: 327 LKRL-----TFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLS 381
Query: 414 LNQLFGGVPLEFGTLTELQYLDLSANKLSSSIPMSI-GNLLKLHYLNLSNNQFSHKIPTE 472
N + + F L +L++LD + L S+ +L L YL++S+
Sbjct: 382 FNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGI 440
Query: 473 FEKLIHLSELDLSHNILQEEIPPQI-CKMESLEKLNLSHNNLSDFIPRCFEEMRSLSWID 531
F L L L ++ N QE P I ++ +L L+LS L P F + SL ++
Sbjct: 441 FNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLN 500
Query: 532 ISYNELQGPIPNS 544
+S+N
Sbjct: 501 MSHNNFFSLDTFP 513
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 263 bits (675), Expect = 1e-77
Identities = 98/446 (21%), Positives = 167/446 (37%), Gaps = 27/446 (6%)
Query: 118 SLSTLDLSQNQLNGSIPCSLDNLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSENRL 177
S LDLS N L S + L L L + + +L L L L+ N +
Sbjct: 29 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPI 88
Query: 178 SGLIPLSLSNLSSLTVMSLFNNSLSGSIPPILGNLKSLSTLGLHINQLNGV-IPPSIGNL 236
L + S LSSL + +L+ +G+LK+L L + N + +P NL
Sbjct: 89 QSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNL 148
Query: 237 SSLRNLSLFNNRLYGFVPKEIGYLKSLS----KLEFCANHLSGVIPHSVGNLTGLVLLNM 292
++L +L L +N++ ++ L + L+ N ++ + P + + L L +
Sbjct: 149 TNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIR-LHKLTL 207
Query: 293 CENHLFGPIPK-SLRNLTSLERVR------FNQNNLYGKVYEAFGDHPNLTFLDLS---Q 342
N + K ++ L LE R N+ NL A NLT +
Sbjct: 208 RNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYL 267
Query: 343 NNFYCEISFNWRNFSKLGTFNASMNNIYGSIPPEIGDSSKLQVLDLSSNHIFGKIPVQLV 402
+ + +I + + + +F+ I + + Q L+L + Q
Sbjct: 268 DYYLDDIIDLFNCLTNVSSFSLVSVTI--ERVKDFSYNFGWQHLELVNCKF-----GQFP 320
Query: 403 KLFSLNKLILSLNQLFGGVPLEFGTLTELQYLDLSANKLS--SSIPMSIGNLLKLHYLNL 460
L + L+ GG L L++LDLS N LS S L YL+L
Sbjct: 321 TLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDL 380
Query: 461 SNNQFSHKIPTEFEKLIHLSELDLSHNILQEEIPPQI-CKMESLEKLNLSHNNLSDFIPR 519
S N + + F L L LD H+ L++ + + +L L++SH +
Sbjct: 381 SFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNG 439
Query: 520 CFEEMRSLSWIDISYNELQGPIPNST 545
F + SL + ++ N Q
Sbjct: 440 IFNGLSSLEVLKMAGNSFQENFLPDI 465
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 205 bits (524), Expect = 8e-57
Identities = 79/409 (19%), Positives = 146/409 (35%), Gaps = 26/409 (6%)
Query: 1 MLNLGFNLLFGNIPPQ-IGNLSKLQYLDLGNNQLSGVI---PPEIGKLNQLRRLYLDVNQ 56
L L N N+ I L+ L+ L + + L L L ++ +
Sbjct: 204 KLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFR 263
Query: 57 L------HGTIPPVIGQLSLINELVFCHNNVSGRIPSSLGNLSNLALLYLNDNSLFGSIP 110
L I + L+ ++ + S L L +
Sbjct: 264 LAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFS--YNFGWQHLELVNCKFGQFPT 321
Query: 111 IVMGNLKSLSTLDLSQNQLNGSIPCSLDNLSNLDTLFLYKNSLS--GPIPSVIGNLKSLL 168
+ LKSL L + N+ + S +L +L+ L L +N LS G SL
Sbjct: 322 L---KLKSLKRLTFTSNKGGNAF--SEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLK 376
Query: 169 QLDLSENRLSGLIPLSLSNLSSLTVMSLFNNSLSGSIPP-ILGNLKSLSTLGLHINQLNG 227
LDLS N + + + L L + +++L + +L++L L +
Sbjct: 377 YLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRV 435
Query: 228 VIPPSIGNLSSLRNLSLFNNRLYGFVPKEI-GYLKSLSKLEFCANHLSGVIPHSVGNLTG 286
LSSL L + N +I L++L+ L+ L + P + +L+
Sbjct: 436 AFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSS 495
Query: 287 LVLLNMCENHLFGPIPKSLRNLTSLERVRFNQNNLYGKVYEAFGDHP-NLTFLDLSQNNF 345
L +LNM N+ F + L SL+ + ++ N++ + P +L FL+L+QN+F
Sbjct: 496 LQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDF 555
Query: 346 YCEISFNW--RNFSKLGTFNASMNNIYGSIPPEIGDSSKLQVLDLSSNH 392
C + + + + P + + L+++
Sbjct: 556 ACTCEHQSFLQWIKDQRQLLVEVERMECATPSDKQGMP-VLSLNITCQM 603
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 312 bits (801), Expect = 5e-93
Identities = 92/576 (15%), Positives = 177/576 (30%), Gaps = 54/576 (9%)
Query: 2 LNLGFNLLFGNIPPQIGNLSKLQYLDLGNNQLSGVIPPEIGKLNQLRRLYLDVNQLHGTI 61
N ++ + N ++ L L G +P IG+L +L+ L + +
Sbjct: 304 FNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSG 363
Query: 62 PPVIGQLSLINELVFCHNNVSGRIPS-SLGNLSNLALLYLNDNSLFGSIPIVMGNLKSLS 120
+ + + + L L L L +++ + + +K S
Sbjct: 364 RLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEM--KPIKKDS 421
Query: 121 TLDLSQNQLNG------SIPCSLDNLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSE 174
+ L Q+ I ++ L+ L ++ + + +V +
Sbjct: 422 RISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNIAV-----DWEDANSDY 476
Query: 175 NRLSGLIPLSLSNLSSLTVMSLFNNSLSGSIPPILGNLKSLSTLGLHINQLNGV------ 228
+ LS SNL LT + L+N +P L +L L +L + N+
Sbjct: 477 AKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKAD 536
Query: 229 ---IPPSIGNLSSLRNLSLFNNRLYGF-VPKEIGYLKSLSKLEFCANHLSGVIPHSVGNL 284
+ ++ + N L F + + L L+ N + + G
Sbjct: 537 WTRLADDEDTGPKIQIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKVR--HLEAFGTN 594
Query: 285 TGLVLLNMCENHLFGPIPKSL-RNLTSLERVRFNQNNLYG-KVYEAFGDHPNLTFLDLSQ 342
L L + N + IP+ +E + F+ N L + +D S
Sbjct: 595 VKLTDLKLDYNQIEE-IPEDFCAFTDQVEGLGFSHNKLKYIPNIFNAKSVYVMGSVDFSY 653
Query: 343 NNF-----YCEISFNWRNFSKLGTFNASMNNIYGSIPPEIGDSSKLQVLDLSSNHI---- 393
N S + T S N I S + + LS+N +
Sbjct: 654 NKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIP 713
Query: 394 ---FGKIPVQLVKLFSLNKLILSLNQLFGGVP--LEFGTLTELQYLDLSANKLSSSIPMS 448
+ L + L N+L + TL L +D+S N SS P
Sbjct: 714 ENSLKPKDGNYKNTYLLTTIDLRFNKL-TSLSDDFRATTLPYLSNMDVSYNCF-SSFPTQ 771
Query: 449 IGNLLKLHYLNL------SNNQFSHKIPTEFEKLIHLSELDLSHNILQEEIPPQICKMES 502
N +L + N+ + PT L +L + N + ++ ++
Sbjct: 772 PLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDI-RKVDEKL--TPQ 828
Query: 503 LEKLNLSHNNLSDFIPRCFEEMRSLSWIDISYNELQ 538
L L+++ N + Y++ Q
Sbjct: 829 LYILDIADNPNISIDVTSVCPYIEAGMYVLLYDKTQ 864
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 292 bits (748), Expect = 1e-85
Identities = 78/568 (13%), Positives = 169/568 (29%), Gaps = 84/568 (14%)
Query: 2 LNLGFNLLFGNIPPQIGNLSKLQYLDLGNNQLSGVIPPEIGK-------LNQLRRLYLDV 54
L+L G +P IG L++L+ L G + + + + R+ +
Sbjct: 328 LSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHY 387
Query: 55 NQLHGTIPPVIGQLSLINELVF----------------------CHNNVSGRIPSSLGNL 92
++ + L+ + + N I ++ L
Sbjct: 388 KKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITFISKAIQRL 447
Query: 93 SNLALLYLNDNSLFGSIPIVMGNLKSLSTLDLSQNQLNGSIPCSLDNLSNLDTLFLYKNS 152
+ L ++Y ++ V + + + S NL +L + LY
Sbjct: 448 TKLQIIYFANSPFTYDNIAV-----DWEDANSDYAKQYENEELSWSNLKDLTDVELYNCP 502
Query: 153 LSGPIPSVIGNLKSLLQLDLSENRLSGL---------IPLSLSNLSSLTVMSLFNNSLSG 203
+P + +L L L+++ NR + + + + N+L
Sbjct: 503 NMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLEE 562
Query: 204 SIPPI-LGNLKSLSTLGLHINQLNGVIPPSIGNLSSLRNLSLFNNRLYGFVPKEIGY-LK 261
L + L L N++ + G L +L L N++ +P++
Sbjct: 563 FPASASLQKMVKLGLLDCVHNKVR--HLEAFGTNVKLTDLKLDYNQIEE-IPEDFCAFTD 619
Query: 262 SLSKLEFCANHLSGV-IPHSVGNLTGLVLLNMCENHLFG-----PIPKSLRNLTSLERVR 315
+ L F N L + + ++ + ++ N + + V
Sbjct: 620 QVEGLGFSHNKLKYIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVT 679
Query: 316 FNQNNLYGKVYEAFGDHPNLTFLDLSQNNFYCEISFNWRNFSKLGTFNASMNNIYGSIPP 375
+ N + E F ++ + LS N + + N
Sbjct: 680 LSYNEIQKFPTELFATGSPISTIILSNNL--------------MTSIP---ENSLKPKDG 722
Query: 376 EIGDSSKLQVLDLSSNHIFGKIPVQLV--KLFSLNKLILSLNQLFGGVPLEFGTLTELQY 433
++ L +DL N + + L L+ + +S N P + ++L+
Sbjct: 723 NYKNTYLLTTIDLRFNKL-TSLSDDFRATTLPYLSNMDVSYNCF-SSFPTQPLNSSQLKA 780
Query: 434 LDL------SANKLSSSIPMSIGNLLKLHYLNLSNNQFSHKIPTEFEKLIHLSELDLSHN 487
+ N++ P I L L + +N + + L LD++ N
Sbjct: 781 FGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDIRK-VDEKL--TPQLYILDIADN 837
Query: 488 ILQEEIPPQICKMESLEKLNLSHNNLSD 515
+C L ++ D
Sbjct: 838 PNISIDVTSVCPYIEAGMYVLLYDKTQD 865
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 228 bits (582), Expect = 6e-63
Identities = 82/453 (18%), Positives = 144/453 (31%), Gaps = 40/453 (8%)
Query: 121 TLDLSQNQLNGSIPCSLDNLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSENRLSGL 180
+ + LDN + L L G +P IG L L L + +
Sbjct: 303 NFNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVS 362
Query: 181 IPLSLSNLSSLTVMSLFNNSLSGSIPP----ILGNLKSLSTLGLHINQLNGVIPPSIGNL 236
L + + + + L L IN+ + P +
Sbjct: 363 GRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSR 422
Query: 237 SSLRNLSL--FNNRLYGFVPKEIGYLKSLSKLEFCANHLSGVIPHSVGNLTGLVLLNMCE 294
SL++ + NR+ F+ K I L L + F + + N
Sbjct: 423 ISLKDTQIGNLTNRI-TFISKAIQRLTKLQIIYFANSPFTYDNI-----AVDWEDANSDY 476
Query: 295 NHLFGPIPKSLRNLTSLERVRFNQNNLYGKVYEAFGDHPNLTFLDLSQNNFYCEISFNWR 354
+ S NL L V ++ + D P L L+++ N
Sbjct: 477 AKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRG--------- 527
Query: 355 NFSKLGTFNASMNNIYGSIPPEIGDSSKLQVLDLSSNHIFG-KIPVQLVKLFSLNKLILS 413
A + + + + K+Q+ + N++ L K+ L L
Sbjct: 528 ------ISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLEEFPASASLQKMVKLGLLDCV 581
Query: 414 LNQLFGGVPLEFGTLTELQYLDLSANKLSSSIPMSIGNLLK-LHYLNLSNNQFSHKIPTE 472
N++ + FGT +L L L N++ IP + L S+N+ + IP
Sbjct: 582 HNKV-RHLE-AFGTNVKLTDLKLDYNQI-EEIPEDFCAFTDQVEGLGFSHNKLKY-IPNI 637
Query: 473 FE--KLIHLSELDLSHNILQEEIP-----PQICKMESLEKLNLSHNNLSDFIPRCFEEMR 525
F + + +D S+N + E K + + LS+N + F F
Sbjct: 638 FNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGS 697
Query: 526 SLSWIDISYNELQGPIPNSTAFKNGLMEGNKGL 558
+S I +S N + NS K+G + L
Sbjct: 698 PISTIILSNNLMTSIPENSLKPKDGNYKNTYLL 730
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 288 bits (739), Expect = 1e-86
Identities = 105/526 (19%), Positives = 187/526 (35%), Gaps = 16/526 (3%)
Query: 2 LNLGFNLLFGNIPPQIGNLSKLQYLDLGNNQLSGVIPPEIGKLNQLRRLYLDVNQLHGTI 61
L FN+L L L +LDL Q+ + ++L L L N L
Sbjct: 38 LEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMA 97
Query: 62 PPVIGQLSLINELVFCHNNVSGRIPSSLGNLSNLALLYLNDNSLFGSIPIVMGNLKSLST 121
+ + L F +S L N L LYL N + + L
Sbjct: 98 ETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKV 157
Query: 122 LDLSQNQLNGSIPCSLDNLSNLDTLFLY--KNSLSGPIPSVIGNLKSLLQLDLSENRLSG 179
LD N ++ + +L L L N ++G I + L+ +
Sbjct: 158 LDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAG-IEPGAFDSAVFQSLNFGGTQNLL 216
Query: 180 LIPLSLSN--LSSLTVMSLFNNSLSGSIPPILGNLKSLS--TLGLHINQLNGVIPPSIGN 235
+I L N + SL + + + P + L +S ++ L + + +
Sbjct: 217 VIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHC 276
Query: 236 LSSLRNLSLFNNRLYGFVPKEIGYLKSLSKLEFCANHLSGVIPHSVGNLTGLVLLNMCEN 295
S L+ L L L +P + L +L KL AN + S N L L++ N
Sbjct: 277 FSGLQELDLTATHL-SELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGN 335
Query: 296 HLFGPI-PKSLRNLTSLERVRFNQNNLY--GKVYEAFGDHPNLTFLDLSQNNFYCEISFN 352
+ L NL +L + + +++ + +L L+LS N +
Sbjct: 336 TKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEA 395
Query: 353 WRNFSKLGTFNASMNNIYGSIPPEI-GDSSKLQVLDLSSNHIFGKIPVQLVKLFSLNKLI 411
++ +L + + + + L+VL+LS + + L +L L
Sbjct: 396 FKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLN 455
Query: 412 LSLNQLFGGVPLE---FGTLTELQYLDLSANKLSSSIPMSIGNLLKLHYLNLSNNQFSHK 468
L N G + TL L+ L LS LSS + +L +++++LS+N+ +
Sbjct: 456 LQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSS 515
Query: 469 IPTEFEKLIHLSELDLSHNILQEEIPPQICKMESLEKLNLSHNNLS 514
L + L+L+ N + +P + + +NL N L
Sbjct: 516 SIEALSHLKGI-YLNLASNHISIILPSLLPILSQQRTINLRQNPLD 560
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 287 bits (737), Expect = 2e-86
Identities = 106/509 (20%), Positives = 189/509 (37%), Gaps = 16/509 (3%)
Query: 48 RRLYLDVNQLHGTIPPVIGQLSLINELVFCHNNVSGRIPSSLGNLSNLALLYLNDNSLFG 107
+ + L+ IP + + L F N + ++ L NL L L ++
Sbjct: 15 KTYNCENLGLN-EIPGTL--PNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYW 71
Query: 108 SIPIVMGNLKSLSTLDLSQNQLNGSIPCSLDNLSNLDTLFLYKNSLSGPIPSVIGNLKSL 167
+ L TL L+ N L +L L LF + +S + N K+L
Sbjct: 72 IHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTL 131
Query: 168 LQLDLSENRLSGLIPLSLSNLSSLTVMSLFNNSLSGSIPPILGNLKSLSTLGLHINQLN- 226
L L N +S + L V+ NN++ + +L+ + L L++N +
Sbjct: 132 ESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDI 191
Query: 227 GVIPPSIGNLSSLRNLSLFNNRLYGFVPKEIGY--LKSLSKLEFCANHLSGVIPHSVGNL 284
I P + + ++L+ + + K + ++SL F + P L
Sbjct: 192 AGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGL 251
Query: 285 TGLVL--LNMCENHLFGPIPKSLRNLTSLERVRFNQNNLYGKVYEAFGDHPNLTFLDLSQ 342
+ + +N+ +++ F + + L+ + +L ++ L L LS
Sbjct: 252 CEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHL-SELPSGLVGLSTLKKLVLSA 310
Query: 343 NNFYCEISFNWRNFSKLGTFNASMNNIYGSIPPE-IGDSSKLQVLDLSSNHI--FGKIPV 399
N F + NF L + N + + + L+ LDLS + I +
Sbjct: 311 NKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNL 370
Query: 400 QLVKLFSLNKLILSLNQLFGGVPLEFGTLTELQYLDLSANKLSSSIPMSI-GNLLKLHYL 458
QL L L L LS N+ F +L+ LDL+ +L S NL L L
Sbjct: 371 QLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVL 430
Query: 459 NLSNNQFSHKIPTEFEKLIHLSELDLSHNILQEEI---PPQICKMESLEKLNLSHNNLSD 515
NLS++ F+ L L L+L N + + + LE L LS +LS
Sbjct: 431 NLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSS 490
Query: 516 FIPRCFEEMRSLSWIDISYNELQGPIPNS 544
F ++ ++ +D+S+N L +
Sbjct: 491 IDQHAFTSLKMMNHVDLSHNRLTSSSIEA 519
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 286 bits (735), Expect = 5e-86
Identities = 109/534 (20%), Positives = 193/534 (36%), Gaps = 19/534 (3%)
Query: 24 QYLDLGNNQLSGVIPPEIGKLNQLRRLYLDVNQLHGTIPPVIGQLSLINELVFCHNNVSG 83
+ + N L+ IP + N L N L +L + L +
Sbjct: 15 KTYNCENLGLN-EIPGTL--PNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYW 71
Query: 84 RIPSSLGNLSNLALLYLNDNSLFGSIPIVMGNLKSLSTLDLSQNQLNGSIPCSLDNLSNL 143
+ + L L L N L + K+L L Q ++ L N L
Sbjct: 72 IHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTL 131
Query: 144 DTLFLYKNSLSGPIPSVIGNLKSLLQLDLSENRLSGLIPLSLSNLSSLTVMSL--FNNSL 201
++L+L N +S + L LD N + L +S+L T +SL N +
Sbjct: 132 ESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDI 191
Query: 202 SGSIPPILGNLKSLSTLGLHINQLNGVIPPSIGN--LSSLRNLSLFNNRLYGFVPKEIGY 259
+ I P + +L Q VI + N + SL + + P
Sbjct: 192 A-GIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEG 250
Query: 260 LKSLS--KLEFCANHLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLRNLTSLERVRFN 317
L +S + ++ + ++ +GL L++ HL +P L L++L+++ +
Sbjct: 251 LCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLSE-LPSGLVGLSTLKKLVLS 309
Query: 318 QNNLYGKVYEAFGDHPNLTFLDLSQNNFYCEISFNW-RNFSKLGTFNASMNNIYGS--IP 374
N + + P+LT L + N E+ N L + S ++I S
Sbjct: 310 ANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCN 369
Query: 375 PEIGDSSKLQVLDLSSNHIFGKIPVQLVKLFSLNKLILSLNQLFGGVPLE-FGTLTELQY 433
++ + S LQ L+LS N + L L L+ +L F L L+
Sbjct: 370 LQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKV 429
Query: 434 LDLSANKLSSSIPMSIGNLLKLHYLNLSNNQFSHKI---PTEFEKLIHLSELDLSHNILQ 490
L+LS + L S L L +LNL N F + L L L LS L
Sbjct: 430 LNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLS 489
Query: 491 EEIPPQICKMESLEKLNLSHNNLSDFIPRCFEEMRSLSWIDISYNELQGPIPNS 544
++ + ++LSHN L+ ++ + +++++ N + +P+
Sbjct: 490 SIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPSL 542
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 267 bits (685), Expect = 6e-79
Identities = 98/463 (21%), Positives = 168/463 (36%), Gaps = 13/463 (2%)
Query: 98 LYLNDNSLFGSIPIVMGNLKSLSTLDLSQNQLNGSIPCSLDNLSNLDTLFLYKNSLSGPI 157
+ L IP S L+ S N L + L NL L L + +
Sbjct: 17 YNCENLGLN-EIPG--TLPNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIH 73
Query: 158 PSVIGNLKSLLQLDLSENRLSGLIPLSLSNLSSLTVMSLFNNSLSGSIPPILGNLKSLST 217
+ L L L+ N L + +LS +L + +S L N K+L +
Sbjct: 74 EDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLES 133
Query: 218 LGLHINQLNGVIPPSIGNLSSLRNLSLFNNRLYGFVPKEIGYLKSLSKLEFCANHLS-GV 276
L L N ++ + P L+ L NN ++ +++ L+ + L N
Sbjct: 134 LYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAG 193
Query: 277 IPHSVGNLTGLVLLNMCENHLFGPIPKSLRN--LTSLERVRFNQNNLYGKVYEAFGD--H 332
I + LN I K L+N + SL F + F
Sbjct: 194 IEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCE 253
Query: 333 PNLTFLDLSQNNFYCEISFNWRNFSKLGTFNASMNNIYGSIPPEIGDSSKLQVLDLSSNH 392
++ ++L ++ F+ S + FS L + + ++ +P + S L+ L LS+N
Sbjct: 254 MSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHL-SELPSGLVGLSTLKKLVLSANK 312
Query: 393 IFGKIPVQLVKLFSLNKLILSLNQLFGGVPLE-FGTLTELQYLDLSANKLSSS--IPMSI 449
+ SL L + N + L L+ LDLS + + +S + +
Sbjct: 313 FENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQL 372
Query: 450 GNLLKLHYLNLSNNQFSHKIPTEFEKLIHLSELDLSHNILQEEIPP-QICKMESLEKLNL 508
NL L LNLS N+ F++ L LDL+ L+ + + L+ LNL
Sbjct: 373 RNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNL 432
Query: 509 SHNNLSDFIPRCFEEMRSLSWIDISYNELQGPIPNSTAFKNGL 551
SH+ L + F+ + +L +++ N T L
Sbjct: 433 SHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTL 475
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 9e-38
Identities = 57/233 (24%), Positives = 96/233 (41%), Gaps = 8/233 (3%)
Query: 2 LNLGFNLLFGNIPPQ-IGNLSKLQYLDLGNNQL--SGVIPPEIGKLNQLRRLYLDVNQLH 58
L++ N + + NL L+ LDL ++ + S ++ L+ L+ L L N+
Sbjct: 330 LSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPL 389
Query: 59 GTIPPVIGQLSLINELVFCHNNVSGRIP-SSLGNLSNLALLYLNDNSLFGSIPIVMGNLK 117
+ + L + + S NL L +L L+ + L S + L
Sbjct: 390 SLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLP 449
Query: 118 SLSTLDLSQNQLNGSI---PCSLDNLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSE 174
+L L+L N SL L L+ L L LS +LK + +DLS
Sbjct: 450 ALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSH 509
Query: 175 NRLSGLIPLSLSNLSSLTVMSLFNNSLSGSIPPILGNLKSLSTLGLHINQLNG 227
NRL+ +LS+L + + +L +N +S +P +L L T+ L N L+
Sbjct: 510 NRLTSSSIEALSHLKGIYL-NLASNHISIILPSLLPILSQQRTINLRQNPLDC 561
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 7e-27
Identities = 49/225 (21%), Positives = 81/225 (36%), Gaps = 25/225 (11%)
Query: 2 LNLGFNLLFGNIPPQIGNLSKLQYLDLGNNQLSGVIPPEI-GKLNQLRRLYLDVNQLHGT 60
LNL +N +L+ LDL +L L+ L+ L L + L +
Sbjct: 381 LNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDIS 440
Query: 61 IPPVIGQLSLINELVFCHNNVSGRI---PSSLGNLSNLALLYLNDNSLFGSIPIVMGNLK 117
+ L + L N+ +SL L L +L L+ L +LK
Sbjct: 441 SEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLK 500
Query: 118 SLSTLDLSQNQLNGSIPCSLDNLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSENRL 177
++ +DLS N+L S +L +L + L L N +S +PS++ L ++L +N L
Sbjct: 501 MMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQQRTINLRQNPL 559
Query: 178 S--------------------GLIPLSLSNLSSLTVMSLFNNSLS 202
N L + L + +LS
Sbjct: 560 DCTCSNIYFLEWYKENMQKLEDTEDTLCENPPLLRGVRLSDVTLS 604
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 272 bits (697), Expect = 3e-84
Identities = 82/279 (29%), Positives = 133/279 (47%), Gaps = 8/279 (2%)
Query: 2 LNLGFNLLFGNIPPQIGNLSKLQYLDLGNNQLSGV--IPPEIGKLNQLRRLYL-DVNQLH 58
+ G + ++ LDL L IP + L L LY+ +N L
Sbjct: 31 TDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLV 90
Query: 59 GTIPPVIGQLSLINELVFCHNNVSGRIPSSLGNLSNLALLYLNDNSLFGSIPIVMGNLKS 118
G IPP I +L+ ++ L H NVSG IP L + L L + N+L G++P + +L +
Sbjct: 91 GPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPN 150
Query: 119 LSTLDLSQNQLNGSIPCSLDNLSNLDT-LFLYKNSLSGPIPSVIGNLKSLLQLDLSENRL 177
L + N+++G+IP S + S L T + + +N L+G IP NL +L +DLS N L
Sbjct: 151 LVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANL-NLAFVDLSRNML 209
Query: 178 SGLIPLSLSNLSSLTVMSLFNNSLSGSIPPILGNLKSLSTLGLHINQLNGVIPPSIGNLS 237
G + + + + L NSL+ + +G K+L+ L L N++ G +P + L
Sbjct: 210 EGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLK 268
Query: 238 SLRNLSLFNNRLYGFVPKEIGYLKSLSKLEFCAN-HLSG 275
L +L++ N L G +P+ G L+ + N L G
Sbjct: 269 FLHSLNVSFNNLCGEIPQG-GNLQRFDVSAYANNKCLCG 306
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 263 bits (675), Expect = 5e-81
Identities = 91/291 (31%), Positives = 138/291 (47%), Gaps = 11/291 (3%)
Query: 13 IPPQIGNLSKLQ----YLDLGNNQLSGVIPPEIGKLNQLRRLYLDVNQLHGT--IPPVIG 66
I +GN + L D N GV+ + ++ L L L IP +
Sbjct: 14 IKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLA 73
Query: 67 QLSLINELVFCH-NNVSGRIPSSLGNLSNLALLYLNDNSLFGSIPIVMGNLKSLSTLDLS 125
L +N L NN+ G IP ++ L+ L LY+ ++ G+IP + +K+L TLD S
Sbjct: 74 NLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFS 133
Query: 126 QNQLNGSIPCSLDNLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQ-LDLSENRLSGLIPLS 184
N L+G++P S+ +L NL + N +SG IP G+ L + +S NRL+G IP +
Sbjct: 134 YNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPT 193
Query: 185 LSNLSSLTVMSLFNNSLSGSIPPILGNLKSLSTLGLHINQLNGVIPPSIGNLSSLRNLSL 244
+NL +L + L N L G + G+ K+ + L N L + +G +L L L
Sbjct: 194 FANL-NLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDL-GKVGLSKNLNGLDL 251
Query: 245 FNNRLYGFVPKEIGYLKSLSKLEFCANHLSGVIPHSVGNLTGLVLLNMCEN 295
NNR+YG +P+ + LK L L N+L G IP GNL + N
Sbjct: 252 RNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQG-GNLQRFDVSAYANN 301
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 249 bits (638), Expect = 9e-76
Identities = 86/347 (24%), Positives = 141/347 (40%), Gaps = 59/347 (17%)
Query: 85 IPSSLGNLSNLA----LLYLNDNSLFGSIPIVMGNLKSLSTLDLSQNQLNGS--IPCSLD 138
I LGN + L+ + + G + ++ LDLS L IP SL
Sbjct: 14 IKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLA 73
Query: 139 NLSNLDTLFLYK-NSLSGPIPSVIGNLKSLLQLDLSENRLSGLIPLSLSNLSSLTVMSLF 197
NL L+ L++ N+L GPIP I L L L ++ +SG IP LS + +L +
Sbjct: 74 NLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFS 133
Query: 198 NNSLSGSIPPILGNLKSLSTLGLHINQLNGVIPPSIGNLSSL-RNLSLFNNRLYGFVPKE 256
N+LSG++PP + +L +L + N+++G IP S G+ S L ++++ NRL G +P
Sbjct: 134 YNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPT 193
Query: 257 IGYLKSLSKLEFCANHLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLRNLTSLERVRF 316
L +L+ ++ N L G G+ +++ +N L + +
Sbjct: 194 FANL-NLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSK------- 244
Query: 317 NQNNLYGKVYEAFGDHPNLTFLDLSQNNFYCEISFNWRNFSKLGTFNASMNNIYGSIPPE 376
NL LDL N YG++P
Sbjct: 245 -----------------NLNGLDLRNNRI------------------------YGTLPQG 263
Query: 377 IGDSSKLQVLDLSSNHIFGKIPVQLVKLFSLNKLILSLNQLFGGVPL 423
+ L L++S N++ G+IP L + + N+ G PL
Sbjct: 264 LTQLKFLHSLNVSFNNLCGEIPQGGN-LQRFDVSAYANNKCLCGSPL 309
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 243 bits (622), Expect = 2e-73
Identities = 85/349 (24%), Positives = 134/349 (38%), Gaps = 57/349 (16%)
Query: 157 IPSVIGNLKSL----LQLDLSENRLSGLIPLSLSNLSSLTVMSLFNNSLSGS--IPPILG 210
I +GN +L D G++ + + + + L +L IP L
Sbjct: 14 IKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLA 73
Query: 211 NLKSLSTLGLH-INQLNGVIPPSIGNLSSLRNLSLFNNRLYGFVPKEIGYLKSLSKLEFC 269
NL L+ L + IN L G IPP+I L+ L L + + + G +P + +K+L L+F
Sbjct: 74 NLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFS 133
Query: 270 ANHLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLRNLTSLERVRFNQNNLYGKVYEAF 329
N LSG +P S+ +L LV + N + G IP S + + L
Sbjct: 134 YNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKL------------------ 175
Query: 330 GDHPNLTFLDLSQNNFYCEISFNWRNFSKLGTFNASMNNIYGSIPPEIGDSSKLQVLDLS 389
T + +S+N G IPP + + L +DLS
Sbjct: 176 -----FTSMTISRNRLT------------------------GKIPPTFANLN-LAFVDLS 205
Query: 390 SNHIFGKIPVQLVKLFSLNKLILSLNQLFGGVPLEFGTLTELQYLDLSANKLSSSIPMSI 449
N + G V + K+ L+ N L + + G L LDL N++ ++P +
Sbjct: 206 RNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGL 264
Query: 450 GNLLKLHYLNLSNNQFSHKIPTEFEKLIHLSELDLSHNILQEEIPPQIC 498
L LH LN+S N +IP L ++N P C
Sbjct: 265 TQLKFLHSLNVSFNNLCGEIPQGG-NLQRFDVSAYANNKCLCGSPLPAC 312
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 232 bits (594), Expect = 2e-69
Identities = 77/326 (23%), Positives = 139/326 (42%), Gaps = 39/326 (11%)
Query: 254 PKEIGYLKSLS----KLEFCANHLSGVIPHSVGNLTGLVLLNMCENHLFG--PIPKSLRN 307
K++G +LS + C GV+ + + L++ +L PIP SL N
Sbjct: 15 KKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLAN 74
Query: 308 LTSLERVRF-NQNNLYGKVYEAFGDHPNLTFLDLSQNNFYCEISFNWRNFSKLGTFNASM 366
L L + NNL G + A L +L ++ N
Sbjct: 75 LPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVS-------------------- 114
Query: 367 NNIYGSIPPEIGDSSKLQVLDLSSNHIFGKIPVQLVKLFSLNKLILSLNQLFGGVPLEFG 426
G+IP + L LD S N + G +P + L +L + N++ G +P +G
Sbjct: 115 ----GAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYG 170
Query: 427 TLTEL-QYLDLSANKLSSSIPMSIGNLLKLHYLNLSNNQFSHKIPTEFEKLIHLSELDLS 485
+ ++L + +S N+L+ IP + NL L +++LS N F + ++ L+
Sbjct: 171 SFSKLFTSMTISRNRLTGKIPPTFANL-NLAFVDLSRNMLEGDASVLFGSDKNTQKIHLA 229
Query: 486 HNILQEEIPPQICKMESLEKLNLSHNNLSDFIPRCFEEMRSLSWIDISYNELQGPIPNST 545
N L ++ ++ ++L L+L +N + +P+ +++ L +++S+N L G IP
Sbjct: 230 KNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGG 288
Query: 546 AFKN---GLMEGNKGLCGNFKALPSC 568
+ NK LCG+ LP+C
Sbjct: 289 NLQRFDVSAYANNKCLCGS--PLPAC 312
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 225 bits (575), Expect = 7e-67
Identities = 67/209 (32%), Positives = 98/209 (46%), Gaps = 5/209 (2%)
Query: 1 MLNLGFNLLFGNIPPQIGNLSKLQYLDLGNNQLSGVIPPEIGKLNQLRRLYLDVNQLHGT 60
L + + G IP + + L LD N LSG +PP I L L + D N++ G
Sbjct: 105 YLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGA 164
Query: 61 IPPVIGQL-SLINELVFCHNNVSGRIPSSLGNLSNLALLYLNDNSLFGSIPIVMGNLKSL 119
IP G L + N ++G+IP + NL NLA + L+ N L G ++ G+ K+
Sbjct: 165 IPDSYGSFSKLFTSMTISRNRLTGKIPPTFANL-NLAFVDLSRNMLEGDASVLFGSDKNT 223
Query: 120 STLDLSQNQLNGSIPCSLDNLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSENRLSG 179
+ L++N L + + NL+ L L N + G +P + LK L L++S N L G
Sbjct: 224 QKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCG 282
Query: 180 LIPLSLSNLSSLTVMSLFNNS-LSGSIPP 207
IP NL V + NN L GS P
Sbjct: 283 EIP-QGGNLQRFDVSAYANNKCLCGSPLP 310
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 270 bits (692), Expect = 3e-83
Identities = 95/293 (32%), Positives = 152/293 (51%), Gaps = 22/293 (7%)
Query: 638 YEEITKATGNFGEKYCIGKGGQRSVYKAELPSGNIFAVKKFKAELFSDETANPSEFLNEV 697
E+ A+ NF K +G+GG VYK L G + AVK+ K E +F EV
Sbjct: 22 LRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQ---GGELQFQTEV 78
Query: 698 LALTEIRHRNIIKFHGFCSNAQHSFIVCEYLARGSLTTILRDDAAAKE-FSWNQRMNVIK 756
++ HRN+++ GFC +V Y+A GS+ + LR+ ++ W +R +
Sbjct: 79 EMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIAL 138
Query: 757 GVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEP---HSSNWTEFA 813
G A L+YLH C P I+HRD+ + N+LLD E+EA V DFG AK ++ H + T
Sbjct: 139 GSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVT--TAVR 196
Query: 814 GTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIE----- 868
GT+G+ APE T +++EK DV+ +GV+ LE+I G D + + + M+++
Sbjct: 197 GTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDL-ARLANDDDVMLLDWVKGL 255
Query: 869 -----VNQILDHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLL 916
+ ++D L +++ +++VA+LC +P RP M EV +L
Sbjct: 256 LKEKKLEALVDVDL--QGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRML 306
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 273 bits (699), Expect = 6e-81
Identities = 111/558 (19%), Positives = 195/558 (34%), Gaps = 51/558 (9%)
Query: 13 IPPQIGNLSKLQYLDLGNNQLSGVIPPEIGKLNQLRRLYLDVNQLHGTIPPVIGQLSLIN 72
+P I S + +DL N L + ++L+ L L ++ L ++
Sbjct: 26 VPDDIP--SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLS 83
Query: 73 ELVFCHNNVSGRIPSSLGNLSNLALLYLNDNSLFGSIPIVMGNLKSLSTLDLSQNQLNG- 131
L+ N + P S L++L L + L +G L +L L+++ N ++
Sbjct: 84 NLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSC 143
Query: 132 SIPCSLDNLSNLDTLFLYKNSLSGPIPSVIGNLK----SLLQLDLSENRLSGLIPLSLSN 187
+P NL+NL + L N + + + L+ L LD+S N + + +
Sbjct: 144 KLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQG 203
Query: 188 LSSLTVMSLFNNSLSGSIPP-ILGNLKSLSTLGLHINQLNGVIPPSIGNLSSLRNL---- 242
+ L ++L N S +I L NL L L + + I S + L
Sbjct: 204 IK-LHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVT 262
Query: 243 ----SLFNNRLYGFVPKEIGYLKSLSKLEFCANHLSGVIPHSVGNLTGLVLLNMCENHLF 298
L + + L ++S + + + V L++ L
Sbjct: 263 IDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKYL--EDVPKHFKWQSLSIIRCQLK 320
Query: 299 GPIPKSLRNLTSLERVRFNQNNLYGKVYEAFGDHPNLTFLDLSQNNFYC--EISFNWRNF 356
L L SL N + P+L++LDLS+N S++
Sbjct: 321 QFPTLDLPFLKSLT---LTMNKG--SISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGT 375
Query: 357 SKLGTFNASMNNIYGSIPPEIGDSSKLQVLDLSSNHIFGKIPVQLVKLFSLNKLILSLNQ 416
+ L + S N + +LQ LD + +
Sbjct: 376 NSLRHLDLSFNGAI-IMSANFMGLEELQHLDFQHSTLKRVTEFSA--------------- 419
Query: 417 LFGGVPLEFGTLTELQYLDLSANKLSSSIPMSIGNLLKLHYLNLSNNQFSHKIPTE-FEK 475
F +L +L YLD+S L L+ L ++ N F + F
Sbjct: 420 --------FLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFAN 471
Query: 476 LIHLSELDLSHNILQEEIPPQICKMESLEKLNLSHNNLSDFIPRCFEEMRSLSWIDISYN 535
+L+ LDLS L++ + L+ LN+SHNNL + ++ SLS +D S+N
Sbjct: 472 TTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFN 531
Query: 536 ELQGPIPNSTAFKNGLME 553
++ F L
Sbjct: 532 RIETSKGILQHFPKSLAF 549
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 273 bits (699), Expect = 7e-81
Identities = 116/531 (21%), Positives = 188/531 (35%), Gaps = 27/531 (5%)
Query: 2 LNLGFNLLFGNIPPQIGNLSKLQYLDLGNNQLSGVIPPEIGKLNQLRRLYLDVNQLHGTI 61
++L FN L N S+LQ+LDL ++ + L+ L L L N +
Sbjct: 37 IDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFS 96
Query: 62 PPVIGQLSLINELVFCHNNVSGRIPSSLGNLSNLALLYLNDNSLFG-SIPIVMGNLKSLS 120
P L+ + LV ++ +G L L L + N + +P NL +L
Sbjct: 97 PGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLV 156
Query: 121 TLDLSQNQLNGSIPCSLDNLSNLD----TLFLYKNSLSGPIPSVIGNLKSLLQLDLSENR 176
+DLS N + L L +L + N + I L +L L N
Sbjct: 157 HVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDF-IQDQAFQGIKLHELTLRGNF 215
Query: 177 LSGLIP-LSLSNLSSLTVMSLFNNSLSGSI------PPILGNLKSLSTLGLHINQLN--G 227
S I L NL+ L V L P I+ L ++ + N
Sbjct: 216 NSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFS 275
Query: 228 VIPPSIGNLSSLRNLSLFNNRLYGFVPKEIGYLKSLSKLEFCANHLSGVIPHSVGNLTGL 287
L+++ +SL + +++ L L +L L
Sbjct: 276 DDIVKFHCLANVSAMSLAGVSI--KYLEDVPKHFKWQSLSIIRCQLKQF---PTLDLPFL 330
Query: 288 VLLNMCENHLFGPIPKSLRNLTSLERVRFNQNNLYGKVYEAFGD--HPNLTFLDLSQNNF 345
L + N I L SL + ++N L ++ D +L LDLS N
Sbjct: 331 KSLTLTMNKG--SISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGA 388
Query: 346 YCEISFNWRNFSKLGTFNASMNNIYGSIPPE-IGDSSKLQVLDLSSNHIFGKIPVQLVKL 404
+S N+ +L + + + KL LD+S + + L
Sbjct: 389 I-IMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGL 447
Query: 405 FSLNKLILSLNQLFGGVPLE-FGTLTELQYLDLSANKLSSSIPMSIGNLLKLHYLNLSNN 463
SLN L ++ N F T L +LDLS +L L +L LN+S+N
Sbjct: 448 TSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHN 507
Query: 464 QFSHKIPTEFEKLIHLSELDLSHNILQEEIPPQICKMESLEKLNLSHNNLS 514
+ + +L LS LD S N ++ +SL NL++N+++
Sbjct: 508 NLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSVA 558
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 265 bits (680), Expect = 3e-78
Identities = 108/528 (20%), Positives = 184/528 (34%), Gaps = 31/528 (5%)
Query: 35 GVIPPEIGKLNQLRRLYLDVNQLHGTIPPVIGQLSLINELVFCHNNVSGRIPSSLGNLSN 94
G + P I + + +L +P I S + N + S N S
Sbjct: 2 GSLNPCIEVVPNIT-YQCMDQKLS-KVPDDIP--SSTKNIDLSFNPLKILKSYSFSNFSE 57
Query: 95 LALLYLNDNSLFGSIPIVMGNLKSLSTLDLSQNQLNGSIPCSLDNLSNLDTLFLYKNSLS 154
L L L+ + L LS L L+ N + P S L++L+ L + L+
Sbjct: 58 LQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLA 117
Query: 155 GPIPSVIGNLKSLLQLDLSENRLSGL-IPLSLSNLSSLTVMSLFNNSLSGSIPPILGNLK 213
IG L +L +L+++ N + +P SNL++L + L N + L L+
Sbjct: 118 SLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLR 177
Query: 214 SLS----TLGLHINQLNGVIPPSIGNLSSLRNLSLFNNRLYGFVPKEIGY-LKSLSKLE- 267
+L + +N ++ I L L+L N + K L L
Sbjct: 178 ENPQVNLSLDMSLNPIDF-IQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRL 236
Query: 268 -----FCANHLSGVIPHSVGNLTGLVL--LNMCENHLFGPIPKSLRNLTSLERVRFNQNN 320
+L P + L + + + + F L ++ + +
Sbjct: 237 ILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVS 296
Query: 321 LYGKVYEAFGDHPNLTFLDLSQNNFYCEISFNWRNFSKLGTFNASMNNIYGSIPPEIGDS 380
+ K E H L + + + + L + +MN SI +
Sbjct: 297 I--KYLEDVPKHFKWQSLSIIRCQL-KQFPTL--DLPFLKSLTLTMNKG--SISFKKVAL 349
Query: 381 SKLQVLDLSSNHI--FGKIPVQLVKLFSLNKLILSLNQLFGGVPLEFGTLTELQYLDLSA 438
L LDLS N + G + SL L LS N + F L ELQ+LD
Sbjct: 350 PSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAI-IMSANFMGLEELQHLDFQH 408
Query: 439 NKLSSSIPMS-IGNLLKLHYLNLSNNQFSHKIPTEFEKLIHLSELDLSHNILQEEIPPQI 497
+ L S +L KL YL++S F L L+ L ++ N ++ +
Sbjct: 409 STLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNV 468
Query: 498 -CKMESLEKLNLSHNNLSDFIPRCFEEMRSLSWIDISYNELQGPIPNS 544
+L L+LS L F+ + L +++S+N L +
Sbjct: 469 FANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSH 516
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 233 bits (596), Expect = 1e-66
Identities = 100/480 (20%), Positives = 174/480 (36%), Gaps = 30/480 (6%)
Query: 83 GRIPSSLGNLSNLALLYLNDNSLFGSIPIVMGNLKSLSTLDLSQNQLNGSIPCSLDNLSN 142
G + + + N+ D L +P + + S +DLS N L S N S
Sbjct: 2 GSLNPCIEVVPNI-TYQCMDQKLS-KVPDDIPS--STKNIDLSFNPLKILKSYSFSNFSE 57
Query: 143 LDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSENRLSGLIPLSLSNLSSLTVMSLFNNSLS 202
L L L + + L L L L+ N + P S S L+SL + L+
Sbjct: 58 LQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLA 117
Query: 203 GSIPPILGNLKSLSTLGLHINQLNGV-IPPSIGNLSSLRNLSLFNNRLYGFVPKEIGYLK 261
+G L +L L + N ++ +P NL++L ++ L N + ++ +L+
Sbjct: 118 SLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLR 177
Query: 262 SLS----KLEFCANHLSGVIPHSVGNLTGLVLLNMCENHLFGPIPK-SLRNLTSLERVRF 316
L+ N + I L L + N I K L+NL L R
Sbjct: 178 ENPQVNLSLDMSLNPIDF-IQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRL 236
Query: 317 NQNNLYGKVYEAFGD--------HPNLTFLDLSQNNFYCEISFNWRNFSKLGTFNASMNN 368
+ + + L+ N + + + + + + + +
Sbjct: 237 ILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVS 296
Query: 369 IYGSIPPEIGDSSKLQVLDLSSNHIFGKIPVQLVKLFSLNKLILSLNQLFGGVPLEFGTL 428
I ++ K Q L + + + P L L L L++N+ + + L
Sbjct: 297 I--KYLEDVPKHFKWQSLSIIRCQL-KQFPTL--DLPFLKSLTLTMNKG--SISFKKVAL 349
Query: 429 TELQYLDLSANKLSSSIPMSIGNL--LKLHYLNLSNNQFSHKIPTEFEKLIHLSELDLSH 486
L YLDLS N LS S S +L L +L+LS N + F L L LD H
Sbjct: 350 PSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAII-MSANFMGLEELQHLDFQH 408
Query: 487 NILQEEIPPQ-ICKMESLEKLNLSHNNLSDFIPRCFEEMRSLSWIDISYNELQGPIPNST 545
+ L+ +E L L++S+ N F + SL+ + ++ N + ++
Sbjct: 409 STLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNV 468
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 236 bits (603), Expect = 7e-68
Identities = 119/541 (21%), Positives = 200/541 (36%), Gaps = 52/541 (9%)
Query: 13 IPPQIGNLSKLQYLDLGNNQLSGVIPPEIGKLNQLRRLYLDVNQLHGTIPPVIGQLSLIN 72
IP + + LDL N L + +L+ L L ++ LS ++
Sbjct: 22 IPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLS 79
Query: 73 ELVFCHNNVSGRIPSSLGNLSNLALLYLNDNSLFGSIPIVMGNLKSLSTLDLSQNQLN-G 131
L+ N + + LS+L L + +L +G+LK+L L+++ N +
Sbjct: 80 TLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSF 139
Query: 132 SIPCSLDNLSNLDTLFLYKNSLSGPIPSVIGNLKSL----LQLDLSENRLSGLIPLSLSN 187
+P NL+NL+ L L N + + + L + L LDLS N ++ + P +
Sbjct: 140 KLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKE 199
Query: 188 LSSLTVMSLFNNSLSGSIPP-ILGNLKSLSTLGLHINQL---NGVIPPSIGNLSSLRNLS 243
+ L ++L NN S ++ + L L L + + + L L NL+
Sbjct: 200 I-RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLT 258
Query: 244 LFNNRLYGF------VPKEIGYLKSLSKLEFCANHLSGVIPHS-VGNLTGLVLLNMCENH 296
+ RL + L ++S + + V S L L+N
Sbjct: 259 IEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQ 318
Query: 297 LFGPIPKSLRNLTSLERVRFNQNNLYGKVYEAFGDHPNLTFLDLSQNNFYCEISFNWRNF 356
L SL+R+ F N + D P+L FLDLS+N ++
Sbjct: 319 F------PTLKLKSLKRLTFTSNKGGNA--FSEVDLPSLEFLDLSRNGLSF-KGCCSQSD 369
Query: 357 SKLGTFNASMNNIYGSIPPEIGDSSKLQVLDLSSNHIFGKIPVQLVKLFSLNKLILSLNQ 416
+ L+ LDLS N + + + L L L +
Sbjct: 370 FGT---------------------TSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSN 407
Query: 417 LFGGVPLE-FGTLTELQYLDLSANKLSSSIPMSIGNLLKLHYLNLSNNQFSHKIPTE-FE 474
L F +L L YLD+S + L L L ++ N F + F
Sbjct: 408 LKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFT 467
Query: 475 KLIHLSELDLSHNILQEEIPPQICKMESLEKLNLSHNNLSDFIPRCFEEMRSLSWIDISY 534
+L +L+ LDLS L++ P + SL+ LN++ N L F+ + SL I +
Sbjct: 468 ELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHT 527
Query: 535 N 535
N
Sbjct: 528 N 528
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 214 bits (547), Expect = 4e-60
Identities = 111/495 (22%), Positives = 185/495 (37%), Gaps = 35/495 (7%)
Query: 72 NELVFCHNNVSGRIPSSLGNLSNLALLYLNDNSLFGSIPIVMGNLKSLSTLDLSQNQLNG 131
N C +IP +L + L L+ N L + L LDLS+ ++
Sbjct: 9 NITYQCMELNFYKIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQT 66
Query: 132 SIPCSLDNLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSENRLSGLIPLSLSNLSSL 191
+ +LS+L TL L N + L SL +L E L+ L + +L +L
Sbjct: 67 IEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTL 126
Query: 192 TVMSLFNNSL-SGSIPPILGNLKSLSTLGLHINQLNGVIPPSIGNLSSLRN----LSLFN 246
+++ +N + S +P NL +L L L N++ + + L + L L
Sbjct: 127 KELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSL 186
Query: 247 NRLYGFVPKEIGYLKSLSKLEFCANHLSGVIPHSV-GNLTGLVLLNMCENHLFG------ 299
N + F+ L KL N S + + L GL + +
Sbjct: 187 NPM-NFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEK 245
Query: 300 ---PIPKSLRNLTSLERVRFNQNNLYG-KVYEAFGDHPNLTFLDLSQNNFYCEISF-NWR 354
+ L NLT +E R + Y + + F N++ L F
Sbjct: 246 FDKSALEGLCNLT-IEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNF 304
Query: 355 NFSKLGTFNASMNNIYGSIPPEIGDSSKLQVLDLSSNHIFGKIPVQLVKLFSLNKLILSL 414
+ L N P + S L+ L +SN V L SL L LS
Sbjct: 305 GWQHLELVNCKFGQF-----PTLKLKS-LKRLTFTSNKGGNAFS--EVDLPSLEFLDLSR 356
Query: 415 NQL--FGGVPLEFGTLTELQYLDLSANKLSSSIPMSIGNLLKLHYLNLSNNQFSHKIPTE 472
N L G T L+YLDLS N + + + + L +L +L+ ++
Sbjct: 357 NGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFS 415
Query: 473 -FEKLIHLSELDLSHNILQEEIPPQICKMESLEKLNLSHNNLSDFIPR-CFEEMRSLSWI 530
F L +L LD+SH + + SLE L ++ N+ + F E+R+L+++
Sbjct: 416 VFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFL 475
Query: 531 DISYNELQGPIPNST 545
D+S +L+ + +
Sbjct: 476 DLSQCQLEQ-LSPTA 489
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 201 bits (513), Expect = 1e-55
Identities = 110/504 (21%), Positives = 182/504 (36%), Gaps = 44/504 (8%)
Query: 2 LNLGFNLLFGNIPPQIGNLSKLQYLDLGNNQLSGVIPPEIGKLNQLRRLYLDVNQLHGTI 61
L+L FN L + +LQ LDL ++ + L+ L L L N +
Sbjct: 33 LDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLA 92
Query: 62 PPVIGQLSLINELVFCHNNVSGRIPSSLGNLSNLALLYLNDNSL-FGSIPIVMGNLKSLS 120
LS + +LV N++ +G+L L L + N + +P NL +L
Sbjct: 93 LGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLE 152
Query: 121 TLDLSQNQLNGSIPCSLDNLSNLD----TLFLYKNSLSGPIPSVIGNLKSLLQLDLSENR 176
LDLS N++ L L + +L L N ++ I L +L L N
Sbjct: 153 HLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNF-IQPGAFKEIRLHKLTLRNNF 211
Query: 177 LSG-LIPLSLSNLSSLTVMSLF------NNSLSGSIPPILGNLKSLSTLGLHINQLNGV- 228
S ++ + L+ L V L +L L L +L+ + L+
Sbjct: 212 DSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYL 271
Query: 229 --IPPSIGNLSSLRNLSLFNNRLYGFVPKEI-------------------GYLKSLSKLE 267
I L+++ + SL + + LKSL +L
Sbjct: 272 DDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLT 331
Query: 268 FCANHLSGVIPHSVGNLTGLVLLNMCENHL--FGPIPKSLRNLTSLERVRFNQNNLYGKV 325
F +N +L L L++ N L G +S TSL+ + + N + +
Sbjct: 332 FTSNKGGNAFSEV--DLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TM 388
Query: 326 YEAFGDHPNLTFLDLSQNNFYCEISFN-WRNFSKLGTFNASMNNIYGSIPPEIGDS-SKL 383
F L LD +N F+ + + L + S + I + S L
Sbjct: 389 SSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTR-VAFNGIFNGLSSL 447
Query: 384 QVLDLSSNHIFGKIPVQ-LVKLFSLNKLILSLNQLFGGVPLEFGTLTELQYLDLSANKLS 442
+VL ++ N +L +L L LS QL P F +L+ LQ L++++N+L
Sbjct: 448 EVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLK 507
Query: 443 SSIPMSIGNLLKLHYLNLSNNQFS 466
S L L + L N +
Sbjct: 508 SVPDGIFDRLTSLQKIWLHTNPWD 531
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 3e-38
Identities = 81/407 (19%), Positives = 134/407 (32%), Gaps = 64/407 (15%)
Query: 2 LNLGFNLL-FGNIPPQIGNLSKLQYLDLGNNQLSGV------------------------ 36
LN+ NL+ +P NL+ L++LDL +N++ +
Sbjct: 129 LNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNP 188
Query: 37 ---IPPEIGKLNQLRRLYLDVNQLHGTIPPVIGQ-------LSLINELVFCHNNVSGRIP 86
I P K +L +L L N + Q L+ N+
Sbjct: 189 MNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDK 248
Query: 87 SSLGNLSNLALLYLNDNSLFGSIPIVMG---NLKSLSTLDLSQNQLNGSIPCSLD----- 138
S+L L NL + L + ++ L ++S+ L + S +
Sbjct: 249 SALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQH 308
Query: 139 --------------NLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSENRLS--GLIP 182
L +L L N V +L SL LDLS N LS G
Sbjct: 309 LELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEV--DLPSLEFLDLSRNGLSFKGCCS 366
Query: 183 LSLSNLSSLTVMSLFNNSLSGSIPPILGNLKSLSTLGLHINQLNGVIPPSI-GNLSSLRN 241
S +SL + L N + ++ L+ L L + L + S+ +L +L
Sbjct: 367 QSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIY 425
Query: 242 LSLFNNRLYGFVPKEIGYLKSLSKLEFCANHLSGVIPHSV-GNLTGLVLLNMCENHLFGP 300
L + + L SL L+ N + L L L++ + L
Sbjct: 426 LDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQL 485
Query: 301 IPKSLRNLTSLERVRFNQNNLYGKVYEAFGDHPNLTFLDLSQNNFYC 347
P + +L+SL+ + N L F +L + L N + C
Sbjct: 486 SPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDC 532
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 2e-30
Identities = 56/231 (24%), Positives = 91/231 (39%), Gaps = 15/231 (6%)
Query: 1 MLNLGFNLLFGNIPPQIGNLSKLQYLDLGNNQLSGVIPPEIGKLNQLRRLYLDVNQLH-- 58
++N F L L+ L +N+ L L L L N L
Sbjct: 311 LVNCKFGQF------PTLKLKSLKRLTFTSNKGGNA--FSEVDLPSLEFLDLSRNGLSFK 362
Query: 59 GTIPPVIGQLSLINELVFCHNNVSGRIPSSLGNLSNLALLYLNDNSLFGSIP--IVMGNL 116
G + + L N V + S+ L L L ++L + V +L
Sbjct: 363 GCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNL-KQMSEFSVFLSL 420
Query: 117 KSLSTLDLSQNQLNGSIPCSLDNLSNLDTLFLYKNSLSGPIPS-VIGNLKSLLQLDLSEN 175
++L LD+S + + LS+L+ L + NS + L++L LDLS+
Sbjct: 421 RNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQC 480
Query: 176 RLSGLIPLSLSNLSSLTVMSLFNNSLSGSIPPILGNLKSLSTLGLHINQLN 226
+L L P + ++LSSL V+++ +N L I L SL + LH N +
Sbjct: 481 QLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWD 531
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 5e-28
Identities = 55/212 (25%), Positives = 84/212 (39%), Gaps = 7/212 (3%)
Query: 2 LNLGFNLLFGNIPPQIGNLSKLQYLDLGNNQLS--GVIPPEIGKLNQLRRLYLDVNQLHG 59
L N GN ++ +L L++LDL N LS G L+ L L N +
Sbjct: 330 LTFTSNKG-GNAFSEV-DLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI- 386
Query: 60 TIPPVIGQLSLINELVFCHNNVSGRIPSS-LGNLSNLALLYLNDNSLFGSIPIVMGNLKS 118
T+ L + L F H+N+ S +L NL L ++ + + L S
Sbjct: 387 TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSS 446
Query: 119 LSTLDLSQNQLNGSI-PCSLDNLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSENRL 177
L L ++ N + P L NL L L + L P+ +L SL L+++ N+L
Sbjct: 447 LEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQL 506
Query: 178 SGLIPLSLSNLSSLTVMSLFNNSLSGSIPPIL 209
+ L+SL + L N S P I
Sbjct: 507 KSVPDGIFDRLTSLQKIWLHTNPWDCSCPRID 538
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 1e-24
Identities = 58/255 (22%), Positives = 96/255 (37%), Gaps = 13/255 (5%)
Query: 309 TSLERVRFNQNNLYGKVYEAFGDHPNLTFLDLSQNNFYCEISFNWRNFSKLGTFNASMNN 368
S + + + N L +F P L LDLS+ +++ S L T + N
Sbjct: 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNP 87
Query: 369 IYGSIPPEIGDSSKLQVLDLSSNHIFGKIPVQLVKLFSLNKLILSLNQL-FGGVPLEFGT 427
I S LQ L ++ + L +L +L ++ N + +P F
Sbjct: 88 IQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSN 147
Query: 428 LTELQYLDLSANKLSSSIPMSIGNLLKLHY----LNLSNNQFSHKIPTEFEKLIHLSELD 483
LT L++LDLS+NK+ S + L ++ L+LS N + I K I L +L
Sbjct: 148 LTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNF-IQPGAFKEIRLHKLT 206
Query: 484 LSHNILQEEIPPQIC-KMESLEKLNL------SHNNLSDFIPRCFEEMRSLSWIDISYNE 536
L +N + + LE L + NL F E + +L+ +
Sbjct: 207 LRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAY 266
Query: 537 LQGPIPNSTAFKNGL 551
L + + N L
Sbjct: 267 LDYYLDDIIDLFNCL 281
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 5e-22
Identities = 44/175 (25%), Positives = 71/175 (40%), Gaps = 4/175 (2%)
Query: 385 VLDLSSNHIFGKIPVQLVKLFSLNKLILSLNQLFGGVPLEFGTLTELQYLDLSANKLSSS 444
+ + KIP L S L LS N L F + ELQ LDLS ++ +
Sbjct: 11 TYQCMELNFY-KIPDNLPF--STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTI 67
Query: 445 IPMSIGNLLKLHYLNLSNNQFSHKIPTEFEKLIHLSELDLSHNILQEEIPPQICKMESLE 504
+ +L L L L+ N F L L +L L I +++L+
Sbjct: 68 EDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLK 127
Query: 505 KLNLSHNNLSDF-IPRCFEEMRSLSWIDISYNELQGPIPNSTAFKNGLMEGNKGL 558
+LN++HN + F +P F + +L +D+S N++Q + + N L
Sbjct: 128 ELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSL 182
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 227 bits (580), Expect = 2e-67
Identities = 94/311 (30%), Positives = 140/311 (45%), Gaps = 29/311 (9%)
Query: 617 RSSSANPFGFFSVLNFNGKVLYEEITKATGNFGEKYCIGKGGQRSVYKAELPSGNIFAVK 676
S + + V + +V ++ +AT NF K+ IG G VYK L G A+K
Sbjct: 10 NSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALK 69
Query: 677 KFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFIVCEYLARGSLTTI 736
+ E EF E+ L+ RH +++ GFC ++ +Y+ G+L
Sbjct: 70 RRTPESSQGI----EEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRH 125
Query: 737 L-RDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSD 795
L D SW QR+ + G A L YLH I +HRD+ S N+LLD + ++D
Sbjct: 126 LYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAI---IHRDVKSINILLDENFVPKITD 182
Query: 796 FGFAKFL----EPHSSNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHP 851
FG +K + H S T GT+GY PE R TEK DVYSFGV+ EV+
Sbjct: 183 FGISKKGTELDQTHLS--TVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSA 240
Query: 852 GDFVSTIFSSISNMIIE----------VNQILDHRLPTPSRDVTDKLRSIMEVAILCLVE 901
++ + N + E + QI+D L + + LR + A+ CL
Sbjct: 241 IV--QSLPREMVN-LAEWAVESHNNGQLEQIVDPNL--ADKIRPESLRKFGDTAVKCLAL 295
Query: 902 NPEARPTMKEV 912
+ E RP+M +V
Sbjct: 296 SSEDRPSMGDV 306
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 222 bits (568), Expect = 7e-66
Identities = 85/297 (28%), Positives = 131/297 (44%), Gaps = 30/297 (10%)
Query: 638 YEEITKATGNFGEKYC------IGKGGQRSVYKAELPSGNIFAVKKFKAELFSDETANPS 691
+ E+ T NF E+ +G+GG VYK + AVKK A +
Sbjct: 17 FYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVN-NTTVAVKKLAAMVDITTEELKQ 75
Query: 692 EFLNEVLALTEIRHRNIIKFHGFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQR 751
+F E+ + + +H N+++ GF S+ +V Y+ GSL L SW+ R
Sbjct: 76 QFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMR 135
Query: 752 MNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFL--EPHSSNW 809
+ +G AN +++LH + +HRDI S N+LLD + A +SDFG A+ +
Sbjct: 136 CKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMT 192
Query: 810 TEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDF----------VSTIF 859
+ GT Y APE A T K D+YSFGV+ LE+I G D I
Sbjct: 193 SRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIE 251
Query: 860 SSISNMIIEVNQILDHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLL 916
+ +D ++ + + + ++ VA CL E RP +K+V LL
Sbjct: 252 DEEKT----IEDYIDKKM---NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLL 301
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 222 bits (567), Expect = 6e-64
Identities = 108/510 (21%), Positives = 193/510 (37%), Gaps = 86/510 (16%)
Query: 7 NLLFGNIPPQIGNLSKLQYLDLGNNQLSGVIPPEIGKLNQLRRLYLDVNQLHGTIPPVIG 66
+ I L++ LG ++ + L+Q+ L D +
Sbjct: 11 DTPINQIFT-DTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGI--------- 58
Query: 67 QLSLINELVFCHNNVSGRIPSSLGNLSNLALLYLNDNSLFGSIPIVMGNLKSLSTLDLSQ 126
+ + L+NL + ++N L P+ NL L + ++
Sbjct: 59 -----------------KSIDGVEYLNNLTQINFSNNQLTDITPL--KNLTKLVDILMNN 99
Query: 127 NQLNGSIPCSLDNLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSENRLSGLIPLSLS 186
NQ+ P L NL+NL L L+ N ++ P + NL +L +L+LS N +S + LS
Sbjct: 100 NQIADITP--LANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISDISALS-- 153
Query: 187 NLSSLTVMSLFNNSLSGSIPPILGNLKSLSTLGLHINQLNGVIPPSIGNLSSLRNLSLFN 246
L+SL +S N ++ P L NL +L L + N+++ + L++L +L N
Sbjct: 154 GLTSLQQLSF-GNQVTDLKP--LANLTTLERLDISSNKVSD--ISVLAKLTNLESLIATN 208
Query: 247 NRLYGFVPKEIGYLKSLSKLEFCANHLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLR 306
N++ P +G L +L +L N L + + +LT L L++ N + P L
Sbjct: 209 NQISDITP--LGILTNLDELSLNGNQLKDIGT--LASLTNLTDLDLANNQISNLAP--LS 262
Query: 307 NLTSLERVRFNQNNLYGKVYEAFGDHPNLTFLDLSQNNFYCEISFNWRNFSKLGTFNASM 366
LT L ++ N + LT L+L++N
Sbjct: 263 GLTKLTELKLGANQI--SNISPLAGLTALTNLELNENQL--------------------- 299
Query: 367 NNIYGSIPPEIGDSSKLQVLDLSSNHIFGKIPVQLVKLFSLNKLILSLNQLFGGVPLEFG 426
I + L L L N+I P + L L +L N++
Sbjct: 300 -----EDISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSD--VSSLA 350
Query: 427 TLTELQYLDLSANKLSSSIPMSIGNLLKLHYLNLSNNQFSHKIPTEFEKLIHLSELDLSH 486
LT + +L N++S P + NL ++ L L++ +++ +S +
Sbjct: 351 NLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTNAPVNYKAN---VSIPNTVK 405
Query: 487 NILQEEIPP-QICKMESLEKLNLSHNNLSD 515
N+ I P I S + +++ N S
Sbjct: 406 NVTGALIAPATISDGGSYTEPDITWNLPSY 435
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 210 bits (538), Expect = 7e-60
Identities = 107/458 (23%), Positives = 186/458 (40%), Gaps = 57/458 (12%)
Query: 87 SSLGNLSNLALLYLNDNSLFGSIPIVMGNLKSLSTLDLSQNQLNGSIPCSLDNLSNLDTL 146
+ L+ L ++ ++ +L ++TL + + ++ L+NL +
Sbjct: 18 FTDTALAEKMKTVLGKTNVTDTVSQ--TDLDQVTTLQADRLGI--KSIDGVEYLNNLTQI 73
Query: 147 FLYKNSLSGPIPSVIGNLKSLLQLDLSENRLSGLIPLSLSNLSSLTVMSLFNNSLSGSIP 206
N L+ P + NL L+ + ++ N+++ + PL+ NL++LT ++LFNN ++ P
Sbjct: 74 NFSNNQLTDITP--LKNLTKLVDILMNNNQIADITPLA--NLTNLTGLTLFNNQITDIDP 129
Query: 207 PILGNLKSLSTLGLHINQLNGVIPPSIGNLSSLRNLSLFNNRLYGFVPKEIGYLKSLSKL 266
L NL +L+ L L N ++ + ++ L+SL+ LS N K + L +L +L
Sbjct: 130 --LKNLTNLNRLELSSNTISDI--SALSGLTSLQQLSFGNQVT---DLKPLANLTTLERL 182
Query: 267 EFCANHLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLRNLTSLERVRFNQNNLYGKVY 326
+ +N +S + + LT L L N + P L LT+L+ + N N L K
Sbjct: 183 DISSNKVSDISV--LAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQL--KDI 236
Query: 327 EAFGDHPNLTFLDLSQNNFYCEISFNWRNFSKLGTFNASMNNIYGSIPPEIGDSSKLQVL 386
NLT LDL+ N S + +KL L
Sbjct: 237 GTLASLTNLTDLDLANNQI--------------------------SNLAPLSGLTKLTEL 270
Query: 387 DLSSNHIFGKIPVQLVKLFSLNKLILSLNQLFGGVPLEFGTLTELQYLDLSANKLSSSIP 446
L +N I P L L +L L L+ NQL L L YL L N +S P
Sbjct: 271 KLGANQISNISP--LAGLTALTNLELNENQLED--ISPISNLKNLTYLTLYFNNISDISP 326
Query: 447 MSIGNLLKLHYLNLSNNQFSHKIPTEFEKLIHLSELDLSHNILQEEIPPQICKMESLEKL 506
+ +L KL L NN+ S + L +++ L HN + + P + + + +L
Sbjct: 327 --VSSLTKLQRLFFYNNKVS--DVSSLANLTNINWLSAGHNQISDLTP--LANLTRITQL 380
Query: 507 NLSHNNLSDFIPRCFEEMRSLSWIDISYNELQGPIPNS 544
L+ ++ + + + L P S
Sbjct: 381 GLNDQAWTNAPVNYKANVSIPNTVKNVTGALIAPATIS 418
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 204 bits (522), Expect = 8e-58
Identities = 103/469 (21%), Positives = 183/469 (39%), Gaps = 58/469 (12%)
Query: 2 LNLGFNLLFGNIPPQIGNLSKLQYLDLGNNQLSGVIPPEIGKLNQLRRLYLDVNQLHGTI 61
L + + L+ L ++ NNQL+ + P + L +L + ++ NQ+
Sbjct: 51 LQADRLGI--KSIDGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADIT 106
Query: 62 PPVIGQLSLINELVFCHNNVSGRIPSSLGNLSNLALLYLNDNSLFGSIPIVMGNLKSLST 121
P + L+ + L +N ++ L NL+NL L L+ N++ S + L SL
Sbjct: 107 P--LANLTNLTGLTLFNNQITD--IDPLKNLTNLNRLELSSNTI--SDISALSGLTSLQQ 160
Query: 122 LDLSQNQLNGSIPCSLDNLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSENRLSGLI 181
L NQ+ P L NL+ L+ L + N +S SV+ L +L L + N++S +
Sbjct: 161 LSFG-NQVTDLKP--LANLTTLERLDISSNKVSD--ISVLAKLTNLESLIATNNQISDIT 215
Query: 182 PLSLSNLSSLTVMSLFNNSLSGSIPPILGNLKSLSTLGLHINQLNGVIPPSIGNLSSLRN 241
P L L++L +SL N L L +L +L+ L L NQ++ + P + L+ L
Sbjct: 216 P--LGILTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTE 269
Query: 242 LSLFNNRLYGFVPKEIGYLKSLSKLEFCANHLSGVIPHSVGNLTGLVLLNMCENHLFGPI 301
L L N++ P + L +L+ LE N L + P + NL L L + N++
Sbjct: 270 LKLGANQISNISP--LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDIS 325
Query: 302 PKSLRNLTSLERVRFNQNNLYGKVYEAFGDHPNLTFLDLSQNNFYCEISFNWRNFSKLGT 361
P + +LT L+R+ F N + + + N+ +L N
Sbjct: 326 P--VSSLTKLQRLFFYNNKV--SDVSSLANLTNINWLSAGHNQI---------------- 365
Query: 362 FNASMNNIYGSIPPEIGDSSKLQVLDLSSNHIFGKIPVQLVKLFSLNKLILSLNQLFGGV 421
S + + +++ L L+ PV S+ + ++
Sbjct: 366 ----------SDLTPLANLTRITQLGLNDQAWTN-APVNYKANVSIPNTVKNVTGAL-IA 413
Query: 422 PLEFGTLTELQYLDLSANKLSSSIPMSIGNLLKLHYLNLSNNQFSHKIP 470
P D++ N L S + + FS +
Sbjct: 414 PATISDGGSYTEPDITWN-LPSYTNEVSYTFSQPVTIGKGTTTFSGTVT 461
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 225 bits (575), Expect = 4e-62
Identities = 129/640 (20%), Positives = 221/640 (34%), Gaps = 63/640 (9%)
Query: 19 NLSKLQYLDLGNNQLSGVIPPEIGKLNQLRRLYLDVNQLHGTIPP-VIGQLSLINELVFC 77
L+ + L L N + V L QL+ L L TI L + L
Sbjct: 22 VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLG 81
Query: 78 HNNVSGRIPSSLGNLSNLALLYLNDNSLFGSI--PIVMGNLKSLSTLDLSQNQLNG-SIP 134
+ + P + L +L L L L ++ NLK+L+ LDLS+NQ+ +
Sbjct: 82 SSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLH 141
Query: 135 CSLDNLSNLDTLFLYKNSLSGPIPSVIGNL--KSLLQLDLSENRLSGLIPLSL------- 185
S L++L ++ N + + L K+L L+ N L + +
Sbjct: 142 PSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPF 201
Query: 186 -----------SNLSSLTVMSLFNNSLSGSIPPILGNLKSLSTLGLHINQLNGVIPPSIG 234
N ++ + F+N++S S L + G + + +
Sbjct: 202 RNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFA 261
Query: 235 NL--SSLRNLSLFNNRLYGFVPKEIGYLKSLSKLEFCANHLSGVIPHSVGNLTGLVLLNM 292
L SS+R+L L + ++ + LK L L N ++ + + L L +LN+
Sbjct: 262 GLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNL 321
Query: 293 CENHLFGPIPKSLRNLTSLERVRFNQNNLYGKVYEAFGDHPNLTFLDLSQNNFYCEISFN 352
N L + L + + +N++ + F L LDL N
Sbjct: 322 SYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTT----- 376
Query: 353 WRNFSKLGTFNASMNNIYGSIPPEIGDSSKLQVLDLSSNHIFG-KIPVQLVKLFSLNKLI 411
+ S N + ++P + ++ LS N + I L+++ L LI
Sbjct: 377 IHFIPSIPDIFLSGNKL-VTLPK---INLTANLIHLSENRLENLDILYFLLRVPHLQILI 432
Query: 412 LSLNQLFGGVPLE--FGTLTELQYLDLSANKLSSSIPMSI-----GNLLKLHYLNLSNNQ 464
L+ N+ + L+ L L N L + + L L L L++N
Sbjct: 433 LNQNRF-SSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNY 491
Query: 465 FSHKIPTEFEKLIHLSELDLSHNILQEEIPPQICKMESLEKLNLSHNNLSDFIPRCFEEM 524
+ P F L L L L+ N L + +LE L++S N L P F
Sbjct: 492 LNSLPPGVFSHLTALRGLSLNSNRLT-VLSHNDLP-ANLEILDISRNQLLAPNPDVFV-- 547
Query: 525 RSLSWIDISYNELQGPIPNSTAFKNGLMEGNKGLCGNF-------------KALPSCDAF 571
SLS +DI++N+ ST F N L N + G +L S
Sbjct: 548 -SLSVLDITHNKFICECELST-FINWLNHTNVTIAGPPADIYCVYPDSFSGVSLFSLSTE 605
Query: 572 TSHKQTFRKKWVVIALPILGMVVLLIGLIGFFFLFRRRKR 611
++ K + + + L + R
Sbjct: 606 GCDEEEVLKSLKFSLFIVCTVTLTLFLMTILTVTKFRGFC 645
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 174 bits (443), Expect = 3e-45
Identities = 95/417 (22%), Positives = 156/417 (37%), Gaps = 39/417 (9%)
Query: 135 CSLDNLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSENRLSGLIPLSLSNLSSLTVM 194
CS D F +L+ V L + +L LS N + + S L L ++
Sbjct: 2 CSFDG----RIAFYRFCNLT----QVPQVLNTTERLLLSFNYIRTVTASSFPFLEQLQLL 53
Query: 195 SLFNNSLSGSIPP-ILGNLKSLSTLGLHINQLNGVIPPSIGNLSSLRNLSLFNNRLYGFV 253
L + +I NL +L L L +++ + P + L L L L+ L V
Sbjct: 54 ELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAV 113
Query: 254 --PKEIGYLKSLSKLEFCANHLSGVIPHSV-GNLTGLVLLNMCENHLFGPIPKSLRNLT- 309
LK+L++L+ N + + H G L L ++ N +F L L
Sbjct: 114 LKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQG 173
Query: 310 -SLERVRFNQNNLYGKVYEAFGDHPN------LTFLDLSQNNFYCEISFNWRNFSKLGTF 362
+L N+LY +V +G N L LD+S N + +I+
Sbjct: 174 KTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDIT------------ 221
Query: 363 NASMNNIYGSIPPEIGDSSKLQVLDLSSNHIFGKIPVQLVKLF--SLNKLILSLNQLFGG 420
N I S + + + ++I L S+ L LS +F
Sbjct: 222 GNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSL 281
Query: 421 VPLEFGTLTELQYLDLSANKLSSSIPMSIGNLLKLHYLNLSNNQFSHKIPTEFEKLIHLS 480
F TL +L+ L+L+ NK++ + L L LNLS N + F L ++
Sbjct: 282 NSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVA 341
Query: 481 ELDLSHNILQEEIPPQICKMESLEKLNLSHNNLSDFIPRCFEEMRSLSWIDISYNEL 537
+DL N + +E L+ L+L N L+ + S+ I +S N+L
Sbjct: 342 YIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALT-----TIHFIPSIPDIFLSGNKL 393
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 3e-35
Identities = 98/547 (17%), Positives = 183/547 (33%), Gaps = 115/547 (21%)
Query: 1 MLNLGFNLLFGNIPPQIGNLSK------LQYLDLGNNQLSGVIPPEIGKLNQLRRLYLDV 54
+L N L+ + G L+ LD+ N + I
Sbjct: 178 FFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDIT------------GNFS 225
Query: 55 NQLHGTIPPVIGQLSLINELVFCHNNVSGRIPSSLGNLSNLAL--LYLNDNSLFGSIPIV 112
N + + + I F +N+ ++ L+ ++ L L+ +F V
Sbjct: 226 NAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRV 285
Query: 113 MGNLKSLSTLDLSQNQLNGSIPCSLDNLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDL 172
LK L L+L+ N++N + L NL L L N L S L + +DL
Sbjct: 286 FETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDL 345
Query: 173 SENRLSGLIPLSLSNLSSLTVMSLFNNSLSGSIPPILGNLKSLSTLGLHINQLNGVIPPS 232
+N ++ + + L L + L +N+L+ +
Sbjct: 346 QKNHIAIIQDQTFKFLEKLQTLDLRDNALT-----------------------------T 376
Query: 233 IGNLSSLRNLSLFNNRLYGFVPKEIGYLKSLSKLEFCANHLSGVIPHSVGNLTGLVLLNM 292
I + S+ ++ L N+ L +L K+ AN + +L+ L N+
Sbjct: 377 IHFIPSIPDIFLSGNK-----------LVTLPKINLTANLI---------HLSENRLENL 416
Query: 293 CENHLFGPIPKSLRNLTSLERVRFNQNNLYGKVYEA-FGDHPNLTFLDLSQNNFYC--EI 349
+ + L+ + NQN + ++P+L L L +N E
Sbjct: 417 DILYFL-------LRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWET 469
Query: 350 SFNWRNFSKLGTFNASMNNIYGSIPPEIGDSSKLQVLDLSSNHIFGKIPVQLVKLFSLNK 409
W F L S LQVL L+ N++ P L +L
Sbjct: 470 ELCWDVFEGL---------------------SHLQVLYLNHNYLNSLPPGVFSHLTALRG 508
Query: 410 LILSLNQLFGGVPLEFGTLTELQYLDLSANKLSSSIPMSIGNLLKLHYLNLSNNQFSHKI 469
L L+ N+L + L+ LD+S N+L + P + L L++++N+F +
Sbjct: 509 LSLNSNRLTVLSHNDL--PANLEILDISRNQLLAPNPDV---FVSLSVLDITHNKFICEC 563
Query: 470 PTE-FEKLIHLSELDLSHNILQEEIPPQICKMESLEKLNLSHNNLSDFIPRCFEEMRSLS 528
F ++ + + ++ + + + S +L +E L
Sbjct: 564 ELSTFINWLNHTNVTIAGPPAD---------IYCVYPDSFSGVSLFSLSTEGCDEEEVLK 614
Query: 529 WIDISYN 535
+ S
Sbjct: 615 SLKFSLF 621
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 213 bits (545), Expect = 4e-60
Identities = 103/530 (19%), Positives = 191/530 (36%), Gaps = 43/530 (8%)
Query: 13 IPPQIGNLSKLQYLDLGNNQLSGVIPPEIGKLNQLRRLYLDVNQLHGTIPPVIGQLSLIN 72
IP + + ++ LDL N+++ + ++ L+ L L ++++ L +
Sbjct: 20 IPSGL--TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLE 77
Query: 73 ELVFCHNNVSGRIPSSLGNLSNLALLYLNDNSLFG-SIPIVMGNLKSLSTLDLSQNQLNG 131
L N++S S G LS+L L L N + + NL +L TL + +
Sbjct: 78 HLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFS 137
Query: 132 SIP-CSLDNLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSENRLSGLIPLSLSNLSS 190
I L++L+ L + SL + +++ + L L + + L+ + LSS
Sbjct: 138 EIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSS 197
Query: 191 LTVMSLFNNSLSGSIPPILGNLKSLSTLGLHINQLNGVIPPSIGNLSSLRNLSLFNNRLY 250
+ + L + +L+ L + S + + + + S L L L + +
Sbjct: 198 VRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEV- 256
Query: 251 GFVPKEIGYLKSLSKLEFCANHLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLRNLTS 310
E +F + V + L++ + +LF + L
Sbjct: 257 -----EFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEK 311
Query: 311 LERVRFNQNNLYGKVYEAFGDHPNLTFLDLSQNNFYCEISFNWRNFSKLGTFNASMNNIY 370
++R+ + ++ +L FLDLS+N E N
Sbjct: 312 VKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAW----------- 360
Query: 371 GSIPPEIGDSSKLQVLDLSSNHI--FGKIPVQLVKLFSLNKLILSLNQLFGGVPLEFGTL 428
LQ L LS NH+ K L+ L +L L +S N +P
Sbjct: 361 ----------PSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTF-HPMPDSCQWP 409
Query: 429 TELQYLDLSANKLSSSIPMSIGNLLKLHYLNLSNNQFSHKIPTEFEKLIHLSELDLSHNI 488
++++L+LS+ + + L L++SNN L L EL +S N
Sbjct: 410 EKMRFLNLSSTGIRV---VKTCIPQTLEVLDVSNNNLDS-FSLF---LPRLQELYISRNK 462
Query: 489 LQEEIPPQICKMESLEKLNLSHNNLSDFIPRCFEEMRSLSWIDISYNELQ 538
L+ +P L + +S N L F+ + SL I + N
Sbjct: 463 LKT-LPD-ASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWD 510
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 193 bits (491), Expect = 8e-53
Identities = 98/494 (19%), Positives = 176/494 (35%), Gaps = 49/494 (9%)
Query: 2 LNLGFNLLFGNIPPQI-GNLSKLQYLDLGNNQLSGVIPPEIGKLNQLRRLYLDVNQLHG- 59
L L + + I +L L++LDL +N LS + G L+ L+ L L N
Sbjct: 55 LILKSSRI-NTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTL 113
Query: 60 TIPPVIGQLSLINELVFCHNNVSGRIP-SSLGNLSNLALLYLNDNSLFGSIPIVMGNLKS 118
+ + L+ + L + I L++L L + SL + +++
Sbjct: 114 GVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRD 173
Query: 119 LSTLDLSQNQLNGSIPCSLDNLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSENRLS 178
+ L L ++ + D LS++ L L +L+ S + + + R S
Sbjct: 174 IHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGS 233
Query: 179 GLIPLSLSNLSSLTVMSLFNNSLSGSIPPILGNLKSLSTLGLHINQLNGVIPPSIGNLSS 238
L S + L L L + + + + ++ + V +
Sbjct: 234 VLTDESFNELLKLLRYILELSEVE------FDDCTLNGLGDFNPSESDVVSELGKVETVT 287
Query: 239 LRNLSLFNNRLYGFVPKEIGYLKSLSKLEFCANHLSGVIPHSVGNLTGLVLLNMCEN--- 295
+R L + L+ + L+ + ++ + + V +L L L++ EN
Sbjct: 288 IRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMV 347
Query: 296 HLFGPIPKSLRNLTSLERVRFNQNNLY--GKVYEAFGDHPNLTFLDLSQNNFYCEISFNW 353
+ SL+ + +QN+L K E NLT LD+S+N F
Sbjct: 348 EEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTF-------- 399
Query: 354 RNFSKLGTFNASMNNIYGSIPPEIGDSSKLQVLDLSSNHIFGKIPVQLVKLFSLNKLILS 413
+P K++ L+LSS I + + +L L +S
Sbjct: 400 -----------------HPMPDSCQWPEKMRFLNLSSTGI-RVVKTCI--PQTLEVLDVS 439
Query: 414 LNQLFGGVPLEFGTLTELQYLDLSANKLSSSIPMSIGNLLKLHYLNLSNNQFSHKIPTEF 473
N L L L LQ L +S NKL ++P L + +S NQ F
Sbjct: 440 NNNL-DSFSLF---LPRLQELYISRNKL-KTLP-DASLFPVLLVMKISRNQLKSVPDGIF 493
Query: 474 EKLIHLSELDLSHN 487
++L L ++ L N
Sbjct: 494 DRLTSLQKIWLHTN 507
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 1e-39
Identities = 71/438 (16%), Positives = 143/438 (32%), Gaps = 64/438 (14%)
Query: 118 SLSTLDLSQNQLNGSIPCSLDNLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSENRL 177
+ D SIP L + + +L L N ++ + +L L L +R+
Sbjct: 6 ASGVCDGRSRSFT-SIPSGL--TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRI 62
Query: 178 SGLIPLSLSNLSSLTVMSLFNNSLSGSIPP-ILGNLKSLSTLGLHINQLNGVIPPS-IGN 235
+ + + +L SL + L +N LS S+ G L SL L L N + S N
Sbjct: 63 NTIEGDAFYSLGSLEHLDLSDNHLS-SLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPN 121
Query: 236 LSSLRNLSLFNNRLYGFVPKEIGYLKSLSKLEFCANHLSGVIPHSVGNLTGLVLLNMCEN 295
L++L+ L + N S + LT L L +
Sbjct: 122 LTNLQTLRIGNV-----------------------ETFSEIRRIDFAGLTSLNELEIKAL 158
Query: 296 HLFGPIPKSLRNLTSLERVRFNQNNLYGKVYEAFGDHPNLTFLDLSQNNFYCEISFNWRN 355
L +SL+++ + + + + + ++ +L+L N F +
Sbjct: 159 SLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLA---RFQFSP 215
Query: 356 FSKLGTFNASMNNIYGSIPPEIGDSSKLQVLDLSSNHIFGKIPVQLVKLFSLNKLILSLN 415
+ + +L L + IL L+
Sbjct: 216 LPVD---------------------EVSSPMKKLAFRGSVLTDESFNELLKLLRYILELS 254
Query: 416 QLFGGVPLEFGTLTELQYLDLSANKLSSSIPMSIGNLLKLHYLNLSNNQFSHKIPTEFEK 475
++ EF T D + ++ + + + L++ + + T +
Sbjct: 255 EV------EFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSL 308
Query: 476 LIHLSELDLSHNILQEEIPPQICK-MESLEKLNLSHNNLSDFI---PRCFEEMRSLSWID 531
L + + + ++ + +P + ++SLE L+LS N + + C SL +
Sbjct: 309 LEKVKRITVENSKVFL-VPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLV 367
Query: 532 ISYNELQGPIPNSTAFKN 549
+S N L+
Sbjct: 368 LSQNHLRSMQKTGEILLT 385
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 4e-33
Identities = 66/369 (17%), Positives = 123/369 (33%), Gaps = 33/369 (8%)
Query: 2 LNLGFNLLFGNIPPQIGNLSKLQYLDLGNNQLSGVIPPEIGKLNQLRRLYLDVNQLHGTI 61
L + L + ++ + +L L ++ + ++ L+ +R L L L
Sbjct: 153 LEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQ 212
Query: 62 PPVIGQLSL------------------INELVFCHNNVSGRIPSSLGNLSNLALLYLNDN 103
+ + NEL+ + + + L N +
Sbjct: 213 FSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPS 272
Query: 104 SLFGSIPIVMGNLKSLSTLDLSQNQLNGSIPCSLDNLSNLDTLFLYKNSLSGPIPSVIGN 163
+ ++ L + Q L + L + + + + + S +
Sbjct: 273 ESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQH 332
Query: 164 LKSLLQLDLSENRLSGLI---PLSLSNLSSLTVMSLFNNSLS--GSIPPILGNLKSLSTL 218
LKSL LDLSEN + SL + L N L IL LK+L++L
Sbjct: 333 LKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSL 392
Query: 219 GLHINQLNGVIPPSIGNLSSLRNLSLFNNRLYGFVPKEIGYLKSLSKLEFCANHLSGVIP 278
+ N + +P S +R L+L + + V I ++L L+ N+L
Sbjct: 393 DISRNTFH-PMPDSCQWPEKMRFLNLSSTGI-RVVKTCI--PQTLEVLDVSNNNLDSFSL 448
Query: 279 HSVGNLTGLVLLNMCENHLFGPIPKSLRNLTSLERVRFNQNNLYGKVYEAFGDHPNLTFL 338
L L L + N L +P + L ++ ++N L F +L +
Sbjct: 449 F----LPRLQELYISRNKLKT-LPDAS-LFPVLLVMKISRNQLKSVPDGIFDRLTSLQKI 502
Query: 339 DLSQNNFYC 347
L N + C
Sbjct: 503 WLHTNPWDC 511
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 206 bits (525), Expect = 6e-60
Identities = 88/312 (28%), Positives = 142/312 (45%), Gaps = 25/312 (8%)
Query: 608 RRKRDPQEKRSSSANPFGFFSVLNFNGK--VLYEEITKATGNFGEKYCIGKGGQRSVYKA 665
P +F + + ++ EK IG G +V++A
Sbjct: 4 HHHHHPMSDYDIPTTENLYFQGAMDGDDMDIPWCDLN-----IKEK--IGAGSFGTVHRA 56
Query: 666 ELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFIVC 725
E G+ AVK + F E N EFL EV + +RH NI+ F G + + IV
Sbjct: 57 EW-HGSDVAVKILMEQDFHAERVN--EFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVT 113
Query: 726 EYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLL 785
EYL+RGSL +L A ++ +R+++ VA ++YLH+ PPIVHR++ S N+L+
Sbjct: 114 EYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN-RNPPIVHRNLKSPNLLV 172
Query: 786 DSEYEAHVSDFGFAKFLEPHSSNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEV 845
D +Y V DFG ++ + AGT + APE+ + EK DVYSFGV+ E+
Sbjct: 173 DKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWEL 232
Query: 846 IKGYHPGDFVSTIFSSISNM-IIEVNQILDHRLPTPSRDVTDKLRSIMEVAILCLVENPE 904
P + +++ ++ RL P ++ ++ +I+E C P
Sbjct: 233 ATLQQP-------WGNLNPAQVVAAVGFKCKRLEIPR-NLNPQVAAIIE---GCWTNEPW 281
Query: 905 ARPTMKEVCNLL 916
RP+ + +LL
Sbjct: 282 KRPSFATIMDLL 293
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 200 bits (510), Expect = 2e-58
Identities = 75/289 (25%), Positives = 122/289 (42%), Gaps = 36/289 (12%)
Query: 638 YEEITKATGNFGEKYCIGKGGQRSVYKAELPSGNIFAVKKFKAELFSDETANPSEFLNEV 697
+ E+T E IG GG VY+A G+ AVK + + D + E
Sbjct: 6 FAELT-----LEEI--IGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEA 57
Query: 698 LALTEIRHRNIIKFHGFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKG 757
++H NII G C + +V E+ G L +L K + +N
Sbjct: 58 KLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSG----KRIPPDILVNWAVQ 113
Query: 758 VANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAH--------VSDFGFAKFLEPHSSNW 809
+A ++YLH + I PI+HRD+ S N+L+ + E ++DFG A+ H +
Sbjct: 114 IARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREW--HRTTK 171
Query: 810 TEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEV 869
AG + APE+ ++ DV+S+GVL E++ G P F I + +
Sbjct: 172 MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVP-------FRGIDGLAV-A 223
Query: 870 NQILDH--RLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLL 916
+ + LP PS + +ME C +P +RP+ + + L
Sbjct: 224 YGVAMNKLALPIPS-TCPEPFAKLME---DCWNPDPHSRPSFTNILDQL 268
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 201 bits (514), Expect = 3e-58
Identities = 75/330 (22%), Positives = 121/330 (36%), Gaps = 53/330 (16%)
Query: 613 PQEKRSSSANPFGFFSVLNFNGKVLYEEITKATGNFGEKYCIGKGGQRSVYKAELPSGNI 672
SS G E + + +G V+KA+L
Sbjct: 3 HHHHHHSSGVDLG------------TENLYFQSMPLQLLEVKARGRFGCVWKAQLL-NEY 49
Query: 673 FAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHS----FIVCEYL 728
AVK F + + EV +L ++H NI++F G +++ +
Sbjct: 50 VAVKIFPIQDKQSW-----QNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFH 104
Query: 729 ARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCI-------PPIVHRDISSK 781
+GSL+ L+ + SWN+ ++ + +A L+YLH D P I HRDI SK
Sbjct: 105 EKGSLSDFLKANV----VSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSK 160
Query: 782 NVLLDSEYEAHVSDFGFAKFLEPHSSNW--TEFAGTVGYAAPELA-----YTMRATEKYD 834
NVLL + A ++DFG A E S GT Y APE+ + A + D
Sbjct: 161 NVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRID 220
Query: 835 VYSFGVLALEVIKGYHPGDFVSTIFS-----------SISNMIIEV-NQILDHRLPTPSR 882
+Y+ G++ E+ D + S+ +M V ++ L
Sbjct: 221 MYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLR-DYW 279
Query: 883 DVTDKLRSIMEVAILCLVENPEARPTMKEV 912
+ + E C + EAR + V
Sbjct: 280 QKHAGMAMLCETIEECWDHDAEARLSAGCV 309
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 200 bits (510), Expect = 6e-58
Identities = 69/282 (24%), Positives = 121/282 (42%), Gaps = 33/282 (11%)
Query: 638 YEEITKATGNFGEKYCIGKGGQRSVYKAELPSGNIFAVKKFKAELFSDETANPSEFLNEV 697
Y+EI E +G+G V KA+ A+K+ ++E F+ E+
Sbjct: 7 YKEIE-----VEEV--VGRGAFGVVCKAKW-RAKDVAIKQIESESERKA------FIVEL 52
Query: 698 LALTEIRHRNIIKFHGFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKG 757
L+ + H NI+K +G C +V EY GSL +L ++ M+
Sbjct: 53 RQLSRVNHPNIVKLYGACL--NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQ 110
Query: 758 VANALSYLHHDCIPPIVHRDISSKNVLLDSEYE-AHVSDFGFAKFLEPHSSNWTEFAGTV 816
+ ++YLH ++HRD+ N+LL + + DFG A + ++ T G+
Sbjct: 111 CSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDI---QTHMTNNKGSA 167
Query: 817 GYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQIL--D 874
+ APE+ +EK DV+S+G++ EVI P F I + +
Sbjct: 168 AWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKP-------FDEIGGPAFRIMWAVHNG 220
Query: 875 HRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLL 916
R P ++ + S+M C ++P RP+M+E+ ++
Sbjct: 221 TRPPLIK-NLPKPIESLMT---RCWSKDPSQRPSMEEIVKIM 258
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 202 bits (515), Expect = 7e-57
Identities = 104/514 (20%), Positives = 186/514 (36%), Gaps = 75/514 (14%)
Query: 13 IPPQIGNLSKLQYLDLGNNQLSGVIPPEIGKLNQLRRLYLDVNQLHGTIPPVIGQLS--L 70
I P+ + + LQ ++ L+ +P E + Y ++ PP G+
Sbjct: 3 INPRNVSNTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMA 61
Query: 71 INELVFC----------HNNVSGRIPSSLGNLSNLALLYLNDNSLFGSIPIVMGNLKSLS 120
++ L C +N +P +L +L + NSL +P + +LKSL
Sbjct: 62 VSRLRDCLDRQAHELELNNLGLSSLPELPPHLESL---VASCNSL-TELPELPQSLKSLL 117
Query: 121 TLDLSQNQLNGSIPCSLDNLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSENRLSGL 180
+ + L+ P L+ L + N L +P + N L +D+ N L L
Sbjct: 118 VDNNNLKALSDLPP-------LLEYLGVSNNQLEK-LPE-LQNSSFLKIIDVDNNSLKKL 168
Query: 181 IPLSLSNLSSLTVMSLFNNSLSGSIPPILGNLKSLSTLGLHINQLNGVIPPSIGNLSSLR 240
L SL ++ NN L +P + NL L+ + N L +P +L
Sbjct: 169 PDL----PPSLEFIAAGNNQLE-ELPEL-QNLPFLTAIYADNNSLK-KLPDLPLSL---E 218
Query: 241 NLSLFNNRLYGFVPKEIGYLKSLSKLEFCANHLSGVIPHSVGNLTGLVLLNMCENHLFGP 300
++ NN L E+ L L+ + N L +P +L L + + L
Sbjct: 219 SIVAGNNILE--ELPELQNLPFLTTIYADNNLLK-TLPDLPPSLEALNVRDNYLTDL--- 272
Query: 301 IPKSLRNLTSLERVRFNQNNLYGKVYEAFGDHPNLTFLDLSQNNFYCEISFNWRNFSKLG 360
P+ ++LT L+ + L PNL +L+ S N + + L
Sbjct: 273 -PELPQSLTFLDVSENIFSGLSELP-------PNLYYLNASSNEI-RSLCDLPPS---LE 320
Query: 361 TFNASMNNIYGSIPPEIGDSSKLQVLDLSSNHIFGKIPVQLVKLFSLNKLILSLNQLFGG 420
N S N + +P +L+ L S NH+ ++P L L+ + N L
Sbjct: 321 ELNVSNNKLI-ELPALPP---RLERLIASFNHL-AEVPELPQNLKQLH---VEYNPL-RE 371
Query: 421 VPLEFGTLTELQYLDLSANKLSSSIPMSIGNLLKLHYLNLSNNQFSHKIPTEFEKLIHLS 480
P ++ +L+ N + +P NL L++ N P E +
Sbjct: 372 FPDIPESVEDLR-----MNSHLAEVPELPQNL---KQLHVETNPLRE-FPDIPESV---E 419
Query: 481 ELDLSHNILQEEIPPQICKMESLEKLNLSHNNLS 514
+L ++ + + + LE H++
Sbjct: 420 DLRMNSERVVDPYEFAHETTDKLEDDVFEHHHHH 453
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 5e-44
Identities = 87/433 (20%), Positives = 154/433 (35%), Gaps = 80/433 (18%)
Query: 115 NLKSLSTLDLSQNQLNGSIPCSLDNLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSE 174
+ L + L +P +N+ + + + P G + + L +
Sbjct: 9 SNTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRD 67
Query: 175 NRLSGLIPLSLSN---------LSSLTVMSLFNNSLSGSIPPILGNLKSLSTLGLHINQL 225
L L+N L + NSL+ +P + +LKSL ++ L
Sbjct: 68 CLDRQAHELELNNLGLSSLPELPPHLESLVASCNSLT-ELPELPQSLKSLLVDNNNLKAL 126
Query: 226 NGVIPPSIGNLSSLRNLSLFNNRLYGFVPKEIGYLKSLSKLEFCANHLSGVIPHSVGNLT 285
+ + P L L + NN+L +P E+ L ++ N L +P +L
Sbjct: 127 SDLPP-------LLEYLGVSNNQL-EKLP-ELQNSSFLKIIDVDNNSLK-KLPDLPPSLE 176
Query: 286 GLVLLNMCENHLFGPIPKSLRNLTSLERVRFNQNNLYGKVYEAFGDHPNLTFLDLSQNNF 345
+ N N L L+NL L + + N+L + +L + N
Sbjct: 177 FIAAGN---NQL--EELPELQNLPFLTAIYADNNSL----KKLPDLPLSLESIVAGNNIL 227
Query: 346 YCEISFNWRNFSKLGTFNASMNNIYGSIPPEIGDSSKLQVLDLSSNHIFGKIPVQLVKLF 405
PE+ + L + +N + +P L
Sbjct: 228 --------------------------EELPELQNLPFLTTIYADNNLL-KTLPDLPPSLE 260
Query: 406 SLNKLILSLNQLFGGVPLEFGTLTELQYLDLSANKLSSSIPMSIGNLLKLHYLNLSNNQF 465
+LN L L P +LT L + + LS P L+YLN S+N+
Sbjct: 261 ALNVRDNYLTDL----PELPQSLTFLDVSENIFSGLSELPP-------NLYYLNASSNEI 309
Query: 466 SHKIPTEFEKLIHLSELDLSHNILQEEIPPQICKMESLEKLNLSHNNLSDFIPRCFEEMR 525
+ + L EL++S+N L E+P + LE+L S N+L++ +P E +
Sbjct: 310 RS-LC---DLPPSLEELNVSNNKL-IELPALPPR---LERLIASFNHLAE-VP---ELPQ 357
Query: 526 SLSWIDISYNELQ 538
+L + + YN L+
Sbjct: 358 NLKQLHVEYNPLR 370
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 192 bits (491), Expect = 1e-55
Identities = 85/290 (29%), Positives = 127/290 (43%), Gaps = 34/290 (11%)
Query: 638 YEEITKATGNFGEKYCIGKGGQRSVYKAELPS-GNIFAVKKFKAELFSDETANPS---EF 693
EI + ++ IGKGG V+K L ++ A+K ET EF
Sbjct: 18 DNEIE-----YEKQ--IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEF 70
Query: 694 LNEVLALTEIRHRNIIKFHGFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMN 753
EV ++ + H NI+K +G N +V E++ G L L D A W+ ++
Sbjct: 71 QREVFIMSNLNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLD--KAHPIKWSVKLR 126
Query: 754 VIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYE-----AHVSDFGFAKFLEPHSSN 808
++ +A + Y+ + PPIVHRD+ S N+ L S E A V+DFG ++ HS
Sbjct: 127 LMLDIALGIEYMQN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ-SVHSV- 183
Query: 809 WTEFAGTVGYAAPEL--AYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMI 866
+ G + APE A TEK D YSF ++ ++ G P D S NMI
Sbjct: 184 -SGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMI 242
Query: 867 IEVNQILDHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLL 916
E R P D +LR+++E LC +P+ RP + L
Sbjct: 243 REEGL----RPTIPE-DCPPRLRNVIE---LCWSGDPKKRPHFSYIVKEL 284
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 193 bits (492), Expect = 7e-55
Identities = 91/368 (24%), Positives = 164/368 (44%), Gaps = 27/368 (7%)
Query: 2 LNLGFNLLFGNIPPQIGNLSKLQYLDLGNNQLSGVIPPEIGKLNQLRRLYLDVNQLHGTI 61
L + I P +L++ L ++ V+ +L + +L + ++ +I
Sbjct: 5 LATLPAPI-NQIFP-DADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVA-SI 59
Query: 62 PPVIGQLSLINELVFCHNNVSGRIPSSLGNLSNLALLYLNDNSLFGSIPIVMGNLKSLST 121
I L+ + L N ++ P L NL L LY+ N + + + NL +L
Sbjct: 60 QG-IEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKI--TDISALQNLTNLRE 114
Query: 122 LDLSQNQLNGSIPCSLDNLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSENRLSGLI 181
L L+++ ++ P L NL+ + +L L N S + N+ L L ++E+++ +
Sbjct: 115 LYLNEDNISDISP--LANLTKMYSLNLGANHNLS-DLSPLSNMTGLNYLTVTESKVKDVT 171
Query: 182 PLSLSNLSSLTVMSLFNNSLSGSIPPILGNLKSLSTLGLHINQLNGVIPPSIGNLSSLRN 241
P ++NL+ L +SL N + P L +L SL ++NQ+ + P + N++ L +
Sbjct: 172 P--IANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP--VANMTRLNS 225
Query: 242 LSLFNNRLYGFVPKEIGYLKSLSKLEFCANHLSGVIPHSVGNLTGLVLLNMCENHLFGPI 301
L + NN++ + L L+ LE N +S + V +LT L +LN+ N +
Sbjct: 226 LKIGNNKITDL--SPLANLSQLTWLEIGTNQISDINA--VKDLTKLKMLNVGSNQISD-- 279
Query: 302 PKSLRNLTSLERVRFNQNNLYGKVYEAFGDHPNLTFLDLSQNNFYCEISFNWRNFSKLGT 361
L NL+ L + N N L + E G NLT L LSQN+ + SK+ +
Sbjct: 280 ISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRPLA--SLSKMDS 337
Query: 362 FNASMNNI 369
+ + I
Sbjct: 338 ADFANQVI 345
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 192 bits (491), Expect = 9e-55
Identities = 83/405 (20%), Positives = 156/405 (38%), Gaps = 73/405 (18%)
Query: 87 SSLGNLSNLALLYLNDNSLFGSIPIVMGNLKSLSTLDLSQNQLNGSIPCSLDNLSNLDTL 146
+L+ L S+ + L+S++ L ++ ++ SI ++ L+NL+ L
Sbjct: 16 FPDADLAEGIRAVLQKASVTDVVTQ--EELESITKLVVAGEKVA-SIQ-GIEYLTNLEYL 71
Query: 147 FLYKNSLSGPIPSVIGNLKSLLQLDLSENRLSGLIPLSLSNLSSLTVMSLFNNSLSGSIP 206
L N ++ P + NL L L + N+++ + L NL++L + L +++S P
Sbjct: 72 NLNGNQITDISP--LSNLVKLTNLYIGTNKITDISALQ--NLTNLRELYLNEDNISDISP 127
Query: 207 PILGNLKSLSTLGLHINQLNGVIPPSIGNLSSLRNLSLFNNRLYGFVPKEIGYLKSLSKL 266
L NL + +L L N + P + N++ L L++ +++ P I L L L
Sbjct: 128 --LANLTKMYSLNLGANHNLSDLSP-LSNMTGLNYLTVTESKVKDVTP--IANLTDLYSL 182
Query: 267 EFCANHLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLRNLTSLERVRFNQNNLYGKVY 326
N + + P + +LT L N + P + N+T L ++ N +
Sbjct: 183 SLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKI--TDL 236
Query: 327 EAFGDHPNLTFLDLSQNNFYCEISFNWRNFSKLGTFNASMNNIYGSIPPEIGDSSKLQVL 386
+ LT+L++ N S + D +KL++L
Sbjct: 237 SPLANLSQLTWLEIGTNQI--------------------------SDINAVKDLTKLKML 270
Query: 387 DLSSNHIFGKIPVQLVKLFSLNKLILSLNQLFGGVPLEFGTLTELQYLDLSANKLSSSIP 446
++ SN I I L++L L L+ N+L +
Sbjct: 271 NVGSNQI-SDIS-------------------------VLNNLSQLNSLFLNNNQLGNEDM 304
Query: 447 MSIGNLLKLHYLNLSNNQFSHKIPTEFEKLIHLSELDLSHNILQE 491
IG L L L LS N + P L + D ++ ++++
Sbjct: 305 EVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVIKK 347
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 192 bits (490), Expect = 1e-54
Identities = 80/420 (19%), Positives = 156/420 (37%), Gaps = 75/420 (17%)
Query: 119 LSTLDLSQNQLNGSIPCSLDNLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSENRLS 178
+TL +N P +L+ L K S++ + L+S+ +L ++ +++
Sbjct: 2 AATLATLPAPINQIFP--DADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVA 57
Query: 179 GLIPLSLSNLSSLTVMSLFNNSLSGSIPPILGNLKSLSTLGLHINQLNGVIPPSIGNLSS 238
+ + L++L ++L N ++ P L NL L+ L + N++ ++ NL++
Sbjct: 58 SIQGIE--YLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKIT--DISALQNLTN 111
Query: 239 LRNLSLFNNRLYGFVPKEIGYLKSLSKLEFCANHLSGVIPHSVGNLTGLVLLNMCENHLF 298
LR L L + + + L + L ANH
Sbjct: 112 LRELYLNEDNISDI--SPLANLTKMYSLNLGANHNLS----------------------- 146
Query: 299 GPIPKSLRNLTSLERVRFNQNNLYGKVYEAFGDHPNLTFLDLSQNNFYCEISFNWRNFSK 358
L N+T L + ++ + K + +L L L+ N
Sbjct: 147 --DLSPLSNMTGLNYLTVTESKV--KDVTPIANLTDLYSLSLNYNQI------------- 189
Query: 359 LGTFNASMNNIYGSIPPEIGDSSKLQVLDLSSNHIFGKIPVQLVKLFSLNKLILSLNQLF 418
+ + L N I P + + LN L + N++
Sbjct: 190 -------------EDISPLASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKIT 234
Query: 419 GGVPLEFGTLTELQYLDLSANKLSSSIPMSIGNLLKLHYLNLSNNQFSHKIPTEFEKLIH 478
L++L +L++ N++S I ++ +L KL LN+ +NQ S + L
Sbjct: 235 D--LSPLANLSQLTWLEIGTNQISD-IN-AVKDLTKLKMLNVGSNQISD--ISVLNNLSQ 288
Query: 479 LSELDLSHNILQEEIPPQICKMESLEKLNLSHNNLSDFIPRCFEEMRSLSWIDISYNELQ 538
L+ L L++N L E I + +L L LS N+++D P + + D + ++
Sbjct: 289 LNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 1e-37
Identities = 67/331 (20%), Positives = 126/331 (38%), Gaps = 50/331 (15%)
Query: 212 LKSLSTLGLHINQLNGVIPPSIGNLSSLRNLSLFNNRLYGFVPKEIGYLKSLSKLEFCAN 271
+L+TL INQ+ +L+ L + V L+S++KL
Sbjct: 2 AATLATLPAPINQI-----FPDADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGE 54
Query: 272 HLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLRNLTSLERVRFNQNNLYGKVYEAFGD 331
++ + + LT L LN+ N + P L NL L + N + A +
Sbjct: 55 KVASIQG--IEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKI--TDISALQN 108
Query: 332 HPNLTFLDLSQNNFYCEISFNWRNFSKLGTFNASMNNIYGSIPPEIGDSSKLQVLDLSSN 391
NL L L+++N S + + +K+ L+L +N
Sbjct: 109 LTNLRELYLNEDNI--------------------------SDISPLANLTKMYSLNLGAN 142
Query: 392 HIFGKIPVQLVKLFSLNKLILSLNQLFGGVPLEFGTLTELQYLDLSANKLSSSIPMSIGN 451
H + L + LN L ++ +++ V LT+L L L+ N++ P + +
Sbjct: 143 HNLSDLSP-LSNMTGLNYLTVTESKV-KDVT-PIANLTDLYSLSLNYNQIEDISP--LAS 197
Query: 452 LLKLHYLNLSNNQFSHKIPTEFEKLIHLSELDLSHNILQEEIPPQICKMESLEKLNLSHN 511
L LHY NQ + P + L+ L + +N + + P + + L L + N
Sbjct: 198 LTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTN 253
Query: 512 NLSDFIPRCFEEMRSLSWIDISYNELQGPIP 542
+SD +++ L +++ N++
Sbjct: 254 QISDINA--VKDLTKLKMLNVGSNQISDISV 282
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 126 bits (320), Expect = 7e-32
Identities = 57/201 (28%), Positives = 94/201 (46%), Gaps = 14/201 (6%)
Query: 2 LNLGFNLLFGNIPPQIGNLSKLQYLDLGNNQLSGVIPPEIGKLNQLRRLYLDVNQLHGTI 61
L + + + ++ P I NL+ L L L NQ+ + P + L L VNQ+
Sbjct: 160 LTVTESKV-KDVTP-IANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDIT 215
Query: 62 PPVIGQLSLINELVFCHNNVSGRIPSSLGNLSNLALLYLNDNSLFGSIPIVMGNLKSLST 121
P + ++ +N L +N ++ S L NLS L L + N + + +L L
Sbjct: 216 P--VANMTRLNSLKIGNNKITD--LSPLANLSQLTWLEIGTNQISDINAV--KDLTKLKM 269
Query: 122 LDLSQNQLNGSIPCSLDNLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSENRLSGLI 181
L++ NQ++ L+NLS L++LFL N L VIG L +L L LS+N ++ +
Sbjct: 270 LNVGSNQISD--ISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIR 327
Query: 182 PLSLSNLSSLTVMSLFNNSLS 202
P L++LS + N +
Sbjct: 328 P--LASLSKMDSADFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 88.0 bits (219), Expect = 9e-19
Identities = 32/161 (19%), Positives = 60/161 (37%), Gaps = 12/161 (7%)
Query: 383 LQVLDLSSNHIFGKIPVQLVKLFSLNKLILSLNQLFGGVPLEFGTLTELQYLDLSANKLS 442
L I P L + +L + + L + L ++ K++
Sbjct: 2 AATLATLPAPINQIFP--DADLAEGIRAVLQKASVTD--VVTQEELESITKLVVAGEKVA 57
Query: 443 SSIPMSIGNLLKLHYLNLSNNQFSHKIPTEFEKLIHLSELDLSHNILQEEIPPQICKMES 502
S I I L L YLNL+ NQ + P L+ L+ L + N + + + +
Sbjct: 58 S-IQ-GIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKI--TDISALQNLTN 111
Query: 503 LEKLNLSHNNLSDFIPRCFEEMRSLSWIDISYNELQGPIPN 543
L +L L+ +N+SD P + + +++ N +
Sbjct: 112 LRELYLNEDNISDISP--LANLTKMYSLNLGANHNLSDLSP 150
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 186 bits (475), Expect = 2e-53
Identities = 58/284 (20%), Positives = 112/284 (39%), Gaps = 32/284 (11%)
Query: 638 YEEITKATGNFGEKYCIGKGGQRSVYKAELPSGNIFAVKKFKAELFSDETANPSEFLNEV 697
++++ F K + + ++K GN VK K +S + +F E
Sbjct: 9 FKQLN-----FLTK--LNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSR--DFNEEC 58
Query: 698 LALTEIRHRNIIKFHGFCSN--AQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVI 755
L H N++ G C + A H ++ ++ GSL +L + +Q +
Sbjct: 59 PRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTN-FVVDQSQAVKFA 117
Query: 756 KGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGT 815
+A +++LH P I ++S++V++D + A +S +
Sbjct: 118 LDMARGMAFLHT-LEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQS-----PGRMYA 171
Query: 816 VGYAAPEL---AYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQI 872
+ APE D++SF VL E++ P F+ +SNM I +
Sbjct: 172 PAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVP-------FADLSNMEIGMKVA 224
Query: 873 LDHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLL 916
L+ PT ++ + +M+ +C+ E+P RP + +L
Sbjct: 225 LEGLRPTIPPGISPHVSKLMK---ICMNEDPAKRPKFDMIVPIL 265
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 178 bits (453), Expect = 5e-50
Identities = 61/295 (20%), Positives = 113/295 (38%), Gaps = 45/295 (15%)
Query: 638 YEEITKATGNFGEKYCIGKGGQRSVYKAELPSGNIFAVKKFKAELFSDETANPSEFLNEV 697
+E++ GE IGKG VY G + A++ E +++ F EV
Sbjct: 32 FEQLE-----IGEL--IGKGRFGQVYHGRW-HGEV-AIRLIDIERDNEDQLK--AFKREV 80
Query: 698 LALTEIRHRNIIKFHGFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKG 757
+A + RH N++ F G C + H I+ +L +++RD A N+ + +
Sbjct: 81 MAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRD--AKIVLDVNKTRQIAQE 138
Query: 758 VANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAK-----FLEPHSSNWTEF 812
+ + YLH I+H+D+ SKNV D + ++DFG
Sbjct: 139 IVKGMGYLHA---KGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQ 194
Query: 813 AGTVGYAAPEL---------AYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSIS 863
G + + APE+ + ++ DV++ G + E+ P F +
Sbjct: 195 NGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWP-------FKTQP 247
Query: 864 NMII--EVNQILDHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLL 916
I ++ + + ++ I+ C E RPT ++ ++L
Sbjct: 248 AEAIIWQMGT--GMKPNLSQIGMGKEISDILL---FCWAFEQEERPTFTKLMDML 297
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 183 bits (465), Expect = 1e-49
Identities = 108/532 (20%), Positives = 189/532 (35%), Gaps = 77/532 (14%)
Query: 13 IPPQIGNLSKLQYLDLGNNQLSGVIPPEIGKLNQLRRLYLDVNQLHGTIPPVIGQLSLIN 72
+P + K L++ N +S + +I L++LR L + N++ +
Sbjct: 15 VPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQ-YLDIS-------- 63
Query: 73 ELVFCHNNVSGRIPSSLGNLSNLALLYLNDNSLFGSIPIVMGNLKSLSTLDLSQNQLNGS 132
VF + L LDLS N+L
Sbjct: 64 --VFKF-------------------------------------NQELEYLDLSHNKLV-K 83
Query: 133 IPCSLDNLSNLDTLFLYKNSL-SGPIPSVIGNLKSLLQLDLSENRLSGLIPLSLSNLSSL 191
I C NL L L N+ + PI GN+ L L LS L L +++L+
Sbjct: 84 ISC--HPTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNIS 141
Query: 192 TVMSLFNNSLSGSIPPILGNLKSLSTLGLHINQLNGVIPPSIGNLSSLRNLSLFNNRLYG 251
V+ + + P L+ +T LHI I ++S +L + +
Sbjct: 142 KVLLVLGETYGEKEDP--EGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIK- 198
Query: 252 FVPKEIGYLKSLSKLEFCANHLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLRNLTSL 311
+ +K + + L+ + + + L + N + L T++
Sbjct: 199 -------CVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRIL--QLVWHTTV 249
Query: 312 ERVRFNQNNLYGKVYEAFGDHPN-----LTFLDLSQNNFYCEISFNWRNFSKLGTFNASM 366
+ L G++ D+ L+ + + F S+ + FS + N ++
Sbjct: 250 WYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTV 309
Query: 367 NNIYGSIPPEIGDSSKLQVLDLSSNHIFGKIPVQLVKLFSLNKLILSLNQL--FGGVPLE 424
+ S LD S+N + + L L LIL +NQL +
Sbjct: 310 SGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEM 369
Query: 425 FGTLTELQYLDLSANKLSSSIPMSI-GNLLKLHYLNLSNNQFSHKIPTEFEKLIHLSELD 483
+ LQ LD+S N +S L LN+S+N + I + LD
Sbjct: 370 TTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCL--PPRIKVLD 427
Query: 484 LSHNILQEEIPPQICKMESLEKLNLSHNNLSDFIPRCFEEMRSLSWIDISYN 535
L N ++ IP Q+ K+E+L++LN++ N L F+ + SL I + N
Sbjct: 428 LHSNKIK-SIPKQVVKLEALQELNVASNQLKSVPDGIFDRLTSLQKIWLHTN 478
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 170 bits (431), Expect = 4e-45
Identities = 83/432 (19%), Positives = 163/432 (37%), Gaps = 28/432 (6%)
Query: 117 KSLSTLDLSQNQLNGSIPCSLDNLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSENR 176
+ + L++SQN ++ + +LS L L + N + SV + L LDLS N+
Sbjct: 21 QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNK 80
Query: 177 LSGLIPLSLSNLSSLTVMSLFNNSLSGSIPP--ILGNLKSLSTLGLHINQLNGVIPPSIG 234
L +S +L + L N+ ++P GN+ L LGL L I
Sbjct: 81 LVK---ISCHPTVNLKHLDLSFNAFD-ALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIA 136
Query: 235 NLSSLRNLSLFNNRLYGFVPKEIGYLKSLSKLEFCANHLSGVIPHSVGNLTGLVLLNMCE 294
+L+ + L + + L + H+ + + + +
Sbjct: 137 HLNISKVLLVLGETYGEKED-----PEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVAN 191
Query: 295 NHLFGPIPKSLRNLTSLERVRFNQNNLYGKVYEAFGDHPNLTFLDLSQNNFYCEISFNWR 354
L +++ + + + + L + L ++ + N+F + W
Sbjct: 192 LELS-----NIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWH 246
Query: 355 NFSKLGTFNASMNNIYGSIPPEIGDSS-----KLQVLDLSSNHIFGKIPVQLVKLFSLNK 409
+ + F+ S + G + D S L + + S+ ++N
Sbjct: 247 --TTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNI 304
Query: 410 LILSLNQLFGGVPLEFGTLTELQYLDLSANKLSSSIPMSIGNLLKLHYLNLSNNQFSH-- 467
+++ L ++ +LD S N L+ ++ + G+L +L L L NQ
Sbjct: 305 KNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELS 364
Query: 468 KIPTEFEKLIHLSELDLSHNILQEEIPPQIC-KMESLEKLNLSHNNLSDFIPRCFEEMRS 526
KI ++ L +LD+S N + + C +SL LN+S N L+D I RC
Sbjct: 365 KIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLP--PR 422
Query: 527 LSWIDISYNELQ 538
+ +D+ N+++
Sbjct: 423 IKVLDLHSNKIK 434
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 7e-34
Identities = 75/405 (18%), Positives = 141/405 (34%), Gaps = 18/405 (4%)
Query: 145 TLFLYKNSLSGPIPSVIGNLKSLLQLDLSENRLSGLIPLSLSNLSSLTVMSLFNNSLSGS 204
+ KN L +P + + L++S+N +S L + +LS L ++ + +N +
Sbjct: 4 LVDRSKNGLIH-VPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYL 60
Query: 205 IPPILGNLKSLSTLGLHINQLNGVIPPSIGNLSSLRNLSLFNNRLYGF-VPKEIGYLKSL 263
+ + L L L N+L + S +L++L L N + KE G + L
Sbjct: 61 DISVFKFNQELEYLDLSHNKLVKI---SCHPTVNLKHLDLSFNAFDALPICKEFGNMSQL 117
Query: 264 SKLEFCANHLSGVIPHSVGNLTGL-VLLNMCENHLFGPIPKSLRNLTSLERVRFNQNNLY 322
L HL + +L VLL + E + P+ L++ + +
Sbjct: 118 KFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTE---SLHIVFPT 174
Query: 323 GKVYEAFGDHPNLTFLDLSQNNFYCEISFNWRNFSKLGTFNASMNNIYGSIPPEIGDSSK 382
K + D T +L +N C + N ++ N ++ +
Sbjct: 175 NKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNL-----TLNN 229
Query: 383 LQVLDLSSNHIFGKIPVQLVKLFSLNKLILSLNQLFGGVPLEFGTLTELQYLDLSANKLS 442
++ S I + V FS++ + L F +L L + ++
Sbjct: 230 IETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFG 289
Query: 443 SSIPMSIGNLLKLHYLNLSNNQFSHKIPTEFEKLIHLSELDLSHNILQEEIPPQICKMES 502
++ N + + K+ LD S+N+L + + +
Sbjct: 290 FPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTE 349
Query: 503 LEKLNLSHNNLS--DFIPRCFEEMRSLSWIDISYNELQGPIPNST 545
LE L L N L I +M+SL +DIS N +
Sbjct: 350 LETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGD 394
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 2e-25
Identities = 57/368 (15%), Positives = 115/368 (31%), Gaps = 48/368 (13%)
Query: 1 MLNLGFNLLFGNIPPQIGNL--SKLQYLDLGNNQLSGVIPPEIGKLNQLRRLYLDVNQLH 58
+L LG P + + L + N + ++ + + L +
Sbjct: 144 LLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLED 203
Query: 59 G------TIPPVIGQLSLINELVFCHNNVSGRIPSSLGNL---SNLALLYLNDNSL---- 105
+I + ++ L + + + L + + +++ L
Sbjct: 204 NKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQL 263
Query: 106 -FGSIPIVMGNLKSLSTLDLSQNQLNGSIPCSLDNLSNLDTLFLYKNSLSGPIPSVIGNL 164
F +LK+LS + + + SN++ + +
Sbjct: 264 DFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKI 323
Query: 165 KSLLQLDLSENRLSGLIPLSLSNLSSLTVMSLFNNSLSGSIPPILG---NLKSLSTLGLH 221
L LD S N L+ + + +L+ L + L N L + I +KSL L +
Sbjct: 324 SPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLK-ELSKIAEMTTQMKSLQQLDIS 382
Query: 222 INQLNGVIPPSI-GNLSSLRNLSLFNNRLYGFVPKEIGYLKSLSKLEFCANHLSGVIPHS 280
N ++ SL +L++ +N L + + + + L+ +N + IP
Sbjct: 383 QNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCL--PPRIKVLDLHSNKIK-SIPKQ 439
Query: 281 VGNLTGLVLLNMCENHLFGPIPKSLRNLTSLERVRFNQNNLYGKVYEAFGDHPNLTFLDL 340
V L L LN+ N L S+ F +L + L
Sbjct: 440 VVKLEALQELNVASN-----------QLKSVPD-------------GIFDRLTSLQKIWL 475
Query: 341 SQNNFYCE 348
N + C
Sbjct: 476 HTNPWDCS 483
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 74.1 bits (182), Expect = 7e-14
Identities = 43/205 (20%), Positives = 67/205 (32%), Gaps = 7/205 (3%)
Query: 365 SMNNIYGSIPPEIGDSSKLQVLDLSSNHIFGKIPVQLVKLFSLNKLILSLNQLFGGVPLE 424
S N I +I SKL++L +S N I L L LS N+L V +
Sbjct: 29 SQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKL---VKIS 85
Query: 425 FGTLTELQYLDLSANKLSS-SIPMSIGNLLKLHYLNLSNNQFSHKIPTEFEKLIHLSELD 483
L++LDLS N + I GN+ +L +L LS L L
Sbjct: 86 CHPTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLL 145
Query: 484 LSHNILQEEIPP---QICKMESLEKLNLSHNNLSDFIPRCFEEMRSLSWIDISYNELQGP 540
+ E+ P Q ESL + ++ + + + +L +I
Sbjct: 146 VLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNK 205
Query: 541 IPNSTAFKNGLMEGNKGLCGNFKAL 565
+ L K +
Sbjct: 206 CSYFLSILAKLQTNPKLSNLTLNNI 230
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 180 bits (458), Expect = 6e-49
Identities = 66/503 (13%), Positives = 156/503 (31%), Gaps = 42/503 (8%)
Query: 17 IGNLSKLQYLDLGNNQLSGVIPPEIGKLNQLRRLYLDVNQLHGTIPPVIGQLSLINELVF 76
N ++ + + ++ L + ++ L L N L + + + L
Sbjct: 6 KQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNL 65
Query: 77 CHNNVSGRIPSSLGNLSNLALLYLNDNSLFGSIPIVMGNLKSLSTLDLSQNQLNGSIPCS 136
N + L +LS L L LN+N + + S+ TL + N ++ +
Sbjct: 66 SSNVLYE--TLDLESLSTLRTLDLNNNYV-QELL----VGPSIETLHAANNNIS-RVS-- 115
Query: 137 LDNLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSENRLSGL-IPLSLSNLSSLTVMS 195
++L N ++ G + LDL N + + ++ +L ++
Sbjct: 116 CSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLN 175
Query: 196 LFNNSLSGSIPPILGNLKSLSTLGLHINQLNGVIPPSIGNLSSLRNLSLFNNRLYGFVPK 255
L N + + + L TL L N+L + P + + + +SL NN+L + K
Sbjct: 176 LQYNFIY-DVKGQV-VFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKL-VLIEK 231
Query: 256 EIGYLKSLSKLEFCANHLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLRNLTSLERVR 315
+ + ++L + N + + + + ++ T
Sbjct: 232 ALRFSQNLEHFDLRGNGFHCGTLRD-FFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGH 290
Query: 316 FNQNNLYGKVYEAFGDHPNLTFLDLSQNNFYCEISFNWRNFSKLGTFNASMNNIYGSIPP 375
+ + F D L L ++ + + +
Sbjct: 291 YGAYCC-EDLPAPFADR--LIALKRKEHA-----------------LLSGQGSETERLEC 330
Query: 376 EIGDSSKLQVLDLSSNHIFGKIPVQLVKLFSLNKLILSLNQLFGGVPLEFGTLTELQYLD 435
E + ++ + +D I ++ + L L V EL
Sbjct: 331 ERENQARQREIDALKEQYRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTL 390
Query: 436 LSANKLSSSIPMSIGNLLKLHYLNLSNNQFSHK-IPTEFEKLIHLSELDLSHNILQEEIP 494
A + + L L ++ + + + + + D+ + ++
Sbjct: 391 QQAVGQ-IELQHATEEQSPLQLLRAIVKRYEEMYVEQQSVQNNAIRDWDMYQHKE-TQLA 448
Query: 495 PQICKMESLE---KLNLSHNNLS 514
+ +++ L L L+ N +
Sbjct: 449 EENARLKKLNGEADLALASANAT 471
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 178 bits (454), Expect = 2e-48
Identities = 64/460 (13%), Positives = 145/460 (31%), Gaps = 24/460 (5%)
Query: 85 IPSSLGNLSNLALLYLNDNSLFGSIPIVMGNLKSLSTLDLSQNQLNGSIPCSLDNLSNLD 144
I N + + + D+SL ++ + + ++ LDLS N L+ L + L+
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 145 TLFLYKNSLSGPIPSVIGNLKSLLQLDLSENRLSGLIPLSLSNLSSLTVMSLFNNSLSGS 204
L L N L + + +L +L LDL+ N + L S+ + NN++S
Sbjct: 62 LLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS-R 113
Query: 205 IPPILGNLKSLSTLGLHINQLNGVIPPSIGNLSSLRNLSLFNNRLYGF-VPKEIGYLKSL 263
+ + + L N++ + G S ++ L L N + + +L
Sbjct: 114 VSC--SRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTL 171
Query: 264 SKLEFCANHLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLRNLTSLERVRFNQNNLYG 323
L N + V L L++ N L + ++ + + N L
Sbjct: 172 EHLNLQYNFIYDVKGQV--VFAKLKTLDLSSNKL-AFMGPEFQSAAGVTWISLRNNKL-V 227
Query: 324 KVYEAFGDHPNLTFLDLSQNNFYCEISFNWRNFSKLGTFNASMNNIYGSIPPEIGDSSKL 383
+ +A NL DL N F+C ++ + ++ + + + +
Sbjct: 228 LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQ-TVAKQTVKKLTGQNEEECTVP 286
Query: 384 QVLDLSSNHIFGKIPVQLVKLFSLNKLILSLNQL----FGGVPLEFGTLTELQYLDLSAN 439
+ + +L +L + +L + E + +D
Sbjct: 287 TLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQREIDALKE 346
Query: 440 KLSSSIPMSIGNLLKLHYLNLSNNQFSHKIPTEFEKLIHLSELDLSHNILQE--EIPPQI 497
+ + I L ++ L E +
Sbjct: 347 QYRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQAVGQIELQHATEEQ 406
Query: 498 CKMESLEKLNLSHNNLSDFIPRCFEEMRSLSWIDISYNEL 537
++ L + + + + + + ++ D+ ++
Sbjct: 407 SPLQLLRAIVKRYEEMY--VEQQSVQNNAIRDWDMYQHKE 444
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 176 bits (447), Expect = 1e-47
Identities = 69/449 (15%), Positives = 132/449 (29%), Gaps = 47/449 (10%)
Query: 108 SIPIVMGNLKSLSTLDLSQNQLNGSIPCSLDNLSNLDTLFLYKNSLSGPIPSVIGNLKSL 167
+I + N ++ + L ++ + N+ L L N LS + + L
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 168 LQLDLSENRLSGLIPLSLSNLSSLTVMSLFNNSLSGSIPPILGNLKSLSTLGLHINQLNG 227
L+LS N L + L +LS+L + L NN + L S+ TL N ++
Sbjct: 61 ELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQE-----LLVGPSIETLHAANNNISR 113
Query: 228 VIPPSIGNLSSLRNLSLFNNRLYGFVPKEIGYLKSLSKLEFCANHLSGV-IPHSVGNLTG 286
V S +N+ L NN++ + G + L+ N + V +
Sbjct: 114 V---SCSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDT 170
Query: 287 LVLLNMCENHLFGPIPKSLRNLTSLERVRFNQNNLYGKVYEAFGDHPNLTFLDLSQNNFY 346
L LN+ N ++ + + L+ + + N L + F +T++ L N
Sbjct: 171 LEHLNLQYNFIYD-VKGQV-VFAKLKTLDLSSNKL-AFMGPEFQSAAGVTWISLRNNKL- 226
Query: 347 CEISFNWRNFSKLGTFNASMNNIYGSIPPEIGDSSKLQVLDLSSNHIFGKIPVQLVKLFS 406
I + S L+ DL N ++ +
Sbjct: 227 ------------------------VLIEKALRFSQNLEHFDLRGNGFHC-GTLRDFFSKN 261
Query: 407 LNKLILSLNQLFGGVPLEFGTLTELQYLDLSANKLSSSIPMSIGNLLKLHYLNLSNNQFS 466
++ + T A L+ L +
Sbjct: 262 QRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQ 321
Query: 467 H----KIPTEFEKLIHLSELDLSHNILQEEIPPQICKMESLEKLNLSHNNLSDFIPRCFE 522
++ E E E+D + I + ++ L L + +
Sbjct: 322 GSETERLECERENQARQREIDALKEQYRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRR 381
Query: 523 EMRSLS---WIDISYNELQGPIPNSTAFK 548
L + ELQ + +
Sbjct: 382 AHAELDGTLQQAVGQIELQHATEEQSPLQ 410
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 170 bits (432), Expect = 1e-45
Identities = 68/501 (13%), Positives = 153/501 (30%), Gaps = 26/501 (5%)
Query: 61 IPPVIGQLSLINELVFCHNNVSGRIPSSLGNLSNLALLYLNDNSLFGSIPIVMGNLKSLS 120
I + + +++ + S + N+ L L+ N L + L
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 121 TLDLSQNQLNGSIPCSLDNLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSENRLSGL 180
L+LS N L ++ L++LS L TL L N + + S+ L + N +S +
Sbjct: 62 LLNLSSNVLYETLD--LESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNISRV 114
Query: 181 IPLSLSNLSSLTVMSLFNNSLSGSIPPILGNLKSLSTLGLHINQLNGVIPPS-IGNLSSL 239
++ L NN ++ G + L L +N+++ V + +L
Sbjct: 115 SCSRGQGKKNI---YLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTL 171
Query: 240 RNLSLFNNRLYGFVPKEIGYLKSLSKLEFCANHLSGVIPHSVGNLTGLVLLNMCENHLFG 299
+L+L N +Y V ++ L L+ +N L+ + + G+ +++ N L
Sbjct: 172 EHLNLQYNFIYD-VKGQV-VFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLVL 228
Query: 300 PIPKSLRNLTSLERVRFNQNNL-YGKVYEAFGDHPNLTFLDLSQNNFYCEISFNWRNFSK 358
I K+LR +LE N G + + F + + + + +
Sbjct: 229 -IEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNE--EECTV 285
Query: 359 LGTFNASMNNIYGSIPPEIG-----DSSKLQVLDLSSNHIFGKIPVQLVKLFSLNKLILS 413
+ P + +L + ++ + ++
Sbjct: 286 PTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSET-ERLECERENQARQREIDAL 344
Query: 414 LNQLFGGVPLEFGTLTELQYLDLSANKLSSSIPMSIGNLLKLHYLNLSNNQFSHKIPTEF 473
Q + L+ L + +L ++
Sbjct: 345 KEQYRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQAVG-QIELQHAT 403
Query: 474 EKLIHLSELDLSHNILQEE-IPPQICKMESLEKLNLSHNNLSDFIPRCFEEMRSLSWIDI 532
E+ L L +E + Q + ++ ++ + + + D+
Sbjct: 404 EEQSPLQLLRAIVKRYEEMYVEQQSVQNNAIRDWDMYQHKETQLAEENARLKKLNGEADL 463
Query: 533 SYNELQGPIPNSTAFKNGLME 553
+ + + L
Sbjct: 464 ALASANATLQELVVREQNLAS 484
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 174 bits (444), Expect = 1e-48
Identities = 53/270 (19%), Positives = 101/270 (37%), Gaps = 24/270 (8%)
Query: 13 IPPQIGNLS--KLQYLDLGNNQLSGVIPPEIGKLNQLRRLYLDVNQLHGTIPPVIGQLSL 70
+ + + L+L + L P + +L+ L+ + +D L +P + Q +
Sbjct: 71 TADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAG 128
Query: 71 INELVFCHNNVSGRIPSSLGNLSNLALLYLNDNSLFGSIPIVMGNLKSLSTLDLSQNQLN 130
+ L N + +P+S+ +L+ L L + +P + +
Sbjct: 129 LETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLAST-------------- 173
Query: 131 GSIPCSLDNLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSENRLSGLIPLSLSNLSS 190
L NL +L L + +P+ I NL++L L + + LS L ++ +L
Sbjct: 174 -DASGEHQGLVNLQSLRLEWTGIRS-LPASIANLQNLKSLKIRNSPLSAL-GPAIHHLPK 230
Query: 191 LTVMSLFNNSLSGSIPPILGNLKSLSTLGL-HINQLNGVIPPSIGNLSSLRNLSLFNNRL 249
L + L + + PPI G L L L + L +P I L+ L L L
Sbjct: 231 LEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNL-LTLPLDIHRLTQLEKLDLRGCVN 289
Query: 250 YGFVPKEIGYLKSLSKLEFCANHLSGVIPH 279
+P I L + + + + + H
Sbjct: 290 LSRLPSLIAQLPANCIILVPPHLQAQLDQH 319
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 172 bits (439), Expect = 6e-48
Identities = 56/321 (17%), Positives = 106/321 (33%), Gaps = 21/321 (6%)
Query: 2 LNLGFNLLFGNIPPQIGNLSKLQYLDLGNNQLSGVIPPEIGKLNQLRRLYLDVNQLHGTI 61
L + + + D N + L
Sbjct: 17 LYFQGSTALRPYHDVLSQWQRHYNADRNRWHS----AWRQANSNNPQIETRTGRALK-AT 71
Query: 62 PPVIGQLSLIN--ELVFCHNNVSGRIPSSLGNLSNLALLYLNDNSLFGSIPIVMGNLKSL 119
++ + L + + P LS+L + ++ L +P M L
Sbjct: 72 ADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGL-MELPDTMQQFAGL 129
Query: 120 STLDLSQNQLNGSIPCSLDNLSNLDTLFLYKNSLSGPIPSVIGN---------LKSLLQL 170
TL L++N L ++P S+ +L+ L L + +P + + L +L L
Sbjct: 130 ETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSL 188
Query: 171 DLSENRLSGLIPLSLSNLSSLTVMSLFNNSLSGSIPPILGNLKSLSTLGLHINQLNGVIP 230
L + L P S++NL +L + + N+ LS ++ P + +L L L L P
Sbjct: 189 RLEWTGIRSL-PASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRNYP 246
Query: 231 PSIGNLSSLRNLSLFNNRLYGFVPKEIGYLKSLSKLEFCANHLSGVIPHSVGNLTGLVLL 290
P G + L+ L L + +P +I L L KL+ +P + L ++
Sbjct: 247 PIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCII 306
Query: 291 NMCENHLFGPIPKSLRNLTSL 311
+ + +
Sbjct: 307 LVPPHLQAQLDQHRPVARPAE 327
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 169 bits (430), Expect = 9e-47
Identities = 59/386 (15%), Positives = 116/386 (30%), Gaps = 75/386 (19%)
Query: 131 GSIPCSLDNLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSENRLSGLIPLSLSNLSS 190
GS + S + L+ ++ P V+ + D + +N ++
Sbjct: 2 GSSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHS----AWRQANSNN 57
Query: 191 LTVMSLFNNSLSGSIPPILGNLKS--LSTLGLHINQLNGVIPPSIGNLSSLRNLSLFNNR 248
+ + +L + +L + L L L P LS L+++++
Sbjct: 58 PQIETRTGRALK-ATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAG 115
Query: 249 LYGFVPKEIGYLKSLSKLEFCANHLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLRNL 308
L +P + L L N L +P S+ +L L L++ +P+ L +
Sbjct: 116 LME-LPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLAST 173
Query: 309 TSLERVRFNQNNLYGKVYEAFGDHPNLTFLDLSQNNFYCEISFNWRNFSKLGTFNASMNN 368
+ NL L L
Sbjct: 174 DASG---------------EHQGLVNLQSLRLEWTGIR---------------------- 196
Query: 369 IYGSIPPEIGDSSKLQVLDLSSNHIFGKIPVQLVKLFSLNKLILSLNQLFGGVPLEFGTL 428
S+P I + L+ L + ++ L +L L
Sbjct: 197 ---SLPASIANLQNLKSLKIRNS-----------PLSAL--------------GPAIHHL 228
Query: 429 TELQYLDLSANKLSSSIPMSIGNLLKLHYLNLSNNQFSHKIPTEFEKLIHLSELDLSHNI 488
+L+ LDL + P G L L L + +P + +L L +LDL +
Sbjct: 229 PKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCV 288
Query: 489 LQEEIPPQICKMESLEKLNLSHNNLS 514
+P I ++ + + + + +
Sbjct: 289 NLSRLPSLIAQLPANCIILVPPHLQA 314
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 165 bits (420), Expect = 2e-45
Identities = 70/390 (17%), Positives = 117/390 (30%), Gaps = 93/390 (23%)
Query: 88 SLGNLSNLALLYLNDNSLFGSIPIVMGNLKSLSTLDLSQNQLNGSIPCSLDNLSNLDTLF 147
+ S LY ++ V+ + D ++ N +N
Sbjct: 7 HHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQA----NSNNPQIET 62
Query: 148 LYKNSLSGPIPSVIGNLKS--LLQLDLSENRLSGLIPLSLSNLSSLTVMSLFNNSLSGSI 205
+L ++ + + L+L L P LS L M++ L +
Sbjct: 63 RTGRALKA-TADLLEDATQPGRVALELRSVPLPQF-PDQAFRLSHLQHMTIDAAGLM-EL 119
Query: 206 PPILGNLKSLSTLGLHINQLNGVIPPSIGNLSSLRNLSLFNNRLYGFVPKEIG------- 258
P + L TL L N L +P SI +L+ LR LS+ +P+ +
Sbjct: 120 PDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGE 178
Query: 259 --YLKSLSKLEFCANHLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLRNLTSLERVRF 316
L +L L + +P S+ NL L L + + L + ++ +L LE
Sbjct: 179 HQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSA-LGPAIHHLPKLEE--- 233
Query: 317 NQNNLYGKVYEAFGDHPNLTFLDLSQNNFYCEISFNWRNFSKLGTFNASMNNIYGSIPPE 376
LDL L + PP
Sbjct: 234 ---------------------LDLRGCT-------------ALR-----------NYPPI 248
Query: 377 IGDSSKLQVLDLSSNHIFGKIPVQLVKLFSLNKLILSLNQLFGGVPLEFGTLTELQYLDL 436
G + L+ L L L+ L PL+ LT+L+ LDL
Sbjct: 249 FGGRAPLKRLILKDCS-------NLLTL-----------------PLDIHRLTQLEKLDL 284
Query: 437 SANKLSSSIPMSIGNLLKLHYLNLSNNQFS 466
S +P I L + + + +
Sbjct: 285 RGCVNLSRLPSLIAQLPANCIILVPPHLQA 314
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 6e-43
Identities = 53/356 (14%), Positives = 106/356 (29%), Gaps = 69/356 (19%)
Query: 73 ELVFCHNNVSGRIPSSLGNLSNLALLYLNDNSLFGSIPIVMGNLKSLSTLDLSQNQLNGS 132
L F + L N N + + L +
Sbjct: 16 NLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQA----NSNNPQIETRTGRALK-A 70
Query: 133 IPCSLDNLS--NLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSENRLSGLIPLSLSNLSS 190
L++ + L L L P L L + + L L P ++ +
Sbjct: 71 TADLLEDATQPGRVALELRSVPLPQ-FPDQAFRLSHLQHMTIDAAGLMEL-PDTMQQFAG 128
Query: 191 LTVMSLFNNSLSGSIPPILGNLKSLSTLGL-HINQL--------NGVIPPSIGNLSSLRN 241
L ++L N L ++P + +L L L + +L + L +L++
Sbjct: 129 LETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQS 187
Query: 242 LSLFNNRLYGFVPKEIGYLKSLSKLEFCANHLSGVIPHSVGNLTGLVLLNMCENHLFGPI 301
L L + +P I L++L L+ + LS + ++ +L L L++
Sbjct: 188 LRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSA-LGPAIHHLPKLEELDLRGCTALRNY 245
Query: 302 PKSLRNLTSLERVRFNQNNLYGKVYEAFGDHPNLTFLDLSQNNFYCEISFNWRNFSKLGT 361
P L+R L L + N
Sbjct: 246 PPIFGGRAPLKR------------------------LILKDCS----------NLL---- 267
Query: 362 FNASMNNIYGSIPPEIGDSSKLQVLDLSSNHIFGKIPVQLVKLFSLNKLILSLNQL 417
++P +I ++L+ LDL ++P + +L + +++ +
Sbjct: 268 ----------TLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQ 313
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 1e-40
Identities = 52/371 (14%), Positives = 106/371 (28%), Gaps = 69/371 (18%)
Query: 184 SLSNLSSLTVMSLFNNSLSGSIPPILGNLKSLSTLGLHINQLNGVIPPSIGNLSSLRNLS 243
+ S + ++ +L + + N ++ + +
Sbjct: 7 HHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHS----AWRQANSNNPQIET 62
Query: 244 LFNNRLYGFVPKEIGYLKS--LSKLEFCANHLSGVIPHSVGNLTGLVLLNMCENHLFGPI 301
L + LE + L P L+ L + + L +
Sbjct: 63 RTGRALKAT-ADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGL-MEL 119
Query: 302 PKSLRNLTSLERVRFNQNNLYGKVYEAFGDHPNLTFLDLSQNNFYCEISFNWRNFSKLGT 361
P +++ LE L L++N
Sbjct: 120 PDTMQQFAGLET------------------------LTLARNPL---------------- 139
Query: 362 FNASMNNIYGSIPPEIGDSSKLQVLDLSSNHIFGKIP---------VQLVKLFSLNKLIL 412
++P I ++L+ L + + ++P + L +L L L
Sbjct: 140 ---------RALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRL 190
Query: 413 SLNQLFGGVPLEFGTLTELQYLDLSANKLSSSIPMSIGNLLKLHYLNLSNNQFSHKIPTE 472
+ +P L L+ L + + LS+ + +I +L KL L+L P
Sbjct: 191 EWTGI-RSLPASIANLQNLKSLKIRNSPLSA-LGPAIHHLPKLEELDLRGCTALRNYPPI 248
Query: 473 FEKLIHLSELDLSHNILQEEIPPQICKMESLEKLNLSHNNLSDFIPRCFEEMRSLSWIDI 532
F L L L +P I ++ LEKL+L +P ++ + I +
Sbjct: 249 FGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILV 308
Query: 533 SYNELQGPIPN 543
+ +
Sbjct: 309 PPHLQAQLDQH 319
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 173 bits (440), Expect = 1e-48
Identities = 72/290 (24%), Positives = 130/290 (44%), Gaps = 36/290 (12%)
Query: 636 VLYEEITKATGNFGEKYCIGKGGQRSVYKAELPSGNIFAVKKFKAELFSDETANPSEFLN 695
+ +IT G++ IG G +VYK + G++ AVK + + F N
Sbjct: 21 IPDGQIT-----VGQR--IGSGSFGTVYKGKW-HGDV-AVKMLNVTAPTPQQLQ--AFKN 69
Query: 696 EVLALTEIRHRNIIKFHGFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVI 755
EV L + RH NI+ F G+ + Q + IV ++ SL L +F + +++
Sbjct: 70 EVGVLRKTRHVNILLFMGYSTAPQLA-IVTQWCEGSSLYHHLHASE--TKFEMKKLIDIA 126
Query: 756 KGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLE--PHSSNWTEFA 813
+ A + YLH I+HRD+ S N+ L + + DFG A S + + +
Sbjct: 127 RQTARGMDYLHA---KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLS 183
Query: 814 GTVGYAAPEL---AYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNM--IIE 868
G++ + APE+ + + + DVY+FG++ E++ G P +S+I+N IIE
Sbjct: 184 GSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLP-------YSNINNRDQIIE 236
Query: 869 V--NQILDHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLL 916
+ L L + +++ +M CL + + RP+ + +
Sbjct: 237 MVGRGSLSPDLSKVRSNCPKRMKRLMA---ECLKKKRDERPSFPRILAEI 283
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 172 bits (439), Expect = 3e-48
Identities = 69/285 (24%), Positives = 111/285 (38%), Gaps = 37/285 (12%)
Query: 648 FGEKYCIGKG--GQRSVYKAELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRH 705
GE +GKG GQ K V K L + FL EV + + H
Sbjct: 14 HGEV--LGKGCFGQ--AIKVTHRETGEVMVMKE---LIRFDEETQRTFLKEVKVMRCLEH 66
Query: 706 RNIIKFHGFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYL 765
N++KF G + + EY+ G+L I++ ++ W+QR++ K +A+ ++YL
Sbjct: 67 PNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKS--MDSQYPWSQRVSFAKDIASGMAYL 124
Query: 766 HHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLE--------------PHSSNWTE 811
H I+HRD++S N L+ V+DFG A+ + P
Sbjct: 125 HS---MNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYT 181
Query: 812 FAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQ 871
G + APE+ EK DV+SFG++ E+I + M +N
Sbjct: 182 VVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLP-----RTMDFGLNV 236
Query: 872 ILDHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLL 916
P + I C +PE RP+ ++ + L
Sbjct: 237 RGFLDRYCPP-NCPPSFFPITV---RCCDLDPEKRPSFVKLEHWL 277
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 171 bits (436), Expect = 6e-48
Identities = 67/299 (22%), Positives = 115/299 (38%), Gaps = 51/299 (17%)
Query: 653 CIGKGGQRSVYKAELPSGNIFAVKKFKAELFSDETANPSEFLNE--VLALTEIRHRNIIK 710
C+GKG V++ G AVK F + + + E + +RH NI+
Sbjct: 15 CVGKGRYGEVWRGSW-QGENVAVKIFSSR-------DEKSWFRETELYNTVMLRHENILG 66
Query: 711 FHGFCSNAQHS----FIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLH 766
F ++HS +++ Y GSL L+ + ++ +A+ L++LH
Sbjct: 67 FIASDMTSRHSSTQLWLITHYHEMGSLYDYLQL----TTLDTVSCLRIVLSIASGLAHLH 122
Query: 767 HD-----CIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSS----NWTEFAGTVG 817
+ P I HRD+ SKN+L+ + ++D G A ++ GT
Sbjct: 123 IEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKR 182
Query: 818 YAAPEL------AYTMRATEKYDVYSFGVLALEVIKGYHPGDFVST----------IFSS 861
Y APE+ + ++ D+++FG++ EV + V S
Sbjct: 183 YMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPS 242
Query: 862 ISNMIIEVNQILDHRLPTPSRDVTD----KLRSIMEVAILCLVENPEARPTMKEVCNLL 916
+M V R P+R +D L +M+ C +NP AR T + L
Sbjct: 243 FEDMRKVVCV-DQQRPNIPNRWFSDPTLTSLAKLMK---ECWYQNPSARLTALRIKKTL 297
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 168 bits (427), Expect = 2e-46
Identities = 75/318 (23%), Positives = 116/318 (36%), Gaps = 56/318 (17%)
Query: 638 YEEITKATGNFGEKYCIGKGGQRSVYKAELPSGNIFAVKKFKAELFSDETANPSEFLNE- 696
E + N IG+G +VYK L AVK F N F+NE
Sbjct: 5 ASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFA-------NRQNFINEK 56
Query: 697 -VLALTEIRHRNIIKFHGFC-----SNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQ 750
+ + + H NI +F +V EY GSL L W
Sbjct: 57 NIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSL----HTSDWVS 112
Query: 751 RMNVIKGVANALSYLHHD------CIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEP 804
+ V L+YLH + P I HRD++S+NVL+ ++ +SDFG + L
Sbjct: 113 SCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTG 172
Query: 805 HSSNWTEF--------AGTVGYAAPE-------LAYTMRATEKYDVYSFGVLALEVI--- 846
+ GT+ Y APE L A ++ D+Y+ G++ E+
Sbjct: 173 NRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRC 232
Query: 847 KGYHPGDFVSTI----------FSSISNMIIEVNQILDHRLPTPSRDVTDK--LRSIMEV 894
PG+ V + +M + V++ R P + +RS+ E
Sbjct: 233 TDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSR-EKQRPKFPEAWKENSLAVRSLKET 291
Query: 895 AILCLVENPEARPTMKEV 912
C ++ EAR T +
Sbjct: 292 IEDCWDQDAEARLTAQXA 309
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 168 bits (428), Expect = 2e-46
Identities = 62/303 (20%), Positives = 107/303 (35%), Gaps = 51/303 (16%)
Query: 648 FGEKYCIGKGGQRSVYKAELPSGNIFAVKKFKAELFSDETANPSEFLNE--VLALTEIRH 705
E IGKG V++ + G AVK F + + E + +RH
Sbjct: 46 LQES--IGKGRFGEVWRGKW-RGEEVAVKIFSSR-------EERSWFREAEIYQTVMLRH 95
Query: 706 RNIIKFHGFCSNAQHS----FIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANA 761
NI+ F + + ++V +Y GSL L + + + A+
Sbjct: 96 ENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR----YTVTVEGMIKLALSTASG 151
Query: 762 LSYLHHD-----CIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSS----NWTEF 812
L++LH + P I HRD+ SKN+L+ ++D G A + +
Sbjct: 152 LAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHR 211
Query: 813 AGTVGYAAPEL------AYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTI---FSSIS 863
GT Y APE+ + ++ D+Y+ G++ E+ + G + +
Sbjct: 212 VGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLV 271
Query: 864 NMIIEVNQILD------HRLPTPSR----DVTDKLRSIMEVAILCLVENPEARPTMKEVC 913
V ++ R P+R + + IM C N AR T +
Sbjct: 272 PSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMR---ECWYANGAARLTALRIK 328
Query: 914 NLL 916
L
Sbjct: 329 KTL 331
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 167 bits (425), Expect = 5e-46
Identities = 63/298 (21%), Positives = 103/298 (34%), Gaps = 49/298 (16%)
Query: 653 CIGKGGQRSVYKAELPSGNIFAVKKFKAELFSDETANPSEFLNE--VLALTEIRHRNIIK 710
IGKG V+ + G AVK F + + E + +RH NI+
Sbjct: 44 QIGKGRYGEVWMGKW-RGEKVAVKVFFTTEEA-------SWFRETEIYQTVLMRHENILG 95
Query: 711 FHGFCSNAQHS----FIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLH 766
F S +++ +Y GSL L+ + + + L +LH
Sbjct: 96 FIAADIKGTGSWTQLYLITDYHENGSLYDYLKS----TTLDAKSMLKLAYSSVSGLCHLH 151
Query: 767 -----HDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNW----TEFAGTVG 817
P I HRD+ SKN+L+ ++D G A ++ GT
Sbjct: 152 TEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKR 211
Query: 818 YAAPEL------AYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTI---FSSISNMIIE 868
Y PE+ ++ D+YSFG++ EV + G V + +
Sbjct: 212 YMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPS 271
Query: 869 VNQILD------HRLPTPSRDVTD----KLRSIMEVAILCLVENPEARPTMKEVCNLL 916
+ + R P+R +D ++ +M C NP +R T V L
Sbjct: 272 YEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTE---CWAHNPASRLTALRVKKTL 326
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 6e-43
Identities = 74/372 (19%), Positives = 129/372 (34%), Gaps = 49/372 (13%)
Query: 20 LSKLQYLDLGNNQLSGVIPPEIGKLNQLRRLYLDVNQLHGTIPPVIGQLSLINELVFCHN 79
+ L++G + L+ +P + + L + N L ++P + +L L N
Sbjct: 39 NNGNAVLNVGESGLT-TLPDCLPA--HITTLVIPDNNLT-SLPALPPELR---TLEVSGN 91
Query: 80 NVSGRIPSSLGNLSNLALLYLNDNSLFGSIPIVMGNLKSLSTLDLSQNQLNGSIPCSLDN 139
++ +P L L++ L L L + NQL S+P
Sbjct: 92 QLT-SLPVLPPGLLELSIFSNPLTHL-------PALPSGLCKLWIFGNQLT-SLPVLPPG 142
Query: 140 LSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSENRLSGLIPLSLSNLSSLTVMSLFNN 199
L L + N L+ +P++ L L N+L+ L P+ S L L+ + +N
Sbjct: 143 LQELS---VSDNQLAS-LPALPSELCK---LWAYNNQLTSL-PMLPSGLQELS---VSDN 191
Query: 200 SLSGSIPPILGNLKSLSTLGLHINQLNGVIPPSIGNLSSLRNLSLFNNRLYGFVPKEIGY 259
L+ S+P + L L + L P L+ L + NRL +P
Sbjct: 192 QLA-SLPTLPSELYKLWAYNNRLTSL----PALPSG---LKELIVSGNRL-TSLPVLPS- 241
Query: 260 LKSLSKLEFCANHLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLRNLTSLERVRFNQN 319
L +L N L+ +P L L + N L +P+SL +L+S V N
Sbjct: 242 --ELKELMVSGNRLTS-LPMLPSGLLSLSVYR---NQL-TRLPESLIHLSSETTVNLEGN 294
Query: 320 NLYGKVYEAFGDHPNLTFLDLSQNNFYCEISFNWRNFSKLGTFNASMNNIYGSIPPEIGD 379
L + +A + + F + R L A +P G+
Sbjct: 295 PLSERTLQALREITSAPGYSGPIIRFDMAGASAPRETRALHLAAA-----DWLVPAREGE 349
Query: 380 SSKLQVLDLSSN 391
+ +
Sbjct: 350 PAPADRWHMFGQ 361
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 148 bits (374), Expect = 3e-37
Identities = 76/421 (18%), Positives = 131/421 (31%), Gaps = 94/421 (22%)
Query: 92 LSNLALLYLNDNSLFGSIPIVMGNLKSLSTLDLSQNQLNGSIPCSLDNLSNLDTLFLYKN 151
+ A+L + ++ L ++P + ++TL + N L S+P L L+ + N
Sbjct: 39 NNGNAVLNVGESGL-TTLPDCLP--AHITTLVIPDNNLT-SLPALPPELRTLE---VSGN 91
Query: 152 SLSGPIPSVIGNLKSLLQLDLSENRLSGLIPLSLSNLSSLTVMSLFNNSLSGSIPPILGN 211
L+ +P + L L L L S L + +F N L+ S+P +
Sbjct: 92 QLTS-LPVLPPGLLELSIFSNPLTHLPAL-------PSGLCKLWIFGNQLT-SLPVLPPG 142
Query: 212 LKSLSTLGLHINQLNGVIPPSIGNLSSLRNLSLFNNRLYGFVPKEIGYLKSLSKLEFCAN 271
L+ LS + L P L L +NN+L +P L+ LS N
Sbjct: 143 LQELSVSDNQLASL----PALPSEL---CKLWAYNNQL-TSLPMLPSGLQELS---VSDN 191
Query: 272 HLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLRNLTSLERVRFNQNNLYGKVYEAFGD 331
L+ +P L L N N L +P L L
Sbjct: 192 QLA-SLPTLPSELYKLWAYN---NRL-TSLPALPSGLKEL-------------------- 226
Query: 332 HPNLTFLDLSQNNFYCEISFNWRNFSKLGTFNASMNNIYGSIPPEIGDSSKLQVLDLSSN 391
+S N S+P +L+ L +S N
Sbjct: 227 -------IVSGNRL-------------------------TSLPVLPS---ELKELMVSGN 251
Query: 392 HIFGKIPVQLVKLFSLNKLILSLNQLFGGVPLEFGTLTELQYLDLSANKLSSSIPMSIGN 451
+ +P+ L SL+ + NQL +P L+ ++L N LS ++
Sbjct: 252 RL-TSLPMLPSGLLSLS---VYRNQL-TRLPESLIHLSSETTVNLEGNPLSERTLQALRE 306
Query: 452 LLKLHYLNLSNNQFSHKIPTEFEKLIHLSELDLSHNILQEEIPPQICKMESLEKLNLSHN 511
+ + +F + + L + L + + N
Sbjct: 307 ITSAPGYSGPIIRFDMAGASAPRETRALHLAAA--DWLVPAREGEPAPADRWHMFGQEDN 364
Query: 512 N 512
Sbjct: 365 A 365
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 6e-37
Identities = 70/316 (22%), Positives = 118/316 (37%), Gaps = 41/316 (12%)
Query: 2 LNLGFNLLFGNIPPQIGNLSKLQYLDLGNNQLSGVIPPEIGKLNQLRRLYLDVNQLHGTI 61
L + N L ++P L + L++ NQL+ +P L +L + L
Sbjct: 66 LVIPDNNL-TSLPALPPEL---RTLEVSGNQLT-SLPVLPPGLLELSIFSNPLTHL---- 116
Query: 62 PPVIGQLSLINELVFCHNNVSGRIPSSLGNLSNLALLYLNDNSLFGSIPIVMGNLKSLST 121
P + L + N +P L L ++DN L S+P + L
Sbjct: 117 PALPSGLCKLW----IFGNQLTSLPVLPPGLQE---LSVSDNQL-ASLPALPSELCK--- 165
Query: 122 LDLSQNQLNGSIPCSLDNLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSENRLSGLI 181
L NQL S+P L L + N L+ +P++ L L NRL+ L
Sbjct: 166 LWAYNNQLT-SLPMLPSGLQELS---VSDNQLAS-LPTLPSELYK---LWAYNNRLTSL- 216
Query: 182 PLSLSNLSSLTVMSLFNNSLSGSIPPILGNLKSLSTLGLHINQLNGVIPPSIGNLSSLRN 241
P S L L + N L+ S+P + LK L + N+L +P L +
Sbjct: 217 PALPSGLKELI---VSGNRLT-SLPVLPSELKELM---VSGNRLTS-LPMLPSG---LLS 265
Query: 242 LSLFNNRLYGFVPKEIGYLKSLSKLEFCANHLSGVIPHSVGNLTGLVLLNMCENHLFGPI 301
LS++ N+L +P+ + +L S + + N LS ++ +T +
Sbjct: 266 LSVYRNQL-TRLPESLIHLSSETTVNLEGNPLSERTLQALREITSAPGYSGPIIRFDMAG 324
Query: 302 PKSLRNLTSLERVRFN 317
+ R +L +
Sbjct: 325 ASAPRETRALHLAAAD 340
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 4e-36
Identities = 78/412 (18%), Positives = 139/412 (33%), Gaps = 116/412 (28%)
Query: 116 LKSLSTLDLSQNQLNGSIPCSLDNLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSEN 175
+ L++ ++ L ++P L +++ TL + N+L+ +P++ L++L ++S N
Sbjct: 39 NNGNAVLNVGESGLT-TLPDCL--PAHITTLVIPDNNLTS-LPALPPELRTL---EVSGN 91
Query: 176 RLSGLIPLSLSNLSSLTVMSLFNNSLSGSIPPILGNLKSLSTLGLHINQLNGVIPPSIGN 235
+L+ S+P + L LS + L +
Sbjct: 92 QLT-------------------------SLPVLPPGLLELSIFSNPLTHLPAL------- 119
Query: 236 LSSLRNLSLFNNRLYGFVPKEIGYLKSLSKLEFCANHLSGVIPHSVGNLTGLVLLNMCEN 295
S L L +F N+L P L +L N L+ +P L L N N
Sbjct: 120 PSGLCKLWIFGNQLTSL-PVLPP---GLQELSVSDNQLA-SLPALPSELCKLWAYN---N 171
Query: 296 HLFGPIPKSLRNLTSLERVRFNQNNLYGKVYEAFGDHPNLTFLDLSQNNFYCEISFNWRN 355
L +P L L +S N
Sbjct: 172 QL-TSLPMLPSGLQEL---------------------------SVSDNQL---------- 193
Query: 356 FSKLGTFNASMNNIYGSIPPEIGDSSKLQVLDLSSNHIFGKIPVQLVKLFSLNKLILSLN 415
S+P +L L +N + +P L +LI+S N
Sbjct: 194 ---------------ASLPTLPS---ELYKLWAYNNRL-TSLPALPS---GLKELIVSGN 231
Query: 416 QLFGGVPLEFGTLTELQYLDLSANKLSSSIPMSIGNLLKLHYLNLSNNQFSHKIPTEFEK 475
+L +P+ +EL+ L +S N+L+S +PM L L++ NQ + +P
Sbjct: 232 RL-TSLPVL---PSELKELMVSGNRLTS-LPMLPSGL---LSLSVYRNQLTR-LPESLIH 282
Query: 476 LIHLSELDLSHNILQEEIPPQICKMESLEKLNLSHNNLSDFIPRCFEEMRSL 527
L + ++L N L E + ++ S + E R+L
Sbjct: 283 LSSETTVNLEGNPLSERTLQALREITSAPGYSGPIIRFDMAGASAPRETRAL 334
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 130 bits (327), Expect = 2e-31
Identities = 72/373 (19%), Positives = 126/373 (33%), Gaps = 92/373 (24%)
Query: 165 KSLLQLDLSENRLSGLIPLSLSNLSSLTVMSLFNNSLSGSIPPILGNLKSLSTLGLHINQ 224
+ + S R + + + + V+++ + L+ ++P L ++TL + N
Sbjct: 16 RRAAPAEESRGRAAVVQKMRACLNNGNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNN 72
Query: 225 LNGVIPPSIGNLSSLRNLSLFNNRLYGFVPKEIGYLKSLSKLEFCANHLSGVIPHSVGNL 284
L +P L R L + N+L +P L LS HL +
Sbjct: 73 LT-SLPALPPEL---RTLEVSGNQLT-SLPVLPPGLLELSIFSNPLTHLPAL-------P 120
Query: 285 TGLVLLNMCENHLFGPIPKSLRNLTSLERVRFNQNNLYGKVYEAFGDHPNLTFLDLSQNN 344
+GL L + N L +P P L L +S N
Sbjct: 121 SGLCKLWIFGNQLTS-LPVLP---------------------------PGLQELSVSDNQ 152
Query: 345 FYCEISFNWRNFSKLGTFNASMNNIYGSIPPEIGDSSKLQVLDLSSNHIFGKIPVQLVKL 404
S+P +L L +N + +P+
Sbjct: 153 L-------------------------ASLPALPS---ELCKLWAYNNQL-TSLPMLP--- 180
Query: 405 FSLNKLILSLNQLFGGVPLEFGTLTELQYLDLSANKLSSSIPMSIGNLLKLHYLNLSNNQ 464
L +L +S NQL +P L +L + N+L+S +P L L +S N+
Sbjct: 181 SGLQELSVSDNQL-ASLPTLPSELYKLWAYN---NRLTS-LPALPSGL---KELIVSGNR 232
Query: 465 FSHKIPTEFEKLIHLSELDLSHNILQEEIPPQICKMESLEKLNLSHNNLSDFIPRCFEEM 524
+ +P L EL +S N L +P L L++ N L+ +P +
Sbjct: 233 LTS-LPVL---PSELKELMVSGNRL-TSLPMLPS---GLLSLSVYRNQLTR-LPESLIHL 283
Query: 525 RSLSWIDISYNEL 537
S + +++ N L
Sbjct: 284 SSETTVNLEGNPL 296
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 77.2 bits (190), Expect = 1e-14
Identities = 39/204 (19%), Positives = 72/204 (35%), Gaps = 40/204 (19%)
Query: 2 LNLGFNLLFGNIPPQIGNLSKL-----------------QYLDLGNNQLSGVIPPEIGKL 44
L++ N L ++P L KL + L + N+L+ +P
Sbjct: 186 LSVSDNQL-ASLPTLPSELYKLWAYNNRLTSLPALPSGLKELIVSGNRLTS-LPVLPS-- 241
Query: 45 NQLRRLYLDVNQLHGTIPPVIGQLSLINELVFCHNNVSGRIPSSLGNLSNLALLYLNDNS 104
+L+ L + N+L ++P + L ++ + N R+P SL +LS+ + L N
Sbjct: 242 -ELKELMVSGNRL-TSLPMLPSGLLSLS----VYRNQLTRLPESLIHLSSETTVNLEGNP 295
Query: 105 LFGSIPIVMGNLKSLSTLDLSQNQLN------GSIPCSLDNLSNLDTLFLYKNSLSGPIP 158
L + L+ +++ + S P L +L P P
Sbjct: 296 L---SERTLQALREITSAPGYSGPIIRFDMAGASAPRETRALHLAAADWLVPAREGEPAP 352
Query: 159 ----SVIGNLKSLLQLDLSENRLS 178
+ G + L +RLS
Sbjct: 353 ADRWHMFGQEDNADAFSLFLDRLS 376
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 59.1 bits (143), Expect = 4e-09
Identities = 17/90 (18%), Positives = 30/90 (33%), Gaps = 8/90 (8%)
Query: 454 KLHYLNLSNNQFSHKIPTEFEKLIHLSELDLSHNILQEEIPPQICKMESLEKLNLSHNNL 513
LN+ + + +P H++ L + N L +P + L L +S N L
Sbjct: 41 GNAVLNVGESGLTT-LPDCLPA--HITTLVIPDNNLTS-LPALPPE---LRTLEVSGNQL 93
Query: 514 SDFIPRCFEEMRSLSWIDISYNELQGPIPN 543
+ +P + LS L
Sbjct: 94 TS-LPVLPPGLLELSIFSNPLTHLPALPSG 122
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 1e-42
Identities = 83/392 (21%), Positives = 146/392 (37%), Gaps = 24/392 (6%)
Query: 85 IPSSLGNLSNLALLYLNDNSLFGSIPIVMGNLKSLSTLDLSQNQLNGSIPCSLDNLSNLD 144
I S+L ++++ + L + + + + LD+ ++
Sbjct: 13 IDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVE 72
Query: 145 TLFLYKNSLSGPIPSVIGNLKSLLQLDLSENRLSGLIPLSLSNLSSLTVMSLFNNSLSGS 204
L L + ++ +L + N + L P N+ LTV+ L N LS S
Sbjct: 73 LLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS-S 131
Query: 205 IPP-ILGNLKSLSTLGLHINQLNGVIPPSIGNLSSLRNLSLFNNRLYGFVPKEIGYLKSL 263
+P I N L+TL + N L + + +SL+NL L +NRL ++ + SL
Sbjct: 132 LPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHV---DLSLIPSL 188
Query: 264 SKLEFCANHLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLRNLTSLERVRFNQNNLYG 323
N LS ++ + L+ N + LT L + NNL
Sbjct: 189 FHANVSYNLLS-----TLAIPIAVEELDASHNSINVVRGPVNVELTIL---KLQHNNL-- 238
Query: 324 KVYEAFGDHPNLTFLDLSQNNFYCEISFN-WRNFSKLGTFNASMNNIYGSIPPEIGDSSK 382
++P L +DLS N +I ++ + +L S N + ++
Sbjct: 239 TDTAWLLNYPGLVEVDLSYNELE-KIMYHPFVKMQRLERLYISNNRL-VALNLYGQPIPT 296
Query: 383 LQVLDLSSNHIFGKIPVQLVKLFSLNKLILSLNQLFGGVPLEFGTLTELQYLDLSANKLS 442
L+VLDLS NH+ + + L L L N + V L+ T L+ L LS N
Sbjct: 297 LKVLDLSHNHL-LHVERNQPQFDRLENLYLDHNSI---VTLKLSTHHTLKNLTLSHNDWD 352
Query: 443 SSIPMSIGNLLKLHYLNLSNNQFSHKIPTEFE 474
+ ++ + + + KI + E
Sbjct: 353 CNSLRAL--FRNVARPAVDDADQHCKIDYQLE 382
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 3e-42
Identities = 71/426 (16%), Positives = 145/426 (34%), Gaps = 49/426 (11%)
Query: 102 DNSLFGSIPIVMGNLKSLSTLDLSQNQLNGSIPCSLDNLSNLDTLFLYKNSLSGPIPSVI 161
+ I + + + + L+N + +++ +++
Sbjct: 6 RQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALL 65
Query: 162 GNLKSLLQLDLSENRLSGLIPLSLSNLSSLTVMSLFNNSLSGSIPP-ILGNLKSLSTLGL 220
+ + + L+L++ ++ + + + ++ + + N++ +PP + N+ L+ L L
Sbjct: 66 DSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVL 124
Query: 221 HINQLNGVIPPSIGNLSSLRNLSLFNNRLYGFVPKEIGYLKSLSKLEFCANHLSGVIPHS 280
N L+ + N L LS+ NN L SL L+ +N L+ V
Sbjct: 125 ERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHV---D 181
Query: 281 VGNLTGLVLLNMCENHLFGPIPKSLRNLTSLERVRFNQNNLYGKVYEAFGDHPNLTFLDL 340
+ + L N+ N L +L ++E + + N++ LT L L
Sbjct: 182 LSLIPSLFHANVSYNLL-----STLAIPIAVEELDASHNSINVVRGPVN---VELTILKL 233
Query: 341 SQNNFYCEISFNWRNFSKLGTFNASMNNIYGSIPPEIGDSSKLQVLDLSSNHIFGKIPVQ 400
NN + + + L +DLS N + +
Sbjct: 234 QHNNL--------------------------TDTAWLLNYPGLVEVDLSYNELEKIMYHP 267
Query: 401 LVKLFSLNKLILSLNQLFGGVPLEFGTLTELQYLDLSANKLSSSIPMSIGNLLKLHYLNL 460
VK+ L +L +S N+L + L + L+ LDLS N L + + +L L L
Sbjct: 268 FVKMQRLERLYISNNRL-VALNLYGQPIPTLKVLDLSHNHL-LHVERNQPQFDRLENLYL 325
Query: 461 SNNQFSHKIPTEFEKLIHLSELDLSHNILQEEIPPQICKMESLEKLNLSHNNLSDFIPRC 520
+N + L L LSHN + + +D +
Sbjct: 326 DHNSIVT-LK--LSTHHTLKNLTLSHNDWDC-----NSLRALFRNVARPAVDDADQHCKI 377
Query: 521 FEEMRS 526
++
Sbjct: 378 DYQLEH 383
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 2e-40
Identities = 70/336 (20%), Positives = 128/336 (38%), Gaps = 22/336 (6%)
Query: 14 PPQIGNLSKLQYLDLGNNQLSGVIPPEIGKLNQLRRLYLDVNQLHGTIPPVI-GQLSLIN 72
+ L+ + + N+ + + + Q+ L L+ Q+ I I
Sbjct: 38 GFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIE-EIDTYAFAYAHTIQ 96
Query: 73 ELVFCHNNVSGRIPSSLGNLSNLALLYLNDNSLFGSIPI-VMGNLKSLSTLDLSQNQLNG 131
+L N + P N+ L +L L N L S+P + N L+TL +S N L
Sbjct: 97 KLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDL-SSLPRGIFHNTPKLTTLSMSNNNLER 155
Query: 132 SIPCSLDNLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSENRLSGLIPLSLSNLSSL 191
+ ++L L L N L+ + + + SL ++S N LS +L+ ++
Sbjct: 156 IEDDTFQATTSLQNLQLSSNRLTH-VD--LSLIPSLFHANVSYNLLS-----TLAIPIAV 207
Query: 192 TVMSLFNNSLSGSIPPILGNLKSLSTLGLHINQLNGVIPPSIGNLSSLRNLSLFNNRLYG 251
+ +NS++ + L+ L L N L + N L + L N L
Sbjct: 208 EELDASHNSIN-VVRG--PVNVELTILKLQHNNLTDT--AWLLNYPGLVEVDLSYNELEK 262
Query: 252 FVPKEIGYLKSLSKLEFCANHLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLRNLTSL 311
+ ++ L +L N L + + L +L++ NHL + ++ L
Sbjct: 263 IMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHL-LHVERNQPQFDRL 320
Query: 312 ERVRFNQNNLYGKVYEAFGDHPNLTFLDLSQNNFYC 347
E + + N++ V H L L LS N++ C
Sbjct: 321 ENLYLDHNSI---VTLKLSTHHTLKNLTLSHNDWDC 353
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 7e-16
Identities = 33/162 (20%), Positives = 61/162 (37%), Gaps = 9/162 (5%)
Query: 2 LNLGFNLLFGNIPPQIGNLSKLQYLDLGNNQLSGVIPPEIGKLNQLRRLYLDVNQLHGTI 61
L L N L + N L +DL N+L ++ K+ +L RLY+ N+L +
Sbjct: 231 LKLQHNNL--TDTAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-AL 287
Query: 62 PPVIGQLSLINELVFCHNNVSGRIPSSLGNLSNLALLYLNDNSLFGSIPIVMGNLKSLST 121
+ + L HN++ + + L LYL+ NS+ ++ + +L
Sbjct: 288 NLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSI-VTLKL--STHHTLKN 343
Query: 122 LDLSQNQLNGSIPCSLDNLSNLDTLFLYKNSLSGPIPSVIGN 163
L LS N + + N+ + I + +
Sbjct: 344 LTLSHNDWDCN--SLRALFRNVARPAVDDADQHCKIDYQLEH 383
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 4e-42
Identities = 50/315 (15%), Positives = 104/315 (33%), Gaps = 19/315 (6%)
Query: 2 LNLGFNLLFGNIPPQIGNLSKLQYLDLGNNQLSGVIPPEIGKLNQLRRLYLDVNQLHGTI 61
+ + L + + ++ LDL N LS + ++ +L L L N L
Sbjct: 15 EKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVL--YE 72
Query: 62 PPVIGQLSLINELVFCHNNVSGRIPSSLGNLSNLALLYLNDNSLFGSIPIVMGNLKSLST 121
+ LS + L +N V L ++ L+ +N++ + +
Sbjct: 73 TLDLESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNI-SRVSC--SRGQGKKN 124
Query: 122 LDLSQNQLNGSIPCSLDNLSNLDTLFLYKNSLSG-PIPSVIGNLKSLLQLDLSENRLSGL 180
+ L+ N++ S + L L N + + + +L L+L N + +
Sbjct: 125 IYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV 184
Query: 181 IPLSLSNLSSLTVMSLFNNSLSGSIPPILGNLKSLSTLGLHINQLNGVIPPSIGNLSSLR 240
+ L + L +N L+ + P + ++ + L N+L +I ++ +L
Sbjct: 185 KG--QVVFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLE 240
Query: 241 NLSLFNNRLYGFVPKEIGYLKSLSKLEFCANHLSGVIPHSVGNLTGLVLL---NMCENHL 297
+ L N + + K+ + + + T L C L
Sbjct: 241 HFDLRGNGFHC-GTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDL 299
Query: 298 FGPIPKSLRNLTSLE 312
P L L
Sbjct: 300 PAPFADRLIALGHHH 314
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 3e-41
Identities = 54/334 (16%), Positives = 109/334 (32%), Gaps = 21/334 (6%)
Query: 13 IPPQIGNLSKLQYLDLGNNQLSGVIPPEIGKLNQLRRLYLDVNQLHGTIPPVIGQLSLIN 72
I N ++ + + ++ L + ++ L L N L + + +
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 73 ELVFCHNNVSGRIPSSLGNLSNLALLYLNDNSLFGSIPIVMGNLKSLSTLDLSQNQLNGS 132
L N + L +LS L L LN+N + + S+ TL + N ++
Sbjct: 62 LLNLSSNVLYE--TLDLESLSTLRTLDLNNNYV-QELL----VGPSIETLHAANNNIS-R 113
Query: 133 IPCSLDNLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSENRLSGL-IPLSLSNLSSL 191
+ ++L N ++ G + LDL N + + ++ +L
Sbjct: 114 VS--CSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTL 171
Query: 192 TVMSLFNNSLSGSIPPILGNLKSLSTLGLHINQLNGVIPPSIGNLSSLRNLSLFNNRLYG 251
++L N + + + L TL L N+L + P + + + +SL NN+L
Sbjct: 172 EHLNLQYNFIY-DVKGQV-VFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKL-V 227
Query: 252 FVPKEIGYLKSLSKLEFCANHLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLRNLTSL 311
+ K + + ++L + N G L N + K L
Sbjct: 228 LIEKALRFSQNLEHFDLRGNGFHC------GTLRDFFSKNQRVQTVAKQTVKKLTGQNEE 281
Query: 312 ERVRFNQNNLYGKVYEAFGDHPNLTFLDLSQNNF 345
E + E + L ++
Sbjct: 282 ECTVPTLGHYGAYCCEDLPAPFADRLIALGHHHH 315
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 7e-39
Identities = 66/382 (17%), Positives = 116/382 (30%), Gaps = 68/382 (17%)
Query: 108 SIPIVMGNLKSLSTLDLSQNQLNGSIPCSLDNLSNLDTLFLYKNSLSGPIPSVIGNLKSL 167
+I + N ++ + L ++ + N+ L L N LS + + L
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 168 LQLDLSENRLSGLIPLSLSNLSSLTVMSLFNNSLSGSIPPILGNLKSLSTLGLHINQLNG 227
L+LS N L + L +LS+L + L NN + L S+ TL N ++
Sbjct: 61 ELLNLSSNVLYETLDLE--SLSTLRTLDLNNNYVQE-----LLVGPSIETLHAANNNIS- 112
Query: 228 VIPPSIGNLSSLRNLSLFNNRLYGFVPKEIGYLKSLSKLEFCANHLSGV-IPHSVGNLTG 286
+ S +N+ L NN++ + G + L+ N + V +
Sbjct: 113 RVSCSR--GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDT 170
Query: 287 LVLLNMCENHLFGPIPKSLRNLTSLERVRFNQNNLYGKVYEAFGDHPNLTFLDLSQNNFY 346
L LN+ N + ++ L LDLS N
Sbjct: 171 LEHLNLQYNFI-----YDVKGQVVF---------------------AKLKTLDLSSNKL- 203
Query: 347 CEISFNWRNFSKLGTFNASMNNIYGSIPPEIGDSSKLQVLDLSSNHIFGKIPVQLVKLFS 406
+ PE ++ + + L +N + I L +
Sbjct: 204 ------------------------AFMGPEFQSAAGVTWISLRNNKL-VLIEKALRFSQN 238
Query: 407 LNKLILSLNQLFGGVPLE-FGTLTELQYLDLSANKLSSSIPMSIGNLLKLHYLNLSNNQF 465
L L N G + F +Q + K + + L
Sbjct: 239 LEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVK---KLTGQNEEECTVPTLGHYGAYC 295
Query: 466 SHKIPTEF-EKLIHLSELDLSH 486
+P F ++LI L H
Sbjct: 296 CEDLPAPFADRLIALGHHHHHH 317
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 2e-37
Identities = 60/334 (17%), Positives = 117/334 (35%), Gaps = 21/334 (6%)
Query: 85 IPSSLGNLSNLALLYLNDNSLFGSIPIVMGNLKSLSTLDLSQNQLNGSIPCSLDNLSNLD 144
I N + + + D+SL ++ + + ++ LDLS N L+ L + L+
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 145 TLFLYKNSLSGPIPSVIGNLKSLLQLDLSENRLSGLIPLSLSNLSSLTVMSLFNNSLSGS 204
L L N L + + +L +L LDL+ N + L S+ + NN++S
Sbjct: 62 LLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS-R 113
Query: 205 IPPILGNLKSLSTLGLHINQLNGVIPPSIGNLSSLRNLSLFNNRLYGF-VPKEIGYLKSL 263
+ + + L N++ + G S ++ L L N + + +L
Sbjct: 114 VSC--SRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTL 171
Query: 264 SKLEFCANHLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLRNLTSLERVRFNQNNLYG 323
L N + + V L L++ N L + ++ + + N L
Sbjct: 172 EHLNLQYNFIY-DVKGQV-VFAKLKTLDLSSNKL-AFMGPEFQSAAGVTWISLRNNKL-V 227
Query: 324 KVYEAFGDHPNLTFLDLSQNNFYCEISFNWRNFSKLGTFNASMNNIYGSIPPEIGDSSKL 383
+ +A NL DL N F+C ++ FSK + + + +
Sbjct: 228 LIEKALRFSQNLEHFDLRGNGFHCGTLRDF--FSKNQRVQTVAKQTVKKLTGQNEEECTV 285
Query: 384 QVLDLSSNHIFGKIPVQLVKLFSLNKLILSLNQL 417
L + +P F+ + L +
Sbjct: 286 PTLGHYGAYCCEDLP----APFADRLIALGHHHH 315
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 3e-37
Identities = 65/352 (18%), Positives = 111/352 (31%), Gaps = 62/352 (17%)
Query: 157 IPSVIGNLKSLLQLDLSENRLSGLIPLSLSNLSSLTVMSLFNNSLSGSIPPILGNLKSLS 216
I + N ++++ L + + ++ + L N LS L L
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 217 TLGLHINQLNGVIPPSIGNLSSLRNLSLFNNRLYGFVPKEIGYLKSLSKLEFCANHLSGV 276
L L N L + +LS+LR L L NN + +E+ S+ L N++S V
Sbjct: 62 LLNLSSNVLYET--LDLESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNISRV 114
Query: 277 IPHSVGNLTGLVLLNMCENHLFGPIPKSLRNLTSLERVRFNQNNLYGKVYEAFGDHPNLT 336
S G + + N + T L G +
Sbjct: 115 ---SCSRGQGKKNIYLANNKI-----------TMLRD-------------LDEGCRSRVQ 147
Query: 337 FLDLSQNNFYCEISFNWRNFSKLGTFNASMNNIYGSIPPEIGDSSKLQVLDLSSNHIFGK 396
+LDL N + + S L+ L+L N I+
Sbjct: 148 YLDLKLNEI-----------DTV------------NFAELAASSDTLEHLNLQYNFIY-D 183
Query: 397 IPVQLVKLFSLNKLILSLNQLFGGVPLEFGTLTELQYLDLSANKLSSSIPMSIGNLLKLH 456
+ V L L LS N+L + EF + + ++ L NKL I ++ L
Sbjct: 184 VK-GQVVFAKLKTLDLSSNKL-AFMGPEFQSAAGVTWISLRNNKLVL-IEKALRFSQNLE 240
Query: 457 YLNLSNNQFSH-KIPTEFEKLIHLSELDLSHNILQEEIPPQICKMESLEKLN 507
+ +L N F + F K + + + C + +L
Sbjct: 241 HFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYG 292
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 9e-37
Identities = 49/263 (18%), Positives = 100/263 (38%), Gaps = 15/263 (5%)
Query: 277 IPHSVGNLTGLVLLNMCENHLFGPIPKSLRNLTSLERVRFNQNNLYGKVYEAFGDHPNLT 336
I N + + ++ L + ++ +++ + + N L L
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 337 FLDLSQNNFYCEISFNWRNFSKLGTFNASMNNIYGSIPPEIGDSSKLQVLDLSSNHIFGK 396
L+LS N Y + + S L T + + N + E+ ++ L ++N+I +
Sbjct: 62 LLNLSSNVLYETLDL--ESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNI-SR 113
Query: 397 IPVQLVKLFSLNKLILSLNQLFGGVPLEFGTLTELQYLDLSANKLSS-SIPMSIGNLLKL 455
+ + L+ N++ L+ G + +QYLDL N++ + + + L
Sbjct: 114 VSCSR--GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTL 171
Query: 456 HYLNLSNNQFSHKIPTEFEKLIHLSELDLSHNILQEEIPPQICKMESLEKLNLSHNNLSD 515
+LNL N + + L LDLS N L + P+ + ++L +N L
Sbjct: 172 EHLNLQYNFIY-DVKGQV-VFAKLKTLDLSSNKL-AFMGPEFQSAAGVTWISLRNNKLVL 228
Query: 516 FIPRCFEEMRSLSWIDISYNELQ 538
I + ++L D+ N
Sbjct: 229 -IEKALRFSQNLEHFDLRGNGFH 250
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 3e-14
Identities = 22/95 (23%), Positives = 43/95 (45%), Gaps = 2/95 (2%)
Query: 444 SIPMSIGNLLKLHYLNLSNNQFSHKIPTEFEKLIHLSELDLSHNILQEEIPPQICKMESL 503
+I N + ++++ + + + ++ ELDLS N L + + L
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 504 EKLNLSHNNLSDFIPRCFEEMRSLSWIDISYNELQ 538
E LNLS N L + + E + +L +D++ N +Q
Sbjct: 61 ELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQ 93
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 4e-08
Identities = 12/74 (16%), Positives = 28/74 (37%)
Query: 469 IPTEFEKLIHLSELDLSHNILQEEIPPQICKMESLEKLNLSHNNLSDFIPRCFEEMRSLS 528
I + ++ + L++ + ++++L+LS N LS L
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 529 WIDISYNELQGPIP 542
+++S N L +
Sbjct: 62 LLNLSSNVLYETLD 75
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 7e-42
Identities = 96/404 (23%), Positives = 158/404 (39%), Gaps = 35/404 (8%)
Query: 118 SLSTLDLSQNQLNGSIPCSLDNLSNLDTLFLYKNSLSGPIPS-VIGNLKSLLQLDLSENR 176
++ +DLS N + S L +L L + + + I + L SL+ L L N+
Sbjct: 31 HVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQ 90
Query: 177 LSGLIPLSLSNLSSLTVMSLFNNSL-SGSIPP-ILGNLKSLSTLGLHINQLNGVIPPSI- 233
L + + L++L V++L +L + L SL L L N + + P S
Sbjct: 91 FLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFF 150
Query: 234 GNLSSLRNLSLFNNRLYGFVPKEIGYLKSLSKLEFCANHLSGVIPHSVGNLTGLVLLNMC 293
N+ L L N++ + +E L + F ++ L+ + L +M
Sbjct: 151 LNMRRFHVLDLTFNKV-KSICEED--LLNFQGKHF-----------TLLRLSSITLQDMN 196
Query: 294 ENHLFGPIPKSLRNLTSLERVRFNQNNLYGKVYEAFGDHPNLTFL-DLSQNNFYCEISFN 352
E L + TS+ + + N + + F D T + L +N Y S
Sbjct: 197 EYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSF 256
Query: 353 WRNFSKLGTFNASMNNIYGSIPPEIGDSSKLQVLDLSSNHIFGKIPVQL-VKLFSLNKLI 411
F N + + S ++ DLS + IF + + L +L
Sbjct: 257 GHT-----NFKDPDNFTFKGLEA-----SGVKTCDLSKSKIF-ALLKSVFSHFTDLEQLT 305
Query: 412 LSLNQLFGGVPLEFGTLTELQYLDLSANKLSSSIPMSIGNLLKLHYLNLSNNQFSHKIPT 471
L+ N++ F LT L L+LS N L S NL KL L+LS N +
Sbjct: 306 LAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRA-LGD 364
Query: 472 E-FEKLIHLSELDLSHNILQEEIPPQI-CKMESLEKLNLSHNNL 513
+ F L +L EL L N L+ +P I ++ SL+K+ L N
Sbjct: 365 QSFLGLPNLKELALDTNQLKS-VPDGIFDRLTSLQKIWLHTNPW 407
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 3e-37
Identities = 82/464 (17%), Positives = 157/464 (33%), Gaps = 93/464 (20%)
Query: 12 NIPPQIGNLSKLQYLDLGNNQLSGVIPPEIGKLNQLRRLYLDVNQLHGTIPPVIGQLSLI 71
+P + Y+DL N ++ + +L L+ L ++ I
Sbjct: 27 ELPAHV------NYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIR--------- 71
Query: 72 NELVFCHNNVSGRIPSSLGNLSNLALLYLNDNSLFGSIPI-VMGNLKSLSTLDLSQNQLN 130
++ LS+L +L L+ N + L +L L L+Q L+
Sbjct: 72 --------------NNTFRGLSSLIILKLDYNQF-LQLETGAFNGLANLEVLTLTQCNLD 116
Query: 131 GSI--PCSLDNLSNLDTLFLYKNSLSGPIP-SVIGNLKSLLQLDLSENRLSGLIPLSLSN 187
G++ L++L+ L L N++ P S N++ LDL+ N++ + L N
Sbjct: 117 GAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLN 176
Query: 188 LSSLTVMSLFNNSLSGSIPPILGNLKSLSTLGLHINQLNGVIPPSIGNLSSLRNLSLFNN 247
L L S++ ++ L + +S+ L L N
Sbjct: 177 FQGKHFTLL--------------RLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGN 222
Query: 248 RLYGFVPKEIGYLKSLSKLEFCANHLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLRN 307
+ K + +K++ + + + + + P + +
Sbjct: 223 GFKESMAKRFFDAIAGTKIQSLIL-----------SNSYNMGSSFGHTNFKDPDNFTFKG 271
Query: 308 L--TSLERVRFNQNNLYGKVYEAFGDHPNLTFLDLSQNNFYCEISFNWRNFSKLGTFNAS 365
L + ++ +++ ++ + F +L L L+QN
Sbjct: 272 LEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEI-------------------- 311
Query: 366 MNNIYGSIPPEIGDS-SKLQVLDLSSNHIFGKIPVQL-VKLFSLNKLILSLNQLFGGVPL 423
I + L L+LS N + G I ++ L L L LS N + +
Sbjct: 312 -----NKIDDNAFWGLTHLLKLNLSQNFL-GSIDSRMFENLDKLEVLDLSYNHI-RALGD 364
Query: 424 E-FGTLTELQYLDLSANKLSSSIPMSI-GNLLKLHYLNLSNNQF 465
+ F L L+ L L N+L S+P I L L + L N +
Sbjct: 365 QSFLGLPNLKELALDTNQL-KSVPDGIFDRLTSLQKIWLHTNPW 407
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 1e-30
Identities = 67/378 (17%), Positives = 119/378 (31%), Gaps = 57/378 (15%)
Query: 2 LNLGFNLLFGNIPPQI-GNLSKLQYLDLGNNQLSGVIPPEI-GKLNQLRRLYLDVNQLHG 59
L + I LS L L L NQ + L L L L L G
Sbjct: 59 LKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFL-QLETGAFNGLANLEVLTLTQCNLDG 117
Query: 60 T-IPP-VIGQLSLINELVFCHNNVSGRIPSSL-GNLSNLALLYLNDNSL----------F 106
+ L+ + LV NN+ P+S N+ +L L N + F
Sbjct: 118 AVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNF 177
Query: 107 GSIPIVMGNLKSLSTLDLSQNQLNGSIPCSLDNLSNLDTLFLYKNSLSGPIPSVIGNLKS 166
+ L S++ D+++ L + +++ TL L N + + +
Sbjct: 178 QGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIA 237
Query: 167 LLQL-------------DLSENRLSGLIPLSLSNL--SSLTVMSLFNNSLSGSIPP-ILG 210
++ + L S + L + + ++ +
Sbjct: 238 GTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIF-ALLKSVFS 296
Query: 211 NLKSLSTLGLHINQLNGVIPPSIGNLSSLRNLSLFNNRLYGFVPKEIGYLKSLSKLEFCA 270
+ L L L N++N + + L+ L L+L N L S+ F
Sbjct: 297 HFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFL-----------GSIDSRMF-- 343
Query: 271 NHLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLRNLTSLERVRFNQNNLYGKVYEAFG 330
NL L +L++ NH+ +S L +L+ + + N L F
Sbjct: 344 -----------ENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLKSVPDGIFD 392
Query: 331 DHPNLTFLDLSQNNFYCE 348
+L + L N + C
Sbjct: 393 RLTSLQKIWLHTNPWDCS 410
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 80.2 bits (198), Expect = 7e-16
Identities = 34/176 (19%), Positives = 58/176 (32%), Gaps = 18/176 (10%)
Query: 372 SIPPEIGDSSKLQVLDLSSNHIFGKIPVQ-LVKLFSLNKLILSLNQLFGGVPLE-FGTLT 429
+P + +DLS N I ++ +L L L + + F L+
Sbjct: 27 ELPAHV------NYVDLSLNSI-AELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLS 79
Query: 430 ELQYLDLSANKLSSSIPMSI-GNLLKLHYLNLSNNQF-SHKIPTE-FEKLIHLSELDLSH 486
L L L N+ + L L L L+ + F+ L L L L
Sbjct: 80 SLIILKLDYNQFLQ-LETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRD 138
Query: 487 NILQEEIPPQI--CKMESLEKLNLSHNNLSDFIPRCFEEMRS--LSWIDISYNELQ 538
N +++ I P M L+L+ N + + + + +S LQ
Sbjct: 139 NNIKK-IQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQ 193
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 1e-41
Identities = 97/498 (19%), Positives = 174/498 (34%), Gaps = 59/498 (11%)
Query: 13 IPPQIGNLSKLQYLDLGNNQLSGVIPPEIGKLNQLRRLYLDVNQLHGTIPPVIGQLSLIN 72
+P + + + L L N +S + P+I L++LR L L N++ ++
Sbjct: 46 VPKDL--PPRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIR-SLDFH-------- 94
Query: 73 ELVFCHNNVSGRIPSSLGNLSNLALLYLNDNSLFGSIPIVMGNLKSLSTLDLSQNQLNGS 132
VF +L L ++ N L +I + SL LDLS N +
Sbjct: 95 --VF-------------LFNQDLEYLDVSHNRL-QNISC--CPMASLRHLDLSFNDFDVL 136
Query: 133 IPCSL-DNLSNLDTLFLYKNSL-SGPIPSVIGNLKSLLQLDLSENRLSGLIPLSLSNLSS 190
C NL+ L L L + V S + LDL + G SL +
Sbjct: 137 PVCKEFGNLTKLTFLGLSAAKFRQLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIP-N 195
Query: 191 LTVMSLFNNSLSGSIPPILGNLKSLSTLGLHINQLNGVIPPSIGNL-------SSLRNLS 243
TV+ L + S + ++ +L L L +LN + +L N++
Sbjct: 196 TTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVT 255
Query: 244 LFNNRLYGFVPKEIG---YLKSLSKLEFCANHLSGVIP-----HSVGNLTGLVLLNMCEN 295
L + ++ + + + L ++ I +S L L++ ++
Sbjct: 256 LQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQ 315
Query: 296 HLFGPIPKSLRNLTSLERVRFNQNNLYGKVYEAFGDHPNLTFLDLSQNNFYCEISFNWRN 355
+ + ++ + TFL+ +QN F +
Sbjct: 316 VFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCST 375
Query: 356 FSKLGTFNASMNNIYGSIPPEIGDSSKLQVLDLSSNHI----FGKIPVQLVKLFSLNKLI 411
+L T N + + + + L+ + S+ L
Sbjct: 376 LKRLQTLILQRNGL-KNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLN 434
Query: 412 LSLNQLFGGVPLEFGTLTE-LQYLDLSANKLSSSIPMSIGNLLKLHYLNLSNNQFSHKIP 470
LS N L G V F L ++ LDL N++ SIP + +L L LN+++NQ +P
Sbjct: 435 LSSNMLTGSV---FRCLPPKVKVLDLHNNRI-MSIPKDVTHLQALQELNVASNQLKS-VP 489
Query: 471 TE-FEKLIHLSELDLSHN 487
F++L L + L N
Sbjct: 490 DGVFDRLTSLQYIWLHDN 507
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 2e-40
Identities = 92/483 (19%), Positives = 167/483 (34%), Gaps = 33/483 (6%)
Query: 75 VFCHNNVSGRIPSSLGNLSNLALLYLNDNSLFGSIPIVMGNLKSLSTLDLSQNQLNGSIP 134
V N +P L L+ NS+ + L L L LS N++ S+
Sbjct: 36 VDYSNRNLTHVPK--DLPPRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIR-SLD 92
Query: 135 CSL-DNLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSENRLSGLIPLSL-SNLSSLT 192
+ +L+ L + N L I + SL LDLS N L NL+ LT
Sbjct: 93 FHVFLFNQDLEYLDVSHNRLQN-ISC--CPMASLRHLDLSFNDFDVLPVCKEFGNLTKLT 149
Query: 193 VMSLFNNSL-SGSIPPILGNLKSLSTLGLHINQLNGVIPPSIGNLSSLRNLSLFNNRLYG 251
+ L + P+ S L L + G S+ ++ L L +
Sbjct: 150 FLGLSAAKFRQLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTV-LHLVFHPNSL 208
Query: 252 FVPKEIGYLKSLSKLEFCANHLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLRN---- 307
F + + +L L+ L+ + + ++ ++
Sbjct: 209 FSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVK 268
Query: 308 ------LTSLERVRFNQNNLYGKVYEAFGDH-----PNLTFLDLSQNNFYCEISFNWRNF 356
+E + + ++ + +L + F + F
Sbjct: 269 LFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVF 328
Query: 357 SKLGTFNASMNNIYGSIPPEIGDSSKLQVLDLSSNHIFGKIPVQLVKLFSLNKLILSLNQ 416
+++ S+++ S L+ + N + L L LIL N
Sbjct: 329 AEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNG 388
Query: 417 L--FGGVPLEFGTLTELQYLDLSANKLSSSI-PMSIGNLLKLHYLNLSNNQFSHKIPTEF 473
L F V L ++ L+ LD+S N L+S + + LNLS+N + + F
Sbjct: 389 LKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSV---F 445
Query: 474 EKL-IHLSELDLSHNILQEEIPPQICKMESLEKLNLSHNNLSDFIPRCFEEMRSLSWIDI 532
L + LDL +N + IP + +++L++LN++ N L F+ + SL +I +
Sbjct: 446 RCLPPKVKVLDLHNNRIMS-IPKDVTHLQALQELNVASNQLKSVPDGVFDRLTSLQYIWL 504
Query: 533 SYN 535
N
Sbjct: 505 HDN 507
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 7e-29
Identities = 87/456 (19%), Positives = 147/456 (32%), Gaps = 71/456 (15%)
Query: 2 LNLGFNLLFGNIPPQIGNLSKLQYLDLGNNQLSGV-IPPEIGKLNQLRRLYLDVNQLHGT 60
L++ N L NI ++ L++LDL N + + E G L +L L L +
Sbjct: 105 LDVSHNRL-QNISC--CPMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQL 161
Query: 61 IPPVIGQLSLINELVFCHNNVSGRIPSSLGNLSNLALLYLNDNSLFGSIPIVMGNLKSLS 120
+ L L L+ + + + N +L+L + V ++ +L
Sbjct: 162 DLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALG 221
Query: 121 TLDLSQNQLNGSIPCSLDNL-------SNLDTLFLYKNSLSGPIPSVIGNL---KSLLQL 170
L LS +LN L L + L + + + + L
Sbjct: 222 HLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYL 281
Query: 171 DLSENRLSGLIPL-----SLSNLSSLTVMSLFNNSLSGSIPPILGNLKSLSTLGLHINQL 225
++ ++ I S + L SL + + N S + ++ L I+
Sbjct: 282 NIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDT 341
Query: 226 NGVIPPSIGNLSSLRNLSLFNNRLYGFVPKEIGYLKSLSKLEFCANHLSGV--IPHSVGN 283
+ + SS L+ N V + LK L L N L + N
Sbjct: 342 PFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKN 401
Query: 284 LTGLVLLNMCENHLFGPIPKSLRNLTSLERVRFNQNNLYGKVYEAFGDHPNLTFLDLSQN 343
++ L L++ N L ++ L+LS N
Sbjct: 402 MSSLETLDVSLNSL-----------------------NSHAYDRTCAWAESILVLNLSSN 438
Query: 344 NFYCEISFNWRNFSKLGTFNASMNNIYGSIPPEIGDSSKLQVLDLSSNHIFGKIPVQLVK 403
+ F L K++VLDL +N I IP +
Sbjct: 439 MLTGSV------FRCL--------------------PPKVKVLDLHNNRI-MSIPKDVTH 471
Query: 404 LFSLNKLILSLNQLFGGVPLEFGTLTELQYLDLSAN 439
L +L +L ++ NQL F LT LQY+ L N
Sbjct: 472 LQALQELNVASNQLKSVPDGVFDRLTSLQYIWLHDN 507
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 4e-25
Identities = 79/423 (18%), Positives = 132/423 (31%), Gaps = 66/423 (15%)
Query: 118 SLSTLDLSQNQLNGSIPCSLDNLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSENRL 177
S +D S L +P L L L +NS+S I L L L LS NR+
Sbjct: 32 LESMVDYSNRNLT-HVPKDL--PPRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRI 88
Query: 178 SGLIPLSLSNLSSLTVMSLFNNSLSGSIPPILGNLKSLSTLGLHINQLNGVIPPSI-GNL 236
L L + + +N L +I + SL L L N + + GNL
Sbjct: 89 RSLDFHVFLFNQDLEYLDVSHNRLQ-NISC--CPMASLRHLDLSFNDFDVLPVCKEFGNL 145
Query: 237 SSLRNLSLFNNRLYGFVPKEIGYLKSLSKLEFCANHLSGVIPHSVGNLTGLVLLNMCENH 296
+ L L L + + L L HLS +LL++ H
Sbjct: 146 TKLTFLGLSAAKF-----------RQLDLLPVAHLHLS------------CILLDLVSYH 182
Query: 297 LFGPIPKSLRNL-TSLERVRFNQNNLYGKVYEAFGDHPNLTFLDLSQNNFYCEISFNWRN 355
+ G +SL+ T++ + F+ N+L + L L LS E
Sbjct: 183 IKGGETESLQIPNTTVLHLVFHPNSL--FSVQVNMSVNALGHLQLSNIKLNDENCQRLMT 240
Query: 356 FSKLGTFNASMNNIYGSIPPEIGDSSKLQVLDLSSNHIFGKIPVQLVKLFSLNKLILSLN 415
F T ++ N+ ++ S +F Q + L +
Sbjct: 241 FLSELTRGPTLLNV---------TLQHIETTWKCSVKLF-----QFFWPRPVEYLNIYNL 286
Query: 416 QLFGGVPLEFGTLTELQYLDLSANKLSSSIPMSIGNLLKLHYLNLSNNQFSHKIPTEFEK 475
+ + E T +E L L ++ N F +
Sbjct: 287 TITERIDREEFTYSETA-------------------LKSLMIEHVKNQVFLFSKEALYSV 327
Query: 476 LIHLSELDLSHNILQEEIPPQICKMESLEKLNLSHNNLSDFIPRCFEEMRSLSWIDISYN 535
++ LS + S LN + N +D + + ++ L + + N
Sbjct: 328 FAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRN 387
Query: 536 ELQ 538
L+
Sbjct: 388 GLK 390
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 3e-23
Identities = 61/367 (16%), Positives = 111/367 (30%), Gaps = 48/367 (13%)
Query: 1 MLNLGFNLLFGNIPPQIGNLSKLQYLDLGNNQLSGVIPPEIGKLNQLRRLYLDVNQLHG- 59
+L+L + G + L L + S +N L L L +L+
Sbjct: 175 LLDLVSYHIKGGETESLQIP-NTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDE 233
Query: 60 ------TIPPVIGQLSLINELVFCHNNVS-GRIPSSLGNLSNLALLYLN--DNSLFGSIP 110
T + + + + H + + YLN + ++ I
Sbjct: 234 NCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERID 293
Query: 111 -----IVMGNLKSLSTLDLSQNQLNGSIPCSLDNLSNLDTLFLYKNSLSGPIPSVIGNLK 165
LKSL + S + ++ L + +
Sbjct: 294 REEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPS 353
Query: 166 SLLQLDLSENRLSGLIPLSLSNLSSLTVMSLFNNSLSGSIPPILGNLKSLSTLGLHINQL 225
S L+ ++N + + S L L + L N L + + K++S+L L
Sbjct: 354 SFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLK-NFFKVALMTKNMSSLETLDVSL 412
Query: 226 N----GVIPPSIGNLSSLRNLSLFNNRLYGFVPKEIGYLKSLSKLEFCANHLSGVIPHSV 281
N + S+ L+L +N L G V + + + L+ N + IP V
Sbjct: 413 NSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCL--PPKVKVLDLHNNRIM-SIPKDV 469
Query: 282 GNLTGLVLLNMCENHLFGPIPKSLRNLTSLERVRFNQNNLYGKVYEAFGDHPNLTFLDLS 341
+L L LN+ N L S+ F +L ++ L
Sbjct: 470 THLQALQELNVASN-----------QLKSVPD-------------GVFDRLTSLQYIWLH 505
Query: 342 QNNFYCE 348
N + C
Sbjct: 506 DNPWDCT 512
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 2e-40
Identities = 78/336 (23%), Positives = 127/336 (37%), Gaps = 28/336 (8%)
Query: 13 IPPQIGNLSKLQYLDLGNNQLSGVIPPEIGKLNQLRRLYLDVNQLHGTIPPVIGQLSLIN 72
+P I ++ + LDLG N++ + E L L L+ N + + P
Sbjct: 26 VPEGI--PTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVS-AVEP--------- 73
Query: 73 ELVFCHNNVSGRIPSSLGNLSNLALLYLNDNSLFGSIPI-VMGNLKSLSTLDLSQNQLNG 131
+ NL NL L L N L IP+ V L +L+ LD+S+N++
Sbjct: 74 --------------GAFNNLFNLRTLGLRSNRL-KLIPLGVFTGLSNLTKLDISENKIVI 118
Query: 132 SIPCSLDNLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSENRLSGLIPLSLSNLSSL 191
+ +L NL +L + N L L SL QL L + L+ + +LS+L L
Sbjct: 119 LLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGL 178
Query: 192 TVMSLFNNSLSGSIPPILGNLKSLSTLGLHINQLNGVIPPSIGNLSSLRNLSLFNNRLYG 251
V+ L + +++ L L L + + P+ +L +LS+ + L
Sbjct: 179 IVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTA 238
Query: 252 FVPKEIGYLKSLSKLEFCANHLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLRNLTSL 311
+ +L L L N +S + + L L + + L P + R L L
Sbjct: 239 VPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYL 298
Query: 312 ERVRFNQNNLYGKVYEAFGDHPNLTFLDLSQNNFYC 347
+ + N L F NL L L N C
Sbjct: 299 RVLNVSGNQLTTLEESVFHSVGNLETLILDSNPLAC 334
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 146 bits (369), Expect = 2e-37
Identities = 74/374 (19%), Positives = 129/374 (34%), Gaps = 53/374 (14%)
Query: 166 SLLQLDLSENRLSGLIPLSLSNLSSLTVMSLFNNSLSGSIPPILGNLKSLSTLGLHINQL 225
+ R +P + + ++ L N + + L L L+ N +
Sbjct: 12 QDRAVLCHRKRFVA-VPEGIP--TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIV 68
Query: 226 NGVIPPSIGNLSSLRNLSLFNNRLYGFVPKEIGYLKSLSKLEFCANHLSGVIPHSVGNLT 285
+ V P + NL +LR L L +NRL L +L+KL+ N + ++ + +L
Sbjct: 69 SAVEPGAFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLY 128
Query: 286 GLVLLNMCENHLFGPIPKSLRNLTSLERVRFNQNNLYGKVYEAFGDHPNLTFLDLSQNNF 345
L L + +N L + AF +L L L + N
Sbjct: 129 NLKSLEVGDNDL-----------VYISH-------------RAFSGLNSLEQLTLEKCNL 164
Query: 346 YCEISFNWRNFSKLGTFNASMNNIYGSIPPEIGDSSKLQVLDLSSNHIFGKIPVQLVKLF 405
I S L L VL L +I +L+
Sbjct: 165 T-SIPTEA--LSHL---------------------HGLIVLRLRHLNINAIRDYSFKRLY 200
Query: 406 SLNKLILSLNQLFGGVPLEFGTLTELQYLDLSANKLSSSIPMSIGNLLKLHYLNLSNNQF 465
L L +S + L L ++ L++ +++ +L+ L +LNLS N
Sbjct: 201 RLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPI 260
Query: 466 SHKIPTEFEKLIHLSELDLSHNILQEEIPPQICK-MESLEKLNLSHNNLSDFIPRCFEEM 524
S + +L+ L E+ L L + P + + L LN+S N L+ F +
Sbjct: 261 STIEGSMLHELLRLQEIQLVGGQLA-VVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSV 319
Query: 525 RSLSWIDISYNELQ 538
+L + + N L
Sbjct: 320 GNLETLILDSNPLA 333
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 1e-30
Identities = 58/266 (21%), Positives = 97/266 (36%), Gaps = 28/266 (10%)
Query: 285 TGLVLLNMCENHLFGPIPKSLRNLTSLERVRFNQNNLYGKVYEAFGDHPNLTFLDLSQNN 344
T LL++ +N + + LE + N+N + AF + NL L L N
Sbjct: 32 TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNR 91
Query: 345 FYCEISFNWRNFSKLGTFNASMNNIYGSIPPEI-GDSSKLQVLDLSSNHIFGKIPVQLVK 403
IP + S L LD+S N I +
Sbjct: 92 L-------------------------KLIPLGVFTGLSNLTKLDISENKIVILLDYMFQD 126
Query: 404 LFSLNKLILSLNQLFGGVPLEFGTLTELQYLDLSANKLSSSIPMSIGNLLKLHYLNLSNN 463
L++L L + N L F L L+ L L L+S ++ +L L L L +
Sbjct: 127 LYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHL 186
Query: 464 QFSHKIPTEFEKLIHLSELDLSHNILQEEIPPQICKMESLEKLNLSHNNLSDFIPRCFEE 523
+ F++L L L++SH + + P +L L+++H NL+
Sbjct: 187 NINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRH 246
Query: 524 MRSLSWIDISYNELQGPIPNSTAFKN 549
+ L ++++SYN + I S
Sbjct: 247 LVYLRFLNLSYNPIST-IEGS-MLHE 270
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 68.6 bits (168), Expect = 3e-12
Identities = 35/153 (22%), Positives = 49/153 (32%), Gaps = 24/153 (15%)
Query: 2 LNLGFNLLFGNIPPQIGNLSKLQYLDLGNNQLSGVIPPEIGKLNQLRRLYLDVNQLHGTI 61
L + + P L L + + L+ V + L LR L L N + TI
Sbjct: 205 LEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPIS-TI 263
Query: 62 PPVIGQLSLINELVFCHNNVSGRIPSSLGNLSNLALLYLNDNSLFGSIPIVMGNLKSLST 121
S L L L + L L P L L
Sbjct: 264 E-----------------------GSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRV 300
Query: 122 LDLSQNQLNGSIPCSLDNLSNLDTLFLYKNSLS 154
L++S NQL ++ NL+TL L N L+
Sbjct: 301 LNVSGNQLTTLEESVFHSVGNLETLILDSNPLA 333
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 157 bits (397), Expect = 3e-40
Identities = 70/410 (17%), Positives = 141/410 (34%), Gaps = 68/410 (16%)
Query: 106 FGSIPIVMGNLKSLSTLDLSQNQLNGSIPCSLDNLSNLDTLFLYKNSLSGPIPSVIGNLK 165
+ I + + + + L+N + +++ +++ + +
Sbjct: 16 YKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFR 75
Query: 166 SLLQLDLSENRLSGLIPLSLSNLSSLTVMSLFNNSLSGSIPP-ILGNLKSLSTLGLHINQ 224
+ L+L++ ++ + + + ++ + + N++ +PP + N+ L+ L L N
Sbjct: 76 QVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERND 134
Query: 225 LNGVIPPSIGNLSSLRNLSLFNNRLYGFVPKEIGYLKSLSKLEFCANHLSGVIPHSVGNL 284
L+ + N L LS+ NN L SL L+ +N L+ V + +
Sbjct: 135 LSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHV---DLSLI 191
Query: 285 TGLVLLNMCENHLFGPIPKSLRNLTSLERVRFNQNNLYGKVYEAFGDHPNLTFLDLSQNN 344
L N+ N L +L ++E + + N++ LT L L N
Sbjct: 192 PSLFHANVSYNLL-----STLAIPIAVEELDASHNSINVVRGPVN---VELTILKLQHN- 242
Query: 345 FYCEISFNWRNFSKLGTFNASMNNIYGSIPPEIGDSSKLQVLDLSSNHIFGKIPVQLVKL 404
N + + L +DLS N + KI
Sbjct: 243 ----------NLTDTAWL---------------LNYPGLVEVDLSYNEL-EKIM------ 270
Query: 405 FSLNKLILSLNQLFGGVPLEFGTLTELQYLDLSANKLSSSIPMSIGNLLKLHYLNLSNNQ 464
F + L+ L +S N+L ++ + + L L+LS+N
Sbjct: 271 -----------------YHPFVKMQRLERLYISNNRL-VALNLYGQPIPTLKVLDLSHNH 312
Query: 465 FSHKIPTEFEKLIHLSELDLSHNILQEEIPPQICKMESLEKLNLSHNNLS 514
H + + L L L HN + + +L+ L LSHN+
Sbjct: 313 LLH-VERNQPQFDRLENLYLDHNSIV-TLKLST--HHTLKNLTLSHNDWD 358
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 1e-38
Identities = 84/475 (17%), Positives = 168/475 (35%), Gaps = 33/475 (6%)
Query: 15 PQIGNLSKLQYLDLGNNQLSGVIPPEIGKLNQLRRLYLDVNQLHGTIPPVI-GQLSLINE 73
+ L+ + + N+ + + + Q+ L L+ Q+ I I +
Sbjct: 45 FEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIE-EIDTYAFAYAHTIQK 103
Query: 74 LVFCHNNVSGRIPSSLGNLSNLALLYLNDNSLFGSIPI-VMGNLKSLSTLDLSQNQLNGS 132
L N + P N+ L +L L N L S+P + N L+TL +S N L
Sbjct: 104 LYMGFNAIRYLPPHVFQNVPLLTVLVLERNDL-SSLPRGIFHNTPKLTTLSMSNNNLERI 162
Query: 133 IPCSLDNLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSENRLSGLIPLSLSNLSSLT 192
+ ++L L L N L+ + + + SL ++S N LS +L+ ++
Sbjct: 163 EDDTFQATTSLQNLQLSSNRLTH-VD--LSLIPSLFHANVSYNLLS-----TLAIPIAVE 214
Query: 193 VMSLFNNSLSGSIPPILGNLKSLSTLGLHINQLNGVIPPSIGNLSSLRNLSLFNNRLYGF 252
+ +NS++ + L+ L L N L + N L + L N L
Sbjct: 215 ELDASHNSIN-VVRG--PVNVELTILKLQHNNLTDT--AWLLNYPGLVEVDLSYNELEKI 269
Query: 253 VPKEIGYLKSLSKLEFCANHLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLRNLTSLE 312
+ ++ L +L N L + + L +L++ NHL + ++ LE
Sbjct: 270 MYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLLH-VERNQPQFDRLE 327
Query: 313 RVRFNQNNLYGKVYEAFGDHPNLTFLDLSQNNFYCEISFNWRNFSKLGTFNASMNNIYGS 372
+ + N++ V H L L LS N++ C F + + +
Sbjct: 328 NLYLDHNSI---VTLKLSTHHTLKNLTLSHNDWDCNSLRAL--FRNVARPAVDDADQHCK 382
Query: 373 IPPEIGDSSKLQVLDLSSNHIFGKIPVQLVKLFSLNKLILSLNQLFGGVPLEFGTLTELQ 432
I ++ L +L++ +L ++ + + G T+ +Q
Sbjct: 383 IDYQLEHG-------LCCKESDKPYLDRLLQYIALTSVVEKVQRAQGRCS-ATDTINSVQ 434
Query: 433 YLDLSANKLSSSIPMSIGNL-LKLHYLNLSNNQFSHKIPTEFEKLIHLSELDLSH 486
L + L +++ L Q +++ + + L L ++
Sbjct: 435 SLSHYITQQGGVPLQGNEQLEAEVNELRAEVQQLTNEQIQQEQLLQGLHAEIDTN 489
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 8e-37
Identities = 86/532 (16%), Positives = 172/532 (32%), Gaps = 78/532 (14%)
Query: 37 IPPEIGKLNQLRRLYLDVNQLHGTIPPVIGQLSLINELVFCHNNVSGRIPSSLGNLSNLA 96
I + +++D+ L+ + F ++ + + L + +
Sbjct: 19 IDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVE 78
Query: 97 LLYLNDNSLFGSIPIVMGNLKSLSTLDLSQNQLNGSIPCSLDNLSNLDTLFLYKNSLSGP 156
LL LND + ++ L + N + P N+ L L L +N LS
Sbjct: 79 LLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSL 138
Query: 157 IPSVIGNLKSLLQLDLSENRLSGLIPLSLSNLSSLTVMSLFNNSLSGSIPPILGNLKSLS 216
+ N L L +S N L + + +SL + L +N L+ + + SL
Sbjct: 139 PRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT-HVDL--SLIPSLF 195
Query: 217 TLGLHINQLNGVIPPSIGNLSSLRNLSLFNNRLYGFVPKEIGYLKSLSKLEFCANHLSGV 276
+ N L+ ++ ++ L +N + V + L+ L+ N+L+
Sbjct: 196 HANVSYNLLS-----TLAIPIAVEELDASHNSI-NVVRGPV--NVELTILKLQHNNLTDT 247
Query: 277 IPHSVGNLTGLVLLNMCENHLFGPIPKSLRNLTSLERVRFNQNNLYGKVYEAFGDHPNLT 336
+ N GLV +++ N L + F L
Sbjct: 248 --AWLLNYPGLVEVDLSYN-----------ELEKIMY-------------HPFVKMQRLE 281
Query: 337 FLDLSQNNFYCEISFNWRNFSKLGTFNASMNNIYGSIPPEIGDSSKLQVLDLSSNHIFGK 396
L +S N ++ L+VLDLS NH+
Sbjct: 282 RLYISNNRL-------------------------VALNLYGQPIPTLKVLDLSHNHL-LH 315
Query: 397 IPVQLVKLFSLNKLILSLNQLFGGVPLEFGTLTELQYLDLSANKLSSSIPMSIGNLLKLH 456
+ + L L L N + V L+ T L+ L LS N + ++ +
Sbjct: 316 VERNQPQFDRLENLYLDHNSI---VTLKLSTHHTLKNLTLSHNDWDCNSLRAL--FRNVA 370
Query: 457 YLNLSNNQFSHKIPTEFEKLIHLSELD----------LSHNILQEEIPPQICKMESLEKL 506
+ + KI + E + E D ++ + E++ + + + +
Sbjct: 371 RPAVDDADQHCKIDYQLEHGLCCKESDKPYLDRLLQYIALTSVVEKVQRAQGRCSATDTI 430
Query: 507 NLSHNNLSDFIPRCFEEMRSLSWIDISYNELQGPIPNSTAFKNGLMEGNKGL 558
N + + ++ ++ NEL+ + T + + +GL
Sbjct: 431 NSVQSLSHYITQQGGVPLQGNEQLEAEVNELRAEVQQLTNEQIQQEQLLQGL 482
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 83.1 bits (205), Expect = 1e-16
Identities = 45/261 (17%), Positives = 87/261 (33%), Gaps = 23/261 (8%)
Query: 2 LNLGFNLLFGNIPPQIGNLSKLQYLDLGNNQLSGVIPPEIGKLNQLRRLYLDVNQLHGTI 61
L L N L + N L +DL N+L ++ K+ +L RLY+ N+L +
Sbjct: 237 LKLQHNNL--TDTAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-AL 293
Query: 62 PPVIGQLSLINELVFCHNNVSGRIPSSLGNLSNLALLYLNDNSLFGSIPIVMGNLKSLST 121
+ + L HN++ + + L LYL+ NS+ ++ + +L
Sbjct: 294 NLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSI-VTLKL--STHHTLKN 349
Query: 122 LDLSQNQLNGSIPCSLDNLSNLDTLFLYKNSLSGPIPSVIGN-------LKSLLQLDLSE 174
L LS N + + N+ + I + + K L L
Sbjct: 350 LTLSHNDWDCN--SLRALFRNVARPAVDDADQHCKIDYQLEHGLCCKESDKPYLDRLLQY 407
Query: 175 NRLSGLI---PLSLSNLSSLTVMSLFNNSLSGSIPPILGNLKSLSTLGLHINQL----NG 227
L+ ++ + S+ ++ + L+ L +N+L
Sbjct: 408 IALTSVVEKVQRAQGRCSATDTINSVQSLSHYITQQGGVPLQGNEQLEAEVNELRAEVQQ 467
Query: 228 VIPPSIGNLSSLRNLSLFNNR 248
+ I L+ L +
Sbjct: 468 LTNEQIQQEQLLQGLHAEIDT 488
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 56.5 bits (136), Expect = 3e-08
Identities = 11/109 (10%), Positives = 37/109 (33%), Gaps = 2/109 (1%)
Query: 430 ELQYLDLSANKLSSSIPMSIGNLLKLHYLNLSNNQFSHKIPTEFEKLIHLSELDLSHNIL 489
+ +Y I ++ + +++ E L + + ++ +
Sbjct: 4 QQRYNVKPRQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTM 63
Query: 490 QEEIPPQI-CKMESLEKLNLSHNNLSDFIPRCFEEMRSLSWIDISYNEL 537
++P + +E LNL+ + + F ++ + + +N +
Sbjct: 64 -RKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAI 111
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 1e-39
Identities = 71/286 (24%), Positives = 112/286 (39%), Gaps = 56/286 (19%)
Query: 646 GNFGEKYCIGKGGQRSVYKAELPSGNIF-AVKKFKAELFSDETANPSEFLNEVLALTEIR 704
GNFGE V+ L + N AVK + L D ++FL E L +
Sbjct: 125 GNFGE-----------VFSGRLRADNTLVAVKSCRETLPPDL---KAKFLQEARILKQYS 170
Query: 705 HRNIIKFHGFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSY 764
H NI++ G C+ Q +IV E + G T LR + + ++ A + Y
Sbjct: 171 HPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTE--GARLRVKTLLQMVGDAAAGMEY 228
Query: 765 LHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLE-----PHSSN------WTEFA 813
L +HRD++++N L+ + +SDFG ++ WT
Sbjct: 229 LESK---CCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWT--- 282
Query: 814 GTVGYAAPELAYTMRATEKYDVYSFGVLALEVI-KGYHPGDFVSTIFSSISNMIIEVNQI 872
APE R + + DV+SFG+L E G P + ++SN + +
Sbjct: 283 ------APEALNYGRYSSESDVWSFGILLWETFSLGASP-------YPNLSNQ--QTREF 327
Query: 873 LDH--RLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLL 916
++ RLP P D + +ME C P RP+ + L
Sbjct: 328 VEKGGRLPCP-ELCPDAVFRLME---QCWAYEPGQRPSFSTIYQEL 369
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 2e-39
Identities = 70/428 (16%), Positives = 146/428 (34%), Gaps = 48/428 (11%)
Query: 93 SNLALLYLNDNSLFGSIPIVMGNLKSLSTLDLSQNQLNGSIPCSLDNLSNLDTLFLYKNS 152
N A + + I L +L++LD + + + ++ L+ L L N+
Sbjct: 18 DNFASEVAAAFEMQATDTISEEQLATLTSLDCHNSSIT-DMT-GIEKLTGLTKLICTSNN 75
Query: 153 LSGPIPSVIGNLKSLLQLDLSENRLSGLIPLSLSNLSSLTVMSLFNNSLSGSIPPILGNL 212
++ + + +L L N+L+ L ++ L+ LT ++ N L+ + +
Sbjct: 76 ITT-LD--LSQNTNLTYLACDSNKLTN---LDVTPLTKLTYLNCDTNKLT-KLD--VSQN 126
Query: 213 KSLSTLGLHINQLNGVIPPSIGNLSSLRNLSLFNNRLYGFVPKEIGYLKSLSKLEFCANH 272
L+ L N L + + + + L L N+ ++ L+ L+ N
Sbjct: 127 PLLTYLNCARNTLTEI---DVSHNTQLTELDCHLNKK--ITKLDVTPQTQLTTLDCSFNK 181
Query: 273 LSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLRNLTSLERVRFNQNNLYGKVYEAFGDH 332
++ + V L LN N++ L L + + N L +
Sbjct: 182 ITEL---DVSQNKLLNRLNCDTNNITKL---DLNQNIQLTFLDCSSNKL--TEID-VTPL 232
Query: 333 PNLTFLDLSQNNFYCEISFNWRNFSKLGTFNASMNNIYGSIPPEIGDSSKLQVLDLSSNH 392
LT+ D S N + SKL T + ++ I + +++L
Sbjct: 233 TQLTYFDCSVNPL---TELDVSTLSKLTTLHCIQTDLL-EID--LTHNTQLIYFQAEGCR 286
Query: 393 IFGKIPVQLVKLFSLNKLILSLNQLFGGVPLEFGTLTELQYLDLSANKLSSSIPMSIGNL 452
++ + L L + L+ +L YL L+ +L+ + + +
Sbjct: 287 KIKELD--VTHNTQLYLLDCQAAGI---TELDLSQNPKLVYLYLNNTELTE---LDVSHN 338
Query: 453 LKLHYLNLSNNQFSHKIPTEFEKLIHLSELDLSHNILQEEIPPQICKMESL------EKL 506
KL L+ N K+ L+ + +P + SL + L
Sbjct: 339 TKLKSLSCVNAHIQ-DFS-SVGKIPALNNNFEAEGQTI-TMPKETLTNNSLTIAVSPDLL 395
Query: 507 NLSHNNLS 514
+ N ++
Sbjct: 396 DQFGNPMN 403
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 7e-36
Identities = 76/455 (16%), Positives = 151/455 (33%), Gaps = 62/455 (13%)
Query: 17 IGNLSKLQYLDLGNNQLSGVIPPEIGKLNQLRRLYLDVNQLHGTIPPVIGQLSLINELVF 76
L+ L LD N+ ++ + I KL L +L N + T+ + Q + + L
Sbjct: 38 EEQLATLTSLDCHNSSITDM--TGIEKLTGLTKLICTSNNI-TTLD--LSQNTNLTYLAC 92
Query: 77 CHNNVSGRIPSSLGNLSNLALLYLNDNSLFGSIPIVMGNLKSLSTLDLSQNQLNGSIPCS 136
N ++ + L+ L L + N L + + L+ L+ ++N L I S
Sbjct: 93 DSNKLTN---LDVTPLTKLTYLNCDTNKL---TKLDVSQNPLLTYLNCARNTLT-EIDVS 145
Query: 137 LDNLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSENRLSGLIPLSLSNLSSLTVMSL 196
+ + L L + N + + L LD S N+++ L +S L ++
Sbjct: 146 --HNTQLTELDCHLNKKITKLD--VTPQTQLTTLDCSFNKITE---LDVSQNKLLNRLNC 198
Query: 197 FNNSLSGSIPPILGNLKSLSTLGLHINQLNGVIPPSIGNLSSLRNLSLFNNRLYGFVPKE 256
N+++ + L L+ L N+L + + L+ L N L +
Sbjct: 199 DTNNIT-KLD--LNQNIQLTFLDCSSNKLTEI---DVTPLTQLTYFDCSVNPLTEL---D 249
Query: 257 IGYLKSLSKLEFCANHLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLRNLTSLERVRF 316
+ L L+ L L + + + T L+ + + + T L +
Sbjct: 250 VSTLSKLTTLHCIQTDLLEI---DLTHNTQLIYFQAEGCRKIKELD--VTHNTQLYLLDC 304
Query: 317 NQNNLYGKVYEAFGDHPNLTFLDLSQNNFYCEISFNWRNFSKLGTFNASMNNIYGSIPPE 376
+ +P L +L L+ + + +KL + + +I
Sbjct: 305 QAAGI---TELDLSQNPKLVYLYLNNTEL---TELDVSHNTKLKSLSCVNAHI--QDFSS 356
Query: 377 IGDSSKLQVLDLSSNHIFGKIPVQLVKLFSLNKLILSLNQLFGGVPLEFGTLTELQYLDL 436
+G L + + ++ K L+ N L V + LD
Sbjct: 357 VGKIPALNNNFEAEG-----------QTITMPKETLTNNSLTIAVSPD--------LLDQ 397
Query: 437 SANKLSSSIPMSIGNLLKLHYLNLSNNQFSHKIPT 471
N + +I G + ++ S P
Sbjct: 398 FGNPM--NIEPGDGGVYDQATNTITWENLSTDNPA 430
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 9e-35
Identities = 62/398 (15%), Positives = 139/398 (34%), Gaps = 41/398 (10%)
Query: 141 SNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSENRLSGLIPLSLSNLSSLTVMSLFNNS 200
N + + L +L LD + ++ + + L+ LT + +N+
Sbjct: 18 DNFASEVAAAFEMQATDTISEEQLATLTSLDCHNSSITDMTG--IEKLTGLTKLICTSNN 75
Query: 201 LSGSIPPILGNLKSLSTLGLHINQLNGVIPPSIGNLSSLRNLSLFNNRLYGFVPKEIGYL 260
++ ++ L +L+ L N+L + + L+ L L+ N+L ++
Sbjct: 76 IT-TLD--LSQNTNLTYLACDSNKLTNL---DVTPLTKLTYLNCDTNKLTKL---DVSQN 126
Query: 261 KSLSKLEFCANHLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLRNLTSLERVRFNQNN 320
L+ L N L+ + V + T L L+ N + + T L + + N
Sbjct: 127 PLLTYLNCARNTLTEI---DVSHNTQLTELDCHLNKKITKLD--VTPQTQLTTLDCSFNK 181
Query: 321 LYGKVYEAFGDHPNLTFLDLSQNNFYCEISFNWRNFSKLGTFNASMNNIYGSIPPEIGDS 380
+ + L L+ NN + +L + S N + I +
Sbjct: 182 ITE---LDVSQNKLLNRLNCDTNNI---TKLDLNQNIQLTFLDCSSNKLT-EID--VTPL 232
Query: 381 SKLQVLDLSSNHIFGKIPVQLVKLFSLNKLILSLNQLFGGVPLEFGTLTELQYLDLSANK 440
++L D S N + + + L L L L + ++ T+L Y +
Sbjct: 233 TQLTYFDCSVNPL---TELDVSTLSKLTTLHCIQTDL---LEIDLTHNTQLIYFQAEGCR 286
Query: 441 LSSSIPMSIGNLLKLHYLNLSNNQFSHKIPTEFEKLIHLSELDLSHNILQEEIPPQICKM 500
+ + + +L+ L+ + + + L L L++ L E+ +
Sbjct: 287 KIKELD--VTHNTQLYLLDCQAAGITEL---DLSQNPKLVYLYLNNTEL-TELD--VSHN 338
Query: 501 ESLEKLNLSHNNLSDFIPRCFEEMRSLSWIDISYNELQ 538
L+ L+ + ++ DF ++ +L+ + +
Sbjct: 339 TKLKSLSCVNAHIQDFSS--VGKIPALNNNFEAEGQTI 374
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 6e-34
Identities = 76/505 (15%), Positives = 157/505 (31%), Gaps = 99/505 (19%)
Query: 19 NLSKLQYLDLGNNQLSGVIPPEIGKLNQLRRLYLDVNQLHGTIPPVIGQLSLINELVFCH 78
N + + +L L L + + +
Sbjct: 19 NFASEVAAAFEMQATDTI---SEEQLATLTSLDCHNSSIT-DMTG--------------- 59
Query: 79 NNVSGRIPSSLGNLSNLALLYLNDNSLFGSIPIVMGNLKSLSTLDLSQNQLNGSIPCSLD 138
+ L+ L L N++ ++ + +L+ L N+L ++ +
Sbjct: 60 ----------IEKLTGLTKLICTSNNI-TTLDL--SQNTNLTYLACDSNKLT-NLD--VT 103
Query: 139 NLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSENRLSGLIPLSLSNLSSLTVMSLFN 198
L+ L L N L+ + L L+ + N L+ + +S+ + LT +
Sbjct: 104 PLTKLTYLNCDTNKLT---KLDVSQNPLLTYLNCARNTLT---EIDVSHNTQLTELDCHL 157
Query: 199 NSLSGSIPPILGNLKSLSTLGLHINQLNGVIPPSIGNLSSLRNLSLFNNRLYGFVPKEIG 258
N + + L+TL N++ + + L L+ N + ++
Sbjct: 158 NKKITKLD--VTPQTQLTTLDCSFNKITEL---DVSQNKLLNRLNCDTNNITKL---DLN 209
Query: 259 YLKSLSKLEFCANHLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLRNLTSLERVRFNQ 318
L+ L+ +N L+ + V LT L + N LT L+
Sbjct: 210 QNIQLTFLDCSSNKLTEI---DVTPLTQLTYFDCSVN-----------PLTELD------ 249
Query: 319 NNLYGKVYEAFGDHPNLTFLDLSQNNFYCEISFNWRNFSKLGTFNASMNNIYGSIPPEIG 378
LT L Q + + + + ++L F A + ++
Sbjct: 250 ----------VSTLSKLTTLHCIQTDL---LEIDLTHNTQLIYFQAEGCRKIKEL--DVT 294
Query: 379 DSSKLQVLDLSSNHIFGKIPVQLVKLFSLNKLILSLNQLFGGVPLEFGTLTELQYLDLSA 438
+++L +LD + I ++ + + L L L+ +L L+ T+L+ L
Sbjct: 295 HNTQLYLLDCQAAGI-TELDLS--QNPKLVYLYLNNTEL---TELDVSHNTKLKSLSCVN 348
Query: 439 NKLSSSIPMSIGNLLKLHYLNLSNNQFSHKIPTEFEKL-----IHLSELDLSHNILQEEI 493
+ S+G + L+ + Q + LD N + I
Sbjct: 349 AHI-QDFS-SVGKIPALNNNFEAEGQTITMPKETLTNNSLTIAVSPDLLDQFGNPMN--I 404
Query: 494 PPQICKMESLEKLNLSHNNLSDFIP 518
P + ++ NLS P
Sbjct: 405 EPGDGGVYDQATNTITWENLSTDNP 429
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 8e-25
Identities = 45/251 (17%), Positives = 86/251 (34%), Gaps = 26/251 (10%)
Query: 14 PPQIGNLSKLQYLDLGNNQLSGVIPPEIGKLNQLRRLYLDVNQLHGTIPPVIGQLSLINE 73
+ ++L LD N+++ + ++ + L RL D N + + + Q +
Sbjct: 163 KLDVTPQTQLTTLDCSFNKITEL---DVSQNKLLNRLNCDTNNIT-KLD--LNQNIQLTF 216
Query: 74 LVFCHNNVSGRIPSSLGNLSNLALLYLNDNSLFGSIPIVMGNLKSLSTLDLSQNQLNGSI 133
L N ++ + L+ L + N L + + L L+TL Q L
Sbjct: 217 LDCSSNKLTE---IDVTPLTQLTYFDCSVNPL-TELDV--STLSKLTTLHCIQTDLL--- 267
Query: 134 PCSLDNLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSENRLSGLIPLSLSNLSSLTV 193
+D N ++ + + L LD ++ L LS L
Sbjct: 268 --EIDLTHNTQLIYFQAEGCRKIKELDVTHNTQLYLLDCQAAGIT---ELDLSQNPKLVY 322
Query: 194 MSLFNNSLSGSIPPILGNLKSLSTLGLHINQLNGVIPPSIGNLSSLRNLSLFNNRLYGFV 253
+ L N L+ + + + L +L + S+G + +L N +
Sbjct: 323 LYLNNTELT-ELD--VSHNTKLKSLSCVNAHIQDF--SSVGKIPALNNNFEAEGQTITM- 376
Query: 254 PKEIGYLKSLS 264
PKE SL+
Sbjct: 377 PKETLTNNSLT 387
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 9e-07
Identities = 27/172 (15%), Positives = 62/172 (36%), Gaps = 17/172 (9%)
Query: 1 MLNLGFNLLFGNIPPQIGNLSKLQYLDLGNNQLSGVIPPEIGKLNQLRRLYLDVNQLHGT 60
++ + + ++L LD ++ + ++ + +L LYL+ +L
Sbjct: 277 LIYFQAEGCRKIKELDVTHNTQLYLLDCQAAGITEL---DLSQNPKLVYLYLNNTELT-E 332
Query: 61 IPPVIGQLSLINELVFCHNNVSGRIPSSLGNLSNLALLYLNDNSLFGSIPIVMGNLKSLS 120
+ + + + L + ++ SS+G + L + + ++P SL+
Sbjct: 333 LD--VSHNTKLKSLSCVNAHIQD--FSSVGKIPALNNNFEAEGQTI-TMPKETLTNNSLT 387
Query: 121 T------LDLSQNQLNGSIPCSLDNLSNLDTLFLYKNSLSGPIPSVIGNLKS 166
LD N +N I + + T + +LS P+V S
Sbjct: 388 IAVSPDLLDQFGNPMN--IEPGDGGVYDQATNTITWENLSTDNPAVTYTFTS 437
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 2e-39
Identities = 58/273 (21%), Positives = 112/273 (41%), Gaps = 32/273 (11%)
Query: 648 FGEKYCIGKGGQRSVYKA-ELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHR 706
F + IG+G ++VYK + + A + + + F E L ++H
Sbjct: 30 FDIE--IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQ--RFKEEAEMLKGLQHP 85
Query: 707 NIIKFHG----FCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANAL 762
NI++F+ + +V E + G+L T L+ K + + + L
Sbjct: 86 NIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKR---FKVMKIKVLRSWCRQILKGL 142
Query: 763 SYLHHDCIPPIVHRDISSKNVLLDSEY-EAHVSDFGFAKFLEPHSSNWTEFAGTVGYAAP 821
+LH PPI+HRD+ N+ + + D G A +S GT + AP
Sbjct: 143 QFLH-TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK--RASFAKAVIGTPEFMAP 199
Query: 822 ELAYTMRATEKYDVYSFGVLALEVIKGYHP---GDFVSTIFSSISNMIIEVNQILDHRLP 878
E+ Y + E DVY+FG+ LE+ +P + I+ +++ +
Sbjct: 200 EM-YEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKP---------A 249
Query: 879 TPSRDVTDKLRSIMEVAILCLVENPEARPTMKE 911
+ + +++ I+E C+ +N + R ++K+
Sbjct: 250 SFDKVAIPEVKEIIE---GCIRQNKDERYSIKD 279
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 2e-35
Identities = 69/279 (24%), Positives = 117/279 (41%), Gaps = 46/279 (16%)
Query: 646 GNFGEKYCIGKGGQRSVYKAELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRH 705
G FG V+ + + A+K + + + +F+ E + ++ H
Sbjct: 19 GQFGL-----------VHLGYWLNKDKVAIKTIR-----EGAMSEEDFIEEAEVMMKLSH 62
Query: 706 RNIIKFHGFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYL 765
+++ +G C +V E++ G L+ LR F+ + + V ++YL
Sbjct: 63 PKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQ--RGLFAAETLLGMCLDVCEGMAYL 120
Query: 766 --HHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGT---VGYAA 820
++HRD++++N L+ VSDFG +F+ +T GT V +A+
Sbjct: 121 EEAC-----VIHRDLAARNCLVGENQVIKVSDFGMTRFVL--DDQYTSSTGTKFPVKWAS 173
Query: 821 PELAYTMRATEKYDVYSFGVLALEVI-KGYHPGDFVSTIFSSISNMIIEVNQILD--HRL 877
PE+ R + K DV+SFGVL EV +G P + + SN EV + + RL
Sbjct: 174 PEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIP-------YENRSNS--EVVEDISTGFRL 224
Query: 878 PTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLL 916
P R + + IM C E PE RP + L
Sbjct: 225 YKP-RLASTHVYQIM---NHCWRERPEDRPAFSRLLRQL 259
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 2e-35
Identities = 71/258 (27%), Positives = 113/258 (43%), Gaps = 19/258 (7%)
Query: 2 LNLGFNLLFGNIPP-QIGNLSKLQYLDLGNNQLSGVIPPEIGKLNQLRRLYLDVNQLHGT 60
L+L N + I NL L L L NN++S + P L +L RLYL NQL
Sbjct: 57 LDLQNNKI-TEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK-E 114
Query: 61 IPPVIGQLSLINELVFCHNNVSGRIPSSLGNLSNLALLYLNDNSLFGSIPIVMG---NLK 117
+P + EL N ++ S L+ + ++ L N L S I G +K
Sbjct: 115 LPE--KMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPL-KSSGIENGAFQGMK 171
Query: 118 SLSTLDLSQNQLNGSIPCSLDNLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSENRL 177
LS + ++ + +IP L +L L L N ++ + + L +L +L LS N +
Sbjct: 172 KLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSI 228
Query: 178 SGLIPLSLSNLSSLTVMSLFNNSLSGSIPPILGNLKSLSTLGLHINQLNGV------IPP 231
S + SL+N L + L NN L +P L + K + + LH N ++ + P
Sbjct: 229 SAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPG 287
Query: 232 SIGNLSSLRNLSLFNNRL 249
+S +SLF+N +
Sbjct: 288 YNTKKASYSGVSLFSNPV 305
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 1e-31
Identities = 66/319 (20%), Positives = 120/319 (37%), Gaps = 49/319 (15%)
Query: 12 NIPPQIGNLSKLQYLDLGNNQLSGVIPPEIGKLNQLRRLYLDVNQLHGTIPPVIGQLSLI 71
++PP LDL NN+++ + + L L L L N++ I
Sbjct: 49 DLPPDT------ALLDLQNNKITEIKDGDFKNLKNLHTLILINNKIS-KIS--------- 92
Query: 72 NELVFCHNNVSGRIPSSLGNLSNLALLYLNDNSLFGSIPIVMGNLKSLSTLDLSQNQLNG 131
P + L L LYL+ N L +P K+L L + +N++
Sbjct: 93 --------------PGAFAPLVKLERLYLSKNQL-KELP--EKMPKTLQELRVHENEITK 135
Query: 132 SIPCSLDNLSNLDTLFLYKNSL-SGPIPS-VIGNLKSLLQLDLSENRLSGLIPLSLSNLS 189
+ L+ + + L N L S I + +K L + +++ ++ + +L+
Sbjct: 136 VRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQGLPPSLT 195
Query: 190 SLTVMSLFNNSLSGSIPP-ILGNLKSLSTLGLHINQLNGVIPPSIGNLSSLRNLSLFNNR 248
L L N ++ + L L +L+ LGL N ++ V S+ N LR L L NN+
Sbjct: 196 EL---HLDGNKIT-KVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNK 251
Query: 249 LYGFVPKEIGYLKSLSKLEFCANHLSGV------IPHSVGNLTGLVLLNMCENHL-FGPI 301
L VP + K + + N++S + P +++ N + + I
Sbjct: 252 LV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEI 310
Query: 302 PKSL-RNLTSLERVRFNQN 319
S R + V+
Sbjct: 311 QPSTFRCVYVRAAVQLGNY 329
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 2e-30
Identities = 65/260 (25%), Positives = 110/260 (42%), Gaps = 23/260 (8%)
Query: 2 LNLGFNLLFGNIPPQI-GNLSKLQYLDLGNNQLSGVIPPEIGKLNQLRRLYLDVNQLHGT 60
L L N + I P L KL+ L L NQL +P ++ L+ L + N++
Sbjct: 81 LILINNKI-SKISPGAFAPLVKLERLYLSKNQLK-ELPEKM--PKTLQELRVHENEIT-K 135
Query: 61 IPP-VIGQLSLINELVFCHNNV-SGRIPS-SLGNLSNLALLYLNDNSLFGSIPIVMGNLK 117
+ V L+ + + N + S I + + + L+ + + D ++ +IP G
Sbjct: 136 VRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNI-TTIP--QGLPP 192
Query: 118 SLSTLDLSQNQLNGSIPCSLDNLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSENRL 177
SL+ L L N++ SL L+NL L L NS+S + N L +L L+ N+L
Sbjct: 193 SLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKL 252
Query: 178 SGLIPLSLSNLSSLTVMSLFNNSLSGSIPP-------ILGNLKSLSTLGLHINQLNGV-I 229
+P L++ + V+ L NN++S +I S S + L N + I
Sbjct: 253 V-KVPGGLADHKYIQVVYLHNNNIS-AIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEI 310
Query: 230 PPSI-GNLSSLRNLSLFNNR 248
PS + + L N +
Sbjct: 311 QPSTFRCVYVRAAVQLGNYK 330
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 4e-30
Identities = 67/350 (19%), Positives = 117/350 (33%), Gaps = 56/350 (16%)
Query: 118 SLSTLDLSQNQLNGSIPCSLDNLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSENRL 177
L + S L +P L + L L N ++ NLK+L L L N++
Sbjct: 32 HLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKI 88
Query: 178 SGLIPLSLSNLSSLTVMSLFNNSLSGSIPPILGNLKSLSTLGLHINQLNGVIPPSIGNLS 237
S + P + + L L + L N L +P K+L L +H N++ V L+
Sbjct: 89 SKISPGAFAPLVKLERLYLSKNQLK-ELPE--KMPKTLQELRVHENEITKVRKSVFNGLN 145
Query: 238 SLRNLSLFNNRL--YGFVPKEIGYLKSLSKLEFCANHLSGVIPHSVGNLTGLVLLNMCEN 295
+ + L N L G +K LS + +++ + +LT L L N
Sbjct: 146 QMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQGLPPSLTELHLDG---N 202
Query: 296 HLFGPIPKSLRNLTSLERVRFNQNNLYGKVYEAFGDHPNLTFLDLSQNNFYCEISFNWRN 355
+ SL+ L +L ++ + N++ + + P+L L L+ N
Sbjct: 203 KITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV--------- 253
Query: 356 FSKLGTFNASMNNIYGSIPPEIGDSSKLQVLDLSSNHIFGKIPVQLVKLFSLNKLILSLN 415
+P + D +QV+ L +N+I I
Sbjct: 254 ----------------KVPGGLADHKYIQVVYLHNNNI-SAIGSNDF------------- 283
Query: 416 QLFGGVPLEFGTLTELQYLDLSANKLS-SSIPMSI-GNLLKLHYLNLSNN 463
P + L +N + I S + + L N
Sbjct: 284 ----CPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNY 329
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 2e-28
Identities = 61/316 (19%), Positives = 112/316 (35%), Gaps = 41/316 (12%)
Query: 229 IPPSIGNLSSLRNLSLFNNRLYGFVPKEIGYLKSLSKLEFCANHLSGVIPHSVGNLTGLV 288
+P + L L NN++ + LK+L L N +S + P + L L
Sbjct: 46 VPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLE 103
Query: 289 LLNMCENHLFGPIPKSLRNLTSLERVRFNQNNLYGKVYEAFGDHPNLTFLDLSQNNFYCE 348
L + +N L +P+ + +L+ +R ++N + F + ++L N
Sbjct: 104 RLYLSKNQLKE-LPEKM--PKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNP-LKS 159
Query: 349 ISFNWRNFSKLGTFNASMNNIYGSIPPEIGDSSKLQVLDLSSNHIFGKIPVQLVKLFSLN 408
F + KL + ++ +I IP L SL
Sbjct: 160 SGIENGAFQGM---------------------KKLSYIRIADTNI-TTIPQGL--PPSLT 195
Query: 409 KLILSLNQLFGGVPLE-FGTLTELQYLDLSANKLSSSIPMSIGNLLKLHYLNLSNNQFSH 467
+L L N++ V L L L LS N +S+ S+ N L L+L+NN+
Sbjct: 196 ELHLDGNKI-TKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVK 254
Query: 468 KIPTEFEKLIHLSELDLSHNILQE------EIPPQICKMESLEKLNLSHNNLSDFI--PR 519
+P ++ + L +N + P K S ++L N + + P
Sbjct: 255 -VPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPS 313
Query: 520 CFEEMRSLSWIDISYN 535
F + + + +
Sbjct: 314 TFRCVYVRAAVQLGNY 329
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 2e-27
Identities = 55/274 (20%), Positives = 100/274 (36%), Gaps = 17/274 (6%)
Query: 285 TGLVLLNMCENHLFGPIPKSLRNLTSLERVRFNQNNLYGKVYEAFGDHPNLTFLDLSQNN 344
LL++ N + +NL +L + N + AF L L LS+N
Sbjct: 52 PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQ 111
Query: 345 FYCEISFNWRNFSKLGTFNASMNNIYGSIPPEI-GDSSKLQVLDLSSNHI-FGKIPVQ-L 401
E+ L N I + + +++ V++L +N + I
Sbjct: 112 LK-ELPEKM--PKTLQELRVHENEIT-KVRKSVFNGLNQMIVVELGTNPLKSSGIENGAF 167
Query: 402 VKLFSLNKLILSLNQLFGGVPLEFGTLTELQYLDLSANKLSSSIPMSIGNLLKLHYLNLS 461
+ L+ + ++ + + G L L L NK++ S+ L L L LS
Sbjct: 168 QGMKKLSYIRIADTNI---TTIPQGLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLS 224
Query: 462 NNQFSHKIPTEFEKLIHLSELDLSHNILQEEIPPQICKMESLEKLNLSHNNLSDF----- 516
N S HL EL L++N L + +P + + ++ + L +NN+S
Sbjct: 225 FNSISAVDNGSLANTPHLRELHLNNNKLVK-VPGGLADHKYIQVVYLHNNNISAIGSNDF 283
Query: 517 -IPRCFEEMRSLSWIDISYNELQGPIPNSTAFKN 549
P + S S + + N +Q + F+
Sbjct: 284 CPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRC 317
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 1e-14
Identities = 38/170 (22%), Positives = 63/170 (37%), Gaps = 33/170 (19%)
Query: 372 SIPPEIGDSSKLQVLDLSSNHIFGKIPVQLVKLFSLNKLILSLNQLFGGVPLEFGTLTEL 431
+P ++ +LDL +N I +I +F L L
Sbjct: 45 KVPKDL--PPDTALLDLQNNKI-TEIK-----------------------DGDFKNLKNL 78
Query: 432 QYLDLSANKLSSSIPMSIGNLLKLHYLNLSNNQFSHKIPTEFEKLIHLSELDLSHNILQE 491
L L NK+S P + L+KL L LS NQ +P + L EL + N +
Sbjct: 79 HTLILINNKISKISPGAFAPLVKLERLYLSKNQLKE-LPEKM--PKTLQELRVHENEIT- 134
Query: 492 EIPPQI-CKMESLEKLNLSHNNLSDFI--PRCFEEMRSLSWIDISYNELQ 538
++ + + + + L N L F+ M+ LS+I I+ +
Sbjct: 135 KVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT 184
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 3e-35
Identities = 62/268 (23%), Positives = 106/268 (39%), Gaps = 19/268 (7%)
Query: 654 IGKGGQRSVYKAE-LPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFH 712
IG G K G I K+ ++ ++EV L E++H NI++++
Sbjct: 14 IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQ--MLVSEVNLLRELKHPNIVRYY 71
Query: 713 G--FCSNAQHSFIVCEYLARGSLTTILRDDAAAKE-FSWNQRMNVIKGVANALSYLH--H 767
+IV EY G L +++ ++ + V+ + AL H
Sbjct: 72 DRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRS 131
Query: 768 DCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGTVGYAAPELAYTM 827
D ++HRD+ NV LD + + DFG A+ L +S F GT Y +PE M
Sbjct: 132 DGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQMNRM 191
Query: 828 RATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRDVTDK 887
EK D++S G L E+ P F++ + +I + + +D+
Sbjct: 192 SYNEKSDIWSLGCLLYELCALMPP-------FTA-FSQKELAGKIREGKFRRIPYRYSDE 243
Query: 888 LRSIMEVAILCLVENPEARPTMKEVCNL 915
L I+ L RP+++E+
Sbjct: 244 LNEIIT---RMLNLKDYHRPSVEEILEN 268
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 3e-35
Identities = 62/272 (22%), Positives = 110/272 (40%), Gaps = 18/272 (6%)
Query: 650 EKY----CIGKGGQRSVYKAE-LPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIR 704
+ IG+G VY+A L G A+KK + D A ++ + E+ L ++
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKAR-ADCIKEIDLLKQLN 90
Query: 705 HRNIIKFHGFCSNAQHSFIVCEYLARGSLTTILRDDAAAKE-FSWNQRMNVIKGVANALS 763
H N+IK++ IV E G L+ +++ K + +AL
Sbjct: 91 HPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALE 150
Query: 764 YLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGTVGYAAPEL 823
++H + +HRDI NV + + + D G +F ++ GT Y +PE
Sbjct: 151 HMHSRRV---MHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPER 207
Query: 824 AYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRD 883
+ K D++S G L E+ P S+ I + P PS
Sbjct: 208 IHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQ-----CDYPPLPSDH 262
Query: 884 VTDKLRSIMEVAILCLVENPEARPTMKEVCNL 915
+++LR ++ +C+ +PE RP + V ++
Sbjct: 263 YSEELRQLVN---MCINPDPEKRPDVTYVYDV 291
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 6e-35
Identities = 75/278 (26%), Positives = 123/278 (44%), Gaps = 44/278 (15%)
Query: 646 GNFGEKYCIGKGGQRSVYKAELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRH 705
G FG V + AVK K + + + EF E + ++ H
Sbjct: 19 GQFGV-----------VKLGKWKGQYDVAVKMIK-----EGSMSEDEFFQEAQTMMKLSH 62
Query: 706 RNIIKFHGFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYL 765
++KF+G CS +IV EY++ G L LR K +Q + + V +++L
Sbjct: 63 PKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSH--GKGLEPSQLLEMCYDVCEGMAFL 120
Query: 766 -HHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGT---VGYAAP 821
H I HRD++++N L+D + VSDFG +++ + GT V ++AP
Sbjct: 121 ESHQFI----HRDLAARNCLVDRDLCVKVSDFGMTRYVL--DDQYVSSVGTKFPVKWSAP 174
Query: 822 ELAYTMRATEKYDVYSFGVLALEVI-KGYHPGDFVSTIFSSISNMIIEVNQILD--HRLP 878
E+ + + + K DV++FG+L EV G P + +N EV + HRL
Sbjct: 175 EVFHYFKYSSKSDVWAFGILMWEVFSLGKMP-------YDLYTNS--EVVLKVSQGHRLY 225
Query: 879 TPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLL 916
P +D + IM C E PE RPT +++ + +
Sbjct: 226 RP-HLASDTIYQIM---YSCWHELPEKRPTFQQLLSSI 259
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 2e-34
Identities = 69/282 (24%), Positives = 113/282 (40%), Gaps = 46/282 (16%)
Query: 646 GNFGEKYCIGKGGQRSVYKAELPSGNIF---AVKKFKAELFSDETANPSEFLNEVLALTE 702
GNFG V K + AVK K E +++ A E L E + +
Sbjct: 28 GNFGT-----------VKKGYYQMKKVVKTVAVKILKNE--ANDPALKDELLAEANVMQQ 74
Query: 703 IRHRNIIKFHGFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANAL 762
+ + I++ G C +V E G L L+ + + + ++ V+ +
Sbjct: 75 LDNPYIVRMIGICEAESW-MLVMEMAELGPLNKYLQQN---RHVKDKNIIELVHQVSMGM 130
Query: 763 SYL--HHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGT---VG 817
YL + VHRD++++NVLL +++ A +SDFG +K L + + V
Sbjct: 131 KYLEESN-----FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVK 185
Query: 818 YAAPELAYTMRATEKYDVYSFGVLALEVI-KGYHPGDFVSTIFSSISNMIIEVNQILDH- 875
+ APE + + K DV+SFGVL E G P + + EV +L+
Sbjct: 186 WYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP-------YRGMKGS--EVTAMLEKG 236
Query: 876 -RLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLL 916
R+ P ++ +M LC + E RP V L
Sbjct: 237 ERMGCP-AGCPREMYDLM---NLCWTYDVENRPGFAAVELRL 274
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 2e-34
Identities = 67/279 (24%), Positives = 122/279 (43%), Gaps = 46/279 (16%)
Query: 646 GNFGEKYCIGKGGQRSVYKAELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRH 705
G FG V + A+K K + + + EF+ E + + H
Sbjct: 35 GQFGV-----------VKYGKWRGQYDVAIKMIK-----EGSMSEDEFIEEAKVMMNLSH 78
Query: 706 RNIIKFHGFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYL 765
+++ +G C+ + FI+ EY+A G L LR+ F Q + + K V A+ YL
Sbjct: 79 EKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREM--RHRFQTQQLLEMCKDVCEAMEYL 136
Query: 766 --HHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGT---VGYAA 820
+HRD++++N L++ + VSDFG ++++ +T G+ V ++
Sbjct: 137 ESKQ-----FLHRDLAARNCLVNDQGVVKVSDFGLSRYVL--DDEYTSSVGSKFPVRWSP 189
Query: 821 PELAYTMRATEKYDVYSFGVLALEVI-KGYHPGDFVSTIFSSISNMIIEVNQILD--HRL 877
PE+ + + K D+++FGVL E+ G P + +N E + + RL
Sbjct: 190 PEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMP-------YERFTNS--ETAEHIAQGLRL 240
Query: 878 PTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLL 916
P ++K+ +IM C E + RPT K + + +
Sbjct: 241 YRP-HLASEKVYTIM---YSCWHEKADERPTFKILLSNI 275
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 3e-34
Identities = 69/282 (24%), Positives = 111/282 (39%), Gaps = 56/282 (19%)
Query: 646 GNFGEKYCIGKGGQRSVYKAELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRH 705
G FG+ V + GN AVK K A FL E +T++RH
Sbjct: 32 GEFGD-----------VMLGDY-RGNKVAVKCIK------NDATAQAFLAEASVMTQLRH 73
Query: 706 RNIIKFHGFCSNAQHS-FIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSY 764
N+++ G + +IV EY+A+GSL LR + + V A+ Y
Sbjct: 74 SNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEY 132
Query: 765 L-HHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSN------WTEFAGTVG 817
L ++ + HRD++++NVL+ + A VSDFG K WT
Sbjct: 133 LEGNNFV----HRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT------- 181
Query: 818 YAAPELAYTMRATEKYDVYSFGVLALEVI-KGYHPGDFVSTIFSSISNMIIEVNQILD-- 874
APE + + K DV+SFG+L E+ G P + I +V ++
Sbjct: 182 --APEALREKKFSTKSDVWSFGILLWEIYSFGRVP-------YPRIPLK--DVVPRVEKG 230
Query: 875 HRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLL 916
+++ P + +M C + RP+ ++ L
Sbjct: 231 YKMDAP-DGCPPAVYEVM---KNCWHLDAAMRPSFLQLREQL 268
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 8e-34
Identities = 69/279 (24%), Positives = 126/279 (45%), Gaps = 44/279 (15%)
Query: 646 GNFGEKYCIGKGGQRSVYKAELPSGNIF-AVKKFKAELFSDETANPSEFLNEVLALTEIR 704
G +GE VY+ ++ AVK K ++T EFL E + EI+
Sbjct: 231 GQYGE-----------VYEGVWKKYSLTVAVKTLK-----EDTMEVEEFLKEAAVMKEIK 274
Query: 705 HRNIIKFHGFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSY 764
H N+++ G C+ +I+ E++ G+L LR+ +E S + + +++A+ Y
Sbjct: 275 HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEY 333
Query: 765 LH-HDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGT---VGYAA 820
L + I HR+++++N L+ + V+DFG ++ + +T AG + + A
Sbjct: 334 LEKKNFI----HRNLAARNCLVGENHLVKVADFGLSRLMT--GDTYTAHAGAKFPIKWTA 387
Query: 821 PELAYTMRATEKYDVYSFGVLALEVI-KGYHPGDFVSTIFSSISNMIIEVNQILD--HRL 877
PE + + K DV++FGVL E+ G P + I +V ++L+ +R+
Sbjct: 388 PESLAYNKFSIKSDVWAFGVLLWEIATYGMSP-------YPGIDLS--QVYELLEKDYRM 438
Query: 878 PTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLL 916
P +K+ +M C NP RP+ E+
Sbjct: 439 ERP-EGCPEKVYELM---RACWQWNPSDRPSFAEIHQAF 473
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 8e-34
Identities = 51/296 (17%), Positives = 112/296 (37%), Gaps = 48/296 (16%)
Query: 646 GNFGEKY----CIGKGGQRSVYKAE-LPSGNIFAVKKFKAELFSDETANPSEFLNEVLAL 700
G + + C+G+GG V++A+ +A+K+ + + + EV AL
Sbjct: 1 GRYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAR---EKVMREVKAL 57
Query: 701 TEIRHRNIIKFHGFC------------SNAQHSFIVCEYLARGSLTTILRDDAAAKEFSW 748
++ H I+++ S + +I + + +L + +E
Sbjct: 58 AKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERER 117
Query: 749 NQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLE----- 803
+ +++ +A A+ +LH ++HRD+ N+ + V DFG ++
Sbjct: 118 SVCLHIFLQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEE 174
Query: 804 -------PHSSNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVS 856
P + T GT Y +PE + + K D++S G++ E++ +P
Sbjct: 175 QTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL---YP----- 226
Query: 857 TIFSSISNMIIEVNQILDHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEV 912
FS+ + + + + + P +++ L +P RP +
Sbjct: 227 --FSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQ---DMLSPSPMERPEAINI 277
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 9e-34
Identities = 70/279 (25%), Positives = 126/279 (45%), Gaps = 44/279 (15%)
Query: 646 GNFGEKYCIGKGGQRSVYKAELPSGNIF-AVKKFKAELFSDETANPSEFLNEVLALTEIR 704
G +GE VY+ ++ AVK K ++T EFL E + EI+
Sbjct: 24 GQYGE-----------VYEGVWKKYSLTVAVKTLK-----EDTMEVEEFLKEAAVMKEIK 67
Query: 705 HRNIIKFHGFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSY 764
H N+++ G C+ +I+ E++ G+L LR+ +E S + + +++A+ Y
Sbjct: 68 HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEY 126
Query: 765 L-HHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGT---VGYAA 820
L + I HRD++++N L+ + V+DFG ++ + +T AG + + A
Sbjct: 127 LEKKNFI----HRDLAARNCLVGENHLVKVADFGLSRLMT--GDTYTAHAGAKFPIKWTA 180
Query: 821 PELAYTMRATEKYDVYSFGVLALEVI-KGYHPGDFVSTIFSSISNMIIEVNQILD--HRL 877
PE + + K DV++FGVL E+ G P + I +V ++L+ +R+
Sbjct: 181 PESLAYNKFSIKSDVWAFGVLLWEIATYGMSP-------YPGIDLS--QVYELLEKDYRM 231
Query: 878 PTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLL 916
P +K+ +M C NP RP+ E+
Sbjct: 232 ERP-EGCPEKVYELM---RACWQWNPSDRPSFAEIHQAF 266
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 2e-33
Identities = 75/284 (26%), Positives = 126/284 (44%), Gaps = 46/284 (16%)
Query: 645 TGNFGEKYCIGKGGQRSVYKAEL---PSGNIF-AVKKFKAELFSDETANPSEFLNEVLAL 700
+G+ GE V L ++ A+K KA + +FL+E +
Sbjct: 59 SGDSGE-----------VCYGRLRVPGQRDVPVAIKALKAGYTERQR---RDFLSEASIM 104
Query: 701 TEIRHRNIIKFHGFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVAN 760
+ H NII+ G + + + IV EY+ GSL T LR +F+ Q + +++GV
Sbjct: 105 GQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTH--DGQFTIMQLVGMLRGVGA 162
Query: 761 ALSYL--HHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGT--- 815
+ YL VHRD++++NVL+DS VSDFG ++ LE G
Sbjct: 163 GMRYLSDLG-----YVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIP 217
Query: 816 VGYAAPELAYTMRATEKYDVYSFGVLALEVI-KGYHPGDFVSTIFSSISNMIIEVNQILD 874
+ + APE + DV+SFGV+ EV+ G P + +++N +V ++
Sbjct: 218 IRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERP-------YWNMTNR--DVISSVE 268
Query: 875 --HRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLL 916
+RLP P L +M + C ++ RP ++ ++L
Sbjct: 269 EGYRLPAP-MGCPHALHQLM---LDCWHKDRAQRPRFSQIVSVL 308
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 2e-33
Identities = 64/282 (22%), Positives = 111/282 (39%), Gaps = 46/282 (16%)
Query: 646 GNFGEKYCIGKGGQRSVYKAEL--PSGNIF-AVKKFKAELFSDETANPSEFLNEVLALTE 702
GNFG V + I A+K K E A+ E + E + +
Sbjct: 21 GNFGS-----------VRQGVYRMRKKQIDVAIKVLKQGT---EKADTEEMMREAQIMHQ 66
Query: 703 IRHRNIIKFHGFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANAL 762
+ + I++ G C +V E G L L +E + ++ V+ +
Sbjct: 67 LDNPYIVRLIGVCQAEAL-MLVMEMAGGGPLHKFLVGKR--EEIPVSNVAELLHQVSMGM 123
Query: 763 SYL--HHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGT---VG 817
YL + VHRD++++NVLL + + A +SDFG +K L S +T + +
Sbjct: 124 KYLEEKN-----FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLK 178
Query: 818 YAAPELAYTMRATEKYDVYSFGVLALEVI-KGYHPGDFVSTIFSSISNMIIEVNQILDH- 875
+ APE + + + DV+S+GV E + G P + + EV ++
Sbjct: 179 WYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKP-------YKKMKGP--EVMAFIEQG 229
Query: 876 -RLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLL 916
R+ P + +L ++M C + E RP V +
Sbjct: 230 KRMECP-PECPPELYALM---SDCWIYKWEDRPDFLTVEQRM 267
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 2e-33
Identities = 62/288 (21%), Positives = 109/288 (37%), Gaps = 57/288 (19%)
Query: 646 GNFGEKYCIGKGGQRSVYKAELPSGNIF-AVKKFKAELFSDETANPSEFLNEVLALTEIR 704
G FG Y KG ++ E I A+K+ + E L+E + +
Sbjct: 26 GAFGTVY---KG----LWIPEGEKVKIPVAIKELREATSPKA---NKEILDEAYVMASVD 75
Query: 705 HRNIIKFHGFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSY 764
+ ++ + G C ++ + + G L +R+ +N +A ++Y
Sbjct: 76 NPHVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNY 132
Query: 765 L--HHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSS-----------NWTE 811
L +VHRD++++NVL+ + ++DFG AK L W
Sbjct: 133 LEDRR-----LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM- 186
Query: 812 FAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVI-KGYHPGDFVSTIFSSISNMIIEVN 870
A E T + DV+S+GV E++ G P + I E++
Sbjct: 187 --------ALESILHRIYTHQSDVWSYGVTVWELMTFGSKP-------YDGIPAS--EIS 229
Query: 871 QILD--HRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLL 916
IL+ RLP P T + IM C + + ++RP +E+
Sbjct: 230 SILEKGERLPQPP-ICTIDVYMIM---RKCWMIDADSRPKFRELIIEF 273
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 2e-33
Identities = 81/285 (28%), Positives = 129/285 (45%), Gaps = 47/285 (16%)
Query: 645 TGNFGEKYCIGKGGQRSVYKAEL--PSGNIF---AVKKFKAELFSDETANPSEFLNEVLA 699
G FGE VYK L SG A+K KA + +FL E
Sbjct: 54 AGEFGE-----------VYKGMLKTSSGKKEVPVAIKTLKAGYTEKQR---VDFLGEAGI 99
Query: 700 LTEIRHRNIIKFHGFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVA 759
+ + H NII+ G S + I+ EY+ G+L LR+ EFS Q + +++G+A
Sbjct: 100 MGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREK--DGEFSVLQLVGMLRGIA 157
Query: 760 NALSYL--HHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGT-- 815
+ YL + VHRD++++N+L++S VSDFG ++ LE +G
Sbjct: 158 AGMKYLANMN-----YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKI 212
Query: 816 -VGYAAPELAYTMRATEKYDVYSFGVLALEVI-KGYHPGDFVSTIFSSISNMIIEVNQIL 873
+ + APE + T DV+SFG++ EV+ G P + +SN EV + +
Sbjct: 213 PIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERP-------YWELSNH--EVMKAI 263
Query: 874 DH--RLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLL 916
+ RLPTP D + +M + C + RP ++ ++L
Sbjct: 264 NDGFRLPTP-MDCPSAIYQLM---MQCWQQERARRPKFADIVSIL 304
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 2e-33
Identities = 68/278 (24%), Positives = 128/278 (46%), Gaps = 44/278 (15%)
Query: 646 GNFGEKYCIGKGGQRSVYKAELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRH 705
G FGE V+ AVK K + +P FL E + +++H
Sbjct: 24 GQFGE-----------VWMGYYNGHTKVAVKSLK-----QGSMSPDAFLAEANLMKQLQH 67
Query: 706 RNIIKFHGFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYL 765
+ +++ + + + +I+ EY+ GSL L+ + + + N+ +++ +A ++++
Sbjct: 68 QRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSG-IKLTINKLLDMAAQIAEGMAFI 125
Query: 766 -HHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGT---VGYAAP 821
+ I HRD+ + N+L+ ++DFG A+ +E + +T G + + AP
Sbjct: 126 EERNYI----HRDLRAANILVSDTLSCKIADFGLARLIE--DNEYTAREGAKFPIKWTAP 179
Query: 822 ELAYTMRATEKYDVYSFGVLALEVI-KGYHPGDFVSTIFSSISNMIIEVNQILD--HRLP 878
E T K DV+SFG+L E++ G P + ++N EV Q L+ +R+
Sbjct: 180 EAINYGTFTIKSDVWSFGILLTEIVTHGRIP-------YPGMTNP--EVIQNLERGYRMV 230
Query: 879 TPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLL 916
P + ++L +M LC E PE RPT + ++L
Sbjct: 231 RP-DNCPEELYQLM---RLCWKERPEDRPTFDYLRSVL 264
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 3e-33
Identities = 62/270 (22%), Positives = 105/270 (38%), Gaps = 22/270 (8%)
Query: 650 EKY----CIGKGGQRSVYKAE-LPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIR 704
EKY IG+G + G + +K+ S + E EV L ++
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKERE--ESRREVAVLANMK 81
Query: 705 HRNIIKFHGFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSY 764
H NI+++ +IV +Y G L + F +Q ++ + AL +
Sbjct: 82 HPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINA-QKGVLFQEDQILDWFVQICLALKH 140
Query: 765 LHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGTVGYAAPELA 824
+H I+HRDI S+N+ L + + DFG A+ L GT Y +PE+
Sbjct: 141 VHD---RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEIC 197
Query: 825 YTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRDV 884
K D+++ G + E+ H F + +M V +I+ P S
Sbjct: 198 ENKPYNNKSDIWALGCVLYELCTLKHA-------FEA-GSMKNLVLKIISGSFPPVSLHY 249
Query: 885 TDKLRSIMEVAILCLVENPEARPTMKEVCN 914
+ LRS++ NP RP++ +
Sbjct: 250 SYDLRSLVS---QLFKRNPRDRPSVNSILE 276
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 4e-33
Identities = 70/284 (24%), Positives = 111/284 (39%), Gaps = 46/284 (16%)
Query: 646 GNFGEKYCIGKGGQRSVYKAEL--PSGNIF--AVKKFKAELFSDETANPSEFLNEVLALT 701
G+FG V + E PSG AVK K ++ S A +F+ EV A+
Sbjct: 29 GSFGV-----------VRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAM-DDFIREVNAMH 76
Query: 702 EIRHRNIIKFHGFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANA 761
+ HRN+I+ +G +V E GSL LR F VA
Sbjct: 77 SLDHRNLIRLYGVVL-TPPMKMVTELAPLGSLLDRLRKHQ--GHFLLGTLSRYAVQVAEG 133
Query: 762 LSYL--HHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGT---V 816
+ YL +HRD++++N+LL + + DFG + L + ++
Sbjct: 134 MGYLESKR-----FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPF 188
Query: 817 GYAAPELAYTMRATEKYDVYSFGVLALEVI-KGYHPGDFVSTIFSSISNMIIEVNQILD- 874
+ APE T + D + FGV E+ G P + ++ ++ +D
Sbjct: 189 AWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEP-------WIGLNGS--QILHKIDK 239
Query: 875 --HRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLL 916
RLP P D + ++M + C PE RPT + + L
Sbjct: 240 EGERLPRP-EDCPQDIYNVM---VQCWAHKPEDRPTFVALRDFL 279
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 5e-33
Identities = 70/278 (25%), Positives = 129/278 (46%), Gaps = 44/278 (15%)
Query: 646 GNFGEKYCIGKGGQRSVYKAELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRH 705
G FGE V+ A AVK K + + FL E + ++H
Sbjct: 199 GQFGE-----------VWMATYNKHTKVAVKTMK-----PGSMSVEAFLAEANVMKTLQH 242
Query: 706 RNIIKFHGFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYL 765
++K H + + +I+ E++A+GSL L+ D + + ++ +A ++++
Sbjct: 243 DKLVKLHAVVTK-EPIYIITEFMAKGSLLDFLKSDEG-SKQPLPKLIDFSAQIAEGMAFI 300
Query: 766 -HHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGT---VGYAAP 821
+ I HRD+ + N+L+ + ++DFG A+ +E + +T G + + AP
Sbjct: 301 EQRNYI----HRDLRAANILVSASLVCKIADFGLARVIE--DNEYTAREGAKFPIKWTAP 354
Query: 822 ELAYTMRATEKYDVYSFGVLALEVI-KGYHPGDFVSTIFSSISNMIIEVNQILD--HRLP 878
E T K DV+SFG+L +E++ G P + +SN EV + L+ +R+P
Sbjct: 355 EAINFGSFTIKSDVWSFGILLMEIVTYGRIP-------YPGMSNP--EVIRALERGYRMP 405
Query: 879 TPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLL 916
P + ++L +IM + C PE RPT + + ++L
Sbjct: 406 RP-ENCPEELYNIM---MRCWKNRPEERPTFEYIQSVL 439
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 6e-33
Identities = 66/256 (25%), Positives = 102/256 (39%), Gaps = 16/256 (6%)
Query: 2 LNLGFNLLFGNIPP-QIGNLSKLQYLDLGNNQLSGVIPPEIGKLNQLRRLYLDVNQLHGT 60
L+L N + + L L L L NN++S + L +L++LY+ N L
Sbjct: 59 LDLQNNDI-SELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNHLV-E 116
Query: 61 IPPVIGQLSLINELVFCHNNVSGRIPSSLGNLSNLALLYLNDNSL-FGSIPIVMGNLKSL 119
IPP S + EL N + L N+ + + N L + L
Sbjct: 117 IPP--NLPSSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKL 174
Query: 120 STLDLSQNQLNGSIPCSLDNLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSENRLSG 179
+ L +S+ +L IP L L+ L L N + + L +L L N++
Sbjct: 175 NYLRISEAKLT-GIPKDL--PETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRM 231
Query: 180 LIPLSLSNLSSLTVMSLFNNSLSGSIPPILGNLKSLSTLGLHINQLNGVIP------PSI 233
+ SLS L +L + L NN LS +P L +LK L + LH N + V
Sbjct: 232 IENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFG 290
Query: 234 GNLSSLRNLSLFNNRL 249
+ +SLFNN +
Sbjct: 291 VKRAYYNGISLFNNPV 306
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 2e-29
Identities = 66/317 (20%), Positives = 109/317 (34%), Gaps = 44/317 (13%)
Query: 229 IPPSIGNLSSLRNLSLFNNRLYGFVPKEIGYLKSLSKLEFCANHLSGVIPHSVGNLTGLV 288
+P I L L NN + + L+ L L N +S + + L L
Sbjct: 48 VPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQ 105
Query: 289 LLNMCENHLFGPIPKSLRNLTSLERVRFNQNNLYGKVYEAFGDHPNLTFLDLSQNNFYCE 348
L + +NHL IP +L +SL +R + N + F N+ +++ N
Sbjct: 106 KLYISKNHLVE-IPPNL--PSSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLE-- 160
Query: 349 ISFNWRNFSKLGTFNASMNNIYGSIPPEIGDSSKLQVLDLSSNHIFGKIPVQLVKLFSLN 408
P D KL L +S + IP L +LN
Sbjct: 161 ---------------------NSGFEPGAFDGLKLNYLRISEAKL-TGIPKDL--PETLN 196
Query: 409 KLILSLNQLFGGVPLE-FGTLTELQYLDLSANKLSSSIPMSIGNLLKLHYLNLSNNQFSH 467
+L L N++ + LE ++L L L N++ S+ L L L+L NN+ S
Sbjct: 197 ELHLDHNKI-QAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLSR 255
Query: 468 KIPTEFEKLIHLSELDLSHNILQEEIPPQI-------CKMESLEKLNLSHNNLSDFI--P 518
+P L L + L N + ++ K ++L +N + + P
Sbjct: 256 -VPAGLPDLKLLQVVYLHTNNIT-KVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQP 313
Query: 519 RCFEEMRSLSWIDISYN 535
F + I
Sbjct: 314 ATFRCVTDRLAIQFGNY 330
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 9e-29
Identities = 72/318 (22%), Positives = 115/318 (36%), Gaps = 48/318 (15%)
Query: 12 NIPPQIGNLSKLQYLDLGNNQLSGVIPPEIGKLNQLRRLYLDVNQLHGTIPPVIGQLSLI 71
I P LDL NN +S + + L L L L N++ I
Sbjct: 51 EISPDT------TLLDLQNNDISELRKDDFKGLQHLYALVLVNNKIS-KIH--------- 94
Query: 72 NELVFCHNNVSGRIPSSLGNLSNLALLYLNDNSLFGSIPIVMGNLKSLSTLDLSQNQLNG 131
+ L L LY++ N L IP SL L + N++
Sbjct: 95 --------------EKAFSPLRKLQKLYISKNHL-VEIP--PNLPSSLVELRIHDNRIRK 137
Query: 132 SIPCSLDNLSNLDTLFLYKNSL-SGPIPSVIGNLKSLLQLDLSENRLSGLIPLSLSNLSS 190
L N++ + + N L + + L L +SE +L+G+ L+
Sbjct: 138 VPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLTGIPKDLPETLNE 197
Query: 191 LTVMSLFNNSLSGSIPP-ILGNLKSLSTLGLHINQLNGVIPPSIGNLSSLRNLSLFNNRL 249
L L +N + +I L L LGL NQ+ + S+ L +LR L L NN+L
Sbjct: 198 L---HLDHNKIQ-AIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKL 253
Query: 250 YGFVPKEIGYLKSLSKLEFCANHLSGVIPHSVGNLT-GLVLLNMCENHLFG-PI------ 301
VP + LK L + N+++ V + + G+ LF P+
Sbjct: 254 S-RVPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQ 312
Query: 302 PKSLRNLTSLERVRFNQN 319
P + R +T ++F
Sbjct: 313 PATFRCVTDRLAIQFGNY 330
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 4e-27
Identities = 63/350 (18%), Positives = 105/350 (30%), Gaps = 55/350 (15%)
Query: 118 SLSTLDLSQNQLNGSIPCSLDNLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSENRL 177
L + S L ++P + + L L N +S L+ L L L N++
Sbjct: 34 HLRVVQCSDLGLK-AVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKI 90
Query: 178 SGLIPLSLSNLSSLTVMSLFNNSLSGSIPPILGNLKSLSTLGLHINQLNGVIPPSIGNLS 237
S + + S L L + + N L IPP SL L +H N++ V L
Sbjct: 91 SKIHEKAFSPLRKLQKLYISKNHLV-EIPP--NLPSSLVELRIHDNRIRKVPKGVFSGLR 147
Query: 238 SLRNLSLFNNRLY-GFVPKEIGYLKSLSKLEFCANHLSGVIPHSVGNLTGLVLLNMCENH 296
++ + + N L L+ L L+G+ L L L + N
Sbjct: 148 NMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLTGIPKDLPETLNELHLDH---NK 204
Query: 297 LFGPIPKSLRNLTSLERVRFNQNNLYGKVYEAFGDHPNLTFLDLSQNNFYCEISFNWRNF 356
+ + L + L R+ N + + P L L L N
Sbjct: 205 IQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS---------- 254
Query: 357 SKLGTFNASMNNIYGSIPPEIGDSSKLQVLDLSSNHIFGKIPVQLVKLFSLNKLILSLNQ 416
+P + D LQV+ L +N+I K+
Sbjct: 255 ---------------RVPAGLPDLKLLQVVYLHTNNI-TKVG----------------VN 282
Query: 417 LFGGVPLEFGTLTELQYLDLSANKLSSSI--PMSIGNLLKLHYLNLSNNQ 464
F V + L N + P + + + N +
Sbjct: 283 DFCPVGF-GVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNYK 331
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 9e-24
Identities = 55/259 (21%), Positives = 95/259 (36%), Gaps = 40/259 (15%)
Query: 285 TGLVLLNMCENHLFGPIPKSLRNLTSLERVRFNQNNLYGKVYEAFGDHPNLTFLDLSQNN 344
LL++ N + + L L + N + +AF L L +S+N+
Sbjct: 54 PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNH 113
Query: 345 FYCEISFNWRNFSKLGTFNASMNNIYGSIPPEIGDSSKLQVLDLSSNHIFGKIPVQ-LVK 403
IPP + S L L + N I K+P
Sbjct: 114 LV-------------------------EIPPNL--PSSLVELRIHDNRIR-KVPKGVFSG 145
Query: 404 LFSLNKLILSLNQLFGGVPLEFGTLT--ELQYLDLSANKLSSSIPMSIGNLLKLHYLNLS 461
L ++N + + N L E G +L YL +S KL+ + L+ L+L
Sbjct: 146 LRNMNCIEMGGNPL-ENSGFEPGAFDGLKLNYLRISEAKLTG---IPKDLPETLNELHLD 201
Query: 462 NNQFSHKIPTE-FEKLIHLSELDLSHNILQEEIPPQICK-MESLEKLNLSHNNLSDFIPR 519
+N+ I E + L L L HN ++ I + +L +L+L +N LS +P
Sbjct: 202 HNKIQ-AIELEDLLRYSKLYRLGLGHNQIRM-IENGSLSFLPTLRELHLDNNKLSR-VPA 258
Query: 520 CFEEMRSLSWIDISYNELQ 538
+++ L + + N +
Sbjct: 259 GLPDLKLLQVVYLHTNNIT 277
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 2e-15
Identities = 34/121 (28%), Positives = 51/121 (42%), Gaps = 3/121 (2%)
Query: 429 TELQYLDLSANKLSSSIPMSIGNLLKLHYLNLSNNQFSHKIPTEFEKLIHLSELDLSHNI 488
+ LDL N +S L L+ L L NN+ S F L L +L +S N
Sbjct: 54 PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNH 113
Query: 489 LQEEIPPQICKMESLEKLNLSHNNLSDFIPRCFEEMRSLSWIDISYNELQGPIPNSTAFK 548
L EIPP + SL +L + N + F +R+++ I++ N L+ AF
Sbjct: 114 L-VEIPPNLPS--SLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFD 170
Query: 549 N 549
Sbjct: 171 G 171
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 2e-09
Identities = 27/137 (19%), Positives = 54/137 (39%), Gaps = 13/137 (9%)
Query: 2 LNLGFNLLFGNIPPQI-GNLSKLQYLDLGNNQLSGVIPPEIGKLNQLRRLYLDVNQLHGT 60
L+L N + I + SKL L LG+NQ+ + + L LR L+LD N+L
Sbjct: 198 LHLDHNKI-QAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-R 255
Query: 61 IPPVIGQLSLINELVFCHNNVSGRIPSS-------LGNLSNLALLYLNDNSL-FGSIPIV 112
+P + L L+ + NN++ ++ + + + L +N + + +
Sbjct: 256 VPAGLPDLKLLQVVYLHTNNIT-KVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPA 314
Query: 113 M-GNLKSLSTLDLSQNQ 128
+ + +
Sbjct: 315 TFRCVTDRLAIQFGNYK 331
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 6e-33
Identities = 70/282 (24%), Positives = 110/282 (39%), Gaps = 56/282 (19%)
Query: 646 GNFGEKYCIGKGGQRSVYKAELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRH 705
G FG+ V + GN AVK K A FL E +T++RH
Sbjct: 204 GEFGD-----------VMLGDY-RGNKVAVKCIK------NDATAQAFLAEASVMTQLRH 245
Query: 706 RNIIKFHGFCSNAQHSF-IVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSY 764
N+++ G + IV EY+A+GSL LR + + V A+ Y
Sbjct: 246 SNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEY 304
Query: 765 L-HHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSN------WTEFAGTVG 817
L ++ + HRD++++NVL+ + A VSDFG K WT
Sbjct: 305 LEGNNFV----HRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT------- 353
Query: 818 YAAPELAYTMRATEKYDVYSFGVLALEVI-KGYHPGDFVSTIFSSISNMIIEVNQILD-- 874
APE + + K DV+SFG+L E+ G P + I +V ++
Sbjct: 354 --APEALREKKFSTKSDVWSFGILLWEIYSFGRVP-------YPRIPLK--DVVPRVEKG 402
Query: 875 HRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLL 916
+++ P + +M C + RPT ++ L
Sbjct: 403 YKMDAP-DGCPPAVYDVM---KNCWHLDAATRPTFLQLREQL 440
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 8e-33
Identities = 74/286 (25%), Positives = 126/286 (44%), Gaps = 46/286 (16%)
Query: 645 TGNFGEKYCIGKGGQRSVYKAELPSGNIF----AVKKFKAELFSDETANPSEFLNEVLAL 700
G FGE V L + A+K K + +FL E +
Sbjct: 55 AGEFGE-----------VCSGRLKLPSKKEISVAIKTLKVGYTEKQRR---DFLGEASIM 100
Query: 701 TEIRHRNIIKFHGFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVAN 760
+ H NII+ G + ++ IV EY+ GSL + LR +F+ Q + +++G+A+
Sbjct: 101 GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKH--DAQFTVIQLVGMLRGIAS 158
Query: 761 ALSYL--HHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGT--- 815
+ YL VHRD++++N+L++S VSDFG + LE G
Sbjct: 159 GMKYLSDMG-----YVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIP 213
Query: 816 VGYAAPELAYTMRATEKYDVYSFGVLALEVI-KGYHPGDFVSTIFSSISNMIIEVNQILD 874
+ + +PE + T DV+S+G++ EV+ G P + +SN +V + +D
Sbjct: 214 IRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP-------YWEMSNQ--DVIKAVD 264
Query: 875 H--RLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLLCK 918
RLP P D L +M + C ++ RP +++ ++L K
Sbjct: 265 EGYRLPPP-MDCPAALYQLM---LDCWQKDRNNRPKFEQIVSILDK 306
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 1e-32
Identities = 70/266 (26%), Positives = 110/266 (41%), Gaps = 34/266 (12%)
Query: 653 CIGKGGQRSVYKA-ELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKF 711
IGKG V+K + + + A+K E DE + E+ L++ + K+
Sbjct: 29 KIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEI---EDIQQEITVLSQCDSPYVTKY 85
Query: 712 HGFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIP 771
+G +I+ EYL GS +L Q +++ + L YLH +
Sbjct: 86 YGSYLKDTKLWIIMEYLGGGSALDLLE----PGPLDETQIATILREILKGLDYLHSE--- 138
Query: 772 PIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGTVGYAAPELAYTMRATE 831
+HRDI + NVLL E ++DFG A L F GT + APE+
Sbjct: 139 KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDS 198
Query: 832 KYDVYSFGVLALEVIKG------YHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRDVT 885
K D++S G+ A+E+ +G HP + +F I + PT + +
Sbjct: 199 KADIWSLGITAIELARGEPPHSELHP---MKVLF-----------LIPKNNPPTLEGNYS 244
Query: 886 DKLRSIMEVAILCLVENPEARPTMKE 911
L+ +E CL + P RPT KE
Sbjct: 245 KPLKEFVE---ACLNKEPSFRPTAKE 267
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 2e-32
Identities = 62/271 (22%), Positives = 105/271 (38%), Gaps = 37/271 (13%)
Query: 651 KYCIGKGGQRSVYKA-ELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNII 709
+ +G+G V++ + +G AVKK + E+F E E++A + I+
Sbjct: 63 QPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVE---------ELVACAGLSSPRIV 113
Query: 710 KFHGFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDC 769
+G I E L GSL +++ E ++ + + L YLH
Sbjct: 114 PLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPE---DRALYYLGQALEGLEYLHTRR 170
Query: 770 IPPIVHRDISSKNVLLDSE-YEAHVSDFGFAKFLEPHSSNWTE-----FAGTVGYAAPEL 823
I+H D+ + NVLL S+ A + DFG A L+P + GT + APE+
Sbjct: 171 ---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEV 227
Query: 824 AYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDH--RLPTPS 881
K D++S + L ++ G HP ++ + P P
Sbjct: 228 VMGKPCDAKVDIWSSCCMMLHMLNGCHP-------WTQYFRG-----PLCLKIASEPPPI 275
Query: 882 RDVTDKLRSIMEVAI-LCLVENPEARPTMKE 911
R++ + AI L + P R + E
Sbjct: 276 REIPPSCAPLTAQAIQEGLRKEPVHRASAME 306
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 2e-32
Identities = 59/289 (20%), Positives = 116/289 (40%), Gaps = 50/289 (17%)
Query: 647 NFGEKY----CIGKGGQRSVYKAE-LPSGNIFAVKKFKAELFSDETANPSEFLNEVLALT 701
FG + IG GG V+KA+ G + +K+ K +++E A EV AL
Sbjct: 8 RFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVK---YNNEKA-----EREVKALA 59
Query: 702 EIRHRNIIKFHGF----------------CSNAQHSFIVCEYLARGSLTTILRDDAAAKE 745
++ H NI+ ++G S + FI E+ +G+L + ++
Sbjct: 60 KLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEK-RRGEK 118
Query: 746 FSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPH 805
+ + + + + Y+H + ++RD+ N+ L + + DFG L+ +
Sbjct: 119 LDKVLALELFEQITKGVDYIHSKKL---INRDLKPSNIFLVDTKQVKIGDFGLVTSLK-N 174
Query: 806 SSNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNM 865
T GT+ Y +PE + ++ D+Y+ G++ E++ S F+ + +
Sbjct: 175 DGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDG 234
Query: 866 IIEVNQILDHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914
II K +++++ L + PE RP E+
Sbjct: 235 II------------SDI-FDKKEKTLLQ---KLLSKKPEDRPNTSEILR 267
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 2e-32
Identities = 64/243 (26%), Positives = 105/243 (43%), Gaps = 10/243 (4%)
Query: 13 IPPQIGNLSKLQYLDLGNNQLSGVIPPEIGKLNQLRRLYLDVNQLH--GTIPPVIGQLSL 70
+P I S L+L +N+L + KL QL +L L N L G +
Sbjct: 22 VPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTS 79
Query: 71 INELVFCHNNVSGRIPSSLGNLSNLALLYLNDNSLFGSIPI-VMGNLKSLSTLDLSQNQL 129
+ L N V + S+ L L L ++L V +L++L LD+S
Sbjct: 80 LKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHT 138
Query: 130 NGSIPCSLDNLSNLDTLFLYKNS-LSGPIPSVIGNLKSLLQLDLSENRLSGLIPLSLSNL 188
+ + LS+L+ L + NS +P + L++L LDLS+ +L L P + ++L
Sbjct: 139 RVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSL 198
Query: 189 SSLTVMSLFNNSLSGSIPP-ILGNLKSLSTLGLHINQLNGVIPPSIGNL-SSLRNLSLFN 246
SSL V+++ +N+ S+ L SL L +N + + + SSL L+L
Sbjct: 199 SSLQVLNMSHNNFF-SLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQ 257
Query: 247 NRL 249
N
Sbjct: 258 NDF 260
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 7e-31
Identities = 59/232 (25%), Positives = 91/232 (39%), Gaps = 10/232 (4%)
Query: 2 LNLGFNLLFGNIPPQI-GNLSKLQYLDLGNNQLS--GVIPPEIGKLNQLRRLYLDVNQLH 58
L L N L ++P + L++L L L +N LS G L+ L L N +
Sbjct: 33 LELESNKL-QSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI 91
Query: 59 GTIPPVIGQLSLINELVFCHNNVSGRIPSSL-GNLSNLALLYLNDNSLFGSIPIVMGNLK 117
T+ L + L F H+N+ S+ +L NL L ++ + + L
Sbjct: 92 -TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLS 150
Query: 118 SLSTLDLSQNQLNGSI-PCSLDNLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSENR 176
SL L ++ N + P L NL L L + L P+ +L SL L++S N
Sbjct: 151 SLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNN 210
Query: 177 LSGLIPLSLSNLSSLTVMSLFNNSLSGSIPP-ILGNL-KSLSTLGLHINQLN 226
L L+SL V+ N + + L + SL+ L L N
Sbjct: 211 FFSLDTFPYKCLNSLQVLDYSLNHIM-TSKKQELQHFPSSLAFLNLTQNDFA 261
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 9e-29
Identities = 57/249 (22%), Positives = 91/249 (36%), Gaps = 29/249 (11%)
Query: 293 CENHLFGPIPKSLRNLTSLERVRFNQNNLYGKVYEAFGDHPNLTFLDLSQNNFYCEISFN 352
C + +P + +S R+ N L + F LT L LS N
Sbjct: 14 CNSKGLTSVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLS-FKGCC 70
Query: 353 WRNFSKLGTFNASMNNIYGSIPPEIGDSSKLQVLDLSSNHIFGKIPVQLVKLFSLNKLIL 412
++ + L+ LDLS N + + + L L L
Sbjct: 71 SQSDFGT---------------------TSLKYLDLSFNGV-ITMSSNFLGLEQLEHLDF 108
Query: 413 SLNQLFGGVPLE-FGTLTELQYLDLSANKLSSSIPMSIGNLLKLHYLNLSNNQFSHKIPT 471
+ L F +L L YLD+S + L L L ++ N F
Sbjct: 109 QHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLP 168
Query: 472 E-FEKLIHLSELDLSHNILQEEIPPQI-CKMESLEKLNLSHNNLSDFIPRCFEEMRSLSW 529
+ F +L +L+ LDLS L+ ++ P + SL+ LN+SHNN ++ + SL
Sbjct: 169 DIFTELRNLTFLDLSQCQLE-QLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQV 227
Query: 530 IDISYNELQ 538
+D S N +
Sbjct: 228 LDYSLNHIM 236
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 2e-24
Identities = 66/327 (20%), Positives = 111/327 (33%), Gaps = 81/327 (24%)
Query: 166 SLLQLDLSENRLSGLIPLSLSNLSSLTVMSLFNNSLSGSIPP-ILGNLKSLSTLGLHINQ 224
S ++ + L+ +P + SS T + L +N L S+P + L L+ L L N
Sbjct: 8 SGTEIRCNSKGLTS-VPTGIP--SSATRLELESNKLQ-SLPHGVFDKLTQLTKLSLSSNG 63
Query: 225 LN--GVIPPSIGNLSSLRNLSLFNNRLYGFVPKEIGYLKSLSKLEFCANHLSGVIPHSV- 281
L+ G S +SL+ L L N + + L+ L L+F ++L + SV
Sbjct: 64 LSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVF 122
Query: 282 GNLTGLVLLNMCENHLFGPIPKSLRNLTSLERVRFNQNNLYGKVYEAFGDHPNLTFLDLS 341
+L L+ L++ H F +L L ++
Sbjct: 123 LSLRNLIYLDISHTHT-----------RVAFN-------------GIFNGLSSLEVLKMA 158
Query: 342 QNNFYCEISFNWRNFSKLGTFNASMNNIYGSIPPEIGDSSKLQVLDLSSNHIFGKIPVQL 401
N+F + +F F++L L LDLS + ++
Sbjct: 159 GNSF--QENFLPDIFTEL---------------------RNLTFLDLSQCQL-EQLSPTA 194
Query: 402 VKLFSLNKLILSLNQLFGGVPLEFGTLTELQYLDLSANKLSSSIPMSIGNLLKLHYLNLS 461
F +L+ LQ L++S N S L L L+ S
Sbjct: 195 -----------------------FNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYS 231
Query: 462 NNQFSHKIPTEFEKLI-HLSELDLSHN 487
N E + L+ L+L+ N
Sbjct: 232 LNHIMTSKKQELQHFPSSLAFLNLTQN 258
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 1e-17
Identities = 39/147 (26%), Positives = 59/147 (40%), Gaps = 5/147 (3%)
Query: 406 SLNKLILSLNQLFGGVPLEFGTLTELQYLDLSANKLS--SSIPMSIGNLLKLHYLNLSNN 463
S +L L N+L F LT+L L LS+N LS S L YL+LS N
Sbjct: 29 SATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFN 88
Query: 464 QFSHKIPTEFEKLIHLSELDLSHNILQEEIPPQI-CKMESLEKLNLSHNNLSDFIPRCFE 522
+ + F L L LD H+ L++ + + +L L++SH + F
Sbjct: 89 GVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFN 147
Query: 523 EMRSLSWIDISYNELQGPIPNSTAFKN 549
+ SL + ++ N Q F
Sbjct: 148 GLSSLEVLKMAGNSFQENFL-PDIFTE 173
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 2e-04
Identities = 15/70 (21%), Positives = 27/70 (38%), Gaps = 3/70 (4%)
Query: 480 SELDLSHNILQEEIPPQICKMESLEKLNLSHNNLSDFIPRCFEEMRSLSWIDISYNELQG 539
+E+ + L +P I S +L L N L F+++ L+ + +S N L
Sbjct: 10 TEIRCNSKGLTS-VPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSF 66
Query: 540 PIPNSTAFKN 549
S +
Sbjct: 67 KGCCSQSDFG 76
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 2e-32
Identities = 63/283 (22%), Positives = 112/283 (39%), Gaps = 39/283 (13%)
Query: 647 NFGEKYCIGKGGQRSVYKAELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEI-RH 705
+F K +G G + ++ + AVK+ E FS EV L E H
Sbjct: 25 SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFAD-------REVQLLRESDEH 77
Query: 706 RNIIKFHGFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQR--MNVIKGVANALS 763
N+I++ + Q +I E L +L ++ K+F+ + +++ + L+
Sbjct: 78 PNVIRYFCTEKDRQFQYIAIE-LCAATL----QEYVEQKDFAHLGLEPITLLQQTTSGLA 132
Query: 764 YLHHDCIPPIVHRDISSKNVLL-----DSEYEAHVSDFGFAKFLEPHSS---NWTEFAGT 815
+LH I VHRD+ N+L+ + +A +SDFG K L + GT
Sbjct: 133 HLHSLNI---VHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGT 189
Query: 816 VGYAAPEL---AYTMRATEKYDVYSFGVLALEVI-KGYHPGDFVSTIFSSISNMIIEVNQ 871
G+ APE+ T D++S G + VI +G HP F ++ + ++ +
Sbjct: 190 EGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHP--FGKSLQRQANILLGACSL 247
Query: 872 ILDHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914
H + + + +P+ RP+ K V
Sbjct: 248 DCLHPEKHEDVIARELIEK-------MIAMDPQKRPSAKHVLK 283
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 2e-32
Identities = 73/278 (26%), Positives = 126/278 (45%), Gaps = 44/278 (15%)
Query: 646 GNFGEKYCIGKGGQRSVYKAELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRH 705
G FGE V+ A+K K T +P FL E + ++RH
Sbjct: 195 GCFGE-----------VWMGTWNGTTRVAIKTLK-----PGTMSPEAFLQEAQVMKKLRH 238
Query: 706 RNIIKFHGFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYL 765
+++ + S + +IV EY+++GSL L+ + K Q +++ +A+ ++Y+
Sbjct: 239 EKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETG-KYLRLPQLVDMAAQIASGMAYV 296
Query: 766 H-HDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGT---VGYAAP 821
+ + HRD+ + N+L+ V+DFG A+ +E + +T G + + AP
Sbjct: 297 ERMNYV----HRDLRAANILVGENLVCKVADFGLARLIE--DNEYTARQGAKFPIKWTAP 350
Query: 822 ELAYTMRATEKYDVYSFGVLALEVI-KGYHPGDFVSTIFSSISNMIIEVNQILD--HRLP 878
E A R T K DV+SFG+L E+ KG P + + N EV ++ +R+P
Sbjct: 351 EAALYGRFTIKSDVWSFGILLTELTTKGRVP-------YPGMVNR--EVLDQVERGYRMP 401
Query: 879 TPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLL 916
P + + L +M C + PE RPT + + L
Sbjct: 402 CP-PECPESLHDLM---CQCWRKEPEERPTFEYLQAFL 435
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 2e-32
Identities = 57/284 (20%), Positives = 108/284 (38%), Gaps = 36/284 (12%)
Query: 654 IGKGGQRSVYKAE-LPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFH 712
+G+GG V E L G+ +A+K+ + E + E E H NI++
Sbjct: 37 LGEGGFSYVDLVEGLHDGHFYALKR----ILCHEQQDREEAQREADMHRLFNHPNILRLV 92
Query: 713 GFCSNAQHS----FIVCEYLARGSLTTILRDDAAAKE-FSWNQRMNVIKGVANALSYLHH 767
+C + + +++ + RG+L + + +Q + ++ G+ L +H
Sbjct: 93 AYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHA 152
Query: 768 DCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSN---------WTEFAGTVGY 818
HRD+ N+LL E + + D G H W T+ Y
Sbjct: 153 ---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISY 209
Query: 819 AAPEL----AYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILD 874
APEL ++ + E+ DV+S G + ++ G P + S + NQ+
Sbjct: 210 RAPELFSVQSHCV-IDERTDVWSLGCVLYAMMFGEGP--YDMVFQKGDSVALAVQNQL-- 264
Query: 875 HRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLLCK 918
+P R + L ++ + +P RP + + + L
Sbjct: 265 -SIPQSPR-HSSALWQLLNS---MMTVDPHQRPHIPLLLSQLEA 303
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 2e-32
Identities = 62/290 (21%), Positives = 110/290 (37%), Gaps = 44/290 (15%)
Query: 646 GNFGEKYCIGKGGQRSVYKAEL--PSGNIF---AVKKFKAELFSDETANPSEFLNEVLAL 700
GNFG V N AVK+ + +F E+ L
Sbjct: 34 GNFGS-----------VELCRYDPLGDNTGALVAVKQLQH----SGPDQQRDFQREIQIL 78
Query: 701 TEIRHRNIIKFHGFCSNAQHS--FIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGV 758
+ I+K+ G +V EYL G L L+ A ++ + +
Sbjct: 79 KALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRA--RLDASRLLLYSSQI 136
Query: 759 ANALSYLH-HDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGT-- 815
+ YL C+ HRD++++N+L++SE ++DFG AK L +
Sbjct: 137 CKGMEYLGSRRCV----HRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQS 192
Query: 816 -VGYAAPELAYTMRATEKYDVYSFGVLALEVI-KGYHP----GDFVSTIFSSISNMII-E 868
+ + APE + + DV+SFGV+ E+ +F+ + +
Sbjct: 193 PIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSR 252
Query: 869 VNQILD--HRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLL 916
+ ++L+ RLP P ++ +M+ LC +P+ RP+ + L
Sbjct: 253 LLELLEEGQRLPAP-PACPAEVHELMK---LCWAPSPQDRPSFSALGPQL 298
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 4e-32
Identities = 67/291 (23%), Positives = 120/291 (41%), Gaps = 50/291 (17%)
Query: 649 GEKY----CIGKGGQRSVYKAELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIR 704
G Y IG GG V++ I+A+K E ++T + + NE+ L +++
Sbjct: 27 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLD--SYRNEIAYLNKLQ 84
Query: 705 HRN--IIKFHGFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANAL 762
+ II+ + + Q+ ++V E L + L+ K +R + K + A+
Sbjct: 85 QHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKK---KSIDPWERKSYWKNMLEAV 140
Query: 763 SYLH-HDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNW--TEFAGTVGYA 819
+H H IVH D+ N L+ + DFG A ++P +++ GTV Y
Sbjct: 141 HTIHQHG----IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYM 195
Query: 820 APEL-----------AYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIE 868
PE + + K DV+S G + + G P F I N I +
Sbjct: 196 PPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP-------FQQIINQISK 248
Query: 869 VNQIL--DHRLPTP---SRDVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914
++ I+ +H + P +D+ D L+ CL +P+ R ++ E+
Sbjct: 249 LHAIIDPNHEIEFPDIPEKDLQDVLKC-------CLKRDPKQRISIPELLA 292
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 5e-32
Identities = 67/291 (23%), Positives = 119/291 (40%), Gaps = 50/291 (17%)
Query: 649 GEKY----CIGKGGQRSVYKAELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIR 704
G Y IG GG V++ I+A+K E ++T + + NE+ L +++
Sbjct: 8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLD--SYRNEIAYLNKLQ 65
Query: 705 H--RNIIKFHGFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANAL 762
II+ + + Q+ ++V E L + L+ K +R + K + A+
Sbjct: 66 QHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKK---KSIDPWERKSYWKNMLEAV 121
Query: 763 SYLH-HDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNW--TEFAGTVGYA 819
+H H IVH D+ N L+ + DFG A ++P +++ GTV Y
Sbjct: 122 HTIHQHG----IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYM 176
Query: 820 APEL-------AYTMRATEKY----DVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIE 868
PE ++ K DV+S G + + G P F I N I +
Sbjct: 177 PPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP-------FQQIINQISK 229
Query: 869 VNQIL--DHRLPTP---SRDVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914
++ I+ +H + P +D+ D L+ CL +P+ R ++ E+
Sbjct: 230 LHAIIDPNHEIEFPDIPEKDLQDVLKC-------CLKRDPKQRISIPELLA 273
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 6e-32
Identities = 55/290 (18%), Positives = 108/290 (37%), Gaps = 57/290 (19%)
Query: 646 GNFGEKYCIGKGGQRSVYKAELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRH 705
G F + + KG +R V +K F ++++ H
Sbjct: 19 GTFTKIF---KGVRREVGDYGQLHETEVLLKVLD----KAHRNYSESFFEAASMMSKLSH 71
Query: 706 RNIIKFHGFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYL 765
++++ +G C + +V E++ GSL T L+ + + ++ V K +A A+ +L
Sbjct: 72 KHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKN--KNCINILWKLEVAKQLAAAMHFL 129
Query: 766 --HHDCIPPIVHRDISSKNVLLDSEYEAH--------VSDFGFAKFLEPHSS-----NWT 810
+ ++H ++ +KN+LL E + +SD G + + P W
Sbjct: 130 EENT-----LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIPWV 184
Query: 811 EFAGTVGYAAPE-LAYTMRATEKYDVYSFGVLALEVI-KGYHPGDFVSTIFSSISNMIIE 868
PE + D +SFG E+ G P S++ +
Sbjct: 185 ---------PPECIENPKNLNLATDKWSFGTTLWEICSGGDKP-------LSALDSQ--R 226
Query: 869 VNQILD--HRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLL 916
Q + H+LP P +L +++ C+ P+ RP+ + + L
Sbjct: 227 KLQFYEDRHQLPAPK---AAELANLI---NNCMDYEPDHRPSFRAIIRDL 270
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 7e-32
Identities = 64/290 (22%), Positives = 113/290 (38%), Gaps = 43/290 (14%)
Query: 646 GNFGEKYCIGKGGQRSVYKAELPSGNIF-----AVKKFKAELFSDETANPSEFLNEVLAL 700
G+FG+ V AVK K E + ++ E+ L
Sbjct: 32 GHFGK-----------VELCRYDPEGDNTGEQVAVKSLKPE---SGGNHIADLKKEIEIL 77
Query: 701 TEIRHRNIIKFHGFCSNAQHS--FIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGV 758
+ H NI+K+ G C+ + ++ E+L GSL L + + + Q++ +
Sbjct: 78 RNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNK--NKINLKQQLKYAVQI 135
Query: 759 ANALSYLH-HDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGT-- 815
+ YL + HRD++++NVL++SE++ + DFG K +E +T
Sbjct: 136 CKGMDYLGSRQYV----HRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDS 191
Query: 816 -VGYAAPELAYTMRATEKYDVYSFGVLALEVI-----KGYHPGDFVSTIFSSISNMII-E 868
V + APE + DV+SFGV E++ F+ I + M +
Sbjct: 192 PVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTR 251
Query: 869 VNQILD--HRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLL 916
+ L RLP P + D++ +M C P R + + +
Sbjct: 252 LVNTLKEGKRLPCP-PNCPDEVYQLM---RKCWEFQPSNRTSFQNLIEGF 297
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 9e-32
Identities = 64/283 (22%), Positives = 117/283 (41%), Gaps = 46/283 (16%)
Query: 653 CIGKGGQRSVYKAELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRH--RNIIK 710
IG GG V++ I+A+K E ++T + + NE+ L +++ II+
Sbjct: 63 QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLD--SYRNEIAYLNKLQQHSDKIIR 120
Query: 711 FHGFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLH-HDC 769
+ + Q+ ++V E L + L+ K +R + K + A+ +H H
Sbjct: 121 LYDYEITDQYIYMVMEC-GNIDLNSWLKKK---KSIDPWERKSYWKNMLEAVHTIHQHG- 175
Query: 770 IPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTE--FAGTVGYAAPEL---- 823
IVH D+ N L+ + DFG A ++P +++ + G V Y PE
Sbjct: 176 ---IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDM 231
Query: 824 -------AYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQIL--D 874
+ + K DV+S G + + G P F I N I +++ I+ +
Sbjct: 232 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP-------FQQIINQISKLHAIIDPN 284
Query: 875 HRLPTP---SRDVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914
H + P +D+ D L+ CL +P+ R ++ E+
Sbjct: 285 HEIEFPDIPEKDLQDVLKC-------CLKRDPKQRISIPELLA 320
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 1e-31
Identities = 73/278 (26%), Positives = 126/278 (45%), Gaps = 44/278 (15%)
Query: 646 GNFGEKYCIGKGGQRSVYKAELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRH 705
G FGE V+ A+K K T +P FL E + ++RH
Sbjct: 278 GCFGE-----------VWMGTWNGTTRVAIKTLK-----PGTMSPEAFLQEAQVMKKLRH 321
Query: 706 RNIIKFHGFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYL 765
+++ + S + +IV EY+++GSL L+ + K Q +++ +A+ ++Y+
Sbjct: 322 EKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETG-KYLRLPQLVDMAAQIASGMAYV 379
Query: 766 H-HDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGT---VGYAAP 821
+ + HRD+ + N+L+ V+DFG A+ +E + +T G + + AP
Sbjct: 380 ERMNYV----HRDLRAANILVGENLVCKVADFGLARLIE--DNEYTARQGAKFPIKWTAP 433
Query: 822 ELAYTMRATEKYDVYSFGVLALEVI-KGYHPGDFVSTIFSSISNMIIEVNQILD--HRLP 878
E A R T K DV+SFG+L E+ KG P + + N EV ++ +R+P
Sbjct: 434 EAALYGRFTIKSDVWSFGILLTELTTKGRVP-------YPGMVNR--EVLDQVERGYRMP 484
Query: 879 TPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLL 916
P + + L +M C + PE RPT + + L
Sbjct: 485 CP-PECPESLHDLM---CQCWRKEPEERPTFEYLQAFL 518
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 1e-31
Identities = 69/282 (24%), Positives = 118/282 (41%), Gaps = 45/282 (15%)
Query: 646 GNFGEKYCIGKGGQRSVYKAELPSGNIF-AVKKFKAELFSDETANPSEFLNEVLALTEIR 704
G FG + KG V+ E S I +K + + + + +LA+ +
Sbjct: 24 GVFGTVH---KG----VWIPEGESIKIPVCIKVIEDKS---GRQSFQAVTDHMLAIGSLD 73
Query: 705 HRNIIKFHGFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSY 764
H +I++ G C +V +YL GSL +R +N +A + Y
Sbjct: 74 HAHIVRLLGLCPG-SSLQLVTQYLPLGSLLDHVRQHR--GALGPQLLLNWGVQIAKGMYY 130
Query: 765 L--HHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGTVG----- 817
L H +VHR+++++NVLL S + V+DFG A L P + +
Sbjct: 131 LEEHG-----MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDK---QLLYSEAKTPIK 182
Query: 818 YAAPELAYTMRATEKYDVYSFGVLALEVI-KGYHPGDFVSTIFSSISNMIIEVNQILD-- 874
+ A E + + T + DV+S+GV E++ G P ++ + EV +L+
Sbjct: 183 WMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEP-------YAGLRLA--EVPDLLEKG 233
Query: 875 HRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLL 916
RL P + T + +M + C + + RPT KE+ N
Sbjct: 234 ERLAQP-QICTIDVYMVM---VKCWMIDENIRPTFKELANEF 271
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 3e-31
Identities = 65/283 (22%), Positives = 113/283 (39%), Gaps = 49/283 (17%)
Query: 646 GNFGEKYCIGKGGQRSVYKAELPSGNIF----AVKKFKAELFSDETANPSEFLNEVLALT 701
G FGE VY+ + AVK K + D +F++E + +
Sbjct: 23 GFFGE-----------VYEGVYTNHKGEKINVAVKTCKKDCTLDN---KEKFMSEAVIMK 68
Query: 702 EIRHRNIIKFHGFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANA 761
+ H +I+K G + ++I+ E G L L + + + A
Sbjct: 69 NLDHPHIVKLIGIIEE-EPTWIIMELYPYGELGHYLERNK--NSLKVLTLVLYSLQICKA 125
Query: 762 LSYL--HHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGT---V 816
++YL + VHRDI+ +N+L+ S + DFG ++++E ++ + + T +
Sbjct: 126 MAYLESIN-----CVHRDIAVRNILVASPECVKLGDFGLSRYIE--DEDYYKASVTRLPI 178
Query: 817 GYAAPELAYTMRATEKYDVYSFGVLALEVI-KGYHPGDFVSTIFSSISNMIIEVNQILDH 875
+ +PE R T DV+ F V E++ G P F + N +V +L+
Sbjct: 179 KWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQP-------FFWLENK--DVIGVLEK 229
Query: 876 --RLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLL 916
RLP P L ++M C +P RP E+ L
Sbjct: 230 GDRLPKP-DLCPPVLYTLM---TRCWDYDPSDRPRFTELVCSL 268
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 3e-31
Identities = 58/263 (22%), Positives = 95/263 (36%), Gaps = 19/263 (7%)
Query: 2 LNLGFNLLFGNIPPQI-GNLSKLQYLDLGNNQLSGVIPPEI-GKLNQLRRLYLDVNQLHG 59
L+L N + I LQ L L +N ++ I + L L L L N L
Sbjct: 57 LDLSNNRI-TYISNSDLQRCVNLQALVLTSNGIN-TIEEDSFSSLGSLEHLDLSYNYLS- 113
Query: 60 TIPP-VIGQLSLINELVFCHNNVSGRIPSSL-GNLSNLALLYLNDNSLFGSIPI-VMGNL 116
+ LS + L N +SL +L+ L +L + + F I L
Sbjct: 114 NLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGL 173
Query: 117 KSLSTLDLSQNQLNGSIPCSLDNLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSENR 176
L L++ + L P SL ++ N+ L L+ + + S+ L+L +
Sbjct: 174 TFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTD 233
Query: 177 LSG--------LIPLSLSNLSSLTVMSLFNNSLSGSIPPILGNLKSLSTLGLHINQLNGV 228
L SL + + + + SL + +L + L L NQL
Sbjct: 234 LDTFHFSELSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQISGLLELEFSRNQLKS- 291
Query: 229 IPPSI-GNLSSLRNLSLFNNRLY 250
+P I L+SL+ + L N
Sbjct: 292 VPDGIFDRLTSLQKIWLHTNPWD 314
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 1e-30
Identities = 66/292 (22%), Positives = 112/292 (38%), Gaps = 31/292 (10%)
Query: 61 IPPVIGQLSLINELVFCHNNVSGRIPSSLGNLSNLALLYLNDNSLFGSIPI-VMGNLKSL 119
+ + L L N N ++ S L NL L L N + +I +L SL
Sbjct: 50 LTEAVKSLDLSN------NRITYISNSDLQRCVNLQALVLTSNGI-NTIEEDSFSSLGSL 102
Query: 120 STLDLSQNQLNGSIPCSL-DNLSNLDTLFLYKNSLSG-PIPSVIGNLKSLLQLDLSEN-R 176
LDLS N L ++ S LS+L L L N S+ +L L L +
Sbjct: 103 EHLDLSYNYL-SNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDT 161
Query: 177 LSGLIPLSLSNLSSLTVMSLFNNSLSGSIPP-ILGNLKSLSTLGLHINQLNGVIPPSIGN 235
+ + + L+ L + + + L S P L +++++S L LH+ Q ++ +
Sbjct: 162 FTKIQRKDFAGLTFLEELEIDASDLQ-SYEPKSLKSIQNVSHLILHMKQHILLLEIFVDV 220
Query: 236 LSSLRNLSLFNNRLYGFVPKEIGYLKSLSKLEFCANHLSGVIPHSVGNLTGLVLLNMCEN 295
SS+ L L + L F + LS E +S+ + + +
Sbjct: 221 TSSVECLELRDTDLDTF------HFSELSTGET----------NSLIKKFTFRNVKITDE 264
Query: 296 HLFGPIPKSLRNLTSLERVRFNQNNLYGKVYEAFGDHPNLTFLDLSQNNFYC 347
LF + K L ++ L + F++N L F +L + L N + C
Sbjct: 265 SLF-QVMKLLNQISGLLELEFSRNQLKSVPDGIFDRLTSLQKIWLHTNPWDC 315
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 4e-26
Identities = 61/330 (18%), Positives = 107/330 (32%), Gaps = 73/330 (22%)
Query: 166 SLLQLDLSENRLSGLIPLSLSNLSSLTVMSLFNNSLSGSIPP-ILGNLKSLSTLGLHINQ 224
++ LDLS NR++ + L +L + L +N ++ +I +L SL L L N
Sbjct: 53 AVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGIN-TIEEDSFSSLGSLEHLDLSYNY 111
Query: 225 LNGVIPPSI-GNLSSLRNLSLFNNRLYGFVPKEIGYLKSLSKLEFCANHLSGVIPHSVGN 283
L + S LSSL L+L N K+L + +
Sbjct: 112 L-SNLSSSWFKPLSSLTFLNLLGNPY-----------KTLGETSL------------FSH 147
Query: 284 LTGLVLLNMCENHLFGPIP-KSLRNLTSLERVRFNQNNLYGKVYEAFGDHPNLTFLDLSQ 342
LT L +L + F I K LT LE + + ++L ++ N++ L L
Sbjct: 148 LTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHM 207
Query: 343 NNFYCEISFNWRNFSKLGTFNASMNNIYGSIPPEIGDS-SKLQVLDLSSNHIFGKIPVQL 401
+ D S ++ L+L +
Sbjct: 208 KQHI-------------------------LLLEIFVDVTSSVECLELRDTDLDT------ 236
Query: 402 VKLFSLNKLILSLNQLFGGVPLEFGTLTELQYLDLSANKLSSSIPMSIGNLLKLHYLNLS 461
++L G + + ++ L + + + L L S
Sbjct: 237 ----------FHFSELSTGETNSLIKKFTFRNVKITDESLFQ-VMKLLNQISGLLELEFS 285
Query: 462 NNQFSHKIPTE-FEKLIHLSELDLSHNILQ 490
NQ +P F++L L ++ L N
Sbjct: 286 RNQLKS-VPDGIFDRLTSLQKIWLHTNPWD 314
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 1e-23
Identities = 45/264 (17%), Positives = 100/264 (37%), Gaps = 15/264 (5%)
Query: 262 SLSKLEFCANHLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLRNLTSLERVRFNQNNL 321
++ L+ N ++ + + L L + N + S +L SLE + + N L
Sbjct: 53 AVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYL 112
Query: 322 YGKVYEAFGDHPNLTFLDLSQNNFYCEISFNW-RNFSKLGTFNASMNNIYGSIPPEIGDS 380
F +LTFL+L N + + + +KL + + I +
Sbjct: 113 SNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAG 172
Query: 381 -SKLQVLDLSSNHIFGKIPVQ-LVKLFSLNKLILSLNQLFGGVPLEFGTLTELQYLDLSA 438
+ L+ L++ ++ + + L + +++ LIL + Q + + + ++ L+L
Sbjct: 173 LTFLEELEIDASDL-QSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRD 231
Query: 439 NKLSSSIPMSI--------GNLLKLHYLNLSNNQFSHKIPTEFEKLIHLSELDLSHNILQ 490
L + + + +++ + ++ L EL+ S N L+
Sbjct: 232 TDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQ-VMKLLNQISGLLELEFSRNQLK 290
Query: 491 EEIPPQICK-MESLEKLNLSHNNL 513
+P I + SL+K+ L N
Sbjct: 291 S-VPDGIFDRLTSLQKIWLHTNPW 313
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 94.0 bits (234), Expect = 9e-21
Identities = 46/272 (16%), Positives = 95/272 (34%), Gaps = 38/272 (13%)
Query: 285 TGLVLLNMCENHLFGPIPKSLRNLTSLERVRFNQNNLYGKVYEAFGDHPNLTFLDLSQNN 344
+ L++ N + L+ +L+ + N + ++F +L LDLS N
Sbjct: 52 EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNY 111
Query: 345 FYCEISFNWRNFSKLGTFNASMNNIYGSIPPEIGDS-SKLQVLDLSSNHIFGKIPVQL-V 402
+S ++ S L L+L N L
Sbjct: 112 ----LS---------------------NLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFS 146
Query: 403 KLFSLNKLILSLNQLFGGVPLE-FGTLTELQYLDLSANKLSSSIPMSIGNLLKLHYLNLS 461
L L L + F + + F LT L+ L++ A+ L S P S+ ++ + +L L
Sbjct: 147 HLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILH 206
Query: 462 NNQFSHKIPTEFEKLIHLSELDLSHNILQEEIPPQIC--------KMESLEKLNLSHNNL 513
Q + + + L+L L ++ K + + ++ +L
Sbjct: 207 MKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESL 266
Query: 514 SDFIPRCFEEMRSLSWIDISYNELQGPIPNST 545
+ + ++ L ++ S N+L+ +P+
Sbjct: 267 FQ-VMKLLNQISGLLELEFSRNQLKS-VPDGI 296
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 3e-31
Identities = 67/282 (23%), Positives = 111/282 (39%), Gaps = 47/282 (16%)
Query: 646 GNFGEKYCIGKGGQRSVYKAELPSGNIF----AVKKFKAELFSDETANPSEFLNEVLALT 701
G FG+ V++ S A+K K +FL E L +
Sbjct: 26 GQFGD-----------VHQGIYMSPENPALAVAIKTCKNCTSDSVR---EKFLQEALTMR 71
Query: 702 EIRHRNIIKFHGFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANA 761
+ H +I+K G + +I+ E G L + L+ + ++ A
Sbjct: 72 QFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRK--YSLDLASLILYAYQLSTA 128
Query: 762 LSYL-HHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGT---VG 817
L+YL + HRDI+++NVL+ S + DFG ++++E S + + + +
Sbjct: 129 LAYLESKRFV----HRDIAARNVLVSSNDCVKLGDFGLSRYME--DSTYYKASKGKLPIK 182
Query: 818 YAAPELAYTMRATEKYDVYSFGVLALEVI-KGYHPGDFVSTIFSSISNMIIEVNQILD-- 874
+ APE R T DV+ FGV E++ G P F + N +V ++
Sbjct: 183 WMAPESINFRRFTSASDVWMFGVCMWEILMHGVKP-------FQGVKNN--DVIGRIENG 233
Query: 875 HRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLL 916
RLP P + L S+M C +P RP E+ L
Sbjct: 234 ERLPMP-PNCPPTLYSLM---TKCWAYDPSRRPRFTELKAQL 271
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 3e-31
Identities = 62/282 (21%), Positives = 110/282 (39%), Gaps = 46/282 (16%)
Query: 646 GNFGEKYCIGKGGQRSVYKAELPSGNIF---AVKKFKAELFSDETANPSEFLNEVLALTE 702
GNFG V + A+K K E A+ E + E + +
Sbjct: 347 GNFGS-----------VRQGVYRMRKKQIDVAIKVLKQGT---EKADTEEMMREAQIMHQ 392
Query: 703 IRHRNIIKFHGFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANAL 762
+ + I++ G C +V E G L L +E + ++ V+ +
Sbjct: 393 LDNPYIVRLIGVCQAEAL-MLVMEMAGGGPLHKFLVGKR--EEIPVSNVAELLHQVSMGM 449
Query: 763 SYL--HHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGT---VG 817
YL + VHR+++++NVLL + + A +SDFG +K L S +T + +
Sbjct: 450 KYLEEKN-----FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLK 504
Query: 818 YAAPELAYTMRATEKYDVYSFGVLALEVI-KGYHPGDFVSTIFSSISNMIIEVNQILDH- 875
+ APE + + + DV+S+GV E + G P + + EV ++
Sbjct: 505 WYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKP-------YKKMKGP--EVMAFIEQG 555
Query: 876 -RLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLL 916
R+ P + +L ++M C + E RP V +
Sbjct: 556 KRMECP-PECPPELYALM---SDCWIYKWEDRPDFLTVEQRM 593
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 5e-31
Identities = 65/259 (25%), Positives = 107/259 (41%), Gaps = 22/259 (8%)
Query: 654 IGKGGQRSVYKAE-LPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFH 712
+G GG +VY AE A+K E F EV +++ H+NI+
Sbjct: 19 LGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETL-KRFEREVHNSSQLSHQNIVSMI 77
Query: 713 GFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPP 772
++V EY+ +L+ + S + +N + + + + H
Sbjct: 78 DVDEEDDCYYLVMEYIEGPTLSEYIESHGP---LSVDTAINFTNQILDGIKHAHDM---R 131
Query: 773 IVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFA-GTVGYAAPELAYTMRATE 831
IVHRDI +N+L+DS + DFG AK L S T GTV Y +PE A E
Sbjct: 132 IVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATDE 191
Query: 832 KYDVYSFGVLALEVIKGYHP--GDFVSTIFSSISNMIIEVNQILDHRLPTPSRDVTDKLR 889
D+YS G++ E++ G P G+ +++S I + + +P + DV +
Sbjct: 192 CTDIYSIGIVLYEMLVGEPPFNGE------TAVSIAI----KHIQDSVPNVTTDVRKDIP 241
Query: 890 SIMEVAIL-CLVENPEARP 907
+ IL ++ R
Sbjct: 242 QSLSNVILRATEKDKANRY 260
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 128 bits (322), Expect = 6e-31
Identities = 63/424 (14%), Positives = 127/424 (29%), Gaps = 42/424 (9%)
Query: 2 LNLGFNLL---FGNIPPQIGNLSKLQYLDLGNNQLSGVIPPEIGKLNQLRRLYLDVNQLH 58
N +N + + + K N+ ++ +NQ L L+ L
Sbjct: 15 QNSFYNTISGTYADYFSAWDKWEKQALPGENRNEAVSLLK--ECLINQFSELQLNRLNLS 72
Query: 59 GTIPPVIGQLSLINELVFCHNNVSGRIPSSLGNLSNLALLYLNDNSLFGSIPIVMGNLKS 118
++P + I L N + +P +L L DN L ++P + +LK
Sbjct: 73 -SLPDNLPP--QITVLEITQNALI-SLPELPASLEY---LDACDNRL-STLPELPASLKH 124
Query: 119 LSTLDLSQNQLNGSIPCSLDNLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSENRLS 178
LD+ NQL +P + + L+ + N L+ +P + +L+ L + N+L+
Sbjct: 125 ---LDVDNNQLT-MLP---ELPALLEYINADNNQLTM-LPELPTSLEV---LSVRNNQLT 173
Query: 179 GLIPLSLSNLSSLTVMSLFNNSLSGSIPPILGNLKSLST----LGLHINQLNGVIPPSIG 234
L L SL + + N L S+P + N++ IP +I
Sbjct: 174 FLPEL----PESLEALDVSTNLLE-SLPAVPVRNHHSEETEIFFRCRENRIT-HIPENIL 227
Query: 235 NLSSLRNLSLFNNRLYGFVPKEIGYLKSLSKLEFCANHLSGVIPHSVGNLTGLVLLNMCE 294
+L + L +N L + + + + + S N L +
Sbjct: 228 SLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFSMSDGQQ--NTLHRPLADAVT 285
Query: 295 NHLFGPIPKSLRNLTSLERVRFNQNNLYGKVYEAFGDHPNLTFLDLSQNNFYCEISFNWR 354
+ + + N + D + + ++
Sbjct: 286 AWFPENKQSDVSQIWHAFEHEEHANTFS-AFLDRLSDTVSARNTSGFREQ----VAAWLE 340
Query: 355 NFSKLGTFNASMNNIYGSIPPEIGDSSKLQVLDLSSNHIFGKIPVQLVKLFSLNKLILSL 414
S + D L +L + + L+
Sbjct: 341 KLSASAELRQQSFAVAADATESCEDRVALTWNNLRKTL-LVHQASEGLFDNDTGALLSLG 399
Query: 415 NQLF 418
++F
Sbjct: 400 REMF 403
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 4e-28
Identities = 52/323 (16%), Positives = 100/323 (30%), Gaps = 59/323 (18%)
Query: 181 IPLSLSNLSSLTVMSLFNN--SLSGSIPPILGNLKSLSTLGLHINQLNGVIPPSIGNLSS 238
I L ++N SL+ S +N + + G + N+ ++ + ++
Sbjct: 3 IMLPINNNFSLSQNSFYNTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKECL--INQ 60
Query: 239 LRNLSLFNNRLYGFVPKEIGYLKSLSKLEFCANHLSGVIPHSVGNLTGLVLLNMCENHLF 298
L L L +P + ++ LE N L +P +L L + + L
Sbjct: 61 FSELQLNRLNL-SSLPDNLP--PQITVLEITQNALI-SLPELPASLEYLDACDNRLSTL- 115
Query: 299 GPIPKSLRNLTSLERVRFNQNNLYGKVYEAFGDHP-NLTFLDLSQNNFYCEISFNWRNFS 357
P+ +L L + N L + P L +++ N
Sbjct: 116 ---PELPASLKHL---DVDNNQL-----TMLPELPALLEYINADNNQL------------ 152
Query: 358 KLGTFNASMNNIYGSIPPEIGDSSKLQVLDLSSNHIFGKIPVQLVKLFSLNKLILSLNQL 417
+P L+VL + +N + +P SL L +S N L
Sbjct: 153 -------------TMLPELPT---SLEVLSVRNNQL-TFLPELPE---SLEALDVSTNLL 192
Query: 418 FGGVPLEFGTLTELQ----YLDLSANKLSSSIPMSIGNLLKLHYLNLSNNQFSHKIPTEF 473
+P + + N+++ IP +I +L + L +N S +I
Sbjct: 193 -ESLPAVPVRNHHSEETEIFFRCRENRITH-IPENILSLDPTCTIILEDNPLSSRIRESL 250
Query: 474 EKLIHLSELDLSHNILQEEIPPQ 496
+ + Q
Sbjct: 251 SQQTAQPDYHGPRIYFSMSDGQQ 273
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 1e-25
Identities = 73/352 (20%), Positives = 120/352 (34%), Gaps = 60/352 (17%)
Query: 2 LNLGFNLLFGNIPPQIGNLSKLQYLDLGNNQLSGVIPPEIGKLNQLRRLYLDVNQLHGTI 61
L + N L ++P +L +YLD +N+LS +P L+ L +D NQL +
Sbjct: 85 LEITQNAL-ISLPELPASL---EYLDACDNRLS-TLPELPA---SLKHLDVDNNQLT-ML 135
Query: 62 PPVIGQLSLINELVFCHNNVSGRIPSSLGNLSNLALLYLNDNSLFGSIPIVMGNLKSLST 121
P + L IN NN +P +L L + +N L +P + +L+
Sbjct: 136 PELPALLEYIN----ADNNQLTMLPELPTSLEVL---SVRNNQL-TFLPELPESLE---A 184
Query: 122 LDLSQNQLNGSIPCSLDNLSNLDT----LFLYKNSLSGPIPSVIGNLKSLLQLDLSENRL 177
LD+S N L S+P + + +N ++ IP I +L + L +N L
Sbjct: 185 LDVSTNLLE-SLPAVPVRNHHSEETEIFFRCRENRITH-IPENILSLDPTCTIILEDNPL 242
Query: 178 SGLIPLSLSNLSSLTVMSLFNNSLSGSIPPILGNLKSLSTLGLHINQLNGVIPPSI---- 233
S I SLS ++ S S N +
Sbjct: 243 SSRIRESLSQQTAQPDYHGPRIYFSMSDGQQ--NTLHRPLADAVTAWFPENKQSDVSQIW 300
Query: 234 -------------------GNLSSLRNLSLFNNRLYGFVPKEIGYLKSLSKLEFCANHLS 274
+ S RN S F ++ ++ K L + ++L + ++
Sbjct: 301 HAFEHEEHANTFSAFLDRLSDTVSARNTSGFREQVAAWLEK----LSASAELRQQSFAVA 356
Query: 275 GVIPHSVGNLTGLVLLNMCENHLF-----GPIPKSLRNLTSLERVRFNQNNL 321
S + L N+ + L G L SL R F L
Sbjct: 357 ADATESCEDRVALTWNNLRKTLLVHQASEGLFDNDTGALLSLGREMFRLEIL 408
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 5e-23
Identities = 56/275 (20%), Positives = 95/275 (34%), Gaps = 35/275 (12%)
Query: 277 IPHSVGNLTGLVLLNMCENHL---FGPIPKSLRNLTSLERVRFNQNNLYGKVYEAFGDHP 333
I + N L N N + + + N+N + E
Sbjct: 3 IMLPINNNFSL-SQNSFYNTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKECL--IN 59
Query: 334 NLTFLDLSQNNFYCEISFNWRNFSKLGTFNASMNNIYGSIPPEIGDSSKLQVLDLSSNHI 393
+ L L++ N S ++ + N + S+P L+ LD N +
Sbjct: 60 QFSELQLNRLNL---SSLPDNLPPQITVLEITQNAL-ISLPELPAS---LEYLDACDNRL 112
Query: 394 FGKIPVQLVKLFSLNKLILSLNQLFGGVPLEFGTLTELQYLDLSANKLSSSIPMSIGNLL 453
+P SL L + NQL +P L +Y++ N+L+ +P +L
Sbjct: 113 -STLPELPA---SLKHLDVDNNQL-TMLPELPALL---EYINADNNQLTM-LPELPTSL- 162
Query: 454 KLHYLNLSNNQFSHKIPTEFEKLIHLSELDLSHNILQEEIPPQICKMESLEK----LNLS 509
L++ NNQ + +P E L LD+S N+L E +P + E+
Sbjct: 163 --EVLSVRNNQLTF-LP---ELPESLEALDVSTNLL-ESLPAVPVRNHHSEETEIFFRCR 215
Query: 510 HNNLSDFIPRCFEEMRSLSWIDISYNELQGPIPNS 544
N ++ IP + I + N L I S
Sbjct: 216 ENRITH-IPENILSLDPTCTIILEDNPLSSRIRES 249
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 44.6 bits (105), Expect = 1e-04
Identities = 22/177 (12%), Positives = 51/177 (28%), Gaps = 8/177 (4%)
Query: 1 MLNLGFNLLFGNIPPQIGNLSKLQYLDLGNNQLSGVIPPEIGKLNQLRRLYLDVNQLHGT 60
N + +IP I +L + L +N LS I + + + +
Sbjct: 211 FFRCRENRI-THIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFSMS 269
Query: 61 IPPVIGQLSLINELVFCHNNVSGRIPSSLGNLSNLALLYLNDNSLFGSIPIVMGNLKSLS 120
+ + S + + + A + + F + + + S
Sbjct: 270 DGQQNTLHRPLADA--VTAWFPENKQSDVSQIWH-AFEHEEHANTFSAFLDRLSDTVSAR 326
Query: 121 TLDLSQNQLNGSIPCSLDNLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSENRL 177
+ Q + L+ LS L +++ + +L +L + L
Sbjct: 327 NTSGFREQ----VAAWLEKLSASAELRQQSFAVAADATESCEDRVALTWNNLRKTLL 379
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 8e-31
Identities = 54/308 (17%), Positives = 97/308 (31%), Gaps = 58/308 (18%)
Query: 653 CIGKGGQR--SVYKA-ELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNII 709
IGKG + +V A P+G V++ E S+E E+ H NI+
Sbjct: 32 VIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVT--FLQGELHVSKLFNHPNIV 89
Query: 710 KFHGFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDC 769
+ ++V ++A GS ++ + +++GV AL Y+HH
Sbjct: 90 PYRATFIADNELWVVTSFMAYGSAKDLIC-THFMDGMNELAIAYILQGVLKALDYIHHM- 147
Query: 770 IPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSN-------WTEFAGTVGYAAPE 822
VHR + + ++L+ + + ++S + H + + +PE
Sbjct: 148 --GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPE 205
Query: 823 LAYTMRA--TEKYDVYSFGVLALEVIKG------YHP----------------------- 851
+ K D+YS G+ A E+ G
Sbjct: 206 VLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPA 265
Query: 852 --------GDFVSTIFSSISNMIIEVNQILDHRLPTPSRDVTDKLRSIMEVAILCLVENP 903
++ S D R + +E CL NP
Sbjct: 266 EELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVE---QCLQRNP 322
Query: 904 EARPTMKE 911
+ARP+
Sbjct: 323 DARPSAST 330
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 8e-31
Identities = 62/277 (22%), Positives = 113/277 (40%), Gaps = 35/277 (12%)
Query: 646 GNFGEKYCIGKGGQRSVYKAELPSGNIF-AVKKFKAELFSDETANPSEFLNEVLALTEIR 704
G FG Y KG ++ E I A+K+ + E L+E + +
Sbjct: 26 GAFGTVY---KG----LWIPEGEKVKIPVAIKELREATSPKA---NKEILDEAYVMASVD 75
Query: 705 HRNIIKFHGFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSY 764
+ ++ + G C ++ + + G L +R+ +N +A ++Y
Sbjct: 76 NPHVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNY 132
Query: 765 LHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGT--VGYAAPE 822
L + VHRD++++NVL+ + ++DFG AK L + G + + A E
Sbjct: 133 LEDRRL---VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 189
Query: 823 LAYTMRATEKYDVYSFGVLALEVI-KGYHPGDFVSTIFSSISNMIIEVNQILD--HRLPT 879
T + DV+S+GV E++ G P + I E++ IL+ RLP
Sbjct: 190 SILHRIYTHQSDVWSYGVTVWELMTFGSKP-------YDGIPAS--EISSILEKGERLPQ 240
Query: 880 PSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLL 916
P T + IM + C + + ++RP +E+
Sbjct: 241 PP-ICTIDVYMIM---VKCWMIDADSRPKFRELIIEF 273
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 9e-31
Identities = 74/294 (25%), Positives = 119/294 (40%), Gaps = 58/294 (19%)
Query: 646 GNFGEKYCIGKGGQRSVYKAELPSGNIF------AVKKFKAELFSDETANPSEFLNEVLA 699
G FGE VY+ ++ AVK E+ S++ +FL E L
Sbjct: 41 GAFGE-----------VYEGQVSGMPNDPSPLQVAVKTLP-EVCSEQD--ELDFLMEALI 86
Query: 700 LTEIRHRNIIKFHGFCSNAQHSFIVCEYLARGSLTTILR----DDAAAKEFSWNQRMNVI 755
+++ H+NI++ G + FI+ E +A G L + LR + + ++V
Sbjct: 87 ISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVA 146
Query: 756 KGVANALSYL--HHDCIPPIVHRDISSKNVLLDSEYEAHV---SDFGFAKFLEPHSSNWT 810
+ +A YL +H +HRDI+++N LL V DFG A+ + + +++
Sbjct: 147 RDIACGCQYLEENH-----FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDI--YRASYY 199
Query: 811 EFAGT----VGYAAPE-LAYTMRATEKYDVYSFGVLALEVI-KGYHPGDFVSTIFSSISN 864
G V + PE T K D +SFGVL E+ GY P + S SN
Sbjct: 200 RKGGCAMLPVKWMPPEAFMEG-IFTSKTDTWSFGVLLWEIFSLGYMP-------YPSKSN 251
Query: 865 MIIEV-NQILD-HRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLL 916
EV + R+ P ++ + IM C PE RP + +
Sbjct: 252 Q--EVLEFVTSGGRMDPP-KNCPGPVYRIMT---QCWQHQPEDRPNFAIILERI 299
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 1e-30
Identities = 64/291 (21%), Positives = 111/291 (38%), Gaps = 45/291 (15%)
Query: 646 GNFGEKYCIGKGGQRSVYKAELP-----SGNIFAVKKFKAELFSDETANPSEFLNEVLAL 700
GNFG V +G + AVKK + +F E+ L
Sbjct: 21 GNFGS-----------VEMCRYDPLQDNTGEVVAVKKLQHSTEEHL----RDFEREIEIL 65
Query: 701 TEIRHRNIIKFHGFCSNAQHS--FIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGV 758
++H NI+K+ G C +A ++ EYL GSL L+ + + + +
Sbjct: 66 KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTSQI 123
Query: 759 ANALSYLH-HDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGT-- 815
+ YL I HRD++++N+L+++E + DFG K L +
Sbjct: 124 CKGMEYLGTKRYI----HRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGES 179
Query: 816 -VGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMI----IEVN 870
+ + APE + + DV+SFGV+ E+ F + + V
Sbjct: 180 PIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVF 239
Query: 871 QILD-----HRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLL 916
+++ RLP P D++ IM C N RP+ +++ +
Sbjct: 240 HLIELLKNNGRLPRP-DGCPDEIYMIMT---ECWNNNVNQRPSFRDLALRV 286
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 1e-30
Identities = 71/290 (24%), Positives = 119/290 (41%), Gaps = 45/290 (15%)
Query: 646 GNFGEKYCIGKGGQRSVYKAEL-----PSGNIFAVKKFKAELFSDETANPSEFLNEVLAL 700
G+FG+ V +G + AVK KA+ + S + E+ L
Sbjct: 42 GHFGK-----------VSLYCYDPTNDGTGEMVAVKALKAD---AGPQHRSGWKQEIDIL 87
Query: 701 TEIRHRNIIKFHGFCSNAQHS--FIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGV 758
+ H +IIK+ G C +A + +V EY+ GSL L Q + + +
Sbjct: 88 RTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRH----SIGLAQLLLFAQQI 143
Query: 759 ANALSYLH-HDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGT-- 815
++YLH I HRD++++NVLLD++ + DFG AK + +
Sbjct: 144 CEGMAYLHAQHYI----HRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDS 199
Query: 816 -VGYAAPELAYTMRATEKYDVYSFGVLALEVI-----KGYHPGDFVSTIFSSISNMI-IE 868
V + APE + DV+SFGV E++ P F+ I + M +
Sbjct: 200 PVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLR 259
Query: 869 VNQILD--HRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLL 916
+ ++L+ RLP P ++ +M+ C RPT + + +L
Sbjct: 260 LTELLERGERLPRP-DKCPAEVYHLMK---NCWETEASFRPTFENLIPIL 305
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 1e-30
Identities = 62/277 (22%), Positives = 107/277 (38%), Gaps = 32/277 (11%)
Query: 645 TGNFGEKYCIGKGGQRSVYKA-ELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEI 703
G++ +GKG VY +L + A+K+ + P E+ +
Sbjct: 21 YDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEI--PERDSRYSQPLH--EEIALHKHL 76
Query: 704 RHRNIIKFHGFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALS 763
+H+NI+++ G S I E + GSL+ +LR + + K + L
Sbjct: 77 KHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLK 136
Query: 764 YLHHDCIPPIVHRDISSKNVLLDSEYEAHV--SDFGFAKFLEPHSSNWTEFAGTVGYAAP 821
YLH + IVHRDI NVL+++ Y + SDFG +K L + F GT+ Y AP
Sbjct: 137 YLHDNQ---IVHRDIKGDNVLINT-YSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAP 192
Query: 822 E--LAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPT 879
E + D++S G +E+ G P F + + ++ ++
Sbjct: 193 EIIDKGPRGYGKAADIWSLGCTIIEMATGKPP-------FYELGEPQAAMFKVGMFKVHP 245
Query: 880 P-----SRDVTDKLRSIMEVAILCLVENPEARPTMKE 911
S + + C +P+ R +
Sbjct: 246 EIPESMSAEAKAFIL-------KCFEPDPDKRACAND 275
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 2e-30
Identities = 64/231 (27%), Positives = 97/231 (41%), Gaps = 13/231 (5%)
Query: 2 LNLGFNLLFGNIPPQI-GNLSKLQYLDLGNNQLSGVIPPEI-GKLNQLRRLYLDVNQLHG 59
LNL N + I +L L+ L LG N + I L L L L N L
Sbjct: 80 LNLMENNI-QMIQADTFRHLHHLEVLQLGRNSIR-QIEVGAFNGLASLNTLELFDNWLT- 136
Query: 60 TIPP-VIGQLSLINELVFCHNNVSGRIPS-SLGNLSNLALLYLNDNSLFGSIPI-VMGNL 116
IP LS + EL +N + IPS + + +L L L + I L
Sbjct: 137 VIPSGAFEYLSKLRELWLRNNPIE-SIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGL 195
Query: 117 KSLSTLDLSQNQLNGSIPCSLDNLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSENR 176
+L L+L + +P +L L L+ L + N P L SL +L + ++
Sbjct: 196 FNLKYLNLGMCNIK-DMP-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQ 253
Query: 177 LSGLIPLSLSNLSSLTVMSLFNNSLSGSIPP-ILGNLKSLSTLGLHINQLN 226
+S + + L+SL ++L +N+LS S+P + L+ L L LH N N
Sbjct: 254 VSLIERNAFDGLASLVELNLAHNNLS-SLPHDLFTPLRYLVELHLHHNPWN 303
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 6e-29
Identities = 68/278 (24%), Positives = 110/278 (39%), Gaps = 34/278 (12%)
Query: 21 SKLQYLDLGNNQLSGVIPPEIGKLNQLRRLYLDVNQLHGTIPPVIGQLSLINELVFCHNN 80
++ + LS +P I + R L L N + I
Sbjct: 54 NQFSKVVCTRRGLS-EVPQGI--PSNTRYLNLMENNIQ-MIQA----------------- 92
Query: 81 VSGRIPSSLGNLSNLALLYLNDNSLFGSIPI-VMGNLKSLSTLDLSQNQLNGSIPC-SLD 138
+ +L +L +L L NS+ I + L SL+TL+L N L IP + +
Sbjct: 93 ------DTFRHLHHLEVLQLGRNSI-RQIEVGAFNGLASLNTLELFDNWLT-VIPSGAFE 144
Query: 139 NLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSE-NRLSGLIPLSLSNLSSLTVMSLF 197
LS L L+L N + + SL++LDL E +L + + L +L ++L
Sbjct: 145 YLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLG 204
Query: 198 NNSLSGSIPPILGNLKSLSTLGLHINQLNGVIPPSIGNLSSLRNLSLFNNRLYGFVPKEI 257
++ +P L L L L + N + P S LSSL+ L + N+++
Sbjct: 205 MCNIK-DMPN-LTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAF 262
Query: 258 GYLKSLSKLEFCANHLSGVIPHSVGNLTGLVLLNMCEN 295
L SL +L N+LS + L LV L++ N
Sbjct: 263 DGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHN 300
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 4e-26
Identities = 63/280 (22%), Positives = 94/280 (33%), Gaps = 34/280 (12%)
Query: 237 SSLRNLSLFNNRLYGFVPKEIGYLKSLSKLEFCANHLSGVIPHSVGNLTGLVLLNMCENH 296
+ + L VP+ I + L N++ + + +L L +L + N
Sbjct: 54 NQFSKVVCTRRGL-SEVPQGI--PSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNS 110
Query: 297 LFGPIPKSLRNLTSLERVRFNQNNLYGKVYEAFGDHPNLTFLDLSQNNFYCEISFNWRNF 356
+ + L SL + N L AF L L L N
Sbjct: 111 IRQIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPI----------- 159
Query: 357 SKLGTFNASMNNIYGSIPPEI-GDSSKLQVLDLSSNHIFGKIPVQ-LVKLFSLNKLILSL 414
SIP L LDL I LF+L L L +
Sbjct: 160 --------------ESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGM 205
Query: 415 NQLFGGVPLEFGTLTELQYLDLSANKLSSSIPMSIGNLLKLHYLNLSNNQFSHKIPTEFE 474
+ +P L L+ L++S N P S L L L + N+Q S F+
Sbjct: 206 CNIKD-MP-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFD 263
Query: 475 KLIHLSELDLSHNILQEEIPPQICK-MESLEKLNLSHNNL 513
L L EL+L+HN L +P + + L +L+L HN
Sbjct: 264 GLASLVELNLAHNNLS-SLPHDLFTPLRYLVELHLHHNPW 302
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 2e-30
Identities = 71/278 (25%), Positives = 122/278 (43%), Gaps = 41/278 (14%)
Query: 645 TGNFGEKYCIGKGGQRSVYKA-ELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEI 703
F +G+G SVYKA +G I A+K+ E ++ E + E+ + +
Sbjct: 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE------SDLQEIIKEISIMQQC 81
Query: 704 RHRNIIKFHGFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALS 763
+++K++G +IV EY GS++ I+R K + ++ +++ L
Sbjct: 82 DSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIR--LRNKTLTEDEIATILQSTLKGLE 139
Query: 764 YLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGTVGYAAPEL 823
YLH +HRDI + N+LL++E A ++DFG A L + GT + APE+
Sbjct: 140 YLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEV 196
Query: 824 AYTMRATEKYDVYSFGVLALEVIKG------YHPGDFVSTIFSSISNMIIEVNQILDHRL 877
+ D++S G+ A+E+ +G HP + IF +I N
Sbjct: 197 IQEIGYNCVADIWSLGITAIEMAEGKPPYADIHP---MRAIF------MIPTN------- 240
Query: 878 PTP----SRDVTDKLRSIMEVAILCLVENPEARPTMKE 911
P P +D ++ CLV++PE R T +
Sbjct: 241 PPPTFRKPELWSDNFTDFVK---QCLVKSPEQRATATQ 275
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 2e-30
Identities = 64/291 (21%), Positives = 111/291 (38%), Gaps = 45/291 (15%)
Query: 646 GNFGEKYCIGKGGQRSVYKAELP-----SGNIFAVKKFKAELFSDETANPSEFLNEVLAL 700
GNFG V +G + AVKK + +F E+ L
Sbjct: 52 GNFGS-----------VEMCRYDPLQDNTGEVVAVKKLQHSTEEHL----RDFEREIEIL 96
Query: 701 TEIRHRNIIKFHGFCSNAQHS--FIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGV 758
++H NI+K+ G C +A ++ EYL GSL L+ + + + +
Sbjct: 97 KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTSQI 154
Query: 759 ANALSYLH-HDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGT-- 815
+ YL I HRD++++N+L+++E + DFG K L +
Sbjct: 155 CKGMEYLGTKRYI----HRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGES 210
Query: 816 -VGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMI----IEVN 870
+ + APE + + DV+SFGV+ E+ F + + V
Sbjct: 211 PIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVF 270
Query: 871 QILD-----HRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLL 916
+++ RLP P D++ IM C N RP+ +++ +
Sbjct: 271 HLIELLKNNGRLPRP-DGCPDEIYMIMT---ECWNNNVNQRPSFRDLALRV 317
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 2e-30
Identities = 68/270 (25%), Positives = 119/270 (44%), Gaps = 41/270 (15%)
Query: 653 CIGKGGQRSVYKA-ELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKF 711
IG+G +VY A ++ +G A+++ + + +NE+L + E ++ NI+ +
Sbjct: 27 KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKK----ELIINEILVMRENKNPNIVNY 82
Query: 712 HGFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIP 771
++V EYLA GSLT ++ Q V + AL +LH +
Sbjct: 83 LDSYLVGDELWVVMEYLAGGSLTDVVT----ETCMDEGQIAAVCRECLQALEFLHSN--- 135
Query: 772 PIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGTVGYAAPELAYTMRATE 831
++HRDI S N+LL + ++DFGF + P S + GT + APE+
Sbjct: 136 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGP 195
Query: 832 KYDVYSFGVLALEVIKG------YHPGDFVSTIFSSISNMIIEVNQILDHRLPTPS---- 881
K D++S G++A+E+I+G +P + ++ +I N TP
Sbjct: 196 KVDIWSLGIMAIEMIEGEPPYLNENP---LRALY------LIATN-------GTPELQNP 239
Query: 882 RDVTDKLRSIMEVAILCLVENPEARPTMKE 911
++ R + CL + E R + KE
Sbjct: 240 EKLSAIFRDFLN---RCLEMDVEKRGSAKE 266
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 3e-30
Identities = 66/280 (23%), Positives = 115/280 (41%), Gaps = 38/280 (13%)
Query: 653 CIGKGGQRSVYKA-ELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKF 711
IG G V A P A+K+ E E L E+ A+++ H NI+ +
Sbjct: 22 VIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSM---DELLKEIQAMSQCHHPNIVSY 78
Query: 712 HGFCSNAQHSFIVCEYLARGSLTTILR-----DDAAAKEFSWNQRMNVIKGVANALSYLH 766
+ ++V + L+ GS+ I++ + + + +++ V L YLH
Sbjct: 79 YTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLH 138
Query: 767 HDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTE-----FAGTVGYAAP 821
+ +HRD+ + N+LL + ++DFG + FL F GT + AP
Sbjct: 139 KN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAP 195
Query: 822 EL-----AYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNM----IIEVNQI 872
E+ Y +A D++SFG+ A+E+ G P + M + N
Sbjct: 196 EVMEQVRGYDFKA----DIWSFGITAIELATGAAP-------YHKYPPMKVLMLTLQNDP 244
Query: 873 LDHRLPTPSRDVTDKL-RSIMEVAILCLVENPEARPTMKE 911
+++ K +S ++ LCL ++PE RPT E
Sbjct: 245 PSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAE 284
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 3e-30
Identities = 74/294 (25%), Positives = 119/294 (40%), Gaps = 58/294 (19%)
Query: 646 GNFGEKYCIGKGGQRSVYKAELPSGNIF------AVKKFKAELFSDETANPSEFLNEVLA 699
G FGE VY+ ++ AVK E+ S++ +FL E L
Sbjct: 82 GAFGE-----------VYEGQVSGMPNDPSPLQVAVKTLP-EVCSEQD--ELDFLMEALI 127
Query: 700 LTEIRHRNIIKFHGFCSNAQHSFIVCEYLARGSLTTILR----DDAAAKEFSWNQRMNVI 755
+++ H+NI++ G + FI+ E +A G L + LR + + ++V
Sbjct: 128 ISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVA 187
Query: 756 KGVANALSYL--HHDCIPPIVHRDISSKNVLLDSEYEAHV---SDFGFAKFLEPHSSNWT 810
+ +A YL +H +HRDI+++N LL V DFG A+ + + + +
Sbjct: 188 RDIACGCQYLEENH-----FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDI--YRAGYY 240
Query: 811 EFAGT----VGYAAPE-LAYTMRATEKYDVYSFGVLALEVI-KGYHPGDFVSTIFSSISN 864
G V + PE T K D +SFGVL E+ GY P + S SN
Sbjct: 241 RKGGCAMLPVKWMPPEAFMEG-IFTSKTDTWSFGVLLWEIFSLGYMP-------YPSKSN 292
Query: 865 MIIEVNQILD--HRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLL 916
EV + + R+ P ++ + IM C PE RP + +
Sbjct: 293 Q--EVLEFVTSGGRMDPP-KNCPGPVYRIMT---QCWQHQPEDRPNFAIILERI 340
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 7e-30
Identities = 67/268 (25%), Positives = 112/268 (41%), Gaps = 37/268 (13%)
Query: 653 CIGKGGQRSVYKA-ELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKF 711
IG+G V A E SG AVK NEV+ + + +H N+++
Sbjct: 52 KIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRR----ELLFNEVVIMRDYQHFNVVEM 107
Query: 712 HGFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIP 771
+ + +++ E+L G+LT I+ + Q V + V AL+YLH
Sbjct: 108 YKSYLVGEELWVLMEFLQGGALTDIVS----QVRLNEEQIATVCEAVLQALAYLHAQ--- 160
Query: 772 PIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGTVGYAAPELAYTMRATE 831
++HRDI S ++LL + +SDFGF + GT + APE+
Sbjct: 161 GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSLYAT 220
Query: 832 KYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNM----IIEVNQILDHRLPTPS----RD 883
+ D++S G++ +E++ G P + S S + + + P P
Sbjct: 221 EVDIWSLGIMVIEMVDGEPP-------YFSDSPVQAMKRLRDS-------PPPKLKNSHK 266
Query: 884 VTDKLRSIMEVAILCLVENPEARPTMKE 911
V+ LR +E LV +P+ R T +E
Sbjct: 267 VSPVLRDFLE---RMLVRDPQERATAQE 291
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 1e-29
Identities = 68/299 (22%), Positives = 106/299 (35%), Gaps = 68/299 (22%)
Query: 646 GNFGEKYCIGKGGQRSVYKAELPSGNIF----AVKKFKAELFSDETANPSEFLNEVLALT 701
G FG V + L + AVK K + S EFL+E +
Sbjct: 45 GEFGS-----------VMEGNLKQEDGTSLKVAVKTMKLDNSSQREIE--EFLSEAACMK 91
Query: 702 EIRHRNIIKFHGFCSNAQ-----HSFIVCEYLARGSLTTILR---DDAAAKEFSWNQRMN 753
+ H N+I+ G C ++ ++ G L T L + K +
Sbjct: 92 DFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLK 151
Query: 754 VIKGVANALSYL--HHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSS---- 807
+ +A + YL + +HRD++++N +L + V+DFG +K +
Sbjct: 152 FMVDIALGMEYLSNRN-----FLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQG 206
Query: 808 -------NWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVI-KGYHPGDFVSTIF 859
W A E T K DV++FGV E+ +G P +
Sbjct: 207 RIAKMPVKWI---------AIESLADRVYTSKSDVWAFGVTMWEIATRGMTP-------Y 250
Query: 860 SSISNMIIEVNQILD--HRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLL 916
+ N E+ L HRL P D D+L IM C +P RPT + L
Sbjct: 251 PGVQNH--EMYDYLLHGHRLKQP-EDCLDELYEIMY---SCWRTDPLDRPTFSVLRLQL 303
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 1e-29
Identities = 57/260 (21%), Positives = 102/260 (39%), Gaps = 26/260 (10%)
Query: 654 IGKGGQRSVYKAELPS-GNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFH 712
+G+GG VY+AE I A+K L SD + E ++ +++ H
Sbjct: 42 VGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFR-TRMQREARTAGRLQEPHVVPIH 100
Query: 713 GFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPP 772
F ++ + L +LR + + + +++ + +AL H
Sbjct: 101 DFGEIDGQLYVDMRLINGVDLAAMLRRQGP---LAPPRAVAIVRQIGSALDAAHAA---G 154
Query: 773 IVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTE---FAGTVGYAAPELAYTMRA 829
HRD+ +N+L+ ++ A++ DFG A T+ GT+ Y APE A
Sbjct: 155 ATHRDVKPENILVSADDFAYLVDFGIASATT--DEKLTQLGNTVGTLYYMAPERFSESHA 212
Query: 830 TEKYDVYSFGVLALEVIKGYHP--GDFVSTIFSSISNMIIEVNQILDHRLPTPSRDVTDK 887
T + D+Y+ + E + G P GD +S + ++ +P PS
Sbjct: 213 TYRADIYALTCVLYECLTGSPPYQGDQLSVMG-----------AHINQAIPRPSTVRPGI 261
Query: 888 LRSIMEVAILCLVENPEARP 907
+ V + +NPE R
Sbjct: 262 PVAFDAVIARGMAKNPEDRY 281
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 2e-29
Identities = 66/231 (28%), Positives = 97/231 (41%), Gaps = 13/231 (5%)
Query: 2 LNLGFNLLFGNIPP-QIGNLSKLQYLDLGNNQLSGVIPPEI-GKLNQLRRLYLDVNQLHG 59
LNL N + I +L L+ L L N + I L L L L N+L
Sbjct: 69 LNLHENQI-QIIKVNSFKHLRHLEILQLSRNHIR-TIEIGAFNGLANLNTLELFDNRLT- 125
Query: 60 TIPP-VIGQLSLINELVFCHNNVSGRIPSSL-GNLSNLALLYLNDNSLFGSIPI-VMGNL 116
TIP LS + EL +N + IPS + +L L L + I L
Sbjct: 126 TIPNGAFVYLSKLKELWLRNNPIE-SIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGL 184
Query: 117 KSLSTLDLSQNQLNGSIPCSLDNLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSENR 176
+L L+L+ L IP +L L LD L L N LS P L L +L + +++
Sbjct: 185 SNLRYLNLAMCNLR-EIP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQ 242
Query: 177 LSGLIPLSLSNLSSLTVMSLFNNSLSGSIPP-ILGNLKSLSTLGLHINQLN 226
+ + + NL SL ++L +N+L+ +P + L L + LH N N
Sbjct: 243 IQVIERNAFDNLQSLVEINLAHNNLT-LLPHDLFTPLHHLERIHLHHNPWN 292
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 4e-28
Identities = 62/263 (23%), Positives = 93/263 (35%), Gaps = 37/263 (14%)
Query: 12 NIPPQIGNLSKLQYLDLGNNQLSGVIPPEIGKLNQLRRLYLDVNQLHGTIPPVIGQLSLI 71
I + L+L NQ+ + L L L L N + TI
Sbjct: 61 GISTN------TRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIR-TIEI-------- 105
Query: 72 NELVFCHNNVSGRIPSSLGNLSNLALLYLNDNSLFGSIPI-VMGNLKSLSTLDLSQNQLN 130
+ L+NL L L DN L +IP L L L L N +
Sbjct: 106 ---------------GAFNGLANLNTLELFDNRL-TTIPNGAFVYLSKLKELWLRNNPIE 149
Query: 131 GSIPCSLDNLSNLDTLFLYK-NSLSGPIPSVIGNLKSLLQLDLSENRLSGLIPLSLSNLS 189
+ + + +L L L + LS L +L L+L+ L IP +L+ L
Sbjct: 150 SIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLRE-IP-NLTPLI 207
Query: 190 SLTVMSLFNNSLSGSIPP-ILGNLKSLSTLGLHINQLNGVIPPSIGNLSSLRNLSLFNNR 248
L + L N LS +I P L L L + +Q+ + + NL SL ++L +N
Sbjct: 208 KLDELDLSGNHLS-AIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNN 266
Query: 249 LYGFVPKEIGYLKSLSKLEFCAN 271
L L L ++ N
Sbjct: 267 LTLLPHDLFTPLHHLERIHLHHN 289
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 5e-28
Identities = 66/277 (23%), Positives = 109/277 (39%), Gaps = 32/277 (11%)
Query: 21 SKLQYLDLGNNQLSGVIPPEIGKLNQLRRLYLDVNQLHGTIPPVIGQLSLINELVFCHNN 80
++ + L +P I R L L NQ+ I
Sbjct: 43 NQFSKVICVRKNLR-EVPDGI--STNTRLLNLHENQIQ-IIKV----------------- 81
Query: 81 VSGRIPSSLGNLSNLALLYLNDNSLFGSIPIVMGNLKSLSTLDLSQNQLNGSIPC-SLDN 139
+S +L +L +L L+ N + L +L+TL+L N+L +IP +
Sbjct: 82 ------NSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLT-TIPNGAFVY 134
Query: 140 LSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSE-NRLSGLIPLSLSNLSSLTVMSLFN 198
LS L L+L N + + SL +LDL E RLS + + LS+L ++L
Sbjct: 135 LSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAM 194
Query: 199 NSLSGSIPPILGNLKSLSTLGLHINQLNGVIPPSIGNLSSLRNLSLFNNRLYGFVPKEIG 258
+L IP L L L L L N L+ + P S L L+ L + +++
Sbjct: 195 CNLR-EIPN-LTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFD 252
Query: 259 YLKSLSKLEFCANHLSGVIPHSVGNLTGLVLLNMCEN 295
L+SL ++ N+L+ + L L +++ N
Sbjct: 253 NLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHN 289
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 9e-26
Identities = 67/233 (28%), Positives = 98/233 (42%), Gaps = 9/233 (3%)
Query: 285 TGLVLLNMCENHLFGPIPKSLRNLTSLERVRFNQNNLYGKVYEAFGDHPNLTFLDLSQNN 344
T LLN+ EN + S ++L LE ++ ++N++ AF NL L+L N
Sbjct: 64 TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNR 123
Query: 345 FYCEISFNW-RNFSKLGTFNASMNNIYGSIPPEI-GDSSKLQVLDLSSNHIFGKIPVQ-L 401
I SKL N I SIP L+ LDL I
Sbjct: 124 LT-TIPNGAFVYLSKLKELWLRNNPI-ESIPSYAFNRIPSLRRLDLGELKRLSYISEGAF 181
Query: 402 VKLFSLNKLILSLNQLFGGVPLEFGTLTELQYLDLSANKLSSSIPMSIGNLLKLHYLNLS 461
L +L L L++ L +P L +L LDLS N LS+ P S L+ L L +
Sbjct: 182 EGLSNLRYLNLAMCNL-REIP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMI 239
Query: 462 NNQFSHKIPTEFEKLIHLSELDLSHNILQEEIPPQICK-MESLEKLNLSHNNL 513
+Q F+ L L E++L+HN L +P + + LE+++L HN
Sbjct: 240 QSQIQVIERNAFDNLQSLVEINLAHNNLT-LLPHDLFTPLHHLERIHLHHNPW 291
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 1e-25
Identities = 58/277 (20%), Positives = 106/277 (38%), Gaps = 34/277 (12%)
Query: 118 SLSTLDLSQNQLNGSIPCSLDNLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSENRL 177
S + + L +P + +N L L++N + + +L+ L L LS N +
Sbjct: 44 QFSKVICVRKNLR-EVPDGIS--TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHI 100
Query: 178 SGLIPLSLSNLSSLTVMSLFNNSLSGSIPP-ILGNLKSLSTLGLHINQLNGVIPPSIGNL 236
+ + + L++L + LF+N L+ +IP L L L L N + + + +
Sbjct: 101 RTIEIGAFNGLANLNTLELFDNRLT-TIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRI 159
Query: 237 SSLRNLSLF-NNRLYGFVPKEIGYLKSLSKLEFCANHLSGVIPHSVGNLTGLVLLNMCEN 295
SLR L L RL L +L L +L + ++ L L L++ N
Sbjct: 160 PSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLREI--PNLTPLIKLDELDLSGN 217
Query: 296 HLFGPIPKSLRNLTSLERVRFNQNNLYGKVYEAFGDHPNLTFLDLSQNNFYCEISFNWRN 355
HL P S + L L+++ Q+ + AF + +L ++L+ NN
Sbjct: 218 HLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNL---------- 267
Query: 356 FSKLGTFNASMNNIYGSIPPEIGDS-SKLQVLDLSSN 391
+P ++ L+ + L N
Sbjct: 268 ---------------TLLPHDLFTPLHHLERIHLHHN 289
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 4e-24
Identities = 64/313 (20%), Positives = 106/313 (33%), Gaps = 14/313 (4%)
Query: 237 SSLRNLSLFNNRLYGFVPKEIGYLKSLSKLEFCANHLSGVIPHSVGNLTGLVLLNMCENH 296
+ + L VP I + L N + + +S +L L +L + NH
Sbjct: 43 NQFSKVICVRKNL-REVPDGI--STNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNH 99
Query: 297 LFGPIPKSLRNLTSLERVRFNQNNLYGKVYEAFGDHPNLTFLDLSQNNFYCEISFNWRNF 356
+ + L +L + N L AF L L L N S+ +
Sbjct: 100 IRTIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRI 159
Query: 357 SKLGTFNASMNNIYGSIPPEI-GDSSKLQVLDLSSNHIFGKIPVQLVKLFSLNKLILSLN 415
L + I S L+ L+L+ ++ +IP L L L++L LS N
Sbjct: 160 PSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNL-REIP-NLTPLIKLDELDLSGN 217
Query: 416 QLFGGVPLEFGTLTELQYLDLSANKLSSSIPMSIGNLLKLHYLNLSNNQFSHKIPTEFEK 475
L P F L LQ L + +++ + NL L +NL++N + F
Sbjct: 218 HLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTP 277
Query: 476 LIHLSELDLSHNILQEEIPPQICKMESL-EKLNLSHNNLSDFIPRCF--EEMRSLSWIDI 532
L HL + L HN C + L + + + RC ++ ++
Sbjct: 278 LHHLERIHLHHNPWNCN-----CDILWLSWWIKDMAPSNTACCARCNTPPNLKGRYIGEL 332
Query: 533 SYNELQGPIPNST 545
N P
Sbjct: 333 DQNYFTCYAPVIV 345
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 2e-29
Identities = 63/310 (20%), Positives = 118/310 (38%), Gaps = 52/310 (16%)
Query: 639 EEITKATGNFGEKYC----IGKGGQRSVYKAELPSGNIFAVKKFKAELFSDETANPSEFL 694
I + +G G +V G AVK+ + L
Sbjct: 4 ANIPNFEQSLKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDI-------AL 56
Query: 695 NEVLALTEI-RHRNIIKFHGFCSNAQHSFIVCEYLARGSLTTIL----RDDAAAKEFSWN 749
E+ LTE H N+I+++ + + +I E +L ++ D K
Sbjct: 57 MEIKLLTESDDHPNVIRYYCSETTDRFLYIALEL-CNLNLQDLVESKNVSDENLKLQKEY 115
Query: 750 QRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAH-------------VSDF 796
+++++ +A+ +++LH I+HRD+ +N+L+ + +SDF
Sbjct: 116 NPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDF 172
Query: 797 GFAKFLEPHSSNWT----EFAGTVGYAAPEL-------AYTMRATEKYDVYSFGVLALEV 845
G K L+ S++ +GT G+ APEL R T D++S G + +
Sbjct: 173 GLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYI 232
Query: 846 I-KGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRDVTDKLRSIMEVAILCLVENPE 904
+ KG HP + S+I I ++++ + + TD + + +P
Sbjct: 233 LSKGKHPFGDKYSRESNIIRGIFSLDEMKCLHDRSLIAEATDLISQ-------MIDHDPL 285
Query: 905 ARPTMKEVCN 914
RPT +V
Sbjct: 286 KRPTAMKVLR 295
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 2e-29
Identities = 67/287 (23%), Positives = 114/287 (39%), Gaps = 52/287 (18%)
Query: 646 GNFGEKYCIGKGGQRSVYKAELPSGN----IFAVKKFKAELFSDETANPSEFLNEVLALT 701
G+FG VY L + AVK + S+FL E + +
Sbjct: 36 GHFGC-----------VYHGTLLDNDGKKIHCAVKSLN-RITDIGE--VSQFLTEGIIMK 81
Query: 702 EIRHRNIIKFHGFCSNAQHS-FIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVAN 760
+ H N++ G C ++ S +V Y+ G L +R++ + + VA
Sbjct: 82 DFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNET--HNPTVKDLIGFGLQVAK 139
Query: 761 ALSYL--HHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGTVGY 818
+ YL VHRD++++N +LD ++ V+DFG A+ + + + G
Sbjct: 140 GMKYLASKK-----FVHRDLAARNCMLDEKFTVKVADFGLARDM--YDKEYYSVHNKTGA 192
Query: 819 A------APELAYTMRATEKYDVYSFGVLALEVI-KGYHPGDFVSTIFSSISNMIIEVNQ 871
A E T + T K DV+SFGVL E++ +G P + ++ ++
Sbjct: 193 KLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP-------YPDVNTF--DITV 243
Query: 872 ILD--HRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLL 916
L RL P D L +M + C E RP+ E+ + +
Sbjct: 244 YLLQGRRLLQP-EYCPDPLYEVM---LKCWHPKAEMRPSFSELVSRI 286
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 3e-29
Identities = 66/285 (23%), Positives = 107/285 (37%), Gaps = 48/285 (16%)
Query: 646 GNFGEKYCIGKGGQRSVYKAELPSGNIF----AVKKFKAELFSDETANPSEFLNEVLALT 701
G+FG VY E A+K + FL E L +
Sbjct: 32 GHFGV-----------VYHGEYIDQAQNRIQCAIKSLSRITEMQQ---VEAFLREGLLMR 77
Query: 702 EIRHRNIIKFHGFCSNAQ-HSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVAN 760
+ H N++ G + ++ Y+ G L +R + + ++ VA
Sbjct: 78 GLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQ--RNPTVKDLISFGLQVAR 135
Query: 761 ALSYL--HHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGT--- 815
+ YL VHRD++++N +LD + V+DFG A+ + +
Sbjct: 136 GMEYLAEQK-----FVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARL 190
Query: 816 -VGYAAPELAYTMRATEKYDVYSFGVLALEVI-KGYHPGDFVSTIFSSISNMIIEVNQIL 873
V + A E T R T K DV+SFGVL E++ +G P + I ++ L
Sbjct: 191 PVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPP-------YRHIDPF--DLTHFL 241
Query: 874 D--HRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLL 916
RLP P D L +M+ C +P RPT + + +
Sbjct: 242 AQGRRLPQP-EYCPDSLYQVMQ---QCWEADPAVRPTFRVLVGEV 282
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 3e-29
Identities = 65/300 (21%), Positives = 113/300 (37%), Gaps = 53/300 (17%)
Query: 648 FGEKY----CIGKGGQRSVYKA-ELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTE 702
+ + +G+G V KA +A+KK + ++ S L+EV+ L
Sbjct: 4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIR--HTEEKL---STILSEVMLLAS 58
Query: 703 IRHRNIIKFHGF-------------CSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWN 749
+ H+ +++++ FI EY G+L ++ +
Sbjct: 59 LNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHS--ENLNQQRD 116
Query: 750 QRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLE------ 803
+ + + + ALSY+H I +HRD+ N+ +D + DFG AK +
Sbjct: 117 EYWRLFRQILEALSYIHSQGI---IHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDIL 173
Query: 804 --------PHSSNWTEFAGTVGYAAPE-LAYTMRATEKYDVYSFGVLALEVIKGYHPGDF 854
S N T GT Y A E L T EK D+YS G++ E+I + G
Sbjct: 174 KLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFSTGME 233
Query: 855 VSTIFSSISNMIIEVNQILDHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914
I + ++ IE P + + I+ L + +P RP + + N
Sbjct: 234 RVNILKKLRSVSIEFP-------PDFDDNKMKVEKKIIR---LLIDHDPNKRPGARTLLN 283
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 5e-29
Identities = 66/285 (23%), Positives = 114/285 (40%), Gaps = 48/285 (16%)
Query: 646 GNFGEKYCIGKGGQRSVYKAELPSGN----IFAVKKFKAELFSDETANPSEFLNEVLALT 701
G+FG VY L + AVK + S+FL E + +
Sbjct: 100 GHFGC-----------VYHGTLLDNDGKKIHCAVKSLN-RITDIGE--VSQFLTEGIIMK 145
Query: 702 EIRHRNIIKFHGFCSNAQHS-FIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVAN 760
+ H N++ G C ++ S +V Y+ G L +R++ + + VA
Sbjct: 146 DFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNET--HNPTVKDLIGFGLQVAK 203
Query: 761 ALSYL--HHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGT--- 815
+ +L VHRD++++N +LD ++ V+DFG A+ + +
Sbjct: 204 GMKFLASKK-----FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKL 258
Query: 816 -VGYAAPELAYTMRATEKYDVYSFGVLALEVI-KGYHPGDFVSTIFSSISNMIIEVNQIL 873
V + A E T + T K DV+SFGVL E++ +G P + ++ ++ L
Sbjct: 259 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP-------YPDVNTF--DITVYL 309
Query: 874 D--HRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLL 916
RL P D L +M + C E RP+ E+ + +
Sbjct: 310 LQGRRLLQP-EYCPDPLYEVM---LKCWHPKAEMRPSFSELVSRI 350
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 7e-29
Identities = 73/300 (24%), Positives = 125/300 (41%), Gaps = 65/300 (21%)
Query: 646 GNFGEKYCIGKGGQRSVYKAELPSGNIF------AVKKFKAELFSDETANPSEFLNEVLA 699
G FG+ V+ AE + + AVK K + +F E
Sbjct: 26 GAFGK-----------VFLAECYNLSPTKDKMLVAVKALKDPTLAAR----KDFQREAEL 70
Query: 700 LTEIRHRNIIKFHGFCSNAQHSFIVCEYLARGSLTTILR-------------DDAAAKEF 746
LT ++H +I+KF+G C + +V EY+ G L LR A E
Sbjct: 71 LTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGEL 130
Query: 747 SWNQRMNVIKGVANALSYL--HHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEP 804
+Q +++ +A+ + YL H VHRD++++N L+ + + DFG ++ +
Sbjct: 131 GLSQMLHIASQIASGMVYLASQH-----FVHRDLATRNCLVGANLLVKIGDFGMSRDV-- 183
Query: 805 HSSNWTEFAGT----VGYAAPE-LAYTMRATEKYDVYSFGVLALEVI-KGYHPGDFVSTI 858
+S+++ G + + PE + Y + T + DV+SFGV+ E+ G P
Sbjct: 184 YSTDYYRVGGHTMLPIRWMPPESIMYR-KFTTESDVWSFGVILWEIFTYGKQP------- 235
Query: 859 FSSISNMIIEV-NQILD-HRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLL 916
+ +SN EV I L P R ++ +M C P+ R +KE+ +L
Sbjct: 236 WFQLSNT--EVIECITQGRVLERP-RVCPKEVYDVML---GCWQREPQQRLNIKEIYKIL 289
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 7e-29
Identities = 64/248 (25%), Positives = 110/248 (44%), Gaps = 18/248 (7%)
Query: 19 NLSKLQYLDLGNNQLSGVIPPEIGKLNQLRRLYLDVNQLHGTIPPVIGQLSLINELVFCH 78
L+ + G + ++ + L+ + L + TI + L+ + L
Sbjct: 17 ALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVT-TIEG-VQYLNNLIGLELKD 72
Query: 79 NNVSGRIPSSLGNLSNLALLYLNDNSLFGSIPIVMGNLKSLSTLDLSQNQLNGSIPCSLD 138
N ++ + L NL+ + L L+ N L I L+S+ TLDL+ Q+ P L
Sbjct: 73 NQITD--LAPLKNLTKITELELSGNPLKNVSAI--AGLQSIKTLDLTSTQITDVTP--LA 126
Query: 139 NLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSENRLSGLIPLSLSNLSSLTVMSLFN 198
LSNL L+L N ++ P + L +L L + ++S L P L+NLS LT + +
Sbjct: 127 GLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSDLTP--LANLSKLTTLKADD 182
Query: 199 NSLSGSIPPILGNLKSLSTLGLHINQLNGVIPPSIGNLSSLRNLSLFNNRLYGFVPKEIG 258
N +S I P L +L +L + L NQ++ V P + N S+L ++L N +
Sbjct: 183 NKIS-DISP-LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTITNQPVFYNN 238
Query: 259 YLKSLSKL 266
L + +
Sbjct: 239 NLVVPNVV 246
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 1e-25
Identities = 56/248 (22%), Positives = 99/248 (39%), Gaps = 18/248 (7%)
Query: 2 LNLGFNLLFGNIPPQIGNLSKLQYLDLGNNQLSGVIPPEIGKLNQLRRLYLDVNQLHGTI 61
+ G + + + +L + L ++ + + LN L L L NQ+ +
Sbjct: 24 IAAGKSNVTDTVT--QADLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKDNQIT-DL 78
Query: 62 PPVIGQLSLINELVFCHNNVSGRIPSSLGNLSNLALLYLNDNSLFGSIPIVMGNLKSLST 121
P + L+ I EL N + S++ L ++ L L + P+ L +L
Sbjct: 79 AP-LKNLTKITELELSGNPLK--NVSAIAGLQSIKTLDLTSTQITDVTPL--AGLSNLQV 133
Query: 122 LDLSQNQLNGSIPCSLDNLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSENRLSGLI 181
L L NQ+ +I L L+NL L + +S P + NL L L +N++S +
Sbjct: 134 LYLDLNQIT-NIS-PLAGLTNLQYLSIGNAQVSDLTP--LANLSKLTTLKADDNKISDIS 189
Query: 182 PLSLSNLSSLTVMSLFNNSLSGSIPPILGNLKSLSTLGLHINQLNGVIPPSIGNLSSLRN 241
P L++L +L + L NN +S + P L N +L + L + NL
Sbjct: 190 P--LASLPNLIEVHLKNNQIS-DVSP-LANTSNLFIVTLTNQTITNQPVFYNNNLVVPNV 245
Query: 242 LSLFNNRL 249
+ +
Sbjct: 246 VKGPSGAP 253
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-25
Identities = 60/243 (24%), Positives = 109/243 (44%), Gaps = 18/243 (7%)
Query: 2 LNLGFNLLFGNIPPQIGNLSKLQYLDLGNNQLSGVIPPEIGKLNQLRRLYLDVNQLHGTI 61
L+ + I + L+ L L+L +NQ++ + P + L ++ L L N L
Sbjct: 46 LSAFGTGV-TTIEG-VQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPL--KN 99
Query: 62 PPVIGQLSLINELVFCHNNVSGRIPSSLGNLSNLALLYLNDNSLFGSIPIVMGNLKSLST 121
I L I L ++ + L LSNL +LYL+ N + P+ L +L
Sbjct: 100 VSAIAGLQSIKTLDLTSTQITD--VTPLAGLSNLQVLYLDLNQITNISPL--AGLTNLQY 155
Query: 122 LDLSQNQLNGSIPCSLDNLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSENRLSGLI 181
L + Q++ P L NLS L TL N +S P + +L +L+++ L N++S +
Sbjct: 156 LSIGNAQVSDLTP--LANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVS 211
Query: 182 PLSLSNLSSLTVMSLFNNSLSGSIPPILGNLKSLSTLGLHINQLNGVIPPSIGNLSSLRN 241
P L+N S+L +++L N +++ NL + + + P +I + + +
Sbjct: 212 P--LANTSNLFIVTLTNQTITNQPVFYNNNLVVPNVVKGPSGAP--IAPATISDNGTYAS 267
Query: 242 LSL 244
+L
Sbjct: 268 PNL 270
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 5e-25
Identities = 61/295 (20%), Positives = 126/295 (42%), Gaps = 25/295 (8%)
Query: 87 SSLGNLSNLALLYLNDNSLFGSIPIVMGNLKSLSTLDLSQNQLNGSIPCSLDNLSNLDTL 146
L+N + +++ ++ +L ++TL + +I + L+NL L
Sbjct: 13 FPDPALANAIKIAAGKSNVTDTVTQ--ADLDGITTLSAFGTGVT-TIE-GVQYLNNLIGL 68
Query: 147 FLYKNSLSGPIPSVIGNLKSLLQLDLSENRLSGLIPLSLSNLSSLTVMSLFNNSLSGSIP 206
L N ++ P + NL + +L+LS N L + ++ L S+ + L + ++ P
Sbjct: 69 ELKDNQITDLAP--LKNLTKITELELSGNPLKNVSA--IAGLQSIKTLDLTSTQITDVTP 124
Query: 207 PILGNLKSLSTLGLHINQLNGVIPPSIGNLSSLRNLSLFNNRLYGFVPKEIGYLKSLSKL 266
L L +L L L +NQ+ + P + L++L+ LS+ N ++ P + L L+ L
Sbjct: 125 --LAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSDLTP--LANLSKLTTL 178
Query: 267 EFCANHLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLRNLTSLERVRFNQNNLYGKVY 326
+ N +S + P + +L L+ +++ N + P L N ++L V + +
Sbjct: 179 KADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTITNQPV 234
Query: 327 EAFGDHPNLTFLDLSQNNFYCEISFNWRNFSKLGTFNASMNNIYGSIPPEIGDSS 381
NL ++ + I+ S GT+ + N+ ++ I + S
Sbjct: 235 FYN---NNLVVPNVVKGPSGAPIAPA--TISDNGTYAS--PNLTWNLTSFINNVS 282
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 2e-22
Identities = 55/262 (20%), Positives = 101/262 (38%), Gaps = 18/262 (6%)
Query: 283 NLTGLVLLNMCENHLFGPIPKSLRNLTSLERVRFNQNNLYGKVYEAFGDHPNLTFLDLSQ 342
L + + ++++ + +L + + + E NL L+L
Sbjct: 17 ALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGV--TTIEGVQYLNNLIGLELKD 72
Query: 343 NNFYCEISFNWRNFSKLGTFNASMNNIYGSIPPEIGDSSKLQVLDLSSNHIFGKIPVQLV 402
N +++ +N +K+ S N + I ++ LDL+S I P L
Sbjct: 73 NQIT-DLA-PLKNLTKITELELSGNPL--KNVSAIAGLQSIKTLDLTSTQITDVTP--LA 126
Query: 403 KLFSLNKLILSLNQLFGGVPLEFGTLTELQYLDLSANKLSSSIPMSIGNLLKLHYLNLSN 462
L +L L L LNQ+ PL LT LQYL + ++S P + NL KL L +
Sbjct: 127 GLSNLQVLYLDLNQITNISPLA--GLTNLQYLSIGNAQVSDLTP--LANLSKLTTLKADD 182
Query: 463 NQFSHKIPTEFEKLIHLSELDLSHNILQEEIPPQICKMESLEKLNLSHNNLSDFIPRCFE 522
N+ S I L +L E+ L +N + + P + +L + L++ +++
Sbjct: 183 NKIS-DIS-PLASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTITNQPVFYNN 238
Query: 523 EMRSLSWIDISYNELQGPIPNS 544
+ + + P S
Sbjct: 239 NLVVPNVVKGPSGAPIAPATIS 260
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 2e-22
Identities = 51/234 (21%), Positives = 95/234 (40%), Gaps = 18/234 (7%)
Query: 305 LRNLTSLERVRFNQNNLYGKVYEAFGDHPNLTFLDLSQNNFYCEISFNWRNFSKLGTFNA 364
L + ++ ++N+ D +T L I + + L
Sbjct: 15 DPALANAIKIAAGKSNVTD--TVTQADLDGITTLSAFGTGVT-TIE-GVQYLNNLIGLEL 70
Query: 365 SMNNIYGSIPPEIGDSSKLQVLDLSSNHIFGKIPVQLVKLFSLNKLILSLNQLFGGVPLE 424
N I + P + + +K+ L+LS N + K + L S+ L L+ Q+ PL
Sbjct: 71 KDNQI-TDLAP-LKNLTKITELELSGNPL--KNVSAIAGLQSIKTLDLTSTQITDVTPLA 126
Query: 425 FGTLTELQYLDLSANKLSSSIPMSIGNLLKLHYLNLSNNQFSHKIPTEFEKLIHLSELDL 484
L+ LQ L L N++++ P + L L YL++ N Q S P L L+ L
Sbjct: 127 --GLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSDLTP--LANLSKLTTLKA 180
Query: 485 SHNILQEEIPPQICKMESLEKLNLSHNNLSDFIPRCFEEMRSLSWIDISYNELQ 538
N + +I P + + +L +++L +N +SD P +L + ++ +
Sbjct: 181 DDNKI-SDISP-LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTIT 230
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 97.1 bits (242), Expect = 4e-22
Identities = 57/308 (18%), Positives = 111/308 (36%), Gaps = 44/308 (14%)
Query: 137 LDNLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSENRLSGLIPLSLSNLSSLTVMSL 196
L+N + K++++ + +L + L ++ + + L++L + L
Sbjct: 15 DPALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVTTIEG--VQYLNNLIGLEL 70
Query: 197 FNNSLSGSIPPILGNLKSLSTLGLHINQLNGVIPPSIGNLSSLRNLSLFNNRLYGFVPKE 256
+N ++ + P L NL ++ L L N L V I L S++ L L + ++ P
Sbjct: 71 KDNQIT-DLAP-LKNLTKITELELSGNPLKNVSA--IAGLQSIKTLDLTSTQITDVTP-- 124
Query: 257 IGYLKSLSKLEFCANHLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLRNLTSLERVRF 316
+ L +L L N ++ + P + LT L L++ + P L NL+ L ++
Sbjct: 125 LAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSDLTP--LANLSKLTTLKA 180
Query: 317 NQNNLYGKVYEAFGDHPNLTFLDLSQNNFYCEISFNWRNFSKLGTFNASMNNIYGSIPPE 376
+ N + PNL + L N IS + P
Sbjct: 181 DDNKI--SDISPLASLPNLIEVHLKNNQ----IS---------------------DVSP- 212
Query: 377 IGDSSKLQVLDLSSNHIFGKIPVQLVKLFSLNKLILSLNQLFGGVPLEFGTLTELQYLDL 436
+ ++S L ++ L++ I + L N + P +L
Sbjct: 213 LANTSNLFIVTLTNQTITNQPVFYNNNLVVPNVVKGPSGAPI--APATISDNGTYASPNL 270
Query: 437 SANKLSSS 444
+ N S
Sbjct: 271 TWNLTSFI 278
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 94.0 bits (234), Expect = 4e-21
Identities = 53/227 (23%), Positives = 95/227 (41%), Gaps = 16/227 (7%)
Query: 2 LNLGFNLLFGNIPPQIGNLSKLQYLDLGNNQLSGVIPPEIGKLNQLRRLYLDVNQLHGTI 61
L L N + ++ P + NL+K+ L+L N L V I L ++ L L Q+
Sbjct: 68 LELKDNQI-TDLAP-LKNLTKITELELSGNPLKNVSA--IAGLQSIKTLDLTSTQITDVT 123
Query: 62 PPVIGQLSLINELVFCHNNVSGRIPSSLGNLSNLALLYLNDNSLFGSIPIVMGNLKSLST 121
P + LS + L N ++ S L L+NL L + + + P+ NL L+T
Sbjct: 124 P--LAGLSNLQVLYLDLNQITN--ISPLAGLTNLQYLSIGNAQVSDLTPL--ANLSKLTT 177
Query: 122 LDLSQNQLNGSIPCSLDNLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSENRLSGLI 181
L N+++ I L +L NL + L N +S P + N +L + L+ ++
Sbjct: 178 LKADDNKIS-DIS-PLASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTITNQP 233
Query: 182 PLSLSNLSSLTVMSLFNNSLSGSIPPILGNLKSLSTLGLHINQLNGV 228
+NL + S + P + + + ++ L N + +
Sbjct: 234 VFYNNNLVVPN--VVKGPSGAPIAPATISDNGTYASPNLTWNLTSFI 278
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 91.3 bits (227), Expect = 3e-20
Identities = 58/327 (17%), Positives = 117/327 (35%), Gaps = 68/327 (20%)
Query: 163 NLKSLLQLDLSENRLSGLIPLSLSNLSSLTVMSLFNNSLSGSIPPILGNLKSLSTLGLHI 222
L + +++ ++ ++ + + +L +T +S F ++ +I + L +L L L
Sbjct: 17 ALANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVT-TIEG-VQYLNNLIGLELKD 72
Query: 223 NQLNGVIPPSIGNLSSLRNLSLFNNRLYGFVPKEIGYLKSLSKLEFCANHLSGVIPHSVG 282
NQ+ + P + NL+ + L L N L I L+S+ L+ + ++ V P +
Sbjct: 73 NQITDLAP--LKNLTKITELELSGNPLKNV--SAIAGLQSIKTLDLTSTQITDVTPLA-- 126
Query: 283 NLTGLVLLNMCENHLFGPIPKSLRNLTSLERVRFNQNNLYGKVYEAFGDHPNLTFLDLSQ 342
L+ L +L + N + ++ L L NL +L +
Sbjct: 127 GLSNLQVLYLDLNQI-----TNISPLAGL---------------------TNLQYLSIGN 160
Query: 343 NNFYCEISFNWRNFSKLGTFNASMNNIYGSIPPEIGDSSKLQVLDLSSNHIFGKIPVQLV 402
+S + P + + SKL L N I I L
Sbjct: 161 AQ----VS---------------------DLTP-LANLSKLTTLKADDNKI-SDIS-PLA 192
Query: 403 KLFSLNKLILSLNQLFGGVPLEFGTLTELQYLDLSANKLSSSIPMSIGNLLKLHYLNLSN 462
L +L ++ L NQ+ PL + L + L+ +++ NL+ +
Sbjct: 193 SLPNLIEVHLKNNQISDVSPLA--NTSNLFIVTLTNQTITNQPVFYNNNLVVP--NVVKG 248
Query: 463 NQFSHKIPTEFEKLIHLSELDLSHNIL 489
+ P + +L+ N+
Sbjct: 249 PSGAPIAPATISDNGTYASPNLTWNLT 275
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 3e-17
Identities = 43/198 (21%), Positives = 80/198 (40%), Gaps = 15/198 (7%)
Query: 340 LSQNNFYCEISFNWRNFSKLGTFNASMNNIYGSIPPEIGDSSKLQVLDLSSNHIFGKIPV 399
++Q I F + A +N+ ++ D + L + I
Sbjct: 3 ITQPTAINVI-FPDPALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGV-TTIEG 58
Query: 400 QLVKLFSLNKLILSLNQLFGGVPLEFGTLTELQYLDLSANKLSSSIPMSIGNLLKLHYLN 459
+ L +L L L NQ+ PL+ LT++ L+LS N L + I L + L+
Sbjct: 59 -VQYLNNLIGLELKDNQITDLAPLK--NLTKITELELSGNPLKNVSA--IAGLQSIKTLD 113
Query: 460 LSNNQFSHKIPTEFEKLIHLSELDLSHNILQEEIPPQICKMESLEKLNLSHNNLSDFIPR 519
L++ Q + P L +L L L N + I P + + +L+ L++ + +SD P
Sbjct: 114 LTSTQITDVTP--LAGLSNLQVLYLDLNQI-TNISP-LAGLTNLQYLSIGNAQVSDLTP- 168
Query: 520 CFEEMRSLSWIDISYNEL 537
+ L+ + N++
Sbjct: 169 -LANLSKLTTLKADDNKI 185
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 8e-29
Identities = 60/302 (19%), Positives = 112/302 (37%), Gaps = 73/302 (24%)
Query: 646 GNFGEKYCIGKGGQRSVYKAELPSGNIF----AVKKFKAELFSDETANPSEFLNEVLALT 701
G FG V +A+L + AVK KA++ + + EFL E +
Sbjct: 34 GEFGS-----------VREAQLKQEDGSFVKVAVKMLKADIIASS--DIEEFLREAACMK 80
Query: 702 EIRHRNIIKFHGFCSNAQ------HSFIVCEYLARGSLTTILRD---DAAAKEFSWNQRM 752
E H ++ K G ++ ++ ++ G L L +
Sbjct: 81 EFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLV 140
Query: 753 NVIKGVANALSYL--HHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSN-- 808
+ +A + YL + +HRD++++N +L + V+DFG ++ + +S +
Sbjct: 141 RFMVDIACGMEYLSSRN-----FIHRDLAARNCMLAEDMTVCVADFGLSRKI--YSGDYY 193
Query: 809 -----------WTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVI-KGYHPGDFVS 856
W A E T DV++FGV E++ +G P
Sbjct: 194 RQGCASKLPVKWL---------ALESLADNLYTVHSDVWAFGVTMWEIMTRGQTP----- 239
Query: 857 TIFSSISNMIIEVNQILD--HRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914
++ I N E+ L +RL P + +++ +M C +P+ RP+ +
Sbjct: 240 --YAGIENA--EIYNYLIGGNRLKQP-PECMEEVYDLMY---QCWSADPKQRPSFTCLRM 291
Query: 915 LL 916
L
Sbjct: 292 EL 293
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 9e-29
Identities = 74/299 (24%), Positives = 122/299 (40%), Gaps = 64/299 (21%)
Query: 646 GNFGEKYCIGKGGQRSVYKAELPSGNIF------AVKKFKAELFSDETANPSEFLNEVLA 699
G FG+ V+ AE + AVK K S +F E
Sbjct: 52 GAFGK-----------VFLAECHNLLPEQDKMLVAVKALKEASESAR----QDFQREAEL 96
Query: 700 LTEIRHRNIIKFHGFCSNAQHSFIVCEYLARGSLTTILR------------DDAAAKEFS 747
LT ++H++I++F G C+ + +V EY+ G L LR +D A
Sbjct: 97 LTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLG 156
Query: 748 WNQRMNVIKGVANALSYL--HHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPH 805
Q + V VA + YL H VHRD++++N L+ + DFG ++ + +
Sbjct: 157 LGQLLAVASQVAAGMVYLAGLH-----FVHRDLATRNCLVGQGLVVKIGDFGMSRDI--Y 209
Query: 806 SSNWTEFAGT----VGYAAPE-LAYTMRATEKYDVYSFGVLALEVI-KGYHPGDFVSTIF 859
S+++ G + + PE + Y + T + DV+SFGV+ E+ G P +
Sbjct: 210 STDYYRVGGRTMLPIRWMPPESILYR-KFTTESDVWSFGVVLWEIFTYGKQP-------W 261
Query: 860 SSISNMIIEVNQILD--HRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLL 916
+SN E + L P R ++ +IM C P+ R ++K+V L
Sbjct: 262 YQLSNT--EAIDCITQGRELERP-RACPPEVYAIMR---GCWQREPQQRHSIKDVHARL 314
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 1e-28
Identities = 59/220 (26%), Positives = 93/220 (42%), Gaps = 15/220 (6%)
Query: 12 NIPPQIGNLSKLQYLDLGNNQLSGVIPPEIGKLNQLRRLYLDVNQLHGTIPP-VIGQLSL 70
IP Q + L N++S V L L+L N L I L+L
Sbjct: 29 GIPAA------SQRIFLHGNRISHVPAASFRACRNLTILWLHSNVL-ARIDAAAFTGLAL 81
Query: 71 INELVFCHNNVSGRIPSS-LGNLSNLALLYLNDNSLFGSIPIVM-GNLKSLSTLDLSQNQ 128
+ +L N + + L L L+L+ L + + L +L L L N
Sbjct: 82 LEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNA 140
Query: 129 LNGSIP-CSLDNLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSENRLSGLIPLSLSN 187
L ++P + +L NL LFL+ N +S L SL +L L +NR++ + P + +
Sbjct: 141 LQ-ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRD 199
Query: 188 LSSLTVMSLFNNSLSGSIPP-ILGNLKSLSTLGLHINQLN 226
L L + LF N+LS ++P L L++L L L+ N
Sbjct: 200 LGRLMTLYLFANNLS-ALPTEALAPLRALQYLRLNDNPWV 238
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 6e-26
Identities = 50/204 (24%), Positives = 87/204 (42%), Gaps = 7/204 (3%)
Query: 2 LNLGFNLLFGNIPPQI-GNLSKLQYLDLGNNQLSGVIPPEIGKLNQLRRLYLDVNQLHGT 60
+ L N + ++P L L L +N L+ + L L +L L N +
Sbjct: 37 IFLHGNRI-SHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRS 95
Query: 61 IPP-VIGQLSLINELVFCHNNVSGRIPS-SLGNLSNLALLYLNDNSLFGSIPI-VMGNLK 117
+ P L ++ L + + L+ L LYL DN+L ++P +L
Sbjct: 96 VDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNAL-QALPDDTFRDLG 153
Query: 118 SLSTLDLSQNQLNGSIPCSLDNLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSENRL 177
+L+ L L N+++ + L +LD L L++N ++ P +L L+ L L N L
Sbjct: 154 NLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNL 213
Query: 178 SGLIPLSLSNLSSLTVMSLFNNSL 201
S L +L+ L +L + L +N
Sbjct: 214 SALPTEALAPLRALQYLRLNDNPW 237
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 6e-26
Identities = 58/232 (25%), Positives = 94/232 (40%), Gaps = 27/232 (11%)
Query: 118 SLSTLDLSQNQLNGSIPCSLDNLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSEN-R 176
+ + L N+++ S NL L+L+ N L+ + L L QLDLS+N +
Sbjct: 33 ASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQ 92
Query: 177 LSGLIPLSLSNLSSLTVMSLFNNSLSGSIPP-ILGNLKSLSTLGLHINQLNGVIPPSIGN 235
L + P + L L + L L + P + L +L L L N L + + +
Sbjct: 93 LRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNALQALPDDTFRD 151
Query: 236 LSSLRNLSLFNNRLYGFVPKEIGYLKSLSKLEFCANHLSGVIPHSVGNLTGLVLLNMCEN 295
L +L +L L NR+ + L SL +L N ++ V PH+ +L L+ L + N
Sbjct: 152 LGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFAN 211
Query: 296 HLFGPIPKSLRNLTSLERVRFNQNNLYGKVYEAFGDHPNLTFLDLSQNNFYC 347
NL++L EA L +L L+ N + C
Sbjct: 212 -----------NLSALPT-------------EALAPLRALQYLRLNDNPWVC 239
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 1e-25
Identities = 65/215 (30%), Positives = 91/215 (42%), Gaps = 13/215 (6%)
Query: 61 IPPVIGQLSLINELVFCHNNVSGRIPSSLGNLSNLALLYLNDNSLFGSIPI-VMGNLKSL 119
IP ++ L N +S +S NL +L+L+ N L I L L
Sbjct: 30 IPAASQRIFLHG------NRISHVPAASFRACRNLTILWLHSNVL-ARIDAAAFTGLALL 82
Query: 120 STLDLSQNQLNGSIPCS-LDNLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSENRLS 178
LDLS N S+ + L L TL L + L P + L +L L L +N L
Sbjct: 83 EQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQ 142
Query: 179 GLIPLSLSNLSSLTVMSLFNNSLSGSIPP-ILGNLKSLSTLGLHINQLNGVIPPSIGNLS 237
L + +L +LT + L N +S S+P L SL L LH N++ V P + +L
Sbjct: 143 ALPDDTFRDLGNLTHLFLHGNRIS-SVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLG 201
Query: 238 SLRNLSLFNNRLYGFVPKEI-GYLKSLSKLEFCAN 271
L L LF N L +P E L++L L N
Sbjct: 202 RLMTLYLFANNL-SALPTEALAPLRALQYLRLNDN 235
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 1e-24
Identities = 58/245 (23%), Positives = 85/245 (34%), Gaps = 29/245 (11%)
Query: 293 CENHLFGPIPKSLRNLTSLERVRFNQNNLYGKVYEAFGDHPNLTFLDLSQNNFYCEISFN 352
C +P + + +R+ + N + +F NLT L L N I
Sbjct: 18 CPQQGLQAVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVL-ARIDAA 74
Query: 353 WRNFSKLGTFNASMNNIYGSIPPEIGDSSKLQVLDLSSNHIFGKIPVQ-LVKLFSLNKLI 411
F+ L + L+ LDLS N + L L+ L
Sbjct: 75 A--FTGL---------------------ALLEQLDLSDNAQLRSVDPATFHGLGRLHTLH 111
Query: 412 LSLNQLFGGVPLEFGTLTELQYLDLSANKLSSSIPMSIGNLLKLHYLNLSNNQFSHKIPT 471
L L P F L LQYL L N L + + +L L +L L N+ S
Sbjct: 112 LDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPER 171
Query: 472 EFEKLIHLSELDLSHNILQEEIPPQI-CKMESLEKLNLSHNNLSDFIPRCFEEMRSLSWI 530
F L L L L N + + P + L L L NNLS +R+L ++
Sbjct: 172 AFRGLHSLDRLLLHQNRVAH-VHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYL 230
Query: 531 DISYN 535
++ N
Sbjct: 231 RLNDN 235
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 4e-21
Identities = 46/209 (22%), Positives = 72/209 (34%), Gaps = 5/209 (2%)
Query: 285 TGLVLLNMCENHLFGPIPKSLRNLTSLERVRFNQNNLYGKVYEAFGDHPNLTFLDLSQNN 344
+ + N + S R +L + + N L AF L LDLS N
Sbjct: 32 AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNA 91
Query: 345 FYCEISFN-WRNFSKLGTFNASMNNIYGSIPPEI-GDSSKLQVLDLSSNHIFGKIPVQ-L 401
+ + +L T + + + P + + LQ L L N + +P
Sbjct: 92 QLRSVDPATFHGLGRLHTLHLDRCGL-QELGPGLFRGLAALQYLYLQDNAL-QALPDDTF 149
Query: 402 VKLFSLNKLILSLNQLFGGVPLEFGTLTELQYLDLSANKLSSSIPMSIGNLLKLHYLNLS 461
L +L L L N++ F L L L L N+++ P + +L +L L L
Sbjct: 150 RDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLF 209
Query: 462 NNQFSHKIPTEFEKLIHLSELDLSHNILQ 490
N S L L L L+ N
Sbjct: 210 ANNLSALPTEALAPLRALQYLRLNDNPWV 238
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 5e-19
Identities = 39/180 (21%), Positives = 64/180 (35%), Gaps = 31/180 (17%)
Query: 372 SIPPEIGDSSKLQVLDLSSNHIFGKIPVQLVKLFSLNKLILSLNQLFGGVPLEFGTLTEL 431
++P I + Q + L N I +P F L
Sbjct: 25 AVPVGI--PAASQRIFLHGNRI-SHVPAAS-----------------------FRACRNL 58
Query: 432 QYLDLSANKLSSSIPMSIGNLLKLHYLNLSNNQFSHKIPTE-FEKLIHLSELDLSHNILQ 490
L L +N L+ + L L L+LS+N + F L L L L LQ
Sbjct: 59 TILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ 118
Query: 491 EEIPPQI-CKMESLEKLNLSHNNLSDFIPRCFEEMRSLSWIDISYNELQGPIPNSTAFKN 549
E + P + + +L+ L L N L F ++ +L+ + + N + +P AF+
Sbjct: 119 E-LGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISS-VPER-AFRG 175
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 2e-28
Identities = 59/275 (21%), Positives = 110/275 (40%), Gaps = 32/275 (11%)
Query: 649 GEKYCI----GKGGQRSVYKA-ELPSGNIFAVK-KFKAELFSDETANPSEFLNEVLALTE 702
+Y GKGG ++ + + +FA K K+ L + E+
Sbjct: 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQRE--KMSMEISIHRS 97
Query: 703 IRHRNIIKFHGFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANAL 762
+ H++++ FHGF + F+V E R SL + + K + + ++ +
Sbjct: 98 LAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHK---RRKALTEPEARYYLRQIVLGC 154
Query: 763 SYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGTVGYAAPE 822
YLH + + +HRD+ N+ L+ + E + DFG A +E GT Y APE
Sbjct: 155 QYLHRNRV---IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPE 211
Query: 823 LAYTMRATEKYDVYSFGVLALEVIKGYHP--GDFVSTIFSSISNMIIEVNQILDHRLPT- 879
+ + + DV+S G + ++ G P + + I ++ +P
Sbjct: 212 VLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKK--------NEYSIPKH 263
Query: 880 PSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914
+ ++ + L +P ARPT+ E+ N
Sbjct: 264 INPVAASLIQKM-------LQTDPTARPTINELLN 291
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 2e-28
Identities = 77/264 (29%), Positives = 122/264 (46%), Gaps = 30/264 (11%)
Query: 654 IGKGGQRSVYKA-ELPSGNIFAVKK-FKAELFSDETANPSEFLNEVLALTEIRHRNIIKF 711
+GKG +VY A E S I A+K FKA+L + + EV + +RH NI++
Sbjct: 17 LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEH--QLRREVEIQSHLRHPNILRL 74
Query: 712 HGFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIP 771
+G+ +A +++ EY G++ L+ +F + I +ANALSY H +
Sbjct: 75 YGYFHDATRVYLILEYAPLGTVYRELQ---KLSKFDEQRTATYITELANALSYCHSKRV- 130
Query: 772 PIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGTVGYAAPELAYTMRATE 831
+HRDI +N+LL S E ++DFG++ SS T+ GT+ Y PE+ E
Sbjct: 131 --IHRDIKPENLLLGSAGELKIADFGWSVHAP--SSRRTDLCGTLDYLPPEMIEGRMHDE 186
Query: 832 KYDVYSFGVLALEVIKGYHP--GDFVSTIFSSISNMIIEVNQILDHRLPTP-SRDVTDKL 888
K D++S GVL E + G P + + IS + + P + D +
Sbjct: 187 KVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV--------EFTFPDFVTEGARDLI 238
Query: 889 RSIMEVAILCLVENPEARPTMKEV 912
+ L NP RP ++EV
Sbjct: 239 SRL-------LKHNPSQRPMLREV 255
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 2e-28
Identities = 67/266 (25%), Positives = 106/266 (39%), Gaps = 31/266 (11%)
Query: 654 IGKGGQRSVYKAE---LPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIK 710
+G GG V+ A AVK +A+L D + F E + H I+
Sbjct: 20 LGFGGMSEVHLARDLRD--HRDVAVKVLRADLARDPSFY-LRFRREAQNAAALNHPAIVA 76
Query: 711 FH--GFCSNAQHS--FIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLH 766
+ G +IV EY+ +L I+ + + + + VI AL++ H
Sbjct: 77 VYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQALNFSH 133
Query: 767 HDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFA---GTVGYAAPEL 823
+ I+HRD+ N+++ + V DFG A+ + ++ T+ A GT Y +PE
Sbjct: 134 QN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQ 190
Query: 824 AYTMRATEKYDVYSFGVLALEVIKGYHP--GDFVSTIFSSISNMIIEVNQILDHRLPTPS 881
A + DVYS G + EV+ G P GD S +S Q + PS
Sbjct: 191 ARGDSVDARSDVYSLGCVLYEVLTGEPPFTGD------SPVSVAY----QHVREDPIPPS 240
Query: 882 RDVTDKLRSIMEVAILCLVENPEARP 907
+ V + L +NPE R
Sbjct: 241 ARHEGLSADLDAVVLKALAKNPENRY 266
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 2e-28
Identities = 51/295 (17%), Positives = 102/295 (34%), Gaps = 50/295 (16%)
Query: 647 NFGEKY----CIGKGGQRSVYKA-ELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALT 701
+ ++ IG G SV+K + G I+A+K+ K L L EV A
Sbjct: 8 RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQ--NALREVYAHA 65
Query: 702 EI-RHRNIIKFHGFCSNAQHSFIVCEYLARGSLTTILRDDAAAKE-FSWNQRMNVIKGVA 759
+ +H +++++ + H I EY GSL + ++ F + +++ V
Sbjct: 66 VLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVG 125
Query: 760 NALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVS-------------------DFGFAK 800
L Y+H +VH DI N+ + + + D G
Sbjct: 126 RGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVT 182
Query: 801 FLEPHSSNWTEFAGTVGYAAPE-LAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIF 859
S+ G + A E L K D+++ + +
Sbjct: 183 ----RISSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPL-------P 231
Query: 860 SSISNMIIEVNQILDHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914
+ ++I RLP + ++ + +++ + + +PE RP+ +
Sbjct: 232 RNGDQW----HEIRQGRLPRIPQVLSQEFTELLK---VMIHPDPERRPSAMALVK 279
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 114 bits (289), Expect = 2e-28
Identities = 59/275 (21%), Positives = 110/275 (40%), Gaps = 32/275 (11%)
Query: 649 GEKYCI----GKGGQRSVYKA-ELPSGNIFAVK-KFKAELFSDETANPSEFLNEVLALTE 702
+Y GKGG ++ + + +FA K K+ L + E+
Sbjct: 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQRE--KMSMEISIHRS 71
Query: 703 IRHRNIIKFHGFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANAL 762
+ H++++ FHGF + F+V E R SL + + K + + ++ +
Sbjct: 72 LAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHK---RRKALTEPEARYYLRQIVLGC 128
Query: 763 SYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGTVGYAAPE 822
YLH + + +HRD+ N+ L+ + E + DFG A +E GT Y APE
Sbjct: 129 QYLHRNRV---IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPE 185
Query: 823 LAYTMRATEKYDVYSFGVLALEVIKGYHP--GDFVSTIFSSISNMIIEVNQILDHRLPTP 880
+ + + DV+S G + ++ G P + + I ++ +P
Sbjct: 186 VLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKK--------NEYSIPKH 237
Query: 881 -SRDVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914
+ ++ + L +P ARPT+ E+ N
Sbjct: 238 INPVAASLIQKM-------LQTDPTARPTINELLN 265
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 3e-28
Identities = 73/313 (23%), Positives = 119/313 (38%), Gaps = 37/313 (11%)
Query: 614 QEKRSSSANPFGFFSVLNFNGKVLYEEITKATGNFGEKYCI----GKGGQRSVYKA-ELP 668
SS F L + IT G+ E Y G G V +
Sbjct: 4 HHHHSSGRENLYFQGDLQATPGMF---ITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKV 60
Query: 669 SGNIFAVKKF-KAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFIVCEY 727
+ A+K K + + S+ L EV L + H NI+K + F + ++ ++V E
Sbjct: 61 THVERAIKIIRKTSVSTSSN---SKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMEC 117
Query: 728 LARGSLTTILRDDAAAKE-FSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLD 786
G L D+ + F+ +IK V + ++YLH IVHRD+ +N+LL+
Sbjct: 118 YKGGE----LFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLE 170
Query: 787 SEYEAH---VSDFGFAKFLEPHSSNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLAL 843
S+ + + DFG + E E GT Y APE+ + EK DV+S GV+
Sbjct: 171 SKEKDALIKIVDFGLSAVFEN-QKKMKERLGTAYYIAPEV-LRKKYDEKCDVWSIGVILF 228
Query: 844 EVIKGYHP--GDFVSTIFSSISNMIIEVNQILDHRLPTPSRDVTDKLRSIMEVAILCLVE 901
++ GY P G I + + S D ++ L
Sbjct: 229 ILLAGYPPFGGQTDQEILRKVEKGKYTFD---SPEWKNVSEGAKDLIKQ-------MLQF 278
Query: 902 NPEARPTMKEVCN 914
+ + R + ++
Sbjct: 279 DSQRRISAQQALE 291
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 4e-28
Identities = 66/272 (24%), Positives = 115/272 (42%), Gaps = 43/272 (15%)
Query: 653 CIGKGGQRSVYKA-ELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKF 711
IG G +VY A ++ + + A+KK + + EV L ++RH N I++
Sbjct: 61 EIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNE-KWQDIIKEVRFLQKLRHPNTIQY 119
Query: 712 HGFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIP 771
G +++V EY GS + +L K + V G L+YLH
Sbjct: 120 RGCYLREHTAWLVMEYCL-GSASDLLE--VHKKPLQEVEIAAVTHGALQGLAYLHSH--- 173
Query: 772 PIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGTVGYAAPELAYTMRATE 831
++HRD+ + N+LL + DFG A + P +S F GT + APE+ M +
Sbjct: 174 NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANS----FVGTPYWMAPEVILAMDEGQ 229
Query: 832 ---KYDVYSFGVLALEVIKG------YHPGDFVSTIFSSISNMIIEVNQILDHRLPTP-- 880
K DV+S G+ +E+ + + +S ++ I + +P
Sbjct: 230 YDGKVDVWSLGITCIELAERKPPLFNMNA---MSALY-----HIA--------QNESPAL 273
Query: 881 -SRDVTDKLRSIMEVAILCLVENPEARPTMKE 911
S ++ R+ ++ CL + P+ RPT +
Sbjct: 274 QSGHWSEYFRNFVD---SCLQKIPQDRPTSEV 302
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 4e-28
Identities = 57/272 (20%), Positives = 108/272 (39%), Gaps = 38/272 (13%)
Query: 653 CIGKGGQRSVYKA-ELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKF 711
+G G VYKA +G + A K + + + +++ E+ L H I+K
Sbjct: 26 ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEEL----EDYIVEIEILATCDHPYIVKL 81
Query: 712 HGFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIP 771
G + +I+ E+ G++ I+ + + Q V + + AL++LH
Sbjct: 82 LGAYYHDGKLWIMIEFCPGGAVDAIML--ELDRGLTEPQIQVVCRQMLEALNFLHSK--- 136
Query: 772 PIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGTVGYAAPELAYTMRATE 831
I+HRD+ + NVL+ E + ++DFG + F GT + APE+ +
Sbjct: 137 RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKD 196
Query: 832 -----KYDVYSFGVLALEVIKG------YHPGDFVSTIFSSISNMIIEVNQILDHRLPTP 880
K D++S G+ +E+ + +P + + I + P
Sbjct: 197 TPYDYKADIWSLGITLIEMAQIEPPHHELNP---MRVLL-----KIA--------KSDPP 240
Query: 881 SRDVTDKL-RSIMEVAILCLVENPEARPTMKE 911
+ K + + L +NPE RP+ +
Sbjct: 241 TLLTPSKWSVEFRDFLKIALDKNPETRPSAAQ 272
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 5e-28
Identities = 62/295 (21%), Positives = 121/295 (41%), Gaps = 56/295 (18%)
Query: 646 GNFGEKYCIGKGGQRSVYKAELPSGNIF------AVKKFKAELFSDETANPSEFLNEVLA 699
G+FG VY+ A+K E EFLNE
Sbjct: 36 GSFGM-----------VYEGVAKGVVKDEPETRVAIKTVNEAASMRE---RIEFLNEASV 81
Query: 700 LTEIRHRNIIKFHGFCSNAQHSFIVCEYLARGSLTTILR-------DDAAAKEFSWNQRM 752
+ E ++++ G S Q + ++ E + RG L + LR ++ S ++ +
Sbjct: 82 MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMI 141
Query: 753 NVIKGVANALSYL--HHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWT 810
+ +A+ ++YL + VHRD++++N ++ ++ + DFG + + + +++
Sbjct: 142 QMAGEIADGMAYLNANK-----FVHRDLAARNCMVAEDFTVKIGDFGMTRDI--YETDYY 194
Query: 811 EFAGT----VGYAAPELAYTMRATEKYDVYSFGVLALEVI-KGYHPGDFVSTIFSSISNM 865
G V + +PE T DV+SFGV+ E+ P + +SN
Sbjct: 195 RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP-------YQGLSNE 247
Query: 866 IIEV-NQILD-HRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLLCK 918
+V +++ L P + D L +M +C NP+ RP+ E+ + + +
Sbjct: 248 --QVLRFVMEGGLLDKP-DNCPDMLFELMR---MCWQYNPKMRPSFLEIISSIKE 296
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 5e-28
Identities = 72/289 (24%), Positives = 118/289 (40%), Gaps = 50/289 (17%)
Query: 645 TGNFGEKYCIGKGGQRSVYKA-ELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEI 703
G F +G G VYK + +G + A+K DE E E+ L +
Sbjct: 23 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT--GDEE---EEIKQEINMLKKY 77
Query: 704 -RHRNIIKFHG------FCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIK 756
HRNI ++G ++V E+ GS+T ++++ + +
Sbjct: 78 SHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKN-TKGNTLKEEWIAYICR 136
Query: 757 GVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGTV 816
+ LS+LH + +HRDI +NVLL E + DFG + L+ F GT
Sbjct: 137 EILRGLSHLHQHKV---IHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTP 193
Query: 817 GYAAPELAYTMRATE-----KYDVYSFGVLALEVIKG------YHPGDFVSTIFSSISNM 865
+ APE+ + K D++S G+ A+E+ +G HP + +F +
Sbjct: 194 YWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHP---MRALF-----L 245
Query: 866 IIEVNQILDHRLPTP---SRDVTDKLRSIMEVAILCLVENPEARPTMKE 911
I R P P S+ + K +S +E CLV+N RP ++
Sbjct: 246 IP--------RNPAPRLKSKKWSKKFQSFIE---SCLVKNHSQRPATEQ 283
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 6e-28
Identities = 69/284 (24%), Positives = 117/284 (41%), Gaps = 33/284 (11%)
Query: 641 ITKATGNFGEKYCI----GKGGQRSVYKA-ELPSGNIFAVKKF-KAELFSDETANPSEFL 694
+ +T F ++Y GKG V + +G AVK K ++ + L
Sbjct: 17 VQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKT--DKESLL 74
Query: 695 NEVLALTEIRHRNIIKFHGFCSNAQHSFIVCEYLARGSLTTILRDDAAAKE-FSWNQRMN 753
EV L ++ H NI+K + F + + ++V E G L D+ +++ FS
Sbjct: 75 REVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGE----LFDEIISRKRFSEVDAAR 130
Query: 754 VIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAH---VSDFGFAKFLEPHSSNWT 810
+I+ V + ++Y+H + IVHRD+ +N+LL+S+ + + DFG + E S
Sbjct: 131 IIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA-SKKMK 186
Query: 811 EFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHP--GDFVSTIFSSISNMIIE 868
+ GT Y APE+ EK DV+S GV+ ++ G P G I +
Sbjct: 187 DKIGTAYYIAPEV-LHGTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYT 245
Query: 869 VNQILDHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEV 912
+ S D +R L P R + ++
Sbjct: 246 FE---LPQWKKVSESAKDLIRK-------MLTYVPSMRISARDA 279
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 6e-28
Identities = 60/290 (20%), Positives = 114/290 (39%), Gaps = 45/290 (15%)
Query: 654 IGKGGQRSVYKAE-LPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIR-HRNIIKF 711
+ +GG VY+A+ + SG +A+K+ + + EV + ++ H NI++F
Sbjct: 36 LAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKN----RAIIQEVCFMKKLSGHPNIVQF 91
Query: 712 HGFCSNAQHS-------FIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSY 764
S + F++ L +G L L+ + S + + + A+ +
Sbjct: 92 CSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQH 151
Query: 765 LHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSN------------WTEF 812
+H PPI+HRD+ +N+LL ++ + DFG A + +
Sbjct: 152 MHR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITR 210
Query: 813 AGTVGYAAPELAYTMR---ATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEV 869
T Y PE+ EK D+++ G + + HP F + +
Sbjct: 211 NTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHP-------FEDGAKL---- 259
Query: 870 NQILDHRLPTPSRDV-TDKLRSIMEVAILCLVENPEARPTMKEVCNLLCK 918
+I++ + P D S++ L NPE R ++ EV + L +
Sbjct: 260 -RIVNGKYSIPPHDTQYTVFHSLIRA---MLQVNPEERLSIAEVVHQLQE 305
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 8e-28
Identities = 65/306 (21%), Positives = 110/306 (35%), Gaps = 76/306 (24%)
Query: 646 GNFGEKYCIGKGGQRSVYKAELPSGNIF------AVKKFKAELFSDETANPSEFLNEVLA 699
FG+ VYK L A+K K + EF +E +
Sbjct: 20 DRFGK-----------VYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLRE---EFRHEAML 65
Query: 700 LTEIRHRNIIKFHGFCSNAQHSFIVCEYLARGSLTTILR-------------DDAAAKEF 746
++H N++ G + Q ++ Y + G L L D
Sbjct: 66 RARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSAL 125
Query: 747 SWNQRMNVIKGVANALSYL--HHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEP 804
++++ +A + YL HH +VH+D++++NVL+ + +SD G + +
Sbjct: 126 EPPDFVHLVAQIAAGMEYLSSHH-----VVHKDLATRNVLVYDKLNVKISDLGLFREVYA 180
Query: 805 HS-----SN------WTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVI-KGYHPG 852
N W APE + + D++S+GV+ EV G P
Sbjct: 181 ADYYKLLGNSLLPIRWM---------APEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP- 230
Query: 853 DFVSTIFSSISNMIIEV-NQILD-HRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMK 910
+ SN +V I + LP P D + ++M I C E P RP K
Sbjct: 231 ------YCGYSNQ--DVVEMIRNRQVLPCP-DDCPAWVYALM---IECWNEFPSRRPRFK 278
Query: 911 EVCNLL 916
++ + L
Sbjct: 279 DIHSRL 284
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 9e-28
Identities = 61/266 (22%), Positives = 113/266 (42%), Gaps = 27/266 (10%)
Query: 654 IGKGGQRSVYKA-ELPSGNIFAVKK-FKAELFSDETANPSEFLNEVLALTEIRHRNIIKF 711
+GKG VY+A + +G A+K K ++ NEV +++H +I++
Sbjct: 19 LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQ--RVQNEVKIHCQLKHPSILEL 76
Query: 712 HGFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIP 771
+ + ++ + ++V E G + L+ K FS N+ + + + + YLH I
Sbjct: 77 YNYFEDSNYVYLVLEMCHNGEMNRYLK--NRVKPFSENEARHFMHQIITGMLYLHSHGI- 133
Query: 772 PIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGTVGYAAPELAYTMRATE 831
+HRD++ N+LL ++DFG A L+ GT Y +PE+A
Sbjct: 134 --LHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATRSAHGL 191
Query: 832 KYDVYSFGVLALEVIKGYHP--GDFVSTIFSSISNMIIEVNQILDHRLPTP-SRDVTDKL 888
+ DV+S G + ++ G P D V + + D+ +P+ S + D +
Sbjct: 192 ESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVL--------ADYEMPSFLSIEAKDLI 243
Query: 889 RSIMEVAILCLVENPEARPTMKEVCN 914
+ L NP R ++ V +
Sbjct: 244 HQL-------LRRNPADRLSLSSVLD 262
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 9e-28
Identities = 60/266 (22%), Positives = 90/266 (33%), Gaps = 22/266 (8%)
Query: 1 MLNLGFNLLFGNIPPQIGNLSKLQYLDLGNNQLSGVIPPEIGKL---NQLRRLYLDVNQL 57
+L I L+ L + ++ I ++ + L+ L L+ ++
Sbjct: 48 LLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEV 107
Query: 58 HGTIPPVIGQLSLINELVFCHNNVS----GRIPSSLGNLSNLAL--LYLNDNSLFGSIPI 111
GT PP + + + + + NVS + L L L +
Sbjct: 108 TGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCE 167
Query: 112 VMGNLKSLSTLDLSQNQLNGSI-------PCSLDNLSNLDTLFLYKNSLSGPIPSVIGNL 164
+ +LSTLDLS N G P L L + SG ++
Sbjct: 168 QVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAAR 227
Query: 165 KSLLQLDLSENRLSGLIP-LSLSNLSSLTVMSLFNNSLSGSIPPILGNLKSLSTLGLHIN 223
L LDLS N L S S L ++L L +P L LS L L N
Sbjct: 228 VQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGL--PAKLSVLDLSYN 284
Query: 224 QLNGVIPPSIGNLSSLRNLSLFNNRL 249
+L+ PS L + NLSL N
Sbjct: 285 RLDRN--PSPDELPQVGNLSLKGNPF 308
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 98.8 bits (246), Expect = 1e-22
Identities = 44/268 (16%), Positives = 84/268 (31%), Gaps = 35/268 (13%)
Query: 283 NLTGLVLLNMCENHLFGPIPKSLRNLTSLERVRFNQNNLYGKVY--EAFGDHPNLTFLDL 340
+L L + + ++ L+ + + G P+L L+L
Sbjct: 69 SLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNL 128
Query: 341 SQNNFYCEISFNWRNFSKLGTFNASMNNIYGSIPPEIGDSSKLQVLDLSSNHIFGKIPVQ 400
++ ++ L L+VL ++ H Q
Sbjct: 129 RNVSWATRDAWLAELQQWLKP--------------------GLKVLSIAQAHSLNFSCEQ 168
Query: 401 LVKLFSLNKLILSLNQLFGGVPLE----FGTLTELQYLDLSANKLSS---SIPMSIGNLL 453
+ +L+ L LS N G L LQ L L + + +
Sbjct: 169 VRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARV 228
Query: 454 KLHYLNLSNNQFSHKIPTE-FEKLIHLSELDLSHNILQEEIPPQICKMESLEKLNLSHNN 512
+L L+LS+N + L+ L+LS L +++P + L L+LS+N
Sbjct: 229 QLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGL-KQVPKGL--PAKLSVLDLSYNR 285
Query: 513 LSDFIPRCFEEMRSLSWIDISYNELQGP 540
L +E+ + + + N
Sbjct: 286 LDRNPS--PDELPQVGNLSLKGNPFLDS 311
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 96.9 bits (241), Expect = 5e-22
Identities = 64/328 (19%), Positives = 98/328 (29%), Gaps = 57/328 (17%)
Query: 199 NSLSGSIPPILGNLKSLSTLGLHIN-QLNGVIPPSIGNLSSLRNLSLFNNRLYGFVPKEI 257
N L + + G +SL L ++ + + I SL+ L++ R+ +
Sbjct: 29 NCLGAADVELYGGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGA 88
Query: 258 GYLKSLSK---LEFCANHLSGVIPHSVGNLTGLVL----LNMCENHLFGPIPKSLRNL-- 308
+ +S L ++G P + TG L L L+
Sbjct: 89 LRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLK 148
Query: 309 TSLERVRFNQNNLYGKVYEAFGDHPNLTFLDLSQNNFYCEISFNWRNFSKLGTFNASMNN 368
L+ + Q + E P L+ LDLS N E
Sbjct: 149 PGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCP----------- 197
Query: 369 IYGSIPPEIGDSSKLQVLDLSSNHIFGKIPVQLVKLFSLNKLILSLNQLFGGVPLEFGTL 428
LQVL L + + G
Sbjct: 198 ---------LKFPTLQVLALRNAG---------------------METPSGVCSALAAAR 227
Query: 429 TELQYLDLSANKLSSSIPMSIGNLL-KLHYLNLSNNQFSHKIPTEFEKLIHLSELDLSHN 487
+LQ LDLS N L + + +L+ LNLS K LS LDLS+N
Sbjct: 228 VQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQVPKGLPAK---LSVLDLSYN 284
Query: 488 ILQEEIPPQICKMESLEKLNLSHNNLSD 515
L P ++ + L+L N D
Sbjct: 285 RLDR--NPSPDELPQVGNLSLKGNPFLD 310
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 86.9 bits (215), Expect = 1e-18
Identities = 51/219 (23%), Positives = 71/219 (32%), Gaps = 23/219 (10%)
Query: 2 LNLGFNLLFGNIPPQIGNLS--KLQYLDLGNNQLSGVIPPEIGKLNQ-----LRRLYLDV 54
L L + G PP + + L L+L N + + +L Q L+ L +
Sbjct: 100 LTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWAT-RDAWLAELQQWLKPGLKVLSIAQ 158
Query: 55 NQLHGTIPPVIGQLSLINELVFCHNNVSGRI-------PSSLGNLSNLALLYLNDNSLFG 107
+ ++ L N G P L LAL + G
Sbjct: 159 AHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSG 218
Query: 108 SIPIVMGNLKSLSTLDLSQNQLNGSIPCSL-DNLSNLDTLFLYKNSLSGPIPSVIGNLKS 166
+ L LDLS N L + D S L++L L L V L +
Sbjct: 219 VCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK----QVPKGLPA 274
Query: 167 LLQ-LDLSENRLSGLIPLSLSNLSSLTVMSLFNNSLSGS 204
L LDLS NRL S L + +SL N S
Sbjct: 275 KLSVLDLSYNRLDRN--PSPDELPQVGNLSLKGNPFLDS 311
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 79.6 bits (196), Expect = 4e-16
Identities = 50/302 (16%), Positives = 87/302 (28%), Gaps = 49/302 (16%)
Query: 18 GNLSKLQYLDLGNNQLSGVIPPEIGKLNQLRRLYLDVNQLHGTIPPVIGQLSLINELVFC 77
G S L + + +I K L+RL + ++ I
Sbjct: 41 GGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGA------------ 88
Query: 78 HNNVSGRIPSSLGNLSNLALLYLNDNSLFGSIP--IVMGNLKSLSTLDLSQNQLNGSIPC 135
+ +S L L L + + G+ P ++ L+ L+L
Sbjct: 89 ---------LRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAW 139
Query: 136 SLD----NLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSENRLSGLIPLSLSNLSSL 191
+ L L + + + +L LDLS+N G L +
Sbjct: 140 LAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISA----- 194
Query: 192 TVMSLFNNSLSGSIPPILGNLKSLSTLGLHINQLNGVIPPSIGNLSSLRNLSLFNNRLYG 251
P L+ L+ + +GV L+ L L +N L
Sbjct: 195 ------------LCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRD 242
Query: 252 FVPKEI-GYLKSLSKLEFCANHLSGVIPHSVGNLTGLVLLNMCENHL-FGPIPKSLRNLT 309
+ L+ L L V L+ +L++ N L P P L +
Sbjct: 243 AAGAPSCDWPSQLNSLNLSFTGLKQVPKGLPAKLS---VLDLSYNRLDRNPSPDELPQVG 299
Query: 310 SL 311
+L
Sbjct: 300 NL 301
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 76.1 bits (187), Expect = 5e-15
Identities = 39/188 (20%), Positives = 70/188 (37%), Gaps = 16/188 (8%)
Query: 374 PPEIGDSSKLQVLDLSSNHIFGKIPVQLVKLFSLNKLI-LSLNQL----FGGVPLEFGTL 428
+I S L+ L + + I +I +++ ++ L L+L L PL T
Sbjct: 61 FTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATG 120
Query: 429 TELQYLDLSANKLSS--SIPMSIGNLLK--LHYLNLSNNQFSHKIPTEFEKLIHLSELDL 484
+L L+L ++ + + LK L L+++ + + LS LDL
Sbjct: 121 PDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDL 180
Query: 485 SHNILQEEIP--PQIC--KMESLEKLNLSHNN---LSDFIPRCFEEMRSLSWIDISYNEL 537
S N E +C K +L+ L L + S L +D+S+N L
Sbjct: 181 SDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSL 240
Query: 538 QGPIPNST 545
+ +
Sbjct: 241 RDAAGAPS 248
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 62.2 bits (151), Expect = 2e-10
Identities = 24/138 (17%), Positives = 48/138 (34%), Gaps = 9/138 (6%)
Query: 422 PLEFGTLTELQYLDLSANKLSSSIP---MSIGNLLKLHYLNLSNNQFSHKIPTEFEKLIH 478
+ L+ L + A ++ S I + + + L L L N + + P +
Sbjct: 61 FTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATG 120
Query: 479 --LSELDLSHNILQEEIPP----QICKMESLEKLNLSHNNLSDFIPRCFEEMRSLSWIDI 532
L+ L+L + Q L+ L+++ + +F +LS +D+
Sbjct: 121 PDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDL 180
Query: 533 SYNELQGPIPNSTAFKNG 550
S N G +A
Sbjct: 181 SDNPELGERGLISALCPL 198
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 9e-28
Identities = 66/305 (21%), Positives = 114/305 (37%), Gaps = 18/305 (5%)
Query: 73 ELVFCHNNVSGRIPSSLGNLSNLALLYLNDNSLFGSIPIVMGNLKSLSTLDLSQNQLNGS 132
E + + P + L S+ ++ L S+ + + + + S
Sbjct: 3 ETITVSTPIKQIFP--DDAFAETIKDNLKKKSVTDAVTQ--NELNSIDQIIANNSDIK-S 57
Query: 133 IPCSLDNLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSENRLSGLIPLSLSNLSSLT 192
+ + L N+ LFL N L+ I + NLK+L L L EN++ L L +L L
Sbjct: 58 VQG-IQYLPNVTKLFLNGNKLTD-I-KPLTNLKNLGWLFLDENKIKDLSSLK--DLKKLK 112
Query: 193 VMSLFNNSLSGSIPPILGNLKSLSTLGLHINQLNGVIPPSIGNLSSLRNLSLFNNRLYGF 252
+SL +N +S I L +L L +L L N++ + + L+ L LSL +N++
Sbjct: 113 SLSLEHNGIS-DING-LVHLPQLESLYLGNNKITDITV--LSRLTKLDTLSLEDNQISDI 168
Query: 253 VPKEIGYLKSLSKLEFCANHLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLRNLTSLE 312
VP + L L L NH+S + + L L +L + NL
Sbjct: 169 VP--LAGLTKLQNLYLSKNHISDLRA--LAGLKNLDVLELFSQECLNKPINHQSNLVVPN 224
Query: 313 RVRFNQNNLYGKVYEAFGDHPNLTFLDLSQNNFYCEISFNWRNFSKLGTFNASMNNIYGS 372
V+ +L + + F E+SF + +G A +
Sbjct: 225 TVKNTDGSLVTPEIISDDGDYEKPNVKWHLPEFTNEVSFIFYQPVTIGKAKARFHGRVTQ 284
Query: 373 IPPEI 377
E+
Sbjct: 285 PLKEV 289
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 117 bits (293), Expect = 3e-27
Identities = 61/383 (15%), Positives = 134/383 (34%), Gaps = 17/383 (4%)
Query: 19 NLSKLQYLDLGNNQLSGVIPPEIGKLNQLRRLYLDVNQLHGTIPPVIGQLSLINELVFCH 78
++ +L ++ + +LN + ++ + + + ++ I L + +L
Sbjct: 19 AFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SVQG-IQYLPNVTKLFLNG 74
Query: 79 NNVSGRIPSSLGNLSNLALLYLNDNSLFGSIPIVMGNLKSLSTLDLSQNQLNGSIPCSLD 138
N ++ I L NL NL L+L++N + + +LK L +L L N ++ I L
Sbjct: 75 NKLT-DI-KPLTNLKNLGWLFLDENKIKDLSSL--KDLKKLKSLSLEHNGIS-DIN-GLV 128
Query: 139 NLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSENRLSGLIPLSLSNLSSLTVMSLFN 198
+L L++L+L N ++ +V+ L L L L +N++S ++P L+ L+ L + L
Sbjct: 129 HLPQLESLYLGNNKIT--DITVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSK 184
Query: 199 NSLSGSIPPILGNLKSLSTLGLHINQLNGVIPPSIGNLSSLRNLSLFNNRLYGFVPKEIG 258
N +S + L LK+L L L + NL + + L
Sbjct: 185 NHIS-DLRA-LAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTPEIISDD 242
Query: 259 YLKSLSKLEFCANHLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLRNLTSLERVRFNQ 318
+++ + + + + K + ++ +
Sbjct: 243 GDYEKPNVKWHLPEFTNEVSFIFYQPVTIGKAKARFHGRVTQPLKEVYTVSYDVDGTVIK 302
Query: 319 NNLYGKVYEAFGDHPNLTFLDLSQNNFYCEISFNWR-NFSKLGTFNASMNNIYGSIPPEI 377
+ P W N + + ++ ++ + E
Sbjct: 303 TKVEAGTRITAPKPPTKQGYVFKGWYTEKNGGHEWNFNTDYMSGNDFTLYAVFKAETTEK 362
Query: 378 GDSSKLQVLDLSSNHIFGKIPVQ 400
+ V + N K+P +
Sbjct: 363 TVNLTRYVKYIRGNAGIYKLPRE 385
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 98.6 bits (245), Expect = 2e-21
Identities = 57/275 (20%), Positives = 98/275 (35%), Gaps = 22/275 (8%)
Query: 283 NLTGLVLLNMCENHLFGPIPKSLRNLTSLERVRFNQNNLYGKVYEAFGDHPNLTFLDLSQ 342
+ N+ + + + L S++++ N +++ K + PN+T L L+
Sbjct: 19 AFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDI--KSVQGIQYLPNVTKLFLNG 74
Query: 343 NNFYCEIS--FNWRNFSKLGTFNASMNNIYGSIPPEIGDSSKLQVLDLSSNHIFGKIPVQ 400
N ++ N LG N I + + D KL+ L L N I I
Sbjct: 75 NK----LTDIKPLTNLKNLGWLFLDENKI-KDLSS-LKDLKKLKSLSLEHNGI-SDING- 126
Query: 401 LVKLFSLNKLILSLNQLFGGVPLEFGTLTELQYLDLSANKLSSSIPMSIGNLLKLHYLNL 460
LV L L L L N++ L LT+L L L N++S +P + L KL L L
Sbjct: 127 LVHLPQLESLYLGNNKITDITVLS--RLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYL 182
Query: 461 SNNQFSHKIPTEFEKLIHLSELDLSHNILQEEIPPQICKMESLEKLNLSHNNLSDFIPRC 520
S N S L +L L+L + + + + +L P
Sbjct: 183 SKNHISD--LRALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVT--PEI 238
Query: 521 FEEMRSLSWIDISYNELQGPIPNSTAFKNGLMEGN 555
+ ++ ++ + S F + G
Sbjct: 239 ISDDGDYEKPNVKWHLPEFTNEVSFIFYQPVTIGK 273
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 96.7 bits (240), Expect = 9e-21
Identities = 56/260 (21%), Positives = 95/260 (36%), Gaps = 18/260 (6%)
Query: 2 LNLGFNLLFGNIPPQIGNLSKLQYLDLGNNQLSGVIPPEIGKLNQLRRLYLDVNQLHGTI 61
+ + + ++ I L + L L N+L+ + P + L L L+LD N++ +
Sbjct: 48 IIANNSDI-KSVQG-IQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDENKIK-DL 102
Query: 62 PPVIGQLSLINELVFCHNNVSGRIPSSLGNLSNLALLYLNDNSLFGSIPIVMGNLKSLST 121
+ L + L HN +S I + L +L L LYL +N + + L L T
Sbjct: 103 SS-LKDLKKLKSLSLEHNGIS-DI-NGLVHLPQLESLYLGNNKITDITVL--SRLTKLDT 157
Query: 122 LDLSQNQLNGSIPCSLDNLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSENRLSGLI 181
L L NQ++ I L L+ L L+L KN +S + LK+L L+L
Sbjct: 158 LSLEDNQIS-DIV-PLAGLTKLQNLYLSKNHIS--DLRALAGLKNLDVLELFSQECLNKP 213
Query: 182 PLSLSNLSSLTVMSLFNNSLSG----SIPPILGNLKSLSTLGLHINQLNGVIPPSIGNLS 237
SNL + + SL S L N+++ + +
Sbjct: 214 INHQSNLVVPNTVKNTDGSLVTPEIISDDGDYEKPNVKWHLPEFTNEVSFIFYQPVTIGK 273
Query: 238 SLRNLSLFNNRLYGFVPKEI 257
+ + V
Sbjct: 274 AKARFHGRVTQPLKEVYTVS 293
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 95.9 bits (238), Expect = 2e-20
Identities = 70/333 (21%), Positives = 111/333 (33%), Gaps = 68/333 (20%)
Query: 196 LFNNSLSGSIPPILGNLKSLSTLGLHINQLNGVIPPSIGNLSSLRNLSLFNNRLYGFVPK 255
+ + I P L + + L+S+ + N+ + +
Sbjct: 6 TVSTPIK-QIFP-DDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSV--Q 59
Query: 256 EIGYLKSLSKLEFCANHLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLRNLTSLERVR 315
I YL +++KL N L+ + P + NL L L + EN + K L +L L
Sbjct: 60 GIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDENKI-----KDLSSLKDL---- 108
Query: 316 FNQNNLYGKVYEAFGDHPNLTFLDLSQNNFYCEISFNWRNFSKLGTFNASMNNIYGSIPP 375
L L L N IS I
Sbjct: 109 -----------------KKLKSLSLEHNG----IS---------------------DING 126
Query: 376 EIGDSSKLQVLDLSSNHIFGKIPVQLVKLFSLNKLILSLNQLFGGVPLEFGTLTELQYLD 435
+ +L+ L L +N I I V L +L L+ L L NQ+ VPL LT+LQ L
Sbjct: 127 -LVHLPQLESLYLGNNKIT-DITV-LSRLTKLDTLSLEDNQISDIVPLA--GLTKLQNLY 181
Query: 436 LSANKLSSSIPMSIGNLLKLHYLNLSNNQFSHKIPTEFEKLIHLSELDLSHNILQEEIPP 495
LS N +S + L L L L + + +K L+ + + + L P
Sbjct: 182 LSKNHISDLRA--LAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVT--PE 237
Query: 496 QICKMESLEKLNLSHNNLSDFIPRCFEEMRSLS 528
I EK N+ + F + ++
Sbjct: 238 IISDDGDYEKPNVKWHLPEFTNEVSFIFYQPVT 270
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 90.6 bits (224), Expect = 7e-19
Identities = 51/245 (20%), Positives = 92/245 (37%), Gaps = 16/245 (6%)
Query: 1 MLNLGFNLLFGNIPPQIGNLSKLQYLDLGNNQLSGVIPPEIGKLNQLRRLYLDVNQLHGT 60
L L N L +I P + NL L +L L N++ + + L +L+ L L+ N +
Sbjct: 69 KLFLNGNKL-TDIKP-LTNLKNLGWLFLDENKIKDLSS--LKDLKKLKSLSLEHNGIS-D 123
Query: 61 IPPVIGQLSLINELVFCHNNVSGRIPSSLGNLSNLALLYLNDNSLFGSIPIVMGNLKSLS 120
I + L + L +N ++ + L L+ L L L DN + I + L L
Sbjct: 124 ING-LVHLPQLESLYLGNNKIT--DITVLSRLTKLDTLSLEDNQI-SDIVPLA-GLTKLQ 178
Query: 121 TLDLSQNQLNGSIPCSLDNLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSENRLSGL 180
L LS+N ++ + +L L NLD L L+ + NL + ++ L
Sbjct: 179 NLYLSKNHIS-DLR-ALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTP 236
Query: 181 IPLS----LSNLSSLTVMSLFNNSLSGSIPPILGNLKSLSTLGLHINQLNGVIPPSIGNL 236
+S + + F N +S + K+ + + Q + ++
Sbjct: 237 EIISDDGDYEKPNVKWHLPEFTNEVSFIFYQPVTIGKAKARFHGRVTQPLKEVYTVSYDV 296
Query: 237 SSLRN 241
Sbjct: 297 DGTVI 301
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 1e-27
Identities = 72/302 (23%), Positives = 122/302 (40%), Gaps = 73/302 (24%)
Query: 646 GNFGEKYCIGKGGQRSVYKAELPSGNIF---AVKKFKAELFSDETANPSEFLNEVLALTE 702
GNFG+ V KA + + A+K+ K D+ +F E+ L +
Sbjct: 36 GNFGQ-----------VLKARIKKDGLRMDAAIKRMKEYASKDD---HRDFAGELEVLCK 81
Query: 703 I-RHRNIIKFHGFCSNAQHSFIVCEYLARGSLTTILR-------------DDAAAKEFSW 748
+ H NII G C + + ++ EY G+L LR ++ A S
Sbjct: 82 LGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSS 141
Query: 749 NQRMNVIKGVANALSYL--HHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHS 806
Q ++ VA + YL +HRD++++N+L+ Y A ++DFG ++ E +
Sbjct: 142 QQLLHFAADVARGMDYLSQKQ-----FIHRDLAARNILVGENYVAKIADFGLSRGQEVYV 196
Query: 807 SN--------WTEFAGTVGYAAPE-LAYTMRATEKYDVYSFGVLALEVI-KGYHPGDFVS 856
W A E L Y+ T DV+S+GVL E++ G P
Sbjct: 197 KKTMGRLPVRWM---------AIESLNYS-VYTTNSDVWSYGVLLWEIVSLGGTP----- 241
Query: 857 TIFSSISNMIIEVNQILD--HRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914
+ ++ E+ + L +RL P + D++ +M C E P RP+ ++
Sbjct: 242 --YCGMTCA--ELYEKLPQGYRLEKP-LNCDDEVYDLM---RQCWREKPYERPSFAQILV 293
Query: 915 LL 916
L
Sbjct: 294 SL 295
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 1e-27
Identities = 68/282 (24%), Positives = 111/282 (39%), Gaps = 47/282 (16%)
Query: 646 GNFGEKYCIGKGGQRSVYKAEL--PSGNIF--AVKKFKAELFSDETANPSEFLNEVLALT 701
G FG+ V++ P A+K K +FL E L +
Sbjct: 401 GQFGD-----------VHQGIYMSPENPAMAVAIKTCKNCTSDSVR---EKFLQEALTMR 446
Query: 702 EIRHRNIIKFHGFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANA 761
+ H +I+K G + +I+ E G L + L+ + ++ A
Sbjct: 447 QFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRK--FSLDLASLILYAYQLSTA 503
Query: 762 LSYLH-HDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGT---VG 817
L+YL VHRDI+++NVL+ S + DFG ++++E S + + + +
Sbjct: 504 LAYLESKRF----VHRDIAARNVLVSSNDCVKLGDFGLSRYME--DSTYYKASKGKLPIK 557
Query: 818 YAAPELAYTMRATEKYDVYSFGVLALEVI-KGYHPGDFVSTIFSSISNMIIEVNQILD-- 874
+ APE R T DV+ FGV E++ G P F + N +V ++
Sbjct: 558 WMAPESINFRRFTSASDVWMFGVCMWEILMHGVKP-------FQGVKNN--DVIGRIENG 608
Query: 875 HRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLL 916
RLP P + L S+M C +P RP E+ L
Sbjct: 609 ERLPMP-PNCPPTLYSLM---TKCWAYDPSRRPRFTELKAQL 646
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 1e-27
Identities = 61/230 (26%), Positives = 88/230 (38%), Gaps = 33/230 (14%)
Query: 19 NLSKLQYLDLGNNQLSGVIPPEIGKLNQLRRLYLDVNQLHGTIPPVIGQLSLINELVFCH 78
++ ++ L+ +PP++ L+L N L T
Sbjct: 8 KVASHLEVNCDKRNLT-ALPPDL--PKDTTILHLSENLL-YTFSL--------------- 48
Query: 79 NNVSGRIPSSLGNLSNLALLYLNDNSLFGSIPIVMGNLKSLSTLDLSQNQLNGSIPCSLD 138
++L + L L L+ L + V G L L TLDLS NQL S+P
Sbjct: 49 --------ATLMPYTRLTQLNLDRAEL-TKLQ-VDGTLPVLGTLDLSHNQLQ-SLPLLGQ 97
Query: 139 NLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSENRLSGLIPLSLSNLSSLTVMSLFN 198
L L L + N L+ + L L +L L N L L P L+ L +SL N
Sbjct: 98 TLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLAN 157
Query: 199 NSLSGSIPP-ILGNLKSLSTLGLHINQLNGVIPPSIGNLSSLRNLSLFNN 247
N+L+ +P +L L++L TL L N L IP L L N
Sbjct: 158 NNLT-ELPAGLLNGLENLDTLLLQENSLYT-IPKGFFGSHLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 1e-22
Identities = 54/215 (25%), Positives = 85/215 (39%), Gaps = 9/215 (4%)
Query: 135 CSLDNLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSENRLSGLIPLSLSNLSSLTVM 194
C + +++ + K +L+ +P + K L LSEN L +L + LT +
Sbjct: 4 CEVSKVASHLEVNCDKRNLTA-LPPDL--PKDTTILHLSENLLYTFSLATLMPYTRLTQL 60
Query: 195 SLFNNSLSGSIPPILGNLKSLSTLGLHINQLNGVIPPSIGNLSSLRNLSLFNNRLYGFVP 254
+L L + + G L L TL L NQL +P L +L L + NRL
Sbjct: 61 NLDRAEL--TKLQVDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPL 117
Query: 255 KEIGYLKSLSKLEFCANHLSGVIPHSV-GNLTGLVLLNMCENHLFGPIPKSLRNLTSLER 313
+ L L +L N L +P + L L++ N+L L L +L+
Sbjct: 118 GALRGLGELQELYLKGNELK-TLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDT 176
Query: 314 VRFNQNNLYGKVYEAFGDHPNLTFLDLSQNNFYCE 348
+ +N+LY F L F L N + C
Sbjct: 177 LLLQENSLYTIPKGFF-GSHLLPFAFLHGNPWLCN 210
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 94.8 bits (236), Expect = 2e-21
Identities = 48/168 (28%), Positives = 79/168 (47%), Gaps = 7/168 (4%)
Query: 372 SIPPEIGDSSKLQVLDLSSNHIFGKIPVQLVKLFSLNKLILSLNQLFGGVPLEFGTLTEL 431
++PP++ +L LS N ++ L+ L +L L +L + + GTL L
Sbjct: 24 ALPPDL--PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAEL-TKLQV-DGTLPVL 79
Query: 432 QYLDLSANKLSSSIPMSIGNLLKLHYLNLSNNQFSHKIPTEFEKLIHLSELDLSHNILQE 491
LDLS N+L S +P+ L L L++S N+ + L L EL L N L+
Sbjct: 80 GTLDLSHNQLQS-LPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELK- 137
Query: 492 EIPPQIC-KMESLEKLNLSHNNLSDFIPRCFEEMRSLSWIDISYNELQ 538
+PP + LEKL+L++NNL++ + +L + + N L
Sbjct: 138 TLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY 185
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 84.8 bits (210), Expect = 4e-18
Identities = 51/176 (28%), Positives = 66/176 (37%), Gaps = 32/176 (18%)
Query: 2 LNLGFNLLFGNIPPQIGNLSKLQYLDLGNNQLSGVIPPEIGKLNQLRRLYLDVNQLHGTI 61
LNL L G L L LDL +NQL +P L L L + N+L ++
Sbjct: 60 LNLDRAEL--TKLQVDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLT-SL 115
Query: 62 PPVIGQLSLINELVFCHNNVSGRIPSSLGNLSNLALLYLNDNSLFGSIPI-VMGNLKSLS 120
P +L L L LYL N L ++P ++ L
Sbjct: 116 P-----------------------LGALRGLGELQELYLKGNEL-KTLPPGLLTPTPKLE 151
Query: 121 TLDLSQNQLNGSIPCSL-DNLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSEN 175
L L+ N L +P L + L NLDTL L +NSL IP L L N
Sbjct: 152 KLSLANNNLT-ELPAGLLNGLENLDTLLLQENSLYT-IPKGFFGSHLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 8e-15
Identities = 46/177 (25%), Positives = 67/177 (37%), Gaps = 10/177 (5%)
Query: 290 LNMCENHLFGPIPKSLRNLTSLERVRFNQNNLYGKVYEAFGDHPNLTFLDLSQNNFYCEI 349
L++ EN L+ +L T L ++ ++ L + G P L LDLS N +
Sbjct: 36 LHLSENLLYTFSLATLMPYTRLTQLNLDRAEL--TKLQVDGTLPVLGTLDLSHNQL-QSL 92
Query: 350 SFNWRNFSKLGTFNASMNNIYGSIPPEIGDS-SKLQVLDLSSNHIFGKIPVQL-VKLFSL 407
+ L + S N + S+P +LQ L L N + +P L L
Sbjct: 93 PLLGQTLPALTVLDVSFNRL-TSLPLGALRGLGELQELYLKGNEL-KTLPPGLLTPTPKL 150
Query: 408 NKLILSLNQLFGGVPLE-FGTLTELQYLDLSANKLSSSIPMSIGNLLKLHYLNLSNN 463
KL L+ N L +P L L L L N L + IP L + L N
Sbjct: 151 EKLSLANNNL-TELPAGLLNGLENLDTLLLQENSLYT-IPKGFFGSHLLPFAFLHGN 205
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 1e-27
Identities = 58/271 (21%), Positives = 109/271 (40%), Gaps = 35/271 (12%)
Query: 654 IGKGGQRSVYKA-ELPSGNIFAVKKFKAELFSDETANPSEFLNEV-LALTEIRHRNIIKF 711
+G+G V K +PSG I AVK+ +A + S E L ++ +++ + + F
Sbjct: 15 LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQ---KRLLMDLDISMRTVDCPFTVTF 71
Query: 712 HG-FCSNAQHSFIVCEYLARGSLTTILRD-DAAAKEFSWNQRMNVIKGVANALSYLHHDC 769
+G I E + SL + + + + + AL +LH
Sbjct: 72 YGALFREGDVW-ICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL 129
Query: 770 IPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGTVGYAAPE------- 822
++HRD+ NVL+++ + + DFG + +L AG Y APE
Sbjct: 130 --SVIHRDVKPSNVLINALGQVKMCDFGISGYLV-DDVAKDIDAGCKPYMAPERINPELN 186
Query: 823 -LAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPT-P 880
Y++++ D++S G+ +E+ P + S ++ Q+++ P P
Sbjct: 187 QKGYSVKS----DIWSLGITMIELAILRFP-------YDSWGTPFQQLKQVVEEPSPQLP 235
Query: 881 SRDVTDKLRSIMEVAILCLVENPEARPTMKE 911
+ + + CL +N + RPT E
Sbjct: 236 ADKFSAEFVDFTS---QCLKKNSKERPTYPE 263
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 1e-27
Identities = 52/267 (19%), Positives = 91/267 (34%), Gaps = 31/267 (11%)
Query: 653 CIGKGGQRSVYKA-ELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEI-RHRNIIK 710
+G G V+K G ++AVK+ + + + + L EV + ++ +H ++
Sbjct: 64 RLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPK--DRARKLAEVGSHEKVGQHPCCVR 121
Query: 711 FHGFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCI 770
++ E SL Q ++ AL++LH
Sbjct: 122 LEQAWEEGGILYLQTEL-CGPSLQQHCEAWG--ASLPEAQVWGYLRDTLLALAHLHSQ-- 176
Query: 771 PPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGTVGYAAPEL---AYTM 827
+VH D+ N+ L + DFG L + G Y APEL +Y
Sbjct: 177 -GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEV-QEGDPRYMAPELLQGSYGT 234
Query: 828 RATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRDVTDK 887
A DV+S G+ LEV L ++ +
Sbjct: 235 AA----DVFSLGLTILEVACNMEL-------PHGGEGWQQLRQGYLPPEFT---AGLSSE 280
Query: 888 LRSIMEVAILCLVENPEARPTMKEVCN 914
LRS++ + L +P+ R T + +
Sbjct: 281 LRSVLV---MMLEPDPKLRATAEALLA 304
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 2e-27
Identities = 63/274 (22%), Positives = 107/274 (39%), Gaps = 37/274 (13%)
Query: 654 IGKGGQRSVYKA-ELPSGNIFAVKKFKAELFSDETANPSEFLNEV-LALTEIRHRNIIKF 711
IG+G SV K PSG I AVK+ ++ + E + L ++ + + I++F
Sbjct: 30 IGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQ---KQLLMDLDVVMRSSDCPYIVQF 86
Query: 712 HGFCSNAQHSFIVCEYLARGSLTTILRD--DAAAKEFSWNQRMNVIKGVANALSYLHHDC 769
+G +I E ++ S + + AL++L +
Sbjct: 87 YGALFREGDCWICMELMS-TSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENL 145
Query: 770 IPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGTVGYAAPE------- 822
I+HRDI N+LLD + DFG + L S T AG Y APE
Sbjct: 146 --KIIHRDIKPSNILLDRSGNIKLCDFGISGQLV-DSIAKTRDAGCRPYMAPERIDPSAS 202
Query: 823 -LAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDH---RLP 878
Y +R+ DV+S G+ E+ G P + +++ ++ Q++ +L
Sbjct: 203 RQGYDVRS----DVWSLGITLYELATGRFP-------YPKWNSVFDQLTQVVKGDPPQLS 251
Query: 879 TPSRDV-TDKLRSIMEVAILCLVENPEARPTMKE 911
+ + + LCL ++ RP KE
Sbjct: 252 NSEEREFSPSFINFVN---LCLTKDESKRPKYKE 282
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 2e-27
Identities = 57/293 (19%), Positives = 113/293 (38%), Gaps = 39/293 (13%)
Query: 654 IGKGGQRSVYKA-ELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFH 712
+G+G +V++ +G++FA+K F F + E L ++ H+NI+K
Sbjct: 17 LGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDV---QMREFEVLKKLNHKNIVKLF 73
Query: 713 GF--CSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCI 770
+ +H ++ E+ GSL T+L + + A ++ + V++ V +++L +
Sbjct: 74 AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG- 132
Query: 771 PPIVHRDISSKNVLLDSEYEAH----VSDFGFAKFLEPHSSNWTEFAGTVGYAAPEL--- 823
IVHR+I N++ + ++DFG A+ LE + GT Y P++
Sbjct: 133 --IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELED-DEQFVSLYGTEEYLHPDMYER 189
Query: 824 -AYTMRATEKY----DVYSFGVLALEVIKGYHP------GDFVSTIFSSI-----SNMII 867
+KY D++S GV G P + I S I
Sbjct: 190 AVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAIS 249
Query: 868 EVNQILDHRLPTPSR-----DVTDKLRSIMEVAI-LCLVENPEARPTMKEVCN 914
V + + + ++ L+ ++ + L + E +
Sbjct: 250 GVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFA 302
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 3e-27
Identities = 78/291 (26%), Positives = 122/291 (41%), Gaps = 40/291 (13%)
Query: 639 EEITKATGNFGEKYCI----GKGGQRSVYKA-ELPSGNIFAVKKF-KAELFSDETANPSE 692
E G F E+Y I GKG V K + + +AVK KA + +T S
Sbjct: 11 RENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDT---ST 67
Query: 693 FLNEVLALTEIRHRNIIKFHGFCSNAQHSFIVCEYLARGSLTTILRDDAAAKE-FSWNQR 751
L EV L ++ H NI+K ++ +IV E G L D+ ++ FS +
Sbjct: 68 ILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGE----LFDEIIKRKRFSEHDA 123
Query: 752 MNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAH---VSDFGFAKFLEPHSSN 808
+IK V + ++Y+H IVHRD+ +N+LL+S+ + + DFG + + ++
Sbjct: 124 ARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ-NTK 179
Query: 809 WTEFAGTVGYAAPEL---AYTMRATEKYDVYSFGVLALEVIKGYHP--GDFVSTIFSSIS 863
+ GT Y APE+ Y EK DV+S GV+ ++ G P G I +
Sbjct: 180 MKDRIGTAYYIAPEVLRGTY----DEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVE 235
Query: 864 NMIIEVNQILDHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914
+ + T S D D +R L +P R T +
Sbjct: 236 TGKYAFD---LPQWRTISDDAKDLIRK-------MLTFHPSLRITATQCLE 276
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 113 bits (283), Expect = 4e-27
Identities = 30/292 (10%), Positives = 69/292 (23%), Gaps = 44/292 (15%)
Query: 654 IGKGGQRSVYKA-ELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFH 712
+ G + V+ ++ FA+K F + + A + + +
Sbjct: 70 LRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSEL-ERLHEATFAAARLLGESPEEAR 128
Query: 713 GFC--------------------------SNAQHSFIVCEYLARGSLTTIL----RDDAA 742
+ ++ A L +
Sbjct: 129 DRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMP-AASVDLELLFSTLDFVYVF 187
Query: 743 AKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFL 802
+ + + + L + VH + N+ + + + D
Sbjct: 188 RGDEGILALHILTAQLIRLAANLQSKGL---VHGHFTPDNLFIMPDGRLMLGDVSALW-- 242
Query: 803 EPHSSNWTEFAGTVGYAAPEL--AYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFS 860
+ + V YA E A T T + + G+ V + P V+
Sbjct: 243 -KVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIK 301
Query: 861 SISNMIIEVNQILDHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEV 912
D + D +++++ L + R E
Sbjct: 302 GSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIG---RFLNFDRRRRLLPLEA 350
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 4e-27
Identities = 56/272 (20%), Positives = 99/272 (36%), Gaps = 38/272 (13%)
Query: 654 IGKGGQRSVYKA-ELPSGNIFAVKKFKAELFSDETANPSEFLNEVLAL-TEIRHRNIIKF 711
+G G V+K +G++ AVK+ + +E L ++ + I++
Sbjct: 33 MGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEEN---KRILMDLDVVLKSHDCPYIVQC 89
Query: 712 HG-FCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCI 770
G F +N I E + + R E + + AL YL
Sbjct: 90 FGTFITNTDVF-IAMELMGTCAEKLKKRMQGPIPE---RILGKMTVAIVKALYYLKEKHG 145
Query: 771 PPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGTVGYAAPE-------- 822
++HRD+ N+LLD + + DFG + L AG Y APE
Sbjct: 146 --VIHRDVKPSNILLDERGQIKLCDFGISGRLV-DDKAKDRSAGCAAYMAPERIDPPDPT 202
Query: 823 -LAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPS 881
Y +RA DV+S G+ +E+ G P + + + ++L P
Sbjct: 203 KPDYDIRA----DVWSLGISLVELATGQFP-------YKNCKTDFEVLTKVLQEEPPLLP 251
Query: 882 RDV--TDKLRSIMEVAILCLVENPEARPTMKE 911
+ + +S ++ CL ++ RP +
Sbjct: 252 GHMGFSGDFQSFVK---DCLTKDHRKRPKYNK 280
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 5e-27
Identities = 64/289 (22%), Positives = 113/289 (39%), Gaps = 30/289 (10%)
Query: 640 EITKATGNFGEKYCIGK--G-GQRS-VYKA-ELPSGNIFAVKKF-KAELFSDETANPSEF 693
++ F + Y + + G G S V + +G FAVK A+ S + +
Sbjct: 14 DMADDDVLFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDL 73
Query: 694 LNEVLALTEIRHRNIIKFHGFCSNAQHSFIVCEYLARGSL-TTILRDDAAAKEFSWNQRM 752
E ++H +I++ S+ ++V E++ L I++ A +S
Sbjct: 74 KREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVAS 133
Query: 753 NVIKGVANALSYLH-HDCIPPIVHRDISSKNVLLDSEYEAH---VSDFGFAKFLEPHSSN 808
+ ++ + AL Y H ++ I+HRD+ VLL S+ + + FG A L
Sbjct: 134 HYMRQILEALRYCHDNN----IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLV 189
Query: 809 WTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVST---IFSSISNM 865
GT + APE+ + DV+ GV+ ++ G P F T +F I
Sbjct: 190 AGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLP--FYGTKERLFEGIIKG 247
Query: 866 IIEVNQILDHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914
++N + S D +R L+ +P R T+ E N
Sbjct: 248 KYKMN---PRQWSHISESAKDLVRR-------MLMLDPAERITVYEALN 286
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 5e-27
Identities = 53/265 (20%), Positives = 90/265 (33%), Gaps = 48/265 (18%)
Query: 653 CIGKGGQRSVYKAE---LPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNII 709
CI GG +Y A + +G +K D A + + E L E+ H +I+
Sbjct: 87 CIAHGGLGWIYLALDRNV-NGRPVVLKGLVHS--GDAEAQ-AMAMAERQFLAEVVHPSIV 142
Query: 710 KFHGF-----CSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSY 764
+ F +IV EY+ SL + + + + + ALSY
Sbjct: 143 QIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ-----KLPVAEAIAYLLEILPALSY 197
Query: 765 LHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGTVGYAAPELA 824
LH +V+ D+ +N++L E + + D G + GT G+ APE+
Sbjct: 198 LHSI---GLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSFGY----LYGTPGFQAPEIV 249
Query: 825 YTMRATEKYDVYSFGVLALEVIKGYHP--GDFVSTIFSSISNMIIEVNQILDHRLPTPSR 882
T T D+Y+ G + G +V + P
Sbjct: 250 RT-GPTVATDIYTVGRTLAALTLDLPTRNGRYVDGL-----------------PEDDPVL 291
Query: 883 DVTDKLRSIMEVAILCLVENPEARP 907
D ++ A + +P R
Sbjct: 292 KTYDSYGRLLRRA---IDPDPRQRF 313
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 5e-27
Identities = 74/321 (23%), Positives = 121/321 (37%), Gaps = 42/321 (13%)
Query: 614 QEKRSSSANPFGFFSVLNFNGKVLYEEITKATGNFGEKYCI----GKGGQRSVYKA-ELP 668
SS +F + N + + K G GE Y G G V E
Sbjct: 3 HHHHHSSGRENLYFQGIAINPGMY---VRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKN 59
Query: 669 SGNIFAVK-----KFKAELFSDETANPSE----FLNEVLALTEIRHRNIIKFHGFCSNAQ 719
+ A+K +F +SD+ N + NE+ L + H NIIK + +
Sbjct: 60 GHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKK 119
Query: 720 HSFIVCEYLARGSLTTILRDDAAAKE-FSWNQRMNVIKGVANALSYLHHDCIPPIVHRDI 778
+ ++V E+ G L + + F N++K + + + YLH IVHRDI
Sbjct: 120 YFYLVTEFYEGGE----LFEQIINRHKFDECDAANIMKQILSGICYLHKHN---IVHRDI 172
Query: 779 SSKNVLLDSEYEAH---VSDFGFAKFLEPHSSNWTEFAGTVGYAAPELAYTMRATEKYDV 835
+N+LL+++ + DFG + F + GT Y APE + EK DV
Sbjct: 173 KPENILLENKNSLLNIKIVDFGLSSFFSK-DYKLRDRLGTAYYIAPE-VLKKKYNEKCDV 230
Query: 836 YSFGVLALEVIKGYHP--GDFVSTIFSSISNMIIEVNQILDHRLPTPSRDVTDKLRSIME 893
+S GV+ ++ GY P G I + + + S + + ++
Sbjct: 231 WSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFD---FNDWKNISDEAKELIKL--- 284
Query: 894 VAILCLVENPEARPTMKEVCN 914
L + R T +E N
Sbjct: 285 ----MLTYDYNKRCTAEEALN 301
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 9e-27
Identities = 57/221 (25%), Positives = 94/221 (42%), Gaps = 20/221 (9%)
Query: 12 NIPPQIGNLSKLQYLDLGNNQLSGVIPPEIGKLNQLRRLYLDVNQLHGTIPP-VIGQLSL 70
N+P + LDL N L + +L+ L L ++ TI LS
Sbjct: 25 NLP------FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSH 77
Query: 71 INELVFCHNNVSGRIPSSLGNLSNLALLYLNDNSLFGSIPIVM-GNLKSLSTLDLSQNQL 129
++ L+ N + + LS+L L + +L S+ G+LK+L L+++ N +
Sbjct: 78 LSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNLI 136
Query: 130 NGSIPCS--LDNLSNLDTLFLYKNSLSGPIPSVIGNLKSL----LQLDLSENRLSGLIPL 183
S NL+NL+ L L N + + + L + L LDLS N ++ + P
Sbjct: 137 Q-SFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPG 195
Query: 184 SLSNLSSLTVMSLFNNSLSGSIPP-ILGNLKSLSTLGLHIN 223
+ + L ++L N L S+P I L SL + LH N
Sbjct: 196 AFKEI-RLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 2e-21
Identities = 58/235 (24%), Positives = 84/235 (35%), Gaps = 36/235 (15%)
Query: 309 TSLERVRFNQNNLYGKVYEAFGDHPNLTFLDLSQNNFYCEISFNWRNFSKLGTFNASMNN 368
S + + + N L +F P L LDLS+ I
Sbjct: 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCE----IQ------------------ 65
Query: 369 IYGSIPPEIGDS-SKLQVLDLSSNHIFGKIPVQL-VKLFSLNKLILSLNQLFGGVPLEFG 426
+I S S L L L+ N I + + L SL KL+ L G
Sbjct: 66 ---TIEDGAYQSLSHLSTLILTGNPI-QSLALGAFSGLSSLQKLVAVETNLASLENFPIG 121
Query: 427 TLTELQYLDLSANKLSSSIPMSI-GNLLKLHYLNLSNNQFSHKIPTE-FEKLIHL----S 480
L L+ L+++ N + S NL L +L+LS+N+ I L +
Sbjct: 122 HLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQS-IYCTDLRVLHQMPLLNL 180
Query: 481 ELDLSHNILQEEIPPQICKMESLEKLNLSHNNLSDFIPRCFEEMRSLSWIDISYN 535
LDLS N + I P K L++L L N L F+ + SL I + N
Sbjct: 181 SLDLSLNPMNF-IQPGAFKEIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 1e-20
Identities = 55/248 (22%), Positives = 89/248 (35%), Gaps = 28/248 (11%)
Query: 75 VFCHNNVSGRIPSSLGNLSNLALLYLNDNSLFGSIPIVMGNLKSLSTLDLSQNQLNGSIP 134
C +IP +L + L L+ N L + L LDLS+ ++ +I
Sbjct: 12 YQCMELNFYKIPDNL--PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIE 68
Query: 135 CSL-DNLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSENRLSGLIPLSLSNLSSLTV 193
+LS+L TL L N + L SL +L E L+ L + +L +L
Sbjct: 69 DGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKE 128
Query: 194 MSLFNNSLSGSIPP--ILGNLKSLSTLGLHINQLNGVIPPSIGNLSSLRNLSLFNNRLYG 251
+++ +N + S NL +L L L N++ I +L L + L N L
Sbjct: 129 LNVAHNLIQ-SFKLPEYFSNLTNLEHLDLSSNKIQ-SIYC--TDLRVLHQMPLLNLSLD- 183
Query: 252 FVPKEIGYLKSLSKLEFCANHLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLRNLTSL 311
N ++ I L L + N L LTSL
Sbjct: 184 ----------------LSLNPMN-FIQPGAFKEIRLKELALDTNQLKSVPDGIFDRLTSL 226
Query: 312 ERVRFNQN 319
+++ + N
Sbjct: 227 QKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 4e-16
Identities = 40/201 (19%), Positives = 71/201 (35%), Gaps = 26/201 (12%)
Query: 302 PKSLRNLTSLERVRFNQNNLYGKVYEAFGDHPNLTFLDLSQNN--------FYCEISFNW 353
S + L+ + ++ + A+ +L+ L L+ N F
Sbjct: 45 SYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAF-------- 96
Query: 354 RNFSKLGTFNASMNNIYGSIPPEIGDS-SKLQVLDLSSNHIFGKIPVQLV--KLFSLNKL 410
S L A N+ S+ L+ L+++ N I + L +L L
Sbjct: 97 SGLSSLQKLVAVETNL-ASLENFPIGHLKTLKELNVAHNLI-QSFKLPEYFSNLTNLEHL 154
Query: 411 ILSLNQLFGGVPLEFGTLTELQY----LDLSANKLSSSIPMSIGNLLKLHYLNLSNNQFS 466
LS N++ + L ++ LDLS N ++ I ++L L L NQ
Sbjct: 155 DLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNF-IQPGAFKEIRLKELALDTNQLK 213
Query: 467 HKIPTEFEKLIHLSELDLSHN 487
F++L L ++ L N
Sbjct: 214 SVPDGIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 4e-16
Identities = 44/180 (24%), Positives = 64/180 (35%), Gaps = 32/180 (17%)
Query: 2 LNLGFNLLFGNIPPQI-GNLSKLQYLDLGNNQLSGVIPPEIGKLNQLRRLYLDVNQLHGT 60
L L N + ++ LS LQ L L+ + IG L L+ L + N +
Sbjct: 81 LILTGNPI-QSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQ-- 137
Query: 61 IPPVIGQLSLINELVFCHNNVSGRIPSSLGNLSNLALLYLNDNSLFGSIPI-VMGNLKSL 119
S F NL+NL L L+ N + SI + L +
Sbjct: 138 --------SFKLPEYFS-------------NLTNLEHLDLSSNKI-QSIYCTDLRVLHQM 175
Query: 120 ----STLDLSQNQLNGSIPCSLDNLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSEN 175
+LDLS N +N P + + L L L N L + L SL ++ L N
Sbjct: 176 PLLNLSLDLSLNPMNFIQPGAFKEI-RLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 3e-13
Identities = 31/123 (25%), Positives = 53/123 (43%), Gaps = 5/123 (4%)
Query: 429 TELQYLDLSANKLSSSIPMSIGNLLKLHYLNLSNNQFSHKIPTE-FEKLIHLSELDLSHN 487
+ LDLS N L S + +L L+LS + I ++ L HLS L L+ N
Sbjct: 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGN 86
Query: 488 ILQEEIPPQI-CKMESLEKLNLSHNNLSDFIPRCFEEMRSLSWIDISYNELQGPIPNSTA 546
+Q + + SL+KL NL+ +++L +++++N +Q
Sbjct: 87 PIQ-SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQS-FKLPEY 144
Query: 547 FKN 549
F N
Sbjct: 145 FSN 147
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 1e-26
Identities = 71/303 (23%), Positives = 127/303 (41%), Gaps = 48/303 (15%)
Query: 618 SSSANPFGFFSVLNFN-GKVLYEEITKATGNFGEKYCIGKGGQRSVYKA-ELPSGNIFAV 675
+ + P F++ +F+ G+ L G FG +VY A E + I A+
Sbjct: 2 ALAEMPKRKFTIDDFDIGRPL------GKGKFG-----------NVYLAREKQNKFIMAL 44
Query: 676 KK-FKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFIVCEYLARGSLT 734
K FK++L + + + E+ + +RH NI++ + + + + +++ E+ RG L
Sbjct: 45 KVLFKSQLEKEGVEH--QLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELY 102
Query: 735 TILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVS 794
L+ F + ++ +A+AL Y H + +HRDI +N+L+ + E ++
Sbjct: 103 KELQ---KHGRFDEQRSATFMEELADALHYCHERKV---IHRDIKPENLLMGYKGELKIA 156
Query: 795 DFGFAKFLEPHSSNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHP--G 852
DFG++ P T GT+ Y PE+ EK D++ GVL E + G P
Sbjct: 157 DFGWSV-HAPSLRRRT-MCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDS 214
Query: 853 DFVSTIFSSISNMIIEVNQILDHRLPT-PSRDVTDKLRSIMEVAILCLVENPEARPTMKE 911
+ I N+ D + P S D + + L +P R +K
Sbjct: 215 PSHTETHRRIVNV--------DLKFPPFLSDGSKDLISKL-------LRYHPPQRLPLKG 259
Query: 912 VCN 914
V
Sbjct: 260 VME 262
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 1e-26
Identities = 77/283 (27%), Positives = 121/283 (42%), Gaps = 40/283 (14%)
Query: 645 TGNFGEKYCI----GKGGQRSVYKA-ELPSGNIFAVKKF-KAELFSDETANPSEFLNEVL 698
G F E+Y I GKG V K + + +AVK KA + +T S L EV
Sbjct: 17 QGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDT---STILREVE 73
Query: 699 ALTEIRHRNIIKFHGFCSNAQHSFIVCEYLARGSLTTILRDDAAAKE-FSWNQRMNVIKG 757
L ++ H NI+K ++ +IV E G L D+ ++ FS + +IK
Sbjct: 74 LLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELF----DEIIKRKRFSEHDAARIIKQ 129
Query: 758 VANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAH---VSDFGFAKFLEPHSSNWTEFAG 814
V + ++Y+H IVHRD+ +N+LL+S+ + + DFG + + ++ + G
Sbjct: 130 VFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ-NTKMKDRIG 185
Query: 815 TVGYAAPEL---AYTMRATEKYDVYSFGVLALEVIKGYHP--GDFVSTIFSSISNMIIEV 869
T Y APE+ Y EK DV+S GV+ ++ G P G I +
Sbjct: 186 TAYYIAPEVLRGTY----DEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAF 241
Query: 870 NQILDHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEV 912
+ + T S D D +R L +P R T +
Sbjct: 242 D---LPQWRTISDDAKDLIRK-------MLTFHPSLRITATQC 274
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 5e-26
Identities = 70/297 (23%), Positives = 116/297 (39%), Gaps = 64/297 (21%)
Query: 642 TKATGNFGEKYCI----GKGGQRSVYKA-ELPSGNIFAVKKFKAELFSDETANPSEFLNE 696
+ T N + + G G V+ + +G +FA+K K + S NE
Sbjct: 1 SMQTTNIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRD----SSLENE 56
Query: 697 VLALTEIRHRNIIKFHGFCSNAQHSFIVCEY----------LARGSLTTILRDDAAAKEF 746
+ L +I+H NI+ + H ++V + L RG T DA+
Sbjct: 57 IAVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYT---EKDAS---- 109
Query: 747 SWNQRMNVIKGVANALSYLH-HDCIPPIVHRDISSKNVLLDSEYEAH---VSDFGFAKFL 802
VI+ V +A+ YLH + IVHRD+ +N+L + E ++DFG +K
Sbjct: 110 ------LVIQQVLSAVKYLHENG----IVHRDLKPENLLYLTPEENSKIMITDFGLSKME 159
Query: 803 EPHSSNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHP--GDFVSTIFS 860
+ + GT GY APE+ ++ D +S GV+ ++ GY P + S +F
Sbjct: 160 QNGI--MSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFE 217
Query: 861 SISNMIIEVNQILDHRLPTP-----SRDVTDKLRSIMEVAILCLVENPEARPTMKEV 912
I E +P S D + L ++P R T ++
Sbjct: 218 KIKEGYYE--------FESPFWDDISESAKDFICH-------LLEKDPNERYTCEKA 259
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 7e-26
Identities = 67/297 (22%), Positives = 112/297 (37%), Gaps = 53/297 (17%)
Query: 653 CIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKF 711
+G G V+K PSG + A K E+ ++ + E+ L E I+ F
Sbjct: 40 ELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIR---NQIIRELQVLHECNSPYIVGF 96
Query: 712 HG-FCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCI 770
+G F S+ + S I E++ GSL +L+ E V V L+YL
Sbjct: 97 YGAFYSDGEIS-ICMEHMDGGSLDQVLKKAGRIPE---QILGKVSIAVIKGLTYLREKH- 151
Query: 771 PPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGTVGYAAPE----LAYT 826
I+HRD+ N+L++S E + DFG + L S F GT Y +PE Y+
Sbjct: 152 -KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI--DSMANSFVGTRSYMSPERLQGTHYS 208
Query: 827 MRATEKYDVYSFGVLALEVIKGYHP--------GDFVSTIFSSISNMIIEVNQILDHRLP 878
+++ D++S G+ +E+ G +P + + R
Sbjct: 209 VQS----DIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPL 264
Query: 879 TPSRDVTDKLRSIMEV--AIL----------------------CLVENPEARPTMKE 911
+ +I E+ I+ CL++NP R +K+
Sbjct: 265 NKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQ 321
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 8e-26
Identities = 64/304 (21%), Positives = 115/304 (37%), Gaps = 41/304 (13%)
Query: 642 TKATGNFGEKYCIGKGGQRSVYKA-ELPSGNIFAVKKFKAELFSDETANPSEFLNEVLAL 700
T+ G + K +G GG V + +G A+K+ + EL + E+ +
Sbjct: 10 TQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRER---WCLEIQIM 66
Query: 701 TEIRHRNIIKFH------GFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNV 754
++ H N++ + + EY G L L +
Sbjct: 67 KKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTL 126
Query: 755 IKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAH---VSDFGFAKFLEPHSSNWTE 811
+ +++AL YLH + I +HRD+ +N++L + + D G+AK L+ TE
Sbjct: 127 LSDISSALRYLHENRI---IHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQ-GELCTE 182
Query: 812 FAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHP-----------------GDF 854
F GT+ Y APEL + T D +SFG LA E I G+ P +
Sbjct: 183 FVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNE 242
Query: 855 VSTIFSSISNMIIEVNQILD-HRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVC 913
++ ++ + + + + L ++ M L+ + R T +
Sbjct: 243 HIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCM------LMWHQRQRGTDPQNP 296
Query: 914 NLLC 917
N+ C
Sbjct: 297 NVGC 300
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 9e-26
Identities = 68/305 (22%), Positives = 109/305 (35%), Gaps = 56/305 (18%)
Query: 638 YEEITKATGNFGEKYCI----GKGGQRSVYKA-ELPSGNIFAVKKFK----AELFSDETA 688
++ + ++Y + G G V A E + A++ A + E
Sbjct: 123 VDDQSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREAD 182
Query: 689 NPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFIVCEY----------LARGSLTTILR 738
E+ L ++ H IIK F + +IV E + L
Sbjct: 183 PALNVETEIEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLK---E 238
Query: 739 DDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAH---VSD 795
+ A+ YLH + I+HRD+ +NVLL S+ E ++D
Sbjct: 239 ATCK----------LYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITD 285
Query: 796 FGFAKFLEPHSSNWTEFAGTVGYAAPE-LAYTMRA--TEKYDVYSFGVLALEVIKGYHPG 852
FG +K L S GT Y APE L A D +S GV+ + GY P
Sbjct: 286 FGHSKILGETSL-MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP- 343
Query: 853 DFVSTIFSSISNMIIEVNQILDHRLPTPS---RDVTDKLRSIMEVAILCLVENPEARPTM 909
FS + +QI + +V++K +++ LV +P+AR T
Sbjct: 344 ------FSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVK---KLLVVDPKARFTT 394
Query: 910 KEVCN 914
+E
Sbjct: 395 EEALR 399
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 1e-25
Identities = 70/311 (22%), Positives = 119/311 (38%), Gaps = 83/311 (26%)
Query: 646 GNFGEKYCIGKGGQRSVYKAELPSGNIF--------AVKKFKAELFSDETANPSEFLNEV 697
G FG+ V AE + AVK K + + S+ ++E+
Sbjct: 46 GAFGQ-----------VVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKD---LSDLVSEM 91
Query: 698 LALTEI-RHRNIIKFHGFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIK 756
+ I +H+NII G C+ +++ EY ++G+L LR V +
Sbjct: 92 EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPE 151
Query: 757 G-------------VANALSYL--HHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKF 801
+A + YL +HRD++++NVL+ ++DFG A+
Sbjct: 152 EQMTFKDLVSCTYQLARGMEYLASQK-----CIHRDLAARNVLVTENNVMKIADFGLARD 206
Query: 802 LEPHSSN-------------WTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVI-K 847
+ ++ + W APE + T + DV+SFGVL E+
Sbjct: 207 I--NNIDYYKKTTNGRLPVKWM---------APEALFDRVYTHQSDVWSFGVLMWEIFTL 255
Query: 848 GYHPGDFVSTIFSSISNMIIEVNQILD--HRLPTPSRDVTDKLRSIMEVAILCLVENPEA 905
G P + I E+ ++L HR+ P + T++L +M C P
Sbjct: 256 GGSP-------YPGIPVE--ELFKLLKEGHRMDKP-ANCTNELYMMMR---DCWHAVPSQ 302
Query: 906 RPTMKEVCNLL 916
RPT K++ L
Sbjct: 303 RPTFKQLVEDL 313
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 1e-25
Identities = 70/314 (22%), Positives = 118/314 (37%), Gaps = 89/314 (28%)
Query: 646 GNFGEKYCIGKGGQRSVYKAELPSGNIF--------AVKKFKAELFSDETANPSE---FL 694
G FG+ V AE + AVK K + A + +
Sbjct: 92 GCFGQ-----------VVMAEAVGIDKDKPKEAVTVAVKMLK------DDATEKDLSDLV 134
Query: 695 NEVLALTEI-RHRNIIKFHGFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMN 753
+E+ + I +H+NII G C+ +++ EY ++G+L LR
Sbjct: 135 SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINR 194
Query: 754 VIKG-------------VANALSYL--HHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGF 798
V + +A + YL +HRD++++NVL+ ++DFG
Sbjct: 195 VPEEQMTFKDLVSCTYQLARGMEYLASQK-----CIHRDLAARNVLVTENNVMKIADFGL 249
Query: 799 AKFLEPHSSN-------------WTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEV 845
A+ + ++ + W APE + T + DV+SFGVL E+
Sbjct: 250 ARDI--NNIDYYKKTTNGRLPVKWM---------APEALFDRVYTHQSDVWSFGVLMWEI 298
Query: 846 I-KGYHPGDFVSTIFSSISNMIIEVNQILD--HRLPTPSRDVTDKLRSIMEVAILCLVEN 902
G P + I E+ ++L HR+ P + T++L +M C
Sbjct: 299 FTLGGSP-------YPGIPVE--ELFKLLKEGHRMDKP-ANCTNELYMMMR---DCWHAV 345
Query: 903 PEARPTMKEVCNLL 916
P RPT K++ L
Sbjct: 346 PSQRPTFKQLVEDL 359
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 2e-25
Identities = 64/284 (22%), Positives = 104/284 (36%), Gaps = 40/284 (14%)
Query: 645 TGNFGEKYCIGK---GGQRS-VYKA-ELPSGNIFAVKKF-KAELFSDETANPSEFLNEVL 698
G + + + G V+ E SG +K K + E+
Sbjct: 17 QGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPM----EQIEAEIE 72
Query: 699 ALTEIRHRNIIKFHGFCSNAQHSFIVCEYLARGSL-TTILRDDAAAKEFSWNQRMNVIKG 757
L + H NIIK + + +IV E G L I+ A K S ++K
Sbjct: 73 VLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQ 132
Query: 758 VANALSYLH-HDCIPPIVHRDISSKNVLLDSEYEAH---VSDFGFAKFLEPHSSNWTEFA 813
+ NAL+Y H +VH+D+ +N+L + DFG A+ + + T A
Sbjct: 133 MMNALAYFHSQH----VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKS-DEHSTNAA 187
Query: 814 GTVGYAAPEL---AYTMRATEKYDVYSFGVLALEVIKGYHP--GDFVSTIFSSISNMIIE 868
GT Y APE+ T K D++S GV+ ++ G P G + + +
Sbjct: 188 GTALYMAPEVFKRDV----TFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPN 243
Query: 869 VNQILDHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEV 912
+ D L+ L ++PE RP+ +V
Sbjct: 244 YAVECRPL----TPQAVDLLKQ-------MLTKDPERRPSAAQV 276
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 2e-25
Identities = 57/295 (19%), Positives = 113/295 (38%), Gaps = 39/295 (13%)
Query: 654 IGKGGQRSVYKA-ELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFH 712
+G+G +V++ +G++FA+K F F + E L ++ H+NI+K
Sbjct: 17 LGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDV---QMREFEVLKKLNHKNIVKLF 73
Query: 713 GF--CSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCI 770
+ +H ++ E+ GSL T+L + + A ++ + V++ V +++L +
Sbjct: 74 AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG- 132
Query: 771 PPIVHRDISSKNVLLDSEYEAH----VSDFGFAKFLEPHSSNWTEFAGTVGYAAPEL--- 823
IVHR+I N++ + ++DFG A+ LE + GT Y P++
Sbjct: 133 --IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELED-DEQFVSLYGTEEYLHPDMYER 189
Query: 824 -AYTMRATEKY----DVYSFGVLALEVIKGYHP------GDFVSTIFSSI-----SNMII 867
+KY D++S GV G P + I S I
Sbjct: 190 AVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAIS 249
Query: 868 EVNQILDHRLPTPSR-----DVTDKLRSIMEVAI-LCLVENPEARPTMKEVCNLL 916
V + + + ++ L+ ++ + L + E +
Sbjct: 250 GVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAET 304
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 3e-25
Identities = 65/317 (20%), Positives = 113/317 (35%), Gaps = 90/317 (28%)
Query: 646 GNFGEKYCIGKGGQRSVYKAELPSGNIF------AVKKFKAELFSDETANPSEFLNEVLA 699
G FG+ V KA AVK K E + L+E
Sbjct: 34 GEFGK-----------VVKATAFHLKGRAGYTTVAVKMLKENASPSE---LRDLLSEFNV 79
Query: 700 LTEIRHRNIIKFHGFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKG-- 757
L ++ H ++IK +G CS ++ EY GSL LR+ +
Sbjct: 80 LKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSL 139
Query: 758 -------------------VANALSYL--HHDCIPPIVHRDISSKNVLLDSEYEAHVSDF 796
++ + YL +VHRD++++N+L+ + +SDF
Sbjct: 140 DHPDERALTMGDLISFAWQISQGMQYLAEMK-----LVHRDLAARNILVAEGRKMKISDF 194
Query: 797 GFAKFLEPHSSN-------------WTEFAGTVGYAAPE-LAYTMRATEKYDVYSFGVLA 842
G ++ + + + W A E L T + DV+SFGVL
Sbjct: 195 GLSRDV--YEEDSYVKRSQGRIPVKWM---------AIESLFDH-IYTTQSDVWSFGVLL 242
Query: 843 LEVI-KGYHPGDFVSTIFSSISNMIIEVNQILD--HRLPTPSRDVTDKLRSIMEVAILCL 899
E++ G +P + I + +L HR+ P + ++++ +M C
Sbjct: 243 WEIVTLGGNP-------YPGIPPE--RLFNLLKTGHRMERP-DNCSEEMYRLML---QCW 289
Query: 900 VENPEARPTMKEVCNLL 916
+ P+ RP ++ L
Sbjct: 290 KQEPDKRPVFADISKDL 306
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 4e-25
Identities = 66/305 (21%), Positives = 110/305 (36%), Gaps = 66/305 (21%)
Query: 642 TKATGNFGEKYCIGK--G-GQRS-VYKA-ELPSGNIFAVK-----KFKAELFSDETANPS 691
+ +T F E Y + G G S V + P+ +AVK + +
Sbjct: 9 SHSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELRE 68
Query: 692 EFLNEVLALTEI-RHRNIIKFHGFCSNAQHSFIVCEY----------LARGSLTTILRDD 740
L EV L ++ H NII+ F+V + + +L+ +
Sbjct: 69 ATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLS---EKE 125
Query: 741 AAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAK 800
+++ + + LH I VHRD+ +N+LLD + ++DFGF+
Sbjct: 126 TR----------KIMRALLEVICALHKLNI---VHRDLKPENILLDDDMNIKLTDFGFSC 172
Query: 801 FLEPHSSNWTEFAGTVGYAAPE-LAYTMRATEK-Y----DVYSFGVLALEVIKGYHP--G 852
L+P E GT Y APE + +M Y D++S GV+ ++ G P
Sbjct: 173 QLDP-GEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWH 231
Query: 853 DFVSTIFSSISNMIIEVNQILDHRLPTP-----SRDVTDKLRSIMEVAILCLVENPEARP 907
+ I + + +P S V D + LV P+ R
Sbjct: 232 RKQMLMLRMIMSGNYQ--------FGSPEWDDYSDTVKDLVSR-------FLVVQPQKRY 276
Query: 908 TMKEV 912
T +E
Sbjct: 277 TAEEA 281
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 4e-25
Identities = 68/294 (23%), Positives = 121/294 (41%), Gaps = 50/294 (17%)
Query: 642 TKATGNFGEKYCIGK--G-GQRS-VYKA-ELPSGNIFAVKKF-KAELFSDETANPSEFLN 695
T F E+Y + + G G S V + ++ +G +A +L + +
Sbjct: 3 TITCTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQK---LER 59
Query: 696 EVLALTEIRHRNIIKFHGFCSNAQHSFIVCEYLARGSLTTILRDDAAAKE-FSWNQRMNV 754
E ++H NI++ H S H +++ + + G L +D A+E +S +
Sbjct: 60 EARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELF----EDIVAREYYSEADASHC 115
Query: 755 IKGVANALSYLH-HDCIPPIVHRDISSKNVLLDSEYEAH---VSDFGFAKFLEPHSSNWT 810
I+ + A+ + H +VHR++ +N+LL S+ + ++DFG A +E W
Sbjct: 116 IQQILEAVLHCHQMG----VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWF 171
Query: 811 EFAGTVGYAAPEL----AYTMRATEKYDVYSFGVLALEVIKGYHP--GDFVSTIFSSISN 864
FAGT GY +PE+ Y + D+++ GV+ ++ GY P + ++
Sbjct: 172 GFAGTPGYLSPEVLRKDPY----GKPVDLWACGVILYILLVGYPPFWDEDQHRLY----- 222
Query: 865 MIIEVNQILDHRLPTPSR---DVTDKLRS-IMEVAILCLVENPEARPTMKEVCN 914
QI PS VT + + I + L NP R T E
Sbjct: 223 -----QQIKAGAYDFPSPEWDTVTPEAKDLINK----MLTINPSKRITAAEALK 267
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 4e-25
Identities = 77/345 (22%), Positives = 136/345 (39%), Gaps = 85/345 (24%)
Query: 620 SANPFGFFSVLNFNGKVLYEEITKATGNFGEKYCIGKG--GQRSVYKAELPSGNIF---- 673
NP L N K+L E + + IG+G G+ V++A P +
Sbjct: 23 HPNPMYQRMPLLLNPKLLSLEYPRNNIEYVRD--IGEGAFGR--VFQARAPGLLPYEPFT 78
Query: 674 --AVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFIVCEYLARG 731
AVK K E +D A +F E + E + NI+K G C+ + ++ EY+A G
Sbjct: 79 MVAVKMLKEEASADMQA---DFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYG 135
Query: 732 SLTTILR---------------------DDAAAKEFSWNQRMNVIKGVANALSYL--HHD 768
L LR S +++ + + VA ++YL
Sbjct: 136 DLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK- 194
Query: 769 CIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSN-------------WTEFAGT 815
VHRD++++N L+ ++DFG ++ + +S++ W
Sbjct: 195 ----FVHRDLATRNCLVGENMVVKIADFGLSRNI--YSADYYKADGNDAIPIRWM----- 243
Query: 816 VGYAAPE-LAYTMRATEKYDVYSFGVLALEVI-KGYHPGDFVSTIFSSISNMIIEV-NQI 872
PE + Y R T + DV+++GV+ E+ G P + +++ EV +
Sbjct: 244 ----PPESIFYN-RYTTESDVWAYGVVLWEIFSYGLQP-------YYGMAHE--EVIYYV 289
Query: 873 LD-HRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLL 916
D + L P + +L ++M LC + P RP+ + +L
Sbjct: 290 RDGNILACP-ENCPLELYNLMR---LCWSKLPADRPSFCSIHRIL 330
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 4e-25
Identities = 60/317 (18%), Positives = 124/317 (39%), Gaps = 37/317 (11%)
Query: 608 RRKRDPQEKRSSSANPFGFFSVLNFNGKVLYEEITKATGNFGEKYCI----GKGGQRSVY 663
+ + + K + S+N + + + + + + + Y I G G V+
Sbjct: 117 EQGKIVRGKGTVSSNYDNYVF--DIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVH 174
Query: 664 KA-ELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSF 722
+ E +GN FA K SD+ E+ ++ +RH ++ H +
Sbjct: 175 RVTERATGNNFAAKFVMTPHESDK----ETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMV 230
Query: 723 IVCEYLARGSLTTILRDDAAAKEFSWNQR--MNVIKGVANALSYLHHDCIPPIVHRDISS 780
++ E+++ G L + A + ++ + ++ V L ++H + VH D+
Sbjct: 231 MIYEFMSGGELF----EKVADEHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKP 283
Query: 781 KNVLLDSEYEAHV--SDFGFAKFLEPHSSNWTEFAGTVGYAAPELAYTMRATEKYDVYSF 838
+N++ ++ + DFG L+P + GT +AAPE+A D++S
Sbjct: 284 ENIMFTTKRSNELKLIDFGLTAHLDPK-QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSV 342
Query: 839 GVLALEVIKGYHP--GDFVSTIFSSISNMIIEVNQILDHRL-PTPSRDVTDKLRSIMEVA 895
GVL+ ++ G P G+ ++ + +D S D D +R
Sbjct: 343 GVLSYILLSGLSPFGGENDDETLRNVKSCDWN----MDDSAFSGISEDGKDFIRK----- 393
Query: 896 ILCLVENPEARPTMKEV 912
L+ +P R T+ +
Sbjct: 394 --LLLADPNTRMTIHQA 408
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 5e-25
Identities = 69/309 (22%), Positives = 121/309 (39%), Gaps = 79/309 (25%)
Query: 646 GNFGEKYCIGKGGQRSVYKAELPSGNIF--------AVKKFKAELFSDETANPSEFLNEV 697
G FG+ V AE + AVK K++ + S+ ++E+
Sbjct: 80 GAFGQ-----------VVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKD---LSDLISEM 125
Query: 698 LALTEI-RHRNIIKFHGFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIK 756
+ I +H+NII G C+ +++ EY ++G+L L+ + +
Sbjct: 126 EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPE 185
Query: 757 G-------------VANALSYL--HHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKF 801
VA + YL +HRD++++NVL+ + ++DFG A+
Sbjct: 186 EQLSSKDLVSCAYQVARGMEYLASKK-----CIHRDLAARNVLVTEDNVMKIADFGLARD 240
Query: 802 LEPH-----SSN------WTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVI-KGY 849
+ ++N W APE + T + DV+SFGVL E+ G
Sbjct: 241 IHHIDYYKKTTNGRLPVKWM---------APEALFDRIYTHQSDVWSFGVLLWEIFTLGG 291
Query: 850 HPGDFVSTIFSSISNMIIEVNQILD--HRLPTPSRDVTDKLRSIMEVAILCLVENPEARP 907
P + + E+ ++L HR+ P + T++L +M C P RP
Sbjct: 292 SP-------YPGVPVE--ELFKLLKEGHRMDKP-SNCTNELYMMMR---DCWHAVPSQRP 338
Query: 908 TMKEVCNLL 916
T K++ L
Sbjct: 339 TFKQLVEDL 347
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 6e-25
Identities = 60/297 (20%), Positives = 118/297 (39%), Gaps = 37/297 (12%)
Query: 629 VLNFNGKVLYEEITKATGNFGEKYCI----GKGGQRSVYKA-ELPSGNIFAVKKFKAELF 683
+ K + + + G+ + Y I G G V++ E +G +F K
Sbjct: 30 YEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYP 89
Query: 684 SDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFIVCEYLARGSLTTILRDDAAA 743
D+ NE+ + ++ H +I H + ++ E+L+ G L D AA
Sbjct: 90 LDK----YTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELF----DRIAA 141
Query: 744 KEFSWNQR--MNVIKGVANALSYLH-HDCIPPIVHRDISSKNVLLDSEYEAHV--SDFGF 798
+++ ++ +N ++ L ++H H IVH DI +N++ +++ + V DFG
Sbjct: 142 EDYKMSEAEVINYMRQACEGLKHMHEHS----IVHLDIKPENIMCETKKASSVKIIDFGL 197
Query: 799 AKFLEPHSSNWTEFAGTVGYAAPE-LAYTMRATEKYDVYSFGVLALEVIKGYHP--GDFV 855
A L P T +AAPE + D+++ GVL ++ G P G+
Sbjct: 198 ATKLNPDEIVKVTT-ATAEFAAPEIVDREP-VGFYTDMWAIGVLGYVLLSGLSPFAGEDD 255
Query: 856 STIFSSISNMIIEVNQILDHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEV 912
++ E + + + S + D +++ L + P R T+ +
Sbjct: 256 LETLQNVKRCDWEFD---EDAFSSVSPEAKDFIKN-------LLQKEPRKRLTVHDA 302
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 9e-25
Identities = 56/285 (19%), Positives = 99/285 (34%), Gaps = 42/285 (14%)
Query: 643 KATGNFGEKYCIGK----GGQRSVYKA-ELPSGNIFAVKKFKAELFSDETANPSEFLNEV 697
G+ + Y + G V A + + A KK D F E+
Sbjct: 2 STKGDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDV----DRFKQEI 57
Query: 698 LALTEIRHRNIIKFHGFCSNAQHSFIVCEYLARGSLTTILRDDAAAKE-FSWNQRMNVIK 756
+ + H NII+ + + ++V E G L + K F + ++K
Sbjct: 58 EIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELF----ERVVHKRVFRESDAARIMK 113
Query: 757 GVANALSYLH-HDCIPPIVHRDISSKNVLLDSEYEAH---VSDFGFAKFLEPHSSNWTEF 812
V +A++Y H + + HRD+ +N L ++ + DFG A +P
Sbjct: 114 DVLSAVAYCHKLN----VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKP-GKMMRTK 168
Query: 813 AGTVGYAAPEL---AYTMRATEKYDVYSFGVLALEVIKGYHP--GDFVSTIFSSISNMII 867
GT Y +P++ Y + D +S GV+ ++ GY P S + I
Sbjct: 169 VGTPYYVSPQVLEGLY----GPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTF 224
Query: 868 EVNQILDHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEV 912
+ S +R L ++P+ R T +
Sbjct: 225 TFP---EKDWLNVSPQAESLIRR-------LLTKSPKQRITSLQA 259
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 1e-24
Identities = 66/298 (22%), Positives = 125/298 (41%), Gaps = 53/298 (17%)
Query: 639 EEITKATGNFGEKY----CIGKGGQRSVYKA-ELPSGNIFAVKKF-KAELFSDETANPSE 692
E + A+ F + Y +GKG V + +G FA K +L + + +
Sbjct: 18 EFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDF---QK 74
Query: 693 FLNEVLALTEIRHRNIIKFHGFCSNAQHSFIVCEYLARGSLTTILRDDAAAKE-FSWNQR 751
E +++H NI++ H ++V + + G L +D A+E +S
Sbjct: 75 LEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELF----EDIVAREFYSEADA 130
Query: 752 MNVIKGVANALSYLH-HDCIPPIVHRDISSKNVLLDSEYEAH---VSDFGFAKFLEPHSS 807
+ I+ + +++Y H + IVHR++ +N+LL S+ + ++DFG A + S
Sbjct: 131 SHCIQQILESIAYCHSNG----IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND-SE 185
Query: 808 NWTEFAGTVGYAAPEL----AYTMRATEKYDVYSFGVLALEVIKGYHP--GDFVSTIFSS 861
W FAGT GY +PE+ Y ++ D+++ GV+ ++ GY P + +++
Sbjct: 186 AWHGFAGTPGYLSPEVLKKDPY----SKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQ 241
Query: 862 ISNMIIEVNQILDHRLPTP-----SRDVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914
I + P+P + + + S L NP+ R T +
Sbjct: 242 IKAGAYD--------YPSPEWDTVTPEAKSLIDS-------MLTVNPKKRITADQALK 284
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 2e-24
Identities = 65/334 (19%), Positives = 109/334 (32%), Gaps = 66/334 (19%)
Query: 634 GKVLYEEITKATGNFGEKYCI----GKGGQRSVYKA-ELPSGNIFAVKKF-KAELFSDET 687
G+ + +KY + G+G V A E + I A+K K ++
Sbjct: 10 GRENLYFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINP 69
Query: 688 ANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFIVCEYLARGSL-------------- 733
+ EV + ++ H NI + + + Q+ +V E G L
Sbjct: 70 KDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGK 129
Query: 734 -----------------------TTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCI 770
+ ++ N+++ + +AL YLH+
Sbjct: 130 CAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ-- 187
Query: 771 PPIVHRDISSKNVLLDSEYEAHV--SDFGFAKFLEPHSSN----WTEFAGTVGYAAPE-L 823
I HRDI +N L + + DFG +K ++ T AGT + APE L
Sbjct: 188 -GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVL 246
Query: 824 AYTMRA-TEKYDVYSFGVLALEVIKGYHP--GDFVSTIFSSISNMIIEVNQILDHRLPTP 880
T + K D +S GVL ++ G P G + S + N + +
Sbjct: 247 NTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFE---NPNYNVL 303
Query: 881 SRDVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914
S D L + L N + R
Sbjct: 304 SPLARDLLSN-------LLNRNVDERFDAMRALQ 330
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 2e-24
Identities = 52/220 (23%), Positives = 94/220 (42%), Gaps = 49/220 (22%)
Query: 645 TGNFGEKYCI----GKGGQRSVYKA-ELPSGNIFAVKKF-KAELFSDETANPSEFLNEVL 698
+ F + Y + GKG V + +G FA K +L + + + E
Sbjct: 1 STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDF---QKLEREAR 57
Query: 699 ALTEIRHRNIIKFHGFCSNAQHSFIVCEY----------LARGSLTTILRDDAAAKEFSW 748
+++H NI++ H ++V + +AR + DA+
Sbjct: 58 ICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYS---EADAS------ 108
Query: 749 NQRMNVIKGVANALSYLH-HDCIPPIVHRDISSKNVLLDSEYE-AHV--SDFGFAKFLEP 804
+ I+ + +++Y H + IVHR++ +N+LL S+ + A V +DFG A +
Sbjct: 109 ----HCIQQILESIAYCHSNG----IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND 160
Query: 805 HSSNWTEFAGTVGYAAPEL----AYTMRATEKYDVYSFGV 840
S W FAGT GY +PE+ Y ++ D+++ GV
Sbjct: 161 -SEAWHGFAGTPGYLSPEVLKKDPY----SKPVDIWACGV 195
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 3e-24
Identities = 51/317 (16%), Positives = 102/317 (32%), Gaps = 59/317 (18%)
Query: 639 EEITKATGNFGEKYCIGKGGQRSVYKAE------LPSGNIFAVKKFKAELFSDETANPSE 692
E + + +G+G VY+A + F +K K ANP E
Sbjct: 58 TEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKP-------ANPWE 110
Query: 693 F---LNEVLALTEIRHRNIIKFHGFCSNAQHSFIVCEYLARGSLTTIL--RDDAAAKEFS 747
F + L +KF+ S +V E + G+L + + K
Sbjct: 111 FYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMP 170
Query: 748 WNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAH-----------VSDF 796
++ + + +H I+H DI N +L + + + D
Sbjct: 171 QGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDL 227
Query: 797 GFAKFLE--PHSSNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHP--- 851
G + ++ P + +T T G+ E+ + D + ++ G +
Sbjct: 228 GQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVK 287
Query: 852 -----------------GDFVSTIFSSISNM----IIEVNQILDHRL-PTPSRDVTDKLR 889
D + F + N+ + +L +L + T+K+R
Sbjct: 288 NEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIR 347
Query: 890 SIMEVAILCLVENPEAR 906
++ I+ L+E +R
Sbjct: 348 ALRNRLIVLLLECKRSR 364
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 3e-24
Identities = 69/308 (22%), Positives = 125/308 (40%), Gaps = 80/308 (25%)
Query: 646 GNFGEKYCIGKGGQRSVYKAE---LPSGNIF---AVKKFKAELFSDETANPSEFLNEVLA 699
G FG+ V +A L + AVK K+ +DE ++E+
Sbjct: 57 GAFGK-----------VVEATAFGLGKEDAVLKVAVKMLKSTAHADE---KEALMSELKI 102
Query: 700 LTEI-RHRNIIKFHGFCSNAQHSFIVCEYLARGSLTTILRD-----------DAAAKEFS 747
++ + +H NI+ G C++ ++ EY G L LR A S
Sbjct: 103 MSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTAS 162
Query: 748 WNQRMNVIKGVANALSYL-HHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHS 806
++ VA +++L +CI HRD++++NVLL + + A + DFG A+ + +
Sbjct: 163 TRDLLHFSSQVAQGMAFLASKNCI----HRDVAARNVLLTNGHVAKIGDFGLARDI--MN 216
Query: 807 SN-------------WTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVI-KGYHP- 851
+ W APE + T + DV+S+G+L E+ G +P
Sbjct: 217 DSNYIVKGNARLPVKWM---------APESIFDCVYTVQSDVWSYGILLWEIFSLGLNPY 267
Query: 852 -GDFVSTIFSSISNMIIEVNQILD--HRLPTPSRDVTDKLRSIMEVAILCLVENPEARPT 908
G V++ + +++ +++ P + SIM+ C P RPT
Sbjct: 268 PGILVNS----------KFYKLVKDGYQMAQP-AFAPKNIYSIMQ---ACWALEPTHRPT 313
Query: 909 MKEVCNLL 916
+++C+ L
Sbjct: 314 FQQICSFL 321
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 4e-24
Identities = 35/238 (14%), Positives = 85/238 (35%), Gaps = 28/238 (11%)
Query: 689 NPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSW 748
++ + +N + S + +I + + +L + + ++
Sbjct: 104 PMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREH 163
Query: 749 NQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLE----- 803
+++ +A A+ +LH + +HRD+ N+ + V DFG ++
Sbjct: 164 GVCLHIFIQIAEAVEFLHSKGL---MHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEE 220
Query: 804 -------PHSSNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVS 856
P + T GT Y +PE + + K D++S G++ E+ +
Sbjct: 221 QTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFEL---LYS----- 272
Query: 857 TIFSSISNMIIEVNQILDHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914
FS+ + + + + + P + +++ L +P RP ++
Sbjct: 273 --FSTQMERVRIITDVRNLKFPLLFTQKYPQEHMMVQ---DMLSPSPTERPEATDIIE 325
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 5e-24
Identities = 52/231 (22%), Positives = 103/231 (44%), Gaps = 16/231 (6%)
Query: 19 NLSKLQYLDLGNNQLSGVIPPEIGKLNQLRRLYLDVNQLHGTIPPVIGQLSLINELVFCH 78
++ +L ++ + +LN + ++ + + + ++ I L + +L
Sbjct: 22 AFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SVQG-IQYLPNVTKLFLNG 77
Query: 79 NNVSGRIPSSLGNLSNLALLYLNDNSLFGSIPIVMGNLKSLSTLDLSQNQLNGSIPCSLD 138
N ++ I L NL NL L+L++N + + + +LK L +L L N ++ I L
Sbjct: 78 NKLT-DI-KPLANLKNLGWLFLDENKV-KDLS-SLKDLKKLKSLSLEHNGIS-DIN-GLV 131
Query: 139 NLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSENRLSGLIPLSLSNLSSLTVMSLFN 198
+L L++L+L N ++ +V+ L L L L +N++S ++PL+ L+ L + L
Sbjct: 132 HLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVPLA--GLTKLQNLYLSK 187
Query: 199 NSLSGSIPPILGNLKSLSTLGLHINQLNGVIPPSIGNLSSLRNLSLFNNRL 249
N +S + L LK+L L L + NL + + L
Sbjct: 188 NHIS-DLRA-LAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSL 236
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 8e-20
Identities = 46/206 (22%), Positives = 86/206 (41%), Gaps = 16/206 (7%)
Query: 333 PNLTFLDLSQNNFYCEISFNWRNFSKLGTFNASMNNIYGSIPPEIGDSSKLQVLDLSSNH 392
+L + + ++ N + + A+ ++I S+ I + L L+ N
Sbjct: 24 AETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDI-KSVQG-IQYLPNVTKLFLNGNK 79
Query: 393 IFGKIPVQLVKLFSLNKLILSLNQLFGGVPLEFGTLTELQYLDLSANKLSSSIPMSIGNL 452
+ I L L +L L L N++ L+ L +L+ L L N +S + +L
Sbjct: 80 L-TDIKP-LANLKNLGWLFLDENKVKDLSSLK--DLKKLKSLSLEHNGISDING--LVHL 133
Query: 453 LKLHYLNLSNNQFSHKIPTEFEKLIHLSELDLSHNILQEEIPPQICKMESLEKLNLSHNN 512
+L L L NN+ + T +L L L L N + +I P + + L+ L LS N+
Sbjct: 134 PQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQI-SDIVP-LAGLTKLQNLYLSKNH 189
Query: 513 LSDFIPRCFEEMRSLSWIDISYNELQ 538
+SD +++L +++ E
Sbjct: 190 ISDLRA--LAGLKNLDVLELFSQECL 213
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 2e-18
Identities = 41/240 (17%), Positives = 83/240 (34%), Gaps = 16/240 (6%)
Query: 305 LRNLTSLERVRFNQNNLYGKVYEAFGDHPNLTFLDLSQNNFYCEISFNWRNFSKLGTFNA 364
+ + ++ + ++ + + ++ + + +
Sbjct: 20 DDAFAETIKDNLKKKSV--TDAVTQNELNSIDQIIANNSDIK-SVQ-GIQYLPNVTKLFL 75
Query: 365 SMNNIYGSIPPEIGDSSKLQVLDLSSNHIFGKIPVQLVKLFSLNKLILSLNQLFGGVPLE 424
+ N + I P + + L L L N + + L L L L L N + L
Sbjct: 76 NGNKL-TDIKP-LANLKNLGWLFLDENKV-KDLSS-LKDLKKLKSLSLEHNGISDINGLV 131
Query: 425 FGTLTELQYLDLSANKLSSSIPMSIGNLLKLHYLNLSNNQFSHKIPTEFEKLIHLSELDL 484
L +L+ L L NK++ + L KL L+L +NQ S +P L L L L
Sbjct: 132 --HLPQLESLYLGNNKITDITV--LSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYL 185
Query: 485 SHNILQEEIPPQICKMESLEKLNLSHNNLSDFIPRCFEEMRSLSWIDISYNELQGPIPNS 544
S N + ++ + +++L+ L L + + + + + L P S
Sbjct: 186 SKNHI-SDLRA-LAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTPEIIS 243
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 4e-18
Identities = 52/235 (22%), Positives = 87/235 (37%), Gaps = 20/235 (8%)
Query: 283 NLTGLVLLNMCENHLFGPIPKSLRNLTSLERVRFNQNNLYGKVYEAFGDHPNLTFLDLSQ 342
+ N+ + + + L S++++ N +++ K + PN+T L L+
Sbjct: 22 AFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDI--KSVQGIQYLPNVTKLFLNG 77
Query: 343 NNFYCEIS--FNWRNFSKLGTFNASMNNIYGSIPPEIGDSSKLQVLDLSSNHIFGKIPVQ 400
N ++ N LG N + + + D KL+ L L N I I
Sbjct: 78 NK----LTDIKPLANLKNLGWLFLDENKV-KDLSS-LKDLKKLKSLSLEHNGI-SDING- 129
Query: 401 LVKLFSLNKLILSLNQLFGGVPLEFGTLTELQYLDLSANKLSSSIPMSIGNLLKLHYLNL 460
LV L L L L N++ L LT+L L L N++S +P + L KL L L
Sbjct: 130 LVHLPQLESLYLGNNKITDITVLS--RLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYL 185
Query: 461 SNNQFSHKIPTEFEKLIHLSELDLSHNILQEEIPPQICKMESLEKLNLSHNNLSD 515
S N S L +L L+L + + + + +L
Sbjct: 186 SKNHISDL--RALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVT 238
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 5e-18
Identities = 52/200 (26%), Positives = 84/200 (42%), Gaps = 14/200 (7%)
Query: 2 LNLGFNLLFGNIPPQIGNLSKLQYLDLGNNQLSGVIPPEIGKLNQLRRLYLDVNQLHGTI 61
+ + + ++ I L + L L N+L+ + P + L L L+LD N++ +
Sbjct: 51 IIANNSDI-KSVQG-IQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVK-DL 105
Query: 62 PPVIGQLSLINELVFCHNNVSGRIPSSLGNLSNLALLYLNDNSLFGSIPIVMGNLKSLST 121
+ L + L HN +S I + L +L L LYL +N + + L L T
Sbjct: 106 SS-LKDLKKLKSLSLEHNGIS-DI-NGLVHLPQLESLYLGNNKITDITVL--SRLTKLDT 160
Query: 122 LDLSQNQLNGSIPCSLDNLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSENRLSGLI 181
L L NQ++ I L L+ L L+L KN +S + LK+L L+L
Sbjct: 161 LSLEDNQIS-DIV-PLAGLTKLQNLYLSKNHISDL--RALAGLKNLDVLELFSQECLNKP 216
Query: 182 PLSLSNLSSLTVMSLFNNSL 201
SNL + + SL
Sbjct: 217 INHQSNLVVPNTVKNTDGSL 236
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 3e-16
Identities = 63/299 (21%), Positives = 101/299 (33%), Gaps = 44/299 (14%)
Query: 216 STLGLHINQLNGVIPPSIGNLSSLRNLSLFNNRLYGFVPKEIGYLKSLSKLEFCANHLSG 275
S + + + +L + V L S+ ++ + +
Sbjct: 5 SETITVPTPIKQIFS--DDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKS 60
Query: 276 VIPHSVGNLTGLVLLNMCENHLFGPIPKSLRNLTSLERVRFNQNNLYGKVYEAFGDHPNL 335
V + L + L + N L K L NL +L + ++N + K + D L
Sbjct: 61 VQG--IQYLPNVTKLFLNGNKL--TDIKPLANLKNLGWLFLDENKV--KDLSSLKDLKKL 114
Query: 336 TFLDLSQNNFYCEISFNWRNFSKLGTFNASMNNIYGSIPPEIGDSSKLQVLDLSSNHIFG 395
L L N IS I + +L+ L L +N I
Sbjct: 115 KSLSLEHNG----IS---------------------DING-LVHLPQLESLYLGNNKIT- 147
Query: 396 KIPVQLVKLFSLNKLILSLNQLFGGVPLEFGTLTELQYLDLSANKLSSSIPMSIGNLLKL 455
I V L +L L+ L L NQ+ VPL LT+LQ L LS N +S + L L
Sbjct: 148 DITV-LSRLTKLDTLSLEDNQISDIVPLA--GLTKLQNLYLSKNHISDLRA--LAGLKNL 202
Query: 456 HYLNLSNNQFSHKIPTEFEKLIHLSELDLSHNILQEEIPPQICKMESLEKLNLSHNNLS 514
L L + + +K L+ + + + L P I EK N+ +
Sbjct: 203 DVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVT--PEIISDDGDYEKPNVKWHLPE 259
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 7e-12
Identities = 42/177 (23%), Positives = 75/177 (42%), Gaps = 12/177 (6%)
Query: 2 LNLGFNLLFGNIPPQIGNLSKLQYLDLGNNQLSGVIPPEIGKLNQLRRLYLDVNQLHGTI 61
L L N + ++ + +L KL+ L L +N +S + + L QL LYL N++ T
Sbjct: 95 LFLDENKV-KDLSS-LKDLKKLKSLSLEHNGISDING--LVHLPQLESLYLGNNKI--TD 148
Query: 62 PPVIGQLSLINELVFCHNNVSGRIPSSLGNLSNLALLYLNDNSLFGSIPIVMGNLKSLST 121
V+ +L+ ++ L N +S L L+ L LYL+ N + + LK+L
Sbjct: 149 ITVLSRLTKLDTLSLEDNQISD--IVPLAGLTKLQNLYLSKNHISDLRAL--AGLKNLDV 204
Query: 122 LDLSQNQLNGSIPCSLDNLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSENRLS 178
L+L + NL +T+ SL P +I + + ++ +
Sbjct: 205 LELFSQECLNKPINHQSNLVVPNTVKNTDGSLVT--PEIISDDGDYEKPNVKWHLPE 259
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 8e-24
Identities = 59/281 (20%), Positives = 105/281 (37%), Gaps = 58/281 (20%)
Query: 654 IGKGGQRSVYKAE-LPSGNIFAVKKF-KAELFSDETANPSEFLN---EVLALTEIRHRNI 708
+G G V+ A VK K ++ D + E+ L+ + H NI
Sbjct: 32 LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91
Query: 709 IKFHGFCSNAQHSFIVCEYLARG-------SLTTILRDDAAAKEFSWNQRMNVIKGVANA 761
IK N +V E G L + A+ F Q + +A
Sbjct: 92 IKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFR--Q-------LVSA 142
Query: 762 LSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGTVGYAAP 821
+ YL I +HRDI +N+++ ++ + DFG A +LE +T F GT+ Y AP
Sbjct: 143 VGYLRLKDI---IHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYT-FCGTIEYCAP 198
Query: 822 ELAYTMRATEKY-----DVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHR 876
E + Y +++S GV ++ +P E+ + ++
Sbjct: 199 E----VLMGNPYRGPELEMWSLGVTLYTLVFEENPFC--------------ELEETVEAA 240
Query: 877 LPTP---SRDVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914
+ P S+++ + + L PE R T++++
Sbjct: 241 IHPPYLVSKELMSLVSGL-------LQPVPERRTTLEKLVT 274
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-23
Identities = 64/310 (20%), Positives = 111/310 (35%), Gaps = 76/310 (24%)
Query: 646 GNFGEKYCIGKGGQRSVYKAE---LPSGNIF---AVKKFKAELFSDETANPSEFLNEVLA 699
G FG+ V +A L + AVK K E ++E+
Sbjct: 34 GAFGK-----------VVEATAYGLIKSDAAMTVAVKMLKPSAHLTE---REALMSELKV 79
Query: 700 LTEI-RHRNIIKFHGFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKG- 757
L+ + H NI+ G C+ + ++ EY G L LR + S +
Sbjct: 80 LSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDE 139
Query: 758 --------------VANALSYL--HHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKF 801
VA +++L + +HRD++++N+LL + DFG A+
Sbjct: 140 LALDLEDLLSFSYQVAKGMAFLASKN-----CIHRDLAARNILLTHGRITKICDFGLARD 194
Query: 802 LEPH-----SSN------WTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVI-KGY 849
++ N W APE + T + DV+S+G+ E+ G
Sbjct: 195 IKNDSNYVVKGNARLPVKWM---------APESIFNCVYTFESDVWSYGIFLWELFSLGS 245
Query: 850 HPGDFVSTIFSSISNMIIEVNQILD-HRLPTPSRDVTDKLRSIMEVAILCLVENPEARPT 908
P + + I + R+ +P ++ IM+ C +P RPT
Sbjct: 246 SP-------YPGMPVDSKFYKMIKEGFRMLSP-EHAPAEMYDIMK---TCWDADPLKRPT 294
Query: 909 MKEVCNLLCK 918
K++ L+ K
Sbjct: 295 FKQIVQLIEK 304
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 1e-23
Identities = 37/295 (12%), Positives = 80/295 (27%), Gaps = 55/295 (18%)
Query: 654 IGKGGQRSVYKAE-LPSGNIFAVK--------------KFKAELFS----DETANPSEFL 694
+G+ + +A +G F V + K E+ N +
Sbjct: 86 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 145
Query: 695 NEVLALTE---IRHRNIIKFHGFCSNAQHSFIVCEYL----ARGSLTT----ILRDDAAA 743
+ + ++ K + + +++ + + +L T +L +
Sbjct: 146 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 205
Query: 744 KEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFL- 802
K + R+ + V L+ LHH + VH + +++LD ++ F
Sbjct: 206 KSLVHHARLQLTLQVIRLLASLHHYGL---VHTYLRPVDIVLDQRGGVFLTGFEHLVRDG 262
Query: 803 EPHSSNWTEFAGTVGYAAPELAYTMRATEKY-----DVYSFGVLALEVIKGYHPGDFVST 857
S A + + D ++ G+ + P
Sbjct: 263 ASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLP--NTDD 320
Query: 858 IFSSISNMIIEVNQILDHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEV 912
S I +P P R + + L E R +
Sbjct: 321 AALGGSEWIFR----SCKNIPQPVRALLEGF----------LRYPKEDRLLPLQA 361
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 2e-23
Identities = 64/330 (19%), Positives = 119/330 (36%), Gaps = 62/330 (18%)
Query: 608 RRKRDPQEKRSSSANPFGFFSVLNFNGKVLYEEITKATGNFGEKYCIGK---GGQRS-VY 663
Q S +A+ + L + + + + + G S VY
Sbjct: 15 TENLYFQSMSSVTASAAPGTASLVPDYWIDG----SNRDALSDFFEVESELGRGATSIVY 70
Query: 664 KA-ELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSF 722
+ + + +A+K K +T + E+ L + H NIIK
Sbjct: 71 RCKQKGTQKPYALKVLK------KTVDKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEIS 124
Query: 723 IVCEY----------LARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLH-HDCIP 771
+V E + +G + DAA + +K + A++YLH +
Sbjct: 125 LVLELVTGGELFDRIVEKGYYS---ERDAA----------DAVKQILEAVAYLHENG--- 168
Query: 772 PIVHRDISSKNVLLDSEYE-AHV--SDFGFAKFLEPHSSNWTEFAGTVGYAAPELAYTMR 828
IVHRD+ +N+L + A + +DFG +K +E GT GY APE+
Sbjct: 169 -IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEH-QVLMKTVCGTPGYCAPEILRGCA 226
Query: 829 ATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSR---DVT 885
+ D++S G++ ++ G+ P F +IL+ S +V+
Sbjct: 227 YGPEVDMWSVGIITYILLCGFEP-------FYDERGDQFMFRRILNCEYYFISPWWDEVS 279
Query: 886 DKLRS-IMEVAILCLVENPEARPTMKEVCN 914
+ + + +V +P+ R T +
Sbjct: 280 LNAKDLVRK----LIVLDPKKRLTTFQALQ 305
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 2e-23
Identities = 59/225 (26%), Positives = 94/225 (41%), Gaps = 43/225 (19%)
Query: 642 TKATGNFGEKYCIGK--G-GQRS-VYKA-ELPSGNIFAVK---KFKAELFSDETANPSEF 693
A F +KY G G S V + +G+ FAVK L ++ E
Sbjct: 86 WAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREA 145
Query: 694 L-NEVLALTEIR-HRNIIKFHGFCSNAQHSFIVCEY----------LARGSLTTILRDDA 741
E L ++ H +II ++ F+V + + +L+ +
Sbjct: 146 TRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALS---EKET 202
Query: 742 AAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKF 801
++++ + A+S+LH + I VHRD+ +N+LLD + +SDFGF+
Sbjct: 203 R----------SIMRSLLEAVSFLHANNI---VHRDLKPENILLDDNMQIRLSDFGFSCH 249
Query: 802 LEPHSSNWTEFAGTVGYAAPE-LAYTMRATEK-Y----DVYSFGV 840
LEP E GT GY APE L +M T Y D+++ GV
Sbjct: 250 LEP-GEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGV 293
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-23
Identities = 65/295 (22%), Positives = 110/295 (37%), Gaps = 47/295 (15%)
Query: 637 LYEEITKATGNFGEKY----CIGKGGQRSVYKA-ELPSGNIFAVKKF--KAELFSDETAN 689
+ +++ + + F + Y IG G + + FAVK ++E
Sbjct: 9 IVQQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEE--- 65
Query: 690 PSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWN 749
E+L L +H NII + ++ ++V E + G L L K FS
Sbjct: 66 -----IEIL-LRYGQHPNIITLKDVYDDGKYVYVVTELMKGGEL---LDKILRQKFFSER 116
Query: 750 QRMNVIKGVANALSYLH-HDCIPPIVHRDISSKNVLLDSEYEAH----VSDFGFAKFLEP 804
+ V+ + + YLH +VHRD+ N+L E + DFGFAK L
Sbjct: 117 EASAVLFTITKTVEYLHAQG----VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRA 172
Query: 805 HSSNWTEFAGTVGYAAPEL----AYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFS 860
+ T + APE+ Y D++S GVL ++ GY P F +
Sbjct: 173 ENGLLMTPCYTANFVAPEVLERQGYDAAC----DIWSLGVLLYTMLTGYTP--FANGPDD 226
Query: 861 SISNMIIEVNQILDHRLPTPS---RDVTDKLRSIMEVAILCLVENPEARPTMKEV 912
+ ++ +I + V+D + ++ L +P R T V
Sbjct: 227 TPEEIL---ARIGSGKFSLSGGYWNSVSDTAKDLVS---KMLHVDPHQRLTAALV 275
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 4e-23
Identities = 30/162 (18%), Positives = 62/162 (38%), Gaps = 7/162 (4%)
Query: 88 SLGNLSNLALLYLNDNSLFGSIPIVMGNLKSLSTLDLSQNQLNGSIPCSLDNLSNLDTLF 147
+ +++L + L + ++ I ++ L ++ P + LSNL+ L
Sbjct: 39 TEAQMNSLTYITLANINVTDLTGI--EYAHNIKDLTINNIHATNYNP--ISGLSNLERLR 94
Query: 148 LYKNSLSGPIPSVIGNLKSLLQLDLSENRLSGLIPLSLSNLSSLTVMSLFNNSLSGSIPP 207
+ ++ + L SL LD+S + I ++ L + + L N I P
Sbjct: 95 IMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIMP 154
Query: 208 ILGNLKSLSTLGLHINQLNGVIPPSIGNLSSLRNLSLFNNRL 249
L L L +L + + ++ I + L L F+ +
Sbjct: 155 -LKTLPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFSQTI 193
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 2e-22
Identities = 33/186 (17%), Positives = 75/186 (40%), Gaps = 10/186 (5%)
Query: 91 NLSNLALLYLNDNSLFGSIPIVMGNLKSLSTLDLSQNQLNGSIPCSLDNLSNLDTLFLYK 150
L +S I + SL+ + L+ + ++ N+ L +
Sbjct: 21 TFKAYLNGLLGQSST---ANITEAQMNSLTYITLANINVTDLTG--IEYAHNIKDLTINN 75
Query: 151 NSLSGPIPSVIGNLKSLLQLDLSENRLSGLIPLSLSNLSSLTVMSLFNNSLSGSIPPILG 210
+ P I L +L +L + ++ +LS L+SLT++ + +++ SI +
Sbjct: 76 IHATNYNP--ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKIN 133
Query: 211 NLKSLSTLGLHINQLNGVIPPSIGNLSSLRNLSLFNNRLYGFVPKEIGYLKSLSKLEFCA 270
L ++++ L N I P + L L++L++ + ++ + I L++L +
Sbjct: 134 TLPKVNSIDLSYNGAITDIMP-LKTLPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFS 190
Query: 271 NHLSGV 276
+ G
Sbjct: 191 QTIGGK 196
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 3e-22
Identities = 31/185 (16%), Positives = 68/185 (36%), Gaps = 10/185 (5%)
Query: 19 NLSKLQYLDLGNNQLSGVIPPEIGKLNQLRRLYLDVNQLHGTIPPVIGQLSLINELVFCH 78
LG + + + ++N L + L + I I +L +
Sbjct: 21 TFKAYLNGLLGQSSTANITE---AQMNSLTYITLANINVTDLTG--IEYAHNIKDLTINN 75
Query: 79 NNVSGRIPSSLGNLSNLALLYLNDNSLFGSIPIVMGNLKSLSTLDLSQNQLNGSIPCSLD 138
+ + + + LSNL L + + + L SL+ LD+S + + SI ++
Sbjct: 76 IHATN--YNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKIN 133
Query: 139 NLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSENRLSGLIPLSLSNLSSLTVMSLFN 198
L ++++ L N I + L L L++ + + + + L + F+
Sbjct: 134 TLPKVNSIDLSYNGAITDI-MPLKTLPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFS 190
Query: 199 NSLSG 203
++ G
Sbjct: 191 QTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 2e-21
Identities = 34/164 (20%), Positives = 66/164 (40%), Gaps = 7/164 (4%)
Query: 17 IGNLSKLQYLDLGNNQLSGVIPPEIGKLNQLRRLYLDVNQLHGTIPPVIGQLSLINELVF 76
++ L Y+ L N ++ + I + ++ L ++ P I LS + L
Sbjct: 40 EAQMNSLTYITLANINVTDLTG--IEYAHNIKDLTINNIHATNYNP--ISGLSNLERLRI 95
Query: 77 CHNNVSGRIPSSLGNLSNLALLYLNDNSLFGSIPIVMGNLKSLSTLDLSQNQLNGSIPCS 136
+V+ +L L++L LL ++ ++ SI + L ++++DLS N I
Sbjct: 96 MGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIM-P 154
Query: 137 LDNLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSENRLSGL 180
L L L +L + + + I + L QL + G
Sbjct: 155 LKTLPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFSQTIGGK 196
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 1e-20
Identities = 28/159 (17%), Positives = 69/159 (43%), Gaps = 7/159 (4%)
Query: 381 SKLQVLDLSSNHIFGKIPVQLVKLFSLNKLILSLNQLFGGVPLEFGTLTELQYLDLSANK 440
+ L + L++ ++ ++ ++ L ++ P+ L+ L+ L +
Sbjct: 44 NSLTYITLANINVTDLTGIE--YAHNIKDLTINNIHATNYNPIS--GLSNLERLRIMGKD 99
Query: 441 LSSSIPMSIGNLLKLHYLNLSNNQFSHKIPTEFEKLIHLSELDLSHNILQEEIPPQICKM 500
++S ++ L L L++S++ I T+ L ++ +DLS+N +I P + +
Sbjct: 100 VTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIMP-LKTL 158
Query: 501 ESLEKLNLSHNNLSDFIPRCFEEMRSLSWIDISYNELQG 539
L+ LN+ + + D+ E+ L+ + + G
Sbjct: 159 PELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFSQTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 1e-17
Identities = 30/201 (14%), Positives = 73/201 (36%), Gaps = 12/201 (5%)
Query: 121 TLDLSQNQLNGSIPCSLDNLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSENRLSGL 180
L +Q N +IP L ++S + + + SL + L+ ++ L
Sbjct: 5 QTGLKASQDNVNIP--DSTFKAYLNGLLGQSSTANITEA---QMNSLTYITLANINVTDL 59
Query: 181 IPLSLSNLSSLTVMSLFNNSLSGSIPPILGNLKSLSTLGLHINQLNGVIPPSIGNLSSLR 240
+ ++ +++ N + P + L +L L + + P++ L+SL
Sbjct: 60 TGIE--YAHNIKDLTINNIHATNYNP--ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLT 115
Query: 241 NLSLFNNRLYGFVPKEIGYLKSLSKLEFCANHLSGVIPHSVGNLTGLVLLNMCENHLFGP 300
L + ++ + +I L ++ ++ N I + L L LN+ + +
Sbjct: 116 LLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIM-PLKTLPELKSLNIQFDGVHDY 174
Query: 301 IPKSLRNLTSLERVRFNQNNL 321
+ + L ++ +
Sbjct: 175 RG--IEDFPKLNQLYAFSQTI 193
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 6e-16
Identities = 34/183 (18%), Positives = 62/183 (33%), Gaps = 10/183 (5%)
Query: 211 NLKSLSTLGLHINQLNGVIPPSIGNLSSLRNLSLFNNRLYGFVPKEIGYLKSLSKLEFCA 270
K+ L + + ++SL ++L N + I Y ++ L
Sbjct: 21 TFKAYLNGLLGQSS---TANITEAQMNSLTYITLANINVTDL--TGIEYAHNIKDLTINN 75
Query: 271 NHLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLRNLTSLERVRFNQNNLYGKVYEAFG 330
H + P + L+ L L + + +L LTSL + + + +
Sbjct: 76 IHATNYNP--ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKIN 133
Query: 331 DHPNLTFLDLSQNNFYCEISFNWRNFSKLGTFNASMNNIYGSIPPEIGDSSKLQVLDLSS 390
P + +DLS N +I + +L + N + + I D KL L S
Sbjct: 134 TLPKVNSIDLSYNGAITDIMPL-KTLPELKSLNIQFDGV-HDYRG-IEDFPKLNQLYAFS 190
Query: 391 NHI 393
I
Sbjct: 191 QTI 193
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 8e-15
Identities = 31/186 (16%), Positives = 64/186 (34%), Gaps = 14/186 (7%)
Query: 283 NLTGLVLLNMCENHLFGPIPKSLRNLTSLERVRFNQNNLYGKVYEAFGDHPNLTFLDLSQ 342
+ + ++ I ++ + SL + N+ N+ L ++
Sbjct: 21 TFKAYLNGLLGQSST-ANITEA--QMNSLTYITLANINV--TDLTGIEYAHNIKDLTINN 75
Query: 343 NNF--YCEISFNWRNFSKLGTFNASMNNIYGSIPPEIGDSSKLQVLDLSSNHIFGKIPVQ 400
+ Y IS S L ++ P + + L +LD+S + I +
Sbjct: 76 IHATNYNPIS----GLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTK 131
Query: 401 LVKLFSLNKLILSLNQLFGGVPLEFGTLTELQYLDLSANKLSSSIPMSIGNLLKLHYLNL 460
+ L +N + LS N + TL EL+ L++ + + I + KL+ L
Sbjct: 132 INTLPKVNSIDLSYNGAITDIM-PLKTLPELKSLNIQFDGVHDYRG--IEDFPKLNQLYA 188
Query: 461 SNNQFS 466
+
Sbjct: 189 FSQTIG 194
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 4e-09
Identities = 19/117 (16%), Positives = 45/117 (38%), Gaps = 7/117 (5%)
Query: 428 LTELQYLDLSANKLSSSIPMSIGNLLKLHYLNLSNNQFSHKIPTEFEKLIHLSELDLSHN 487
L + + ++ + L Y+ L+N + T E ++ +L +++
Sbjct: 22 FKAYLNGLLGQSSTA---NITEAQMNSLTYITLANINVTD--LTGIEYAHNIKDLTINNI 76
Query: 488 ILQEEIPPQICKMESLEKLNLSHNNLSDFIPRCFEEMRSLSWIDISYNELQGPIPNS 544
P I + +LE+L + +++ + SL+ +DIS++ I
Sbjct: 77 HA-TNYNP-ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTK 131
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 45.7 bits (109), Expect = 1e-05
Identities = 18/83 (21%), Positives = 35/83 (42%), Gaps = 3/83 (3%)
Query: 1 MLNLGFNLLFGNIPPQIGNLSKLQYLDLGNNQLSGVIPPEIGKLNQLRRLYLDVNQLHGT 60
+L++ + +I +I L K+ +DL N I P + L +L+ L + + +H
Sbjct: 116 LLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIMP-LKTLPELKSLNIQFDGVHDY 174
Query: 61 IPPVIGQLSLINELVFCHNNVSG 83
I +N+L + G
Sbjct: 175 RG--IEDFPKLNQLYAFSQTIGG 195
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 4e-23
Identities = 63/204 (30%), Positives = 93/204 (45%), Gaps = 30/204 (14%)
Query: 23 LQYLDLGNNQLSGVIPPEIGKLNQLRRLYLDVNQLHGTIPPVIGQLSLINELVFCHNNVS 82
+ LDL +N+LS + +L +LR LYL+ N+L T+P +F
Sbjct: 39 TKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLPAG----------IF------ 81
Query: 83 GRIPSSLGNLSNLALLYLNDNSLFGSIPI-VMGNLKSLSTLDLSQNQLNGSIPCSL-DNL 140
L NL L++ DN L ++PI V L +L+ L L +NQL S+P + D+L
Sbjct: 82 -------KELKNLETLWVTDNKL-QALPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSL 132
Query: 141 SNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSENRLSGLIPLSLSNLSSLTVMSLFNNS 200
+ L L L N L V L SL +L L N+L + + L+ L + L NN
Sbjct: 133 TKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQ 192
Query: 201 LSGSIPP-ILGNLKSLSTLGLHIN 223
L +P +L+ L L L N
Sbjct: 193 LK-RVPEGAFDSLEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 2e-19
Identities = 60/233 (25%), Positives = 94/233 (40%), Gaps = 33/233 (14%)
Query: 119 LSTLDLSQNQLNGSIPCSLDNLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSENRLS 178
+++D S +L +IP ++ ++ L L N LS L L L L++N+L
Sbjct: 18 KNSVDCSSKKLT-AIPSNI--PADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ 74
Query: 179 GLIPLSLSNLSSLTVMSLFNNSLSGSIPP-ILGNLKSLSTLGLHINQLNGVIPPSI-GNL 236
L L +L + + +N L ++P + L +L+ L L NQL +PP + +L
Sbjct: 75 TLPAGIFKELKNLETLWVTDNKLQ-ALPIGVFDQLVNLAELRLDRNQLKS-LPPRVFDSL 132
Query: 237 SSLRNLSLFNNRLYGFVPKEIGYLKSLSKLEFCANHLSGVIPHSV-GNLTGLVLLNMCEN 295
+ L LSL N L+SL P V LT L L + N
Sbjct: 133 TKLTYLSLGYNE-----------LQSL--------------PKGVFDKLTSLKELRLYNN 167
Query: 296 HLFGPIPKSLRNLTSLERVRFNQNNLYGKVYEAFGDHPNLTFLDLSQNNFYCE 348
L + LT L+ ++ + N L AF L L L +N + C
Sbjct: 168 QLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQENPWDCT 220
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 6e-18
Identities = 50/173 (28%), Positives = 83/173 (47%), Gaps = 14/173 (8%)
Query: 372 SIPPEIGDSSKLQVLDLSSNHIFGKIPVQLVKLFSLNKLILSLNQLF---GGVPLEFGTL 428
+IP I + + LDL SN + +L L L L+ N+L G+ F L
Sbjct: 30 AIPSNI--PADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGI---FKEL 84
Query: 429 TELQYLDLSANKLSSSIPMSI-GNLLKLHYLNLSNNQFSHKIPTE-FEKLIHLSELDLSH 486
L+ L ++ NKL + +P+ + L+ L L L NQ +P F+ L L+ L L +
Sbjct: 85 KNLETLWVTDNKLQA-LPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGY 142
Query: 487 NILQEEIPPQIC-KMESLEKLNLSHNNLSDFIPRCFEEMRSLSWIDISYNELQ 538
N LQ +P + K+ SL++L L +N L F+++ L + + N+L+
Sbjct: 143 NELQS-LPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLK 194
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 2e-17
Identities = 51/177 (28%), Positives = 86/177 (48%), Gaps = 12/177 (6%)
Query: 365 SMNNIYGSIPPEIGDS-SKLQVLDLSSNHIFGKIPVQL-VKLFSLNKLILSLNQLFGGVP 422
N + S+P + +KL++L L+ N + +P + +L +L L ++ N+L +P
Sbjct: 45 QSNKL-SSLPSKAFHRLTKLRLLYLNDNKL-QTLPAGIFKELKNLETLWVTDNKL-QALP 101
Query: 423 LE-FGTLTELQYLDLSANKLSSSIPMSI-GNLLKLHYLNLSNNQFSHKIPTE-FEKLIHL 479
+ F L L L L N+L S +P + +L KL YL+L N+ +P F+KL L
Sbjct: 102 IGVFDQLVNLAELRLDRNQLKS-LPPRVFDSLTKLTYLSLGYNELQ-SLPKGVFDKLTSL 159
Query: 480 SELDLSHNILQEEIPPQIC-KMESLEKLNLSHNNLSDFIPRCFEEMRSLSWIDISYN 535
EL L +N L+ +P K+ L+ L L +N L F+ + L + + N
Sbjct: 160 KELRLYNNQLKR-VPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 2e-17
Identities = 52/180 (28%), Positives = 81/180 (45%), Gaps = 4/180 (2%)
Query: 118 SLSTLDLSQNQLNGSIPCSLDNLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSENRL 177
LDL N+L+ + L+ L L+L N L + LK+L L +++N+L
Sbjct: 38 DTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNKL 97
Query: 178 SGLIPLSLSNLSSLTVMSLFNNSLSGSIPP-ILGNLKSLSTLGLHINQLNGVIPPSI-GN 235
L L +L + L N L S+PP + +L L+ L L N+L +P +
Sbjct: 98 QALPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNELQ-SLPKGVFDK 155
Query: 236 LSSLRNLSLFNNRLYGFVPKEIGYLKSLSKLEFCANHLSGVIPHSVGNLTGLVLLNMCEN 295
L+SL+ L L+NN+L L L L+ N L V + +L L +L + EN
Sbjct: 156 LTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 4e-15
Identities = 48/155 (30%), Positives = 71/155 (45%), Gaps = 10/155 (6%)
Query: 2 LNLGFNLLFGNIPPQI-GNLSKLQYLDLGNNQLSGVIPPEI-GKLNQLRRLYLDVNQLHG 59
L L N L +P I L L+ L + +N+L +P + +L L L LD NQL
Sbjct: 66 LYLNDNKL-QTLPAGIFKELKNLETLWVTDNKLQ-ALPIGVFDQLVNLAELRLDRNQLK- 122
Query: 60 TIPP-VIGQLSLINELVFCHNNVSGRIPSSL-GNLSNLALLYLNDNSLFGSIPI-VMGNL 116
++PP V L+ + L +N + +P + L++L L L +N L +P L
Sbjct: 123 SLPPRVFDSLTKLTYLSLGYNELQ-SLPKGVFDKLTSLKELRLYNNQL-KRVPEGAFDKL 180
Query: 117 KSLSTLDLSQNQLNGSIPCSLDNLSNLDTLFLYKN 151
L TL L NQL + D+L L L L +N
Sbjct: 181 TELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 2e-14
Identities = 53/186 (28%), Positives = 82/186 (44%), Gaps = 16/186 (8%)
Query: 334 NLTFLDLSQNNFYCEISFN-WRNFSKLGTFNASMNNIYGSIPPEIGDS-SKLQVLDLSSN 391
+ LDL N + + +KL + N + ++P I L+ L ++ N
Sbjct: 38 DTKKLDLQSNKLS-SLPSKAFHRLTKLRLLYLNDNKL-QTLPAGIFKELKNLETLWVTDN 95
Query: 392 HIFGKIPVQL-VKLFSLNKLILSLNQLF---GGVPLEFGTLTELQYLDLSANKLSSSIPM 447
+ +P+ + +L +L +L L NQL V F +LT+L YL L N+L S +P
Sbjct: 96 KL-QALPIGVFDQLVNLAELRLDRNQLKSLPPRV---FDSLTKLTYLSLGYNELQS-LPK 150
Query: 448 SI-GNLLKLHYLNLSNNQFSHKIPTEFEKLIHLSELDLSHNILQEEIPPQI-CKMESLEK 505
+ L L L L NNQ F+KL L L L +N L+ +P +E L+
Sbjct: 151 GVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLK-RVPEGAFDSLEKLKM 209
Query: 506 LNLSHN 511
L L N
Sbjct: 210 LQLQEN 215
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 4e-23
Identities = 58/289 (20%), Positives = 111/289 (38%), Gaps = 37/289 (12%)
Query: 638 YEEITKATGNFGEKY------CIGKGGQRSVYKA-ELPSGNIFAVKKFKAELFSDETANP 690
+ +T G Y +G G V+K E +G A K K D+
Sbjct: 75 HRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDK---- 130
Query: 691 SEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQ 750
E NE+ + ++ H N+I+ + + +V EY+ G L D + ++ +
Sbjct: 131 EEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELF----DRIIDESYNLTE 186
Query: 751 R--MNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHV--SDFGFAKFLEPHS 806
+ +K + + ++H I+H D+ +N+L + + DFG A+ +P
Sbjct: 187 LDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKP-R 242
Query: 807 SNWTEFAGTVGYAAPE-LAYTMRATEKYDVYSFGVLALEVIKGYHP--GDFVSTIFSSIS 863
GT + APE + Y + D++S GV+A ++ G P GD + ++I
Sbjct: 243 EKLKVNFGTPEFLAPEVVNYD-FVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNIL 301
Query: 864 NMIIEVNQILDHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEV 912
++ D S + + + L++ R + E
Sbjct: 302 ACRWDLE---DEEFQDISEEAKEFISK-------LLIKEKSWRISASEA 340
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 4e-23
Identities = 58/299 (19%), Positives = 105/299 (35%), Gaps = 53/299 (17%)
Query: 654 IGKGGQRSVYKAELPSGNIFAVKK-FKAELFSDETANPSEFL------------NEVLAL 700
+ +G + E +A+KK K+ L S NE+ +
Sbjct: 39 LNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQII 97
Query: 701 TEIRHRNIIKFHGFCSNAQHSFIVCEYLARGSLTTILR-----DDAAAKEFSWNQRMNVI 755
T+I++ + G +N +I+ EY+ S+ D +I
Sbjct: 98 TDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCII 157
Query: 756 KGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGT 815
K V N+ SY+H++ I HRD+ N+L+D +SDFG ++++ GT
Sbjct: 158 KSVLNSFSYIHNEK--NICHRDVKPSNILMDKNGRVKLSDFGESEYMV--DKKIKGSRGT 213
Query: 816 VGYAAPEL-----AYTMRATEKYDVYSFGVLALEVIKGYHP--GDF-VSTIFSSISN--- 864
+ PE +Y K D++S G+ + P + +F++I
Sbjct: 214 YEFMPPEFFSNESSY---NGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRTKNI 270
Query: 865 ---------MIIEVNQILDHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914
+ N+ S + D L+ L +NP R T ++
Sbjct: 271 EYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLF-------LRKNPAERITSEDALK 322
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 5e-23
Identities = 66/283 (23%), Positives = 112/283 (39%), Gaps = 34/283 (12%)
Query: 645 TGNFGEKYCI----GKGGQRSVYKA-ELPSGNIFAVKKF-KAELFSDETANPSE-FLNEV 697
+ Y I G G V K E +G +A K K + + E EV
Sbjct: 7 QQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREV 66
Query: 698 LALTEIRHRNIIKFHGFCSNAQHSFIVCEYLARGSLTTILRDDAAAKE-FSWNQRMNVIK 756
L ++ H N+I H N ++ E ++ G L D A KE S + + IK
Sbjct: 67 SILRQVLHHNVITLHDVYENRTDVVLILELVSGGELF----DFLAQKESLSEEEATSFIK 122
Query: 757 GVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAH----VSDFGFAKFLEPHSSNWTEF 812
+ + ++YLH I H D+ +N++L + + DFG A +E +
Sbjct: 123 QILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIED-GVEFKNI 178
Query: 813 AGTVGYAAPE-LAYTMRATEKYDVYSFGVLALEVIKGYHP--GDFVSTIFSSISNMIIEV 869
GT + APE + Y + D++S GV+ ++ G P GD ++I+++ +
Sbjct: 179 FGTPEFVAPEIVNYE-PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDF 237
Query: 870 NQILDHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEV 912
+ + S D +R LV+ R T++E
Sbjct: 238 D---EEFFSHTSELAKDFIRK-------LLVKETRKRLTIQEA 270
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 5e-23
Identities = 68/300 (22%), Positives = 101/300 (33%), Gaps = 64/300 (21%)
Query: 647 NFGEKYCI----GKGGQRSVYKA-ELPSGNIFAVKKF-KAELFSDETANPSE---FLNEV 697
++Y + G G V A E + A+K K + E+
Sbjct: 7 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEI 66
Query: 698 LALTEIRHRNIIKFHGFCSNAQHSFIVCEYL----------ARGSLTTILRDDAAAKEFS 747
L ++ H IIK F + +IV E + L
Sbjct: 67 EILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLK---EATCK----- 117
Query: 748 WNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAH---VSDFGFAKFLEP 804
+ A+ YLH + I+HRD+ +NVLL S+ E ++DFG +K L
Sbjct: 118 -----LYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE 169
Query: 805 HSSNWTEFAGTVGYAAPE-LAYTMRA--TEKYDVYSFGVLALEVIKGYHPGDFVSTIFSS 861
S GT Y APE L A D +S GV+ + GY P FS
Sbjct: 170 TSL-MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP-------FSE 221
Query: 862 ISNMIIEVNQIL--DHRLPTP-----SRDVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914
+ +QI + S D ++ LV +P+AR T +E
Sbjct: 222 HRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKK-------LLVVDPKARFTTEEALR 274
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 5e-23
Identities = 68/288 (23%), Positives = 115/288 (39%), Gaps = 42/288 (14%)
Query: 645 TGNFGEKY-------CIGKGGQRSVYKA-ELPSGNIFAVKKFKAELFSDETANPSEFLNE 696
F + Y +G+G K S FAVK + ++ E
Sbjct: 3 DSPFYQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEAN-------TQKE 55
Query: 697 VLALTEIR-HRNIIKFHGFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVI 755
+ AL H NI+K H + H+F+V E L G L K FS + ++
Sbjct: 56 ITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGEL---FERIKKKKHFSETEASYIM 112
Query: 756 KGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAH---VSDFGFAKFLEPHSSNWTEF 812
+ + +A+S++H + VHRD+ +N+L E + + DFGFA+ P +
Sbjct: 113 RKLVSAVSHMHDVGV---VHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTP 169
Query: 813 AGTVGYAAPEL----AYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIE 868
T+ YAAPEL Y D++S GV+ ++ G P F S S +E
Sbjct: 170 CFTLHYAAPELLNQNGYDESC----DLWSLGVILYTMLSGQVP--FQSHDRSLTCTSAVE 223
Query: 869 V-NQILDHRLPTPS---RDVTDKLRSIMEVAILCLVENPEARPTMKEV 912
+ +I ++V+ + + +++ L +P R M +
Sbjct: 224 IMKKIKKGDFSFEGEAWKNVSQEAKDLIQ---GLLTVDPNKRLKMSGL 268
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 7e-23
Identities = 67/283 (23%), Positives = 112/283 (39%), Gaps = 34/283 (12%)
Query: 645 TGNFGEKYCI----GKGGQRSVYKA-ELPSGNIFAVKKF-KAELFSDETANPSEFL-NEV 697
+ Y I G G V K E +G +A K K + + E + EV
Sbjct: 7 QQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREV 66
Query: 698 LALTEIRHRNIIKFHGFCSNAQHSFIVCEYLARGSLTTILRDDAAAKE-FSWNQRMNVIK 756
L ++ H NII H N ++ E ++ G L D A KE S + + IK
Sbjct: 67 SILRQVLHPNIITLHDVYENRTDVVLILELVSGGELF----DFLAQKESLSEEEATSFIK 122
Query: 757 GVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAH----VSDFGFAKFLEPHSSNWTEF 812
+ + ++YLH I H D+ +N++L + + DFG A +E +
Sbjct: 123 QILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIED-GVEFKNI 178
Query: 813 AGTVGYAAPE-LAYTMRATEKYDVYSFGVLALEVIKGYHP--GDFVSTIFSSISNMIIEV 869
GT + APE + Y + D++S GV+ ++ G P GD ++I+ + +
Sbjct: 179 FGTPEFVAPEIVNYE-PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDF 237
Query: 870 NQILDHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEV 912
+ + S D +R LV+ R T++E
Sbjct: 238 D---EEFFSQTSELAKDFIRK-------LLVKETRKRLTIQEA 270
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 8e-23
Identities = 65/310 (20%), Positives = 106/310 (34%), Gaps = 81/310 (26%)
Query: 646 GNFGEKYCIGKGGQRSVYKAEL------PSGNIFAVKKFKAELFSDETANPSEFLNEVLA 699
G FG+ V +A+ + AVK K E ++E+
Sbjct: 38 GAFGQ-----------VIEADAFGIDKTATCRTVAVKMLKEGATHSEH---RALMSELKI 83
Query: 700 LTEI-RHRNIIKFHGFCS-NAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKG 757
L I H N++ G C+ ++ E+ G+L+T LR ++ K
Sbjct: 84 LIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKD 143
Query: 758 -------------VANALSYL--HHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFL 802
VA + +L +HRD++++N+LL + + DFG A+ +
Sbjct: 144 FLTLEHLICYSFQVAKGMEFLASRK-----CIHRDLAARNILLSEKNVVKICDFGLARDI 198
Query: 803 EPHSSN-------------WTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVI-KG 848
+ W APE + T + DV+SFGVL E+ G
Sbjct: 199 --YKDPDYVRKGDARLPLKWM---------APETIFDRVYTIQSDVWSFGVLLWEIFSLG 247
Query: 849 YHPGDFVSTIFSSISNMIIEVNQILD--HRLPTPSRDVTDKLRSIMEVAILCLVENPEAR 906
P + + E + L R+ P T ++ M C P R
Sbjct: 248 ASP-------YPGVKID-EEFCRRLKEGTRMRAP-DYTTPEMYQTML---DCWHGEPSQR 295
Query: 907 PTMKEVCNLL 916
PT E+ L
Sbjct: 296 PTFSELVEHL 305
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 99.2 bits (248), Expect = 9e-23
Identities = 70/284 (24%), Positives = 112/284 (39%), Gaps = 36/284 (12%)
Query: 645 TGNFGEKYCI----GKGGQRSVYKA-ELPSGNIFAVKKF-KAELFSDETANPSEFL-NEV 697
N + Y G G V K E +G +A K K S E + EV
Sbjct: 6 QENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREV 65
Query: 698 LALTEIRHRNIIKFHGFCSNAQHSFIVCEYLARGSLTTILRDDAAAKE-FSWNQRMNVIK 756
L EI+H N+I H N ++ E +A G L D A KE + + +K
Sbjct: 66 SILKEIQHPNVITLHEVYENKTDVILILELVAGGELF----DFLAEKESLTEEEATEFLK 121
Query: 757 GVANALSYLH-HDCIPPIVHRDISSKNVLLDSEYEAH----VSDFGFAKFLEPHSSNWTE 811
+ N + YLH I H D+ +N++L + DFG A ++ + +
Sbjct: 122 QILNGVYYLHSLQ----IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF-GNEFKN 176
Query: 812 FAGTVGYAAPE-LAYTMRATEKYDVYSFGVLALEVIKGYHP--GDFVSTIFSSISNMIIE 868
GT + APE + Y + D++S GV+ ++ G P GD +++S + E
Sbjct: 177 IFGTPEFVAPEIVNYE-PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYE 235
Query: 869 VNQILDHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEV 912
D S D +R LV++P+ R T+++
Sbjct: 236 FE---DEYFSNTSALAKDFIRR-------LLVKDPKKRMTIQDS 269
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 99.5 bits (248), Expect = 1e-22
Identities = 51/243 (20%), Positives = 86/243 (35%), Gaps = 16/243 (6%)
Query: 13 IPPQIGNLSKLQYLDLGNNQLSGVIPPEIGKLNQLRRLYLDVNQLHGTIPP-VIGQLSLI 71
IP + L +L + L ++ + N + I V L +
Sbjct: 24 IPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKL 81
Query: 72 NELVFCHNNVSGRIPSS-LGNLSNLALLYLNDNSLFGSIP-IVMGNLKSLSTLDLSQNQL 129
+E+ N I NL NL L +++ + +P + + LD+ N
Sbjct: 82 HEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGI-KHLPDVHKIHSLQKVLLDIQDNIN 140
Query: 130 NGSIP-CSLDNLS-NLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSE-NRLSGLIPLSLS 186
+I S LS L+L KN + I + N L +L+LS+ N L L
Sbjct: 141 IHTIERNSFVGLSFESVILWLNKNGIQE-IHNSAFNGTQLDELNLSDNNNLEELPNDVFH 199
Query: 187 NLSSLTVMSLFNNSLSGSIPP-ILGNLKSLSTLGLHINQLNGVIPPSIGNLSSLRNLSLF 245
S ++ + + S+P L NLK L + + P++ L +L SL
Sbjct: 200 GASGPVILDISRTRIH-SLPSYGLENLKKLRARSTYNLK----KLPTLEKLVALMEASLT 254
Query: 246 NNR 248
Sbjct: 255 YPS 257
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 83.7 bits (207), Expect = 2e-17
Identities = 46/256 (17%), Positives = 90/256 (35%), Gaps = 15/256 (5%)
Query: 142 NLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSENRLSGLIPLSLSNLSSLTVMSLFNNSL 201
+ ++ ++ IPS + ++ ++L +L + + S L + + N +
Sbjct: 10 SNRVFLCQESKVTE-IPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDV 66
Query: 202 SGSIPP-ILGNLKSLSTLGL-HINQLNGVIPPSI-GNLSSLRNLSLFNNRLYGFVPKEIG 258
I + NL L + + N L I P NL +L+ L + N +
Sbjct: 67 LEVIEADVFSNLPKLHEIRIEKANNLL-YINPEAFQNLPNLQYLLISNTGIKHLPDVHKI 125
Query: 259 YLKSLSKLEFCANHLSGVIPHSV--GNLTGLVLLNMCENHLFGPIPKSLRNLTSLERVRF 316
+ L+ N I + G V+L + +N + I S N T L+ +
Sbjct: 126 HSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGI-QEIHNSAFNGTQLDELNL 184
Query: 317 NQNNLYGKV-YEAFGDHPNLTFLDLSQNNFYCEISFNWRNFSKLGTFNASMNNIYGSIPP 375
+ NN ++ + F LD+S+ + S+ N KL + +P
Sbjct: 185 SDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARS---TYNLKKLPT 241
Query: 376 EIGDSSKLQVLDLSSN 391
+ L L+
Sbjct: 242 -LEKLVALMEASLTYP 256
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 83.0 bits (205), Expect = 5e-17
Identities = 41/163 (25%), Positives = 66/163 (40%), Gaps = 6/163 (3%)
Query: 381 SKLQVLDLSSNHIFGKIPVQ-LVKLFSLNKLILS-LNQLFGGVPLEFGTLTELQYLDLSA 438
L+ +++S N + I L L+++ + N L P F L LQYL +S
Sbjct: 54 GDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISN 113
Query: 439 NKLSSSIPMSIGNLLKLHYLNLSNNQFSHKIPTE-FEKL-IHLSELDLSHNILQEEIPPQ 496
+ + + L+ L++ +N H I F L L L+ N +QE I
Sbjct: 114 TGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQE-IHNS 172
Query: 497 ICKMESLEKLNLSHNNLSDFIPR-CFEEMRSLSWIDISYNELQ 538
L++LNLS NN + +P F +DIS +
Sbjct: 173 AFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIH 215
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 77.9 bits (192), Expect = 2e-15
Identities = 45/278 (16%), Positives = 88/278 (31%), Gaps = 35/278 (12%)
Query: 238 SLRNLSLFNNRLYGFVPKEIGYLKSLSKLEFCANHLSGVIPHSVGNLTGLVLLNMCENHL 297
S R +++ +P ++ ++ +L F L + + L + + +N +
Sbjct: 10 SNRVFLCQESKV-TEIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDV 66
Query: 298 FGPIPKS-LRNLTSLERVRF-NQNNLYGKVYEAFGDHPNLTFLDLSQNNFYCEISFNWRN 355
I NL L +R NNL EAF + PNL +L +S + +
Sbjct: 67 LEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIH 126
Query: 356 FSKLGTFNASMNNIYGSIPPEI--GDSSKLQVLDLSSNHIFGKIPVQLVKLFSLNKLILS 413
+ + N +I G S + +L L+ N I +I
Sbjct: 127 SLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGI-QEIHNSA------------ 173
Query: 414 LNQLFGGVPLEFGTLTELQYLDLSANKLSSSIPMSIGNLLKLHYLNLSNNQFSHKIPTEF 473
F + N L L++S +
Sbjct: 174 -----------FNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGL 222
Query: 474 EKLIHLSELDLSHNILQEEIPPQICKMESLEKLNLSHN 511
E L L + +++P + K+ +L + +L++
Sbjct: 223 ENLKKLRARSTYNL---KKLPT-LEKLVALMEASLTYP 256
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 69.9 bits (171), Expect = 8e-13
Identities = 19/112 (16%), Positives = 34/112 (30%), Gaps = 2/112 (1%)
Query: 426 GTLTELQYLDLSANKLSSSIPMSIGNLLKLHYLNLSNNQFSHKIPTE-FEKLIHLSELDL 484
L KL + L + +S N I + F L L E+ +
Sbjct: 27 DLPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRI 86
Query: 485 SHNILQEEIPPQICK-MESLEKLNLSHNNLSDFIPRCFEEMRSLSWIDISYN 535
I P+ + + +L+ L +S+ + +DI N
Sbjct: 87 EKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDN 138
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 2e-22
Identities = 61/279 (21%), Positives = 110/279 (39%), Gaps = 38/279 (13%)
Query: 647 NFGEKYCI----GKGGQRSVYKA-ELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALT 701
EKY I G+G V++ E S + K K + E+ L
Sbjct: 2 ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQV-----LVKKEISILN 56
Query: 702 EIRHRNIIKFHGFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQR--MNVIKGVA 759
RHRNI+ H + + ++ E+++ + + F N+R ++ + V
Sbjct: 57 IARHRNILHLHESFESMEELVMIFEFISGLDIF----ERINTSAFELNEREIVSYVHQVC 112
Query: 760 NALSYLH-HDCIPPIVHRDISSKNVLLDSEYEAHV--SDFGFAKFLEPHSSNWTEFAGTV 816
AL +LH H+ I H DI +N++ + + + +FG A+ L+P N+
Sbjct: 113 EALQFLHSHN----IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP-GDNFRLLFTAP 167
Query: 817 GYAAPE-LAYTMRATEKYDVYSFGVLALEVIKGYHP--GDFVSTIFSSISNMIIEVNQIL 873
Y APE + + +T D++S G L ++ G +P + I +I N +
Sbjct: 168 EYYAPEVHQHDVVSTAT-DMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFD--- 223
Query: 874 DHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEV 912
+ S + D + LV+ ++R T E
Sbjct: 224 EEAFKEISIEAMDFVDR-------LLVKERKSRMTASEA 255
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 3e-22
Identities = 66/320 (20%), Positives = 112/320 (35%), Gaps = 91/320 (28%)
Query: 646 GNFGEKYCIGKGGQRSVYKAELPSGNIF------AVKKFKAELFSDETANPSE---FLNE 696
G FG+ V A + AVK K E A+ SE ++E
Sbjct: 56 GAFGK-----------VMNATAYGISKTGVSIQVAVKMLK------EKADSSEREALMSE 98
Query: 697 VLALTEI-RHRNIIKFHGFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVI 755
+ +T++ H NI+ G C+ + +++ EY G L LR + N
Sbjct: 99 LKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQK 158
Query: 756 KG--------------------VANALSYL--HHDCIPPIVHRDISSKNVLLDSEYEAHV 793
+ VA + +L VHRD++++NVL+ +
Sbjct: 159 RLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS-----CVHRDLAARNVLVTHGKVVKI 213
Query: 794 SDFGFAKFLEPHSSN-------------WTEFAGTVGYAAPELAYTMRATEKYDVYSFGV 840
DFG A+ + S + W APE + T K DV+S+G+
Sbjct: 214 CDFGLARDI--MSDSNYVVRGNARLPVKWM---------APESLFEGIYTIKSDVWSYGI 262
Query: 841 LALEVI-KGYHPGDFVSTIFSSISNMIIEVNQILD-HRLPTPSRDVTDKLRSIMEVAILC 898
L E+ G +P + I I + ++ P T+++ IM+ C
Sbjct: 263 LLWEIFSLGVNP-------YPGIPVDANFYKLIQNGFKMDQP-FYATEEIYIIMQ---SC 311
Query: 899 LVENPEARPTMKEVCNLLCK 918
+ RP+ + + L
Sbjct: 312 WAFDSRKRPSFPNLTSFLGC 331
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 3e-22
Identities = 65/309 (21%), Positives = 112/309 (36%), Gaps = 63/309 (20%)
Query: 645 TGNFGEKY-----CIGKGGQRSVYKA-ELPSGNIFAVK---KFKAELFSDETANPSEFLN 695
+G F + Y +G+G V L + +AVK K S
Sbjct: 7 SGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGH-------IRSRVFR 59
Query: 696 EVLALTEIR-HRNIIKFHGFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNV 754
EV L + + HRN+++ F ++V E + GS+ L + F+ + V
Sbjct: 60 EVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSI---LSHIHKRRHFNELEASVV 116
Query: 755 IKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAH---VSDFGFAKFLEPHSS---- 807
++ VA+AL +LH+ I HRD+ +N+L + + + DF ++ +
Sbjct: 117 VQDVASALDFLHN---KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPI 173
Query: 808 ---NWTEFAGTVGYAAPE-LAYTMRATEKY----DVYSFGVLALEVIKGYHP-------- 851
G+ Y APE + Y D++S GV+ ++ GY P
Sbjct: 174 STPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSD 233
Query: 852 -GDFVSTIFSSISNMIIEVNQIL--DHRLPTP-----SRDVTDKLRSIMEVAILCLVENP 903
G + NM+ E I + P S D + LV +
Sbjct: 234 CGWDRGEACPACQNMLFE--SIQEGKYEFPDKDWAHISCAAKDLISK-------LLVRDA 284
Query: 904 EARPTMKEV 912
+ R + +V
Sbjct: 285 KQRLSAAQV 293
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 98.5 bits (245), Expect = 4e-22
Identities = 42/300 (14%), Positives = 86/300 (28%), Gaps = 64/300 (21%)
Query: 654 IGKGGQRSVYKA-ELPSGNIFAVK--------------KFKAELFS----DETANPSE-- 692
+G+ + +A + +G F V + K E+ N +
Sbjct: 81 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 140
Query: 693 ----FLNEVLALTEIRHRNIIKFHG-FCSNAQHSFIVCEYLARGSLTT----ILRDDAAA 743
F+ + + + + +I+ S + +L T +L +
Sbjct: 141 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 200
Query: 744 KEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLE 803
K + R+ + V L+ LHH + VH + +++LD ++ F
Sbjct: 201 KSLVHHARLQLTLQVIRLLASLHHYGL---VHTYLRPVDIVLDQRGGVFLTGFEHLV--- 254
Query: 804 PHSSNWTEFAGTVGYAAPEL-----------AYTMRATEKYDVYSFGVLALEVIKGYHPG 852
+ + G+ PEL T +D ++ G++ + P
Sbjct: 255 -RDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLP- 312
Query: 853 DFVSTIFSSISNMIIEVNQILDHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEV 912
S I +P P R + + L E R +
Sbjct: 313 -ITKDAALGGSEWIFR----SCKNIPQPVRALLEGF----------LRYPKEDRLLPLQA 357
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 96.5 bits (241), Expect = 4e-22
Identities = 68/281 (24%), Positives = 115/281 (40%), Gaps = 34/281 (12%)
Query: 647 NFGEKYCI----GKGGQRSVYKA-ELPSGNIFAVKKF-KAELFSDETANPSE-FLNEVLA 699
+ Y + G G V K + +G +A K K L S E EV
Sbjct: 2 MVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNI 61
Query: 700 LTEIRHRNIIKFHGFCSNAQHSFIVCEYLARGSLTTILRDDAAAKE-FSWNQRMNVIKGV 758
L EIRH NII H N ++ E ++ G L D A KE + ++ +K +
Sbjct: 62 LREIRHPNIITLHDIFENKTDVVLILELVSGGELF----DFLAEKESLTEDEATQFLKQI 117
Query: 759 ANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAH----VSDFGFAKFLEPHSSNWTEFAG 814
+ + YLH I H D+ +N++L + + + DFG A +E + + G
Sbjct: 118 LDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEA-GNEFKNIFG 173
Query: 815 TVGYAAPE-LAYTMRATEKYDVYSFGVLALEVIKGYHP--GDFVSTIFSSISNMIIEVNQ 871
T + APE + Y + D++S GV+ ++ G P G+ ++IS + + +
Sbjct: 174 TPEFVAPEIVNYE-PLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFD- 231
Query: 872 ILDHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEV 912
+ S D +R LV++P+ R T+ +
Sbjct: 232 --EEYFSNTSELAKDFIRR-------LLVKDPKRRMTIAQS 263
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 96.4 bits (240), Expect = 4e-22
Identities = 31/258 (12%), Positives = 63/258 (24%), Gaps = 46/258 (17%)
Query: 653 CIGKGGQRSVYKAE---LPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNII 709
G ++A L A+ + + E L+ L L+ I +
Sbjct: 38 FHGGVPPLQFWQALDTAL--DRQVALTFVDPQGVLPDDV-LQETLSRTLRLSRIDKPGVA 94
Query: 710 KFHGFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDC 769
+ +V E++ GSL + + + ++ +A A H
Sbjct: 95 RVLDVVHTRAGGLVVAEWIRGGSLQEVADTSPSPVG-----AIRAMQSLAAAADAAHRA- 148
Query: 770 IPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGTVGYAAPELAYTMRA 829
+ V VS G A
Sbjct: 149 --GVALSIDHPSRVR--------VSIDGDVV------------LAYPATMPD-------A 179
Query: 830 TEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRDVTDKLR 889
+ D+ G ++ P + + + + + + P+ D
Sbjct: 180 NPQDDIRGIGASLYALLVNRWPLP-----EAGVRSGLAPAERDTAGQPIEPADIDRDIPF 234
Query: 890 SIMEVAILCLVENPEARP 907
I VA + + R
Sbjct: 235 QISAVAARSVQGDGGIRS 252
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 2e-21
Identities = 48/231 (20%), Positives = 88/231 (38%), Gaps = 17/231 (7%)
Query: 17 IGNLSKLQYLDLGNNQLSGVIPPEIGKLNQLRRLYLDVNQLHGTIPPVIGQLSLINELVF 76
L+ +LG ++ ++ +L+ ++ D + + ++ + + + EL
Sbjct: 15 DPGLANAVKQNLGKQSVTDLVS--QKELSGVQNFNGDNSNIQ-SLAG-MQFFTNLKELHL 70
Query: 77 CHNNVSGRIPSSLGNLSNLALLYLNDNSLFGSIPIVMGNLKSLSTLDLSQNQLNGSIPCS 136
HN +S + S L +L+ L L +N N L + LS L L N+L S
Sbjct: 71 SHNQIS-DL-SPLKDLTKLEELSVNRNRL---KNLNGIPSACLSRLFLDNNEL--RDTDS 123
Query: 137 LDNLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSENRLSGLIPLSLSNLSSLTVMSL 196
L +L NL+ L + N L ++G L L LDL N ++ L+ L + + L
Sbjct: 124 LIHLKNLEILSIRNNKLKS--IVMLGFLSKLEVLDLHGNEITNTGG--LTRLKKVNWIDL 179
Query: 197 FNNSLSGSIPPILGNLKSLSTLGLHINQLNGVIPPSIGNLSSLRNLSLFNN 247
L +T+ + + P I N S + +
Sbjct: 180 TGQKCVNEPVKYQPELYITNTVKDPDGRW--ISPYYISNGGSYVDGCVLWE 228
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 6e-19
Identities = 46/205 (22%), Positives = 77/205 (37%), Gaps = 18/205 (8%)
Query: 87 SSLGNLSNLALLYLNDNSLFGSIPIVMGNLKSLSTLDLSQNQLNGSIPCSLDNLSNLDTL 146
L+N L S+ + L + + + + S+ + +NL L
Sbjct: 13 FPDPGLANAVKQNLGKQSVTDLVSQ--KELSGVQNFNGDNSNIQ-SLA-GMQFFTNLKEL 68
Query: 147 FLYKNSLSGPIPSVIGNLKSLLQLDLSENRLSGLIPLSLSNLSSLTVMSLFNNSLSGSIP 206
L N +S P + +L L +L ++ NRL L + + LS L L NN L
Sbjct: 69 HLSHNQISDLSP--LKDLTKLEELSVNRNRLKNLNGIPSACLSRL---FLDNNELR-DTD 122
Query: 207 PILGNLKSLSTLGLHINQLNGVIPPSIGNLSSLRNLSLFNNRLYGFVPKEIGYLKSLSKL 266
L +LK+L L + N+L + +G LS L L L N + + LK ++ +
Sbjct: 123 S-LIHLKNLEILSIRNNKLKSI--VMLGFLSKLEVLDLHGNEITNT--GGLTRLKKVNWI 177
Query: 267 EFCANHLSGVIPHSVGNLTGLVLLN 291
+ V L + N
Sbjct: 178 DLTGQKCV---NEPVKYQPELYITN 199
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 3e-15
Identities = 41/201 (20%), Positives = 77/201 (38%), Gaps = 15/201 (7%)
Query: 2 LNLGFNLLFGNIPPQIGNLSKLQYLDLGNNQLSGVIPPEIGKLNQLRRLYLDVNQLHGTI 61
N + + ++ + + L+ L L +NQ+S + P + L +L L ++ N+L +
Sbjct: 46 FNGDNSNI-QSLAG-MQFFTNLKELHLSHNQISDLSP--LKDLTKLEELSVNRNRLK-NL 100
Query: 62 PPVIGQLSLINELVFCHNNVSGRIPSSLGNLSNLALLYLNDNSLFGSIPIVMGNLKSLST 121
I L + L +N + SL +L NL +L + +N L + + G L L
Sbjct: 101 NG-IPSACL-SRLFLDNNELRD--TDSLIHLKNLEILSIRNNKLKSIVML--GFLSKLEV 154
Query: 122 LDLSQNQLNGSIPCSLDNLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSENRLSGLI 181
LDL N++ + L L ++ + L L + + R +
Sbjct: 155 LDLHGNEI--TNTGGLTRLKKVNWIDLTGQKCVNEPVKYQPELYITNTVKDPDGRW--IS 210
Query: 182 PLSLSNLSSLTVMSLFNNSLS 202
P +SN S +
Sbjct: 211 PYYISNGGSYVDGCVLWELPV 231
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 2e-14
Identities = 42/212 (19%), Positives = 78/212 (36%), Gaps = 15/212 (7%)
Query: 333 PNLTFLDLSQNNFYCEISFNWRNFSKLGTFNASMNNIYGSIPPEIGDSSKLQVLDLSSNH 392
N +L + + +S S + FN +NI S+ + + L+ L LS N
Sbjct: 19 ANAVKQNLGKQSVTDLVSQK--ELSGVQNFNGDNSNI-QSLAG-MQFFTNLKELHLSHNQ 74
Query: 393 IFGKIPVQLVKLFSLNKLILSLNQLFGGVPLEFGTLTELQYLDLSANKLSSSIPMSIGNL 452
I + L L L +L ++ N+L L L L L N+L + + +L
Sbjct: 75 I-SDLS-PLKDLTKLEELSVNRNRL---KNLNGIPSACLSRLFLDNNELRDTDS--LIHL 127
Query: 453 LKLHYLNLSNNQFSHKIPTEFEKLIHLSELDLSHNILQEEIPPQICKMESLEKLNLSHNN 512
L L++ NN+ L L LDL N + + +++ + ++L+
Sbjct: 128 KNLEILSIRNNKLKS--IVMLGFLSKLEVLDLHGNEITNTGG--LTRLKKVNWIDLTGQK 183
Query: 513 LSDFIPRCFEEMRSLSWIDISYNELQGPIPNS 544
+ + E+ + + P S
Sbjct: 184 CVNEPVKYQPELYITNTVKDPDGRWISPYYIS 215
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 2e-14
Identities = 44/246 (17%), Positives = 98/246 (39%), Gaps = 21/246 (8%)
Query: 271 NHLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLRNLTSLERVRFNQNNLYGKVYEAFG 330
++ V P L V N+ + + + + L+ ++ + +N+ +
Sbjct: 7 TPINQVFP--DPGLANAVKQNLGKQSVTDLVS--QKELSGVQNFNGDNSNI--QSLAGMQ 60
Query: 331 DHPNLTFLDLSQNNFYCEISFNWRNFSKLGTFNASMNNIYGSIPPEIGDSSKLQVLDLSS 390
NL L LS N ++S ++ +KL + + N + ++ S+ L L L +
Sbjct: 61 FFTNLKELHLSHNQIS-DLS-PLKDLTKLEELSVNRNRL-KNLNG--IPSACLSRLFLDN 115
Query: 391 NHIFGKIPVQLVKLFSLNKLILSLNQLFGGVPLEFGTLTELQYLDLSANKLSSSIPMSIG 450
N + L+ L +L L + N+L V L L++L+ LDL N+++++ +
Sbjct: 116 NELR-DTDS-LIHLKNLEILSIRNNKLKSIVMLG--FLSKLEVLDLHGNEITNTGG--LT 169
Query: 451 NLLKLHYLNLSNNQFSHKIPTEFEKLIHLSELDLSHNILQEEIPP-QICKMESLEKLNLS 509
L K+++++L+ + ++ +L + + + I P I S +
Sbjct: 170 RLKKVNWIDLTGQKCVNEPVKYQPELYITNTV---KDPDGRWISPYYISNGGSYVDGCVL 226
Query: 510 HNNLSD 515
Sbjct: 227 WELPVY 232
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 2e-11
Identities = 40/192 (20%), Positives = 73/192 (38%), Gaps = 13/192 (6%)
Query: 2 LNLGFNLLFGNIPPQIGNLSKLQYLDLGNNQLSGVIPPEIGKLNQLRRLYLDVNQLHGTI 61
L+L N + ++ P + +L+KL+ L + N+L + L RL+LD N+L
Sbjct: 68 LHLSHNQI-SDLSP-LKDLTKLEELSVNRNRLKNL---NGIPSACLSRLFLDNNEL--RD 120
Query: 62 PPVIGQLSLINELVFCHNNVSGRIPSSLGNLSNLALLYLNDNSLFGSIPIVMGNLKSLST 121
+ L + L +N + LG LS L +L L+ N + + + LK ++
Sbjct: 121 TDSLIHLKNLEILSIRNNKLKS--IVMLGFLSKLEVLDLHGNEITNTGGL--TRLKKVNW 176
Query: 122 LDLSQNQLNGSIPCSLDNLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSENRLSGLI 181
+DL+ + L +T+ P I N S + +
Sbjct: 177 IDLTGQKCVNEPVKYQPELYITNTVKDPDGRWISPYY--ISNGGSYVDGCVLWELPVYTD 234
Query: 182 PLSLSNLSSLTV 193
+S + V
Sbjct: 235 EVSYKFSEYINV 246
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 3e-21
Identities = 71/291 (24%), Positives = 121/291 (41%), Gaps = 43/291 (14%)
Query: 641 ITKATGNFGEKYCI-----GKGGQRSVYKA-ELPSGNIFAVKKFKAELFSDETANPSEFL 694
++ NF Y + G+G V + +G +A K K + +E L
Sbjct: 19 YFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQD--CRAEIL 76
Query: 695 NEVLALTEIRHR-NIIKFHGFCSNAQHSFIVCEYLARGSL-TTILRDDAAAKEFSWNQRM 752
+E+ L + +I H N ++ EY A G + + L + A+ S N +
Sbjct: 77 HEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPEL--AEMVSENDVI 134
Query: 753 NVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAH---VSDFGFAKFLEPHSSNW 809
+IK + + YLH + IVH D+ +N+LL S Y + DFG ++ + +
Sbjct: 135 RLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGH-ACEL 190
Query: 810 TEFAGTVGYAAPE-LAYTMRATEKYDVYSFGVLALEVIKGYHP--GDFVSTIFSSISNMI 866
E GT Y APE L Y T D+++ G++A ++ P G+ + +IS +
Sbjct: 191 REIMGTPEYLAPEILNYD-PITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVN 249
Query: 867 IEVNQILDHRLPTP-----SRDVTDKLRSIMEVAILCLVENPEARPTMKEV 912
++ S+ TD ++S LV+NPE RPT +
Sbjct: 250 VD--------YSEETFSSVSQLATDFIQS-------LLVKNPEKRPTAEIC 285
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 4e-21
Identities = 63/284 (22%), Positives = 101/284 (35%), Gaps = 62/284 (21%)
Query: 654 IGKGGQRSVYKAE-LPSGNIFAVK------KFKAELFSDETANPSEFLNEVLALTEIRHR 706
+GKGG +V+ L A+K SD P E H
Sbjct: 39 LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98
Query: 707 NIIKFHGFCSNAQHSFIVCEYLARG-------SLTTILRDDAAAKEFSWNQRMNVIKGVA 759
+I+ + + +V E + L + + F Q V
Sbjct: 99 GVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFG--Q-------VV 149
Query: 760 NALSYLHHDCIPPIVHRDISSKNVLLDSEY-EAHVSDFGFAKFLEPHSSNWTEFAGTVGY 818
A+ + H + VHRDI +N+L+D A + DFG L H +T+F GT Y
Sbjct: 150 AAIQHCHSRGV---VHRDIKDENILIDLRRGCAKLIDFGSGALL--HDEPYTDFDGTRVY 204
Query: 819 AAPELAYTMRATEKY-----DVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQIL 873
+ PE + +Y V+S G+L +++ G P + +IL
Sbjct: 205 SPPE----WISRHQYHALPATVWSLGILLYDMVCGDIPFE--------------RDQEIL 246
Query: 874 DHRLPTP---SRDVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914
+ L P S D +R CL P +RP+++E+
Sbjct: 247 EAELHFPAHVSPDCCALIRR-------CLAPKPSSRPSLEEILL 283
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 94.1 bits (234), Expect = 1e-20
Identities = 45/171 (26%), Positives = 79/171 (46%), Gaps = 16/171 (9%)
Query: 372 SIPPEIGDSSKLQVLDLSSNHIFGKIPVQ--LVKLFSLNKLILSLNQLFGGVPLE-FGTL 428
++P + S +LDLS N++ ++ + +L +L+ L+LS N L + E F +
Sbjct: 32 NVPQSL--PSYTALLDLSHNNL-SRLRAEWTPTRLTNLHSLLLSHNHL-NFISSEAFVPV 87
Query: 429 TELQYLDLSANKLSSSIPMSI-GNLLKLHYLNLSNNQFSHKIPTE-FEKLIHLSELDLSH 486
L+YLDLS+N L + + + +L L L L NN + FE + L +L LS
Sbjct: 88 PNLRYLDLSSNHLHT-LDEFLFSDLQALEVLLLYNNHIVV-VDRNAFEDMAQLQKLYLSQ 145
Query: 487 NILQEEIPPQI----CKMESLEKLNLSHNNLSDFIPRCFEEMRSLSWIDIS 533
N + P ++ K+ L L+LS N L +++ + +
Sbjct: 146 NQISR-FPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLY 195
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 91.1 bits (226), Expect = 9e-20
Identities = 48/187 (25%), Positives = 75/187 (40%), Gaps = 14/187 (7%)
Query: 72 NELVFCHNNVSGRIPSSLGNLSNLALLYLNDNSLFGSIP--IVMGNLKSLSTLDLSQNQL 129
+ ++ C +P SL S ALL L+ N+L + L +L +L LS N L
Sbjct: 20 SNILSCSKQQLPNVPQSL--PSYTALLDLSHNNL-SRLRAEWTPTRLTNLHSLLLSHNHL 76
Query: 130 NGSIP-CSLDNLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSENRLSGLIPLSLSNL 188
N I + + NL L L N L + +L++L L L N + + + ++
Sbjct: 77 N-FISSEAFVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDM 135
Query: 189 SSLTVMSLFNNSLSGSIPP----ILGNLKSLSTLGLHINQLNGVIPPSIGNLSSL--RNL 242
+ L + L N +S P L L L L N+L + + L + L
Sbjct: 136 AQLQKLYLSQNQIS-RFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGL 194
Query: 243 SLFNNRL 249
L NN L
Sbjct: 195 YLHNNPL 201
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 84.5 bits (209), Expect = 2e-17
Identities = 55/251 (21%), Positives = 85/251 (33%), Gaps = 44/251 (17%)
Query: 2 LNLGFNLLFGNIPPQI--GNLSKLQYLDLGNNQLSGVIPPEI-GKLNQLRRLYLDVNQLH 58
L+L N L + + L+ L L L +N L+ I E + LR L L N LH
Sbjct: 44 LDLSHNNL-SRLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPVPNLRYLDLSSNHLH 101
Query: 59 GTIPPVIGQLSLINELVFCHNNVSGRIPSSLGNLSNLALLYLNDNSLFGSIPI-VMGNLK 117
T+ +L L +L L +N + + ++
Sbjct: 102 -TLD-----------------------EFLFSDLQALEVLLLYNNHI-VVVDRNAFEDMA 136
Query: 118 SLSTLDLSQNQLNGSIP----CSLDNLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQ--LD 171
L L LSQNQ++ P + L L L L N L + + L + ++ L
Sbjct: 137 QLQKLYLSQNQIS-RFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLY 195
Query: 172 LSENRLS---GLIPLSLSNL--SSLTVMSLFNNSLSGSIPPILGNLKSLSTLGLHINQLN 226
L N L L L S+ L+ + F L L N+ SL + +
Sbjct: 196 LHNNPLECDCKLYQL-FSHWQYRQLSSVMDFQEDLYCMHSKKLHNIFSLDFFNCSEYKES 254
Query: 227 GVIPPSIGNLS 237
L+
Sbjct: 255 AWEAHLGDTLT 265
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 84.1 bits (208), Expect = 2e-17
Identities = 47/199 (23%), Positives = 77/199 (38%), Gaps = 42/199 (21%)
Query: 12 NIPPQIGNLSKLQYLDLGNNQLSGVIPPEI--GKLNQLRRLYLDVNQLHGTIPPVIGQLS 69
++P LDL +N LS + E +L L L L N L+ I
Sbjct: 36 SLPSYT------ALLDLSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHLN-FIS------- 80
Query: 70 LINELVFCHNNVSGRIPSSLGNLSNLALLYLNDNSLFGSIPI-VMGNLKSLSTLDLSQNQ 128
+ + NL L L+ N L ++ + +L++L L L N
Sbjct: 81 ----------------SEAFVPVPNLRYLDLSSNHL-HTLDEFLFSDLQALEVLLLYNNH 123
Query: 129 LNGSIP-CSLDNLSNLDTLFLYKNSLSGPIPSVIGN---LKSLLQLDLSENRLSGLIPLS 184
+ + + ++++ L L+L +N +S +I + L L+ LDLS N+L L
Sbjct: 124 IV-VVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTD 182
Query: 185 LSNLSSLTVMS--LFNNSL 201
L L + L NN L
Sbjct: 183 LQKLPAWVKNGLYLHNNPL 201
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 80.3 bits (198), Expect = 3e-16
Identities = 35/113 (30%), Positives = 55/113 (48%), Gaps = 5/113 (4%)
Query: 429 TELQYLDLSANKLSSSIP-MSIGNLLKLHYLNLSNNQFSHKIPTE-FEKLIHLSELDLSH 486
+ LDLS N LS + L LH L LS+N + I +E F + +L LDLS
Sbjct: 39 SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNF-ISSEAFVPVPNLRYLDLSS 97
Query: 487 NILQEEIPPQIC-KMESLEKLNLSHNNLSDFIPRCFEEMRSLSWIDISYNELQ 538
N L + + +++LE L L +N++ FE+M L + +S N++
Sbjct: 98 NHLHT-LDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQIS 149
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 74.9 bits (184), Expect = 2e-14
Identities = 48/157 (30%), Positives = 68/157 (43%), Gaps = 13/157 (8%)
Query: 365 SMNNIYGSIPPEIGDS--SKLQVLDLSSNHIFGKIPVQ-LVKLFSLNKLILSLNQLFGGV 421
S NN+ + E + + L L LS NH+ I + V + +L L LS N L +
Sbjct: 47 SHNNL-SRLRAEWTPTRLTNLHSLLLSHNHL-NFISSEAFVPVPNLRYLDLSSNHL-HTL 103
Query: 422 PLE-FGTLTELQYLDLSANKLSSSIPMSIGNLLKLHYLNLSNNQFSHKIPTE----FEKL 476
F L L+ L L N + + ++ +L L LS NQ S P E KL
Sbjct: 104 DEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISR-FPVELIKDGNKL 162
Query: 477 IHLSELDLSHNILQEEIPPQICKMESLEKLNLS-HNN 512
L LDLS N L++ + K+ + K L HNN
Sbjct: 163 PKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNN 199
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 74.9 bits (184), Expect = 2e-14
Identities = 45/237 (18%), Positives = 80/237 (33%), Gaps = 40/237 (16%)
Query: 170 LDLSENRLSGLIP-LSLSNLSSLTVMSLFNNSLSGSIPP-ILGNLKSLSTLGLHINQLNG 227
LDLS N LS L + + L++L + L +N L+ I + +L L L N L+
Sbjct: 44 LDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPVPNLRYLDLSSNHLHT 102
Query: 228 VIPPSIGNLSSLRNLSLFNNRLYGFVPKEIGYLKSLSKLEFCANHLSGVIPHSV-GNLTG 286
+ +L +L L L+NN + V+ + ++
Sbjct: 103 LDEFLFSDLQALEVLLLYNNHI-------------------------VVVDRNAFEDMAQ 137
Query: 287 LVLLNMCENHLFGPIP----KSLRNLTSLERVRFNQNNLYGKVYEAFGDHPNLT--FLDL 340
L L + +N + P K L L + + N L P L L
Sbjct: 138 LQKLYLSQNQISR-FPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYL 196
Query: 341 SQNNFYCE----ISFNWRNFSKLGTFNASMNNIYGSIPPEIGDSSKLQVLDLSSNHI 393
N C+ F+ + +L + ++Y ++ + L + S
Sbjct: 197 HNNPLECDCKLYQLFSHWQYRQLSSVMDFQEDLYCMHSKKLHNIFSLDFFNCSEYKE 253
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 72.2 bits (177), Expect = 1e-13
Identities = 48/166 (28%), Positives = 70/166 (42%), Gaps = 16/166 (9%)
Query: 333 PNLTFLDLSQNNFYCEISFNW--RNFSKLGTFNASMNNIYGSIPPEIGDS-SKLQVLDLS 389
LDLS NN + W + L + S N++ I E L+ LDLS
Sbjct: 39 SYTALLDLSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHL-NFISSEAFVPVPNLRYLDLS 96
Query: 390 SNHIFGKIPVQ-LVKLFSLNKLILSLNQLFGGVPLE-FGTLTELQYLDLSANKLSSSIP- 446
SNH+ + L +L L+L N + V F + +LQ L LS N++ S P
Sbjct: 97 SNHL-HTLDEFLFSDLQALEVLLLYNNHI-VVVDRNAFEDMAQLQKLYLSQNQI-SRFPV 153
Query: 447 ---MSIGNLLKLHYLNLSNNQFSHKIPTEFEKLIHLSE--LDLSHN 487
L KL L+LS+N+ T+ +KL + L L +N
Sbjct: 154 ELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNN 199
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 59.5 bits (144), Expect = 2e-09
Identities = 31/121 (25%), Positives = 58/121 (47%), Gaps = 10/121 (8%)
Query: 432 QYLDLSANKLSSSIPMSIGNLLKLHYLNLSNNQFSHKIPTE--FEKLIHLSELDLSHNIL 489
L S +L + +P S+ + L+LS+N S ++ E +L +L L LSHN L
Sbjct: 21 NILSCSKQQLPN-VPQSLPSYTA--LLDLSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHL 76
Query: 490 QEEIPPQI-CKMESLEKLNLSHNNLSDFIPRCFEEMRSLSWIDISYNELQGPIPNSTAFK 548
I + + +L L+LS N+L F ++++L + + N + + + AF+
Sbjct: 77 NF-ISSEAFVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIVV-VDRN-AFE 133
Query: 549 N 549
+
Sbjct: 134 D 134
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 3e-20
Identities = 60/300 (20%), Positives = 112/300 (37%), Gaps = 45/300 (15%)
Query: 635 KVLYEEITKATGNFGEKY-----CIGKGGQRSVYKA-ELPSGNIFAVKKF-KAELFSDET 687
+VL++ + Y +G G V + +G A+K + E
Sbjct: 13 EVLFQGPEPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQEV 72
Query: 688 ANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHS----FIVCEYLARGSL-TTILRDDAA 742
+ +I+ N H I+ E + G L + I +
Sbjct: 73 --------DHH-WQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQ--ERG 121
Query: 743 AKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAH---VSDFGFA 799
+ F+ + +++ + A+ +LH I HRD+ +N+L S+ + ++DFGFA
Sbjct: 122 DQAFTEREAAEIMRDIGTAIQFLHSHNI---AHRDVKPENLLYTSKEKDAVLKLTDFGFA 178
Query: 800 KFLEPHSSNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIF 859
K ++ T Y APE+ + + D++S GV+ ++ G+ P F S
Sbjct: 179 KETTQNA--LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPP--FYSNTG 234
Query: 860 SSISNMIIEVNQILDHRLPTP-----SRDVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914
+IS + ++ + P P S D +R L +P R T+ + N
Sbjct: 235 QAISPGMKRRIRLGQYGFPNPEWSEVSEDAKQLIRL-------LLKTDPTERLTITQFMN 287
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 5e-20
Identities = 79/459 (17%), Positives = 135/459 (29%), Gaps = 80/459 (17%)
Query: 117 KSLSTLDLSQNQLN-GSIPCSLDNLSNLDTLFLYKNSLS----GPIPSVIGNLKSLLQLD 171
+ +LD+ +L+ L L + L L+ I S + +L +L+
Sbjct: 3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 62
Query: 172 LSENRL--SGLIPLS---LSNLSSLTVMSLFNNSLS----GSIPPILGNLKSLSTLGLHI 222
L N L G+ + + + +SL N L+ G + L L +L L L
Sbjct: 63 LRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSD 122
Query: 223 NQLNGVIPPSIG-----NLSSLRNLSLFNNRLYGFVPKEIGYLKSLSKLEFCANHLSGVI 277
N L + L L L L L+ V+
Sbjct: 123 NLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLS----------------AASCEPLASVL 166
Query: 278 PHSVGNLTGLVLLNMCENHL----FGPIPKSLRNLT-SLERVRFNQNNLYGKVYEAFGD- 331
L + N + + + L++ LE ++ +
Sbjct: 167 RAK----PDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGI 222
Query: 332 ---HPNLTFLDLSQNNFY----CEISFNWRN-FSKLGTFNASMNNI----YGSIPPEIGD 379
+L L L N E+ + S+L T I G + +
Sbjct: 223 VASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRA 282
Query: 380 SSKLQVLDLSSNHIFGKIPVQLVKLF-----SLNKLILSLNQL--FGGVPLE--FGTLTE 430
L+ L L+ N + + L + L L +
Sbjct: 283 KESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRF 342
Query: 431 LQYLDLSANKLSSSIPMSIGNLLK-----LHYLNLSNNQFSHK----IPTEFEKLIHLSE 481
L L +S N+L + + L L L L++ S + L E
Sbjct: 343 LLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRE 402
Query: 482 LDLSHNILQEEIPPQICKM-----ESLEKLNLSHNNLSD 515
LDLS+N L + Q+ + LE+L L S+
Sbjct: 403 LDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSE 441
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 7e-19
Identities = 75/450 (16%), Positives = 142/450 (31%), Gaps = 95/450 (21%)
Query: 141 SNLDTLFLYKNSLSGP-IPSVIGNLKSLLQLDLSENRLS--GLIPLS--LSNLSSLTVMS 195
++ +L + LS ++ L+ + L + L+ +S L +L ++
Sbjct: 3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 62
Query: 196 LFNNSLSGS-IPPILGNLKSLSTLGLHINQLNGVIPPSIGNLSSLRNLSLFNNRLYGFVP 254
L +N L + +L L++ S ++ LSL N L
Sbjct: 63 LRSNELGDVGVHCVLQGLQTPSC--------------------KIQKLSLQNCCL----- 97
Query: 255 KEIGYLKSLSKLEFCANHLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSL-----RNLT 309
LS + L L++ +N L + L
Sbjct: 98 -----------TGAGCGVLSSTLRTL----PTLQELHLSDNLLGDAGLQLLCEGLLDPQC 142
Query: 310 SLERVRFNQNNLYGKVYEAFGD----HPNLTFLDLSQNNFY-------CEISFNWRNFSK 358
LE+++ +L E P+ L +S N+ C+ + + +
Sbjct: 143 RLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKD--SPCQ 200
Query: 359 LGTFNASMNNI----YGSIPPEIGDSSKLQVLDLSSNHIFGK-----IPVQLVKLFSLNK 409
L + + + + L+ L L SN + P L L
Sbjct: 201 LEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRT 260
Query: 410 LILSLNQL--FGGVPLEFG--TLTELQYLDLSANKLSSSIPMSIGNLLK-----LHYLNL 460
L + + G L L+ L L+ N+L + L L L +
Sbjct: 261 LWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWV 320
Query: 461 SNNQFSHK----IPTEFEKLIHLSELDLSHNILQEEIPPQICKM-----ESLEKLNLSHN 511
+ F+ + + L EL +S+N L++ ++C+ L L L+
Sbjct: 321 KSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADC 380
Query: 512 NLSD----FIPRCFEEMRSLSWIDISYNEL 537
++SD + SL +D+S N L
Sbjct: 381 DVSDSSCSSLAATLLANHSLRELDLSNNCL 410
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 5e-15
Identities = 92/510 (18%), Positives = 150/510 (29%), Gaps = 136/510 (26%)
Query: 21 SKLQYLDLGNNQLSGVIPPEIGK-LNQLRRLYLDVNQLHGT----IPPVIGQLSLINELV 75
+Q LD+ +LS E+ L Q + + LD L I + + EL
Sbjct: 3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 62
Query: 76 FCHNNVSGRIPSSLGNL-----SNLALLYLNDNSL----FGSIPIVMGNLKSLSTLDLSQ 126
N + + + L L + L G + + L +L L LS
Sbjct: 63 LRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSD 122
Query: 127 NQLNGS-----IPCSLDNLSNLDTLFLYKNSLS----GPIPSVIGNLKSLLQLDLSENRL 177
N L + LD L+ L L SLS P+ SV+ +L +S N +
Sbjct: 123 NLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDI 182
Query: 178 S--GLIPLS---LSNLSSLTVMSLFNNSLS----GSIPPILGNLKSLSTLGLHINQL--N 226
+ G+ L + L + L + ++ + I+ + SL L L N+L
Sbjct: 183 NEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDV 242
Query: 227 GVIPPSIGNL---SSLRNLSLFNNRLYGFVPKEIGYLKSLSKLEFCANHLSGVIPHSVGN 283
G+ G L S LR L ++ + L V+
Sbjct: 243 GMAELCPGLLHPSSRLRTLWIWECGIT----------------AKGCGDLCRVLRAK--- 283
Query: 284 LTGLVLLNMCENHLFGPIPKSL-----RNLTSLERVRFNQNNLYGKVYEAFGD----HPN 334
L L++ N L + L LE + + F +
Sbjct: 284 -ESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRF 342
Query: 335 LTFLDLSQNNFYCEISFNWRNFSKLGTFNASMNNIYGSIPPEIGDS-------------S 381
L L +S N + D+ S
Sbjct: 343 LLELQISNNR--------------------------------LEDAGVRELCQGLGQPGS 370
Query: 382 KLQVLDLSSNHIFGKIPVQLVKLFSLNKLILSLNQLFGGVPLEFGTLTELQYLDLSANKL 441
L+VL L+ + L N +L E LDLS N L
Sbjct: 371 VLRVLWLADCDVSDSSCSSLAATLLANH-----------------SLRE---LDLSNNCL 410
Query: 442 SSSIPMSIGNLLK-----LHYLNLSNNQFS 466
+ + + ++ L L L + +S
Sbjct: 411 GDAGILQLVESVRQPGCLLEQLVLYDIYWS 440
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 2e-14
Identities = 55/353 (15%), Positives = 102/353 (28%), Gaps = 52/353 (14%)
Query: 237 SSLRNLSLFNNRL-YGFVPKEIGYLKSLSKLEFCANHLS----GVIPHSVGNLTGLVLLN 291
+++L + L + + L+ + L+ I ++ L LN
Sbjct: 3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 62
Query: 292 MCENHLFGPIPKSL-----RNLTSLERVRFNQNNL----YGKVYEAFGDHPNLTFLDLSQ 342
+ N L + ++++ L G + P L L LS
Sbjct: 63 LRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSD 122
Query: 343 NNFYCE-----ISFNWRNFSKLGTFNASMNNI----YGSIPPEIGDSSKLQVLDLSSNHI 393
N +L ++ + + + L +S+N I
Sbjct: 123 NLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDI 182
Query: 394 FGKIPVQL------VKLFSLNKLILSLNQL--FGGVPL--EFGTLTELQYLDLSANKLSS 443
+ V++ L L L + L + L+ L L +NKL
Sbjct: 183 -NEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGD 241
Query: 444 SIPMSIGNLLK-----LHYLNLSNNQFSHK----IPTEFEKLIHLSELDLSHNILQEEIP 494
+ L L L + + K + L EL L+ N L +E
Sbjct: 242 VGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGA 301
Query: 495 PQICKM-----ESLEKLNLSHNNLSD----FIPRCFEEMRSLSWIDISYNELQ 538
+C+ LE L + + + + R L + IS N L+
Sbjct: 302 RLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLE 354
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 7e-11
Identities = 68/379 (17%), Positives = 124/379 (32%), Gaps = 70/379 (18%)
Query: 17 IGNLSKLQYLDLGNNQLSGVIPPEIGKL-----NQLRRLYLDVNQLHGT----IPPVIGQ 67
+ L L+L +N+L V + + ++++L L L G + +
Sbjct: 52 LRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRT 111
Query: 68 LSLINELVFCHNNVSGRIPSSLG-----NLSNLALLYLNDNSL----FGSIPIVMGNLKS 118
L + EL N + L L L L SL + V+
Sbjct: 112 LPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPD 171
Query: 119 LSTLDLSQNQLNGSIPCSL-----DNLSNLDTLFLYKNSLS----GPIPSVIGNLKSLLQ 169
L +S N +N + L D+ L+ L L ++ + ++ + SL +
Sbjct: 172 FKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRE 231
Query: 170 LDLSENRL--SGLIPLS---LSNLSSLTVMSLFNNSLS----GSIPPILGNLKSLSTLGL 220
L L N+L G+ L L S L + ++ ++ G + +L +SL L L
Sbjct: 232 LALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSL 291
Query: 221 HINQL--NGVIPPSIG---NLSSLRNLSLFNNRLYGFVPKEIGYLKSLSKLEFCANHLSG 275
N+L G L +L + + C +H S
Sbjct: 292 AGNELGDEGARLLCETLLEPGCQLESLWVKSCS--------FT--------AACCSHFSS 335
Query: 276 VIPHSVGNLTGLVLLNMCENHLFGPIPKSL-----RNLTSLERVRFNQNNL----YGKVY 326
V+ + L+ L + N L + L + + L + ++ +
Sbjct: 336 VLAQN----RFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLA 391
Query: 327 EAFGDHPNLTFLDLSQNNF 345
+ +L LDLS N
Sbjct: 392 ATLLANHSLRELDLSNNCL 410
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 9e-07
Identities = 29/183 (15%), Positives = 58/183 (31%), Gaps = 47/183 (25%)
Query: 380 SSKLQVLDLSSNHIFGKIPVQLVKLFS-LNKLILSLNQL--FGGVPL--EFGTLTELQYL 434
S +Q LD+ + +L+ L + L L + L L
Sbjct: 2 SLDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAEL 61
Query: 435 DLSANKLSSSIPMSIGNLLK-----LHYLNLSNNQFSHK----IPTEFEKLIHLSELDLS 485
+L +N+L + L+ + L+L N + + + L L EL LS
Sbjct: 62 NLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLS 121
Query: 486 HNILQEE-------------------------IPPQICK--------MESLEKLNLSHNN 512
N+L + + C+ ++L +S+N+
Sbjct: 122 DNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNND 181
Query: 513 LSD 515
+++
Sbjct: 182 INE 184
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 2e-19
Identities = 61/287 (21%), Positives = 107/287 (37%), Gaps = 70/287 (24%)
Query: 654 IGKGGQRSVYKAE-LPSGNIFAVK---KFKAELFSDETANPSEFLNEVLALTEIRHR--N 707
+G GG SVY + A+K K + + + + EV+ L ++
Sbjct: 51 LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM-EVVLLKKVSSGFSG 109
Query: 708 IIKFHGFCSNAQHSFIVCEY-----------LARGSLTTILRDDAAAKEFSWNQRMNVIK 756
+I+ + ++ E RG+L + A+ F W Q
Sbjct: 110 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGAL-----QEELARSFFW-Q------ 157
Query: 757 GVANALSYLHHDCIPPIVHRDISSKNVLLDSEY-EAHVSDFGFAKFLEPHSSNWTEFAGT 815
V A+ + H+ + +HRDI +N+L+D E + DFG L + +T+F GT
Sbjct: 158 -VLEAVRHCHNCGV---LHRDIKDENILIDLNRGELKLIDFGSGALL--KDTVYTDFDGT 211
Query: 816 VGYAAPELAYTMRATEKY-----DVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVN 870
Y+ PE +Y V+S G+L +++ G P +
Sbjct: 212 RVYSPPE----WIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE--------------HDE 253
Query: 871 QILDHRLPTP---SRDVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914
+I+ ++ S + +R CL P RPT +E+ N
Sbjct: 254 EIIRGQVFFRQRVSSECQHLIRW-------CLALRPSDRPTFEEIQN 293
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 3e-19
Identities = 58/237 (24%), Positives = 95/237 (40%), Gaps = 36/237 (15%)
Query: 13 IPPQIGNLSKLQYLDLGNNQLSGVIPPEIGKLNQLRRLYLDVNQLHGTIPPVIGQLSLIN 72
P ++ +L ++ +LN + ++ + + + ++
Sbjct: 13 FPDDA--FAETIKANLKKKSVTDA--VTQNELNSIDQIIANNSDIK-SVQG--------- 58
Query: 73 ELVFCHNNVSGRIPSSLGNLSNLALLYLNDNSLFGSIPIVMGNLKSLSTLDLSQNQLNGS 132
I L N+ L L N L I + L +L+ L L+ NQL S
Sbjct: 59 ------------IQY----LPNVRYLALGGNKL-HDIS-ALKELTNLTYLILTGNQLQ-S 99
Query: 133 IPCSL-DNLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSENRLSGLIPLSLSNLSSL 191
+P + D L+NL L L +N L V L +L L+L+ N+L L L++L
Sbjct: 100 LPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNL 159
Query: 192 TVMSLFNNSLSGSIPP-ILGNLKSLSTLGLHINQLNGVIPPSIGNLSSLRNLSLFNN 247
T + L N L S+P + L L L L+ NQL V L+SL+ + L +N
Sbjct: 160 TELDLSYNQLQ-SLPEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDN 215
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 3e-13
Identities = 47/180 (26%), Positives = 81/180 (45%), Gaps = 11/180 (6%)
Query: 372 SIPPEIGDSSKLQVLDLSSNHIFGKIPVQLVKLFSLNKLILSLNQLFG-GVPLEFGTLTE 430
+ +S + + +++ I +Q L ++ L L N+L LT
Sbjct: 33 DAVTQNELNS-IDQIIANNSDIKSVQGIQ--YLPNVRYLALGGNKLHDISA---LKELTN 86
Query: 431 LQYLDLSANKLSSSIPMSIGNLLKLHYLNLSNNQFSHKIPTEFEKLIHLSELDLSHNILQ 490
L YL L+ N+L S L L L L NQ F+KL +L+ L+L+HN LQ
Sbjct: 87 LTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQ 146
Query: 491 EEIPPQIC-KMESLEKLNLSHNNLSDFIPRCFEEMRSLSWIDISYNELQGPIPNSTAFKN 549
+P + K+ +L +L+LS+N L F+++ L + + N+L+ +P+ F
Sbjct: 147 S-LPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQLKS-VPDG-VFDR 203
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 3e-13
Identities = 48/171 (28%), Positives = 78/171 (45%), Gaps = 16/171 (9%)
Query: 372 SIPPEIGDSSKLQVLDLSSNHIFGKIPVQLVKLFSLNKLILSLNQLFGGVPLEFGTLTEL 431
P + ++ +L Q +L S++++I + + + L +
Sbjct: 12 IFPDDA--FAETIKANLKKKS-VTDAVTQ-NELNSIDQIIANNSDIKSVQG--IQYLPNV 65
Query: 432 QYLDLSANKLSSSIPMSIG---NLLKLHYLNLSNNQFSHKIPTEFEKLIHLSELDLSHNI 488
+YL L NKL I L L YL L+ NQ F+KL +L EL L N
Sbjct: 66 RYLALGGNKLHD-----ISALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQ 120
Query: 489 LQEEIPPQIC-KMESLEKLNLSHNNLSDFIPRCFEEMRSLSWIDISYNELQ 538
LQ +P + K+ +L LNL+HN L F+++ +L+ +D+SYN+LQ
Sbjct: 121 LQ-SLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQ 170
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 1e-12
Identities = 50/201 (24%), Positives = 82/201 (40%), Gaps = 17/201 (8%)
Query: 98 LYLNDNSLFGSIPIVMGNLKSLSTLDLSQNQLNGSIPCSLDNLSNLDTLFLYKNSLSGPI 157
L S+ L S+ + + + + S+ + L N+ L L N L
Sbjct: 24 ANLKKKSV-TDAV-TQNELNSIDQIIANNSDIK-SVQ-GIQYLPNVRYLALGGNKLHDI- 78
Query: 158 PSVIGNLKSLLQLDLSENRLSGLIPLSLSNLSSLTVMSLFNNSLSGSIPP-ILGNLKSLS 216
S + L +L L L+ N+L L L++L + L N L S+P + L +L+
Sbjct: 79 -SALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQ-SLPDGVFDKLTNLT 136
Query: 217 TLGLHINQLNGVIPPSI-GNLSSLRNLSLFNNRLYGFVPKEI-GYLKSLSKLEFCANHLS 274
L L NQL +P + L++L L L N+L +P+ + L L L N L
Sbjct: 137 YLNLAHNQLQ-SLPKGVFDKLTNLTELDLSYNQL-QSLPEGVFDKLTQLKDLRLYQNQLK 194
Query: 275 GVIPH----SVGNLTGLVLLN 291
V P + +L + L +
Sbjct: 195 SV-PDGVFDRLTSLQYIWLHD 214
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 8e-11
Identities = 50/193 (25%), Positives = 77/193 (39%), Gaps = 40/193 (20%)
Query: 304 SLRNLTSLERVRFNQNNLYGKVYEAFGDHPNLTFLDLSQNNFYCEISFNWRNFSKLGTFN 363
+ L S++++ N +++ K + PN+ +L L N +
Sbjct: 36 TQNELNSIDQIIANNSDI--KSVQGIQYLPNVRYLALGGNKL-----------HDISAL- 81
Query: 364 ASMNNIYGSIPPEIGDS-SKLQVLDLSSNHIFGKIPVQLV-KLFSLNKLILSLNQLF--- 418
+ L L L+ N +P + KL +L +L+L NQL
Sbjct: 82 ---------------KELTNLTYLILTGNQ-LQSLPNGVFDKLTNLKELVLVENQLQSLP 125
Query: 419 GGVPLEFGTLTELQYLDLSANKLSSSIPMSIGNLLKLHYLNLSNNQFSHKIPTE-FEKLI 477
GV F LT L YL+L+ N+L S L L L+LS NQ +P F+KL
Sbjct: 126 DGV---FDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQ-SLPEGVFDKLT 181
Query: 478 HLSELDLSHNILQ 490
L +L L N L+
Sbjct: 182 QLKDLRLYQNQLK 194
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 3e-09
Identities = 42/132 (31%), Positives = 61/132 (46%), Gaps = 10/132 (7%)
Query: 2 LNLGFNLLFGNIPPQI-GNLSKLQYLDLGNNQLSGVIPPEI-GKLNQLRRLYLDVNQLHG 59
L L N L ++P + L+ L+ L L NQL + P + KL L L L NQL
Sbjct: 90 LILTGNQL-QSLPNGVFDKLTNLKELVLVENQLQSL-PDGVFDKLTNLTYLNLAHNQLQ- 146
Query: 60 TIPP-VIGQLSLINELVFCHNNVSGRIPSSL-GNLSNLALLYLNDNSLFGSIPI-VMGNL 116
++P V +L+ + EL +N + +P + L+ L L L N L S+P V L
Sbjct: 147 SLPKGVFDKLTNLTELDLSYNQLQ-SLPEGVFDKLTQLKDLRLYQNQL-KSVPDGVFDRL 204
Query: 117 KSLSTLDLSQNQ 128
SL + L N
Sbjct: 205 TSLQYIWLHDNP 216
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 1e-08
Identities = 65/281 (23%), Positives = 98/281 (34%), Gaps = 90/281 (32%)
Query: 190 SLTVMSLFNNSLSGSIPPILGNLKSLSTLGLHINQLNGVIPPSIGNLSSLRNLSLFNNRL 249
+L S++ L S+ + + + + V I L ++R L+L N+L
Sbjct: 20 ETIKANLKKKSVT-DAVTQNE-LNSIDQIIANNSDIKSV--QGIQYLPNVRYLALGGNKL 75
Query: 250 YGFVPKEIG---YLKSLSKLEFCANHLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLR 306
+I L +L+ L N L + LT L L + EN
Sbjct: 76 -----HDISALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVEN----------- 119
Query: 307 NLTSLERVRFNQNNLYGKVYEAFGDHP-NLTFLDLSQNNFYCEISFNWRNFSKLGTFNAS 365
L SL F D NLT+L+L+ N +L
Sbjct: 120 QLQSLPDGVF--------------DKLTNLTYLNLAHN--------------QL------ 145
Query: 366 MNNIYGSIPPEIGDS-SKLQVLDLSSNHIFGKIPVQLVKLFSLNKLILSLNQLFGGVPLE 424
S+P + D + L LDLS N +L SL + GV
Sbjct: 146 -----QSLPKGVFDKLTNLTELDLSYN-----------QLQSLPE----------GV--- 176
Query: 425 FGTLTELQYLDLSANKLSSSIPMSI-GNLLKLHYLNLSNNQ 464
F LT+L+ L L N+L S+P + L L Y+ L +N
Sbjct: 177 FDKLTQLKDLRLYQNQL-KSVPDGVFDRLTSLQYIWLHDNP 216
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 4e-19
Identities = 64/269 (23%), Positives = 109/269 (40%), Gaps = 45/269 (16%)
Query: 654 IGKGGQRSVYKAEL-PSGNIFAVKKF-KAELFS-DETANPSEFLNEVLALTEIRHRNIIK 710
IGKG V + + ++A+K K + +E N E+ + + H ++
Sbjct: 23 IGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRN---VFKELQIMQGLEHPFLVN 79
Query: 711 FHGFCSNAQHSFIVCEYLARGSLTTILR-----DDAAAKEFSWNQRMNVIKGVANALSYL 765
+ + F+V + L G L L+ + K F I + AL YL
Sbjct: 80 LWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLF--------ICELVMALDYL 131
Query: 766 H-HDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGTVGYAAPELA 824
I+HRD+ N+LLD H++DF A L + T AGT Y APE+
Sbjct: 132 QNQR----IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITT-MAGTKPYMAPEM- 185
Query: 825 YTMRATEKY----DVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTP 880
++ R Y D +S GV A E+++G P + +S ++ + + P
Sbjct: 186 FSSRKGAGYSFAVDWWSLGVTAYELLRGRRP--YHIRSSTSSKEIV---HTFETTVVTYP 240
Query: 881 ---SRDVTDKLRSIMEVAILCLVENPEAR 906
S+++ L+ ++E NP+ R
Sbjct: 241 SAWSQEMVSLLKKLLEP-------NPDQR 262
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 5e-19
Identities = 40/208 (19%), Positives = 77/208 (37%), Gaps = 12/208 (5%)
Query: 23 LQYLDLGNNQLSGVIPPEIGKLNQLRRLYLDVNQLHGTIPP-VIGQLSLINELVFCHNNV 81
Q L L L + L + R+Y+ ++ + LS + + +
Sbjct: 33 TQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRN 92
Query: 82 SGRIPSS-LGNLSNLALLYLNDNSLFGSIP--IVMGNLKSLSTLDLSQNQLNGSIP-CSL 137
I L L L L + + L P + + L+++ N SIP +
Sbjct: 93 LTYIDPDALKELPLLKFLGIFNTGL-KMFPDLTKVYSTDIFFILEITDNPYMTSIPVNAF 151
Query: 138 DNLSN-LDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSENR-LSGLIPLSLSNL-SSLTVM 194
L N TL LY N + + N L + L++N+ L+ + + + S +++
Sbjct: 152 QGLCNETLTLKLYNNGFTS-VQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLL 210
Query: 195 SLFNNSLSGSIPP-ILGNLKSLSTLGLH 221
+ S++ ++P L +LK L
Sbjct: 211 DVSQTSVT-ALPSKGLEHLKELIARNTW 237
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 3e-18
Identities = 40/203 (19%), Positives = 73/203 (35%), Gaps = 30/203 (14%)
Query: 2 LNLGFNLLFGNIPPQI-GNLSKLQYLDLGNNQLSGVIPPEI-GKLNQLRRLYLDVNQLHG 59
+ + ++ + NLSK+ ++++ N + I P+ +L L+ L + L
Sbjct: 60 IYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLK- 118
Query: 60 TIPPVIGQLSLINELVFCHNNVSGRIPSSLGNLSNLALLYLNDNSLFGSIP--IVMGNLK 117
P + + + + +L + DN SIP G
Sbjct: 119 MFPDL----------------------TKVYSTDIFFILEITDNPYMTSIPVNAFQGLCN 156
Query: 118 SLSTLDLSQNQLNGSIPCSLDNLSNLDTLFLYKNSLSGPIPS-VIGNLKSLLQ-LDLSEN 175
TL L N S+ N + LD ++L KN I G + S LD+S+
Sbjct: 157 ETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQT 215
Query: 176 RLSGLIPLSLSNLSSLTVMSLFN 198
++ L L +L L + +
Sbjct: 216 SVTALPSKGLEHLKELIARNTWT 238
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 5e-17
Identities = 35/207 (16%), Positives = 79/207 (38%), Gaps = 11/207 (5%)
Query: 73 ELVFCHNNVSGRIPSSLGNLSNLALLYLNDNSLFGSIPI-VMGNLKSLSTLDLSQNQLNG 131
L ++ + NL N++ +Y++ + + NL ++ +++ +
Sbjct: 35 TLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLT 94
Query: 132 SIPCS-LDNLSNLDTLFLYKNSLSG-PIPSVIGNLKSLLQLDLSEN-RLSGLIPLSLSNL 188
I L L L L ++ L P + + + L++++N ++ + + L
Sbjct: 95 YIDPDALKELPLLKFLGIFNTGLKMFPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQGL 154
Query: 189 SSLTV-MSLFNNSLSGSIPPILGNLKSLSTLGLHINQLNGVIPPSI--GNLSSLRNLSLF 245
+ T+ + L+NN + S+ N L + L+ N+ VI G S L +
Sbjct: 155 CNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVS 213
Query: 246 NNRLYGFVPKEIGYLKSLSKLEFCANH 272
+ +P + L+ L +L
Sbjct: 214 QTSV-TALPSKG--LEHLKELIARNTW 237
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 3e-14
Identities = 39/242 (16%), Positives = 80/242 (33%), Gaps = 35/242 (14%)
Query: 293 CENHLFGPIPKSLRNLTSLERVRFNQNNLYGKVYEAFGDHPNLTFLDLSQNNFYCEISFN 352
IP + +L + + +L AF + PN++ + +S + ++ +
Sbjct: 18 VTCKDIQRIPSLPPSTQTL---KLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESH 74
Query: 353 WRNFSKLGTFNASMNNIYGSIPPEIGDSSKLQVLDLSSNHIFGKIPVQ-LVKLFSLNKLI 411
+F L SK+ +++ + I L +L L L
Sbjct: 75 --SFYNL---------------------SKVTHIEIRNTRNLTYIDPDALKELPLLKFLG 111
Query: 412 LSLNQL--FGGVPLEFGTLTELQYLDLSANKLSSSIP-MSIGNLLK-LHYLNLSNNQFSH 467
+ L F + + L+++ N +SIP + L L L NN F+
Sbjct: 112 IFNTGLKMFPDLTK-VYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFTS 170
Query: 468 KIPTEFEKLIHLSELDLSHNILQEEIPPQICK--MESLEKLNLSHNNLSDFIPRCFEEMR 525
+ L + L+ N I L++S +++ + E ++
Sbjct: 171 -VQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTALPSKGLEHLK 229
Query: 526 SL 527
L
Sbjct: 230 EL 231
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 4e-14
Identities = 40/211 (18%), Positives = 80/211 (37%), Gaps = 12/211 (5%)
Query: 141 SNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSENRLSGLIPLSLSNLSSLTVMSLFNNS 200
+ + + IPS+ + + L L E L + + SNL +++ + + +
Sbjct: 11 HQEEDFRVTCKDIQR-IPSLPPSTQ---TLKLIETHLRTIPSHAFSNLPNISRIYVSIDV 66
Query: 201 LSGSIPP-ILGNLKSLSTLGLHINQLNGVIPPSI-GNLSSLRNLSLFNNRLYGFVPKE-I 257
+ NL ++ + + + I P L L+ L +FN L F +
Sbjct: 67 TLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLKMFPDLTKV 126
Query: 258 GYLKSLSKLEFCAN-HLSGVIPHSVGNLTG-LVLLNMCENHLFGPIPKSLRNLTSLERVR 315
LE N +++ + ++ L + L + N + N T L+ V
Sbjct: 127 YSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGF-TSVQGYAFNGTKLDAVY 185
Query: 316 FNQNNLYGKVYE-AF-GDHPNLTFLDLSQNN 344
N+N + + AF G + + LD+SQ +
Sbjct: 186 LNKNKYLTVIDKDAFGGVYSGPSLLDVSQTS 216
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 1e-10
Identities = 22/125 (17%), Positives = 46/125 (36%), Gaps = 4/125 (3%)
Query: 428 LTELQYLDLSANKLSSSIPMSIGNLLKLHYLNLSNNQFSHKIPTE-FEKLIHLSELDLSH 486
Q L L L + + NL + + +S + ++ + F L ++ +++ +
Sbjct: 30 PPSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRN 89
Query: 487 NILQEEIPPQICK-MESLEKLNLSHNNLSDFIPRCF-EEMRSLSWIDISYNELQGPIPNS 544
I P K + L+ L + + L F ++I+ N IP +
Sbjct: 90 TRNLTYIDPDALKELPLLKFLGIFNTGLKMFPDLTKVYSTDIFFILEITDNPYMTSIPVN 149
Query: 545 TAFKN 549
AF+
Sbjct: 150 -AFQG 153
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 8e-09
Identities = 16/125 (12%), Positives = 44/125 (35%), Gaps = 11/125 (8%)
Query: 429 TELQYLDLSANKLSS--SIPMSIGNLLKLHYLNLSNNQFSHKIPTEFEKLIHLSELDLSH 486
+ + ++ + S+P S L L F L ++S + +S
Sbjct: 11 HQEEDFRVTCKDIQRIPSLPPS------TQTLKLIETHLRTIPSHAFSNLPNISRIYVSI 64
Query: 487 NILQEEIPPQI-CKMESLEKLNLSHNNLSDFIPR-CFEEMRSLSWIDISYNELQGPIPNS 544
++ +++ + + + + + +I +E+ L ++ I L+ P+
Sbjct: 65 DVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLKM-FPDL 123
Query: 545 TAFKN 549
T +
Sbjct: 124 TKVYS 128
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 1e-18
Identities = 55/232 (23%), Positives = 97/232 (41%), Gaps = 44/232 (18%)
Query: 696 EVLALTEIRHRNIIKFHGFCSNAQHSFIVCEYLARGSL-TTI-----LRDDAAAKEFSWN 749
EV + + H NI+K + +++ EY + G + + +++ A +F
Sbjct: 64 EVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFR-- 121
Query: 750 QRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNW 809
Q + +A+ Y H I VHRD+ ++N+LLD++ ++DFGF+
Sbjct: 122 Q-------IVSAVQYCHQKRI---VHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLD 171
Query: 810 TEFAGTVGYAAPEL----AYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNM 865
F G YAAPEL Y DV+S GV+ ++ G P F N+
Sbjct: 172 A-FCGAPPYAAPELFQGKKYDGPEV---DVWSLGVILYTLVSGSLP--FDG------QNL 219
Query: 866 IIEVNQILDHRLPTP---SRDVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914
++L + P S D + L+ + + NP R T++++
Sbjct: 220 KELRERVLRGKYRIPFYMSTDCENLLKRFLVL-------NPIKRGTLEQIMK 264
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 88.3 bits (218), Expect = 3e-18
Identities = 43/214 (20%), Positives = 77/214 (35%), Gaps = 12/214 (5%)
Query: 14 PPQIGNLSKLQYLDLGNNQLSGVIPPEIGKLNQLRRLYLDVNQLHGTIPPVIGQLSLINE 73
+L +L + + V+ E+ +L+ L + TI I + ++
Sbjct: 342 CRDSATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTI---ILLMRALDP 397
Query: 74 LVFCHNNVSGRIPSSLGNLSNLALLYLNDNSLFGSIPIVMGNLKSLSTLDLSQNQLNGSI 133
L++ + + A L + ++ + L L+ L ++
Sbjct: 398 LLYEKETLQYFSTLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDL--TV 455
Query: 134 PCSLDNLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSENRLSGLIPLSLSNLSSLTV 193
C L+ L + L L N L +P + L+ L L S+N L + ++NL L
Sbjct: 456 LCHLEQLLLVTHLDLSHNRLRA-LPPALAALRCLEVLQASDNALENV--DGVANLPRLQE 512
Query: 194 MSLFNNSLSGSIPPI--LGNLKSLSTLGLHINQL 225
+ L NN L I L + L L L N L
Sbjct: 513 LLLCNNRLQ-QSAAIQPLVSCPRLVLLNLQGNSL 545
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 84.4 bits (208), Expect = 6e-17
Identities = 49/318 (15%), Positives = 96/318 (30%), Gaps = 35/318 (11%)
Query: 249 LYGFVPKEIGYLKSLSKLEFCANHLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLRNL 308
L P ++ +S+ E C + + L+L+ RN
Sbjct: 236 LGRAEPHDVLCCVHVSREEACLSVCFSRPLTVGSRMGTLLLMVDEAPLSVEWRTPDGRNR 295
Query: 309 TS------LERVRFNQNNLYGKVYEAFGDHPNLTFLDLSQNNFYCEISFNWRNFSKLGTF 362
S L N + + L ++ C + +L
Sbjct: 296 PSHVWLCDLPAASLNDQLPQHTFRVIWTGSDSQKECVLLKDRPECWCR-DSATDEQLFRC 354
Query: 363 NASMNNIYGSIPPEIGDSSKLQVLDLSSNHIFGKIPVQLVKLFSLNKLILSLNQL----- 417
S+ + E+ +LQ L+ + I + + L L +L
Sbjct: 355 ELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKA 413
Query: 418 ----------------FGGVPLEFGTLTELQYLDLSANKLSSSIPMSIGNLLKLHYLNLS 461
+ +++ L L+ L+ + + LL + +L+LS
Sbjct: 414 VDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLTV-LC-HLEQLLLVTHLDLS 471
Query: 462 NNQFSHKIPTEFEKLIHLSELDLSHNILQEEIPPQICKMESLEKLNLSHNNLSDF-IPRC 520
+N+ +P L L L S N L E + + + L++L L +N L +
Sbjct: 472 HNRLR-ALPPALAALRCLEVLQASDNAL-ENVDG-VANLPRLQELLLCNNRLQQSAAIQP 528
Query: 521 FEEMRSLSWIDISYNELQ 538
L +++ N L
Sbjct: 529 LVSCPRLVLLNLQGNSLC 546
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 79.8 bits (196), Expect = 2e-15
Identities = 34/138 (24%), Positives = 55/138 (39%), Gaps = 6/138 (4%)
Query: 379 DSSKLQVLDLSSNHIFGKIPVQLVKLFSLNKLILSLNQLFGGVPLEFGTLTELQYLDLSA 438
D + LD + + V ++ + L L+ L V L + +LDLS
Sbjct: 415 DPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDL--TVLCHLEQLLLVTHLDLSH 472
Query: 439 NKLSSSIPMSIGNLLKLHYLNLSNNQFSHKIPTEFEKLIHLSELDLSHN-ILQEEIPPQI 497
N+L + +P ++ L L L S+N + + L L EL L +N + Q +
Sbjct: 473 NRLRA-LPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPL 529
Query: 498 CKMESLEKLNLSHNNLSD 515
L LNL N+L
Sbjct: 530 VSCPRLVLLNLQGNSLCQ 547
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 74.0 bits (181), Expect = 1e-13
Identities = 47/268 (17%), Positives = 86/268 (32%), Gaps = 16/268 (5%)
Query: 215 LSTLGLHINQLNGVIPPSIGNLSSLRNLSLFNNRLYGFVPKEIGYLKSLSKLEFCANHLS 274
L L+ S + L +R + ++ + L + E +
Sbjct: 304 LPAASLNDQLPQHTFRVIWTGSDSQKECVLLKDRPECW-CRDSATDEQLFRCELSVEKST 362
Query: 275 GVIP--HSVGNLTGLVLLNMCENHLFGPIPKSLRNLTSLERVRFNQNNLYGKVYEAFGDH 332
+ S L L N + ++L L + + L D
Sbjct: 363 VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAV------DP 416
Query: 333 PNLTFLDLSQNNFYCEISFNWRNFSKLGTFNASMNNIYGSIPPEIGDSSKLQVLDLSSNH 392
+LD ++ F E S ++ + + + ++ ++ + + LDLS N
Sbjct: 417 MRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDL--TVLCHLEQLLLVTHLDLSHNR 474
Query: 393 IFGKIPVQLVKLFSLNKLILSLNQLFGGVPLEFGTLTELQYLDLSANKLSS-SIPMSIGN 451
+ +P L L L L S N L L LQ L L N+L + + +
Sbjct: 475 LR-ALPPALAALRCLEVLQASDNALE--NVDGVANLPRLQELLLCNNRLQQSAAIQPLVS 531
Query: 452 LLKLHYLNLSNNQFSHKIPTEFEKLIHL 479
+L LNL N + E+L +
Sbjct: 532 CPRLVLLNLQGNSLC-QEEGIQERLAEM 558
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 70.2 bits (171), Expect = 1e-12
Identities = 40/185 (21%), Positives = 68/185 (36%), Gaps = 18/185 (9%)
Query: 14 PPQIGNLSKLQYLDLGNNQLSGVIPPEIGKLNQLRRLYLDVNQLHGTIPPVIGQLSLINE 73
+ L + + L V P L+ LR +L N + + L L
Sbjct: 392 MRALDPLLYEKETLQYFSTLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHL--- 448
Query: 74 LVFCHNNVSGRIPSSLGNLSNLALLYLNDNSLFGSIPIVMGNLKSLSTLDLSQNQLNGSI 133
H +++ + L L + L L+ N L ++P + L+ L L S N L ++
Sbjct: 449 ---AHKDLT-VLCH-LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NV 501
Query: 134 PCSLDNLSNLDTLFLYKNSLSG-PIPSVIGNLKSLLQLDLSENRLSGL------IPLSLS 186
+ NL L L L N L + + L+ L+L N L + L
Sbjct: 502 D-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLP 560
Query: 187 NLSSL 191
++SS+
Sbjct: 561 SVSSI 565
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 67.1 bits (163), Expect = 1e-11
Identities = 44/243 (18%), Positives = 75/243 (30%), Gaps = 32/243 (13%)
Query: 77 CHNNVSGRIPSSLGNLSNLALLYLNDNSLFGSIPIVMGNLKSLSTLDLSQNQLNGSIPCS 136
+ I + + LL + L +LS + +
Sbjct: 313 LPQHTFRVIWTGSDSQKECVLLKDRPECW----CRDSATDEQLFRCELSVEKST-VLQSE 367
Query: 137 LDNLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSENRLSGL---------------- 180
L++ L L I ++ L LL + S L
Sbjct: 368 LESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLDDLRS 427
Query: 181 -----IPLSLSNLSSLTVMSLFNNSLSGSIPPILGNLKSLSTLGLHINQLNGVIPPSIGN 235
+ + + V+ L + L+ + L L ++ L L N+L +PP++
Sbjct: 428 KFLLENSVLKMEYADVRVLHLAHKDLT-VLCH-LEQLLLVTHLDLSHNRLR-ALPPALAA 484
Query: 236 LSSLRNLSLFNNRLYGFVPKEIGYLKSLSKLEFCANHLSGV-IPHSVGNLTGLVLLNMCE 294
L L L +N L + L L +L C N L + + LVLLN+
Sbjct: 485 LRCLEVLQASDNALENV--DGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQG 542
Query: 295 NHL 297
N L
Sbjct: 543 NSL 545
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 65.2 bits (158), Expect = 6e-11
Identities = 33/165 (20%), Positives = 55/165 (33%), Gaps = 35/165 (21%)
Query: 12 NIPPQIGNLSKLQYLDLGNNQLSGVIPPEIGKLNQLRRLYLDVNQLHGTIPPVIGQLSLI 71
+ ++ L L + L+ + + +L + L L N+L
Sbjct: 432 ENSVLKMEYADVRVLHLAHKDLTVL--CHLEQLLLVTHLDLSHNRLR------------- 476
Query: 72 NELVFCHNNVSGRIPSSLGNLSNLALLYLNDNSLFGSIPIVMGNLKSLSTLDLSQNQLNG 131
+P +L L L +L +DN+L ++ V NL L L L N+L
Sbjct: 477 ------------ALPPALAALRCLEVLQASDNALE-NVDGV-ANLPRLQELLLCNNRLQ- 521
Query: 132 SIPC--SLDNLSNLDTLFLYKNSLSGP---IPSVIGNLKSLLQLD 171
L + L L L NSL + L S+ +
Sbjct: 522 QSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSIL 566
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 54.4 bits (130), Expect = 1e-07
Identities = 20/84 (23%), Positives = 34/84 (40%), Gaps = 6/84 (7%)
Query: 1 MLNLGFNLLFGNIPPQIGNLSKLQYLDLGNNQLSGVIPPEIGKLNQLRRLYLDVNQLHGT 60
L+L N L +PP + L L+ L +N L V + L +L+ L L N+L
Sbjct: 467 HLDLSHNRLR-ALPPALAALRCLEVLQASDNALENV--DGVANLPRLQELLLCNNRL-QQ 522
Query: 61 IPPV--IGQLSLINELVFCHNNVS 82
+ + + L N++
Sbjct: 523 SAAIQPLVSCPRLVLLNLQGNSLC 546
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 3e-18
Identities = 67/280 (23%), Positives = 103/280 (36%), Gaps = 52/280 (18%)
Query: 654 IGKGGQRSVYKAE-LPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFH 712
IG G + + AVK + DE E++ +RH NI++F
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQ-----REIINHRSLRHPNIVRFK 82
Query: 713 GFCSNAQHSFIVCEYLARGSL-TTI-----LRDDAAAKEFSWNQRMNVIKGVANALSYLH 766
H I+ EY + G L I +D A F Q ++ GV SY H
Sbjct: 83 EVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQ--Q---LLSGV----SYCH 133
Query: 767 HDCIPPIVHRDISSKNVLLDSEYEAH--VSDFGFAKFLEPHSSNWTEFAGTVGYAAPELA 824
I HRD+ +N LLD + DFG++K HS + GT Y APE
Sbjct: 134 SMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS-TVGTPAYIAPE-- 187
Query: 825 YTMRATEKY-----DVYSFGVLALEVIKGYHP--GDFVSTIFSSISNMIIEVNQILDHRL 877
+ ++Y DV+S GV ++ G +P + I+ V + +
Sbjct: 188 --VLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSV----KYSI 241
Query: 878 PTP---SRDVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914
P S + + I V +P R ++ E+
Sbjct: 242 PDDIRISPECCHLISRI-------FVADPATRISIPEIKT 274
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 4e-18
Identities = 42/155 (27%), Positives = 70/155 (45%), Gaps = 7/155 (4%)
Query: 75 VFCHNNVSGRIPSSLGNLSNLALLYLNDNSLFGSIPI--VMGNLKSLSTLDLSQNQLNGS 132
V C N +IP + A L LN+N + + L L ++ S N++
Sbjct: 16 VDCSNQKLNKIPEHIP--QYTAELRLNNNEF-TVLEATGIFKKLPQLRKINFSNNKITDI 72
Query: 133 IPCSLDNLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSENRLSGLIPLSLSNLSSLT 192
+ + S ++ + L N L + L+SL L L NR++ + S LSS+
Sbjct: 73 EEGAFEGASGVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVR 132
Query: 193 VMSLFNNSLSGSIPP-ILGNLKSLSTLGLHINQLN 226
++SL++N ++ ++ P L SLSTL L N N
Sbjct: 133 LLSLYDNQIT-TVAPGAFDTLHSLSTLNLLANPFN 166
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 6e-17
Identities = 29/129 (22%), Positives = 50/129 (38%), Gaps = 3/129 (2%)
Query: 121 TLDLSQNQLNGSIPCSL-DNLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSENRLSG 179
L L+ N+ + L L + N ++ + ++ L+ NRL
Sbjct: 36 ELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLEN 95
Query: 180 LIPLSLSNLSSLTVMSLFNNSLSGSIPP-ILGNLKSLSTLGLHINQLNGVIPPSIGNLSS 238
+ L SL + L +N ++ + L S+ L L+ NQ+ V P + L S
Sbjct: 96 VQHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHS 154
Query: 239 LRNLSLFNN 247
L L+L N
Sbjct: 155 LSTLNLLAN 163
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 2e-15
Identities = 36/144 (25%), Positives = 57/144 (39%), Gaps = 13/144 (9%)
Query: 12 NIPPQIGNLSKLQYLDLGNNQLSGVIPPEI-GKLNQLRRLYLDVNQLHGTIPP-VIGQLS 69
+IP L L NN+ + + I KL QLR++ N++ I S
Sbjct: 29 HIPQYT------AELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKIT-DIEEGAFEGAS 81
Query: 70 LINELVFCHNNVSGRIPSSLGNLSNLALLYLNDNSLFGSIPI-VMGNLKSLSTLDLSQNQ 128
+NE++ N + L +L L L N + + L S+ L L NQ
Sbjct: 82 GVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRI-TCVGNDSFIGLSSVRLLSLYDNQ 140
Query: 129 LNGSIPC-SLDNLSNLDTLFLYKN 151
+ ++ + D L +L TL L N
Sbjct: 141 IT-TVAPGAFDTLHSLSTLNLLAN 163
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 1e-13
Identities = 25/112 (22%), Positives = 50/112 (44%), Gaps = 3/112 (2%)
Query: 429 TELQYLDLSANKLSSSIPMSI-GNLLKLHYLNLSNNQFSHKIPTEFEKLIHLSELDLSHN 487
L L+ N+ + I L +L +N SNN+ + FE ++E+ L+ N
Sbjct: 32 QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSN 91
Query: 488 ILQEEIPPQIC-KMESLEKLNLSHNNLSDFIPRCFEEMRSLSWIDISYNELQ 538
L+ + ++ +ESL+ L L N ++ F + S+ + + N++
Sbjct: 92 RLE-NVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQIT 142
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 5e-13
Identities = 27/130 (20%), Positives = 59/130 (45%), Gaps = 5/130 (3%)
Query: 409 KLILSLNQLFGGVPL-EFGTLTELQYLDLSANKLSSSIPMSIGNLLKLHYLNLSNNQFSH 467
+L L+ N+ F L +L+ ++ S NK++ + ++ + L++N+ +
Sbjct: 36 ELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLEN 95
Query: 468 KIPTE-FEKLIHLSELDLSHNILQEEIPPQI-CKMESLEKLNLSHNNLSDFIPRCFEEMR 525
+ + F+ L L L L N + + + S+ L+L N ++ P F+ +
Sbjct: 96 -VQHKMFKGLESLKTLMLRSNRITC-VGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLH 153
Query: 526 SLSWIDISYN 535
SLS +++ N
Sbjct: 154 SLSTLNLLAN 163
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 2e-10
Identities = 28/112 (25%), Positives = 52/112 (46%), Gaps = 10/112 (8%)
Query: 381 SKLQVLDLSSNHIFGKIPVQ-LVKLFSLNKLILSLNQLF---GGVPLEFGTLTELQYLDL 436
+L+ ++ S+N I I +N+++L+ N+L + F L L+ L L
Sbjct: 57 PQLRKINFSNNKI-TDIEEGAFEGASGVNEILLTSNRLENVQHKM---FKGLESLKTLML 112
Query: 437 SANKLSSSIPMSI-GNLLKLHYLNLSNNQFSHKIPTEFEKLIHLSELDLSHN 487
+N+++ + L + L+L +NQ + P F+ L LS L+L N
Sbjct: 113 RSNRITC-VGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLAN 163
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 6e-09
Identities = 29/163 (17%), Positives = 53/163 (32%), Gaps = 29/163 (17%)
Query: 189 SSLTVMSLFNNSLSGSIPP--ILGNLKSLSTLGLHINQLNGVIPPSIGNLSSLRNLSLFN 246
+ L NN + + I L L + N++ + + S + + L +
Sbjct: 32 QYTAELRLNNNEFT-VLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTS 90
Query: 247 NRLYGFVPKEIGYLKSLSKLEFCANHLSGVIPHSV-GNLTGLVLLNMCENHLFGPIPKSL 305
NRL +++ H + L L L + N + S
Sbjct: 91 NRL-----------ENV--------------QHKMFKGLESLKTLMLRSNRITCVGNDSF 125
Query: 306 RNLTSLERVRFNQNNLYGKVYEAFGDHPNLTFLDLSQNNFYCE 348
L+S+ + N + AF +L+ L+L N F C
Sbjct: 126 IGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNCN 168
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 85.9 bits (213), Expect = 7e-18
Identities = 73/330 (22%), Positives = 118/330 (35%), Gaps = 56/330 (16%)
Query: 607 RRRKRDPQEKRSSSANPFGFFSVLNFNGKVLYEEITKATGNFGEKY-----CIGKGGQRS 661
P + F F V + + + Y +G G
Sbjct: 26 PALPHPPAQPPPPPPQQFPQFHVKSG--------LQIKKNAIIDDYKVTSQVLGLGINGK 77
Query: 662 VYKA-ELPSGNIFAVKKF-KAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNA- 718
V + + FA+K E E+ + +I++ N
Sbjct: 78 VLQIFNKRTQEKFALKMLQDCPKARREV--------ELH-WRASQCPHIVRIVDVYENLY 128
Query: 719 ---QHSFIVCEYLARGSL-TTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIV 774
+ IV E L G L + I D + F+ + ++K + A+ YLH I
Sbjct: 129 AGRKCLLIVMECLDGGELFSRIQ--DRGDQAFTEREASEIMKSIGEAIQYLHSINI---A 183
Query: 775 HRDISSKNVLLDSEYEAH---VSDFGFAKFLEPHSSNWTEFAGTVGYAAPELAYTMRATE 831
HRD+ +N+L S+ ++DFGFAK H+S T T Y APE+ + +
Sbjct: 184 HRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS-LTTPCYTPYYVAPEVLGPEKYDK 242
Query: 832 KYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQIL--DHRLPTP-----SRDV 884
D++S GV+ ++ GY P F S +IS + +I + P P S +V
Sbjct: 243 SCDMWSLGVIMYILLCGYPP--FYSNHGLAISPGMKT--RIRMGQYEFPNPEWSEVSEEV 298
Query: 885 TDKLRSIMEVAILCLVENPEARPTMKEVCN 914
+R+ L P R T+ E N
Sbjct: 299 KMLIRN-------LLKTEPTQRMTITEFMN 321
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 1e-17
Identities = 30/128 (23%), Positives = 55/128 (42%), Gaps = 2/128 (1%)
Query: 121 TLDLSQNQLNGSIPCSLDNLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSENRLSGL 180
+ L QN + P + L + L N +S P L+SL L L N+++ L
Sbjct: 36 EIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKITEL 95
Query: 181 IPLSLSNLSSLTVMSLFNNSLSGSIPP-ILGNLKSLSTLGLHINQLNGVIPPSIGNLSSL 239
L SL ++ L N ++ + +L +L+ L L+ N+L + + L ++
Sbjct: 96 PKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAI 154
Query: 240 RNLSLFNN 247
+ + L N
Sbjct: 155 QTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 2e-17
Identities = 35/131 (26%), Positives = 65/131 (49%), Gaps = 4/131 (3%)
Query: 98 LYLNDNSLFGSIPIVMGNLKSLSTLDLSQNQLNGSIPC-SLDNLSNLDTLFLYKNSLSGP 156
+ L N++ P K L +DLS NQ++ + + L +L++L LY N ++
Sbjct: 37 IRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGNKITEL 95
Query: 157 IPSVIGNLKSLLQLDLSENRLSGLIPLSLSNLSSLTVMSLFNNSLSGSIPP-ILGNLKSL 215
S+ L SL L L+ N+++ L + +L +L ++SL++N L +I L+++
Sbjct: 96 PKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQ-TIAKGTFSPLRAI 154
Query: 216 STLGLHINQLN 226
T+ L N
Sbjct: 155 QTMHLAQNPFI 165
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 2e-16
Identities = 38/143 (26%), Positives = 62/143 (43%), Gaps = 12/143 (8%)
Query: 12 NIPPQIGNLSKLQYLDLGNNQLSGVIPPEIGKLNQLRRLYLDVNQLHGTIPP-VIGQLSL 70
N+P I + L N + + P +LRR+ L NQ+ + P L
Sbjct: 29 NLPETI------TEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRS 81
Query: 71 INELVFCHNNVSGRIPSSL-GNLSNLALLYLNDNSLFGSIPI-VMGNLKSLSTLDLSQNQ 128
+N LV N ++ +P SL L +L LL LN N + + + +L +L+ L L N+
Sbjct: 82 LNSLVLYGNKIT-ELPKSLFEGLFSLQLLLLNANKI-NCLRVDAFQDLHNLNLLSLYDNK 139
Query: 129 LNGSIPCSLDNLSNLDTLFLYKN 151
L + L + T+ L +N
Sbjct: 140 LQTIAKGTFSPLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 5e-15
Identities = 31/129 (24%), Positives = 57/129 (44%), Gaps = 4/129 (3%)
Query: 73 ELVFCHNNVSGRIPSSLGNLSNLALLYLNDNSLFGSIPI-VMGNLKSLSTLDLSQNQLNG 131
E+ N + P + L + L++N + + L+SL++L L N++
Sbjct: 36 EIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQI-SELAPDAFQGLRSLNSLVLYGNKIT- 93
Query: 132 SIPCSL-DNLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSENRLSGLIPLSLSNLSS 190
+P SL + L +L L L N ++ +L +L L L +N+L + + S L +
Sbjct: 94 ELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRA 153
Query: 191 LTVMSLFNN 199
+ M L N
Sbjct: 154 IQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 9e-15
Identities = 31/128 (24%), Positives = 56/128 (43%), Gaps = 2/128 (1%)
Query: 409 KLILSLNQLFGGVPLEFGTLTELQYLDLSANKLSSSIPMSIGNLLKLHYLNLSNNQFSHK 468
++ L N + P F +L+ +DLS N++S P + L L+ L L N+ +
Sbjct: 36 EIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKITEL 95
Query: 469 IPTEFEKLIHLSELDLSHNILQEEIPPQI-CKMESLEKLNLSHNNLSDFIPRCFEEMRSL 527
+ FE L L L L+ N + + + +L L+L N L F +R++
Sbjct: 96 PKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAI 154
Query: 528 SWIDISYN 535
+ ++ N
Sbjct: 155 QTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 3e-14
Identities = 30/111 (27%), Positives = 54/111 (48%), Gaps = 2/111 (1%)
Query: 429 TELQYLDLSANKLSSSIPMSIGNLLKLHYLNLSNNQFSHKIPTEFEKLIHLSELDLSHNI 488
+ + L N + P + KL ++LSNNQ S P F+ L L+ L L N
Sbjct: 32 ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNK 91
Query: 489 LQEEIPPQI-CKMESLEKLNLSHNNLSDFIPRCFEEMRSLSWIDISYNELQ 538
+ E +P + + SL+ L L+ N ++ F+++ +L+ + + N+LQ
Sbjct: 92 ITE-LPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQ 141
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 4e-14
Identities = 33/127 (25%), Positives = 63/127 (49%), Gaps = 2/127 (1%)
Query: 141 SNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSENRLSGLIPLSLSNLSSLTVMSLFNNS 200
+ + L +N++ P K L ++DLS N++S L P + L SL + L+ N
Sbjct: 32 ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNK 91
Query: 201 LSGSIPP-ILGNLKSLSTLGLHINQLNGVIPPSIGNLSSLRNLSLFNNRLYGFVPKEIGY 259
++ +P + L SL L L+ N++N + + +L +L LSL++N+L
Sbjct: 92 IT-ELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSP 150
Query: 260 LKSLSKL 266
L+++ +
Sbjct: 151 LRAIQTM 157
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 7e-12
Identities = 35/186 (18%), Positives = 63/186 (33%), Gaps = 52/186 (27%)
Query: 170 LDLSENRLSGLIPLSLSNLSSLTVMSLFNNSLSGSIPP-ILGNLKSLSTLGLHINQLNGV 228
+ L +N + + P + S L + L NN +S + P L+SL++L L+ N++
Sbjct: 37 IRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGNKIT-E 94
Query: 229 IPPSI-GNLSSLRNLSLFNNRLYGFVPKEIGYLKSLSKLEFCANHLSGVIPHSVGNLTGL 287
+P S+ L SL+ L L N++ +
Sbjct: 95 LPKSLFEGLFSLQLLLLNANKI-----------NC--------------LRVDA------ 123
Query: 288 VLLNMCENHLFGPIPKSLRNLTSLERVRFNQNNLYGKVYEAFGDHPNLTFLDLSQNNFYC 347
++L +L + N L F + + L+QN F C
Sbjct: 124 -----------------FQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFIC 166
Query: 348 EISFNW 353
+ W
Sbjct: 167 DCHLKW 172
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 5e-09
Identities = 39/160 (24%), Positives = 63/160 (39%), Gaps = 30/160 (18%)
Query: 309 TSLERVRFNQNNLYGKVYEAFGDHPNLTFLDLSQNNFYCEISFNWRNFSKLGTFNASMNN 368
++ +R QN + AF + L +DLS N +IS
Sbjct: 32 ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNN----QIS------------------ 69
Query: 369 IYGSIPPEIGDS-SKLQVLDLSSNHIFGKIPVQL-VKLFSLNKLILSLNQLFGGVPLE-F 425
+ P+ L L L N I ++P L LFSL L+L+ N++ + ++ F
Sbjct: 70 ---ELAPDAFQGLRSLNSLVLYGNKI-TELPKSLFEGLFSLQLLLLNANKI-NCLRVDAF 124
Query: 426 GTLTELQYLDLSANKLSSSIPMSIGNLLKLHYLNLSNNQF 465
L L L L NKL + + L + ++L+ N F
Sbjct: 125 QDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPF 164
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 3e-17
Identities = 61/274 (22%), Positives = 109/274 (39%), Gaps = 36/274 (13%)
Query: 654 IGKGGQRSVYKAE-LPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFH 712
+G+G V + + AVK K + + E+ L +RH+N+I+
Sbjct: 13 LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72
Query: 713 GFCSNA--QHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCI 770
N Q ++V EY + +L D K F Q + + L YLH I
Sbjct: 73 DVLYNEEKQKMYMVMEY-CVCGMQEML-DSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGI 130
Query: 771 PPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWT--EFAGTVGYAAPELAYTMR 828
VH+DI N+LL + +S G A+ L P +++ T G+ + PE+A
Sbjct: 131 ---VHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIA---N 184
Query: 829 ATEKY-----DVYSFGVLALEVIKGYHP--GDFVSTIFSSISNMIIEVNQILDHRLPT-P 880
+ + D++S GV + G +P GD + +F +I + +P
Sbjct: 185 GLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKG--------SYAIPGDC 236
Query: 881 SRDVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914
++D L+ + L P R +++++
Sbjct: 237 GPPLSDLLKGM-------LEYEPAKRFSIRQIRQ 263
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 4e-17
Identities = 50/234 (21%), Positives = 97/234 (41%), Gaps = 42/234 (17%)
Query: 696 EVLALTEIRHRNIIKFHG--FCSNAQHSFIVCEYLARGSLTTI-----LRDDAAAKEFSW 748
E+ L ++ H N++K N H ++V E + +G + + L +D A F
Sbjct: 86 EIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQARFYF-- 143
Query: 749 NQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSN 808
+ + + YLH+ I +HRDI N+L+ + ++DFG + + +
Sbjct: 144 -------QDLIKGIEYLHYQKI---IHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDAL 193
Query: 809 WTEFAGTVGYAAPEL------AYTMRATEKYDVYSFGVLALEVIKGYHP--GDFVSTIFS 860
+ GT + APE ++ +A DV++ GV + G P + + + S
Sbjct: 194 LSNTVGTPAFMAPESLSETRKIFSGKAL---DVWAMGVTLYCFVFGQCPFMDERIMCLHS 250
Query: 861 SISNMIIEVNQILDHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914
I + +E P + D+ D + +++ NPE+R + E+
Sbjct: 251 KIKSQALEF-----PDQPDIAEDLKDLITRMLDK-------NPESRIVVPEIKL 292
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 80.3 bits (199), Expect = 1e-16
Identities = 59/237 (24%), Positives = 92/237 (38%), Gaps = 48/237 (20%)
Query: 696 EVLALTEIRHRNIIKFHGFCSNAQHSFIVCEYLARGSL-TTI-----LRDDAAAKEFSWN 749
E+ + H N++KF+G ++ EY + G L I + + A + F
Sbjct: 55 EICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFH-- 112
Query: 750 QRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNW 809
Q ++ GV YLH I HRDI +N+LLD +SDFG A ++
Sbjct: 113 Q---LMAGV----VYLHGIGI---THRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 162
Query: 810 ---TEFAGTVGYAAPEL----AYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSI 862
GT+ Y APEL + E DV+S G++ ++ G P +
Sbjct: 163 LLNK-MCGTLPYVAPELLKRREF---HAEPVDVWSCGIVLTAMLAGELP-------WDQP 211
Query: 863 SNMIIEVNQILDHRLPTP-----SRDVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914
S+ E + + + L I LVENP AR T+ ++
Sbjct: 212 SDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKI-------LVENPSARITIPDIKK 261
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 1e-16
Identities = 53/178 (29%), Positives = 73/178 (41%), Gaps = 28/178 (15%)
Query: 24 QYLDLGNNQLSGVIPPEIGKLNQLRRLYLDVNQLHGTIPPVIGQLSLINELVFCHNNVSG 83
+ LDL + L+ + L +L L LD NQL T+ G VF
Sbjct: 38 EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQL-QTLSA--G--------VFDD----- 81
Query: 84 RIPSSLGNLSNLALLYLNDNSLFGSIPI-VMGNLKSLSTLDLSQNQLNGSIPCSL-DNLS 141
L+ L L L +N L S+P+ V +L L L L NQL S+P + D L+
Sbjct: 82 --------LTELGTLGLANNQL-ASLPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLT 131
Query: 142 NLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSENRLSGLIPLSLSNLSSLTVMSLFNN 199
L L L N L L +L L LS N+L + + L L ++LF N
Sbjct: 132 KLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 5e-15
Identities = 52/155 (33%), Positives = 74/155 (47%), Gaps = 10/155 (6%)
Query: 2 LNLGFNLLFGNIPPQIGNLSKLQYLDLGNNQLSGVIPPEI-GKLNQLRRLYLDVNQLHGT 60
L+L L L+KL +L+L NQL + + L +L L L NQL +
Sbjct: 40 LDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSAGVFDDLTELGTLGLANNQLA-S 97
Query: 61 IPP-VIGQLSLINELVFCHNNVSGRIPSSL-GNLSNLALLYLNDNSLFGSIPI-VMGNLK 117
+P V L+ +++L N + +PS + L+ L L LN N L SIP L
Sbjct: 98 LPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKELRLNTNQL-QSIPAGAFDKLT 155
Query: 118 SLSTLDLSQNQLNGSIP-CSLDNLSNLDTLFLYKN 151
+L TL LS NQL S+P + D L L T+ L+ N
Sbjct: 156 NLQTLSLSTNQLQ-SVPHGAFDRLGKLQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 74.0 bits (182), Expect = 1e-14
Identities = 56/170 (32%), Positives = 80/170 (47%), Gaps = 14/170 (8%)
Query: 372 SIPPEIGDSSKLQVLDLSSNHIFGKIPVQLVKLFSLNKLILSLNQLF---GGVPLEFGTL 428
S+P I + + LDL S + L L L L NQL GV F L
Sbjct: 28 SVPSGIPADT--EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGV---FDDL 82
Query: 429 TELQYLDLSANKLSSSIPMSI-GNLLKLHYLNLSNNQFSHKIPTE-FEKLIHLSELDLSH 486
TEL L L+ N+L+S +P+ + +L +L L L NQ +P+ F++L L EL L+
Sbjct: 83 TELGTLGLANNQLAS-LPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKELRLNT 140
Query: 487 NILQEEIPPQIC-KMESLEKLNLSHNNLSDFIPRCFEEMRSLSWIDISYN 535
N LQ IP K+ +L+ L+LS N L F+ + L I + N
Sbjct: 141 NQLQS-IPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 2e-13
Identities = 51/188 (27%), Positives = 75/188 (39%), Gaps = 40/188 (21%)
Query: 169 QLDLSENRLSGLIPLSLSNLSSLTVMSLFNNSLSGSIPP-ILGNLKSLSTLGLHINQLNG 227
+LDL L+ L + L+ LT ++L N L ++ + +L L TLGL NQL
Sbjct: 39 KLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSAGVFDDLTELGTLGLANNQLA- 96
Query: 228 VIPPSI-GNLSSLRNLSLFNNRLYGFVPKEIGYLKSLSKLEFCANHLSGVIPHSV-GNLT 285
+P + +L+ L L L N+ LKSL P V LT
Sbjct: 97 SLPLGVFDHLTQLDKLYLGGNQ-----------LKSL--------------PSGVFDRLT 131
Query: 286 GLVLLNMCENHLFGPIPKSL-----RNLTSLERVRFNQNNLYGKVYEAFGDHPNLTFLDL 340
L L + N L +S+ LT+L+ + + N L + AF L + L
Sbjct: 132 KLKELRLNTNQL-----QSIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITL 186
Query: 341 SQNNFYCE 348
N F C
Sbjct: 187 FGNQFDCS 194
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 4e-12
Identities = 44/152 (28%), Positives = 61/152 (40%), Gaps = 4/152 (2%)
Query: 122 LDLSQNQLNGSIPCSLDNLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSENRLSGLI 181
LDL L + L+ L L L N L V +L L L L+ N+L+ L
Sbjct: 40 LDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLASLP 99
Query: 182 PLSLSNLSSLTVMSLFNNSLSGSIPP-ILGNLKSLSTLGLHINQLNGVIPPSI-GNLSSL 239
+L+ L + L N L S+P + L L L L+ NQL IP L++L
Sbjct: 100 LGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKELRLNTNQLQ-SIPAGAFDKLTNL 157
Query: 240 RNLSLFNNRLYGFVPKEIGYLKSLSKLEFCAN 271
+ LSL N+L L L + N
Sbjct: 158 QTLSLSTNQLQSVPHGAFDRLGKLQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 7e-12
Identities = 42/144 (29%), Positives = 73/144 (50%), Gaps = 8/144 (5%)
Query: 409 KLILSLNQLFGGVPLEFGTLTELQYLDLSANKLSSSIPMSIGNLL-KLHYLNLSNNQFSH 467
KL L L F LT+L +L+L N+L + + + + L +L L L+NNQ +
Sbjct: 39 KLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQT-LSAGVFDDLTELGTLGLANNQLA- 96
Query: 468 KIPTE-FEKLIHLSELDLSHNILQEEIPPQIC-KMESLEKLNLSHNNLSDFIPRCFEEMR 525
+P F+ L L +L L N L+ +P + ++ L++L L+ N L F+++
Sbjct: 97 SLPLGVFDHLTQLDKLYLGGNQLKS-LPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLT 155
Query: 526 SLSWIDISYNELQGPIPNSTAFKN 549
+L + +S N+LQ +P+ AF
Sbjct: 156 NLQTLSLSTNQLQS-VPHG-AFDR 177
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 1e-09
Identities = 47/185 (25%), Positives = 71/185 (38%), Gaps = 36/185 (19%)
Query: 309 TSLERVRFNQNNLYGKVYEAFGDHPNLTFLDLSQNNFYCEISFNWRNFSKLGTFNASMNN 368
E++ L F LT+L+L N
Sbjct: 35 ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQL----------------------- 71
Query: 369 IYGSIPPEIGDS-SKLQVLDLSSNHIFGKIPVQLV-KLFSLNKLILSLNQLFG---GVPL 423
++ + D ++L L L++N + +P+ + L L+KL L NQL GV
Sbjct: 72 --QTLSAGVFDDLTELGTLGLANNQL-ASLPLGVFDHLTQLDKLYLGGNQLKSLPSGV-- 126
Query: 424 EFGTLTELQYLDLSANKLSSSIPMSI-GNLLKLHYLNLSNNQFSHKIPTEFEKLIHLSEL 482
F LT+L+ L L+ N+L S IP L L L+LS NQ F++L L +
Sbjct: 127 -FDRLTKLKELRLNTNQLQS-IPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTI 184
Query: 483 DLSHN 487
L N
Sbjct: 185 TLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 2e-08
Identities = 31/111 (27%), Positives = 51/111 (45%), Gaps = 2/111 (1%)
Query: 429 TELQYLDLSANKLSSSIPMSIGNLLKLHYLNLSNNQFSHKIPTEFEKLIHLSELDLSHNI 488
+ + LDL + L++ + L KL +LNL NQ F+ L L L L++N
Sbjct: 35 ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQ 94
Query: 489 LQEEIPPQI-CKMESLEKLNLSHNNLSDFIPRCFEEMRSLSWIDISYNELQ 538
L +P + + L+KL L N L F+ + L + ++ N+LQ
Sbjct: 95 LA-SLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQ 144
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 82.5 bits (204), Expect = 2e-16
Identities = 67/301 (22%), Positives = 109/301 (36%), Gaps = 51/301 (16%)
Query: 613 PQEKRSSSANPFGFFSVLNFNGKVLYEEITKATGNFGEKYCIGKGGQRSVYKAEL-PSGN 671
E++ + N F + VL GK G FGE V ++ +G
Sbjct: 175 WLERQPVTKNTFRQYRVL---GK----------GGFGE-----------VCACQVRATGK 210
Query: 672 IFAVKKFKAELF--SDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFIVCEYLA 729
++A KK + + A LNE L ++ R ++ +V +
Sbjct: 211 MYACKKLEKKRIKKRKGEAMA---LNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMN 267
Query: 730 RGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEY 789
G L + F + + + L LH + I V+RD+ +N+LLD
Sbjct: 268 GGDLKFHIYH-MGQAGFPEARAVFYAAEICCGLEDLHRERI---VYRDLKPENILLDD-- 321
Query: 790 EAHV--SDFGFAKFLEPHSSNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIK 847
H+ SD G A + + GTVGY APE+ R T D ++ G L E+I
Sbjct: 322 HGHIRISDLGLAVHVPEGQTIKG-RVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIA 380
Query: 848 GYHP--GDFVSTIFSSISNMIIEVNQILDHRLPTPSRDVTDKLRSIMEVAILCLVENPEA 905
G P + ++ EV + R +R + +L L ++P
Sbjct: 381 GQSPFQQRKKKIKREEVERLVKEVPEEYSERFSPQARSLCSQL----------LCKDPAE 430
Query: 906 R 906
R
Sbjct: 431 R 431
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 7e-16
Identities = 44/151 (29%), Positives = 61/151 (40%), Gaps = 27/151 (17%)
Query: 2 LNLGFNLLFGNIPPQIGNLSKLQYLDLGNNQLSGVIPPEI-GKLNQLRRLYLDVNQLHGT 60
L L N + P +L L+ L LG+NQL + P + L QL L L NQL
Sbjct: 45 LYLHDNQITKLEPGVFDSLINLKELYLGSNQLGAL-PVGVFDSLTQLTVLDLGTNQLT-V 102
Query: 61 IPPVIGQLSLINELVFCHNNVSGRIPSSLGNLSNLALLYLNDNSLFGSIPIVMGNLKSLS 120
+P VF L +L L++ N L +P + L L+
Sbjct: 103 LPS--A--------VF-------------DRLVHLKELFMCCNKL-TELPRGIERLTHLT 138
Query: 121 TLDLSQNQLNGSIPCSLDNLSNLDTLFLYKN 151
L L QNQL + D LS+L +L+ N
Sbjct: 139 HLALDQNQLKSIPHGAFDRLSSLTHAYLFGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 1e-14
Identities = 41/126 (32%), Positives = 56/126 (44%), Gaps = 1/126 (0%)
Query: 122 LDLSQNQLNGSIPCSLDNLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSENRLSGLI 181
L L NQ+ P D+L NL L+L N L V +L L LDL N+L+ L
Sbjct: 45 LYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQLTVLP 104
Query: 182 PLSLSNLSSLTVMSLFNNSLSGSIPPILGNLKSLSTLGLHINQLNGVIPPSIGNLSSLRN 241
L L + + N L+ +P + L L+ L L NQL + + LSSL +
Sbjct: 105 SAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTH 163
Query: 242 LSLFNN 247
LF N
Sbjct: 164 AYLFGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 3e-13
Identities = 39/128 (30%), Positives = 63/128 (49%), Gaps = 3/128 (2%)
Query: 409 KLILSLNQLFGGVPLEFGTLTELQYLDLSANKLSSSIPMSI-GNLLKLHYLNLSNNQFSH 467
L L NQ+ P F +L L+ L L +N+L ++P+ + +L +L L+L NQ +
Sbjct: 44 ILYLHDNQITKLEPGVFDSLINLKELYLGSNQL-GALPVGVFDSLTQLTVLDLGTNQLTV 102
Query: 468 KIPTEFEKLIHLSELDLSHNILQEEIPPQICKMESLEKLNLSHNNLSDFIPRCFEEMRSL 527
F++L+HL EL + N L E+P I ++ L L L N L F+ + SL
Sbjct: 103 LPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSL 161
Query: 528 SWIDISYN 535
+ + N
Sbjct: 162 THAYLFGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 2e-12
Identities = 45/145 (31%), Positives = 68/145 (46%), Gaps = 12/145 (8%)
Query: 372 SIPPEIGDSSKLQVLDLSSNHIFGKIPVQLVKLFSLNKLILSLNQLF---GGVPLEFGTL 428
S+P I ++ Q+L L N I P L +L +L L NQL GV F +L
Sbjct: 33 SVPAGIPTNA--QILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGV---FDSL 87
Query: 429 TELQYLDLSANKLSSSIPMSI-GNLLKLHYLNLSNNQFSHKIPTEFEKLIHLSELDLSHN 487
T+L LDL N+L + +P ++ L+ L L + N+ ++P E+L HL+ L L N
Sbjct: 88 TQLTVLDLGTNQL-TVLPSAVFDRLVHLKELFMCCNKL-TELPRGIERLTHLTHLALDQN 145
Query: 488 ILQEEIPPQICKMESLEKLNLSHNN 512
L+ ++ SL L N
Sbjct: 146 QLKSIPHGAFDRLSSLTHAYL-FGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 2e-12
Identities = 46/129 (35%), Positives = 65/129 (50%), Gaps = 5/129 (3%)
Query: 73 ELVFCHNNVSGRIPSSLGNLSNLALLYLNDNSLFGSIPI-VMGNLKSLSTLDLSQNQLNG 131
L N ++ P +L NL LYL N L G++P+ V +L L+ LDL NQL
Sbjct: 44 ILYLHDNQITKLEPGVFDSLINLKELYLGSNQL-GALPVGVFDSLTQLTVLDLGTNQLT- 101
Query: 132 SIPCSL-DNLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSENRLSGLIPLSLSNLSS 190
+P ++ D L +L LF+ N L+ +P I L L L L +N+L + + LSS
Sbjct: 102 VLPSAVFDRLVHLKELFMCCNKLTE-LPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSS 160
Query: 191 LTVMSLFNN 199
LT LF N
Sbjct: 161 LTHAYLFGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 3e-10
Identities = 35/122 (28%), Positives = 60/122 (49%), Gaps = 5/122 (4%)
Query: 429 TELQYLDLSANKLSSSIPMSIGNLLKLHYLNLSNNQFSHKIPTEFEKLIHLSELDLSHNI 488
T Q L L N+++ P +L+ L L L +NQ F+ L L+ LDL N
Sbjct: 40 TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQ 99
Query: 489 LQEEIPPQIC-KMESLEKLNLSHNNLSDFIPRCFEEMRSLSWIDISYNELQGPIPNSTAF 547
L +P + ++ L++L + N L++ +PR E + L+ + + N+L+ IP+ AF
Sbjct: 100 LT-VLPSAVFDRLVHLKELFMCCNKLTE-LPRGIERLTHLTHLALDQNQLKS-IPHG-AF 155
Query: 548 KN 549
Sbjct: 156 DR 157
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 58.6 bits (142), Expect = 1e-09
Identities = 37/127 (29%), Positives = 60/127 (47%), Gaps = 3/127 (2%)
Query: 141 SNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSENRLSGLIPLSLSNLSSLTVMSLFNNS 200
+N L+L+ N ++ P V +L +L +L L N+L L +L+ LTV+ L N
Sbjct: 40 TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQ 99
Query: 201 LSGSIPP-ILGNLKSLSTLGLHINQLNGVIPPSIGNLSSLRNLSLFNNRLYGFVPKEIGY 259
L+ +P + L L L + N+L +P I L+ L +L+L N+L
Sbjct: 100 LT-VLPSAVFDRLVHLKELFMCCNKLTE-LPRGIERLTHLTHLALDQNQLKSIPHGAFDR 157
Query: 260 LKSLSKL 266
L SL+
Sbjct: 158 LSSLTHA 164
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 2e-06
Identities = 44/133 (33%), Positives = 66/133 (49%), Gaps = 5/133 (3%)
Query: 218 LGLHINQLNGVIPPSIGNLSSLRNLSLFNNRLYGFVPKEI-GYLKSLSKLEFCANHLSGV 276
L LH NQ+ + P +L +L+ L L +N+L G +P + L L+ L+ N L+ V
Sbjct: 45 LYLHDNQITKLEPGVFDSLINLKELYLGSNQL-GALPVGVFDSLTQLTVLDLGTNQLT-V 102
Query: 277 IPHSV-GNLTGLVLLNMCENHLFGPIPKSLRNLTSLERVRFNQNNLYGKVYEAFGDHPNL 335
+P +V L L L MC N L +P+ + LT L + +QN L + AF +L
Sbjct: 103 LPSAVFDRLVHLKELFMCCNKL-TELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSL 161
Query: 336 TFLDLSQNNFYCE 348
T L N + CE
Sbjct: 162 THAYLFGNPWDCE 174
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 7e-16
Identities = 59/237 (24%), Positives = 92/237 (38%), Gaps = 48/237 (20%)
Query: 696 EVLALTEIRHRNIIKFHGFCSNAQHSFIVCEYLARGSL-TTI-----LRDDAAAKEFSWN 749
E+ + H N++KF+G ++ EY + G L I + + A + F
Sbjct: 55 EICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFH-- 112
Query: 750 QRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNW 809
Q ++ GV YLH I HRDI +N+LLD +SDFG A ++
Sbjct: 113 Q---LMAGV----VYLHGIGI---THRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 162
Query: 810 ---TEFAGTVGYAAPEL----AYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSI 862
GT+ Y APEL + E DV+S G++ ++ G P +
Sbjct: 163 LLNK-MCGTLPYVAPELLKRREF---HAEPVDVWSCGIVLTAMLAGELP-------WDQP 211
Query: 863 SNMIIEVNQILDHRLPTP-----SRDVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914
S+ E + + + L I LVENP AR T+ ++
Sbjct: 212 SDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKI-------LVENPSARITIPDIKK 261
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 77.2 bits (191), Expect = 1e-15
Identities = 68/277 (24%), Positives = 112/277 (40%), Gaps = 50/277 (18%)
Query: 654 IGKGGQRSVYKAE-LPSGNIFAVKKF-KAELFSDETANPSEFLNEVLALTEIRHRNIIKF 711
+G G V E +G+ AVK + ++ + E+ L RH +IIK
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILNRQKI--RSLDVVGKIKREIQNLKLFRHPHIIKL 76
Query: 712 HGFCSNAQHSFIVCEYLARGSL------TTILRDDAAAKEFSWNQRMNVIKGVANALSYL 765
+ S F+V EY++ G L + + A + F Q + +A+ Y
Sbjct: 77 YQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQ--Q-------ILSAVDYC 127
Query: 766 HHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGTVGYAAPELAY 825
H + VHRD+ +NVLLD+ A ++DFG + + T G+ YAAPE
Sbjct: 128 HRHMV---VHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRT-SCGSPNYAAPE--- 180
Query: 826 TMRATEKY-----DVYSFGVLALEVIKGYHP--GDFVSTIFSSISNMIIEVNQILDHRLP 878
+ + Y D++S GV+ ++ G P + V T+F I +P
Sbjct: 181 -VISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGG--------VFYIP 231
Query: 879 T-PSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914
+R V L + L +P R T+K++
Sbjct: 232 EYLNRSVATLLMHM-------LQVDPLKRATIKDIRE 261
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 78.6 bits (194), Expect = 2e-15
Identities = 52/266 (19%), Positives = 100/266 (37%), Gaps = 37/266 (13%)
Query: 654 IGKGGQRSVYKA-ELPSGNIFAVKKF-KAELFS-DETANPSEFLNEVLALTEIRHRNIIK 710
IG+G V + ++A+K K E+ ++A F E + +++
Sbjct: 77 IGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAF---FWEERDIMAFANSPWVVQ 133
Query: 711 FHGFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLH-HDC 769
+ ++ ++V EY+ G L ++ + + V AL +H
Sbjct: 134 LFYAFQDDRYLYMVMEYMPGGDLVNLMSN----YDVPEKWARFYTAEVVLALDAIHSMG- 188
Query: 770 IPPIVHRDISSKNVLLDSEYEAHV--SDFGFAKFLEPHSSNWTE-FAGTVGYAAPELAYT 826
+HRD+ N+LLD H+ +DFG + + GT Y +PE+ +
Sbjct: 189 ---FIHRDVKPDNMLLD--KSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKS 243
Query: 827 MRATEKY----DVYSFGVLALEVIKGYHP--GDFVSTIFSSISNMIIEVNQILDHRLPTP 880
Y D +S GV E++ G P D + +S I N + P
Sbjct: 244 QGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSL------TFP-D 296
Query: 881 SRDVTDKLRSIMEVAILCLVENPEAR 906
D++ + ++++ + + E R
Sbjct: 297 DNDISKEAKNLICA----FLTDREVR 318
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 2e-15
Identities = 50/215 (23%), Positives = 90/215 (41%), Gaps = 36/215 (16%)
Query: 653 CIGKGGQRSVYKA-ELPSGNIFAVKKF-KAELFS-DETANPSEFLNEVLALTEIRHRNII 709
+G+G +V A EL + +A+K K + ++ E ++ + H +
Sbjct: 37 ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPY---VTRERDVMSRLDHPFFV 93
Query: 710 KFHGFCSNAQHSFIVCEYLARGSLTTILR-----DDAAAK----EFSWNQRMNVIKGVAN 760
K + + + + Y G L +R D+ + E + +
Sbjct: 94 KLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE------------IVS 141
Query: 761 ALSYLH-HDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSN---WTEFAGTV 816
AL YLH I+HRD+ +N+LL+ + ++DFG AK L P S + F GT
Sbjct: 142 ALEYLHGKG----IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANS-FVGTA 196
Query: 817 GYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHP 851
Y +PEL A + D+++ G + +++ G P
Sbjct: 197 QYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 231
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 3e-15
Identities = 62/270 (22%), Positives = 100/270 (37%), Gaps = 39/270 (14%)
Query: 654 IGKGGQRSVYKAEL-PSGNIFAVKKF-KAELFS-DETANPSEFLNEVLALTEIRHRNIIK 710
IG+G V ++ +G ++A+K K ++ E + F E L R I +
Sbjct: 69 IGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSC---FREERDVLVNGDRRWITQ 125
Query: 711 FHGFCS--NAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHD 768
H + + + ++V EY G L T+L + + + A+ +H
Sbjct: 126 LH--FAFQDENYLYLVMEYYVGGDLLTLLSK--FGERIPAEMARFYLAEIVMAIDSVHRL 181
Query: 769 CIPPIVHRDISSKNVLLDSEYEAHV--SDFGFAKFLEPHSSNWTE-FAGTVGYAAPELAY 825
VHRDI N+LLD H+ +DFG L + + GT Y +PE+
Sbjct: 182 GY---VHRDIKPDNILLD--RCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQ 236
Query: 826 TMRATEKYDVY-------SFGVLALEVIKGYHP--GDFVSTIFSSISNMIIEVNQILDHR 876
+ Y + GV A E+ G P D + + I V+
Sbjct: 237 AVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKI------VHYKEHLS 290
Query: 877 LPTPSRDVTDKLRSIMEVAILCLVENPEAR 906
LP V ++ R I L+ PE R
Sbjct: 291 LPLVDEGVPEEARDF----IQRLLCPPETR 316
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 78.7 bits (194), Expect = 3e-15
Identities = 62/307 (20%), Positives = 105/307 (34%), Gaps = 48/307 (15%)
Query: 607 RRRKRDPQEKRSSSANPFGFFSVLNFNGKVLYEEITKATGNFGEKYCIGKGGQRSVYKAE 666
R + E + + F F VL G+ G FGE V+ +
Sbjct: 170 RFLQWKWLEAQPMGEDWFLDFRVL---GR----------GGFGE-----------VFACQ 205
Query: 667 L-PSGNIFAVKKFKAELF--SDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFI 723
+ +G ++A KK + + E L ++ R I+ +
Sbjct: 206 MKATGKLYACKKLNKKRLKKRKGYQGA---MVEKKILAKVHSRFIVSLAYAFETKTDLCL 262
Query: 724 VCEYLARGSLTT-ILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKN 782
V + G + I D F + + + + L +LH I ++RD+ +N
Sbjct: 263 VMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNI---IYRDLKPEN 319
Query: 783 VLLDSEYEAHVSDFGFAK-FLEPHSSNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVL 841
VLLD + +SD G A + +AGT G+ APEL D ++ GV
Sbjct: 320 VLLDDDGNVRISDLGLAVELKAGQTKTKG-YAGTPGFMAPELLLGEEYDFSVDYFALGVT 378
Query: 842 ALEVIKGYHP--GDFVSTIFSSISNMIIEVNQILDHRLPTPSRDVTDKLRSIMEVAILCL 899
E+I P + ++E + S+D + L L
Sbjct: 379 LYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFSPASKDFCEAL----------L 428
Query: 900 VENPEAR 906
++PE R
Sbjct: 429 QKDPEKR 435
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 3e-15
Identities = 64/248 (25%), Positives = 109/248 (43%), Gaps = 28/248 (11%)
Query: 654 IGKGGQRSVYKAEL-PSGNIFAVKKF-KAELFS-DETANPSEFLNEVLALTEIRHRNIIK 710
+G G V + SGN +A+K K ++ + + LNE L + ++K
Sbjct: 49 LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEH---TLNEKRILQAVNFPFLVK 105
Query: 711 FHGFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLH-HDC 769
+ + ++V EY+A G + + LR FS + YLH D
Sbjct: 106 LEFSFKDNSNLYMVMEYVAGGEMFSHLRR---IGRFSEPHARFYAAQIVLTFEYLHSLD- 161
Query: 770 IPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGTVGYAAPELAYTMRA 829
+++RD+ +N+L+D + V+DFGFAK WT GT APE+ +
Sbjct: 162 ---LIYRDLKPENLLIDQQGYIQVTDFGFAK--RVKGRTWT-LCGTPEALAPEIILSKGY 215
Query: 830 TEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTP---SRDVTD 886
+ D ++ GVL E+ GY P F + + I +I+ ++ P S D+ D
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPP-------FFADQPIQI-YEKIVSGKVRFPSHFSSDLKD 267
Query: 887 KLRSIMEV 894
LR++++V
Sbjct: 268 LLRNLLQV 275
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 2e-14
Identities = 64/418 (15%), Positives = 113/418 (27%), Gaps = 108/418 (25%)
Query: 113 MGNLKSLSTLDLSQNQLNG----SIPCSLDNLSNLDTLFLYKNSLSGP----IPSVIGNL 164
M S+ L + + S+ L ++ + L N++ + I +
Sbjct: 1 MARF-SIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASK 59
Query: 165 KSLLQLDLSENRLSGLIPLSLSNLSSLTVMSLFNNSLSGSIPPILGNLKSLSTLGLHINQ 224
K L + S+ + L L L L T+ L N
Sbjct: 60 KDLEIAEFSDIFTGRVKDEIPEALRLLLQA--------------LLKCPKLHTVRLSDNA 105
Query: 225 L--NGVIP--PSIGNLSSLRNLSLFNNRLYGFVPKEIGYLKSLSKLEFCANHLSGVIPHS 280
P + + L +L L NN +G ++ +
Sbjct: 106 FGPTAQEPLIDFLSKHTPLEHLYLHNNG--------LG--------PQAGAKIARALQEL 149
Query: 281 VGNLTGLVLLNMCENHLFGPIPKSLRNLTSLERVRFNQNNLYGK----VYEAFGDHPNLT 336
N K +N L + +N L + F H L
Sbjct: 150 AVN-------------------KKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLH 190
Query: 337 FLDLSQNNFYCEISFNWRNFSKLGTFNASMNNIYGSIPPEIGDSSKLQVLDLSSNHIFGK 396
+ + QN E G + + + +L+VLDL N
Sbjct: 191 TVKMVQNGIRPE-----------GIEHL--------LLEGLAYCQELKVLDLQDNTF-TH 230
Query: 397 IPVQ-----LVKLFSLNKLILSLNQL--FGGVP----LEFGTLTELQYLDLSANKLSSSI 445
+ L +L +L L+ L G LQ L L N++
Sbjct: 231 LGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDA 290
Query: 446 PMSIGNLLK-----LHYLNLSNNQFS------HKIPTEFEKLIHLSELDLSHNILQEE 492
++ ++ L +L L+ N+FS +I F +L +
Sbjct: 291 VRTLKTVIDEKMPDLLFLELNGNRFSEEDDVVDEIREVFSTRGRGELDELDDMEELTD 348
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 8e-12
Identities = 57/355 (16%), Positives = 107/355 (30%), Gaps = 86/355 (24%)
Query: 209 LGNLKSLSTLGLHINQLNGV----IPPSIGNLSSLRNLSLFNNRLYGFVPKEIGYLKSLS 264
+ S+ L ++ + + + S++ + L N IG
Sbjct: 1 MARF-SIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNT--------IG------ 45
Query: 265 KLEFCANHLSGVIPHSVGNLTGLVLLNMCENHLFGPIP-------KSLRNLTSLERVRFN 317
A LS I +L ++ + IP ++L L VR +
Sbjct: 46 --TEAARWLSENIASKK-DLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLS 102
Query: 318 QNNLYGK----VYEAFGDHPNLTFLDLSQNNF-------------YCEISFNWRNFSKLG 360
N + + H L L L N ++ +N L
Sbjct: 103 DNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLR 162
Query: 361 TFNASMNNIYG----SIPPEIGDSSKLQVLDLSSNHIFGK-IPVQLVKLFSLNKLILSLN 415
+ N + L + + N I + I L++ +
Sbjct: 163 SIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYC------- 215
Query: 416 QLFGGVPLEFGTLTELQYLDLSANKLS----SSIPMSIGNLLKLHYLNLSNNQFSHK--- 468
EL+ LDL N + S++ +++ + L L L++ S +
Sbjct: 216 -------------QELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAA 262
Query: 469 -IPTEFEKLIH--LSELDLSHNILQEEIPPQIC-----KMESLEKLNLSHNNLSD 515
+ F KL + L L L +N ++ + + KM L L L+ N S+
Sbjct: 263 AVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSE 317
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 66.7 bits (163), Expect = 1e-11
Identities = 44/296 (14%), Positives = 83/296 (28%), Gaps = 57/296 (19%)
Query: 284 LTGLVL-LNMCENHLFGPIPKSLRNLTSLERVRFNQNNLYGK-----VYEAFGDHPNLTF 337
+ G L L+ + L S++ + + N + G + E +L
Sbjct: 6 IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTI-GTEAARWLSENIASKKDLEI 64
Query: 338 LDLSQNNFYCEISFNWRNFSKLGTFNASMNNIYGSIPPEIGDSSKLQVLDLSSNHIFGKI 397
+ S G + + + KL + LS N
Sbjct: 65 AEFSDIF--------------TGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTA 110
Query: 398 PVQLVKLFSLNK----LILSLNQL--FGGVPL-----------EFGTLTELQYLDLSANK 440
L+ S + L L N L G + + L+ + N+
Sbjct: 111 QEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNR 170
Query: 441 LSSSIPMSIGNLLK----LHYLNLSNNQFSHK-----IPTEFEKLIHLSELDLSHNILQE 491
L + + LH + + N + + L LDL N
Sbjct: 171 LENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTH 230
Query: 492 E----IPPQICKMESLEKLNLSHNNLSD----FIPRCFEEM--RSLSWIDISYNEL 537
+ + +L +L L+ LS + F ++ L + + YNE+
Sbjct: 231 LGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEI 286
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 60.5 bits (147), Expect = 1e-09
Identities = 38/275 (13%), Positives = 80/275 (29%), Gaps = 58/275 (21%)
Query: 17 IGNLSKLQYLDLGNNQLSG----VIPPEIGKLNQLRRLYLDVNQLHGTIPPVIGQLSLIN 72
+ ++ + L N + + I L
Sbjct: 28 LLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIF--------------TG 73
Query: 73 ELVFCHNNVSGRIPSSLGNLSNLALLYLNDNSL--FGSIPIV--MGNLKSLSTLDLSQNQ 128
+ + +L L + L+DN+ P++ + L L L N
Sbjct: 74 RVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNG 133
Query: 129 L-------------NGSIPCSLDNLSNLDTLFLYKNSLSGP----IPSVIGNLKSLLQLD 171
L ++ N L ++ +N L + + L +
Sbjct: 134 LGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVK 193
Query: 172 LSENRL-----SGLIPLSLSNLSSLTVMSLFNNSLSG----SIPPILGNLKSLSTLGLHI 222
+ +N + L+ L+ L V+ L +N+ + ++ L + +L LGL+
Sbjct: 194 MVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLND 253
Query: 223 NQL--NGVIPPSIGNL------SSLRNLSLFNNRL 249
L G ++ + L+ L L N +
Sbjct: 254 CLLSARGAA--AVVDAFSKLENIGLQTLRLQYNEI 286
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 1e-08
Identities = 42/235 (17%), Positives = 67/235 (28%), Gaps = 39/235 (16%)
Query: 19 NLSKLQYLDLGNNQLS--GVIP--PEIGKLNQLRRLYLDVNQLHGTIPPVIGQLSLINEL 74
KL + L +N P + K L LYL N L + L
Sbjct: 92 KCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLG-----PQAGAKIARAL 146
Query: 75 VFCHNNVSGRIPSSLGNLSNLALLYLNDNSL--FGSIPI--VMGNLKSLSTLDLSQNQLN 130
N N L + N L + + L T+ + QN +
Sbjct: 147 QELAVN------KKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIR 200
Query: 131 -----GSIPCSLDNLSNLDTLFLYKNSLSGP----IPSVIGNLKSLLQLDLSENRLS--G 179
+ L L L L N+ + + + + +L +L L++ LS G
Sbjct: 201 PEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARG 260
Query: 180 LIP----LSLSNLSSLTVMSLFNNSLSGSIPPILG-----NLKSLSTLGLHINQL 225
S L + L N + L + L L L+ N+
Sbjct: 261 AAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRF 315
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 3e-06
Identities = 25/169 (14%), Positives = 44/169 (26%), Gaps = 35/169 (20%)
Query: 405 FSLNKLILSLNQLF--GGVPL--EFGTLTELQYLDLSANKLSSSIPMSIGNLLK----LH 456
FS+ L L+ + + ++ + LS N + + + + L
Sbjct: 4 FSIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLE 63
Query: 457 YLNLSNNQFSHKIPTEFE----------KLIHLSELDLSHNILQEEIPPQICKM----ES 502
S+ E K L + LS N +
Sbjct: 64 IAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTP 123
Query: 503 LEKLNLSHNNLSD-------------FIPRCFEEMRSLSWIDISYNELQ 538
LE L L +N L + + + L I N L+
Sbjct: 124 LEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLE 172
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 45.9 bits (109), Expect = 4e-05
Identities = 38/199 (19%), Positives = 67/199 (33%), Gaps = 37/199 (18%)
Query: 17 IGNLSKLQYLDLGNNQLS-------------GVIPPEIGKLNQLRRLYLDVNQLHG---- 59
+ + L++L L NN L + + LR + N+L
Sbjct: 118 LSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMK 177
Query: 60 TIPPVIGQLSLINELVFCHNN-----VSGRIPSSLGNLSNLALLYLNDNSL--FGSIPI- 111
L++ + N + + L L +L L DN+ GS +
Sbjct: 178 EWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALA 237
Query: 112 -VMGNLKSLSTLDLSQNQLNG----SIPCSLDNLSN--LDTLFLYKNSLSGP-----IPS 159
+ + +L L L+ L+ ++ + L N L TL L N +
Sbjct: 238 IALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTV 297
Query: 160 VIGNLKSLLQLDLSENRLS 178
+ + LL L+L+ NR S
Sbjct: 298 IDEKMPDLLFLELNGNRFS 316
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 3e-14
Identities = 49/153 (32%), Positives = 64/153 (41%), Gaps = 30/153 (19%)
Query: 2 LNLGFNLLFGNIPPQIGNLSKLQYLDLGNNQLSGVIPPEI-GKLNQLRRLYLDVNQLHGT 60
L+L N L L+ L L LG N+L + P + KL L L L NQL +
Sbjct: 33 LDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSL-PNGVFNKLTSLTYLNLSTNQLQ-S 90
Query: 61 IPPVIGQLSLINELVFCHNNVSGRIPSSLGNLSNLALLYLNDNSLFGSIPI-VMGNLKSL 119
+P G VF L+ L L LN N L S+P V L L
Sbjct: 91 LPN--G--------VFDK-------------LTQLKELALNTNQL-QSLPDGVFDKLTQL 126
Query: 120 STLDLSQNQLNGSIP-CSLDNLSNLDTLFLYKN 151
L L QNQL S+P D L++L ++L+ N
Sbjct: 127 KDLRLYQNQLK-SVPDGVFDRLTSLQYIWLHDN 158
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 1e-13
Identities = 42/127 (33%), Positives = 57/127 (44%), Gaps = 2/127 (1%)
Query: 122 LDLSQNQLNGSIPCSLDNLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSENRLSGLI 181
LDL N L D L++L L+L N L V L SL L+LS N+L L
Sbjct: 33 LDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQSLP 92
Query: 182 PLSLSNLSSLTVMSLFNNSLSGSIPP-ILGNLKSLSTLGLHINQLNGVIPPSIGNLSSLR 240
L+ L ++L N L S+P + L L L L+ NQL V L+SL+
Sbjct: 93 NGVFDKLTQLKELALNTNQLQ-SLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQ 151
Query: 241 NLSLFNN 247
+ L +N
Sbjct: 152 YIWLHDN 158
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 2e-12
Identities = 46/155 (29%), Positives = 67/155 (43%), Gaps = 6/155 (3%)
Query: 72 NELVFCHNNVSGRIPSSLGNLSNLALLYLNDNSLFGSIPIVMGNLKSLSTLDLSQNQLNG 131
V C++ +P+ G + L L NSL V L SL+ L L N+L
Sbjct: 9 GTTVECYSQGRTSVPT--GIPAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ- 65
Query: 132 SIPCSL-DNLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSENRLSGLIPLSLSNLSS 190
S+P + + L++L L L N L V L L +L L+ N+L L L+
Sbjct: 66 SLPNGVFNKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQ 125
Query: 191 LTVMSLFNNSLSGSIPP-ILGNLKSLSTLGLHINQ 224
L + L+ N L S+P + L SL + LH N
Sbjct: 126 LKDLRLYQNQLK-SVPDGVFDRLTSLQYIWLHDNP 159
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 3e-11
Identities = 46/129 (35%), Positives = 57/129 (44%), Gaps = 4/129 (3%)
Query: 409 KLILSLNQLFGGVPLEFGTLTELQYLDLSANKLSSSIPMSIGNLLKLHYLNLSNNQFSHK 468
L L N L F LT L L L NKL S L L YLNLS NQ
Sbjct: 32 YLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQSL 91
Query: 469 IPTEFEKLIHLSELDLSHNILQEEIPPQIC-KMESLEKLNLSHNNLSDFIPR-CFEEMRS 526
F+KL L EL L+ N LQ +P + K+ L+ L L N L +P F+ + S
Sbjct: 92 PNGVFDKLTQLKELALNTNQLQ-SLPDGVFDKLTQLKDLRLYQNQLKS-VPDGVFDRLTS 149
Query: 527 LSWIDISYN 535
L +I + N
Sbjct: 150 LQYIWLHDN 158
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 9e-11
Identities = 48/146 (32%), Positives = 71/146 (48%), Gaps = 14/146 (9%)
Query: 372 SIPPEIGDSSKLQVLDLSSNHIFGKIPVQLVKLFSLNKLILSLNQLF---GGVPLEFGTL 428
S+P I + LDL +N + +L SL +L L N+L GV F L
Sbjct: 21 SVPTGIPAQT--TYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGV---FNKL 75
Query: 429 TELQYLDLSANKLSSSIPMSI-GNLLKLHYLNLSNNQFSHKIPTE-FEKLIHLSELDLSH 486
T L YL+LS N+L S+P + L +L L L+ NQ +P F+KL L +L L
Sbjct: 76 TSLTYLNLSTNQL-QSLPNGVFDKLTQLKELALNTNQLQ-SLPDGVFDKLTQLKDLRLYQ 133
Query: 487 NILQEEIPPQIC-KMESLEKLNLSHN 511
N L+ +P + ++ SL+ + L N
Sbjct: 134 NQLK-SVPDGVFDRLTSLQYIWLHDN 158
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 2e-09
Identities = 36/125 (28%), Positives = 55/125 (44%), Gaps = 4/125 (3%)
Query: 426 GTLTELQYLDLSANKLSSSIPMSIGNLLKLHYLNLSNNQFSHKIPTEFEKLIHLSELDLS 485
G + YLDL N L S L L L L N+ F KL L+ L+LS
Sbjct: 25 GIPAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLS 84
Query: 486 HNILQEEIPPQIC-KMESLEKLNLSHNNLSDFIPRCFEEMRSLSWIDISYNELQGPIPNS 544
N LQ +P + K+ L++L L+ N L F+++ L + + N+L+ +P+
Sbjct: 85 TNQLQ-SLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKS-VPDG 142
Query: 545 TAFKN 549
F
Sbjct: 143 -VFDR 146
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 2e-06
Identities = 40/130 (30%), Positives = 57/130 (43%), Gaps = 11/130 (8%)
Query: 169 QLDLSENRLSGLIPLSLSNLSSLTVMSLFNNSLSGSIPP-ILGNLKSLSTLGLHINQLNG 227
LDL N L L L+SLT + L N L S+P + L SL+ L L NQL
Sbjct: 32 YLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLPNGVFNKLTSLTYLNLSTNQLQ- 89
Query: 228 VIPPSI-GNLSSLRNLSLFNNRLYGFVPKEI-GYLKSLSKLEFCANHLSGVIPH----SV 281
+P + L+ L+ L+L N+L +P + L L L N L V P +
Sbjct: 90 SLPNGVFDKLTQLKELALNTNQL-QSLPDGVFDKLTQLKDLRLYQNQLKSV-PDGVFDRL 147
Query: 282 GNLTGLVLLN 291
+L + L +
Sbjct: 148 TSLQYIWLHD 157
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 3e-14
Identities = 60/279 (21%), Positives = 111/279 (39%), Gaps = 55/279 (19%)
Query: 654 IGKGGQRSVYKAE-LPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFH 712
+G+G V A + A+K +L ++ E+ L +RH +IIK +
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALKFISRQLL-KKSDMHMRVEREISYLKLLRHPHIIKLY 75
Query: 713 GFCSNAQHSFIVCEY---------LARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALS 763
+ +V EY + + +T +D + F Q + A+
Sbjct: 76 DVITTPTDIVMVIEYAGGELFDYIVEKKRMT----EDEGRRFFQ--Q-------IICAIE 122
Query: 764 YLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGTVGYAAPEL 823
Y H I VHRD+ +N+LLD ++DFG + + + T G+ YAAPE
Sbjct: 123 YCHRHKI---VHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKT-SCGSPNYAAPE- 177
Query: 824 AYTMRATEKY-----DVYSFGVLALEVIKGYHP--GDFVSTIFSSISNMIIEVNQILDHR 876
+ + Y DV+S G++ ++ G P +F+ +F +++ +
Sbjct: 178 ---VINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSC--------VYV 226
Query: 877 LPT-PSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914
+P S +R + +V +P R T++E+
Sbjct: 227 MPDFLSPGAQSLIRRM-------IVADPMQRITIQEIRR 258
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 74.4 bits (183), Expect = 5e-14
Identities = 67/277 (24%), Positives = 114/277 (41%), Gaps = 50/277 (18%)
Query: 654 IGKGGQRSVYKAE-LPSGNIFAVKKF-KAELFSDETANPSEFLNEVLALTEIRHRNIIKF 711
+G G V + +G+ AVK + ++ S + E+ L RH +IIK
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIR--REIQNLKLFRHPHIIKL 81
Query: 712 HGFCSNAQHSFIVCEYLARGSL------TTILRDDAAAKEFSWNQRMNVIKGVANALSYL 765
+ S F+V EY++ G L L + + + F Q + + + Y
Sbjct: 82 YQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQ--Q-------ILSGVDYC 132
Query: 766 HHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGTVGYAAPELAY 825
H + VHRD+ +NVLLD+ A ++DFG + + T G+ YAAPE
Sbjct: 133 HRHMV---VHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRT-SCGSPNYAAPE--- 185
Query: 826 TMRATEKY-----DVYSFGVLALEVIKGYHP--GDFVSTIFSSISNMIIEVNQILDHRLP 878
+ + Y D++S GV+ ++ G P D V T+F I + P
Sbjct: 186 -VISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDG--------IFYTP 236
Query: 879 T-PSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914
+ V L+ +++V +P R T+K++
Sbjct: 237 QYLNPSVISLLKHMLQV-------DPMKRATIKDIRE 266
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 73.3 bits (180), Expect = 1e-13
Identities = 57/235 (24%), Positives = 89/235 (37%), Gaps = 45/235 (19%)
Query: 654 IGKGGQRSVYKAEL-PSGNIFAVKKF-KAELFS-DETANPSEFLNEVLALTEIRHRNIIK 710
IG+G V +L + +FA+K K E+ ETA F E L + I
Sbjct: 82 IGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETAC---FREERDVLVNGDSKWITT 138
Query: 711 FHGFCSNAQHSFIVCEYLARGSLTTILR------DDAAAK----EFSWNQRMNVIKGVAN 760
H + + ++V +Y G L T+L + A+ E +
Sbjct: 139 LHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAE------------MVI 186
Query: 761 ALSYLH-HDCIPPIVHRDISSKNVLLDSEYEAHV--SDFGFAKFLEPHSSNWTE-FAGTV 816
A+ +H VHRDI N+L+D H+ +DFG L + + GT
Sbjct: 187 AIDSVHQLH----YVHRDIKPDNILMD--MNGHIRLADFGSCLKLMEDGTVQSSVAVGTP 240
Query: 817 GYAAPE-LAYTMRATEKY----DVYSFGVLALEVIKGYHP--GDFVSTIFSSISN 864
Y +PE L +Y D +S GV E++ G P + + + I N
Sbjct: 241 DYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMN 295
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 1e-13
Identities = 40/106 (37%), Positives = 57/106 (53%), Gaps = 3/106 (2%)
Query: 146 LFLYKNSLSGPIPSVIGNLKSLLQLDLSENRLSGLIPLSLSNLSSLTVMSLFNNSLSGSI 205
L+L N + +P + N K L +DLS NR+S L S SN++ L + L N L I
Sbjct: 36 LYLDGNQFTL-VPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLR-CI 93
Query: 206 PP-ILGNLKSLSTLGLHINQLNGVIPPSIGNLSSLRNLSLFNNRLY 250
PP LKSL L LH N ++ V + +LS+L +L++ N LY
Sbjct: 94 PPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLY 139
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 3e-13
Identities = 35/106 (33%), Positives = 49/106 (46%), Gaps = 3/106 (2%)
Query: 122 LDLSQNQLNGSIPCSLDNLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSENRLSGLI 181
L L NQ +P L N +L + L N +S N+ LL L LS NRL +
Sbjct: 36 LYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLRCIP 94
Query: 182 PLSLSNLSSLTVMSLFNNSLSGSIPP-ILGNLKSLSTLGLHINQLN 226
P + L SL ++SL N +S +P +L +LS L + N L
Sbjct: 95 PRTFDGLKSLRLLSLHGNDIS-VVPEGAFNDLSALSHLAIGANPLY 139
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 3e-11
Identities = 31/106 (29%), Positives = 47/106 (44%), Gaps = 5/106 (4%)
Query: 48 RRLYLDVNQLHGTIPPVIGQLSLINELVFCHNNVSGRIPSSLGNLSNLALLYLNDNSLFG 107
LYLD NQ +P + + + +N +S S N++ L L L+ N L
Sbjct: 34 TELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRL-R 91
Query: 108 SIPI-VMGNLKSLSTLDLSQNQLNGSIP-CSLDNLSNLDTLFLYKN 151
IP LKSL L L N ++ +P + ++LS L L + N
Sbjct: 92 CIPPRTFDGLKSLRLLSLHGNDIS-VVPEGAFNDLSALSHLAIGAN 136
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 3e-10
Identities = 37/143 (25%), Positives = 57/143 (39%), Gaps = 31/143 (21%)
Query: 2 LNLGFNLLFGNIPPQIGNLSKLQYLDLGNNQLSGVIPPEI-GKLNQLRRLYLDVNQLHGT 60
L L N +P ++ N L +DL NN++S + + + QL L L N+L
Sbjct: 36 LYLDGNQF-TLVPKELSNYKHLTLIDLSNNRIS-TLSNQSFSNMTQLLTLILSYNRLR-C 92
Query: 61 IPPVIGQLSLINELVFCHNNVSGRIPSSLGNLSNLALLYLNDNSLFGSIPI-VMGNLKSL 119
IPP F L +L LL L+ N + +P +L +L
Sbjct: 93 IPP----------RTF-------------DGLKSLRLLSLHGNDI-SVVPEGAFNDLSAL 128
Query: 120 STLDLSQNQLNGSIPCSLDNLSN 142
S L + N L C++ LS+
Sbjct: 129 SHLAIGANPLYCD--CNMQWLSD 149
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 2e-09
Identities = 28/83 (33%), Positives = 38/83 (45%), Gaps = 3/83 (3%)
Query: 409 KLILSLNQLFGGVPLEFGTLTELQYLDLSANKLSSSIPMSIGNLLKLHYLNLSNNQFSHK 468
+L L NQ VP E L +DLS N++S+ S N+ +L L LS N+
Sbjct: 35 ELYLDGNQF-TLVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLR-C 92
Query: 469 IPTE-FEKLIHLSELDLSHNILQ 490
IP F+ L L L L N +
Sbjct: 93 IPPRTFDGLKSLRLLSLHGNDIS 115
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 53.8 bits (130), Expect = 3e-08
Identities = 29/104 (27%), Positives = 46/104 (44%), Gaps = 10/104 (9%)
Query: 367 NNIYGSIPPEIGDSSKLQVLDLSSNHIFGKIPV----QLVKLFSLNKLILSLNQLFGGVP 422
N + +P E+ + L ++DLS+N I + + + L LILS N+L P
Sbjct: 40 GNQFTLVPKELSNYKHLTLIDLSNNRI-STLSNQSFSNMTQ---LLTLILSYNRLRCIPP 95
Query: 423 LEFGTLTELQYLDLSANKLSSSIPMSI-GNLLKLHYLNLSNNQF 465
F L L+ L L N + S +P +L L +L + N
Sbjct: 96 RTFDGLKSLRLLSLHGNDI-SVVPEGAFNDLSALSHLAIGANPL 138
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 8e-08
Identities = 30/93 (32%), Positives = 47/93 (50%), Gaps = 5/93 (5%)
Query: 458 LNLSNNQFSHKIPTEFEKLIHLSELDLSHNILQEEIPPQIC-KMESLEKLNLSHNNLSDF 516
L L NQF+ +P E HL+ +DLS+N + + Q M L L LS+N L
Sbjct: 36 LYLDGNQFT-LVPKELSNYKHLTLIDLSNNRIST-LSNQSFSNMTQLLTLILSYNRLRCI 93
Query: 517 IPRCFEEMRSLSWIDISYNELQGPIPNSTAFKN 549
PR F+ ++SL + + N++ +P AF +
Sbjct: 94 PPRTFDGLKSLRLLSLHGNDISV-VPEG-AFND 124
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 40.7 bits (96), Expect = 7e-04
Identities = 30/114 (26%), Positives = 49/114 (42%), Gaps = 11/114 (9%)
Query: 240 RNLSLFNNRLYGFVPKEIGYLKSLSKLEFCANHLSGVIPHSVGNLTGLVLLNMCENHLFG 299
L L N+ VPKE+ K L+ ++ N +S + S N+T L+ L + N L
Sbjct: 34 TELYLDGNQF-TLVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRL-- 90
Query: 300 PIPKSL-----RNLTSLERVRFNQNNLYGKVYEAFGDHPNLTFLDLSQNNFYCE 348
+ + L SL + + N++ AF D L+ L + N YC+
Sbjct: 91 ---RCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYCD 141
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 73.0 bits (179), Expect = 2e-13
Identities = 58/311 (18%), Positives = 102/311 (32%), Gaps = 51/311 (16%)
Query: 603 FFLFRRRKRDPQEKRSSSANPFGFFSVLNFNGKVLYEEITKATGNFGEKYCIGKGGQRSV 662
F + ++ + + N F ++ G+ G FGE V
Sbjct: 170 KFTRFCQWKNVELNIHLTMNDFSVHRII---GR----------GGFGE-----------V 205
Query: 663 YKAEL-PSGNIFAVKKF-KAELFSDETANPSEFLNE--VLALT-EIRHRNIIKFHGFCSN 717
Y +G ++A+K K + + + LNE +L+L I+
Sbjct: 206 YGCRKADTGKMYAMKCLDKKRIKMKQGETLA--LNERIMLSLVSTGDCPFIVCMSYAFHT 263
Query: 718 AQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRD 777
+ + + G L L FS + L ++H+ + V+RD
Sbjct: 264 PDKLSFILDLMNGGDLHYHLS---QHGVFSEADMRFYAAEIILGLEHMHNRFV---VYRD 317
Query: 778 ISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGTVGYAAPE-LAYTMRATEKYDVY 836
+ N+LLD +SD G A GT GY APE L + D +
Sbjct: 318 LKPANILLDEHGHVRISDLGLACDF-SKKKPHA-SVGTHGYMAPEVLQKGVAYDSSADWF 375
Query: 837 SFGVLALEVIKGYHP-GDFVSTIFSSISNMIIEVNQILDHRLPTPSRDVTDKLRSIMEVA 895
S G + ++++G+ P + I M + + L R + + L
Sbjct: 376 SLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGL------- 428
Query: 896 ILCLVENPEAR 906
L + R
Sbjct: 429 ---LQRDVNRR 436
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 71.8 bits (176), Expect = 3e-13
Identities = 43/192 (22%), Positives = 79/192 (41%), Gaps = 28/192 (14%)
Query: 650 EKYCIGKGGQRSVYKA---ELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHR 706
E +G+G VYKA + +A+K+ + E+ L E++H
Sbjct: 25 EGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI------SMSACREIALLRELKHP 78
Query: 707 NIIKFHG-FCSNAQHS-FIVCEYLARGSLTTILRDDAAAKEFSWNQRMN--VIKGVA--- 759
N+I F S+A +++ +Y L I++ A+K ++ ++K +
Sbjct: 79 NVISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQI 137
Query: 760 -NALSYLHHDCIPPIVHRDISSKNVLLDSEYEAH----VSDFGFAKFLEPHSSNWTEFAG 814
+ + YLH + ++HRD+ N+L+ E ++D GFA+ +
Sbjct: 138 LDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDP 194
Query: 815 ---TVGYAAPEL 823
T Y APEL
Sbjct: 195 VVVTFWYRAPEL 206
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 70.6 bits (173), Expect = 9e-13
Identities = 64/295 (21%), Positives = 113/295 (38%), Gaps = 56/295 (18%)
Query: 614 QEKRSSSANPFGFFSVLNFNGKVLYEEITKATGNFGEKY----CIGKGGQRSVYKA-ELP 668
S S F+SV E+ +T ++Y IG G Q V A +
Sbjct: 36 HYNMSKSKVDNQFYSV----------EVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAV 85
Query: 669 SGNIFAVKK----FKAELFSDETANPSEFLNEVLALTEIRHRNIIKFH------GFCSNA 718
A+KK F+ + + E++ + + H+NII
Sbjct: 86 LDRNVAIKKLSRPFQNQTHAKRA------YRELVLMKCVNHKNIISLLNVFTPQKTLEEF 139
Query: 719 QHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDI 778
Q ++V E + +L +++ E + ++ + + +LH I +HRD+
Sbjct: 140 QDVYLVMELMD-ANLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAGI---IHRDL 190
Query: 779 SSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGTVGYAAPELAYTMRATEKYDVYSF 838
N+++ S+ + DFG A+ S T + T Y APE+ M E D++S
Sbjct: 191 KPSNIVVKSDCTLKILDFGLARTAGT-SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSV 249
Query: 839 GVLALEVIKG--YHPG-DFVSTIFSSISNMIIEVNQILDHRLPTPSRDVTDKLRS 890
G + E+++ PG D++ N +IE L TP + KL+
Sbjct: 250 GCIMGEMVRHKILFPGRDYIDQW-----NKVIEQ-------LGTPCPEFMKKLQP 292
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 1e-12
Identities = 62/259 (23%), Positives = 102/259 (39%), Gaps = 27/259 (10%)
Query: 653 CIGKGGQRSVYKAEL-PSGNIFAVKKFKAELF--SDETANPSEFLNEVLALTEIRHRNII 709
+GKG V + +G +A+K K E+ DE A+ L E L RH +
Sbjct: 155 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAH---TLTENRVLQNSRHPFLT 211
Query: 710 KFHGFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDC 769
V EY G L L + + FS ++ + +AL YLH +
Sbjct: 212 ALKYSFQTHDRLCFVMEYANGGELFFHLSRE---RVFSEDRARFYGAEIVSALDYLHSEK 268
Query: 770 IPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGTVGYAAPELAYTMRA 829
+V+RD+ +N++LD + ++DFG K + F GT Y APE+
Sbjct: 269 --NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDY 326
Query: 830 TEKYDVYSFGVLALEVIKGYHP--GDFVSTIFSSISNMIIEVNQILDHRLPTPSRDVTDK 887
D + GV+ E++ G P +F IL + P R + +
Sbjct: 327 GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLF----------ELILMEEIRFP-RTLGPE 375
Query: 888 LRSIMEVAILCLVENPEAR 906
+S++ L ++P+ R
Sbjct: 376 AKSLLS---GLLKKDPKQR 391
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 69.1 bits (170), Expect = 1e-12
Identities = 72/251 (28%), Positives = 113/251 (45%), Gaps = 34/251 (13%)
Query: 654 IGKGGQRSVYKAEL-PSGNIFAVKKF-KAELFS-DETANPSEFLNEVLALTEIRHRNIIK 710
+G G V+ +G +A+K K + + + +E L L+ + H II+
Sbjct: 14 LGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEH---TNDERLMLSIVTHPFIIR 70
Query: 711 FHGFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNV-IKGVANALSYLH-HD 768
G +AQ F++ +Y+ G L ++LR ++ F N V AL YLH D
Sbjct: 71 MWGTFQDAQQIFMIMDYIEGGELFSLLRK---SQRFP-NPVAKFYAAEVCLALEYLHSKD 126
Query: 769 CIPPIVHRDISSKNVLLDSEYEAHV--SDFGFAKFLEPHSSNWTEFAGTVGYAAPELAYT 826
I++RD+ +N+LLD H+ +DFGFAK +T GT Y APE+ T
Sbjct: 127 ----IIYRDLKPENILLD--KNGHIKITDFGFAK--YVPDVTYT-LCGTPDYIAPEVVST 177
Query: 827 MRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTP---SRD 883
+ D +SFG+L E++ GY P F + M +IL+ L P + D
Sbjct: 178 KPYNKSIDWWSFGILIYEMLAGYTP-------FYDSNTMKT-YEKILNAELRFPPFFNED 229
Query: 884 VTDKLRSIMEV 894
V D L ++
Sbjct: 230 VKDLLSRLITR 240
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 2e-12
Identities = 45/179 (25%), Positives = 77/179 (43%), Gaps = 13/179 (7%)
Query: 650 EKY-CIGKGGQRS---VYKA-ELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIR 704
EKY +G G+ S V K +G I A+KKF D+ + E+ L ++R
Sbjct: 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLES--DDDKMVKKIAMREIKLLKQLR 82
Query: 705 HRNIIKFHGFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSY 764
H N++ C + ++V E++ ++ L + + + + N + +
Sbjct: 83 HENLVNLLEVCKKKKRWYLVFEFVDH-TILDDL--ELFPNGLDYQVVQKYLFQIINGIGF 139
Query: 765 LHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGTVGYAAPEL 823
H I +HRDI +N+L+ + DFGFA+ L + + T Y APEL
Sbjct: 140 CHSHNI---IHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPEL 195
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 68.8 bits (168), Expect = 2e-12
Identities = 38/164 (23%), Positives = 67/164 (40%), Gaps = 20/164 (12%)
Query: 758 VANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGT-- 815
VA + +L +HRD++++N+LL + + DFG A+ + ++
Sbjct: 202 VAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIY-KDPDYVRKGDARL 257
Query: 816 -VGYAAPELAYTMRATEKYDVYSFGVLALEVIK-GYHPGDFVSTIFSSISNMIIEVNQIL 873
+ + APE + T + DV+SFGVL E+ G P + + ++
Sbjct: 258 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP-------YPGVKIDEEFCRRLK 310
Query: 874 D-HRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLL 916
+ R+ P T ++ M C P RPT E+ L
Sbjct: 311 EGTRMRAP-DYTTPEMYQTML---DCWHGEPSQRPTFSELVEHL 350
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 2e-12
Identities = 40/130 (30%), Positives = 59/130 (45%), Gaps = 28/130 (21%)
Query: 24 QYLDLGNNQLSGVIPPEIGKLNQLRRLYLDVNQLHGTIPPVIGQLSLINELVFCHNNVSG 83
L+L +N+L + KL QL +L L NQ+ ++P G VF
Sbjct: 31 TRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQ-SLPD--G--------VFDK----- 74
Query: 84 RIPSSLGNLSNLALLYLNDNSLFGSIPI-VMGNLKSLSTLDLSQNQLNGSIP-CSLDNLS 141
L+ L +LYL++N L S+P V L L L L NQL S+P D L+
Sbjct: 75 --------LTKLTILYLHENKL-QSLPNGVFDKLTQLKELALDTNQLK-SVPDGIFDRLT 124
Query: 142 NLDTLFLYKN 151
+L ++L+ N
Sbjct: 125 SLQKIWLHTN 134
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 61.5 bits (150), Expect = 5e-11
Identities = 34/108 (31%), Positives = 47/108 (43%), Gaps = 2/108 (1%)
Query: 141 SNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSENRLSGLIPLSLSNLSSLTVMSLFNNS 200
S+ L L N L V L L +L LS+N++ L L+ LT++ L N
Sbjct: 28 SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENK 87
Query: 201 LSGSIPP-ILGNLKSLSTLGLHINQLNGVIPPSIGNLSSLRNLSLFNN 247
L S+P + L L L L NQL V L+SL+ + L N
Sbjct: 88 LQ-SLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 134
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 55.3 bits (134), Expect = 6e-09
Identities = 35/109 (32%), Positives = 51/109 (46%), Gaps = 4/109 (3%)
Query: 429 TELQYLDLSANKLSSSIPMSIGNLLKLHYLNLSNNQFSHKIPTEFEKLIHLSELDLSHNI 488
+ L+L +NKL S L +L L+LS NQ F+KL L+ L L N
Sbjct: 28 SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENK 87
Query: 489 LQEEIPPQIC-KMESLEKLNLSHNNLSDFIPR-CFEEMRSLSWIDISYN 535
LQ +P + K+ L++L L N L +P F+ + SL I + N
Sbjct: 88 LQ-SLPNGVFDKLTQLKELALDTNQLKS-VPDGIFDRLTSLQKIWLHTN 134
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 8e-09
Identities = 41/120 (34%), Positives = 53/120 (44%), Gaps = 10/120 (8%)
Query: 372 SIPPEIGDSSKLQVLDLSSNHIFGKIPVQLVKLFSLNKLILSLNQLFG---GVPLEFGTL 428
S+P I S L+L SN + KL L KL LS NQ+ GV F L
Sbjct: 21 SVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGV---FDKL 75
Query: 429 TELQYLDLSANKLSSSIPMSI-GNLLKLHYLNLSNNQFSHKIPTEFEKLIHLSELDLSHN 487
T+L L L NKL S+P + L +L L L NQ F++L L ++ L N
Sbjct: 76 TKLTILYLHENKL-QSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 134
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 53.4 bits (129), Expect = 3e-08
Identities = 36/130 (27%), Positives = 53/130 (40%), Gaps = 28/130 (21%)
Query: 48 RRLYLDVNQLHGTIPPVIGQLSLINELVFCHNNVSGRIPSSLGNLSNLALLYLNDNSLFG 107
RL L+ N+L ++P VF L+ L L L+ N +
Sbjct: 31 TRLELESNKLQ-SLPHG----------VFDK-------------LTQLTKLSLSQNQI-Q 65
Query: 108 SIPI-VMGNLKSLSTLDLSQNQLNGSIPCSL-DNLSNLDTLFLYKNSLSGPIPSVIGNLK 165
S+P V L L+ L L +N+L S+P + D L+ L L L N L + L
Sbjct: 66 SLPDGVFDKLTKLTILYLHENKLQ-SLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLT 124
Query: 166 SLLQLDLSEN 175
SL ++ L N
Sbjct: 125 SLQKIWLHTN 134
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 45.3 bits (108), Expect = 2e-05
Identities = 25/94 (26%), Positives = 43/94 (45%), Gaps = 4/94 (4%)
Query: 457 YLNLSNNQFSHKIPTEFEKLIHLSELDLSHNILQEEIPPQIC-KMESLEKLNLSHNNLSD 515
L L +N+ F+KL L++L LS N +Q +P + K+ L L L N L
Sbjct: 32 RLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQS-LPDGVFDKLTKLTILYLHENKLQS 90
Query: 516 FIPRCFEEMRSLSWIDISYNELQGPIPNSTAFKN 549
F+++ L + + N+L+ +P+ F
Sbjct: 91 LPNGVFDKLTQLKELALDTNQLKS-VPDG-IFDR 122
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 2e-04
Identities = 22/58 (37%), Positives = 32/58 (55%), Gaps = 4/58 (6%)
Query: 2 LNLGFNLLFGNIPPQI-GNLSKLQYLDLGNNQLSGVIPPEI-GKLNQLRRLYLDVNQL 57
L+L N + ++P + L+KL L L N+L +P + KL QL+ L LD NQL
Sbjct: 57 LSLSQNQI-QSLPDGVFDKLTKLTILYLHENKLQ-SLPNGVFDKLTQLKELALDTNQL 112
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 67.2 bits (165), Expect = 4e-12
Identities = 41/171 (23%), Positives = 73/171 (42%), Gaps = 9/171 (5%)
Query: 654 IGKGGQRSVYKA-ELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFH 712
IG+G V+K +G I A+KKF D+ L E+ L +++H N++
Sbjct: 11 IGEGSYGVVFKCRNRDTGQIVAIKKFLES--EDDPVIKKIALREIRMLKQLKHPNLVNLL 68
Query: 713 GFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPP 772
+ +V EY ++ L D + + ++ A+++ H
Sbjct: 69 EVFRRKRRLHLVFEYCDH-TVLHEL--DRYQRGVPEHLVKSITWQTLQAVNFCHKHNC-- 123
Query: 773 IVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGTVGYAAPEL 823
+HRD+ +N+L+ + DFGFA+ L S + + T Y +PEL
Sbjct: 124 -IHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPEL 173
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 67.8 bits (165), Expect = 4e-12
Identities = 21/102 (20%), Positives = 34/102 (33%), Gaps = 4/102 (3%)
Query: 439 NKLSSSIPMSIGNLLKLHYLNLSNNQFSHKIPTE-FEKLIHLSELDLSHNILQEEIPPQI 497
+ + L L + N Q + L L L + + L + P
Sbjct: 17 RDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGL-RFVAPDA 75
Query: 498 -CKMESLEKLNLSHNNLSDFIPRCFEEMRSLSWIDISYNELQ 538
L +LNLS N L + + + SL + +S N L
Sbjct: 76 FHFTPRLSRLNLSFNALESLSWKTVQGL-SLQELVLSGNPLH 116
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 59.8 bits (144), Expect = 1e-09
Identities = 24/128 (18%), Positives = 40/128 (31%), Gaps = 26/128 (20%)
Query: 75 VFCHNNVSGRIPSSLGNLSNLALLYLNDNSLFGSIP-IVMGNLKSLSTLDLSQNQLNGSI 133
+ C + + L NL LY+ + + + L L L + ++ L +
Sbjct: 13 LRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FV 71
Query: 134 PCSLDNLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSENRLSGLIPLSLSNLSSLTV 193
P L +L+LS N L L ++ L SL
Sbjct: 72 A-----------------------PDAFHFTPRLSRLNLSFNALESLSWKTVQGL-SLQE 107
Query: 194 MSLFNNSL 201
+ L N L
Sbjct: 108 LVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 57.8 bits (139), Expect = 6e-09
Identities = 20/101 (19%), Positives = 35/101 (34%), Gaps = 2/101 (1%)
Query: 127 NQLNGSIPCSLDNLSNLDTLFLYKNSLSGPIPS-VIGNLKSLLQLDLSENRLSGLIPLSL 185
L NL L++ + + L L L + ++ L + P +
Sbjct: 17 RDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAF 76
Query: 186 SNLSSLTVMSLFNNSLSGSIPPILGNLKSLSTLGLHINQLN 226
L+ ++L N+L S+ SL L L N L+
Sbjct: 77 HFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLH 116
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 57.4 bits (138), Expect = 9e-09
Identities = 30/160 (18%), Positives = 48/160 (30%), Gaps = 9/160 (5%)
Query: 397 IPVQLVKLFSLNKLILSLNQLFGGVPLE-FGTLTELQYLDLSANKLSSSIPMSIGNLLKL 455
L +L +L + Q + L L EL+ L + + L P + +L
Sbjct: 23 SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRL 82
Query: 456 HYLNLSNNQFSHKIPTEFEKLIHLSELDLSHNILQEEIPPQICKMESLEKLNLSHNNLSD 515
LNLS N + L L EL LS N L C + L++
Sbjct: 83 SRLNLSFNALESLSWKTVQGL-SLQELVLSGNPLHCS-----CALRWLQRWEEEGLGGVP 136
Query: 516 FIPRCFEEMRSLSWIDISYNELQGPIPNSTAFKNGLMEGN 555
L+ + + P + G+
Sbjct: 137 EQKLQCHGQGPLAHMPNAS--CGVPTLKVQVPNASVDVGD 174
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 57.1 bits (137), Expect = 1e-08
Identities = 13/78 (16%), Positives = 30/78 (38%), Gaps = 1/78 (1%)
Query: 462 NNQFSHKIPTEFEKLIHLSELDLSHNILQEEIPPQ-ICKMESLEKLNLSHNNLSDFIPRC 520
+ +L+EL + + + + + + + L L + + L P
Sbjct: 16 TRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDA 75
Query: 521 FEEMRSLSWIDISYNELQ 538
F LS +++S+N L+
Sbjct: 76 FHFTPRLSRLNLSFNALE 93
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 54.7 bits (131), Expect = 7e-08
Identities = 21/101 (20%), Positives = 31/101 (30%), Gaps = 4/101 (3%)
Query: 55 NQLHGTIPPVIGQLSLINELVFCHNNVSGRIPS-SLGNLSNLALLYLNDNSLFGSIPI-V 112
+ + EL + + L L L L + + L +
Sbjct: 17 RDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGL-RFVAPDA 75
Query: 113 MGNLKSLSTLDLSQNQLNGSIPCSLDNLSNLDTLFLYKNSL 153
LS L+LS N L ++ LS L L L N L
Sbjct: 76 FHFTPRLSRLNLSFNALESLSWKTVQGLS-LQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 53.6 bits (128), Expect = 1e-07
Identities = 23/120 (19%), Positives = 38/120 (31%), Gaps = 26/120 (21%)
Query: 12 NIPPQIGNLSKLQYLDLGNNQLSGVIPPE-IGKLNQLRRLYLDVNQLHGTIPPVIGQLSL 70
+ + L L + N Q + + L +LR L + + L +
Sbjct: 22 DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVA-------- 72
Query: 71 INELVFCHNNVSGRIPSSLGNLSNLALLYLNDNSLFGSIPIVMGNLKSLSTLDLSQNQLN 130
P + L+ L L+ N+L S+ SL L LS N L+
Sbjct: 73 ---------------PDAFHFTPRLSRLNLSFNAL-ESLSWKTVQGLSLQELVLSGNPLH 116
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 50.5 bits (120), Expect = 1e-06
Identities = 23/100 (23%), Positives = 34/100 (34%), Gaps = 2/100 (2%)
Query: 175 NRLSGLIPLSLSNLSSLTVMSLFNNSLSGSIPP-ILGNLKSLSTLGLHINQLNGVIPPSI 233
+ L +LT + + N + L L L L + + L V P +
Sbjct: 17 RDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAF 76
Query: 234 GNLSSLRNLSLFNNRLYGFVPKEIGYLKSLSKLEFCANHL 273
L L+L N L K + L SL +L N L
Sbjct: 77 HFTPRLSRLNLSFNALESLSWKTVQGL-SLQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 49.7 bits (118), Expect = 2e-06
Identities = 20/119 (16%), Positives = 35/119 (29%), Gaps = 24/119 (20%)
Query: 229 IPPSIGNLSSLRNLSLFNNRLYGFVPKEIGYLKSLSKLEFCANHLSGVIPHSVGNLTGLV 288
+ +L L + N HL + + L L
Sbjct: 23 SLHHLPGAENLTELYIENQ-----------------------QHLQHLELRDLRGLGELR 59
Query: 289 LLNMCENHLFGPIPKSLRNLTSLERVRFNQNNLYGKVYEAFGDHPNLTFLDLSQNNFYC 347
L + ++ L P + L R+ + N L ++ +L L LS N +C
Sbjct: 60 NLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTV-QGLSLQELVLSGNPLHC 117
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 46.3 bits (109), Expect = 3e-05
Identities = 15/71 (21%), Positives = 28/71 (39%), Gaps = 3/71 (4%)
Query: 2 LNLGFNLLFGNIPPQ-IGNLSKLQYLDLGNNQLSGVIPPEI-GKLNQLRRLYLDVNQLHG 59
L + ++ + + L +L+ L + + L + P+ +L RL L N L
Sbjct: 36 LYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPDAFHFTPRLSRLNLSFNALES 94
Query: 60 TIPPVIGQLSL 70
+ LSL
Sbjct: 95 LSWKTVQGLSL 105
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 45.9 bits (108), Expect = 4e-05
Identities = 22/101 (21%), Positives = 38/101 (37%), Gaps = 2/101 (1%)
Query: 198 NNSLSGSIPPILGNLKSLSTLGLHINQLNGVIPP-SIGNLSSLRNLSLFNNRLYGFVPKE 256
+ L ++L+ L + Q + + L LRNL++ + L P
Sbjct: 16 TRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDA 75
Query: 257 IGYLKSLSKLEFCANHLSGVIPHSVGNLTGLVLLNMCENHL 297
+ LS+L N L + +V L+ L L + N L
Sbjct: 76 FHFTPRLSRLNLSFNALESLSWKTVQGLS-LQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 45.5 bits (107), Expect = 6e-05
Identities = 24/126 (19%), Positives = 37/126 (29%), Gaps = 26/126 (20%)
Query: 269 CANHLSGVIPHSVGNLTGLVLLNMCENHLFGPIPK-SLRNLTSLERVRFNQNNLYGKVYE 327
C + H + L L + + LR L L + ++ L +
Sbjct: 15 CTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPD 74
Query: 328 AFGDHPNLTFLDLSQNNFYCEISFNWRNFSKLGTFNASMNNIYGSIPPEIGDSSKLQVLD 387
AF P L+ L+LS N S+ + LQ L
Sbjct: 75 AFHFTPRLSRLNLSFNAL-------------------------ESLSWKTVQGLSLQELV 109
Query: 388 LSSNHI 393
LS N +
Sbjct: 110 LSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 43.6 bits (102), Expect = 2e-04
Identities = 19/127 (14%), Positives = 35/127 (27%), Gaps = 28/127 (22%)
Query: 293 CENHLFGPIPKSLRNLTSLERVRFNQNNLYGKV-YEAFGDHPNLTFLDLSQNNFYCEISF 351
C L +L + + L L + ++
Sbjct: 15 CTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGL------ 68
Query: 352 NWRNFSKLGTFNASMNNIYGSIPPEIGDS-SKLQVLDLSSNHIFGKIPVQLVKLFSLNKL 410
+ P+ +L L+LS N + + + V+ SL +L
Sbjct: 69 -------------------RFVAPDAFHFTPRLSRLNLSFNAL-ESLSWKTVQGLSLQEL 108
Query: 411 ILSLNQL 417
+LS N L
Sbjct: 109 VLSGNPL 115
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 8e-12
Identities = 54/280 (19%), Positives = 89/280 (31%), Gaps = 43/280 (15%)
Query: 633 NGKVLYEEITKATGNFGEKY----CIGKGGQRSVYKAELPSGNIFAVKKFKAELFSDETA 688
G+ ++ Y I G +V G A+K+ + T
Sbjct: 5 KGEAAMRDLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTV 64
Query: 689 NPSEFLNEVLA---------LTEIRHRNIIK-FHGFCSNAQHSF----IVCEYLARGSLT 734
N + L L H NI+ F + + +V E + L
Sbjct: 65 NI--LSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLA 121
Query: 735 TILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVS 794
++ S + + L LH +VHRD+ N+LL + +
Sbjct: 122 QVIH--DQRIVISPQHIQYFMYHILLGLHVLHE---AGVVHRDLHPGNILLADNNDITIC 176
Query: 795 DFGFAKFLEPHSSNWTEFAGTVGYAAPELAYT-MRATEKYDVYSFGVLALEVIKG--YHP 851
DF A+ +N T + Y APEL T+ D++S G + E+
Sbjct: 177 DFNLAREDTA-DANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFR 235
Query: 852 G-DFVSTIFSSISNMIIEVNQILDHRLPTPSRDVTDKLRS 890
G F + + N I+EV + TP + S
Sbjct: 236 GSTFYNQL-----NKIVEV-------VGTPKIEDVVMFSS 263
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 8e-12
Identities = 30/107 (28%), Positives = 50/107 (46%), Gaps = 3/107 (2%)
Query: 122 LDLSQNQLNGSIPCSL-DNLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSENRLSGL 180
L L+ N+L L L +L L L +N L+G P+ + +L L EN++ +
Sbjct: 34 LLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEI 93
Query: 181 IPLSLSNLSSLTVMSLFNNSLSGSIPP-ILGNLKSLSTLGLHINQLN 226
L L ++L++N +S + P +L SL++L L N N
Sbjct: 94 SNKMFLGLHQLKTLNLYDNQIS-CVMPGSFEHLNSLTSLNLASNPFN 139
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 2e-11
Identities = 33/106 (31%), Positives = 54/106 (50%), Gaps = 3/106 (2%)
Query: 144 DTLFLYKNSLSG-PIPSVIGNLKSLLQLDLSENRLSGLIPLSLSNLSSLTVMSLFNNSLS 202
L L N L + G L L++L+L N+L+G+ P + S + + L N +
Sbjct: 32 TELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIK 91
Query: 203 GSIPP-ILGNLKSLSTLGLHINQLNGVIPPSIGNLSSLRNLSLFNN 247
I + L L TL L+ NQ++ V+P S +L+SL +L+L +N
Sbjct: 92 -EISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASN 136
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 1e-09
Identities = 37/145 (25%), Positives = 54/145 (37%), Gaps = 33/145 (22%)
Query: 2 LNLGFNLLFGNIPPQ--IGNLSKLQYLDLGNNQLSGVIPPEI-GKLNQLRRLYLDVNQLH 58
L L N L G I G L L L+L NQL+G I P + ++ L L N++
Sbjct: 34 LLLNDNEL-GRISSDGLFGRLPHLVKLELKRNQLTG-IEPNAFEGASHIQELQLGENKIK 91
Query: 59 GTIPPVIGQLSLINELVFCHNNVSGRIPSSLGNLSNLALLYLNDNSLFGSIPI-VMGNLK 117
I +F L L L L DN + + +L
Sbjct: 92 -EISN--K--------MF-------------LGLHQLKTLNLYDNQI-SCVMPGSFEHLN 126
Query: 118 SLSTLDLSQNQLNGSIPCSLDNLSN 142
SL++L+L+ N N + C L +
Sbjct: 127 SLTSLNLASNPFNCN--CHLAWFAE 149
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 3e-09
Identities = 37/123 (30%), Positives = 55/123 (44%), Gaps = 15/123 (12%)
Query: 372 SIPPEIGDSSKLQVLDLSSNHIFGKIPVQLV--KLFSLNKLILSLNQ---LFGGVPLEFG 426
IP +I + L L+ N + G+I + +L L KL L NQ + F
Sbjct: 22 EIPRDIPLHT--TELLLNDNEL-GRISSDGLFGRLPHLVKLELKRNQLTGIEPNA---FE 75
Query: 427 TLTELQYLDLSANKLSSSIPMSI-GNLLKLHYLNLSNNQFSHKIPTE-FEKLIHLSELDL 484
+ +Q L L NK+ I + L +L LNL +NQ S + FE L L+ L+L
Sbjct: 76 GASHIQELQLGENKI-KEISNKMFLGLHQLKTLNLYDNQIS-CVMPGSFEHLNSLTSLNL 133
Query: 485 SHN 487
+ N
Sbjct: 134 ASN 136
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 1e-06
Identities = 25/106 (23%), Positives = 44/106 (41%), Gaps = 12/106 (11%)
Query: 367 NNIYGSIPPE-IGDS-SKLQVLDLSSNHIFGKIPVQLV-KLFSLNKLILSLNQLF---GG 420
+N G I + + L L+L N + I + +L L N++
Sbjct: 38 DNELGRISSDGLFGRLPHLVKLELKRNQL-TGIEPNAFEGASHIQELQLGENKIKEISNK 96
Query: 421 VPLEFGTLTELQYLDLSANKLSSSIPMSI-GNLLKLHYLNLSNNQF 465
+ F L +L+ L+L N++S + +L L LNL++N F
Sbjct: 97 M---FLGLHQLKTLNLYDNQISC-VMPGSFEHLNSLTSLNLASNPF 138
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 1e-06
Identities = 21/96 (21%), Positives = 46/96 (47%), Gaps = 7/96 (7%)
Query: 457 YLNLSNNQFSHKIPTE--FEKLIHLSELDLSHNILQEEIPPQIC-KMESLEKLNLSHNNL 513
L L++N+ +I ++ F +L HL +L+L N L I P +++L L N +
Sbjct: 33 ELLLNDNELG-RISSDGLFGRLPHLVKLELKRNQLTG-IEPNAFEGASHIQELQLGENKI 90
Query: 514 SDFIPRCFEEMRSLSWIDISYNELQGPIPNSTAFKN 549
+ + F + L +++ N++ + +F++
Sbjct: 91 KEISNKMFLGLHQLKTLNLYDNQISC-VMPG-SFEH 124
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 3e-11
Identities = 63/254 (24%), Positives = 101/254 (39%), Gaps = 48/254 (18%)
Query: 654 IGKGGQRSVYKA-ELPSGNIFAVKK----FKAELFSDETANPSEFLNEVLALTEIRHRNI 708
IG G Q V A + A+KK F+ + + E++ + + H+NI
Sbjct: 33 IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRA------YRELVLMKCVNHKNI 86
Query: 709 IK-FHGFCSNAQHS-----FIVCEYLARGSLTTILR---DDAAAKEFSWNQRMNVIKGVA 759
I + F +IV E + +L +++ D + Q + IK
Sbjct: 87 IGLLNVFTPQKSLEEFQDVYIVMELMD-ANLCQVIQMELDHERMSYLLY-QMLCGIK--- 141
Query: 760 NALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGTVGYA 819
+LH I+HRD+ N+++ S+ + DFG A+ S T + T Y
Sbjct: 142 ----HLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT-SFMMTPYVVTRYYR 193
Query: 820 APELAYTMRATEKYDVYSFGVLALEVIKG--YHPG-DFVSTIFSSISNMIIEVNQILDHR 876
APE+ M E D++S G + E+IKG PG D + N +IE
Sbjct: 194 APEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQW-----NKVIEQ------- 241
Query: 877 LPTPSRDVTDKLRS 890
L TP + KL+
Sbjct: 242 LGTPCPEFMKKLQP 255
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 64.1 bits (157), Expect = 4e-11
Identities = 41/163 (25%), Positives = 77/163 (47%), Gaps = 8/163 (4%)
Query: 662 VYKA-ELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQH 720
VYKA +G + A+KK + + ++ PS + E+ L E+ H NI+K
Sbjct: 19 VYKARNKLTGEVVALKKIRLDTETEGV--PSTAIREISLLKELNHPNIVKLLDVIHTENK 76
Query: 721 SFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISS 780
++V E+L + L + D +A + + + L++ H + +HRD+
Sbjct: 77 LYLVFEFLHQ-DLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCHSHRV---LHRDLKP 131
Query: 781 KNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGTVGYAAPEL 823
+N+L+++E ++DFG A+ +T T+ Y APE+
Sbjct: 132 QNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEI 174
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 63.7 bits (156), Expect = 5e-11
Identities = 47/170 (27%), Positives = 82/170 (48%), Gaps = 8/170 (4%)
Query: 654 IGKGGQRSVYKAELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHG 713
IG+G VYKA+ G FA+KK + E + PS + E+ L E++H NI+K +
Sbjct: 10 IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGI--PSTTIREISILKELKHSNIVKLYD 67
Query: 714 FCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPI 773
+ +V E+L + L +L D + + + N ++Y H +
Sbjct: 68 VIHTKKRLVLVFEHLDQ-DLKKLL--DVCEGGLESVTAKSFLLQLLNGIAYCHDRRV--- 121
Query: 774 VHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGTVGYAAPEL 823
+HRD+ +N+L++ E E ++DFG A+ +T T+ Y AP++
Sbjct: 122 LHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDV 171
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 63.8 bits (156), Expect = 5e-11
Identities = 37/167 (22%), Positives = 74/167 (44%), Gaps = 13/167 (7%)
Query: 662 VYKA-ELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQH 720
VYK +G A+K+ K + E PS + E+ + E++H NI++ +
Sbjct: 21 VYKGLNKTTGVYVALKEVKLD---SEEGTPSTAIREISLMKELKHENIVRLYDVIHTENK 77
Query: 721 SFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVA----NALSYLHHDCIPPIVHR 776
+V E++ L + D +N++K L++ H + I +HR
Sbjct: 78 LTLVFEFMDN-DLKKYM-DSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKI---LHR 132
Query: 777 DISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGTVGYAAPEL 823
D+ +N+L++ + + DFG A+ + ++ T+ Y AP++
Sbjct: 133 DLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPDV 179
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592 | Back alignment and structure |
|---|
Score = 65.0 bits (158), Expect = 7e-11
Identities = 73/485 (15%), Positives = 157/485 (32%), Gaps = 57/485 (11%)
Query: 74 LVFCHNNVSGRIPSSLGNLSNLALLYLNDNSLFGSIPIVMG------------NLKSLST 121
+ C+ R+ NL +L L ++F IP G NL+ L +
Sbjct: 57 MALCYTATPDRLSRRFPNLRSLKLKGKPRAAMFNLIPENWGGYVTPWVTEISNNLRQLKS 116
Query: 122 LDLSQNQL--NGSIPCSLDNLSNLDTLFLYKNSL--SGPIPSVIGNLKSLLQLDLSENRL 177
+ + + + +L+TL L K S + + S++ + + + L + E+
Sbjct: 117 VHFRRMIVSDLDLDRLAKARADDLETLKLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSF 176
Query: 178 SGLIPLSLS----NLSSLTVMSLFNNSLSG----SIPPILGNLKSLSTLGL-HINQLNGV 228
S L + +SL V++ + + + I N +SL ++ + L V
Sbjct: 177 SEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEILELV 236
Query: 229 -IPPSIGNLSSLRNLSLFNNRLYGFVPKEIGYLKSLSKLEFCANHLSGVIPHSVGNLTGL 287
+ NL SL + + + + L +L + +P +
Sbjct: 237 GFFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMGPNE-MPILFPFAAQI 295
Query: 288 VLLNMCENHLFGP-IPKSLRNLTSLERVRFNQNNLYGKVYEAFGDH-PNLTFLDLSQNNF 345
L++ L ++ +LE + +N + + E + L L + +
Sbjct: 296 RKLDLLYALLETEDHCTLIQKCPNLEVLET-RNVIGDRGLEVLAQYCKQLKRLRIERGAD 354
Query: 346 YCEISFNWRNFSKLGTFNASMNNIYGSIPPEIGDSSKLQVLDLSSNHI----FGKIPVQL 401
+ S+ G + +L+ + + + I I L
Sbjct: 355 EQGMEDEEGLVSQRGLIALAQGC------------QELEYMAVYVSDITNESLESIGTYL 402
Query: 402 VKLFSLNKLILSLNQLFGGVPLEFG------TLTELQYLDLSAN--KLSSSIPMSIGNLL 453
L ++L + +PL+ G +L+ L+ IG
Sbjct: 403 KNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLRQGGLTDLGLSYIGQYS 462
Query: 454 K-LHYLNLSNNQFSHK-IPTEFEKLIHLSELDLSH-NILQEEIPPQICKMESLEKLNLSH 510
+ ++ L S + + +L +L++ + I + K+ SL L +
Sbjct: 463 PNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSERAIAAAVTKLPSLRYLWVQG 522
Query: 511 NNLSD 515
S
Sbjct: 523 YRASM 527
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 63.8 bits (156), Expect = 7e-11
Identities = 42/178 (23%), Positives = 76/178 (42%), Gaps = 19/178 (10%)
Query: 654 IGKG--GQRSVYKA-ELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIK 710
+G+G G+ VYKA + + A+K+ + L +E P + EV L E++HRNII+
Sbjct: 42 LGEGTYGE--VYKAIDTVTNETVAIKRIR--LEHEEEGVPGTAIREVSLLKELQHRNIIE 97
Query: 711 FHGFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCI 770
+ ++ EY L + + S + + + N +++ H
Sbjct: 98 LKSVIHHNHRLHLIFEYAEN-DLKKYMDK---NPDVSMRVIKSFLYQLINGVNFCHSRR- 152
Query: 771 PPIVHRDISSKNVLLDSEYEAH-----VSDFGFAKFLEPHSSNWTEFAGTVGYAAPEL 823
+HRD+ +N+LL + + DFG A+ +T T+ Y PE+
Sbjct: 153 --CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYRPPEI 208
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 63.3 bits (155), Expect = 7e-11
Identities = 41/170 (24%), Positives = 81/170 (47%), Gaps = 8/170 (4%)
Query: 654 IGKGGQRSVYKAELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHG 713
+G+G VYKA+ G I A+K+ + + + PS + E+ L E+ H NI+
Sbjct: 29 VGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGI--PSTAIREISLLKELHHPNIVSLID 86
Query: 714 FCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPI 773
+ + +V E++ + L +L D +Q + + +++ H I
Sbjct: 87 VIHSERCLTLVFEFMEK-DLKKVL--DENKTGLQDSQIKIYLYQLLRGVAHCHQHRI--- 140
Query: 774 VHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGTVGYAAPEL 823
+HRD+ +N+L++S+ ++DFG A+ ++T T+ Y AP++
Sbjct: 141 LHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDV 190
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 63.4 bits (155), Expect = 8e-11
Identities = 64/266 (24%), Positives = 106/266 (39%), Gaps = 44/266 (16%)
Query: 654 IGKGGQRSVYKAEL-PSGNIFAVKKFKAELF--SDETANPSEFLNEVLALTEIRHRNIIK 710
+GKG V +G +A+K + E+ DE A+ + E L RH +
Sbjct: 13 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHT---VTESRVLQNTRHPFLTA 69
Query: 711 FHGFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLH-HDC 769
V EY G L L + + F+ + + +AL YLH D
Sbjct: 70 LKYAFQTHDRLCFVMEYANGGELFFHLSRE---RVFTEERARFYGAEIVSALEYLHSRD- 125
Query: 770 IPPIVHRDISSKNVLLDSEYEAHV--SDFGFAK-FLEPHSSNWTEFAGTVGYAAPEL--- 823
+V+RDI +N++LD + H+ +DFG K + ++ T F GT Y APE+
Sbjct: 126 ---VVYRDIKLENLMLDK--DGHIKITDFGLCKEGISDGATMKT-FCGTPEYLAPEVLED 179
Query: 824 -AYTMRATEKYDVYSFGVLALEVIKGYHP--GDFVSTIFSSISNMIIEVNQILDHRLPTP 880
Y D + GV+ E++ G P +F IL + P
Sbjct: 180 NDYGRAV----DWWGLGVVMYEMMCGRLPFYNQDHERLF----------ELILMEEIRFP 225
Query: 881 SRDVTDKLRSIMEVAILCLVENPEAR 906
R ++ + +S++ L ++P+ R
Sbjct: 226 -RTLSPEAKSLLA---GLLKKDPKQR 247
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 62.5 bits (153), Expect = 1e-10
Identities = 34/163 (20%), Positives = 74/163 (45%), Gaps = 9/163 (5%)
Query: 662 VYKA-ELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQH 720
V+KA + I A+K+ + + + PS L E+ L E++H+NI++ H + +
Sbjct: 18 VFKAKNRETHEIVALKRVRLDDDDEGV--PSSALREICLLKELKHKNIVRLHDVLHSDKK 75
Query: 721 SFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISS 780
+V E+ + L D+ + + + + L + H + +HRD+
Sbjct: 76 LTLVFEFCDQ-DLKKYF--DSCNGDLDPEIVKSFLFQLLKGLGFCHSRNV---LHRDLKP 129
Query: 781 KNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGTVGYAAPEL 823
+N+L++ E +++FG A+ ++ T+ Y P++
Sbjct: 130 QNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDV 172
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 64.1 bits (155), Expect = 2e-10
Identities = 90/550 (16%), Positives = 176/550 (32%), Gaps = 162/550 (29%)
Query: 43 KLNQLRR-LY-LDVNQ---LHGTIPPVIGQLSLINELVFCHNNVSGRIPSSLGNLSNLAL 97
+LR+ L L + + G V+G SG+ + +AL
Sbjct: 136 PYLKLRQALLELRPAKNVLIDG----VLG---------------SGK--------TWVAL 168
Query: 98 LYLNDNSLFGSIP-----IVMGNLKSLSTLDLSQNQLNGSIPCSLDNLSNLDTLFLYKNS 152
+ + + + N S T+ +L I + + S+ + +
Sbjct: 169 DVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSS------N 222
Query: 153 LSGPIPSVIGNLKSLLQLDLSENRLSGLIPLSLSNLSSLTVMSLFNNSLSGSIPPILGNL 212
+ I S+ L+ LL+ EN L L+ L N+ + + FN S IL
Sbjct: 223 IKLRIHSIQAELRRLLKSKPYENCL--LV---LLNVQNAKAWNAFNLSC-----KIL--- 269
Query: 213 KSLSTLGLHI-NQLNGVIPPSIGNLSSLRNLSLFNNRLYGFVPKEIGYLKSLSKLEFCAN 271
L+T + + L+ ++SL ++ P E S L +
Sbjct: 270 --LTTRFKQVTDFLSAATT---------THISL-DHHSMTLTPDE-----VKSLLLKYLD 312
Query: 272 HLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLRN-LTSLERVRFNQNNLYGKVYEAFG 330
+P V T L++ I +S+R+ L + + + + + E+
Sbjct: 313 CRPQDLPREV-LTTNPRRLSI--------IAESIRDGLATWDNWKHVNCDKLTTIIESSL 363
Query: 331 DHPNLTFLDLSQNNFYCEISFNWRNFSKLGTFNASMNNIYGSIPPEIGDSSKLQVL--DL 388
+ L + + F +L F S + IP + L ++ D+
Sbjct: 364 N--VLEPAEYRKM------------FDRLSVFPPSAH-----IPTIL-----LSLIWFDV 399
Query: 389 SSNHIFGKIPVQLVKLFSLNK----LILSLNQLFGGVPLEFGTLTEL------QYL---- 434
+ + + +L K + K +S+ ++ + ++ L Y
Sbjct: 400 IKSDVM-VVVNKLHKYSLVEKQPKESTISIPSIYLELKVKLENEYALHRSIVDHYNIPKT 458
Query: 435 ----DLSANKLSSSIPMSIG------------NLLKLHYLNLSNNQFSHKIPTEF--EKL 476
DL L IG L ++ +L+ F +K+
Sbjct: 459 FDSDDLIPPYLDQYFYSHIGHHLKNIEHPERMTLFRMVFLDFR-----------FLEQKI 507
Query: 477 IHLSELDLSH----NILQ--EEIPPQICKMESLEKLNLSHNNLSDFIPRCFEEMRSLSWI 530
H S + N LQ + P IC + + + N + DF+P+ E + +
Sbjct: 508 RHDSTAWNASGSILNTLQQLKFYKPYICDNDPKYERLV--NAILDFLPKIEENLICSKYT 565
Query: 531 DISYNELQGP 540
D+ L
Sbjct: 566 DLLRIALMAE 575
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 62.2 bits (150), Expect = 7e-10
Identities = 88/720 (12%), Positives = 191/720 (26%), Gaps = 230/720 (31%)
Query: 271 NHL---SGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLRNLTSLERVR--FNQNNLYGKV 325
+H+ +G + ++ + +N + +++ S E + +
Sbjct: 5 HHMDFETGEHQYQYKDILSVFEDAFVDNFDCKDVQDMPKSILSKEEIDHIIMSKDAVSGT 64
Query: 326 YEAFGDHPNLTFLDLSQNNFY-------CEISFNWRNFSKLGTFNASMNNIYGSIPPEIG 378
F L Q I++ + + I E
Sbjct: 65 LRLFW------TLLSKQEEMVQKFVEEVLRINYKF---------------LMSPIKTEQR 103
Query: 379 DSSKLQVLDLS-------SNHIFGKIPVQLVKLF-SLNKLILSLNQ-----LFG--GVPL 423
S + + + N +F K V ++ + L + +L L + G G
Sbjct: 104 QPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLG--- 160
Query: 424 EFG--TLTELQYLD-LSANKLSSSIPMSIGNLLKLHYLNLSNNQFSHKIPTEFEKLIHLS 480
G + LD + K+ + I +LNL N + +KL++
Sbjct: 161 -SGKTWVA----LDVCLSYKVQCKMDFKI------FWLNLKNCNSPETVLEMLQKLLYQI 209
Query: 481 ELDLSHNILQEEIPPQICKMESLEKLNL----SHNN----LSD---------FIPRCFEE 523
+ + + E L + N L + F C
Sbjct: 210 DPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWNAFNLSC--- 266
Query: 524 MRSL------SWIDISYNELQGPIPNSTAFKNGLMEGN-KGLCGNF-----KALPSCDAF 571
+ L D I L K L + + LP +
Sbjct: 267 -KILLTTRFKQVTDFLSAATTTHIS-LDHHSMTLTPDEVKSLLLKYLDCRPQDLPR-EVL 323
Query: 572 TSHKQTFRKKWVVIALPILGMVVLLIGLIGFFFLFRRRKRDPQEKRSSSANPFGFFSVLN 631
T++ P + +I RD + +
Sbjct: 324 TTN-------------P------RRLSIIA------ESIRD-------------GLATWD 345
Query: 632 FNGKVLYEEITKATGNFGEKYCIGKGGQRSVYKAELPSGNIFAVKKFKAELFSDETANPS 691
V +++T + + R ++ +V F P+
Sbjct: 346 NWKHVNCDKLTTIIESSLN--VLEPAEYRKMFDR-------LSV-------FPPSAHIPT 389
Query: 692 EFLNEVLAL--TEIRHRNIIKFHGFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWN 749
+L+L ++ +++ +V + L + SL + + KE +
Sbjct: 390 I----LLSLIWFDVIKSDVMV------------VVNK-LHKYSL--VEKQ---PKEST-- 425
Query: 750 QRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAH---VSDFGFAKFLEPH- 805
+ ++ ++ K L++EY H V + K +
Sbjct: 426 -------------ISIPS------IYLELKVK---LENEYALHRSIVDHYNIPKTFDSDD 463
Query: 806 -SSNWTEFAGTVGYAAPELAYTMRATEKYD-------VY-SFGVLALEVIKGYHPGDFVS 856
+ + Y + + ++ E + V+ F L ++ +
Sbjct: 464 LIPPYLD-----QYFYSHIGHHLKNIEHPERMTLFRMVFLDFRFLEQKIRHDSTAWNASG 518
Query: 857 TIFSSISNMIIEVNQILDHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLL 916
+I +++ + I D+ P R V IL + E + +LL
Sbjct: 519 SILNTLQQLKFYKPYICDND-PKYERLVNA---------ILDFLPKIEENLICSKYTDLL 568
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 60.3 bits (145), Expect = 3e-09
Identities = 72/486 (14%), Positives = 145/486 (29%), Gaps = 116/486 (23%)
Query: 209 LGNLKSLSTLGLHINQLNGVIPPSIGNLSSLRNLSLFNNRLYGFVPKEIGYLKSLSKLEF 268
L L+ + + GV G + + + ++ + +I +L
Sbjct: 144 LLELRPAKNVLID-----GV--LGSGK-TWVALDVCLSYKVQCKMDFKIFWL-------- 187
Query: 269 CANHLSGVIPHSVGNL-TGLVLLNMCENHLFGPIPKSLRNLTSLERVRFNQNNLYGKVYE 327
++ N + +L M + L+ P ++ +++ ++
Sbjct: 188 -----------NLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRR 236
Query: 328 AFG--DHPN-LTFLDLSQN-------NFYCEISFNWRNFSKLGTFNASMNNIYGSIPPEI 377
+ N L L QN N C+I R + I +
Sbjct: 237 LLKSKPYENCLLVLLNVQNAKAWNAFNLSCKILLTTRFKQ---VTDFLSAATTTHISLDH 293
Query: 378 GDS--SKLQVLDLSS---NHIFGKIPVQLVKLFSLNKLILSLNQLFGGVPLEFGTLTELQ 432
+ +V L + +P +++ N LS+ + +
Sbjct: 294 HSMTLTPDEVKSLLLKYLDCRPQDLPREVLTT---NPRRLSI---IAESIRDGLATWD-N 346
Query: 433 YLDLSANKLSSSIPMSIGNL----LKLHYLNLSNNQFSHKIPTEFEKLIHLSELDLSHNI 488
+ ++ +KL++ I S+ L + + LS + F H+ + LS +
Sbjct: 347 WKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLS-------V---FPPSAHIPTILLS--L 394
Query: 489 LQEEIPPQICK--MESLEKLNLSHNNLSDFIPRCFEEMRSLSWIDISYNELQGPIPNSTA 546
+ ++ + L K +L + ++S I Y EL+ + N A
Sbjct: 395 IWFDVIKSDVMVVVNKLHKYSLVEKQPKES---------TISIPSI-YLELKVKLENEYA 444
Query: 547 FKNGLME---GNKGLCGNFKALPSCDA-FTSHKQTFRKKWVVIALPILGMVVLLIGLIGF 602
+++ K + P D F SH +G + I
Sbjct: 445 LHRSIVDHYNIPKTFDSDDLIPPYLDQYFYSH---------------IGHHLKNIEHPER 489
Query: 603 FFLFRRRKRD---PQEK-RSSSANPFGFFSVLN------------FNGKVLYEEITKATG 646
LFR D ++K R S S+LN + YE + A
Sbjct: 490 MTLFRMVFLDFRFLEQKIRHDSTAWNASGSILNTLQQLKFYKPYICDNDPKYERLVNAIL 549
Query: 647 NFGEKY 652
+F K
Sbjct: 550 DFLPKI 555
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 2e-10
Identities = 60/271 (22%), Positives = 112/271 (41%), Gaps = 48/271 (17%)
Query: 639 EEITKATGNFGEKY----CIGKGGQRSVYKA-ELPSGNIFAVKK----FKAELFSDETAN 689
+E+TK Y +G G +V A + +G A+KK F++ELF+
Sbjct: 14 QEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRA-- 71
Query: 690 PSEFLNEVLALTEIRHRNIIKFH------GFCSNAQHSFIVCEYLARGSLTTILRDDAAA 743
E+ L +RH N+I + ++V ++ L +++
Sbjct: 72 ----YRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMK----H 122
Query: 744 KEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLE 803
++ ++ ++ + L Y+H I+HRD+ N+ ++ + E + DFG A+ +
Sbjct: 123 EKLGEDRIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQAD 179
Query: 804 PHSSNWTEFAGTVGYAAPELAYT-MRATEKYDVYSFGVLALEVIKG--YHPG-DFVSTIF 859
T + T Y APE+ MR T+ D++S G + E+I G G D + +
Sbjct: 180 S---EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQL- 235
Query: 860 SSISNMIIEVNQILDHRLPTPSRDVTDKLRS 890
I++V TP + +L+S
Sbjct: 236 ----KEIMKV-------TGTPPAEFVQRLQS 255
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 61.8 bits (151), Expect = 3e-10
Identities = 67/264 (25%), Positives = 104/264 (39%), Gaps = 39/264 (14%)
Query: 654 IGKGGQRSVYKAEL-PSGNIFAVKKFKAE--LFSDETANP-SEFLNEVLALTEIRHRNII 709
+GKG V+ AE + FA+K K + L D+ E VL+L H +
Sbjct: 25 LGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVE--KRVLSLA-WEHPFLT 81
Query: 710 KFHGFCS-NAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLH-H 767
++ F V EYL G L ++ +F ++ + L +LH
Sbjct: 82 HMF-CTFQTKENLFFVMEYLNGGDLMYHIQS---CHKFDLSRATFYAAEIILGLQFLHSK 137
Query: 768 DCIPPIVHRDISSKNVLLDSEYEAHV--SDFGFAK-FLEPHSSNWTEFAGTVGYAAPELA 824
IV+RD+ N+LLD + H+ +DFG K + + T F GT Y APE+
Sbjct: 138 G----IVYRDLKLDNILLDK--DGHIKIADFGMCKENMLGDAKTNT-FCGTPDYIAPEIL 190
Query: 825 YTMRATEKYDVYSFGVLALEVIKGYHP--GDFVSTIFSSISNMIIEVNQILDHRLPTPSR 882
+ D +SFGVL E++ G P G +F + I P R
Sbjct: 191 LGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELF----------HSIRMDNPFYP-R 239
Query: 883 DVTDKLRSIMEVAILCLVENPEAR 906
+ + + ++ V PE R
Sbjct: 240 WLEKEAKDLLVK---LFVREPEKR 260
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 61.5 bits (150), Expect = 3e-10
Identities = 41/171 (23%), Positives = 77/171 (45%), Gaps = 10/171 (5%)
Query: 654 IGKGGQRSVYKA-ELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFH 712
+G+G +VYK + N+ A+K+ + E E P + EV L +++H NI+ H
Sbjct: 10 LGEGTYATVYKGKSKLTDNLVALKEIRLE---HEEGAPCTAIREVSLLKDLKHANIVTLH 66
Query: 713 GFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPP 772
+ +V EYL + L L D + + + + L+Y H +
Sbjct: 67 DIIHTEKSLTLVFEYLDK-DLKQYL--DDCGNIINMHNVKLFLFQLLRGLAYCHRQKV-- 121
Query: 773 IVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGTVGYAAPEL 823
+HRD+ +N+L++ E ++DFG A+ + + T+ Y P++
Sbjct: 122 -LHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVVTLWYRPPDI 171
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 62.7 bits (152), Expect = 3e-10
Identities = 62/260 (23%), Positives = 106/260 (40%), Gaps = 31/260 (11%)
Query: 654 IGKGGQRSVYKAEL-PSGNIFAVKKF-KAELFSDETANPSEFLNEVLALTEIRHRNIIKF 711
+GKG V +E + ++AVK K + D+ + VLAL + + +
Sbjct: 349 LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALP-GKPPFLTQL 407
Query: 712 HGFCS-NAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCI 770
H C + V EY+ G L ++ F + +A L +L
Sbjct: 408 H-SCFQTMDRLYFVMEYVNGGDLMYHIQQV---GRFKEPHAVFYAAEIAIGLFFLQSK-- 461
Query: 771 PPIVHRDISSKNVLLDSEYEAHV--SDFGFAKFLEPHSSNWTEFAGTVGYAAPELAYTMR 828
I++RD+ NV+LDS E H+ +DFG K F GT Y APE+
Sbjct: 462 -GIIYRDLKLDNVMLDS--EGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQP 518
Query: 829 ATEKYDVYSFGVLALEVIKGYHP--GDFVSTIFSSISNMIIEVNQILDHRLPTPSRDVTD 886
+ D ++FGVL E++ G P G+ +F I++H + P + ++
Sbjct: 519 YGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELF----------QSIMEHNVAYP-KSMSK 567
Query: 887 KLRSIMEVAILCLVENPEAR 906
+ +I + + ++P R
Sbjct: 568 EAVAICKG---LMTKHPGKR 584
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 3e-10
Identities = 49/201 (24%), Positives = 87/201 (43%), Gaps = 35/201 (17%)
Query: 638 YEEITKATGNFGEKYCIGKG--GQRSVYKA-ELPSGNIFAVKKFKAELFSDETANPSEFL 694
YE++ K IG+G G+ V+KA +G A+KK E +++ P L
Sbjct: 19 YEKLAK----------IGQGTFGE--VFKARHRKTGQKVALKKVLME--NEKEGFPITAL 64
Query: 695 NEVLALTEIRHRNIIKFHGFCSNAQHS--------FIVCEYLARGSLTTILRDDAAAKEF 746
E+ L ++H N++ C ++V ++ L +L +F
Sbjct: 65 REIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLL--SNVLVKF 121
Query: 747 SWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFA-KFLEPH 805
+ ++ V++ + N L Y+H + I +HRD+ + NVL+ + ++DFG A F
Sbjct: 122 TLSEIKRVMQMLLNGLYYIHRNKI---LHRDMKAANVLITRDGVLKLADFGLARAFSLAK 178
Query: 806 SSNWTEFAGTVG---YAAPEL 823
+S + V Y PEL
Sbjct: 179 NSQPNRYTNRVVTLWYRPPEL 199
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 61.5 bits (150), Expect = 3e-10
Identities = 58/255 (22%), Positives = 104/255 (40%), Gaps = 51/255 (20%)
Query: 654 IGKGGQRSVYKA-ELPSGNIFAVKK----FKAELFSDETANPSEFLNEVLALTEIRHRNI 708
+G G SV A + SG A+KK F++E+F+ E+L L ++H N+
Sbjct: 32 VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRA------YRELLLLKHMQHENV 85
Query: 709 IKFH------GFCSNAQHSFIVCEYLARGSLTTILR---DDAAAKEFSWNQRMNVIKGVA 759
I N ++V ++ L I+ + + + Q ++KG
Sbjct: 86 IGLLDVFTPASSLRNFYDFYLVMPFMQT-DLQKIMGLKFSEEKIQYLVY-Q---MLKG-- 138
Query: 760 NALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGTVGYA 819
L Y+H +VHRD+ N+ ++ + E + DFG A+ + T + T Y
Sbjct: 139 --LKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGLARHADA---EMTGYVVTRWYR 190
Query: 820 APELAYT-MRATEKYDVYSFGVLALEVIKG--YHPG-DFVSTIFSSISNMIIEVNQILDH 875
APE+ + M + D++S G + E++ G G D++ + I++V
Sbjct: 191 APEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQL-----TQILKV------ 239
Query: 876 RLPTPSRDVTDKLRS 890
P + KL
Sbjct: 240 -TGVPGTEFVQKLND 253
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 4e-10
Identities = 64/262 (24%), Positives = 102/262 (38%), Gaps = 56/262 (21%)
Query: 654 IGKGGQRSVYKA-ELPSGNIFAVKKFKAELFSD-ETANPSEFLNEVLALTEIRHRNIIK- 710
G+G +V E +G A+KK + D N L + L + H NI++
Sbjct: 31 AGQGTFGTVQLGKEKSTGMSVAIKK----VIQDPRFRNRE--LQIMQDLAVLHHPNIVQL 84
Query: 711 FHGFCSNAQHSF------IVCEYLARGSLTTILRDDAAAKEFSWNQRMNV--IKG----V 758
F + + +V EY+ +L R+ IK +
Sbjct: 85 QSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRR-----QVAPPPILIKVFLFQL 138
Query: 759 ANALSYLHHDCIPPIVHRDISSKNVLLD-SEYEAHVSDFGFAKFLEPHSSNWTEFAGTVG 817
++ LH + + HRDI NVL++ ++ + DFG AK L P N + +
Sbjct: 139 IRSIGCLHLPSV-NVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPN-VAYICSRY 196
Query: 818 YAAPELAYTMRATEKY----DVYSFG-VLALEVIKGYH--PGDFVSTIFSSIS--NMIIE 868
Y APEL + + Y D++S G + A E++ G GD +S + I+
Sbjct: 197 YRAPEL---IFGNQHYTTAVDIWSVGCIFA-EMMLGEPIFRGD------NSAGQLHEIVR 246
Query: 869 VNQILDHRLPTPSRDVTDKLRS 890
V L PSR+V KL
Sbjct: 247 V-------LGCPSREVLRKLNP 261
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 4e-10
Identities = 65/309 (21%), Positives = 105/309 (33%), Gaps = 81/309 (26%)
Query: 634 GKVLYEEITKATGNFGEKY-----CIGKGGQRSVYKA-ELPSGNIFAVKKF-KAELFSDE 686
G + + + Y +G G V + + FA+K
Sbjct: 1 GPHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKAR-- 58
Query: 687 TANPSEFLNEVLALTEI-RHRNIIKFHGFCSNA----QHSFIVCEYLARGSL-TTILRDD 740
EV + +I++ N + IV E L G L + I D
Sbjct: 59 --------REVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQ--D 108
Query: 741 AAAKEFSWNQRMNVIKGVANALSYLH-HDCIPPIVHRDISSKNVLLDSEYEAH---VSDF 796
+ F+ + ++K + A+ YLH + I HRD+ +N+L S+ ++DF
Sbjct: 109 RGDQAFTEREASEIMKSIGEAIQYLHSIN----IAHRDVKPENLLYTSKRPNAILKLTDF 164
Query: 797 GFAKFLEPHSSNWTEFAGTVGYAAPELAYTMRATEKY----DVYSFGVLALEVIKGYHPG 852
GFA E EKY D++S GV+ ++ GY P
Sbjct: 165 GFA---------------------KETT-----GEKYDKSCDMWSLGVIMYILLCGYPP- 197
Query: 853 DFVSTIFSSISNMIIEVNQIL--DHRLPTP-----SRDVTDKLRSIMEVAILCLVENPEA 905
F S +IS + +I + P P S +V +R+ L P
Sbjct: 198 -FYSNHGLAISPGMKT--RIRMGQYEFPNPEWSEVSEEVKMLIRN-------LLKTEPTQ 247
Query: 906 RPTMKEVCN 914
R T+ E N
Sbjct: 248 RMTITEFMN 256
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 5e-10
Identities = 58/271 (21%), Positives = 110/271 (40%), Gaps = 48/271 (17%)
Query: 639 EEITKATGNFGEKY----CIGKGGQRSVYKA-ELPSGNIFAVKK----FKAELFSDETAN 689
+E+ K E+Y +G G SV A + +G AVKK F++ + + T
Sbjct: 18 QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT-- 75
Query: 690 PSEFLNEVLALTEIRHRNIIKFH------GFCSNAQHSFIVCEYLARGSLTTILRDDAAA 743
E+ L ++H N+I ++V + L I++
Sbjct: 76 ----YRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVK----C 126
Query: 744 KEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLE 803
++ + + +I + L Y+H I+HRD+ N+ ++ + E + DFG A+
Sbjct: 127 QKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR--- 180
Query: 804 PHSSNWTEFAGTVGYAAPELAYT-MRATEKYDVYSFGVLALEVIKG--YHPG-DFVSTIF 859
+ T + T Y APE+ M + D++S G + E++ G PG D + +
Sbjct: 181 HTADEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQL- 239
Query: 860 SSISNMIIEVNQILDHRLPTPSRDVTDKLRS 890
+I+ + + TP ++ K+ S
Sbjct: 240 ----KLILRL-------VGTPGAELLKKISS 259
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 60.3 bits (147), Expect = 7e-10
Identities = 51/214 (23%), Positives = 86/214 (40%), Gaps = 38/214 (17%)
Query: 623 PFGFFSVLNFNGKVLYEEITKATGNFGEKYCIGKG--GQRSVYKA-ELPSGNIFAVKKFK 679
P G + YE + + IG G G VYKA + SG+ A+K +
Sbjct: 2 PLGSMATSR------YEPVAE----------IGVGAYGT--VYKARDPHSGHFVALKSVR 43
Query: 680 AELFSDETAN-PSEFLNEVLALTEIR---HRNIIK----FHGFCSNAQHS-FIVCEYLAR 730
P + EV L + H N+++ ++ + +V E++ +
Sbjct: 44 VPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ 103
Query: 731 GSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYE 790
L T L D A ++++ L +LH +CI VHRD+ +N+L+ S
Sbjct: 104 -DLRTYL-DKAPPPGLPAETIKDLMRQFLRGLDFLHANCI---VHRDLKPENILVTSGGT 158
Query: 791 AHVSDFGFAK-FLEPHSSNWTEFAGTVGYAAPEL 823
++DFG A+ + T T+ Y APE+
Sbjct: 159 VKLADFGLARIYSYQM--ALTPVVVTLWYRAPEV 190
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 7e-10
Identities = 62/259 (23%), Positives = 108/259 (41%), Gaps = 54/259 (20%)
Query: 654 IGKGGQRSVYKA-ELPSGNIFAVKKFKAELFSDETANPSEF----LNEVLALTEIRHRNI 708
IG+G V A + + A+KK F +T + L E+ L RH NI
Sbjct: 35 IGEGAYGMVCSAYDNLNKVRVAIKKISP--FEHQT-----YCQRTLREIKILLRFRHENI 87
Query: 709 IK-FHGFCSNAQHSF----IVCEY----LARGSLTTILRDDAAAKEFSWNQRMNVIKGVA 759
I + IV + L + T L +D F + Q +++G
Sbjct: 88 IGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI-CYFLY-Q---ILRG-- 140
Query: 760 NALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSN---WTEFAGTV 816
L Y+H ++HRD+ N+LL++ + + DFG A+ +P + TE+ T
Sbjct: 141 --LKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 195
Query: 817 GYAAPELAYT-MRATEKYDVYSFG-VLALEVIKG--YHPG-DFVSTIFSSISNMIIEVNQ 871
Y APE+ T+ D++S G +LA E++ PG ++ + N I+ +
Sbjct: 196 WYRAPEIMLNSKGYTKSIDIWSVGCILA-EMLSNRPIFPGKHYLDQL-----NHILGI-- 247
Query: 872 ILDHRLPTPSRDVTDKLRS 890
L +PS++ + + +
Sbjct: 248 -----LGSPSQEDLNCIIN 261
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 1e-09
Identities = 47/269 (17%), Positives = 89/269 (33%), Gaps = 55/269 (20%)
Query: 306 RNLTSLERVRFNQNNLYGKVYEAFGD-----HPNLTFLDLSQNNFYCEISFNWRNFSKLG 360
S+ + + N+L K + N+T L+LS N ++++ +L
Sbjct: 48 NTPASVTSLNLSGNSLGFKNSDELVQILAAIPANVTSLNLSGNFL------SYKSSDELV 101
Query: 361 TFNASMNNIYGSIPPEIGDSSKLQVLDLSSNHIFGKIPVQLVKLF-----SLNKLILSLN 415
A++ + VLDL N K + + F S+ L L N
Sbjct: 102 KTLAAIP-------------FTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGN 148
Query: 416 QL--FGGVPLEFGTLTE---LQYLDLSANKLSSSIPMSIGNLLK-----LHYLNLSNNQF 465
L L + L+L N L+S + L + L+LS N
Sbjct: 149 DLGIKSSDELIQILAAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLL 208
Query: 466 SHKIPTEFEKLI-----HLSELDLSHNILQEEIPPQICKME----SLEKLNLSHNNLSDF 516
K E + H+ L+L N L + ++ L+ + L ++ + +
Sbjct: 209 GLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNM 268
Query: 517 IPRC-------FEEMRSLSWIDISYNELQ 538
F ++ + +D + E+
Sbjct: 269 SKEQCKALGAAFPNIQKIILVDKNGKEIH 297
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 2e-07
Identities = 61/383 (15%), Positives = 119/383 (31%), Gaps = 86/383 (22%)
Query: 157 IPSVIGNLKSLLQLDLSENRLS--GLIPLS---LSNLSSLTVMSLFNNSLS----GSIPP 207
+ + LDLS N L + L + +S+T ++L NSL +
Sbjct: 14 VEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQ 73
Query: 208 IL-GNLKSLSTLGLHINQLNGVIPPSIGNL-----SSLRNLSLFNNRLYGFVPKEIGYLK 261
IL ++++L L N L+ + ++ L L N
Sbjct: 74 ILAAIPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFS----------- 122
Query: 262 SLSKLEFCANHLSGVIPHSVGNLTGLVLLNMCENHLFGP-----IPKSLRNL-TSLERVR 315
++ + + LN+ N L G + + L + ++ +
Sbjct: 123 -----SKSSSEFKQAFSN---LPASITSLNLRGNDL-GIKSSDELIQILAAIPANVNSLN 173
Query: 316 FNQNNLYGKVYEAFGD-----HPNLTFLDLSQNNFYCEISFNWRNFSKLGTFNASMNNIY 370
NNL K ++T LDLS N + ++++L +S+
Sbjct: 174 LRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLK------SYAELAYIFSSIP--- 224
Query: 371 GSIPPEIGDSSKLQVLDLSSNHIFGKIPVQLVKLFSLNK----LILSLNQL--FGGVPLE 424
+ + L+L N + G L L K + L + + +
Sbjct: 225 ----------NHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCK 274
Query: 425 -----FGTLTELQYLDLSANKLSSSIPMSIGNLLK-----LHYLNLSNN-----QFSHKI 469
F + ++ +D + ++ S + I NL++ +L N Q
Sbjct: 275 ALGAAFPNIQKIILVDKNGKEIHPSHSIPISNLIRELSGKADVPSLLNQCLIFAQKHQTN 334
Query: 470 PTEFEKLIHLSELDLSHNILQEE 492
+ L E + L E
Sbjct: 335 IEDLNIPDELRESIQTCKPLLEH 357
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 3e-07
Identities = 45/268 (16%), Positives = 88/268 (32%), Gaps = 57/268 (21%)
Query: 19 NLSKLQYLDLGNNQLSGVIPPEIGKL-----NQLRRLYLDVNQLHGTIPPVIGQLSLINE 73
+ + L+L N L E+ ++ + L L N L L+
Sbjct: 49 TPASVTSLNLSGNSLGFKNSDELVQILAAIPANVTSLNLSGNFLS-----YKSSDELVKT 103
Query: 74 LVFCHNNVSGRIPSSLGNLSNLALLYLNDNSL--FGSIPIVMG---NLKSLSTLDLSQNQ 128
L + +L L N S S+++L+L N
Sbjct: 104 LAAIP--------------FTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGND 149
Query: 129 LNGSIPCSL------DNLSNLDTLFLYKNSLSGP----IPSVIGNL-KSLLQLDLSENRL 177
L G +N+++L L N+L+ + + ++ S+ LDLS N L
Sbjct: 150 L-GIKSSDELIQILAAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLL 208
Query: 178 --SGLIPLS---LSNLSSLTVMSLFNNSLSGS----IPPILGNLKSLSTLGLHINQLNGV 228
L+ S + + ++L N L G + + +LK L T+ L + + +
Sbjct: 209 GLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNM 268
Query: 229 -------IPPSIGNLSSLRNLSLFNNRL 249
+ + N+ + + +
Sbjct: 269 SKEQCKALGAAFPNIQKIILVDKNGKEI 296
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 3e-07
Identities = 57/373 (15%), Positives = 116/373 (31%), Gaps = 72/373 (19%)
Query: 98 LYLNDNSLFGSIPI--VMGNLKSLSTLDLSQNQLNGSIPCSL-----DNLSNLDTLFLYK 150
+ GS P+ +++LDLS N L L + +++ +L L
Sbjct: 1 MNYKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSG 60
Query: 151 NSLSGPIPSVIG-----NLKSLLQLDLSENRLS--GLIPLS---LSNLSSLTVMSLFNNS 200
NSL + ++ L+LS N LS L + ++TV+ L N
Sbjct: 61 NSLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWND 120
Query: 201 LSGSIPPILGNL-----KSLSTLGLHINQLNGVIPPSIGNL-----SSLRNLSLFNNRLY 250
S S+++L L N L + + +++ +L+L N L
Sbjct: 121 FSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLA 180
Query: 251 GFVPKEIGYLKSLSKLEFCANHLSGVIPHSVGNLTGLVLLNMCENHL----FGPIPKSLR 306
L+ + ++T L++ N L + +
Sbjct: 181 ----------------SKNCAELAKFLASIPASVT---SLDLSANLLGLKSYAELAYIFS 221
Query: 307 -NLTSLERVRFNQNNLYGK----VYEAFGDHPNLTFLDLSQNNF-------YCEISFNWR 354
+ + N L+G + +L + L + + +
Sbjct: 222 SIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFP 281
Query: 355 NFSKLGTFNASMNNIYGSIPPEIGDS-----SKLQVLDLSSNHIF----GKIPVQLVKLF 405
N K+ + + I+ S I + K V L + + + ++ + +
Sbjct: 282 NIQKIILVDKNGKEIHPSHSIPISNLIRELSGKADVPSLLNQCLIFAQKHQTNIEDLNIP 341
Query: 406 S-LNKLILSLNQL 417
L + I + L
Sbjct: 342 DELRESIQTCKPL 354
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 5e-07
Identities = 35/179 (19%), Positives = 66/179 (36%), Gaps = 39/179 (21%)
Query: 380 SSKLQVLDLSSNHIFGKIPVQLVKLFSLNKLILSLNQLFGGVPLEFGTLTELQYLDLSAN 439
+ LDLS N+++ V+L++ F+ + L+LS N
Sbjct: 21 PHGVTSLDLSLNNLYSISTVELIQAFANTP-------------------ASVTSLNLSGN 61
Query: 440 KLSSSIPMSIGNLLK-----LHYLNLSNNQFSHKIPTEFEKLI-----HLSELDLSHNIL 489
L + +L + LNLS N S+K E K + ++ LDL N
Sbjct: 62 SLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDF 121
Query: 490 QEEIPPQICKM-----ESLEKLNLSHNNLSD----FIPRCFEEM-RSLSWIDISYNELQ 538
+ + + S+ LNL N+L + + + +++ +++ N L
Sbjct: 122 SSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLA 180
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 59.5 bits (145), Expect = 1e-09
Identities = 67/265 (25%), Positives = 111/265 (41%), Gaps = 38/265 (14%)
Query: 653 CIGKGGQRSVYKAELP----SGNIFAVKKF-KAELFSDETANPSEFLNEVLALTEIRHRN 707
+G+G V+ + + ++A+K KA L + E L E+ H
Sbjct: 31 VLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRV---RTKMERDILVEVNHPF 87
Query: 708 IIKFHGFC-SNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLH 766
I+K H + +++ ++L G L T L + F+ + +A AL +LH
Sbjct: 88 IVKLH-YAFQTEGKLYLILDFLRGGDLFTRLSKE---VMFTEEDVKFYLAELALALDHLH 143
Query: 767 -HDCIPPIVHRDISSKNVLLDSEYEAHV--SDFGFAKFLEPHSSNWTEFAGTVGYAAPEL 823
I++RD+ +N+LLD E H+ +DFG +K H F GTV Y APE+
Sbjct: 144 SLG----IIYRDLKPENILLD--EEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEV 197
Query: 824 AYTMRATEKYDVYSFGVLALEVIKGYHP--GDFVSTIFSSISNMIIEVNQILDHRLPTPS 881
T+ D +SFGVL E++ G P G IL +L P
Sbjct: 198 VNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETM----------TMILKAKLGMP- 246
Query: 882 RDVTDKLRSIMEVAILCLVENPEAR 906
+ ++ + +S++ + NP R
Sbjct: 247 QFLSPEAQSLLR---MLFKRNPANR 268
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 2e-09
Identities = 69/261 (26%), Positives = 112/261 (42%), Gaps = 24/261 (9%)
Query: 654 IGKGGQRSVYKAEL-PSGNIFAVKKF-KAELFSDETANPSEFLNEVLALTEIRHRNIIKF 711
IG+G V L + I+A+K K + DE + + V H ++
Sbjct: 17 IGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQA-SNHPFLVGL 75
Query: 712 HGFC-SNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLH-HDC 769
H C F V EY+ G L ++ ++ ++ AL+YLH
Sbjct: 76 H-SCFQTESRLFFVIEYVNGGDLMFHMQRQ---RKLPEEHARFYSAEISLALNYLHERG- 130
Query: 770 IPPIVHRDISSKNVLLDSEYEAHV--SDFGFAK-FLEPHSSNWTEFAGTVGYAAPELAYT 826
I++RD+ NVLLDS E H+ +D+G K L P + T F GT Y APE+
Sbjct: 131 ---IIYRDLKLDNVLLDS--EGHIKLTDYGMCKEGLRPGDTTST-FCGTPNYIAPEILRG 184
Query: 827 MRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEV-NQILDHRLPTPSRDVT 885
D ++ GVL E++ G P D V + + N + IL+ ++ P R ++
Sbjct: 185 EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIP-RSLS 243
Query: 886 DKLRSIMEVAILCLVENPEAR 906
K S+++ L ++P+ R
Sbjct: 244 VKAASVLK---SFLNKDPKER 261
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 2e-09
Identities = 67/265 (25%), Positives = 115/265 (43%), Gaps = 41/265 (15%)
Query: 654 IGKGGQRSVYKAEL-PSGNIFAVKKFKAE--LFSDETANPSEFLNE--VLALTEIRHRNI 708
IGKG V A +AVK + + L E + ++E VL ++H +
Sbjct: 46 IGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHI---MSERNVLLKN-VKHPFL 101
Query: 709 IKFHGFC-SNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLH- 766
+ H F A + V +Y+ G L L+ + + F + +A+AL YLH
Sbjct: 102 VGLH-FSFQTADKLYFVLDYINGGELFYHLQRE---RCFLEPRARFYAAEIASALGYLHS 157
Query: 767 HDCIPPIVHRDISSKNVLLDSEYEAHV--SDFGFAK-FLEPHSSNWTEFAGTVGYAAPEL 823
+ IV+RD+ +N+LLDS + H+ +DFG K +E +S+ T F GT Y APE+
Sbjct: 158 LN----IVYRDLKPENILLDS--QGHIVLTDFGLCKENIEHNSTTST-FCGTPEYLAPEV 210
Query: 824 AYTMRATEKYDVYSFGVLALEVIKGYHP--GDFVSTIFSSISNMIIEVNQILDHRLPTPS 881
+ D + G + E++ G P + ++ + IL+ L
Sbjct: 211 LHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMY----------DNILNKPLQLK- 259
Query: 882 RDVTDKLRSIMEVAILCLVENPEAR 906
++T+ R ++E L ++ R
Sbjct: 260 PNITNSARHLLE---GLLQKDRTKR 281
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 2e-09
Identities = 69/263 (26%), Positives = 113/263 (42%), Gaps = 28/263 (10%)
Query: 654 IGKGGQRSVYKAEL-PSGNIFAVKKFKAELF--SDETANP-SEFLNEVLALTEIRHRNII 709
IG+G V L + I+A++ K EL ++ +E V H ++
Sbjct: 60 IGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTE--KHVFEQA-SNHPFLV 116
Query: 710 KFHGFC-SNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLH-H 767
H C F V EY+ G L ++ ++ ++ AL+YLH
Sbjct: 117 GLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQ---RKLPEEHARFYSAEISLALNYLHER 172
Query: 768 DCIPPIVHRDISSKNVLLDSEYEAHV--SDFGFAK-FLEPHSSNWTEFAGTVGYAAPELA 824
I++RD+ NVLLDS E H+ +D+G K L P + T F GT Y APE+
Sbjct: 173 G----IIYRDLKLDNVLLDS--EGHIKLTDYGMCKEGLRPGDTTST-FCGTPNYIAPEIL 225
Query: 825 YTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEV-NQILDHRLPTPSRD 883
D ++ GVL E++ G P D V + + N + IL+ ++ P R
Sbjct: 226 RGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIP-RS 284
Query: 884 VTDKLRSIMEVAILCLVENPEAR 906
++ K S+++ L ++P+ R
Sbjct: 285 LSVKAASVLK---SFLNKDPKER 304
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 56.3 bits (136), Expect = 3e-09
Identities = 38/158 (24%), Positives = 59/158 (37%), Gaps = 29/158 (18%)
Query: 115 NLKSLSTLDLSQNQLN-GSIPCSLDNLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLS 173
++ L L + N G I NL+ L L L S + L L +L+LS
Sbjct: 22 TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI--SVSNLPKLPKLKKLELS 79
Query: 174 ENRLSGLIPLSLSNLSSLTVMSLFNNSLSGSIPPILGNLKSLSTLGLHINQLNGVIPPSI 233
ENR+ G + + L +LT ++L N L ++ +L L
Sbjct: 80 ENRIFGGLDMLAEKLPNLTHLNLSGNKLK--------DISTLEPL--------------- 116
Query: 234 GNLSSLRNLSLFNN---RLYGFVPKEIGYLKSLSKLEF 268
L L++L LFN L + L L+ L+
Sbjct: 117 KKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDG 154
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 54.0 bits (130), Expect = 2e-08
Identities = 35/138 (25%), Positives = 60/138 (43%), Gaps = 7/138 (5%)
Query: 44 LNQLRRLYLDVNQLH-GTIPPVIGQLSLINELVFCHNNVSGRIPSSLGNLSNLALLYLND 102
+R L LD + + G I + + + L + + + S+L L L L L++
Sbjct: 23 PAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-SV-SNLPKLPKLKKLELSE 80
Query: 103 NSLFGSIPIVMGNLKSLSTLDLSQNQLNG-SIPCSLDNLSNLDTLFLYKNSLSGPI---P 158
N +FG + ++ L +L+ L+LS N+L S L L L +L L+ ++
Sbjct: 81 NRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRE 140
Query: 159 SVIGNLKSLLQLDLSENR 176
SV L L LD +
Sbjct: 141 SVFKLLPQLTYLDGYDRE 158
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 6e-08
Identities = 30/110 (27%), Positives = 47/110 (42%), Gaps = 6/110 (5%)
Query: 385 VLDLSSNHIFGKIPVQLVKLFSLNKLILSLNQLFGGVPLE-FGTLTELQYLDLSANKLSS 443
VLD ++ GKI + +L L L L + + L +L+ L+LS N++
Sbjct: 30 VLDNCKSND-GKIEGLTAEFVNLEFLSLINVGL---ISVSNLPKLPKLKKLELSENRIFG 85
Query: 444 SIPMSIGNLLKLHYLNLSNNQFSH-KIPTEFEKLIHLSELDLSHNILQEE 492
+ M L L +LNLS N+ +KL L LDL + +
Sbjct: 86 GLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNL 135
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 3e-09
Identities = 72/252 (28%), Positives = 113/252 (44%), Gaps = 56/252 (22%)
Query: 654 IGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLN-EVLALTEIRHRNIIK- 710
IG G VY+A+L SG + A+KK + F N E+ + ++ H NI++
Sbjct: 62 IGNGSFGVVYQAKLCDSGELVAIKKVLQD---------KRFKNRELQIMRKLDHCNIVRL 112
Query: 711 FHGFCSNAQHS-----FIVCEYLARGSLTTILRDDAAAKEFSWNQRM--NVIKG----VA 759
+ F S+ + +V +Y+ ++ + R + AK Q + +K +
Sbjct: 113 RYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAK-----QTLPVIYVKLYMYQLF 166
Query: 760 NALSYLH-HDCIPPIVHRDISSKNVLLDSE-YEAHVSDFGFAKFLEPHSSNWTEFAGTVG 817
+L+Y+H I HRDI +N+LLD + + DFG AK L N + +
Sbjct: 167 RSLAYIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN-VSYICSRY 221
Query: 818 YAAPELAYT-MRATEKYDVYSFG-VLALEVIKGYH--PGDFVSTIFSSIS--NMIIEVNQ 871
Y APEL + T DV+S G VLA E++ G PGD S + II+V
Sbjct: 222 YRAPELIFGATDYTSSIDVWSAGCVLA-ELLLGQPIFPGD------SGVDQLVEIIKV-- 272
Query: 872 ILDHRLPTPSRD 883
L TP+R+
Sbjct: 273 -----LGTPTRE 279
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 3e-09
Identities = 30/142 (21%), Positives = 57/142 (40%), Gaps = 7/142 (4%)
Query: 409 KLILSLNQLFGGVPLEFGTLTELQYLDLSANKLSSSIPMSIGNLLKLHYLNLSNNQFSHK 468
+L + + + TL ++L LS N + I S+ + L L+L N K
Sbjct: 29 ELHGMIPPIEK-MDATLSTLKACKHLALSTNNIEK-I-SSLSGMENLRILSLGRNLIK-K 84
Query: 469 IPTEFEKLIHLSELDLSHNILQEEIPPQICKMESLEKLNLSHNNLSDFIP-RCFEEMRSL 527
I L EL +S+N + + I K+ +L L +S+N ++++ + L
Sbjct: 85 IENLDAVADTLEELWISYNQI-ASLSG-IEKLVNLRVLYMSNNKITNWGEIDKLAALDKL 142
Query: 528 SWIDISYNELQGPIPNSTAFKN 549
+ ++ N L + A
Sbjct: 143 EDLLLAGNPLYNDYKENNATSE 164
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 4e-09
Identities = 33/172 (19%), Positives = 67/172 (38%), Gaps = 23/172 (13%)
Query: 2 LNLGFNLLFGNIPPQIGNLSKLQYLDLGNNQLSGVIPPEIGKLNQLRRLYLDVNQLHGTI 61
L+ + + + L ++L L N + + + + LR L L N + I
Sbjct: 30 LHGMIPPIE-KMDATLSTLKACKHLALSTNNIEKISS--LSGMENLRILSLGRNLIK-KI 85
Query: 62 PPVIGQLSLINELVFCHNNVSGRIPSSLGNLSNLALLYLNDNSLFGSIPIV--MGNLKSL 119
+ + EL +N ++ + S + L NL +LY+++N + + + + L L
Sbjct: 86 ENLDAVADTLEELWISYNQIA-SL-SGIEKLVNLRVLYMSNNKI-TNWGEIDKLAALDKL 142
Query: 120 STLDLSQNQLNGSIPCSLDNLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLD 171
L L+ N P ++ + Y+ V+ L +L +LD
Sbjct: 143 EDLLLAGN------PLY-NDYKENNATSEYR-------IEVVKRLPNLKKLD 180
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 2e-08
Identities = 30/158 (18%), Positives = 58/158 (36%), Gaps = 21/158 (13%)
Query: 122 LDLSQNQLNGSIPCSLDNLSNLDTLFLYKNSLSGPIPSV--IGNLKSLLQLDLSENRLSG 179
L + + +L L L L N+ I + + +++L L L N +
Sbjct: 30 LHGMIPPIEK-MDATLSTLKACKHLALSTNN----IEKISSLSGMENLRILSLGRNLIKK 84
Query: 180 LIPLSLSNLSSLTVMSLFNNSLSGSIPPILGNLKSLSTLGLHINQLNGVIP-PSIGNLSS 238
+ L + +L + + N ++ S+ + L +L L + N++ + L
Sbjct: 85 IENLD-AVADTLEELWISYNQIA-SLSG-IEKLVNLRVLYMSNNKITNWGEIDKLAALDK 141
Query: 239 LRNLSLFNNRLYGFVPKE----------IGYLKSLSKL 266
L +L L N LY + + L +L KL
Sbjct: 142 LEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKL 179
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 4e-08
Identities = 32/133 (24%), Positives = 57/133 (42%), Gaps = 9/133 (6%)
Query: 135 CSLDNLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSENRLSGLIPLSLSNLSSLTVM 194
++ L + + + + LK+ L LS N + + LS + +L ++
Sbjct: 20 VVATEAEKVE-LHGMIPPIEK-MDATLSTLKACKHLALSTNNIEKISSLS--GMENLRIL 75
Query: 195 SLFNNSLSGSIPPILGNLKSLSTLGLHINQLNGVIPPSIGNLSSLRNLSLFNNRLYGFVP 254
SL N + I + +L L + NQ+ + I L +LR L + NN++ +
Sbjct: 76 SLGRNLIK-KIENLDAVADTLEELWISYNQIASL--SGIEKLVNLRVLYMSNNKITNW-- 130
Query: 255 KEIGYLKSLSKLE 267
EI L +L KLE
Sbjct: 131 GEIDKLAALDKLE 143
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 4e-09
Identities = 31/134 (23%), Positives = 61/134 (45%), Gaps = 7/134 (5%)
Query: 43 KLNQLRRLYLDVNQL-HGTIPPVIGQLSLINELVFCHNNVSGRIPSSLGNLSNLALLYLN 101
+ ++ L LD ++ G + + + + L + ++ I ++L L+ L L L+
Sbjct: 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SI-ANLPKLNKLKKLELS 72
Query: 102 DNSLFGSIPIVMGNLKSLSTLDLSQNQLNG-SIPCSLDNLSNLDTLFLYKNSLSGPI--- 157
DN + G + ++ +L+ L+LS N++ S L L NL +L L+ ++
Sbjct: 73 DNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYR 132
Query: 158 PSVIGNLKSLLQLD 171
+V L L LD
Sbjct: 133 ENVFKLLPQLTYLD 146
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 2e-08
Identities = 27/111 (24%), Positives = 48/111 (43%), Gaps = 4/111 (3%)
Query: 115 NLKSLSTLDLSQNQLN-GSIPCSLDNLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLS 173
+ L L ++ N G + D L+ L L+ + + L L +L+LS
Sbjct: 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT--SIANLPKLNKLKKLELS 72
Query: 174 ENRLSGLIPLSLSNLSSLTVMSLFNNSLSG-SIPPILGNLKSLSTLGLHIN 223
+NR+SG + + +LT ++L N + S L L++L +L L
Sbjct: 73 DNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 4e-08
Identities = 27/112 (24%), Positives = 46/112 (41%), Gaps = 6/112 (5%)
Query: 379 DSSKLQVLDLSSNHI-FGKIPVQLVKLFSLNKLILSLNQLFGGVPLE-FGTLTELQYLDL 436
S ++ L L ++ GK+ + L L L + L +L+ L+L
Sbjct: 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGL---TSIANLPKLNKLKKLEL 71
Query: 437 SANKLSSSIPMSIGNLLKLHYLNLSNNQFSH-KIPTEFEKLIHLSELDLSHN 487
S N++S + + L +LNLS N+ +KL +L LDL +
Sbjct: 72 SDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 1e-07
Identities = 27/112 (24%), Positives = 47/112 (41%), Gaps = 5/112 (4%)
Query: 427 TLTELQYLDLSANKLSSSIPMSIGNLLKLHYLNLSNNQFSHKIPTEFEKLIHLSELDLSH 486
+ EL LD S + + +L +L+ N + I KL L +L+LS
Sbjct: 18 DVKEL-VLDNSRSNEGK-LEGLTDEFEELEFLSTINVGLT-SI-ANLPKLNKLKKLELSD 73
Query: 487 NILQEEIPPQICKMESLEKLNLSHNNLSDF-IPRCFEEMRSLSWIDISYNEL 537
N + + K +L LNLS N + D +++ +L +D+ E+
Sbjct: 74 NRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEV 125
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 1e-06
Identities = 20/91 (21%), Positives = 42/91 (46%), Gaps = 7/91 (7%)
Query: 451 NLLKLHYLNLSNNQFSH-KIPTEFEKLIHLSELDLSHNILQ--EEIPPQICKMESLEKLN 507
+ L L N++ + K+ ++ L L + L +P K+ L+KL
Sbjct: 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSIANLP----KLNKLKKLE 70
Query: 508 LSHNNLSDFIPRCFEEMRSLSWIDISYNELQ 538
LS N +S + E+ +L+ +++S N+++
Sbjct: 71 LSDNRVSGGLEVLAEKCPNLTHLNLSGNKIK 101
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 1e-04
Identities = 26/111 (23%), Positives = 45/111 (40%), Gaps = 6/111 (5%)
Query: 17 IGNLSKLQYLDLGNNQLSGVIPPEIGKLNQLRRLYLDVNQLHGTIPPVIGQLSLINELVF 76
+L++L N L+ + + KLN+L++L L N++ G + + + + L
Sbjct: 38 TDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNL 95
Query: 77 CHNNVSG-RIPSSLGNLSNLALLYLNDN---SLFGSIPIVMGNLKSLSTLD 123
N + L L NL L L + +L V L L+ LD
Sbjct: 96 SGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLD 146
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 58.4 bits (142), Expect = 4e-09
Identities = 50/173 (28%), Positives = 74/173 (42%), Gaps = 26/173 (15%)
Query: 662 VYKA-ELPSGNIFAVKKFKAELFSDE------TANPSEFLNEVLALTEIRHRNIIKFHGF 714
VYKA + + I A+KK K S+ TA L E+ L E+ H NII
Sbjct: 26 VYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTA-----LREIKLLQELSHPNIIGLLDA 80
Query: 715 CSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKG----VANALSYLHHDCI 770
+ + +V +++ L I++D + + + IK L YLH I
Sbjct: 81 FGHKSNISLVFDFMET-DLEVIIKD--NSLVLT----PSHIKAYMLMTLQGLEYLHQHWI 133
Query: 771 PPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGTVGYAAPEL 823
+HRD+ N+LLD ++DFG AK + +T T Y APEL
Sbjct: 134 ---LHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPEL 183
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 7e-09
Identities = 70/251 (27%), Positives = 106/251 (42%), Gaps = 53/251 (21%)
Query: 654 IGKGGQRSVYKAELPSGNIFAVKKFKAELFSDETANPSEFLN-EVLALTEIRHRNIIK-F 711
IG G V++A+L + A+KK + F N E+ + ++H N++
Sbjct: 48 IGNGSFGVVFQAKLVESDEVAIKKVLQD---------KRFKNRELQIMRIVKHPNVVDLK 98
Query: 712 HGFCSNAQHS-----FIVCEYLARGSLTTILRDDAAAKEFSWNQRM--NVIKG----VAN 760
F SN +V EY+ ++ R A Q M +IK +
Sbjct: 99 AFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKL-----KQTMPMLLIKLYMYQLLR 152
Query: 761 ALSYLHHDCIPPIVHRDISSKNVLLDSE-YEAHVSDFGFAKFLEPHSSNWTEFAGTVGYA 819
+L+Y+H I HRDI +N+LLD + DFG AK L N + + Y
Sbjct: 153 SLAYIHSIGI---CHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPN-VSYICSRYYR 208
Query: 820 APELAYT-MRATEKYDVYSFG-VLALEVIKGY--HPGDFVSTIFSSIS--NMIIEVNQIL 873
APEL + T D++S G V+A E+++G PG+ S I II+V
Sbjct: 209 APELIFGATNYTTNIDIWSTGCVMA-ELMQGQPLFPGE------SGIDQLVEIIKV---- 257
Query: 874 DHRLPTPSRDV 884
L TPSR+
Sbjct: 258 ---LGTPSREQ 265
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 7e-09
Identities = 43/152 (28%), Positives = 75/152 (49%), Gaps = 20/152 (13%)
Query: 761 ALSYLH-HDCIPPIVHRDISSKNVLLDSEYEAHV--SDFGFAK-FLEPHSSNWTEFAGTV 816
AL +LH I++RDI +N+LLDS HV +DFG +K F+ + +F GT+
Sbjct: 171 ALEHLHKLG----IIYRDIKLENILLDS--NGHVVLTDFGLSKEFVADETERAYDFCGTI 224
Query: 817 GYAAPELAYTMRA--TEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILD 874
Y AP++ + + D +S GVL E++ G P F + I +IL
Sbjct: 225 EYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP--FTVDGEKNSQAEISR--RILK 280
Query: 875 HRLPTPSRDVTDKLRSIMEVAILCLVENPEAR 906
P P ++++ + +++ L+++P+ R
Sbjct: 281 SEPPYP-QEMSALAKDLIQ---RLLMKDPKKR 308
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 1e-08
Identities = 64/263 (24%), Positives = 108/263 (41%), Gaps = 37/263 (14%)
Query: 654 IGKGGQRSVYKAEL-PSGNIFAVKKFKAE--LFSDETANP-SEFLNEVLALTEIRHRNII 709
+GKG V A + +G+++AVK K + L D+ +E +L+L H +
Sbjct: 31 LGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTE--KRILSLA-RNHPFLT 87
Query: 710 KFHGFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLH-HD 768
+ F V E++ G L ++ + F + + +AL +LH
Sbjct: 88 QLFCCFQTPDRLFFVMEFVNGGDLMFHIQKS---RRFDEARARFYAAEIISALMFLHDKG 144
Query: 769 CIPPIVHRDISSKNVLLDSEYEAHV--SDFGFAK-FLEPHSSNWTEFAGTVGYAAPELAY 825
I++RD+ NVLLD E H +DFG K + + T F GT Y APE+
Sbjct: 145 ----IIYRDLKLDNVLLDH--EGHCKLADFGMCKEGICNGVTTAT-FCGTPDYIAPEILQ 197
Query: 826 TMRATEKYDVYSFGVLALEVIKGYHP--GDFVSTIFSSISNMIIEVNQILDHRLPTPSRD 883
M D ++ GVL E++ G+ P + +F IL+ + P
Sbjct: 198 EMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLF----------EAILNDEVVYP-TW 246
Query: 884 VTDKLRSIMEVAILCLVENPEAR 906
+ + I++ + +NP R
Sbjct: 247 LHEDATGILKS---FMTKNPTMR 266
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 1e-08
Identities = 43/130 (33%), Positives = 59/130 (45%), Gaps = 31/130 (23%)
Query: 24 QYLDLGNNQLSGVIPPEIGKLNQLRRLYLDVNQLHGTIPPVIGQLSLINELVFCHNNVSG 83
++ N +L+ V P I +RL+L+ NQ+ + P G VF H
Sbjct: 15 TLVNCQNIRLASV-PAGI--PTDKQRLWLNNNQIT-KLEP--G--------VFDH----- 55
Query: 84 RIPSSLGNLSNLALLYLNDNSLFGSIPI-VMGNLKSLSTLDLSQNQLNGSIP-CSLDNLS 141
L NL LY N N L +IP V L L+ LDL+ N L SIP + DNL
Sbjct: 56 --------LVNLQQLYFNSNKL-TAIPTGVFDKLTQLTQLDLNDNHLK-SIPRGAFDNLK 105
Query: 142 NLDTLFLYKN 151
+L ++LY N
Sbjct: 106 SLTHIYLYNN 115
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 6e-07
Identities = 24/79 (30%), Positives = 42/79 (53%), Gaps = 2/79 (2%)
Query: 170 LDLSENRLSGLIPLSLSNLSSLTVMSLFNNSLSGSIPP-ILGNLKSLSTLGLHINQLNGV 228
L L+ N+++ L P +L +L + +N L+ +IP + L L+ L L+ N L +
Sbjct: 38 LWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLT-AIPTGVFDKLTQLTQLDLNDNHLKSI 96
Query: 229 IPPSIGNLSSLRNLSLFNN 247
+ NL SL ++ L+NN
Sbjct: 97 PRGAFDNLKSLTHIYLYNN 115
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174 | Back alignment and structure |
|---|
Score = 47.2 bits (113), Expect = 4e-06
Identities = 29/78 (37%), Positives = 40/78 (51%)
Query: 122 LDLSQNQLNGSIPCSLDNLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSENRLSGLI 181
L L+ NQ+ P D+L NL L+ N L+ V L L QLDL++N L +
Sbjct: 38 LWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDNHLKSIP 97
Query: 182 PLSLSNLSSLTVMSLFNN 199
+ NL SLT + L+NN
Sbjct: 98 RGAFDNLKSLTHIYLYNN 115
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 6e-06
Identities = 27/84 (32%), Positives = 44/84 (52%), Gaps = 2/84 (2%)
Query: 141 SNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSENRLSGLIPLSLSNLSSLTVMSLFNNS 200
++ L+L N ++ P V +L +L QL + N+L+ + L+ LT + L +N
Sbjct: 33 TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDNH 92
Query: 201 LSGSIPP-ILGNLKSLSTLGLHIN 223
L SIP NLKSL+ + L+ N
Sbjct: 93 LK-SIPRGAFDNLKSLTHIYLYNN 115
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 4e-05
Identities = 27/94 (28%), Positives = 41/94 (43%), Gaps = 28/94 (29%)
Query: 372 SIPPEIGDSSKLQVLDLSSNHIFGKIPVQLVKLFSLNKLILSLNQLFGGVPLEFGTLTEL 431
S+P I + Q L L++N Q+ KL GV F L L
Sbjct: 26 SVPAGI--PTDKQRLWLNNN--------QITKLEP-------------GV---FDHLVNL 59
Query: 432 QYLDLSANKLSSSIPMSI-GNLLKLHYLNLSNNQ 464
Q L ++NKL ++IP + L +L L+L++N
Sbjct: 60 QQLYFNSNKL-TAIPTGVFDKLTQLTQLDLNDNH 92
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174 | Back alignment and structure |
|---|
Score = 42.6 bits (101), Expect = 1e-04
Identities = 16/39 (41%), Positives = 22/39 (56%), Gaps = 2/39 (5%)
Query: 20 LSKLQYLDLGNNQLSGVIPPEI-GKLNQLRRLYLDVNQL 57
L LQ L +N+L+ IP + KL QL +L L+ N L
Sbjct: 56 LVNLQQLYFNSNKLT-AIPTGVFDKLTQLTQLDLNDNHL 93
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174 | Back alignment and structure |
|---|
Score = 41.1 bits (97), Expect = 4e-04
Identities = 31/101 (30%), Positives = 53/101 (52%), Gaps = 7/101 (6%)
Query: 432 QYLDLSANKLSSSIPMSIGNLLKLHYLNLSNNQFSHKIPTEFEKLIHLSELDLSHNILQE 491
++ +L+S +P I L L+NNQ + P F+ L++L +L + N L
Sbjct: 15 TLVNCQNIRLAS-VPAGI--PTDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLT- 70
Query: 492 EIPPQIC-KMESLEKLNLSHNNLSDFIPR-CFEEMRSLSWI 530
IP + K+ L +L+L+ N+L IPR F+ ++SL+ I
Sbjct: 71 AIPTGVFDKLTQLTQLDLNDNHLKS-IPRGAFDNLKSLTHI 110
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 1e-08
Identities = 52/259 (20%), Positives = 99/259 (38%), Gaps = 45/259 (17%)
Query: 654 IGKGGQRSVYKA-ELPSGNIFAVKK--FKAELFSDETANPSEFLNEVLALTEIRHRNIIK 710
+G GG V+ A + A+KK L E+ + + H NI+K
Sbjct: 19 LGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHA------LREIKIIRRLDHDNIVK 72
Query: 711 ----------FHGFCSNAQHSF----IVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIK 756
+ IV EY+ L +L +
Sbjct: 73 VFEILGPSGSQLTDDVGSLTELNSVYIVQEYME-TDLANVLE----QGPLLEEHARLFMY 127
Query: 757 GVANALSYLHHDCIPPIVHRDISSKNVLLDSE-YEAHVSDFGFAKFLEPHSSN---WTEF 812
+ L Y+H ++HRD+ N+ +++E + DFG A+ ++PH S+ +E
Sbjct: 128 QLLRGLKYIHS---ANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEG 184
Query: 813 AGTVGYAAPELAYT-MRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQ 871
T Y +P L + T+ D+++ G + E++ G T+F+ ++ + ++
Sbjct: 185 LVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTG-------KTLFAG-AHELEQMQL 236
Query: 872 ILDHRLPTPSRDVTDKLRS 890
IL+ +P + +L S
Sbjct: 237 ILES-IPVVHEEDRQELLS 254
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 2e-08
Identities = 20/97 (20%), Positives = 40/97 (41%), Gaps = 11/97 (11%)
Query: 424 EFGTLTELQYLDLSANKLSSSIPMSIGNLL----KLHYLNLSNNQFSHKIPTEFEKLIHL 479
++ + LDL K+ I NL + ++ S+N+ K+ F L L
Sbjct: 14 QYTNAVRDRELDLRGYKIPV-----IENLGATLDQFDAIDFSDNEIR-KLDG-FPLLRRL 66
Query: 480 SELDLSHNILQEEIPPQICKMESLEKLNLSHNNLSDF 516
L +++N + + L +L L++N+L +
Sbjct: 67 KTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVEL 103
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 2e-08
Identities = 35/179 (19%), Positives = 58/179 (32%), Gaps = 41/179 (22%)
Query: 1 MLNLGFNLLFGNIPPQIGNLSKLQYLDLGNNQLSGVIPPEIGKLNQLRRLYLDVNQLHGT 60
M+ L L+ Q N + + LDL ++ VI L+Q + N++
Sbjct: 1 MVKLTAELI--EQAAQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-- 55
Query: 61 IPPVIGQLSLINELVFCHNNVSGRIPSSLGNLSNLALLYLNDNSLFGSIPIVMGNLKSLS 120
L L L L +N+N + + L L+
Sbjct: 56 --------KLDG----------------FPLLRRLKTLLVNNNRICRIGEGLDQALPDLT 91
Query: 121 TLDLSQNQLNG-SIPCSLDNLSNLDTLFLYKNSLSGPI-------PSVIGNLKSLLQLD 171
L L+ N L L +L +L L + +N P+ VI + + LD
Sbjct: 92 ELILTNNSLVELGDLDPLASLKSLTYLCILRN----PVTNKKHYRLYVIYKVPQVRVLD 146
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 2e-08
Identities = 34/159 (21%), Positives = 50/159 (31%), Gaps = 33/159 (20%)
Query: 115 NLKSLSTLDLSQNQLNGSIPCSLDNLSNLDTLFLYKNSLSGPIPSVIG--NLKSLLQLDL 172
N LDL ++ I L D + N I + G L+ L L +
Sbjct: 17 NAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNE----IRKLDGFPLLRRLKTLLV 71
Query: 173 SENRLSGLIPLSLSNLSSLTVMSLFNNSLSGSIPPILGNLKSLSTLGLHINQLNGVIPPS 232
+ NR+ + L LT + L NNSL L L L
Sbjct: 72 NNNRICRIGEGLDQALPDLTELILTNNSLV--------ELGDLDPL-------------- 109
Query: 233 IGNLSSLRNLSLFNN---RLYGFVPKEIGYLKSLSKLEF 268
+L SL L + N + I + + L+F
Sbjct: 110 -ASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRVLDF 147
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 8e-08
Identities = 17/107 (15%), Positives = 41/107 (38%), Gaps = 9/107 (8%)
Query: 434 LDLSANKLSSSIPMSIGNLLKLHYLNLSNNQFSHKIPTEFEKLIHLSELDLSHNILQ--E 491
+ L+A + + N ++ L+L + I L +D S N ++ +
Sbjct: 2 VKLTAELIEQA--AQYTNAVRDRELDLRGYK-IPVIENLGATLDQFDAIDFSDNEIRKLD 58
Query: 492 EIPPQICKMESLEKLNLSHNNLSDFIPRCFEEMRSLSWIDISYNELQ 538
P + L+ L +++N + + + L+ + ++ N L
Sbjct: 59 GFP----LLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLV 101
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 1e-06
Identities = 21/88 (23%), Positives = 36/88 (40%), Gaps = 3/88 (3%)
Query: 382 KLQVLDLSSNHIFGKIPVQLVKLFSLNKLILSLNQLFGGVPLEFGTLTELQYLDLSANKL 441
+ +D S N I K+ L L L+++ N++ L +L L L+ N L
Sbjct: 43 QFDAIDFSDNEI-RKLD-GFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSL 100
Query: 442 SS-SIPMSIGNLLKLHYLNLSNNQFSHK 468
+ +L L YL + N ++K
Sbjct: 101 VELGDLDPLASLKSLTYLCILRNPVTNK 128
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 56.1 bits (136), Expect = 2e-08
Identities = 65/272 (23%), Positives = 110/272 (40%), Gaps = 55/272 (20%)
Query: 654 IGKGGQRSVYKAEL-PSGNIFAVKKFKAE--LFSDETANP-SEFLNEVLALTEIRHRNII 709
+GKG V +E + ++AVK K + + D+ E VLAL + +
Sbjct: 28 LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVE--KRVLALPG-KPPFLT 84
Query: 710 KFHGFC-SNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIK---------GVA 759
+ H C + V EY+ G L Q++ K +A
Sbjct: 85 QLH-SCFQTMDRLYFVMEYVNGGDL------------MYHIQQVGRFKEPHAVFYAAEIA 131
Query: 760 NALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHV--SDFGFAK-FLEPHSSNWTEFAGTV 816
L +L I++RD+ NV+LDS E H+ +DFG K + + T F GT
Sbjct: 132 IGLFFLQSK---GIIYRDLKLDNVMLDS--EGHIKIADFGMCKENIWDGVTTKT-FCGTP 185
Query: 817 GYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHP--GDFVSTIFSSISNMIIEVNQILD 874
Y APE+ + D ++FGVL E++ G P G+ +F I++
Sbjct: 186 DYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELF----------QSIME 235
Query: 875 HRLPTPSRDVTDKLRSIMEVAILCLVENPEAR 906
H + P + ++ + +I + + ++P R
Sbjct: 236 HNVAYP-KSMSKEAVAICKG---LMTKHPGKR 263
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170 | Back alignment and structure |
|---|
Score = 53.4 bits (129), Expect = 3e-08
Identities = 38/130 (29%), Positives = 53/130 (40%), Gaps = 31/130 (23%)
Query: 24 QYLDLGNNQLSGVIPPEIGKLNQLRRLYLDVNQLHGTIPPVIGQLSLINELVFCHNNVSG 83
+D L+ V P I + LYL NQ+ + P G VF
Sbjct: 12 TTVDCSGKSLASV-PTGI--PTTTQVLYLYDNQIT-KLEP--G--------VFDR----- 52
Query: 84 RIPSSLGNLSNLALLYLNDNSLFGSIPI-VMGNLKSLSTLDLSQNQLNGSIP-CSLDNLS 141
L+ L L L++N L +P V L L+ L L+ NQL SIP + DNL
Sbjct: 53 --------LTQLTRLDLDNNQL-TVLPAGVFDKLTQLTQLSLNDNQLK-SIPRGAFDNLK 102
Query: 142 NLDTLFLYKN 151
+L ++L N
Sbjct: 103 SLTHIWLLNN 112
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170 | Back alignment and structure |
|---|
Score = 49.9 bits (120), Expect = 4e-07
Identities = 27/79 (34%), Positives = 42/79 (53%), Gaps = 2/79 (2%)
Query: 170 LDLSENRLSGLIPLSLSNLSSLTVMSLFNNSLSGSIPP-ILGNLKSLSTLGLHINQLNGV 228
L L +N+++ L P L+ LT + L NN L+ +P + L L+ L L+ NQL +
Sbjct: 35 LYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLT-VLPAGVFDKLTQLTQLSLNDNQLKSI 93
Query: 229 IPPSIGNLSSLRNLSLFNN 247
+ NL SL ++ L NN
Sbjct: 94 PRGAFDNLKSLTHIWLLNN 112
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170 | Back alignment and structure |
|---|
Score = 48.4 bits (116), Expect = 2e-06
Identities = 36/103 (34%), Positives = 46/103 (44%), Gaps = 6/103 (5%)
Query: 75 VFCHNNVSGRIPSSLGNLSNLALLYLNDNSLFGSIPIVMGNLKSLSTLDLSQNQLNGSIP 134
V C +P+ G + +LYL DN + P V L L+ LDL NQL +P
Sbjct: 14 VDCSGKSLASVPT--GIPTTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLT-VLP 70
Query: 135 CSL-DNLSNLDTLFLYKNSLSGPIPS-VIGNLKSLLQLDLSEN 175
+ D L+ L L L N L IP NLKSL + L N
Sbjct: 71 AGVFDKLTQLTQLSLNDNQLKS-IPRGAFDNLKSLTHIWLLNN 112
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170 | Back alignment and structure |
|---|
Score = 46.8 bits (112), Expect = 5e-06
Identities = 40/116 (34%), Positives = 51/116 (43%), Gaps = 28/116 (24%)
Query: 13 IPPQIGNLSKLQYLDLGNNQLSGVIPPEIGKLNQLRRLYLDVNQLHGTIPPVIGQLSLIN 72
+P I + Q L L +NQ++ + P +L QL RL LD NQL +P G
Sbjct: 24 VPTGI--PTTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLT-VLPA--G------ 72
Query: 73 ELVFCHNNVSGRIPSSLGNLSNLALLYLNDNSLFGSIPI-VMGNLKSLSTLDLSQN 127
VF L+ L L LNDN L SIP NLKSL+ + L N
Sbjct: 73 --VF-------------DKLTQLTQLSLNDNQL-KSIPRGAFDNLKSLTHIWLLNN 112
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170 | Back alignment and structure |
|---|
Score = 45.7 bits (109), Expect = 1e-05
Identities = 28/82 (34%), Positives = 38/82 (46%)
Query: 118 SLSTLDLSQNQLNGSIPCSLDNLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSENRL 177
+ L L NQ+ P D L+ L L L N L+ V L L QL L++N+L
Sbjct: 31 TTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDNQL 90
Query: 178 SGLIPLSLSNLSSLTVMSLFNN 199
+ + NL SLT + L NN
Sbjct: 91 KSIPRGAFDNLKSLTHIWLLNN 112
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170 | Back alignment and structure |
|---|
Score = 44.1 bits (105), Expect = 4e-05
Identities = 36/118 (30%), Positives = 52/118 (44%), Gaps = 30/118 (25%)
Query: 372 SIPPEIGDSSKLQVLDLSSNHIFGKIPVQLVKLFSLNKLILSLNQLFGGVPLEFGTLTEL 431
S+P I + QVL L N Q+ KL GV F LT+L
Sbjct: 23 SVPTGI--PTTTQVLYLYDN--------QITKLEP-------------GV---FDRLTQL 56
Query: 432 QYLDLSANKLSSSIPMSI-GNLLKLHYLNLSNNQFSHKIPTE-FEKLIHLSELDLSHN 487
LDL N+L + +P + L +L L+L++NQ IP F+ L L+ + L +N
Sbjct: 57 TRLDLDNNQL-TVLPAGVFDKLTQLTQLSLNDNQL-KSIPRGAFDNLKSLTHIWLLNN 112
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170 | Back alignment and structure |
|---|
Score = 42.2 bits (100), Expect = 2e-04
Identities = 33/101 (32%), Positives = 52/101 (51%), Gaps = 7/101 (6%)
Query: 432 QYLDLSANKLSSSIPMSIGNLLKLHYLNLSNNQFSHKIPTEFEKLIHLSELDLSHNILQE 491
+D S L+S +P I L L +NQ + P F++L L+ LDL +N L
Sbjct: 12 TTVDCSGKSLAS-VPTGI--PTTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLT- 67
Query: 492 EIPPQIC-KMESLEKLNLSHNNLSDFIPR-CFEEMRSLSWI 530
+P + K+ L +L+L+ N L IPR F+ ++SL+ I
Sbjct: 68 VLPAGVFDKLTQLTQLSLNDNQLKS-IPRGAFDNLKSLTHI 107
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 55.6 bits (135), Expect = 3e-08
Identities = 65/272 (23%), Positives = 115/272 (42%), Gaps = 50/272 (18%)
Query: 653 CIGKGGQRSVYKAELP----SGNIFAVKKF-KAELFS--DETANPSEFLNEVLALTEIRH 705
+GKGG V++ +G IFA+K KA + +TA+ E L E++H
Sbjct: 24 VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHT---KAERNILEEVKH 80
Query: 706 RNIIKFHGFC-SNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSY 764
I+ + +++ EYL+ G L L + F + + ++ AL +
Sbjct: 81 PFIVDLI-YAFQTGGKLYLILEYLSGGELFMQLERE---GIFMEDTACFYLAEISMALGH 136
Query: 765 LH-HDCIPPIVHRDISSKNVLLDSEYEAHV--SDFGFAK-FLEPHSSNWTEFAGTVGYAA 820
LH I++RD+ +N++L+ + HV +DFG K + + T F GT+ Y A
Sbjct: 137 LHQKG----IIYRDLKPENIMLNH--QGHVKLTDFGLCKESIHDGTVTHT-FCGTIEYMA 189
Query: 821 PEL----AYTMRATEKYDVYSFGVLALEVIKGYHP--GDFVSTIFSSISNMIIEVNQILD 874
PE+ + D +S G L +++ G P G+ ++IL
Sbjct: 190 PEILMRSGHNRAV----DWWSLGALMYDMLTGAPPFTGENRKKTI----------DKILK 235
Query: 875 HRLPTPSRDVTDKLRSIMEVAILCLVENPEAR 906
+L P +T + R +++ L N +R
Sbjct: 236 CKLNLP-PYLTQEARDLLK---KLLKRNAASR 263
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 55.7 bits (133), Expect = 3e-08
Identities = 27/163 (16%), Positives = 53/163 (32%), Gaps = 21/163 (12%)
Query: 371 GSIPPEIGDSSKLQVLDLSSNHIFGKIPVQLVKLFSLNKLILSLNQLFGGVPLEFGT--L 428
+ P + L L + + L L + L V + L
Sbjct: 162 VDLSPVLDAMPLLNNLKIKGTNNLSIGKKPRPNL---KSLEIISGGLPDSVVEDILGSDL 218
Query: 429 TELQYLDL---SANKLSSSIPMSIGNLL------KLHYLNLSNNQFSHKIPT---EFEKL 476
L+ L L + L L +L + + + + + E + L
Sbjct: 219 PNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDIL 278
Query: 477 IHLSELDLSHNILQ----EEIPPQICKMESLEKLNLSHNNLSD 515
L +D+S +L + + K++ L+ +N+ +N LSD
Sbjct: 279 PQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSD 321
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 48.8 bits (115), Expect = 5e-06
Identities = 26/155 (16%), Positives = 65/155 (41%), Gaps = 21/155 (13%)
Query: 380 SSKLQVLDLSSNHIFGKIPVQLV--KLFSLNKLILSL---NQLFGGVP------LEFGTL 428
L+ L++ S + + ++ L +L KL+L + + F G
Sbjct: 192 RPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRF 251
Query: 429 TELQYLDLSANKLSSSIPMSIGN---LLKLHYLNLSNNQFSHK----IPTEFEKLIHLSE 481
L++L + + + + L +L +++S + + + +K+ HL
Sbjct: 252 PNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKF 311
Query: 482 LDLSHNILQEEIPPQICKMESLE-KLNLSHNNLSD 515
+++ +N L +E+ ++ +SL K+++S + D
Sbjct: 312 INMKYNYLSDEMKKELQ--KSLPMKIDVSDSQEYD 344
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 43.8 bits (102), Expect = 2e-04
Identities = 30/186 (16%), Positives = 60/186 (32%), Gaps = 26/186 (13%)
Query: 11 GNIPPQIGNLSKLQYLDLGNNQLSGVIPPEIGKLNQLRRLYLDVNQLHGTIPPVIGQLSL 70
++ P + + L L + + L+ L + L ++ I L
Sbjct: 162 VDLSPVLDAMPLLNNLKIKGTNNLSIGKK---PRPNLKSLEIISGGLPDSVVEDILGSDL 218
Query: 71 IN----ELVFCHNNVSGRIPS-------SLGNLSNLALLYLNDNSLFGSIPIVMGN---L 116
N L + S NL L + D + + L
Sbjct: 219 PNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDIL 278
Query: 117 KSLSTLDLSQNQLNGS----IPCSLDNLSNLDTLFLYKNSLSGPIPSVIGNLKSLL--QL 170
L T+D+S L + +D + +L + + N LS + L+ L ++
Sbjct: 279 PQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLS---DEMKKELQKSLPMKI 335
Query: 171 DLSENR 176
D+S+++
Sbjct: 336 DVSDSQ 341
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 43.0 bits (100), Expect = 3e-04
Identities = 39/264 (14%), Positives = 81/264 (30%), Gaps = 72/264 (27%)
Query: 229 IPPSIGNLSSLRNLSLFNNRLYGFVPKEIGYLKSLSKLEFCANHLSGVIPHSVG-----N 283
+ P + + L NL + K +L LE + L + + N
Sbjct: 164 LSPVLDAMPLLNNLKIKGTNNLSIGKKP---RPNLKSLEIISGGLPDSVVEDILGSDLPN 220
Query: 284 LTGLVLLNMCENHLFGPIPKSLRNLTSLERVRFNQNNLYGKVYEAFGDHPNLTFLDLSQN 343
L LVL E++ F R L S +R PNL +L +
Sbjct: 221 LEKLVLYVGVEDYGFDGDMNVFRPLFSKDR------------------FPNLKWLGIVDA 262
Query: 344 NFYCEISFNWRNFSKLGTFNASMNNIYGSIPPEIGDSSKLQVLDLSSNHIFGKIPVQLVK 403
+ + L +L+ +D+S+ + + L+
Sbjct: 263 EEQNVVVEMFLESDIL---------------------PQLETMDISAGVLTDEGARLLLD 301
Query: 404 LFSLNKLILSLNQLFGGVPLEFGTLTELQYLDLSANKLSSSIPMSIGNLLKLHYLNLSNN 463
+ L+++++ N LS + + L + +++S++
Sbjct: 302 HVD--------------------KIKHLKFINMKYNYLSDEMKKELQKSLPMK-IDVSDS 340
Query: 464 QFSHKIPTEFEKLIHLSELDLSHN 487
Q + ++EL+ H+
Sbjct: 341 Q----EYDDDYSYPMITELEHHHH 360
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 42.2 bits (98), Expect = 6e-04
Identities = 19/105 (18%), Positives = 35/105 (33%), Gaps = 13/105 (12%)
Query: 87 SSLGNLSNLALLYLNDNSLFGSIP------IVMGNLKSLSTLDLSQNQLNGSIPCSL--- 137
S L NL L L ++ F +L L + + +
Sbjct: 216 SDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLES 275
Query: 138 DNLSNLDTLFLYKNSLSG----PIPSVIGNLKSLLQLDLSENRLS 178
D L L+T+ + L+ + + +K L +++ N LS
Sbjct: 276 DILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLS 320
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 4e-08
Identities = 56/283 (19%), Positives = 97/283 (34%), Gaps = 72/283 (25%)
Query: 654 IGKGGQRSVYKA-ELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIK-- 710
+G G V + ++ SG FA+KK + P E+ + + H NIIK
Sbjct: 15 LGTGSFGIVCEVFDIESGKRFALKKVLQD--------PRYKNRELDIMKVLDHVNIIKLV 66
Query: 711 --FHGFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMN--------------- 753
F+ + + ++ +
Sbjct: 67 DYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHK 126
Query: 754 VIKGVAN-------------------ALSYLHHDCIPPIVHRDISSKNVLLDSE-YEAHV 793
V+K A+ ++H I HRDI +N+L++S+ +
Sbjct: 127 VLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHS---LGICHRDIKPQNLLVNSKDNTLKL 183
Query: 794 SDFGFAKFLEPHSSNWTEFAGTVGYAAPELAYT-MRATEKYDVYSFG-VLALEVIKGYH- 850
DFG AK L P + + + Y APEL T D++S G V E+I G
Sbjct: 184 CDFGSAKKLIPSEPS-VAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFG-ELILGKPL 241
Query: 851 -PGDFVSTIFSSIS--NMIIEVNQILDHRLPTPSRDVTDKLRS 890
G+ +SI II++ + TP+++ ++
Sbjct: 242 FSGE------TSIDQLVRIIQI-------MGTPTKEQMIRMNP 271
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 8e-08
Identities = 44/228 (19%), Positives = 83/228 (36%), Gaps = 49/228 (21%)
Query: 638 YEEITKATGNFGEKYCIGKGGQRSVYKA-ELPSGNIFAVKKFKAELFSDETANPSEFLNE 696
Y+ + K +G+G V++A + + VK K + E
Sbjct: 38 YQLVRK----------LGRGKYSEVFEAINITNNEKVVVKILKPV-------KKKKIKRE 80
Query: 697 VLALTEIR-HRNIIK----FHGFCSNAQHSFIVCEYLARGSLTTILR--DDAAAKEFSWN 749
+ L +R NII S + + E++ + + D + +
Sbjct: 81 IKILENLRGGPNIITLADIVKDPVSR-TPALVF-EHVNNTDFKQLYQTLTDYDIRFY--- 135
Query: 750 QRMNVIKGVANALSYLH-HDCIPPIVHRDISSKNVLLDSEY-EAHVSDFGFAKFLEPHSS 807
+ + AL Y H I+HRD+ NV++D E+ + + D+G A+F P
Sbjct: 136 -----MYEILKALDYCHSMG----IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP-GQ 185
Query: 808 NWTEFAGTVGYAAPELAYTMRATEKY----DVYSFGVLALEVIKGYHP 851
+ + + PEL + + Y D++S G + +I P
Sbjct: 186 EYNVRVASRYFKGPEL---LVDYQMYDYSLDMWSLGCMLASMIFRKEP 230
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 53.8 bits (130), Expect = 1e-07
Identities = 66/294 (22%), Positives = 102/294 (34%), Gaps = 96/294 (32%)
Query: 654 IGKGGQRSVYKA-ELPSGNIFAVKKFKAELFSDETANPSEF----LNEVLALTEIRHRNI 708
+G+G V A P+G I A+KK + F F L E+ L +H NI
Sbjct: 19 LGEGAYGVVCSATHKPTGEIVAIKKIEP--FDKPL-----FALRTLREIKILKHFKHENI 71
Query: 709 IK-FHGFCSNAQHSF----IVCEY--------LARGSLTT---------ILRDDAAAKEF 746
I F+ ++ +F I+ E ++ L+ LR
Sbjct: 72 ITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTLR-------- 123
Query: 747 SWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFA------- 799
A+ LH ++HRD+ N+L++S + V DFG A
Sbjct: 124 --------------AVKVLHG---SNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESA 166
Query: 800 ---KFLEPHSSNWTEFAGTVGYAAPELAYT-MRATEKYDVYSFGVLALEVIKG--YHPG- 852
S EF T Y APE+ T + + DV+S G + E+ PG
Sbjct: 167 ADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGR 226
Query: 853 DFVSTIFSSISNMIIEVNQILDHRLPTPSRDVTDKLRSIMEVAILCLVENPEAR 906
D+ + +I + + TP D L +E+P AR
Sbjct: 227 DYRHQL-----LLIFGI-------IGTPHSD-----------NDLRCIESPRAR 257
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 53.7 bits (130), Expect = 1e-07
Identities = 49/215 (22%), Positives = 90/215 (41%), Gaps = 34/215 (15%)
Query: 638 YEEITKATGNFGEKYCIGKG--GQRSVYKA--ELPSGNIFAVKKFKAELFSDETANPSEF 693
YE + + IG+G G+ V+KA G A+K+ + + + E P
Sbjct: 13 YECVAE----------IGEGAYGK--VFKARDLKNGGRFVALKRVRVQ--TGEEGMPLST 58
Query: 694 LNEVLALTEIR---HRNIIK----FHGFCSNAQHS-FIVCEYLARGSLTTILRDDAAAKE 745
+ EV L + H N+++ ++ + +V E++ + LTT L D
Sbjct: 59 IREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYL-DKVPEPG 116
Query: 746 FSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAK-FLEP 804
+++ + L +LH + VHRD+ +N+L+ S + ++DFG A+ +
Sbjct: 117 VPTETIKDMMFQLLRGLDFLHSHRV---VHRDLKPQNILVTSSGQIKLADFGLARIYSFQ 173
Query: 805 HSSNWTEFAGTVGYAAPELAYTMRATEKYDVYSFG 839
T T+ Y APE+ D++S G
Sbjct: 174 M--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVG 206
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 52.1 bits (125), Expect = 6e-07
Identities = 64/354 (18%), Positives = 112/354 (31%), Gaps = 83/354 (23%)
Query: 608 RRKRDPQEKRSSSANPFGFFSVLNFNGKVL--YEEITKATGNFGEKYCIGKGGQRSVYKA 665
++ Q K+ S+ P + + ++ YE IG G V +A
Sbjct: 23 SQQEGQQRKQHHSSKPTASMPRPHSDWQIPDRYEIRHL----------IGTGSYGHVCEA 72
Query: 666 -ELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIK-FHGFCSNAQHSF- 722
+ + A+KK +F D + L E+ L + H +++K F
Sbjct: 73 YDKLEKRVVAIKKI-LRVFEDLI-DCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFD 130
Query: 723 ---IVCEYLARGSLTTILR-----DDAAAKEFSWNQRMNVIKGVANALSYLH-HDCIPPI 773
+V E + R + K +N ++ G + Y+H I
Sbjct: 131 ELYVVLEIADS-DFKKLFRTPVYLTELHIKTLLYN----LLVG----VKYVHSAG----I 177
Query: 774 VHRDISSKNVLLDSEYEAHVSDFGFA---------------------------KFLEPHS 806
+HRD+ N L++ + V DFG A +
Sbjct: 178 LHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLK 237
Query: 807 SNWTEFAGTVGYAAPELAYTMRATEKY----DVYS----FGVLALEVIKGYHPGDFVSTI 858
T T Y APEL + E Y DV+S F L + + +
Sbjct: 238 RQLTGHVVTRWYRAPEL---ILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHADRGPL 294
Query: 859 FSSISNMIIEVNQILDHRLPTPSRDVTDKLRSIMEV------AILCLVENPEAR 906
F S + +Q + +R D+L I + + +E +A+
Sbjct: 295 FPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAK 348
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 4e-06
Identities = 31/154 (20%), Positives = 58/154 (37%), Gaps = 18/154 (11%)
Query: 380 SSKLQVLDLSSNHIFGKIPVQLVK-LFSLNKLILSLNQL-FGGVPLEFGTLTE----LQY 433
L ++L+S + L+ KL L LN L L +
Sbjct: 100 RHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLLHDQCQITT 159
Query: 434 LDLSANKLSSSIPMSIGNLLK----LHYLNLSNNQFSHK----IPTEFEKLIHLSELDLS 485
L LS N L+++ + L + +L+L + + + + ++ L EL+++
Sbjct: 160 LRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVA 219
Query: 486 HNILQEEIPPQICKM----ESLEKLNLSHNNLSD 515
+N + + + SLE L+L N LS
Sbjct: 220 YNGAGDTAALALARAAREHPSLELLHLYFNELSS 253
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 2e-05
Identities = 24/124 (19%), Positives = 47/124 (37%), Gaps = 20/124 (16%)
Query: 431 LQYLDLSANKLSSSIPMSIGN-LLKLHYLNLSNNQFSHKIPTEFEKL--------IHLSE 481
L ++L++ +L + ++ L+ L L N P + L ++
Sbjct: 103 LDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLG---PEACKDLRDLLLHDQCQITT 159
Query: 482 LDLSHNILQEEIPPQICKM----ESLEKLNLSHNNLSD----FIPRCFEEMRSLSWIDIS 533
L LS+N L + + S+ L+L H L D + + R L ++++
Sbjct: 160 LRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVA 219
Query: 534 YNEL 537
YN
Sbjct: 220 YNGA 223
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372 | Back alignment and structure |
|---|
Score = 43.2 bits (102), Expect = 3e-04
Identities = 55/431 (12%), Positives = 114/431 (26%), Gaps = 109/431 (25%)
Query: 103 NSLFGSIPIVMGNLKSLSTLDLSQNQLNGSIPCSLDNLSNLDTLFLYKNSLSGPIPSVIG 162
++ + + NL +L + +L L LD +
Sbjct: 12 RAVLAQLGCPIKNLDALENAQAIKKKLGKLGRQVLPPSELLD-HLFFHYEFQN-QRFSAE 69
Query: 163 NLKSLLQLDLSENRLS--GLIPLS---LSNLSSLTVMSLFNNSLSG-SIPPILGNLKSLS 216
L SL QL+L+ R++ ++ S +L ++L + L + +L
Sbjct: 70 VLSSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRAR 129
Query: 217 TLGLHINQL--NGVIPPSIG-----NLSSLRNLSLFNNRLYGFVPKEIGYLKSLSKLEFC 269
LGL +N L + + + L L NN L
Sbjct: 130 KLGLQLNSLGPEACK--DLRDLLLHDQCQITTLRLSNNPLT----------------AAG 171
Query: 270 ANHLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLRNLTSLERVRFNQNNLYGKVYEAF 329
L + + T + L++ L G + L L
Sbjct: 172 VAVLMEGLAGN----TSVTHLSLLHTGL-GD--EGLELLA-----------------AQL 207
Query: 330 GDHPNLTFLDLSQNNFYCEISFNWRNFSKLGTFNASMNNIYGSIPPEIGDSSKLQVLDLS 389
+ L L+++ N G A ++ + L++L L
Sbjct: 208 DRNRQLQELNVAYNG--------------AGDTAAL------ALARAAREHPSLELLHLY 247
Query: 390 SNHIFGKIPVQLVKLFSLNKLILSLNQLFGGVPLEFGTLTELQYLDLSANKLSSSIPMSI 449
N + + L L + + +S + +
Sbjct: 248 FNELSSEGRQVLRDLGGAAE-----------------GGARVVVSLTEGTAVSEYWSVIL 290
Query: 450 GNLLK-LHYLNLSNNQFSHKIPTEFEKLIHLSELDLSHNILQEEIPPQICKM----ESLE 504
+ + L+ + + Q + + L DL + P + ++ +
Sbjct: 291 SEVQRNLNSWDRARVQ----------RHLELLLRDLEDSRGATLNPWRKAQLLRVEGEVR 340
Query: 505 KLNLSHNNLSD 515
L +
Sbjct: 341 ALLEQLGSSGS 351
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 48.0 bits (113), Expect = 8e-06
Identities = 28/190 (14%), Positives = 47/190 (24%), Gaps = 50/190 (26%)
Query: 654 IGKGGQRSVYKAELPSGNIFAVKKF----KAELFSDETANPSEFLNEVLALTEI------ 703
IG+G V++ A+K + E L E++ E+
Sbjct: 28 IGEGVFGEVFQTIAD-HTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGE 86
Query: 704 ---RHRNIIKFHGFC------------------------------SNAQHSFIVCEYLAR 730
R I + FIV E+
Sbjct: 87 VCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFG 146
Query: 731 GSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYE 790
G + K S +++ + +L+ HRD+ NVLL
Sbjct: 147 GIDL----EQMRTKLSSLATAKSILHQLTASLAVAEASL--RFEHRDLHWGNVLLKKTSL 200
Query: 791 AHVSDFGFAK 800
+ K
Sbjct: 201 KKLHYTLNGK 210
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 9e-06
Identities = 37/190 (19%), Positives = 69/190 (36%), Gaps = 42/190 (22%)
Query: 639 EEITKATGN---FGEKYCIGKGGQRSVYKAE---------LPSGNIFAVK------KFKA 680
+T +G + Q +Y+A P F++K +
Sbjct: 34 TVLTDKSGRQWKLKSF--QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFN 91
Query: 681 ELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSN-AQHSFIVCEYLARGSLTTILRD 739
E + A +N+ L I GF + ++ F+V L R SL + D
Sbjct: 92 EQNFFQRAAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGR-SLQS-ALD 149
Query: 740 DAAAKEFSWNQRMNVIKGVA-------NALSYLHHDCIPPIVHRDISSKNVLLDSEYEAH 792
+ S + V +AL +LH + VH +++++N+ +D E ++
Sbjct: 150 VSPKHVLS-------ERSVLQVACRLLDALEFLHENEY---VHGNVTAENIFVDPEDQSQ 199
Query: 793 V--SDFGFAK 800
V + +GFA
Sbjct: 200 VTLAGYGFAF 209
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 47.5 bits (113), Expect = 1e-05
Identities = 40/199 (20%), Positives = 70/199 (35%), Gaps = 46/199 (23%)
Query: 654 IGKGGQRSVYKAELPSGNIFAVKKFKA-------------ELFSDETANPSEFLNEVLAL 700
IG+GG +Y A++ S EL + A E + + +
Sbjct: 43 IGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRT 102
Query: 701 TEIRHRNIIKFHGF----CSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIK 756
++++ + K+ G + + F++ + L I +A AK FS K
Sbjct: 103 RKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGS-DLQKIY--EANAKRFS-------RK 152
Query: 757 GVA-------NALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHV--SDFGFAKFLEPHSS 807
V + L Y+H VH DI + N+LL+ + V D+G A P
Sbjct: 153 TVLQLSLRILDILEYIHEHEY---VHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGV 209
Query: 808 NW-------TEFAGTVGYA 819
+ GT+ +
Sbjct: 210 HKAYAADPKRCHDGTIEFT 228
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 3e-05
Identities = 52/257 (20%), Positives = 93/257 (36%), Gaps = 68/257 (26%)
Query: 654 IGKGGQRSVYKAE-LPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIR-------- 704
+G G +V+ A+ + + A+K + + E A +E+ L +
Sbjct: 27 LGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAA-----EDEIKLLQRVNDADNTKED 81
Query: 705 ---HRNIIK------FHGFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQR---M 752
+I+K G N H +V E L +L +++ + R +
Sbjct: 82 SMGANHILKLLDHFNHKG--PNGVHVVMVFEVL-GENLLALIKK--------YEHRGIPL 130
Query: 753 NVIKGVA----NALSYLHHDCIPPIVHRDISSKNVLLDSEYEAH------VSDFGFAKFL 802
+K ++ L Y+H C I+H DI +NVL++ ++D G A +
Sbjct: 131 IYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWY 188
Query: 803 EPHSSNW--TEFAGTVGYAAPE----LAYTMRATEKYDVYSFGVLALEVIKGYH--PGDF 854
+ H +N T Y +PE + A D++S L E+I G D
Sbjct: 189 DEHYTNSIQTRE-----YRSPEVLLGAPWGCGA----DIWSTACLIFELITGDFLFEPDE 239
Query: 855 VSTIFSSIS--NMIIEV 869
+ IIE+
Sbjct: 240 GHSYTKDDDHIAQIIEL 256
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 46.7 bits (111), Expect = 3e-05
Identities = 63/360 (17%), Positives = 102/360 (28%), Gaps = 113/360 (31%)
Query: 612 DPQEKRSSSANPFGFFSVLNFNGKVLYEEITKATGNFGEKYCIGKGGQRSVYKA-ELPSG 670
SS F + N + Y IG+G VY A + +
Sbjct: 2 HHHHHHSSGRENLYFQGIKNVHVPDNYIIKHL----------IGRGSYGYVYLAYDKNTE 51
Query: 671 NIFAVKK----FKAELFSDETANPSEFLNEVLALTEIRHRNIIK-FHGFCSNAQHSF--- 722
A+KK F+ + L E+ L ++ II+ + + F
Sbjct: 52 KNVAIKKVNRMFEDLIDCKRI------LREITILNRLKSDYIIRLYDLIIPDDLLKFDEL 105
Query: 723 -IVCEYL---------ARGSLTT---------ILRDDAAAKEFSWNQRMNVIKGVANALS 763
IV E LT +L +
Sbjct: 106 YIVLEIADSDLKKLFKTPIFLTEEHIKTILYNLLL----------------------GEN 143
Query: 764 YLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEP------------------- 804
++H I+HRD+ N LL+ + V DFG A+ +
Sbjct: 144 FIHE---SGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPH 200
Query: 805 ---HSSNWTEFAGTVGYAAPELAYTMRATEKY----DVYSFG-VLALEVIKGYHPGDFVS 856
T T Y APEL + E Y D++S G + A E++
Sbjct: 201 NKNLKKQLTSHVVTRWYRAPEL---ILLQENYTKSIDIWSTGCIFA-ELLNMLQSHINDP 256
Query: 857 T----IFSSISNMIIEVNQILDHRLPTPSRDVTDKLRSIMEV------AILCLVENPEAR 906
T +F S + ++ + + D+L I + L + PE
Sbjct: 257 TNRFPLFPGSSCFPLSPDR---NSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVI 313
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 6e-05
Identities = 35/171 (20%), Positives = 59/171 (34%), Gaps = 38/171 (22%)
Query: 654 IGKGGQRSVYKAE-LPSGNIFAVKKFKAE------LFSD----ETANPSEFLNEVLALTE 702
IG GG +Y A A K E LFS+ + + + + + +
Sbjct: 45 IGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQ 104
Query: 703 IRHRNIIKFHGF----CSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGV 758
+ + I F+G + F+V E L L I N V
Sbjct: 105 LDYLGIPLFYGSGLTEFKGRSYRFMVMERLGI-DLQKI---------SGQNGTFK-KSTV 153
Query: 759 A-------NALSYLHHDCIPPIVHRDISSKNVLLDSEYE--AHVSDFGFAK 800
+ L Y+H + VH DI + N+LL + +++D+G +
Sbjct: 154 LQLGIRMLDVLEYIHENEY---VHGDIKAANLLLGYKNPDQVYLADYGLSY 201
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594 | Back alignment and structure |
|---|
Score = 44.5 bits (105), Expect = 1e-04
Identities = 23/148 (15%), Positives = 40/148 (27%), Gaps = 13/148 (8%)
Query: 381 SKLQVLDLSSNHIFGKIPVQLVKLFSLNKLILSLNQLFGGVPLEFGTL-------TELQY 433
L+ LDL + + L ++SLN + F L L+
Sbjct: 156 RNLKELDLRESDVDDVSGHWLSHFPDTYTSLVSLNISCLASEVSFSALERLVTRCPNLKS 215
Query: 434 LDLSANKLSSSIPMSIGNLLKLHYLNLS------NNQFSHKIPTEFEKLIHLSELDLSHN 487
L L+ + + +L L + L L +
Sbjct: 216 LKLNRAVPLEKLATLLQRAPQLEELGTGGYTAEVRPDVYSGLSVALSGCKELRCLSGFWD 275
Query: 488 ILQEEIPPQICKMESLEKLNLSHNNLSD 515
+ +P L LNLS+ +
Sbjct: 276 AVPAYLPAVYSVCSRLTTLNLSYATVQS 303
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594 | Back alignment and structure |
|---|
Score = 43.3 bits (102), Expect = 4e-04
Identities = 55/449 (12%), Positives = 129/449 (28%), Gaps = 54/449 (12%)
Query: 85 IPSSLGNLSNLALLYLNDNSLFGSIPIVMGNLKSLSTLDLSQNQLNGSIPCSLDNLSNLD 144
P + +L +L + L F ++ ++ +L +L L++ + L L+
Sbjct: 179 FPDTYTSLVSLNISCLASEVSFSALERLVTRCPNLKSLKLNRAVPLEKLATLLQRAPQLE 238
Query: 145 TLFLYKNSLSGPIPSVIGNLKSLLQLDLSENRLSGLIPLSLSNLSSLTVMSLFNNSLSGS 204
L + + + ++LS L +S F +++
Sbjct: 239 ELGTGGYT------------------AEVRPDVYSGLSVALSGCKELRCLSGFWDAVPAY 280
Query: 205 IPPILGNLKSLSTLGLHINQLNGV-IPPSIGNLSSLRNLSLFNNRLYGFVPKEIGYLKSL 263
+P + L+TL L + + + L+ L + + + K L
Sbjct: 281 LPAVYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDYIEDAGLEVLASTCKDL 340
Query: 264 SKLEFCANHLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLRNLTSLERVRFNQNNLYG 323
+L + LT L+++ LE V + +
Sbjct: 341 RELRVF--PSEPFVMEPNVALTEQGLVSVS------------MGCPKLESVLYFCRQMTN 386
Query: 324 KVYEAFGDH-PNLTFLDLSQNNFYCEISFNW-----------RNFSKLGTFNASMNNIYG 371
+ PN+T L + L + S
Sbjct: 387 AALITIARNRPNMTRFRLCIIEPKAPDYLTLEPLDIGFGAIVEHCKDLRRLSLSGLLTDK 446
Query: 372 SIPPEIGDSSKLQVLDLSSNHIFGKIPVQLVK-LFSLNKLILSLNQLFG-GVPLEFGTLT 429
+ K+++L ++ ++ SL KL + + L
Sbjct: 447 VFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDKALLANASKLE 506
Query: 430 ELQYLDLSANKLSSSIPMSIGN---LLKLHYLNLSNNQFSHKIPTEFEKLIHLSELDLSH 486
++ L +S+ +S +G L + ++ S E++ +
Sbjct: 507 TMRSLWMSSCSVSFGACKLLGQKMPKLNVEVIDERGAPDSRPESCPVERVFIYRTVAGP- 565
Query: 487 NILQEEIPPQICKMESLEKLNLSHNNLSD 515
+ ++P + M+ + S ++
Sbjct: 566 ---RFDMPGFVWNMDQDSTMRFSRQIITT 591
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A Length = 267 | Back alignment and structure |
|---|
Score = 43.1 bits (101), Expect = 2e-04
Identities = 35/175 (20%), Positives = 60/175 (34%), Gaps = 44/175 (25%)
Query: 332 HPNLTFLDLS--QNNFYCEISFNWRNFSKLGTFNASMNNIYGSIPPEIGDSSKLQVLDLS 389
+ LDL +++ ++ A++ I +IP +L L+LS
Sbjct: 126 DGSQQALDLKGLRSDPDLVAQNIDVVLNRRSCMAATLRIIEENIP-------ELLSLNLS 178
Query: 390 SNHIFGKIPVQLVKLFSLNKLILSLNQLFGGVPLEFGTLTELQYLDLSANKLSSSIPMSI 449
+N ++ +L + S+ + L+ L+LS N+L S +
Sbjct: 179 NNRLY-----RLDDMSSIVQ-----------------KAPNLKILNLSGNELKSERELDK 216
Query: 450 GNLLKLHYLNLSNNQFSHKIPTE-------FEKLIHLSELDLSHNILQEEIPPQI 497
LKL L L N + E+ L LD E+PP I
Sbjct: 217 IKGLKLEELWLDGNSLCDTFRDQSTYISAIRERFPKLLRLD------GHELPPPI 265
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 43.0 bits (101), Expect = 3e-04
Identities = 49/275 (17%), Positives = 86/275 (31%), Gaps = 82/275 (29%)
Query: 647 NFGEKYCI----GKGGQRSVYKAE-LPSGNIFAVKKFKAELFSDETANPSEFLNEVLALT 701
F +Y + G G +V+ + + A+K K+ ETA L+E+ L
Sbjct: 34 LFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETA-----LDEIRLLK 88
Query: 702 EIR--------HRNIIK------FHGFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFS 747
+R +++ G N H +V E + L + + +
Sbjct: 89 SVRNSDPNDPNREMVVQLLDDFKISG--VNGTHICMVFE-VLGHHLLKWIIK-SNYQGLP 144
Query: 748 WNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSE------------------- 788
+I+ V L YLH C I+H DI +N+LL
Sbjct: 145 LPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGA 202
Query: 789 ------------------------------YEAHVSDFGFAKFLEPHSSNWTEFAGTVGY 818
+ ++D G A ++ H TE T Y
Sbjct: 203 PPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHF---TEDIQTRQY 259
Query: 819 AAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGD 853
+ E+ D++S +A E+ G + +
Sbjct: 260 RSLEVLIGSGYNTPADIWSTACMAFELATGDYLFE 294
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 4e-04
Identities = 34/188 (18%), Positives = 64/188 (34%), Gaps = 28/188 (14%)
Query: 648 FGEKY----CIGKGGQRSVYKAE-LPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTE 702
G +Y IG G +Y + +G A+K + + E
Sbjct: 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVK------TKHPQLHIESKIYKM 60
Query: 703 IRH-RNIIKFHGFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANA 761
++ I + ++ +V E L SL + +++FS + + + +
Sbjct: 61 MQGGVGIPTIRWCGAEGDYNVMVMELLGP-SLEDLFN--FCSRKFSLKTVLLLADQMISR 117
Query: 762 LSYLHHDCIPPIVHRDISSKNVLL---DSEYEAHVSDFGFAKFLEPHSSNW-------TE 811
+ Y+H +HRD+ N L+ ++ DFG AK ++
Sbjct: 118 IEYIHSKNF---IHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKN 174
Query: 812 FAGTVGYA 819
GT YA
Sbjct: 175 LTGTARYA 182
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 42.8 bits (101), Expect = 4e-04
Identities = 62/283 (21%), Positives = 106/283 (37%), Gaps = 85/283 (30%)
Query: 654 IGKGGQRSVYKA-ELPSGNIFAVKKFKAELFSDETANPSEFLNEVLA---LTEIR----- 704
+GKG V+K+ + +G + AVKK + F N A EI
Sbjct: 17 LGKGAYGIVWKSIDRRTGEVVAVKKI---------FDA--FQNSTDAQRTFREIMILTEL 65
Query: 705 --HRNIIKFHGFC--SNAQHSFIVCEY----LARGSLTTILRDDAAAKEFSWNQRMNVIK 756
H NI+ N + ++V +Y L IL + + +IK
Sbjct: 66 SGHENIVNLLNVLRADNDRDVYLVFDYMETDLHAVIRANILEPVHK-QYVVYQ----LIK 120
Query: 757 GVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFA----------------- 799
+ YLH ++HRD+ N+LL++E V+DFG +
Sbjct: 121 V----IKYLHS---GGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSI 173
Query: 800 ----KFLEPHSSNWTEFAGTVGYAAPELAYTMRATEKY----DVYSFG-VLALEVIKGYH 850
+ + T++ T Y APE+ + + KY D++S G +L E++ G
Sbjct: 174 NENTENFDDDQPILTDYVATRWYRAPEI---LLGSTKYTKGIDMWSLGCILG-EILCGKP 229
Query: 851 --PG-DFVSTIFSSISNMIIEVNQILDHRLPTPSRDVTDKLRS 890
PG ++ + II V + PS + + ++S
Sbjct: 230 IFPGSSTMNQL-----ERIIGV-------IDFPSNEDVESIQS 260
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Length = 336 | Back alignment and structure |
|---|
Score = 41.8 bits (98), Expect = 7e-04
Identities = 45/225 (20%), Positives = 74/225 (32%), Gaps = 27/225 (12%)
Query: 19 NLSKLQYLDLGNNQLSGVIPPEIGKLNQLRRLYLDVNQLHGTIPPVIGQLSLINELVFCH 78
SKLQ L L +LS I + K + L RL L S +E
Sbjct: 116 QCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLS-------------GCSGFSEFALQT 162
Query: 79 NNVSGRIPSSLGNLSNLALLY---LNDNSLFGSIPIVMGNLKSLSTLDLSQNQLNGSIPC 135
+ SS L L L + + + ++ V + L+ +N +
Sbjct: 163 ------LLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLST 216
Query: 136 SLDNLSNLDTLFLYK-NSLSGPIPSVIGNLKSLLQLDLSE-NRLSGLIPLSLSNLSSLTV 193
+ NL L L L L L L LS + L L + +L
Sbjct: 217 LVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKT 276
Query: 194 MSLFNNSLSGSIPPILGNLKSLSTLGLHINQLNGVIPPSIGNLSS 238
+ +F G++ + L L ++ + + P+IGN +
Sbjct: 277 LQVFGIVPDGTLQLLKEALPHLQ---INCSHFTTIARPTIGNKKN 318
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 8e-04
Identities = 34/198 (17%), Positives = 63/198 (31%), Gaps = 46/198 (23%)
Query: 648 FGEKY----CIGKGGQRSVYKAE-LPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTE 702
G + IG G + + L + A+K + + E +
Sbjct: 7 VGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIK------LEPMKSRAPQLHLEYRFYKQ 60
Query: 703 IRH-RNIIKFHGFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVA-- 759
+ I + + F +++ +V E L SL + F R +K V
Sbjct: 61 LGSGDGIPQVYYFGPCGKYNAMVLELLGP-SLEDL---------FDLCDRTFSLKTVLMI 110
Query: 760 -----NALSYLH-HDCIPPIVHRDISSKNVLL-----DSEYEAHVSDFGFAKFLEPHSSN 808
+ + Y+H + I +RD+ +N L+ ++ H+ DF AK +
Sbjct: 111 AIQLISRMEYVHSKNLI----YRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETK 166
Query: 809 W-------TEFAGTVGYA 819
GT Y
Sbjct: 167 KHIPYREHKSLTGTARYM 184
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 Length = 185 | Back alignment and structure |
|---|
Score = 40.4 bits (95), Expect = 9e-04
Identities = 16/101 (15%), Positives = 33/101 (32%), Gaps = 14/101 (13%)
Query: 429 TELQYLDLSANKLSSSIPMSIGNLLK----LHYLNLSNNQFSHK----IPTEFEKLIHLS 480
T ++ + + + + ++ +LK L LN+ +N S + + L
Sbjct: 65 TYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVEALQSNTSLI 124
Query: 481 ELDLSHNILQ------EEIPPQICKMESLEKLNLSHNNLSD 515
EL + + EI + K +L K
Sbjct: 125 ELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQGP 165
|
Structure Templates Detected by HHsearch 
Original result of HHsearch against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 918 | |||
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 100.0 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 100.0 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 100.0 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 100.0 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 100.0 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 100.0 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 100.0 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 100.0 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 100.0 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 100.0 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 100.0 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 100.0 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 100.0 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 100.0 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 100.0 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 100.0 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 100.0 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 100.0 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 100.0 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 100.0 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 100.0 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 100.0 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 100.0 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 100.0 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 99.97 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 99.97 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.97 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.97 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.97 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.97 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.97 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.96 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.96 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.96 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.96 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.96 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 99.96 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.96 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.96 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.95 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 99.95 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.95 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.95 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.95 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.95 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.95 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.95 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.95 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.94 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.94 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.93 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.93 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 99.93 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 99.93 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.93 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.92 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.92 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.92 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.92 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.91 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.91 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.9 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.9 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.9 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.9 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.89 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.89 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.89 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.89 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.89 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.88 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.88 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.88 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.88 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.88 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.87 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.85 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.84 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.84 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.84 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.84 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.83 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.82 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.82 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.82 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.82 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.81 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.81 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.8 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.8 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.8 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.79 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 99.78 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 99.77 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.77 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.77 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.77 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.76 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.76 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.75 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.75 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.74 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 99.73 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.73 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 99.73 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.72 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.71 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.71 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 99.71 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.7 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 99.7 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.68 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.68 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.68 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.66 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.64 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.63 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.63 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.63 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.59 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.59 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.58 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.57 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.55 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 99.55 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.55 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 99.53 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.49 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.46 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 99.34 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.34 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.34 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 99.33 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 99.33 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 99.31 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.17 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.01 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 98.93 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.92 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 98.88 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.78 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.58 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.54 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.52 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.43 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.36 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.32 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.26 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.23 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.13 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.01 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 97.95 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 97.89 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.88 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.8 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 97.67 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.65 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 97.51 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.48 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.47 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 97.41 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 97.25 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.05 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.05 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.04 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 96.99 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.74 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.74 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 96.57 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.53 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.21 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.15 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.28 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 94.74 | |
| 2l2t_A | 44 | Receptor tyrosine-protein kinase ERBB-4; transmemb | 92.33 | |
| 2ks1_B | 44 | Epidermal growth factor receptor; ERBB1, ERBB2, tr | 91.95 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 89.63 | |
| 2jwa_A | 44 | Receptor tyrosine-protein kinase ERBB-2; transmemb | 87.05 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 82.73 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 82.5 |
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-72 Score=685.43 Aligned_cols=564 Identities=30% Similarity=0.448 Sum_probs=429.1
Q ss_pred ccCCCCCCccCCccCCCCCCCCEEeCCCCcccccCCc--cccCCCCCCEEEcccccccccCCCCc-CCCCCCCEEEcccc
Q 044366 3 NLGFNLLFGNIPPQIGNLSKLQYLDLGNNQLSGVIPP--EIGKLNQLRRLYLDVNQLHGTIPPVI-GQLSLINELVFCHN 79 (918)
Q Consensus 3 ~~~~~~~~~~~p~~~~~l~~L~~L~L~~n~i~~~~p~--~l~~l~~L~~L~L~~n~l~~~~p~~~-~~l~~L~~L~l~~n 79 (918)
++++|++. .+|+.++++++|++|||++|++++.+|. .++.+++|++|+|++|.+++.+|..+ ..+++|++|++++|
T Consensus 83 ~~~~~~~~-~l~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~Ls~n 161 (768)
T 3rgz_A 83 FLSNSHIN-GSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSAN 161 (768)
T ss_dssp ECTTSCEE-ECCCCCCCCTTCCEEECCSSEEEEEGGGGGGGGGCTTCCEEECCSSEEECCSSCCSCCCCTTCSEEECCSS
T ss_pred CCcCCCcC-CCchhhccCCCCCEEECCCCcCCCcCCChHHHhCCCCCCEEECcCCccCCcCCHHHhccCCCCCEEECCCC
Confidence 34444443 3445666666666666666666655555 66666666666666666665555544 55666666666666
Q ss_pred cccccCCcc---ccCC----------------------CCCCEEEccCCcccccCccccCCCCCCCEEECcCCcCCCcCC
Q 044366 80 NVSGRIPSS---LGNL----------------------SNLALLYLNDNSLFGSIPIVMGNLKSLSTLDLSQNQLNGSIP 134 (918)
Q Consensus 80 ~~~~~~p~~---l~~l----------------------~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~ 134 (918)
.+++..|.. +.++ ++|++|+|++|++.+..|. +.++++|++|+|++|++++..|
T Consensus 162 ~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~l~~L~~L~Ls~n~l~~~~~~-l~~l~~L~~L~Ls~n~l~~~~~ 240 (768)
T 3rgz_A 162 SISGANVVGWVLSDGCGELKHLAISGNKISGDVDVSRCVNLEFLDVSSNNFSTGIPF-LGDCSALQHLDISGNKLSGDFS 240 (768)
T ss_dssp CCEEETHHHHHHTTCCTTCCEEECCSSEEESCCBCTTCTTCCEEECCSSCCCSCCCB-CTTCCSCCEEECCSSCCCSCHH
T ss_pred ccCCcCChhhhhhccCCCCCEEECCCCcccccCCcccCCcCCEEECcCCcCCCCCcc-cccCCCCCEEECcCCcCCCccc
Confidence 665555444 4444 4455555555554444443 5555555555555555554445
Q ss_pred cCCCCCCCCceeeccccccccCCCcccccccccCeeeccccccCCcCCccCCCC-CCCcEeeccCcccccCCCccccCCC
Q 044366 135 CSLDNLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSENRLSGLIPLSLSNL-SSLTVMSLFNNSLSGSIPPILGNLK 213 (918)
Q Consensus 135 ~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l-~~L~~L~L~~N~l~~~~~~~~~~l~ 213 (918)
..++++++|++|++++|++++..|.. .+++|++|++++|++++.+|..+... ++|++|+|++|.+++..|..|.+++
T Consensus 241 ~~l~~l~~L~~L~Ls~n~l~~~~~~~--~l~~L~~L~L~~n~l~~~ip~~~~~~~~~L~~L~Ls~n~l~~~~p~~~~~l~ 318 (768)
T 3rgz_A 241 RAISTCTELKLLNISSNQFVGPIPPL--PLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCS 318 (768)
T ss_dssp HHTTTCSSCCEEECCSSCCEESCCCC--CCTTCCEEECCSSEEEESCCCCSCTTCTTCSEEECCSSEEEECCCGGGGGCT
T ss_pred HHHhcCCCCCEEECCCCcccCccCcc--ccCCCCEEECcCCccCCccCHHHHhhcCcCCEEECcCCcCCCccchHHhcCC
Confidence 55555555555555555555443332 45555555555555554555555443 6777777777777666677777777
Q ss_pred CcceeecccccccCCCCCC-CcCCCcCCeEEcccCcCcCCCCccccccC-CCCeEecCCCccCCcCCCcCCC--CCCCcE
Q 044366 214 SLSTLGLHINQLNGVIPPS-IGNLSSLRNLSLFNNRLYGFVPKEIGYLK-SLSKLEFCANHLSGVIPHSVGN--LTGLVL 289 (918)
Q Consensus 214 ~L~~L~L~~n~l~~~~~~~-~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~-~L~~L~l~~n~l~~~~~~~~~~--l~~L~~ 289 (918)
+|++|++++|++++.+|.. +..+++|++|++++|++++..|..+..++ +|+.|++++|++.+..|..+.. +++|+.
T Consensus 319 ~L~~L~L~~n~l~~~ip~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~ 398 (768)
T 3rgz_A 319 LLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQE 398 (768)
T ss_dssp TCCEEECCSSEEEEECCHHHHTTCTTCCEEECCSSEEEECCCTTHHHHTTTCSEEECCSSEEEEECCTTTTCSTTCCCCE
T ss_pred CccEEECCCCcccCcCCHHHHhcCCCCCEEeCcCCccCccccHHHHhhhcCCcEEEccCCCcCCCcChhhhhcccCCccE
Confidence 7777777777776555544 66777777777777777766666666666 7777777777777666666665 778889
Q ss_pred EEccCCcCcCCCCccccCCCCCCeEEeecccccCccccccCCCCCccEEeCCCCccccccCcccccccccceeecccccc
Q 044366 290 LNMCENHLFGPIPKSLRNLTSLERVRFNQNNLYGKVYEAFGDHPNLTFLDLSQNNFYCEISFNWRNFSKLGTFNASMNNI 369 (918)
Q Consensus 290 L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~n~i 369 (918)
|++++|++++.+|..+.++++|++|++++|.+....+..|..+++|+.|++++|.+.......+..++.|+.|++++|++
T Consensus 399 L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l 478 (768)
T 3rgz_A 399 LYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDL 478 (768)
T ss_dssp EECCSSEEEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCC
T ss_pred EECCCCccccccCHHHhcCCCCCEEECcCCcccCcccHHHhcCCCCCEEECCCCcccCcCCHHHcCCCCceEEEecCCcc
Confidence 99999998888999999999999999999999988888999999999999999999888888888999999999999999
Q ss_pred ccCCCcCcCCCCCCcEEEccCceeccccccchhhccccCceecccccccCCCCCCCCCCCcccEEeccCccccccCccc-
Q 044366 370 YGSIPPEIGDSSKLQVLDLSSNHIFGKIPVQLVKLFSLNKLILSLNQLFGGVPLEFGTLTELQYLDLSANKLSSSIPMS- 448 (918)
Q Consensus 370 ~~~~~~~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~- 448 (918)
.+.+|..+..+++|++|+|++|++.+.+|.++..+++|+.|+|++|++++.+|..+..+++|++|+|++|.+++.+|..
T Consensus 479 ~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~ 558 (768)
T 3rgz_A 479 TGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAM 558 (768)
T ss_dssp CSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEEECCGGGGGCTTCCEEECCSSEEESBCCGGG
T ss_pred cCcCCHHHhcCCCCCEEEccCCccCCcCChHHhcCCCCCEEECCCCcccCcCCHHHcCCCCCCEEECCCCccCCcCChHH
Confidence 9999999999999999999999999999999999999999999999999999999999999999999999988766643
Q ss_pred ---------------------------------------------------------------------cccccccceec
Q 044366 449 ---------------------------------------------------------------------IGNLLKLHYLN 459 (918)
Q Consensus 449 ---------------------------------------------------------------------~~~l~~L~~L~ 459 (918)
|..+++|+.||
T Consensus 559 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~g~~~~~~~~l~~L~~Ld 638 (768)
T 3rgz_A 559 FKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLD 638 (768)
T ss_dssp GTTTTCBCCSTTCSCEEEEEECCSCCTTCCSSEEEEECTTCCGGGGGGGGGTCCSCTTSCEEEEECCCSCSSSBCCCEEE
T ss_pred hcccchhhhhccccccccccccccccccccccccccccccccchhhhccccccccccccceecccCchhhhccccccEEE
Confidence 33457899999
Q ss_pred ccCcccCCCCchhhccccccceEeccCCcCCCCCchhccccCCcceEecCCCcccccCcccccCCCCccEEEccCCcCCC
Q 044366 460 LSNNQFSHKIPTEFEKLIHLSELDLSHNILQEEIPPQICKMESLEKLNLSHNNLSDFIPRCFEEMRSLSWIDISYNELQG 539 (918)
Q Consensus 460 Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~ 539 (918)
|++|++++.+|..|+.+++|+.|+|++|++++.+|..|+.+++|+.|||++|++++.+|..+..+++|++||+++|+++|
T Consensus 639 Ls~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ls~N~l~g 718 (768)
T 3rgz_A 639 MSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSG 718 (768)
T ss_dssp CCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEEECCSSEEEE
T ss_pred CcCCcccccCCHHHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECcCCcccc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCcc---cccccccCCCCccCCCCCCCCCCccC
Q 044366 540 PIPNSTA---FKNGLMEGNKGLCGNFKALPSCDAFT 572 (918)
Q Consensus 540 ~~p~~~~---~~~~~~~~n~~~c~~~~~~~~c~~~~ 572 (918)
.+|...+ +....+.||+++||.+. ++|....
T Consensus 719 ~iP~~~~~~~~~~~~~~gN~~Lcg~~l--~~C~~~~ 752 (768)
T 3rgz_A 719 PIPEMGQFETFPPAKFLNNPGLCGYPL--PRCDPSN 752 (768)
T ss_dssp ECCSSSSGGGSCGGGGCSCTEEESTTS--CCCCSCC
T ss_pred cCCCchhhccCCHHHhcCCchhcCCCC--cCCCCCc
Confidence 9998765 45567999999999874 4886543
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-67 Score=643.10 Aligned_cols=539 Identities=31% Similarity=0.435 Sum_probs=416.7
Q ss_pred CcccCCCCCCcc---CCccCCCCCCCCEEeCCCCcccccCCccccCCCCCCEEEcccccccccCCC--CcCCCCCCCEEE
Q 044366 1 MLNLGFNLLFGN---IPPQIGNLSKLQYLDLGNNQLSGVIPPEIGKLNQLRRLYLDVNQLHGTIPP--VIGQLSLINELV 75 (918)
Q Consensus 1 ~l~~~~~~~~~~---~p~~~~~l~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~--~~~~l~~L~~L~ 75 (918)
.|+|+++++.|. +|+.++++++|+.++++.+.+. .+|..|+.+++|++|+|++|.+++.+|. .++.+++|++|+
T Consensus 54 ~L~L~~~~l~g~~~~l~~~l~~L~~L~~l~~~~~~~~-~l~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~l~~l~~L~~L~ 132 (768)
T 3rgz_A 54 SIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHIN-GSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLN 132 (768)
T ss_dssp EEECTTSCCCEEHHHHHHHTTTCTTCCEEECTTSCEE-ECCCCCCCCTTCCEEECCSSEEEEEGGGGGGGGGCTTCCEEE
T ss_pred EEECCCCCcCCccCccChhHhccCcccccCCcCCCcC-CCchhhccCCCCCEEECCCCcCCCcCCChHHHhCCCCCCEEE
Confidence 379999999999 9999999999999999999997 6789999999999999999999998999 999999999999
Q ss_pred cccccccccCCccc-cCCCCCCEEEccCCcccccCccc---cCCCCCCCEEECcCCcCCCcCCcCCCCCCCCceeecccc
Q 044366 76 FCHNNVSGRIPSSL-GNLSNLALLYLNDNSLFGSIPIV---MGNLKSLSTLDLSQNQLNGSIPCSLDNLSNLDTLFLYKN 151 (918)
Q Consensus 76 l~~n~~~~~~p~~l-~~l~~L~~L~L~~n~i~~~~~~~---~~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n 151 (918)
+++|.+.+..|..+ .++++|++|+|++|++++..|.. +.++++|++|++++|++++..| +..+++|++|+|++|
T Consensus 133 Ls~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~Ls~n 210 (768)
T 3rgz_A 133 VSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAISGNKISGDVD--VSRCVNLEFLDVSSN 210 (768)
T ss_dssp CCSSEEECCSSCCSCCCCTTCSEEECCSSCCEEETHHHHHHTTCCTTCCEEECCSSEEESCCB--CTTCTTCCEEECCSS
T ss_pred CcCCccCCcCCHHHhccCCCCCEEECCCCccCCcCChhhhhhccCCCCCEEECCCCcccccCC--cccCCcCCEEECcCC
Confidence 99999998888876 89999999999999999887766 6677777777777777665433 256666666666666
Q ss_pred ccccCCCcccccccccCeeeccccccCCcCCccCCCCCCCcEeeccCcccccCCCccccCCCCcceeecccccccCCCCC
Q 044366 152 SLSGPIPSVIGNLKSLLQLDLSENRLSGLIPLSLSNLSSLTVMSLFNNSLSGSIPPILGNLKSLSTLGLHINQLNGVIPP 231 (918)
Q Consensus 152 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~ 231 (918)
++++.+|. |+.+++|++|++++|++++..|..+..+++|++|++++|.+++..|.. .+++|++|++++|++++.+|.
T Consensus 211 ~l~~~~~~-l~~l~~L~~L~Ls~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~--~l~~L~~L~L~~n~l~~~ip~ 287 (768)
T 3rgz_A 211 NFSTGIPF-LGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPL--PLKSLQYLSLAENKFTGEIPD 287 (768)
T ss_dssp CCCSCCCB-CTTCCSCCEEECCSSCCCSCHHHHTTTCSSCCEEECCSSCCEESCCCC--CCTTCCEEECCSSEEEESCCC
T ss_pred cCCCCCcc-cccCCCCCEEECcCCcCCCcccHHHhcCCCCCEEECCCCcccCccCcc--ccCCCCEEECcCCccCCccCH
Confidence 66655554 666666666666666666655666666666666666666665444432 445555555555555544444
Q ss_pred CCcCC-CcCCeEEcccCcCcCCCCccccccCCCCeEecCCCccC-------------------------CcCCCcCCCCC
Q 044366 232 SIGNL-SSLRNLSLFNNRLYGFVPKEIGYLKSLSKLEFCANHLS-------------------------GVIPHSVGNLT 285 (918)
Q Consensus 232 ~~~~l-~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~-------------------------~~~~~~~~~l~ 285 (918)
.+... ++|++|++++|.+++..|..++.+++|++|++++|.+. +..|..+..++
T Consensus 288 ~~~~~~~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~ip~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~ 367 (768)
T 3rgz_A 288 FLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLS 367 (768)
T ss_dssp CSCTTCTTCSEEECCSSEEEECCCGGGGGCTTCCEEECCSSEEEEECCHHHHTTCTTCCEEECCSSEEEECCCTTHHHHT
T ss_pred HHHhhcCcCCEEECcCCcCCCccchHHhcCCCccEEECCCCcccCcCCHHHHhcCCCCCEEeCcCCccCccccHHHHhhh
Confidence 44332 45555555555554444444555555555555555544 44444444443
Q ss_pred -CCcEEEccCCcCcCCCCccccC--CCCCCeEEeecccccCccccccCCCCCccEEeCCCCccccccCccccccccccee
Q 044366 286 -GLVLLNMCENHLFGPIPKSLRN--LTSLERVRFNQNNLYGKVYEAFGDHPNLTFLDLSQNNFYCEISFNWRNFSKLGTF 362 (918)
Q Consensus 286 -~L~~L~l~~n~l~~~~~~~l~~--l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l 362 (918)
+|+.|++++|++.+.+|..+.. +++|++|++++|.+....+..|..+++|++|++++|.++......+..+++|+.|
T Consensus 368 ~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L 447 (768)
T 3rgz_A 368 ASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDL 447 (768)
T ss_dssp TTCSEEECCSSEEEEECCTTTTCSTTCCCCEEECCSSEEEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEE
T ss_pred cCCcEEEccCCCcCCCcChhhhhcccCCccEEECCCCccccccCHHHhcCCCCCEEECcCCcccCcccHHHhcCCCCCEE
Confidence 4555555555554444444444 5667777777777776777778888888888888888887777778888889999
Q ss_pred eccccccccCCCcCcCCCCCCcEEEccCceeccccccchhhccccCceecccccccCCCCCCCCCCCcccEEeccCcccc
Q 044366 363 NASMNNIYGSIPPEIGDSSKLQVLDLSSNHIFGKIPVQLVKLFSLNKLILSLNQLFGGVPLEFGTLTELQYLDLSANKLS 442 (918)
Q Consensus 363 ~l~~n~i~~~~~~~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~ 442 (918)
++++|.+.+.+|..+..+++|++|+|++|++.+..|..+.++++|+.|+|++|++++.+|.+++.+++|++|+|++|.++
T Consensus 448 ~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 527 (768)
T 3rgz_A 448 KLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFS 527 (768)
T ss_dssp ECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCE
T ss_pred ECCCCcccCcCCHHHcCCCCceEEEecCCcccCcCCHHHhcCCCCCEEEccCCccCCcCChHHhcCCCCCEEECCCCccc
Confidence 99999998888888888999999999999998888999999999999999999998888999999999999999999999
Q ss_pred ccCccccccccccceecccCcccCCCCchhh-------------------------------------------------
Q 044366 443 SSIPMSIGNLLKLHYLNLSNNQFSHKIPTEF------------------------------------------------- 473 (918)
Q Consensus 443 ~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~------------------------------------------------- 473 (918)
+.+|..+..+++|++|+|++|++++.+|..+
T Consensus 528 ~~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 607 (768)
T 3rgz_A 528 GNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRL 607 (768)
T ss_dssp EECCGGGGGCTTCCEEECCSSEEESBCCGGGGTTTTCBCCSTTCSCEEEEEECCSCCTTCCSSEEEEECTTCCGGGGGGG
T ss_pred CcCCHHHcCCCCCCEEECCCCccCCcCChHHhcccchhhhhccccccccccccccccccccccccccccccccchhhhcc
Confidence 8889999999999999999999887766543
Q ss_pred ---------------------ccccccceEeccCCcCCCCCchhccccCCcceEecCCCcccccCcccccCCCCccEEEc
Q 044366 474 ---------------------EKLIHLSELDLSHNILQEEIPPQICKMESLEKLNLSHNNLSDFIPRCFEEMRSLSWIDI 532 (918)
Q Consensus 474 ---------------------~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~l~l 532 (918)
..+++|+.|||++|++++.+|..++.+++|+.|+|++|++++.+|..+..+++|+.|||
T Consensus 608 ~~~~~~~l~~~~~~g~~~~~~~~l~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdL 687 (768)
T 3rgz_A 608 STRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDL 687 (768)
T ss_dssp GGTCCSCTTSCEEEEECCCSCSSSBCCCEEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEEC
T ss_pred ccccccccccceecccCchhhhccccccEEECcCCcccccCCHHHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEEC
Confidence 33567889999999999999999999999999999999999999999999999999999
Q ss_pred cCCcCCCCCCCCc
Q 044366 533 SYNELQGPIPNST 545 (918)
Q Consensus 533 ~~N~l~~~~p~~~ 545 (918)
++|+++|.+|..-
T Consensus 688 s~N~l~g~ip~~l 700 (768)
T 3rgz_A 688 SSNKLDGRIPQAM 700 (768)
T ss_dssp CSSCCEECCCGGG
T ss_pred CCCcccCcCChHH
Confidence 9999999998753
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-62 Score=594.20 Aligned_cols=537 Identities=25% Similarity=0.261 Sum_probs=275.2
Q ss_pred ccCCCCCCccCCccCCCCCCCCEEeCCCCcccccCCccccCCCCCCEEEcccccccccCCCCcCCCCCCCEEEccccccc
Q 044366 3 NLGFNLLFGNIPPQIGNLSKLQYLDLGNNQLSGVIPPEIGKLNQLRRLYLDVNQLHGTIPPVIGQLSLINELVFCHNNVS 82 (918)
Q Consensus 3 ~~~~~~~~~~~p~~~~~l~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~ 82 (918)
+.++++++ .+|..+. +++++|+|++|++++..+.+|+++++|++|+|++|++++..|..++.+++|++|++++|.++
T Consensus 10 ~cs~~~L~-~ip~~~~--~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~ 86 (680)
T 1ziw_A 10 DCSHLKLT-QVPDDLP--TNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELS 86 (680)
T ss_dssp ECCSSCCS-SCCSCSC--TTCSEEECCSSCCCCCCGGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSSCCC
T ss_pred ECCCCCcc-ccccccC--CCCcEEECCCCCCCCcCHHHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECCCCccC
Confidence 44444444 4554433 45555555555555444444555555555555555555444555555555555555555555
Q ss_pred ccCCccccCCCCCCEEEccCCcccccCccccCCCCCCCEEECcCCcCCCcCCcCCCCCCCCceeeccccccccCCCcccc
Q 044366 83 GRIPSSLGNLSNLALLYLNDNSLFGSIPIVMGNLKSLSTLDLSQNQLNGSIPCSLDNLSNLDTLFLYKNSLSGPIPSVIG 162 (918)
Q Consensus 83 ~~~p~~l~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~ 162 (918)
+..+..|+++++|++|+|++|++.+..|..|+++++|++|+|++|.+++..|..++++++|++|++++|.+++..+..+.
T Consensus 87 ~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~ 166 (680)
T 1ziw_A 87 QLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELD 166 (680)
T ss_dssp CCCTTTTTTCTTCSEEECCSSCCCCCCSCTTTTCTTCCEEECCSSCCSCCCCCSSSCCTTCCEEECCSSCCCCBCHHHHG
T ss_pred ccChhhhccCCCCCEEECCCCccCccChhHccccCCCCEEECCCCcccccCchhhcccccCCEEEccCCcccccCHHHhh
Confidence 33333455555555555555555544445555555555555555555554555555555555555555555544444333
Q ss_pred --cccccCeeeccccccCCcCCccCCCC---------------------------CCCcEeeccCcccccCCCccccCCC
Q 044366 163 --NLKSLLQLDLSENRLSGLIPLSLSNL---------------------------SSLTVMSLFNNSLSGSIPPILGNLK 213 (918)
Q Consensus 163 --~l~~L~~L~Ls~N~l~~~~~~~~~~l---------------------------~~L~~L~L~~N~l~~~~~~~~~~l~ 213 (918)
.+++|++|++++|++++..+..|..+ ++|+.|++++|.+++..|..|.+++
T Consensus 167 ~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~~~l~~~~~~~~~~~l~~~~L~~L~L~~n~l~~~~~~~~~~l~ 246 (680)
T 1ziw_A 167 IFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLK 246 (680)
T ss_dssp GGTTCEESEEECTTCCCCCBCTTGGGGSSEECEEECTTCCCHHHHHHHHHHHHTTSCCCEEECTTSCCCEECTTTTGGGG
T ss_pred ccccccccEEECCCCcccccChhhhhhhhhhhhhhccccccChhhHHHHHHHhhhccccEEEccCCcccccChhHhhccC
Confidence 23455555555555554444433322 3344455555555544455555443
Q ss_pred C--cceeecccccccCCCCCCCcCCCcCCeEEcccCcCcCCCCccccccCCCCeEecCCCccCC---------cCCCcCC
Q 044366 214 S--LSTLGLHINQLNGVIPPSIGNLSSLRNLSLFNNRLYGFVPKEIGYLKSLSKLEFCANHLSG---------VIPHSVG 282 (918)
Q Consensus 214 ~--L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~---------~~~~~~~ 282 (918)
. |++|++++|++++..+..|..+++|++|++++|++.+..+..+..+++|+.|++++|...+ +....|.
T Consensus 247 ~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~~~~~~~~~~~~lp~i~~~~~~ 326 (680)
T 1ziw_A 247 WTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQ 326 (680)
T ss_dssp GSCCCEEECTTSCCCEECTTTTTTCTTCCEEECCSCCBSEECTTTTTTCTTCCEEECTTCBCCC------CCEECTTTTT
T ss_pred cCCCCEEECCCCCcCccCcccccCcccccEeeCCCCccCccChhhhcCCCCccEEeccchhhhcccccccccccChhhcc
Confidence 3 5555555555555444555555555555555555555545455555555555554443221 1111344
Q ss_pred CCCCCcEEEccCCcCcCCCCccccCCCCCC----------------------------eEEeecccccCccccccCCCCC
Q 044366 283 NLTGLVLLNMCENHLFGPIPKSLRNLTSLE----------------------------RVRFNQNNLYGKVYEAFGDHPN 334 (918)
Q Consensus 283 ~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~----------------------------~L~l~~n~l~~~~~~~~~~l~~ 334 (918)
.+++|+.|++++|++.+..+..|.++++|+ .|++++|.+..+.+..|..+++
T Consensus 327 ~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~~~~~~l~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~ 406 (680)
T 1ziw_A 327 WLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGH 406 (680)
T ss_dssp TCTTCCEEECCSCCBCCCCTTTTTTCTTCCEEECTTCBSCCCEECTTTTGGGTTSCCCEEECTTSCCCEECTTTTTTCTT
T ss_pred cCCCCCEEECCCCccCCCChhHhccccCCcEEECCCCchhhhhcchhhhcccccCcCceEECCCCCCCeEChhhhhCCCC
Confidence 444555555555555444444444444444 4555555555555555555555
Q ss_pred ccEEeCCCCcccc-ccCcccccccccceeeccccccccCCCcCcCCCCCCcEEEccCceec--cccccchhhccccCcee
Q 044366 335 LTFLDLSQNNFYC-EISFNWRNFSKLGTFNASMNNIYGSIPPEIGDSSKLQVLDLSSNHIF--GKIPVQLVKLFSLNKLI 411 (918)
Q Consensus 335 L~~L~Ls~N~l~~-~~~~~~~~~~~L~~l~l~~n~i~~~~~~~~~~~~~L~~L~L~~N~l~--~~~~~~~~~l~~L~~L~ 411 (918)
|+.|++++|.+.. +....|.+++.|+.|++++|.+.+..+..|..+++|+.|++++|.+. +..|..|.++++|+.|+
T Consensus 407 L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~p~~~~~l~~L~~L~ 486 (680)
T 1ziw_A 407 LEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILD 486 (680)
T ss_dssp CCEEECCSSCCEEECCSGGGTTCTTCCEEECCSCSEEECCTTTTTTCTTCCEEECTTSCCBCTTCSSCTTTTCTTCCEEE
T ss_pred CCEEeCCCCcCccccCcccccCcccccEEecCCCCcceeChhhhhcCcccccchhccccccccccCCcccccCCCCCEEE
Confidence 5555555555543 22244555555555555555555555555555555555555555554 33455555555555555
Q ss_pred cccccccCCCCCCCCCCCcccEEeccCccccccCc--------cccccccccceecccCcccCCCCchhhccccccceEe
Q 044366 412 LSLNQLFGGVPLEFGTLTELQYLDLSANKLSSSIP--------MSIGNLLKLHYLNLSNNQFSHKIPTEFEKLIHLSELD 483 (918)
Q Consensus 412 L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--------~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 483 (918)
|++|++++..+..|..+++|++|+|++|.+++..+ ..|.++++|+.|+|++|+|+.+.+..|.++++|+.|+
T Consensus 487 Ls~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~ 566 (680)
T 1ziw_A 487 LSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIID 566 (680)
T ss_dssp CCSSCCCCCCTTTTTTCTTCCEEECCSSCCGGGGSTTSTTSCCCTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCCCCCCcCChhhhccccccCEEeCCCCCccccchhhccCCcchhhcCCCCCCEEECCCCCCCCCCHHHcccccCcceeE
Confidence 55555555555555555555555555555553211 1244555555555555555544444555555555555
Q ss_pred ccCCcCCCCCchhccccCCcceEecCCCcccccCccccc-CCCCccEEEccCCcCCCCCC
Q 044366 484 LSHNILQEEIPPQICKMESLEKLNLSHNNLSDFIPRCFE-EMRSLSWIDISYNELQGPIP 542 (918)
Q Consensus 484 Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~-~l~~L~~l~l~~N~l~~~~p 542 (918)
|++|+|++..+..|..+++|+.|+|++|+|+++.+..|. .+++|+.|++++|+|.|.++
T Consensus 567 Ls~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~l~l~~N~~~c~c~ 626 (680)
T 1ziw_A 567 LGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCE 626 (680)
T ss_dssp CCSSCCCCCCTTTTTTCTTCCEEECTTSCCCBCCHHHHHHHHTTCSEEECTTCCCCBCCC
T ss_pred CCCCCCCcCCHhHhCCCCCCCEEECCCCcCCccChhHhcccccccCEEEccCCCcccCCc
Confidence 555555554444455555555555555555555555554 45555555555555555554
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-62 Score=590.08 Aligned_cols=534 Identities=23% Similarity=0.224 Sum_probs=429.6
Q ss_pred CEEeCCCCcccccCCccccCCCCCCEEEcccccccccCCCCcCCCCCCCEEEcccccccccCCccccCCCCCCEEEccCC
Q 044366 24 QYLDLGNNQLSGVIPPEIGKLNQLRRLYLDVNQLHGTIPPVIGQLSLINELVFCHNNVSGRIPSSLGNLSNLALLYLNDN 103 (918)
Q Consensus 24 ~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~l~~l~~L~~L~L~~n 103 (918)
+.+|.++++++ .+|..+. +++++|+|++|++++..+..|..+++|++|++++|.+++..|..|+++++|++|+|++|
T Consensus 7 ~~~~cs~~~L~-~ip~~~~--~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n 83 (680)
T 1ziw_A 7 EVADCSHLKLT-QVPDDLP--TNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHN 83 (680)
T ss_dssp SEEECCSSCCS-SCCSCSC--TTCSEEECCSSCCCCCCGGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSS
T ss_pred CeeECCCCCcc-ccccccC--CCCcEEECCCCCCCCcCHHHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECCCC
Confidence 68999999998 7888776 79999999999999766678999999999999999999988999999999999999999
Q ss_pred cccccCccccCCCCCCCEEECcCCcCCCcCCcCCCCCCCCceeeccccccccCCCcccccccccCeeeccccccCCcCCc
Q 044366 104 SLFGSIPIVMGNLKSLSTLDLSQNQLNGSIPCSLDNLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSENRLSGLIPL 183 (918)
Q Consensus 104 ~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~ 183 (918)
++++..+..|+++++|++|+|++|++++..|..|+++++|++|++++|.+++..+..|+++++|++|++++|++++..+.
T Consensus 84 ~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~ 163 (680)
T 1ziw_A 84 ELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSE 163 (680)
T ss_dssp CCCCCCTTTTTTCTTCSEEECCSSCCCCCCSCTTTTCTTCCEEECCSSCCSCCCCCSSSCCTTCCEEECCSSCCCCBCHH
T ss_pred ccCccChhhhccCCCCCEEECCCCccCccChhHccccCCCCEEECCCCcccccCchhhcccccCCEEEccCCcccccCHH
Confidence 99977777899999999999999999988888999999999999999999999999999999999999999999988776
Q ss_pred cCC--CCCCCcEeeccCcccccCCCccccCC---------------------------CCcceeecccccccCCCCCCCc
Q 044366 184 SLS--NLSSLTVMSLFNNSLSGSIPPILGNL---------------------------KSLSTLGLHINQLNGVIPPSIG 234 (918)
Q Consensus 184 ~~~--~l~~L~~L~L~~N~l~~~~~~~~~~l---------------------------~~L~~L~L~~n~l~~~~~~~~~ 234 (918)
.+. .+++|++|++++|.+++..|..|..+ ++|+.|++++|.+++..+..|.
T Consensus 164 ~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~~~l~~~~~~~~~~~l~~~~L~~L~L~~n~l~~~~~~~~~ 243 (680)
T 1ziw_A 164 ELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFL 243 (680)
T ss_dssp HHGGGTTCEESEEECTTCCCCCBCTTGGGGSSEECEEECTTCCCHHHHHHHHHHHHTTSCCCEEECTTSCCCEECTTTTG
T ss_pred HhhccccccccEEECCCCcccccChhhhhhhhhhhhhhccccccChhhHHHHHHHhhhccccEEEccCCcccccChhHhh
Confidence 654 56899999999999998888877654 5678888899999988889998
Q ss_pred CCCc--CCeEEcccCcCcCCCCccccccCCCCeEecCCCccCCcCCCcCCCCCCCcEEEccCCcCcC-----CCC----c
Q 044366 235 NLSS--LRNLSLFNNRLYGFVPKEIGYLKSLSKLEFCANHLSGVIPHSVGNLTGLVLLNMCENHLFG-----PIP----K 303 (918)
Q Consensus 235 ~l~~--L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~-----~~~----~ 303 (918)
+++. |+.|++++|++++..+..|..+++|++|++++|++.+..|..|.++++|+.|++++|...+ .+| .
T Consensus 244 ~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~~~~~~~~~~~~lp~i~~~ 323 (680)
T 1ziw_A 244 GLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDF 323 (680)
T ss_dssp GGGGSCCCEEECTTSCCCEECTTTTTTCTTCCEEECCSCCBSEECTTTTTTCTTCCEEECTTCBCCC------CCEECTT
T ss_pred ccCcCCCCEEECCCCCcCccCcccccCcccccEeeCCCCccCccChhhhcCCCCccEEeccchhhhcccccccccccChh
Confidence 8865 9999999999999999999999999999999999999999999999999999999876543 233 3
Q ss_pred cccCCCCCCeEEeecccccCccccccCCCCCccEEeCCCCccc----------------------------cccCccccc
Q 044366 304 SLRNLTSLERVRFNQNNLYGKVYEAFGDHPNLTFLDLSQNNFY----------------------------CEISFNWRN 355 (918)
Q Consensus 304 ~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~----------------------------~~~~~~~~~ 355 (918)
.|..+++|++|++++|.+..+.+..|..+++|++|++++|.+. .+....|..
T Consensus 324 ~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~~~~~~l~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~ 403 (680)
T 1ziw_A 324 SFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSW 403 (680)
T ss_dssp TTTTCTTCCEEECCSCCBCCCCTTTTTTCTTCCEEECTTCBSCCCEECTTTTGGGTTSCCCEEECTTSCCCEECTTTTTT
T ss_pred hcccCCCCCEEECCCCccCCCChhHhccccCCcEEECCCCchhhhhcchhhhcccccCcCceEECCCCCCCeEChhhhhC
Confidence 7889999999999999999999999999999988888887632 222233344
Q ss_pred ccccceeeccccccccCCC-cCcCCCCCCcEEEccCceeccccccchhhccccCceeccccccc--CCCCCCCCCCCccc
Q 044366 356 FSKLGTFNASMNNIYGSIP-PEIGDSSKLQVLDLSSNHIFGKIPVQLVKLFSLNKLILSLNQLF--GGVPLEFGTLTELQ 432 (918)
Q Consensus 356 ~~~L~~l~l~~n~i~~~~~-~~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~--~~~~~~~~~l~~L~ 432 (918)
+++|+.|++++|.+.+.+| ..|..+++|++|++++|++.+..+..|..+++|+.|++++|++. +..|..|..+++|+
T Consensus 404 l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~p~~~~~l~~L~ 483 (680)
T 1ziw_A 404 LGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLT 483 (680)
T ss_dssp CTTCCEEECCSSCCEEECCSGGGTTCTTCCEEECCSCSEEECCTTTTTTCTTCCEEECTTSCCBCTTCSSCTTTTCTTCC
T ss_pred CCCCCEEeCCCCcCccccCcccccCcccccEEecCCCCcceeChhhhhcCcccccchhccccccccccCCcccccCCCCC
Confidence 4444445555444443333 34444455555555555554444445555555555555555544 34566677778888
Q ss_pred EEeccCccccccCccccccccccceecccCcccCCCCc--------hhhccccccceEeccCCcCCCCCchhccccCCcc
Q 044366 433 YLDLSANKLSSSIPMSIGNLLKLHYLNLSNNQFSHKIP--------TEFEKLIHLSELDLSHNILQEEIPPQICKMESLE 504 (918)
Q Consensus 433 ~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--------~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~ 504 (918)
+|+|++|.|+++.+..|..+++|++|+|++|++++..+ ..|.++++|++|+|++|+|+.+.+..|.++++|+
T Consensus 484 ~L~Ls~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~ 563 (680)
T 1ziw_A 484 ILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELK 563 (680)
T ss_dssp EEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCGGGGSTTSTTSCCCTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCC
T ss_pred EEECCCCCCCcCChhhhccccccCEEeCCCCCccccchhhccCCcchhhcCCCCCCEEECCCCCCCCCCHHHcccccCcc
Confidence 88888888887777778888888888888888765422 2367788888888888888765556788888888
Q ss_pred eEecCCCcccccCcccccCCCCccEEEccCCcCCCCCCCCc-----ccccccccCCCCccC
Q 044366 505 KLNLSHNNLSDFIPRCFEEMRSLSWIDISYNELQGPIPNST-----AFKNGLMEGNKGLCG 560 (918)
Q Consensus 505 ~L~L~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~p~~~-----~~~~~~~~~n~~~c~ 560 (918)
.|+|++|+++++.+..|..+++|+.|++++|++++..|... ....-...+|++.|.
T Consensus 564 ~L~Ls~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~l~l~~N~~~c~ 624 (680)
T 1ziw_A 564 IIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCT 624 (680)
T ss_dssp EEECCSSCCCCCCTTTTTTCTTCCEEECTTSCCCBCCHHHHHHHHTTCSEEECTTCCCCBC
T ss_pred eeECCCCCCCcCCHhHhCCCCCCCEEECCCCcCCccChhHhcccccccCEEEccCCCcccC
Confidence 88888888888888888888888888888888887665421 122234678888884
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-60 Score=566.01 Aligned_cols=533 Identities=22% Similarity=0.237 Sum_probs=471.9
Q ss_pred cccCCCCCCccCCccCCCCCCCCEEeCCCCcccccCCccccCCCCCCEEEcccccccccCCCCcCCCCCCCEEEcccccc
Q 044366 2 LNLGFNLLFGNIPPQIGNLSKLQYLDLGNNQLSGVIPPEIGKLNQLRRLYLDVNQLHGTIPPVIGQLSLINELVFCHNNV 81 (918)
Q Consensus 2 l~~~~~~~~~~~p~~~~~l~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~~ 81 (918)
++.++.+++ .+|..+.. .+++|+|++|++++..|.+|+++++|++|+|++|++++..|..|+++++|++|++++|.+
T Consensus 17 ~~c~~~~l~-~iP~~l~~--~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l 93 (606)
T 3t6q_A 17 YNCENLGLN-EIPGTLPN--STECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPL 93 (606)
T ss_dssp EECTTSCCS-SCCTTSCT--TCCEEECTTCCCSEECTTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCC
T ss_pred EECCCCCcc-cCcCCCCC--cCcEEEccCCccCcCChhHhccCccceEEECCCCccceeChhhccCccccCeeeCCCCcc
Confidence 456666777 88887654 799999999999988899999999999999999999988899999999999999999999
Q ss_pred cccCCccccCCCCCCEEEccCCcccccCccccCCCCCCCEEECcCCcCCCcCCcCCCCCCCCceeeccccccccCCCccc
Q 044366 82 SGRIPSSLGNLSNLALLYLNDNSLFGSIPIVMGNLKSLSTLDLSQNQLNGSIPCSLDNLSNLDTLFLYKNSLSGPIPSVI 161 (918)
Q Consensus 82 ~~~~p~~l~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~ 161 (918)
++..|..|+++++|++|++++|++++..|..|.++++|++|++++|++++..+..+.++++|++|++++|.+++..+..|
T Consensus 94 ~~~~~~~~~~l~~L~~L~L~~n~i~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~ 173 (606)
T 3t6q_A 94 IFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDM 173 (606)
T ss_dssp SEECTTTTSSCTTCCEEECTTSCCSCGGGSCCTTCTTCCEEECCSSCCCCCCCCTTCCCTTCCEEECCSSCCCEECHHHH
T ss_pred cccChhhhcccccccEeeccccCcccCCcchhccCCcccEEECCCCcccccCcccccCCcccCEEEcccCcccccChhhh
Confidence 98889999999999999999999998778899999999999999999997555566669999999999999998888899
Q ss_pred ccccccC--eeeccccccCCcCCccCCCCCCCcEeeccCcccccCCCccccCCCCcceeeccccccc-----CCCCCCCc
Q 044366 162 GNLKSLL--QLDLSENRLSGLIPLSLSNLSSLTVMSLFNNSLSGSIPPILGNLKSLSTLGLHINQLN-----GVIPPSIG 234 (918)
Q Consensus 162 ~~l~~L~--~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~-----~~~~~~~~ 234 (918)
+.+++|+ .|++++|.+++..|..|.. .+|+.|++++|.. .+..+..+.++....+..+.+. .+.+..|.
T Consensus 174 ~~l~~L~~l~L~l~~n~l~~~~~~~~~~-~~L~~L~l~~~~~---~~~~~~~l~~~~l~~l~~~~~~~~~~~~i~~~~~~ 249 (606)
T 3t6q_A 174 SSLQQATNLSLNLNGNDIAGIEPGAFDS-AVFQSLNFGGTQN---LLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFE 249 (606)
T ss_dssp HTTTTCCSEEEECTTCCCCEECTTTTTT-CEEEEEECTTCSC---HHHHHHHTTTCEEEEEECCCCTTSCCCCCCGGGGG
T ss_pred hhhcccceeEEecCCCccCccChhHhhh-ccccccccCCchh---HHHHhhhccccchhheechhhccccccccChhHhc
Confidence 9999999 8999999999888877655 6899999999872 3455555555554444333222 22233344
Q ss_pred CCC--cCCeEEcccCcCcCCCCccccccCCCCeEecCCCccCCcCCCcCCCCCCCcEEEccCCcCcCCCCccccCCCCCC
Q 044366 235 NLS--SLRNLSLFNNRLYGFVPKEIGYLKSLSKLEFCANHLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLRNLTSLE 312 (918)
Q Consensus 235 ~l~--~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~ 312 (918)
++. +|+.|++++|.++++.+..|..+++|++|++++|++. ..|..+..+++|+.|++++|++.+..|..+.++++|+
T Consensus 250 ~l~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~-~lp~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~ 328 (606)
T 3t6q_A 250 GLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLT 328 (606)
T ss_dssp GGGGSEEEEEECTTCCCSSCCTTTTTTCTTCSEEECTTSCCS-CCCSSCCSCTTCCEEECTTCCCSBGGGGCGGGCTTCS
T ss_pred hhhcCceeEEEeecCccCccCHHHhccccCCCEEeccCCccC-CCChhhcccccCCEEECccCCcCcCchhhhhccCcCC
Confidence 443 7899999999999988888999999999999999998 5677889999999999999999988899999999999
Q ss_pred eEEeeccccc-CccccccCCCCCccEEeCCCCcccccc--CcccccccccceeeccccccccCCCcCcCCCCCCcEEEcc
Q 044366 313 RVRFNQNNLY-GKVYEAFGDHPNLTFLDLSQNNFYCEI--SFNWRNFSKLGTFNASMNNIYGSIPPEIGDSSKLQVLDLS 389 (918)
Q Consensus 313 ~L~l~~n~l~-~~~~~~~~~l~~L~~L~Ls~N~l~~~~--~~~~~~~~~L~~l~l~~n~i~~~~~~~~~~~~~L~~L~L~ 389 (918)
+|++++|.+. .++...|..+++|++|++++|.+.... ...+..+++|+.|++++|.+.+..|..|..+++|+.|+++
T Consensus 329 ~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~ 408 (606)
T 3t6q_A 329 HLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLA 408 (606)
T ss_dssp EEECCSCSSCCBCCSSTTTTCTTCCEEECCSSCCCEEEESTTTTTTCTTCCEEECCSCSCEEECTTTTTTCTTCSEEECT
T ss_pred EEECCCCCcccccchhhhhccCcCCEEECCCCccccccCcchhcccCCCCCEEECCCCcCCcCCHHHhcCCccCCeEECC
Confidence 9999999987 566777999999999999999998776 6678899999999999999999999999999999999999
Q ss_pred Cceeccccccc-hhhccccCceecccccccCCCCCCCCCCCcccEEeccCcccccc---CccccccccccceecccCccc
Q 044366 390 SNHIFGKIPVQ-LVKLFSLNKLILSLNQLFGGVPLEFGTLTELQYLDLSANKLSSS---IPMSIGNLLKLHYLNLSNNQF 465 (918)
Q Consensus 390 ~N~l~~~~~~~-~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~---~~~~~~~l~~L~~L~Ls~N~l 465 (918)
+|++.+..+.. +..+++|+.|++++|++.+..+..+..+++|++|+|++|.+++. .+..+..+++|++|+|++|++
T Consensus 409 ~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l 488 (606)
T 3t6q_A 409 FTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDL 488 (606)
T ss_dssp TCCEECCTTCCTTTTCTTCCEEECTTCCCBTTCTTTTTTCTTCCEEECTTCBCGGGEECSSCGGGGCTTCCEEECTTSCC
T ss_pred CCcCCCcccchhhhCcccCCEEECCCCccCCcCHHHHhCCCCCCEEECCCCCCCccccccchhhccCCCccEEECCCCcc
Confidence 99998776654 89999999999999999999999999999999999999999862 336789999999999999999
Q ss_pred CCCCchhhccccccceEeccCCcCCCCCchhccccCCcceEecCCCcccccCcccccCCCCccEEEccCCcCCCCCCC
Q 044366 466 SHKIPTEFEKLIHLSELDLSHNILQEEIPPQICKMESLEKLNLSHNNLSDFIPRCFEEMRSLSWIDISYNELQGPIPN 543 (918)
Q Consensus 466 ~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~p~ 543 (918)
++..|..|..+++|++|+|++|++++..|..|..++.| .|+|++|++++..|..|..+++|+.|++++|+|+|.++.
T Consensus 489 ~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L-~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~~ 565 (606)
T 3t6q_A 489 SSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQQRTINLRQNPLDCTCSN 565 (606)
T ss_dssp CEECTTTTTTCTTCCEEECCSSCCCGGGGGGGTTCCSC-EEECCSSCCCCCCGGGHHHHHTSSEEECTTCCEECSGGG
T ss_pred CccChhhhccccCCCEEECCCCccCcCChhHhCccccc-EEECcCCcccccCHhhcccCCCCCEEeCCCCCccccCCc
Confidence 99999999999999999999999999999999999999 999999999999999999999999999999999998874
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-59 Score=576.47 Aligned_cols=524 Identities=23% Similarity=0.204 Sum_probs=464.0
Q ss_pred cccCCCCCCccCCccCCCCCCCCEEeCCCCcccccCCccccCCCCCCEEEcccccccccC-CCCcCCCCCCCEEEccccc
Q 044366 2 LNLGFNLLFGNIPPQIGNLSKLQYLDLGNNQLSGVIPPEIGKLNQLRRLYLDVNQLHGTI-PPVIGQLSLINELVFCHNN 80 (918)
Q Consensus 2 l~~~~~~~~~~~p~~~~~l~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~n~l~~~~-p~~~~~l~~L~~L~l~~n~ 80 (918)
.|.++++++ .+|. -.++|++|||++|+|++..|.+|..+++|++|+|++|...+.+ |..|+.+++|++|++++|.
T Consensus 9 ~dcs~~~L~-~vP~---lp~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~ 84 (844)
T 3j0a_A 9 AFYRFCNLT-QVPQ---VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSK 84 (844)
T ss_dssp EEESCCCSS-CCCS---SCTTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCC
T ss_pred EEccCCCCC-CCCC---CCCCcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCc
Confidence 466788888 8887 4689999999999999888999999999999999999665565 8899999999999999999
Q ss_pred ccccCCccccCCCCCCEEEccCCcccccCccc--cCCCCCCCEEECcCCcCCCcCC-cCCCCCCCCceeeccccccccCC
Q 044366 81 VSGRIPSSLGNLSNLALLYLNDNSLFGSIPIV--MGNLKSLSTLDLSQNQLNGSIP-CSLDNLSNLDTLFLYKNSLSGPI 157 (918)
Q Consensus 81 ~~~~~p~~l~~l~~L~~L~L~~n~i~~~~~~~--~~~l~~L~~L~Ls~n~i~~~~~-~~l~~l~~L~~L~L~~n~l~~~~ 157 (918)
+.+..|.+|.++++|++|+|++|.+.+..|.. |.++++|++|+|++|.+++..+ ..|+++++|++|+|++|.+++..
T Consensus 85 l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~~~ 164 (844)
T 3j0a_A 85 IYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVC 164 (844)
T ss_dssp CCEECTTSSCSCSSCCCEECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCCCC
T ss_pred CcccCHhHccCCcccCEeeCcCCCCCcccccCccccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCcCCeeC
Confidence 99999999999999999999999998766654 9999999999999999987655 57999999999999999999999
Q ss_pred Ccccccc--cccCeeeccccccCCcCCccCCCCCC------CcEeeccCcccccCCCccccCC---CCcceeeccc----
Q 044366 158 PSVIGNL--KSLLQLDLSENRLSGLIPLSLSNLSS------LTVMSLFNNSLSGSIPPILGNL---KSLSTLGLHI---- 222 (918)
Q Consensus 158 ~~~~~~l--~~L~~L~Ls~N~l~~~~~~~~~~l~~------L~~L~L~~N~l~~~~~~~~~~l---~~L~~L~L~~---- 222 (918)
+..|..+ ++|+.|++++|.+.+..+..+..+++ |+.|++++|.+++..+..+... .+++.|.++.
T Consensus 165 ~~~l~~l~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~~~l~~L~l~~~~~~ 244 (844)
T 3j0a_A 165 EHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMG 244 (844)
T ss_dssp SGGGHHHHHCSSCCCEECCSBSCCCCCCCCCSSSCTTTTCCBSEEBCSSCCSSTTTTSGGGGTSCSCCBSEEECCSSCCB
T ss_pred HHHcccccCCccceEECCCCccccccccchhhcCCccccCceeEEecCCCcCchhHHHHHHhhcCcccccceeccccccc
Confidence 9999988 89999999999999988887777766 9999999999988777776643 5677887763
Q ss_pred -----ccccCCCCCCCcCC--CcCCeEEcccCcCcCCCCccccccCCCCeEecCCCccCCcCCCcCCCCCCCcEEEccCC
Q 044366 223 -----NQLNGVIPPSIGNL--SSLRNLSLFNNRLYGFVPKEIGYLKSLSKLEFCANHLSGVIPHSVGNLTGLVLLNMCEN 295 (918)
Q Consensus 223 -----n~l~~~~~~~~~~l--~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n 295 (918)
+.+.......|.++ ++|+.|++++|.+.+..+..|..+++|+.|++++|++.+..+..|.++++|+.|++++|
T Consensus 245 ~~~~~~~l~~~~~~~f~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N 324 (844)
T 3j0a_A 245 AGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYN 324 (844)
T ss_dssp CSSSCSSSTTGGGTTTTTTTTSCCCEEECTTCCCCEECSCCSSSCCCCCEEEEESCCCCEECTTTTTTCSSCCEEEEESC
T ss_pred ccccccccCCCChhhhhccccCCccEEECCCCcccccChhhhhcCCCCCEEECCCCcCCCCChHHhcCCCCCCEEECCCC
Confidence 33444444556554 78999999999999999999999999999999999999999999999999999999999
Q ss_pred cCcCCCCccccCCCCCCeEEeecccccCccccccCCCCCccEEeCCCCccccccCcccccccccceeeccccccccCCCc
Q 044366 296 HLFGPIPKSLRNLTSLERVRFNQNNLYGKVYEAFGDHPNLTFLDLSQNNFYCEISFNWRNFSKLGTFNASMNNIYGSIPP 375 (918)
Q Consensus 296 ~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~n~i~~~~~~ 375 (918)
++.+..|..|.++++|+.|++++|.+..+++..|..+++|+.|++++|.++.+.. ++.|+.+++++|++. .+|.
T Consensus 325 ~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~-----~~~L~~L~l~~N~l~-~l~~ 398 (844)
T 3j0a_A 325 LLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTTIHF-----IPSIPDIFLSGNKLV-TLPK 398 (844)
T ss_dssp CCSCCCSCSCSSCTTCCEEECCSCCCCCCCSSCSCSCCCCCEEEEETCCSCCCSS-----CCSCSEEEEESCCCC-CCCC
T ss_pred CCCccCHHHhcCCCCCCEEECCCCCCCccChhhhcCCCCCCEEECCCCCCCcccC-----CCCcchhccCCCCcc-cccc
Confidence 9999999999999999999999999999999999999999999999999985433 788999999999998 4444
Q ss_pred CcCCCCCCcEEEccCceeccccc-cchhhccccCceecccccccCCCCC-CCCCCCcccEEeccCcccc-----ccCccc
Q 044366 376 EIGDSSKLQVLDLSSNHIFGKIP-VQLVKLFSLNKLILSLNQLFGGVPL-EFGTLTELQYLDLSANKLS-----SSIPMS 448 (918)
Q Consensus 376 ~~~~~~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~~-~~~~l~~L~~L~Ls~N~l~-----~~~~~~ 448 (918)
. ..+++.|++++|++.+... ..+.++++|+.|+|++|++++..+. .+..+++|++|+|++|.++ +..+..
T Consensus 399 ~---~~~l~~L~ls~N~l~~l~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~~~ 475 (844)
T 3j0a_A 399 I---NLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDV 475 (844)
T ss_dssp C---CTTCCEEECCSCCCCSSTTHHHHTTCTTCCEEEEESCCCCCCCSSSSSCSCTTCCBCEEESCCCSSSCCSCCCSSC
T ss_pred c---ccccceeecccCccccCchhhhhhcCCccceeeCCCCcccccccccccccCCccccccCCCCccccccccccchhh
Confidence 3 4689999999999986533 2355889999999999999876554 4667899999999999997 345567
Q ss_pred cccccccceecccCcccCCCCchhhccccccceEeccCCcCCCCCchhccccCCcceEecCCCcccccCcccccCCCCcc
Q 044366 449 IGNLLKLHYLNLSNNQFSHKIPTEFEKLIHLSELDLSHNILQEEIPPQICKMESLEKLNLSHNNLSDFIPRCFEEMRSLS 528 (918)
Q Consensus 449 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~ 528 (918)
|.++++|+.|+|++|+|++.+|..|.++++|+.|+|++|+|++..+..+. ++|+.|+|++|+|++..|..|. +|+
T Consensus 476 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~--~~L~~L~Ls~N~l~~~~~~~~~---~L~ 550 (844)
T 3j0a_A 476 FEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLP--ANLEILDISRNQLLAPNPDVFV---SLS 550 (844)
T ss_dssp SSCBCCEECCCCCHHHHTTCCTTSSSSCCSCSEEEEESCCCSSCCCCCCC--SCCCEEEEEEECCCCCCSCCCS---SCC
T ss_pred hcCcccccEEECCCCcccccChhHccchhhhheeECCCCCCCccChhhhh--ccccEEECCCCcCCCCChhHhC---CcC
Confidence 89999999999999999999999999999999999999999987777776 8999999999999999998764 789
Q ss_pred EEEccCCcCCCCCCC
Q 044366 529 WIDISYNELQGPIPN 543 (918)
Q Consensus 529 ~l~l~~N~l~~~~p~ 543 (918)
.|++++|++.|.++.
T Consensus 551 ~l~l~~Np~~C~c~~ 565 (844)
T 3j0a_A 551 VLDITHNKFICECEL 565 (844)
T ss_dssp EEEEEEECCCCSSSC
T ss_pred EEEecCCCccccccc
Confidence 999999999999875
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-58 Score=548.75 Aligned_cols=528 Identities=20% Similarity=0.228 Sum_probs=469.5
Q ss_pred cccCCCCCCccCCccCCCCCCCCEEeCCCCcccccCCccccCCCCCCEEEcccccccccCCCCcCCCCCCCEEEcccccc
Q 044366 2 LNLGFNLLFGNIPPQIGNLSKLQYLDLGNNQLSGVIPPEIGKLNQLRRLYLDVNQLHGTIPPVIGQLSLINELVFCHNNV 81 (918)
Q Consensus 2 l~~~~~~~~~~~p~~~~~l~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~~ 81 (918)
++.++++++ .+|..+. ++|++|+|++|++++..+.+|.++++|++|+|++|++++..|..|+++++|++|++++|.+
T Consensus 16 ~~c~~~~l~-~ip~~~~--~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~l 92 (606)
T 3vq2_A 16 YQCMDQKLS-KVPDDIP--SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPI 92 (606)
T ss_dssp EECTTSCCS-SCCTTSC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCC
T ss_pred eEccCCCcc-cCCCCCC--CCcCEEECCCCCcCEeChhhccCCccCcEEeCCCCcccccCHHHhhchhhcCEeECCCCcc
Confidence 467788888 8898765 8999999999999988888999999999999999999987788999999999999999999
Q ss_pred cccCCccccCCCCCCEEEccCCcccccCccccCCCCCCCEEECcCCcCCC-cCCcCCCCCCCCceeeccccccccCCCcc
Q 044366 82 SGRIPSSLGNLSNLALLYLNDNSLFGSIPIVMGNLKSLSTLDLSQNQLNG-SIPCSLDNLSNLDTLFLYKNSLSGPIPSV 160 (918)
Q Consensus 82 ~~~~p~~l~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~-~~~~~l~~l~~L~~L~L~~n~l~~~~~~~ 160 (918)
++..|.+|+++++|++|+|++|++.+..+..++++++|++|++++|++++ .+|..++++++|++|++++|++++..+..
T Consensus 93 ~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n~l~~~~~~~ 172 (606)
T 3vq2_A 93 QSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVND 172 (606)
T ss_dssp CCCCTTSSTTCTTCCEEECTTSCCCCSSSSCCTTCTTCCEEECCSSCCCCCCCCGGGGTCTTCCEEECCSSCCCEECTTT
T ss_pred cccChhhcCCcccCCEEEccCCccccccccccCCCCCCCEEeCCCCcccceechHhHhhcCCCCEEEccCCcceecChhh
Confidence 98889999999999999999999998888899999999999999999986 46999999999999999999999998999
Q ss_pred cccccccC----eeeccccccCCcCCccCCCCCCCcEeeccCcccc-cCCCccccCCCCcceeecccccccCC------C
Q 044366 161 IGNLKSLL----QLDLSENRLSGLIPLSLSNLSSLTVMSLFNNSLS-GSIPPILGNLKSLSTLGLHINQLNGV------I 229 (918)
Q Consensus 161 ~~~l~~L~----~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~L~~n~l~~~------~ 229 (918)
|+.+++|+ +|++++|.++++.+..+... +|+.|++++|.++ +..|..+.+++.|+.+++..+.+... .
T Consensus 173 ~~~l~~L~~~l~~L~l~~n~l~~~~~~~~~~~-~L~~L~L~~n~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~~l~~~~ 251 (606)
T 3vq2_A 173 LQFLRENPQVNLSLDMSLNPIDFIQDQAFQGI-KLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFE 251 (606)
T ss_dssp THHHHHCTTCCCEEECTTCCCCEECTTTTTTC-EEEEEEEESCCSCHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCC
T ss_pred hhhhhccccccceeeccCCCcceeCcccccCc-eeeeeeccCCccchhHHHHHhccccccccccccccccccCCcccccC
Confidence 99888876 79999999998877777665 8999999999986 45677899999999999876655421 1
Q ss_pred CCCCcCCC--cCCeEEc-ccCcCcCCCCccccccCCCCeEecCCCccCCcCCCcCCCCCCCcEEEccCCcCcCCCCcccc
Q 044366 230 PPSIGNLS--SLRNLSL-FNNRLYGFVPKEIGYLKSLSKLEFCANHLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLR 306 (918)
Q Consensus 230 ~~~~~~l~--~L~~L~L-s~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~ 306 (918)
+..+.++. .++.+++ ..|.+.+..|. +..+++|+.|++++|.+... | .+..+++|+.|++++|.+ +.+| .+
T Consensus 252 ~~~~~~l~~l~l~~l~l~~~~~~~~~~~~-~~~l~~L~~L~l~~~~~~~l-~-~l~~~~~L~~L~l~~n~l-~~lp-~~- 325 (606)
T 3vq2_A 252 PSIMEGLCDVTIDEFRLTYTNDFSDDIVK-FHCLANVSAMSLAGVSIKYL-E-DVPKHFKWQSLSIIRCQL-KQFP-TL- 325 (606)
T ss_dssp GGGGTTGGGSEEEEEEECCCTTCCGGGGS-CGGGTTCSEEEEESCCCCCC-C-CCCTTCCCSEEEEESCCC-SSCC-CC-
T ss_pred hHHhhhhhhccHhheeccccccccccccc-cccCCCCCEEEecCccchhh-h-hccccccCCEEEcccccC-cccc-cC-
Confidence 12222222 4667777 77788877776 89999999999999999754 4 889999999999999999 5677 45
Q ss_pred CCCCCCeEEeecccccCccccccCCCCCccEEeCCCCcccccc--CcccccccccceeeccccccccCCCcCcCCCCCCc
Q 044366 307 NLTSLERVRFNQNNLYGKVYEAFGDHPNLTFLDLSQNNFYCEI--SFNWRNFSKLGTFNASMNNIYGSIPPEIGDSSKLQ 384 (918)
Q Consensus 307 ~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~--~~~~~~~~~L~~l~l~~n~i~~~~~~~~~~~~~L~ 384 (918)
.+++|++|++++|.... ...+..+++|+.|++++|.++... ...+..++.|+.|++++|.+.+ +|..+..+++|+
T Consensus 326 ~l~~L~~L~l~~n~~~~--~~~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~-~~~~~~~l~~L~ 402 (606)
T 3vq2_A 326 DLPFLKSLTLTMNKGSI--SFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAII-MSANFMGLEELQ 402 (606)
T ss_dssp CCSSCCEEEEESCSSCE--ECCCCCCTTCCEEECCSSCEEEEEECCHHHHCCSCCCEEECCSCSEEE-ECCCCTTCTTCC
T ss_pred CCCccceeeccCCcCcc--chhhccCCCCCEEECcCCccCCCcchhhhhccCCcccEeECCCCcccc-chhhccCCCCCC
Confidence 99999999999995443 336788999999999999998764 6678889999999999999985 568899999999
Q ss_pred EEEccCceeccccc-cchhhccccCceecccccccCCCCCCCCCCCcccEEeccCccccc-cCccccccccccceecccC
Q 044366 385 VLDLSSNHIFGKIP-VQLVKLFSLNKLILSLNQLFGGVPLEFGTLTELQYLDLSANKLSS-SIPMSIGNLLKLHYLNLSN 462 (918)
Q Consensus 385 ~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-~~~~~~~~l~~L~~L~Ls~ 462 (918)
.|++++|++.+..+ ..+..+++|+.|++++|++.+..|..+..+++|++|+|++|.+++ ..|..|..+++|+.|+|++
T Consensus 403 ~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~ 482 (606)
T 3vq2_A 403 HLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSK 482 (606)
T ss_dssp EEECTTSEEESTTTTTTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTT
T ss_pred eeECCCCccCCccChhhhhccccCCEEECcCCCCCccchhhhcCCCCCCEEECCCCcCCCcchHHhhccCCCCCEEECCC
Confidence 99999999998887 789999999999999999999999999999999999999999997 4788999999999999999
Q ss_pred cccCCCCchhhccccccceEeccCCcCCCCCchhccccCCcceEecCCCcccccCcccccCCC-CccEEEccCCcCCCCC
Q 044366 463 NQFSHKIPTEFEKLIHLSELDLSHNILQEEIPPQICKMESLEKLNLSHNNLSDFIPRCFEEMR-SLSWIDISYNELQGPI 541 (918)
Q Consensus 463 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~-~L~~l~l~~N~l~~~~ 541 (918)
|++++..|..|.++++|++|+|++|++++..|..|..+++|+.|+|++|+|++ +|..+..++ +|+.|++++|+|+|.+
T Consensus 483 n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~-~p~~~~~l~~~L~~l~l~~N~~~c~c 561 (606)
T 3vq2_A 483 CQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIET-SKGILQHFPKSLAFFNLTNNSVACIC 561 (606)
T ss_dssp SCCCEECTTTTTTCTTCCEEECCSSCCSCEEGGGTTTCTTCCEEECTTSCCCC-EESCGGGSCTTCCEEECCSCCCCCSS
T ss_pred CcCCccChhhhcccccCCEEECCCCcCCCcCHHHccCCCcCCEEECCCCcCcc-cCHhHhhhcccCcEEEccCCCcccCC
Confidence 99999999999999999999999999999889999999999999999999996 566688887 5999999999999988
Q ss_pred CC
Q 044366 542 PN 543 (918)
Q Consensus 542 p~ 543 (918)
+.
T Consensus 562 ~~ 563 (606)
T 3vq2_A 562 EH 563 (606)
T ss_dssp TT
T ss_pred cc
Confidence 86
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-57 Score=542.14 Aligned_cols=512 Identities=20% Similarity=0.220 Sum_probs=448.2
Q ss_pred CcccCCCCCCccCCccCCCCCCCCEEeCCCCcccccCCccccCCCCCCEEEcccccccccCCCCcCCCCCCCEEEccccc
Q 044366 1 MLNLGFNLLFGNIPPQIGNLSKLQYLDLGNNQLSGVIPPEIGKLNQLRRLYLDVNQLHGTIPPVIGQLSLINELVFCHNN 80 (918)
Q Consensus 1 ~l~~~~~~~~~~~p~~~~~l~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~ 80 (918)
.|+|++|.+++..|..|+++++|++|+|++|++++..|.+|+++++|++|+|++|++++..|..|+.+++|++|++++|.
T Consensus 37 ~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~ 116 (606)
T 3t6q_A 37 CLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTG 116 (606)
T ss_dssp EEECTTCCCSEECTTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCSEECTTTTSSCTTCCEEECTTSC
T ss_pred EEEccCCccCcCChhHhccCccceEEECCCCccceeChhhccCccccCeeeCCCCcccccChhhhcccccccEeeccccC
Confidence 48999999998888899999999999999999998899999999999999999999998889999999999999999999
Q ss_pred ccccCCccccCCCCCCEEEccCCcccccCccccCCCCCCCEEECcCCcCCCcCCcCCCCCCCCc--eeeccccccccCCC
Q 044366 81 VSGRIPSSLGNLSNLALLYLNDNSLFGSIPIVMGNLKSLSTLDLSQNQLNGSIPCSLDNLSNLD--TLFLYKNSLSGPIP 158 (918)
Q Consensus 81 ~~~~~p~~l~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~--~L~L~~n~l~~~~~ 158 (918)
+++..|..+.++++|++|++++|++.+..+..+..+++|++|++++|++++..|..++.+++|+ +|++++|.+++..+
T Consensus 117 i~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~l~L~l~~n~l~~~~~ 196 (606)
T 3t6q_A 117 ISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAGIEP 196 (606)
T ss_dssp CSCGGGSCCTTCTTCCEEECCSSCCCCCCCCTTCCCTTCCEEECCSSCCCEECHHHHHTTTTCCSEEEECTTCCCCEECT
T ss_pred cccCCcchhccCCcccEEECCCCcccccCcccccCCcccCEEEcccCcccccChhhhhhhcccceeEEecCCCccCccCh
Confidence 9987788999999999999999999976555666699999999999999988888899999999 89999999998888
Q ss_pred cccccccccCeeeccccccCCcCCccCCCCCCCcEeeccCcccc-----cCCCccccCCC--CcceeecccccccCCCCC
Q 044366 159 SVIGNLKSLLQLDLSENRLSGLIPLSLSNLSSLTVMSLFNNSLS-----GSIPPILGNLK--SLSTLGLHINQLNGVIPP 231 (918)
Q Consensus 159 ~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-----~~~~~~~~~l~--~L~~L~L~~n~l~~~~~~ 231 (918)
..|.. .+|+.|++++|.. .+..+..+.++....+..+.+. .+.+..|..+. +|+.|++++|.+++..+.
T Consensus 197 ~~~~~-~~L~~L~l~~~~~---~~~~~~~l~~~~l~~l~~~~~~~~~~~~i~~~~~~~l~~~~L~~L~l~~n~l~~~~~~ 272 (606)
T 3t6q_A 197 GAFDS-AVFQSLNFGGTQN---LLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSN 272 (606)
T ss_dssp TTTTT-CEEEEEECTTCSC---HHHHHHHTTTCEEEEEECCCCTTSCCCCCCGGGGGGGGGSEEEEEECTTCCCSSCCTT
T ss_pred hHhhh-ccccccccCCchh---HHHHhhhccccchhheechhhccccccccChhHhchhhcCceeEEEeecCccCccCHH
Confidence 87765 6899999999872 2334445554444333322221 22334454444 788999999999988888
Q ss_pred CCcCCCcCCeEEcccCcCcCCCCccccccCCCCeEecCCCccCCcCCCcCCCCCCCcEEEccCCcCcCCCC-ccccCCCC
Q 044366 232 SIGNLSSLRNLSLFNNRLYGFVPKEIGYLKSLSKLEFCANHLSGVIPHSVGNLTGLVLLNMCENHLFGPIP-KSLRNLTS 310 (918)
Q Consensus 232 ~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~-~~l~~l~~ 310 (918)
.|..+++|++|++++|+++ ..|..+..+++|++|++++|++.+..|..+..+++|+.|++++|.+.+.+| ..+.++++
T Consensus 273 ~~~~l~~L~~L~l~~n~l~-~lp~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~ 351 (606)
T 3t6q_A 273 TFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLEN 351 (606)
T ss_dssp TTTTCTTCSEEECTTSCCS-CCCSSCCSCTTCCEEECTTCCCSBGGGGCGGGCTTCSEEECCSCSSCCBCCSSTTTTCTT
T ss_pred HhccccCCCEEeccCCccC-CCChhhcccccCCEEECccCCcCcCchhhhhccCcCCEEECCCCCcccccchhhhhccCc
Confidence 8999999999999999998 456678889999999999999998888889999999999999998885554 45889999
Q ss_pred CCeEEeecccccCcc--ccccCCCCCccEEeCCCCccccccCcccccccccceeeccccccccCCCcC-cCCCCCCcEEE
Q 044366 311 LERVRFNQNNLYGKV--YEAFGDHPNLTFLDLSQNNFYCEISFNWRNFSKLGTFNASMNNIYGSIPPE-IGDSSKLQVLD 387 (918)
Q Consensus 311 L~~L~l~~n~l~~~~--~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~n~i~~~~~~~-~~~~~~L~~L~ 387 (918)
|++|++++|.+..+. +..+..+++|++|++++|++.......+..+++|+.|++++|.+.+..+.. +..+++|++|+
T Consensus 352 L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~ 431 (606)
T 3t6q_A 352 LRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLN 431 (606)
T ss_dssp CCEEECCSSCCCEEEESTTTTTTCTTCCEEECCSCSCEEECTTTTTTCTTCSEEECTTCCEECCTTCCTTTTCTTCCEEE
T ss_pred CCEEECCCCccccccCcchhcccCCCCCEEECCCCcCCcCCHHHhcCCccCCeEECCCCcCCCcccchhhhCcccCCEEE
Confidence 999999999998877 677889999999999999998888888889999999999999998776654 88999999999
Q ss_pred ccCceeccccccchhhccccCceecccccccCC---CCCCCCCCCcccEEeccCccccccCccccccccccceecccCcc
Q 044366 388 LSSNHIFGKIPVQLVKLFSLNKLILSLNQLFGG---VPLEFGTLTELQYLDLSANKLSSSIPMSIGNLLKLHYLNLSNNQ 464 (918)
Q Consensus 388 L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~---~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~ 464 (918)
+++|.+.+..|..+..+++|++|++++|++++. .+..+..+++|++|+|++|.+++..|..|..+++|+.|+|++|+
T Consensus 432 l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~ 511 (606)
T 3t6q_A 432 LSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNR 511 (606)
T ss_dssp CTTCCCBTTCTTTTTTCTTCCEEECTTCBCGGGEECSSCGGGGCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSC
T ss_pred CCCCccCCcCHHHHhCCCCCCEEECCCCCCCccccccchhhccCCCccEEECCCCccCccChhhhccccCCCEEECCCCc
Confidence 999999998999999999999999999999762 34668899999999999999999889999999999999999999
Q ss_pred cCCCCchhhccccccceEeccCCcCCCCCchhccccCCcceEecCCCcccccCc
Q 044366 465 FSHKIPTEFEKLIHLSELDLSHNILQEEIPPQICKMESLEKLNLSHNNLSDFIP 518 (918)
Q Consensus 465 l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~ 518 (918)
+++..|..|..++.| .|+|++|++++.+|..+..+++|+.|+|++|+++...+
T Consensus 512 l~~~~~~~l~~l~~L-~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~ 564 (606)
T 3t6q_A 512 LTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQQRTINLRQNPLDCTCS 564 (606)
T ss_dssp CCGGGGGGGTTCCSC-EEECCSSCCCCCCGGGHHHHHTSSEEECTTCCEECSGG
T ss_pred cCcCChhHhCccccc-EEECcCCcccccCHhhcccCCCCCEEeCCCCCccccCC
Confidence 999999999999999 99999999999999999999999999999999987433
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-56 Score=550.34 Aligned_cols=502 Identities=23% Similarity=0.205 Sum_probs=443.5
Q ss_pred CcccCCCCCCccCCccCCCCCCCCEEeCCCCccccc-CCccccCCCCCCEEEcccccccccCCCCcCCCCCCCEEEcccc
Q 044366 1 MLNLGFNLLFGNIPPQIGNLSKLQYLDLGNNQLSGV-IPPEIGKLNQLRRLYLDVNQLHGTIPPVIGQLSLINELVFCHN 79 (918)
Q Consensus 1 ~l~~~~~~~~~~~p~~~~~l~~L~~L~L~~n~i~~~-~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n 79 (918)
+|||++|.+.+..|..|.++++|++|+|++|...+. .|.+|+++++|++|+|++|++++..|..|+.+++|++|++++|
T Consensus 28 ~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~n 107 (844)
T 3j0a_A 28 RLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFC 107 (844)
T ss_dssp EEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECTTSSCSCSSCCCEECTTC
T ss_pred EEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCHhHccCCcccCEeeCcCC
Confidence 489999999988899999999999999999965444 4889999999999999999999888999999999999999999
Q ss_pred cccccCCcc--ccCCCCCCEEEccCCcccccCc-cccCCCCCCCEEECcCCcCCCcCCcCCCCC--CCCceeeccccccc
Q 044366 80 NVSGRIPSS--LGNLSNLALLYLNDNSLFGSIP-IVMGNLKSLSTLDLSQNQLNGSIPCSLDNL--SNLDTLFLYKNSLS 154 (918)
Q Consensus 80 ~~~~~~p~~--l~~l~~L~~L~L~~n~i~~~~~-~~~~~l~~L~~L~Ls~n~i~~~~~~~l~~l--~~L~~L~L~~n~l~ 154 (918)
.+++..|.. |.++++|++|+|++|.+.+..+ ..|+++++|++|+|++|.+++..+..+..+ ++|+.|++++|.+.
T Consensus 108 ~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~~~~~~l~~l~~~~L~~L~L~~n~l~ 187 (844)
T 3j0a_A 108 GLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLY 187 (844)
T ss_dssp CCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCCCCSGGGHHHHHCSSCCCEECCSBSC
T ss_pred CCCcccccCccccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCcCCeeCHHHcccccCCccceEECCCCccc
Confidence 999877765 9999999999999999987655 579999999999999999999899999888 89999999999999
Q ss_pred cCCCcccccccc------cCeeeccccccCCcCCccCCCC---CCCcEeeccC---------cccccCCCccccCC--CC
Q 044366 155 GPIPSVIGNLKS------LLQLDLSENRLSGLIPLSLSNL---SSLTVMSLFN---------NSLSGSIPPILGNL--KS 214 (918)
Q Consensus 155 ~~~~~~~~~l~~------L~~L~Ls~N~l~~~~~~~~~~l---~~L~~L~L~~---------N~l~~~~~~~~~~l--~~ 214 (918)
+..+..++.+++ |+.|++++|.+++..+..+... .+++.|.++. |.+.+..+..|.++ ++
T Consensus 188 ~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~~~l~~L~l~~~~~~~~~~~~~l~~~~~~~f~~l~~~~ 267 (844)
T 3j0a_A 188 SRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSS 267 (844)
T ss_dssp CCCCCCCCSSSCTTTTCCBSEEBCSSCCSSTTTTSGGGGTSCSCCBSEEECCSSCCBCSSSCSSSTTGGGTTTTTTTTSC
T ss_pred cccccchhhcCCccccCceeEEecCCCcCchhHHHHHHhhcCcccccceecccccccccccccccCCCChhhhhccccCC
Confidence 888887777666 9999999999988777766543 5678888773 33443444556655 78
Q ss_pred cceeecccccccCCCCCCCcCCCcCCeEEcccCcCcCCCCccccccCCCCeEecCCCccCCcCCCcCCCCCCCcEEEccC
Q 044366 215 LSTLGLHINQLNGVIPPSIGNLSSLRNLSLFNNRLYGFVPKEIGYLKSLSKLEFCANHLSGVIPHSVGNLTGLVLLNMCE 294 (918)
Q Consensus 215 L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~ 294 (918)
|+.|++++|.+++..+..|..+++|+.|+|++|++++..+..|..+++|++|++++|.+.+..+..|..+++|+.|++++
T Consensus 268 L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~ 347 (844)
T 3j0a_A 268 VRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQK 347 (844)
T ss_dssp CCEEECTTCCCCEECSCCSSSCCCCCEEEEESCCCCEECTTTTTTCSSCCEEEEESCCCSCCCSCSCSSCTTCCEEECCS
T ss_pred ccEEECCCCcccccChhhhhcCCCCCEEECCCCcCCCCChHHhcCCCCCCEEECCCCCCCccCHHHhcCCCCCCEEECCC
Confidence 99999999999998899999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CcCcCCCCccccCCCCCCeEEeecccccCccccccCCCCCccEEeCCCCccccccCcccccccccceeeccccccccCCC
Q 044366 295 NHLFGPIPKSLRNLTSLERVRFNQNNLYGKVYEAFGDHPNLTFLDLSQNNFYCEISFNWRNFSKLGTFNASMNNIYGSIP 374 (918)
Q Consensus 295 n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~n~i~~~~~ 374 (918)
|++....+..|.++++|+.|++++|.+..+.. +++|+.|++++|+++.++.. ...++.+++++|++.+...
T Consensus 348 N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~-----~~~L~~L~l~~N~l~~l~~~----~~~l~~L~ls~N~l~~l~~ 418 (844)
T 3j0a_A 348 NHIAIIQDQTFKFLEKLQTLDLRDNALTTIHF-----IPSIPDIFLSGNKLVTLPKI----NLTANLIHLSENRLENLDI 418 (844)
T ss_dssp CCCCCCCSSCSCSCCCCCEEEEETCCSCCCSS-----CCSCSEEEEESCCCCCCCCC----CTTCCEEECCSCCCCSSTT
T ss_pred CCCCccChhhhcCCCCCCEEECCCCCCCcccC-----CCCcchhccCCCCccccccc----ccccceeecccCccccCch
Confidence 99998888999999999999999999986543 78999999999999865443 5678999999999986533
Q ss_pred c-CcCCCCCCcEEEccCceecccccc-chhhccccCceeccccccc-----CCCCCCCCCCCcccEEeccCccccccCcc
Q 044366 375 P-EIGDSSKLQVLDLSSNHIFGKIPV-QLVKLFSLNKLILSLNQLF-----GGVPLEFGTLTELQYLDLSANKLSSSIPM 447 (918)
Q Consensus 375 ~-~~~~~~~L~~L~L~~N~l~~~~~~-~~~~l~~L~~L~L~~N~l~-----~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~ 447 (918)
. .+..+++|+.|+|++|++++..+. .+..+++|+.|+|++|.+. +..+..|..+++|++|+|++|.|++..|.
T Consensus 419 ~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~ 498 (844)
T 3j0a_A 419 LYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPG 498 (844)
T ss_dssp HHHHTTCTTCCEEEEESCCCCCCCSSSSSCSCTTCCBCEEESCCCSSSCCSCCCSSCSSCBCCEECCCCCHHHHTTCCTT
T ss_pred hhhhhcCCccceeeCCCCcccccccccccccCCccccccCCCCccccccccccchhhhcCcccccEEECCCCcccccChh
Confidence 2 356899999999999999866544 4566889999999999997 44456789999999999999999999999
Q ss_pred ccccccccceecccCcccCCCCchhhccccccceEeccCCcCCCCCchhccccCCcceEecCCCccccc
Q 044366 448 SIGNLLKLHYLNLSNNQFSHKIPTEFEKLIHLSELDLSHNILQEEIPPQICKMESLEKLNLSHNNLSDF 516 (918)
Q Consensus 448 ~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ 516 (918)
.|..+++|+.|+|++|+|++..|..|. ++|+.|||++|+|++.+|..|. +|+.|++++|++...
T Consensus 499 ~~~~l~~L~~L~Ls~N~l~~l~~~~~~--~~L~~L~Ls~N~l~~~~~~~~~---~L~~l~l~~Np~~C~ 562 (844)
T 3j0a_A 499 VFSHLTALRGLSLNSNRLTVLSHNDLP--ANLEILDISRNQLLAPNPDVFV---SLSVLDITHNKFICE 562 (844)
T ss_dssp SSSSCCSCSEEEEESCCCSSCCCCCCC--SCCCEEEEEEECCCCCCSCCCS---SCCEEEEEEECCCCS
T ss_pred HccchhhhheeECCCCCCCccChhhhh--ccccEEECCCCcCCCCChhHhC---CcCEEEecCCCcccc
Confidence 999999999999999999988888777 7999999999999998887764 799999999999764
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-55 Score=525.30 Aligned_cols=507 Identities=22% Similarity=0.228 Sum_probs=450.2
Q ss_pred CcccCCCCCCccCCccCCCCCCCCEEeCCCCcccccCCccccCCCCCCEEEcccccccccCCCCcCCCCCCCEEEccccc
Q 044366 1 MLNLGFNLLFGNIPPQIGNLSKLQYLDLGNNQLSGVIPPEIGKLNQLRRLYLDVNQLHGTIPPVIGQLSLINELVFCHNN 80 (918)
Q Consensus 1 ~l~~~~~~~~~~~p~~~~~l~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~ 80 (918)
.|+|++|.+.+..|..|+++++|++|+|++|++++..|.+|+++++|++|+|++|++++..|..|+++++|++|++++|.
T Consensus 36 ~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~ 115 (606)
T 3vq2_A 36 NIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETK 115 (606)
T ss_dssp EEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCCCCTTSSTTCTTCCEEECTTSC
T ss_pred EEECCCCCcCEeChhhccCCccCcEEeCCCCcccccCHHHhhchhhcCEeECCCCcccccChhhcCCcccCCEEEccCCc
Confidence 38999999998888899999999999999999998889999999999999999999997779999999999999999999
Q ss_pred ccccCCccccCCCCCCEEEccCCcccc-cCccccCCCCCCCEEECcCCcCCCcCCcCCCCCCCCc----eeecccccccc
Q 044366 81 VSGRIPSSLGNLSNLALLYLNDNSLFG-SIPIVMGNLKSLSTLDLSQNQLNGSIPCSLDNLSNLD----TLFLYKNSLSG 155 (918)
Q Consensus 81 ~~~~~p~~l~~l~~L~~L~L~~n~i~~-~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~----~L~L~~n~l~~ 155 (918)
+++..|..|+++++|++|++++|.+.+ ..|..|+++++|++|++++|++++..|..++.+++|+ +|++++|.+++
T Consensus 116 l~~~~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~~l~~L~l~~n~l~~ 195 (606)
T 3vq2_A 116 LASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDF 195 (606)
T ss_dssp CCCSSSSCCTTCTTCCEEECCSSCCCCCCCCGGGGTCTTCCEEECCSSCCCEECTTTTHHHHHCTTCCCEEECTTCCCCE
T ss_pred cccccccccCCCCCCCEEeCCCCcccceechHhHhhcCCCCEEEccCCcceecChhhhhhhhccccccceeeccCCCcce
Confidence 997777899999999999999999986 5699999999999999999999988888898887766 89999999998
Q ss_pred CCCcccccccccCeeeccccccC-CcCCccCCCCCCCcEeeccCccccc------CCCccccCCC--Ccceeec-ccccc
Q 044366 156 PIPSVIGNLKSLLQLDLSENRLS-GLIPLSLSNLSSLTVMSLFNNSLSG------SIPPILGNLK--SLSTLGL-HINQL 225 (918)
Q Consensus 156 ~~~~~~~~l~~L~~L~Ls~N~l~-~~~~~~~~~l~~L~~L~L~~N~l~~------~~~~~~~~l~--~L~~L~L-~~n~l 225 (918)
+.+..+... +|++|++++|.+. +..+..+..+++|+.+++..+.+.. ..+..+..+. +++.+++ ..|.+
T Consensus 196 ~~~~~~~~~-~L~~L~L~~n~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~l~~~~~~ 274 (606)
T 3vq2_A 196 IQDQAFQGI-KLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDF 274 (606)
T ss_dssp ECTTTTTTC-EEEEEEEESCCSCHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCGGGGTTGGGSEEEEEEECCCTTC
T ss_pred eCcccccCc-eeeeeeccCCccchhHHHHHhccccccccccccccccccCCcccccChHHhhhhhhccHhheeccccccc
Confidence 887777766 9999999999987 4567788999999999887665542 1222333333 4556666 67788
Q ss_pred cCCCCCCCcCCCcCCeEEcccCcCcCCCCccccccCCCCeEecCCCccCCcCCCcCCCCCCCcEEEccCCcCcCCCCccc
Q 044366 226 NGVIPPSIGNLSSLRNLSLFNNRLYGFVPKEIGYLKSLSKLEFCANHLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSL 305 (918)
Q Consensus 226 ~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l 305 (918)
.+..|. +..+++|+.|++++|.+..+ | .+..+++|++|++++|.+. ..| .+ .+++|+.|++++|+..+.. .+
T Consensus 275 ~~~~~~-~~~l~~L~~L~l~~~~~~~l-~-~l~~~~~L~~L~l~~n~l~-~lp-~~-~l~~L~~L~l~~n~~~~~~--~~ 346 (606)
T 3vq2_A 275 SDDIVK-FHCLANVSAMSLAGVSIKYL-E-DVPKHFKWQSLSIIRCQLK-QFP-TL-DLPFLKSLTLTMNKGSISF--KK 346 (606)
T ss_dssp CGGGGS-CGGGTTCSEEEEESCCCCCC-C-CCCTTCCCSEEEEESCCCS-SCC-CC-CCSSCCEEEEESCSSCEEC--CC
T ss_pred cccccc-cccCCCCCEEEecCccchhh-h-hccccccCCEEEcccccCc-ccc-cC-CCCccceeeccCCcCccch--hh
Confidence 877776 89999999999999999864 4 7889999999999999994 556 45 9999999999999655433 67
Q ss_pred cCCCCCCeEEeecccccCcc--ccccCCCCCccEEeCCCCccccccCcccccccccceeeccccccccCCC-cCcCCCCC
Q 044366 306 RNLTSLERVRFNQNNLYGKV--YEAFGDHPNLTFLDLSQNNFYCEISFNWRNFSKLGTFNASMNNIYGSIP-PEIGDSSK 382 (918)
Q Consensus 306 ~~l~~L~~L~l~~n~l~~~~--~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~n~i~~~~~-~~~~~~~~ 382 (918)
..+++|++|++++|.+..+. +..+..+++|++|++++|.+..++ ..+..+++|+.|++++|.+.+..+ ..+..+++
T Consensus 347 ~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~-~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~ 425 (606)
T 3vq2_A 347 VALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAIIMS-ANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEK 425 (606)
T ss_dssp CCCTTCCEEECCSSCEEEEEECCHHHHCCSCCCEEECCSCSEEEEC-CCCTTCTTCCEEECTTSEEESTTTTTTTTTCTT
T ss_pred ccCCCCCEEECcCCccCCCcchhhhhccCCcccEeECCCCccccch-hhccCCCCCCeeECCCCccCCccChhhhhcccc
Confidence 79999999999999998875 677889999999999999998766 778899999999999999998887 68999999
Q ss_pred CcEEEccCceeccccccchhhccccCceecccccccC-CCCCCCCCCCcccEEeccCccccccCccccccccccceeccc
Q 044366 383 LQVLDLSSNHIFGKIPVQLVKLFSLNKLILSLNQLFG-GVPLEFGTLTELQYLDLSANKLSSSIPMSIGNLLKLHYLNLS 461 (918)
Q Consensus 383 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~-~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls 461 (918)
|++|++++|.+.+..|..+.++++|++|++++|++++ ..|..|..+++|++|+|++|.+++..|..|..+++|++|+|+
T Consensus 426 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls 505 (606)
T 3vq2_A 426 LLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMS 505 (606)
T ss_dssp CCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECC
T ss_pred CCEEECcCCCCCccchhhhcCCCCCCEEECCCCcCCCcchHHhhccCCCCCEEECCCCcCCccChhhhcccccCCEEECC
Confidence 9999999999999999999999999999999999987 478999999999999999999999999999999999999999
Q ss_pred CcccCCCCchhhccccccceEeccCCcCCCCCchhccccC-CcceEecCCCcccccCc
Q 044366 462 NNQFSHKIPTEFEKLIHLSELDLSHNILQEEIPPQICKME-SLEKLNLSHNNLSDFIP 518 (918)
Q Consensus 462 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~-~L~~L~L~~N~l~~~~~ 518 (918)
+|++++..|..|..+++|++|+|++|+|+ .+|..+..++ +|+.|++++|++....+
T Consensus 506 ~N~l~~~~~~~~~~l~~L~~L~l~~N~l~-~~p~~~~~l~~~L~~l~l~~N~~~c~c~ 562 (606)
T 3vq2_A 506 HNNLLFLDSSHYNQLYSLSTLDCSFNRIE-TSKGILQHFPKSLAFFNLTNNSVACICE 562 (606)
T ss_dssp SSCCSCEEGGGTTTCTTCCEEECTTSCCC-CEESCGGGSCTTCCEEECCSCCCCCSST
T ss_pred CCcCCCcCHHHccCCCcCCEEECCCCcCc-ccCHhHhhhcccCcEEEccCCCcccCCc
Confidence 99999999999999999999999999998 5777799887 69999999999986433
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-53 Score=497.84 Aligned_cols=506 Identities=23% Similarity=0.266 Sum_probs=393.3
Q ss_pred cCCCCCCccCCccCCCCCCCCEEeCCCCcccccCCccccCCCCCCEEEcccccccccCCCCcCCCCCCCEEEcccccccc
Q 044366 4 LGFNLLFGNIPPQIGNLSKLQYLDLGNNQLSGVIPPEIGKLNQLRRLYLDVNQLHGTIPPVIGQLSLINELVFCHNNVSG 83 (918)
Q Consensus 4 ~~~~~~~~~~p~~~~~l~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~ 83 (918)
-++.+++ .+|..+. +++++|+|++|++++..+.+|..+++|++|+|++|++++..|..|+.+++|++|++++|.+++
T Consensus 14 c~~~~l~-~ip~~l~--~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~ 90 (570)
T 2z63_A 14 CMELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQS 90 (570)
T ss_dssp CCSSCCS-SCCSSSC--SSCCEEECCSCCCCEECTTTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCE
T ss_pred eCCCCcc-ccCCCcc--ccccEEEccCCccCccChhHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcCCcCCc
Confidence 3444555 7787653 578999999999987778889999999999999999987777888999999999999999987
Q ss_pred cCCccccCCCCCCEEEccCCcccccCccccCCCCCCCEEECcCCcCCCc-CCcCCCCCCCCceeeccccccccCCCcccc
Q 044366 84 RIPSSLGNLSNLALLYLNDNSLFGSIPIVMGNLKSLSTLDLSQNQLNGS-IPCSLDNLSNLDTLFLYKNSLSGPIPSVIG 162 (918)
Q Consensus 84 ~~p~~l~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~-~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~ 162 (918)
..|..|.++++|++|++++|++.+..+..++++++|++|++++|.+++. +|..++++++|++|++++|++++..+..|+
T Consensus 91 ~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~l~~n~l~~~~~~~~~ 170 (570)
T 2z63_A 91 LALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLR 170 (570)
T ss_dssp ECTTTTTTCTTCCEEECTTSCCCCSTTCSCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECTTSCCCEECGGGGH
T ss_pred cCHhhhcCccccccccccccccccCCCccccccccccEEecCCCccceecChhhhcccCCCCEEeCcCCccceecHHHcc
Confidence 7788899999999999999999877666788999999999999998863 688899999999999999999888888888
Q ss_pred ccccc----CeeeccccccCCcCCccCCCCCCCcEeeccCccccc-CCCccccCCCCcceeeccccccc------CCCCC
Q 044366 163 NLKSL----LQLDLSENRLSGLIPLSLSNLSSLTVMSLFNNSLSG-SIPPILGNLKSLSTLGLHINQLN------GVIPP 231 (918)
Q Consensus 163 ~l~~L----~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~-~~~~~~~~l~~L~~L~L~~n~l~------~~~~~ 231 (918)
.+++| +.|++++|.++++.+..|..+ +|+.|++++|.... ..+..+..++.++.+.+....+. .....
T Consensus 171 ~l~~L~~~~~~L~l~~n~l~~~~~~~~~~~-~L~~L~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~ 249 (570)
T 2z63_A 171 VLHQMPLLNLSLDLSLNPMNFIQPGAFKEI-RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKS 249 (570)
T ss_dssp HHHTCTTCCCEEECTTCCCCEECTTTTTTC-EEEEEEEESCCSCTTHHHHHHHTTTTCEEEEEEEEECCCCSSCEECCTT
T ss_pred chhccchhhhhcccCCCCceecCHHHhccC-cceeEecccccccccchhhhhcCccccceeeeccccccCchhhhhcchh
Confidence 88888 889999999998888877766 79999998885431 23455677777777666544322 12222
Q ss_pred CCcCCC--cCCeEEcccC-cCcCCCCccccccCCCCeEecCCCccCCcCCCcCCCCCCCcEEEccCCcCcCCCCccccCC
Q 044366 232 SIGNLS--SLRNLSLFNN-RLYGFVPKEIGYLKSLSKLEFCANHLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLRNL 308 (918)
Q Consensus 232 ~~~~l~--~L~~L~Ls~n-~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l 308 (918)
.+.++. .++.++++++ .+.+..+..+..+++|+.|++++|.+.+ .|..+..+ +|+.|++++|.+. .+|. ..+
T Consensus 250 ~~~~l~~l~l~~l~l~~~~~~~~~~~~~~~~l~~L~~L~l~~~~l~~-l~~~~~~~-~L~~L~l~~n~~~-~l~~--~~l 324 (570)
T 2z63_A 250 ALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIER-VKDFSYNF-GWQHLELVNCKFG-QFPT--LKL 324 (570)
T ss_dssp TTGGGGGSEEEEEEEEETTEEESCSTTTTGGGTTCSEEEEESCEECS-CCBCCSCC-CCSEEEEESCBCS-SCCB--CBC
T ss_pred hhccccccchhhhhhhcchhhhhhchhhhcCcCcccEEEecCccchh-hhhhhccC-CccEEeeccCccc-ccCc--ccc
Confidence 333333 2445555555 5555556666666666666666666663 44455555 6666666666665 2232 345
Q ss_pred CCCCeEEeecccccCccccccCCCCCccEEeCCCCccccccCcccccccccceeeccccccccCC--CcCcCCCCCCcEE
Q 044366 309 TSLERVRFNQNNLYGKVYEAFGDHPNLTFLDLSQNNFYCEISFNWRNFSKLGTFNASMNNIYGSI--PPEIGDSSKLQVL 386 (918)
Q Consensus 309 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~n~i~~~~--~~~~~~~~~L~~L 386 (918)
++|+.|++++|.+....+. ..+++|+.|++++|.+ .+.. +..+..+++|++|
T Consensus 325 ~~L~~L~l~~n~~~~~~~~--~~~~~L~~L~l~~n~l------------------------~~~~~~~~~~~~~~~L~~L 378 (570)
T 2z63_A 325 KSLKRLTFTSNKGGNAFSE--VDLPSLEFLDLSRNGL------------------------SFKGCCSQSDFGTTSLKYL 378 (570)
T ss_dssp SSCCEEEEESCBSCCBCCC--CBCTTCCEEECCSSCC------------------------BEEEEEEHHHHTCSCCCEE
T ss_pred cccCEEeCcCCcccccccc--ccCCCCCEEeCcCCcc------------------------CccccccccccccCccCEE
Confidence 5555666655555433222 3445555555555544 3332 4567778889999
Q ss_pred EccCceeccccccchhhccccCceecccccccCCCC-CCCCCCCcccEEeccCccccccCccccccccccceecccCccc
Q 044366 387 DLSSNHIFGKIPVQLVKLFSLNKLILSLNQLFGGVP-LEFGTLTELQYLDLSANKLSSSIPMSIGNLLKLHYLNLSNNQF 465 (918)
Q Consensus 387 ~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l 465 (918)
++++|.+.+..+. +..+++|+.|++++|++.+..+ ..+..+++|++|++++|.+++..|..|..+++|+.|+|++|++
T Consensus 379 ~l~~n~l~~~~~~-~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l 457 (570)
T 2z63_A 379 DLSFNGVITMSSN-FLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSF 457 (570)
T ss_dssp ECCSCSEEEEEEE-EETCTTCCEEECTTSEEESCTTSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEE
T ss_pred ECCCCcccccccc-ccccCCCCEEEccCCccccccchhhhhcCCCCCEEeCcCCcccccchhhhhcCCcCcEEECcCCcC
Confidence 9999998865554 8889999999999999987766 5788999999999999999988999999999999999999999
Q ss_pred C-CCCchhhccccccceEeccCCcCCCCCchhccccCCcceEecCCCcccccCcccccCCCCccEEEccCCcCCCCCCCC
Q 044366 466 S-HKIPTEFEKLIHLSELDLSHNILQEEIPPQICKMESLEKLNLSHNNLSDFIPRCFEEMRSLSWIDISYNELQGPIPNS 544 (918)
Q Consensus 466 ~-~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~p~~ 544 (918)
+ +.+|..|..+++|++|+|++|++++..|..|..+++|+.|+|++|++++..|..|..+++|+.|++++|+++|.+|..
T Consensus 458 ~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~~ 537 (570)
T 2z63_A 458 QENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRI 537 (570)
T ss_dssp GGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTTT
T ss_pred ccccchhhhhcccCCCEEECCCCccccCChhhhhcccCCCEEeCCCCcCCCCCHHHhhcccCCcEEEecCCcccCCCcch
Confidence 7 568899999999999999999999888999999999999999999999998999999999999999999999999975
Q ss_pred c
Q 044366 545 T 545 (918)
Q Consensus 545 ~ 545 (918)
.
T Consensus 538 ~ 538 (570)
T 2z63_A 538 D 538 (570)
T ss_dssp H
T ss_pred H
Confidence 4
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-51 Score=485.80 Aligned_cols=485 Identities=23% Similarity=0.226 Sum_probs=410.0
Q ss_pred CcccCCCCCCccCCccCCCCCCCCEEeCCCCcccccCCccccCCCCCCEEEcccccccccCCCCcCCCCCCCEEEccccc
Q 044366 1 MLNLGFNLLFGNIPPQIGNLSKLQYLDLGNNQLSGVIPPEIGKLNQLRRLYLDVNQLHGTIPPVIGQLSLINELVFCHNN 80 (918)
Q Consensus 1 ~l~~~~~~~~~~~p~~~~~l~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~ 80 (918)
.|+|++|.+.+..|.+|.++++|++|+|++|++++..|.+|+++++|++|+|++|++++..|..|+.+++|++|++++|.
T Consensus 32 ~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~ 111 (570)
T 2z63_A 32 NLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETN 111 (570)
T ss_dssp EEECCSCCCCEECTTTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTSC
T ss_pred EEEccCCccCccChhHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcCCcCCccCHhhhcCccccccccccccc
Confidence 38999999998888889999999999999999998888899999999999999999997778899999999999999999
Q ss_pred ccccCCccccCCCCCCEEEccCCcccc-cCccccCCCCCCCEEECcCCcCCCcCCcCCCCCCCC----ceeecccccccc
Q 044366 81 VSGRIPSSLGNLSNLALLYLNDNSLFG-SIPIVMGNLKSLSTLDLSQNQLNGSIPCSLDNLSNL----DTLFLYKNSLSG 155 (918)
Q Consensus 81 ~~~~~p~~l~~l~~L~~L~L~~n~i~~-~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L----~~L~L~~n~l~~ 155 (918)
+++..+..|+++++|++|++++|.+.+ ..|..|+++++|++|++++|++++..+..++.+++| +.|++++|.+++
T Consensus 112 l~~l~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~~~~~L~l~~n~l~~ 191 (570)
T 2z63_A 112 LASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNF 191 (570)
T ss_dssp CCCSTTCSCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECTTSCCCEECGGGGHHHHTCTTCCCEEECTTCCCCE
T ss_pred cccCCCccccccccccEEecCCCccceecChhhhcccCCCCEEeCcCCccceecHHHccchhccchhhhhcccCCCCcee
Confidence 996666689999999999999999986 369999999999999999999998888889999988 899999999999
Q ss_pred CCCcccccccccCeeeccccccCC-cCCccCCCCCCCcEeeccCccc------ccCCCccccCCCC--cceeecccc-cc
Q 044366 156 PIPSVIGNLKSLLQLDLSENRLSG-LIPLSLSNLSSLTVMSLFNNSL------SGSIPPILGNLKS--LSTLGLHIN-QL 225 (918)
Q Consensus 156 ~~~~~~~~l~~L~~L~Ls~N~l~~-~~~~~~~~l~~L~~L~L~~N~l------~~~~~~~~~~l~~--L~~L~L~~n-~l 225 (918)
+.+..|..+ +|++|++++|.... ..+..+..+++++.+.+..+.+ .......|..+.+ ++.++++.+ .+
T Consensus 192 ~~~~~~~~~-~L~~L~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~l~~~~~~ 270 (570)
T 2z63_A 192 IQPGAFKEI-RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYY 270 (570)
T ss_dssp ECTTTTTTC-EEEEEEEESCCSCTTHHHHHHHTTTTCEEEEEEEEECCCCSSCEECCTTTTGGGGGSEEEEEEEEETTEE
T ss_pred cCHHHhccC-cceeEecccccccccchhhhhcCccccceeeeccccccCchhhhhcchhhhccccccchhhhhhhcchhh
Confidence 988888876 89999999986542 2345667778887776654332 2233344444443 567777777 77
Q ss_pred cCCCCCCCcCCCcCCeEEcccCcCcCCCCccccccCCCCeEecCCCccCCcCCCcCCCCCCCcEEEccCCcCcCCCCccc
Q 044366 226 NGVIPPSIGNLSSLRNLSLFNNRLYGFVPKEIGYLKSLSKLEFCANHLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSL 305 (918)
Q Consensus 226 ~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l 305 (918)
.+..+..+..+++|+.|++++|.+.+ .|..+..+ +|++|++++|.+... |. ..+++|+.|++++|.+.+..+.
T Consensus 271 ~~~~~~~~~~l~~L~~L~l~~~~l~~-l~~~~~~~-~L~~L~l~~n~~~~l-~~--~~l~~L~~L~l~~n~~~~~~~~-- 343 (570)
T 2z63_A 271 LDDIIDLFNCLTNVSSFSLVSVTIER-VKDFSYNF-GWQHLELVNCKFGQF-PT--LKLKSLKRLTFTSNKGGNAFSE-- 343 (570)
T ss_dssp ESCSTTTTGGGTTCSEEEEESCEECS-CCBCCSCC-CCSEEEEESCBCSSC-CB--CBCSSCCEEEEESCBSCCBCCC--
T ss_pred hhhchhhhcCcCcccEEEecCccchh-hhhhhccC-CccEEeeccCccccc-Cc--ccccccCEEeCcCCcccccccc--
Confidence 77888999999999999999999984 67777788 999999999999844 33 4788999999999998876665
Q ss_pred cCCCCCCeEEeecccccCcc--ccccCCCCCccEEeCCCCccccccCcccccccccceeeccccccccCCCcCcCCCCCC
Q 044366 306 RNLTSLERVRFNQNNLYGKV--YEAFGDHPNLTFLDLSQNNFYCEISFNWRNFSKLGTFNASMNNIYGSIPPEIGDSSKL 383 (918)
Q Consensus 306 ~~l~~L~~L~l~~n~l~~~~--~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~n~i~~~~~~~~~~~~~L 383 (918)
..+++|++|++++|.+.... +..+..+++|++|++++|.+.... ..+..+++|
T Consensus 344 ~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~-------------------------~~~~~l~~L 398 (570)
T 2z63_A 344 VDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMS-------------------------SNFLGLEQL 398 (570)
T ss_dssp CBCTTCCEEECCSSCCBEEEEEEHHHHTCSCCCEEECCSCSEEEEE-------------------------EEEETCTTC
T ss_pred ccCCCCCEEeCcCCccCccccccccccccCccCEEECCCCcccccc-------------------------ccccccCCC
Confidence 78999999999999998775 567788899999999998876322 235667778
Q ss_pred cEEEccCceeccccc-cchhhccccCceecccccccCCCCCCCCCCCcccEEeccCcccc-ccCccccccccccceeccc
Q 044366 384 QVLDLSSNHIFGKIP-VQLVKLFSLNKLILSLNQLFGGVPLEFGTLTELQYLDLSANKLS-SSIPMSIGNLLKLHYLNLS 461 (918)
Q Consensus 384 ~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~~~~~~~~~l~~L~~L~Ls 461 (918)
+.|++++|.+.+..+ ..+..+++|+.|++++|++.+..+..|..+++|++|+|++|.++ +.+|..|..+++|++|+|+
T Consensus 399 ~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l~ 478 (570)
T 2z63_A 399 EHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLS 478 (570)
T ss_dssp CEEECTTSEEESCTTSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECT
T ss_pred CEEEccCCccccccchhhhhcCCCCCEEeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhcccCCCEEECC
Confidence 888888888776655 46777888888888888888888888888899999999999887 5678888889999999999
Q ss_pred CcccCCCCchhhccccccceEeccCCcCCCCCchhccccCCcceEecCCCcccccCc
Q 044366 462 NNQFSHKIPTEFEKLIHLSELDLSHNILQEEIPPQICKMESLEKLNLSHNNLSDFIP 518 (918)
Q Consensus 462 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~ 518 (918)
+|++++..|..|..+++|++|+|++|++++..|..|..+++|+.|++++|++++..|
T Consensus 479 ~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 535 (570)
T 2z63_A 479 QCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 535 (570)
T ss_dssp TSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTT
T ss_pred CCccccCChhhhhcccCCCEEeCCCCcCCCCCHHHhhcccCCcEEEecCCcccCCCc
Confidence 999988888889999999999999999988888888899999999999999987655
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-51 Score=483.32 Aligned_cols=482 Identities=22% Similarity=0.224 Sum_probs=327.4
Q ss_pred EEeCCCCcccccCCccccCCCCCCEEEcccccccccCCCCcCCCCCCCEEEcccccccccCCccccCCCCCCEEEccCCc
Q 044366 25 YLDLGNNQLSGVIPPEIGKLNQLRRLYLDVNQLHGTIPPVIGQLSLINELVFCHNNVSGRIPSSLGNLSNLALLYLNDNS 104 (918)
Q Consensus 25 ~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~l~~l~~L~~L~L~~n~ 104 (918)
+.|.++++++ .+|..+. ++|++|+|++|++++..|..|..+++|++|++++|.+++..|.+|..+++|++|+|++|+
T Consensus 9 ~c~~~~~~l~-~ip~~~~--~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~ 85 (549)
T 2z81_A 9 VCDGRSRSFT-SIPSGLT--AAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNH 85 (549)
T ss_dssp EEECTTSCCS-SCCSCCC--TTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSC
T ss_pred eEECCCCccc-cccccCC--CCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhccccccCCEEECCCCc
Confidence 3455566665 5555443 556666666666665555566666666666666666665556666666677777777776
Q ss_pred ccccCccccCCCCCCCEEECcCCcCCCc-CCcCCCCCCCCceeeccccc-cccCCCcccccccccCeeeccccccCCcCC
Q 044366 105 LFGSIPIVMGNLKSLSTLDLSQNQLNGS-IPCSLDNLSNLDTLFLYKNS-LSGPIPSVIGNLKSLLQLDLSENRLSGLIP 182 (918)
Q Consensus 105 i~~~~~~~~~~l~~L~~L~Ls~n~i~~~-~~~~l~~l~~L~~L~L~~n~-l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~ 182 (918)
+.+..|..|+++++|++|+|++|++++. .|..++++++|++|++++|. +..+.+..|+++++|++|++++|++++..|
T Consensus 86 l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~ 165 (549)
T 2z81_A 86 LSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQS 165 (549)
T ss_dssp CCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECT
T ss_pred cCccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEEECCCCccccccCHhhhhcccccCeeeccCCcccccCh
Confidence 6666666666677777777777766642 35566667777777777766 444444566677777777777777776666
Q ss_pred ccCCCCCCCcEeeccCcccccCCCccccCCCCcceeecccccccCCC---CCCCcCCCcCCeEEcccCcCcCCCCc----
Q 044366 183 LSLSNLSSLTVMSLFNNSLSGSIPPILGNLKSLSTLGLHINQLNGVI---PPSIGNLSSLRNLSLFNNRLYGFVPK---- 255 (918)
Q Consensus 183 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~---~~~~~~l~~L~~L~Ls~n~l~~~~~~---- 255 (918)
..+..+++|++|++++|.+.......+..+++|++|++++|++++.. ......+++|+.|++++|.+++..+.
T Consensus 166 ~~l~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~ 245 (549)
T 2z81_A 166 QSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLK 245 (549)
T ss_dssp TTTTTCSEEEEEEEECSBSTTHHHHHHHSTTTBSEEEEESCBCTTCCCCCCSSCCCCCCCCEEEEESCEEEHHHHHHHHG
T ss_pred hhhhccccCceEecccCcccccchhhHhhcccccEEEccCCccccccccccchhhhhhcccceeccccccchhHHHHHHH
Confidence 66777777777777777665332223345677777777777776532 12234466777777777776643332
Q ss_pred cccccCCCCeEecCCCccCCcCC------CcCCCCCCCcEEEccCCcCcCC-----CCccccCCCCCCeEEeecccccCc
Q 044366 256 EIGYLKSLSKLEFCANHLSGVIP------HSVGNLTGLVLLNMCENHLFGP-----IPKSLRNLTSLERVRFNQNNLYGK 324 (918)
Q Consensus 256 ~~~~l~~L~~L~l~~n~l~~~~~------~~~~~l~~L~~L~l~~n~l~~~-----~~~~l~~l~~L~~L~l~~n~l~~~ 324 (918)
.+..+++|+.+++++|.+.+... ..+..+.+|+.|++.++.+... .+..+....+|++|++++|.+..+
T Consensus 246 ~~~~~~~L~~l~l~~~~~~~~~~~~~~~~~~~~~l~~L~~L~l~~~~i~~~~~~~~l~~~~~~~~~L~~L~l~~n~l~~i 325 (549)
T 2z81_A 246 LLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLV 325 (549)
T ss_dssp GGGGCTTCCEEEEESCEEECCSCCCCCTTTCCCCCTTCCEEEEESCBCSCGGGSCCCCHHHHHSTTCCEEEEESSCCCCC
T ss_pred HhhhhccccccccccccccccccccccchhhhhhhcccccccccccccchhhhcccchhhhhhcccceEEEeccCccccC
Confidence 23456677777777777654321 2234455666666666554321 112223344555555555555555
Q ss_pred cccccCCCCCccEEeCCCCccccccCcccccccccceeeccccccccCCC---cCcCCCCCCcEEEccCceeccccc--c
Q 044366 325 VYEAFGDHPNLTFLDLSQNNFYCEISFNWRNFSKLGTFNASMNNIYGSIP---PEIGDSSKLQVLDLSSNHIFGKIP--V 399 (918)
Q Consensus 325 ~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~n~i~~~~~---~~~~~~~~L~~L~L~~N~l~~~~~--~ 399 (918)
+...+..+++|++|++++|++ .+..| ..++.+++|++|+|++|+|++..+ .
T Consensus 326 p~~~~~~l~~L~~L~Ls~N~l------------------------~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~ 381 (549)
T 2z81_A 326 PCSFSQHLKSLEFLDLSENLM------------------------VEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGE 381 (549)
T ss_dssp CHHHHHHCTTCCEEECCSSCC------------------------CHHHHHHHTCTTSSTTCCEEECTTSCCCCHHHHHH
T ss_pred CHHHHhcCccccEEEccCCcc------------------------ccccccchhhhhccccCcEEEccCCcccccccchh
Confidence 544444455555555555554 44332 236778889999999999986543 4
Q ss_pred chhhccccCceecccccccCCCCCCCCCCCcccEEeccCccccccCccccccccccceecccCcccCCCCchhhcccccc
Q 044366 400 QLVKLFSLNKLILSLNQLFGGVPLEFGTLTELQYLDLSANKLSSSIPMSIGNLLKLHYLNLSNNQFSHKIPTEFEKLIHL 479 (918)
Q Consensus 400 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L 479 (918)
.+..+++|++|++++|+++ .+|..+..+++|++|+|++|.|+. +|..+. ++|++|+|++|+|++.+ ..+++|
T Consensus 382 ~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~~L~~L~Ls~N~l~~-l~~~~~--~~L~~L~Ls~N~l~~~~----~~l~~L 453 (549)
T 2z81_A 382 ILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIRV-VKTCIP--QTLEVLDVSNNNLDSFS----LFLPRL 453 (549)
T ss_dssp HGGGCTTCCEEECTTCCCC-CCCSCCCCCTTCCEEECTTSCCSC-CCTTSC--TTCSEEECCSSCCSCCC----CCCTTC
T ss_pred hhhcCCCCCEEECCCCCCc-cCChhhcccccccEEECCCCCccc-ccchhc--CCceEEECCCCChhhhc----ccCChh
Confidence 5888999999999999997 567788899999999999999984 444432 68999999999998653 578999
Q ss_pred ceEeccCCcCCCCCchhccccCCcceEecCCCcccccCcccccCCCCccEEEccCCcCCCCCCC
Q 044366 480 SELDLSHNILQEEIPPQICKMESLEKLNLSHNNLSDFIPRCFEEMRSLSWIDISYNELQGPIPN 543 (918)
Q Consensus 480 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~p~ 543 (918)
++|+|++|+|+ .+|. ...+++|+.|+|++|++++..|..|..+++|+.|++++|+|+|.+|.
T Consensus 454 ~~L~Ls~N~l~-~ip~-~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~ 515 (549)
T 2z81_A 454 QELYISRNKLK-TLPD-ASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR 515 (549)
T ss_dssp CEEECCSSCCS-SCCC-GGGCTTCCEEECCSSCCCCCCTTGGGGCTTCCEEECCSSCBCCCHHH
T ss_pred cEEECCCCccC-cCCC-cccCccCCEEecCCCccCCcCHHHHhcCcccCEEEecCCCccCCCcc
Confidence 99999999998 4565 46789999999999999999999999999999999999999999884
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-51 Score=436.62 Aligned_cols=255 Identities=21% Similarity=0.317 Sum_probs=207.8
Q ss_pred CCCCceeeccccceEEEEEEeC------CCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCc
Q 044366 647 NFGEKYCIGKGGQRSVYKAELP------SGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQH 720 (918)
Q Consensus 647 ~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 720 (918)
++...+.||+|+||.||+|.+. +++.||||+++.. ......++|.+|+.++++++|||||+++|+|.+++.
T Consensus 27 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~---~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~ 103 (308)
T 4gt4_A 27 AVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDK---AEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQP 103 (308)
T ss_dssp GEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC----CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcc---cChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCE
Confidence 4556778999999999999762 5678999999753 233446789999999999999999999999999999
Q ss_pred eEEEEEeccCCChhHHhhcccc-------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCC
Q 044366 721 SFIVCEYLARGSLTTILRDDAA-------------AKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDS 787 (918)
Q Consensus 721 ~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~ 787 (918)
.++|||||++|+|.+++..... ...++|.++++|+.|||+||+|||+. +||||||||+|||+++
T Consensus 104 ~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLK~~NILl~~ 180 (308)
T 4gt4_A 104 LSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVYD 180 (308)
T ss_dssp CEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECG
T ss_pred EEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCccccceEECC
Confidence 9999999999999999965321 24589999999999999999999999 9999999999999999
Q ss_pred CCcEEEeccccccccCCCCC--CceecccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhhhhhhhh
Q 044366 788 EYEAHVSDFGFAKFLEPHSS--NWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIK-GYHPGDFVSTIFSSISN 864 (918)
Q Consensus 788 ~~~~kl~DfG~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~p~~~~~~~~~~~~~ 864 (918)
++.+||+|||+|+....... ......||++|||||++.++.++.++|||||||++|||+| |+.||...... .+.
T Consensus 181 ~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~--~~~- 257 (308)
T 4gt4_A 181 KLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ--DVV- 257 (308)
T ss_dssp GGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHH--HHH-
T ss_pred CCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHH--HHH-
Confidence 99999999999987644322 2345678999999999999999999999999999999998 89998654321 111
Q ss_pred hHhhhhhhcccCCCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhC
Q 044366 865 MIIEVNQILDHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLLCK 918 (918)
Q Consensus 865 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~ 918 (918)
..+.....++.+... +..+.+++.+||+.||++||||+||++.|+.
T Consensus 258 -----~~i~~~~~~~~p~~~---~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a 303 (308)
T 4gt4_A 258 -----EMIRNRQVLPCPDDC---PAWVYALMIECWNEFPSRRPRFKDIHSRLRA 303 (308)
T ss_dssp -----HHHHTTCCCCCCTTC---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred -----HHHHcCCCCCCcccc---hHHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence 111122222222222 3457889999999999999999999999863
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-51 Score=437.21 Aligned_cols=254 Identities=26% Similarity=0.419 Sum_probs=207.1
Q ss_pred cCCCCceeeccccceEEEEEEeC------CCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCC
Q 044366 646 GNFGEKYCIGKGGQRSVYKAELP------SGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQ 719 (918)
Q Consensus 646 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~ 719 (918)
++|...+.||+|+||.||+|++. +++.||||+++.. .....++|.+|++++++++|||||+++|+|.+++
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~----~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~ 88 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA----SDNARKDFHREAELLTNLQHEHIVKFYGVCVEGD 88 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC----CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC----ChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCC
Confidence 56778899999999999999763 4778999998653 2233578999999999999999999999999999
Q ss_pred ceEEEEEeccCCChhHHhhccc----------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCC
Q 044366 720 HSFIVCEYLARGSLTTILRDDA----------AAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEY 789 (918)
Q Consensus 720 ~~~lv~e~~~~gsL~~~l~~~~----------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~ 789 (918)
..++|||||++|+|.++++..+ ....++|.++++|+.|||+||+|||++ +||||||||+|||+++++
T Consensus 89 ~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDlKp~NILl~~~~ 165 (299)
T 4asz_A 89 PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENL 165 (299)
T ss_dssp SEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGG
T ss_pred EEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccCHhhEEECCCC
Confidence 9999999999999999997642 235699999999999999999999999 999999999999999999
Q ss_pred cEEEeccccccccCCCCCCc--eecccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhhhhhhhhhH
Q 044366 790 EAHVSDFGFAKFLEPHSSNW--TEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIK-GYHPGDFVSTIFSSISNMI 866 (918)
Q Consensus 790 ~~kl~DfG~~~~~~~~~~~~--~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~p~~~~~~~~~~~~~~~ 866 (918)
.+||+|||+|+......... ....||+.|||||++.+..++.++|||||||++|||+| |+.||...... .+ .
T Consensus 166 ~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~--~~---~ 240 (299)
T 4asz_A 166 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN--EV---I 240 (299)
T ss_dssp CEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH--HH---H
T ss_pred cEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH--HH---H
Confidence 99999999998765433321 23468999999999999999999999999999999999 89998754321 11 1
Q ss_pred hhhhhhcccCCCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 044366 867 IEVNQILDHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLLC 917 (918)
Q Consensus 867 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 917 (918)
..+.....+..+... +.++.+++.+||+.||++|||++||++.|+
T Consensus 241 ---~~i~~~~~~~~p~~~---~~~~~~li~~cl~~dP~~RPs~~~i~~~L~ 285 (299)
T 4asz_A 241 ---ECITQGRVLQRPRTC---PQEVYELMLGCWQREPHMRKNIKGIHTLLQ 285 (299)
T ss_dssp ---HHHHHTCCCCCCTTC---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred ---HHHHcCCCCCCCccc---hHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence 111122222222222 346788999999999999999999999885
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-50 Score=470.90 Aligned_cols=479 Identities=20% Similarity=0.203 Sum_probs=378.4
Q ss_pred cccCCCCCCccCCccCCCCCCCCEEeCCCCcccccCCccccCCCCCCEEEcccccccccCCCCcCCCCCCCEEEcccccc
Q 044366 2 LNLGFNLLFGNIPPQIGNLSKLQYLDLGNNQLSGVIPPEIGKLNQLRRLYLDVNQLHGTIPPVIGQLSLINELVFCHNNV 81 (918)
Q Consensus 2 l~~~~~~~~~~~p~~~~~l~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~~ 81 (918)
.+.++++++ .+|+.+. ++|++|+|++|++++..|.+|..+++|++|+|++|++++..|..|+.+++|++|++++|.+
T Consensus 10 c~~~~~~l~-~ip~~~~--~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l 86 (549)
T 2z81_A 10 CDGRSRSFT-SIPSGLT--AAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHL 86 (549)
T ss_dssp EECTTSCCS-SCCSCCC--TTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCC
T ss_pred EECCCCccc-cccccCC--CCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhccccccCCEEECCCCcc
Confidence 366788888 8998765 8999999999999988899999999999999999999988889999999999999999999
Q ss_pred cccCCccccCCCCCCEEEccCCcccc-cCccccCCCCCCCEEECcCCc-CCCcCCcCCCCCCCCceeeccccccccCCCc
Q 044366 82 SGRIPSSLGNLSNLALLYLNDNSLFG-SIPIVMGNLKSLSTLDLSQNQ-LNGSIPCSLDNLSNLDTLFLYKNSLSGPIPS 159 (918)
Q Consensus 82 ~~~~p~~l~~l~~L~~L~L~~n~i~~-~~~~~~~~l~~L~~L~Ls~n~-i~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~ 159 (918)
++..|..|+++++|++|++++|++++ ..|..+.++++|++|++++|+ +....+..+.++++|++|++++|++++..|.
T Consensus 87 ~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~ 166 (549)
T 2z81_A 87 SSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQ 166 (549)
T ss_dssp CSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTT
T ss_pred CccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEEECCCCccccccCHhhhhcccccCeeeccCCcccccChh
Confidence 97777789999999999999999986 356789999999999999998 4544457899999999999999999999999
Q ss_pred ccccccccCeeeccccccCCcCCccCCCCCCCcEeeccCcccccCC---CccccCCCCcceeecccccccCCCC----CC
Q 044366 160 VIGNLKSLLQLDLSENRLSGLIPLSLSNLSSLTVMSLFNNSLSGSI---PPILGNLKSLSTLGLHINQLNGVIP----PS 232 (918)
Q Consensus 160 ~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~---~~~~~~l~~L~~L~L~~n~l~~~~~----~~ 232 (918)
.++.+++|++|++++|.+..+....+..+++|++|++++|++++.. ......+++|+.|++++|.+++..+ ..
T Consensus 167 ~l~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~ 246 (549)
T 2z81_A 167 SLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKL 246 (549)
T ss_dssp TTTTCSEEEEEEEECSBSTTHHHHHHHSTTTBSEEEEESCBCTTCCCCCCSSCCCCCCCCEEEEESCEEEHHHHHHHHGG
T ss_pred hhhccccCceEecccCcccccchhhHhhcccccEEEccCCccccccccccchhhhhhcccceeccccccchhHHHHHHHH
Confidence 9999999999999999998665444567899999999999998642 2334568899999999999875433 33
Q ss_pred CcCCCcCCeEEcccCcCcCCC------CccccccCCCCeEecCCCccCCcC-----CCcCCCCCCCcEEEccCCcCcCCC
Q 044366 233 IGNLSSLRNLSLFNNRLYGFV------PKEIGYLKSLSKLEFCANHLSGVI-----PHSVGNLTGLVLLNMCENHLFGPI 301 (918)
Q Consensus 233 ~~~l~~L~~L~Ls~n~l~~~~------~~~~~~l~~L~~L~l~~n~l~~~~-----~~~~~~l~~L~~L~l~~n~l~~~~ 301 (918)
+..+++|+.|++++|.+.+.. ...+..+.+|+.|++.++.+.... +..+....+|+.|++++|++. .+
T Consensus 247 ~~~~~~L~~l~l~~~~~~~~~~~~~~~~~~~~~l~~L~~L~l~~~~i~~~~~~~~l~~~~~~~~~L~~L~l~~n~l~-~i 325 (549)
T 2z81_A 247 LRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVF-LV 325 (549)
T ss_dssp GGGCTTCCEEEEESCEEECCSCCCCCTTTCCCCCTTCCEEEEESCBCSCGGGSCCCCHHHHHSTTCCEEEEESSCCC-CC
T ss_pred hhhhccccccccccccccccccccccchhhhhhhcccccccccccccchhhhcccchhhhhhcccceEEEeccCccc-cC
Confidence 467789999999999887642 234567889999999999876432 111233568999999999997 45
Q ss_pred Cccc-cCCCCCCeEEeecccccCccc---cccCCCCCccEEeCCCCccccccC--cccccccccceeeccccccccCCCc
Q 044366 302 PKSL-RNLTSLERVRFNQNNLYGKVY---EAFGDHPNLTFLDLSQNNFYCEIS--FNWRNFSKLGTFNASMNNIYGSIPP 375 (918)
Q Consensus 302 ~~~l-~~l~~L~~L~l~~n~l~~~~~---~~~~~l~~L~~L~Ls~N~l~~~~~--~~~~~~~~L~~l~l~~n~i~~~~~~ 375 (918)
|..+ .++++|++|++++|.+.+..+ ..+..+++|++|++++|+++.... ..+..+
T Consensus 326 p~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l------------------- 386 (549)
T 2z81_A 326 PCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTL------------------- 386 (549)
T ss_dssp CHHHHHHCTTCCEEECCSSCCCHHHHHHHTCTTSSTTCCEEECTTSCCCCHHHHHHHGGGC-------------------
T ss_pred CHHHHhcCccccEEEccCCccccccccchhhhhccccCcEEEccCCcccccccchhhhhcC-------------------
Confidence 5544 689999999999999987553 347788999999999999875432 224444
Q ss_pred CcCCCCCCcEEEccCceeccccccchhhccccCceecccccccCCCCCCCCCCCcccEEeccCccccccCcccccccccc
Q 044366 376 EIGDSSKLQVLDLSSNHIFGKIPVQLVKLFSLNKLILSLNQLFGGVPLEFGTLTELQYLDLSANKLSSSIPMSIGNLLKL 455 (918)
Q Consensus 376 ~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L 455 (918)
++|++|++++|+|+ .+|..+..+++|+.|++++|++++... .+ .++|++|+|++|+|++. +..+++|
T Consensus 387 -----~~L~~L~Ls~N~l~-~lp~~~~~~~~L~~L~Ls~N~l~~l~~-~~--~~~L~~L~Ls~N~l~~~----~~~l~~L 453 (549)
T 2z81_A 387 -----KNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIRVVKT-CI--PQTLEVLDVSNNNLDSF----SLFLPRL 453 (549)
T ss_dssp -----TTCCEEECTTCCCC-CCCSCCCCCTTCCEEECTTSCCSCCCT-TS--CTTCSEEECCSSCCSCC----CCCCTTC
T ss_pred -----CCCCEEECCCCCCc-cCChhhcccccccEEECCCCCcccccc-hh--cCCceEEECCCCChhhh----cccCChh
Confidence 44555555555554 344444455555555555555543222 11 24788888888888754 2467788
Q ss_pred ceecccCcccCCCCchhhccccccceEeccCCcCCCCCchhccccCCcceEecCCCcccccCc
Q 044366 456 HYLNLSNNQFSHKIPTEFEKLIHLSELDLSHNILQEEIPPQICKMESLEKLNLSHNNLSDFIP 518 (918)
Q Consensus 456 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~ 518 (918)
++|+|++|+|+ .+|. ...+++|++|+|++|+|++.+|..|..+++|+.|+|++|++++..|
T Consensus 454 ~~L~Ls~N~l~-~ip~-~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 514 (549)
T 2z81_A 454 QELYISRNKLK-TLPD-ASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 514 (549)
T ss_dssp CEEECCSSCCS-SCCC-GGGCTTCCEEECCSSCCCCCCTTGGGGCTTCCEEECCSSCBCCCHH
T ss_pred cEEECCCCccC-cCCC-cccCccCCEEecCCCccCCcCHHHHhcCcccCEEEecCCCccCCCc
Confidence 88888888887 4454 4567888888888888888778888888888888888888877554
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-51 Score=430.58 Aligned_cols=257 Identities=25% Similarity=0.359 Sum_probs=200.3
Q ss_pred hcCCCCceeeccccceEEEEEEeCCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEEE
Q 044366 645 TGNFGEKYCIGKGGQRSVYKAELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFIV 724 (918)
Q Consensus 645 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 724 (918)
.+++...+.||+|+||+||+|++. ..||||+++... ......++|.+|++++++++|||||+++|++.+ +..++|
T Consensus 35 ~~~l~l~~~iG~G~fG~Vy~~~~~--~~vAvK~~~~~~--~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iV 109 (307)
T 3omv_A 35 ASEVMLSTRIGSGSFGTVYKGKWH--GDVAVKILKVVD--PTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIV 109 (307)
T ss_dssp TTSCCEEEECCCCSSSEEEEEESS--SEEEEEECCCSS--CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEE
T ss_pred HHHeEEeeEEeeCCCcEEEEEEEC--CcEEEEEEEecC--CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEE
Confidence 356788899999999999999874 369999987532 222335789999999999999999999999865 568999
Q ss_pred EEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccCC
Q 044366 725 CEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEP 804 (918)
Q Consensus 725 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~~ 804 (918)
||||++|+|.++++... .+++|.+++.|+.|||+||+|||+. +||||||||+|||+++++.+||+|||+|+....
T Consensus 110 mEy~~gGsL~~~l~~~~--~~l~~~~~~~i~~qia~gL~yLH~~---~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~ 184 (307)
T 3omv_A 110 TQWCEGSSLYKHLHVQE--TKFQMFQLIDIARQTAQGMDYLHAK---NIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSR 184 (307)
T ss_dssp EECCSSCBHHHHHHTSC--CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCSSSEEEETTEEEEECCCSSCBC---
T ss_pred EEcCCCCCHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CccCCccCHHHEEECCCCcEEEeeccCceeccc
Confidence 99999999999997642 4589999999999999999999999 999999999999999999999999999987653
Q ss_pred CC--CCceeccccccccccccccc---CCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCCC
Q 044366 805 HS--SNWTEFAGTVGYAAPELAYT---MRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPT 879 (918)
Q Consensus 805 ~~--~~~~~~~g~~~y~aPE~~~~---~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 879 (918)
.. ......+||+.|||||++.+ ..|+.++|||||||++|||+||+.||....... .+..... .....+..+.
T Consensus 185 ~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~-~~~~~~~--~~~~~p~~~~ 261 (307)
T 3omv_A 185 WSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRD-QIIFMVG--RGYASPDLSK 261 (307)
T ss_dssp ---------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH-HHHHHHH--TTCCCCCSTT
T ss_pred CCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHH-HHHHHHh--cCCCCCCccc
Confidence 32 22345689999999999864 358999999999999999999999987543211 1111100 1111111111
Q ss_pred CCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 044366 880 PSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLLC 917 (918)
Q Consensus 880 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 917 (918)
. ..+....+.+++.+||+.||++||||+||++.|+
T Consensus 262 ~---~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le 296 (307)
T 3omv_A 262 L---YKNCPKAMKRLVADCVKKVKEERPLFPQILSSIE 296 (307)
T ss_dssp S---CTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHH
T ss_pred c---cccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHH
Confidence 1 1223456888999999999999999999998875
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-51 Score=437.30 Aligned_cols=254 Identities=25% Similarity=0.394 Sum_probs=201.4
Q ss_pred cCCCCceeeccccceEEEEEEeC------CCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCC
Q 044366 646 GNFGEKYCIGKGGQRSVYKAELP------SGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQ 719 (918)
Q Consensus 646 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~ 719 (918)
.+|...+.||+|+||.||+|++. +++.||||+++.. .....++|.+|++++++++|||||+++|+|.+++
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~----~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~ 116 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA----SESARQDFQREAELLTMLQHQHIVRFFGVCTEGR 116 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC----SHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC----CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence 45677789999999999999764 4788999998652 2233578999999999999999999999999999
Q ss_pred ceEEEEEeccCCChhHHhhcccc------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCC
Q 044366 720 HSFIVCEYLARGSLTTILRDDAA------------AKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDS 787 (918)
Q Consensus 720 ~~~lv~e~~~~gsL~~~l~~~~~------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~ 787 (918)
..++|||||++|+|.++++.... ..+++|.++++|+.|||+||+|||+. +||||||||+|||+++
T Consensus 117 ~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLKp~NILl~~ 193 (329)
T 4aoj_A 117 PLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVGQ 193 (329)
T ss_dssp SEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEET
T ss_pred EEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHhhEEECC
Confidence 99999999999999999976432 24689999999999999999999999 9999999999999999
Q ss_pred CCcEEEeccccccccCCCCC--CceecccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhhhhhhhh
Q 044366 788 EYEAHVSDFGFAKFLEPHSS--NWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIK-GYHPGDFVSTIFSSISN 864 (918)
Q Consensus 788 ~~~~kl~DfG~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~p~~~~~~~~~~~~~ 864 (918)
++.+||+|||+|+....... ......||+.|||||++.+..++.++|||||||++|||+| |+.||...... ..
T Consensus 194 ~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~-~~--- 269 (329)
T 4aoj_A 194 GLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNT-EA--- 269 (329)
T ss_dssp TTEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHH-HH---
T ss_pred CCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHH-HH---
Confidence 99999999999987654332 2234678999999999999999999999999999999999 89998754321 11
Q ss_pred hHhhhhhhcccCCCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 044366 865 MIIEVNQILDHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLLC 917 (918)
Q Consensus 865 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 917 (918)
.. .+.....++.+... ..++.+++.+||+.||++||||+||++.|+
T Consensus 270 -~~---~i~~g~~~~~p~~~---~~~~~~li~~cl~~dP~~RPs~~ei~~~L~ 315 (329)
T 4aoj_A 270 -ID---CITQGRELERPRAC---PPEVYAIMRGCWQREPQQRHSIKDVHARLQ 315 (329)
T ss_dssp -HH---HHHHTCCCCCCTTC---CHHHHHHHHHHCCSSTTTSCCHHHHHHHHH
T ss_pred -HH---HHHcCCCCCCcccc---cHHHHHHHHHHcCcChhHCcCHHHHHHHHH
Confidence 11 11111112222222 346788999999999999999999999885
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-50 Score=435.09 Aligned_cols=249 Identities=27% Similarity=0.401 Sum_probs=210.2
Q ss_pred cCCCCceeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEEE
Q 044366 646 GNFGEKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFIV 724 (918)
Q Consensus 646 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 724 (918)
..|+..+.||+|+||.||+|.. .+|+.||||++.... ....+.+.+|+++++.++|||||++++++.+++..|+|
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~----~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iv 149 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRK----QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVV 149 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGG----CSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCc----hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 4688899999999999999965 579999999997542 23356789999999999999999999999999999999
Q ss_pred EEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccCC
Q 044366 725 CEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEP 804 (918)
Q Consensus 725 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~~ 804 (918)
||||++|+|.+++... .+++.+++.|+.||+.||+|||++ +||||||||+|||++.++.+||+|||+|+.+..
T Consensus 150 mEy~~gg~L~~~l~~~----~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~ 222 (346)
T 4fih_A 150 MEFLEGGALTDIVTHT----RMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK 222 (346)
T ss_dssp ECCCTTEEHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCS
T ss_pred EeCCCCCcHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEECCCCCEEEecCcCceecCC
Confidence 9999999999999753 489999999999999999999999 999999999999999999999999999998876
Q ss_pred CCCCceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCCCCCcch
Q 044366 805 HSSNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRDV 884 (918)
Q Consensus 805 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 884 (918)
........+||+.|||||++.+..|+.++||||+||++|||++|+.||...... .. .. .+... .+......
T Consensus 223 ~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~-~~----~~---~i~~~-~~~~~~~~ 293 (346)
T 4fih_A 223 EVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL-KA----MK---MIRDN-LPPRLKNL 293 (346)
T ss_dssp SSCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH-HH----HH---HHHHS-SCCCCSCG
T ss_pred CCCcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH-HH----HH---HHHcC-CCCCCCcc
Confidence 666666789999999999999999999999999999999999999998654321 11 11 11111 11111222
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 885 TDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 885 ~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
.....++.+++.+||+.||++|||++|+++
T Consensus 294 ~~~s~~~~dli~~~L~~dP~~R~ta~e~l~ 323 (346)
T 4fih_A 294 HKVSPSLKGFLDRLLVRDPAQRATAAELLK 323 (346)
T ss_dssp GGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 233456889999999999999999999975
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-51 Score=484.48 Aligned_cols=447 Identities=18% Similarity=0.243 Sum_probs=267.4
Q ss_pred CCCEEeCCCCcccccCCccccCCCCCCEEEccccccc------c------cCCCCcCCCCCCCEEEcccccccccCCccc
Q 044366 22 KLQYLDLGNNQLSGVIPPEIGKLNQLRRLYLDVNQLH------G------TIPPVIGQLSLINELVFCHNNVSGRIPSSL 89 (918)
Q Consensus 22 ~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~n~l~------~------~~p~~~~~l~~L~~L~l~~n~~~~~~p~~l 89 (918)
.++.|+|++|++.|.+|.+|+.|++|++|+|++|.+. + .+|... +..|+ +++++|.+.+.+|..+
T Consensus 82 ~V~~L~L~~~~l~g~lp~~l~~L~~L~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~--~~~l~-l~l~~~~l~~~~~~~~ 158 (636)
T 4eco_A 82 RVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQ--KQKMR-MHYQKTFVDYDPREDF 158 (636)
T ss_dssp CEEEEECTTSCCEEEECGGGGGCTTCCEEESCCGGGGGTCCSBSTTSBCTTCCHHH--HHHHH-THHHHHHTCCCGGGGS
T ss_pred CEEEEEecCcccCCcCChHHhcCccceEEECcCCccccCCccccccccccCchHHH--HHHHH-hhHHHhhhccCchhhH
Confidence 5666666666666666666666666666666666541 1 122211 22333 4444444444443333
Q ss_pred cC-------------------CCCCCEEEcc--CCcccccCccccCCCCCCCEEECcCCcCCCc----------------
Q 044366 90 GN-------------------LSNLALLYLN--DNSLFGSIPIVMGNLKSLSTLDLSQNQLNGS---------------- 132 (918)
Q Consensus 90 ~~-------------------l~~L~~L~L~--~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~---------------- 132 (918)
.. ...++.+.+. .|++++ +|..|+++++|++|+|++|++++.
T Consensus 159 ~~~~~~l~~~~l~~~~~~~~~~~~l~~l~l~~~~n~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~ 237 (636)
T 4eco_A 159 SDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQ 237 (636)
T ss_dssp CHHHHHHHHHCTTSCCCCCCCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHH
T ss_pred HHHHHHHhhcCccccccccccccchhhhhhccccCCCcc-CCHHHhcccCCCEEECcCCccccccccccccccccchhcc
Confidence 21 0111222221 355555 555666666666666666666653
Q ss_pred -CCcCCC--CCCCCceeeccccccccCCCcccccccccCeeeccccc-cCC-cCCccCCCC------CCCcEeeccCccc
Q 044366 133 -IPCSLD--NLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSENR-LSG-LIPLSLSNL------SSLTVMSLFNNSL 201 (918)
Q Consensus 133 -~~~~l~--~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~-l~~-~~~~~~~~l------~~L~~L~L~~N~l 201 (918)
+|..++ ++++|++|+|++|++.+.+|..|+++++|++|++++|+ +++ .+|..+..+ ++|++|++++|++
T Consensus 238 ~ip~~l~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l 317 (636)
T 4eco_A 238 YKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNL 317 (636)
T ss_dssp HTTSCCCGGGCTTCCEEEEECCTTCSSCCTTTTTCSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCC
T ss_pred cCchhhhhcccCCCCEEEecCCcCCccChHHHhcCCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCcC
Confidence 566666 66666666666666666666666666666666666665 555 445555444 6666666666666
Q ss_pred ccCCCc--cccCCCCcceeecccccccCCCCCCCcCCCcCCeEEcccCcCcCCCCccccccCC-CCeEecCCCccCCcCC
Q 044366 202 SGSIPP--ILGNLKSLSTLGLHINQLNGVIPPSIGNLSSLRNLSLFNNRLYGFVPKEIGYLKS-LSKLEFCANHLSGVIP 278 (918)
Q Consensus 202 ~~~~~~--~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~-L~~L~l~~n~l~~~~~ 278 (918)
+ .+|. .+.++++|++|++++|++++.+| .|..+++|++|++++|+++ ..|..+..+++ |++|++++|++. .+|
T Consensus 318 ~-~ip~~~~l~~l~~L~~L~L~~N~l~g~ip-~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~~L~~L~Ls~N~l~-~lp 393 (636)
T 4eco_A 318 K-TFPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNLAYNQIT-EIPANFCGFTEQVENLSFAHNKLK-YIP 393 (636)
T ss_dssp S-SCCCHHHHTTCTTCCEEECCSCCCEEECC-CCEEEEEESEEECCSSEEE-ECCTTSEEECTTCCEEECCSSCCS-SCC
T ss_pred C-ccCchhhhccCCCCCEEeCcCCcCccchh-hhCCCCCCCEEECCCCccc-cccHhhhhhcccCcEEEccCCcCc-ccc
Confidence 6 4555 66666666666666666665555 6666666666666666666 44555666666 777777777666 445
Q ss_pred CcCCCCC--CCcEEEccCCcCcCCCCcccc-------CCCCCCeEEeecccccCccccccCCCCCccEEeCCCCcccccc
Q 044366 279 HSVGNLT--GLVLLNMCENHLFGPIPKSLR-------NLTSLERVRFNQNNLYGKVYEAFGDHPNLTFLDLSQNNFYCEI 349 (918)
Q Consensus 279 ~~~~~l~--~L~~L~l~~n~l~~~~~~~l~-------~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~ 349 (918)
..+..+. +|+.|++++|++.+..|..+. .+++|++|++++|.+..++...|..+++|+.|+|++|.++.++
T Consensus 394 ~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~~~~~~~~~~~L~~L~Ls~N~l~~lp~~~~~~l~~L~~L~Ls~N~l~~i~ 473 (636)
T 4eco_A 394 NIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIP 473 (636)
T ss_dssp SCCCTTCSSCEEEEECCSSCTTTTTTCSSCTTCSSCCCCCCEEEEECCSSCCCSCCTHHHHTTCCCSEEECCSSCCSBCC
T ss_pred hhhhhcccCccCEEECcCCcCCCcchhhhcccccccccCCCCCEEECcCCccCcCCHHHHccCCCCCEEECCCCCCCCcC
Confidence 5555543 677777777777777776666 6677777777777777777777777788888888888776444
Q ss_pred CcccccccccceeeccccccccCCCcCcCCCCCCcEEEccCceeccccccchh--hccccCceecccccccCCCCCCCCC
Q 044366 350 SFNWRNFSKLGTFNASMNNIYGSIPPEIGDSSKLQVLDLSSNHIFGKIPVQLV--KLFSLNKLILSLNQLFGGVPLEFGT 427 (918)
Q Consensus 350 ~~~~~~~~~L~~l~l~~n~i~~~~~~~~~~~~~L~~L~L~~N~l~~~~~~~~~--~l~~L~~L~L~~N~l~~~~~~~~~~ 427 (918)
...+.... ..+..+++|+.|+|++|+|+ .+|..+. .+++|+.|+|++|++++ +|..+..
T Consensus 474 ~~~~~~~~-----------------~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~-ip~~~~~ 534 (636)
T 4eco_A 474 KNSLKDEN-----------------ENFKNTYLLTSIDLRFNKLT-KLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLN 534 (636)
T ss_dssp SSSSEETT-----------------EECTTGGGCCEEECCSSCCC-BCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGG
T ss_pred HHHhcccc-----------------ccccccCCccEEECcCCcCC-ccChhhhhccCCCcCEEECCCCCCCC-cChhhhc
Confidence 33332211 01222335666666666666 4455554 56666666666666655 5555666
Q ss_pred CCcccEEeccCccccccCccccccccccceecccCcccCCCCchhhccccccceEeccCCcCCCCCchhccccCCcceEe
Q 044366 428 LTELQYLDLSANKLSSSIPMSIGNLLKLHYLNLSNNQFSHKIPTEFEKLIHLSELDLSHNILQEEIPPQICKMESLEKLN 507 (918)
Q Consensus 428 l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 507 (918)
+++|++|+|++|+ ++++|++.+.+|..|..+++|++|+|++|+|+ .+|..+. ++|+.|+
T Consensus 535 l~~L~~L~Ls~N~------------------~ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~-~ip~~~~--~~L~~L~ 593 (636)
T 4eco_A 535 SSTLKGFGIRNQR------------------DAQGNRTLREWPEGITLCPSLTQLQIGSNDIR-KVNEKIT--PNISVLD 593 (636)
T ss_dssp CSSCCEEECCSCB------------------CTTCCBCCCCCCTTGGGCSSCCEEECCSSCCC-BCCSCCC--TTCCEEE
T ss_pred CCCCCEEECCCCc------------------ccccCcccccChHHHhcCCCCCEEECCCCcCC-ccCHhHh--CcCCEEE
Confidence 6666666666554 45556666666666666666666666666663 4455444 5666666
Q ss_pred cCCCccccc
Q 044366 508 LSHNNLSDF 516 (918)
Q Consensus 508 L~~N~l~~~ 516 (918)
|++|++..+
T Consensus 594 Ls~N~l~~~ 602 (636)
T 4eco_A 594 IKDNPNISI 602 (636)
T ss_dssp CCSCTTCEE
T ss_pred CcCCCCccc
Confidence 666665543
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-51 Score=436.71 Aligned_cols=252 Identities=22% Similarity=0.329 Sum_probs=204.9
Q ss_pred cCCCCceeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEEE
Q 044366 646 GNFGEKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFIV 724 (918)
Q Consensus 646 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 724 (918)
++|+..+.||+|+||.||+|+. .+|+.||||+++..... ....+.|.+|++++++++|||||++++++.+++..|+|
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~--~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiV 101 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMS--SKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIV 101 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSC--HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCC--HHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEE
Confidence 6899999999999999999964 57999999999764322 22356899999999999999999999999999999999
Q ss_pred EEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccCC
Q 044366 725 CEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEP 804 (918)
Q Consensus 725 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~~ 804 (918)
|||+++|+|.+++...+ ...+++.+++.|+.||+.||+|||++ +||||||||+|||++.++.+||+|||+|+....
T Consensus 102 mEy~~gg~L~~~i~~~~-~~~~~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~ 177 (350)
T 4b9d_A 102 MDYCEGGDLFKRINAQK-GVLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNS 177 (350)
T ss_dssp EECCTTCBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHHT---TCEETTCCGGGEEECTTCCEEECSTTEESCCCH
T ss_pred EeCCCCCcHHHHHHHcC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCCEEEcccccceeecC
Confidence 99999999999997643 34579999999999999999999999 999999999999999999999999999987754
Q ss_pred CCCCceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCCCCCcch
Q 044366 805 HSSNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRDV 884 (918)
Q Consensus 805 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 884 (918)
........+||+.|||||++.+..|+.++||||+||++|||+||+.||...... . ....+.....+......
T Consensus 178 ~~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~-~-------~~~~i~~~~~~~~~~~~ 249 (350)
T 4b9d_A 178 TVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMK-N-------LVLKIISGSFPPVSLHY 249 (350)
T ss_dssp HHHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH-H-------HHHHHHHTCCCCCCTTS
T ss_pred CcccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH-H-------HHHHHHcCCCCCCCccC
Confidence 333334568999999999999999999999999999999999999998754321 1 11122223333222222
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 885 TDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 885 ~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
..++.+++.+||+.||++|||++|+++
T Consensus 250 ---s~~~~~li~~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 250 ---SYDLRSLVSQLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp ---CHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ---CHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 346788999999999999999999975
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-48 Score=465.41 Aligned_cols=524 Identities=21% Similarity=0.227 Sum_probs=435.9
Q ss_pred CCCccCCccCCCCCCCCEEeCCCCcccccCCccccCCCCCCEEEcccccccccCCCCcCCCCCCCEEEcccccccccCCc
Q 044366 8 LLFGNIPPQIGNLSKLQYLDLGNNQLSGVIPPEIGKLNQLRRLYLDVNQLHGTIPPVIGQLSLINELVFCHNNVSGRIPS 87 (918)
Q Consensus 8 ~~~~~~p~~~~~l~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~ 87 (918)
+++ .||+.+- +++++|||++|+|++..|.+|..+++|++|+|++|+|++..|..|.++++|++|+|++|++++..+.
T Consensus 42 ~l~-~vP~~lp--~~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~ 118 (635)
T 4g8a_A 42 NFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALG 118 (635)
T ss_dssp CCS-SCCSSSC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECGG
T ss_pred CcC-ccCCCCC--cCCCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCCCCCHH
Confidence 455 7887642 4799999999999977778999999999999999999976677899999999999999999977778
Q ss_pred cccCCCCCCEEEccCCcccccCccccCCCCCCCEEECcCCcCCCc-CCcCCCCCCCCceeeccccccccCCCcccccccc
Q 044366 88 SLGNLSNLALLYLNDNSLFGSIPIVMGNLKSLSTLDLSQNQLNGS-IPCSLDNLSNLDTLFLYKNSLSGPIPSVIGNLKS 166 (918)
Q Consensus 88 ~l~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~-~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~ 166 (918)
.|.++++|++|+|++|++++..+..|+++++|++|+|++|+++.. .|..++.+++|++|++++|+++++.+..|..+.+
T Consensus 119 ~f~~L~~L~~L~Ls~N~l~~l~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~L~~ 198 (635)
T 4g8a_A 119 AFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQ 198 (635)
T ss_dssp GGTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHT
T ss_pred HhcCCCCCCEEECCCCcCCCCChhhhhcCcccCeeccccCccccCCCchhhccchhhhhhcccCccccccccccccchhh
Confidence 899999999999999999988888899999999999999999764 5778899999999999999999888888888776
Q ss_pred cC----eeeccccccCCcCCccCCCCCCCcEeeccCccccc-CCCccccCCCCcceeeccccc------ccCCCCCCCcC
Q 044366 167 LL----QLDLSENRLSGLIPLSLSNLSSLTVMSLFNNSLSG-SIPPILGNLKSLSTLGLHINQ------LNGVIPPSIGN 235 (918)
Q Consensus 167 L~----~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~-~~~~~~~~l~~L~~L~L~~n~------l~~~~~~~~~~ 235 (918)
++ .++++.|.++.+.+..+.. ..+..+++.+|.... ..+..+..+..++...+..+. +.......+..
T Consensus 199 l~~~~~~~~ls~n~l~~i~~~~~~~-~~~~~l~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~ 277 (635)
T 4g8a_A 199 MPLLNLSLDLSLNPMNFIQPGAFKE-IRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEG 277 (635)
T ss_dssp CTTCCCEEECTTCCCCEECTTTTTT-CEEEEEEEESCCSSHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCTTTTGG
T ss_pred hhhhhhhhhcccCcccccCcccccc-hhhhhhhhhcccccccccchhhcCCccccccccccccccccccccccccccccc
Confidence 65 5788999998776655544 456788888886542 334567778888777765443 33333445566
Q ss_pred CCcCCeEEcccCcCcC---CCCccccccCCCCeEecCCCccCCcCCCcCCCCCCCcEEEccCCcCcCCCCccccCCCCCC
Q 044366 236 LSSLRNLSLFNNRLYG---FVPKEIGYLKSLSKLEFCANHLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLRNLTSLE 312 (918)
Q Consensus 236 l~~L~~L~Ls~n~l~~---~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~ 312 (918)
+..+..+++..+.... .....+..+.+++.+.+.++.+.... .+....+++.|++.+|.+....+. .+..|+
T Consensus 278 ~~~l~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~~~~~~--~~~~~~~L~~L~l~~~~~~~~~~~---~l~~L~ 352 (635)
T 4g8a_A 278 LCNLTIEEFRLAYLDYYLDGIIDLFNCLTNVSSFSLVSVTIERVK--DFSYNFGWQHLELVNCKFGQFPTL---KLKSLK 352 (635)
T ss_dssp GGGSEEEEEEEECCCSCEEECTTTTGGGTTCSEEEEESCEEEECG--GGGSCCCCSEEEEESCEESSCCCC---BCTTCC
T ss_pred ccchhhhhhhhhhhcccccchhhhhhhhccccccccccccccccc--ccccchhhhhhhcccccccCcCcc---cchhhh
Confidence 6677777766654432 23345677889999999999887554 356677899999999998766553 457788
Q ss_pred eEEeecccccCccccccCCCCCccEEeCCCCcccccc--CcccccccccceeeccccccccCCCcCcCCCCCCcEEEccC
Q 044366 313 RVRFNQNNLYGKVYEAFGDHPNLTFLDLSQNNFYCEI--SFNWRNFSKLGTFNASMNNIYGSIPPEIGDSSKLQVLDLSS 390 (918)
Q Consensus 313 ~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~--~~~~~~~~~L~~l~l~~n~i~~~~~~~~~~~~~L~~L~L~~ 390 (918)
.+++.+|.+.... .+..+++|+.|++++|.+.... ...+.....++.++++.|.+.. .+..+..+++|+.+++++
T Consensus 353 ~l~l~~n~~~~~~--~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~~~~~~~~~-~~~~~~~l~~L~~l~l~~ 429 (635)
T 4g8a_A 353 RLTFTSNKGGNAF--SEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTISLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQH 429 (635)
T ss_dssp EEEEESCCSCCBC--CCCBCTTCCEEECCSSCCBEEEECCHHHHSCSCCCEEECCSCSEEE-ECSCCTTCTTCCEEECTT
T ss_pred hcccccccCCCCc--ccccccccccchhhccccccccccccchhhhhhhhhhhcccccccc-ccccccccccccchhhhh
Confidence 9999999876543 3456899999999999987543 3445677889999999998875 456788999999999999
Q ss_pred ceeccccc-cchhhccccCceecccccccCCCCCCCCCCCcccEEeccCccc-cccCccccccccccceecccCcccCCC
Q 044366 391 NHIFGKIP-VQLVKLFSLNKLILSLNQLFGGVPLEFGTLTELQYLDLSANKL-SSSIPMSIGNLLKLHYLNLSNNQFSHK 468 (918)
Q Consensus 391 N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l-~~~~~~~~~~l~~L~~L~Ls~N~l~~~ 468 (918)
|......+ ..+..+.+++.++++.|++.+..+..+..+++|+.|+|++|.+ .+..|..|..+++|++|+|++|+|+++
T Consensus 430 ~~~~~~~~~~~~~~l~~l~~l~ls~n~l~~~~~~~~~~~~~L~~L~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N~L~~l 509 (635)
T 4g8a_A 430 SNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQL 509 (635)
T ss_dssp SEEESTTSSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEE
T ss_pred ccccccccccccccccccccccccccccccccccccccchhhhhhhhhhcccccccCchhhhhccccCEEECCCCccCCc
Confidence 88875544 5678899999999999999999999999999999999999975 456788999999999999999999999
Q ss_pred CchhhccccccceEeccCCcCCCCCchhccccCCcceEecCCCcccccCcccccCC-CCccEEEccCCcCCCCCCC
Q 044366 469 IPTEFEKLIHLSELDLSHNILQEEIPPQICKMESLEKLNLSHNNLSDFIPRCFEEM-RSLSWIDISYNELQGPIPN 543 (918)
Q Consensus 469 ~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l-~~L~~l~l~~N~l~~~~p~ 543 (918)
.|.+|.++++|++|+|++|+|++..|..|.++++|++|+|++|+|+++.|..|..+ ++|+.|+|++|+|+|.+..
T Consensus 510 ~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~~L~~L~L~~Np~~C~C~~ 585 (635)
T 4g8a_A 510 SPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEH 585 (635)
T ss_dssp CTTTTTTCTTCCEEECTTSCCCBCCCGGGTTCTTCCEEECTTSCCCBCCSSCTTCCCTTCCEEECTTCCBCCSGGG
T ss_pred ChHHHcCCCCCCEEECCCCcCCCCChhHHhCCCCCCEEECCCCcCCCCCHHHHHhhhCcCCEEEeeCCCCcccCCc
Confidence 99999999999999999999999999999999999999999999999999999998 6899999999999998763
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-50 Score=481.44 Aligned_cols=436 Identities=21% Similarity=0.288 Sum_probs=298.6
Q ss_pred cccCCCCCCccCCccCCCCCCCCEEeCCCCccc------c------cCCccccCCCCCCEEEcccccccccCCCCcCCC-
Q 044366 2 LNLGFNLLFGNIPPQIGNLSKLQYLDLGNNQLS------G------VIPPEIGKLNQLRRLYLDVNQLHGTIPPVIGQL- 68 (918)
Q Consensus 2 l~~~~~~~~~~~p~~~~~l~~L~~L~L~~n~i~------~------~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l- 68 (918)
|+|++|++.|.+|+++++|++|++|+|++|.+. + .+|.+. +.+|+ ++++.|.+.+.+|..+..+
T Consensus 86 L~L~~~~l~g~lp~~l~~L~~L~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~--~~~l~-l~l~~~~l~~~~~~~~~~~~ 162 (636)
T 4eco_A 86 LSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQ--KQKMR-MHYQKTFVDYDPREDFSDLI 162 (636)
T ss_dssp EECTTSCCEEEECGGGGGCTTCCEEESCCGGGGGTCCSBSTTSBCTTCCHHH--HHHHH-THHHHHHTCCCGGGGSCHHH
T ss_pred EEecCcccCCcCChHHhcCccceEEECcCCccccCCccccccccccCchHHH--HHHHH-hhHHHhhhccCchhhHHHHH
Confidence 677777777777777777777777777777652 1 233333 45566 7777777766666555421
Q ss_pred ------------------CCCCEEEcc--cccccccCCccccCCCCCCEEEccCCccccc-----------------Ccc
Q 044366 69 ------------------SLINELVFC--HNNVSGRIPSSLGNLSNLALLYLNDNSLFGS-----------------IPI 111 (918)
Q Consensus 69 ------------------~~L~~L~l~--~n~~~~~~p~~l~~l~~L~~L~L~~n~i~~~-----------------~~~ 111 (918)
..++.+.+. .|++++ +|.+|+++++|++|+|++|++++. +|.
T Consensus 163 ~~l~~~~l~~~~~~~~~~~~l~~l~l~~~~n~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~ 241 (636)
T 4eco_A 163 KDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTE 241 (636)
T ss_dssp HHHHHHCTTSCCCCCCCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTS
T ss_pred HHHhhcCccccccccccccchhhhhhccccCCCcc-CCHHHhcccCCCEEECcCCccccccccccccccccchhcccCch
Confidence 112222222 466776 777777777777777777777764 677
Q ss_pred ccC--CCCCCCEEECcCCcCCCcCCcCCCCCCCCceeeccccc-ccc-CCCcccccc------cccCeeeccccccCCcC
Q 044366 112 VMG--NLKSLSTLDLSQNQLNGSIPCSLDNLSNLDTLFLYKNS-LSG-PIPSVIGNL------KSLLQLDLSENRLSGLI 181 (918)
Q Consensus 112 ~~~--~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~-l~~-~~~~~~~~l------~~L~~L~Ls~N~l~~~~ 181 (918)
.++ ++++|++|+|++|++.+.+|..++++++|++|++++|+ +++ .+|..++.+ ++|++|++++|+++ .+
T Consensus 242 ~l~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~-~i 320 (636)
T 4eco_A 242 DLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK-TF 320 (636)
T ss_dssp CCCGGGCTTCCEEEEECCTTCSSCCTTTTTCSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS-SC
T ss_pred hhhhcccCCCCEEEecCCcCCccChHHHhcCCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCcCC-cc
Confidence 777 77777777777777777777777777777777777777 766 566666665 77777777777777 44
Q ss_pred Cc--cCCCCCCCcEeeccCcccccCCCccccCCCCcceeecccccccCCCCCCCcCCCc-CCeEEcccCcCcCCCCcccc
Q 044366 182 PL--SLSNLSSLTVMSLFNNSLSGSIPPILGNLKSLSTLGLHINQLNGVIPPSIGNLSS-LRNLSLFNNRLYGFVPKEIG 258 (918)
Q Consensus 182 ~~--~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~-L~~L~Ls~n~l~~~~~~~~~ 258 (918)
|. .+..+++|++|++++|++++.+| .|..+++|++|++++|+++ .+|..+..+++ |++|++++|+++ ..|..+.
T Consensus 321 p~~~~l~~l~~L~~L~L~~N~l~g~ip-~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~~L~~L~Ls~N~l~-~lp~~~~ 397 (636)
T 4eco_A 321 PVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNLAYNQIT-EIPANFCGFTEQVENLSFAHNKLK-YIPNIFD 397 (636)
T ss_dssp CCHHHHTTCTTCCEEECCSCCCEEECC-CCEEEEEESEEECCSSEEE-ECCTTSEEECTTCCEEECCSSCCS-SCCSCCC
T ss_pred CchhhhccCCCCCEEeCcCCcCccchh-hhCCCCCCCEEECCCCccc-cccHhhhhhcccCcEEEccCCcCc-ccchhhh
Confidence 55 67777777777777777776666 7777777777777777777 55666777777 777777777777 4455555
Q ss_pred ccC--CCCeEecCCCccCCcCCCcCC-------CCCCCcEEEccCCcCcCCCCccccCCCCCCeEEeecccccCcccccc
Q 044366 259 YLK--SLSKLEFCANHLSGVIPHSVG-------NLTGLVLLNMCENHLFGPIPKSLRNLTSLERVRFNQNNLYGKVYEAF 329 (918)
Q Consensus 259 ~l~--~L~~L~l~~n~l~~~~~~~~~-------~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~ 329 (918)
.+. +|+.|++++|++.+..|..+. .+++|+.|++++|++....+..+..+++|++|++++|.+..++...+
T Consensus 398 ~~~l~~L~~L~Ls~N~l~~~~p~~l~~~~~~~~~~~~L~~L~Ls~N~l~~lp~~~~~~l~~L~~L~Ls~N~l~~i~~~~~ 477 (636)
T 4eco_A 398 AKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSL 477 (636)
T ss_dssp TTCSSCEEEEECCSSCTTTTTTCSSCTTCSSCCCCCCEEEEECCSSCCCSCCTHHHHTTCCCSEEECCSSCCSBCCSSSS
T ss_pred hcccCccCEEECcCCcCCCcchhhhcccccccccCCCCCEEECcCCccCcCCHHHHccCCCCCEEECCCCCCCCcCHHHh
Confidence 443 777777777777777777666 66677777777777775555556667777777777777776666555
Q ss_pred CCCC-------CccEEeCCCCccccccCcccccccccceeeccccccccCCCcCcC--CCCCCcEEEccCceeccccccc
Q 044366 330 GDHP-------NLTFLDLSQNNFYCEISFNWRNFSKLGTFNASMNNIYGSIPPEIG--DSSKLQVLDLSSNHIFGKIPVQ 400 (918)
Q Consensus 330 ~~l~-------~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~n~i~~~~~~~~~--~~~~L~~L~L~~N~l~~~~~~~ 400 (918)
.... +|+.|+|++|++ . .+|..+. .+++|+.|+|++|+|++ +|..
T Consensus 478 ~~~~~~~~~l~~L~~L~Ls~N~l------------------------~-~lp~~~~~~~l~~L~~L~Ls~N~l~~-ip~~ 531 (636)
T 4eco_A 478 KDENENFKNTYLLTSIDLRFNKL------------------------T-KLSDDFRATTLPYLVGIDLSYNSFSK-FPTQ 531 (636)
T ss_dssp EETTEECTTGGGCCEEECCSSCC------------------------C-BCCGGGSTTTCTTCCEEECCSSCCSS-CCCG
T ss_pred ccccccccccCCccEEECcCCcC------------------------C-ccChhhhhccCCCcCEEECCCCCCCC-cChh
Confidence 4332 444444444443 3 4555555 67777777777777775 6777
Q ss_pred hhhccccCceecccccccCCCCCCCCCCCcccEEeccCccccccCccccccccccceecccCcccCCCCchhhccccccc
Q 044366 401 LVKLFSLNKLILSLNQLFGGVPLEFGTLTELQYLDLSANKLSSSIPMSIGNLLKLHYLNLSNNQFSHKIPTEFEKLIHLS 480 (918)
Q Consensus 401 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~ 480 (918)
+..+++|+.|+|++|+ ++++|.+.+.+|..|..+++|+.|+|++|+|+ .+|..+. ++|+
T Consensus 532 ~~~l~~L~~L~Ls~N~------------------~ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~-~ip~~~~--~~L~ 590 (636)
T 4eco_A 532 PLNSSTLKGFGIRNQR------------------DAQGNRTLREWPEGITLCPSLTQLQIGSNDIR-KVNEKIT--PNIS 590 (636)
T ss_dssp GGGCSSCCEEECCSCB------------------CTTCCBCCCCCCTTGGGCSSCCEEECCSSCCC-BCCSCCC--TTCC
T ss_pred hhcCCCCCEEECCCCc------------------ccccCcccccChHHHhcCCCCCEEECCCCcCC-ccCHhHh--CcCC
Confidence 7777777777777775 56677777777777777777777777777773 5555554 5777
Q ss_pred eEeccCCcCCCC
Q 044366 481 ELDLSHNILQEE 492 (918)
Q Consensus 481 ~L~Ls~N~l~~~ 492 (918)
.|||++|++...
T Consensus 591 ~L~Ls~N~l~~~ 602 (636)
T 4eco_A 591 VLDIKDNPNISI 602 (636)
T ss_dssp EEECCSCTTCEE
T ss_pred EEECcCCCCccc
Confidence 777777776543
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-50 Score=466.56 Aligned_cols=458 Identities=22% Similarity=0.215 Sum_probs=297.9
Q ss_pred CEEeCCCCcccccCCccccCCCCCCEEEcccccccccCCCCcCCCCCCCEEEcccccccccCCccccCCCCCCEEEccCC
Q 044366 24 QYLDLGNNQLSGVIPPEIGKLNQLRRLYLDVNQLHGTIPPVIGQLSLINELVFCHNNVSGRIPSSLGNLSNLALLYLNDN 103 (918)
Q Consensus 24 ~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~l~~l~~L~~L~L~~n 103 (918)
++||+++|+++ .+|..+. ++|++|+|++|++++..|..|..+++|++|++++|++++..|..|+++++|++|+|++|
T Consensus 3 ~~l~ls~n~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N 79 (520)
T 2z7x_B 3 FLVDRSKNGLI-HVPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHN 79 (520)
T ss_dssp CEEECTTSCCS-SCCCSCC--TTCSEEECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSS
T ss_pred ceEecCCCCcc-ccccccc--ccccEEECCCCcccccChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCCC
Confidence 57889999988 6787776 88999999999888666678888888888888888888777888888888888888888
Q ss_pred cccccCccccCCCCCCCEEECcCCcCCC-cCCcCCCCCCCCceeeccccccccCCCccccccccc--Ceeecccccc--C
Q 044366 104 SLFGSIPIVMGNLKSLSTLDLSQNQLNG-SIPCSLDNLSNLDTLFLYKNSLSGPIPSVIGNLKSL--LQLDLSENRL--S 178 (918)
Q Consensus 104 ~i~~~~~~~~~~l~~L~~L~Ls~n~i~~-~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L--~~L~Ls~N~l--~ 178 (918)
+|+. +|.. .+++|++|+|++|++++ ..|..++++++|++|++++|++++ ..|..+++| ++|++++|.+ .
T Consensus 80 ~l~~-lp~~--~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~---~~~~~l~~L~L~~L~l~~n~l~~~ 153 (520)
T 2z7x_B 80 KLVK-ISCH--PTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEK---SSVLPIAHLNISKVLLVLGETYGE 153 (520)
T ss_dssp CCCE-EECC--CCCCCSEEECCSSCCSSCCCCGGGGGCTTCCEEEEEESSCCG---GGGGGGTTSCEEEEEEEECTTTTS
T ss_pred ceee-cCcc--ccCCccEEeccCCccccccchhhhccCCcceEEEecCcccch---hhccccccceeeEEEeeccccccc
Confidence 8874 4444 78888888888888876 357788888888888888888775 456777777 8888888888 6
Q ss_pred CcCCccCCCCC-CCcEeeccCcccccCCC-ccccCCCCcceeeccccc-------ccCCCCCCCcCCCcCCeEEcccCcC
Q 044366 179 GLIPLSLSNLS-SLTVMSLFNNSLSGSIP-PILGNLKSLSTLGLHINQ-------LNGVIPPSIGNLSSLRNLSLFNNRL 249 (918)
Q Consensus 179 ~~~~~~~~~l~-~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~n~-------l~~~~~~~~~~l~~L~~L~Ls~n~l 249 (918)
+..|..+..+. +...+++++|.+.+..+ ..+.++++|+.|++++|. +.+.++ .+..+++|+.|++++|.+
T Consensus 154 ~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~-~l~~l~~L~~L~l~~~~l 232 (520)
T 2z7x_B 154 KEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILA-KLQTNPKLSNLTLNNIET 232 (520)
T ss_dssp SCCTTTTTTCCEEEEEEECCSSSCCCCCCCCCCTTCSEEEECCEEECCSTTTTHHHHHHHH-GGGGCTTCCEEEEEEEEE
T ss_pred ccccccccccccceEEEEeccCcchhhhhhhhhhcccceeeccccccccccccceeecchh-hhccccchhhcccccccc
Confidence 66666666655 33456677777655433 356667777777777775 444443 566667777777777666
Q ss_pred cCCCCcccc---ccCCCCeEecCCCccCCcCCCcC-----CCCCCCcEEEccCCcCcCCCC-ccccCCCCCCeEEeeccc
Q 044366 250 YGFVPKEIG---YLKSLSKLEFCANHLSGVIPHSV-----GNLTGLVLLNMCENHLFGPIP-KSLRNLTSLERVRFNQNN 320 (918)
Q Consensus 250 ~~~~~~~~~---~l~~L~~L~l~~n~l~~~~~~~~-----~~l~~L~~L~l~~n~l~~~~~-~~l~~l~~L~~L~l~~n~ 320 (918)
++..+..+. ..++|++|++++|++.+..|..+ ..+++|+.+++++|.+ .+| ..+..+
T Consensus 233 ~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~~~l~~L~~l~l~~n~~--~~p~~~~~~~------------ 298 (520)
T 2z7x_B 233 TWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVF--GFPQSYIYEI------------ 298 (520)
T ss_dssp EHHHHHHHHHHHHTSSCSEEEEEEEEEESCCCCCCCCCCSCCCCEEEEEEEEECCC--CSCTHHHHHH------------
T ss_pred CHHHHHHHHHHhhhCcccEEEeecccccCccccchhhcccccCceeEeccccccce--ecchhhhhcc------------
Confidence 532221111 12356666666666555555544 4444455555544444 122 222222
Q ss_pred ccCccccccCCCCCccEEeCCCCccccccCcccccccccceeeccccccccCCCcCcCCCCCCcEEEccCceeccccccc
Q 044366 321 LYGKVYEAFGDHPNLTFLDLSQNNFYCEISFNWRNFSKLGTFNASMNNIYGSIPPEIGDSSKLQVLDLSSNHIFGKIPVQ 400 (918)
Q Consensus 321 l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~n~i~~~~~~~~~~~~~L~~L~L~~N~l~~~~~~~ 400 (918)
| ...+|+.|++++|.+.... .+..+++|++|++++|++++..|..
T Consensus 299 --------~-~~~~L~~L~l~~n~l~~~~--------------------------~~~~l~~L~~L~Ls~n~l~~~~~~~ 343 (520)
T 2z7x_B 299 --------F-SNMNIKNFTVSGTRMVHML--------------------------CPSKISPFLHLDFSNNLLTDTVFEN 343 (520)
T ss_dssp --------H-HTCCCSEEEEESSCCCCCC--------------------------CCSSCCCCCEEECCSSCCCTTTTTT
T ss_pred --------c-ccCceeEEEcCCCcccccc--------------------------chhhCCcccEEEeECCccChhhhhh
Confidence 0 0023444444444432111 0123344444444444444444444
Q ss_pred hhhccccCceecccccccC--CCCCCCCCCCcccEEeccCccccccCcc-ccccccccceecccCcccCCCCchhhcccc
Q 044366 401 LVKLFSLNKLILSLNQLFG--GVPLEFGTLTELQYLDLSANKLSSSIPM-SIGNLLKLHYLNLSNNQFSHKIPTEFEKLI 477 (918)
Q Consensus 401 ~~~l~~L~~L~L~~N~l~~--~~~~~~~~l~~L~~L~Ls~N~l~~~~~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~ 477 (918)
+..+++|++|+|++|++++ ..|..+..+++|++|+|++|.+++.+|. .+..+++|++|+|++|++++..|..+. +
T Consensus 344 ~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~--~ 421 (520)
T 2z7x_B 344 CGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLP--P 421 (520)
T ss_dssp CCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTTCCEEECCSSCCCGGGGGSCC--T
T ss_pred hccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcccccchhccCccCCEEECcCCCCCcchhhhhc--c
Confidence 4444444444444444443 2234456666777777777777753333 466677777777777777665555554 5
Q ss_pred ccceEeccCCcCCCCCchhccccCCcceEecCCCcccccCcccccCCCCccEEEccCCcCCCCCCC
Q 044366 478 HLSELDLSHNILQEEIPPQICKMESLEKLNLSHNNLSDFIPRCFEEMRSLSWIDISYNELQGPIPN 543 (918)
Q Consensus 478 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~p~ 543 (918)
+|+.|+|++|+|+ .+|..+..+++|+.|+|++|+|+++.+..|..+++|+.|++++|+++|.++.
T Consensus 422 ~L~~L~Ls~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~l~~N~~~c~c~~ 486 (520)
T 2z7x_B 422 RIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR 486 (520)
T ss_dssp TCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCBCCCHHH
T ss_pred cCCEEECCCCccc-ccchhhhcCCCCCEEECCCCcCCccCHHHhccCCcccEEECcCCCCcccCCc
Confidence 7888888888887 5666666888888888888888865555588888888888888888887663
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-49 Score=436.26 Aligned_cols=249 Identities=26% Similarity=0.395 Sum_probs=210.0
Q ss_pred cCCCCceeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEEE
Q 044366 646 GNFGEKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFIV 724 (918)
Q Consensus 646 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 724 (918)
..|+..+.||+|+||.||+|+. .+|+.||||++... .....+.+.+|+.+++.++|||||++++++.+++..|+|
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~----~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iV 226 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLR----KQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVV 226 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEST----TCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEecc----chhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEE
Confidence 5699999999999999999965 57999999999753 233456789999999999999999999999999999999
Q ss_pred EEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccCC
Q 044366 725 CEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEP 804 (918)
Q Consensus 725 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~~ 804 (918)
||||++|+|.++++.. .+++.++..|+.||+.||+|||++ +||||||||+|||++.+|.+||+|||+|+.+..
T Consensus 227 mEy~~gG~L~~~i~~~----~l~e~~~~~~~~qil~aL~ylH~~---~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~ 299 (423)
T 4fie_A 227 MEFLEGGALTDIVTHT----RMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK 299 (423)
T ss_dssp EECCTTEEHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSTTTEEECTTCCEEECCCTTCEECCS
T ss_pred EeCCCCCcHHHHHhcc----CCCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEecCccceECCC
Confidence 9999999999999753 489999999999999999999999 999999999999999999999999999998876
Q ss_pred CCCCceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCCCCCcch
Q 044366 805 HSSNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRDV 884 (918)
Q Consensus 805 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 884 (918)
........+||+.|||||++.+..|+.++||||+||++|||++|+.||...... .. ...+......... ..
T Consensus 300 ~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~-~~----~~~i~~~~~~~~~----~~ 370 (423)
T 4fie_A 300 EVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL-KA----MKMIRDNLPPRLK----NL 370 (423)
T ss_dssp SCCCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH-HH----HHHHHHSCCCCCS----CT
T ss_pred CCccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH-HH----HHHHHcCCCCCCc----cc
Confidence 666666789999999999999999999999999999999999999998654321 11 1111111111111 11
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 885 TDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 885 ~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
......+.+++.+||+.||++|||++|+++
T Consensus 371 ~~~s~~~~dli~~~L~~dP~~R~ta~ell~ 400 (423)
T 4fie_A 371 HKVSPSLKGFLDRLLVRDPAQRATAAELLK 400 (423)
T ss_dssp TSSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 122356788999999999999999999975
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-48 Score=469.70 Aligned_cols=473 Identities=17% Similarity=0.186 Sum_probs=311.6
Q ss_pred CCCCEEeCCCCcccccCCccccCCCCCCEEEc-ccccccccCCCCcCCCC-CCCE-----EE----------cccccccc
Q 044366 21 SKLQYLDLGNNQLSGVIPPEIGKLNQLRRLYL-DVNQLHGTIPPVIGQLS-LINE-----LV----------FCHNNVSG 83 (918)
Q Consensus 21 ~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L-~~n~l~~~~p~~~~~l~-~L~~-----L~----------l~~n~~~~ 83 (918)
..++.|+|++|++.|.+|.+|+.|++|++|+| ++|.+.|..|....... .+.. +. .....+..
T Consensus 323 ~~V~~L~Ls~~~L~G~ip~~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~ 402 (876)
T 4ecn_A 323 GRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSD 402 (876)
T ss_dssp SCEEEEECTTTCCEEEECGGGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCH
T ss_pred CCEEEEECccCCCCCcCchHHhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhH
Confidence 46888999999999899999999999999999 88888765443211110 0000 00 00000000
Q ss_pred -----------cCCccccCCCCCCEEEccC--CcccccCccccCCCCCCCEEECcCCcCCC-----------------cC
Q 044366 84 -----------RIPSSLGNLSNLALLYLND--NSLFGSIPIVMGNLKSLSTLDLSQNQLNG-----------------SI 133 (918)
Q Consensus 84 -----------~~p~~l~~l~~L~~L~L~~--n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~-----------------~~ 133 (918)
..+........++.+.+.. |++++ +|..|++|++|++|+|++|++++ .+
T Consensus 403 l~~~~l~~~~~~~~i~~~~~l~l~~l~l~~~~N~L~~-IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~i 481 (876)
T 4ecn_A 403 LLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITF-ISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYE 481 (876)
T ss_dssp HHHHHHHTCTTSCCCCCCCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHT
T ss_pred HHHHHhhhCccccccccccccchhhceeccccCcccc-hhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccC
Confidence 0011111122333333333 55655 56666666666666666666665 26
Q ss_pred CcCCC--CCCCCceeeccccccccCCCcccccccccCeeeccccc-cCC-cCCccCC-------CCCCCcEeeccCcccc
Q 044366 134 PCSLD--NLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSENR-LSG-LIPLSLS-------NLSSLTVMSLFNNSLS 202 (918)
Q Consensus 134 ~~~l~--~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~-l~~-~~~~~~~-------~l~~L~~L~L~~N~l~ 202 (918)
|..++ ++++|++|+|++|.+.+.+|..|+++++|++|+|++|+ +++ .+|..+. .+++|++|+|++|.++
T Consensus 482 P~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~ 561 (876)
T 4ecn_A 482 NEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE 561 (876)
T ss_dssp TSCCCGGGCTTCCEEEEESCTTCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC
T ss_pred ChhhhhccCCCCCEEECcCCCCCccChHHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCC
Confidence 66666 77777777777777776777777777777777777776 665 4454433 3347777777777777
Q ss_pred cCCCc--cccCCCCcceeecccccccCCCCCCCcCCCcCCeEEcccCcCcCCCCccccccCC-CCeEecCCCccCCcCCC
Q 044366 203 GSIPP--ILGNLKSLSTLGLHINQLNGVIPPSIGNLSSLRNLSLFNNRLYGFVPKEIGYLKS-LSKLEFCANHLSGVIPH 279 (918)
Q Consensus 203 ~~~~~--~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~-L~~L~l~~n~l~~~~~~ 279 (918)
.+|. .|.++++|+.|+|++|+++ .+| .|..+++|+.|+|++|+++ ..|..+..+++ |+.|++++|++. .+|.
T Consensus 562 -~ip~~~~l~~L~~L~~L~Ls~N~l~-~lp-~~~~L~~L~~L~Ls~N~l~-~lp~~l~~l~~~L~~L~Ls~N~L~-~lp~ 636 (876)
T 4ecn_A 562 -EFPASASLQKMVKLGLLDCVHNKVR-HLE-AFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLK-YIPN 636 (876)
T ss_dssp -BCCCHHHHTTCTTCCEEECTTSCCC-BCC-CCCTTSEESEEECCSSCCS-CCCTTSCEECTTCCEEECCSSCCC-SCCS
T ss_pred -ccCChhhhhcCCCCCEEECCCCCcc-cch-hhcCCCcceEEECcCCccc-cchHHHhhccccCCEEECcCCCCC-cCch
Confidence 5666 7777777777777777777 455 6777777888888888777 55666777777 888888888777 5566
Q ss_pred cCCCCCC--CcEEEccCCcCcCCCCccc---c--CCCCCCeEEeecccccCccccccCCCCCccEEeCCCCccccccCcc
Q 044366 280 SVGNLTG--LVLLNMCENHLFGPIPKSL---R--NLTSLERVRFNQNNLYGKVYEAFGDHPNLTFLDLSQNNFYCEISFN 352 (918)
Q Consensus 280 ~~~~l~~--L~~L~l~~n~l~~~~~~~l---~--~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~ 352 (918)
.+..+.. |+.|++++|++.+.+|... . .+++|+.|++++|.+..++...+..+++|+.|+|++|++..++...
T Consensus 637 ~~~~~~~~~L~~L~Ls~N~l~g~ip~l~~~l~~~~~~~L~~L~Ls~N~L~~lp~~~~~~l~~L~~L~Ls~N~L~~ip~~~ 716 (876)
T 4ecn_A 637 IFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENS 716 (876)
T ss_dssp CCCTTCSSCEEEEECCSSCTTTTSSSCSSCTTTCCCCCEEEEECCSSCCCSCCHHHHHTTCCCSEEECCSCCCSCCCTTS
T ss_pred hhhccccCCCCEEECcCCcCCCccccchhhhccccCCCcCEEEccCCcCCccCHHHHccCCCCCEEECCCCcCCccChHH
Confidence 6666544 8888888888876655322 2 3447888888888888888877888888999999988887444332
Q ss_pred cccccccceeeccccccccCCCcCcCCCCCCcEEEccCceeccccccchh--hccccCceecccccccCCCCCCCCCCCc
Q 044366 353 WRNFSKLGTFNASMNNIYGSIPPEIGDSSKLQVLDLSSNHIFGKIPVQLV--KLFSLNKLILSLNQLFGGVPLEFGTLTE 430 (918)
Q Consensus 353 ~~~~~~L~~l~l~~n~i~~~~~~~~~~~~~L~~L~L~~N~l~~~~~~~~~--~l~~L~~L~L~~N~l~~~~~~~~~~l~~ 430 (918)
+.... ..+.++++|+.|+|++|+|+ .+|..+. .+++|+.|+|++|++++ +|..+..+++
T Consensus 717 ~~~~~-----------------~~l~nl~~L~~L~Ls~N~L~-~lp~~l~~~~l~~L~~L~Ls~N~L~~-lp~~l~~L~~ 777 (876)
T 4ecn_A 717 LKPKD-----------------GNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQ 777 (876)
T ss_dssp SSCTT-----------------SCCTTGGGCCEEECCSSCCC-CCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCTT
T ss_pred hcccc-----------------ccccccCCccEEECCCCCCc-cchHHhhhccCCCcCEEEeCCCCCCc-cchhhhcCCC
Confidence 22111 11223346777777777776 4566665 67777777777777765 4666667777
Q ss_pred ccEEeccCccccccCccccccccccceecccCcccCCCCchhhccccccceEeccCCcCCCCCchhccccCCcceEecCC
Q 044366 431 LQYLDLSANKLSSSIPMSIGNLLKLHYLNLSNNQFSHKIPTEFEKLIHLSELDLSHNILQEEIPPQICKMESLEKLNLSH 510 (918)
Q Consensus 431 L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~ 510 (918)
|+.|+|++|. ++++|++.+.+|..|..+++|+.|+|++|+| +.+|..+. ++|+.|+|++
T Consensus 778 L~~L~Ls~N~------------------~ls~N~l~~~ip~~l~~L~~L~~L~Ls~N~L-~~Ip~~l~--~~L~~LdLs~ 836 (876)
T 4ecn_A 778 LKAFGIRHQR------------------DAEGNRILRQWPTGITTCPSLIQLQIGSNDI-RKVDEKLT--PQLYILDIAD 836 (876)
T ss_dssp CCEEECCCCB------------------CTTCCBCCCCCCTTGGGCSSCCEEECCSSCC-CBCCSCCC--SSSCEEECCS
T ss_pred CCEEECCCCC------------------CcccccccccChHHHhcCCCCCEEECCCCCC-CccCHhhc--CCCCEEECCC
Confidence 7777777765 5666777777777777777777777777777 45666554 4777777777
Q ss_pred CcccccCcccccCCCCccEEEccCCcCCC
Q 044366 511 NNLSDFIPRCFEEMRSLSWIDISYNELQG 539 (918)
Q Consensus 511 N~l~~~~~~~~~~l~~L~~l~l~~N~l~~ 539 (918)
|++..+.+..|.....+..+.|++|++++
T Consensus 837 N~l~~i~~~~~~~~~~~~~~~L~~n~~~~ 865 (876)
T 4ecn_A 837 NPNISIDVTSVCPYIEAGMYVLLYDKTQD 865 (876)
T ss_dssp CTTCEEECGGGHHHHHTTCCEEECCTTSE
T ss_pred CCCCccChHHccccccchheeecCCCccc
Confidence 77777666666666566666777776663
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-49 Score=419.01 Aligned_cols=248 Identities=21% Similarity=0.331 Sum_probs=208.1
Q ss_pred cCCCCceeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEEE
Q 044366 646 GNFGEKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFIV 724 (918)
Q Consensus 646 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 724 (918)
++|+..+.||+|+||.||+|+. .+|+.||||++....... ....+.+.+|++++++++|||||++++++.+++..|+|
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yiv 110 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIK-ENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFG 110 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHH-TTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCC-HHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 5699999999999999999954 579999999997643322 23467899999999999999999999999999999999
Q ss_pred EEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccCC
Q 044366 725 CEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEP 804 (918)
Q Consensus 725 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~~ 804 (918)
|||+++|+|.+++++.+ .+++.+++.++.||+.||+|||++ +||||||||+|||++.++.+||+|||+|+.+.+
T Consensus 111 mEy~~gG~L~~~i~~~~---~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~ 184 (311)
T 4aw0_A 111 LSYAKNGELLKYIRKIG---SFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSP 184 (311)
T ss_dssp ECCCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EecCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEEcCCCCEEEEEcCCceecCC
Confidence 99999999999998643 499999999999999999999999 999999999999999999999999999998764
Q ss_pred CCC--CceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCCCCCc
Q 044366 805 HSS--NWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSR 882 (918)
Q Consensus 805 ~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 882 (918)
... .....+||+.|||||++.+..|+.++||||+||++|||++|+.||...... . . ...+....+..+ .
T Consensus 185 ~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~-~----~---~~~i~~~~~~~p-~ 255 (311)
T 4aw0_A 185 ESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEG-L----I---FAKIIKLEYDFP-E 255 (311)
T ss_dssp TTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-H----H---HHHHHHTCCCCC-T
T ss_pred CCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-H----H---HHHHHcCCCCCC-c
Confidence 432 345678999999999999999999999999999999999999998754321 1 1 111122222211 1
Q ss_pred chHHHHHHHHHHHHHcccCCCCCCCCHHHH
Q 044366 883 DVTDKLRSIMEVAILCLVENPEARPTMKEV 912 (918)
Q Consensus 883 ~~~~~~~~l~~li~~cl~~dp~~RPt~~ev 912 (918)
.. ..++.+++.+|++.||++|||++|+
T Consensus 256 ~~---s~~~~dli~~lL~~dp~~R~t~~e~ 282 (311)
T 4aw0_A 256 KF---FPKARDLVEKLLVLDATKRLGCEEM 282 (311)
T ss_dssp TC---CHHHHHHHHHHSCSSGGGSTTSGGG
T ss_pred cc---CHHHHHHHHHHccCCHhHCcChHHH
Confidence 22 2457889999999999999999986
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-48 Score=453.31 Aligned_cols=453 Identities=21% Similarity=0.218 Sum_probs=363.8
Q ss_pred CcccCCCCCCccCCccCCCCCCCCEEeCCCCcccccCCccccCCCCCCEEEcccccccccCCCCcCCCCCCCEEEccccc
Q 044366 1 MLNLGFNLLFGNIPPQIGNLSKLQYLDLGNNQLSGVIPPEIGKLNQLRRLYLDVNQLHGTIPPVIGQLSLINELVFCHNN 80 (918)
Q Consensus 1 ~l~~~~~~~~~~~p~~~~~l~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~ 80 (918)
+||+++|+++ .+|+.+. ++|++|+|++|++++..|.+|..+++|++|+|++|++++..|..|+.+++|++|++++|+
T Consensus 4 ~l~ls~n~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~ 80 (520)
T 2z7x_B 4 LVDRSKNGLI-HVPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNK 80 (520)
T ss_dssp EEECTTSCCS-SCCCSCC--TTCSEEECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSSC
T ss_pred eEecCCCCcc-ccccccc--ccccEEECCCCcccccChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCCCc
Confidence 4899999999 7998876 899999999999997777899999999999999999998789999999999999999999
Q ss_pred ccccCCccccCCCCCCEEEccCCcccc-cCccccCCCCCCCEEECcCCcCCCcCCcCCCCCCCC--ceeecccccc--cc
Q 044366 81 VSGRIPSSLGNLSNLALLYLNDNSLFG-SIPIVMGNLKSLSTLDLSQNQLNGSIPCSLDNLSNL--DTLFLYKNSL--SG 155 (918)
Q Consensus 81 ~~~~~p~~l~~l~~L~~L~L~~n~i~~-~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L--~~L~L~~n~l--~~ 155 (918)
++ .+|.. .+++|++|+|++|++++ ..|..|+++++|++|++++|++++ ..+..+++| ++|++++|.+ .+
T Consensus 81 l~-~lp~~--~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~---~~~~~l~~L~L~~L~l~~n~l~~~~ 154 (520)
T 2z7x_B 81 LV-KISCH--PTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEK---SSVLPIAHLNISKVLLVLGETYGEK 154 (520)
T ss_dssp CC-EEECC--CCCCCSEEECCSSCCSSCCCCGGGGGCTTCCEEEEEESSCCG---GGGGGGTTSCEEEEEEEECTTTTSS
T ss_pred ee-ecCcc--ccCCccEEeccCCccccccchhhhccCCcceEEEecCcccch---hhccccccceeeEEEeecccccccc
Confidence 99 57766 89999999999999987 468999999999999999999986 467778888 9999999999 77
Q ss_pred CCCccccccc-ccCeeeccccccCCcC-CccCCCCCCCcEeeccCcc-------cccCCCccccCCCCcceeeccccccc
Q 044366 156 PIPSVIGNLK-SLLQLDLSENRLSGLI-PLSLSNLSSLTVMSLFNNS-------LSGSIPPILGNLKSLSTLGLHINQLN 226 (918)
Q Consensus 156 ~~~~~~~~l~-~L~~L~Ls~N~l~~~~-~~~~~~l~~L~~L~L~~N~-------l~~~~~~~~~~l~~L~~L~L~~n~l~ 226 (918)
..|..|..+. +...+++++|.+.+.. +..+..+++|+.|++++|. +.+.++ .+..+++|+.|++++|.++
T Consensus 155 ~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~-~l~~l~~L~~L~l~~~~l~ 233 (520)
T 2z7x_B 155 EDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILA-KLQTNPKLSNLTLNNIETT 233 (520)
T ss_dssp CCTTTTTTCCEEEEEEECCSSSCCCCCCCCCCTTCSEEEECCEEECCSTTTTHHHHHHHH-GGGGCTTCCEEEEEEEEEE
T ss_pred cccccccccccceEEEEeccCcchhhhhhhhhhcccceeeccccccccccccceeecchh-hhccccchhhccccccccC
Confidence 8888888766 4556788899887644 4578889999999999997 665555 7899999999999999887
Q ss_pred CCCCCCCc---CCCcCCeEEcccCcCcCCCCccc-----cccCCCCeEecCCCccCCcCCCcCCCC---CCCcEEEccCC
Q 044366 227 GVIPPSIG---NLSSLRNLSLFNNRLYGFVPKEI-----GYLKSLSKLEFCANHLSGVIPHSVGNL---TGLVLLNMCEN 295 (918)
Q Consensus 227 ~~~~~~~~---~l~~L~~L~Ls~n~l~~~~~~~~-----~~l~~L~~L~l~~n~l~~~~~~~~~~l---~~L~~L~l~~n 295 (918)
+..+..+. ..++|++|++++|++++..|..+ ..+++|+.+++++|.+ ......+..+ ++|+.|++++|
T Consensus 234 ~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~~~l~~L~~l~l~~n~~-~~p~~~~~~~~~~~~L~~L~l~~n 312 (520)
T 2z7x_B 234 WNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVF-GFPQSYIYEIFSNMNIKNFTVSGT 312 (520)
T ss_dssp HHHHHHHHHHHHTSSCSEEEEEEEEEESCCCCCCCCCCSCCCCEEEEEEEEECCC-CSCTHHHHHHHHTCCCSEEEEESS
T ss_pred HHHHHHHHHHhhhCcccEEEeecccccCccccchhhcccccCceeEeccccccce-ecchhhhhcccccCceeEEEcCCC
Confidence 53222111 24589999999999998888887 8999999999999999 3332344333 45777777777
Q ss_pred cCcCCCCccccCCCCCCeEEeecccccCccccccCCCCCccEEeCCCCccccccCcccccccccceeeccccccccCCCc
Q 044366 296 HLFGPIPKSLRNLTSLERVRFNQNNLYGKVYEAFGDHPNLTFLDLSQNNFYCEISFNWRNFSKLGTFNASMNNIYGSIPP 375 (918)
Q Consensus 296 ~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~n~i~~~~~~ 375 (918)
.+.... .+..+++|++|++++|.++ +..|.
T Consensus 313 ~l~~~~--------------------------~~~~l~~L~~L~Ls~n~l~------------------------~~~~~ 342 (520)
T 2z7x_B 313 RMVHML--------------------------CPSKISPFLHLDFSNNLLT------------------------DTVFE 342 (520)
T ss_dssp CCCCCC--------------------------CCSSCCCCCEEECCSSCCC------------------------TTTTT
T ss_pred cccccc--------------------------chhhCCcccEEEeECCccC------------------------hhhhh
Confidence 654221 1134455666666655543 34555
Q ss_pred CcCCCCCCcEEEccCceecc--ccccchhhccccCceecccccccCCCC-CCCCCCCcccEEeccCccccccCccccccc
Q 044366 376 EIGDSSKLQVLDLSSNHIFG--KIPVQLVKLFSLNKLILSLNQLFGGVP-LEFGTLTELQYLDLSANKLSSSIPMSIGNL 452 (918)
Q Consensus 376 ~~~~~~~L~~L~L~~N~l~~--~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l 452 (918)
.+..+++|++|+|++|+|.+ ..|..+..+++|+.|++++|++++.+| ..+..+++|++|+|++|.+++..|..+.
T Consensus 343 ~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~-- 420 (520)
T 2z7x_B 343 NCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLP-- 420 (520)
T ss_dssp TCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTTCCEEECCSSCCCGGGGGSCC--
T ss_pred hhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcccccchhccCccCCEEECcCCCCCcchhhhhc--
Confidence 66667777777777777765 345667777888888888888877344 4578889999999999999877776664
Q ss_pred cccceecccCcccCCCCchhhccccccceEeccCCcCCCCCchhccccCCcceEecCCCcccccC
Q 044366 453 LKLHYLNLSNNQFSHKIPTEFEKLIHLSELDLSHNILQEEIPPQICKMESLEKLNLSHNNLSDFI 517 (918)
Q Consensus 453 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 517 (918)
++|+.|+|++|+|+ .+|..+..+++|++|+|++|+|++..+..|..+++|+.|+|++|++++..
T Consensus 421 ~~L~~L~Ls~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~l~~N~~~c~c 484 (520)
T 2z7x_B 421 PRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSC 484 (520)
T ss_dssp TTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCBCCCH
T ss_pred ccCCEEECCCCccc-ccchhhhcCCCCCEEECCCCcCCccCHHHhccCCcccEEECcCCCCcccC
Confidence 78999999999998 66777779999999999999998644445889999999999999998743
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-49 Score=425.11 Aligned_cols=249 Identities=23% Similarity=0.286 Sum_probs=200.2
Q ss_pred hcCCCCceeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEE
Q 044366 645 TGNFGEKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFI 723 (918)
Q Consensus 645 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 723 (918)
.+.|...++||+|+||.||+|+. .+|+.||||+++.... +.+|+.+++.++|||||++++++.+++..|+
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~---------~~~E~~il~~l~HpnIV~l~~~~~~~~~~~i 127 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF---------RVEELVACAGLSSPRIVPLYGAVREGPWVNI 127 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC---------CTHHHHTTTTCCCTTBCCEEEEEEETTEEEE
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh---------HHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 34677888999999999999965 5799999999875321 2479999999999999999999999999999
Q ss_pred EEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCC-cEEEecccccccc
Q 044366 724 VCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEY-EAHVSDFGFAKFL 802 (918)
Q Consensus 724 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~-~~kl~DfG~~~~~ 802 (918)
||||+++|+|.++++..+ .+++.+++.|+.||+.||+|||++ +||||||||+|||++.++ .+||+|||+|+.+
T Consensus 128 vmEy~~gg~L~~~l~~~~---~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~ 201 (336)
T 4g3f_A 128 FMELLEGGSLGQLIKQMG---CLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCL 201 (336)
T ss_dssp EECCCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCCGGGEEECTTSCCEEECCCTTCEEC
T ss_pred EEeccCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEeCCCCEEEEeeCCCCeEc
Confidence 999999999999998653 499999999999999999999999 999999999999999987 6999999999987
Q ss_pred CCCCCC-----ceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCC
Q 044366 803 EPHSSN-----WTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRL 877 (918)
Q Consensus 803 ~~~~~~-----~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 877 (918)
.+.... ....+||+.|||||++.+..|+.++||||+||++|||+||+.||...... .+.. . +.....
T Consensus 202 ~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~--~~~~---~---i~~~~~ 273 (336)
T 4g3f_A 202 QPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRG--PLCL---K---IASEPP 273 (336)
T ss_dssp ------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCS--CCHH---H---HHHSCC
T ss_pred cCCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHH--HHHH---H---HHcCCC
Confidence 654321 12357999999999999999999999999999999999999998643221 0110 1 111111
Q ss_pred CCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 044366 878 PTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLLC 917 (918)
Q Consensus 878 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 917 (918)
+ ...........+.+++.+||+.||++|||++|+++.|.
T Consensus 274 ~-~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~ 312 (336)
T 4g3f_A 274 P-IREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVG 312 (336)
T ss_dssp G-GGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred C-chhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHH
Confidence 0 00001122356788999999999999999999998764
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-48 Score=411.74 Aligned_cols=246 Identities=22% Similarity=0.329 Sum_probs=196.5
Q ss_pred CCceeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEeccccc----CCceEE
Q 044366 649 GEKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSN----AQHSFI 723 (918)
Q Consensus 649 ~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~----~~~~~l 723 (918)
...+.||+|+||.||+|.. .+++.||+|++...... ....+.|.+|++++++++|||||++++++.+ ++..++
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~--~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~l 106 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLT--KSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL 106 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSC--HHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCC--HHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEE
Confidence 5566799999999999955 57899999998754322 2235679999999999999999999999854 356899
Q ss_pred EEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--eEEcCCCCCCeeeCC-CCcEEEecccccc
Q 044366 724 VCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPP--IVHRDISSKNVLLDS-EYEAHVSDFGFAK 800 (918)
Q Consensus 724 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~--ivH~dlk~~Nill~~-~~~~kl~DfG~~~ 800 (918)
|||||++|+|.+++++. ..+++..++.|+.||+.||+|||++ + ||||||||+|||++. ++.+||+|||+|+
T Consensus 107 vmEy~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~ylH~~---~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~ 180 (290)
T 3fpq_A 107 VTELMTSGTLKTYLKRF---KVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT 180 (290)
T ss_dssp EEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCCCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred EEeCCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CCCEEecccChhheeEECCCCCEEEEeCcCCE
Confidence 99999999999999864 3589999999999999999999998 6 999999999999985 7899999999998
Q ss_pred ccCCCCCCceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCCCC
Q 044366 801 FLEPHSSNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTP 880 (918)
Q Consensus 801 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 880 (918)
.... ......+||+.|||||++.+ +|+.++|||||||++|||+||+.||.......... ..+.....+..
T Consensus 181 ~~~~--~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~-------~~i~~~~~~~~ 250 (290)
T 3fpq_A 181 LKRA--SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIY-------RRVTSGVKPAS 250 (290)
T ss_dssp GCCT--TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHH-------HHHTTTCCCGG
T ss_pred eCCC--CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHH-------HHHHcCCCCCC
Confidence 6432 33456789999999998865 69999999999999999999999986433221111 11111111110
Q ss_pred CcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 881 SRDVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 881 ~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
......+++.+++.+||+.||++|||++|+++
T Consensus 251 --~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 251 --FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp --GGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred --CCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 01112245788999999999999999999986
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-48 Score=407.64 Aligned_cols=248 Identities=23% Similarity=0.331 Sum_probs=191.2
Q ss_pred cCCCCceeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEEE
Q 044366 646 GNFGEKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFIV 724 (918)
Q Consensus 646 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 724 (918)
++|++.+.||+|+||.||+|.. .+|+.||||+++...... ....+.+.+|+++++.++|||||++++++.+++..|+|
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv 91 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAK-SDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMV 91 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCC-HHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence 6899999999999999999965 579999999997643332 33467899999999999999999999999999999999
Q ss_pred EEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccCC
Q 044366 725 CEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEP 804 (918)
Q Consensus 725 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~~ 804 (918)
|||+ +|+|.+++.+. ..+++.++..++.||+.||+|||++ +|+||||||+||++++++.+||+|||+|+...+
T Consensus 92 mEy~-~g~L~~~l~~~---~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~ 164 (275)
T 3hyh_A 92 IEYA-GNELFDYIVQR---DKMSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTD 164 (275)
T ss_dssp EECC-CEEHHHHHHHS---CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTCCEEECCSSCC-----
T ss_pred EeCC-CCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCChHHeEECCCCCEEEeecCCCeecCC
Confidence 9999 57999999764 3599999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCCceecccccccccccccccCCC-CcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCCCCCcc
Q 044366 805 HSSNWTEFAGTVGYAAPELAYTMRA-TEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRD 883 (918)
Q Consensus 805 ~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 883 (918)
.. .....+||+.|||||++.+..+ +.++||||+||++|||+||+.||...... ... ..+....++.+ ..
T Consensus 165 ~~-~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~-----~~~---~~i~~~~~~~p-~~ 234 (275)
T 3hyh_A 165 GN-FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIP-----VLF---KNISNGVYTLP-KF 234 (275)
T ss_dssp -----------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-----HHH---HHHHHTCCCCC-TT
T ss_pred CC-ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHH-----HHH---HHHHcCCCCCC-CC
Confidence 32 3345689999999999998876 57999999999999999999998754321 111 11111222211 22
Q ss_pred hHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 884 VTDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 884 ~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
. ..++.+++.+||+.||++|||++|+++
T Consensus 235 ~---s~~~~~li~~~L~~dP~~R~s~~eil~ 262 (275)
T 3hyh_A 235 L---SPGAAGLIKRMLIVNPLNRISIHEIMQ 262 (275)
T ss_dssp S---CHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred C---CHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 2 245788999999999999999999986
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-48 Score=467.46 Aligned_cols=444 Identities=21% Similarity=0.248 Sum_probs=350.9
Q ss_pred CCCCEEEcccccccccCCCCcCCCCCCCEEEc-ccccccccCCccccCC-CCCCEEE---------------ccCCcccc
Q 044366 45 NQLRRLYLDVNQLHGTIPPVIGQLSLINELVF-CHNNVSGRIPSSLGNL-SNLALLY---------------LNDNSLFG 107 (918)
Q Consensus 45 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l-~~n~~~~~~p~~l~~l-~~L~~L~---------------L~~n~i~~ 107 (918)
.+++.|+|++|.+.|.+|+.|+.|++|++|+| ++|.+.|..|-..... ..+.... .....+..
T Consensus 323 ~~V~~L~Ls~~~L~G~ip~~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~ 402 (876)
T 4ecn_A 323 GRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSD 402 (876)
T ss_dssp SCEEEEECTTTCCEEEECGGGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCH
T ss_pred CCEEEEECccCCCCCcCchHHhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhH
Confidence 57888888888888888888888888888888 7777776644221111 0000000 00000000
Q ss_pred -----------cCccccCCCCCCCEEECcC--CcCCCcCCcCCCCCCCCceeecccccccc-----------------CC
Q 044366 108 -----------SIPIVMGNLKSLSTLDLSQ--NQLNGSIPCSLDNLSNLDTLFLYKNSLSG-----------------PI 157 (918)
Q Consensus 108 -----------~~~~~~~~l~~L~~L~Ls~--n~i~~~~~~~l~~l~~L~~L~L~~n~l~~-----------------~~ 157 (918)
..+........++.+.++. |++++ +|..++++++|++|+|++|++++ .+
T Consensus 403 l~~~~l~~~~~~~~i~~~~~l~l~~l~l~~~~N~L~~-IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~i 481 (876)
T 4ecn_A 403 LLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITF-ISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYE 481 (876)
T ss_dssp HHHHHHHTCTTSCCCCCCCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHT
T ss_pred HHHHHhhhCccccccccccccchhhceeccccCcccc-hhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccC
Confidence 0111112233455555554 88987 89999999999999999999998 27
Q ss_pred Ccccc--cccccCeeeccccccCCcCCccCCCCCCCcEeeccCcc-ccc-CCCccccCCC-------Ccceeeccccccc
Q 044366 158 PSVIG--NLKSLLQLDLSENRLSGLIPLSLSNLSSLTVMSLFNNS-LSG-SIPPILGNLK-------SLSTLGLHINQLN 226 (918)
Q Consensus 158 ~~~~~--~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~-l~~-~~~~~~~~l~-------~L~~L~L~~n~l~ 226 (918)
|..++ ++++|++|+|++|.+.+.+|..|.++++|+.|+|++|+ +++ .+|..+..++ +|+.|+|++|+++
T Consensus 482 P~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~ 561 (876)
T 4ecn_A 482 NEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE 561 (876)
T ss_dssp TSCCCGGGCTTCCEEEEESCTTCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC
T ss_pred ChhhhhccCCCCCEEECcCCCCCccChHHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCC
Confidence 77777 99999999999999999999999999999999999998 887 6777666554 9999999999999
Q ss_pred CCCCC--CCcCCCcCCeEEcccCcCcCCCCccccccCCCCeEecCCCccCCcCCCcCCCCCC-CcEEEccCCcCcCCCCc
Q 044366 227 GVIPP--SIGNLSSLRNLSLFNNRLYGFVPKEIGYLKSLSKLEFCANHLSGVIPHSVGNLTG-LVLLNMCENHLFGPIPK 303 (918)
Q Consensus 227 ~~~~~--~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~-L~~L~l~~n~l~~~~~~ 303 (918)
.+|. .|.++++|+.|+|++|+++ ..| .+..+++|+.|++++|++. .+|..+..+++ |+.|++++|++. .+|.
T Consensus 562 -~ip~~~~l~~L~~L~~L~Ls~N~l~-~lp-~~~~L~~L~~L~Ls~N~l~-~lp~~l~~l~~~L~~L~Ls~N~L~-~lp~ 636 (876)
T 4ecn_A 562 -EFPASASLQKMVKLGLLDCVHNKVR-HLE-AFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLK-YIPN 636 (876)
T ss_dssp -BCCCHHHHTTCTTCCEEECTTSCCC-BCC-CCCTTSEESEEECCSSCCS-CCCTTSCEECTTCCEEECCSSCCC-SCCS
T ss_pred -ccCChhhhhcCCCCCEEECCCCCcc-cch-hhcCCCcceEEECcCCccc-cchHHHhhccccCCEEECcCCCCC-cCch
Confidence 6777 8999999999999999999 556 8999999999999999999 77888999999 999999999998 7788
Q ss_pred cccCCCC--CCeEEeecccccCccccccC-----CCCCccEEeCCCCccccccCcccccccccceeeccccccccCCCcC
Q 044366 304 SLRNLTS--LERVRFNQNNLYGKVYEAFG-----DHPNLTFLDLSQNNFYCEISFNWRNFSKLGTFNASMNNIYGSIPPE 376 (918)
Q Consensus 304 ~l~~l~~--L~~L~l~~n~l~~~~~~~~~-----~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~n~i~~~~~~~ 376 (918)
.+..+.. |+.|++++|.+....+.... ..++|+.|+|++|.+.. +|..
T Consensus 637 ~~~~~~~~~L~~L~Ls~N~l~g~ip~l~~~l~~~~~~~L~~L~Ls~N~L~~-------------------------lp~~ 691 (876)
T 4ecn_A 637 IFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQK-------------------------FPTE 691 (876)
T ss_dssp CCCTTCSSCEEEEECCSSCTTTTSSSCSSCTTTCCCCCEEEEECCSSCCCS-------------------------CCHH
T ss_pred hhhccccCCCCEEECcCCcCCCccccchhhhccccCCCcCEEEccCCcCCc-------------------------cCHH
Confidence 8877765 99999999999875543321 23478888888887763 3333
Q ss_pred -cCCCCCCcEEEccCceeccccccchh-------hccccCceecccccccCCCCCCCC--CCCcccEEeccCccccccCc
Q 044366 377 -IGDSSKLQVLDLSSNHIFGKIPVQLV-------KLFSLNKLILSLNQLFGGVPLEFG--TLTELQYLDLSANKLSSSIP 446 (918)
Q Consensus 377 -~~~~~~L~~L~L~~N~l~~~~~~~~~-------~l~~L~~L~L~~N~l~~~~~~~~~--~l~~L~~L~Ls~N~l~~~~~ 446 (918)
+..+++|+.|+|++|+|....+..+. ++++|+.|+|++|+++ .+|..+. .+++|+.|+|++|.|++ +|
T Consensus 692 ~~~~l~~L~~L~Ls~N~L~~ip~~~~~~~~~~l~nl~~L~~L~Ls~N~L~-~lp~~l~~~~l~~L~~L~Ls~N~L~~-lp 769 (876)
T 4ecn_A 692 LFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFSS-FP 769 (876)
T ss_dssp HHHTTCCCSEEECCSCCCSCCCTTSSSCTTSCCTTGGGCCEEECCSSCCC-CCCGGGSTTTCTTCCEEECCSSCCSS-CC
T ss_pred HHccCCCCCEEECCCCcCCccChHHhccccccccccCCccEEECCCCCCc-cchHHhhhccCCCcCEEEeCCCCCCc-cc
Confidence 23566677777777777633333332 3459999999999998 5677776 99999999999999997 78
Q ss_pred cccccccccceecccCcccCCCCchhhccccccceEeccCCcCCCCCchhccccCCcceEecCCCcccccCcccccCCCC
Q 044366 447 MSIGNLLKLHYLNLSNNQFSHKIPTEFEKLIHLSELDLSHNILQEEIPPQICKMESLEKLNLSHNNLSDFIPRCFEEMRS 526 (918)
Q Consensus 447 ~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~ 526 (918)
..+..+++|+.|+|++|+ ++++|++.+.+|..|..+++|+.|+|++|+| +.+|..+. ++
T Consensus 770 ~~l~~L~~L~~L~Ls~N~------------------~ls~N~l~~~ip~~l~~L~~L~~L~Ls~N~L-~~Ip~~l~--~~ 828 (876)
T 4ecn_A 770 TQPLNSSQLKAFGIRHQR------------------DAEGNRILRQWPTGITTCPSLIQLQIGSNDI-RKVDEKLT--PQ 828 (876)
T ss_dssp CGGGGCTTCCEEECCCCB------------------CTTCCBCCCCCCTTGGGCSSCCEEECCSSCC-CBCCSCCC--SS
T ss_pred hhhhcCCCCCEEECCCCC------------------CcccccccccChHHHhcCCCCCEEECCCCCC-CccCHhhc--CC
Confidence 889999999999999998 7899999999999999999999999999999 55676665 69
Q ss_pred ccEEEccCCcCCCCCC
Q 044366 527 LSWIDISYNELQGPIP 542 (918)
Q Consensus 527 L~~l~l~~N~l~~~~p 542 (918)
|+.|||++|++...-+
T Consensus 829 L~~LdLs~N~l~~i~~ 844 (876)
T 4ecn_A 829 LYILDIADNPNISIDV 844 (876)
T ss_dssp SCEEECCSCTTCEEEC
T ss_pred CCEEECCCCCCCccCh
Confidence 9999999999985433
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-49 Score=420.19 Aligned_cols=261 Identities=22% Similarity=0.346 Sum_probs=196.8
Q ss_pred cCCCCceeeccccceEEEEEEeCCCCEEEEEEcccccccCCCCChHHHH--HHHHHHhhccCCceeeEecccccCC----
Q 044366 646 GNFGEKYCIGKGGQRSVYKAELPSGNIFAVKKFKAELFSDETANPSEFL--NEVLALTEIRHRNIIKFHGFCSNAQ---- 719 (918)
Q Consensus 646 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~--~e~~~l~~l~h~niv~~~~~~~~~~---- 719 (918)
.+|...+.||+|+||.||+|++ +|+.||||+++... .+.+. .|+..+.+++|||||+++|+|.+++
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~-------~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~ 74 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE-------ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWT 74 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGG-------HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccc-------hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCce
Confidence 3466778999999999999987 68999999986421 23334 4555567889999999999997654
Q ss_pred ceEEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCC-----CCCeEEcCCCCCCeeeCCCCcEEEe
Q 044366 720 HSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDC-----IPPIVHRDISSKNVLLDSEYEAHVS 794 (918)
Q Consensus 720 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~-----~~~ivH~dlk~~Nill~~~~~~kl~ 794 (918)
..++|||||++|+|.++++.. .++|+++++++.|+|+||+|||+++ .++||||||||+|||++.++.+||+
T Consensus 75 ~~~lV~Ey~~~gsL~~~l~~~----~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~ 150 (303)
T 3hmm_A 75 QLWLVSDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIA 150 (303)
T ss_dssp EEEEEEECCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEEC
T ss_pred EEEEEecCCCCCcHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEE
Confidence 579999999999999999764 3899999999999999999999862 3589999999999999999999999
Q ss_pred ccccccccCCCCCC----ceecccccccccccccccC------CCCcccchhhHHHHHHHHHhCCCCCCcchh---hhhh
Q 044366 795 DFGFAKFLEPHSSN----WTEFAGTVGYAAPELAYTM------RATEKYDVYSFGVLALEVIKGYHPGDFVST---IFSS 861 (918)
Q Consensus 795 DfG~~~~~~~~~~~----~~~~~g~~~y~aPE~~~~~------~~~~~~Dv~slG~vl~el~tg~~p~~~~~~---~~~~ 861 (918)
|||+|+........ ....+||+.|||||++.+. .++.++|||||||++|||+||+.|+..... .+..
T Consensus 151 DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~ 230 (303)
T 3hmm_A 151 DLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYD 230 (303)
T ss_dssp CCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTT
T ss_pred eCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchh
Confidence 99999877544322 2345799999999998754 467899999999999999999887543221 1110
Q ss_pred hh----hhHhhhhhhcccCCC-CCCc--chHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhC
Q 044366 862 IS----NMIIEVNQILDHRLP-TPSR--DVTDKLRSIMEVAILCLVENPEARPTMKEVCNLLCK 918 (918)
Q Consensus 862 ~~----~~~~~~~~~~~~~~~-~~~~--~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~ 918 (918)
.. ........+...... ..+. ...+....+.+++.+||+.||++||||+||++.|++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~ 294 (303)
T 3hmm_A 231 LVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ 294 (303)
T ss_dssp TSCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHH
T ss_pred cccccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHH
Confidence 00 000111111222221 1111 123455678999999999999999999999999863
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-49 Score=414.70 Aligned_cols=249 Identities=26% Similarity=0.352 Sum_probs=198.4
Q ss_pred cCCCCceeeccccceEEEEEEe----CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCce
Q 044366 646 GNFGEKYCIGKGGQRSVYKAEL----PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHS 721 (918)
Q Consensus 646 ~~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 721 (918)
++|++.+.||+|+||.||+|+. .+++.||||+++....... ....+.+|++++++++|||||++++++.+++..
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~--~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~ 101 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVR--DRVRTKMERDILVEVNHPFIVKLHYAFQTEGKL 101 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEE--ECC------CCCCCCCCTTEECEEEEEEETTEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChH--HHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEE
Confidence 5699999999999999999964 2578999999976433222 234688999999999999999999999999999
Q ss_pred EEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccc
Q 044366 722 FIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKF 801 (918)
Q Consensus 722 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~ 801 (918)
|+||||+++|+|.+++.+.+ .+++.++..++.||+.||+|||++ +||||||||+|||++.++.+||+|||+|+.
T Consensus 102 ~ivmEy~~gg~L~~~l~~~~---~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~ 175 (304)
T 3ubd_A 102 YLILDFLRGGDLFTRLSKEV---MFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKE 175 (304)
T ss_dssp EEEECCCTTCEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTSCEEEESSEEEEC
T ss_pred EEEEEcCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHeEEcCCCCEEeccccccee
Confidence 99999999999999998653 489999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCCceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCCCCC
Q 044366 802 LEPHSSNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPS 881 (918)
Q Consensus 802 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 881 (918)
...........+||+.|||||++.+..|+.++||||+||++|||+||+.||...... .. ...+....++.+
T Consensus 176 ~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~-~~-------~~~i~~~~~~~p- 246 (304)
T 3ubd_A 176 SIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRK-ET-------MTMILKAKLGMP- 246 (304)
T ss_dssp -----CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HH-------HHHHHHCCCCCC-
T ss_pred ccCCCccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHH-HH-------HHHHHcCCCCCC-
Confidence 665555556678999999999999999999999999999999999999998754321 11 111122222221
Q ss_pred cchHHHHHHHHHHHHHcccCCCCCCCCH-----HHHHH
Q 044366 882 RDVTDKLRSIMEVAILCLVENPEARPTM-----KEVCN 914 (918)
Q Consensus 882 ~~~~~~~~~l~~li~~cl~~dp~~RPt~-----~evl~ 914 (918)
... ..++.+++.+||+.||++|||+ +|+++
T Consensus 247 ~~~---s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~ 281 (304)
T 3ubd_A 247 QFL---SPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR 281 (304)
T ss_dssp TTS---CHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred CcC---CHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence 222 2457889999999999999984 56653
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-48 Score=423.07 Aligned_cols=263 Identities=22% Similarity=0.345 Sum_probs=209.7
Q ss_pred HHHHHHhcCCCCceeeccccceEEEEEEeC------CCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccC-CceeeE
Q 044366 639 EEITKATGNFGEKYCIGKGGQRSVYKAELP------SGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRH-RNIIKF 711 (918)
Q Consensus 639 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~~ 711 (918)
++++...++|...+.||+|+||.||+|.+. .++.||||+++... .....++|.+|++++++++| ||||++
T Consensus 57 ~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~---~~~~~~~~~~E~~il~~l~hhpnIV~l 133 (353)
T 4ase_A 57 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA---THSEHRALMSELKILIHIGHHLNVVNL 133 (353)
T ss_dssp HHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTC---CHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred cccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEcccc---ChHHHHHHHHHHHHHHHcCCCCcEEEE
Confidence 344455678999999999999999999653 23579999986532 22235679999999999965 899999
Q ss_pred eccccc-CCceEEEEEeccCCChhHHhhcccc-------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcC
Q 044366 712 HGFCSN-AQHSFIVCEYLARGSLTTILRDDAA-------------AKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRD 777 (918)
Q Consensus 712 ~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~d 777 (918)
+|+|.+ ++..++|||||++|+|.++++.... ...++|.+++.|+.|||+||+|||++ +|||||
T Consensus 134 ~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~---~iiHRD 210 (353)
T 4ase_A 134 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRD 210 (353)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSC
T ss_pred EEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC---CeecCc
Confidence 999865 4578999999999999999976432 24589999999999999999999999 999999
Q ss_pred CCCCCeeeCCCCcEEEeccccccccCCCCCC--ceecccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCc
Q 044366 778 ISSKNVLLDSEYEAHVSDFGFAKFLEPHSSN--WTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIK-GYHPGDF 854 (918)
Q Consensus 778 lk~~Nill~~~~~~kl~DfG~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~p~~~ 854 (918)
|||+|||+++++.+||+|||+|+.+..+... .....||+.|||||++.+..|+.++|||||||++|||+| |+.||..
T Consensus 211 LK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~ 290 (353)
T 4ase_A 211 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 290 (353)
T ss_dssp CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred cCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCC
Confidence 9999999999999999999999977554332 234578999999999999999999999999999999998 8999865
Q ss_pred chhhhhhhhhhHhhhhhhcccCCCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 044366 855 VSTIFSSISNMIIEVNQILDHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLLC 917 (918)
Q Consensus 855 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 917 (918)
..... .+.. .+.+ ..+++.+ ... ..++.+++.+||+.||++|||++||++.|+
T Consensus 291 ~~~~~-~~~~---~i~~--g~~~~~p-~~~---~~~~~~li~~c~~~dP~~RPt~~eil~~L~ 343 (353)
T 4ase_A 291 VKIDE-EFCR---RLKE--GTRMRAP-DYT---TPEMYQTMLDCWHGEPSQRPTFSELVEHLG 343 (353)
T ss_dssp CCCSH-HHHH---HHHH--TCCCCCC-TTC---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCHHH-HHHH---HHHc--CCCCCCC-ccC---CHHHHHHHHHHcCcChhHCcCHHHHHHHHH
Confidence 43211 1111 1111 1122222 222 246788999999999999999999999875
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-47 Score=407.24 Aligned_cols=250 Identities=20% Similarity=0.352 Sum_probs=192.9
Q ss_pred cCCCCceeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCC-----
Q 044366 646 GNFGEKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQ----- 719 (918)
Q Consensus 646 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----- 719 (918)
++|++.+.||+|+||.||+|+. .+|+.||||+++... .....+.+.+|++++++++|||||++++++.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~ 81 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN---RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKL 81 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS---SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-----
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC---CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccc
Confidence 3588999999999999999965 579999999987532 2223467999999999999999999999986543
Q ss_pred -------ceEEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEE
Q 044366 720 -------HSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAH 792 (918)
Q Consensus 720 -------~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~k 792 (918)
..|+||||+++|+|.+++.........++..++.|+.||++||+|||++ +||||||||+|||++.++.+|
T Consensus 82 ~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~---~IiHRDlKp~NILl~~~~~vK 158 (299)
T 4g31_A 82 QPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVK 158 (299)
T ss_dssp -----CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEE
T ss_pred cccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHC---cCccccCcHHHeEECCCCcEE
Confidence 3689999999999999998765555567888999999999999999999 999999999999999999999
Q ss_pred EeccccccccCCCCCC------------ceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhh
Q 044366 793 VSDFGFAKFLEPHSSN------------WTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFS 860 (918)
Q Consensus 793 l~DfG~~~~~~~~~~~------------~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~ 860 (918)
|+|||+|+.+...... ....+||+.|||||++.+..|+.++||||+||++|||++ ||........
T Consensus 159 l~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~~~ 235 (299)
T 4g31_A 159 VGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVR 235 (299)
T ss_dssp ECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHH
T ss_pred EccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHHHH
Confidence 9999999877543221 234579999999999999999999999999999999996 6653221111
Q ss_pred hhhhhHhhhhhhcccCCCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 861 SISNMIIEVNQILDHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 861 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
..........+ .......+...+++.+||+.||++|||+.|+++
T Consensus 236 -------~~~~~~~~~~p---~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 236 -------TLTDVRNLKFP---PLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp -------HHHHHHTTCCC---HHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -------HHHHHhcCCCC---CCCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 11111222222 223344456778999999999999999999986
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=441.23 Aligned_cols=506 Identities=24% Similarity=0.231 Sum_probs=422.6
Q ss_pred CcccCCCCCCccCCccCCCCCCCCEEeCCCCcccccCCccccCCCCCCEEEcccccccccCCCCcCCCCCCCEEEccccc
Q 044366 1 MLNLGFNLLFGNIPPQIGNLSKLQYLDLGNNQLSGVIPPEIGKLNQLRRLYLDVNQLHGTIPPVIGQLSLINELVFCHNN 80 (918)
Q Consensus 1 ~l~~~~~~~~~~~p~~~~~l~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~ 80 (918)
+|||++|.|++..|.+|.++++|++|||++|+|++..|.+|+++++|++|+|++|+|++..+..|.++++|++|++++|+
T Consensus 56 ~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~L~~L~~L~Ls~N~ 135 (635)
T 4g8a_A 56 NLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETN 135 (635)
T ss_dssp EEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECGGGGTTCTTCCEEECTTSC
T ss_pred EEEeeCCCCCCCCHHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCCCCCHHHhcCCCCCCEEECCCCc
Confidence 48999999996666789999999999999999998888899999999999999999996666789999999999999999
Q ss_pred ccccCCccccCCCCCCEEEccCCcccc-cCccccCCCCCCCEEECcCCcCCCcCCcCCCCCCCCc----eeecccccccc
Q 044366 81 VSGRIPSSLGNLSNLALLYLNDNSLFG-SIPIVMGNLKSLSTLDLSQNQLNGSIPCSLDNLSNLD----TLFLYKNSLSG 155 (918)
Q Consensus 81 ~~~~~p~~l~~l~~L~~L~L~~n~i~~-~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~----~L~L~~n~l~~ 155 (918)
+++..+..|+++++|++|+|++|.+.. ..|..+..+++|++|+|++|+|++..+..+..+.+++ .++++.|.++.
T Consensus 136 l~~l~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~L~~l~~~~~~~~ls~n~l~~ 215 (635)
T 4g8a_A 136 LASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNF 215 (635)
T ss_dssp CCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCCEEECTTCCCCE
T ss_pred CCCCChhhhhcCcccCeeccccCccccCCCchhhccchhhhhhcccCccccccccccccchhhhhhhhhhhhcccCcccc
Confidence 997777789999999999999999975 4678899999999999999999988888887766554 68899999997
Q ss_pred CCCcccccccccCeeeccccccCC-cCCccCCCCCCCcEeeccCcc------cccCCCccccCCCCcceeecccccccC-
Q 044366 156 PIPSVIGNLKSLLQLDLSENRLSG-LIPLSLSNLSSLTVMSLFNNS------LSGSIPPILGNLKSLSTLGLHINQLNG- 227 (918)
Q Consensus 156 ~~~~~~~~l~~L~~L~Ls~N~l~~-~~~~~~~~l~~L~~L~L~~N~------l~~~~~~~~~~l~~L~~L~L~~n~l~~- 227 (918)
+.+..+.. ..++.+++++|.... ..+..+..+..++...+..+. +.......+..+..+....+..+....
T Consensus 216 i~~~~~~~-~~~~~l~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~~l~~~~~~~~ 294 (635)
T 4g8a_A 216 IQPGAFKE-IRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYY 294 (635)
T ss_dssp ECTTTTTT-CEEEEEEEESCCSSHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCTTTTGGGGGSEEEEEEEECCCSC
T ss_pred cCcccccc-hhhhhhhhhcccccccccchhhcCCcccccccccccccccccccccccccccccccchhhhhhhhhhhccc
Confidence 76666654 467889998886652 334556777878777665433 233334456666677777666554432
Q ss_pred --CCCCCCcCCCcCCeEEcccCcCcCCCCccccccCCCCeEecCCCccCCcCCCcCCCCCCCcEEEccCCcCcCCCCccc
Q 044366 228 --VIPPSIGNLSSLRNLSLFNNRLYGFVPKEIGYLKSLSKLEFCANHLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSL 305 (918)
Q Consensus 228 --~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l 305 (918)
.....+..+.+++.+++.++.+... ..+.....|+.|++.+|.+....+. .+..|+.+++..|.+... ...
T Consensus 295 ~~~~~~~~~~~~~l~~l~~~~~~~~~~--~~~~~~~~L~~L~l~~~~~~~~~~~---~l~~L~~l~l~~n~~~~~--~~~ 367 (635)
T 4g8a_A 295 LDGIIDLFNCLTNVSSFSLVSVTIERV--KDFSYNFGWQHLELVNCKFGQFPTL---KLKSLKRLTFTSNKGGNA--FSE 367 (635)
T ss_dssp EEECTTTTGGGTTCSEEEEESCEEEEC--GGGGSCCCCSEEEEESCEESSCCCC---BCTTCCEEEEESCCSCCB--CCC
T ss_pred ccchhhhhhhhcccccccccccccccc--cccccchhhhhhhcccccccCcCcc---cchhhhhcccccccCCCC--ccc
Confidence 2334566778899999999988754 3456678899999999998866544 456788899999887543 345
Q ss_pred cCCCCCCeEEeecccccCcc--ccccCCCCCccEEeCCCCccccccCcccccccccceeeccccccccCCC-cCcCCCCC
Q 044366 306 RNLTSLERVRFNQNNLYGKV--YEAFGDHPNLTFLDLSQNNFYCEISFNWRNFSKLGTFNASMNNIYGSIP-PEIGDSSK 382 (918)
Q Consensus 306 ~~l~~L~~L~l~~n~l~~~~--~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~n~i~~~~~-~~~~~~~~ 382 (918)
..+++|+.+++++|.+.... +..+..+.+|+.++++.|.+.... ..+..++.|+.++++.|+.....+ ..|..+.+
T Consensus 368 ~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~~~~~~~~~~~-~~~~~l~~L~~l~l~~~~~~~~~~~~~~~~l~~ 446 (635)
T 4g8a_A 368 VDLPSLEFLDLSRNGLSFKGCCSQSDFGTISLKYLDLSFNGVITMS-SNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRN 446 (635)
T ss_dssp CBCTTCCEEECCSSCCBEEEECCHHHHSCSCCCEEECCSCSEEEEC-SCCTTCTTCCEEECTTSEEESTTSSCTTTTCTT
T ss_pred ccccccccchhhccccccccccccchhhhhhhhhhhcccccccccc-ccccccccccchhhhhccccccccccccccccc
Confidence 57899999999999986543 344567789999999999886544 457788999999999988876655 46888999
Q ss_pred CcEEEccCceeccccccchhhccccCceecccccc-cCCCCCCCCCCCcccEEeccCccccccCccccccccccceeccc
Q 044366 383 LQVLDLSSNHIFGKIPVQLVKLFSLNKLILSLNQL-FGGVPLEFGTLTELQYLDLSANKLSSSIPMSIGNLLKLHYLNLS 461 (918)
Q Consensus 383 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l-~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls 461 (918)
++.++++.|.+.+..+..+..+++|+.|+|++|++ .+..|..|..+++|++|||++|+|++..|..|.++++|++|+|+
T Consensus 447 l~~l~ls~n~l~~~~~~~~~~~~~L~~L~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N~L~~l~~~~f~~l~~L~~L~Ls 526 (635)
T 4g8a_A 447 LIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMS 526 (635)
T ss_dssp CCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECT
T ss_pred cccccccccccccccccccccchhhhhhhhhhcccccccCchhhhhccccCEEECCCCccCCcChHHHcCCCCCCEEECC
Confidence 99999999999999999999999999999999985 45678899999999999999999999999999999999999999
Q ss_pred CcccCCCCchhhccccccceEeccCCcCCCCCchhcccc-CCcceEecCCCcccc
Q 044366 462 NNQFSHKIPTEFEKLIHLSELDLSHNILQEEIPPQICKM-ESLEKLNLSHNNLSD 515 (918)
Q Consensus 462 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l-~~L~~L~L~~N~l~~ 515 (918)
+|+|+++.|..|.++++|++|||++|+|++..|..|..+ ++|+.|+|++|+++.
T Consensus 527 ~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~~L~~L~L~~Np~~C 581 (635)
T 4g8a_A 527 HNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFAC 581 (635)
T ss_dssp TSCCCBCCCGGGTTCTTCCEEECTTSCCCBCCSSCTTCCCTTCCEEECTTCCBCC
T ss_pred CCcCCCCChhHHhCCCCCCEEECCCCcCCCCCHHHHHhhhCcCCEEEeeCCCCcc
Confidence 999999999999999999999999999999999999988 689999999999985
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=443.11 Aligned_cols=460 Identities=21% Similarity=0.183 Sum_probs=254.7
Q ss_pred CCEEeCCCCcccccCCccccCCCCCCEEEcccccccccCCCCcCCCCCCCEEEcccccccccCCccccCCCCCCEEEccC
Q 044366 23 LQYLDLGNNQLSGVIPPEIGKLNQLRRLYLDVNQLHGTIPPVIGQLSLINELVFCHNNVSGRIPSSLGNLSNLALLYLND 102 (918)
Q Consensus 23 L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~l~~l~~L~~L~L~~ 102 (918)
.+++|+++|+++ .+|..+. ++|++|+|++|++++..|..|..+++|++|++++|.+++..|+.|.++++|++|+|++
T Consensus 33 ~~~l~ls~~~L~-~ip~~~~--~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~ 109 (562)
T 3a79_B 33 ESMVDYSNRNLT-HVPKDLP--PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSH 109 (562)
T ss_dssp CCEEECTTSCCC-SCCTTSC--TTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTT
T ss_pred CcEEEcCCCCCc-cCCCCCC--CCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCC
Confidence 355666666665 3554443 5566666666665543344555555555555555555544455555555555555555
Q ss_pred CcccccCccccCCCCCCCEEECcCCcCCCc-CCcCCCCCCCCceeeccccccccCCCccccccccc--CeeeccccccCC
Q 044366 103 NSLFGSIPIVMGNLKSLSTLDLSQNQLNGS-IPCSLDNLSNLDTLFLYKNSLSGPIPSVIGNLKSL--LQLDLSENRLSG 179 (918)
Q Consensus 103 n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~-~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L--~~L~Ls~N~l~~ 179 (918)
|+|+. +|.. .+++|++|+|++|++++. .|..|+++++|++|++++|++++. .+..+++| ++|++++|++..
T Consensus 110 N~l~~-lp~~--~l~~L~~L~Ls~N~l~~l~~p~~~~~l~~L~~L~L~~n~l~~~---~~~~l~~L~L~~L~L~~n~l~~ 183 (562)
T 3a79_B 110 NRLQN-ISCC--PMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQL---DLLPVAHLHLSCILLDLVSYHI 183 (562)
T ss_dssp SCCCE-ECSC--CCTTCSEEECCSSCCSBCCCCGGGGGCTTCCEEEEECSBCCTT---TTGGGTTSCEEEEEEEESSCCC
T ss_pred CcCCc-cCcc--ccccCCEEECCCCCccccCchHhhcccCcccEEecCCCccccC---chhhhhhceeeEEEeecccccc
Confidence 55542 2322 455555555555555432 234455555555555555554431 23333333 555555554400
Q ss_pred cCCccCCCCCCCcEeeccCcccccCCCccccCCC-CcceeecccccccCCCCC-CCcCCCcCCeEEcccCcCc----CCC
Q 044366 180 LIPLSLSNLSSLTVMSLFNNSLSGSIPPILGNLK-SLSTLGLHINQLNGVIPP-SIGNLSSLRNLSLFNNRLY----GFV 253 (918)
Q Consensus 180 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~-~L~~L~L~~n~l~~~~~~-~~~~l~~L~~L~Ls~n~l~----~~~ 253 (918)
++..|..|..+. ....++++.|.+.+..+. .+..+++|+.|++++|+.. ...
T Consensus 184 ----------------------~~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~l~~~ 241 (562)
T 3a79_B 184 ----------------------KGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTF 241 (562)
T ss_dssp ----------------------CSSSCCEEEECCEEEEEEEECSSSCCCCCCEEEESSEEEEEEEEEECCSTTHHHHHHH
T ss_pred ----------------------cccCcccccccCcceEEEEecCccchhhhhhhcccccceEEEecccccccccchHHHH
Confidence 334444444332 111234444444332221 2334455555555554310 001
Q ss_pred CccccccCCCCeEecCCCccCCcCCCc---CCCCCCCcEEEccCCcCcCCCCccc-----cCCCCCCeEEeecccccCcc
Q 044366 254 PKEIGYLKSLSKLEFCANHLSGVIPHS---VGNLTGLVLLNMCENHLFGPIPKSL-----RNLTSLERVRFNQNNLYGKV 325 (918)
Q Consensus 254 ~~~~~~l~~L~~L~l~~n~l~~~~~~~---~~~l~~L~~L~l~~n~l~~~~~~~l-----~~l~~L~~L~l~~n~l~~~~ 325 (918)
...+..+++|+.|+++++.+.+..... .....+|+.|++++|.+.+.+|..+ .+++.|+.+++..|.+ .++
T Consensus 242 ~~~l~~l~~L~~L~L~~~~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~ip~~~~~~~~~~L~~L~~~~~~~~~~-~~p 320 (562)
T 3a79_B 242 LSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVF-LFS 320 (562)
T ss_dssp HHHHHSCSSCEEEEEEEEEECHHHHHHHHHHHTTSSEEEEEEEEEEECSCCCCCCCCCCSCSCCEEEEEEEEECCC-SSC
T ss_pred HHHHhccCcceEEEecCCcCcHHHHHHHHHhhhcccccEEEEeccEeeccccchhhhcccccchheehhhccccee-ecC
Confidence 123344455555555544443211000 0112356666666666665555554 4444444444444444 222
Q ss_pred ccccCC---CCCccEEeCCCCccccccCcccccccccceeeccccccccCCCcCcCCCCCCcEEEccCceeccccccchh
Q 044366 326 YEAFGD---HPNLTFLDLSQNNFYCEISFNWRNFSKLGTFNASMNNIYGSIPPEIGDSSKLQVLDLSSNHIFGKIPVQLV 402 (918)
Q Consensus 326 ~~~~~~---l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~n~i~~~~~~~~~~~~~L~~L~L~~N~l~~~~~~~~~ 402 (918)
...+.. ..+|+.|++++|.+... . ....+++|++|++++|++++..|..+.
T Consensus 321 ~~~~~~~~~~~~L~~L~l~~n~~~~~------------------------~--~~~~l~~L~~L~l~~n~l~~~~~~~~~ 374 (562)
T 3a79_B 321 KEALYSVFAEMNIKMLSISDTPFIHM------------------------V--CPPSPSSFTFLNFTQNVFTDSVFQGCS 374 (562)
T ss_dssp HHHHHHHHHTCCCSEEEEESSCCCCC------------------------C--CCSSCCCCCEEECCSSCCCTTTTTTCC
T ss_pred hhhhhhhhccCcceEEEccCCCcccc------------------------c--CccCCCCceEEECCCCccccchhhhhc
Confidence 221111 13456666666554311 0 114556666677777766666666666
Q ss_pred hccccCceecccccccCCC--CCCCCCCCcccEEeccCccccc-cCccccccccccceecccCcccCCCCchhhcccccc
Q 044366 403 KLFSLNKLILSLNQLFGGV--PLEFGTLTELQYLDLSANKLSS-SIPMSIGNLLKLHYLNLSNNQFSHKIPTEFEKLIHL 479 (918)
Q Consensus 403 ~l~~L~~L~L~~N~l~~~~--~~~~~~l~~L~~L~Ls~N~l~~-~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L 479 (918)
++++|+.|+|++|++++.. |..|..+++|++|+|++|.+++ ..+..+..+++|++|+|++|++++..|..+. ++|
T Consensus 375 ~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~--~~L 452 (562)
T 3a79_B 375 TLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLP--PKV 452 (562)
T ss_dssp SCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBSCCSSCCCCCCTTCCEEECCSSCCCGGGGSSCC--TTC
T ss_pred ccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcCCCccChhhhcCcccCCEEECCCCCCCcchhhhhc--CcC
Confidence 6677777777777766533 3557778888888888888886 3444577788888888888888765555443 588
Q ss_pred ceEeccCCcCCCCCchhccccCCcceEecCCCcccccCcccccCCCCccEEEccCCcCCCCCCC
Q 044366 480 SELDLSHNILQEEIPPQICKMESLEKLNLSHNNLSDFIPRCFEEMRSLSWIDISYNELQGPIPN 543 (918)
Q Consensus 480 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~p~ 543 (918)
++|+|++|+|+ .+|..+..+++|+.|+|++|+|+++.+..|..+++|+.|++++|+|+|.+|.
T Consensus 453 ~~L~L~~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~l~~N~~~c~c~~ 515 (562)
T 3a79_B 453 KVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTCPG 515 (562)
T ss_dssp SEEECCSSCCC-CCCTTTTSSCCCSEEECCSSCCCCCCTTSTTTCTTCCCEECCSCCBCCCHHH
T ss_pred CEEECCCCcCc-ccChhhcCCCCCCEEECCCCCCCCCCHHHHhcCCCCCEEEecCCCcCCCcch
Confidence 88888888887 5666666888899999999988875555588889999999999999988775
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-45 Score=428.48 Aligned_cols=456 Identities=21% Similarity=0.219 Sum_probs=343.7
Q ss_pred CcccCCCCCCccCCccCCCCCCCCEEeCCCCcccccCCccccCCCCCCEEEcccccccccCCCCcCCCCCCCEEEccccc
Q 044366 1 MLNLGFNLLFGNIPPQIGNLSKLQYLDLGNNQLSGVIPPEIGKLNQLRRLYLDVNQLHGTIPPVIGQLSLINELVFCHNN 80 (918)
Q Consensus 1 ~l~~~~~~~~~~~p~~~~~l~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~ 80 (918)
++|+++|+++ .+|..+. ++|++|+|++|++++..|.+|..+++|++|+|++|++++..|..|..+++|++|++++|.
T Consensus 35 ~l~ls~~~L~-~ip~~~~--~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~ 111 (562)
T 3a79_B 35 MVDYSNRNLT-HVPKDLP--PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNR 111 (562)
T ss_dssp EEECTTSCCC-SCCTTSC--TTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTTSC
T ss_pred EEEcCCCCCc-cCCCCCC--CCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCCCc
Confidence 3789999999 5998765 899999999999997777899999999999999999998889999999999999999999
Q ss_pred ccccCCccccCCCCCCEEEccCCccccc-CccccCCCCCCCEEECcCCcCCCcCCcCCCCCCCC--ceeecccccc--cc
Q 044366 81 VSGRIPSSLGNLSNLALLYLNDNSLFGS-IPIVMGNLKSLSTLDLSQNQLNGSIPCSLDNLSNL--DTLFLYKNSL--SG 155 (918)
Q Consensus 81 ~~~~~p~~l~~l~~L~~L~L~~n~i~~~-~~~~~~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L--~~L~L~~n~l--~~ 155 (918)
++ .+|.. .+++|++|+|++|++.+. .|..|+++++|++|++++|+++.. .+.++++| ++|++++|++ ++
T Consensus 112 l~-~lp~~--~l~~L~~L~Ls~N~l~~l~~p~~~~~l~~L~~L~L~~n~l~~~---~~~~l~~L~L~~L~L~~n~l~~~~ 185 (562)
T 3a79_B 112 LQ-NISCC--PMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQL---DLLPVAHLHLSCILLDLVSYHIKG 185 (562)
T ss_dssp CC-EECSC--CCTTCSEEECCSSCCSBCCCCGGGGGCTTCCEEEEECSBCCTT---TTGGGTTSCEEEEEEEESSCCCCS
T ss_pred CC-ccCcc--ccccCCEEECCCCCccccCchHhhcccCcccEEecCCCccccC---chhhhhhceeeEEEeecccccccc
Confidence 99 67776 899999999999999874 468999999999999999999863 45666666 9999999999 88
Q ss_pred CCCccccccc-ccCeeeccccccCCcCC-ccCCCCCCCcEeeccCccc-----ccCCCccccCCCCcceeecccccccCC
Q 044366 156 PIPSVIGNLK-SLLQLDLSENRLSGLIP-LSLSNLSSLTVMSLFNNSL-----SGSIPPILGNLKSLSTLGLHINQLNGV 228 (918)
Q Consensus 156 ~~~~~~~~l~-~L~~L~Ls~N~l~~~~~-~~~~~l~~L~~L~L~~N~l-----~~~~~~~~~~l~~L~~L~L~~n~l~~~ 228 (918)
..|..|..+. ..-.+++++|.+.+..+ ..+..+++|+.|++++|+. .+ ....|..+++|+.|++.++.+.+.
T Consensus 186 ~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~l~~-~~~~l~~l~~L~~L~L~~~~l~~~ 264 (562)
T 3a79_B 186 GETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMT-FLSELTRGPTLLNVTLQHIETTWK 264 (562)
T ss_dssp SSCCEEEECCEEEEEEEECSSSCCCCCCEEEESSEEEEEEEEEECCSTTHHHHHH-HHHHHHSCSSCEEEEEEEEEECHH
T ss_pred cCcccccccCcceEEEEecCccchhhhhhhcccccceEEEecccccccccchHHH-HHHHHhccCcceEEEecCCcCcHH
Confidence 8888888765 22256788888776443 3566778888888888752 11 123455666666666665554321
Q ss_pred CCCCCcCCCcCCeEEcccCcCcCCCCccccccCCCCeEecCCCccCCcCCCcC-----CCCCCCcEEEccCCcCcCCCC-
Q 044366 229 IPPSIGNLSSLRNLSLFNNRLYGFVPKEIGYLKSLSKLEFCANHLSGVIPHSV-----GNLTGLVLLNMCENHLFGPIP- 302 (918)
Q Consensus 229 ~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~-----~~l~~L~~L~l~~n~l~~~~~- 302 (918)
. +.+.. .. ...++|++|++++|.+.+.+|..+ ..++.|+.+++..|.+ .+|
T Consensus 265 ~-------------------~~~~~-~~-~~~~~L~~L~l~~n~l~~~ip~~~~~~~~~~L~~L~~~~~~~~~~--~~p~ 321 (562)
T 3a79_B 265 C-------------------SVKLF-QF-FWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVF--LFSK 321 (562)
T ss_dssp H-------------------HHHHH-HH-HTTSSEEEEEEEEEEECSCCCCCCCCCCSCSCCEEEEEEEEECCC--SSCH
T ss_pred H-------------------HHHHH-Hh-hhcccccEEEEeccEeeccccchhhhcccccchheehhhccccee--ecCh
Confidence 1 10000 00 111244555555555544444443 5556666666666665 233
Q ss_pred ccccC---CCCCCeEEeecccccCccccccCCCCCccEEeCCCCccccccCcccccccccceeeccccccccCCCcCcCC
Q 044366 303 KSLRN---LTSLERVRFNQNNLYGKVYEAFGDHPNLTFLDLSQNNFYCEISFNWRNFSKLGTFNASMNNIYGSIPPEIGD 379 (918)
Q Consensus 303 ~~l~~---l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~n~i~~~~~~~~~~ 379 (918)
..+.. ..+|++|++++|.+.... .+..+++|++|++++|.++ +..|..+..
T Consensus 322 ~~~~~~~~~~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~l~~n~l~------------------------~~~~~~~~~ 375 (562)
T 3a79_B 322 EALYSVFAEMNIKMLSISDTPFIHMV--CPPSPSSFTFLNFTQNVFT------------------------DSVFQGCST 375 (562)
T ss_dssp HHHHHHHHTCCCSEEEEESSCCCCCC--CCSSCCCCCEEECCSSCCC------------------------TTTTTTCCS
T ss_pred hhhhhhhccCcceEEEccCCCccccc--CccCCCCceEEECCCCccc------------------------cchhhhhcc
Confidence 33322 257888888888875433 1256677777777777654 456777888
Q ss_pred CCCCcEEEccCceeccc--cccchhhccccCceecccccccC-CCCCCCCCCCcccEEeccCccccccCccccccccccc
Q 044366 380 SSKLQVLDLSSNHIFGK--IPVQLVKLFSLNKLILSLNQLFG-GVPLEFGTLTELQYLDLSANKLSSSIPMSIGNLLKLH 456 (918)
Q Consensus 380 ~~~L~~L~L~~N~l~~~--~~~~~~~l~~L~~L~L~~N~l~~-~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~ 456 (918)
+++|++|+|++|+|++. .|..+.++++|+.|+|++|++++ ..+..+..+++|++|+|++|.+++..|..+. ++|+
T Consensus 376 l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~--~~L~ 453 (562)
T 3a79_B 376 LKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLP--PKVK 453 (562)
T ss_dssp CSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBSCCSSCCCCCCTTCCEEECCSSCCCGGGGSSCC--TTCS
T ss_pred cCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcCCCccChhhhcCcccCCEEECCCCCCCcchhhhhc--CcCC
Confidence 88888899999888864 34668888999999999999988 4445688899999999999999877666554 7899
Q ss_pred eecccCcccCCCCchhhccccccceEeccCCcCCCCCchhccccCCcceEecCCCcccccCc
Q 044366 457 YLNLSNNQFSHKIPTEFEKLIHLSELDLSHNILQEEIPPQICKMESLEKLNLSHNNLSDFIP 518 (918)
Q Consensus 457 ~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~ 518 (918)
.|+|++|+|+ .+|..+..+++|++|+|++|+|++..+..|..+++|+.|+|++|++++..+
T Consensus 454 ~L~L~~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~l~~N~~~c~c~ 514 (562)
T 3a79_B 454 VLDLHNNRIM-SIPKDVTHLQALQELNVASNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTCP 514 (562)
T ss_dssp EEECCSSCCC-CCCTTTTSSCCCSEEECCSSCCCCCCTTSTTTCTTCCCEECCSCCBCCCHH
T ss_pred EEECCCCcCc-ccChhhcCCCCCCEEECCCCCCCCCCHHHHhcCCCCCEEEecCCCcCCCcc
Confidence 9999999998 456666699999999999999995444449999999999999999987543
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-44 Score=394.58 Aligned_cols=259 Identities=21% Similarity=0.316 Sum_probs=199.4
Q ss_pred cCCCCceeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccc------cC
Q 044366 646 GNFGEKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCS------NA 718 (918)
Q Consensus 646 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~------~~ 718 (918)
++|++.+.||+|+||.||+|.. .+|+.||||+++... ......+.+.+|+++++.++|||||++++++. +.
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~--~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~ 131 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAF--DVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEF 131 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTT--SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccc--cchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccC
Confidence 5799999999999999999954 589999999997532 12223467889999999999999999999864 34
Q ss_pred CceEEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEecccc
Q 044366 719 QHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGF 798 (918)
Q Consensus 719 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~ 798 (918)
+..|+|||||+ |+|.+++... +.+++.++..++.||+.||+|||++ +||||||||+|||++.++.+||+|||+
T Consensus 132 ~~~~ivmE~~~-g~L~~~i~~~---~~l~~~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NIl~~~~~~~Ki~DFGl 204 (398)
T 4b99_A 132 KSVYVVLDLME-SDLHQIIHSS---QPLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFGM 204 (398)
T ss_dssp CCEEEEEECCS-EEHHHHHTSS---SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTT
T ss_pred CEEEEEEeCCC-CCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---cCcCCCcCccccccCCCCCEEEeecce
Confidence 67899999996 6899999764 3599999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCC----CCCceecccccccccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhh-----
Q 044366 799 AKFLEPH----SSNWTEFAGTVGYAAPELAYTM-RATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIE----- 868 (918)
Q Consensus 799 ~~~~~~~----~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~----- 868 (918)
|+.+... .......+||+.|||||++.+. .++.++||||+||++|||++|++||...... .........
T Consensus 205 a~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~-~~l~~I~~~~g~p~ 283 (398)
T 4b99_A 205 ARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYV-HQLQLIMMVLGTPS 283 (398)
T ss_dssp CBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHH-HHHHHHHHHHCCCC
T ss_pred eeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHH-HHHHHHHHhcCCCC
Confidence 9876433 2233457899999999998875 4689999999999999999999998654321 111110000
Q ss_pred -----------hhhhcccCCCCCCcchH----HHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 869 -----------VNQILDHRLPTPSRDVT----DKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 869 -----------~~~~~~~~~~~~~~~~~----~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
.........+....... ....++.+++.+||+.||++|||++|+++
T Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 344 (398)
T 4b99_A 284 PAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR 344 (398)
T ss_dssp GGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred hHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 00000000011111111 11356789999999999999999999875
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=386.99 Aligned_cols=203 Identities=27% Similarity=0.363 Sum_probs=173.7
Q ss_pred HHHHHHHhcCCCCceeeccccceEEEEEEe----CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhc-cCCceeeEe
Q 044366 638 YEEITKATGNFGEKYCIGKGGQRSVYKAEL----PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEI-RHRNIIKFH 712 (918)
Q Consensus 638 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~ 712 (918)
++.+....++|++.+.||+|+||.||+|+. .+++.||||++... .....+.+|+++++.+ +||||++++
T Consensus 13 ~~~~p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~------~~~~~~~~E~~~l~~~~~h~nIv~l~ 86 (361)
T 4f9c_A 13 YEAVPQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPT------SHPIRIAAELQCLTVAGGQDNVMGVK 86 (361)
T ss_dssp HHHSGGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTT------SCHHHHHHHHHHHHHTCSBTTBCCCS
T ss_pred HHhcCCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccc------cCHHHHHHHHHHHHHhcCCCCCceEE
Confidence 344455678899999999999999999954 25788999988542 2356789999999998 699999999
Q ss_pred cccccCCceEEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCC-CcE
Q 044366 713 GFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSE-YEA 791 (918)
Q Consensus 713 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~-~~~ 791 (918)
+++.+.++.++||||+++|+|.++++ .+++.++..++.|++.||+|||++ |||||||||+|||++.+ +.+
T Consensus 87 ~~~~~~~~~~lvmE~~~g~~L~~~~~------~l~~~~~~~~~~qll~al~ylH~~---gIiHRDiKPeNiLl~~~~~~~ 157 (361)
T 4f9c_A 87 YCFRKNDHVVIAMPYLEHESFLDILN------SLSFQEVREYMLNLFKALKRIHQF---GIVHRDVKPSNFLYNRRLKKY 157 (361)
T ss_dssp EEEEETTEEEEEEECCCCCCHHHHHT------TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEE
T ss_pred EEEEECCEEEEEEeCCCcccHHHHHc------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCcCCHHHeEEeCCCCeE
Confidence 99999999999999999999999984 289999999999999999999999 99999999999999877 799
Q ss_pred EEeccccccccCCCCC----------------------------CceecccccccccccccccC-CCCcccchhhHHHHH
Q 044366 792 HVSDFGFAKFLEPHSS----------------------------NWTEFAGTVGYAAPELAYTM-RATEKYDVYSFGVLA 842 (918)
Q Consensus 792 kl~DfG~~~~~~~~~~----------------------------~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~vl 842 (918)
||+|||+|+...+... .....+||+.|+|||++.+. .++.++||||+||++
T Consensus 158 kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il 237 (361)
T 4f9c_A 158 ALVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIF 237 (361)
T ss_dssp EECCCTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHH
T ss_pred EECcCCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHH
Confidence 9999999986543221 12335799999999999775 589999999999999
Q ss_pred HHHHhCCCCCCcc
Q 044366 843 LEVIKGYHPGDFV 855 (918)
Q Consensus 843 ~el~tg~~p~~~~ 855 (918)
|||++|+.||...
T Consensus 238 ~ell~G~~Pf~~~ 250 (361)
T 4f9c_A 238 LSLLSGRYPFYKA 250 (361)
T ss_dssp HHHHHTCSSSSCC
T ss_pred HHHHHCCCCCCCC
Confidence 9999999998543
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-43 Score=399.35 Aligned_cols=392 Identities=21% Similarity=0.217 Sum_probs=266.6
Q ss_pred CEEEccCCcccccCccccCCCCCCCEEECcCCcCCCcCCcCCCCCCCCceeeccccccc-cCCCcccccccccCeeeccc
Q 044366 96 ALLYLNDNSLFGSIPIVMGNLKSLSTLDLSQNQLNGSIPCSLDNLSNLDTLFLYKNSLS-GPIPSVIGNLKSLLQLDLSE 174 (918)
Q Consensus 96 ~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~l~-~~~~~~~~~l~~L~~L~Ls~ 174 (918)
+.++.+++.++ .+|. + .++|++|+|++|+|++..|..|+++++|++|++++|.+. .+.+..|.++++|++|+|++
T Consensus 13 ~~~~c~~~~l~-~lp~-l--~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~Ls~ 88 (455)
T 3v47_A 13 YNAICINRGLH-QVPE-L--PAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDY 88 (455)
T ss_dssp TEEECCSSCCS-SCCC-C--CTTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEECTT
T ss_pred cccCcCCCCcc-cCCC-C--CCccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECcccccccccCCEEeCCC
Confidence 45677777776 4454 2 267888888888887777777888888888888888775 34456677777777777777
Q ss_pred cccCCcCCccCCCCCCCcEeeccCcccccCCCc--cccCCCCcceeecccccccCCCCCC-CcCCCcCCeEEcccCcCcC
Q 044366 175 NRLSGLIPLSLSNLSSLTVMSLFNNSLSGSIPP--ILGNLKSLSTLGLHINQLNGVIPPS-IGNLSSLRNLSLFNNRLYG 251 (918)
Q Consensus 175 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~--~~~~l~~L~~L~L~~n~l~~~~~~~-~~~l~~L~~L~Ls~n~l~~ 251 (918)
|++++..|..|.++++|++|+|++|.+++..+. .|..+++|++|+|++|.+++..|.. +.++++|++|++++|++++
T Consensus 89 n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~ 168 (455)
T 3v47_A 89 NQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKS 168 (455)
T ss_dssp CTTCEECTTTTTTCTTCCEEECTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCCGGGGGCTTCCEEECTTCCBSC
T ss_pred CccCccChhhccCcccCCEEeCCCCCCCccccCcccccCcccCCEEECCCCccCccCcccccCCCCcccEEeCCCCcccc
Confidence 777777677777777777777777777653333 3666666666666666666655544 5666666666666666666
Q ss_pred CCCcccccc--CCCCeEecCCCccCCcCCCcCCCCCCCcEEEccCCcCcCCCCccccCCCCCCeEEeecccccCcccccc
Q 044366 252 FVPKEIGYL--KSLSKLEFCANHLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLRNLTSLERVRFNQNNLYGKVYEAF 329 (918)
Q Consensus 252 ~~~~~~~~l--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~ 329 (918)
..+..+..+ .+|+.|++++|.+....+..+.. .....+..+++|++|++++|.+....+..+
T Consensus 169 ~~~~~l~~l~~~~L~~L~l~~n~l~~~~~~~~~~----------------~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~ 232 (455)
T 3v47_A 169 ICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGW----------------EKCGNPFKNTSITTLDLSGNGFKESMAKRF 232 (455)
T ss_dssp CCTTTSGGGTTCEEEEEECTTCBCTTCSTTCTTH----------------HHHCCTTTTCEEEEEECTTSCCCHHHHHHH
T ss_pred cChhhhhccccccccccccccCcccccchhhccc----------------cccccccccceeeeEecCCCcccccchhhh
Confidence 655555544 45555555555555443322110 000011223344444444444433333332
Q ss_pred CC---CCCccEEeCCCCccccccCcccccccccceeeccccccccCCCcCcCCCCCCcEEEccCceeccccccchhhc--
Q 044366 330 GD---HPNLTFLDLSQNNFYCEISFNWRNFSKLGTFNASMNNIYGSIPPEIGDSSKLQVLDLSSNHIFGKIPVQLVKL-- 404 (918)
Q Consensus 330 ~~---l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~n~i~~~~~~~~~~~~~L~~L~L~~N~l~~~~~~~~~~l-- 404 (918)
.. .++|+.|++++|.+.... +..+.+....+..+.++
T Consensus 233 ~~~~~~~~L~~L~l~~~~~~~~~--------------------------------------~~~~~~~~~~~~~~~~~~~ 274 (455)
T 3v47_A 233 FDAIAGTKIQSLILSNSYNMGSS--------------------------------------FGHTNFKDPDNFTFKGLEA 274 (455)
T ss_dssp HHHTTTCCEEEEECTTCTTTSCC--------------------------------------TTCCSSCCCCTTTTGGGTT
T ss_pred hccccccceeeEeeccccccccc--------------------------------------cchhhhccCcccccccccc
Confidence 22 255666666665442110 01111111222223322
Q ss_pred cccCceecccccccCCCCCCCCCCCcccEEeccCccccccCccccccccccceecccCcccCCCCchhhccccccceEec
Q 044366 405 FSLNKLILSLNQLFGGVPLEFGTLTELQYLDLSANKLSSSIPMSIGNLLKLHYLNLSNNQFSHKIPTEFEKLIHLSELDL 484 (918)
Q Consensus 405 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 484 (918)
++|+.|++++|++++..|..|..+++|++|+|++|.+++..|..|..+++|++|+|++|++++..|..|..+++|++|+|
T Consensus 275 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 354 (455)
T 3v47_A 275 SGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDL 354 (455)
T ss_dssp SCCCEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEEC
T ss_pred cCceEEEecCccccccchhhcccCCCCCEEECCCCcccccChhHhcCcccCCEEECCCCccCCcChhHhcCcccCCEEEC
Confidence 46777777777777777888888888999999999998888888888999999999999998888888999999999999
Q ss_pred cCCcCCCCCchhccccCCcceEecCCCcccccCcccccCCCCccEEEccCCcCCCCCCCCc
Q 044366 485 SHNILQEEIPPQICKMESLEKLNLSHNNLSDFIPRCFEEMRSLSWIDISYNELQGPIPNST 545 (918)
Q Consensus 485 s~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~p~~~ 545 (918)
++|+|++..|..|..+++|+.|+|++|+|+++.+..|..+++|+.|++++|+++|.+|...
T Consensus 355 s~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~ 415 (455)
T 3v47_A 355 SYNHIRALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRID 415 (455)
T ss_dssp CSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTTTH
T ss_pred CCCcccccChhhccccccccEEECCCCccccCCHhHhccCCcccEEEccCCCcccCCCcch
Confidence 9999988888899999999999999999999888888999999999999999999998643
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-43 Score=405.72 Aligned_cols=252 Identities=19% Similarity=0.328 Sum_probs=208.5
Q ss_pred hcCCCCceeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEE
Q 044366 645 TGNFGEKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFI 723 (918)
Q Consensus 645 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 723 (918)
.++|++.+.||+|+||.||+|.. .+|+.||+|++.... ....+.+.+|+++++.++|||||++++++.+++..++
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~----~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~i 231 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH----ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVM 231 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS----HHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEE
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccc----hhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEE
Confidence 36899999999999999999955 579999999986532 2235678999999999999999999999999999999
Q ss_pred EEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCC--CcEEEeccccccc
Q 044366 724 VCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSE--YEAHVSDFGFAKF 801 (918)
Q Consensus 724 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~--~~~kl~DfG~~~~ 801 (918)
|||||++|+|.+++... ...+++.++..++.||+.||+|||++ +|+||||||+|||++.+ +.+||+|||+|+.
T Consensus 232 v~E~~~gg~L~~~i~~~--~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~ 306 (573)
T 3uto_A 232 IYEFMSGGELFEKVADE--HNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAH 306 (573)
T ss_dssp EEECCCCCBHHHHHTCT--TSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCSSCEE
T ss_pred EEeecCCCcHHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhccccCCCCCCEEEeeccceeE
Confidence 99999999999999654 23589999999999999999999999 99999999999999864 8999999999998
Q ss_pred cCCCCCCceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCCCCC
Q 044366 802 LEPHSSNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPS 881 (918)
Q Consensus 802 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 881 (918)
+.+.. .....+||+.|||||++.+..|+.++||||+||++|||++|+.||...... . ....+.......+.
T Consensus 307 ~~~~~-~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~-~-------~~~~i~~~~~~~~~ 377 (573)
T 3uto_A 307 LDPKQ-SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD-E-------TLRNVKSCDWNMDD 377 (573)
T ss_dssp CCTTS-EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH-H-------HHHHHHTTCCCCCS
T ss_pred ccCCC-ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH-H-------HHHHHHhCCCCCCc
Confidence 76543 345568999999999999999999999999999999999999998754321 1 11111122222222
Q ss_pred cchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 882 RDVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 882 ~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
.........+.+++.+||+.||.+|||++|+++
T Consensus 378 ~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~ 410 (573)
T 3uto_A 378 SAFSGISEDGKDFIRKLLLADPNTRMTIHQALE 410 (573)
T ss_dssp GGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 222223456788999999999999999999986
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-43 Score=403.76 Aligned_cols=252 Identities=20% Similarity=0.243 Sum_probs=200.0
Q ss_pred hcCCCCceeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHH---HHHHhhccCCceeeEecccccCCc
Q 044366 645 TGNFGEKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNE---VLALTEIRHRNIIKFHGFCSNAQH 720 (918)
Q Consensus 645 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e---~~~l~~l~h~niv~~~~~~~~~~~ 720 (918)
.++|.+.++||+|+||.||+|+. .+|+.||||++.+...... .....+.+| +.+++.++|||||++++++.+++.
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~-~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ 266 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMK-QGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDK 266 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHT-TCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSE
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchh-hhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCE
Confidence 35799999999999999999955 5799999999976433222 223334444 566677899999999999999999
Q ss_pred eEEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEecccccc
Q 044366 721 SFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAK 800 (918)
Q Consensus 721 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~ 800 (918)
.|+||||++||+|.+++... +.+++..++.++.||+.||+|||++ +||||||||+|||++.+|.+||+|||+|+
T Consensus 267 lylVmEy~~GGdL~~~l~~~---~~l~E~~a~~y~~qIl~aL~yLH~~---gIiHRDLKPeNILld~~G~vKL~DFGlA~ 340 (689)
T 3v5w_A 267 LSFILDLMNGGDLHYHLSQH---GVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLAC 340 (689)
T ss_dssp EEEEECCCCSCBHHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred EEEEEecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHeEEeCCCCEEecccceee
Confidence 99999999999999999864 3499999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCCceeccccccccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCCC
Q 044366 801 FLEPHSSNWTEFAGTVGYAAPELAYT-MRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPT 879 (918)
Q Consensus 801 ~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 879 (918)
.+.... ....+||+.|||||++.+ ..|+.++||||+||++|||++|+.||....... .... ...+.......
T Consensus 341 ~~~~~~--~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~--~~~i---~~~i~~~~~~~ 413 (689)
T 3v5w_A 341 DFSKKK--PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD--KHEI---DRMTLTMAVEL 413 (689)
T ss_dssp ECSSCC--CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCC--HHHH---HHHHHHCCCCC
T ss_pred ecCCCC--CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH--HHHH---HHhhcCCCCCC
Confidence 775432 345689999999999964 579999999999999999999999986432210 0011 11111111111
Q ss_pred CCcchHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 044366 880 PSRDVTDKLRSIMEVAILCLVENPEARPT-----MKEVCN 914 (918)
Q Consensus 880 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt-----~~evl~ 914 (918)
+ ... ..++.+++.+||+.||++|++ ++||++
T Consensus 414 p-~~~---S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~ 449 (689)
T 3v5w_A 414 P-DSF---SPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 449 (689)
T ss_dssp C-TTS---CHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred C-ccC---CHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence 1 122 245788999999999999998 677653
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-42 Score=388.40 Aligned_cols=426 Identities=28% Similarity=0.300 Sum_probs=194.0
Q ss_pred CCCCCCEEeCCCCcccccCCccccCCCCCCEEEcccccccccCCCCcCCCCCCCEEEcccccccccCCccccCCCCCCEE
Q 044366 19 NLSKLQYLDLGNNQLSGVIPPEIGKLNQLRRLYLDVNQLHGTIPPVIGQLSLINELVFCHNNVSGRIPSSLGNLSNLALL 98 (918)
Q Consensus 19 ~l~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~l~~l~~L~~L 98 (918)
..+.|++|++++|++ +.+|.+|+++++|++|++++|++++.+|..++.+.+|+.+++.+|.. .++++|
T Consensus 9 ~~~~L~~L~l~~n~l-~~iP~~i~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~-----------~~l~~L 76 (454)
T 1jl5_A 9 SNTFLQEPLRHSSNL-TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLD-----------RQAHEL 76 (454)
T ss_dssp --------------------------CCHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHH-----------HTCSEE
T ss_pred ccccchhhhcccCch-hhCChhHhcccchhhhhccCCcccccCCcccccchhcchhhhhhhhc-----------cCCCEE
Confidence 468899999999999 58899999999999999999999888999999888775555444432 345555
Q ss_pred EccCCcccccCccccCCCCCCCEEECcCCcCCCcCCcCCCCCCCCceeeccccccccCCCcccccccccCeeeccccccC
Q 044366 99 YLNDNSLFGSIPIVMGNLKSLSTLDLSQNQLNGSIPCSLDNLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSENRLS 178 (918)
Q Consensus 99 ~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~ 178 (918)
++++|++++ .|.. .++|++|++++|++++ +|.. +++|++|++++|+++++.. . .++|++|++++|+++
T Consensus 77 ~l~~~~l~~-lp~~---~~~L~~L~l~~n~l~~-lp~~---~~~L~~L~l~~n~l~~l~~-~---~~~L~~L~L~~n~l~ 144 (454)
T 1jl5_A 77 ELNNLGLSS-LPEL---PPHLESLVASCNSLTE-LPEL---PQSLKSLLVDNNNLKALSD-L---PPLLEYLGVSNNQLE 144 (454)
T ss_dssp ECTTSCCSC-CCSC---CTTCSEEECCSSCCSS-CCCC---CTTCCEEECCSSCCSCCCS-C---CTTCCEEECCSSCCS
T ss_pred EecCCcccc-CCCC---cCCCCEEEccCCcCCc-cccc---cCCCcEEECCCCccCcccC-C---CCCCCEEECcCCCCC
Confidence 555555543 2221 2455555555555554 3322 2455555555555553211 1 145555666655555
Q ss_pred CcCCccCCCCCCCcEeeccCcccccCCCccccCCCCcceeecccccccCCCCCCCcCCCcCCeEEcccCcCcCCCCcccc
Q 044366 179 GLIPLSLSNLSSLTVMSLFNNSLSGSIPPILGNLKSLSTLGLHINQLNGVIPPSIGNLSSLRNLSLFNNRLYGFVPKEIG 258 (918)
Q Consensus 179 ~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~ 258 (918)
++ | .|..+++|++|++++|++++ +|..+ .+|++|++++|++++. | .+.++++|++|++++|+++++ |..
T Consensus 145 ~l-p-~~~~l~~L~~L~l~~N~l~~-lp~~~---~~L~~L~L~~n~l~~l-~-~~~~l~~L~~L~l~~N~l~~l-~~~-- 213 (454)
T 1jl5_A 145 KL-P-ELQNSSFLKIIDVDNNSLKK-LPDLP---PSLEFIAAGNNQLEEL-P-ELQNLPFLTAIYADNNSLKKL-PDL-- 213 (454)
T ss_dssp SC-C-CCTTCTTCCEEECCSSCCSC-CCCCC---TTCCEEECCSSCCSSC-C-CCTTCTTCCEEECCSSCCSSC-CCC--
T ss_pred CC-c-ccCCCCCCCEEECCCCcCcc-cCCCc---ccccEEECcCCcCCcC-c-cccCCCCCCEEECCCCcCCcC-CCC--
Confidence 42 3 35555556666666655553 23222 3555666666655542 2 355556666666666655542 211
Q ss_pred ccCCCCeEecCCCccCCcCCCcCCCCCCCcEEEccCCcCcCCCCccccCCCCCCeEEeecccccCccccccCCCCCccEE
Q 044366 259 YLKSLSKLEFCANHLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLRNLTSLERVRFNQNNLYGKVYEAFGDHPNLTFL 338 (918)
Q Consensus 259 ~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L 338 (918)
.++|++|++++|.+.. .| .+..+++|+.|++++|++.+ +|.. +++|+.|++++|.+.+++.. .++|+.|
T Consensus 214 -~~~L~~L~l~~n~l~~-lp-~~~~l~~L~~L~l~~N~l~~-l~~~---~~~L~~L~l~~N~l~~l~~~----~~~L~~L 282 (454)
T 1jl5_A 214 -PLSLESIVAGNNILEE-LP-ELQNLPFLTTIYADNNLLKT-LPDL---PPSLEALNVRDNYLTDLPEL----PQSLTFL 282 (454)
T ss_dssp -CTTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSS-CCSC---CTTCCEEECCSSCCSCCCCC----CTTCCEE
T ss_pred -cCcccEEECcCCcCCc-cc-ccCCCCCCCEEECCCCcCCc-cccc---ccccCEEECCCCcccccCcc----cCcCCEE
Confidence 1355666666665552 33 25555666666666665553 2221 24566666666665554321 2556666
Q ss_pred eCCCCccccccCcccccccccceeeccccccccCCCcCcCCC-CCCcEEEccCceeccccccchhhccccCceecccccc
Q 044366 339 DLSQNNFYCEISFNWRNFSKLGTFNASMNNIYGSIPPEIGDS-SKLQVLDLSSNHIFGKIPVQLVKLFSLNKLILSLNQL 417 (918)
Q Consensus 339 ~Ls~N~l~~~~~~~~~~~~~L~~l~l~~n~i~~~~~~~~~~~-~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l 417 (918)
++++|.++.++.. .+.|+.|++++|.+.+. ..+ ++|++|++++|++++ +|.. +++|+.|++++|++
T Consensus 283 ~ls~N~l~~l~~~----~~~L~~L~l~~N~l~~i-----~~~~~~L~~L~Ls~N~l~~-lp~~---~~~L~~L~L~~N~l 349 (454)
T 1jl5_A 283 DVSENIFSGLSEL----PPNLYYLNASSNEIRSL-----CDLPPSLEELNVSNNKLIE-LPAL---PPRLERLIASFNHL 349 (454)
T ss_dssp ECCSSCCSEESCC----CTTCCEEECCSSCCSEE-----CCCCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCC
T ss_pred ECcCCccCcccCc----CCcCCEEECcCCcCCcc-----cCCcCcCCEEECCCCcccc-cccc---CCcCCEEECCCCcc
Confidence 6666666543211 13555555555555431 122 367777777777765 3333 36677777777777
Q ss_pred cCCCCCCCCCCCcccEEeccCccccc--cCccccccccccceecccCcccCCCCchhhccccccceEeccCCcCCC--CC
Q 044366 418 FGGVPLEFGTLTELQYLDLSANKLSS--SIPMSIGNLLKLHYLNLSNNQFSHKIPTEFEKLIHLSELDLSHNILQE--EI 493 (918)
Q Consensus 418 ~~~~~~~~~~l~~L~~L~Ls~N~l~~--~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~--~~ 493 (918)
++. |. .+++|++|+|++|.+++ .+|..+.. |+.|.+.+.+|.. +++|+.||+++|++++ .+
T Consensus 350 ~~l-p~---~l~~L~~L~L~~N~l~~l~~ip~~l~~--------L~~n~~~~~i~~~---~~~L~~L~ls~N~l~~~~~i 414 (454)
T 1jl5_A 350 AEV-PE---LPQNLKQLHVEYNPLREFPDIPESVED--------LRMNSHLAEVPEL---PQNLKQLHVETNPLREFPDI 414 (454)
T ss_dssp SCC-CC---CCTTCCEEECCSSCCSSCCCCCTTCCE--------EECCC-------------------------------
T ss_pred ccc-cc---hhhhccEEECCCCCCCcCCCChHHHHh--------hhhcccccccccc---cCcCCEEECCCCcCCccccc
Confidence 643 33 35677777777777776 44544432 2345555555543 4789999999999986 44
Q ss_pred chhccccCCcceEecCCCcccccCcccccCC
Q 044366 494 PPQICKMESLEKLNLSHNNLSDFIPRCFEEM 524 (918)
Q Consensus 494 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l 524 (918)
| ++|+.|.+.+|.+.+..+.+....
T Consensus 415 P------~sl~~L~~~~~~~~~~~~~~~~~~ 439 (454)
T 1jl5_A 415 P------ESVEDLRMNSERVVDPYEFAHETT 439 (454)
T ss_dssp -------------------------------
T ss_pred h------hhHhheeCcCcccCCccccCHHHh
Confidence 4 357778899999888766555443
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=390.54 Aligned_cols=386 Identities=22% Similarity=0.238 Sum_probs=302.7
Q ss_pred CEEEcccccccccCCccccCCCCCCEEEccCCcccccCccccCCCCCCCEEECcCCcCCCc-CCcCCCCCCCCceeeccc
Q 044366 72 NELVFCHNNVSGRIPSSLGNLSNLALLYLNDNSLFGSIPIVMGNLKSLSTLDLSQNQLNGS-IPCSLDNLSNLDTLFLYK 150 (918)
Q Consensus 72 ~~L~l~~n~~~~~~p~~l~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~-~~~~l~~l~~L~~L~L~~ 150 (918)
+.++.+++.++ .+|. +. ++|++|+|++|.+++..|..|.++++|++|+|++|.+.+. .+..|.++++|++|+|++
T Consensus 13 ~~~~c~~~~l~-~lp~-l~--~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~Ls~ 88 (455)
T 3v47_A 13 YNAICINRGLH-QVPE-LP--AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDY 88 (455)
T ss_dssp TEEECCSSCCS-SCCC-CC--TTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEECTT
T ss_pred cccCcCCCCcc-cCCC-CC--CccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECcccccccccCCEEeCCC
Confidence 46788888887 6776 43 8999999999999988899999999999999999999744 467899999999999999
Q ss_pred cccccCCCcccccccccCeeeccccccCCcCCc--cCCCCCCCcEeeccCcccccCCCcc-ccCCCCcceeecccccccC
Q 044366 151 NSLSGPIPSVIGNLKSLLQLDLSENRLSGLIPL--SLSNLSSLTVMSLFNNSLSGSIPPI-LGNLKSLSTLGLHINQLNG 227 (918)
Q Consensus 151 n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~--~~~~l~~L~~L~L~~N~l~~~~~~~-~~~l~~L~~L~L~~n~l~~ 227 (918)
|++++..|..|+++++|++|+|++|++++..+. .|..+++|++|+|++|.+++..|.. |.++++|++|++++|++++
T Consensus 89 n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~ 168 (455)
T 3v47_A 89 NQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKS 168 (455)
T ss_dssp CTTCEECTTTTTTCTTCCEEECTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCCGGGGGCTTCCEEECTTCCBSC
T ss_pred CccCccChhhccCcccCCEEeCCCCCCCccccCcccccCcccCCEEECCCCccCccCcccccCCCCcccEEeCCCCcccc
Confidence 999999899999999999999999999985443 4999999999999999999887776 8999999999999999999
Q ss_pred CCCCCCcCC--CcCCeEEcccCcCcCCCCcccc--------ccCCCCeEecCCCccCCcCCCcCCCCCCCcEEEccCCcC
Q 044366 228 VIPPSIGNL--SSLRNLSLFNNRLYGFVPKEIG--------YLKSLSKLEFCANHLSGVIPHSVGNLTGLVLLNMCENHL 297 (918)
Q Consensus 228 ~~~~~~~~l--~~L~~L~Ls~n~l~~~~~~~~~--------~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l 297 (918)
..+..+..+ .+|+.|++++|.+.+..+..+. .+++|++|++++|++.+..|..+...
T Consensus 169 ~~~~~l~~l~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~------------- 235 (455)
T 3v47_A 169 ICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDA------------- 235 (455)
T ss_dssp CCTTTSGGGTTCEEEEEECTTCBCTTCSTTCTTHHHHCCTTTTCEEEEEECTTSCCCHHHHHHHHHH-------------
T ss_pred cChhhhhccccccccccccccCcccccchhhccccccccccccceeeeEecCCCcccccchhhhhcc-------------
Confidence 988888876 7899999999999876654432 33445555555555544444333222
Q ss_pred cCCCCccccCCCCCCeEEeecccccCccccccCCCCCccEEeCCCCccccccCcccccccccceeeccccccccCCCcCc
Q 044366 298 FGPIPKSLRNLTSLERVRFNQNNLYGKVYEAFGDHPNLTFLDLSQNNFYCEISFNWRNFSKLGTFNASMNNIYGSIPPEI 377 (918)
Q Consensus 298 ~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~n~i~~~~~~~~ 377 (918)
...++|+.|++++|.+.... +..+.+.......+.+
T Consensus 236 --------~~~~~L~~L~l~~~~~~~~~--------------~~~~~~~~~~~~~~~~---------------------- 271 (455)
T 3v47_A 236 --------IAGTKIQSLILSNSYNMGSS--------------FGHTNFKDPDNFTFKG---------------------- 271 (455)
T ss_dssp --------TTTCCEEEEECTTCTTTSCC--------------TTCCSSCCCCTTTTGG----------------------
T ss_pred --------ccccceeeEeeccccccccc--------------cchhhhccCccccccc----------------------
Confidence 01144555555555432211 1112221111111110
Q ss_pred CCCCCCcEEEccCceeccccccchhhccccCceecccccccCCCCCCCCCCCcccEEeccCccccccCccccccccccce
Q 044366 378 GDSSKLQVLDLSSNHIFGKIPVQLVKLFSLNKLILSLNQLFGGVPLEFGTLTELQYLDLSANKLSSSIPMSIGNLLKLHY 457 (918)
Q Consensus 378 ~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~ 457 (918)
...++|+.|++++|++.+..|..+..+++|++|+|++|++++..+..|..+++|++|+|++|.+++..|..|..+++|++
T Consensus 272 ~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~ 351 (455)
T 3v47_A 272 LEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEV 351 (455)
T ss_dssp GTTSCCCEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTTCCE
T ss_pred ccccCceEEEecCccccccchhhcccCCCCCEEECCCCcccccChhHhcCcccCCEEECCCCccCCcChhHhcCcccCCE
Confidence 01246777777777777777777778888888888888888778888888899999999999998888888889999999
Q ss_pred ecccCcccCCCCchhhccccccceEeccCCcCCCCCchhccccCCcceEecCCCcccccCc
Q 044366 458 LNLSNNQFSHKIPTEFEKLIHLSELDLSHNILQEEIPPQICKMESLEKLNLSHNNLSDFIP 518 (918)
Q Consensus 458 L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~ 518 (918)
|+|++|++++..|..|.++++|++|+|++|+|++..+..|..+++|+.|+|++|++++..|
T Consensus 352 L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~ 412 (455)
T 3v47_A 352 LDLSYNHIRALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 412 (455)
T ss_dssp EECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTT
T ss_pred EECCCCcccccChhhccccccccEEECCCCccccCCHhHhccCCcccEEEccCCCcccCCC
Confidence 9999999988888899999999999999999988777778889999999999999988665
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-42 Score=388.97 Aligned_cols=426 Identities=25% Similarity=0.262 Sum_probs=269.8
Q ss_pred CccccCCCCCCEEEcccccccccCCCCcCCCCCCCEEEcccccccccCCccccCCCCCCEEEccCCcccccCccccCCCC
Q 044366 38 PPEIGKLNQLRRLYLDVNQLHGTIPPVIGQLSLINELVFCHNNVSGRIPSSLGNLSNLALLYLNDNSLFGSIPIVMGNLK 117 (918)
Q Consensus 38 p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~l~~l~~L~~L~L~~n~i~~~~~~~~~~l~ 117 (918)
|+.+ +.++|++|++++|.+ +.+|..|+++++|++|++++|.+.+.+|.+++.+++|+.+++.+|.. .
T Consensus 5 p~~~-~~~~L~~L~l~~n~l-~~iP~~i~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~-----------~ 71 (454)
T 1jl5_A 5 PRNV-SNTFLQEPLRHSSNL-TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLD-----------R 71 (454)
T ss_dssp -------------------------------CCHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHH-----------H
T ss_pred cccc-ccccchhhhcccCch-hhCChhHhcccchhhhhccCCcccccCCcccccchhcchhhhhhhhc-----------c
Confidence 4444 468999999999999 59999999999999999999999999999999999999888888753 4
Q ss_pred CCCEEECcCCcCCCcCCcCCCCCCCCceeeccccccccCCCcccccccccCeeeccccccCCcCCccCCCCCCCcEeecc
Q 044366 118 SLSTLDLSQNQLNGSIPCSLDNLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSENRLSGLIPLSLSNLSSLTVMSLF 197 (918)
Q Consensus 118 ~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~ 197 (918)
+|++|++++|.+++ +|.. .++|++|++++|.+++ +|.. +++|++|++++|+++++.. . .++|++|+++
T Consensus 72 ~l~~L~l~~~~l~~-lp~~---~~~L~~L~l~~n~l~~-lp~~---~~~L~~L~l~~n~l~~l~~-~---~~~L~~L~L~ 139 (454)
T 1jl5_A 72 QAHELELNNLGLSS-LPEL---PPHLESLVASCNSLTE-LPEL---PQSLKSLLVDNNNLKALSD-L---PPLLEYLGVS 139 (454)
T ss_dssp TCSEEECTTSCCSC-CCSC---CTTCSEEECCSSCCSS-CCCC---CTTCCEEECCSSCCSCCCS-C---CTTCCEEECC
T ss_pred CCCEEEecCCcccc-CCCC---cCCCCEEEccCCcCCc-cccc---cCCCcEEECCCCccCcccC-C---CCCCCEEECc
Confidence 78999999999995 4442 3789999999999997 4543 4889999999999997532 1 2689999999
Q ss_pred CcccccCCCccccCCCCcceeecccccccCCCCCCCcCCCcCCeEEcccCcCcCCCCccccccCCCCeEecCCCccCCcC
Q 044366 198 NNSLSGSIPPILGNLKSLSTLGLHINQLNGVIPPSIGNLSSLRNLSLFNNRLYGFVPKEIGYLKSLSKLEFCANHLSGVI 277 (918)
Q Consensus 198 ~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~ 277 (918)
+|++++ +| .|.++++|++|++++|++++ +|..+ .+|++|++++|+++++ | .+..+++|+.|++++|++.++
T Consensus 140 ~n~l~~-lp-~~~~l~~L~~L~l~~N~l~~-lp~~~---~~L~~L~L~~n~l~~l-~-~~~~l~~L~~L~l~~N~l~~l- 210 (454)
T 1jl5_A 140 NNQLEK-LP-ELQNSSFLKIIDVDNNSLKK-LPDLP---PSLEFIAAGNNQLEEL-P-ELQNLPFLTAIYADNNSLKKL- 210 (454)
T ss_dssp SSCCSS-CC-CCTTCTTCCEEECCSSCCSC-CCCCC---TTCCEEECCSSCCSSC-C-CCTTCTTCCEEECCSSCCSSC-
T ss_pred CCCCCC-Cc-ccCCCCCCCEEECCCCcCcc-cCCCc---ccccEEECcCCcCCcC-c-cccCCCCCCEEECCCCcCCcC-
Confidence 999996 56 59999999999999999986 44433 5899999999999974 4 589999999999999999864
Q ss_pred CCcCCCCCCCcEEEccCCcCcCCCCccccCCCCCCeEEeecccccCccccccCCCCCccEEeCCCCccccccCccccccc
Q 044366 278 PHSVGNLTGLVLLNMCENHLFGPIPKSLRNLTSLERVRFNQNNLYGKVYEAFGDHPNLTFLDLSQNNFYCEISFNWRNFS 357 (918)
Q Consensus 278 ~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~ 357 (918)
|.. .++|+.|++++|++. .+| .+.++++|++|++++|.+..++. ..++|+.|++++|.++.++. ..+
T Consensus 211 ~~~---~~~L~~L~l~~n~l~-~lp-~~~~l~~L~~L~l~~N~l~~l~~----~~~~L~~L~l~~N~l~~l~~----~~~ 277 (454)
T 1jl5_A 211 PDL---PLSLESIVAGNNILE-ELP-ELQNLPFLTTIYADNNLLKTLPD----LPPSLEALNVRDNYLTDLPE----LPQ 277 (454)
T ss_dssp CCC---CTTCCEEECCSSCCS-SCC-CCTTCTTCCEEECCSSCCSSCCS----CCTTCCEEECCSSCCSCCCC----CCT
T ss_pred CCC---cCcccEEECcCCcCC-ccc-ccCCCCCCCEEECCCCcCCcccc----cccccCEEECCCCcccccCc----ccC
Confidence 332 258999999999998 556 48899999999999999987653 24789999999998876443 236
Q ss_pred ccceeeccccccccCCCcCcCCCCCCcEEEccCceeccccccchhhc-cccCceecccccccCCCCCCCCCCCcccEEec
Q 044366 358 KLGTFNASMNNIYGSIPPEIGDSSKLQVLDLSSNHIFGKIPVQLVKL-FSLNKLILSLNQLFGGVPLEFGTLTELQYLDL 436 (918)
Q Consensus 358 ~L~~l~l~~n~i~~~~~~~~~~~~~L~~L~L~~N~l~~~~~~~~~~l-~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 436 (918)
.|+.|++++|++.+. |.. .++|+.|++++|++++. + .+ .+|+.|++++|++++ +|.. +++|++|++
T Consensus 278 ~L~~L~ls~N~l~~l-~~~---~~~L~~L~l~~N~l~~i-~----~~~~~L~~L~Ls~N~l~~-lp~~---~~~L~~L~L 344 (454)
T 1jl5_A 278 SLTFLDVSENIFSGL-SEL---PPNLYYLNASSNEIRSL-C----DLPPSLEELNVSNNKLIE-LPAL---PPRLERLIA 344 (454)
T ss_dssp TCCEEECCSSCCSEE-SCC---CTTCCEEECCSSCCSEE-C----CCCTTCCEEECCSSCCSC-CCCC---CTTCCEEEC
T ss_pred cCCEEECcCCccCcc-cCc---CCcCCEEECcCCcCCcc-c----CCcCcCCEEECCCCcccc-cccc---CCcCCEEEC
Confidence 788888888887752 111 15778888888877642 1 22 477778888887775 3332 467778888
Q ss_pred cCccccccCccccccccccceecccCcccCC--CCchhhccccccceEeccCCcCCCCCchhccccCCcceEecCCCccc
Q 044366 437 SANKLSSSIPMSIGNLLKLHYLNLSNNQFSH--KIPTEFEKLIHLSELDLSHNILQEEIPPQICKMESLEKLNLSHNNLS 514 (918)
Q Consensus 437 s~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~--~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 514 (918)
++|.+++ +|. .+++|++|+|++|++++ .+|..+..+ +.|.+.+.+|.. +++|+.|++++|+++
T Consensus 345 ~~N~l~~-lp~---~l~~L~~L~L~~N~l~~l~~ip~~l~~L--------~~n~~~~~i~~~---~~~L~~L~ls~N~l~ 409 (454)
T 1jl5_A 345 SFNHLAE-VPE---LPQNLKQLHVEYNPLREFPDIPESVEDL--------RMNSHLAEVPEL---PQNLKQLHVETNPLR 409 (454)
T ss_dssp CSSCCSC-CCC---CCTTCCEEECCSSCCSSCCCCCTTCCEE--------ECCC--------------------------
T ss_pred CCCcccc-ccc---hhhhccEEECCCCCCCcCCCChHHHHhh--------hhcccccccccc---cCcCCEEECCCCcCC
Confidence 8887774 444 35777888888888776 455555432 345555555553 478999999999999
Q ss_pred c--cCcccccCCCCccEEEccCCcCCCCCCCC
Q 044366 515 D--FIPRCFEEMRSLSWIDISYNELQGPIPNS 544 (918)
Q Consensus 515 ~--~~~~~~~~l~~L~~l~l~~N~l~~~~p~~ 544 (918)
+ .+|. +++.|.+.+|.+.+++|..
T Consensus 410 ~~~~iP~------sl~~L~~~~~~~~~~~~~~ 435 (454)
T 1jl5_A 410 EFPDIPE------SVEDLRMNSERVVDPYEFA 435 (454)
T ss_dssp --------------------------------
T ss_pred ccccchh------hHhheeCcCcccCCccccC
Confidence 7 4553 4667788999999887754
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-42 Score=374.58 Aligned_cols=280 Identities=33% Similarity=0.603 Sum_probs=227.3
Q ss_pred CccCHHHHHHHhcCCCCceeeccccceEEEEEEeCCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEec
Q 044366 634 GKVLYEEITKATGNFGEKYCIGKGGQRSVYKAELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHG 713 (918)
Q Consensus 634 ~~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~ 713 (918)
..+++.++..+.++|...+.||+|+||.||+|+..+|+.||||++...... .....+.+|+++++.++||||+++++
T Consensus 18 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~ 94 (326)
T 3uim_A 18 KRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQ---GGELQFQTEVEMISMAVHRNLLRLRG 94 (326)
T ss_dssp EECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC--------CCCHHHHHHHGGGTCCCTTBCCCCE
T ss_pred ceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCc---hHHHHHHHHHHHHHhccCCCccceEE
Confidence 456788999999999999999999999999998888999999998764322 22347999999999999999999999
Q ss_pred ccccCCceEEEEEeccCCChhHHhhccc-ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEE
Q 044366 714 FCSNAQHSFIVCEYLARGSLTTILRDDA-AAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAH 792 (918)
Q Consensus 714 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~k 792 (918)
++.+++..++||||+++|+|.++++... ....+++..++.++.|++.||+|||+.+.++|+||||||+||+++.++.+|
T Consensus 95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~k 174 (326)
T 3uim_A 95 FCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAV 174 (326)
T ss_dssp EECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEE
T ss_pred EEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEE
Confidence 9999999999999999999999998754 234589999999999999999999998777999999999999999999999
Q ss_pred EeccccccccCCCCCC-ceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhh---
Q 044366 793 VSDFGFAKFLEPHSSN-WTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIE--- 868 (918)
Q Consensus 793 l~DfG~~~~~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~--- 868 (918)
|+|||++......... .....||+.|+|||++.+..++.++||||||+++|||++|+.||+...............
T Consensus 175 l~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 254 (326)
T 3uim_A 175 VGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKG 254 (326)
T ss_dssp ECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTT
T ss_pred eccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHH
Confidence 9999999877544332 334568999999999998889999999999999999999999986332111100000011
Q ss_pred ------hhhhcccCCCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhC
Q 044366 869 ------VNQILDHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLLCK 918 (918)
Q Consensus 869 ------~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~ 918 (918)
.....+.... .....+....+.+++.+||+.||++|||++||++.|++
T Consensus 255 ~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~ 308 (326)
T 3uim_A 255 LLKEKKLEALVDVDLQ--GNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 308 (326)
T ss_dssp TTSSCCSTTSSCTTCT--TSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHT
T ss_pred HhhchhhhhhcChhhc--cccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcC
Confidence 1111111111 22345667889999999999999999999999999863
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=364.52 Aligned_cols=250 Identities=26% Similarity=0.395 Sum_probs=209.4
Q ss_pred hcCCCCceeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEE
Q 044366 645 TGNFGEKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFI 723 (918)
Q Consensus 645 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 723 (918)
.++|...+.||+|+||.||+|.. .+|+.||||++... .....+.+.+|+.+++.++||||+++++++..++..++
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 94 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQ----QQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWV 94 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGG----GCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecc----cccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEE
Confidence 46899999999999999999964 67999999998653 23346789999999999999999999999999999999
Q ss_pred EEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccC
Q 044366 724 VCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLE 803 (918)
Q Consensus 724 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~ 803 (918)
||||+++|+|.+++... .+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++....
T Consensus 95 v~e~~~~~~L~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 167 (297)
T 3fxz_A 95 VMEYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT 167 (297)
T ss_dssp EEECCTTCBHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEECCCCCCHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEECCCCCEEEeeCCCceecC
Confidence 99999999999999754 389999999999999999999999 99999999999999999999999999998877
Q ss_pred CCCCCceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCCCCCcc
Q 044366 804 PHSSNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRD 883 (918)
Q Consensus 804 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 883 (918)
..........||+.|+|||++.+..++.++||||+||++|||++|+.||.......... ............
T Consensus 168 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~-----~~~~~~~~~~~~---- 238 (297)
T 3fxz_A 168 PEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY-----LIATNGTPELQN---- 238 (297)
T ss_dssp STTCCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH-----HHHHHCSCCCSC----
T ss_pred CcccccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH-----HHHhCCCCCCCC----
Confidence 66555566789999999999999999999999999999999999999986543321110 011111111111
Q ss_pred hHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 884 VTDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 884 ~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
.......+.+++.+||+.||++|||++|+++
T Consensus 239 ~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 269 (297)
T 3fxz_A 239 PEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ 269 (297)
T ss_dssp GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 1122356788999999999999999999975
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-42 Score=368.70 Aligned_cols=263 Identities=30% Similarity=0.461 Sum_probs=203.0
Q ss_pred HHHHHHhcCCCCceeeccccceEEEEEEeCCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccC
Q 044366 639 EEITKATGNFGEKYCIGKGGQRSVYKAELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNA 718 (918)
Q Consensus 639 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~ 718 (918)
.++....++|.+.+.||+|+||.||+|+. +|+.||||++..... .....+.|.+|++++++++||||+++++++.+.
T Consensus 30 ~~~~i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 106 (309)
T 3p86_A 30 DDMDIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDF--HAERVNEFLREVAIMKRLRHPNIVLFMGAVTQP 106 (309)
T ss_dssp --CBCCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCC--SHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST
T ss_pred ccccCChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCC--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC
Confidence 34444567899999999999999999976 688999999865321 122246789999999999999999999999999
Q ss_pred CceEEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--eEEcCCCCCCeeeCCCCcEEEecc
Q 044366 719 QHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPP--IVHRDISSKNVLLDSEYEAHVSDF 796 (918)
Q Consensus 719 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~--ivH~dlk~~Nill~~~~~~kl~Df 796 (918)
+..++||||+++|+|.+++........+++.+++.++.|++.||+|||+. + |+||||||+||+++.++.+||+||
T Consensus 107 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~~~ivH~Dikp~NIll~~~~~~kL~Df 183 (309)
T 3p86_A 107 PNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR---NPPIVHRNLKSPNLLVDKKYTVKVCDF 183 (309)
T ss_dssp TCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTS---SSCCCCTTCCGGGEEECTTCCEEECCC
T ss_pred CceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcC---CCCEECCCCChhhEEEeCCCcEEECCC
Confidence 99999999999999999998765445589999999999999999999999 8 999999999999999999999999
Q ss_pred ccccccCCCCCCceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccC
Q 044366 797 GFAKFLEPHSSNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHR 876 (918)
Q Consensus 797 G~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 876 (918)
|+++.............||+.|+|||++.+..++.++||||||+++|||++|+.||....... ..... ......
T Consensus 184 g~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~-----~~~~~-~~~~~~ 257 (309)
T 3p86_A 184 GLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQ-----VVAAV-GFKCKR 257 (309)
T ss_dssp C-----------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHH-----HHHHH-HHSCCC
T ss_pred CCCccccccccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-----HHHHH-HhcCCC
Confidence 999876554444455679999999999999999999999999999999999999987543211 00010 001111
Q ss_pred CCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 044366 877 LPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLLC 917 (918)
Q Consensus 877 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 917 (918)
.. .... ....+.+++.+||+.||++|||++|+++.|+
T Consensus 258 ~~-~~~~---~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~ 294 (309)
T 3p86_A 258 LE-IPRN---LNPQVAAIIEGCWTNEPWKRPSFATIMDLLR 294 (309)
T ss_dssp CC-CCTT---SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CC-CCcc---CCHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 11 1111 2245788999999999999999999999885
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-41 Score=364.23 Aligned_cols=261 Identities=25% Similarity=0.369 Sum_probs=214.8
Q ss_pred CccCHHHHHHHhcC----------CCCceeeccccceEEEEEEeC-CCCEEEEEEcccccccCCCCChHHHHHHHHHHhh
Q 044366 634 GKVLYEEITKATGN----------FGEKYCIGKGGQRSVYKAELP-SGNIFAVKKFKAELFSDETANPSEFLNEVLALTE 702 (918)
Q Consensus 634 ~~~~~~~~~~~~~~----------~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~ 702 (918)
+.++++++..+++. |...+.||+|+||.||+|+.. +|+.||||++... .....+.+.+|+.+++.
T Consensus 23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~----~~~~~~~~~~E~~~l~~ 98 (321)
T 2c30_A 23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLR----KQQRRELLFNEVVIMRD 98 (321)
T ss_dssp --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETT----TCCSHHHHHHHHHHHTT
T ss_pred CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEecc----chhHHHHHHHHHHHHHh
Confidence 45778888887764 666779999999999999765 7999999998653 23446789999999999
Q ss_pred ccCCceeeEecccccCCceEEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCC
Q 044366 703 IRHRNIIKFHGFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKN 782 (918)
Q Consensus 703 l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~N 782 (918)
++||||+++++++..++..++||||+++|+|.+++... .+++.+++.++.|++.||+|||+. +|+||||||+|
T Consensus 99 l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~----~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~N 171 (321)
T 2c30_A 99 YQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQV----RLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDS 171 (321)
T ss_dssp CCCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTTC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGG
T ss_pred CCCCCcceEEEEEEECCEEEEEEecCCCCCHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHH
Confidence 99999999999999999999999999999999998753 489999999999999999999999 99999999999
Q ss_pred eeeCCCCcEEEeccccccccCCCCCCceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhh
Q 044366 783 VLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSI 862 (918)
Q Consensus 783 ill~~~~~~kl~DfG~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~ 862 (918)
|+++.++.+||+|||++..............||+.|+|||++.+..++.++||||||+++|||++|+.||....... .
T Consensus 172 Ill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~-~- 249 (321)
T 2c30_A 172 ILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQ-A- 249 (321)
T ss_dssp EEECTTCCEEECCCTTCEECCSSSCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-H-
T ss_pred EEECCCCcEEEeeeeeeeecccCccccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-H-
Confidence 99999999999999999887655444556689999999999999999999999999999999999999986543211 1
Q ss_pred hhhHhhhhhhcccCCCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 863 SNMIIEVNQILDHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 863 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
...... ...+. ..........+.+++.+||+.||++|||++|+++
T Consensus 250 ---~~~~~~---~~~~~-~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 294 (321)
T 2c30_A 250 ---MKRLRD---SPPPK-LKNSHKVSPVLRDFLERMLVRDPQERATAQELLD 294 (321)
T ss_dssp ---HHHHHH---SSCCC-CTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ---HHHHhc---CCCCC-cCccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 111111 11111 1111122356888999999999999999999986
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-41 Score=366.46 Aligned_cols=272 Identities=32% Similarity=0.494 Sum_probs=219.9
Q ss_pred CHHHHHHHhcCCCCceeeccccceEEEEEEeCCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccc
Q 044366 637 LYEEITKATGNFGEKYCIGKGGQRSVYKAELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCS 716 (918)
Q Consensus 637 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~ 716 (918)
.+.++..++++|...+.||+|+||.||+|...+|+.||||++... .....+.+.+|+++++.++||||+++++++.
T Consensus 30 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 105 (321)
T 2qkw_B 30 PLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPE----SSQGIEEFETEIETLSFCRHPHLVSLIGFCD 105 (321)
T ss_dssp CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSC----CSSHHHHHHHHHHGGGSCCCTTBCCEEEECC
T ss_pred cHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEeccc----ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEc
Confidence 344556678999999999999999999999888999999987653 2334678999999999999999999999999
Q ss_pred cCCceEEEEEeccCCChhHHhhccc-ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEec
Q 044366 717 NAQHSFIVCEYLARGSLTTILRDDA-AAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSD 795 (918)
Q Consensus 717 ~~~~~~lv~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~D 795 (918)
+++..++||||+++|+|.+++.... ....+++.+++.++.|+++||+|||+. +|+||||||+||+++.++.+||+|
T Consensus 106 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~D 182 (321)
T 2qkw_B 106 ERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITD 182 (321)
T ss_dssp CTTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCSTTEEECTTCCEEECC
T ss_pred CCCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCC---CeecCCCCHHHEEECCCCCEEEee
Confidence 9999999999999999999997653 233589999999999999999999999 999999999999999999999999
Q ss_pred cccccccCCCCC--CceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhh--hhhhhhH-----
Q 044366 796 FGFAKFLEPHSS--NWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIF--SSISNMI----- 866 (918)
Q Consensus 796 fG~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~--~~~~~~~----- 866 (918)
||++........ ......||+.|+|||++.+..++.++||||||+++|||++|+.||....... .......
T Consensus 183 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~ 262 (321)
T 2qkw_B 183 FGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNN 262 (321)
T ss_dssp CTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTT
T ss_pred cccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhcccc
Confidence 999987543222 2234568999999999998899999999999999999999999976432210 0000000
Q ss_pred hhhhhhcccCCCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 044366 867 IEVNQILDHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLLC 917 (918)
Q Consensus 867 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 917 (918)
.......+.... .....+....+.+++.+||+.||++|||++|+++.|+
T Consensus 263 ~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~ 311 (321)
T 2qkw_B 263 GQLEQIVDPNLA--DKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLE 311 (321)
T ss_dssp TCCCSSSSSSCT--TCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred ccHHHhcChhhc--cccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHH
Confidence 001111122111 1223566778999999999999999999999999886
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=358.27 Aligned_cols=277 Identities=31% Similarity=0.506 Sum_probs=224.5
Q ss_pred CccCHHHHHHHhcCCCCc------eeeccccceEEEEEEeCCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCc
Q 044366 634 GKVLYEEITKATGNFGEK------YCIGKGGQRSVYKAELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRN 707 (918)
Q Consensus 634 ~~~~~~~~~~~~~~~~~~------~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~n 707 (918)
..+.+.++..++.+|... +.||+|+||.||+|.. +++.||||++............+.+.+|+++++.++|||
T Consensus 13 ~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ 91 (307)
T 2nru_A 13 HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHEN 91 (307)
T ss_dssp EECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTT
T ss_pred CcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCC
Confidence 356789999999999888 8999999999999987 689999999876432233344678999999999999999
Q ss_pred eeeEecccccCCceEEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCC
Q 044366 708 IIKFHGFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDS 787 (918)
Q Consensus 708 iv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~ 787 (918)
|+++++++.+++..++||||+++|+|.+++........+++..++.++.|++.||+|||+. +|+||||||+||+++.
T Consensus 92 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nili~~ 168 (307)
T 2nru_A 92 LVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDE 168 (307)
T ss_dssp BCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECT
T ss_pred eEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEEcC
Confidence 9999999999999999999999999999998655556689999999999999999999999 9999999999999999
Q ss_pred CCcEEEeccccccccCCCCCC--ceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhh--hhhh
Q 044366 788 EYEAHVSDFGFAKFLEPHSSN--WTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIF--SSIS 863 (918)
Q Consensus 788 ~~~~kl~DfG~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~--~~~~ 863 (918)
++.+||+|||++......... .....|++.|+|||.+.+ .++.++||||||+++|+|++|+.||+...... ..+.
T Consensus 169 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~ 247 (307)
T 2nru_A 169 AFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIK 247 (307)
T ss_dssp TCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHH
T ss_pred CCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHH
Confidence 999999999999876543222 233568999999998865 57889999999999999999999986543211 0111
Q ss_pred hhH----hhhhhhcccCCCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhC
Q 044366 864 NMI----IEVNQILDHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLLCK 918 (918)
Q Consensus 864 ~~~----~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~ 918 (918)
... ......++.... .........+.+++.+||+.||.+|||++++++.|++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~ 303 (307)
T 2nru_A 248 EEIEDEEKTIEDYIDKKMN---DADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQE 303 (307)
T ss_dssp HHHHTTSCCHHHHSCSSCS---CCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred HHhhhhhhhhhhhcccccc---ccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHH
Confidence 100 011222222222 2234556789999999999999999999999999863
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=360.22 Aligned_cols=255 Identities=25% Similarity=0.420 Sum_probs=205.4
Q ss_pred hcCCCCceeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEE
Q 044366 645 TGNFGEKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFI 723 (918)
Q Consensus 645 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 723 (918)
.++|...+.||+|+||.||+|.. .+++.||+|++... .....+.|.+|+++++.++||||+++++++.+++..++
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~----~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 84 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF----DEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNF 84 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCC----CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccC----CHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEE
Confidence 46788899999999999999965 57999999987542 23345789999999999999999999999999999999
Q ss_pred EEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccC
Q 044366 724 VCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLE 803 (918)
Q Consensus 724 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~ 803 (918)
||||+++|+|.++++.. ...+++.+++.++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 85 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 159 (310)
T 3s95_A 85 ITEYIKGGTLRGIIKSM--DSQYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLARLMV 159 (310)
T ss_dssp EEECCTTCBHHHHHHHC--CTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEECTTSCEEECCCTTCEECC
T ss_pred EEEecCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCcCeEEECCCCCEEEeecccceecc
Confidence 99999999999999864 24589999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCCc--------------eecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhh
Q 044366 804 PHSSNW--------------TEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEV 869 (918)
Q Consensus 804 ~~~~~~--------------~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~ 869 (918)
...... ....||+.|+|||++.+..++.++||||||+++|||++|..|+...............
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~-- 237 (310)
T 3s95_A 160 DEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVR-- 237 (310)
T ss_dssp --------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHH--
T ss_pred cccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhh--
Confidence 432211 1457899999999999999999999999999999999999986543221111111000
Q ss_pred hhhcccCCCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 044366 870 NQILDHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLLC 917 (918)
Q Consensus 870 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 917 (918)
.......+.. ....+.+++.+||+.||++|||++|+++.|+
T Consensus 238 -~~~~~~~~~~------~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~ 278 (310)
T 3s95_A 238 -GFLDRYCPPN------CPPSFFPITVRCCDLDPEKRPSFVKLEHWLE 278 (310)
T ss_dssp -HHHHHTCCTT------CCTTHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred -ccccccCCCC------CCHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 1111111111 1134788999999999999999999999885
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=363.78 Aligned_cols=256 Identities=21% Similarity=0.279 Sum_probs=208.3
Q ss_pred HhcCCCCceeeccccceEEEEEEe-CCCCEEEEEEcccccccCC--CCChHHHHHHHHHHhhccCCceeeEecccccCCc
Q 044366 644 ATGNFGEKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDE--TANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQH 720 (918)
Q Consensus 644 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 720 (918)
..++|.+.+.||+|+||.||+|.. .+|+.||+|+++....... ....+.+.+|+.+++.++||||+++++++.+++.
T Consensus 10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 89 (361)
T 2yab_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTD 89 (361)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCE
Confidence 346789999999999999999965 4799999999976433221 1235789999999999999999999999999999
Q ss_pred eEEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCC----cEEEecc
Q 044366 721 SFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEY----EAHVSDF 796 (918)
Q Consensus 721 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~----~~kl~Df 796 (918)
.++||||+++|+|.+++... ..+++.+++.++.||+.||+|||+. +|+||||||+||+++.++ .+||+||
T Consensus 90 ~~lv~e~~~gg~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~~~vkl~DF 163 (361)
T 2yab_A 90 VVLILELVSGGELFDFLAQK---ESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDF 163 (361)
T ss_dssp EEEEEECCCSCBHHHHHTTC---SCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred EEEEEEcCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeCCCCCccCEEEEec
Confidence 99999999999999999764 3589999999999999999999999 999999999999998877 7999999
Q ss_pred ccccccCCCCCCceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccC
Q 044366 797 GFAKFLEPHSSNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHR 876 (918)
Q Consensus 797 G~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 876 (918)
|++....... ......||+.|+|||++.+..++.++||||+||++|+|++|+.||...... .. ...+....
T Consensus 164 G~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~-~~-------~~~i~~~~ 234 (361)
T 2yab_A 164 GLAHEIEDGV-EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ-ET-------LANITAVS 234 (361)
T ss_dssp SSCEECCTTC-CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH-HH-------HHHHHTTC
T ss_pred CCceEcCCCC-ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH-HH-------HHHHHhcC
Confidence 9998776432 234567999999999999989999999999999999999999998654321 11 11111111
Q ss_pred CCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 877 LPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 877 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
..............+.+++.+||..||++|||+.|+++
T Consensus 235 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 235 YDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp CCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CCCCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 11111111122356889999999999999999999975
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=366.95 Aligned_cols=256 Identities=23% Similarity=0.368 Sum_probs=207.1
Q ss_pred hcCCCCceeeccccceEEEEEEe--------CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhc-cCCceeeEeccc
Q 044366 645 TGNFGEKYCIGKGGQRSVYKAEL--------PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEI-RHRNIIKFHGFC 715 (918)
Q Consensus 645 ~~~~~~~~~lg~G~~g~Vy~~~~--------~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~ 715 (918)
.++|...+.||+|+||.||+|+. .++..||||+++... .....+.+.+|+++++.+ +||||+++++++
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~ 156 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA---TEKDLSDLVSEMEMMKMIGKHKNIINLLGAC 156 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTC---BHHHHHHHHHHHHHHHHSCCCTTBCCEEEEE
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCc---CHHHHHHHHHHHHHHHHhcCCCCEeeEEEEE
Confidence 46788999999999999999964 245679999987531 222356799999999999 899999999999
Q ss_pred ccCCceEEEEEeccCCChhHHhhcccc-------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCC
Q 044366 716 SNAQHSFIVCEYLARGSLTTILRDDAA-------------AKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKN 782 (918)
Q Consensus 716 ~~~~~~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~N 782 (918)
.+++..++||||+++|+|.++++.... ...+++.+++.++.||+.||+|||+. +|+||||||+|
T Consensus 157 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~N 233 (370)
T 2psq_A 157 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARN 233 (370)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGG
T ss_pred ccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---Ceeccccchhh
Confidence 999999999999999999999986532 23589999999999999999999999 99999999999
Q ss_pred eeeCCCCcEEEeccccccccCCCCC--CceecccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhhh
Q 044366 783 VLLDSEYEAHVSDFGFAKFLEPHSS--NWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIK-GYHPGDFVSTIF 859 (918)
Q Consensus 783 ill~~~~~~kl~DfG~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~p~~~~~~~~ 859 (918)
|+++.++.+||+|||+++....... ......+++.|+|||++.+..++.++|||||||++|||++ |+.||......
T Consensus 234 Ill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~- 312 (370)
T 2psq_A 234 VLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE- 312 (370)
T ss_dssp EEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG-
T ss_pred EEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHH-
Confidence 9999999999999999987654332 2233456789999999999999999999999999999999 99997653221
Q ss_pred hhhhhhHhhhhhhcccCCCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 044366 860 SSISNMIIEVNQILDHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLLC 917 (918)
Q Consensus 860 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 917 (918)
...... .....+..+.. ....+.+++.+||+.||++|||+.|+++.|+
T Consensus 313 ----~~~~~~---~~~~~~~~~~~---~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~ 360 (370)
T 2psq_A 313 ----ELFKLL---KEGHRMDKPAN---CTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 360 (370)
T ss_dssp ----GHHHHH---HTTCCCCCCTT---SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred ----HHHHHH---hcCCCCCCCCC---CCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 111111 11111111111 2346888999999999999999999999986
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=366.07 Aligned_cols=258 Identities=22% Similarity=0.269 Sum_probs=209.2
Q ss_pred hcCCCCceeeccccceEEEEEEe-CCCCEEEEEEcccccccC-CCCChHHHHHHHHHHhhccCCceeeEecccccCCceE
Q 044366 645 TGNFGEKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSD-ETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSF 722 (918)
Q Consensus 645 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 722 (918)
.++|...+.||+|+||.||+|.. .+|+.||||++....... .....+.+.+|+.+++.++||||+++++++.+++..+
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 35789999999999999999965 579999999986543222 2234678999999999999999999999999999999
Q ss_pred EEEEeccCCChhHHhhccc-ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCc---EEEecccc
Q 044366 723 IVCEYLARGSLTTILRDDA-AAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYE---AHVSDFGF 798 (918)
Q Consensus 723 lv~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~---~kl~DfG~ 798 (918)
+||||+++|+|.+++.... ....+++..++.++.||+.||+|||+. +|+||||||+||+++.++. +||+|||+
T Consensus 103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~ 179 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGV 179 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChHHeEEecCCCCCcEEEecCcc
Confidence 9999999999998886542 234589999999999999999999999 9999999999999987654 99999999
Q ss_pred ccccCCCCCCceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCC
Q 044366 799 AKFLEPHSSNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLP 878 (918)
Q Consensus 799 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 878 (918)
+..............||+.|+|||++.+..++.++||||+||++|+|++|+.||...... . ...+......
T Consensus 180 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--~-------~~~i~~~~~~ 250 (351)
T 3c0i_A 180 AIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKER--L-------FEGIIKGKYK 250 (351)
T ss_dssp CEECCTTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHHH--H-------HHHHHHTCCC
T ss_pred eeEecCCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHHH--H-------HHHHHcCCCC
Confidence 988766544445567999999999999989999999999999999999999998754221 0 1111111111
Q ss_pred CCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 879 TPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 879 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
............+.+++.+||+.||++|||+.|+++
T Consensus 251 ~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 251 MNPRQWSHISESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp CCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 111111122356889999999999999999999975
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=360.73 Aligned_cols=250 Identities=24% Similarity=0.391 Sum_probs=206.6
Q ss_pred HhcCCCCceeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceE
Q 044366 644 ATGNFGEKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSF 722 (918)
Q Consensus 644 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 722 (918)
..++|...+.||+|+||.||+|.. .+|+.||||++..... .....+.+.+|+++++.++||||+++++++...+..+
T Consensus 13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 90 (328)
T 3fe3_A 13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQL--NPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLY 90 (328)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcC--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEE
Confidence 457899999999999999999965 6899999999876432 2223567889999999999999999999999999999
Q ss_pred EEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEecccccccc
Q 044366 723 IVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFL 802 (918)
Q Consensus 723 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~ 802 (918)
+||||+++|+|.+++...+ .+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++...
T Consensus 91 lv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 164 (328)
T 3fe3_A 91 LIMEYASGGEVFDYLVAHG---RMKEKEARSKFRQIVSAVQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEF 164 (328)
T ss_dssp EEECCCTTCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTCCGGG
T ss_pred EEEECCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCCHHHEEEcCCCCEEEeeccCceec
Confidence 9999999999999997643 489999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCCCceecccccccccccccccCCCC-cccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCCCCC
Q 044366 803 EPHSSNWTEFAGTVGYAAPELAYTMRAT-EKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPS 881 (918)
Q Consensus 803 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~-~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 881 (918)
... .......||+.|+|||++.+..++ .++||||+||++|||++|+.||+..... ... ..+.......+.
T Consensus 165 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~--~~~------~~i~~~~~~~p~ 235 (328)
T 3fe3_A 165 TVG-GKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLK--ELR------ERVLRGKYRIPF 235 (328)
T ss_dssp SSS-CGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHH------HHHHHCCCCCCT
T ss_pred CCC-CccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHH--HHH------HHHHhCCCCCCC
Confidence 543 234556799999999999888765 7999999999999999999998754321 111 111112221111
Q ss_pred cchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 882 RDVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 882 ~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
. ....+.+++.+||+.||.+|||++|+++
T Consensus 236 -~---~s~~~~~li~~~L~~dP~~R~t~~eil~ 264 (328)
T 3fe3_A 236 -Y---MSTDCENLLKRFLVLNPIKRGTLEQIMK 264 (328)
T ss_dssp -T---SCHHHHHHHHHHCCSSTTTSCCHHHHTT
T ss_pred -C---CCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 1 2245788999999999999999999975
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=366.52 Aligned_cols=255 Identities=25% Similarity=0.339 Sum_probs=202.9
Q ss_pred HhcCCCCceeeccccceEEEEEEeC-CCCEEEEEEcccccccCCCCChHHHHHHHHHHhhc-cCCceeeEecccccCCce
Q 044366 644 ATGNFGEKYCIGKGGQRSVYKAELP-SGNIFAVKKFKAELFSDETANPSEFLNEVLALTEI-RHRNIIKFHGFCSNAQHS 721 (918)
Q Consensus 644 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~ 721 (918)
..++|...++||+|+||.||+|+.. +++.||+|+++...... ....+.+.+|..+++++ +||||+++++++.+++..
T Consensus 50 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~-~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~ 128 (396)
T 4dc2_A 50 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVND-DEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRL 128 (396)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC-----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred ChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccC-HHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEE
Confidence 3467999999999999999999654 68899999998754332 23346788999999887 899999999999999999
Q ss_pred EEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccc
Q 044366 722 FIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKF 801 (918)
Q Consensus 722 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~ 801 (918)
++||||+++|+|.+++... ..+++..++.++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++.
T Consensus 129 ~lV~E~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFGla~~ 202 (396)
T 4dc2_A 129 FFVIEYVNGGDLMFHMQRQ---RKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKE 202 (396)
T ss_dssp EEEEECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEEEEcCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEECCCCCEEEeecceeee
Confidence 9999999999999999764 3489999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCCceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHh-hhhhhcccCCCCC
Q 044366 802 LEPHSSNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMII-EVNQILDHRLPTP 880 (918)
Q Consensus 802 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 880 (918)
...........+||+.|+|||++.+..++.++||||+||++|||++|+.||............... ....+.......+
T Consensus 203 ~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p 282 (396)
T 4dc2_A 203 GLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIP 282 (396)
T ss_dssp CCCTTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCCCC
T ss_pred cccCCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccCCC
Confidence 544444556678999999999999999999999999999999999999998643221111010001 1111222222211
Q ss_pred CcchHHHHHHHHHHHHHcccCCCCCCCCH
Q 044366 881 SRDVTDKLRSIMEVAILCLVENPEARPTM 909 (918)
Q Consensus 881 ~~~~~~~~~~l~~li~~cl~~dp~~RPt~ 909 (918)
.. ....+.+++.+||+.||++||++
T Consensus 283 -~~---~s~~~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 283 -RS---LSVKAASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp -TT---SCHHHHHHHHHHTCSCTTTSTTC
T ss_pred -Cc---CCHHHHHHHHHHhcCCHhHcCCC
Confidence 11 22457889999999999999995
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-40 Score=358.57 Aligned_cols=251 Identities=24% Similarity=0.301 Sum_probs=207.9
Q ss_pred hcCCCCceeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEE
Q 044366 645 TGNFGEKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFI 723 (918)
Q Consensus 645 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 723 (918)
.++|...+.||+|+||.||+|+. .+|+.||+|+++..... .....+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~l 82 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVII-AKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCF 82 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHH-HTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhh-hhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEE
Confidence 36788999999999999999965 47999999999764322 22346788999999999999999999999999999999
Q ss_pred EEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccC
Q 044366 724 VCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLE 803 (918)
Q Consensus 724 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~ 803 (918)
||||+++|+|.+++... ..+++.+++.++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 83 v~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 156 (337)
T 1o6l_A 83 VMEYANGGELFFHLSRE---RVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGI 156 (337)
T ss_dssp EEECCTTCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred EEeCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCCHHHEEECCCCCEEEeeccchhhcc
Confidence 99999999999999764 3489999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCCceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCCCCCcc
Q 044366 804 PHSSNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRD 883 (918)
Q Consensus 804 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 883 (918)
..........||+.|+|||++.+..++.++||||+||++|||++|+.||...... .. . ..+.......+ ..
T Consensus 157 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~--~~---~---~~i~~~~~~~p-~~ 227 (337)
T 1o6l_A 157 SDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE--RL---F---ELILMEEIRFP-RT 227 (337)
T ss_dssp CTTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH--HH---H---HHHHHCCCCCC-TT
T ss_pred cCCCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHH--HH---H---HHHHcCCCCCC-CC
Confidence 5444555678999999999999999999999999999999999999998654321 01 1 11111111111 11
Q ss_pred hHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 044366 884 VTDKLRSIMEVAILCLVENPEARP-----TMKEVCN 914 (918)
Q Consensus 884 ~~~~~~~l~~li~~cl~~dp~~RP-----t~~evl~ 914 (918)
....+.+++.+||+.||++|| +++|+++
T Consensus 228 ---~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~ 260 (337)
T 1o6l_A 228 ---LSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp ---SCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred ---CCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHc
Confidence 224678899999999999999 8999875
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=354.66 Aligned_cols=265 Identities=20% Similarity=0.271 Sum_probs=209.9
Q ss_pred hcCCCCceeeccccceEEEEEEeC-CCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCC--ce
Q 044366 645 TGNFGEKYCIGKGGQRSVYKAELP-SGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQ--HS 721 (918)
Q Consensus 645 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~--~~ 721 (918)
.++|...+.||+|+||.||+|... +|+.||||++.... .....+.+.+|++++++++||||+++++++.... ..
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 84 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNIS---FLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHK 84 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGG---GGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEecccc---ccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceE
Confidence 357889999999999999999654 69999999987532 2234678899999999999999999999987654 77
Q ss_pred EEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeee----CCCCcEEEeccc
Q 044366 722 FIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLL----DSEYEAHVSDFG 797 (918)
Q Consensus 722 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill----~~~~~~kl~DfG 797 (918)
++||||+++|+|.+++........+++.+++.++.|++.||+|||+. +|+||||||+||++ +.++.+||+|||
T Consensus 85 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg 161 (319)
T 4euu_A 85 VLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFG 161 (319)
T ss_dssp EEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEECTTSCEEEEECCCT
T ss_pred EEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEeccCCCCceEEEccCC
Confidence 99999999999999998765555589999999999999999999999 99999999999999 778889999999
Q ss_pred cccccCCCCCCceecccccccccccccc--------cCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhh
Q 044366 798 FAKFLEPHSSNWTEFAGTVGYAAPELAY--------TMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEV 869 (918)
Q Consensus 798 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~--------~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~ 869 (918)
+++....... .....||+.|+|||++. +..++.++|||||||++|||++|+.||.................
T Consensus 162 ~a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~ 240 (319)
T 4euu_A 162 AARELEDDEQ-FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKII 240 (319)
T ss_dssp TCEECCTTCC-BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHH
T ss_pred CceecCCCCc-eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHh
Confidence 9987765433 34457899999999886 56789999999999999999999999853322111111111000
Q ss_pred hhh-----------------cccCCCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 044366 870 NQI-----------------LDHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLL 916 (918)
Q Consensus 870 ~~~-----------------~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L 916 (918)
... .....+............+.+++.+||+.||++|||++|+++..
T Consensus 241 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~ 304 (319)
T 4euu_A 241 TGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAET 304 (319)
T ss_dssp HHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHH
T ss_pred cCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhcc
Confidence 000 00112222233345667789999999999999999999999864
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=357.44 Aligned_cols=257 Identities=25% Similarity=0.365 Sum_probs=200.4
Q ss_pred hcCCCCceeeccccceEEEEEEeCCCCEEEEEEcccccccCCCCChHHHHHHHHHHhh--ccCCceeeEeccccc----C
Q 044366 645 TGNFGEKYCIGKGGQRSVYKAELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTE--IRHRNIIKFHGFCSN----A 718 (918)
Q Consensus 645 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~~~~~~~~----~ 718 (918)
.++|...+.||+|+||.||+|+. +|+.||||++... ....+.+|.+++.. ++||||+++++++.. .
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~-------~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~ 78 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR-------DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSS 78 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG-------GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc-------cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCC
Confidence 46899999999999999999987 7899999998642 24566777777766 799999999998643 3
Q ss_pred CceEEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHH--------hCCCCCeEEcCCCCCCeeeCCCCc
Q 044366 719 QHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLH--------HDCIPPIVHRDISSKNVLLDSEYE 790 (918)
Q Consensus 719 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH--------~~~~~~ivH~dlk~~Nill~~~~~ 790 (918)
...++||||+++|+|.++++.. .+++..+++++.|++.||+||| +. +|+||||||+||+++.++.
T Consensus 79 ~~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~Nill~~~~~ 151 (301)
T 3q4u_A 79 TQLWLITHYHEMGSLYDYLQLT----TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP---AIAHRDLKSKNILVKKNGQ 151 (301)
T ss_dssp EEEEEEECCCTTCBHHHHHTTC----CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC---EEECSCCCGGGEEECTTSC
T ss_pred ceeEEehhhccCCCHHHHHhhc----ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC---CeecCCCChHhEEEcCCCC
Confidence 5689999999999999999643 4899999999999999999999 77 9999999999999999999
Q ss_pred EEEeccccccccCCCCCC----ceecccccccccccccccC------CCCcccchhhHHHHHHHHHhC----------CC
Q 044366 791 AHVSDFGFAKFLEPHSSN----WTEFAGTVGYAAPELAYTM------RATEKYDVYSFGVLALEVIKG----------YH 850 (918)
Q Consensus 791 ~kl~DfG~~~~~~~~~~~----~~~~~g~~~y~aPE~~~~~------~~~~~~Dv~slG~vl~el~tg----------~~ 850 (918)
+||+|||+++........ .....||+.|+|||++.+. .++.++||||||+++|||++| +.
T Consensus 152 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~ 231 (301)
T 3q4u_A 152 CCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKP 231 (301)
T ss_dssp EEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCC
T ss_pred EEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccc
Confidence 999999999876544332 2234789999999999876 455799999999999999999 77
Q ss_pred CCCcchhhhhhhhhhHhhhhhhcccCCCCCCc--chHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhC
Q 044366 851 PGDFVSTIFSSISNMIIEVNQILDHRLPTPSR--DVTDKLRSIMEVAILCLVENPEARPTMKEVCNLLCK 918 (918)
Q Consensus 851 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~ 918 (918)
||................ .. .....+..+. ........+.+++.+||+.||++|||++|+++.|++
T Consensus 232 pf~~~~~~~~~~~~~~~~-~~-~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~ 299 (301)
T 3q4u_A 232 PFYDVVPNDPSFEDMRKV-VC-VDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTK 299 (301)
T ss_dssp TTTTTSCSSCCHHHHHHH-HT-TSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHH
T ss_pred cccccCCCCcchhhhhHH-Hh-ccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhc
Confidence 764332211111111111 11 1111111111 123456789999999999999999999999999863
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=373.41 Aligned_cols=256 Identities=22% Similarity=0.310 Sum_probs=208.1
Q ss_pred HHhcCCCCceeeccccceEEEEEE-eCCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCce
Q 044366 643 KATGNFGEKYCIGKGGQRSVYKAE-LPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHS 721 (918)
Q Consensus 643 ~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 721 (918)
...++|...+.||+|+||.||+|. ..+|+.||+|++...... ....+.+.+|+++++.++||||+++++++.+++..
T Consensus 8 ~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 85 (444)
T 3soa_A 8 RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLS--ARDHQKLEREARICRLLKHPNIVRLHDSISEEGHH 85 (444)
T ss_dssp HHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCH--HHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEE
T ss_pred cccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCC--HHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEE
Confidence 345779999999999999999995 457999999998754221 12246789999999999999999999999999999
Q ss_pred EEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeC---CCCcEEEecccc
Q 044366 722 FIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLD---SEYEAHVSDFGF 798 (918)
Q Consensus 722 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~---~~~~~kl~DfG~ 798 (918)
++||||+++|+|.+++.... .+++.++..++.||+.||+|||+. +|+||||||+||+++ .++.+||+|||+
T Consensus 86 ~lv~E~~~gg~L~~~i~~~~---~~~e~~~~~i~~qil~aL~~lH~~---givHrDlKp~NIll~~~~~~~~vkL~DFG~ 159 (444)
T 3soa_A 86 YLIFDLVTGGELFEDIVARE---YYSEADASHCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGL 159 (444)
T ss_dssp EEEECCCBCCBHHHHHHHCS---CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSSTTEEESBSSTTCCEEECCCSS
T ss_pred EEEEEeCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEeccCCCCcEEEccCce
Confidence 99999999999999997643 489999999999999999999999 999999999999998 457899999999
Q ss_pred ccccCCCCCCceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCC
Q 044366 799 AKFLEPHSSNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLP 878 (918)
Q Consensus 799 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 878 (918)
+..............||+.|+|||++.+..++.++||||+||++|+|++|+.||...... .. . ..+......
T Consensus 160 a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~-~~----~---~~i~~~~~~ 231 (444)
T 3soa_A 160 AIEVEGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQH-RL----Y---QQIKAGAYD 231 (444)
T ss_dssp CBCCCTTCCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-HH----H---HHHHHTCCC
T ss_pred eEEecCCCceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHH-HH----H---HHHHhCCCC
Confidence 988776555555678999999999999989999999999999999999999998654321 01 1 111111111
Q ss_pred CCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 879 TPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 879 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
.+..........+.+++.+||+.||++|||++|+++
T Consensus 232 ~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~ 267 (444)
T 3soa_A 232 FPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALK 267 (444)
T ss_dssp CCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CCccccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 111122223356888999999999999999999986
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=360.21 Aligned_cols=251 Identities=20% Similarity=0.278 Sum_probs=206.8
Q ss_pred hcCCCCceeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEE
Q 044366 645 TGNFGEKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFI 723 (918)
Q Consensus 645 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 723 (918)
.++|...+.||+|+||.||+|.. .+|+.||+|.+... ......+.+|+++++.++||||+++++++.+.+..++
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~-----~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 78 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-----GTDQVLVKKEISILNIARHRNILHLHESFESMEELVM 78 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-----THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEE
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC-----cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEE
Confidence 46789999999999999999965 46889999998642 2234678999999999999999999999999999999
Q ss_pred EEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCC--CCcEEEeccccccc
Q 044366 724 VCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDS--EYEAHVSDFGFAKF 801 (918)
Q Consensus 724 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~--~~~~kl~DfG~~~~ 801 (918)
||||+++|+|.+++... ...+++.+++.++.|++.||+|||+. +|+||||||+||+++. ++.+||+|||++..
T Consensus 79 v~e~~~g~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~---givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~ 153 (321)
T 1tki_A 79 IFEFISGLDIFERINTS--AFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQ 153 (321)
T ss_dssp EECCCCCCBHHHHHTSS--SCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEE
T ss_pred EEEeCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEccCCCCCEEEEECCCCeE
Confidence 99999999999999754 23589999999999999999999999 9999999999999987 78999999999988
Q ss_pred cCCCCCCceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCCCCC
Q 044366 802 LEPHSSNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPS 881 (918)
Q Consensus 802 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 881 (918)
..+. .......||+.|+|||++.+..++.++||||+||++|+|++|..||...... . ....+.........
T Consensus 154 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-~-------~~~~i~~~~~~~~~ 224 (321)
T 1tki_A 154 LKPG-DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ-Q-------IIENIMNAEYTFDE 224 (321)
T ss_dssp CCTT-CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH-H-------HHHHHHHTCCCCCH
T ss_pred CCCC-CccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHH-H-------HHHHHHcCCCCCCh
Confidence 7643 3345567899999999999888899999999999999999999998654321 1 11111122222111
Q ss_pred cchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 882 RDVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 882 ~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
.........+.+++.+|++.||++|||+.|+++
T Consensus 225 ~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~ 257 (321)
T 1tki_A 225 EAFKEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp HHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred hhhccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 111223456889999999999999999999986
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=362.21 Aligned_cols=254 Identities=28% Similarity=0.444 Sum_probs=202.9
Q ss_pred hcCCCCceeeccccceEEEEEEeC----CCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCc
Q 044366 645 TGNFGEKYCIGKGGQRSVYKAELP----SGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQH 720 (918)
Q Consensus 645 ~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 720 (918)
.++|.+.+.||+|+||.||+|... .+..||||+++... .....+.|.+|+++++.++||||+++++++.+++.
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 124 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY---TERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRL 124 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTC---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGC
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCC---CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCc
Confidence 356888899999999999999763 34569999987532 22235679999999999999999999999999999
Q ss_pred eEEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEecccccc
Q 044366 721 SFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAK 800 (918)
Q Consensus 721 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~ 800 (918)
.++||||+++|+|.++++.. ...+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++
T Consensus 125 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 199 (325)
T 3kul_A 125 AMIVTEYMENGSLDTFLRTH--DGQFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVCKVSDFGLSR 199 (325)
T ss_dssp CEEEEECCTTCBHHHHHHTT--TTCSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCSSCE
T ss_pred cEEEeeCCCCCcHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEECCCCCEEECCCCccc
Confidence 99999999999999999754 24589999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCCc---eecccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhhhhhhhhhHhhhhhhcccC
Q 044366 801 FLEPHSSNW---TEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIK-GYHPGDFVSTIFSSISNMIIEVNQILDHR 876 (918)
Q Consensus 801 ~~~~~~~~~---~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 876 (918)
......... ....+|+.|+|||++.+..++.++||||||+++|||++ |+.||...... ......... ..
T Consensus 200 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~-----~~~~~~~~~--~~ 272 (325)
T 3kul_A 200 VLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNR-----DVISSVEEG--YR 272 (325)
T ss_dssp ECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHH-----HHHHHHHTT--CC
T ss_pred ccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHH-----HHHHHHHcC--CC
Confidence 775443221 22345778999999998899999999999999999999 99998654321 011111111 11
Q ss_pred CCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 044366 877 LPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLLC 917 (918)
Q Consensus 877 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 917 (918)
.+. ... ....+.+++.+||+.||++|||++|+++.|+
T Consensus 273 ~~~-~~~---~~~~l~~li~~~l~~dp~~Rps~~eil~~L~ 309 (325)
T 3kul_A 273 LPA-PMG---CPHALHQLMLDCWHKDRAQRPRFSQIVSVLD 309 (325)
T ss_dssp CCC-CTT---CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCC-CCC---cCHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 111 111 2346888999999999999999999999986
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-40 Score=355.16 Aligned_cols=262 Identities=19% Similarity=0.304 Sum_probs=203.3
Q ss_pred HhcCCCCceeeccccceEEEEEEeCCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEE
Q 044366 644 ATGNFGEKYCIGKGGQRSVYKAELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFI 723 (918)
Q Consensus 644 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 723 (918)
..++|...+.||+|+||.||+|+..+|+.||+|++.... ......+.+.+|++++++++||||+++++++.+++..++
T Consensus 19 l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 96 (311)
T 3niz_A 19 LMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDA--EDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTL 96 (311)
T ss_dssp SSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC--------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEE
T ss_pred hHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEeccc--ccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEE
Confidence 347899999999999999999988889999999987542 122234678999999999999999999999999999999
Q ss_pred EEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccC
Q 044366 724 VCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLE 803 (918)
Q Consensus 724 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~ 803 (918)
||||+++ +|.+++.... ..+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 97 v~e~~~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~ 170 (311)
T 3niz_A 97 VFEFMEK-DLKKVLDENK--TGLQDSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFG 170 (311)
T ss_dssp EEECCSE-EHHHHHHTCT--TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEETT
T ss_pred EEcCCCC-CHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCchHhEEECCCCCEEEccCcCceecC
Confidence 9999985 8888886542 4589999999999999999999999 99999999999999999999999999999876
Q ss_pred CCCCCceeccccccccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhh----------
Q 044366 804 PHSSNWTEFAGTVGYAAPELAYT-MRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQI---------- 872 (918)
Q Consensus 804 ~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~---------- 872 (918)
..........||+.|+|||++.+ ..++.++||||+||++|||++|+.||....... ............
T Consensus 171 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~ 249 (311)
T 3niz_A 171 IPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDD-QLPKIFSILGTPNPREWPQVQE 249 (311)
T ss_dssp SCCC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTT-HHHHHHHHHCCCCTTTSGGGTT
T ss_pred CCcccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHHCCCChHHhhhhhc
Confidence 55555556678999999999876 568999999999999999999999986543211 111110000000
Q ss_pred ----cccCCCCCCcc-h----HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 873 ----LDHRLPTPSRD-V----TDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 873 ----~~~~~~~~~~~-~----~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
........... . .....++.+++.+||+.||++|||++|+++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 250 LPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp SHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred cchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 00000000000 0 012246789999999999999999999986
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-40 Score=347.23 Aligned_cols=254 Identities=25% Similarity=0.402 Sum_probs=208.7
Q ss_pred HhcCCCCceeeccccceEEEEEEeCCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEE
Q 044366 644 ATGNFGEKYCIGKGGQRSVYKAELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFI 723 (918)
Q Consensus 644 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 723 (918)
..++|...+.||+|+||.||+|+..+++.||+|+++.. ....+++.+|++++++++||||+++++++.+++..++
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~-----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 80 (268)
T 3sxs_A 6 KREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEG-----SMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYI 80 (268)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBT-----TBCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEE
T ss_pred chhheeeeeeeccCCCceEEEEEecCceeEEEEEeccC-----CCcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEE
Confidence 34678899999999999999999888889999998653 2345789999999999999999999999999999999
Q ss_pred EEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccC
Q 044366 724 VCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLE 803 (918)
Q Consensus 724 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~ 803 (918)
||||+++++|.+++... ...+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++....
T Consensus 81 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~ 155 (268)
T 3sxs_A 81 VTEYISNGCLLNYLRSH--GKGLEPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVL 155 (268)
T ss_dssp EEECCTTCBHHHHHHHH--GGGCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCSGGGEEECTTCCEEECCTTCEEECC
T ss_pred EEEccCCCcHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCcceEEECCCCCEEEccCccceecc
Confidence 99999999999999764 23589999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCC-ceecccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhhhhhhhhhHhhhhhhcccCCCCCC
Q 044366 804 PHSSN-WTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIK-GYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPS 881 (918)
Q Consensus 804 ~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 881 (918)
..... .....+++.|+|||.+.+..++.++||||+|+++|||++ |+.||+...... ..... ........+
T Consensus 156 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~-----~~~~~---~~~~~~~~~ 227 (268)
T 3sxs_A 156 DDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSE-----VVLKV---SQGHRLYRP 227 (268)
T ss_dssp TTCEEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHH-----HHHHH---HTTCCCCCC
T ss_pred hhhhhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHH-----HHHHH---HcCCCCCCC
Confidence 43321 123345678999999998889999999999999999999 999986543211 11111 111111111
Q ss_pred cchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhC
Q 044366 882 RDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLLCK 918 (918)
Q Consensus 882 ~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~ 918 (918)
... ...+.+++.+||+.||++|||++|+++.|++
T Consensus 228 ~~~---~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~ 261 (268)
T 3sxs_A 228 HLA---SDTIYQIMYSCWHELPEKRPTFQQLLSSIEP 261 (268)
T ss_dssp TTS---CHHHHHHHHHTTCSSGGGSCCHHHHHHHHGG
T ss_pred CcC---hHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 111 2457889999999999999999999999863
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-40 Score=354.05 Aligned_cols=259 Identities=24% Similarity=0.331 Sum_probs=204.1
Q ss_pred hcCCCCceeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEE
Q 044366 645 TGNFGEKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFI 723 (918)
Q Consensus 645 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 723 (918)
.++|.+.+.||+|+||.||+|+. .+++.||+|++...... .....+.|.+|+.+++.++||||+++++++.+++..++
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 88 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPRE-KEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYL 88 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSC-CHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccc-cHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEE
Confidence 46799999999999999999964 57999999998653221 22234678999999999999999999999999999999
Q ss_pred EEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccC
Q 044366 724 VCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLE 803 (918)
Q Consensus 724 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~ 803 (918)
||||+++|+|.+++.... .+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++....
T Consensus 89 v~e~~~g~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 162 (294)
T 4eqm_A 89 VMEYIEGPTLSEYIESHG---PLSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALS 162 (294)
T ss_dssp EEECCCSCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCSSSTTC-
T ss_pred EEeCCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEEeCCCccccc
Confidence 999999999999997653 489999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCC-CceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCCCC-C
Q 044366 804 PHSS-NWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTP-S 881 (918)
Q Consensus 804 ~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~ 881 (918)
.... ......||+.|+|||.+.+..++.++||||+|+++|||++|+.||........... ......+.. .
T Consensus 163 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~--------~~~~~~~~~~~ 234 (294)
T 4eqm_A 163 ETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIK--------HIQDSVPNVTT 234 (294)
T ss_dssp ------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHH--------HHSSCCCCHHH
T ss_pred cccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHH--------HhhccCCCcch
Confidence 4332 23345689999999999999999999999999999999999999875443211111 111111110 0
Q ss_pred cchHHHHHHHHHHHHHcccCCCCCCC-CHHHHHHHhhC
Q 044366 882 RDVTDKLRSIMEVAILCLVENPEARP-TMKEVCNLLCK 918 (918)
Q Consensus 882 ~~~~~~~~~l~~li~~cl~~dp~~RP-t~~evl~~L~~ 918 (918)
.........+.+++.+|++.||++|| +++++.+.|++
T Consensus 235 ~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~ 272 (294)
T 4eqm_A 235 DVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSS 272 (294)
T ss_dssp HSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHT
T ss_pred hcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHH
Confidence 00111235688899999999999999 89999888753
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-40 Score=357.07 Aligned_cols=255 Identities=21% Similarity=0.309 Sum_probs=206.9
Q ss_pred hcCCCCceeeccccceEEEEEEe-CCCCEEEEEEcccccccCC--CCChHHHHHHHHHHhhccCCceeeEecccccCCce
Q 044366 645 TGNFGEKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDE--TANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHS 721 (918)
Q Consensus 645 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 721 (918)
.++|...+.||+|+||.||+|.. .+|+.||+|++........ ....+.+.+|+.+++.++||||+++++++.+++..
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 89 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 89 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 35688999999999999999965 4799999999876433221 22467899999999999999999999999999999
Q ss_pred EEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCC----cEEEeccc
Q 044366 722 FIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEY----EAHVSDFG 797 (918)
Q Consensus 722 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~----~~kl~DfG 797 (918)
++||||+++|+|.+++... ..+++.+++.++.|++.||+|||+. +|+||||||+||+++.++ .+||+|||
T Consensus 90 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg 163 (326)
T 2y0a_A 90 ILILELVAGGELFDFLAEK---ESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFG 163 (326)
T ss_dssp EEEEECCCSCBHHHHHTTS---SCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEEcCCCCCHHHHHHhc---CCcCHHHHHHHHHHHHHHHHHHHHC---CeEcCCCCHHHEEEecCCCCCCCEEEEECC
Confidence 9999999999999999754 3589999999999999999999999 999999999999999887 79999999
Q ss_pred cccccCCCCCCceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCC
Q 044366 798 FAKFLEPHSSNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRL 877 (918)
Q Consensus 798 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 877 (918)
+++...... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...... .... .+.....
T Consensus 164 ~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-~~~~-------~~~~~~~ 234 (326)
T 2y0a_A 164 LAHKIDFGN-EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ-ETLA-------NVSAVNY 234 (326)
T ss_dssp TCEECCTTS-CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH-HHHH-------HHHHTCC
T ss_pred CCeECCCCC-ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHH-HHHH-------HHHhcCC
Confidence 998775432 234467999999999999889999999999999999999999998643321 1111 1111111
Q ss_pred CCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 878 PTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 878 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
.............+.+++.+||+.||++|||++|+++
T Consensus 235 ~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 271 (326)
T 2y0a_A 235 EFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 271 (326)
T ss_dssp CCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred CcCccccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 1111111122356789999999999999999999986
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=362.21 Aligned_cols=265 Identities=26% Similarity=0.365 Sum_probs=203.5
Q ss_pred HhcCCCCceeeccccceEEEEEEeCCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCC----
Q 044366 644 ATGNFGEKYCIGKGGQRSVYKAELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQ---- 719 (918)
Q Consensus 644 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~---- 719 (918)
..++|...+.||+|+||.||+|+.. ++.||||++.... .....+..|+.++++++||||+++++++....
T Consensus 22 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~-----~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 95 (322)
T 3soc_A 22 QSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQD-----KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDV 95 (322)
T ss_dssp TTEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGG-----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSE
T ss_pred chhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCc-----hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCc
Confidence 3467899999999999999999874 7999999986531 22345677888899999999999999997644
Q ss_pred ceEEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCC-------CCCeEEcCCCCCCeeeCCCCcEE
Q 044366 720 HSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDC-------IPPIVHRDISSKNVLLDSEYEAH 792 (918)
Q Consensus 720 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~-------~~~ivH~dlk~~Nill~~~~~~k 792 (918)
..++||||+++|+|.++++.. .+++.+++.++.|+++||+|||+.+ .++|+||||||+||+++.++.+|
T Consensus 96 ~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~k 171 (322)
T 3soc_A 96 DLWLITAFHEKGSLSDFLKAN----VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTAC 171 (322)
T ss_dssp EEEEEEECCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEE
T ss_pred eEEEEEecCCCCCHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEE
Confidence 369999999999999999763 3899999999999999999999862 23899999999999999999999
Q ss_pred EeccccccccCCCCCC--ceeccccccccccccccc-----CCCCcccchhhHHHHHHHHHhCCCCCCcchhhhh--hhh
Q 044366 793 VSDFGFAKFLEPHSSN--WTEFAGTVGYAAPELAYT-----MRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFS--SIS 863 (918)
Q Consensus 793 l~DfG~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~-----~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~--~~~ 863 (918)
|+|||+++........ .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||........ ...
T Consensus 172 L~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~ 251 (322)
T 3soc_A 172 IADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEE 251 (322)
T ss_dssp ECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHH
T ss_pred EccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhh
Confidence 9999999876544322 233578999999999876 3556789999999999999999999864322100 000
Q ss_pred -----hhHhhhh-hhcccCC-CCCCc--chHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhC
Q 044366 864 -----NMIIEVN-QILDHRL-PTPSR--DVTDKLRSIMEVAILCLVENPEARPTMKEVCNLLCK 918 (918)
Q Consensus 864 -----~~~~~~~-~~~~~~~-~~~~~--~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~ 918 (918)
....... ....... +.... ........+.+++.+||+.||++|||++|+++.|++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~ 315 (322)
T 3soc_A 252 EIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQ 315 (322)
T ss_dssp HHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred hhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 0000111 1111111 11111 122345679999999999999999999999999863
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-40 Score=348.37 Aligned_cols=252 Identities=23% Similarity=0.373 Sum_probs=207.5
Q ss_pred hcCCCCceeeccccceEEEEEEeCCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEEE
Q 044366 645 TGNFGEKYCIGKGGQRSVYKAELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFIV 724 (918)
Q Consensus 645 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 724 (918)
.++|...+.||+|+||.||+|...+++.||+|++... ....+++.+|++++++++||||+++++++.+++..++|
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~-----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG-----AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLV 83 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTT-----SBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEE
T ss_pred hhhceeeheecCCCccEEEEEEecCCCeEEEEEeccc-----ccCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEE
Confidence 3578888999999999999998888999999998753 23457899999999999999999999999999999999
Q ss_pred EEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccCC
Q 044366 725 CEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEP 804 (918)
Q Consensus 725 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~~ 804 (918)
|||+++|+|.+++.... ..+++.+++.++.|+++||+|||+. +|+||||||+||+++.++.+||+|||++.....
T Consensus 84 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 158 (269)
T 4hcu_A 84 FEFMEHGCLSDYLRTQR--GLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD 158 (269)
T ss_dssp EECCTTCBHHHHHHTTT--TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCEEECCTTGGGGBCC
T ss_pred EEeCCCCcHHHHHHhcC--cccCHHHHHHHHHHHHHHHHHHHhC---CeecCCcchheEEEcCCCCEEeccccccccccc
Confidence 99999999999997643 4589999999999999999999999 999999999999999999999999999987643
Q ss_pred CCC-CceecccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhhhhhhhhhHhhhhhhcccCCCCCCc
Q 044366 805 HSS-NWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIK-GYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSR 882 (918)
Q Consensus 805 ~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 882 (918)
... ......+++.|+|||.+.+..++.++||||+|+++|||++ |+.||...... ........ ......+.
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~-----~~~~~~~~---~~~~~~~~ 230 (269)
T 4hcu_A 159 DQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS-----EVVEDIST---GFRLYKPR 230 (269)
T ss_dssp HHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-----HHHHHHHT---TCCCCCCT
T ss_pred cccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHH-----HHHHHHhc---CccCCCCC
Confidence 221 1223456778999999999999999999999999999999 99998654321 11111111 11111111
Q ss_pred chHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 044366 883 DVTDKLRSIMEVAILCLVENPEARPTMKEVCNLLC 917 (918)
Q Consensus 883 ~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 917 (918)
.. ...+.+++.+||+.||++|||++|+++.|+
T Consensus 231 ~~---~~~~~~li~~~l~~~p~~Rps~~~ll~~l~ 262 (269)
T 4hcu_A 231 LA---STHVYQIMNHCWRERPEDRPAFSRLLRQLA 262 (269)
T ss_dssp TS---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred cC---CHHHHHHHHHHccCCcccCcCHHHHHHHHH
Confidence 11 245788999999999999999999999986
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-40 Score=347.56 Aligned_cols=257 Identities=24% Similarity=0.377 Sum_probs=194.9
Q ss_pred hcCCCCceeeccccceEEEEEEeCCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEEE
Q 044366 645 TGNFGEKYCIGKGGQRSVYKAELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFIV 724 (918)
Q Consensus 645 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 724 (918)
.++|...+.||+|+||.||+|.. .|+.||||+++...........+.+.+|+++++.++||||+++++++.+++..++|
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV 84 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEE-TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred hhheeeeeeeccCCCeEEEEEEE-cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence 36788899999999999999987 48999999987654444445567899999999999999999999999999999999
Q ss_pred EEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCC--------CCcEEEecc
Q 044366 725 CEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDS--------EYEAHVSDF 796 (918)
Q Consensus 725 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~--------~~~~kl~Df 796 (918)
|||+++++|.+++.. ..+++.+++.++.|+++||+|||+....+|+||||||+||+++. ++.+||+||
T Consensus 85 ~e~~~~~~L~~~~~~----~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Df 160 (271)
T 3dtc_A 85 MEFARGGPLNRVLSG----KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDF 160 (271)
T ss_dssp EECCTTEEHHHHHTS----SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCC
T ss_pred EEcCCCCCHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccC
Confidence 999999999999864 34899999999999999999999992222999999999999986 678999999
Q ss_pred ccccccCCCCCCceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccC
Q 044366 797 GFAKFLEPHSSNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHR 876 (918)
Q Consensus 797 G~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 876 (918)
|++........ ....|++.|+|||.+.+..++.++||||+|+++|+|++|+.||.......... .......
T Consensus 161 g~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~-------~~~~~~~ 231 (271)
T 3dtc_A 161 GLAREWHRTTK--MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAY-------GVAMNKL 231 (271)
T ss_dssp CC---------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHH-------HHHTSCC
T ss_pred Ccccccccccc--cCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH-------hhhcCCC
Confidence 99987654322 24578999999999999899999999999999999999999987543221110 0000111
Q ss_pred CCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhC
Q 044366 877 LPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLLCK 918 (918)
Q Consensus 877 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~ 918 (918)
....... ....+.+++.+||+.||++|||+.|+++.|++
T Consensus 232 ~~~~~~~---~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~ 270 (271)
T 3dtc_A 232 ALPIPST---CPEPFAKLMEDCWNPDPHSRPSFTNILDQLTT 270 (271)
T ss_dssp CCCCCTT---CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC
T ss_pred CCCCCcc---cCHHHHHHHHHHhcCCcccCcCHHHHHHHHhc
Confidence 1111111 22468889999999999999999999999874
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=357.47 Aligned_cols=251 Identities=18% Similarity=0.348 Sum_probs=202.7
Q ss_pred hcCCCCceeeccccceEEEEEEeC-CCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCC----
Q 044366 645 TGNFGEKYCIGKGGQRSVYKAELP-SGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQ---- 719 (918)
Q Consensus 645 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~---- 719 (918)
.++|+..+.||+|+||.||+|+.. +|+.||||+++... .....+.+.+|++++++++||||+++++++.+..
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 81 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN---RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKW 81 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS---TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC---chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchh
Confidence 457889999999999999999765 89999999987532 3334578999999999999999999999875433
Q ss_pred -----------------------------------------------------ceEEEEEeccCCChhHHhhcccccCCC
Q 044366 720 -----------------------------------------------------HSFIVCEYLARGSLTTILRDDAAAKEF 746 (918)
Q Consensus 720 -----------------------------------------------------~~~lv~e~~~~gsL~~~l~~~~~~~~l 746 (918)
..++||||+++|+|.+++.........
T Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~ 161 (332)
T 3qd2_B 82 QEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDR 161 (332)
T ss_dssp HHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGS
T ss_pred hhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccch
Confidence 379999999999999999887666667
Q ss_pred CHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccCCCCC------------Cceeccc
Q 044366 747 SWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSS------------NWTEFAG 814 (918)
Q Consensus 747 ~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~~~~~------------~~~~~~g 814 (918)
++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++....... ......|
T Consensus 162 ~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~g 238 (332)
T 3qd2_B 162 EHGVCLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVG 238 (332)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-
T ss_pred hhHHHHHHHHHHHHHHHHHHhC---CeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCC
Confidence 8888999999999999999999 999999999999999999999999999988765421 1233568
Q ss_pred ccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCCCCCcchHHHHHHHHHH
Q 044366 815 TVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRDVTDKLRSIMEV 894 (918)
Q Consensus 815 ~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 894 (918)
|+.|+|||++.+..++.++||||+|+++|||++|..|+..... . ......... +.........+.++
T Consensus 239 t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~~~-------~---~~~~~~~~~---~~~~~~~~~~~~~l 305 (332)
T 3qd2_B 239 TKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERVR-------I---ITDVRNLKF---PLLFTQKYPQEHMM 305 (332)
T ss_dssp CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHHHH-------H---HHHHHTTCC---CHHHHHHCHHHHHH
T ss_pred CcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHHHH-------H---HHHhhccCC---CcccccCChhHHHH
Confidence 9999999999999999999999999999999999877321111 0 111111111 12233445677899
Q ss_pred HHHcccCCCCCCCCHHHHHH
Q 044366 895 AILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 895 i~~cl~~dp~~RPt~~evl~ 914 (918)
+.+||+.||++|||++|+++
T Consensus 306 i~~~l~~~p~~Rps~~~~l~ 325 (332)
T 3qd2_B 306 VQDMLSPSPTERPEATDIIE 325 (332)
T ss_dssp HHHHHCSSGGGSCCHHHHHH
T ss_pred HHHHccCCCCcCCCHHHHhh
Confidence 99999999999999999986
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-40 Score=358.70 Aligned_cols=254 Identities=26% Similarity=0.344 Sum_probs=202.1
Q ss_pred hcCCCCceeeccccceEEEEEEeC-CCCEEEEEEcccccccCCCCChHHHHHHHHHHhhc-cCCceeeEecccccCCceE
Q 044366 645 TGNFGEKYCIGKGGQRSVYKAELP-SGNIFAVKKFKAELFSDETANPSEFLNEVLALTEI-RHRNIIKFHGFCSNAQHSF 722 (918)
Q Consensus 645 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~ 722 (918)
.++|...+.||+|+||.||+|+.. +|+.||+|+++...... ....+.+.+|..+++++ +||||+++++++.+.+..+
T Consensus 8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~ 86 (345)
T 3a8x_A 8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVND-DEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLF 86 (345)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCS-HHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcc-hHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEE
Confidence 357889999999999999999664 68999999997643222 22245688999999888 8999999999999999999
Q ss_pred EEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEecccccccc
Q 044366 723 IVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFL 802 (918)
Q Consensus 723 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~ 802 (918)
+||||+++|+|.+++... ..+++..++.++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus 87 lv~e~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~ 160 (345)
T 3a8x_A 87 FVIEYVNGGDLMFHMQRQ---RKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEG 160 (345)
T ss_dssp EEECCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCGGGCBCS
T ss_pred EEEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEEeccccccc
Confidence 999999999999999764 3489999999999999999999999 9999999999999999999999999999875
Q ss_pred CCCCCCceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhH-hhhhhhcccCCCCCC
Q 044366 803 EPHSSNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMI-IEVNQILDHRLPTPS 881 (918)
Q Consensus 803 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 881 (918)
...........||+.|+|||++.+..++.++||||+||++|||++|+.||.............. .....+.......+
T Consensus 161 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p- 239 (345)
T 3a8x_A 161 LRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIP- 239 (345)
T ss_dssp CCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCCCC-
T ss_pred cCCCCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCCCC-
Confidence 4444445567899999999999999999999999999999999999999864321110000000 01111112222111
Q ss_pred cchHHHHHHHHHHHHHcccCCCCCCCCH
Q 044366 882 RDVTDKLRSIMEVAILCLVENPEARPTM 909 (918)
Q Consensus 882 ~~~~~~~~~l~~li~~cl~~dp~~RPt~ 909 (918)
.. ....+.+++.+||+.||++||++
T Consensus 240 ~~---~s~~~~~li~~lL~~dP~~R~~~ 264 (345)
T 3a8x_A 240 RS---LSVKAASVLKSFLNKDPKERLGC 264 (345)
T ss_dssp TT---SCHHHHHHHHHHTCSSTTTSTTC
T ss_pred CC---CCHHHHHHHHHHhcCCHhHCCCC
Confidence 11 22457889999999999999995
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-39 Score=369.40 Aligned_cols=328 Identities=23% Similarity=0.217 Sum_probs=295.7
Q ss_pred CCEEeCCCCcccccCCccccCCCCCCEEEcccccccccCCCCcCCCCCCCEEEcccccccccCCccccCCCCCCEEEccC
Q 044366 23 LQYLDLGNNQLSGVIPPEIGKLNQLRRLYLDVNQLHGTIPPVIGQLSLINELVFCHNNVSGRIPSSLGNLSNLALLYLND 102 (918)
Q Consensus 23 L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~l~~l~~L~~L~L~~ 102 (918)
-+.++.++++++ .+|..+. +++++|+|++|++++..|..|..+++|++|++++|.+++..|..|.++++|++|+|++
T Consensus 13 ~~~v~c~~~~l~-~ip~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~ 89 (477)
T 2id5_A 13 DRAVLCHRKRFV-AVPEGIP--TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRS 89 (477)
T ss_dssp TTEEECCSCCCS-SCCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCS
T ss_pred CCEEEeCCCCcC-cCCCCCC--CCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCC
Confidence 357888888887 6777664 5889999999999877788899999999999999999888888999999999999999
Q ss_pred CcccccCccccCCCCCCCEEECcCCcCCCcCCcCCCCCCCCceeeccccccccCCCcccccccccCeeeccccccCCcCC
Q 044366 103 NSLFGSIPIVMGNLKSLSTLDLSQNQLNGSIPCSLDNLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSENRLSGLIP 182 (918)
Q Consensus 103 n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~ 182 (918)
|++....+..|.++++|++|+|++|++++..+..|.++++|++|++++|.++++.+..|.++++|++|++++|+++++.+
T Consensus 90 n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~ 169 (477)
T 2id5_A 90 NRLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPT 169 (477)
T ss_dssp SCCCSCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEECCTTCCEECTTSSTTCTTCCEEEEESCCCSSCCH
T ss_pred CcCCccCcccccCCCCCCEEECCCCccccCChhHccccccCCEEECCCCccceeChhhccCCCCCCEEECCCCcCcccCh
Confidence 99987777788899999999999999998888889999999999999999998888899999999999999999998877
Q ss_pred ccCCCCCCCcEeeccCcccccCCCccccCCCCcceeecccccccCCCCCCCcCCCcCCeEEcccCcCcCCCCccccccCC
Q 044366 183 LSLSNLSSLTVMSLFNNSLSGSIPPILGNLKSLSTLGLHINQLNGVIPPSIGNLSSLRNLSLFNNRLYGFVPKEIGYLKS 262 (918)
Q Consensus 183 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~ 262 (918)
..|..+++|+.|++++|.+.+..+..|..+++|+.|++++|...+..+..+....+|++|++++|+++.+.+..+..+++
T Consensus 170 ~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~ 249 (477)
T 2id5_A 170 EALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVY 249 (477)
T ss_dssp HHHTTCTTCCEEEEESCCCCEECTTCSCSCTTCCEEEEECCTTCCEECTTTTTTCCCSEEEEESSCCCSCCHHHHTTCTT
T ss_pred hHhcccCCCcEEeCCCCcCcEeChhhcccCcccceeeCCCCccccccCcccccCccccEEECcCCcccccCHHHhcCccc
Confidence 78899999999999999999888888999999999999998877666666666679999999999999877778999999
Q ss_pred CCeEecCCCccCCcCCCcCCCCCCCcEEEccCCcCcCCCCccccCCCCCCeEEeecccccCccccccCCCCCccEEeCCC
Q 044366 263 LSKLEFCANHLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLRNLTSLERVRFNQNNLYGKVYEAFGDHPNLTFLDLSQ 342 (918)
Q Consensus 263 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~ 342 (918)
|+.|++++|++.+..+..|..+++|+.|++++|++.+..|..|.++++|++|++++|.+..++...|..+++|+.|++++
T Consensus 250 L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~ 329 (477)
T 2id5_A 250 LRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDS 329 (477)
T ss_dssp CCEEECCSSCCCEECTTSCTTCTTCCEEECCSSCCSEECTTTBTTCTTCCEEECCSSCCSCCCGGGBSCGGGCCEEECCS
T ss_pred cCeeECCCCcCCccChhhccccccCCEEECCCCccceECHHHhcCcccCCEEECCCCcCceeCHhHcCCCcccCEEEccC
Confidence 99999999999999888999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CccccccCccc
Q 044366 343 NNFYCEISFNW 353 (918)
Q Consensus 343 N~l~~~~~~~~ 353 (918)
|++.|+|...|
T Consensus 330 N~l~c~c~~~~ 340 (477)
T 2id5_A 330 NPLACDCRLLW 340 (477)
T ss_dssp SCEECSGGGHH
T ss_pred CCccCccchHh
Confidence 99999987655
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=361.97 Aligned_cols=253 Identities=23% Similarity=0.325 Sum_probs=201.6
Q ss_pred HHhcCCCCceeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhc-cCCceeeEecccccCCc
Q 044366 643 KATGNFGEKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEI-RHRNIIKFHGFCSNAQH 720 (918)
Q Consensus 643 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~ 720 (918)
...++|...+.||+|+||.||+|+. .+|+.||||+++...... ....+.+.+|..+++.+ +||||+++++++.+.+.
T Consensus 20 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~-~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~ 98 (353)
T 3txo_A 20 LGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQ-DDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDR 98 (353)
T ss_dssp ---CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHH-HTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred CchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcc-hhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCE
Confidence 3457899999999999999999965 468999999997643222 23356788999999988 79999999999999999
Q ss_pred eEEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEecccccc
Q 044366 721 SFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAK 800 (918)
Q Consensus 721 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~ 800 (918)
.++||||+++|+|.+++... ..+++.+++.++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++
T Consensus 99 ~~lv~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NILl~~~g~ikL~DFG~a~ 172 (353)
T 3txo_A 99 LFFVMEFVNGGDLMFHIQKS---RRFDEARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCK 172 (353)
T ss_dssp EEEEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred EEEEEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCCHHHEEECCCCCEEEcccccee
Confidence 99999999999999999764 3489999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCCceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCCCC
Q 044366 801 FLEPHSSNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTP 880 (918)
Q Consensus 801 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 880 (918)
............+||+.|+|||++.+..++.++||||+||++|||++|+.||...... . . ...+.......+
T Consensus 173 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~-~----~---~~~i~~~~~~~p 244 (353)
T 3txo_A 173 EGICNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENED-D----L---FEAILNDEVVYP 244 (353)
T ss_dssp CSCC---------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHH-H----H---HHHHHHCCCCCC
T ss_pred ecccCCccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHH-H----H---HHHHHcCCCCCC
Confidence 6554444455678999999999999989999999999999999999999998754321 1 1 111112222211
Q ss_pred CcchHHHHHHHHHHHHHcccCCCCCCCCH------HHHHH
Q 044366 881 SRDVTDKLRSIMEVAILCLVENPEARPTM------KEVCN 914 (918)
Q Consensus 881 ~~~~~~~~~~l~~li~~cl~~dp~~RPt~------~evl~ 914 (918)
. . ....+.+++.+|++.||++||++ +|+++
T Consensus 245 ~-~---~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 245 T-W---LHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp T-T---SCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred C-C---CCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 1 1 22457889999999999999998 66654
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=350.22 Aligned_cols=261 Identities=18% Similarity=0.287 Sum_probs=203.3
Q ss_pred cCCCCceeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEEE
Q 044366 646 GNFGEKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFIV 724 (918)
Q Consensus 646 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 724 (918)
++|+..+.||+|+||.||+|.. .+|+.||||+++... ......+.+.+|++++++++||||+++++++.+++..++|
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 79 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDD--DDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLV 79 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSC--SSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccC--CcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEE
Confidence 5788999999999999999965 478999999987642 2223357889999999999999999999999999999999
Q ss_pred EEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccCC
Q 044366 725 CEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEP 804 (918)
Q Consensus 725 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~~ 804 (918)
|||+++ ++.+++... ...+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.....
T Consensus 80 ~e~~~~-~l~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lH~~---~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 153 (292)
T 3o0g_A 80 FEFCDQ-DLKKYFDSC--NGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGI 153 (292)
T ss_dssp EECCSE-EHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCS
T ss_pred EecCCC-CHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecCC
Confidence 999986 666665543 24589999999999999999999999 999999999999999999999999999988765
Q ss_pred CCCCceecccccccccccccccCC-CCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCC------
Q 044366 805 HSSNWTEFAGTVGYAAPELAYTMR-ATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRL------ 877 (918)
Q Consensus 805 ~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~------ 877 (918)
.........||+.|+|||++.+.. ++.++||||+||++|||++|..|+........................+
T Consensus 154 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 233 (292)
T 3o0g_A 154 PVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKL 233 (292)
T ss_dssp CCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGS
T ss_pred ccccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhccc
Confidence 555556668899999999998766 7999999999999999999988853333222222211111000000000
Q ss_pred ------------CCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 878 ------------PTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 878 ------------~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
.............+.+++.+|++.||++|||++|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 282 (292)
T 3o0g_A 234 PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp TTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence 0000011123356789999999999999999999985
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=361.75 Aligned_cols=235 Identities=20% Similarity=0.199 Sum_probs=150.8
Q ss_pred CCccCCccCCCCCCCCEEeCCCCcccccCCccccCCCCCCEEEcccccccccCCCCcCCCCCCCEEEcccccccccCCcc
Q 044366 9 LFGNIPPQIGNLSKLQYLDLGNNQLSGVIPPEIGKLNQLRRLYLDVNQLHGTIPPVIGQLSLINELVFCHNNVSGRIPSS 88 (918)
Q Consensus 9 ~~~~~p~~~~~l~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~ 88 (918)
..+..|..++++++|++|+|++|++++ +| +++.+++|++|+|++|++++ +| ++.+++|++|++++|.+++. |
T Consensus 30 ~~~~~~~~~~~l~~L~~L~Ls~n~l~~-~~-~l~~l~~L~~L~Ls~n~l~~-~~--~~~l~~L~~L~Ls~N~l~~~-~-- 101 (457)
T 3bz5_A 30 MQATDTISEEQLATLTSLDCHNSSITD-MT-GIEKLTGLTKLICTSNNITT-LD--LSQNTNLTYLACDSNKLTNL-D-- 101 (457)
T ss_dssp CCTTSEEEHHHHTTCCEEECCSSCCCC-CT-TGGGCTTCSEEECCSSCCSC-CC--CTTCTTCSEEECCSSCCSCC-C--
T ss_pred cCcccccChhHcCCCCEEEccCCCccc-Ch-hhcccCCCCEEEccCCcCCe-Ec--cccCCCCCEEECcCCCCcee-e--
Confidence 344455567778888888888888874 45 67888888888888888774 44 67777777777777777743 3
Q ss_pred ccCCCCCCEEEccCCcccccCccccCCCCCCCEEECcCCcCCCcCCcCCCCCCCCceeeccccccccCCCcccccccccC
Q 044366 89 LGNLSNLALLYLNDNSLFGSIPIVMGNLKSLSTLDLSQNQLNGSIPCSLDNLSNLDTLFLYKNSLSGPIPSVIGNLKSLL 168 (918)
Q Consensus 89 l~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~ 168 (918)
++.+++|++|++++|++++. | +..+++|++|++++|++++. .++++++|++|++++|+..+.. .++.+++|+
T Consensus 102 ~~~l~~L~~L~L~~N~l~~l-~--~~~l~~L~~L~l~~N~l~~l---~l~~l~~L~~L~l~~n~~~~~~--~~~~l~~L~ 173 (457)
T 3bz5_A 102 VTPLTKLTYLNCDTNKLTKL-D--VSQNPLLTYLNCARNTLTEI---DVSHNTQLTELDCHLNKKITKL--DVTPQTQLT 173 (457)
T ss_dssp CTTCTTCCEEECCSSCCSCC-C--CTTCTTCCEEECTTSCCSCC---CCTTCTTCCEEECTTCSCCCCC--CCTTCTTCC
T ss_pred cCCCCcCCEEECCCCcCCee-c--CCCCCcCCEEECCCCcccee---ccccCCcCCEEECCCCCccccc--ccccCCcCC
Confidence 66777777777777777653 3 66777777777777777653 2666677777777777433232 356666666
Q ss_pred eeeccccccCCcCCccCCCCCCCcEeeccCcccccCCCccccCCCCcceeecccccccCCCCCCCcCCCcCCeEEcccCc
Q 044366 169 QLDLSENRLSGLIPLSLSNLSSLTVMSLFNNSLSGSIPPILGNLKSLSTLGLHINQLNGVIPPSIGNLSSLRNLSLFNNR 248 (918)
Q Consensus 169 ~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~ 248 (918)
+|++++|+++++ | +..+++|+.|++++|++++. .+..+++|++|++++|+++++ | +..+++|+.|++++|+
T Consensus 174 ~L~ls~n~l~~l-~--l~~l~~L~~L~l~~N~l~~~---~l~~l~~L~~L~Ls~N~l~~i-p--~~~l~~L~~L~l~~N~ 244 (457)
T 3bz5_A 174 TLDCSFNKITEL-D--VSQNKLLNRLNCDTNNITKL---DLNQNIQLTFLDCSSNKLTEI-D--VTPLTQLTYFDCSVNP 244 (457)
T ss_dssp EEECCSSCCCCC-C--CTTCTTCCEEECCSSCCSCC---CCTTCTTCSEEECCSSCCSCC-C--CTTCTTCSEEECCSSC
T ss_pred EEECCCCcccee-c--cccCCCCCEEECcCCcCCee---ccccCCCCCEEECcCCccccc-C--ccccCCCCEEEeeCCc
Confidence 666666666654 2 55666666666666666643 255666666666666666652 2 5555666666666666
Q ss_pred CcCCCCccccccCCCCeEecCCC
Q 044366 249 LYGFVPKEIGYLKSLSKLEFCAN 271 (918)
Q Consensus 249 l~~~~~~~~~~l~~L~~L~l~~n 271 (918)
+++.. +..+++|+.|++++|
T Consensus 245 l~~~~---~~~l~~L~~L~l~~n 264 (457)
T 3bz5_A 245 LTELD---VSTLSKLTTLHCIQT 264 (457)
T ss_dssp CSCCC---CTTCTTCCEEECTTC
T ss_pred CCCcC---HHHCCCCCEEeccCC
Confidence 65543 234455555555443
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=348.94 Aligned_cols=260 Identities=23% Similarity=0.310 Sum_probs=200.4
Q ss_pred cCCCCceeeccccceEEEEEEeCCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEEEE
Q 044366 646 GNFGEKYCIGKGGQRSVYKAELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFIVC 725 (918)
Q Consensus 646 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 725 (918)
++|...+.||+|+||.||+|+..+|+.||+|+++.... .....+.+.+|+++++.++||||+++++++.+++..++||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 79 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKE--DEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVF 79 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSG--GGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEE
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEecccc--ccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEE
Confidence 57888999999999999999878899999999875432 2233478899999999999999999999999999999999
Q ss_pred EeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccCCC
Q 044366 726 EYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPH 805 (918)
Q Consensus 726 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~~~ 805 (918)
||+++ +|.+++.... ..+++.+++.++.|+++||+|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 80 e~~~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 153 (288)
T 1ob3_A 80 EHLDQ-DLKKLLDVCE--GGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIP 153 (288)
T ss_dssp ECCSE-EHHHHHHTST--TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-
T ss_pred EecCC-CHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEeECccccccCcc
Confidence 99986 9999987542 4589999999999999999999999 9999999999999999999999999999877654
Q ss_pred CCCceecccccccccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhh-------------
Q 044366 806 SSNWTEFAGTVGYAAPELAYTM-RATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQ------------- 871 (918)
Q Consensus 806 ~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~------------- 871 (918)
........||+.|+|||++.+. .++.++||||+||++|||++|+.||....... ...........
T Consensus 154 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 232 (288)
T 1ob3_A 154 VRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEAD-QLMRIFRILGTPNSKNWPNVTELP 232 (288)
T ss_dssp --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCCCCTTTSTTGGGST
T ss_pred ccccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHHCCCChhhchhhhccc
Confidence 4444556789999999998764 58999999999999999999999987543211 11111000000
Q ss_pred hcccCCCCC-----CcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 872 ILDHRLPTP-----SRDVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 872 ~~~~~~~~~-----~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
..+...... ..........+.+++.+||+.||++|||++|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 280 (288)
T 1ob3_A 233 KYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (288)
T ss_dssp TCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 000000000 0000112356789999999999999999999985
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-40 Score=366.54 Aligned_cols=255 Identities=25% Similarity=0.394 Sum_probs=205.3
Q ss_pred HhcCCCCceeeccccceEEEEEEeC-CCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceE
Q 044366 644 ATGNFGEKYCIGKGGQRSVYKAELP-SGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSF 722 (918)
Q Consensus 644 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 722 (918)
..++|...+.||+|+||.||+|... +++.||||+++... .....++|.+|++++++++||||+++++++.+++..+
T Consensus 112 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 188 (377)
T 3cbl_A 112 NHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETL---PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIY 188 (377)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTS---CHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCE
T ss_pred chHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccC---CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcE
Confidence 3467888999999999999999765 79999999986531 1122356889999999999999999999999999999
Q ss_pred EEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEecccccccc
Q 044366 723 IVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFL 802 (918)
Q Consensus 723 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~ 802 (918)
+||||+++|+|.++++.. ...+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus 189 lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~ 263 (377)
T 3cbl_A 189 IVMELVQGGDFLTFLRTE--GARLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKISDFGMSREE 263 (377)
T ss_dssp EEEECCTTCBHHHHHHHH--GGGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred EEEEcCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CcCCcccCHHHEEEcCCCcEEECcCCCceec
Confidence 999999999999999764 23589999999999999999999999 9999999999999999999999999999865
Q ss_pred CCCCCCc--eecccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhhhhhhhhhHhhhhhhcccCCCC
Q 044366 803 EPHSSNW--TEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIK-GYHPGDFVSTIFSSISNMIIEVNQILDHRLPT 879 (918)
Q Consensus 803 ~~~~~~~--~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 879 (918)
....... ....+++.|+|||++.+..++.++|||||||++|||++ |..||...... .... .... ..+.+.
T Consensus 264 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~--~~~~---~~~~--~~~~~~ 336 (377)
T 3cbl_A 264 ADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQ--QTRE---FVEK--GGRLPC 336 (377)
T ss_dssp TTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHH--HHHH---HHHT--TCCCCC
T ss_pred CCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH--HHHH---HHHc--CCCCCC
Confidence 4321111 12235778999999998899999999999999999998 99998654321 1111 1111 111221
Q ss_pred CCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 044366 880 PSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLLC 917 (918)
Q Consensus 880 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 917 (918)
+ ... ...+.+++.+||+.||++|||++++++.|+
T Consensus 337 ~-~~~---~~~l~~li~~cl~~dP~~Rps~~~i~~~L~ 370 (377)
T 3cbl_A 337 P-ELC---PDAVFRLMEQCWAYEPGQRPSFSTIYQELQ 370 (377)
T ss_dssp C-TTC---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred C-CCC---CHHHHHHHHHHcCCCchhCcCHHHHHHHHH
Confidence 1 112 245788999999999999999999999886
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-40 Score=364.16 Aligned_cols=254 Identities=27% Similarity=0.459 Sum_probs=194.8
Q ss_pred hcCCCCceeeccccceEEEEEEeC----CCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCc
Q 044366 645 TGNFGEKYCIGKGGQRSVYKAELP----SGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQH 720 (918)
Q Consensus 645 ~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 720 (918)
..+|...+.||+|+||.||+|+.. ++..||||+++... .....++|.+|++++++++||||+++++++.+++.
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 120 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY---TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKP 120 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc---CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCc
Confidence 357899999999999999999764 57789999986531 22235679999999999999999999999999999
Q ss_pred eEEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEecccccc
Q 044366 721 SFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAK 800 (918)
Q Consensus 721 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~ 800 (918)
.++||||+++|+|.++++.. ...+++.+++.++.||++||+|||+. +|+||||||+||+++.++.+||+|||+++
T Consensus 121 ~~lv~e~~~~~sL~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 195 (373)
T 2qol_A 121 VMIVTEYMENGSLDSFLRKH--DAQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLGR 195 (373)
T ss_dssp CEEEEECCTTCBHHHHHHTT--TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC----
T ss_pred eEEEEeCCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEEcCCCCEEECcCcccc
Confidence 99999999999999999764 34589999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCC---ceecccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhhhhhhhhhHhhhhhhcccC
Q 044366 801 FLEPHSSN---WTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIK-GYHPGDFVSTIFSSISNMIIEVNQILDHR 876 (918)
Q Consensus 801 ~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 876 (918)
........ .....+++.|+|||++.+..++.++||||||+++|||++ |+.||...... . ........ .+
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~--~---~~~~i~~~--~~ 268 (373)
T 2qol_A 196 VLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQ--D---VIKAVDEG--YR 268 (373)
T ss_dssp ------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHH--H---HHHHHHTT--EE
T ss_pred ccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHH--H---HHHHHHcC--CC
Confidence 77543221 122335678999999999999999999999999999998 99998644321 1 11111111 11
Q ss_pred CCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 044366 877 LPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLLC 917 (918)
Q Consensus 877 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 917 (918)
.+.+ . .....+.+++.+||+.||++||+++||++.|+
T Consensus 269 ~~~~-~---~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~ 305 (373)
T 2qol_A 269 LPPP-M---DCPAALYQLMLDCWQKDRNNRPKFEQIVSILD 305 (373)
T ss_dssp CCCC-T---TCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCCC-c---cccHHHHHHHHHHhCcChhhCcCHHHHHHHHH
Confidence 1111 1 12346888999999999999999999999885
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=363.88 Aligned_cols=345 Identities=28% Similarity=0.422 Sum_probs=171.0
Q ss_pred CCCCCEEEccCCcccccCccccCCCCCCCEEECcCCcCCCcCCcCCCCCCCCceeeccccccccCCCcccccccccCeee
Q 044366 92 LSNLALLYLNDNSLFGSIPIVMGNLKSLSTLDLSQNQLNGSIPCSLDNLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLD 171 (918)
Q Consensus 92 l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 171 (918)
+++|+.|++++|.+.. .| .+..+++|++|+|++|.+++..+ +.++++|++|++++|.+++..+ ++.+++|++|+
T Consensus 45 l~~l~~L~l~~~~i~~-l~-~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~ 118 (466)
T 1o6v_A 45 LDQVTTLQADRLGIKS-ID-GVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTGLT 118 (466)
T ss_dssp HHTCCEEECCSSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG--GTTCTTCCEEE
T ss_pred hccccEEecCCCCCcc-Cc-chhhhcCCCEEECCCCccCCchh--hhccccCCEEECCCCccccChh--hcCCCCCCEEE
Confidence 3455555555555542 23 24455555555555555553322 5555555555555555554433 55555555555
Q ss_pred ccccccCCcCCccCCCCCCCcEeeccCcccccCCCccccCCCCcceeecccccccCCCCCCCcCCCcCCeEEcccCcCcC
Q 044366 172 LSENRLSGLIPLSLSNLSSLTVMSLFNNSLSGSIPPILGNLKSLSTLGLHINQLNGVIPPSIGNLSSLRNLSLFNNRLYG 251 (918)
Q Consensus 172 Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~ 251 (918)
+++|+++++.+ +..+++|++|++++|.+++. ..+..+++|++|+++ |.+.... .+.++++|+.|++++|.+++
T Consensus 119 L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~l~-~~~~~~~--~~~~l~~L~~L~l~~n~l~~ 191 (466)
T 1o6v_A 119 LFNNQITDIDP--LKNLTNLNRLELSSNTISDI--SALSGLTSLQQLSFG-NQVTDLK--PLANLTTLERLDISSNKVSD 191 (466)
T ss_dssp CCSSCCCCCGG--GTTCTTCSEEEEEEEEECCC--GGGTTCTTCSEEEEE-ESCCCCG--GGTTCTTCCEEECCSSCCCC
T ss_pred CCCCCCCCChH--HcCCCCCCEEECCCCccCCC--hhhccCCcccEeecC-CcccCch--hhccCCCCCEEECcCCcCCC
Confidence 55555554432 55555555555555555532 235555555555554 3333221 25555666666666666553
Q ss_pred CCCccccccCCCCeEecCCCccCCcCCCcCCCCCCCcEEEccCCcCcCCCCccccCCCCCCeEEeecccccCccccccCC
Q 044366 252 FVPKEIGYLKSLSKLEFCANHLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLRNLTSLERVRFNQNNLYGKVYEAFGD 331 (918)
Q Consensus 252 ~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~ 331 (918)
. ..+..+++|++|++++|.+.+..+ +..+++|+.|++++|++.+. ..+..+++|+.|++++|.+....+ +..
T Consensus 192 ~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~ 263 (466)
T 1o6v_A 192 I--SVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP--LSG 263 (466)
T ss_dssp C--GGGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTT
T ss_pred C--hhhccCCCCCEEEecCCccccccc--ccccCCCCEEECCCCCcccc--hhhhcCCCCCEEECCCCccccchh--hhc
Confidence 3 234555555555555555554433 34445555555555544432 223334444444444444333322 333
Q ss_pred CCCccEEeCCCCccccccCcccccccccceeeccccccccCCCcCcCCCCCCcEEEccCceeccccccchhhccccCcee
Q 044366 332 HPNLTFLDLSQNNFYCEISFNWRNFSKLGTFNASMNNIYGSIPPEIGDSSKLQVLDLSSNHIFGKIPVQLVKLFSLNKLI 411 (918)
Q Consensus 332 l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~n~i~~~~~~~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 411 (918)
+++|+.|++ ++|.+.+..+ +..+++|+.|+
T Consensus 264 l~~L~~L~l------------------------------------------------~~n~l~~~~~--~~~l~~L~~L~ 293 (466)
T 1o6v_A 264 LTKLTELKL------------------------------------------------GANQISNISP--LAGLTALTNLE 293 (466)
T ss_dssp CTTCSEEEC------------------------------------------------CSSCCCCCGG--GTTCTTCSEEE
T ss_pred CCCCCEEEC------------------------------------------------CCCccCcccc--ccCCCccCeEE
Confidence 333333333 3333332222 33334444444
Q ss_pred cccccccCCCCCCCCCCCcccEEeccCccccccCccccccccccceecccCcccCCCCchhhccccccceEeccCCcCCC
Q 044366 412 LSLNQLFGGVPLEFGTLTELQYLDLSANKLSSSIPMSIGNLLKLHYLNLSNNQFSHKIPTEFEKLIHLSELDLSHNILQE 491 (918)
Q Consensus 412 L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~ 491 (918)
+++|++.+..+ +..+++|++|+|++|.+++..| +..+++|+.|++++|++++. ..+..+++|+.|++++|++++
T Consensus 294 L~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~ 367 (466)
T 1o6v_A 294 LNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSDV--SSLANLTNINWLSAGHNQISD 367 (466)
T ss_dssp CCSSCCSCCGG--GGGCTTCSEEECCSSCCSCCGG--GGGCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCB
T ss_pred cCCCcccCchh--hcCCCCCCEEECcCCcCCCchh--hccCccCCEeECCCCccCCc--hhhccCCCCCEEeCCCCccCc
Confidence 44444433322 4445555555555555554433 45555555555555555543 345555566666666666555
Q ss_pred CCchhccccCCcceEecCCCcccc
Q 044366 492 EIPPQICKMESLEKLNLSHNNLSD 515 (918)
Q Consensus 492 ~~~~~~~~l~~L~~L~L~~N~l~~ 515 (918)
..| +..+++|+.|++++|++++
T Consensus 368 ~~~--~~~l~~L~~L~l~~n~~~~ 389 (466)
T 1o6v_A 368 LTP--LANLTRITQLGLNDQAWTN 389 (466)
T ss_dssp CGG--GTTCTTCCEEECCCEEEEC
T ss_pred cch--hhcCCCCCEEeccCCcccC
Confidence 444 5555566666666665555
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-40 Score=361.46 Aligned_cols=254 Identities=23% Similarity=0.349 Sum_probs=206.5
Q ss_pred HhcCCCCceeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceE
Q 044366 644 ATGNFGEKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSF 722 (918)
Q Consensus 644 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 722 (918)
..++|...+.||+|+||.||+|.. .+|+.||+|++..... .....+.+.+|+++++.++||||+++++++.+++..+
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ 104 (362)
T 2bdw_A 27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL--SARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHY 104 (362)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEE
Confidence 456799999999999999999965 4799999999875322 1123467899999999999999999999999999999
Q ss_pred EEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCC---cEEEeccccc
Q 044366 723 IVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEY---EAHVSDFGFA 799 (918)
Q Consensus 723 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~---~~kl~DfG~~ 799 (918)
+||||+++|+|.+++... ..+++.+++.++.||+.||+|||+. +|+||||||+||+++.++ .+||+|||++
T Consensus 105 lv~e~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a 178 (362)
T 2bdw_A 105 LVFDLVTGGELFEDIVAR---EFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLA 178 (362)
T ss_dssp EEECCCCSCBHHHHHTTC---SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred EEEecCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEeecCcc
Confidence 999999999999998754 3489999999999999999999999 999999999999998654 5999999999
Q ss_pred cccCCCCCCceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCCC
Q 044366 800 KFLEPHSSNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPT 879 (918)
Q Consensus 800 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 879 (918)
....... ......||+.|+|||++.+..++.++||||+||++|+|++|+.||...... . .. ..+.......
T Consensus 179 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~-~----~~---~~i~~~~~~~ 249 (362)
T 2bdw_A 179 IEVNDSE-AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH-R----LY---AQIKAGAYDY 249 (362)
T ss_dssp BCCTTCC-SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-H----HH---HHHHHTCCCC
T ss_pred eEecCCc-ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH-H----HH---HHHHhCCCCC
Confidence 8776432 334567999999999999989999999999999999999999998654321 0 11 1111111221
Q ss_pred CCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 880 PSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 880 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
+..........+.+++.+||+.||++|||+.|+++
T Consensus 250 ~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 284 (362)
T 2bdw_A 250 PSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALK 284 (362)
T ss_dssp CTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred CcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 22222233456889999999999999999999875
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-39 Score=363.25 Aligned_cols=269 Identities=19% Similarity=0.200 Sum_probs=132.0
Q ss_pred CCCcCCCCCCCEEEcccccccccCCccccCCCCCCEEEccCCcccccCccccCCCCCCCEEECcCCcCCCcCCcCCCCCC
Q 044366 62 PPVIGQLSLINELVFCHNNVSGRIPSSLGNLSNLALLYLNDNSLFGSIPIVMGNLKSLSTLDLSQNQLNGSIPCSLDNLS 141 (918)
Q Consensus 62 p~~~~~l~~L~~L~l~~n~~~~~~p~~l~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~l~~l~ 141 (918)
+..++.+++|++|++++|.+++ +| ++..+++|++|+|++|++++. | ++.+++|++|++++|++++. + +++++
T Consensus 35 ~~~~~~l~~L~~L~Ls~n~l~~-~~-~l~~l~~L~~L~Ls~n~l~~~-~--~~~l~~L~~L~Ls~N~l~~~-~--~~~l~ 106 (457)
T 3bz5_A 35 TISEEQLATLTSLDCHNSSITD-MT-GIEKLTGLTKLICTSNNITTL-D--LSQNTNLTYLACDSNKLTNL-D--VTPLT 106 (457)
T ss_dssp EEEHHHHTTCCEEECCSSCCCC-CT-TGGGCTTCSEEECCSSCCSCC-C--CTTCTTCSEEECCSSCCSCC-C--CTTCT
T ss_pred ccChhHcCCCCEEEccCCCccc-Ch-hhcccCCCCEEEccCCcCCeE-c--cccCCCCCEEECcCCCCcee-e--cCCCC
Confidence 3344455555555555555553 23 455555555555555555432 2 44555555555555555532 1 44455
Q ss_pred CCceeeccccccccCCCcccccccccCeeeccccccCCcCCccCCCCCCCcEeeccCcccccCCCccccCCCCcceeecc
Q 044366 142 NLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSENRLSGLIPLSLSNLSSLTVMSLFNNSLSGSIPPILGNLKSLSTLGLH 221 (918)
Q Consensus 142 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~ 221 (918)
+|++|++++|+++++ + ++.+++|++|++++|+++++ .+..+++|++|++++|...+.+
T Consensus 107 ~L~~L~L~~N~l~~l-~--~~~l~~L~~L~l~~N~l~~l---~l~~l~~L~~L~l~~n~~~~~~---------------- 164 (457)
T 3bz5_A 107 KLTYLNCDTNKLTKL-D--VSQNPLLTYLNCARNTLTEI---DVSHNTQLTELDCHLNKKITKL---------------- 164 (457)
T ss_dssp TCCEEECCSSCCSCC-C--CTTCTTCCEEECTTSCCSCC---CCTTCTTCCEEECTTCSCCCCC----------------
T ss_pred cCCEEECCCCcCCee-c--CCCCCcCCEEECCCCcccee---ccccCCcCCEEECCCCCccccc----------------
Confidence 555555555555432 1 44445555555555554443 1444444444444444322222
Q ss_pred cccccCCCCCCCcCCCcCCeEEcccCcCcCCCCccccccCCCCeEecCCCccCCcCCCcCCCCCCCcEEEccCCcCcCCC
Q 044366 222 INQLNGVIPPSIGNLSSLRNLSLFNNRLYGFVPKEIGYLKSLSKLEFCANHLSGVIPHSVGNLTGLVLLNMCENHLFGPI 301 (918)
Q Consensus 222 ~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~ 301 (918)
.+..+++|++|++++|+++++ | +..+++|+.|++++|++.+. .+..+++|+.|++++|++++ +
T Consensus 165 ----------~~~~l~~L~~L~ls~n~l~~l-~--l~~l~~L~~L~l~~N~l~~~---~l~~l~~L~~L~Ls~N~l~~-i 227 (457)
T 3bz5_A 165 ----------DVTPQTQLTTLDCSFNKITEL-D--VSQNKLLNRLNCDTNNITKL---DLNQNIQLTFLDCSSNKLTE-I 227 (457)
T ss_dssp ----------CCTTCTTCCEEECCSSCCCCC-C--CTTCTTCCEEECCSSCCSCC---CCTTCTTCSEEECCSSCCSC-C
T ss_pred ----------ccccCCcCCEEECCCCcccee-c--cccCCCCCEEECcCCcCCee---ccccCCCCCEEECcCCcccc-c
Confidence 244445555555555555442 1 44445555555555555443 24445555555555555554 2
Q ss_pred CccccCCCCCCeEEeecccccCccccccCCCCCccEEeCCCCccccccCcccccccccceeeccccccccCCCcCcCCCC
Q 044366 302 PKSLRNLTSLERVRFNQNNLYGKVYEAFGDHPNLTFLDLSQNNFYCEISFNWRNFSKLGTFNASMNNIYGSIPPEIGDSS 381 (918)
Q Consensus 302 ~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~n~i~~~~~~~~~~~~ 381 (918)
| +..+++|+.|++++|.+..++ +..+++|+.|++++|++ +.+++++|.+.+.+| ++.++
T Consensus 228 p--~~~l~~L~~L~l~~N~l~~~~---~~~l~~L~~L~l~~n~L--------------~~L~l~~n~~~~~~~--~~~l~ 286 (457)
T 3bz5_A 228 D--VTPLTQLTYFDCSVNPLTELD---VSTLSKLTTLHCIQTDL--------------LEIDLTHNTQLIYFQ--AEGCR 286 (457)
T ss_dssp C--CTTCTTCSEEECCSSCCSCCC---CTTCTTCCEEECTTCCC--------------SCCCCTTCTTCCEEE--CTTCT
T ss_pred C--ccccCCCCEEEeeCCcCCCcC---HHHCCCCCEEeccCCCC--------------CEEECCCCccCCccc--ccccc
Confidence 3 455555555555555555543 33455666666665532 345555555444443 34455
Q ss_pred CCcEEEccCceeccccc
Q 044366 382 KLQVLDLSSNHIFGKIP 398 (918)
Q Consensus 382 ~L~~L~L~~N~l~~~~~ 398 (918)
+|+.|++++|...+.+|
T Consensus 287 ~L~~L~Ls~n~~l~~l~ 303 (457)
T 3bz5_A 287 KIKELDVTHNTQLYLLD 303 (457)
T ss_dssp TCCCCCCTTCTTCCEEE
T ss_pred cCCEEECCCCcccceec
Confidence 66666666665444333
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-40 Score=357.37 Aligned_cols=249 Identities=22% Similarity=0.310 Sum_probs=203.0
Q ss_pred hcCCCCceeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEE
Q 044366 645 TGNFGEKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFI 723 (918)
Q Consensus 645 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 723 (918)
.++|.+.+.||+|+||.||+|.. .+|+.||||++....... ......+.+|+.+++.++||||+++++++.+++..++
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 86 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKK-SDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVM 86 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHH-TTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccc-hhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence 36899999999999999999965 689999999987643322 2335678999999999999999999999999999999
Q ss_pred EEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccC
Q 044366 724 VCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLE 803 (918)
Q Consensus 724 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~ 803 (918)
||||+ +|+|.+++... ..+++.+++.++.|++.||+|||+. +|+||||||+||++++++.+||+|||++....
T Consensus 87 v~E~~-~g~l~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~ 159 (336)
T 3h4j_B 87 VIEYA-GGELFDYIVEK---KRMTEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMT 159 (336)
T ss_dssp EECCC-CEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHH---TCCCCCCSTTTEEECTTCCEEECCSSCTBTTT
T ss_pred EEECC-CCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCchhhEEEcCCCCEEEEEeccceecc
Confidence 99999 67999988764 3489999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCCceecccccccccccccccCCC-CcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCCCCCc
Q 044366 804 PHSSNWTEFAGTVGYAAPELAYTMRA-TEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSR 882 (918)
Q Consensus 804 ~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 882 (918)
... ......||+.|+|||++.+..+ +.++||||+||++|+|++|+.||+..... .. ...+...... .+.
T Consensus 160 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~-----~~---~~~i~~~~~~-~p~ 229 (336)
T 3h4j_B 160 DGN-FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIP-----NL---FKKVNSCVYV-MPD 229 (336)
T ss_dssp TSB-TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSST-----TC---BCCCCSSCCC-CCT
T ss_pred CCc-ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHH-----HH---HHHHHcCCCC-Ccc
Confidence 432 2344579999999999988776 68999999999999999999998643211 00 0111111111 111
Q ss_pred chHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 883 DVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 883 ~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
. ....+.+++.+||+.||.+|||++|+++
T Consensus 230 ~---~s~~~~~li~~~L~~dP~~Rpt~~eil~ 258 (336)
T 3h4j_B 230 F---LSPGAQSLIRRMIVADPMQRITIQEIRR 258 (336)
T ss_dssp T---SCHHHHHHHHTTSCSSGGGSCCHHHHTT
T ss_pred c---CCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 1 2245788999999999999999999875
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=348.73 Aligned_cols=253 Identities=22% Similarity=0.323 Sum_probs=198.1
Q ss_pred hcCCCCceeeccccceEEEEEEe-CCCCEEEEEEcccccccCC----------------------CCChHHHHHHHHHHh
Q 044366 645 TGNFGEKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDE----------------------TANPSEFLNEVLALT 701 (918)
Q Consensus 645 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~----------------------~~~~~~~~~e~~~l~ 701 (918)
.++|...+.||+|+||.||+|.. .+|+.||||++........ ....+.+.+|+++++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 46899999999999999999964 5789999999865432111 112467899999999
Q ss_pred hccCCceeeEeccccc--CCceEEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCC
Q 044366 702 EIRHRNIIKFHGFCSN--AQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDIS 779 (918)
Q Consensus 702 ~l~h~niv~~~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk 779 (918)
.++||||+++++++.+ .+..++||||+++|+|.++... ..+++.+++.++.|+++||+|||+. +|+|||||
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlk 164 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL----KPLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDIK 164 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCC
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCC
Confidence 9999999999999876 5678999999999999887643 3589999999999999999999999 99999999
Q ss_pred CCCeeeCCCCcEEEeccccccccCCCCCCceecccccccccccccccCC---CCcccchhhHHHHHHHHHhCCCCCCcch
Q 044366 780 SKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGTVGYAAPELAYTMR---ATEKYDVYSFGVLALEVIKGYHPGDFVS 856 (918)
Q Consensus 780 ~~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~---~~~~~Dv~slG~vl~el~tg~~p~~~~~ 856 (918)
|+||+++.++.+||+|||+++.............||+.|+|||++.+.. ++.++|||||||++|||++|+.||....
T Consensus 165 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 244 (298)
T 2zv2_A 165 PSNLLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDER 244 (298)
T ss_dssp GGGEEECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred HHHEEECCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCcc
Confidence 9999999999999999999988765544445567999999999997765 3778999999999999999999986543
Q ss_pred hhhhhhhhhHhhhhhhcccCCCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 857 TIFSSISNMIIEVNQILDHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 857 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
.. .. ... +.......+. .......+.+++.+||+.||++|||++|+++
T Consensus 245 ~~--~~---~~~---~~~~~~~~~~--~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 245 IM--CL---HSK---IKSQALEFPD--QPDIAEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp HH--HH---HHH---HHHCCCCCCS--SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred HH--HH---HHH---HhcccCCCCC--ccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 21 01 011 1111111110 0112246788999999999999999999974
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-40 Score=352.42 Aligned_cols=262 Identities=21% Similarity=0.359 Sum_probs=202.1
Q ss_pred HhcCCCCceeeccccceEEEEEEe-----CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEeccccc-
Q 044366 644 ATGNFGEKYCIGKGGQRSVYKAEL-----PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSN- 717 (918)
Q Consensus 644 ~~~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~- 717 (918)
..++|+..+.||+|+||.||+|++ .+++.||||++... .....+.|.+|++++++++||||+++++++..
T Consensus 8 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 83 (295)
T 3ugc_A 8 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS----TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSA 83 (295)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC----CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHH
T ss_pred CHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC----CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence 346788999999999999999974 36889999998643 22335679999999999999999999998854
Q ss_pred -CCceEEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEecc
Q 044366 718 -AQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDF 796 (918)
Q Consensus 718 -~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Df 796 (918)
....++||||+++|+|.+++.... ..+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.+||+||
T Consensus 84 ~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Df 158 (295)
T 3ugc_A 84 GRRNLKLIMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDF 158 (295)
T ss_dssp HHTSCEEEEECCTTCBHHHHHHHCG--GGCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCC
T ss_pred CCCceEEEEEeCCCCCHHHHHHhcc--cccCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHhhEEEcCCCeEEEccC
Confidence 456899999999999999997653 3589999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCCC---ceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhh-h------hH
Q 044366 797 GFAKFLEPHSSN---WTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSIS-N------MI 866 (918)
Q Consensus 797 G~~~~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~-~------~~ 866 (918)
|++......... .....++..|+|||.+.+..++.++||||||+++|||++|..|+........... . ..
T Consensus 159 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (295)
T 3ugc_A 159 GLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIV 238 (295)
T ss_dssp CSCC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHH
T ss_pred cccccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhH
Confidence 999877543321 2234567789999999999999999999999999999999999765432211100 0 00
Q ss_pred hhhh-hhcccCCCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 044366 867 IEVN-QILDHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLLC 917 (918)
Q Consensus 867 ~~~~-~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 917 (918)
.... ............. ....+.+++.+||+.||++|||++|+++.|+
T Consensus 239 ~~~~~~~~~~~~~~~~~~---~~~~l~~li~~~l~~dp~~Rps~~el~~~L~ 287 (295)
T 3ugc_A 239 FHLIELLKNNGRLPRPDG---CPDEIYMIMTECWNNNVNQRPSFRDLALRVD 287 (295)
T ss_dssp HHHHHHHHTTCCCCCCTT---CCHHHHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred HHHHHHHhccCcCCCCcC---cCHHHHHHHHHHcCCChhhCCCHHHHHHHHH
Confidence 0111 1111111111122 2346888999999999999999999999886
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=354.40 Aligned_cols=252 Identities=24% Similarity=0.351 Sum_probs=194.8
Q ss_pred hcCCCCceeeccccceEEEEEEe----CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCc
Q 044366 645 TGNFGEKYCIGKGGQRSVYKAEL----PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQH 720 (918)
Q Consensus 645 ~~~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 720 (918)
.++|...+.||+|+||.||+|+. .+|+.||+|+++.............+.+|+++++.++||||+++++++..++.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 46799999999999999999975 47899999999765433333345678899999999999999999999999999
Q ss_pred eEEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEecccccc
Q 044366 721 SFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAK 800 (918)
Q Consensus 721 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~ 800 (918)
.++||||+++|+|.+++.... .+++.+++.++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~ 169 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLEREG---IFMEDTACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCK 169 (327)
T ss_dssp EEEEEECCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTSCEEECCCSCC-
T ss_pred EEEEEeCCCCCcHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhC---CEEcccCCHHHeEECCCCcEEEEeCCccc
Confidence 999999999999999997643 489999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCCceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCCCC
Q 044366 801 FLEPHSSNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTP 880 (918)
Q Consensus 801 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 880 (918)
.............||+.|+|||++.+..++.++||||||+++|||++|+.||...... ... ..+.......+
T Consensus 170 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-~~~-------~~i~~~~~~~p 241 (327)
T 3a62_A 170 ESIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRK-KTI-------DKILKCKLNLP 241 (327)
T ss_dssp ---------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHH-------HHHHHTCCCCC
T ss_pred ccccCCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHH-HHH-------HHHHhCCCCCC
Confidence 6554444444567899999999999989999999999999999999999998754321 111 11111111111
Q ss_pred CcchHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 044366 881 SRDVTDKLRSIMEVAILCLVENPEARP-----TMKEVCN 914 (918)
Q Consensus 881 ~~~~~~~~~~l~~li~~cl~~dp~~RP-----t~~evl~ 914 (918)
.. ....+.+++.+||+.||++|| +++|+++
T Consensus 242 -~~---~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~ 276 (327)
T 3a62_A 242 -PY---LTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA 276 (327)
T ss_dssp -TT---SCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred -CC---CCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence 11 124678899999999999999 7888865
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-40 Score=354.98 Aligned_cols=252 Identities=24% Similarity=0.326 Sum_probs=201.6
Q ss_pred hcCCCCceeeccccceEEEEEEeC-CCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEE
Q 044366 645 TGNFGEKYCIGKGGQRSVYKAELP-SGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFI 723 (918)
Q Consensus 645 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 723 (918)
.++|...+.||+|+||.||+|... +++.||||++..... ....+.+.+|+.+++.++||||+++++++.+++..++
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 82 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA---VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYL 82 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC----------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccc---cchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEE
Confidence 367899999999999999999654 799999999865322 2223568899999999999999999999999999999
Q ss_pred EEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccC
Q 044366 724 VCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLE 803 (918)
Q Consensus 724 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~ 803 (918)
||||+++|+|.+++... ..+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++..+.
T Consensus 83 v~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 156 (323)
T 3tki_A 83 FLEYCSGGELFDRIEPD---IGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFR 156 (323)
T ss_dssp EEECCTTEEGGGGSBTT---TBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECE
T ss_pred EEEcCCCCcHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CccccccchHHEEEeCCCCEEEEEeeccceec
Confidence 99999999999999754 3489999999999999999999999 99999999999999999999999999998664
Q ss_pred CCC--CCceecccccccccccccccCCC-CcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCCCC
Q 044366 804 PHS--SNWTEFAGTVGYAAPELAYTMRA-TEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTP 880 (918)
Q Consensus 804 ~~~--~~~~~~~g~~~y~aPE~~~~~~~-~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 880 (918)
... .......||+.|+|||++.+..+ +.++||||+||++|||++|+.||+............ ........
T Consensus 157 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~-------~~~~~~~~ 229 (323)
T 3tki_A 157 YNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDW-------KEKKTYLN 229 (323)
T ss_dssp ETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHH-------HTTCTTST
T ss_pred cCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHH-------hcccccCC
Confidence 322 22345678999999999987775 778999999999999999999987543321111110 00111000
Q ss_pred CcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 881 SRDVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 881 ~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
........+.+++.+||+.||++|||++|+++
T Consensus 230 --~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~ 261 (323)
T 3tki_A 230 --PWKKIDSAPLALLHKILVENPSARITIPDIKK 261 (323)
T ss_dssp --TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred --ccccCCHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 11122356788999999999999999999975
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=350.68 Aligned_cols=262 Identities=20% Similarity=0.328 Sum_probs=192.1
Q ss_pred hcCCCCceeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEE
Q 044366 645 TGNFGEKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFI 723 (918)
Q Consensus 645 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 723 (918)
.++|...+.||+|+||.||+|.. .+|+.||+|+++... .....+.+.+|+++++.++||||+++++++.+++..++
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 80 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDS---EEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTL 80 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCS---TTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeeccc---ccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEE
Confidence 46789999999999999999965 478999999987542 23345788999999999999999999999999999999
Q ss_pred EEEeccCCChhHHhhccc---ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEecccccc
Q 044366 724 VCEYLARGSLTTILRDDA---AAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAK 800 (918)
Q Consensus 724 v~e~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~ 800 (918)
||||++ |+|.+++.... ....+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++
T Consensus 81 v~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~ 156 (317)
T 2pmi_A 81 VFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLAR 156 (317)
T ss_dssp EEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCSSCE
T ss_pred EEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCChHHeEEcCCCCEEECcCccce
Confidence 999998 59999987542 224589999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCCceecccccccccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhh----------
Q 044366 801 FLEPHSSNWTEFAGTVGYAAPELAYTM-RATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEV---------- 869 (918)
Q Consensus 801 ~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~---------- 869 (918)
.............||+.|+|||++.+. .++.++|||||||++|||++|+.||....... .........
T Consensus 157 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~ 235 (317)
T 2pmi_A 157 AFGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEE-QLKLIFDIMGTPNESLWPS 235 (317)
T ss_dssp ETTSCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCSCCTTTCGG
T ss_pred ecCCCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCCCChhHhhh
Confidence 876554444556789999999998764 58999999999999999999999987543211 111110000
Q ss_pred -hhhc--ccCCC-CCCcchH---------HHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 870 -NQIL--DHRLP-TPSRDVT---------DKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 870 -~~~~--~~~~~-~~~~~~~---------~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
.... ..... ....... .....+.+++.+||+.||++|||++|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~ 293 (317)
T 2pmi_A 236 VTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH 293 (317)
T ss_dssp GGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence 0000 00000 0000011 12246889999999999999999999975
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=346.17 Aligned_cols=253 Identities=23% Similarity=0.387 Sum_probs=205.1
Q ss_pred HhcCCCCceeeccccceEEEEEEeCCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEE
Q 044366 644 ATGNFGEKYCIGKGGQRSVYKAELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFI 723 (918)
Q Consensus 644 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 723 (918)
..++|...+.||+|+||.||+|+..+++.||+|+++.. ....+++.+|+++++.++||||+++++++.+++..++
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~-----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 96 (283)
T 3gen_A 22 DPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG-----SMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFI 96 (283)
T ss_dssp CGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTT-----SBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred CHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCC-----CCCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEE
Confidence 45678889999999999999999888889999998753 2345789999999999999999999999999999999
Q ss_pred EEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccC
Q 044366 724 VCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLE 803 (918)
Q Consensus 724 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~ 803 (918)
||||+++|+|.+++.... ..+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++....
T Consensus 97 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~ 171 (283)
T 3gen_A 97 ITEYMANGCLLNYLREMR--HRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVL 171 (283)
T ss_dssp EECCCTTCBHHHHHHCGG--GCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTSCEEECSTTGGGGBC
T ss_pred EEeccCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCccceEEEcCCCCEEEcccccccccc
Confidence 999999999999997642 3589999999999999999999999 99999999999999999999999999998764
Q ss_pred CCCC-CceecccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhhhhhhhhhHhhhhhhcccCCCCCC
Q 044366 804 PHSS-NWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIK-GYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPS 881 (918)
Q Consensus 804 ~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 881 (918)
.... ......+++.|+|||++.+..++.++||||+|+++|||++ |+.||...... ........... ....
T Consensus 172 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~-----~~~~~~~~~~~---~~~~ 243 (283)
T 3gen_A 172 DDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS-----ETAEHIAQGLR---LYRP 243 (283)
T ss_dssp CHHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHH-----HHHHHHHTTCC---CCCC
T ss_pred ccccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChh-----HHHHHHhcccC---CCCC
Confidence 3211 1223346788999999998899999999999999999998 99998654321 11111111111 1111
Q ss_pred cchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 044366 882 RDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLLC 917 (918)
Q Consensus 882 ~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 917 (918)
... ...+.+++.+||+.||++|||++|+++.|.
T Consensus 244 ~~~---~~~l~~li~~~l~~~p~~Rps~~~ll~~L~ 276 (283)
T 3gen_A 244 HLA---SEKVYTIMYSCWHEKADERPTFKILLSNIL 276 (283)
T ss_dssp TTC---CHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred CcC---CHHHHHHHHHHccCChhHCcCHHHHHHHHH
Confidence 111 246788999999999999999999999885
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-40 Score=356.72 Aligned_cols=253 Identities=23% Similarity=0.320 Sum_probs=205.8
Q ss_pred HHHhcCCCCceeeccccceEEEEEEeC-CCCEEEEEEcccccccCCCCChHHHHHHHHHHhhc-cCCceeeEecccccCC
Q 044366 642 TKATGNFGEKYCIGKGGQRSVYKAELP-SGNIFAVKKFKAELFSDETANPSEFLNEVLALTEI-RHRNIIKFHGFCSNAQ 719 (918)
Q Consensus 642 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~ 719 (918)
....++|...+.||+|+||.||+|+.. +|+.||||+++...... ....+.+..|..+++.+ +||||+++++++.+.+
T Consensus 13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~ 91 (345)
T 1xjd_A 13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLM-DDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKE 91 (345)
T ss_dssp ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHH-TTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSS
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhh-hhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCC
Confidence 445688999999999999999999664 68999999997643221 23456788999999887 8999999999999999
Q ss_pred ceEEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccc
Q 044366 720 HSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFA 799 (918)
Q Consensus 720 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~ 799 (918)
..++||||+++|+|.+++... ..+++.+++.++.||+.||+|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 92 ~~~lv~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a 165 (345)
T 1xjd_A 92 NLFFVMEYLNGGDLMYHIQSC---HKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMC 165 (345)
T ss_dssp EEEEEEECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEEEEEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCChhhEEECCCCCEEEeEChhh
Confidence 999999999999999999764 3489999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCCceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCCC
Q 044366 800 KFLEPHSSNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPT 879 (918)
Q Consensus 800 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 879 (918)
+.............||+.|+|||++.+..++.++||||+||++|||++|+.||...... . .. ..+.......
T Consensus 166 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~-~----~~---~~i~~~~~~~ 237 (345)
T 1xjd_A 166 KENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE-E----LF---HSIRMDNPFY 237 (345)
T ss_dssp BCCCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-H----HH---HHHHHCCCCC
T ss_pred hhcccCCCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHH-H----HH---HHHHhCCCCC
Confidence 87554444455678999999999999999999999999999999999999998654321 1 11 1111111111
Q ss_pred CCcchHHHHHHHHHHHHHcccCCCCCCCCHH-HHH
Q 044366 880 PSRDVTDKLRSIMEVAILCLVENPEARPTMK-EVC 913 (918)
Q Consensus 880 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~-evl 913 (918)
+.. ....+.+++.+||+.||++||++. |++
T Consensus 238 -p~~---~s~~~~~li~~lL~~dp~~R~~~~~~i~ 268 (345)
T 1xjd_A 238 -PRW---LEKEAKDLLVKLFVREPEKRLGVRGDIR 268 (345)
T ss_dssp -CTT---SCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred -Ccc---cCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence 111 224678899999999999999987 554
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=359.16 Aligned_cols=252 Identities=18% Similarity=0.292 Sum_probs=205.6
Q ss_pred hcCCCCceeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEE
Q 044366 645 TGNFGEKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFI 723 (918)
Q Consensus 645 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 723 (918)
.++|.+.+.||+|+||.||+|.. .+|+.||+|++.... ......+.+|+++++.++||||+++++++.+++..++
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~----~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~l 125 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY----PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVL 125 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS----HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEE
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccc----hhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEE
Confidence 46799999999999999999965 478999999986531 1224578999999999999999999999999999999
Q ss_pred EEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCC--CCcEEEeccccccc
Q 044366 724 VCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDS--EYEAHVSDFGFAKF 801 (918)
Q Consensus 724 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~--~~~~kl~DfG~~~~ 801 (918)
||||+++|+|.+++... ...+++.+++.++.||+.||+|||+. +|+||||||+||+++. ++.+||+|||+++.
T Consensus 126 v~E~~~gg~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~vkL~DFG~a~~ 200 (387)
T 1kob_A 126 ILEFLSGGELFDRIAAE--DYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATK 200 (387)
T ss_dssp EEECCCCCBHHHHTTCT--TCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEE
T ss_pred EEEcCCCCcHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccchHHeEEecCCCCceEEEeccccee
Confidence 99999999999999754 23589999999999999999999999 9999999999999974 46799999999988
Q ss_pred cCCCCCCceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCCCCC
Q 044366 802 LEPHSSNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPS 881 (918)
Q Consensus 802 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 881 (918)
..... ......||+.|+|||++.+..++.++||||+||++|||++|+.||...... .... .+....+....
T Consensus 201 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~-~~~~-------~i~~~~~~~~~ 271 (387)
T 1kob_A 201 LNPDE-IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL-ETLQ-------NVKRCDWEFDE 271 (387)
T ss_dssp CCTTS-CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH-HHHH-------HHHHCCCCCCS
T ss_pred cCCCc-ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHH-HHHH-------HHHhCCCCCCc
Confidence 76433 334557999999999999989999999999999999999999998754321 1111 11111111111
Q ss_pred cchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 882 RDVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 882 ~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
.........+.+++.+||+.||++|||+.|+++
T Consensus 272 ~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 304 (387)
T 1kob_A 272 DAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE 304 (387)
T ss_dssp STTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred cccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence 111223356889999999999999999999986
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-40 Score=363.77 Aligned_cols=265 Identities=21% Similarity=0.310 Sum_probs=209.5
Q ss_pred CHHHHHHHhcCCCCceeeccccceEEEEEEe------CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhc-cCCcee
Q 044366 637 LYEEITKATGNFGEKYCIGKGGQRSVYKAEL------PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEI-RHRNII 709 (918)
Q Consensus 637 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv 709 (918)
.....+...++|...+.||+|+||.||+|++ .+++.||||+++... .....+.+.+|+++++++ +||||+
T Consensus 13 ~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~hpniv 89 (359)
T 3vhe_A 13 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA---THSEHRALMSELKILIHIGHHLNVV 89 (359)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC---CHHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred CcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcC---CHHHHHHHHHHHHHHHhhcCCccee
Confidence 3455666778999999999999999999963 356899999986531 222246799999999999 799999
Q ss_pred eEecccccCC-ceEEEEEeccCCChhHHhhcccc----------------------------------------------
Q 044366 710 KFHGFCSNAQ-HSFIVCEYLARGSLTTILRDDAA---------------------------------------------- 742 (918)
Q Consensus 710 ~~~~~~~~~~-~~~lv~e~~~~gsL~~~l~~~~~---------------------------------------------- 742 (918)
++++++.+.+ ..++||||+++|+|.++++....
T Consensus 90 ~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 169 (359)
T 3vhe_A 90 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVE 169 (359)
T ss_dssp CEEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC----------------------------------------
T ss_pred eeeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccc
Confidence 9999987654 58999999999999999976532
Q ss_pred -----------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccCCC
Q 044366 743 -----------------AKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPH 805 (918)
Q Consensus 743 -----------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~~~ 805 (918)
...+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~ 246 (359)
T 3vhe_A 170 EKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKD 246 (359)
T ss_dssp --------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSC
T ss_pred ccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCcEEEEeccceeeeccc
Confidence 11289999999999999999999999 9999999999999999999999999999876443
Q ss_pred CC--CceecccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhhhhhhhhhHhhhhhhcccCCCCCCc
Q 044366 806 SS--NWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIK-GYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSR 882 (918)
Q Consensus 806 ~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 882 (918)
.. ......||+.|+|||++.+..++.++||||||+++|||++ |+.||......... . ..... ........
T Consensus 247 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~-~---~~~~~---~~~~~~~~ 319 (359)
T 3vhe_A 247 PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF-C---RRLKE---GTRMRAPD 319 (359)
T ss_dssp TTCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHH-H---HHHHH---TCCCCCCT
T ss_pred ccchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHH-H---HHHHc---CCCCCCCC
Confidence 32 2234567899999999999999999999999999999998 99998654321111 1 11111 11111111
Q ss_pred chHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 044366 883 DVTDKLRSIMEVAILCLVENPEARPTMKEVCNLLC 917 (918)
Q Consensus 883 ~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 917 (918)
. ....+.+++.+||+.||++|||++|+++.|+
T Consensus 320 ~---~~~~l~~li~~~l~~dP~~Rps~~ell~~L~ 351 (359)
T 3vhe_A 320 Y---TTPEMYQTMLDCWHGEPSQRPTFSELVEHLG 351 (359)
T ss_dssp T---CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred C---CCHHHHHHHHHHccCChhhCCCHHHHHHHHH
Confidence 1 2245788999999999999999999999986
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=353.91 Aligned_cols=250 Identities=25% Similarity=0.355 Sum_probs=182.8
Q ss_pred ceeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhcc-CCceeeEecccccCCceEEEEEec
Q 044366 651 KYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIR-HRNIIKFHGFCSNAQHSFIVCEYL 728 (918)
Q Consensus 651 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~ 728 (918)
.+.||+|+||.||+|.. .+|+.||||++... ....+.+|+.+++.++ ||||+++++++.+++..++||||+
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-------~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~ 88 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR-------MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELL 88 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG-------GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCC
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChh-------hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEcc
Confidence 46799999999999965 47899999998642 2467889999999997 999999999999999999999999
Q ss_pred cCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCC---cEEEeccccccccCCC
Q 044366 729 ARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEY---EAHVSDFGFAKFLEPH 805 (918)
Q Consensus 729 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~---~~kl~DfG~~~~~~~~ 805 (918)
++|+|.+++... ..+++.+++.++.|++.||+|||+. +|+||||||+||+++.++ .+||+|||+++.....
T Consensus 89 ~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~ 162 (325)
T 3kn6_A 89 NGGELFERIKKK---KHFSETEASYIMRKLVSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPD 162 (325)
T ss_dssp CSCBHHHHHHHC---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEC----CEEEECCCTTCEECCC-
T ss_pred CCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCHHHEEEecCCCcccEEEeccccceecCCC
Confidence 999999999864 3489999999999999999999999 999999999999998765 7999999999877665
Q ss_pred CCCceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCCCCCcchH
Q 044366 806 SSNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRDVT 885 (918)
Q Consensus 806 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 885 (918)
........||+.|+|||++.+..++.++||||+|+++|||++|+.||......... .........+.............
T Consensus 163 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~-~~~~~~~~~i~~~~~~~~~~~~~ 241 (325)
T 3kn6_A 163 NQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTC-TSAVEIMKKIKKGDFSFEGEAWK 241 (325)
T ss_dssp ---------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------C-CCHHHHHHHHTTTCCCCCSHHHH
T ss_pred CCcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCcccccc-ccHHHHHHHHHcCCCCCCccccc
Confidence 55555667899999999999999999999999999999999999998754321110 01111122222333322222223
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 886 DKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 886 ~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
.....+.+++.+||+.||++|||++|+++
T Consensus 242 ~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 270 (325)
T 3kn6_A 242 NVSQEAKDLIQGLLTVDPNKRLKMSGLRY 270 (325)
T ss_dssp TSCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred CCCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence 34567889999999999999999998863
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=357.95 Aligned_cols=260 Identities=23% Similarity=0.403 Sum_probs=209.0
Q ss_pred HHHHhcCCCCceeeccccceEEEEEEeC------CCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecc
Q 044366 641 ITKATGNFGEKYCIGKGGQRSVYKAELP------SGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGF 714 (918)
Q Consensus 641 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~ 714 (918)
+....++|...+.||+|+||.||+|+.. +++.||||+++... .....+.|.+|+++++.++||||++++++
T Consensus 42 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~hp~iv~~~~~ 118 (343)
T 1luf_A 42 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA---SADMQADFQREAALMAEFDNPNIVKLLGV 118 (343)
T ss_dssp TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC---CHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred eEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc---CHHHHHHHHHHHHHHHhCCCCCEEEEEEE
Confidence 3445678999999999999999999663 35889999987532 22235679999999999999999999999
Q ss_pred cccCCceEEEEEeccCCChhHHhhcccc---------------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCe
Q 044366 715 CSNAQHSFIVCEYLARGSLTTILRDDAA---------------------AKEFSWNQRMNVIKGVANALSYLHHDCIPPI 773 (918)
Q Consensus 715 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i 773 (918)
+.+++..++||||+++|+|.+++..... ...+++.+++.++.||++||+|||+. +|
T Consensus 119 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---~i 195 (343)
T 1luf_A 119 CAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KF 195 (343)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TC
T ss_pred EccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC---Ce
Confidence 9999999999999999999999976421 25689999999999999999999999 99
Q ss_pred EEcCCCCCCeeeCCCCcEEEeccccccccCCCCC--CceecccccccccccccccCCCCcccchhhHHHHHHHHHh-CCC
Q 044366 774 VHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSS--NWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIK-GYH 850 (918)
Q Consensus 774 vH~dlk~~Nill~~~~~~kl~DfG~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~ 850 (918)
+||||||+||+++.++.+||+|||++........ ......+++.|+|||++.+..++.++||||||+++|||++ |..
T Consensus 196 vH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~ 275 (343)
T 1luf_A 196 VHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ 275 (343)
T ss_dssp CCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred ecCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCC
Confidence 9999999999999999999999999987643321 2234567899999999999899999999999999999999 999
Q ss_pred CCCcchhhhhhhhhhHhhhhhhcccCCCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 044366 851 PGDFVSTIFSSISNMIIEVNQILDHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLLC 917 (918)
Q Consensus 851 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 917 (918)
||...... .. . ..+.....+...... ...+.+++.+||+.||++|||+.++++.|+
T Consensus 276 p~~~~~~~--~~---~---~~~~~~~~~~~~~~~---~~~l~~li~~~l~~~p~~Rps~~~~~~~L~ 331 (343)
T 1luf_A 276 PYYGMAHE--EV---I---YYVRDGNILACPENC---PLELYNLMRLCWSKLPADRPSFCSIHRILQ 331 (343)
T ss_dssp TTTTSCHH--HH---H---HHHHTTCCCCCCTTC---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred cCCCCChH--HH---H---HHHhCCCcCCCCCCC---CHHHHHHHHHHcccCcccCCCHHHHHHHHH
Confidence 98644321 11 1 111112222222222 246888999999999999999999999986
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=359.78 Aligned_cols=257 Identities=24% Similarity=0.362 Sum_probs=207.5
Q ss_pred HhcCCCCceeeccccceEEEEEEe--------CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhc-cCCceeeEecc
Q 044366 644 ATGNFGEKYCIGKGGQRSVYKAEL--------PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEI-RHRNIIKFHGF 714 (918)
Q Consensus 644 ~~~~~~~~~~lg~G~~g~Vy~~~~--------~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~ 714 (918)
..++|...+.||+|+||.||+|+. ..++.||||+++... .....+.+.+|+++++.+ +||||++++++
T Consensus 67 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~ 143 (382)
T 3tt0_A 67 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA---TEKDLSDLISEMEMMKMIGKHKNIINLLGA 143 (382)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTC---CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred chhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeecccc---CHHHHHHHHHHHHHHHHhcCCchhhhheee
Confidence 346888999999999999999964 233579999986531 222346799999999999 99999999999
Q ss_pred cccCCceEEEEEeccCCChhHHhhcccc-------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCC
Q 044366 715 CSNAQHSFIVCEYLARGSLTTILRDDAA-------------AKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSK 781 (918)
Q Consensus 715 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~ 781 (918)
+.+++..++||||+++|+|.+++..... ...+++.+++.++.|++.||+|||+. +|+||||||+
T Consensus 144 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~ 220 (382)
T 3tt0_A 144 CTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAAR 220 (382)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGG
T ss_pred eccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCcc
Confidence 9999999999999999999999986532 24589999999999999999999999 9999999999
Q ss_pred CeeeCCCCcEEEeccccccccCCCCC--CceecccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhh
Q 044366 782 NVLLDSEYEAHVSDFGFAKFLEPHSS--NWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIK-GYHPGDFVSTI 858 (918)
Q Consensus 782 Nill~~~~~~kl~DfG~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~p~~~~~~~ 858 (918)
||+++.++.+||+|||+++....... ......+|+.|+|||++.+..++.++|||||||++|||++ |..||......
T Consensus 221 NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~ 300 (382)
T 3tt0_A 221 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE 300 (382)
T ss_dssp GEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH
T ss_pred eEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 99999999999999999987654332 2233456889999999999999999999999999999999 99998644321
Q ss_pred hhhhhhhHhhhhhhcccCCCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 044366 859 FSSISNMIIEVNQILDHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLLC 917 (918)
Q Consensus 859 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 917 (918)
........ .......... ...+.+++.+||+.||++|||++|+++.|+
T Consensus 301 -----~~~~~~~~---~~~~~~~~~~---~~~l~~li~~~l~~dP~~Rps~~ell~~L~ 348 (382)
T 3tt0_A 301 -----ELFKLLKE---GHRMDKPSNC---TNELYMMMRDCWHAVPSQRPTFKQLVEDLD 348 (382)
T ss_dssp -----HHHHHHHT---TCCCCCCSSC---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred -----HHHHHHHc---CCCCCCCccC---CHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 11111111 1111111222 246788999999999999999999999886
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-40 Score=357.01 Aligned_cols=256 Identities=16% Similarity=0.188 Sum_probs=204.2
Q ss_pred hcCCCCceeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhc-cCCceeeEecccccCCceE
Q 044366 645 TGNFGEKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEI-RHRNIIKFHGFCSNAQHSF 722 (918)
Q Consensus 645 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~ 722 (918)
.++|...+.||+|+||.||+|.. .+|+.||||++.... ..+.+.+|+++++.+ +||||+++++++..++..+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~ 81 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS------RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNA 81 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTC------SSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEecccc------chHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccE
Confidence 36789999999999999999964 689999999986431 134688999999999 9999999999999999999
Q ss_pred EEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCc-----EEEeccc
Q 044366 723 IVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYE-----AHVSDFG 797 (918)
Q Consensus 723 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~-----~kl~DfG 797 (918)
+||||+ +++|.+++... ...+++.+++.++.|++.||+|||+. +|+||||||+||+++.++. +||+|||
T Consensus 82 lv~e~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~---~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg 155 (330)
T 2izr_A 82 MVLELL-GPSLEDLFDLC--DRTFSLKTVLMIAIQLISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQVIHIIDFA 155 (330)
T ss_dssp EEEECC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTCTTSEEECCCT
T ss_pred EEEEeC-CCCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeeccCCCCCCceEEEEEcc
Confidence 999999 89999999864 34589999999999999999999999 9999999999999999887 9999999
Q ss_pred cccccCCCCCC-------ceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhh
Q 044366 798 FAKFLEPHSSN-------WTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVN 870 (918)
Q Consensus 798 ~~~~~~~~~~~-------~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~ 870 (918)
+++.+...... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...... ........
T Consensus 156 ~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~--~~~~~~~~-- 231 (330)
T 2izr_A 156 LAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKAD--TLKERYQK-- 231 (330)
T ss_dssp TCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCS--SHHHHHHH--
T ss_pred cceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccc--cHHHHHHH--
Confidence 99876543321 23567999999999999999999999999999999999999998754211 00110111
Q ss_pred hhcccCCCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 044366 871 QILDHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLLC 917 (918)
Q Consensus 871 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 917 (918)
+.....+.+..........+.+++..||+.||.+||+++++.+.|+
T Consensus 232 -i~~~~~~~~~~~~~~~~p~~~~li~~~l~~~p~~RP~~~~l~~~l~ 277 (330)
T 2izr_A 232 -IGDTKRATPIEVLCENFPEMATYLRYVRRLDFFEKPDYDYLRKLFT 277 (330)
T ss_dssp -HHHHHHHSCHHHHTTTCHHHHHHHHHHHHCCTTCCCCHHHHHHHHH
T ss_pred -HHhhhccCCHHHHhccChHHHHHHHHHHhCCCCCCCCHHHHHHHHH
Confidence 1000000000000001127889999999999999999999999875
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-40 Score=366.74 Aligned_cols=260 Identities=18% Similarity=0.258 Sum_probs=207.2
Q ss_pred HHHHHHhcCCCCceeeccccceEEEEEEeC-CCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEeccccc
Q 044366 639 EEITKATGNFGEKYCIGKGGQRSVYKAELP-SGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSN 717 (918)
Q Consensus 639 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~ 717 (918)
.++....++|...+.||+|+||.||+|+.. +++.||+|+++...... ....+.+.+|+.+++.++||||+++++++.+
T Consensus 62 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~-~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~ 140 (410)
T 3v8s_A 62 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIK-RSDSAFFWEERDIMAFANSPWVVQLFYAFQD 140 (410)
T ss_dssp HHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHH-TCCCSTHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred HhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhh-hHHHHHHHHHHHHHHhCCCCCCCeEEEEEEE
Confidence 344556688999999999999999999664 68999999987632222 2224568899999999999999999999999
Q ss_pred CCceEEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccc
Q 044366 718 AQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFG 797 (918)
Q Consensus 718 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG 797 (918)
++..++||||+++|+|.++++.. .+++..++.++.||+.||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 141 ~~~~~lV~E~~~gg~L~~~l~~~----~~~e~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFG 213 (410)
T 3v8s_A 141 DRYLYMVMEYMPGGDLVNLMSNY----DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFG 213 (410)
T ss_dssp SSEEEEEECCCTTEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCT
T ss_pred CCEEEEEEeCCCCCcHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeeECCCCCEEEeccc
Confidence 99999999999999999999753 389999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCC-CceecccccccccccccccCC----CCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhh
Q 044366 798 FAKFLEPHSS-NWTEFAGTVGYAAPELAYTMR----ATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQI 872 (918)
Q Consensus 798 ~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~----~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 872 (918)
+++....... .....+||+.|+|||++.+.. ++.++|||||||++|||++|+.||...... ............
T Consensus 214 ~a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~-~~~~~i~~~~~~- 291 (410)
T 3v8s_A 214 TCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV-GTYSKIMNHKNS- 291 (410)
T ss_dssp TCEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHH-HHHHHHHTHHHH-
T ss_pred eeEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChh-hHHHHHHhcccc-
Confidence 9987654432 223567999999999998665 788999999999999999999998654321 111111110001
Q ss_pred cccCCCCCCcchHHHHHHHHHHHHHcccCCCCC--CCCHHHHHH
Q 044366 873 LDHRLPTPSRDVTDKLRSIMEVAILCLVENPEA--RPTMKEVCN 914 (918)
Q Consensus 873 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~--RPt~~evl~ 914 (918)
...+.. .. ....+.+++.+|++.+|++ ||+++|+++
T Consensus 292 --~~~p~~-~~---~s~~~~~li~~lL~~~~~rlgR~~~~ei~~ 329 (410)
T 3v8s_A 292 --LTFPDD-ND---ISKEAKNLICAFLTDREVRLGRNGVEEIKR 329 (410)
T ss_dssp --CCCCTT-CC---CCHHHHHHHHHHSSCGGGCTTSSCHHHHHT
T ss_pred --ccCCCc-cc---ccHHHHHHHHHHccChhhhCCCCCHHHHhc
Confidence 111111 11 1245788899999999998 999999975
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=369.60 Aligned_cols=255 Identities=23% Similarity=0.422 Sum_probs=207.7
Q ss_pred HHhcCCCCceeeccccceEEEEEEeCCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceE
Q 044366 643 KATGNFGEKYCIGKGGQRSVYKAELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSF 722 (918)
Q Consensus 643 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 722 (918)
...++|...+.||+|+||.||+|...+++.||||+++.. ....++|.+|+.+++.++||||+++++++. .+..+
T Consensus 185 i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~-----~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~ 258 (454)
T 1qcf_A 185 IPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG-----SMSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIY 258 (454)
T ss_dssp CCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTT-----SBCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCE
T ss_pred echHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCC-----CccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccE
Confidence 345678889999999999999999888899999998752 234789999999999999999999999986 56789
Q ss_pred EEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEecccccccc
Q 044366 723 IVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFL 802 (918)
Q Consensus 723 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~ 802 (918)
+||||+++|+|.++++... ...+++.+++.++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus 259 lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~ 334 (454)
T 1qcf_A 259 IITEFMAKGSLLDFLKSDE-GSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVI 334 (454)
T ss_dssp EEECCCTTCBHHHHHHSHH-HHTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTCCEEECSTTGGGGB
T ss_pred EEEeecCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEECCCCcEEEeeCCCceEc
Confidence 9999999999999997643 23478999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCC-CceecccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhhhhhhhhhHhhhhhhcccCCCCC
Q 044366 803 EPHSS-NWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIK-GYHPGDFVSTIFSSISNMIIEVNQILDHRLPTP 880 (918)
Q Consensus 803 ~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 880 (918)
..... ......++..|+|||++.+..++.++|||||||++|||++ |+.||...... .+. ..+.. ..+.+.+
T Consensus 335 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~--~~~---~~i~~--~~~~~~~ 407 (454)
T 1qcf_A 335 EDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP--EVI---RALER--GYRMPRP 407 (454)
T ss_dssp CCHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH--HHH---HHHHH--TCCCCCC
T ss_pred CCCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHH--HHH---HHHHc--CCCCCCC
Confidence 53211 1123346788999999998899999999999999999999 99998654321 111 11111 1112211
Q ss_pred CcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhC
Q 044366 881 SRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLLCK 918 (918)
Q Consensus 881 ~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~ 918 (918)
.. ....+.+++.+||+.||++|||+++|++.|+.
T Consensus 408 -~~---~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~ 441 (454)
T 1qcf_A 408 -EN---CPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 441 (454)
T ss_dssp -TT---SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred -CC---CCHHHHHHHHHHccCChhHCcCHHHHHHHHHH
Confidence 12 23468889999999999999999999999863
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-39 Score=354.42 Aligned_cols=252 Identities=23% Similarity=0.348 Sum_probs=203.9
Q ss_pred cCCCCceeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEEE
Q 044366 646 GNFGEKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFIV 724 (918)
Q Consensus 646 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 724 (918)
++|.+.+.||+|+||.||+|.. .+|+.||+|++...... .....+.+.+|+++++.++||||+++++++.+.+..++|
T Consensus 15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~-~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv 93 (384)
T 4fr4_A 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCV-ERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMV 93 (384)
T ss_dssp GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHH-HTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcc-cHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 6789999999999999999965 46899999998764322 233467899999999999999999999999999999999
Q ss_pred EEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccCC
Q 044366 725 CEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEP 804 (918)
Q Consensus 725 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~~ 804 (918)
|||+++|+|.+++... ..+++..++.++.||+.||+|||+. +|+||||||+||+++.++.+||+|||++..+..
T Consensus 94 ~e~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 167 (384)
T 4fr4_A 94 VDLLLGGDLRYHLQQN---VHFKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPR 167 (384)
T ss_dssp ECCCTTEEHHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEECCCCCEEEeccceeeeccC
Confidence 9999999999999764 3489999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCCceeccccccccccccccc---CCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCCCCC
Q 044366 805 HSSNWTEFAGTVGYAAPELAYT---MRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPS 881 (918)
Q Consensus 805 ~~~~~~~~~g~~~y~aPE~~~~---~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 881 (918)
. .......||+.|+|||++.+ ..++.++||||+||++|||++|+.||....... ....... +...... .+
T Consensus 168 ~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~--~~~~~~~---~~~~~~~-~p 240 (384)
T 4fr4_A 168 E-TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTS--SKEIVHT---FETTVVT-YP 240 (384)
T ss_dssp T-CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSC--HHHHHHH---HHHCCCC-CC
T ss_pred C-CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCcc--HHHHHHH---HhhcccC-CC
Confidence 3 33455689999999999864 458899999999999999999999986432211 1111111 1111111 11
Q ss_pred cchHHHHHHHHHHHHHcccCCCCCCCC-HHHHHH
Q 044366 882 RDVTDKLRSIMEVAILCLVENPEARPT-MKEVCN 914 (918)
Q Consensus 882 ~~~~~~~~~l~~li~~cl~~dp~~RPt-~~evl~ 914 (918)
.. ....+.+++.+||+.||++||+ ++++.+
T Consensus 241 ~~---~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 241 SA---WSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp TT---SCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred Cc---CCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 11 2246788999999999999998 676653
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=356.39 Aligned_cols=259 Identities=22% Similarity=0.330 Sum_probs=206.2
Q ss_pred HHhcCCCCceeeccccceEEEEEEe------CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhc-cCCceeeEeccc
Q 044366 643 KATGNFGEKYCIGKGGQRSVYKAEL------PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEI-RHRNIIKFHGFC 715 (918)
Q Consensus 643 ~~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~ 715 (918)
...++|...+.||+|+||.||+|.. .+++.||||+++... .....+.+.+|+.+++++ +||||+++++++
T Consensus 42 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 118 (344)
T 1rjb_A 42 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA---DSSEREALMSELKMMTQLGSHENIVNLLGAC 118 (344)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC---------CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc---CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 3557899999999999999999974 245689999987532 233457899999999999 899999999999
Q ss_pred ccCCceEEEEEeccCCChhHHhhccccc--------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEE
Q 044366 716 SNAQHSFIVCEYLARGSLTTILRDDAAA--------------------KEFSWNQRMNVIKGVANALSYLHHDCIPPIVH 775 (918)
Q Consensus 716 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~--------------------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH 775 (918)
..++..++||||+++|+|.+++...... ..+++.+++.++.|++.||+|||+. +|+|
T Consensus 119 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH 195 (344)
T 1rjb_A 119 TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVH 195 (344)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEE
T ss_pred eeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC---Cccc
Confidence 9999999999999999999999765321 3479999999999999999999999 9999
Q ss_pred cCCCCCCeeeCCCCcEEEeccccccccCCCCCC--ceecccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCC
Q 044366 776 RDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSN--WTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIK-GYHPG 852 (918)
Q Consensus 776 ~dlk~~Nill~~~~~~kl~DfG~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~p~ 852 (918)
|||||+||+++.++.+||+|||++......... .....||+.|+|||++.+..++.++||||||+++|||++ |..||
T Consensus 196 ~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~ 275 (344)
T 1rjb_A 196 RDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPY 275 (344)
T ss_dssp TTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSS
T ss_pred CCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCc
Confidence 999999999999999999999999876544332 223456889999999999899999999999999999998 99998
Q ss_pred CcchhhhhhhhhhHhhhhhhcccCCCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 044366 853 DFVSTIFSSISNMIIEVNQILDHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLLC 917 (918)
Q Consensus 853 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 917 (918)
........ .. ....... ....... ....+.+++.+||+.||.+|||+.|+++.|+
T Consensus 276 ~~~~~~~~-~~---~~~~~~~---~~~~~~~---~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~ 330 (344)
T 1rjb_A 276 PGIPVDAN-FY---KLIQNGF---KMDQPFY---ATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 330 (344)
T ss_dssp TTCCCSHH-HH---HHHHTTC---CCCCCTT---CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred ccCCcHHH-HH---HHHhcCC---CCCCCCC---CCHHHHHHHHHHcCCCchhCcCHHHHHHHHH
Confidence 65432111 11 1111111 1111111 2346888999999999999999999999885
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=355.42 Aligned_cols=251 Identities=22% Similarity=0.328 Sum_probs=190.0
Q ss_pred HhcCCCCceeeccccceEEEEEEeC-CCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceE
Q 044366 644 ATGNFGEKYCIGKGGQRSVYKAELP-SGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSF 722 (918)
Q Consensus 644 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 722 (918)
..++|...+.||+|+||.||+|+.. +++.||||+++... ..+.+.+|++++++++||||+++++++.+++..+
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 124 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV------DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEIS 124 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC----------------CHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch------hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEE
Confidence 4577999999999999999999664 68899999987531 2456889999999999999999999999999999
Q ss_pred EEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCC---CCcEEEeccccc
Q 044366 723 IVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDS---EYEAHVSDFGFA 799 (918)
Q Consensus 723 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~---~~~~kl~DfG~~ 799 (918)
+||||+++|+|.+++... ..+++.+++.++.|++.||+|||+. +|+||||||+||+++. ++.+||+|||++
T Consensus 125 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a 198 (349)
T 2w4o_A 125 LVLELVTGGELFDRIVEK---GYYSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLS 198 (349)
T ss_dssp EEECCCCSCBHHHHHTTC---SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESSSSTTCCEEECCCC--
T ss_pred EEEEeCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCcccEEEecCCCCCCEEEccCccc
Confidence 999999999999999764 3489999999999999999999999 9999999999999975 789999999999
Q ss_pred cccCCCCCCceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCCC
Q 044366 800 KFLEPHSSNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPT 879 (918)
Q Consensus 800 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 879 (918)
+...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.......... ..+.......
T Consensus 199 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~-------~~i~~~~~~~ 270 (349)
T 2w4o_A 199 KIVEHQV-LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMF-------RRILNCEYYF 270 (349)
T ss_dssp ---------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHH-------HHHHTTCCCC
T ss_pred cccCccc-ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHH-------HHHHhCCCcc
Confidence 8765432 2344678999999999999899999999999999999999999986443221111 1111111111
Q ss_pred CCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 880 PSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 880 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
...........+.+++.+||+.||++|||+.|+++
T Consensus 271 ~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 305 (349)
T 2w4o_A 271 ISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ 305 (349)
T ss_dssp CTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 11111223356889999999999999999999986
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-39 Score=346.01 Aligned_cols=248 Identities=27% Similarity=0.407 Sum_probs=205.3
Q ss_pred hcCCCCceeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEE
Q 044366 645 TGNFGEKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFI 723 (918)
Q Consensus 645 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 723 (918)
.++|...+.||+|+||.||+|+. .+|+.||+|+++..... .....+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 83 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVV-RLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFM 83 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHH-HTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEE
Confidence 36788999999999999999965 47999999999764322 22346788999999999999999999999999999999
Q ss_pred EEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccC
Q 044366 724 VCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLE 803 (918)
Q Consensus 724 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~ 803 (918)
||||+++|+|.+++... ..+++..++.++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 84 v~e~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~ 157 (318)
T 1fot_A 84 IMDYIEGGELFSLLRKS---QRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVP 157 (318)
T ss_dssp EECCCCSCBHHHHHHHT---SSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECS
T ss_pred EEeCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChheEEEcCCCCEEEeecCcceecC
Confidence 99999999999999764 3489999999999999999999999 99999999999999999999999999998764
Q ss_pred CCCCCceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCCCCCcc
Q 044366 804 PHSSNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRD 883 (918)
Q Consensus 804 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 883 (918)
.. .....||+.|+|||++.+..++.++||||+||++|||++|+.||...... .. ...+.......+ ..
T Consensus 158 ~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-~~-------~~~i~~~~~~~p-~~ 225 (318)
T 1fot_A 158 DV---TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTM-KT-------YEKILNAELRFP-PF 225 (318)
T ss_dssp SC---BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH-HH-------HHHHHHCCCCCC-TT
T ss_pred Cc---cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH-HH-------HHHHHhCCCCCC-CC
Confidence 32 23457899999999999999999999999999999999999998654321 11 111112222111 11
Q ss_pred hHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 044366 884 VTDKLRSIMEVAILCLVENPEARP-----TMKEVCN 914 (918)
Q Consensus 884 ~~~~~~~l~~li~~cl~~dp~~RP-----t~~evl~ 914 (918)
....+.+++.+|++.||++|| +++|+++
T Consensus 226 ---~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~ 258 (318)
T 1fot_A 226 ---FNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 258 (318)
T ss_dssp ---SCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred ---CCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence 124678899999999999999 8888874
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=359.00 Aligned_cols=256 Identities=25% Similarity=0.375 Sum_probs=204.6
Q ss_pred hcCCCCceeeccccceEEEEEEeC------CCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccC
Q 044366 645 TGNFGEKYCIGKGGQRSVYKAELP------SGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNA 718 (918)
Q Consensus 645 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~ 718 (918)
.++|...+.||+|+||.||+|.+. +++.||||+++... .......+.+|+.++++++||||+++++++.++
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 146 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC---SEQDELDFLMEALIISKFNHQNIVRCIGVSLQS 146 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSC---CHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEeccccc---ChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecC
Confidence 367888999999999999999742 46789999986421 222345789999999999999999999999999
Q ss_pred CceEEEEEeccCCChhHHhhccc----ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCC---cE
Q 044366 719 QHSFIVCEYLARGSLTTILRDDA----AAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEY---EA 791 (918)
Q Consensus 719 ~~~~lv~e~~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~---~~ 791 (918)
+..++||||+++|+|.++++... ....+++.+++.++.||++||+|||+. +|+||||||+||+++.++ .+
T Consensus 147 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~ 223 (367)
T 3l9p_A 147 LPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVA 223 (367)
T ss_dssp SSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCE
T ss_pred CCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEEecCCCCceE
Confidence 99999999999999999997653 124589999999999999999999999 999999999999999555 59
Q ss_pred EEeccccccccCCCC--CCceecccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhhhhhhhhhHhh
Q 044366 792 HVSDFGFAKFLEPHS--SNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIK-GYHPGDFVSTIFSSISNMIIE 868 (918)
Q Consensus 792 kl~DfG~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~p~~~~~~~~~~~~~~~~~ 868 (918)
||+|||+++...... .......||+.|+|||++.+..++.++|||||||++|||++ |+.||...... ....
T Consensus 224 kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~-----~~~~- 297 (367)
T 3l9p_A 224 KIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ-----EVLE- 297 (367)
T ss_dssp EECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH-----HHHH-
T ss_pred EECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH-----HHHH-
Confidence 999999998653221 22234567899999999999999999999999999999998 99998654321 1111
Q ss_pred hhhhcccCCCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 044366 869 VNQILDHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLLC 917 (918)
Q Consensus 869 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 917 (918)
.+............ ...+.+++.+||+.||++|||++|+++.|+
T Consensus 298 --~i~~~~~~~~~~~~---~~~l~~li~~~l~~dP~~Rps~~eil~~l~ 341 (367)
T 3l9p_A 298 --FVTSGGRMDPPKNC---PGPVYRIMTQCWQHQPEDRPNFAIILERIE 341 (367)
T ss_dssp --HHHTTCCCCCCTTC---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred --HHHcCCCCCCCccC---CHHHHHHHHHHcCCCHhHCcCHHHHHHHHH
Confidence 11111111111222 245788999999999999999999999885
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-39 Score=353.95 Aligned_cols=253 Identities=22% Similarity=0.318 Sum_probs=206.4
Q ss_pred HHhcCCCCceeeccccceEEEEEEeC-CCCEEEEEEcccccccCCCCChHHHHHHHHHHhhc-cCCceeeEecccccCCc
Q 044366 643 KATGNFGEKYCIGKGGQRSVYKAELP-SGNIFAVKKFKAELFSDETANPSEFLNEVLALTEI-RHRNIIKFHGFCSNAQH 720 (918)
Q Consensus 643 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~ 720 (918)
...++|...+.||+|+||.||+|+.. +|+.||+|+++...... ....+.+..|..++..+ +||+|+++++++.+.+.
T Consensus 17 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~-~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~ 95 (353)
T 2i0e_A 17 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQ-DDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDR 95 (353)
T ss_dssp --CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHH-TTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSE
T ss_pred CchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhc-chHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCE
Confidence 34578999999999999999999665 58899999997643222 23467789999999888 89999999999999999
Q ss_pred eEEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEecccccc
Q 044366 721 SFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAK 800 (918)
Q Consensus 721 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~ 800 (918)
.++||||+++|+|.+++.... .+++.+++.++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++
T Consensus 96 ~~lv~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~ 169 (353)
T 2i0e_A 96 LYFVMEYVNGGDLMYHIQQVG---RFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCK 169 (353)
T ss_dssp EEEEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred EEEEEeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEEcCCCcEEEEeCCccc
Confidence 999999999999999997643 489999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCCceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCCCC
Q 044366 801 FLEPHSSNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTP 880 (918)
Q Consensus 801 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 880 (918)
.............||+.|+|||++.+..++.++|||||||++|||++|+.||...... .. ...+.......+
T Consensus 170 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~-----~~---~~~i~~~~~~~p 241 (353)
T 2i0e_A 170 ENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED-----EL---FQSIMEHNVAYP 241 (353)
T ss_dssp CCCCTTCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH-----HH---HHHHHHCCCCCC
T ss_pred ccccCCcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHH-----HH---HHHHHhCCCCCC
Confidence 7554444455678999999999999999999999999999999999999998654321 11 111112222211
Q ss_pred CcchHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 044366 881 SRDVTDKLRSIMEVAILCLVENPEARPT-----MKEVCN 914 (918)
Q Consensus 881 ~~~~~~~~~~l~~li~~cl~~dp~~RPt-----~~evl~ 914 (918)
.. ....+.+++.+||+.||++||+ ++|+++
T Consensus 242 -~~---~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~ 276 (353)
T 2i0e_A 242 -KS---MSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 276 (353)
T ss_dssp -TT---SCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred -CC---CCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 11 2346788999999999999995 566653
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=355.89 Aligned_cols=263 Identities=23% Similarity=0.239 Sum_probs=205.3
Q ss_pred HHHHhcCCCCceeeccccceEEEEEEe-CCCCEEEEEEcccccccC-CCCChHHHHHHHHHHhhccCCceeeEecccccC
Q 044366 641 ITKATGNFGEKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSD-ETANPSEFLNEVLALTEIRHRNIIKFHGFCSNA 718 (918)
Q Consensus 641 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~ 718 (918)
+....++|...+.||+|+||.||+|.. .+++.||+|++....... .....+.+.+|+++++.++||||+++++++.++
T Consensus 21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 100 (345)
T 3hko_A 21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDE 100 (345)
T ss_dssp HHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred hhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccC
Confidence 346678899999999999999999955 578999999987643221 233467899999999999999999999999999
Q ss_pred CceEEEEEeccCCChhHHhhcccc-------------------------------------cCCCCHHHHHHHHHHHHHH
Q 044366 719 QHSFIVCEYLARGSLTTILRDDAA-------------------------------------AKEFSWNQRMNVIKGVANA 761 (918)
Q Consensus 719 ~~~~lv~e~~~~gsL~~~l~~~~~-------------------------------------~~~l~~~~~~~i~~~i~~~ 761 (918)
+..++||||+++|+|.+++..... ...+++..++.++.|++.|
T Consensus 101 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~ 180 (345)
T 3hko_A 101 QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA 180 (345)
T ss_dssp SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHH
T ss_pred CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHH
Confidence 999999999999999999863110 1124677889999999999
Q ss_pred HHHHHhCCCCCeEEcCCCCCCeeeCCCC--cEEEeccccccccCCCCC----Cceeccccccccccccccc--CCCCccc
Q 044366 762 LSYLHHDCIPPIVHRDISSKNVLLDSEY--EAHVSDFGFAKFLEPHSS----NWTEFAGTVGYAAPELAYT--MRATEKY 833 (918)
Q Consensus 762 l~~LH~~~~~~ivH~dlk~~Nill~~~~--~~kl~DfG~~~~~~~~~~----~~~~~~g~~~y~aPE~~~~--~~~~~~~ 833 (918)
|+|||+. +|+||||||+||+++.++ .+||+|||++..+..... ......||+.|+|||++.+ ..++.++
T Consensus 181 l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~ 257 (345)
T 3hko_A 181 LHYLHNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKC 257 (345)
T ss_dssp HHHHHHT---TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHH
T ss_pred HHHHHHC---CccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHH
Confidence 9999999 999999999999998776 899999999987643221 2345678999999999875 6788999
Q ss_pred chhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHH
Q 044366 834 DVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVC 913 (918)
Q Consensus 834 Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl 913 (918)
||||||+++|||++|+.||....... . ...+..................+.+++.+||+.||.+|||+.|++
T Consensus 258 DiwslG~il~el~~g~~pf~~~~~~~-~-------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l 329 (345)
T 3hko_A 258 DAWSAGVLLHLLLMGAVPFPGVNDAD-T-------ISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRAL 329 (345)
T ss_dssp HHHHHHHHHHHHHHSSCSSCCSSHHH-H-------HHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHH
T ss_pred HHHHHHHHHHHHHHCCCCCCCCChHH-H-------HHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHh
Confidence 99999999999999999986543321 1 111112222222222222345688999999999999999999998
Q ss_pred H
Q 044366 914 N 914 (918)
Q Consensus 914 ~ 914 (918)
+
T Consensus 330 ~ 330 (345)
T 3hko_A 330 Q 330 (345)
T ss_dssp H
T ss_pred c
Confidence 6
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=344.27 Aligned_cols=252 Identities=24% Similarity=0.375 Sum_probs=185.3
Q ss_pred hcCCCCceeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEE
Q 044366 645 TGNFGEKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFI 723 (918)
Q Consensus 645 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 723 (918)
.++|.+.+.||+|+||.||+|.. .+|+.||||++....... ....+.+.+|+++++.++||||+++++++.+.+..++
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 88 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYK-AGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYL 88 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHH-TTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhh-hhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEE
Confidence 46789999999999999999965 579999999986543222 2335789999999999999999999999999999999
Q ss_pred EEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccC
Q 044366 724 VCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLE 803 (918)
Q Consensus 724 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~ 803 (918)
||||+++++|.+++... ...+++.+++.++.|+++||+|||+. +++||||||+||+++.++.+||+|||.+....
T Consensus 89 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~ 163 (278)
T 3cok_A 89 VLEMCHNGEMNRYLKNR--VKPFSENEARHFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLK 163 (278)
T ss_dssp EEECCTTEEHHHHHHTC--SSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSSCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEecCCCCcHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEEeecceeecc
Confidence 99999999999999764 24589999999999999999999999 99999999999999999999999999998776
Q ss_pred CCCCCceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCCCCCcc
Q 044366 804 PHSSNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRD 883 (918)
Q Consensus 804 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 883 (918)
..........|++.|+|||.+.+..++.++||||+|+++|||++|+.||...... .. ...........+ ..
T Consensus 164 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-----~~---~~~~~~~~~~~~-~~ 234 (278)
T 3cok_A 164 MPHEKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVK-----NT---LNKVVLADYEMP-SF 234 (278)
T ss_dssp ----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-------------CCSSCCCCC-TT
T ss_pred CCCCcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHH-----HH---HHHHhhcccCCc-cc
Confidence 4444444567899999999999888999999999999999999999998643211 00 011111111111 11
Q ss_pred hHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 884 VTDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 884 ~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
....+.+++.+||+.||++|||++|+++
T Consensus 235 ---~~~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 235 ---LSIEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp ---SCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred ---cCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 2246788999999999999999999975
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=357.94 Aligned_cols=247 Identities=22% Similarity=0.295 Sum_probs=197.1
Q ss_pred CceeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEEEEEec
Q 044366 650 EKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFIVCEYL 728 (918)
Q Consensus 650 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 728 (918)
..+.||+|+||.||+|.. .+|+.||+|+++... ....+.+.+|++++++++||||+++++++.+.+..++||||+
T Consensus 93 ~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~ 168 (373)
T 2x4f_A 93 KTEILGGGRFGQVHKCEETATGLKLAAKIIKTRG----MKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYV 168 (373)
T ss_dssp EEEECC-----CEEEEEETTTCCEEEEEEEECCS----HHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred cceEEecCcCEEEEEEEEcCCCcEEEEEEEcccc----cccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCC
Confidence 356799999999999965 579999999987532 123568999999999999999999999999999999999999
Q ss_pred cCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeee--CCCCcEEEeccccccccCCCC
Q 044366 729 ARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLL--DSEYEAHVSDFGFAKFLEPHS 806 (918)
Q Consensus 729 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill--~~~~~~kl~DfG~~~~~~~~~ 806 (918)
++|+|.+++... ...+++.+++.++.||++||+|||+. +|+||||||+||++ +.++.+||+|||+++.+.+..
T Consensus 169 ~~~~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~ 243 (373)
T 2x4f_A 169 DGGELFDRIIDE--SYNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE 243 (373)
T ss_dssp TTCEEHHHHHHT--GGGCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC
T ss_pred CCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc
Confidence 999999988754 23589999999999999999999999 99999999999999 667899999999998876433
Q ss_pred CCceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCCCCCcchHH
Q 044366 807 SNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRDVTD 886 (918)
Q Consensus 807 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 886 (918)
. .....||+.|+|||++.+..++.++|||||||++|||++|+.||...... .. ...+....+.........
T Consensus 244 ~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~-~~-------~~~i~~~~~~~~~~~~~~ 314 (373)
T 2x4f_A 244 K-LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDA-ET-------LNNILACRWDLEDEEFQD 314 (373)
T ss_dssp B-CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHH-HH-------HHHHHHTCCCSCSGGGTT
T ss_pred c-cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH-HH-------HHHHHhccCCCChhhhcc
Confidence 2 33457899999999999889999999999999999999999998654321 11 111122222222222223
Q ss_pred HHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 887 KLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 887 ~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
....+.+++.+||+.||.+|||++|+++
T Consensus 315 ~~~~~~~li~~~L~~dp~~Rps~~e~l~ 342 (373)
T 2x4f_A 315 ISEEAKEFISKLLIKEKSWRISASEALK 342 (373)
T ss_dssp SCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 3457889999999999999999999986
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-39 Score=348.64 Aligned_cols=255 Identities=21% Similarity=0.286 Sum_probs=207.1
Q ss_pred hcCCCCceeeccccceEEEEEEe-CCCCEEEEEEcccccccCC--CCChHHHHHHHHHHhhccCCceeeEecccccCCce
Q 044366 645 TGNFGEKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDE--TANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHS 721 (918)
Q Consensus 645 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 721 (918)
.++|.+.+.||+|+||.||+|.. .+|+.||||++........ ....+.+.+|+.+++.++||||+++++++.+++..
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 46788999999999999999965 4799999999876433221 12367899999999999999999999999999999
Q ss_pred EEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCC----cEEEeccc
Q 044366 722 FIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEY----EAHVSDFG 797 (918)
Q Consensus 722 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~----~~kl~DfG 797 (918)
++||||+++++|.+++... ..+++.+++.++.|++.||+|||+. +|+||||||+||+++.++ .+||+|||
T Consensus 91 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~lH~~---~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg 164 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQK---ESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFG 164 (321)
T ss_dssp EEEECCCCSCBHHHHHHTC---SCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCCT
T ss_pred EEEEEcCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChHHEEEecCCCCcCCEEEccCc
Confidence 9999999999999999764 3489999999999999999999999 999999999999999887 79999999
Q ss_pred cccccCCCCCCceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCC
Q 044366 798 FAKFLEPHSSNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRL 877 (918)
Q Consensus 798 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 877 (918)
++....... ......||+.|+|||++.+..++.++||||||+++|+|++|+.||...... ... ..+.....
T Consensus 165 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-~~~-------~~i~~~~~ 235 (321)
T 2a2a_A 165 LAHEIEDGV-EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ-ETL-------ANITSVSY 235 (321)
T ss_dssp TCEECCTTC-CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH-HHH-------HHHHTTCC
T ss_pred cceecCccc-cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHH-HHH-------HHHHhccc
Confidence 998775432 234457899999999999989999999999999999999999998654321 111 11111111
Q ss_pred CCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 878 PTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 878 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
..+..........+.+++.+||+.||++|||++|+++
T Consensus 236 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~ 272 (321)
T 2a2a_A 236 DFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALR 272 (321)
T ss_dssp CCCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred ccChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 1111001122356889999999999999999999986
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=353.92 Aligned_cols=252 Identities=23% Similarity=0.303 Sum_probs=201.6
Q ss_pred HhcCCCCceeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhc-cCCceeeEecccccCCce
Q 044366 644 ATGNFGEKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEI-RHRNIIKFHGFCSNAQHS 721 (918)
Q Consensus 644 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~ 721 (918)
..++|...+.||+|+||.||+|.. .+|+.||||++.... ..+.+|++++.++ +||||+++++++.+++..
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~--------~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~ 91 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSK--------RDPTEEIEILLRYGQHPNIITLKDVYDDGKYV 91 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTT--------CCCHHHHHHHHHHTTSTTBCCEEEEEECSSEE
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEccc--------CChHHHHHHHHHhcCCCCcCeEEEEEEcCCEE
Confidence 356799999999999999999965 478999999986531 1235788888888 799999999999999999
Q ss_pred EEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCC----CcEEEeccc
Q 044366 722 FIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSE----YEAHVSDFG 797 (918)
Q Consensus 722 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~----~~~kl~DfG 797 (918)
++||||+++|+|.+++... ..+++.+++.++.||+.||+|||+. +|+||||||+||++.++ +.+||+|||
T Consensus 92 ~lv~E~~~gg~L~~~i~~~---~~~~~~~~~~~~~qi~~al~~lH~~---givHrDlkp~NIl~~~~~~~~~~~kl~Dfg 165 (342)
T 2qr7_A 92 YVVTELMKGGELLDKILRQ---KFFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFG 165 (342)
T ss_dssp EEEECCCCSCBHHHHHHTC---TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSCSGGGEEECCCT
T ss_pred EEEEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcEeccCCHHHEEEecCCCCcCeEEEEECC
Confidence 9999999999999999764 3489999999999999999999999 99999999999998543 359999999
Q ss_pred cccccCCCCCCceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCC
Q 044366 798 FAKFLEPHSSNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRL 877 (918)
Q Consensus 798 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 877 (918)
++..............||+.|+|||++.+..++.++||||+||++|||++|+.||...... ...... ..+.....
T Consensus 166 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~--~~~~~~---~~i~~~~~ 240 (342)
T 2qr7_A 166 FAKQLRAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDD--TPEEIL---ARIGSGKF 240 (342)
T ss_dssp TCEECBCTTCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTS--CHHHHH---HHHHHCCC
T ss_pred CcccCcCCCCceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcC--CHHHHH---HHHccCCc
Confidence 9998766555555667899999999998888999999999999999999999998643211 011111 11111222
Q ss_pred CCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 878 PTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 878 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
.............+.+++.+||+.||++|||++|+++
T Consensus 241 ~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~ 277 (342)
T 2qr7_A 241 SLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR 277 (342)
T ss_dssp CCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred ccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 2111111223356888999999999999999999875
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=341.43 Aligned_cols=256 Identities=29% Similarity=0.421 Sum_probs=201.6
Q ss_pred hcCCCCceeeccccceEEEEEEe-CCCCEEEEEEcccccccCCC---CChHHHHHHHHHHhhccCCceeeEecccccCCc
Q 044366 645 TGNFGEKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDET---ANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQH 720 (918)
Q Consensus 645 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 720 (918)
.++|...+.||+|+||.||+|+. .+++.||+|++......... ...+.+.+|++++++++||||+++++++.+..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 96 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP- 96 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence 46889999999999999999965 57999999998653222111 11267999999999999999999999987655
Q ss_pred eEEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--eEEcCCCCCCeeeCCCCc-----EEE
Q 044366 721 SFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPP--IVHRDISSKNVLLDSEYE-----AHV 793 (918)
Q Consensus 721 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~--ivH~dlk~~Nill~~~~~-----~kl 793 (918)
++||||+++|+|.+++... ...+++..++.++.|++.||+|||+. + |+||||||+||+++.++. +||
T Consensus 97 -~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~ivH~dikp~Nil~~~~~~~~~~~~kl 170 (287)
T 4f0f_A 97 -RMVMEFVPCGDLYHRLLDK--AHPIKWSVKLRLMLDIALGIEYMQNQ---NPPIVHRDLRSPNIFLQSLDENAPVCAKV 170 (287)
T ss_dssp -EEEEECCTTCBHHHHHHCT--TSCCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCSCCSGGGEEESCCCTTCSCCEEE
T ss_pred -eEEEEecCCCCHHHHHhcc--cCCccHHHHHHHHHHHHHHHHHHHhC---CCCeecCCCCcceEEEeccCCCCceeEEe
Confidence 7999999999999988754 34589999999999999999999999 8 999999999999988776 999
Q ss_pred eccccccccCCCCCCceecccccccccccccc--cCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhh
Q 044366 794 SDFGFAKFLEPHSSNWTEFAGTVGYAAPELAY--TMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQ 871 (918)
Q Consensus 794 ~DfG~~~~~~~~~~~~~~~~g~~~y~aPE~~~--~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 871 (918)
+|||+++.... ......|++.|+|||++. ...++.++||||+|+++|||++|+.||.............. ...
T Consensus 171 ~Dfg~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~--~~~ 245 (287)
T 4f0f_A 171 ADFGLSQQSVH---SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMI--REE 245 (287)
T ss_dssp CCCTTCBCCSS---CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHH--HHS
T ss_pred CCCCccccccc---cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHH--hcc
Confidence 99999985433 334567899999999984 45578899999999999999999999864432111101000 001
Q ss_pred hcccCCCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhC
Q 044366 872 ILDHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLLCK 918 (918)
Q Consensus 872 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~ 918 (918)
...+..... ....+.+++.+||+.||++|||++|+++.|++
T Consensus 246 ---~~~~~~~~~---~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 286 (287)
T 4f0f_A 246 ---GLRPTIPED---CPPRLRNVIELCWSGDPKKRPHFSYIVKELSE 286 (287)
T ss_dssp ---CCCCCCCTT---SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred ---CCCCCCCcc---cCHHHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence 111111111 23468889999999999999999999999874
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-39 Score=351.29 Aligned_cols=247 Identities=23% Similarity=0.306 Sum_probs=205.3
Q ss_pred cCCCCceeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEEE
Q 044366 646 GNFGEKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFIV 724 (918)
Q Consensus 646 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 724 (918)
++|...+.||+|+||.||+|+. .+|+.||+|++...... .....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 119 (350)
T 1rdq_E 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVV-KLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHH-HTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhc-cHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence 6788999999999999999965 47999999998764322 223467899999999999999999999999999999999
Q ss_pred EEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccCC
Q 044366 725 CEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEP 804 (918)
Q Consensus 725 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~~ 804 (918)
|||+++|+|.+++.... .+++.+++.++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 120 ~e~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~ 193 (350)
T 1rdq_E 120 MEYVAGGEMFSHLRRIG---RFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193 (350)
T ss_dssp EECCTTCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred EcCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCccceEEECCCCCEEEcccccceeccC
Confidence 99999999999998643 489999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCCceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCCCCCcch
Q 044366 805 HSSNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRDV 884 (918)
Q Consensus 805 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 884 (918)
. .....||+.|+|||++.+..++.++|||||||++|||++|+.||...... .. ...+.......+ ..
T Consensus 194 ~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~-~~-------~~~i~~~~~~~p-~~- 260 (350)
T 1rdq_E 194 R---TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI-QI-------YEKIVSGKVRFP-SH- 260 (350)
T ss_dssp C---BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HH-------HHHHHHCCCCCC-TT-
T ss_pred C---cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHH-HH-------HHHHHcCCCCCC-CC-
Confidence 3 23457899999999999999999999999999999999999998654321 11 111111222111 11
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 044366 885 TDKLRSIMEVAILCLVENPEARPT-----MKEVCN 914 (918)
Q Consensus 885 ~~~~~~l~~li~~cl~~dp~~RPt-----~~evl~ 914 (918)
....+.+++.+||+.||++||+ ++|+++
T Consensus 261 --~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~ 293 (350)
T 1rdq_E 261 --FSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp --CCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred --CCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence 2246788999999999999998 888764
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=356.14 Aligned_cols=345 Identities=29% Similarity=0.425 Sum_probs=154.1
Q ss_pred CCCCCEEeCCCCcccccCCccccCCCCCCEEEcccccccccCCCCcCCCCCCCEEEcccccccccCCccccCCCCCCEEE
Q 044366 20 LSKLQYLDLGNNQLSGVIPPEIGKLNQLRRLYLDVNQLHGTIPPVIGQLSLINELVFCHNNVSGRIPSSLGNLSNLALLY 99 (918)
Q Consensus 20 l~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~l~~l~~L~~L~ 99 (918)
+++|+.|+++++.++ .+| .+..+++|++|+|++|++++ +|. +..+++|++|++++|.+++..| +.++++|++|+
T Consensus 45 l~~l~~L~l~~~~i~-~l~-~~~~l~~L~~L~Ls~n~l~~-~~~-~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~ 118 (466)
T 1o6v_A 45 LDQVTTLQADRLGIK-SID-GVEYLNNLTQINFSNNQLTD-ITP-LKNLTKLVDILMNNNQIADITP--LANLTNLTGLT 118 (466)
T ss_dssp HHTCCEEECCSSCCC-CCT-TGGGCTTCCEEECCSSCCCC-CGG-GTTCTTCCEEECCSSCCCCCGG--GTTCTTCCEEE
T ss_pred hccccEEecCCCCCc-cCc-chhhhcCCCEEECCCCccCC-chh-hhccccCCEEECCCCccccChh--hcCCCCCCEEE
Confidence 445555555555554 333 25555555555555555552 222 4455555555555554443222 44444455555
Q ss_pred ccCCcccccCccccCCCCCCCEEECcCCcCCCcCCcCCCCCCCCceeeccccccccCCCcccccccccCeeeccccccCC
Q 044366 100 LNDNSLFGSIPIVMGNLKSLSTLDLSQNQLNGSIPCSLDNLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSENRLSG 179 (918)
Q Consensus 100 L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~ 179 (918)
+++|++.+..+ +..+++|++|++++|.+++. + .+.++++|++|+++ |.+.+.. .+..+++|++|++++|.+++
T Consensus 119 L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~-~-~~~~l~~L~~L~l~-~~~~~~~--~~~~l~~L~~L~l~~n~l~~ 191 (466)
T 1o6v_A 119 LFNNQITDIDP--LKNLTNLNRLELSSNTISDI-S-ALSGLTSLQQLSFG-NQVTDLK--PLANLTTLERLDISSNKVSD 191 (466)
T ss_dssp CCSSCCCCCGG--GTTCTTCSEEEEEEEEECCC-G-GGTTCTTCSEEEEE-ESCCCCG--GGTTCTTCCEEECCSSCCCC
T ss_pred CCCCCCCCChH--HcCCCCCCEEECCCCccCCC-h-hhccCCcccEeecC-CcccCch--hhccCCCCCEEECcCCcCCC
Confidence 54444443221 44444444444444444421 1 24444444444443 2222221 14444444444444444443
Q ss_pred cCCccCCCCCCCcEeeccCcccccCCCccccCCCCcceeecccccccCCCCCCCcCCCcCCeEEcccCcCcCCCCccccc
Q 044366 180 LIPLSLSNLSSLTVMSLFNNSLSGSIPPILGNLKSLSTLGLHINQLNGVIPPSIGNLSSLRNLSLFNNRLYGFVPKEIGY 259 (918)
Q Consensus 180 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~ 259 (918)
+ ..+..+++|++|++++|.+++..+ +..+++|+.|++++|++++. ..+..
T Consensus 192 ~--------------------------~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~l~~ 241 (466)
T 1o6v_A 192 I--------------------------SVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDI--GTLAS 241 (466)
T ss_dssp C--------------------------GGGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC--GGGGG
T ss_pred C--------------------------hhhccCCCCCEEEecCCccccccc--ccccCCCCEEECCCCCcccc--hhhhc
Confidence 2 224444444444444444443322 33444444444444444432 23444
Q ss_pred cCCCCeEecCCCccCCcCCCcCCCCCCCcEEEccCCcCcCCCCccccCCCCCCeEEeecccccCccccccCCCCCccEEe
Q 044366 260 LKSLSKLEFCANHLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLRNLTSLERVRFNQNNLYGKVYEAFGDHPNLTFLD 339 (918)
Q Consensus 260 l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ 339 (918)
+++|+.|++++|.+.+..+ +..+++|+.|++++|++.+..+ +..+++|++|++++|.+..+.+ +..+++|+.|+
T Consensus 242 l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~ 315 (466)
T 1o6v_A 242 LTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISP--ISNLKNLTYLT 315 (466)
T ss_dssp CTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCSCCGG--GGGCTTCSEEE
T ss_pred CCCCCEEECCCCccccchh--hhcCCCCCEEECCCCccCcccc--ccCCCccCeEEcCCCcccCchh--hcCCCCCCEEE
Confidence 4444444444444443332 4444444444444444443222 4444444444444444444332 34444444444
Q ss_pred CCCCccccccCcccccccccceeeccccccccCCCcCcCCCCCCcEEEccCceeccccccchhhccccCceecccccccC
Q 044366 340 LSQNNFYCEISFNWRNFSKLGTFNASMNNIYGSIPPEIGDSSKLQVLDLSSNHIFGKIPVQLVKLFSLNKLILSLNQLFG 419 (918)
Q Consensus 340 Ls~N~l~~~~~~~~~~~~~L~~l~l~~n~i~~~~~~~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 419 (918)
+++|+++.. .| +..+++|+.|++++|++++. ..+..+++|+.|++++|++++
T Consensus 316 L~~n~l~~~------------------------~~--~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~ 367 (466)
T 1o6v_A 316 LYFNNISDI------------------------SP--VSSLTKLQRLFFYNNKVSDV--SSLANLTNINWLSAGHNQISD 367 (466)
T ss_dssp CCSSCCSCC------------------------GG--GGGCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCB
T ss_pred CcCCcCCCc------------------------hh--hccCccCCEeECCCCccCCc--hhhccCCCCCEEeCCCCccCc
Confidence 444444322 11 33344444444444444432 234444445555555554444
Q ss_pred CCCCCCCCCCcccEEeccCccccc
Q 044366 420 GVPLEFGTLTELQYLDLSANKLSS 443 (918)
Q Consensus 420 ~~~~~~~~l~~L~~L~Ls~N~l~~ 443 (918)
..| +..+++|++|++++|.+++
T Consensus 368 ~~~--~~~l~~L~~L~l~~n~~~~ 389 (466)
T 1o6v_A 368 LTP--LANLTRITQLGLNDQAWTN 389 (466)
T ss_dssp CGG--GTTCTTCCEEECCCEEEEC
T ss_pred cch--hhcCCCCCEEeccCCcccC
Confidence 443 4445555555555555553
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-39 Score=362.18 Aligned_cols=264 Identities=20% Similarity=0.253 Sum_probs=209.2
Q ss_pred HHHHHHHhcCCCCceeeccccceEEEEEEeC-CCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccc
Q 044366 638 YEEITKATGNFGEKYCIGKGGQRSVYKAELP-SGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCS 716 (918)
Q Consensus 638 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~ 716 (918)
+.+.....++|...++||+|+||.||+|+.. +++.||+|+++...... ....+.+.+|..+++.++||||+++++++.
T Consensus 66 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~-~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 144 (437)
T 4aw2_A 66 VKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLK-RAETACFREERDVLVNGDSKWITTLHYAFQ 144 (437)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHH-TTTTCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred hhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhh-HHHHHHHHHHHHHHHhCCCCCEEEEEEEEe
Confidence 3455556789999999999999999999765 58899999987632222 222455899999999999999999999999
Q ss_pred cCCceEEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEecc
Q 044366 717 NAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDF 796 (918)
Q Consensus 717 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Df 796 (918)
+++..++||||+++|+|.+++... ...+++..++.++.||+.||+|||+. +||||||||+||+++.++.+||+||
T Consensus 145 ~~~~~~lV~Ey~~gg~L~~~l~~~--~~~l~e~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILl~~~g~vkL~DF 219 (437)
T 4aw2_A 145 DDNNLYLVMDYYVGGDLLTLLSKF--EDRLPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADF 219 (437)
T ss_dssp CSSEEEEEECCCTTCBHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCC
T ss_pred eCCEEEEEEecCCCCcHHHHHHHc--cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeeEcCCCCEEEcch
Confidence 999999999999999999999763 24589999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCCC-ceecccccccccccccc-----cCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhh
Q 044366 797 GFAKFLEPHSSN-WTEFAGTVGYAAPELAY-----TMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVN 870 (918)
Q Consensus 797 G~~~~~~~~~~~-~~~~~g~~~y~aPE~~~-----~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~ 870 (918)
|+++........ ....+||+.|+|||++. ...++.++|||||||++|||++|+.||...... ...........
T Consensus 220 Gla~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~-~~~~~i~~~~~ 298 (437)
T 4aw2_A 220 GSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV-ETYGKIMNHKE 298 (437)
T ss_dssp TTCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHH-HHHHHHHTHHH
T ss_pred hhhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChh-HHHHhhhhccc
Confidence 999876544332 23467999999999987 456899999999999999999999998754321 11111111101
Q ss_pred hhcccCCCCCCcchHHHHHHHHHHHHHcccCCCCC--CCCHHHHHH
Q 044366 871 QILDHRLPTPSRDVTDKLRSIMEVAILCLVENPEA--RPTMKEVCN 914 (918)
Q Consensus 871 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~--RPt~~evl~ 914 (918)
....+..... ....+.+++.+|+..+|++ ||+++|+++
T Consensus 299 ---~~~~p~~~~~---~s~~~~dLi~~lL~~~~~r~~r~~~~eil~ 338 (437)
T 4aw2_A 299 ---RFQFPTQVTD---VSENAKDLIRRLICSREHRLGQNGIEDFKK 338 (437)
T ss_dssp ---HCCCCSSCCC---SCHHHHHHHHTTSSCGGGCTTTTTTHHHHT
T ss_pred ---cccCCccccc---CCHHHHHHHHHHhcccccccCCCCHHHHhC
Confidence 1112221111 2245778899999888888 999999875
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-39 Score=369.60 Aligned_cols=255 Identities=24% Similarity=0.394 Sum_probs=208.0
Q ss_pred HhcCCCCceeeccccceEEEEEEeC-CCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceE
Q 044366 644 ATGNFGEKYCIGKGGQRSVYKAELP-SGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSF 722 (918)
Q Consensus 644 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 722 (918)
...+|...+.||+|+||.||+|... +++.||||+++.. ....++|.+|++++++++||||++++++|.+++..+
T Consensus 218 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 292 (495)
T 1opk_A 218 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-----TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY 292 (495)
T ss_dssp CGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSS-----SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred CHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCc-----ccchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEE
Confidence 3456888899999999999999765 4889999998652 234688999999999999999999999999999999
Q ss_pred EEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEecccccccc
Q 044366 723 IVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFL 802 (918)
Q Consensus 723 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~ 802 (918)
+||||+++|+|.++++... ...+++..++.++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus 293 lv~E~~~~g~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 368 (495)
T 1opk_A 293 IITEFMTYGNLLDYLRECN-RQEVSAVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLSRLM 368 (495)
T ss_dssp EEEECCTTCBHHHHHHHSC-TTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCTTCEECC
T ss_pred EEEEccCCCCHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEECCCCcEEEeecccceec
Confidence 9999999999999998643 34589999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCCC-ceecccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhhhhhhhhhHhhhhhhcccCCCCC
Q 044366 803 EPHSSN-WTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIK-GYHPGDFVSTIFSSISNMIIEVNQILDHRLPTP 880 (918)
Q Consensus 803 ~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 880 (918)
...... .....+++.|+|||++.+..++.++|||||||++|||++ |..||...... . ....+... .+.+.
T Consensus 369 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~--~---~~~~~~~~--~~~~~- 440 (495)
T 1opk_A 369 TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS--Q---VYELLEKD--YRMER- 440 (495)
T ss_dssp TTCCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGG--G---HHHHHHTT--CCCCC-
T ss_pred cCCceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHH--H---HHHHHHcC--CCCCC-
Confidence 543221 122345788999999998899999999999999999999 99997654321 1 11111111 11111
Q ss_pred CcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhC
Q 044366 881 SRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLLCK 918 (918)
Q Consensus 881 ~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~ 918 (918)
+.. ....+.+++.+||+.||++|||++++++.|++
T Consensus 441 ~~~---~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~ 475 (495)
T 1opk_A 441 PEG---CPEKVYELMRACWQWNPSDRPSFAEIHQAFET 475 (495)
T ss_dssp CTT---CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred CCC---CCHHHHHHHHHHcCcChhHCcCHHHHHHHHHH
Confidence 111 22467889999999999999999999999863
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=352.19 Aligned_cols=253 Identities=23% Similarity=0.311 Sum_probs=193.5
Q ss_pred HhcCCCCceeeccccceEEEEEEeC-CCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceE
Q 044366 644 ATGNFGEKYCIGKGGQRSVYKAELP-SGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSF 722 (918)
Q Consensus 644 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 722 (918)
..++|...+.||+|+||.||+|+.. +|+.||||++... ....+.+.+|+.+++.++||||+++++++.+++..+
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 92 (361)
T 3uc3_A 18 DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERG-----AAIDENVQREIINHRSLRHPNIVRFKEVILTPTHLA 92 (361)
T ss_dssp CTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESS-----TTSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred CCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecC-----ccccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEE
Confidence 3468999999999999999999654 7999999998652 223467899999999999999999999999999999
Q ss_pred EEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCc--EEEecccccc
Q 044366 723 IVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYE--AHVSDFGFAK 800 (918)
Q Consensus 723 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~--~kl~DfG~~~ 800 (918)
+||||+++|+|.+++...+ .+++.+++.++.|++.||+|||+. +|+||||||+||+++.++. +||+|||+++
T Consensus 93 lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~ql~~~L~~LH~~---~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~ 166 (361)
T 3uc3_A 93 IIMEYASGGELYERICNAG---RFSEDEARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGSPAPRLKICDFGYSK 166 (361)
T ss_dssp EEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCCSCCCCGGGEEECSSSSCCEEECCCCCC-
T ss_pred EEEEeCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCceEEEeecCccc
Confidence 9999999999999997643 489999999999999999999999 9999999999999987765 9999999997
Q ss_pred ccCCCCCCceecccccccccccccccCCCCcc-cchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCCC
Q 044366 801 FLEPHSSNWTEFAGTVGYAAPELAYTMRATEK-YDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPT 879 (918)
Q Consensus 801 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~-~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 879 (918)
..... .......||+.|+|||++.+..++.+ +||||+||++|+|++|+.||......... .. ....+.......
T Consensus 167 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~-~~---~~~~~~~~~~~~ 241 (361)
T 3uc3_A 167 SSVLH-SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDY-RK---TIQRILSVKYSI 241 (361)
T ss_dssp ---------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCH-HH---HHHHHHTTCCCC
T ss_pred ccccc-CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHH-HH---HHHHHhcCCCCC
Confidence 54322 22344579999999999988887655 89999999999999999998754321111 11 111111211111
Q ss_pred CCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 880 PSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 880 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
+.. ......+.+++.+||+.||++|||+.|+++
T Consensus 242 ~~~--~~~s~~~~~li~~~L~~dP~~Rps~~ell~ 274 (361)
T 3uc3_A 242 PDD--IRISPECCHLISRIFVADPATRISIPEIKT 274 (361)
T ss_dssp CTT--SCCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred CCc--CCCCHHHHHHHHHHccCChhHCcCHHHHHh
Confidence 111 011246788999999999999999999975
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=356.48 Aligned_cols=261 Identities=23% Similarity=0.379 Sum_probs=207.0
Q ss_pred HHHHhcCCCCceeeccccceEEEEEEeC-CC-----CEEEEEEcccccccCCCCChHHHHHHHHHHhhc-cCCceeeEec
Q 044366 641 ITKATGNFGEKYCIGKGGQRSVYKAELP-SG-----NIFAVKKFKAELFSDETANPSEFLNEVLALTEI-RHRNIIKFHG 713 (918)
Q Consensus 641 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~-----~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~ 713 (918)
.+...++|...+.||+|+||.||+|... ++ ..||+|.+.... .....+.+.+|+.+++.+ +||||+++++
T Consensus 41 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~h~~iv~~~~ 117 (333)
T 2i1m_A 41 WEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA---HADEKEALMSELKIMSHLGQHENIVNLLG 117 (333)
T ss_dssp GBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC---CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred ccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc---ChHHHHHHHHHHHHHHhhcCCCCeeeEEE
Confidence 3445678999999999999999999653 23 479999986532 122356799999999999 8999999999
Q ss_pred ccccCCceEEEEEeccCCChhHHhhcccc-----------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCC
Q 044366 714 FCSNAQHSFIVCEYLARGSLTTILRDDAA-----------AKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKN 782 (918)
Q Consensus 714 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~-----------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~N 782 (918)
++.+++..++||||+++|+|.+++..... ...+++.+++.++.|++.||+|||+. +|+||||||+|
T Consensus 118 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~N 194 (333)
T 2i1m_A 118 ACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK---NCIHRDVAARN 194 (333)
T ss_dssp EECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGG
T ss_pred EEecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCcccce
Confidence 99999999999999999999999975421 24579999999999999999999999 99999999999
Q ss_pred eeeCCCCcEEEeccccccccCCCCCC--ceecccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhhh
Q 044366 783 VLLDSEYEAHVSDFGFAKFLEPHSSN--WTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIK-GYHPGDFVSTIF 859 (918)
Q Consensus 783 ill~~~~~~kl~DfG~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~p~~~~~~~~ 859 (918)
|+++.++.+||+|||++......... .....+++.|+|||++.+..++.++||||||+++|||++ |..||.......
T Consensus 195 Il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~ 274 (333)
T 2i1m_A 195 VLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNS 274 (333)
T ss_dssp CEEEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSH
T ss_pred EEECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhH
Confidence 99999999999999999876543322 223456789999999999899999999999999999998 899976433211
Q ss_pred hhhhhhHhhhhhhcccCCCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 044366 860 SSISNMIIEVNQILDHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLLC 917 (918)
Q Consensus 860 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 917 (918)
. .... ...... .. ..... ...+.+++.+||+.||.+|||+.|+++.|+
T Consensus 275 ~-~~~~---~~~~~~--~~-~~~~~---~~~l~~li~~~l~~~p~~Rps~~~l~~~L~ 322 (333)
T 2i1m_A 275 K-FYKL---VKDGYQ--MA-QPAFA---PKNIYSIMQACWALEPTHRPTFQQICSFLQ 322 (333)
T ss_dssp H-HHHH---HHHTCC--CC-CCTTC---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred H-HHHH---HhcCCC--CC-CCCCC---CHHHHHHHHHHhccChhhCcCHHHHHHHHH
Confidence 1 1111 111111 11 11111 246788999999999999999999999885
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-39 Score=349.02 Aligned_cols=257 Identities=23% Similarity=0.356 Sum_probs=207.4
Q ss_pred HhcCCCCceeeccccceEEEEEEe------CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEeccccc
Q 044366 644 ATGNFGEKYCIGKGGQRSVYKAEL------PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSN 717 (918)
Q Consensus 644 ~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~ 717 (918)
..++|...+.||+|+||.||+|.. .+++.||||+++... .....+.+.+|+++++.++||||+++++++.+
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 97 (314)
T 2ivs_A 21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA---SPSELRDLLSEFNVLKQVNHPHVIKLYGACSQ 97 (314)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTC---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCC---CHHHHHHHHHHHHHHhhCCCCceeeEEEEEec
Confidence 456788999999999999999964 345889999986531 22235678999999999999999999999999
Q ss_pred CCceEEEEEeccCCChhHHhhcccc---------------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEc
Q 044366 718 AQHSFIVCEYLARGSLTTILRDDAA---------------------AKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHR 776 (918)
Q Consensus 718 ~~~~~lv~e~~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~ 776 (918)
++..++||||+++|+|.+++..... ...+++.+++.++.|+++||+|||+. +|+||
T Consensus 98 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~ 174 (314)
T 2ivs_A 98 DGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLVHR 174 (314)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT---TEECC
T ss_pred CCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC---CCccc
Confidence 9999999999999999999976532 23489999999999999999999999 99999
Q ss_pred CCCCCCeeeCCCCcEEEeccccccccCCCCCC--ceecccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCC
Q 044366 777 DISSKNVLLDSEYEAHVSDFGFAKFLEPHSSN--WTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIK-GYHPGD 853 (918)
Q Consensus 777 dlk~~Nill~~~~~~kl~DfG~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~p~~ 853 (918)
||||+||+++.++.+||+|||++......... .....+++.|+|||.+.+..++.++||||+|+++|||++ |+.||.
T Consensus 175 dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~ 254 (314)
T 2ivs_A 175 DLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYP 254 (314)
T ss_dssp CCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred ccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 99999999999999999999999877544332 223456788999999999889999999999999999999 999986
Q ss_pred cchhhhhhhhhhHhhhhhhcccCCCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 044366 854 FVSTIFSSISNMIIEVNQILDHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLLC 917 (918)
Q Consensus 854 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 917 (918)
..... ... ..... ........ .....+.+++.+||+.||++|||++|+++.|+
T Consensus 255 ~~~~~--~~~---~~~~~---~~~~~~~~---~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~ 307 (314)
T 2ivs_A 255 GIPPE--RLF---NLLKT---GHRMERPD---NCSEEMYRLMLQCWKQEPDKRPVFADISKDLE 307 (314)
T ss_dssp TCCGG--GHH---HHHHT---TCCCCCCT---TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCCHH--HHH---HHhhc---CCcCCCCc---cCCHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 54321 111 11111 11111111 12346888999999999999999999999886
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-39 Score=340.61 Aligned_cols=251 Identities=21% Similarity=0.282 Sum_probs=205.0
Q ss_pred HhcCCCCceeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceE
Q 044366 644 ATGNFGEKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSF 722 (918)
Q Consensus 644 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 722 (918)
..++|...+.||+|+||.||+|.. .+++.||+|++.... ....+.+.+|+++++.++||||+++++++.+++..+
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (277)
T 3f3z_A 7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYF----VEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIY 82 (277)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGG----CSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhc----cchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEE
Confidence 346789999999999999999965 467899999987642 234678999999999999999999999999999999
Q ss_pred EEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeee---CCCCcEEEeccccc
Q 044366 723 IVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLL---DSEYEAHVSDFGFA 799 (918)
Q Consensus 723 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill---~~~~~~kl~DfG~~ 799 (918)
+||||+++++|.+++.... .+++.+++.++.|++.||+|||+. +|+||||||+||++ +.++.+||+|||++
T Consensus 83 lv~e~~~~~~L~~~~~~~~---~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~ 156 (277)
T 3f3z_A 83 LVMELCTGGELFERVVHKR---VFRESDAARIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLA 156 (277)
T ss_dssp EEEECCCSCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTC
T ss_pred EEEeccCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEecCCCCCcEEEEecccc
Confidence 9999999999999987643 489999999999999999999999 99999999999999 78889999999999
Q ss_pred cccCCCCCCceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCCC
Q 044366 800 KFLEPHSSNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPT 879 (918)
Q Consensus 800 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 879 (918)
....+.. ......||+.|+|||++.+. ++.++||||+|+++|||++|+.||....... . ...+.......
T Consensus 157 ~~~~~~~-~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-----~---~~~~~~~~~~~ 226 (277)
T 3f3z_A 157 ARFKPGK-MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSE-----V---MLKIREGTFTF 226 (277)
T ss_dssp EECCTTS-CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-----H---HHHHHHCCCCC
T ss_pred eeccCcc-chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHH-----H---HHHHHhCCCCC
Confidence 8776433 33445789999999998764 8999999999999999999999987543211 0 11111112221
Q ss_pred CCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 880 PSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 880 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
+..........+.+++.+|++.||++|||+.|+++
T Consensus 227 ~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 227 PEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp CHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred CchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 11111123457889999999999999999999875
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=362.79 Aligned_cols=249 Identities=28% Similarity=0.413 Sum_probs=202.0
Q ss_pred HhcCCCCceeeccccceEEEEEEeCCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCC-ceE
Q 044366 644 ATGNFGEKYCIGKGGQRSVYKAELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQ-HSF 722 (918)
Q Consensus 644 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-~~~ 722 (918)
..++|...+.||+|+||.||+|... |+.||||+++.. ...+.|.+|++++++++||||+++++++...+ ..+
T Consensus 191 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 263 (450)
T 1k9a_A 191 NMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND------ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLY 263 (450)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSC------TTSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEE
T ss_pred ChHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCc------hHHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceE
Confidence 3467888899999999999999874 789999998653 23578999999999999999999999986654 789
Q ss_pred EEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEecccccccc
Q 044366 723 IVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFL 802 (918)
Q Consensus 723 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~ 802 (918)
+||||+++|+|.++++... ...+++..++.++.||++||+|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus 264 iv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~ 339 (450)
T 1k9a_A 264 IVTEYMAKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEA 339 (450)
T ss_dssp EEEECCTTCBHHHHHHHHC-TTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEEecCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEECCCCCEEEeeCCCcccc
Confidence 9999999999999998653 23479999999999999999999999 9999999999999999999999999999865
Q ss_pred CCCCCCceecccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhhhhhhhhhHhhhhhhcccCCCCCC
Q 044366 803 EPHSSNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIK-GYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPS 881 (918)
Q Consensus 803 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 881 (918)
.... ....+++.|+|||++.+..++.++||||||+++|||++ |+.||...... . ....+.. ..+.+. +
T Consensus 340 ~~~~---~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~--~---~~~~i~~--~~~~~~-p 408 (450)
T 1k9a_A 340 SSTQ---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK--D---VVPRVEK--GYKMDA-P 408 (450)
T ss_dssp C---------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTT--T---HHHHHHT--TCCCCC-C
T ss_pred cccc---cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH--H---HHHHHHc--CCCCCC-C
Confidence 4321 22356889999999999999999999999999999998 99998654321 1 1111111 111111 1
Q ss_pred cchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 044366 882 RDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLLC 917 (918)
Q Consensus 882 ~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 917 (918)
.. ....+.+++.+||+.||++|||+.++++.|+
T Consensus 409 ~~---~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~ 441 (450)
T 1k9a_A 409 DG---CPPAVYDVMKNCWHLDAATRPTFLQLREQLE 441 (450)
T ss_dssp TT---CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred Cc---CCHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence 22 2346788999999999999999999999885
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=344.68 Aligned_cols=251 Identities=26% Similarity=0.413 Sum_probs=196.1
Q ss_pred cCCCCceeeccccceEEEEEEeCCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEEEE
Q 044366 646 GNFGEKYCIGKGGQRSVYKAELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFIVC 725 (918)
Q Consensus 646 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 725 (918)
++|...+.||+|+||.||+|+. .++.||||++... ...+.|.+|++++++++||||+++++++.+ ..++||
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~------~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~ 78 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIESE------SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVM 78 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEECSST------THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEE
T ss_pred hHeeeeeEeecCCCceEEEEEE-CCeeEEEEEecCh------hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEE
Confidence 5788889999999999999987 4788999998532 235789999999999999999999999874 489999
Q ss_pred EeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCc-EEEeccccccccCC
Q 044366 726 EYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYE-AHVSDFGFAKFLEP 804 (918)
Q Consensus 726 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~-~kl~DfG~~~~~~~ 804 (918)
||+++|+|.+++........+++.+++.++.|+++||+|||+....+|+||||||+||+++.++. +||+|||++.....
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~ 158 (307)
T 2eva_A 79 EYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQT 158 (307)
T ss_dssp ECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC------
T ss_pred EcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccccc
Confidence 99999999999987654455899999999999999999999932229999999999999998886 79999999986543
Q ss_pred CCCCceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCCCCCcch
Q 044366 805 HSSNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRDV 884 (918)
Q Consensus 805 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 884 (918)
. .....||+.|+|||++.+..++.++||||||+++|||++|+.||+........... .......+.....
T Consensus 159 ~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~------~~~~~~~~~~~~~- 228 (307)
T 2eva_A 159 H---MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMW------AVHNGTRPPLIKN- 228 (307)
T ss_dssp ---------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHH------HHHTTCCCCCBTT-
T ss_pred c---cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHH------HHhcCCCCCcccc-
Confidence 2 23346899999999999999999999999999999999999998643321111100 1111111111111
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 044366 885 TDKLRSIMEVAILCLVENPEARPTMKEVCNLLC 917 (918)
Q Consensus 885 ~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 917 (918)
....+.+++.+||+.||++|||++|+++.|+
T Consensus 229 --~~~~l~~li~~~l~~dp~~Rps~~ell~~L~ 259 (307)
T 2eva_A 229 --LPKPIESLMTRCWSKDPSQRPSMEEIVKIMT 259 (307)
T ss_dssp --CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred --cCHHHHHHHHHHhcCChhhCcCHHHHHHHHH
Confidence 2245788999999999999999999999875
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-39 Score=349.39 Aligned_cols=259 Identities=21% Similarity=0.345 Sum_probs=208.3
Q ss_pred HhcCCCCceeeccccceEEEEEEe------CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhc-cCCceeeEecccc
Q 044366 644 ATGNFGEKYCIGKGGQRSVYKAEL------PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEI-RHRNIIKFHGFCS 716 (918)
Q Consensus 644 ~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~ 716 (918)
..++|...+.||+|+||.||+|.. .+++.||||+++... .....+.+.+|+.+++++ +||||+++++++.
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 97 (313)
T 1t46_A 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA---HLTEREALMSELKVLSYLGNHMNIVNLLGACT 97 (313)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC---CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcch---hHHHHHHHHHHHHHHhhcccCCCeeeEEEEEe
Confidence 346788999999999999999964 357799999987532 122357799999999999 9999999999999
Q ss_pred cCCceEEEEEeccCCChhHHhhcccc---------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCC
Q 044366 717 NAQHSFIVCEYLARGSLTTILRDDAA---------------AKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSK 781 (918)
Q Consensus 717 ~~~~~~lv~e~~~~gsL~~~l~~~~~---------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~ 781 (918)
+++..++||||+++|+|.+++..... ...+++.+++.++.|+++||+|||+. +|+||||||+
T Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~ 174 (313)
T 1t46_A 98 IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAAR 174 (313)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGG
T ss_pred cCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccc
Confidence 99999999999999999999976532 22489999999999999999999999 9999999999
Q ss_pred CeeeCCCCcEEEeccccccccCCCCCC--ceecccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhh
Q 044366 782 NVLLDSEYEAHVSDFGFAKFLEPHSSN--WTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIK-GYHPGDFVSTI 858 (918)
Q Consensus 782 Nill~~~~~~kl~DfG~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~p~~~~~~~ 858 (918)
||+++.++.+||+|||++......... .....+++.|+|||++.+..++.++||||||+++|||++ |+.||......
T Consensus 175 Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~ 254 (313)
T 1t46_A 175 NILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD 254 (313)
T ss_dssp GEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS
T ss_pred eEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccch
Confidence 999999999999999999877654332 223456789999999999999999999999999999999 99998654321
Q ss_pred hhhhhhhHhhhhhhcccCCCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhC
Q 044366 859 FSSISNMIIEVNQILDHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLLCK 918 (918)
Q Consensus 859 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~ 918 (918)
... .. ........ ..... ....+.+++.+||+.||.+|||++|+++.|++
T Consensus 255 ~~~-~~---~~~~~~~~---~~~~~---~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~ 304 (313)
T 1t46_A 255 SKF-YK---MIKEGFRM---LSPEH---APAEMYDIMKTCWDADPLKRPTFKQIVQLIEK 304 (313)
T ss_dssp HHH-HH---HHHHTCCC---CCCTT---SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred hHH-HH---HhccCCCC---CCccc---CCHHHHHHHHHHcCCCchhCcCHHHHHHHHHH
Confidence 111 11 11111111 11111 22468889999999999999999999999863
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-39 Score=346.35 Aligned_cols=262 Identities=22% Similarity=0.342 Sum_probs=205.0
Q ss_pred hcCCCCceeeccccceEEEEEEe-----CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccC-
Q 044366 645 TGNFGEKYCIGKGGQRSVYKAEL-----PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNA- 718 (918)
Q Consensus 645 ~~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~- 718 (918)
...|...+.||+|+||.||+|++ .+++.||||+++... .....+.+.+|+++++.++||||+++++++.+.
T Consensus 20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 96 (302)
T 4e5w_A 20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES---GGNHIADLKKEIEILRNLYHENIVKYKGICTEDG 96 (302)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC--------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC--
T ss_pred hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccc---cchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCC
Confidence 35588889999999999999973 468899999987542 334467899999999999999999999999766
Q ss_pred -CceEEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccc
Q 044366 719 -QHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFG 797 (918)
Q Consensus 719 -~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG 797 (918)
...++||||+++|+|.+++.... ..+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 97 ~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg 171 (302)
T 4e5w_A 97 GNGIKLIMEFLPSGSLKEYLPKNK--NKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFG 171 (302)
T ss_dssp -CCEEEEEECCTTCBHHHHHHHHT--TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCT
T ss_pred CceEEEEEEeCCCCcHHHHHHhcc--ccCCHHHHHHHHHHHHHHHHHhhcC---CcccCCCchheEEEcCCCCEEECccc
Confidence 66899999999999999996542 3589999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCC---ceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhh-------hhhHh
Q 044366 798 FAKFLEPHSSN---WTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSI-------SNMII 867 (918)
Q Consensus 798 ~~~~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~-------~~~~~ 867 (918)
++......... .....||..|+|||++.+..++.++||||+|+++|||++|+.|+.......... .....
T Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 251 (302)
T 4e5w_A 172 LTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTR 251 (302)
T ss_dssp TCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHH
T ss_pred ccccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHH
Confidence 99887654422 234567888999999999899999999999999999999999854332111000 00000
Q ss_pred hhhhhcccCCCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 044366 868 EVNQILDHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLLC 917 (918)
Q Consensus 868 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 917 (918)
................ ....+.+++.+||+.||.+|||++|+++.|+
T Consensus 252 ~~~~~~~~~~~~~~~~---~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~ 298 (302)
T 4e5w_A 252 LVNTLKEGKRLPCPPN---CPDEVYQLMRKCWEFQPSNRTSFQNLIEGFE 298 (302)
T ss_dssp HHHHHHTTCCCCCCTT---CCHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred HHHHHhccCCCCCCCC---CCHHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Confidence 1111111111111112 2346889999999999999999999999986
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-39 Score=350.50 Aligned_cols=253 Identities=23% Similarity=0.419 Sum_probs=197.0
Q ss_pred hcCCCCceeeccccceEEEEEEe-CCCCE----EEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCC
Q 044366 645 TGNFGEKYCIGKGGQRSVYKAEL-PSGNI----FAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQ 719 (918)
Q Consensus 645 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~----vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~ 719 (918)
.++|...+.||+|+||.||+|.. .+|+. ||+|.++.. ......+.|.+|+.++++++||||+++++++.++.
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 90 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA---TSPKANKEILDEAYVMASVDNPHVCRLLGICLTST 90 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC----------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccc---cCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC
Confidence 35788999999999999999964 35554 577877542 23344678999999999999999999999998754
Q ss_pred ceEEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccc
Q 044366 720 HSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFA 799 (918)
Q Consensus 720 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~ 799 (918)
.++|+||+++|+|.+++.... ..+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 91 -~~~v~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a 164 (327)
T 3poz_A 91 -VQLITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLA 164 (327)
T ss_dssp -EEEEEECCTTCBHHHHHHHST--TSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTHH
T ss_pred -eEEEEEecCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCChheEEECCCCCEEEccCcce
Confidence 789999999999999997643 4589999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCC--ceecccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhhhhhhhhhHhhhhhhcccC
Q 044366 800 KFLEPHSSN--WTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIK-GYHPGDFVSTIFSSISNMIIEVNQILDHR 876 (918)
Q Consensus 800 ~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 876 (918)
+........ .....+|+.|+|||++.+..++.++|||||||++|||++ |+.||+..... .... .... ...
T Consensus 165 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--~~~~---~~~~--~~~ 237 (327)
T 3poz_A 165 KLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS--EISS---ILEK--GER 237 (327)
T ss_dssp HHHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG--GHHH---HHHT--TCC
T ss_pred eEccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHH--HHHH---HHHc--CCC
Confidence 877544332 233456889999999999999999999999999999999 99998654321 1111 1111 111
Q ss_pred CCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 044366 877 LPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLLC 917 (918)
Q Consensus 877 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 917 (918)
.+.+ .. ....+.+++.+||+.||++|||+.|+++.|+
T Consensus 238 ~~~~-~~---~~~~~~~li~~~l~~~p~~Rps~~ell~~l~ 274 (327)
T 3poz_A 238 LPQP-PI---CTIDVYMIMVKCWMIDADSRPKFRELIIEFS 274 (327)
T ss_dssp CCCC-TT---BCHHHHHHHHHHTCSCGGGSCCHHHHHHHHH
T ss_pred CCCC-cc---CCHHHHHHHHHHcCCChhhCCCHHHHHHHHH
Confidence 1111 11 2346788999999999999999999999875
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-39 Score=365.51 Aligned_cols=254 Identities=26% Similarity=0.449 Sum_probs=201.9
Q ss_pred HhcCCCCceeeccccceEEEEEEeCCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEE
Q 044366 644 ATGNFGEKYCIGKGGQRSVYKAELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFI 723 (918)
Q Consensus 644 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 723 (918)
..++|...+.||+|+||.||+|....+..||||+++.. ....++|.+|++++++++||||+++++++.+ +..++
T Consensus 182 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~-----~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~i 255 (452)
T 1fmk_A 182 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-----TMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYI 255 (452)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTT-----SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred ChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccC-----CCCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEE
Confidence 45678888999999999999999888888999998753 2346789999999999999999999999876 67899
Q ss_pred EEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccC
Q 044366 724 VCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLE 803 (918)
Q Consensus 724 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~ 803 (918)
||||+++|+|.++++... ...+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 256 v~e~~~~gsL~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~ 331 (452)
T 1fmk_A 256 VTEYMSKGSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIE 331 (452)
T ss_dssp EECCCTTCBHHHHHSHHH-HTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC---
T ss_pred EehhhcCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEECCCCCEEECCCccceecC
Confidence 999999999999997532 24589999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCC-ceecccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhhhhhhhhhHhhhhhhcccCCCCCC
Q 044366 804 PHSSN-WTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIK-GYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPS 881 (918)
Q Consensus 804 ~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 881 (918)
..... .....++..|+|||++.+..++.++||||||+++|||++ |+.||...... .+ ...+.. ..+.+.+
T Consensus 332 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~--~~---~~~i~~--~~~~~~~- 403 (452)
T 1fmk_A 332 DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR--EV---LDQVER--GYRMPCP- 403 (452)
T ss_dssp -----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--HH---HHHHHT--TCCCCCC-
T ss_pred CCceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHH--HH---HHHHHc--CCCCCCC-
Confidence 43221 223456789999999999999999999999999999999 99998644321 01 111111 1111111
Q ss_pred cchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhC
Q 044366 882 RDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLLCK 918 (918)
Q Consensus 882 ~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~ 918 (918)
.. ....+.+++.+||+.||++|||++++++.|+.
T Consensus 404 ~~---~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~ 437 (452)
T 1fmk_A 404 PE---CPESLHDLMCQCWRKEPEERPTFEYLQAFLED 437 (452)
T ss_dssp TT---SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred CC---CCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 12 23467889999999999999999999998863
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-39 Score=359.29 Aligned_cols=266 Identities=20% Similarity=0.270 Sum_probs=209.3
Q ss_pred hcCCCCceeeccccceEEEEEEeC-CCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCC--ce
Q 044366 645 TGNFGEKYCIGKGGQRSVYKAELP-SGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQ--HS 721 (918)
Q Consensus 645 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~--~~ 721 (918)
.++|...+.||+|+||.||+|... +|+.||||+++... .....+.+.+|++++++++||||+++++++.+.+ ..
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~ 84 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNIS---FLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHK 84 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGG---GGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEecccc---ccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCee
Confidence 357889999999999999999654 69999999987532 2234678899999999999999999999987654 77
Q ss_pred EEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeee----CCCCcEEEeccc
Q 044366 722 FIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLL----DSEYEAHVSDFG 797 (918)
Q Consensus 722 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill----~~~~~~kl~DfG 797 (918)
++||||+++|+|.++++.......+++.+++.++.|++.||+|||+. +|+||||||+||++ +.++.+||+|||
T Consensus 85 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG 161 (396)
T 4eut_A 85 VLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFG 161 (396)
T ss_dssp EEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEECTTSCEEEEECCGG
T ss_pred EEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCcCHHHEEEeecCCCceeEEEecCC
Confidence 99999999999999998765555589999999999999999999999 99999999999999 777889999999
Q ss_pred cccccCCCCCCceeccccccccccccccc--------CCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhh
Q 044366 798 FAKFLEPHSSNWTEFAGTVGYAAPELAYT--------MRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEV 869 (918)
Q Consensus 798 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~--------~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~ 869 (918)
+++...... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.................
T Consensus 162 ~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~ 240 (396)
T 4eut_A 162 AARELEDDE-QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKII 240 (396)
T ss_dssp GCEECCCGG-GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHH
T ss_pred CceEccCCC-ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHh
Confidence 998765432 2234578999999999865 5678899999999999999999999753322111111110000
Q ss_pred hhh-----------------cccCCCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 044366 870 NQI-----------------LDHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLLC 917 (918)
Q Consensus 870 ~~~-----------------~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 917 (918)
... .....+............+.+++.+||+.||++||+++|+++.++
T Consensus 241 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~ 305 (396)
T 4eut_A 241 TGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETS 305 (396)
T ss_dssp HSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHH
T ss_pred cCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHH
Confidence 000 000112222223456677889999999999999999999998774
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=369.37 Aligned_cols=252 Identities=24% Similarity=0.286 Sum_probs=197.0
Q ss_pred HhcCCCCceeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceE
Q 044366 644 ATGNFGEKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSF 722 (918)
Q Consensus 644 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 722 (918)
..++|...+.||+|+||.||+|.. .+|+.||||+++..... .......+.+|+.+++.++||||+++++++.+.+..+
T Consensus 146 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~ 224 (446)
T 4ejn_A 146 TMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIV-AKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLC 224 (446)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC--------------CCCCCSCTTSCCEEEEEEETTEEE
T ss_pred ChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhh-hhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEE
Confidence 346799999999999999999954 57999999999764322 2233467889999999999999999999999999999
Q ss_pred EEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEEcCCCCCCeeeCCCCcEEEeccccccc
Q 044366 723 IVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHH-DCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKF 801 (918)
Q Consensus 723 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~ 801 (918)
+||||+++|+|.+++.... .+++..++.++.||+.||+|||+ . +|+||||||+||+++.++.+||+|||+++.
T Consensus 225 lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---giiHrDlkp~NIll~~~~~~kl~DFG~a~~ 298 (446)
T 4ejn_A 225 FVMEYANGGELFFHLSRER---VFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKE 298 (446)
T ss_dssp EEECCCSSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCCCGGGEEECSSSCEEECCCCCCCT
T ss_pred EEEeeCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHhhcC---CEEECCCCHHHEEECCCCCEEEccCCCcee
Confidence 9999999999999997643 48999999999999999999998 7 999999999999999999999999999987
Q ss_pred cCCCCCCceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCCCCC
Q 044366 802 LEPHSSNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPS 881 (918)
Q Consensus 802 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 881 (918)
............||+.|+|||++.+..++.++|||||||++|||++|+.||...... ... ..+.......+
T Consensus 299 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~--~~~------~~i~~~~~~~p- 369 (446)
T 4ejn_A 299 GIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE--KLF------ELILMEEIRFP- 369 (446)
T ss_dssp TCC-----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHH------HHHHHCCCCCC-
T ss_pred ccCCCcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH--HHH------HHHHhCCCCCC-
Confidence 655544555678999999999999999999999999999999999999998654321 000 11111111111
Q ss_pred cchHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 044366 882 RDVTDKLRSIMEVAILCLVENPEARP-----TMKEVCN 914 (918)
Q Consensus 882 ~~~~~~~~~l~~li~~cl~~dp~~RP-----t~~evl~ 914 (918)
.. ....+.+++.+||+.||++|| +++|+++
T Consensus 370 ~~---~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~ 404 (446)
T 4ejn_A 370 RT---LGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ 404 (446)
T ss_dssp TT---SCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred cc---CCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence 11 124678899999999999999 9999975
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=341.23 Aligned_cols=253 Identities=22% Similarity=0.348 Sum_probs=204.8
Q ss_pred hcCCCCceeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEE
Q 044366 645 TGNFGEKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFI 723 (918)
Q Consensus 645 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 723 (918)
.++|.+.+.||+|+||.||+|.. .+|+.||+|++..... .....+.+.+|+.++++++||||+++++++.+++..++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 82 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL--SARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL 82 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccC--CHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEE
Confidence 46899999999999999999965 5699999999876432 22234678899999999999999999999999999999
Q ss_pred EEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCc---EEEecccccc
Q 044366 724 VCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYE---AHVSDFGFAK 800 (918)
Q Consensus 724 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~---~kl~DfG~~~ 800 (918)
||||+++|+|.+++... ..+++.+++.++.|++.||+|||+. +|+||||||+||+++.++. +||+|||.+.
T Consensus 83 v~e~~~~~~l~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~ 156 (284)
T 3kk8_A 83 VFDLVTGGELFEDIVAR---EFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAI 156 (284)
T ss_dssp EECCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSTTCCEEECCCTTCE
T ss_pred EEecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcCcCCCCHHHEEEecCCCCCcEEEeeceeeE
Confidence 99999999999988764 3489999999999999999999999 9999999999999987655 9999999998
Q ss_pred ccCCCCCCceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCCCC
Q 044366 801 FLEPHSSNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTP 880 (918)
Q Consensus 801 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 880 (918)
...... ......|++.|+|||++.+..++.++||||+|+++|+|++|+.||....... ..... .......+
T Consensus 157 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~-----~~~~~---~~~~~~~~ 227 (284)
T 3kk8_A 157 EVNDSE-AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR-----LYAQI---KAGAYDYP 227 (284)
T ss_dssp ECCSSC-BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-----HHHHH---HHTCCCCC
T ss_pred EcccCc-cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhH-----HHHHH---HhccccCC
Confidence 765432 2344678999999999999999999999999999999999999986543211 11111 11111111
Q ss_pred CcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 881 SRDVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 881 ~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
..........+.+++.+||+.||++|||++|+++
T Consensus 228 ~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (284)
T 3kk8_A 228 SPEWDTVTPEAKSLIDSMLTVNPKKRITADQALK 261 (284)
T ss_dssp TTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred chhhcccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 1111222356888999999999999999999976
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-39 Score=358.79 Aligned_cols=265 Identities=21% Similarity=0.277 Sum_probs=203.5
Q ss_pred HhcCCCCceeeccc--cceEEEEEEeC-CCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCc
Q 044366 644 ATGNFGEKYCIGKG--GQRSVYKAELP-SGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQH 720 (918)
Q Consensus 644 ~~~~~~~~~~lg~G--~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 720 (918)
..++|++.+.||+| +||.||+|+.. +|+.||||+++..... ....+.+.+|+.+++.++||||+++++++.+++.
T Consensus 23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 100 (389)
T 3gni_B 23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACS--NEMVTFLQGELHVSKLFNHPNIVPYRATFIADNE 100 (389)
T ss_dssp CGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSC--HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred CCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccC--hHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCE
Confidence 34689999999999 99999999654 7999999999764322 2234678889999999999999999999999999
Q ss_pred eEEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEecccccc
Q 044366 721 SFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAK 800 (918)
Q Consensus 721 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~ 800 (918)
.++||||+++|+|.+++.... ...+++..++.++.||+.||+|||+. +|+||||||+||+++.++.+||+|||.+.
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~kl~dfg~~~ 176 (389)
T 3gni_B 101 LWVVTSFMAYGSAKDLICTHF-MDGMNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNL 176 (389)
T ss_dssp EEEEEECCTTCBHHHHHHHTC-TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCGGGCE
T ss_pred EEEEEEccCCCCHHHHHhhhc-ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccccce
Confidence 999999999999999997653 24489999999999999999999999 99999999999999999999999999986
Q ss_pred ccCCCC-------CCceeccccccccccccccc--CCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhh
Q 044366 801 FLEPHS-------SNWTEFAGTVGYAAPELAYT--MRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQ 871 (918)
Q Consensus 801 ~~~~~~-------~~~~~~~g~~~y~aPE~~~~--~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 871 (918)
...... .......||+.|+|||++.+ ..++.++||||+||++|||++|+.||...................
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 256 (389)
T 3gni_B 177 SMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPC 256 (389)
T ss_dssp ECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC-------
T ss_pred eeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCc
Confidence 543221 11123468999999999987 578999999999999999999999986533221111100000000
Q ss_pred hcccC---------------------------CC-------CCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 872 ILDHR---------------------------LP-------TPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 872 ~~~~~---------------------------~~-------~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
..+.. .+ ............+.+++.+||+.||++|||++|+++
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~ 333 (389)
T 3gni_B 257 LLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLN 333 (389)
T ss_dssp -------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred cccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 00000 00 000011122356889999999999999999999974
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-39 Score=339.27 Aligned_cols=252 Identities=23% Similarity=0.373 Sum_probs=206.8
Q ss_pred hcCCCCceeeccccceEEEEEEeCCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEEE
Q 044366 645 TGNFGEKYCIGKGGQRSVYKAELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFIV 724 (918)
Q Consensus 645 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 724 (918)
.++|...+.||+|+||.||+|...+++.||+|++... ....+.+.+|+++++.++||||+++++++.+++..++|
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~-----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 81 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG-----AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLV 81 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTT-----TBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhheeeeeEecCCCceeEEEEEecCCCeEEEEEcccc-----CCCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEE
Confidence 3578888999999999999998888899999998753 22357899999999999999999999999999999999
Q ss_pred EEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccCC
Q 044366 725 CEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEP 804 (918)
Q Consensus 725 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~~ 804 (918)
|||+++++|.+++.... ..+++.+++.++.|++.||+|||+. +++||||||+||+++.++.+||+|||++.....
T Consensus 82 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~ 156 (267)
T 3t9t_A 82 TEFMEHGCLSDYLRTQR--GLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD 156 (267)
T ss_dssp ECCCTTCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECGGGCEEECCTTGGGGBCC
T ss_pred EeCCCCCcHHHHHhhCc--ccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEECCCCCEEEccccccccccc
Confidence 99999999999997642 4589999999999999999999999 999999999999999999999999999987643
Q ss_pred CCC-CceecccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhhhhhhhhhHhhhhhhcccCCCCCCc
Q 044366 805 HSS-NWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIK-GYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSR 882 (918)
Q Consensus 805 ~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 882 (918)
... ......++..|+|||++.+..++.++||||+|+++|||++ |+.||...... ....... .......+.
T Consensus 157 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-----~~~~~i~---~~~~~~~~~ 228 (267)
T 3t9t_A 157 DQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS-----EVVEDIS---TGFRLYKPR 228 (267)
T ss_dssp HHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-----HHHHHHH---TTCCCCCCT
T ss_pred ccccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHH-----HHHHHHh---cCCcCCCCc
Confidence 211 1123456788999999998899999999999999999999 89998654321 0111111 111111111
Q ss_pred chHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 044366 883 DVTDKLRSIMEVAILCLVENPEARPTMKEVCNLLC 917 (918)
Q Consensus 883 ~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 917 (918)
. ....+.+++.+||+.||++|||++|+++.|+
T Consensus 229 ~---~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~ 260 (267)
T 3t9t_A 229 L---ASTHVYQIMNHCWRERPEDRPAFSRLLRQLA 260 (267)
T ss_dssp T---SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred c---CcHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 1 1246788999999999999999999999986
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-39 Score=349.65 Aligned_cols=259 Identities=21% Similarity=0.335 Sum_probs=191.3
Q ss_pred HHhcCCCCceeeccccceEEEEEEeCC-CC---EEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccC
Q 044366 643 KATGNFGEKYCIGKGGQRSVYKAELPS-GN---IFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNA 718 (918)
Q Consensus 643 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~---~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~ 718 (918)
...++|...+.||+|+||.||+|.... ++ .||||+++.... .....+.+.+|+++++.++||||+++++++...
T Consensus 20 i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 97 (323)
T 3qup_A 20 IPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADII--ASSDIEEFLREAACMKEFDHPHVAKLVGVSLRS 97 (323)
T ss_dssp CC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC--------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC
T ss_pred cChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEeccccc--CHHHHHHHHHHHHHHHHCCCCceehhhceeecc
Confidence 345689999999999999999997643 32 799999876422 223357899999999999999999999999776
Q ss_pred Cce------EEEEEeccCCChhHHhhcccc---cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCC
Q 044366 719 QHS------FIVCEYLARGSLTTILRDDAA---AKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEY 789 (918)
Q Consensus 719 ~~~------~lv~e~~~~gsL~~~l~~~~~---~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~ 789 (918)
+.. ++||||+++|+|.+++..... ...+++.+++.++.|+++||+|||+. +|+||||||+||+++.++
T Consensus 98 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~Dikp~NIli~~~~ 174 (323)
T 3qup_A 98 RAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAEDM 174 (323)
T ss_dssp -------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTS
T ss_pred ccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC---CcccCCCCcceEEEcCCC
Confidence 654 999999999999999965431 22589999999999999999999999 999999999999999999
Q ss_pred cEEEeccccccccCCCCCC--ceecccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhhhhhhhhhH
Q 044366 790 EAHVSDFGFAKFLEPHSSN--WTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIK-GYHPGDFVSTIFSSISNMI 866 (918)
Q Consensus 790 ~~kl~DfG~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~p~~~~~~~~~~~~~~~ 866 (918)
.+||+|||+++........ .....+++.|+|||.+.+..++.++||||||+++|||++ |+.||....... ..
T Consensus 175 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~-----~~ 249 (323)
T 3qup_A 175 TVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAE-----IY 249 (323)
T ss_dssp CEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG-----HH
T ss_pred CEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHH-----HH
Confidence 9999999999876543321 223456789999999999999999999999999999999 899986543210 00
Q ss_pred hhhhhhcccCCCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 044366 867 IEVNQILDHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLLC 917 (918)
Q Consensus 867 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 917 (918)
.............. ....+.+++.+||+.||++|||+.++++.|+
T Consensus 250 ---~~~~~~~~~~~~~~---~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~ 294 (323)
T 3qup_A 250 ---NYLIGGNRLKQPPE---CMEEVYDLMYQCWSADPKQRPSFTCLRMELE 294 (323)
T ss_dssp ---HHHHTTCCCCCCTT---CCHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred ---HHHhcCCCCCCCCc---cCHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 11111111111111 2246888999999999999999999999886
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=348.64 Aligned_cols=267 Identities=24% Similarity=0.326 Sum_probs=200.4
Q ss_pred HHHHHHHhcCCCCceeeccccceEEEEEEeCCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhc--cCCceeeEeccc
Q 044366 638 YEEITKATGNFGEKYCIGKGGQRSVYKAELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEI--RHRNIIKFHGFC 715 (918)
Q Consensus 638 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l--~h~niv~~~~~~ 715 (918)
........++|...+.||+|+||.||+|+.. |+.||||++... ....+..|.+++... +||||+++++++
T Consensus 29 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~-------~~~~~~~e~~~~~~~~~~h~~i~~~~~~~ 100 (337)
T 3mdy_A 29 LLVQRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTT-------EEASWFRETEIYQTVLMRHENILGFIAAD 100 (337)
T ss_dssp HHHHTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGG-------GHHHHHHHHHHHTSTTCCCTTBCCEEEEE
T ss_pred cccccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecc-------ccchhhhHHHHHHHHhhcCCCeeeEEEEE
Confidence 3344455678999999999999999999874 899999998542 134556666666554 899999999998
Q ss_pred ccC----CceEEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCC-----CCCeEEcCCCCCCeeeC
Q 044366 716 SNA----QHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDC-----IPPIVHRDISSKNVLLD 786 (918)
Q Consensus 716 ~~~----~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~-----~~~ivH~dlk~~Nill~ 786 (918)
... ...++||||+++|+|.++++.. .+++.+++.++.|++.||+|||+.. .++|+||||||+||+++
T Consensus 101 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~ 176 (337)
T 3mdy_A 101 IKGTGSWTQLYLITDYHENGSLYDYLKST----TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVK 176 (337)
T ss_dssp EESCGGGCEEEEEECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEEC
T ss_pred ccCCCCCCceEEEEeccCCCcHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEEC
Confidence 776 6789999999999999999753 4899999999999999999999762 23899999999999999
Q ss_pred CCCcEEEeccccccccCCCCCCc----eecccccccccccccccCCCCcc------cchhhHHHHHHHHHhC--------
Q 044366 787 SEYEAHVSDFGFAKFLEPHSSNW----TEFAGTVGYAAPELAYTMRATEK------YDVYSFGVLALEVIKG-------- 848 (918)
Q Consensus 787 ~~~~~kl~DfG~~~~~~~~~~~~----~~~~g~~~y~aPE~~~~~~~~~~------~Dv~slG~vl~el~tg-------- 848 (918)
.++.+||+|||+++.+....... ....||+.|+|||++.+...+.+ +|||||||++|||++|
T Consensus 177 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~ 256 (337)
T 3mdy_A 177 KNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVE 256 (337)
T ss_dssp TTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCC
T ss_pred CCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccc
Confidence 99999999999998765443221 24578999999999987766654 9999999999999999
Q ss_pred --CCCCCcchhhhhhhhhhHhhhhhhcccCCCCCC-cchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 044366 849 --YHPGDFVSTIFSSISNMIIEVNQILDHRLPTPS-RDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLLC 917 (918)
Q Consensus 849 --~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 917 (918)
+.||............... .......+...+. .........+.+++.+||+.||++|||++|+++.|+
T Consensus 257 ~~~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~ 327 (337)
T 3mdy_A 257 EYQLPYHDLVPSDPSYEDMRE-IVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLA 327 (337)
T ss_dssp CCCCTTTTTSCSSCCHHHHHH-HHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred cccccHhhhcCCCCchhhhHH-HHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHH
Confidence 4554332111111111111 0111111111111 112255677999999999999999999999999986
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-40 Score=354.33 Aligned_cols=255 Identities=24% Similarity=0.325 Sum_probs=194.8
Q ss_pred hcCCCCceeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCc---
Q 044366 645 TGNFGEKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQH--- 720 (918)
Q Consensus 645 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~--- 720 (918)
.++|...+.||+|+||.||+|+. .+++.||||+++..... .......+.+|++++++++||||+++++++.....
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~ 89 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLAR-DPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP 89 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTT-SHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccC-CHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCc
Confidence 46899999999999999999964 67899999998764221 22224578999999999999999999999866544
Q ss_pred -eEEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccc
Q 044366 721 -SFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFA 799 (918)
Q Consensus 721 -~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~ 799 (918)
.++||||+++|+|.++++... .+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 90 ~~~lv~e~~~g~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~a 163 (311)
T 3ork_A 90 LPYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIA 163 (311)
T ss_dssp EEEEEEECCCEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEETTSCEEECCCSCC
T ss_pred ccEEEEecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEcCCCCEEEeeccCc
Confidence 399999999999999997643 489999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCC---CceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccC
Q 044366 800 KFLEPHSS---NWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHR 876 (918)
Q Consensus 800 ~~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 876 (918)
..+..... ......||+.|+|||++.+..++.++||||||+++|||++|+.||.......... ......
T Consensus 164 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~--------~~~~~~ 235 (311)
T 3ork_A 164 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAY--------QHVRED 235 (311)
T ss_dssp ------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH--------HHHHCC
T ss_pred ccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHH--------HHhcCC
Confidence 87654322 2234568999999999999999999999999999999999999987543321110 011111
Q ss_pred CCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 877 LPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 877 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
...+..........+.+++.+||+.||++||++.++++
T Consensus 236 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~ 273 (311)
T 3ork_A 236 PIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMR 273 (311)
T ss_dssp CCCHHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHH
T ss_pred CCCcccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHH
Confidence 11100001112356889999999999999998777664
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-39 Score=354.61 Aligned_cols=250 Identities=25% Similarity=0.311 Sum_probs=195.6
Q ss_pred hcCCCCceeeccccceEEEEEEeC-CCCEEEEEEcccccccCCCCChHHHHHHHHH-HhhccCCceeeEecccccCCceE
Q 044366 645 TGNFGEKYCIGKGGQRSVYKAELP-SGNIFAVKKFKAELFSDETANPSEFLNEVLA-LTEIRHRNIIKFHGFCSNAQHSF 722 (918)
Q Consensus 645 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~-l~~l~h~niv~~~~~~~~~~~~~ 722 (918)
.++|...+.||+|+||.||+|+.. +++.||+|+++....... .....+.+|..+ ++.++||||+++++++.+.+..+
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~-~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~ 115 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKK-KEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLY 115 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC--------------CCBCCCCCTTBCCEEEEEECSSEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhh-HHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEE
Confidence 467999999999999999999654 688999999976543322 224556777776 57789999999999999999999
Q ss_pred EEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEecccccccc
Q 044366 723 IVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFL 802 (918)
Q Consensus 723 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~ 802 (918)
+||||+++|+|.+++.... .+++..++.++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus 116 lv~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~ikL~DFG~a~~~ 189 (373)
T 2r5t_A 116 FVLDYINGGELFYHLQRER---CFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKEN 189 (373)
T ss_dssp EEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCBCGGG
T ss_pred EEEeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEeeCcccccc
Confidence 9999999999999997643 489999999999999999999999 9999999999999999999999999999875
Q ss_pred CCCCCCceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCCCCCc
Q 044366 803 EPHSSNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSR 882 (918)
Q Consensus 803 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 882 (918)
...........||+.|+|||++.+..++.++|||||||++|||++|+.||...... .. ...+.......+ .
T Consensus 190 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~-~~-------~~~i~~~~~~~~-~ 260 (373)
T 2r5t_A 190 IEHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA-EM-------YDNILNKPLQLK-P 260 (373)
T ss_dssp BCCCCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHH-HH-------HHHHHHSCCCCC-S
T ss_pred ccCCCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHH-HH-------HHHHHhcccCCC-C
Confidence 54444455678999999999999999999999999999999999999998654321 11 111111111111 1
Q ss_pred chHHHHHHHHHHHHHcccCCCCCCCCHHHHH
Q 044366 883 DVTDKLRSIMEVAILCLVENPEARPTMKEVC 913 (918)
Q Consensus 883 ~~~~~~~~l~~li~~cl~~dp~~RPt~~evl 913 (918)
.. ...+.+++.+||+.||++||++.+.+
T Consensus 261 ~~---~~~~~~li~~lL~~dp~~R~~~~~~~ 288 (373)
T 2r5t_A 261 NI---TNSARHLLEGLLQKDRTKRLGAKDDF 288 (373)
T ss_dssp SS---CHHHHHHHHHHTCSSGGGSTTTTTTH
T ss_pred CC---CHHHHHHHHHHcccCHHhCCCCCCCH
Confidence 12 24578899999999999999985433
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-39 Score=339.47 Aligned_cols=251 Identities=20% Similarity=0.299 Sum_probs=201.6
Q ss_pred hcCCCCceeeccccceEEEEEEeCCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccC--CceE
Q 044366 645 TGNFGEKYCIGKGGQRSVYKAELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNA--QHSF 722 (918)
Q Consensus 645 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~ 722 (918)
.++|...+.||+|+||.||+|+. .|+.||||+++.... .....+.|.+|+.+++.++||||+++++++.+. +..+
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~avK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 85 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDW--STRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPT 85 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECCTTC--CHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCE
T ss_pred HHHhHHHHHhcCCCcceEEEEEE-CCeeEEEEEeccccc--CHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeE
Confidence 36788899999999999999987 489999999876321 222346799999999999999999999999776 7889
Q ss_pred EEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--eEEcCCCCCCeeeCCCCcEEEecccccc
Q 044366 723 IVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPP--IVHRDISSKNVLLDSEYEAHVSDFGFAK 800 (918)
Q Consensus 723 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~--ivH~dlk~~Nill~~~~~~kl~DfG~~~ 800 (918)
+||||+++|+|.+++.... ...+++.+++.++.|++.||+|||+. + ++||||||+||+++.++.++++|||++.
T Consensus 86 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~ 161 (271)
T 3kmu_A 86 LITHWMPYGSLYNVLHEGT-NFVVDQSQAVKFALDMARGMAFLHTL---EPLIPRHALNSRSVMIDEDMTARISMADVKF 161 (271)
T ss_dssp EEEECCTTCBHHHHHHSCS-SCCCCHHHHHHHHHHHHHHHHHHTTS---SSCCTTCCCSGGGEEECTTSCEEEEGGGSCC
T ss_pred eeecccCCCcHHHHHhhcc-cCCCCHHHHHHHHHHHHHHHHHHhcC---CCceecCCCccceEEEcCCcceeEEecccee
Confidence 9999999999999998643 23589999999999999999999998 7 9999999999999999999999999876
Q ss_pred ccCCCCCCceecccccccccccccccCCCCc---ccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCC
Q 044366 801 FLEPHSSNWTEFAGTVGYAAPELAYTMRATE---KYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRL 877 (918)
Q Consensus 801 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~---~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 877 (918)
.... ....||+.|+|||.+.+..++. ++||||||+++|||++|+.||......... .. .......
T Consensus 162 ~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~-----~~--~~~~~~~ 229 (271)
T 3kmu_A 162 SFQS-----PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIG-----MK--VALEGLR 229 (271)
T ss_dssp TTSC-----TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHH-----HH--HHHSCCC
T ss_pred eecc-----cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHH-----HH--HHhcCCC
Confidence 5432 2346799999999998765544 799999999999999999998654321110 00 0111111
Q ss_pred CCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 044366 878 PTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLLC 917 (918)
Q Consensus 878 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 917 (918)
+..... ....+.+++.+||+.||++|||++|+++.|+
T Consensus 230 ~~~~~~---~~~~~~~li~~~l~~~p~~Rps~~~il~~L~ 266 (271)
T 3kmu_A 230 PTIPPG---ISPHVSKLMKICMNEDPAKRPKFDMIVPILE 266 (271)
T ss_dssp CCCCTT---CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCCCCC---CCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 111112 2346888999999999999999999999986
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-39 Score=341.60 Aligned_cols=254 Identities=24% Similarity=0.344 Sum_probs=192.8
Q ss_pred HhcCCCCceeeccccceEEEEEEeC----CCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCC
Q 044366 644 ATGNFGEKYCIGKGGQRSVYKAELP----SGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQ 719 (918)
Q Consensus 644 ~~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~ 719 (918)
..++|...+.||+|+||.||+|... .+..||+|+++.. ......+.+.+|+.++++++||||+++++++. ++
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~ 88 (281)
T 1mp8_A 13 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC---TSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-EN 88 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT---TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SS
T ss_pred ehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEecccc---CCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cC
Confidence 4568889999999999999999653 2457999997653 12223567999999999999999999999985 46
Q ss_pred ceEEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccc
Q 044366 720 HSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFA 799 (918)
Q Consensus 720 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~ 799 (918)
..++||||+++|+|.+++.... ..+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 89 ~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 163 (281)
T 1mp8_A 89 PVWIIMELCTLGELRSFLQVRK--YSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLS 163 (281)
T ss_dssp SCEEEEECCTTEEHHHHHHHTT--TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC----
T ss_pred ccEEEEecCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHEEECCCCCEEECccccc
Confidence 7899999999999999997542 3589999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCC-CceecccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhhhhhhhhhHhhhhhhcccCC
Q 044366 800 KFLEPHSS-NWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIK-GYHPGDFVSTIFSSISNMIIEVNQILDHRL 877 (918)
Q Consensus 800 ~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 877 (918)
+....... ......+++.|+|||++.+..++.++||||||+++|||++ |..||...... . ... .+.....
T Consensus 164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~-~----~~~---~i~~~~~ 235 (281)
T 1mp8_A 164 RYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN-D----VIG---RIENGER 235 (281)
T ss_dssp ---------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG-G----HHH---HHHTTCC
T ss_pred cccCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHH-H----HHH---HHHcCCC
Confidence 87654332 2233456789999999998899999999999999999997 99998654321 0 111 1111111
Q ss_pred CCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 044366 878 PTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLLC 917 (918)
Q Consensus 878 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 917 (918)
...... ....+.+++.+||+.||++|||+.|+++.|+
T Consensus 236 ~~~~~~---~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~ 272 (281)
T 1mp8_A 236 LPMPPN---CPPTLYSLMTKCWAYDPSRRPRFTELKAQLS 272 (281)
T ss_dssp CCCCTT---CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCCCCC---CCHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 111112 2346788999999999999999999999886
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=348.68 Aligned_cols=257 Identities=23% Similarity=0.369 Sum_probs=205.5
Q ss_pred HhcCCCCceeeccccceEEEEEEe--------CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhc-cCCceeeEecc
Q 044366 644 ATGNFGEKYCIGKGGQRSVYKAEL--------PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEI-RHRNIIKFHGF 714 (918)
Q Consensus 644 ~~~~~~~~~~lg~G~~g~Vy~~~~--------~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~ 714 (918)
..++|...+.||+|+||.||+|+. .+++.||||+++... .....+.+.+|+++++.+ +||||++++++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~ 109 (334)
T 2pvf_A 33 PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA---TEKDLSDLVSEMEMMKMIGKHKNIINLLGA 109 (334)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC---CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred CHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC---cHHHHHHHHHHHHHHHHhhcCCCEeeEEEE
Confidence 347899999999999999999975 356789999987532 222356789999999999 89999999999
Q ss_pred cccCCceEEEEEeccCCChhHHhhcccc-------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCC
Q 044366 715 CSNAQHSFIVCEYLARGSLTTILRDDAA-------------AKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSK 781 (918)
Q Consensus 715 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~ 781 (918)
+.+++..++||||+++|+|.+++..... ...+++.+++.++.|+++||+|||+. +|+||||||+
T Consensus 110 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~ 186 (334)
T 2pvf_A 110 CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAAR 186 (334)
T ss_dssp ECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGG
T ss_pred EccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCccc
Confidence 9999999999999999999999986532 23489999999999999999999999 9999999999
Q ss_pred CeeeCCCCcEEEeccccccccCCCCCC--ceecccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhh
Q 044366 782 NVLLDSEYEAHVSDFGFAKFLEPHSSN--WTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIK-GYHPGDFVSTI 858 (918)
Q Consensus 782 Nill~~~~~~kl~DfG~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~p~~~~~~~ 858 (918)
||+++.++.+||+|||+++........ .....+++.|+|||++.+..++.++||||||+++|||++ |+.||......
T Consensus 187 NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~ 266 (334)
T 2pvf_A 187 NVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE 266 (334)
T ss_dssp GEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHH
T ss_pred eEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHH
Confidence 999999999999999999877543321 223456789999999998889999999999999999999 99998644321
Q ss_pred hhhhhhhHhhhhhhcccCCCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 044366 859 FSSISNMIIEVNQILDHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLLC 917 (918)
Q Consensus 859 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 917 (918)
. ....... ......... ....+.+++.+||+.||.+|||+.|+++.|+
T Consensus 267 --~---~~~~~~~---~~~~~~~~~---~~~~l~~li~~~l~~dp~~Rps~~ell~~L~ 314 (334)
T 2pvf_A 267 --E---LFKLLKE---GHRMDKPAN---CTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 314 (334)
T ss_dssp --H---HHHHHHH---TCCCCCCTT---CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred --H---HHHHHhc---CCCCCCCcc---CCHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 1 1111111 111111111 2246788999999999999999999999886
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-39 Score=347.37 Aligned_cols=260 Identities=22% Similarity=0.319 Sum_probs=198.1
Q ss_pred cCCCCceeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEEE
Q 044366 646 GNFGEKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFIV 724 (918)
Q Consensus 646 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 724 (918)
++|...+.||+|+||.||+|.. .+|+.||||++.... ......+.+.+|++++++++||||+++++++.+++..++|
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESE--DDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLV 80 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCC--C-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccc--cchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEE
Confidence 6788999999999999999965 469999999886531 1222246788999999999999999999999999999999
Q ss_pred EEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccCC
Q 044366 725 CEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEP 804 (918)
Q Consensus 725 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~~ 804 (918)
|||+++++|.+++... ..+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||.+.....
T Consensus 81 ~e~~~~~~l~~~~~~~---~~~~~~~~~~i~~~l~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 154 (311)
T 4agu_A 81 FEYCDHTVLHELDRYQ---RGVPEHLVKSITWQTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTG 154 (311)
T ss_dssp EECCSEEHHHHHHHTS---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECC-
T ss_pred EEeCCCchHHHHHhhh---cCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCChhhEEEcCCCCEEEeeCCCchhccC
Confidence 9999999999988754 3489999999999999999999999 999999999999999999999999999988765
Q ss_pred CCCCceeccccccccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhh-------------h
Q 044366 805 HSSNWTEFAGTVGYAAPELAYT-MRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEV-------------N 870 (918)
Q Consensus 805 ~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~-------------~ 870 (918)
.........|++.|+|||++.+ ..++.++||||+|+++|+|++|+.||......... ....... .
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 233 (311)
T 4agu_A 155 PSDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQL-YLIRKTLGDLIPRHQQVFSTN 233 (311)
T ss_dssp -----------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH-HHHHHHHCSCCHHHHHHHHTC
T ss_pred cccccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHHHhcccccccccccccc
Confidence 5544556678999999999876 56799999999999999999999998654332111 0000000 0
Q ss_pred h-hcccCCCCCCc--c----hHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 871 Q-ILDHRLPTPSR--D----VTDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 871 ~-~~~~~~~~~~~--~----~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
. ......+.+.. . .......+.+++.+||+.||++|||++|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 284 (311)
T 4agu_A 234 QYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH 284 (311)
T ss_dssp GGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred cccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 0 00011111100 0 0122346889999999999999999999985
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-39 Score=341.23 Aligned_cols=253 Identities=25% Similarity=0.328 Sum_probs=198.6
Q ss_pred hcCCCCceeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEE
Q 044366 645 TGNFGEKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFI 723 (918)
Q Consensus 645 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 723 (918)
.++|...+.||+|+||.||+|.. .+|+.||+|++.... .....+.+.+|+++++.++||||+++++++.+.+..++
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 97 (285)
T 3is5_A 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDR---SQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYI 97 (285)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGG---CCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccc---cchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEE
Confidence 35788999999999999999965 578999999987642 33446889999999999999999999999999999999
Q ss_pred EEEeccCCChhHHhhccc-ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeee---CCCCcEEEeccccc
Q 044366 724 VCEYLARGSLTTILRDDA-AAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLL---DSEYEAHVSDFGFA 799 (918)
Q Consensus 724 v~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill---~~~~~~kl~DfG~~ 799 (918)
||||+++|+|.+++.... ....+++..++.++.|+++||+|||+. +|+||||||+||++ +.++.+||+|||++
T Consensus 98 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a 174 (285)
T 3is5_A 98 VMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLA 174 (285)
T ss_dssp EECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEESSSSTTCCEEECCCCCC
T ss_pred EEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCCCHHHEEEecCCCCCCEEEEeeecc
Confidence 999999999999986542 235589999999999999999999999 99999999999999 45678999999999
Q ss_pred cccCCCCCCceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCCC
Q 044366 800 KFLEPHSSNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPT 879 (918)
Q Consensus 800 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 879 (918)
....... ......|++.|+|||++. ..++.++||||+|+++|||++|+.||...... ..... ..........
T Consensus 175 ~~~~~~~-~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~--~~~~~----~~~~~~~~~~ 246 (285)
T 3is5_A 175 ELFKSDE-HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLE--EVQQK----ATYKEPNYAV 246 (285)
T ss_dssp CC-----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHH----HHHCCCCCCC
T ss_pred eecCCcc-cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHH--HHHhh----hccCCccccc
Confidence 8765432 234567899999999876 46889999999999999999999998654321 11100 0111111111
Q ss_pred CCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 880 PSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 880 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
.... ....+.+++.+||+.||++|||++|+++
T Consensus 247 ~~~~---~~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 247 ECRP---LTPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp --CC---CCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred ccCc---CCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1111 2246788999999999999999999985
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=345.41 Aligned_cols=262 Identities=21% Similarity=0.302 Sum_probs=196.5
Q ss_pred HhcCCCCceeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceE
Q 044366 644 ATGNFGEKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSF 722 (918)
Q Consensus 644 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 722 (918)
..++|.+.+.||+|+||.||+|.. .+|+.||||+++..... .....+.+.+|+.+++.++||||+++++++..++..+
T Consensus 30 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 108 (310)
T 2wqm_A 30 TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLM-DAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELN 108 (310)
T ss_dssp SGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred cccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhcc-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEE
Confidence 346799999999999999999964 57999999998753211 1223567899999999999999999999999999999
Q ss_pred EEEEeccCCChhHHhhccc-ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccc
Q 044366 723 IVCEYLARGSLTTILRDDA-AAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKF 801 (918)
Q Consensus 723 lv~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~ 801 (918)
+||||+++|+|.+++.... ....+++.+++.++.|+++||+|||+. +++||||||+||+++.++.+||+|||++..
T Consensus 109 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~ 185 (310)
T 2wqm_A 109 IVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRF 185 (310)
T ss_dssp EEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCC-----
T ss_pred EEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCcHHHEEEcCCCCEEEEeccceee
Confidence 9999999999999997532 234589999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCCceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCCCCC
Q 044366 802 LEPHSSNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPS 881 (918)
Q Consensus 802 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 881 (918)
............|++.|+|||++.+..++.++||||||+++|+|++|+.||.......... .. .+.....+...
T Consensus 186 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~---~~---~~~~~~~~~~~ 259 (310)
T 2wqm_A 186 FSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSL---CK---KIEQCDYPPLP 259 (310)
T ss_dssp -------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHH---HH---HHHTTCSCCCC
T ss_pred ecCCCccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHH---HH---HhhcccCCCCc
Confidence 7654444445678999999999999899999999999999999999999976432111111 11 11111111111
Q ss_pred cchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 044366 882 RDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLLC 917 (918)
Q Consensus 882 ~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 917 (918)
. ......+.+++.+||+.||++|||++++++.|+
T Consensus 260 ~--~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~ 293 (310)
T 2wqm_A 260 S--DHYSEELRQLVNMCINPDPEKRPDVTYVYDVAK 293 (310)
T ss_dssp T--TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred c--cccCHHHHHHHHHHcCCChhhCCCHHHHHHHHH
Confidence 1 112346888999999999999999999999886
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=342.36 Aligned_cols=265 Identities=22% Similarity=0.292 Sum_probs=202.0
Q ss_pred HHhcCCCCceeeccccceEEEEEEe-CCCCEEEEEEcccccccC-CCCChHHHHHHHHHHhhcc---CCceeeEeccccc
Q 044366 643 KATGNFGEKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSD-ETANPSEFLNEVLALTEIR---HRNIIKFHGFCSN 717 (918)
Q Consensus 643 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~-~~~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~ 717 (918)
...++|+..+.||+|+||.||+|+. .+|+.||||+++...... .......+.+|+++++.++ ||||+++++++..
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~ 85 (308)
T 3g33_A 6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCAT 85 (308)
T ss_dssp ----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred ccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeec
Confidence 3467999999999999999999965 579999999987543222 2223457788888887775 9999999999876
Q ss_pred CC-----ceEEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEE
Q 044366 718 AQ-----HSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAH 792 (918)
Q Consensus 718 ~~-----~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~k 792 (918)
.. ..++||||++ |+|.+++.... ...+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.+|
T Consensus 86 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~k 160 (308)
T 3g33_A 86 SRTDREIKVTLVFEHVD-QDLRTYLDKAP-PPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVK 160 (308)
T ss_dssp CCSSSEEEEEEEEECCC-CBHHHHHHTCC-TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCTTTEEECTTSCEE
T ss_pred cCCCCceeEEEEehhhh-cCHHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEE
Confidence 54 5799999997 59999998654 23489999999999999999999999 999999999999999999999
Q ss_pred EeccccccccCCCCCCceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhh
Q 044366 793 VSDFGFAKFLEPHSSNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQI 872 (918)
Q Consensus 793 l~DfG~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 872 (918)
|+|||+++...... ......||+.|+|||++.+..++.++||||+||++|||++|+.||....... ............
T Consensus 161 l~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-~~~~i~~~~~~~ 238 (308)
T 3g33_A 161 LADFGLARIYSYQM-ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEAD-QLGKIFDLIGLP 238 (308)
T ss_dssp ECSCSCTTTSTTCC-CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHH-HHHHHHHHHCCC
T ss_pred EeeCccccccCCCc-ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCC
Confidence 99999998765433 2345678999999999999999999999999999999999999986543321 111111110000
Q ss_pred cccC-----------CCCCC-cch----HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 873 LDHR-----------LPTPS-RDV----TDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 873 ~~~~-----------~~~~~-~~~----~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
.... .+... ... .+....+.+++.+|++.||++|||+.|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 296 (308)
T 3g33_A 239 PEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ 296 (308)
T ss_dssp CTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence 0000 00000 000 112356889999999999999999999985
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=338.93 Aligned_cols=254 Identities=22% Similarity=0.335 Sum_probs=203.2
Q ss_pred cCCCCceeeccccceEEEEEEeC-CCCEEEEEEcccccccCC--CCChHHHHHHHHHHhhccCCceeeEecccccCCceE
Q 044366 646 GNFGEKYCIGKGGQRSVYKAELP-SGNIFAVKKFKAELFSDE--TANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSF 722 (918)
Q Consensus 646 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 722 (918)
++|...+.||+|+||.||+|... +|+.||+|.++....... ....+.+.+|+++++.++||||+++++++.+++..+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 56888999999999999999665 799999999876433322 224678999999999999999999999999999999
Q ss_pred EEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCC----cEEEecccc
Q 044366 723 IVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEY----EAHVSDFGF 798 (918)
Q Consensus 723 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~----~~kl~DfG~ 798 (918)
+||||+++++|.+++... ..+++.+++.++.|++.||+|||+. +++||||||+||+++.++ .+||+|||.
T Consensus 85 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~ 158 (283)
T 3bhy_A 85 LILELVSGGELFDFLAEK---ESLTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGI 158 (283)
T ss_dssp EEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred EEEeecCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChHHEEEecCCCCCCceEEEeccc
Confidence 999999999999999764 3489999999999999999999999 999999999999998877 799999999
Q ss_pred ccccCCCCCCceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCC
Q 044366 799 AKFLEPHSSNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLP 878 (918)
Q Consensus 799 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 878 (918)
+....... ......|++.|+|||++.+..++.++||||||+++|+|++|+.||...... ... ..+......
T Consensus 159 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-~~~-------~~~~~~~~~ 229 (283)
T 3bhy_A 159 AHKIEAGN-EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQ-ETL-------TNISAVNYD 229 (283)
T ss_dssp CEECC---------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHH-HHH-------HHHHTTCCC
T ss_pred ceeccCCC-cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchH-HHH-------HHhHhcccC
Confidence 98765432 234456899999999999889999999999999999999999998654321 110 111111111
Q ss_pred CCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 879 TPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 879 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
............+.+++.+||+.||++|||+.|+++
T Consensus 230 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 265 (283)
T 3bhy_A 230 FDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLE 265 (283)
T ss_dssp CCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHh
Confidence 111111122356889999999999999999999986
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-39 Score=346.29 Aligned_cols=259 Identities=21% Similarity=0.308 Sum_probs=197.5
Q ss_pred HHhcCCCCceeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCce
Q 044366 643 KATGNFGEKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHS 721 (918)
Q Consensus 643 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 721 (918)
...++|...+.||+|+||.||+|.. .+++.||+|++...... .....+.+.+|+.+++.++||||+++++++..++..
T Consensus 31 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~ 109 (309)
T 2h34_A 31 TQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSS-DPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQL 109 (309)
T ss_dssp ---CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGG-SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEE
T ss_pred cEeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCccccc-CHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeE
Confidence 3457899999999999999999965 47899999998764322 222246789999999999999999999999999999
Q ss_pred EEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccc
Q 044366 722 FIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKF 801 (918)
Q Consensus 722 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~ 801 (918)
++||||+++++|.+++... ..+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++..
T Consensus 110 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~ 183 (309)
T 2h34_A 110 YVDMRLINGVDLAAMLRRQ---GPLAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIASA 183 (309)
T ss_dssp EEEEECCCCEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSCCC---
T ss_pred EEEEEecCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---cCCcCCCChHHEEEcCCCCEEEecCccCcc
Confidence 9999999999999999764 3489999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCC-CCceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCCCC
Q 044366 802 LEPHS-SNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTP 880 (918)
Q Consensus 802 ~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 880 (918)
..... .......|++.|+|||++.+..++.++||||||+++|||++|+.||...... .... . +....+..
T Consensus 184 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~---~----~~~~~~~~ 254 (309)
T 2h34_A 184 TTDEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS--VMGA---H----INQAIPRP 254 (309)
T ss_dssp -------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH--HHHH---H----HHSCCCCG
T ss_pred ccccccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH--HHHH---H----hccCCCCc
Confidence 65432 2233457899999999999989999999999999999999999998754321 1111 1 11111111
Q ss_pred CcchHHHHHHHHHHHHHcccCCCCCCC-CHHHHHHHhh
Q 044366 881 SRDVTDKLRSIMEVAILCLVENPEARP-TMKEVCNLLC 917 (918)
Q Consensus 881 ~~~~~~~~~~l~~li~~cl~~dp~~RP-t~~evl~~L~ 917 (918)
..........+.+++.+||+.||++|| +++++++.|+
T Consensus 255 ~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~ 292 (309)
T 2h34_A 255 STVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAH 292 (309)
T ss_dssp GGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred cccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHH
Confidence 011111224578899999999999999 9999999885
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=359.62 Aligned_cols=250 Identities=24% Similarity=0.361 Sum_probs=206.2
Q ss_pred hcCCCCceeeccccceEEEEEEeC-CCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEE
Q 044366 645 TGNFGEKYCIGKGGQRSVYKAELP-SGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFI 723 (918)
Q Consensus 645 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 723 (918)
.++|...+.||+|+||.||+|... +|+.||||++....... ....+.+.+|+.+++.++||||+++++++...+..++
T Consensus 15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~l 93 (476)
T 2y94_A 15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRS-LDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFM 93 (476)
T ss_dssp ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHH-TTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccC-HHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 367899999999999999999654 79999999997643222 2335789999999999999999999999999999999
Q ss_pred EEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccC
Q 044366 724 VCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLE 803 (918)
Q Consensus 724 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~ 803 (918)
||||+++|+|.+++... ..+++.+++.++.||+.||+|||+. +|+||||||+||+++.++.+||+|||++....
T Consensus 94 v~E~~~gg~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDLkp~NIll~~~~~vkL~DFG~a~~~~ 167 (476)
T 2y94_A 94 VMEYVSGGELFDYICKN---GRLDEKESRRLFQQILSGVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMS 167 (476)
T ss_dssp EEECCSSEEHHHHTTSS---SSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred EEeCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CCCcccccHHHEEEecCCCeEEEeccchhhcc
Confidence 99999999999999754 3589999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCCceecccccccccccccccCCC-CcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCCCCCc
Q 044366 804 PHSSNWTEFAGTVGYAAPELAYTMRA-TEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSR 882 (918)
Q Consensus 804 ~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 882 (918)
... ......||+.|+|||++.+..+ +.++||||+||++|||++|+.||+..... ... ..+.......+ .
T Consensus 168 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~-----~~~---~~i~~~~~~~p-~ 237 (476)
T 2y94_A 168 DGE-FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVP-----TLF---KKICDGIFYTP-Q 237 (476)
T ss_dssp TTC-CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSH-----HHH---HHHHTTCCCCC-T
T ss_pred ccc-cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHH-----HHH---HHHhcCCcCCC-c
Confidence 432 3345679999999999988765 68999999999999999999998754321 111 11112222111 1
Q ss_pred chHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 883 DVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 883 ~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
.. ...+.+++.+||+.||++|||++|+++
T Consensus 238 ~~---s~~~~~Li~~~L~~dP~~Rpt~~eil~ 266 (476)
T 2y94_A 238 YL---NPSVISLLKHMLQVDPMKRATIKDIRE 266 (476)
T ss_dssp TC---CHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cC---CHHHHHHHHHHcCCCchhCcCHHHHHh
Confidence 11 245788999999999999999999985
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=343.41 Aligned_cols=255 Identities=16% Similarity=0.187 Sum_probs=204.6
Q ss_pred hcCCCCceeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhc-cCCceeeEecccccCCceE
Q 044366 645 TGNFGEKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEI-RHRNIIKFHGFCSNAQHSF 722 (918)
Q Consensus 645 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~ 722 (918)
.++|...+.||+|+||.||+|.. .+|+.||||++... ...+.+.+|+..++.+ +|++++++++++.++...+
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~ 82 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRR------SDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNV 82 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECC------TTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccC------CccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeE
Confidence 46799999999999999999964 68999999988542 1234678999999999 7999999999999999999
Q ss_pred EEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCc-----EEEeccc
Q 044366 723 IVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYE-----AHVSDFG 797 (918)
Q Consensus 723 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~-----~kl~DfG 797 (918)
+||||+ +++|.+++... ...+++.+++.++.|++.||+|||+. +|+||||||+||+++.++. +||+|||
T Consensus 83 lv~e~~-~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg 156 (298)
T 1csn_A 83 LVIDLL-GPSLEDLLDLC--GRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFG 156 (298)
T ss_dssp EEEECC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCT
T ss_pred EEEEec-CCCHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEeccCCCCCCCeEEEEECc
Confidence 999999 89999999864 23589999999999999999999999 9999999999999988776 9999999
Q ss_pred cccccCCCCC-------CceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhh--hhhhhhHhh
Q 044366 798 FAKFLEPHSS-------NWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIF--SSISNMIIE 868 (918)
Q Consensus 798 ~~~~~~~~~~-------~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~--~~~~~~~~~ 868 (918)
+++....... ......||+.|+|||++.+..++.++||||||+++|||++|+.||....... .........
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~ 236 (298)
T 1csn_A 157 MVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEK 236 (298)
T ss_dssp TCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHH
T ss_pred cccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhh
Confidence 9987765432 1244578999999999999999999999999999999999999987532211 111110000
Q ss_pred hhhhcccCCCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 044366 869 VNQILDHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLLC 917 (918)
Q Consensus 869 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 917 (918)
... ...+ .........+.+++.+||+.||++|||+++|++.|+
T Consensus 237 ~~~---~~~~---~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~ 279 (298)
T 1csn_A 237 KQS---TPLR---ELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFS 279 (298)
T ss_dssp HHH---SCHH---HHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHH
T ss_pred ccC---ccHH---HHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHH
Confidence 000 0000 000012356889999999999999999999999885
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-39 Score=348.41 Aligned_cols=253 Identities=25% Similarity=0.390 Sum_probs=198.7
Q ss_pred hcCCCCceeeccccceEEEEEEe-CCCCE----EEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCC
Q 044366 645 TGNFGEKYCIGKGGQRSVYKAEL-PSGNI----FAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQ 719 (918)
Q Consensus 645 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~----vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~ 719 (918)
.++|...+.||+|+||.||+|.. .+++. ||+|.+... ........+.+|+.+++.++||||+++++++. ++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~---~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~ 87 (325)
T 3kex_A 12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDK---SGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GS 87 (325)
T ss_dssp TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCT---TSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BS
T ss_pred HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEecccc---ccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CC
Confidence 35788899999999999999965 45554 777776543 12233456789999999999999999999986 46
Q ss_pred ceEEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccc
Q 044366 720 HSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFA 799 (918)
Q Consensus 720 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~ 799 (918)
..++||||+++|+|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 88 ~~~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a 162 (325)
T 3kex_A 88 SLQLVTQYLPLGSLLDHVRQH--RGALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVA 162 (325)
T ss_dssp SEEEEEECCTTCBSHHHHHSS--GGGSCTTHHHHHHHHHHHHHHHHHHT---TCCCSCCSSTTEEESSSSCEEECSCSGG
T ss_pred ccEEEEEeCCCCCHHHHHHHc--cccCCHHHHHHHHHHHHHHHHHHHhC---CCCCCccchheEEECCCCeEEECCCCcc
Confidence 689999999999999999764 23588999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCC--CceecccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhhhhhhhhhHhhhhhhcccC
Q 044366 800 KFLEPHSS--NWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIK-GYHPGDFVSTIFSSISNMIIEVNQILDHR 876 (918)
Q Consensus 800 ~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 876 (918)
+.+..... ......++..|+|||++.+..++.++||||||+++|||++ |+.||...... ... ...... ..
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--~~~---~~~~~~--~~ 235 (325)
T 3kex_A 163 DLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLA--EVP---DLLEKG--ER 235 (325)
T ss_dssp GGSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTT--HHH---HHHHTT--CB
T ss_pred cccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHH--HHH---HHHHcC--CC
Confidence 98755432 2344567889999999999999999999999999999999 99998654321 111 111111 11
Q ss_pred CCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 044366 877 LPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLLC 917 (918)
Q Consensus 877 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 917 (918)
...+ .. ....+.+++.+||+.||.+|||+.|+++.|+
T Consensus 236 ~~~~-~~---~~~~~~~li~~~l~~dp~~Rps~~el~~~l~ 272 (325)
T 3kex_A 236 LAQP-QI---CTIDVYMVMVKCWMIDENIRPTFKELANEFT 272 (325)
T ss_dssp CCCC-TT---BCTTTTHHHHHHTCSCTTTSCCHHHHHHHHH
T ss_pred CCCC-Cc---CcHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 1111 11 1234778899999999999999999999885
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-39 Score=349.48 Aligned_cols=246 Identities=22% Similarity=0.331 Sum_probs=204.1
Q ss_pred HhcCCCCceeeccccceEEEEEE-eCCCCEEEEEEcccccccCC----CCChHHHHHHHHHHhhccCCceeeEecccccC
Q 044366 644 ATGNFGEKYCIGKGGQRSVYKAE-LPSGNIFAVKKFKAELFSDE----TANPSEFLNEVLALTEIRHRNIIKFHGFCSNA 718 (918)
Q Consensus 644 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~----~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~ 718 (918)
..++|...+.||+|+||.||+|. ..+|+.||||+++....... ......+.+|+++++.++||||+++++++.+.
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 101 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ 101 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence 45689999999999999999996 45789999999876432221 11345678899999999999999999999999
Q ss_pred CceEEEEEeccCC-ChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccc
Q 044366 719 QHSFIVCEYLARG-SLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFG 797 (918)
Q Consensus 719 ~~~~lv~e~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG 797 (918)
+..++||||+.+| +|.+++.... .+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 102 ~~~~lv~e~~~~g~~l~~~~~~~~---~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg 175 (335)
T 3dls_A 102 GFFQLVMEKHGSGLDLFAFIDRHP---RLDEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDFG 175 (335)
T ss_dssp SEEEEEEECCTTSCBHHHHHHTCC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCT
T ss_pred CEEEEEEEeCCCCccHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeEEeccCHHHEEEcCCCcEEEeecc
Confidence 9999999999777 9999997643 489999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCCceecccccccccccccccCCC-CcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccC
Q 044366 798 FAKFLEPHSSNWTEFAGTVGYAAPELAYTMRA-TEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHR 876 (918)
Q Consensus 798 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 876 (918)
++........ .....||+.|+|||++.+..+ +.++||||||+++|||++|+.||...... ....
T Consensus 176 ~a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--------------~~~~ 240 (335)
T 3dls_A 176 SAAYLERGKL-FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET--------------VEAA 240 (335)
T ss_dssp TCEECCTTCC-BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG--------------TTTC
T ss_pred cceECCCCCc-eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH--------------Hhhc
Confidence 9987764433 345679999999999988776 78999999999999999999998643221 1111
Q ss_pred CCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 877 LPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 877 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
...+ .. ....+.+++.+||+.||++|||++|+++
T Consensus 241 ~~~~-~~---~~~~l~~li~~~L~~dP~~Rps~~ell~ 274 (335)
T 3dls_A 241 IHPP-YL---VSKELMSLVSGLLQPVPERRTTLEKLVT 274 (335)
T ss_dssp CCCS-SC---CCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cCCC-cc---cCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1111 11 1245788999999999999999999986
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=349.94 Aligned_cols=250 Identities=23% Similarity=0.347 Sum_probs=195.7
Q ss_pred hcCCCCceeeccccceEEEEEEeCCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccC--CceeeEecccccCCceE
Q 044366 645 TGNFGEKYCIGKGGQRSVYKAELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRH--RNIIKFHGFCSNAQHSF 722 (918)
Q Consensus 645 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~~~~~~~~~~~~~ 722 (918)
.++|.+.+.||+|+||.||+|...+++.||||++.... ......+.+.+|+++++.++| |||+++++++.+++..+
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~ 85 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEE--ADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIY 85 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTT--CCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccc--cchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEE
Confidence 45688999999999999999988889999999987532 122234678999999999976 99999999999999999
Q ss_pred EEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEecccccccc
Q 044366 723 IVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFL 802 (918)
Q Consensus 723 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~ 802 (918)
+|||| .+|+|.+++... ..+++.+++.++.|++.||+|||+. +|+||||||+||+++ ++.+||+|||+++..
T Consensus 86 lv~e~-~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~al~~lH~~---~iiHrDikp~NIll~-~~~~kl~DFG~a~~~ 157 (343)
T 3dbq_A 86 MVMEC-GNIDLNSWLKKK---KSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQM 157 (343)
T ss_dssp EEECC-CSEEHHHHHHHS---CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEEEECCCSSSCCC
T ss_pred EEEeC-CCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEE-CCcEEEeeccccccc
Confidence 99995 577999999864 3489999999999999999999999 999999999999997 578999999999877
Q ss_pred CCCCCC--ceeccccccccccccccc-----------CCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhh
Q 044366 803 EPHSSN--WTEFAGTVGYAAPELAYT-----------MRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEV 869 (918)
Q Consensus 803 ~~~~~~--~~~~~g~~~y~aPE~~~~-----------~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~ 869 (918)
...... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||........ ..
T Consensus 158 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-------~~ 230 (343)
T 3dbq_A 158 QPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS-------KL 230 (343)
T ss_dssp ------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHH-------HH
T ss_pred CcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHH-------HH
Confidence 544322 235679999999999865 6788999999999999999999999865332111 11
Q ss_pred hhhcccCCCC-CCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 870 NQILDHRLPT-PSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 870 ~~~~~~~~~~-~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
....+..... .+... ...+.+++.+||+.||++|||+.|+++
T Consensus 231 ~~~~~~~~~~~~~~~~---~~~l~~li~~~L~~dp~~Rpt~~e~l~ 273 (343)
T 3dbq_A 231 HAIIDPNHEIEFPDIP---EKDLQDVLKCCLKRDPKQRISIPELLA 273 (343)
T ss_dssp HHHHCTTSCCCCCCCS---CHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHhcCCcccCCcccC---CHHHHHHHHHHcCCChhHCCCHHHHHh
Confidence 1122211111 11111 235788999999999999999999975
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=337.43 Aligned_cols=253 Identities=22% Similarity=0.397 Sum_probs=205.1
Q ss_pred HhcCCCCceeeccccceEEEEEEeCCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEE
Q 044366 644 ATGNFGEKYCIGKGGQRSVYKAELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFI 723 (918)
Q Consensus 644 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 723 (918)
..++|...+.||+|+||.||+|...+++.||||+++.. ....+.+.+|+++++.++||||+++++++.+ +..++
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~-----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~ 84 (279)
T 1qpc_A 11 PRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQG-----SMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYI 84 (279)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTT-----SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred CHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCC-----cccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEE
Confidence 34678889999999999999998888889999998652 2346789999999999999999999999864 56899
Q ss_pred EEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccC
Q 044366 724 VCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLE 803 (918)
Q Consensus 724 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~ 803 (918)
||||+++++|.+++.... ...+++.+++.++.|++.||+|||+. +++||||||+||++++++.+||+|||.+....
T Consensus 85 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 160 (279)
T 1qpc_A 85 ITEYMENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIE 160 (279)
T ss_dssp EEECCTTCBHHHHTTSHH-HHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred EEecCCCCCHHHHHhcCC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHhhEEEcCCCCEEECCCccccccc
Confidence 999999999999997642 23589999999999999999999999 99999999999999999999999999998775
Q ss_pred CCCCC-ceecccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhhhhhhhhhHhhhhhhcccCCCCCC
Q 044366 804 PHSSN-WTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIK-GYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPS 881 (918)
Q Consensus 804 ~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 881 (918)
..... .....++..|+|||.+.+..++.++||||||+++|||++ |+.||...... . ....... .......
T Consensus 161 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~-~----~~~~~~~---~~~~~~~ 232 (279)
T 1qpc_A 161 DNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP-E----VIQNLER---GYRMVRP 232 (279)
T ss_dssp SSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-H----HHHHHHT---TCCCCCC
T ss_pred CcccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHH-H----HHHHHhc---ccCCCCc
Confidence 43221 123346788999999998889999999999999999999 89997653321 1 1111111 1111111
Q ss_pred cchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 044366 882 RDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLLC 917 (918)
Q Consensus 882 ~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 917 (918)
.. ....+.+++.+|++.||++|||++++++.|+
T Consensus 233 ~~---~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~ 265 (279)
T 1qpc_A 233 DN---CPEELYQLMRLCWKERPEDRPTFDYLRSVLE 265 (279)
T ss_dssp TT---CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred cc---ccHHHHHHHHHHhccChhhCCCHHHHHHHHH
Confidence 11 2246888999999999999999999999885
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-39 Score=345.16 Aligned_cols=255 Identities=24% Similarity=0.392 Sum_probs=208.9
Q ss_pred HHhcCCCCceeeccccceEEEEEEeC-CCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCce
Q 044366 643 KATGNFGEKYCIGKGGQRSVYKAELP-SGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHS 721 (918)
Q Consensus 643 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 721 (918)
...++|...+.||+|+||.||+|... +++.||+|++.. .....+.+.+|+++++.++||||+++++++.+++..
T Consensus 10 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 84 (288)
T 3kfa_A 10 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-----DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPF 84 (288)
T ss_dssp CCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECS-----CSTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSE
T ss_pred ccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCc-----CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCE
Confidence 45678899999999999999999664 588999999864 223467899999999999999999999999999999
Q ss_pred EEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccc
Q 044366 722 FIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKF 801 (918)
Q Consensus 722 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~ 801 (918)
++||||+++|+|.+++.... ...+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||.+..
T Consensus 85 ~~v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~ 160 (288)
T 3kfa_A 85 YIITEFMTYGNLLDYLRECN-RQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRL 160 (288)
T ss_dssp EEEEECCTTEEHHHHHHHCC-TTTSCHHHHHHHHHHHHHHHHHHHHH---TCCCSCCSGGGEEECGGGCEEECCCCGGGT
T ss_pred EEEEEcCCCCcHHHHHHhcc-cCCccHhHHHHHHHHHHHHHHHHHHC---CccCCCCCcceEEEcCCCCEEEccCcccee
Confidence 99999999999999997643 34589999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCC-ceecccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhhhhhhhhhHhhhhhhcccCCCC
Q 044366 802 LEPHSSN-WTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIK-GYHPGDFVSTIFSSISNMIIEVNQILDHRLPT 879 (918)
Q Consensus 802 ~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 879 (918)
....... .....+++.|+|||.+.+..++.++||||+|+++|+|++ |..||...... ........... . .
T Consensus 161 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~-----~~~~~~~~~~~--~-~ 232 (288)
T 3kfa_A 161 MTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS-----QVYELLEKDYR--M-E 232 (288)
T ss_dssp SCSSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG-----GHHHHHHTTCC--C-C
T ss_pred ccCCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH-----HHHHHHhccCC--C-C
Confidence 7544322 223456788999999999999999999999999999999 99997643321 11111111111 1 1
Q ss_pred CCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 044366 880 PSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLLC 917 (918)
Q Consensus 880 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 917 (918)
.... ....+.+++.+|++.||.+|||++|+++.|+
T Consensus 233 ~~~~---~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~ 267 (288)
T 3kfa_A 233 RPEG---CPEKVYELMRACWQWNPSDRPSFAEIHQAFE 267 (288)
T ss_dssp CCTT---CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCCC---CCHHHHHHHHHHhCCChhhCcCHHHHHHHHH
Confidence 1111 2246888999999999999999999999885
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=356.18 Aligned_cols=263 Identities=22% Similarity=0.266 Sum_probs=206.4
Q ss_pred HHHHHHHhcCCCCceeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccc
Q 044366 638 YEEITKATGNFGEKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCS 716 (918)
Q Consensus 638 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~ 716 (918)
+.+.....++|...+.||+|+||.||+|+. .+|+.||+|+++...... ....+.+.+|..++..++||||+++++++.
T Consensus 53 ~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~-~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 131 (412)
T 2vd5_A 53 LKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLK-RGEVSCFREERDVLVNGDRRWITQLHFAFQ 131 (412)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHH-HGGGCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred hhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhh-HHHHHHHHHHHHHHHhcCCCCeeeEEEEEe
Confidence 344555678999999999999999999966 479999999986532211 112346889999999999999999999999
Q ss_pred cCCceEEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEecc
Q 044366 717 NAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDF 796 (918)
Q Consensus 717 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Df 796 (918)
+++..++||||+++|+|.+++.+.+ ..+++..++.++.||+.||+|||+. +|+||||||+||+++.++.+||+||
T Consensus 132 ~~~~~~lVmE~~~gg~L~~~l~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILld~~g~vkL~DF 206 (412)
T 2vd5_A 132 DENYLYLVMEYYVGGDLLTLLSKFG--ERIPAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNILLDRCGHIRLADF 206 (412)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHHHS--SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCC
T ss_pred eCCEEEEEEcCCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccCHHHeeecCCCCEEEeec
Confidence 9999999999999999999997642 3589999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCCC-ceecccccccccccccc-------cCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhh
Q 044366 797 GFAKFLEPHSSN-WTEFAGTVGYAAPELAY-------TMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIE 868 (918)
Q Consensus 797 G~~~~~~~~~~~-~~~~~g~~~y~aPE~~~-------~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~ 868 (918)
|+++........ ....+||+.|+|||++. +..++.++|||||||++|||++|+.||...... ........
T Consensus 207 Gla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~-~~~~~i~~- 284 (412)
T 2vd5_A 207 GSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTA-ETYGKIVH- 284 (412)
T ss_dssp TTCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHH-HHHHHHHT-
T ss_pred hhheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHH-HHHHHHHh-
Confidence 999877654332 23457999999999987 356899999999999999999999998654321 11111110
Q ss_pred hhhhcccCCCCCCcchHHHHHHHHHHHHHcccCCCCCC---CCHHHHHH
Q 044366 869 VNQILDHRLPTPSRDVTDKLRSIMEVAILCLVENPEAR---PTMKEVCN 914 (918)
Q Consensus 869 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~R---Pt~~evl~ 914 (918)
... ....+..... ....+.+++.+||. +|++| |+++|+++
T Consensus 285 ~~~--~~~~p~~~~~---~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~ 327 (412)
T 2vd5_A 285 YKE--HLSLPLVDEG---VPEEARDFIQRLLC-PPETRLGRGGAGDFRT 327 (412)
T ss_dssp HHH--HCCCC----C---CCHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred ccc--CcCCCccccC---CCHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence 000 0111111111 23467889999999 99998 68999864
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-39 Score=342.21 Aligned_cols=260 Identities=25% Similarity=0.402 Sum_probs=194.5
Q ss_pred HHhcCCCCceeeccccceEEEEEEeCCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceE
Q 044366 643 KATGNFGEKYCIGKGGQRSVYKAELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSF 722 (918)
Q Consensus 643 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 722 (918)
...++|...+.||+|+||.||+|+.. ..||||+++... ......+.|.+|+++++.++||||+++++++ ..+..+
T Consensus 21 i~~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~ 95 (289)
T 3og7_A 21 IPDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTA--PTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLA 95 (289)
T ss_dssp CCTTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSS--CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCE
T ss_pred cCccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccC--CCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccE
Confidence 44578999999999999999999863 469999987532 1223356799999999999999999999965 456689
Q ss_pred EEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEecccccccc
Q 044366 723 IVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFL 802 (918)
Q Consensus 723 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~ 802 (918)
+||||+++++|.+++... ...+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++...
T Consensus 96 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~ 170 (289)
T 3og7_A 96 IVTQWCEGSSLYHHLHAS--ETKFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFGLATEK 170 (289)
T ss_dssp EEEECCCEEEHHHHHTTC-----CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEECCCC-----
T ss_pred EEEEecCCCcHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCCCEEEccceecccc
Confidence 999999999999999654 34589999999999999999999999 9999999999999999999999999999865
Q ss_pred CCCC--CCceecccccccccccccc---cCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCC
Q 044366 803 EPHS--SNWTEFAGTVGYAAPELAY---TMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRL 877 (918)
Q Consensus 803 ~~~~--~~~~~~~g~~~y~aPE~~~---~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 877 (918)
.... .......||+.|+|||++. +..++.++||||||+++|||++|+.||.......... .... ........
T Consensus 171 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~-~~~~--~~~~~~~~ 247 (289)
T 3og7_A 171 SRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQII-EMVG--RGSLSPDL 247 (289)
T ss_dssp -------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHH-HHHH--HTSCCCCT
T ss_pred ccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHH-HHhc--ccccCcch
Confidence 4322 2234457899999999986 5678889999999999999999999987543321111 1110 01111111
Q ss_pred CCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhC
Q 044366 878 PTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLLCK 918 (918)
Q Consensus 878 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~ 918 (918)
.. ........+.+++.+||+.||++|||++|+++.|++
T Consensus 248 ~~---~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~ 285 (289)
T 3og7_A 248 SK---VRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEE 285 (289)
T ss_dssp TS---SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred hh---ccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHH
Confidence 11 111233568899999999999999999999999863
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=355.46 Aligned_cols=251 Identities=24% Similarity=0.308 Sum_probs=190.7
Q ss_pred cCCCCc-eeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhh-ccCCceeeEeccccc----C
Q 044366 646 GNFGEK-YCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTE-IRHRNIIKFHGFCSN----A 718 (918)
Q Consensus 646 ~~~~~~-~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~-l~h~niv~~~~~~~~----~ 718 (918)
++|... +.||+|+||.||+|.. .+|+.||||+++. ...+.+|++++.+ .+||||+++++++.. .
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~---------~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~ 131 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD---------CPKARREVELHWRASQCPHIVRIVDVYENLYAGR 131 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC---------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTE
T ss_pred ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc---------chhHHHHHHHHHHhcCCCCcceEeEEEeecccCC
Confidence 456665 6899999999999955 4799999999853 2467889888744 589999999998764 5
Q ss_pred CceEEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCC---CCcEEEec
Q 044366 719 QHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDS---EYEAHVSD 795 (918)
Q Consensus 719 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~---~~~~kl~D 795 (918)
+..++||||+++|+|.+++.... ...+++.+++.++.||+.||+|||+. +|+||||||+||+++. ++.+||+|
T Consensus 132 ~~~~lv~E~~~gg~L~~~l~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~~~kl~D 207 (400)
T 1nxk_A 132 KCLLIVMECLDGGELFSRIQDRG-DQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTD 207 (400)
T ss_dssp EEEEEEEECCCSEEHHHHHHCC----CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSTTCCEEECC
T ss_pred cEEEEEEEeCCCCcHHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCcceEEEecCCCCccEEEEe
Confidence 67899999999999999998643 34589999999999999999999999 9999999999999998 78899999
Q ss_pred cccccccCCCCCCceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhccc
Q 044366 796 FGFAKFLEPHSSNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDH 875 (918)
Q Consensus 796 fG~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 875 (918)
||+++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......... ...... +...
T Consensus 208 FG~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~-~~~~~~---i~~~ 282 (400)
T 1nxk_A 208 FGFAKETTSHN-SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS-PGMKTR---IRMG 282 (400)
T ss_dssp CTTCEECC------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSC-CSHHHH---HHHT
T ss_pred cccccccCCCC-ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcccccc-HHHHHH---HHcC
Confidence 99998765332 234567899999999999999999999999999999999999998654321100 000011 1111
Q ss_pred CCCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 876 RLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 876 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
....+..........+.+++.+||+.||++|||++|+++
T Consensus 283 ~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 321 (400)
T 1nxk_A 283 QYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 321 (400)
T ss_dssp CCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred cccCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 111111111223356889999999999999999999986
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-39 Score=349.06 Aligned_cols=259 Identities=18% Similarity=0.275 Sum_probs=193.4
Q ss_pred cCCCCceeeccccceEEEEEEeC-CCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEEE
Q 044366 646 GNFGEKYCIGKGGQRSVYKAELP-SGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFIV 724 (918)
Q Consensus 646 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 724 (918)
++|...+.||+|+||.||+|... +++.||||+++..... .....+.+|+++++.++||||+++++++.+++..++|
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 78 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEE---GAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLV 78 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC---------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEE
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEeccccc---ccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEE
Confidence 57889999999999999999654 7999999998754321 1122456799999999999999999999999999999
Q ss_pred EEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccCC
Q 044366 725 CEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEP 804 (918)
Q Consensus 725 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~~ 804 (918)
|||++ |+|.+++... ...+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 79 ~e~~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~ 152 (324)
T 3mtl_A 79 FEYLD-KDLKQYLDDC--GNIINMHNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSI 152 (324)
T ss_dssp EECCS-EEHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCCGGGEEECTTCCEEECSSSEEECC--
T ss_pred ecccc-cCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCcCHHHEEECCCCCEEEccCcccccccC
Confidence 99998 5999988764 24589999999999999999999999 999999999999999999999999999987665
Q ss_pred CCCCceeccccccccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccC-------
Q 044366 805 HSSNWTEFAGTVGYAAPELAYT-MRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHR------- 876 (918)
Q Consensus 805 ~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~------- 876 (918)
.........||+.|+|||++.+ ..++.++||||+||++|||++|+.||...... .................
T Consensus 153 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~~~~ 231 (324)
T 3mtl_A 153 PTKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVE-EQLHFIFRILGTPTEETWPGILSN 231 (324)
T ss_dssp ----------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHHHHCCCCTTTSTTGGGC
T ss_pred CccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhCCCChHhchhhhcc
Confidence 5545556678999999999876 56899999999999999999999998754321 11111110000000000
Q ss_pred -------CCCCC-cc----hHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 877 -------LPTPS-RD----VTDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 877 -------~~~~~-~~----~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
.+... .. .......+.+++.+|++.||++|||++|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 281 (324)
T 3mtl_A 232 EEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK 281 (324)
T ss_dssp HHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 00000 00 0012356789999999999999999999975
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-38 Score=339.48 Aligned_cols=249 Identities=26% Similarity=0.401 Sum_probs=207.3
Q ss_pred hcCCCCceeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEE
Q 044366 645 TGNFGEKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFI 723 (918)
Q Consensus 645 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 723 (918)
.+.|...+.||+|+||.||+|.. .+++.||||++.... .....+.+.+|+.+++.++||||+++++++.+++..++
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 97 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEE---AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWI 97 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTT---CSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccc---cHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEE
Confidence 45688999999999999999954 579999999987542 23346889999999999999999999999999999999
Q ss_pred EEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccC
Q 044366 724 VCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLE 803 (918)
Q Consensus 724 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~ 803 (918)
||||+++++|.+++.. ..+++.+++.++.|++.||+|||+. +++||||||+||+++.++.+||+|||++....
T Consensus 98 v~e~~~~~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~ 170 (303)
T 3a7i_A 98 IMEYLGGGSALDLLEP----GPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLT 170 (303)
T ss_dssp EEECCTTEEHHHHHTT----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECB
T ss_pred EEEeCCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChheEEECCCCCEEEeecccceecC
Confidence 9999999999999974 3489999999999999999999999 99999999999999999999999999998876
Q ss_pred CCCCCceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCCCCCcc
Q 044366 804 PHSSNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRD 883 (918)
Q Consensus 804 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 883 (918)
..........|++.|+|||++.+..++.++||||||+++|+|++|+.||....... ..... .....+.....
T Consensus 171 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-----~~~~~---~~~~~~~~~~~ 242 (303)
T 3a7i_A 171 DTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMK-----VLFLI---PKNNPPTLEGN 242 (303)
T ss_dssp TTBCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-----HHHHH---HHSCCCCCCSS
T ss_pred ccccccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHH-----HHHHh---hcCCCCCCccc
Confidence 55444455678999999999999899999999999999999999999986543211 00111 11111111112
Q ss_pred hHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 884 VTDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 884 ~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
. ...+.+++.+||+.||++|||++|+++
T Consensus 243 ~---~~~l~~li~~~l~~dp~~Rps~~~ll~ 270 (303)
T 3a7i_A 243 Y---SKPLKEFVEACLNKEPSFRPTAKELLK 270 (303)
T ss_dssp C---CHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred c---CHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 2 245788999999999999999999976
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=338.11 Aligned_cols=250 Identities=28% Similarity=0.419 Sum_probs=202.0
Q ss_pred HhcCCCCceeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceE
Q 044366 644 ATGNFGEKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSF 722 (918)
Q Consensus 644 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 722 (918)
+.++|.+.+.||+|+||.||+|.. .+++.||+|++....... ......+.+|+++++.++||||+++++++.+.+..+
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 85 (279)
T 3fdn_A 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEK-AGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVY 85 (279)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHH-HTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccch-hhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEE
Confidence 457899999999999999999955 468899999986543222 233577999999999999999999999999999999
Q ss_pred EEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEecccccccc
Q 044366 723 IVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFL 802 (918)
Q Consensus 723 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~ 802 (918)
+||||+++|+|.+++.... .+++..++.++.|++.||+|||+. +|+||||||+||+++.++.++|+|||++...
T Consensus 86 lv~e~~~~~~l~~~l~~~~---~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~ 159 (279)
T 3fdn_A 86 LILEYAPLGTVYRELQKLS---KFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHA 159 (279)
T ss_dssp EEECCCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTT---TCEECCCCGGGEEECTTSCEEECSCCEESCC
T ss_pred EEEecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHhEEEcCCCCEEEEeccccccC
Confidence 9999999999999997643 489999999999999999999999 9999999999999999999999999998655
Q ss_pred CCCCCCceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCCCCCc
Q 044366 803 EPHSSNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSR 882 (918)
Q Consensus 803 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 882 (918)
... ......|++.|+|||.+.+..++.++||||+|+++|+|++|+.||...... ........ .....+ .
T Consensus 160 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-----~~~~~~~~---~~~~~~-~ 228 (279)
T 3fdn_A 160 PSS--RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ-----ETYKRISR---VEFTFP-D 228 (279)
T ss_dssp ----------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHH-----HHHHHHHH---TCCCCC-T
T ss_pred Ccc--cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHH-----HHHHHHHh---CCCCCC-C
Confidence 432 224457899999999999989999999999999999999999998754321 11111111 111111 1
Q ss_pred chHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 883 DVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 883 ~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
. ....+.+++.+||+.||++|||++|+++
T Consensus 229 ~---~~~~~~~li~~~l~~~p~~Rps~~e~l~ 257 (279)
T 3fdn_A 229 F---VTEGARDLISRLLKHNPSQRPMLREVLE 257 (279)
T ss_dssp T---SCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred c---CCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 1 1245778999999999999999999986
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-39 Score=351.05 Aligned_cols=262 Identities=21% Similarity=0.350 Sum_probs=209.3
Q ss_pred HHHHHhcCCCCceeeccccceEEEEEEeC------CCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEec
Q 044366 640 EITKATGNFGEKYCIGKGGQRSVYKAELP------SGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHG 713 (918)
Q Consensus 640 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~ 713 (918)
+.+...++|...+.||+|+||.||+|... +++.||||.+.... .......+.+|+++++.++||||+++++
T Consensus 19 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~ 95 (322)
T 1p4o_A 19 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA---SMRERIEFLNEASVMKEFNCHHVVRLLG 95 (322)
T ss_dssp TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS---CHHHHHHHHHHHHHGGGCCCTTBCCEEE
T ss_pred hhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEeccccc---CHHHHHHHHHHHHHHHhcCCCCEeeeEE
Confidence 33456688999999999999999999543 47789999986431 2223457899999999999999999999
Q ss_pred ccccCCceEEEEEeccCCChhHHhhcccc-------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeC
Q 044366 714 FCSNAQHSFIVCEYLARGSLTTILRDDAA-------AKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLD 786 (918)
Q Consensus 714 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~ 786 (918)
++.+++..++||||+++|+|.+++..... ...+++.+++.++.|++.||+|||+. +|+||||||+||+++
T Consensus 96 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~NIli~ 172 (322)
T 1p4o_A 96 VVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVA 172 (322)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEEC
T ss_pred EEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CCccCCCccceEEEc
Confidence 99999999999999999999999976431 14579999999999999999999999 999999999999999
Q ss_pred CCCcEEEeccccccccCCCCCC--ceecccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhhhhhhh
Q 044366 787 SEYEAHVSDFGFAKFLEPHSSN--WTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIK-GYHPGDFVSTIFSSIS 863 (918)
Q Consensus 787 ~~~~~kl~DfG~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~p~~~~~~~~~~~~ 863 (918)
.++.+||+|||++......... .....+++.|+|||++.+..++.++||||+|+++|||++ |+.||...... ..
T Consensus 173 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~--~~- 249 (322)
T 1p4o_A 173 EDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE--QV- 249 (322)
T ss_dssp TTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHH--HH-
T ss_pred CCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHH--HH-
Confidence 9999999999999866443221 123456889999999999899999999999999999999 88997654321 00
Q ss_pred hhHhhhhhhcccCCCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhC
Q 044366 864 NMIIEVNQILDHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLLCK 918 (918)
Q Consensus 864 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~ 918 (918)
. ..+........... ....+.+++.+||+.||.+|||+.|+++.|++
T Consensus 250 --~---~~~~~~~~~~~~~~---~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~ 296 (322)
T 1p4o_A 250 --L---RFVMEGGLLDKPDN---CPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 296 (322)
T ss_dssp --H---HHHHTTCCCCCCTT---CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGG
T ss_pred --H---HHHHcCCcCCCCCC---CCHHHHHHHHHHcCCCcccCcCHHHHHHHHHH
Confidence 0 11111111111122 22457889999999999999999999998863
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=344.23 Aligned_cols=247 Identities=21% Similarity=0.247 Sum_probs=193.3
Q ss_pred hcCCCCceeeccccceEEEEEEeC-CCCEEEEEEcccccccCCCCChHHHHHHHHHHhhc-cCCceeeEecccccCCceE
Q 044366 645 TGNFGEKYCIGKGGQRSVYKAELP-SGNIFAVKKFKAELFSDETANPSEFLNEVLALTEI-RHRNIIKFHGFCSNAQHSF 722 (918)
Q Consensus 645 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~ 722 (918)
.++|...++||+|+||+||+|... +|+.||||++..... .......+..|+..+..+ +||||+++++++.+++..+
T Consensus 56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~ 133 (311)
T 3p1a_A 56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFR--GPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILY 133 (311)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCC--SHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred hhheeeeheeccCCCeEEEEEEECCCCeEEEEEEeccccc--ChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEE
Confidence 367999999999999999999665 799999998765321 112234556666666555 8999999999999999999
Q ss_pred EEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEecccccccc
Q 044366 723 IVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFL 802 (918)
Q Consensus 723 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~ 802 (918)
+||||+ +++|.+++.... ..+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++...
T Consensus 134 lv~e~~-~~~L~~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~ 207 (311)
T 3p1a_A 134 LQTELC-GPSLQQHCEAWG--ASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVEL 207 (311)
T ss_dssp EEEECC-CCBHHHHHHHHC--SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECGGGCEEECCCTTCEEC
T ss_pred EEEecc-CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEccceeeeec
Confidence 999999 669999887653 4589999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCCCceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCCCCCc
Q 044366 803 EPHSSNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSR 882 (918)
Q Consensus 803 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 882 (918)
.... ......||+.|+|||++.+ .++.++|||||||++|||++|..|+...... . .+.....+. .
T Consensus 208 ~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~~-~----------~~~~~~~~~--~ 272 (311)
T 3p1a_A 208 GTAG-AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEGW-Q----------QLRQGYLPP--E 272 (311)
T ss_dssp C-------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHH-H----------HHTTTCCCH--H
T ss_pred ccCC-CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccHH-H----------HHhccCCCc--c
Confidence 5432 2344568999999999876 7899999999999999999997765432211 1 111111110 0
Q ss_pred chHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 883 DVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 883 ~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
........+.+++.+||+.||++|||++|+++
T Consensus 273 ~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 273 FTAGLSSELRSVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred cccCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 01112356889999999999999999999986
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-38 Score=337.13 Aligned_cols=253 Identities=23% Similarity=0.337 Sum_probs=200.0
Q ss_pred cCCCCceeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEEE
Q 044366 646 GNFGEKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFIV 724 (918)
Q Consensus 646 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 724 (918)
++|.....||+|+||.||+|.. .+++.||||.+... .....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 97 (295)
T 2clq_A 22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPER----DSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIF 97 (295)
T ss_dssp CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECC----CC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCC----chHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEE
Confidence 3455666899999999999964 57899999998653 233457899999999999999999999999999999999
Q ss_pred EEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCC-CCcEEEeccccccccC
Q 044366 725 CEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDS-EYEAHVSDFGFAKFLE 803 (918)
Q Consensus 725 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~-~~~~kl~DfG~~~~~~ 803 (918)
|||+++++|.+++........+++..++.++.|++.||+|||+. +++||||||+||+++. ++.+||+|||.+....
T Consensus 98 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~ 174 (295)
T 2clq_A 98 MEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLA 174 (295)
T ss_dssp EECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTCCEEECCTTTCEESC
T ss_pred EEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhC---CEEccCCChhhEEEECCCCCEEEeecccccccC
Confidence 99999999999998764445578999999999999999999999 9999999999999987 8999999999998776
Q ss_pred CCCCCceecccccccccccccccCC--CCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCCCCC
Q 044366 804 PHSSNWTEFAGTVGYAAPELAYTMR--ATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPS 881 (918)
Q Consensus 804 ~~~~~~~~~~g~~~y~aPE~~~~~~--~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 881 (918)
..........|++.|+|||++.+.. ++.++||||||+++|+|++|+.||............ . ... ...+...
T Consensus 175 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~---~--~~~-~~~~~~~ 248 (295)
T 2clq_A 175 GINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFK---V--GMF-KVHPEIP 248 (295)
T ss_dssp C-----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHH---H--HHH-CCCCCCC
T ss_pred CCCCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHh---h--ccc-ccccccc
Confidence 5443344567899999999987643 789999999999999999999998643321111110 0 000 1111111
Q ss_pred cchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 882 RDVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 882 ~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
.. ....+.+++.+||+.||++|||++|+++
T Consensus 249 ~~---~~~~~~~li~~~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 249 ES---MSAEAKAFILKCFEPDPDKRACANDLLV 278 (295)
T ss_dssp TT---SCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred cc---CCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 11 2246788999999999999999999985
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=348.07 Aligned_cols=267 Identities=22% Similarity=0.292 Sum_probs=199.5
Q ss_pred HHHHhcCCCCceeeccccceEEEEEEeC-CCCEEEEEEcccccccCC-CCChHHHHHHHHHHhhccCCceeeEecccccC
Q 044366 641 ITKATGNFGEKYCIGKGGQRSVYKAELP-SGNIFAVKKFKAELFSDE-TANPSEFLNEVLALTEIRHRNIIKFHGFCSNA 718 (918)
Q Consensus 641 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~ 718 (918)
+....++|...+.||+|+||.||+|... +|+.||||++........ ....+.+.+|+++++.++||||+++++++.+.
T Consensus 5 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 84 (346)
T 1ua2_A 5 VKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHK 84 (346)
T ss_dssp --------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCT
T ss_pred hHHHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeC
Confidence 3445678999999999999999999664 699999999875432211 12235788999999999999999999999999
Q ss_pred CceEEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEecccc
Q 044366 719 QHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGF 798 (918)
Q Consensus 719 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~ 798 (918)
+..++||||+++ +|.+++... ...+++.+++.++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 85 ~~~~lv~e~~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~ 158 (346)
T 1ua2_A 85 SNISLVFDFMET-DLEVIIKDN--SLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGL 158 (346)
T ss_dssp TCCEEEEECCSE-EHHHHHTTC--CSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGG
T ss_pred CceEEEEEcCCC-CHHHHHHhc--CcCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEEcCCCCEEEEeccc
Confidence 999999999986 899888754 24588899999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCCceecccccccccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCC
Q 044366 799 AKFLEPHSSNWTEFAGTVGYAAPELAYTM-RATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRL 877 (918)
Q Consensus 799 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 877 (918)
++.............||+.|+|||++.+. .++.++|||||||++|||++|.+||...... .................+
T Consensus 159 a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~-~~~~~i~~~~~~~~~~~~ 237 (346)
T 1ua2_A 159 AKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDL-DQLTRIFETLGTPTEEQW 237 (346)
T ss_dssp GSTTTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHHHCCCCTTTS
T ss_pred ceeccCCcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHH-HHHHHHHHHcCCCChhhh
Confidence 98876555555566789999999998764 4789999999999999999999997654321 111111111000000000
Q ss_pred CC------------CCc-c----hHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 878 PT------------PSR-D----VTDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 878 ~~------------~~~-~----~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
+. ... . .......+.+++.+||+.||++|||++|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 291 (346)
T 1ua2_A 238 PDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 291 (346)
T ss_dssp SSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred hhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhc
Confidence 00 000 0 0112357889999999999999999999986
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-39 Score=353.85 Aligned_cols=263 Identities=17% Similarity=0.260 Sum_probs=199.0
Q ss_pred HhcCCCCceeeccccceEEEEEEeCC------CCEEEEEEcccccccC-------CCCChHHHHHHHHHHhhccCCceee
Q 044366 644 ATGNFGEKYCIGKGGQRSVYKAELPS------GNIFAVKKFKAELFSD-------ETANPSEFLNEVLALTEIRHRNIIK 710 (918)
Q Consensus 644 ~~~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~-------~~~~~~~~~~e~~~l~~l~h~niv~ 710 (918)
..++|.+.+.||+|+||.||+|.... ++.||||++....... .......+..|+..++.++||||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 45689999999999999999997654 4789999976431100 0001123445566677778999999
Q ss_pred EecccccC----CceEEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeC
Q 044366 711 FHGFCSNA----QHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLD 786 (918)
Q Consensus 711 ~~~~~~~~----~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~ 786 (918)
+++++... ...++||||+ +++|.+++... ...+++.+++.|+.||+.||+|||+. +|+||||||+||+++
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~--~~~l~~~~~~~i~~qi~~~l~~lH~~---~iiHrDlkp~Nill~ 186 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEAN--AKRFSRKTVLQLSLRILDILEYIHEH---EYVHGDIKASNLLLN 186 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHT--TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEE
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEEecCCHHHEEEe
Confidence 99998654 4589999999 89999999764 34589999999999999999999999 999999999999999
Q ss_pred --CCCcEEEeccccccccCCCCCC-------ceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchh
Q 044366 787 --SEYEAHVSDFGFAKFLEPHSSN-------WTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVST 857 (918)
Q Consensus 787 --~~~~~kl~DfG~~~~~~~~~~~-------~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~ 857 (918)
.++.+||+|||+++.+...... .....||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 187 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~ 266 (364)
T 3op5_A 187 YKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLK 266 (364)
T ss_dssp SSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTT
T ss_pred cCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCcccccc
Confidence 8899999999999876543221 1334599999999999999999999999999999999999999874322
Q ss_pred hhhhhhhhH----hhhhhhcccCCCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 044366 858 IFSSISNMI----IEVNQILDHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLLC 917 (918)
Q Consensus 858 ~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 917 (918)
......... .......+..++.. .....+.+++..||+.||++||+++++++.|+
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~ 325 (364)
T 3op5_A 267 DPKYVRDSKIRYRENIASLMDKCFPAA-----NAPGEIAKYMETVKLLDYTEKPLYENLRDILL 325 (364)
T ss_dssp CHHHHHHHHHHHHHCHHHHHHHHSCTT-----CCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHH
T ss_pred CHHHHHHHHHHhhhhHHHHHHHhcccc-----cCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHH
Confidence 111111111 11122222222111 11246888999999999999999999999885
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=364.55 Aligned_cols=256 Identities=22% Similarity=0.304 Sum_probs=207.4
Q ss_pred hcCCCCceeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEE
Q 044366 645 TGNFGEKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFI 723 (918)
Q Consensus 645 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 723 (918)
.++|...+.||+|+||.||+|+. .+|+.||+|++...... .......+.+|+++++.++||||+++++++.+.+..++
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~-~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~l 261 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIK-KRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCL 261 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHH-HTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhh-hhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEE
Confidence 46788999999999999999965 47999999998764322 22346778999999999999999999999999999999
Q ss_pred EEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccC
Q 044366 724 VCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLE 803 (918)
Q Consensus 724 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~ 803 (918)
||||+++|+|.+++.... ...+++..++.++.||+.||+|||+. +||||||||+||+++.++.+||+|||++....
T Consensus 262 VmEy~~gg~L~~~l~~~~-~~~l~e~~~~~i~~qIl~aL~yLH~~---gIvHrDLKPeNILld~~g~vKL~DFGla~~~~ 337 (576)
T 2acx_A 262 VLTLMNGGDLKFHIYHMG-QAGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVP 337 (576)
T ss_dssp EECCCCSCBHHHHHHSSS-SCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEEcCCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCchheEEEeCCCCeEEEecccceecc
Confidence 999999999999997653 33489999999999999999999999 99999999999999999999999999998775
Q ss_pred CCCCCceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCCCCCcc
Q 044366 804 PHSSNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRD 883 (918)
Q Consensus 804 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 883 (918)
... ......||+.|+|||++.+..++.++|||||||++|||++|+.||........ ..... ..+..........
T Consensus 338 ~~~-~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~-~~~i~----~~i~~~~~~~p~~ 411 (576)
T 2acx_A 338 EGQ-TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIK-REEVE----RLVKEVPEEYSER 411 (576)
T ss_dssp TTC-CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCC-HHHHH----HHHHHCCCCCCTT
T ss_pred cCc-cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchh-HHHHH----HHhhcccccCCcc
Confidence 433 33446899999999999998999999999999999999999999875432100 00011 1111111111111
Q ss_pred hHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 044366 884 VTDKLRSIMEVAILCLVENPEARP-----TMKEVCN 914 (918)
Q Consensus 884 ~~~~~~~l~~li~~cl~~dp~~RP-----t~~evl~ 914 (918)
....+.+++.+||+.||++|| +++|+++
T Consensus 412 ---~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~ 444 (576)
T 2acx_A 412 ---FSPQARSLCSQLLCKDPAERLGCRGGSAREVKE 444 (576)
T ss_dssp ---SCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred ---CCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence 224678899999999999999 7888864
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-38 Score=347.25 Aligned_cols=263 Identities=23% Similarity=0.328 Sum_probs=206.6
Q ss_pred CHHHHHHHhcCCCCceeeccccceEEEEEEeCCCCEEEEEEcccccccCCCCChHHHHHHHHHHhh--ccCCceeeEecc
Q 044366 637 LYEEITKATGNFGEKYCIGKGGQRSVYKAELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTE--IRHRNIIKFHGF 714 (918)
Q Consensus 637 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~~~~~ 714 (918)
.........++|...+.||+|+||.||+|+. +|+.||||++... ....+.+|++++.. ++||||++++++
T Consensus 33 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~-------~~~~~~~e~~~~~~~~l~h~ni~~~~~~ 104 (342)
T 1b6c_B 33 PLLVQRTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR-------EERSWFREAEIYQTVMLRHENILGFIAA 104 (342)
T ss_dssp CHHHHHHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG-------GHHHHHHHHHHHHHSCCCCTTBCCEEEE
T ss_pred ceeecccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch-------hHHHHHHHHHHHHHhhcCCCcEEEEEee
Confidence 3444456678899999999999999999987 5899999998542 24678889998887 789999999999
Q ss_pred cccCC----ceEEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHH--------hCCCCCeEEcCCCCCC
Q 044366 715 CSNAQ----HSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLH--------HDCIPPIVHRDISSKN 782 (918)
Q Consensus 715 ~~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH--------~~~~~~ivH~dlk~~N 782 (918)
+.... ..++||||+++|+|.+++... .+++.+++.++.|++.||+||| +. +|+||||||+|
T Consensus 105 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~N 177 (342)
T 1b6c_B 105 DNKDNGTWTQLWLVSDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKP---AIAHRDLKSKN 177 (342)
T ss_dssp EECCCSSCCCEEEEECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC---EEECSCCSGGG
T ss_pred ecccCCccceeEEEEeecCCCcHHHHHhcc----CccHHHHHHHHHHHHHHHHHHHHHHhhhcccC---CeeeCCCCHHH
Confidence 87765 789999999999999999753 4899999999999999999999 77 99999999999
Q ss_pred eeeCCCCcEEEeccccccccCCCCCC----ceecccccccccccccccC------CCCcccchhhHHHHHHHHHhC----
Q 044366 783 VLLDSEYEAHVSDFGFAKFLEPHSSN----WTEFAGTVGYAAPELAYTM------RATEKYDVYSFGVLALEVIKG---- 848 (918)
Q Consensus 783 ill~~~~~~kl~DfG~~~~~~~~~~~----~~~~~g~~~y~aPE~~~~~------~~~~~~Dv~slG~vl~el~tg---- 848 (918)
|+++.++.+||+|||++......... .....||+.|+|||++.+. .++.++||||||+++|||++|
T Consensus 178 Ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~ 257 (342)
T 1b6c_B 178 ILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIG 257 (342)
T ss_dssp EEECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBT
T ss_pred EEECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcC
Confidence 99999999999999999877554322 2345789999999998765 234689999999999999999
Q ss_pred ------CCCCCcchhhhhhhhhhHhhhhhhcccCC-CCCCc--chHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 044366 849 ------YHPGDFVSTIFSSISNMIIEVNQILDHRL-PTPSR--DVTDKLRSIMEVAILCLVENPEARPTMKEVCNLLC 917 (918)
Q Consensus 849 ------~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~--~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 917 (918)
..||............... ....... +.... ...+....+.+++.+||+.||++|||+.||++.|+
T Consensus 258 ~~~~~~~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~ 332 (342)
T 1b6c_B 258 GIHEDYQLPYYDLVPSDPSVEEMRK---VVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 332 (342)
T ss_dssp TBCCCCCCTTTTTSCSSCCHHHHHH---HHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHH
T ss_pred CcccccccCccccCcCcccHHHHHH---HHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHH
Confidence 6676433211111111111 1111111 11111 12345567999999999999999999999999986
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=349.96 Aligned_cols=263 Identities=25% Similarity=0.387 Sum_probs=208.9
Q ss_pred CHHHHHHHhcCCCCceeeccccceEEEEEEeC-CCCEEEEEEcccccccCC----CCChHHHHHHHHHHhhc-cCCceee
Q 044366 637 LYEEITKATGNFGEKYCIGKGGQRSVYKAELP-SGNIFAVKKFKAELFSDE----TANPSEFLNEVLALTEI-RHRNIIK 710 (918)
Q Consensus 637 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~----~~~~~~~~~e~~~l~~l-~h~niv~ 710 (918)
.+.......++|.+.+.||+|+||.||+|... +|+.||||+++....... ....+.+.+|+++++.+ +||||++
T Consensus 85 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~ 164 (365)
T 2y7j_A 85 DWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIIT 164 (365)
T ss_dssp HHHHHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCC
T ss_pred cchhhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 34455666788999999999999999999764 799999999865321111 11135688999999999 7999999
Q ss_pred EecccccCCceEEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCc
Q 044366 711 FHGFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYE 790 (918)
Q Consensus 711 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~ 790 (918)
+++++...+..++||||+++|+|.+++... ..+++..++.++.||+.||+|||+. ||+||||||+||+++.++.
T Consensus 165 ~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~---~~l~~~~~~~i~~qi~~~L~~LH~~---gi~H~Dlkp~NIl~~~~~~ 238 (365)
T 2y7j_A 165 LIDSYESSSFMFLVFDLMRKGELFDYLTEK---VALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENILLDDNMQ 238 (365)
T ss_dssp EEEEEEBSSEEEEEECCCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCC
T ss_pred EEEEEeeCCEEEEEEEeCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCC
Confidence 999999999999999999999999999754 3489999999999999999999999 9999999999999999999
Q ss_pred EEEeccccccccCCCCCCceeccccccccccccccc------CCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhh
Q 044366 791 AHVSDFGFAKFLEPHSSNWTEFAGTVGYAAPELAYT------MRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISN 864 (918)
Q Consensus 791 ~kl~DfG~~~~~~~~~~~~~~~~g~~~y~aPE~~~~------~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~ 864 (918)
+||+|||++..+.... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...... ...
T Consensus 239 ikl~DfG~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~-~~~-- 314 (365)
T 2y7j_A 239 IRLSDFGFSCHLEPGE-KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQI-LML-- 314 (365)
T ss_dssp EEECCCTTCEECCTTC-CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-HHH--
T ss_pred EEEEecCcccccCCCc-ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHH-HHH--
Confidence 9999999998776433 2345678999999998864 35788999999999999999999998654321 000
Q ss_pred hHhhhhhhcccCCCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 865 MIIEVNQILDHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 865 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
..+..................+.+++.+||+.||++|||++|+++
T Consensus 315 -----~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 315 -----RMIMEGQYQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp -----HHHHHTCCCCCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred -----HHHHhCCCCCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 111111111111111122356889999999999999999999986
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-38 Score=359.41 Aligned_cols=257 Identities=21% Similarity=0.275 Sum_probs=194.9
Q ss_pred hcCCCCceeeccccceEEEEEE-eCCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccC-----
Q 044366 645 TGNFGEKYCIGKGGQRSVYKAE-LPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNA----- 718 (918)
Q Consensus 645 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~----- 718 (918)
.++|...+.||+|+||.||+|. ..+|+.||||++..... .....+.+.+|+.+++.++||||+++++++...
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~ 138 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ--NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEE 138 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGG--SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTT
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECcccc--ChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCcccc
Confidence 4789999999999999999995 45799999999875421 223356789999999999999999999998554
Q ss_pred -CceEEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccc
Q 044366 719 -QHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFG 797 (918)
Q Consensus 719 -~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG 797 (918)
...++||||+++ ++.+.+.. .+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 139 ~~~~~lv~E~~~~-~l~~~~~~-----~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDlkp~NIll~~~~~~kl~DFG 209 (464)
T 3ttj_A 139 FQDVYLVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG 209 (464)
T ss_dssp CCEEEEEEECCSE-EHHHHHTS-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCC
T ss_pred CCeEEEEEeCCCC-CHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChHhEEEeCCCCEEEEEEE
Confidence 356999999986 56666643 389999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCCceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHh----------
Q 044366 798 FAKFLEPHSSNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMII---------- 867 (918)
Q Consensus 798 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~---------- 867 (918)
+++..... ......+||+.|+|||++.+..++.++||||+||++|||++|+.||....... .+.....
T Consensus 210 ~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~-~~~~i~~~lg~p~~~~~ 287 (464)
T 3ttj_A 210 LARTAGTS-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID-QWNKVIEQLGTPCPEFM 287 (464)
T ss_dssp CC-----C-CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHHHCSCCHHHH
T ss_pred eeeecCCC-cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHhcCCCCHHHH
Confidence 99876543 23355689999999999999999999999999999999999999987543211 1111000
Q ss_pred -----hhhhhcccCCC----------------CCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 868 -----EVNQILDHRLP----------------TPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 868 -----~~~~~~~~~~~----------------~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
........... ............+.+++.+||+.||++|||++|+++
T Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 355 (464)
T 3ttj_A 288 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 355 (464)
T ss_dssp TTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 00011111100 001111122467899999999999999999999985
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-38 Score=361.27 Aligned_cols=256 Identities=20% Similarity=0.303 Sum_probs=207.6
Q ss_pred cCCCCceeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEEE
Q 044366 646 GNFGEKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFIV 724 (918)
Q Consensus 646 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 724 (918)
++|...+.||+|+||.||+|+. .+|+.||+|++....... ......+.+|+++++.++||||+++++++.+.+..++|
T Consensus 185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~-~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 263 (543)
T 3c4z_A 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKK-RKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV 263 (543)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHH-TTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhh-hHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence 5788889999999999999976 479999999997643322 23467899999999999999999999999999999999
Q ss_pred EEeccCCChhHHhhcccc-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccC
Q 044366 725 CEYLARGSLTTILRDDAA-AKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLE 803 (918)
Q Consensus 725 ~e~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~ 803 (918)
|||+++|+|.+++..... ...+++..++.++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++.+.
T Consensus 264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~---gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~ 340 (543)
T 3c4z_A 264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELK 340 (543)
T ss_dssp ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHc---CCcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence 999999999999976432 34589999999999999999999999 99999999999999999999999999999876
Q ss_pred CCCCCceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCCCCCcc
Q 044366 804 PHSSNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRD 883 (918)
Q Consensus 804 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 883 (918)
..........||+.|+|||++.+..++.++|||||||++|||++|+.||........ ..... ..+.......+ ..
T Consensus 341 ~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~-~~~~~---~~i~~~~~~~p-~~ 415 (543)
T 3c4z_A 341 AGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE-NKELK---QRVLEQAVTYP-DK 415 (543)
T ss_dssp TTCCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCC-HHHHH---HHHHHCCCCCC-TT
T ss_pred CCCcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchh-HHHHH---HHHhhcccCCC-cc
Confidence 554444556899999999999999999999999999999999999999875422100 00111 11111111111 11
Q ss_pred hHHHHHHHHHHHHHcccCCCCCCCCH-----HHHH
Q 044366 884 VTDKLRSIMEVAILCLVENPEARPTM-----KEVC 913 (918)
Q Consensus 884 ~~~~~~~l~~li~~cl~~dp~~RPt~-----~evl 913 (918)
....+.+++.+||+.||++||++ ++++
T Consensus 416 ---~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~ 447 (543)
T 3c4z_A 416 ---FSPASKDFCEALLQKDPEKRLGFRDGSCDGLR 447 (543)
T ss_dssp ---SCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHH
T ss_pred ---cCHHHHHHHHHhccCCHhHCCCCcccCHHHHH
Confidence 22467888999999999999965 5665
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=339.57 Aligned_cols=252 Identities=23% Similarity=0.385 Sum_probs=207.6
Q ss_pred HhcCCCCceeeccccceEEEEEEeC-CCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceE
Q 044366 644 ATGNFGEKYCIGKGGQRSVYKAELP-SGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSF 722 (918)
Q Consensus 644 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 722 (918)
..++|...+.||+|+||.||+|... +++.||+|++...... .....+.+.+|+.+++.++||||+++++++.+++..+
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 91 (294)
T 2rku_A 13 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLL-KPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVF 91 (294)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCC-SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred cccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhcc-CHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEE
Confidence 3467889999999999999999654 6889999998764322 2223567899999999999999999999999999999
Q ss_pred EEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEecccccccc
Q 044366 723 IVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFL 802 (918)
Q Consensus 723 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~ 802 (918)
+||||+++++|.+++... ..+++.+++.++.|+++||+|||+. +++||||||+||+++.++.+||+|||.+...
T Consensus 92 lv~e~~~~~~L~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~ 165 (294)
T 2rku_A 92 VVLELCRRRSLLELHKRR---KALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKV 165 (294)
T ss_dssp EEEECCTTCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEcCCCCEEEEeccCceec
Confidence 999999999999998764 3489999999999999999999999 9999999999999999999999999999887
Q ss_pred CCCCCCceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCCCCCc
Q 044366 803 EPHSSNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSR 882 (918)
Q Consensus 803 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 882 (918)
...........|++.|+|||++.+..++.++||||+|+++|+|++|+.||+...... . .. .........+ .
T Consensus 166 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-~----~~---~~~~~~~~~~-~ 236 (294)
T 2rku_A 166 EYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE-T----YL---RIKKNEYSIP-K 236 (294)
T ss_dssp CSTTCCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH-H----HH---HHHTTCCCCC-T
T ss_pred ccCccccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-H----HH---HHhhccCCCc-c
Confidence 655444555678999999999999889999999999999999999999987543211 0 11 1111111111 1
Q ss_pred chHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 883 DVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 883 ~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
. ....+.+++.+||+.||++|||++|+++
T Consensus 237 ~---~~~~~~~li~~~l~~~p~~Rps~~~ll~ 265 (294)
T 2rku_A 237 H---INPVAASLIQKMLQTDPTARPTINELLN 265 (294)
T ss_dssp T---SCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred c---cCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence 1 1245788999999999999999999875
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=348.91 Aligned_cols=247 Identities=26% Similarity=0.396 Sum_probs=198.8
Q ss_pred cCCCCceeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEEE
Q 044366 646 GNFGEKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFIV 724 (918)
Q Consensus 646 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 724 (918)
..|...+.||+|+||.||+|+. .+|+.||||++...... .....+.+.+|++++++++||||+++++++.+++..++|
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 132 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQ-SNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 132 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSC-HHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEcccccc-chHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEE
Confidence 4588889999999999999964 68999999998653211 112245789999999999999999999999999999999
Q ss_pred EEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccCC
Q 044366 725 CEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEP 804 (918)
Q Consensus 725 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~~ 804 (918)
|||++ |++.+++... ...+++.+++.++.|+++||+|||+. +|+||||||+||+++.++.+||+|||++....+
T Consensus 133 ~e~~~-g~l~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~ 206 (348)
T 1u5q_A 133 MEYCL-GSASDLLEVH--KKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 206 (348)
T ss_dssp EECCS-EEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred EecCC-CCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEeeccCceecCC
Confidence 99997 5888888643 24589999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCCceecccccccccccccc---cCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCCC-C
Q 044366 805 HSSNWTEFAGTVGYAAPELAY---TMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPT-P 880 (918)
Q Consensus 805 ~~~~~~~~~g~~~y~aPE~~~---~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~ 880 (918)
. ....||+.|+|||++. +..++.++|||||||++|||++|+.||....... .. ..+.....+. .
T Consensus 207 ~----~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~-~~-------~~~~~~~~~~~~ 274 (348)
T 1u5q_A 207 A----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-AL-------YHIAQNESPALQ 274 (348)
T ss_dssp B----CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-HH-------HHHHHSCCCCCC
T ss_pred C----CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH-HH-------HHHHhcCCCCCC
Confidence 3 3357899999999884 5678999999999999999999999976543211 11 1111111111 1
Q ss_pred CcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 881 SRDVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 881 ~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
.... ...+.+++.+||+.||++|||++++++
T Consensus 275 ~~~~---~~~l~~li~~~l~~dP~~Rps~~~ll~ 305 (348)
T 1u5q_A 275 SGHW---SEYFRNFVDSCLQKIPQDRPTSEVLLK 305 (348)
T ss_dssp CTTS---CHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCCC---CHHHHHHHHHHcccChhhCcCHHHHhh
Confidence 1112 245788999999999999999999975
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=343.55 Aligned_cols=257 Identities=24% Similarity=0.369 Sum_probs=202.9
Q ss_pred CCCceeeccccceEEEEEEeC-----CCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEeccccc--CCc
Q 044366 648 FGEKYCIGKGGQRSVYKAELP-----SGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSN--AQH 720 (918)
Q Consensus 648 ~~~~~~lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~ 720 (918)
|...+.||+|+||.||+|.+. +|+.||||+++... .....+.+.+|+++++.++||||+++++++.+ ...
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 109 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADA---GPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAAS 109 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTC---CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEecccc---ChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCce
Confidence 488899999999999988542 68899999987531 22235679999999999999999999999976 467
Q ss_pred eEEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEecccccc
Q 044366 721 SFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAK 800 (918)
Q Consensus 721 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~ 800 (918)
.++||||+++|+|.+++... .+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.
T Consensus 110 ~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~i~~~l~~~l~~LH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~ 182 (318)
T 3lxp_A 110 LQLVMEYVPLGSLRDYLPRH----SIGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAK 182 (318)
T ss_dssp EEEEECCCTTCBHHHHGGGS----CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCE
T ss_pred EEEEEecccCCcHHHHHhhC----CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEEcCCCCEEECCccccc
Confidence 89999999999999999764 389999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCC---ceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhh------hhHhhhhh
Q 044366 801 FLEPHSSN---WTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSIS------NMIIEVNQ 871 (918)
Q Consensus 801 ~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~------~~~~~~~~ 871 (918)
........ .....++..|+|||++.+..++.++||||+|+++|||++|+.||........... .......+
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (318)
T 3lxp_A 183 AVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTE 262 (318)
T ss_dssp ECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHH
T ss_pred cccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHH
Confidence 87654321 2334578889999999998899999999999999999999999765432111000 00011111
Q ss_pred hcccC-CCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 044366 872 ILDHR-LPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLLC 917 (918)
Q Consensus 872 ~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 917 (918)
..... ...... .....+.+++.+||+.||++|||++|+++.|+
T Consensus 263 ~~~~~~~~~~~~---~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~ 306 (318)
T 3lxp_A 263 LLERGERLPRPD---KCPAEVYHLMKNCWETEASFRPTFENLIPILK 306 (318)
T ss_dssp HHHTTCCCCCCT---TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHhcccCCCCCc---cccHHHHHHHHHHcCCCcccCcCHHHHHHHHH
Confidence 11111 111111 22356888999999999999999999999886
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=349.69 Aligned_cols=262 Identities=18% Similarity=0.191 Sum_probs=197.1
Q ss_pred hcCCCCceeeccccceEEEEEEeC----CCCEEEEEEcccccccC-------CCCChHHHHHHHHHHhhccCCceeeEec
Q 044366 645 TGNFGEKYCIGKGGQRSVYKAELP----SGNIFAVKKFKAELFSD-------ETANPSEFLNEVLALTEIRHRNIIKFHG 713 (918)
Q Consensus 645 ~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~-------~~~~~~~~~~e~~~l~~l~h~niv~~~~ 713 (918)
.++|...+.||+|+||.||+|... ++..||||++....... .......+.+|+..++.++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 467899999999999999999764 67889999986531100 0012245778888999999999999999
Q ss_pred cccc----CCceEEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCC
Q 044366 714 FCSN----AQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEY 789 (918)
Q Consensus 714 ~~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~ 789 (918)
++.. ....++||||+ +++|.+++.... .+++.+++.++.||+.||+|||+. +|+||||||+||+++.++
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~ 188 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQNG---TFKKSTVLQLGIRMLDVLEYIHEN---EYVHGDIKAANLLLGYKN 188 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBGGG---BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEESSS
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCcCHHHEEEccCC
Confidence 9877 67899999999 899999997653 589999999999999999999999 999999999999998887
Q ss_pred --cEEEeccccccccCCCCC-------CceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhh
Q 044366 790 --EAHVSDFGFAKFLEPHSS-------NWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFS 860 (918)
Q Consensus 790 --~~kl~DfG~~~~~~~~~~-------~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~ 860 (918)
.+||+|||+++.+..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||........
T Consensus 189 ~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~ 268 (345)
T 2v62_A 189 PDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPV 268 (345)
T ss_dssp TTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHH
T ss_pred CCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccH
Confidence 999999999987643221 12345789999999999999999999999999999999999999854221111
Q ss_pred hhhhhHhhhhhhcc----cCCCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhC
Q 044366 861 SISNMIIEVNQILD----HRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLLCK 918 (918)
Q Consensus 861 ~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~ 918 (918)
.............. ...+ .. .....+.+++.+||+.||++|||+++|++.|++
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~--~~---~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~ 325 (345)
T 2v62_A 269 AVQTAKTNLLDELPQSVLKWAP--SG---SSCCEIAQFLVCAHSLAYDEKPNYQALKKILNP 325 (345)
T ss_dssp HHHHHHHHHHHTTTHHHHHHSC--TT---SCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCT
T ss_pred HHHHHHHhhcccccHHHHhhcc--cc---ccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 11111111100000 0000 00 122468889999999999999999999999864
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=344.72 Aligned_cols=259 Identities=20% Similarity=0.311 Sum_probs=196.5
Q ss_pred cCCCCc-eeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhc-cCCceeeEecccccCCceE
Q 044366 646 GNFGEK-YCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEI-RHRNIIKFHGFCSNAQHSF 722 (918)
Q Consensus 646 ~~~~~~-~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~ 722 (918)
+.|.+. +.||+|+||.||+|.. .+++.||||++... .....+.+.+|+++++++ +||||+++++++.+++..+
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~ 87 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQ----PGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFY 87 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECC----SSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeC----cchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEE
Confidence 456663 6799999999999964 57999999998653 234467899999999885 7999999999999999999
Q ss_pred EEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCc---EEEeccccc
Q 044366 723 IVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYE---AHVSDFGFA 799 (918)
Q Consensus 723 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~---~kl~DfG~~ 799 (918)
+||||+++|+|.+++.... .+++.+++.++.|++.||+|||+. +|+||||||+||+++.++. +||+|||++
T Consensus 88 lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~ 161 (316)
T 2ac3_A 88 LVFEKMRGGSILSHIHKRR---HFNELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLG 161 (316)
T ss_dssp EEEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESCSSSSCSEEECCTTCC
T ss_pred EEEEcCCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEEccCCCcCceEEEEccCc
Confidence 9999999999999997643 489999999999999999999999 9999999999999998776 999999999
Q ss_pred cccCCCCC-------Cceeccccccccccccccc-----CCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhh----
Q 044366 800 KFLEPHSS-------NWTEFAGTVGYAAPELAYT-----MRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSIS---- 863 (918)
Q Consensus 800 ~~~~~~~~-------~~~~~~g~~~y~aPE~~~~-----~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~---- 863 (918)
........ ......||+.|+|||++.+ ..++.++||||+||++|||++|+.||...........
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~ 241 (316)
T 2ac3_A 162 SGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEA 241 (316)
T ss_dssp C-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----C
T ss_pred cccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCccccccccccccccc
Confidence 86643211 1223468999999999875 5578899999999999999999999865422100000
Q ss_pred --h-hHhhhhhhcccCCCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 864 --N-MIIEVNQILDHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 864 --~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
. .......+.......+..........+.+++.+||+.||++|||++|+++
T Consensus 242 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 295 (316)
T 2ac3_A 242 CPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ 295 (316)
T ss_dssp CHHHHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred chhHHHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence 0 00001111112221111111122356889999999999999999999986
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=346.68 Aligned_cols=261 Identities=23% Similarity=0.339 Sum_probs=205.7
Q ss_pred hcCCCCceeeccccceEEEEEEe-----CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccc--c
Q 044366 645 TGNFGEKYCIGKGGQRSVYKAEL-----PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCS--N 717 (918)
Q Consensus 645 ~~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~--~ 717 (918)
.++|...+.||+|+||.||+|++ .+++.||||++... .....+.+.+|+++++.++||||+++++++. +
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 97 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS----GPDQQRDFQREIQILKALHSDFIVKYRGVSYGPG 97 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC----CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC----CHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCC
Confidence 36788899999999999999973 46889999998653 2223467999999999999999999999875 4
Q ss_pred CCceEEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccc
Q 044366 718 AQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFG 797 (918)
Q Consensus 718 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG 797 (918)
....++||||+++|+|.+++.... ..+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 98 ~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg 172 (327)
T 3lxl_A 98 RQSLRLVMEYLPSGCLRDFLQRHR--ARLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVKIADFG 172 (327)
T ss_dssp SCEEEEEEECCTTCBHHHHHHHHG--GGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCGG
T ss_pred CceEEEEEeecCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChhhEEECCCCCEEEcccc
Confidence 567899999999999999997642 3489999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCC---ceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhh------hhHhh
Q 044366 798 FAKFLEPHSSN---WTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSIS------NMIIE 868 (918)
Q Consensus 798 ~~~~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~------~~~~~ 868 (918)
++......... .....|+..|+|||++.+..++.++||||||+++|+|++|+.||........... .....
T Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 252 (327)
T 3lxl_A 173 LAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSR 252 (327)
T ss_dssp GCEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHH
T ss_pred cceecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHH
Confidence 99877544321 2334578889999999998899999999999999999999999754332110000 00011
Q ss_pred hhhhc-ccCCCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 044366 869 VNQIL-DHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLLC 917 (918)
Q Consensus 869 ~~~~~-~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 917 (918)
..+.. ......... .....+.+++.+||+.||++|||++|+++.|+
T Consensus 253 ~~~~~~~~~~~~~~~---~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~ 299 (327)
T 3lxl_A 253 LLELLEEGQRLPAPP---ACPAEVHELMKLCWAPSPQDRPSFSALGPQLD 299 (327)
T ss_dssp HHHHHHTTCCCCCCT---TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHHhhcccCCCCCC---cccHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 11111 111111111 22346888999999999999999999999886
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-38 Score=351.95 Aligned_cols=249 Identities=22% Similarity=0.331 Sum_probs=196.4
Q ss_pred cCCCCceeeccccceEEEEEEeCCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhcc--CCceeeEecccccCCceEE
Q 044366 646 GNFGEKYCIGKGGQRSVYKAELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIR--HRNIIKFHGFCSNAQHSFI 723 (918)
Q Consensus 646 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~--h~niv~~~~~~~~~~~~~l 723 (918)
.+|.+.+.||+|+||.||+|...+++.||||++..... .....+.+.+|+++++.++ ||||+++++++..++..++
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~l 133 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEA--DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 133 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccc--cHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEE
Confidence 45899999999999999999887899999999865321 2223577999999999996 5999999999999999999
Q ss_pred EEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccC
Q 044366 724 VCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLE 803 (918)
Q Consensus 724 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~ 803 (918)
||| +.+++|.+++.... .+++.+++.++.||+.||+|||+. +|+||||||+||+++ ++.+||+|||+++.+.
T Consensus 134 v~E-~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~ 205 (390)
T 2zmd_A 134 VME-CGNIDLNSWLKKKK---SIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQ 205 (390)
T ss_dssp EEE-CCSEEHHHHHHHCS---SCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCCGGGEEES-SSCEEECCCSSSCCC-
T ss_pred EEe-cCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEEE-CCeEEEEecCcccccc
Confidence 999 56789999998653 589999999999999999999999 999999999999996 5799999999998775
Q ss_pred CCCC--Cceeccccccccccccccc-----------CCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhh
Q 044366 804 PHSS--NWTEFAGTVGYAAPELAYT-----------MRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVN 870 (918)
Q Consensus 804 ~~~~--~~~~~~g~~~y~aPE~~~~-----------~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~ 870 (918)
.... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||......... ..
T Consensus 206 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~-------~~ 278 (390)
T 2zmd_A 206 PDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK-------LH 278 (390)
T ss_dssp --------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHH-------HH
T ss_pred CCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHH-------HH
Confidence 4332 1244679999999999865 36889999999999999999999998643221111 11
Q ss_pred hhcccCCCC-CCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 871 QILDHRLPT-PSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 871 ~~~~~~~~~-~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
.+.+..... .+... ...+.+++.+||+.||++|||+.|+++
T Consensus 279 ~~~~~~~~~~~~~~~---~~~~~~li~~~L~~dP~~Rps~~ell~ 320 (390)
T 2zmd_A 279 AIIDPNHEIEFPDIP---EKDLQDVLKCCLKRDPKQRISIPELLA 320 (390)
T ss_dssp HHHCTTSCCCCCCCS---CHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHhCccccCCCCccc---hHHHHHHHHHHcccChhhCCCHHHHhh
Confidence 222221111 11111 245788999999999999999999985
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=347.26 Aligned_cols=263 Identities=19% Similarity=0.265 Sum_probs=194.4
Q ss_pred HHHhcCCCCceeeccccceEEEEEE-eCCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCc
Q 044366 642 TKATGNFGEKYCIGKGGQRSVYKAE-LPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQH 720 (918)
Q Consensus 642 ~~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 720 (918)
....++|...+.||+|+||.||+|. ..+|+.||||+++.... .....+.+.+|+++++.++||||+++++++.+++.
T Consensus 30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 107 (329)
T 3gbz_A 30 ATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHE--EEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHR 107 (329)
T ss_dssp --CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC----------CHHHHHHGGGCCCTTBCCEEEEEEETTE
T ss_pred ccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEccccc--ccccchhHHHHHHHHHHcCCCCcceEEEEEecCCE
Confidence 3456789999999999999999995 45799999999975422 22234567899999999999999999999999999
Q ss_pred eEEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeC-----CCCcEEEec
Q 044366 721 SFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLD-----SEYEAHVSD 795 (918)
Q Consensus 721 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~-----~~~~~kl~D 795 (918)
.++||||+++ +|.+++.... .+++.+++.++.||+.||+|||+. +|+||||||+||+++ .++.+||+|
T Consensus 108 ~~lv~e~~~~-~L~~~~~~~~---~~~~~~~~~i~~ql~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~kl~D 180 (329)
T 3gbz_A 108 LHLIFEYAEN-DLKKYMDKNP---DVSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGD 180 (329)
T ss_dssp EEEEEECCSE-EHHHHHHHCT---TCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEC-----CCEEEECC
T ss_pred EEEEEecCCC-CHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CEECCCCCHHHEEEecCCCCccceEEECc
Confidence 9999999985 9999997653 489999999999999999999999 999999999999994 455699999
Q ss_pred cccccccCCCCCCceecccccccccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhc-
Q 044366 796 FGFAKFLEPHSSNWTEFAGTVGYAAPELAYTM-RATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQIL- 873 (918)
Q Consensus 796 fG~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~- 873 (918)
||+++.............||+.|+|||++.+. .++.++||||+||++|||++|+.||....... .............
T Consensus 181 fg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-~~~~~~~~~~~~~~ 259 (329)
T 3gbz_A 181 FGLARAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEID-QLFKIFEVLGLPDD 259 (329)
T ss_dssp TTHHHHHC-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHHHCCCCT
T ss_pred CCCccccCCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHH-HHHHHHHHhCCCch
Confidence 99998876554555566789999999999874 48999999999999999999999986543321 1111111000000
Q ss_pred ------------ccCCCCCCc-chHH-----HHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 874 ------------DHRLPTPSR-DVTD-----KLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 874 ------------~~~~~~~~~-~~~~-----~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
....+.... .... ....+.+++.+||+.||++|||++|+++
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 260 TTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp TTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 000011000 1111 1256789999999999999999999986
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=351.89 Aligned_cols=252 Identities=27% Similarity=0.416 Sum_probs=189.6
Q ss_pred CCCCceeeccccceEEEEEEeC--CC--CEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccc-cCCce
Q 044366 647 NFGEKYCIGKGGQRSVYKAELP--SG--NIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCS-NAQHS 721 (918)
Q Consensus 647 ~~~~~~~lg~G~~g~Vy~~~~~--~~--~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~-~~~~~ 721 (918)
.|...+.||+|+||.||+|... ++ ..||||.++.. ......+.|.+|+.++++++||||+++++++. .++..
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ 166 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI---TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP 166 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSC---SCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCC
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCC---CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCe
Confidence 4566789999999999999653 22 36899988642 22334578999999999999999999999864 45678
Q ss_pred EEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccc
Q 044366 722 FIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKF 801 (918)
Q Consensus 722 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~ 801 (918)
++||||+++|+|.++++.. ...+++.+++.++.||++||+|||+. +|+||||||+||+++.++.+||+|||+++.
T Consensus 167 ~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DFG~a~~ 241 (373)
T 3c1x_A 167 LVVLPYMKHGDLRNFIRNE--THNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARD 241 (373)
T ss_dssp EEEEECCTTCBHHHHHHCT--TCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC-----
T ss_pred EEEEECCCCCCHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCccchheEEECCCCCEEEeecccccc
Confidence 9999999999999999764 24578999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCC----CceecccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhhhhhhhhhHhhhhhhcccC
Q 044366 802 LEPHSS----NWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIK-GYHPGDFVSTIFSSISNMIIEVNQILDHR 876 (918)
Q Consensus 802 ~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 876 (918)
+..... ......+++.|+|||++.+..++.++||||||+++|||++ |.+||...... .. . .. .....
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~-~~-~---~~---~~~~~ 313 (373)
T 3c1x_A 242 MYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF-DI-T---VY---LLQGR 313 (373)
T ss_dssp ----------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSS-CH-H---HH---HHTTC
T ss_pred ccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHH-HH-H---HH---HHcCC
Confidence 643321 1233456789999999999999999999999999999999 67776543221 00 0 01 11111
Q ss_pred CCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 044366 877 LPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLLC 917 (918)
Q Consensus 877 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 917 (918)
....+... ...+.+++.+||+.||++|||++|+++.|+
T Consensus 314 ~~~~p~~~---~~~l~~li~~cl~~dp~~RPs~~ell~~L~ 351 (373)
T 3c1x_A 314 RLLQPEYC---PDPLYEVMLKCWHPKAEMRPSFSELVSRIS 351 (373)
T ss_dssp CCCCCTTC---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCCCCCCC---CHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 11111122 245788999999999999999999999885
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=345.06 Aligned_cols=253 Identities=22% Similarity=0.402 Sum_probs=195.8
Q ss_pred hcCCCCceeeccccceEEEEEEe-CCCCE----EEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCC
Q 044366 645 TGNFGEKYCIGKGGQRSVYKAEL-PSGNI----FAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQ 719 (918)
Q Consensus 645 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~----vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~ 719 (918)
.++|...+.||+|+||.||+|.. .+++. ||+|.+... ......+.+.+|+.+++.++||||+++++++..+.
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~---~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 90 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA---TSPKANKEILDEAYVMASVDNPHVCRLLGICLTST 90 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCC---SSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccc---cCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC
Confidence 46789999999999999999964 45654 466665432 23445688999999999999999999999998755
Q ss_pred ceEEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccc
Q 044366 720 HSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFA 799 (918)
Q Consensus 720 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~ 799 (918)
.++|+||+++|+|.+++.... ..+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 91 -~~~v~~~~~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kL~DfG~a 164 (327)
T 3lzb_A 91 -VQLITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLA 164 (327)
T ss_dssp -EEEEECCCSSCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTC-
T ss_pred -ceEEEEecCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHhhC---CCcCCCCCHHHEEEcCCCCEEEccCcce
Confidence 789999999999999997653 4589999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCC--ceecccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhhhhhhhhhHhhhhhhcccC
Q 044366 800 KFLEPHSSN--WTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIK-GYHPGDFVSTIFSSISNMIIEVNQILDHR 876 (918)
Q Consensus 800 ~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 876 (918)
+........ .....+|+.|+|||++.+..++.++||||||+++|||++ |+.||+..... .... .... ...
T Consensus 165 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~--~~~~---~~~~--~~~ 237 (327)
T 3lzb_A 165 KLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS--EISS---ILEK--GER 237 (327)
T ss_dssp ---------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG--GHHH---HHHT--TCC
T ss_pred eEccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHH--HHHH---HHHc--CCC
Confidence 876543322 233456789999999999999999999999999999999 99998654321 1111 1111 111
Q ss_pred CCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 044366 877 LPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLLC 917 (918)
Q Consensus 877 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 917 (918)
.+. ... ....+.+++.+||+.||.+|||+.|+++.|+
T Consensus 238 ~~~-~~~---~~~~l~~li~~~l~~dp~~Rps~~ell~~L~ 274 (327)
T 3lzb_A 238 LPQ-PPI---CTIDVYMIMRKCWMIDADSRPKFRELIIEFS 274 (327)
T ss_dssp CCC-CTT---BCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCC-Ccc---CCHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence 111 111 2245788999999999999999999999886
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-39 Score=340.92 Aligned_cols=257 Identities=24% Similarity=0.346 Sum_probs=204.2
Q ss_pred hcCCCCceeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEeccc--ccCCce
Q 044366 645 TGNFGEKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFC--SNAQHS 721 (918)
Q Consensus 645 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~--~~~~~~ 721 (918)
.++|...+.||+|+||.||+|.. .+|+.||+|++..... .....+.+.+|++++++++||||+++++++ ...+..
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 82 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM--TEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTL 82 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccC--CHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceE
Confidence 46788999999999999999965 4799999999875322 122356799999999999999999999987 446788
Q ss_pred EEEEEeccCCChhHHhhccc-ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCC-----eEEcCCCCCCeeeCCCCcEEEec
Q 044366 722 FIVCEYLARGSLTTILRDDA-AAKEFSWNQRMNVIKGVANALSYLHHDCIPP-----IVHRDISSKNVLLDSEYEAHVSD 795 (918)
Q Consensus 722 ~lv~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~-----ivH~dlk~~Nill~~~~~~kl~D 795 (918)
++||||+++|+|.+++.... ....+++.+++.++.|++.||+|||+. + ++||||||+||+++.++.+||+|
T Consensus 83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~~~~~~ivH~dl~p~NIl~~~~~~~kl~d 159 (279)
T 2w5a_A 83 YIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR---SDGGHTVLHRDLKPANVFLDGKQNVKLGD 159 (279)
T ss_dssp EEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH---C------CCCCCSGGGEEECSSSCEEECC
T ss_pred EEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcc---cCCCCeeEEeccchhhEEEcCCCCEEEec
Confidence 99999999999999997643 234589999999999999999999998 7 99999999999999999999999
Q ss_pred cccccccCCCCCCceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhccc
Q 044366 796 FGFAKFLEPHSSNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDH 875 (918)
Q Consensus 796 fG~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 875 (918)
||.+..............|++.|+|||++.+..++.++||||||+++|+|++|+.||...... .. .. .+...
T Consensus 160 fg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~---~~---~i~~~ 231 (279)
T 2w5a_A 160 FGLARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK--EL---AG---KIREG 231 (279)
T ss_dssp CCHHHHC---CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHH--HH---HH---HHHHT
T ss_pred CchheeeccccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHH--HH---HH---HHhhc
Confidence 999987765433334457899999999999989999999999999999999999998754321 11 11 11111
Q ss_pred CCCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 044366 876 RLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLLC 917 (918)
Q Consensus 876 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 917 (918)
..+..... ....+.+++.+||+.||++|||++|+++.+.
T Consensus 232 ~~~~~~~~---~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~ 270 (279)
T 2w5a_A 232 KFRRIPYR---YSDELNEIITRMLNLKDYHRPSVEEILENPL 270 (279)
T ss_dssp CCCCCCTT---SCHHHHHHHHHHTCSSGGGSCCHHHHHTSTT
T ss_pred ccccCCcc---cCHHHHHHHHHHcCCCcccCCCHHHHHhChh
Confidence 12111112 2246888999999999999999999997653
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=345.23 Aligned_cols=265 Identities=22% Similarity=0.321 Sum_probs=207.8
Q ss_pred ccCHHHHHHHhcCCCCc-eeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhc-cCCceeeE
Q 044366 635 KVLYEEITKATGNFGEK-YCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEI-RHRNIIKF 711 (918)
Q Consensus 635 ~~~~~~~~~~~~~~~~~-~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~ 711 (918)
.+.+...+...++|... +.||+|+||.||+|.. .+|+.||+|+++.... .......+.+|+.+++.+ +||||+++
T Consensus 17 n~~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~~iv~~ 94 (327)
T 3lm5_A 17 NLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRR--GQDCRAEILHEIAVLELAKSCPRVINL 94 (327)
T ss_dssp CCCSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEET--TEECHHHHHHHHHHHHHTTTCTTBCCE
T ss_pred hhHHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhc--chHHHHHHHHHHHHHHhccCCCCEEEE
Confidence 34445556667778777 8899999999999965 4799999999876432 223467899999999999 46999999
Q ss_pred ecccccCCceEEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCC---C
Q 044366 712 HGFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDS---E 788 (918)
Q Consensus 712 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~---~ 788 (918)
++++.+.+..++||||+++|+|.+++.... ...+++.+++.++.|++.||+|||+. +|+||||||+||+++. +
T Consensus 95 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~i~~ql~~~L~~LH~~---givH~Dikp~NIl~~~~~~~ 170 (327)
T 3lm5_A 95 HEVYENTSEIILILEYAAGGEIFSLCLPEL-AEMVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIYPL 170 (327)
T ss_dssp EEEEECSSEEEEEEECCTTEEGGGGGSSCC--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESCBTTB
T ss_pred EEEEEeCCeEEEEEEecCCCcHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCChHHEEEecCCCC
Confidence 999999999999999999999999986542 34589999999999999999999999 9999999999999998 7
Q ss_pred CcEEEeccccccccCCCCCCceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhh
Q 044366 789 YEAHVSDFGFAKFLEPHSSNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIE 868 (918)
Q Consensus 789 ~~~kl~DfG~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~ 868 (918)
+.+||+|||++....... ......||+.|+|||++.+..++.++||||+|+++|||++|+.||....... ....
T Consensus 171 ~~~kL~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-----~~~~ 244 (327)
T 3lm5_A 171 GDIKIVDFGMSRKIGHAC-ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQE-----TYLN 244 (327)
T ss_dssp CCEEECCGGGCEEC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-----HHHH
T ss_pred CcEEEeeCccccccCCcc-ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchH-----HHHH
Confidence 899999999998775432 2344678999999999999999999999999999999999999986543211 1111
Q ss_pred hhhhcccCCCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 869 VNQILDHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 869 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
.... ...............+.+++.+||+.||++|||++|+++
T Consensus 245 i~~~---~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~ 287 (327)
T 3lm5_A 245 ISQV---NVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLS 287 (327)
T ss_dssp HHHT---CCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred HHhc---ccccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhC
Confidence 1111 111111111223356888999999999999999999975
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-37 Score=356.31 Aligned_cols=320 Identities=23% Similarity=0.234 Sum_probs=175.7
Q ss_pred ceeeccccccccCCCcccccccccCeeeccccccCCcCCccCCCCCCCcEeeccCcccccCCCccccCCCCcceeecccc
Q 044366 144 DTLFLYKNSLSGPIPSVIGNLKSLLQLDLSENRLSGLIPLSLSNLSSLTVMSLFNNSLSGSIPPILGNLKSLSTLGLHIN 223 (918)
Q Consensus 144 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n 223 (918)
+.++.++++++.+ |..+. ++++.|+|++|+++++.+..|.++++|++|+|++|.+++..|..|.++++|++|+|++|
T Consensus 14 ~~v~c~~~~l~~i-p~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n 90 (477)
T 2id5_A 14 RAVLCHRKRFVAV-PEGIP--TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSN 90 (477)
T ss_dssp TEEECCSCCCSSC-CSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred CEEEeCCCCcCcC-CCCCC--CCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCC
Confidence 3455566666533 33322 35666666666666655556666666666666666666555566666666666666666
Q ss_pred cccCCCCCCCcCCCcCCeEEcccCcCcCCCCccccccCCCCeEecCCCccCCcCCCcCCCCCCCcEEEccCCcCcCCCCc
Q 044366 224 QLNGVIPPSIGNLSSLRNLSLFNNRLYGFVPKEIGYLKSLSKLEFCANHLSGVIPHSVGNLTGLVLLNMCENHLFGPIPK 303 (918)
Q Consensus 224 ~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~ 303 (918)
+++.+.+..|.++++|++|+|++|++.+..+..|..+++|++|++++|.+.+..+..|.++++|+.|++++|++++..+.
T Consensus 91 ~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~ 170 (477)
T 2id5_A 91 RLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTE 170 (477)
T ss_dssp CCCSCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEECCTTCCEECTTSSTTCTTCCEEEEESCCCSSCCHH
T ss_pred cCCccCcccccCCCCCCEEECCCCccccCChhHccccccCCEEECCCCccceeChhhccCCCCCCEEECCCCcCcccChh
Confidence 66655545555666666666666666555555555555566555555555555555555555555555555555544444
Q ss_pred cccCCCCCCeEEeecccccCccccccCCCCCccEEeCCCCccccccCcccccccccceeeccccccccCCCcCcCCCCCC
Q 044366 304 SLRNLTSLERVRFNQNNLYGKVYEAFGDHPNLTFLDLSQNNFYCEISFNWRNFSKLGTFNASMNNIYGSIPPEIGDSSKL 383 (918)
Q Consensus 304 ~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~n~i~~~~~~~~~~~~~L 383 (918)
.+.++++|+.|++++|.+..+....|..+++|+.|++++|+ ..+.++..+....+|
T Consensus 171 ~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~~~------------------------~~~~~~~~~~~~~~L 226 (477)
T 2id5_A 171 ALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWP------------------------YLDTMTPNCLYGLNL 226 (477)
T ss_dssp HHTTCTTCCEEEEESCCCCEECTTCSCSCTTCCEEEEECCT------------------------TCCEECTTTTTTCCC
T ss_pred HhcccCCCcEEeCCCCcCcEeChhhcccCcccceeeCCCCc------------------------cccccCcccccCccc
Confidence 45555555555555555544444444444444444444433 333344444444466
Q ss_pred cEEEccCceeccccccchhhccccCceecccccccCCCCCCCCCCCcccEEeccCccccccCccccccccccceecccCc
Q 044366 384 QVLDLSSNHIFGKIPVQLVKLFSLNKLILSLNQLFGGVPLEFGTLTELQYLDLSANKLSSSIPMSIGNLLKLHYLNLSNN 463 (918)
Q Consensus 384 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N 463 (918)
+.|+|++|+|+...+..+..+++|+.|+|++|++++..+..|..+++|++|+|++|.+++..|..|..+++|+.|+|++|
T Consensus 227 ~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N 306 (477)
T 2id5_A 227 TSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGN 306 (477)
T ss_dssp SEEEEESSCCCSCCHHHHTTCTTCCEEECCSSCCCEECTTSCTTCTTCCEEECCSSCCSEECTTTBTTCTTCCEEECCSS
T ss_pred cEEECcCCcccccCHHHhcCccccCeeECCCCcCCccChhhccccccCCEEECCCCccceECHHHhcCcccCCEEECCCC
Confidence 66666666666444445555555555555555555555555555555555555555555555555555555555555555
Q ss_pred ccCCCCchhhccccccceEeccCCcCC
Q 044366 464 QFSHKIPTEFEKLIHLSELDLSHNILQ 490 (918)
Q Consensus 464 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~ 490 (918)
+|++..+..|..+++|+.|+|++|.++
T Consensus 307 ~l~~~~~~~~~~l~~L~~L~l~~N~l~ 333 (477)
T 2id5_A 307 QLTTLEESVFHSVGNLETLILDSNPLA 333 (477)
T ss_dssp CCSCCCGGGBSCGGGCCEEECCSSCEE
T ss_pred cCceeCHhHcCCCcccCEEEccCCCcc
Confidence 555444444555555555555555554
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-38 Score=344.08 Aligned_cols=253 Identities=28% Similarity=0.438 Sum_probs=196.5
Q ss_pred cCCCCceeeccccceEEEEEEeCC-----CCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCc
Q 044366 646 GNFGEKYCIGKGGQRSVYKAELPS-----GNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQH 720 (918)
Q Consensus 646 ~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 720 (918)
.+|...+.||+|+||.||+|.... +..||||+++... .......+.+|+++++.++||||+++++++.+.+.
T Consensus 44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 120 (333)
T 1mqb_A 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY---TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKP 120 (333)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC---CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC---CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCC
Confidence 466778899999999999996532 2359999986532 22234578999999999999999999999999999
Q ss_pred eEEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEecccccc
Q 044366 721 SFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAK 800 (918)
Q Consensus 721 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~ 800 (918)
.++||||+++|+|.+++... ...+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++
T Consensus 121 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~ 195 (333)
T 1mqb_A 121 MMIITEYMENGALDKFLREK--DGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSR 195 (333)
T ss_dssp EEEEEECCTTEEHHHHHHHT--TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred cEEEEeCCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChheEEECCCCcEEECCCCcch
Confidence 99999999999999999764 24589999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCC---ceecccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhhhhhhhhhHhhhhhhcccC
Q 044366 801 FLEPHSSN---WTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIK-GYHPGDFVSTIFSSISNMIIEVNQILDHR 876 (918)
Q Consensus 801 ~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 876 (918)
........ .....+++.|+|||++.+..++.++||||||+++|||++ |+.||...... . ... .+....
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~--~---~~~---~~~~~~ 267 (333)
T 1mqb_A 196 VLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH--E---VMK---AINDGF 267 (333)
T ss_dssp ---------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--H---HHH---HHHTTC
T ss_pred hhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHH--H---HHH---HHHCCC
Confidence 76543221 123345788999999998899999999999999999999 99998643321 0 111 111111
Q ss_pred CCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 044366 877 LPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLLC 917 (918)
Q Consensus 877 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 917 (918)
....... ....+.+++.+||+.||++||+++|+++.|+
T Consensus 268 ~~~~~~~---~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~ 305 (333)
T 1mqb_A 268 RLPTPMD---CPSAIYQLMMQCWQQERARRPKFADIVSILD 305 (333)
T ss_dssp CCCCCTT---CBHHHHHHHHHHTCSSTTTSCCHHHHHHHHH
T ss_pred cCCCccc---CCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 1111111 2346788999999999999999999999885
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=356.98 Aligned_cols=257 Identities=24% Similarity=0.302 Sum_probs=193.9
Q ss_pred HHhcCCCCceeeccccceEEEEEEe-CCCCEEEEEEcccccccCC----CCChHHHHHHHHHHhhccCCceeeEeccccc
Q 044366 643 KATGNFGEKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDE----TANPSEFLNEVLALTEIRHRNIIKFHGFCSN 717 (918)
Q Consensus 643 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~----~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~ 717 (918)
...++|...+.||+|+||.||+|.. .+++.||||++........ ......+.+|++++++++||||+++++++..
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~ 211 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA 211 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence 4567899999999999999999954 5789999999876432211 1123458899999999999999999999754
Q ss_pred CCceEEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCC---cEEEe
Q 044366 718 AQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEY---EAHVS 794 (918)
Q Consensus 718 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~---~~kl~ 794 (918)
+..++||||+++|+|.+++... ..+++.+++.++.|++.||+|||+. +|+||||||+||+++.++ .+||+
T Consensus 212 -~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kl~ 284 (419)
T 3i6u_A 212 -EDYYIVLELMEGGELFDKVVGN---KRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKIT 284 (419)
T ss_dssp -SEEEEEEECCTTCBGGGGTSSS---CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSSSCCEEEC
T ss_pred -CceEEEEEcCCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCCCcceEEEe
Confidence 4579999999999999998754 3489999999999999999999999 999999999999997544 59999
Q ss_pred ccccccccCCCCCCceeccccccccccccccc---CCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhh
Q 044366 795 DFGFAKFLEPHSSNWTEFAGTVGYAAPELAYT---MRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQ 871 (918)
Q Consensus 795 DfG~~~~~~~~~~~~~~~~g~~~y~aPE~~~~---~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 871 (918)
|||+++..... .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||........... .
T Consensus 285 DFG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~-------~ 356 (419)
T 3i6u_A 285 DFGHSKILGET-SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKD-------Q 356 (419)
T ss_dssp CSSTTTSCC------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHH-------H
T ss_pred ecccceecCCC-ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHH-------H
Confidence 99999876543 23345678999999999853 5678899999999999999999999865332111111 0
Q ss_pred hcccCCCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 872 ILDHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 872 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
+..................+.+++.+||+.||++|||++|+++
T Consensus 357 i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 399 (419)
T 3i6u_A 357 ITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 399 (419)
T ss_dssp HHTTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HhcCCCCCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 1111111111111122356889999999999999999999986
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-38 Score=340.46 Aligned_cols=252 Identities=25% Similarity=0.389 Sum_probs=201.6
Q ss_pred HHhcCCCCceeeccccceEEEEEEeC-CCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCce
Q 044366 643 KATGNFGEKYCIGKGGQRSVYKAELP-SGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHS 721 (918)
Q Consensus 643 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 721 (918)
...++|...+.||+|+||.||+|... +|+.||||.+... ...+.+.+|+.+++.++||||+++++++...+..
T Consensus 26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 99 (314)
T 3com_A 26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE------SDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDL 99 (314)
T ss_dssp ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETT------SCCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEE
T ss_pred cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCch------HHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEE
Confidence 45578999999999999999999654 6999999998652 2357899999999999999999999999999999
Q ss_pred EEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccc
Q 044366 722 FIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKF 801 (918)
Q Consensus 722 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~ 801 (918)
++||||+++|+|.+++... ...+++.+++.++.|++.||+|||+. +++||||||+||+++.++.+||+|||.+..
T Consensus 100 ~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~ 174 (314)
T 3com_A 100 WIVMEYCGAGSVSDIIRLR--NKTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQ 174 (314)
T ss_dssp EEEEECCTTEEHHHHHHHH--TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEeecCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCcCHHHEEECCCCCEEEeecccchh
Confidence 9999999999999999743 34589999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCCceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCCCCC
Q 044366 802 LEPHSSNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPS 881 (918)
Q Consensus 802 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 881 (918)
............|++.|+|||.+.+..++.++||||||+++|+|++|+.||......... ...........
T Consensus 175 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-----~~~~~~~~~~~---- 245 (314)
T 3com_A 175 LTDTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAI-----FMIPTNPPPTF---- 245 (314)
T ss_dssp CBTTBSCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHH-----HHHHHSCCCCC----
T ss_pred hhhhccccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHH-----HHHhcCCCccc----
Confidence 765544445567899999999999989999999999999999999999998654321110 01111111111
Q ss_pred cchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 882 RDVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 882 ~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
.........+.+++.+||+.||.+|||+.++++
T Consensus 246 ~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 246 RKPELWSDNFTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp SSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred CCcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 111112356889999999999999999999975
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-38 Score=348.42 Aligned_cols=263 Identities=22% Similarity=0.261 Sum_probs=204.9
Q ss_pred HHHHHHHhcCCCCceeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhcc-----CCceeeE
Q 044366 638 YEEITKATGNFGEKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIR-----HRNIIKF 711 (918)
Q Consensus 638 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-----h~niv~~ 711 (918)
+.+.....++|.+.+.||+|+||.||+|+. .+++.||||+++.. ......+..|+++++.++ ||||+++
T Consensus 27 ~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~ 101 (360)
T 3llt_A 27 WKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-----KKYTRSAKIEADILKKIQNDDINNNNIVKY 101 (360)
T ss_dssp CCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-----HHHHHHHHHHHHHHHHTCCCSTTGGGBCCE
T ss_pred eecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-----hhhhhhhHHHHHHHHHhcccCCCCCCeecc
Confidence 334445568899999999999999999965 57899999998642 122456788999999986 9999999
Q ss_pred ecccccCCceEEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCC----
Q 044366 712 HGFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDS---- 787 (918)
Q Consensus 712 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~---- 787 (918)
++++...+..++||||+ +++|.+++.... ...+++.+++.++.||+.||+|||+. +|+||||||+||+++.
T Consensus 102 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~ 176 (360)
T 3llt_A 102 HGKFMYYDHMCLIFEPL-GPSLYEIITRNN-YNGFHIEDIKLYCIEILKALNYLRKM---SLTHTDLKPENILLDDPYFE 176 (360)
T ss_dssp EEEEEETTEEEEEECCC-CCBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCTTCC
T ss_pred cceeeECCeeEEEEcCC-CCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCcccEEEcccccc
Confidence 99999999999999999 889999998654 23489999999999999999999999 9999999999999975
Q ss_pred ---------------------CCcEEEeccccccccCCCCCCceecccccccccccccccCCCCcccchhhHHHHHHHHH
Q 044366 788 ---------------------EYEAHVSDFGFAKFLEPHSSNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVI 846 (918)
Q Consensus 788 ---------------------~~~~kl~DfG~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~ 846 (918)
++.+||+|||++....... ....||+.|+|||++.+..++.++||||+||++|||+
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell 253 (360)
T 3llt_A 177 KSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYH---GSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELY 253 (360)
T ss_dssp EEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSCC---CSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHH
T ss_pred ccccchhcccccccccccccCCCCEEEEeccCceecCCCC---cCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHH
Confidence 7889999999998754322 3457899999999999999999999999999999999
Q ss_pred hCCCCCCcchhhhhhhhhhHhh-----------h-----h-----hhcccCCCCCCcchHH--------------HHHHH
Q 044366 847 KGYHPGDFVSTIFSSISNMIIE-----------V-----N-----QILDHRLPTPSRDVTD--------------KLRSI 891 (918)
Q Consensus 847 tg~~p~~~~~~~~~~~~~~~~~-----------~-----~-----~~~~~~~~~~~~~~~~--------------~~~~l 891 (918)
+|+.||....... ........ . . ......++........ ....+
T Consensus 254 ~g~~pf~~~~~~~-~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l 332 (360)
T 3llt_A 254 TGSLLFRTHEHME-HLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELF 332 (360)
T ss_dssp HSSCSCCCSSHHH-HHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHH
T ss_pred HCCCCCCCCcHHH-HHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHH
Confidence 9999986543211 11000000 0 0 0000011111111110 01467
Q ss_pred HHHHHHcccCCCCCCCCHHHHHH
Q 044366 892 MEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 892 ~~li~~cl~~dp~~RPt~~evl~ 914 (918)
.+++.+||+.||++|||++|+++
T Consensus 333 ~~li~~~L~~dP~~Rpta~elL~ 355 (360)
T 3llt_A 333 CDFLYSILQIDPTLRPSPAELLK 355 (360)
T ss_dssp HHHHHHHCCSSGGGSCCHHHHTT
T ss_pred HHHHHHHhcCChhhCCCHHHHhc
Confidence 79999999999999999999975
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-38 Score=333.15 Aligned_cols=252 Identities=24% Similarity=0.331 Sum_probs=203.6
Q ss_pred hcCCCCceeeccccceEEEEEEeC-CCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEE
Q 044366 645 TGNFGEKYCIGKGGQRSVYKAELP-SGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFI 723 (918)
Q Consensus 645 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 723 (918)
.++|...+.||+|+||.||+|... +++.||||++.... .....+.+.+|+.+++.++||||+++++++.+++..++
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 82 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKR---AVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYL 82 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGG---CTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeecc---chhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEE
Confidence 467889999999999999999654 79999999986532 22335789999999999999999999999999999999
Q ss_pred EEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccC
Q 044366 724 VCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLE 803 (918)
Q Consensus 724 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~ 803 (918)
||||+++++|.+++... ..+++.+++.++.|++.||+|||+. +++||||||+||+++.++.+||+|||.+....
T Consensus 83 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~ 156 (276)
T 2yex_A 83 FLEYCSGGELFDRIEPD---IGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFR 156 (276)
T ss_dssp EEECCTTEEGGGGSBTT---TBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECE
T ss_pred EEEecCCCcHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCChHHEEEccCCCEEEeeCCCccccC
Confidence 99999999999998754 3489999999999999999999999 99999999999999999999999999998664
Q ss_pred CCC--CCceecccccccccccccccCCC-CcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCCCC
Q 044366 804 PHS--SNWTEFAGTVGYAAPELAYTMRA-TEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTP 880 (918)
Q Consensus 804 ~~~--~~~~~~~g~~~y~aPE~~~~~~~-~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 880 (918)
... .......|++.|+|||++.+..+ +.++||||||+++|||++|+.||+........... ... .....
T Consensus 157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~----~~~---~~~~~- 228 (276)
T 2yex_A 157 YNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSD----WKE---KKTYL- 228 (276)
T ss_dssp ETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHH----HHT---TCTTS-
T ss_pred CCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHH----hhh---ccccc-
Confidence 322 22344578999999999987665 77999999999999999999998754322111111 000 00000
Q ss_pred CcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 881 SRDVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 881 ~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
.........+.+++.+||+.||++|||++|+++
T Consensus 229 -~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 229 -NPWKKIDSAPLALLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp -TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -CchhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence 011122346788999999999999999999975
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-38 Score=345.33 Aligned_cols=252 Identities=22% Similarity=0.388 Sum_probs=207.5
Q ss_pred HhcCCCCceeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceE
Q 044366 644 ATGNFGEKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSF 722 (918)
Q Consensus 644 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 722 (918)
..++|...+.||+|+||.||+|.. .+++.||+|++...... .....+.+.+|+.+++.++||||+++++++.+.+..+
T Consensus 39 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 117 (335)
T 2owb_A 39 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLL-KPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVF 117 (335)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCC-SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred cCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhc-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEE
Confidence 346788999999999999999965 46889999998764322 2223567899999999999999999999999999999
Q ss_pred EEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEecccccccc
Q 044366 723 IVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFL 802 (918)
Q Consensus 723 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~ 802 (918)
+||||+++++|.+++... ..+++.+++.++.|+++||+|||+. +|+||||||+||+++.++.+||+|||++...
T Consensus 118 lv~e~~~~~~L~~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~ 191 (335)
T 2owb_A 118 VVLELCRRRSLLELHKRR---KALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKV 191 (335)
T ss_dssp EEECCCTTCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEecCCCCCHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CCEecCCCchhEEEcCCCCEEEeeccCceec
Confidence 999999999999998764 3489999999999999999999999 9999999999999999999999999999887
Q ss_pred CCCCCCceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCCCCCc
Q 044366 803 EPHSSNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSR 882 (918)
Q Consensus 803 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 882 (918)
...........|++.|+|||++.+..++.++||||||+++|||++|+.||....... . .... .......+ .
T Consensus 192 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~----~~~~---~~~~~~~~-~ 262 (335)
T 2owb_A 192 EYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE-T----YLRI---KKNEYSIP-K 262 (335)
T ss_dssp CSTTCCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH-H----HHHH---HHTCCCCC-T
T ss_pred ccCcccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHH-H----HHHH---hcCCCCCC-c
Confidence 655444555678999999999999889999999999999999999999987543211 1 1111 11111111 1
Q ss_pred chHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 883 DVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 883 ~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
.. ...+.+++.+||+.||++|||++|+++
T Consensus 263 ~~---~~~~~~li~~~l~~dp~~Rps~~ell~ 291 (335)
T 2owb_A 263 HI---NPVAASLIQKMLQTDPTARPTINELLN 291 (335)
T ss_dssp TS---CHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred cC---CHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11 245788999999999999999999875
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-38 Score=361.45 Aligned_cols=253 Identities=24% Similarity=0.338 Sum_probs=205.1
Q ss_pred HhcCCCCceeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceE
Q 044366 644 ATGNFGEKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSF 722 (918)
Q Consensus 644 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 722 (918)
..++|.+.+.||+|+||.||+|.. .+|+.||||++..... .......+.+|++++++++||||+++++++.+.+..+
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 97 (486)
T 3mwu_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASA--KNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFY 97 (486)
T ss_dssp HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHH--BCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccc--cchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEE
Confidence 346799999999999999999965 4799999999875432 2234678999999999999999999999999999999
Q ss_pred EEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeC---CCCcEEEeccccc
Q 044366 723 IVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLD---SEYEAHVSDFGFA 799 (918)
Q Consensus 723 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~---~~~~~kl~DfG~~ 799 (918)
+||||+++|+|.+++... ..+++.+++.++.|++.||+|||+. +|+||||||+||+++ .++.+||+|||++
T Consensus 98 lv~e~~~~~~L~~~~~~~---~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a 171 (486)
T 3mwu_A 98 IVGELYTGGELFDEIIKR---KRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLS 171 (486)
T ss_dssp EEECCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEESSSSTTCCEEECSCSCT
T ss_pred EEEEcCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEEECCcC
Confidence 999999999999988764 3489999999999999999999999 999999999999995 4567999999999
Q ss_pred cccCCCCCCceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCCC
Q 044366 800 KFLEPHSSNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPT 879 (918)
Q Consensus 800 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 879 (918)
+...... ......||+.|+|||++.+ .++.++||||+||++|+|++|+.||...... .. ...+.......
T Consensus 172 ~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-~~-------~~~i~~~~~~~ 241 (486)
T 3mwu_A 172 TCFQQNT-KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEY-DI-------LKRVETGKYAF 241 (486)
T ss_dssp TTBCCC-----CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-HH-------HHHHHHTCCCS
T ss_pred eECCCCC-ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HH-------HHHHHhCCCCC
Confidence 8765432 3345679999999999876 5899999999999999999999998654321 11 11111122222
Q ss_pred CCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 880 PSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 880 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
...........+.+++.+||+.||.+|||+.|+++
T Consensus 242 ~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~ 276 (486)
T 3mwu_A 242 DLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (486)
T ss_dssp CSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred CCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 22222333456889999999999999999999986
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=343.71 Aligned_cols=264 Identities=21% Similarity=0.313 Sum_probs=208.7
Q ss_pred HHHHHHHhcCCCCceeeccccceEEEEEEe------CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhc-cCCceee
Q 044366 638 YEEITKATGNFGEKYCIGKGGQRSVYKAEL------PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEI-RHRNIIK 710 (918)
Q Consensus 638 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~ 710 (918)
........++|...+.||+|+||.||+|.. .+++.||||+++... .....+.+.+|+.+++++ +||||++
T Consensus 19 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~hp~iv~ 95 (316)
T 2xir_A 19 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA---THSEHRALMSELKILIHIGHHLNVVN 95 (316)
T ss_dssp HHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC---CHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred ccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCC---CcHHHHHHHHHHHHHHhcccCCCeee
Confidence 445555678999999999999999999963 356899999986532 122346789999999999 7999999
Q ss_pred EecccccCC-ceEEEEEeccCCChhHHhhcccc-------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEc
Q 044366 711 FHGFCSNAQ-HSFIVCEYLARGSLTTILRDDAA-------------AKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHR 776 (918)
Q Consensus 711 ~~~~~~~~~-~~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~ 776 (918)
+++++...+ ..++||||+++|+|.+++..... ...+++.+++.++.|+++||+|||+. +|+||
T Consensus 96 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~ 172 (316)
T 2xir_A 96 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHR 172 (316)
T ss_dssp EEEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT---TCCCS
T ss_pred EEEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC---Ccccc
Confidence 999987654 58999999999999999986532 12378999999999999999999999 99999
Q ss_pred CCCCCCeeeCCCCcEEEeccccccccCCCCCC--ceecccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCC
Q 044366 777 DISSKNVLLDSEYEAHVSDFGFAKFLEPHSSN--WTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIK-GYHPGD 853 (918)
Q Consensus 777 dlk~~Nill~~~~~~kl~DfG~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~p~~ 853 (918)
||||+||+++.++.+||+|||+++........ .....||+.|+|||++.+..++.++||||||+++|||++ |+.||.
T Consensus 173 dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~ 252 (316)
T 2xir_A 173 DLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP 252 (316)
T ss_dssp CCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred cCccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCc
Confidence 99999999999999999999999876544332 223457889999999999999999999999999999998 999986
Q ss_pred cchhhhhhhhhhHhhhhhhcccCCCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 044366 854 FVSTIFSSISNMIIEVNQILDHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLLC 917 (918)
Q Consensus 854 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 917 (918)
......... ..... ......... ....+.+++.+||+.||.+|||++|+++.|+
T Consensus 253 ~~~~~~~~~----~~~~~---~~~~~~~~~---~~~~l~~li~~~l~~dp~~Rps~~ell~~L~ 306 (316)
T 2xir_A 253 GVKIDEEFC----RRLKE---GTRMRAPDY---TTPEMYQTMLDCWHGEPSQRPTFSELVEHLG 306 (316)
T ss_dssp TCCCSHHHH----HHHHH---TCCCCCCTT---CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred ccchhHHHH----HHhcc---CccCCCCCC---CCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 543211111 11111 111111111 2246888999999999999999999999885
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-38 Score=352.85 Aligned_cols=261 Identities=22% Similarity=0.361 Sum_probs=190.4
Q ss_pred HHhcCCCCceeeccccceEEEEEE-eCCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhcc-CCceeeEecccccC--
Q 044366 643 KATGNFGEKYCIGKGGQRSVYKAE-LPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIR-HRNIIKFHGFCSNA-- 718 (918)
Q Consensus 643 ~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~-- 718 (918)
...++|...+.||+|+||.||+|. ..+|+.||||++.... ........+.+|+.+++.+. ||||+++++++..+
T Consensus 6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~--~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~ 83 (388)
T 3oz6_A 6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAF--QNSTDAQRTFREIMILTELSGHENIVNLLNVLRADND 83 (388)
T ss_dssp HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC----CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTS
T ss_pred cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccc--cChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCC
Confidence 456789999999999999999995 4579999999986532 12233567889999999997 99999999998644
Q ss_pred CceEEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEecccc
Q 044366 719 QHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGF 798 (918)
Q Consensus 719 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~ 798 (918)
...++||||++ |+|.++++.. .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 84 ~~~~lv~e~~~-~~L~~~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~ 155 (388)
T 3oz6_A 84 RDVYLVFDYME-TDLHAVIRAN----ILEPVHKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGL 155 (388)
T ss_dssp SCEEEEEECCS-EEHHHHHHHT----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred CEEEEEecccC-cCHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHeEEcCCCCEEecCCcc
Confidence 47899999998 5899998753 489999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCC---------------------CCCceeccccccccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCcch
Q 044366 799 AKFLEPH---------------------SSNWTEFAGTVGYAAPELAYT-MRATEKYDVYSFGVLALEVIKGYHPGDFVS 856 (918)
Q Consensus 799 ~~~~~~~---------------------~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~vl~el~tg~~p~~~~~ 856 (918)
|+.+... .......+||+.|+|||++.+ ..++.++||||+||++|||++|+.||....
T Consensus 156 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~ 235 (388)
T 3oz6_A 156 SRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSS 235 (388)
T ss_dssp CEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred cccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 9876431 112234579999999999876 678999999999999999999999986543
Q ss_pred hhhhhhhhhHhhh-----------------------hhhcccCCCCCCcchH-------------HHHHHHHHHHHHccc
Q 044366 857 TIFSSISNMIIEV-----------------------NQILDHRLPTPSRDVT-------------DKLRSIMEVAILCLV 900 (918)
Q Consensus 857 ~~~~~~~~~~~~~-----------------------~~~~~~~~~~~~~~~~-------------~~~~~l~~li~~cl~ 900 (918)
... ......... ................ .....+.+++.+||+
T Consensus 236 ~~~-~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~ 314 (388)
T 3oz6_A 236 TMN-QLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQ 314 (388)
T ss_dssp HHH-HHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCC
T ss_pred HHH-HHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhc
Confidence 211 111100000 0000000000000011 112468899999999
Q ss_pred CCCCCCCCHHHHHH
Q 044366 901 ENPEARPTMKEVCN 914 (918)
Q Consensus 901 ~dp~~RPt~~evl~ 914 (918)
.||++|||++|+++
T Consensus 315 ~dP~~R~t~~e~l~ 328 (388)
T 3oz6_A 315 FNPNKRISANDALK 328 (388)
T ss_dssp SSGGGSCCHHHHTT
T ss_pred cCcccCCCHHHHhC
Confidence 99999999999975
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=348.16 Aligned_cols=262 Identities=26% Similarity=0.349 Sum_probs=196.4
Q ss_pred HhcCCCCceeeccccceEEEEEEeCCCCEEEEEEcccccccCCCCChHHHHHHHHH--HhhccCCceeeEeccc-----c
Q 044366 644 ATGNFGEKYCIGKGGQRSVYKAELPSGNIFAVKKFKAELFSDETANPSEFLNEVLA--LTEIRHRNIIKFHGFC-----S 716 (918)
Q Consensus 644 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~--l~~l~h~niv~~~~~~-----~ 716 (918)
..++|...+.||+|+||.||+|+. +++.||||++... ....+..|.++ ++.++||||+++++++ .
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~-------~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~ 82 (336)
T 3g2f_A 11 DLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFA-------NRQNFINEKNIYRVPLMEHDNIARFIVGDERVTAD 82 (336)
T ss_dssp CTTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGG-------GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTT
T ss_pred ChHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeecc-------chhhHHHHHHHHHHHhccCcchhhheecccccccC
Confidence 347899999999999999999976 7899999998643 13445555555 4458999999999743 3
Q ss_pred cCCceEEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCC------CCCeEEcCCCCCCeeeCCCCc
Q 044366 717 NAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDC------IPPIVHRDISSKNVLLDSEYE 790 (918)
Q Consensus 717 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~------~~~ivH~dlk~~Nill~~~~~ 790 (918)
.....++||||+++|+|.+++.... .++..++.++.|+++||+|||+.+ .++|+||||||+||+++.++.
T Consensus 83 ~~~~~~lv~e~~~~g~L~~~l~~~~----~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~ 158 (336)
T 3g2f_A 83 GRMEYLLVMEYYPNGSLXKYLSLHT----SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGT 158 (336)
T ss_dssp SCEEEEEEECCCTTCBHHHHHHHCC----BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSC
T ss_pred CCceEEEEEecCCCCcHHHHHhhcc----cchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCc
Confidence 3446789999999999999997543 589999999999999999999873 238999999999999999999
Q ss_pred EEEeccccccccCCCCC--------Cceeccccccccccccccc-------CCCCcccchhhHHHHHHHHHhCCCCCCcc
Q 044366 791 AHVSDFGFAKFLEPHSS--------NWTEFAGTVGYAAPELAYT-------MRATEKYDVYSFGVLALEVIKGYHPGDFV 855 (918)
Q Consensus 791 ~kl~DfG~~~~~~~~~~--------~~~~~~g~~~y~aPE~~~~-------~~~~~~~Dv~slG~vl~el~tg~~p~~~~ 855 (918)
+||+|||+++.+..... ......||+.|+|||++.+ ..++.++|||||||++|||++|..|+...
T Consensus 159 ~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~ 238 (336)
T 3g2f_A 159 CVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPG 238 (336)
T ss_dssp EEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTT
T ss_pred EEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCc
Confidence 99999999987653221 1234568999999999876 45677899999999999999997764322
Q ss_pred hhhhhhh-------------hhhHh-hhhhhcccCCCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 044366 856 STIFSSI-------------SNMII-EVNQILDHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLLC 917 (918)
Q Consensus 856 ~~~~~~~-------------~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 917 (918)
....... ..... ..........+............+.+++.+||+.||++|||++|+++.|+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~ 314 (336)
T 3g2f_A 239 ESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMA 314 (336)
T ss_dssp SCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred cchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHH
Confidence 1100000 00000 00111112222222233345667999999999999999999999999886
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-38 Score=339.64 Aligned_cols=251 Identities=24% Similarity=0.365 Sum_probs=201.8
Q ss_pred HhcCCCCceeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceE
Q 044366 644 ATGNFGEKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSF 722 (918)
Q Consensus 644 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 722 (918)
..++|...+.||+|+||.||+|+. .+|+.||+|+++... ....+.+.+|+++++.++||||+++++++.+.+..+
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (304)
T 2jam_A 7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSP----AFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYY 82 (304)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC----------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEeccc----ccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEE
Confidence 346788999999999999999965 479999999987532 223467899999999999999999999999999999
Q ss_pred EEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeee---CCCCcEEEeccccc
Q 044366 723 IVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLL---DSEYEAHVSDFGFA 799 (918)
Q Consensus 723 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill---~~~~~~kl~DfG~~ 799 (918)
+||||+++|+|.+++.... .+++.+++.++.|++.||+|||+. +|+||||||+||++ +.++.+||+|||++
T Consensus 83 lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~ 156 (304)
T 2jam_A 83 LVMQLVSGGELFDRILERG---VYTEKDASLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLS 156 (304)
T ss_dssp EEECCCCSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCSCCGGGCEESSSSTTCCEEBCSCSTT
T ss_pred EEEEcCCCccHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEecCCCCCCEEEccCCcc
Confidence 9999999999999987643 489999999999999999999999 99999999999999 77889999999999
Q ss_pred cccCCCCCCceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCCC
Q 044366 800 KFLEPHSSNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPT 879 (918)
Q Consensus 800 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 879 (918)
...... ......|++.|+|||++.+..++.++||||+|+++|||++|+.||...... .... .+.......
T Consensus 157 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-----~~~~---~i~~~~~~~ 226 (304)
T 2jam_A 157 KMEQNG--IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETES-----KLFE---KIKEGYYEF 226 (304)
T ss_dssp CCCCCB--TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHH-----HHHH---HHHHCCCCC
T ss_pred eecCCC--ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH-----HHHH---HHHcCCCCC
Confidence 764432 223456899999999999999999999999999999999999998643321 0111 111111111
Q ss_pred CCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 880 PSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 880 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
...........+.+++.+|++.||++|||++|+++
T Consensus 227 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (304)
T 2jam_A 227 ESPFWDDISESAKDFICHLLEKDPNERYTCEKALS 261 (304)
T ss_dssp CTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred CccccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 11111123356889999999999999999999985
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=364.13 Aligned_cols=253 Identities=23% Similarity=0.356 Sum_probs=207.8
Q ss_pred hcCCCCceeeccccceEEEEEEeC-CCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEE
Q 044366 645 TGNFGEKYCIGKGGQRSVYKAELP-SGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFI 723 (918)
Q Consensus 645 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 723 (918)
.++|...+.||+|+||.||+|... +|+.||||++...... .....+.+.+|++++++++||||+++++++.+.+..++
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 103 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVK-QKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYL 103 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC-BSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcc-cchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 457899999999999999999654 7999999998764322 23456889999999999999999999999999999999
Q ss_pred EEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeee---CCCCcEEEecccccc
Q 044366 724 VCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLL---DSEYEAHVSDFGFAK 800 (918)
Q Consensus 724 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill---~~~~~~kl~DfG~~~ 800 (918)
||||+++|+|.+++... ..+++.+++.++.||+.||+|||+. +|+||||||+||++ +.++.+||+|||+++
T Consensus 104 v~e~~~~~~L~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~ 177 (484)
T 3nyv_A 104 VGEVYTGGELFDEIISR---KRFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLST 177 (484)
T ss_dssp EECCCCSCBHHHHHHTC---SCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCTTHHH
T ss_pred EEecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEecCCCCCcEEEEeeeeeE
Confidence 99999999999998764 3489999999999999999999999 99999999999999 567899999999998
Q ss_pred ccCCCCCCceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCCCC
Q 044366 801 FLEPHSSNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTP 880 (918)
Q Consensus 801 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 880 (918)
.+.... ......||+.|+|||++.+ .++.++||||+||++|+|++|+.||...... .. ...+........
T Consensus 178 ~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-~~-------~~~i~~~~~~~~ 247 (484)
T 3nyv_A 178 HFEASK-KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEY-DI-------LKKVEKGKYTFE 247 (484)
T ss_dssp HBCCCC-SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HH-------HHHHHHCCCCCC
T ss_pred Eccccc-ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHH-HH-------HHHHHcCCCCCC
Confidence 776433 3345679999999999876 6899999999999999999999998754321 11 111112222222
Q ss_pred CcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 881 SRDVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 881 ~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
..........+.+++.+||+.||.+|||++|+++
T Consensus 248 ~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 281 (484)
T 3nyv_A 248 LPQWKKVSESAKDLIRKMLTYVPSMRISARDALD 281 (484)
T ss_dssp SGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CcccccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence 2222333456889999999999999999999985
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-38 Score=337.35 Aligned_cols=248 Identities=19% Similarity=0.351 Sum_probs=199.0
Q ss_pred hcCCCCceeeccccceEEEEEEeC-CC-------CEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccc
Q 044366 645 TGNFGEKYCIGKGGQRSVYKAELP-SG-------NIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCS 716 (918)
Q Consensus 645 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~-------~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~ 716 (918)
.++|...+.||+|+||.||+|... ++ ..||+|++... .....+.+.+|+++++.++||||+++++++.
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 82 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKA----HRNYSESFFEAASMMSKLSHKHLVLNYGVCV 82 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGG----GGGGHHHHHHHHHHHHTSCCTTBCCEEEEEC
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccc----cHHHHHHHHHHHHHHHhCCCCCEeEEEEEEE
Confidence 467888999999999999999543 34 47999998653 2233578999999999999999999999999
Q ss_pred cCCceEEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCc------
Q 044366 717 NAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYE------ 790 (918)
Q Consensus 717 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~------ 790 (918)
+++..++||||+++|+|.+++.... ..+++..++.++.|++.||+|||+. +|+||||||+||+++.++.
T Consensus 83 ~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~ 157 (289)
T 4fvq_A 83 CGDENILVQEFVKFGSLDTYLKKNK--NCINILWKLEVAKQLAAAMHFLEEN---TLIHGNVCAKNILLIREEDRKTGNP 157 (289)
T ss_dssp CTTCCEEEEECCTTCBHHHHHHHTG--GGCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEEECCBGGGTBC
T ss_pred eCCCCEEEEECCCCCCHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHhhC---CeECCCcCcceEEEecCCccccccc
Confidence 9999999999999999999998643 3489999999999999999999999 9999999999999998887
Q ss_pred --EEEeccccccccCCCCCCceeccccccccccccccc-CCCCcccchhhHHHHHHHHHhCCCC-CCcchhhhhhhhhhH
Q 044366 791 --AHVSDFGFAKFLEPHSSNWTEFAGTVGYAAPELAYT-MRATEKYDVYSFGVLALEVIKGYHP-GDFVSTIFSSISNMI 866 (918)
Q Consensus 791 --~kl~DfG~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~vl~el~tg~~p-~~~~~~~~~~~~~~~ 866 (918)
+||+|||++..... .....|++.|+|||++.+ ..++.++||||||+++|||++|..| +...... ...
T Consensus 158 ~~~kl~Dfg~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~-~~~---- 228 (289)
T 4fvq_A 158 PFIKLSDPGISITVLP----KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQ-RKL---- 228 (289)
T ss_dssp CEEEECCCCSCTTTSC----HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH-HHH----
T ss_pred ceeeeccCcccccccC----ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchH-HHH----
Confidence 99999999976543 233467899999999987 6789999999999999999996554 4332211 100
Q ss_pred hhhhhhcccCCCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhC
Q 044366 867 IEVNQILDHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLLCK 918 (918)
Q Consensus 867 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~ 918 (918)
..... ....+... ...+.+++.+||+.||++|||++|+++.|++
T Consensus 229 -~~~~~-~~~~~~~~------~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~ 272 (289)
T 4fvq_A 229 -QFYED-RHQLPAPK------AAELANLINNCMDYEPDHRPSFRAIIRDLNS 272 (289)
T ss_dssp -HHHHT-TCCCCCCS------SCTTHHHHHHHSCSSGGGSCCHHHHHHHHHT
T ss_pred -HHhhc-cCCCCCCC------CHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 00000 11111111 1347788999999999999999999999864
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-38 Score=360.93 Aligned_cols=252 Identities=24% Similarity=0.347 Sum_probs=200.1
Q ss_pred hcCCCCceeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEE
Q 044366 645 TGNFGEKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFI 723 (918)
Q Consensus 645 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 723 (918)
.++|...+.||+|+||.||+|+. .+++.||+|+++..... ......+.+|+.+++.++||||+++++++.+.+..++
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 113 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVS--TSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYL 113 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-------CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccC--chHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence 45789999999999999999965 47899999998764322 2335789999999999999999999999999999999
Q ss_pred EEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCC---CcEEEecccccc
Q 044366 724 VCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSE---YEAHVSDFGFAK 800 (918)
Q Consensus 724 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~---~~~kl~DfG~~~ 800 (918)
||||+++|+|.+++... ..+++.+++.++.||+.||+|||+. +|+||||||+||+++.. +.+||+|||+++
T Consensus 114 v~e~~~~g~L~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~ 187 (494)
T 3lij_A 114 VMECYKGGELFDEIIHR---MKFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSA 187 (494)
T ss_dssp EEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred EEecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChhhEEEeCCCCCCcEEEEECCCCe
Confidence 99999999999988764 3489999999999999999999999 99999999999999764 459999999998
Q ss_pred ccCCCCCCceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCCCC
Q 044366 801 FLEPHSSNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTP 880 (918)
Q Consensus 801 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 880 (918)
...... ......||+.|+|||++. ..++.++||||+||++|+|++|+.||...... . . ...+........
T Consensus 188 ~~~~~~-~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-~----~---~~~i~~~~~~~~ 257 (494)
T 3lij_A 188 VFENQK-KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQ-E----I---LRKVEKGKYTFD 257 (494)
T ss_dssp ECBTTB-CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-H----H---HHHHHHTCCCCC
T ss_pred ECCCCc-cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHH-H----H---HHHHHhCCCCCC
Confidence 776433 334567999999999886 46899999999999999999999998754321 1 1 111111222222
Q ss_pred CcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 881 SRDVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 881 ~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
..........+.+++.+||+.||.+|||+.|+++
T Consensus 258 ~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 291 (494)
T 3lij_A 258 SPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALE 291 (494)
T ss_dssp SGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred chhcccCCHHHHHHHHHHCCCChhhCccHHHHhc
Confidence 2222233456889999999999999999999874
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=367.25 Aligned_cols=254 Identities=26% Similarity=0.448 Sum_probs=206.3
Q ss_pred HhcCCCCceeeccccceEEEEEEeCCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEE
Q 044366 644 ATGNFGEKYCIGKGGQRSVYKAELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFI 723 (918)
Q Consensus 644 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 723 (918)
..++|...+.||+|+||.||+|.+..+..||||+++.. ....++|.+|++++++++||||+++++++.+ +..++
T Consensus 265 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~-----~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~l 338 (535)
T 2h8h_A 265 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-----TMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYI 338 (535)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTT-----SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred chhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCC-----CCCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceE
Confidence 45678888999999999999999888888999998753 2346789999999999999999999999876 67899
Q ss_pred EEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccC
Q 044366 724 VCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLE 803 (918)
Q Consensus 724 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~ 803 (918)
||||+++|+|.++++... ...+++.+++.|+.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 339 v~e~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 414 (535)
T 2h8h_A 339 VTEYMSKGSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIE 414 (535)
T ss_dssp EECCCTTEEHHHHHSHHH-HTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCTTSTTTCC
T ss_pred eeehhcCCcHHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEEcCCCcEEEcccccceecC
Confidence 999999999999997542 23489999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCC-CceecccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhhhhhhhhhHhhhhhhcccCCCCCC
Q 044366 804 PHSS-NWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIK-GYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPS 881 (918)
Q Consensus 804 ~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 881 (918)
.... ......++..|+|||++.+..++.++|||||||++|||++ |+.||...... .+ ...+.. ..+.+.+
T Consensus 415 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~--~~---~~~i~~--~~~~~~~- 486 (535)
T 2h8h_A 415 DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR--EV---LDQVER--GYRMPCP- 486 (535)
T ss_dssp CHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHH--HH---HHHHHT--TCCCCCC-
T ss_pred CCceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH--HH---HHHHHc--CCCCCCC-
Confidence 3211 1123346789999999999899999999999999999999 89998654321 11 111111 1111111
Q ss_pred cchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhC
Q 044366 882 RDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLLCK 918 (918)
Q Consensus 882 ~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~ 918 (918)
.. ....+.++|.+||+.||++|||+++|++.|++
T Consensus 487 ~~---~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~ 520 (535)
T 2h8h_A 487 PE---CPESLHDLMCQCWRKEPEERPTFEYLQAFLED 520 (535)
T ss_dssp TT---CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred CC---CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 12 23467889999999999999999999999863
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-38 Score=335.43 Aligned_cols=252 Identities=23% Similarity=0.311 Sum_probs=202.0
Q ss_pred cCCCCce-eeccccceEEEEEEeC---CCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCce
Q 044366 646 GNFGEKY-CIGKGGQRSVYKAELP---SGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHS 721 (918)
Q Consensus 646 ~~~~~~~-~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 721 (918)
++|.+.. .||+|+||.||+|... +++.||||+++.. ......+.+.+|+++++.++||||+++++++ ..+..
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~ 84 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG---TEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEAL 84 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSS---CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSE
T ss_pred HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCc---cchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCc
Confidence 4555555 8999999999999653 6788999998753 1223356799999999999999999999999 45668
Q ss_pred EEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccc
Q 044366 722 FIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKF 801 (918)
Q Consensus 722 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~ 801 (918)
++||||+++++|.+++... ...+++.+++.++.|+++||+|||+. +|+||||||+||+++.++.+||+|||++..
T Consensus 85 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~ 159 (287)
T 1u59_A 85 MLVMEMAGGGPLHKFLVGK--REEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKA 159 (287)
T ss_dssp EEEEECCTTEEHHHHHTTC--TTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEEeCCCCCHHHHHHhC--CccCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCchheEEEcCCCCEEECcccceee
Confidence 9999999999999999753 34589999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCC---ceecccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhhhhhhhhhHhhhhhhcccCC
Q 044366 802 LEPHSSN---WTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIK-GYHPGDFVSTIFSSISNMIIEVNQILDHRL 877 (918)
Q Consensus 802 ~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 877 (918)
....... .....+|+.|+|||++.+..++.++||||||+++|||++ |+.||...... .. .... .....
T Consensus 160 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--~~---~~~i---~~~~~ 231 (287)
T 1u59_A 160 LGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP--EV---MAFI---EQGKR 231 (287)
T ss_dssp CTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH--HH---HHHH---HTTCC
T ss_pred eccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH--HH---HHHH---hcCCc
Confidence 7544322 123346889999999998889999999999999999998 99998654321 01 1111 11111
Q ss_pred CCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 044366 878 PTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLLC 917 (918)
Q Consensus 878 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 917 (918)
+..+.. ....+.+++.+||+.||++||++.|+++.|+
T Consensus 232 ~~~~~~---~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~ 268 (287)
T 1u59_A 232 MECPPE---CPPELYALMSDCWIYKWEDRPDFLTVEQRMR 268 (287)
T ss_dssp CCCCTT---CCHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred CCCCCC---cCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 111112 2346888999999999999999999999885
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-38 Score=336.51 Aligned_cols=253 Identities=25% Similarity=0.342 Sum_probs=197.9
Q ss_pred CCCCceeeccccceEEEEEEeC-CCC---EEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCce-
Q 044366 647 NFGEKYCIGKGGQRSVYKAELP-SGN---IFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHS- 721 (918)
Q Consensus 647 ~~~~~~~lg~G~~g~Vy~~~~~-~~~---~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~- 721 (918)
.|...+.||+|+||.||+|... +++ .||+|.+... ......+.|.+|+++++.++||||+++++++.+.+..
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 98 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRI---TEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLP 98 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTC---CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCC
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeecccc---ccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCc
Confidence 4556688999999999999643 333 7999998652 2223356889999999999999999999999766655
Q ss_pred EEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccc
Q 044366 722 FIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKF 801 (918)
Q Consensus 722 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~ 801 (918)
++||||+.+|+|.+++... ...+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.
T Consensus 99 ~~v~e~~~~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~ 173 (298)
T 3pls_A 99 HVLLPYMCHGDLLQFIRSP--QRNPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFGLARD 173 (298)
T ss_dssp EEEECCCTTCBHHHHHHCT--TCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECCTTSSCT
T ss_pred EEEEecccCCCHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEeCcCCCccc
Confidence 9999999999999999764 34589999999999999999999999 999999999999999999999999999986
Q ss_pred cCCCC----CCceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCC
Q 044366 802 LEPHS----SNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRL 877 (918)
Q Consensus 802 ~~~~~----~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 877 (918)
..... .......+++.|+|||.+.+..++.++||||||+++|+|++|..|+.......... .... ....
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~----~~~~---~~~~ 246 (298)
T 3pls_A 174 ILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLT----HFLA---QGRR 246 (298)
T ss_dssp TTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHH----HHHH---TTCC
T ss_pred ccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHH----HHhh---cCCC
Confidence 64322 12234567899999999999999999999999999999999665533222111111 1111 1111
Q ss_pred CCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 044366 878 PTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLLC 917 (918)
Q Consensus 878 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 917 (918)
....... ...+.+++.+||+.||.+|||++++++.|+
T Consensus 247 ~~~~~~~---~~~l~~li~~~l~~~p~~Rps~~~ll~~l~ 283 (298)
T 3pls_A 247 LPQPEYC---PDSLYQVMQQCWEADPAVRPTFRVLVGEVE 283 (298)
T ss_dssp CCCCTTC---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCCCccc---hHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 1111112 246788999999999999999999999886
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-38 Score=337.47 Aligned_cols=254 Identities=26% Similarity=0.394 Sum_probs=197.9
Q ss_pred hcCCCCceeeccccceEEEEEEeCC----CCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEeccc-ccCC
Q 044366 645 TGNFGEKYCIGKGGQRSVYKAELPS----GNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFC-SNAQ 719 (918)
Q Consensus 645 ~~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~-~~~~ 719 (918)
..+|...+.||+|+||.||+|...+ +..||+|.+... ......+.+.+|+.++++++||||+++++++ ..++
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 100 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI---TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEG 100 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTC---CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSS
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccC---CCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCC
Confidence 3467888999999999999996532 235899988652 2223356799999999999999999999985 5566
Q ss_pred ceEEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccc
Q 044366 720 HSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFA 799 (918)
Q Consensus 720 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~ 799 (918)
..++||||+++|+|.++++.. ...+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 101 ~~~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~ql~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~a 175 (298)
T 3f66_A 101 SPLVVLPYMKHGDLRNFIRNE--THNPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLA 175 (298)
T ss_dssp CCEEEEECCTTCBHHHHHHCT--TCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSCGGG
T ss_pred ceEEEEeCCCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEECCCCCEEECccccc
Confidence 889999999999999999764 34579999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCC----CceecccccccccccccccCCCCcccchhhHHHHHHHHHhC-CCCCCcchhhhhhhhhhHhhhhhhcc
Q 044366 800 KFLEPHSS----NWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKG-YHPGDFVSTIFSSISNMIIEVNQILD 874 (918)
Q Consensus 800 ~~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg-~~p~~~~~~~~~~~~~~~~~~~~~~~ 874 (918)
........ ......+|+.|+|||.+.+..++.++||||+|+++|||++| .+||...... ... . ....
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~-~~~----~---~~~~ 247 (298)
T 3f66_A 176 RDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF-DIT----V---YLLQ 247 (298)
T ss_dssp CCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTT-THH----H---HHHT
T ss_pred ccccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHH-HHH----H---HHhc
Confidence 87654321 12344577899999999999999999999999999999995 5555433211 111 0 1111
Q ss_pred cCCCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 044366 875 HRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLLC 917 (918)
Q Consensus 875 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 917 (918)
.......... ...+.+++.+||+.||++|||++|+++.|+
T Consensus 248 ~~~~~~~~~~---~~~l~~li~~~l~~~p~~Rps~~ell~~L~ 287 (298)
T 3f66_A 248 GRRLLQPEYC---PDPLYEVMLKCWHPKAEMRPSFSELVSRIS 287 (298)
T ss_dssp TCCCCCCTTC---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCCCCCCccC---CHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 1111111112 245888999999999999999999999986
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-38 Score=361.28 Aligned_cols=255 Identities=25% Similarity=0.361 Sum_probs=202.5
Q ss_pred HhcCCCCceeeccccceEEEEEEe-CCCCEEEEEEcccccccCC---------CCChHHHHHHHHHHhhccCCceeeEec
Q 044366 644 ATGNFGEKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDE---------TANPSEFLNEVLALTEIRHRNIIKFHG 713 (918)
Q Consensus 644 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~---------~~~~~~~~~e~~~l~~l~h~niv~~~~ 713 (918)
..++|.+.+.||+|+||.||+|.. .+++.||||++........ ....+.+.+|+.+++.++||||+++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 457899999999999999999965 4689999999876432211 133578999999999999999999999
Q ss_pred ccccCCceEEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCC---c
Q 044366 714 FCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEY---E 790 (918)
Q Consensus 714 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~---~ 790 (918)
++.+++..++||||+++|+|.+++... ..+++.+++.++.||+.||+|||+. +|+||||||+||+++.++ .
T Consensus 114 ~~~~~~~~~lv~e~~~gg~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~ 187 (504)
T 3q5i_A 114 VFEDKKYFYLVTEFYEGGELFEQIINR---HKFDECDAANIMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLLN 187 (504)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESSTTCCSS
T ss_pred EEEcCCEEEEEEecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCcHHHEEEecCCCCcc
Confidence 999999999999999999999998764 3489999999999999999999999 999999999999998876 6
Q ss_pred EEEeccccccccCCCCCCceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhh
Q 044366 791 AHVSDFGFAKFLEPHSSNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVN 870 (918)
Q Consensus 791 ~kl~DfG~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~ 870 (918)
+||+|||++....... ......||+.|+|||++.+ .++.++||||+||++|+|++|+.||...... . . ..
T Consensus 188 ~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-~----~---~~ 257 (504)
T 3q5i_A 188 IKIVDFGLSSFFSKDY-KLRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQ-D----I---IK 257 (504)
T ss_dssp EEECCCTTCEECCTTS-CBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-H----H---HH
T ss_pred EEEEECCCCEEcCCCC-ccccccCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHHhCCCCCCCCCHH-H----H---HH
Confidence 9999999998776432 3345679999999999874 6899999999999999999999998754321 1 1 11
Q ss_pred hhcccCCCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 871 QILDHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 871 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
.+..................+.+++.+||+.||.+|||++|+++
T Consensus 258 ~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~ 301 (504)
T 3q5i_A 258 KVEKGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALN 301 (504)
T ss_dssp HHHHCCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHcCCCCCCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 11111111111111122356889999999999999999999975
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-38 Score=336.16 Aligned_cols=254 Identities=25% Similarity=0.350 Sum_probs=201.2
Q ss_pred HhcCCCCce-eeccccceEEEEEEe---CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCC
Q 044366 644 ATGNFGEKY-CIGKGGQRSVYKAEL---PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQ 719 (918)
Q Consensus 644 ~~~~~~~~~-~lg~G~~g~Vy~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~ 719 (918)
..++|...+ .||+|+||.||+|.. .+++.||||+++... ......+++.+|+++++.++||||+++++++ ..+
T Consensus 14 ~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~ 90 (291)
T 1xbb_A 14 DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA--NDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAE 90 (291)
T ss_dssp CGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-------CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESS
T ss_pred cchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccc--cCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCC
Confidence 345677777 899999999999943 346889999987542 1222357899999999999999999999999 567
Q ss_pred ceEEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccc
Q 044366 720 HSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFA 799 (918)
Q Consensus 720 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~ 799 (918)
..++||||+++++|.+++... ..+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 91 ~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~ 164 (291)
T 1xbb_A 91 SWMLVMEMAELGPLNKYLQQN---RHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLS 164 (291)
T ss_dssp SEEEEEECCTTEEHHHHHHHC---TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTC
T ss_pred CcEEEEEeCCCCCHHHHHHhC---cCCCHHHHHHHHHHHHHHHHHHHhC---CeEcCCCCcceEEEeCCCcEEEccCCcc
Confidence 789999999999999999864 3489999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCCc---eecccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhhhhhhhhhHhhhhhhccc
Q 044366 800 KFLEPHSSNW---TEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIK-GYHPGDFVSTIFSSISNMIIEVNQILDH 875 (918)
Q Consensus 800 ~~~~~~~~~~---~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 875 (918)
.......... ....+++.|+|||.+.+..++.++||||||+++|||++ |+.||...... ... .... ..
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--~~~---~~~~---~~ 236 (291)
T 1xbb_A 165 KALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS--EVT---AMLE---KG 236 (291)
T ss_dssp EECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--HHH---HHHH---TT
T ss_pred eeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHH--HHH---HHHH---cC
Confidence 8775543321 22345788999999998889999999999999999999 99998754321 111 1111 11
Q ss_pred CCCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 044366 876 RLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLLC 917 (918)
Q Consensus 876 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 917 (918)
..+..... ....+.+++.+||+.||++||++.++++.|+
T Consensus 237 ~~~~~~~~---~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~ 275 (291)
T 1xbb_A 237 ERMGCPAG---CPREMYDLMNLCWTYDVENRPGFAAVELRLR 275 (291)
T ss_dssp CCCCCCTT---CCHHHHHHHHHHTCSSTTTSCCHHHHHHHHH
T ss_pred CCCCCCCC---CCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 11111111 2346888999999999999999999999886
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-38 Score=348.10 Aligned_cols=257 Identities=23% Similarity=0.332 Sum_probs=203.0
Q ss_pred hcCCCCceeeccccceEEEEEEe----CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhc-cCCceeeEecccccCC
Q 044366 645 TGNFGEKYCIGKGGQRSVYKAEL----PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEI-RHRNIIKFHGFCSNAQ 719 (918)
Q Consensus 645 ~~~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~ 719 (918)
.++|...+.||+|+||.||+|+. .+|+.||||+++...........+.+.+|+++++.+ +||||+++++++..++
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 36799999999999999999976 478999999987644333333456678899999999 6999999999999999
Q ss_pred ceEEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccc
Q 044366 720 HSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFA 799 (918)
Q Consensus 720 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~ 799 (918)
..++||||+++|+|.+++.... .+++.+++.++.||+.||+|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 133 ~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~DfG~a 206 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLSQRE---RFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLS 206 (355)
T ss_dssp EEEEEECCCCSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred eEEEEeecCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCcEEEeeCCCC
Confidence 9999999999999999997643 489999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCC-Cceeccccccccccccccc--CCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccC
Q 044366 800 KFLEPHSS-NWTEFAGTVGYAAPELAYT--MRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHR 876 (918)
Q Consensus 800 ~~~~~~~~-~~~~~~g~~~y~aPE~~~~--~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 876 (918)
+.+..... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||....... ...... .......
T Consensus 207 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~-~~~~~~---~~~~~~~ 282 (355)
T 1vzo_A 207 KEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKN-SQAEIS---RRILKSE 282 (355)
T ss_dssp EECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCC-CHHHHH---HHHHHCC
T ss_pred eecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccc-hHHHHH---HHHhccC
Confidence 87643322 2334579999999999985 347889999999999999999999986432211 001111 1111111
Q ss_pred CCCCCcchHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 044366 877 LPTPSRDVTDKLRSIMEVAILCLVENPEARP-----TMKEVCNL 915 (918)
Q Consensus 877 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~RP-----t~~evl~~ 915 (918)
.+ .... ....+.+++.+||+.||++|| +++|+++.
T Consensus 283 ~~-~~~~---~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h 322 (355)
T 1vzo_A 283 PP-YPQE---MSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 322 (355)
T ss_dssp CC-CCTT---SCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred CC-CCcc---cCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcC
Confidence 11 1111 224578899999999999999 99999763
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-38 Score=334.59 Aligned_cols=254 Identities=22% Similarity=0.327 Sum_probs=199.8
Q ss_pred HhcCCCCceeeccccceEEEEEEeCC----CCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCC
Q 044366 644 ATGNFGEKYCIGKGGQRSVYKAELPS----GNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQ 719 (918)
Q Consensus 644 ~~~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~ 719 (918)
..++|...+.||+|+||.||+|.... +..||+|.++... .....+.|.+|+.+++.++||||+++++++.+ +
T Consensus 10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~ 85 (281)
T 3cc6_A 10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC---TLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-E 85 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS---CHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-S
T ss_pred cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc---CchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-C
Confidence 45678899999999999999996432 3469999987532 22235789999999999999999999999865 4
Q ss_pred ceEEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccc
Q 044366 720 HSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFA 799 (918)
Q Consensus 720 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~ 799 (918)
..++||||+++++|.+++... ...+++.+++.++.|+++||+|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 86 ~~~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 160 (281)
T 3cc6_A 86 PTWIIMELYPYGELGHYLERN--KNSLKVLTLVLYSLQICKAMAYLESI---NCVHRDIAVRNILVASPECVKLGDFGLS 160 (281)
T ss_dssp SCEEEEECCTTCBHHHHHHHH--TTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEEETTEEEECCCCGG
T ss_pred CCEEEEecCCCCCHHHHHHhc--cccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEECCCCcEEeCccCCC
Confidence 568999999999999999764 24589999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCC-CceecccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhhhhhhhhhHhhhhhhcccCC
Q 044366 800 KFLEPHSS-NWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIK-GYHPGDFVSTIFSSISNMIIEVNQILDHRL 877 (918)
Q Consensus 800 ~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 877 (918)
........ ......+++.|+|||++.+..++.++||||||+++|||++ |+.||...... ... ...... ...
T Consensus 161 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~--~~~---~~~~~~--~~~ 233 (281)
T 3cc6_A 161 RYIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENK--DVI---GVLEKG--DRL 233 (281)
T ss_dssp GCC---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGG--GHH---HHHHHT--CCC
T ss_pred cccccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChH--HHH---HHHhcC--CCC
Confidence 87654332 2233456889999999998899999999999999999998 99998643321 011 111110 111
Q ss_pred CCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 044366 878 PTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLLC 917 (918)
Q Consensus 878 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 917 (918)
+. ... ....+.+++.+||+.||++|||++|+++.|+
T Consensus 234 ~~-~~~---~~~~l~~li~~~l~~~p~~Rps~~ell~~L~ 269 (281)
T 3cc6_A 234 PK-PDL---CPPVLYTLMTRCWDYDPSDRPRFTELVCSLS 269 (281)
T ss_dssp CC-CTT---CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CC-CCC---CCHHHHHHHHHHccCCchhCcCHHHHHHHHH
Confidence 11 111 2245888999999999999999999999886
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=333.22 Aligned_cols=249 Identities=24% Similarity=0.372 Sum_probs=205.0
Q ss_pred hcCCCCceeeccccceEEEEEEeC-CCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEE
Q 044366 645 TGNFGEKYCIGKGGQRSVYKAELP-SGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFI 723 (918)
Q Consensus 645 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 723 (918)
.++|...+.||+|+||.||+|... +++.||+|++....... ....+.+.+|+++++.++||||+++++++.+++..++
T Consensus 13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 91 (284)
T 2vgo_A 13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEK-EGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYL 91 (284)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHH-TTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccch-HHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEE
Confidence 467889999999999999999654 68899999986543222 2335789999999999999999999999999999999
Q ss_pred EEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccC
Q 044366 724 VCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLE 803 (918)
Q Consensus 724 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~ 803 (918)
||||+++|+|.+++.... .+++.+++.++.|++.||+|||+. +++||||||+||+++.++.+||+|||++....
T Consensus 92 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~ 165 (284)
T 2vgo_A 92 MLEFAPRGELYKELQKHG---RFDEQRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHAP 165 (284)
T ss_dssp EECCCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTCCEEECCCTTCEECS
T ss_pred EEEeCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEEcCCCCEEEecccccccCc
Confidence 999999999999997643 489999999999999999999999 99999999999999999999999999997654
Q ss_pred CCCCCceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCCCCCcc
Q 044366 804 PHSSNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRD 883 (918)
Q Consensus 804 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 883 (918)
.. ......|++.|+|||++.+..++.++||||||+++|+|++|+.||....... . ...+.......+ ..
T Consensus 166 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~-------~~~~~~~~~~~~-~~ 234 (284)
T 2vgo_A 166 SL--RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTE-T-------HRRIVNVDLKFP-PF 234 (284)
T ss_dssp SS--CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH-H-------HHHHHTTCCCCC-TT
T ss_pred cc--ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhH-H-------HHHHhccccCCC-Cc
Confidence 32 2234578999999999999899999999999999999999999987543211 0 011111111111 11
Q ss_pred hHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 884 VTDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 884 ~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
....+.+++.+|++.||.+|||++|+++
T Consensus 235 ---~~~~~~~li~~~l~~~p~~Rps~~~ll~ 262 (284)
T 2vgo_A 235 ---LSDGSKDLISKLLRYHPPQRLPLKGVME 262 (284)
T ss_dssp ---SCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ---CCHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence 1245788999999999999999999985
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-38 Score=340.62 Aligned_cols=262 Identities=23% Similarity=0.332 Sum_probs=196.1
Q ss_pred HHHHHhcCCCCceeeccccceEEEEEEeC----CCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEeccc
Q 044366 640 EITKATGNFGEKYCIGKGGQRSVYKAELP----SGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFC 715 (918)
Q Consensus 640 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~ 715 (918)
++....++|...+.||+|+||.||+|... +++.||+|+++.... .....+.+.+|+.++++++||||+++++++
T Consensus 28 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 105 (313)
T 3brb_A 28 DVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNS--SQREIEEFLSEAACMKDFSHPNVIRLLGVC 105 (313)
T ss_dssp TTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CC--CHHHHHHHHHHHHHHHTCCCTTBCCCCEEE
T ss_pred hcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEecccc--chhHHHHHHHHHHHHhcCCCCCeeeeeEEE
Confidence 33445678889999999999999999553 345899999875321 122246799999999999999999999998
Q ss_pred ccCC-----ceEEEEEeccCCChhHHhhcc---cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCC
Q 044366 716 SNAQ-----HSFIVCEYLARGSLTTILRDD---AAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDS 787 (918)
Q Consensus 716 ~~~~-----~~~lv~e~~~~gsL~~~l~~~---~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~ 787 (918)
.+.+ ..++||||+++|+|.+++... .....+++.+++.++.|+++||+|||+. +|+||||||+||+++.
T Consensus 106 ~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~ 182 (313)
T 3brb_A 106 IEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCMLRD 182 (313)
T ss_dssp EC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCSGGGEEECT
T ss_pred eeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcC
Confidence 7654 359999999999999998543 2235689999999999999999999999 9999999999999999
Q ss_pred CCcEEEeccccccccCCCCC--CceecccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhhhhhhhh
Q 044366 788 EYEAHVSDFGFAKFLEPHSS--NWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIK-GYHPGDFVSTIFSSISN 864 (918)
Q Consensus 788 ~~~~kl~DfG~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~p~~~~~~~~~~~~~ 864 (918)
++.+||+|||++........ ......+++.|+|||.+.+..++.++||||||+++|||++ |..||...... .
T Consensus 183 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~--~--- 257 (313)
T 3brb_A 183 DMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNH--E--- 257 (313)
T ss_dssp TSCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG--G---
T ss_pred CCcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHH--H---
Confidence 99999999999987654322 1233456889999999999999999999999999999999 88887654321 0
Q ss_pred hHhhhhhhcccCCCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 044366 865 MIIEVNQILDHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLLC 917 (918)
Q Consensus 865 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 917 (918)
... .......+..... ....+.+++.+||+.||++|||++++++.|+
T Consensus 258 ~~~---~~~~~~~~~~~~~---~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~ 304 (313)
T 3brb_A 258 MYD---YLLHGHRLKQPED---CLDELYEIMYSCWRTDPLDRPTFSVLRLQLE 304 (313)
T ss_dssp HHH---HHHTTCCCCCBTT---CCHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred HHH---HHHcCCCCCCCcc---ccHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 011 1111111111111 2346888999999999999999999999886
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-38 Score=344.47 Aligned_cols=262 Identities=23% Similarity=0.344 Sum_probs=198.4
Q ss_pred hcCCCCceeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEE
Q 044366 645 TGNFGEKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFI 723 (918)
Q Consensus 645 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 723 (918)
.++|...+.||+|+||.||+|.. .+|+.||||++.... ......+.+.+|+++++.++||||+++++++.+.+..++
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 101 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESD--DDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYL 101 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCS--SCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCC--CchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEE
Confidence 46788999999999999999965 469999999986531 122224568899999999999999999999999999999
Q ss_pred EEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccC
Q 044366 724 VCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLE 803 (918)
Q Consensus 724 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~ 803 (918)
||||+++++|.++.... ..+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++....
T Consensus 102 v~e~~~~~~l~~~~~~~---~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 175 (331)
T 4aaa_A 102 VFEFVDHTILDDLELFP---NGLDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLA 175 (331)
T ss_dssp EEECCSEEHHHHHHHST---TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCTTC----
T ss_pred EEecCCcchHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHHC---CEEccCcChheEEEcCCCcEEEEeCCCceeec
Confidence 99999999998887643 3489999999999999999999999 99999999999999999999999999998776
Q ss_pred CCCCCceecccccccccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhH-------------hhh
Q 044366 804 PHSSNWTEFAGTVGYAAPELAYTM-RATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMI-------------IEV 869 (918)
Q Consensus 804 ~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~-------------~~~ 869 (918)
..........|++.|+|||++.+. .++.++||||+|+++|+|++|+.||.............. ...
T Consensus 176 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (331)
T 4aaa_A 176 APGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKN 255 (331)
T ss_dssp --------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHC
T ss_pred CCccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhc
Confidence 555445566789999999998875 689999999999999999999999875543211110000 000
Q ss_pred hhhcccCCCCCCc--c----hHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 870 NQILDHRLPTPSR--D----VTDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 870 ~~~~~~~~~~~~~--~----~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
........+.... . .......+.+++.+||+.||++|||++|+++
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 306 (331)
T 4aaa_A 256 PVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH 306 (331)
T ss_dssp GGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred cccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 0000011111100 0 1122457889999999999999999999875
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=342.83 Aligned_cols=261 Identities=21% Similarity=0.316 Sum_probs=200.0
Q ss_pred hcCCCCceeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEeccccc------
Q 044366 645 TGNFGEKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSN------ 717 (918)
Q Consensus 645 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~------ 717 (918)
.++|...+.||+|+||.||+|+. .+|+.||||++..... .......+.+|+++++.++||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 93 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENE--KEGFPITALREIKILQLLKHENVVNLIEICRTKASPYN 93 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSC--SSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-----
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccc--cccchHHHHHHHHHHHhccCCCcccHhheeeccccccc
Confidence 46899999999999999999965 5799999999866432 23335678999999999999999999999866
Q ss_pred --CCceEEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEec
Q 044366 718 --AQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSD 795 (918)
Q Consensus 718 --~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~D 795 (918)
.+..++||||+++ ++.+.+.... ..+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|
T Consensus 94 ~~~~~~~lv~e~~~~-~l~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~kl~D 167 (351)
T 3mi9_A 94 RCKGSIYLVFDFCEH-DLAGLLSNVL--VKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLAD 167 (351)
T ss_dssp ---CEEEEEEECCSE-EHHHHHHCTT--SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECC
T ss_pred cCCceEEEEEeccCC-CHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCCEEEcc
Confidence 4468999999985 7877776542 3589999999999999999999999 999999999999999999999999
Q ss_pred cccccccCCCC----CCceeccccccccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhh
Q 044366 796 FGFAKFLEPHS----SNWTEFAGTVGYAAPELAYT-MRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVN 870 (918)
Q Consensus 796 fG~~~~~~~~~----~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~ 870 (918)
||+++.+.... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||....... ..........
T Consensus 168 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-~~~~i~~~~~ 246 (351)
T 3mi9_A 168 FGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQH-QLALISQLCG 246 (351)
T ss_dssp CTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHC
T ss_pred chhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhC
Confidence 99998765322 22345678999999999876 457999999999999999999999987543211 0110000000
Q ss_pred hhcccC---------------CCCCCcchHHH------HHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 871 QILDHR---------------LPTPSRDVTDK------LRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 871 ~~~~~~---------------~~~~~~~~~~~------~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
...... .........+. ...+.+++.+||+.||++|||++|+++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 311 (351)
T 3mi9_A 247 SITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 311 (351)
T ss_dssp CCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence 000000 00001111111 245889999999999999999999985
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=367.10 Aligned_cols=245 Identities=22% Similarity=0.322 Sum_probs=195.3
Q ss_pred eeccccceEEEEEEeC---CCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEEEEEecc
Q 044366 653 CIGKGGQRSVYKAELP---SGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFIVCEYLA 729 (918)
Q Consensus 653 ~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 729 (918)
.||+|+||.||+|.+. ++..||||+++.. ......++|.+|+++++.++||||+++++++.. +..++||||++
T Consensus 343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~---~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~ 418 (613)
T 2ozo_A 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG---TEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAG 418 (613)
T ss_dssp EEEECSSSEEEEEEEECSSCEEEEEEEECCCC---CSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCT
T ss_pred EEecCCCcEEEEEEEecCCCcEEEEEEEcCCC---CChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCC
Confidence 7999999999999653 4667999998764 233456889999999999999999999999976 56899999999
Q ss_pred CCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccCCCCCCc
Q 044366 730 RGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNW 809 (918)
Q Consensus 730 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~~~~~~~ 809 (918)
+|+|.+++... ...+++.+++.++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++.+.......
T Consensus 419 ~g~L~~~l~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 493 (613)
T 2ozo_A 419 GGPLHKFLVGK--REEIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYY 493 (613)
T ss_dssp TCBHHHHHTTC--TTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCSTTTTCC------
T ss_pred CCcHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCcee
Confidence 99999999754 34589999999999999999999999 99999999999999999999999999998765433221
Q ss_pred ---eecccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhhhhhhhhhHhhhhhhcccCCCCCCcchH
Q 044366 810 ---TEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIK-GYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRDVT 885 (918)
Q Consensus 810 ---~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 885 (918)
....+++.|+|||++.+..++.++|||||||++|||++ |+.||...... .+. .. +........+..
T Consensus 494 ~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~--~~~---~~---i~~~~~~~~p~~-- 563 (613)
T 2ozo_A 494 TARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP--EVM---AF---IEQGKRMECPPE-- 563 (613)
T ss_dssp --------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSH--HHH---HH---HHTTCCCCCCTT--
T ss_pred eeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHH--HHH---HH---HHcCCCCCCCCc--
Confidence 22345689999999999999999999999999999998 99998754321 111 11 111111111112
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 044366 886 DKLRSIMEVAILCLVENPEARPTMKEVCNLLC 917 (918)
Q Consensus 886 ~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 917 (918)
....+.+++.+||+.||++||++++|++.|+
T Consensus 564 -~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~ 594 (613)
T 2ozo_A 564 -CPPELYALMSDCWIYKWEDRPDFLTVEQRMR 594 (613)
T ss_dssp -CCHHHHHHHHHTTCSSTTTSCCHHHHHHHHH
T ss_pred -CCHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence 2356888999999999999999999999885
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=350.51 Aligned_cols=258 Identities=17% Similarity=0.224 Sum_probs=200.0
Q ss_pred hcCCCCceeeccccceEEEEEEeC---------CCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceee-----
Q 044366 645 TGNFGEKYCIGKGGQRSVYKAELP---------SGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIK----- 710 (918)
Q Consensus 645 ~~~~~~~~~lg~G~~g~Vy~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~----- 710 (918)
.++|...+.||+|+||.||+|... +++.||||++... +.+.+|++++++++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~---------~~~~~E~~~l~~l~h~niv~~~~~~ 111 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD---------GRLFNEQNFFQRAAKPLQVNKWKKL 111 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT---------STHHHHHHHHHHHCCHHHHHHHHHH
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc---------chHHHHHHHHHHhcccchhhhhhhh
Confidence 368999999999999999999765 3789999998642 35789999999999999998
Q ss_pred ----------Eeccccc-CCceEEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCC
Q 044366 711 ----------FHGFCSN-AQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDIS 779 (918)
Q Consensus 711 ----------~~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk 779 (918)
+++++.. ++..++||||+ +++|.+++.... ...+++.+++.++.||+.||+|||+. +|+|||||
T Consensus 112 ~~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dik 186 (352)
T 2jii_A 112 YSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSP-KHVLSERSVLQVACRLLDALEFLHEN---EYVHGNVT 186 (352)
T ss_dssp TTCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCC
T ss_pred ccCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCC-cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCC
Confidence 4555544 67889999999 899999998642 34589999999999999999999999 99999999
Q ss_pred CCCeeeCCCC--cEEEeccccccccCCCCC-------CceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCC
Q 044366 780 SKNVLLDSEY--EAHVSDFGFAKFLEPHSS-------NWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYH 850 (918)
Q Consensus 780 ~~Nill~~~~--~~kl~DfG~~~~~~~~~~-------~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~ 850 (918)
|+||+++.++ .+||+|||+++.+..... ......||+.|+|||++.+..++.++||||||+++|||++|+.
T Consensus 187 p~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~ 266 (352)
T 2jii_A 187 AENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFL 266 (352)
T ss_dssp GGGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCC
T ss_pred HHHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCC
Confidence 9999999998 899999999987654322 1233478999999999999899999999999999999999999
Q ss_pred CCCcchhhhhhhhhhHhhhhhhcccCCCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 044366 851 PGDFVSTIFSSISNMIIEVNQILDHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLLC 917 (918)
Q Consensus 851 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 917 (918)
||.........+............. ..............+.+++.+||+.||++|||++++++.|+
T Consensus 267 pf~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~ 332 (352)
T 2jii_A 267 PWTNCLPNTEDIMKQKQKFVDKPGP-FVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLE 332 (352)
T ss_dssp TTGGGTTCHHHHHHHHHHHHHSCCC-EECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHH
T ss_pred CcccCCcCHHHHHHHHHhccCChhh-hhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHH
Confidence 9875432222222211111111000 00000000112356888999999999999999999999885
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-38 Score=348.83 Aligned_cols=249 Identities=16% Similarity=0.125 Sum_probs=200.0
Q ss_pred HHhcCCCCceeeccccceEEEEE------EeCCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhcc---CCceeeEec
Q 044366 643 KATGNFGEKYCIGKGGQRSVYKA------ELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIR---HRNIIKFHG 713 (918)
Q Consensus 643 ~~~~~~~~~~~lg~G~~g~Vy~~------~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~~~~ 713 (918)
...++|.+.+.||+|+||.||+| ...+++.||||+++.. ...++..|+++++.++ |+||+++++
T Consensus 62 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-------~~~~~~~e~~~~~~l~~~~~~~iv~~~~ 134 (365)
T 3e7e_A 62 LGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA-------NPWEFYIGTQLMERLKPSMQHMFMKFYS 134 (365)
T ss_dssp CSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC-------CHHHHHHHHHHHHHSCGGGGGGBCCEEE
T ss_pred ECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC-------ChhHHHHHHHHHHHhhhhhhhhhhhhhe
Confidence 34577999999999999999999 3457899999998642 3567888888888886 999999999
Q ss_pred ccccCCceEEEEEeccCCChhHHhhccc--ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCC----
Q 044366 714 FCSNAQHSFIVCEYLARGSLTTILRDDA--AAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDS---- 787 (918)
Q Consensus 714 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~--~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~---- 787 (918)
++..++..++||||+++|+|.+++.... ....+++.+++.|+.||+.||+|||+. +||||||||+||+++.
T Consensus 135 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~ivHrDiKp~NIll~~~~~~ 211 (365)
T 3e7e_A 135 AHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLE 211 (365)
T ss_dssp EEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECGGGTC
T ss_pred eeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEecccccC
Confidence 9999999999999999999999997532 245699999999999999999999999 9999999999999998
Q ss_pred -------CCcEEEeccccccccCC--CCCCceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhh
Q 044366 788 -------EYEAHVSDFGFAKFLEP--HSSNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTI 858 (918)
Q Consensus 788 -------~~~~kl~DfG~~~~~~~--~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~ 858 (918)
++.+||+|||+|+.+.. .........||+.|+|||++.+..++.++|||||||++|||++|+.||......
T Consensus 212 ~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~ 291 (365)
T 3e7e_A 212 QDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGG 291 (365)
T ss_dssp C------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETT
T ss_pred ccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCC
Confidence 89999999999976542 223345567999999999999999999999999999999999999997533221
Q ss_pred hhhhhhhHhhhhhhcccCCCCCCcchHHHHHHHHHHHHHcccCCCCCC-CCHHHHHHHhh
Q 044366 859 FSSISNMIIEVNQILDHRLPTPSRDVTDKLRSIMEVAILCLVENPEAR-PTMKEVCNLLC 917 (918)
Q Consensus 859 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~R-Pt~~evl~~L~ 917 (918)
. .......... .. ...+.+++..|++.+|.+| |++.++.+.|+
T Consensus 292 ~-----------~~~~~~~~~~--~~---~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~ 335 (365)
T 3e7e_A 292 E-----------CKPEGLFRRL--PH---LDMWNEFFHVMLNIPDCHHLPSLDLLRQKLK 335 (365)
T ss_dssp E-----------EEECSCCTTC--SS---HHHHHHHHHHHHCCCCTTCCCCHHHHHHHHH
T ss_pred c-----------eeechhcccc--Cc---HHHHHHHHHHHcCCCCCCcchHHHHHHHHHH
Confidence 0 0011111111 11 2356678888999999998 57777776654
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-38 Score=341.13 Aligned_cols=254 Identities=25% Similarity=0.370 Sum_probs=200.4
Q ss_pred cCCCCceeeccccceEEEEEEe-CCCCEE--EEEEcccccccCCCCChHHHHHHHHHHhhc-cCCceeeEecccccCCce
Q 044366 646 GNFGEKYCIGKGGQRSVYKAEL-PSGNIF--AVKKFKAELFSDETANPSEFLNEVLALTEI-RHRNIIKFHGFCSNAQHS 721 (918)
Q Consensus 646 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~v--avK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~ 721 (918)
++|...+.||+|+||.||+|+. .+|+.+ |+|.++... .....+.+.+|+++++++ +||||+++++++.+++..
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~ 101 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA---SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYL 101 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC---------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeecccc---chHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCce
Confidence 6788999999999999999965 456644 999886432 223456799999999999 899999999999999999
Q ss_pred EEEEEeccCCChhHHhhccc-------------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCC
Q 044366 722 FIVCEYLARGSLTTILRDDA-------------AAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSE 788 (918)
Q Consensus 722 ~lv~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~ 788 (918)
++||||+++|+|.+++.... ....+++.+++.++.|++.||+|||+. +|+||||||+||+++.+
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~ 178 (327)
T 1fvr_A 102 YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGEN 178 (327)
T ss_dssp EEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGG
T ss_pred EEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCccceEEEcCC
Confidence 99999999999999997643 234689999999999999999999999 99999999999999999
Q ss_pred CcEEEeccccccccCCCCCCceecccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhhhhhhhhhHh
Q 044366 789 YEAHVSDFGFAKFLEPHSSNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIK-GYHPGDFVSTIFSSISNMII 867 (918)
Q Consensus 789 ~~~kl~DfG~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~p~~~~~~~~~~~~~~~~ 867 (918)
+.+||+|||+++...... ......+++.|+|||++.+..++.++||||||+++|||++ |+.||...... ....
T Consensus 179 ~~~kL~Dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~-----~~~~ 252 (327)
T 1fvr_A 179 YVAKIADFGLSRGQEVYV-KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA-----ELYE 252 (327)
T ss_dssp GCEEECCTTCEESSCEEC-CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-----HHHH
T ss_pred CeEEEcccCcCccccccc-cccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHH-----HHHH
Confidence 999999999997543221 1233456889999999998889999999999999999998 99998654321 0111
Q ss_pred hhhhhcccCCCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 044366 868 EVNQILDHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLLC 917 (918)
Q Consensus 868 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 917 (918)
. +........... ....+.+++.+||+.||++|||++|+++.|.
T Consensus 253 ~---~~~~~~~~~~~~---~~~~l~~li~~~l~~dp~~Rps~~ell~~L~ 296 (327)
T 1fvr_A 253 K---LPQGYRLEKPLN---CDDEVYDLMRQCWREKPYERPSFAQILVSLN 296 (327)
T ss_dssp H---GGGTCCCCCCTT---BCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred H---hhcCCCCCCCCC---CCHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 1 111111111111 2246888999999999999999999999875
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=334.32 Aligned_cols=248 Identities=21% Similarity=0.321 Sum_probs=200.0
Q ss_pred HhcCCCCceeeccccceEEEEEEeC-CCCEEEEEEcccccccCCCCChHHHHHHHHHHhhc-cCCceeeEecccccCCce
Q 044366 644 ATGNFGEKYCIGKGGQRSVYKAELP-SGNIFAVKKFKAELFSDETANPSEFLNEVLALTEI-RHRNIIKFHGFCSNAQHS 721 (918)
Q Consensus 644 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~ 721 (918)
..++|...+.||+|+||.||+|... +++.||||+++.... ......++.+|+..+..+ +||||+++++++.+++..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~ 86 (289)
T 1x8b_A 9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLA--GSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHM 86 (289)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCT--TSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEE
T ss_pred ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEeccccc--ccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeE
Confidence 3567999999999999999999654 799999999875322 223356789999999999 999999999999999999
Q ss_pred EEEEEeccCCChhHHhhcccc-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCC------------
Q 044366 722 FIVCEYLARGSLTTILRDDAA-AKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSE------------ 788 (918)
Q Consensus 722 ~lv~e~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~------------ 788 (918)
++||||+++|+|.+++..... ...+++.+++.++.||+.||+|||+. +|+||||||+||+++.+
T Consensus 87 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~~~~~~~~~~ 163 (289)
T 1x8b_A 87 LIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDE 163 (289)
T ss_dssp EEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC--------------
T ss_pred EEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeecCCCHHHEEEcCCCCCccccccccc
Confidence 999999999999999976432 24589999999999999999999999 99999999999999844
Q ss_pred -------CcEEEeccccccccCCCCCCceecccccccccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCcchhhhh
Q 044366 789 -------YEAHVSDFGFAKFLEPHSSNWTEFAGTVGYAAPELAYTM-RATEKYDVYSFGVLALEVIKGYHPGDFVSTIFS 860 (918)
Q Consensus 789 -------~~~kl~DfG~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~ 860 (918)
..+||+|||.+....... ...|++.|+|||++.+. .++.++||||||+++|+|++|.+|+......
T Consensus 164 ~~~~~~~~~~kl~Dfg~~~~~~~~~----~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~-- 237 (289)
T 1x8b_A 164 DDWASNKVMFKIGDLGHVTRISSPQ----VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQW-- 237 (289)
T ss_dssp ------CCCEEECCCTTCEETTCSC----CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHHH--
T ss_pred ccccCCceEEEEcccccccccCCcc----ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhHH--
Confidence 479999999998775432 23589999999998765 5668999999999999999998875433211
Q ss_pred hhhhhHhhhhhhcccCCCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 861 SISNMIIEVNQILDHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 861 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
..+.....+..+... ...+.+++.+||+.||++|||++|+++
T Consensus 238 ---------~~~~~~~~~~~~~~~---~~~~~~li~~~l~~dp~~Rps~~~ll~ 279 (289)
T 1x8b_A 238 ---------HEIRQGRLPRIPQVL---SQEFTELLKVMIHPDPERRPSAMALVK 279 (289)
T ss_dssp ---------HHHHTTCCCCCSSCC---CHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ---------HHHHcCCCCCCCccc---CHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence 111112222222222 245788999999999999999999985
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=339.59 Aligned_cols=254 Identities=24% Similarity=0.387 Sum_probs=196.8
Q ss_pred HHHhcCCCCceeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhc-cCCceeeEeccccc--
Q 044366 642 TKATGNFGEKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEI-RHRNIIKFHGFCSN-- 717 (918)
Q Consensus 642 ~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~-- 717 (918)
....++|...+.||+|+||.||+|.. .+|+.||||++... ....+.+.+|+.+++++ +||||+++++++..
T Consensus 20 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-----~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 94 (326)
T 2x7f_A 20 RDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-----GDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKN 94 (326)
T ss_dssp CCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-----SSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC
T ss_pred cCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecC-----cccHHHHHHHHHHHHhccCCCCeeeeeeEEeecc
Confidence 34568899999999999999999965 57999999998642 23357899999999999 89999999999865
Q ss_pred ----CCceEEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEE
Q 044366 718 ----AQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHV 793 (918)
Q Consensus 718 ----~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl 793 (918)
.+..++||||+++|+|.+++.... ...+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||
T Consensus 95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~kl 170 (326)
T 2x7f_A 95 PPGMDDQLWLVMEFCGAGSVTDLIKNTK-GNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKL 170 (326)
T ss_dssp --CCCCEEEEEEECCTTEEHHHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEE
T ss_pred CccccceEEEEEEcCCCCcHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCcHHHEEEcCCCCEEE
Confidence 467899999999999999998653 34589999999999999999999999 9999999999999999999999
Q ss_pred eccccccccCCCCCCceecccccccccccccc-----cCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhh
Q 044366 794 SDFGFAKFLEPHSSNWTEFAGTVGYAAPELAY-----TMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIE 868 (918)
Q Consensus 794 ~DfG~~~~~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~ 868 (918)
+|||++..............|++.|+|||++. +..++.++||||||+++|+|++|+.||........ ...
T Consensus 171 ~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-----~~~ 245 (326)
T 2x7f_A 171 VDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRA-----LFL 245 (326)
T ss_dssp CCCTTTC-------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHH-----HHH
T ss_pred eeCcCceecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHH-----HHH
Confidence 99999987755443444567899999999986 56688999999999999999999999865432111 011
Q ss_pred hhhhcccCCCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 869 VNQILDHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 869 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
... ........... ...+.+++.+||+.||.+|||++|+++
T Consensus 246 ~~~--~~~~~~~~~~~---~~~l~~li~~~l~~dp~~Rps~~~ll~ 286 (326)
T 2x7f_A 246 IPR--NPAPRLKSKKW---SKKFQSFIESCLVKNHSQRPATEQLMK 286 (326)
T ss_dssp HHH--SCCCCCSCSCS---CHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred hhc--CccccCCcccc---CHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 111 11111111112 246788999999999999999999986
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=344.65 Aligned_cols=256 Identities=20% Similarity=0.296 Sum_probs=193.9
Q ss_pred hcCCCCceeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCC----
Q 044366 645 TGNFGEKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQ---- 719 (918)
Q Consensus 645 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~---- 719 (918)
.++|...+.||+|+||.||+|.. .+|+.||||++.... ......+.+.+|+++++.++||||+++++++...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~ 101 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF--QSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDD 101 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTT--SSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTT
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccc--cCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCcccc
Confidence 46799999999999999999965 579999999986532 12223467899999999999999999999986653
Q ss_pred --ceEEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccc
Q 044366 720 --HSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFG 797 (918)
Q Consensus 720 --~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG 797 (918)
..++||||+ +++|.++++.. .+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 102 ~~~~~lv~e~~-~~~L~~~~~~~----~l~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg 173 (367)
T 1cm8_A 102 FTDFYLVMPFM-GTDLGKLMKHE----KLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFG 173 (367)
T ss_dssp CCCCEEEEECC-SEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCT
T ss_pred CceEEEEEecC-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCHHHEEEcCCCCEEEEeee
Confidence 469999999 78999999753 489999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCCceeccccccccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHh---------
Q 044366 798 FAKFLEPHSSNWTEFAGTVGYAAPELAYT-MRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMII--------- 867 (918)
Q Consensus 798 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~--------- 867 (918)
+++..... .....+|+.|+|||++.+ ..++.++||||+||++|||++|+.||....... .......
T Consensus 174 ~a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-~l~~i~~~~g~~~~~~ 249 (367)
T 1cm8_A 174 LARQADSE---MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLD-QLKEIMKVTGTPPAEF 249 (367)
T ss_dssp TCEECCSS---CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHHHCCCCHHH
T ss_pred cccccccc---cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHhcCCCCHHH
Confidence 99876532 334578999999999877 678999999999999999999999987543211 1110000
Q ss_pred ----------hhhhhcccCC-CCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 868 ----------EVNQILDHRL-PTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 868 ----------~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
.......... .............+.+++.+|++.||++|||++|+++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~ 307 (367)
T 1cm8_A 250 VQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 307 (367)
T ss_dssp HHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhc
Confidence 0000000000 0000011122356889999999999999999999986
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-38 Score=340.25 Aligned_cols=253 Identities=23% Similarity=0.336 Sum_probs=198.6
Q ss_pred HhcCCCCceeeccccceEEEEEEeC-CCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceE
Q 044366 644 ATGNFGEKYCIGKGGQRSVYKAELP-SGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSF 722 (918)
Q Consensus 644 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 722 (918)
..++|++.+.||+|+||.||+|... +|+.||+|++... .....+.+.+|+++++.++||||+++++++..++..+
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 92 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETK----SEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLW 92 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC--------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEE
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCC----CHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEE
Confidence 3467899999999999999999664 6899999998653 3344688999999999999999999999999999999
Q ss_pred EEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEecccccccc
Q 044366 723 IVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFL 802 (918)
Q Consensus 723 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~ 802 (918)
+||||+++++|.+++... ...+++.+++.++.|++.||+|||+. +++||||||+||+++.++.+||+|||++...
T Consensus 93 lv~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 167 (302)
T 2j7t_A 93 IMIEFCPGGAVDAIMLEL--DRGLTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKN 167 (302)
T ss_dssp EEEECCTTEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTSCEEECCCHHHHHH
T ss_pred EEEEeCCCCcHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEECCCCCEEEEECCCCccc
Confidence 999999999999998753 24589999999999999999999999 9999999999999999999999999998643
Q ss_pred CCCCCCceecccccccccccccc-----cCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCC
Q 044366 803 EPHSSNWTEFAGTVGYAAPELAY-----TMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRL 877 (918)
Q Consensus 803 ~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 877 (918)
...........|++.|+|||++. +..++.++||||||+++|+|++|+.||........ ... ......
T Consensus 168 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-----~~~---~~~~~~ 239 (302)
T 2j7t_A 168 LKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV-----LLK---IAKSDP 239 (302)
T ss_dssp HHHHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH-----HHH---HHHSCC
T ss_pred cccccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHH-----HHH---HhccCC
Confidence 22212223456899999999883 56788999999999999999999999865432110 011 111111
Q ss_pred CCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 878 PTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 878 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
+.. .........+.+++.+||+.||++|||++|+++
T Consensus 240 ~~~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 240 PTL-LTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp CCC-SSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred ccc-CCccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 110 111122356888999999999999999999975
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=331.96 Aligned_cols=248 Identities=21% Similarity=0.320 Sum_probs=197.2
Q ss_pred CCCCceeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEeccccc----CCce
Q 044366 647 NFGEKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSN----AQHS 721 (918)
Q Consensus 647 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~----~~~~ 721 (918)
.|...+.||+|+||.||+|.. .++..||+|++...... ....+.+.+|+.+++.++||||+++++++.. ....
T Consensus 27 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 104 (290)
T 1t4h_A 27 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLT--KSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCI 104 (290)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSC--HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEE
T ss_pred eEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhC--HHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceE
Confidence 467778899999999999955 57889999998754322 2235679999999999999999999998754 4568
Q ss_pred EEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--eEEcCCCCCCeeeC-CCCcEEEecccc
Q 044366 722 FIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPP--IVHRDISSKNVLLD-SEYEAHVSDFGF 798 (918)
Q Consensus 722 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~--ivH~dlk~~Nill~-~~~~~kl~DfG~ 798 (918)
++||||+++|+|.+++... ..+++..++.++.|++.||+|||+. + |+||||||+||+++ .++.+||+|||+
T Consensus 105 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~ 178 (290)
T 1t4h_A 105 VLVTELMTSGTLKTYLKRF---KVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGL 178 (290)
T ss_dssp EEEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTG
T ss_pred EEEEEecCCCCHHHHHHHc---cCCCHHHHHHHHHHHHHHHHHHHcC---CCCEEECCCCHHHEEEECCCCCEEEeeCCC
Confidence 9999999999999999764 3489999999999999999999998 7 99999999999998 789999999999
Q ss_pred ccccCCCCCCceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCC
Q 044366 799 AKFLEPHSSNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLP 878 (918)
Q Consensus 799 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 878 (918)
+...... ......|++.|+|||++.+ .++.++||||+|+++|+|++|+.||........... .......+
T Consensus 179 ~~~~~~~--~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~-------~~~~~~~~ 248 (290)
T 1t4h_A 179 ATLKRAS--FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYR-------RVTSGVKP 248 (290)
T ss_dssp GGGCCTT--SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHH-------HHTTTCCC
T ss_pred ccccccc--ccccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHH-------HHhccCCc
Confidence 9765432 3345678999999998874 589999999999999999999999865432211111 11111111
Q ss_pred CCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 879 TPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 879 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
. .........+.+++.+||+.||++|||++|+++
T Consensus 249 ~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 282 (290)
T 1t4h_A 249 A--SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp G--GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred c--ccCCCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 0 001111246889999999999999999999986
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=369.42 Aligned_cols=252 Identities=22% Similarity=0.307 Sum_probs=207.6
Q ss_pred HHhcCCCCceeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhc-cCCceeeEecccccCCc
Q 044366 643 KATGNFGEKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEI-RHRNIIKFHGFCSNAQH 720 (918)
Q Consensus 643 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~ 720 (918)
...++|...+.||+|+||.||+|+. .+++.||||+++...... ....+.+..|..++..+ +||+|+++++++.+.+.
T Consensus 338 ~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~-~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~ 416 (674)
T 3pfq_A 338 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQ-DDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDR 416 (674)
T ss_dssp --CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHH-TTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSE
T ss_pred ccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEecccccc-HHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCE
Confidence 3457899999999999999999965 478899999997643222 23357788999999887 79999999999999999
Q ss_pred eEEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEecccccc
Q 044366 721 SFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAK 800 (918)
Q Consensus 721 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~ 800 (918)
.++||||+++|+|.+++.... .+++.+++.++.||+.||+|||+. +||||||||+|||++.++.+||+|||+++
T Consensus 417 ~~lV~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---gIiHrDLKp~NILl~~~g~ikL~DFGla~ 490 (674)
T 3pfq_A 417 LYFVMEYVNGGDLMYHIQQVG---RFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCK 490 (674)
T ss_dssp EEEEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---SEECCCCCSTTEEECSSSCEEECCCTTCE
T ss_pred EEEEEeCcCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeEeccCChhhEEEcCCCcEEEeecceee
Confidence 999999999999999998643 489999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCCceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCCCC
Q 044366 801 FLEPHSSNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTP 880 (918)
Q Consensus 801 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 880 (918)
.............||+.|+|||++.+..++.++|||||||++|||++|+.||...... .....+.......+
T Consensus 491 ~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~--------~~~~~i~~~~~~~p 562 (674)
T 3pfq_A 491 ENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED--------ELFQSIMEHNVAYP 562 (674)
T ss_dssp ECCCTTCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHHSSCCCCC
T ss_pred ccccCCcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHH--------HHHHHHHhCCCCCC
Confidence 7554445556678999999999999999999999999999999999999998754321 11112222222221
Q ss_pred CcchHHHHHHHHHHHHHcccCCCCCCCCH-----HHHH
Q 044366 881 SRDVTDKLRSIMEVAILCLVENPEARPTM-----KEVC 913 (918)
Q Consensus 881 ~~~~~~~~~~l~~li~~cl~~dp~~RPt~-----~evl 913 (918)
.. ...++.+++.+||+.||++||++ +||+
T Consensus 563 -~~---~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~ 596 (674)
T 3pfq_A 563 -KS---MSKEAVAICKGLMTKHPGKRLGCGPEGERDIK 596 (674)
T ss_dssp -TT---SCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHH
T ss_pred -cc---CCHHHHHHHHHHccCCHHHCCCCCCCcHHHHh
Confidence 11 23467889999999999999997 6665
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=330.85 Aligned_cols=250 Identities=24% Similarity=0.343 Sum_probs=196.8
Q ss_pred hcCCCCceeeccccceEEEEEEeC-CCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEE
Q 044366 645 TGNFGEKYCIGKGGQRSVYKAELP-SGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFI 723 (918)
Q Consensus 645 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 723 (918)
.++|.+.+.||+|+||.||+|... +|+.||||++...... .....+.+.+|+++++.++||||+++++++.+++..++
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 88 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIR-SLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFM 88 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHH-HTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEecccccc-chhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEE
Confidence 468899999999999999999764 7999999998764322 23346789999999999999999999999999999999
Q ss_pred EEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccC
Q 044366 724 VCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLE 803 (918)
Q Consensus 724 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~ 803 (918)
||||+++++|.+++.... .+++.+++.++.|++.||+|||+. +++||||||+||+++.++.+||+|||++....
T Consensus 89 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~ 162 (276)
T 2h6d_A 89 VMEYVSGGELFDYICKHG---RVEEMEARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMS 162 (276)
T ss_dssp EEECCCSCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHH---CSSCCCCCGGGEEECTTSCEEECCCCGGGCCC
T ss_pred EEeccCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChhhEEECCCCCEEEeecccccccC
Confidence 999999999999997643 489999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCCceecccccccccccccccCCC-CcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCCCCCc
Q 044366 804 PHSSNWTEFAGTVGYAAPELAYTMRA-TEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSR 882 (918)
Q Consensus 804 ~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 882 (918)
... ......|++.|+|||.+.+..+ +.++||||||+++|+|++|+.||+..... ...... ....... +.
T Consensus 163 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-----~~~~~~---~~~~~~~-~~ 232 (276)
T 2h6d_A 163 DGE-FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVP-----TLFKKI---RGGVFYI-PE 232 (276)
T ss_dssp C--------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHH-----HHHHHH---HHCCCCC-CT
T ss_pred CCc-ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHH-----HHHHHh---hcCcccC-ch
Confidence 432 2234568999999999987765 68999999999999999999998654321 111111 1111111 11
Q ss_pred chHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 883 DVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 883 ~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
.. ...+.+++.+||+.||++|||++|+++
T Consensus 233 ~~---~~~l~~li~~~l~~~p~~Rps~~~~l~ 261 (276)
T 2h6d_A 233 YL---NRSVATLLMHMLQVDPLKRATIKDIRE 261 (276)
T ss_dssp TS---CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hc---CHHHHHHHHHHccCChhhCCCHHHHHh
Confidence 11 245788999999999999999999986
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=331.41 Aligned_cols=245 Identities=22% Similarity=0.392 Sum_probs=201.7
Q ss_pred HhcCCCCceeeccccceEEEEEEeC-CCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEeccccc-----
Q 044366 644 ATGNFGEKYCIGKGGQRSVYKAELP-SGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSN----- 717 (918)
Q Consensus 644 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~----- 717 (918)
..++|...+.||+|+||.||+|... +|+.||+|+++.. .+.+.+|+++++.++||||+++++++..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 80 (284)
T 2a19_B 9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYN--------NEKAEREVKALAKLDHVNIVHYNGCWDGFDYDP 80 (284)
T ss_dssp HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECC--------SGGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-
T ss_pred hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEeccc--------cHHHHHHHHHHHhCCCCCEEEEeeeEeccccCc
Confidence 4467899999999999999999764 7999999998652 1456899999999999999999998754
Q ss_pred -----------CCceEEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeC
Q 044366 718 -----------AQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLD 786 (918)
Q Consensus 718 -----------~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~ 786 (918)
....++||||+++|+|.+++.... ...+++..++.++.|++.||+|||+. +|+||||||+||+++
T Consensus 81 ~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~ 156 (284)
T 2a19_B 81 ETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRR-GEKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLV 156 (284)
T ss_dssp --------CCEEEEEEEEECCCCSCBHHHHHHHGG-GSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEE
T ss_pred ccccccccccCcceEEEEEeccCCCCHHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHEEEc
Confidence 445799999999999999997643 34589999999999999999999999 999999999999999
Q ss_pred CCCcEEEeccccccccCCCCCCceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhH
Q 044366 787 SEYEAHVSDFGFAKFLEPHSSNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMI 866 (918)
Q Consensus 787 ~~~~~kl~DfG~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~ 866 (918)
.++.+||+|||++........ .....|++.|+|||++.+..++.++||||||+++|||++|..|+.......
T Consensus 157 ~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~------- 228 (284)
T 2a19_B 157 DTKQVKIGDFGLVTSLKNDGK-RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFF------- 228 (284)
T ss_dssp ETTEEEECCCTTCEESSCCSC-CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHHHHH-------
T ss_pred CCCCEEECcchhheecccccc-ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHHHHH-------
Confidence 999999999999987765432 234568999999999999899999999999999999999998853221111
Q ss_pred hhhhhhcccCCCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 044366 867 IEVNQILDHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLLC 917 (918)
Q Consensus 867 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 917 (918)
. .......+. . ....+.+++.+||+.||++|||+.|+++.|+
T Consensus 229 ~---~~~~~~~~~---~---~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~ 270 (284)
T 2a19_B 229 T---DLRDGIISD---I---FDKKEKTLLQKLLSKKPEDRPNTSEILRTLT 270 (284)
T ss_dssp H---HHHTTCCCT---T---SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred H---Hhhcccccc---c---CCHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 1 111111111 1 1235778999999999999999999999875
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-38 Score=353.92 Aligned_cols=199 Identities=23% Similarity=0.350 Sum_probs=166.9
Q ss_pred hcCCCCceeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccC-----
Q 044366 645 TGNFGEKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNA----- 718 (918)
Q Consensus 645 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~----- 718 (918)
.++|.+.+.||+|+||.||+|.. .+|+.||||++.... ......+.+.+|+++++.++||||+++++++...
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~ 102 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMF--EDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKF 102 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTT--TSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchh--cChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcC
Confidence 46899999999999999999954 578999999986531 1223356889999999999999999999998665
Q ss_pred CceEEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEecccc
Q 044366 719 QHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGF 798 (918)
Q Consensus 719 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~ 798 (918)
+..++||||++ |+|.++++.. ..+++..++.++.||++||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 103 ~~~~lv~e~~~-~~L~~~~~~~---~~l~~~~~~~i~~qil~aL~~LH~~---givHrDlkp~NILl~~~~~~kL~DFGl 175 (432)
T 3n9x_A 103 DELYIVLEIAD-SDLKKLFKTP---IFLTEEHIKTILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGL 175 (432)
T ss_dssp CCEEEEEECCS-EEHHHHHHSS---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred CeEEEEEecCC-cCHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHeEECCCCCEEEccCCC
Confidence 57899999997 5999999764 3489999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCC----------------------Cceeccccccccccccc-ccCCCCcccchhhHHHHHHHHHhCCCCC
Q 044366 799 AKFLEPHSS----------------------NWTEFAGTVGYAAPELA-YTMRATEKYDVYSFGVLALEVIKGYHPG 852 (918)
Q Consensus 799 ~~~~~~~~~----------------------~~~~~~g~~~y~aPE~~-~~~~~~~~~Dv~slG~vl~el~tg~~p~ 852 (918)
++....... .....+||+.|+|||++ .+..++.++||||+||++|||++|..|+
T Consensus 176 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~ 252 (432)
T 3n9x_A 176 ARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH 252 (432)
T ss_dssp CEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred cccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccc
Confidence 987754321 13556789999999986 5667999999999999999999865554
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-38 Score=333.77 Aligned_cols=248 Identities=28% Similarity=0.397 Sum_probs=194.6
Q ss_pred hcCCCCceeeccccceEEEEEEeCCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEeccccc-CCceEE
Q 044366 645 TGNFGEKYCIGKGGQRSVYKAELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSN-AQHSFI 723 (918)
Q Consensus 645 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~~~~l 723 (918)
.++|...+.||+|+||.||+|+. .|+.||||+++.. ...+.+.+|+++++.++||||+++++++.+ .+..++
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~------~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~l 92 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND------ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYI 92 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCC------C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEE
T ss_pred hhhceEEeEEecCCCceEEEEEE-cCCEEEEEEecch------hHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEE
Confidence 46789999999999999999987 5889999998642 235789999999999999999999998654 457899
Q ss_pred EEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccC
Q 044366 724 VCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLE 803 (918)
Q Consensus 724 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~ 803 (918)
||||+++|+|.+++.... ...+++.+++.++.|+++||+|||+. +++||||||+||+++.++.+||+|||++....
T Consensus 93 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~ 168 (278)
T 1byg_A 93 VTEYMAKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS 168 (278)
T ss_dssp EECCCTTEEHHHHHHHHH-HHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC-----
T ss_pred EEecCCCCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCcceEEEeCCCcEEEeecccccccc
Confidence 999999999999997643 23378999999999999999999999 99999999999999999999999999998654
Q ss_pred CCCCCceecccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhhhhhhhhhHhhhhhhcccCCCCCCc
Q 044366 804 PHSSNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIK-GYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSR 882 (918)
Q Consensus 804 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 882 (918)
... ....+++.|+|||.+.+..++.++||||||+++|||++ |+.||...... ....... .........
T Consensus 169 ~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~-----~~~~~~~---~~~~~~~~~ 237 (278)
T 1byg_A 169 STQ---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK-----DVVPRVE---KGYKMDAPD 237 (278)
T ss_dssp ----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG-----GHHHHHT---TTCCCCCCT
T ss_pred ccc---cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHH-----HHHHHHh---cCCCCCCcc
Confidence 322 23457889999999999899999999999999999998 99998643221 1111111 111111111
Q ss_pred chHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 044366 883 DVTDKLRSIMEVAILCLVENPEARPTMKEVCNLLC 917 (918)
Q Consensus 883 ~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 917 (918)
. ....+.+++.+||+.||++|||+.|+++.|+
T Consensus 238 ~---~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~ 269 (278)
T 1byg_A 238 G---CPPAVYEVMKNCWHLDAAMRPSFLQLREQLE 269 (278)
T ss_dssp T---CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred c---CCHHHHHHHHHHhcCChhhCCCHHHHHHHHH
Confidence 1 2346888999999999999999999999886
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-38 Score=340.95 Aligned_cols=257 Identities=25% Similarity=0.382 Sum_probs=201.4
Q ss_pred HhcCCCCceeeccccceEEEEEEe------CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEeccccc
Q 044366 644 ATGNFGEKYCIGKGGQRSVYKAEL------PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSN 717 (918)
Q Consensus 644 ~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~ 717 (918)
..++|...+.||+|+||.||+|.. .+++.||||++.... ......++.+|+.++++++||||+++++++.+
T Consensus 28 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 104 (327)
T 2yfx_A 28 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC---SEQDELDFLMEALIISKFNHQNIVRCIGVSLQ 104 (327)
T ss_dssp CGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSC---CHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred ChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEecccc---chhhHHHHHHHHHHHhhCCCCCCCeEEEEEcC
Confidence 347899999999999999999973 357789999986421 22235678999999999999999999999999
Q ss_pred CCceEEEEEeccCCChhHHhhcccc----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCC---CCc
Q 044366 718 AQHSFIVCEYLARGSLTTILRDDAA----AKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDS---EYE 790 (918)
Q Consensus 718 ~~~~~lv~e~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~---~~~ 790 (918)
.+..++||||+++|+|.+++..... ...+++.+++.++.|++.||+|||+. +|+||||||+||+++. +..
T Consensus 105 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~i~H~dlkp~NIli~~~~~~~~ 181 (327)
T 2yfx_A 105 SLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRV 181 (327)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCC
T ss_pred CCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeecCcCCHhHEEEecCCCcce
Confidence 9999999999999999999986532 24589999999999999999999999 9999999999999994 446
Q ss_pred EEEeccccccccCCCCC--CceecccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhhhhhhhhhHh
Q 044366 791 AHVSDFGFAKFLEPHSS--NWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIK-GYHPGDFVSTIFSSISNMII 867 (918)
Q Consensus 791 ~kl~DfG~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~p~~~~~~~~~~~~~~~~ 867 (918)
+||+|||++........ ......|++.|+|||++.+..++.++||||||+++|||++ |+.||...... ... .
T Consensus 182 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--~~~---~ 256 (327)
T 2yfx_A 182 AKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ--EVL---E 256 (327)
T ss_dssp EEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH--HHH---H
T ss_pred EEECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHH--HHH---H
Confidence 99999999986543322 2234567899999999998899999999999999999998 99997644321 111 1
Q ss_pred hhhhhcccCCCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 044366 868 EVNQILDHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLLC 917 (918)
Q Consensus 868 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 917 (918)
.+............ ...+.+++.+||+.||++||+++|+++.|+
T Consensus 257 ---~~~~~~~~~~~~~~---~~~l~~li~~~l~~dp~~Rps~~~ll~~l~ 300 (327)
T 2yfx_A 257 ---FVTSGGRMDPPKNC---PGPVYRIMTQCWQHQPEDRPNFAIILERIE 300 (327)
T ss_dssp ---HHHTTCCCCCCTTC---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred ---HHhcCCCCCCCCCC---CHHHHHHHHHHhcCChhhCcCHHHHHHHHH
Confidence 11111111111222 246788999999999999999999999875
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-38 Score=340.53 Aligned_cols=257 Identities=21% Similarity=0.333 Sum_probs=200.5
Q ss_pred hcCCCCceeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccc----cCC
Q 044366 645 TGNFGEKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCS----NAQ 719 (918)
Q Consensus 645 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~----~~~ 719 (918)
.++|...+.||+|+||.||+|.. .+|+.||||++... .....+.+.+|+++++.++||||+++++++. ...
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 103 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH----EQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKH 103 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEES----SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecC----CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCc
Confidence 46799999999999999999965 68999999998652 2233578999999999999999999999986 345
Q ss_pred ceEEEEEeccCCChhHHhhccc-ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEecccc
Q 044366 720 HSFIVCEYLARGSLTTILRDDA-AAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGF 798 (918)
Q Consensus 720 ~~~lv~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~ 798 (918)
..++||||+++|+|.+++.... ....+++.+++.++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 104 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~dfg~ 180 (317)
T 2buj_A 104 EAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGS 180 (317)
T ss_dssp EEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCSS
T ss_pred eeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCCEEEEecCc
Confidence 7899999999999999997632 235689999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCC---------ceecccccccccccccccCC---CCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhH
Q 044366 799 AKFLEPHSSN---------WTEFAGTVGYAAPELAYTMR---ATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMI 866 (918)
Q Consensus 799 ~~~~~~~~~~---------~~~~~g~~~y~aPE~~~~~~---~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~ 866 (918)
+......... .....|++.|+|||++.+.. ++.++||||||+++|||++|+.||+...........
T Consensus 181 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~-- 258 (317)
T 2buj_A 181 MNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVAL-- 258 (317)
T ss_dssp CEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHH--
T ss_pred chhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhH--
Confidence 8765422111 12345799999999987544 688999999999999999999997532211111111
Q ss_pred hhhhhhcccCCCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 044366 867 IEVNQILDHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLLC 917 (918)
Q Consensus 867 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 917 (918)
.... ....+.. . .....+.+++.+||+.||.+|||++|+++.|+
T Consensus 259 -~~~~--~~~~~~~-~---~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~ 302 (317)
T 2buj_A 259 -AVQN--QLSIPQS-P---RHSSALWQLLNSMMTVDPHQRPHIPLLLSQLE 302 (317)
T ss_dssp -HHHC--C--CCCC-T---TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred -Hhhc--cCCCCcc-c---cCCHHHHHHHHHHhhcChhhCCCHHHHHHHhh
Confidence 1111 1111111 1 12346888999999999999999999999885
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-37 Score=332.58 Aligned_cols=257 Identities=17% Similarity=0.235 Sum_probs=197.7
Q ss_pred HhcCCCCceeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEeccc-ccCCce
Q 044366 644 ATGNFGEKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFC-SNAQHS 721 (918)
Q Consensus 644 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~-~~~~~~ 721 (918)
..++|...+.||+|+||.||+|.. .+++.||||++.... ....+.+|+++++.++|++++..++++ ..++..
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT------KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYN 80 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---------CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccc------cchHHHHHHHHHHHhcCCCCCCeeeeecCCCCce
Confidence 457899999999999999999964 678999999865431 123578999999999988877766655 667788
Q ss_pred EEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeee---CCCCcEEEecccc
Q 044366 722 FIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLL---DSEYEAHVSDFGF 798 (918)
Q Consensus 722 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill---~~~~~~kl~DfG~ 798 (918)
++||||+ +++|.+++... ...+++.+++.++.|++.||+|||+. +|+||||||+||++ +.++.+||+|||+
T Consensus 81 ~lv~e~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~ 154 (296)
T 4hgt_A 81 VMVMELL-GPSLEDLFNFC--SRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGL 154 (296)
T ss_dssp EEEEECC-CCBHHHHHHHT--TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECCGGGTTCEEECCCTT
T ss_pred EEEEEcc-CCCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeeeeccCCCCeEEEecCcc
Confidence 9999999 89999999754 23589999999999999999999999 99999999999999 7889999999999
Q ss_pred ccccCCCCC-------CceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhh
Q 044366 799 AKFLEPHSS-------NWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQ 871 (918)
Q Consensus 799 ~~~~~~~~~-------~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 871 (918)
++....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......... ........
T Consensus 155 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~--~~~~~~~~ 232 (296)
T 4hgt_A 155 AKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKR--QKYERISE 232 (296)
T ss_dssp CEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSS--SHHHHHHH
T ss_pred ceeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhh--hhhhhhhc
Confidence 987755432 123457899999999999999999999999999999999999998653321100 00000000
Q ss_pred hcccCCCCCCc-chHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 044366 872 ILDHRLPTPSR-DVTDKLRSIMEVAILCLVENPEARPTMKEVCNLLC 917 (918)
Q Consensus 872 ~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 917 (918)
.....+.. ........+.+++.+||+.||++|||++++++.|+
T Consensus 233 ---~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (296)
T 4hgt_A 233 ---KKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFR 276 (296)
T ss_dssp ---HHHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHH
T ss_pred ---ccccchhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHH
Confidence 00000000 00011246889999999999999999999999885
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-37 Score=331.42 Aligned_cols=255 Identities=16% Similarity=0.223 Sum_probs=200.5
Q ss_pred hcCCCCceeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEeccc-ccCCceE
Q 044366 645 TGNFGEKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFC-SNAQHSF 722 (918)
Q Consensus 645 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~-~~~~~~~ 722 (918)
.++|...+.||+|+||.||+|+. .+|+.||||++... ...+.+.+|+.+++.++|++++..++++ ..++..+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~ 81 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVK------TKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNV 81 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESC------SSCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCC------cchhHHHHHHHHHHHhhcCCCCCccccccCCCCceE
Confidence 46899999999999999999965 68999999987642 1235789999999999988876666655 5667789
Q ss_pred EEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeC---CCCcEEEeccccc
Q 044366 723 IVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLD---SEYEAHVSDFGFA 799 (918)
Q Consensus 723 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~---~~~~~kl~DfG~~ 799 (918)
+||||+ +++|.+++... ...+++.+++.++.|++.||+|||+. +|+||||||+||+++ .++.+||+|||++
T Consensus 82 lv~e~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~ 155 (296)
T 3uzp_A 82 MVMELL-GPSLEDLFNFC--SRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLA 155 (296)
T ss_dssp EEEECC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCTTC
T ss_pred EEEEec-CCCHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHeEEecCCCCCeEEEeeCCCc
Confidence 999999 88999999743 23589999999999999999999999 999999999999994 7889999999999
Q ss_pred cccCCCCCC-------ceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhh--hhhhhhHhhhh
Q 044366 800 KFLEPHSSN-------WTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIF--SSISNMIIEVN 870 (918)
Q Consensus 800 ~~~~~~~~~-------~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~--~~~~~~~~~~~ 870 (918)
......... .....||+.|+|||++.+..++.++||||||+++|||++|+.||....... .........
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~-- 233 (296)
T 3uzp_A 156 KKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEK-- 233 (296)
T ss_dssp EECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHH--
T ss_pred ccccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhccc--
Confidence 877654321 244578999999999999999999999999999999999999987532210 011110000
Q ss_pred hhcccCCCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 044366 871 QILDHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLLC 917 (918)
Q Consensus 871 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 917 (918)
. .....+. ........+.+++.+||+.||++|||++++++.|+
T Consensus 234 ~-~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~ 276 (296)
T 3uzp_A 234 K-MSTPIEV---LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFR 276 (296)
T ss_dssp H-HHSCHHH---HTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHH
T ss_pred c-cCCchHH---HHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHH
Confidence 0 0000000 00011246888999999999999999999999886
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=340.12 Aligned_cols=261 Identities=22% Similarity=0.373 Sum_probs=204.3
Q ss_pred hcCCCCceeeccccceEEEEEEe-----CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccC-
Q 044366 645 TGNFGEKYCIGKGGQRSVYKAEL-----PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNA- 718 (918)
Q Consensus 645 ~~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~- 718 (918)
.++|...+.||+|+||.||+|+. .+|+.||||++... .....+.+.+|+++++.++||||+++++++...
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 115 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS----TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG 115 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC----CSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC--
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC----CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecC
Confidence 45688899999999999999973 46889999998652 233356899999999999999999999988654
Q ss_pred -CceEEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccc
Q 044366 719 -QHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFG 797 (918)
Q Consensus 719 -~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG 797 (918)
...++||||+++|+|.+++.... ..+++.+++.++.|+++||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 116 ~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kL~Dfg 190 (326)
T 2w1i_A 116 RRNLKLIMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFG 190 (326)
T ss_dssp --CCEEEECCCTTCBHHHHHHHST--TSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCT
T ss_pred CCceEEEEECCCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEEcCCCcEEEecCc
Confidence 37899999999999999997653 3589999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCC---ceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhh-h------hhHh
Q 044366 798 FAKFLEPHSSN---WTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSI-S------NMII 867 (918)
Q Consensus 798 ~~~~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~-~------~~~~ 867 (918)
++......... .....++..|+|||.+.+..++.++||||||+++|||++|..|+.......... . ....
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (326)
T 2w1i_A 191 LTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVF 270 (326)
T ss_dssp TCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHH
T ss_pred chhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHH
Confidence 99887654322 123456778999999998889999999999999999999999865432111000 0 0000
Q ss_pred hhhhhcccC-CCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 044366 868 EVNQILDHR-LPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLLC 917 (918)
Q Consensus 868 ~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 917 (918)
...+.+... ....... ....+.+++.+||+.||++|||+.|+++.|+
T Consensus 271 ~~~~~~~~~~~~~~~~~---~~~~l~~li~~cl~~dP~~Rps~~el~~~L~ 318 (326)
T 2w1i_A 271 HLIELLKNNGRLPRPDG---CPDEIYMIMTECWNNNVNQRPSFRDLALRVD 318 (326)
T ss_dssp HHHHHHHTTCCCCCCTT---CCHHHHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred HHHHHhhcCCCCCCCCc---ccHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 111111111 1111111 2356888999999999999999999999886
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=356.29 Aligned_cols=195 Identities=22% Similarity=0.349 Sum_probs=154.4
Q ss_pred hcCCCCceeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccc-----cC
Q 044366 645 TGNFGEKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCS-----NA 718 (918)
Q Consensus 645 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~-----~~ 718 (918)
.++|.+.+.||+|+||.||+|.. .+|+.||||++.... ......+.+.+|+++++.++||||+++++++. ..
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 129 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVF--EDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKF 129 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTT--SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhh--cCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccC
Confidence 36799999999999999999954 579999999986531 12233567899999999999999999999984 33
Q ss_pred CceEEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEecccc
Q 044366 719 QHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGF 798 (918)
Q Consensus 719 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~ 798 (918)
...|+||||++ |+|.++++.. ..+++..++.++.||+.||+|||+. +||||||||+|||++.++.+||+|||+
T Consensus 130 ~~~~lv~e~~~-~~L~~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~---~iiHrDlKp~NILl~~~~~~kl~DFGl 202 (458)
T 3rp9_A 130 DELYVVLEIAD-SDFKKLFRTP---VYLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGL 202 (458)
T ss_dssp CCEEEEECCCS-EEHHHHHHSS---CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTT
T ss_pred ceEEEEEeccc-cchhhhcccC---CCCCHHHHHHHHHHHHHHHHHHHhC---CcCCCCCChhhEEECCCCCEeeccccc
Confidence 57899999985 6999998764 3589999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCC---------------------------Cceeccccccccccccc-ccCCCCcccchhhHHHHHHHHHhC
Q 044366 799 AKFLEPHSS---------------------------NWTEFAGTVGYAAPELA-YTMRATEKYDVYSFGVLALEVIKG 848 (918)
Q Consensus 799 ~~~~~~~~~---------------------------~~~~~~g~~~y~aPE~~-~~~~~~~~~Dv~slG~vl~el~tg 848 (918)
++....... .....+||+.|+|||++ .+..++.++|||||||++|||++|
T Consensus 203 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg 280 (458)
T 3rp9_A 203 ARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM 280 (458)
T ss_dssp CBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred chhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence 987653221 22445789999999976 566799999999999999999994
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=355.37 Aligned_cols=245 Identities=16% Similarity=0.156 Sum_probs=189.2
Q ss_pred hcCCCCceeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHH---HHHhhccCCceeeEe-------c
Q 044366 645 TGNFGEKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEV---LALTEIRHRNIIKFH-------G 713 (918)
Q Consensus 645 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~---~~l~~l~h~niv~~~-------~ 713 (918)
.++|...+.||+|+||.||+|.. .+|+.||||++...... .....+.|.+|+ +.++.++||||++++ +
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~ 150 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERP-PSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD 150 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-C-CTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeecccc-chHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhh
Confidence 46788889999999999999975 57999999999753222 223357899999 455666899999998 4
Q ss_pred ccccCC-----------------ceEEEEEeccCCChhHHhhcccc----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCC
Q 044366 714 FCSNAQ-----------------HSFIVCEYLARGSLTTILRDDAA----AKEFSWNQRMNVIKGVANALSYLHHDCIPP 772 (918)
Q Consensus 714 ~~~~~~-----------------~~~lv~e~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ 772 (918)
++.+++ ..++||||+ +|+|.+++..... ...+++..++.|+.||+.||+|||+. +
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ 226 (377)
T 3byv_A 151 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---G 226 (377)
T ss_dssp EEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT---T
T ss_pred hhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC---C
Confidence 444332 378999999 5799999986431 12244688899999999999999999 9
Q ss_pred eEEcCCCCCCeeeCCCCcEEEeccccccccCCCCCCceecccccccccccccccC-----------CCCcccchhhHHHH
Q 044366 773 IVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGTVGYAAPELAYTM-----------RATEKYDVYSFGVL 841 (918)
Q Consensus 773 ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-----------~~~~~~Dv~slG~v 841 (918)
|+||||||+||+++.++.+||+|||+++.... ......| +.|+|||++.+. .++.++|||||||+
T Consensus 227 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~---~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~i 302 (377)
T 3byv_A 227 LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA---RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLV 302 (377)
T ss_dssp EECSCCCGGGEEECTTCCEEECCGGGCEETTC---EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHH
T ss_pred eecCCCCHHHEEEcCCCCEEEEechhheecCC---cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHH
Confidence 99999999999999999999999999986432 3344567 999999999887 89999999999999
Q ss_pred HHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 842 ALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 842 l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
+|||++|+.||....... . ...+. ...+ . ....+.+++.+||+.||++|||+.|+++
T Consensus 303 l~elltg~~Pf~~~~~~~-~-------~~~~~-~~~~----~---~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 359 (377)
T 3byv_A 303 IYWIWCADLPITKDAALG-G-------SEWIF-RSCK----N---IPQPVRALLEGFLRYPKEDRLLPLQAME 359 (377)
T ss_dssp HHHHHHSSCCC------C-C-------SGGGG-SSCC----C---CCHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred HHHHHHCCCCCccccccc-c-------hhhhh-hhcc----C---CCHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence 999999999986433210 0 00111 1111 1 1246788999999999999999999985
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-37 Score=335.98 Aligned_cols=252 Identities=18% Similarity=0.267 Sum_probs=199.1
Q ss_pred cCCCCceeeccccceEEEEEE-eCCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhcc-CCceeeEeccccc--CCce
Q 044366 646 GNFGEKYCIGKGGQRSVYKAE-LPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIR-HRNIIKFHGFCSN--AQHS 721 (918)
Q Consensus 646 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~--~~~~ 721 (918)
++|...+.||+|+||.||+|. ..+++.||||+++. ...+.+.+|+++++.++ ||||+++++++.+ ....
T Consensus 36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~-------~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~ 108 (330)
T 3nsz_A 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP-------VKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTP 108 (330)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS-------CCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCE
T ss_pred CceEEEEEecccCCeEEEEEEECCCCcEEEEEEecc-------cchHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCce
Confidence 678899999999999999995 46899999999853 23578999999999997 9999999999977 6678
Q ss_pred EEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCC-cEEEecccccc
Q 044366 722 FIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEY-EAHVSDFGFAK 800 (918)
Q Consensus 722 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~-~~kl~DfG~~~ 800 (918)
++||||+++++|.+++.. +++.+++.++.|++.||+|||+. +|+||||||+||+++.++ .+||+|||+++
T Consensus 109 ~lv~e~~~~~~l~~~~~~------~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~ 179 (330)
T 3nsz_A 109 ALVFEHVNNTDFKQLYQT------LTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAE 179 (330)
T ss_dssp EEEEECCCCCCHHHHGGG------CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred EEEEeccCchhHHHHHHh------CCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEcCCCCEEEEEeCCCce
Confidence 999999999999999853 78899999999999999999999 999999999999999776 89999999998
Q ss_pred ccCCCCCCceeccccccccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHh-----hhhhhcc
Q 044366 801 FLEPHSSNWTEFAGTVGYAAPELAYT-MRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMII-----EVNQILD 874 (918)
Q Consensus 801 ~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~-----~~~~~~~ 874 (918)
....... .....|+..|+|||++.+ ..++.++||||+||++|||++|+.||............... .......
T Consensus 180 ~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 258 (330)
T 3nsz_A 180 FYHPGQE-YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYID 258 (330)
T ss_dssp ECCTTCC-CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHH
T ss_pred EcCCCCc-cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHH
Confidence 7654332 344578999999999877 66899999999999999999999998543322222111110 0000000
Q ss_pred cCCCC---------------------CCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 875 HRLPT---------------------PSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 875 ~~~~~---------------------~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
..... ...........+.+++.+||+.||++|||++|+++
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~ 319 (330)
T 3nsz_A 259 KYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 319 (330)
T ss_dssp HTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred HhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 00000 00001112357889999999999999999999986
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-37 Score=333.21 Aligned_cols=256 Identities=24% Similarity=0.350 Sum_probs=204.9
Q ss_pred HhcCCCCceeeccccceEEEEEEe-CCCCEEEEEEcccccccCC-----CCChHHHHHHHHHHhhcc-CCceeeEecccc
Q 044366 644 ATGNFGEKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDE-----TANPSEFLNEVLALTEIR-HRNIIKFHGFCS 716 (918)
Q Consensus 644 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~-----~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~ 716 (918)
..++|...+.||+|+||.||+|.. .+|+.||||+++....... ....+.+.+|++++++++ ||||+++++++.
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (298)
T 1phk_A 15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 94 (298)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence 457899999999999999999965 4789999999865321110 112356889999999995 999999999999
Q ss_pred cCCceEEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEecc
Q 044366 717 NAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDF 796 (918)
Q Consensus 717 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Df 796 (918)
.++..++||||+++++|.+++... ..+++.+++.++.|++.||+|||+. +++||||||+||+++.++.+||+||
T Consensus 95 ~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~df 168 (298)
T 1phk_A 95 TNTFFFLVFDLMKKGELFDYLTEK---VTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDF 168 (298)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCC
T ss_pred cCCeEEEEEeccCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEcCCCcEEEecc
Confidence 999999999999999999999764 3489999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCCCceecccccccccccccc------cCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhh
Q 044366 797 GFAKFLEPHSSNWTEFAGTVGYAAPELAY------TMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVN 870 (918)
Q Consensus 797 G~~~~~~~~~~~~~~~~g~~~y~aPE~~~------~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~ 870 (918)
|.+....... ......|++.|+|||++. ...++.++||||||+++|||++|+.||...... ... .
T Consensus 169 g~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-~~~-------~ 239 (298)
T 1phk_A 169 GFSCQLDPGE-KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQM-LML-------R 239 (298)
T ss_dssp TTCEECCTTC-CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHH-------H
T ss_pred cchhhcCCCc-ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHH-HHH-------H
Confidence 9998775433 234457899999999885 446788999999999999999999998654321 000 1
Q ss_pred hhcccCCCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 871 QILDHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 871 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
.+..................+.+++.+||+.||++|||++|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 240 MIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp HHHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred HHhcCCcccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 11111111111222233456889999999999999999999975
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-37 Score=332.17 Aligned_cols=253 Identities=23% Similarity=0.312 Sum_probs=200.2
Q ss_pred hcCCCCceeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEeccc--ccCCce
Q 044366 645 TGNFGEKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFC--SNAQHS 721 (918)
Q Consensus 645 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~--~~~~~~ 721 (918)
.++|.+.+.||+|+||.||+|.. .+++.||+|+++...........+.+.+|+++++.++||||+++++++ .+.+..
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 47899999999999999999965 478999999997654333334467899999999999999999999988 455688
Q ss_pred EEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccc
Q 044366 722 FIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKF 801 (918)
Q Consensus 722 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~ 801 (918)
++||||++++ +.+++.... ...+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||.+..
T Consensus 84 ~lv~e~~~~~-l~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~ 158 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSVP-EKRFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEA 158 (305)
T ss_dssp EEEEECCSEE-HHHHHHHST-TCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEehhccCC-HHHHHHhCc-ccccCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEcCCCcEEeeccccccc
Confidence 9999999876 777776543 34689999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCC--CceecccccccccccccccCC--CCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCC
Q 044366 802 LEPHSS--NWTEFAGTVGYAAPELAYTMR--ATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRL 877 (918)
Q Consensus 802 ~~~~~~--~~~~~~g~~~y~aPE~~~~~~--~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 877 (918)
..+... ......|++.|+|||++.+.. ++.++||||||+++|||++|+.||...... .. . ..+.....
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-~~----~---~~i~~~~~ 230 (305)
T 2wtk_C 159 LHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIY-KL----F---ENIGKGSY 230 (305)
T ss_dssp CCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHH-HH----H---HHHHHCCC
T ss_pred cCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHH-HH----H---HHHhcCCC
Confidence 654322 223456899999999987644 377999999999999999999998754321 11 1 11111111
Q ss_pred CCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 878 PTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 878 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
..+ .. ....+.+++.+||+.||++|||++|+++
T Consensus 231 ~~~-~~---~~~~l~~li~~~l~~dp~~Rps~~~ll~ 263 (305)
T 2wtk_C 231 AIP-GD---CGPPLSDLLKGMLEYEPAKRFSIRQIRQ 263 (305)
T ss_dssp CCC-SS---SCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred CCC-Cc---cCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 111 11 2245778999999999999999999986
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=366.43 Aligned_cols=246 Identities=26% Similarity=0.356 Sum_probs=195.4
Q ss_pred eeeccccceEEEEEEe---CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEEEEEec
Q 044366 652 YCIGKGGQRSVYKAEL---PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFIVCEYL 728 (918)
Q Consensus 652 ~~lg~G~~g~Vy~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 728 (918)
+.||+|+||.||+|.+ ..++.||||+++... ......++|.+|++++++++|||||++++++.. +..++||||+
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~ 451 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA--NDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMA 451 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGG--GCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECC
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEecccc--CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEcc
Confidence 4799999999999954 246789999987642 222335789999999999999999999999964 5588999999
Q ss_pred cCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccCCCCCC
Q 044366 729 ARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSN 808 (918)
Q Consensus 729 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~~~~~~ 808 (918)
++|+|.+++... ..+++.+++.|+.||+.||+|||+. +||||||||+||+++.++.+||+|||+++.+......
T Consensus 452 ~~g~L~~~l~~~---~~l~~~~~~~i~~qi~~~L~yLH~~---~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~ 525 (635)
T 4fl3_A 452 ELGPLNKYLQQN---RHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY 525 (635)
T ss_dssp TTEEHHHHHHHC---TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC----
T ss_pred CCCCHHHHHhhC---CCCCHHHHHHHHHHHHHHHHHHHHC---CEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccc
Confidence 999999999754 3489999999999999999999999 9999999999999999999999999999877544321
Q ss_pred ---ceecccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhhhhhhhhhHhhhhhhcccCCCCCCcch
Q 044366 809 ---WTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIK-GYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRDV 884 (918)
Q Consensus 809 ---~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 884 (918)
.....+|+.|+|||++.+..++.++|||||||++|||++ |+.||...... .+. ..+. .......+..
T Consensus 526 ~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~--~~~---~~i~---~~~~~~~p~~- 596 (635)
T 4fl3_A 526 YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS--EVT---AMLE---KGERMGCPAG- 596 (635)
T ss_dssp ---------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--HHH---HHHH---TTCCCCCCTT-
T ss_pred cccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH--HHH---HHHH---cCCCCCCCCC-
Confidence 223456789999999999999999999999999999998 99998654321 111 1111 1111111112
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 044366 885 TDKLRSIMEVAILCLVENPEARPTMKEVCNLLC 917 (918)
Q Consensus 885 ~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 917 (918)
....+.+++.+||+.||++||++++|++.|+
T Consensus 597 --~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~ 627 (635)
T 4fl3_A 597 --CPREMYDLMNLCWTYDVENRPGFAAVELRLR 627 (635)
T ss_dssp --CCHHHHHHHHHHTCSSTTTSCCHHHHHHHHH
T ss_pred --CCHHHHHHHHHHcCCCHhHCcCHHHHHHHHH
Confidence 2356888999999999999999999999886
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-37 Score=342.00 Aligned_cols=257 Identities=22% Similarity=0.294 Sum_probs=191.7
Q ss_pred hcCCCCceeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCC----
Q 044366 645 TGNFGEKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQ---- 719 (918)
Q Consensus 645 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~---- 719 (918)
.++|...+.||+|+||.||+|.. .+|+.||||++.... ......+.+.+|+.+++.++||||+++++++...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 101 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPF--QNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEE 101 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTT--SSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTT
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEecccc--CChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccc
Confidence 46899999999999999999954 578999999987532 12223467889999999999999999999986654
Q ss_pred --ceEEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccc
Q 044366 720 --HSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFG 797 (918)
Q Consensus 720 --~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG 797 (918)
..++||||+++ +|.+++.. .+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 102 ~~~~~lv~e~~~~-~l~~~~~~-----~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg 172 (371)
T 2xrw_A 102 FQDVYIVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG 172 (371)
T ss_dssp CCEEEEEEECCSE-EHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCCC
T ss_pred ccceEEEEEcCCC-CHHHHHhh-----ccCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEEEee
Confidence 67999999985 78888853 389999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCCceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHh----------
Q 044366 798 FAKFLEPHSSNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMII---------- 867 (918)
Q Consensus 798 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~---------- 867 (918)
+++...... ......||+.|+|||++.+..++.++||||+||++|||++|+.||........ ......
T Consensus 173 ~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-~~~i~~~~~~~~~~~~ 250 (371)
T 2xrw_A 173 LARTAGTSF-MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQ-WNKVIEQLGTPCPEFM 250 (371)
T ss_dssp C-----------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHC-CCCCCHHHH
T ss_pred ccccccccc-ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHhCCCCHHHH
Confidence 998765322 23446789999999999998999999999999999999999999875432110 000000
Q ss_pred -----hhhhhcccC----------------CCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 868 -----EVNQILDHR----------------LPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 868 -----~~~~~~~~~----------------~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
......... .+............+.+++.+||+.||++|||++|+++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 318 (371)
T 2xrw_A 251 KKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ 318 (371)
T ss_dssp TTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhC
Confidence 000000000 01111111223567899999999999999999999986
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-38 Score=340.02 Aligned_cols=256 Identities=25% Similarity=0.320 Sum_probs=196.5
Q ss_pred HhcCCCCceeeccccceEEEEEEe-CCCCEEEEEEccccccc----CCCCChHHHHHHHHHHhhccCCceeeEecccccC
Q 044366 644 ATGNFGEKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFS----DETANPSEFLNEVLALTEIRHRNIIKFHGFCSNA 718 (918)
Q Consensus 644 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~----~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~ 718 (918)
..++|.+.+.||+|+||.||+|.. .+++.||||++...... ........+.+|+++++.++||||+++++++..+
T Consensus 8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 87 (322)
T 2ycf_A 8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE 87 (322)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence 456799999999999999999965 56899999998654321 1112234688999999999999999999998765
Q ss_pred CceEEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCc---EEEec
Q 044366 719 QHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYE---AHVSD 795 (918)
Q Consensus 719 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~---~kl~D 795 (918)
+ .++||||+++|+|.+++... ..+++.+++.++.||+.||+|||+. +|+||||||+||+++.++. +||+|
T Consensus 88 ~-~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~D 160 (322)
T 2ycf_A 88 D-YYIVLELMEGGELFDKVVGN---KRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITD 160 (322)
T ss_dssp S-EEEEEECCTTEETHHHHSTT---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSSSCCEEECC
T ss_pred c-eEEEEecCCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEecCCCCCeEEEcc
Confidence 5 89999999999999998754 3589999999999999999999999 9999999999999987664 99999
Q ss_pred cccccccCCCCCCceecccccccccccccc---cCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhh
Q 044366 796 FGFAKFLEPHSSNWTEFAGTVGYAAPELAY---TMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQI 872 (918)
Q Consensus 796 fG~~~~~~~~~~~~~~~~g~~~y~aPE~~~---~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 872 (918)
||++...... .......|++.|+|||++. +..++.++||||||+++|+|++|+.||.......... ...
T Consensus 161 fg~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~-~~~------ 232 (322)
T 2ycf_A 161 FGHSKILGET-SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLK-DQI------ 232 (322)
T ss_dssp CTTCEECCCC-HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHH-HHH------
T ss_pred Cccceecccc-cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHH-HHH------
Confidence 9999876532 2223456899999999874 4668899999999999999999999986543211111 000
Q ss_pred cccCCCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 873 LDHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 873 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
..................+.+++.+||+.||++|||++|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 233 TSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp HHTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HhCccccCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 011111111111122356889999999999999999999985
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-38 Score=337.93 Aligned_cols=259 Identities=25% Similarity=0.398 Sum_probs=186.2
Q ss_pred HHHhcCCCCceeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCc
Q 044366 642 TKATGNFGEKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQH 720 (918)
Q Consensus 642 ~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 720 (918)
....++|...+.||+|+||.||+|.. .+++.||||++..... ....+++.+|+++++.++||||+++++++..++.
T Consensus 11 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 87 (303)
T 2vwi_A 11 SINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC---QTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDE 87 (303)
T ss_dssp --CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC-------------------CCCCCCCTTBCCEEEEEESSSC
T ss_pred ccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhc---chhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCC
Confidence 34567899999999999999999965 4789999999865321 2335678899999999999999999999999999
Q ss_pred eEEEEEeccCCChhHHhhcc-----cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEec
Q 044366 721 SFIVCEYLARGSLTTILRDD-----AAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSD 795 (918)
Q Consensus 721 ~~lv~e~~~~gsL~~~l~~~-----~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~D 795 (918)
.++||||+++|+|.+++... .....+++..++.++.|++.||+|||+. +++||||||+||+++.++.+||+|
T Consensus 88 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~d 164 (303)
T 2vwi_A 88 LWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIAD 164 (303)
T ss_dssp EEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECC
T ss_pred cEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCCChhhEEEcCCCCEEEEe
Confidence 99999999999999998742 1234589999999999999999999999 999999999999999999999999
Q ss_pred cccccccCCCCC-----Cceeccccccccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhh
Q 044366 796 FGFAKFLEPHSS-----NWTEFAGTVGYAAPELAYT-MRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEV 869 (918)
Q Consensus 796 fG~~~~~~~~~~-----~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~ 869 (918)
||++........ ......|++.|+|||++.+ ..++.++||||||+++|||++|+.||...........
T Consensus 165 fg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~------ 238 (303)
T 2vwi_A 165 FGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLML------ 238 (303)
T ss_dssp CHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHH------
T ss_pred ccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHH------
Confidence 999987653321 1234568999999999876 5689999999999999999999999875432211100
Q ss_pred hhhcccCCCCCC------cchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 870 NQILDHRLPTPS------RDVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 870 ~~~~~~~~~~~~------~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
......+... .........+.+++.+||+.||.+|||++|+++
T Consensus 239 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 239 --TLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp --HHTSSCCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred --HhccCCCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 0000000000 000112346788999999999999999999986
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=332.98 Aligned_cols=256 Identities=26% Similarity=0.402 Sum_probs=194.5
Q ss_pred hcCCCCceeeccccceEEEEEEeC--CCC--EEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCc
Q 044366 645 TGNFGEKYCIGKGGQRSVYKAELP--SGN--IFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQH 720 (918)
Q Consensus 645 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~--~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 720 (918)
.++|...+.||+|+||.||+|++. +++ .||||+++..... .....+.+.+|+++++.++||||+++++++..+.
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~- 94 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLS-QPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP- 94 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC---------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccC-CHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-
Confidence 467899999999999999999642 333 6899998764322 2233578999999999999999999999997765
Q ss_pred eEEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEecccccc
Q 044366 721 SFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAK 800 (918)
Q Consensus 721 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~ 800 (918)
.++||||+++|+|.+++.... ..+++.+++.++.|+++||+|||+. +++||||||+||+++.++.+||+|||++.
T Consensus 95 ~~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~ 169 (291)
T 1u46_A 95 MKMVTELAPLGSLLDRLRKHQ--GHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMR 169 (291)
T ss_dssp CEEEEECCTTCBHHHHHHHHG--GGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred ceeeEecccCCCHHHHHHhcc--CCcCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEEcCCCCEEEccccccc
Confidence 899999999999999997642 3589999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCC---ceecccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhhhhhhhhhHhhhhhhcccC
Q 044366 801 FLEPHSSN---WTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIK-GYHPGDFVSTIFSSISNMIIEVNQILDHR 876 (918)
Q Consensus 801 ~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 876 (918)
........ .....++..|+|||++.+..++.++||||||+++|||++ |+.||...... ........ ....
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-----~~~~~~~~-~~~~ 243 (291)
T 1u46_A 170 ALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS-----QILHKIDK-EGER 243 (291)
T ss_dssp ECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-----HHHHHHHT-SCCC
T ss_pred cccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHH-----HHHHHHHc-cCCC
Confidence 87554332 223457788999999998889999999999999999999 99998654321 01111111 0111
Q ss_pred CCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 044366 877 LPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLLC 917 (918)
Q Consensus 877 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 917 (918)
.+. .. .....+.+++.+||+.||++|||+.++++.|+
T Consensus 244 ~~~-~~---~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~ 280 (291)
T 1u46_A 244 LPR-PE---DCPQDIYNVMVQCWAHKPEDRPTFVALRDFLL 280 (291)
T ss_dssp CCC-CT---TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCC-Cc---CcCHHHHHHHHHHccCCcccCcCHHHHHHHHH
Confidence 111 11 22356888999999999999999999999885
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-37 Score=342.28 Aligned_cols=270 Identities=20% Similarity=0.261 Sum_probs=200.3
Q ss_pred CHHHHHHHhcCCCCceeeccccceEEEEEEeCCCCEEEEEEcccccccCCCC-------ChHHHHHHHHHHhhccCCcee
Q 044366 637 LYEEITKATGNFGEKYCIGKGGQRSVYKAELPSGNIFAVKKFKAELFSDETA-------NPSEFLNEVLALTEIRHRNII 709 (918)
Q Consensus 637 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~-------~~~~~~~e~~~l~~l~h~niv 709 (918)
...++....++|...+.||+|+||.||+|...+|+.||||++.......... ..+.+.+|+++++.++||||+
T Consensus 13 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv 92 (362)
T 3pg1_A 13 LIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNIL 92 (362)
T ss_dssp HHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred HHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCcc
Confidence 3567788889999999999999999999988889999999987643222111 126899999999999999999
Q ss_pred eEecccc-----cCCceEEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCee
Q 044366 710 KFHGFCS-----NAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVL 784 (918)
Q Consensus 710 ~~~~~~~-----~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil 784 (918)
++++++. .....++||||++ |+|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+||+
T Consensus 93 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl 166 (362)
T 3pg1_A 93 GLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQ--RIVISPQHIQYFMYHILLGLHVLHEA---GVVHRDLHPGNIL 166 (362)
T ss_dssp CCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCT--TSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEE
T ss_pred ceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHC---cCEecCCChHHEE
Confidence 9999983 3346799999998 5888888754 34589999999999999999999999 9999999999999
Q ss_pred eCCCCcEEEeccccccccCCCCCCceeccccccccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhh
Q 044366 785 LDSEYEAHVSDFGFAKFLEPHSSNWTEFAGTVGYAAPELAYT-MRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSIS 863 (918)
Q Consensus 785 l~~~~~~kl~DfG~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~ 863 (918)
++.++.+||+|||++....... ......|++.|+|||++.+ ..++.++||||+||++|+|++|+.||...... ....
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-~~~~ 244 (362)
T 3pg1_A 167 LADNNDITICDFNLAREDTADA-NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFY-NQLN 244 (362)
T ss_dssp ECTTCCEEECCTTC----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHH
T ss_pred EcCCCCEEEEecCccccccccc-ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHH-HHHH
Confidence 9999999999999998654332 2344578999999999876 67899999999999999999999998754321 1111
Q ss_pred hhHh----------------hhhhhcccCCCC-CCcchH----HHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 864 NMII----------------EVNQILDHRLPT-PSRDVT----DKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 864 ~~~~----------------~~~~~~~~~~~~-~~~~~~----~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
.... ............ +..... .....+.+++.+||+.||++|||++|+++
T Consensus 245 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 316 (362)
T 3pg1_A 245 KIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR 316 (362)
T ss_dssp HHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHc
Confidence 1100 000001111111 111111 11356889999999999999999999985
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=341.46 Aligned_cols=256 Identities=21% Similarity=0.353 Sum_probs=204.8
Q ss_pred hcCCCCceeeccccceEEEEEEeCCCCEEEEEEcccccccCCCC-------------ChHHHHHHHHHHhhccCCceeeE
Q 044366 645 TGNFGEKYCIGKGGQRSVYKAELPSGNIFAVKKFKAELFSDETA-------------NPSEFLNEVLALTEIRHRNIIKF 711 (918)
Q Consensus 645 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~-------------~~~~~~~e~~~l~~l~h~niv~~ 711 (918)
.++|.+.+.||+|+||.||+|.. +|+.||||++.......... ..+.+.+|+++++.++||||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 46899999999999999999987 99999999987643322110 01789999999999999999999
Q ss_pred ecccccCCceEEEEEeccCCChhHH------hhcccccCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEEcCCCCCCee
Q 044366 712 HGFCSNAQHSFIVCEYLARGSLTTI------LRDDAAAKEFSWNQRMNVIKGVANALSYLHH-DCIPPIVHRDISSKNVL 784 (918)
Q Consensus 712 ~~~~~~~~~~~lv~e~~~~gsL~~~------l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~ivH~dlk~~Nil 784 (918)
++++.+++..++||||+++|+|.++ +.... ...+++..++.++.|++.||+|||+ . +++||||||+||+
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---~i~H~dl~p~Nil 184 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNY-TCFIPIQVIKCIIKSVLNSFSYIHNEK---NICHRDVKPSNIL 184 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSS-CCCCCHHHHHHHHHHHHHHHHHHHHTS---CEECCCCCGGGEE
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhcc-ccCCCHHHHHHHHHHHHHHHHHHhccC---CEeecCCChHhEE
Confidence 9999999999999999999999999 54321 3568999999999999999999999 8 9999999999999
Q ss_pred eCCCCcEEEeccccccccCCCCCCceecccccccccccccccC-CCCc-ccchhhHHHHHHHHHhCCCCCCcchhhhhhh
Q 044366 785 LDSEYEAHVSDFGFAKFLEPHSSNWTEFAGTVGYAAPELAYTM-RATE-KYDVYSFGVLALEVIKGYHPGDFVSTIFSSI 862 (918)
Q Consensus 785 l~~~~~~kl~DfG~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~-~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~ 862 (918)
++.++.+||+|||.+...... ......|++.|+|||++.+. .++. ++||||||+++|||++|+.||..........
T Consensus 185 ~~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~ 262 (348)
T 2pml_X 185 MDKNGRVKLSDFGESEYMVDK--KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELF 262 (348)
T ss_dssp ECTTSCEEECCCTTCEECBTT--EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHHH
T ss_pred EcCCCcEEEeccccccccccc--cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHH
Confidence 999999999999999876543 33446789999999999877 5666 9999999999999999999987543311111
Q ss_pred hhhHhhhhhhcccCCCCCC---------------cchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 863 SNMIIEVNQILDHRLPTPS---------------RDVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 863 ~~~~~~~~~~~~~~~~~~~---------------~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
.. +.......+. .........+.+++.+||+.||.+|||++|+++
T Consensus 263 ~~-------i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 263 NN-------IRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp HH-------HTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred HH-------HhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 11 1111111000 000122356889999999999999999999986
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=343.48 Aligned_cols=258 Identities=23% Similarity=0.316 Sum_probs=201.8
Q ss_pred hcCCCCceeeccccceEEEEEEeC-CCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEE
Q 044366 645 TGNFGEKYCIGKGGQRSVYKAELP-SGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFI 723 (918)
Q Consensus 645 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 723 (918)
.++|...+.||+|+||.||+|... +|+.||+|++.... .....+.+.+|+.+++.++||||+++++++.+++..++
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 108 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI---KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI 108 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCC---CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEE
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEecccc---CHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEE
Confidence 357889999999999999999654 79999999987532 22235678999999999999999999999999999999
Q ss_pred EEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccC
Q 044366 724 VCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLE 803 (918)
Q Consensus 724 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~ 803 (918)
||||+++|+|.+++.... .+++..+..++.|++.||+|||+.. +|+||||||+||+++.++.+||+|||++....
T Consensus 109 v~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 183 (360)
T 3eqc_A 109 CMEHMDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 183 (360)
T ss_dssp EECCCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHHH--CCCCSCCSGGGEEECTTCCEEECCCCCCHHHH
T ss_pred EEECCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHhC--CEEcCCccHHHEEECCCCCEEEEECCCCcccc
Confidence 999999999999997643 4899999999999999999999832 89999999999999999999999999997653
Q ss_pred CCCCCceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhh-------------------
Q 044366 804 PHSSNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISN------------------- 864 (918)
Q Consensus 804 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~------------------- 864 (918)
.. ......||+.|+|||++.+..++.++||||||+++|||++|+.||............
T Consensus 184 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (360)
T 3eqc_A 184 DS--MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG 261 (360)
T ss_dssp HH--C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC------------------
T ss_pred cc--cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCC
Confidence 22 123457899999999999999999999999999999999999998653321100000
Q ss_pred ---------------hHhhhhhhcccCCCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 865 ---------------MIIEVNQILDHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 865 ---------------~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
.............+.... ......+.+++.+||+.||++|||++|+++
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 324 (360)
T 3eqc_A 262 RPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPS--GVFSLEFQDFVNKCLIKNPAERADLKQLMV 324 (360)
T ss_dssp ------------CCCHHHHHHHHHHSCCCCCCT--TTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred CcccccccCCCCcccchhhhhHHhccCCCCCCc--ccccHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 000000111111111110 112346889999999999999999999975
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=341.40 Aligned_cols=251 Identities=22% Similarity=0.338 Sum_probs=185.7
Q ss_pred HhcCCCCceeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhcc-CCceeeEeccc------
Q 044366 644 ATGNFGEKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIR-HRNIIKFHGFC------ 715 (918)
Q Consensus 644 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~------ 715 (918)
...+|...+.||+|+||.||+|+. .+|+.||||++... .....+.+.+|+.+++++. ||||+++++++
T Consensus 26 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~ 101 (337)
T 3ll6_A 26 GELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN----EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEE 101 (337)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEES----SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTT
T ss_pred cCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCC----chHHHHHHHHHHHHHHHhccCCChhhccccccccccc
Confidence 345789999999999999999965 57999999998543 2233567899999999996 99999999988
Q ss_pred --ccCCceEEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--eEEcCCCCCCeeeCCCCcE
Q 044366 716 --SNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPP--IVHRDISSKNVLLDSEYEA 791 (918)
Q Consensus 716 --~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~--ivH~dlk~~Nill~~~~~~ 791 (918)
......++||||++ |+|.+++........+++.+++.++.||+.||+|||+. + |+||||||+||+++.++.+
T Consensus 102 ~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~~~ivH~Dikp~NIl~~~~~~~ 177 (337)
T 3ll6_A 102 SDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQ---KPPIIHRDLKVENLLLSNQGTI 177 (337)
T ss_dssp STTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCCCCCGGGCEECTTSCE
T ss_pred cccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCEEEccCCcccEEECCCCCE
Confidence 33455899999996 69999997654455699999999999999999999998 8 9999999999999999999
Q ss_pred EEeccccccccCCCCCC------------ceeccccccccccccc---ccCCCCcccchhhHHHHHHHHHhCCCCCCcch
Q 044366 792 HVSDFGFAKFLEPHSSN------------WTEFAGTVGYAAPELA---YTMRATEKYDVYSFGVLALEVIKGYHPGDFVS 856 (918)
Q Consensus 792 kl~DfG~~~~~~~~~~~------------~~~~~g~~~y~aPE~~---~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~ 856 (918)
||+|||++......... .....||+.|+|||++ .+..++.++||||||+++|||++|+.||....
T Consensus 178 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~ 257 (337)
T 3ll6_A 178 KLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGA 257 (337)
T ss_dssp EBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC----
T ss_pred EEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchh
Confidence 99999999876543221 1134589999999998 56678899999999999999999999986432
Q ss_pred hhhhhhhhhHhhhhhhcccCCCC-CCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 044366 857 TIFSSISNMIIEVNQILDHRLPT-PSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLLC 917 (918)
Q Consensus 857 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 917 (918)
.. ......... ..... ...+.+++.+||+.||++|||++|+++.|+
T Consensus 258 ~~------------~~~~~~~~~~~~~~~---~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 304 (337)
T 3ll6_A 258 KL------------RIVNGKYSIPPHDTQ---YTVFHSLIRAMLQVNPEERLSIAEVVHQLQ 304 (337)
T ss_dssp --------------------CCCCTTCCS---SGGGHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred HH------------HhhcCcccCCccccc---chHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 21 001111111 11111 134778899999999999999999999885
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=332.78 Aligned_cols=255 Identities=22% Similarity=0.333 Sum_probs=187.0
Q ss_pred hcCCCCceeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEE
Q 044366 645 TGNFGEKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFI 723 (918)
Q Consensus 645 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 723 (918)
.++|+..+.||+|+||.||+|.. .+|+.||||+++..... ....+.+.++...++.++||||+++++++.+++..++
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~l 83 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNS--QEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWI 83 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CH--HHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEE
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCc--HHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEE
Confidence 46789999999999999999965 57999999998753211 1112334455555788899999999999999999999
Q ss_pred EEEeccCCChhHHhhcc-cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEecccccccc
Q 044366 724 VCEYLARGSLTTILRDD-AAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFL 802 (918)
Q Consensus 724 v~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~ 802 (918)
||||+++ +|.+++... .....+++..++.++.|++.||+|||+.+ +|+||||||+||+++.++.+||+|||++...
T Consensus 84 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 160 (290)
T 3fme_A 84 CMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFGISGYL 160 (290)
T ss_dssp EEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHS--CCCCCCCSGGGCEECTTCCEEBCCC------
T ss_pred EEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecCCcccc
Confidence 9999984 888887653 22356899999999999999999999853 8999999999999999999999999999876
Q ss_pred CCCCCCceeccccccccccccc----ccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCC
Q 044366 803 EPHSSNWTEFAGTVGYAAPELA----YTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLP 878 (918)
Q Consensus 803 ~~~~~~~~~~~g~~~y~aPE~~----~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 878 (918)
..... .....|++.|+|||++ .+..++.++||||+|+++|||++|+.||+............ .....+
T Consensus 161 ~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~-------~~~~~~ 232 (290)
T 3fme_A 161 VDDVA-KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQV-------VEEPSP 232 (290)
T ss_dssp ----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHH-------HHSCCC
T ss_pred ccccc-ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHH-------hccCCC
Confidence 54322 2334689999999996 56678999999999999999999999987543322221111 111111
Q ss_pred CCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 879 TPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 879 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
.... ......+.+++.+||+.||++|||++|+++
T Consensus 233 ~~~~--~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 233 QLPA--DKFSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp CCCT--TTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred Cccc--ccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 1111 112346888999999999999999999976
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-37 Score=345.48 Aligned_cols=199 Identities=22% Similarity=0.278 Sum_probs=172.2
Q ss_pred hcCCCCceeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhc------cCCceeeEeccccc
Q 044366 645 TGNFGEKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEI------RHRNIIKFHGFCSN 717 (918)
Q Consensus 645 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l------~h~niv~~~~~~~~ 717 (918)
..+|.+.+.||+|+||.||+|.. .+++.||||+++.. ......+.+|+.+++.+ +|+||+++++++..
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-----~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~ 170 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-----KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTF 170 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-----HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEE
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-----cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeeccc
Confidence 46799999999999999999954 56899999998652 12245678888888877 56799999999999
Q ss_pred CCceEEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCc--EEEec
Q 044366 718 AQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYE--AHVSD 795 (918)
Q Consensus 718 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~--~kl~D 795 (918)
.+..++||||++ ++|.+++.... ...+++..++.++.||+.||+|||+. +|+||||||+||+++.++. +||+|
T Consensus 171 ~~~~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NILl~~~~~~~vkL~D 245 (429)
T 3kvw_A 171 RNHICMTFELLS-MNLYELIKKNK-FQGFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVID 245 (429)
T ss_dssp TTEEEEEECCCC-CBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHHH---TEECSCCSGGGEEESSTTSCCEEECC
T ss_pred CCeEEEEEeccC-CCHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEccCCCcceEEee
Confidence 999999999996 59999987654 24489999999999999999999999 9999999999999999987 99999
Q ss_pred cccccccCCCCCCceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcch
Q 044366 796 FGFAKFLEPHSSNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVS 856 (918)
Q Consensus 796 fG~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~ 856 (918)
||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 246 FG~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~ 303 (429)
T 3kvw_A 246 FGSSCYEHQR---VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGED 303 (429)
T ss_dssp CTTCEETTCC---CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cccceecCCc---ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCC
Confidence 9999765433 234578999999999999999999999999999999999999986543
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-37 Score=328.31 Aligned_cols=255 Identities=24% Similarity=0.330 Sum_probs=205.2
Q ss_pred HHHhcCCCCceeeccccceEEEEEEeC-CCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCc
Q 044366 642 TKATGNFGEKYCIGKGGQRSVYKAELP-SGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQH 720 (918)
Q Consensus 642 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 720 (918)
....++|.+.+.||+|+||.||+|... +++.||+|++..... .....+.+.+|++++++++||||+++++++.+.+.
T Consensus 18 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 95 (287)
T 2wei_A 18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASA--KNKDTSTILREVELLKKLDHPNIMKLFEILEDSSS 95 (287)
T ss_dssp HHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGB--SSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred HHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEeccccc--chHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCe
Confidence 344578999999999999999999654 799999999876432 23456789999999999999999999999999999
Q ss_pred eEEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCC---CcEEEeccc
Q 044366 721 SFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSE---YEAHVSDFG 797 (918)
Q Consensus 721 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~---~~~kl~DfG 797 (918)
.++||||+++++|.+++.... .+++.+++.++.|++.||+|||+. +++||||||+||+++.+ +.+||+|||
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg 169 (287)
T 2wei_A 96 FYIVGELYTGGELFDEIIKRK---RFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFG 169 (287)
T ss_dssp EEEEECCCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECSTT
T ss_pred EEEEEEccCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChhhEEEecCCCcccEEEeccC
Confidence 999999999999999887543 489999999999999999999999 99999999999999764 469999999
Q ss_pred cccccCCCCCCceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCC
Q 044366 798 FAKFLEPHSSNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRL 877 (918)
Q Consensus 798 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 877 (918)
++....... ......|++.|+|||.+.+ .++.++||||||+++|+|++|+.||...... .. .. .+.....
T Consensus 170 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-~~----~~---~~~~~~~ 239 (287)
T 2wei_A 170 LSTCFQQNT-KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEY-DI----LK---RVETGKY 239 (287)
T ss_dssp GGGTBCCCS-SCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HH----HH---HHHHCCC
T ss_pred cceeecCCC-ccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHH-HH----HH---HHHcCCC
Confidence 998765432 2234568999999998876 4889999999999999999999998654321 11 11 1111111
Q ss_pred CCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 878 PTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 878 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
.............+.+++.+||+.||++|||++|+++
T Consensus 240 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 240 AFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp CCCSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCchhhhhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence 1111111223356889999999999999999999986
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-38 Score=347.40 Aligned_cols=256 Identities=11% Similarity=0.037 Sum_probs=180.0
Q ss_pred cCCCCceeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhc--cCCceeeEec-------cc
Q 044366 646 GNFGEKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEI--RHRNIIKFHG-------FC 715 (918)
Q Consensus 646 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l--~h~niv~~~~-------~~ 715 (918)
.+|...+.||+|+||.||+|.. .+|+.||||++...... .....+.+.+|+.+++.+ +||||++++. ++
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAEN-SRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTT-HHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccc-cccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence 4588899999999999999965 47899999999764221 112245677885555555 6999887553 33
Q ss_pred ccC-----------------CceEEEEEeccCCChhHHhhcccccCCCCHHHH------HHHHHHHHHHHHHHHhCCCCC
Q 044366 716 SNA-----------------QHSFIVCEYLARGSLTTILRDDAAAKEFSWNQR------MNVIKGVANALSYLHHDCIPP 772 (918)
Q Consensus 716 ~~~-----------------~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~------~~i~~~i~~~l~~LH~~~~~~ 772 (918)
... ...++||||++ |+|.+++..... .+++..+ +.++.||+.||+|||+. +
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~--~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~---~ 214 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF--VYVFRGDEGILALHILTAQLIRLAANLQSK---G 214 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH--SCCCCHHHHHHHHHHHHHHHHHHHHHHHHT---T
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc--ccchhhhhhhhhHHHHHHHHHHHHHHHHHC---C
Confidence 221 34799999999 899999986522 2455556 78889999999999999 9
Q ss_pred eEEcCCCCCCeeeCCCCcEEEeccccccccCCCCCCceeccccccccccccccc--CCCCcccchhhHHHHHHHHHhCCC
Q 044366 773 IVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGTVGYAAPELAYT--MRATEKYDVYSFGVLALEVIKGYH 850 (918)
Q Consensus 773 ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~~Dv~slG~vl~el~tg~~ 850 (918)
|+||||||+||+++.++.+||+|||+++..... .....+++.|+|||++.+ ..++.++|||||||++|||++|+.
T Consensus 215 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~ 291 (371)
T 3q60_A 215 LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR---GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFL 291 (371)
T ss_dssp EEETTCSGGGEEECTTSCEEECCGGGEEETTCE---EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSC
T ss_pred CccCcCCHHHEEECCCCCEEEEecceeeecCCC---ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCC
Confidence 999999999999999999999999999876432 224567799999999987 678999999999999999999999
Q ss_pred CCCcchhhhhhhhhhHhhhhhhcccCCCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 851 PGDFVSTIFSSISNMIIEVNQILDHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 851 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
||.............. ............+ ........+.+++.+||+.||++|||++|+++
T Consensus 292 Pf~~~~~~~~~~~~~~-~~~~~~~~~~~~~--~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 292 PFGLVTPGIKGSWKRP-SLRVPGTDSLAFG--SCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp STTBCCTTCTTCCCBC-CTTSCCCCSCCCT--TSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred CCCCcCcccccchhhh-hhhhccccccchh--hccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 9875432111000000 0000001111111 01122356888999999999999999999874
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=343.31 Aligned_cols=256 Identities=20% Similarity=0.311 Sum_probs=181.7
Q ss_pred hcCCCCceeeccccceEEEEEE-eCCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccC-----
Q 044366 645 TGNFGEKYCIGKGGQRSVYKAE-LPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNA----- 718 (918)
Q Consensus 645 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~----- 718 (918)
.++|...+.||+|+||.||+|. ..+|+.||||++.... ......+.+.+|+++++.++||||+++++++...
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~ 105 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF--QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEE 105 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTT--SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGG
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccc--cCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCcccc
Confidence 4789999999999999999995 4679999999986532 1222356788999999999999999999988543
Q ss_pred -CceEEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccc
Q 044366 719 -QHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFG 797 (918)
Q Consensus 719 -~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG 797 (918)
...++|+||+ +++|.++++. ..+++..++.++.||++||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 106 ~~~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kL~DFG 177 (367)
T 2fst_X 106 FNDVYLVTHLM-GADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFG 177 (367)
T ss_dssp CCCCEEEEECC-CEECC---------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC--
T ss_pred CCeEEEEeccc-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHhhEEECCCCCEEEeecc
Confidence 5679999999 6799998865 3489999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCCceeccccccccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhh--------
Q 044366 798 FAKFLEPHSSNWTEFAGTVGYAAPELAYT-MRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIE-------- 868 (918)
Q Consensus 798 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~-------- 868 (918)
+++..... .....||+.|+|||++.+ ..++.++||||+||++|||++|+.||....... ........
T Consensus 178 ~a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-~l~~i~~~~g~p~~~~ 253 (367)
T 2fst_X 178 LARHTADE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID-QLKLILRLVGTPGAEL 253 (367)
T ss_dssp ----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCSCCHHH
T ss_pred cccccccc---CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCCHHH
Confidence 99875432 344678999999999877 678999999999999999999999986543211 11110000
Q ss_pred --------hhhhcccCCCCCCcchH----HHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 869 --------VNQILDHRLPTPSRDVT----DKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 869 --------~~~~~~~~~~~~~~~~~----~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
...........+..... .....+.+++.+||+.||++|||++|+++
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~ 311 (367)
T 2fst_X 254 LKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 311 (367)
T ss_dssp HTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhc
Confidence 00000000000111111 11356889999999999999999999975
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-37 Score=340.63 Aligned_cols=259 Identities=23% Similarity=0.279 Sum_probs=194.4
Q ss_pred HHHhcCCCCceeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEeccccc---
Q 044366 642 TKATGNFGEKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSN--- 717 (918)
Q Consensus 642 ~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--- 717 (918)
+...++|...+.||+|+||.||+|.. .+|+.||||++.... ....+|+++++.++||||+++++++..
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~--------~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 74 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDP--------RYKNRELDIMKVLDHVNIIKLVDYFYTTGD 74 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCT--------TSCCHHHHHHTTCCCTTBCCEEEEEEEC--
T ss_pred ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCc--------chHHHHHHHHHHcCCCCccchhheeeecCc
Confidence 44567899999999999999999954 689999999986431 112479999999999999999998833
Q ss_pred -----------------------------------CCceEEEEEeccCCChhHHhhcc-cccCCCCHHHHHHHHHHHHHH
Q 044366 718 -----------------------------------AQHSFIVCEYLARGSLTTILRDD-AAAKEFSWNQRMNVIKGVANA 761 (918)
Q Consensus 718 -----------------------------------~~~~~lv~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~ 761 (918)
....++||||++ |+|.+.+... .....+++..++.++.|+++|
T Consensus 75 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~a 153 (383)
T 3eb0_A 75 EEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRA 153 (383)
T ss_dssp -----------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHH
Confidence 334789999998 4888877643 224568999999999999999
Q ss_pred HHHHHhCCCCCeEEcCCCCCCeeeC-CCCcEEEeccccccccCCCCCCceecccccccccccccccC-CCCcccchhhHH
Q 044366 762 LSYLHHDCIPPIVHRDISSKNVLLD-SEYEAHVSDFGFAKFLEPHSSNWTEFAGTVGYAAPELAYTM-RATEKYDVYSFG 839 (918)
Q Consensus 762 l~~LH~~~~~~ivH~dlk~~Nill~-~~~~~kl~DfG~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG 839 (918)
|+|||+. +|+||||||+||+++ .++.+||+|||+++....... .....||+.|+|||++.+. .++.++||||+|
T Consensus 154 L~~LH~~---gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG 229 (383)
T 3eb0_A 154 VGFIHSL---GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP-SVAYICSRFYRAPELMLGATEYTPSIDLWSIG 229 (383)
T ss_dssp HHHHHTT---TEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC-CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHH
T ss_pred HHHHHHC---cCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC-CcCcccCCCccCHHHhcCCCCCCcchhhhhHH
Confidence 9999999 999999999999997 688999999999987754433 2345789999999998765 489999999999
Q ss_pred HHHHHHHhCCCCCCcchhhhhhhhhhHh--------hhhh----hcccCCCCCC-cchHH-----HHHHHHHHHHHcccC
Q 044366 840 VLALEVIKGYHPGDFVSTIFSSISNMII--------EVNQ----ILDHRLPTPS-RDVTD-----KLRSIMEVAILCLVE 901 (918)
Q Consensus 840 ~vl~el~tg~~p~~~~~~~~~~~~~~~~--------~~~~----~~~~~~~~~~-~~~~~-----~~~~l~~li~~cl~~ 901 (918)
|++|||++|+.||........ ...... .... ......+... ..... ....+.+++.+||+.
T Consensus 230 ~il~ell~g~~pf~~~~~~~~-~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 308 (383)
T 3eb0_A 230 CVFGELILGKPLFSGETSIDQ-LVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRY 308 (383)
T ss_dssp HHHHHHHHSSCSSCCSSHHHH-HHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCS
T ss_pred HHHHHHHhCCCCCCCCChHHH-HHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccC
Confidence 999999999999875433211 111100 0000 0000111110 11111 234588999999999
Q ss_pred CCCCCCCHHHHHH
Q 044366 902 NPEARPTMKEVCN 914 (918)
Q Consensus 902 dp~~RPt~~evl~ 914 (918)
||++|||+.|+++
T Consensus 309 dP~~R~t~~e~l~ 321 (383)
T 3eb0_A 309 EPDLRINPYEAMA 321 (383)
T ss_dssp SGGGSCCHHHHHT
T ss_pred ChhhCCCHHHHhc
Confidence 9999999999974
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-37 Score=340.33 Aligned_cols=258 Identities=20% Similarity=0.285 Sum_probs=198.5
Q ss_pred hcCCCCceeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccC-----
Q 044366 645 TGNFGEKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNA----- 718 (918)
Q Consensus 645 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~----- 718 (918)
.++|...+.||+|+||.||+|.. .+++.||||++... ......+.+.+|++++++++||||+++++++...
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 102 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPF---EHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQM 102 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCT---TCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTC
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccc---cCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCcccc
Confidence 46899999999999999999954 47889999998642 1222346789999999999999999999998654
Q ss_pred CceEEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEecccc
Q 044366 719 QHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGF 798 (918)
Q Consensus 719 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~ 798 (918)
...++||||+++ +|.++++.. .+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 103 ~~~~iv~e~~~~-~L~~~l~~~----~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~ 174 (364)
T 3qyz_A 103 KDVYIVQDLMET-DLYKLLKTQ----HLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGL 174 (364)
T ss_dssp CCEEEEEECCSE-EHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred ceEEEEEcccCc-CHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChHhEEECCCCCEEEEeCcc
Confidence 468999999984 999998753 489999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCC---Cceeccccccccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhh------
Q 044366 799 AKFLEPHSS---NWTEFAGTVGYAAPELAYT-MRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIE------ 868 (918)
Q Consensus 799 ~~~~~~~~~---~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~------ 868 (918)
++....... ......||+.|+|||++.+ ..++.++||||+||++|||++|+.||....... ........
T Consensus 175 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-~~~~i~~~~~~~~~ 253 (364)
T 3qyz_A 175 ARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLD-QLNHILGILGSPSQ 253 (364)
T ss_dssp CEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGG-HHHHHHHHHCSCCH
T ss_pred eEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHH-HHHHHHHHhCCCCH
Confidence 987654322 1244578999999998754 458999999999999999999999986543211 11110000
Q ss_pred --h--------hhhcccCCCCCCcch----HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 869 --V--------NQILDHRLPTPSRDV----TDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 869 --~--------~~~~~~~~~~~~~~~----~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
. ............... ......+.+++.+||+.||++|||++|+++
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 313 (364)
T 3qyz_A 254 EDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 313 (364)
T ss_dssp HHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0 000000000000001 112356889999999999999999999985
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-37 Score=340.70 Aligned_cols=257 Identities=22% Similarity=0.269 Sum_probs=193.1
Q ss_pred hcCCCCceeeccccceEEEEEEeCCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCC-----
Q 044366 645 TGNFGEKYCIGKGGQRSVYKAELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQ----- 719 (918)
Q Consensus 645 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----- 719 (918)
..+|...+.||+|+||.||+|+...+..||+|++.... ....+|+++++.++||||+++++++...+
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~--------~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~ 110 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDK--------RFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDE 110 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCT--------TSCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSC
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCc--------chHHHHHHHHHhCCCCCcceEEEEEEecCCCCCc
Confidence 45789999999999999999988777779999875421 11237999999999999999999984433
Q ss_pred -ceEEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeC-CCCcEEEeccc
Q 044366 720 -HSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLD-SEYEAHVSDFG 797 (918)
Q Consensus 720 -~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~-~~~~~kl~DfG 797 (918)
..++||||++++.+............+++..++.++.||++||+|||+. +|+||||||+||+++ .++.+||+|||
T Consensus 111 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~kL~DFG 187 (394)
T 4e7w_A 111 VFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFG 187 (394)
T ss_dssp EEEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred eEEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEcCCCCcEEEeeCC
Confidence 3789999998754443332222345689999999999999999999999 999999999999999 78999999999
Q ss_pred cccccCCCCCCceecccccccccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHh---------
Q 044366 798 FAKFLEPHSSNWTEFAGTVGYAAPELAYTM-RATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMII--------- 867 (918)
Q Consensus 798 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~--------- 867 (918)
+++....... .....||+.|+|||++.+. .++.++||||+||++|||++|+.||........ ......
T Consensus 188 ~a~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~-l~~i~~~~g~p~~~~ 265 (394)
T 4e7w_A 188 SAKILIAGEP-NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQ-LVEIIKVLGTPSREQ 265 (394)
T ss_dssp TCEECCTTCC-CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHHHCCCCHHH
T ss_pred CcccccCCCC-CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHhCCCCHHH
Confidence 9987654333 2345789999999998765 589999999999999999999999875432211 111000
Q ss_pred --hh-hhhcccCCCCCCc-chHH-----HHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 868 --EV-NQILDHRLPTPSR-DVTD-----KLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 868 --~~-~~~~~~~~~~~~~-~~~~-----~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
.. ........+.... .... ....+.+++.+||+.||++|||+.|+++
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 321 (394)
T 4e7w_A 266 IKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALC 321 (394)
T ss_dssp HHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred HHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhc
Confidence 00 0011111111111 1111 2357889999999999999999999975
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-36 Score=337.71 Aligned_cols=311 Identities=21% Similarity=0.190 Sum_probs=177.9
Q ss_pred ccccCeeeccccccCCcCCccCCCCCCCcEeeccCcccccCCCccccCCCCcceeecccccccCCCCCCCcCCCcCCeEE
Q 044366 164 LKSLLQLDLSENRLSGLIPLSLSNLSSLTVMSLFNNSLSGSIPPILGNLKSLSTLGLHINQLNGVIPPSIGNLSSLRNLS 243 (918)
Q Consensus 164 l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 243 (918)
++++++|++++|.++.+++..|..+++|++|++++|.+++..+..|..+++|++|++++|.+++..|..|.++++|++|+
T Consensus 44 l~~l~~l~l~~~~l~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 123 (390)
T 3o6n_A 44 LNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLV 123 (390)
T ss_dssp GCCCSEEEEESCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred cCCceEEEecCCchhhCChhHhcccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEE
Confidence 45555566666555555444455555555555555555554445555555555555555555555555555555555555
Q ss_pred cccCcCcCCCCccccccCCCCeEecCCCccCCcCCCcCCCCCCCcEEEccCCcCcCCCCccccCCCCCCeEEeecccccC
Q 044366 244 LFNNRLYGFVPKEIGYLKSLSKLEFCANHLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLRNLTSLERVRFNQNNLYG 323 (918)
Q Consensus 244 Ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~ 323 (918)
+++|+++.+++..|..+++|++|++++|++.+..+..|..+++|+.|++++|++ ..
T Consensus 124 L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l------------------------~~ 179 (390)
T 3o6n_A 124 LERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRL------------------------TH 179 (390)
T ss_dssp CCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTSSCTTCCEEECCSSCC------------------------SB
T ss_pred CCCCccCcCCHHHhcCCCCCcEEECCCCccCccChhhccCCCCCCEEECCCCcC------------------------Cc
Confidence 555555544444445555555555555555544444444444444444444444 33
Q ss_pred ccccccCCCCCccEEeCCCCccccccCcccccccccceeeccccccccCCCcCcCCCCCCcEEEccCceeccccccchhh
Q 044366 324 KVYEAFGDHPNLTFLDLSQNNFYCEISFNWRNFSKLGTFNASMNNIYGSIPPEIGDSSKLQVLDLSSNHIFGKIPVQLVK 403 (918)
Q Consensus 324 ~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~n~i~~~~~~~~~~~~~L~~L~L~~N~l~~~~~~~~~~ 403 (918)
++ +..+++|+.|++++|.+... ...++|+.|++++|.+..... . .
T Consensus 180 ~~---~~~l~~L~~L~l~~n~l~~~-----------------------------~~~~~L~~L~l~~n~l~~~~~-~--~ 224 (390)
T 3o6n_A 180 VD---LSLIPSLFHANVSYNLLSTL-----------------------------AIPIAVEELDASHNSINVVRG-P--V 224 (390)
T ss_dssp CC---GGGCTTCSEEECCSSCCSEE-----------------------------ECCSSCSEEECCSSCCCEEEC-C--C
T ss_pred cc---cccccccceeeccccccccc-----------------------------CCCCcceEEECCCCeeeeccc-c--c
Confidence 32 22334555555555544311 111234444555554443211 1 1
Q ss_pred ccccCceecccccccCCCCCCCCCCCcccEEeccCccccccCccccccccccceecccCcccCCCCchhhccccccceEe
Q 044366 404 LFSLNKLILSLNQLFGGVPLEFGTLTELQYLDLSANKLSSSIPMSIGNLLKLHYLNLSNNQFSHKIPTEFEKLIHLSELD 483 (918)
Q Consensus 404 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 483 (918)
.++|+.|++++|++++. ..+..+++|++|+|++|.+++..|..|..+++|+.|+|++|++++ +|..+..+++|++|+
T Consensus 225 ~~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~ 301 (390)
T 3o6n_A 225 NVELTILKLQHNNLTDT--AWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLD 301 (390)
T ss_dssp CSSCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECCSSCCCE-EECSSSCCTTCCEEE
T ss_pred cccccEEECCCCCCccc--HHHcCCCCccEEECCCCcCCCcChhHccccccCCEEECCCCcCcc-cCcccCCCCCCCEEE
Confidence 23555555555555432 345666677777777777776666777777777777777777764 455556677777777
Q ss_pred ccCCcCCCCCchhccccCCcceEecCCCcccccCcccccCCCCccEEEccCCcCCCC
Q 044366 484 LSHNILQEEIPPQICKMESLEKLNLSHNNLSDFIPRCFEEMRSLSWIDISYNELQGP 540 (918)
Q Consensus 484 Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~ 540 (918)
|++|+++ .+|..+..+++|+.|+|++|+++++. +..+++|+.|++++|+|+|.
T Consensus 302 L~~n~l~-~~~~~~~~l~~L~~L~L~~N~i~~~~---~~~~~~L~~L~l~~N~~~~~ 354 (390)
T 3o6n_A 302 LSHNHLL-HVERNQPQFDRLENLYLDHNSIVTLK---LSTHHTLKNLTLSHNDWDCN 354 (390)
T ss_dssp CCSSCCC-CCGGGHHHHTTCSEEECCSSCCCCCC---CCTTCCCSEEECCSSCEEHH
T ss_pred CCCCcce-ecCccccccCcCCEEECCCCccceeC---chhhccCCEEEcCCCCccch
Confidence 7777776 45556667777777777777776642 55667777788888877764
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-37 Score=330.64 Aligned_cols=250 Identities=24% Similarity=0.418 Sum_probs=191.0
Q ss_pred hcCCCCceeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEeccccc------
Q 044366 645 TGNFGEKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSN------ 717 (918)
Q Consensus 645 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~------ 717 (918)
.++|+..+.||+|+||.||+|.. .+|+.||||++... ....+.+.+|+++++.++||||+++++++.+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 79 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-----EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVK 79 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-----HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-----HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhh
Confidence 46788999999999999999965 57999999998642 1235678999999999999999999998744
Q ss_pred -------CCceEEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCc
Q 044366 718 -------AQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYE 790 (918)
Q Consensus 718 -------~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~ 790 (918)
.+..++||||+++|+|.+++.... ..+++.+++.++.|+++||+|||+. +++||||||+||+++.++.
T Consensus 80 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dlkp~Nil~~~~~~ 154 (303)
T 1zy4_A 80 PMTAVKKKSTLFIQMEYCENGTLYDLIHSEN--LNQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRN 154 (303)
T ss_dssp ------CEEEEEEEEECCCSCBHHHHHHHSC--GGGCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSC
T ss_pred hhcccccCCceEEEEecCCCCCHHHhhhccc--cccchHHHHHHHHHHHHHHHHHHhC---CeecccCCHHhEEEcCCCC
Confidence 456899999999999999997542 3478899999999999999999999 9999999999999999999
Q ss_pred EEEeccccccccCCCC--------------CCceecccccccccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCcc
Q 044366 791 AHVSDFGFAKFLEPHS--------------SNWTEFAGTVGYAAPELAYTM-RATEKYDVYSFGVLALEVIKGYHPGDFV 855 (918)
Q Consensus 791 ~kl~DfG~~~~~~~~~--------------~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~vl~el~tg~~p~~~~ 855 (918)
+||+|||.+....... .......|++.|+|||++.+. .++.++||||||+++|||++ |+...
T Consensus 155 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~ 231 (303)
T 1zy4_A 155 VKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTG 231 (303)
T ss_dssp EEECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSH
T ss_pred EEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCc
Confidence 9999999998764321 122345689999999998764 68999999999999999998 43322
Q ss_pred hhhhhhhhhhHhhhhhhcccCCCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 856 STIFSSISNMIIEVNQILDHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 856 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
...... ....... ....+. .........+.+++.+||+.||.+|||++|+++
T Consensus 232 ~~~~~~----~~~~~~~-~~~~~~--~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 283 (303)
T 1zy4_A 232 MERVNI----LKKLRSV-SIEFPP--DFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN 283 (303)
T ss_dssp HHHHHH----HHHHHST-TCCCCT--TCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hhHHHH----HHhcccc-ccccCc--cccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence 211111 1111111 111111 111222345788999999999999999999986
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=332.39 Aligned_cols=263 Identities=21% Similarity=0.306 Sum_probs=201.9
Q ss_pred HHhcCCCCceeeccccceEEEEEEe--CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhc---cCCceeeEecccc-
Q 044366 643 KATGNFGEKYCIGKGGQRSVYKAEL--PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEI---RHRNIIKFHGFCS- 716 (918)
Q Consensus 643 ~~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l---~h~niv~~~~~~~- 716 (918)
.+.++|...+.||+|+||.||+|.. .+|+.||+|+++..... ......+.+|+.+++.+ +||||+++++++.
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~ 85 (326)
T 1blx_A 8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGE--EGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTV 85 (326)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCT--TSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEE
T ss_pred CchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCccc--ccCCchhhHHHHHHHhhhccCCCCeEeeeeeeee
Confidence 3557899999999999999999976 46889999998764322 22234677888887776 8999999999986
Q ss_pred ----cCCceEEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEE
Q 044366 717 ----NAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAH 792 (918)
Q Consensus 717 ----~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~k 792 (918)
.....++||||++ |+|.+++.... ...+++.+++.++.|++.||+|||+. ||+||||||+||+++.++.+|
T Consensus 86 ~~~~~~~~~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---gi~H~dlkp~Nili~~~~~~k 160 (326)
T 1blx_A 86 SRTDRETKLTLVFEHVD-QDLTTYLDKVP-EPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIK 160 (326)
T ss_dssp EECSSEEEEEEEEECCS-CBHHHHHHHSC-TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEE
T ss_pred cccCCCceEEEEEecCC-CCHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHHHeEEcCCCCEE
Confidence 5567899999998 69999997653 23489999999999999999999999 999999999999999999999
Q ss_pred EeccccccccCCCCCCceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhh-
Q 044366 793 VSDFGFAKFLEPHSSNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQ- 871 (918)
Q Consensus 793 l~DfG~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~- 871 (918)
|+|||+++...... ......|++.|+|||++.+..++.++||||||+++|||++|+.||....... ...........
T Consensus 161 l~Dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~~~~i~~~~~~~ 238 (326)
T 1blx_A 161 LADFGLARIYSFQM-ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD-QLGKILDVIGLP 238 (326)
T ss_dssp ECSCCSCCCCCGGG-GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCCC
T ss_pred EecCcccccccCCC-CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHH-HHHHHHHHcCCC
Confidence 99999998664322 2344578999999999999899999999999999999999999987543321 11111100000
Q ss_pred --------------hcccCC-CCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 872 --------------ILDHRL-PTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 872 --------------~~~~~~-~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
...... .............+.+++.+||+.||++|||+.|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 296 (326)
T 1blx_A 239 GEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 296 (326)
T ss_dssp CGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 000000 0000001122356788999999999999999999984
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-37 Score=334.65 Aligned_cols=257 Identities=22% Similarity=0.340 Sum_probs=199.4
Q ss_pred HHHhcCCCCceeeccccceEEEEEEeCCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCce
Q 044366 642 TKATGNFGEKYCIGKGGQRSVYKAELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHS 721 (918)
Q Consensus 642 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 721 (918)
....++|...+.||+|+||.||+|.... .||+|+++.... .....+.|.+|+.+++.++||||+++++++.+++..
T Consensus 29 ~i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 104 (319)
T 2y4i_B 29 DIPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERD--NEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHL 104 (319)
T ss_dssp SSCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSC--CCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCE
T ss_pred cCCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCC--CHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCce
Confidence 3445788999999999999999998643 499999876422 223345678999999999999999999999999999
Q ss_pred EEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccc
Q 044366 722 FIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKF 801 (918)
Q Consensus 722 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~ 801 (918)
++||||+++++|.+++... ...+++.+++.++.|++.||+|||+. +++||||||+||+++ ++.+||+|||+++.
T Consensus 105 ~iv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~ 178 (319)
T 2y4i_B 105 AIITSLCKGRTLYSVVRDA--KIVLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFYD-NGKVVITDFGLFSI 178 (319)
T ss_dssp EEECBCCCSEEHHHHTTSS--CCCCCSHHHHHHHHHHHHHHHHHHHT---TCCCCCCCSTTEEEC---CCEECCCSCCC-
T ss_pred EEEeecccCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChhhEEEe-CCCEEEeecCCccc
Confidence 9999999999999999764 24589999999999999999999999 999999999999998 67999999999876
Q ss_pred cCCC-----CCCceeccccccccccccccc---------CCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHh
Q 044366 802 LEPH-----SSNWTEFAGTVGYAAPELAYT---------MRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMII 867 (918)
Q Consensus 802 ~~~~-----~~~~~~~~g~~~y~aPE~~~~---------~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~ 867 (918)
.... ........|++.|+|||++.+ ..++.++||||||+++|||++|+.||....... ...
T Consensus 179 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-----~~~ 253 (319)
T 2y4i_B 179 SGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEA-----IIW 253 (319)
T ss_dssp ---------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHH-----HHH
T ss_pred cccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-----HHH
Confidence 5321 122234568999999999864 347889999999999999999999987543211 111
Q ss_pred hhhhhcccCCCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhC
Q 044366 868 EVNQILDHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLLCK 918 (918)
Q Consensus 868 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~ 918 (918)
........... ... ....+.+++.+||+.||++|||++++++.|++
T Consensus 254 ~~~~~~~~~~~--~~~---~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~ 299 (319)
T 2y4i_B 254 QMGTGMKPNLS--QIG---MGKEISDILLFCWAFEQEERPTFTKLMDMLEK 299 (319)
T ss_dssp HHHTTCCCCCC--CSS---CCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTT
T ss_pred HhccCCCCCCC--cCC---CCHHHHHHHHHHhcCChhhCcCHHHHHHHHHH
Confidence 11111111111 111 12357889999999999999999999999864
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-36 Score=343.98 Aligned_cols=254 Identities=17% Similarity=0.235 Sum_probs=200.7
Q ss_pred hcCCCCceeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccC-CceeeEecccccCCceE
Q 044366 645 TGNFGEKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRH-RNIIKFHGFCSNAQHSF 722 (918)
Q Consensus 645 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~~~~~~~~~~~~~ 722 (918)
.++|.+.+.||+|+||.||+|.. .+++.||||++.... ...++..|+++++.++| +++..+..++...+..+
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~------~~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~ 79 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT------KHPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNV 79 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTC------SSCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccc------ccHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEE
Confidence 46899999999999999999964 679999999876431 12458899999999976 56666666777888899
Q ss_pred EEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeee---CCCCcEEEeccccc
Q 044366 723 IVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLL---DSEYEAHVSDFGFA 799 (918)
Q Consensus 723 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill---~~~~~~kl~DfG~~ 799 (918)
+||||+ +++|.+++... ...+++.+++.|+.||+.||+|||+. +||||||||+||++ +.++.+||+|||++
T Consensus 80 lvme~~-g~sL~~ll~~~--~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDIKP~NILl~~~~~~~~vkL~DFGla 153 (483)
T 3sv0_A 80 LVMDLL-GPSLEDLFNFC--SRKLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIIDFGLA 153 (483)
T ss_dssp EEEECC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTTCEEECCCTTC
T ss_pred EEEECC-CCCHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCcceEEEecCCCCCeEEEEeCCcc
Confidence 999999 88999999754 23589999999999999999999999 99999999999999 57889999999999
Q ss_pred cccCCCCCC-------ceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhh--hhhhhhhHh-hh
Q 044366 800 KFLEPHSSN-------WTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTI--FSSISNMII-EV 869 (918)
Q Consensus 800 ~~~~~~~~~-------~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~--~~~~~~~~~-~~ 869 (918)
+.+...... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...... ...+..... ..
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~ 233 (483)
T 3sv0_A 154 KKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV 233 (483)
T ss_dssp EECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHH
T ss_pred eeccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccc
Confidence 877654322 12567899999999999999999999999999999999999998754321 111111000 00
Q ss_pred hhhcccCCCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 044366 870 NQILDHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLLC 917 (918)
Q Consensus 870 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 917 (918)
....... ......++.+++..||+.||++||++++|++.|+
T Consensus 234 ~~~~~~l-------~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~ 274 (483)
T 3sv0_A 234 ATSIEAL-------CRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFR 274 (483)
T ss_dssp HSCHHHH-------HTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHH
T ss_pred cccHHHH-------hcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHH
Confidence 0000000 0011246889999999999999999999999875
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-37 Score=338.28 Aligned_cols=266 Identities=20% Similarity=0.209 Sum_probs=190.3
Q ss_pred HHHHHHHhcCCCCceeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccc
Q 044366 638 YEEITKATGNFGEKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCS 716 (918)
Q Consensus 638 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~ 716 (918)
........++|.+.+.||+|+||.||+|.. .+|+.||||++... ......+.+|++.++.++||||+++++++.
T Consensus 15 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~~~~~~~l~~l~h~niv~~~~~~~ 89 (360)
T 3e3p_A 15 DERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQD-----PRFRNRELQIMQDLAVLHHPNIVQLQSYFY 89 (360)
T ss_dssp SHHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECC-----TTCCCHHHHHHHHHHHHCCTTBCCEEEEEE
T ss_pred hhhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecC-----ccccHHHHHHHHHHHhcCCCCcccHHHhhh
Confidence 345677889999999999999999999965 57999999988542 223456788888899999999999999985
Q ss_pred cCCc-------eEEEEEeccCCChhHHhhc-ccccCCCCHHHHHHHHHHHHHHHHHHH--hCCCCCeEEcCCCCCCeeeC
Q 044366 717 NAQH-------SFIVCEYLARGSLTTILRD-DAAAKEFSWNQRMNVIKGVANALSYLH--HDCIPPIVHRDISSKNVLLD 786 (918)
Q Consensus 717 ~~~~-------~~lv~e~~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~~i~~~l~~LH--~~~~~~ivH~dlk~~Nill~ 786 (918)
..+. .++||||+++ ++.+.+.. ......+++..++.++.|++.|++||| +. +|+||||||+||+++
T Consensus 90 ~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~---~ivH~Dlkp~NIll~ 165 (360)
T 3e3p_A 90 TLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSV---NVCHRDIKPHNVLVN 165 (360)
T ss_dssp EECSSCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTT---CCBCSCCCGGGEEEE
T ss_pred ccccccccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCC---CeecCcCCHHHEEEe
Confidence 4332 7899999986 55554432 223455899999999999999999999 87 999999999999999
Q ss_pred C-CCcEEEeccccccccCCCCCCceecccccccccccccccCC-CCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhh
Q 044366 787 S-EYEAHVSDFGFAKFLEPHSSNWTEFAGTVGYAAPELAYTMR-ATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISN 864 (918)
Q Consensus 787 ~-~~~~kl~DfG~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~ 864 (918)
. ++.+||+|||+++....... .....||+.|+|||++.+.. ++.++|||||||++|||++|+.||....... ....
T Consensus 166 ~~~~~~kl~Dfg~a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~-~~~~ 243 (360)
T 3e3p_A 166 EADGTLKLCDFGSAKKLSPSEP-NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAG-QLHE 243 (360)
T ss_dssp TTTTEEEECCCTTCBCCCTTSC-CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHH
T ss_pred CCCCcEEEeeCCCceecCCCCC-cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHH-HHHH
Confidence 7 89999999999987764332 23457899999999987654 8999999999999999999999987543221 1111
Q ss_pred hHhh-------hhhhcccCC-----C-CCCcch--------HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 865 MIIE-------VNQILDHRL-----P-TPSRDV--------TDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 865 ~~~~-------~~~~~~~~~-----~-~~~~~~--------~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
.... ......... . ...... ......+.+++.+||+.||.+|||+.|+++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 314 (360)
T 3e3p_A 244 IVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALC 314 (360)
T ss_dssp HHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhc
Confidence 1000 000000000 0 000000 012457889999999999999999999975
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=336.40 Aligned_cols=255 Identities=22% Similarity=0.324 Sum_probs=195.0
Q ss_pred hcCCCCceeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCce--
Q 044366 645 TGNFGEKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHS-- 721 (918)
Q Consensus 645 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~-- 721 (918)
.++|...+.||+|+||.||+|.. .+|+.||||++..... .....+.+.+|+.+++.++||||+++++++...+..
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 118 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQ--SEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRN 118 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTS--SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTT
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEeccccc--chhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCccc
Confidence 46888999999999999999954 5799999999875321 122246789999999999999999999999776654
Q ss_pred ----EEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccc
Q 044366 722 ----FIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFG 797 (918)
Q Consensus 722 ----~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG 797 (918)
++||||++ ++|.+++.. .+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 119 ~~~~~lv~e~~~-~~l~~~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kL~Dfg 189 (371)
T 4exu_A 119 FYDFYLVMPFMQ-TDLQKIMGM-----EFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFG 189 (371)
T ss_dssp CCCCEEEEECCC-EEHHHHTTS-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECSTT
T ss_pred ceeEEEEEcccc-ccHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCcCHHHeEECCCCCEEEEecC
Confidence 99999998 588888743 389999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCCceeccccccccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhh--------
Q 044366 798 FAKFLEPHSSNWTEFAGTVGYAAPELAYT-MRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIE-------- 868 (918)
Q Consensus 798 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~-------- 868 (918)
+++..... .....||+.|+|||++.+ ..++.++||||+||++|+|++|+.||....... ........
T Consensus 190 ~a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~ 265 (371)
T 4exu_A 190 LARHADAE---MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD-QLTQILKVTGVPGTEF 265 (371)
T ss_dssp CC-----------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCCCCHHH
T ss_pred cccccccC---cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCCCcHHH
Confidence 99865432 234578999999999887 678999999999999999999999987543211 11111000
Q ss_pred --------hhhhcccCCCCCCcchH----HHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 869 --------VNQILDHRLPTPSRDVT----DKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 869 --------~~~~~~~~~~~~~~~~~----~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
................. .....+.+++.+||+.||++|||++|+++
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 323 (371)
T 4exu_A 266 VQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 323 (371)
T ss_dssp HTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred HHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhc
Confidence 00000000111111111 12357889999999999999999999975
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-37 Score=344.25 Aligned_cols=258 Identities=21% Similarity=0.270 Sum_probs=198.2
Q ss_pred hcCCCCceeeccccceEEEEEE-eCCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhcc--------CCceeeEeccc
Q 044366 645 TGNFGEKYCIGKGGQRSVYKAE-LPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIR--------HRNIIKFHGFC 715 (918)
Q Consensus 645 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~--------h~niv~~~~~~ 715 (918)
.++|.+.+.||+|+||.||+|. ..+++.||||+++.. ....+.+.+|+++++.++ |+||+++++++
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~ 110 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-----EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDF 110 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-----HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-----CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecce
Confidence 4789999999999999999995 457899999998642 223467899999999986 78899999998
Q ss_pred c----cCCceEEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCC--
Q 044366 716 S----NAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEY-- 789 (918)
Q Consensus 716 ~----~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~-- 789 (918)
. .+...++||||+ ++++.+++.... ...+++.+++.++.||+.||+|||+++ +|+||||||+||+++.++
T Consensus 111 ~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~--givHrDikp~NIll~~~~~~ 186 (397)
T 1wak_A 111 KISGVNGTHICMVFEVL-GHHLLKWIIKSN-YQGLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQY 186 (397)
T ss_dssp EEEETTEEEEEEEECCC-CCBHHHHHHHTT-TSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECCCCSGGGEEECCCHHH
T ss_pred eecCCCCceEEEEEecc-CccHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHeeEeccchh
Confidence 6 566889999999 456666665432 245899999999999999999999964 899999999999999775
Q ss_pred -----------------------------------------------cEEEeccccccccCCCCCCceeccccccccccc
Q 044366 790 -----------------------------------------------EAHVSDFGFAKFLEPHSSNWTEFAGTVGYAAPE 822 (918)
Q Consensus 790 -----------------------------------------------~~kl~DfG~~~~~~~~~~~~~~~~g~~~y~aPE 822 (918)
.+||+|||.++..... .....||+.|+|||
T Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~---~~~~~gt~~y~aPE 263 (397)
T 1wak_A 187 IRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH---FTEDIQTRQYRSLE 263 (397)
T ss_dssp HHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC---SCSCCSCGGGCCHH
T ss_pred hhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc---CccCCCCCcccCCh
Confidence 7999999999876543 23457899999999
Q ss_pred ccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhh-----hhhhhhHhhhh--------------hhccc-----CCC
Q 044366 823 LAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIF-----SSISNMIIEVN--------------QILDH-----RLP 878 (918)
Q Consensus 823 ~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~-----~~~~~~~~~~~--------------~~~~~-----~~~ 878 (918)
++.+..++.++|||||||++|||++|+.||....... ........... ..... ...
T Consensus 264 ~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~ 343 (397)
T 1wak_A 264 VLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHIT 343 (397)
T ss_dssp HHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCC
T ss_pred hhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCcccccccc
Confidence 9999999999999999999999999999986432110 00000000000 00000 000
Q ss_pred C------------CCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 879 T------------PSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 879 ~------------~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
. ...........+.+++.+||+.||++|||++|+++
T Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 344 KLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp CCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred ccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 0 00112345567899999999999999999999985
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-37 Score=345.30 Aligned_cols=199 Identities=20% Similarity=0.355 Sum_probs=154.3
Q ss_pred CCCC-ceeeccccceEEEEEEeC---CCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEeccc--ccCCc
Q 044366 647 NFGE-KYCIGKGGQRSVYKAELP---SGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFC--SNAQH 720 (918)
Q Consensus 647 ~~~~-~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~--~~~~~ 720 (918)
.|.. .++||+|+||.||+|+.. +++.||||++... .....+.+|+++++.++||||+++++++ ..+..
T Consensus 21 ~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~------~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 94 (405)
T 3rgf_A 21 LFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGT------GISMSACREIALLRELKHPNVISLQKVFLSHADRK 94 (405)
T ss_dssp HEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSS------SCCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTE
T ss_pred hhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCC------CCCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCe
Confidence 3544 457999999999999764 5789999998642 2235789999999999999999999998 45778
Q ss_pred eEEEEEeccCCChhHHhhccc------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeee----CCCCc
Q 044366 721 SFIVCEYLARGSLTTILRDDA------AAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLL----DSEYE 790 (918)
Q Consensus 721 ~~lv~e~~~~gsL~~~l~~~~------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill----~~~~~ 790 (918)
.++||||+++ +|.+++.... ....+++..++.++.||+.||+|||+. +|+||||||+||++ +.++.
T Consensus 95 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~ 170 (405)
T 3rgf_A 95 VWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGR 170 (405)
T ss_dssp EEEEEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECCSSTTTTC
T ss_pred EEEEEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeCCCcCHHHeEEecCCCCCCc
Confidence 9999999975 8888876432 123489999999999999999999999 99999999999999 67789
Q ss_pred EEEeccccccccCCCC---CCceecccccccccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCcc
Q 044366 791 AHVSDFGFAKFLEPHS---SNWTEFAGTVGYAAPELAYTM-RATEKYDVYSFGVLALEVIKGYHPGDFV 855 (918)
Q Consensus 791 ~kl~DfG~~~~~~~~~---~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~vl~el~tg~~p~~~~ 855 (918)
+||+|||+++.+.... .......||+.|+|||++.+. .++.++||||+||++|||++|+.||...
T Consensus 171 ~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~ 239 (405)
T 3rgf_A 171 VKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 239 (405)
T ss_dssp EEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCC
T ss_pred EEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCc
Confidence 9999999998775432 223446789999999998874 5899999999999999999999998643
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=342.56 Aligned_cols=255 Identities=24% Similarity=0.319 Sum_probs=191.8
Q ss_pred cCCCCceeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEeccccc------C
Q 044366 646 GNFGEKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSN------A 718 (918)
Q Consensus 646 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~------~ 718 (918)
.+|...+.||+|+||.||+|.. .+|+.||||++.... ..+.+|+++++.++||||+++++++.. .
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~--------~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~ 125 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK--------RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDE 125 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT--------TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc--------hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcc
Confidence 4688889999999999999976 469999999986421 123479999999999999999998743 2
Q ss_pred CceEEEEEeccCCChhHHhhcc-cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCC-CcEEEecc
Q 044366 719 QHSFIVCEYLARGSLTTILRDD-AAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSE-YEAHVSDF 796 (918)
Q Consensus 719 ~~~~lv~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~-~~~kl~Df 796 (918)
...++||||+++ ++.+.+... .....+++..++.++.||++||+|||+. +|+||||||+||+++.+ +.+||+||
T Consensus 126 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NILl~~~~~~~kl~DF 201 (420)
T 1j1b_A 126 VYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDF 201 (420)
T ss_dssp EEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEEETTTTEEEECCC
T ss_pred eeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChhhEEEeCCCCeEEeccc
Confidence 236799999986 676666432 2245689999999999999999999999 99999999999999965 56899999
Q ss_pred ccccccCCCCCCceecccccccccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHh--------
Q 044366 797 GFAKFLEPHSSNWTEFAGTVGYAAPELAYTM-RATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMII-------- 867 (918)
Q Consensus 797 G~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~-------- 867 (918)
|+++.+..... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||....... .+.....
T Consensus 202 G~a~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~-~l~~i~~~lg~p~~~ 279 (420)
T 1j1b_A 202 GSAKQLVRGEP-NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD-QLVEIIKVLGTPTRE 279 (420)
T ss_dssp TTCEECCTTCC-CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHHHCSCCHH
T ss_pred hhhhhcccCCC-ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCCHH
Confidence 99987654332 2345789999999998764 78999999999999999999999987543221 1111110
Q ss_pred hhhhh----cccCCCCCCcc-hH-----HHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 868 EVNQI----LDHRLPTPSRD-VT-----DKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 868 ~~~~~----~~~~~~~~~~~-~~-----~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
.+... .....+..... +. .....+.+++.+||+.||++|||+.|+++
T Consensus 280 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~ 336 (420)
T 1j1b_A 280 QIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 336 (420)
T ss_dssp HHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence 00000 00011111111 11 11357889999999999999999999975
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=329.17 Aligned_cols=252 Identities=22% Similarity=0.329 Sum_probs=195.8
Q ss_pred HHhcCCCCceeeccccceEEEEEEeCCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhcc--CCceeeEecccccCCc
Q 044366 643 KATGNFGEKYCIGKGGQRSVYKAELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIR--HRNIIKFHGFCSNAQH 720 (918)
Q Consensus 643 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~--h~niv~~~~~~~~~~~ 720 (918)
...++|.+.+.||+|+||.||+|...+|+.||||++..... .....+.+.+|++++++++ ||||+++++++..++.
T Consensus 25 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~ 102 (313)
T 3cek_A 25 VKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEA--DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY 102 (313)
T ss_dssp ETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSC--CHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSE
T ss_pred eccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccc--cccchHHHHHHHHHHHhccccCCceEEEEEEeecCCE
Confidence 44567999999999999999999888899999999865321 2223567899999999997 5999999999999999
Q ss_pred eEEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEecccccc
Q 044366 721 SFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAK 800 (918)
Q Consensus 721 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~ 800 (918)
.++||| +.+++|.+++.... .+++.+++.++.|+++||+|||+. +|+||||||+||++++ +.+||+|||++.
T Consensus 103 ~~lv~e-~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~ 174 (313)
T 3cek_A 103 IYMVME-CGNIDLNSWLKKKK---SIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVD-GMLKLIDFGIAN 174 (313)
T ss_dssp EEEEEC-CCSEEHHHHHHHCS---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEET-TEEEECCCSSSC
T ss_pred EEEEEe-cCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEEEC-CeEEEeeccccc
Confidence 999999 56789999998643 589999999999999999999999 9999999999999964 899999999998
Q ss_pred ccCCCCCC--ceeccccccccccccccc-----------CCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHh
Q 044366 801 FLEPHSSN--WTEFAGTVGYAAPELAYT-----------MRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMII 867 (918)
Q Consensus 801 ~~~~~~~~--~~~~~g~~~y~aPE~~~~-----------~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~ 867 (918)
........ .....|++.|+|||++.+ ..++.++||||||+++|||++|+.||..........
T Consensus 175 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~----- 249 (313)
T 3cek_A 175 QMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKL----- 249 (313)
T ss_dssp C--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHH-----
T ss_pred cccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHH-----
Confidence 76543321 234568999999999865 467889999999999999999999986543221111
Q ss_pred hhhhhcccCCC-CCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 868 EVNQILDHRLP-TPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 868 ~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
....+.... ...... ...+.+++.+||+.||++||+++|+++
T Consensus 250 --~~~~~~~~~~~~~~~~---~~~l~~li~~~l~~dp~~Rps~~ell~ 292 (313)
T 3cek_A 250 --HAIIDPNHEIEFPDIP---EKDLQDVLKCCLKRDPKQRISIPELLA 292 (313)
T ss_dssp --HHHHCTTSCCCCCCCS---CHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred --HHHHhcccccCCcccc---hHHHHHHHHHHccCCcccCcCHHHHhc
Confidence 111111111 111111 246788999999999999999999985
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=332.92 Aligned_cols=252 Identities=21% Similarity=0.283 Sum_probs=172.7
Q ss_pred HhcCCCCce-eeccccceEEEEEEeC-CCCEEEEEEcccccccCCCCChHHHHHHHH-HHhhccCCceeeEeccccc---
Q 044366 644 ATGNFGEKY-CIGKGGQRSVYKAELP-SGNIFAVKKFKAELFSDETANPSEFLNEVL-ALTEIRHRNIIKFHGFCSN--- 717 (918)
Q Consensus 644 ~~~~~~~~~-~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~-~l~~l~h~niv~~~~~~~~--- 717 (918)
..++|.+.+ .||+|+||.||+|... +|+.||||++... ....+|+. .++.++||||+++++++..
T Consensus 26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~ 96 (336)
T 3fhr_A 26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS---------PKARQEVDHHWQASGGPHIVCILDVYENMHH 96 (336)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS---------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEET
T ss_pred ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc---------HHHHHHHHHHHHhcCCCChHHHHHHHhhccC
Confidence 456788854 6999999999999654 7999999998542 12233333 4566799999999999865
Q ss_pred -CCceEEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCC---CcEEE
Q 044366 718 -AQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSE---YEAHV 793 (918)
Q Consensus 718 -~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~---~~~kl 793 (918)
+...++||||+++|+|.+++.... ...+++.+++.++.|++.||+|||+. +|+||||||+||+++.+ +.+||
T Consensus 97 ~~~~~~lv~e~~~gg~L~~~l~~~~-~~~l~~~~~~~i~~ql~~~l~~LH~~---~ivH~dlkp~NIll~~~~~~~~~kl 172 (336)
T 3fhr_A 97 GKRCLLIIMECMEGGELFSRIQERG-DQAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKL 172 (336)
T ss_dssp TEEEEEEEEECCTTEEHHHHHHTC--CCCCBHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEE
T ss_pred CCceEEEEEeccCCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEEecCCCceEEE
Confidence 456899999999999999998653 34589999999999999999999999 99999999999999864 55999
Q ss_pred eccccccccCCCCCCceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhc
Q 044366 794 SDFGFAKFLEPHSSNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQIL 873 (918)
Q Consensus 794 ~DfG~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 873 (918)
+|||++...... ......||+.|+|||++.+..++.++||||||+++|+|++|+.||......... .... ....
T Consensus 173 ~Dfg~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~--~~~~--~~~~ 246 (336)
T 3fhr_A 173 TDFGFAKETTQN--ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAIS--PGMK--RRIR 246 (336)
T ss_dssp CCCTTCEEC------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------
T ss_pred eccccceecccc--ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhh--hhHH--Hhhh
Confidence 999999876532 223456899999999998888999999999999999999999998644321100 0000 0011
Q ss_pred ccCCCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 874 DHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 874 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
......+..........+.+++.+||+.||++|||++|+++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 287 (336)
T 3fhr_A 247 LGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMN 287 (336)
T ss_dssp ----CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred ccccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 11111111111223356888999999999999999999986
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=336.32 Aligned_cols=258 Identities=23% Similarity=0.321 Sum_probs=196.6
Q ss_pred hcCCCCceeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccC-----
Q 044366 645 TGNFGEKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNA----- 718 (918)
Q Consensus 645 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~----- 718 (918)
.++|...+.||+|+||.||+|.. .+|+.||||++... ........+.+|+++++.++||||+++++++..+
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 86 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPF---DKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENF 86 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC---SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTC
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeeccc---ccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCcc
Confidence 46889999999999999999965 47899999998642 1222345788999999999999999999987654
Q ss_pred CceEEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEecccc
Q 044366 719 QHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGF 798 (918)
Q Consensus 719 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~ 798 (918)
...++||||++ |+|.+++... .+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 87 ~~~~lv~e~~~-~~L~~~~~~~----~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~ 158 (353)
T 2b9h_A 87 NEVYIIQELMQ-TDLHRVISTQ----MLSDDHIQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGL 158 (353)
T ss_dssp CCEEEEECCCS-EEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTT
T ss_pred ceEEEEEeccC-ccHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEcCCCcEEEEeccc
Confidence 67899999997 5999998753 489999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCC----------ceeccccccccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHh
Q 044366 799 AKFLEPHSSN----------WTEFAGTVGYAAPELAYT-MRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMII 867 (918)
Q Consensus 799 ~~~~~~~~~~----------~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~ 867 (918)
+......... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||........ ......
T Consensus 159 a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~~~~~~ 237 (353)
T 2b9h_A 159 ARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQ-LLLIFG 237 (353)
T ss_dssp CEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHH
T ss_pred ccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHH-HHHHHH
Confidence 9876533211 123468999999998764 6789999999999999999999999875432110 000000
Q ss_pred h-----------------hhhhcccCCCCCCcc----hHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 868 E-----------------VNQILDHRLPTPSRD----VTDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 868 ~-----------------~~~~~~~~~~~~~~~----~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
. ..+............ .......+.+++.+||+.||++|||++|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (353)
T 2b9h_A 238 IIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE 305 (353)
T ss_dssp HHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 0 000000000000000 0122356889999999999999999999986
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-36 Score=330.63 Aligned_cols=257 Identities=18% Similarity=0.265 Sum_probs=200.4
Q ss_pred hcCCCCceeeccccceEEEEEEe--CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCc------eeeEecccc
Q 044366 645 TGNFGEKYCIGKGGQRSVYKAEL--PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRN------IIKFHGFCS 716 (918)
Q Consensus 645 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~n------iv~~~~~~~ 716 (918)
.++|.+.+.||+|+||.||+|.. .+|+.||||+++.. ....+.+.+|+++++.++|++ ++++++++.
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-----~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~ 87 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-----DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFE 87 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-----HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEE
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-----CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccc
Confidence 46899999999999999999964 46889999998642 122467889999999997765 999999999
Q ss_pred cCCceEEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCC---------
Q 044366 717 NAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDS--------- 787 (918)
Q Consensus 717 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~--------- 787 (918)
..+..++||||+ +++|.+++.... ...+++.+++.++.|++.||+|||+. +|+||||||+||+++.
T Consensus 88 ~~~~~~lv~e~~-~~~l~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~~ 162 (339)
T 1z57_A 88 HHGHICIVFELL-GLSTYDFIKENG-FLPFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNP 162 (339)
T ss_dssp ETTEEEEEEECC-CCBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCCCEEEEEC-
T ss_pred cCCcEEEEEcCC-CCCHHHHHHhcC-CCCCcHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeccccccccCC
Confidence 999999999999 789999997653 24589999999999999999999999 9999999999999987
Q ss_pred ----------CCcEEEeccccccccCCCCCCceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchh
Q 044366 788 ----------EYEAHVSDFGFAKFLEPHSSNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVST 857 (918)
Q Consensus 788 ----------~~~~kl~DfG~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~ 857 (918)
++.+||+|||++...... .....||+.|+|||++.+..++.++||||||+++|||++|+.||.....
T Consensus 163 ~~~~~~~~~~~~~~kl~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~ 239 (339)
T 1z57_A 163 KIKRDERTLINPDIKVVDFGSATYDDEH---HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDS 239 (339)
T ss_dssp ---CEEEEESCCCEEECCCSSCEETTSC---CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCH
T ss_pred ccccccccccCCCceEeeCcccccCccc---cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCh
Confidence 668999999999875432 2345789999999999999999999999999999999999999865432
Q ss_pred hhh--hhhhhHh----hh-hhh-----c---ccCCC-----------------CCCcchHHHHHHHHHHHHHcccCCCCC
Q 044366 858 IFS--SISNMII----EV-NQI-----L---DHRLP-----------------TPSRDVTDKLRSIMEVAILCLVENPEA 905 (918)
Q Consensus 858 ~~~--~~~~~~~----~~-~~~-----~---~~~~~-----------------~~~~~~~~~~~~l~~li~~cl~~dp~~ 905 (918)
... .+..... .. ... . ...+. ............+.+++.+||+.||.+
T Consensus 240 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~ 319 (339)
T 1z57_A 240 KEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAK 319 (339)
T ss_dssp HHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTT
T ss_pred HHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCccc
Confidence 110 0000000 00 000 0 00000 000111234567899999999999999
Q ss_pred CCCHHHHHH
Q 044366 906 RPTMKEVCN 914 (918)
Q Consensus 906 RPt~~evl~ 914 (918)
|||++|+++
T Consensus 320 Rpt~~ell~ 328 (339)
T 1z57_A 320 RITLREALK 328 (339)
T ss_dssp SCCHHHHTT
T ss_pred ccCHHHHhc
Confidence 999999975
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-36 Score=333.72 Aligned_cols=255 Identities=20% Similarity=0.301 Sum_probs=194.3
Q ss_pred hcCCCCceeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCc---
Q 044366 645 TGNFGEKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQH--- 720 (918)
Q Consensus 645 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~--- 720 (918)
.++|...+.||+|+||.||+|.. .+|+.||||++.... ......+.+.+|+.+++.++||||+++++++...+.
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 100 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF--QSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRN 100 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTT--SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGG
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccc--cchHHHHHHHHHHHHHHhcCCCCcccHhheEeccccccc
Confidence 36788899999999999999965 579999999986532 112224678999999999999999999999876654
Q ss_pred ---eEEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccc
Q 044366 721 ---SFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFG 797 (918)
Q Consensus 721 ---~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG 797 (918)
.++||||++ |+|.+++.. .+++.+++.++.||+.||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 101 ~~~~~lv~e~~~-~~l~~~~~~-----~~~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg 171 (353)
T 3coi_A 101 FYDFYLVMPFMQ-TDLQKIMGL-----KFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFG 171 (353)
T ss_dssp CCCCEEEEECCS-EEGGGTTTS-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTCCEEECSTT
T ss_pred ceeEEEEecccc-CCHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEeECCCCcEEEeecc
Confidence 499999998 588888743 389999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCCceeccccccccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhh--------
Q 044366 798 FAKFLEPHSSNWTEFAGTVGYAAPELAYT-MRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIE-------- 868 (918)
Q Consensus 798 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~-------- 868 (918)
+++..... .....||+.|+|||++.+ ..++.++||||+|+++|||++|+.||...... .........
T Consensus 172 ~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~-~~~~~i~~~~~~~~~~~ 247 (353)
T 3coi_A 172 LARHADAE---MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYL-DQLTQILKVTGVPGTEF 247 (353)
T ss_dssp CTTC-----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHH-HHHHHHHHHHCBCCHHH
T ss_pred cccCCCCC---ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhCCCCHHH
Confidence 99865432 234578999999999876 67899999999999999999999998654321 111110000
Q ss_pred ------------hhhhcccCCCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 869 ------------VNQILDHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 869 ------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
......................+.+++.+|++.||++|||++|+++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 305 (353)
T 3coi_A 248 VQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 305 (353)
T ss_dssp HTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred HHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 0000000000111111223457889999999999999999999975
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=359.15 Aligned_cols=256 Identities=23% Similarity=0.335 Sum_probs=200.8
Q ss_pred HHHhcCCCCceeeccccceEEEEEEeC----CCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEeccccc
Q 044366 642 TKATGNFGEKYCIGKGGQRSVYKAELP----SGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSN 717 (918)
Q Consensus 642 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~ 717 (918)
+...++|...+.||+|+||.||+|... .+..||||+++... .....+.|.+|+.+++.++||||+++++++.
T Consensus 386 ~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~- 461 (656)
T 2j0j_A 386 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCT---SDSVREKFLQEALTMRQFDHPHIVKLIGVIT- 461 (656)
T ss_dssp BCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTT---CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-
T ss_pred ccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccC---CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-
Confidence 344567888899999999999999653 24579999876421 2223467999999999999999999999985
Q ss_pred CCceEEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccc
Q 044366 718 AQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFG 797 (918)
Q Consensus 718 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG 797 (918)
++..++||||+++|+|.+++.... ..+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 462 ~~~~~lv~E~~~~g~L~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDikp~NILl~~~~~vkL~DFG 536 (656)
T 2j0j_A 462 ENPVWIIMELCTLGELRSFLQVRK--FSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFG 536 (656)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTT--TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCC
T ss_pred cCceEEEEEcCCCCcHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchHhEEEeCCCCEEEEecC
Confidence 456899999999999999997542 3589999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCC-CceecccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhhhhhhhhhHhhhhhhccc
Q 044366 798 FAKFLEPHSS-NWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIK-GYHPGDFVSTIFSSISNMIIEVNQILDH 875 (918)
Q Consensus 798 ~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 875 (918)
+++....... ......+++.|+|||++.+..++.++||||||+++|||++ |..||...... . .... +...
T Consensus 537 ~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~-~----~~~~---i~~~ 608 (656)
T 2j0j_A 537 LSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN-D----VIGR---IENG 608 (656)
T ss_dssp CCCSCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-H----HHHH---HHHT
T ss_pred CCeecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHH-H----HHHH---HHcC
Confidence 9987654332 2233456789999999998899999999999999999997 99998654321 1 1111 1111
Q ss_pred CCCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 044366 876 RLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLLC 917 (918)
Q Consensus 876 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 917 (918)
.....+.. ....+.+++.+||+.||++|||+.|+++.|+
T Consensus 609 ~~~~~~~~---~~~~l~~li~~~l~~dP~~RPs~~el~~~L~ 647 (656)
T 2j0j_A 609 ERLPMPPN---CPPTLYSLMTKCWAYDPSRRPRFTELKAQLS 647 (656)
T ss_dssp CCCCCCTT---CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCCCCCcc---ccHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence 11111112 2246788999999999999999999999885
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-36 Score=354.05 Aligned_cols=333 Identities=20% Similarity=0.176 Sum_probs=197.1
Q ss_pred ccccCeeeccccccCCcCCccCCCCCCCcEeeccCcccccCCCccccCCCCcceeecccccccCCCCCCCcCCCcCCeEE
Q 044366 164 LKSLLQLDLSENRLSGLIPLSLSNLSSLTVMSLFNNSLSGSIPPILGNLKSLSTLGLHINQLNGVIPPSIGNLSSLRNLS 243 (918)
Q Consensus 164 l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 243 (918)
+++++.|++++|.+..+++..|..+++|++|+|++|.+++..+..|..+++|++|+|++|.+++.+|..|+++++|++|+
T Consensus 50 l~~l~~l~l~~~~l~~lp~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 129 (597)
T 3oja_B 50 LNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLV 129 (597)
T ss_dssp GCCCSEEEESSCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCCceEEEeeCCCCCCcCHHHHccCCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEE
Confidence 34555555555555555444455555555555555555554444555555555555555555555444455555555555
Q ss_pred cccCcCcCCCCccccccCCCCeEecCCCccCCcCCCcCCCCCCCcEEEccCCcCcCCCCccccCCCCCCeEEeecccccC
Q 044366 244 LFNNRLYGFVPKEIGYLKSLSKLEFCANHLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLRNLTSLERVRFNQNNLYG 323 (918)
Q Consensus 244 Ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~ 323 (918)
|++|.++++++..|..+++|++|++++|.+.+..|..|..+++|+.|++++|.+ ..
T Consensus 130 L~~n~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l------------------------~~ 185 (597)
T 3oja_B 130 LERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRL------------------------TH 185 (597)
T ss_dssp CCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECTTSCC------------------------SB
T ss_pred eeCCCCCCCCHHHhccCCCCCEEEeeCCcCCCCChhhhhcCCcCcEEECcCCCC------------------------CC
Confidence 555555544444445555555555555555544444444444444444444444 43
Q ss_pred ccccccCCCCCccEEeCCCCccccccCcccccccccceeeccccccccCCCcCcCCCCCCcEEEccCceeccccccchhh
Q 044366 324 KVYEAFGDHPNLTFLDLSQNNFYCEISFNWRNFSKLGTFNASMNNIYGSIPPEIGDSSKLQVLDLSSNHIFGKIPVQLVK 403 (918)
Q Consensus 324 ~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~n~i~~~~~~~~~~~~~L~~L~L~~N~l~~~~~~~~~~ 403 (918)
++ +..+++|+.|++++|.+... ....+|+.|++++|.+....+..
T Consensus 186 ~~---~~~l~~L~~L~l~~n~l~~l-----------------------------~~~~~L~~L~ls~n~l~~~~~~~--- 230 (597)
T 3oja_B 186 VD---LSLIPSLFHANVSYNLLSTL-----------------------------AIPIAVEELDASHNSINVVRGPV--- 230 (597)
T ss_dssp CC---GGGCTTCSEEECCSSCCSEE-----------------------------ECCTTCSEEECCSSCCCEEECSC---
T ss_pred cC---hhhhhhhhhhhcccCccccc-----------------------------cCCchhheeeccCCccccccccc---
Confidence 32 22334555555555554311 11123555555555554322221
Q ss_pred ccccCceecccccccCCCCCCCCCCCcccEEeccCccccccCccccccccccceecccCcccCCCCchhhccccccceEe
Q 044366 404 LFSLNKLILSLNQLFGGVPLEFGTLTELQYLDLSANKLSSSIPMSIGNLLKLHYLNLSNNQFSHKIPTEFEKLIHLSELD 483 (918)
Q Consensus 404 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 483 (918)
.++|+.|+|++|.+++ +..+..+++|++|+|++|.+++..|..|..+++|+.|+|++|++++ +|..+..+++|+.|+
T Consensus 231 ~~~L~~L~L~~n~l~~--~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~L~~L~ 307 (597)
T 3oja_B 231 NVELTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLD 307 (597)
T ss_dssp CSCCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECTTSCCCE-EECSSSCCTTCCEEE
T ss_pred CCCCCEEECCCCCCCC--ChhhccCCCCCEEECCCCccCCCCHHHhcCccCCCEEECCCCCCCC-CCcccccCCCCcEEE
Confidence 1356666666666654 2456677778888888888877777778888888888888888865 466667778888888
Q ss_pred ccCCcCCCCCchhccccCCcceEecCCCcccccCcccccCCCCccEEEccCCcCCCCCCCC--cccccccccCCCCccCC
Q 044366 484 LSHNILQEEIPPQICKMESLEKLNLSHNNLSDFIPRCFEEMRSLSWIDISYNELQGPIPNS--TAFKNGLMEGNKGLCGN 561 (918)
Q Consensus 484 Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~p~~--~~~~~~~~~~n~~~c~~ 561 (918)
|++|.|+ .+|..+..+++|+.|+|++|+++++. +..+++|+.|++++|+|+|.++.. ..+....+.++...|+.
T Consensus 308 Ls~N~l~-~i~~~~~~l~~L~~L~L~~N~l~~~~---~~~~~~L~~L~l~~N~~~~~~~~~~~~~~~~~~~~~~~~~C~~ 383 (597)
T 3oja_B 308 LSHNHLL-HVERNQPQFDRLENLYLDHNSIVTLK---LSTHHTLKNLTLSHNDWDCNSLRALFRNVARPAVDDADQHCKI 383 (597)
T ss_dssp CCSSCCC-CCGGGHHHHTTCSEEECCSSCCCCCC---CCTTCCCSEEECCSSCEEHHHHHHHTTTCCTTTBCCCCCCCCT
T ss_pred CCCCCCC-ccCcccccCCCCCEEECCCCCCCCcC---hhhcCCCCEEEeeCCCCCChhHHHHHHHHhhhccccccccCCc
Confidence 8888887 46677777888888888888887653 566778888888888888764321 12333346677777875
Q ss_pred C
Q 044366 562 F 562 (918)
Q Consensus 562 ~ 562 (918)
.
T Consensus 384 ~ 384 (597)
T 3oja_B 384 D 384 (597)
T ss_dssp T
T ss_pred c
Confidence 3
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-35 Score=330.84 Aligned_cols=317 Identities=21% Similarity=0.230 Sum_probs=281.0
Q ss_pred CCCCCCEEeCCCCcccccCCccccCCCCCCEEEcccccccccCCCCcCCCCCCCEEEcccccccccCCccccCCCCCCEE
Q 044366 19 NLSKLQYLDLGNNQLSGVIPPEIGKLNQLRRLYLDVNQLHGTIPPVIGQLSLINELVFCHNNVSGRIPSSLGNLSNLALL 98 (918)
Q Consensus 19 ~l~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~l~~l~~L~~L 98 (918)
.++++++|++++|.++...+..+..+++|++|+|++|++++..|..|..+++|++|++++|.+++..|..|+.+++|++|
T Consensus 43 ~l~~l~~l~l~~~~l~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 122 (390)
T 3o6n_A 43 TLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVL 122 (390)
T ss_dssp GGCCCSEEEEESCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred ccCCceEEEecCCchhhCChhHhcccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEE
Confidence 46899999999999985555557899999999999999997777799999999999999999998888899999999999
Q ss_pred EccCCcccccCccccCCCCCCCEEECcCCcCCCcCCcCCCCCCCCceeeccccccccCCCcccccccccCeeeccccccC
Q 044366 99 YLNDNSLFGSIPIVMGNLKSLSTLDLSQNQLNGSIPCSLDNLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSENRLS 178 (918)
Q Consensus 99 ~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~ 178 (918)
+|++|++....+..|.++++|++|++++|++++..|..+.++++|++|++++|++++. .++.+++|+.|++++|.++
T Consensus 123 ~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~---~~~~l~~L~~L~l~~n~l~ 199 (390)
T 3o6n_A 123 VLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHV---DLSLIPSLFHANVSYNLLS 199 (390)
T ss_dssp ECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTSSCTTCCEEECCSSCCSBC---CGGGCTTCSEEECCSSCCS
T ss_pred ECCCCccCcCCHHHhcCCCCCcEEECCCCccCccChhhccCCCCCCEEECCCCcCCcc---ccccccccceeeccccccc
Confidence 9999999977666789999999999999999988888999999999999999999865 3677899999999999988
Q ss_pred CcCCccCCCCCCCcEeeccCcccccCCCccccCCCCcceeecccccccCCCCCCCcCCCcCCeEEcccCcCcCCCCcccc
Q 044366 179 GLIPLSLSNLSSLTVMSLFNNSLSGSIPPILGNLKSLSTLGLHINQLNGVIPPSIGNLSSLRNLSLFNNRLYGFVPKEIG 258 (918)
Q Consensus 179 ~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~ 258 (918)
++ ...++|+.|++++|.+..... ...++|+.|++++|.+++. ..+..+++|++|++++|.+++..|..+.
T Consensus 200 ~~-----~~~~~L~~L~l~~n~l~~~~~---~~~~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~Ls~n~l~~~~~~~~~ 269 (390)
T 3o6n_A 200 TL-----AIPIAVEELDASHNSINVVRG---PVNVELTILKLQHNNLTDT--AWLLNYPGLVEVDLSYNELEKIMYHPFV 269 (390)
T ss_dssp EE-----ECCSSCSEEECCSSCCCEEEC---CCCSSCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCEEESGGGT
T ss_pred cc-----CCCCcceEEECCCCeeeeccc---cccccccEEECCCCCCccc--HHHcCCCCccEEECCCCcCCCcChhHcc
Confidence 54 334689999999999986533 2347899999999999864 5789999999999999999998899999
Q ss_pred ccCCCCeEecCCCccCCcCCCcCCCCCCCcEEEccCCcCcCCCCccccCCCCCCeEEeecccccCccccccCCCCCccEE
Q 044366 259 YLKSLSKLEFCANHLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLRNLTSLERVRFNQNNLYGKVYEAFGDHPNLTFL 338 (918)
Q Consensus 259 ~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L 338 (918)
.+++|++|++++|++.+. +..+..+++|+.|++++|++. .+|..+..+++|++|++++|.+..++ +..+++|+.|
T Consensus 270 ~l~~L~~L~L~~n~l~~~-~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~l~~L~~L~L~~N~i~~~~---~~~~~~L~~L 344 (390)
T 3o6n_A 270 KMQRLERLYISNNRLVAL-NLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTLK---LSTHHTLKNL 344 (390)
T ss_dssp TCSSCCEEECCSSCCCEE-ECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEECCSSCCCCCC---CCTTCCCSEE
T ss_pred ccccCCEEECCCCcCccc-CcccCCCCCCCEEECCCCcce-ecCccccccCcCCEEECCCCccceeC---chhhccCCEE
Confidence 999999999999999864 556788999999999999998 56777889999999999999998875 6778999999
Q ss_pred eCCCCccccccCccc
Q 044366 339 DLSQNNFYCEISFNW 353 (918)
Q Consensus 339 ~Ls~N~l~~~~~~~~ 353 (918)
++++|++.|++...+
T Consensus 345 ~l~~N~~~~~~~~~~ 359 (390)
T 3o6n_A 345 TLSHNDWDCNSLRAL 359 (390)
T ss_dssp ECCSSCEEHHHHHHH
T ss_pred EcCCCCccchhHHHH
Confidence 999999999865443
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-37 Score=355.16 Aligned_cols=262 Identities=25% Similarity=0.334 Sum_probs=200.5
Q ss_pred HhcCCCCceeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEeccccc-----
Q 044366 644 ATGNFGEKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSN----- 717 (918)
Q Consensus 644 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~----- 717 (918)
..++|.+.+.||+|+||.||+|.. .+|+.||||+++... .....+.+.+|+++++.++||||+++++++..
T Consensus 12 ~~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~---~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~ 88 (676)
T 3qa8_A 12 TCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQEL---SPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLA 88 (676)
T ss_dssp -----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCC---CHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCC
T ss_pred CCCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccC---CHHHHHHHHHHHHHHHhCCCCCCCceeeeeccccccc
Confidence 347899999999999999999965 579999999986531 22235679999999999999999999998765
Q ss_pred -CCceEEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCc---EEE
Q 044366 718 -AQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYE---AHV 793 (918)
Q Consensus 718 -~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~---~kl 793 (918)
++..++||||+++|+|.+++........+++..++.++.|++.||+|||+. +|+||||||+||+++.++. +||
T Consensus 89 ~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~---gIVHrDLKP~NILl~~~g~~~~vKL 165 (676)
T 3qa8_A 89 PNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKI 165 (676)
T ss_dssp TTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHT---TBCCCCCCSTTEEEECCSSSCEEEE
T ss_pred CCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEeecCCCceeEEE
Confidence 677899999999999999998765555689999999999999999999999 9999999999999997765 999
Q ss_pred eccccccccCCCCCCceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhh-----
Q 044366 794 SDFGFAKFLEPHSSNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIE----- 868 (918)
Q Consensus 794 ~DfG~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~----- 868 (918)
+|||.+....... ......|++.|+|||++.+..++.++||||+|+++|+|++|+.||........+.......
T Consensus 166 ~DFG~a~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~ 244 (676)
T 3qa8_A 166 IDLGYAKELDQGE-LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHI 244 (676)
T ss_dssp CSCCCCCBTTSCC-CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------C
T ss_pred ccccccccccccc-ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhh
Confidence 9999998775433 2345678999999999999999999999999999999999999986543222211110000
Q ss_pred -hhhh------cccCCCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHH
Q 044366 869 -VNQI------LDHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEV 912 (918)
Q Consensus 869 -~~~~------~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ev 912 (918)
.... .....+.+..........+.+++.+||+.||++|||++|+
T Consensus 245 ~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~el 295 (676)
T 3qa8_A 245 VVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQN 295 (676)
T ss_dssp CSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTC
T ss_pred hhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHH
Confidence 0000 0111122222223345678999999999999999999774
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-36 Score=333.39 Aligned_cols=202 Identities=23% Similarity=0.249 Sum_probs=170.7
Q ss_pred HhcCCCCceeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhcc-CC-----ceeeEecccc
Q 044366 644 ATGNFGEKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIR-HR-----NIIKFHGFCS 716 (918)
Q Consensus 644 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~-----niv~~~~~~~ 716 (918)
..++|.+.+.||+|+||.||+|.. .+++.||||+++.. .....++..|+.+++.++ |+ +|+++++++.
T Consensus 52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~ 126 (382)
T 2vx3_A 52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-----KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFM 126 (382)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-----HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEE
T ss_pred eeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-----HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeec
Confidence 457899999999999999999965 47889999998642 122456778888888885 44 4999999999
Q ss_pred cCCceEEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeC--CCCcEEEe
Q 044366 717 NAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLD--SEYEAHVS 794 (918)
Q Consensus 717 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~--~~~~~kl~ 794 (918)
..+..++||||++ |+|.+++.... ...+++..++.++.|++.||+|||++ ..+|+||||||+||+++ .++.+||+
T Consensus 127 ~~~~~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~ 203 (382)
T 2vx3_A 127 FRNHLCLVFEMLS-YNLYDLLRNTN-FRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIV 203 (382)
T ss_dssp ETTEEEEEEECCC-CBHHHHHHHTT-TSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEEC
T ss_pred cCCceEEEEecCC-CCHHHHHhhcC-cCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEE
Confidence 9999999999996 59999997653 24589999999999999999999952 12899999999999995 46789999
Q ss_pred ccccccccCCCCCCceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcch
Q 044366 795 DFGFAKFLEPHSSNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVS 856 (918)
Q Consensus 795 DfG~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~ 856 (918)
|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 204 DFG~a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~ 262 (382)
T 2vx3_A 204 DFGSSCQLGQR---IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGAN 262 (382)
T ss_dssp CCTTCEETTCC---CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred eccCceecccc---cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999877543 234578999999999999999999999999999999999999987543
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=331.77 Aligned_cols=257 Identities=20% Similarity=0.330 Sum_probs=190.5
Q ss_pred hcCCCCceeeccccceEEEEEEeC-CCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccc-------
Q 044366 645 TGNFGEKYCIGKGGQRSVYKAELP-SGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCS------- 716 (918)
Q Consensus 645 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~------- 716 (918)
.++|...+.||+|+||.||+|... +|+.||||++... .....+.+.+|+++++.++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 85 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT----DPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLT 85 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECC----SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCC
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecC----ChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccc
Confidence 467899999999999999999664 5899999998643 2233577899999999999999999998763
Q ss_pred -------cCCceEEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeC-CC
Q 044366 717 -------NAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLD-SE 788 (918)
Q Consensus 717 -------~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~-~~ 788 (918)
+....++||||++ |+|.+++.. .++++..++.++.|++.||+|||+. +|+||||||+||+++ ++
T Consensus 86 ~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~ 157 (320)
T 2i6l_A 86 DDVGSLTELNSVYIVQEYME-TDLANVLEQ----GPLLEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFINTED 157 (320)
T ss_dssp C----CCSCSEEEEEEECCS-EEHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTT
T ss_pred cccccccccCceeEEeeccC-CCHHHHhhc----CCccHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCC
Confidence 3467899999998 599999864 3489999999999999999999999 999999999999997 56
Q ss_pred CcEEEeccccccccCCCCC---Cceeccccccccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhh
Q 044366 789 YEAHVSDFGFAKFLEPHSS---NWTEFAGTVGYAAPELAYT-MRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISN 864 (918)
Q Consensus 789 ~~~kl~DfG~~~~~~~~~~---~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~ 864 (918)
+.+||+|||+++...+... ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||....... ....
T Consensus 158 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~-~~~~ 236 (320)
T 2i6l_A 158 LVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELE-QMQL 236 (320)
T ss_dssp TEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHH
T ss_pred CeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHH-HHHH
Confidence 7999999999987654321 2234567899999998865 678999999999999999999999987544211 1110
Q ss_pred hHhh--------hhhh-------cccCCCCCCcch----HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 865 MIIE--------VNQI-------LDHRLPTPSRDV----TDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 865 ~~~~--------~~~~-------~~~~~~~~~~~~----~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
.... ..+. .......+.... ......+.+++.+||+.||++|||++|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (320)
T 2i6l_A 237 ILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS 305 (320)
T ss_dssp HHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred HHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence 0000 0000 000000000000 112356889999999999999999999975
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-36 Score=339.95 Aligned_cols=250 Identities=24% Similarity=0.316 Sum_probs=187.2
Q ss_pred CCCCceeeccccceEEEEEEeCCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhc-cCCceeeEecccccCCceEEEE
Q 044366 647 NFGEKYCIGKGGQRSVYKAELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEI-RHRNIIKFHGFCSNAQHSFIVC 725 (918)
Q Consensus 647 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~ 725 (918)
.|...+.||+|+||+||.+...+|+.||||++... ..+.+.+|+++++++ +||||+++++++.+++..++||
T Consensus 16 ~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~-------~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~ 88 (434)
T 2rio_A 16 LVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID-------FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIAL 88 (434)
T ss_dssp CEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG-------GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred eeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH-------HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEE
Confidence 45556789999999998776668999999998652 135678999999887 8999999999999999999999
Q ss_pred EeccCCChhHHhhcccccCC----CCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCC-------------
Q 044366 726 EYLARGSLTTILRDDAAAKE----FSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSE------------- 788 (918)
Q Consensus 726 e~~~~gsL~~~l~~~~~~~~----l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~------------- 788 (918)
||++ |+|.+++........ .++..++.++.||+.||+|||+. +|+||||||+||+++.+
T Consensus 89 E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~~~~~~~~~~~ 164 (434)
T 2rio_A 89 ELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAEN 164 (434)
T ss_dssp CCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEECCHHHHSCCTTCCCS
T ss_pred ecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCcccccccccCCCc
Confidence 9996 699999976532111 13345678999999999999999 99999999999999754
Q ss_pred CcEEEeccccccccCCCCCC----ceeccccccccccccccc-------CCCCcccchhhHHHHHHHHHh-CCCCCCcch
Q 044366 789 YEAHVSDFGFAKFLEPHSSN----WTEFAGTVGYAAPELAYT-------MRATEKYDVYSFGVLALEVIK-GYHPGDFVS 856 (918)
Q Consensus 789 ~~~kl~DfG~~~~~~~~~~~----~~~~~g~~~y~aPE~~~~-------~~~~~~~Dv~slG~vl~el~t-g~~p~~~~~ 856 (918)
+.+||+|||++......... .....||+.|+|||++.+ ..++.++|||||||++|||++ |+.||+...
T Consensus 165 ~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~ 244 (434)
T 2rio_A 165 LRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKY 244 (434)
T ss_dssp CEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTT
T ss_pred eEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCch
Confidence 48999999999887654322 234579999999999875 568999999999999999999 999986443
Q ss_pred hhhhhhhhhHhhhhhhcccCCCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 857 TIFSSISNMIIEVNQILDHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 857 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
.... ... ....... .............+.+++.+||+.||++|||+.|+++
T Consensus 245 ~~~~---~i~---~~~~~~~-~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 245 SRES---NII---RGIFSLD-EMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp THHH---HHH---HTCCCCC-CCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hhHH---HHh---cCCCCcc-cccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 2111 100 1111100 0111122345567899999999999999999999985
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=330.43 Aligned_cols=247 Identities=23% Similarity=0.335 Sum_probs=200.9
Q ss_pred HHHhcCCCCceeeccccceEEEEEE-eCCCCEEEEEEcccccccCC--CCChHHHHHHHHHHhhcc--CCceeeEecccc
Q 044366 642 TKATGNFGEKYCIGKGGQRSVYKAE-LPSGNIFAVKKFKAELFSDE--TANPSEFLNEVLALTEIR--HRNIIKFHGFCS 716 (918)
Q Consensus 642 ~~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~--~~~~~~~~~e~~~l~~l~--h~niv~~~~~~~ 716 (918)
....++|...+.||+|+||.||+|. ..+|+.||||++........ ....+.+.+|+.+++.++ ||||+++++++.
T Consensus 39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~ 118 (320)
T 3a99_A 39 EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE 118 (320)
T ss_dssp -CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE
T ss_pred CCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEe
Confidence 3456789999999999999999995 45789999999976533221 112356778999999996 599999999999
Q ss_pred cCCceEEEEEeccC-CChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeC-CCCcEEEe
Q 044366 717 NAQHSFIVCEYLAR-GSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLD-SEYEAHVS 794 (918)
Q Consensus 717 ~~~~~~lv~e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~-~~~~~kl~ 794 (918)
.++..++||||+.+ ++|.+++... ..+++..++.++.|+++||+|||+. +|+||||||+||+++ +++.+||+
T Consensus 119 ~~~~~~lv~e~~~~~~~L~~~l~~~---~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~kL~ 192 (320)
T 3a99_A 119 RPDSFVLILERPEPVQDLFDFITER---GALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLI 192 (320)
T ss_dssp CSSEEEEEEECCSSEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEEC
T ss_pred cCCcEEEEEEcCCCCccHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcEeCCCCHHHEEEeCCCCCEEEe
Confidence 99999999999986 8999999764 3489999999999999999999999 999999999999999 77899999
Q ss_pred ccccccccCCCCCCceecccccccccccccccCCC-CcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhc
Q 044366 795 DFGFAKFLEPHSSNWTEFAGTVGYAAPELAYTMRA-TEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQIL 873 (918)
Q Consensus 795 DfG~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 873 (918)
|||+++..... ......||+.|+|||++.+..+ +.++||||||+++|||++|+.||+.......
T Consensus 193 Dfg~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~------------- 257 (320)
T 3a99_A 193 DFGSGALLKDT--VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIR------------- 257 (320)
T ss_dssp CCTTCEECCSS--CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHHHH-------------
T ss_pred eCccccccccc--cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhhhhc-------------
Confidence 99999876543 2334568999999999987666 6789999999999999999999875432110
Q ss_pred ccCCCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 874 DHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 874 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
..... .... ...+.+++.+||+.||++|||++|+++
T Consensus 258 -~~~~~-~~~~---~~~~~~li~~~l~~dp~~Rps~~~ll~ 293 (320)
T 3a99_A 258 -GQVFF-RQRV---SSECQHLIRWCLALRPSDRPTFEEIQN 293 (320)
T ss_dssp -CCCCC-SSCC---CHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -ccccc-cccC---CHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00000 1111 245788999999999999999999986
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-36 Score=326.98 Aligned_cols=249 Identities=22% Similarity=0.312 Sum_probs=191.7
Q ss_pred HHHHHhcCCCCceeeccccceEEEEEEe-CCCCEEEEEEcccccccCC--CCChHHHHHHHHHHhhc----cCCceeeEe
Q 044366 640 EITKATGNFGEKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDE--TANPSEFLNEVLALTEI----RHRNIIKFH 712 (918)
Q Consensus 640 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~--~~~~~~~~~e~~~l~~l----~h~niv~~~ 712 (918)
+.+...++|...+.||+|+||.||+|.. .+|+.||||++........ ......+.+|+.+++++ +||||++++
T Consensus 25 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~ 104 (312)
T 2iwi_A 25 DREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLL 104 (312)
T ss_dssp --------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEE
T ss_pred chhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEE
Confidence 4455668899999999999999999965 5789999999865432211 11234466799999888 899999999
Q ss_pred cccccCCceEEEEEe-ccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeC-CCCc
Q 044366 713 GFCSNAQHSFIVCEY-LARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLD-SEYE 790 (918)
Q Consensus 713 ~~~~~~~~~~lv~e~-~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~-~~~~ 790 (918)
+++...+..++|||| +++++|.+++.... .+++.+++.++.|+++||+|||+. +|+||||||+||+++ .++.
T Consensus 105 ~~~~~~~~~~~v~e~~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~ 178 (312)
T 2iwi_A 105 DWFETQEGFMLVLERPLPAQDLFDYITEKG---PLGEGPSRCFFGQVVAAIQHCHSR---GVVHRDIKDENILIDLRRGC 178 (312)
T ss_dssp EEC-----CEEEEECCSSEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHH---TEECCCCSGGGEEEETTTTE
T ss_pred EEEecCCeEEEEEEecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChhhEEEeCCCCe
Confidence 999999999999999 78999999997643 489999999999999999999999 999999999999999 7899
Q ss_pred EEEeccccccccCCCCCCceecccccccccccccccCCCC-cccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhh
Q 044366 791 AHVSDFGFAKFLEPHSSNWTEFAGTVGYAAPELAYTMRAT-EKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEV 869 (918)
Q Consensus 791 ~kl~DfG~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~-~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~ 869 (918)
+||+|||++...... ......|+..|+|||++.+..+. .++||||||+++|||++|+.||.......
T Consensus 179 ~kl~dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---------- 246 (312)
T 2iwi_A 179 AKLIDFGSGALLHDE--PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQEIL---------- 246 (312)
T ss_dssp EEECCCSSCEECCSS--CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHHH----------
T ss_pred EEEEEcchhhhcccC--cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHHHh----------
Confidence 999999999877543 23445689999999998876664 58999999999999999999986532210
Q ss_pred hhhcccCCCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 870 NQILDHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 870 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
......+ .. ....+.+++.+||+.||++|||++|+++
T Consensus 247 ----~~~~~~~-~~---~~~~~~~li~~~l~~~p~~Rps~~e~l~ 283 (312)
T 2iwi_A 247 ----EAELHFP-AH---VSPDCCALIRRCLAPKPSSRPSLEEILL 283 (312)
T ss_dssp ----HTCCCCC-TT---SCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred ----hhccCCc-cc---CCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0111111 11 2245788999999999999999999987
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-36 Score=338.57 Aligned_cols=249 Identities=24% Similarity=0.284 Sum_probs=187.0
Q ss_pred HhcCCCCceeeccccceEEEEEEeCCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhc-cCCceeeEecccccCCceE
Q 044366 644 ATGNFGEKYCIGKGGQRSVYKAELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEI-RHRNIIKFHGFCSNAQHSF 722 (918)
Q Consensus 644 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~ 722 (918)
...+|...+.||+|+||.||.....+|+.||||++.... ...+.+|+++++.+ +||||+++++++.+.+..+
T Consensus 22 ~~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~-------~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~ 94 (432)
T 3p23_A 22 GKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPEC-------FSFADREVQLLRESDEHPNVIRYFCTEKDRQFQY 94 (432)
T ss_dssp TTEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTT-------EEECHHHHHHHHHSCCCTTBCCEEEEEEETTEEE
T ss_pred ccEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHH-------HHHHHHHHHHHHhccCCCCcCeEEEEEecCCEEE
Confidence 345688889999999999766655689999999986432 22357899999999 7999999999999999999
Q ss_pred EEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCC-----CCcEEEeccc
Q 044366 723 IVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDS-----EYEAHVSDFG 797 (918)
Q Consensus 723 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~-----~~~~kl~DfG 797 (918)
+||||++ |+|.+++.... ...++.+++.++.||+.||+|||+. +|+||||||+||+++. ...+||+|||
T Consensus 95 lv~E~~~-g~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG 168 (432)
T 3p23_A 95 IAIELCA-ATLQEYVEQKD--FAHLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFG 168 (432)
T ss_dssp EEEECCS-EEHHHHHHSSS--CCCCSSCHHHHHHHHHHHHHHHHHT---TCCCCCCSTTSEEECCCBTTTBCCEEECCTT
T ss_pred EEEECCC-CCHHHHHHhcC--CCccchhHHHHHHHHHHHHHHHHHC---cCEeCCCCHHHEEEecCCCCCceeEEEeccc
Confidence 9999997 59999997653 2244556789999999999999999 9999999999999953 2368899999
Q ss_pred cccccCCCC---CCceecccccccccccccc---cCCCCcccchhhHHHHHHHHHh-CCCCCCcchhhhhhhhhhHhhhh
Q 044366 798 FAKFLEPHS---SNWTEFAGTVGYAAPELAY---TMRATEKYDVYSFGVLALEVIK-GYHPGDFVSTIFSSISNMIIEVN 870 (918)
Q Consensus 798 ~~~~~~~~~---~~~~~~~g~~~y~aPE~~~---~~~~~~~~Dv~slG~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~ 870 (918)
+++...... .......||+.|+|||++. +..++.++||||+||++|||++ |..||........ .
T Consensus 169 ~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~------~--- 239 (432)
T 3p23_A 169 LCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQA------N--- 239 (432)
T ss_dssp EEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHH------H---
T ss_pred ceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHH------H---
Confidence 998775432 2234467999999999997 4567889999999999999999 8999753321110 0
Q ss_pred hhcccCCCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 871 QILDHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 871 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
....................+.+++.+||+.||++|||++|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 240 ILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp HHTTCCCCTTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHhccCCccccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 01111101111111223345788999999999999999999984
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-36 Score=333.62 Aligned_cols=258 Identities=19% Similarity=0.270 Sum_probs=196.5
Q ss_pred hcCCCCceeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhcc-----------CCceeeEe
Q 044366 645 TGNFGEKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIR-----------HRNIIKFH 712 (918)
Q Consensus 645 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-----------h~niv~~~ 712 (918)
.++|...+.||+|+||.||+|.. .+|+.||||++... ....+.+.+|++++++++ ||||++++
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~ 92 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-----KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLL 92 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-----HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCC
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-----ccchhhhhHHHHHHHHhhcccccchhccccchHHHHH
Confidence 46899999999999999999964 57899999998642 122467889999998886 89999999
Q ss_pred cccccCC----ceEEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeC--
Q 044366 713 GFCSNAQ----HSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLD-- 786 (918)
Q Consensus 713 ~~~~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~-- 786 (918)
+++...+ ..++||||+ +++|.+++.... ...+++..++.++.||+.||+|||+++ +|+||||||+||+++
T Consensus 93 ~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~--~ivH~Dikp~NIll~~~ 168 (373)
T 1q8y_A 93 DHFNHKGPNGVHVVMVFEVL-GENLLALIKKYE-HRGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIV 168 (373)
T ss_dssp EEEEEEETTEEEEEEEECCC-CEEHHHHHHHTT-TSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGEEEEEE
T ss_pred HHhhccCCCCceEEEEEecC-CCCHHHHHHHhh-ccCCcHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChHHeEEecc
Confidence 9986543 789999999 789999997643 244899999999999999999999953 899999999999994
Q ss_pred ----CCCcEEEeccccccccCCCCCCceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhh-
Q 044366 787 ----SEYEAHVSDFGFAKFLEPHSSNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSS- 861 (918)
Q Consensus 787 ----~~~~~kl~DfG~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~- 861 (918)
..+.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|||++|+.||.........
T Consensus 169 ~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~ 245 (373)
T 1q8y_A 169 DSPENLIQIKIADLGNACWYDEH---YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTK 245 (373)
T ss_dssp ETTTTEEEEEECCCTTCEETTBC---CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------C
T ss_pred CCCcCcceEEEcccccccccCCC---CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCC
Confidence 4457999999999876543 23357899999999999999999999999999999999999998743311000
Q ss_pred hhhhHhhhhhhccc-----------------------CCCC------------CCcchHHHHHHHHHHHHHcccCCCCCC
Q 044366 862 ISNMIIEVNQILDH-----------------------RLPT------------PSRDVTDKLRSIMEVAILCLVENPEAR 906 (918)
Q Consensus 862 ~~~~~~~~~~~~~~-----------------------~~~~------------~~~~~~~~~~~l~~li~~cl~~dp~~R 906 (918)
.........+.... .... ...........+.+++.+||+.||++|
T Consensus 246 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 325 (373)
T 1q8y_A 246 DDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKR 325 (373)
T ss_dssp HHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTC
T ss_pred hHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCcccc
Confidence 00000000000000 0000 001123456788999999999999999
Q ss_pred CCHHHHHH
Q 044366 907 PTMKEVCN 914 (918)
Q Consensus 907 Pt~~evl~ 914 (918)
||++|+++
T Consensus 326 pt~~ell~ 333 (373)
T 1q8y_A 326 ADAGGLVN 333 (373)
T ss_dssp BCHHHHHT
T ss_pred CCHHHHhh
Confidence 99999986
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-36 Score=330.19 Aligned_cols=256 Identities=24% Similarity=0.349 Sum_probs=178.4
Q ss_pred hcCCCCceeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHH-HHhhccCCceeeEecccccCCceE
Q 044366 645 TGNFGEKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVL-ALTEIRHRNIIKFHGFCSNAQHSF 722 (918)
Q Consensus 645 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~-~l~~l~h~niv~~~~~~~~~~~~~ 722 (918)
.++|...+.||+|+||.||+|.. .+|+.||||+++... ......++..|+. +++.++||||+++++++.+++..+
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~ 97 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTV---DEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCW 97 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCC---CHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeeccc---CchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceE
Confidence 36788899999999999999966 479999999987532 1122345666666 677789999999999999999999
Q ss_pred EEEEeccCCChhHHhhcc--cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEecccccc
Q 044366 723 IVCEYLARGSLTTILRDD--AAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAK 800 (918)
Q Consensus 723 lv~e~~~~gsL~~~l~~~--~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~ 800 (918)
+||||+++ +|.+++... .....+++..++.++.|++.||+|||+.. +|+||||||+||+++.++.+||+|||+++
T Consensus 98 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--~ivH~dlkp~NIll~~~~~~kl~Dfg~~~ 174 (327)
T 3aln_A 98 ICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENL--KIIHRDIKPSNILLDRSGNIKLCDFGISG 174 (327)
T ss_dssp EEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHH--SCCCSCCCGGGEEEETTTEEEECCCSSSC
T ss_pred EEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccC--CEeECCCCHHHEEEcCCCCEEEccCCCce
Confidence 99999985 888877632 12345899999999999999999999953 89999999999999999999999999998
Q ss_pred ccCCCCCCceeccccccccccccc----ccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccC
Q 044366 801 FLEPHSSNWTEFAGTVGYAAPELA----YTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHR 876 (918)
Q Consensus 801 ~~~~~~~~~~~~~g~~~y~aPE~~----~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 876 (918)
....... .....|++.|+|||++ .+..++.++||||||+++|||++|+.||......... ........
T Consensus 175 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-------~~~~~~~~ 246 (327)
T 3aln_A 175 QLVDSIA-KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQ-------LTQVVKGD 246 (327)
T ss_dssp C-------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC--------------CCCCCSC
T ss_pred ecccccc-cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHH-------HHHHhcCC
Confidence 7654322 2334689999999998 4567899999999999999999999998654321111 11111211
Q ss_pred CCCCC-cchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 877 LPTPS-RDVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 877 ~~~~~-~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
.+... .........+.+++.+||+.||++|||++|+++
T Consensus 247 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 247 PPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp CCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 11111 011122356888999999999999999999975
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-35 Score=327.15 Aligned_cols=256 Identities=18% Similarity=0.229 Sum_probs=197.7
Q ss_pred hcCCCCceeeccccceEEEEEEeC-CC-CEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCc------eeeEecccc
Q 044366 645 TGNFGEKYCIGKGGQRSVYKAELP-SG-NIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRN------IIKFHGFCS 716 (918)
Q Consensus 645 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~-~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~n------iv~~~~~~~ 716 (918)
.++|.+.+.||+|+||.||+|... ++ +.||+|+++.. ....+.+.+|+.+++.++|++ ++.+++++.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-----~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~ 92 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-----GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFN 92 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-----HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEE
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-----ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeee
Confidence 478999999999999999999653 44 68999998642 122467889999999998766 899999999
Q ss_pred cCCceEEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeee-----------
Q 044366 717 NAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLL----------- 785 (918)
Q Consensus 717 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill----------- 785 (918)
..+..++||||+ ++++.+++.... ...+++.+++.++.||+.||+|||+. +|+||||||+||++
T Consensus 93 ~~~~~~lv~e~~-~~~l~~~l~~~~-~~~~~~~~~~~i~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~~ 167 (355)
T 2eu9_A 93 FHGHMCIAFELL-GKNTFEFLKENN-FQPYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNE 167 (355)
T ss_dssp ETTEEEEEEECC-CCBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEESCCCEEEEECC
T ss_pred eCCeEEEEEecc-CCChHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecccccccccc
Confidence 999999999999 567777776543 24589999999999999999999999 99999999999999
Q ss_pred --------CCCCcEEEeccccccccCCCCCCceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchh
Q 044366 786 --------DSEYEAHVSDFGFAKFLEPHSSNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVST 857 (918)
Q Consensus 786 --------~~~~~~kl~DfG~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~ 857 (918)
+.++.+||+|||+++...... ....||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 168 ~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~ 244 (355)
T 2eu9_A 168 HKSCEEKSVKNTSIRVADFGSATFDHEHH---TTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHEN 244 (355)
T ss_dssp C-CCCEEEESCCCEEECCCTTCEETTSCC---CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred cccccccccCCCcEEEeecCccccccccc---cCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCH
Confidence 567899999999998754332 345789999999999999999999999999999999999999875432
Q ss_pred hhhhhhhhHhhh--------hhhcc--------cCCCC-----------------CCcchHHHHHHHHHHHHHcccCCCC
Q 044366 858 IFSSISNMIIEV--------NQILD--------HRLPT-----------------PSRDVTDKLRSIMEVAILCLVENPE 904 (918)
Q Consensus 858 ~~~~~~~~~~~~--------~~~~~--------~~~~~-----------------~~~~~~~~~~~l~~li~~cl~~dp~ 904 (918)
... ........ ..... ..++. ...........+.+++.+||+.||+
T Consensus 245 ~~~-~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~ 323 (355)
T 2eu9_A 245 REH-LVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPA 323 (355)
T ss_dssp HHH-HHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTT
T ss_pred HHH-HHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChh
Confidence 110 00000000 00000 00000 0001112345788999999999999
Q ss_pred CCCCHHHHHH
Q 044366 905 ARPTMKEVCN 914 (918)
Q Consensus 905 ~RPt~~evl~ 914 (918)
+|||++|+++
T Consensus 324 ~Rpt~~e~l~ 333 (355)
T 2eu9_A 324 QRITLAEALL 333 (355)
T ss_dssp TSCCHHHHTT
T ss_pred hCcCHHHHhc
Confidence 9999999974
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-36 Score=324.10 Aligned_cols=253 Identities=20% Similarity=0.290 Sum_probs=178.4
Q ss_pred hcCCCCceeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEE
Q 044366 645 TGNFGEKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFI 723 (918)
Q Consensus 645 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 723 (918)
.++|...+.||+|+||.||+|.. .+|+.||||++...... ....+.+.++..+++.++||||+++++++.+++..++
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~l 101 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNK--EENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFI 101 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCH--HHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccc--hHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEE
Confidence 46788899999999999999966 47999999998753211 1112334445556788899999999999999999999
Q ss_pred EEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEEcCCCCCCeeeCCCCcEEEecccccccc
Q 044366 724 VCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHH-DCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFL 802 (918)
Q Consensus 724 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~ 802 (918)
||||+ ++.+..+.... ...+++..++.++.|+++||+|||+ . +++||||||+||+++.++.+||+|||++...
T Consensus 102 v~e~~-~~~~~~l~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~ 175 (318)
T 2dyl_A 102 AMELM-GTCAEKLKKRM--QGPIPERILGKMTVAIVKALYYLKEKH---GVIHRDVKPSNILLDERGQIKLCDFGISGRL 175 (318)
T ss_dssp EECCC-SEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHHH---CCCCCCCCGGGEEECTTSCEEECCCTTC---
T ss_pred EEecc-CCcHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHhhC---CEEeCCCCHHHEEECCCCCEEEEECCCchhc
Confidence 99999 44555554432 2458999999999999999999998 6 8999999999999999999999999999876
Q ss_pred CCCCCCceecccccccccccccc-----cCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCC
Q 044366 803 EPHSSNWTEFAGTVGYAAPELAY-----TMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRL 877 (918)
Q Consensus 803 ~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 877 (918)
.... ......|++.|+|||++. +..++.++||||||+++|||++|+.||............. .....
T Consensus 176 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~-------~~~~~ 247 (318)
T 2dyl_A 176 VDDK-AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKV-------LQEEP 247 (318)
T ss_dssp ------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHH-------HHSCC
T ss_pred cCCc-cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHH-------hccCC
Confidence 5432 223456899999999984 4568889999999999999999999987533222211111 11111
Q ss_pred CCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 878 PTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 878 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
+... ........+.+++.+||+.||.+|||++|+++
T Consensus 248 ~~~~-~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 248 PLLP-GHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp CCCC-SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred CCCC-ccCCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 1111 00112246788999999999999999999875
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-34 Score=317.80 Aligned_cols=307 Identities=26% Similarity=0.400 Sum_probs=235.0
Q ss_pred CCCCCCCCEEeCCCCcccccCCccccCCCCCCEEEcccccccccCCCCcCCCCCCCEEEcccccccccCCccccCCCCCC
Q 044366 17 IGNLSKLQYLDLGNNQLSGVIPPEIGKLNQLRRLYLDVNQLHGTIPPVIGQLSLINELVFCHNNVSGRIPSSLGNLSNLA 96 (918)
Q Consensus 17 ~~~l~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~l~~l~~L~ 96 (918)
+..+++|++|++++|+++ .+| .+..+++|++|++++|+++ .+|. +..+++|++|++++|.++. + +++..+++|+
T Consensus 40 ~~~l~~L~~L~l~~~~i~-~~~-~~~~~~~L~~L~l~~n~i~-~~~~-~~~l~~L~~L~L~~n~i~~-~-~~~~~l~~L~ 113 (347)
T 4fmz_A 40 QEELESITKLVVAGEKVA-SIQ-GIEYLTNLEYLNLNGNQIT-DISP-LSNLVKLTNLYIGTNKITD-I-SALQNLTNLR 113 (347)
T ss_dssp HHHHTTCSEEECCSSCCC-CCT-TGGGCTTCCEEECCSSCCC-CCGG-GTTCTTCCEEECCSSCCCC-C-GGGTTCTTCS
T ss_pred chhcccccEEEEeCCccc-cch-hhhhcCCccEEEccCCccc-cchh-hhcCCcCCEEEccCCcccC-c-hHHcCCCcCC
Confidence 456888999999999887 444 4888999999999999888 4555 8888888888888888874 3 4688888888
Q ss_pred EEEccCCcccccCccccCCCCCCCEEECcCCcCCCcCCcCCCCCCCCceeeccccccccCCCcccccccccCeeeccccc
Q 044366 97 LLYLNDNSLFGSIPIVMGNLKSLSTLDLSQNQLNGSIPCSLDNLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSENR 176 (918)
Q Consensus 97 ~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~ 176 (918)
+|++++|.+.+..+ +..+++|++|++++|...... ..+..+++|++|++++|.+.+..+ +..+++|++|++++|.
T Consensus 114 ~L~l~~n~i~~~~~--~~~l~~L~~L~l~~n~~~~~~-~~~~~l~~L~~L~l~~~~~~~~~~--~~~l~~L~~L~l~~n~ 188 (347)
T 4fmz_A 114 ELYLNEDNISDISP--LANLTKMYSLNLGANHNLSDL-SPLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQ 188 (347)
T ss_dssp EEECTTSCCCCCGG--GTTCTTCCEEECTTCTTCCCC-GGGTTCTTCCEEECCSSCCCCCGG--GGGCTTCSEEECTTSC
T ss_pred EEECcCCcccCchh--hccCCceeEEECCCCCCcccc-cchhhCCCCcEEEecCCCcCCchh--hccCCCCCEEEccCCc
Confidence 88888888875433 788888888888888655333 347888888888888888876543 7788888888888888
Q ss_pred cCCcCCccCCCCCCCcEeeccCcccccCCCccccCCCCcceeecccccccCCCCCCCcCCCcCCeEEcccCcCcCCCCcc
Q 044366 177 LSGLIPLSLSNLSSLTVMSLFNNSLSGSIPPILGNLKSLSTLGLHINQLNGVIPPSIGNLSSLRNLSLFNNRLYGFVPKE 256 (918)
Q Consensus 177 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~ 256 (918)
++++.+ +..+++|+.|++++|.+++..+ +..+++|++|++++|.++...+ +..+++|++|++++|.+++. ..
T Consensus 189 l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~ 260 (347)
T 4fmz_A 189 IEDISP--LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISDI--NA 260 (347)
T ss_dssp CCCCGG--GGGCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCC--GG
T ss_pred cccccc--ccCCCccceeecccCCCCCCch--hhcCCcCCEEEccCCccCCCcc--hhcCCCCCEEECCCCccCCC--hh
Confidence 886644 7778888888888888875433 7788888888888888876543 77788888888888888754 45
Q ss_pred ccccCCCCeEecCCCccCCcCCCcCCCCCCCcEEEccCCcCcCCCCccccCCCCCCeEEeecccccCccccccCCCCCcc
Q 044366 257 IGYLKSLSKLEFCANHLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLRNLTSLERVRFNQNNLYGKVYEAFGDHPNLT 336 (918)
Q Consensus 257 ~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~ 336 (918)
+..+++|++|++++|++.+. ..+..+++|+.|++++|++.+..+..+.++++|++|++++|.+..+.+ +..+++|+
T Consensus 261 ~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~ 336 (347)
T 4fmz_A 261 VKDLTKLKMLNVGSNQISDI--SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMD 336 (347)
T ss_dssp GTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCGGGHHHHHTCTTCSEEECCSSSCCCCGG--GGGCTTCS
T ss_pred HhcCCCcCEEEccCCccCCC--hhhcCCCCCCEEECcCCcCCCcChhHhhccccCCEEEccCCccccccC--hhhhhccc
Confidence 77778888888888887764 346777777788887777777777777777777777777777777665 66677777
Q ss_pred EEeCCCCccc
Q 044366 337 FLDLSQNNFY 346 (918)
Q Consensus 337 ~L~Ls~N~l~ 346 (918)
.|++++|+|+
T Consensus 337 ~L~l~~N~i~ 346 (347)
T 4fmz_A 337 SADFANQVIK 346 (347)
T ss_dssp EESSSCC---
T ss_pred eeehhhhccc
Confidence 7777777664
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-34 Score=317.54 Aligned_cols=307 Identities=24% Similarity=0.378 Sum_probs=183.8
Q ss_pred cccccccCeeeccccccCCcCCccCCCCCCCcEeeccCcccccCCCccccCCCCcceeecccccccCCCCCCCcCCCcCC
Q 044366 161 IGNLKSLLQLDLSENRLSGLIPLSLSNLSSLTVMSLFNNSLSGSIPPILGNLKSLSTLGLHINQLNGVIPPSIGNLSSLR 240 (918)
Q Consensus 161 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~ 240 (918)
+..+++|++|++++|.+..+ + .+..+++|++|++++|.+++..+ +..+++|++|++++|.++.. +.+.++++|+
T Consensus 40 ~~~l~~L~~L~l~~~~i~~~-~-~~~~~~~L~~L~l~~n~i~~~~~--~~~l~~L~~L~L~~n~i~~~--~~~~~l~~L~ 113 (347)
T 4fmz_A 40 QEELESITKLVVAGEKVASI-Q-GIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKITDI--SALQNLTNLR 113 (347)
T ss_dssp HHHHTTCSEEECCSSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCC--GGGTTCTTCS
T ss_pred chhcccccEEEEeCCccccc-h-hhhhcCCccEEEccCCccccchh--hhcCCcCCEEEccCCcccCc--hHHcCCCcCC
Confidence 44556666666666666543 2 25555666666666666554322 55555555555555555532 2355555555
Q ss_pred eEEcccCcCcCCCCccccccCCCCeEecCCCccCCcCCCcCCCCCCCcEEEccCCcCcCCCCccccCCCCCCeEEeeccc
Q 044366 241 NLSLFNNRLYGFVPKEIGYLKSLSKLEFCANHLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLRNLTSLERVRFNQNN 320 (918)
Q Consensus 241 ~L~Ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~ 320 (918)
+|++++|.+.+..+ +..+++|+.|++++|.... .++ .+..+++|++|++++|.
T Consensus 114 ~L~l~~n~i~~~~~--~~~l~~L~~L~l~~n~~~~------------------------~~~-~~~~l~~L~~L~l~~~~ 166 (347)
T 4fmz_A 114 ELYLNEDNISDISP--LANLTKMYSLNLGANHNLS------------------------DLS-PLSNMTGLNYLTVTESK 166 (347)
T ss_dssp EEECTTSCCCCCGG--GTTCTTCCEEECTTCTTCC------------------------CCG-GGTTCTTCCEEECCSSC
T ss_pred EEECcCCcccCchh--hccCCceeEEECCCCCCcc------------------------ccc-chhhCCCCcEEEecCCC
Confidence 55555555553322 4445555555555543332 222 24444555555555555
Q ss_pred ccCccccccCCCCCccEEeCCCCccccccCcccccccccceeeccccccccCCCcCcCCCCCCcEEEccCceeccccccc
Q 044366 321 LYGKVYEAFGDHPNLTFLDLSQNNFYCEISFNWRNFSKLGTFNASMNNIYGSIPPEIGDSSKLQVLDLSSNHIFGKIPVQ 400 (918)
Q Consensus 321 l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~n~i~~~~~~~~~~~~~L~~L~L~~N~l~~~~~~~ 400 (918)
+..+.. +..+++|+.|++++|.+.... . +..+++|+.|++++|.+.+..+
T Consensus 167 ~~~~~~--~~~l~~L~~L~l~~n~l~~~~-------------------------~-~~~l~~L~~L~l~~n~l~~~~~-- 216 (347)
T 4fmz_A 167 VKDVTP--IANLTDLYSLSLNYNQIEDIS-------------------------P-LASLTSLHYFTAYVNQITDITP-- 216 (347)
T ss_dssp CCCCGG--GGGCTTCSEEECTTSCCCCCG-------------------------G-GGGCTTCCEEECCSSCCCCCGG--
T ss_pred cCCchh--hccCCCCCEEEccCCcccccc-------------------------c-ccCCCccceeecccCCCCCCch--
Confidence 444433 445555666666665553211 1 3444555566666665554333
Q ss_pred hhhccccCceecccccccCCCCCCCCCCCcccEEeccCccccccCccccccccccceecccCcccCCCCchhhccccccc
Q 044366 401 LVKLFSLNKLILSLNQLFGGVPLEFGTLTELQYLDLSANKLSSSIPMSIGNLLKLHYLNLSNNQFSHKIPTEFEKLIHLS 480 (918)
Q Consensus 401 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~ 480 (918)
+..+++|++|++++|++++..+ +..+++|++|++++|.+++. ..+..+++|+.|++++|++++. ..|..+++|+
T Consensus 217 ~~~~~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~ 290 (347)
T 4fmz_A 217 VANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISDI--NAVKDLTKLKMLNVGSNQISDI--SVLNNLSQLN 290 (347)
T ss_dssp GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCS
T ss_pred hhcCCcCCEEEccCCccCCCcc--hhcCCCCCEEECCCCccCCC--hhHhcCCCcCEEEccCCccCCC--hhhcCCCCCC
Confidence 5556666666666666655443 66777777777777777753 3577777888888888887654 4577778888
Q ss_pred eEeccCCcCCCCCchhccccCCcceEecCCCcccccCcccccCCCCccEEEccCCcCC
Q 044366 481 ELDLSHNILQEEIPPQICKMESLEKLNLSHNNLSDFIPRCFEEMRSLSWIDISYNELQ 538 (918)
Q Consensus 481 ~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~ 538 (918)
.|++++|++++..|..+..+++|+.|+|++|++++..| +..+++|+.||+++|+++
T Consensus 291 ~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~N~i~ 346 (347)
T 4fmz_A 291 SLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVIK 346 (347)
T ss_dssp EEECCSSCCCGGGHHHHHTCTTCSEEECCSSSCCCCGG--GGGCTTCSEESSSCC---
T ss_pred EEECcCCcCCCcChhHhhccccCCEEEccCCccccccC--hhhhhccceeehhhhccc
Confidence 88888888877777778888888888888888877665 777788888888888765
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=342.63 Aligned_cols=315 Identities=21% Similarity=0.247 Sum_probs=277.8
Q ss_pred CCCCCCEEeCCCCcccccCCccccCCCCCCEEEcccccccccCCCCcCCCCCCCEEEcccccccccCCccccCCCCCCEE
Q 044366 19 NLSKLQYLDLGNNQLSGVIPPEIGKLNQLRRLYLDVNQLHGTIPPVIGQLSLINELVFCHNNVSGRIPSSLGNLSNLALL 98 (918)
Q Consensus 19 ~l~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~l~~l~~L~~L 98 (918)
.+.+++.|++++|.+....+..+..+++|++|+|++|.+++..|..|+.+++|++|++++|.+++..|..|+++++|++|
T Consensus 49 ~l~~l~~l~l~~~~l~~lp~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 128 (597)
T 3oja_B 49 TLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVL 128 (597)
T ss_dssp GGCCCSEEEESSCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred cCCCceEEEeeCCCCCCcCHHHHccCCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEE
Confidence 46789999999999986666668899999999999999997778899999999999999999998888889999999999
Q ss_pred EccCCcccccCccccCCCCCCCEEECcCCcCCCcCCcCCCCCCCCceeeccccccccCCCcccccccccCeeeccccccC
Q 044366 99 YLNDNSLFGSIPIVMGNLKSLSTLDLSQNQLNGSIPCSLDNLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSENRLS 178 (918)
Q Consensus 99 ~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~ 178 (918)
+|++|.+++..+..|.++++|++|+|++|.+++..|..|+++++|++|+|++|.+++.. ++.+++|+.|++++|.++
T Consensus 129 ~L~~n~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~---~~~l~~L~~L~l~~n~l~ 205 (597)
T 3oja_B 129 VLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVD---LSLIPSLFHANVSYNLLS 205 (597)
T ss_dssp ECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECTTSCCSBCC---GGGCTTCSEEECCSSCCS
T ss_pred EeeCCCCCCCCHHHhccCCCCCEEEeeCCcCCCCChhhhhcCCcCcEEECcCCCCCCcC---hhhhhhhhhhhcccCccc
Confidence 99999999777777899999999999999999888889999999999999999998753 667889999999999988
Q ss_pred CcCCccCCCCCCCcEeeccCcccccCCCccccCCCCcceeecccccccCCCCCCCcCCCcCCeEEcccCcCcCCCCcccc
Q 044366 179 GLIPLSLSNLSSLTVMSLFNNSLSGSIPPILGNLKSLSTLGLHINQLNGVIPPSIGNLSSLRNLSLFNNRLYGFVPKEIG 258 (918)
Q Consensus 179 ~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~ 258 (918)
++ ...++|+.|++++|.++...+.. .++|+.|+|++|.+++ +..+..+++|+.|+|++|.+++..|..|.
T Consensus 206 ~l-----~~~~~L~~L~ls~n~l~~~~~~~---~~~L~~L~L~~n~l~~--~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~ 275 (597)
T 3oja_B 206 TL-----AIPIAVEELDASHNSINVVRGPV---NVELTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNELEKIMYHPFV 275 (597)
T ss_dssp EE-----ECCTTCSEEECCSSCCCEEECSC---CSCCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCEEESGGGT
T ss_pred cc-----cCCchhheeeccCCccccccccc---CCCCCEEECCCCCCCC--ChhhccCCCCCEEECCCCccCCCCHHHhc
Confidence 54 34568999999999998654432 3689999999999986 36789999999999999999999899999
Q ss_pred ccCCCCeEecCCCccCCcCCCcCCCCCCCcEEEccCCcCcCCCCccccCCCCCCeEEeecccccCccccccCCCCCccEE
Q 044366 259 YLKSLSKLEFCANHLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLRNLTSLERVRFNQNNLYGKVYEAFGDHPNLTFL 338 (918)
Q Consensus 259 ~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L 338 (918)
.+++|+.|++++|.+.++ |..+..+++|+.|++++|.+. .+|..+..+++|+.|++++|.+..++ +..+++|+.|
T Consensus 276 ~l~~L~~L~Ls~N~l~~l-~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~l~~L~~L~L~~N~l~~~~---~~~~~~L~~L 350 (597)
T 3oja_B 276 KMQRLERLYISNNRLVAL-NLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTLK---LSTHHTLKNL 350 (597)
T ss_dssp TCSSCCEEECTTSCCCEE-ECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEECCSSCCCCCC---CCTTCCCSEE
T ss_pred CccCCCEEECCCCCCCCC-CcccccCCCCcEEECCCCCCC-ccCcccccCCCCCEEECCCCCCCCcC---hhhcCCCCEE
Confidence 999999999999999864 666778999999999999998 57778899999999999999998775 6677899999
Q ss_pred eCCCCccccccCc
Q 044366 339 DLSQNNFYCEISF 351 (918)
Q Consensus 339 ~Ls~N~l~~~~~~ 351 (918)
++++|+|.|.+..
T Consensus 351 ~l~~N~~~~~~~~ 363 (597)
T 3oja_B 351 TLSHNDWDCNSLR 363 (597)
T ss_dssp ECCSSCEEHHHHH
T ss_pred EeeCCCCCChhHH
Confidence 9999999987643
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-35 Score=314.66 Aligned_cols=231 Identities=13% Similarity=0.086 Sum_probs=180.8
Q ss_pred hcCCCCceeeccccceEEEEEEeC-CCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEE
Q 044366 645 TGNFGEKYCIGKGGQRSVYKAELP-SGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFI 723 (918)
Q Consensus 645 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 723 (918)
.++|.+.+.||+|+||.||+|... +|+.||||++...... .....+.|.+|+..++.++||||+++++++.+++..++
T Consensus 30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 108 (286)
T 3uqc_A 30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVL-PDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLV 108 (286)
T ss_dssp TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCS-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECccccc-CHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEE
Confidence 367999999999999999999654 5899999999764221 12224789999999999999999999999999999999
Q ss_pred EEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccC
Q 044366 724 VCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLE 803 (918)
Q Consensus 724 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~ 803 (918)
||||+++++|.++++.. ....++.+|+.|++.||+|||+. +|+||||||+||+++.++.+||+++|
T Consensus 109 v~e~~~g~~L~~~l~~~-----~~~~~~~~i~~ql~~aL~~lH~~---givH~Dikp~NIll~~~g~~kl~~~~------ 174 (286)
T 3uqc_A 109 VAEWIRGGSLQEVADTS-----PSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDVVLAYPA------ 174 (286)
T ss_dssp EEECCCEEEHHHHHTTC-----CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEETTSCEEECSCC------
T ss_pred EEEecCCCCHHHHHhcC-----CChHHHHHHHHHHHHHHHHHHHC---CCccCCCCcccEEEcCCCCEEEEecc------
Confidence 99999999999999642 35567899999999999999999 99999999999999999999998543
Q ss_pred CCCCCceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCCCCCcc
Q 044366 804 PHSSNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRD 883 (918)
Q Consensus 804 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 883 (918)
|++ .++.++|||||||++|||++|+.||....... .+.. .........+.....
T Consensus 175 --------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~-~~~~----~~~~~~~~~~~~~~~ 228 (286)
T 3uqc_A 175 --------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRS-GLAP----AERDTAGQPIEPADI 228 (286)
T ss_dssp --------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCC-CSEE----CCBCTTSCBCCHHHH
T ss_pred --------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcch-hhHH----HHHHhccCCCChhhc
Confidence 333 36789999999999999999999987543211 0000 000001111110000
Q ss_pred hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 044366 884 VTDKLRSIMEVAILCLVENPEARPTMKEVCNLLC 917 (918)
Q Consensus 884 ~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 917 (918)
.......+.+++.+||+.||++| |++|+++.|+
T Consensus 229 ~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~ 261 (286)
T 3uqc_A 229 DRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQ 261 (286)
T ss_dssp CTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHH
T ss_pred ccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHH
Confidence 11223568899999999999999 9999999986
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-33 Score=303.99 Aligned_cols=286 Identities=24% Similarity=0.288 Sum_probs=172.2
Q ss_pred CCCEEeCCCCcccccCCccccCCCCCCEEEcccccccccCCCCcCCCCCCCEEEcccccccccCCccccCCCCCCEEEcc
Q 044366 22 KLQYLDLGNNQLSGVIPPEIGKLNQLRRLYLDVNQLHGTIPPVIGQLSLINELVFCHNNVSGRIPSSLGNLSNLALLYLN 101 (918)
Q Consensus 22 ~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~l~~l~~L~~L~L~ 101 (918)
+++++++++++++ .+|..+. ++|++|+|++|++++..|..|..+++|++|++++|.+++..|..|+++++|++|+++
T Consensus 34 ~l~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 110 (332)
T 2ft3_A 34 HLRVVQCSDLGLK-AVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYIS 110 (332)
T ss_dssp ETTEEECCSSCCS-SCCSCCC--TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECC
T ss_pred cCCEEECCCCCcc-ccCCCCC--CCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECC
Confidence 5777777777776 5666553 567777777777765555567777777777777777766666667777777777777
Q ss_pred CCcccccCccccCCCCCCCEEECcCCcCCCcCCcCCCCCCCCceeecccccccc--CCCcccccccccCeeeccccccCC
Q 044366 102 DNSLFGSIPIVMGNLKSLSTLDLSQNQLNGSIPCSLDNLSNLDTLFLYKNSLSG--PIPSVIGNLKSLLQLDLSENRLSG 179 (918)
Q Consensus 102 ~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~l~~--~~~~~~~~l~~L~~L~Ls~N~l~~ 179 (918)
+|+++ .+|..+. ++|++|++++|+++...+..+.++++|++|++++|.++. ..+..|..+ +|++|++++|++++
T Consensus 111 ~n~l~-~l~~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l-~L~~L~l~~n~l~~ 186 (332)
T 2ft3_A 111 KNHLV-EIPPNLP--SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL-KLNYLRISEAKLTG 186 (332)
T ss_dssp SSCCC-SCCSSCC--TTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSC-CCSCCBCCSSBCSS
T ss_pred CCcCC-ccCcccc--ccCCEEECCCCccCccCHhHhCCCccCCEEECCCCccccCCCCcccccCC-ccCEEECcCCCCCc
Confidence 77666 3333333 567777777777665555556666677777777766642 455566666 66666666666665
Q ss_pred cCCccCCCCCCCcEeeccCcccccCCCccccCCCCcceeecccccccCCCCCCCcCCCcCCeEEcccCcCcCCCCccccc
Q 044366 180 LIPLSLSNLSSLTVMSLFNNSLSGSIPPILGNLKSLSTLGLHINQLNGVIPPSIGNLSSLRNLSLFNNRLYGFVPKEIGY 259 (918)
Q Consensus 180 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~ 259 (918)
++. .+. ++|++|++++|.+++..+..|..+++|+.|++++|++++..+..|..+++|++|++++|+++ ..|..+..
T Consensus 187 l~~-~~~--~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~ 262 (332)
T 2ft3_A 187 IPK-DLP--ETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPD 262 (332)
T ss_dssp CCS-SSC--SSCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCC-BCCTTGGG
T ss_pred cCc-ccc--CCCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCe-ecChhhhc
Confidence 422 222 46666666666666555566666666666666666666655555666666666666666666 34444566
Q ss_pred cCCCCeEecCCCccCCcCCCcCCCC------CCCcEEEccCCcCc--CCCCccccCCCCCCeEEeec
Q 044366 260 LKSLSKLEFCANHLSGVIPHSVGNL------TGLVLLNMCENHLF--GPIPKSLRNLTSLERVRFNQ 318 (918)
Q Consensus 260 l~~L~~L~l~~n~l~~~~~~~~~~l------~~L~~L~l~~n~l~--~~~~~~l~~l~~L~~L~l~~ 318 (918)
+++|+.|++++|++.++.+..|... ..|+.|++++|++. +..|..|..+++|+.+++++
T Consensus 263 l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~l~~L~l~~N~~~~~~~~~~~~~~l~~L~~l~l~~ 329 (332)
T 2ft3_A 263 LKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGN 329 (332)
T ss_dssp CTTCCEEECCSSCCCBCCTTSSSCSSCCSSSCCBSEEECCSSSSCGGGSCGGGGTTBCCSTTEEC--
T ss_pred CccCCEEECCCCCCCccChhHccccccccccccccceEeecCcccccccCcccccccchhhhhhccc
Confidence 6666666666666665555555432 33444444444443 33334444444444444433
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-34 Score=309.83 Aligned_cols=231 Identities=23% Similarity=0.305 Sum_probs=178.7
Q ss_pred hcCCCCc-eeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHH-hhccCCceeeEeccccc----
Q 044366 645 TGNFGEK-YCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLAL-TEIRHRNIIKFHGFCSN---- 717 (918)
Q Consensus 645 ~~~~~~~-~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l-~~l~h~niv~~~~~~~~---- 717 (918)
.++|.+. +.||+|+||.||+|.. .+++.||+|+++. ...+.+|++++ +..+||||+++++++..
T Consensus 16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~---------~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~ 86 (299)
T 3m2w_A 16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD---------CPKARREVELHWRASQCPHIVRIVDVYENLYAG 86 (299)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC---------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETT
T ss_pred ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc---------cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCC
Confidence 3567666 7799999999999955 5799999999853 24678899887 55699999999999876
Q ss_pred CCceEEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCC---CCcEEEe
Q 044366 718 AQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDS---EYEAHVS 794 (918)
Q Consensus 718 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~---~~~~kl~ 794 (918)
+...++||||+++|+|.+++.... ...+++.+++.++.|++.||+|||+. +|+||||||+||+++. ++.+||+
T Consensus 87 ~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~kl~ 162 (299)
T 3m2w_A 87 RKCLLIVMECLDGGELFSRIQDRG-DQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLT 162 (299)
T ss_dssp EEEEEEEECCCCSCBHHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEEC
T ss_pred CceEEEEEeecCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEecCCCCCcEEEe
Confidence 677899999999999999998753 34589999999999999999999999 9999999999999998 7889999
Q ss_pred ccccccccCCCCCCceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcc
Q 044366 795 DFGFAKFLEPHSSNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILD 874 (918)
Q Consensus 795 DfG~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 874 (918)
|||++..... ..++.++||||+||++|||++|+.||......... .. .......
T Consensus 163 Dfg~a~~~~~----------------------~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~-~~---~~~~~~~ 216 (299)
T 3m2w_A 163 DFGFAKETTG----------------------EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS-PG---MKTRIRM 216 (299)
T ss_dssp CCTTCEECTT----------------------CGGGGHHHHHHHHHHHHHHHHSSCSCCC--------CC---SCCSSCT
T ss_pred cccccccccc----------------------ccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhh-HH---HHHHHhh
Confidence 9999875431 34677999999999999999999998644321100 00 0001111
Q ss_pred cCCCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 875 HRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 875 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
.....+..........+.+++.+||+.||++|||++|+++
T Consensus 217 ~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~ 256 (299)
T 3m2w_A 217 GQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 256 (299)
T ss_dssp TCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 1111111111123457889999999999999999999986
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-34 Score=317.24 Aligned_cols=246 Identities=17% Similarity=0.146 Sum_probs=187.6
Q ss_pred hcCCCCceeeccccceEEEEEEeCCCCEEEEEEccccccc----CCCCChHHHHHHHHHHhhcc----------------
Q 044366 645 TGNFGEKYCIGKGGQRSVYKAELPSGNIFAVKKFKAELFS----DETANPSEFLNEVLALTEIR---------------- 704 (918)
Q Consensus 645 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~----~~~~~~~~~~~e~~~l~~l~---------------- 704 (918)
.++|...+.||+|+||.||+|+. +|+.||||+++..... ......+.+.+|+.+++.++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 46788899999999999999987 7899999999764321 12333578999999999986
Q ss_pred ----------CCceeeEeccccc-------------CCceEEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHH
Q 044366 705 ----------HRNIIKFHGFCSN-------------AQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANA 761 (918)
Q Consensus 705 ----------h~niv~~~~~~~~-------------~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~ 761 (918)
||||+++++++.+ .+..++||||+++|++.+.+.+ ..+++.+++.++.||+.|
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~----~~~~~~~~~~i~~qi~~a 173 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT----KLSSLATAKSILHQLTAS 173 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT----TCCCHHHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh----cCCCHHHHHHHHHHHHHH
Confidence 5555566665554 6789999999999977666643 347999999999999999
Q ss_pred HHHHH-hCCCCCeEEcCCCCCCeeeCCCC--------------------cEEEeccccccccCCCCCCceeccccccccc
Q 044366 762 LSYLH-HDCIPPIVHRDISSKNVLLDSEY--------------------EAHVSDFGFAKFLEPHSSNWTEFAGTVGYAA 820 (918)
Q Consensus 762 l~~LH-~~~~~~ivH~dlk~~Nill~~~~--------------------~~kl~DfG~~~~~~~~~~~~~~~~g~~~y~a 820 (918)
|+||| +. +|+||||||+|||++.++ .+||+|||+|+..... ...||+.|+|
T Consensus 174 L~~lH~~~---~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-----~~~gt~~y~a 245 (336)
T 2vuw_A 174 LAVAEASL---RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-----IVVFCDVSMD 245 (336)
T ss_dssp HHHHHHHH---CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-----EEECCCCTTC
T ss_pred HHHHHHhC---CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-----cEEEeecccC
Confidence 99999 88 999999999999999887 8999999999876532 3479999999
Q ss_pred ccccccCCCCcccchhhHHHH-HHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCCCCCcchHHHHHHHHHHHHHcc
Q 044366 821 PELAYTMRATEKYDVYSFGVL-ALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRDVTDKLRSIMEVAILCL 899 (918)
Q Consensus 821 PE~~~~~~~~~~~Dv~slG~v-l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl 899 (918)
||++.+.. +.++||||+|++ .+++++|..||.... +............................++.+++.+||
T Consensus 246 PE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L 320 (336)
T 2vuw_A 246 EDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVL----WLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTML 320 (336)
T ss_dssp SGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHH----HHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGG
T ss_pred hhhhcCCC-ccceehhhhhCCCCcccccccCCCcchh----hhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHh
Confidence 99998766 889999998777 778888999963211 101111111111111111122223456678999999999
Q ss_pred cCCCCCCCCHHHHH
Q 044366 900 VENPEARPTMKEVC 913 (918)
Q Consensus 900 ~~dp~~RPt~~evl 913 (918)
+.| |++|++
T Consensus 321 ~~d-----sa~e~l 329 (336)
T 2vuw_A 321 NFS-----SATDLL 329 (336)
T ss_dssp GSS-----SHHHHH
T ss_pred ccC-----CHHHHH
Confidence 976 999998
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-33 Score=302.59 Aligned_cols=294 Identities=20% Similarity=0.219 Sum_probs=206.6
Q ss_pred CCCCEEEcccccccccCCCCcCCCCCCCEEEcccccccccCCccccCCCCCCEEEccCCcccccCccccCCCCCCCEEEC
Q 044366 45 NQLRRLYLDVNQLHGTIPPVIGQLSLINELVFCHNNVSGRIPSSLGNLSNLALLYLNDNSLFGSIPIVMGNLKSLSTLDL 124 (918)
Q Consensus 45 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~l~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L 124 (918)
.+|+.++++++.++ .+|..+. ++|++|++++|.+++..|..|.++++|++|+|++|++++..|..|.++++|++|+|
T Consensus 33 c~l~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 109 (332)
T 2ft3_A 33 CHLRVVQCSDLGLK-AVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYI 109 (332)
T ss_dssp EETTEEECCSSCCS-SCCSCCC--TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEEC
T ss_pred ccCCEEECCCCCcc-ccCCCCC--CCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEEC
Confidence 46889999999888 7787764 68888888888888777778888888888888888888777888888888888888
Q ss_pred cCCcCCCcCCcCCCCCCCCceeeccccccccCCCcccccccccCeeeccccccCC--cCCccCCCCCCCcEeeccCcccc
Q 044366 125 SQNQLNGSIPCSLDNLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSENRLSG--LIPLSLSNLSSLTVMSLFNNSLS 202 (918)
Q Consensus 125 s~n~i~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~--~~~~~~~~l~~L~~L~L~~N~l~ 202 (918)
++|+++ .+|..+. ++|++|++++|+++++.+..|.++++|++|++++|.++. ..+..+..+ +|++|++++|+++
T Consensus 110 ~~n~l~-~l~~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l-~L~~L~l~~n~l~ 185 (332)
T 2ft3_A 110 SKNHLV-EIPPNLP--SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL-KLNYLRISEAKLT 185 (332)
T ss_dssp CSSCCC-SCCSSCC--TTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSC-CCSCCBCCSSBCS
T ss_pred CCCcCC-ccCcccc--ccCCEEECCCCccCccCHhHhCCCccCCEEECCCCccccCCCCcccccCC-ccCEEECcCCCCC
Confidence 888888 4555544 788888888888887777778888888888888888853 556677777 7888888888877
Q ss_pred cCCCccccCCCCcceeecccccccCCCCCCCcCCCcCCeEEcccCcCcCCCCccccccCCCCeEecCCCccCCcCCCcCC
Q 044366 203 GSIPPILGNLKSLSTLGLHINQLNGVIPPSIGNLSSLRNLSLFNNRLYGFVPKEIGYLKSLSKLEFCANHLSGVIPHSVG 282 (918)
Q Consensus 203 ~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~ 282 (918)
+ +|..+. ++|++|++++|.+++..+..|..+++|+.|++++|++++..+..+..+++|++|++++|++. .+|..+.
T Consensus 186 ~-l~~~~~--~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~ 261 (332)
T 2ft3_A 186 G-IPKDLP--ETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLP 261 (332)
T ss_dssp S-CCSSSC--SSCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCC-BCCTTGG
T ss_pred c-cCcccc--CCCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCe-ecChhhh
Confidence 5 343333 57777777777777766667777777777777777777766666777777777777777776 4455566
Q ss_pred CCCCCcEEEccCCcCcCCCCccccCCCCCCeEEeecccccCccccccCCCCCccEEeCCCCccc--cccCcccccccccc
Q 044366 283 NLTGLVLLNMCENHLFGPIPKSLRNLTSLERVRFNQNNLYGKVYEAFGDHPNLTFLDLSQNNFY--CEISFNWRNFSKLG 360 (918)
Q Consensus 283 ~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~--~~~~~~~~~~~~L~ 360 (918)
.+++|+.|++++|++++..+..|..... -...+.|+.|++++|++. .+....|..++.|+
T Consensus 262 ~l~~L~~L~l~~N~l~~~~~~~~~~~~~------------------~~~~~~l~~L~l~~N~~~~~~~~~~~~~~l~~L~ 323 (332)
T 2ft3_A 262 DLKLLQVVYLHTNNITKVGVNDFCPVGF------------------GVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRL 323 (332)
T ss_dssp GCTTCCEEECCSSCCCBCCTTSSSCSSC------------------CSSSCCBSEEECCSSSSCGGGSCGGGGTTBCCST
T ss_pred cCccCCEEECCCCCCCccChhHcccccc------------------ccccccccceEeecCcccccccCcccccccchhh
Confidence 6666666666666666555555543210 000234555555555554 33344455555555
Q ss_pred eeecccc
Q 044366 361 TFNASMN 367 (918)
Q Consensus 361 ~l~l~~n 367 (918)
.+++++|
T Consensus 324 ~l~l~~n 330 (332)
T 2ft3_A 324 AIQFGNY 330 (332)
T ss_dssp TEEC---
T ss_pred hhhcccc
Confidence 5555554
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-34 Score=344.95 Aligned_cols=237 Identities=23% Similarity=0.339 Sum_probs=190.0
Q ss_pred hcCCCCceeeccccceEEEEEEeC--CCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCc--
Q 044366 645 TGNFGEKYCIGKGGQRSVYKAELP--SGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQH-- 720 (918)
Q Consensus 645 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-- 720 (918)
.++|.+.+.||+|+||.||+|... +|+.||||++... ......+.|.+|++++++++||||+++++++...+.
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 155 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHS---GDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHG 155 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSS---CCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTS
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCcc---CCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCC
Confidence 378999999999999999999664 6899999998642 122234678999999999999999999999977655
Q ss_pred ---eEEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccc
Q 044366 721 ---SFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFG 797 (918)
Q Consensus 721 ---~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG 797 (918)
.|+||||+++++|.+++.. .+++.+++.|+.||+.||+|||+. +|+||||||+||+++.+ .+||+|||
T Consensus 156 ~~~~~lv~E~~~g~~L~~~~~~-----~l~~~~~~~~~~qi~~aL~~lH~~---giiHrDlkp~NIll~~~-~~kl~DFG 226 (681)
T 2pzi_A 156 DPVGYIVMEYVGGQSLKRSKGQ-----KLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLG 226 (681)
T ss_dssp CEEEEEEEECCCCEECC----C-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSS-CEEECCCT
T ss_pred CceeEEEEEeCCCCcHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHC---CCeecccChHHeEEeCC-cEEEEecc
Confidence 6999999999999988754 489999999999999999999999 99999999999999986 89999999
Q ss_pred cccccCCCCCCceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCC
Q 044366 798 FAKFLEPHSSNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRL 877 (918)
Q Consensus 798 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 877 (918)
+++..... ....||+.|+|||++.+. ++.++|||||||++|+|++|..|+..... ...
T Consensus 227 ~a~~~~~~----~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~-----------------~~~ 284 (681)
T 2pzi_A 227 AVSRINSF----GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYV-----------------DGL 284 (681)
T ss_dssp TCEETTCC----SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEEC-----------------SSC
T ss_pred cchhcccC----CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCccccc-----------------ccc
Confidence 99876543 345789999999998765 48899999999999999999888543110 001
Q ss_pred CCCCcchHHHHHHHHHHHHHcccCCCCCCCC-HHHHHHHh
Q 044366 878 PTPSRDVTDKLRSIMEVAILCLVENPEARPT-MKEVCNLL 916 (918)
Q Consensus 878 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt-~~evl~~L 916 (918)
+. ..........+.+++.+||+.||++||+ ++++.+.+
T Consensus 285 ~~-~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l 323 (681)
T 2pzi_A 285 PE-DDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQL 323 (681)
T ss_dssp CT-TCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHH
T ss_pred cc-cccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHH
Confidence 11 1112223457889999999999999996 55555443
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-32 Score=301.07 Aligned_cols=289 Identities=21% Similarity=0.285 Sum_probs=254.0
Q ss_pred CCCEEeCCCCcccccCCccccCCCCCCEEEcccccccccCCCCcCCCCCCCEEEcccccccccCCccccCCCCCCEEEcc
Q 044366 22 KLQYLDLGNNQLSGVIPPEIGKLNQLRRLYLDVNQLHGTIPPVIGQLSLINELVFCHNNVSGRIPSSLGNLSNLALLYLN 101 (918)
Q Consensus 22 ~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~l~~l~~L~~L~L~ 101 (918)
++++++++++.++ .+|..+. ++|++|+|++|++++..+..|+.+++|++|++++|.+++..|..|..+++|++|+++
T Consensus 32 ~l~~l~~~~~~l~-~lp~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls 108 (330)
T 1xku_A 32 HLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLS 108 (330)
T ss_dssp ETTEEECTTSCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred CCeEEEecCCCcc-ccCccCC--CCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEECC
Confidence 7999999999998 7787665 689999999999997666689999999999999999998889999999999999999
Q ss_pred CCcccccCccccCCCCCCCEEECcCCcCCCcCCcCCCCCCCCceeecccccccc--CCCcccccccccCeeeccccccCC
Q 044366 102 DNSLFGSIPIVMGNLKSLSTLDLSQNQLNGSIPCSLDNLSNLDTLFLYKNSLSG--PIPSVIGNLKSLLQLDLSENRLSG 179 (918)
Q Consensus 102 ~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~l~~--~~~~~~~~l~~L~~L~Ls~N~l~~ 179 (918)
+|+++ ..|..+. ++|++|++++|++++..+..+.++++|++|++++|.++. ..+..|.++++|++|++++|.++.
T Consensus 109 ~n~l~-~l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~ 185 (330)
T 1xku_A 109 KNQLK-ELPEKMP--KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITT 185 (330)
T ss_dssp SSCCS-BCCSSCC--TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCCS
T ss_pred CCcCC-ccChhhc--ccccEEECCCCcccccCHhHhcCCccccEEECCCCcCCccCcChhhccCCCCcCEEECCCCcccc
Confidence 99998 4555444 799999999999998777789999999999999999964 677889999999999999999997
Q ss_pred cCCccCCCCCCCcEeeccCcccccCCCccccCCCCcceeecccccccCCCCCCCcCCCcCCeEEcccCcCcCCCCccccc
Q 044366 180 LIPLSLSNLSSLTVMSLFNNSLSGSIPPILGNLKSLSTLGLHINQLNGVIPPSIGNLSSLRNLSLFNNRLYGFVPKEIGY 259 (918)
Q Consensus 180 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~ 259 (918)
++. .+. ++|++|++++|++++..+..|..+++|++|++++|.+++..+..+..+++|++|++++|+++ ..|..+..
T Consensus 186 l~~-~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~ 261 (330)
T 1xku_A 186 IPQ-GLP--PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLAD 261 (330)
T ss_dssp CCS-SCC--TTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTT
T ss_pred CCc-ccc--ccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCceeChhhccCCCCCCEEECCCCcCc-cCChhhcc
Confidence 643 333 78999999999999888899999999999999999999888888999999999999999999 56777899
Q ss_pred cCCCCeEecCCCccCCcCCCcCCCC------CCCcEEEccCCcCcC--CCCccccCCCCCCeEEeeccc
Q 044366 260 LKSLSKLEFCANHLSGVIPHSVGNL------TGLVLLNMCENHLFG--PIPKSLRNLTSLERVRFNQNN 320 (918)
Q Consensus 260 l~~L~~L~l~~n~l~~~~~~~~~~l------~~L~~L~l~~n~l~~--~~~~~l~~l~~L~~L~l~~n~ 320 (918)
+++|++|++++|+++++.+..|... ..++.|++++|++.. +.|..|..+.+++.+++++|+
T Consensus 262 l~~L~~L~l~~N~i~~~~~~~f~~~~~~~~~~~l~~l~l~~N~~~~~~i~~~~f~~~~~l~~l~L~~N~ 330 (330)
T 1xku_A 262 HKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNYK 330 (330)
T ss_dssp CSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSCGGGSCGGGGTTCCCGGGEEC----
T ss_pred CCCcCEEECCCCcCCccChhhcCCcccccccccccceEeecCcccccccCccccccccceeEEEecccC
Confidence 9999999999999999888888654 788999999999864 677899999999999999885
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-32 Score=297.88 Aligned_cols=291 Identities=20% Similarity=0.223 Sum_probs=258.9
Q ss_pred CCCCCEEEcccccccccCCCCcCCCCCCCEEEcccccccccCCccccCCCCCCEEEccCCcccccCccccCCCCCCCEEE
Q 044366 44 LNQLRRLYLDVNQLHGTIPPVIGQLSLINELVFCHNNVSGRIPSSLGNLSNLALLYLNDNSLFGSIPIVMGNLKSLSTLD 123 (918)
Q Consensus 44 l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~l~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~ 123 (918)
..+|+.++++++.++ .+|..+. +.|++|++++|++++..+..|.++++|++|+|++|++++..|..|..+++|++|+
T Consensus 30 ~c~l~~l~~~~~~l~-~lp~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 106 (330)
T 1xku_A 30 QCHLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLY 106 (330)
T ss_dssp EEETTEEECTTSCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEE
T ss_pred cCCCeEEEecCCCcc-ccCccCC--CCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEE
Confidence 447999999999998 7888765 6899999999999987777999999999999999999988899999999999999
Q ss_pred CcCCcCCCcCCcCCCCCCCCceeeccccccccCCCcccccccccCeeeccccccCC--cCCccCCCCCCCcEeeccCccc
Q 044366 124 LSQNQLNGSIPCSLDNLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSENRLSG--LIPLSLSNLSSLTVMSLFNNSL 201 (918)
Q Consensus 124 Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~--~~~~~~~~l~~L~~L~L~~N~l 201 (918)
|++|+++ .+|..+. ++|++|++++|++++..+..|.++++|++|++++|.++. ..+..|..+++|++|++++|.+
T Consensus 107 Ls~n~l~-~l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l 183 (330)
T 1xku_A 107 LSKNQLK-ELPEKMP--KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNI 183 (330)
T ss_dssp CCSSCCS-BCCSSCC--TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCC
T ss_pred CCCCcCC-ccChhhc--ccccEEECCCCcccccCHhHhcCCccccEEECCCCcCCccCcChhhccCCCCcCEEECCCCcc
Confidence 9999999 5565554 799999999999998888889999999999999999974 6678899999999999999999
Q ss_pred ccCCCccccCCCCcceeecccccccCCCCCCCcCCCcCCeEEcccCcCcCCCCccccccCCCCeEecCCCccCCcCCCcC
Q 044366 202 SGSIPPILGNLKSLSTLGLHINQLNGVIPPSIGNLSSLRNLSLFNNRLYGFVPKEIGYLKSLSKLEFCANHLSGVIPHSV 281 (918)
Q Consensus 202 ~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~ 281 (918)
+. +|..+. ++|++|++++|++++..+..|..+++|++|++++|.+++..+..+..+++|++|++++|++. .+|..+
T Consensus 184 ~~-l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l 259 (330)
T 1xku_A 184 TT-IPQGLP--PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGL 259 (330)
T ss_dssp CS-CCSSCC--TTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTT
T ss_pred cc-CCcccc--ccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCceeChhhccCCCCCCEEECCCCcCc-cCChhh
Confidence 85 454443 79999999999999888889999999999999999999988889999999999999999999 567789
Q ss_pred CCCCCCcEEEccCCcCcCCCCccccCC------CCCCeEEeecccccC--ccccccCCCCCccEEeCCCCc
Q 044366 282 GNLTGLVLLNMCENHLFGPIPKSLRNL------TSLERVRFNQNNLYG--KVYEAFGDHPNLTFLDLSQNN 344 (918)
Q Consensus 282 ~~l~~L~~L~l~~n~l~~~~~~~l~~l------~~L~~L~l~~n~l~~--~~~~~~~~l~~L~~L~Ls~N~ 344 (918)
..+++|+.|++++|++++..+..|... ..++.+++++|.+.. +.+..|..+++++.++|++|+
T Consensus 260 ~~l~~L~~L~l~~N~i~~~~~~~f~~~~~~~~~~~l~~l~l~~N~~~~~~i~~~~f~~~~~l~~l~L~~N~ 330 (330)
T 1xku_A 260 ADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNYK 330 (330)
T ss_dssp TTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSCGGGSCGGGGTTCCCGGGEEC----
T ss_pred ccCCCcCEEECCCCcCCccChhhcCCcccccccccccceEeecCcccccccCccccccccceeEEEecccC
Confidence 999999999999999998888888644 788999999999875 777899999999999999985
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-34 Score=321.42 Aligned_cols=244 Identities=16% Similarity=0.150 Sum_probs=180.2
Q ss_pred cCCCCceeeccccceEEEEEE-eCCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccC-CceeeEe-----------
Q 044366 646 GNFGEKYCIGKGGQRSVYKAE-LPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRH-RNIIKFH----------- 712 (918)
Q Consensus 646 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~~~----------- 712 (918)
..|...+.||+|+||.||+|. ..+|+.||||+++..... .....+.|.+|+.+++.++| +|.....
T Consensus 78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~-~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 156 (413)
T 3dzo_A 78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERP-PSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 156 (413)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC-----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCc-cHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence 457777899999999999996 567999999998743222 22346789999999999977 3221111
Q ss_pred ----------ccccc-----CCceEEEEEeccCCChhHHhhcc----cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCe
Q 044366 713 ----------GFCSN-----AQHSFIVCEYLARGSLTTILRDD----AAAKEFSWNQRMNVIKGVANALSYLHHDCIPPI 773 (918)
Q Consensus 713 ----------~~~~~-----~~~~~lv~e~~~~gsL~~~l~~~----~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i 773 (918)
.++.. ....+++|+++ +++|.++++.. .....+++..++.++.|+++||+|||+. +|
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i 232 (413)
T 3dzo_A 157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GL 232 (413)
T ss_dssp EECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred cccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC---Cc
Confidence 11111 22456777765 57999988521 1234578899999999999999999999 99
Q ss_pred EEcCCCCCCeeeCCCCcEEEeccccccccCCCCCCceeccccccccccccc----------ccCCCCcccchhhHHHHHH
Q 044366 774 VHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGTVGYAAPELA----------YTMRATEKYDVYSFGVLAL 843 (918)
Q Consensus 774 vH~dlk~~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~g~~~y~aPE~~----------~~~~~~~~~Dv~slG~vl~ 843 (918)
+||||||+||+++.++.+||+|||+++..... .....| +.|+|||++ .+..++.++|||||||++|
T Consensus 233 iHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~---~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~ 308 (413)
T 3dzo_A 233 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS---AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIY 308 (413)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTEE---ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHH
T ss_pred ccCCcccceEEEecCCeEEEEeccceeecCCc---cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHH
Confidence 99999999999999999999999999865433 334567 999999998 5556888999999999999
Q ss_pred HHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 844 EVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 844 el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
||++|+.||....... . ....... .. .. ...+.+++.+||+.||++||++.|+++
T Consensus 309 elltg~~Pf~~~~~~~-~-------~~~~~~~-~~----~~---~~~~~~li~~~l~~dP~~Rpt~~~~l~ 363 (413)
T 3dzo_A 309 WIWCADLPNTDDAALG-G-------SEWIFRS-CK----NI---PQPVRALLEGFLRYPKEDRLLPLQAME 363 (413)
T ss_dssp HHHHSSCCCCTTGGGS-C-------SGGGGSS-CC----CC---CHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHHCCCCCCCcchhh-h-------HHHHHhh-cc----cC---CHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 9999999986543210 0 0111111 11 11 246888999999999999999888754
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-33 Score=304.13 Aligned_cols=252 Identities=31% Similarity=0.501 Sum_probs=234.3
Q ss_pred CCCCEEeCCCCcccc--cCCccccCCCCCCEEEccc-ccccccCCCCcCCCCCCCEEEcccccccccCCccccCCCCCCE
Q 044366 21 SKLQYLDLGNNQLSG--VIPPEIGKLNQLRRLYLDV-NQLHGTIPPVIGQLSLINELVFCHNNVSGRIPSSLGNLSNLAL 97 (918)
Q Consensus 21 ~~L~~L~L~~n~i~~--~~p~~l~~l~~L~~L~L~~-n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~l~~l~~L~~ 97 (918)
.++++|+|++|++++ .+|.+|+.+++|++|+|++ |.+.+.+|..|+.+++|++|++++|.+++.+|..|..+++|++
T Consensus 50 ~~l~~L~L~~~~l~~~~~~~~~l~~l~~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~ 129 (313)
T 1ogq_A 50 YRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVT 129 (313)
T ss_dssp CCEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCE
T ss_pred ceEEEEECCCCCccCCcccChhHhCCCCCCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCE
Confidence 579999999999998 8999999999999999995 9999899999999999999999999999999999999999999
Q ss_pred EEccCCcccccCccccCCCCCCCEEECcCCcCCCcCCcCCCCCC-CCceeeccccccccCCCcccccccccCeeeccccc
Q 044366 98 LYLNDNSLFGSIPIVMGNLKSLSTLDLSQNQLNGSIPCSLDNLS-NLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSENR 176 (918)
Q Consensus 98 L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~l~~l~-~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~ 176 (918)
|+|++|++.+..|..|..+++|++|+|++|++++.+|..+..++ +|++|++++|++++..|..|..++ |++|++++|+
T Consensus 130 L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~-L~~L~Ls~N~ 208 (313)
T 1ogq_A 130 LDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNM 208 (313)
T ss_dssp EECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCC-CSEEECCSSE
T ss_pred EeCCCCccCCcCChHHhcCCCCCeEECcCCcccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCCc-ccEEECcCCc
Confidence 99999999989999999999999999999999988999999998 999999999999988999999987 9999999999
Q ss_pred cCCcCCccCCCCCCCcEeeccCcccccCCCccccCCCCcceeecccccccCCCCCCCcCCCcCCeEEcccCcCcCCCCcc
Q 044366 177 LSGLIPLSLSNLSSLTVMSLFNNSLSGSIPPILGNLKSLSTLGLHINQLNGVIPPSIGNLSSLRNLSLFNNRLYGFVPKE 256 (918)
Q Consensus 177 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~ 256 (918)
+++..|..|..+++|+.|+|++|.+++.++. +..+++|++|++++|++++.+|..|..+++|++|++++|++++..|..
T Consensus 209 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~~ 287 (313)
T 1ogq_A 209 LEGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQG 287 (313)
T ss_dssp EEECCGGGCCTTSCCSEEECCSSEECCBGGG-CCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCS
T ss_pred ccCcCCHHHhcCCCCCEEECCCCceeeecCc-ccccCCCCEEECcCCcccCcCChHHhcCcCCCEEECcCCcccccCCCC
Confidence 9988899999999999999999999866555 888999999999999999889999999999999999999999888876
Q ss_pred ccccCCCCeEecCCCc-cCC
Q 044366 257 IGYLKSLSKLEFCANH-LSG 275 (918)
Q Consensus 257 ~~~l~~L~~L~l~~n~-l~~ 275 (918)
..+++|+.+++++|+ +.+
T Consensus 288 -~~l~~L~~l~l~~N~~lc~ 306 (313)
T 1ogq_A 288 -GNLQRFDVSAYANNKCLCG 306 (313)
T ss_dssp -TTGGGSCGGGTCSSSEEES
T ss_pred -ccccccChHHhcCCCCccC
Confidence 889999999999998 554
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-33 Score=303.15 Aligned_cols=252 Identities=33% Similarity=0.530 Sum_probs=232.0
Q ss_pred CCCCEEEcccccccc--cCCCCcCCCCCCCEEEccc-ccccccCCccccCCCCCCEEEccCCcccccCccccCCCCCCCE
Q 044366 45 NQLRRLYLDVNQLHG--TIPPVIGQLSLINELVFCH-NNVSGRIPSSLGNLSNLALLYLNDNSLFGSIPIVMGNLKSLST 121 (918)
Q Consensus 45 ~~L~~L~L~~n~l~~--~~p~~~~~l~~L~~L~l~~-n~~~~~~p~~l~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~ 121 (918)
.+++.|+|++|++++ .+|..++.+++|++|++++ |++.+.+|..|.++++|++|+|++|++++..|..|.++++|++
T Consensus 50 ~~l~~L~L~~~~l~~~~~~~~~l~~l~~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~ 129 (313)
T 1ogq_A 50 YRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVT 129 (313)
T ss_dssp CCEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCE
T ss_pred ceEEEEECCCCCccCCcccChhHhCCCCCCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCE
Confidence 689999999999998 8999999999999999995 9999999999999999999999999999889999999999999
Q ss_pred EECcCCcCCCcCCcCCCCCCCCceeeccccccccCCCccccccc-ccCeeeccccccCCcCCccCCCCCCCcEeeccCcc
Q 044366 122 LDLSQNQLNGSIPCSLDNLSNLDTLFLYKNSLSGPIPSVIGNLK-SLLQLDLSENRLSGLIPLSLSNLSSLTVMSLFNNS 200 (918)
Q Consensus 122 L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~-~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~ 200 (918)
|+|++|++++.+|..+.++++|++|++++|++++..|..+..++ +|++|++++|++++..|..+..++ |++|++++|.
T Consensus 130 L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~-L~~L~Ls~N~ 208 (313)
T 1ogq_A 130 LDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNM 208 (313)
T ss_dssp EECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCC-CSEEECCSSE
T ss_pred EeCCCCccCCcCChHHhcCCCCCeEECcCCcccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCCc-ccEEECcCCc
Confidence 99999999988999999999999999999999988899999998 999999999999988898998887 9999999999
Q ss_pred cccCCCccccCCCCcceeecccccccCCCCCCCcCCCcCCeEEcccCcCcCCCCccccccCCCCeEecCCCccCCcCCCc
Q 044366 201 LSGSIPPILGNLKSLSTLGLHINQLNGVIPPSIGNLSSLRNLSLFNNRLYGFVPKEIGYLKSLSKLEFCANHLSGVIPHS 280 (918)
Q Consensus 201 l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~ 280 (918)
+++..|..|..+++|+.|++++|++++.++. +..+++|++|++++|++++..|..+..+++|++|++++|++.+.+|..
T Consensus 209 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~~ 287 (313)
T 1ogq_A 209 LEGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQG 287 (313)
T ss_dssp EEECCGGGCCTTSCCSEEECCSSEECCBGGG-CCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCS
T ss_pred ccCcCCHHHhcCCCCCEEECCCCceeeecCc-ccccCCCCEEECcCCcccCcCChHHhcCcCCCEEECcCCcccccCCCC
Confidence 9988899999999999999999999876555 788899999999999999889999999999999999999999888876
Q ss_pred CCCCCCCcEEEccCCc-CcC
Q 044366 281 VGNLTGLVLLNMCENH-LFG 299 (918)
Q Consensus 281 ~~~l~~L~~L~l~~n~-l~~ 299 (918)
..+++|+.+++++|+ +.+
T Consensus 288 -~~l~~L~~l~l~~N~~lc~ 306 (313)
T 1ogq_A 288 -GNLQRFDVSAYANNKCLCG 306 (313)
T ss_dssp -TTGGGSCGGGTCSSSEEES
T ss_pred -ccccccChHHhcCCCCccC
Confidence 889999999999997 443
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=99.97 E-value=1.6e-35 Score=339.92 Aligned_cols=383 Identities=17% Similarity=0.109 Sum_probs=200.0
Q ss_pred CCCCEEECcCCcCCCcCCcC-CCCCCCCceeeccccccccC----CCcccccccccCeeeccccccCCcCCccC-CCCC-
Q 044366 117 KSLSTLDLSQNQLNGSIPCS-LDNLSNLDTLFLYKNSLSGP----IPSVIGNLKSLLQLDLSENRLSGLIPLSL-SNLS- 189 (918)
Q Consensus 117 ~~L~~L~Ls~n~i~~~~~~~-l~~l~~L~~L~L~~n~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~-~~l~- 189 (918)
++|++|||++|+++...... +..+++|++|++++|+++.. ++..+..+++|++|+|++|.+.+..+..+ ..++
T Consensus 3 ~~l~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~ 82 (461)
T 1z7x_W 3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQT 82 (461)
T ss_dssp EEEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCS
T ss_pred ccceehhhhhcccCchhHHHHHhhcCCccEEEccCCCCCHHHHHHHHHHHHhCCCcCEEeCCCCcCChHHHHHHHHHHhh
Confidence 45777888888776543322 56677777777777777632 24456666777777777777764333222 2233
Q ss_pred ---CCcEeeccCccccc----CCCccccCCCCcceeecccccccCCCCCCC-----cCCCcCCeEEcccCcCcCCC----
Q 044366 190 ---SLTVMSLFNNSLSG----SIPPILGNLKSLSTLGLHINQLNGVIPPSI-----GNLSSLRNLSLFNNRLYGFV---- 253 (918)
Q Consensus 190 ---~L~~L~L~~N~l~~----~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~-----~~l~~L~~L~Ls~n~l~~~~---- 253 (918)
+|++|+|++|.++. .++..+..+++|++|++++|.++...+..+ ...++|++|++++|++++..
T Consensus 83 ~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l 162 (461)
T 1z7x_W 83 PSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPL 162 (461)
T ss_dssp TTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHH
T ss_pred CCCceeEEEccCCCCCHHHHHHHHHHHccCCceeEEECCCCcCchHHHHHHHHHHhcCCCcceEEECCCCCCCHHHHHHH
Confidence 57777777777663 335566667777777777776654322222 12345677777776666433
Q ss_pred CccccccCCCCeEecCCCccCCcCCCcCC-----CCCCCcEEEccCCcCcCC----CCccccCCCCCCeEEeecccccCc
Q 044366 254 PKEIGYLKSLSKLEFCANHLSGVIPHSVG-----NLTGLVLLNMCENHLFGP----IPKSLRNLTSLERVRFNQNNLYGK 324 (918)
Q Consensus 254 ~~~~~~l~~L~~L~l~~n~l~~~~~~~~~-----~l~~L~~L~l~~n~l~~~----~~~~l~~l~~L~~L~l~~n~l~~~ 324 (918)
+..+..+++|++|++++|.+....+..+. ..++|+.|++++|.++.. ++..+..+++|++|++++|.+...
T Consensus 163 ~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~ 242 (461)
T 1z7x_W 163 ASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDV 242 (461)
T ss_dssp HHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHH
T ss_pred HHHHhhCCCCCEEECcCCCcchHHHHHHHHHHhcCCCCceEEEccCCCCcHHHHHHHHHHHHhCCCccEEeccCCcCChH
Confidence 33344456666666666665543333222 133555555555555432 233444444455555544444332
Q ss_pred c-----ccccCCCCCccEEeCCCCccccccCcccccccccceeeccccccccCCCcCcCCCCCCcEEEccCceecccccc
Q 044366 325 V-----YEAFGDHPNLTFLDLSQNNFYCEISFNWRNFSKLGTFNASMNNIYGSIPPEIGDSSKLQVLDLSSNHIFGKIPV 399 (918)
Q Consensus 325 ~-----~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~n~i~~~~~~~~~~~~~L~~L~L~~N~l~~~~~~ 399 (918)
. ...+..+++|+.|++++|.++..... .++..+..+++|++|+|++|.+....+.
T Consensus 243 ~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~--------------------~l~~~l~~~~~L~~L~Ls~n~i~~~~~~ 302 (461)
T 1z7x_W 243 GMAELCPGLLHPSSRLRTLWIWECGITAKGCG--------------------DLCRVLRAKESLKELSLAGNELGDEGAR 302 (461)
T ss_dssp HHHHHHHHHTSTTCCCCEEECTTSCCCHHHHH--------------------HHHHHHHHCTTCCEEECTTCCCHHHHHH
T ss_pred HHHHHHHHHhcCCCCceEEECcCCCCCHHHHH--------------------HHHHHHhhCCCcceEECCCCCCchHHHH
Confidence 2 11112234444444444433211000 0222333344455555555554433222
Q ss_pred chhhccccCceecccccccCCCCCCCCCCCcccEEeccCcccccc----CccccccccccceecccCcccCCCCchhhcc
Q 044366 400 QLVKLFSLNKLILSLNQLFGGVPLEFGTLTELQYLDLSANKLSSS----IPMSIGNLLKLHYLNLSNNQFSHKIPTEFEK 475 (918)
Q Consensus 400 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~ 475 (918)
.+... .....++|++|+|++|.+++. ++..+..+++|++|+|++|++++..+..+..
T Consensus 303 ~l~~~-------------------l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~ 363 (461)
T 1z7x_W 303 LLCET-------------------LLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQ 363 (461)
T ss_dssp HHHHH-------------------HTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHH
T ss_pred HHHHH-------------------hccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCccccccHHHHHH
Confidence 22221 001124566666666666543 3344455566666666666665444444432
Q ss_pred -----ccccceEeccCCcCCC----CCchhccccCCcceEecCCCcccccCccccc-----CCCCccEEEccCCcCC
Q 044366 476 -----LIHLSELDLSHNILQE----EIPPQICKMESLEKLNLSHNNLSDFIPRCFE-----EMRSLSWIDISYNELQ 538 (918)
Q Consensus 476 -----l~~L~~L~Ls~N~l~~----~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~-----~l~~L~~l~l~~N~l~ 538 (918)
.++|++|+|++|+|++ .+|..+..+++|++|+|++|++++.....+. ...+|+.|++.+|.+.
T Consensus 364 ~l~~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~N~i~~~~~~~l~~~l~~~~~~L~~L~~~~~~~~ 440 (461)
T 1z7x_W 364 GLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWS 440 (461)
T ss_dssp HHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCCHHHHHHHHHHHTSTTCCCCEEECTTCCCC
T ss_pred HHcCCCCceEEEECCCCCCChhhHHHHHHHHHhCCCccEEECCCCCCCHHHHHHHHHHhccCCcchhheeecccccC
Confidence 4566666666666654 4556666666666666666666643211111 1234566666665554
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=99.97 E-value=5.2e-35 Score=335.74 Aligned_cols=361 Identities=19% Similarity=0.149 Sum_probs=224.0
Q ss_pred CCCceeeccccccccCCCcc-cccccccCeeeccccccCCc----CCccCCCCCCCcEeeccCcccccCCCccc-cCCC-
Q 044366 141 SNLDTLFLYKNSLSGPIPSV-IGNLKSLLQLDLSENRLSGL----IPLSLSNLSSLTVMSLFNNSLSGSIPPIL-GNLK- 213 (918)
Q Consensus 141 ~~L~~L~L~~n~l~~~~~~~-~~~l~~L~~L~Ls~N~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~~~~~~-~~l~- 213 (918)
++|++|+|++|+++...... +..+++|++|++++|.+++. ++..+..+++|++|+|++|.+++..+..+ ..++
T Consensus 3 ~~l~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~ 82 (461)
T 1z7x_W 3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQT 82 (461)
T ss_dssp EEEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCS
T ss_pred ccceehhhhhcccCchhHHHHHhhcCCccEEEccCCCCCHHHHHHHHHHHHhCCCcCEEeCCCCcCChHHHHHHHHHHhh
Confidence 46777777777776443332 66677777777777777632 23455666777777777777654322222 2233
Q ss_pred ---CcceeecccccccC----CCCCCCcCCCcCCeEEcccCcCcCCCCccccccCCCCeEecCCCccCCcCCCcCCCCCC
Q 044366 214 ---SLSTLGLHINQLNG----VIPPSIGNLSSLRNLSLFNNRLYGFVPKEIGYLKSLSKLEFCANHLSGVIPHSVGNLTG 286 (918)
Q Consensus 214 ---~L~~L~L~~n~l~~----~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~ 286 (918)
+|++|+|++|.++. .++..+..+++|++|++++|.+++..+..+... .+...++
T Consensus 83 ~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~-------------------l~~~~~~ 143 (461)
T 1z7x_W 83 PSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEG-------------------LLDPQCR 143 (461)
T ss_dssp TTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHH-------------------HTSTTCC
T ss_pred CCCceeEEEccCCCCCHHHHHHHHHHHccCCceeEEECCCCcCchHHHHHHHHH-------------------HhcCCCc
Confidence 46666666665552 224445555555555555555543222222110 0111233
Q ss_pred CcEEEccCCcCcCCC----CccccCCCCCCeEEeecccccCccccccC-----CCCCccEEeCCCCccccccCccccccc
Q 044366 287 LVLLNMCENHLFGPI----PKSLRNLTSLERVRFNQNNLYGKVYEAFG-----DHPNLTFLDLSQNNFYCEISFNWRNFS 357 (918)
Q Consensus 287 L~~L~l~~n~l~~~~----~~~l~~l~~L~~L~l~~n~l~~~~~~~~~-----~l~~L~~L~Ls~N~l~~~~~~~~~~~~ 357 (918)
|+.|++++|++++.. +..+..+++|++|++++|.+.......+. ..++|+.|++++|.++.....
T Consensus 144 L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~------ 217 (461)
T 1z7x_W 144 LEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCR------ 217 (461)
T ss_dssp CCEEECTTSCCBGGGHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHH------
T ss_pred ceEEECCCCCCCHHHHHHHHHHHhhCCCCCEEECcCCCcchHHHHHHHHHHhcCCCCceEEEccCCCCcHHHHH------
Confidence 444444444444322 33444455555555555555443333332 244566666666655421100
Q ss_pred ccceeeccccccccCCCcCcCCCCCCcEEEccCceeccccc-----cchhhccccCceecccccccCC----CCCCCCCC
Q 044366 358 KLGTFNASMNNIYGSIPPEIGDSSKLQVLDLSSNHIFGKIP-----VQLVKLFSLNKLILSLNQLFGG----VPLEFGTL 428 (918)
Q Consensus 358 ~L~~l~l~~n~i~~~~~~~~~~~~~L~~L~L~~N~l~~~~~-----~~~~~l~~L~~L~L~~N~l~~~----~~~~~~~l 428 (918)
.++..+..+++|++|++++|.+..... ..+..+++|++|++++|++++. ++..+..+
T Consensus 218 --------------~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~ 283 (461)
T 1z7x_W 218 --------------DLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAK 283 (461)
T ss_dssp --------------HHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHC
T ss_pred --------------HHHHHHHhCCCccEEeccCCcCChHHHHHHHHHHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhC
Confidence 123344556667777777776654322 1222456777777777777653 34556668
Q ss_pred CcccEEeccCccccccCccccccc-----cccceecccCcccCCC----CchhhccccccceEeccCCcCCCCCchhccc
Q 044366 429 TELQYLDLSANKLSSSIPMSIGNL-----LKLHYLNLSNNQFSHK----IPTEFEKLIHLSELDLSHNILQEEIPPQICK 499 (918)
Q Consensus 429 ~~L~~L~Ls~N~l~~~~~~~~~~l-----~~L~~L~Ls~N~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~ 499 (918)
++|++|+|++|.++...+..+... ++|+.|+|++|.+++. ++..+..+++|++|+|++|+|++..+..+..
T Consensus 284 ~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~ 363 (461)
T 1z7x_W 284 ESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQ 363 (461)
T ss_dssp TTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHH
T ss_pred CCcceEECCCCCCchHHHHHHHHHhccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCccccccHHHHHH
Confidence 899999999999886544444433 6999999999999865 4667778899999999999998766665553
Q ss_pred -----cCCcceEecCCCcccc----cCcccccCCCCccEEEccCCcCCCC
Q 044366 500 -----MESLEKLNLSHNNLSD----FIPRCFEEMRSLSWIDISYNELQGP 540 (918)
Q Consensus 500 -----l~~L~~L~L~~N~l~~----~~~~~~~~l~~L~~l~l~~N~l~~~ 540 (918)
.++|+.|+|++|++++ .+|..+..+++|+.||+++|++++.
T Consensus 364 ~l~~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~N~i~~~ 413 (461)
T 1z7x_W 364 GLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDA 413 (461)
T ss_dssp HHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCCHH
T ss_pred HHcCCCCceEEEECCCCCCChhhHHHHHHHHHhCCCccEEECCCCCCCHH
Confidence 6799999999999996 6888899999999999999999853
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=9.5e-31 Score=288.50 Aligned_cols=274 Identities=20% Similarity=0.185 Sum_probs=177.1
Q ss_pred EEcccccccccCCccccCCCCCCEEEccCCcccccCccccCCCCCCCEEECcCCcCCCcCCcCCCCCCCCceeecccccc
Q 044366 74 LVFCHNNVSGRIPSSLGNLSNLALLYLNDNSLFGSIPIVMGNLKSLSTLDLSQNQLNGSIPCSLDNLSNLDTLFLYKNSL 153 (918)
Q Consensus 74 L~l~~n~~~~~~p~~l~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~l 153 (918)
.+++++.++ .+|..+. ++|++|++++|++++..+..|.++++|++|+|++|++++..|..|.++++|++|++++|++
T Consensus 36 c~~~~~~l~-~iP~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l 112 (353)
T 2z80_A 36 CKGSSGSLN-SIPSGLT--EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYL 112 (353)
T ss_dssp EECCSTTCS-SCCTTCC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCC
T ss_pred eeCCCCCcc-ccccccc--ccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCEEECCCCcC
Confidence 344444444 3444333 3555555555555554444555566666666666666555555566666666666666666
Q ss_pred ccCCCcccccccccCeeeccccccCCcCC-ccCCCCCCCcEeeccCc-ccccCCCccccCCCCcceeecccccccCCCCC
Q 044366 154 SGPIPSVIGNLKSLLQLDLSENRLSGLIP-LSLSNLSSLTVMSLFNN-SLSGSIPPILGNLKSLSTLGLHINQLNGVIPP 231 (918)
Q Consensus 154 ~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~-~~~~~l~~L~~L~L~~N-~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~ 231 (918)
+++.+..|+++++|++|++++|+++++.+ ..|..+++|++|++++| .+....+..|.++++|++|++++|++++..|.
T Consensus 113 ~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~ 192 (353)
T 2z80_A 113 SNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPK 192 (353)
T ss_dssp SSCCHHHHTTCTTCSEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTT
T ss_pred CcCCHhHhCCCccCCEEECCCCCCcccCchhhhccCCCCcEEECCCCccccccCHHHccCCCCCCEEECCCCCcCccCHH
Confidence 65444446666666666666666665444 45666666666666666 35555555666666666666666666666666
Q ss_pred CCcCCCcCCeEEcccCcCcCCCCccccccCCCCeEecCCCccCCcCCCcCC---CCCCCcEEEccCCcCcC----CCCcc
Q 044366 232 SIGNLSSLRNLSLFNNRLYGFVPKEIGYLKSLSKLEFCANHLSGVIPHSVG---NLTGLVLLNMCENHLFG----PIPKS 304 (918)
Q Consensus 232 ~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~---~l~~L~~L~l~~n~l~~----~~~~~ 304 (918)
.+..+++|++|++++|++.......+..+++|+.|++++|.+.+..+..+. ....++.+++.++.+.+ .+|..
T Consensus 193 ~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~~~~~~l~~l~L~~~~l~~~~l~~l~~~ 272 (353)
T 2z80_A 193 SLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKL 272 (353)
T ss_dssp TTTTCSEEEEEEEECSCSTTHHHHHHHHTTTEEEEEEESCBCTTCCCC------CCCCCCEEEEESCBCCHHHHHHHHHH
T ss_pred HHhccccCCeecCCCCccccchhhhhhhcccccEEECCCCccccccccccccccccchhhccccccccccCcchhhhHHH
Confidence 666666666666666666544434444566677777777766655444332 34567777777777654 35778
Q ss_pred ccCCCCCCeEEeecccccCccccccCCCCCccEEeCCCCccccccC
Q 044366 305 LRNLTSLERVRFNQNNLYGKVYEAFGDHPNLTFLDLSQNNFYCEIS 350 (918)
Q Consensus 305 l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~ 350 (918)
+.++++|++|++++|.++.++...|..+++|++|++++|++.|++.
T Consensus 273 l~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~~~~~~~ 318 (353)
T 2z80_A 273 LNQISGLLELEFSRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 318 (353)
T ss_dssp HHTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred HhcccCCCEEECCCCCCCccCHHHHhcCCCCCEEEeeCCCccCcCC
Confidence 8899999999999999999998889999999999999999998875
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.7e-29 Score=287.21 Aligned_cols=254 Identities=25% Similarity=0.300 Sum_probs=175.0
Q ss_pred CCEEEccCCcccccCccccCCCCCCCEEECcCCcCCCcCCcCCCCCCCCceeeccccccccCCCcccccccccCeeeccc
Q 044366 95 LALLYLNDNSLFGSIPIVMGNLKSLSTLDLSQNQLNGSIPCSLDNLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSE 174 (918)
Q Consensus 95 L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~ 174 (918)
...++.+++.++ .+|..+. ++++.|+|++|+|+...+..|.++++|++|+|++|+++++.+..|.++++|++|+|++
T Consensus 45 ~~~v~c~~~~l~-~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~ 121 (440)
T 3zyj_A 45 FSKVICVRKNLR-EVPDGIS--TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFD 121 (440)
T ss_dssp SCEEECCSCCCS-SCCSCCC--TTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCS
T ss_pred CCEEEeCCCCcC-cCCCCCC--CCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECCC
Confidence 344555555554 3333332 4555666666666555555566666666666666666655555666666666666666
Q ss_pred cccCCcCCccCCCCCCCcEeeccCcccccCCCccccCCCCcceeeccc-ccccCCCCCCCcCCCcCCeEEcccCcCcCCC
Q 044366 175 NRLSGLIPLSLSNLSSLTVMSLFNNSLSGSIPPILGNLKSLSTLGLHI-NQLNGVIPPSIGNLSSLRNLSLFNNRLYGFV 253 (918)
Q Consensus 175 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~-n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~ 253 (918)
|+++.+.+..|..+++|++|+|++|.++.+.+..|.++++|++|++++ |.+..+.+..|.++++|++|++++|+++.+
T Consensus 122 n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~~- 200 (440)
T 3zyj_A 122 NRLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLREI- 200 (440)
T ss_dssp SCCSSCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCSSC-
T ss_pred CcCCeeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcCccc-
Confidence 666655555566666666666666666655555666666666666666 344444444566777777777777777644
Q ss_pred CccccccCCCCeEecCCCccCCcCCCcCCCCCCCcEEEccCCcCcCCCCccccCCCCCCeEEeecccccCccccccCCCC
Q 044366 254 PKEIGYLKSLSKLEFCANHLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLRNLTSLERVRFNQNNLYGKVYEAFGDHP 333 (918)
Q Consensus 254 ~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~ 333 (918)
| .+..+++|+.|++++|++.+..+..|.++++|+.|++++|++.+..+..|.++++|++|+|++|+++.++...|..++
T Consensus 201 ~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~ 279 (440)
T 3zyj_A 201 P-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLH 279 (440)
T ss_dssp C-CCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCEEECTTSCCCCCCTTTTSSCT
T ss_pred c-ccCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeEEChhhhcCCCCCCEEECCCCCCCccChhHhcccc
Confidence 2 366777777777777777777777788888888888888888877888888888888888888888888888999999
Q ss_pred CccEEeCCCCccccccCccc
Q 044366 334 NLTFLDLSQNNFYCEISFNW 353 (918)
Q Consensus 334 ~L~~L~Ls~N~l~~~~~~~~ 353 (918)
+|+.|+|++|+|.|+|...|
T Consensus 280 ~L~~L~L~~Np~~CdC~l~~ 299 (440)
T 3zyj_A 280 HLERIHLHHNPWNCNCDILW 299 (440)
T ss_dssp TCCEEECCSSCEECSSTTHH
T ss_pred CCCEEEcCCCCccCCCCchH
Confidence 99999999999999998654
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.97 E-value=3.6e-30 Score=277.97 Aligned_cols=244 Identities=25% Similarity=0.272 Sum_probs=125.6
Q ss_pred ccCCCCCCccCCccCCCCCCCCEEeCCCCcccccCCccccCCCCCCEEEcccccccc--cCCCCcCCCCCCCEEEccccc
Q 044366 3 NLGFNLLFGNIPPQIGNLSKLQYLDLGNNQLSGVIPPEIGKLNQLRRLYLDVNQLHG--TIPPVIGQLSLINELVFCHNN 80 (918)
Q Consensus 3 ~~~~~~~~~~~p~~~~~l~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~n~l~~--~~p~~~~~l~~L~~L~l~~n~ 80 (918)
+.++++++ .+|..+. ++|++|+|++|+++...+..|..+++|++|+|++|+++. ..|..+..+++|++|++++|.
T Consensus 13 ~c~~~~l~-~ip~~~~--~~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~ 89 (306)
T 2z66_A 13 RCNSKGLT-SVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNG 89 (306)
T ss_dssp ECCSSCCS-SCCSCCC--TTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEEEEEEHHHHSCSCCCEEECCSCS
T ss_pred EcCCCCcc-cCCCCCC--CCCCEEECCCCccCccCHhHhhccccCCEEECCCCccCcccCcccccccccccCEEECCCCc
Confidence 34445554 4554432 455666666666553322334556666666666655542 123444445555555555555
Q ss_pred ccccCCccccCCCCCCEEEccCCcccccCc-cccCCCCCCCEEECcCCcCCCcCCcCCCCCCCCceeecccccccc-CCC
Q 044366 81 VSGRIPSSLGNLSNLALLYLNDNSLFGSIP-IVMGNLKSLSTLDLSQNQLNGSIPCSLDNLSNLDTLFLYKNSLSG-PIP 158 (918)
Q Consensus 81 ~~~~~p~~l~~l~~L~~L~L~~n~i~~~~~-~~~~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~l~~-~~~ 158 (918)
++ .+|..+..+++|++|++++|++.+..+ ..+..+++|++|++++|++++..+..+.++++|++|++++|.+++ ..|
T Consensus 90 i~-~l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~ 168 (306)
T 2z66_A 90 VI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLP 168 (306)
T ss_dssp EE-EEEEEEETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCEEGGGEEC
T ss_pred cc-cChhhcCCCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEEECCCCccccccch
Confidence 55 344445555555555555555543333 345555555555555555554455555555555555555555543 344
Q ss_pred cccccccccCeeeccccccCCcCCccCCCCCCCcEeeccCcccccCCCccccCCCCcceeecccccccCCCCCCCcCCC-
Q 044366 159 SVIGNLKSLLQLDLSENRLSGLIPLSLSNLSSLTVMSLFNNSLSGSIPPILGNLKSLSTLGLHINQLNGVIPPSIGNLS- 237 (918)
Q Consensus 159 ~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~- 237 (918)
..|..+++|++|++++|++++..|..|..+++|++|+|++|++++..+..|..+++|+.|++++|++++..+..+..++
T Consensus 169 ~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~ 248 (306)
T 2z66_A 169 DIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPS 248 (306)
T ss_dssp SCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCCSGGGTTCTTCCEEECTTSCCCBCSSSSCCCCCT
T ss_pred hHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccCccChhhccCcccCCEeECCCCCCcccCHHHHHhhhc
Confidence 4555555555555555555554455555555555555555555544444455555555555555555544444444442
Q ss_pred cCCeEEcccCcCc
Q 044366 238 SLRNLSLFNNRLY 250 (918)
Q Consensus 238 ~L~~L~Ls~n~l~ 250 (918)
+|++|++++|.++
T Consensus 249 ~L~~L~L~~N~~~ 261 (306)
T 2z66_A 249 SLAFLNLTQNDFA 261 (306)
T ss_dssp TCCEEECTTCCEE
T ss_pred cCCEEEccCCCee
Confidence 4555555555544
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=4.3e-30 Score=283.20 Aligned_cols=284 Identities=18% Similarity=0.160 Sum_probs=225.6
Q ss_pred CccCCCCCCCCEEeCCCCcccccCCccccCCCCCCEEEcccccccccCCCCcCCCCCCCEEEcccccccccCCccccCCC
Q 044366 14 PPQIGNLSKLQYLDLGNNQLSGVIPPEIGKLNQLRRLYLDVNQLHGTIPPVIGQLSLINELVFCHNNVSGRIPSSLGNLS 93 (918)
Q Consensus 14 p~~~~~l~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~l~~l~ 93 (918)
++....++.....++++++++ .+|..+. ++|++|++++|++++..+..+..+++|++|++++|.+++..|..|.+++
T Consensus 24 ~~~~~~C~~~~~c~~~~~~l~-~iP~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~ 100 (353)
T 2z80_A 24 NQASLSCDRNGICKGSSGSLN-SIPSGLT--EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLG 100 (353)
T ss_dssp ---CCEECTTSEEECCSTTCS-SCCTTCC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCT
T ss_pred CccCCCCCCCeEeeCCCCCcc-ccccccc--ccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCC
Confidence 334455677778999999998 7787666 4899999999999965566899999999999999999988888899999
Q ss_pred CCCEEEccCCcccccCccccCCCCCCCEEECcCCcCCCcCC-cCCCCCCCCceeecccc-ccccCCCcccccccccCeee
Q 044366 94 NLALLYLNDNSLFGSIPIVMGNLKSLSTLDLSQNQLNGSIP-CSLDNLSNLDTLFLYKN-SLSGPIPSVIGNLKSLLQLD 171 (918)
Q Consensus 94 ~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~-~~l~~l~~L~~L~L~~n-~l~~~~~~~~~~l~~L~~L~ 171 (918)
+|++|+|++|++++..+..|.++++|++|++++|+++...+ ..+.++++|++|++++| .++.+.+..|+++++|++|+
T Consensus 101 ~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~ 180 (353)
T 2z80_A 101 SLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELE 180 (353)
T ss_dssp TCCEEECCSSCCSSCCHHHHTTCTTCSEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEE
T ss_pred CCCEEECCCCcCCcCCHhHhCCCccCCEEECCCCCCcccCchhhhccCCCCcEEECCCCccccccCHHHccCCCCCCEEE
Confidence 99999999999987766678999999999999999985444 47889999999999998 57777788899999999999
Q ss_pred ccccccCCcCCccCCCCCCCcEeeccCcccccCCCccccCCCCcceeecccccccCCCCCCCc---CCCcCCeEEcccCc
Q 044366 172 LSENRLSGLIPLSLSNLSSLTVMSLFNNSLSGSIPPILGNLKSLSTLGLHINQLNGVIPPSIG---NLSSLRNLSLFNNR 248 (918)
Q Consensus 172 Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~---~l~~L~~L~Ls~n~ 248 (918)
+++|++++..|..|..+++|++|++++|.++...+..+..+++|++|++++|.+++..+..+. ..+.++.++++++.
T Consensus 181 l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~~~~~~l~~l~L~~~~ 260 (353)
T 2z80_A 181 IDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVK 260 (353)
T ss_dssp EEETTCCEECTTTTTTCSEEEEEEEECSCSTTHHHHHHHHTTTEEEEEEESCBCTTCCCC------CCCCCCEEEEESCB
T ss_pred CCCCCcCccCHHHHhccccCCeecCCCCccccchhhhhhhcccccEEECCCCccccccccccccccccchhhcccccccc
Confidence 999999988888999999999999999998755444556688999999999999876554443 35667788888877
Q ss_pred CcCC----CCccccccCCCCeEecCCCccCCcCCCcCCCCCCCcEEEccCCcCcCC
Q 044366 249 LYGF----VPKEIGYLKSLSKLEFCANHLSGVIPHSVGNLTGLVLLNMCENHLFGP 300 (918)
Q Consensus 249 l~~~----~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~ 300 (918)
+.+. .|..+..+++|++|++++|++..+.+..|..+++|+.|++++|++...
T Consensus 261 l~~~~l~~l~~~l~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~~~~~ 316 (353)
T 2z80_A 261 ITDESLFQVMKLLNQISGLLELEFSRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCS 316 (353)
T ss_dssp CCHHHHHHHHHHHHTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCBCCC
T ss_pred ccCcchhhhHHHHhcccCCCEEECCCCCCCccCHHHHhcCCCCCEEEeeCCCccCc
Confidence 7642 345566777777777777777755555567777777777777776643
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.97 E-value=1.8e-29 Score=288.09 Aligned_cols=234 Identities=24% Similarity=0.280 Sum_probs=145.8
Q ss_pred CCCEEECcCCcCCCcCCcCCCCCCCCceeeccccccccCCCcccccccccCeeeccccccCCcCCccCCCCCCCcEeecc
Q 044366 118 SLSTLDLSQNQLNGSIPCSLDNLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSENRLSGLIPLSLSNLSSLTVMSLF 197 (918)
Q Consensus 118 ~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~ 197 (918)
+|++|+|++|+|++..+..|.++++|++|+|++|+++++.+..|.++++|++|+|++|+++.+.+..|..+++|++|+|+
T Consensus 76 ~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 155 (452)
T 3zyi_A 76 NTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLR 155 (452)
T ss_dssp TCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSBCCTTTSSSCTTCCEEECC
T ss_pred CccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCCCcCCccChhhhcccCCCCEEECC
Confidence 44444444444444444444444444444444444444444444555555555555555554444445555555555555
Q ss_pred CcccccCCCccccCCCCcceeeccc-ccccCCCCCCCcCCCcCCeEEcccCcCcCCCCccccccCCCCeEecCCCccCCc
Q 044366 198 NNSLSGSIPPILGNLKSLSTLGLHI-NQLNGVIPPSIGNLSSLRNLSLFNNRLYGFVPKEIGYLKSLSKLEFCANHLSGV 276 (918)
Q Consensus 198 ~N~l~~~~~~~~~~l~~L~~L~L~~-n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~ 276 (918)
+|+++.+.+..|.++++|+.|++++ |.+..+.+..|.++++|++|+|++|+++++ | .+..+++|+.|++++|++.+.
T Consensus 156 ~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~~-~-~~~~l~~L~~L~Ls~N~l~~~ 233 (452)
T 3zyi_A 156 NNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKDM-P-NLTPLVGLEELEMSGNHFPEI 233 (452)
T ss_dssp SCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCSSC-C-CCTTCTTCCEEECTTSCCSEE
T ss_pred CCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCccccc-c-cccccccccEEECcCCcCccc
Confidence 5555544444555555555555555 333333334455666666666666666543 2 355666666677777776666
Q ss_pred CCCcCCCCCCCcEEEccCCcCcCCCCccccCCCCCCeEEeecccccCccccccCCCCCccEEeCCCCccccccCccc
Q 044366 277 IPHSVGNLTGLVLLNMCENHLFGPIPKSLRNLTSLERVRFNQNNLYGKVYEAFGDHPNLTFLDLSQNNFYCEISFNW 353 (918)
Q Consensus 277 ~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~ 353 (918)
.|..|.++++|+.|++++|++.+..+..|.++++|++|++++|.++.++...|..+++|+.|+|++|++.|+|...|
T Consensus 234 ~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~CdC~~~~ 310 (452)
T 3zyi_A 234 RPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPWNCDCDILW 310 (452)
T ss_dssp CGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTSSTTCTTCCEEECCSSCEECSTTTHH
T ss_pred CcccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEEECCCCcCCccChHHhccccCCCEEEccCCCcCCCCCchH
Confidence 66677777777777777777777777777888888888888888888888888899999999999999999998654
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.6e-29 Score=272.85 Aligned_cols=279 Identities=22% Similarity=0.298 Sum_probs=158.3
Q ss_pred CEEEcccccccccCCccccCCCCCCEEEccCCcccccCccccCCCCCCCEEECcCCcCCCc--CCcCCCCCCCCceeecc
Q 044366 72 NELVFCHNNVSGRIPSSLGNLSNLALLYLNDNSLFGSIPIVMGNLKSLSTLDLSQNQLNGS--IPCSLDNLSNLDTLFLY 149 (918)
Q Consensus 72 ~~L~l~~n~~~~~~p~~l~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~--~~~~l~~l~~L~~L~L~ 149 (918)
+.++++++.++ .+|..+. ++|++|+|++|+++...+..|.++++|++|+|++|+++.. .+..+.++++|++|+++
T Consensus 10 ~~l~c~~~~l~-~ip~~~~--~~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~Ls 86 (306)
T 2z66_A 10 TEIRCNSKGLT-SVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLS 86 (306)
T ss_dssp TEEECCSSCCS-SCCSCCC--TTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEEEEEEHHHHSCSCCCEEECC
T ss_pred CEEEcCCCCcc-cCCCCCC--CCCCEEECCCCccCccCHhHhhccccCCEEECCCCccCcccCcccccccccccCEEECC
Confidence 35566666665 5555443 5666666666666644444556666666666666666532 13444455666666666
Q ss_pred ccccccCCCcccccccccCeeeccccccCCcCC-ccCCCCCCCcEeeccCcccccCCCccccCCCCcceeecccccccC-
Q 044366 150 KNSLSGPIPSVIGNLKSLLQLDLSENRLSGLIP-LSLSNLSSLTVMSLFNNSLSGSIPPILGNLKSLSTLGLHINQLNG- 227 (918)
Q Consensus 150 ~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~- 227 (918)
+|.++. .+..+..+++|++|++++|++++..+ ..+..+++|++|++++|.+.+..+..|..+++|++|++++|.+++
T Consensus 87 ~n~i~~-l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~ 165 (306)
T 2z66_A 87 FNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQEN 165 (306)
T ss_dssp SCSEEE-EEEEEETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCEEGGG
T ss_pred CCcccc-ChhhcCCCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEEECCCCccccc
Confidence 666553 33445555666666666665555433 345555555555555555554444555555555555555555543
Q ss_pred CCCCCCcCCCcCCeEEcccCcCcCCCCccccccCCCCeEecCCCccCCcCCCcCCCCCCCcEEEccCCcCcCCCCccccC
Q 044366 228 VIPPSIGNLSSLRNLSLFNNRLYGFVPKEIGYLKSLSKLEFCANHLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLRN 307 (918)
Q Consensus 228 ~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~ 307 (918)
..|..+..+ ++|++|++++|++.+..|..|..+++|+.|++++|++++..+..+..
T Consensus 166 ~~~~~~~~l------------------------~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~ 221 (306)
T 2z66_A 166 FLPDIFTEL------------------------RNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKC 221 (306)
T ss_dssp EECSCCTTC------------------------TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCCSGGGTT
T ss_pred cchhHHhhC------------------------cCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccCccChhhccC
Confidence 234444444 44555555555554444555555555555555555555555555666
Q ss_pred CCCCCeEEeecccccCccccccCCCC-CccEEeCCCCccccccCccc--ccccccceeeccccccccCCCcCcC
Q 044366 308 LTSLERVRFNQNNLYGKVYEAFGDHP-NLTFLDLSQNNFYCEISFNW--RNFSKLGTFNASMNNIYGSIPPEIG 378 (918)
Q Consensus 308 l~~L~~L~l~~n~l~~~~~~~~~~l~-~L~~L~Ls~N~l~~~~~~~~--~~~~~L~~l~l~~n~i~~~~~~~~~ 378 (918)
+++|+.|++++|.+....+..+..++ +|+.|++++|++.|+|...+ ..+...+.+....+.+....|..+.
T Consensus 222 l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~L~~N~~~~~c~~~~~~~~l~~~~~~~~~~~~~~C~~p~~~~ 295 (306)
T 2z66_A 222 LNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATPSDKQ 295 (306)
T ss_dssp CTTCCEEECTTSCCCBCSSSSCCCCCTTCCEEECTTCCEECSGGGHHHHHHHHHTGGGBSCGGGCBEEESGGGT
T ss_pred cccCCEeECCCCCCcccCHHHHHhhhccCCEEEccCCCeecccChHHHHHHHHhhhhhhccccccccCCchhhC
Confidence 66666666666666666666777774 89999999999998876431 2233444444444455444444443
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.7e-29 Score=268.06 Aligned_cols=252 Identities=24% Similarity=0.287 Sum_probs=148.4
Q ss_pred CEEEccCCcccccCccccCCCCCCCEEECcCCcCCCcCCcCCCCCCCCceeeccccccccCCCcccccccccCeeecccc
Q 044366 96 ALLYLNDNSLFGSIPIVMGNLKSLSTLDLSQNQLNGSIPCSLDNLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSEN 175 (918)
Q Consensus 96 ~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N 175 (918)
+.++++++.++ .+|..+ .++|++|++++|++++..+..|.++++|++|++++|.++++.+..|.++++|++|++++|
T Consensus 14 ~~~~c~~~~l~-~ip~~~--~~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n 90 (285)
T 1ozn_A 14 VTTSCPQQGLQ-AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDN 90 (285)
T ss_dssp CEEECCSSCCS-SCCTTC--CTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSC
T ss_pred eEEEcCcCCcc-cCCcCC--CCCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCC
Confidence 45666666665 334322 346666666666666555555666666666666666666555555555666666666655
Q ss_pred c-cCCcCCccCCCCCCCcEeeccCcccccCCCccccCCCCcceeecccccccCCCCCCCcCCCcCCeEEcccCcCcCCCC
Q 044366 176 R-LSGLIPLSLSNLSSLTVMSLFNNSLSGSIPPILGNLKSLSTLGLHINQLNGVIPPSIGNLSSLRNLSLFNNRLYGFVP 254 (918)
Q Consensus 176 ~-l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~ 254 (918)
. ++.+.+..|..+++|++|++++|.+++..+..|.++++|+ +|++++|++++..+
T Consensus 91 ~~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~------------------------~L~l~~n~l~~~~~ 146 (285)
T 1ozn_A 91 AQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQ------------------------YLYLQDNALQALPD 146 (285)
T ss_dssp TTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCC------------------------EEECCSSCCCCCCT
T ss_pred CCccccCHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCCC------------------------EEECCCCcccccCH
Confidence 4 5554455555555555555555555544444444444444 44555554444444
Q ss_pred ccccccCCCCeEecCCCccCCcCCCcCCCCCCCcEEEccCCcCcCCCCccccCCCCCCeEEeecccccCccccccCCCCC
Q 044366 255 KEIGYLKSLSKLEFCANHLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLRNLTSLERVRFNQNNLYGKVYEAFGDHPN 334 (918)
Q Consensus 255 ~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~ 334 (918)
..+..+++|++|++++|++.+..+..|..+++|+.|++++|++.+..|..|.++++|++|++++|.+..+++..|..+++
T Consensus 147 ~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~ 226 (285)
T 1ozn_A 147 DTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRA 226 (285)
T ss_dssp TTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTT
T ss_pred hHhccCCCccEEECCCCcccccCHHHhcCccccCEEECCCCcccccCHhHccCcccccEeeCCCCcCCcCCHHHcccCcc
Confidence 44445555555555555555444445555666666666666666666666777777777777777777777777888899
Q ss_pred ccEEeCCCCccccccCcccccccccceeeccccccccCCCc
Q 044366 335 LTFLDLSQNNFYCEISFNWRNFSKLGTFNASMNNIYGSIPP 375 (918)
Q Consensus 335 L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~n~i~~~~~~ 375 (918)
|+.|++++|++.|++...+. ...++.+..+.+.+....|+
T Consensus 227 L~~L~l~~N~~~c~~~~~~~-~~~l~~~~~~~~~~~c~~p~ 266 (285)
T 1ozn_A 227 LQYLRLNDNPWVCDCRARPL-WAWLQKFRGSSSEVPCSLPQ 266 (285)
T ss_dssp CCEEECCSSCEECSGGGHHH-HHHHHHCCSEECCCBEEESG
T ss_pred cCEEeccCCCccCCCCcHHH-HHHHHhcccccCccccCCch
Confidence 99999999999988875421 12233333444444444443
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.96 E-value=1.8e-28 Score=279.69 Aligned_cols=247 Identities=26% Similarity=0.271 Sum_probs=159.4
Q ss_pred CCEEEcccccccccCCCCcCCCCCCCEEEcccccccccCCccccCCCCCCEEEccCCcccccCccccCCCCCCCEEECcC
Q 044366 47 LRRLYLDVNQLHGTIPPVIGQLSLINELVFCHNNVSGRIPSSLGNLSNLALLYLNDNSLFGSIPIVMGNLKSLSTLDLSQ 126 (918)
Q Consensus 47 L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~l~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~ 126 (918)
.+.++.++..++ .+|..+. +++++|++++|++++..|..|.++++|++|+|++|+|.+..+..|.++++|++|+|++
T Consensus 56 ~~~v~c~~~~l~-~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~ 132 (452)
T 3zyi_A 56 FSKVVCTRRGLS-EVPQGIP--SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFD 132 (452)
T ss_dssp SCEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred CcEEEECCCCcC-ccCCCCC--CCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCC
Confidence 345555555555 4555443 4566666666666655566666666666666666666666666666666666666666
Q ss_pred CcCCCcCCcCCCCCCCCceeeccccccccCCCcccccccccCeeeccc-cccCCcCCccCCCCCCCcEeeccCcccccCC
Q 044366 127 NQLNGSIPCSLDNLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSE-NRLSGLIPLSLSNLSSLTVMSLFNNSLSGSI 205 (918)
Q Consensus 127 n~i~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~-N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 205 (918)
|+++...+..|.++++|++|+|++|+++.+.+..|..+++|++|++++ |.+..+.+..|.++++|++|+|++|++++.
T Consensus 133 n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~~- 211 (452)
T 3zyi_A 133 NWLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKDM- 211 (452)
T ss_dssp SCCSBCCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCSSC-
T ss_pred CcCCccChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCccccc-
Confidence 666655555566666666666666666655555666666666666666 445544455566666666666666666643
Q ss_pred CccccCCCCcceeecccccccCCCCCCCcCCCcCCeEEcccCcCcCCCCccccccCCCCeEecCCCccCCcCCCcCCCCC
Q 044366 206 PPILGNLKSLSTLGLHINQLNGVIPPSIGNLSSLRNLSLFNNRLYGFVPKEIGYLKSLSKLEFCANHLSGVIPHSVGNLT 285 (918)
Q Consensus 206 ~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~ 285 (918)
| .+..+++|++|+|++|++++..|..|.++++|+.|++++|+++++.+..|..+++|+.|++++|++.++.+..|..++
T Consensus 212 ~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~ 290 (452)
T 3zyi_A 212 P-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLR 290 (452)
T ss_dssp C-CCTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTSSTTCT
T ss_pred c-cccccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEEECCCCcCCccChHHhcccc
Confidence 2 366666777777777777666666677777777777777777766666677777777777777777766666677777
Q ss_pred CCcEEEccCCcCc
Q 044366 286 GLVLLNMCENHLF 298 (918)
Q Consensus 286 ~L~~L~l~~n~l~ 298 (918)
+|+.|++++|++.
T Consensus 291 ~L~~L~L~~Np~~ 303 (452)
T 3zyi_A 291 YLVELHLHHNPWN 303 (452)
T ss_dssp TCCEEECCSSCEE
T ss_pred CCCEEEccCCCcC
Confidence 7777777777654
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=3e-29 Score=267.69 Aligned_cols=255 Identities=22% Similarity=0.242 Sum_probs=169.8
Q ss_pred CEEeCCCCcccccCCccccCCCCCCEEEcccccccccCCCCcCCCCCCCEEEcccccccccCCccccCCCCCCEEEccCC
Q 044366 24 QYLDLGNNQLSGVIPPEIGKLNQLRRLYLDVNQLHGTIPPVIGQLSLINELVFCHNNVSGRIPSSLGNLSNLALLYLNDN 103 (918)
Q Consensus 24 ~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~l~~l~~L~~L~L~~n 103 (918)
+.++.++++++ .+|..+ .++|++|+|++|++++..+..|..+++|++|++++|.+++..|..|..+++|++|++++|
T Consensus 14 ~~~~c~~~~l~-~ip~~~--~~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n 90 (285)
T 1ozn_A 14 VTTSCPQQGLQ-AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDN 90 (285)
T ss_dssp CEEECCSSCCS-SCCTTC--CTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSC
T ss_pred eEEEcCcCCcc-cCCcCC--CCCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCC
Confidence 56667777666 555443 356777777777776555556677777777777777776666667777777777777777
Q ss_pred c-ccccCccccCCCCCCCEEECcCCcCCCcCCcCCCCCCCCceeeccccccccCCCcccccccccCeeeccccccCCcCC
Q 044366 104 S-LFGSIPIVMGNLKSLSTLDLSQNQLNGSIPCSLDNLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSENRLSGLIP 182 (918)
Q Consensus 104 ~-i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~ 182 (918)
. +....|..|..+++|++|++++|++++..|..+.++++|++|++++|++++..+..|+.+++|++|++++|+++++.+
T Consensus 91 ~~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~ 170 (285)
T 1ozn_A 91 AQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPE 170 (285)
T ss_dssp TTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECT
T ss_pred CCccccCHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCCcccccCH
Confidence 5 665556667777777777777777776666667777777777777777776666667777777777777777776666
Q ss_pred ccCCCCCCCcEeeccCcccccCCCccccCCCCcceeecccccccCCCCCCCcCCCcCCeEEcccCcCcCCCCccccccCC
Q 044366 183 LSLSNLSSLTVMSLFNNSLSGSIPPILGNLKSLSTLGLHINQLNGVIPPSIGNLSSLRNLSLFNNRLYGFVPKEIGYLKS 262 (918)
Q Consensus 183 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~ 262 (918)
..|..+++|++|++++|.+++..|..|..+++|+.|++++|++++..+..+..+++|++|++++|.+....+. ......
T Consensus 171 ~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~~~~-~~~~~~ 249 (285)
T 1ozn_A 171 RAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRA-RPLWAW 249 (285)
T ss_dssp TTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGGG-HHHHHH
T ss_pred HHhcCccccCEEECCCCcccccCHhHccCcccccEeeCCCCcCCcCCHHHcccCcccCEEeccCCCccCCCCc-HHHHHH
Confidence 6677777777777777777766677777777777777777777765555567777777777777776643221 111223
Q ss_pred CCeEecCCCccCCcCCCcCC
Q 044366 263 LSKLEFCANHLSGVIPHSVG 282 (918)
Q Consensus 263 L~~L~l~~n~l~~~~~~~~~ 282 (918)
++.+..+.+.+....|..+.
T Consensus 250 l~~~~~~~~~~~c~~p~~l~ 269 (285)
T 1ozn_A 250 LQKFRGSSSEVPCSLPQRLA 269 (285)
T ss_dssp HHHCCSEECCCBEEESGGGT
T ss_pred HHhcccccCccccCCchHhC
Confidence 44444555666555555443
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=2.2e-28 Score=277.91 Aligned_cols=247 Identities=24% Similarity=0.262 Sum_probs=183.7
Q ss_pred CCEEEcccccccccCCCCcCCCCCCCEEEcccccccccCCccccCCCCCCEEEccCCcccccCccccCCCCCCCEEECcC
Q 044366 47 LRRLYLDVNQLHGTIPPVIGQLSLINELVFCHNNVSGRIPSSLGNLSNLALLYLNDNSLFGSIPIVMGNLKSLSTLDLSQ 126 (918)
Q Consensus 47 L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~l~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~ 126 (918)
.+.++.+++.++ .+|..+. .++++|++++|++++..+..|.++++|++|+|++|+|....+..|.++++|++|+|++
T Consensus 45 ~~~v~c~~~~l~-~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~ 121 (440)
T 3zyj_A 45 FSKVICVRKNLR-EVPDGIS--TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFD 121 (440)
T ss_dssp SCEEECCSCCCS-SCCSCCC--TTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCS
T ss_pred CCEEEeCCCCcC-cCCCCCC--CCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECCC
Confidence 456666666666 5666554 5667777777777766667777777777777777777766667777777777777777
Q ss_pred CcCCCcCCcCCCCCCCCceeeccccccccCCCcccccccccCeeeccc-cccCCcCCccCCCCCCCcEeeccCcccccCC
Q 044366 127 NQLNGSIPCSLDNLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSE-NRLSGLIPLSLSNLSSLTVMSLFNNSLSGSI 205 (918)
Q Consensus 127 n~i~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~-N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 205 (918)
|+++...+..|.++++|++|+|++|+++.+.+..|..+++|++|++++ |.+..+.+..|.++++|++|+|++|.++.+
T Consensus 122 n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~~- 200 (440)
T 3zyj_A 122 NRLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLREI- 200 (440)
T ss_dssp SCCSSCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCSSC-
T ss_pred CcCCeeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcCccc-
Confidence 777766666677777777777777777776666777777777777777 455555556677777788888888777743
Q ss_pred CccccCCCCcceeecccccccCCCCCCCcCCCcCCeEEcccCcCcCCCCccccccCCCCeEecCCCccCCcCCCcCCCCC
Q 044366 206 PPILGNLKSLSTLGLHINQLNGVIPPSIGNLSSLRNLSLFNNRLYGFVPKEIGYLKSLSKLEFCANHLSGVIPHSVGNLT 285 (918)
Q Consensus 206 ~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~ 285 (918)
| .+..+++|++|+|++|++++..+..|.++++|+.|+|++|+++++.+..|..+++|+.|+|++|++..+.+..|..++
T Consensus 201 ~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~ 279 (440)
T 3zyj_A 201 P-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLH 279 (440)
T ss_dssp C-CCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCEEECTTSCCCCCCTTTTSSCT
T ss_pred c-ccCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeEEChhhhcCCCCCCEEECCCCCCCccChhHhcccc
Confidence 3 467777888888888888777777788888888888888888877777788888888888888888877777778888
Q ss_pred CCcEEEccCCcCc
Q 044366 286 GLVLLNMCENHLF 298 (918)
Q Consensus 286 ~L~~L~l~~n~l~ 298 (918)
+|+.|++++|++.
T Consensus 280 ~L~~L~L~~Np~~ 292 (440)
T 3zyj_A 280 HLERIHLHHNPWN 292 (440)
T ss_dssp TCCEEECCSSCEE
T ss_pred CCCEEEcCCCCcc
Confidence 8888888888764
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.5e-31 Score=317.35 Aligned_cols=432 Identities=14% Similarity=0.048 Sum_probs=232.3
Q ss_pred CCccccCCCCCCEEEccCCccc---ccCccccC------------CCCCCCEEECcCCcCCCcCCcCCCCC-C-CCceee
Q 044366 85 IPSSLGNLSNLALLYLNDNSLF---GSIPIVMG------------NLKSLSTLDLSQNQLNGSIPCSLDNL-S-NLDTLF 147 (918)
Q Consensus 85 ~p~~l~~l~~L~~L~L~~n~i~---~~~~~~~~------------~l~~L~~L~Ls~n~i~~~~~~~l~~l-~-~L~~L~ 147 (918)
.+..+..+++|++|+|+++... +..|..++ .+++|++|+|++|.+++..+..+... + +|++|+
T Consensus 65 ~~~~~~~~~~L~~L~L~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~L~~L~ 144 (592)
T 3ogk_B 65 PDRLSRRFPNLRSLKLKGKPRAAMFNLIPENWGGYVTPWVTEISNNLRQLKSVHFRRMIVSDLDLDRLAKARADDLETLK 144 (592)
T ss_dssp HHHHHHHCTTCSEEEEECSCGGGGGTCSCTTSCCBCHHHHHHHHHHCTTCCEEEEESCBCCHHHHHHHHHHHGGGCCEEE
T ss_pred hHHHHHhCCCCeEEEecCCcchhhcccccccccccchHHHHHHHhhCCCCCeEEeeccEecHHHHHHHHHhccccCcEEE
Confidence 3444566777888888775321 12222222 56677777777776665444444442 2 377777
Q ss_pred ccccc-ccc-CCCcccccccccCeeeccccccCCcC----CccCCCCCCCcEeeccCcccccC----CCccccCCCCcce
Q 044366 148 LYKNS-LSG-PIPSVIGNLKSLLQLDLSENRLSGLI----PLSLSNLSSLTVMSLFNNSLSGS----IPPILGNLKSLST 217 (918)
Q Consensus 148 L~~n~-l~~-~~~~~~~~l~~L~~L~Ls~N~l~~~~----~~~~~~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~ 217 (918)
|++|. ++. ..+..+..+++|++|+|++|.+++.. +..+..+++|++|++++|.+++. ++..+.++++|++
T Consensus 145 L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~~L~L~~n~~~~~~~~~l~~~~~~~~~L~~ 224 (592)
T 3ogk_B 145 LDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVS 224 (592)
T ss_dssp EESCEEEEHHHHHHHHHHCTTCSEEECTTCEEECCCSHHHHHHHHHCCCCCEEECTTCCCSSCCHHHHHHHHHHCTTCCE
T ss_pred CcCCCCcCHHHHHHHHhhCCCCCEEECccccccCcchhHHHHHHhcCCCccEEEeeccCCCccCHHHHHHHHhhCCCCcE
Confidence 76665 110 01112235666677777666665442 12234456666666666666522 2233445566666
Q ss_pred eecccccccCCCCCCCcCCCcCCeEEcccCcCc---CCCCccccccCCCCeEecCCCccCCcCCCcCCCCCCCcEEEccC
Q 044366 218 LGLHINQLNGVIPPSIGNLSSLRNLSLFNNRLY---GFVPKEIGYLKSLSKLEFCANHLSGVIPHSVGNLTGLVLLNMCE 294 (918)
Q Consensus 218 L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~---~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~ 294 (918)
|++++|.+.+ .+..+..+++|++|+++.+... ...+..+..+++|+.|+++++... ..|..+..+++|+.|++++
T Consensus 225 L~L~~~~~~~-l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~~-~l~~~~~~~~~L~~L~Ls~ 302 (592)
T 3ogk_B 225 VKVGDFEILE-LVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMGPN-EMPILFPFAAQIRKLDLLY 302 (592)
T ss_dssp EECSSCBGGG-GHHHHHHCTTCCEEEECBCCCCTTCTTSSSCCCCCTTCCEEEETTCCTT-TGGGGGGGGGGCCEEEETT
T ss_pred EeccCccHHH-HHHHHhhhhHHHhhcccccccccchHHHHHHhhccccccccCccccchh-HHHHHHhhcCCCcEEecCC
Confidence 6666666554 3345555666666666543221 112233444555555555543222 3333444455555555555
Q ss_pred CcCcCCCC-ccccCCCCCCeEEeecccccCcc-ccccCCCCCccEEeCCC---CccccccCcccccccccceeecccccc
Q 044366 295 NHLFGPIP-KSLRNLTSLERVRFNQNNLYGKV-YEAFGDHPNLTFLDLSQ---NNFYCEISFNWRNFSKLGTFNASMNNI 369 (918)
Q Consensus 295 n~l~~~~~-~~l~~l~~L~~L~l~~n~l~~~~-~~~~~~l~~L~~L~Ls~---N~l~~~~~~~~~~~~~L~~l~l~~n~i 369 (918)
|.+++... ..+.++++|++|+++ +.+.... ...+..+++|+.|++++ ++..... .|.+
T Consensus 303 ~~l~~~~~~~~~~~~~~L~~L~L~-~~~~~~~l~~~~~~~~~L~~L~L~~g~~~~~~~~~----------------~~~~ 365 (592)
T 3ogk_B 303 ALLETEDHCTLIQKCPNLEVLETR-NVIGDRGLEVLAQYCKQLKRLRIERGADEQGMEDE----------------EGLV 365 (592)
T ss_dssp CCCCHHHHHHHHTTCTTCCEEEEE-GGGHHHHHHHHHHHCTTCCEEEEECCCCSSTTSST----------------TCCC
T ss_pred CcCCHHHHHHHHHhCcCCCEEecc-CccCHHHHHHHHHhCCCCCEEEeecCccccccccc----------------cCcc
Confidence 55432222 223444555555554 2222111 11122334444444441 0000000 1233
Q ss_pred ccC-CCcCcCCCCCCcEEEccCceeccccccchhh-ccccCceecc----cccccCC-----CCCCCCCCCcccEEeccC
Q 044366 370 YGS-IPPEIGDSSKLQVLDLSSNHIFGKIPVQLVK-LFSLNKLILS----LNQLFGG-----VPLEFGTLTELQYLDLSA 438 (918)
Q Consensus 370 ~~~-~~~~~~~~~~L~~L~L~~N~l~~~~~~~~~~-l~~L~~L~L~----~N~l~~~-----~~~~~~~l~~L~~L~Ls~ 438 (918)
+.. ++..+..+++|++|+++.|.+++..+..+.. +++|+.|+++ .|++++. ++..+..+++|++|+|++
T Consensus 366 ~~~~~~~l~~~~~~L~~L~l~~~~l~~~~~~~l~~~~~~L~~L~l~~~~~~n~l~~~p~~~~~~~~~~~~~~L~~L~L~~ 445 (592)
T 3ogk_B 366 SQRGLIALAQGCQELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYL 445 (592)
T ss_dssp CHHHHHHHHHHCTTCSEEEEEESCCCHHHHHHHHHHCCSCCEEEEEECSCCSCCSSCCCHHHHHHHHHHCTTCCEEEEEC
T ss_pred CHHHHHHHHhhCccCeEEEeecCCccHHHHHHHHhhCCCCcEEEEeecCCCccccCchHHHHHHHHHHhCCCCCEEEEec
Confidence 221 1111334677888888777777666666655 7778888885 5666543 122245678888888874
Q ss_pred c--cccccCccccc-cccccceecccCcccCCC-CchhhccccccceEeccCCcCCCCC-chhccccCCcceEecCCCcc
Q 044366 439 N--KLSSSIPMSIG-NLLKLHYLNLSNNQFSHK-IPTEFEKLIHLSELDLSHNILQEEI-PPQICKMESLEKLNLSHNNL 513 (918)
Q Consensus 439 N--~l~~~~~~~~~-~l~~L~~L~Ls~N~l~~~-~~~~~~~l~~L~~L~Ls~N~l~~~~-~~~~~~l~~L~~L~L~~N~l 513 (918)
| .+++.....+. .+++|++|+|++|++++. .+..+.++++|+.|+|++|.|++.. +..+..+++|+.|+|++|++
T Consensus 446 ~~~~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~ls~n~i 525 (592)
T 3ogk_B 446 RQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSERAIAAAVTKLPSLRYLWVQGYRA 525 (592)
T ss_dssp CGGGCCHHHHHHHHHSCTTCCEEEECSCCSSHHHHHHHHTCCTTCCEEEEESCCCBHHHHHHHHHHCSSCCEEEEESCBC
T ss_pred CCCCccHHHHHHHHHhCccceEeeccCCCCCHHHHHHHHhcCcccCeeeccCCCCcHHHHHHHHHhcCccCeeECcCCcC
Confidence 3 35544444443 377888888888888753 3445577888888888888876543 33445678888888888888
Q ss_pred cccCcccc-cCCCCccEEEccCC
Q 044366 514 SDFIPRCF-EEMRSLSWIDISYN 535 (918)
Q Consensus 514 ~~~~~~~~-~~l~~L~~l~l~~N 535 (918)
++.....+ ..++.+....+..+
T Consensus 526 t~~~~~~l~~~~p~l~~~~~~~~ 548 (592)
T 3ogk_B 526 SMTGQDLMQMARPYWNIELIPSR 548 (592)
T ss_dssp CTTCTTGGGGCCTTEEEEEECCC
T ss_pred CHHHHHHHHHhCCCcEEEEecCc
Confidence 76533333 35676666655554
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.96 E-value=5.5e-30 Score=293.56 Aligned_cols=235 Identities=22% Similarity=0.237 Sum_probs=153.0
Q ss_pred CCCCeEecCCCccCCcCCCcCCCCCCCcEEEccCCcCcCCCCccccCCCCCCeEEeecccccCccccccCCCCCccEEeC
Q 044366 261 KSLSKLEFCANHLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLRNLTSLERVRFNQNNLYGKVYEAFGDHPNLTFLDL 340 (918)
Q Consensus 261 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L 340 (918)
++|+.|++++|.+.+..|..|..+++|+.|++++|.+++..| +..+++|+.|++++|.+..++.. ++|+.|++
T Consensus 34 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l~~~-----~~L~~L~L 106 (487)
T 3oja_A 34 WNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELLVG-----PSIETLHA 106 (487)
T ss_dssp GGCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEEEEEC-----TTCCEEEC
T ss_pred CCccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCCCCCC-----CCcCEEEC
Confidence 356666666666665555556666666666666665554333 44555555555555544433321 44444444
Q ss_pred CCCccccccCcccccccccceeeccccccccCCCcCcCCCCCCcEEEccCceeccccccchhhccccCceecccccccCC
Q 044366 341 SQNNFYCEISFNWRNFSKLGTFNASMNNIYGSIPPEIGDSSKLQVLDLSSNHIFGKIPVQLVKLFSLNKLILSLNQLFGG 420 (918)
Q Consensus 341 s~N~l~~~~~~~~~~~~~L~~l~l~~n~i~~~~~~~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ 420 (918)
++|. +.+..+. .+++|+.|+|++|.|++..|..+..+++|+.|+|++|++++.
T Consensus 107 ~~N~------------------------l~~~~~~---~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~ 159 (487)
T 3oja_A 107 ANNN------------------------ISRVSCS---RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTV 159 (487)
T ss_dssp CSSC------------------------CCCEEEC---CCSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEE
T ss_pred cCCc------------------------CCCCCcc---ccCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCc
Confidence 4444 4333322 245677777777777777777777777777777777777776
Q ss_pred CCCCCC-CCCcccEEeccCccccccCccccccccccceecccCcccCCCCchhhccccccceEeccCCcCCCCCchhccc
Q 044366 421 VPLEFG-TLTELQYLDLSANKLSSSIPMSIGNLLKLHYLNLSNNQFSHKIPTEFEKLIHLSELDLSHNILQEEIPPQICK 499 (918)
Q Consensus 421 ~~~~~~-~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~ 499 (918)
.|..+. .+++|++|+|++|.|++..+ +..+++|+.|+|++|+|++.+| .|..+++|+.|+|++|.|++ +|..+..
T Consensus 160 ~~~~l~~~l~~L~~L~Ls~N~l~~~~~--~~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~~-lp~~l~~ 235 (487)
T 3oja_A 160 NFAELAASSDTLEHLNLQYNFIYDVKG--QVVFAKLKTLDLSSNKLAFMGP-EFQSAAGVTWISLRNNKLVL-IEKALRF 235 (487)
T ss_dssp EGGGGGGGTTTCCEEECTTSCCCEEEC--CCCCTTCCEEECCSSCCCEECG-GGGGGTTCSEEECTTSCCCE-ECTTCCC
T ss_pred ChHHHhhhCCcccEEecCCCccccccc--cccCCCCCEEECCCCCCCCCCH-hHcCCCCccEEEecCCcCcc-cchhhcc
Confidence 666665 67778888888888775522 3347778888888888876544 47777888888888888874 5666777
Q ss_pred cCCcceEecCCCccc-ccCcccccCCCCccEEEcc
Q 044366 500 MESLEKLNLSHNNLS-DFIPRCFEEMRSLSWIDIS 533 (918)
Q Consensus 500 l~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~l~l~ 533 (918)
+++|+.|+|++|+++ +.+|..+..++.|+.++++
T Consensus 236 l~~L~~L~l~~N~l~c~~~~~~~~~l~~L~~l~~~ 270 (487)
T 3oja_A 236 SQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQ 270 (487)
T ss_dssp CTTCCEEECTTCCBCHHHHHHHHTTCHHHHHHHHH
T ss_pred CCCCCEEEcCCCCCcCcchHHHHHhCCCCcEEecc
Confidence 778888888888877 4566777777777777765
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.6e-28 Score=266.68 Aligned_cols=235 Identities=22% Similarity=0.287 Sum_probs=146.9
Q ss_pred CCCCCEEeCCCCcccccCCccccCCCCCCEEEcccccccccCCCCcCCCCCCCEEEcccccccccCCccccCCCCCCEEE
Q 044366 20 LSKLQYLDLGNNQLSGVIPPEIGKLNQLRRLYLDVNQLHGTIPPVIGQLSLINELVFCHNNVSGRIPSSLGNLSNLALLY 99 (918)
Q Consensus 20 l~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~l~~l~~L~~L~ 99 (918)
.+.+++|+|++|+++ .+|..++.+++|++|+|++|+++ .+|..++.+++|++|++++|.++ .+|..|..+++|++|+
T Consensus 80 ~~~l~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~ 156 (328)
T 4fcg_A 80 QPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELS 156 (328)
T ss_dssp STTCCEEEEESSCCS-SCCSCGGGGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEE
T ss_pred ccceeEEEccCCCch-hcChhhhhCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEE
Confidence 466777777777776 66777777777777777777777 67777777777777777777776 6666677777777777
Q ss_pred ccCCcccccCccccCCCCCCCEEECcCCcCCCcCCcCCCCCCCCceeeccccccccCCCcccccccccCeeeccccccCC
Q 044366 100 LNDNSLFGSIPIVMGNLKSLSTLDLSQNQLNGSIPCSLDNLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSENRLSG 179 (918)
Q Consensus 100 L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~ 179 (918)
|++|++.+..|..+.. . ..+..+.++++|++|+|++|+++ .+|..|+.+++|++|+|++|++++
T Consensus 157 L~~n~~~~~~p~~~~~------~---------~~~~~~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~~ 220 (328)
T 4fcg_A 157 IRACPELTELPEPLAS------T---------DASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSA 220 (328)
T ss_dssp EEEETTCCCCCSCSEE------E---------C-CCCEEESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCCC
T ss_pred CCCCCCccccChhHhh------c---------cchhhhccCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCCc
Confidence 7776666666655433 0 01112233555555555555555 344555556666666666666654
Q ss_pred cCCccCCCCCCCcEeeccCcccccCCCccccCCCCcceeecccccccCCCCCCCcCCCcCCeEEcccCcCcCCCCccccc
Q 044366 180 LIPLSLSNLSSLTVMSLFNNSLSGSIPPILGNLKSLSTLGLHINQLNGVIPPSIGNLSSLRNLSLFNNRLYGFVPKEIGY 259 (918)
Q Consensus 180 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~ 259 (918)
+ |..+..+++|++|+|++|.+.+.+|..|..+++|++|+|++|.+.+.+|..+.++++|++|+|++|++.+..|..+..
T Consensus 221 l-~~~l~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~iP~~l~~ 299 (328)
T 4fcg_A 221 L-GPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQ 299 (328)
T ss_dssp C-CGGGGGCTTCCEEECTTCTTCCBCCCCTTCCCCCCEEECTTCTTCCBCCTTGGGCTTCCEEECTTCTTCCCCCGGGGG
T ss_pred C-chhhccCCCCCEEECcCCcchhhhHHHhcCCCCCCEEECCCCCchhhcchhhhcCCCCCEEeCCCCCchhhccHHHhh
Confidence 3 334555666666666666655555666666666666666666665566666666666666666666666666666666
Q ss_pred cCCCCeEecCCCccC
Q 044366 260 LKSLSKLEFCANHLS 274 (918)
Q Consensus 260 l~~L~~L~l~~n~l~ 274 (918)
+++|+.+++..+.+.
T Consensus 300 L~~L~~l~l~~~~~~ 314 (328)
T 4fcg_A 300 LPANCIILVPPHLQA 314 (328)
T ss_dssp SCTTCEEECCGGGSC
T ss_pred ccCceEEeCCHHHHH
Confidence 666666666655544
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.95 E-value=5.6e-28 Score=262.47 Aligned_cols=235 Identities=21% Similarity=0.254 Sum_probs=200.4
Q ss_pred CCCCCEEEcccccccccCCCCcCCCCCCCEEEcccccccccCCccccCCCCCCEEEccCCcccccCccccCCCCCCCEEE
Q 044366 44 LNQLRRLYLDVNQLHGTIPPVIGQLSLINELVFCHNNVSGRIPSSLGNLSNLALLYLNDNSLFGSIPIVMGNLKSLSTLD 123 (918)
Q Consensus 44 l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~l~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~ 123 (918)
..+++.|+|++|+++ .+|..++.+++|++|++++|.++ .+|..++.+++|++|+|++|++. .+|..+.++++|++|+
T Consensus 80 ~~~l~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~ 156 (328)
T 4fcg_A 80 QPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELS 156 (328)
T ss_dssp STTCCEEEEESSCCS-SCCSCGGGGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEE
T ss_pred ccceeEEEccCCCch-hcChhhhhCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEE
Confidence 467888888888887 77777777888888888888777 77777777888888888888776 5677777777888888
Q ss_pred CcCCcCCCcCCcCCCCCCCCceeeccccccccCCCcccccccccCeeeccccccCCcCCccCCCCCCCcEeeccCccccc
Q 044366 124 LSQNQLNGSIPCSLDNLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSENRLSGLIPLSLSNLSSLTVMSLFNNSLSG 203 (918)
Q Consensus 124 Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 203 (918)
|++|++.+.+|..+... ..++.|.++++|++|+|++|+++ .+|..+..+++|++|+|++|.+++
T Consensus 157 L~~n~~~~~~p~~~~~~---------------~~~~~~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~~ 220 (328)
T 4fcg_A 157 IRACPELTELPEPLAST---------------DASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSA 220 (328)
T ss_dssp EEEETTCCCCCSCSEEE---------------C-CCCEEESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCCC
T ss_pred CCCCCCccccChhHhhc---------------cchhhhccCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCCc
Confidence 87777766666655431 12345778999999999999999 557789999999999999999995
Q ss_pred CCCccccCCCCcceeecccccccCCCCCCCcCCCcCCeEEcccCcCcCCCCccccccCCCCeEecCCCccCCcCCCcCCC
Q 044366 204 SIPPILGNLKSLSTLGLHINQLNGVIPPSIGNLSSLRNLSLFNNRLYGFVPKEIGYLKSLSKLEFCANHLSGVIPHSVGN 283 (918)
Q Consensus 204 ~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~ 283 (918)
+|..+..+++|++|++++|.+.+.+|..|.++++|++|++++|++.+..|..+..+++|++|++++|++.+.+|..+..
T Consensus 221 -l~~~l~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~iP~~l~~ 299 (328)
T 4fcg_A 221 -LGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQ 299 (328)
T ss_dssp -CCGGGGGCTTCCEEECTTCTTCCBCCCCTTCCCCCCEEECTTCTTCCBCCTTGGGCTTCCEEECTTCTTCCCCCGGGGG
T ss_pred -CchhhccCCCCCEEECcCCcchhhhHHHhcCCCCCCEEECCCCCchhhcchhhhcCCCCCEEeCCCCCchhhccHHHhh
Confidence 5667999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCcEEEccCCcCc
Q 044366 284 LTGLVLLNMCENHLF 298 (918)
Q Consensus 284 l~~L~~L~l~~n~l~ 298 (918)
+++|+.+++..+.+.
T Consensus 300 L~~L~~l~l~~~~~~ 314 (328)
T 4fcg_A 300 LPANCIILVPPHLQA 314 (328)
T ss_dssp SCTTCEEECCGGGSC
T ss_pred ccCceEEeCCHHHHH
Confidence 999999999987664
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=99.95 E-value=3.6e-31 Score=313.97 Aligned_cols=425 Identities=14% Similarity=0.052 Sum_probs=300.7
Q ss_pred CCCCcCCCCCCCEEEccccccc---ccCCcccc------------CCCCCCEEEccCCcccccCccccCCC--CCCCEEE
Q 044366 61 IPPVIGQLSLINELVFCHNNVS---GRIPSSLG------------NLSNLALLYLNDNSLFGSIPIVMGNL--KSLSTLD 123 (918)
Q Consensus 61 ~p~~~~~l~~L~~L~l~~n~~~---~~~p~~l~------------~l~~L~~L~L~~n~i~~~~~~~~~~l--~~L~~L~ 123 (918)
.+..+..+++|++|++++|... +.+|..++ .+++|++|+|++|.+++..+..+... .+|++|+
T Consensus 65 ~~~~~~~~~~L~~L~L~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~L~~L~ 144 (592)
T 3ogk_B 65 PDRLSRRFPNLRSLKLKGKPRAAMFNLIPENWGGYVTPWVTEISNNLRQLKSVHFRRMIVSDLDLDRLAKARADDLETLK 144 (592)
T ss_dssp HHHHHHHCTTCSEEEEECSCGGGGGTCSCTTSCCBCHHHHHHHHHHCTTCCEEEEESCBCCHHHHHHHHHHHGGGCCEEE
T ss_pred hHHHHHhCCCCeEEEecCCcchhhcccccccccccchHHHHHHHhhCCCCCeEEeeccEecHHHHHHHHHhccccCcEEE
Confidence 3445567889999999886432 23443333 78999999999999987766666663 4599999
Q ss_pred CcCCc-CCC-cCCcCCCCCCCCceeeccccccccCC----CcccccccccCeeeccccccCCcC----CccCCCCCCCcE
Q 044366 124 LSQNQ-LNG-SIPCSLDNLSNLDTLFLYKNSLSGPI----PSVIGNLKSLLQLDLSENRLSGLI----PLSLSNLSSLTV 193 (918)
Q Consensus 124 Ls~n~-i~~-~~~~~l~~l~~L~~L~L~~n~l~~~~----~~~~~~l~~L~~L~Ls~N~l~~~~----~~~~~~l~~L~~ 193 (918)
|++|. ++. .++....++++|++|+|++|.+++.. +..+..+++|++|++++|.++++. +..+..+++|+.
T Consensus 145 L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~~L~L~~n~~~~~~~~~l~~~~~~~~~L~~ 224 (592)
T 3ogk_B 145 LDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVS 224 (592)
T ss_dssp EESCEEEEHHHHHHHHHHCTTCSEEECTTCEEECCCSHHHHHHHHHCCCCCEEECTTCCCSSCCHHHHHHHHHHCTTCCE
T ss_pred CcCCCCcCHHHHHHHHhhCCCCCEEECccccccCcchhHHHHHHhcCCCccEEEeeccCCCccCHHHHHHHHhhCCCCcE
Confidence 99987 221 12223347899999999999987653 334567899999999999998433 334567899999
Q ss_pred eeccCcccccCCCccccCCCCcceeeccccccc---CCCCCCCcCCCcCCeEEcccCcCcCCCCccccccCCCCeEecCC
Q 044366 194 MSLFNNSLSGSIPPILGNLKSLSTLGLHINQLN---GVIPPSIGNLSSLRNLSLFNNRLYGFVPKEIGYLKSLSKLEFCA 270 (918)
Q Consensus 194 L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~---~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~l~~ 270 (918)
|++++|.+.+ .+..+..+++|++|+++.+... ...+..+..+++|+.|+++++... ..+..+..+++|++|++++
T Consensus 225 L~L~~~~~~~-l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~~-~l~~~~~~~~~L~~L~Ls~ 302 (592)
T 3ogk_B 225 VKVGDFEILE-LVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMGPN-EMPILFPFAAQIRKLDLLY 302 (592)
T ss_dssp EECSSCBGGG-GHHHHHHCTTCCEEEECBCCCCTTCTTSSSCCCCCTTCCEEEETTCCTT-TGGGGGGGGGGCCEEEETT
T ss_pred EeccCccHHH-HHHHHhhhhHHHhhcccccccccchHHHHHHhhccccccccCccccchh-HHHHHHhhcCCCcEEecCC
Confidence 9999999986 6688999999999999864432 233456778899999999987544 5677788899999999999
Q ss_pred CccCCcCC-CcCCCCCCCcEEEccCCcCcCCCCccccCCCCCCeEEeec-----------ccccCccccc-cCCCCCccE
Q 044366 271 NHLSGVIP-HSVGNLTGLVLLNMCENHLFGPIPKSLRNLTSLERVRFNQ-----------NNLYGKVYEA-FGDHPNLTF 337 (918)
Q Consensus 271 n~l~~~~~-~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~-----------n~l~~~~~~~-~~~l~~L~~ 337 (918)
|.+..... ..+..+++|+.|+++++...+.++..+.++++|++|++++ |.++...... +..+++|+.
T Consensus 303 ~~l~~~~~~~~~~~~~~L~~L~L~~~~~~~~l~~~~~~~~~L~~L~L~~g~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~ 382 (592)
T 3ogk_B 303 ALLETEDHCTLIQKCPNLEVLETRNVIGDRGLEVLAQYCKQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQGCQELEY 382 (592)
T ss_dssp CCCCHHHHHHHHTTCTTCCEEEEEGGGHHHHHHHHHHHCTTCCEEEEECCCCSSTTSSTTCCCCHHHHHHHHHHCTTCSE
T ss_pred CcCCHHHHHHHHHhCcCCCEEeccCccCHHHHHHHHHhCCCCCEEEeecCccccccccccCccCHHHHHHHHhhCccCeE
Confidence 99765443 3367899999999994433333445557889999999993 5555433322 344677888
Q ss_pred EeCCCCccccccCcccccccccceeeccccccccCCCcCcCC-CCCCcEEEcc----Cceeccc-----cccchhhcccc
Q 044366 338 LDLSQNNFYCEISFNWRNFSKLGTFNASMNNIYGSIPPEIGD-SSKLQVLDLS----SNHIFGK-----IPVQLVKLFSL 407 (918)
Q Consensus 338 L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~n~i~~~~~~~~~~-~~~L~~L~L~----~N~l~~~-----~~~~~~~l~~L 407 (918)
|+++.|.++.. .+..+.. +++|+.|+++ .|.+++. .+..+.++++|
T Consensus 383 L~l~~~~l~~~------------------------~~~~l~~~~~~L~~L~l~~~~~~n~l~~~p~~~~~~~~~~~~~~L 438 (592)
T 3ogk_B 383 MAVYVSDITNE------------------------SLESIGTYLKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKL 438 (592)
T ss_dssp EEEEESCCCHH------------------------HHHHHHHHCCSCCEEEEEECSCCSCCSSCCCHHHHHHHHHHCTTC
T ss_pred EEeecCCccHH------------------------HHHHHHhhCCCCcEEEEeecCCCccccCchHHHHHHHHHHhCCCC
Confidence 87766665422 2222222 4566666664 5556542 23335667778
Q ss_pred Cceeccccc--ccCCCCCCC-CCCCcccEEeccCccccc-cCccccccccccceecccCcccCCC-CchhhccccccceE
Q 044366 408 NKLILSLNQ--LFGGVPLEF-GTLTELQYLDLSANKLSS-SIPMSIGNLLKLHYLNLSNNQFSHK-IPTEFEKLIHLSEL 482 (918)
Q Consensus 408 ~~L~L~~N~--l~~~~~~~~-~~l~~L~~L~Ls~N~l~~-~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~~l~~L~~L 482 (918)
+.|++++|. +++.....+ ..+++|++|+|++|.+++ .++..+..+++|++|+|++|.|++. .+..+..+++|+.|
T Consensus 439 ~~L~L~~~~~~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L 518 (592)
T 3ogk_B 439 RRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSERAIAAAVTKLPSLRYL 518 (592)
T ss_dssp CEEEEECCGGGCCHHHHHHHHHSCTTCCEEEECSCCSSHHHHHHHHTCCTTCCEEEEESCCCBHHHHHHHHHHCSSCCEE
T ss_pred CEEEEecCCCCccHHHHHHHHHhCccceEeeccCCCCCHHHHHHHHhcCcccCeeeccCCCCcHHHHHHHHHhcCccCee
Confidence 888876433 433322222 236789999999999875 3444557789999999999998654 34445678999999
Q ss_pred eccCCcCCCCCchhc-cccCCcceEecCCC
Q 044366 483 DLSHNILQEEIPPQI-CKMESLEKLNLSHN 511 (918)
Q Consensus 483 ~Ls~N~l~~~~~~~~-~~l~~L~~L~L~~N 511 (918)
+|++|++++.....+ ..++.+....+..+
T Consensus 519 ~ls~n~it~~~~~~l~~~~p~l~~~~~~~~ 548 (592)
T 3ogk_B 519 WVQGYRASMTGQDLMQMARPYWNIELIPSR 548 (592)
T ss_dssp EEESCBCCTTCTTGGGGCCTTEEEEEECCC
T ss_pred ECcCCcCCHHHHHHHHHhCCCcEEEEecCc
Confidence 999999987644444 35677777766655
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.1e-29 Score=274.30 Aligned_cols=248 Identities=24% Similarity=0.231 Sum_probs=145.3
Q ss_pred cCCCCCCEEEcccccccccCCCCcCCCCCCCEEEccccccc-ccCCcccc-------CCCCCCEEEccCCcccccCcccc
Q 044366 42 GKLNQLRRLYLDVNQLHGTIPPVIGQLSLINELVFCHNNVS-GRIPSSLG-------NLSNLALLYLNDNSLFGSIPIVM 113 (918)
Q Consensus 42 ~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~-~~~p~~l~-------~l~~L~~L~L~~n~i~~~~~~~~ 113 (918)
+..++|++|++++|.+ .+|..+... |++|++++|.+. ..+|..+. ++++|++|+|++|++++..|..+
T Consensus 40 ~~~~~L~~l~l~~n~l--~~p~~~~~~--L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~ 115 (312)
T 1wwl_A 40 GGGRSLEYLLKRVDTE--ADLGQFTDI--IKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPL 115 (312)
T ss_dssp EEEEECTTHHHHCCTT--CCCHHHHHH--HHHCCCCEEEEEEEECBHHHHHHHHHHHTTSCCCEEEEEEEBCBSCCCCCS
T ss_pred ccCCCceeEeeccccc--ccHHHHHHH--HhhcccccccccCCCcCHHHHHHHHHhcCcCCccEEEccCCcccchhHHHH
Confidence 3444555555555555 444444433 555555555552 23444433 45666666666666655555544
Q ss_pred --CCCCCCCEEECcCCcCCCcCCcCCCCC-----CCCceeeccccccccCCCcccccccccCeeeccccccCCcC--Ccc
Q 044366 114 --GNLKSLSTLDLSQNQLNGSIPCSLDNL-----SNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSENRLSGLI--PLS 184 (918)
Q Consensus 114 --~~l~~L~~L~Ls~n~i~~~~~~~l~~l-----~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~--~~~ 184 (918)
..+++|++|+|++|++++. |..++.+ ++|++|+|++|++++..+..|+.+++|++|++++|++.+.. +..
T Consensus 116 ~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~ 194 (312)
T 1wwl_A 116 LEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISA 194 (312)
T ss_dssp SSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHHHHHHHH
T ss_pred HHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCcchHHHHH
Confidence 5566666666666666644 5555554 56666666666666555566666666666666666654321 112
Q ss_pred --CCCCCCCcEeeccCccccc---CCCccccCCCCcceeecccccccCCCC-CCCcCCCcCCeEEcccCcCcCCCCcccc
Q 044366 185 --LSNLSSLTVMSLFNNSLSG---SIPPILGNLKSLSTLGLHINQLNGVIP-PSIGNLSSLRNLSLFNNRLYGFVPKEIG 258 (918)
Q Consensus 185 --~~~l~~L~~L~L~~N~l~~---~~~~~~~~l~~L~~L~L~~n~l~~~~~-~~~~~l~~L~~L~Ls~n~l~~~~~~~~~ 258 (918)
+..+++|++|+|++|++++ .....+..+++|++|++++|++++..| ..+..+++|++|+|++|+++. .|..+.
T Consensus 195 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~-ip~~~~ 273 (312)
T 1wwl_A 195 LCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQ-VPKGLP 273 (312)
T ss_dssp SCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCCCTTCCEEECTTSCCSS-CCSSCC
T ss_pred HHhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhhcCCCCEEECCCCccCh-hhhhcc
Confidence 2566666666666666652 112334556677777777777766553 345556777777777777763 344443
Q ss_pred ccCCCCeEecCCCccCCcCCCcCCCCCCCcEEEccCCcCcC
Q 044366 259 YLKSLSKLEFCANHLSGVIPHSVGNLTGLVLLNMCENHLFG 299 (918)
Q Consensus 259 ~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~ 299 (918)
++|++|++++|++.+. |. +..+++|+.|++++|++++
T Consensus 274 --~~L~~L~Ls~N~l~~~-p~-~~~l~~L~~L~L~~N~l~~ 310 (312)
T 1wwl_A 274 --AKLSVLDLSYNRLDRN-PS-PDELPQVGNLSLKGNPFLD 310 (312)
T ss_dssp --SEEEEEECCSSCCCSC-CC-TTTSCEEEEEECTTCTTTC
T ss_pred --CCceEEECCCCCCCCC-hh-HhhCCCCCEEeccCCCCCC
Confidence 6677777777777765 44 7777777777777777754
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.95 E-value=7.1e-29 Score=268.09 Aligned_cols=249 Identities=22% Similarity=0.223 Sum_probs=210.0
Q ss_pred CCCCCCCCEEeCCCCcccccCCccccCCCCCCEEEccccccc-ccCCCCcC-------CCCCCCEEEcccccccccCCcc
Q 044366 17 IGNLSKLQYLDLGNNQLSGVIPPEIGKLNQLRRLYLDVNQLH-GTIPPVIG-------QLSLINELVFCHNNVSGRIPSS 88 (918)
Q Consensus 17 ~~~l~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~n~l~-~~~p~~~~-------~l~~L~~L~l~~n~~~~~~p~~ 88 (918)
++..++|++|++++|++ .+|..+... |++|+|++|++. ..+|..+. .+++|++|++++|.+++.+|..
T Consensus 39 ~~~~~~L~~l~l~~n~l--~~p~~~~~~--L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~ 114 (312)
T 1wwl_A 39 YGGGRSLEYLLKRVDTE--ADLGQFTDI--IKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPP 114 (312)
T ss_dssp EEEEEECTTHHHHCCTT--CCCHHHHHH--HHHCCCCEEEEEEEECBHHHHHHHHHHHTTSCCCEEEEEEEBCBSCCCCC
T ss_pred EccCCCceeEeeccccc--ccHHHHHHH--HhhcccccccccCCCcCHHHHHHHHHhcCcCCccEEEccCCcccchhHHH
Confidence 45667799999999999 678777766 899999999994 45777665 7899999999999999889988
Q ss_pred c--cCCCCCCEEEccCCcccccCccccCCC-----CCCCEEECcCCcCCCcCCcCCCCCCCCceeeccccccccC--CCc
Q 044366 89 L--GNLSNLALLYLNDNSLFGSIPIVMGNL-----KSLSTLDLSQNQLNGSIPCSLDNLSNLDTLFLYKNSLSGP--IPS 159 (918)
Q Consensus 89 l--~~l~~L~~L~L~~n~i~~~~~~~~~~l-----~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~l~~~--~~~ 159 (918)
+ ..+++|++|+|++|++++. |..+..+ ++|++|+|++|++++..|..++++++|++|+|++|++.+. .+.
T Consensus 115 ~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~ 193 (312)
T 1wwl_A 115 LLEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLIS 193 (312)
T ss_dssp SSSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHHHHHHH
T ss_pred HHHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCcchHHHH
Confidence 7 8999999999999999876 7777777 8999999999999988889999999999999999997654 233
Q ss_pred cc--ccccccCeeeccccccCCcC---CccCCCCCCCcEeeccCcccccCCC-ccccCCCCcceeecccccccCCCCCCC
Q 044366 160 VI--GNLKSLLQLDLSENRLSGLI---PLSLSNLSSLTVMSLFNNSLSGSIP-PILGNLKSLSTLGLHINQLNGVIPPSI 233 (918)
Q Consensus 160 ~~--~~l~~L~~L~Ls~N~l~~~~---~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~n~l~~~~~~~~ 233 (918)
.+ ..+++|++|+|++|+++++. ...+..+++|++|+|++|++++..| ..+..+++|++|+|++|+++ .+|..+
T Consensus 194 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~-~ip~~~ 272 (312)
T 1wwl_A 194 ALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGL 272 (312)
T ss_dssp HSCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCCCTTCCEEECTTSCCS-SCCSSC
T ss_pred HHHhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhhcCCCCEEECCCCccC-hhhhhc
Confidence 33 88999999999999998432 2345678999999999999997664 56777899999999999998 456666
Q ss_pred cCCCcCCeEEcccCcCcCCCCccccccCCCCeEecCCCccCC
Q 044366 234 GNLSSLRNLSLFNNRLYGFVPKEIGYLKSLSKLEFCANHLSG 275 (918)
Q Consensus 234 ~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~ 275 (918)
. ++|++|++++|++++. |. +..+++|++|++++|++++
T Consensus 273 ~--~~L~~L~Ls~N~l~~~-p~-~~~l~~L~~L~L~~N~l~~ 310 (312)
T 1wwl_A 273 P--AKLSVLDLSYNRLDRN-PS-PDELPQVGNLSLKGNPFLD 310 (312)
T ss_dssp C--SEEEEEECCSSCCCSC-CC-TTTSCEEEEEECTTCTTTC
T ss_pred c--CCceEEECCCCCCCCC-hh-HhhCCCCCEEeccCCCCCC
Confidence 5 8999999999999977 54 8899999999999999875
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.3e-29 Score=294.08 Aligned_cols=188 Identities=19% Similarity=0.143 Sum_probs=133.9
Q ss_pred eccccceEEEEE-EeCCCCEEEEEEcccccccCC------CCChHHHHHHHHHHhhc-cCCceeeEecccccCCceEEEE
Q 044366 654 IGKGGQRSVYKA-ELPSGNIFAVKKFKAELFSDE------TANPSEFLNEVLALTEI-RHRNIIKFHGFCSNAQHSFIVC 725 (918)
Q Consensus 654 lg~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~------~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~ 725 (918)
.+.|+.|.+..+ +.-.|+.||||++........ ....++|.+|+++++++ .|+||+++++++++++..||||
T Consensus 242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM 321 (569)
T 4azs_A 242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM 321 (569)
T ss_dssp -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence 566777777666 444699999999875422111 12235799999999999 7999999999999999999999
Q ss_pred EeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccCCC
Q 044366 726 EYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPH 805 (918)
Q Consensus 726 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~~~ 805 (918)
||++|++|.+++.+.+ +++.. +|+.||+.||+|+|++ |||||||||+|||+++++.+||+|||+|+.....
T Consensus 322 Eyv~G~~L~d~i~~~~---~l~~~---~I~~QIl~AL~ylH~~---GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~ 392 (569)
T 4azs_A 322 EKLPGRLLSDMLAAGE---EIDRE---KILGSLLRSLAALEKQ---GFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQD 392 (569)
T ss_dssp ECCCSEEHHHHHHTTC---CCCHH---HHHHHHHHHHHHHHHT---TCEESCCCGGGEEECTTSCEEECCCTTEESCC--
T ss_pred ecCCCCcHHHHHHhCC---CCCHH---HHHHHHHHHHHHHHHC---CceeccCchHhEEECCCCCEEEeecccCeeCCCC
Confidence 9999999999998653 35654 5889999999999999 9999999999999999999999999999987766
Q ss_pred CCCceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCC
Q 044366 806 SSNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHP 851 (918)
Q Consensus 806 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p 851 (918)
.......+||+.|||||++.+ .+..++|+||+|++.+++.+|..+
T Consensus 393 ~~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 393 CSWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp -CCSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred CccccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence 555667789999999999876 467789999999998887665433
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.95 E-value=9.3e-27 Score=271.74 Aligned_cols=268 Identities=25% Similarity=0.305 Sum_probs=215.7
Q ss_pred CCCCEEeCCCCcccccCCccccCCCCCCEEEcccccccccCCCCcCCCCCCCEEEcccccccccCCccccCCCCCCEEEc
Q 044366 21 SKLQYLDLGNNQLSGVIPPEIGKLNQLRRLYLDVNQLHGTIPPVIGQLSLINELVFCHNNVSGRIPSSLGNLSNLALLYL 100 (918)
Q Consensus 21 ~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~l~~l~~L~~L~L 100 (918)
.++++|++++|+++ .+|..+. ++|++|+|++|+++ .+|. .+++|++|++++|+++ .+|. .+++|++|+|
T Consensus 40 ~~l~~L~ls~n~L~-~lp~~l~--~~L~~L~L~~N~l~-~lp~---~l~~L~~L~Ls~N~l~-~lp~---~l~~L~~L~L 108 (622)
T 3g06_A 40 NGNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPA---LPPELRTLEVSGNQLT-SLPV---LPPGLLELSI 108 (622)
T ss_dssp HCCCEEECCSSCCS-CCCSCCC--TTCSEEEECSCCCS-CCCC---CCTTCCEEEECSCCCS-CCCC---CCTTCCEEEE
T ss_pred CCCcEEEecCCCcC-ccChhhC--CCCcEEEecCCCCC-CCCC---cCCCCCEEEcCCCcCC-cCCC---CCCCCCEEEC
Confidence 35889999999998 7787776 78999999999988 6776 5688999999999888 5665 6788999999
Q ss_pred cCCcccccCccccCCCCCCCEEECcCCcCCCcCCcCCCCCCCCceeeccccccccCCCcccccccccCeeeccccccCCc
Q 044366 101 NDNSLFGSIPIVMGNLKSLSTLDLSQNQLNGSIPCSLDNLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSENRLSGL 180 (918)
Q Consensus 101 ~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~ 180 (918)
++|++++. |. .+++|++|++++|+++. +|.. +++|++|+|++|+++++ |. .+++|+.|++++|+++++
T Consensus 109 s~N~l~~l-~~---~l~~L~~L~L~~N~l~~-lp~~---l~~L~~L~Ls~N~l~~l-~~---~~~~L~~L~L~~N~l~~l 176 (622)
T 3g06_A 109 FSNPLTHL-PA---LPSGLCKLWIFGNQLTS-LPVL---PPGLQELSVSDNQLASL-PA---LPSELCKLWAYNNQLTSL 176 (622)
T ss_dssp CSCCCCCC-CC---CCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSCC-CC---CCTTCCEEECCSSCCSCC
T ss_pred cCCcCCCC-CC---CCCCcCEEECCCCCCCc-CCCC---CCCCCEEECcCCcCCCc-CC---ccCCCCEEECCCCCCCCC
Confidence 99998754 43 56889999999999985 5543 47899999999998864 33 347889999999999975
Q ss_pred CCccCCCCCCCcEeeccCcccccCCCccccCCCCcceeecccccccCCCCCCCcCCCcCCeEEcccCcCcCCCCcccccc
Q 044366 181 IPLSLSNLSSLTVMSLFNNSLSGSIPPILGNLKSLSTLGLHINQLNGVIPPSIGNLSSLRNLSLFNNRLYGFVPKEIGYL 260 (918)
Q Consensus 181 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l 260 (918)
. ..+++|+.|++++|.+++ +|.. +++|+.|++++|.++.+ |. .+++|+.|++++|++++++ ..+
T Consensus 177 ~----~~~~~L~~L~Ls~N~l~~-l~~~---~~~L~~L~L~~N~l~~l-~~---~~~~L~~L~Ls~N~L~~lp----~~l 240 (622)
T 3g06_A 177 P----MLPSGLQELSVSDNQLAS-LPTL---PSELYKLWAYNNRLTSL-PA---LPSGLKELIVSGNRLTSLP----VLP 240 (622)
T ss_dssp C----CCCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSSC-CC---CCTTCCEEECCSSCCSCCC----CCC
T ss_pred c----ccCCCCcEEECCCCCCCC-CCCc---cchhhEEECcCCccccc-CC---CCCCCCEEEccCCccCcCC----CCC
Confidence 3 456889999999999985 3432 47899999999999854 33 2478999999999998643 456
Q ss_pred CCCCeEecCCCccCCcCCCcCCCCCCCcEEEccCCcCcCCCCccccCCCCCCeEEeecccccCccccccCCC
Q 044366 261 KSLSKLEFCANHLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLRNLTSLERVRFNQNNLYGKVYEAFGDH 332 (918)
Q Consensus 261 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l 332 (918)
++|+.|++++|+|..+.+ .+++|+.|++++|+++ .+|..+.++++|+.|++++|.+.+..+..+..+
T Consensus 241 ~~L~~L~Ls~N~L~~lp~----~~~~L~~L~Ls~N~L~-~lp~~l~~l~~L~~L~L~~N~l~~~~~~~l~~L 307 (622)
T 3g06_A 241 SELKELMVSGNRLTSLPM----LPSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALREI 307 (622)
T ss_dssp TTCCEEECCSSCCSCCCC----CCTTCCEEECCSSCCC-SCCGGGGGSCTTCEEECCSCCCCHHHHHHHHHH
T ss_pred CcCcEEECCCCCCCcCCc----ccccCcEEeCCCCCCC-cCCHHHhhccccCEEEecCCCCCCcCHHHHHhc
Confidence 889999999999985443 5688999999999998 668889999999999999999988877766544
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.95 E-value=3.6e-26 Score=266.77 Aligned_cols=267 Identities=26% Similarity=0.299 Sum_probs=207.4
Q ss_pred CCCCEEEcccccccccCCCCcCCCCCCCEEEcccccccccCCccccCCCCCCEEEccCCcccccCccccCCCCCCCEEEC
Q 044366 45 NQLRRLYLDVNQLHGTIPPVIGQLSLINELVFCHNNVSGRIPSSLGNLSNLALLYLNDNSLFGSIPIVMGNLKSLSTLDL 124 (918)
Q Consensus 45 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~l~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L 124 (918)
.+++.|++++|.++ .+|..+. ++|++|++++|+++ .+|. .+++|++|+|++|+|+. +|. .+++|++|+|
T Consensus 40 ~~l~~L~ls~n~L~-~lp~~l~--~~L~~L~L~~N~l~-~lp~---~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~L 108 (622)
T 3g06_A 40 NGNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPA---LPPELRTLEVSGNQLTS-LPV---LPPGLLELSI 108 (622)
T ss_dssp HCCCEEECCSSCCS-CCCSCCC--TTCSEEEECSCCCS-CCCC---CCTTCCEEEECSCCCSC-CCC---CCTTCCEEEE
T ss_pred CCCcEEEecCCCcC-ccChhhC--CCCcEEEecCCCCC-CCCC---cCCCCCEEEcCCCcCCc-CCC---CCCCCCEEEC
Confidence 35889999999988 7888776 78999999999888 5665 56889999999999874 444 6788999999
Q ss_pred cCCcCCCcCCcCCCCCCCCceeeccccccccCCCcccccccccCeeeccccccCCcCCccCCCCCCCcEeeccCcccccC
Q 044366 125 SQNQLNGSIPCSLDNLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSENRLSGLIPLSLSNLSSLTVMSLFNNSLSGS 204 (918)
Q Consensus 125 s~n~i~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ 204 (918)
++|++++ +|. .+++|++|++++|++++++ .. +++|++|+|++|+++++. . .+++|+.|++++|.+++
T Consensus 109 s~N~l~~-l~~---~l~~L~~L~L~~N~l~~lp-~~---l~~L~~L~Ls~N~l~~l~-~---~~~~L~~L~L~~N~l~~- 175 (622)
T 3g06_A 109 FSNPLTH-LPA---LPSGLCKLWIFGNQLTSLP-VL---PPGLQELSVSDNQLASLP-A---LPSELCKLWAYNNQLTS- 175 (622)
T ss_dssp CSCCCCC-CCC---CCTTCCEEECCSSCCSCCC-CC---CTTCCEEECCSSCCSCCC-C---CCTTCCEEECCSSCCSC-
T ss_pred cCCcCCC-CCC---CCCCcCEEECCCCCCCcCC-CC---CCCCCEEECcCCcCCCcC-C---ccCCCCEEECCCCCCCC-
Confidence 9999885 444 5678899999999988643 32 488999999999988753 2 34678899999999885
Q ss_pred CCccccCCCCcceeecccccccCCCCCCCcCCCcCCeEEcccCcCcCCCCccccccCCCCeEecCCCccCCcCCCcCCCC
Q 044366 205 IPPILGNLKSLSTLGLHINQLNGVIPPSIGNLSSLRNLSLFNNRLYGFVPKEIGYLKSLSKLEFCANHLSGVIPHSVGNL 284 (918)
Q Consensus 205 ~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l 284 (918)
+| ..+++|+.|++++|+++++ |. .+++|+.|++++|.++.+.. .+++|+.|++++|++.++ | ..+
T Consensus 176 l~---~~~~~L~~L~Ls~N~l~~l-~~---~~~~L~~L~L~~N~l~~l~~----~~~~L~~L~Ls~N~L~~l-p---~~l 240 (622)
T 3g06_A 176 LP---MLPSGLQELSVSDNQLASL-PT---LPSELYKLWAYNNRLTSLPA----LPSGLKELIVSGNRLTSL-P---VLP 240 (622)
T ss_dssp CC---CCCTTCCEEECCSSCCSCC-CC---CCTTCCEEECCSSCCSSCCC----CCTTCCEEECCSSCCSCC-C---CCC
T ss_pred Cc---ccCCCCcEEECCCCCCCCC-CC---ccchhhEEECcCCcccccCC----CCCCCCEEEccCCccCcC-C---CCC
Confidence 44 4568889999999998864 33 24788999999999885432 347899999999998864 3 456
Q ss_pred CCCcEEEccCCcCcCCCCccccCCCCCCeEEeecccccCccccccCCCCCccEEeCCCCccccccCccccc
Q 044366 285 TGLVLLNMCENHLFGPIPKSLRNLTSLERVRFNQNNLYGKVYEAFGDHPNLTFLDLSQNNFYCEISFNWRN 355 (918)
Q Consensus 285 ~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~ 355 (918)
++|+.|++++|+++. +|. .+++|+.|++++|.|..++ ..|..+++|+.|+|++|++.......+..
T Consensus 241 ~~L~~L~Ls~N~L~~-lp~---~~~~L~~L~Ls~N~L~~lp-~~l~~l~~L~~L~L~~N~l~~~~~~~l~~ 306 (622)
T 3g06_A 241 SELKELMVSGNRLTS-LPM---LPSGLLSLSVYRNQLTRLP-ESLIHLSSETTVNLEGNPLSERTLQALRE 306 (622)
T ss_dssp TTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCCSCC-GGGGGSCTTCEEECCSCCCCHHHHHHHHH
T ss_pred CcCcEEECCCCCCCc-CCc---ccccCcEEeCCCCCCCcCC-HHHhhccccCEEEecCCCCCCcCHHHHHh
Confidence 788999999998885 443 5678899999999998774 45888899999999999987655544443
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.95 E-value=5.2e-29 Score=269.81 Aligned_cols=256 Identities=18% Similarity=0.162 Sum_probs=120.9
Q ss_pred CEEeCCCCcccccCCccccCCCCCCEEEcccccccccCCCCcCCCCCCCEEEcccccccccCCccccCCCCCCEEEccCC
Q 044366 24 QYLDLGNNQLSGVIPPEIGKLNQLRRLYLDVNQLHGTIPPVIGQLSLINELVFCHNNVSGRIPSSLGNLSNLALLYLNDN 103 (918)
Q Consensus 24 ~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~l~~l~~L~~L~L~~n 103 (918)
+.++++++.+...++..+..+++|++|+|++|++++..|..|..+++|++|++++|.+++..| +..+++|++|++++|
T Consensus 13 ~i~~ls~~~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~Ls~n 90 (317)
T 3o53_A 13 KIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNN 90 (317)
T ss_dssp EEESCCTTTHHHHHHHHHTTGGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEE--ETTCTTCCEEECCSS
T ss_pred eEeeccccchhhhHHHHhccCCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchh--hhhcCCCCEEECcCC
Confidence 334444444443333333334444444444444443333444444444444444444443322 444555555555555
Q ss_pred cccccCccccCCCCCCCEEECcCCcCCCcCCcCCCCCCCCceeeccccccccCCCcccccccccCeeeccccccCCcCCc
Q 044366 104 SLFGSIPIVMGNLKSLSTLDLSQNQLNGSIPCSLDNLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSENRLSGLIPL 183 (918)
Q Consensus 104 ~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~ 183 (918)
++++.. ..++|++|++++|++++..+.. +++|++|++++|++++..+..|+.+++|++|++++|++++..+.
T Consensus 91 ~l~~l~-----~~~~L~~L~l~~n~l~~~~~~~---~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~ 162 (317)
T 3o53_A 91 YVQELL-----VGPSIETLHAANNNISRVSCSR---GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFA 162 (317)
T ss_dssp EEEEEE-----ECTTCCEEECCSSCCSEEEECC---CSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEEEGG
T ss_pred cccccc-----CCCCcCEEECCCCccCCcCccc---cCCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCcccHH
Confidence 544221 1245555555555554333222 34455555555555544444555555555555555555544444
Q ss_pred cC-CCCCCCcEeeccCcccccCCCccccCCCCcceeecccccccCCCCCCCcCCCcCCeEEcccCcCcCCCCccccccCC
Q 044366 184 SL-SNLSSLTVMSLFNNSLSGSIPPILGNLKSLSTLGLHINQLNGVIPPSIGNLSSLRNLSLFNNRLYGFVPKEIGYLKS 262 (918)
Q Consensus 184 ~~-~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~ 262 (918)
.+ ..+++|++|+|++|.+++.. ....+++|++|+|++|++++.+ ..+..+++|+.|++++|++++ .|..+..+++
T Consensus 163 ~~~~~l~~L~~L~L~~N~l~~~~--~~~~l~~L~~L~Ls~N~l~~l~-~~~~~l~~L~~L~L~~N~l~~-l~~~~~~l~~ 238 (317)
T 3o53_A 163 ELAASSDTLEHLNLQYNFIYDVK--GQVVFAKLKTLDLSSNKLAFMG-PEFQSAAGVTWISLRNNKLVL-IEKALRFSQN 238 (317)
T ss_dssp GGGGGTTTCCEEECTTSCCCEEE--CCCCCTTCCEEECCSSCCCEEC-GGGGGGTTCSEEECTTSCCCE-ECTTCCCCTT
T ss_pred HHhhccCcCCEEECCCCcCcccc--cccccccCCEEECCCCcCCcch-hhhcccCcccEEECcCCcccc-hhhHhhcCCC
Confidence 33 24455555555555554331 1223455555555555555332 235555555555555555553 2334455555
Q ss_pred CCeEecCCCccC-CcCCCcCCCCCCCcEEEcc
Q 044366 263 LSKLEFCANHLS-GVIPHSVGNLTGLVLLNMC 293 (918)
Q Consensus 263 L~~L~l~~n~l~-~~~~~~~~~l~~L~~L~l~ 293 (918)
|+.|++++|++. +..+..+..+++|+.+++.
T Consensus 239 L~~L~l~~N~~~~~~~~~~~~~~~~L~~l~l~ 270 (317)
T 3o53_A 239 LEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQ 270 (317)
T ss_dssp CCEEECTTCCCBHHHHHHHHHTCHHHHHHHHH
T ss_pred CCEEEccCCCccCcCHHHHHhccccceEEECC
Confidence 555555555555 4444445555555555555
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.95 E-value=4.6e-29 Score=270.19 Aligned_cols=267 Identities=20% Similarity=0.208 Sum_probs=189.4
Q ss_pred CCeEEcccCcCcCCCCccccccCCCCeEecCCCccCCcCCCcCCCCCCCcEEEccCCcCcCCCCccccCCCCCCeEEeec
Q 044366 239 LRNLSLFNNRLYGFVPKEIGYLKSLSKLEFCANHLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLRNLTSLERVRFNQ 318 (918)
Q Consensus 239 L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~ 318 (918)
++.++++++.+.......+..+++|++|++++|.+.+..|..|..+++|+.|++++|++.+..+ +..+++|++|++++
T Consensus 12 l~i~~ls~~~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~Ls~ 89 (317)
T 3o53_A 12 YKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNN 89 (317)
T ss_dssp EEEESCCTTTHHHHHHHHHTTGGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEE--ETTCTTCCEEECCS
T ss_pred eeEeeccccchhhhHHHHhccCCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchh--hhhcCCCCEEECcC
Confidence 4445556666554444445555666777777766666655666666666666666666654333 55555555555555
Q ss_pred ccccCccccccCCCCCccEEeCCCCccccccCcccccccccceeeccccccccCCCcCcCCCCCCcEEEccCceeccccc
Q 044366 319 NNLYGKVYEAFGDHPNLTFLDLSQNNFYCEISFNWRNFSKLGTFNASMNNIYGSIPPEIGDSSKLQVLDLSSNHIFGKIP 398 (918)
Q Consensus 319 n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~n~i~~~~~~~~~~~~~L~~L~L~~N~l~~~~~ 398 (918)
|.+.+++. .++|++|++++|.+ .+..+. .+++|++|++++|++++..+
T Consensus 90 n~l~~l~~-----~~~L~~L~l~~n~l------------------------~~~~~~---~~~~L~~L~l~~N~l~~~~~ 137 (317)
T 3o53_A 90 NYVQELLV-----GPSIETLHAANNNI------------------------SRVSCS---RGQGKKNIYLANNKITMLRD 137 (317)
T ss_dssp SEEEEEEE-----CTTCCEEECCSSCC------------------------SEEEEC---CCSSCEEEECCSSCCCSGGG
T ss_pred CccccccC-----CCCcCEEECCCCcc------------------------CCcCcc---ccCCCCEEECCCCCCCCccc
Confidence 55544332 24555555555544 433322 24678888888888888778
Q ss_pred cchhhccccCceecccccccCCCCCCC-CCCCcccEEeccCccccccCccccccccccceecccCcccCCCCchhhcccc
Q 044366 399 VQLVKLFSLNKLILSLNQLFGGVPLEF-GTLTELQYLDLSANKLSSSIPMSIGNLLKLHYLNLSNNQFSHKIPTEFEKLI 477 (918)
Q Consensus 399 ~~~~~l~~L~~L~L~~N~l~~~~~~~~-~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~ 477 (918)
..+..+++|+.|+|++|++++..+..+ ..+++|++|+|++|.|++. + ....+++|++|+|++|+|++..+ .|..++
T Consensus 138 ~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~-~-~~~~l~~L~~L~Ls~N~l~~l~~-~~~~l~ 214 (317)
T 3o53_A 138 LDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV-K-GQVVFAKLKTLDLSSNKLAFMGP-EFQSAA 214 (317)
T ss_dssp BCTGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE-E-CCCCCTTCCEEECCSSCCCEECG-GGGGGT
T ss_pred hhhhccCCCCEEECCCCCCCcccHHHHhhccCcCCEEECCCCcCccc-c-cccccccCCEEECCCCcCCcchh-hhcccC
Confidence 888888888888888888887766666 4688999999999999865 2 23348899999999999986544 588999
Q ss_pred ccceEeccCCcCCCCCchhccccCCcceEecCCCccc-ccCcccccCCCCccEEEccC-CcCCCCCCC
Q 044366 478 HLSELDLSHNILQEEIPPQICKMESLEKLNLSHNNLS-DFIPRCFEEMRSLSWIDISY-NELQGPIPN 543 (918)
Q Consensus 478 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~l~l~~-N~l~~~~p~ 543 (918)
+|+.|+|++|+|+ .+|..+..+++|+.|+|++|+++ +..|..+..+++|+.+++++ +.++|..|.
T Consensus 215 ~L~~L~L~~N~l~-~l~~~~~~l~~L~~L~l~~N~~~~~~~~~~~~~~~~L~~l~l~~~~~l~~~~~~ 281 (317)
T 3o53_A 215 GVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEE 281 (317)
T ss_dssp TCSEEECTTSCCC-EECTTCCCCTTCCEEECTTCCCBHHHHHHHHHTCHHHHHHHHHHHHHHHSSSSC
T ss_pred cccEEECcCCccc-chhhHhhcCCCCCEEEccCCCccCcCHHHHHhccccceEEECCCchhccCCchh
Confidence 9999999999998 46778888999999999999998 66888889999999999984 456655443
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2.2e-26 Score=244.10 Aligned_cols=211 Identities=26% Similarity=0.254 Sum_probs=171.8
Q ss_pred CccEEeCCCCccccccCcccccccccceeeccccccccCCCcCcCCCCCCcEEEccCceeccccccchhhccccCceecc
Q 044366 334 NLTFLDLSQNNFYCEISFNWRNFSKLGTFNASMNNIYGSIPPEIGDSSKLQVLDLSSNHIFGKIPVQLVKLFSLNKLILS 413 (918)
Q Consensus 334 ~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~n~i~~~~~~~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~ 413 (918)
+|++|++++|.++.+....|.+++.|+.|++++|++.+..+..|..+++|++|+|++|++++..+..|.++++|++|+++
T Consensus 29 ~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~ 108 (276)
T 2z62_A 29 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAV 108 (276)
T ss_dssp TCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECT
T ss_pred CccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEECC
Confidence 34444444444444444444444455555555555555566678888899999999999988888888999999999999
Q ss_pred cccccCCCCCCCCCCCcccEEeccCcccccc-CccccccccccceecccCcccCCCCchhhccccccc----eEeccCCc
Q 044366 414 LNQLFGGVPLEFGTLTELQYLDLSANKLSSS-IPMSIGNLLKLHYLNLSNNQFSHKIPTEFEKLIHLS----ELDLSHNI 488 (918)
Q Consensus 414 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~----~L~Ls~N~ 488 (918)
+|++.+..+..+..+++|++|+|++|.+++. +|..|..+++|++|+|++|++++..+..|..+++|+ .|++++|+
T Consensus 109 ~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~l~l~L~ls~n~ 188 (276)
T 2z62_A 109 ETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNP 188 (276)
T ss_dssp TSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCEEEECCSSC
T ss_pred CCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCCCcCCHHHhhhhhhccccceeeecCCCc
Confidence 9999888887899999999999999999874 588999999999999999999988888998888888 89999999
Q ss_pred CCCCCchhccccCCcceEecCCCcccccCcccccCCCCccEEEccCCcCCCCCCCCc
Q 044366 489 LQEEIPPQICKMESLEKLNLSHNNLSDFIPRCFEEMRSLSWIDISYNELQGPIPNST 545 (918)
Q Consensus 489 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~p~~~ 545 (918)
|++..+..+.. .+|+.|+|++|+++++.+..|..+++|+.|++++|+++|.+|.-.
T Consensus 189 l~~~~~~~~~~-~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~~l~ 244 (276)
T 2z62_A 189 MNFIQPGAFKE-IRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRID 244 (276)
T ss_dssp CCEECTTSSCS-CCEEEEECCSSCCSCCCTTTTTTCCSCCEEECCSSCBCCCTTTTH
T ss_pred ccccCccccCC-CcccEEECCCCceeecCHhHhcccccccEEEccCCcccccCCchH
Confidence 98766655554 589999999999999888889999999999999999999988643
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.94 E-value=3.3e-27 Score=270.54 Aligned_cols=192 Identities=23% Similarity=0.238 Sum_probs=97.8
Q ss_pred CCCEEEccCCcccccCccccCCCCCCCEEECcCCcCCCcCCcCCCCCCCCceeeccccccccCCCcccccccccCeeecc
Q 044366 94 NLALLYLNDNSLFGSIPIVMGNLKSLSTLDLSQNQLNGSIPCSLDNLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLS 173 (918)
Q Consensus 94 ~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls 173 (918)
+|++|+|++|.+++..|..|..+++|++|+|++|.+++..| +..+++|++|+|++|.++++.+ .++|++|+++
T Consensus 35 ~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l~~-----~~~L~~L~L~ 107 (487)
T 3oja_A 35 NVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELLV-----GPSIETLHAA 107 (487)
T ss_dssp GCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEEEEE-----CTTCCEEECC
T ss_pred CccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCCCCC-----CCCcCEEECc
Confidence 56666666666665555566666666666666666654433 5556666666666666553321 2555666666
Q ss_pred ccccCCcCCccCCCCCCCcEeeccCcccccCCCccccCCCCcceeecccccccCCCCCCCc-CCCcCCeEEcccCcCcCC
Q 044366 174 ENRLSGLIPLSLSNLSSLTVMSLFNNSLSGSIPPILGNLKSLSTLGLHINQLNGVIPPSIG-NLSSLRNLSLFNNRLYGF 252 (918)
Q Consensus 174 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~-~l~~L~~L~Ls~n~l~~~ 252 (918)
+|.++++.+.. +++|+.|+|++|.+++..|..|..+++|+.|+|++|.+++.+|..+. .+++|+.|+|++|.+++.
T Consensus 108 ~N~l~~~~~~~---l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~~~ 184 (487)
T 3oja_A 108 NNNISRVSCSR---GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV 184 (487)
T ss_dssp SSCCCCEEECC---CSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE
T ss_pred CCcCCCCCccc---cCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCccccc
Confidence 66555543322 34555555555555554455555555555555555555544444443 445555555555555443
Q ss_pred CCccccccCCCCeEecCCCccCCcCCCcCCCCCCCcEEEccCCcCc
Q 044366 253 VPKEIGYLKSLSKLEFCANHLSGVIPHSVGNLTGLVLLNMCENHLF 298 (918)
Q Consensus 253 ~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~ 298 (918)
.+ ...+++|+.|++++|.+.++++. +..+++|+.|++++|.++
T Consensus 185 ~~--~~~l~~L~~L~Ls~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~ 227 (487)
T 3oja_A 185 KG--QVVFAKLKTLDLSSNKLAFMGPE-FQSAAGVTWISLRNNKLV 227 (487)
T ss_dssp EC--CCCCTTCCEEECCSSCCCEECGG-GGGGTTCSEEECTTSCCC
T ss_pred cc--cccCCCCCEEECCCCCCCCCCHh-HcCCCCccEEEecCCcCc
Confidence 11 12244444444444444432222 333444444444444433
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.93 E-value=2e-25 Score=235.61 Aligned_cols=206 Identities=23% Similarity=0.231 Sum_probs=172.2
Q ss_pred ccEEeCCCCccccccCcccccccccceeeccccccccCCCcCcCCCCCCcEEEccCceeccccccchhhccccCceeccc
Q 044366 335 LTFLDLSQNNFYCEISFNWRNFSKLGTFNASMNNIYGSIPPEIGDSSKLQVLDLSSNHIFGKIPVQLVKLFSLNKLILSL 414 (918)
Q Consensus 335 L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~n~i~~~~~~~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~ 414 (918)
.+.+++++|.++.++... .+.++.|++++|++.+..+..|..+++|++|+|++|+|+...+..|.++++|++|+|++
T Consensus 18 ~~~l~~~~~~l~~ip~~~---~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~ 94 (270)
T 2o6q_A 18 KNSVDCSSKKLTAIPSNI---PADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTD 94 (270)
T ss_dssp TTEEECTTSCCSSCCSCC---CTTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCTTTTSSCTTCCEEECCS
T ss_pred CCEEEccCCCCCccCCCC---CCCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeChhhhcCCCCCCEEECCC
Confidence 344444444444333211 13455555555556556666788889999999999999877777788899999999999
Q ss_pred ccccCCCCCCCCCCCcccEEeccCccccccCccccccccccceecccCcccCCCCchhhccccccceEeccCCcCCCCCc
Q 044366 415 NQLFGGVPLEFGTLTELQYLDLSANKLSSSIPMSIGNLLKLHYLNLSNNQFSHKIPTEFEKLIHLSELDLSHNILQEEIP 494 (918)
Q Consensus 415 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~ 494 (918)
|++++..+..|..+++|++|+|++|.+++..+..|..+++|++|+|++|+|++..+..|..+++|++|+|++|+|++..+
T Consensus 95 n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~ 174 (270)
T 2o6q_A 95 NKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLKRVPE 174 (270)
T ss_dssp SCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCT
T ss_pred CcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCcccceeEecCCcCcEeCh
Confidence 99988888888999999999999999998888889999999999999999998888889999999999999999998888
Q ss_pred hhccccCCcceEecCCCcccccCcccccCCCCccEEEccCCcCCCCCCC
Q 044366 495 PQICKMESLEKLNLSHNNLSDFIPRCFEEMRSLSWIDISYNELQGPIPN 543 (918)
Q Consensus 495 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~p~ 543 (918)
..|..+++|+.|+|++|+++++.+..|..+++|+.|++++|+|+|.++.
T Consensus 175 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~~ 223 (270)
T 2o6q_A 175 GAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQENPWDCTCNG 223 (270)
T ss_dssp TTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCSSSS
T ss_pred hHhccCCCcCEEECCCCcCCcCCHHHhccccCCCEEEecCCCeeCCCcc
Confidence 8899999999999999999998888899999999999999999998764
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=9e-26 Score=239.45 Aligned_cols=230 Identities=22% Similarity=0.261 Sum_probs=154.6
Q ss_pred EEEccCCcccccCccccCCCCCCCEEECcCCcCCCcCCcCCCCCCCCceeeccccccccCCCcccccccccCeeeccccc
Q 044366 97 LLYLNDNSLFGSIPIVMGNLKSLSTLDLSQNQLNGSIPCSLDNLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSENR 176 (918)
Q Consensus 97 ~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~ 176 (918)
..+..+..+. .+|..+. ++|++|++++|++++..+..|.++++|++|++++|+++++.+..|.++++|++|++++|+
T Consensus 11 ~~~c~~~~l~-~ip~~l~--~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~ 87 (276)
T 2z62_A 11 TYQCMELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNP 87 (276)
T ss_dssp EEECTTSCCS-SCCSSSC--TTCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCC
T ss_pred eEEecCCCcc-ccCCCCC--CCccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCc
Confidence 4555666654 4454443 468888888888876666677777788888888887777766677777777777777777
Q ss_pred cCCcCCccCCCCCCCcEeeccCcccccCCCccccCCCCcceeecccccccCC-CCCCCcCCCcCCeEEcccCcCcCCCCc
Q 044366 177 LSGLIPLSLSNLSSLTVMSLFNNSLSGSIPPILGNLKSLSTLGLHINQLNGV-IPPSIGNLSSLRNLSLFNNRLYGFVPK 255 (918)
Q Consensus 177 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~-~~~~~~~l~~L~~L~Ls~n~l~~~~~~ 255 (918)
++++.+..|.++++|++|++++|.+++..+..+..+++|++|++++|.+++. .|..|.++++|++|++++|+++++.+.
T Consensus 88 l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~~ 167 (276)
T 2z62_A 88 IQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCT 167 (276)
T ss_dssp CCEECTTTTTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGG
T ss_pred cCccChhhhcCCccccEEECCCCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCCCcCCHH
Confidence 7777666777777777777777777766555666777777777777776653 355666666666666666666665555
Q ss_pred cccccCCCCeEecCCCccCCcCCCcCCCCCCCcEEEccCCcCcCCCCccccCCCCCCeEEeecccccCccccccCCCCCc
Q 044366 256 EIGYLKSLSKLEFCANHLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLRNLTSLERVRFNQNNLYGKVYEAFGDHPNL 335 (918)
Q Consensus 256 ~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L 335 (918)
.+..+++|+.+.+ .|++++|++.+..+..+.. .+|++|++++|.+..++...|..+++|
T Consensus 168 ~~~~l~~L~~l~l--------------------~L~ls~n~l~~~~~~~~~~-~~L~~L~L~~n~l~~~~~~~~~~l~~L 226 (276)
T 2z62_A 168 DLRVLHQMPLLNL--------------------SLDLSLNPMNFIQPGAFKE-IRLKELALDTNQLKSVPDGIFDRLTSL 226 (276)
T ss_dssp GGHHHHTCTTCCE--------------------EEECCSSCCCEECTTSSCS-CCEEEEECCSSCCSCCCTTTTTTCCSC
T ss_pred Hhhhhhhccccce--------------------eeecCCCcccccCccccCC-CcccEEECCCCceeecCHhHhcccccc
Confidence 5555555551100 3444444444333333332 256666666667767777777888889
Q ss_pred cEEeCCCCccccccC
Q 044366 336 TFLDLSQNNFYCEIS 350 (918)
Q Consensus 336 ~~L~Ls~N~l~~~~~ 350 (918)
+.|++++|++.|+|.
T Consensus 227 ~~L~l~~N~~~c~c~ 241 (276)
T 2z62_A 227 QKIWLHTNPWDCSCP 241 (276)
T ss_dssp CEEECCSSCBCCCTT
T ss_pred cEEEccCCcccccCC
Confidence 999999999988875
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=99.93 E-value=4.3e-29 Score=296.24 Aligned_cols=445 Identities=15% Similarity=0.118 Sum_probs=264.2
Q ss_pred EEEcccccccccCCccccCCCCCCEEEccCCcccc---cCcc------------ccCCCCCCCEEECcCCcCCCcCCcCC
Q 044366 73 ELVFCHNNVSGRIPSSLGNLSNLALLYLNDNSLFG---SIPI------------VMGNLKSLSTLDLSQNQLNGSIPCSL 137 (918)
Q Consensus 73 ~L~l~~n~~~~~~p~~l~~l~~L~~L~L~~n~i~~---~~~~------------~~~~l~~L~~L~Ls~n~i~~~~~~~l 137 (918)
.+++..+... ..+..+..+++|++|++++|.... ..|. .+..+++|++|+|++|.+++..+..+
T Consensus 47 ~l~~~~~~~~-~~~~~~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~~~~~~~~~l 125 (594)
T 2p1m_B 47 KVFIGNCYAV-SPATVIRRFPKVRSVELKGKPHFADFNLVPDGWGGYVYPWIEAMSSSYTWLEEIRLKRMVVTDDCLELI 125 (594)
T ss_dssp EEEESSTTSS-CHHHHHHHCTTCCEEEEECSCGGGGGTCSCTTSCCBCHHHHHHHHHHCTTCCEEEEESCBCCHHHHHHH
T ss_pred EEeecccccc-CHHHHHhhCCCceEEeccCCCchhhcccccccccchhhHHHHHHHHhCCCCCeEEeeCcEEcHHHHHHH
Confidence 4555544332 222345677889999999875321 1111 12357788888888888876655555
Q ss_pred C-CCCCCceeecccc-ccccC-CCcccccccccCeeeccccccCCcCCccCC----CCCCCcEeeccCcc--ccc-CCCc
Q 044366 138 D-NLSNLDTLFLYKN-SLSGP-IPSVIGNLKSLLQLDLSENRLSGLIPLSLS----NLSSLTVMSLFNNS--LSG-SIPP 207 (918)
Q Consensus 138 ~-~l~~L~~L~L~~n-~l~~~-~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~----~l~~L~~L~L~~N~--l~~-~~~~ 207 (918)
. .+++|++|+|++| .++.. .+..+.++++|++|+|++|.+++..+..+. .+++|+.|++++|. ++. ..+.
T Consensus 126 ~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~~~L~~L~l~~~~~~~~~~~l~~ 205 (594)
T 2p1m_B 126 AKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLVSLNISCLASEVSFSALER 205 (594)
T ss_dssp HHHCTTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTTCCCCCEEECTTCCSCCCHHHHHH
T ss_pred HHhCCCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhcCCcCcEEEecccCCcCCHHHHHH
Confidence 4 5788888888888 44432 333445788888888888887765444333 56688888888876 211 0111
Q ss_pred cccCCCCcceeecccc-cccCCCCCCCcCCCcCCeEEcccCc-------CcCCCCccccccCCCCeE-ecCCCccCCcCC
Q 044366 208 ILGNLKSLSTLGLHIN-QLNGVIPPSIGNLSSLRNLSLFNNR-------LYGFVPKEIGYLKSLSKL-EFCANHLSGVIP 278 (918)
Q Consensus 208 ~~~~l~~L~~L~L~~n-~l~~~~~~~~~~l~~L~~L~Ls~n~-------l~~~~~~~~~~l~~L~~L-~l~~n~l~~~~~ 278 (918)
.+..+++|+.|++++| .+++ ++..+..+++|++|+++.+. +.+ .+..+.++++|+.| .+.+... ...+
T Consensus 206 l~~~~~~L~~L~L~~~~~~~~-l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~-l~~~l~~~~~L~~Ls~~~~~~~-~~l~ 282 (594)
T 2p1m_B 206 LVTRCPNLKSLKLNRAVPLEK-LATLLQRAPQLEELGTGGYTAEVRPDVYSG-LSVALSGCKELRCLSGFWDAVP-AYLP 282 (594)
T ss_dssp HHHHCTTCCEEECCTTSCHHH-HHHHHHHCTTCSEEECSBCCCCCCHHHHHH-HHHHHHTCTTCCEEECCBTCCG-GGGG
T ss_pred HHHhCCCCcEEecCCCCcHHH-HHHHHhcCCcceEcccccccCccchhhHHH-HHHHHhcCCCcccccCCcccch-hhHH
Confidence 2344578888888877 3443 45556677778888755443 222 12245666777776 3333222 1223
Q ss_pred CcCCCCCCCcEEEccCCcCcCCCC-ccccCCCCCCeEEeecccccCccccc-cCCCCCccEEeCCCCccccccCcccccc
Q 044366 279 HSVGNLTGLVLLNMCENHLFGPIP-KSLRNLTSLERVRFNQNNLYGKVYEA-FGDHPNLTFLDLSQNNFYCEISFNWRNF 356 (918)
Q Consensus 279 ~~~~~l~~L~~L~l~~n~l~~~~~-~~l~~l~~L~~L~l~~n~l~~~~~~~-~~~l~~L~~L~Ls~N~l~~~~~~~~~~~ 356 (918)
..+..+++|+.|++++|.+..... ..+.++++|++|++++| +....... ...+++|+.|+++++.-..
T Consensus 283 ~~~~~~~~L~~L~L~~~~l~~~~l~~~~~~~~~L~~L~l~~~-~~~~~l~~l~~~~~~L~~L~L~~~~~~g--------- 352 (594)
T 2p1m_B 283 AVYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDY-IEDAGLEVLASTCKDLRELRVFPSEPFV--------- 352 (594)
T ss_dssp GGHHHHTTCCEEECTTCCCCHHHHHHHHTTCTTCCEEEEEGG-GHHHHHHHHHHHCTTCCEEEEECSCTTC---------
T ss_pred HHHHhhCCCCEEEccCCCCCHHHHHHHHhcCCCcCEEeCcCc-cCHHHHHHHHHhCCCCCEEEEecCcccc---------
Confidence 333355667777777766543221 22446666666666666 32221111 1235666666663321000
Q ss_pred cccceeeccccccccCCCcCc-CCCCCCcEEEccCceeccccccchh-hccccCceecc--c----ccccCCCC-----C
Q 044366 357 SKLGTFNASMNNIYGSIPPEI-GDSSKLQVLDLSSNHIFGKIPVQLV-KLFSLNKLILS--L----NQLFGGVP-----L 423 (918)
Q Consensus 357 ~~L~~l~l~~n~i~~~~~~~~-~~~~~L~~L~L~~N~l~~~~~~~~~-~l~~L~~L~L~--~----N~l~~~~~-----~ 423 (918)
..+.+.++......+ ..+++|+.|+++.|.++......+. .+++|+.|+++ + |.+++... .
T Consensus 353 ------~~~~~~l~~~~l~~l~~~~~~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~ 426 (594)
T 2p1m_B 353 ------MEPNVALTEQGLVSVSMGCPKLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTLEPLDIGFGA 426 (594)
T ss_dssp ------SSCSSCCCHHHHHHHHHHCTTCCEEEEEESCCCHHHHHHHHHHCTTCCEEEEEESSTTCCCTTTCCCTHHHHHH
T ss_pred ------cccCCCCCHHHHHHHHHhchhHHHHHHhcCCcCHHHHHHHHhhCCCcceeEeecccCCCcccccCCchhhHHHH
Confidence 001122221111112 2357788888877777765555554 47788888888 3 44442211 1
Q ss_pred CCCCCCcccEEeccCccccccCcccccc-ccccceecccCcccCCCCchhh-ccccccceEeccCCcCCCCCch-hcccc
Q 044366 424 EFGTLTELQYLDLSANKLSSSIPMSIGN-LLKLHYLNLSNNQFSHKIPTEF-EKLIHLSELDLSHNILQEEIPP-QICKM 500 (918)
Q Consensus 424 ~~~~l~~L~~L~Ls~N~l~~~~~~~~~~-l~~L~~L~Ls~N~l~~~~~~~~-~~l~~L~~L~Ls~N~l~~~~~~-~~~~l 500 (918)
.+..+++|++|+|++ .++......+.. +++|+.|+|++|.+++..+..+ ..+++|++|+|++|.+++..+. ....+
T Consensus 427 l~~~~~~L~~L~L~~-~l~~~~~~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~~~~~~~~~~~~l 505 (594)
T 2p1m_B 427 IVEHCKDLRRLSLSG-LLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDKALLANASKL 505 (594)
T ss_dssp HHHHCTTCCEEECCS-SCCHHHHHHHHHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCSCCHHHHHHTGGGG
T ss_pred HHhhCCCccEEeecC-cccHHHHHHHHHhchhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCCCcHHHHHHHHHhC
Confidence 145677888999877 666544445554 7888999999988876555555 6688899999999988654443 34457
Q ss_pred CCcceEecCCCcccccCcccc-cCCCCccEEEccCCcCC
Q 044366 501 ESLEKLNLSHNNLSDFIPRCF-EEMRSLSWIDISYNELQ 538 (918)
Q Consensus 501 ~~L~~L~L~~N~l~~~~~~~~-~~l~~L~~l~l~~N~l~ 538 (918)
++|+.|+|++|+++......+ ..+++|+...+..+.-.
T Consensus 506 ~~L~~L~l~~~~~~~~~~~~l~~~lp~l~i~~~~~~~~~ 544 (594)
T 2p1m_B 506 ETMRSLWMSSCSVSFGACKLLGQKMPKLNVEVIDERGAP 544 (594)
T ss_dssp GGSSEEEEESSCCBHHHHHHHHHHCTTEEEEEECSSSCG
T ss_pred CCCCEEeeeCCCCCHHHHHHHHHhCCCCEEEEecCCCcc
Confidence 889999999998855433344 45777777666665433
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=99.93 E-value=2.8e-29 Score=297.92 Aligned_cols=86 Identities=15% Similarity=0.070 Sum_probs=54.9
Q ss_pred CCcccEEeccCccccccCcccc-ccccccceecccCcccCCCCch-hhccccccceEeccCCcCCCCCchhc-cccCCcc
Q 044366 428 LTELQYLDLSANKLSSSIPMSI-GNLLKLHYLNLSNNQFSHKIPT-EFEKLIHLSELDLSHNILQEEIPPQI-CKMESLE 504 (918)
Q Consensus 428 l~~L~~L~Ls~N~l~~~~~~~~-~~l~~L~~L~Ls~N~l~~~~~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~-~~l~~L~ 504 (918)
+++|++|+|++|.+++.....+ ..+++|+.|+|++|.+++.... ....+++|+.|++++|+++......+ ..++.|+
T Consensus 455 ~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~l~~~lp~l~ 534 (594)
T 2p1m_B 455 AKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDKALLANASKLETMRSLWMSSCSVSFGACKLLGQKMPKLN 534 (594)
T ss_dssp CTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCSCCHHHHHHTGGGGGGSSEEEEESSCCBHHHHHHHHHHCTTEE
T ss_pred chhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCCCcHHHHHHHHHhCCCCCEEeeeCCCCCHHHHHHHHHhCCCCE
Confidence 5667777777777765433333 5577788888888887544333 33457788888888887754333334 4567777
Q ss_pred eEecCCCcc
Q 044366 505 KLNLSHNNL 513 (918)
Q Consensus 505 ~L~L~~N~l 513 (918)
...+..+.-
T Consensus 535 i~~~~~~~~ 543 (594)
T 2p1m_B 535 VEVIDERGA 543 (594)
T ss_dssp EEEECSSSC
T ss_pred EEEecCCCc
Confidence 767766643
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.93 E-value=1.4e-24 Score=229.09 Aligned_cols=206 Identities=26% Similarity=0.328 Sum_probs=131.5
Q ss_pred CCCEEECcCCcCCCcCCcCCCCCCCCceeeccccccccCCCcccccccccCeeeccccccCCcCCccCCCCCCCcEeecc
Q 044366 118 SLSTLDLSQNQLNGSIPCSLDNLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSENRLSGLIPLSLSNLSSLTVMSLF 197 (918)
Q Consensus 118 ~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~ 197 (918)
+.+++++++++++ .+|..+. ++|++|+|++|+++++.+..|.++++|++|++++|+++.+.+..|..+++|++|+++
T Consensus 17 ~~~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~ 93 (270)
T 2o6q_A 17 NKNSVDCSSKKLT-AIPSNIP--ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVT 93 (270)
T ss_dssp TTTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCTTTTSSCTTCCEEECC
T ss_pred CCCEEEccCCCCC-ccCCCCC--CCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeChhhhcCCCCCCEEECC
Confidence 4677777777777 3554443 456677777777666655566666666666666666665555555666666666666
Q ss_pred CcccccCCCccccCCCCcceeecccccccCCCCCCCcCCCcCCeEEcccCcCcCCCCccccccCCCCeEecCCCccCCcC
Q 044366 198 NNSLSGSIPPILGNLKSLSTLGLHINQLNGVIPPSIGNLSSLRNLSLFNNRLYGFVPKEIGYLKSLSKLEFCANHLSGVI 277 (918)
Q Consensus 198 ~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~ 277 (918)
+|+++...+..|..+++|++|++++|+++...+..|..+++|++|++++|+++ +..
T Consensus 94 ~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~------------------------~~~ 149 (270)
T 2o6q_A 94 DNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQ------------------------SLP 149 (270)
T ss_dssp SSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC------------------------CCC
T ss_pred CCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCcCC------------------------ccC
Confidence 66665544445555555555555555555444444445555555555555444 444
Q ss_pred CCcCCCCCCCcEEEccCCcCcCCCCccccCCCCCCeEEeecccccCccccccCCCCCccEEeCCCCccccccC
Q 044366 278 PHSVGNLTGLVLLNMCENHLFGPIPKSLRNLTSLERVRFNQNNLYGKVYEAFGDHPNLTFLDLSQNNFYCEIS 350 (918)
Q Consensus 278 ~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~ 350 (918)
+..|..+++|+.|++++|++.+..+..|.++++|++|++++|.+..++...|..+++|+.|++++|++.|+|.
T Consensus 150 ~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~ 222 (270)
T 2o6q_A 150 KGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQENPWDCTCN 222 (270)
T ss_dssp TTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCSSS
T ss_pred HhHccCCcccceeEecCCcCcEeChhHhccCCCcCEEECCCCcCCcCCHHHhccccCCCEEEecCCCeeCCCc
Confidence 4445555555555555555555555566666777777777777777777778888999999999999999886
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.92 E-value=1e-24 Score=230.43 Aligned_cols=209 Identities=28% Similarity=0.338 Sum_probs=111.8
Q ss_pred ccCCCCCCEEEcccccccccCCCCcCCCCCCCEEEcccccccccCCccccCCCCCCEEEccCCcccccCccccCCCCCCC
Q 044366 41 IGKLNQLRRLYLDVNQLHGTIPPVIGQLSLINELVFCHNNVSGRIPSSLGNLSNLALLYLNDNSLFGSIPIVMGNLKSLS 120 (918)
Q Consensus 41 l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~l~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~ 120 (918)
+..+++|+.|++++|.++ .+ +.+..+++|++|++++|.+++ ...+..+++|++|++++|.+++..+..|..+++|+
T Consensus 37 ~~~l~~L~~L~l~~~~i~-~~-~~l~~l~~L~~L~l~~n~l~~--~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~ 112 (272)
T 3rfs_A 37 QNELNSIDQIIANNSDIK-SV-QGIQYLPNVRYLALGGNKLHD--ISALKELTNLTYLILTGNQLQSLPNGVFDKLTNLK 112 (272)
T ss_dssp HHHHTTCCEEECTTSCCC-CC-TTGGGCTTCCEEECTTSCCCC--CGGGTTCTTCCEEECTTSCCCCCCTTTTTTCTTCC
T ss_pred cccccceeeeeeCCCCcc-cc-cccccCCCCcEEECCCCCCCC--chhhcCCCCCCEEECCCCccCccChhHhcCCcCCC
Confidence 344444555555554443 22 224444555555555554442 12455555555555555555555444555555555
Q ss_pred EEECcCCcCCCcCCcCCCCCCCCceeeccccccccCCCcccccccccCeeeccccccCCcCCccCCCCCCCcEeeccCcc
Q 044366 121 TLDLSQNQLNGSIPCSLDNLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSENRLSGLIPLSLSNLSSLTVMSLFNNS 200 (918)
Q Consensus 121 ~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~ 200 (918)
+|+|++|++++..+..++++++|++|++++|++++..+..|+.+++|++|++++|+++++.+..|..+++|++|++++|+
T Consensus 113 ~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~ 192 (272)
T 3rfs_A 113 ELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQ 192 (272)
T ss_dssp EEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred EEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEECCCCCcCccCHHHhcCCccCCEEECCCCc
Confidence 55555555554444445555555555555555555555555555555555555555555555555555555566665555
Q ss_pred cccCCCccccCCCCcceeecccccccCCCCCCCcCCCcCCeEEcccCcCcCCCCcccccc
Q 044366 201 LSGSIPPILGNLKSLSTLGLHINQLNGVIPPSIGNLSSLRNLSLFNNRLYGFVPKEIGYL 260 (918)
Q Consensus 201 l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l 260 (918)
+++..+..|..+++|+.|++++|.+.+ .+++|+.|+++.|.+++..|..++.+
T Consensus 193 l~~~~~~~~~~l~~L~~L~l~~N~~~~-------~~~~l~~l~~~~n~~~g~ip~~~~~~ 245 (272)
T 3rfs_A 193 LKSVPDGVFDRLTSLQYIWLHDNPWDC-------TCPGIRYLSEWINKHSGVVRNSAGSV 245 (272)
T ss_dssp CSCCCTTTTTTCTTCCEEECCSSCBCC-------CTTTTHHHHHHHHHTGGGBBCTTSCB
T ss_pred CCccCHHHHhCCcCCCEEEccCCCccc-------cCcHHHHHHHHHHhCCCcccCccccc
Confidence 555555555555566666666555442 23455556666666665555554443
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.92 E-value=3.7e-24 Score=227.84 Aligned_cols=203 Identities=29% Similarity=0.286 Sum_probs=101.6
Q ss_pred CCCCCCCCEEeCCCCcccccCCccccCCCCCCEEEcccccccccCCCCcCCCCCCCEEEcccccccccCCccccCCCCCC
Q 044366 17 IGNLSKLQYLDLGNNQLSGVIPPEIGKLNQLRRLYLDVNQLHGTIPPVIGQLSLINELVFCHNNVSGRIPSSLGNLSNLA 96 (918)
Q Consensus 17 ~~~l~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~l~~l~~L~ 96 (918)
++++++++++++++++++ .+|..+. +++++|+|++|++++. .|..|..+++|+
T Consensus 6 ~~~l~~l~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~N~l~~~------------------------~~~~~~~l~~L~ 58 (290)
T 1p9a_G 6 VSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTF------------------------SLATLMPYTRLT 58 (290)
T ss_dssp EECSTTCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEE------------------------EGGGGTTCTTCC
T ss_pred ccccCCccEEECCCCCCC-cCCCCCC--CCCCEEEcCCCcCCcc------------------------CHHHhhcCCCCC
Confidence 455555666666665555 4444443 3455555555555433 334444444444
Q ss_pred EEEccCCcccccCccccCCCCCCCEEECcCCcCCCcCCcCCCCCCCCceeeccccccccCCCcccccccccCeeeccccc
Q 044366 97 LLYLNDNSLFGSIPIVMGNLKSLSTLDLSQNQLNGSIPCSLDNLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSENR 176 (918)
Q Consensus 97 ~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~ 176 (918)
+|+|++|.|++..+ ...+++|++|+|++|+++ .+|..+.++++|++|++++|+++++.++.|.++++|++|+|++|+
T Consensus 59 ~L~L~~n~l~~~~~--~~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~ 135 (290)
T 1p9a_G 59 QLNLDRAELTKLQV--DGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNE 135 (290)
T ss_dssp EEECTTSCCCEEEC--CSCCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSC
T ss_pred EEECCCCccCcccC--CCCCCcCCEEECCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCC
Confidence 44444444443222 144455555555555554 344444555555555555555554444455555555555555555
Q ss_pred cCCcCCccCCCCCCCcEeeccCcccccCCCccccCCCCcceeecccccccCCCCCCCcCCCcCCeEEcccCcCc
Q 044366 177 LSGLIPLSLSNLSSLTVMSLFNNSLSGSIPPILGNLKSLSTLGLHINQLNGVIPPSIGNLSSLRNLSLFNNRLY 250 (918)
Q Consensus 177 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~ 250 (918)
++++++..|..+++|+.|+|++|+++...+..|..+++|+.|+|++|+++. +|..+..+.+|+.|+|++|.+.
T Consensus 136 l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~-ip~~~~~~~~L~~l~L~~Np~~ 208 (290)
T 1p9a_G 136 LKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLYT-IPKGFFGSHLLPFAFLHGNPWL 208 (290)
T ss_dssp CCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCCC-CCTTTTTTCCCSEEECCSCCBC
T ss_pred CCccChhhcccccCCCEEECCCCcCCccCHHHhcCcCCCCEEECCCCcCCc-cChhhcccccCCeEEeCCCCcc
Confidence 555544445555555555555555554444444555555555555555552 3333444445555555555543
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.92 E-value=4.1e-24 Score=227.45 Aligned_cols=194 Identities=25% Similarity=0.270 Sum_probs=139.0
Q ss_pred cccCCCCCCccCCccCCCCCCCCEEeCCCCcccccCCccccCCCCCCEEEcccccccccCCCCcCCCCCCCEEEcccccc
Q 044366 2 LNLGFNLLFGNIPPQIGNLSKLQYLDLGNNQLSGVIPPEIGKLNQLRRLYLDVNQLHGTIPPVIGQLSLINELVFCHNNV 81 (918)
Q Consensus 2 l~~~~~~~~~~~p~~~~~l~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~~ 81 (918)
+++++++++ .+|+.+. +++++|+|++|++++..|..|..+++|++|+|++|++++ +|.. +.+++|++|++++|.+
T Consensus 15 l~~~~~~l~-~ip~~~~--~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~-~~l~~L~~L~Ls~N~l 89 (290)
T 1p9a_G 15 VNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTK-LQVD-GTLPVLGTLDLSHNQL 89 (290)
T ss_dssp EECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCE-EECC-SCCTTCCEEECCSSCC
T ss_pred EECCCCCCC-cCCCCCC--CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCc-ccCC-CCCCcCCEEECCCCcC
Confidence 678999998 7888765 799999999999998888999999999999999999984 3433 6677777777777777
Q ss_pred cccCCccccCCCCCCEEEccCCcccccCccccCCCCCCCEEECcCCcCCCcCCcCCCCCCCCceeeccccccccCCCccc
Q 044366 82 SGRIPSSLGNLSNLALLYLNDNSLFGSIPIVMGNLKSLSTLDLSQNQLNGSIPCSLDNLSNLDTLFLYKNSLSGPIPSVI 161 (918)
Q Consensus 82 ~~~~p~~l~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~ 161 (918)
+ .+|..+..+++|++|+|++|+|++..+..|.++++|++|+|++|++++..+..|.++++|++|+|++|+++++.++.|
T Consensus 90 ~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~ 168 (290)
T 1p9a_G 90 Q-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLL 168 (290)
T ss_dssp S-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTT
T ss_pred C-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECCCCcCCccCHHHh
Confidence 6 566666667777777777777766666666667777777777777665555556666666666666666665555556
Q ss_pred ccccccCeeeccccccCCcCCccCCCCCCCcEeeccCcccc
Q 044366 162 GNLKSLLQLDLSENRLSGLIPLSLSNLSSLTVMSLFNNSLS 202 (918)
Q Consensus 162 ~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 202 (918)
..+++|++|+|++|+++.+ |..+..+.+|+.|+|++|.+.
T Consensus 169 ~~l~~L~~L~L~~N~l~~i-p~~~~~~~~L~~l~L~~Np~~ 208 (290)
T 1p9a_G 169 NGLENLDTLLLQENSLYTI-PKGFFGSHLLPFAFLHGNPWL 208 (290)
T ss_dssp TTCTTCCEEECCSSCCCCC-CTTTTTTCCCSEEECCSCCBC
T ss_pred cCcCCCCEEECCCCcCCcc-ChhhcccccCCeEEeCCCCcc
Confidence 6666666666666666643 334444555666666666554
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.92 E-value=8.1e-25 Score=231.22 Aligned_cols=208 Identities=27% Similarity=0.343 Sum_probs=106.9
Q ss_pred CCCCCCCEEEcccccccccCCccccCCCCCCEEEccCCcccccCccccCCCCCCCEEECcCCcCCCcCCcCCCCCCCCce
Q 044366 66 GQLSLINELVFCHNNVSGRIPSSLGNLSNLALLYLNDNSLFGSIPIVMGNLKSLSTLDLSQNQLNGSIPCSLDNLSNLDT 145 (918)
Q Consensus 66 ~~l~~L~~L~l~~n~~~~~~p~~l~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~ 145 (918)
..+.+|++|++++|.++ .+ .++..+++|++|++++|++.+. ..+..+++|++|+|++|++++..+..+.++++|++
T Consensus 38 ~~l~~L~~L~l~~~~i~-~~-~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~ 113 (272)
T 3rfs_A 38 NELNSIDQIIANNSDIK-SV-QGIQYLPNVRYLALGGNKLHDI--SALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKE 113 (272)
T ss_dssp HHHTTCCEEECTTSCCC-CC-TTGGGCTTCCEEECTTSCCCCC--GGGTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCE
T ss_pred ccccceeeeeeCCCCcc-cc-cccccCCCCcEEECCCCCCCCc--hhhcCCCCCCEEECCCCccCccChhHhcCCcCCCE
Confidence 34455555555555544 12 2345555555555555555432 24455555555555555555444444555555555
Q ss_pred eeccccccccCCCcccccccccCeeeccccccCCcCCccCCCCCCCcEeeccCcccccCCCccccCCCCcceeecccccc
Q 044366 146 LFLYKNSLSGPIPSVIGNLKSLLQLDLSENRLSGLIPLSLSNLSSLTVMSLFNNSLSGSIPPILGNLKSLSTLGLHINQL 225 (918)
Q Consensus 146 L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l 225 (918)
|++++|++++..+..|+.+++|++|++++|+++++.+..|..+++|++|++++|++++..+..|..+++|++|++++|++
T Consensus 114 L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l 193 (272)
T 3rfs_A 114 LVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQL 193 (272)
T ss_dssp EECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCC
T ss_pred EECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEECCCCCcCccCHHHhcCCccCCEEECCCCcC
Confidence 55555555554444455555555555555555555444455555555555555555544444455555555555555555
Q ss_pred cCCCCCCCcCCCcCCeEEcccCcCcCCCCccccccCCCCeEecCCCccCCcCCCcCCCC
Q 044366 226 NGVIPPSIGNLSSLRNLSLFNNRLYGFVPKEIGYLKSLSKLEFCANHLSGVIPHSVGNL 284 (918)
Q Consensus 226 ~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l 284 (918)
++..+..+..+++|+.|++++|.+.+ .+++|+.|+++.|.+.+.+|..++.+
T Consensus 194 ~~~~~~~~~~l~~L~~L~l~~N~~~~-------~~~~l~~l~~~~n~~~g~ip~~~~~~ 245 (272)
T 3rfs_A 194 KSVPDGVFDRLTSLQYIWLHDNPWDC-------TCPGIRYLSEWINKHSGVVRNSAGSV 245 (272)
T ss_dssp SCCCTTTTTTCTTCCEEECCSSCBCC-------CTTTTHHHHHHHHHTGGGBBCTTSCB
T ss_pred CccCHHHHhCCcCCCEEEccCCCccc-------cCcHHHHHHHHHHhCCCcccCccccc
Confidence 55444445555555555555554442 13345555555555555555544443
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=6.1e-25 Score=253.59 Aligned_cols=187 Identities=16% Similarity=0.194 Sum_probs=146.1
Q ss_pred CCceeeccccceEEEEEEeCCCCEEEEEEcccccccCC----CCChHHHHHHHHHHhhccCCceeeEecccccCCceEEE
Q 044366 649 GEKYCIGKGGQRSVYKAELPSGNIFAVKKFKAELFSDE----TANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFIV 724 (918)
Q Consensus 649 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~----~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 724 (918)
...+.||+|+||.||+|.. .++.+|+|+......... ....+.|.+|++++++++||||+++..++...+..++|
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 4456899999999999954 678899998644221111 11134589999999999999999766666677788999
Q ss_pred EEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccCC
Q 044366 725 CEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEP 804 (918)
Q Consensus 725 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~~ 804 (918)
|||+++|+|.+++.. +..++.|+++||+|||+. +|+||||||+||+++. .+||+|||+++....
T Consensus 418 mE~~~ggsL~~~l~~-----------~~~i~~qi~~aL~~LH~~---gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~ 481 (540)
T 3en9_A 418 MSYINGKLAKDVIED-----------NLDIAYKIGEIVGKLHKN---DVIHNDLTTSNFIFDK--DLYIIDFGLGKISNL 481 (540)
T ss_dssp EECCCSEEHHHHSTT-----------CTHHHHHHHHHHHHHHHT---TEECTTCCTTSEEESS--SEEECCCTTCEECCC
T ss_pred EECCCCCCHHHHHHH-----------HHHHHHHHHHHHHHHHHC---cCccCCCCHHHEEECC--eEEEEECccCEECCC
Confidence 999999999999975 458999999999999999 9999999999999999 999999999998764
Q ss_pred CCCC-------ceeccccccccccccccc--CCCCcccchhhHHHHHHHHHhCCCCC
Q 044366 805 HSSN-------WTEFAGTVGYAAPELAYT--MRATEKYDVYSFGVLALEVIKGYHPG 852 (918)
Q Consensus 805 ~~~~-------~~~~~g~~~y~aPE~~~~--~~~~~~~Dv~slG~vl~el~tg~~p~ 852 (918)
.... .....||+.|||||++.. ..|+..+|+|+.++-..+.+.++.++
T Consensus 482 ~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 482 DEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp HHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred ccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 3221 135678999999999976 56788899999999888888776654
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.91 E-value=5.7e-24 Score=220.23 Aligned_cols=177 Identities=18% Similarity=0.238 Sum_probs=72.5
Q ss_pred CCEEEcccccccccCCccccCCCCCCEEEccCCc-ccccCccccCCCCCCCEEECcC-CcCCCcCCcCCCCCCCCceeec
Q 044366 71 INELVFCHNNVSGRIPSSLGNLSNLALLYLNDNS-LFGSIPIVMGNLKSLSTLDLSQ-NQLNGSIPCSLDNLSNLDTLFL 148 (918)
Q Consensus 71 L~~L~l~~n~~~~~~p~~l~~l~~L~~L~L~~n~-i~~~~~~~~~~l~~L~~L~Ls~-n~i~~~~~~~l~~l~~L~~L~L 148 (918)
|++|++++|++++..+..|.++++|++|++++|+ ++...+..|.++++|++|++++ |+++...+..|.++++|++|++
T Consensus 33 l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L~l 112 (239)
T 2xwt_C 33 TQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGI 112 (239)
T ss_dssp CCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEEEE
T ss_pred ccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEEeC
Confidence 3333333333333333334444444444444443 3333333444444444444444 4444333333444444444444
Q ss_pred cccccccCCCcccccccccC---eeecccc-ccCCcCCccCCCCCCCc-EeeccCcccccCCCccccCCCCcceeecccc
Q 044366 149 YKNSLSGPIPSVIGNLKSLL---QLDLSEN-RLSGLIPLSLSNLSSLT-VMSLFNNSLSGSIPPILGNLKSLSTLGLHIN 223 (918)
Q Consensus 149 ~~n~l~~~~~~~~~~l~~L~---~L~Ls~N-~l~~~~~~~~~~l~~L~-~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n 223 (918)
++|+++++ |+ |..+++|+ +|++++| +++++.+..|.++++|+ +|++++|+++.+.+..|.. ++|+.|++++|
T Consensus 113 ~~n~l~~l-p~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~~i~~~~~~~-~~L~~L~L~~n 189 (239)
T 2xwt_C 113 FNTGLKMF-PD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFTSVQGYAFNG-TKLDAVYLNKN 189 (239)
T ss_dssp EEECCCSC-CC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCCEECTTTTTT-CEEEEEECTTC
T ss_pred CCCCCccc-cc-cccccccccccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCcccCHhhcCC-CCCCEEEcCCC
Confidence 44444431 22 33333333 4444444 44444333444444444 4444444444322222322 34444444444
Q ss_pred c-ccCCCCCCCcCC-CcCCeEEcccCcCc
Q 044366 224 Q-LNGVIPPSIGNL-SSLRNLSLFNNRLY 250 (918)
Q Consensus 224 ~-l~~~~~~~~~~l-~~L~~L~Ls~n~l~ 250 (918)
+ ++.+.+..|.++ ++|+.|++++|+++
T Consensus 190 ~~l~~i~~~~~~~l~~~L~~L~l~~N~l~ 218 (239)
T 2xwt_C 190 KYLTVIDKDAFGGVYSGPSLLDVSQTSVT 218 (239)
T ss_dssp TTCCEECTTTTTTCSBCCSEEECTTCCCC
T ss_pred CCcccCCHHHhhccccCCcEEECCCCccc
Confidence 2 443333444444 44444444444444
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.90 E-value=3.3e-23 Score=216.07 Aligned_cols=182 Identities=27% Similarity=0.270 Sum_probs=158.7
Q ss_pred cceeeccccccccCCCcCcCCCCCCcEEEccCceeccccccchhhccccCceecccccccCCCCCCCCCCCcccEEeccC
Q 044366 359 LGTFNASMNNIYGSIPPEIGDSSKLQVLDLSSNHIFGKIPVQLVKLFSLNKLILSLNQLFGGVPLEFGTLTELQYLDLSA 438 (918)
Q Consensus 359 L~~l~l~~n~i~~~~~~~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~ 438 (918)
.+.++++++.+. .+|..+. ++++.|+|++|+|.+..+..|.++++|++|+|++|++++..+..|..+++|++|+|++
T Consensus 16 ~~~l~~~~~~l~-~~p~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~ 92 (251)
T 3m19_A 16 KKEVDCQGKSLD-SVPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLAN 92 (251)
T ss_dssp GTEEECTTCCCS-SCCSCCC--TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTT
T ss_pred CeEEecCCCCcc-ccCCCCC--CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEECCC
Confidence 345555655555 4555444 5889999999999988888899999999999999999988888899999999999999
Q ss_pred ccccccCccccccccccceecccCcccCCCCchhhccccccceEeccCCcCCCCCchhccccCCcceEecCCCcccccCc
Q 044366 439 NKLSSSIPMSIGNLLKLHYLNLSNNQFSHKIPTEFEKLIHLSELDLSHNILQEEIPPQICKMESLEKLNLSHNNLSDFIP 518 (918)
Q Consensus 439 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~ 518 (918)
|.|++..+..|..+++|++|+|++|+|++..+..|..+++|++|+|++|+|++..+..|..+++|+.|+|++|+++++.+
T Consensus 93 n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~ 172 (251)
T 3m19_A 93 NQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSVPH 172 (251)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCT
T ss_pred CcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCEEECCCCcCCccCH
Confidence 99998888888999999999999999998888889999999999999999998777789999999999999999999888
Q ss_pred ccccCCCCccEEEccCCcCCCCCCC
Q 044366 519 RCFEEMRSLSWIDISYNELQGPIPN 543 (918)
Q Consensus 519 ~~~~~l~~L~~l~l~~N~l~~~~p~ 543 (918)
..|..+++|+.|++++|+|+|..+.
T Consensus 173 ~~~~~l~~L~~L~l~~N~~~c~~~~ 197 (251)
T 3m19_A 173 GAFDRLGKLQTITLFGNQFDCSRCE 197 (251)
T ss_dssp TTTTTCTTCCEEECCSCCBCTTSTT
T ss_pred HHHhCCCCCCEEEeeCCceeCCccc
Confidence 8999999999999999999987443
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.90 E-value=2.1e-23 Score=216.01 Aligned_cols=196 Identities=18% Similarity=0.171 Sum_probs=138.8
Q ss_pred CCCEEEcccccccccCCCCcCCCCCCCEEEccccc-ccccCCccccCCCCCCEEEccC-CcccccCccccCCCCCCCEEE
Q 044366 46 QLRRLYLDVNQLHGTIPPVIGQLSLINELVFCHNN-VSGRIPSSLGNLSNLALLYLND-NSLFGSIPIVMGNLKSLSTLD 123 (918)
Q Consensus 46 ~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~-~~~~~p~~l~~l~~L~~L~L~~-n~i~~~~~~~~~~l~~L~~L~ 123 (918)
+|++|++++|++++..+..|..+++|++|++++|. ++...+..|.++++|++|++++ |+++...+..|.++++|++|+
T Consensus 32 ~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L~ 111 (239)
T 2xwt_C 32 STQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLG 111 (239)
T ss_dssp TCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEEE
T ss_pred cccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEEe
Confidence 67777777777764444466677777777777775 6655555677777777777776 777766666777777777777
Q ss_pred CcCCcCCCcCCcCCCCCCCCc---eeecccc-ccccCCCcccccccccC-eeeccccccCCcCCccCCCCCCCcEeeccC
Q 044366 124 LSQNQLNGSIPCSLDNLSNLD---TLFLYKN-SLSGPIPSVIGNLKSLL-QLDLSENRLSGLIPLSLSNLSSLTVMSLFN 198 (918)
Q Consensus 124 Ls~n~i~~~~~~~l~~l~~L~---~L~L~~n-~l~~~~~~~~~~l~~L~-~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~ 198 (918)
+++|++++ +|. +..+++|+ +|++++| +++++.+..|.++++|+ +|++++|+++.+.+..|.. ++|+.|++++
T Consensus 112 l~~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~~i~~~~~~~-~~L~~L~L~~ 188 (239)
T 2xwt_C 112 IFNTGLKM-FPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFTSVQGYAFNG-TKLDAVYLNK 188 (239)
T ss_dssp EEEECCCS-CCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCCEECTTTTTT-CEEEEEECTT
T ss_pred CCCCCCcc-ccc-cccccccccccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCcccCHhhcCC-CCCCEEEcCC
Confidence 77777774 454 66677776 7777777 77776666777777777 7777777777655555555 6778888888
Q ss_pred cc-cccCCCccccCC-CCcceeecccccccCCCCCCCcCCCcCCeEEcccC
Q 044366 199 NS-LSGSIPPILGNL-KSLSTLGLHINQLNGVIPPSIGNLSSLRNLSLFNN 247 (918)
Q Consensus 199 N~-l~~~~~~~~~~l-~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n 247 (918)
|+ ++.+.+..|.++ ++|+.|++++|+++.+.+. .+++|+.|+++++
T Consensus 189 n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~~l~~~---~~~~L~~L~l~~~ 236 (239)
T 2xwt_C 189 NKYLTVIDKDAFGGVYSGPSLLDVSQTSVTALPSK---GLEHLKELIARNT 236 (239)
T ss_dssp CTTCCEECTTTTTTCSBCCSEEECTTCCCCCCCCT---TCTTCSEEECTTC
T ss_pred CCCcccCCHHHhhccccCCcEEECCCCccccCChh---HhccCceeeccCc
Confidence 84 776666777777 7888888888888754433 4667778877765
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.90 E-value=1.5e-25 Score=247.46 Aligned_cols=252 Identities=19% Similarity=0.158 Sum_probs=179.9
Q ss_pred CcccCCCCCCccCCccCCCCCCCCEEeCCCCcccccCC----ccccCCC-CCCEEEcccccccccCCCCcCCC-----CC
Q 044366 1 MLNLGFNLLFGNIPPQIGNLSKLQYLDLGNNQLSGVIP----PEIGKLN-QLRRLYLDVNQLHGTIPPVIGQL-----SL 70 (918)
Q Consensus 1 ~l~~~~~~~~~~~p~~~~~l~~L~~L~L~~n~i~~~~p----~~l~~l~-~L~~L~L~~n~l~~~~p~~~~~l-----~~ 70 (918)
+++|++|.++|.+|+.+...++|++|||++|++++..+ ..+..++ +|++|+|++|++++..+..+..+ ++
T Consensus 2 ~~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~ 81 (362)
T 3goz_A 2 NYKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPAN 81 (362)
T ss_dssp EEECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTT
T ss_pred ccccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCC
Confidence 36789999999999888888889999999999986666 7788898 89999999999997767777765 88
Q ss_pred CCEEEcccccccccCCccccC----C-CCCCEEEccCCcccccCccccC----C-CCCCCEEECcCCcCCCcC----CcC
Q 044366 71 INELVFCHNNVSGRIPSSLGN----L-SNLALLYLNDNSLFGSIPIVMG----N-LKSLSTLDLSQNQLNGSI----PCS 136 (918)
Q Consensus 71 L~~L~l~~n~~~~~~p~~l~~----l-~~L~~L~L~~n~i~~~~~~~~~----~-l~~L~~L~Ls~n~i~~~~----~~~ 136 (918)
|++|++++|.+++..+..+.. + ++|++|+|++|++++..+..+. . .++|++|+|++|++++.. +..
T Consensus 82 L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~ 161 (362)
T 3goz_A 82 VTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQI 161 (362)
T ss_dssp CCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHHHHH
T ss_pred ccEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHHHHH
Confidence 999999999988766664443 3 7899999999988876665443 3 358888888888887533 233
Q ss_pred CCCCC-CCceeeccccccccCCCccccc----c-cccCeeeccccccCCcC----CccCCC-CCCCcEeeccCcccccCC
Q 044366 137 LDNLS-NLDTLFLYKNSLSGPIPSVIGN----L-KSLLQLDLSENRLSGLI----PLSLSN-LSSLTVMSLFNNSLSGSI 205 (918)
Q Consensus 137 l~~l~-~L~~L~L~~n~l~~~~~~~~~~----l-~~L~~L~Ls~N~l~~~~----~~~~~~-l~~L~~L~L~~N~l~~~~ 205 (918)
+..++ +|++|+|++|++++..+..+.. + ++|++|+|++|.+++.. +..+.. .++|++|+|++|.+++..
T Consensus 162 l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~i~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~ 241 (362)
T 3goz_A 162 LAAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPS 241 (362)
T ss_dssp HHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHHSCTTCCEEECCSSCCCCCC
T ss_pred HhcCCccccEeeecCCCCchhhHHHHHHHHHhCCCCCCEEECCCCCCChhHHHHHHHHHhcCCCCceEEECcCCCCCcHH
Confidence 34454 7888888888887666554443 3 58888888888877532 233433 347777888877776543
Q ss_pred C----ccccCCCCcceeecccccccCCCC-------CCCcCCCcCCeEEcccCcCcCC
Q 044366 206 P----PILGNLKSLSTLGLHINQLNGVIP-------PSIGNLSSLRNLSLFNNRLYGF 252 (918)
Q Consensus 206 ~----~~~~~l~~L~~L~L~~n~l~~~~~-------~~~~~l~~L~~L~Ls~n~l~~~ 252 (918)
+ ..+..+++|+.|+|++|.+..+.+ ..+..+++|+.|++++|++...
T Consensus 242 ~~~l~~~~~~l~~L~~L~L~~n~l~~i~~~~~~~l~~~~~~l~~L~~LdL~~N~l~~~ 299 (362)
T 3goz_A 242 LENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPS 299 (362)
T ss_dssp HHHHHHTTTTTTTCSEEEEEHHHHTTCCHHHHHHHHTTSTTCCEEEEECTTSCBCCGG
T ss_pred HHHHHHHHhcCCCccEEEeccCCccccCHHHHHHHHHHhccCCceEEEecCCCcCCCc
Confidence 3 234556677777777776443222 2345555666666666666543
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.90 E-value=9.9e-25 Score=240.90 Aligned_cols=251 Identities=20% Similarity=0.220 Sum_probs=166.0
Q ss_pred EecCCCccCCcCCCcCCCCCCCcEEEccCCcCcCCCC----ccccCCC-CCCeEEeecccccCccccccCCC-----CCc
Q 044366 266 LEFCANHLSGVIPHSVGNLTGLVLLNMCENHLFGPIP----KSLRNLT-SLERVRFNQNNLYGKVYEAFGDH-----PNL 335 (918)
Q Consensus 266 L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~----~~l~~l~-~L~~L~l~~n~l~~~~~~~~~~l-----~~L 335 (918)
++++.|.+++.+|..+...++|+.|++++|.+.+..+ ..+.+++ +|++|++++|.+.......+..+ ++|
T Consensus 3 ~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L 82 (362)
T 3goz_A 3 YKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANV 82 (362)
T ss_dssp EECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTC
T ss_pred cccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCCc
Confidence 4566666666655555555556666666666665555 5555555 56666666666655554444433 555
Q ss_pred cEEeCCCCccccccCcccccccccceeeccccccccCCCcC----cCCC-CCCcEEEccCceeccccccchhhc-----c
Q 044366 336 TFLDLSQNNFYCEISFNWRNFSKLGTFNASMNNIYGSIPPE----IGDS-SKLQVLDLSSNHIFGKIPVQLVKL-----F 405 (918)
Q Consensus 336 ~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~n~i~~~~~~~----~~~~-~~L~~L~L~~N~l~~~~~~~~~~l-----~ 405 (918)
++|+|++|.++ +..+.. +..+ ++|++|+|++|+|++..+..+... .
T Consensus 83 ~~L~Ls~n~l~------------------------~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~ 138 (362)
T 3goz_A 83 TSLNLSGNFLS------------------------YKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPA 138 (362)
T ss_dssp CEEECCSSCGG------------------------GSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCT
T ss_pred cEEECcCCcCC------------------------hHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCC
Confidence 55555555554 333332 3333 677777777777776665555442 4
Q ss_pred ccCceecccccccCCCCCC----CCCCC-cccEEeccCccccccCcccccc----c-cccceecccCcccCCC----Cch
Q 044366 406 SLNKLILSLNQLFGGVPLE----FGTLT-ELQYLDLSANKLSSSIPMSIGN----L-LKLHYLNLSNNQFSHK----IPT 471 (918)
Q Consensus 406 ~L~~L~L~~N~l~~~~~~~----~~~l~-~L~~L~Ls~N~l~~~~~~~~~~----l-~~L~~L~Ls~N~l~~~----~~~ 471 (918)
+|++|+|++|++++..... +..++ +|++|+|++|.|++..+..+.. + ++|+.|+|++|+|++. ++.
T Consensus 139 ~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~i~~~~~~~l~~ 218 (362)
T 3goz_A 139 SITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAY 218 (362)
T ss_dssp TCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHH
T ss_pred ceeEEEccCCcCCHHHHHHHHHHHhcCCccccEeeecCCCCchhhHHHHHHHHHhCCCCCCEEECCCCCCChhHHHHHHH
Confidence 7888888888776543322 33444 8999999999998766655543 3 5899999999998764 344
Q ss_pred hhccc-cccceEeccCCcCCCCCch----hccccCCcceEecCCCcccccC-------cccccCCCCccEEEccCCcCCC
Q 044366 472 EFEKL-IHLSELDLSHNILQEEIPP----QICKMESLEKLNLSHNNLSDFI-------PRCFEEMRSLSWIDISYNELQG 539 (918)
Q Consensus 472 ~~~~l-~~L~~L~Ls~N~l~~~~~~----~~~~l~~L~~L~L~~N~l~~~~-------~~~~~~l~~L~~l~l~~N~l~~ 539 (918)
.+..+ ++|++|||++|+|++..+. .+..+++|+.|+|++|++.++. +..+..+++|+.||+++|++.+
T Consensus 219 ~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~~~~l~~L~~L~L~~n~l~~i~~~~~~~l~~~~~~l~~L~~LdL~~N~l~~ 298 (362)
T 3goz_A 219 IFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHP 298 (362)
T ss_dssp HHHHSCTTCCEEECCSSCCCCCCHHHHHHTTTTTTTCSEEEEEHHHHTTCCHHHHHHHHTTSTTCCEEEEECTTSCBCCG
T ss_pred HHhcCCCCceEEECcCCCCCcHHHHHHHHHHhcCCCccEEEeccCCccccCHHHHHHHHHHhccCCceEEEecCCCcCCC
Confidence 55553 5899999999999876553 3466788999999999865543 3467788899999999999886
Q ss_pred C
Q 044366 540 P 540 (918)
Q Consensus 540 ~ 540 (918)
.
T Consensus 299 ~ 299 (362)
T 3goz_A 299 S 299 (362)
T ss_dssp G
T ss_pred c
Confidence 5
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.89 E-value=3.3e-23 Score=223.47 Aligned_cols=179 Identities=20% Similarity=0.204 Sum_probs=82.5
Q ss_pred CCCCEEEcccccccccCCccc--cCCCCCCEEEccCCcccccCc----cccCCCCCCCEEECcCCcCCCcCCcCCCCCCC
Q 044366 69 SLINELVFCHNNVSGRIPSSL--GNLSNLALLYLNDNSLFGSIP----IVMGNLKSLSTLDLSQNQLNGSIPCSLDNLSN 142 (918)
Q Consensus 69 ~~L~~L~l~~n~~~~~~p~~l--~~l~~L~~L~L~~n~i~~~~~----~~~~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~ 142 (918)
++|++|++++|.+.+..|..+ ..+++|++|+|++|++.+..+ ..+..+++|++|+|++|++++..+..++++++
T Consensus 91 ~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~ 170 (310)
T 4glp_A 91 SRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAHSPAFSCEQVRAFPA 170 (310)
T ss_dssp SCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBCSCCCEEEEECCSSCCCCTTSCCCCTT
T ss_pred CceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhccCCCEEEeeCCCcchhhHHHhccCCC
Confidence 345555555555555555555 555555555555555554322 22334555555555555555444455555555
Q ss_pred Cceeecccccccc---CC-CcccccccccCeeeccccccCCcCCc---cCCCCCCCcEeeccCcccccCCCccccCC---
Q 044366 143 LDTLFLYKNSLSG---PI-PSVIGNLKSLLQLDLSENRLSGLIPL---SLSNLSSLTVMSLFNNSLSGSIPPILGNL--- 212 (918)
Q Consensus 143 L~~L~L~~n~l~~---~~-~~~~~~l~~L~~L~Ls~N~l~~~~~~---~~~~l~~L~~L~L~~N~l~~~~~~~~~~l--- 212 (918)
|++|+|++|++.+ .. +..+..+++|++|+|++|+++.+.+. .+..+++|++|+|++|++++..|..+..+
T Consensus 171 L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~ 250 (310)
T 4glp_A 171 LTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGMETPTGVCAALAAAGVQPHSLDLSHNSLRATVNPSAPRCMWS 250 (310)
T ss_dssp CCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCCCHHHHHHHHHHHTCCCSSEECTTSCCCCCCCSCCSSCCCC
T ss_pred CCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCCchHHHHHHHHhcCCCCCEEECCCCCCCccchhhHHhccCc
Confidence 5555555555432 11 11224445555555555555432111 12344444444444444444434333333
Q ss_pred CCcceeecccccccCCCCCCCcCCCcCCeEEcccCcCc
Q 044366 213 KSLSTLGLHINQLNGVIPPSIGNLSSLRNLSLFNNRLY 250 (918)
Q Consensus 213 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~ 250 (918)
++|++|+|++|+++. +|..+. ++|+.|+|++|+++
T Consensus 251 ~~L~~L~Ls~N~l~~-lp~~~~--~~L~~L~Ls~N~l~ 285 (310)
T 4glp_A 251 SALNSLNLSFAGLEQ-VPKGLP--AKLRVLDLSSNRLN 285 (310)
T ss_dssp TTCCCEECCSSCCCS-CCSCCC--SCCSCEECCSCCCC
T ss_pred CcCCEEECCCCCCCc-hhhhhc--CCCCEEECCCCcCC
Confidence 344444444444442 222221 34444444444444
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.89 E-value=1.8e-23 Score=225.51 Aligned_cols=226 Identities=21% Similarity=0.235 Sum_probs=187.9
Q ss_pred CCCCEEeCCCCcccccCCc---cccCCCCCCEEEcccccccccCCCCc--CCCCCCCEEEcccccccccCC----ccccC
Q 044366 21 SKLQYLDLGNNQLSGVIPP---EIGKLNQLRRLYLDVNQLHGTIPPVI--GQLSLINELVFCHNNVSGRIP----SSLGN 91 (918)
Q Consensus 21 ~~L~~L~L~~n~i~~~~p~---~l~~l~~L~~L~L~~n~l~~~~p~~~--~~l~~L~~L~l~~n~~~~~~p----~~l~~ 91 (918)
..++.|.+.++.+....-. .+..+++|++|++++|++++..|..+ ..+++|++|++++|.+++..+ ..+..
T Consensus 64 ~~l~~l~l~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~ 143 (310)
T 4glp_A 64 LRVRRLTVGAAQVPAQLLVGALRVLAYSRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWL 143 (310)
T ss_dssp CCCCEEEECSCCCBHHHHHHHHHHHHHSCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTB
T ss_pred cceeEEEEeCCcCCHHHHHHHHHhcccCceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhh
Confidence 3478889988887532111 12345779999999999999999988 999999999999999997555 44567
Q ss_pred CCCCCEEEccCCcccccCccccCCCCCCCEEECcCCcCCCc--C--CcCCCCCCCCceeeccccccccCCCc---ccccc
Q 044366 92 LSNLALLYLNDNSLFGSIPIVMGNLKSLSTLDLSQNQLNGS--I--PCSLDNLSNLDTLFLYKNSLSGPIPS---VIGNL 164 (918)
Q Consensus 92 l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~--~--~~~l~~l~~L~~L~L~~n~l~~~~~~---~~~~l 164 (918)
+++|++|+|++|++.+..+..|..+++|++|+|++|++.+. + +..+..+++|++|+|++|+++..... .++.+
T Consensus 144 ~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~l~~~l 223 (310)
T 4glp_A 144 KPGLKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGMETPTGVCAALAAAG 223 (310)
T ss_dssp CSCCCEEEEECCSSCCCCTTSCCCCTTCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCCCHHHHHHHHHHHT
T ss_pred ccCCCEEEeeCCCcchhhHHHhccCCCCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCCchHHHHHHHHhcC
Confidence 99999999999999988889999999999999999998752 2 33457899999999999999743221 35788
Q ss_pred cccCeeeccccccCCcCCccCCCC---CCCcEeeccCcccccCCCccccCCCCcceeecccccccCCCCCCCcCCCcCCe
Q 044366 165 KSLLQLDLSENRLSGLIPLSLSNL---SSLTVMSLFNNSLSGSIPPILGNLKSLSTLGLHINQLNGVIPPSIGNLSSLRN 241 (918)
Q Consensus 165 ~~L~~L~Ls~N~l~~~~~~~~~~l---~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~ 241 (918)
++|++|+|++|++++..|..+..+ ++|++|+|++|+++ .+|..+. ++|++|+|++|+++++ | .+..+++|+.
T Consensus 224 ~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~~--~~L~~L~Ls~N~l~~~-~-~~~~l~~L~~ 298 (310)
T 4glp_A 224 VQPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLE-QVPKGLP--AKLRVLDLSSNRLNRA-P-QPDELPEVDN 298 (310)
T ss_dssp CCCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCC-SCCSCCC--SCCSCEECCSCCCCSC-C-CTTSCCCCSC
T ss_pred CCCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCC-chhhhhc--CCCCEEECCCCcCCCC-c-hhhhCCCccE
Confidence 999999999999999878777776 69999999999999 4566664 7999999999999975 3 3688899999
Q ss_pred EEcccCcCcC
Q 044366 242 LSLFNNRLYG 251 (918)
Q Consensus 242 L~Ls~n~l~~ 251 (918)
|++++|++++
T Consensus 299 L~L~~N~l~~ 308 (310)
T 4glp_A 299 LTLDGNPFLV 308 (310)
T ss_dssp EECSSTTTSC
T ss_pred EECcCCCCCC
Confidence 9999999874
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.89 E-value=8.6e-23 Score=219.56 Aligned_cols=209 Identities=28% Similarity=0.387 Sum_probs=138.3
Q ss_pred EeCCCCcccccCCccccCCCCCCEEEcccccccccCCCCcCCCCCCCEEEcccccccccCCccccCCCCCCEEEccCCcc
Q 044366 26 LDLGNNQLSGVIPPEIGKLNQLRRLYLDVNQLHGTIPPVIGQLSLINELVFCHNNVSGRIPSSLGNLSNLALLYLNDNSL 105 (918)
Q Consensus 26 L~L~~n~i~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~l~~l~~L~~L~L~~n~i 105 (918)
+.+..+.+++.. .+..+++|++|++++|.++ .+| .+..+++|++|++++|.+++. +. +..+++|++|+|++|++
T Consensus 24 ~~l~~~~~~~~~--~~~~l~~L~~L~l~~~~i~-~l~-~~~~l~~L~~L~L~~n~i~~~-~~-~~~l~~L~~L~L~~n~l 97 (308)
T 1h6u_A 24 IAAGKSNVTDTV--TQADLDGITTLSAFGTGVT-TIE-GVQYLNNLIGLELKDNQITDL-AP-LKNLTKITELELSGNPL 97 (308)
T ss_dssp HHTTCSSTTSEE--CHHHHHTCCEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCC-GG-GTTCCSCCEEECCSCCC
T ss_pred HHhCCCCcCcee--cHHHcCCcCEEEeeCCCcc-Cch-hhhccCCCCEEEccCCcCCCC-hh-HccCCCCCEEEccCCcC
Confidence 344445544321 2445666666666666665 344 456666666666666666533 33 66677777777777776
Q ss_pred cccCccccCCCCCCCEEECcCCcCCCcCCcCCCCCCCCceeeccccccccCCCcccccccccCeeeccccccCCcCCccC
Q 044366 106 FGSIPIVMGNLKSLSTLDLSQNQLNGSIPCSLDNLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSENRLSGLIPLSL 185 (918)
Q Consensus 106 ~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~ 185 (918)
.+. + .+..+++|++|++++|++++. + .+.++++|++|++++|++++..+ ++.+++|++|++++|+++++.+ +
T Consensus 98 ~~~-~-~~~~l~~L~~L~l~~n~l~~~-~-~l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~~~--l 169 (308)
T 1h6u_A 98 KNV-S-AIAGLQSIKTLDLTSTQITDV-T-PLAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSDLTP--L 169 (308)
T ss_dssp SCC-G-GGTTCTTCCEEECTTSCCCCC-G-GGTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--G
T ss_pred CCc-h-hhcCCCCCCEEECCCCCCCCc-h-hhcCCCCCCEEECCCCccCcCcc--ccCCCCccEEEccCCcCCCChh--h
Confidence 543 2 566777777777777777643 2 26777777777777777775533 7777777777777777776544 7
Q ss_pred CCCCCCcEeeccCcccccCCCccccCCCCcceeecccccccCCCCCCCcCCCcCCeEEcccCcCcCC
Q 044366 186 SNLSSLTVMSLFNNSLSGSIPPILGNLKSLSTLGLHINQLNGVIPPSIGNLSSLRNLSLFNNRLYGF 252 (918)
Q Consensus 186 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~ 252 (918)
..+++|+.|++++|++++..+ +..+++|++|++++|++++.. .+..+++|+.|++++|++++.
T Consensus 170 ~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~L~~N~l~~~~--~l~~l~~L~~L~l~~N~i~~~ 232 (308)
T 1h6u_A 170 ANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVS--PLANTSNLFIVTLTNQTITNQ 232 (308)
T ss_dssp TTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECTTSCCCBCG--GGTTCTTCCEEEEEEEEEECC
T ss_pred cCCCCCCEEECCCCccCcChh--hcCCCCCCEEEccCCccCccc--cccCCCCCCEEEccCCeeecC
Confidence 777778888888887775433 777788888888888887654 367778888888888888753
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.89 E-value=9e-23 Score=219.42 Aligned_cols=192 Identities=27% Similarity=0.385 Sum_probs=90.2
Q ss_pred CCCCCCEEEcccccccccCCccccCCCCCCEEEccCCcccccCccccCCCCCCCEEECcCCcCCCcCCcCCCCCCCCcee
Q 044366 67 QLSLINELVFCHNNVSGRIPSSLGNLSNLALLYLNDNSLFGSIPIVMGNLKSLSTLDLSQNQLNGSIPCSLDNLSNLDTL 146 (918)
Q Consensus 67 ~l~~L~~L~l~~n~~~~~~p~~l~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L 146 (918)
.+.+|++|++++|.++ .+| .+..+++|++|+|++|++.+..+ +..+++|++|+|++|++++. ..+..+++|++|
T Consensus 39 ~l~~L~~L~l~~~~i~-~l~-~~~~l~~L~~L~L~~n~i~~~~~--~~~l~~L~~L~L~~n~l~~~--~~~~~l~~L~~L 112 (308)
T 1h6u_A 39 DLDGITTLSAFGTGVT-TIE-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLKNV--SAIAGLQSIKTL 112 (308)
T ss_dssp HHHTCCEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCSCC--GGGTTCTTCCEE
T ss_pred HcCCcCEEEeeCCCcc-Cch-hhhccCCCCEEEccCCcCCCChh--HccCCCCCEEEccCCcCCCc--hhhcCCCCCCEE
Confidence 3444555555555444 222 34445555555555555443222 44455555555555554432 234445555555
Q ss_pred eccccccccCCCcccccccccCeeeccccccCCcCCccCCCCCCCcEeeccCcccccCCCccccCCCCcceeeccccccc
Q 044366 147 FLYKNSLSGPIPSVIGNLKSLLQLDLSENRLSGLIPLSLSNLSSLTVMSLFNNSLSGSIPPILGNLKSLSTLGLHINQLN 226 (918)
Q Consensus 147 ~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~ 226 (918)
++++|+++++. .+..+++|++|++++|+++++.+ +..+++|++|++++|++++..+ +..+++|+.|++++|+++
T Consensus 113 ~l~~n~l~~~~--~l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~ 186 (308)
T 1h6u_A 113 DLTSTQITDVT--PLAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSDLTP--LANLSKLTTLKADDNKIS 186 (308)
T ss_dssp ECTTSCCCCCG--GGTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCC
T ss_pred ECCCCCCCCch--hhcCCCCCCEEECCCCccCcCcc--ccCCCCccEEEccCCcCCCChh--hcCCCCCCEEECCCCccC
Confidence 55555554331 24445555555555555544322 4444555555555555543222 444555555555555554
Q ss_pred CCCCCCCcCCCcCCeEEcccCcCcCCCCccccccCCCCeEecCCCccC
Q 044366 227 GVIPPSIGNLSSLRNLSLFNNRLYGFVPKEIGYLKSLSKLEFCANHLS 274 (918)
Q Consensus 227 ~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~ 274 (918)
+..+ +..+++|++|++++|++++.. .+..+++|+.|++++|++.
T Consensus 187 ~~~~--l~~l~~L~~L~L~~N~l~~~~--~l~~l~~L~~L~l~~N~i~ 230 (308)
T 1h6u_A 187 DISP--LASLPNLIEVHLKNNQISDVS--PLANTSNLFIVTLTNQTIT 230 (308)
T ss_dssp CCGG--GGGCTTCCEEECTTSCCCBCG--GGTTCTTCCEEEEEEEEEE
T ss_pred cChh--hcCCCCCCEEEccCCccCccc--cccCCCCCCEEEccCCeee
Confidence 3322 444455555555555554332 2444455555555555544
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.89 E-value=1.2e-22 Score=222.97 Aligned_cols=240 Identities=16% Similarity=0.132 Sum_probs=118.2
Q ss_pred CEEeCCCCcccccCCccccCCCCCCEEEcccccccccCCCCcCCCCCCCEEEcccccccccCC-ccccCCCCCCE-EEcc
Q 044366 24 QYLDLGNNQLSGVIPPEIGKLNQLRRLYLDVNQLHGTIPPVIGQLSLINELVFCHNNVSGRIP-SSLGNLSNLAL-LYLN 101 (918)
Q Consensus 24 ~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p-~~l~~l~~L~~-L~L~ 101 (918)
+.++.++++++ .+|..+ .+++++|+|++|+|+...+..|.++++|++|++++|.+.+.+| ..|.++++|++ +.++
T Consensus 12 ~~v~C~~~~Lt-~iP~~l--~~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~ 88 (350)
T 4ay9_X 12 RVFLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEK 88 (350)
T ss_dssp TEEEEESTTCC-SCCTTC--CTTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEE
T ss_pred CEEEecCCCCC-ccCcCc--CCCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhccc
Confidence 34455555555 445444 2445555555555552222345555555555555555543333 34555555443 3344
Q ss_pred CCcccccCccccCCCCCCCEEECcCCcCCCcCCcCCCCCCCCceeeccc-cccccCCCccccccc-ccCeeeccccccCC
Q 044366 102 DNSLFGSIPIVMGNLKSLSTLDLSQNQLNGSIPCSLDNLSNLDTLFLYK-NSLSGPIPSVIGNLK-SLLQLDLSENRLSG 179 (918)
Q Consensus 102 ~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~-n~l~~~~~~~~~~l~-~L~~L~Ls~N~l~~ 179 (918)
.|++....|+.|..+++|++|++++|+++...+..+....++..|++.+ +++..+.+..|..+. .++.|+|++|+|+.
T Consensus 89 ~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~~~~l~~L~L~~N~i~~ 168 (350)
T 4ay9_X 89 ANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQE 168 (350)
T ss_dssp ETTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCCE
T ss_pred CCcccccCchhhhhccccccccccccccccCCchhhcccchhhhhhhccccccccccccchhhcchhhhhhccccccccC
Confidence 4555555555555555555555555555544444444444555555533 445544444554443 35555566665554
Q ss_pred cCCccCCCCCCCcEeecc-CcccccCCCccccCCCCcceeecccccccCCCCCCCcCCCcCCeEEcccCcCcCCCCcccc
Q 044366 180 LIPLSLSNLSSLTVMSLF-NNSLSGSIPPILGNLKSLSTLGLHINQLNGVIPPSIGNLSSLRNLSLFNNRLYGFVPKEIG 258 (918)
Q Consensus 180 ~~~~~~~~l~~L~~L~L~-~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~ 258 (918)
+.+..|. ..+|++|+++ +|.++.+.+++|.++++|++|+|++|+|+.+++..|.++++|+.+++ +.+. ..| .+.
T Consensus 169 i~~~~f~-~~~L~~l~l~~~n~l~~i~~~~f~~l~~L~~LdLs~N~l~~lp~~~~~~L~~L~~l~~--~~l~-~lP-~l~ 243 (350)
T 4ay9_X 169 IHNSAFN-GTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARST--YNLK-KLP-TLE 243 (350)
T ss_dssp ECTTSST-TEEEEEEECTTCTTCCCCCTTTTTTEECCSEEECTTSCCCCCCSSSCTTCCEEECTTC--TTCC-CCC-CTT
T ss_pred CChhhcc-ccchhHHhhccCCcccCCCHHHhccCcccchhhcCCCCcCccChhhhccchHhhhccC--CCcC-cCC-Cch
Confidence 4443332 3445555554 34455444445555666666666666665444333333332222222 1232 222 245
Q ss_pred ccCCCCeEecCCC
Q 044366 259 YLKSLSKLEFCAN 271 (918)
Q Consensus 259 ~l~~L~~L~l~~n 271 (918)
.+++|+.+++.++
T Consensus 244 ~l~~L~~l~l~~~ 256 (350)
T 4ay9_X 244 KLVALMEASLTYP 256 (350)
T ss_dssp TCCSCCEEECSCH
T ss_pred hCcChhhCcCCCC
Confidence 5566666666543
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.88 E-value=3.9e-22 Score=207.91 Aligned_cols=178 Identities=24% Similarity=0.274 Sum_probs=104.7
Q ss_pred CCCEEeCCCCcccccCCccccCCCCCCEEEcccccccccCCCCcCCCCCCCEEEcccccccccCCccccCCCCCCEEEcc
Q 044366 22 KLQYLDLGNNQLSGVIPPEIGKLNQLRRLYLDVNQLHGTIPPVIGQLSLINELVFCHNNVSGRIPSSLGNLSNLALLYLN 101 (918)
Q Consensus 22 ~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~l~~l~~L~~L~L~ 101 (918)
..+++++++++++ .+|..+. ++|++|+|++|++++..|..|..+++|++|++++|.+++..|..|..+++|++|+|+
T Consensus 15 ~~~~l~~~~~~l~-~~p~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 91 (251)
T 3m19_A 15 GKKEVDCQGKSLD-SVPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLA 91 (251)
T ss_dssp GGTEEECTTCCCS-SCCSCCC--TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECT
T ss_pred CCeEEecCCCCcc-ccCCCCC--CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEECC
Confidence 4566777777776 5665554 466677777766665555556666666666666666665555555666666666666
Q ss_pred CCcccccCccccCCCCCCCEEECcCCcCCCcCCcCCCCCCCCceeeccccccccCCCcccccccccCeeeccccccCCcC
Q 044366 102 DNSLFGSIPIVMGNLKSLSTLDLSQNQLNGSIPCSLDNLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSENRLSGLI 181 (918)
Q Consensus 102 ~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~ 181 (918)
+|++++..+..|..+++|++|+|++|+|++..+..|.++++|++|+|++|+++++.+..|+.+++|++|+|++|+++++.
T Consensus 92 ~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 171 (251)
T 3m19_A 92 NNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSVP 171 (251)
T ss_dssp TSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCC
T ss_pred CCcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCEEECCCCcCCccC
Confidence 66665555555555666666666666665444444555555555555555555555545555555555555555555555
Q ss_pred CccCCCCCCCcEeeccCcccc
Q 044366 182 PLSLSNLSSLTVMSLFNNSLS 202 (918)
Q Consensus 182 ~~~~~~l~~L~~L~L~~N~l~ 202 (918)
+..|..+++|+.|+|++|.++
T Consensus 172 ~~~~~~l~~L~~L~l~~N~~~ 192 (251)
T 3m19_A 172 HGAFDRLGKLQTITLFGNQFD 192 (251)
T ss_dssp TTTTTTCTTCCEEECCSCCBC
T ss_pred HHHHhCCCCCCEEEeeCCcee
Confidence 555555555555555555554
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.88 E-value=2.5e-24 Score=235.57 Aligned_cols=254 Identities=19% Similarity=0.224 Sum_probs=194.3
Q ss_pred CCCEEeCCCCcccccCCccccCC--CCCCEEEcccccccccCCCCcCCCCCCCEEEccccccccc-CCccccCCCCCCEE
Q 044366 22 KLQYLDLGNNQLSGVIPPEIGKL--NQLRRLYLDVNQLHGTIPPVIGQLSLINELVFCHNNVSGR-IPSSLGNLSNLALL 98 (918)
Q Consensus 22 ~L~~L~L~~n~i~~~~p~~l~~l--~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~-~p~~l~~l~~L~~L 98 (918)
.++.||++++++. |..+..+ ++++.|++++|.+.+..+ .+..+++|++|++++|.+++. +|..+..+++|++|
T Consensus 48 ~~~~l~l~~~~~~---~~~~~~~~~~~l~~L~l~~n~l~~~~~-~~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L 123 (336)
T 2ast_B 48 LWQTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLA-EHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNL 123 (336)
T ss_dssp TSSEEECTTCBCC---HHHHHHHHHTTCSEEECTTCEECSCCC-SCCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEE
T ss_pred hheeeccccccCC---HHHHHhhhhccceEEEcCCccccccch-hhccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEE
Confidence 4788888888876 4567777 888888888888885444 466788888888888888765 77778888889999
Q ss_pred EccCCcccccCccccCCCCCCCEEECcCC-cCCCc-CCcCCCCCCCCceeecccc-ccccC-CCccccccc-ccCeeecc
Q 044366 99 YLNDNSLFGSIPIVMGNLKSLSTLDLSQN-QLNGS-IPCSLDNLSNLDTLFLYKN-SLSGP-IPSVIGNLK-SLLQLDLS 173 (918)
Q Consensus 99 ~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n-~i~~~-~~~~l~~l~~L~~L~L~~n-~l~~~-~~~~~~~l~-~L~~L~Ls 173 (918)
+|++|.+++..+..+..+++|++|+|++| .+++. ++..+.++++|++|++++| .+++. .+..+..++ +|++|+++
T Consensus 124 ~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l~ 203 (336)
T 2ast_B 124 SLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLS 203 (336)
T ss_dssp ECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECC
T ss_pred eCcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChHHHHHHHHhcccCCCEEEeC
Confidence 99988888777888888888999999888 67652 5556778888999999888 88753 456678888 89999999
Q ss_pred ccc--cC-CcCCccCCCCCCCcEeeccCcc-cccCCCccccCCCCcceeeccccc-ccCCCCCCCcCCCcCCeEEcccCc
Q 044366 174 ENR--LS-GLIPLSLSNLSSLTVMSLFNNS-LSGSIPPILGNLKSLSTLGLHINQ-LNGVIPPSIGNLSSLRNLSLFNNR 248 (918)
Q Consensus 174 ~N~--l~-~~~~~~~~~l~~L~~L~L~~N~-l~~~~~~~~~~l~~L~~L~L~~n~-l~~~~~~~~~~l~~L~~L~Ls~n~ 248 (918)
+|. ++ ...+..+..+++|++|++++|. +++..+..+..+++|++|++++|. +.......+..+++|+.|++++|
T Consensus 204 ~~~~~~~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~l~~l~~L~~L~l~~~~~~~~~~~~~l~~~~~L~~L~l~~~- 282 (336)
T 2ast_B 204 GYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI- 282 (336)
T ss_dssp SCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS-
T ss_pred CCcccCCHHHHHHHHhhCCCCCEEeCCCCCcCCHHHHHHHhCCCCCCEeeCCCCCCCCHHHHHHHhcCCCCCEEeccCc-
Confidence 884 44 2345566778889999999988 666667788888999999998885 33222225778889999999988
Q ss_pred CcCCCCcccccc-CCCCeEecCCCccCCcCCCcCCC
Q 044366 249 LYGFVPKEIGYL-KSLSKLEFCANHLSGVIPHSVGN 283 (918)
Q Consensus 249 l~~~~~~~~~~l-~~L~~L~l~~n~l~~~~~~~~~~ 283 (918)
+. ...+..+ .+++.|+++.|++++..|..+..
T Consensus 283 i~---~~~~~~l~~~l~~L~l~~n~l~~~~~~~~~~ 315 (336)
T 2ast_B 283 VP---DGTLQLLKEALPHLQINCSHFTTIARPTIGN 315 (336)
T ss_dssp SC---TTCHHHHHHHSTTSEESCCCSCCTTCSSCSS
T ss_pred cC---HHHHHHHHhhCcceEEecccCccccCCcccc
Confidence 33 3344444 34777888999999888877664
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.88 E-value=2.8e-24 Score=235.21 Aligned_cols=254 Identities=19% Similarity=0.190 Sum_probs=195.7
Q ss_pred CCCEEEcccccccccCCCCcCCC--CCCCEEEcccccccccCCccccCCCCCCEEEccCCccccc-CccccCCCCCCCEE
Q 044366 46 QLRRLYLDVNQLHGTIPPVIGQL--SLINELVFCHNNVSGRIPSSLGNLSNLALLYLNDNSLFGS-IPIVMGNLKSLSTL 122 (918)
Q Consensus 46 ~L~~L~L~~n~l~~~~p~~~~~l--~~L~~L~l~~n~~~~~~p~~l~~l~~L~~L~L~~n~i~~~-~~~~~~~l~~L~~L 122 (918)
.++.+++++|.+. |..+..+ ..++.|++++|.+.+..+. +..+++|++|++++|.+.+. .|..+..+++|++|
T Consensus 48 ~~~~l~l~~~~~~---~~~~~~~~~~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L 123 (336)
T 2ast_B 48 LWQTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNL 123 (336)
T ss_dssp TSSEEECTTCBCC---HHHHHHHHHTTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEE
T ss_pred hheeeccccccCC---HHHHHhhhhccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEE
Confidence 4788999988776 4556666 7889999999988866554 55789999999999988755 77788888999999
Q ss_pred ECcCCcCCCcCCcCCCCCCCCceeecccc-ccccC-CCcccccccccCeeecccc-ccCCc-CCccCCCCC-CCcEeecc
Q 044366 123 DLSQNQLNGSIPCSLDNLSNLDTLFLYKN-SLSGP-IPSVIGNLKSLLQLDLSEN-RLSGL-IPLSLSNLS-SLTVMSLF 197 (918)
Q Consensus 123 ~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n-~l~~~-~~~~~~~l~~L~~L~Ls~N-~l~~~-~~~~~~~l~-~L~~L~L~ 197 (918)
+|++|++++..+..++++++|++|++++| .+++. .+..+..+++|++|++++| .+++. .+..+..++ +|++|+++
T Consensus 124 ~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l~ 203 (336)
T 2ast_B 124 SLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLS 203 (336)
T ss_dssp ECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECC
T ss_pred eCcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChHHHHHHHHhcccCCCEEEeC
Confidence 99999888777788888899999999998 67642 4566788899999999999 88754 355677888 89999999
Q ss_pred Ccc--cc-cCCCccccCCCCcceeeccccc-ccCCCCCCCcCCCcCCeEEcccCc-CcCCCCccccccCCCCeEecCCCc
Q 044366 198 NNS--LS-GSIPPILGNLKSLSTLGLHINQ-LNGVIPPSIGNLSSLRNLSLFNNR-LYGFVPKEIGYLKSLSKLEFCANH 272 (918)
Q Consensus 198 ~N~--l~-~~~~~~~~~l~~L~~L~L~~n~-l~~~~~~~~~~l~~L~~L~Ls~n~-l~~~~~~~~~~l~~L~~L~l~~n~ 272 (918)
+|. ++ ..++..+..+++|++|++++|. ++...+..+..+++|++|++++|. +.......+..+++|+.|++++|
T Consensus 204 ~~~~~~~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~l~~l~~L~~L~l~~~~~~~~~~~~~l~~~~~L~~L~l~~~- 282 (336)
T 2ast_B 204 GYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI- 282 (336)
T ss_dssp SCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS-
T ss_pred CCcccCCHHHHHHHHhhCCCCCEEeCCCCCcCCHHHHHHHhCCCCCCEeeCCCCCCCCHHHHHHHhcCCCCCEEeccCc-
Confidence 984 44 3446677788899999999998 666666778888999999999985 32222235778889999999988
Q ss_pred cCCcCCCcCCCC-CCCcEEEccCCcCcCCCCccccC
Q 044366 273 LSGVIPHSVGNL-TGLVLLNMCENHLFGPIPKSLRN 307 (918)
Q Consensus 273 l~~~~~~~~~~l-~~L~~L~l~~n~l~~~~~~~l~~ 307 (918)
+. ...+..+ ..+..|++++|++++..|..+..
T Consensus 283 i~---~~~~~~l~~~l~~L~l~~n~l~~~~~~~~~~ 315 (336)
T 2ast_B 283 VP---DGTLQLLKEALPHLQINCSHFTTIARPTIGN 315 (336)
T ss_dssp SC---TTCHHHHHHHSTTSEESCCCSCCTTCSSCSS
T ss_pred cC---HHHHHHHHhhCcceEEecccCccccCCcccc
Confidence 33 3334444 23677778889998888877654
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.88 E-value=1.5e-25 Score=250.06 Aligned_cols=241 Identities=19% Similarity=0.218 Sum_probs=134.0
Q ss_pred CCccccCCCCCCEEEccccccccc----CCCCcCCCCCCCEEEcccc---cccccCCccc-------cCCCCCCEEEccC
Q 044366 37 IPPEIGKLNQLRRLYLDVNQLHGT----IPPVIGQLSLINELVFCHN---NVSGRIPSSL-------GNLSNLALLYLND 102 (918)
Q Consensus 37 ~p~~l~~l~~L~~L~L~~n~l~~~----~p~~~~~l~~L~~L~l~~n---~~~~~~p~~l-------~~l~~L~~L~L~~ 102 (918)
++..+..+++|++|+|++|++++. ++..+..+++|++|++++| ++++.+|.++ ..+++|++|+|++
T Consensus 24 l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~~L~~L~Ls~ 103 (386)
T 2ca6_A 24 VFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSD 103 (386)
T ss_dssp TSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCS
T ss_pred HHHHHhcCCCccEEECCCCCCCHHHHHHHHHHHHhCCCccEEeCcccccCccccchhHHHHHHHHHHhhCCcccEEECCC
Confidence 344444444444444444444432 2222334444444444442 2223333333 4556666666666
Q ss_pred Ccccc----cCccccCCCCCCCEEECcCCcCCCcCCcCC----CCC---------CCCceeeccccccc-cCCC---ccc
Q 044366 103 NSLFG----SIPIVMGNLKSLSTLDLSQNQLNGSIPCSL----DNL---------SNLDTLFLYKNSLS-GPIP---SVI 161 (918)
Q Consensus 103 n~i~~----~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~l----~~l---------~~L~~L~L~~n~l~-~~~~---~~~ 161 (918)
|.+.. .+|..+..+++|++|+|++|.++...+..+ ..+ ++|++|+|++|+++ ...+ ..|
T Consensus 104 n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l 183 (386)
T 2ca6_A 104 NAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTF 183 (386)
T ss_dssp CCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHH
T ss_pred CcCCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCCCCcHHHHHHHHHH
Confidence 66654 245555566666666666666653322222 222 56666666666665 2222 345
Q ss_pred ccccccCeeeccccccCC-----cCCccCCCCCCCcEeeccCcccc----cCCCccccCCCCcceeecccccccCC----
Q 044366 162 GNLKSLLQLDLSENRLSG-----LIPLSLSNLSSLTVMSLFNNSLS----GSIPPILGNLKSLSTLGLHINQLNGV---- 228 (918)
Q Consensus 162 ~~l~~L~~L~Ls~N~l~~-----~~~~~~~~l~~L~~L~L~~N~l~----~~~~~~~~~l~~L~~L~L~~n~l~~~---- 228 (918)
..+++|++|+|++|+++. +.+..+..+++|+.|+|++|.++ ..+|..+..+++|+.|+|++|.++..
T Consensus 184 ~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~ 263 (386)
T 2ca6_A 184 QSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAA 263 (386)
T ss_dssp HHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHH
T ss_pred HhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCCcCEEECCCCCCchhhHHH
Confidence 566677777777776662 23335666677777777777764 34555666777777777777776643
Q ss_pred CCCCC--cCCCcCCeEEcccCcCcC----CCCccc-cccCCCCeEecCCCccCCcC
Q 044366 229 IPPSI--GNLSSLRNLSLFNNRLYG----FVPKEI-GYLKSLSKLEFCANHLSGVI 277 (918)
Q Consensus 229 ~~~~~--~~l~~L~~L~Ls~n~l~~----~~~~~~-~~l~~L~~L~l~~n~l~~~~ 277 (918)
++..+ ..+++|++|+|++|.+++ ..|..+ ..+++|++|++++|++.+..
T Consensus 264 l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N~l~~~~ 319 (386)
T 2ca6_A 264 VVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEED 319 (386)
T ss_dssp HHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCTTS
T ss_pred HHHHHhhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEEccCCcCCcch
Confidence 23334 236777777777777765 244444 45677777777777777554
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.88 E-value=5.3e-25 Score=245.65 Aligned_cols=241 Identities=18% Similarity=0.222 Sum_probs=104.7
Q ss_pred CCCCcCCCCCCCEEEcccccccccCC----ccccCCCCCCEEEccCCcc---cccCcccc-------CCCCCCCEEECcC
Q 044366 61 IPPVIGQLSLINELVFCHNNVSGRIP----SSLGNLSNLALLYLNDNSL---FGSIPIVM-------GNLKSLSTLDLSQ 126 (918)
Q Consensus 61 ~p~~~~~l~~L~~L~l~~n~~~~~~p----~~l~~l~~L~~L~L~~n~i---~~~~~~~~-------~~l~~L~~L~Ls~ 126 (918)
++..+..+++|++|++++|.+....+ ..|..+++|++|+|++|.+ .+..|..+ ..+++|++|+|++
T Consensus 24 l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~~L~~L~Ls~ 103 (386)
T 2ca6_A 24 VFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSD 103 (386)
T ss_dssp TSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCS
T ss_pred HHHHHhcCCCccEEECCCCCCCHHHHHHHHHHHHhCCCccEEeCcccccCccccchhHHHHHHHHHHhhCCcccEEECCC
Confidence 44444444555555555555443322 2234445555555554322 22223222 3445555555555
Q ss_pred CcCCC----cCCcCCCCCCCCceeeccccccccCCCcccc----cc---------cccCeeeccccccCC-cCC---ccC
Q 044366 127 NQLNG----SIPCSLDNLSNLDTLFLYKNSLSGPIPSVIG----NL---------KSLLQLDLSENRLSG-LIP---LSL 185 (918)
Q Consensus 127 n~i~~----~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~----~l---------~~L~~L~Ls~N~l~~-~~~---~~~ 185 (918)
|+++. .+|..+..+++|++|+|++|.++...+..+. .+ ++|++|+|++|+++. ..+ ..+
T Consensus 104 n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l 183 (386)
T 2ca6_A 104 NAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTF 183 (386)
T ss_dssp CCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHH
T ss_pred CcCCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCCCCcHHHHHHHHHH
Confidence 55543 2333444445555555555554422222222 22 455555555555441 111 233
Q ss_pred CCCCCCcEeeccCccccc-----CCCccccCCCCcceeeccccccc----CCCCCCCcCCCcCCeEEcccCcCcCC----
Q 044366 186 SNLSSLTVMSLFNNSLSG-----SIPPILGNLKSLSTLGLHINQLN----GVIPPSIGNLSSLRNLSLFNNRLYGF---- 252 (918)
Q Consensus 186 ~~l~~L~~L~L~~N~l~~-----~~~~~~~~l~~L~~L~L~~n~l~----~~~~~~~~~l~~L~~L~Ls~n~l~~~---- 252 (918)
..+++|++|+|++|+++. ..+..+..+++|+.|+|++|.++ ..++..+..+++|++|+|++|.+++.
T Consensus 184 ~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~ 263 (386)
T 2ca6_A 184 QSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAA 263 (386)
T ss_dssp HHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHH
T ss_pred HhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCCcCEEECCCCCCchhhHHH
Confidence 344455555555554441 12224444555555555555543 22333444445555555555554432
Q ss_pred CCcccc--ccCCCCeEecCCCccCC----cCCCcC-CCCCCCcEEEccCCcCcCCC
Q 044366 253 VPKEIG--YLKSLSKLEFCANHLSG----VIPHSV-GNLTGLVLLNMCENHLFGPI 301 (918)
Q Consensus 253 ~~~~~~--~l~~L~~L~l~~n~l~~----~~~~~~-~~l~~L~~L~l~~n~l~~~~ 301 (918)
.+..+. .+++|++|++++|.+.. ..|..+ .++++|+.|++++|++++..
T Consensus 264 l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N~l~~~~ 319 (386)
T 2ca6_A 264 VVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEED 319 (386)
T ss_dssp HHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCTTS
T ss_pred HHHHHhhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEEccCCcCCcch
Confidence 122221 14455555555555544 133333 33455555555555554433
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.87 E-value=1.2e-21 Score=215.05 Aligned_cols=238 Identities=18% Similarity=0.150 Sum_probs=123.9
Q ss_pred EEcccccccccCCccccCCCCCCEEEccCCcccccCccccCCCCCCCEEECcCCcCCCcC-CcCCCCCCCCce-eecccc
Q 044366 74 LVFCHNNVSGRIPSSLGNLSNLALLYLNDNSLFGSIPIVMGNLKSLSTLDLSQNQLNGSI-PCSLDNLSNLDT-LFLYKN 151 (918)
Q Consensus 74 L~l~~n~~~~~~p~~l~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~-~~~l~~l~~L~~-L~L~~n 151 (918)
++.++++++ .+|..+. +++++|+|++|+|+.+.+++|.++++|++|+|++|++.+.+ +.+|.++++|++ +.+++|
T Consensus 14 v~C~~~~Lt-~iP~~l~--~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~~N 90 (350)
T 4ay9_X 14 FLCQESKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKAN 90 (350)
T ss_dssp EEEESTTCC-SCCTTCC--TTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEEET
T ss_pred EEecCCCCC-ccCcCcC--CCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhcccCC
Confidence 344444444 4444432 45555555555555444445555555555555555554333 234555555443 344455
Q ss_pred ccccCCCcccccccccCeeeccccccCCcCCccCCCCCCCcEeeccC-cccccCCCccccCCC-CcceeecccccccCCC
Q 044366 152 SLSGPIPSVIGNLKSLLQLDLSENRLSGLIPLSLSNLSSLTVMSLFN-NSLSGSIPPILGNLK-SLSTLGLHINQLNGVI 229 (918)
Q Consensus 152 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~-N~l~~~~~~~~~~l~-~L~~L~L~~n~l~~~~ 229 (918)
+++.+.++.|..+++|++|++++|+++.+.+..+....++..|++.+ |.+..+.+..|..+. .++.|+|++|+|+.+.
T Consensus 91 ~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~~~~l~~L~L~~N~i~~i~ 170 (350)
T 4ay9_X 91 NLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIH 170 (350)
T ss_dssp TCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCCEEC
T ss_pred cccccCchhhhhccccccccccccccccCCchhhcccchhhhhhhccccccccccccchhhcchhhhhhccccccccCCC
Confidence 55555555556666666666666666555555555555555555543 345544444555543 4555666666665443
Q ss_pred CCCCcCCCcCCeEEccc-CcCcCCCCccccccCCCCeEecCCCccCCcCCCcCCCCCCCcEEEccCCcCcCCCCccccCC
Q 044366 230 PPSIGNLSSLRNLSLFN-NRLYGFVPKEIGYLKSLSKLEFCANHLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLRNL 308 (918)
Q Consensus 230 ~~~~~~l~~L~~L~Ls~-n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l 308 (918)
+..|. ..+|+.|++++ |.++.+.++.|..+++|+.|++++|+|+.+.+..|.++++|+.+ ++.-...+| .+.++
T Consensus 171 ~~~f~-~~~L~~l~l~~~n~l~~i~~~~f~~l~~L~~LdLs~N~l~~lp~~~~~~L~~L~~l---~~~~l~~lP-~l~~l 245 (350)
T 4ay9_X 171 NSAFN-GTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRAR---STYNLKKLP-TLEKL 245 (350)
T ss_dssp TTSST-TEEEEEEECTTCTTCCCCCTTTTTTEECCSEEECTTSCCCCCCSSSCTTCCEEECT---TCTTCCCCC-CTTTC
T ss_pred hhhcc-ccchhHHhhccCCcccCCCHHHhccCcccchhhcCCCCcCccChhhhccchHhhhc---cCCCcCcCC-CchhC
Confidence 33332 34566666653 45555555556666666666666666665555444443333332 222222344 35666
Q ss_pred CCCCeEEeecc
Q 044366 309 TSLERVRFNQN 319 (918)
Q Consensus 309 ~~L~~L~l~~n 319 (918)
++|+.+++.++
T Consensus 246 ~~L~~l~l~~~ 256 (350)
T 4ay9_X 246 VALMEASLTYP 256 (350)
T ss_dssp CSCCEEECSCH
T ss_pred cChhhCcCCCC
Confidence 67777766543
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.85 E-value=8.5e-22 Score=208.02 Aligned_cols=156 Identities=18% Similarity=0.142 Sum_probs=122.2
Q ss_pred HHHHHHhcCCCCceeeccccceEEEEEEeCCCCEEEEEEcccccccCC--C------------CChHHHHHHHHHHhhcc
Q 044366 639 EEITKATGNFGEKYCIGKGGQRSVYKAELPSGNIFAVKKFKAELFSDE--T------------ANPSEFLNEVLALTEIR 704 (918)
Q Consensus 639 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~--~------------~~~~~~~~e~~~l~~l~ 704 (918)
..+......|...+.||+|+||.||+|...+|+.||||.++....... . .....+.+|+++++.++
T Consensus 83 ~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~ 162 (282)
T 1zar_A 83 HRLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ 162 (282)
T ss_dssp HHHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc
Confidence 344455566778899999999999999778899999999865321111 0 12456899999999999
Q ss_pred CCceeeEecccccCCceEEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCee
Q 044366 705 HRNIIKFHGFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVL 784 (918)
Q Consensus 705 h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil 784 (918)
| +++.+++.. +..++||||+++|+|.+ +.. .+...++.|++.||+|||+. +|+||||||+||+
T Consensus 163 --~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~---------~~~~~i~~qi~~~l~~lH~~---giiHrDlkp~NIL 225 (282)
T 1zar_A 163 --G-LAVPKVYAW-EGNAVLMELIDAKELYR-VRV---------ENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVL 225 (282)
T ss_dssp --T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC---------SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEE
T ss_pred --C-CCcCeEEec-cceEEEEEecCCCcHHH-cch---------hhHHHHHHHHHHHHHHHHHC---CCEeCCCCHHHEE
Confidence 4 666665533 56799999999999998 432 12457999999999999999 9999999999999
Q ss_pred eCCCCcEEEeccccccccCCCCCCceecccccccccccccc
Q 044366 785 LDSEYEAHVSDFGFAKFLEPHSSNWTEFAGTVGYAAPELAY 825 (918)
Q Consensus 785 l~~~~~~kl~DfG~~~~~~~~~~~~~~~~g~~~y~aPE~~~ 825 (918)
++ ++.+||+|||+|+.. ..|+|||++.
T Consensus 226 l~-~~~vkl~DFG~a~~~-------------~~~~a~e~l~ 252 (282)
T 1zar_A 226 VS-EEGIWIIDFPQSVEV-------------GEEGWREILE 252 (282)
T ss_dssp EE-TTEEEECCCTTCEET-------------TSTTHHHHHH
T ss_pred EE-CCcEEEEECCCCeEC-------------CCCCHHHHHH
Confidence 99 999999999999743 3478898874
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.84 E-value=1.7e-20 Score=189.41 Aligned_cols=141 Identities=30% Similarity=0.370 Sum_probs=64.1
Q ss_pred ccCCCCCCEEEccCCcccccCccccCCCCCCCEEECcCCcCCCcCCcCCCCCCCCceeeccccccccCCCcccccccccC
Q 044366 89 LGNLSNLALLYLNDNSLFGSIPIVMGNLKSLSTLDLSQNQLNGSIPCSLDNLSNLDTLFLYKNSLSGPIPSVIGNLKSLL 168 (918)
Q Consensus 89 l~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~ 168 (918)
|..+++|++|++++|++++..+..|..+++|++|+|++|++++..+..+.++++|++|++++|+++++.+..|..+++|+
T Consensus 48 ~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~ 127 (208)
T 2o6s_A 48 FDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLK 127 (208)
T ss_dssp TTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCC
T ss_pred hcccccCcEEECCCCccCccChhhcCCCCCcCEEECCCCcCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCC
Confidence 34444444444444444433333344444444444444444433333344444444444444444444444444444444
Q ss_pred eeeccccccCCcCCccCCCCCCCcEeeccCcccccCCCccccCCCCcceeecccccccCCCCCCCcCC
Q 044366 169 QLDLSENRLSGLIPLSLSNLSSLTVMSLFNNSLSGSIPPILGNLKSLSTLGLHINQLNGVIPPSIGNL 236 (918)
Q Consensus 169 ~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l 236 (918)
+|++++|+++++.+..|..+++|++|++++|.+.+ .+++|+.|+++.|++++.+|..++.+
T Consensus 128 ~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~-------~~~~l~~L~~~~n~~~g~ip~~~~~l 188 (208)
T 2o6s_A 128 DLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDC-------TCPGIRYLSEWINKHSGVVRNSAGSV 188 (208)
T ss_dssp EEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCC-------CTTTTHHHHHHHHHCTTTBBCTTSSB
T ss_pred EEECCCCccceeCHHHhccCCCccEEEecCCCeec-------CCCCHHHHHHHHHhCCceeeccCccc
Confidence 55554444444444444444455555555444331 23344455555555554444444433
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.84 E-value=1.6e-20 Score=189.66 Aligned_cols=181 Identities=24% Similarity=0.281 Sum_probs=118.3
Q ss_pred CEEeCCCCcccccCCccccCCCCCCEEEcccccccccCCCCcCCCCCCCEEEcccccccccCCccccCCCCCCEEEccCC
Q 044366 24 QYLDLGNNQLSGVIPPEIGKLNQLRRLYLDVNQLHGTIPPVIGQLSLINELVFCHNNVSGRIPSSLGNLSNLALLYLNDN 103 (918)
Q Consensus 24 ~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~l~~l~~L~~L~L~~n 103 (918)
+.++.+++.++ .+|..+ .++|++|++++|++++..+..++.+++|++|++++|++++..+..|..+++|++|+|++|
T Consensus 10 ~~v~c~~~~l~-~~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n 86 (208)
T 2o6s_A 10 TTVECYSQGRT-SVPTGI--PAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTN 86 (208)
T ss_dssp TEEECCSSCCS-SCCSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEEecCCCcc-CCCCCC--CCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCCC
Confidence 45566666665 445433 346666666666666444444566666666666666666544455666777777777777
Q ss_pred cccccCccccCCCCCCCEEECcCCcCCCcCCcCCCCCCCCceeeccccccccCCCcccccccccCeeeccccccCCcCCc
Q 044366 104 SLFGSIPIVMGNLKSLSTLDLSQNQLNGSIPCSLDNLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSENRLSGLIPL 183 (918)
Q Consensus 104 ~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~ 183 (918)
++++..+..|..+++|++|++++|++++..+..+.++++|++|++++|+++++.+..|..+++|++|++++|.+.+
T Consensus 87 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~---- 162 (208)
T 2o6s_A 87 QLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDC---- 162 (208)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCC----
T ss_pred cCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEEecCCCeec----
Confidence 7766655566777777777777777776555566777777777777777776666667777777777777776553
Q ss_pred cCCCCCCCcEeeccCcccccCCCccccCCCC
Q 044366 184 SLSNLSSLTVMSLFNNSLSGSIPPILGNLKS 214 (918)
Q Consensus 184 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~ 214 (918)
.+++|++|+++.|++++.+|..++.++.
T Consensus 163 ---~~~~l~~L~~~~n~~~g~ip~~~~~l~~ 190 (208)
T 2o6s_A 163 ---TCPGIRYLSEWINKHSGVVRNSAGSVAP 190 (208)
T ss_dssp ---CTTTTHHHHHHHHHCTTTBBCTTSSBCT
T ss_pred ---CCCCHHHHHHHHHhCCceeeccCccccC
Confidence 3456777777777777777776665544
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.84 E-value=5.7e-21 Score=194.30 Aligned_cols=156 Identities=22% Similarity=0.275 Sum_probs=121.3
Q ss_pred cEEEccCceeccccccchhhccccCceecccccccCCCCCCCCCCCcccEEeccCccccccCccccccccccceecccCc
Q 044366 384 QVLDLSSNHIFGKIPVQLVKLFSLNKLILSLNQLFGGVPLEFGTLTELQYLDLSANKLSSSIPMSIGNLLKLHYLNLSNN 463 (918)
Q Consensus 384 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N 463 (918)
+.+++++|.++. +|..+. ++|+.|+|++|+++++.+..|..+++|++|+|++|.|+++.|..|.++++|++|+|++|
T Consensus 14 ~~v~c~~~~l~~-iP~~l~--~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N 90 (220)
T 2v9t_B 14 NIVDCRGKGLTE-IPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGN 90 (220)
T ss_dssp TEEECTTSCCSS-CCSSCC--TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSS
T ss_pred CEEEcCCCCcCc-CCCccC--cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCC
Confidence 345555665553 333332 46677777777777677777788888888888888888777888888888888888888
Q ss_pred ccCCCCchhhccccccceEeccCCcCCCCCchhccccCCcceEecCCCcccccCcccccCCCCccEEEccCCcCCCCCC
Q 044366 464 QFSHKIPTEFEKLIHLSELDLSHNILQEEIPPQICKMESLEKLNLSHNNLSDFIPRCFEEMRSLSWIDISYNELQGPIP 542 (918)
Q Consensus 464 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~p 542 (918)
+|+.+.+..|.++++|++|+|++|+|++..|..|..+++|+.|+|++|+|+++.+..|..+++|+.|++++|+|.|.++
T Consensus 91 ~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c~ 169 (220)
T 2v9t_B 91 KITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFICDCH 169 (220)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEECSGG
T ss_pred cCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcCCCCc
Confidence 8887777778888888888888888888778888888888888888888888888888888888888888888887654
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.84 E-value=7e-21 Score=193.66 Aligned_cols=156 Identities=20% Similarity=0.205 Sum_probs=123.2
Q ss_pred EEEccCceeccccccchhhccccCceecccccccCCCC-CCCCCCCcccEEeccCccccccCccccccccccceecccCc
Q 044366 385 VLDLSSNHIFGKIPVQLVKLFSLNKLILSLNQLFGGVP-LEFGTLTELQYLDLSANKLSSSIPMSIGNLLKLHYLNLSNN 463 (918)
Q Consensus 385 ~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N 463 (918)
.+++++|.++. +|..+. ..++.|+|++|++++..+ ..|..+++|++|+|++|.|+++.+..|..+++|++|+|++|
T Consensus 15 ~l~~s~n~l~~-iP~~~~--~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N 91 (220)
T 2v70_A 15 TVDCSNQKLNK-IPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSN 91 (220)
T ss_dssp EEECCSSCCSS-CCSCCC--TTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred EeEeCCCCccc-CccCCC--CCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCCC
Confidence 55556665553 333332 234666677776666543 45777888888888888888777778888888888888888
Q ss_pred ccCCCCchhhccccccceEeccCCcCCCCCchhccccCCcceEecCCCcccccCcccccCCCCccEEEccCCcCCCCCCC
Q 044366 464 QFSHKIPTEFEKLIHLSELDLSHNILQEEIPPQICKMESLEKLNLSHNNLSDFIPRCFEEMRSLSWIDISYNELQGPIPN 543 (918)
Q Consensus 464 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~p~ 543 (918)
+|++..+..|.++++|++|+|++|+|++..|..|..+++|+.|+|++|+|+++.|..|..+++|+.|++++|+|+|.++.
T Consensus 92 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~l 171 (220)
T 2v70_A 92 RLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNCNCYL 171 (220)
T ss_dssp CCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEECSGGG
T ss_pred ccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCcCCCch
Confidence 88888888888888999999999999888888888888999999999999888888899999999999999999987764
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.83 E-value=4.7e-21 Score=211.09 Aligned_cols=180 Identities=26% Similarity=0.274 Sum_probs=151.9
Q ss_pred ceeeccccccccCCCcCcCCCCCCcEEEccCceeccccccchh-hccccCceecccccccCCCCCCCCCCCcccEEeccC
Q 044366 360 GTFNASMNNIYGSIPPEIGDSSKLQVLDLSSNHIFGKIPVQLV-KLFSLNKLILSLNQLFGGVPLEFGTLTELQYLDLSA 438 (918)
Q Consensus 360 ~~l~l~~n~i~~~~~~~~~~~~~L~~L~L~~N~l~~~~~~~~~-~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~ 438 (918)
+.+++++|++. .+|..+. ..++.|+|++|+|++..+..|. ++++|+.|+|++|+|+++.+..|..+++|++|+|++
T Consensus 21 ~~l~c~~~~l~-~iP~~~~--~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~ 97 (361)
T 2xot_A 21 NILSCSKQQLP-NVPQSLP--SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSS 97 (361)
T ss_dssp TEEECCSSCCS-SCCSSCC--TTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred CEEEeCCCCcC-ccCccCC--CCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCC
Confidence 35666666665 3555443 4588999999999888888887 889999999999999988888899999999999999
Q ss_pred ccccccCccccccccccceecccCcccCCCCchhhccccccceEeccCCcCCCCCchhc---cccCCcceEecCCCcccc
Q 044366 439 NKLSSSIPMSIGNLLKLHYLNLSNNQFSHKIPTEFEKLIHLSELDLSHNILQEEIPPQI---CKMESLEKLNLSHNNLSD 515 (918)
Q Consensus 439 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~---~~l~~L~~L~L~~N~l~~ 515 (918)
|+|+++.+..|..+++|+.|+|++|+|+++.|..|.++++|+.|+|++|+|++..+..| ..+++|+.|+|++|+|++
T Consensus 98 N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 177 (361)
T 2xot_A 98 NHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLKK 177 (361)
T ss_dssp SCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGGGTC----CTTCCEEECCSSCCCC
T ss_pred CcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCeeCHHHhcCcccCCcCCEEECCCCCCCc
Confidence 99998878889999999999999999998888999999999999999999987666666 568999999999999998
Q ss_pred cCcccccCCCCc--cEEEccCCcCCCCCC
Q 044366 516 FIPRCFEEMRSL--SWIDISYNELQGPIP 542 (918)
Q Consensus 516 ~~~~~~~~l~~L--~~l~l~~N~l~~~~p 542 (918)
+.+..|..++.+ +.|+|++|+|+|.+.
T Consensus 178 l~~~~~~~l~~~~l~~l~l~~N~~~C~C~ 206 (361)
T 2xot_A 178 LPLTDLQKLPAWVKNGLYLHNNPLECDCK 206 (361)
T ss_dssp CCHHHHHHSCHHHHTTEECCSSCEECCHH
T ss_pred cCHHHhhhccHhhcceEEecCCCccCCcC
Confidence 888888888874 889999999998764
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.82 E-value=5.3e-20 Score=188.53 Aligned_cols=157 Identities=26% Similarity=0.312 Sum_probs=128.2
Q ss_pred CcEEEccCceeccccccchhhccccCceecccccccCCCCCCCCCCCcccEEeccCccccccCccccccccccceecccC
Q 044366 383 LQVLDLSSNHIFGKIPVQLVKLFSLNKLILSLNQLFGGVPLEFGTLTELQYLDLSANKLSSSIPMSIGNLLKLHYLNLSN 462 (918)
Q Consensus 383 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~ 462 (918)
-+.++.+++++. .+|..+. ++|+.|+|++|++++..+..|..+++|++|+|++|.|+.+.+..|..+++|+.|+|++
T Consensus 21 ~~~v~c~~~~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~ 97 (229)
T 3e6j_A 21 GTTVDCRSKRHA-SVPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGT 97 (229)
T ss_dssp TTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CCEeEccCCCcC-ccCCCCC--CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEECCC
Confidence 456777777776 3343333 6778888888888887788888888888888888888877667788888889999999
Q ss_pred cccCCCCchhhccccccceEeccCCcCCCCCchhccccCCcceEecCCCcccccCcccccCCCCccEEEccCCcCCCCCC
Q 044366 463 NQFSHKIPTEFEKLIHLSELDLSHNILQEEIPPQICKMESLEKLNLSHNNLSDFIPRCFEEMRSLSWIDISYNELQGPIP 542 (918)
Q Consensus 463 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~p 542 (918)
|+|+++.+..|..+++|++|+|++|+|+ .+|..+..+++|+.|+|++|+|+++.+..|..+++|+.|++++|+|+|.++
T Consensus 98 N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~ 176 (229)
T 3e6j_A 98 NQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNPWDCECR 176 (229)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCBCTTBG
T ss_pred CcCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCCccCCcc
Confidence 9888777778888889999999999987 677888888899999999999988877888889999999999999998876
Q ss_pred C
Q 044366 543 N 543 (918)
Q Consensus 543 ~ 543 (918)
.
T Consensus 177 ~ 177 (229)
T 3e6j_A 177 D 177 (229)
T ss_dssp G
T ss_pred h
Confidence 3
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.82 E-value=3.1e-20 Score=213.92 Aligned_cols=188 Identities=22% Similarity=0.279 Sum_probs=116.6
Q ss_pred CCcEEEccCCcCcCCCCccccCCCCCCeEEeecccccCccccccCCCCCccEEeCCCCccccccCcccccccccceeecc
Q 044366 286 GLVLLNMCENHLFGPIPKSLRNLTSLERVRFNQNNLYGKVYEAFGDHPNLTFLDLSQNNFYCEISFNWRNFSKLGTFNAS 365 (918)
Q Consensus 286 ~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~ 365 (918)
+|+.|++++|.+++ +|..+ .++|+.|++++|.|..++ ..+++|++|++++|.|
T Consensus 60 ~L~~L~Ls~n~L~~-lp~~l--~~~L~~L~Ls~N~l~~ip----~~l~~L~~L~Ls~N~l-------------------- 112 (571)
T 3cvr_A 60 QFSELQLNRLNLSS-LPDNL--PPQITVLEITQNALISLP----ELPASLEYLDACDNRL-------------------- 112 (571)
T ss_dssp TCSEEECCSSCCSC-CCSCC--CTTCSEEECCSSCCSCCC----CCCTTCCEEECCSSCC--------------------
T ss_pred CccEEEeCCCCCCc-cCHhH--cCCCCEEECcCCCCcccc----cccCCCCEEEccCCCC--------------------
Confidence 56666666666654 33323 144555555555555443 2234455555554444
Q ss_pred ccccccCCCcCcCCCCCCcEEEccCceeccccccchhhccccCceecccccccCCCCCCCCCCCcccEEeccCccccccC
Q 044366 366 MNNIYGSIPPEIGDSSKLQVLDLSSNHIFGKIPVQLVKLFSLNKLILSLNQLFGGVPLEFGTLTELQYLDLSANKLSSSI 445 (918)
Q Consensus 366 ~n~i~~~~~~~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~ 445 (918)
.+ +|. +.. +|++|+|++|+|++ +|. .+++|+.|+|++|+++++ |. .+++|++|+|++|.|++ +
T Consensus 113 ----~~-ip~-l~~--~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~l~~l-p~---~l~~L~~L~Ls~N~L~~-l 175 (571)
T 3cvr_A 113 ----ST-LPE-LPA--SLKHLDVDNNQLTM-LPE---LPALLEYINADNNQLTML-PE---LPTSLEVLSVRNNQLTF-L 175 (571)
T ss_dssp ----SC-CCC-CCT--TCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSCC-CC---CCTTCCEEECCSSCCSC-C
T ss_pred ----CC-cch-hhc--CCCEEECCCCcCCC-CCC---cCccccEEeCCCCccCcC-CC---cCCCcCEEECCCCCCCC-c
Confidence 43 444 433 67777777777765 333 456777777777777653 33 45677777777777775 4
Q ss_pred ccccccccccceecccCcccCCCCchhhcccccc-------ceEeccCCcCCCCCchhccccCCcceEecCCCcccccCc
Q 044366 446 PMSIGNLLKLHYLNLSNNQFSHKIPTEFEKLIHL-------SELDLSHNILQEEIPPQICKMESLEKLNLSHNNLSDFIP 518 (918)
Q Consensus 446 ~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L-------~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~ 518 (918)
|. |. ++|+.|+|++|+|+ .+|. |.. +| +.|+|++|+|+ .+|..+..+++|+.|+|++|+|++.+|
T Consensus 176 p~-l~--~~L~~L~Ls~N~L~-~lp~-~~~--~L~~~~~~L~~L~Ls~N~l~-~lp~~l~~l~~L~~L~L~~N~l~~~~p 247 (571)
T 3cvr_A 176 PE-LP--ESLEALDVSTNLLE-SLPA-VPV--RNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIR 247 (571)
T ss_dssp CC-CC--TTCCEEECCSSCCS-SCCC-CC----------CCEEEECCSSCCC-CCCGGGGGSCTTEEEECCSSSCCHHHH
T ss_pred ch-hh--CCCCEEECcCCCCC-chhh-HHH--hhhcccccceEEecCCCcce-ecCHHHhcCCCCCEEEeeCCcCCCcCH
Confidence 44 55 77777788777776 3444 544 56 78888888887 466666667888888888888877777
Q ss_pred ccccCCC
Q 044366 519 RCFEEMR 525 (918)
Q Consensus 519 ~~~~~l~ 525 (918)
..+..+.
T Consensus 248 ~~l~~l~ 254 (571)
T 3cvr_A 248 ESLSQQT 254 (571)
T ss_dssp HHHHHHH
T ss_pred HHHHHhh
Confidence 7766653
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.82 E-value=3.3e-20 Score=197.51 Aligned_cols=190 Identities=25% Similarity=0.407 Sum_probs=138.7
Q ss_pred CCEEeCCCCcccccCCccccCCCCCCEEEcccccccccCCCCcCCCCCCCEEEcccccccccCCccccCCCCCCEEEccC
Q 044366 23 LQYLDLGNNQLSGVIPPEIGKLNQLRRLYLDVNQLHGTIPPVIGQLSLINELVFCHNNVSGRIPSSLGNLSNLALLYLND 102 (918)
Q Consensus 23 L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~l~~l~~L~~L~L~~ 102 (918)
+..+.+..+.+++. ..+..+++|++|++++|.++ .+| .+..+++|++|++++|.+++..+ +..+++|++|++++
T Consensus 26 ~~~~~l~~~~~~~~--~~~~~l~~L~~L~l~~~~i~-~~~-~~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~ 99 (291)
T 1h6t_A 26 TIKDNLKKKSVTDA--VTQNELNSIDQIIANNSDIK-SVQ-GIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDE 99 (291)
T ss_dssp HHHHHTTCSCTTSE--ECHHHHHTCCEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCS
T ss_pred HHHHHhcCCCcccc--cchhhcCcccEEEccCCCcc-cCh-hHhcCCCCCEEEccCCccCCCcc--cccCCCCCEEECCC
Confidence 34445666666533 23456777777777777776 343 36677777777777777774333 77778888888888
Q ss_pred CcccccCccccCCCCCCCEEECcCCcCCCcCCcCCCCCCCCceeeccccccccCCCcccccccccCeeeccccccCCcCC
Q 044366 103 NSLFGSIPIVMGNLKSLSTLDLSQNQLNGSIPCSLDNLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSENRLSGLIP 182 (918)
Q Consensus 103 n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~ 182 (918)
|++++ .| .+..+++|++|++++|++++. ..+..+++|++|++++|+++++ ..++.+++|++|++++|+++++.+
T Consensus 100 n~l~~-~~-~l~~l~~L~~L~L~~n~i~~~--~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~N~l~~~~~ 173 (291)
T 1h6t_A 100 NKVKD-LS-SLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP 173 (291)
T ss_dssp SCCCC-GG-GGTTCTTCCEEECTTSCCCCC--GGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG
T ss_pred CcCCC-Ch-hhccCCCCCEEECCCCcCCCC--hhhcCCCCCCEEEccCCcCCcc--hhhccCCCCCEEEccCCccccchh
Confidence 88764 23 477888888888888888753 4677788888888888888765 577888888888888888887655
Q ss_pred ccCCCCCCCcEeeccCcccccCCCccccCCCCcceeecccccccCC
Q 044366 183 LSLSNLSSLTVMSLFNNSLSGSIPPILGNLKSLSTLGLHINQLNGV 228 (918)
Q Consensus 183 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~ 228 (918)
+..+++|++|++++|.+++. + .+..+++|+.|++++|+++..
T Consensus 174 --l~~l~~L~~L~L~~N~i~~l-~-~l~~l~~L~~L~l~~n~i~~~ 215 (291)
T 1h6t_A 174 --LAGLTKLQNLYLSKNHISDL-R-ALAGLKNLDVLELFSQECLNK 215 (291)
T ss_dssp --GTTCTTCCEEECCSSCCCBC-G-GGTTCTTCSEEEEEEEEEECC
T ss_pred --hcCCCccCEEECCCCcCCCC-h-hhccCCCCCEEECcCCcccCC
Confidence 78888888888888888754 3 478888888888888888754
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.82 E-value=3.6e-20 Score=197.20 Aligned_cols=190 Identities=27% Similarity=0.407 Sum_probs=123.8
Q ss_pred CCEEEcccccccccCCCCcCCCCCCCEEEcccccccccCCccccCCCCCCEEEccCCcccccCccccCCCCCCCEEECcC
Q 044366 47 LRRLYLDVNQLHGTIPPVIGQLSLINELVFCHNNVSGRIPSSLGNLSNLALLYLNDNSLFGSIPIVMGNLKSLSTLDLSQ 126 (918)
Q Consensus 47 L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~l~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~ 126 (918)
+..+.+..+.+++. ..+..+++|++|++++|.+.. ++ .+..+++|++|+|++|++++..+ +..+++|++|++++
T Consensus 26 ~~~~~l~~~~~~~~--~~~~~l~~L~~L~l~~~~i~~-~~-~~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~ 99 (291)
T 1h6t_A 26 TIKDNLKKKSVTDA--VTQNELNSIDQIIANNSDIKS-VQ-GIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDE 99 (291)
T ss_dssp HHHHHTTCSCTTSE--ECHHHHHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCS
T ss_pred HHHHHhcCCCcccc--cchhhcCcccEEEccCCCccc-Ch-hHhcCCCCCEEEccCCccCCCcc--cccCCCCCEEECCC
Confidence 33344555554422 123456677777777777663 33 36677777777777777765443 67777777777777
Q ss_pred CcCCCcCCcCCCCCCCCceeeccccccccCCCcccccccccCeeeccccccCCcCCccCCCCCCCcEeeccCcccccCCC
Q 044366 127 NQLNGSIPCSLDNLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSENRLSGLIPLSLSNLSSLTVMSLFNNSLSGSIP 206 (918)
Q Consensus 127 n~i~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~ 206 (918)
|++++ ++ .+..+++|++|++++|+++++ ..+..+++|++|++++|+++++ ..+..+++|++|++++|++++..+
T Consensus 100 n~l~~-~~-~l~~l~~L~~L~L~~n~i~~~--~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~N~l~~~~~ 173 (291)
T 1h6t_A 100 NKVKD-LS-SLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP 173 (291)
T ss_dssp SCCCC-GG-GGTTCTTCCEEECTTSCCCCC--GGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG
T ss_pred CcCCC-Ch-hhccCCCCCEEECCCCcCCCC--hhhcCCCCCCEEEccCCcCCcc--hhhccCCCCCEEEccCCccccchh
Confidence 77764 22 367777777777777777654 4566777777777777777765 456677777777777777765443
Q ss_pred ccccCCCCcceeecccccccCCCCCCCcCCCcCCeEEcccCcCcCC
Q 044366 207 PILGNLKSLSTLGLHINQLNGVIPPSIGNLSSLRNLSLFNNRLYGF 252 (918)
Q Consensus 207 ~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~ 252 (918)
+..+++|+.|++++|.++.. ..+..+++|+.|++++|+++..
T Consensus 174 --l~~l~~L~~L~L~~N~i~~l--~~l~~l~~L~~L~l~~n~i~~~ 215 (291)
T 1h6t_A 174 --LAGLTKLQNLYLSKNHISDL--RALAGLKNLDVLELFSQECLNK 215 (291)
T ss_dssp --GTTCTTCCEEECCSSCCCBC--GGGTTCTTCSEEEEEEEEEECC
T ss_pred --hcCCCccCEEECCCCcCCCC--hhhccCCCCCEEECcCCcccCC
Confidence 67777777777777777654 2366777777777777777643
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.81 E-value=7.8e-20 Score=210.58 Aligned_cols=189 Identities=26% Similarity=0.292 Sum_probs=125.7
Q ss_pred CCCEEEcccccccccCCCCcCCCCCCCEEEcccccccccCCccccCCCCCCEEEccCCcccccCccccCCCCCCCEEECc
Q 044366 46 QLRRLYLDVNQLHGTIPPVIGQLSLINELVFCHNNVSGRIPSSLGNLSNLALLYLNDNSLFGSIPIVMGNLKSLSTLDLS 125 (918)
Q Consensus 46 ~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~l~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls 125 (918)
+|+.|+|++|++++ +|..+. ++|++|++++|.++ .+| ..+++|++|+|++|+|++ +|. +.+ +|++|+|+
T Consensus 60 ~L~~L~Ls~n~L~~-lp~~l~--~~L~~L~Ls~N~l~-~ip---~~l~~L~~L~Ls~N~l~~-ip~-l~~--~L~~L~Ls 128 (571)
T 3cvr_A 60 QFSELQLNRLNLSS-LPDNLP--PQITVLEITQNALI-SLP---ELPASLEYLDACDNRLST-LPE-LPA--SLKHLDVD 128 (571)
T ss_dssp TCSEEECCSSCCSC-CCSCCC--TTCSEEECCSSCCS-CCC---CCCTTCCEEECCSSCCSC-CCC-CCT--TCCEEECC
T ss_pred CccEEEeCCCCCCc-cCHhHc--CCCCEEECcCCCCc-ccc---cccCCCCEEEccCCCCCC-cch-hhc--CCCEEECC
Confidence 66666666666653 555442 55666666666666 455 335677777777777765 444 444 67777777
Q ss_pred CCcCCCcCCcCCCCCCCCceeeccccccccCCCcccccccccCeeeccccccCCcCCccCCCCCCCcEeeccCcccccCC
Q 044366 126 QNQLNGSIPCSLDNLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSENRLSGLIPLSLSNLSSLTVMSLFNNSLSGSI 205 (918)
Q Consensus 126 ~n~i~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 205 (918)
+|+|++ +|. .+++|++|+|++|+++++ |. .+++|++|+|++|+++++ |. |. ++|+.|+|++|+|+ .+
T Consensus 129 ~N~l~~-lp~---~l~~L~~L~Ls~N~l~~l-p~---~l~~L~~L~Ls~N~L~~l-p~-l~--~~L~~L~Ls~N~L~-~l 195 (571)
T 3cvr_A 129 NNQLTM-LPE---LPALLEYINADNNQLTML-PE---LPTSLEVLSVRNNQLTFL-PE-LP--ESLEALDVSTNLLE-SL 195 (571)
T ss_dssp SSCCSC-CCC---CCTTCCEEECCSSCCSCC-CC---CCTTCCEEECCSSCCSCC-CC-CC--TTCCEEECCSSCCS-SC
T ss_pred CCcCCC-CCC---cCccccEEeCCCCccCcC-CC---cCCCcCEEECCCCCCCCc-ch-hh--CCCCEEECcCCCCC-ch
Confidence 777775 444 466777777777777753 33 456777777777777764 33 54 77777777777777 34
Q ss_pred CccccCCCCc-------ceeecccccccCCCCCCCcCCCcCCeEEcccCcCcCCCCccccccCC
Q 044366 206 PPILGNLKSL-------STLGLHINQLNGVIPPSIGNLSSLRNLSLFNNRLYGFVPKEIGYLKS 262 (918)
Q Consensus 206 ~~~~~~l~~L-------~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~ 262 (918)
|. |.. +| +.|+|++|+|+. +|..+..+++|+.|+|++|++++..|..+..+..
T Consensus 196 p~-~~~--~L~~~~~~L~~L~Ls~N~l~~-lp~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~ 255 (571)
T 3cvr_A 196 PA-VPV--RNHHSEETEIFFRCRENRITH-IPENILSLDPTCTIILEDNPLSSRIRESLSQQTA 255 (571)
T ss_dssp CC-CC----------CCEEEECCSSCCCC-CCGGGGGSCTTEEEECCSSSCCHHHHHHHHHHHH
T ss_pred hh-HHH--hhhcccccceEEecCCCccee-cCHHHhcCCCCCEEEeeCCcCCCcCHHHHHHhhc
Confidence 44 443 56 888888888884 5666777888999999999888877777766543
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.81 E-value=8.9e-20 Score=212.69 Aligned_cols=198 Identities=25% Similarity=0.399 Sum_probs=134.8
Q ss_pred CCEEeCCCCcccccCCccccCCCCCCEEEcccccccccCCCCcCCCCCCCEEEcccccccccCCccccCCCCCCEEEccC
Q 044366 23 LQYLDLGNNQLSGVIPPEIGKLNQLRRLYLDVNQLHGTIPPVIGQLSLINELVFCHNNVSGRIPSSLGNLSNLALLYLND 102 (918)
Q Consensus 23 L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~l~~l~~L~~L~L~~ 102 (918)
+..+.++.+.+.+..+ +..+.+|+.|++++|.+. .+| .+..+++|++|+|++|.+.+..| +..+++|+.|+|++
T Consensus 23 l~~l~l~~~~i~~~~~--~~~L~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~ 96 (605)
T 1m9s_A 23 TIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SVQ-GIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDE 96 (605)
T ss_dssp HHHHHTTCSCTTSEEC--HHHHTTCCCCBCTTCCCC-CCT-TGGGCTTCCEEECTTSCCCCCGG--GGGCTTCCEEECCS
T ss_pred HHHHhccCCCcccccc--hhcCCCCCEEECcCCCCC-CCh-HHccCCCCCEEEeeCCCCCCChh--hccCCCCCEEECcC
Confidence 4445566666653322 556666666677666665 343 46666777777777776664333 67777777777777
Q ss_pred CcccccCccccCCCCCCCEEECcCCcCCCcCCcCCCCCCCCceeeccccccccCCCcccccccccCeeeccccccCCcCC
Q 044366 103 NSLFGSIPIVMGNLKSLSTLDLSQNQLNGSIPCSLDNLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSENRLSGLIP 182 (918)
Q Consensus 103 n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~ 182 (918)
|.+.+ +| .+..+++|++|+|++|++++. ..+..+++|+.|+|++|+++++ ..|+.+++|+.|+|++|+++++.|
T Consensus 97 N~l~~-l~-~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~~~~ 170 (605)
T 1m9s_A 97 NKIKD-LS-SLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP 170 (605)
T ss_dssp SCCCC-CT-TSTTCTTCCEEECTTSCCCCC--GGGGGCTTCSEEECCSSCCCCC--GGGGSCTTCSEEECCSSCCCCCGG
T ss_pred CCCCC-Ch-hhccCCCCCEEEecCCCCCCC--ccccCCCccCEEECCCCccCCc--hhhcccCCCCEEECcCCcCCCchh
Confidence 77764 22 577777777777777777743 3577777777777777777755 567777888888888888877655
Q ss_pred ccCCCCCCCcEeeccCcccccCCCccccCCCCcceeecccccccCCCCCCCcCC
Q 044366 183 LSLSNLSSLTVMSLFNNSLSGSIPPILGNLKSLSTLGLHINQLNGVIPPSIGNL 236 (918)
Q Consensus 183 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l 236 (918)
+..+++|+.|+|++|.|++. ..+..+++|+.|+|++|.+...+...+..+
T Consensus 171 --l~~l~~L~~L~Ls~N~i~~l--~~l~~l~~L~~L~L~~N~l~~~p~~~~~~l 220 (605)
T 1m9s_A 171 --LAGLTKLQNLYLSKNHISDL--RALAGLKNLDVLELFSQECLNKPINHQSNL 220 (605)
T ss_dssp --GTTCTTCCEEECCSSCCCBC--GGGTTCTTCSEEECCSEEEECCCCCCCSSC
T ss_pred --hccCCCCCEEECcCCCCCCC--hHHccCCCCCEEEccCCcCcCCcccccccE
Confidence 77778888888888888754 357778888888888888776544333333
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.80 E-value=2.3e-19 Score=182.39 Aligned_cols=158 Identities=22% Similarity=0.365 Sum_probs=105.1
Q ss_pred EeeccCcccccCCCccccCCCCcceeecccccccCCCCCCCcCCCcCCeEEcccCcCcCCCCccccccCCCCeEecCCCc
Q 044366 193 VMSLFNNSLSGSIPPILGNLKSLSTLGLHINQLNGVIPPSIGNLSSLRNLSLFNNRLYGFVPKEIGYLKSLSKLEFCANH 272 (918)
Q Consensus 193 ~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~l~~n~ 272 (918)
.+++++|.++. +|..+. ++|+.|++++|.++.+.+..|.++++|++|+|++|+++++.|..|..+++|++|+|++|+
T Consensus 15 ~v~c~~~~l~~-iP~~l~--~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~ 91 (220)
T 2v9t_B 15 IVDCRGKGLTE-IPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNK 91 (220)
T ss_dssp EEECTTSCCSS-CCSSCC--TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSSC
T ss_pred EEEcCCCCcCc-CCCccC--cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCCc
Confidence 44444444442 232222 345555555555555544555555666666666666665555666666666666666666
Q ss_pred cCCcCCCcCCCCCCCcEEEccCCcCcCCCCccccCCCCCCeEEeecccccCccccccCCCCCccEEeCCCCccccccCcc
Q 044366 273 LSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLRNLTSLERVRFNQNNLYGKVYEAFGDHPNLTFLDLSQNNFYCEISFN 352 (918)
Q Consensus 273 l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~ 352 (918)
|..+.+..|.++++|+.|++++|++.+..|..|.++++|+.|++++|.+..+++..|..+++|+.|+|++|+|.|+|...
T Consensus 92 l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c~l~ 171 (220)
T 2v9t_B 92 ITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFICDCHLK 171 (220)
T ss_dssp CCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEECSGGGH
T ss_pred CCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcCCCCccH
Confidence 66555555666667777777777777666777777777888888888888888888888999999999999999988754
Q ss_pred c
Q 044366 353 W 353 (918)
Q Consensus 353 ~ 353 (918)
|
T Consensus 172 ~ 172 (220)
T 2v9t_B 172 W 172 (220)
T ss_dssp H
T ss_pred H
Confidence 4
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.80 E-value=1.3e-19 Score=211.45 Aligned_cols=171 Identities=29% Similarity=0.464 Sum_probs=78.6
Q ss_pred CCCCCCEEEcccccccccCCccccCCCCCCEEEccCCcccccCccccCCCCCCCEEECcCCcCCCcCCcCCCCCCCCcee
Q 044366 67 QLSLINELVFCHNNVSGRIPSSLGNLSNLALLYLNDNSLFGSIPIVMGNLKSLSTLDLSQNQLNGSIPCSLDNLSNLDTL 146 (918)
Q Consensus 67 ~l~~L~~L~l~~n~~~~~~p~~l~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L 146 (918)
.+.+|++|++++|.+. .+| .|..+++|+.|+|++|++.+..| +..+++|+.|+|++|++++ +| .+..+++|++|
T Consensus 41 ~L~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~-l~-~l~~l~~L~~L 114 (605)
T 1m9s_A 41 ELNSIDQIIANNSDIK-SVQ-GIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDENKIKD-LS-SLKDLKKLKSL 114 (605)
T ss_dssp HHTTCCCCBCTTCCCC-CCT-TGGGCTTCCEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCC-CT-TSTTCTTCCEE
T ss_pred cCCCCCEEECcCCCCC-CCh-HHccCCCCCEEEeeCCCCCCChh--hccCCCCCEEECcCCCCCC-Ch-hhccCCCCCEE
Confidence 4444444455444444 222 34444555555555554443322 4444455555555554442 11 34444445555
Q ss_pred eccccccccCCCcccccccccCeeeccccccCCcCCccCCCCCCCcEeeccCcccccCCCccccCCCCcceeeccccccc
Q 044366 147 FLYKNSLSGPIPSVIGNLKSLLQLDLSENRLSGLIPLSLSNLSSLTVMSLFNNSLSGSIPPILGNLKSLSTLGLHINQLN 226 (918)
Q Consensus 147 ~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~ 226 (918)
+|++|+++++ ..+..+++|+.|+|++|+++++ ..+..+++|+.|+|++|.+++..| +..+++|+.|+|++|+++
T Consensus 115 ~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~i~ 188 (605)
T 1m9s_A 115 SLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHIS 188 (605)
T ss_dssp ECTTSCCCCC--GGGGGCTTCSEEECCSSCCCCC--GGGGSCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCC
T ss_pred EecCCCCCCC--ccccCCCccCEEECCCCccCCc--hhhcccCCCCEEECcCCcCCCchh--hccCCCCCEEECcCCCCC
Confidence 5555544432 2344444555555555544443 234444445555555554443333 444445555555555444
Q ss_pred CCCCCCCcCCCcCCeEEcccCcCcC
Q 044366 227 GVIPPSIGNLSSLRNLSLFNNRLYG 251 (918)
Q Consensus 227 ~~~~~~~~~l~~L~~L~Ls~n~l~~ 251 (918)
+. ..+..+++|+.|+|++|++.+
T Consensus 189 ~l--~~l~~l~~L~~L~L~~N~l~~ 211 (605)
T 1m9s_A 189 DL--RALAGLKNLDVLELFSQECLN 211 (605)
T ss_dssp BC--GGGTTCTTCSEEECCSEEEEC
T ss_pred CC--hHHccCCCCCEEEccCCcCcC
Confidence 32 234444445555555544443
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.80 E-value=1.5e-19 Score=198.96 Aligned_cols=112 Identities=28% Similarity=0.323 Sum_probs=43.8
Q ss_pred CCCCCCEEEccCCcccccCccccCCCCCCCEEECcCCcCCCcCCcCCCCCCCCceeeccccccccCCCcccccccccCee
Q 044366 91 NLSNLALLYLNDNSLFGSIPIVMGNLKSLSTLDLSQNQLNGSIPCSLDNLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQL 170 (918)
Q Consensus 91 ~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 170 (918)
.+++|++|+|++|+|++..+..|.++++|++|+|++|+|+...+..|.++++|++|+|++|+|+++.+..|.++++|++|
T Consensus 62 ~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L 141 (361)
T 2xot_A 62 RLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKL 141 (361)
T ss_dssp CCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEE
T ss_pred cccccCEEECCCCcCCccChhhccCCCCCCEEECCCCcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEE
Confidence 33344444444444433333334444444444444444443333333444444444444444443333344444444444
Q ss_pred eccccccCCcCCccC---CCCCCCcEeeccCcccc
Q 044366 171 DLSENRLSGLIPLSL---SNLSSLTVMSLFNNSLS 202 (918)
Q Consensus 171 ~Ls~N~l~~~~~~~~---~~l~~L~~L~L~~N~l~ 202 (918)
+|++|+++++.+..| ..+++|+.|+|++|+|+
T Consensus 142 ~L~~N~l~~l~~~~~~~~~~l~~L~~L~L~~N~l~ 176 (361)
T 2xot_A 142 YLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLK 176 (361)
T ss_dssp ECCSSCCCSCCGGGTC----CTTCCEEECCSSCCC
T ss_pred ECCCCcCCeeCHHHhcCcccCCcCCEEECCCCCCC
Confidence 444444443333222 22344444444444444
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.79 E-value=6.3e-19 Score=179.15 Aligned_cols=111 Identities=28% Similarity=0.394 Sum_probs=42.8
Q ss_pred cCCCCCCCEEECcCCcCCCcCCcCCCCCCCCceeeccccccccCCCcccccccccCeeeccccccCCcCCccCCCCCCCc
Q 044366 113 MGNLKSLSTLDLSQNQLNGSIPCSLDNLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSENRLSGLIPLSLSNLSSLT 192 (918)
Q Consensus 113 ~~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~ 192 (918)
|..+++|++|+|++|+|++..+..|.++++|++|+|++|+++++.+..|.++++|++|+|++|+++++.|..|..+++|+
T Consensus 53 ~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~ 132 (220)
T 2v70_A 53 FKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVR 132 (220)
T ss_dssp GGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCS
T ss_pred hccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCCCccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCC
Confidence 33334444444444444333333333333344444444433333333333344444444444444333333333333333
Q ss_pred EeeccCcccccCCCccccCCCCcceeecccc
Q 044366 193 VMSLFNNSLSGSIPPILGNLKSLSTLGLHIN 223 (918)
Q Consensus 193 ~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n 223 (918)
+|+|++|++++..|..|..+++|+.|+|++|
T Consensus 133 ~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N 163 (220)
T 2v70_A 133 LLSLYDNQITTVAPGAFDTLHSLSTLNLLAN 163 (220)
T ss_dssp EEECTTSCCCCBCTTTTTTCTTCCEEECCSC
T ss_pred EEECCCCcCCEECHHHhcCCCCCCEEEecCc
Confidence 3333333333333333333333333333333
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.78 E-value=8.1e-20 Score=198.62 Aligned_cols=221 Identities=13% Similarity=0.066 Sum_probs=124.8
Q ss_pred CCCCCEEECcCCcCCCcCCcCCCCCCCCceeeccccccccCCCcccccccccCeeecccc----ccCCcCCccCCCCCCC
Q 044366 116 LKSLSTLDLSQNQLNGSIPCSLDNLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSEN----RLSGLIPLSLSNLSSL 191 (918)
Q Consensus 116 l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N----~l~~~~~~~~~~l~~L 191 (918)
+++|++|+|.+ .++.+.+.+|.++++|++|++.+|.+..+.+.+|.++.++..+.+..+ ....+...+|.++.+|
T Consensus 100 ~~~L~~l~L~~-~i~~I~~~aF~~~~~L~~l~l~~n~i~~i~~~aF~~~~~l~~l~~~~~~~~~~~~~i~~~~f~~~~~L 178 (329)
T 3sb4_A 100 KQTLEKVILSE-KIKNIEDAAFKGCDNLKICQIRKKTAPNLLPEALADSVTAIFIPLGSSDAYRFKNRWEHFAFIEGEPL 178 (329)
T ss_dssp CTTCCC-CBCT-TCCEECTTTTTTCTTCCEEEBCCSSCCEECTTSSCTTTCEEEECTTCTHHHHTSTTTTTSCEEESCCC
T ss_pred cCCCcEEECCc-cccchhHHHhhcCcccceEEcCCCCccccchhhhcCCCceEEecCcchhhhhcccccccccccccccc
Confidence 55555555554 444444444555555555555555554444455555444444444432 1222333445555555
Q ss_pred c-EeeccCccc-ccCCCccccCCCCcceeecccccccCCCCCCC-cCCCcCCeEEcccCcCcCCCCccccccCCCCeEec
Q 044366 192 T-VMSLFNNSL-SGSIPPILGNLKSLSTLGLHINQLNGVIPPSI-GNLSSLRNLSLFNNRLYGFVPKEIGYLKSLSKLEF 268 (918)
Q Consensus 192 ~-~L~L~~N~l-~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~-~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~l 268 (918)
+ .+.+....- .......-....++..+.+.++-.. .....+ ..+++|+.|+|++|+++.+.+.+|.++.+|+++++
T Consensus 179 ~~~i~~~~~~~l~~~~~~~~~~~~~~~~l~~~~~l~~-~~~~~l~~~~~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l 257 (329)
T 3sb4_A 179 ETTIQVGAMGKLEDEIMKAGLQPRDINFLTIEGKLDN-ADFKLIRDYMPNLVSLDISKTNATTIPDFTFAQKKYLLKIKL 257 (329)
T ss_dssp EEEEEECTTCCHHHHHHHTTCCGGGCSEEEEEECCCH-HHHHHHHHHCTTCCEEECTTBCCCEECTTTTTTCTTCCEEEC
T ss_pred ceeEEecCCCcHHHHHhhcccCccccceEEEeeeecH-HHHHHHHHhcCCCeEEECCCCCcceecHhhhhCCCCCCEEEC
Confidence 5 344332211 0000000112344455554443211 100111 13567777777777777777777777777777777
Q ss_pred CCCccCCcCCCcCCCCCCCc-EEEccCCcCcCCCCccccCCCCCCeEEeecccccCccccccCCCCCccEEeC
Q 044366 269 CANHLSGVIPHSVGNLTGLV-LLNMCENHLFGPIPKSLRNLTSLERVRFNQNNLYGKVYEAFGDHPNLTFLDL 340 (918)
Q Consensus 269 ~~n~l~~~~~~~~~~l~~L~-~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L 340 (918)
.+| +..+.+.+|.++++|+ .+++.+ .++.+.+.+|.++++|+++++++|.+..+...+|.++++|+.++.
T Consensus 258 ~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l~l~~n~i~~I~~~aF~~~~~L~~ly~ 328 (329)
T 3sb4_A 258 PHN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYVLATGDKITTLGDELFGNGVPSKLIYK 328 (329)
T ss_dssp CTT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEEEECSSCCCEECTTTTCTTCCCCEEEC
T ss_pred Ccc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEEEeCCCccCccchhhhcCCcchhhhcc
Confidence 776 6667777777777777 777777 666667778888888888888888888888888888888887763
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.77 E-value=2.8e-19 Score=194.34 Aligned_cols=218 Identities=12% Similarity=0.057 Sum_probs=101.8
Q ss_pred CCCCceeeccccccccCCCcccccccccCeeeccccccCCcCCccCCCCCCCcEeeccCcc----cccCCCccccCCCCc
Q 044366 140 LSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSENRLSGLIPLSLSNLSSLTVMSLFNNS----LSGSIPPILGNLKSL 215 (918)
Q Consensus 140 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~----l~~~~~~~~~~l~~L 215 (918)
+++|++|+|.+ .++.+.+.+|.++++|+.|++++|.+..+.+.+|.++.++..+.+..+. ...+...+|.++..|
T Consensus 100 ~~~L~~l~L~~-~i~~I~~~aF~~~~~L~~l~l~~n~i~~i~~~aF~~~~~l~~l~~~~~~~~~~~~~i~~~~f~~~~~L 178 (329)
T 3sb4_A 100 KQTLEKVILSE-KIKNIEDAAFKGCDNLKICQIRKKTAPNLLPEALADSVTAIFIPLGSSDAYRFKNRWEHFAFIEGEPL 178 (329)
T ss_dssp CTTCCC-CBCT-TCCEECTTTTTTCTTCCEEEBCCSSCCEECTTSSCTTTCEEEECTTCTHHHHTSTTTTTSCEEESCCC
T ss_pred cCCCcEEECCc-cccchhHHHhhcCcccceEEcCCCCccccchhhhcCCCceEEecCcchhhhhcccccccccccccccc
Confidence 55555555554 4444444455555555555555555444444455444444444443321 111222333344444
Q ss_pred c-eeecccccc-cCCCCCCCcCCCcCCeEEcccCcCcCCCCccc-cccCCCCeEecCCCccCCcCCCcCCCCCCCcEEEc
Q 044366 216 S-TLGLHINQL-NGVIPPSIGNLSSLRNLSLFNNRLYGFVPKEI-GYLKSLSKLEFCANHLSGVIPHSVGNLTGLVLLNM 292 (918)
Q Consensus 216 ~-~L~L~~n~l-~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~-~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l 292 (918)
+ .+.+....- .......--...+++.+.+.++-.. .....+ ..+++|+.+++++|.+..+.+.+|.++++|+.+++
T Consensus 179 ~~~i~~~~~~~l~~~~~~~~~~~~~~~~l~~~~~l~~-~~~~~l~~~~~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l 257 (329)
T 3sb4_A 179 ETTIQVGAMGKLEDEIMKAGLQPRDINFLTIEGKLDN-ADFKLIRDYMPNLVSLDISKTNATTIPDFTFAQKKYLLKIKL 257 (329)
T ss_dssp EEEEEECTTCCHHHHHHHTTCCGGGCSEEEEEECCCH-HHHHHHHHHCTTCCEEECTTBCCCEECTTTTTTCTTCCEEEC
T ss_pred ceeEEecCCCcHHHHHhhcccCccccceEEEeeeecH-HHHHHHHHhcCCCeEEECCCCCcceecHhhhhCCCCCCEEEC
Confidence 3 222221110 0000000011234444444443111 111111 12566666666666666666666666666666666
Q ss_pred cCCcCcCCCCccccCCCCCC-eEEeecccccCccccccCCCCCccEEeCCCCccccccCcccccccccce
Q 044366 293 CENHLFGPIPKSLRNLTSLE-RVRFNQNNLYGKVYEAFGDHPNLTFLDLSQNNFYCEISFNWRNFSKLGT 361 (918)
Q Consensus 293 ~~n~l~~~~~~~l~~l~~L~-~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~ 361 (918)
.+| +..+.+.+|.++.+|+ .+.+.+ .+..+...+|.++++|+.+++++|.++.+....|.++++|+.
T Consensus 258 ~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l~l~~n~i~~I~~~aF~~~~~L~~ 325 (329)
T 3sb4_A 258 PHN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYVLATGDKITTLGDELFGNGVPSKL 325 (329)
T ss_dssp CTT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEEEECSSCCCEECTTTTCTTCCCCE
T ss_pred Ccc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEEEeCCCccCccchhhhcCCcchhh
Confidence 665 5555556666666666 666655 555666666666666666666655555544444444444443
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.77 E-value=4.2e-18 Score=174.35 Aligned_cols=134 Identities=32% Similarity=0.388 Sum_probs=74.0
Q ss_pred CCCCEEEcccccccccCCccccCCCCCCEEEccCCcccccCccccCCCCCCCEEECcCCcCCCcCCcCCCCCCCCceeec
Q 044366 69 SLINELVFCHNNVSGRIPSSLGNLSNLALLYLNDNSLFGSIPIVMGNLKSLSTLDLSQNQLNGSIPCSLDNLSNLDTLFL 148 (918)
Q Consensus 69 ~~L~~L~l~~n~~~~~~p~~l~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L 148 (918)
++|++|++++|.+++..|..|..+++|++|+|++|+|....+..|..+++|++|+|++|+|++..+..|..+++|++|+|
T Consensus 40 ~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L 119 (229)
T 3e6j_A 40 TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFM 119 (229)
T ss_dssp TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEECCCCcCCccChhHhCcchhhCeEec
Confidence 33444444444444444444555555555555555555444444555555555555555555444444555555666666
Q ss_pred cccccccCCCcccccccccCeeeccccccCCcCCccCCCCCCCcEeeccCccccc
Q 044366 149 YKNSLSGPIPSVIGNLKSLLQLDLSENRLSGLIPLSLSNLSSLTVMSLFNNSLSG 203 (918)
Q Consensus 149 ~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 203 (918)
++|+++ .+|..+..+++|++|+|++|+++++.+..|..+++|+.|+|++|.+..
T Consensus 120 s~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c 173 (229)
T 3e6j_A 120 CCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNPWDC 173 (229)
T ss_dssp CSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCBCT
T ss_pred cCCccc-ccCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCCccC
Confidence 666555 334555566666666666666665555556666666666666666553
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.77 E-value=1.6e-19 Score=189.02 Aligned_cols=169 Identities=25% Similarity=0.325 Sum_probs=98.2
Q ss_pred CCCCCEEeCCCCcccccCCccccCCCCCCEEEcccccccccCCCCcCCCCCCCEEEcccccccccCCccccCCCCCCEEE
Q 044366 20 LSKLQYLDLGNNQLSGVIPPEIGKLNQLRRLYLDVNQLHGTIPPVIGQLSLINELVFCHNNVSGRIPSSLGNLSNLALLY 99 (918)
Q Consensus 20 l~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~l~~l~~L~~L~ 99 (918)
+.++..++++++.+++ ++ .+..+++|++|++++|+++ .+| .+..+++|++|++++|.+++..+ +..+++|++|+
T Consensus 18 l~~l~~l~l~~~~i~~-~~-~~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L~ 91 (263)
T 1xeu_A 18 LANAVKQNLGKQSVTD-LV-SQKELSGVQNFNGDNSNIQ-SLA-GMQFFTNLKELHLSHNQISDLSP--LKDLTKLEELS 91 (263)
T ss_dssp HHHHHHHHHTCSCTTS-EE-CHHHHTTCSEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCEEE
T ss_pred HHHHHHHHhcCCCccc-cc-chhhcCcCcEEECcCCCcc-cch-HHhhCCCCCEEECCCCccCCChh--hccCCCCCEEE
Confidence 4556666677777663 33 4666777777777777666 444 45566666666666666653332 66666666666
Q ss_pred ccCCcccccCccccCCCCCCCEEECcCCcCCCcCCcCCCCCCCCceeeccccccccCCCcccccccccCeeeccccccCC
Q 044366 100 LNDNSLFGSIPIVMGNLKSLSTLDLSQNQLNGSIPCSLDNLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSENRLSG 179 (918)
Q Consensus 100 L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~ 179 (918)
|++|++++. |. +.. ++|++|+|++|++++. ..+.++++|++|++++|+++++ ..++.+++|++|++++|++++
T Consensus 92 L~~N~l~~l-~~-~~~-~~L~~L~L~~N~l~~~--~~l~~l~~L~~L~Ls~N~i~~~--~~l~~l~~L~~L~L~~N~i~~ 164 (263)
T 1xeu_A 92 VNRNRLKNL-NG-IPS-ACLSRLFLDNNELRDT--DSLIHLKNLEILSIRNNKLKSI--VMLGFLSKLEVLDLHGNEITN 164 (263)
T ss_dssp CCSSCCSCC-TT-CCC-SSCCEEECCSSCCSBS--GGGTTCTTCCEEECTTSCCCBC--GGGGGCTTCCEEECTTSCCCB
T ss_pred CCCCccCCc-Cc-ccc-CcccEEEccCCccCCC--hhhcCcccccEEECCCCcCCCC--hHHccCCCCCEEECCCCcCcc
Confidence 666666542 22 222 5666666666666542 2355566666666666666543 245556666666666666655
Q ss_pred cCCccCCCCCCCcEeeccCccccc
Q 044366 180 LIPLSLSNLSSLTVMSLFNNSLSG 203 (918)
Q Consensus 180 ~~~~~~~~l~~L~~L~L~~N~l~~ 203 (918)
. ..+..+++|+.|++++|.++.
T Consensus 165 ~--~~l~~l~~L~~L~l~~N~~~~ 186 (263)
T 1xeu_A 165 T--GGLTRLKKVNWIDLTGQKCVN 186 (263)
T ss_dssp C--TTSTTCCCCCEEEEEEEEEEC
T ss_pred h--HHhccCCCCCEEeCCCCcccC
Confidence 4 445555566666666665553
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.77 E-value=7.8e-19 Score=183.76 Aligned_cols=165 Identities=24% Similarity=0.342 Sum_probs=145.2
Q ss_pred cccCCCCCCccCCccCCCCCCCCEEeCCCCcccccCCccccCCCCCCEEEcccccccccCCCCcCCCCCCCEEEcccccc
Q 044366 2 LNLGFNLLFGNIPPQIGNLSKLQYLDLGNNQLSGVIPPEIGKLNQLRRLYLDVNQLHGTIPPVIGQLSLINELVFCHNNV 81 (918)
Q Consensus 2 l~~~~~~~~~~~p~~~~~l~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~~ 81 (918)
|++++|.++ .+| .+.++++|++|++++|+++ .+| .+..+++|++|+|++|+++ .+|. +..+++|++|++++|++
T Consensus 24 l~l~~~~i~-~~~-~~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~L~~N~i~-~~~~-l~~l~~L~~L~L~~N~l 97 (263)
T 1xeu_A 24 QNLGKQSVT-DLV-SQKELSGVQNFNGDNSNIQ-SLA-GMQFFTNLKELHLSHNQIS-DLSP-LKDLTKLEELSVNRNRL 97 (263)
T ss_dssp HHHTCSCTT-SEE-CHHHHTTCSEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCC-CCGG-GTTCSSCCEEECCSSCC
T ss_pred HHhcCCCcc-ccc-chhhcCcCcEEECcCCCcc-cch-HHhhCCCCCEEECCCCccC-CChh-hccCCCCCEEECCCCcc
Confidence 578888888 555 5889999999999999998 566 7999999999999999999 4555 99999999999999999
Q ss_pred cccCCccccCCCCCCEEEccCCcccccCccccCCCCCCCEEECcCCcCCCcCCcCCCCCCCCceeeccccccccCCCccc
Q 044366 82 SGRIPSSLGNLSNLALLYLNDNSLFGSIPIVMGNLKSLSTLDLSQNQLNGSIPCSLDNLSNLDTLFLYKNSLSGPIPSVI 161 (918)
Q Consensus 82 ~~~~p~~l~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~ 161 (918)
++ +|. +.. ++|++|+|++|++++. + .+..+++|++|+|++|++++. + .++.+++|++|++++|++++. ..+
T Consensus 98 ~~-l~~-~~~-~~L~~L~L~~N~l~~~-~-~l~~l~~L~~L~Ls~N~i~~~-~-~l~~l~~L~~L~L~~N~i~~~--~~l 168 (263)
T 1xeu_A 98 KN-LNG-IPS-ACLSRLFLDNNELRDT-D-SLIHLKNLEILSIRNNKLKSI-V-MLGFLSKLEVLDLHGNEITNT--GGL 168 (263)
T ss_dssp SC-CTT-CCC-SSCCEEECCSSCCSBS-G-GGTTCTTCCEEECTTSCCCBC-G-GGGGCTTCCEEECTTSCCCBC--TTS
T ss_pred CC-cCc-ccc-CcccEEEccCCccCCC-h-hhcCcccccEEECCCCcCCCC-h-HHccCCCCCEEECCCCcCcch--HHh
Confidence 85 444 333 9999999999999864 3 699999999999999999965 3 789999999999999999976 789
Q ss_pred ccccccCeeeccccccCCcC
Q 044366 162 GNLKSLLQLDLSENRLSGLI 181 (918)
Q Consensus 162 ~~l~~L~~L~Ls~N~l~~~~ 181 (918)
..+++|+.|++++|++....
T Consensus 169 ~~l~~L~~L~l~~N~~~~~~ 188 (263)
T 1xeu_A 169 TRLKKVNWIDLTGQKCVNEP 188 (263)
T ss_dssp TTCCCCCEEEEEEEEEECCC
T ss_pred ccCCCCCEEeCCCCcccCCc
Confidence 99999999999999998763
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.76 E-value=1.1e-18 Score=174.38 Aligned_cols=154 Identities=18% Similarity=0.245 Sum_probs=102.6
Q ss_pred ccCCCCCCEEEcccccccccCCCCcCCCCCCCEEEcccccccccCCccccCCCCCCEEEccCCcccccCccccCCCCCCC
Q 044366 41 IGKLNQLRRLYLDVNQLHGTIPPVIGQLSLINELVFCHNNVSGRIPSSLGNLSNLALLYLNDNSLFGSIPIVMGNLKSLS 120 (918)
Q Consensus 41 l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~l~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~ 120 (918)
...+++|++|++++|+++ .+| .+..+++|++|++++|.++ .+..+..+++|++|++++|++++..+..+..+++|+
T Consensus 40 ~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~--~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~ 115 (197)
T 4ezg_A 40 EAQMNSLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHAT--NYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLT 115 (197)
T ss_dssp HHHHHTCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCS--CCGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCC
T ss_pred hhhcCCccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCC--cchhhhcCCCCCEEEeECCccCcccChhhcCCCCCC
Confidence 355666666666666666 455 4666666666666666543 334666677777777777777665666677777777
Q ss_pred EEECcCCcCCCcCCcCCCCCCCCceeeccccc-cccCCCcccccccccCeeeccccccCCcCCccCCCCCCCcEeeccCc
Q 044366 121 TLDLSQNQLNGSIPCSLDNLSNLDTLFLYKNS-LSGPIPSVIGNLKSLLQLDLSENRLSGLIPLSLSNLSSLTVMSLFNN 199 (918)
Q Consensus 121 ~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~-l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N 199 (918)
+|++++|++++..|..++++++|++|++++|. ++.+ + .+..+++|++|++++|+++++. .+..+++|++|++++|
T Consensus 116 ~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~~~-~-~l~~l~~L~~L~l~~n~i~~~~--~l~~l~~L~~L~l~~N 191 (197)
T 4ezg_A 116 LLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDI-M-PLKTLPELKSLNIQFDGVHDYR--GIEDFPKLNQLYAFSQ 191 (197)
T ss_dssp EEECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCCCC-G-GGGGCSSCCEEECTTBCCCCCT--TGGGCSSCCEEEECBC
T ss_pred EEEecCCccCcHhHHHHhhCCCCCEEEccCCCCcccc-H-hhcCCCCCCEEECCCCCCcChH--HhccCCCCCEEEeeCc
Confidence 77777777776566667777777777777776 5533 3 5777777777777777777643 5677777777777777
Q ss_pred ccc
Q 044366 200 SLS 202 (918)
Q Consensus 200 ~l~ 202 (918)
++.
T Consensus 192 ~i~ 194 (197)
T 4ezg_A 192 TIG 194 (197)
T ss_dssp ---
T ss_pred ccC
Confidence 765
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.76 E-value=2e-18 Score=172.35 Aligned_cols=154 Identities=16% Similarity=0.204 Sum_probs=109.2
Q ss_pred cCCCCCCCEEEcccccccccCCccccCCCCCCEEEccCCcccccCccccCCCCCCCEEECcCCcCCCcCCcCCCCCCCCc
Q 044366 65 IGQLSLINELVFCHNNVSGRIPSSLGNLSNLALLYLNDNSLFGSIPIVMGNLKSLSTLDLSQNQLNGSIPCSLDNLSNLD 144 (918)
Q Consensus 65 ~~~l~~L~~L~l~~n~~~~~~p~~l~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~ 144 (918)
...+++|++|++++|.++ .+| .+..+++|++|++++|.+. .+..+..+++|++|++++|++++..+..++++++|+
T Consensus 40 ~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~--~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~ 115 (197)
T 4ezg_A 40 EAQMNSLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHAT--NYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLT 115 (197)
T ss_dssp HHHHHTCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCS--CCGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCC
T ss_pred hhhcCCccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCC--cchhhhcCCCCCEEEeECCccCcccChhhcCCCCCC
Confidence 356677777777777777 555 5777777777777777664 233677777777777777777766677777777777
Q ss_pred eeeccccccccCCCcccccccccCeeeccccc-cCCcCCccCCCCCCCcEeeccCcccccCCCccccCCCCcceeecccc
Q 044366 145 TLFLYKNSLSGPIPSVIGNLKSLLQLDLSENR-LSGLIPLSLSNLSSLTVMSLFNNSLSGSIPPILGNLKSLSTLGLHIN 223 (918)
Q Consensus 145 ~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~-l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n 223 (918)
+|++++|++++..+..|+.+++|++|++++|+ ++.+ + .+..+++|++|++++|++++. + .+..+++|+.|++++|
T Consensus 116 ~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~~~-~-~l~~l~~L~~L~l~~n~i~~~-~-~l~~l~~L~~L~l~~N 191 (197)
T 4ezg_A 116 LLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDI-M-PLKTLPELKSLNIQFDGVHDY-R-GIEDFPKLNQLYAFSQ 191 (197)
T ss_dssp EEECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCCCC-G-GGGGCSSCCEEECTTBCCCCC-T-TGGGCSSCCEEEECBC
T ss_pred EEEecCCccCcHhHHHHhhCCCCCEEEccCCCCcccc-H-hhcCCCCCCEEECCCCCCcCh-H-HhccCCCCCEEEeeCc
Confidence 77777777776666777777777777777776 6554 3 577777777777777777753 2 5777777777777777
Q ss_pred ccc
Q 044366 224 QLN 226 (918)
Q Consensus 224 ~l~ 226 (918)
++.
T Consensus 192 ~i~ 194 (197)
T 4ezg_A 192 TIG 194 (197)
T ss_dssp ---
T ss_pred ccC
Confidence 765
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.75 E-value=4.1e-21 Score=222.76 Aligned_cols=187 Identities=22% Similarity=0.205 Sum_probs=94.4
Q ss_pred CCCCCCCEEeCCCCcccccCCccccCCCCCCEEEcccccccccCCCCcCCCCCCCEEEcccccccccCCccccCCCCCCE
Q 044366 18 GNLSKLQYLDLGNNQLSGVIPPEIGKLNQLRRLYLDVNQLHGTIPPVIGQLSLINELVFCHNNVSGRIPSSLGNLSNLAL 97 (918)
Q Consensus 18 ~~l~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~l~~l~~L~~ 97 (918)
..+++|+.|+|++|+++ .+|.+|+.+++|+.|++++|.....+|. .+..+...+..|..++.+++|+.
T Consensus 346 ~~~~~L~~L~Ls~n~L~-~Lp~~i~~l~~L~~L~l~~n~~l~~l~~-----------ll~~~~~~~~~~~~l~~l~~L~~ 413 (567)
T 1dce_A 346 ATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIIL-----------LMRALDPLLYEKETLQYFSTLKA 413 (567)
T ss_dssp STTTTSSSCCCCHHHHH-HHHHHHHHHHHHHHHCTTCHHHHHHHHH-----------HHHHHCTGGGHHHHHHHHHHHHH
T ss_pred ccCccceeccCChhhHH-hhHHHHHHHHHHHHhccccchhhhhHHH-----------HHHhcccccCCHHHHHHHHhccc
Confidence 45666666667666665 5666666666666666655531101110 00111233455555555555555
Q ss_pred EE-ccCC-------------cccccCccccCCCCCCCEEECcCCcCCCcCCcCCCCCCCCceeeccccccccCCCccccc
Q 044366 98 LY-LNDN-------------SLFGSIPIVMGNLKSLSTLDLSQNQLNGSIPCSLDNLSNLDTLFLYKNSLSGPIPSVIGN 163 (918)
Q Consensus 98 L~-L~~n-------------~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~ 163 (918)
|+ ++.| .++...+ ..|+.|+|++|+|++ +|. ++++++|+.|+|++|+++ .+|..|+.
T Consensus 414 L~~l~~n~~~~L~~l~l~~n~i~~l~~------~~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~-~lp~~~~~ 484 (567)
T 1dce_A 414 VDPMRAAYLDDLRSKFLLENSVLKMEY------ADVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLR-ALPPALAA 484 (567)
T ss_dssp HCGGGHHHHHHHHHHHHHHHHHHHHHH------TTCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCC-CCCGGGGG
T ss_pred CcchhhcccchhhhhhhhcccccccCc------cCceEEEecCCCCCC-CcC-ccccccCcEeecCccccc-ccchhhhc
Confidence 55 4444 3332111 135555555555553 343 555555555555555555 33445555
Q ss_pred ccccCeeeccccccCCcCCccCCCCCCCcEeeccCcccccCC-CccccCCCCcceeecccccccC
Q 044366 164 LKSLLQLDLSENRLSGLIPLSLSNLSSLTVMSLFNNSLSGSI-PPILGNLKSLSTLGLHINQLNG 227 (918)
Q Consensus 164 l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~-~~~~~~l~~L~~L~L~~n~l~~ 227 (918)
+++|++|+|++|+|+++ | .+..+++|+.|+|++|+|++.. |..|..+++|+.|+|++|++++
T Consensus 485 l~~L~~L~Ls~N~l~~l-p-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~ 547 (567)
T 1dce_A 485 LRCLEVLQASDNALENV-D-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 547 (567)
T ss_dssp CTTCCEEECCSSCCCCC-G-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGGG
T ss_pred CCCCCEEECCCCCCCCC-c-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEecCCcCCC
Confidence 55555555555555543 2 4555555555555555555443 4445555555555555555443
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.75 E-value=2.8e-18 Score=170.42 Aligned_cols=133 Identities=26% Similarity=0.311 Sum_probs=96.0
Q ss_pred CceecccccccCCCCCCCCCCCcccEEeccCccccccCcc-ccccccccceecccCcccCCCCchhhccccccceEeccC
Q 044366 408 NKLILSLNQLFGGVPLEFGTLTELQYLDLSANKLSSSIPM-SIGNLLKLHYLNLSNNQFSHKIPTEFEKLIHLSELDLSH 486 (918)
Q Consensus 408 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~ 486 (918)
+.+++++|+++. +|..+. .+|++|+|++|.|++..+. .|..+++|++|+|++|+|++..|..|.++++|++|+|++
T Consensus 11 ~~l~~s~~~l~~-ip~~~~--~~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~ 87 (192)
T 1w8a_A 11 TTVDCTGRGLKE-IPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE 87 (192)
T ss_dssp TEEECTTSCCSS-CCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred CEEEcCCCCcCc-CccCCC--CCCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCC
Confidence 345555555532 333222 2677777777777765553 477777888888888888777777788888888888888
Q ss_pred CcCCCCCchhccccCCcceEecCCCcccccCcccccCCCCccEEEccCCcCCCCCCC
Q 044366 487 NILQEEIPPQICKMESLEKLNLSHNNLSDFIPRCFEEMRSLSWIDISYNELQGPIPN 543 (918)
Q Consensus 487 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~p~ 543 (918)
|+|++..+..|.++++|+.|+|++|+|++..|..|..+++|+.|++++|+|+|.++.
T Consensus 88 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~l 144 (192)
T 1w8a_A 88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHL 144 (192)
T ss_dssp CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGG
T ss_pred CcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCcc
Confidence 888777777777788888888888888877777788888888888888888877664
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.74 E-value=4.7e-21 Score=222.21 Aligned_cols=203 Identities=22% Similarity=0.210 Sum_probs=149.8
Q ss_pred CCCCCCEEEcccccccccCCccccCCCCCCEEEccCCc-------------ccccCccccCCCCCCCEEE-CcCCcCCCc
Q 044366 67 QLSLINELVFCHNNVSGRIPSSLGNLSNLALLYLNDNS-------------LFGSIPIVMGNLKSLSTLD-LSQNQLNGS 132 (918)
Q Consensus 67 ~l~~L~~L~l~~n~~~~~~p~~l~~l~~L~~L~L~~n~-------------i~~~~~~~~~~l~~L~~L~-Ls~n~i~~~ 132 (918)
.+++|+.|++++|.++ .+|+.++++++|+.|++++|. +.+..|..+..+++|+.|+ ++.|.+
T Consensus 347 ~~~~L~~L~Ls~n~L~-~Lp~~i~~l~~L~~L~l~~n~~l~~l~~ll~~~~~~~~~~~~l~~l~~L~~L~~l~~n~~--- 422 (567)
T 1dce_A 347 TDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYL--- 422 (567)
T ss_dssp TTTTSSSCCCCHHHHH-HHHHHHHHHHHHHHHCTTCHHHHHHHHHHHHHHCTGGGHHHHHHHHHHHHHHCGGGHHHH---
T ss_pred cCccceeccCChhhHH-hhHHHHHHHHHHHHhccccchhhhhHHHHHHhcccccCCHHHHHHHHhcccCcchhhccc---
Confidence 3444444555555444 445555555555555554432 4456677777788888887 666544
Q ss_pred CCcCCCCCCCCceeeccccccccCCCcccccccccCeeeccccccCCcCCccCCCCCCCcEeeccCcccccCCCccccCC
Q 044366 133 IPCSLDNLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSENRLSGLIPLSLSNLSSLTVMSLFNNSLSGSIPPILGNL 212 (918)
Q Consensus 133 ~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l 212 (918)
.+|+.+.+.+|.++.+.+ ..|+.|+|++|+++++ |. |..+++|+.|+|++|.|+ .+|..|+.+
T Consensus 423 --------~~L~~l~l~~n~i~~l~~------~~L~~L~Ls~n~l~~l-p~-~~~l~~L~~L~Ls~N~l~-~lp~~~~~l 485 (567)
T 1dce_A 423 --------DDLRSKFLLENSVLKMEY------ADVRVLHLAHKDLTVL-CH-LEQLLLVTHLDLSHNRLR-ALPPALAAL 485 (567)
T ss_dssp --------HHHHHHHHHHHHHHHHHH------TTCSEEECTTSCCSSC-CC-GGGGTTCCEEECCSSCCC-CCCGGGGGC
T ss_pred --------chhhhhhhhcccccccCc------cCceEEEecCCCCCCC-cC-ccccccCcEeecCccccc-ccchhhhcC
Confidence 346666777777765432 2488999999999975 54 889999999999999998 678889999
Q ss_pred CCcceeecccccccCCCCCCCcCCCcCCeEEcccCcCcCCC-CccccccCCCCeEecCCCccCCcCCCc---CCCCCCCc
Q 044366 213 KSLSTLGLHINQLNGVIPPSIGNLSSLRNLSLFNNRLYGFV-PKEIGYLKSLSKLEFCANHLSGVIPHS---VGNLTGLV 288 (918)
Q Consensus 213 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~-~~~~~~l~~L~~L~l~~n~l~~~~~~~---~~~l~~L~ 288 (918)
++|+.|+|++|+++++ | .++++++|+.|+|++|+|++.. |..+..+++|+.|++++|++.+.++.. +..+++|+
T Consensus 486 ~~L~~L~Ls~N~l~~l-p-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~l~~~lp~L~ 563 (567)
T 1dce_A 486 RCLEVLQASDNALENV-D-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVS 563 (567)
T ss_dssp TTCCEEECCSSCCCCC-G-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSCTTHHHHHCTTCS
T ss_pred CCCCEEECCCCCCCCC-c-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCccHHHHHHHHCcccC
Confidence 9999999999999874 4 7889999999999999999876 889999999999999999998776533 23478888
Q ss_pred EEEc
Q 044366 289 LLNM 292 (918)
Q Consensus 289 ~L~l 292 (918)
.|++
T Consensus 564 ~L~l 567 (567)
T 1dce_A 564 SILT 567 (567)
T ss_dssp EEEC
T ss_pred ccCC
Confidence 8864
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=99.73 E-value=6.3e-17 Score=179.33 Aligned_cols=265 Identities=12% Similarity=0.127 Sum_probs=158.6
Q ss_pred CCCCCEEEccCCcccccCccccCCCCCCCEEECcCCcCCCcCCcCCCCCCCCceeeccccccccCCCcccccccccCeee
Q 044366 92 LSNLALLYLNDNSLFGSIPIVMGNLKSLSTLDLSQNQLNGSIPCSLDNLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLD 171 (918)
Q Consensus 92 l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 171 (918)
...++.+.+.++ ++.+...+|.+. +|+.+++..+ ++.+...+|.+. +|+.+.+.. .++.+...+|.++++|+.++
T Consensus 112 ~~~l~~i~ip~~-i~~I~~~aF~~~-~L~~i~l~~~-i~~I~~~aF~~~-~L~~i~lp~-~l~~I~~~aF~~c~~L~~l~ 186 (401)
T 4fdw_A 112 LKGYNEIILPNS-VKSIPKDAFRNS-QIAKVVLNEG-LKSIGDMAFFNS-TVQEIVFPS-TLEQLKEDIFYYCYNLKKAD 186 (401)
T ss_dssp CSSCSEEECCTT-CCEECTTTTTTC-CCSEEECCTT-CCEECTTTTTTC-CCCEEECCT-TCCEECSSTTTTCTTCCEEE
T ss_pred cCCccEEEECCc-cCEehHhhcccC-CccEEEeCCC-ccEECHHhcCCC-CceEEEeCC-CccEehHHHhhCcccCCeee
Confidence 355555555543 444555566553 5666666554 554555556553 466666654 45555556666666666666
Q ss_pred ccccccCCcCCccCCCCCCCcEeeccCcccccCCCccccCCCCcceeecccccccCCCCCCCcCCCcCCeEEcccCcCcC
Q 044366 172 LSENRLSGLIPLSLSNLSSLTVMSLFNNSLSGSIPPILGNLKSLSTLGLHINQLNGVIPPSIGNLSSLRNLSLFNNRLYG 251 (918)
Q Consensus 172 Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~ 251 (918)
+++|+++.+...+|. +.+|+.+.+..+ ++.+...+|.++++|+.+.+..| ++.+....|.+ .+|+.+.+. +.++.
T Consensus 187 l~~n~l~~I~~~aF~-~~~L~~l~lp~~-l~~I~~~aF~~~~~L~~l~l~~~-l~~I~~~aF~~-~~L~~i~lp-~~i~~ 261 (401)
T 4fdw_A 187 LSKTKITKLPASTFV-YAGIEEVLLPVT-LKEIGSQAFLKTSQLKTIEIPEN-VSTIGQEAFRE-SGITTVKLP-NGVTN 261 (401)
T ss_dssp CTTSCCSEECTTTTT-TCCCSEEECCTT-CCEECTTTTTTCTTCCCEECCTT-CCEECTTTTTT-CCCSEEEEE-TTCCE
T ss_pred cCCCcceEechhhEe-ecccCEEEeCCc-hheehhhHhhCCCCCCEEecCCC-ccCcccccccc-CCccEEEeC-CCccE
Confidence 666666655555555 456666666533 55455566666666666666653 44455555555 566666663 34555
Q ss_pred CCCccccccCCCCeEecCCCccC-----CcCCCcCCCCCCCcEEEccCCcCcCCCCccccCCCCCCeEEeecccccCccc
Q 044366 252 FVPKEIGYLKSLSKLEFCANHLS-----GVIPHSVGNLTGLVLLNMCENHLFGPIPKSLRNLTSLERVRFNQNNLYGKVY 326 (918)
Q Consensus 252 ~~~~~~~~l~~L~~L~l~~n~l~-----~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~ 326 (918)
+...+|.++++|+.+++.+|.+. .+.+.+|.++++|+.+.+.+ .+..+...+|.++++|+.+.+.. .+..+..
T Consensus 262 I~~~aF~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~~-~i~~I~~~aF~~c~~L~~l~lp~-~l~~I~~ 339 (401)
T 4fdw_A 262 IASRAFYYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIPE-SIRILGQGLLGGNRKVTQLTIPA-NVTQINF 339 (401)
T ss_dssp ECTTTTTTCTTCCEEEEESSCCCCCTTCEECTTTTTTCTTCCEECCCT-TCCEECTTTTTTCCSCCEEEECT-TCCEECT
T ss_pred EChhHhhCCCCCCEEEeCCccccCCcccEECHHHhhCCccCCeEEeCC-ceEEEhhhhhcCCCCccEEEECc-cccEEcH
Confidence 55666666666666666665544 45556666666666666663 35555566666667777776633 3666666
Q ss_pred cccCCCCCccEEeCCCCccccccCccccccc-ccceeecccccc
Q 044366 327 EAFGDHPNLTFLDLSQNNFYCEISFNWRNFS-KLGTFNASMNNI 369 (918)
Q Consensus 327 ~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~-~L~~l~l~~n~i 369 (918)
.+|... +|+.+++++|.+..+....|.+++ .+..+.+..+.+
T Consensus 340 ~aF~~~-~L~~l~l~~n~~~~l~~~~F~~~~~~l~~l~vp~~~~ 382 (401)
T 4fdw_A 340 SAFNNT-GIKEVKVEGTTPPQVFEKVWYGFPDDITVIRVPAESV 382 (401)
T ss_dssp TSSSSS-CCCEEEECCSSCCBCCCSSCCCSCTTCCEEEECGGGH
T ss_pred HhCCCC-CCCEEEEcCCCCcccccccccCCCCCccEEEeCHHHH
Confidence 667666 677777777666666666666663 556666655544
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.73 E-value=5.1e-18 Score=176.99 Aligned_cols=141 Identities=18% Similarity=0.197 Sum_probs=107.2
Q ss_pred CCCceeeccccceEEEEEEe-CCCCE--EEEEEcccccccCCC--------------------CChHHHHHHHHHHhhcc
Q 044366 648 FGEKYCIGKGGQRSVYKAEL-PSGNI--FAVKKFKAELFSDET--------------------ANPSEFLNEVLALTEIR 704 (918)
Q Consensus 648 ~~~~~~lg~G~~g~Vy~~~~-~~~~~--vavK~~~~~~~~~~~--------------------~~~~~~~~e~~~l~~l~ 704 (918)
|.+.+.||+|+||.||+|.. .+|+. ||||+++........ .....+.+|+..++.++
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 56778999999999999976 68999 999987543111000 00136889999999998
Q ss_pred CCce--eeEecccccCCceEEEEEeccC-C----ChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHH-hCCCCCeEEc
Q 044366 705 HRNI--IKFHGFCSNAQHSFIVCEYLAR-G----SLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLH-HDCIPPIVHR 776 (918)
Q Consensus 705 h~ni--v~~~~~~~~~~~~~lv~e~~~~-g----sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH-~~~~~~ivH~ 776 (918)
|+++ +.++++ +..++||||+.+ | +|.++... .++.++..++.|++.|++||| +. +|+||
T Consensus 129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~------~~~~~~~~i~~qi~~~l~~lH~~~---givHr 195 (258)
T 1zth_A 129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE------LKELDVEGIFNDVVENVKRLYQEA---ELVHA 195 (258)
T ss_dssp HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG------GGGSCHHHHHHHHHHHHHHHHHTS---CEECS
T ss_pred hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc------cChHHHHHHHHHHHHHHHHHHHHC---CEEeC
Confidence 8764 334432 357899999953 4 66665432 224467889999999999999 88 99999
Q ss_pred CCCCCCeeeCCCCcEEEeccccccccC
Q 044366 777 DISSKNVLLDSEYEAHVSDFGFAKFLE 803 (918)
Q Consensus 777 dlk~~Nill~~~~~~kl~DfG~~~~~~ 803 (918)
||||+|||+++ .++|+|||+|....
T Consensus 196 Dlkp~NILl~~--~~~liDFG~a~~~~ 220 (258)
T 1zth_A 196 DLSEYNIMYID--KVYFIDMGQAVTLR 220 (258)
T ss_dssp SCSTTSEEESS--SEEECCCTTCEETT
T ss_pred CCCHHHEEEcC--cEEEEECcccccCC
Confidence 99999999998 99999999997653
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=99.73 E-value=9.2e-17 Score=177.99 Aligned_cols=267 Identities=10% Similarity=0.067 Sum_probs=215.1
Q ss_pred CCCCCCEEECcCCcCCCcCCcCCCCCCCCceeeccccccccCCCcccccccccCeeeccccccCCcCCccCCCCCCCcEe
Q 044366 115 NLKSLSTLDLSQNQLNGSIPCSLDNLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSENRLSGLIPLSLSNLSSLTVM 194 (918)
Q Consensus 115 ~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L 194 (918)
.+..++.+.+.. .++.+...+|.+. +|+.+.+..+ ++.+...+|.+. +|+.+.+.. .++.+.+.+|.+|++|+.+
T Consensus 111 ~~~~l~~i~ip~-~i~~I~~~aF~~~-~L~~i~l~~~-i~~I~~~aF~~~-~L~~i~lp~-~l~~I~~~aF~~c~~L~~l 185 (401)
T 4fdw_A 111 ILKGYNEIILPN-SVKSIPKDAFRNS-QIAKVVLNEG-LKSIGDMAFFNS-TVQEIVFPS-TLEQLKEDIFYYCYNLKKA 185 (401)
T ss_dssp ECSSCSEEECCT-TCCEECTTTTTTC-CCSEEECCTT-CCEECTTTTTTC-CCCEEECCT-TCCEECSSTTTTCTTCCEE
T ss_pred ecCCccEEEECC-ccCEehHhhcccC-CccEEEeCCC-ccEECHHhcCCC-CceEEEeCC-CccEehHHHhhCcccCCee
Confidence 346788888765 5665777788875 7899988776 777777888884 688888885 6777777889999999999
Q ss_pred eccCcccccCCCccccCCCCcceeecccccccCCCCCCCcCCCcCCeEEcccCcCcCCCCccccccCCCCeEecCCCccC
Q 044366 195 SLFNNSLSGSIPPILGNLKSLSTLGLHINQLNGVIPPSIGNLSSLRNLSLFNNRLYGFVPKEIGYLKSLSKLEFCANHLS 274 (918)
Q Consensus 195 ~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~ 274 (918)
++++|.++.+...+|. ..+|+.+.+..+ ++.+....|.++++|+.+++.+| ++.+...+|.+ .+|+.+.+ .+.+.
T Consensus 186 ~l~~n~l~~I~~~aF~-~~~L~~l~lp~~-l~~I~~~aF~~~~~L~~l~l~~~-l~~I~~~aF~~-~~L~~i~l-p~~i~ 260 (401)
T 4fdw_A 186 DLSKTKITKLPASTFV-YAGIEEVLLPVT-LKEIGSQAFLKTSQLKTIEIPEN-VSTIGQEAFRE-SGITTVKL-PNGVT 260 (401)
T ss_dssp ECTTSCCSEECTTTTT-TCCCSEEECCTT-CCEECTTTTTTCTTCCCEECCTT-CCEECTTTTTT-CCCSEEEE-ETTCC
T ss_pred ecCCCcceEechhhEe-ecccCEEEeCCc-hheehhhHhhCCCCCCEEecCCC-ccCcccccccc-CCccEEEe-CCCcc
Confidence 9998888877777777 588999988844 77777788888989999999875 66677778877 78999988 55677
Q ss_pred CcCCCcCCCCCCCcEEEccCCcCc-----CCCCccccCCCCCCeEEeecccccCccccccCCCCCccEEeCCCCcccccc
Q 044366 275 GVIPHSVGNLTGLVLLNMCENHLF-----GPIPKSLRNLTSLERVRFNQNNLYGKVYEAFGDHPNLTFLDLSQNNFYCEI 349 (918)
Q Consensus 275 ~~~~~~~~~l~~L~~L~l~~n~l~-----~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~ 349 (918)
.+...+|.++++|+.+.+.+|.+. .+.+.+|.++++|+.+.+. +.+..+...+|.++++|+.+++..| ++.+.
T Consensus 261 ~I~~~aF~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~-~~i~~I~~~aF~~c~~L~~l~lp~~-l~~I~ 338 (401)
T 4fdw_A 261 NIASRAFYYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIP-ESIRILGQGLLGGNRKVTQLTIPAN-VTQIN 338 (401)
T ss_dssp EECTTTTTTCTTCCEEEEESSCCCCCTTCEECTTTTTTCTTCCEECCC-TTCCEECTTTTTTCCSCCEEEECTT-CCEEC
T ss_pred EEChhHhhCCCCCCEEEeCCccccCCcccEECHHHhhCCccCCeEEeC-CceEEEhhhhhcCCCCccEEEECcc-ccEEc
Confidence 778888999999999998887765 4667888899999999988 5588888889998899999999655 77888
Q ss_pred CcccccccccceeeccccccccCCCcCcCCCC-CCcEEEccCceec
Q 044366 350 SFNWRNFSKLGTFNASMNNIYGSIPPEIGDSS-KLQVLDLSSNHIF 394 (918)
Q Consensus 350 ~~~~~~~~~L~~l~l~~n~i~~~~~~~~~~~~-~L~~L~L~~N~l~ 394 (918)
..+|.++ +|+.+.+++|.+....+..|.+++ +++.|.+..+.+.
T Consensus 339 ~~aF~~~-~L~~l~l~~n~~~~l~~~~F~~~~~~l~~l~vp~~~~~ 383 (401)
T 4fdw_A 339 FSAFNNT-GIKEVKVEGTTPPQVFEKVWYGFPDDITVIRVPAESVE 383 (401)
T ss_dssp TTSSSSS-CCCEEEECCSSCCBCCCSSCCCSCTTCCEEEECGGGHH
T ss_pred HHhCCCC-CCCEEEEcCCCCcccccccccCCCCCccEEEeCHHHHH
Confidence 8888888 899999999888877777788874 7888888887764
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.72 E-value=8.6e-18 Score=166.85 Aligned_cols=129 Identities=30% Similarity=0.306 Sum_probs=72.3
Q ss_pred eeeccccccccCCCcCcCCCCCCcEEEccCceecccccc-chhhccccCceecccccccCCCCCCCCCCCcccEEeccCc
Q 044366 361 TFNASMNNIYGSIPPEIGDSSKLQVLDLSSNHIFGKIPV-QLVKLFSLNKLILSLNQLFGGVPLEFGTLTELQYLDLSAN 439 (918)
Q Consensus 361 ~l~l~~n~i~~~~~~~~~~~~~L~~L~L~~N~l~~~~~~-~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N 439 (918)
.+++++|++. .+|..+.. ++++|+|++|+|++..+. .|..+++|+.|+|++|++++..|..|..+++|++|+|++|
T Consensus 12 ~l~~s~~~l~-~ip~~~~~--~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N 88 (192)
T 1w8a_A 12 TVDCTGRGLK-EIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGEN 88 (192)
T ss_dssp EEECTTSCCS-SCCSCCCT--TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSC
T ss_pred EEEcCCCCcC-cCccCCCC--CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCCC
Confidence 4445555553 34443332 566666666666654443 3555556666666666655555555555566666666666
Q ss_pred cccccCccccccccccceecccCcccCCCCchhhccccccceEeccCCcCCCC
Q 044366 440 KLSSSIPMSIGNLLKLHYLNLSNNQFSHKIPTEFEKLIHLSELDLSHNILQEE 492 (918)
Q Consensus 440 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~ 492 (918)
+|++..+..|..+++|++|+|++|+|++..|..|..+++|++|+|++|.+++.
T Consensus 89 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~ 141 (192)
T 1w8a_A 89 KIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCN 141 (192)
T ss_dssp CCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCS
T ss_pred cCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCc
Confidence 65555555555555555555555555555555555555555555555555543
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.71 E-value=2.7e-18 Score=205.58 Aligned_cols=218 Identities=22% Similarity=0.222 Sum_probs=86.6
Q ss_pred CCCCEEeCCCCcccccCCccccCCCCCCEEE-----cccccccccCCCCcCCCCCCCEEEcccccccccCCccccCCCCC
Q 044366 21 SKLQYLDLGNNQLSGVIPPEIGKLNQLRRLY-----LDVNQLHGTIPPVIGQLSLINELVFCHNNVSGRIPSSLGNLSNL 95 (918)
Q Consensus 21 ~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~-----L~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~l~~l~~L 95 (918)
+.++.|+|.+|.+. ..+..+.....|+.+. +..|++. ..|..+..+..|++|+|++|.+. .+|..+..+++|
T Consensus 173 ~~~~~l~L~~n~~~-~~~~~~l~~l~Ls~~~i~~~~~~~n~~~-~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~~l~~L 249 (727)
T 4b8c_D 173 PLTPKIELFANGKD-EANQALLQHKKLSQYSIDEDDDIENRMV-MPKDSKYDDQLWHALDLSNLQIF-NISANIFKYDFL 249 (727)
T ss_dssp ---------------------------------------------------CCCCCCEEECTTSCCS-CCCGGGGGCCSC
T ss_pred CccceEEeeCCCCC-cchhhHhhcCccCcccccCcccccccee-cChhhhccCCCCcEEECCCCCCC-CCChhhcCCCCC
Confidence 34556666666665 2343333333333332 2223333 44555666666666666666666 556555566666
Q ss_pred CEEEccCCcccccCccccCCCCCCCEEECcCCcCCCcCCcCCCCCCCCceeeccccccccCCCcccccccccCeeecccc
Q 044366 96 ALLYLNDNSLFGSIPIVMGNLKSLSTLDLSQNQLNGSIPCSLDNLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSEN 175 (918)
Q Consensus 96 ~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N 175 (918)
++|+|++|.|+ .+|..|.+|++|++|+|++|+|+ .+|..|++|++|++|+|++|.|+ .+|..|+.+++|++|+|++|
T Consensus 250 ~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~-~lp~~~~~l~~L~~L~L~~N 326 (727)
T 4b8c_D 250 TRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-SLPAELGSCFQLKYFYFFDNMVT-TLPWEFGNLCNLQFLGVEGN 326 (727)
T ss_dssp SCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-SCCSSGGGGTTCSEEECCSSCCC-CCCSSTTSCTTCCCEECTTS
T ss_pred CEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-ccChhhcCCCCCCEEECCCCCCC-ccChhhhcCCCccEEeCCCC
Confidence 66666666665 55666666666666666666666 45666666666666666666665 33445666666666666666
Q ss_pred ccCCcCCccCCCCCC-CcEeeccCcccccCCCccccCCCCcceeecccc--------cccCCCCCCCcCCCcCCeEEccc
Q 044366 176 RLSGLIPLSLSNLSS-LTVMSLFNNSLSGSIPPILGNLKSLSTLGLHIN--------QLNGVIPPSIGNLSSLRNLSLFN 246 (918)
Q Consensus 176 ~l~~~~~~~~~~l~~-L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n--------~l~~~~~~~~~~l~~L~~L~Ls~ 246 (918)
.+++.+|..+..+.. +..|+|++|.+++.+|.. |+.|+++.| .+.+..+..+..+..++...+++
T Consensus 327 ~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~~p~~------l~~l~l~~n~~~~~~~~~l~~~~~~~~~~l~~~~~~~ls~ 400 (727)
T 4b8c_D 327 PLEKQFLKILTEKSVTGLIFYLRDNRPEIPLPHE------RRFIEINTDGEPQREYDSLQQSTEHLATDLAKRTFTVLSY 400 (727)
T ss_dssp CCCSHHHHHHHHHHHHHHHHHHHHCCCCCCCCCC----------------------------------------------
T ss_pred ccCCCChHHHhhcchhhhHHhhccCcccCcCccc------cceeEeecccccccccCCccccccchhhcccccceeeeec
Confidence 666665555543321 123566666666555542 334444444 33333344455566667777777
Q ss_pred CcCc
Q 044366 247 NRLY 250 (918)
Q Consensus 247 n~l~ 250 (918)
|-+.
T Consensus 401 Nil~ 404 (727)
T 4b8c_D 401 NTLC 404 (727)
T ss_dssp -CCC
T ss_pred cccc
Confidence 7665
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.71 E-value=2.8e-17 Score=163.05 Aligned_cols=132 Identities=26% Similarity=0.271 Sum_probs=111.7
Q ss_pred CceecccccccCCCCCCCCCCCcccEEeccCccccccCccccccccccceecccCcccCCCCchhhccccccceEeccCC
Q 044366 408 NKLILSLNQLFGGVPLEFGTLTELQYLDLSANKLSSSIPMSIGNLLKLHYLNLSNNQFSHKIPTEFEKLIHLSELDLSHN 487 (918)
Q Consensus 408 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N 487 (918)
+.+++++|+++.+ |..+ .++|++|+|++|.|+ .+|..|..+++|+.|+|++|+|+++.+..|.++++|++|+|++|
T Consensus 13 ~~l~~~~~~l~~i-p~~~--~~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N 88 (193)
T 2wfh_A 13 TVVRCSNKGLKVL-PKGI--PRDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYN 88 (193)
T ss_dssp TEEECTTSCCSSC-CSCC--CTTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEEcCCCCCCcC-CCCC--CCCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCC
Confidence 3455666665533 3322 257899999999998 56788999999999999999999888889999999999999999
Q ss_pred cCCCCCchhccccCCcceEecCCCcccccCcccccCCCCccEEEccCCcCCCCCCC
Q 044366 488 ILQEEIPPQICKMESLEKLNLSHNNLSDFIPRCFEEMRSLSWIDISYNELQGPIPN 543 (918)
Q Consensus 488 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~p~ 543 (918)
+|++..|..|.++++|+.|+|++|+|+++.+..|..+++|+.|++++|+|.|.+..
T Consensus 89 ~l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C~c~l 144 (193)
T 2wfh_A 89 RLRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYCDCNM 144 (193)
T ss_dssp CCCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEECSGGG
T ss_pred ccCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCeecCCcC
Confidence 99988888899999999999999999998888899999999999999999987653
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=99.71 E-value=2.4e-16 Score=175.78 Aligned_cols=136 Identities=8% Similarity=0.002 Sum_probs=63.6
Q ss_pred ccccCccccCCCCCCCEEECcCCcCCCcCCcCCCCCCCCceeeccccccccCCCcccccccccCeeeccccccCCcCCcc
Q 044366 105 LFGSIPIVMGNLKSLSTLDLSQNQLNGSIPCSLDNLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSENRLSGLIPLS 184 (918)
Q Consensus 105 i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~ 184 (918)
++.+...+|.++.+|+.+.+.. .++.+...+|.++++|+.+++..+ ++.+...+|.++++|+.+.+..+ +..+...+
T Consensus 59 VtsIg~~AF~~c~~L~~i~lp~-~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~c~~L~~i~~p~~-l~~i~~~a 135 (394)
T 4fs7_A 59 VVSIGYAAFQGCRKVTEIKIPS-TVREIGEFAFENCSKLEIINIPDS-VKMIGRCTFSGCYALKSILLPLM-LKSIGVEA 135 (394)
T ss_dssp EEEECTTTTTTCTTEEEEECCT-TCCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCCCCCCTT-CCEECTTT
T ss_pred EeEhHHHHhhCCCCceEEEeCC-CccCcchhHhhCCCCCcEEEeCCC-ceEccchhhcccccchhhcccCc-eeeeccee
Confidence 3444555666666666666653 355455556666666666666543 44444555556666655555433 33333444
Q ss_pred CCCCCCCcEeeccCcccccCCCccccCCCCcceeecccccccCCCCCCCcCCCcCCeEEccc
Q 044366 185 LSNLSSLTVMSLFNNSLSGSIPPILGNLKSLSTLGLHINQLNGVIPPSIGNLSSLRNLSLFN 246 (918)
Q Consensus 185 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~ 246 (918)
|.++..+........ ..+...+|.++++|+.+.+..+. ..+....|.++.+|+.+++..
T Consensus 136 F~~~~~~~~~~~~~~--~~i~~~aF~~c~~L~~i~l~~~~-~~I~~~~F~~c~~L~~i~l~~ 194 (394)
T 4fs7_A 136 FKGCDFKEITIPEGV--TVIGDEAFATCESLEYVSLPDSM-ETLHNGLFSGCGKLKSIKLPR 194 (394)
T ss_dssp TTTCCCSEEECCTTC--CEECTTTTTTCTTCCEEECCTTC-CEECTTTTTTCTTCCBCCCCT
T ss_pred eecccccccccCccc--cccchhhhcccCCCcEEecCCcc-ceeccccccCCCCceEEEcCC
Confidence 544433322222211 11223344444444444443332 223333444444444444433
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.70 E-value=3.3e-18 Score=204.78 Aligned_cols=141 Identities=29% Similarity=0.401 Sum_probs=65.7
Q ss_pred CcCcCCCCCCcEEEccCceeccccccchhhccccCceecccccccCCCCCCCCCCCcccEEeccCccccccCcccccccc
Q 044366 374 PPEIGDSSKLQVLDLSSNHIFGKIPVQLVKLFSLNKLILSLNQLFGGVPLEFGTLTELQYLDLSANKLSSSIPMSIGNLL 453 (918)
Q Consensus 374 ~~~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~ 453 (918)
+..|..+++|+.|+|++|+|. .+|..+..+++|+.|+|++|+|+ .+|..|..+++|++|+|++|.|+ .+|..|+.++
T Consensus 217 ~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~ 293 (727)
T 4b8c_D 217 KDSKYDDQLWHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-SLPAELGSCF 293 (727)
T ss_dssp -----CCCCCCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-SCCSSGGGGT
T ss_pred hhhhccCCCCcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-ccChhhcCCC
Confidence 344444555555555555554 33333444555555555555554 34444455555555555555555 3344555555
Q ss_pred ccceecccCcccCCCCchhhccccccceEeccCCcCCCCCchhccccCC-cceEecCCCcccccCc
Q 044366 454 KLHYLNLSNNQFSHKIPTEFEKLIHLSELDLSHNILQEEIPPQICKMES-LEKLNLSHNNLSDFIP 518 (918)
Q Consensus 454 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~-L~~L~L~~N~l~~~~~ 518 (918)
+|++|+|++|.|+ .+|..|..+++|+.|+|++|.|++.+|..+..+.. +..|+|++|.+++.+|
T Consensus 294 ~L~~L~L~~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~~p 358 (727)
T 4b8c_D 294 QLKYFYFFDNMVT-TLPWEFGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYLRDNRPEIPLP 358 (727)
T ss_dssp TCSEEECCSSCCC-CCCSSTTSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCCCCCC
T ss_pred CCCEEECCCCCCC-ccChhhhcCCCccEEeCCCCccCCCChHHHhhcchhhhHHhhccCcccCcCc
Confidence 5555555555554 33444555555555555555555444444433221 1224455555544444
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=99.70 E-value=4.4e-16 Score=173.58 Aligned_cols=335 Identities=12% Similarity=0.041 Sum_probs=186.4
Q ss_pred cccccCCccccCCCCCCEEEccCCcccccCccccCCCCCCCEEECcCCcCCCcCCcCCCCCCCCceeeccccccccCCCc
Q 044366 80 NVSGRIPSSLGNLSNLALLYLNDNSLFGSIPIVMGNLKSLSTLDLSQNQLNGSIPCSLDNLSNLDTLFLYKNSLSGPIPS 159 (918)
Q Consensus 80 ~~~~~~p~~l~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~ 159 (918)
.++..-..+|.++++|+.+.+..+ ++.+...+|.++.+|+.+++..+ ++.+...+|.++.+|+.+.+..+ +..+...
T Consensus 58 ~VtsIg~~AF~~c~~L~~i~lp~~-i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~c~~L~~i~~p~~-l~~i~~~ 134 (394)
T 4fs7_A 58 DVVSIGYAAFQGCRKVTEIKIPST-VREIGEFAFENCSKLEIINIPDS-VKMIGRCTFSGCYALKSILLPLM-LKSIGVE 134 (394)
T ss_dssp EEEEECTTTTTTCTTEEEEECCTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCCCCCCTT-CCEECTT
T ss_pred eEeEhHHHHhhCCCCceEEEeCCC-ccCcchhHhhCCCCCcEEEeCCC-ceEccchhhcccccchhhcccCc-eeeecce
Confidence 455455667888888888888754 66667778888888888888754 55566677888888888777654 4446666
Q ss_pred ccccccccCeeeccccccCCcCCccCCCCCCCcEeeccCcccccCCCccccCCCCcceeecccccccCCCCCCCcCCCcC
Q 044366 160 VIGNLKSLLQLDLSENRLSGLIPLSLSNLSSLTVMSLFNNSLSGSIPPILGNLKSLSTLGLHINQLNGVIPPSIGNLSSL 239 (918)
Q Consensus 160 ~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L 239 (918)
+|.++..++...... +..+...+|.++++|+.+.+.++.. .+...+|.++.+|+.+.+..+ ++.+....|.++..|
T Consensus 135 aF~~~~~~~~~~~~~--~~~i~~~aF~~c~~L~~i~l~~~~~-~I~~~~F~~c~~L~~i~l~~~-~~~I~~~~F~~~~~L 210 (394)
T 4fs7_A 135 AFKGCDFKEITIPEG--VTVIGDEAFATCESLEYVSLPDSME-TLHNGLFSGCGKLKSIKLPRN-LKIIRDYCFAECILL 210 (394)
T ss_dssp TTTTCCCSEEECCTT--CCEECTTTTTTCTTCCEEECCTTCC-EECTTTTTTCTTCCBCCCCTT-CCEECTTTTTTCTTC
T ss_pred eeecccccccccCcc--ccccchhhhcccCCCcEEecCCccc-eeccccccCCCCceEEEcCCC-ceEeCchhhcccccc
Confidence 777765444333332 2334456788888888888876543 366677888888888888766 554556677777777
Q ss_pred CeEEcccCcCcCCCCccccccCCCCeEecCCCccCCcCCCcCCCCCCCcEEEccCCcCcCCCCccccCCCCCCeEEeecc
Q 044366 240 RNLSLFNNRLYGFVPKEIGYLKSLSKLEFCANHLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLRNLTSLERVRFNQN 319 (918)
Q Consensus 240 ~~L~Ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n 319 (918)
+.+.+.++... + .+.+....+|+.+.+..+ +..+....|.++..++.+.+..+.. .+....|.++..++.+.+..+
T Consensus 211 ~~i~~~~~~~~-i-~~~~~~~~~l~~i~ip~~-~~~i~~~~f~~~~~l~~~~~~~~~~-~i~~~~F~~~~~l~~~~~~~~ 286 (394)
T 4fs7_A 211 ENMEFPNSLYY-L-GDFALSKTGVKNIIIPDS-FTELGKSVFYGCTDLESISIQNNKL-RIGGSLFYNCSGLKKVIYGSV 286 (394)
T ss_dssp CBCCCCTTCCE-E-CTTTTTTCCCCEEEECTT-CCEECSSTTTTCSSCCEEEECCTTC-EECSCTTTTCTTCCEEEECSS
T ss_pred ceeecCCCceE-e-ehhhcccCCCceEEECCC-ceecccccccccccceeEEcCCCcc-eeeccccccccccceeccCce
Confidence 77776665432 1 122222345555555332 2223333444444444444433321 122333333333333333221
Q ss_pred cccCccccccCCCCCccEEeCCCCccccccCcccccccccceeeccccccccCCCcCcCCCCCCcEEEccCceecccccc
Q 044366 320 NLYGKVYEAFGDHPNLTFLDLSQNNFYCEISFNWRNFSKLGTFNASMNNIYGSIPPEIGDSSKLQVLDLSSNHIFGKIPV 399 (918)
Q Consensus 320 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~n~i~~~~~~~~~~~~~L~~L~L~~N~l~~~~~~ 399 (918)
. +... .|..+.+|+.+.+..+ ++.+...
T Consensus 287 ~---i~~~------------------------------------------------~F~~~~~L~~i~l~~~-i~~I~~~ 314 (394)
T 4fs7_A 287 I---VPEK------------------------------------------------TFYGCSSLTEVKLLDS-VKFIGEE 314 (394)
T ss_dssp E---ECTT------------------------------------------------TTTTCTTCCEEEECTT-CCEECTT
T ss_pred e---eccc------------------------------------------------cccccccccccccccc-cceechh
Confidence 1 1122 3334444444444433 3333444
Q ss_pred chhhccccCceecccccccCCCCCCCCCCCcccEEeccCccccccCccccccccccceecccCcccCCCCchhhcccccc
Q 044366 400 QLVKLFSLNKLILSLNQLFGGVPLEFGTLTELQYLDLSANKLSSSIPMSIGNLLKLHYLNLSNNQFSHKIPTEFEKLIHL 479 (918)
Q Consensus 400 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L 479 (918)
+|.++.+|+.++|..+ ++.+...+|.++++|+.+++..| ++.+...+|.++++|+.+++..+ ++ ....+|.++++|
T Consensus 315 aF~~c~~L~~i~lp~~-v~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~lp~~-~~-~~~~~F~~c~~L 390 (394)
T 4fs7_A 315 AFESCTSLVSIDLPYL-VEEIGKRSFRGCTSLSNINFPLS-LRKIGANAFQGCINLKKVELPKR-LE-QYRYDFEDTTKF 390 (394)
T ss_dssp TTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTBTTCTTCCEEEEEGG-GG-GGGGGBCTTCEE
T ss_pred hhcCCCCCCEEEeCCc-ccEEhHHhccCCCCCCEEEECcc-ccEehHHHhhCCCCCCEEEECCC-CE-EhhheecCCCCC
Confidence 4555555555555422 44444555666666666666554 55455556666666666666544 22 223456666655
Q ss_pred ce
Q 044366 480 SE 481 (918)
Q Consensus 480 ~~ 481 (918)
+.
T Consensus 391 ~~ 392 (394)
T 4fs7_A 391 KW 392 (394)
T ss_dssp EE
T ss_pred cE
Confidence 54
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.68 E-value=1.1e-16 Score=156.84 Aligned_cols=133 Identities=26% Similarity=0.241 Sum_probs=101.2
Q ss_pred CceecccccccCCCCCCCCCCCcccEEeccCccccccCccccccccccceecccCcccCCCCchhhccccccceEeccCC
Q 044366 408 NKLILSLNQLFGGVPLEFGTLTELQYLDLSANKLSSSIPMSIGNLLKLHYLNLSNNQFSHKIPTEFEKLIHLSELDLSHN 487 (918)
Q Consensus 408 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N 487 (918)
+.+++++|+++... ..+ .++|++|++++|.+++..+..|..+++|++|+|++|+|++..+..|..+++|++|+|++|
T Consensus 10 ~~l~~~~~~l~~~p-~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N 86 (177)
T 2o6r_A 10 TEIRCNSKGLTSVP-TGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHEN 86 (177)
T ss_dssp TEEECCSSCCSSCC-TTC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEEecCCCCccCC-CCC--CCCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCCC
Confidence 45555666655433 222 257788888888888766667778888888888888887777777788888888888888
Q ss_pred cCCCCCchhccccCCcceEecCCCcccccCcccccCCCCccEEEccCCcCCCCCCC
Q 044366 488 ILQEEIPPQICKMESLEKLNLSHNNLSDFIPRCFEEMRSLSWIDISYNELQGPIPN 543 (918)
Q Consensus 488 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~p~ 543 (918)
+|++..+..|..+++|+.|+|++|+++++.+..|..+++|+.|++++|+++|.+|.
T Consensus 87 ~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~ 142 (177)
T 2o6r_A 87 KLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR 142 (177)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCHHH
T ss_pred CccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeeccCcc
Confidence 88877777778888888888888888887777778888888888888888887763
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.68 E-value=7.4e-17 Score=156.54 Aligned_cols=130 Identities=26% Similarity=0.308 Sum_probs=69.8
Q ss_pred cCceeccccccc-CCCCCCCCCCCcccEEeccCccccccCccccccccccceecccCcccCCCCchhhccccccceEecc
Q 044366 407 LNKLILSLNQLF-GGVPLEFGTLTELQYLDLSANKLSSSIPMSIGNLLKLHYLNLSNNQFSHKIPTEFEKLIHLSELDLS 485 (918)
Q Consensus 407 L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls 485 (918)
|+.|++++|+++ +.+|..+..+++|++|+|++|.|++. ..|..+++|++|+|++|++++.+|..+..+++|++|+|+
T Consensus 26 L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls 103 (168)
T 2ell_A 26 VRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLS 103 (168)
T ss_dssp CSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEECB
T ss_pred CCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEecc
Confidence 333333333333 23333444455555555555555543 445555555555555555554455555555666666666
Q ss_pred CCcCCCCCc-hhccccCCcceEecCCCcccccCc---ccccCCCCccEEEccCCcCC
Q 044366 486 HNILQEEIP-PQICKMESLEKLNLSHNNLSDFIP---RCFEEMRSLSWIDISYNELQ 538 (918)
Q Consensus 486 ~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~---~~~~~l~~L~~l~l~~N~l~ 538 (918)
+|+|++..+ ..+..+++|+.|+|++|++++..+ ..+..+++|+.||+++|.++
T Consensus 104 ~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~ 160 (168)
T 2ell_A 104 GNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQ 160 (168)
T ss_dssp SSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSC
T ss_pred CCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChh
Confidence 666654321 455566666666666666665444 35566666666666666554
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.68 E-value=9.7e-17 Score=155.70 Aligned_cols=135 Identities=23% Similarity=0.201 Sum_probs=120.2
Q ss_pred CCCCcEEEccCceec-cccccchhhccccCceecccccccCCCCCCCCCCCcccEEeccCccccccCcccccccccccee
Q 044366 380 SSKLQVLDLSSNHIF-GKIPVQLVKLFSLNKLILSLNQLFGGVPLEFGTLTELQYLDLSANKLSSSIPMSIGNLLKLHYL 458 (918)
Q Consensus 380 ~~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L 458 (918)
.++|+.|++++|.+. +.+|..+..+++|+.|+|++|++++. ..+..+++|++|+|++|.+++.+|..+..+++|++|
T Consensus 23 ~~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L 100 (168)
T 2ell_A 23 PAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHL 100 (168)
T ss_dssp TTSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEE
T ss_pred cccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEE
Confidence 368999999999997 67788889999999999999999876 788999999999999999998788888889999999
Q ss_pred cccCcccCCCCc-hhhccccccceEeccCCcCCCCCc---hhccccCCcceEecCCCccccc
Q 044366 459 NLSNNQFSHKIP-TEFEKLIHLSELDLSHNILQEEIP---PQICKMESLEKLNLSHNNLSDF 516 (918)
Q Consensus 459 ~Ls~N~l~~~~~-~~~~~l~~L~~L~Ls~N~l~~~~~---~~~~~l~~L~~L~L~~N~l~~~ 516 (918)
+|++|+|++..+ ..|..+++|+.|++++|.+++..+ ..+..+++|+.|++++|.+...
T Consensus 101 ~Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~ 162 (168)
T 2ell_A 101 NLSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQEA 162 (168)
T ss_dssp ECBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSCBC
T ss_pred eccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChhhc
Confidence 999999986533 789999999999999999997655 5899999999999999998764
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.66 E-value=1.1e-16 Score=151.94 Aligned_cols=128 Identities=24% Similarity=0.301 Sum_probs=98.1
Q ss_pred cccCceeccccccc-CCCCCCCCCCCcccEEeccCccccccCccccccccccceecccCcccCCCCchhhccccccceEe
Q 044366 405 FSLNKLILSLNQLF-GGVPLEFGTLTELQYLDLSANKLSSSIPMSIGNLLKLHYLNLSNNQFSHKIPTEFEKLIHLSELD 483 (918)
Q Consensus 405 ~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 483 (918)
++|+.|++++|+++ +.+|..+..+++|++|++++|.+++. ..+..+++|++|+|++|+|++.+|..+..+++|++|+
T Consensus 17 ~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ 94 (149)
T 2je0_A 17 SDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLN 94 (149)
T ss_dssp GGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEE
T ss_pred ccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEE
Confidence 45666667777666 45666677778888888888888765 6677888888888888888776777777788888888
Q ss_pred ccCCcCCCC-CchhccccCCcceEecCCCcccccCc---ccccCCCCccEEEccC
Q 044366 484 LSHNILQEE-IPPQICKMESLEKLNLSHNNLSDFIP---RCFEEMRSLSWIDISY 534 (918)
Q Consensus 484 Ls~N~l~~~-~~~~~~~l~~L~~L~L~~N~l~~~~~---~~~~~l~~L~~l~l~~ 534 (918)
+++|+|++. .+..+..+++|+.|++++|++++..+ ..+..+++|+.||+++
T Consensus 95 ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~d 149 (149)
T 2je0_A 95 LSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGYD 149 (149)
T ss_dssp CTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTBC
T ss_pred CCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCCC
Confidence 888888763 34778888888888888888887665 5778888888888763
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.64 E-value=2e-16 Score=150.02 Aligned_cols=128 Identities=23% Similarity=0.170 Sum_probs=106.3
Q ss_pred CCCcEEEccCceec-cccccchhhccccCceecccccccCCCCCCCCCCCcccEEeccCccccccCccccccccccceec
Q 044366 381 SKLQVLDLSSNHIF-GKIPVQLVKLFSLNKLILSLNQLFGGVPLEFGTLTELQYLDLSANKLSSSIPMSIGNLLKLHYLN 459 (918)
Q Consensus 381 ~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 459 (918)
++|+.|++++|.+. +.+|..+..+++|+.|++++|++++. ..+..+++|++|+|++|.+++.+|..+..+++|++|+
T Consensus 17 ~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ 94 (149)
T 2je0_A 17 SDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLN 94 (149)
T ss_dssp GGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEE
T ss_pred ccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEE
Confidence 56777888888776 56677777788888888888888766 6788899999999999999977888888899999999
Q ss_pred ccCcccCCC-CchhhccccccceEeccCCcCCCCCc---hhccccCCcceEecCC
Q 044366 460 LSNNQFSHK-IPTEFEKLIHLSELDLSHNILQEEIP---PQICKMESLEKLNLSH 510 (918)
Q Consensus 460 Ls~N~l~~~-~~~~~~~l~~L~~L~Ls~N~l~~~~~---~~~~~l~~L~~L~L~~ 510 (918)
+++|++++. .+..|..+++|++|++++|.+++..+ ..+..+++|+.|++++
T Consensus 95 ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~d 149 (149)
T 2je0_A 95 LSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGYD 149 (149)
T ss_dssp CTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTBC
T ss_pred CCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCCC
Confidence 999999864 34789999999999999999987665 5788899999999874
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.63 E-value=9.8e-16 Score=149.98 Aligned_cols=132 Identities=28% Similarity=0.265 Sum_probs=96.5
Q ss_pred cEEEccCceeccccccchhhccccCceecccccccCCCCCCCCCCCcccEEeccCccccccCccccccccccceecccCc
Q 044366 384 QVLDLSSNHIFGKIPVQLVKLFSLNKLILSLNQLFGGVPLEFGTLTELQYLDLSANKLSSSIPMSIGNLLKLHYLNLSNN 463 (918)
Q Consensus 384 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N 463 (918)
+.+++++|+++.. |..+. ++|+.|++++|++++..+..|..+++|++|+|++|.|++..+..|..+++|++|+|++|
T Consensus 10 ~~l~~~~~~l~~~-p~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N 86 (177)
T 2o6r_A 10 TEIRCNSKGLTSV-PTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHEN 86 (177)
T ss_dssp TEEECCSSCCSSC-CTTCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEEecCCCCccC-CCCCC--CCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCCC
Confidence 4556666666532 32222 46677777777777666667777888888888888888766666778888888888888
Q ss_pred ccCCCCchhhccccccceEeccCCcCCCCCchhccccCCcceEecCCCcccccCc
Q 044366 464 QFSHKIPTEFEKLIHLSELDLSHNILQEEIPPQICKMESLEKLNLSHNNLSDFIP 518 (918)
Q Consensus 464 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~ 518 (918)
+|++..+..|..+++|++|+|++|+|++..+..|..+++|+.|+|++|++++..|
T Consensus 87 ~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 141 (177)
T 2o6r_A 87 KLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 141 (177)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred CccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeeccCc
Confidence 8887777777888888888888888886666667778888888888888876443
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.63 E-value=3.6e-16 Score=168.37 Aligned_cols=149 Identities=10% Similarity=0.062 Sum_probs=104.9
Q ss_pred HHhcCCCCceeeccccceEEEEEEeCCCCEEEEEEcccccccCC----------CCChHHHHHHHHHHhhccCCceeeEe
Q 044366 643 KATGNFGEKYCIGKGGQRSVYKAELPSGNIFAVKKFKAELFSDE----------TANPSEFLNEVLALTEIRHRNIIKFH 712 (918)
Q Consensus 643 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~----------~~~~~~~~~e~~~l~~l~h~niv~~~ 712 (918)
....-|++...||+|++|.||+|...+|+.||||+++....... .........+.++.....|+|+++++
T Consensus 92 ~rg~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~ 171 (397)
T 4gyi_A 92 ARKDVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALY 171 (397)
T ss_dssp HTTSCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred HCCCEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHH
Confidence 33344889999999999999999888999999998764322110 01122333444444444455555554
Q ss_pred ccccc------CCceEEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeC
Q 044366 713 GFCSN------AQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLD 786 (918)
Q Consensus 713 ~~~~~------~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~ 786 (918)
..... ....++||||+++++|.++... +....++.|++.++.|||+. |||||||||.|||++
T Consensus 172 ~~gv~vp~p~~~~~~~LVME~i~G~~L~~l~~~---------~~~~~l~~qll~~l~~lH~~---gIVHrDLKp~NILl~ 239 (397)
T 4gyi_A 172 EEGFPVPEPIAQSRHTIVMSLVDALPMRQVSSV---------PDPASLYADLIALILRLAKH---GLIHGDFNEFNILIR 239 (397)
T ss_dssp HTTCSCCCEEEEETTEEEEECCSCEEGGGCCCC---------SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEE
T ss_pred hcCCCCCeeeeccCceEEEEecCCccHhhhccc---------HHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEe
Confidence 33211 1234799999999888665421 12456889999999999999 999999999999998
Q ss_pred CCC----------cEEEeccccccccC
Q 044366 787 SEY----------EAHVSDFGFAKFLE 803 (918)
Q Consensus 787 ~~~----------~~kl~DfG~~~~~~ 803 (918)
+++ .+.|+||+-+....
T Consensus 240 ~dgd~~d~~~~~~~~~iID~~Q~V~~~ 266 (397)
T 4gyi_A 240 EEKDAEDPSSITLTPIIIXFPQMVSMD 266 (397)
T ss_dssp EEECSSCTTSEEEEEEECCCTTCEETT
T ss_pred CCCCcccccccccceEEEEeCCcccCC
Confidence 876 38999999876543
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.63 E-value=1.8e-15 Score=150.01 Aligned_cols=127 Identities=28% Similarity=0.354 Sum_probs=67.2
Q ss_pred CEEeCCCCcccccCCccccCCCCCCEEEcccccccccCCCCcCCCCCCCEEEcccccccccCCccccCCCCCCEEEccCC
Q 044366 24 QYLDLGNNQLSGVIPPEIGKLNQLRRLYLDVNQLHGTIPPVIGQLSLINELVFCHNNVSGRIPSSLGNLSNLALLYLNDN 103 (918)
Q Consensus 24 ~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~l~~l~~L~~L~L~~n 103 (918)
+++++++|+++ .+|..+. ++|++|+|++|+++ .+|..|..+++|++|++++|.+++..+..|.++++|++|+|++|
T Consensus 13 ~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N 88 (193)
T 2wfh_A 13 TVVRCSNKGLK-VLPKGIP--RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYN 88 (193)
T ss_dssp TEEECTTSCCS-SCCSCCC--TTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEEcCCCCCC-cCCCCCC--CCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCC
Confidence 46667777666 5555443 45666666666665 45555555555555555555555444444555555555555555
Q ss_pred cccccCccccCCCCCCCEEECcCCcCCCcCCcCCCCCCCCceeeccccccc
Q 044366 104 SLFGSIPIVMGNLKSLSTLDLSQNQLNGSIPCSLDNLSNLDTLFLYKNSLS 154 (918)
Q Consensus 104 ~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~l~ 154 (918)
+|++..|..|..+++|++|+|++|+|+...+..|..+++|+.|+|++|.+.
T Consensus 89 ~l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~ 139 (193)
T 2wfh_A 89 RLRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLY 139 (193)
T ss_dssp CCCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEE
T ss_pred ccCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCee
Confidence 555444444555555555555555555433334444444444444444443
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.59 E-value=7.6e-16 Score=150.53 Aligned_cols=106 Identities=21% Similarity=0.229 Sum_probs=65.9
Q ss_pred cccEEeccCccccccCccccccccccceecccCcccCCCCchhhccccccceEeccCCcCCCCCch--hccccCCcceEe
Q 044366 430 ELQYLDLSANKLSSSIPMSIGNLLKLHYLNLSNNQFSHKIPTEFEKLIHLSELDLSHNILQEEIPP--QICKMESLEKLN 507 (918)
Q Consensus 430 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~--~~~~l~~L~~L~ 507 (918)
+|++|+|++|.|++. ..|..+++|++|+|++|+|++..+..|..+++|++|+|++|+|+. +|. .+..+++|+.|+
T Consensus 43 ~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~-~~~~~~l~~l~~L~~L~ 119 (176)
T 1a9n_A 43 QFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVE-LGDLDPLASLKSLTYLC 119 (176)
T ss_dssp CCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEECCSCCCCC-GGGGGGGGGCTTCCEEE
T ss_pred CCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCCCEEECCCCcCCc-chhhHhhhcCCCCCEEE
Confidence 566666666666643 456666666666666666665555555666666666666666653 343 566666677777
Q ss_pred cCCCcccccCcc---cccCCCCccEEEccCCcCC
Q 044366 508 LSHNNLSDFIPR---CFEEMRSLSWIDISYNELQ 538 (918)
Q Consensus 508 L~~N~l~~~~~~---~~~~l~~L~~l~l~~N~l~ 538 (918)
|++|+++...+. .+..+++|+.||+++|...
T Consensus 120 l~~N~i~~~~~~~~~~~~~l~~L~~Ld~~~n~~~ 153 (176)
T 1a9n_A 120 ILRNPVTNKKHYRLYVIYKVPQVRVLDFQKVKLK 153 (176)
T ss_dssp CCSSGGGGSTTHHHHHHHHCTTCSEETTEECCHH
T ss_pred ecCCCCCCcHhHHHHHHHHCCccceeCCCcCCHH
Confidence 777776653222 3666777777777776654
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.59 E-value=3e-17 Score=163.94 Aligned_cols=151 Identities=23% Similarity=0.254 Sum_probs=109.7
Q ss_pred CCcEEEccCceecccccc------chhhccccCceecccccccCCCCCCCCCCCcccEEeccCccccccCcccccccccc
Q 044366 382 KLQVLDLSSNHIFGKIPV------QLVKLFSLNKLILSLNQLFGGVPLEFGTLTELQYLDLSANKLSSSIPMSIGNLLKL 455 (918)
Q Consensus 382 ~L~~L~L~~N~l~~~~~~------~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L 455 (918)
.++.++++.|.+.+..|. .+..+++|++|+|++|++++ +| .+..+++|++|+|++|.|+ .+|..+..+++|
T Consensus 19 ~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~~~~L 95 (198)
T 1ds9_A 19 SVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADTL 95 (198)
T ss_dssp CCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHHHHHC
T ss_pred cccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhhcCCcC
Confidence 344444444444444443 66777777777777777765 34 6777788888888888888 466677777888
Q ss_pred ceecccCcccCCCCchhhccccccceEeccCCcCCCCCc-hhccccCCcceEecCCCcccccCcc----------cccCC
Q 044366 456 HYLNLSNNQFSHKIPTEFEKLIHLSELDLSHNILQEEIP-PQICKMESLEKLNLSHNNLSDFIPR----------CFEEM 524 (918)
Q Consensus 456 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~~----------~~~~l 524 (918)
++|+|++|+|++ +| .|..+++|+.|+|++|+|++..+ ..+..+++|+.|++++|++++..|. .+..+
T Consensus 96 ~~L~L~~N~l~~-l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~~l 173 (198)
T 1ds9_A 96 EELWISYNQIAS-LS-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRL 173 (198)
T ss_dssp SEEEEEEEECCC-HH-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHHHHHHTTTTHHHHHHHHHHHC
T ss_pred CEEECcCCcCCc-CC-ccccCCCCCEEECCCCcCCchhHHHHHhcCCCCCEEEecCCccccccccccchHHHHHHHHHhC
Confidence 888888888875 34 68888888888888888875433 4688888888999999988776554 37788
Q ss_pred CCccEEEccCCcCCC
Q 044366 525 RSLSWIDISYNELQG 539 (918)
Q Consensus 525 ~~L~~l~l~~N~l~~ 539 (918)
++|+.|| +|+++.
T Consensus 174 ~~L~~Ld--~~~i~~ 186 (198)
T 1ds9_A 174 PNLKKLD--GMPVDV 186 (198)
T ss_dssp SSCSEEC--CGGGTT
T ss_pred CCcEEEC--CcccCH
Confidence 8999886 777764
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.58 E-value=4.1e-15 Score=144.12 Aligned_cols=111 Identities=27% Similarity=0.361 Sum_probs=88.4
Q ss_pred cccEEeccCccccccCccccccccccceecccCcccCCCCchhhccccccceEeccCCcCCCCCchhccccCCcceEecC
Q 044366 430 ELQYLDLSANKLSSSIPMSIGNLLKLHYLNLSNNQFSHKIPTEFEKLIHLSELDLSHNILQEEIPPQICKMESLEKLNLS 509 (918)
Q Consensus 430 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~ 509 (918)
..+.|++++|.++. +|..+. ++|++|+|++|+|+++.|..|.++++|++|+|++|+|++..+..|.++++|+.|+|+
T Consensus 10 ~~~~l~~s~n~l~~-ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~ 86 (170)
T 3g39_A 10 SGTTVDCSGKSLAS-VPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLN 86 (170)
T ss_dssp ETTEEECTTSCCSS-CCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred CCCEEEeCCCCcCc-cCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECC
Confidence 35678888888874 555443 678888888888887778888888888888888888887777777888888888888
Q ss_pred CCcccccCcccccCCCCccEEEccCCcCCCCCCC
Q 044366 510 HNNLSDFIPRCFEEMRSLSWIDISYNELQGPIPN 543 (918)
Q Consensus 510 ~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~p~ 543 (918)
+|+|+++.+..|..+++|+.|+|++|+|+|.++.
T Consensus 87 ~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c~~ 120 (170)
T 3g39_A 87 DNQLKSIPRGAFDNLKSLTHIWLLNNPWDCACSD 120 (170)
T ss_dssp SSCCCCCCTTTTTTCTTCCEEECCSSCBCTTBGG
T ss_pred CCccCEeCHHHhcCCCCCCEEEeCCCCCCCCchh
Confidence 8888887777888888888888888888887764
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.57 E-value=2e-15 Score=147.58 Aligned_cols=134 Identities=19% Similarity=0.150 Sum_probs=112.6
Q ss_pred CcCCCCCCcEEEccCceeccccccchhhcc-ccCceecccccccCCCCCCCCCCCcccEEeccCccccccCccccccccc
Q 044366 376 EIGDSSKLQVLDLSSNHIFGKIPVQLVKLF-SLNKLILSLNQLFGGVPLEFGTLTELQYLDLSANKLSSSIPMSIGNLLK 454 (918)
Q Consensus 376 ~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~-~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~ 454 (918)
.+..+.+|+.|++++|+++.. +. +..+. +|+.|+|++|++++. ..|..+++|++|+|++|.|++..+..|..+++
T Consensus 14 ~~~~~~~L~~L~l~~n~l~~i-~~-~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~ 89 (176)
T 1a9n_A 14 QYTNAVRDRELDLRGYKIPVI-EN-LGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPD 89 (176)
T ss_dssp EEECTTSCEEEECTTSCCCSC-CC-GGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTT
T ss_pred hcCCcCCceEEEeeCCCCchh-HH-hhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCC
Confidence 456678889999999988854 43 55555 899999999999876 67889999999999999999766666789999
Q ss_pred cceecccCcccCCCCch--hhccccccceEeccCCcCCCCCch----hccccCCcceEecCCCcccc
Q 044366 455 LHYLNLSNNQFSHKIPT--EFEKLIHLSELDLSHNILQEEIPP----QICKMESLEKLNLSHNNLSD 515 (918)
Q Consensus 455 L~~L~Ls~N~l~~~~~~--~~~~l~~L~~L~Ls~N~l~~~~~~----~~~~l~~L~~L~L~~N~l~~ 515 (918)
|++|+|++|+|+. +|. .|..+++|+.|++++|.++. .|. .+..+++|+.|++++|.+..
T Consensus 90 L~~L~L~~N~i~~-~~~~~~l~~l~~L~~L~l~~N~i~~-~~~~~~~~~~~l~~L~~Ld~~~n~~~~ 154 (176)
T 1a9n_A 90 LTELILTNNSLVE-LGDLDPLASLKSLTYLCILRNPVTN-KKHYRLYVIYKVPQVRVLDFQKVKLKE 154 (176)
T ss_dssp CCEEECCSCCCCC-GGGGGGGGGCTTCCEEECCSSGGGG-STTHHHHHHHHCTTCSEETTEECCHHH
T ss_pred CCEEECCCCcCCc-chhhHhhhcCCCCCEEEecCCCCCC-cHhHHHHHHHHCCccceeCCCcCCHHH
Confidence 9999999999964 555 78999999999999999985 555 48899999999999998865
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.55 E-value=1.1e-16 Score=159.92 Aligned_cols=156 Identities=24% Similarity=0.264 Sum_probs=129.5
Q ss_pred cccccccceeeccccccccCCCc------CcCCCCCCcEEEccCceeccccccchhhccccCceecccccccCCCCCCCC
Q 044366 353 WRNFSKLGTFNASMNNIYGSIPP------EIGDSSKLQVLDLSSNHIFGKIPVQLVKLFSLNKLILSLNQLFGGVPLEFG 426 (918)
Q Consensus 353 ~~~~~~L~~l~l~~n~i~~~~~~------~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~ 426 (918)
|.....+..++++.+.+.+..|. .+..+++|++|+|++|+|++ +| .+..+++|+.|++++|+++ .+|..+.
T Consensus 14 ~~~~~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~ 90 (198)
T 1ds9_A 14 FEERKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDA 90 (198)
T ss_dssp HHHTTCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHH
T ss_pred HHhcccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhh
Confidence 44445566666666666666665 88899999999999999986 55 8999999999999999998 4566677
Q ss_pred CCCcccEEeccCccccccCccccccccccceecccCcccCCCCc-hhhccccccceEeccCCcCCCCCch----------
Q 044366 427 TLTELQYLDLSANKLSSSIPMSIGNLLKLHYLNLSNNQFSHKIP-TEFEKLIHLSELDLSHNILQEEIPP---------- 495 (918)
Q Consensus 427 ~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~-~~~~~l~~L~~L~Ls~N~l~~~~~~---------- 495 (918)
.+++|++|+|++|.+++ +| .+..+++|+.|+|++|+|++..+ ..+..+++|++|++++|.+++.+|.
T Consensus 91 ~~~~L~~L~L~~N~l~~-l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~ 168 (198)
T 1ds9_A 91 VADTLEELWISYNQIAS-LS-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIE 168 (198)
T ss_dssp HHHHCSEEEEEEEECCC-HH-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHHHHHHTTTTHHHHHHH
T ss_pred cCCcCCEEECcCCcCCc-CC-ccccCCCCCEEECCCCcCCchhHHHHHhcCCCCCEEEecCCccccccccccchHHHHHH
Confidence 78999999999999996 44 68899999999999999986443 5789999999999999999876554
Q ss_pred hccccCCcceEecCCCcccc
Q 044366 496 QICKMESLEKLNLSHNNLSD 515 (918)
Q Consensus 496 ~~~~l~~L~~L~L~~N~l~~ 515 (918)
.+..+++|+.|+ +|.++.
T Consensus 169 ~~~~l~~L~~Ld--~~~i~~ 186 (198)
T 1ds9_A 169 VVKRLPNLKKLD--GMPVDV 186 (198)
T ss_dssp HHHHCSSCSEEC--CGGGTT
T ss_pred HHHhCCCcEEEC--CcccCH
Confidence 378899999987 788765
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=99.55 E-value=1.3e-13 Score=153.52 Aligned_cols=108 Identities=9% Similarity=0.165 Sum_probs=44.9
Q ss_pred CCCCCCCCcccEEeccCccccccCccccccccccceecccCcccCCCCchhhccccccceEeccCCcCCCCCchhccccC
Q 044366 422 PLEFGTLTELQYLDLSANKLSSSIPMSIGNLLKLHYLNLSNNQFSHKIPTEFEKLIHLSELDLSHNILQEEIPPQICKME 501 (918)
Q Consensus 422 ~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~ 501 (918)
..+|.++++|+.+.+. +.++.+...+|.++.+|+.++|..+ ++.+...+|.++.+|+.+.+..+ ++.+...+|.++.
T Consensus 281 ~~aF~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~~L~~i~ip~s-v~~I~~~aF~~C~ 357 (394)
T 4gt6_A 281 TGAFMNCPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCEQLERIAIPSS-VTKIPESAFSNCT 357 (394)
T ss_dssp TTTTTTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEECTT-CCBCCGGGGTTCT
T ss_pred CcccccccccccccCC-CcccccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCCCCCEEEECcc-cCEEhHhHhhCCC
Confidence 3344444444444443 2233333444444455555554433 33344445555555555555433 3334444555555
Q ss_pred CcceEecCCCcccccCcccccCCCCccEEEccCC
Q 044366 502 SLEKLNLSHNNLSDFIPRCFEEMRSLSWIDISYN 535 (918)
Q Consensus 502 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~l~l~~N 535 (918)
+|+.+++.+|... ..+|....+|+.+.+..|
T Consensus 358 ~L~~i~~~~~~~~---~~~~~~~~~L~~i~i~~~ 388 (394)
T 4gt6_A 358 ALNNIEYSGSRSQ---WNAISTDSGLQNLPVAPG 388 (394)
T ss_dssp TCCEEEESSCHHH---HHTCBCCCCC--------
T ss_pred CCCEEEECCceee---hhhhhccCCCCEEEeCCC
Confidence 5555555544332 123344444555544443
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.55 E-value=1.3e-14 Score=141.07 Aligned_cols=108 Identities=25% Similarity=0.351 Sum_probs=81.1
Q ss_pred cEEeccCccccccCccccccccccceecccCcccCCCCchhhccccccceEeccCCcCCCCCchhccccCCcceEecCCC
Q 044366 432 QYLDLSANKLSSSIPMSIGNLLKLHYLNLSNNQFSHKIPTEFEKLIHLSELDLSHNILQEEIPPQICKMESLEKLNLSHN 511 (918)
Q Consensus 432 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N 511 (918)
+.+++++|.++ .+|..+. ++|+.|+|++|+|++..|..|.++++|++|+|++|+|+++.+..|..+++|+.|+|++|
T Consensus 15 ~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N 91 (174)
T 2r9u_A 15 TLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDN 91 (174)
T ss_dssp SEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred cEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCC
Confidence 57777777776 4455443 67777888888877777777777888888888888887666666777788888888888
Q ss_pred cccccCcccccCCCCccEEEccCCcCCCCCC
Q 044366 512 NLSDFIPRCFEEMRSLSWIDISYNELQGPIP 542 (918)
Q Consensus 512 ~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~p 542 (918)
+|+++.+..|..+++|+.|+|++|+|+|.++
T Consensus 92 ~l~~l~~~~~~~l~~L~~L~L~~N~~~c~~~ 122 (174)
T 2r9u_A 92 HLKSIPRGAFDNLKSLTHIYLYNNPWDCECR 122 (174)
T ss_dssp CCCCCCTTTTTTCTTCSEEECCSSCBCTTBG
T ss_pred ccceeCHHHhccccCCCEEEeCCCCcccccc
Confidence 8887766677788888888888888887655
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=99.53 E-value=3.4e-13 Score=150.11 Aligned_cols=336 Identities=9% Similarity=0.084 Sum_probs=160.2
Q ss_pred ccccCccccCCCC-CCCEEECcCCcCCCcCCcCCCCCCCCceeeccccc---cccCCCcccccccccCeeeccccccCCc
Q 044366 105 LFGSIPIVMGNLK-SLSTLDLSQNQLNGSIPCSLDNLSNLDTLFLYKNS---LSGPIPSVIGNLKSLLQLDLSENRLSGL 180 (918)
Q Consensus 105 i~~~~~~~~~~l~-~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~---l~~~~~~~~~~l~~L~~L~Ls~N~l~~~ 180 (918)
++.+...+|.+++ .|+.+.+-.+ ++.+...+|.++++|+.+.+..|. ++.+...+|.++.+|+.+.+..+ ++.+
T Consensus 51 Vt~Ig~~aF~~~~~~L~sI~iP~s-vt~Ig~~AF~~C~~L~~i~~~~n~p~~l~~Ig~~aF~~c~~L~~i~~~~~-~~~I 128 (394)
T 4gt6_A 51 VSKIGDRVFCNYKYVLTSVQIPDT-VTEIGSNAFYNCTSLKRVTIQDNKPSCVKKIGRQAFMFCSELTDIPILDS-VTEI 128 (394)
T ss_dssp EEEECTTTTTTCCSCCCEEEECTT-CCEECTTTTTTCTTCCEEEEGGGCCCCCCEECTTTTTTCTTCCBCGGGTT-CSEE
T ss_pred eeEcCHhhccCCCCcCEEEEECCC-eeEEhHHHhhCCccCceEeecCCCCCeeeEechhhchhcccceeeccCCc-ccee
Confidence 3445556676664 4777777643 555666677777777777776653 55455566666666666666543 3434
Q ss_pred CCccCCCCCCCcEeeccCcccccCCCccccCCCCcceeecccccccCCCCCCCcCCCcCCeEEcccCcCcCCCCcccccc
Q 044366 181 IPLSLSNLSSLTVMSLFNNSLSGSIPPILGNLKSLSTLGLHINQLNGVIPPSIGNLSSLRNLSLFNNRLYGFVPKEIGYL 260 (918)
Q Consensus 181 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l 260 (918)
...+|..+.+|+.+.+..+ +..+...+|.++.+|+.+.+..+ ++.+....|.+ .+|+.+.+..+-.. +....|..+
T Consensus 129 ~~~aF~~c~~L~~i~lp~~-~~~I~~~~F~~c~~L~~i~~~~~-~~~I~~~aF~~-~~l~~i~ip~~~~~-i~~~af~~c 204 (394)
T 4gt6_A 129 DSEAFHHCEELDTVTIPEG-VTSVADGMFSYCYSLHTVTLPDS-VTAIEERAFTG-TALTQIHIPAKVTR-IGTNAFSEC 204 (394)
T ss_dssp CTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTT-CCCSEEEECTTCCE-ECTTTTTTC
T ss_pred hhhhhhhhcccccccccce-eeeecccceecccccccccccce-eeEeccccccc-cceeEEEECCcccc-cccchhhhc
Confidence 4556666666666666543 22244455556666666655443 33233334433 34555555443221 333344444
Q ss_pred CCCCeEecCCCccCCcCCCcCCCCCCCcEEEccCCcCcCCCCccccCCCCCCeEEeecccccCccccccCCCCCccEEeC
Q 044366 261 KSLSKLEFCANHLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLRNLTSLERVRFNQNNLYGKVYEAFGDHPNLTFLDL 340 (918)
Q Consensus 261 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L 340 (918)
.+++......+........ .+. .+.........+.....+..+.+
T Consensus 205 ~~l~~~~~~~~~~~~~~~~------------------------~~~-----------~~~~~~~~~~~~~~~~~~~~~~i 249 (394)
T 4gt6_A 205 FALSTITSDSESYPAIDNV------------------------LYE-----------KSANGDYALIRYPSQREDPAFKI 249 (394)
T ss_dssp TTCCEEEECCSSSCBSSSC------------------------EEE-----------ECTTSCEEEEECCTTCCCSEEEC
T ss_pred cccceecccccccccccce------------------------eec-----------ccccccccccccccccccceEEc
Confidence 4444443333222211000 000 00000000001111111222221
Q ss_pred CCCccccccCcccccccccceeeccccccccCCCcCcCCCCCCcEEEccCceeccccccchhhccccCceecccccccCC
Q 044366 341 SQNNFYCEISFNWRNFSKLGTFNASMNNIYGSIPPEIGDSSKLQVLDLSSNHIFGKIPVQLVKLFSLNKLILSLNQLFGG 420 (918)
Q Consensus 341 s~N~l~~~~~~~~~~~~~L~~l~l~~n~i~~~~~~~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ 420 (918)
. +.++. .-..+|.++..|+.+.+..+... +....|.++.+|+.+.+. +.++.+
T Consensus 250 p-~~v~~------------------------i~~~aF~~c~~L~~i~lp~~~~~-I~~~aF~~c~~L~~i~l~-~~i~~I 302 (394)
T 4gt6_A 250 P-NGVAR------------------------IETHAFDSCAYLASVKMPDSVVS-IGTGAFMNCPALQDIEFS-SRITEL 302 (394)
T ss_dssp C-TTEEE------------------------ECTTTTTTCSSCCEEECCTTCCE-ECTTTTTTCTTCCEEECC-TTCCEE
T ss_pred C-CcceE------------------------cccceeeecccccEEecccccce-ecCcccccccccccccCC-Cccccc
Confidence 1 11111 22223444444444444433222 344445555555555553 334445
Q ss_pred CCCCCCCCCcccEEeccCccccccCccccccccccceecccCcccCCCCchhhccccccceEeccCCcCCCCCchhcccc
Q 044366 421 VPLEFGTLTELQYLDLSANKLSSSIPMSIGNLLKLHYLNLSNNQFSHKIPTEFEKLIHLSELDLSHNILQEEIPPQICKM 500 (918)
Q Consensus 421 ~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l 500 (918)
...+|.++.+|+.++|..+ ++.+...+|.++.+|+.+.+..+ ++.+...+|.++.+|+.+++.+|... ...+...
T Consensus 303 ~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~~L~~i~ip~s-v~~I~~~aF~~C~~L~~i~~~~~~~~---~~~~~~~ 377 (394)
T 4gt6_A 303 PESVFAGCISLKSIDIPEG-ITQILDDAFAGCEQLERIAIPSS-VTKIPESAFSNCTALNNIEYSGSRSQ---WNAISTD 377 (394)
T ss_dssp CTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEECTT-CCBCCGGGGTTCTTCCEEEESSCHHH---HHTCBCC
T ss_pred CceeecCCCCcCEEEeCCc-ccEehHhHhhCCCCCCEEEECcc-cCEEhHhHhhCCCCCCEEEECCceee---hhhhhcc
Confidence 5556666666777766644 55455566777777777777544 55566667777777777777766542 1345556
Q ss_pred CCcceEecCCCcc
Q 044366 501 ESLEKLNLSHNNL 513 (918)
Q Consensus 501 ~~L~~L~L~~N~l 513 (918)
.+|+.+.+..|.+
T Consensus 378 ~~L~~i~i~~~~~ 390 (394)
T 4gt6_A 378 SGLQNLPVAPGSI 390 (394)
T ss_dssp CCC----------
T ss_pred CCCCEEEeCCCCE
Confidence 6677766665543
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.49 E-value=7.1e-14 Score=135.34 Aligned_cols=106 Identities=27% Similarity=0.268 Sum_probs=74.4
Q ss_pred CceecccccccCCCCCCCCCCCcccEEeccCccccccCccccccccccceecccCcccCCCCchhhccccccceEeccCC
Q 044366 408 NKLILSLNQLFGGVPLEFGTLTELQYLDLSANKLSSSIPMSIGNLLKLHYLNLSNNQFSHKIPTEFEKLIHLSELDLSHN 487 (918)
Q Consensus 408 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N 487 (918)
+.+++++|+++. +|..+ .++|++|+|++|.|+++.|..|..+++|++|+|++|+|+++.+..|.++++|++|+|++|
T Consensus 12 ~~l~~s~n~l~~-ip~~~--~~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N 88 (170)
T 3g39_A 12 TTVDCSGKSLAS-VPTGI--PTTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDN 88 (170)
T ss_dssp TEEECTTSCCSS-CCSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEEeCCCCcCc-cCccC--CCCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCC
Confidence 445555555543 23322 256777777777777766777777777777777777777776777777777777777777
Q ss_pred cCCCCCchhccccCCcceEecCCCccccc
Q 044366 488 ILQEEIPPQICKMESLEKLNLSHNNLSDF 516 (918)
Q Consensus 488 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ 516 (918)
+|++..+..|..+++|+.|+|++|+++..
T Consensus 89 ~l~~~~~~~~~~l~~L~~L~L~~N~~~c~ 117 (170)
T 3g39_A 89 QLKSIPRGAFDNLKSLTHIWLLNNPWDCA 117 (170)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCBCTT
T ss_pred ccCEeCHHHhcCCCCCCEEEeCCCCCCCC
Confidence 77766666677777788888888877654
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.46 E-value=1.8e-13 Score=132.86 Aligned_cols=87 Identities=26% Similarity=0.331 Sum_probs=57.2
Q ss_pred CcccEEeccCccccccCccccccccccceecccCcccCCCCchhhccccccceEeccCCcCCCCCchhccccCCcceEec
Q 044366 429 TELQYLDLSANKLSSSIPMSIGNLLKLHYLNLSNNQFSHKIPTEFEKLIHLSELDLSHNILQEEIPPQICKMESLEKLNL 508 (918)
Q Consensus 429 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 508 (918)
++|++|+|++|.|++..|..|.++++|++|+|++|+|+++.+..|.++++|++|+|++|+|++..+..|..+++|+.|+|
T Consensus 33 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L 112 (174)
T 2r9u_A 33 TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDNHLKSIPRGAFDNLKSLTHIYL 112 (174)
T ss_dssp TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEEC
T ss_pred CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCCccceeCHHHhccccCCCEEEe
Confidence 45666666666666665666666666666666666666655555666666677777777666555555666667777777
Q ss_pred CCCcccc
Q 044366 509 SHNNLSD 515 (918)
Q Consensus 509 ~~N~l~~ 515 (918)
++|++..
T Consensus 113 ~~N~~~c 119 (174)
T 2r9u_A 113 YNNPWDC 119 (174)
T ss_dssp CSSCBCT
T ss_pred CCCCccc
Confidence 7776664
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.34 E-value=1.2e-14 Score=159.46 Aligned_cols=141 Identities=21% Similarity=0.187 Sum_probs=73.6
Q ss_pred CCCcEEEccCceeccccccchh-hccccCceecccccccCCCCCCC-----CCCCcccEEeccCcccccc----Cccccc
Q 044366 381 SKLQVLDLSSNHIFGKIPVQLV-KLFSLNKLILSLNQLFGGVPLEF-----GTLTELQYLDLSANKLSSS----IPMSIG 450 (918)
Q Consensus 381 ~~L~~L~L~~N~l~~~~~~~~~-~l~~L~~L~L~~N~l~~~~~~~~-----~~l~~L~~L~Ls~N~l~~~----~~~~~~ 450 (918)
++|++|+|++|.|.......+. .+.+|+.|+|++|+++......+ ...++|++|+|++|.|+.. ++..+.
T Consensus 101 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~ 180 (372)
T 3un9_A 101 HALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLA 180 (372)
T ss_dssp SCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHHHSTTCCCCEEECCSSCCHHHHHHHHHHHHH
T ss_pred CCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHHHhcCCccceeeCCCCCCChHHHHHHHHHHh
Confidence 4666777777766533332222 34456666666665543222222 2345566666666666532 223334
Q ss_pred cccccceecccCcccCCCC----chhhccccccceEeccCCcCCCCC----chhccccCCcceEecCCCcccccCcccc
Q 044366 451 NLLKLHYLNLSNNQFSHKI----PTEFEKLIHLSELDLSHNILQEEI----PPQICKMESLEKLNLSHNNLSDFIPRCF 521 (918)
Q Consensus 451 ~l~~L~~L~Ls~N~l~~~~----~~~~~~l~~L~~L~Ls~N~l~~~~----~~~~~~l~~L~~L~L~~N~l~~~~~~~~ 521 (918)
.+++|++|+|++|+|++.. +..+...++|++|+|++|.|++.. +..+...++|+.|+|++|+|++.....+
T Consensus 181 ~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~~~l~~~L~~~~~L~~L~Ls~N~i~~~g~~~L 259 (372)
T 3un9_A 181 GNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFNELSSEGRQVL 259 (372)
T ss_dssp TCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHHHHHHHHHHHCSSCCEEECTTSSCCHHHHHHH
T ss_pred cCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHHHHHHHHHHhCCCCCEEeccCCCCCHHHHHHH
Confidence 5566666666666664322 334455556666666666665422 2233344566666666666655433333
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.34 E-value=7.8e-13 Score=144.68 Aligned_cols=90 Identities=23% Similarity=0.221 Sum_probs=50.9
Q ss_pred CCCCCcccEEeccC-ccccccCccccccccccceecccCcccCCCCchhhccccccceEeccCCcCCCCCchhccccCCc
Q 044366 425 FGTLTELQYLDLSA-NKLSSSIPMSIGNLLKLHYLNLSNNQFSHKIPTEFEKLIHLSELDLSHNILQEEIPPQICKMESL 503 (918)
Q Consensus 425 ~~~l~~L~~L~Ls~-N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L 503 (918)
+..+++|++|+|++ |.|+++.+..|.++++|+.|+|++|+|+++.|..|.++++|+.|+|++|+|++..+..|..++ |
T Consensus 27 l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~-L 105 (347)
T 2ifg_A 27 LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLS-L 105 (347)
T ss_dssp SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSCCSCCCSTTTCSCC-C
T ss_pred CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCCCccceeCHHHcccCC-c
Confidence 55555555666653 555555555555555666666666666555555555566666666666666544444444443 5
Q ss_pred ceEecCCCcccc
Q 044366 504 EKLNLSHNNLSD 515 (918)
Q Consensus 504 ~~L~L~~N~l~~ 515 (918)
+.|+|++|+|..
T Consensus 106 ~~l~l~~N~~~c 117 (347)
T 2ifg_A 106 QELVLSGNPLHC 117 (347)
T ss_dssp CEEECCSSCCCC
T ss_pred eEEEeeCCCccC
Confidence 555665555553
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.34 E-value=1.2e-12 Score=143.17 Aligned_cols=108 Identities=21% Similarity=0.214 Sum_probs=99.8
Q ss_pred cEEeccCc-cccccCccccccccccceecccC-cccCCCCchhhccccccceEeccCCcCCCCCchhccccCCcceEecC
Q 044366 432 QYLDLSAN-KLSSSIPMSIGNLLKLHYLNLSN-NQFSHKIPTEFEKLIHLSELDLSHNILQEEIPPQICKMESLEKLNLS 509 (918)
Q Consensus 432 ~~L~Ls~N-~l~~~~~~~~~~l~~L~~L~Ls~-N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~ 509 (918)
..++++++ .|++ +|. +..+++|+.|+|++ |+|+++.+..|.++++|+.|+|++|+|++..|..|.++++|+.|+|+
T Consensus 11 ~~v~~~~~n~l~~-ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~ 88 (347)
T 2ifg_A 11 SGLRCTRDGALDS-LHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLS 88 (347)
T ss_dssp SCEECCSSCCCTT-TTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECC
T ss_pred CEEEcCCCCCCCc-cCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCC
Confidence 45799998 8995 677 99999999999996 99999888999999999999999999999999999999999999999
Q ss_pred CCcccccCcccccCCCCccEEEccCCcCCCCCC
Q 044366 510 HNNLSDFIPRCFEEMRSLSWIDISYNELQGPIP 542 (918)
Q Consensus 510 ~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~p 542 (918)
+|+|+++.+..|..++ |+.|+|++|+|+|.++
T Consensus 89 ~N~l~~~~~~~~~~~~-L~~l~l~~N~~~c~c~ 120 (347)
T 2ifg_A 89 FNALESLSWKTVQGLS-LQELVLSGNPLHCSCA 120 (347)
T ss_dssp SSCCSCCCSTTTCSCC-CCEEECCSSCCCCCGG
T ss_pred CCccceeCHHHcccCC-ceEEEeeCCCccCCCc
Confidence 9999998888888877 9999999999998765
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.33 E-value=3.7e-14 Score=155.50 Aligned_cols=159 Identities=22% Similarity=0.252 Sum_probs=124.5
Q ss_pred CCCcEEEccCceeccccccchhhc-----cccCceecccccccCCCCCCC-CCCCcccEEeccCccccccCccccc----
Q 044366 381 SKLQVLDLSSNHIFGKIPVQLVKL-----FSLNKLILSLNQLFGGVPLEF-GTLTELQYLDLSANKLSSSIPMSIG---- 450 (918)
Q Consensus 381 ~~L~~L~L~~N~l~~~~~~~~~~l-----~~L~~L~L~~N~l~~~~~~~~-~~l~~L~~L~Ls~N~l~~~~~~~~~---- 450 (918)
++|+.|+|++|.|+......+... .+|++|+|++|.++......+ ..+++|++|+|++|.|+......+.
T Consensus 72 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L~ 151 (372)
T 3un9_A 72 SSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLL 151 (372)
T ss_dssp TTCCEEECTTSCCCHHHHHHHHHHHSSCSSCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHHH
T ss_pred hhCCEEEecCCCCCHHHHHHHHHHHhhCCCCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHHH
Confidence 578999999999986655555554 689999999999865333222 3467899999999999865444442
Q ss_pred -cccccceecccCcccCCC----CchhhccccccceEeccCCcCCCCC----chhccccCCcceEecCCCccccc----C
Q 044366 451 -NLLKLHYLNLSNNQFSHK----IPTEFEKLIHLSELDLSHNILQEEI----PPQICKMESLEKLNLSHNNLSDF----I 517 (918)
Q Consensus 451 -~l~~L~~L~Ls~N~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~~----~~~~~~l~~L~~L~L~~N~l~~~----~ 517 (918)
..++|+.|+|++|+|+.. ++..+..+++|++|||++|.|++.. +..+...++|+.|+|++|.|++. +
T Consensus 152 ~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~~~l 231 (372)
T 3un9_A 152 HDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALAL 231 (372)
T ss_dssp STTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHHHHH
T ss_pred hcCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHHHHH
Confidence 457899999999999753 3445577899999999999997543 55677888999999999999864 3
Q ss_pred cccccCCCCccEEEccCCcCCC
Q 044366 518 PRCFEEMRSLSWIDISYNELQG 539 (918)
Q Consensus 518 ~~~~~~l~~L~~l~l~~N~l~~ 539 (918)
+.++...++|+.|||++|+++.
T Consensus 232 ~~~L~~~~~L~~L~Ls~N~i~~ 253 (372)
T 3un9_A 232 ARAAREHPSLELLHLYFNELSS 253 (372)
T ss_dssp HHHHHHCSSCCEEECTTSSCCH
T ss_pred HHHHHhCCCCCEEeccCCCCCH
Confidence 4455667999999999999874
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=99.33 E-value=6.4e-11 Score=131.08 Aligned_cols=316 Identities=9% Similarity=0.016 Sum_probs=150.2
Q ss_pred cccCCCCCCEEEccCCcccccCccccCCCCCCCEEECcCCcCCCcCCcCCCCCCCCceeeccccccccCCCccccccccc
Q 044366 88 SLGNLSNLALLYLNDNSLFGSIPIVMGNLKSLSTLDLSQNQLNGSIPCSLDNLSNLDTLFLYKNSLSGPIPSVIGNLKSL 167 (918)
Q Consensus 88 ~l~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L 167 (918)
++....+|+.+.+... ++.+...+|.++.+|+.++|..+ ++.+...+|.+. +|+.+.+-.+ ++.+...+|... +|
T Consensus 41 ~~~~~~~i~~v~ip~~-vt~Ig~~aF~~C~~L~~I~lp~~-v~~Ig~~aF~~c-~l~~i~~~~~-l~~I~~~aF~~~-~L 115 (379)
T 4h09_A 41 WYKDRDRISEVRVNSG-ITSIGEANFNSCYNMTKVTVAST-VTSIGDGAFADT-KLQSYTGMER-VKKFGDYVFQGT-DL 115 (379)
T ss_dssp TGGGGGGCSEEEECTT-EEEECTTTTTTCTTCCEEEECTT-CCEECTTTTTTC-CCCEEEECTT-CCEECTTTTTTC-CC
T ss_pred ccccccCCEEEEeCCC-ccChHHHHhhCCCCCCEEEeCCc-ceEechhhhcCC-CCceEECCce-eeEeccceeccC-Cc
Confidence 4555566777777643 55566667777777777777543 554555666665 4555555432 443444455443 56
Q ss_pred CeeeccccccCCcCCccCCCCCCCcEeeccCcccccCCCccccCCCCcceeecccccccCCCCCCCcCCCcCCeEEcccC
Q 044366 168 LQLDLSENRLSGLIPLSLSNLSSLTVMSLFNNSLSGSIPPILGNLKSLSTLGLHINQLNGVIPPSIGNLSSLRNLSLFNN 247 (918)
Q Consensus 168 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n 247 (918)
+.+.+..+ ++.+...+|.++ +|+.+.+..+ ++.+...+|..+.+++.+.+..+.........+ . .+
T Consensus 116 ~~i~lp~~-~~~i~~~~F~~~-~l~~~~~~~~-v~~i~~~~f~~~~~l~~~~~~~~~~~~~~~~~~-~----------~~ 181 (379)
T 4h09_A 116 DDFEFPGA-TTEIGNYIFYNS-SVKRIVIPKS-VTTIKDGIGYKAENLEKIEVSSNNKNYVAENYV-L----------YN 181 (379)
T ss_dssp SEEECCTT-CCEECTTTTTTC-CCCEEEECTT-CCEECSCTTTTCTTCCEEEECTTCSSEEEETTE-E----------EE
T ss_pred ccccCCCc-cccccccccccc-eeeeeeccce-eeccccchhcccccccccccccccceeecccce-e----------cc
Confidence 66665543 222333344443 3444433322 222333444445555444443332211100000 0 00
Q ss_pred cCcCCCCccccccCCCCeEecCCCccCCcCCCcCCCCCCCcEEEccCCcCcCCCCccccCCCCCCeEEeecccccCcccc
Q 044366 248 RLYGFVPKEIGYLKSLSKLEFCANHLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLRNLTSLERVRFNQNNLYGKVYE 327 (918)
Q Consensus 248 ~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~ 327 (918)
... .....+.....+..+.+.... .......+....+|+.+.+..+ +..+...+|.++..|+.+.+..+ ++.+...
T Consensus 182 ~~~-~~~~~~~~~~~~~~~~~~~~~-~~i~~~~f~~~~~l~~i~~~~~-~~~i~~~~f~~~~~L~~i~lp~~-v~~I~~~ 257 (379)
T 4h09_A 182 KNK-TILESYPAAKTGTEFTIPSTV-KTVTAYGFSYGKNLKKITITSG-VTTLGDGAFYGMKALDEIAIPKN-VTSIGSF 257 (379)
T ss_dssp TTS-SEEEECCTTCCCSEEECCTTC-CEECTTTTTTCSSCSEEECCTT-CCEECTTTTTTCSSCCEEEECTT-CCEECTT
T ss_pred ccc-ceeccccccccccccccccce-eEEeecccccccccceeeeccc-eeEEccccccCCccceEEEcCCC-ccEeCcc
Confidence 000 011122223333333333222 1133334444445555554332 22233444555555555555433 4444455
Q ss_pred ccCCCCCccEEeCCCCccccccCcccccccccceeeccccccccCCCcCcCCCCCCcEEEccCceeccccccchhhcccc
Q 044366 328 AFGDHPNLTFLDLSQNNFYCEISFNWRNFSKLGTFNASMNNIYGSIPPEIGDSSKLQVLDLSSNHIFGKIPVQLVKLFSL 407 (918)
Q Consensus 328 ~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~n~i~~~~~~~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L 407 (918)
+|....+|+.+.+..+ +.. .-...|.++++|+.+.+.++.++.+....|.++.+|
T Consensus 258 aF~~~~~l~~i~l~~~-i~~------------------------i~~~aF~~c~~L~~i~l~~~~i~~I~~~aF~~c~~L 312 (379)
T 4h09_A 258 LLQNCTALKTLNFYAK-VKT------------------------VPYLLCSGCSNLTKVVMDNSAIETLEPRVFMDCVKL 312 (379)
T ss_dssp TTTTCTTCCEEEECCC-CSE------------------------ECTTTTTTCTTCCEEEECCTTCCEECTTTTTTCTTC
T ss_pred ccceeehhcccccccc-cee------------------------ccccccccccccccccccccccceehhhhhcCCCCC
Confidence 5555555555544322 332 333345555556666665555555555566666666
Q ss_pred CceecccccccCCCCCCCCCCCcccEEeccCccccccCcccccccc
Q 044366 408 NKLILSLNQLFGGVPLEFGTLTELQYLDLSANKLSSSIPMSIGNLL 453 (918)
Q Consensus 408 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~ 453 (918)
+.+.|..+ ++.+...+|.++++|+.+.+..+ ++.+...+|.+..
T Consensus 313 ~~i~lp~~-l~~I~~~aF~~C~~L~~i~ip~~-v~~I~~~aF~~c~ 356 (379)
T 4h09_A 313 SSVTLPTA-LKTIQVYAFKNCKALSTISYPKS-ITLIESGAFEGSS 356 (379)
T ss_dssp CEEECCTT-CCEECTTTTTTCTTCCCCCCCTT-CCEECTTTTTTSS
T ss_pred CEEEcCcc-ccEEHHHHhhCCCCCCEEEECCc-cCEEchhHhhCCC
Confidence 66666533 44555566677777777777544 5545555666543
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=99.31 E-value=8.1e-11 Score=130.26 Aligned_cols=152 Identities=12% Similarity=0.051 Sum_probs=115.7
Q ss_pred CccccccCCCCCccEEeCCCCccccccCcccccccccceeeccccccccCCCcCcCCCCCCcEEEccCceeccccccchh
Q 044366 323 GKVYEAFGDHPNLTFLDLSQNNFYCEISFNWRNFSKLGTFNASMNNIYGSIPPEIGDSSKLQVLDLSSNHIFGKIPVQLV 402 (918)
Q Consensus 323 ~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~n~i~~~~~~~~~~~~~L~~L~L~~N~l~~~~~~~~~ 402 (918)
.+...+|....+|+.+.+..+ +..+....|.+...|+.+.+..+ +..+-..+|.++.+|+.+.+..+ +..+....|.
T Consensus 207 ~i~~~~f~~~~~l~~i~~~~~-~~~i~~~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~~-i~~i~~~aF~ 283 (379)
T 4h09_A 207 TVTAYGFSYGKNLKKITITSG-VTTLGDGAFYGMKALDEIAIPKN-VTSIGSFLLQNCTALKTLNFYAK-VKTVPYLLCS 283 (379)
T ss_dssp EECTTTTTTCSSCSEEECCTT-CCEECTTTTTTCSSCCEEEECTT-CCEECTTTTTTCTTCCEEEECCC-CSEECTTTTT
T ss_pred EEeecccccccccceeeeccc-eeEEccccccCCccceEEEcCCC-ccEeCccccceeehhcccccccc-ceeccccccc
Confidence 344445555556666665433 44555566666666666666554 44455667888889999998765 6667788899
Q ss_pred hccccCceecccccccCCCCCCCCCCCcccEEeccCccccccCccccccccccceecccCcccCCCCchhhcccccc
Q 044366 403 KLFSLNKLILSLNQLFGGVPLEFGTLTELQYLDLSANKLSSSIPMSIGNLLKLHYLNLSNNQFSHKIPTEFEKLIHL 479 (918)
Q Consensus 403 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L 479 (918)
++.+|+.+.+.++.++.+...+|.++.+|+.++|..+ ++.+...+|.++.+|+.+.+..+ ++.+...+|.+..-+
T Consensus 284 ~c~~L~~i~l~~~~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~ip~~-v~~I~~~aF~~c~~~ 358 (379)
T 4h09_A 284 GCSNLTKVVMDNSAIETLEPRVFMDCVKLSSVTLPTA-LKTIQVYAFKNCKALSTISYPKS-ITLIESGAFEGSSIT 358 (379)
T ss_dssp TCTTCCEEEECCTTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCCCCCCTT-CCEECTTTTTTSSCC
T ss_pred cccccccccccccccceehhhhhcCCCCCCEEEcCcc-ccEEHHHHhhCCCCCCEEEECCc-cCEEchhHhhCCCCC
Confidence 9999999999999998888999999999999999865 77677789999999999999766 777788899887433
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.17 E-value=6.8e-11 Score=123.57 Aligned_cols=146 Identities=12% Similarity=0.032 Sum_probs=113.8
Q ss_pred HHHhcCCCCceeeccccceEEEEEEeCCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhcc-CCceeeEecccccCCc
Q 044366 642 TKATGNFGEKYCIGKGGQRSVYKAELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIR-HRNIIKFHGFCSNAQH 720 (918)
Q Consensus 642 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~ 720 (918)
....+.|......+.|+.+.||++... |+.+++|+...... .....+.+|+++++.+. +..+.++++++.+.+.
T Consensus 10 ~~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~----~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~ 84 (263)
T 3tm0_A 10 KKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYK----GTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGW 84 (263)
T ss_dssp HHHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGT----TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTE
T ss_pred HHHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccC----CCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCc
Confidence 445567888888888999999999754 78999999765311 12345889999999884 6778899999888889
Q ss_pred eEEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCC-------------------------------
Q 044366 721 SFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDC------------------------------- 769 (918)
Q Consensus 721 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~------------------------------- 769 (918)
.++||||++|.++.+.... ..+...++.+++++++.||+..
T Consensus 85 ~~lv~e~i~G~~l~~~~~~--------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (263)
T 3tm0_A 85 SNLLMSEADGVLCSEEYED--------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCE 156 (263)
T ss_dssp EEEEEECCSSEEHHHHCCT--------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGG
T ss_pred eEEEEEecCCeehhhccCC--------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccc
Confidence 9999999999998876421 1123478899999999999810
Q ss_pred -------------------------CCCeEEcCCCCCCeeeCCCCcEEEecccccc
Q 044366 770 -------------------------IPPIVHRDISSKNVLLDSEYEAHVSDFGFAK 800 (918)
Q Consensus 770 -------------------------~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~ 800 (918)
.+.++|+|+++.||+++++..+.|+||+.+.
T Consensus 157 ~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 157 NWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp GGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred cccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 1358999999999999876556799998775
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.01 E-value=5.2e-10 Score=116.75 Aligned_cols=137 Identities=12% Similarity=0.101 Sum_probs=100.3
Q ss_pred CCCCceeeccccceEEEEEEeCCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCc--eeeEecccccCCceEEE
Q 044366 647 NFGEKYCIGKGGQRSVYKAELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRN--IIKFHGFCSNAQHSFIV 724 (918)
Q Consensus 647 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~~~~~~~~~~~~~lv 724 (918)
.+......+.|..+.||++...+|+.+++|..... ....+.+|+.+++.+.+.+ +.+++++...++..++|
T Consensus 21 ~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~-------~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v 93 (264)
T 1nd4_A 21 GYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG-------ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLL 93 (264)
T ss_dssp TCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC-------TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEE
T ss_pred CCceEecccCCCCceEEEEecCCCCeEEEEeCCcc-------cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEE
Confidence 34433333456669999998777888999986532 1245789999999886544 55688888877888999
Q ss_pred EEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCC-----------------------------------
Q 044366 725 CEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDC----------------------------------- 769 (918)
Q Consensus 725 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~----------------------------------- 769 (918)
|||++|.++. ... .+ ...++.++++.++.||+..
T Consensus 94 ~e~i~G~~l~--~~~------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (264)
T 1nd4_A 94 LGEVPGQDLL--SSH------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEH 162 (264)
T ss_dssp EECCSSEETT--TSC------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGG
T ss_pred EEecCCcccC--cCc------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhc
Confidence 9999998884 211 11 2356778888888888752
Q ss_pred --------------------CCCeEEcCCCCCCeeeCCCCcEEEeccccccc
Q 044366 770 --------------------IPPIVHRDISSKNVLLDSEYEAHVSDFGFAKF 801 (918)
Q Consensus 770 --------------------~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~ 801 (918)
.+.++|+|++|.||+++++..+.|+|||.+..
T Consensus 163 ~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 163 QGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp TTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred cCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 11399999999999998776677999998764
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=98.93 E-value=1.7e-10 Score=125.04 Aligned_cols=83 Identities=13% Similarity=0.196 Sum_probs=43.6
Q ss_pred ccccCeeeccccccCCcCCccC---CCCCCCcEeeccCcccccCC----CccccCCCCcceeecccccccCCCCCCCcC-
Q 044366 164 LKSLLQLDLSENRLSGLIPLSL---SNLSSLTVMSLFNNSLSGSI----PPILGNLKSLSTLGLHINQLNGVIPPSIGN- 235 (918)
Q Consensus 164 l~~L~~L~Ls~N~l~~~~~~~~---~~l~~L~~L~L~~N~l~~~~----~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~- 235 (918)
+++|++|+|++|.+.+..+..+ ..+++|++|+|+.|.+.+.. +..+..+++|+.|+|++|.++......+..
T Consensus 251 ~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i~d~~~~~l~~a 330 (362)
T 2ra8_A 251 FPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEMKKELQKS 330 (362)
T ss_dssp CTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBBCCHHHHHHHHHH
T ss_pred CCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCcCCHHHHHHHHHH
Confidence 4566666666665543221111 13566777777766665422 222345567777777777665432222221
Q ss_pred CCcCCeEEcccCc
Q 044366 236 LSSLRNLSLFNNR 248 (918)
Q Consensus 236 l~~L~~L~Ls~n~ 248 (918)
+ ...+++++++
T Consensus 331 l--g~~~~~~~~~ 341 (362)
T 2ra8_A 331 L--PMKIDVSDSQ 341 (362)
T ss_dssp C--CSEEECCSBC
T ss_pred c--CCEEEecCCc
Confidence 1 2457777766
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.92 E-value=3.3e-09 Score=116.27 Aligned_cols=144 Identities=14% Similarity=0.237 Sum_probs=107.4
Q ss_pred CceeeccccceEEEEEEeCCCCEEEEEEcc--cccccCCCCChHHHHHHHHHHhhcc--CCceeeEecccccC---CceE
Q 044366 650 EKYCIGKGGQRSVYKAELPSGNIFAVKKFK--AELFSDETANPSEFLNEVLALTEIR--HRNIIKFHGFCSNA---QHSF 722 (918)
Q Consensus 650 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~--~~~~~~~~~~~~~~~~e~~~l~~l~--h~niv~~~~~~~~~---~~~~ 722 (918)
..+.++.|.++.||++... +..+++|+.. .... ......+.+|+.+++.+. +..++++++++.+. +..+
T Consensus 42 ~~~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~---~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~ 117 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKL---LPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAF 117 (359)
T ss_dssp EEEECCC-CCSCEEEEECS-SCEEEEECCCC-------------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCE
T ss_pred eEEEcCCcccceEEEEEEC-CceEEEEeCCCCCCCC---CCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeE
Confidence 4567999999999999875 4678888765 3211 112346788999999986 45678888888766 4589
Q ss_pred EEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCC---------------------------------
Q 044366 723 IVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDC--------------------------------- 769 (918)
Q Consensus 723 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--------------------------------- 769 (918)
+||||++|..+.+.. ...++..++..++.+++++|+.||+..
T Consensus 118 ~vme~v~G~~l~~~~-----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (359)
T 3dxp_A 118 YIMEFVSGRVLWDQS-----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETE 192 (359)
T ss_dssp EEEECCCCBCCCCTT-----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCS
T ss_pred EEEEecCCeecCCCc-----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCc
Confidence 999999998775422 123678888999999999999999831
Q ss_pred ----------------------CCCeEEcCCCCCCeeeCCCCc--EEEecccccccc
Q 044366 770 ----------------------IPPIVHRDISSKNVLLDSEYE--AHVSDFGFAKFL 802 (918)
Q Consensus 770 ----------------------~~~ivH~dlk~~Nill~~~~~--~kl~DfG~~~~~ 802 (918)
.+.++|||+++.||+++.++. +.|+||+.+...
T Consensus 193 ~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g 249 (359)
T 3dxp_A 193 SIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG 249 (359)
T ss_dssp CCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred CChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence 247899999999999998753 689999988753
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=98.88 E-value=3.7e-10 Score=122.46 Aligned_cols=83 Identities=19% Similarity=0.189 Sum_probs=45.7
Q ss_pred cccCCCCCCEEEccCCccc---------ccCccccCCCCCCCEEECcCCcCCCcCCcCCCCCCCCceeeccccccccCCC
Q 044366 88 SLGNLSNLALLYLNDNSLF---------GSIPIVMGNLKSLSTLDLSQNQLNGSIPCSLDNLSNLDTLFLYKNSLSGPIP 158 (918)
Q Consensus 88 ~l~~l~~L~~L~L~~n~i~---------~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~l~~~~~ 158 (918)
++..+++|+.|.+..+... +.+...+..+++|+.|+|++|.-. .++. +. +++|++|+|..|.+.....
T Consensus 134 s~~~l~~L~~L~l~~~~~e~~~is~~~~~~L~~ll~~~P~L~~L~L~g~~~l-~l~~-~~-~~~L~~L~L~~~~l~~~~l 210 (362)
T 2ra8_A 134 NKEKFAHFEGLFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGTNNL-SIGK-KP-RPNLKSLEIISGGLPDSVV 210 (362)
T ss_dssp THHHHTTCSEEEECCCCTTTCCGGGCBCCBCHHHHHTCTTCCEEEEECCBTC-BCCS-CB-CTTCSEEEEECSBCCHHHH
T ss_pred hhhhcchhhheeecCcchhhcccccccccCHHHHHhcCCCCcEEEEeCCCCc-eecc-cc-CCCCcEEEEecCCCChHHH
Confidence 3445566666666543221 123344566677777777776311 1222 32 6677777777777653322
Q ss_pred cccc--cccccCeeecc
Q 044366 159 SVIG--NLKSLLQLDLS 173 (918)
Q Consensus 159 ~~~~--~l~~L~~L~Ls 173 (918)
..+. .+++|++|+|+
T Consensus 211 ~~l~~~~lp~L~~L~L~ 227 (362)
T 2ra8_A 211 EDILGSDLPNLEKLVLY 227 (362)
T ss_dssp HHHHHSBCTTCCEEEEE
T ss_pred HHHHHccCCCCcEEEEe
Confidence 3333 56777777765
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.78 E-value=2.3e-09 Score=114.53 Aligned_cols=182 Identities=23% Similarity=0.246 Sum_probs=122.0
Q ss_pred ceeeccccceEEEEEEeCCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhcc-CCc--eeeEecccccCC---ceEEE
Q 044366 651 KYCIGKGGQRSVYKAELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIR-HRN--IIKFHGFCSNAQ---HSFIV 724 (918)
Q Consensus 651 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~n--iv~~~~~~~~~~---~~~lv 724 (918)
.+.++.|....||++. +.+++|+.... .....+.+|.+.++.+. +.. +.++++....++ ..|+|
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~------~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~v 94 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKHS------RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAG 94 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESSH------HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEE
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCCc------chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEE
Confidence 4568999999999863 56888875432 22467899999998883 322 445555544333 35899
Q ss_pred EEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCC-----------------------------------
Q 044366 725 CEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDC----------------------------------- 769 (918)
Q Consensus 725 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~----------------------------------- 769 (918)
|||++|.++.+.... .++..++..++.++++.++.||+..
T Consensus 95 m~~i~G~~l~~~~~~-----~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 169 (304)
T 3sg8_A 95 FTKIKGVPLTPLLLN-----NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQ 169 (304)
T ss_dssp EECCCCEECCHHHHH-----TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHH
T ss_pred EcccCCeECCccccc-----cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCccc
Confidence 999999888754322 2677788889999999999998621
Q ss_pred --------------------CCCeEEcCCCCCCeeeCC--CCcEEEeccccccccCCCCCCceeccccccc---cccccc
Q 044366 770 --------------------IPPIVHRDISSKNVLLDS--EYEAHVSDFGFAKFLEPHSSNWTEFAGTVGY---AAPELA 824 (918)
Q Consensus 770 --------------------~~~ivH~dlk~~Nill~~--~~~~kl~DfG~~~~~~~~~~~~~~~~g~~~y---~aPE~~ 824 (918)
.+.++|+|+++.||++++ ...+.++||+.+....+... . .....+ .+|+..
T Consensus 170 ~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~D-l---~~~~~~~~~~~~~~~ 245 (304)
T 3sg8_A 170 MKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDND-F---ISLMEDDEEYGMEFV 245 (304)
T ss_dssp HHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHH-H---HTTCCTTTSCCHHHH
T ss_pred HHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHH-H---HHHHhhccccCHHHH
Confidence 135799999999999998 45678999999876533210 0 000011 122211
Q ss_pred c----c-C---------CCCcccchhhHHHHHHHHHhCCCC
Q 044366 825 Y----T-M---------RATEKYDVYSFGVLALEVIKGYHP 851 (918)
Q Consensus 825 ~----~-~---------~~~~~~Dv~slG~vl~el~tg~~p 851 (918)
. . + +.....+.|++|.++|++.+|..+
T Consensus 246 ~~~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~ 286 (304)
T 3sg8_A 246 SKILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMD 286 (304)
T ss_dssp HHHHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHH
T ss_pred HHHHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHH
Confidence 1 0 0 011236899999999999999877
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.58 E-value=8.8e-09 Score=100.68 Aligned_cols=113 Identities=11% Similarity=0.161 Sum_probs=67.8
Q ss_pred CCCCcccEEeccCc-ccccc----CccccccccccceecccCcccCCCC----chhhccccccceEeccCCcCCCC----
Q 044366 426 GTLTELQYLDLSAN-KLSSS----IPMSIGNLLKLHYLNLSNNQFSHKI----PTEFEKLIHLSELDLSHNILQEE---- 492 (918)
Q Consensus 426 ~~l~~L~~L~Ls~N-~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~~----~~~~~~l~~L~~L~Ls~N~l~~~---- 492 (918)
...++|++|+|++| .|... +...+...++|++|+|++|+|.... ...+...+.|++|+|++|.|++.
T Consensus 33 ~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g~~~ 112 (185)
T 1io0_A 33 NNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILA 112 (185)
T ss_dssp TTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHH
T ss_pred hcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHHHHH
Confidence 34456666666666 66531 2334444566777777777765322 23344446677777777777643
Q ss_pred CchhccccCCcceEec--CCCccccc----CcccccCCCCccEEEccCCcCC
Q 044366 493 IPPQICKMESLEKLNL--SHNNLSDF----IPRCFEEMRSLSWIDISYNELQ 538 (918)
Q Consensus 493 ~~~~~~~l~~L~~L~L--~~N~l~~~----~~~~~~~l~~L~~l~l~~N~l~ 538 (918)
+...+...+.|++|+| ++|.|+.. +...+...++|+.|+|++|.+.
T Consensus 113 l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~ 164 (185)
T 1io0_A 113 LVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG 164 (185)
T ss_dssp HHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred HHHHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence 2444555667777777 66777653 2344555677788888777765
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.54 E-value=1.2e-08 Score=104.48 Aligned_cols=105 Identities=30% Similarity=0.351 Sum_probs=66.2
Q ss_pred CCCCCcccE--EeccCcccc---ccCccccccccccceecccCcccCCC--CchhhccccccceEeccCCcCCCCCchhc
Q 044366 425 FGTLTELQY--LDLSANKLS---SSIPMSIGNLLKLHYLNLSNNQFSHK--IPTEFEKLIHLSELDLSHNILQEEIPPQI 497 (918)
Q Consensus 425 ~~~l~~L~~--L~Ls~N~l~---~~~~~~~~~l~~L~~L~Ls~N~l~~~--~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~ 497 (918)
|...+.|.. ++++.|... ..++....++++|+.|+|++|+|+++ +|..+..+++|+.|+|++|+|++. ..+
T Consensus 137 l~~dp~L~~~~l~l~~N~~~~~~~~l~i~~~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l 214 (267)
T 3rw6_A 137 LRSDPDLVAQNIDVVLNRRSCMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--REL 214 (267)
T ss_dssp GGGCHHHHHTTCCCCTTSHHHHHHHHHHHHHHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGG
T ss_pred cCCCcchhhcCccccCCHHHHHHHHHHHHHhhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhh
Confidence 444455655 667777443 11122224567788888888888763 346667788888888888888754 233
Q ss_pred cccC--CcceEecCCCcccccCc-------ccccCCCCccEEE
Q 044366 498 CKME--SLEKLNLSHNNLSDFIP-------RCFEEMRSLSWID 531 (918)
Q Consensus 498 ~~l~--~L~~L~L~~N~l~~~~~-------~~~~~l~~L~~l~ 531 (918)
..+. +|+.|+|++|++++..| ..+..+++|+.||
T Consensus 215 ~~l~~l~L~~L~L~~Npl~~~~~~~~~y~~~il~~~P~L~~LD 257 (267)
T 3rw6_A 215 DKIKGLKLEELWLDGNSLCDTFRDQSTYISAIRERFPKLLRLD 257 (267)
T ss_dssp GGGTTSCCSEEECTTSTTGGGCSSHHHHHHHHHHHCTTCCEES
T ss_pred hhcccCCcceEEccCCcCccccCcchhHHHHHHHHCcccCeEC
Confidence 3333 77888888888776444 2356677777664
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.43 E-value=1.8e-08 Score=98.53 Aligned_cols=120 Identities=14% Similarity=0.122 Sum_probs=75.5
Q ss_pred CcCCCCCCcEEEccCc-eeccccccchhhccccCceecccccccCCCCCCCCCCCcccEEeccCcccccc----Cccccc
Q 044366 376 EIGDSSKLQVLDLSSN-HIFGKIPVQLVKLFSLNKLILSLNQLFGGVPLEFGTLTELQYLDLSANKLSSS----IPMSIG 450 (918)
Q Consensus 376 ~~~~~~~L~~L~L~~N-~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~----~~~~~~ 450 (918)
.+...++|++|+|++| .|.......+. ..+...++|++|+|++|.|... +...+.
T Consensus 31 ~l~~~~~L~~L~L~~n~~i~~~g~~~l~--------------------~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~ 90 (185)
T 1io0_A 31 IQNNDPDLEEVNLNNIMNIPVPTLKACA--------------------EALKTNTYVKKFSIVGTRSNDPVAFALAEMLK 90 (185)
T ss_dssp HHTTCTTCCEEECTTCTTCCHHHHHHHH--------------------HHHTTCCSCCEEECTTSCCCHHHHHHHHHHHH
T ss_pred HHhcCCCCCEEEecCCCCCCHHHHHHHH--------------------HHHHhCCCcCEEECcCCCCChHHHHHHHHHHH
Confidence 3455666777777776 66432221111 1233445677778887777642 233445
Q ss_pred cccccceecccCcccCCC----CchhhccccccceEec--cCCcCCCCC----chhccccCCcceEecCCCcccc
Q 044366 451 NLLKLHYLNLSNNQFSHK----IPTEFEKLIHLSELDL--SHNILQEEI----PPQICKMESLEKLNLSHNNLSD 515 (918)
Q Consensus 451 ~l~~L~~L~Ls~N~l~~~----~~~~~~~l~~L~~L~L--s~N~l~~~~----~~~~~~l~~L~~L~L~~N~l~~ 515 (918)
..++|++|+|++|+|+.. +...+...+.|++|+| ++|.|+... ...+...++|+.|+|++|.+..
T Consensus 91 ~n~~L~~L~L~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~~ 165 (185)
T 1io0_A 91 VNNTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQGP 165 (185)
T ss_dssp HCSSCCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHHH
T ss_pred hCCCcCEEECcCCcCCHHHHHHHHHHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCCh
Confidence 557788888888888643 3445666678888888 778886542 3344556788888888888753
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.36 E-value=1.1e-07 Score=97.29 Aligned_cols=94 Identities=23% Similarity=0.228 Sum_probs=72.5
Q ss_pred cccccccce--ecccCcccC---CCCchhhccccccceEeccCCcCCCC--CchhccccCCcceEecCCCcccccCcccc
Q 044366 449 IGNLLKLHY--LNLSNNQFS---HKIPTEFEKLIHLSELDLSHNILQEE--IPPQICKMESLEKLNLSHNNLSDFIPRCF 521 (918)
Q Consensus 449 ~~~l~~L~~--L~Ls~N~l~---~~~~~~~~~l~~L~~L~Ls~N~l~~~--~~~~~~~l~~L~~L~L~~N~l~~~~~~~~ 521 (918)
|...+.|.. ++++.|+.. ...+....++++|+.|+|++|+|++. +|..+..+++|+.|+|++|+|++. ..+
T Consensus 137 l~~dp~L~~~~l~l~~N~~~~~~~~l~i~~~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l 214 (267)
T 3rw6_A 137 LRSDPDLVAQNIDVVLNRRSCMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--REL 214 (267)
T ss_dssp GGGCHHHHHTTCCCCTTSHHHHHHHHHHHHHHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGG
T ss_pred cCCCcchhhcCccccCCHHHHHHHHHHHHHhhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhh
Confidence 555566776 788999643 22233346789999999999999984 457778999999999999999986 234
Q ss_pred cCCC--CccEEEccCCcCCCCCCCC
Q 044366 522 EEMR--SLSWIDISYNELQGPIPNS 544 (918)
Q Consensus 522 ~~l~--~L~~l~l~~N~l~~~~p~~ 544 (918)
..+. +|+.|+|++|++++.+|..
T Consensus 215 ~~l~~l~L~~L~L~~Npl~~~~~~~ 239 (267)
T 3rw6_A 215 DKIKGLKLEELWLDGNSLCDTFRDQ 239 (267)
T ss_dssp GGGTTSCCSEEECTTSTTGGGCSSH
T ss_pred hhcccCCcceEEccCCcCccccCcc
Confidence 4444 9999999999999887753
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.26 E-value=1.8e-06 Score=90.10 Aligned_cols=135 Identities=15% Similarity=0.185 Sum_probs=98.0
Q ss_pred eeccccce-EEEEEEeC-CCCEEEEEEcccccccCCCCChHHHHHHHHHHhhcc-CCceeeEecccccCCceEEEEEecc
Q 044366 653 CIGKGGQR-SVYKAELP-SGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIR-HRNIIKFHGFCSNAQHSFIVCEYLA 729 (918)
Q Consensus 653 ~lg~G~~g-~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~ 729 (918)
.+..|..| .||+.... +++.+.+|+-... ...++.+|...++.+. +--+.++++++.+++..++|||+++
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~-------~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~ 103 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS-------VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIP 103 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETH-------HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCC
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCC-------CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeC
Confidence 45556655 68988654 5677899975432 2456888999998884 4447788899988899999999999
Q ss_pred CCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCC----------------------------------------
Q 044366 730 RGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDC---------------------------------------- 769 (918)
Q Consensus 730 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---------------------------------------- 769 (918)
+.++.+...... .+...++.++++.++.||+..
T Consensus 104 G~~~~~~~~~~~-------~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 176 (272)
T 4gkh_A 104 GKTAFQVLEEYP-------DSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPV 176 (272)
T ss_dssp SEEHHHHHHHCG-------GGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCH
T ss_pred CccccccccCCH-------HHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHH
Confidence 988877654321 223456667777777777521
Q ss_pred ---------------CCCeEEcCCCCCCeeeCCCCcEEEeccccccc
Q 044366 770 ---------------IPPIVHRDISSKNVLLDSEYEAHVSDFGFAKF 801 (918)
Q Consensus 770 ---------------~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~ 801 (918)
.+.++|+|+.+.||++++++.+-|+||+.+..
T Consensus 177 ~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 177 EQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 01378999999999999877778999998864
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.23 E-value=4.3e-06 Score=88.80 Aligned_cols=138 Identities=15% Similarity=0.150 Sum_probs=95.5
Q ss_pred ceeeccccceEEEEEEeCCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCC---ceeeEecccc-cCCceEEEEE
Q 044366 651 KYCIGKGGQRSVYKAELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHR---NIIKFHGFCS-NAQHSFIVCE 726 (918)
Q Consensus 651 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~---niv~~~~~~~-~~~~~~lv~e 726 (918)
.+.++.|....||+. |+.+++|+-... .....+.+|.++++.+.+. .+.+++.++. ..+..++|||
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~~~------~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e 93 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPKSQ------QGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYR 93 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEESSH------HHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEE
T ss_pred eeecCCCcceeEEEE----CCEEEEEecCCc------hHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEe
Confidence 456888999999997 567888874221 1246789999999999642 3556666663 4556789999
Q ss_pred eccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhC--------------------------------------
Q 044366 727 YLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHD-------------------------------------- 768 (918)
Q Consensus 727 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-------------------------------------- 768 (918)
|++|.++.+.... .++..+...++.++++.|+.||+.
T Consensus 94 ~i~G~~l~~~~~~-----~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~ 168 (306)
T 3tdw_A 94 KVQGQILGEDGMA-----VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESL 168 (306)
T ss_dssp CCCSEECHHHHHT-----TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHH
T ss_pred ccCCeECchhhhh-----hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhh
Confidence 9999888763211 134445555555555555555542
Q ss_pred -------------------CCCCeEEcCCCCCCeeeCC---CCc-EEEeccccccccC
Q 044366 769 -------------------CIPPIVHRDISSKNVLLDS---EYE-AHVSDFGFAKFLE 803 (918)
Q Consensus 769 -------------------~~~~ivH~dlk~~Nill~~---~~~-~kl~DfG~~~~~~ 803 (918)
..+.++|+|+++.||++++ ++. +.|+||+.+....
T Consensus 169 ~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~gd 226 (306)
T 3tdw_A 169 RDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAISD 226 (306)
T ss_dssp HHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEEC
T ss_pred HHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCCC
Confidence 2235799999999999998 455 4899999887543
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.01 E-value=1.2e-05 Score=87.74 Aligned_cols=84 Identities=5% Similarity=-0.030 Sum_probs=56.3
Q ss_pred ceee-ccccceEEEEEEeC-------CCCEEEEEEcccccccCCCCChHHHHHHHHHHhhcc-C--CceeeEecccccC-
Q 044366 651 KYCI-GKGGQRSVYKAELP-------SGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIR-H--RNIIKFHGFCSNA- 718 (918)
Q Consensus 651 ~~~l-g~G~~g~Vy~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h--~niv~~~~~~~~~- 718 (918)
.+.| +.|....+|+.... +++.+++|........ .......+.+|+.+++.+. + -.+.++++++.+.
T Consensus 25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~-~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~ 103 (357)
T 3ats_A 25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDV-PVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGD 103 (357)
T ss_dssp EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGC-CSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSST
T ss_pred EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCcc-ccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCC
Confidence 3567 88889999998654 2678889876442100 0001245778888888884 3 3567788877655
Q ss_pred --CceEEEEEeccCCChhH
Q 044366 719 --QHSFIVCEYLARGSLTT 735 (918)
Q Consensus 719 --~~~~lv~e~~~~gsL~~ 735 (918)
+..++||||++|.++.+
T Consensus 104 ~~g~~~~v~e~l~G~~l~~ 122 (357)
T 3ats_A 104 VLGTPFFLMDYVEGVVPPD 122 (357)
T ss_dssp TTSSCEEEEECCCCBCCCB
T ss_pred ccCCceEEEEecCCCChhh
Confidence 45789999999877653
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=97.95 E-value=1.7e-06 Score=82.02 Aligned_cols=82 Identities=11% Similarity=0.126 Sum_probs=40.0
Q ss_pred CCEEEcccccccccCCCCcCCCCCCCEEEccccc-ccccCCccccCC----CCCCEEEccCCc-ccccCccccCCCCCCC
Q 044366 47 LRRLYLDVNQLHGTIPPVIGQLSLINELVFCHNN-VSGRIPSSLGNL----SNLALLYLNDNS-LFGSIPIVMGNLKSLS 120 (918)
Q Consensus 47 L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~-~~~~~p~~l~~l----~~L~~L~L~~n~-i~~~~~~~~~~l~~L~ 120 (918)
|+.||++++.|+..--..+..+++|++|+|++|. ++..--..++.+ ++|++|+|++|. |++..-..+..+++|+
T Consensus 63 L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~L~ 142 (176)
T 3e4g_A 63 IQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRNLK 142 (176)
T ss_dssp EEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTTCC
T ss_pred EeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCCCC
Confidence 4444444444433323333444444444444442 332222233332 256666666663 5554444556667777
Q ss_pred EEECcCCc
Q 044366 121 TLDLSQNQ 128 (918)
Q Consensus 121 ~L~Ls~n~ 128 (918)
+|+|+++.
T Consensus 143 ~L~L~~c~ 150 (176)
T 3e4g_A 143 YLFLSDLP 150 (176)
T ss_dssp EEEEESCT
T ss_pred EEECCCCC
Confidence 77777664
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=97.89 E-value=3.8e-06 Score=79.54 Aligned_cols=84 Identities=13% Similarity=0.100 Sum_probs=53.4
Q ss_pred CcccEEeccCccccccCccccccccccceecccCcc-cCCCCchhhccc----cccceEeccCC-cCCCCCchhccccCC
Q 044366 429 TELQYLDLSANKLSSSIPMSIGNLLKLHYLNLSNNQ-FSHKIPTEFEKL----IHLSELDLSHN-ILQEEIPPQICKMES 502 (918)
Q Consensus 429 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~-l~~~~~~~~~~l----~~L~~L~Ls~N-~l~~~~~~~~~~l~~ 502 (918)
..|++|||+++.|+...-..+..+++|+.|+|++|. |++..-..+..+ ++|++|+|++| +||+.--..+..+++
T Consensus 61 ~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~ 140 (176)
T 3e4g_A 61 YKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRN 140 (176)
T ss_dssp CCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTT
T ss_pred ceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCC
Confidence 357777777777765444556667777777777774 654433444443 35777777776 366554555666777
Q ss_pred cceEecCCCc
Q 044366 503 LEKLNLSHNN 512 (918)
Q Consensus 503 L~~L~L~~N~ 512 (918)
|+.|+|+++.
T Consensus 141 L~~L~L~~c~ 150 (176)
T 3e4g_A 141 LKYLFLSDLP 150 (176)
T ss_dssp CCEEEEESCT
T ss_pred CCEEECCCCC
Confidence 7777777764
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.88 E-value=5.1e-05 Score=83.91 Aligned_cols=79 Identities=14% Similarity=-0.005 Sum_probs=51.1
Q ss_pred ceeeccccceEEEEEEeC-CCCEEEEEEcccccc---cCCCCChHHHHHHHHHHhhccC--C-ceeeEecccccCCceEE
Q 044366 651 KYCIGKGGQRSVYKAELP-SGNIFAVKKFKAELF---SDETANPSEFLNEVLALTEIRH--R-NIIKFHGFCSNAQHSFI 723 (918)
Q Consensus 651 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~~~~~e~~~l~~l~h--~-niv~~~~~~~~~~~~~l 723 (918)
.+.+|.|..+.||++... +++.|+||....... .........+..|.++++.+.. + .+.+++.+ +.+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 457999999999999654 578899998653211 1111234567889999888742 3 34455544 3445689
Q ss_pred EEEeccCC
Q 044366 724 VCEYLARG 731 (918)
Q Consensus 724 v~e~~~~g 731 (918)
||||+++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999763
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.80 E-value=4.8e-05 Score=82.27 Aligned_cols=141 Identities=17% Similarity=0.224 Sum_probs=81.3
Q ss_pred eeeccccceEEEEEEeCCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccC--CceeeEecc------cccCCceEE
Q 044366 652 YCIGKGGQRSVYKAELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRH--RNIIKFHGF------CSNAQHSFI 723 (918)
Q Consensus 652 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~~~~~------~~~~~~~~l 723 (918)
+.|+.|..+.||++...+| .+++|+.... ...+..|..+++.+.. -.+.+++.. ...++..++
T Consensus 38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~--------~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~ 108 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRP--------EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFV 108 (346)
T ss_dssp EECC----CEEEEEEETTE-EEEEEEECSC--------HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEE
T ss_pred eeccccccCcEEEEEeCCC-CEEEEecCCC--------HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEE
Confidence 4566677899999987555 4889987541 2344456666665531 123444431 124566789
Q ss_pred EEEeccCCChh-----------H---Hhhcccc----c-------CCCCHHHH---------------------------
Q 044366 724 VCEYLARGSLT-----------T---ILRDDAA----A-------KEFSWNQR--------------------------- 751 (918)
Q Consensus 724 v~e~~~~gsL~-----------~---~l~~~~~----~-------~~l~~~~~--------------------------- 751 (918)
||||++|.++. + .++.... . ..-.|...
T Consensus 109 l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 188 (346)
T 2q83_A 109 VYDWIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLY 188 (346)
T ss_dssp EEECCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHH
T ss_pred EEEeecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHH
Confidence 99999986542 0 1111100 0 00123221
Q ss_pred ----HHHHHHHHHHHHHHHh----------CCCCCeEEcCCCCCCeeeCCCCcEEEeccccccc
Q 044366 752 ----MNVIKGVANALSYLHH----------DCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKF 801 (918)
Q Consensus 752 ----~~i~~~i~~~l~~LH~----------~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~ 801 (918)
..+...+..+++++++ ...+.++|+|+++.||+++.++.+.++||+.+..
T Consensus 189 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 189 LQEIDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred HHHHHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 1112234456667763 1234899999999999998888999999998753
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=97.67 E-value=9.5e-06 Score=78.37 Aligned_cols=108 Identities=20% Similarity=0.255 Sum_probs=67.0
Q ss_pred CcccEEeccCc-cccc----cCccccccccccceecccCcccCCC----CchhhccccccceEeccCCcCCCC----Cch
Q 044366 429 TELQYLDLSAN-KLSS----SIPMSIGNLLKLHYLNLSNNQFSHK----IPTEFEKLIHLSELDLSHNILQEE----IPP 495 (918)
Q Consensus 429 ~~L~~L~Ls~N-~l~~----~~~~~~~~l~~L~~L~Ls~N~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~----~~~ 495 (918)
+.|++|+|++| .|.. .+.+.+...+.|+.|+|++|+|... +.+++..-+.|+.|+|++|+|++. +..
T Consensus 41 ~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~ala~ 120 (197)
T 1pgv_A 41 TDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLR 120 (197)
T ss_dssp SSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHH
T ss_pred CCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHHHHHHH
Confidence 46777777764 6652 2334455566777777777777543 233444556788888888877643 223
Q ss_pred hccccCCcceEecCCC---cccc----cCcccccCCCCccEEEccCCc
Q 044366 496 QICKMESLEKLNLSHN---NLSD----FIPRCFEEMRSLSWIDISYNE 536 (918)
Q Consensus 496 ~~~~l~~L~~L~L~~N---~l~~----~~~~~~~~l~~L~~l~l~~N~ 536 (918)
++..-..|+.|+|++| .+.. .+..++..-++|+.|+++.|.
T Consensus 121 aL~~N~tL~~L~L~n~~~~~ig~~g~~~ia~aL~~N~tL~~L~l~~~~ 168 (197)
T 1pgv_A 121 STLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFAS 168 (197)
T ss_dssp HTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCC
T ss_pred HHhhCCceeEEECCCCcCcCcCHHHHHHHHHHHHhCCCcCeEeccCCC
Confidence 4455567888888765 3332 134456667788888887664
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.65 E-value=0.00023 Score=75.08 Aligned_cols=140 Identities=17% Similarity=0.155 Sum_probs=92.9
Q ss_pred CCceeeccccceEEEEEEeCCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhcc---CCceeeEecccccCCceEEEE
Q 044366 649 GEKYCIGKGGQRSVYKAELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIR---HRNIIKFHGFCSNAQHSFIVC 725 (918)
Q Consensus 649 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~~~lv~ 725 (918)
...+.|+.|....+|+... +++.+++|+.... ....|..|...++.+. ...++++++++...+..++||
T Consensus 39 ~~~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~-------~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvm 110 (312)
T 3jr1_A 39 KHKEKLYSGEMNEIWLIND-EVQTVFVKINERS-------YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLL 110 (312)
T ss_dssp CEEEEECCSSSSEEEEEES-SSCEEEEEEEEGG-------GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEE
T ss_pred eeeEEeCCccceeeeEEEE-CCCeEEEEeCCcc-------cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEE
Confidence 3446799999999999986 5678899986431 2567889999998884 366888888888778899999
Q ss_pred EeccCCChhH-----------Hhhcccc-c----------C--------CCCHHHHH---HHHH----------------
Q 044366 726 EYLARGSLTT-----------ILRDDAA-A----------K--------EFSWNQRM---NVIK---------------- 756 (918)
Q Consensus 726 e~~~~gsL~~-----------~l~~~~~-~----------~--------~l~~~~~~---~i~~---------------- 756 (918)
||+++..+.. .++.... . + .-+|.+.. ++..
T Consensus 111 e~l~G~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~ 190 (312)
T 3jr1_A 111 EALNKSKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNID 190 (312)
T ss_dssp ECCCCCCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHH
T ss_pred EeccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHH
Confidence 9999876521 1122111 0 0 01454322 1111
Q ss_pred HHHHH-HHHHHh-CCCCCeEEcCCCCCCeeeCCCCcEEEeccc
Q 044366 757 GVANA-LSYLHH-DCIPPIVHRDISSKNVLLDSEYEAHVSDFG 797 (918)
Q Consensus 757 ~i~~~-l~~LH~-~~~~~ivH~dlk~~Nill~~~~~~kl~DfG 797 (918)
.+++. ...|.. ...|.++|+|+.+.|++++.++ +.+.|++
T Consensus 191 ~l~~~l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 191 LIVQIVADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHHHHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHHHHHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 11111 223432 2246899999999999999887 8899974
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=97.51 E-value=0.00012 Score=66.18 Aligned_cols=60 Identities=18% Similarity=0.230 Sum_probs=44.3
Q ss_pred eEeccCCcCC-CCCchhccccCCcceEecCCCcccccCcccccCCCCccEEEccCCcCCCCCC
Q 044366 481 ELDLSHNILQ-EEIPPQICKMESLEKLNLSHNNLSDFIPRCFEEMRSLSWIDISYNELQGPIP 542 (918)
Q Consensus 481 ~L~Ls~N~l~-~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~p 542 (918)
.++.+++.++ ..+|..+. ++|+.|+|++|+|+.+.+..|..+++|+.|+|++|+|.|.+-
T Consensus 12 ~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~CdC~ 72 (130)
T 3rfe_A 12 LVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWRCDCR 72 (130)
T ss_dssp EEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCBCSGG
T ss_pred EEEeCCCCCccccCCCCCC--cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCeeccCc
Confidence 6677777775 23454433 368888888888888888888888888888888888887654
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.48 E-value=0.00039 Score=72.91 Aligned_cols=80 Identities=18% Similarity=0.237 Sum_probs=58.1
Q ss_pred cCCCCceeeccccceEEEEEEeCCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhcc-C--CceeeEecccccCCceE
Q 044366 646 GNFGEKYCIGKGGQRSVYKAELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIR-H--RNIIKFHGFCSNAQHSF 722 (918)
Q Consensus 646 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h--~niv~~~~~~~~~~~~~ 722 (918)
........+|.|..+.||+.+..+|+.|.+|+.... .......|..|...++.+. . -.+++++++. ..+
T Consensus 15 ~~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~----~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~ 86 (288)
T 3f7w_A 15 REVAAVAERGHSHRWHLYRVELADGTPLFVKALPDD----APALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRT 86 (288)
T ss_dssp CCEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTT----CCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTE
T ss_pred CCeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCC----CcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----Cce
Confidence 345666789999999999999999999999986432 2223456889999998884 2 2345555542 348
Q ss_pred EEEEeccCCCh
Q 044366 723 IVCEYLARGSL 733 (918)
Q Consensus 723 lv~e~~~~gsL 733 (918)
+||||++++..
T Consensus 87 lv~e~l~~~~~ 97 (288)
T 3f7w_A 87 LAMEWVDERPP 97 (288)
T ss_dssp EEEECCCCCCC
T ss_pred EEEEeecccCC
Confidence 89999987643
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.47 E-value=0.00064 Score=75.59 Aligned_cols=76 Identities=14% Similarity=0.159 Sum_probs=48.7
Q ss_pred CCeEEcCCCCCCeeeCCCCcEEEeccccccccCCCCCCceeccc--ccccccccccccC---CCCcccchhhHHHHHHHH
Q 044366 771 PPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAG--TVGYAAPELAYTM---RATEKYDVYSFGVLALEV 845 (918)
Q Consensus 771 ~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~g--~~~y~aPE~~~~~---~~~~~~Dv~slG~vl~el 845 (918)
+.++|||+++.||++++++ ++++||+.+....+... ...... ...|++|+..... +.....++...+..+|+.
T Consensus 232 ~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~D-la~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (420)
T 2pyw_A 232 QALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFD-IGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWNL 309 (420)
T ss_dssp CEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHH-HHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHHH
T ss_pred CeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHH-HHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHHH
Confidence 4899999999999999876 99999998875432110 011111 1346666655321 122345566888888888
Q ss_pred HhC
Q 044366 846 IKG 848 (918)
Q Consensus 846 ~tg 848 (918)
+++
T Consensus 310 y~~ 312 (420)
T 2pyw_A 310 FNK 312 (420)
T ss_dssp HHH
T ss_pred HHH
Confidence 765
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=97.41 E-value=2.1e-05 Score=75.98 Aligned_cols=87 Identities=17% Similarity=0.219 Sum_probs=52.7
Q ss_pred CCCcccEEeccCcccccc----CccccccccccceecccCcccCCCC----chhhccccccceEeccCC---cCCCC---
Q 044366 427 TLTELQYLDLSANKLSSS----IPMSIGNLLKLHYLNLSNNQFSHKI----PTEFEKLIHLSELDLSHN---ILQEE--- 492 (918)
Q Consensus 427 ~l~~L~~L~Ls~N~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~~----~~~~~~l~~L~~L~Ls~N---~l~~~--- 492 (918)
.-+.|+.|+|++|.|... +.+.+...+.|+.|+|++|+|+... .+++..-+.|++|+|++| .|...
T Consensus 68 ~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~ala~aL~~N~tL~~L~L~n~~~~~ig~~g~~ 147 (197)
T 1pgv_A 68 NSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQRQSVLGNQVEM 147 (197)
T ss_dssp TCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCCSSCCCCHHHHH
T ss_pred hCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHHHHHHHHHhhCCceeEEECCCCcCcCcCHHHHH
Confidence 345677777777777632 3344445667777777777775432 233444466788888765 33321
Q ss_pred -CchhccccCCcceEecCCCcc
Q 044366 493 -IPPQICKMESLEKLNLSHNNL 513 (918)
Q Consensus 493 -~~~~~~~l~~L~~L~L~~N~l 513 (918)
+...+..-+.|+.|+++.|.+
T Consensus 148 ~ia~aL~~N~tL~~L~l~~~~~ 169 (197)
T 1pgv_A 148 DMMMAIEENESLLRVGISFASM 169 (197)
T ss_dssp HHHHHHHHCSSCCEEECCCCCH
T ss_pred HHHHHHHhCCCcCeEeccCCCc
Confidence 334455667788888877754
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=97.25 E-value=0.00029 Score=63.62 Aligned_cols=62 Identities=18% Similarity=0.278 Sum_probs=48.9
Q ss_pred EEEccCCcCc-CCCCccccCCCCCCeEEeecccccCccccccCCCCCccEEeCCCCccccccCcc
Q 044366 289 LLNMCENHLF-GPIPKSLRNLTSLERVRFNQNNLYGKVYEAFGDHPNLTFLDLSQNNFYCEISFN 352 (918)
Q Consensus 289 ~L~l~~n~l~-~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~ 352 (918)
.++.+++.++ ..+|..+. .+|++|+|++|+|+.++.+.|..+++|+.|+|++|+|.|+|...
T Consensus 12 ~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~CdC~l~ 74 (130)
T 3rfe_A 12 LVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWRCDCRLV 74 (130)
T ss_dssp EEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCBCSGGGH
T ss_pred EEEeCCCCCccccCCCCCC--cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCeeccCccH
Confidence 5666666665 23443322 35888999999999999999999999999999999999999854
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.05 E-value=0.0048 Score=65.86 Aligned_cols=144 Identities=13% Similarity=0.156 Sum_probs=83.9
Q ss_pred ceeeccccceEEEEEEeCCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCc--eeeEecc-----cccCCceEE
Q 044366 651 KYCIGKGGQRSVYKAELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRN--IIKFHGF-----CSNAQHSFI 723 (918)
Q Consensus 651 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~~~~~-----~~~~~~~~l 723 (918)
...++ |....||++...+|+.+++|..... ......+..|..+++.+.... +++++.. ...++..++
T Consensus 31 ~~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~-----~~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~ 104 (328)
T 1zyl_A 31 LTPLN-SYENRVYQFQDEDRRRFVVKFYRPE-----RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFA 104 (328)
T ss_dssp CEEEC-CSSSEEEEECCTTCCCEEEEEECTT-----TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEE
T ss_pred EEeec-CcccceEEEEcCCCCEEEEEEcCCC-----CCCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEE
Confidence 34577 8888999988777888999987532 123466778888888774322 4445543 112345678
Q ss_pred EEEeccCCChh-----HH---------hhccc---c---cCCCCHHHH----HHH---------------HHHHHHHHHH
Q 044366 724 VCEYLARGSLT-----TI---------LRDDA---A---AKEFSWNQR----MNV---------------IKGVANALSY 764 (918)
Q Consensus 724 v~e~~~~gsL~-----~~---------l~~~~---~---~~~l~~~~~----~~i---------------~~~i~~~l~~ 764 (918)
||||++|.++. .+ ++... . ...+++... ..+ ...+.+.++.
T Consensus 105 l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 184 (328)
T 1zyl_A 105 VFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAA 184 (328)
T ss_dssp EEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHH
T ss_pred EEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHH
Confidence 99999875432 11 11100 0 011222211 001 1111222333
Q ss_pred HHhC----CCCCeEEcCCCCCCeeeCCCCcEEEecccccccc
Q 044366 765 LHHD----CIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFL 802 (918)
Q Consensus 765 LH~~----~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~ 802 (918)
+.+. ..+.++|+|+++.||+++ + .+.++||+.+...
T Consensus 185 l~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~g 224 (328)
T 1zyl_A 185 VTAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARNG 224 (328)
T ss_dssp HHHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCEE
T ss_pred HHHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCcC
Confidence 3221 233678999999999999 4 8999999887643
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.05 E-value=0.0017 Score=69.67 Aligned_cols=143 Identities=17% Similarity=0.132 Sum_probs=73.9
Q ss_pred eeeccccceE-EEEEEeCCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccC--CceeeEecccccCCceEEEEEec
Q 044366 652 YCIGKGGQRS-VYKAELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRH--RNIIKFHGFCSNAQHSFIVCEYL 728 (918)
Q Consensus 652 ~~lg~G~~g~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~~~~~~~~~~~~~lv~e~~ 728 (918)
+.++.|+... +|+....+|+.+++|..... . ...+..|+.+++.+.. -.+.+++.+..+.+ ++|||++
T Consensus 24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~----~---~~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l 94 (333)
T 3csv_A 24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPE----E---GGDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDL 94 (333)
T ss_dssp CC--------CCEEEECTTCCEEEEEECCTT----T---TCCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCC
T ss_pred eECCCCCCCceEEEEEcCCCCeEEEEECCCC----C---CccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeC
Confidence 3465555544 66776544777877764321 1 0223456666666632 23456666543333 7899999
Q ss_pred cCCChhHHhhcccc-----------------------cCCCCHHHHH-------H-------------HHHHHHHHHHHH
Q 044366 729 ARGSLTTILRDDAA-----------------------AKEFSWNQRM-------N-------------VIKGVANALSYL 765 (918)
Q Consensus 729 ~~gsL~~~l~~~~~-----------------------~~~l~~~~~~-------~-------------i~~~i~~~l~~L 765 (918)
.+.++.+++..... ...++..... . ....+.+.++.+
T Consensus 95 ~~~~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l 174 (333)
T 3csv_A 95 GDALFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQI 174 (333)
T ss_dssp CSCBHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHH
T ss_pred CCcchHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHH
Confidence 77666554432100 0112211110 0 001112222333
Q ss_pred H---hCCCCCeEEcCCCCCCeeeCCC----CcEEEeccccccccC
Q 044366 766 H---HDCIPPIVHRDISSKNVLLDSE----YEAHVSDFGFAKFLE 803 (918)
Q Consensus 766 H---~~~~~~ivH~dlk~~Nill~~~----~~~kl~DfG~~~~~~ 803 (918)
. ....+.++|||+.+.||+++.+ +.+.++||+.+..-.
T Consensus 175 ~~~~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G~ 219 (333)
T 3csv_A 175 LSAQLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLGH 219 (333)
T ss_dssp HHHHCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEEC
T ss_pred HHhcccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcCC
Confidence 1 1123478999999999999875 679999999887543
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.04 E-value=0.0027 Score=67.60 Aligned_cols=159 Identities=11% Similarity=0.109 Sum_probs=90.2
Q ss_pred cCHHHHHHHhcCCCC-----ceeeccccceEEEEEEeCCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCc--e
Q 044366 636 VLYEEITKATGNFGE-----KYCIGKGGQRSVYKAELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRN--I 708 (918)
Q Consensus 636 ~~~~~~~~~~~~~~~-----~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~n--i 708 (918)
++.+++......|.. .+.|+.|....+|+....+| .+++|..... .....+..|+.+++.+.... +
T Consensus 7 ~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~------~~~~~l~~e~~~l~~L~~~g~~v 79 (322)
T 2ppq_A 7 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKR------VEKNDLPFFLGLMQHLAAKGLSC 79 (322)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC---------CCHHHHHHHHHHHHHHTTCCC
T ss_pred CCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCC------CCHHHHHHHHHHHHHHHHCCCCC
Confidence 445566666666764 23567788899999987665 5788987542 11345667888877774322 3
Q ss_pred eeEeccc------ccCCceEEEEEeccCCChhH----H----------hhcc----cccC--C---CCHHHHHH------
Q 044366 709 IKFHGFC------SNAQHSFIVCEYLARGSLTT----I----------LRDD----AAAK--E---FSWNQRMN------ 753 (918)
Q Consensus 709 v~~~~~~------~~~~~~~lv~e~~~~gsL~~----~----------l~~~----~~~~--~---l~~~~~~~------ 753 (918)
.+++... ...+..+++++|++|..+.. . ++.. .... . ..|...+.
T Consensus 80 P~~~~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~ 159 (322)
T 2ppq_A 80 PLPLPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERA 159 (322)
T ss_dssp CCBCCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGG
T ss_pred CcccCCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHH
Confidence 3444321 12355789999999865421 0 1111 0000 0 11322111
Q ss_pred ------HHHHHHHHHHHHHhC----CCCCeEEcCCCCCCeeeCCCCcEEEeccccccc
Q 044366 754 ------VIKGVANALSYLHHD----CIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKF 801 (918)
Q Consensus 754 ------i~~~i~~~l~~LH~~----~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~ 801 (918)
+...+.+.++++++. ..++++|+|+.+.||+++++..+.++||+.+..
T Consensus 160 ~~~~~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 160 DEVEKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp GGTSTTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HhhhhhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 011244555666532 134789999999999998876568999997763
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=96.99 E-value=0.0022 Score=67.59 Aligned_cols=140 Identities=16% Similarity=0.144 Sum_probs=75.9
Q ss_pred CceeeccccceEEEEEEeCCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCce-eeEecccccCCceEEEEEec
Q 044366 650 EKYCIGKGGQRSVYKAELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNI-IKFHGFCSNAQHSFIVCEYL 728 (918)
Q Consensus 650 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~~ 728 (918)
..+.|+.|....+|+. +.+++|+..... .. .....+|+..++.+....+ .+++++. .+.-++|+||+
T Consensus 22 ~i~~l~gG~tN~~~~~-----~~~vlR~~~~~~--~~---~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i 89 (301)
T 3dxq_A 22 GPLERLGGLTNLVFRA-----GDLCLRIPGKGT--EE---YINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYI 89 (301)
T ss_dssp SCEEEESCSSEEEEEE-----TTEEEEEECC---------CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECC
T ss_pred ceeEcCCcccccccee-----eeEEEECCCCCc--cc---eeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeec
Confidence 3678999999999998 567888765421 11 1123567777777642222 4555543 33457899999
Q ss_pred -cCCChhHH------------------hhcccc--cCCCC-HHHHHHHHHH--------------HHHHH----HHHHh-
Q 044366 729 -ARGSLTTI------------------LRDDAA--AKEFS-WNQRMNVIKG--------------VANAL----SYLHH- 767 (918)
Q Consensus 729 -~~gsL~~~------------------l~~~~~--~~~l~-~~~~~~i~~~--------------i~~~l----~~LH~- 767 (918)
++.++... ++.... ....+ +.....+... +.+.+ +.+..
T Consensus 90 ~~g~~l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~ 169 (301)
T 3dxq_A 90 AGAQTMSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAH 169 (301)
T ss_dssp TTCEECCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSS
T ss_pred CCCccCCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhc
Confidence 65444320 011100 00011 1111111111 11111 11111
Q ss_pred CCCCCeEEcCCCCCCeeeCCCCcEEEecccccccc
Q 044366 768 DCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFL 802 (918)
Q Consensus 768 ~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~ 802 (918)
...+.++|+|+.+.||+ ..++.+.++||..+..-
T Consensus 170 ~~~~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~g 203 (301)
T 3dxq_A 170 PLPLAACHCDPLCENFL-DTGERMWIVDWEYSGMN 203 (301)
T ss_dssp CCCCEEECSCCCGGGEE-ECSSCEEECCCTTCEEE
T ss_pred CCCceeeccCCCcCCEE-ECCCCEEEEecccccCC
Confidence 12235899999999999 55667899999988753
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.74 E-value=0.0048 Score=66.76 Aligned_cols=141 Identities=18% Similarity=0.248 Sum_probs=84.7
Q ss_pred eeeccccceEEEEEEeC--------CCCEEEEEEcccccccCCCCChHHHHHHHHHHhhcc-CCceeeEecccccCCceE
Q 044366 652 YCIGKGGQRSVYKAELP--------SGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIR-HRNIIKFHGFCSNAQHSF 722 (918)
Q Consensus 652 ~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~ 722 (918)
+.+..|....+|++..+ +++.|.+|+... .......+.+|..+++.+. +.-..++++++.+ .
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~-----~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g 126 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGA-----ILQGVDSLVLESVMFAILAERSLGPQLYGVFPE----G 126 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC--------CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----E
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCC-----ccchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----c
Confidence 45777888899999765 357899998532 1223566779999988884 3333566766654 3
Q ss_pred EEEEeccCCChhHH-h----------------hccc--ccCCCC--HHHHHHHHHHHHH-------------------HH
Q 044366 723 IVCEYLARGSLTTI-L----------------RDDA--AAKEFS--WNQRMNVIKGVAN-------------------AL 762 (918)
Q Consensus 723 lv~e~~~~gsL~~~-l----------------~~~~--~~~~l~--~~~~~~i~~~i~~-------------------~l 762 (918)
+||||++|.++..- + +... -..... |.++.++..++.. .+
T Consensus 127 ~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~ 206 (379)
T 3feg_A 127 RLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEM 206 (379)
T ss_dssp EEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHH
T ss_pred cEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHH
Confidence 99999998655311 1 1110 011122 4555556554422 23
Q ss_pred HHH----HhC-CCCCeEEcCCCCCCeeeCCC----CcEEEeccccccc
Q 044366 763 SYL----HHD-CIPPIVHRDISSKNVLLDSE----YEAHVSDFGFAKF 801 (918)
Q Consensus 763 ~~L----H~~-~~~~ivH~dlk~~Nill~~~----~~~kl~DfG~~~~ 801 (918)
+++ ... ....++|+|+.+.||+++.+ +.+.++||..+..
T Consensus 207 ~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 207 GNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 333 221 22368899999999999876 6899999998864
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.74 E-value=0.0037 Score=69.30 Aligned_cols=73 Identities=19% Similarity=0.242 Sum_probs=50.1
Q ss_pred ceeeccccceEEEEEEeCC--------CCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCce-eeEecccccCCce
Q 044366 651 KYCIGKGGQRSVYKAELPS--------GNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNI-IKFHGFCSNAQHS 721 (918)
Q Consensus 651 ~~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~ 721 (918)
.+.|+.|....+|++..++ ++.|.+|+.... ...+.+..|..+++.+...++ +++++.+.+
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~------~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~---- 147 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP------ETESHLVAESVIFTLLSERHLGPKLYGIFSG---- 147 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC------CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC------CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----
Confidence 3568888899999998653 578999986321 112566789999888853333 566665543
Q ss_pred EEEEEeccCCCh
Q 044366 722 FIVCEYLARGSL 733 (918)
Q Consensus 722 ~lv~e~~~~gsL 733 (918)
.+|+||++|.++
T Consensus 148 g~v~e~l~G~~l 159 (429)
T 1nw1_A 148 GRLEEYIPSRPL 159 (429)
T ss_dssp EEEECCCCEEEC
T ss_pred CEEEEEeCCccc
Confidence 389999986444
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=96.57 E-value=0.0081 Score=58.08 Aligned_cols=103 Identities=19% Similarity=0.134 Sum_probs=67.7
Q ss_pred CChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccCCCCCCce
Q 044366 731 GSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWT 810 (918)
Q Consensus 731 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~~~~~~~~ 810 (918)
.+|.+.|... +.+++++++|.++.|.+.+|.-.-.... . ..+=+.|..|++..+|.|.+.+ +.+.
T Consensus 33 vSL~eIL~~~--~~PlsEEqaWALc~Qc~~~L~~~~~~~~-~-~~~i~~~~~i~l~~dG~V~f~~-~~s~---------- 97 (229)
T 2yle_A 33 LSLEEILRLY--NQPINEEQAWAVCYQCCGSLRAAARRRQ-P-RHRVRSAAQIRVWRDGAVTLAP-AADD---------- 97 (229)
T ss_dssp EEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTTC-C-CCCCCSGGGEEEETTSCEEECC-C-------------
T ss_pred ccHHHHHHHc--CCCcCHHHHHHHHHHHHHHHHhhhhccc-C-CceecCCcceEEecCCceeccc-cccc----------
Confidence 3899999876 4679999999999999999887632111 1 1233456888999999988764 1110
Q ss_pred ecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCC
Q 044366 811 EFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHP 851 (918)
Q Consensus 811 ~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p 851 (918)
.....+.|||... ...+.+.=|||+|+++|.-+--..|
T Consensus 98 --~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~ 135 (229)
T 2yle_A 98 --AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK 135 (229)
T ss_dssp -----------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred --ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence 1123566888764 3456788999999999999865555
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.53 E-value=0.0089 Score=66.53 Aligned_cols=74 Identities=16% Similarity=0.083 Sum_probs=47.0
Q ss_pred ceeeccccceEEEEEEeCC-CCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCce-eeEecccccCCceEEEEEec
Q 044366 651 KYCIGKGGQRSVYKAELPS-GNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNI-IKFHGFCSNAQHSFIVCEYL 728 (918)
Q Consensus 651 ~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~~ 728 (918)
.+.|+.|-...+|++...+ ++.+++|+.... ... ..+..+|..+++.+...++ .++++++.. ..||||+
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~----~~~-~idR~~E~~vl~~L~~~gl~P~ll~~~~~----G~v~e~I 183 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPK----TDE-IINREREKKISCILYNKNIAKKIYVFFTN----GRIEEFM 183 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-----CCS-CSCHHHHHHHHHHHTTSSSBCCEEEEETT----EEEEECC
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCC----hhh-hcCHHHHHHHHHHHHhcCCCCCEEEEeCC----eEEEEee
Confidence 3568888899999998765 478888876432 111 1112578888888854433 567776632 3599999
Q ss_pred cCCCh
Q 044366 729 ARGSL 733 (918)
Q Consensus 729 ~~gsL 733 (918)
+|.++
T Consensus 184 ~G~~l 188 (458)
T 2qg7_A 184 DGYAL 188 (458)
T ss_dssp CSEEC
T ss_pred CCccC
Confidence 87544
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.21 E-value=0.0071 Score=65.75 Aligned_cols=73 Identities=12% Similarity=0.108 Sum_probs=43.0
Q ss_pred eeeccccceEEEEEEeCC---------CCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCc-eeeEecccccCCce
Q 044366 652 YCIGKGGQRSVYKAELPS---------GNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRN-IIKFHGFCSNAQHS 721 (918)
Q Consensus 652 ~~lg~G~~g~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~~~~~~~~~~~~ 721 (918)
+.++.|....+|+....+ ++.+++|+..... .. ..+...|..+++.+.... +.++++... -
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~--~~---~~~~~~E~~~l~~L~~~g~~P~~~~~~~----~ 109 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHV--DE---LYNTISEFEVYKTMSKYKIAPQLLNTFN----G 109 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTG--GG---TSCHHHHHHHHHHHHHTTSSCCEEEEET----T
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCc--cc---eecHHHHHHHHHHHHhcCCCCceEEecC----C
Confidence 457888888999997654 2688888865421 11 112357888887774333 345665432 3
Q ss_pred EEEEEeccCCCh
Q 044366 722 FIVCEYLARGSL 733 (918)
Q Consensus 722 ~lv~e~~~~gsL 733 (918)
++||||++|.++
T Consensus 110 ~~v~e~i~G~~l 121 (369)
T 3c5i_A 110 GRIEEWLYGDPL 121 (369)
T ss_dssp EEEEECCCSEEC
T ss_pred cEEEEEecCCcC
Confidence 789999987544
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.15 E-value=0.029 Score=59.96 Aligned_cols=32 Identities=25% Similarity=0.312 Sum_probs=28.2
Q ss_pred CCeEEcCCCCCCeeeCCCCcEEEecccccccc
Q 044366 771 PPIVHRDISSKNVLLDSEYEAHVSDFGFAKFL 802 (918)
Q Consensus 771 ~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~ 802 (918)
..++|+|+.+.||++++++.+.++||+.+...
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~ 237 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPMLA 237 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCeeC
Confidence 47899999999999998888999999887654
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=94.74 E-value=0.11 Score=56.76 Aligned_cols=140 Identities=9% Similarity=0.064 Sum_probs=83.4
Q ss_pred eeeccccceEEEEEEeCC--------CCEEEEEEcccccccCCCCChHHHHHHHHHHhhcc-CCceeeEecccccCCceE
Q 044366 652 YCIGKGGQRSVYKAELPS--------GNIFAVKKFKAELFSDETANPSEFLNEVLALTEIR-HRNIIKFHGFCSNAQHSF 722 (918)
Q Consensus 652 ~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~ 722 (918)
+.+..|....+|+....+ ++.|.+|+.... .....+..+|..+++.+. +.-..++++.+. -+
T Consensus 76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~-----t~~~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~ 146 (424)
T 3mes_A 76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKH-----VGKFYDSKVELDVFRYLSNINIAPNIIADFP----EG 146 (424)
T ss_dssp EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCC-----C-CCCCHHHHHHHHHHHHHTTSSCCEEEEET----TE
T ss_pred EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCC-----cchhcCHHHHHHHHHHHHhcCCCCCEEEEcC----CC
Confidence 467778889999997753 578999986431 111223467888888774 332445555332 37
Q ss_pred EEEEeccCCChhH--H-----h----------hccc----------ccCCCCHHHHHHHHHHH-----------------
Q 044366 723 IVCEYLARGSLTT--I-----L----------RDDA----------AAKEFSWNQRMNVIKGV----------------- 758 (918)
Q Consensus 723 lv~e~~~~gsL~~--~-----l----------~~~~----------~~~~l~~~~~~~i~~~i----------------- 758 (918)
.||||++|.++.. + . +... ...+--|.++.++..++
T Consensus 147 ~I~efI~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~~ 226 (424)
T 3mes_A 147 RIEEFIDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELYS 226 (424)
T ss_dssp EEEECCCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHHH
T ss_pred EEEEEeCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccHH
Confidence 8999999865421 0 0 1100 01111244444444332
Q ss_pred --HHHHHHHHhC---------------------CCCCeEEcCCCCCCeeeCCCCcEEEeccccccc
Q 044366 759 --ANALSYLHHD---------------------CIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKF 801 (918)
Q Consensus 759 --~~~l~~LH~~---------------------~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~ 801 (918)
...+++|.+. ....++|+|+.+.||+ +.++.+.++||..+..
T Consensus 227 ~l~~e~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~ 291 (424)
T 3mes_A 227 KILEEIDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSAI 291 (424)
T ss_dssp HHHHHHHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred HHHHHHHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCCc
Confidence 2223333211 1236789999999999 7788999999998864
|
| >2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=92.33 E-value=0.082 Score=36.16 Aligned_cols=28 Identities=29% Similarity=0.344 Sum_probs=11.8
Q ss_pred EehhHHHHHHHHHHHHHhhhhhhcccCC
Q 044366 585 IALPILGMVVLLIGLIGFFFLFRRRKRD 612 (918)
Q Consensus 585 i~~~~~~~~~~~~~~~~~~~~~~r~~~~ 612 (918)
|+..+++.+++++++++.+++++||++.
T Consensus 12 IA~gVVgGv~~v~ii~~~~~~~~RRRr~ 39 (44)
T 2l2t_A 12 IAAGVIGGLFILVIVGLTFAVYVRRKSI 39 (44)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHTTCS
T ss_pred EEEeehHHHHHHHHHHHHHHHHhhhhhh
Confidence 3444444333333444444444444443
|
| >2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=91.95 E-value=0.11 Score=35.71 Aligned_cols=27 Identities=33% Similarity=0.421 Sum_probs=11.8
Q ss_pred EehhHHHHHHHHHHHHHhhhhhhcccC
Q 044366 585 IALPILGMVVLLIGLIGFFFLFRRRKR 611 (918)
Q Consensus 585 i~~~~~~~~~~~~~~~~~~~~~~r~~~ 611 (918)
|+..+++.+++++++++.+++++||++
T Consensus 13 IA~gVVgGv~~~~ii~~~~~~~~RRr~ 39 (44)
T 2ks1_B 13 IATGMVGALLLLLVVALGIGLFMRRRH 39 (44)
T ss_dssp STHHHHHHHHHHHHHHHHHHHHHHTTT
T ss_pred EEeehhHHHHHHHHHHHHHHHHhhhhH
Confidence 444444434443444444444444443
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=89.63 E-value=0.17 Score=55.26 Aligned_cols=29 Identities=24% Similarity=0.533 Sum_probs=24.6
Q ss_pred eEEcCCCCCCeee------CCCCcEEEeccccccc
Q 044366 773 IVHRDISSKNVLL------DSEYEAHVSDFGFAKF 801 (918)
Q Consensus 773 ivH~dlk~~Nill------~~~~~~kl~DfG~~~~ 801 (918)
++|+|+.+.||++ +++..++++||..|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 5799999999999 4456799999998864
|
| >2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A | Back alignment and structure |
|---|
Probab=87.05 E-value=0.34 Score=33.06 Aligned_cols=6 Identities=17% Similarity=0.495 Sum_probs=2.4
Q ss_pred ehhHHH
Q 044366 586 ALPILG 591 (918)
Q Consensus 586 ~~~~~~ 591 (918)
+..+++
T Consensus 15 a~~vVG 20 (44)
T 2jwa_A 15 ISAVVG 20 (44)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 333444
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=82.73 E-value=1.2 Score=43.05 Aligned_cols=116 Identities=10% Similarity=0.086 Sum_probs=77.6
Q ss_pred cCCceeeEecccccCCceEEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCe
Q 044366 704 RHRNIIKFHGFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNV 783 (918)
Q Consensus 704 ~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Ni 783 (918)
.||+.++. .+-.+++...+.|+.-+ +...|-. -...+...+++++.+|+....++++. +|--++|+|+
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~--~~~~f~~----ik~~~~~eKlr~l~ni~~l~~~~~~r-----~tf~L~P~NL 110 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDIND--NHTPFDN----IKSFTKNEKLRYLLNIKNLEEVNRTR-----YTFVLAPDEL 110 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCT--TSEEGGG----GGGSCHHHHHHHHHHGGGGGGGGGSS-----EECCCSGGGE
T ss_pred cCCcccce-EEEEcccEEEEEEEcCc--ccCCHHH----HHhcCHHHHHHHHHHHHHHHHHhcCc-----eEEEEecceE
Confidence 57887765 34455565555555433 2222221 22368899999999999988777655 7889999999
Q ss_pred eeCCCCcEEEeccccccccCCCCCCceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 044366 784 LLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGD 853 (918)
Q Consensus 784 ll~~~~~~kl~DfG~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~ 853 (918)
+++.++.+++.-.|+...+.|. ..+...=.-.+=+++..++++++.|+
T Consensus 111 ~f~~~~~p~i~~RGik~~l~P~----------------------~~~ee~fL~qyKAliiall~~K~~Fe 158 (215)
T 4ann_A 111 FFTRDGLPIAKTRGLQNVVDPL----------------------PVSEAEFLTRYKALVICAFNEKQSFD 158 (215)
T ss_dssp EECTTSCEEESCCEETTTBSCC----------------------CCCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred EEcCCCCEEEEEccCccCCCCC----------------------CCCHHHHHHHHHHHHHHHHcCCCCHH
Confidence 9999999999888766544321 11111222346678888899888854
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=82.50 E-value=2 Score=41.69 Aligned_cols=114 Identities=11% Similarity=0.061 Sum_probs=75.3
Q ss_pred cCCceeeEecccccCCceEEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHH-HHHhCCCCCeEEcCCCCCC
Q 044366 704 RHRNIIKFHGFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALS-YLHHDCIPPIVHRDISSKN 782 (918)
Q Consensus 704 ~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~-~LH~~~~~~ivH~dlk~~N 782 (918)
.||++ -..+-.+++...+.++.-+++.=...++ ..+..++++++.+|+.... ++++. +|--++|+|
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~------~~~~~eKlrll~nl~~L~~~~~~~r-----~tf~l~P~N 114 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIR------KTTLLSRIRAAIHLVSKVKHHSARR-----LIFIVCPEN 114 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHH------TSCHHHHHHHHHHHHHHHSSCCSSS-----EECCCCGGG
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHH------hcCHHHHHHHHHHHHHHHHHhhhCc-----eeEEEeCce
Confidence 57777 3333356666667676554432222332 2688899999999998777 66544 788999999
Q ss_pred eeeCCCCcEEEeccccccccCCCCCCceecccccccccccccccCCCCcccch-hhHHHHHHHHHhCCCCCC
Q 044366 783 VLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGTVGYAAPELAYTMRATEKYDV-YSFGVLALEVIKGYHPGD 853 (918)
Q Consensus 783 ill~~~~~~kl~DfG~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv-~slG~vl~el~tg~~p~~ 853 (918)
++++.++.+++.-.|+-..+.| .. .+ ..|. -.+=+++..++.+++.|+
T Consensus 115 L~f~~~~~p~i~hRGi~~~lpP-----------------~e-----~~-ee~fl~qyKali~all~~K~~Fe 163 (219)
T 4ano_A 115 LMFNRALEPFFLHVGVKESLPP-----------------DE-----WD-DERLLREVKATVLALTEGEYRFD 163 (219)
T ss_dssp EEECTTCCEEESCCEETTTBSS-----------------CS-----CC-HHHHHHHHHHHHHHHTTCSSCHH
T ss_pred EEEeCCCcEEEEEcCCcccCCC-----------------CC-----CC-HHHHHHHHHHHHHHHHcCCCCHH
Confidence 9999999999988886654432 21 11 1222 235667777888877754
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| 918 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 7e-58 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 8e-57 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 2e-55 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 5e-54 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 4e-53 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 4e-53 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 1e-52 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 6e-52 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 2e-51 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 2e-51 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 9e-51 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 1e-50 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 1e-50 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 2e-50 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 8e-50 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 1e-49 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 3e-49 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 4e-48 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 6e-48 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 7e-48 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 1e-47 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 1e-47 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 3e-47 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 4e-47 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 2e-46 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 2e-46 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 1e-45 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 2e-45 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 2e-45 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 5e-45 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 1e-44 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 2e-44 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 7e-44 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 3e-43 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 7e-43 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 3e-42 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 8e-42 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 1e-41 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 1e-40 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 4e-40 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 2e-39 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 3e-39 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 5e-39 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 2e-38 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 2e-38 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 1e-37 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 1e-37 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 8e-37 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 1e-35 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 1e-35 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 4e-35 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 8e-35 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 1e-34 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 2e-34 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 3e-33 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 5e-33 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 2e-32 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 3e-32 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 5e-31 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 8e-29 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 6e-28 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-26 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-25 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 5e-24 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 1e-21 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 6e-21 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 5e-20 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 5e-19 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 6e-23 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 6e-23 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 1e-22 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 3e-22 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 4e-22 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 1e-20 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 3e-17 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 3e-10 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 7e-10 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 1e-22 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 5e-22 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 9e-20 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 1e-18 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 3e-17 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 1e-16 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 3e-13 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 4e-12 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 1e-06 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 1e-20 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 2e-19 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 5e-18 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 8e-18 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 7e-14 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 6e-13 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 1e-09 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 5e-08 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 7e-20 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 3e-18 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 2e-13 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 5e-12 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 3e-10 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 4e-08 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 8e-08 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 6e-04 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 9e-04 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 1e-12 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 3e-09 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 3e-08 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 7e-07 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 2e-06 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 4e-06 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 2e-04 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 0.004 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 4e-11 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 2e-09 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 1e-08 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 2e-08 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 2e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-10 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-09 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 7e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 9e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 9e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.003 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 2e-09 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 7e-07 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 3e-04 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 2e-09 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 7e-09 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 5e-08 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 2e-07 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 2e-07 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 2e-05 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 6e-04 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 7e-04 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 9e-04 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 0.004 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 9e-09 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 4e-08 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 6e-07 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 6e-07 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 4e-06 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 1e-05 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 2e-04 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 4e-04 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 1e-08 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 1e-08 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 3e-05 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 1e-07 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 2e-07 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 6e-07 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 1e-06 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 9e-05 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 1e-04 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 2e-04 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 5e-04 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 1e-07 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 5e-07 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 1e-04 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 1e-04 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 3e-04 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 0.001 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 0.002 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 3e-07 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 6e-05 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 7e-05 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 9e-04 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 0.004 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 0.004 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 1e-06 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 3e-06 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 3e-05 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 4e-05 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 4e-05 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 6e-05 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 3e-05 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 4e-05 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 8e-05 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 1e-04 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 4e-04 | |
| d1m9la_ | 198 | c.10.3.1 (A:) Outer arm dynein light chain 1 {Gree | 0.003 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (503), Expect = 7e-58
Identities = 64/275 (23%), Positives = 121/275 (44%), Gaps = 25/275 (9%)
Query: 648 FGEKYCIGKGGQRSVYKAELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRN 707
G++ IG G +VYK + AVK + + F NEV L + RH N
Sbjct: 12 VGQR--IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQ--QLQAFKNEVGVLRKTRHVN 65
Query: 708 IIKFHGFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHH 767
I+ F G+ + IV ++ SL L +F + +++ + A + YLH
Sbjct: 66 ILLFMGYSTA-PQLAIVTQWCEGSSLYHHLHI--IETKFEMIKLIDIARQTAQGMDYLHA 122
Query: 768 DCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSN--WTEFAGTVGYAAPELAY 825
I+HRD+ S N+ L + + DFG A S + + + +G++ + APE+
Sbjct: 123 ---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIR 179
Query: 826 TMRA---TEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQIL-DHRLPTPS 881
+ + DVY+FG++ E++ G P +S+I+N + + + P S
Sbjct: 180 MQDKNPYSFQSDVYAFGIVLYELMTGQLP-------YSNINNRDQIIFMVGRGYLSPDLS 232
Query: 882 RDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLL 916
+ ++ +++ + CL + + RP ++ +
Sbjct: 233 KVRSNCPKAMKRLMAECLKKKRDERPLFPQILASI 267
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (495), Expect = 8e-57
Identities = 65/272 (23%), Positives = 114/272 (41%), Gaps = 19/272 (6%)
Query: 647 NFGEKYCIGKGGQRSVYKAE-LPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRH 705
++ Y IG G K G I K+ ++ A ++EV L E++H
Sbjct: 5 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTE--AEKQMLVSEVNLLRELKH 62
Query: 706 RNIIKFHGFCSNAQHS--FIVCEYLARGSLTTILRDDAAAKE-FSWNQRMNVIKGVANAL 762
NI++++ + ++ +IV EY G L +++ ++ + V+ + AL
Sbjct: 63 PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 122
Query: 763 SYLH--HDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGTVGYAA 820
H D ++HRD+ NV LD + + DFG A+ L +S F GT Y +
Sbjct: 123 KECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMS 182
Query: 821 PELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTP 880
PE M EK D++S G L E+ P F++ S + +I + +
Sbjct: 183 PEQMNRMSYNEKSDIWSLGCLLYELCALMPP-------FTAFSQKEL-AGKIREGKFRRI 234
Query: 881 SRDVTDKLRSIMEVAILCLVENPEARPTMKEV 912
+D+L I+ L RP+++E+
Sbjct: 235 PYRYSDELNEIIT---RMLNLKDYHRPSVEEI 263
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (485), Expect = 2e-55
Identities = 62/278 (22%), Positives = 123/278 (44%), Gaps = 23/278 (8%)
Query: 640 EITKATGNFGEKYCIGKGGQRSVYKAELPSGNIFAVKKFKAELFSDETANPSEFLNEVLA 699
E+ + T E+ +G G V+ AVK K + +P FL E
Sbjct: 9 EVPRETLKLVER--LGAGQFGEVWMGYYNGHTKVAVKSLK-----QGSMSPDAFLAEANL 61
Query: 700 LTEIRHRNIIKFHGFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVA 759
+ +++H+ +++ + + +I+ EY+ GSL L+ + K + N+ +++ +A
Sbjct: 62 MKQLQHQRLVRLYAVVTQEPI-YIITEYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIA 119
Query: 760 NALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNW-TEFAGTVGY 818
++++ +HRD+ + N+L+ ++DFG A+ +E + + +
Sbjct: 120 EGMAFIEERNY---IHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKW 176
Query: 819 AAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLP 878
APE T K DV+SFG+L E++ + ++N + N +R+
Sbjct: 177 TAPEAINYGTFTIKSDVWSFGILLTEIVTHGRI------PYPGMTNPEVIQNLERGYRMV 230
Query: 879 TPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLL 916
P + ++L +M LC E PE RPT + ++L
Sbjct: 231 RPD-NCPEELYQLMR---LCWKERPEDRPTFDYLRSVL 264
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (474), Expect = 5e-54
Identities = 60/271 (22%), Positives = 105/271 (38%), Gaps = 23/271 (8%)
Query: 647 NFGEKYCIGKGGQRSVYKAELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHR 706
F ++ IG G V+ + + A+K + S+E +F+ E + ++ H
Sbjct: 8 TFVQE--IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEE-----DFIEEAEVMMKLSHP 60
Query: 707 NIIKFHGFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLH 766
+++ +G C +V E++ G L+ LR F+ + + V +
Sbjct: 61 KLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQ--RGLFAAETLLGMCLDVCEG---MA 115
Query: 767 HDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTE-FAGTVGYAAPELAY 825
+ ++HRD++++N L+ VSDFG +F+ + V +A+PE+
Sbjct: 116 YLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFS 175
Query: 826 TMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRDVT 885
R + K DV+SFGVL EV + V I R +
Sbjct: 176 FSRYSSKSDVWSFGVLMWEVFSEGKI-------PYENRSNSEVVEDISTGFRLYKPRLAS 228
Query: 886 DKLRSIMEVAILCLVENPEARPTMKEVCNLL 916
+ IM C E PE RP + L
Sbjct: 229 THVYQIMN---HCWKERPEDRPAFSRLLRQL 256
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 185 bits (470), Expect = 4e-53
Identities = 72/298 (24%), Positives = 129/298 (43%), Gaps = 38/298 (12%)
Query: 638 YEEITKATGNFGEKY---------CIGKGGQRSVYKAELPSGN----IFAVKKFKAELFS 684
+E+ +A F ++ IG G V L A+K K+
Sbjct: 9 FEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTE 68
Query: 685 DETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFIVCEYLARGSLTTILRDDAAAK 744
+ +FL+E + + H N+I G + + I+ E++ GSL + LR +
Sbjct: 69 KQRR---DFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQND--G 123
Query: 745 EFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEP 804
+F+ Q + +++G+A + YL VHRD++++N+L++S VSDFG ++FLE
Sbjct: 124 QFTVIQLVGMLRGIAAGMKYLADMNY---VHRDLAARNILVNSNLVCKVSDFGLSRFLED 180
Query: 805 HSSNWTE-----FAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVI-KGYHPGDFVSTI 858
+S+ T + + APE + T DV+S+G++ EV+ G P
Sbjct: 181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERP------- 233
Query: 859 FSSISNMIIEVNQILDHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLL 916
+ ++N + +N I P D L +M C ++ RP ++ N L
Sbjct: 234 YWDMTNQDV-INAIEQDYRLPPPMDCPSALHQLML---DCWQKDRNHRPKFGQIVNTL 287
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (466), Expect = 4e-53
Identities = 63/272 (23%), Positives = 118/272 (43%), Gaps = 25/272 (9%)
Query: 647 NFGEKYCIGKGGQRSVYKAELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHR 706
F ++ +G G V + A+K K S++ EF+ E + + H
Sbjct: 7 TFLKE--LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED-----EFIEEAKVMMNLSHE 59
Query: 707 NIIKFHGFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLH 766
+++ +G C+ + FI+ EY+A G L LR+ F Q + + K V A+ YL
Sbjct: 60 KLVQLYGVCTKQRPIFIITEYMANGCLLNYLREM--RHRFQTQQLLEMCKDVCEAMEYLE 117
Query: 767 HDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPH-SSNWTEFAGTVGYAAPELAY 825
+HRD++++N L++ + VSDFG ++++ ++ V ++ PE+
Sbjct: 118 S---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLM 174
Query: 826 TMRATEKYDVYSFGVLALEVI-KGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRDV 884
+ + K D+++FGVL E+ G P + +N I
Sbjct: 175 YSKFSSKSDIWAFGVLMWEIYSLGKMP-------YERFTNSET-AEHIAQGLRLYRPHLA 226
Query: 885 TDKLRSIMEVAILCLVENPEARPTMKEVCNLL 916
++K+ +IM C E + RPT K + + +
Sbjct: 227 SEKVYTIMY---SCWHEKADERPTFKILLSNI 255
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (466), Expect = 1e-52
Identities = 68/278 (24%), Positives = 121/278 (43%), Gaps = 23/278 (8%)
Query: 640 EITKATGNFGEKYCIGKGGQRSVYKAELPSGNIFAVKKFKAELFSDETANPSEFLNEVLA 699
EI + + K +G+G V+ A+K K S E FL E
Sbjct: 13 EIPRESLRLEVK--LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-----AFLQEAQV 65
Query: 700 LTEIRHRNIIKFHGFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVA 759
+ ++RH +++ + S + +IV EY+++GSL L+ + K Q +++ +A
Sbjct: 66 MKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETG-KYLRLPQLVDMAAQIA 123
Query: 760 NALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPH-SSNWTEFAGTVGY 818
+ ++Y+ VHRD+ + N+L+ V+DFG A+ +E + + + +
Sbjct: 124 SGMAYVERMNY---VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW 180
Query: 819 AAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLP 878
APE A R T K DV+SFG+L E+ + + N + +R+P
Sbjct: 181 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRV------PYPGMVNREVLDQVERGYRMP 234
Query: 879 TPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLL 916
P + + L +M C + PE RPT + + L
Sbjct: 235 CPP-ECPESLHDLMC---QCWRKEPEERPTFEYLQAFL 268
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (459), Expect = 6e-52
Identities = 74/262 (28%), Positives = 115/262 (43%), Gaps = 22/262 (8%)
Query: 654 IGKGGQRSVYKAELP-SGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFH 712
+GKG +VY A S I A+K + EV + +RH NI++ +
Sbjct: 14 LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGV-EHQLRREVEIQSHLRHPNILRLY 72
Query: 713 GFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPP 772
G+ +A +++ EY G++ L+ +F + I +ANALSY H
Sbjct: 73 GYFHDATRVYLILEYAPLGTVYRELQKL---SKFDEQRTATYITELANALSYCHS---KR 126
Query: 773 IVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGTVGYAAPELAYTMRATEK 832
++HRDI +N+LL S E ++DFG++ SS T GT+ Y PE+ EK
Sbjct: 127 VIHRDIKPENLLLGSAGELKIADFGWSVHAP--SSRRTTLCGTLDYLPPEMIEGRMHDEK 184
Query: 833 YDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRDVTDKLRSIM 892
D++S GVL E + G P F + + +I P VT+ R ++
Sbjct: 185 VDLWSLGVLCYEFLVGKPP-------FEANTYQET-YKRISRVEFTFPD-FVTEGARDLI 235
Query: 893 EVAILCLVENPEARPTMKEVCN 914
L NP RP ++EV
Sbjct: 236 S---RLLKHNPSQRPMLREVLE 254
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (458), Expect = 2e-51
Identities = 67/275 (24%), Positives = 123/275 (44%), Gaps = 27/275 (9%)
Query: 646 GNFGEKY----CIGKGGQRSVYKA-ELPSGNIFAVKKFKAELFSDETANPSEFLNEVLAL 700
G+ +KY IG+G +VY A ++ +G A+++ + + +NE+L +
Sbjct: 16 GDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKK----ELIINEILVM 71
Query: 701 TEIRHRNIIKFHGFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVAN 760
E ++ NI+ + ++V EYLA GSLT ++ + Q V +
Sbjct: 72 RENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE----TCMDEGQIAAVCRECLQ 127
Query: 761 ALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGTVGYAA 820
AL +LH + + +HRDI S N+LL + ++DFGF + P S + GT + A
Sbjct: 128 ALEFLHSNQV---IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMA 184
Query: 821 PELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTP 880
PE+ K D++S G++A+E+I+G P + + + + +
Sbjct: 185 PEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP-------YLNENPLRALYLIATNGTPELQ 237
Query: 881 S-RDVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914
+ ++ R + CL + E R + KE+
Sbjct: 238 NPEKLSAIFRDFLN---RCLDMDVEKRGSAKELLQ 269
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (460), Expect = 2e-51
Identities = 67/301 (22%), Positives = 116/301 (38%), Gaps = 43/301 (14%)
Query: 647 NFGEKYCIGKGGQRSVYKAE-LPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRH 705
+F + +G G V+K PSG + A K E+ + A ++ + E+ L E
Sbjct: 7 DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI---KPAIRNQIIRELQVLHECNS 63
Query: 706 RNIIKFHGFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYL 765
I+ F+G + I E++ GSL +L+ A V V L+YL
Sbjct: 64 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK---AGRIPEQILGKVSIAVIKGLTYL 120
Query: 766 HHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGTVGYAAPELAY 825
I+HRD+ N+L++S E + DFG + L + F GT Y +PE
Sbjct: 121 REKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA--NSFVGTRSYMSPERLQ 176
Query: 826 TMRATEKYDVYSFGVLALEVIKGYHP------------------GDFVSTIFSSISNMII 867
+ + D++S G+ +E+ G +P GD T +
Sbjct: 177 GTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP 236
Query: 868 EVNQILDHRLPTPSRDVTDKLRSIMEVAIL--------------CLVENPEARPTMKEVC 913
+ +D R P ++ D + + + CL++NP R +K++
Sbjct: 237 LSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLM 296
Query: 914 N 914
Sbjct: 297 V 297
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (450), Expect = 9e-51
Identities = 69/264 (26%), Positives = 107/264 (40%), Gaps = 25/264 (9%)
Query: 654 IGKGGQRSVYKAELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHG 713
IGKG V + GN AVK K + A FL E +T++RH N+++ G
Sbjct: 15 IGKGEFGDVMLGDY-RGNKVAVKCIKND------ATAQAFLAEASVMTQLRHSNLVQLLG 67
Query: 714 FCSNAQHS-FIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPP 772
+ +IV EY+A+GSL LR + + V A+ YL
Sbjct: 68 VIVEEKGGLYIVTEYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEG---NN 123
Query: 773 IVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGTVGYAAPELAYTMRATEK 832
VHRD++++NVL+ + A VSDFG K SS V + APE + + K
Sbjct: 124 FVHRDLAARNVLVSEDNVAKVSDFGLTKEA---SSTQDTGKLPVKWTAPEALREKKFSTK 180
Query: 833 YDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRDVTDKLRSIM 892
DV+SFG+L E+ + I + V ++ + +M
Sbjct: 181 SDVWSFGILLWEIYSFGRV------PYPRIPLKDV-VPRVEKGYKMDAPDGCPPAVYEVM 233
Query: 893 EVAILCLVENPEARPTMKEVCNLL 916
+ C + RP+ ++ L
Sbjct: 234 K---NCWHLDAAMRPSFLQLREQL 254
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (451), Expect = 1e-50
Identities = 58/270 (21%), Positives = 105/270 (38%), Gaps = 27/270 (10%)
Query: 654 IGKGGQRSVYKAEL---PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIK 710
+G G SV + A+K K +T E + E + ++ + I++
Sbjct: 17 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTE---EMMREAQIMHQLDNPYIVR 73
Query: 711 FHGFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCI 770
G C + +V E G L L +E + ++ V+ + YL
Sbjct: 74 LIGVCQA-EALMLVMEMAGGGPLHKFLVGKR--EEIPVSNVAELLHQVSMGMKYLEE--- 127
Query: 771 PPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTE---FAGTVGYAAPELAYTM 827
VHRD++++NVLL + + A +SDFG +K L S +T + + APE
Sbjct: 128 KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFR 187
Query: 828 RATEKYDVYSFGVLALEVI-KGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRDVTD 886
+ + + DV+S+GV E + G P + + + + I + +
Sbjct: 188 KFSSRSDVWSYGVTMWEALSYGQKP-------YKKMKGPEV-MAFIEQGKRMECPPECPP 239
Query: 887 KLRSIMEVAILCLVENPEARPTMKEVCNLL 916
+L ++M C + E RP V +
Sbjct: 240 ELYALMS---DCWIYKWEDRPDFLTVEQRM 266
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (450), Expect = 1e-50
Identities = 63/270 (23%), Positives = 106/270 (39%), Gaps = 27/270 (10%)
Query: 654 IGKGGQRSVYKAELP---SGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIK 710
+G G +V K AVK K E +++ A E L E + ++ + I++
Sbjct: 15 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNE--ANDPALKDELLAEANVMQQLDNPYIVR 72
Query: 711 FHGFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCI 770
G C + +V E G L L+ + + + ++ V+ + YL
Sbjct: 73 MIGICEA-ESWMLVMEMAELGPLNKYLQQN---RHVKDKNIIELVHQVSMGMKYLEE--- 125
Query: 771 PPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEP---HSSNWTEFAGTVGYAAPELAYTM 827
VHRD++++NVLL +++ A +SDFG +K L + T V + APE
Sbjct: 126 SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY 185
Query: 828 RATEKYDVYSFGVLALEVI-KGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRDVTD 886
+ + K DV+SFGVL E G P + + + +
Sbjct: 186 KFSSKSDVWSFGVLMWEAFSYGQKP-------YRGMKGSEV-TAMLEKGERMGCPAGCPR 237
Query: 887 KLRSIMEVAILCLVENPEARPTMKEVCNLL 916
++ +M LC + E RP V L
Sbjct: 238 EMYDLMN---LCWTYDVENRPGFAAVELRL 264
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (448), Expect = 2e-50
Identities = 60/274 (21%), Positives = 111/274 (40%), Gaps = 28/274 (10%)
Query: 648 FGEKYCIGKGGQRSVYKAELP-SGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHR 706
F + IG+G ++VYK + A + + + F E L ++H
Sbjct: 13 FDIE--IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKS--ERQRFKEEAEMLKGLQHP 68
Query: 707 NIIKFHGFC----SNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANAL 762
NI++F+ + +V E + G+L T L+ K + + + L
Sbjct: 69 NIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRF---KVMKIKVLRSWCRQILKGL 125
Query: 763 SYLHHDCIPPIVHRDISSKNVLLDSE-YEAHVSDFGFAKFLEPHSSNWTEFAGTVGYAAP 821
+LH PPI+HRD+ N+ + + D G A + GT + AP
Sbjct: 126 QFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFA--KAVIGTPEFMAP 182
Query: 822 ELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLP-TP 880
E+ Y + E DVY+FG+ LE+ +P +S N ++ P +
Sbjct: 183 EM-YEEKYDESVDVYAFGMCMLEMATSEYP-------YSECQNAAQIYRRVTSGVKPASF 234
Query: 881 SRDVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914
+ +++ I+E C+ +N + R ++K++ N
Sbjct: 235 DKVAIPEVKEIIE---GCIRQNKDERYSIKDLLN 265
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 176 bits (446), Expect = 8e-50
Identities = 61/292 (20%), Positives = 118/292 (40%), Gaps = 45/292 (15%)
Query: 654 IGKGGQRSVYKAELP------SGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRN 707
IG+G V++A P + AVK K E +D A +F E + E + N
Sbjct: 21 IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQA---DFQREAALMAEFDNPN 77
Query: 708 IIKFHGFCSNAQHSFIVCEYLARGSLTTILRD---------------------DAAAKEF 746
I+K G C+ + ++ EY+A G L LR
Sbjct: 78 IVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPL 137
Query: 747 SWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEP-- 804
S +++ + + VA ++YL VHRD++++N L+ ++DFG ++ +
Sbjct: 138 SCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSAD 194
Query: 805 HSSNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISN 864
+ A + + PE + R T + DV+++GV+ E+ + +++
Sbjct: 195 YYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ------PYYGMAH 248
Query: 865 MIIEVNQILDHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLL 916
+ + + D + + +L ++M LC + P RP+ + +L
Sbjct: 249 EEV-IYYVRDGNILACPENCPLELYNLMR---LCWSKLPADRPSFCSIHRIL 296
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 175 bits (446), Expect = 1e-49
Identities = 62/265 (23%), Positives = 110/265 (41%), Gaps = 25/265 (9%)
Query: 654 IGKGGQRSVYKAE-LPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFH 712
IG G +VY A + + + A+KK + + EV L ++RH N I++
Sbjct: 23 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEK-WQDIIKEVRFLQKLRHPNTIQYR 81
Query: 713 GFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPP 772
G +++V EY + + K + V G L+YLH
Sbjct: 82 GCYLREHTAWLVMEYCLGSASDLLEVHK---KPLQEVEIAAVTHGALQGLAYLHS---HN 135
Query: 773 IVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGTVGYAAPELAYTM---RA 829
++HRD+ + N+LL + DFG A + P +S F GT + APE+ M +
Sbjct: 136 MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANS----FVGTPYWMAPEVILAMDEGQY 191
Query: 830 TEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRDVTDKLR 889
K DV+S G+ +E+ + P +++ M + + S ++ R
Sbjct: 192 DGKVDVWSLGITCIELAERKPP-------LFNMNAMSALYHIAQNESPALQSGHWSEYFR 244
Query: 890 SIMEVAILCLVENPEARPTMKEVCN 914
+ ++ CL + P+ RPT + +
Sbjct: 245 NFVD---SCLQKIPQDRPTSEVLLK 266
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (441), Expect = 3e-49
Identities = 62/289 (21%), Positives = 123/289 (42%), Gaps = 33/289 (11%)
Query: 638 YEEITKATGNFGEKY----CIGKGGQRSVYKAE-LPSGNIFAVKKFKAELFSDETANPSE 692
YE +T+ N + + +G G VYKA+ + + A K + + +
Sbjct: 1 YEHVTRDL-NPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEE----LED 55
Query: 693 FLNEVLALTEIRHRNIIKFHGFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRM 752
++ E+ L H NI+K + +I+ E+ A G++ ++ + + + +Q
Sbjct: 56 YMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLE--LERPLTESQIQ 113
Query: 753 NVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEF 812
V K +AL+YLH I+HRD+ + N+L + + ++DFG + F
Sbjct: 114 VVCKQTLDALNYLHD---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSF 170
Query: 813 AGTVGYAAPELAYTMRA-----TEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMII 867
GT + APE+ + K DV+S G+ +E+ + P ++ M +
Sbjct: 171 IGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPP-------HHELNPMRV 223
Query: 868 EVNQILDHRLPTPSR--DVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914
+ +I PT ++ + + ++ CL +N +AR T ++
Sbjct: 224 -LLKIAKSEPPTLAQPSRWSSNFKDFLK---KCLEKNVDARWTTSQLLQ 268
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (432), Expect = 4e-48
Identities = 70/271 (25%), Positives = 119/271 (43%), Gaps = 26/271 (9%)
Query: 654 IGKGGQRSVYKAELPSGN-----IFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNI 708
IG G VYK L + + A+K KA + +FL E + + H NI
Sbjct: 15 IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRV---DFLGEAGIMGQFSHHNI 71
Query: 709 IKFHGFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHD 768
I+ G S + I+ EY+ G+L LR+ EFS Q + +++G+A + YL +
Sbjct: 72 IRLEGVISKYKPMMIITEYMENGALDKFLREKD--GEFSVLQLVGMLRGIAAGMKYLAN- 128
Query: 769 CIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEP---HSSNWTEFAGTVGYAAPELAY 825
VHRD++++N+L++S VSDFG ++ LE + + + + APE
Sbjct: 129 --MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAIS 186
Query: 826 TMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRDVT 885
+ T DV+SFG++ EV+ + +SN + + I D D
Sbjct: 187 YRKFTSASDVWSFGIVMWEVMTYGER------PYWELSNHEV-MKAINDGFRLPTPMDCP 239
Query: 886 DKLRSIMEVAILCLVENPEARPTMKEVCNLL 916
+ +M C + RP ++ ++L
Sbjct: 240 SAIYQLMM---QCWQQERARRPKFADIVSIL 267
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (432), Expect = 6e-48
Identities = 60/294 (20%), Positives = 107/294 (36%), Gaps = 41/294 (13%)
Query: 653 CIGKGGQRSVYKAELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFH 712
IGKG V++ + G AVK F + E+ +RH NI+ F
Sbjct: 10 SIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSW-----FREAEIYQTVMLRHENILGFI 63
Query: 713 GFCSNAQHS----FIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHD 768
+ + ++V +Y GSL L + + + A+ L++LH +
Sbjct: 64 AADNKDNGTWTQLWLVSDYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHME 119
Query: 769 CI-----PPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNW----TEFAGTVGYA 819
+ P I HRD+ SKN+L+ ++D G A + + GT Y
Sbjct: 120 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYM 179
Query: 820 APELAYTM------RATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMI------- 866
APE+ + ++ D+Y+ G++ E+ + G +++
Sbjct: 180 APEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVE 239
Query: 867 ----IEVNQILDHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLL 916
+ Q L +P + LR + ++ C N AR T + L
Sbjct: 240 EMRKVVCEQKLRPNIP-NRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTL 292
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (432), Expect = 7e-48
Identities = 68/279 (24%), Positives = 111/279 (39%), Gaps = 29/279 (10%)
Query: 647 NFGEKYCIGKGGQRSVYKAELPSGN----IFAVKKFKAELFSDETANPSEFLNEVLALTE 702
+F E IG+G VY L + AVK E S+FL E + + +
Sbjct: 30 HFNEV--IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEV---SQFLTEGIIMKD 84
Query: 703 IRHRNIIKFHGFCSNAQHS-FIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANA 761
H N++ G C ++ S +V Y+ G L +R++ + + VA
Sbjct: 85 FSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNET--HNPTVKDLIGFGLQVAKG 142
Query: 762 LSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEP----HSSNWTEFAGTVG 817
+ VHRD++++N +LD ++ V+DFG A+ + N T V
Sbjct: 143 M---KFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVK 199
Query: 818 YAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRL 877
+ A E T + T K DV+SFGVL E++ P + ++ I +L R
Sbjct: 200 WMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP------PYPDVNTFDI-TVYLLQGRR 252
Query: 878 PTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLL 916
D L +M C E RP+ E+ + +
Sbjct: 253 LLQPEYCPDPLYEVML---KCWHPKAEMRPSFSELVSRI 288
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (428), Expect = 1e-47
Identities = 64/276 (23%), Positives = 105/276 (38%), Gaps = 28/276 (10%)
Query: 648 FGEKY----CIGKGGQRSVYKAE-LPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTE 702
F E + +G+G V A + AVK + D P E+
Sbjct: 3 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDC---PENIKKEICINKM 59
Query: 703 IRHRNIIKFHGFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANAL 762
+ H N++KF+G ++ EY + G L + D + +
Sbjct: 60 LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD---IGMPEPDAQRFFHQLMAGV 116
Query: 763 SYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSN--WTEFAGTVGYAA 820
YLH I HRDI +N+LLD +SDFG A ++ + GT+ Y A
Sbjct: 117 VYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVA 173
Query: 821 PELAYTMR-ATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRL-P 878
PEL E DV+S G++ ++ G P + S+ E + + +
Sbjct: 174 PELLKRREFHAEPVDVWSCGIVLTAMLAGELP-------WDQPSDSCQEYSDWKEKKTYL 226
Query: 879 TPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914
P + + +++ LVENP AR T+ ++
Sbjct: 227 NPWKKIDSAPLALLH---KILVENPSARITIPDIKK 259
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 169 bits (428), Expect = 1e-47
Identities = 64/279 (22%), Positives = 116/279 (41%), Gaps = 23/279 (8%)
Query: 640 EITKATGNFGEKYCIGKGGQRSVYKAELP-SGNIFAVKKFKAELFSDETANPSEFLNEVL 698
E+ + K +G G VY+ AVK K + E EFL E
Sbjct: 13 EMERTDITMKHK--LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-----EFLKEAA 65
Query: 699 ALTEIRHRNIIKFHGFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGV 758
+ EI+H N+++ G C+ +I+ E++ G+L LR + +E S + + +
Sbjct: 66 VMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLR-ECNRQEVSAVVLLYMATQI 124
Query: 759 ANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSN-WTEFAGTVG 817
++A+ YL +HRD++++N L+ + V+DFG ++ + + +
Sbjct: 125 SSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK 181
Query: 818 YAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRL 877
+ APE + + K DV++FGVL E+ + I + D+R+
Sbjct: 182 WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMS------PYPGIDLSQVYELLEKDYRM 235
Query: 878 PTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLL 916
P +K+ +M C NP RP+ E+
Sbjct: 236 ERPE-GCPEKVYELMR---ACWQWNPSDRPSFAEIHQAF 270
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (429), Expect = 3e-47
Identities = 63/299 (21%), Positives = 111/299 (37%), Gaps = 48/299 (16%)
Query: 648 FGEKYCIGKGGQRSVYKAELPSGN------IFAVKKFKAELFSDETANPSEFLNEVLALT 701
FG+ +G G V A + AVK K + S E ++E+ +T
Sbjct: 41 FGKV--LGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSERE---ALMSELKMMT 95
Query: 702 EI-RHRNIIKFHGFCSNAQHSFIVCEYLARGSLTTILRD--------------------D 740
++ H NI+ G C+ + +++ EY G L LR +
Sbjct: 96 QLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEE 155
Query: 741 AAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAK 800
++ + VA + +L VHRD++++NVL+ + DFG A+
Sbjct: 156 EDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLAR 212
Query: 801 FLEPHSSN--WTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVI-KGYHPGDFVST 857
+ S+ V + APE + T K DV+S+G+L E+ G +P
Sbjct: 213 DIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP------ 266
Query: 858 IFSSISNMIIEVNQILDHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLL 916
+ I I + T+++ IM+ C + RP+ + + L
Sbjct: 267 -YPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQ---SCWAFDSRKRPSFPNLTSFL 321
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (427), Expect = 4e-47
Identities = 63/287 (21%), Positives = 113/287 (39%), Gaps = 36/287 (12%)
Query: 647 NFGEKYCIGKGGQRSVYKAELPSGN---IFAVKKFKAELFSDETANPSEFLNEVLALTEI 703
F + IG+G V KA + A+K+ K D+ +F E+ L ++
Sbjct: 13 KFQDV--IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHR---DFAGELEVLCKL 67
Query: 704 -RHRNIIKFHGFCSNAQHSFIVCEYLARGSLTTILR-------------DDAAAKEFSWN 749
H NII G C + + ++ EY G+L LR ++ A S
Sbjct: 68 GHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQ 127
Query: 750 QRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNW 809
Q ++ VA + YL +HRD++++N+L+ Y A ++DFG ++ E +
Sbjct: 128 QLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKT 184
Query: 810 TEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEV 869
V + A E T DV+S+GVL E++ + ++ +
Sbjct: 185 M-GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT------PYCGMTCAEL-Y 236
Query: 870 NQILDHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLL 916
++ + D++ +M C E P RP+ ++ L
Sbjct: 237 EKLPQGYRLEKPLNCDDEVYDLMR---QCWREKPYERPSFAQILVSL 280
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 168 bits (426), Expect = 2e-46
Identities = 54/266 (20%), Positives = 107/266 (40%), Gaps = 25/266 (9%)
Query: 654 IGKGGQRSVYKA-ELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFH 712
+G G V++ E +GN FA K SD E+ ++ +RH ++ H
Sbjct: 34 LGTGAFGVVHRVTERATGNNFAAKFVMTPHESD----KETVRKEIQTMSVLRHPTLVNLH 89
Query: 713 GFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPP 772
+ ++ E+++ G L + D + S ++ + ++ V L ++H +
Sbjct: 90 DAFEDDNEMVMIYEFMSGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMHENN--- 144
Query: 773 IVHRDISSKNVLLDSEYEAHV--SDFGFAKFLEPHSSNWTEFAGTVGYAAPELAYTMRAT 830
VH D+ +N++ ++ + DFG L+P S GT +AAPE+A
Sbjct: 145 YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKV-TTGTAEFAAPEVAEGKPVG 203
Query: 831 EKYDVYSFGVLALEVIKGYHP--GDFVSTIFSSISNMIIEVNQILDHRLPTPSRDVTDKL 888
D++S GVL+ ++ G P G+ ++ + ++ + +D K
Sbjct: 204 YYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRK- 262
Query: 889 RSIMEVAILCLVENPEARPTMKEVCN 914
L+ +P R T+ +
Sbjct: 263 ---------LLLADPNTRMTIHQALE 279
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (420), Expect = 2e-46
Identities = 61/264 (23%), Positives = 106/264 (40%), Gaps = 22/264 (8%)
Query: 654 IGKGGQRSVYKA-ELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFH 712
+G+G +V A EL + +A+K + E P E ++ + H +K +
Sbjct: 16 LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVP-YVTRERDVMSRLDHPFFVKLY 74
Query: 713 GFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPP 772
+ + + Y G L +R F + +AL YLH
Sbjct: 75 FTFQDDEKLYFGLSYAKNGELLKYIRKI---GSFDETCTRFYTAEIVSALEYLHG---KG 128
Query: 773 IVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNW--TEFAGTVGYAAPELAYTMRAT 830
I+HRD+ +N+LL+ + ++DFG AK L P S F GT Y +PEL A
Sbjct: 129 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSAC 188
Query: 831 EKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRDVTDKLRS 890
+ D+++ G + +++ G P F + + +I +I+ P K R
Sbjct: 189 KSSDLWALGCIIYQLVAGLPP-------FRAGNEYLI-FQKIIKLEYDFPE-KFFPKARD 239
Query: 891 IMEVAILCLVENPEARPTMKEVCN 914
++E LV + R +E+
Sbjct: 240 LVE---KLLVLDATKRLGCEEMEG 260
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (415), Expect = 1e-45
Identities = 63/293 (21%), Positives = 111/293 (37%), Gaps = 41/293 (13%)
Query: 648 FGEKYCIGKGGQRSVYKAEL------PSGNIFAVKKFKAELFSDETANPSEFLNEVLALT 701
FG+ +G G V +A + AVK K E ++E+ L+
Sbjct: 27 FGKT--LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTERE---ALMSELKVLS 81
Query: 702 EI-RHRNIIKFHGFCSNAQHSFIVCEYLARGSLTTILRD---------------DAAAKE 745
+ H NI+ G C+ + ++ EY G L LR +
Sbjct: 82 YLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELA 141
Query: 746 FSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPH 805
++ VA +++L +HRD++++N+LL + DFG A+ ++
Sbjct: 142 LDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIKND 198
Query: 806 SSNW--TEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSIS 863
S+ V + APE + T + DV+S+G+ E+ + S
Sbjct: 199 SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFY 258
Query: 864 NMIIEVNQILDHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLL 916
MI E R+ +P ++ IM+ C +P RPT K++ L+
Sbjct: 259 KMIKE-----GFRMLSPE-HAPAEMYDIMK---TCWDADPLKRPTFKQIVQLI 302
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 164 bits (415), Expect = 2e-45
Identities = 59/279 (21%), Positives = 111/279 (39%), Gaps = 24/279 (8%)
Query: 643 KATGNFGEKY----CIGKGGQRSVYKAE-LPSGNIFAVKKFKAELFSDETANPSEFLNEV 697
K + + Y +G G V AE + + A+K + + NE+
Sbjct: 2 KQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGK---EGSMENEI 58
Query: 698 LALTEIRHRNIIKFHGFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKG 757
L +I+H NI+ + H +++ + ++ G L + + ++ +I
Sbjct: 59 AVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEK---GFYTERDASRLIFQ 115
Query: 758 VANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGTVG 817
V +A+ YLH I + + LD + + +SDFG +K +P S T GT G
Sbjct: 116 VLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLST-ACGTPG 174
Query: 818 YAAPELAYTMRATEKYDVYSFGVLALEVIKGYHP--GDFVSTIFSSISNMIIEVNQILDH 875
Y APE+ ++ D +S GV+A ++ GY P + + +F I E +
Sbjct: 175 YVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWD 234
Query: 876 RLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914
+ ++D + ++PE R T ++
Sbjct: 235 DISDSAKDFIRH----------LMEKDPEKRFTCEQALQ 263
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 164 bits (417), Expect = 2e-45
Identities = 55/293 (18%), Positives = 111/293 (37%), Gaps = 29/293 (9%)
Query: 631 NFNGKVLYEEITKATGNFGEKY----CIGKGGQRSVYKA-ELPSGNIFAVKKFKAELFSD 685
+ K + + + G+ + Y +G G V++ E +G +F K D
Sbjct: 10 DIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLD 69
Query: 686 ETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFIVCEYLARGSLTTILRDDAAAKE 745
+ NE+ + ++ H +I H + ++ E+L+ G L + + +
Sbjct: 70 K----YTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAE--DYK 123
Query: 746 FSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHV--SDFGFAKFLE 803
S + +N ++ L ++H IVH DI +N++ +++ + V DFG A L
Sbjct: 124 MSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLN 180
Query: 804 PHSSNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHP--GDFVSTIFSS 861
P T +AAPE+ D+++ GVL ++ G P G+ +
Sbjct: 181 PDEIVKV-TTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQN 239
Query: 862 ISNMIIEVNQILDHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914
+ E ++ + ++D L + P R T+ +
Sbjct: 240 VKRCDWEFDEDAFSSVSPEAKDFIKN----------LLQKEPRKRLTVHDALE 282
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (408), Expect = 5e-45
Identities = 66/272 (24%), Positives = 106/272 (38%), Gaps = 27/272 (9%)
Query: 654 IGKGGQRSVYKAELPSGN----IFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNII 709
+G G V + E + + AVK K ++ S A +F+ EV A+ + HRN+I
Sbjct: 16 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAM-DDFIREVNAMHSLDHRNLI 74
Query: 710 KFHGFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDC 769
+ +G +V E GSL LR F VA + YL
Sbjct: 75 RLYGVVLTPPM-KMVTELAPLGSLLDRLRKHQ--GHFLLGTLSRYAVQVAEGMGYLES-- 129
Query: 770 IPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNW---TEFAGTVGYAAPELAYT 826
+HRD++++N+LL + + DFG + L + ++ + APE T
Sbjct: 130 -KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT 188
Query: 827 MRATEKYDVYSFGVLALEVI-KGYHPGDFVSTIFSSISNM-IIEVNQILDHRLPTPSRDV 884
+ D + FGV E+ G P + ++ I+ RLP P D
Sbjct: 189 RTFSHASDTWMFGVTLWEMFTYGQEP-------WIGLNGSQILHKIDKEGERLPRPE-DC 240
Query: 885 TDKLRSIMEVAILCLVENPEARPTMKEVCNLL 916
+ ++M C PE RPT + + L
Sbjct: 241 PQDIYNVMV---QCWAHKPEDRPTFVALRDFL 269
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (409), Expect = 1e-44
Identities = 57/284 (20%), Positives = 115/284 (40%), Gaps = 33/284 (11%)
Query: 648 FGEKYCIGKGGQRSVYKAEL------PSGNIFAVKKFKAELFSDETANPSEFLNEVLALT 701
+ +G+G VY+ A+K E EFLNE +
Sbjct: 24 MSRE--LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI---EFLNEASVMK 78
Query: 702 EIRHRNIIKFHGFCSNAQHSFIVCEYLARGSLTTILR-------DDAAAKEFSWNQRMNV 754
E ++++ G S Q + ++ E + RG L + LR ++ S ++ + +
Sbjct: 79 EFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQM 138
Query: 755 IKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSS--NWTEF 812
+A+ ++YL+ VHRD++++N ++ ++ + DFG + + +
Sbjct: 139 AGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKG 195
Query: 813 AGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQI 872
V + +PE T DV+SFGV+ E+ + +SN + + +
Sbjct: 196 LLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQ------PYQGLSNEQV-LRFV 248
Query: 873 LDHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLL 916
++ L + D L +M +C NP+ RP+ E+ + +
Sbjct: 249 MEGGLLDKPDNCPDMLFELMR---MCWQYNPKMRPSFLEIISSI 289
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (403), Expect = 2e-44
Identities = 62/270 (22%), Positives = 105/270 (38%), Gaps = 26/270 (9%)
Query: 653 CIGKGGQRSVYKAELPSGN----IFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNI 708
CIG+G V++ S A+K K + +FL E L + + H +I
Sbjct: 14 CIGEGQFGDVHQGIYMSPENPALAVAIKTCK---NCTSDSVREKFLQEALTMRQFDHPHI 70
Query: 709 IKFHGFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHD 768
+K G + +I+ E G L + L+ + ++ AL+YL
Sbjct: 71 VKLIGVITE-NPVWIIMELCTLGELRSFLQVRK--YSLDLASLILYAYQLSTALAYLES- 126
Query: 769 CIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSS-NWTEFAGTVGYAAPELAYTM 827
VHRDI+++NVL+ S + DFG ++++E + ++ + + APE
Sbjct: 127 --KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFR 184
Query: 828 RATEKYDVYSFGVLALEVI-KGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRDVTD 886
R T DV+ FGV E++ G P + +I + +
Sbjct: 185 RFTSASDVWMFGVCMWEILMHGVKPFQG--------VKNNDVIGRIENGERLPMPPNCPP 236
Query: 887 KLRSIMEVAILCLVENPEARPTMKEVCNLL 916
L S+M C +P RP E+ L
Sbjct: 237 TLYSLMT---KCWAYDPSRRPRFTELKAQL 263
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (404), Expect = 7e-44
Identities = 55/275 (20%), Positives = 110/275 (40%), Gaps = 32/275 (11%)
Query: 650 EKY----CIGKGGQRSVYKA-ELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIR 704
EKY +G+G V++ E S + K K + E+ L R
Sbjct: 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQV-----LVKKEISILNIAR 59
Query: 705 HRNIIKFHGFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSY 764
HRNI+ H + + ++ E+++ + + A E + + ++ + V AL +
Sbjct: 60 HRNILHLHESFESMEELVMIFEFISGLDIFERINTS--AFELNEREIVSYVHQVCEALQF 117
Query: 765 LHHDCIPPIVHRDISSKNVLLDSEYEAHV--SDFGFAKFLEPHSSNWTEFAGTVGYAAPE 822
LH I H DI +N++ + + + +FG A+ L+P + Y APE
Sbjct: 118 LHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL-LFTAPEYYAPE 173
Query: 823 LAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPS- 881
+ + D++S G L ++ G +P F + +N I + I++
Sbjct: 174 VHQHDVVSTATDMWSLGTLVYVLLSGINP-------FLAETNQQI-IENIMNAEYTFDEE 225
Query: 882 --RDVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914
++++ + ++ LV+ ++R T E
Sbjct: 226 AFKEISIEAMDFVD---RLLVKERKSRMTASEALQ 257
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (398), Expect = 3e-43
Identities = 58/259 (22%), Positives = 99/259 (38%), Gaps = 19/259 (7%)
Query: 654 IGKGGQRSVYKAE-LPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFH 712
+GKG V+ AE + FA+K K ++ + + + + H +
Sbjct: 10 LGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMF 69
Query: 713 GFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPP 772
++ F V EYL G L ++ +F ++ + L +LH I
Sbjct: 70 CTFQTKENLFFVMEYLNGGDLMYHIQS---CHKFDLSRATFYAAEIILGLQFLHSKGI-- 124
Query: 773 IVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGTVGYAAPELAYTMRATEK 832
V+RD+ N+LLD + ++DFG K + F GT Y APE+ +
Sbjct: 125 -VYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNHS 183
Query: 833 YDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRDVTDKLRSIM 892
D +SFGVL E++ G P F E+ + P R + + + ++
Sbjct: 184 VDWWSFGVLLYEMLIGQSP-------FHGQDEE--ELFHSIRMDNPFYPRWLEKEAKDLL 234
Query: 893 EVAILCLVENPEARPTMKE 911
V PE R ++
Sbjct: 235 V---KLFVREPEKRLGVRG 250
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 155 bits (392), Expect = 7e-43
Identities = 66/281 (23%), Positives = 116/281 (41%), Gaps = 32/281 (11%)
Query: 647 NFGEKY----CIGKGGQRSVYKAE-LPSGNIFAVKKFKAELFSDETANPSEFLNEVLALT 701
+ ++Y +G GG V+ A L AVK +A+L D + F E
Sbjct: 4 HLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSF-YLRFRREAQNAA 62
Query: 702 EIRHRNIIKFHGFC----SNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKG 757
+ H I+ + +IV EY+ +L I+ + + + + VI
Sbjct: 63 ALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE---GPMTPKRAIEVIAD 119
Query: 758 VANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTE---FAG 814
AL++ H I+HRD+ N+++ + V DFG A+ + ++ T+ G
Sbjct: 120 ACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIG 176
Query: 815 TVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILD 874
T Y +PE A + DVYS G + EV+ G P F+ S + + + +
Sbjct: 177 TAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP-------FTGDSPVSVAYQHVRE 229
Query: 875 HRLPTPSR--DVTDKLRSIMEVAILCLVENPEARP-TMKEV 912
+P +R ++ L +++ L +NPE R T E+
Sbjct: 230 DPIPPSARHEGLSADLDAVVL---KALAKNPENRYQTAAEM 267
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (389), Expect = 3e-42
Identities = 61/287 (21%), Positives = 113/287 (39%), Gaps = 40/287 (13%)
Query: 654 IGKGGQRSVYKAELPS--------GNIFAVKKFKAELFSDETANPSEFLNEVLALTEI-R 704
+G+G V AE AVK K++ + S+ ++E+ + I +
Sbjct: 21 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDL---SDLISEMEMMKMIGK 77
Query: 705 HRNIIKFHGFCSNAQHSFIVCEYLARGSLTTILR-------------DDAAAKEFSWNQR 751
H+NII G C+ +++ EY ++G+L L+ ++ S
Sbjct: 78 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 137
Query: 752 MNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWT- 810
++ VA + YL +HRD++++NVL+ + ++DFG A+ +
Sbjct: 138 VSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 194
Query: 811 -EFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEV 869
V + APE + T + DV+SFGVL E+ + + +
Sbjct: 195 TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGS------PYPGVPVEEL-F 247
Query: 870 NQILDHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLL 916
+ + + T++L +M C P RPT K++ L
Sbjct: 248 KLLKEGHRMDKPSNCTNELYMMMR---DCWHAVPSQRPTFKQLVEDL 291
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (388), Expect = 8e-42
Identities = 58/284 (20%), Positives = 107/284 (37%), Gaps = 27/284 (9%)
Query: 640 EITKATGNFGEKYCIGKGGQRSVYKAELPSGN-----IFAVKKFKAELFSDETANPSEFL 694
I K T F + +G G +VYK A+K+ + E L
Sbjct: 4 RILKET-EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK---EIL 59
Query: 695 NEVLALTEIRHRNIIKFHGFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNV 754
+E + + + ++ + G C + ++ + + G L +R+ +N
Sbjct: 60 DEAYVMASVDNPHVCRLLGICLTSTV-QLITQLMPFGCLLDYVREHK--DNIGSQYLLNW 116
Query: 755 IKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNW--TEF 812
+A ++YL +VHRD++++NVL+ + ++DFG AK L +
Sbjct: 117 CVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 173
Query: 813 AGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQI 872
+ + A E T + DV+S+GV E++ + I I
Sbjct: 174 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSK------PYDGIPASEISSILE 227
Query: 873 LDHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLL 916
RLP P T + IM C + + ++RP +E+
Sbjct: 228 KGERLPQPP-ICTIDVYMIMV---KCWMIDADSRPKFRELIIEF 267
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 151 bits (383), Expect = 1e-41
Identities = 66/284 (23%), Positives = 114/284 (40%), Gaps = 32/284 (11%)
Query: 648 FGEKY----CIGKGGQRSVYKAE-LPSGNIFAVKKFKAELFSDETANPSE-----FLNEV 697
F E Y +G+G V + P+ +AVK +A + L EV
Sbjct: 1 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEV 60
Query: 698 LALTEIR-HRNIIKFHGFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIK 756
L ++ H NII+ F+V + + +G L L + S + +++
Sbjct: 61 DILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEK---VTLSEKETRKIMR 117
Query: 757 GVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGTV 816
+ + LH IVHRD+ +N+LLD + ++DFGF+ L+P E GT
Sbjct: 118 ALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKL-REVCGTP 173
Query: 817 GYAAPELAYTMRA------TEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVN 870
Y APE+ ++ D++S GV+ ++ G P F M++ +
Sbjct: 174 SYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP-------FWHRKQMLM-LR 225
Query: 871 QILDHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914
I+ S + D ++ ++ LV P+ R T +E
Sbjct: 226 MIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 148 bits (375), Expect = 1e-40
Identities = 64/287 (22%), Positives = 117/287 (40%), Gaps = 30/287 (10%)
Query: 650 EKY----CIGKGGQRSVYKAELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRH 705
EKY IG+G VYKA+ G FA+KK + E + PS + E+ L E++H
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEG--IPSTTIREISILKELKH 59
Query: 706 RNIIKFHGFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYL 765
NI+K + + +V E+L + + + + + + N ++Y
Sbjct: 60 SNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCE---GGLESVTAKSFLLQLLNGIAYC 116
Query: 766 HHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGTVGYAAPE-LA 824
H ++HRD+ +N+L++ E E ++DFG A+ +T T+ Y AP+ L
Sbjct: 117 HD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLM 173
Query: 825 YTMRATEKYDVYSFGVLALEVIKGYHP--GDFVSTIFSSISNM-----------IIEVNQ 871
+ + + D++S G + E++ G G + I + + E+ +
Sbjct: 174 GSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPK 233
Query: 872 ILDHRLPTPSRDVTDKLRSIMEVAI----LCLVENPEARPTMKEVCN 914
+ L+ + E I L +P R T K+
Sbjct: 234 YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 148 bits (375), Expect = 4e-40
Identities = 60/260 (23%), Positives = 105/260 (40%), Gaps = 23/260 (8%)
Query: 653 CIGKGGQRSVYKAE-LPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKF 711
+G G V+ +G +A+K K E+ +E L L+ + H II+
Sbjct: 11 TLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQ-VEHTNDERLMLSIVTHPFIIRM 69
Query: 712 HGFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIP 771
G +AQ F++ +Y+ G L ++LR + L +
Sbjct: 70 WGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEV------CLALEYLHSK 123
Query: 772 PIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGTVGYAAPELAYTMRATE 831
I++RD+ +N+LLD ++DFGFAK++ GT Y APE+ T +
Sbjct: 124 DIIYRDLKPENILLDKNGHIKITDFGFAKYVP---DVTYTLCGTPDYIAPEVVSTKPYNK 180
Query: 832 KYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRDVTDKLRSI 891
D +SFG+L E++ GY P F + M +IL+ L P + ++ +
Sbjct: 181 SIDWWSFGILIYEMLAGYTP-------FYDSNTMKT-YEKILNAELRFPP-FFNEDVKDL 231
Query: 892 MEVAILCLVENPEARPTMKE 911
+ + + R +
Sbjct: 232 LS---RLITRDLSQRLGNLQ 248
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (367), Expect = 2e-39
Identities = 57/280 (20%), Positives = 111/280 (39%), Gaps = 26/280 (9%)
Query: 654 IGKGGQRSVYKAE-LPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFH 712
IG+G VYKA +G + A+KK + + ++ PS + E+ L E+ H NI+K
Sbjct: 10 IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEG--VPSTAIREISLLKELNHPNIVKLL 67
Query: 713 GFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPP 772
++V E+L + + + + + L++ H +
Sbjct: 68 DVIHTENKLYLVFEFLHQDLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFCHSHRV-- 123
Query: 773 IVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGTVGYAAPE-LAYTMRATE 831
+HRD+ +N+L+++E ++DFG A+ +T T+ Y APE L +
Sbjct: 124 -LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYST 182
Query: 832 KYDVYSFGVLALEVIKGYHP--GDFVSTIFSSISNMIIEVNQIL--------DHRLPTP- 880
D++S G + E++ GD I + ++++ D++ P
Sbjct: 183 AVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPK 242
Query: 881 --SRDVTDKLRSIMEVAI----LCLVENPEARPTMKEVCN 914
+D + + + E L +P R + K
Sbjct: 243 WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 282
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (366), Expect = 3e-39
Identities = 59/281 (20%), Positives = 108/281 (38%), Gaps = 30/281 (10%)
Query: 647 NFGEKY----CIGKGGQRSVYKA-ELPSGNIFAVKKFKAELFSDETANPS--EFLNEVLA 699
N + Y +G G V K E +G +A K K S + EV
Sbjct: 7 NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSI 66
Query: 700 LTEIRHRNIIKFHGFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVA 759
L EI+H N+I H N ++ E +A G L L + + + + +K +
Sbjct: 67 LKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEK---ESLTEEEATEFLKQIL 123
Query: 760 NALSYLHHDCIPPIVHRDISSKNVLLDSE----YEAHVSDFGFAKFLEPHSSNWTEFAGT 815
N +++ I H D+ +N++L + DFG A ++ + + GT
Sbjct: 124 NG---VYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-FKNIFGT 179
Query: 816 VGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHP--GDFVSTIFSSISNMIIEVNQIL 873
+ APE+ + D++S GV+ ++ G P GD +++S + E
Sbjct: 180 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEY 239
Query: 874 DHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914
++D + LV++P+ R T+++
Sbjct: 240 FSNTSALAKDFIRR----------LLVKDPKKRMTIQDSLQ 270
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (368), Expect = 5e-39
Identities = 65/271 (23%), Positives = 116/271 (42%), Gaps = 29/271 (10%)
Query: 654 IGKGGQRSVYKAE-LPSGNIFAVKKFKAELFSDETANPSEFLNEV-LALTEIRHRNIIKF 711
+G G V + + FA+K + + + EV L + +I++
Sbjct: 20 LGLGINGKVLQIFNKRTQEKFALKMLQ---------DCPKARREVELHWRASQCPHIVRI 70
Query: 712 HGFCSNA----QHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHH 767
N + IV E L G L + ++D + F+ + ++K + A+ YLH
Sbjct: 71 VDVYENLYAGRKCLLIVMECLDGGELFSRIQD-RGDQAFTEREASEIMKSIGEAIQYLHS 129
Query: 768 DCIPPIVHRDISSKNVLLDSEYE---AHVSDFGFAKFLEPHSSNWTEFAGTVGYAAPELA 824
I HRD+ +N+L S+ ++DFGFAK H+S T T Y APE+
Sbjct: 130 INI---AHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT-PCYTPYYVAPEVL 185
Query: 825 YTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSR-D 883
+ + D++S GV+ ++ GY P F S +IS + ++ + P P +
Sbjct: 186 GPEKYDKSCDMWSLGVIMYILLCGYPP--FYSNHGLAISPGMKTRIRMGQYEFPNPEWSE 243
Query: 884 VTDKLRSIMEVAILCLVENPEARPTMKEVCN 914
V+++++ ++ L P R T+ E N
Sbjct: 244 VSEEVKMLIR---NLLKTEPTQRMTITEFMN 271
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 143 bits (361), Expect = 2e-38
Identities = 40/284 (14%), Positives = 86/284 (30%), Gaps = 32/284 (11%)
Query: 649 GEKY----CIGKGGQRSVYKAE-LPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEI 703
G +Y IG G +Y + +G A+K + + E +
Sbjct: 6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQ------LHIESKIYKMM 59
Query: 704 RHRNIIKFHGFC-SNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANAL 762
+ I +C + ++ +V E L ++FS + + + + +
Sbjct: 60 QGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCS---RKFSLKTVLLLADQMISRI 116
Query: 763 SYLHHDCIPPIVHRDISSKNVL---LDSEYEAHVSDFGFAKFLEPHSSN-------WTEF 812
Y+H +HRD+ N L ++ DFG AK ++
Sbjct: 117 EYIHSKNF---IHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNL 173
Query: 813 AGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQI 872
GT YA+ + + + D+ S G + + G + +
Sbjct: 174 TGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLG-SLPWQGLKAATKRQKYERISEKK 232
Query: 873 LDHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLL 916
+ + + + + + C + +P + L
Sbjct: 233 MSTPIEVLCKGYPSEFATYLN---FCRSLRFDDKPDYSYLRQLF 273
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (361), Expect = 2e-38
Identities = 57/286 (19%), Positives = 102/286 (35%), Gaps = 38/286 (13%)
Query: 654 IGKGGQRSVYKA------ELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHR- 706
+G+G V +A + + AVK K E ++E+ L I H
Sbjct: 21 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHR---ALMSELKILIHIGHHL 77
Query: 707 NIIKFHGFC-SNAQHSFIVCEYLARGSLTTILR-------------DDAAAKEFSWNQRM 752
N++ G C ++ E+ G+L+T LR +D + +
Sbjct: 78 NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI 137
Query: 753 NVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNW--T 810
VA + +L +HRD++++N+LL + + DFG A+ +
Sbjct: 138 CYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG 194
Query: 811 EFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVN 870
+ + + APE + T + DV+SFGVL E+ + +
Sbjct: 195 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS------PYPGVKIDEEFCR 248
Query: 871 QILDHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLL 916
++ + T ++ M C P RPT E+ L
Sbjct: 249 RLKEGTRMRAPDYTTPEMYQTML---DCWHGEPSQRPTFSELVEHL 291
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (353), Expect = 1e-37
Identities = 57/268 (21%), Positives = 105/268 (39%), Gaps = 32/268 (11%)
Query: 654 IGKGGQRSVYKA-ELPSGNIFAVKKFKAELFSD--ETANPSEFLNEVLALTEIR--HRNI 708
+G GG SVY + A+K + + SD E N + EV+ L ++ +
Sbjct: 12 LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 71
Query: 709 IKFHGFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHD 768
I+ + ++ E + + V A+ + H+
Sbjct: 72 IRLLDWFERPDSFVLILERPEPVQDLFDFITE--RGALQEELARSFFWQVLEAVRHCHN- 128
Query: 769 CIPPIVHRDISSKNVLLD-SEYEAHVSDFGFAKFLEPHSSNWTEFAGTVGYAAPE-LAYT 826
++HRDI +N+L+D + E + DFG L + +T+F GT Y+ PE + Y
Sbjct: 129 --CGVLHRDIKDENILIDLNRGELKLIDFGSGALL--KDTVYTDFDGTRVYSPPEWIRYH 184
Query: 827 MRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRDVTD 886
V+S G+L +++ G P + +I+ ++ R V+
Sbjct: 185 RYHGRSAAVWSLGILLYDMVCGDIPFE--------------HDEEIIRGQVFFRQR-VSS 229
Query: 887 KLRSIMEVAILCLVENPEARPTMKEVCN 914
+ + ++ CL P RPT +E+ N
Sbjct: 230 ECQHLIR---WCLALRPSDRPTFEEIQN 254
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (355), Expect = 1e-37
Identities = 61/283 (21%), Positives = 101/283 (35%), Gaps = 31/283 (10%)
Query: 654 IGKGGQRSVYKAE-LPSGNIFAVKKFKAELFSDETAN-PSEFLNEVLALTEIRHRNIIKF 711
+G+G +VYKA + I A+KK K S+ L E+ L E+ H NII
Sbjct: 6 LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 65
Query: 712 HGFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIP 771
+ + +V +++ I + + + + L YLH I
Sbjct: 66 LDAFGHKSNISLVFDFMETDLEVIIKDNS---LVLTPSHIKAYMLMTLQGLEYLHQHWI- 121
Query: 772 PIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGTVGYAAPELAYTMRA-T 830
+HRD+ N+LLD ++DFG AK + +T T Y APEL + R
Sbjct: 122 --LHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYG 179
Query: 831 EKYDVYSFGVLALEVIKGYHP--GDFVSTIFSSISNMI-----------------IEVNQ 871
D+++ G + E++ GD + I + +
Sbjct: 180 VGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKS 239
Query: 872 ILDHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914
L D L +++ + NP AR T +
Sbjct: 240 FPGIPLHHIFSAAGDDLLDLIQ---GLFLFNPCARITATQALK 279
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 140 bits (354), Expect = 8e-37
Identities = 52/261 (19%), Positives = 95/261 (36%), Gaps = 23/261 (8%)
Query: 654 IGKGGQRSVYKAELP-SGNIFAVKKFKAELFSDETANPSEFLNEVLA---LTEIRHRNII 709
IG+GG VY +G ++A+K + + + LNE + ++ I+
Sbjct: 12 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMK-QGETLALNERIMLSLVSTGDCPFIV 70
Query: 710 KFHGFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDC 769
+ + + G L L FS + L ++H+
Sbjct: 71 CMSYAFHTPDKLSFILDLMNGGDLHYHLSQH---GVFSEADMRFYAAEIILGLEHMHN-- 125
Query: 770 IPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGTVGYAAPE-LAYTMR 828
+V+RD+ N+LLD +SD G A + + GT GY APE L +
Sbjct: 126 -RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV--GTHGYMAPEVLQKGVA 182
Query: 829 ATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRDVTDKL 888
D +S G + ++++G+ P T E++++ + +L
Sbjct: 183 YDSSADWFSLGCMLFKLLRGHSPFRQHKT------KDKHEIDRMTLTMAVELPDSFSPEL 236
Query: 889 RSIMEVAILCLVENPEARPTM 909
RS++E L + R
Sbjct: 237 RSLLE---GLLQRDVNRRLGC 254
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (343), Expect = 1e-35
Identities = 57/299 (19%), Positives = 102/299 (34%), Gaps = 40/299 (13%)
Query: 647 NFGEKY----CIGKGGQRSVYKA-ELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALT 701
+ G +Y IG+G V A + + A+KK + L E+ L
Sbjct: 5 DVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPF---EHQTYCQRTLREIKILL 61
Query: 702 EIRHRNIIKFHGFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANA 761
RH NII + + YL + L + S + + +
Sbjct: 62 RFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRG 121
Query: 762 LSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEP---HSSNWTEFAGTVGY 818
L Y+H ++HRD+ N+LL++ + + DFG A+ +P H+ TE+ T Y
Sbjct: 122 LKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWY 178
Query: 819 AAPELAYT-MRATEKYDVYSFGVLALEVIKGYHP----------------------GDFV 855
APE+ T+ D++S G + E++ D
Sbjct: 179 RAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLN 238
Query: 856 STIFSSISNMIIEVNQILDHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914
I N ++ + + K +++ L NP R +++
Sbjct: 239 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLD---KMLTFNPHKRIEVEQALA 294
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (342), Expect = 1e-35
Identities = 54/259 (20%), Positives = 98/259 (37%), Gaps = 20/259 (7%)
Query: 654 IGKGGQRSVYKAE-LPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFH 712
+GKG V +G +A+K + E+ + + + E L RH +
Sbjct: 13 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAK-DEVAHTVTESRVLQNTRHPFLTALK 71
Query: 713 GFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPP 772
V EY G L L + + F+ + + +AL +
Sbjct: 72 YAFQTHDRLCFVMEYANGGELFFHLSRE---RVFTEERARFYGAEIVSAL---EYLHSRD 125
Query: 773 IVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGTVGYAAPELAYTMRATEK 832
+V+RDI +N++LD + ++DFG K + F GT Y APE+
Sbjct: 126 VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRA 185
Query: 833 YDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRDVTDKLRSIM 892
D + GV+ E++ G P F + + + IL + P R ++ + +S++
Sbjct: 186 VDWWGLGVVMYEMMCGRLP-------FYNQDHERL-FELILMEEIRFP-RTLSPEAKSLL 236
Query: 893 EVAILCLVENPEARPTMKE 911
L ++P+ R
Sbjct: 237 A---GLLKKDPKQRLGGGP 252
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 133 bits (336), Expect = 4e-35
Identities = 45/289 (15%), Positives = 92/289 (31%), Gaps = 36/289 (12%)
Query: 649 GEKY----CIGKGGQRSVYKAE-LPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEI 703
G Y IG+G +++ L + A+K ++ + +E +
Sbjct: 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRR------SDAPQLRDEYRTYKLL 57
Query: 704 RHRNII-KFHGFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANAL 762
I + F H+ +V + L + ++FS K + +
Sbjct: 58 AGCTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCG---RKFSVKTVAMAAKQMLARV 114
Query: 763 SYLHHDCIPPIVHRDISSKNVLLDSEYEAH-----VSDFGFAKFLEPHSSN-------WT 810
+H +V+RDI N L+ + V DFG KF +
Sbjct: 115 QSIHE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKK 171
Query: 811 EFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVN 870
+GT Y + + + D+ + G + + ++G P + + +
Sbjct: 172 NLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKA-----ATNKQKYE 226
Query: 871 QILDHRLPTPSRDVTDKL-RSIMEVAILCLVENPEARPTMKEVCNLLCK 918
+I + + TP R++ + +A P + L K
Sbjct: 227 RIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSK 275
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (334), Expect = 8e-35
Identities = 52/289 (17%), Positives = 105/289 (36%), Gaps = 39/289 (13%)
Query: 654 IGKGGQRSVYKAE--LPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEI---RHRNI 708
IG+G V+KA G A+K+ + + + P + EV L + H N+
Sbjct: 15 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEG--MPLSTIREVAVLRHLETFEHPNV 72
Query: 709 IKFHGFCSNAQ-----HSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALS 763
++ C+ ++ +V E++ + T D +++ + L
Sbjct: 73 VRLFDVCTVSRTDRETKLTLVFEHVDQDLTT--YLDKVPEPGVPTETIKDMMFQLLRGLD 130
Query: 764 YLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGTVGYAAPEL 823
+LH + VHRD+ +N+L+ S + ++DFG A+ + + T+ Y APE+
Sbjct: 131 FLHSHRV---VHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTS-VVVTLWYRAPEV 186
Query: 824 AYTMRATEKYDVYSFGVLALEVIKGYHP--GDFVSTIFSSISNMI--------------- 866
D++S G + E+ + G I ++I
Sbjct: 187 LLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALP 246
Query: 867 -IEVNQILDHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914
+ + D+ + + ++ CL NP R + +
Sbjct: 247 RQAFHSKSAQPIEKFVTDIDELGKDLLL---KCLTFNPAKRISAYSALS 292
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (332), Expect = 1e-34
Identities = 52/289 (17%), Positives = 113/289 (39%), Gaps = 32/289 (11%)
Query: 650 EKY----CIGKGGQRSVYKAE-LPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIR 704
+KY IG+G +V+KA+ + I A+K+ + + D+ PS L E+ L E++
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLD--DDDEGVPSSALREICLLKELK 59
Query: 705 HRNIIKFHGFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSY 764
H+NI++ H + + +V E+ + + V + L
Sbjct: 60 HKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCN------GDLDPEIVKSFLFQLLKG 113
Query: 765 LHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGTVGYAAPELA 824
L ++HRD+ +N+L++ E +++FG A+ ++ T+ Y P++
Sbjct: 114 LGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVL 173
Query: 825 YTMRA-TEKYDVYSFGVLALEVIKGYHP---GDFVSTIFSSISNM-----------IIEV 869
+ + + D++S G + E+ P G+ V I + + ++
Sbjct: 174 FGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKL 233
Query: 870 NQILDHRLPTPSRDVTDKLRSIMEVAI----LCLVENPEARPTMKEVCN 914
+ + + + + + + L NP R + +E
Sbjct: 234 PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (334), Expect = 2e-34
Identities = 60/286 (20%), Positives = 96/286 (33%), Gaps = 36/286 (12%)
Query: 654 IGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFH 712
IG G VY+A+L SG + A+KK + E+ + ++ H NI++
Sbjct: 28 IGNGSFGVVYQAKLCDSGELVAIKKVLQD--------KRFKNRELQIMRKLDHCNIVRLR 79
Query: 713 GFC------SNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLH 766
F + + +V +Y+ A + + + +L+Y+H
Sbjct: 80 YFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 139
Query: 767 HDCIPPIVHRDISSKNVLLDSEYEAH-VSDFGFAKFLEPHSSNWTEFAGTVGYAAPELAY 825
I HRDI +N+LLD + + DFG AK L N + A +
Sbjct: 140 S---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFG 196
Query: 826 TMRATEKYDVYSFGVLALEVIKGYHP--GDFVSTIFSSISNMIIE-------------VN 870
T DV+S G + E++ G GD I ++
Sbjct: 197 ATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTE 256
Query: 871 QILDHRLPTPSRDVTDKLRSIMEVAIL--CLVENPEARPTMKEVCN 914
P V +A+ L P AR T E C
Sbjct: 257 FKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (323), Expect = 3e-33
Identities = 54/295 (18%), Positives = 104/295 (35%), Gaps = 42/295 (14%)
Query: 654 IGKGGQRSVYKAE-LPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFH 712
IG+G V+KA +G A+KK E +++ P L E+ L ++H N++
Sbjct: 18 IGQGTFGEVFKARHRKTGQKVALKKVLME--NEKEGFPITALREIKILQLLKHENVVNLI 75
Query: 713 GFCSNAQ--------HSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSY 764
C ++V ++ + +F+ ++ V++ + L+
Sbjct: 76 EICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVL---VKFTLSEIKRVMQML---LNG 129
Query: 765 LHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSS----NWTEFAGTVGYAA 820
L++ I+HRD+ + NVL+ + ++DFG A+ + +T T+ Y
Sbjct: 130 LYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRP 189
Query: 821 PELAYTMRA-TEKYDVYSFGVLALEVIKGYHP-----------------GDFVSTIFSSI 862
PEL R D++ G + E+ G ++ ++
Sbjct: 190 PELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNV 249
Query: 863 SNMIIEVNQILDHRLPTPSRDVTDKLRSIMEVAIL---CLVENPEARPTMKEVCN 914
N + L +D L LV +P R + N
Sbjct: 250 DNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 304
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (322), Expect = 5e-33
Identities = 54/264 (20%), Positives = 102/264 (38%), Gaps = 22/264 (8%)
Query: 654 IGKGGQRSVYKAEL----PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHR-NI 708
+G G V+ +G ++A+K K + E L IR +
Sbjct: 32 LGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFL 91
Query: 709 IKFHGFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHD 768
+ H ++ +Y+ G L T L E + + L H
Sbjct: 92 VTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYV------GEIVLALEHL 145
Query: 769 CIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWT-EFAGTVGYAAPELAYTM 827
I++RDI +N+LLDS ++DFG +K + +F GT+ Y AP++
Sbjct: 146 HKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGG 205
Query: 828 RA--TEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRDVT 885
+ + D +S GVL E++ G P F N E+++ + P ++++
Sbjct: 206 DSGHDKAVDWWSLGVLMYELLTGASP--FTV---DGEKNSQAEISRRILKSEPPYPQEMS 260
Query: 886 DKLRSIMEVAILCLVENPEARPTM 909
+ +++ L+++P+ R
Sbjct: 261 ALAKDLIQ---RLLMKDPKKRLGC 281
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 126 bits (318), Expect = 2e-32
Identities = 54/267 (20%), Positives = 100/267 (37%), Gaps = 28/267 (10%)
Query: 654 IGKGGQRSVYKAE-LPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFH 712
+G G V + SGN +A+K + LNE L + ++K
Sbjct: 49 LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKL-KQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 713 GFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPP 772
+ + ++V EY+A G + + LR FS + YLH +
Sbjct: 108 FSFKDNSNLYMVMEYVAGGEMFSHLRRI---GRFSEPHARFYAAQIVLTFEYLHSLDL-- 162
Query: 773 IVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTEFAGTVGYAAPELAYTMRATEK 832
++RD+ +N+L+D + V+DFGFAK GT APE+ + +
Sbjct: 163 -IYRDLKPENLLIDQQGYIQVTDFGFAKR---VKGRTWTLCGTPEALAPEIILSKGYNKA 218
Query: 833 YDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRDVTDKLRSIM 892
D ++ GVL E+ GY P F + + ++ + + + L+ ++
Sbjct: 219 VDWWALGVLIYEMAAGYPP-------FFADQPI--QIYEKIVSGKVRFPSHFSSDLKDLL 269
Query: 893 EVAILCLVENPE-----ARPTMKEVCN 914
L + + + ++ N
Sbjct: 270 R---NLLQVDLTKRFGNLKNGVNDIKN 293
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (317), Expect = 3e-32
Identities = 59/304 (19%), Positives = 107/304 (35%), Gaps = 36/304 (11%)
Query: 638 YEEITKATGNFGEKY----CIGKGGQRSVYKA-ELPSGNIFAVKKFKAELFSDETANPSE 692
+E+TK Y +G G +V A + +G A+KK S+ A
Sbjct: 6 RQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAK--R 63
Query: 693 FLNEVLALTEIRHRNIIKFHGFCSNAQHSFIVCE-YLARGSLTTILRDDAAAKEFSWNQR 751
E+ L +RH N+I + + + YL + T L ++ ++
Sbjct: 64 AYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRI 123
Query: 752 MNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSNWTE 811
++ + L Y+H I HRD+ N+ ++ + E + DFG A+ + + +
Sbjct: 124 QFLVYQMLKGLRYIHAAGII---HRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVV 180
Query: 812 FAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVN- 870
A + MR T+ D++S G + E+I G F + I++V
Sbjct: 181 T--RWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTL--FKGSDHLDQLKEIMKVTG 236
Query: 871 ----------------QILDHRLPTPSRDVTDKLRSIMEVAI----LCLVENPEARPTMK 910
+ +D L + +A+ LV + E R T
Sbjct: 237 TPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAG 296
Query: 911 EVCN 914
E
Sbjct: 297 EALA 300
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (308), Expect = 5e-31
Identities = 54/306 (17%), Positives = 103/306 (33%), Gaps = 40/306 (13%)
Query: 638 YEEITKATGNFGEKY----CIGKGGQRSVYKAE-LPSGNIFAVKKFKAELFSDETANPSE 692
+E+ K E+Y +G G SV A +G AVKK S +
Sbjct: 6 RQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII--HAKR 63
Query: 693 FLNEVLALTEIRHRNIIKFHGFCSNAQ-----HSFIVCEYLARGSLTTILRDDAAAKEFS 747
E+ L ++H N+I + A+ + + +L L I++ ++ +
Sbjct: 64 TYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC----QKLT 119
Query: 748 WNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSS 807
+ +I + L Y+H I HRD+ N+ ++ + E + DFG A+ +
Sbjct: 120 DDHVQFLIYQILRGLKYIHSADII---HRDLKPSNLAVNEDCELKILDFGLARHTDDE-- 174
Query: 808 NWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHP--GDFVSTIFSSISNM 865
A A + M + D++S G + E++ G G I +
Sbjct: 175 MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL 234
Query: 866 II-------------EVNQILDHRLPTPSRDVTDKLRSIMEVAI----LCLVENPEARPT 908
+ + P + + +A+ LV + + R T
Sbjct: 235 VGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT 294
Query: 909 MKEVCN 914
+
Sbjct: 295 AAQALA 300
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (291), Expect = 8e-29
Identities = 57/316 (18%), Positives = 106/316 (33%), Gaps = 53/316 (16%)
Query: 640 EITKATGNFGEKY----CIGKGGQRSVYKA-ELPSGNIFAVKKFKAELFSDETANPSEFL 694
E+ +T ++Y IG G Q V A + A+KK + A
Sbjct: 7 EVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAK--RAY 64
Query: 695 NEVLALTEIRHRNIIKFHGFCS------NAQHSFIVCEYLARGSLTTILRDDAAAKEFSW 748
E++ + + H+NII + Q ++V E + I E
Sbjct: 65 RELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ------MELDH 118
Query: 749 NQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSN 808
+ ++ + + +LH I +HRD+ N+++ S+ + DFG A+ S
Sbjct: 119 ERMSYLLYQMLCGIKHLHSAGI---IHRDLKPSNIVVKSDCTLKILDFGLART-AGTSFM 174
Query: 809 WTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHP----------------- 851
T + T Y APE+ M E D++S G + E+++
Sbjct: 175 MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQL 234
Query: 852 ----GDFVSTIFSSISNMIIEVNQILDHRLPTPSRDVTDKLRSIMEVAIL---------C 898
+F+ + ++ N + + P D S
Sbjct: 235 GTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKM 294
Query: 899 LVENPEARPTMKEVCN 914
LV +P R ++ +
Sbjct: 295 LVIDPAKRISVDDALQ 310
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 113 bits (283), Expect = 6e-28
Identities = 55/313 (17%), Positives = 102/313 (32%), Gaps = 54/313 (17%)
Query: 638 YEEITKATGNFGEKY----CIGKGGQRSVYKAE-LPSGNIFAVKKFKAELFSDETANPSE 692
YE GN + Y +G+G V++A + + VK K +
Sbjct: 24 YESHVVEWGNQ-DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV-------KKKK 75
Query: 693 FLNEVLALTEIR-HRNIIKFHGFCSNAQHS--FIVCEYLARGSLTTILRDDAAAKEFSWN 749
E+ L +R NII + +V E++ + + +
Sbjct: 76 IKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY------QTLTDY 129
Query: 750 QRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSE-YEAHVSDFGFAKFLEPHSSN 808
+ + AL Y H I HRD+ NV++D E + + D+G A+F P
Sbjct: 130 DIRFYMYEILKALDYCHSMGIM---HRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE- 185
Query: 809 WTEFAGTVGYAAPELAYTMRA-TEKYDVYSFGVLALEVIKGYHP---------------- 851
+ + + PEL + D++S G + +I P
Sbjct: 186 YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAK 245
Query: 852 GDFVSTIFSSISNMIIEVNQILDHRLPTPSRDVTDKLRSIMEVAIL----------CLVE 901
++ I IE++ + L SR ++ ++ L
Sbjct: 246 VLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRY 305
Query: 902 NPEARPTMKEVCN 914
+ ++R T +E
Sbjct: 306 DHQSRLTAREAME 318
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 110 bits (275), Expect = 2e-26
Identities = 76/403 (18%), Positives = 144/403 (35%), Gaps = 53/403 (13%)
Query: 156 PIPSVI--GNLKSLLQLDLSENRLSGLIPLSLSNLSSLTVMSLFNNSLSGSIPPILGNLK 213
PI + L ++ L + ++ + S ++L +T + + SI + L
Sbjct: 11 PINQIFTDTALAEKMKTVLGKTNVTDTV--SQTDLDQVTTLQADRLGIK-SIDGV-EYLN 66
Query: 214 SLSTLGLHINQLNGVIPPSIGNLSSLRNLSLFNNRLYGFVPKEIGYLKSLSKLEFCANHL 273
+L+ + NQL + P + NL+ L ++ + NN++ P + L
Sbjct: 67 NLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITD 124
Query: 274 SGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLRNLTSLERVRFNQNNLYGKVYEAFGDHP 333
+ + + + ++ ++++L + Q +G
Sbjct: 125 IDPLKN------------LTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLA 172
Query: 334 NLTFLDLSQNNF-YCEISFNWRNFSKLGTFNASMNNIYGSIPPEIGDSSKLQVLDLSSNH 392
NLT L+ + + L + A+ N I P I + L L L+ N
Sbjct: 173 NLTTLERLDISSNKVSDISVLAKLTNLESLIATNNQISDITPLGI--LTNLDELSLNGNQ 230
Query: 393 IFGKIPVQLVKLFSLNKLILSLNQLFGGVPLEFGTLTELQYLDLSANKLSSSIP------ 446
+ L L +L L L+ NQ+ P LT+L L L AN++S+ P
Sbjct: 231 LKD--IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISPLAGLTA 286
Query: 447 --------------MSIGNLLKLHYLNLSNNQFSHKIPTEFEKLIHLSELDLSHNILQEE 492
I NL L YL L N S P L L L ++N + +
Sbjct: 287 LTNLELNENQLEDISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD- 343
Query: 493 IPPQICKMESLEKLNLSHNNLSDFIPRCFEEMRSLSWIDISYN 535
+ + ++ L+ HN +SD P + ++ + ++
Sbjct: 344 -VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 107 bits (267), Expect = 2e-25
Identities = 76/389 (19%), Positives = 140/389 (35%), Gaps = 39/389 (10%)
Query: 138 DNLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSENRLSGLIPLSLSNLSSLTVMSLF 197
L+ L K +++ + +L + L + + + L++LT ++
Sbjct: 19 TALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKSID--GVEYLNNLTQINFS 74
Query: 198 NNSLSGSIPPILGNLKSLSTLGLHINQLNGVIPPSIGNLSSLRNLSLFNNRLYGFVP--- 254
NN L+ P L NL L + ++ NQ+ + P + + L +
Sbjct: 75 NNQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLT 132
Query: 255 ------------KEIGYLKSLSKLEFCANHLSGVIPHSVGNLTGLVLLNMCENHLFGPIP 302
+I L L+ L+ + + NLT L L++ N +
Sbjct: 133 NLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISV 192
Query: 303 KSLRNLTSLERVRFNQNNLYGKVYEAFGDHPNLTFLDLSQNNFYCEISFNWRNFSKLGTF 362
+ LT+LE + N + G NL L L+ N + + + L
Sbjct: 193 LA--KLTNLESLIATNNQISD--ITPLGILTNLDELSLNGNQLKDIGTL--ASLTNLTDL 246
Query: 363 NASMNNIYGSIPPEIGDSSKLQVLDLSSNHIFGKIPVQLVKLFSLNKLILSLNQLFGGVP 422
+ + N I P + +KL L L +N I P+ + + LN+
Sbjct: 247 DLANNQISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNL----ELNENQLEDI 300
Query: 423 LEFGTLTELQYLDLSANKLSSSIPMSIGNLLKLHYLNLSNNQFSHKIPTEFEKLIHLSEL 482
L L YL L N +S P + +L KL L +NN+ S + L +++ L
Sbjct: 301 SPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINWL 356
Query: 483 DLSHNILQEEIPPQICKMESLEKLNLSHN 511
HN + + P + + + +L L+
Sbjct: 357 SAGHNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 102 bits (255), Expect = 5e-24
Identities = 72/386 (18%), Positives = 136/386 (35%), Gaps = 35/386 (9%)
Query: 91 NLSNLALLYLNDNSLFGSIPIVMGNLKSLSTLDLSQNQLNGSIPCSLDNLSNLDTLFLYK 150
L+ L ++ ++ +L ++TL + + SI ++ L+NL +
Sbjct: 20 ALAEKMKTVLGKTNVTDTVSQ--TDLDQVTTLQADRLGIK-SID-GVEYLNNLTQINFSN 75
Query: 151 NSLSGPIPSVIGNLKSLLQLDLSENRLSGLIPLSLSNLSSLTVMSLFNNSLSGSIPPILG 210
N L+ P + NL L+ + ++ N+++ + PL+ + + + + +
Sbjct: 76 NQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTN 133
Query: 211 ---------NLKSLSTLGLHINQLNGVIPPSIGNLSSLRNLS----LFNNRLYGFVPKEI 257
+ +S L + + +L L NL+ L + +
Sbjct: 134 LNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVL 193
Query: 258 GYLKSLSKLEFCANHLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLRNLTSLERVRFN 317
L +L L N +S + P LT L L++ N L +L +LT+L +
Sbjct: 194 AKLTNLESLIATNNQISDITPLG--ILTNLDELSLNGNQLKD--IGTLASLTNLTDLDLA 249
Query: 318 QNNLYGKVYEAFGDHPNLTFLDLSQNNFYCEISFNWRNFSKLGTFNASMNNIYGSIPPEI 377
N + LT L L N N +N I
Sbjct: 250 NNQISN--LAPLSGLTKLTELKLGANQISNISPLAGLTALT----NLELNENQLEDISPI 303
Query: 378 GDSSKLQVLDLSSNHIFGKIPVQLVKLFSLNKLILSLNQLFGGVPLEFGTLTELQYLDLS 437
+ L L L N+I PV L L +L + N++ LT + +L
Sbjct: 304 SNLKNLTYLTLYFNNISDISPVS--SLTKLQRLFFANNKVSD--VSSLANLTNINWLSAG 359
Query: 438 ANKLSSSIPMSIGNLLKLHYLNLSNN 463
N++S P + NL ++ L L++
Sbjct: 360 HNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 95.8 bits (237), Expect = 1e-21
Identities = 54/202 (26%), Positives = 87/202 (43%), Gaps = 32/202 (15%)
Query: 18 GNLSKLQYLDLGNNQLSGVIPPEIGKLNQLRRLYLDVNQLHGTIPPVIGQLSLINELVFC 77
L+ L+ L NNQ+S + P I L L L+ NQL + L+ + +L
Sbjct: 194 AKLTNLESLIATNNQISDITPLGILT--NLDELSLNGNQLKD--IGTLASLTNLTDLDLA 249
Query: 78 HNNVSGRIPSSLGNLSNLALLYLNDNSLFGSIPIV--------------------MGNLK 117
+N +S P L L+ L L L N + P+ + NLK
Sbjct: 250 NNQISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPISNLK 307
Query: 118 SLSTLDLSQNQLNGSIPCSLDNLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSENRL 177
+L+ L L N ++ P + +L+ L LF N +S S + NL ++ L N++
Sbjct: 308 NLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSDV--SSLANLTNINWLSAGHNQI 363
Query: 178 SGLIPLSLSNLSSLTVMSLFNN 199
S L P L+NL+ +T + L +
Sbjct: 364 SDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 93.9 bits (232), Expect = 6e-21
Identities = 83/340 (24%), Positives = 144/340 (42%), Gaps = 31/340 (9%)
Query: 17 IGNLSKLQYLDLGNNQLSGVIPPEIGKLNQLRRLYLDVNQLHGTIPPVIGQLSLINELVF 76
+ L+ L ++ NNQL+ + P + L +L + ++ NQ+ P L
Sbjct: 62 VEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFN 119
Query: 77 CHNNVSGRIP------------SSLGNLSNLALLYLNDNSLFGSIPIVMGNLKSLSTLDL 124
+ +++ ++S L+ L FG+ + L +L+TL+
Sbjct: 120 NQITDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLER 179
Query: 125 SQNQLNGSIPCSLD-NLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSENRLSGLIPL 183
N S+ L+NL++L N +S P I +L +L L+ N+L
Sbjct: 180 LDISSNKVSDISVLAKLTNLESLIATNNQISDITPLGIL--TNLDELSLNGNQLKD--IG 235
Query: 184 SLSNLSSLTVMSLFNNSLSGSIPPILGNLKSLSTLGLHINQLNGVIPPSIGNLSSLRNLS 243
+L++L++LT + L NN +S P L L L+ L L NQ++ + P + L++L NL
Sbjct: 236 TLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLE 291
Query: 244 LFNNRLYGFVPKEIGYLKSLSKLEFCANHLSGVIPHSVGNLTGLVLLNMCENHLFGPIPK 303
L N I LK+L+ L N++S + P V +LT L L N +
Sbjct: 292 LNEN--QLEDISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VS 345
Query: 304 SLRNLTSLERVRFNQNNLYGKVYEAFGDHPNLTFLDLSQN 343
SL NLT++ + N + + +T L L+
Sbjct: 346 SLANLTNINWLSAGHNQISDLT--PLANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 90.8 bits (224), Expect = 5e-20
Identities = 50/175 (28%), Positives = 76/175 (43%), Gaps = 14/175 (8%)
Query: 1 MLNLGFNLLFGNIPPQIGNLSKLQYLDLGNNQLSGVIPPEIGKLNQLRRLYLDVNQLHGT 60
L+L N L + +L+ L LDL NNQ+S + P + L +L L L NQ+
Sbjct: 223 ELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNI 278
Query: 61 IPPVIGQLSLINELVFCHNNVSGRIPSSLGNLSNLALLYLNDNSLFGSIPIVMGNLKSLS 120
P L N S + NL NL L L N++ P+ +L L
Sbjct: 279 SPLA----GLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDISPV--SSLTKLQ 332
Query: 121 TLDLSQNQLNGSIPCSLDNLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSEN 175
L + N+++ SL NL+N++ L N +S P + NL + QL L++
Sbjct: 333 RLFFANNKVSD--VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 87.7 bits (216), Expect = 5e-19
Identities = 72/367 (19%), Positives = 139/367 (37%), Gaps = 33/367 (8%)
Query: 14 PPQIGNLSKLQYLDLGNNQLSGVIPPEIGKLNQLRRLYLDVNQLHGTIPPVIGQLSLINE 73
+L ++ L + + + LN L ++ NQL P + L+ + +
Sbjct: 37 TVSQTDLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVD 92
Query: 74 LVFCHNNVSGRIPSSLGNLSNLALLYLNDNSLFGSIPIVMG---------NLKSLSTLDL 124
++ +N ++ P + L+ N + + + + +S L
Sbjct: 93 ILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNRLELSSNTISDISALSG 152
Query: 125 SQNQLNGSIPCSLDNLSNLDTL----FLYKNSLSGPIPSVIGNLKSLLQLDLSENRLSGL 180
+ S + +L L L L +S SV+ L +L L + N++S +
Sbjct: 153 LTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLAKLTNLESLIATNNQISDI 212
Query: 181 IPLSLSNLSSLTVMSLFNNSLSGSIPPILGNLKSLSTLGLHINQLNGVIPPSIGNLSSLR 240
P L L++L +SL N L L +L +L+ L L NQ++ + P + L+ L
Sbjct: 213 TP--LGILTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLT 266
Query: 241 NLSLFNNRLYGFVPKEIGYLKSLSKLEFCANHLSGVIPHSVGNLTGLVLLNMCENHLFGP 300
L L N++ P + L +L+ LE N + NL L L + N++
Sbjct: 267 ELKLGANQISNISP--LAGLTALTNLELNENQ--LEDISPISNLKNLTYLTLYFNNISDI 322
Query: 301 IPKSLRNLTSLERVRFNQNNLYGKVYEAFGDHPNLTFLDLSQNNFYCEISFNWRNFSKLG 360
P + +LT L+R+ F N + + + N+ +L N N +++
Sbjct: 323 SP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQISDLTPL--ANLTRIT 376
Query: 361 TFNASMN 367
+
Sbjct: 377 QLGLNDQ 383
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 98.2 bits (243), Expect = 6e-23
Identities = 60/276 (21%), Positives = 107/276 (38%), Gaps = 13/276 (4%)
Query: 75 VFCHNNVSGRIPSSLGNLSNLALLYLNDNSLFGSIPIVMGNLKSLSTLDLSQNQLNGSIP 134
V C + ++P L + ALL L +N + NLK+L TL L N+++ P
Sbjct: 15 VQCSDLGLEKVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISP 72
Query: 135 CSLDNLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSENRLSGLIPLSLSNLSSLTVM 194
+ L L+ L+L KN L + L+ L + ++ + L+ + + +
Sbjct: 73 GAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELG 132
Query: 195 SLFNNSLSGSIPPILGNLKSLSTLGLHINQLNGVIPPSIGNLSSLRNLSLFNNRLYGFVP 254
+ SG +K LS + + + + G SL L L N++
Sbjct: 133 T-NPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQ---GLPPSLTELHLDGNKITKVDA 188
Query: 255 KEIGYLKSLSKLEFCANHLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLRNLTSLERV 314
+ L +L+KL N +S V S+ N L L++ N L +P L + ++ V
Sbjct: 189 ASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVV 247
Query: 315 RFNQNNLYGKVYEAF------GDHPNLTFLDLSQNN 344
+ NN+ F + + + L N
Sbjct: 248 YLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNP 283
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 98.2 bits (243), Expect = 6e-23
Identities = 64/345 (18%), Positives = 109/345 (31%), Gaps = 52/345 (15%)
Query: 190 SLTVMSLFNNSLSGSIPPILGNLKSLSTLGLHINQLNGVIPPSIGNLSSLRNLSLFNNRL 249
L V+ + L +P L + L L N++ + NL +L L L NN++
Sbjct: 11 HLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKI 67
Query: 250 YGFVPKEIGYLKSLSKLEFCANHLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLRNLT 309
P L L +L N L + L L + + + L +
Sbjct: 68 SKISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMI 127
Query: 310 SLERVRFNQNNLYGKVYEAFGDHPNLTFLDLSQNNFYCEISFNWRNFSKLGTFNASMNNI 369
+E + N G AF L+++ ++ N
Sbjct: 128 VVE-LGTNPLKSSGIENGAFQGMKKLSYIRIADTNI------------------------ 162
Query: 370 YGSIPPEIGDSSKLQVLDLSSNHIFGKIPVQLVKLFSLNKLILSLNQLFGGVPLEFGTLT 429
+IP + L L L N I L L +L KL LS N +
Sbjct: 163 -TTIPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTP 219
Query: 430 ELQYLDLSANKLSSSIPMSIGNLLKLHYLNLSNNQFSHKIPTEFEKLIHLSELDLSHNIL 489
L+ L L+ NKL +P + + + + L NN S +F + +
Sbjct: 220 HLRELHLNNNKLVK-VPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNT--------- 269
Query: 490 QEEIPPQICKMESLEKLNLSHNNLSDF--IPRCFEEMRSLSWIDI 532
K S ++L N + + P F + + + +
Sbjct: 270 ---------KKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQL 305
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 97.4 bits (241), Expect = 1e-22
Identities = 58/277 (20%), Positives = 96/277 (34%), Gaps = 23/277 (8%)
Query: 117 KSLSTLDLSQNQLNGSIPCSLDNLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSENR 176
+ LDL N++ NL NL TL L N +S P L L +L LS+N+
Sbjct: 31 PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQ 90
Query: 177 LSGLIPLSLSNLSSLTVMSLFNNSLSGSIPPILGNLKSLSTLGLHINQLNGVIPPSIGNL 236
L L L L V + S+ L + + LG + + +G+ + +
Sbjct: 91 LKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVE-LGTNPLKSSGIENGAFQGM 149
Query: 237 SSLRNLSLFNNRLYGFVPKEIGYLKSLSKLEFCANHLSGVIPHSVGNLTGLVLLNMCENH 296
L + + + + G SL++L N ++ V S+ L L L + N
Sbjct: 150 KKLSYIRIADTNITTIPQ---GLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNS 206
Query: 297 LFGPIPKSLRNLTSLERVRFNQNNLYGKVYEAFGDHPNLTFLDLSQNNFYCEISFNWRNF 356
+ SL N L + N N L DH + + L NN
Sbjct: 207 ISAVDNGSLANTPHLRELHLNNNKLVKVPGG-LADHKYIQVVYLHNNNI----------- 254
Query: 357 SKLGTFNASMNNIYGSIPPEIGDSSKLQVLDLSSNHI 393
+++ + P + + L SN +
Sbjct: 255 -------SAIGSNDFCPPGYNTKKASYSGVSLFSNPV 284
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 96.3 bits (238), Expect = 3e-22
Identities = 66/257 (25%), Positives = 111/257 (43%), Gaps = 15/257 (5%)
Query: 1 MLNLGFNLLFGNIPPQIGNLSKLQYLDLGNNQLSGVIPPEIGKLNQLRRLYLDVNQLHGT 60
+L+L N + NL L L L NN++S + P L +L RLYL NQL
Sbjct: 35 LLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK-E 93
Query: 61 IPPVIGQLSLINELVFCHNNVSGRIPSSLGNLSNLALLYLND--NSLFGSIPIVMGNLKS 118
+P + + + EL N ++ S L+ + ++ L G +K
Sbjct: 94 LPEKMPK--TLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKK 151
Query: 119 LSTLDLSQNQLNGSIPCSLDNLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSENRLS 178
LS + ++ + +IP L +L L L N ++ + + L +L +L LS N +S
Sbjct: 152 LSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSIS 208
Query: 179 GLIPLSLSNLSSLTVMSLFNNSLSGSIPPILGNLKSLSTLGLHINQLNGV------IPPS 232
+ SL+N L + L NN L +P L + K + + LH N ++ + P
Sbjct: 209 AVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGY 267
Query: 233 IGNLSSLRNLSLFNNRL 249
+S +SLF+N +
Sbjct: 268 NTKKASYSGVSLFSNPV 284
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 95.9 bits (237), Expect = 4e-22
Identities = 53/268 (19%), Positives = 95/268 (35%), Gaps = 12/268 (4%)
Query: 285 TGLVLLNMCENHLFGPIPKSLRNLTSLERVRFNQNNLYGKVYEAFGDHPNLTFLDLSQNN 344
LL++ N + +NL +L + N + AF L L LS+N
Sbjct: 31 PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQ 90
Query: 345 FYCEISFNWRNFSKLGTFNASMNNIYGSIPPEIGDSSKLQVLDLSSNHIFGKIPVQLVKL 404
+ +L + + S+ + ++ L + G +
Sbjct: 91 LKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVE-LGTNPLKSSGIENGAFQGM 149
Query: 405 FSLNKLILSLNQLFGGVPLEFGTLTELQYLDLSANKLSSSIPMSIGNLLKLHYLNLSNNQ 464
L+ + ++ + + G L L L NK++ S+ L L L LS N
Sbjct: 150 KKLSYIRIADTNI---TTIPQGLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNS 206
Query: 465 FSHKIPTEFEKLIHLSELDLSHNILQEEIPPQICKMESLEKLNLSHNNLSDFIPRCF--- 521
S HL EL L++N L + +P + + ++ + L +NN+S F
Sbjct: 207 ISAVDNGSLANTPHLRELHLNNNKLVK-VPGGLADHKYIQVVYLHNNNISAIGSNDFCPP 265
Query: 522 ---EEMRSLSWIDISYNELQ-GPIPNST 545
+ S S + + N +Q I ST
Sbjct: 266 GYNTKKASYSGVSLFSNPVQYWEIQPST 293
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 91.3 bits (225), Expect = 1e-20
Identities = 52/268 (19%), Positives = 100/268 (37%), Gaps = 13/268 (4%)
Query: 13 IPPQIGNLSKLQYLDLGNNQLSGVIPPEIGKLNQLRRLYLDVNQLHGTIPPVIGQLSLIN 72
+P + LDL NN+++ + + L L L L N++ P L +
Sbjct: 25 VPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLE 82
Query: 73 ELVFCHNNVSGRIPSSLGNLSNLALLYLNDNSLFGSIPIVMGNLKSLSTLDLSQNQLNGS 132
L N + L L + + S+ + + + L + + +G
Sbjct: 83 RLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVE-LGTNPLKSSGI 141
Query: 133 IPCSLDNLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSENRLSGLIPLSLSNLSSLT 192
+ + L + + +++ IP G SL +L L N+++ + SL L++L
Sbjct: 142 ENGAFQGMKKLSYIRIADTNIT-TIPQ--GLPPSLTELHLDGNKITKVDAASLKGLNNLA 198
Query: 193 VMSLFNNSLSGSIPPILGNLKSLSTLGLHINQLNGVIPPSIGNLSSLRNLSLFNNRLYGF 252
+ L NS+S L N L L L+ N+L +P + + ++ + L NN +
Sbjct: 199 KLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAI 257
Query: 253 ------VPKEIGYLKSLSKLEFCANHLS 274
P S S + +N +
Sbjct: 258 GSNDFCPPGYNTKKASYSGVSLFSNPVQ 285
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 81.6 bits (200), Expect = 3e-17
Identities = 42/252 (16%), Positives = 88/252 (34%), Gaps = 7/252 (2%)
Query: 293 CENHLFGPIPKSLRNLTSLERVRFNQNNLYGKVYEAFGDHPNLTFLDLSQNNFYCEISFN 352
C + +PK L + N + F + NL L L N
Sbjct: 17 CSDLGLEKVPKDL--PPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGA 74
Query: 353 WRNFSKLGTFNASMNNIYGSIPPEIGDSSKLQVLDLSSNHIFGKIPVQLVKLFSLNKLIL 412
+ KL S N + +L+V + + + L ++ + L
Sbjct: 75 FAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVE-LGT 133
Query: 413 SLNQLFGGVPLEFGTLTELQYLDLSANKLSSSIPMSIGNLLKLHYLNLSNNQFSHKIPTE 472
+ + G F + +L Y+ ++ +++ + G L L+L N+ +
Sbjct: 134 NPLKSSGIENGAFQGMKKLSYIRIADTNITT---IPQGLPPSLTELHLDGNKITKVDAAS 190
Query: 473 FEKLIHLSELDLSHNILQEEIPPQICKMESLEKLNLSHNNLSDFIPRCFEEMRSLSWIDI 532
+ L +L++L LS N + + L +L+L++N L +P + + + + +
Sbjct: 191 LKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKL-VKVPGGLADHKYIQVVYL 249
Query: 533 SYNELQGPIPNS 544
N + N
Sbjct: 250 HNNNISAIGSND 261
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 60.1 bits (144), Expect = 3e-10
Identities = 27/121 (22%), Positives = 39/121 (32%)
Query: 429 TELQYLDLSANKLSSSIPMSIGNLLKLHYLNLSNNQFSHKIPTEFEKLIHLSELDLSHNI 488
+ LDL NK++ NL LH L L NN+ S P F L+ L L LS N
Sbjct: 31 PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQ 90
Query: 489 LQEEIPPQICKMESLEKLNLSHNNLSDFIPRCFEEMRSLSWIDISYNELQGPIPNSTAFK 548
L+E ++ L + + +M + K
Sbjct: 91 LKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMK 150
Query: 549 N 549
Sbjct: 151 K 151
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 58.9 bits (141), Expect = 7e-10
Identities = 26/144 (18%), Positives = 54/144 (37%), Gaps = 3/144 (2%)
Query: 430 ELQYLDLSANKLSSSIPMSIGNLLKLHYLNLSNNQFSHKIPTEFEKLIHLSELDLSHNIL 489
L+ + S L +P + L+L NN+ + +F+ L +L L L +N +
Sbjct: 11 HLRVVQCSDLGLEK-VPKDLPPDTA--LLDLQNNKITEIKDGDFKNLKNLHTLILINNKI 67
Query: 490 QEEIPPQICKMESLEKLNLSHNNLSDFIPRCFEEMRSLSWIDISYNELQGPIPNSTAFKN 549
+ P + LE+L LS N L + + + ++ L + +++ + N
Sbjct: 68 SKISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMI 127
Query: 550 GLMEGNKGLCGNFKALPSCDAFTS 573
+ G L + +
Sbjct: 128 VVELGTNPLKSSGIENGAFQGMKK 151
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 96.8 bits (239), Expect = 1e-22
Identities = 64/276 (23%), Positives = 112/276 (40%), Gaps = 8/276 (2%)
Query: 121 TLDLSQNQLNGSIPCSLDNLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSENRLSGL 180
T Q L ++P + + +FL+ N +S + ++L L L N L+ +
Sbjct: 15 TTSCPQQGLQ-AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARI 71
Query: 181 IPLSLSNLSSLTVMSLFNNSLSGSIPP-ILGNLKSLSTLGLHINQLNGVIPPSIGNLSSL 239
+ + L+ L + L +N+ S+ P L L TL L L + P L++L
Sbjct: 72 DAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAAL 131
Query: 240 RNLSLFNNRLYGFVPKEIGYLKSLSKLEFCANHLSGVIPHSVGNLTGLVLLNMCENHLFG 299
+ L L +N L L +L+ L N +S V + L L L + +N +
Sbjct: 132 QYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAH 191
Query: 300 PIPKSLRNLTSLERVRFNQNNLYGKVYEAFGDHPNLTFLDLSQNNFYCEISFNWRNFSKL 359
P + R+L L + NNL EA L +L L+ N + C+ ++ L
Sbjct: 192 VHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARP-LWAWL 250
Query: 360 GTFNASMNNIYGSIPPEIGDSSKLQVLDLSSNHIFG 395
F S + + S+P + + L++N + G
Sbjct: 251 QKFRGSSSEVPCSLPQRLAG---RDLKRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 95.3 bits (235), Expect = 5e-22
Identities = 65/264 (24%), Positives = 104/264 (39%), Gaps = 7/264 (2%)
Query: 13 IPPQIGNLSKLQYLDLGNNQLSGVIPPEIGKLNQLRRLYLDVNQLHGTIPPVIGQLSLIN 72
+P I Q + L N++S V L L+L N L L+L+
Sbjct: 26 VPVGIPAA--SQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLE 83
Query: 73 ELVFCHNNVSGRI-PSSLGNLSNLALLYLNDNSLFGSIPIVMGNLKSLSTLDLSQNQLNG 131
+L N + P++ L L L+L+ L P + L +L L L N L
Sbjct: 84 QLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQA 143
Query: 132 SIPCSLDNLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSENRLSGLIPLSLSNLSSL 191
+ +L NL LFL+ N +S L SL +L L +NR++ + P + +L L
Sbjct: 144 LPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRL 203
Query: 192 TVMSLFNNSLSGSIPPILGNLKSLSTLGLHINQLNGVIPPSIGNLSSLRNLSLFNNRLYG 251
+ LF N+LS L L++L L L+ N + + L+ ++ +
Sbjct: 204 MTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVC-DCRARPLWAWLQKFRGSSSEVPC 262
Query: 252 FVPKEIGYLKSLSKLEFCANHLSG 275
+P+ L AN L G
Sbjct: 263 SLPQR---LAGRDLKRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 88.3 bits (217), Expect = 9e-20
Identities = 63/275 (22%), Positives = 104/275 (37%), Gaps = 8/275 (2%)
Query: 26 LDLGNNQLSGVIPPEIGKLNQLRRLYLDVNQLHGTIPPVIGQLSLINELVFCHNNVSGRI 85
L +P I +R++L N++ + L N ++
Sbjct: 16 TSCPQQGLQ-AVPVGIPAA--SQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARID 72
Query: 86 PSSLGNLSNLALLYLNDNSLFGSI-PIVMGNLKSLSTLDLSQNQLNGSIPCSLDNLSNLD 144
++ L+ L L L+DN+ S+ P L L TL L + L P L+ L
Sbjct: 73 AAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQ 132
Query: 145 TLFLYKNSLSGPIPSVIGNLKSLLQLDLSENRLSGLIPLSLSNLSSLTVMSLFNNSLSGS 204
L+L N+L +L +L L L NR+S + + L SL + L N ++
Sbjct: 133 YLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHV 192
Query: 205 IPPILGNLKSLSTLGLHINQLNGVIPPSIGNLSSLRNLSLFNNRLYGFVPKEIGYLKSLS 264
P +L L TL L N L+ + ++ L +L+ L L +N + L
Sbjct: 193 HPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVC-DCRARPLWAWLQ 251
Query: 265 KLEFCANHLSGVIPHSVGNLTGLVLLNMCENHLFG 299
K ++ + +P L G L + N L G
Sbjct: 252 KFRGSSSEVPCSLP---QRLAGRDLKRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 85.2 bits (209), Expect = 1e-18
Identities = 55/288 (19%), Positives = 87/288 (30%), Gaps = 31/288 (10%)
Query: 253 VPKEIGYLKSLSKLEFCANHLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLRNLTSLE 312
VP I + ++ N +S V S L +L + N L + L LE
Sbjct: 26 VPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLE 83
Query: 313 RVRFNQNNLYGKVYE-AFGDHPNLTFLDLSQNNFYCEISFNWRNFSKLGTFNASMNNIYG 371
++ + N V F L L L + +R + L N +
Sbjct: 84 QLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQA 143
Query: 372 SIPPEIGDSSKLQVLDLSSNHIFGKIPVQLVKLFSLNKLILSLNQLFGGVPLEFGTLTEL 431
D L L L N I F L L
Sbjct: 144 LPDDTFRDLGNLTHLFLHGNRISSVPE------------------------RAFRGLHSL 179
Query: 432 QYLDLSANKLSSSIPMSIGNLLKLHYLNLSNNQFSHKIPTEFEKLIHLSELDLSHNILQE 491
L L N+++ P + +L +L L L N S L L L L+ N
Sbjct: 180 DRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVC 239
Query: 492 EIPPQICKMESLEKLNLSHNNLSDFIPRCFEEMRSLSWIDISYNELQG 539
+ + L+K S + + +P + + ++ N+LQG
Sbjct: 240 DCRARP-LWAWLQKFRGSSSEVPCSLP---QRLAGRDLKRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 81.0 bits (198), Expect = 3e-17
Identities = 57/253 (22%), Positives = 87/253 (34%), Gaps = 4/253 (1%)
Query: 293 CENHLFGPIPKSLRNLTSLERVRFNQNNLYGKVYEAFGDHPNLTFLDLSQNNFYCEISFN 352
C +P + + +R+ + N + +F NLT L L N +
Sbjct: 18 CPQQGLQAVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAA 75
Query: 353 WRNFSKLGTFNASMNNIYGSIPP-EIGDSSKLQVLDLSSNHIFGKIPVQLVKLFSLNKLI 411
+ + L + S N S+ P +L L L + P L +L L
Sbjct: 76 FTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLY 135
Query: 412 LSLNQLFGGVPLEFGTLTELQYLDLSANKLSSSIPMSIGNLLKLHYLNLSNNQFSHKIPT 471
L N L F L L +L L N++SS + L L L L N+ +H P
Sbjct: 136 LQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPH 195
Query: 472 EFEKLIHLSELDLSHNILQEEIPPQICKMESLEKLNLSHNNLSDFIPRCFEEMRSLSWID 531
F L L L L N L + + +L+ L L+ N R L
Sbjct: 196 AFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPW-VCDCRARPLWAWLQKFR 254
Query: 532 ISYNELQGPIPNS 544
S +E+ +P
Sbjct: 255 GSSSEVPCSLPQR 267
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 79.5 bits (194), Expect = 1e-16
Identities = 51/260 (19%), Positives = 82/260 (31%), Gaps = 6/260 (2%)
Query: 229 IPPSIGNLSSLRNLSLFNNRLYGFVPKEIGYLKSLSKLEFCANHLSGVIPHSVGNLTGLV 288
+P I ++ + + L NR+ ++L+ L +N L+ + + L L
Sbjct: 26 VPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLE 83
Query: 289 LLNMCENHLFGPI-PKSLRNLTSLERVRFNQNNLYGKVYEAFGDHPNLTFLDLSQNNFYC 347
L++ +N + P + L L + ++ L F L +L L N
Sbjct: 84 QLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQA 143
Query: 348 EISFNWRNFSKLGTFNASMNNIYGSIPPEIGDSSKLQVLDLSSNHIFGKIPVQLVKLFSL 407
+R+ L N I L L L N + P L L
Sbjct: 144 LPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRL 203
Query: 408 NKLILSLNQLFGGVPLEFGTLTELQYLDLSANKLSSSIPMSIGNLLKLHYLNLSNNQFSH 467
L L N L L LQYL L+ N L S+++
Sbjct: 204 MTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRA-RPLWAWLQKFRGSSSEVPC 262
Query: 468 KIPTEFE--KLIHLSELDLS 485
+P L L+ DL
Sbjct: 263 SLPQRLAGRDLKRLAANDLQ 282
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 69.1 bits (167), Expect = 3e-13
Identities = 41/178 (23%), Positives = 65/178 (36%), Gaps = 4/178 (2%)
Query: 2 LNLGFNLLFGNIPPQIGNLSKLQYLDLGNNQLSGVIPPEIGKLNQLRRLYLDVNQLHGTI 61
L+L L P L+ LQYL L +N L + L L L+L N++
Sbjct: 110 LHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVP 169
Query: 62 PPVIGQLSLINELVFCHNNVSGRIPSSLGNLSNLALLYLNDNSLFGSIPIVMGNLKSLST 121
L ++ L+ N V+ P + +L L LYL N+L + L++L
Sbjct: 170 ERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQY 229
Query: 122 LDLSQNQLNGSIPCSLDNLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSENRLSG 179
L L+ N + + L + + +P L L+ N L G
Sbjct: 230 LRLNDNPWVCDCR-ARPLWAWLQKFRGSSSEVPCSLPQ---RLAGRDLKRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 65.6 bits (158), Expect = 4e-12
Identities = 41/155 (26%), Positives = 56/155 (36%), Gaps = 4/155 (2%)
Query: 1 MLNLGFNLLFGNIPPQIGNLSKLQYLDLGNNQLSGVIPPEIGKLNQLRRLYLDVNQLHGT 60
L L N L +L L +L L N++S V L+ L RL L N++
Sbjct: 133 YLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHV 192
Query: 61 IPPVIGQLSLINELVFCHNNVSGRIPSSLGNLSNLALLYLNDNSLFGSIPIVMGNLKSLS 120
P L + L NN+S +L L L L LNDN L
Sbjct: 193 HPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRAR-PLWAWLQ 251
Query: 121 TLDLSQNQLNGSIPCSLDNLSNLDTLFLYKNSLSG 155
S +++ S+P L+ D L N L G
Sbjct: 252 KFRGSSSEVPCSLP---QRLAGRDLKRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 49.0 bits (115), Expect = 1e-06
Identities = 31/134 (23%), Positives = 50/134 (37%), Gaps = 3/134 (2%)
Query: 421 VPLEFGTLTELQYLDLSANKLSSSIPMSIGNLLKLHYLNLSNNQFSHKIPTEFEKLIHLS 480
VP+ + Q + L N++S S L L L +N + F L L
Sbjct: 26 VPVGIPAAS--QRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLE 83
Query: 481 ELDLSHNILQEEIPP-QICKMESLEKLNLSHNNLSDFIPRCFEEMRSLSWIDISYNELQG 539
+LDLS N + P + L L+L L + P F + +L ++ + N LQ
Sbjct: 84 QLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQA 143
Query: 540 PIPNSTAFKNGLME 553
++ L
Sbjct: 144 LPDDTFRDLGNLTH 157
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 91.7 bits (226), Expect = 1e-20
Identities = 70/265 (26%), Positives = 104/265 (39%), Gaps = 5/265 (1%)
Query: 162 GNLKSLLQLDLSENRLSGL--IPLSLSNLSSLTVMSLFNN-SLSGSIPPILGNLKSLSTL 218
+ LDLS L IP SL+NL L + + +L G IPP + L L L
Sbjct: 47 TQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYL 106
Query: 219 GLHINQLNGVIPPSIGNLSSLRNLSLFNNRLYGFVPKEIGYLKSLSKLEFCANHLSGVIP 278
+ ++G IP + + +L L N L G +P I L +L + F N +SG IP
Sbjct: 107 YITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIP 166
Query: 279 HSVGNLTGLVLLNMCENHLFGPIPKSLRNLTSLERVRFNQNNLYGKVYEAFGDHPNLTFL 338
S G+ + L + +L V ++N L G FG N T
Sbjct: 167 DSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKN-TQK 225
Query: 339 DLSQNNFYCEISFNWRNFSKLGTFNASMNNIYGSIPPEIGDSSKLQVLDLSSNHIFGKIP 398
N L + N IYG++P + L L++S N++ G+IP
Sbjct: 226 IHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP 285
Query: 399 VQLVKLFSLNKLILSLNQLFGGVPL 423
Q L + + N+ G PL
Sbjct: 286 -QGGNLQRFDVSAYANNKCLCGSPL 309
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 87.9 bits (216), Expect = 2e-19
Identities = 62/307 (20%), Positives = 102/307 (33%), Gaps = 33/307 (10%)
Query: 268 FCANHLSGVIPHSVGNLTGLVLLNMCENHLFG--PIPKSLRNLTSLERVRFNQN-NLYGK 324
C GV+ + + L++ +L PIP SL NL L + NL G
Sbjct: 33 CCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGP 92
Query: 325 VYEAFGDHPNLTFLDLSQNNFYCEISFNWRNFSKLGTFNASMNNIYGSIPPEIGDSSKLQ 384
+ A L +L ++ N I L T + S N + G++PP I L
Sbjct: 93 IPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLV 152
Query: 385 VLDLSSNHIFGKIPVQLVKLFSLNKLILSLNQLFGGVPLEFGTLTELQYLDLSANKLSSS 444
+ N I G IP L + N+L+
Sbjct: 153 GITFDGNRISGAIPDSYGSFSKLFTSMTISR-----------------------NRLTGK 189
Query: 445 IPMSIGNLLKLHYLNLSNNQFSHKIPTEFEKLIHLSELDLSHNILQEEIPPQICKMESLE 504
IP + NL N +++ + + K +
Sbjct: 190 IPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGL 249
Query: 505 KLNLSHNNLSDFIPRCFEEMRSLSWIDISYNELQGPIPNSTAFKN---GLMEGNKGLCGN 561
+L +N + +P+ +++ L +++S+N L G IP + NK LCG
Sbjct: 250 --DLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCG- 306
Query: 562 FKALPSC 568
LP+C
Sbjct: 307 -SPLPAC 312
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 84.0 bits (206), Expect = 5e-18
Identities = 63/276 (22%), Positives = 100/276 (36%), Gaps = 5/276 (1%)
Query: 226 NGVIPPSIGNLSSLRNLSLFNNRLYGF--VPKEIGYLKSLSKLEFCANH-LSGVIPHSVG 282
GV+ + + NL L L +P + L L+ L + L G IP ++
Sbjct: 39 LGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIA 98
Query: 283 NLTGLVLLNMCENHLFGPIPKSLRNLTSLERVRFNQNNLYGKVYEAFGDHPNLTFLDLSQ 342
LT L L + ++ G IP L + +L + F+ N L G + + PNL +
Sbjct: 99 KLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDG 158
Query: 343 NNFYCEISFNWRNFSKLGTFNASMNNIYGSIPPEIGDSSKLQVLDLSSNHIFGKIPVQLV 402
N I ++ +FSKL T N P + L S ++ L
Sbjct: 159 NRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAF-VDLSRNMLEGDASVLF 217
Query: 403 KLFSLNKLILSLNQLFGGVPLEFGTLTELQYLDLSANKLSSSIPMSIGNLLKLHYLNLSN 462
+ I + G L LDL N++ ++P + L LH LN+S
Sbjct: 218 GSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSF 277
Query: 463 NQFSHKIPTEFEKLIHLSELDLSHNILQEEIPPQIC 498
N +IP + L ++N P C
Sbjct: 278 NNLCGEIP-QGGNLQRFDVSAYANNKCLCGSPLPAC 312
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 83.3 bits (204), Expect = 8e-18
Identities = 74/252 (29%), Positives = 111/252 (44%), Gaps = 7/252 (2%)
Query: 2 LNLGFNLLFGN--IPPQIGNLSKLQYLDL-GNNQLSGVIPPEIGKLNQLRRLYLDVNQLH 58
L+L L IP + NL L +L + G N L G IPP I KL QL LY+ +
Sbjct: 55 LDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVS 114
Query: 59 GTIPPVIGQLSLINELVFCHNNVSGRIPSSLGNLSNLALLYLNDNSLFGSIPIVMGNLKS 118
G IP + Q+ + L F +N +SG +P S+ +L NL + + N + G+IP G+
Sbjct: 115 GAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSK 174
Query: 119 LST-LDLSQNQLNGSIPCSLDNLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSENRL 177
L T + +S+N+L G IP + NL+ + + Q
Sbjct: 175 LFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNT--QKIHLAKNS 232
Query: 178 SGLIPLSLSNLSSLTVMSLFNNSLSGSIPPILGNLKSLSTLGLHINQLNGVIPPSIGNLS 237
+ +L + L NN + G++P L LK L +L + N L G I P GNL
Sbjct: 233 LAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEI-PQGGNLQ 291
Query: 238 SLRNLSLFNNRL 249
+ NN+
Sbjct: 292 RFDVSAYANNKC 303
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 71.3 bits (173), Expect = 7e-14
Identities = 67/276 (24%), Positives = 115/276 (41%), Gaps = 7/276 (2%)
Query: 76 FCHNNVSGRIPSSLGNLSNLALLYLNDNSLFGSIPI--VMGNLKSLSTLDLSQN-QLNGS 132
C+ G + + + L L+ +L PI + NL L+ L + L G
Sbjct: 33 CCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGP 92
Query: 133 IPCSLDNLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSENRLSGLIPLSLSNLSSLT 192
IP ++ L+ L L++ ++SG IP + +K+L+ LD S N LSG +P S+S+L +L
Sbjct: 93 IPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLV 152
Query: 193 VMSLFNNSLSGSIPPILGNLKSLSTLGLHI-NQLNGVIPPSIGNLSSLRNLSLFNNRLYG 251
++ N +SG+IP G+ L T N+L G IPP+ NL+ N
Sbjct: 153 GITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGD 212
Query: 252 FVPKEIGYLKSLSKLEFCANHLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLRNLTSL 311
+ + + + + L N ++G +P+ L L L
Sbjct: 213 ASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLR--NNRIYGTLPQGLTQLKFL 270
Query: 312 ERVRFNQNNLYGKVYEAFGDHPNLTFLDLSQNNFYC 347
+ + NNL G++ + G+ + N C
Sbjct: 271 HSLNVSFNNLCGEIPQ-GGNLQRFDVSAYANNKCLC 305
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 68.6 bits (166), Expect = 6e-13
Identities = 76/289 (26%), Positives = 113/289 (39%), Gaps = 27/289 (9%)
Query: 35 GVIPPEIGKLNQLRRLYLDVNQLHGTIPPVIGQLSLINELVFCHNNVSGRIPSSLGNLSN 94
GV+ + ++ L L L P IPSSL NL
Sbjct: 40 GVLCDTDTQTYRVNNLDLSGLNLPKPYP----------------------IPSSLANLPY 77
Query: 95 LALLYLNDN-SLFGSIPIVMGNLKSLSTLDLSQNQLNGSIPCSLDNLSNLDTLFLYKNSL 153
L LY+ +L G IP + L L L ++ ++G+IP L + L TL N+L
Sbjct: 78 LNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNAL 137
Query: 154 SGPIPSVIGNLKSLLQLDLSENRLSGLIPLSLSNLSSLTV-MSLFNNSLSGSIPPILGNL 212
SG +P I +L +L+ + NR+SG IP S + S L M++ N L+G IPP NL
Sbjct: 138 SGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANL 197
Query: 213 KSLSTLGLHINQLNGVIPPSIGNLSSLRNLSLFNNRLYGFVPKEIGYLKSLSKLEFCANH 272
+ F ++G K+L+ L+ N
Sbjct: 198 NLAFVDLSRNMLEGDASVLFGSD--KNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNR 255
Query: 273 LSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLRNLTSLERVRFNQNNL 321
+ G +P + L L LN+ N+L G IP NL + + N
Sbjct: 256 IYGTLPQGLTQLKFLHSLNVSFNNLCGEIP-QGGNLQRFDVSAYANNKC 303
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 58.2 bits (139), Expect = 1e-09
Identities = 16/60 (26%), Positives = 26/60 (43%), Gaps = 1/60 (1%)
Query: 3 NLGFNLLFGNIPPQIGNLSKLQYLDLGNNQLSGVIPPEIGKLNQLRRLYLDVNQLHGTIP 62
+L N ++G +P + L L L++ N L G I P+ G L + N+ P
Sbjct: 250 DLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEI-PQGGNLQRFDVSAYANNKCLCGSP 308
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 53.6 bits (127), Expect = 5e-08
Identities = 36/160 (22%), Positives = 58/160 (36%), Gaps = 3/160 (1%)
Query: 426 GTLTELQYLDLSANKLSS--SIPMSIGNLLKLHYLNLSNN-QFSHKIPTEFEKLIHLSEL 482
+ LDLS L IP S+ NL L++L + IP KL L L
Sbjct: 47 TQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYL 106
Query: 483 DLSHNILQEEIPPQICKMESLEKLNLSHNNLSDFIPRCFEEMRSLSWIDISYNELQGPIP 542
++H + IP + ++++L L+ S+N LS +P + +L I N + G IP
Sbjct: 107 YITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIP 166
Query: 543 NSTAFKNGLMEGNKGLCGNFKALPSCDAFTSHKQTFRKKW 582
+S + L +
Sbjct: 167 DSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSR 206
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 90.1 bits (222), Expect = 7e-20
Identities = 50/273 (18%), Positives = 92/273 (33%), Gaps = 30/273 (10%)
Query: 654 IGKGGQRSVYKAE-LPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIK-- 710
+G G +V+ A+ + + A+K + + E +E+ L + + K
Sbjct: 21 LGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTE-----AAEDEIKLLQRVNDADNTKED 75
Query: 711 -------------FHGFCSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKG 757
F+ N H +V E L L I + + + + K
Sbjct: 76 SMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEH--RGIPLIYVKQISKQ 133
Query: 758 VANALSYLHHDCIPPIVHRDISSKNVLLDSE-YEAHVSDFGFAKFLEPHSS--NWTEFAG 814
+ L Y+H C I+H DI +NVL++ ++ A ++T
Sbjct: 134 LLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQ 191
Query: 815 TVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILD 874
T Y +PE+ D++S L E+I G F S + + QI++
Sbjct: 192 TREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFL--FEPDEGHSYTKDDDHIAQIIE 249
Query: 875 HRLPTPSRDVTDKLRSIMEVAILCLVENPEARP 907
PS + + + L+ N
Sbjct: 250 LLGELPSYLLRNGKYTRTFFNSRGLLRNISKLK 282
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 81.4 bits (200), Expect = 3e-18
Identities = 30/175 (17%), Positives = 51/175 (29%), Gaps = 27/175 (15%)
Query: 654 IGKGGQRSVYKAELPSGNIFAVKKFKAELFSDETANPS------EFLNEVLALTEIRHRN 707
+G+G + +V+ VK K S + F + R
Sbjct: 8 MGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRA 67
Query: 708 IIKFHGFCSNAQHSFIVCEYLA-RGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLH 766
+ K G + Y ++ L D V+ + ++ +
Sbjct: 68 LQKLQGLA-------VPKVYAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFY 120
Query: 767 HDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAK---------FLEPHSSNWTEF 812
H IVH D+S NVL+ E + DF + LE N +
Sbjct: 121 HRG---IVHGDLSQYNVLVS-EEGIWIIDFPQSVEVGEEGWREILERDVRNIITY 171
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 69.0 bits (167), Expect = 2e-13
Identities = 52/219 (23%), Positives = 85/219 (38%), Gaps = 7/219 (3%)
Query: 135 CSLDNLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSENRLSGLIPLSLSNLSSLTVM 194
C + +++ + K +L+ +P + K L LSEN L +L + LT +
Sbjct: 4 CEVSKVASHLEVNCDKRNLTA-LPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQL 60
Query: 195 SLFNNSLSGSIPPILGNLKSLSTLGLHINQLNGVIPPSIGNLSSLRNLSLFNNRLYGFVP 254
+L L+ L L TL L NQ +P L +L L + NRL
Sbjct: 61 NLDRAELTKLQVDG--TLPVLGTLDLSHNQ-LQSLPLLGQTLPALTVLDVSFNRLTSLPL 117
Query: 255 KEIGYLKSLSKLEFCANHLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLRNLTSLERV 314
+ L L +L N L + P + L L++ N+L L L +L+ +
Sbjct: 118 GALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTL 177
Query: 315 RFNQNNLYGKVYEAFGDHPNLTFLDLSQNNFYCEISFNW 353
+N+LY + + F L F L N + C +
Sbjct: 178 LLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLCNCEILY 215
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 65.1 bits (157), Expect = 5e-12
Identities = 46/208 (22%), Positives = 73/208 (35%), Gaps = 7/208 (3%)
Query: 184 SLSNLSSLTVMSLFNNSLSGSIPPILGNLKSLSTLGLHINQLNGVIPPSIGNLSSLRNLS 243
+S ++S ++ +L+ ++PP L K + L L N L ++ + L L+
Sbjct: 5 EVSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLN 61
Query: 244 LFNNRLYGFVPKEIGYLKSLSKLEFCANHLSGVIPHSVGNLTGLVLLNMCENHLFGPIPK 303
L L L L L+ N L + L +L++ N L
Sbjct: 62 LDRAELTKLQVDG--TLPVLGTLDLSHNQLQSLPLLGQTL-PALTVLDVSFNRLTSLPLG 118
Query: 304 SLRNLTSLERVRFNQNNLYGKVYEAFGDHPNLTFLDLSQNNFYCEISFNWRNFSKLGTFN 363
+LR L L+ + N L P L L L+ NN + L T
Sbjct: 119 ALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLL 178
Query: 364 ASMNNIYGSIPPEIGDSSKLQVLDLSSN 391
N++Y +IP S L L N
Sbjct: 179 LQENSLY-TIPKGFFGSHLLPFAFLHGN 205
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 59.7 bits (143), Expect = 3e-10
Identities = 43/189 (22%), Positives = 65/189 (34%), Gaps = 6/189 (3%)
Query: 13 IPPQIGNLSKLQYLDLGNNQLSGVIPPEIGKLNQLRRLYLDVNQLHGTIPPVIGQLSLIN 72
+PP + L L N L + +L +L LD +L +
Sbjct: 25 LPPDLPKD--TTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVDGTLPV---L 79
Query: 73 ELVFCHNNVSGRIPSSLGNLSNLALLYLNDNSLFGSIPIVMGNLKSLSTLDLSQNQLNGS 132
+ +N +P L L +L ++ N L + L L L L N+L
Sbjct: 80 GTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTL 139
Query: 133 IPCSLDNLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSENRLSGLIPLSLSNLSSLT 192
P L L+ L L N+L+ ++ L++L L L EN L IP L
Sbjct: 140 PPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLYT-IPKGFFGSHLLP 198
Query: 193 VMSLFNNSL 201
L N
Sbjct: 199 FAFLHGNPW 207
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 53.6 bits (127), Expect = 4e-08
Identities = 42/213 (19%), Positives = 74/213 (34%), Gaps = 29/213 (13%)
Query: 347 CEISFNWRNFSKLGTFNASMNNIYGSIPPEIGDSSKLQVLDLSSNHIFGKIPVQLVKLFS 406
CE+S + N N+ ++PP++ +L LS N ++ L+
Sbjct: 4 CEVS----KVASHLEVNCDKRNLT-ALPPDLPKD--TTILHLSENLLYTFSLATLMPYTR 56
Query: 407 LNKLILSLNQLFGGVPLEFGTLTELQYLDLSAN---------------------KLSSSI 445
L +L L +L + L + +L+S
Sbjct: 57 LTQLNLDRAELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLP 116
Query: 446 PMSIGNLLKLHYLNLSNNQFSHKIPTEFEKLIHLSELDLSHNILQEEIPPQICKMESLEK 505
++ L +L L L N+ P L +L L++N L E + +E+L+
Sbjct: 117 LGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDT 176
Query: 506 LNLSHNNLSDFIPRCFEEMRSLSWIDISYNELQ 538
L L N+L IP+ F L + + N
Sbjct: 177 LLLQENSLYT-IPKGFFGSHLLPFAFLHGNPWL 208
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 52.4 bits (124), Expect = 8e-08
Identities = 44/176 (25%), Positives = 67/176 (38%), Gaps = 4/176 (2%)
Query: 2 LNLGFNLLFGNIPPQIGNLSKLQYLDLGNNQLSGVIPPEIGKLNQLRRLYLDVNQLHGTI 61
L+L NLL+ + ++L L+L +L+ + + L + ++
Sbjct: 36 LHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVDGTLPVLGTLDLS---HNQLQSL 92
Query: 62 PPVIGQLSLINELVFCHNNVSGRIPSSLGNLSNLALLYLNDNSLFGSIPIVMGNLKSLST 121
P + L + L N ++ +L L L LYL N L P ++ L
Sbjct: 93 PLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEK 152
Query: 122 LDLSQNQLNGSIPCSLDNLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSENRL 177
L L+ N L L+ L NLDTL L +NSL IP L L N
Sbjct: 153 LSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPW 207
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.5 bits (93), Expect = 6e-04
Identities = 23/158 (14%), Positives = 51/158 (32%), Gaps = 5/158 (3%)
Query: 421 VPLEFGTLTELQYLDLSANKLSSSIPMSIGNLLKLHYLNLSNNQFSHKIPTEFEKLIHLS 480
+P + + L LS N L + ++ +L LNL + + ++
Sbjct: 25 LPPDLPK--DTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVDGTLPVLGTL 82
Query: 481 ELDLSHNILQEEIPPQICKMESLEKLNLSHNNLSDFIPRCFEEMRSLSWIDISYNELQGP 540
+ + + +P + +L L++S N L+ + L + + NEL+
Sbjct: 83 D---LSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTL 139
Query: 541 IPNSTAFKNGLMEGNKGLCGNFKALPSCDAFTSHKQTF 578
P L + + + + T
Sbjct: 140 PPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTL 177
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.7 bits (91), Expect = 9e-04
Identities = 13/53 (24%), Positives = 16/53 (30%), Gaps = 1/53 (1%)
Query: 6 FNLLFGNIPPQIGNLSKLQYLDLGNNQLSGVIPPEIGKLNQLRRLYLDVNQLH 58
N L + L L L L N L IP + L +L N
Sbjct: 157 NNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWL 208
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 67.9 bits (164), Expect = 1e-12
Identities = 54/343 (15%), Positives = 94/343 (27%), Gaps = 28/343 (8%)
Query: 165 KSLLQLDLSENRLSGLIPLSLSNLSSLTVMSLFNNSLSGSIPPILGNLKSLSTLGLHINQ 224
+ +L+L+ LS L P +L SL NSL+ +P + +LKSL ++
Sbjct: 38 RQAHELELNNLGLSSL-PELPPHLESL---VASCNSLT-ELPELPQSLKSLLVDNNNLKA 92
Query: 225 LNGVIPPSIGNLSSLRNLSLFNNRLYGFVPKEIGYLKSLSKLEFCANHLSGVIPHSVGNL 284
L+ + P L S K+ N+ +P +L
Sbjct: 93 LSDLPP----------LLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKKLPDLPPSL 142
Query: 285 TGLVLLNMCENHLFGPIPKSLRNLTSLERVRFNQNNLYGKVYEAFGDHPNLTFLDLSQNN 344
+ N L + N + + +
Sbjct: 143 EFIAAGNNQLEELPELQN---LPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPE 199
Query: 345 FYCEISFNWRNFSKLGTFNASMNNIYGSIPPEIGDSSKLQVLDLSSNHIFGKIPVQLVKL 404
+ S L
Sbjct: 200 LQNLPFLTTIYADNNLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGL 259
Query: 405 FSLNKLILSLNQLFGGVPLEFGTLTELQYLDLSANKLSSSIPMSIGNLLKLHYLNLSNNQ 464
L + LN + L+ L++S NKL +P L L S N
Sbjct: 260 SELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKL-IELPALPPR---LERLIASFNH 315
Query: 465 FSHKIPTEFEKLIHLSELDLSHNILQEEIPPQICKMESLEKLN 507
+ +P + +L +L + +N L+ E P +E L ++N
Sbjct: 316 LAE-VPELPQ---NLKQLHVEYNPLR-EFPDIPESVEDL-RMN 352
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 57.5 bits (137), Expect = 3e-09
Identities = 56/338 (16%), Positives = 106/338 (31%), Gaps = 28/338 (8%)
Query: 117 KSLSTLDLSQNQLNGSIPCSLDNLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSENR 176
+ L+L+ L+ S+P + +L++L NSL+ +P + +LK L + N
Sbjct: 38 RQAHELELNNLGLS-SLP---ELPPHLESLVASCNSLT-ELPELPQSLK---SLLVDNNN 89
Query: 177 LSGLIPLSLSNLSSLTVMSLFNNSLSGSIPPILGNLKSLSTLGLHINQLNGVIPPSIGNL 236
L L L L + S+ I+ N +
Sbjct: 90 LKALSDL----------PPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKKLPDLP 139
Query: 237 SSLRNLSLFNNRLYGFVPKEIGYLKSLSKLEFCANHLSGVIPHSVGNLTGLVLLNMCENH 296
SL ++ NN+L + + + + +P S+ ++ +
Sbjct: 140 PSLEFIAAGNNQLEELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPE 199
Query: 297 LFGPIPKSLRNLTSLERVRFNQNNLYGKVYEAFGDHPNLTFLDLSQNNFYCEISFNWRNF 356
L + + + ++ F +
Sbjct: 200 LQNLPFLTTIYADNNLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGL 259
Query: 357 SKLGTFNASMNNIYGSIPPEIGDSSKLQVLDLSSNHIFGKIPVQLVKLFSLNKLILSLNQ 416
S+L +N I L+ L++S+N + ++P L +LI S N
Sbjct: 260 SELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKL-IELPAL---PPRLERLIASFNH 315
Query: 417 LFGGVPLEFGTLTELQYLDLSANKLSS--SIPMSIGNL 452
L VP L+ L + N L IP S+ +L
Sbjct: 316 L-AEVP---ELPQNLKQLHVEYNPLREFPDIPESVEDL 349
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 54.4 bits (129), Expect = 3e-08
Identities = 24/92 (26%), Positives = 36/92 (39%), Gaps = 10/92 (10%)
Query: 99 YLNDNSLFGSIPIVMGNLKSLSTLDLSQNQLNGSIPCSLDNLSNLDTLFLYKNSLSGPIP 158
N+ I + SL L++S N+L +P L L N L+ +P
Sbjct: 266 LYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLERLI---ASFNHLAE-VP 320
Query: 159 SVIGNLKSLLQLDLSENRLSGL--IPLSLSNL 188
+ NLK L + N L IP S+ +L
Sbjct: 321 ELPQNLKQL---HVEYNPLREFPDIPESVEDL 349
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 49.8 bits (117), Expect = 7e-07
Identities = 24/89 (26%), Positives = 43/89 (48%), Gaps = 9/89 (10%)
Query: 456 HYLNLSNNQFSHKIPTEFEKLIHLSELDLSHNILQEEIPPQICKMESLEKLNLSHNNLSD 515
N S++I + + L EL++S+N L E+P LE+L S N+L++
Sbjct: 263 PPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKL-IELPALPP---RLERLIASFNHLAE 318
Query: 516 FIPRCFEEMRSLSWIDISYNELQGPIPNS 544
+P E ++L + + YN L+ P+
Sbjct: 319 -VP---ELPQNLKQLHVEYNPLRE-FPDI 342
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 48.7 bits (114), Expect = 2e-06
Identities = 19/95 (20%), Positives = 33/95 (34%), Gaps = 9/95 (9%)
Query: 1 MLNLGFNLLFGNIPPQIGNLSKLQYLDLGNNQLSGVIPPEIGKLNQLRRLYLDVNQLHGT 60
N I L+ L++ NN+L +P + L RL N L
Sbjct: 264 PNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLIE-LPALPPR---LERLIASFNHL-AE 318
Query: 61 IPPVIGQLSLINELVFCHNNVSGRIPSSLGNLSNL 95
+P + L +L +N + P ++ +L
Sbjct: 319 VPELPQNLK---QLHVEYNPLRE-FPDIPESVEDL 349
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 47.5 bits (111), Expect = 4e-06
Identities = 19/93 (20%), Positives = 34/93 (36%), Gaps = 9/93 (9%)
Query: 51 YLDVNQLHGTIPPVIGQLSLINELVFCHNNVSGRIPSSLGNLSNLALLYLNDNSLFGSIP 110
+N I + + EL +N + +P+ L L + N L +P
Sbjct: 266 LYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLER---LIASFNHL-AEVP 320
Query: 111 IVMGNLKSLSTLDLSQNQLNGSIPCSLDNLSNL 143
+ NLK L + N L P +++ +L
Sbjct: 321 ELPQNLK---QLHVEYNPLR-EFPDIPESVEDL 349
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 42.1 bits (97), Expect = 2e-04
Identities = 60/345 (17%), Positives = 101/345 (29%), Gaps = 37/345 (10%)
Query: 93 SNLALLYLNDNSLFGSIPIVMGNLKSLSTLDLSQNQLNGSIPCSLDNLSNLDTLFLYKNS 152
L LN+ L S+P + +L+SL S N L +P +L +L +
Sbjct: 38 RQAHELELNNLGL-SSLPELPPHLESL---VASCNSLT-ELPELPQSLKSLLVDNNNLKA 92
Query: 153 LSGPIPSVIGNLKSLLQLDLSENRLSGLIPLSLSNLSSLTVMSLFNNSLSGSIPPILGNL 212
LS P + S QL+ N S L ++ + NNSL
Sbjct: 93 LSDLPPLLEYLGVSNNQLEKLPEL---------QNSSFLKIIDVDNNSLKKLPDLPPSL- 142
Query: 213 KSLSTLGLHINQLNGVIPPSIGNLSSLRNLSLFNNRLYGFVPKEIGYLKSLSKLEFCANH 272
+ L +L L+ L S +
Sbjct: 143 --------EFIAAGNNQLEELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNIL 194
Query: 273 LSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLRNLTSLERVRFNQNNLYGKVYEAFGDH 332
++ LT + N L P + + ++
Sbjct: 195 EELPELQNLPFLTTIYADNNLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSEN 254
Query: 333 PNLTFLDLSQNNFYCEISFNW-----RNFSKLGTFNASMNNIYGSIPPEIGDSSKLQVLD 387
+L N +Y S N L N S N + +P +L+ L
Sbjct: 255 IFSGLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKL-IELPALPP---RLERLI 310
Query: 388 LSSNHIFGKIPVQLVKLFSLNKLILSLNQLFGGVPLEFGTLTELQ 432
S NH+ ++P +L +L + N L P ++ +L+
Sbjct: 311 ASFNHL-AEVPEL---PQNLKQLHVEYNPL-REFPDIPESVEDLR 350
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 38.3 bits (87), Expect = 0.004
Identities = 23/76 (30%), Positives = 31/76 (40%), Gaps = 5/76 (6%)
Query: 454 KLHYLNLSNNQFSHKIPTEFEKLIHLSELDLSHNILQEEIPPQICKMESLEKLNLSHNNL 513
+ H L L+N S +P E HL L S N L E+P ++SL N + L
Sbjct: 39 QAHELELNNLGLS-SLP---ELPPHLESLVASCNSL-TELPELPQSLKSLLVDNNNLKAL 93
Query: 514 SDFIPRCFEEMRSLSW 529
SD P S +
Sbjct: 94 SDLPPLLEYLGVSNNQ 109
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 62.4 bits (150), Expect = 4e-11
Identities = 38/253 (15%), Positives = 82/253 (32%), Gaps = 17/253 (6%)
Query: 7 NLLFGNIPPQIGNLSKLQYLDLGNNQLSGVIPPEI-GKLNQLRRLYLDVNQLHGTIPPVI 65
+ + ++Q++DL N+ + I + ++L+ L L+ +L I +
Sbjct: 32 RSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTL 91
Query: 66 GQLSLINELVFCHNNVSGRIPSSLGNLSNLALLYLNDNSLFGSIPIVMGNLKSLSTLDLS 125
+ S + L + S L LN + F + + + ++
Sbjct: 92 AKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETIT 151
Query: 126 QNQLNG---------SIPCSLDNLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSE-N 175
Q L+G + + L L L L LS
Sbjct: 152 QLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCY 211
Query: 176 RLSGLIPLSLSNLSSLTVMSLFNNSLSGSIPPILGNLKSLSTLGLHINQLNGVIPPSIGN 235
+ L L + +L + +F G++ + L L ++ + + P+IGN
Sbjct: 212 DIIPETLLELGEIPTLKTLQVFGIVPDGTLQLLKEALPHLQ---INCSHFTTIARPTIGN 268
Query: 236 LSSLRNLSLFNNR 248
+N ++ +
Sbjct: 269 ---KKNQEIWGIK 278
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 57.0 bits (136), Expect = 2e-09
Identities = 35/162 (21%), Positives = 62/162 (38%), Gaps = 5/162 (3%)
Query: 384 QVLDLSSNHIFGKIPVQLVKLFSLNKLILSLNQLFGGVPL-EFGTLTELQYLDLSANKLS 442
Q LDL+ ++ + +L+ S + + F PL E + +Q++DLS + +
Sbjct: 3 QTLDLTGKNLHPDVTGRLL---SQGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIE 59
Query: 443 -SSIPMSIGNLLKLHYLNLSNNQFSHKIPTEFEKLIHLSELDLSHNILQEEIPPQICKME 501
S++ + KL L+L + S I K +L L+LS E Q
Sbjct: 60 VSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSS 119
Query: 502 SLEKLNLSHNNLSDFIPRCFEEMRSLSWIDISYNELQGPIPN 543
L+ + DF + + + I+ L G N
Sbjct: 120 CSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKN 161
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 55.1 bits (131), Expect = 1e-08
Identities = 40/271 (14%), Positives = 86/271 (31%), Gaps = 16/271 (5%)
Query: 24 QYLDLGNNQLSGVIPPEIGKLNQLRRLYLDVNQLHGTIPPVIGQLSLINELVFCHNNVSG 83
Q LDL L + + + + + + + + ++ +
Sbjct: 3 QTLDLTGKNLHPDVTGRLLSQG-VIAFRCPRSFMDQPLAEHFSPFRV-QHMDLSNSVIEV 60
Query: 84 R-IPSSLGNLSNLALLYLNDNSLFGSIPIVMGNLKSLSTLDLSQNQL-----NGSIPCSL 137
+ L S L L L L I + +L L+LS ++ S
Sbjct: 61 STLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSC 120
Query: 138 DNLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSENRLSGLIPLSLSNLSSLTVMSLF 197
L L+ + + + +V +++ QL+LS R + + + +
Sbjct: 121 SRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHL 180
Query: 198 NNSL----SGSIPPILGNLKSLSTLGL-HINQLNGVIPPSIGNLSSLRNLSLFNNRLYGF 252
+ S L L L L + +G + +L+ L +F G
Sbjct: 181 DLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGT 240
Query: 253 VPKEIGYLKSLSKLEFCANHLSGVIPHSVGN 283
+ ++L L+ +H + + ++GN
Sbjct: 241 LQLLK---EALPHLQINCSHFTTIARPTIGN 268
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 54.7 bits (130), Expect = 2e-08
Identities = 43/305 (14%), Positives = 87/305 (28%), Gaps = 50/305 (16%)
Query: 170 LDLSENRLSGLIPLSLSNLSSLTVMSLFNNSLSGSIPPILGNLKSLSTLGLHINQLNGVI 229
LDL+ L + L + + + + + + + + L + +
Sbjct: 5 LDLTGKNLHPDVTGRLLSQG-VIAFRCPRSFMDQPLAEHFSPFR-VQHMDLSNSVIEVST 62
Query: 230 PPSI-GNLSSLRNLSLFNNRLYGFVPKEIGYLKSLSKLEF--CANHLSGVIPHSVGNLTG 286
I S L+NLSL RL + + +L +L C+ + + + +
Sbjct: 63 LHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSR 122
Query: 287 LVLLNMCENHLFGPIPKSLRNLTSLERVRFNQNNLYGKVYEAFGDHPNLTFLDLSQNNFY 346
L LN+ F + ++ V L +N
Sbjct: 123 LDELNLSWCF------------------DFTEKHVQVAVAHVSETITQLNLSGYRKNLQK 164
Query: 347 CEISFNWRNFSKLGTFNASMN-NIYGSIPPEIGDSSKLQVLDLSSNHIFGKIPVQLVKLF 405
++S R L + S + + E + LQ L LS
Sbjct: 165 SDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRC-------------- 210
Query: 406 SLNKLILSLNQLFGGVPLEFGTLTELQYLDLSANKLSSSIPMSIGNLLKLHYLNLSNNQF 465
+ LE G + L+ L + ++ + L L ++ + F
Sbjct: 211 ---------YDIIPETLLELGEIPTLKTLQVFGIVPDGTLQLLKEALPH---LQINCSHF 258
Query: 466 SHKIP 470
+
Sbjct: 259 TTIAR 263
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 48.2 bits (113), Expect = 2e-06
Identities = 39/270 (14%), Positives = 85/270 (31%), Gaps = 16/270 (5%)
Query: 290 LNMCENHLFGPIPKSLRNLTSLERVRFNQNNLYGKVYEAFGDHPNLTFLDLSQNNFYCE- 348
L++ +L + L + + R ++ + + E F + +DLS +
Sbjct: 5 LDLTGKNLHPDVTGRLLSQ-GVIAFRCPRSFMDQPLAEHFS-PFRVQHMDLSNSVIEVST 62
Query: 349 ISFNWRNFSKLGTFNASMNNIYGSIPPEIGDSSKLQVLDLSSNHIFGKIPVQ-----LVK 403
+ SKL + + I + +S L L+LS F + +Q +
Sbjct: 63 LHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSR 122
Query: 404 LFSLNKLILSLNQLFGGVPLEFGTLTELQYLDLSANKLSSSIPMSIGNLLKLHYLNLSNN 463
L LN + L+LS + + + + L +
Sbjct: 123 LDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDL 182
Query: 464 QFSHKIPTEFEKLI----HLSELDLSH-NILQEEIPPQICKMESLEKLNLSHNNLSDFIP 518
S + + + +L L LS + E ++ ++ +L+ L + +
Sbjct: 183 SDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQ 242
Query: 519 RCFEEMRSLSWIDISYNELQGPIPNSTAFK 548
E + L I+ + + K
Sbjct: 243 LLKEALPHL---QINCSHFTTIARPTIGNK 269
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 62.7 bits (150), Expect = 1e-10
Identities = 55/451 (12%), Positives = 110/451 (24%), Gaps = 22/451 (4%)
Query: 94 NLALLYLNDNSL-FGSIPIVMGNLKSLSTLDLSQNQLNG----SIPCSLDNLSNLDTLFL 148
++ L + L ++ L+ + L L I +L L L L
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 149 YKNSLSGPIPSVIG-----NLKSLLQLDLSENRLSGLIPLSLSNLSSLTVMSLFNNSLSG 203
N L + + +L L L+G LS+ +
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDN 122
Query: 204 SIPPILGNLKSLSTLGLHINQLNGVIPPSIGNLSSLRNLSLFNNRLYGFVPKEIGYLKSL 263
+ L L + + +S L+ F +
Sbjct: 123 LLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDIN 182
Query: 264 SKLEFCANHLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLRNLTSLERVRFNQNNLYG 323
P + L +N + + + N+ G
Sbjct: 183 EAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVG 242
Query: 324 KVYEAFGDHPNLTFLDLSQNNFYCEISFNWRNFSKLGTFNASMNNIYGSIPPEIGDSSKL 383
G + L + + ++ S+ + + + ++L
Sbjct: 243 MAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARL 302
Query: 384 QVLDLSSNHIFGKIPVQLVKLFSLNKLILSLNQLFGGVPLEFGTLTELQYLDLSANKLSS 443
L + F+ + L L ++ + D
Sbjct: 303 LCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVR---E 359
Query: 444 SIPMSIGNLLKLHYLNLSNNQFSHK----IPTEFEKLIHLSELDLSHNILQEEIPPQICK 499
L L L++ S + L ELDLS+N L + Q+ +
Sbjct: 360 LCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVE 419
Query: 500 -----MESLEKLNLSHNNLSDFIPRCFEEMR 525
LE+L L S+ + + +
Sbjct: 420 SVRQPGCLLEQLVLYDIYWSEEMEDRLQALE 450
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 59.6 bits (142), Expect = 1e-09
Identities = 19/116 (16%), Positives = 41/116 (35%), Gaps = 10/116 (8%)
Query: 430 ELQYLDLSANKLSSSIPMSIGNLLK-LHYLNLSNNQFSHK----IPTEFEKLIHLSELDL 484
++Q LD+ +LS + + LL+ + L + + I + L+EL+L
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 485 SHNILQEEIPPQICKM-----ESLEKLNLSHNNLSDFIPRCFEEMRSLSWIDISYN 535
N L + + + ++KL+L + L+ +
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELH 118
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 50.4 bits (118), Expect = 7e-07
Identities = 21/93 (22%), Positives = 34/93 (36%), Gaps = 15/93 (16%)
Query: 431 LQYLDLSANKLSSSIPMSIGNLLK----LHYLNLSNNQFSHKIPTEFEKLI-----HLSE 481
L+ L L+ +S S S+ L L L+LSNN + + + L +
Sbjct: 371 LRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQ 430
Query: 482 LDLSHNILQEEIPPQICKMESLEKLNLSHNNLS 514
L L EE+ + L+ L +L
Sbjct: 431 LVLYDIYWSEEME------DRLQALEKDKPSLR 457
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 50.0 bits (117), Expect = 9e-07
Identities = 26/213 (12%), Positives = 54/213 (25%), Gaps = 10/213 (4%)
Query: 380 SSKLQVLDLSSNHIFGKIPVQLVKLF-SLNKLILSLNQL----FGGVPLEFGTLTELQYL 434
S +Q LD+ + +L+ L + L L + L L
Sbjct: 1 SLDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAEL 60
Query: 435 DLSANKLSSSIPMSIGNLL-----KLHYLNLSNNQFSHKIPTEFEKLIHLSELDLSHNIL 489
+L +N+L + L K+ L+L N + + ++
Sbjct: 61 NLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLS 120
Query: 490 QEEIPPQICKMESLEKLNLSHNNLSDFIPRCFEEMRSLSWIDISYNELQGPIPNSTAFKN 549
+ ++ L+ + C S + + + +
Sbjct: 121 DNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNND 180
Query: 550 GLMEGNKGLCGNFKALPSCDAFTSHKQTFRKKW 582
G + LC K P +
Sbjct: 181 INEAGVRVLCQGLKDSPCQLEALKLESCGVTSD 213
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.1 bits (107), Expect = 2e-05
Identities = 22/99 (22%), Positives = 32/99 (32%), Gaps = 9/99 (9%)
Query: 76 FCHNNVSGRIPSSLGNLSNLALLYLNDNSL----FGSIPIVMGNLKSLSTLDLSQNQLNG 131
V S L +L+L D + S+ + SL LDLS N L
Sbjct: 352 LEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGD 411
Query: 132 SIPCSL-----DNLSNLDTLFLYKNSLSGPIPSVIGNLK 165
+ L L+ L LY S + + L+
Sbjct: 412 AGILQLVESVRQPGCLLEQLVLYDIYWSEEMEDRLQALE 450
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.4 bits (100), Expect = 9e-05
Identities = 20/94 (21%), Positives = 32/94 (34%), Gaps = 13/94 (13%)
Query: 163 NLKSLLQLDLSENRLSGL----IPLSLSNLSSLTVMSLFNNSLSGSIPPILG-----NLK 213
L L L++ +S + +L SL + L NN L + L
Sbjct: 367 PGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGC 426
Query: 214 SLSTLGLHINQLNGVIPPSIGNLS----SLRNLS 243
L L L+ + + + L SLR +S
Sbjct: 427 LLEQLVLYDIYWSEEMEDRLQALEKDKPSLRVIS 460
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.0 bits (99), Expect = 1e-04
Identities = 21/96 (21%), Positives = 31/96 (32%), Gaps = 13/96 (13%)
Query: 113 MGNLKSLSTLDLSQNQLNG----SIPCSLDNLSNLDTLFLYKNSLSGPIPSVIG-----N 163
L L L+ ++ S+ +L +L L L N L +
Sbjct: 365 GQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQP 424
Query: 164 LKSLLQLDLSENRLSGLIPLSLSNLS----SLTVMS 195
L QL L + S + L L SL V+S
Sbjct: 425 GCLLEQLVLYDIYWSEEMEDRLQALEKDKPSLRVIS 460
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.7 bits (98), Expect = 2e-04
Identities = 18/90 (20%), Positives = 30/90 (33%), Gaps = 5/90 (5%)
Query: 71 INELVFCHNNVS-GRIPSSLGNLSNLALLYLNDNSL----FGSIPIVMGNLKSLSTLDLS 125
I L +S R L L ++ L+D L I + +L+ L+L
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 126 QNQLNGSIPCSLDNLSNLDTLFLYKNSLSG 155
N+L + + + K SL
Sbjct: 64 SNELGDVGVHCVLQGLQTPSCKIQKLSLQN 93
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.7 bits (98), Expect = 2e-04
Identities = 18/116 (15%), Positives = 33/116 (28%), Gaps = 23/116 (19%)
Query: 345 FYCEISFNWRNFSKLGTFNASMNNI----YGSIPPEIGDSSKLQVLDLSSNHIFGKIPVQ 400
+ S L + ++ S+ + + L+ LDLS+N + +Q
Sbjct: 357 VRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQ 416
Query: 401 LVKLFSLNKLILSLNQLFGGVPLEFGTLTELQYLDLSANKLSSSIPMSIGNLLKLH 456
LV+ L+ L L S + + L K
Sbjct: 417 LVESVRQPG-------------------CLLEQLVLYDIYWSEEMEDRLQALEKDK 453
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.8 bits (88), Expect = 0.003
Identities = 22/112 (19%), Positives = 31/112 (27%), Gaps = 26/112 (23%)
Query: 23 LQYLDLGNNQLSGVIPPEI-GKLNQLRRLYLDVNQLHGTIPPVIGQLSLINELVFCHNNV 81
+Q LD+ +LS E+ L Q + + LD L
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARC------------------- 44
Query: 82 SGRIPSSLGNLSNLALLYLNDNSLFGSIPIVMG-----NLKSLSTLDLSQNQ 128
I S+L LA L L N L + + L L
Sbjct: 45 -KDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCC 95
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 58.4 bits (139), Expect = 2e-09
Identities = 40/339 (11%), Positives = 84/339 (24%), Gaps = 26/339 (7%)
Query: 165 KSLLQLDLSENRLSGLIPLSLSNLSSLTVMSLFNNSLSG----SIPPILGNLKSLSTLGL 220
KSL ++ + L S+ + L N++ + + + K L
Sbjct: 8 KSLKLDAITTEDEKSVFA-VLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEF 66
Query: 221 HINQ---LNGVIPPSIGNLSSLRNLSLFNNRLYGFVPKEIGYLKSLSKLEFCANHLSGVI 277
+ IP ++ L + + + + +
Sbjct: 67 SDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHL 126
Query: 278 PHSVGNLTGLVLLNMCENHLFGPIPKSLRNLTSLERVRFNQNNLYGKVYEAFGDHPNLTF 337
L + + K +N L + +N L + +
Sbjct: 127 YLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHR 186
Query: 338 LDLSQNNFYCEISFNWRNFSKLGTFNASMNNIYGSIPPEIGDSSKLQVLDLSSNHIFGKI 397
L + I L + L ++
Sbjct: 187 LLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLR 246
Query: 398 PVQLVKLFSLNKLILSLNQLFGGVPLEFGTLTELQYLDLSANKLSSSIPMSI-----GNL 452
+ L + L+ + LQ L L N++ ++ +
Sbjct: 247 ELGLN-----DCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKM 301
Query: 453 LKLHYLNLSNNQFSH--KIPTEFEKLI------HLSELD 483
L +L L+ N+FS + E ++ L ELD
Sbjct: 302 PDLLFLELNGNRFSEEDDVVDEIREVFSTRGRGELDELD 340
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 50.3 bits (118), Expect = 7e-07
Identities = 42/342 (12%), Positives = 110/342 (32%), Gaps = 46/342 (13%)
Query: 214 SLSTLGLHINQLNGV----IPPSIGNLSSLRNLSLFNNRLYGFVPKEIGYLKSLSKLEFC 269
S+ L ++ + + + S++ + L N + + + ++++ +
Sbjct: 4 SIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLS--ENIASKK-- 59
Query: 270 ANHLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLRNLTSLERVRFNQNNLYGKVYEAF 329
+L ++ + IP++LR L + +
Sbjct: 60 -------------DLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFG 106
Query: 330 GDHPNLTFLDLSQNNFYCEISFNWRNFSKLGTFNASMNNIYGSIPPEIGDSSKLQVLDLS 389
LS++ + + + ++ + ++ L+ +
Sbjct: 107 PTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICG 166
Query: 390 SNHIFGKIPVQLVKLFSLNKLILSLNQLFGGVPLEFGTLTELQYLD-------------L 436
N + + K F ++L+ ++ + G+ E L+ L
Sbjct: 167 RNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNT 226
Query: 437 SANKLSSSIPMSIGNLLKLHYLNLSNNQFSHKIPT------EFEKLIHLSELDLSHNILQ 490
+ SS++ +++ + L L L++ S + + I L L L +N ++
Sbjct: 227 FTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIE 286
Query: 491 EEIPPQIC-----KMESLEKLNLSHNNLSDFIPRCFEEMRSL 527
+ + KM L L L+ N S+ +E+R +
Sbjct: 287 LDAVRTLKTVIDEKMPDLLFLELNGNRFSE-EDDVVDEIREV 327
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 41.8 bits (96), Expect = 3e-04
Identities = 43/371 (11%), Positives = 86/371 (23%), Gaps = 50/371 (13%)
Query: 94 NLALLYLNDNSLFGSIPIVMGNLKSLSTLDLSQNQLNGSIPCSLDNLSNLDTLFLYKNSL 153
+L L + S+ V+ S+ + LS N +
Sbjct: 9 SLKLDAITTEDE-KSVFAVLLEDDSVKEIVLSGNTIG--------------------TEA 47
Query: 154 SGPIPSVIGNLKSLLQLDLSEN---RLSGLIPLSLSNLSSLTVMSLFNNSLSGSIPPILG 210
+ + I + K L + S+ R+ IP +L L + +++ S
Sbjct: 48 ARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGP 107
Query: 211 NLKSLSTLGLHINQLNGVIPPSIGNLSSLRNLSLFNNRLYGFVPKEIGYLKSLSKLEFCA 270
+ L + + L + V K+ L +
Sbjct: 108 TAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGR 167
Query: 271 NHLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLRNLTSLERVRFNQNNLYGKVYEAFG 330
N L T + + + L L +
Sbjct: 168 NRL-ENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNT 226
Query: 331 DHPNLTFLDLSQNNFYCEISFNWRNFSKLGTFNASMNNIYGSIPPEIGDSSKLQVLDLSS 390
+ + + N L + ++ LQ L L
Sbjct: 227 FTHLGSSALAIALKSWPNLRELGLNDCLLS----ARGAAAVVDAFSKLENIGLQTLRLQY 282
Query: 391 NHIFGKIPVQLVKLFSLNKLILSLNQLFGGVPLEFGTLTELQYLDLSANKLS--SSIPMS 448
N I L + + +L +L+L+ N+ S +
Sbjct: 283 NEIELDAVRTLKTVI-------------------DEKMPDLLFLELNGNRFSEEDDVVDE 323
Query: 449 IGNLLKLHYLN 459
I +
Sbjct: 324 IREVFSTRGRG 334
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 56.6 bits (135), Expect = 2e-09
Identities = 36/252 (14%), Positives = 73/252 (28%), Gaps = 42/252 (16%)
Query: 211 NLKSLSTLGLHINQLNGVIPPSIGNLSSLRNLSLFNNRLYGFVPKEIGYLKSLSKLEFCA 270
L + + + + + + +L + LS F + + + YL +L LE
Sbjct: 17 ALANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKD 72
Query: 271 NHLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLRNLTSLERVRFNQNNLYGKVYEAFG 330
N ++ + P N+ + L+N++++ ++ +
Sbjct: 73 NQITDLAPLK----------NLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDV 122
Query: 331 DHPNLTFLDLSQNNFYCEISFNWRNFSKLGTFNASMNNIYGSIPPEIGDSSKLQVLDLSS 390
+I+ S+ N S + + SKL L
Sbjct: 123 TPLAGLSNLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADD 182
Query: 391 NHIFGKIPVQLVKLFSLNKLILSLNQLFGGVPLEFGTLTELQYLDLSANKLSSSIPMSIG 450
N I P +L L + L N++S P +
Sbjct: 183 NKISDISP--------------------------LASLPNLIEVHLKNNQISDVSP--LA 214
Query: 451 NLLKLHYLNLSN 462
N L + L+N
Sbjct: 215 NTSNLFIVTLTN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 55.0 bits (131), Expect = 7e-09
Identities = 31/218 (14%), Positives = 66/218 (30%), Gaps = 22/218 (10%)
Query: 283 NLTGLVLLNMCENHLFGPIPKSLRNLTSLERVRFNQNNLYGKVYEAFGDHPNLTFLDLSQ 342
L + + ++++ + ++ +L + + + E NL L+L
Sbjct: 17 ALANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGV--TTIEGVQYLNNLIGLELKD 72
Query: 343 NNFYCEISFNWRNFSKLGTFNASMNNIYGSIPPEIGDSSKLQVLDLSSNHIFGKIPVQLV 402
N + + +I + ++ L
Sbjct: 73 NQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQ 132
Query: 403 KLFSLNKLILSLNQLFGGV--------------PLEFGTLTELQYLDLSANKLSSSIPMS 448
L+ I +++ L G L++L L NK+S P
Sbjct: 133 VLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP-- 190
Query: 449 IGNLLKLHYLNLSNNQFSHKIPTEFEKLIHLSELDLSH 486
+ +L L ++L NNQ S P +L + L++
Sbjct: 191 LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 52.3 bits (124), Expect = 5e-08
Identities = 42/213 (19%), Positives = 75/213 (35%), Gaps = 26/213 (12%)
Query: 2 LNLGFNLLFGNIPPQIGNLSKLQYLDLGNNQLSGVIPPEIGKLNQLRRLYLDVNQLHGTI 61
+ G + + + +L + L ++ + + LN L L L NQ+
Sbjct: 24 IAAGKSNVTDTVT--QADLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKDNQIT--D 77
Query: 62 PPVIGQLSLINELVFCHNNVSGRIPSSLGNLSNLALLYLNDNSLFGS------------- 108
+ L+ I EL N + + L +
Sbjct: 78 LAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQVLYLD 137
Query: 109 ---IPIVMGNLKSLSTLDLSQNQLNGSIPCSLDNLSNLDTLFLYKNSLSGPIPSVIGNLK 165
I + + LS S L NLS L TL N +S P + +L
Sbjct: 138 LNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP--LASLP 195
Query: 166 SLLQLDLSENRLSGLIPLSLSNLSSLTVMSLFN 198
+L+++ L N++S + P L+N S+L +++L N
Sbjct: 196 NLIEVHLKNNQISDVSP--LANTSNLFIVTLTN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 50.8 bits (120), Expect = 2e-07
Identities = 40/263 (15%), Positives = 79/263 (30%), Gaps = 45/263 (17%)
Query: 156 PIPSVI--GNLKSLLQLDLSENRLSGLIPLSLSNLSSLTVMSLFNNSLSGSIPPILGNLK 213
I + L + +++ ++ ++ + + ++L +T +S F +
Sbjct: 8 AINVIFPDPALANAIKIAAGKSNVTDTV--TQADLDGITTLSAFGT-----------GVT 54
Query: 214 SLSTLGLHINQLNGVIPPSIGNLSSLRNLSLFNNRLYGFVPKEIGYLKSLSKLEFCANHL 273
++ + L++L L L +N++ P + + +L
Sbjct: 55 TIE---------------GVQYLNNLIGLELKDNQITDLAPLKNLTKITELELSGNPLKN 99
Query: 274 SGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLRNLTSLERVRFNQNNLYGKVYEAFGDHP 333
I T + + +L+ L N + L G +
Sbjct: 100 VSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQVLYLDLNQITNISPLAGLTNLQYLSI- 158
Query: 334 NLTFLDLSQNNFYCEISFNWRNFSKLGTFNASMNNIYGSIPPEIGDSSKLQVLDLSSNHI 393
N N SKL T A N I P + L + L +N I
Sbjct: 159 ---------GNAQVSDLTPLANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQI 207
Query: 394 FGKIPVQLVKLFSLNKLILSLNQ 416
P L +L + L+ NQ
Sbjct: 208 SDVSP--LANTSNLFIVTLT-NQ 227
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 50.4 bits (119), Expect = 2e-07
Identities = 40/228 (17%), Positives = 75/228 (32%), Gaps = 18/228 (7%)
Query: 19 NLSKLQYLDLGNNQLSGVIPPEIGKLNQLRRLYLDVNQLHGTIPPVIGQLSLINELVFCH 78
L+ + G + ++ + L+ + L + TI + L+ + L
Sbjct: 17 ALANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVT-TIEG-VQYLNNLIGLELKD 72
Query: 79 NNVSGRIPSSLGNLSNLALLYLNDNSLFGSIPIVMGNLKSLSTLDLSQNQLNGSIPCSLD 138
N ++ P L N +I + T + + +L
Sbjct: 73 NQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQ 132
Query: 139 NLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSENRLSGLIPLSLSNLSSLTVMSLFN 198
L + L+G + L+NLS LT + +
Sbjct: 133 VLYLDLNQITNISPLAGLTNLQYLS----------IGNAQVSDLTPLANLSKLTTLKADD 182
Query: 199 NSLSGSIPPILGNLKSLSTLGLHINQLNGVIPPSIGNLSSLRNLSLFN 246
N +S P L +L +L + L NQ++ V P + N S+L ++L N
Sbjct: 183 NKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 44.6 bits (104), Expect = 2e-05
Identities = 29/218 (13%), Positives = 68/218 (31%), Gaps = 22/218 (10%)
Query: 138 DNLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSENRLSGLIPLSLSNLSSLTVMSLF 197
L+N + K++++ + +L + L ++ + + L++L + L
Sbjct: 16 PALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVTTIEG--VQYLNNLIGLELK 71
Query: 198 NNSLSGSIPPILGNLKSLSTLGLHINQLNGVIPPSIGNLSSLRNLSLFNNRLYGFVPKEI 257
+N ++ P + L + + I + + + +
Sbjct: 72 DNQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNL 131
Query: 258 GYLKSLSKLEFCANHLSGVIPH--------------SVGNLTGLVLLNMCENHLFGPIPK 303
L + L+G+ + NL+ L L +N + P
Sbjct: 132 QVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP- 190
Query: 304 SLRNLTSLERVRFNQNNLYGKVYEAFGDHPNLTFLDLS 341
L +L +L V N + + NL + L+
Sbjct: 191 -LASLPNLIEVHLKNNQISD--VSPLANTSNLFIVTLT 225
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 40.0 bits (92), Expect = 6e-04
Identities = 40/229 (17%), Positives = 82/229 (35%), Gaps = 19/229 (8%)
Query: 91 NLSNLALLYLNDNSLFGSIPIVMGNLKSLSTLDLSQNQLNGSIPCSLDNLSNLDTLFLYK 150
L+N + +++ ++ +L ++TL + +I + L+NL L L
Sbjct: 17 ALANAIKIAAGKSNVTDTVTQ--ADLDGITTLSAFGTGVT-TIE-GVQYLNNLIGLELKD 72
Query: 151 NSLSGPIPSVIGNLKSLLQLDLSENRLSGLIPLSLSNLSSLTVMSLFNNSLSGSIPPILG 210
N ++ P L + + ++ +L S + L
Sbjct: 73 NQITDLAP------LKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLA 126
Query: 211 NLKSLSTLGLHINQLNGVIPPSIGNLSSLRNLSLFNNRLYGFVPKEIGYLKSLSKLEFCA 270
L +L L L +NQ+ + P + + + L L+ L+
Sbjct: 127 GLSNLQVLYLDLNQITNISPLAGLTNLQYLS----IGNAQVSDLTPLANLSKLTTLKADD 182
Query: 271 NHLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLRNLTSLERVRF-NQ 318
N +S + P + +L L+ +++ N + P L N ++L V NQ
Sbjct: 183 NKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQ 227
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 39.6 bits (91), Expect = 7e-04
Identities = 20/78 (25%), Positives = 34/78 (43%), Gaps = 5/78 (6%)
Query: 51 YLDVNQLHGTIPPVIGQLSLINELVFCHNNVSGRIPSSLGNLSNLALLYLNDNSLFGSIP 110
YL + + + LS + L N +S P L +L NL ++L +N + P
Sbjct: 155 YLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP 212
Query: 111 IVMGNLKSLSTLDLSQNQ 128
+ N +L + L+ NQ
Sbjct: 213 L--ANTSNLFIVTLT-NQ 227
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 39.6 bits (91), Expect = 9e-04
Identities = 13/42 (30%), Positives = 20/42 (47%), Gaps = 3/42 (7%)
Query: 15 PQIGNLSKLQYLDLGNNQLSGVIPPEIGKLNQLRRLYLDVNQ 56
+ +L L + L NNQ+S V P + + L + L NQ
Sbjct: 189 SPLASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT-NQ 227
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 37.3 bits (85), Expect = 0.004
Identities = 33/207 (15%), Positives = 63/207 (30%), Gaps = 22/207 (10%)
Query: 74 LVFCHNNVSGRIPSSLGNLSNLALLYLNDNSLFGSIPIVMGNLKSLSTLDLSQNQLNGSI 133
+ +NV+ + + +L + L + + L +L L+L NQ+
Sbjct: 24 IAAGKSNVTDTVTQA--DLDGITTLSAFGTGVTTIEGV--QYLNNLIGLELKDNQITDLA 79
Query: 134 PCSLDNLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSENRLSGLIPLSLSNLSSLTV 193
P L I + L + +L L
Sbjct: 80 PLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQVLYLDLN 139
Query: 194 MSLFNNSL--------------SGSIPPILGNLKSLSTLGLHINQLNGVIPPSIGNLSSL 239
+ L S L NL L+TL N+++ + P + +L +L
Sbjct: 140 QITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP--LASLPNL 197
Query: 240 RNLSLFNNRLYGFVPKEIGYLKSLSKL 266
+ L NN++ P + +L +
Sbjct: 198 IEVHLKNNQISDVSP--LANTSNLFIV 222
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 52.4 bits (125), Expect = 9e-09
Identities = 24/109 (22%), Positives = 42/109 (38%), Gaps = 6/109 (5%)
Query: 432 QYLDLSANKLSSSIPMSIGNLLKLHYLNLSNNQFSHKIPTEFEKLIHLSELDLSHNILQE 491
+ L L+ L+ + LL + +L+LS+N+ P L L L S N
Sbjct: 1 RVLHLAHKDLTV--LCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDN--AL 55
Query: 492 EIPPQICKMESLEKLNLSHNNLSDF-IPRCFEEMRSLSWIDISYNELQG 539
E + + L++L L +N L + L +++ N L
Sbjct: 56 ENVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 50.5 bits (120), Expect = 4e-08
Identities = 27/129 (20%), Positives = 47/129 (36%), Gaps = 12/129 (9%)
Query: 24 QYLDLGNNQLSGVIPPEIGKLNQLRRLYLDVNQLHGTIPPVIGQLSLINELVFCHNNVSG 83
+ L L + L+ + + +L + L L N+L P + L +
Sbjct: 1 RVLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNAL--- 55
Query: 84 RIPSSLGNLSNLALLYLNDNSLFGSIPI-VMGNLKSLSTLDLSQNQLNG------SIPCS 136
+ NL L L L +N L S I + + L L+L N L +
Sbjct: 56 ENVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEM 115
Query: 137 LDNLSNLDT 145
L ++S++ T
Sbjct: 116 LPSVSSILT 124
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 47.0 bits (111), Expect = 6e-07
Identities = 31/126 (24%), Positives = 52/126 (41%), Gaps = 9/126 (7%)
Query: 1 MLNLGFNLLFGNIPPQIGNLSKLQYLDLGNNQLSGVIPPEIGKLNQLRRLYLDVNQLHGT 60
+L+L L + + L + +LDL +N+L +PP + L L L +
Sbjct: 2 VLHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRA-LPPALAALRCLE--VLQASDNALE 56
Query: 61 IPPVIGQLSLINELVFCHNNV-SGRIPSSLGNLSNLALLYLNDNSL---FGSIPIVMGNL 116
+ L + EL+ C+N + L + L LL L NSL G + L
Sbjct: 57 NVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEML 116
Query: 117 KSLSTL 122
S+S++
Sbjct: 117 PSVSSI 122
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 47.0 bits (111), Expect = 6e-07
Identities = 29/120 (24%), Positives = 46/120 (38%), Gaps = 7/120 (5%)
Query: 121 TLDLSQNQLNGSIPCSLDNLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSENRLSGL 180
L L+ L ++ C L+ L + L L N L P+ + L+ L L S+N L +
Sbjct: 2 VLHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPPA-LAALRCLEVLQASDNALENV 58
Query: 181 IPLSLSNLSSLTVMSLFNNSL-SGSIPPILGNLKSLSTLGLHINQLNGVIPPSIGNLSSL 239
++ L + L NN L + L + L L L N L L+ +
Sbjct: 59 DGVANLP--RLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ-EEGIQERLAEM 115
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 44.7 bits (105), Expect = 4e-06
Identities = 28/110 (25%), Positives = 43/110 (39%), Gaps = 6/110 (5%)
Query: 384 QVLDLSSNHIFGKIPVQLVKLFSLNKLILSLNQLFGGVPLEFGTLTELQYLDLSANKLSS 443
+VL L+ + + L +L + L LS N+L P L L+ L S N L +
Sbjct: 1 RVLHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNALEN 57
Query: 444 SIPMSIGNLLKLHYLNLSNNQFSH-KIPTEFEKLIHLSELDLSHNILQEE 492
++ +L L L NN+ L L+L N L +E
Sbjct: 58 VDGVANLP--RLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQE 105
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 43.6 bits (102), Expect = 1e-05
Identities = 26/119 (21%), Positives = 40/119 (33%), Gaps = 6/119 (5%)
Query: 74 LVFCHNNVSGRIPSSLGNLSNLALLYLNDNSLFGSIPIVMGNLKSLSTLDLSQNQLNGSI 133
L H +++ + L L + L L+ N L P + L+ L L S N L
Sbjct: 3 LHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNALENVD 59
Query: 134 PCSLDNLSNLDTLFLYKNSL-SGPIPSVIGNLKSLLQLDLSENRLSGLIPLSLSNLSSL 191
+ L L L N L + + L+ L+L N L + L
Sbjct: 60 GVANLP--RLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEML 116
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 39.7 bits (92), Expect = 2e-04
Identities = 24/106 (22%), Positives = 38/106 (35%), Gaps = 6/106 (5%)
Query: 217 TLGLHINQLNGVIPPSIGNLSSLRNLSLFNNRLYGFVPKEIGYLKSLSKLEFCANHLSGV 276
L L L + + L + +L L +NRL P + L+ L L+ N L V
Sbjct: 2 VLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNALENV 58
Query: 277 IPHSVGNLTGLVLLNMCENHLFG-PIPKSLRNLTSLERVRFNQNNL 321
+ L +C N L + L + L + N+L
Sbjct: 59 DGVANLPRLQ--ELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSL 102
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 38.9 bits (90), Expect = 4e-04
Identities = 19/130 (14%), Positives = 41/130 (31%), Gaps = 10/130 (7%)
Query: 290 LNMCENHLFGPIPKSLRNLTSLERVRFNQNNLYGKVYEAFGDHPNLTFLDLSQNNFYCEI 349
L++ L + L L + + + N L A L L S N
Sbjct: 3 LHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRAL-PPALAALRCLEVLQASDNALENVD 59
Query: 350 SFNWRNFSKLGTFNASMNNI-YGSIPPEIGDSSKLQVLDLSSNHIFGKIPVQLVKLFSLN 408
+ N + + + +L +L+L N + + +Q L
Sbjct: 60 GVANLPRLQ--ELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQE----RLA 113
Query: 409 KLILSLNQLF 418
+++ S++ +
Sbjct: 114 EMLPSVSSIL 123
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 52.9 bits (126), Expect = 1e-08
Identities = 31/134 (23%), Positives = 60/134 (44%), Gaps = 6/134 (4%)
Query: 387 DLSSNHIFGKIPVQLVKLFSLNKLILSLNQLFGGVPLEFGTLTELQYLDLSANKLSSSIP 446
+L + ++ + + K + ++ L L L + L+ + +++++
Sbjct: 3 ELKPEQVE-QLKLIMSKRYDGSQQALDLKGL--RSDPDLVAQNIDVVLNRR-SSMAATLR 58
Query: 447 MSIGNLLKLHYLNLSNNQFSHK--IPTEFEKLIHLSELDLSHNILQEEIPPQICKMESLE 504
+ N+ +L LNLSNN+ + + +K +L L+LS N L+ E K LE
Sbjct: 59 IIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLE 118
Query: 505 KLNLSHNNLSDFIP 518
+L L N+LSD
Sbjct: 119 ELWLDGNSLSDTFR 132
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 52.9 bits (126), Expect = 1e-08
Identities = 28/154 (18%), Positives = 56/154 (36%), Gaps = 6/154 (3%)
Query: 84 RIPSSLGNLSNLALLYLNDNSLFGSIPIVMGNLKSLSTLDLSQNQLNGSIPCSLDNLSNL 143
++ + + + L+ L + L+ + ++ +N+ L
Sbjct: 11 QLKLIMSKRYDGSQQALDLKGL--RSDPDLVAQNIDVVLNRRSSMAA-TLRIIEENIPEL 67
Query: 144 DTLFLYKNSLSG--PIPSVIGNLKSLLQLDLSENRLSGLIPLSLSNLSSLTVMSLFNNSL 201
+L L N L + S++ +L L+LS N L L L + L NSL
Sbjct: 68 LSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSL 127
Query: 202 SGSIPPILGNLKSLSTLGLHINQLNGV-IPPSIG 234
S + + ++ + +L+G +PP I
Sbjct: 128 SDTFRDQSTYISAIRERFPKLLRLDGHELPPPIA 161
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.9 bits (100), Expect = 3e-05
Identities = 32/135 (23%), Positives = 50/135 (37%), Gaps = 16/135 (11%)
Query: 372 SIPPEIGDSSKLQVLDLSSNHIFGKIPVQLVKLFSLNKLILSLNQL--FGGVPLEFGTLT 429
P++ + VL+ S+ + + + + L L LS N+L +
Sbjct: 33 RSDPDLVAQNIDVVLNRRSS-MAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAP 91
Query: 430 ELQYLDLSANKLSSSIPMSIGNLLKLHYLNLSNNQFSHKIPTE-------FEKLIHLSEL 482
L+ L+LS N+L S + LKL L L N S + E+ L L
Sbjct: 92 NLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISAIRERFPKLLRL 151
Query: 483 DLSHNILQEEIPPQI 497
D E+PP I
Sbjct: 152 D------GHELPPPI 160
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 51.0 bits (120), Expect = 1e-07
Identities = 42/170 (24%), Positives = 75/170 (44%), Gaps = 5/170 (2%)
Query: 75 VFCHNNVSGRIPSSLGNLSNLALLYLNDNSLFGSIPIVM-GNLKSLSTLDLSQNQLNGSI 133
V C IP + + L LNDN L + G L L L+L +NQL G
Sbjct: 13 VDCTGRGLKEIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIE 70
Query: 134 PCSLDNLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSENRLSGLIPLSLSNLSSLTV 193
P + + S++ L L +N + + L L L+L +N++S ++P S +L+SLT
Sbjct: 71 PNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTS 130
Query: 194 MSLFNNSLSGSIPPILGNLKSLSTLGLHINQLNGVIPPSIGNLSSLRNLS 243
++L +N + + + L L+ P + ++ +++L
Sbjct: 131 LNLASNPFNC-NCHLAWFAEWLRKKSLNGGAARCGAPSKVRDV-QIKDLP 178
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 50.2 bits (118), Expect = 2e-07
Identities = 46/175 (26%), Positives = 67/175 (38%), Gaps = 7/175 (4%)
Query: 372 SIPPEIGDSSKLQVLDLSSNHIFGKIPVQLVKLFS-LNKLILSLNQLFGGVPLEFGTLTE 430
IP +I L L+ N + L L KL L NQL G P F +
Sbjct: 22 EIPRDI--PLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASH 79
Query: 431 LQYLDLSANKLSSSIPMSIGNLLKLHYLNLSNNQFSHKIPTEFEKLIHLSELDLSHNILQ 490
+Q L L NK+ L +L LNL +NQ S +P FE L L+ L+ +
Sbjct: 80 IQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLN-LASNPF 138
Query: 491 EEIPPQICKMESLEKLNLSHNNLSDFIPRCFEEMRSLSWIDISYNELQGPIPNST 545
E L K +L+ P ++R + D+ ++E + NS
Sbjct: 139 NCNCHLAWFAEWLRKKSLNGGAARCGAP---SKVRDVQIKDLPHSEFKCSSENSE 190
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 48.6 bits (114), Expect = 6e-07
Identities = 38/165 (23%), Positives = 63/165 (38%), Gaps = 7/165 (4%)
Query: 229 IPPSIGNLSSLRNLSLFNNRLYGFVPKEI-GYLKSLSKLEFCANHLSGVIPHSVGNLTGL 287
IP I L L +N L + G L L KLE N L+G+ P++ + +
Sbjct: 23 IPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHI 80
Query: 288 VLLNMCENHLFGPIPKSLRNLTSLERVRFNQNNLYGKVYEAFGDHPNLTFLDLSQNNFYC 347
L + EN + K L L+ + N + + +F +LT L+L+ N F C
Sbjct: 81 QELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNC 140
Query: 348 EISFNWRNFSKLGTFNASMNNIYGSIPPEIGDSSKLQVLDLSSNH 392
W L + + P ++ +Q+ DL +
Sbjct: 141 NCHLAW-FAEWLRKKSLNGGAARCGAPSKV---RDVQIKDLPHSE 181
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 47.9 bits (112), Expect = 1e-06
Identities = 42/166 (25%), Positives = 63/166 (37%), Gaps = 7/166 (4%)
Query: 13 IPPQIGNLSKLQYLDLGNNQLSGVIPPEI-GKLNQLRRLYLDVNQLHGTIPPVIGQLSLI 71
IP I L L +N+L + + G+L L +L L NQL G P S I
Sbjct: 23 IPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHI 80
Query: 72 NELVFCHNNVSGRIPSSLGNLSNLALLYLNDNSLFGSIPIVMGNLKSLSTLDLSQNQLNG 131
EL N + L L L L DN + +P +L SL++L+L+ N N
Sbjct: 81 QELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNC 140
Query: 132 SIPCSLDNLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSENRL 177
+ + L L + PS ++ + DL +
Sbjct: 141 NCHLA-WFAEWLRKKSLNGGAARCGAPS---KVRDVQIKDLPHSEF 182
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 42.1 bits (97), Expect = 9e-05
Identities = 33/158 (20%), Positives = 50/158 (31%), Gaps = 5/158 (3%)
Query: 333 PNLTFLDLSQNNFYCEISFNWR-NFSKLGTFNASMNNIYGSIPPEIGDSSKLQVLDLSSN 391
+ T L L+ N S L N + G P +S +Q L L N
Sbjct: 29 LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGEN 88
Query: 392 HIFGKIPVQLVKLFSLNKLILSLNQLFGGVPLEFGTLTELQYLDLSANKLSSSIPMSIGN 451
I + L L L L NQ+ +P F L L L+ A+ +
Sbjct: 89 KIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLN-LASNPFNCNCHLAWF 147
Query: 452 LLKLHYLNLSNNQFSHKIPTEFEKLIHLSELDLSHNIL 489
L +L+ P++ + DL H+
Sbjct: 148 AEWLRKKSLNGGAARCGAPSKVR---DVQIKDLPHSEF 182
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 41.7 bits (96), Expect = 1e-04
Identities = 16/96 (16%), Positives = 31/96 (32%), Gaps = 4/96 (4%)
Query: 10 FGNIPPQIGNLSKLQYLDLGNNQLSGVIPPEIGKLNQLRRLYLDVNQLHGTIPPVIGQLS 69
L +L+ L+L +NQ+S V+P LN L L + +
Sbjct: 91 KEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLN-LASNPFNCNCHLAWFAE 149
Query: 70 LINELVFCHNNVSGRIPSSLGNLSNLALLYLNDNSL 105
+ + PS + ++ + L +
Sbjct: 150 WLRKKSLNGGAARCGAPSK---VRDVQIKDLPHSEF 182
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 40.9 bits (94), Expect = 2e-04
Identities = 44/184 (23%), Positives = 63/184 (34%), Gaps = 8/184 (4%)
Query: 166 SLLQLDLSENRLSGLIPLSLSNLSSLTVMSLFNNSLSGSIPPIL-GNLKSLSTLGLHINQ 224
+D + L IP + T + L +N L L G L L L L NQ
Sbjct: 9 EGTTVDCTGRGLKE-IPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQ 65
Query: 225 LNGVIPPSIGNLSSLRNLSLFNNRLYGFVPKEIGYLKSLSKLEFCANHLSGVIPHSVGNL 284
L G+ P + S ++ L L N++ K L L L N +S V+P S +L
Sbjct: 66 LTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHL 125
Query: 285 TGLVLLNMCENHLFGPIPKSLRNLTSLERVRFNQNNLYGKVYEAFGDHPNLTFLDLSQNN 344
L LN+ N L + N A ++ DL +
Sbjct: 126 NSLTSLNLASNPFNCNCH-LAWFAEWLRKKSLNGGAARC---GAPSKVRDVQIKDLPHSE 181
Query: 345 FYCE 348
F C
Sbjct: 182 FKCS 185
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 39.8 bits (91), Expect = 5e-04
Identities = 20/112 (17%), Positives = 38/112 (33%), Gaps = 8/112 (7%)
Query: 30 NNQLSGVIPPEIGKLNQLRRLYLDVNQLHGTIPPVIGQLSLINELVFCHNNVSGRIPSSL 89
N++ + L+QL+ L L NQ+ +P L+ + + +N
Sbjct: 87 ENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTS-LNLASNPFNCNCHLA 145
Query: 90 GNLSNLALLYLNDNSLFGSIPIVMGNLKSLSTLDLSQNQLNGSIPCSLDNLS 141
L LN + P ++ + DL ++ CS +N
Sbjct: 146 WFAEWLRKKSLNGGAARCGAP---SKVRDVQIKDLPHSEFK----CSSENSE 190
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 51.4 bits (121), Expect = 1e-07
Identities = 32/223 (14%), Positives = 65/223 (29%), Gaps = 9/223 (4%)
Query: 253 VPKEIGYLKSLSKLEFCANHLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLRNLTSLE 312
+P ++ ++ +L F L + + L + + +N + I + +
Sbjct: 23 IPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKL 80
Query: 313 RVRFNQNNLYGKVYEAFGDHPNLTFLDLSQNNFY----CEISFNWRNFSKLGTFNASMNN 368
+ L +N ++ L ++N
Sbjct: 81 HEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINI 140
Query: 369 IYGSIPPEIGDSSKLQVLDLSSNHIFGKIPVQLVKLFSLNKLILSLNQLFGGVPLEFGTL 428
+G S + +L L+ N I + N L F
Sbjct: 141 HTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGA 200
Query: 429 TELQYLDLSANKLSSSIPMSIGNLLKLHYLNLSNNQFSHKIPT 471
+ LD+S ++ S + NL KL + N + K+PT
Sbjct: 201 SGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK---KLPT 240
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 49.5 bits (116), Expect = 5e-07
Identities = 35/224 (15%), Positives = 65/224 (29%), Gaps = 33/224 (14%)
Query: 13 IPPQIGNLSKLQYLDLGNNQLSGVIPPEIGKLNQLRRLYLDVNQLHGTIPPVIGQLSLIN 72
IP + L +L + L ++ + N + I +
Sbjct: 23 IPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKL 80
Query: 73 E--LVFCHNNVSGRIPSSLGNLSNLALLYLNDNSLFGSIPI------------------- 111
+ NN+ P + NL NL L +++ + +
Sbjct: 81 HEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINI 140
Query: 112 -------VMGNLKSLSTLDLSQNQLNGSIPCSLDNLSNLDTLFLYKNSLSGPIPSVIGNL 164
+G L L++N + C+ + + N+L V
Sbjct: 141 HTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGA 200
Query: 165 KSLLQLDLSENRLSGLIPLSLSNLSSLTVMSLFNNSLSGSIPPI 208
+ LD+S R+ L L NL L S +N +P +
Sbjct: 201 SGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK---KLPTL 241
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.2 bits (97), Expect = 1e-04
Identities = 42/243 (17%), Positives = 71/243 (29%), Gaps = 10/243 (4%)
Query: 278 PHSVGNLTGLVLLNMCENHLFGPIPKSLRNLTSLERVRFNQNNLYGKVYEAFGDHPNLTF 337
H + + + V L C+ IP L + +RF L AF +L
Sbjct: 2 HHRICHCSNRVFL--CQESKVTEIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEK 57
Query: 338 LDLSQNNFYCEISFNWRNFSKLGTFNASM--NNIYGSIPPEIGDSSKLQVLDLSSNHIFG 395
+++SQN+ I + + NN+ P + LQ L +S+ I
Sbjct: 58 IEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKH 117
Query: 396 KIPV--QLVKLFSLNKLILSLNQLFGGVPLEFGTLTELQYLDLSANKLSSSIPMSIGNLL 453
V L + ++N G E L L+ N + +
Sbjct: 118 LPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQ 177
Query: 454 KLHYLNLSNNQFSHKIPTEFEKLIHLSELDLSHNILQEEIPPQICKMESLEKLNLSHNNL 513
NN F LD+S + + ++ L + NL
Sbjct: 178 LDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARST--YNL 235
Query: 514 SDF 516
Sbjct: 236 KKL 238
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.2 bits (97), Expect = 1e-04
Identities = 31/223 (13%), Positives = 59/223 (26%), Gaps = 9/223 (4%)
Query: 277 IPHSVGNLTGLVLLNMCENHLFGPIPKSLRNLTSLERVRFNQNNLYGKVYEAFGDHPNLT 336
IP + + L L + LE++ +QN++ + +
Sbjct: 23 IPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKL 80
Query: 337 FLDLSQ--NNFYCEISFNWRNFSKLGTFNASMNNIYGSIPPEIGDSSKLQVLDLSS--NH 392
+ NN ++N L S I S + +LD+ N
Sbjct: 81 HEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINI 140
Query: 393 IFGKIPVQLVKLFSLNKLILSLNQLFGGVPLEFGTLTELQYLDLSANKLSSSIPMSIGNL 452
+ + F L L+ N + F + N L
Sbjct: 141 HTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGA 200
Query: 453 LKLHYLNLSNNQFSHKIPTEFEKLIHLSELDLSHNILQEEIPP 495
L++S + E L L + +++P
Sbjct: 201 SGPVILDISRTRIHSLPSYGLENLKKLRARSTYNL---KKLPT 240
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.4 bits (95), Expect = 3e-04
Identities = 35/223 (15%), Positives = 68/223 (30%), Gaps = 9/223 (4%)
Query: 157 IPSVIGNLKSLLQLDLSENRLSGLIPLSLSNLSSLTVMSLFNNSLSGSIPPILGNLKSLS 216
IPS + ++ ++L +L + + S L + + N + I + +
Sbjct: 23 IPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKL 80
Query: 217 TLGLHINQLNGVIPPSIGNLSSLRNLSLFNNRLY----GFVPKEIGYLKSLSKLEFCANH 272
N + + L + V K K L ++ N
Sbjct: 81 HEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINI 140
Query: 273 LSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLRNLTSLERVRFNQNNLYGKVYEAFGDH 332
+ VG V+L + +N + + E + NNL + F
Sbjct: 141 HTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGA 200
Query: 333 PNLTFLDLSQNNFYCEISFNWRNFSKLGTFNASMNNIYGSIPP 375
LD+S+ + S+ N KL + N+ +P
Sbjct: 201 SGPVILDISRTRIHSLPSYGLENLKKLRARS--TYNL-KKLPT 240
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.5 bits (90), Expect = 0.001
Identities = 11/78 (14%), Positives = 19/78 (24%)
Query: 456 HYLNLSNNQFSHKIPTEFEKLIHLSELDLSHNILQEEIPPQICKMESLEKLNLSHNNLSD 515
L L+ N F +N L+E L++S +
Sbjct: 156 VILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHS 215
Query: 516 FIPRCFEEMRSLSWIDIS 533
E ++ L
Sbjct: 216 LPSYGLENLKKLRARSTY 233
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.7 bits (88), Expect = 0.002
Identities = 9/56 (16%), Positives = 19/56 (33%), Gaps = 4/56 (7%)
Query: 10 FGNIPPQI-GNLSKLQYLDLGNNQLSGVIPPEIGKLNQLRRLYLDVNQLHGTIPPV 64
+P + S LD+ ++ + + L +LR L +P +
Sbjct: 189 LEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLR--ARSTYNL-KKLPTL 241
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 49.2 bits (116), Expect = 3e-07
Identities = 18/125 (14%), Positives = 39/125 (31%), Gaps = 3/125 (2%)
Query: 423 LEFGTLTELQYLDLSANKLSSSIPMSIGNLLKLHYLNLSNNQFSHKIPTEFEKLIHLSEL 482
++ + LDL K+ I L + ++ S+N+ F L L L
Sbjct: 12 AQYTNAVRDRELDLRGYKIPV-IENLGATLDQFDAIDFSDNEIRKLDG--FPLLRRLKTL 68
Query: 483 DLSHNILQEEIPPQICKMESLEKLNLSHNNLSDFIPRCFEEMRSLSWIDISYNELQGPIP 542
+++N + + L +L L++N+L +
Sbjct: 69 LVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKK 128
Query: 543 NSTAF 547
+ +
Sbjct: 129 HYRLY 133
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.2 bits (98), Expect = 6e-05
Identities = 29/164 (17%), Positives = 50/164 (30%), Gaps = 31/164 (18%)
Query: 15 PQIGNLSKLQYLDLGNNQLSGVIPPEIGKLNQLRRLYLDVNQLHGTIPPVIGQLSLINEL 74
Q N + + LDL ++ VI L+Q + N++
Sbjct: 12 AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR---------------- 54
Query: 75 VFCHNNVSGRIPSSLGNLSNLALLYLNDNSLFGSIPIVMGNLKSLSTLDLSQNQLNG-SI 133
L L L +N+N + + L L+ L L+ N L
Sbjct: 55 ----------KLDGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGD 104
Query: 134 PCSLDNLSNLDTLFLY---KNSLSGPIPSVIGNLKSLLQLDLSE 174
L +L +L L + + VI + + LD +
Sbjct: 105 LDPLASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRVLDFQK 148
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.8 bits (97), Expect = 7e-05
Identities = 27/149 (18%), Positives = 49/149 (32%), Gaps = 9/149 (6%)
Query: 124 LSQNQLNGSIPCSLDNLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSENRLSGLIPL 183
L+ + + N L L + I ++ L +D S+N + L
Sbjct: 3 LTAELIEQAA--QYTNAVRDRELDLRGYKIPV-IENLGATLDQFDAIDFSDNEIRKLDG- 58
Query: 184 SLSNLSSLTVMSLFNNSLSGSIPPILGNLKSLSTLGLHINQLNGV-IPPSIGNLSSLRNL 242
L L + + NN + + L L+ L L N L + + +L SL L
Sbjct: 59 -FPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYL 117
Query: 243 SLFN---NRLYGFVPKEIGYLKSLSKLEF 268
+ + I + + L+F
Sbjct: 118 CILRNPVTNKKHYRLYVIYKVPQVRVLDF 146
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.8 bits (89), Expect = 9e-04
Identities = 22/129 (17%), Positives = 51/129 (39%), Gaps = 7/129 (5%)
Query: 2 LNLGFNLLFGNIPPQIGNLSKLQYLDLGNNQLSGVIPPEIGKLNQLRRLYLDVNQLHGTI 61
L+L + I L + +D +N++ + L +L+ L ++ N++
Sbjct: 23 LDLRGYKI-PVIENLGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIG 79
Query: 62 PPVIGQLSLINELVFCHNNVSG----RIPSSLGNLSNLALLYLNDNSLFGSIPIVMGNLK 117
+ L + EL+ +N++ +SL +L+ L +L + V+ +
Sbjct: 80 EGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKHYRLYVIYKVP 139
Query: 118 SLSTLDLSQ 126
+ LD +
Sbjct: 140 QVRVLDFQK 148
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 36.8 bits (84), Expect = 0.004
Identities = 26/135 (19%), Positives = 44/135 (32%), Gaps = 7/135 (5%)
Query: 355 NFSKLGTFNASMNNIYGSIPPEIGDSSKLQVLDLSSNHIFGKIPVQLVKLFSLNKLILSL 414
N + + I I + +D S N I L L L+++
Sbjct: 16 NAVRDRELDLRGYKI-PVIENLGATLDQFDAIDFSDNEIRKLDGFP--LLRRLKTLLVNN 72
Query: 415 NQLFGGVPLEFGTLTELQYLDLSANKLSS-SIPMSIGNLLKLHYLNLSNNQFSHKI---P 470
N++ L +L L L+ N L + +L L YL + N ++K
Sbjct: 73 NRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKHYRL 132
Query: 471 TEFEKLIHLSELDLS 485
K+ + LD
Sbjct: 133 YVIYKVPQVRVLDFQ 147
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 36.8 bits (84), Expect = 0.004
Identities = 26/161 (16%), Positives = 52/161 (32%), Gaps = 31/161 (19%)
Query: 375 PEIGDSSKLQVLDLSSNHIFGKIPVQLVKLFSLNKLILSLNQLFGGVPLEFGTLTELQYL 434
+ ++ + + LDL I + TL + +
Sbjct: 12 AQYTNAVRDRELDLRGYKI-------------------------PVIENLGATLDQFDAI 46
Query: 435 DLSANKLSSSIPMSIGNLLKLHYLNLSNNQFSHKIPTEFEKLIHLSELDLSHNILQE--- 491
D S N++ L +L L ++NN+ + L L+EL L++N L E
Sbjct: 47 DFSDNEIRKLDGFP--LLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGD 104
Query: 492 -EIPPQICKMESLEKLNLSHNNLSDFIPRCFEEMRSLSWID 531
+ + + L L N + ++ + +D
Sbjct: 105 LDPLASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRVLD 145
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 48.5 bits (114), Expect = 1e-06
Identities = 33/216 (15%), Positives = 69/216 (31%), Gaps = 22/216 (10%)
Query: 253 VPKEIGY------LKSLSKLEFCANHLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLR 306
VP I K ++ + + L + + + + ++
Sbjct: 10 VPTPIKQIFSDDAFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKSVQG--IQ 65
Query: 307 NLTSLERVRFNQNNLYGKVYEAFGDHPNLTFLDLSQNNFYCEISFNWRNFSKLGTFNASM 366
L ++ ++ N N L A NL L + + K +
Sbjct: 66 YLPNVTKLFLNGNKLTDIKPLA-----NLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLE 120
Query: 367 NNIYGSIPPEIGDSSKLQVLDLSSNHIFGKIPVQLVKLFSLNKLILSLNQLFGGVPLEFG 426
+N I + + ++ + +L KL +L+ ++ + +
Sbjct: 121 HNGISDINGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDI-----VPLA 175
Query: 427 TLTELQYLDLSANKLSSSIPMSIGNLLKLHYLNLSN 462
LT+LQ L LS N +S + ++ L L L L +
Sbjct: 176 GLTKLQNLYLSKNHISD-LR-ALAGLKNLDVLELFS 209
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 46.9 bits (110), Expect = 3e-06
Identities = 40/197 (20%), Positives = 69/197 (35%), Gaps = 16/197 (8%)
Query: 2 LNLGFNLLFGNIPPQIGNLSKLQYLDLGNNQLSGVIPPEIGKLNQLRRLYLDVNQLHGTI 61
NL + + L+ + + N+ + V I L + +L+L+ N+L
Sbjct: 29 DNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNGNKLTDIK 84
Query: 62 PPVIGQLSLINELVFCHNNVSGRIPSSLGNLSNLALLYLNDNSLFGSIPIVMGNLKSLST 121
P + L + + + I + G +
Sbjct: 85 P--------LANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDINGLVHLPQL 136
Query: 122 LDLSQNQLNGSIPCSLDNLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSENRLSGLI 181
L + L L+ LDTL L N +S +P + L L L LS+N +S L
Sbjct: 137 ESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISDLR 194
Query: 182 PLSLSNLSSLTVMSLFN 198
L+ L +L V+ LF+
Sbjct: 195 A--LAGLKNLDVLELFS 209
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 43.8 bits (102), Expect = 3e-05
Identities = 31/198 (15%), Positives = 70/198 (35%), Gaps = 22/198 (11%)
Query: 351 FNWRNFSKLGTFNASMNNIYGSIPPEIGDSSKLQVLDLSSNHIFGKIPVQLVKLFSLNKL 410
F+ F++ N ++ ++ + + + + +++ I +Q L ++ KL
Sbjct: 18 FSDDAFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKSVQGIQ--YLPNVTKL 73
Query: 411 ILSLNQLFGGVPLEFGTLTELQYLDLSANKLS---------------SSIPMSIGNLLKL 455
L+ N+L PL +LD + K + I L+ L
Sbjct: 74 FLNGNKLTDIKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDINGLVHL 133
Query: 456 HYLNLSNNQFSHKIPTEFEKLIHLSELDLSHNILQEEIPPQICKMESLEKLNLSHNNLSD 515
L + + + + +I P + + L+ L LS N++SD
Sbjct: 134 PQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVP-LAGLTKLQNLYLSKNHISD 192
Query: 516 FIPRCFEEMRSLSWIDIS 533
R +++L +++
Sbjct: 193 L--RALAGLKNLDVLELF 208
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 43.5 bits (101), Expect = 4e-05
Identities = 38/206 (18%), Positives = 66/206 (32%), Gaps = 17/206 (8%)
Query: 211 NLKSLSTLGLHINQLNGVIPPSIGNLSSLRNLSLFNNRLYGFVPKEIGYLKSLSKLEFCA 270
L + + + L+S+ + N+ + I YL +++KL
Sbjct: 22 AFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNG 77
Query: 271 NHLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLRNLTSLERVRFNQNNLYGKVYEAFG 330
N L+ + NL L L + EN + + +L
Sbjct: 78 NKLTD--IKPLANLKNLGWLFLDENKVKDLSSLKDLK-------KLKSLSLEHNGISDIN 128
Query: 331 DHPNLTFLDLSQNNFYCEISFNWRNFSKLGTFNASMNNIYGSIPPEIGDSSKLQVLDLSS 390
+L L+ + + +N I P + +KLQ L LS
Sbjct: 129 GLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVP-LAGLTKLQNLYLSK 187
Query: 391 NHIFGKIPVQLVKLFSLNKLILSLNQ 416
NHI + L L +L+ L L +Q
Sbjct: 188 NHI-SDLRA-LAGLKNLDVLELF-SQ 210
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 43.5 bits (101), Expect = 4e-05
Identities = 35/194 (18%), Positives = 66/194 (34%), Gaps = 26/194 (13%)
Query: 91 NLSNLALLYLNDNSLFGSIPIVMGNLKSLSTLDLSQNQLNGSIPCSLDNLSNLDTLFLYK 150
+ L S+ ++ L S+ + + + + + L N+ LFL
Sbjct: 22 AFAETIKDNLKKKSVTDAVTQ--NELNSIDQIIANNSDIKS--VQGIQYLPNVTKLFLNG 77
Query: 151 NSLSGPIPSVIGNLKSLLQLDLSENRLS-----------------GLIPLSLSNLSSLTV 193
N L+ P + NLK+L L L EN++ ++ L L
Sbjct: 78 NKLTDIKP--LANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDINGLVHLPQ 135
Query: 194 MSLFNNSLSGSIPPILGNLKSLSTLGLHINQLNGVIPPSIGNLSSLRNLSLFNNRLYGFV 253
+ + + + + + I P + L+ L+NL L N +
Sbjct: 136 LESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVP-LAGLTKLQNLYLSKNHISDL- 193
Query: 254 PKEIGYLKSLSKLE 267
+ + LK+L LE
Sbjct: 194 -RALAGLKNLDVLE 206
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 42.7 bits (99), Expect = 6e-05
Identities = 38/206 (18%), Positives = 78/206 (37%), Gaps = 17/206 (8%)
Query: 19 NLSKLQYLDLGNNQLSGVIPPEIGKLNQLRRLYLDVNQLHGTIPPVIGQLSLINELVFCH 78
++ +L ++ + +LN + ++ + + + I L + +L
Sbjct: 22 AFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNG 77
Query: 79 NNVSGRIPSSLGNLSNLALLYLNDNSLFGSIPIVMGNLKSLSTLDLSQNQLNGSIPCSLD 138
N ++ L+NL L + ++ I L
Sbjct: 78 NKLTDIK-----PLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDI-NGLV 131
Query: 139 NLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSENRLSGLIPLSLSNLSSLTVMSLFN 198
+L L++L+L N ++ + L L L L +N++S ++PL+ L+ L + L
Sbjct: 132 HLPQLESLYLGNNKITDITV--LSRLTKLDTLSLEDNQISDIVPLA--GLTKLQNLYLSK 187
Query: 199 NSLSGSIPPILGNLKSLSTLGLHINQ 224
N +S + L LK+L L L +Q
Sbjct: 188 NHIS-DLRA-LAGLKNLDVLELF-SQ 210
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 43.5 bits (101), Expect = 3e-05
Identities = 32/190 (16%), Positives = 68/190 (35%), Gaps = 23/190 (12%)
Query: 19 NLSKLQYLDLGNNQLSGVIPPEIGKLNQLRRLYLDVNQLHGTIPPVIGQLSLINELVFCH 78
L++ LG ++ + L+Q+ L D + +I + L+ + ++ F +
Sbjct: 16 ALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIK-SIDG-VEYLNNLTQINFSN 71
Query: 79 NNVSGRIPSSLGNLSNLALLYLNDNSLFGSIPIVMGNLKSLSTLDLSQNQLNGSIPCSLD 138
N ++ P L+ N + + + + + +L+
Sbjct: 72 NQLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLN 131
Query: 139 NLSNLDTLFLYK----------------NSLSGPIPSVIGNLKSLLQLDLSENRLSGLIP 182
L N ++ P + NL +L +LD+S N++S +
Sbjct: 132 RLELSSNTISDISALSGLTSLQQLNFSSNQVTDLKP--LANLTTLERLDISSNKVSDISV 189
Query: 183 LS-LSNLSSL 191
L+ L+NL SL
Sbjct: 190 LAKLTNLESL 199
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 43.1 bits (100), Expect = 4e-05
Identities = 30/200 (15%), Positives = 67/200 (33%), Gaps = 16/200 (8%)
Query: 283 NLTGLVLLNMCENHLFGPIPKSLRNLTSLERVRFNQNNLYGKVYEAFGDHPNLTFLDLSQ 342
L + + + ++ + ++ +L + ++ ++ + K + NLT ++ S
Sbjct: 16 ALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGI--KSIDGVEYLNNLTQINFSN 71
Query: 343 NNFYCEISFNWRNFSKLGTFNASMNNIYGSIPPEIGDSSKLQVLDLSSNHIFGKIPVQLV 402
N N + + + + ++ K L
Sbjct: 72 NQLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLN 131
Query: 403 KLFSLNKLILSLNQLFGGVPLEFGTLTELQYLDLSANKLSSSIPMSIGNLLKLHYLNLSN 462
+L + I ++ L G L+ + Q DL + NL L L++S+
Sbjct: 132 RLELSSNTISDISALSGLTSLQQLNFSSNQVTDLK----------PLANLTTLERLDISS 181
Query: 463 NQFSHKIPTEFEKLIHLSEL 482
N+ S + KL +L L
Sbjct: 182 NKVSD--ISVLAKLTNLESL 199
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.7 bits (96), Expect = 8e-05
Identities = 28/144 (19%), Positives = 47/144 (32%), Gaps = 3/144 (2%)
Query: 75 VFCHNNVSGRIPSSLGNLSNLALLYLNDNSLFGSIP-IVMGNLKSLSTLDLSQNQLNGSI 133
+ C + + L NL LY+ + + + L L L + ++ L
Sbjct: 13 LRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVA 72
Query: 134 PCSLDNLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSENRLSGLIPLS-LSNLSSLT 192
P + L L L N+L + SL +L LS N L L L
Sbjct: 73 PDAFHFTPRLSRLNLSFNALES-LSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEG 131
Query: 193 VMSLFNNSLSGSIPPILGNLKSLS 216
+ + L L ++ + S
Sbjct: 132 LGGVPEQKLQCHGQGPLAHMPNAS 155
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.3 bits (95), Expect = 1e-04
Identities = 21/134 (15%), Positives = 42/134 (31%), Gaps = 3/134 (2%)
Query: 12 NIPPQIGNLSKLQYLDLGNNQLSGVIPPEI-GKLNQLRRLYLDVNQLHGTIPPVIGQLSL 70
+ + L L + N Q + L +LR L + + L P
Sbjct: 22 DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPR 81
Query: 71 INELVFCHNNVSGRIPSSLGNLSNLALLYLNDNSLFGSIPIV-MGNLKSLSTLDLSQNQL 129
++ L N + + +L L L+ N L S + + + + + +L
Sbjct: 82 LSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKL 140
Query: 130 NGSIPCSLDNLSNL 143
L ++ N
Sbjct: 141 QCHGQGPLAHMPNA 154
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.8 bits (91), Expect = 4e-04
Identities = 20/113 (17%), Positives = 35/113 (30%), Gaps = 3/113 (2%)
Query: 427 TLTELQYLDLSANKLSSSIPMSIGNLLKLHYLNLSNNQFSHKIPTEFEK-LIHLSELDLS 485
L + + + L L + N Q + + L L L +
Sbjct: 6 CPHGSSGLRCTRDGALD-SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIV 64
Query: 486 HNILQEEIPPQICKMESLEKLNLSHNNLSDFIPRCFEEMRSLSWIDISYNELQ 538
+ L+ P L +LNLS N L + + + + +S N L
Sbjct: 65 KSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSL-QELVLSGNPLH 116
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} Length = 198 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Score = 37.7 bits (86), Expect = 0.003
Identities = 29/176 (16%), Positives = 54/176 (30%), Gaps = 24/176 (13%)
Query: 2 LNLGFNLLFGNIPP------QIGNLSKLQYLDLGNNQLSGVIPPEIGKLNQLRRLYLDVN 55
L G IPP + L ++L L N + + + + LR L +
Sbjct: 23 TEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEKI--SSLSGMENLR--ILSLG 78
Query: 56 QLHGTIPPVIGQLSLINELVFCHNNVSGRIPSSLGNLSNLALLYLNDNSLFGSIPIVMGN 115
+ + ++ E ++ N + ++ L N+ +
Sbjct: 79 RNLIKKIENLDAVADTLEELWISYNQIASLSGIEKLVNLRVLYMSNNKITNWGEIDKLAA 138
Query: 116 LKSLSTLDLSQNQLNGSIPCSLDNLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLD 171
L L L L+ N L + N+ S V+ L +L +LD
Sbjct: 139 LDKLEDLLLAGNPLYNDYKEN--------------NATSEYRIEVVKRLPNLKKLD 180
|
Homologous Domains Detected by HHsearch 
Original result of HHsearch against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 918 | |||
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.97 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.97 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.96 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.96 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.95 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.94 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.94 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.93 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.9 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.9 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.85 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.84 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.83 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.8 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.8 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.79 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.78 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.78 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.77 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.76 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.75 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.74 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.74 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.74 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.73 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.58 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.55 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.55 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.54 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.53 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.51 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.46 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.45 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.43 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.42 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.38 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.37 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.82 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.56 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.3 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.93 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.86 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.69 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.38 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 97.36 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 97.0 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.97 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 95.82 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 95.7 |
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-48 Score=412.06 Aligned_cols=249 Identities=26% Similarity=0.417 Sum_probs=208.9
Q ss_pred cCCCCceeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEEE
Q 044366 646 GNFGEKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFIV 724 (918)
Q Consensus 646 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 724 (918)
++|+..+.||+|+||.||+|.. .+|+.||||+++.. .....+.+.+|+++++.++|||||++++++.+++..++|
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~----~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 95 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQ----QQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV 95 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGG----GCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecc----cChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEE
Confidence 4799999999999999999964 57999999998753 223467899999999999999999999999999999999
Q ss_pred EEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccCC
Q 044366 725 CEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEP 804 (918)
Q Consensus 725 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~~ 804 (918)
|||+++|+|.+++.+. .+++.+++.++.||+.||+|||+. +||||||||+|||++.++.+||+|||+|+.+..
T Consensus 96 mEy~~gg~L~~~~~~~----~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~ 168 (293)
T d1yhwa1 96 MEYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP 168 (293)
T ss_dssp EECCTTCBHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCS
T ss_pred EEecCCCcHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCcHHHeEECCCCcEeeccchhheeecc
Confidence 9999999999988653 489999999999999999999999 999999999999999999999999999998876
Q ss_pred CCCCceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCCCCCcch
Q 044366 805 HSSNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRDV 884 (918)
Q Consensus 805 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 884 (918)
........+||+.|+|||++.+..++.++||||+||++|||++|+.||....... ... .......+.. ...
T Consensus 169 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~-~~~-------~~~~~~~~~~-~~~ 239 (293)
T d1yhwa1 169 EQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR-ALY-------LIATNGTPEL-QNP 239 (293)
T ss_dssp TTCCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-HHH-------HHHHHCSCCC-SSG
T ss_pred ccccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHH-HHH-------HHHhCCCCCC-CCc
Confidence 6656667789999999999999999999999999999999999999986543211 111 1111111110 111
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 885 TDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 885 ~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
......+.+++.+||+.||++|||++|+++
T Consensus 240 ~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 240 EKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp GGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred ccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 122356888999999999999999999875
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.9e-49 Score=408.74 Aligned_cols=252 Identities=23% Similarity=0.363 Sum_probs=197.7
Q ss_pred cCCCCceeeccccceEEEEEEeCCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEEEE
Q 044366 646 GNFGEKYCIGKGGQRSVYKAELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFIVC 725 (918)
Q Consensus 646 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 725 (918)
.+|...+.||+|+||.||+|.+.+++.||||+++. .....++|.+|++++++++|||||+++|+|.+++..++||
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~-----~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~ 79 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIRE-----GAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVF 79 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCS-----SSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECC-----CcCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEE
Confidence 46788899999999999999988899999999865 2334678999999999999999999999999999999999
Q ss_pred EeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccCCC
Q 044366 726 EYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPH 805 (918)
Q Consensus 726 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~~~ 805 (918)
||+++|+|.+++... ...+++..++.++.|||+||+|||+. +|+||||||+||++++++.+||+|||+++.....
T Consensus 80 E~~~~g~L~~~l~~~--~~~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~ 154 (263)
T d1sm2a_ 80 EFMEHGCLSDYLRTQ--RGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD 154 (263)
T ss_dssp ECCTTCBHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECSCC--------
T ss_pred EecCCCcHHHHhhcc--ccCCCHHHHHHHHHHHHHHHHhhhcc---ceeecccchhheeecCCCCeEecccchheeccCC
Confidence 999999999998764 34589999999999999999999999 9999999999999999999999999999877544
Q ss_pred CCC-ceecccccccccccccccCCCCcccchhhHHHHHHHHHhC-CCCCCcchhhhhhhhhhHhhhhhhcccCCCCCCcc
Q 044366 806 SSN-WTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKG-YHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRD 883 (918)
Q Consensus 806 ~~~-~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 883 (918)
... .....||+.|+|||++.+..++.++|||||||++|||+|| ++|+..... ..... .+.. ...+..+..
T Consensus 155 ~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~-~~~~~----~i~~---~~~~~~p~~ 226 (263)
T d1sm2a_ 155 QYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN-SEVVE----DIST---GFRLYKPRL 226 (263)
T ss_dssp ----------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCH-HHHHH----HHHH---TCCCCCCTT
T ss_pred CceeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCH-HHHHH----HHHh---cCCCCCccc
Confidence 332 2345789999999999999999999999999999999995 555443221 11111 1111 111111111
Q ss_pred hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhC
Q 044366 884 VTDKLRSIMEVAILCLVENPEARPTMKEVCNLLCK 918 (918)
Q Consensus 884 ~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~ 918 (918)
. ..++.+++.+||+.||++|||++||++.|++
T Consensus 227 ~---~~~l~~li~~cl~~~p~~Rps~~~il~~L~~ 258 (263)
T d1sm2a_ 227 A---STHVYQIMNHCWKERPEDRPAFSRLLRQLAE 258 (263)
T ss_dssp S---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred c---CHHHHHHHHHHccCCHhHCcCHHHHHHHHHH
Confidence 1 2467889999999999999999999999863
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-48 Score=407.72 Aligned_cols=257 Identities=24% Similarity=0.389 Sum_probs=200.8
Q ss_pred hcCCCCceeeccccceEEEEEEeCCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEEE
Q 044366 645 TGNFGEKYCIGKGGQRSVYKAELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFIV 724 (918)
Q Consensus 645 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 724 (918)
.++|...+.||+|+||.||+|++. ..||||+++... ......+.|.+|++++++++|||||+++|++.+ +..++|
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv 81 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTA--PTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIV 81 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSS--CCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEE
T ss_pred cccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEccc--CCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEE
Confidence 467899999999999999999864 469999987542 223446789999999999999999999998765 568999
Q ss_pred EEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccCC
Q 044366 725 CEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEP 804 (918)
Q Consensus 725 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~~ 804 (918)
|||+++|+|.+++.... ..+++.+++.|+.|||+||+|||+. +||||||||+|||++.++.+||+|||+|+....
T Consensus 82 ~Ey~~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~ 156 (276)
T d1uwha_ 82 TQWCEGSSLYHHLHIIE--TKFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSR 156 (276)
T ss_dssp EECCCEEEHHHHHHTSC--CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEEECCCCCSCC---
T ss_pred EecCCCCCHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHhcC---CEeccccCHHHEEEcCCCCEEEccccceeeccc
Confidence 99999999999997543 4589999999999999999999999 999999999999999999999999999987654
Q ss_pred CCC--Cceeccccccccccccccc---CCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCCC
Q 044366 805 HSS--NWTEFAGTVGYAAPELAYT---MRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPT 879 (918)
Q Consensus 805 ~~~--~~~~~~g~~~y~aPE~~~~---~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 879 (918)
... ......||+.|||||++.+ ..++.++|||||||++|||+||+.||......... ..... .....+....
T Consensus 157 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~-~~~~~--~~~~~p~~~~ 233 (276)
T d1uwha_ 157 WSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQI-IFMVG--RGYLSPDLSK 233 (276)
T ss_dssp ---------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHH-HHHHH--HTSCCCCGGG
T ss_pred cCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHH-HHHHh--cCCCCCcchh
Confidence 322 3345679999999999864 34789999999999999999999998754322111 11110 1111111111
Q ss_pred CCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 044366 880 PSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLLC 917 (918)
Q Consensus 880 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 917 (918)
.. ......+.+++.+||+.||++|||++||++.|+
T Consensus 234 ~~---~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le 268 (276)
T d1uwha_ 234 VR---SNCPKAMKRLMAECLKKKRDERPLFPQILASIE 268 (276)
T ss_dssp SC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred cc---ccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHH
Confidence 11 122356888999999999999999999999886
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-48 Score=407.83 Aligned_cols=251 Identities=24% Similarity=0.325 Sum_probs=202.5
Q ss_pred cCCCCceeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEEE
Q 044366 646 GNFGEKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFIV 724 (918)
Q Consensus 646 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 724 (918)
++|++.+.||+|+||+||+|+. .+|+.||||++..... ....+.+.+|++++++++||||+++++++.+++..++|
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~---~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~iv 81 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA---VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF 81 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC----------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhc---chHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEE
Confidence 5788999999999999999965 5799999999876422 22345689999999999999999999999999999999
Q ss_pred EEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccCC
Q 044366 725 CEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEP 804 (918)
Q Consensus 725 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~~ 804 (918)
|||+++|+|.+++... ..+++.+++.++.||++||+|||+. +|+||||||+|||+++++.+||+|||+|+....
T Consensus 82 mEy~~gg~L~~~l~~~---~~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~ 155 (271)
T d1nvra_ 82 LEYCSGGELFDRIEPD---IGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRY 155 (271)
T ss_dssp EECCTTEEGGGGSBTT---TBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECEE
T ss_pred EeccCCCcHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHc---CCccCcccHHHEEECCCCCEEEccchhheeecc
Confidence 9999999999999754 3589999999999999999999999 999999999999999999999999999987653
Q ss_pred CC--CCceecccccccccccccccCCC-CcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCCCCC
Q 044366 805 HS--SNWTEFAGTVGYAAPELAYTMRA-TEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPS 881 (918)
Q Consensus 805 ~~--~~~~~~~g~~~y~aPE~~~~~~~-~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 881 (918)
.. ......+||+.|||||++.+..+ +.++||||+||++|||++|+.||............ .........
T Consensus 156 ~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~-------~~~~~~~~~- 227 (271)
T d1nvra_ 156 NNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSD-------WKEKKTYLN- 227 (271)
T ss_dssp TTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHH-------HHTTCTTST-
T ss_pred CCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHH-------HhcCCCCCC-
Confidence 32 22345689999999999988776 57899999999999999999998654332111111 111111111
Q ss_pred cchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 882 RDVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 882 ~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
.......++.+++.+||+.||++|||++|+++
T Consensus 228 -~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 228 -PWKKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp -TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -ccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 11122346778999999999999999999975
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-48 Score=402.98 Aligned_cols=249 Identities=28% Similarity=0.420 Sum_probs=208.1
Q ss_pred hcCCCCceeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEE
Q 044366 645 TGNFGEKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFI 723 (918)
Q Consensus 645 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 723 (918)
.++|++.+.||+|+||.||+|+. .+|+.||+|++......+ ....+.+.+|+++++.++|||||++++++.+++..++
T Consensus 5 l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i 83 (263)
T d2j4za1 5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEK-AGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL 83 (263)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHH-TTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred hhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccC-hHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEE
Confidence 35788999999999999999965 579999999987643332 3346789999999999999999999999999999999
Q ss_pred EEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccC
Q 044366 724 VCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLE 803 (918)
Q Consensus 724 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~ 803 (918)
||||+++|+|.+++.... .+++.+++.++.||++||+|||++ +||||||||+||+++.++.+||+|||+|....
T Consensus 84 vmEy~~~g~L~~~l~~~~---~l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~ 157 (263)
T d2j4za1 84 ILEYAPLGTVYRELQKLS---KFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP 157 (263)
T ss_dssp EEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCSCSCCC
T ss_pred EEeecCCCcHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeeeeeccccceecCCCCEeecccceeeecC
Confidence 999999999999997643 489999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCCceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCCCCCcc
Q 044366 804 PHSSNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRD 883 (918)
Q Consensus 804 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 883 (918)
.. ......||+.|+|||++.+..++.++|||||||++|||++|+.||+..... .. ...+....+..+ ..
T Consensus 158 ~~--~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~-----~~---~~~i~~~~~~~p-~~ 226 (263)
T d2j4za1 158 SS--RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ-----ET---YKRISRVEFTFP-DF 226 (263)
T ss_dssp CC--CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHH-----HH---HHHHHTTCCCCC-TT
T ss_pred CC--cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHH-----HH---HHHHHcCCCCCC-cc
Confidence 33 334568999999999999999999999999999999999999998754321 11 111112222111 11
Q ss_pred hHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 884 VTDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 884 ~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
. ..++.+++.+||+.||++|||++|+++
T Consensus 227 ~---s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 227 V---TEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp S---CHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred C---CHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 2 245788999999999999999999986
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.3e-49 Score=409.39 Aligned_cols=256 Identities=24% Similarity=0.359 Sum_probs=194.8
Q ss_pred cCCCCceeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEeccccc--CCceE
Q 044366 646 GNFGEKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSN--AQHSF 722 (918)
Q Consensus 646 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~ 722 (918)
++|++.+.||+|+||.||+|+. .+|+.||||++...... ....+.|.+|++++++++|||||++++++.+ ++..+
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~--~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ 81 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMT--EAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLY 81 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSC--HHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCC--HHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEE
Confidence 5789999999999999999965 57999999998764322 2235679999999999999999999998854 45689
Q ss_pred EEEEeccCCChhHHhhccc-ccCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCeEEcCCCCCCeeeCCCCcEEEeccccc
Q 044366 723 IVCEYLARGSLTTILRDDA-AAKEFSWNQRMNVIKGVANALSYLHHDC--IPPIVHRDISSKNVLLDSEYEAHVSDFGFA 799 (918)
Q Consensus 723 lv~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~--~~~ivH~dlk~~Nill~~~~~~kl~DfG~~ 799 (918)
+||||+++|+|.+++.+.. ....+++.+++.++.||+.||+|||+.. ..+||||||||+|||++.++.+||+|||+|
T Consensus 82 ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a 161 (269)
T d2java1 82 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA 161 (269)
T ss_dssp EEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHH
T ss_pred EEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccce
Confidence 9999999999999997542 3456999999999999999999999861 114999999999999999999999999999
Q ss_pred cccCCCCCCceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCCC
Q 044366 800 KFLEPHSSNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPT 879 (918)
Q Consensus 800 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 879 (918)
+.+...........||+.|+|||++.+..++.++|||||||++|||+||+.||...... ... ..+.....+.
T Consensus 162 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~-----~~~---~~i~~~~~~~ 233 (269)
T d2java1 162 RILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK-----ELA---GKIREGKFRR 233 (269)
T ss_dssp HHC-----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH-----HHH---HHHHHTCCCC
T ss_pred eecccCCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHH-----HHH---HHHHcCCCCC
Confidence 98876555556678999999999999999999999999999999999999998754321 111 1112222222
Q ss_pred CCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 880 PSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 880 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
.+... ..++.+++.+||+.||++|||++|+++
T Consensus 234 ~~~~~---s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 234 IPYRY---SDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp CCTTS---CHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCccc---CHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 22222 245788999999999999999999975
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-48 Score=406.48 Aligned_cols=253 Identities=21% Similarity=0.359 Sum_probs=205.3
Q ss_pred hcCCCCceeeccccceEEEEEEeCCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEEE
Q 044366 645 TGNFGEKYCIGKGGQRSVYKAELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFIV 724 (918)
Q Consensus 645 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 724 (918)
.++|+..+.||+|+||.||+|.+++++.||||+++. .....++|.+|++++++++|||||+++|++.+ +..++|
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~-----~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv 85 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQ-----GSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYII 85 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECT-----TSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred HHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEcc-----CcCCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEE
Confidence 467888899999999999999998889999999864 23346789999999999999999999998865 567999
Q ss_pred EEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccCC
Q 044366 725 CEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEP 804 (918)
Q Consensus 725 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~~ 804 (918)
|||+++|+|.+++.... ...+++.++++|+.|||+||+|||+. +|+||||||+||++++++.+||+|||+|+...+
T Consensus 86 ~Ey~~~g~L~~~~~~~~-~~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~ 161 (272)
T d1qpca_ 86 TEYMENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIED 161 (272)
T ss_dssp EECCTTCBHHHHTTSHH-HHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred EEeCCCCcHHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccchhheeeecccceeeccccceEEccC
Confidence 99999999999886543 34589999999999999999999999 999999999999999999999999999998764
Q ss_pred CCC-CceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCCCCCcc
Q 044366 805 HSS-NWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRD 883 (918)
Q Consensus 805 ~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 883 (918)
... ......||+.|+|||++.+..++.++|||||||++|||+||..|+........... . +.....+..+..
T Consensus 162 ~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~----~---i~~~~~~~~p~~ 234 (272)
T d1qpca_ 162 NEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQ----N---LERGYRMVRPDN 234 (272)
T ss_dssp SCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHH----H---HHTTCCCCCCTT
T ss_pred CccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHH----H---HHhcCCCCCccc
Confidence 432 22345688999999999998999999999999999999996655432222111111 1 111111111122
Q ss_pred hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 044366 884 VTDKLRSIMEVAILCLVENPEARPTMKEVCNLLC 917 (918)
Q Consensus 884 ~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 917 (918)
. ...+.+++.+||+.||++|||++||++.|+
T Consensus 235 ~---~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~ 265 (272)
T d1qpca_ 235 C---PEELYQLMRLCWKERPEDRPTFDYLRSVLE 265 (272)
T ss_dssp C---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred C---hHHHHHHHHHHcCCCHhHCcCHHHHHHHhh
Confidence 2 245788999999999999999999999875
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2e-48 Score=413.17 Aligned_cols=254 Identities=28% Similarity=0.476 Sum_probs=193.4
Q ss_pred cCCCCceeeccccceEEEEEEeC-CCC---EEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCce
Q 044366 646 GNFGEKYCIGKGGQRSVYKAELP-SGN---IFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHS 721 (918)
Q Consensus 646 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~---~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 721 (918)
++|+..+.||+|+||.||+|... +|+ .||||++.... .....++|.+|++++++++|||||+++|++.+++..
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~ 102 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY---TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPV 102 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSC---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECccc---CHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEE
Confidence 34556689999999999999764 333 58999876532 222356899999999999999999999999999999
Q ss_pred EEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccc
Q 044366 722 FIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKF 801 (918)
Q Consensus 722 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~ 801 (918)
++||||+++|+|.+++... ...++|.+++.|+.|||+||+|||+. +|+||||||+|||++.++.+||+|||+|+.
T Consensus 103 ~iv~Ey~~~g~L~~~~~~~--~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~ 177 (299)
T d1jpaa_ 103 MIITEFMENGSLDSFLRQN--DGQFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDFGLSRF 177 (299)
T ss_dssp EEEEECCTTEEHHHHHHTT--TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC-----
T ss_pred EEEEEecCCCcceeeeccc--cCCCCHHHHHHHHHHHHHHHHHHhhC---CCccCccccceEEECCCCcEEECCcccceE
Confidence 9999999999999998764 34589999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCCc-----eecccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhhhhhhhhhHhhhhhhccc
Q 044366 802 LEPHSSNW-----TEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIK-GYHPGDFVSTIFSSISNMIIEVNQILDH 875 (918)
Q Consensus 802 ~~~~~~~~-----~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 875 (918)
........ ....||+.|||||++.+..++.++|||||||++|||+| |+.||...... . ....+.. ..
T Consensus 178 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~--~---~~~~i~~--~~ 250 (299)
T d1jpaa_ 178 LEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ--D---VINAIEQ--DY 250 (299)
T ss_dssp ------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--H---HHHHHHT--TC
T ss_pred ccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHH--H---HHHHHHc--CC
Confidence 75443221 22457899999999999999999999999999999998 89998654321 1 1111111 11
Q ss_pred CCCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhC
Q 044366 876 RLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLLCK 918 (918)
Q Consensus 876 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~ 918 (918)
+++. +.. ....+.+++.+||+.||++|||++||++.|++
T Consensus 251 ~~~~-~~~---~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~ 289 (299)
T d1jpaa_ 251 RLPP-PMD---CPSALHQLMLDCWQKDRNHRPKFGQIVNTLDK 289 (299)
T ss_dssp CCCC-CTT---CCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred CCCC-Ccc---chHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 2222 222 23467889999999999999999999998863
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.3e-48 Score=412.07 Aligned_cols=255 Identities=23% Similarity=0.352 Sum_probs=208.3
Q ss_pred HhcCCCCceeeccccceEEEEEEeC-CCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceE
Q 044366 644 ATGNFGEKYCIGKGGQRSVYKAELP-SGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSF 722 (918)
Q Consensus 644 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 722 (918)
..++|...+.||+|+||.||+|.+. +|+.||||+++.. ....++|.+|++++++++|||||+++|+|.+++..+
T Consensus 15 ~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~-----~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 89 (287)
T d1opja_ 15 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-----TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY 89 (287)
T ss_dssp CGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTT-----CSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred cHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCc-----cchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeE
Confidence 4467888899999999999999664 6889999998652 334678999999999999999999999999999999
Q ss_pred EEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEecccccccc
Q 044366 723 IVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFL 802 (918)
Q Consensus 723 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~ 802 (918)
+||||+++|+|.+++.... ...+++..++.|+.|||+||+|||+. +|+||||||+|||+++++.+||+|||+|+..
T Consensus 90 iv~E~~~~g~l~~~l~~~~-~~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~ 165 (287)
T d1opja_ 90 IITEFMTYGNLLDYLRECN-RQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLM 165 (287)
T ss_dssp EEEECCTTCBHHHHHHHSC-TTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCCTTTC
T ss_pred EEeecccCcchHHHhhhcc-ccchHHHHHHHHHHHHHHHHHHHHHC---CcccCccccCeEEECCCCcEEEccccceeec
Confidence 9999999999999997643 34689999999999999999999999 9999999999999999999999999999877
Q ss_pred CCCCCC-ceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCCCCC
Q 044366 803 EPHSSN-WTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPS 881 (918)
Q Consensus 803 ~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 881 (918)
...... .....|++.|+|||++.+..++.++|||||||++|||++|..|+......... ...+.. ...+..+
T Consensus 166 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~----~~~i~~---~~~~~~~ 238 (287)
T d1opja_ 166 TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV----YELLEK---DYRMERP 238 (287)
T ss_dssp CSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH----HHHHHT---TCCCCCC
T ss_pred CCCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHH----HHHHhc---CCCCCCC
Confidence 554332 23345789999999999999999999999999999999977765332221111 111111 1111111
Q ss_pred cchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 044366 882 RDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLLC 917 (918)
Q Consensus 882 ~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 917 (918)
... ...+.+++.+||+.||++|||++||++.|+
T Consensus 239 ~~~---~~~l~~li~~cl~~dP~~Rps~~ei~~~L~ 271 (287)
T d1opja_ 239 EGC---PEKVYELMRACWQWNPSDRPSFAEIHQAFE 271 (287)
T ss_dssp TTC---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred ccc---hHHHHHHHHHHcCCCHhHCcCHHHHHHHHH
Confidence 222 346888999999999999999999998875
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-47 Score=396.84 Aligned_cols=251 Identities=22% Similarity=0.388 Sum_probs=210.4
Q ss_pred cCCCCceeeccccceEEEEEEeCCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEEEE
Q 044366 646 GNFGEKYCIGKGGQRSVYKAELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFIVC 725 (918)
Q Consensus 646 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 725 (918)
++|+..++||+|+||+||+|++++++.||||+++.. ....++|.+|++++++++||||++++|+|.+++..++||
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~-----~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~ 78 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG-----SMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIIT 78 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESS-----SSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEE
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcC-----cCCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEE
Confidence 578899999999999999999988889999998753 334678999999999999999999999999999999999
Q ss_pred EeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccCCC
Q 044366 726 EYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPH 805 (918)
Q Consensus 726 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~~~ 805 (918)
||+++|+|.+++.... ..+++..+++++.|+|+||+|||+. +|+||||||+||++++++.+||+|||+++.....
T Consensus 79 Ey~~~g~l~~~~~~~~--~~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~ 153 (258)
T d1k2pa_ 79 EYMANGCLLNYLREMR--HRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD 153 (258)
T ss_dssp ECCTTEEHHHHHHSGG--GCCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSS
T ss_pred EccCCCcHHHhhhccc--cCCcHHHHHHHHHHHHHHHHHHhhc---CcccccccceeEEEcCCCcEEECcchhheeccCC
Confidence 9999999999986553 3589999999999999999999999 9999999999999999999999999999876554
Q ss_pred CC-CceecccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhhhhhhhhhHhhhhhhcccCCCCCCcc
Q 044366 806 SS-NWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIK-GYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRD 883 (918)
Q Consensus 806 ~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 883 (918)
.. ......||+.|+|||.+.+..++.++|||||||++|||+| |+.||+..... .+.. .+. ....+..+..
T Consensus 154 ~~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~--~~~~---~i~---~~~~~~~p~~ 225 (258)
T d1k2pa_ 154 EYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS--ETAE---HIA---QGLRLYRPHL 225 (258)
T ss_dssp SCCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHH--HHHH---HHH---TTCCCCCCTT
T ss_pred CceeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHH--HHHH---HHH---hCCCCCCccc
Confidence 33 2334678999999999999999999999999999999998 89998754321 1111 111 1111111222
Q ss_pred hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 044366 884 VTDKLRSIMEVAILCLVENPEARPTMKEVCNLLC 917 (918)
Q Consensus 884 ~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 917 (918)
. ...+.+++.+||+.||++|||++|+++.|.
T Consensus 226 ~---~~~l~~li~~cl~~dP~~RPt~~eil~~L~ 256 (258)
T d1k2pa_ 226 A---SEKVYTIMYSCWHEKADERPTFKILLSNIL 256 (258)
T ss_dssp C---CHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred c---cHHHHHHHHHHccCCHhHCcCHHHHHHHhh
Confidence 2 246889999999999999999999999874
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-48 Score=409.56 Aligned_cols=251 Identities=23% Similarity=0.320 Sum_probs=204.9
Q ss_pred cCCCCceeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEEE
Q 044366 646 GNFGEKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFIV 724 (918)
Q Consensus 646 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 724 (918)
+.|++.+.||+|+||.||+|+. .+|+.||||+++.. .....+.|.+|++++++++|||||++++++.+++..++|
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~----~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv 87 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTK----SEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWIL 87 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS----SSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcC----CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEE
Confidence 4688899999999999999965 57999999998653 233357899999999999999999999999999999999
Q ss_pred EEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccCC
Q 044366 725 CEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEP 804 (918)
Q Consensus 725 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~~ 804 (918)
|||+++|+|.+++.+. ...+++.++..++.||+.||+|||++ +||||||||+|||++.++.+||+|||+|+....
T Consensus 88 mEy~~~g~L~~~~~~~--~~~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~ 162 (288)
T d2jfla1 88 IEFCAGGAVDAVMLEL--ERPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTR 162 (288)
T ss_dssp EECCTTEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECHH
T ss_pred EecCCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CEEEeecChhheeECCCCCEEEEechhhhccCC
Confidence 9999999999998654 24589999999999999999999999 999999999999999999999999999986643
Q ss_pred CCCCceecccccccccccccc-----cCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCCC
Q 044366 805 HSSNWTEFAGTVGYAAPELAY-----TMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPT 879 (918)
Q Consensus 805 ~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 879 (918)
.........||+.|+|||++. +..++.++||||+||++|||++|+.||...... .. ...+.....+.
T Consensus 163 ~~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~-~~-------~~~i~~~~~~~ 234 (288)
T d2jfla1 163 TIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPM-RV-------LLKIAKSEPPT 234 (288)
T ss_dssp HHHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGG-GH-------HHHHHHSCCCC
T ss_pred CcccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHH-HH-------HHHHHcCCCCC
Confidence 333334567999999999984 456789999999999999999999998654321 11 11111111111
Q ss_pred CCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 880 PSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 880 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
. ........++.+++.+||+.||++|||++|+++
T Consensus 235 ~-~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 235 L-AQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp C-SSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred C-CccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1 111223356888999999999999999999975
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-47 Score=400.96 Aligned_cols=252 Identities=23% Similarity=0.307 Sum_probs=202.6
Q ss_pred cCCCCcee-eccccceEEEEEEeC---CCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCce
Q 044366 646 GNFGEKYC-IGKGGQRSVYKAELP---SGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHS 721 (918)
Q Consensus 646 ~~~~~~~~-lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 721 (918)
++|...+. ||+|+||.||+|.+. ++..||||+++... .....++|.+|++++++++|||||+++|++.+ +..
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~---~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~ 83 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT---EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EAL 83 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC---CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhc---CHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeE
Confidence 44555564 999999999999653 35579999987532 22335789999999999999999999999865 468
Q ss_pred EEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccc
Q 044366 722 FIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKF 801 (918)
Q Consensus 722 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~ 801 (918)
++||||+++|+|.+++... ...+++.+++.++.|||+||+|||+. +|+||||||+||+++.++.+||+|||+|+.
T Consensus 84 ~lvmE~~~~g~L~~~l~~~--~~~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~ 158 (285)
T d1u59a_ 84 MLVMEMAGGGPLHKFLVGK--REEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKA 158 (285)
T ss_dssp EEEEECCTTEEHHHHHTTC--TTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEEeCCCCcHHHHhhcc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCcCchhheeeccCCceeeccchhhhc
Confidence 9999999999999998654 24589999999999999999999999 999999999999999999999999999998
Q ss_pred cCCCCCC---ceecccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhhhhhhhhhHhhhhhhcccCC
Q 044366 802 LEPHSSN---WTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIK-GYHPGDFVSTIFSSISNMIIEVNQILDHRL 877 (918)
Q Consensus 802 ~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 877 (918)
+...... .....||+.|+|||++.+..++.++|||||||++|||+| |+.||...... .+. .. +.....
T Consensus 159 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~--~~~---~~---i~~~~~ 230 (285)
T d1u59a_ 159 LGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP--EVM---AF---IEQGKR 230 (285)
T ss_dssp CTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH--HHH---HH---HHTTCC
T ss_pred ccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHH--HHH---HH---HHcCCC
Confidence 7654332 234568899999999999999999999999999999998 89998754321 111 11 111222
Q ss_pred CCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 044366 878 PTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLLC 917 (918)
Q Consensus 878 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 917 (918)
+..+... +.++.+++.+||+.||++|||+.+|++.|+
T Consensus 231 ~~~p~~~---~~~l~~li~~cl~~~p~~RPs~~~i~~~L~ 267 (285)
T d1u59a_ 231 MECPPEC---PPELYALMSDCWIYKWEDRPDFLTVEQRMR 267 (285)
T ss_dssp CCCCTTC---CHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred CCCCCcC---CHHHHHHHHHHcCCCHhHCcCHHHHHHHHH
Confidence 2222222 246788999999999999999999998875
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.1e-47 Score=404.81 Aligned_cols=252 Identities=25% Similarity=0.361 Sum_probs=190.9
Q ss_pred hcCCCCceeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEE
Q 044366 645 TGNFGEKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFI 723 (918)
Q Consensus 645 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 723 (918)
.+.|+..+.||+|+||.||+|+. .+|+.||||++...... ...+.+.+|+++++.++|||||++++++.+++..++
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 84 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALE---GKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYL 84 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC-------------CHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhh---hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 46799999999999999999965 57999999999764322 224568899999999999999999999999999999
Q ss_pred EEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeC---CCCcEEEecccccc
Q 044366 724 VCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLD---SEYEAHVSDFGFAK 800 (918)
Q Consensus 724 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~---~~~~~kl~DfG~~~ 800 (918)
||||+++|+|.+++... ..+++.++..++.||+.||+|||+. +||||||||+||+++ +++.+||+|||+|+
T Consensus 85 vmE~~~gg~L~~~l~~~---~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~ 158 (307)
T d1a06a_ 85 IMQLVSGGELFDRIVEK---GFYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSK 158 (307)
T ss_dssp EECCCCSCBHHHHHHTC---SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCC----
T ss_pred EEeccCCCcHHHhhhcc---cCCCHHHHHHHHHHHHHHHHhhhhc---eeeeEEecccceeecccCCCceEEEeccceeE
Confidence 99999999999999764 3599999999999999999999999 999999999999995 57899999999998
Q ss_pred ccCCCCCCceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCCCC
Q 044366 801 FLEPHSSNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTP 880 (918)
Q Consensus 801 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 880 (918)
...... .....+||+.|+|||++.+..++.++||||+||++|||++|+.||...... . . ...+.......+
T Consensus 159 ~~~~~~-~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~-~----~---~~~i~~~~~~~~ 229 (307)
T d1a06a_ 159 MEDPGS-VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDA-K----L---FEQILKAEYEFD 229 (307)
T ss_dssp ---------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-H----H---HHHHHTTCCCCC
T ss_pred EccCCC-eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHH-H----H---HHHHhccCCCCC
Confidence 765433 234567999999999999999999999999999999999999998754321 0 1 111112222111
Q ss_pred CcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 881 SRDVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 881 ~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
..........+.+++.+||+.||++|||++|+++
T Consensus 230 ~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 263 (307)
T d1a06a_ 230 SPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ 263 (307)
T ss_dssp TTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred CccccCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 1112223356889999999999999999999987
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.2e-47 Score=396.44 Aligned_cols=246 Identities=26% Similarity=0.362 Sum_probs=196.4
Q ss_pred eeeccccceEEEEEEeC---CCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEEEEEec
Q 044366 652 YCIGKGGQRSVYKAELP---SGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFIVCEYL 728 (918)
Q Consensus 652 ~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 728 (918)
+.||+|+||.||+|.+. .++.||||+++... ......++|.+|++++++++|||||+++|+|.+ +..++||||+
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~ 89 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA--NDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMA 89 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECC
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhh--CCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcC
Confidence 57999999999999653 35689999987542 222335789999999999999999999999865 4578999999
Q ss_pred cCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccCCCCCC
Q 044366 729 ARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSN 808 (918)
Q Consensus 729 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~~~~~~ 808 (918)
++|+|.++++... .+++.+++.++.|||.||+|||+. +||||||||+||+++.++.+|++|||+++.+......
T Consensus 90 ~~g~L~~~l~~~~---~l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~ 163 (277)
T d1xbba_ 90 ELGPLNKYLQQNR---HVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY 163 (277)
T ss_dssp TTEEHHHHHHHCT---TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSE
T ss_pred CCCcHHHHHhhcc---CCCHHHHHHHHHHHHHHHhhHHhC---CcccCCCcchhhcccccCcccccchhhhhhccccccc
Confidence 9999999997643 489999999999999999999999 9999999999999999999999999999877654332
Q ss_pred c---eecccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhhhhhhhhhHhhhhhhcccCCCCCCcch
Q 044366 809 W---TEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIK-GYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRDV 884 (918)
Q Consensus 809 ~---~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 884 (918)
. ....||+.|+|||++.+..++.++|||||||++|||+| |+.||...... .+.. . +.....++.+...
T Consensus 164 ~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~--~~~~---~---i~~~~~~~~p~~~ 235 (277)
T d1xbba_ 164 YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS--EVTA---M---LEKGERMGCPAGC 235 (277)
T ss_dssp EEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--HHHH---H---HHTTCCCCCCTTC
T ss_pred cccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHH--HHHH---H---HHcCCCCCCCccc
Confidence 2 33568999999999999999999999999999999998 89998754321 1111 1 1111122222222
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 044366 885 TDKLRSIMEVAILCLVENPEARPTMKEVCNLLC 917 (918)
Q Consensus 885 ~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 917 (918)
+.++.+++.+||+.||++|||+++|++.|+
T Consensus 236 ---~~~~~~li~~cl~~dp~~RPs~~~i~~~L~ 265 (277)
T d1xbba_ 236 ---PREMYDLMNLCWTYDVENRPGFAAVELRLR 265 (277)
T ss_dssp ---CHHHHHHHHHHTCSSTTTSCCHHHHHHHHH
T ss_pred ---CHHHHHHHHHHcCCCHhHCcCHHHHHHHhh
Confidence 346788999999999999999999988774
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-46 Score=392.24 Aligned_cols=246 Identities=22% Similarity=0.323 Sum_probs=195.8
Q ss_pred CCceeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEeccccc----CCceEE
Q 044366 649 GEKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSN----AQHSFI 723 (918)
Q Consensus 649 ~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~----~~~~~l 723 (918)
...+.||+|+||+||+|.. .+++.||+|++...... ....+.|.+|++++++++|||||++++++.+ +...++
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~--~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~i 89 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLT--KSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL 89 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSC--HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCC--HHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEE
Confidence 4556899999999999965 57899999998764322 2235679999999999999999999999854 356799
Q ss_pred EEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--eEEcCCCCCCeeeC-CCCcEEEecccccc
Q 044366 724 VCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPP--IVHRDISSKNVLLD-SEYEAHVSDFGFAK 800 (918)
Q Consensus 724 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~--ivH~dlk~~Nill~-~~~~~kl~DfG~~~ 800 (918)
||||+++|+|.+++.+.. .+++.+++.++.||++||+|||++ + |+||||||+||+++ +++.+||+|||+|+
T Consensus 90 vmE~~~~g~L~~~l~~~~---~~~~~~~~~~~~qi~~gl~yLH~~---~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~ 163 (270)
T d1t4ha_ 90 VTELMTSGTLKTYLKRFK---VMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT 163 (270)
T ss_dssp EEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred EEeCCCCCcHHHHHhccc---cccHHHHHHHHHHHHHHHHHHHHC---CCCEEeCCcChhhceeeCCCCCEEEeecCcce
Confidence 999999999999997643 489999999999999999999998 6 99999999999997 47899999999998
Q ss_pred ccCCCCCCceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCCCC
Q 044366 801 FLEPHSSNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTP 880 (918)
Q Consensus 801 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 880 (918)
.... ......+||+.|||||++.+ .++.++||||+||++|||++|+.||........... .+.....+..
T Consensus 164 ~~~~--~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~-------~i~~~~~~~~ 233 (270)
T d1t4ha_ 164 LKRA--SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYR-------RVTSGVKPAS 233 (270)
T ss_dssp GCCT--TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHH-------HHTTTCCCGG
T ss_pred eccC--CccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHH-------HHHcCCCCcc
Confidence 6543 23356789999999998875 599999999999999999999999864332211111 1111111110
Q ss_pred CcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 881 SRDVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 881 ~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
......+++.+++.+||+.||++|||++|+++
T Consensus 234 --~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 234 --FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp --GGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred --cCccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 01112245788999999999999999999986
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-47 Score=399.75 Aligned_cols=249 Identities=21% Similarity=0.326 Sum_probs=204.2
Q ss_pred cCCCCceeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEEE
Q 044366 646 GNFGEKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFIV 724 (918)
Q Consensus 646 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 724 (918)
++|++.+.||+|+||.||+|+. .+|+.||||+++...... ....+.+.+|++++++++||||+++++++.+++..|+|
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~iv 86 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIK-ENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFG 86 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHH-TTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccC-HHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEE
Confidence 5689999999999999999965 579999999987643322 23467899999999999999999999999999999999
Q ss_pred EEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccCC
Q 044366 725 CEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEP 804 (918)
Q Consensus 725 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~~ 804 (918)
|||+++|+|.+++...+ .+++.+++.++.|++.||+|||+. +||||||||+||++++++.+||+|||+|+.+..
T Consensus 87 mEy~~gg~L~~~~~~~~---~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~ 160 (288)
T d1uu3a_ 87 LSYAKNGELLKYIRKIG---SFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSP 160 (288)
T ss_dssp ECCCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECC-
T ss_pred EEccCCCCHHHhhhccC---CCCHHHHHHHHHHHHHHHHhhccc---cEEcCcCCccccccCCCceEEecccccceeccc
Confidence 99999999999987653 489999999999999999999999 999999999999999999999999999988754
Q ss_pred CCC--CceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCCCCCc
Q 044366 805 HSS--NWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSR 882 (918)
Q Consensus 805 ~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 882 (918)
... .....+||+.|+|||++.+..++.++||||+||++|||++|+.||...... .. ...+....+..+ .
T Consensus 161 ~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~-~~-------~~~i~~~~~~~p-~ 231 (288)
T d1uu3a_ 161 ESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEY-LI-------FQKIIKLEYDFP-E 231 (288)
T ss_dssp ---------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-HH-------HHHHHTTCCCCC-T
T ss_pred CCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHH-HH-------HHHHHcCCCCCC-c
Confidence 322 234567999999999999999999999999999999999999998754321 11 111122222211 1
Q ss_pred chHHHHHHHHHHHHHcccCCCCCCCCHHHHH
Q 044366 883 DVTDKLRSIMEVAILCLVENPEARPTMKEVC 913 (918)
Q Consensus 883 ~~~~~~~~l~~li~~cl~~dp~~RPt~~evl 913 (918)
.. ..++.+++.+||+.||++|||++|++
T Consensus 232 ~~---s~~~~~li~~~L~~dP~~R~t~~e~~ 259 (288)
T d1uu3a_ 232 KF---FPKARDLVEKLLVLDATKRLGCEEME 259 (288)
T ss_dssp TC---CHHHHHHHHTTSCSSGGGSTTSGGGT
T ss_pred cC---CHHHHHHHHHHccCCHhHCcCHHHHc
Confidence 22 24578899999999999999999863
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.5e-47 Score=398.27 Aligned_cols=254 Identities=27% Similarity=0.417 Sum_probs=197.1
Q ss_pred cCCCCceeeccccceEEEEEEeCCC-----CEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCc
Q 044366 646 GNFGEKYCIGKGGQRSVYKAELPSG-----NIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQH 720 (918)
Q Consensus 646 ~~~~~~~~lg~G~~g~Vy~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 720 (918)
.+|+..++||+|+||.||+|.+..+ ..||||+++... ......+|.+|++++++++|||||+++|++.+.+.
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~ 83 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY---TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKP 83 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC---CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECccc---ChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCc
Confidence 5688889999999999999976432 379999986532 22234679999999999999999999999999999
Q ss_pred eEEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEecccccc
Q 044366 721 SFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAK 800 (918)
Q Consensus 721 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~ 800 (918)
.++||||+++|++.+++... ...+++.++++++.|||.||+|||+. +|+||||||+|||++.++.+||+|||+|+
T Consensus 84 ~~~v~e~~~~~~l~~~~~~~--~~~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~ 158 (283)
T d1mqba_ 84 MMIITEYMENGALDKFLREK--DGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSR 158 (283)
T ss_dssp EEEEEECCTTEEHHHHHHHT--TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred eEEEEEecccCcchhhhhcc--cccccHHHHHHHHHHHHHhhhhcccc---ccccCccccceEEECCCCeEEEcccchhh
Confidence 99999999999999988754 34589999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCC---ceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCC
Q 044366 801 FLEPHSSN---WTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRL 877 (918)
Q Consensus 801 ~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 877 (918)
.+...... .....||+.|+|||++.+..++.++|||||||++|||++|..|+......... .. .+.+...
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~----~~---~i~~~~~ 231 (283)
T d1mqba_ 159 VLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEV----MK---AINDGFR 231 (283)
T ss_dssp ---------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH----HH---HHHTTCC
T ss_pred cccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHH----HH---HHhccCC
Confidence 77543322 23356899999999999999999999999999999999976664332221111 11 1111212
Q ss_pred CCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 044366 878 PTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLLC 917 (918)
Q Consensus 878 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 917 (918)
++.+... ...+.+++.+||+.||++||||+||++.|+
T Consensus 232 ~~~~~~~---~~~l~~li~~cl~~~p~~RPt~~eil~~L~ 268 (283)
T d1mqba_ 232 LPTPMDC---PSAIYQLMMQCWQQERARRPKFADIVSILD 268 (283)
T ss_dssp CCCCTTC---BHHHHHHHHHHTCSSTTTSCCHHHHHHHHH
T ss_pred CCCchhh---HHHHHHHHHHHCcCCHhHCcCHHHHHHHHH
Confidence 2222222 345788999999999999999999999885
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-47 Score=410.27 Aligned_cols=257 Identities=24% Similarity=0.320 Sum_probs=204.3
Q ss_pred hcCCCCceeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEE
Q 044366 645 TGNFGEKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFI 723 (918)
Q Consensus 645 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 723 (918)
.++|++.+.||+|+||+||+|+. .+|+.||+|+++... .....+.+.+|+.++++++|||||++++++.+++..++
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~---~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~i 81 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI---KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI 81 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC---CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhh---CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 56899999999999999999965 579999999987532 23335789999999999999999999999999999999
Q ss_pred EEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEEcCCCCCCeeeCCCCcEEEecccccccc
Q 044366 724 VCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHH-DCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFL 802 (918)
Q Consensus 724 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~ 802 (918)
||||+++|+|.+++.+.+ .+++..++.++.|++.||+|||+ + +|+||||||+|||++.++.+||+|||+|+.+
T Consensus 82 VmEy~~gg~L~~~l~~~~---~l~~~~~~~~~~qil~aL~yLH~~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~ 155 (322)
T d1s9ja_ 82 CMEHMDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFGVSGQL 155 (322)
T ss_dssp EEECCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHHH---CCCCSCCSGGGEEECTTCCEEECCCCCCHHH
T ss_pred EEEcCCCCcHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHHhC---CEEccccCHHHeeECCCCCEEEeeCCCcccc
Confidence 999999999999997643 48999999999999999999996 5 8999999999999999999999999999876
Q ss_pred CCCCCCceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhH----------------
Q 044366 803 EPHSSNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMI---------------- 866 (918)
Q Consensus 803 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~---------------- 866 (918)
.+.. ....+||+.|+|||++.+..++.++||||+||++|||++|+.||..............
T Consensus 156 ~~~~--~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (322)
T d1s9ja_ 156 IDSM--ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTP 233 (322)
T ss_dssp HHHT--C---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC------------------
T ss_pred CCCc--cccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccc
Confidence 4322 2356899999999999999999999999999999999999999864332110000000
Q ss_pred ------------------hhhhhhcccCCCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 867 ------------------IEVNQILDHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 867 ------------------~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
..........++.... .....++.+++.+||+.||++|||++|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~s~~~~dli~~~L~~dP~~R~ta~e~L~ 297 (322)
T d1s9ja_ 234 GRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPS--GVFSLEFQDFVNKCLIKNPAERADLKQLMV 297 (322)
T ss_dssp ------------CCCCHHHHHHHHHTSCCCCCCB--TTBCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cccccccccccccchhHHHHHhhhhccCCccCcc--ccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence 0000000000111100 011246888999999999999999999975
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-46 Score=395.61 Aligned_cols=253 Identities=25% Similarity=0.407 Sum_probs=200.4
Q ss_pred hcCCCCceeeccccceEEEEEEeCCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEEE
Q 044366 645 TGNFGEKYCIGKGGQRSVYKAELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFIV 724 (918)
Q Consensus 645 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 724 (918)
.++|++.+.||+|+||.||+|..++++.||||+++.. ....+.|.+|+.++++++|||||+++|++.+ +..++|
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~-----~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv 89 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-----TMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIV 89 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTT-----SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred HHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcc-----cCCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEE
Confidence 3679999999999999999999888889999998652 3346789999999999999999999999865 567999
Q ss_pred EEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccCC
Q 044366 725 CEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEP 804 (918)
Q Consensus 725 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~~ 804 (918)
|||+++|+|..++.... ...++|.+++.++.|||+||+|||+. +|+||||||+||+++.++++||+|||+|+.+.+
T Consensus 90 ~Ey~~~g~l~~~~~~~~-~~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~ 165 (285)
T d1fmka3 90 TEYMSKGSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIED 165 (285)
T ss_dssp ECCCTTCBHHHHHSHHH-HTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC----
T ss_pred EEecCCCchhhhhhhcc-cccchHHHHHHHHHHHHHHHHHHhhh---heecccccceEEEECCCCcEEEcccchhhhccC
Confidence 99999999999987643 34589999999999999999999999 999999999999999999999999999987654
Q ss_pred CCC-CceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCCCCCcc
Q 044366 805 HSS-NWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRD 883 (918)
Q Consensus 805 ~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 883 (918)
... ......||+.|+|||++.++.++.++|||||||++|||++|..|+........... .+.. ..+.+ ....
T Consensus 166 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~----~i~~--~~~~~-~~~~ 238 (285)
T d1fmka3 166 NEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLD----QVER--GYRMP-CPPE 238 (285)
T ss_dssp ----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHH----HHHT--TCCCC-CCTT
T ss_pred CCceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHH----HHHh--cCCCC-CCcc
Confidence 332 33446789999999999999999999999999999999997666443322111111 1111 11111 1222
Q ss_pred hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 044366 884 VTDKLRSIMEVAILCLVENPEARPTMKEVCNLLC 917 (918)
Q Consensus 884 ~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 917 (918)
. ..++.++|.+||+.||++||++++|++.|+
T Consensus 239 ~---~~~l~~li~~cl~~dP~~Rps~~~i~~~L~ 269 (285)
T d1fmka3 239 C---PESLHDLMCQCWRKEPEERPTFEYLQAFLE 269 (285)
T ss_dssp S---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred c---CHHHHHHHHHHcccCHhHCcCHHHHHHHHh
Confidence 2 246888999999999999999999999875
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-46 Score=397.50 Aligned_cols=255 Identities=21% Similarity=0.305 Sum_probs=209.0
Q ss_pred hcCCCCceeeccccceEEEEEEe-CCCCEEEEEEcccccccC--CCCChHHHHHHHHHHhhccCCceeeEecccccCCce
Q 044366 645 TGNFGEKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSD--ETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHS 721 (918)
Q Consensus 645 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 721 (918)
.++|++.+.||+|+||.||+|+. .+|+.||||+++...... .....+.|.+|++++++++|||||++++++.+++..
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 46799999999999999999965 579999999997644332 223467899999999999999999999999999999
Q ss_pred EEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCC----cEEEeccc
Q 044366 722 FIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEY----EAHVSDFG 797 (918)
Q Consensus 722 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~----~~kl~DfG 797 (918)
++||||+++|+|.+++...+ .+++.+++.++.|++.||+|||+. +||||||||+||+++.++ .+|++|||
T Consensus 89 ~iv~E~~~gg~L~~~i~~~~---~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~~~~~vkl~DfG 162 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAEKE---SLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFG 162 (293)
T ss_dssp EEEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEEcCCCccccchhcccc---ccchhHHHHHHHHHHHHHHhhhhc---ceeecccccceEEEecCCCcccceEecchh
Confidence 99999999999999997643 489999999999999999999999 999999999999998876 49999999
Q ss_pred cccccCCCCCCceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCC
Q 044366 798 FAKFLEPHSSNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRL 877 (918)
Q Consensus 798 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 877 (918)
+|....... ......||+.|+|||++.+..++.++||||+||++|||++|+.||...... ... ..+.....
T Consensus 163 ~a~~~~~~~-~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~-~~~-------~~i~~~~~ 233 (293)
T d1jksa_ 163 LAHKIDFGN-EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ-ETL-------ANVSAVNY 233 (293)
T ss_dssp TCEECTTSC-BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHH-------HHHHTTCC
T ss_pred hhhhcCCCc-cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHH-HHH-------HHHHhcCC
Confidence 998875433 334567899999999999999999999999999999999999998754321 111 11111111
Q ss_pred CCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 878 PTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 878 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
..+..........+.+++.+||+.||++|||++|+++
T Consensus 234 ~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 234 EFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp CCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1111111122356889999999999999999999986
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-46 Score=403.34 Aligned_cols=257 Identities=22% Similarity=0.357 Sum_probs=204.1
Q ss_pred hcCCCCceeeccccceEEEEEEeCC-C-----CEEEEEEcccccccCCCCChHHHHHHHHHHhhc-cCCceeeEeccccc
Q 044366 645 TGNFGEKYCIGKGGQRSVYKAELPS-G-----NIFAVKKFKAELFSDETANPSEFLNEVLALTEI-RHRNIIKFHGFCSN 717 (918)
Q Consensus 645 ~~~~~~~~~lg~G~~g~Vy~~~~~~-~-----~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~ 717 (918)
.++|+..+.||+|+||.||+|+... + ..||||++.... .......|.+|+.+++++ +|||||+++|++.+
T Consensus 36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~ 112 (325)
T d1rjba_ 36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA---DSSEREALMSELKMMTQLGSHENIVNLLGACTL 112 (325)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC---------CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEecccc---CHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEee
Confidence 3678889999999999999996532 2 269999886532 233457899999999998 89999999999999
Q ss_pred CCceEEEEEeccCCChhHHhhcccc--------------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcC
Q 044366 718 AQHSFIVCEYLARGSLTTILRDDAA--------------------AKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRD 777 (918)
Q Consensus 718 ~~~~~lv~e~~~~gsL~~~l~~~~~--------------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~d 777 (918)
.+..++||||+++|+|.++++.... ...+++.+++.++.||++||+|||+. +|||||
T Consensus 113 ~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~IiHRD 189 (325)
T d1rjba_ 113 SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRD 189 (325)
T ss_dssp SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETT
T ss_pred CCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---Ceeecc
Confidence 9999999999999999999976431 23589999999999999999999999 999999
Q ss_pred CCCCCeeeCCCCcEEEeccccccccCCCCCC--ceecccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCc
Q 044366 778 ISSKNVLLDSEYEAHVSDFGFAKFLEPHSSN--WTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIK-GYHPGDF 854 (918)
Q Consensus 778 lk~~Nill~~~~~~kl~DfG~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~p~~~ 854 (918)
|||+||+++.++.+||+|||+|+........ .....||+.|||||++.+..++.++|||||||++|||+| |+.||..
T Consensus 190 lKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~ 269 (325)
T d1rjba_ 190 LAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPG 269 (325)
T ss_dssp CSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred CchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCC
Confidence 9999999999999999999999876554432 234567999999999999999999999999999999998 8999864
Q ss_pred chhhhhhhhhhHhhhhhhcccCCCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 044366 855 VSTIFSSISNMIIEVNQILDHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLLC 917 (918)
Q Consensus 855 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 917 (918)
..... ..... .... .+++ .+... ..++.++|.+||+.||++|||++||++.|.
T Consensus 270 ~~~~~-~~~~~---~~~~--~~~~-~p~~~---~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 270 IPVDA-NFYKL---IQNG--FKMD-QPFYA---TEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp CCCSH-HHHHH---HHTT--CCCC-CCTTC---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCHHH-HHHHH---HhcC--CCCC-CCCcC---CHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 33211 11111 1111 1111 11222 246888999999999999999999999884
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=6.7e-47 Score=402.15 Aligned_cols=248 Identities=25% Similarity=0.371 Sum_probs=201.2
Q ss_pred cCCCCceeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEEE
Q 044366 646 GNFGEKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFIV 724 (918)
Q Consensus 646 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 724 (918)
..|+..+.||+|+||.||+|+. .+|+.||||+++...... ....+.|.+|++++++++|||||++++++.+++..++|
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv 93 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQS-NEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 93 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCH-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccC-HHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEE
Confidence 3588899999999999999964 578999999987632221 22246789999999999999999999999999999999
Q ss_pred EEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccCC
Q 044366 725 CEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEP 804 (918)
Q Consensus 725 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~~ 804 (918)
|||+++|++..++... ..+++.+++.++.||+.||+|||+. +||||||||+|||++.++.+||+|||+|.....
T Consensus 94 ~E~~~~g~l~~~~~~~---~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~ 167 (309)
T d1u5ra_ 94 MEYCLGSASDLLEVHK---KPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 167 (309)
T ss_dssp EECCSEEHHHHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred EEecCCCchHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEECCCCCEEEeecccccccCC
Confidence 9999999998776543 3589999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCCceeccccccccccccccc---CCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCCCCC
Q 044366 805 HSSNWTEFAGTVGYAAPELAYT---MRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPS 881 (918)
Q Consensus 805 ~~~~~~~~~g~~~y~aPE~~~~---~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 881 (918)
. ....||+.|||||++.+ ..|+.++|||||||++|||++|+.||...... .. ...+.....+...
T Consensus 168 ~----~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~-~~-------~~~i~~~~~~~~~ 235 (309)
T d1u5ra_ 168 A----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-SA-------LYHIAQNESPALQ 235 (309)
T ss_dssp B----CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH-HH-------HHHHHHSCCCCCS
T ss_pred C----CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHH-HH-------HHHHHhCCCCCCC
Confidence 2 34579999999999864 45899999999999999999999998644321 11 1111112221111
Q ss_pred cchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 882 RDVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 882 ~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
. ......+.+++.+||+.||++|||++|+++
T Consensus 236 ~--~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 236 S--GHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp C--TTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred C--CCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 1 112346888999999999999999999875
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.8e-46 Score=405.84 Aligned_cols=252 Identities=19% Similarity=0.330 Sum_probs=207.9
Q ss_pred hcCCCCceeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEE
Q 044366 645 TGNFGEKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFI 723 (918)
Q Consensus 645 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 723 (918)
.++|++.+.||+|+||.||+|+. .+|+.||||++.... ....+.+.+|++++++++|||||++++++.+++..++
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~----~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i 100 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH----ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVM 100 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCS----HHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEE
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccc----hhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 35899999999999999999965 579999999986532 2235678999999999999999999999999999999
Q ss_pred EEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCC--CCcEEEeccccccc
Q 044366 724 VCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDS--EYEAHVSDFGFAKF 801 (918)
Q Consensus 724 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~--~~~~kl~DfG~~~~ 801 (918)
||||+++|+|.+++... ...+++.+++.|+.||+.||+|||+. +||||||||+|||++. ++.+||+|||+|+.
T Consensus 101 vmE~~~gg~L~~~l~~~--~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~ 175 (350)
T d1koaa2 101 IYEFMSGGELFEKVADE--HNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAH 175 (350)
T ss_dssp EECCCCSCBHHHHHTCT--TSCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEECCCTTCEE
T ss_pred EEEcCCCCCHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhc---CCeeeeechhHeeeccCCCCeEEEeecchhee
Confidence 99999999999999654 24589999999999999999999999 9999999999999964 57899999999998
Q ss_pred cCCCCCCceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCCCCC
Q 044366 802 LEPHSSNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPS 881 (918)
Q Consensus 802 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 881 (918)
+.... ......||+.|||||++.+..++.++||||+||++|||++|+.||...... ... ..+.......+.
T Consensus 176 ~~~~~-~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~-~~~-------~~i~~~~~~~~~ 246 (350)
T d1koaa2 176 LDPKQ-SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD-ETL-------RNVKSCDWNMDD 246 (350)
T ss_dssp CCTTS-CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHH-------HHHHHTCCCSCC
T ss_pred ccccc-ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHH-HHH-------HHHHhCCCCCCc
Confidence 76543 335578999999999999999999999999999999999999998644321 111 111112222222
Q ss_pred cchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 882 RDVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 882 ~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
.........+.+++.+||+.||++|||++|+++
T Consensus 247 ~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 279 (350)
T d1koaa2 247 SAFSGISEDGKDFIRKLLLADPNTRMTIHQALE 279 (350)
T ss_dssp GGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred ccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 222233456889999999999999999999986
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=3e-46 Score=404.34 Aligned_cols=252 Identities=18% Similarity=0.290 Sum_probs=207.8
Q ss_pred hcCCCCceeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEE
Q 044366 645 TGNFGEKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFI 723 (918)
Q Consensus 645 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 723 (918)
.++|++.+.||+|+||.||+|.. .+|+.||||+++... ....+.+.+|++++++++|||||++++++.+++..++
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~----~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~i 103 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY----PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVL 103 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS----HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcc----hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 35799999999999999999964 579999999987532 2224678899999999999999999999999999999
Q ss_pred EEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeC--CCCcEEEeccccccc
Q 044366 724 VCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLD--SEYEAHVSDFGFAKF 801 (918)
Q Consensus 724 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~--~~~~~kl~DfG~~~~ 801 (918)
||||+++|+|.+++... ..++++.+++.|+.||+.||+|||+. |||||||||+|||++ .++.+||+|||+|+.
T Consensus 104 vmE~~~gg~L~~~~~~~--~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~ 178 (352)
T d1koba_ 104 ILEFLSGGELFDRIAAE--DYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATK 178 (352)
T ss_dssp EEECCCCCBHHHHTTCT--TCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEE
T ss_pred EEEcCCCChHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccccccccccccCCCeEEEeeccccee
Confidence 99999999999887654 34589999999999999999999999 999999999999998 568999999999998
Q ss_pred cCCCCCCceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCCCCC
Q 044366 802 LEPHSSNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPS 881 (918)
Q Consensus 802 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 881 (918)
+.+.. ......||+.|+|||++.+..++.++||||+||++|||+||+.||...... .. ...+.......+.
T Consensus 179 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~-~~-------~~~i~~~~~~~~~ 249 (352)
T d1koba_ 179 LNPDE-IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL-ET-------LQNVKRCDWEFDE 249 (352)
T ss_dssp CCTTS-CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH-HH-------HHHHHHCCCCCCS
T ss_pred cCCCC-ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH-HH-------HHHHHhCCCCCCc
Confidence 76543 345567999999999999999999999999999999999999998654321 11 1111111121111
Q ss_pred cchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 882 RDVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 882 ~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
........++.+++.+||+.||++|||++|+++
T Consensus 250 ~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 282 (352)
T d1koba_ 250 DAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE 282 (352)
T ss_dssp STTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred ccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 122223456789999999999999999999976
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-45 Score=396.96 Aligned_cols=251 Identities=24% Similarity=0.300 Sum_probs=210.6
Q ss_pred hcCCCCceeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEE
Q 044366 645 TGNFGEKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFI 723 (918)
Q Consensus 645 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 723 (918)
.++|++.+.||+|+||.||+|+. .+|+.||||+++...... ....+.+.+|+.+++.++||||+++++++.+++..++
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~-~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~i 82 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIA-KDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCF 82 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHH-TTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEE
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccC-HHHHHHHHHHHHHHHhCCCCCEEEEEeeecccccccc
Confidence 35799999999999999999965 589999999997653332 2346789999999999999999999999999999999
Q ss_pred EEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccC
Q 044366 724 VCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLE 803 (918)
Q Consensus 724 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~ 803 (918)
||||+++|+|.+++...+ .+++..++.++.||+.||+|||++ +|+||||||+||+++++|.+||+|||+|+...
T Consensus 83 v~ey~~gg~L~~~~~~~~---~~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~ 156 (337)
T d1o6la_ 83 VMEYANGGELFFHLSRER---VFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGI 156 (337)
T ss_dssp EEECCTTCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred ceeccCCCchhhhhhccc---CCcHHHHHHHHHHHhhhhhhhhhc---CccccccCHHHeEecCCCCEEEeecccccccc
Confidence 999999999999998753 489999999999999999999999 99999999999999999999999999999876
Q ss_pred CCCCCceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCCCCCcc
Q 044366 804 PHSSNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRD 883 (918)
Q Consensus 804 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 883 (918)
.........+||+.|+|||++.+..++.++||||+||++|||++|++||...... .+ . ..+....+..+ ..
T Consensus 157 ~~~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~--~~---~---~~i~~~~~~~p-~~ 227 (337)
T d1o6la_ 157 SDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE--RL---F---ELILMEEIRFP-RT 227 (337)
T ss_dssp CTTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH--HH---H---HHHHHCCCCCC-TT
T ss_pred cCCcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHH--HH---H---HHHhcCCCCCC-cc
Confidence 6555566678999999999999999999999999999999999999998754321 11 1 11111222211 22
Q ss_pred hHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 044366 884 VTDKLRSIMEVAILCLVENPEARPT-----MKEVCN 914 (918)
Q Consensus 884 ~~~~~~~l~~li~~cl~~dp~~RPt-----~~evl~ 914 (918)
. ..++.++|.+||+.||++||+ ++|+++
T Consensus 228 ~---s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 228 L---SPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp S---CHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred C---CHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence 2 245788999999999999994 788764
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-46 Score=385.43 Aligned_cols=247 Identities=28% Similarity=0.403 Sum_probs=194.6
Q ss_pred cCCCCceeeccccceEEEEEEeCCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEeccccc-CCceEEE
Q 044366 646 GNFGEKYCIGKGGQRSVYKAELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSN-AQHSFIV 724 (918)
Q Consensus 646 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~~~~lv 724 (918)
++|+..+.||+|+||.||+|++ .|+.||||+++.. ...++|.+|++++++++||||++++|+|.+ .+..++|
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~------~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv 79 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND------ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIV 79 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCC------C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEE
T ss_pred HHeEEeEEEecCCCeEEEEEEE-CCeEEEEEEECcH------HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEE
Confidence 5677889999999999999988 5789999998642 235789999999999999999999998854 4678999
Q ss_pred EEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccCC
Q 044366 725 CEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEP 804 (918)
Q Consensus 725 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~~ 804 (918)
|||+++|+|.+++.... ...++|..+++|+.|||.||+|||+. +|+||||||+||+++.++.+|++|||+++...+
T Consensus 80 ~ey~~~g~L~~~l~~~~-~~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~ 155 (262)
T d1byga_ 80 TEYMAKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 155 (262)
T ss_dssp ECCCTTEEHHHHHHHHH-HHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC------
T ss_pred EeccCCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHhhccccccC---ceeccccchHhheecCCCCEeecccccceecCC
Confidence 99999999999997643 23489999999999999999999999 999999999999999999999999999987644
Q ss_pred CCCCceecccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhhhhhhhhhHhhhhhhcccCCCCCCcc
Q 044366 805 HSSNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIK-GYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRD 883 (918)
Q Consensus 805 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 883 (918)
.. ....+++.|+|||++.+..++.++|||||||++|||+| |+.|+...... .....+. ....++.+..
T Consensus 156 ~~---~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~-----~~~~~i~---~~~~~~~~~~ 224 (262)
T d1byga_ 156 TQ---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK-----DVVPRVE---KGYKMDAPDG 224 (262)
T ss_dssp ---------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG-----GHHHHHT---TTCCCCCCTT
T ss_pred CC---ccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHH-----HHHHHHH---cCCCCCCCcc
Confidence 32 33467899999999999999999999999999999998 67776543221 1111111 1112222222
Q ss_pred hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 044366 884 VTDKLRSIMEVAILCLVENPEARPTMKEVCNLLC 917 (918)
Q Consensus 884 ~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 917 (918)
. ...+.+++.+||+.||++||||.|+++.|+
T Consensus 225 ~---~~~~~~li~~cl~~dP~~Rps~~~l~~~L~ 255 (262)
T d1byga_ 225 C---PPAVYEVMKNCWHLDAAMRPSFLQLREQLE 255 (262)
T ss_dssp C---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred C---CHHHHHHHHHHcccCHhHCcCHHHHHHHHH
Confidence 2 246788999999999999999999999986
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5e-46 Score=396.42 Aligned_cols=262 Identities=23% Similarity=0.379 Sum_probs=209.6
Q ss_pred HHHHHhcCCCCceeeccccceEEEEEEeC------CCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEec
Q 044366 640 EITKATGNFGEKYCIGKGGQRSVYKAELP------SGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHG 713 (918)
Q Consensus 640 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~ 713 (918)
+++...++|+..+.||+|+||.||+|+.. +++.||||+++... .....++|.+|++++++++||||+++++
T Consensus 7 ~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~---~~~~~~~~~~E~~il~~l~h~niv~~~~ 83 (301)
T d1lufa_ 7 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA---SADMQADFQREAALMAEFDNPNIVKLLG 83 (301)
T ss_dssp HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC---CHHHHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred hccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhc---ChHHHHHHHHHHHHHHhcCCCCccccee
Confidence 34445678999999999999999999753 45789999986532 2223567999999999999999999999
Q ss_pred ccccCCceEEEEEeccCCChhHHhhccc---------------------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCC
Q 044366 714 FCSNAQHSFIVCEYLARGSLTTILRDDA---------------------AAKEFSWNQRMNVIKGVANALSYLHHDCIPP 772 (918)
Q Consensus 714 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~---------------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ 772 (918)
+|.+++..++||||+++|+|.++++... ....+++.+++.|+.|+|.||+|||+. +
T Consensus 84 ~~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~ 160 (301)
T d1lufa_ 84 VCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---K 160 (301)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---T
T ss_pred eeccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC---C
Confidence 9999999999999999999999996432 123489999999999999999999999 9
Q ss_pred eEEcCCCCCCeeeCCCCcEEEeccccccccCCCCCC--ceecccccccccccccccCCCCcccchhhHHHHHHHHHhCC-
Q 044366 773 IVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSSN--WTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGY- 849 (918)
Q Consensus 773 ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~- 849 (918)
+|||||||+||+++.++.+||+|||+|+...+.... .....|++.|+|||++.+..++.++|||||||++|||++|.
T Consensus 161 ivHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~ 240 (301)
T d1lufa_ 161 FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGL 240 (301)
T ss_dssp CCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTC
T ss_pred eEeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCC
Confidence 999999999999999999999999999876543322 23456889999999999999999999999999999999986
Q ss_pred CCCCcchhhhhhhhhhHhhhhhhcccCCCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhC
Q 044366 850 HPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLLCK 918 (918)
Q Consensus 850 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~ 918 (918)
+||...... +.. ..+.....++.+... +.++.+++.+||+.||++||||.||++.|++
T Consensus 241 ~p~~~~~~~-e~~-------~~v~~~~~~~~p~~~---~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~ 298 (301)
T d1lufa_ 241 QPYYGMAHE-EVI-------YYVRDGNILACPENC---PLELYNLMRLCWSKLPADRPSFCSIHRILQR 298 (301)
T ss_dssp CTTTTSCHH-HHH-------HHHHTTCCCCCCTTC---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCCCCCCHH-HHH-------HHHHcCCCCCCCccc---hHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 565543221 111 112222222222222 2468889999999999999999999999874
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=2.4e-45 Score=384.04 Aligned_cols=254 Identities=25% Similarity=0.369 Sum_probs=206.9
Q ss_pred cCCCCceeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCC-----ChHHHHHHHHHHhhcc-CCceeeEecccccC
Q 044366 646 GNFGEKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETA-----NPSEFLNEVLALTEIR-HRNIIKFHGFCSNA 718 (918)
Q Consensus 646 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~-----~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~ 718 (918)
++|+..+.||+|+||+||+|+. .+|+.||||+++......... ..+.+.+|+.++++++ ||||+++++++.++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 5789999999999999999965 579999999987643222111 1246889999999997 99999999999999
Q ss_pred CceEEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEecccc
Q 044366 719 QHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGF 798 (918)
Q Consensus 719 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~ 798 (918)
+..|+||||+++|+|.++++... .+++.+++.++.||++||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~~~---~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~ 156 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTEKV---TLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGF 156 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred cceEEEEEcCCCchHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHc---CCcccccccceEEEcCCCCeEEccchh
Confidence 99999999999999999997643 489999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCCceeccccccccccccccc------CCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhh
Q 044366 799 AKFLEPHSSNWTEFAGTVGYAAPELAYT------MRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQI 872 (918)
Q Consensus 799 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~------~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 872 (918)
++.+.+.. ......||+.|+|||.+.+ ..++.++||||+||++|||++|+.||....... .. ..+
T Consensus 157 a~~~~~~~-~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~--~~------~~i 227 (277)
T d1phka_ 157 SCQLDPGE-KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML--ML------RMI 227 (277)
T ss_dssp CEECCTTC-CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HH------HHH
T ss_pred eeEccCCC-ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHH--HH------HHH
Confidence 99876543 3355689999999998863 346789999999999999999999987543211 11 111
Q ss_pred cccCCCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 873 LDHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 873 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
.......+........+++.+++.+||+.||++|||++|+++
T Consensus 228 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~ 269 (277)
T d1phka_ 228 MSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269 (277)
T ss_dssp HHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred HhCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 112221122222334457889999999999999999999976
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=7.4e-46 Score=390.58 Aligned_cols=259 Identities=25% Similarity=0.328 Sum_probs=200.7
Q ss_pred hcCCCCceeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCC----
Q 044366 645 TGNFGEKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQ---- 719 (918)
Q Consensus 645 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~---- 719 (918)
.++|.+.+.||+|+||.||+|.. .+|+.||||+++.....+ ....+.|.+|+++++.++||||+++++++...+
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~-~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~ 84 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARD-PSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP 84 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTC-HHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccC-HHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCc
Confidence 46799999999999999999964 689999999997643222 223467999999999999999999999986543
Q ss_pred ceEEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccc
Q 044366 720 HSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFA 799 (918)
Q Consensus 720 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~ 799 (918)
..|+||||+++|+|.+++...+ .+++.+++.++.||+.||+|||+. +||||||||+||+++.++..+++|||.+
T Consensus 85 ~~~lvmE~~~g~~L~~~~~~~~---~l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~~l~d~~~~ 158 (277)
T d1o6ya_ 85 LPYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIA 158 (277)
T ss_dssp EEEEEEECCCEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCEEECCCTTC
T ss_pred eEEEEEECCCCCEehhhhcccC---CCCHHHHHHHHHHHHHHHHHHHhC---CccCccccCcccccCccccceeehhhhh
Confidence 3789999999999999987653 489999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCCCC---CceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccC
Q 044366 800 KFLEPHSS---NWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHR 876 (918)
Q Consensus 800 ~~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 876 (918)
........ .....+||+.|+|||++.+..++.++||||+||++|||+||+.||....... .. .......
T Consensus 159 ~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~-~~-------~~~~~~~ 230 (277)
T d1o6ya_ 159 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS-VA-------YQHVRED 230 (277)
T ss_dssp EECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HH-------HHHHHCC
T ss_pred hhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHH-HH-------HHHHhcC
Confidence 76643322 2345679999999999999999999999999999999999999987543211 10 1111111
Q ss_pred CCCCCcchHHHHHHHHHHHHHcccCCCCCCC-CHHHHHHHhhC
Q 044366 877 LPTPSRDVTDKLRSIMEVAILCLVENPEARP-TMKEVCNLLCK 918 (918)
Q Consensus 877 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~RP-t~~evl~~L~~ 918 (918)
...+..........+.+++.+||+.||++|| |++++++.|.|
T Consensus 231 ~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r 273 (277)
T d1o6ya_ 231 PIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVR 273 (277)
T ss_dssp CCCGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred CCCCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHH
Confidence 1111111112235688899999999999999 89999988753
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-45 Score=384.40 Aligned_cols=253 Identities=24% Similarity=0.352 Sum_probs=193.3
Q ss_pred hcCCCCceeeccccceEEEEEEeCC----CCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCc
Q 044366 645 TGNFGEKYCIGKGGQRSVYKAELPS----GNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQH 720 (918)
Q Consensus 645 ~~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 720 (918)
.++|+..+.||+|+||.||+|.+.. +..||||.++... .....+.|.+|++++++++||||++++|++. ++.
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~ 81 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT---SDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENP 81 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT---SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSS
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEecccc---CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCe
Confidence 4578889999999999999997642 3468999886431 2223567999999999999999999999986 467
Q ss_pred eEEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEecccccc
Q 044366 721 SFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAK 800 (918)
Q Consensus 721 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~ 800 (918)
.++||||+++|++.+++... ...+++.+++.++.||++||+|||+. +|+||||||+||+++.++.+||+|||+|+
T Consensus 82 ~~iv~E~~~~g~l~~~~~~~--~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~Kl~DfG~a~ 156 (273)
T d1mp8a_ 82 VWIIMELCTLGELRSFLQVR--KYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSR 156 (273)
T ss_dssp CEEEEECCTTEEHHHHHHHT--TTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC-----
T ss_pred EEEEEEeccCCcHHhhhhcc--CCCCCHHHHHHHHHHHHHHhhhhccc---CeeccccchhheeecCCCcEEEccchhhe
Confidence 89999999999999987654 34589999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCC-CceecccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhhhhhhhhhHhhhhhhcccCCC
Q 044366 801 FLEPHSS-NWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIK-GYHPGDFVSTIFSSISNMIIEVNQILDHRLP 878 (918)
Q Consensus 801 ~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 878 (918)
....... ......||+.|+|||++.+..++.++|||||||++|||++ |.+||...... .... .+.....+
T Consensus 157 ~~~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~-----~~~~---~i~~~~~~ 228 (273)
T d1mp8a_ 157 YMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN-----DVIG---RIENGERL 228 (273)
T ss_dssp --------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG-----GHHH---HHHTTCCC
T ss_pred eccCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHH-----HHHH---HHHcCCCC
Confidence 7654332 2344568999999999999999999999999999999998 89997654321 1111 11111111
Q ss_pred CCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 044366 879 TPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLLC 917 (918)
Q Consensus 879 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 917 (918)
+.+... ...+.+++.+||+.||++|||++||++.|+
T Consensus 229 ~~~~~~---~~~~~~li~~cl~~dp~~Rps~~ei~~~L~ 264 (273)
T d1mp8a_ 229 PMPPNC---PPTLYSLMTKCWAYDPSRRPRFTELKAQLS 264 (273)
T ss_dssp CCCTTC---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCCCCC---CHHHHHHHHHHcCCCHhHCcCHHHHHHHHH
Confidence 222222 346888999999999999999999999875
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.2e-44 Score=386.29 Aligned_cols=247 Identities=28% Similarity=0.411 Sum_probs=205.8
Q ss_pred cCCCCceeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEEE
Q 044366 646 GNFGEKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFIV 724 (918)
Q Consensus 646 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 724 (918)
++|++.+.||+|+||.||+|+. .+|+.||||+++..... .....+.+.+|+.+++.++|||||++++++.+++..++|
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 82 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVV-RLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 82 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHH-HTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHcc-CHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeE
Confidence 5688999999999999999965 57999999999764332 233467899999999999999999999999999999999
Q ss_pred EEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccCC
Q 044366 725 CEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEP 804 (918)
Q Consensus 725 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~~ 804 (918)
|||+++|++..++.... .+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+....
T Consensus 83 mE~~~gg~l~~~~~~~~---~~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~ 156 (316)
T d1fota_ 83 MDYIEGGELFSLLRKSQ---RFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPD 156 (316)
T ss_dssp ECCCCSCBHHHHHHHTS---SCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred eeecCCccccccccccc---cccccHHHHHHHHHHHhhhhhccC---cEEccccCchheeEcCCCCEEEecCccceEecc
Confidence 99999999999987653 478899999999999999999999 999999999999999999999999999988754
Q ss_pred CCCCceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCCCCCcch
Q 044366 805 HSSNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRDV 884 (918)
Q Consensus 805 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 884 (918)
. .....||+.|+|||++.+..++.++||||+||++|||++|+.||...... . ....+.......+ ...
T Consensus 157 ~---~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~-~-------~~~~i~~~~~~~p-~~~ 224 (316)
T d1fota_ 157 V---TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTM-K-------TYEKILNAELRFP-PFF 224 (316)
T ss_dssp C---BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH-H-------HHHHHHHCCCCCC-TTS
T ss_pred c---cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHH-H-------HHHHHHcCCCCCC-CCC
Confidence 3 23467999999999999999999999999999999999999998754321 1 1111112222111 112
Q ss_pred HHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 044366 885 TDKLRSIMEVAILCLVENPEARP-----TMKEVCN 914 (918)
Q Consensus 885 ~~~~~~l~~li~~cl~~dp~~RP-----t~~evl~ 914 (918)
..++.+++.+|++.||.+|| |++|+++
T Consensus 225 ---s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~ 256 (316)
T d1fota_ 225 ---NEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 256 (316)
T ss_dssp ---CHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred ---CHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence 24578899999999999996 8999874
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-45 Score=383.22 Aligned_cols=256 Identities=26% Similarity=0.397 Sum_probs=194.8
Q ss_pred cCCCCceeeccccceEEEEEEeC--CC--CEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCce
Q 044366 646 GNFGEKYCIGKGGQRSVYKAELP--SG--NIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHS 721 (918)
Q Consensus 646 ~~~~~~~~lg~G~~g~Vy~~~~~--~~--~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 721 (918)
++|+..+.||+|+||.||+|++. ++ ..||||+++..... .....++|.+|+.++++++||||++++|++.+ +..
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~-~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~ 85 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLS-QPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPM 85 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC---------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcC-CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cch
Confidence 56888999999999999999653 33 37899998764332 23335789999999999999999999999976 467
Q ss_pred EEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccc
Q 044366 722 FIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKF 801 (918)
Q Consensus 722 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~ 801 (918)
++||||+++|++.+++... ...+++..++.++.|||+||+|||+. +|+||||||+||+++.++.+||+|||+++.
T Consensus 86 ~lv~e~~~~~~l~~~~~~~--~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~vkl~DfGl~~~ 160 (273)
T d1u46a_ 86 KMVTELAPLGSLLDRLRKH--QGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRA 160 (273)
T ss_dssp EEEEECCTTCBHHHHHHHH--GGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred heeeeeecCcchhhhhhcc--cCCCCHHHHHHHHHHHHHHHHHhhhC---CEeeeeecHHHhccccccceeeccchhhhh
Confidence 8999999999999988754 24589999999999999999999999 999999999999999999999999999998
Q ss_pred cCCCCCC---ceecccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhhhhhhhhhHhhhhhhcccCC
Q 044366 802 LEPHSSN---WTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIK-GYHPGDFVSTIFSSISNMIIEVNQILDHRL 877 (918)
Q Consensus 802 ~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 877 (918)
....... .....|+..|+|||++.+..++.++|||||||++|||+| |+.||...... +... .+.+ ...++
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~-~~~~----~i~~-~~~~~ 234 (273)
T d1u46a_ 161 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS-QILH----KIDK-EGERL 234 (273)
T ss_dssp CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-HHHH----HHHT-SCCCC
T ss_pred cccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHH-HHHH----HHHh-CCCCC
Confidence 7654332 233467889999999999999999999999999999998 89998644321 1111 1111 01111
Q ss_pred CCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhC
Q 044366 878 PTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLLCK 918 (918)
Q Consensus 878 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~ 918 (918)
+ ..... +..+.+++.+||+.||++||||+||.+.|.+
T Consensus 235 ~-~~~~~---~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~ 271 (273)
T d1u46a_ 235 P-RPEDC---PQDIYNVMVQCWAHKPEDRPTFVALRDFLLE 271 (273)
T ss_dssp C-CCTTC---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred C-Ccccc---cHHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence 1 11222 2467889999999999999999999998863
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-45 Score=390.49 Aligned_cols=252 Identities=22% Similarity=0.422 Sum_probs=198.3
Q ss_pred cCCCCceeeccccceEEEEEEe-CCCC----EEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCc
Q 044366 646 GNFGEKYCIGKGGQRSVYKAEL-PSGN----IFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQH 720 (918)
Q Consensus 646 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~----~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 720 (918)
.+|++.+.||+|+||.||+|.+ .+|+ .||||+++.. ......++|.+|++++++++|||||+++|+|.++ .
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~ 84 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA---TSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-T 84 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC-------CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-S
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccc---cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-C
Confidence 4689999999999999999965 3555 5888887643 2334468899999999999999999999999765 5
Q ss_pred eEEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEecccccc
Q 044366 721 SFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAK 800 (918)
Q Consensus 721 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~ 800 (918)
.++++||+.+|+|.+++... ...+++..+++++.|||+||+|||++ +||||||||+||+++.++.+||+|||+|+
T Consensus 85 ~~~v~e~~~~~~l~~~~~~~--~~~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~kl~DFGla~ 159 (317)
T d1xkka_ 85 VQLITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAK 159 (317)
T ss_dssp EEEEEECCTTCBHHHHHHHT--SSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCCSHHH
T ss_pred eeEEEEeccCCccccccccc--ccCCCHHHHHHHHHHHHHHHHHHHHc---CcccCcchhhcceeCCCCCeEeeccccce
Confidence 67889999999999988764 34589999999999999999999999 99999999999999999999999999999
Q ss_pred ccCCCCCC--ceecccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhhhhhhhhhHhhhhhhcccCC
Q 044366 801 FLEPHSSN--WTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIK-GYHPGDFVSTIFSSISNMIIEVNQILDHRL 877 (918)
Q Consensus 801 ~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 877 (918)
........ .....||+.|+|||++.++.++.++|||||||++|||+| |+.||+..... .+.... .. ..++
T Consensus 160 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~--~~~~~i---~~--~~~~ 232 (317)
T d1xkka_ 160 LLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS--EISSIL---EK--GERL 232 (317)
T ss_dssp HTTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGG--GHHHHH---HH--TCCC
T ss_pred ecccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHH--HHHHHH---Hc--CCCC
Confidence 87654432 234568999999999999999999999999999999998 78887654321 111111 11 1112
Q ss_pred CCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 044366 878 PTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLLC 917 (918)
Q Consensus 878 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 917 (918)
+. +... ...+.+++.+||+.||++|||+.|+++.|+
T Consensus 233 ~~-p~~~---~~~~~~li~~cl~~dP~~RPs~~eil~~l~ 268 (317)
T d1xkka_ 233 PQ-PPIC---TIDVYMIMVKCWMIDADSRPKFRELIIEFS 268 (317)
T ss_dssp CC-CTTB---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CC-Cccc---CHHHHHHHHHhCCCChhhCcCHHHHHHHHH
Confidence 22 1222 245788999999999999999999998774
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-45 Score=390.08 Aligned_cols=251 Identities=20% Similarity=0.274 Sum_probs=206.2
Q ss_pred hcCCCCceeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEE
Q 044366 645 TGNFGEKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFI 723 (918)
Q Consensus 645 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 723 (918)
.++|.+.+.||+|+||+||+|.. .+|+.||||+++... .....+.+|+++++.++|||||++++++.+++..|+
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-----~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~l 78 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-----TDQVLVKKEISILNIARHRNILHLHESFESMEELVM 78 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-----HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc-----ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEE
Confidence 46799999999999999999965 578999999987531 224568899999999999999999999999999999
Q ss_pred EEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCC--CcEEEeccccccc
Q 044366 724 VCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSE--YEAHVSDFGFAKF 801 (918)
Q Consensus 724 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~--~~~kl~DfG~~~~ 801 (918)
||||+++|+|.+++... ...+++.+++.|+.||++||+|||+. +|+||||||+||+++.+ ..+||+|||+++.
T Consensus 79 vmE~~~gg~L~~~i~~~--~~~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~ 153 (321)
T d1tkia_ 79 IFEFISGLDIFERINTS--AFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQ 153 (321)
T ss_dssp EECCCCCCBHHHHHTSS--SCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEE
T ss_pred EEecCCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHc---CCCcccccccceeecCCCceEEEEcccchhhc
Confidence 99999999999999764 23589999999999999999999999 99999999999999854 5799999999987
Q ss_pred cCCCCCCceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCCCCC
Q 044366 802 LEPHSSNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPS 881 (918)
Q Consensus 802 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 881 (918)
..... ......+++.|+|||...+..++.++||||+||++|+|++|+.||...... . ....+.......+.
T Consensus 154 ~~~~~-~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~-~-------~~~~i~~~~~~~~~ 224 (321)
T d1tkia_ 154 LKPGD-NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ-Q-------IIENIMNAEYTFDE 224 (321)
T ss_dssp CCTTC-EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH-H-------HHHHHHHTCCCCCH
T ss_pred cccCC-cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHH-H-------HHHHHHhCCCCCCh
Confidence 65432 334567899999999999999999999999999999999999998754321 1 11112222222111
Q ss_pred cchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 882 RDVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 882 ~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
........++.+++.+|++.||++|||++|+++
T Consensus 225 ~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 257 (321)
T d1tkia_ 225 EAFKEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp HHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred hhccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 111122356889999999999999999999986
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-45 Score=390.75 Aligned_cols=249 Identities=24% Similarity=0.329 Sum_probs=205.4
Q ss_pred cCCCCceeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHh-hccCCceeeEecccccCCceEE
Q 044366 646 GNFGEKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALT-EIRHRNIIKFHGFCSNAQHSFI 723 (918)
Q Consensus 646 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~-~l~h~niv~~~~~~~~~~~~~l 723 (918)
++|.+.+.||+|+||+||+|.. .+|+.||||+++...... ....+.+..|..++. .++|||||++++++.+++..|+
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~-~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yi 80 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLM-DDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFF 80 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHH-TTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccC-hHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeE
Confidence 5788999999999999999955 579999999997643222 233566777777665 6899999999999999999999
Q ss_pred EEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccC
Q 044366 724 VCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLE 803 (918)
Q Consensus 724 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~ 803 (918)
||||+++|+|.++++... .+++.+++.++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++...
T Consensus 81 vmEy~~~g~L~~~i~~~~---~~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~ 154 (320)
T d1xjda_ 81 VMEYLNGGDLMYHIQSCH---KFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENM 154 (320)
T ss_dssp EEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EEeecCCCcHHHHhhccC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCcccceeecCCCceeccccchhhhcc
Confidence 999999999999998643 489999999999999999999999 99999999999999999999999999999776
Q ss_pred CCCCCceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCCCCCcc
Q 044366 804 PHSSNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRD 883 (918)
Q Consensus 804 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 883 (918)
..........||+.|+|||++.+..++.++||||+||++|||++|+.||...... .+ .. .+....+. .+..
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~--~~---~~---~i~~~~~~-~p~~ 225 (320)
T d1xjda_ 155 LGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE--EL---FH---SIRMDNPF-YPRW 225 (320)
T ss_dssp CTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HH---HH---HHHHCCCC-CCTT
T ss_pred cccccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHH--HH---HH---HHHcCCCC-CCcc
Confidence 6666666678999999999999999999999999999999999999998754321 11 11 11111111 1122
Q ss_pred hHHHHHHHHHHHHHcccCCCCCCCCHH-HHH
Q 044366 884 VTDKLRSIMEVAILCLVENPEARPTMK-EVC 913 (918)
Q Consensus 884 ~~~~~~~l~~li~~cl~~dp~~RPt~~-evl 913 (918)
. ...+.+++.+||+.||++|||+. |++
T Consensus 226 ~---s~~~~dli~~~L~~dP~~R~s~~~~l~ 253 (320)
T d1xjda_ 226 L---EKEAKDLLVKLFVREPEKRLGVRGDIR 253 (320)
T ss_dssp S---CHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred C---CHHHHHHHHHhcccCCCCCcCHHHHHH
Confidence 2 24578899999999999999985 664
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-44 Score=388.75 Aligned_cols=252 Identities=23% Similarity=0.298 Sum_probs=200.6
Q ss_pred hcCCCCce-eeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhc-cCCceeeEeccccc----
Q 044366 645 TGNFGEKY-CIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEI-RHRNIIKFHGFCSN---- 717 (918)
Q Consensus 645 ~~~~~~~~-~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~---- 717 (918)
.++|.+.. .||+|+||.||+|+. .+|+.||||+++. ...+.+|++++.++ +|||||++++++.+
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~---------~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~ 80 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD---------CPKARREVELHWRASQCPHIVRIVDVYENLYAG 80 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC---------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETT
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC---------cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccC
Confidence 36788764 699999999999954 6899999999853 35678999987655 89999999998864
Q ss_pred CCceEEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCC---CCcEEEe
Q 044366 718 AQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDS---EYEAHVS 794 (918)
Q Consensus 718 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~---~~~~kl~ 794 (918)
+...|+|||||++|+|.+++.... ...+++.+++.|+.||+.||+|||+. +|+||||||+||+++. ++.+||+
T Consensus 81 ~~~~~ivmEy~~gg~L~~~i~~~~-~~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~~~Kl~ 156 (335)
T d2ozaa1 81 RKCLLIVMECLDGGELFSRIQDRG-DQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLT 156 (335)
T ss_dssp EEEEEEEEECCCSEEHHHHHHSCS-CCCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTCCEEEC
T ss_pred CCEEEEEEECCCCCcHHHHHHhcC-CCCcCHHHHHHHHHHHHHHHHHHHHc---CCcccccccccccccccccccccccc
Confidence 467899999999999999997643 34689999999999999999999999 9999999999999986 4579999
Q ss_pred ccccccccCCCCCCceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcc
Q 044366 795 DFGFAKFLEPHSSNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILD 874 (918)
Q Consensus 795 DfG~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 874 (918)
|||+|+....... .....||+.|+|||++.+..|+.++||||+||++|+|+||+.||....... .... ....+..
T Consensus 157 DFG~a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~-~~~~---~~~~i~~ 231 (335)
T d2ozaa1 157 DFGFAKETTSHNS-LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA-ISPG---MKTRIRM 231 (335)
T ss_dssp CCTTCEECCCCCC-CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC------------CCCS
T ss_pred ccceeeeccCCCc-cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHH-HHHH---HHHHHhc
Confidence 9999987765433 345679999999999999999999999999999999999999986432210 0000 0111112
Q ss_pred cCCCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 875 HRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 875 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
.....+.........++.+++.+||+.||++|||+.|+++
T Consensus 232 ~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 271 (335)
T d2ozaa1 232 GQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271 (335)
T ss_dssp CSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 2222222223344567899999999999999999999976
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.1e-44 Score=394.49 Aligned_cols=251 Identities=20% Similarity=0.223 Sum_probs=199.2
Q ss_pred cCCCCceeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHH---HHHHhhccCCceeeEecccccCCce
Q 044366 646 GNFGEKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNE---VLALTEIRHRNIIKFHGFCSNAQHS 721 (918)
Q Consensus 646 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e---~~~l~~l~h~niv~~~~~~~~~~~~ 721 (918)
++|++.+.||+|+||.||+|+. .+|+.||||++........ .....+.+| +++++.++|||||++++++.+++..
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~-~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~ 82 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMK-QGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 82 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHH-TCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchh-hHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEE
Confidence 5799999999999999999965 5799999999865432221 223444454 6667777899999999999999999
Q ss_pred EEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccc
Q 044366 722 FIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKF 801 (918)
Q Consensus 722 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~ 801 (918)
|+||||+++|+|.+++.... .+++.+++.++.||+.||+|||+. +||||||||+|||++.++.+||+|||+|+.
T Consensus 83 ~ivmE~~~gg~L~~~l~~~~---~~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~iKl~DFGla~~ 156 (364)
T d1omwa3 83 SFILDLMNGGDLHYHLSQHG---VFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACD 156 (364)
T ss_dssp EEEECCCCSCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSCEEECCCTTCEE
T ss_pred EEEEEecCCCcHHHHHHhcc---cccHHHHHHHHHHHHHHHHHHHHC---CccceeeccceeEEcCCCcEEEeeeceeee
Confidence 99999999999999997643 489999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCCceeccccccccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCCCC
Q 044366 802 LEPHSSNWTEFAGTVGYAAPELAYT-MRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTP 880 (918)
Q Consensus 802 ~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 880 (918)
+.... .....||+.|+|||++.+ ..++.++||||+||++|||+||+.||....... ............. ..
T Consensus 157 ~~~~~--~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~-----~~~~~~~~~~~~~-~~ 228 (364)
T d1omwa3 157 FSKKK--PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD-----KHEIDRMTLTMAV-EL 228 (364)
T ss_dssp CSSSC--CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSC-----HHHHHHHSSSCCC-CC
T ss_pred cCCCc--ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHH-----HHHHHHhcccCCC-CC
Confidence 76432 234579999999999864 568999999999999999999999986543210 0000111111111 11
Q ss_pred CcchHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 044366 881 SRDVTDKLRSIMEVAILCLVENPEARPT-----MKEVCN 914 (918)
Q Consensus 881 ~~~~~~~~~~l~~li~~cl~~dp~~RPt-----~~evl~ 914 (918)
+... ..++.++|.+||+.||++||| ++|+++
T Consensus 229 ~~~~---s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 229 PDSF---SPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp CSSS---CHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred CCCC---CHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 1222 245788999999999999999 688764
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3e-44 Score=388.71 Aligned_cols=247 Identities=23% Similarity=0.304 Sum_probs=206.6
Q ss_pred cCCCCceeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEEE
Q 044366 646 GNFGEKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFIV 724 (918)
Q Consensus 646 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 724 (918)
++|++.+.||+|+||.||+|+. .+|+.||||++......+ ....+.+.+|+++++.++|||||++++++.+.+..++|
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v 119 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVK-LKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHH-TTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccC-HHHHHHHHHHHHHHHHcCCCcEeecccccccccccccc
Confidence 5799999999999999999965 579999999987543322 33467899999999999999999999999999999999
Q ss_pred EEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccCC
Q 044366 725 CEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEP 804 (918)
Q Consensus 725 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~~ 804 (918)
|||+.+|+|.+++...+ .+++.+++.++.||+.||+|||+. +||||||||+|||++.++.+||+|||+|+.+..
T Consensus 120 ~e~~~~g~l~~~l~~~~---~l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~ 193 (350)
T d1rdqe_ 120 MEYVAGGEMFSHLRRIG---RFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193 (350)
T ss_dssp EECCTTCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred cccccccchhhhHhhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CEecCcCCHHHcccCCCCCEEeeeceeeeeccc
Confidence 99999999999997653 489999999999999999999999 999999999999999999999999999998754
Q ss_pred CCCCceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCCCCCcch
Q 044366 805 HSSNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPSRDV 884 (918)
Q Consensus 805 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 884 (918)
. .....||+.|||||++.+..++.++||||+||++|||+||+.||...... . ....+....+..+ ..
T Consensus 194 ~---~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~-~-------~~~~i~~~~~~~p-~~- 260 (350)
T d1rdqe_ 194 R---TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI-Q-------IYEKIVSGKVRFP-SH- 260 (350)
T ss_dssp C---BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-H-------HHHHHHHCCCCCC-TT-
T ss_pred c---cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHH-H-------HHHHHhcCCCCCC-cc-
Confidence 3 23467999999999999999999999999999999999999998754321 1 1111122222221 12
Q ss_pred HHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 044366 885 TDKLRSIMEVAILCLVENPEARP-----TMKEVCN 914 (918)
Q Consensus 885 ~~~~~~l~~li~~cl~~dp~~RP-----t~~evl~ 914 (918)
...++.+++.+||+.||.+|+ |++|+++
T Consensus 261 --~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 261 --FSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp --CCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred --CCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 224578899999999999994 8999875
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-44 Score=385.87 Aligned_cols=258 Identities=22% Similarity=0.342 Sum_probs=206.6
Q ss_pred hcCCCCceeeccccceEEEEEEe------CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhc-cCCceeeEeccccc
Q 044366 645 TGNFGEKYCIGKGGQRSVYKAEL------PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEI-RHRNIIKFHGFCSN 717 (918)
Q Consensus 645 ~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~ 717 (918)
.++|+..++||+|+||.||+|++ .+++.||||+++... ......+|.+|+.+++++ +|||||+++|+|.+
T Consensus 22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~---~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~ 98 (311)
T d1t46a_ 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA---HLTEREALMSELKVLSYLGNHMNIVNLLGACTI 98 (311)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC---CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECccc---CHHHHHHHHHHHHHHHhccCCCCEEEEEEEEee
Confidence 46788899999999999999964 356789999987532 223356799999999999 69999999999999
Q ss_pred CCceEEEEEeccCCChhHHhhccc---------------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCC
Q 044366 718 AQHSFIVCEYLARGSLTTILRDDA---------------AAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKN 782 (918)
Q Consensus 718 ~~~~~lv~e~~~~gsL~~~l~~~~---------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~N 782 (918)
++..++||||+++|+|.++++... ....+++.++.+++.|||+||+|||++ ++|||||||+|
T Consensus 99 ~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDLKp~N 175 (311)
T d1t46a_ 99 GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARN 175 (311)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGG
T ss_pred CCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---Ceeeccccccc
Confidence 999999999999999999997643 123589999999999999999999999 99999999999
Q ss_pred eeeCCCCcEEEeccccccccCCCCCCc--eecccccccccccccccCCCCcccchhhHHHHHHHHHhC-CCCCCcchhhh
Q 044366 783 VLLDSEYEAHVSDFGFAKFLEPHSSNW--TEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKG-YHPGDFVSTIF 859 (918)
Q Consensus 783 ill~~~~~~kl~DfG~~~~~~~~~~~~--~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg-~~p~~~~~~~~ 859 (918)
|+++.++.+|++|||.++......... ....||+.|+|||++.+..++.++|||||||++|||+|+ .+|+..... .
T Consensus 176 Il~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~-~ 254 (311)
T d1t46a_ 176 ILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV-D 254 (311)
T ss_dssp EEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCS-S
T ss_pred ccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCH-H
Confidence 999999999999999999876543322 345789999999999999999999999999999999995 555443322 1
Q ss_pred hhhhhhHhhhhhhcccCCCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhC
Q 044366 860 SSISNMIIEVNQILDHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLLCK 918 (918)
Q Consensus 860 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~ 918 (918)
..+..... . ...+..+.. ....+.++|.+||+.||++||||+||+++|++
T Consensus 255 ~~~~~~i~---~---~~~~~~~~~---~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~ 304 (311)
T d1t46a_ 255 SKFYKMIK---E---GFRMLSPEH---APAEMYDIMKTCWDADPLKRPTFKQIVQLIEK 304 (311)
T ss_dssp HHHHHHHH---H---TCCCCCCTT---SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHHHHHh---c---CCCCCCccc---ccHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 11111111 1 111111112 22468899999999999999999999999864
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-44 Score=385.67 Aligned_cols=255 Identities=24% Similarity=0.356 Sum_probs=200.8
Q ss_pred cCCCCceeeccccceEEEEEEeC-CCC--EEEEEEcccccccCCCCChHHHHHHHHHHhhc-cCCceeeEecccccCCce
Q 044366 646 GNFGEKYCIGKGGQRSVYKAELP-SGN--IFAVKKFKAELFSDETANPSEFLNEVLALTEI-RHRNIIKFHGFCSNAQHS 721 (918)
Q Consensus 646 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~--~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~ 721 (918)
++|+..+.||+|+||.||+|.+. +|. .||||+++... .....++|.+|+++++++ +|||||+++|+|.+++..
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~ 86 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA---SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYL 86 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC---------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECccc---ChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCee
Confidence 67888899999999999999664 444 47788875432 223356899999999998 799999999999999999
Q ss_pred EEEEEeccCCChhHHhhcc-------------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCC
Q 044366 722 FIVCEYLARGSLTTILRDD-------------AAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSE 788 (918)
Q Consensus 722 ~lv~e~~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~ 788 (918)
++||||+++|+|.++++.. .....+++.++++++.|||+||.|+|+. +|+||||||+||+++.+
T Consensus 87 ~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL~~~~ 163 (309)
T d1fvra_ 87 YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGEN 163 (309)
T ss_dssp EEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGG
T ss_pred EEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC---CccccccccceEEEcCC
Confidence 9999999999999999754 2245689999999999999999999999 99999999999999999
Q ss_pred CcEEEeccccccccCCCCCCceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCC-CCCcchhhhhhhhhhHh
Q 044366 789 YEAHVSDFGFAKFLEPHSSNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYH-PGDFVSTIFSSISNMII 867 (918)
Q Consensus 789 ~~~kl~DfG~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~-p~~~~~~~~~~~~~~~~ 867 (918)
+.+||+|||+++....... .....||..|+|||.+.+..++.++|||||||++|||++|.. ||..... .. ..
T Consensus 164 ~~~kl~DfG~a~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~-~~----~~- 236 (309)
T d1fvra_ 164 YVAKIADFGLSRGQEVYVK-KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC-AE----LY- 236 (309)
T ss_dssp GCEEECCTTCEESSCEECC-C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH-HH----HH-
T ss_pred CceEEcccccccccccccc-ccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCH-HH----HH-
Confidence 9999999999986543322 234568999999999999999999999999999999999765 5553321 11 11
Q ss_pred hhhhhcccCCCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhC
Q 044366 868 EVNQILDHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLLCK 918 (918)
Q Consensus 868 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~ 918 (918)
..+.....+..+... ..++.++|.+||+.||++||||+||++.|++
T Consensus 237 --~~i~~~~~~~~~~~~---~~~~~~li~~cl~~dP~~RPs~~eil~~L~~ 282 (309)
T d1fvra_ 237 --EKLPQGYRLEKPLNC---DDEVYDLMRQCWREKPYERPSFAQILVSLNR 282 (309)
T ss_dssp --HHGGGTCCCCCCTTB---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred --HHHHhcCCCCCCccC---CHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 111111122222222 3468889999999999999999999998853
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-44 Score=382.31 Aligned_cols=249 Identities=25% Similarity=0.396 Sum_probs=197.4
Q ss_pred ceeeccccceEEEEEEeCCC----CEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEeccccc-CCceEEEE
Q 044366 651 KYCIGKGGQRSVYKAELPSG----NIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSN-AQHSFIVC 725 (918)
Q Consensus 651 ~~~lg~G~~g~Vy~~~~~~~----~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~~~~lv~ 725 (918)
.++||+|+||+||+|.+..+ ..||||+++.. ......++|.+|++++++++||||++++|++.+ ++..++||
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~---~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ 108 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI---TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVL 108 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCC---CCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEE
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcc---cCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEE
Confidence 46799999999999976432 26899998642 223335789999999999999999999999865 56789999
Q ss_pred EeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccCCC
Q 044366 726 EYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPH 805 (918)
Q Consensus 726 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~~~ 805 (918)
||+++|+|.++++.. ....++.++++++.|+|+||.|+|+. +|+||||||+||++++++.+||+|||+++.....
T Consensus 109 E~~~~g~l~~~~~~~--~~~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~ 183 (311)
T d1r0pa_ 109 PYMKHGDLRNFIRNE--THNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 183 (311)
T ss_dssp ECCTTCBHHHHHHCT--TCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTT
T ss_pred EEeecCchhhhhccc--cccchHHHHHHHHHHHHHhhhhhccc---CcccCCccHHhEeECCCCCEEEecccchhhcccc
Confidence 999999999998765 33578899999999999999999999 9999999999999999999999999999876543
Q ss_pred CCC----ceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCCCCCC
Q 044366 806 SSN----WTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRLPTPS 881 (918)
Q Consensus 806 ~~~----~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 881 (918)
... .....||+.|+|||.+.+..++.++||||||+++|||+||..|+........... .+.....+..+
T Consensus 184 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~-------~i~~g~~~~~p 256 (311)
T d1r0pa_ 184 EFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITV-------YLLQGRRLLQP 256 (311)
T ss_dssp TCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHH-------HHHTTCCCCCC
T ss_pred ccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHH-------HHHcCCCCCCc
Confidence 222 2335689999999999999999999999999999999998888654332211111 11111122222
Q ss_pred cchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 044366 882 RDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLLC 917 (918)
Q Consensus 882 ~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 917 (918)
... ...+.++|.+||+.||++||++.||++.|+
T Consensus 257 ~~~---~~~l~~li~~cl~~dP~~RPs~~ei~~~L~ 289 (311)
T d1r0pa_ 257 EYC---PDPLYEVMLKCWHPKAEMRPSFSELVSRIS 289 (311)
T ss_dssp TTC---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred ccC---cHHHHHHHHHHcCCCHhHCcCHHHHHHHHH
Confidence 222 245788999999999999999999999986
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-44 Score=384.13 Aligned_cols=261 Identities=23% Similarity=0.352 Sum_probs=195.6
Q ss_pred cCCCCceeeccccceEEEEEEeCCCCEEEEEEcccccccCCCCChHHHHHH--HHHHhhccCCceeeEecccccCC----
Q 044366 646 GNFGEKYCIGKGGQRSVYKAELPSGNIFAVKKFKAELFSDETANPSEFLNE--VLALTEIRHRNIIKFHGFCSNAQ---- 719 (918)
Q Consensus 646 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e--~~~l~~l~h~niv~~~~~~~~~~---- 719 (918)
.+|...+.||+|+||.||+|++ +|+.||||+++.. ..+.+.+| +..++.++||||++++|+|.+.+
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~-------~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~ 74 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR-------EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWT 74 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGG-------GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECcc-------chhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcce
Confidence 3566778899999999999987 6899999998642 12344444 44556789999999999996543
Q ss_pred ceEEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCC-----CCCeEEcCCCCCCeeeCCCCcEEEe
Q 044366 720 HSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDC-----IPPIVHRDISSKNVLLDSEYEAHVS 794 (918)
Q Consensus 720 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~-----~~~ivH~dlk~~Nill~~~~~~kl~ 794 (918)
..++||||+++|+|.+++++. .++|.++++++.|+|.||+|+|+.. .++||||||||+|||+++++.+||+
T Consensus 75 ~~~lv~Ey~~~g~L~~~l~~~----~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~ 150 (303)
T d1vjya_ 75 QLWLVSDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIA 150 (303)
T ss_dssp EEEEEEECCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEEC
T ss_pred EEEEEEecccCCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEE
Confidence 579999999999999999864 3899999999999999999999731 2399999999999999999999999
Q ss_pred ccccccccCCCCC----CceecccccccccccccccCC------CCcccchhhHHHHHHHHHhCCCCCCcchhhh---hh
Q 044366 795 DFGFAKFLEPHSS----NWTEFAGTVGYAAPELAYTMR------ATEKYDVYSFGVLALEVIKGYHPGDFVSTIF---SS 861 (918)
Q Consensus 795 DfG~~~~~~~~~~----~~~~~~g~~~y~aPE~~~~~~------~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~---~~ 861 (918)
|||+++....... ......||+.|+|||++.+.. ++.++|||||||++|||+||..|+....... ..
T Consensus 151 DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~ 230 (303)
T d1vjya_ 151 DLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYD 230 (303)
T ss_dssp CCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTT
T ss_pred ecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhh
Confidence 9999987754432 223567999999999987542 5778999999999999999988864322110 00
Q ss_pred h----hhhHhhhhhhcccCC-CCCCc--chHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhC
Q 044366 862 I----SNMIIEVNQILDHRL-PTPSR--DVTDKLRSIMEVAILCLVENPEARPTMKEVCNLLCK 918 (918)
Q Consensus 862 ~----~~~~~~~~~~~~~~~-~~~~~--~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~ 918 (918)
. ............... +..+. ...+....+.+++.+||+.||++|||+.||++.|++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~ 294 (303)
T d1vjya_ 231 LVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ 294 (303)
T ss_dssp TSCSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHH
T ss_pred cccccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHH
Confidence 0 000011111112121 11111 123455679999999999999999999999998863
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-44 Score=383.31 Aligned_cols=258 Identities=21% Similarity=0.250 Sum_probs=196.9
Q ss_pred CceeeccccceEEEEEEe-CCCCEEEEEEcccccccCC-CCChHHHHHHHHHHhhccCCceeeEecccccCCceEEEEEe
Q 044366 650 EKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDE-TANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFIVCEY 727 (918)
Q Consensus 650 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 727 (918)
..++||+|+||+||+|+. .+|+.||||+++....... ....+.+.+|++++++++|||||++++++.+++..++||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 357899999999999965 5799999999976433221 12246789999999999999999999999999999999999
Q ss_pred ccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccCCCCC
Q 044366 728 LARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPHSS 807 (918)
Q Consensus 728 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~~~~~ 807 (918)
++++++..+.... ..+++.++..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+|+.......
T Consensus 82 ~~~~~~~~~~~~~---~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~ 155 (299)
T d1ua2a_ 82 METDLEVIIKDNS---LVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR 155 (299)
T ss_dssp CSEEHHHHHTTCC---SSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC
T ss_pred hcchHHhhhhhcc---cCCCHHHHHHHHHHHHHHHHHhhcc---ceecccCCcceEEecCCCccccccCccccccCCCcc
Confidence 9988777666533 3488899999999999999999999 999999999999999999999999999988766555
Q ss_pred CceecccccccccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhh----hhc--------c
Q 044366 808 NWTEFAGTVGYAAPELAYTM-RATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVN----QIL--------D 874 (918)
Q Consensus 808 ~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~----~~~--------~ 874 (918)
.....+||+.|+|||++.+. .++.++||||+||++|||++|++||...... +.......... +.. .
T Consensus 156 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~-~~l~~i~~~~~~~~~~~~~~~~~~~~~ 234 (299)
T d1ua2a_ 156 AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDL-DQLTRIFETLGTPTEEQWPDMCSLPDY 234 (299)
T ss_dssp CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHHHCCCCTTTSSSTTSSTTC
T ss_pred cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHH-HHHHHHHHhcCCCChhhccchhccchh
Confidence 55567899999999988654 5799999999999999999999998654321 11111110000 000 0
Q ss_pred cCCCCC-Ccch----HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 875 HRLPTP-SRDV----TDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 875 ~~~~~~-~~~~----~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
...... .... ......+.+++.+||+.||++|||++|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~ 279 (299)
T d1ua2a_ 235 VTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279 (299)
T ss_dssp CCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred hhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence 000000 0000 112356889999999999999999999986
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-44 Score=384.96 Aligned_cols=258 Identities=21% Similarity=0.324 Sum_probs=194.5
Q ss_pred HhcCCCCceeeccccceEEEEEEeC------CCCEEEEEEcccccccCCCCChHHHHHHHHHHhhc-cCCceeeEecccc
Q 044366 644 ATGNFGEKYCIGKGGQRSVYKAELP------SGNIFAVKKFKAELFSDETANPSEFLNEVLALTEI-RHRNIIKFHGFCS 716 (918)
Q Consensus 644 ~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~ 716 (918)
..++|...+.||+|+||.||+|... +++.||||+++... .....+.+.+|+..+.++ +|+||+.+++++.
T Consensus 11 ~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~---~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~ 87 (299)
T d1ywna1 11 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA---THSEHRALMSELKILIHIGHHLNVVNLLGACT 87 (299)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC-------CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEcccc---CcHHHHHHHHHHHHHHhhcCCCeEEEeeeeec
Confidence 3467999999999999999999642 34689999987532 222346788888888877 6899999999876
Q ss_pred c-CCceEEEEEeccCCChhHHhhcccc-------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCC
Q 044366 717 N-AQHSFIVCEYLARGSLTTILRDDAA-------------AKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKN 782 (918)
Q Consensus 717 ~-~~~~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~N 782 (918)
. +...++||||+++|+|.++++.... ...+++.+++.++.||++||+|||++ +||||||||+|
T Consensus 88 ~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHrDlKp~N 164 (299)
T d1ywna1 88 KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARN 164 (299)
T ss_dssp STTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGG
T ss_pred cCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC---CCcCCcCCccc
Confidence 5 4568999999999999999975431 23489999999999999999999999 99999999999
Q ss_pred eeeCCCCcEEEeccccccccCCCCC--CceecccccccccccccccCCCCcccchhhHHHHHHHHHhCC-CCCCcchhhh
Q 044366 783 VLLDSEYEAHVSDFGFAKFLEPHSS--NWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGY-HPGDFVSTIF 859 (918)
Q Consensus 783 ill~~~~~~kl~DfG~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~-~p~~~~~~~~ 859 (918)
|++++++.+||+|||+|+....... ......||+.|+|||++.+..++.++|||||||++|||+||. .||......
T Consensus 165 ILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~- 243 (299)
T d1ywna1 165 ILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID- 243 (299)
T ss_dssp EEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCS-
T ss_pred eeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHH-
Confidence 9999999999999999987654433 234467999999999999999999999999999999999975 566543221
Q ss_pred hhhhhhHhhhhhhcccCCCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 044366 860 SSISNMIIEVNQILDHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLLC 917 (918)
Q Consensus 860 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 917 (918)
..+.. ...+ ...+..+.. ...++.+++.+||+.||++|||++|+++.|+
T Consensus 244 ~~~~~---~~~~---~~~~~~~~~---~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~ 292 (299)
T d1ywna1 244 EEFCR---RLKE---GTRMRAPDY---TTPEMYQTMLDCWHGEPSQRPTFSELVEHLG 292 (299)
T ss_dssp HHHHH---HHHH---TCCCCCCTT---CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHHH---HHhc---CCCCCCCcc---CCHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence 11111 1111 111111111 2246788999999999999999999999886
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-44 Score=381.63 Aligned_cols=257 Identities=24% Similarity=0.364 Sum_probs=202.6
Q ss_pred hcCCCCceeeccccceEEEEEEeCC--------CCEEEEEEcccccccCCCCChHHHHHHHHHHhhc-cCCceeeEeccc
Q 044366 645 TGNFGEKYCIGKGGQRSVYKAELPS--------GNIFAVKKFKAELFSDETANPSEFLNEVLALTEI-RHRNIIKFHGFC 715 (918)
Q Consensus 645 ~~~~~~~~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~ 715 (918)
.++|...+.||+|+||.||+|+... +..||||+++... ......++.+|+..+.++ +|||||+++++|
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~ 88 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA---TEKDLSDLISEMEMMKMIGKHKNIINLLGAC 88 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTC---CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECccc---ChHHHHHHHHHHHHHHHhcCCCeEEeccccc
Confidence 4678888999999999999996422 2479999987532 222357889999999888 899999999999
Q ss_pred ccCCceEEEEEeccCCChhHHhhcccc-------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCC
Q 044366 716 SNAQHSFIVCEYLARGSLTTILRDDAA-------------AKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKN 782 (918)
Q Consensus 716 ~~~~~~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~N 782 (918)
.+++..++||||+++|+|.++++.... ...+++.+++.++.|||.||+|||+. +||||||||+|
T Consensus 89 ~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDiKp~N 165 (299)
T d1fgka_ 89 TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARN 165 (299)
T ss_dssp CSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGG
T ss_pred ccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC---CEEeeeecccc
Confidence 999999999999999999999976532 34589999999999999999999999 99999999999
Q ss_pred eeeCCCCcEEEeccccccccCCCCC--CceecccccccccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhhh
Q 044366 783 VLLDSEYEAHVSDFGFAKFLEPHSS--NWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIK-GYHPGDFVSTIF 859 (918)
Q Consensus 783 ill~~~~~~kl~DfG~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~t-g~~p~~~~~~~~ 859 (918)
|+++.++.+||+|||+++....... ......|++.|+|||++.++.++.++|||||||++|||++ |+.||......
T Consensus 166 iLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~- 244 (299)
T d1fgka_ 166 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE- 244 (299)
T ss_dssp EEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH-
T ss_pred eeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHH-
Confidence 9999999999999999987754432 2234568999999999999999999999999999999998 68887643321
Q ss_pred hhhhhhHhhhhhhcccCCCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhC
Q 044366 860 SSISNMIIEVNQILDHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLLCK 918 (918)
Q Consensus 860 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~ 918 (918)
.+ ...+. ....+..+... ...+.+++.+||+.||.+||||+||++.|++
T Consensus 245 -~~---~~~i~---~~~~~~~p~~~---~~~l~~li~~cl~~dP~~Rps~~eil~~L~~ 293 (299)
T d1fgka_ 245 -EL---FKLLK---EGHRMDKPSNC---TNELYMMMRDCWHAVPSQRPTFKQLVEDLDR 293 (299)
T ss_dssp -HH---HHHHH---TTCCCCCCSSC---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred -HH---HHHHH---cCCCCCCCccc---hHHHHHHHHHHccCCHhHCcCHHHHHHHHHH
Confidence 11 11111 11112222222 2458889999999999999999999999864
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-44 Score=382.02 Aligned_cols=257 Identities=21% Similarity=0.345 Sum_probs=207.6
Q ss_pred hcCCCCceeeccccceEEEEEEeC------CCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccC
Q 044366 645 TGNFGEKYCIGKGGQRSVYKAELP------SGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNA 718 (918)
Q Consensus 645 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~ 718 (918)
.++|...+.||+|+||.||+|.+. +++.||||+++... .......|.+|++++++++||||++++|++..+
T Consensus 19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~---~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~ 95 (308)
T d1p4oa_ 19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA---SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG 95 (308)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS---CHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSS
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECccc---ChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecC
Confidence 467888899999999999999652 35789999986531 222345799999999999999999999999999
Q ss_pred CceEEEEEeccCCChhHHhhccc-------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcE
Q 044366 719 QHSFIVCEYLARGSLTTILRDDA-------AAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEA 791 (918)
Q Consensus 719 ~~~~lv~e~~~~gsL~~~l~~~~-------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~ 791 (918)
+..++||||+++|+|.+++.... ....+++..+.+++.|+|+||+|||+. +|+||||||+||++++++.+
T Consensus 96 ~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLld~~~~~ 172 (308)
T d1p4oa_ 96 QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTV 172 (308)
T ss_dssp SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCCE
T ss_pred CceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeeceEcCCceeecCCceE
Confidence 99999999999999999986532 123478999999999999999999999 99999999999999999999
Q ss_pred EEeccccccccCCCCCC--ceecccccccccccccccCCCCcccchhhHHHHHHHHHhCC-CCCCcchhhhhhhhhhHhh
Q 044366 792 HVSDFGFAKFLEPHSSN--WTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGY-HPGDFVSTIFSSISNMIIE 868 (918)
Q Consensus 792 kl~DfG~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~-~p~~~~~~~~~~~~~~~~~ 868 (918)
||+|||+|+........ .....||+.|+|||.+.+..++.++||||||+++|||+||. .|+...... ..
T Consensus 173 Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~-~~------- 244 (308)
T d1p4oa_ 173 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE-QV------- 244 (308)
T ss_dssp EECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHH-HH-------
T ss_pred EEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHH-HH-------
Confidence 99999999876544332 23346899999999999999999999999999999999985 666543221 11
Q ss_pred hhhhcccCCCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhC
Q 044366 869 VNQILDHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLLCK 918 (918)
Q Consensus 869 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~ 918 (918)
...+.+...+..+... ...+.+++.+||+.||++|||++||++.|++
T Consensus 245 ~~~i~~~~~~~~p~~~---~~~l~~li~~cl~~~P~~RPs~~~il~~L~~ 291 (308)
T d1p4oa_ 245 LRFVMEGGLLDKPDNC---PDMLFELMRMCWQYNPKMRPSFLEIISSIKE 291 (308)
T ss_dssp HHHHHTTCCCCCCTTC---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHGG
T ss_pred HHHHHhCCCCCCcccc---hHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 1122222222222222 2468889999999999999999999999864
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-44 Score=382.10 Aligned_cols=261 Identities=23% Similarity=0.321 Sum_probs=201.6
Q ss_pred cCCCCceeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEEE
Q 044366 646 GNFGEKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFIV 724 (918)
Q Consensus 646 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 724 (918)
++|++.+.||+|+||+||+|.. .+|+.||||+++.... .....+.+.+|++++++++|||||++++++.+++..++|
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~--~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv 79 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE--TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLV 79 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC---------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhc--ChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEE
Confidence 5789999999999999999964 6899999999976432 223457899999999999999999999999999999999
Q ss_pred EEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccCC
Q 044366 725 CEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEP 804 (918)
Q Consensus 725 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~~ 804 (918)
|||+.++ +.+++.... ...+++.+++.++.||+.||+|||+. +||||||||+||+++.++.+||+|||.|+....
T Consensus 80 ~e~~~~~-~~~~~~~~~-~~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~ 154 (298)
T d1gz8a_ 80 FEFLHQD-LKKFMDASA-LTGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV 154 (298)
T ss_dssp EECCSEE-HHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTHHHHHCC
T ss_pred EeecCCc-hhhhhhhhc-ccCCCHHHHHHHHHHHHHHHHHhhcC---CEEccccCchheeecccCcceeccCCcceeccC
Confidence 9999764 444443322 34589999999999999999999999 999999999999999999999999999988876
Q ss_pred CCCCceecccccccccccccccCC-CCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhh-----------hhhh
Q 044366 805 HSSNWTEFAGTVGYAAPELAYTMR-ATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIE-----------VNQI 872 (918)
Q Consensus 805 ~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~-----------~~~~ 872 (918)
.........||+.|+|||++.... ++.++||||+||++|+|++|+.||....... ........ ....
T Consensus 155 ~~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~~ 233 (298)
T d1gz8a_ 155 PVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID-QLFRIFRTLGTPDEVVWPGVTSM 233 (298)
T ss_dssp CSBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCCCCTTTSTTGGGS
T ss_pred CcccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHH-HHHHHHHhcCCCchhhccccccc
Confidence 655556678999999999877655 5789999999999999999999987543211 11110000 0000
Q ss_pred cc--cCCCCC-CcchH----HHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 873 LD--HRLPTP-SRDVT----DKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 873 ~~--~~~~~~-~~~~~----~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
.+ ...+.. ..... ....++.+++.+|++.||++|||++|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~ 282 (298)
T d1gz8a_ 234 PDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 282 (298)
T ss_dssp TTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 00 000010 11111 12256889999999999999999999986
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=7.5e-44 Score=377.53 Aligned_cols=260 Identities=23% Similarity=0.321 Sum_probs=201.1
Q ss_pred cCCCCceeeccccceEEEEEEeCCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEEEE
Q 044366 646 GNFGEKYCIGKGGQRSVYKAELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFIVC 725 (918)
Q Consensus 646 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 725 (918)
++|...+.||+|+||+||+|+.++|+.||||+++.... .....+.|.+|+.++++++||||+++++++.+++..++|+
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~ 79 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKE--DEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVF 79 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSG--GGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEE
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhc--ChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEE
Confidence 57889999999999999999888999999999976432 2233578999999999999999999999999999999999
Q ss_pred EeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccCCC
Q 044366 726 EYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEPH 805 (918)
Q Consensus 726 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~~~ 805 (918)
||+.++.+..+.... ..+++.+++.++.||+.||+|||+. +||||||||+||+++.++.+|++|||.|.....+
T Consensus 80 e~~~~~~~~~~~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~ 153 (286)
T d1ob3a_ 80 EHLDQDLKKLLDVCE---GGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIP 153 (286)
T ss_dssp ECCSEEHHHHHHTST---TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-
T ss_pred EeehhhhHHHHHhhc---CCcchhhhHHHHHHHHHHHHHhccC---cEEecCCCCceeeEcCCCCEEecccccceecccC
Confidence 999887777666543 4589999999999999999999999 9999999999999999999999999999887665
Q ss_pred CCCceecccccccccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhh-----------hhhhc
Q 044366 806 SSNWTEFAGTVGYAAPELAYTM-RATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIE-----------VNQIL 873 (918)
Q Consensus 806 ~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~-----------~~~~~ 873 (918)
........+++.|+|||.+.+. .++.++||||+||++|||++|+.||....... ........ .....
T Consensus 154 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~~~ 232 (286)
T d1ob3a_ 154 VRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEAD-QLMRIFRILGTPNSKNWPNVTELP 232 (286)
T ss_dssp --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCCCCTTTSTTGGGST
T ss_pred ccccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHH-HHHHHHHhhCCCChhhccchhhhh
Confidence 5555566789999999998754 56899999999999999999999987543211 11110000 00000
Q ss_pred --ccCC----CCC-CcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 874 --DHRL----PTP-SRDVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 874 --~~~~----~~~-~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
.... +.+ ..........+.+++.+||+.||++|||++|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 233 KYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp TCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000 000 0001112356789999999999999999999984
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-44 Score=374.19 Aligned_cols=244 Identities=23% Similarity=0.333 Sum_probs=198.5
Q ss_pred hcCCCCceeeccccceEEEEEEe-CCCCEEEEEEcccccccCC--CCChHHHHHHHHHHhhcc--CCceeeEecccccCC
Q 044366 645 TGNFGEKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDE--TANPSEFLNEVLALTEIR--HRNIIKFHGFCSNAQ 719 (918)
Q Consensus 645 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~--~~~~~~~~~e~~~l~~l~--h~niv~~~~~~~~~~ 719 (918)
.++|++.+.||+|+||.||+|+. .+|+.||||+++.....+. ......+.+|+.++++++ |||||++++++.+++
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence 36799999999999999999954 5799999999976443321 122345779999999996 899999999999999
Q ss_pred ceEEEEEeccC-CChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCC-CcEEEeccc
Q 044366 720 HSFIVCEYLAR-GSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSE-YEAHVSDFG 797 (918)
Q Consensus 720 ~~~lv~e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~-~~~kl~DfG 797 (918)
..++||||+++ +++.+++... ..+++.+++.++.||++||+|||+. +|+||||||+||+++.+ +.+||+|||
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~~~---~~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~~~~~vkl~DFG 156 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFITER---GALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFG 156 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred eEEEEEEeccCcchHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CCccccCcccceEEecCCCeEEECccc
Confidence 99999999976 5788887654 3489999999999999999999999 99999999999999854 799999999
Q ss_pred cccccCCCCCCceecccccccccccccccCCC-CcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccC
Q 044366 798 FAKFLEPHSSNWTEFAGTVGYAAPELAYTMRA-TEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHR 876 (918)
Q Consensus 798 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 876 (918)
+|+..... ......||+.|+|||++.+..+ +.++||||+||++|||++|+.||....... ...
T Consensus 157 ~a~~~~~~--~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~i~--------------~~~ 220 (273)
T d1xwsa_ 157 SGALLKDT--VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEII--------------RGQ 220 (273)
T ss_dssp TCEECCSS--CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHHH--------------HCC
T ss_pred cceecccc--cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchHHh--------------hcc
Confidence 99875432 3345689999999999987765 567899999999999999999987543211 011
Q ss_pred CCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 877 LPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 877 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
... .... ..++.+++.+||+.||++|||++|+++
T Consensus 221 ~~~-~~~~---s~~~~~li~~~L~~dp~~R~s~~eil~ 254 (273)
T d1xwsa_ 221 VFF-RQRV---SSECQHLIRWCLALRPSDRPTFEEIQN 254 (273)
T ss_dssp CCC-SSCC---CHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred cCC-CCCC---CHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 111 1112 245788999999999999999999976
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-42 Score=369.76 Aligned_cols=262 Identities=21% Similarity=0.317 Sum_probs=197.5
Q ss_pred HhcCCCCceeeccccceEEEEEEe-CC-CCEEEEEEcccccccCCCCChHHHHHHHHHHhhc---cCCceeeEecccc--
Q 044366 644 ATGNFGEKYCIGKGGQRSVYKAEL-PS-GNIFAVKKFKAELFSDETANPSEFLNEVLALTEI---RHRNIIKFHGFCS-- 716 (918)
Q Consensus 644 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l---~h~niv~~~~~~~-- 716 (918)
..++|++.+.||+|+||+||+|+. .+ ++.||||+++...... .....+.+|+.+++.+ +||||+++++++.
T Consensus 5 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~--~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~ 82 (305)
T d1blxa_ 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE--GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVS 82 (305)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTT--SCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEE
T ss_pred CcCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccc--hHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccc
Confidence 357899999999999999999965 44 5679999997653322 2234567888877766 7999999999884
Q ss_pred ---cCCceEEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEE
Q 044366 717 ---NAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHV 793 (918)
Q Consensus 717 ---~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl 793 (918)
.....+++|||++++++....... ...+++..++.++.|++.||+|||++ +||||||||+|||++.++.+||
T Consensus 83 ~~~~~~~~~~~~e~~~~~~~~~~~~~~--~~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~~~~kl 157 (305)
T d1blxa_ 83 RTDRETKLTLVFEHVDQDLTTYLDKVP--EPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKL 157 (305)
T ss_dssp ECSSEEEEEEEEECCSCBHHHHHHHSC--TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEE
T ss_pred ccccCceEEEEEEeccCCchhhhhhcc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecCCCccEEEEcCCCCeee
Confidence 335689999999987766544332 34589999999999999999999999 9999999999999999999999
Q ss_pred eccccccccCCCCCCceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhh----
Q 044366 794 SDFGFAKFLEPHSSNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEV---- 869 (918)
Q Consensus 794 ~DfG~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~---- 869 (918)
+|||++...... .......||+.|+|||++.+..++.++||||+||++|||++|+.||...... +.........
T Consensus 158 ~dfg~~~~~~~~-~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~-~~~~~i~~~~~~~~ 235 (305)
T d1blxa_ 158 ADFGLARIYSFQ-MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV-DQLGKILDVIGLPG 235 (305)
T ss_dssp CSCCSCCCCCGG-GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHHHHCCCC
T ss_pred cchhhhhhhccc-ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHH-HHHHHHHHhhCCCc
Confidence 999999865432 2335568999999999999999999999999999999999999998754321 1111110000
Q ss_pred -----------hhhcccCCCCC-CcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 870 -----------NQILDHRLPTP-SRDVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 870 -----------~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
..........+ ..........+.+++.+||+.||++|||++|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~ 292 (305)
T d1blxa_ 236 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292 (305)
T ss_dssp GGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred hhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 00000000000 0001112346788999999999999999999975
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-41 Score=359.14 Aligned_cols=261 Identities=18% Similarity=0.276 Sum_probs=207.2
Q ss_pred cCCCCceeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCCceEEE
Q 044366 646 GNFGEKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQHSFIV 724 (918)
Q Consensus 646 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 724 (918)
++|++.+.||+|+||+||+|+. .+|+.||||+++... ......+.+.+|+.+++.++||||+++++++.+....++|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv 79 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDD--DDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLV 79 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSC--SSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhh--CChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEE
Confidence 5789999999999999999964 689999999997642 2333467899999999999999999999999999999999
Q ss_pred EEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccccccCC
Q 044366 725 CEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKFLEP 804 (918)
Q Consensus 725 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~~~~ 804 (918)
+|++.++++..++... +.+++..++.++.|++.||+|||+. +||||||||+||+++.++.+|++|||.++....
T Consensus 80 ~~~~~~~~l~~~~~~~---~~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~ 153 (292)
T d1unla_ 80 FEFCDQDLKKYFDSCN---GDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGI 153 (292)
T ss_dssp EECCSEEHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCS
T ss_pred eeeccccccccccccc---cccchhHHHHHHHHHHHHHHHhhcC---CEeeecccCcccccccCCceeeeecchhhcccC
Confidence 9999999988887654 3489999999999999999999999 999999999999999999999999999998776
Q ss_pred CCCCceecccccccccccccccCC-CCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhh-----------h
Q 044366 805 HSSNWTEFAGTVGYAAPELAYTMR-ATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQ-----------I 872 (918)
Q Consensus 805 ~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~-----------~ 872 (918)
.........+++.|+|||.+.+.. ++.++||||+||++|||++|+.||................... .
T Consensus 154 ~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (292)
T d1unla_ 154 PVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKL 233 (292)
T ss_dssp CCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGS
T ss_pred CCccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhc
Confidence 655555667889999999887665 6899999999999999999999964433322222211110000 0
Q ss_pred cccC-------CCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 873 LDHR-------LPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 873 ~~~~-------~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
.+.. ..............+.+++.+|++.||++||||+|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~ 282 (292)
T d1unla_ 234 PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp TTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred ccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000 00001111122356788999999999999999999975
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-40 Score=359.07 Aligned_cols=261 Identities=21% Similarity=0.293 Sum_probs=195.9
Q ss_pred hcCCCCceeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEeccccc------
Q 044366 645 TGNFGEKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSN------ 717 (918)
Q Consensus 645 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~------ 717 (918)
.++|++.+.||+|+||+||+|+. .+|+.||||++..... .....+++.+|++++++++||||+++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~--~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~ 86 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENE--KEGFPITALREIKILQLLKHENVVNLIEICRTKASPYN 86 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----C--TTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhc--chHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccc
Confidence 47899999999999999999965 6899999999876432 23345789999999999999999999998744
Q ss_pred --CCceEEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEec
Q 044366 718 --AQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSD 795 (918)
Q Consensus 718 --~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~D 795 (918)
.+..++||||++++.+..+... ...+++.+++.++.|++.||.|||+. +|+||||||+||+++.++.+|++|
T Consensus 87 ~~~~~~~iv~e~~~~~~~~~~~~~---~~~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~~~kl~d 160 (318)
T d3blha1 87 RCKGSIYLVFDFCEHDLAGLLSNV---LVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLAD 160 (318)
T ss_dssp ----CEEEEEECCCEEHHHHHTCT---TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECC
T ss_pred ccCceEEEEEeccCCCccchhhhc---ccccccHHHHHHHHHHHHHHHHhccC---CEEecCcCchheeecCCCcEEeee
Confidence 3468999999988776655443 23589999999999999999999999 999999999999999999999999
Q ss_pred cccccccCCCCC----CceecccccccccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhh
Q 044366 796 FGFAKFLEPHSS----NWTEFAGTVGYAAPELAYTM-RATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVN 870 (918)
Q Consensus 796 fG~~~~~~~~~~----~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~ 870 (918)
||+++.+..... ......||+.|+|||++.+. .++.++||||+||++|||++|+.||+...... ..........
T Consensus 161 fg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~-~~~~i~~~~~ 239 (318)
T d3blha1 161 FGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQH-QLALISQLCG 239 (318)
T ss_dssp CTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHC
T ss_pred cceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHH-HHHHHHHhcC
Confidence 999987654322 22345789999999998765 68999999999999999999999987543211 1111100000
Q ss_pred hhcc---------------cCCCCCCcchHHH------HHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 871 QILD---------------HRLPTPSRDVTDK------LRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 871 ~~~~---------------~~~~~~~~~~~~~------~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
.... ...........+. ...+.+++.+||+.||++|||++|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~ 304 (318)
T d3blha1 240 SITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 304 (318)
T ss_dssp CCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHc
Confidence 0000 0000111111111 245678999999999999999999986
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-41 Score=366.93 Aligned_cols=260 Identities=20% Similarity=0.251 Sum_probs=194.1
Q ss_pred hcCCCCceeeccccceEEEEEE-eCCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCC----
Q 044366 645 TGNFGEKYCIGKGGQRSVYKAE-LPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQ---- 719 (918)
Q Consensus 645 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~---- 719 (918)
+.+|++.+.||+|+||+||+|. ..+|+.||||+++... .....+.+.+|+++++.++||||+++++++....
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~---~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~ 83 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE---HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQM 83 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT---CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTC
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc---ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeecccccc
Confidence 3578999999999999999995 5689999999986531 2223567899999999999999999999986543
Q ss_pred ceEEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccccc
Q 044366 720 HSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFA 799 (918)
Q Consensus 720 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~ 799 (918)
..+++++|+.+|+|.+++... .+++..++.++.|++.||+|||++ +||||||||+|||++.++.+||+|||+|
T Consensus 84 ~~~~l~~~~~~g~L~~~l~~~----~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl~DfG~a 156 (345)
T d1pmea_ 84 KDVYLVTHLMGADLYKLLKTQ----HLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLA 156 (345)
T ss_dssp CCEEEEEECCCEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred ceEEEEEeecCCchhhhhhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCcceEEECCCCCEEEcccCce
Confidence 235556677789999999753 489999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCC---Cceecccccccccccccc-cCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHh--------
Q 044366 800 KFLEPHSS---NWTEFAGTVGYAAPELAY-TMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMII-------- 867 (918)
Q Consensus 800 ~~~~~~~~---~~~~~~g~~~y~aPE~~~-~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~-------- 867 (918)
........ .....+||+.|+|||++. +..++.++||||+||++|||++|+.||...............
T Consensus 157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 236 (345)
T d1pmea_ 157 RVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQED 236 (345)
T ss_dssp EECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHH
T ss_pred eeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhh
Confidence 87644322 234567899999999985 456788999999999999999999998654321110000000
Q ss_pred -------hhhhhcccCCCCCCcchH----HHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 868 -------EVNQILDHRLPTPSRDVT----DKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 868 -------~~~~~~~~~~~~~~~~~~----~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
.................. ....++.+++.+|++.||++|||++|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~ 294 (345)
T d1pmea_ 237 LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 294 (345)
T ss_dssp HHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred hhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000000000000000111 11246889999999999999999999985
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-41 Score=365.20 Aligned_cols=257 Identities=20% Similarity=0.265 Sum_probs=192.0
Q ss_pred hcCCCCceeeccccceEEEEEE-eCCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEecccccCC----
Q 044366 645 TGNFGEKYCIGKGGQRSVYKAE-LPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSNAQ---- 719 (918)
Q Consensus 645 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~---- 719 (918)
.++|++.+.||+|+||+||+|. ..+|+.||||+++.... .....+.+.+|+++++.++|||||++++++...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~--~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~ 94 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQ--SELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDD 94 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTS--SHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTT
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhc--ChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccc
Confidence 4689999999999999999995 45799999999975321 2223467899999999999999999999986554
Q ss_pred --ceEEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEeccc
Q 044366 720 --HSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFG 797 (918)
Q Consensus 720 --~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG 797 (918)
..++||||+ +++|..+.+. ..+++..++.++.||+.||+|||+. +||||||||+|||++.++.+|++|||
T Consensus 95 ~~~~~lv~e~~-~~~l~~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~kl~Dfg 166 (346)
T d1cm8a_ 95 FTDFYLVMPFM-GTDLGKLMKH----EKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFG 166 (346)
T ss_dssp CCCCEEEEECC-SEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCT
T ss_pred cceEEEEEecc-cccHHHHHHh----ccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCcchhhccccccccccccc
Confidence 569999999 4578777754 3499999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCCceecccccccccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhh-----------
Q 044366 798 FAKFLEPHSSNWTEFAGTVGYAAPELAYTM-RATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNM----------- 865 (918)
Q Consensus 798 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~----------- 865 (918)
+|+..... .....||+.|+|||++.+. .++.++||||+||++|||++|+.||.............
T Consensus 167 ~a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 243 (346)
T d1cm8a_ 167 LARQADSE---MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFV 243 (346)
T ss_dssp TCEECCSS---CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred ceeccCCc---cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHH
Confidence 99876543 3456789999999998764 56899999999999999999999986543211100000
Q ss_pred -------HhhhhhhcccCC-CCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 866 -------IIEVNQILDHRL-PTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 866 -------~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
............ .............+.+++.+||+.||++|||++|+++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~ 300 (346)
T d1cm8a_ 244 QRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 300 (346)
T ss_dssp HTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred hhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 000000000000 0000011112346788999999999999999999986
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-41 Score=367.77 Aligned_cols=255 Identities=24% Similarity=0.290 Sum_probs=191.7
Q ss_pred CCCCceeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEeccccc------CC
Q 044366 647 NFGEKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSN------AQ 719 (918)
Q Consensus 647 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~------~~ 719 (918)
+|...++||+|+||+||+|+. .+|+.||||+++... ..+.+|++++++++||||+++++++.. ..
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~--------~~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~ 92 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK--------RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEV 92 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--------SSCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCC
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccc--------hHHHHHHHHHHhcCCCCCCcEEEEEEecCccCCce
Confidence 578889999999999999965 579999999986531 112479999999999999999998843 33
Q ss_pred ceEEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCC-cEEEecccc
Q 044366 720 HSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEY-EAHVSDFGF 798 (918)
Q Consensus 720 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~-~~kl~DfG~ 798 (918)
+.++||||+++|.+............+++.+++.++.||+.||+|||++ +|+||||||+|||++.++ .+||+|||+
T Consensus 93 ~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~kl~DFG~ 169 (350)
T d1q5ka_ 93 YLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGS 169 (350)
T ss_dssp EEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCEEECCCTT
T ss_pred EEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhc---CCcccCCCcceEEEecCCCceeEecccc
Confidence 5789999998764444443333345699999999999999999999999 999999999999999875 899999999
Q ss_pred ccccCCCCCCceeccccccccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHh--------hh
Q 044366 799 AKFLEPHSSNWTEFAGTVGYAAPELAYT-MRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMII--------EV 869 (918)
Q Consensus 799 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~--------~~ 869 (918)
++....... .....|++.|+|||.+.+ ..++.++||||+||++|||++|+.||....... ....... ..
T Consensus 170 a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~-~l~~i~~~~g~~~~~~~ 247 (350)
T d1q5ka_ 170 AKQLVRGEP-NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD-QLVEIIKVLGTPTREQI 247 (350)
T ss_dssp CEECCTTSC-CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHH-HHHHHHHHHCCCCHHHH
T ss_pred hhhccCCcc-cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHH-HHHHHHHHhCCChHHhh
Confidence 987754433 344678999999998765 568999999999999999999999986543211 1111000 00
Q ss_pred ----hhhcccCCCCCC------cchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 870 ----NQILDHRLPTPS------RDVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 870 ----~~~~~~~~~~~~------~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
........+... ........++.+++.+||+.||++|||++|+++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 302 (350)
T d1q5ka_ 248 REMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302 (350)
T ss_dssp HHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000111111100 001112346888999999999999999999985
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-41 Score=360.77 Aligned_cols=255 Identities=24% Similarity=0.352 Sum_probs=203.0
Q ss_pred cCCCCceeeccccceEEEEEEe----CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccC-CceeeEecccccCCc
Q 044366 646 GNFGEKYCIGKGGQRSVYKAEL----PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRH-RNIIKFHGFCSNAQH 720 (918)
Q Consensus 646 ~~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~~~~~~~~~~~ 720 (918)
++|++.+.||+|+||.||+|.. .+|+.||||+++...........+.+.+|++++++++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 6699999999999999999954 25899999999765443344446778999999999977 899999999999999
Q ss_pred eEEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEecccccc
Q 044366 721 SFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAK 800 (918)
Q Consensus 721 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~ 800 (918)
.++||||+.+|+|.+++.... .+++..++.++.||+.|++|+|+. +||||||||+||+++.++.+||+|||+++
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~~---~~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~vkL~DFG~a~ 177 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQRE---RFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSK 177 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred eeeeeecccccHHHHHHHhcc---cccHHHHHHHHHHHHHHHHHhhcC---CEEeccCCccceeecCCCCEEEeeccchh
Confidence 999999999999999997654 378899999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCC-CceecccccccccccccccC--CCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhcccCC
Q 044366 801 FLEPHSS-NWTEFAGTVGYAAPELAYTM--RATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQILDHRL 877 (918)
Q Consensus 801 ~~~~~~~-~~~~~~g~~~y~aPE~~~~~--~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 877 (918)
.+..... ......|++.|+|||.+.+. .++.++||||+||++|||++|+.||....... ...... .......+
T Consensus 178 ~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~-~~~~i~---~~~~~~~~ 253 (322)
T d1vzoa_ 178 EFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKN-SQAEIS---RRILKSEP 253 (322)
T ss_dssp ECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCC-CHHHHH---HHHHHCCC
T ss_pred hhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHH---HhcccCCC
Confidence 7654322 23456789999999998754 46789999999999999999999986543211 111111 11111111
Q ss_pred CCCCcchHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 044366 878 PTPSRDVTDKLRSIMEVAILCLVENPEARP-----TMKEVCN 914 (918)
Q Consensus 878 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RP-----t~~evl~ 914 (918)
+.+ . .....+.+++.+||+.||++|| |++|+++
T Consensus 254 ~~~-~---~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 254 PYP-Q---EMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp CCC-T---TSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred CCc-c---cCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 111 1 1235688899999999999999 5888875
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=3.2e-40 Score=356.91 Aligned_cols=252 Identities=19% Similarity=0.267 Sum_probs=196.2
Q ss_pred cCCCCceeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhcc-CCceeeEeccccc--CCce
Q 044366 646 GNFGEKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIR-HRNIIKFHGFCSN--AQHS 721 (918)
Q Consensus 646 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~--~~~~ 721 (918)
++|++.+.||+|+||+||+|+. .+|+.||||+++. ...+.+.+|++++++++ ||||+++++++.. ....
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~-------~~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~ 107 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP-------VKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTP 107 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS-------SCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECH-------HHHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCce
Confidence 5799999999999999999965 5799999999864 23578899999999995 9999999999864 4568
Q ss_pred EEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCC-cEEEecccccc
Q 044366 722 FIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEY-EAHVSDFGFAK 800 (918)
Q Consensus 722 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~-~~kl~DfG~~~ 800 (918)
++||||+++|+|..+.+ .+++.+++.++.||+.||+|||++ +||||||||+|||++.++ .+|++|||+|+
T Consensus 108 ~~v~e~~~~~~L~~~~~------~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~DFG~a~ 178 (328)
T d3bqca1 108 ALVFEHVNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAE 178 (328)
T ss_dssp EEEEECCCSCBGGGTTT------SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCGGGCE
T ss_pred eEEEeecCCCcHHHHhc------CCCHHHHHHHHHHHHHHHHHHhhc---ccccccccccceEEcCCCCeeeecccccce
Confidence 99999999999987643 389999999999999999999999 999999999999998655 68999999998
Q ss_pred ccCCCCCCceecccccccccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhh-----------
Q 044366 801 FLEPHSSNWTEFAGTVGYAAPELAYTM-RATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIE----------- 868 (918)
Q Consensus 801 ~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~----------- 868 (918)
...+... .....+|+.|+|||.+.+. .++.++||||+||++|||++|+.||................
T Consensus 179 ~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~ 257 (328)
T d3bqca1 179 FYHPGQE-YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYID 257 (328)
T ss_dssp ECCTTCC-CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHH
T ss_pred eccCCCc-ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhh
Confidence 8765432 3456789999999998765 47999999999999999999999986543322111111000
Q ss_pred ---------hhhhcccCCC------CCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 869 ---------VNQILDHRLP------TPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 869 ---------~~~~~~~~~~------~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
.......... ...........++.+++.+|++.||++|||++|+++
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 258 KYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp HTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000000000 000111122356889999999999999999999986
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.2e-40 Score=350.98 Aligned_cols=256 Identities=16% Similarity=0.200 Sum_probs=192.9
Q ss_pred cCCCCceeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCcee-eEecccccCCceEE
Q 044366 646 GNFGEKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNII-KFHGFCSNAQHSFI 723 (918)
Q Consensus 646 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv-~~~~~~~~~~~~~l 723 (918)
++|+..+.||+|+||.||+|+. .+|+.||||++.... ..+++..|+++++.++|++++ .+.++..+++..++
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~------~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~i 80 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT------KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVM 80 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCT------TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEE
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhc------cCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEE
Confidence 5799999999999999999964 578999999876531 124578999999999876655 55555677888999
Q ss_pred EEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCC---CCcEEEecccccc
Q 044366 724 VCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDS---EYEAHVSDFGFAK 800 (918)
Q Consensus 724 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~---~~~~kl~DfG~~~ 800 (918)
||||++ |++.+.+... ...+++..+..++.|++.||+|||+. +|+||||||+||+++. +..+|++|||+|+
T Consensus 81 vme~~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~ 154 (299)
T d1ckia_ 81 VMELLG-PSLEDLFNFC--SRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 154 (299)
T ss_dssp EEECCC-CBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCSSCE
T ss_pred EEEEcC-Cchhhhhhhc--cCCCcHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHhhccccccCCCceeeeeccCcce
Confidence 999995 5676666543 34589999999999999999999999 9999999999999864 4579999999999
Q ss_pred ccCCCCC-------CceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhhhhhhc
Q 044366 801 FLEPHSS-------NWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIEVNQIL 873 (918)
Q Consensus 801 ~~~~~~~-------~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 873 (918)
.+..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||....................
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~- 233 (299)
T d1ckia_ 155 KYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKM- 233 (299)
T ss_dssp ECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHH-
T ss_pred eccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccC-
Confidence 8764332 12345799999999999999999999999999999999999999865432211111000000000
Q ss_pred ccCCCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 044366 874 DHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLLC 917 (918)
Q Consensus 874 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 917 (918)
. .+. .......+.++.+++.+||+.||++||+++++.+.|+
T Consensus 234 ~--~~~-~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~ 274 (299)
T d1ckia_ 234 S--TPI-EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFR 274 (299)
T ss_dssp H--SCH-HHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHH
T ss_pred C--CCh-hHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHH
Confidence 0 000 0000112246888999999999999999999887764
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=3.4e-40 Score=349.36 Aligned_cols=256 Identities=17% Similarity=0.188 Sum_probs=199.5
Q ss_pred hcCCCCceeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccC-CceeeEecccccCCceE
Q 044366 645 TGNFGEKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRH-RNIIKFHGFCSNAQHSF 722 (918)
Q Consensus 645 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~~~~~~~~~~~~~ 722 (918)
.++|.+.+.||+|+||.||+|+. .+|+.||||++... .....+.+|++.++.++| +|++.+++++..+...+
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~------~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~ 77 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRR------SDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNV 77 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECC------TTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccc------cCcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccE
Confidence 36899999999999999999964 57899999987542 122457788999999865 89999999999999999
Q ss_pred EEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCC-----CCcEEEeccc
Q 044366 723 IVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDS-----EYEAHVSDFG 797 (918)
Q Consensus 723 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~-----~~~~kl~DfG 797 (918)
+||||+ +++|.+++... ...+++.++..++.|++.||+|||+. +|+||||||+||+++. ++.+||+|||
T Consensus 78 ~vme~~-~~~l~~~~~~~--~~~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~~vkl~DFG 151 (293)
T d1csna_ 78 LVIDLL-GPSLEDLLDLC--GRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFG 151 (293)
T ss_dssp EEEECC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCT
T ss_pred EEEEec-CCCHHHHHHhh--ccchhhHHHHHHHHHHHHHHHHHHHC---CceeccCCccceeecCcccccCCceEEcccc
Confidence 999999 57999998754 34589999999999999999999999 9999999999999975 5689999999
Q ss_pred cccccCCCCC-------CceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhh-hHhhh
Q 044366 798 FAKFLEPHSS-------NWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISN-MIIEV 869 (918)
Q Consensus 798 ~~~~~~~~~~-------~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~-~~~~~ 869 (918)
+|+.+..... ......||+.|||||++.+..++.++|||||||++|||++|+.||............ .....
T Consensus 152 ~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~ 231 (293)
T d1csna_ 152 MVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEK 231 (293)
T ss_dssp TCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHH
T ss_pred eeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhc
Confidence 9987754321 223457999999999999999999999999999999999999998643321111000 00000
Q ss_pred hhhcccCCCCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 044366 870 NQILDHRLPTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCNLLC 917 (918)
Q Consensus 870 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 917 (918)
..... .+.... ..++++.+++..|++.+|++||+++.+.+.|+
T Consensus 232 ~~~~~--~~~l~~---~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~ 274 (293)
T d1csna_ 232 KQSTP--LRELCA---GFPEEFYKYMHYARNLAFDATPDYDYLQGLFS 274 (293)
T ss_dssp HHHSC--HHHHTT---TSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHH
T ss_pred cCCCC--hHHhcC---CCCHHHHHHHHHHhcCCcccCcCHHHHHHHHH
Confidence 00000 000001 11246788889999999999999998887764
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-39 Score=355.99 Aligned_cols=257 Identities=20% Similarity=0.267 Sum_probs=188.8
Q ss_pred cCCCCceeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEeccccc------C
Q 044366 646 GNFGEKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSN------A 718 (918)
Q Consensus 646 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~------~ 718 (918)
++|++.+.||+|+||+||+|.. .+|+.||||+++.... .....+.+.+|+.++++++||||+++++++.. .
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~--~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~ 94 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ--NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF 94 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTS--SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhc--CHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccC
Confidence 5799999999999999999965 5799999999976432 22234578999999999999999999999853 4
Q ss_pred CceEEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEecccc
Q 044366 719 QHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGF 798 (918)
Q Consensus 719 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~ 798 (918)
.+.|+||||+.++.+. .+. ..+++.+++.++.||+.||+|||+. ||+||||||+||+++.++.+|++|||.
T Consensus 95 ~~~~iv~Ey~~~~l~~-~~~-----~~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~kl~df~~ 165 (355)
T d2b1pa1 95 QDVYLVMELMDANLCQ-VIQ-----MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL 165 (355)
T ss_dssp CEEEEEEECCSEEHHH-HHT-----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC
T ss_pred ceeEEEEeccchHHHH-hhh-----cCCCHHHHHHHHHHHHHHHHHhhhc---ccccccCCccccccccccceeeechhh
Confidence 6789999999775444 443 2389999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCCceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhhh--------------hhh
Q 044366 799 AKFLEPHSSNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSS--------------ISN 864 (918)
Q Consensus 799 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~--------------~~~ 864 (918)
++..... .......+|+.|+|||++.+..++.++||||+||++|||++|+.||......... +..
T Consensus 166 ~~~~~~~-~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~ 244 (355)
T d2b1pa1 166 ARTAGTS-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 244 (355)
T ss_dssp ----------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTT
T ss_pred hhccccc-cccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHH
Confidence 8866543 2334567899999999999999999999999999999999999998643321100 000
Q ss_pred hHhhhhhhcccCC----------------CCCCcchHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 865 MIIEVNQILDHRL----------------PTPSRDVTDKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 865 ~~~~~~~~~~~~~----------------~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
............. +............+.+++.+|++.||++||||+|+++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~ 310 (355)
T d2b1pa1 245 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 310 (355)
T ss_dssp SCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred hhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 0000111111111 1111112334567899999999999999999999984
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-39 Score=352.21 Aligned_cols=257 Identities=19% Similarity=0.273 Sum_probs=193.3
Q ss_pred hcCCCCceeeccccceEEEEEE-eCCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCceeeEeccccc-----C
Q 044366 645 TGNFGEKYCIGKGGQRSVYKAE-LPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNIIKFHGFCSN-----A 718 (918)
Q Consensus 645 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-----~ 718 (918)
.++|++.+.||+|+||+||+|+ ..+|+.||||+++.... .....+.+.+|++++++++|||||++++++.. .
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~--~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~ 94 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ--SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEE 94 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTS--SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTT
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhc--ChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeecccccc
Confidence 4679999999999999999995 46899999999875321 22234678999999999999999999998753 2
Q ss_pred CceEEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEecccc
Q 044366 719 QHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVSDFGF 798 (918)
Q Consensus 719 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~ 798 (918)
...+++++|+.+|+|.+++... ++++.+++.++.||+.||+|||+. +|+||||||+||+++.++.+|++|||.
T Consensus 95 ~~~~~i~~~~~gg~L~~~~~~~----~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~kl~dfg~ 167 (348)
T d2gfsa1 95 FNDVYLVTHLMGADLNNIVKCQ----KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGL 167 (348)
T ss_dssp CCCCEEEEECCSEEHHHHHTTC----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC--
T ss_pred CceEEEEEeecCCchhhhcccc----cccHHHHHHHHHHHHHHHHHHHhC---CCcccccCCccccccccccccccccch
Confidence 3456777888899999999643 489999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCCceecccccccccccccccCC-CCcccchhhHHHHHHHHHhCCCCCCcchhhhhhhhhhHhh---------
Q 044366 799 AKFLEPHSSNWTEFAGTVGYAAPELAYTMR-ATEKYDVYSFGVLALEVIKGYHPGDFVSTIFSSISNMIIE--------- 868 (918)
Q Consensus 799 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~~~~~~~~~--------- 868 (918)
+..... ......|++.|+|||...+.. ++.++||||+||++|+|++|+.||......... ......
T Consensus 168 a~~~~~---~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~-~~i~~~~~~~~~~~~ 243 (348)
T d2gfsa1 168 ARHTDD---EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQL-KLILRLVGTPGAELL 243 (348)
T ss_dssp --CCTG---GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHH-HHHHHHHCCCCHHHH
T ss_pred hcccCc---ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHH-HHHHHhcCCCChHHh
Confidence 976543 233457899999999876654 688999999999999999999998654321110 000000
Q ss_pred -------hhhhcccCCCCCCcchH----HHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 044366 869 -------VNQILDHRLPTPSRDVT----DKLRSIMEVAILCLVENPEARPTMKEVCN 914 (918)
Q Consensus 869 -------~~~~~~~~~~~~~~~~~----~~~~~l~~li~~cl~~dp~~RPt~~evl~ 914 (918)
................. .....+.+++.+|++.||++|||++|+++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~ 300 (348)
T d2gfsa1 244 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 300 (348)
T ss_dssp TTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhc
Confidence 00000000000011111 12356789999999999999999999986
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=4.3e-35 Score=321.81 Aligned_cols=258 Identities=18% Similarity=0.217 Sum_probs=188.6
Q ss_pred cCCCCceeeccccceEEEEEEe-CCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhcc-----------CCceeeEec
Q 044366 646 GNFGEKYCIGKGGQRSVYKAEL-PSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIR-----------HRNIIKFHG 713 (918)
Q Consensus 646 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-----------h~niv~~~~ 713 (918)
++|.+.+.||+|+||+||+|+. .+|+.||||+++... ...+.+.+|+++++.++ |+||+++++
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-----~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~ 87 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-----VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLD 87 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-----HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-----cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEE
Confidence 4699999999999999999965 689999999987532 22356788998888775 578999998
Q ss_pred cccc--CCceEEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEEcCCCCCCeeeCCCC-
Q 044366 714 FCSN--AQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHH-DCIPPIVHRDISSKNVLLDSEY- 789 (918)
Q Consensus 714 ~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~ivH~dlk~~Nill~~~~- 789 (918)
++.. ....++|++++..+..............+++..+..++.||+.|++|||+ . +|+||||||+|||++.++
T Consensus 88 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~---~IvHrDlKp~NIll~~~~~ 164 (362)
T d1q8ya_ 88 HFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRC---GIIHTDIKPENVLMEIVDS 164 (362)
T ss_dssp EEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT---CEECSCCSGGGEEEEEEET
T ss_pred EeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhc---CcccccCChhHeeeeccCc
Confidence 8754 35567777777655444333333345568999999999999999999998 5 999999999999998665
Q ss_pred -----cEEEeccccccccCCCCCCceecccccccccccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhhhh----
Q 044366 790 -----EAHVSDFGFAKFLEPHSSNWTEFAGTVGYAAPELAYTMRATEKYDVYSFGVLALEVIKGYHPGDFVSTIFS---- 860 (918)
Q Consensus 790 -----~~kl~DfG~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~vl~el~tg~~p~~~~~~~~~---- 860 (918)
.++++|||.+...... .....||+.|+|||++.+..++.++||||+||++++|++|+.||........
T Consensus 165 ~~~~~~~kl~dfg~s~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~ 241 (362)
T d1q8ya_ 165 PENLIQIKIADLGNACWYDEH---YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDD 241 (362)
T ss_dssp TTTEEEEEECCCTTCEETTBC---CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHH
T ss_pred ccccceeeEeecccccccccc---cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchh
Confidence 3899999999865432 2345789999999999999999999999999999999999999864321100
Q ss_pred -hhhhhHhh--------------hhhhcc-----cCCCC------------CCcchHHHHHHHHHHHHHcccCCCCCCCC
Q 044366 861 -SISNMIIE--------------VNQILD-----HRLPT------------PSRDVTDKLRSIMEVAILCLVENPEARPT 908 (918)
Q Consensus 861 -~~~~~~~~--------------~~~~~~-----~~~~~------------~~~~~~~~~~~l~~li~~cl~~dp~~RPt 908 (918)
........ .....+ ..... ...........+.+++.+|+..||.+|||
T Consensus 242 ~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpt 321 (362)
T d1q8ya_ 242 DHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRAD 321 (362)
T ss_dssp HHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBC
T ss_pred HHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcC
Confidence 00000000 000000 00000 01112345678999999999999999999
Q ss_pred HHHHHH
Q 044366 909 MKEVCN 914 (918)
Q Consensus 909 ~~evl~ 914 (918)
|+|+++
T Consensus 322 a~e~L~ 327 (362)
T d1q8ya_ 322 AGGLVN 327 (362)
T ss_dssp HHHHHT
T ss_pred HHHHhc
Confidence 999986
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.97 E-value=1.9e-29 Score=279.28 Aligned_cols=356 Identities=24% Similarity=0.331 Sum_probs=199.1
Q ss_pred EccCCcccccCccccCCCCCCCEEECcCCcCCCcCCcCCCCCCCCceeeccccccccCCCcccccccccCeeeccccccC
Q 044366 99 YLNDNSLFGSIPIVMGNLKSLSTLDLSQNQLNGSIPCSLDNLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSENRLS 178 (918)
Q Consensus 99 ~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~ 178 (918)
.++.+.+++.+. ...+.+|++|+++++.|+.. +.+..+++|++|+|++|+|+++. .|+++++|++|++++|++.
T Consensus 28 ~l~~~~~~~~~~--~~~l~~l~~L~l~~~~I~~l--~gl~~L~nL~~L~Ls~N~l~~l~--~l~~L~~L~~L~L~~n~i~ 101 (384)
T d2omza2 28 VLGKTNVTDTVS--QTDLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTDIT--PLKNLTKLVDILMNNNQIA 101 (384)
T ss_dssp HTTCSSTTSEEC--HHHHTTCCEEECCSSCCCCC--TTGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCC
T ss_pred HhCCCCCCCccC--HHHhCCCCEEECCCCCCCCc--cccccCCCCCEEeCcCCcCCCCc--cccCCcccccccccccccc
Confidence 455555554332 23556777888888777743 35667777777777777777553 3777777777777777777
Q ss_pred CcCCccCCCCCCCcEeeccCcccccCCCccccCCCCcceeecccccccCCCCCCCcCCCcCCeEEcccCcCcCCCCcccc
Q 044366 179 GLIPLSLSNLSSLTVMSLFNNSLSGSIPPILGNLKSLSTLGLHINQLNGVIPPSIGNLSSLRNLSLFNNRLYGFVPKEIG 258 (918)
Q Consensus 179 ~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~ 258 (918)
++. .+..+++|+.|++++|.+++.. .......+..+....|.+....+................. ....+.
T Consensus 102 ~i~--~l~~l~~L~~L~~~~~~~~~~~--~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~ 172 (384)
T d2omza2 102 DIT--PLANLTNLTGLTLFNNQITDID--PLKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVT-----DLKPLA 172 (384)
T ss_dssp CCG--GGTTCTTCCEEECCSSCCCCCG--GGTTCTTCSEEEEEEEEECCCGGGTTCTTCSEEEEEESCC-----CCGGGT
T ss_pred ccc--cccccccccccccccccccccc--cccccccccccccccccccccccccccccccccccccccc-----hhhhhc
Confidence 653 3666777777777777666432 2334455566666666554332221111111111111111 111222
Q ss_pred ccCCCCeEecCCCccCCcCCCcCCCCCCCcEEEccCCcCcCCCCccccCCCCCCeEEeecccccCccccccCCCCCccEE
Q 044366 259 YLKSLSKLEFCANHLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLRNLTSLERVRFNQNNLYGKVYEAFGDHPNLTFL 338 (918)
Q Consensus 259 ~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L 338 (918)
.......... ..|.. .....+..+++++.+++++|.+..+.+ +...++|+.|
T Consensus 173 ~~~~~~~~~~------------------------~~~~~--~~~~~~~~l~~~~~l~l~~n~i~~~~~--~~~~~~L~~L 224 (384)
T d2omza2 173 NLTTLERLDI------------------------SSNKV--SDISVLAKLTNLESLIATNNQISDITP--LGILTNLDEL 224 (384)
T ss_dssp TCTTCCEEEC------------------------CSSCC--CCCGGGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEE
T ss_pred cccccccccc------------------------ccccc--ccccccccccccceeeccCCccCCCCc--ccccCCCCEE
Confidence 2222222333 33322 122334444455555555555444432 2334455555
Q ss_pred eCCCCccccccCcccccccccceeeccccccccCCCcCcCCCCCCcEEEccCceeccccccchhhccccCceeccccccc
Q 044366 339 DLSQNNFYCEISFNWRNFSKLGTFNASMNNIYGSIPPEIGDSSKLQVLDLSSNHIFGKIPVQLVKLFSLNKLILSLNQLF 418 (918)
Q Consensus 339 ~Ls~N~l~~~~~~~~~~~~~L~~l~l~~n~i~~~~~~~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 418 (918)
++++|.++.. +.+..+++|+.|++++|++++..+ +..+++|+.|++++|+++
T Consensus 225 ~l~~n~l~~~--------------------------~~l~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~~~l~ 276 (384)
T d2omza2 225 SLNGNQLKDI--------------------------GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQIS 276 (384)
T ss_dssp ECCSSCCCCC--------------------------GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCC
T ss_pred ECCCCCCCCc--------------------------chhhcccccchhccccCccCCCCc--ccccccCCEeeccCcccC
Confidence 5555554321 233444555555555555543322 445555666666666655
Q ss_pred CCCCCCCCCCCcccEEeccCccccccCccccccccccceecccCcccCCCCchhhccccccceEeccCCcCCCCCchhcc
Q 044366 419 GGVPLEFGTLTELQYLDLSANKLSSSIPMSIGNLLKLHYLNLSNNQFSHKIPTEFEKLIHLSELDLSHNILQEEIPPQIC 498 (918)
Q Consensus 419 ~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~ 498 (918)
+.. .+..++.++.++++.|.+++. ..+..+++++.|++++|+|++.. .+..+++|++|++++|+|++ ++ .+.
T Consensus 277 ~~~--~~~~~~~l~~l~~~~n~l~~~--~~~~~~~~l~~L~ls~n~l~~l~--~l~~l~~L~~L~L~~n~l~~-l~-~l~ 348 (384)
T d2omza2 277 NIS--PLAGLTALTNLELNENQLEDI--SPISNLKNLTYLTLYFNNISDIS--PVSSLTKLQRLFFANNKVSD-VS-SLA 348 (384)
T ss_dssp CCG--GGTTCTTCSEEECCSSCCSCC--GGGGGCTTCSEEECCSSCCSCCG--GGGGCTTCCEEECCSSCCCC-CG-GGG
T ss_pred CCC--ccccccccccccccccccccc--cccchhcccCeEECCCCCCCCCc--ccccCCCCCEEECCCCCCCC-Ch-hHc
Confidence 432 255666777777777777642 34666777777777777776543 26777777777777777764 23 577
Q ss_pred ccCCcceEecCCCcccccCcccccCCCCccEEEccCC
Q 044366 499 KMESLEKLNLSHNNLSDFIPRCFEEMRSLSWIDISYN 535 (918)
Q Consensus 499 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~l~l~~N 535 (918)
++++|++|+|++|+|+++.| +.++++|+.|+|++|
T Consensus 349 ~l~~L~~L~l~~N~l~~l~~--l~~l~~L~~L~L~~N 383 (384)
T d2omza2 349 NLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383 (384)
T ss_dssp GCTTCCEEECCSSCCCBCGG--GTTCTTCSEEECCCE
T ss_pred CCCCCCEEECCCCcCCCChh--hccCCCCCEeeCCCC
Confidence 77777777777777777554 677777777777776
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.97 E-value=5.6e-29 Score=275.51 Aligned_cols=356 Identities=25% Similarity=0.338 Sum_probs=240.3
Q ss_pred EcccccccccCCccccCCCCCCEEEccCCcccccCccccCCCCCCCEEECcCCcCCCcCCcCCCCCCCCceeeccccccc
Q 044366 75 VFCHNNVSGRIPSSLGNLSNLALLYLNDNSLFGSIPIVMGNLKSLSTLDLSQNQLNGSIPCSLDNLSNLDTLFLYKNSLS 154 (918)
Q Consensus 75 ~l~~n~~~~~~p~~l~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~l~ 154 (918)
.+..+.+++.++ ...+.+|++|++++|.|+.. +.+..+++|++|+|++|+|++.. .++++++|++|++++|+++
T Consensus 28 ~l~~~~~~~~~~--~~~l~~l~~L~l~~~~I~~l--~gl~~L~nL~~L~Ls~N~l~~l~--~l~~L~~L~~L~L~~n~i~ 101 (384)
T d2omza2 28 VLGKTNVTDTVS--QTDLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTDIT--PLKNLTKLVDILMNNNQIA 101 (384)
T ss_dssp HTTCSSTTSEEC--HHHHTTCCEEECCSSCCCCC--TTGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCC
T ss_pred HhCCCCCCCccC--HHHhCCCCEEECCCCCCCCc--cccccCCCCCEEeCcCCcCCCCc--cccCCcccccccccccccc
Confidence 455566665444 35678999999999999854 35788999999999999999653 3999999999999999999
Q ss_pred cCCCcccccccccCeeeccccccCCcCCccCCCCCCCcEeeccCcccccCCCccccCCCCcceeecccccccCCCCCCCc
Q 044366 155 GPIPSVIGNLKSLLQLDLSENRLSGLIPLSLSNLSSLTVMSLFNNSLSGSIPPILGNLKSLSTLGLHINQLNGVIPPSIG 234 (918)
Q Consensus 155 ~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~ 234 (918)
++. .++.+++|+.|++++|.+++..+ ......+..+....|.+....+.................. ...+.
T Consensus 102 ~i~--~l~~l~~L~~L~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~ 172 (384)
T d2omza2 102 DIT--PLANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTD-----LKPLA 172 (384)
T ss_dssp CCG--GGTTCTTCCEEECCSSCCCCCGG--GTTCTTCSEEEEEEEEECCCGGGTTCTTCSEEEEEESCCC-----CGGGT
T ss_pred ccc--ccccccccccccccccccccccc--ccccccccccccccccccccccccccccccccccccccch-----hhhhc
Confidence 653 48999999999999999997643 4556778888888888875544333333333322222222 23455
Q ss_pred CCCcCCeEEcccCcCcCCCCccccccCCCCeEecCCCccCCcCCCcCCCCCCCcEEEccCCcCcCCCCccccCCCCCCeE
Q 044366 235 NLSSLRNLSLFNNRLYGFVPKEIGYLKSLSKLEFCANHLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLRNLTSLERV 314 (918)
Q Consensus 235 ~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L 314 (918)
............|... ....+..+++++.+++++|.+.+..| +...++|+.|++++|+++.. ..+..+++|+.+
T Consensus 173 ~~~~~~~~~~~~~~~~--~~~~~~~l~~~~~l~l~~n~i~~~~~--~~~~~~L~~L~l~~n~l~~~--~~l~~l~~L~~L 246 (384)
T d2omza2 173 NLTTLERLDISSNKVS--DISVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDI--GTLASLTNLTDL 246 (384)
T ss_dssp TCTTCCEEECCSSCCC--CCGGGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEE
T ss_pred cccccccccccccccc--cccccccccccceeeccCCccCCCCc--ccccCCCCEEECCCCCCCCc--chhhcccccchh
Confidence 5666677777777654 34567788889999999998886644 34556777777777776532 245555555555
Q ss_pred EeecccccCccccccCCCCCccEEeCCCCccccccCcccccccccceeeccccccccCCCcCcCCCCCCcEEEccCceec
Q 044366 315 RFNQNNLYGKVYEAFGDHPNLTFLDLSQNNFYCEISFNWRNFSKLGTFNASMNNIYGSIPPEIGDSSKLQVLDLSSNHIF 394 (918)
Q Consensus 315 ~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~n~i~~~~~~~~~~~~~L~~L~L~~N~l~ 394 (918)
++++|.+..+.+ +..+++|++|+++ +|+++
T Consensus 247 ~l~~n~l~~~~~--~~~~~~L~~L~l~------------------------------------------------~~~l~ 276 (384)
T d2omza2 247 DLANNQISNLAP--LSGLTKLTELKLG------------------------------------------------ANQIS 276 (384)
T ss_dssp ECCSSCCCCCGG--GTTCTTCSEEECC------------------------------------------------SSCCC
T ss_pred ccccCccCCCCc--ccccccCCEeecc------------------------------------------------CcccC
Confidence 555555544332 3334444444444 44443
Q ss_pred cccccchhhccccCceecccccccCCCCCCCCCCCcccEEeccCccccccCccccccccccceecccCcccCCCCchhhc
Q 044366 395 GKIPVQLVKLFSLNKLILSLNQLFGGVPLEFGTLTELQYLDLSANKLSSSIPMSIGNLLKLHYLNLSNNQFSHKIPTEFE 474 (918)
Q Consensus 395 ~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~ 474 (918)
+.. .+..+..++.+.++.|++.+. ..+..++++++|++++|++++.. .+..+++|+.|++++|+|++ ++ .|+
T Consensus 277 ~~~--~~~~~~~l~~l~~~~n~l~~~--~~~~~~~~l~~L~ls~n~l~~l~--~l~~l~~L~~L~L~~n~l~~-l~-~l~ 348 (384)
T d2omza2 277 NIS--PLAGLTALTNLELNENQLEDI--SPISNLKNLTYLTLYFNNISDIS--PVSSLTKLQRLFFANNKVSD-VS-SLA 348 (384)
T ss_dssp CCG--GGTTCTTCSEEECCSSCCSCC--GGGGGCTTCSEEECCSSCCSCCG--GGGGCTTCCEEECCSSCCCC-CG-GGG
T ss_pred CCC--ccccccccccccccccccccc--cccchhcccCeEECCCCCCCCCc--ccccCCCCCEEECCCCCCCC-Ch-hHc
Confidence 221 233444455555555555432 23556677777888888777543 36777888888888888864 33 577
Q ss_pred cccccceEeccCCcCCCCCchhccccCCcceEecCCC
Q 044366 475 KLIHLSELDLSHNILQEEIPPQICKMESLEKLNLSHN 511 (918)
Q Consensus 475 ~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N 511 (918)
++++|++|+|++|+|++..| +.++++|+.|+|++|
T Consensus 349 ~l~~L~~L~l~~N~l~~l~~--l~~l~~L~~L~L~~N 383 (384)
T d2omza2 349 NLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383 (384)
T ss_dssp GCTTCCEEECCSSCCCBCGG--GTTCTTCSEEECCCE
T ss_pred CCCCCCEEECCCCcCCCChh--hccCCCCCEeeCCCC
Confidence 88888888888888876544 777888888888877
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.96 E-value=1.2e-29 Score=272.16 Aligned_cols=253 Identities=31% Similarity=0.491 Sum_probs=220.8
Q ss_pred CCCCEEeCCCCcccc--cCCccccCCCCCCEEEccc-ccccccCCCCcCCCCCCCEEEcccccccccCCccccCCCCCCE
Q 044366 21 SKLQYLDLGNNQLSG--VIPPEIGKLNQLRRLYLDV-NQLHGTIPPVIGQLSLINELVFCHNNVSGRIPSSLGNLSNLAL 97 (918)
Q Consensus 21 ~~L~~L~L~~n~i~~--~~p~~l~~l~~L~~L~L~~-n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~l~~l~~L~~ 97 (918)
..++.|||++|++.+ .+|.+|++|++|++|+|++ |+++|.+|..|+++++|++|++++|++.+..|..+..+.+|+.
T Consensus 50 ~~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~ 129 (313)
T d1ogqa_ 50 YRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVT 129 (313)
T ss_dssp CCEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCE
T ss_pred EEEEEEECCCCCCCCCCCCChHHhcCccccccccccccccccccccccccccccchhhhccccccccccccccchhhhcc
Confidence 468899999998876 4789999999999999986 7888889999999999999999999999888888999999999
Q ss_pred EEccCCcccccCccccCCCCCCCEEECcCCcCCCcCCcCCCCCCCC-ceeeccccccccCCCcccccccccCeeeccccc
Q 044366 98 LYLNDNSLFGSIPIVMGNLKSLSTLDLSQNQLNGSIPCSLDNLSNL-DTLFLYKNSLSGPIPSVIGNLKSLLQLDLSENR 176 (918)
Q Consensus 98 L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L-~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~ 176 (918)
++++.|.+.+..|..+.++++|+++++++|.+++.+|..+..+.++ +.+++++|++++..+..+..+..+ .++++++.
T Consensus 130 l~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~-~l~l~~~~ 208 (313)
T d1ogqa_ 130 LDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLA-FVDLSRNM 208 (313)
T ss_dssp EECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCS-EEECCSSE
T ss_pred cccccccccccCchhhccCcccceeeccccccccccccccccccccccccccccccccccccccccccccc-cccccccc
Confidence 9999999888889999999999999999999988888888888775 889999999998888888877554 68999998
Q ss_pred cCCcCCccCCCCCCCcEeeccCcccccCCCccccCCCCcceeecccccccCCCCCCCcCCCcCCeEEcccCcCcCCCCcc
Q 044366 177 LSGLIPLSLSNLSSLTVMSLFNNSLSGSIPPILGNLKSLSTLGLHINQLNGVIPPSIGNLSSLRNLSLFNNRLYGFVPKE 256 (918)
Q Consensus 177 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~ 256 (918)
..+.+|..+..+++++.+++++|.+.+.+ ..+..+++|+.|+|++|++++.+|..|+++++|++|+|++|++++..| .
T Consensus 209 ~~~~~~~~~~~~~~l~~l~~~~~~l~~~~-~~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP-~ 286 (313)
T d1ogqa_ 209 LEGDASVLFGSDKNTQKIHLAKNSLAFDL-GKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP-Q 286 (313)
T ss_dssp EEECCGGGCCTTSCCSEEECCSSEECCBG-GGCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECC-C
T ss_pred ccccccccccccccccccccccccccccc-cccccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCC-C
Confidence 88888888889999999999999988654 468888999999999999998889999999999999999999997777 4
Q ss_pred ccccCCCCeEecCCCc-cCCc
Q 044366 257 IGYLKSLSKLEFCANH-LSGV 276 (918)
Q Consensus 257 ~~~l~~L~~L~l~~n~-l~~~ 276 (918)
++.+++|+.+++++|+ +.+.
T Consensus 287 ~~~L~~L~~l~l~~N~~l~g~ 307 (313)
T d1ogqa_ 287 GGNLQRFDVSAYANNKCLCGS 307 (313)
T ss_dssp STTGGGSCGGGTCSSSEEEST
T ss_pred cccCCCCCHHHhCCCccccCC
Confidence 5788899999999997 4543
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.96 E-value=4.1e-29 Score=267.82 Aligned_cols=251 Identities=33% Similarity=0.507 Sum_probs=219.6
Q ss_pred CCCCCEEEcccccccc--cCCCCcCCCCCCCEEEccc-ccccccCCccccCCCCCCEEEccCCcccccCccccCCCCCCC
Q 044366 44 LNQLRRLYLDVNQLHG--TIPPVIGQLSLINELVFCH-NNVSGRIPSSLGNLSNLALLYLNDNSLFGSIPIVMGNLKSLS 120 (918)
Q Consensus 44 l~~L~~L~L~~n~l~~--~~p~~~~~l~~L~~L~l~~-n~~~~~~p~~l~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~ 120 (918)
-.+++.|+|++|.+.+ .+|..++.|++|++|++++ |+++|.+|.+|++|++|++|+|++|++.+..+..+..+.+|+
T Consensus 49 ~~~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~ 128 (313)
T d1ogqa_ 49 TYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLV 128 (313)
T ss_dssp CCCEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCC
T ss_pred cEEEEEEECCCCCCCCCCCCChHHhcCccccccccccccccccccccccccccccchhhhccccccccccccccchhhhc
Confidence 3478899999998886 5789999999999999986 788888999999999999999999999988888899999999
Q ss_pred EEECcCCcCCCcCCcCCCCCCCCceeeccccccccCCCccccccccc-CeeeccccccCCcCCccCCCCCCCcEeeccCc
Q 044366 121 TLDLSQNQLNGSIPCSLDNLSNLDTLFLYKNSLSGPIPSVIGNLKSL-LQLDLSENRLSGLIPLSLSNLSSLTVMSLFNN 199 (918)
Q Consensus 121 ~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L-~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N 199 (918)
+++++.|++...+|..++++++|+++++++|.+++.+|+.+..+..+ +.+++++|++++..+..+..+..+ .+++++|
T Consensus 129 ~l~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~-~l~l~~~ 207 (313)
T d1ogqa_ 129 TLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLA-FVDLSRN 207 (313)
T ss_dssp EEECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCS-EEECCSS
T ss_pred ccccccccccccCchhhccCcccceeeccccccccccccccccccccccccccccccccccccccccccccc-ccccccc
Confidence 99999999988889999999999999999999998888888888776 888999999998888888776544 6899999
Q ss_pred ccccCCCccccCCCCcceeecccccccCCCCCCCcCCCcCCeEEcccCcCcCCCCccccccCCCCeEecCCCccCCcCCC
Q 044366 200 SLSGSIPPILGNLKSLSTLGLHINQLNGVIPPSIGNLSSLRNLSLFNNRLYGFVPKEIGYLKSLSKLEFCANHLSGVIPH 279 (918)
Q Consensus 200 ~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~ 279 (918)
...+.+|..+..+++|+.+++++|.+.+.+ ..+..+++|+.|+|++|++++..|..++.+++|++|+|++|++++.+|.
T Consensus 208 ~~~~~~~~~~~~~~~l~~l~~~~~~l~~~~-~~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~ 286 (313)
T d1ogqa_ 208 MLEGDASVLFGSDKNTQKIHLAKNSLAFDL-GKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ 286 (313)
T ss_dssp EEEECCGGGCCTTSCCSEEECCSSEECCBG-GGCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCC
T ss_pred cccccccccccccccccccccccccccccc-cccccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCCC
Confidence 988888888899999999999999998654 4678889999999999999988898999999999999999999987774
Q ss_pred cCCCCCCCcEEEccCCcC
Q 044366 280 SVGNLTGLVLLNMCENHL 297 (918)
Q Consensus 280 ~~~~l~~L~~L~l~~n~l 297 (918)
+.++++|+.+++++|+.
T Consensus 287 -~~~L~~L~~l~l~~N~~ 303 (313)
T d1ogqa_ 287 -GGNLQRFDVSAYANNKC 303 (313)
T ss_dssp -STTGGGSCGGGTCSSSE
T ss_pred -cccCCCCCHHHhCCCcc
Confidence 67888999999999873
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.95 E-value=1.3e-26 Score=247.20 Aligned_cols=244 Identities=23% Similarity=0.246 Sum_probs=116.1
Q ss_pred cceeecccccccCCCCCCCcCCCcCCeEEcccCcCcCCCCccccccCCCCeEecCCCccCCcCCCcCCCCCCCcEEEccC
Q 044366 215 LSTLGLHINQLNGVIPPSIGNLSSLRNLSLFNNRLYGFVPKEIGYLKSLSKLEFCANHLSGVIPHSVGNLTGLVLLNMCE 294 (918)
Q Consensus 215 L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~ 294 (918)
++.++-+++.++.+ |..+. +++++|+|++|+|+.+.+..|..+++|++|++++|++..+.|..|.++++|+.|++++
T Consensus 12 ~~~~~C~~~~L~~l-P~~l~--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~~ 88 (305)
T d1xkua_ 12 LRVVQCSDLGLEKV-PKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSK 88 (305)
T ss_dssp TTEEECTTSCCCSC-CCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred CCEEEecCCCCCcc-CCCCC--CCCCEEECcCCcCCCcChhHhhccccccccccccccccccchhhhhCCCccCEecccC
Confidence 44555555555533 33332 3566666666666655555556666666666666666655555555566666666666
Q ss_pred CcCcCCCCccccCCCCCCeEEeecccccCccccccCCCCCccEEeCCCCccccccCcccccccccceeeccccccccCCC
Q 044366 295 NHLFGPIPKSLRNLTSLERVRFNQNNLYGKVYEAFGDHPNLTFLDLSQNNFYCEISFNWRNFSKLGTFNASMNNIYGSIP 374 (918)
Q Consensus 295 n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~n~i~~~~~ 374 (918)
|+++...... ...++.|++.+|.+..+....+.....+..++...|+... ....+
T Consensus 89 n~l~~l~~~~---~~~l~~L~~~~n~l~~l~~~~~~~~~~~~~l~~~~n~~~~----------------------~~~~~ 143 (305)
T d1xkua_ 89 NQLKELPEKM---PKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKS----------------------SGIEN 143 (305)
T ss_dssp SCCSBCCSSC---CTTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCG----------------------GGBCT
T ss_pred CccCcCccch---hhhhhhhhccccchhhhhhhhhhccccccccccccccccc----------------------cCCCc
Confidence 5555332211 1344445555555555544444444444444444443221 11223
Q ss_pred cCcCCCCCCcEEEccCceeccccccchhhccccCceecccccccCCCCCCCCCCCcccEEeccCccccccCccccccccc
Q 044366 375 PEIGDSSKLQVLDLSSNHIFGKIPVQLVKLFSLNKLILSLNQLFGGVPLEFGTLTELQYLDLSANKLSSSIPMSIGNLLK 454 (918)
Q Consensus 375 ~~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~ 454 (918)
..+..+++|+.+++++|.+... |..+ .++|+.|++++|.++...+..|..++.+++|++++|.+++..+..|.++++
T Consensus 144 ~~~~~l~~L~~l~l~~n~l~~l-~~~~--~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~ 220 (305)
T d1xkua_ 144 GAFQGMKKLSYIRIADTNITTI-PQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPH 220 (305)
T ss_dssp TGGGGCTTCCEEECCSSCCCSC-CSSC--CTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTT
T ss_pred cccccccccCccccccCCcccc-Cccc--CCccCEEECCCCcCCCCChhHhhcccccccccccccccccccccccccccc
Confidence 3444455555555555555421 2111 233444444444444444444444444444444444444444444444444
Q ss_pred cceecccCcccCCCCchhhccccccceEeccCCcCC
Q 044366 455 LHYLNLSNNQFSHKIPTEFEKLIHLSELDLSHNILQ 490 (918)
Q Consensus 455 L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~ 490 (918)
|++|+|++|+|+ .+|.+|..+++|++|+|++|+|+
T Consensus 221 L~~L~L~~N~L~-~lp~~l~~l~~L~~L~Ls~N~i~ 255 (305)
T d1xkua_ 221 LRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNIS 255 (305)
T ss_dssp CCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCC
T ss_pred ceeeeccccccc-ccccccccccCCCEEECCCCccC
Confidence 444444444443 22334444444444444444444
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.94 E-value=4.7e-26 Score=242.87 Aligned_cols=281 Identities=22% Similarity=0.290 Sum_probs=157.8
Q ss_pred CCEEeCCCCcccccCCccccCCCCCCEEEcccccccccCC-CCcCCCCCCCEEEcccccccccCCccccCCCCCCEEEcc
Q 044366 23 LQYLDLGNNQLSGVIPPEIGKLNQLRRLYLDVNQLHGTIP-PVIGQLSLINELVFCHNNVSGRIPSSLGNLSNLALLYLN 101 (918)
Q Consensus 23 L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~n~l~~~~p-~~~~~l~~L~~L~l~~n~~~~~~p~~l~~l~~L~~L~L~ 101 (918)
++.+|=++++++ .+|..+. +++++|+|++|+|+ .+| ..|..+++|++|++++|.+....|..|.++++|++|+++
T Consensus 12 ~~~~~C~~~~L~-~lP~~l~--~~l~~L~Ls~N~i~-~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~ 87 (305)
T d1xkua_ 12 LRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKIT-EIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLS 87 (305)
T ss_dssp TTEEECTTSCCC-SCCCSCC--TTCCEEECCSSCCC-CBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred CCEEEecCCCCC-ccCCCCC--CCCCEEECcCCcCC-CcChhHhhccccccccccccccccccchhhhhCCCccCEeccc
Confidence 445555555555 4455443 45555666665555 333 345555556666666555555445555566666666666
Q ss_pred CCcccccCccccCCCCCCCEEECcCCcCCCcCCcCCCCCCCCceeeccccccc--cCCCcccccccccCeeeccccccCC
Q 044366 102 DNSLFGSIPIVMGNLKSLSTLDLSQNQLNGSIPCSLDNLSNLDTLFLYKNSLS--GPIPSVIGNLKSLLQLDLSENRLSG 179 (918)
Q Consensus 102 ~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~l~--~~~~~~~~~l~~L~~L~Ls~N~l~~ 179 (918)
+|+++.. |..+ ...|+.|+++.|.+....+..+.....++.+....|... ...+..|..+++|+.+++++|.+..
T Consensus 88 ~n~l~~l-~~~~--~~~l~~L~~~~n~l~~l~~~~~~~~~~~~~l~~~~n~~~~~~~~~~~~~~l~~L~~l~l~~n~l~~ 164 (305)
T d1xkua_ 88 KNQLKEL-PEKM--PKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITT 164 (305)
T ss_dssp SSCCSBC-CSSC--CTTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCCS
T ss_pred CCccCcC-ccch--hhhhhhhhccccchhhhhhhhhhccccccccccccccccccCCCccccccccccCccccccCCccc
Confidence 6655532 2221 235556666666655444444445555555555554332 2223455556666666666666654
Q ss_pred cCCccCCCCCCCcEeeccCcccccCCCccccCCCCcceeecccccccCCCCCCCcCCCcCCeEEcccCcCcCCCCccccc
Q 044366 180 LIPLSLSNLSSLTVMSLFNNSLSGSIPPILGNLKSLSTLGLHINQLNGVIPPSIGNLSSLRNLSLFNNRLYGFVPKEIGY 259 (918)
Q Consensus 180 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~ 259 (918)
+.. . .+++|+.|++++|.++...+..|.+++.++.|++++|.+++..+..+.++++|++|+|++|+|+.+ |..+..
T Consensus 165 l~~-~--~~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~~l-p~~l~~ 240 (305)
T d1xkua_ 165 IPQ-G--LPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKV-PGGLAD 240 (305)
T ss_dssp CCS-S--CCTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCSSC-CTTTTT
T ss_pred cCc-c--cCCccCEEECCCCcCCCCChhHhhccccccccccccccccccccccccccccceeeeccccccccc-cccccc
Confidence 322 2 135566666666666655566666666666666666666666566666666666666666666643 445666
Q ss_pred cCCCCeEecCCCccCCcCCCcC------CCCCCCcEEEccCCcCc--CCCCccccCCCCCCeE
Q 044366 260 LKSLSKLEFCANHLSGVIPHSV------GNLTGLVLLNMCENHLF--GPIPKSLRNLTSLERV 314 (918)
Q Consensus 260 l~~L~~L~l~~n~l~~~~~~~~------~~l~~L~~L~l~~n~l~--~~~~~~l~~l~~L~~L 314 (918)
+++|+.|++++|+|+.+....| ..+.+|+.|++++|++. ...|..|+-+.....+
T Consensus 241 l~~L~~L~Ls~N~i~~i~~~~f~~~~~~~~~~~L~~L~L~~N~~~~~~~~~~~f~~~~~~~~~ 303 (305)
T d1xkua_ 241 HKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAV 303 (305)
T ss_dssp CSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSCGGGSCGGGGTTCCCGGGE
T ss_pred ccCCCEEECCCCccCccChhhccCcchhcccCCCCEEECCCCcCccCcCCHhHhcccccCccc
Confidence 6666666666666665543333 34566777777777664 3556666655544443
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.94 E-value=1.5e-26 Score=243.80 Aligned_cols=251 Identities=25% Similarity=0.280 Sum_probs=149.5
Q ss_pred EEccCCcccccCccccCCCCCCCEEECcCCcCCCcCCcCCCCCCCCceeeccccccccCCCcccccccccCeeecccccc
Q 044366 98 LYLNDNSLFGSIPIVMGNLKSLSTLDLSQNQLNGSIPCSLDNLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSENRL 177 (918)
Q Consensus 98 L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l 177 (918)
++.++++++ .+|..+. +++++|+|++|+|+.+.+.+|.++++|++|++++|++..+.+..+..+..++.+..+
T Consensus 16 v~c~~~~L~-~iP~~ip--~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~---- 88 (284)
T d1ozna_ 16 TSCPQQGLQ-AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLS---- 88 (284)
T ss_dssp EECCSSCCS-SCCTTCC--TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECC----
T ss_pred EEcCCCCCC-ccCCCCC--CCCCEEECcCCcCCCCCHHHhhccccccccccccccccccccccccccccccccccc----
Confidence 445555554 3343332 345555555555554444455555555555555555554444444444444444432
Q ss_pred CCcCCccCCCCCCCcEeeccCcccccCCCccccCCCCcceeecccccccCCCCCCCcCCCcCCeEEcccCcCcCCCCccc
Q 044366 178 SGLIPLSLSNLSSLTVMSLFNNSLSGSIPPILGNLKSLSTLGLHINQLNGVIPPSIGNLSSLRNLSLFNNRLYGFVPKEI 257 (918)
Q Consensus 178 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~ 257 (918)
..|.++...+..|.++++|++|++++|.+....+..+..+.+|+.+++++|.++++.+..|
T Consensus 89 -------------------~~~~~~~l~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f 149 (284)
T d1ozna_ 89 -------------------DNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTF 149 (284)
T ss_dssp -------------------SCTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTT
T ss_pred -------------------cccccccccchhhcccccCCEEecCCcccccccccccchhcccchhhhccccccccChhHh
Confidence 2333443444445555555555555555544444455555556666666666655555556
Q ss_pred cccCCCCeEecCCCccCCcCCCcCCCCCCCcEEEccCCcCcCCCCccccCCCCCCeEEeecccccCccccccCCCCCccE
Q 044366 258 GYLKSLSKLEFCANHLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLRNLTSLERVRFNQNNLYGKVYEAFGDHPNLTF 337 (918)
Q Consensus 258 ~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~ 337 (918)
..+++|+.|++++|.+..+.+..|.++++|+.+++++|++++..|..|.++++|++|++++|.+..+++..|..+++|++
T Consensus 150 ~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~ 229 (284)
T d1ozna_ 150 RDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQY 229 (284)
T ss_dssp TTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCE
T ss_pred ccccchhhcccccCcccccchhhhccccccchhhhhhccccccChhHhhhhhhcccccccccccccccccccccccccCE
Confidence 66666666666666666666666677777777777777777777777777778888888888888888888888999999
Q ss_pred EeCCCCccccccCcccccccccceeeccccccccCCCc
Q 044366 338 LDLSQNNFYCEISFNWRNFSKLGTFNASMNNIYGSIPP 375 (918)
Q Consensus 338 L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~n~i~~~~~~ 375 (918)
|++++|++.|+|...|- ...++.+....+++....|.
T Consensus 230 L~l~~N~l~C~C~~~~l-~~~l~~~~~~~~~~~C~~p~ 266 (284)
T d1ozna_ 230 LRLNDNPWVCDCRARPL-WAWLQKFRGSSSEVPCSLPQ 266 (284)
T ss_dssp EECCSSCEECSGGGHHH-HHHHHHCCSEECCCBEEESG
T ss_pred EEecCCCCCCCccchHH-HHHHHhCcCCCCceEeCCch
Confidence 99999999999875431 12233344444444433333
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.93 E-value=6.3e-26 Score=238.92 Aligned_cols=222 Identities=23% Similarity=0.267 Sum_probs=118.6
Q ss_pred EeCCCCcccccCCccccCCCCCCEEEcccccccccCCCCcCCCCCCCEEEcccccccccCCccccCCCCCCEEEcc-CCc
Q 044366 26 LDLGNNQLSGVIPPEIGKLNQLRRLYLDVNQLHGTIPPVIGQLSLINELVFCHNNVSGRIPSSLGNLSNLALLYLN-DNS 104 (918)
Q Consensus 26 L~L~~n~i~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~l~~l~~L~~L~L~-~n~ 104 (918)
++.++++++ .+|..+. +.+++|+|++|+|+...+..|.++++|++|++++|.+....+..+..+..++.+... .|.
T Consensus 16 v~c~~~~L~-~iP~~ip--~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~~~ 92 (284)
T d1ozna_ 16 TSCPQQGLQ-AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQ 92 (284)
T ss_dssp EECCSSCCS-SCCTTCC--TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTT
T ss_pred EEcCCCCCC-ccCCCCC--CCCCEEECcCCcCCCCCHHHhhccccccccccccccccccccccccccccccccccccccc
Confidence 344455544 4444332 344555555555553333345555555555555555554444555555555555433 344
Q ss_pred ccccCccccCCCCCCCEEECcCCcCCCcCCcCCCCCCCCceeeccccccccCCCcccccccccCeeeccccccCCcCCcc
Q 044366 105 LFGSIPIVMGNLKSLSTLDLSQNQLNGSIPCSLDNLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSENRLSGLIPLS 184 (918)
Q Consensus 105 i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~ 184 (918)
+....+..|.++++|++|++++|.+....+..+....+|+.+++++|+++++.++.|+.+++|+.|++++|+++++.+.+
T Consensus 93 ~~~l~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~ 172 (284)
T d1ozna_ 93 LRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERA 172 (284)
T ss_dssp CCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTT
T ss_pred cccccchhhcccccCCEEecCCcccccccccccchhcccchhhhccccccccChhHhccccchhhcccccCcccccchhh
Confidence 44444555555555555555555555444445555555555555555555555555555555555555555555555555
Q ss_pred CCCCCCCcEeeccCcccccCCCccccCCCCcceeecccccccCCCCCCCcCCCcCCeEEcccCcCc
Q 044366 185 LSNLSSLTVMSLFNNSLSGSIPPILGNLKSLSTLGLHINQLNGVIPPSIGNLSSLRNLSLFNNRLY 250 (918)
Q Consensus 185 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~ 250 (918)
|.++++|+.+++++|+++++.|..|.++++|++|++++|.+++..+..|.++++|++|++++|.+.
T Consensus 173 f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~ 238 (284)
T d1ozna_ 173 FRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWV 238 (284)
T ss_dssp TTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEE
T ss_pred hccccccchhhhhhccccccChhHhhhhhhcccccccccccccccccccccccccCEEEecCCCCC
Confidence 555555555555555555555555555555555555555555555555555555555555555554
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.90 E-value=1.7e-23 Score=217.44 Aligned_cols=207 Identities=23% Similarity=0.273 Sum_probs=128.4
Q ss_pred CCCCCCEEECcCCcCCCcCCcCCCCCCCCceeeccccccccCCCcccccccccCeeeccccccCCcCCccCCCCCCCcEe
Q 044366 115 NLKSLSTLDLSQNQLNGSIPCSLDNLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSENRLSGLIPLSLSNLSSLTVM 194 (918)
Q Consensus 115 ~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L 194 (918)
+...+.+.|.+++.++ .+|..+. +++++|+|++|+|+++.+++|.++++|++|+|++|+|+.+. .+..+++|++|
T Consensus 8 ~~~~~~~v~C~~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~l~--~~~~l~~L~~L 82 (266)
T d1p9ag_ 8 KVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQ--VDGTLPVLGTL 82 (266)
T ss_dssp CSTTCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEE--CCSCCTTCCEE
T ss_pred ccCCCeEEEccCCCCC-eeCcCcC--cCCCEEECcCCcCCCcCHHHhhccccccccccccccccccc--ccccccccccc
Confidence 4456667777877777 4565553 46777777777777666666777777777777777776442 24556666666
Q ss_pred eccCcccccCCCccccCCCCcceeecccccccCCCCCCCcCCCcCCeEEcccCcCcCCCCccccccCCCCeEecCCCccC
Q 044366 195 SLFNNSLSGSIPPILGNLKSLSTLGLHINQLNGVIPPSIGNLSSLRNLSLFNNRLYGFVPKEIGYLKSLSKLEFCANHLS 274 (918)
Q Consensus 195 ~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~ 274 (918)
+|++|+++. .+..+.++++|+.|++++|.+....+ ..+..+.+++.|++++|.+.
T Consensus 83 ~Ls~N~l~~-~~~~~~~l~~L~~L~l~~~~~~~~~~------------------------~~~~~l~~l~~L~l~~n~l~ 137 (266)
T d1p9ag_ 83 DLSHNQLQS-LPLLGQTLPALTVLDVSFNRLTSLPL------------------------GALRGLGELQELYLKGNELK 137 (266)
T ss_dssp ECCSSCCSS-CCCCTTTCTTCCEEECCSSCCCCCCS------------------------STTTTCTTCCEEECTTSCCC
T ss_pred ccccccccc-cccccccccccccccccccccceeec------------------------cccccccccccccccccccc
Confidence 666666653 34445555555555555555544444 44444444555555555555
Q ss_pred CcCCCcCCCCCCCcEEEccCCcCcCCCCccccCCCCCCeEEeecccccCccccccCCCCCccEEeCCCCccccccCcc
Q 044366 275 GVIPHSVGNLTGLVLLNMCENHLFGPIPKSLRNLTSLERVRFNQNNLYGKVYEAFGDHPNLTFLDLSQNNFYCEISFN 352 (918)
Q Consensus 275 ~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~ 352 (918)
.+.+..+..+++++.+++++|++++..+..|..+++|++|+|++|+|+.++.+.| .+++|+.|+|++|+|.|+|...
T Consensus 138 ~l~~~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~~lp~~~~-~~~~L~~L~L~~Np~~CdC~~~ 214 (266)
T d1p9ag_ 138 TLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLYTIPKGFF-GSHLLPFAFLHGNPWLCNCEIL 214 (266)
T ss_dssp CCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCCCCCTTTT-TTCCCSEEECCSCCBCCSGGGH
T ss_pred eeccccccccccchhcccccccccccCccccccccccceeecccCCCcccChhHC-CCCCCCEEEecCCCCCCCcchH
Confidence 4444555555555555555555555555566666666666666666665555444 5788999999999999998754
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.90 E-value=6.5e-23 Score=213.09 Aligned_cols=159 Identities=33% Similarity=0.315 Sum_probs=71.1
Q ss_pred ccccCCCCCCEEEccCCcccccCccccCCCCCCCEEECcCCcCCCcCCcCCCCCCCCceeeccccccccCCCcccccccc
Q 044366 87 SSLGNLSNLALLYLNDNSLFGSIPIVMGNLKSLSTLDLSQNQLNGSIPCSLDNLSNLDTLFLYKNSLSGPIPSVIGNLKS 166 (918)
Q Consensus 87 ~~l~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~ 166 (918)
.+|.++++|++|+|++|+|+.. | .++.+++|++|+|++|+++ ..+..+.++++|++|++++|.+.++.+..+..+.+
T Consensus 49 ~~f~~l~~L~~L~L~~N~l~~l-~-~~~~l~~L~~L~Ls~N~l~-~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~ 125 (266)
T d1p9ag_ 49 ATLMPYTRLTQLNLDRAELTKL-Q-VDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGE 125 (266)
T ss_dssp GGGTTCTTCCEEECTTSCCCEE-E-CCSCCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTT
T ss_pred HHhhcccccccccccccccccc-c-ccccccccccccccccccc-ccccccccccccccccccccccceeeccccccccc
Confidence 3344444444444444444321 1 2334444444444444444 22334444444444444444444444444444444
Q ss_pred cCeeeccccccCCcCCccCCCCCCCcEeeccCcccccCCCccccCCCCcceeecccccccCCCCCCCcCCCcCCeEEccc
Q 044366 167 LLQLDLSENRLSGLIPLSLSNLSSLTVMSLFNNSLSGSIPPILGNLKSLSTLGLHINQLNGVIPPSIGNLSSLRNLSLFN 246 (918)
Q Consensus 167 L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~ 246 (918)
+++|++++|.++.+.+..+..+++|+.|++++|++++..+..|..+++|++|+|++|+|+ .+|..+..+++|+.|+|++
T Consensus 126 l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~ 204 (266)
T d1p9ag_ 126 LQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHG 204 (266)
T ss_dssp CCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCS
T ss_pred cccccccccccceeccccccccccchhcccccccccccCccccccccccceeecccCCCc-ccChhHCCCCCCCEEEecC
Confidence 444444444444444444444444444444444444444444444444444444444444 2333333444444444444
Q ss_pred CcC
Q 044366 247 NRL 249 (918)
Q Consensus 247 n~l 249 (918)
|.+
T Consensus 205 Np~ 207 (266)
T d1p9ag_ 205 NPW 207 (266)
T ss_dssp CCB
T ss_pred CCC
Confidence 443
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.85 E-value=5.1e-22 Score=194.79 Aligned_cols=168 Identities=17% Similarity=0.123 Sum_probs=120.3
Q ss_pred CCceeeccccceEEEEEEeCCCCEEEEEEcccccccCCC--------------CChHHHHHHHHHHhhccCCceeeEecc
Q 044366 649 GEKYCIGKGGQRSVYKAELPSGNIFAVKKFKAELFSDET--------------ANPSEFLNEVLALTEIRHRNIIKFHGF 714 (918)
Q Consensus 649 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~--------------~~~~~~~~e~~~l~~l~h~niv~~~~~ 714 (918)
.+.++||+|+||.||+|...+|+.||||+++........ .....+..|...+.++.|++++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 456889999999999998889999999987643221100 001234567888889999999888765
Q ss_pred cccCCceEEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCeeeCCCCcEEEe
Q 044366 715 CSNAQHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCIPPIVHRDISSKNVLLDSEYEAHVS 794 (918)
Q Consensus 715 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~ 794 (918)
. ..++||||++++.+.+ +++.....++.|+++|++|||+. +|+||||||+|||++++ .++++
T Consensus 83 ~----~~~lvme~~~~~~~~~----------l~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NILv~~~-~~~li 144 (191)
T d1zara2 83 E----GNAVLMELIDAKELYR----------VRVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVSEE-GIWII 144 (191)
T ss_dssp E----TTEEEEECCCCEEGGG----------CCCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEETT-EEEEC
T ss_pred c----CCEEEEEeeccccccc----------hhhHHHHHHHHHHHHHHHHHhhC---CEEEccCChhheeeeCC-CEEEE
Confidence 3 2479999998754432 33445678999999999999999 99999999999999865 58999
Q ss_pred ccccccccCCCCCCceeccccccccccc-----ccccCCCCcccchhhHHHHH
Q 044366 795 DFGFAKFLEPHSSNWTEFAGTVGYAAPE-----LAYTMRATEKYDVYSFGVLA 842 (918)
Q Consensus 795 DfG~~~~~~~~~~~~~~~~g~~~y~aPE-----~~~~~~~~~~~Dv~slG~vl 842 (918)
|||.|.....+... .|.... ......|+.++|+||..--+
T Consensus 145 DFG~a~~~~~~~~~--------~~l~rd~~~~~~~f~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 145 DFPQSVEVGEEGWR--------EILERDVRNIITYFSRTYRTEKDINSAIDRI 189 (191)
T ss_dssp CCTTCEETTSTTHH--------HHHHHHHHHHHHHHHHHHCCCCCHHHHHHHH
T ss_pred ECCCcccCCCCCcH--------HHHHHHHHHHHHHHcCCCCCcccHHHHHHHH
Confidence 99999765432211 111110 01235678899999975433
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.84 E-value=5.5e-19 Score=191.76 Aligned_cols=179 Identities=27% Similarity=0.289 Sum_probs=96.6
Q ss_pred CCCEEeCCCCcccccCCccccCCCCCCEEEcccccccccCCCCcCCCCCCCEEEcccccccccCCccccCCCCCCEEEcc
Q 044366 22 KLQYLDLGNNQLSGVIPPEIGKLNQLRRLYLDVNQLHGTIPPVIGQLSLINELVFCHNNVSGRIPSSLGNLSNLALLYLN 101 (918)
Q Consensus 22 ~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~l~~l~~L~~L~L~ 101 (918)
++++|||++++++ .+|+. .++|++|+|++|+|+ .+|..+ .+|++|++++|.++ .+++ +. +.|++|+++
T Consensus 39 ~l~~LdLs~~~L~-~lp~~---~~~L~~L~Ls~N~l~-~lp~~~---~~L~~L~l~~n~l~-~l~~-lp--~~L~~L~L~ 106 (353)
T d1jl5a_ 39 QAHELELNNLGLS-SLPEL---PPHLESLVASCNSLT-ELPELP---QSLKSLLVDNNNLK-ALSD-LP--PLLEYLGVS 106 (353)
T ss_dssp TCSEEECTTSCCS-CCCSC---CTTCSEEECCSSCCS-SCCCCC---TTCCEEECCSSCCS-CCCS-CC--TTCCEEECC
T ss_pred CCCEEEeCCCCCC-CCCCC---CCCCCEEECCCCCCc-ccccch---hhhhhhhhhhcccc-hhhh-hc--ccccccccc
Confidence 5778888888877 56643 457778888888777 666543 45667777777665 3332 11 346666666
Q ss_pred CCcccccCccccCCCCCCCEEECcCCcCCCcCCcCCCCCCCCceeeccccccccCCCcccccccccCeeeccccccCCcC
Q 044366 102 DNSLFGSIPIVMGNLKSLSTLDLSQNQLNGSIPCSLDNLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSENRLSGLI 181 (918)
Q Consensus 102 ~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~ 181 (918)
+|.+. ..|. ++.+++|++|++++|.++. .+.. ...+..+.+..+... ....++.++.++.|++++|.+....
T Consensus 107 ~n~l~-~lp~-~~~l~~L~~L~l~~~~~~~-~~~~---~~~l~~l~~~~~~~~--~~~~l~~l~~l~~L~l~~n~~~~~~ 178 (353)
T d1jl5a_ 107 NNQLE-KLPE-LQNSSFLKIIDVDNNSLKK-LPDL---PPSLEFIAAGNNQLE--ELPELQNLPFLTAIYADNNSLKKLP 178 (353)
T ss_dssp SSCCS-SCCC-CTTCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCS--SCCCCTTCTTCCEEECCSSCCSSCC
T ss_pred ccccc-cccc-hhhhccceeeccccccccc-cccc---cccccchhhcccccc--ccccccccccceecccccccccccc
Confidence 66665 3332 4566666666666666652 2222 234445555544443 2234555556666666665555321
Q ss_pred CccCCCCCCCcEeeccCcccccCCCccccCCCCcceeeccccccc
Q 044366 182 PLSLSNLSSLTVMSLFNNSLSGSIPPILGNLKSLSTLGLHINQLN 226 (918)
Q Consensus 182 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~ 226 (918)
. .....+.+...++.+.. . ..+..++.|+.+++++|...
T Consensus 179 ~----~~~~~~~l~~~~~~~~~-~-~~~~~l~~L~~l~l~~n~~~ 217 (353)
T d1jl5a_ 179 D----LPLSLESIVAGNNILEE-L-PELQNLPFLTTIYADNNLLK 217 (353)
T ss_dssp C----CCTTCCEEECCSSCCSS-C-CCCTTCTTCCEEECCSSCCS
T ss_pred c----ccccccccccccccccc-c-cccccccccccccccccccc
Confidence 1 11223344444444431 1 12344555555555555443
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.83 E-value=7.3e-19 Score=190.76 Aligned_cols=296 Identities=27% Similarity=0.264 Sum_probs=207.9
Q ss_pred CcccCCCCCCccCCccCCCCCCCCEEeCCCCcccccCCccccCCCCCCEEEcccccccccCCCCcCCCCCCCEEEccccc
Q 044366 1 MLNLGFNLLFGNIPPQIGNLSKLQYLDLGNNQLSGVIPPEIGKLNQLRRLYLDVNQLHGTIPPVIGQLSLINELVFCHNN 80 (918)
Q Consensus 1 ~l~~~~~~~~~~~p~~~~~l~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~ 80 (918)
+|||++|+++ .+|+. +++|++|+|++|+|+ .+|.. +.+|+.|++++|+++ .++.. ...|++|++++|.
T Consensus 42 ~LdLs~~~L~-~lp~~---~~~L~~L~Ls~N~l~-~lp~~---~~~L~~L~l~~n~l~-~l~~l---p~~L~~L~L~~n~ 109 (353)
T d1jl5a_ 42 ELELNNLGLS-SLPEL---PPHLESLVASCNSLT-ELPEL---PQSLKSLLVDNNNLK-ALSDL---PPLLEYLGVSNNQ 109 (353)
T ss_dssp EEECTTSCCS-CCCSC---CTTCSEEECCSSCCS-SCCCC---CTTCCEEECCSSCCS-CCCSC---CTTCCEEECCSSC
T ss_pred EEEeCCCCCC-CCCCC---CCCCCEEECCCCCCc-ccccc---hhhhhhhhhhhcccc-hhhhh---ccccccccccccc
Confidence 4899999998 79975 578999999999999 77865 468999999999998 55532 2469999999999
Q ss_pred ccccCCccccCCCCCCEEEccCCcccccCccccCCCCCCCEEECcCCcCCCcCCcCCCCCCCCceeeccccccccCCCcc
Q 044366 81 VSGRIPSSLGNLSNLALLYLNDNSLFGSIPIVMGNLKSLSTLDLSQNQLNGSIPCSLDNLSNLDTLFLYKNSLSGPIPSV 160 (918)
Q Consensus 81 ~~~~~p~~l~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~ 160 (918)
+. .+|. ++.+++|+.|++++|.+... +. ....+..+.+..+... .+..+..++.++.|++++|.......
T Consensus 110 l~-~lp~-~~~l~~L~~L~l~~~~~~~~-~~---~~~~l~~l~~~~~~~~--~~~~l~~l~~l~~L~l~~n~~~~~~~-- 179 (353)
T d1jl5a_ 110 LE-KLPE-LQNSSFLKIIDVDNNSLKKL-PD---LPPSLEFIAAGNNQLE--ELPELQNLPFLTAIYADNNSLKKLPD-- 179 (353)
T ss_dssp CS-SCCC-CTTCTTCCEEECCSSCCSCC-CC---CCTTCCEEECCSSCCS--SCCCCTTCTTCCEEECCSSCCSSCCC--
T ss_pred cc-cccc-hhhhccceeecccccccccc-cc---ccccccchhhcccccc--ccccccccccceeccccccccccccc--
Confidence 98 5664 68899999999999998643 32 3467888999887765 34568889999999999999874422
Q ss_pred cccccccCeeeccccccCCcCCccCCCCCCCcEeeccCcccccCCCccccCCCCcceeecccccccCCCCCCCcCCCcCC
Q 044366 161 IGNLKSLLQLDLSENRLSGLIPLSLSNLSSLTVMSLFNNSLSGSIPPILGNLKSLSTLGLHINQLNGVIPPSIGNLSSLR 240 (918)
Q Consensus 161 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~ 240 (918)
.....+.+..+++.+... ..+..++.|+.+++++|.... .+ ....++..+.+..+.+... + .....+.
T Consensus 180 --~~~~~~~l~~~~~~~~~~--~~~~~l~~L~~l~l~~n~~~~-~~---~~~~~l~~~~~~~~~~~~~-~---~~~~~l~ 247 (353)
T d1jl5a_ 180 --LPLSLESIVAGNNILEEL--PELQNLPFLTTIYADNNLLKT-LP---DLPPSLEALNVRDNYLTDL-P---ELPQSLT 247 (353)
T ss_dssp --CCTTCCEEECCSSCCSSC--CCCTTCTTCCEEECCSSCCSS-CC---SCCTTCCEEECCSSCCSCC-C---CCCTTCC
T ss_pred --cccccccccccccccccc--ccccccccccccccccccccc-cc---ccccccccccccccccccc-c---ccccccc
Confidence 223456677777776643 246788999999999998763 33 3345678888888887643 2 2235667
Q ss_pred eEEcccCcCcCCCCccccccCCCCeEecCCCccCCcCCCcCCCCCCCcEEEccCCcCcCCCCccccCCCCCCeEEeeccc
Q 044366 241 NLSLFNNRLYGFVPKEIGYLKSLSKLEFCANHLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLRNLTSLERVRFNQNN 320 (918)
Q Consensus 241 ~L~Ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~ 320 (918)
..++..+.+.+... -.......++..+.+.+. ...+++|++|++++|++.. +|. .+++|+.|++++|+
T Consensus 248 ~~~~~~~~~~~l~~----l~~~~~~~~~~~~~~~~~----~~~~~~L~~L~Ls~N~l~~-lp~---~~~~L~~L~L~~N~ 315 (353)
T d1jl5a_ 248 FLDVSENIFSGLSE----LPPNLYYLNASSNEIRSL----CDLPPSLEELNVSNNKLIE-LPA---LPPRLERLIASFNH 315 (353)
T ss_dssp EEECCSSCCSEESC----CCTTCCEEECCSSCCSEE----CCCCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSC
T ss_pred cccccccccccccc----ccchhcccccccCccccc----cccCCCCCEEECCCCccCc-ccc---ccCCCCEEECCCCc
Confidence 77777766543211 113445566666666533 2234667777777777763 343 24566677777777
Q ss_pred ccCccccccCCCCCccEEeCCCCccc
Q 044366 321 LYGKVYEAFGDHPNLTFLDLSQNNFY 346 (918)
Q Consensus 321 l~~~~~~~~~~l~~L~~L~Ls~N~l~ 346 (918)
|++++. .+++|+.|++++|+++
T Consensus 316 L~~l~~----~~~~L~~L~L~~N~L~ 337 (353)
T d1jl5a_ 316 LAEVPE----LPQNLKQLHVEYNPLR 337 (353)
T ss_dssp CSCCCC----CCTTCCEEECCSSCCS
T ss_pred CCcccc----ccCCCCEEECcCCcCC
Confidence 665542 2346666666666665
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.80 E-value=1.4e-19 Score=185.19 Aligned_cols=220 Identities=15% Similarity=0.147 Sum_probs=116.8
Q ss_pred CEEeCCCCcccccCCccccCCCCCCEEEcccccccccCCCCcCCCCCCCEEEcccccccccC-CccccCCCCCCEEEccC
Q 044366 24 QYLDLGNNQLSGVIPPEIGKLNQLRRLYLDVNQLHGTIPPVIGQLSLINELVFCHNNVSGRI-PSSLGNLSNLALLYLND 102 (918)
Q Consensus 24 ~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~-p~~l~~l~~L~~L~L~~ 102 (918)
+.++.++++++ .+|..+. +++++|+|++|+|+...+..|.++++|++|++++|.+...+ +..|.+++++++|.+..
T Consensus 11 ~~i~c~~~~l~-~iP~~l~--~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~ 87 (242)
T d1xwdc1 11 RVFLCQESKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEK 87 (242)
T ss_dssp SEEEEESCSCS-SCCSCSC--SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEEC
T ss_pred CEEEEeCCCCC-CcCCCCC--CCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeeccccccccccccccccc
Confidence 34455555554 4444432 34555555555555222234555555555555555544332 33455566666665543
Q ss_pred -CcccccCccccCCCCCCCEEECcCCcCCCcCCc-CCCCCCCCceeeccccccccCCCccccccc-ccCeeeccccccCC
Q 044366 103 -NSLFGSIPIVMGNLKSLSTLDLSQNQLNGSIPC-SLDNLSNLDTLFLYKNSLSGPIPSVIGNLK-SLLQLDLSENRLSG 179 (918)
Q Consensus 103 -n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~-~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~-~L~~L~Ls~N~l~~ 179 (918)
|++....+..|.++++|++|++++|+++...+. .+..+..++.+...++.+..+.+..|.+++ .++.|++++|+++.
T Consensus 88 ~n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~~~l~~L~l~~n~l~~ 167 (242)
T d1xwdc1 88 ANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQE 167 (242)
T ss_dssp CTTCCEECTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCCE
T ss_pred cccccccccccccccccccccccchhhhcccccccccccccccccccccccccccccccccccccccceeeecccccccc
Confidence 455555555566666666666666665532221 223344444455555555555555555543 56666666666665
Q ss_pred cCCccCCCCCCCcEeeccCcccccCCCccccCCCCcceeecccccccCCCCCCCcCCCcCCeEEccc
Q 044366 180 LIPLSLSNLSSLTVMSLFNNSLSGSIPPILGNLKSLSTLGLHINQLNGVIPPSIGNLSSLRNLSLFN 246 (918)
Q Consensus 180 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~ 246 (918)
+.+..|....-++.+++++|+++.+.+..|.++++|++|+|++|+++.+.+..|.++++|+.|++.+
T Consensus 168 i~~~~~~~~~l~~~~~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~l~~~~ 234 (242)
T d1xwdc1 168 IHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYN 234 (242)
T ss_dssp ECTTTTTTCCEEEEECTTCTTCCCCCTTTTTTSCCCSEEECTTSCCCCCCSSSCTTCCEEESSSEES
T ss_pred cccccccchhhhccccccccccccccHHHhcCCCCCCEEECCCCcCCccCHHHHcCCcccccCcCCC
Confidence 5444443322233344566666655555566666666666666666655555566666666655543
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.80 E-value=5.1e-20 Score=180.51 Aligned_cols=178 Identities=28% Similarity=0.251 Sum_probs=144.6
Q ss_pred ceeeccccccccCCCcCcCCCCCCcEEEccCceecc-ccccchhhccccCceecccccccCCCCCCCCCCCcccEEeccC
Q 044366 360 GTFNASMNNIYGSIPPEIGDSSKLQVLDLSSNHIFG-KIPVQLVKLFSLNKLILSLNQLFGGVPLEFGTLTELQYLDLSA 438 (918)
Q Consensus 360 ~~l~l~~n~i~~~~~~~~~~~~~L~~L~L~~N~l~~-~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~ 438 (918)
+.++.++++++ .+|..+. +++++|+|++|+|++ ..+..|.++++|+.|+|++|++....+..|..+++|++|+|++
T Consensus 11 ~~v~Cs~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~ 87 (192)
T d1w8aa_ 11 TTVDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE 87 (192)
T ss_dssp TEEECTTSCCS-SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred CEEEEeCCCcC-ccCCCCC--CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeecc
Confidence 35666667666 5666553 689999999999975 4567788999999999999999999999999999999999999
Q ss_pred ccccccCccccccccccceecccCcccCCCCchhhccccccceEeccCCcCCCCCchhccccCCcceEecCCCcccccCc
Q 044366 439 NKLSSSIPMSIGNLLKLHYLNLSNNQFSHKIPTEFEKLIHLSELDLSHNILQEEIPPQICKMESLEKLNLSHNNLSDFIP 518 (918)
Q Consensus 439 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~ 518 (918)
|+|+.+.+..|.++++|++|+|++|+|+++.|++|..+++|++|+|++|.+....... .-...++.+.++.|.++...|
T Consensus 88 N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~~~-~~~~~l~~~~l~~~~~~c~~p 166 (192)
T d1w8aa_ 88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLA-WFAEWLRKKSLNGGAARCGAP 166 (192)
T ss_dssp CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGH-HHHHHHHHHCCSGGGCBBCSS
T ss_pred ccccccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccccccchH-HHhhhhhhhcccCCCeEeCCC
Confidence 9999888889999999999999999999888999999999999999999997543322 222357778888888887667
Q ss_pred ccccCCCCccEEEccCCcCCCCCCCC
Q 044366 519 RCFEEMRSLSWIDISYNELQGPIPNS 544 (918)
Q Consensus 519 ~~~~~l~~L~~l~l~~N~l~~~~p~~ 544 (918)
..+ ..++.+||+.|+++|..+..
T Consensus 167 ~~l---~~~~l~~L~~n~l~C~~~~~ 189 (192)
T d1w8aa_ 167 SKV---RDVQIKDLPHSEFKCSSENS 189 (192)
T ss_dssp TTT---TTSBGGGSCTTTCCCCCC--
T ss_pred hhh---cCCEeeecCHhhCcCCCCCC
Confidence 554 45667789999999876653
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.79 E-value=3.5e-19 Score=182.09 Aligned_cols=218 Identities=17% Similarity=0.132 Sum_probs=99.4
Q ss_pred CEEEcccccccccCCCCcCCCCCCCEEEcccccccccCCccccCCCCCCEEEccCCcccc-cCccccCCCCCCCEEECcC
Q 044366 48 RRLYLDVNQLHGTIPPVIGQLSLINELVFCHNNVSGRIPSSLGNLSNLALLYLNDNSLFG-SIPIVMGNLKSLSTLDLSQ 126 (918)
Q Consensus 48 ~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~l~~l~~L~~L~L~~n~i~~-~~~~~~~~l~~L~~L~Ls~ 126 (918)
+.++.++..++ .+|+.+. +++++|++++|+++...+.+|.++++|++|++++|.+.. ..+.+|.+++++++|++..
T Consensus 11 ~~i~c~~~~l~-~iP~~l~--~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~ 87 (242)
T d1xwdc1 11 RVFLCQESKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEK 87 (242)
T ss_dssp SEEEEESCSCS-SCCSCSC--SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEEC
T ss_pred CEEEEeCCCCC-CcCCCCC--CCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeeccccccccccccccccc
Confidence 34444444444 4444432 345555555555553333345555555555555555443 2233445555555555432
Q ss_pred -CcCCCcCCcCCCCCCCCceeeccccccccCCCc-ccccccccCeeeccccccCCcCCccCCCCC-CCcEeeccCccccc
Q 044366 127 -NQLNGSIPCSLDNLSNLDTLFLYKNSLSGPIPS-VIGNLKSLLQLDLSENRLSGLIPLSLSNLS-SLTVMSLFNNSLSG 203 (918)
Q Consensus 127 -n~i~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~-~L~~L~L~~N~l~~ 203 (918)
|++....+..|.++++|++|++++|.+....+. .+..++.+..+..+++.+..+.+..|.+++ .++.|++++|+++.
T Consensus 88 ~n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~~~l~~L~l~~n~l~~ 167 (242)
T d1xwdc1 88 ANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQE 167 (242)
T ss_dssp CTTCCEECTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCCE
T ss_pred cccccccccccccccccccccccchhhhcccccccccccccccccccccccccccccccccccccccceeeecccccccc
Confidence 344444444455555555555555555432221 122334444444444455444444444443 44555555555554
Q ss_pred CCCccccCCCCcceeecccccccCCCCCCCcCCCcCCeEEcccCcCcCCCCccccccCCCCeEec
Q 044366 204 SIPPILGNLKSLSTLGLHINQLNGVIPPSIGNLSSLRNLSLFNNRLYGFVPKEIGYLKSLSKLEF 268 (918)
Q Consensus 204 ~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~l 268 (918)
+.+..|.....++.+.+++|+++.+.+..|.++++|++|+|++|+++.+++..|..+++|+.+++
T Consensus 168 i~~~~~~~~~l~~~~~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~l~~ 232 (242)
T d1xwdc1 168 IHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARST 232 (242)
T ss_dssp ECTTTTTTCCEEEEECTTCTTCCCCCTTTTTTSCCCSEEECTTSCCCCCCSSSCTTCCEEESSSE
T ss_pred cccccccchhhhccccccccccccccHHHhcCCCCCCEEECCCCcCCccCHHHHcCCcccccCcC
Confidence 33333322222222234445555444444555555555555555555444444444444444433
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.78 E-value=6.8e-19 Score=177.73 Aligned_cols=207 Identities=27% Similarity=0.344 Sum_probs=149.8
Q ss_pred CCCEEeCCCCcccccCCccccCCCCCCEEEcccccccccCCCCcCCCCCCCEEEcccccccccCCccccCCCCCCEEEcc
Q 044366 22 KLQYLDLGNNQLSGVIPPEIGKLNQLRRLYLDVNQLHGTIPPVIGQLSLINELVFCHNNVSGRIPSSLGNLSNLALLYLN 101 (918)
Q Consensus 22 ~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~l~~l~~L~~L~L~ 101 (918)
++..++++.+++++. ..+..+.+|+.|++.+|+|+ .++ .+..+++|++|++++|.+++.. .+..+++|++++++
T Consensus 20 ~~~~~~l~~~~~~d~--~~~~~l~~L~~L~l~~~~i~-~l~-~l~~l~~L~~L~ls~n~i~~~~--~l~~l~~l~~l~~~ 93 (227)
T d1h6ua2 20 NAIKIAAGKSNVTDT--VTQADLDGITTLSAFGTGVT-TIE-GVQYLNNLIGLELKDNQITDLA--PLKNLTKITELELS 93 (227)
T ss_dssp HHHHHHTTCSSTTSE--ECHHHHHTCCEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCCG--GGTTCCSCCEEECC
T ss_pred HHHHHHhCCCCcCCc--CCHHHcCCcCEEECCCCCCC-cch-hHhcCCCCcEeecCCceeeccc--cccccccccccccc
Confidence 334456666676643 24566777777777777776 443 4777777777777777776433 27777888888888
Q ss_pred CCcccccCccccCCCCCCCEEECcCCcCCCcCCcCCCCCCCCceeeccccccccCCCcccccccccCeeeccccccCCcC
Q 044366 102 DNSLFGSIPIVMGNLKSLSTLDLSQNQLNGSIPCSLDNLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSENRLSGLI 181 (918)
Q Consensus 102 ~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~ 181 (918)
+|.++. + ..+.++++|++++++++.+.+. ..+...+.++.+.++++.+... ..+..+++|++|++++|++.+..
T Consensus 94 ~n~~~~-i-~~l~~l~~L~~l~l~~~~~~~~--~~~~~~~~~~~l~~~~~~~~~~--~~~~~~~~L~~L~l~~n~~~~~~ 167 (227)
T d1h6ua2 94 GNPLKN-V-SAIAGLQSIKTLDLTSTQITDV--TPLAGLSNLQVLYLDLNQITNI--SPLAGLTNLQYLSIGNAQVSDLT 167 (227)
T ss_dssp SCCCSC-C-GGGTTCTTCCEEECTTSCCCCC--GGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCCEEECCSSCCCCCG
T ss_pred cccccc-c-cccccccccccccccccccccc--chhccccchhhhhchhhhhchh--hhhccccccccccccccccccch
Confidence 887763 2 3577788888888888877643 3456677888888888887643 34677788888888888887543
Q ss_pred CccCCCCCCCcEeeccCcccccCCCccccCCCCcceeecccccccCCCCCCCcCCCcCCeEEccc
Q 044366 182 PLSLSNLSSLTVMSLFNNSLSGSIPPILGNLKSLSTLGLHINQLNGVIPPSIGNLSSLRNLSLFN 246 (918)
Q Consensus 182 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~ 246 (918)
.+.++++|+.|+|++|+++++ ..|.++++|++|+|++|+++++. .++++++|+.|++++
T Consensus 168 --~l~~l~~L~~L~Ls~n~l~~l--~~l~~l~~L~~L~Ls~N~lt~i~--~l~~l~~L~~L~lsn 226 (227)
T d1h6ua2 168 --PLANLSKLTTLKADDNKISDI--SPLASLPNLIEVHLKNNQISDVS--PLANTSNLFIVTLTN 226 (227)
T ss_dssp --GGTTCTTCCEEECCSSCCCCC--GGGGGCTTCCEEECTTSCCCBCG--GGTTCTTCCEEEEEE
T ss_pred --hhcccccceecccCCCccCCC--hhhcCCCCCCEEECcCCcCCCCc--ccccCCCCCEEEeeC
Confidence 477888888888888888754 23788888888888888888653 378888888888874
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.78 E-value=9e-19 Score=176.85 Aligned_cols=208 Identities=24% Similarity=0.332 Sum_probs=142.2
Q ss_pred CCCCCEEEcccccccccCCCCcCCCCCCCEEEcccccccccCCccccCCCCCCEEEccCCcccccCccccCCCCCCCEEE
Q 044366 44 LNQLRRLYLDVNQLHGTIPPVIGQLSLINELVFCHNNVSGRIPSSLGNLSNLALLYLNDNSLFGSIPIVMGNLKSLSTLD 123 (918)
Q Consensus 44 l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~l~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~ 123 (918)
+.++..++++.+++++.+ .+..+.+|++|++.+|+++ .+ +++..+++|++|++++|++.+..| +..+++|++++
T Consensus 18 l~~~~~~~l~~~~~~d~~--~~~~l~~L~~L~l~~~~i~-~l-~~l~~l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l~ 91 (227)
T d1h6ua2 18 LANAIKIAAGKSNVTDTV--TQADLDGITTLSAFGTGVT-TI-EGVQYLNNLIGLELKDNQITDLAP--LKNLTKITELE 91 (227)
T ss_dssp HHHHHHHHTTCSSTTSEE--CHHHHHTCCEEECTTSCCC-CC-TTGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEE
T ss_pred HHHHHHHHhCCCCcCCcC--CHHHcCCcCEEECCCCCCC-cc-hhHhcCCCCcEeecCCceeecccc--ccccccccccc
Confidence 334445566666666432 3456777777888777777 34 357777888888888877765433 67777788888
Q ss_pred CcCCcCCCcCCcCCCCCCCCceeeccccccccCCCcccccccccCeeeccccccCCcCCccCCCCCCCcEeeccCccccc
Q 044366 124 LSQNQLNGSIPCSLDNLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSENRLSGLIPLSLSNLSSLTVMSLFNNSLSG 203 (918)
Q Consensus 124 Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 203 (918)
+++|.++.. ..+.++++|+.++++++...+. ..+...+.++.+.++++.+... ..+..+++|+.|++++|.+.+
T Consensus 92 ~~~n~~~~i--~~l~~l~~L~~l~l~~~~~~~~--~~~~~~~~~~~l~~~~~~~~~~--~~~~~~~~L~~L~l~~n~~~~ 165 (227)
T d1h6ua2 92 LSGNPLKNV--SAIAGLQSIKTLDLTSTQITDV--TPLAGLSNLQVLYLDLNQITNI--SPLAGLTNLQYLSIGNAQVSD 165 (227)
T ss_dssp CCSCCCSCC--GGGTTCTTCCEEECTTSCCCCC--GGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCCEEECCSSCCCC
T ss_pred ccccccccc--cccccccccccccccccccccc--chhccccchhhhhchhhhhchh--hhhcccccccccccccccccc
Confidence 887777632 3567777778888777776643 3456667777777777777644 236667777888887777764
Q ss_pred CCCccccCCCCcceeecccccccCCCCCCCcCCCcCCeEEcccCcCcCCCCccccccCCCCeEecC
Q 044366 204 SIPPILGNLKSLSTLGLHINQLNGVIPPSIGNLSSLRNLSLFNNRLYGFVPKEIGYLKSLSKLEFC 269 (918)
Q Consensus 204 ~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~l~ 269 (918)
. ..+.++++|++|+|++|+++++ ..++++++|++|+|++|+++++. .+..+++|+.|+++
T Consensus 166 ~--~~l~~l~~L~~L~Ls~n~l~~l--~~l~~l~~L~~L~Ls~N~lt~i~--~l~~l~~L~~L~ls 225 (227)
T d1h6ua2 166 L--TPLANLSKLTTLKADDNKISDI--SPLASLPNLIEVHLKNNQISDVS--PLANTSNLFIVTLT 225 (227)
T ss_dssp C--GGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCCEEECTTSCCCBCG--GGTTCTTCCEEEEE
T ss_pred c--hhhcccccceecccCCCccCCC--hhhcCCCCCCEEECcCCcCCCCc--ccccCCCCCEEEee
Confidence 3 3367777788888888777754 23677777888888888777653 36777777777775
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.77 E-value=4.2e-22 Score=225.15 Aligned_cols=398 Identities=18% Similarity=0.108 Sum_probs=189.2
Q ss_pred CCCEEEccCCcccccC-ccccCCCCCCCEEECcCCcCCCc----CCcCCCCCCCCceeeccccccccCC----Ccccc-c
Q 044366 94 NLALLYLNDNSLFGSI-PIVMGNLKSLSTLDLSQNQLNGS----IPCSLDNLSNLDTLFLYKNSLSGPI----PSVIG-N 163 (918)
Q Consensus 94 ~L~~L~L~~n~i~~~~-~~~~~~l~~L~~L~Ls~n~i~~~----~~~~l~~l~~L~~L~L~~n~l~~~~----~~~~~-~ 163 (918)
+|+.|+++.|++++.. ...+..+++|++|+|++|.|+.. ++..+..+++|++|+|++|.|+... ...+. .
T Consensus 3 ~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~ 82 (460)
T d1z7xw1 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTP 82 (460)
T ss_dssp EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCST
T ss_pred CCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhcC
Confidence 5777888888876432 23345567778888888877632 2344566677777777777765211 11111 1
Q ss_pred ccccCeeeccccccCCc----CCccCCCCCCCcEeeccCcccccCCCccccCCCCcceeecccccccCCCCCCCcCCCcC
Q 044366 164 LKSLLQLDLSENRLSGL----IPLSLSNLSSLTVMSLFNNSLSGSIPPILGNLKSLSTLGLHINQLNGVIPPSIGNLSSL 239 (918)
Q Consensus 164 l~~L~~L~Ls~N~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L 239 (918)
..+|++|+|++|++++. ++..+..+++|++|++++|.+.......+... +. ......
T Consensus 83 ~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~~~~~~~l~~~--l~-----------------~~~~~~ 143 (460)
T d1z7xw1 83 SCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEG--LL-----------------DPQCRL 143 (460)
T ss_dssp TCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHH--HT-----------------STTCCC
T ss_pred CCCCCEEECCCCCccccccccccchhhccccccccccccccchhhhhhhhhhc--cc-----------------cccccc
Confidence 23577777777766543 13345566666666666666653211111100 00 000011
Q ss_pred CeEEcccCcCcCCC----CccccccCCCCeEecCCCccCCcCCCc-----CCCCCCCcEEEccCCcCcCCC----Ccccc
Q 044366 240 RNLSLFNNRLYGFV----PKEIGYLKSLSKLEFCANHLSGVIPHS-----VGNLTGLVLLNMCENHLFGPI----PKSLR 306 (918)
Q Consensus 240 ~~L~Ls~n~l~~~~----~~~~~~l~~L~~L~l~~n~l~~~~~~~-----~~~l~~L~~L~l~~n~l~~~~----~~~l~ 306 (918)
.........+.... ...+.....++.++++++.+....... .........+++..+.+.... ...+.
T Consensus 144 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ls~~~~~~~~~~~~~~~l~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~ 223 (460)
T d1z7xw1 144 EKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVA 223 (460)
T ss_dssp CEEECTTSCCBGGGHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHH
T ss_pred ccccccccccchhhhcccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhccccccc
Confidence 11122111111000 011122334444444444332110000 011123334455444432211 12233
Q ss_pred CCCCCCeEEeecccccCc-----cccccCCCCCccEEeCCCCccccccCcccccccccceeeccccccccCCCcCcCCCC
Q 044366 307 NLTSLERVRFNQNNLYGK-----VYEAFGDHPNLTFLDLSQNNFYCEISFNWRNFSKLGTFNASMNNIYGSIPPEIGDSS 381 (918)
Q Consensus 307 ~l~~L~~L~l~~n~l~~~-----~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~n~i~~~~~~~~~~~~ 381 (918)
....++.+.+.+|.+... ....+.....++.+++++|.+.......+ ...+...+
T Consensus 224 ~~~~~~~l~~~~n~~~~~~~~~~~~~~~~~~~~l~~l~l~~n~i~~~~~~~~--------------------~~~l~~~~ 283 (460)
T d1z7xw1 224 SKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDL--------------------CRVLRAKE 283 (460)
T ss_dssp HCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHH--------------------HHHHHHCT
T ss_pred ccccccccchhhccccccccchhhcccccccccccccccccccccccccccc--------------------cccccccc
Confidence 455566666666554321 12233445566666776666543321110 01112223
Q ss_pred CCcEEEccCceeccccccchh-----hccccCceecccccccCCCCC----CCCCCCcccEEeccCcccccc----Cccc
Q 044366 382 KLQVLDLSSNHIFGKIPVQLV-----KLFSLNKLILSLNQLFGGVPL----EFGTLTELQYLDLSANKLSSS----IPMS 448 (918)
Q Consensus 382 ~L~~L~L~~N~l~~~~~~~~~-----~l~~L~~L~L~~N~l~~~~~~----~~~~l~~L~~L~Ls~N~l~~~----~~~~ 448 (918)
.++.+++++|.+.......+. ....|+.+++++|.++..... .+...++|++|+|++|.|+.. ++..
T Consensus 284 ~l~~l~l~~n~i~~~~~~~l~~~l~~~~~~L~~l~l~~~~l~~~~~~~l~~~~~~~~~L~~L~Ls~N~i~~~g~~~l~~~ 363 (460)
T d1z7xw1 284 SLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQG 363 (460)
T ss_dssp TCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHH
T ss_pred cccccccccccccccccchhhccccccccccccccccccchhhhhhhhcccccccccchhhhheeeecccCcccchhhhh
Confidence 334444444443321111110 112344444444444322111 122345677888888877632 2222
Q ss_pred cc-cccccceecccCcccCCC----CchhhccccccceEeccCCcCCCCCchhc----c-ccCCcceEecCCCcccccCc
Q 044366 449 IG-NLLKLHYLNLSNNQFSHK----IPTEFEKLIHLSELDLSHNILQEEIPPQI----C-KMESLEKLNLSHNNLSDFIP 518 (918)
Q Consensus 449 ~~-~l~~L~~L~Ls~N~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~----~-~l~~L~~L~L~~N~l~~~~~ 518 (918)
+. ..+.|++|+|++|+|+.. ++..+..+++|++|||++|+|++.....+ . ....|+.|++++|.+.+...
T Consensus 364 l~~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~l~l~~~~~~~~~~ 443 (460)
T d1z7xw1 364 LGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEEME 443 (460)
T ss_dssp HTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCCHHHHHHHHHHHTSTTCCCCEEECTTCCCCHHHH
T ss_pred hhcccCCCCEEECCCCCCChHHHHHHHHHHhcCCCCCEEECCCCcCCHHHHHHHHHHHHhCCCccCEEECCCCCCCHHHH
Confidence 32 355688888888888643 33445666788888888888875433333 2 23468888888888875433
Q ss_pred ccc----cCCCCccEE
Q 044366 519 RCF----EEMRSLSWI 530 (918)
Q Consensus 519 ~~~----~~l~~L~~l 530 (918)
..+ ...|+|++|
T Consensus 444 ~~l~~l~~~~~~l~~~ 459 (460)
T d1z7xw1 444 DRLQALEKDKPSLRVI 459 (460)
T ss_dssp HHHHHHHHHCTTSEEE
T ss_pred HHHHHHHHhCCCCEEe
Confidence 333 345666654
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.76 E-value=2.1e-21 Score=219.34 Aligned_cols=378 Identities=19% Similarity=0.103 Sum_probs=223.3
Q ss_pred CCceeeccccccccCC-CcccccccccCeeeccccccCCc----CCccCCCCCCCcEeeccCcccccCC----Ccccc-C
Q 044366 142 NLDTLFLYKNSLSGPI-PSVIGNLKSLLQLDLSENRLSGL----IPLSLSNLSSLTVMSLFNNSLSGSI----PPILG-N 211 (918)
Q Consensus 142 ~L~~L~L~~n~l~~~~-~~~~~~l~~L~~L~Ls~N~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~~----~~~~~-~ 211 (918)
+|++|++++|++++.. ...+..+++++.|+|++|.++.. +...+..+++|++|+|++|.|+... ...+. .
T Consensus 3 ~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~ 82 (460)
T d1z7xw1 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTP 82 (460)
T ss_dssp EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCST
T ss_pred CCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhcC
Confidence 6888999999987532 33466788888899998887732 2334567788888888888875321 11222 2
Q ss_pred CCCcceeecccccccCC----CCCCCcCCCcCCeEEcccCcCcCCCCccccc-----cCCCCeEecCCCccCCcCCCcCC
Q 044366 212 LKSLSTLGLHINQLNGV----IPPSIGNLSSLRNLSLFNNRLYGFVPKEIGY-----LKSLSKLEFCANHLSGVIPHSVG 282 (918)
Q Consensus 212 l~~L~~L~L~~n~l~~~----~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~-----l~~L~~L~l~~n~l~~~~~~~~~ 282 (918)
..+|++|+|++|+++.. ++..+..+++|++|++++|.+.......+.. .............+......
T Consensus 83 ~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~--- 159 (460)
T d1z7xw1 83 SCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCE--- 159 (460)
T ss_dssp TCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHH---
T ss_pred CCCCCEEECCCCCccccccccccchhhccccccccccccccchhhhhhhhhhcccccccccccccccccccchhhhc---
Confidence 34677777777777543 2234556677777777777765322221110 11112222222211100000
Q ss_pred CCCCCcEEEccCCcCcCCCCccccCCCCCCeEEeecccccCccccc----c-CCCCCccEEeCCCCccccccCc----cc
Q 044366 283 NLTGLVLLNMCENHLFGPIPKSLRNLTSLERVRFNQNNLYGKVYEA----F-GDHPNLTFLDLSQNNFYCEISF----NW 353 (918)
Q Consensus 283 ~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~----~-~~l~~L~~L~Ls~N~l~~~~~~----~~ 353 (918)
.....+.....++.+.++++.+....... + ........+++..+.+...... .+
T Consensus 160 -----------------~~~~~l~~~~~~~~~~ls~~~~~~~~~~~~~~~l~~~~~~~~~l~~~~~~~~~~~~~~~~~~l 222 (460)
T d1z7xw1 160 -----------------PLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIV 222 (460)
T ss_dssp -----------------HHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHH
T ss_pred -----------------ccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhcccccc
Confidence 00112233344455555544433211111 0 1122344556655554432211 12
Q ss_pred ccccccceeecccccccc-----CCCcCcCCCCCCcEEEccCceecccc----ccchhhccccCceecccccccCCCCCC
Q 044366 354 RNFSKLGTFNASMNNIYG-----SIPPEIGDSSKLQVLDLSSNHIFGKI----PVQLVKLFSLNKLILSLNQLFGGVPLE 424 (918)
Q Consensus 354 ~~~~~L~~l~l~~n~i~~-----~~~~~~~~~~~L~~L~L~~N~l~~~~----~~~~~~l~~L~~L~L~~N~l~~~~~~~ 424 (918)
.....++.++++.|.+.. ..+..+.....++.+++++|.+.... ...+...+.++.+++++|.++......
T Consensus 223 ~~~~~~~~l~~~~n~~~~~~~~~~~~~~~~~~~~l~~l~l~~n~i~~~~~~~~~~~l~~~~~l~~l~l~~n~i~~~~~~~ 302 (460)
T d1z7xw1 223 ASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARL 302 (460)
T ss_dssp HHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHH
T ss_pred cccccccccchhhccccccccchhhcccccccccccccccccccccccccccccccccccccccccccccccccccccch
Confidence 234556666666665432 12233455678999999999886432 233456778999999999885321111
Q ss_pred -----CCCCCcccEEeccCccccccCcc----ccccccccceecccCcccCCCC----chhhc-cccccceEeccCCcCC
Q 044366 425 -----FGTLTELQYLDLSANKLSSSIPM----SIGNLLKLHYLNLSNNQFSHKI----PTEFE-KLIHLSELDLSHNILQ 490 (918)
Q Consensus 425 -----~~~l~~L~~L~Ls~N~l~~~~~~----~~~~l~~L~~L~Ls~N~l~~~~----~~~~~-~l~~L~~L~Ls~N~l~ 490 (918)
....+.|+.+++++|.++..... .+...++|++|+|++|+|++.. +..+. ..+.|++|+|++|.|+
T Consensus 303 l~~~l~~~~~~L~~l~l~~~~l~~~~~~~l~~~~~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n~i~ 382 (460)
T d1z7xw1 303 LCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVS 382 (460)
T ss_dssp HHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCC
T ss_pred hhccccccccccccccccccchhhhhhhhcccccccccchhhhheeeecccCcccchhhhhhhcccCCCCEEECCCCCCC
Confidence 12346899999999998854333 3345568999999999996532 23332 4567999999999997
Q ss_pred CC----CchhccccCCcceEecCCCcccccCcc----ccc-CCCCccEEEccCCcCCC
Q 044366 491 EE----IPPQICKMESLEKLNLSHNNLSDFIPR----CFE-EMRSLSWIDISYNELQG 539 (918)
Q Consensus 491 ~~----~~~~~~~l~~L~~L~L~~N~l~~~~~~----~~~-~l~~L~~l~l~~N~l~~ 539 (918)
+. ++..+..+++|++|+|++|+|++.... .+. +...|+.|++++|.+..
T Consensus 383 ~~~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~l~l~~~~~~~ 440 (460)
T d1z7xw1 383 DSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSE 440 (460)
T ss_dssp HHHHHHHHHHHHHCCCCCEEECCSSSCCHHHHHHHHHHHTSTTCCCCEEECTTCCCCH
T ss_pred hHHHHHHHHHHhcCCCCCEEECCCCcCCHHHHHHHHHHHHhCCCccCEEECCCCCCCH
Confidence 53 344566779999999999999864332 232 33479999999999874
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.75 E-value=2.2e-18 Score=171.30 Aligned_cols=183 Identities=26% Similarity=0.427 Sum_probs=132.5
Q ss_pred CEEeCCCCcccccCCccccCCCCCCEEEcccccccccCCCCcCCCCCCCEEEcccccccccCCccccCCCCCCEEEccCC
Q 044366 24 QYLDLGNNQLSGVIPPEIGKLNQLRRLYLDVNQLHGTIPPVIGQLSLINELVFCHNNVSGRIPSSLGNLSNLALLYLNDN 103 (918)
Q Consensus 24 ~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~l~~l~~L~~L~L~~n 103 (918)
...+++.+.+++.++ ...+.+|++|++++|.++ .++ .+..+++|++|++++|.+++ ++ .++.+++|++|++++|
T Consensus 27 i~~~l~~~~~~~~~~--~~~L~~L~~L~l~~~~i~-~l~-~l~~l~~L~~L~L~~n~i~~-l~-~~~~l~~L~~L~l~~n 100 (210)
T d1h6ta2 27 IKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SVQ-GIQYLPNVTKLFLNGNKLTD-IK-PLANLKNLGWLFLDEN 100 (210)
T ss_dssp HHHHTTCSCTTSEEC--HHHHHTCCEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCC-CG-GGTTCTTCCEEECCSS
T ss_pred HHHHhCcCccCCccC--HHHhcCccEEECcCCCCC-Cch-hHhhCCCCCEEeCCCccccC-cc-ccccCccccccccccc
Confidence 334566666664433 235667777777777776 333 36777777788887777774 33 3677888888888888
Q ss_pred cccccCccccCCCCCCCEEECcCCcCCCcCCcCCCCCCCCceeeccccccccCCCcccccccccCeeeccccccCCcCCc
Q 044366 104 SLFGSIPIVMGNLKSLSTLDLSQNQLNGSIPCSLDNLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSENRLSGLIPL 183 (918)
Q Consensus 104 ~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~ 183 (918)
+|++ +| .+..+++|+.|++++|.+.. ...+.++++|+.+++++|.+++. ..+..+++|+++++++|+++++.
T Consensus 101 ~i~~-l~-~l~~l~~L~~L~l~~~~~~~--~~~l~~l~~l~~l~~~~n~l~~~--~~~~~l~~L~~l~l~~n~l~~i~-- 172 (210)
T d1h6ta2 101 KVKD-LS-SLKDLKKLKSLSLEHNGISD--INGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIV-- 172 (210)
T ss_dssp CCCC-GG-GGTTCTTCCEEECTTSCCCC--CGGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCG--
T ss_pred cccc-cc-cccccccccccccccccccc--ccccccccccccccccccccccc--ccccccccccccccccccccccc--
Confidence 8864 33 57778888888888888763 23577788888888888888743 45777888888888888888653
Q ss_pred cCCCCCCCcEeeccCcccccCCCccccCCCCcceeeccc
Q 044366 184 SLSNLSSLTVMSLFNNSLSGSIPPILGNLKSLSTLGLHI 222 (918)
Q Consensus 184 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~ 222 (918)
.+.++++|++|+|++|+|+++ + .|.++++|++|+|++
T Consensus 173 ~l~~l~~L~~L~Ls~N~i~~l-~-~l~~l~~L~~L~Ls~ 209 (210)
T d1h6ta2 173 PLAGLTKLQNLYLSKNHISDL-R-ALAGLKNLDVLELFS 209 (210)
T ss_dssp GGTTCTTCCEEECCSSCCCBC-G-GGTTCTTCSEEEEEE
T ss_pred cccCCCCCCEEECCCCCCCCC-h-hhcCCCCCCEEEccC
Confidence 377888888888888888753 3 588888888888864
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.74 E-value=6.7e-18 Score=166.24 Aligned_cols=178 Identities=29% Similarity=0.423 Sum_probs=112.1
Q ss_pred EEeCCCCcccccCCccccCCCCCCEEEcccccccccCCCCcCCCCCCCEEEcccccccccCCccccCCCCCCEEEccCCc
Q 044366 25 YLDLGNNQLSGVIPPEIGKLNQLRRLYLDVNQLHGTIPPVIGQLSLINELVFCHNNVSGRIPSSLGNLSNLALLYLNDNS 104 (918)
Q Consensus 25 ~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~l~~l~~L~~L~L~~n~ 104 (918)
.+.++.+.+++..+ ...+.++++|++++|.++ .++ .+..+++|++|++++|.+++.. .++++++|++|++++|.
T Consensus 22 ~~~l~~~~~~~~~~--~~~l~~l~~L~l~~~~i~-~l~-~l~~l~nL~~L~Ls~N~l~~~~--~l~~l~~L~~L~l~~n~ 95 (199)
T d2omxa2 22 KTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIK-SID-GVEYLNNLTQINFSNNQLTDIT--PLKNLTKLVDILMNNNQ 95 (199)
T ss_dssp HHHTTCSSTTSEEC--HHHHTTCCEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSC
T ss_pred HHHhCCCCCCCccC--HHHhcCCCEEECCCCCCC-Ccc-ccccCCCcCcCccccccccCcc--cccCCcccccccccccc
Confidence 34455555553322 344556666666666665 332 3556666666666666665322 26667777777777776
Q ss_pred ccccCccccCCCCCCCEEECcCCcCCCcCCcCCCCCCCCceeeccccccccCCCcccccccccCeeeccccccCCcCCcc
Q 044366 105 LFGSIPIVMGNLKSLSTLDLSQNQLNGSIPCSLDNLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSENRLSGLIPLS 184 (918)
Q Consensus 105 i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~ 184 (918)
+... + .+.++++|+.|++++|.+... ..+.++++|+.|++++|++..+ +.+..+++|++|++++|+++++. .
T Consensus 96 ~~~~-~-~l~~l~~L~~L~l~~~~~~~~--~~~~~l~~L~~L~l~~n~l~~~--~~l~~~~~L~~L~l~~n~l~~l~--~ 167 (199)
T d2omxa2 96 IADI-T-PLANLTNLTGLTLFNNQITDI--DPLKNLTNLNRLELSSNTISDI--SALSGLTSLQQLNFSSNQVTDLK--P 167 (199)
T ss_dssp CCCC-G-GGTTCTTCSEEECCSSCCCCC--GGGTTCTTCSEEECCSSCCCCC--GGGTTCTTCSEEECCSSCCCCCG--G
T ss_pred cccc-c-ccccccccccccccccccccc--cccchhhhhHHhhhhhhhhccc--ccccccccccccccccccccCCc--c
Confidence 6532 2 366777777777777776643 2466677777777777777643 35677777777777777777653 3
Q ss_pred CCCCCCCcEeeccCcccccCCCccccCCCCccee
Q 044366 185 LSNLSSLTVMSLFNNSLSGSIPPILGNLKSLSTL 218 (918)
Q Consensus 185 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 218 (918)
+.++++|++|++++|+++++ +.+..+++|++|
T Consensus 168 l~~l~~L~~L~ls~N~i~~i--~~l~~L~~L~~L 199 (199)
T d2omxa2 168 LANLTTLERLDISSNKVSDI--SVLAKLTNLESL 199 (199)
T ss_dssp GTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEE
T ss_pred ccCCCCCCEEECCCCCCCCC--ccccCCCCCCcC
Confidence 67777777777777777753 346777777765
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.74 E-value=5.5e-18 Score=165.81 Aligned_cols=173 Identities=21% Similarity=0.254 Sum_probs=100.6
Q ss_pred CCEEeCCCCcccccCCccccCCCCCCEEEcccccccccC-CCCcCCCCCCCEEEcccccccccCCccccCCCCCCEEEcc
Q 044366 23 LQYLDLGNNQLSGVIPPEIGKLNQLRRLYLDVNQLHGTI-PPVIGQLSLINELVFCHNNVSGRIPSSLGNLSNLALLYLN 101 (918)
Q Consensus 23 L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~n~l~~~~-p~~~~~l~~L~~L~l~~n~~~~~~p~~l~~l~~L~~L~L~ 101 (918)
.+.++.++++++ .+|..+. +++++|+|++|+|++.+ +..|..+++|++|++++|++....+..|..+++|++|+|+
T Consensus 10 ~~~v~Cs~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls 86 (192)
T d1w8aa_ 10 GTTVDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLG 86 (192)
T ss_dssp TTEEECTTSCCS-SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred CCEEEEeCCCcC-ccCCCCC--CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeec
Confidence 356777777777 6666653 56777777777776433 3445666666666666666666666666666666666666
Q ss_pred CCcccccCccccCCCCCCCEEECcCCcCCCcCCcCCCCCCCCceeeccccccccCCCcccccccccCeeeccccccCCcC
Q 044366 102 DNSLFGSIPIVMGNLKSLSTLDLSQNQLNGSIPCSLDNLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSENRLSGLI 181 (918)
Q Consensus 102 ~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~ 181 (918)
+|+|....|.+|.++++|++|+|++|+|+++.+.+|.++++|++|+|++|.+.... +...-...++.+.+..+.++...
T Consensus 87 ~N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~-~~~~~~~~l~~~~l~~~~~~c~~ 165 (192)
T d1w8aa_ 87 ENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNC-HLAWFAEWLRKKSLNGGAARCGA 165 (192)
T ss_dssp SCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSG-GGHHHHHHHHHHCCSGGGCBBCS
T ss_pred cccccccCHHHHhCCCcccccccCCccccccCHHHhcCCccccccccccccccccc-chHHHhhhhhhhcccCCCeEeCC
Confidence 66666666666666666666666666666655666666666666666666665321 11111223444455555544333
Q ss_pred CccCCCCCCCcEeeccCcccc
Q 044366 182 PLSLSNLSSLTVMSLFNNSLS 202 (918)
Q Consensus 182 ~~~~~~l~~L~~L~L~~N~l~ 202 (918)
|.. +..++.++|+.|.+.
T Consensus 166 p~~---l~~~~l~~L~~n~l~ 183 (192)
T d1w8aa_ 166 PSK---VRDVQIKDLPHSEFK 183 (192)
T ss_dssp STT---TTTSBGGGSCTTTCC
T ss_pred Chh---hcCCEeeecCHhhCc
Confidence 322 233344455555443
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.74 E-value=5.9e-18 Score=168.11 Aligned_cols=180 Identities=27% Similarity=0.412 Sum_probs=103.2
Q ss_pred EEcccccccccCCCCcCCCCCCCEEEcccccccccCCccccCCCCCCEEEccCCcccccCccccCCCCCCCEEECcCCcC
Q 044366 50 LYLDVNQLHGTIPPVIGQLSLINELVFCHNNVSGRIPSSLGNLSNLALLYLNDNSLFGSIPIVMGNLKSLSTLDLSQNQL 129 (918)
Q Consensus 50 L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~l~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i 129 (918)
.++..+.+++.++. ..+..|++|++++|.++. ++ ++..+++|++|+|++|+|++.. .++.+++|++|++++|+|
T Consensus 29 ~~l~~~~~~~~~~~--~~L~~L~~L~l~~~~i~~-l~-~l~~l~~L~~L~L~~n~i~~l~--~~~~l~~L~~L~l~~n~i 102 (210)
T d1h6ta2 29 DNLKKKSVTDAVTQ--NELNSIDQIIANNSDIKS-VQ-GIQYLPNVTKLFLNGNKLTDIK--PLANLKNLGWLFLDENKV 102 (210)
T ss_dssp HHTTCSCTTSEECH--HHHHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCC
T ss_pred HHhCcCccCCccCH--HHhcCccEEECcCCCCCC-ch-hHhhCCCCCEEeCCCccccCcc--ccccCccccccccccccc
Confidence 34555555433332 245666777777776663 22 3666677777777777766432 356666777777777766
Q ss_pred CCcCCcCCCCCCCCceeeccccccccCCCcccccccccCeeeccccccCCcCCccCCCCCCCcEeeccCcccccCCCccc
Q 044366 130 NGSIPCSLDNLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSENRLSGLIPLSLSNLSSLTVMSLFNNSLSGSIPPIL 209 (918)
Q Consensus 130 ~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~ 209 (918)
++ +| .+.++++|+.|++++|.+... ..+..+++++.+++++|.+++. ..+..+++|+++++++|++++.. .+
T Consensus 103 ~~-l~-~l~~l~~L~~L~l~~~~~~~~--~~l~~l~~l~~l~~~~n~l~~~--~~~~~l~~L~~l~l~~n~l~~i~--~l 174 (210)
T d1h6ta2 103 KD-LS-SLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIV--PL 174 (210)
T ss_dssp CC-GG-GGTTCTTCCEEECTTSCCCCC--GGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCG--GG
T ss_pred cc-cc-ccccccccccccccccccccc--cccccccccccccccccccccc--ccccccccccccccccccccccc--cc
Confidence 63 23 466666666666666666532 3456666666666666666543 23455566666666666665321 25
Q ss_pred cCCCCcceeecccccccCCCCCCCcCCCcCCeEEcc
Q 044366 210 GNLKSLSTLGLHINQLNGVIPPSIGNLSSLRNLSLF 245 (918)
Q Consensus 210 ~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls 245 (918)
.++++|++|+|++|+++.+ +.+.++++|++|+|+
T Consensus 175 ~~l~~L~~L~Ls~N~i~~l--~~l~~l~~L~~L~Ls 208 (210)
T d1h6ta2 175 AGLTKLQNLYLSKNHISDL--RALAGLKNLDVLELF 208 (210)
T ss_dssp TTCTTCCEEECCSSCCCBC--GGGTTCTTCSEEEEE
T ss_pred cCCCCCCEEECCCCCCCCC--hhhcCCCCCCEEEcc
Confidence 5555666666666655532 235555555555554
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.73 E-value=1.4e-17 Score=163.81 Aligned_cols=179 Identities=26% Similarity=0.408 Sum_probs=112.4
Q ss_pred CEEEcccccccccCCCCcCCCCCCCEEEcccccccccCCccccCCCCCCEEEccCCcccccCccccCCCCCCCEEECcCC
Q 044366 48 RRLYLDVNQLHGTIPPVIGQLSLINELVFCHNNVSGRIPSSLGNLSNLALLYLNDNSLFGSIPIVMGNLKSLSTLDLSQN 127 (918)
Q Consensus 48 ~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~l~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n 127 (918)
.++.++.+.+++.++ ...+.++++|++++|.++. + ++++.+++|++|++++|++++..| ++++++|++|++++|
T Consensus 21 i~~~l~~~~~~~~~~--~~~l~~l~~L~l~~~~i~~-l-~~l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l~~n 94 (199)
T d2omxa2 21 MKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKS-I-DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNN 94 (199)
T ss_dssp HHHHTTCSSTTSEEC--HHHHTTCCEEECTTSCCCC-C-TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSS
T ss_pred HHHHhCCCCCCCccC--HHHhcCCCEEECCCCCCCC-c-cccccCCCcCcCccccccccCccc--ccCCccccccccccc
Confidence 344455555553222 2345667777777777662 3 346667777777777777764432 667777777777777
Q ss_pred cCCCcCCcCCCCCCCCceeeccccccccCCCcccccccccCeeeccccccCCcCCccCCCCCCCcEeeccCcccccCCCc
Q 044366 128 QLNGSIPCSLDNLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSENRLSGLIPLSLSNLSSLTVMSLFNNSLSGSIPP 207 (918)
Q Consensus 128 ~i~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~ 207 (918)
.+... + .++++++|+.|++++|.+... ..+..+++|+.|++++|++..+ ..+..+++|+.|++++|++++. .
T Consensus 95 ~~~~~-~-~l~~l~~L~~L~l~~~~~~~~--~~~~~l~~L~~L~l~~n~l~~~--~~l~~~~~L~~L~l~~n~l~~l--~ 166 (199)
T d2omxa2 95 QIADI-T-PLANLTNLTGLTLFNNQITDI--DPLKNLTNLNRLELSSNTISDI--SALSGLTSLQQLNFSSNQVTDL--K 166 (199)
T ss_dssp CCCCC-G-GGTTCTTCSEEECCSSCCCCC--GGGTTCTTCSEEECCSSCCCCC--GGGTTCTTCSEEECCSSCCCCC--G
T ss_pred ccccc-c-ccccccccccccccccccccc--cccchhhhhHHhhhhhhhhccc--ccccccccccccccccccccCC--c
Confidence 76632 2 366677777777777766643 3466677777777777776643 2466677777777777777643 2
Q ss_pred cccCCCCcceeecccccccCCCCCCCcCCCcCCeE
Q 044366 208 ILGNLKSLSTLGLHINQLNGVIPPSIGNLSSLRNL 242 (918)
Q Consensus 208 ~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 242 (918)
.+.++++|++|++++|+++.+ +.++.+++|++|
T Consensus 167 ~l~~l~~L~~L~ls~N~i~~i--~~l~~L~~L~~L 199 (199)
T d2omxa2 167 PLANLTTLERLDISSNKVSDI--SVLAKLTNLESL 199 (199)
T ss_dssp GGTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEE
T ss_pred cccCCCCCCEEECCCCCCCCC--ccccCCCCCCcC
Confidence 366777777777777777653 245666666654
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.58 E-value=6e-16 Score=145.61 Aligned_cols=125 Identities=20% Similarity=0.111 Sum_probs=77.7
Q ss_pred ccccCceecccccccCCCCCCCCCCCcccEEeccCccccccCccccccccccceecccCcccCCCCchhhccccccceEe
Q 044366 404 LFSLNKLILSLNQLFGGVPLEFGTLTELQYLDLSANKLSSSIPMSIGNLLKLHYLNLSNNQFSHKIPTEFEKLIHLSELD 483 (918)
Q Consensus 404 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 483 (918)
...+++|+|++|+|+.+ +..+..+++|++|||++|.|+.. +.|..+++|++|++++|+|+.+.+..+..+++|+.|+
T Consensus 17 ~~~lr~L~L~~n~I~~i-~~~~~~l~~L~~L~Ls~N~i~~l--~~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~~L~ 93 (162)
T d1a9na_ 17 AVRDRELDLRGYKIPVI-ENLGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELI 93 (162)
T ss_dssp TTSCEEEECTTSCCCSC-CCGGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEE
T ss_pred cCcCcEEECCCCCCCcc-CccccccccCCEEECCCCCCCcc--CCcccCcchhhhhcccccccCCCccccccccccccce
Confidence 33444444444444433 33345566677777777777643 2466677777777777777665555666677777777
Q ss_pred ccCCcCCCCCc-hhccccCCcceEecCCCcccccC---cccccCCCCccEEE
Q 044366 484 LSHNILQEEIP-PQICKMESLEKLNLSHNNLSDFI---PRCFEEMRSLSWID 531 (918)
Q Consensus 484 Ls~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~---~~~~~~l~~L~~l~ 531 (918)
|++|+|+.... ..+..+++|+.|++++|+++... +..+..+++|++||
T Consensus 94 L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~~~~~~r~~~i~~lp~L~~LD 145 (162)
T d1a9na_ 94 LTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRVLD 145 (162)
T ss_dssp CCSCCCCCGGGGGGGGGCTTCCEEECCSSGGGGSTTHHHHHHHHCTTCSEET
T ss_pred eccccccccccccccccccccchhhcCCCccccccchHHHHHHHCCCcCeeC
Confidence 77777764322 35667777777777777776532 23466677777775
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.55 E-value=2.3e-15 Score=141.58 Aligned_cols=128 Identities=20% Similarity=0.198 Sum_probs=85.6
Q ss_pred ccCCCCCCEEEccCCcccccCccccCCCCCCCEEECcCCcCCCcCCcCCCCCCCCceeeccccccccCCCcccccccccC
Q 044366 89 LGNLSNLALLYLNDNSLFGSIPIVMGNLKSLSTLDLSQNQLNGSIPCSLDNLSNLDTLFLYKNSLSGPIPSVIGNLKSLL 168 (918)
Q Consensus 89 l~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~ 168 (918)
+.+..+|++|+|++|+|+.+ +..+..+++|++|+|++|+|+.. +.+..+++|++|++++|+++.+.+..+..+++|+
T Consensus 14 ~~n~~~lr~L~L~~n~I~~i-~~~~~~l~~L~~L~Ls~N~i~~l--~~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~ 90 (162)
T d1a9na_ 14 YTNAVRDRELDLRGYKIPVI-ENLGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLT 90 (162)
T ss_dssp EECTTSCEEEECTTSCCCSC-CCGGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCC
T ss_pred ccCcCcCcEEECCCCCCCcc-CccccccccCCEEECCCCCCCcc--CCcccCcchhhhhcccccccCCCccccccccccc
Confidence 45566777777777777643 55566677777777777777743 3467777777777777777766666667777777
Q ss_pred eeeccccccCCcCC-ccCCCCCCCcEeeccCcccccCCC---ccccCCCCcceee
Q 044366 169 QLDLSENRLSGLIP-LSLSNLSSLTVMSLFNNSLSGSIP---PILGNLKSLSTLG 219 (918)
Q Consensus 169 ~L~Ls~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~---~~~~~l~~L~~L~ 219 (918)
.|++++|+++.+.. ..+..+++|++|++++|.++.... ..+..+++|+.||
T Consensus 91 ~L~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~~~~~~r~~~i~~lp~L~~LD 145 (162)
T d1a9na_ 91 ELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRVLD 145 (162)
T ss_dssp EEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGGGSTTHHHHHHHHCTTCSEET
T ss_pred cceeccccccccccccccccccccchhhcCCCccccccchHHHHHHHCCCcCeeC
Confidence 77777777775532 356667777777777777664321 2355556666554
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.55 E-value=7.2e-15 Score=131.13 Aligned_cols=101 Identities=24% Similarity=0.339 Sum_probs=42.1
Q ss_pred EEeccCccccccCccccccccccceecccCcccCCCCchhhccccccceEeccCCcCCCCCchhccccCCcceEecCCCc
Q 044366 433 YLDLSANKLSSSIPMSIGNLLKLHYLNLSNNQFSHKIPTEFEKLIHLSELDLSHNILQEEIPPQICKMESLEKLNLSHNN 512 (918)
Q Consensus 433 ~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~ 512 (918)
.|||++|+|+. ++ .+..+++|++|++++|+|+ .+|..|+.+++|+.|++++|+|++. | .+..+++|+.|++++|+
T Consensus 2 ~L~Ls~n~l~~-l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~l-~-~~~~l~~L~~L~l~~N~ 76 (124)
T d1dcea3 2 VLHLAHKDLTV-LC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALENV-D-GVANLPRLQELLLCNNR 76 (124)
T ss_dssp EEECTTSCCSS-CC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCCC-G-GGTTCSSCCEEECCSSC
T ss_pred EEEcCCCCCCC-Cc-ccccCCCCCEEECCCCccC-cchhhhhhhhccccccccccccccc-C-ccccccccCeEECCCCc
Confidence 34444444442 22 2444444444444444443 2233344444444444444444322 1 24444444444444444
Q ss_pred ccccCc-ccccCCCCccEEEccCCcCC
Q 044366 513 LSDFIP-RCFEEMRSLSWIDISYNELQ 538 (918)
Q Consensus 513 l~~~~~-~~~~~l~~L~~l~l~~N~l~ 538 (918)
|++... ..+..+++|+.|++++|+++
T Consensus 77 i~~~~~~~~l~~~~~L~~L~l~~N~i~ 103 (124)
T d1dcea3 77 LQQSAAIQPLVSCPRLVLLNLQGNSLC 103 (124)
T ss_dssp CCSSSTTGGGGGCTTCCEEECTTSGGG
T ss_pred cCCCCCchhhcCCCCCCEEECCCCcCC
Confidence 443321 23444444444444444444
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.54 E-value=5e-16 Score=161.77 Aligned_cols=179 Identities=18% Similarity=0.185 Sum_probs=72.2
Q ss_pred CCCCEEEccccccccc-CCccccCCCCCCEEEccCCcccccCccccCCCCCCCEEECcCC-cCCCcC-CcCCCCCCCCce
Q 044366 69 SLINELVFCHNNVSGR-IPSSLGNLSNLALLYLNDNSLFGSIPIVMGNLKSLSTLDLSQN-QLNGSI-PCSLDNLSNLDT 145 (918)
Q Consensus 69 ~~L~~L~l~~n~~~~~-~p~~l~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n-~i~~~~-~~~l~~l~~L~~ 145 (918)
..|++|++++|.+... ++..+..+++|++|+|++|.+++..+..++.+++|++|+++++ .++... ...+.++++|++
T Consensus 46 ~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L~~ 125 (284)
T d2astb2 46 FRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDE 125 (284)
T ss_dssp BCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCE
T ss_pred CCCCEEECCCCccCHHHHHHHHHhCCCcccccccccCCCcHHHHHHhcCCCCcCccccccccccccccchhhHHHHhccc
Confidence 3444555544444322 2223344455555555555554444444555555555555553 333210 111223444555
Q ss_pred eeccccc-cccC-CCccccc-ccccCeeecccc--ccCCc-CCccCCCCCCCcEeeccCc-ccccCCCccccCCCCccee
Q 044366 146 LFLYKNS-LSGP-IPSVIGN-LKSLLQLDLSEN--RLSGL-IPLSLSNLSSLTVMSLFNN-SLSGSIPPILGNLKSLSTL 218 (918)
Q Consensus 146 L~L~~n~-l~~~-~~~~~~~-l~~L~~L~Ls~N--~l~~~-~~~~~~~l~~L~~L~L~~N-~l~~~~~~~~~~l~~L~~L 218 (918)
|+++++. ++.. ....+.. .++|+.|+++++ .++.. ....+..+++|++|++++| .+++.....+..+++|++|
T Consensus 126 L~ls~c~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L 205 (284)
T d2astb2 126 LNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHL 205 (284)
T ss_dssp EECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEE
T ss_pred cccccccccccccchhhhcccccccchhhhcccccccccccccccccccccccccccccccCCCchhhhhhcccCcCCEE
Confidence 5554432 2110 0111111 234555555432 12211 0111223444555555443 2333333344444444444
Q ss_pred ecccc-cccCCCCCCCcCCCcCCeEEcccC
Q 044366 219 GLHIN-QLNGVIPPSIGNLSSLRNLSLFNN 247 (918)
Q Consensus 219 ~L~~n-~l~~~~~~~~~~l~~L~~L~Ls~n 247 (918)
++++| .++......++.+++|+.|+++++
T Consensus 206 ~L~~C~~i~~~~l~~L~~~~~L~~L~l~~~ 235 (284)
T d2astb2 206 SLSRCYDIIPETLLELGEIPTLKTLQVFGI 235 (284)
T ss_dssp ECTTCTTCCGGGGGGGGGCTTCCEEECTTS
T ss_pred ECCCCCCCChHHHHHHhcCCCCCEEeeeCC
Confidence 44442 333322233444455555555444
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.53 E-value=6.4e-16 Score=160.95 Aligned_cols=251 Identities=17% Similarity=0.175 Sum_probs=177.4
Q ss_pred cccCCCCCCccCCccCCCCCCCCEEeCCCCcccccCCccccCCCCCCEEEccccccccc-CCCCcCCCCCCCEEEccccc
Q 044366 2 LNLGFNLLFGNIPPQIGNLSKLQYLDLGNNQLSGVIPPEIGKLNQLRRLYLDVNQLHGT-IPPVIGQLSLINELVFCHNN 80 (918)
Q Consensus 2 l~~~~~~~~~~~p~~~~~l~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~n~l~~~-~p~~~~~l~~L~~L~l~~n~ 80 (918)
|||+++.+.......+.. ..+..+.++...+. ..........+|++||+++|.++.. ++..+..+++|++|++++|.
T Consensus 5 lDLs~~~l~~~~l~~l~~-~~~~~lrl~~~~~~-~~~~~~~~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~ 82 (284)
T d2astb2 5 LDLTGKNLHPDVTGRLLS-QGVIAFRCPRSFMD-QPLAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLR 82 (284)
T ss_dssp EECTTCBCCHHHHHHHHH-TTCSEEECTTCEEC-SCCCSCCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCB
T ss_pred EECCCCCCCchHHHHHHh-ccceEeeccccccc-cchhhhccCCCCCEEECCCCccCHHHHHHHHHhCCCcccccccccC
Confidence 688888775433333322 34677888877765 4444556677999999999988743 45567889999999999999
Q ss_pred ccccCCccccCCCCCCEEEccCC-ccccc-CccccCCCCCCCEEECcCC-cCCCc-CCcCCCC-CCCCceeeccccc--c
Q 044366 81 VSGRIPSSLGNLSNLALLYLNDN-SLFGS-IPIVMGNLKSLSTLDLSQN-QLNGS-IPCSLDN-LSNLDTLFLYKNS--L 153 (918)
Q Consensus 81 ~~~~~p~~l~~l~~L~~L~L~~n-~i~~~-~~~~~~~l~~L~~L~Ls~n-~i~~~-~~~~l~~-l~~L~~L~L~~n~--l 153 (918)
+.+..+..++.+++|++|++++| .+++. ....+.++++|++|+++++ .++.. ....+.. .++|+.|+++++. +
T Consensus 83 l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L~~L~ls~c~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~i 162 (284)
T d2astb2 83 LSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNL 162 (284)
T ss_dssp CCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGS
T ss_pred CCcHHHHHHhcCCCCcCccccccccccccccchhhHHHHhccccccccccccccccchhhhcccccccchhhhccccccc
Confidence 98888889999999999999996 55532 2223456899999999996 45432 1222333 4689999999753 3
Q ss_pred ccC-CCcccccccccCeeecccc-ccCCcCCccCCCCCCCcEeeccCc-ccccCCCccccCCCCcceeecccccccCCCC
Q 044366 154 SGP-IPSVIGNLKSLLQLDLSEN-RLSGLIPLSLSNLSSLTVMSLFNN-SLSGSIPPILGNLKSLSTLGLHINQLNGVIP 230 (918)
Q Consensus 154 ~~~-~~~~~~~l~~L~~L~Ls~N-~l~~~~~~~~~~l~~L~~L~L~~N-~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~ 230 (918)
+.. +...+.++++|++|++++| .+++.....+..+++|++|++++| .+++.....+.++++|+.|++.++ ++ .
T Consensus 163 ~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~~~L~~L~l~~~-~~---d 238 (284)
T d2astb2 163 QKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI-VP---D 238 (284)
T ss_dssp CHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS-SC---T
T ss_pred ccccccccccccccccccccccccCCCchhhhhhcccCcCCEEECCCCCCCChHHHHHHhcCCCCCEEeeeCC-CC---H
Confidence 321 2223467899999999986 577666778889999999999996 677666677889999999999887 33 2
Q ss_pred CCCcCC-CcCCeEEcccCcCcCCCCcccc
Q 044366 231 PSIGNL-SSLRNLSLFNNRLYGFVPKEIG 258 (918)
Q Consensus 231 ~~~~~l-~~L~~L~Ls~n~l~~~~~~~~~ 258 (918)
..+..+ ..+..|.+..++++...+..++
T Consensus 239 ~~l~~l~~~lp~L~i~~~~ls~~~~~~~~ 267 (284)
T d2astb2 239 GTLQLLKEALPHLQINCSHFTTIARPTIG 267 (284)
T ss_dssp TCHHHHHHHSTTSEESCCCSCCTTCSSCS
T ss_pred HHHHHHHHhCccccccCccCCCCCCCccC
Confidence 233322 2455556677777765544443
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.51 E-value=2.8e-14 Score=127.28 Aligned_cols=54 Identities=26% Similarity=0.435 Sum_probs=24.6
Q ss_pred EEeCCCCcccccCCccccCCCCCCEEEcccccccccCCCCcCCCCCCCEEEcccccc
Q 044366 25 YLDLGNNQLSGVIPPEIGKLNQLRRLYLDVNQLHGTIPPVIGQLSLINELVFCHNNV 81 (918)
Q Consensus 25 ~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~~ 81 (918)
+|||++|+++ .++ .++.+++|++|++++|+|+ .+|+.++.+++|++|++++|.+
T Consensus 2 ~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i 55 (124)
T d1dcea3 2 VLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNAL 55 (124)
T ss_dssp EEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCC
T ss_pred EEEcCCCCCC-CCc-ccccCCCCCEEECCCCccC-cchhhhhhhhcccccccccccc
Confidence 4555555554 332 2555555555555555554 3333333333333333333333
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.46 E-value=2e-15 Score=162.54 Aligned_cols=183 Identities=19% Similarity=0.253 Sum_probs=115.5
Q ss_pred cccceeeccccccccC----CCcCcCCCCCCcEEEccCceeccccccch-------------hhccccCceecccccccC
Q 044366 357 SKLGTFNASMNNIYGS----IPPEIGDSSKLQVLDLSSNHIFGKIPVQL-------------VKLFSLNKLILSLNQLFG 419 (918)
Q Consensus 357 ~~L~~l~l~~n~i~~~----~~~~~~~~~~L~~L~L~~N~l~~~~~~~~-------------~~l~~L~~L~L~~N~l~~ 419 (918)
++|+.|++++|.+... +...+..+++|++|++++|.+.......+ ...+.|+.+++++|++..
T Consensus 93 ~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~L~~l~l~~n~i~~ 172 (344)
T d2ca6a1 93 PKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLEN 172 (344)
T ss_dssp TTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTG
T ss_pred CCcccccccccccccccccchhhhhcccccchheecccccccccccccccccccccccccccccCcccceeecccccccc
Confidence 3444444444444332 11223445677777777777642211111 234467778888877653
Q ss_pred CC----CCCCCCCCcccEEeccCcccccc-----CccccccccccceecccCcccCCC----CchhhccccccceEeccC
Q 044366 420 GV----PLEFGTLTELQYLDLSANKLSSS-----IPMSIGNLLKLHYLNLSNNQFSHK----IPTEFEKLIHLSELDLSH 486 (918)
Q Consensus 420 ~~----~~~~~~l~~L~~L~Ls~N~l~~~-----~~~~~~~l~~L~~L~Ls~N~l~~~----~~~~~~~l~~L~~L~Ls~ 486 (918)
.. ...+...+.|++|+|++|.|+.. +...+...++|+.|+|++|.|+.. +...+...++|++|+|++
T Consensus 173 ~~~~~l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~Ls~ 252 (344)
T d2ca6a1 173 GSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLND 252 (344)
T ss_dssp GGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTT
T ss_pred cccccccchhhhhhhhcccccccccccccccccchhhhhcchhhhcccccccccccccccccccccccccccchhhhhhc
Confidence 22 22234567888889988888632 334566778899999999987543 334567788899999999
Q ss_pred CcCCCCCchhc----c--ccCCcceEecCCCccccc----Cccccc-CCCCccEEEccCCcCCC
Q 044366 487 NILQEEIPPQI----C--KMESLEKLNLSHNNLSDF----IPRCFE-EMRSLSWIDISYNELQG 539 (918)
Q Consensus 487 N~l~~~~~~~~----~--~l~~L~~L~L~~N~l~~~----~~~~~~-~l~~L~~l~l~~N~l~~ 539 (918)
|.|++.....+ . ....|++|+|++|+|+.. +...+. +.++|+.|++++|++..
T Consensus 253 n~i~~~g~~~l~~~l~~~~~~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~L~~L~l~~N~~~~ 316 (344)
T d2ca6a1 253 CLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSE 316 (344)
T ss_dssp CCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCT
T ss_pred CccCchhhHHHHHHhhhccCCCCCEEECCCCcCChHHHHHHHHHHHccCCCCCEEECCCCcCCC
Confidence 98875433333 2 235789999999988753 233332 56789999999999864
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.45 E-value=1.1e-15 Score=164.47 Aligned_cols=42 Identities=24% Similarity=0.233 Sum_probs=20.6
Q ss_pred ccCCCCCCEEEccCCccccc----CccccCCCCCCCEEECcCCcCC
Q 044366 89 LGNLSNLALLYLNDNSLFGS----IPIVMGNLKSLSTLDLSQNQLN 130 (918)
Q Consensus 89 l~~l~~L~~L~L~~n~i~~~----~~~~~~~l~~L~~L~Ls~n~i~ 130 (918)
+...++|++|+|++|.+... ....+...++|++|++++|.++
T Consensus 89 l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~n~l~ 134 (344)
T d2ca6a1 89 LLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLG 134 (344)
T ss_dssp HTTCTTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCH
T ss_pred HhhCCCcccccccccccccccccchhhhhcccccchheeccccccc
Confidence 33445555566665555432 1222334455666666555543
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.43 E-value=3.8e-15 Score=145.30 Aligned_cols=135 Identities=23% Similarity=0.223 Sum_probs=98.7
Q ss_pred cccchhhccccCceecccccccCCCCCCCCCCCcccEEeccCccccccCccccccccccceecccCcccCCCCchhhccc
Q 044366 397 IPVQLVKLFSLNKLILSLNQLFGGVPLEFGTLTELQYLDLSANKLSSSIPMSIGNLLKLHYLNLSNNQFSHKIPTEFEKL 476 (918)
Q Consensus 397 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l 476 (918)
.+..+..+++|++|+|++|+|+.+ + .+..+++|++|+|++|.|+. ++..+..+++|+.|++++|+|+.+ ..+..+
T Consensus 40 l~~sl~~L~~L~~L~Ls~n~I~~i-~-~l~~l~~L~~L~Ls~N~i~~-i~~~~~~~~~L~~L~l~~N~i~~l--~~~~~l 114 (198)
T d1m9la_ 40 MDATLSTLKACKHLALSTNNIEKI-S-SLSGMENLRILSLGRNLIKK-IENLDAVADTLEELWISYNQIASL--SGIEKL 114 (198)
T ss_dssp CHHHHHHTTTCCEEECSEEEESCC-C-CHHHHTTCCEEECCEEEECS-CSSHHHHHHHCCEEECSEEECCCH--HHHHHH
T ss_pred hhhHHhcccccceeECcccCCCCc-c-cccCCccccChhhccccccc-cccccccccccccccccccccccc--cccccc
Confidence 345677777788888888877654 2 47778888888888888874 455555667888888888888743 457888
Q ss_pred cccceEeccCCcCCCCCc-hhccccCCcceEecCCCcccccCccc----------ccCCCCccEEEccCCcCC
Q 044366 477 IHLSELDLSHNILQEEIP-PQICKMESLEKLNLSHNNLSDFIPRC----------FEEMRSLSWIDISYNELQ 538 (918)
Q Consensus 477 ~~L~~L~Ls~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~~~----------~~~l~~L~~l~l~~N~l~ 538 (918)
++|+.|+|++|+|++... ..+..+++|+.|+|++|+++...+.. +..+|+|+.|| +.+++
T Consensus 115 ~~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~r~~vi~~lp~L~~LD--~~~I~ 185 (198)
T d1m9la_ 115 VNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD--GMPVD 185 (198)
T ss_dssp HHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHHHHHCTTTTHHHHHHHHHHHCSSCCEES--SGGGT
T ss_pred ccccccccccchhccccccccccCCCccceeecCCCccccCcccccchhhHHHHHHHHCCCcCEeC--CccCC
Confidence 888888888888875432 46788888889999888887654432 56788888876 55544
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.42 E-value=1.9e-13 Score=127.29 Aligned_cols=111 Identities=20% Similarity=0.157 Sum_probs=78.1
Q ss_pred CcccEEeccCccccccCccccccccccceecccCc-ccCCCCchhhccccccceEeccCCcCCCCCchhccccCCcceEe
Q 044366 429 TELQYLDLSANKLSSSIPMSIGNLLKLHYLNLSNN-QFSHKIPTEFEKLIHLSELDLSHNILQEEIPPQICKMESLEKLN 507 (918)
Q Consensus 429 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N-~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 507 (918)
...+.++.+++.+. ..|..+..+++|+.|++++| .|+.+.+++|.++++|+.|+|++|+|+.+.+.+|..+++|+.|+
T Consensus 8 ~~~~~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~ 86 (156)
T d2ifga3 8 HGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLN 86 (156)
T ss_dssp SSSSCEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEE
T ss_pred CCCCeEEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCccccccccccccccee
Confidence 34455677777666 34556666777777777655 47666667777777777777777777776677777777777777
Q ss_pred cCCCcccccCcccccCCCCccEEEccCCcCCCCC
Q 044366 508 LSHNNLSDFIPRCFEEMRSLSWIDISYNELQGPI 541 (918)
Q Consensus 508 L~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~ 541 (918)
|++|+|+.+.+..|..+ +|+.|+|++|+|.|.+
T Consensus 87 Ls~N~l~~l~~~~~~~~-~l~~L~L~~Np~~C~C 119 (156)
T d2ifga3 87 LSFNALESLSWKTVQGL-SLQELVLSGNPLHCSC 119 (156)
T ss_dssp CCSSCCSCCCSTTTCSC-CCCEEECCSSCCCCCG
T ss_pred ccCCCCcccChhhhccc-cccccccCCCcccCCc
Confidence 77777777666666554 5777888888877654
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.38 E-value=9.1e-13 Score=122.60 Aligned_cols=142 Identities=15% Similarity=0.162 Sum_probs=96.0
Q ss_pred CcCCeEEcccCcCcCCCCccccccCCCCeEecCCC-ccCCcCCCcCCCCCCCcEEEccCCcCcCCCCccccCCCCCCeEE
Q 044366 237 SSLRNLSLFNNRLYGFVPKEIGYLKSLSKLEFCAN-HLSGVIPHSVGNLTGLVLLNMCENHLFGPIPKSLRNLTSLERVR 315 (918)
Q Consensus 237 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~l~~n-~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~ 315 (918)
...+.++++++.+.. .|..+..+++|++|++++| .+..+.+..|.++++|+.|++++|+|+.+.+.+|.++++|++|+
T Consensus 8 ~~~~~l~c~~~~~~~-~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~ 86 (156)
T d2ifga3 8 HGSSGLRCTRDGALD-SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLN 86 (156)
T ss_dssp SSSSCEECCSSCCCT-TTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEE
T ss_pred CCCCeEEecCCCCcc-CcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCccccccccccccccee
Confidence 344556666666653 3555666677777777655 36666667777777788888888888777778888888888888
Q ss_pred eecccccCccccccCCCCCccEEeCCCCccccccCcccc-cccccceeeccccccccCCCcCcCCC
Q 044366 316 FNQNNLYGKVYEAFGDHPNLTFLDLSQNNFYCEISFNWR-NFSKLGTFNASMNNIYGSIPPEIGDS 380 (918)
Q Consensus 316 l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~-~~~~L~~l~l~~n~i~~~~~~~~~~~ 380 (918)
|++|+|+.++...|..+ +|+.|+|++|+|.|+|...|- .+.......+..+++....|..+.++
T Consensus 87 Ls~N~l~~l~~~~~~~~-~l~~L~L~~Np~~C~C~~~~l~~~~~~~~~~~~~~~~~C~~p~~l~~~ 151 (156)
T d2ifga3 87 LSFNALESLSWKTVQGL-SLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQGPLAHM 151 (156)
T ss_dssp CCSSCCSCCCSTTTCSC-CCCEEECCSSCCCCCGGGHHHHHHHHTTCSSCGGGCCCCSSSSCSSCC
T ss_pred ccCCCCcccChhhhccc-cccccccCCCcccCCchHHHHHHHHHhccCccCcCCcEECcChHHCcC
Confidence 88888888888888665 699999999999999876432 22222222333344444444444443
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.37 E-value=6.8e-15 Score=143.49 Aligned_cols=114 Identities=23% Similarity=0.274 Sum_probs=65.9
Q ss_pred cCCccccCCCCCCEEEccCCcccccCccccCCCCCCCEEECcCCcCCCcCCcCCCCCCCCceeeccccccccCCCccccc
Q 044366 84 RIPSSLGNLSNLALLYLNDNSLFGSIPIVMGNLKSLSTLDLSQNQLNGSIPCSLDNLSNLDTLFLYKNSLSGPIPSVIGN 163 (918)
Q Consensus 84 ~~p~~l~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~ 163 (918)
.+|.++..+++|++|+|++|+|+.. + .+..+++|++|+|++|+|+ .+|.....+++|++|++++|+++.+ +.+..
T Consensus 39 ~l~~sl~~L~~L~~L~Ls~n~I~~i-~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~~l--~~~~~ 113 (198)
T d1m9la_ 39 KMDATLSTLKACKHLALSTNNIEKI-S-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIASL--SGIEK 113 (198)
T ss_dssp CCHHHHHHTTTCCEEECSEEEESCC-C-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECCCH--HHHHH
T ss_pred hhhhHHhcccccceeECcccCCCCc-c-cccCCccccChhhcccccc-ccccccccccccccccccccccccc--ccccc
Confidence 3445566666666666666666532 2 3556666666666666665 2333333345566666666666643 34556
Q ss_pred ccccCeeeccccccCCcCC-ccCCCCCCCcEeeccCcccc
Q 044366 164 LKSLLQLDLSENRLSGLIP-LSLSNLSSLTVMSLFNNSLS 202 (918)
Q Consensus 164 l~~L~~L~Ls~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~ 202 (918)
+++|+.|++++|+++.+.. ..+..+++|+.|+|++|.+.
T Consensus 114 l~~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~ 153 (198)
T d1m9la_ 114 LVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLY 153 (198)
T ss_dssp HHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHH
T ss_pred cccccccccccchhccccccccccCCCccceeecCCCccc
Confidence 6666666666666665422 34555666666666666554
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.82 E-value=3.8e-10 Score=105.31 Aligned_cols=125 Identities=26% Similarity=0.164 Sum_probs=86.2
Q ss_pred cCceecccccccCCCCCCCCCCCcccEEeccCccccccCccccccccccceecccCcccCCCC--chhhccccccceEec
Q 044366 407 LNKLILSLNQLFGGVPLEFGTLTELQYLDLSANKLSSSIPMSIGNLLKLHYLNLSNNQFSHKI--PTEFEKLIHLSELDL 484 (918)
Q Consensus 407 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~--~~~~~~l~~L~~L~L 484 (918)
.+.|++++++.. ..+..+..+..++..+|.+. .++..+..+++|++|+|++|+|+.+. +..+..+++|+.|||
T Consensus 24 ~~~Ldls~l~~~----~~l~~~~~~~~l~~~~~~~~-~l~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~L 98 (162)
T d1koha1 24 QQALDLKGLRSD----PDLVAQNIDVVLNRRSSMAA-TLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNL 98 (162)
T ss_dssp SCCBCCCCCSSC----TTTTTTTCCCCTTSHHHHHH-HHHHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCC
T ss_pred hCeeecccCCCC----chhhhccchhhcchhhhHhh-hhHHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCccccccc
Confidence 444555544321 12344455555666666554 44555667889999999999998653 456788999999999
Q ss_pred cCCcCCCCCchhccccCCcceEecCCCcccccCcc-------cccCCCCccEEEccCCcCC
Q 044366 485 SHNILQEEIPPQICKMESLEKLNLSHNNLSDFIPR-------CFEEMRSLSWIDISYNELQ 538 (918)
Q Consensus 485 s~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-------~~~~l~~L~~l~l~~N~l~ 538 (918)
++|+|+...+-.+.+...|+.|+|++|++++.... .+..+|+|+.|| |+++.
T Consensus 99 s~N~i~~l~~l~~l~~~~L~~L~L~~Npl~~~~~~~~~y~~~i~~~~P~L~~LD--g~~v~ 157 (162)
T d1koha1 99 SGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISAIRERFPKLLRLD--GHELP 157 (162)
T ss_dssp TTSCCCCGGGHHHHTTCCCSSCCCTTSTTSSSSSSHHHHHHHHHTTSTTCCEET--TEECC
T ss_pred ccCccccchhhhhhhccccceeecCCCCcCcCcccchhHHHHHHHHCCCCCEEC--cCCCc
Confidence 99999876554555566799999999999875442 366789999875 66553
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.56 E-value=3.7e-09 Score=98.45 Aligned_cols=88 Identities=23% Similarity=0.121 Sum_probs=43.3
Q ss_pred CCCCCCceeeccccccccCCCcccccccccCeeeccccccCCcCC--ccCCCCCCCcEeeccCcccccCCCccccCCCCc
Q 044366 138 DNLSNLDTLFLYKNSLSGPIPSVIGNLKSLLQLDLSENRLSGLIP--LSLSNLSSLTVMSLFNNSLSGSIPPILGNLKSL 215 (918)
Q Consensus 138 ~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L 215 (918)
..+..+..+...++... .++..+..+++|++|+|++|+|+.+.+ ..+..+++|+.|+|++|.|+...+-.+....+|
T Consensus 39 ~~~~~~~~l~~~~~~~~-~l~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~L 117 (162)
T d1koha1 39 VAQNIDVVLNRRSSMAA-TLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKL 117 (162)
T ss_dssp TTTTCCCCTTSHHHHHH-HHHHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCCC
T ss_pred hhccchhhcchhhhHhh-hhHHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccccchhhhhhhcccc
Confidence 33344444444444433 333444556666666666666665432 234445566666666666554322222233344
Q ss_pred ceeeccccccc
Q 044366 216 STLGLHINQLN 226 (918)
Q Consensus 216 ~~L~L~~n~l~ 226 (918)
+.|++++|.+.
T Consensus 118 ~~L~L~~Npl~ 128 (162)
T d1koha1 118 EELWLDGNSLS 128 (162)
T ss_dssp SSCCCTTSTTS
T ss_pred ceeecCCCCcC
Confidence 55555555544
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.30 E-value=1.5e-06 Score=87.82 Aligned_cols=149 Identities=13% Similarity=0.072 Sum_probs=102.5
Q ss_pred HHHHHhcCCCCceeeccccceEEEEEEeCCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhcc-CCceeeEecccccC
Q 044366 640 EITKATGNFGEKYCIGKGGQRSVYKAELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIR-HRNIIKFHGFCSNA 718 (918)
Q Consensus 640 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~ 718 (918)
++......|+..+..+.++.+.||+... +++.+.+|+.... .......+.+|...++.+. +--+.+++.+..++
T Consensus 8 ~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~----~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~ 82 (263)
T d1j7la_ 8 ELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSR----YKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHD 82 (263)
T ss_dssp HHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGG----GTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEET
T ss_pred HHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCC----cccchhhHHHHHHHHHHHhccCCCCcEEEEEecC
Confidence 5556666776666555555678999875 5666788876543 2222345678888887774 44467778888888
Q ss_pred CceEEEEEeccCCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHhCCC----------------------------
Q 044366 719 QHSFIVCEYLARGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHHDCI---------------------------- 770 (918)
Q Consensus 719 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~---------------------------- 770 (918)
+..++||+++++.++.+..... .....++.++++.++.||+...
T Consensus 83 ~~~~lv~~~l~G~~~~~~~~~~--------~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (263)
T d1j7la_ 83 GWSNLLMSEADGVLCSEEYEDE--------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVD 154 (263)
T ss_dssp TEEEEEEECCSSEEHHHHTTTC--------SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCC
T ss_pred CceEEEEEeccccccccccccc--------ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhh
Confidence 8899999999998876654321 1123356666667777775210
Q ss_pred ----------------------------CCeEEcCCCCCCeeeCCCCcEEEeccccccc
Q 044366 771 ----------------------------PPIVHRDISSKNVLLDSEYEAHVSDFGFAKF 801 (918)
Q Consensus 771 ----------------------------~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~ 801 (918)
+.++|+|+.|.||++++++.+.|+||+.+..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 155 CENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp GGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred hhcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 1378999999999999876677999997763
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.93 E-value=2e-06 Score=79.89 Aligned_cols=109 Identities=19% Similarity=0.235 Sum_probs=64.3
Q ss_pred CCcccEEeccCc-ccccc----CccccccccccceecccCcccCCC----CchhhccccccceEeccCCcCCCCC----c
Q 044366 428 LTELQYLDLSAN-KLSSS----IPMSIGNLLKLHYLNLSNNQFSHK----IPTEFEKLIHLSELDLSHNILQEEI----P 494 (918)
Q Consensus 428 l~~L~~L~Ls~N-~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~~----~ 494 (918)
.++|++|+|+++ .++.. +...+...+.|+.|+|++|.+... +...+...+.|++|+|++|.|++.. .
T Consensus 14 ~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l~ 93 (167)
T d1pgva_ 14 DTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLL 93 (167)
T ss_dssp CSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHH
T ss_pred CCCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHHHH
Confidence 356777777653 35421 223444556677777777776532 2233445567777777777776432 2
Q ss_pred hhccccCCcceEecCCCccccc-------CcccccCCCCccEEEccCCc
Q 044366 495 PQICKMESLEKLNLSHNNLSDF-------IPRCFEEMRSLSWIDISYNE 536 (918)
Q Consensus 495 ~~~~~l~~L~~L~L~~N~l~~~-------~~~~~~~l~~L~~l~l~~N~ 536 (918)
..+...++|++|+|++|++..+ +...+...++|+.|+++++.
T Consensus 94 ~aL~~n~sL~~L~l~~n~~~~~g~~~~~~l~~~L~~n~sL~~l~l~~~~ 142 (167)
T d1pgva_ 94 RSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFAS 142 (167)
T ss_dssp HHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCC
T ss_pred HHHHhCCcCCEEECCCCcCCCccHHHHHHHHHHHHhCCCccEeeCcCCC
Confidence 3345556778888877765542 33445556778888776654
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.86 E-value=1.5e-05 Score=79.67 Aligned_cols=131 Identities=14% Similarity=0.121 Sum_probs=85.5
Q ss_pred eeccccc-eEEEEEEeCCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccC--CceeeEecccccCCceEEEEEecc
Q 044366 653 CIGKGGQ-RSVYKAELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRH--RNIIKFHGFCSNAQHSFIVCEYLA 729 (918)
Q Consensus 653 ~lg~G~~-g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~~~~~~~~~~~~~lv~e~~~ 729 (918)
.+..|.. +.||+....++..+.+|..... ....+..|...++.+.. -.+.+++++..+++..++||+|++
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~-------~~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~ 89 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSG-------ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVP 89 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSC-------TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCS
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCcc-------CHhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeee
Confidence 3555554 6789998888888889975432 12346778888877743 335677888888888999999998
Q ss_pred CCChhHHhhcccccCCCCHHHHHHHHHHHHHHHHHHHh------------------------------------------
Q 044366 730 RGSLTTILRDDAAAKEFSWNQRMNVIKGVANALSYLHH------------------------------------------ 767 (918)
Q Consensus 730 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~------------------------------------------ 767 (918)
|.++.+.- .+. ...+.++++.++-||+
T Consensus 90 G~~~~~~~--------~~~---~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (255)
T d1nd4a_ 90 GQDLLSSH--------LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAP 158 (255)
T ss_dssp SEETTTSC--------CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCH
T ss_pred cccccccc--------ccH---HHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHH
Confidence 86653311 010 1112223333333332
Q ss_pred ---------CC----CCCeEEcCCCCCCeeeCCCCcEEEeccccccc
Q 044366 768 ---------DC----IPPIVHRDISSKNVLLDSEYEAHVSDFGFAKF 801 (918)
Q Consensus 768 ---------~~----~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~ 801 (918)
.. .+.++|+|+.|.||+++++..+.|+||+.+..
T Consensus 159 ~~~~~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 159 AELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp HHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence 21 12479999999999999876678999997753
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.69 E-value=3.8e-06 Score=77.90 Aligned_cols=87 Identities=16% Similarity=0.154 Sum_probs=52.0
Q ss_pred CCCcccEEeccCcccccc----CccccccccccceecccCcccCCCC----chhhccccccceEeccCCcCCCC------
Q 044366 427 TLTELQYLDLSANKLSSS----IPMSIGNLLKLHYLNLSNNQFSHKI----PTEFEKLIHLSELDLSHNILQEE------ 492 (918)
Q Consensus 427 ~l~~L~~L~Ls~N~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~~----~~~~~~l~~L~~L~Ls~N~l~~~------ 492 (918)
..+.|++|+|++|.++.. +...+...+.|+.|+|++|.|+... -.++...+.|++|+|++|.+...
T Consensus 42 ~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l~~aL~~n~sL~~L~l~~n~~~~~g~~~~~ 121 (167)
T d1pgva_ 42 NSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQRQSVLGNQVEM 121 (167)
T ss_dssp TCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCCSSCCCCHHHHH
T ss_pred hCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHHHHHHHHhCCcCCEEECCCCcCCCccHHHHH
Confidence 345677777777766532 2233445567777777777775432 22344456677777777765432
Q ss_pred -CchhccccCCcceEecCCCcc
Q 044366 493 -IPPQICKMESLEKLNLSHNNL 513 (918)
Q Consensus 493 -~~~~~~~l~~L~~L~L~~N~l 513 (918)
+...+...++|+.|+++.+..
T Consensus 122 ~l~~~L~~n~sL~~l~l~~~~~ 143 (167)
T d1pgva_ 122 DMMMAIEENESLLRVGISFASM 143 (167)
T ss_dssp HHHHHHHHCSSCCEEECCCCCH
T ss_pred HHHHHHHhCCCccEeeCcCCCc
Confidence 233444567788888876644
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.38 E-value=0.00029 Score=74.68 Aligned_cols=79 Identities=15% Similarity=0.032 Sum_probs=50.5
Q ss_pred eeeccccceEEEEEEeC-CCCEEEEEEccccccc---CCCCChHHHHHHHHHHhhcc-C--CceeeEecccccCCceEEE
Q 044366 652 YCIGKGGQRSVYKAELP-SGNIFAVKKFKAELFS---DETANPSEFLNEVLALTEIR-H--RNIIKFHGFCSNAQHSFIV 724 (918)
Q Consensus 652 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~~~~~e~~~l~~l~-h--~niv~~~~~~~~~~~~~lv 724 (918)
+.||.|....||++... +|+.|+||.-...... .......+...|.+.++.+. + ..+++++.+ +++..++|
T Consensus 32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~lv 109 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV 109 (392)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEEE
Confidence 46899999999999765 4678999975432111 12233455667888887763 2 345666655 34556899
Q ss_pred EEeccCCC
Q 044366 725 CEYLARGS 732 (918)
Q Consensus 725 ~e~~~~gs 732 (918)
|||+++..
T Consensus 110 mE~L~~~~ 117 (392)
T d2pula1 110 MEDLSHLK 117 (392)
T ss_dssp ECCCTTSE
T ss_pred EeccCCcc
Confidence 99997653
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=97.36 E-value=2e-05 Score=72.79 Aligned_cols=109 Identities=11% Similarity=0.172 Sum_probs=63.2
Q ss_pred CCcccEEeccC-cccccc----CccccccccccceecccCcccCCCC----chhhccccccceEeccCCcCCCC----Cc
Q 044366 428 LTELQYLDLSA-NKLSSS----IPMSIGNLLKLHYLNLSNNQFSHKI----PTEFEKLIHLSELDLSHNILQEE----IP 494 (918)
Q Consensus 428 l~~L~~L~Ls~-N~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~~----~~~~~~l~~L~~L~Ls~N~l~~~----~~ 494 (918)
.+.|++|+|++ +.|+.. +...+...+.|+.|+|++|.++... ...+...+.++.+++++|.++.. +.
T Consensus 16 ~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~l~ 95 (166)
T d1io0a_ 16 DPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALV 95 (166)
T ss_dssp CTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHH
T ss_pred CCCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHHHHH
Confidence 45666777765 345421 2233445666777777777665332 22344556777777777776533 22
Q ss_pred hhccccCCcceEec--CCCcccc----cCcccccCCCCccEEEccCCc
Q 044366 495 PQICKMESLEKLNL--SHNNLSD----FIPRCFEEMRSLSWIDISYNE 536 (918)
Q Consensus 495 ~~~~~l~~L~~L~L--~~N~l~~----~~~~~~~~l~~L~~l~l~~N~ 536 (918)
..+...++|+.++| ++|.+.. .+...+...++|+.|++++|+
T Consensus 96 ~~l~~~~~L~~l~L~l~~n~i~~~~~~~La~~L~~n~~L~~L~l~~~~ 143 (166)
T d1io0a_ 96 EALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQ 143 (166)
T ss_dssp HGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSS
T ss_pred HHHHhCccccEEeeccCCCcCcHHHHHHHHHHHHhCCCcCEEeCcCCC
Confidence 44556667765444 4666654 234455567778888877664
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=97.00 E-value=3.5e-05 Score=71.14 Aligned_cols=89 Identities=17% Similarity=0.173 Sum_probs=56.5
Q ss_pred CCCCCcccEEeccCcccccc----CccccccccccceecccCcccCCC----CchhhccccccceEec--cCCcCCCC--
Q 044366 425 FGTLTELQYLDLSANKLSSS----IPMSIGNLLKLHYLNLSNNQFSHK----IPTEFEKLIHLSELDL--SHNILQEE-- 492 (918)
Q Consensus 425 ~~~l~~L~~L~Ls~N~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~----~~~~~~~l~~L~~L~L--s~N~l~~~-- 492 (918)
+...++|++|+|++|.++.. +...+...++++.|++++|.++.. +...+...++|+.++| ++|.+...
T Consensus 42 l~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~l~~~l~~~~~L~~l~L~l~~n~i~~~~~ 121 (166)
T d1io0a_ 42 LKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGNNVE 121 (166)
T ss_dssp HTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHH
T ss_pred HhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHHHHHHHHHhCccccEEeeccCCCcCcHHHH
Confidence 34556777888888877642 223445667788888888877533 2234556677776444 56667542
Q ss_pred --CchhccccCCcceEecCCCcc
Q 044366 493 --IPPQICKMESLEKLNLSHNNL 513 (918)
Q Consensus 493 --~~~~~~~l~~L~~L~L~~N~l 513 (918)
+...+...+.|+.|+++.|..
T Consensus 122 ~~La~~L~~n~~L~~L~l~~~~~ 144 (166)
T d1io0a_ 122 MEIANMLEKNTTLLKFGYHFTQQ 144 (166)
T ss_dssp HHHHHHHHHCSSCCEEECCCSSH
T ss_pred HHHHHHHHhCCCcCEEeCcCCCC
Confidence 344455678888888877754
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.97 E-value=0.0014 Score=67.22 Aligned_cols=136 Identities=13% Similarity=0.163 Sum_probs=78.8
Q ss_pred ceEEEEEEeCCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCce--eeEec-----ccccCCceEEEEEeccCC
Q 044366 659 QRSVYKAELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNI--IKFHG-----FCSNAQHSFIVCEYLARG 731 (918)
Q Consensus 659 ~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni--v~~~~-----~~~~~~~~~lv~e~~~~g 731 (918)
.-.||+++.++|+.|++|+.+.. ....+++..|...+..+....+ +..+. ....++..+.+++|++|.
T Consensus 35 EN~vy~v~~~dg~~~VlK~~rp~-----~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~ 109 (325)
T d1zyla1 35 ENRVYQFQDEDRRRFVVKFYRPE-----RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGR 109 (325)
T ss_dssp SSEEEEECCTTCCCEEEEEECTT-----TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCE
T ss_pred cceeEEEEcCCCCEEEEEEeCCC-----CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCc
Confidence 45799999999999999997652 3346778889988888753322 22221 123345678899998764
Q ss_pred Chh-----HHh---------hc----cc--ccCCCCH-------------------HHHHHHHHHHHHHHHHHHh----C
Q 044366 732 SLT-----TIL---------RD----DA--AAKEFSW-------------------NQRMNVIKGVANALSYLHH----D 768 (918)
Q Consensus 732 sL~-----~~l---------~~----~~--~~~~l~~-------------------~~~~~i~~~i~~~l~~LH~----~ 768 (918)
.+. .+- +. .. .....++ .....+...+.+.++.+.. .
T Consensus 110 ~~~~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~ 189 (325)
T d1zyla1 110 QFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWRED 189 (325)
T ss_dssp ECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSC
T ss_pred CCCCCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhcccc
Confidence 321 110 00 00 0011111 1111122222333333322 2
Q ss_pred CCCCeEEcCCCCCCeeeCCCCcEEEeccccccc
Q 044366 769 CIPPIVHRDISSKNVLLDSEYEAHVSDFGFAKF 801 (918)
Q Consensus 769 ~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~~ 801 (918)
...++||+|+.+.||+++++ ..++||+-++.
T Consensus 190 ~p~~liHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 190 FTVLRLHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp SCCEECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred CCceeecCCCCcccEEEeCC--ceEEechhccc
Confidence 23478999999999999754 45899998864
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=95.82 E-value=0.018 Score=60.41 Aligned_cols=72 Identities=18% Similarity=0.179 Sum_probs=48.5
Q ss_pred eeeccccceEEEEEEeCCC--------CEEEEEEcccccccCCCCChHHHHHHHHHHhhcc-CCceeeEecccccCCceE
Q 044366 652 YCIGKGGQRSVYKAELPSG--------NIFAVKKFKAELFSDETANPSEFLNEVLALTEIR-HRNIIKFHGFCSNAQHSF 722 (918)
Q Consensus 652 ~~lg~G~~g~Vy~~~~~~~--------~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~ 722 (918)
+.|+.|-.-.+|++..+++ +.|.+++.-. ........+|..+++.+. +.-..++++++.+ +
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~------~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g 117 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN------PETESHLVAESVIFTLLSERHLGPKLYGIFSG----G 117 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS------CCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----E
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC------cchhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----c
Confidence 4688888899999976543 4566665431 223445678888888884 4334577777653 6
Q ss_pred EEEEeccCCCh
Q 044366 723 IVCEYLARGSL 733 (918)
Q Consensus 723 lv~e~~~~gsL 733 (918)
+|+||+++.++
T Consensus 118 ~I~efi~g~~l 128 (395)
T d1nw1a_ 118 RLEEYIPSRPL 128 (395)
T ss_dssp EEECCCCEEEC
T ss_pred eEEEEeccccC
Confidence 89999987544
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=95.70 E-value=0.024 Score=57.37 Aligned_cols=159 Identities=12% Similarity=0.086 Sum_probs=84.1
Q ss_pred ccCHHHHHHHhcCCCCcee-----eccccceEEEEEEeCCCCEEEEEEcccccccCCCCChHHHHHHHHHHhhccCCce-
Q 044366 635 KVLYEEITKATGNFGEKYC-----IGKGGQRSVYKAELPSGNIFAVKKFKAELFSDETANPSEFLNEVLALTEIRHRNI- 708 (918)
Q Consensus 635 ~~~~~~~~~~~~~~~~~~~-----lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni- 708 (918)
.++.++++....+|...+. |..|.--+.|+.+..+|+ +++|++... ...++...|++++..+....+
T Consensus 2 ~ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g~-yVLri~~~~------~~~~~l~~~~~~l~~L~~~g~p 74 (316)
T d2ppqa1 2 DITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDP-LILTLYEKR------VEKNDLPFFLGLMQHLAAKGLS 74 (316)
T ss_dssp CCCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCC-EEEEEECC---------CCHHHHHHHHHHHHHHTTCC
T ss_pred CCCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCCc-EEEEEcCCC------CCHHHHHHHHHHHHhhhhcccc
Confidence 3556778888888876543 446666788999876665 889987542 112445566777777643322
Q ss_pred -eeEecc------cccCCceEEEEEeccCCChhHH-----------h---hcc----c--ccCCCC--------------
Q 044366 709 -IKFHGF------CSNAQHSFIVCEYLARGSLTTI-----------L---RDD----A--AAKEFS-------------- 747 (918)
Q Consensus 709 -v~~~~~------~~~~~~~~lv~e~~~~gsL~~~-----------l---~~~----~--~~~~l~-------------- 747 (918)
...+.. ....+..+.++.+..+...... + +.. . ......
T Consensus 75 vp~pi~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (316)
T d2ppqa1 75 CPLPLPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEER 154 (316)
T ss_dssp CCCBCCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGG
T ss_pred ccccceecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHh
Confidence 211111 1223445667777665422110 0 000 0 000000
Q ss_pred ----HHHHHHHHHHHHHHHHHHHh-CCCCCeEEcCCCCCCeeeCCCCcEEEecccccc
Q 044366 748 ----WNQRMNVIKGVANALSYLHH-DCIPPIVHRDISSKNVLLDSEYEAHVSDFGFAK 800 (918)
Q Consensus 748 ----~~~~~~i~~~i~~~l~~LH~-~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~~~ 800 (918)
.......+..+...+...+. ..+.|+||+|+.+.||+++++...-+.||+.+.
T Consensus 155 ~~~~~~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 155 ADEVEKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp GGGTSTTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhhcchhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 01111122222222222222 123489999999999999988777899999886
|